patient_id,text,t_label,n_label,m_label,tnm_label
TCGA-JX-A3PZ,"Addre Internal #: 1GOs. UTERUS, CERVIX, HYSTERECTOMY. - MODERATELY DIFFERENTTATED SQUAMOUS CELT CARCINOMA (5 CM. IN GREATEST DIMENSION) r INVADING 5 MM INTO A 20 MM THICK. CERVIX, WITH PROMINENT VASCULAR SPACE INVASION. (SEE COMMENT). 7808. UTERUS, RADICAL HYSTERECTOMY - PROLTFERATIVE PATTERN. - NO TUMOR IDENTIFIRO. UTERUS, MYOMETRIUM, RADICAL HYSTTERECTOMY - NO TUMOR IDENTIFIED. VAGINA, RADICAL HYSTERECTOMY - NO TUMOR IDENTIFIED. PARAMETRIAL TISSUES, RADICAL HYSTEREC/OMY - NO TUMOR IDENTIFIED. LYMPH NODES (2), PARAMETRIAL, RADICAL HYSTEREICTOMY. - NO TUMOR IDENTIFIED IN 2 LYMPH NODES. LYMPH NODES (4), RIGHT EXTERNAL ILIAC, BIOPSY. NO TUMOR IDENTIFIED IN 4 LYMPH NODES. LYMPH NODES (8), LEFT EXTERNAL ILIAC, BIOPSY. - NO TUMOR IDENTIFIED IN A LYMPH NODES. LYMPH NODES, (2), LEFT OBTURATOR, BIOPSY. - NO TUMOR IDENTIFIED IN ? LYMPH NODES. LYMPH NODES, (4), RIGHT OBTURATOR, BIOPSY. - NO TUMOR IDENTIFIED IN 4 LYMPY NODES. 1958. LYMPH NODE (1), LEFT COMMON, BIOPSY. - NO TUMOR IDENTIFIED IN 1 LYMPH NODE. LYMPH NODE (1), PERIAORTIC, BIOPSY. - NO TUMOR IDENTIFIES IN 1. LYMPR NODE. --1-- - heratinizing, NOS. MOG. SPECIMEN (s) SUBMITTED. Part 1: FS1-LYMPH NODE, LEFT EXTERNAL. Part 3: FS2-LYMPA NODE, JEFT OBTURATOR. Part. 3: PS3-LYMPH NODE, RIGHT EXTERNAL. Part 4: FS4-LYMPH NODE, RIGHT OBTURATOR. Part 5: UTERUS, CERVIX. Part 6: LEFT EXTERNAL ILIAC NODES. Part 7: LEFT OBTURATOR LYMPH NODES. Part 8 : LEFT COMMON LYMPH NODES. Part 9: RIGHT EXTERNAL ILIAC LYMPH NODES. Part 10: RIGHT OBTURATOR LYMPH NODES. Part 11: PER1-AORTIC LYMPH NODES. HISTORY. The patient is a. year old woman with cervical carcinom-. Clinical diagnosis: Cervical carcipoma. Operative procedure and. findings: Radical hysterectomy. An intraoperative non-microscopic. consultation was obtained and interpreted as: ""Utners, called to. O.R. to examine radical hysterectomy specimen. Inked; bivalved. Tumor saved for. tissue bank. Specimen placed in formalin. FROZEN. FSI: txxph node, left external iliac, biopsy. - ""No evidence of metastatio carcinoma, "". Tymph node, left obturator, biopay. ""No evidence of metastatio carcipoma, "". FS3: Lymph node, right external lise, biopsy. - ""No evidence of metastatic careinoma,"". FS4: Lymph node, right obturator, biopsy. ""No evidence of metastatic carcinoma, "". CROSS. The specimensiark received in eleven consiners of formalin. each. inhelled with the patient's name, The first container is Tabeled. ""I.. external podes FS1, and contains lymph note. fragments. Labelen FSI. Jar 0. --2--. GROSS (continued). The second container is labeled ""FS2, L. obturator lymph nodes, "". and contains two 1.0 cm lymph node fragments. Labeled FS2. Jar a. The third container is labeled ""FS3, R. external iliac lymph. node, and contains a single 1.2 cm lymph node. LAbeled FS3. Jar. The fourth container is labeled ""L. external iliac nodes for. permanents, and contains a 4.0 x 3. o x 3.0 cm aggregate of. fibrofatty tissue with two lymph nodes. Blocks submitted. A1 -. 1886. one node all; A2 - one node bisected all. Jar 1. The fifth container is labeled ""I, obturator lymph nodes for. permanents, and contains a 2.0 x 2.0 x 2.0 cm aggregate of shiny. tan tissue fragments and yellow fibroadipose tissue with no. grossly identifiable lymph node tissue. Labeled B1. Jar o. The sixth container is labeled ""L. common lymph nodes, and. contains a 1.0 x 1.0 x 1.0 cm aggregate of yellow fibroadipose. tissue and shiny tan, serosal tissue. No lymph nodes are seen. grossly. Labeled C1 and C2. Jar 0. The seventh container is labeled ""R. external iliac lymph nodes, "". and contains a 4.0 x 4.0 x 4.0 cm aggregate of fibrofatty tissue. with two 1.2 cm lymph nodes. Labeled D1 and D2. Jar 1. The eighth container is labeled ""R. obturator lymph nodes,. and contains two 0,2 cm fragments of lymph node tissue. Labeled. FS4. Jar 0. The ninth container is labeled ""R. obturator lymph nodes for. permanent, and contains a 3.0 x 3.0 x 3.0 cm aggregate of. fibrofatty tissue with two lymph nodes. Blocks submitted. E1. one node bisected all; E2 - one node bisected all. Jar 1. PRBA. The tenth container is labeled ""periaortic lymph node, and. contains a single 1.8 cm lymph node with attached fibrofatty. tissue. Labeled F1. The eleventh container is labeled ""uterus, cervix, and contains. 92. o grams radical hysterectomy specimen. The cervical as is. markedly dilated by a 5.0 x 3.5 x 3.0 cm fungating excphytic firm. mass. The outer surface of the mass in covered with shaggy tan. and maroon necrotic-appearing tissue, while the cut surface is. uniformly firm and white. The majority of the tumor is tethered. to the posterior cervical wall from the 3 to 9 o'clock position. 1108. 808. GROSS (continued). A 2.5 x 1.5 x 1.0 cm nodule is present at the 12 'clock position,. possibly representing direct extension from the main tumor mass at. 6 o'clock. The tumor does not grossly invade the cervical stroma,. the generous 1.0 to 1.5 cm rim of vaginal cuff present on the. BAR. posterior portion of the specimen, or the 1.5 to 2. em rim of. vaginal cuff present on the anterior half of the specimen. The. 3.0 x 2.0 x 1.0 cm and 2.5 x 2.1 x 1.0 cm swaths of paracervical. soft tissue on the right and left sides of the specimen,. respectively, are similarly uninvolved by tumor. The uterine. fundus has a length of 5.5 cm, a maximal width of 4.0 cm, and a. maximal dimension of 2. cm. It i.s covered by glistening tan. serosa which shows no evidence of involvement by tumor. The myometrium ranges in thickness from 1.0 cm at the level of. lower uterine segment to 1.8 cm at the level of mid fundus. It. is. red-brown and firm and displays no lesions. The endometrium. BGR. displays uniform thickness of 0.2 cm. It is composed of the usual. tan velvety tissue with no focal lesions. Blocks submitted: CX1. and CX2 - contiguous section of cervix at 6 o'clock; CX3 and CX4. contiguous sections of cervix at 9 o'clock; CX5 and CX6 -. contiguous sections of cervix at 3 o'clock; CX7 and CX8. contiguous sections of cervix at 12 RP1 through RP3 -. right parametrial tissues, all; LP1 through LP3 - left parametrial. tissues, all; EM1 and EM2 - full thickness sections of. endometrium and myometrium. Jar 3. COMMENT. HRG. Histologic sections of the cervical tumor show that it is composed. of large nests of moderately dif.ferentiated stuamous cell. carcinoma with focal keratinisation. In some areas the neoplastic. squamous cells display prominent cytoplasmic clearing, a feature. which was appreciated on this patient's prior biopsy. The growth pattern of the tumor is almost entirely exophytic, a. feature which makes measurement of the depth of invision. difficult. However, the lesion clearly invades the cervical. stroma. The point of deepest invasion occurs at the posterior. cervix (5:00 o'clock), where the tumor invades to a depth of 5 mm. in a 20 mm thick cervix. There is no paracervical soft tissue. present on the posterior cervical wall at this point and the. serosal surface of the cervix therefore represents the margin of. resection. Thus; the most deeply invasive tumor is 15 ram from the. deep surgical resection margin. Prominent vascolar space invasion. is seen. No tumor is identified in the uterine corpus, the vagina,. or the parametrial tissues. Similarly, no tumor is identified in. the 22 regional lymph nodes examined, including two parametrial. --4--. GROB. COMMENT (continued). lymph nodes. Selected slides from this case were reviewed by Dr. who concurs that this neoplasm represents a squamous cell. carcinoma of the cervix. SYNOPTIC REPORTING FORM FOR UTERINE CERVICAL NEOPLASMS. 1a. A neoplasm is PRESENT. 2. The HISTOLOGIC DIAGNOSIS is: squamous cell (epidermoid) carcinoma, invasive type. Keratinizing subtype (. FRBO. 3. The MAXIMUM DEPTH OF TUMOR INVASION is 5 mm. (. 4. The BREADTH (MAXIMUM HORIZONTAL DIMENSION) OF THE TUMOR. 50 mm. 5. The TOTAL THICKNESS OF THE CERVIX is 20 mm. 6. Lymphatic invasion by tumor IS identified and is. WIDESPREAD. (UT3A). The NUCLEAR GRADE of the tumor is: 2. (Moderately-differentiated. The tumor DOES NOT invade through the entire thickness. of the cervix to involve contiguous parametrial. tissues. 9. The tumor DORS NOT involve the uterine corpus. ando. The tumor DOES NOT involve the vagina. Metastasis to regional lymph nodes is ABSENT. 12. The total number of metastatically-involved nodes is 0. 13. The total number of regional nodes examined is 22. (. Extracapsular extension of metastatic tumor through the. lymph node capsule is NOT APPLICABLE; NO METASTASIS. IS SEEN. 15. DETAILED STAGING INFORMATION: A. TUMOR GROWTH: THE PRIMARY NEOPLASM IS CLASSIFIED AS: TNM SCHEME. FIGO SCHEME. DEFINITION. IB. Tumor confined to uterus. but larger than T1a2/ IA2. 8880. REGIONAL LYMPH NODES are classified as: NO (Regional nodes are NOT involved by metastanis). C. DISTANT METASTASES: The status of distant tissues is: M0 (Distant metastases are repontedly absent). 15. THE FINAL STAGE OF THE TUMOR IS: AJCC SCHEME. FIGO SCHEME. 1b. IB. The pathologic stage assigned here should be regarded as. provisional, and may change after integration of clinical. data not provided with this specimen. --5--.",T1,N0,M0,T1N0M0
TCGA-A3-3317,"Laboratory Patient Report. Print Date/Time : Surgical Pathol. Histopathological Examination. Complete : Pre-Op - Diagnosis : Left Renal Mass. Specimens. : Kidney, Left. Frozen Diagnosis. GROSS EXAMINATION. The specimen is received in a container labeled with the. name of the patient and labeled as kidney, left. The. specimen consists of a kidney and attached perinephric fat. which measures en bloc 24 X 14 X 10 cm and weighs 1709 g. The ureter and vascular margins of resection are submitted. in block 1. The lower pole and midportion of the kidney. shows a large golden yellow mass measuring 12. 0 X 9.0 X 7.0. cm. The mass grossly bulges against the capsule and is. focally adherent to the capsule. Sections of the capsule. adjacent to the mass are submitted in block 2. The kidney. stripped of capsule and fat measures 13.5 X 11.0 X 7.0 cm. and weighs 542 g. Sections of the mass are submitted in. block 3-8. Sections of the renal sinus are submitted in. blocks 9-10. The pelvis and calices are not grossly. dilated. The cortex averages 0. cm. A random section of. kidney is submitted in block 11. Sectioning through the. attached fat shows an adrenal gland measuring 8.0 x 2.5 X. F. Representative sections are submitted in block 12. MICROSCOPIC EXAMINATION: Multiple sections of kidney shows a renal cell carcinoma. with clear cell features, moderately rell-differentiated. consistent with a Fuhrman grade 2 forming a tumor mass that. by description measures up to 12 cm greatest diameter. Sections of the capsule show no apparent adherence of the. tumor to the capsule or in the surrounding pericapsular. adipose tissue. Both the ureter and vascular margins are. free of tumor. No definite blood vessel invasion by the. tumor could be seen. Section of the area of the renal sinus. is negative for tumor and the pelvis of the kidney and. bordering ureter is also negative. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. of 2. DIAGNOSIS BASED ON GROSS AND MICROSCOPIC EXAMINATION : Left kidney, radical nephrectomy, left: Renal cell. carcinoma, clear cell type, Fuhrman grade 2, 12 cm greatest. diameter. No invasion of capsule, no blood vessel invasion identified. with ureter and vascular margin of resection free of tumor. Renal sinus free of tumor. Adrenal gland, benign. Pathologic stage pT2, NX, MX provisional stage II. [T-71000 4-83103 189.0 P3-44070]. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. of 2.",T2,N0,M0,T2N0M0
TCGA-CJ-4643,"DIAGNOSIS. (A) RIGHT KIDNEY AND ADRENAL GLAND: RENAL CELL CARCINOMA, CONVENTIONAL (90% CLEAR CELLS AND 10% EOSINOPHILIC CELLS),. FURHMAN'S NUCLEAR GRADE 3. TUMOR CONFINED TO KIDNEY. TUMOR MEASURES 9.5 CM IN GREATEST DIMENSION. Vascular, ureteral and soft tissue margins of resection free of tumor. Adrenal gland with nodular cortical hyperplasia. GROSS DESCRIPTION. (A). RIGHT KIDNEY AND ADRENAL GLAND - A nephrectomy specimen (22.0 x 13.5 x 6,3 cm) including the right kidney (13.0x 5.5 x. 4.0 cm), a segment of the renal artery, the renal vein, two ureters (7.5 and 12.0 cm in length x approximately 0.4 cm in average. diameter), and the adrenal gland (0.6 x 3.7 x 1.8 cm). There is a 9.5 x 7.2 x 6.0 cm well-circumscribed tumor in the mid portion of the kidney. Centrally, the tumor has a myxoid appearance. with a focus of calcification; the periphery is orange-yellow and slightly friable. There are no definitive areas of hemorrhage or. recrosis. The tumor pushes onto the renal pelvis but does not invade it. There is no extention into the adipose tissue, renal sinus,. unal vein, or Gerota's fascia. The. adjacent kidney parenchyma is unremarkable. The pelvicalyceal system is smooth and devoid of any lesions. One possible hilar. lymph node measures 1.7 x 0.9 x 0.9 cm. Serial cross sections of the adrenal gland show an enlarged cortex measuring 0.5 cm. The remainder of the adrenal gland is. unremarkable. Portions of tumor have been submitted for possible electron microscopy and to the tumor bank. INK CODE: Black - Gerota's fascia and capsule nearest tumor. SECTION CODE: A1, both ureters, renal artery, and renal vein margins, en face; A2, enlarged portion of adrenal gland; A3, kidney,. representative sections; A4-A5, tumor within pelvis; A6-A8, tumor with inked capsule; A9-A10, tumor with adjacent kidney; A11, tumor;. A12, representative sections of Gerota's fascia overlying tumor; A13, one possible lymph node; A14, tumor with sinus;. A15,. tumor. with. pelvis; A16, adrenal gland, representative section. CLINICAL HISTORY. Right renal mass. 1.",T2,N0,M0,T2N0M0
TCGA-AO-A0J3,"Clinical Diagnosis & History: Right breast cancer with axillary positive FNA. Specimens Submitted: 1: SP: Right breast and axillary contents level 1 and 2. 2: SP:Additional level one lymph node , right axilla. DIAGNOSIS: 1. BREAST, RIGHT; MODIFIED RADICAL MASTECTOMY: - MULTIPLE FOCI INVASIVE DUCTAL CARCINOMA WITH NEUROENDOCRINE. DIFFERENTIATION, HISTOLOGIC GRADE III/III (SLIGHT OR NO TUBULE FORMATION). NUCLEAR GRADE III/III (MARKED VARIATION IN SIZE AND SHAPE) RANGING IN SIZE. FROM 0.1 CM TO 4.2 CM. - THERE IS A DOMINANT TUMOR MASS WHICH MEASURES 4.2 CM IN GREATEST DIMENSION. WITH MULTIPLE SATELLITE NODULES SPANNING AN AREA OF 9.0 CM. - DUCTAL CARCINOMA IN-SITU (DCIS) IS ALSO IDENTIFIED, SOLID, FLAT/CLINGING,. MICROPAPILLARY, AND CRIBRIFORM TYPES WITH INTERMEDIATE TO HIGH NUCLEAR GRADE. AND MILD NECROSIS. - THE DCIS CONSTITUTES LESS THAN OR EQUAL TO 25% OF THE TOTAL TUMOR MASS,. AND IS PRESENT ADMIXED WITH THE INVASIVE COMPONENT. - THE INVASIVE CARCINOIMA IS LOCATED IN ALL FOUR QUADRANTS AND THE. CENTRAL AREA. - THE DCIS IS LOCATED IN ALL FOUR QUADRANTS AND THE CENTRAL AREA. - SMALL FOCUS OF LOBULAR CARCINOMA IN SITU (LCIS) IS IDENTIFIED. - NO INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINOMA. IS IDENTIFIED. - CALCIFICATIONS ARE PRESENT IN THE INVASIVE AND IN SITU CARCINOMA. NO VASCULAR INVASION IS NOTED. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. - NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - BIOPSY SITE, FIBROCYSTIC, AND COLUMNAR CHANGES AND MICROSCOPIC. INTRADUCTAL PAPILLOMAS ARE ALSO IDENTIFIED. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF POSITIVE. LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES EXAMINED) : LEVEL I: 0/23; LEVEL II: 0/11; INTRAMAMMARY (ELEVEN o' CLOCK) : 1/1. - THE METASTATIC FOCUS MEASURES 1.9 CM. - THERE IS NO EXTRANODAL EXTENSION OF CARCINOMA. LYMPH NODE, LEVEL ONE, RIGHT AXILLA, ADDITIONAL; EXCISION: - ONE BENIGN LYMPH NODE (0/1). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: M.D. 1) The specimen is received fresh and labeled, ""right breast and axillary. contents levels 1 and 2"" and consists of a breast measuring 33.0 x 27.5 x. 6.0 cm with overlying skin ellipse measuring 33.0 x 17.0 cm. Situated. centrally on the skin surface is a flattened nipple measuring 0.9 x 0.9 cm. and areola measuring 4.2 cm. The skin shows bruising at the 8 o'clock. positions. No definitive scars are appreciated. A suture demarcates the. axillary contents which measures 11.0 x 6.5 cm. Two tags are present,. designating levels 1 and 2. The posterior surface of the breast is inked. black and the anterior/superior red and interior/inferior green. The. specimen is serially sectioned to reveal a firm tumor nodule measuring 4.2. x 3.5 x 3.2 cm located centrally at the subareolar aspect, located 1.0 cm. from the deep margin with surrounding firm satellite extension involving a. 9.0 x 5.5 x 5.0 cm area involving all four quadrants. A full face section of. the largest tumor nodule is taken, sectioned and submitted accordingly. Additional representative sections showing the satellite nodules are. submitted. The remaining breast tissue shows, lobular adipose tissue with. scant white fibrous breast tissue. The axillary tissue is dissected to. reveal an enlarged tan lymph node located in the upper outer quadrant at 11. o'clock position, measuring 2.5 cm in greatest dimension with a grossly. positive cut surface. A representative section of the lymph node is. submitted. All identified lymph nodes are submitted. Representative sections. are submitted. All dissected lymph nodes are entirely submitted. Summary of sections: N - nipple. NB - nipple base. S - representative skin. D - tumor to deep margin. TN- largest tumor nodule to surrounding papillary nodules. PN- surrounding papillary tumor nodules. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. LN11 grossly positive 11 o'clock lymph node. LN1- lymph nodes (level 1). BLN1- bisected lymph nodes (level 1). TLN1- - trisected lymph nodes (level 1). SLNIserially sectioned single lymph node (level 1). LN2 - lymph nodes (level 2). BLN2 bisected lymph node (level 2). 2) The specimen is received in formalin, labeled ""Additional level 1 lymph. node, right axilla"" and consists of a single pink tan fatty lymph node. measuring 1.2 x 1 x 0.3 cm. The lymph node is entirely submitted. Summary of sections: LN- lymph node. Summary of Sections: Part 1: SP: Right breast and axillary contents level 1 and 2. Block. Sect. Site. PCs. 4. BLN1. 4. 1. BLN2. 1. 1. D. 1. 2. LIQ. 2. 3. LN1. 3. 1. LN11. 1. 2. LN2. 2. 2. LOQ. 2. 3. N. 3. 1. NB. 1. 1. S. 1. 4. SLN1. 4. 3. TLN1. 3. 2. TN. 2. 3. 3. 2. UIQ. 2. 2. UOQ. 2. Part 2: SP:Additional level one lymph node , right axilla. Block. Sect. Site. PCs. 1. LN. 1. Procedures/Addenda: Addendum. Date Complete: D. Addendum Diagnosis. RIGHT BREAST AND AXILLARY CONTENTS, LEVEL 1 AND 2: - IMMUNOHISTOCHEMICAL STAINS SHOW THE TUMOR CELLS TO BE NEGATIVE FOR. HER2 (G/1+). M.D.",T2,N1,M0,T2N1M0
TCGA-F2-7276,"Diagnosis : FSA: Liver, Segment 4, excision. - Liver parenchyma with macrovesicular steatosis (approximately. 5%) and bile stasis. - Benign bile duct proliferation. - No evidence of malignancy. FSB : Right diaphragm, excision. - Fibroadipose tissue with scattered chronic inflammation. - No evidence of malignancy. FSC : Liver, Segment 7, excision. Liver parenchyma with macrovesicular steatosis (approximately. 5%) and bile stasis and bile duct proliferation. - No evidence of malignancy. FSD : Liver, Segment 2, excision. - Fragment of benign cyst wall. - No evidence of malignancy. FSE : Liver, Segment 3, excision. - Fragment of benign cyst wall. - Hyalinized nodule. - No evidence of malignancy. FSF: Common bile duct margin, removal. - Fibrous tissue with scattered biliary ducts and chronic. inflammation. - No evidence of malignancy. FSG : Pancreatic duct margin, removal. - Fibrous tissue with scattered pancreatic ductules. - No evidence of malignancy. H: Gallbladder, cholecystectomy. - Chronic cholecystitis. - No evidence of malignancy. I: Lymph node, portal, removal. - One lymph node negative for malignancy (0/1). J: Lymph node, common hepatic, removal. - One lymph node positive for metastatic adenocarcinoma (1/1). K: Pancreas, stomach and small bowel, partial. pancreaticoduodenectomy. Tumor Histologic Type : Ductal adenocarcinoma. Histologic grade : Well-differentiated -. Tumor size: 5.5 cm. Tumor site: Head with extension into body. Tumor focality. Unifocal. Microscopic extent of invasion: Peripancreatic soft tissues : Present (K8). Duodenum Absent. Ampulla: Present (K6). Other organs or structures : N/A. Lymphovascular Invasion: Present (K16). Perineural Invasion: Present (K11, K12). Margins. Pancreatic neck: Negative. Bile duct: Negative. Posterior pancreatic surface (deep radial margin) : Negative but. close; <1mm (K11). Peripancreatic soft tissues: Negative but close; < 1mm (K14). Proximal (gastric) : Negative. Distal (duodenal) : Negative. Regional lymph nodes (all specimens except part L). Total number with metastasis: 8. Total number examined: 16. Additional pathologic findings : Acute serositis. Diagnosis of other organs or structures n/a. AJCC PATHOLOGIC TNM STAGE: pT3 pN1. Note: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. L: Mesentery, colon, removal. - One lymph node positive for metastatic adenocarcinoma (1/1). Intraoperative Consult Diagnosis: A frozen section consultation was requested by Dr. on. at. from. FSA1: Liver, Segment 4, biopsy. - Bile duct proliferation, benign. FSB1: Diaphragm, right, biopsy. - Fibroadipose tissue with inflammation and atypical cells. No. definite metastatic carcinoma. FSC1 : Liver, Segment 7, biopsy. - Bile duct proliferation with atypia. - Marked inflammation and cholestasis. - No definite metastatic carcinoma. FSD1: Liver, Segment 2, biopsy. - No tumor seen. FSE1 : Liver, Segment 3, biopsy. - Bile duct proliferation, no tumor seen. FSF1: Common bile duct, margin. - No carcinoma identified. FSG1: Pancreatic duct margin. - No carcinoma identified. Drs. and additional help was received from i the diagnosis was. delivered to the requesting physician at. Frozen Section Pathologist: Clinical History. +year-old with a clinical diagnosis of pancreatic cancer. Gross Description: Received are twelve appropriately labeled containers. . Containers. A-G are received fresh for frozen section. Container A is additionally labeled ""liver, Segment 4."" The. container holds a yellow cassette that is additionally labeled. FSA1. At frozen section the specimen was described. as measuring 7 X 4 X 2 mm and appeared as a red/tan soft tissue. fragment. The specimen was totally submitted in block FSA1,. Container B is additionally labeled ""right diaphragm. "" The. container holds one yellow cassette that is additionally labeled. FSB1. II At frozen section the specimen was described. as measuring 2 X 2 mm and appeared as a red/tan soft tissue. fragment. The specimen was totally submitted as FSB1,. Container C is additionally labeled ""Segment 7. The container. holds one yellow cassette that is additionally labeled. FSC1. At frozen section the specimen was described as. three fragments that measured 1 x 0.5 X 0.2 cm in aggregate. The. specimen was totally submitted in block FSC1,. Container D is additionally labeled ""Segment 2. The container. holds one yellow cassette that is additionally labeled. FSD1 "" At frozen section the specimen was described as. three fragments of soft tissue that measured 1 x 0.2 X 0.2 cm in. aggregate. The specimen was totally submitted in block FSD1,. Container E is additionally labeled ""Segment 3. The container. holds one yellow cassette that is additionally labeled I. FSE1. "" At frozen section the specimen was described as. measuring 1 X 1 X 0.2 cm and appeared as a liver fragment with a. nodule at the center (2 X 2 mm and white) The specimen was. totally submitted in block FSE1,. Container F is additionally labeled ""common bile duct margin. "". The container holds one yellow cassette that is additionally. labeled. FSF1. "" At frozen section the specimen was. described as measuring 2.4 X 1.3 X 0.4 cm and appeared as a. pink/tan soft tissue fragment. The specimen was totally. submitted into block FSF1,. Container G is additionally labeled ""pancreatic duct margin. II. The container holds one yellow cassette that is additionally. labeled II. FSG1. "" At frozen section the specimen was. described as measuring 3 X 3 x 2 mm and appeared as a red/tan. soft tissue fragment that was totally submitted into block FSG1,. Container H is additionally labeled ""gallbladder. "". Previously opened: No. Measurements : 7 X 3 X 2.4 cm. External surface Appears pink and smooth with no evidence of. fibrofatty adhesions. Wall thickness: 0.2 cm uniformly. Mucosa: Patchy green color with hemorrhagic appearance; texture. appears velvety. Stones present : No. Other comments: : None. Block #: H1, cross section of cystic duct and longitudinal. section of gallbladder wall. Container I is additionally labeled ""portal node. "" The container. holds one piece of fibroadipose tissue that measures 1.5 x 0.5 X. 0.4 cm. The specimen has been bisected and totally submitted. into block Il,. Container J is additionally labeled ""common hepatic node. "" The. container holds one piece of fibroadipose tissue that measures. 1. 4 X 1.2 X 1.0 cm. The specimen has been bisected and totally. submitted in block J1,. Container K is additionally labeled ""pancreatic duodenectomy,. short stitch=pancreatic duct, short proline=portal vein margin,. long stitch=common bile duct, long proline=uncinate margin"". Specimen fixation: Formalin. Specimen type: Pancreaticoduodenectomy. Organs received (Whipple Specimen) : Duodenum 17 X 2.2 cm,. stomach 3.2 x 6 X 1 cm, pancreas 3 X 2.3 x 2 cm. Orientation: This specimen has been previously inked as follows: yellow/common bile duct, blue/pancreatic margin, black/uncinate,. green/pancreatic body, red/portal vein; short stitch =. pancreatic duct, short stitch = portal vein margin, long stitch. = common bile duct, long stitch = uncinate margin. Tumor location: Head of pancreas. Gross appearance of tumor: The mass is within the head and body. of the pancreas; the mass is ill-defined and appears yellow/tan. with infiltrative nodular growth; the mass is solid with no. areas of apparent necrosis or hemorrhage. Tumor dimensions: 5.5 X 3 X 3 cm. Extent of invasion: Confined/non confined to the pancreas : Grossly confined. Involvement of the ampulla : Absent. Involvement of the duodenum: Absent. Involvement of the bile duct Absent. Involvement of adjacent vessels: The lesion is close to the. location of the portal vein; there is indefinite involvement by. gross examination. Spleen (if applicable) : Not applicable. Gallbladder (if applicable) : Not applicable. Stomach (if applicable) : Absent. Surgical margins: Pancreatic body: Negative, 0.2 cm away. Uncinate (Retroperitoneal) : Negative, 0.1 cm away. Common Bile duct: Negative, 0.6 cm away. Proximal margin (stomach) : (Stomach), negative, 9.5 cm away. Distal margin (duodenum) : (Duodenum), negative, 12.5 cm away. Peripancreatic soft tissues: Negative, 0.4 cm away. Lymph nodes: There are 5 candidate lymph nodes identified. Two candidate lymph nodes are identified between the duodenum. and the uncinate. The smallest measures 0.4 X 0.3 X 0.3 cm and. the largest measures 1 x 0.5 X 0.3 cm. Three candidate lymph. nodes are identified in the fatty tissue surrounding the. stomach. These perigastric lymph nodes range in size from 0.2 X. 0.2 X 0.2 cm to 0.3 X 0.3 X 0.3 cm. Other remarkable findings None. Digital photograph taken: No. Tissue submitted for special investigation: Yes. Block Summary : Inking : : yellow/common bile duct, blue/pancreatic margin,. black/uncinate, green/pancreatio body. K1-K2 - - Proximal margin, en face. K3 - K4 - Distal margin, en face. K5 - Portal vein margin, en face. K6-K10 - - Ampulla of Vater, perpendicular section (common bile. duct located in K10). K11-K14 - - Uncinate margin, perpendicular sections (one section. per cassette). K15-K23 - - Pancreatic body margin, perpendicularly sectioned (one. section every 2 cassettes K17-K22). K24-K25 - Periuncinate lymph nodes, bisected (one lymph node per. cassette). K26 - Three candidate perigastric lymph nodes (not bisected). K27 - Duodenum and tumor. K28 - Representative sections of normal duodenum. K29 - Two representative sections of central tumor. Container L is additionally labeled ""colon mesentery. 11 The. container holds one piece of tan/yellow fibroadipose tissue that. measures 0.7 x 0.6 X 0.3 cm. The specimen has been bisected and. submitted in block L1,.",T3,N1,M0,T3N1M0
TCGA-E9-A1RE,"OC ID: Gross Description: Breast with the tumor of 3.5 x 3 cm in size; fatty tissue lymph nodes are dense, hyperemic, up to 1 cm in their diameter. Microscopic Description: Infiltrating duct carcinoma; G2. Ten lymph nodes were examined, nine lymph nodes demonstrated metastases. Diagnosis Details: Tumor Features: Unknown,Tumor Extent: T2tumorsizemore than 2cmnot more than 5 cm, Venous Invasion: Absent,. Margins: Absent, Treatment Effect: Comments: BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Upper outer quadrant. Tumor size: 3 x 0x3.5 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 9/10 positive for metastasis (Axillary 9/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Uninvolved. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None. Laterality: Left, upper outer quadrant.",T2,N2,M0,T2N2M0
TCGA-44-3398,"SPECIMEN. A. Lymph node level 10. B. Right lower lobe. C. Lymph node level 7. D. Lymph node level 3. E. Lymph node R4. CLINICAL NOTES. GROSS DESCRIPTION. A. Received in formalin, labeled ""lymph node level 10"". and. consists of multiple pieces of black soft tissue measuring 2 cm in. greatest aggregate dimension. AS-1. B. The specimen is received unfixed labeled ""right lower. lobe"" and consists of a lobe weighing 266 grams and. measuring 16 X 12 X 7 cm. There is a subtotal probable mass. measuring 2.5 X 1.5 X 2 cm. There is a puckered appearance over the. mass. Portions of the specimen are taken for research purposes. Additional sections after fixation. There is a stapled margin on. one. side of the specimen measuring 5 cm in length and there is a. stapled. bronchial margin as well. C. Received in formalin, labeled ""lymph node level 7"" and. consists of multiple pieces of black soft tissue. measuring. 2 cm in greatest aggregate dimension. AS-1. D. Received in formalin, labeled ""lymph node level 3"" and. consists of a piece of white and black and yellow soft. tissue measuring 2.5 x 1.5 X 0.3 cm. AS-1. E. Received in formalin, labeled ""lymph node - R4"" and. consists of multiple pieces of yellow and black soft. tissue. measuring 3 x 3 x 0.5 cm in aggregate. AS-2. MICROSCOPIC DESCRIPTION. A. There is no evidence of malignancy in any of ten lymph node. pieces. B. Tumor type : Non-small cell carcinoma. Tumor grade 3 out of 3. Mitotic Index: 1 mitoses/10 HPF's (1 HPF = 0.19 sq mm). Tumor size: 2.5 cm. Bronchial resection margin: Negative for malignancy. Pulmonary margin of resection Negative for malignancy. Pleura: Negative for malignancy. Vascular invasion: Absent. Attached lymph nodes There is no evidence of malignancy. in. any of 3 lymph nodes. pTNM Stage T1b NO. Non-tumorous lung: Mild to moderate emphysema. C. There's no evidence of malignancy in any of multiple lymph node. pieces. Approximately 12 pieces are present. D. A single lymph node is negative for malignancy. E. There is no evidence of malignancy in any of 16 lymph node. pieces. DIAGNOSIS. A. Lymph node, level 10, biopsy: There is no evidence of. malignancy in any of ten lymph node pieces. B. Lung, right lower lobe, resection: Poorly differentiated. non-small cell carcinoma. DIAGNOSIS. C. Lymph node, level 7, biopsy: There is no evidence of malignancy. in. any of 12 lymph nodes pieces. D. Lymph node, level 3, biopsy: A single lymph node is negative for. malignancy. E. Lymph node, R4, biopsy: There's no evidence of malignancy in any. of 16 lymph nodes pieces.",T1,N0,M0,T1N0M0
TCGA-05-4403,"Main diagnosis/diagnoses: Large peripheral bronchopulmonary, histologically mixed, highly mucigenous. adenocarcinoma of the right upper lobe of the lung with a markedly predominant bronchiolo-. alveolar of mucinous type and a small acinar and solid part, located mainly in S3. TNM classification pT2 pNO R0, stage IB. C 3 34.1 M 8255/3. Comment/supplementary remark: There is no evidence that the visceral pleura is infiltrated by the carcinoma. The resection. margin of bronchus and vessels and all the lymph nodes removed and identified are tumor-. free.",T2,N0,M0,T2N0M0
TCGA-EW-A1P6,"Revised. F. Pathologic Interpretation: AMENDMENT,. A. SUPERIOR MEDIAL MARGIN, RULE OUT TUMOR: - No malignancy seen. B. SENTINEL NODE #1: - Microscopic foci of carcinoma are highlighted by Keratin (1/1). C. SENTINEL NODE #2: - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin is negative for carcinoma. D. SENTINEL NODE #3: - Metastatic carcinoma to one lymph node (1/1) with extracapsular extension. E. RIGHT BREAST MASS: - Invasive ductal carcinoma Nottingham grade 2 (3+2+1); 4.2 cm in greatest dimension. - Specimen margins are negative for tumor closest margins are anterior and superior, 0.2 cm (See Tumor Summary). - Lymphovascular invasion is identified. F. ADDITIONAL AXILLARY FAT: - No malignancy seen in one lymph node (0/1). G. ADDITIONAL SUPERIOR MARGIN: - Microscopic focus of invasive ductal carcinoma, 0.1 cm, adjacent to inked resection margin. The focus of invasive carcinoma is present at the inked margin adjacent to previous resection. The ""new"" inked margin is free of tumor. - Lymphatic tumor emboli are identified. H. RIGHT AXILLARY CONTENTS: - No malignancy seen in nineteen lymph nodes (0/19). I. ADDITIONAL AXILLARY CONTENTS LEVEL 2-3 LYMPH NODES: - No malignancy seen in two lymph nodes (0/2). Tumor Summary: Specimen: Partial breast. Procedure: - Excision without wire-guided localization. Lymph Node Sampling: - Sentinel lymph nodes. - Axillary dissection. Specimen Integrity: - Multiple designated specimens. Specimen Size: - Greatest dimension: 8.5 cm. Additional dimension: 6 x 5 cm. Laterality: (Right. Tumor Size: SURGICAL PATHOL Report. - Greatest dimension of largest focus of invasion over 0.1 cm: 4.2 cm. - Additional dimensions: 3.8 x 2.8 cm. Tumor Focality: - Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of tumor: - Skin: Skin is not present. - Skeletal muscle: No skeletal muscle present. Lobular Carcinoma IN Situ (LCIS): - Not identified. Histologic Type of Invasive Carcinoma: - Invasive ductal carcinoma. Histologic Grade: - Glandular (Acinar)/Tubular Differentiation: - Score 3: <10% of tumor area forming glandular/tubular structures. - Nuclear Pleomorphism: - Score 2: Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and. Shape. - Mitotic Count: - Score 1. - Overall Grade: - Grade 2: scores of 6 or 7. Margins: - Margins negative for invasive carcinoma. Lymph-Vascular Invasion: - Present. Lymph Nodes: - Number of sentinel lymph nodes examined: 3. - Total number of lymph nodes examined (sentinel and Nonsentinel): 25. - Number of lymph nodes with macrometastases (>0.2 cm): 2. Extranodal Extension: - Present. Method of Evaluation of Sentinel Lymph Nodes: - Hematoxylin and eosin (H&E), one level. - Immunohistochemistry. Pathologic Staging: - Primary Tumor: pT2: Tumor >20 mm but <50 mm in greatest dimension. - Regional Lymph Nodes: pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mm. - Distant Metastasis: Not applicable. Anciliary Studies: Estrogen Receptor: - Performed on another specimen: Results: Immunoreactive tumor cells present (1%). Progesterone Receptor. - Performed on another specimen: Results: Immunoreactive tumor cells present (1%). HER2/neu. - Performed on another specimen: Results: Negative (Score 0). Clinical History: - Palpable mass. Pathologic Staging (pTNM): pT2, N1a, M-not applicable. PREVIOUSLY ISSUED DIAGNOSIS: A. SUPERIOR MEDIAL MARGIN, RULE OUT TUMOR: - No malignancy seen. B. SENTINEL NODE #1: - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. C. SENTINEL NODE #2: SURGICAL PATHOL Report. - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. D. SENTINEL NODE #3: - Metastatic carcinoma to one lymph node (1/1) with extracapsular extension. E. RIGHT BREAST MASS: - Invasive ductal carcinoma Nottingham grade 2 (3+2+1); 4.2 cm in greatest dimension. - Specimen margins are negative for tumor closest margins are anterior and superior, 0.2 cm (See. Tumor. Summary). Lymphovascular invasion is identified. F. ADDITIONAL AXILLARY FAT: - No malignancy seen in one lymph node (0/1). G. ADDITIONAL SUPERIOR MARGIN: - Microscopic focus of invasive ductal carcinoma, 0.1 cm, adjacent to inked resection margin. - Lymphatic tumor emboli are identified. H. RIGHT AXILLARY CONTENTS: - No malignancy seen in nineteen lymph nodes (0/19). I. ADDITIONAL AXILLARY CONTENTS LEVEL 2-3 LYMPH NODES: - No malignancy seen in two lymph nodes (0/2). Tumor Summary: Specimen: - Partial breast. Procedure: - Excision without wire-guided localization. Lymph Node Sampling: - Sentinel lymph nodes. - Axillary dissection. Specimen Integrity: - Multiple designated specimens. Specimen Size: - Greatest dimension: 8.5 cm. . Additional dimension: 6 x 5 cm. Laterality: - Right. Tumor Size: Greatest dimension of largest focus of invasion over 0.1 cm: 4.2 cm. - Additional dimensions: 3.8 x 2.8 cm. Tumor Focality: - Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of tumor: - Skin: Skin is not present. - Skeletal muscle: No skeletal muscle present. Lobular Carcinoma IN Situ (LCIS): - Not identified. Histologic Type of Invasive Carcinoma: - Invasive ductal carcinoma. Histologic Grade: - Glandular (Acinar)/Tubular Differentiation: - Score 3: <10% of tumor area forming glandular/tubular structures. - Nuclear Pleomorphism: - Score 2: Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in bothisize and. Shape. - Mitotic Count: - Score 1. - Overall Grade: - Grade 2: scores of 6 or 7. Margins: SURGICAL PATHOL Report. - Margins positive for invasive carcinoma. Specify margin and Extent of involvement: Superior margin, focal. Lymph-Vascular Invasion: - Present. Lymph Nodes: - Number of sentinel lymph nodes examined: 3. - Total number of lymph nodes examined (sentinel and Nonsentinel): 25. - Number of lymph nodes with macrometastases (>0.2 cm): 1. Extranodal Extension: - Present. Method of Evaluation of Sentinel Lymph Nodes: - Hematoxylin and eosin (H&E), one level. - Immunohistochemistry. Pathologic Staging: - Primary Tumor: pT2: Tumor >20 mm but 50 mm in greatest dimension. - Regional Lymph Nodes: pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mn. - Distant Metastasis: Not applicable. Anciliary Studies: Estrogen Receptor: Performe. another specimen. Results: Immunoreactive tumor cells present (1%). Progesterone p. ed on another specimen: Results: Immunoreactive tumor cells present (1%). HER?. med on another specimen: Results: Negative (Score 0). Clinical History: - Palpable mass. Pathologic Staging (pTNM): pT2, N1a, M-not applicable. NOTE: Nome immunhisruchen. NO analyse specific reagents (ASRs) validated by owr lahnvatory. These ASRs are nseful indicators that do mat require FDA approval. These clomes are used: IDS-ER. 7 All stains are used with formalin or molecular frxed, paraffin emhedded rissue. Detection is by Emision Method. The rdmits are read by. pathologies as positive or negative. As the attending pathologist, / attest that 1: (i) Examined the relevant preparation(s). for the specimen(s): and (ii) Rendered the diagnosis(es). MD. Amendments. Amended. Reason: Diagnosis editing/clarification. New information provided to Dr. by physician. Previous Signout Date: Intraoperative Consultation. A. Superior medial margin, rule out tumor, FS: No tumor seen. B. Sentinel node #1, FS: Negative for carcinoma (touch prep and frozen). C. Sentinel node #2, FS: Negative for carcinoma (touch prep and frozen). D. Sentinel node #3, FS: Atypical cells on touch prep-carcinoma cannot be excluded. FS: Metastatic carcinoma in lymph node. : MD. SURGICAL PATHOL Report. MD. Clinical History: female with right breast mass. Biopsy shows invasive ductal carcinoma. Operation Performed. Lumpectomy right breast with sentinel node. Pre Operative Diagnosis: Breast cancer. Specimen(s) Received: A: Superior medial margin, rule out tumor, FS. B: Sentinel node #1, FS. C: Sentinel node #2, FS. D: Sentinel node #3, FS. E: Right breast mass. F: Additional axillary fat. G: Additional superior margin. H: Right axillary contents. I: Additional axillary contents level 2-3 lymph nodes. Gross Description: A. Received fresh are two yellow-tan tissue fragments,measuring up to 1.0 cm in length. In toto in one cassette for frozen. B. Received fresh is a light brown lymph node 1.5 x 1.0 cm. in toto in one cassette for frozen. C. Received fresh is a lymph node, measuring 2.0 x 1.5 cm. In toto in one cassette for frozen. D. Received fresh is a lymph node, measuring 1.2 x 1.0 cm. In toto in one cassette for frozen. E. Received in formalin is a yellow-tan fibroadipose tissue fragment, weighing 89 grams, measuring 8.5 x 6.0 x 5.0 cm. The. specimen is oriented with a short superior, long lateral and double stitch deep margin. Inked as follows: Superior in blue,. inferior in green, deep black, anterior yellow, lateral orange and medial red. Cross section through the specimen shows. yellow-tan cut surface. There is an ovoid, markedly firm, tumoral mass, measuring 4.2 x 3.8 x 2.8 cm. The mass is. within 2 mm from superior and anterior inferior margin. No other firm masses were grossly identified. Sections submitted. as follows: 1&2. Composite resection of the largest axis of the mass from antero-inferior to superior margin. 3-5. Additional section of the mass in relation with the antero-inferior margin. 6&7. Section of the mass in relation with the deep resection margin. 8. Medial margin. 9. Lateral margin. F. Received in formalin are multiple yellow-tan adipose tissue fragments, measuring 6.0 x 4.0 x 1.0 cm in aggregate. No. lymph nodes were grossly identified. Sections from the fat tissue in three cassettes. G. Received in formalin is a yellow-tan adipose tissue fragment (additional superior margin), measuring 6.0 x 3.0 1.0. cm. Multiple sutures orient the specimen as a true margin. The true margin in green. The opposite margin in black. Cross. section through the specimen shows a yellow-tan cut surface. No masses were grossly present. Submitted ih. toto. in. eight cassettes. H. Received in formalin are multiple yellow-tan fibroadipose tissue fragments, measuring 10.0 x 7.0 x 3.0 cm in aggregates. Twenty lymph nodes are present, measuring up to 0.8 x 0.7 cm in greatest dimension. Sections as follows: 1. Two lymph nodes in toto. 2-8. Three lymph nodes in toto per cassette. I. Received are multiple yellow-tan fibroadipose tissue fragments, measuring 5.0 x 3.0 x 1.0 cm. Four lymph nodes are. identified, measuring up to 0.6 x 0.4 cm. Sections as follows: 1&2. Two lymph nodes in toto per cassette. SURGICAL PATHOL Report.",T2,N1,M0,T2N1M0
TCGA-55-6982,"Histopathological Examination. Complete: Pre-Op Diagnosis : Lung Cancer. Specimens. : Lymph Node, St 4, Lower Paratracheal. Lymph Node, St 4, Lower lower Paratracheal lobe nodule. Lung Biopsy, right. Lymph Node, St 9, Pulmonary Ligament. Lung, Right Lower Lobe. Lymph Node, Right Hilar. Lymph Node, St 4, Lower Paratracheal. Lymph Node, St 8, Paraesophageal. Lymph Node, St 4, Lower Paratracheal. Lymph Node, St 9, Pulmonary Ligament. Lung Biopsy, right lower lobe nodule. Lymph Node, Right Hilar. Lymph Node, St 4, Lower Paratracheal. Lung, Right Lower Lobe. Lymph Node, St 8, Paraesophageal. Frozen Diagnosis. Block#. : A-1. Re-Ex?. : no. FS-Diag. : Benign lymph node. Comment. : none. Consult by: none. Block#. : B-1. Re-Ex?. : no. FS-Diag. : Benign lymph node. Comment. : none. Consult by : none. Block#. : E-1. Re-Ex?. : no. FS-Diag. Bronchial margin free of tumor. Comment. : none. Consult by : none. Block#. : E-2. Re-Ex?. : yes. FS-Diag. Bronchial margin free of tumor. Comment. : none. Consult by: none. Block#. : E-3. Re-Ex?. : yes. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATI( IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. Path # : Visit # : FS-Diag : Non-small cell carcinoma. Comment. : none. Consult by : none. GROSS EXAMINATION. A. The specimen is received in a container labeled with the. name of the patient and labeled as lymph node, station four,. lower paratracheal The specimen consists of an oval pink. tan fragment of lymphoid tissue. The specimen measures 1. 0. x 1. 0 x 0.4 cm. The specimen is totally submitted for. frozen section. FROZEN SECTION DIAGNOSIS: Benign lymph node. B. The specimen is received in a container labeled with the. name of the patient and labeled as lymph node, station four,. lower paratracheal. The specimen consists of an ovoid pink. tan fragment of lymphoid tissue which measures 1.0 x 0.8. X. 0.4 cm. The specimen is totally submitted for frozen. section. FROZEN SECTION DIAGNOSIS: Benign lymph node. C. The specimen is received in a container labeled with the. name of the patient and labeled as lung biopsy, right lower. lobe nodule. The specimen consists of a gray pink wedge. biopsy of lung tissue which measures and 6.5 X 3.0 x 1.5. cm. The specimen has a palpable 0.8 cm calcified nodule. The serosal surface exhibits anthracotic stippling. The. surgical margins are closed with rows of silver colored. metal staples. The staple margin is removed and the margin. is marked with ink. The specimen is serially sectioned and. the calcified nodule is submitted in block one for routine. processing following rapid decalcification. The remaining. specimen except for the stapled margin is submitted in. blocks two through four. D. The specimen is received in a container labeled with the. name of the patient and labeled as lymph node, station nine,. pulmonary ligament. The specimen consists of an ovoid piece. of gray tan rubbery tissue which measures 1.2 X 0.7 x 0.3. cm. The specimen is bisected revealing an anthracotic lymph. node. The specimen is totally submitted. E. The specimen is received in a container labeled with the. name of the patient and labeled as lung, right lower lobe. The specimen consists of a gray pink piece of lung tissue. which measures 18 x 8 X 4.5 cm. The serosal surface. exhibits anthracotic stippling. The surgical margin is. closed with rows of silver colored metal staples. The. serosal surface is puckered and umbilicated. This area is. marked with ink. Under this area is a gray tan indurated. nodule which measures 3.5 cm in greatest dimension. This. nodule is located 1.2 cm from the nearest stapled margin. A. frozen section is performed on the bronchial margins in two. blocks with a frozen section on the tumor nodule on frozen. section block three. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. of 4. FROZEN SECTION DIAGNOSIS: E-1, UL bronchus-bronchial margin. free of tumor, E-2, lower bronchus- bronchial margin free of. tumor. E-3, tumor nodule- non-small cell carcinoma. The stapled surgical margin is removed and the margin is. marked with ink. Additional sections of bronchial margins. are submitted in block four, anthracotic lymph nodes are. sampled in block five, tumor nodule and inked margin are. sampled in block six. The umbilicated area is sampled in. block seven. The area of tumor appears to be within 0.5 cm. of the closest bronchial margin and is sampled in block. eight. The remainder of the specimen is serially. sectioned. Sectioning reveals a 0.3 cm nodule distant of. the primary nodule. This nodule is submitted in block. nine. A representative section of normal appearing lung. tissue is submitted in block 10. F. The specimen is received in a container labeled with the. name of the patient and labeled as lymph node, right hilar. The specimen consists of an ovoid piece of blue gray rubbery. tissue which measures 2.0 X 0.6 X 0.5 cm. The specimen is. sectioned revealing an anthracotic lymph node. The specimen. is totally submitted. G. The specimen is received in a container labeled with the. name of the patient and labeled as lymph node, station four,. lower paratracheal. The specimen consists of two shaggy. fragments of gray tan soft tissue measuring in aggregate 1.5. x 0.8 x 0.3 cm. The specimen is totally submitted. H. The specimen is received in a container labeled with the. name of the patient and labeled as lymph node, station. eight, paraesophageal The specimen consists of a gray tan. anthracotic lymph node measuring 0.5 X 0.5 x 0.3 cm. The. specimen is totally submitted. DIAGNOSIS BASED ON GROSS AND MICROSCOPIC EXAMINATION: A. Lymph node, station 4, lower paratracheal biopsy : Negative for malignancy. [T-C4000 M-09470 V71.1 P3-44050]. B. Lymph node, station 4, lower paratracheal biopsy. Negative for malignancy. [T-C4000 M-09470 V71. P3-44050]. C. Lung, right lower lobe, wedge biopsy: Calcified granuloma. [T-28000 M-09470 V71.7 P3-44070]. D. Lymph node, station 9 biopsy Negative for malignancy. (T-C4000 M-09470 V71.1 P3-44050]. E. SPECIMEN TYPE: Lobectomy. LATERALITY: Right lower. TUMOR SITE: Lower lobe. TUMOR SIZE: 3.5 cm. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. Path # : Visit # : HISTOLOGIC TYPE: Adenocarcinoma, not otherwise specified. HISTOLOGIC GRADE: Grade III, poorly differentiated. >RIMARY TUMOR (PT) : T2: : Tumor greater than 3 cm in greatest. limension. EGIONAL LYMPH NODES (PN) : N1: Metastases in ipsilateral. peribronchial and ipsilateral hilar lymph nodes. NUMBER EXAMINED: Two. NUMBER INVOLVED: One. DISTANT METASTASIS: MX. MARGINS Margins uninvolved by invasive carcinoma. DISTANCE OF INVASIVE FROM CLOSEST MARGIN: 5 mm. SPECIFY MARGIN: Lower lobe bronchus. DIRECT EXTENSION OF TUMOR: Visceral pleura. VENOUS (LARGE VESSEL) INVASION (V) : Present. ARTERIAL (LARGE VESSEL) INVASION: Present. LYMPHATIC (SMALL VESSEL) INVASION (L) : Present. ADDITIONAL PATHOLOGIC FINDINGS Calcified granuloma. peribronchial lymph node. [T-28000 M-81403 162.9 P3-44090]. Intradepartmental consultation was obtained. F. Lymph node, right hilar biopsy Negative for malignancy. [T-C4000 M-09470 V71. P3-44050]. G. Lymph node, station 4, lower paratracheal biopsy: Negative for malignancy. [T-C4000 M-09470 V71. P3-44050]. H. Lymph node, station 8, periesophageal biopsy: Negative. for malignancy. [T-C4000 M-09470 V71.1 P3-44050]. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. of 4. MR# : Visit #: :",T2,N1,M0,T2N1M0
TCGA-B0-5713,"PATIENT HISTORY: Not given. PRE-OP DIAGNOSIS: Left renal cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Left laparoscopic nephrectomy. FINAL DIAGNOSIS: KIDNEY, LEFT, LAPAROSCOPIC NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR) CELL TYPE. B. FUHRMAN'S NUCLEAR GRADE IS 3 of 4. c. THE GREATEST DIAMETER OF THE NEOPLASM IS 7.2 CM. D. THE NEOPLASM IS CONFINED WITHIN THE RENAL CAPSULE. E. TUMOR INVADES INTO THE RENAL VEIN WITH INVOLVEMENT OF THE VESSEL WALL. F.-. ALL SURGICAL MARGINS ARE FREE OF THE NEOPLASM. G. THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. H. THE ADRENAL GLAND IS NOT SUBMITTED. I. TNM STAGE: pT3b NX MX. MICROSCOPIC: SYNOPTIC DATA - PRIMARY KIDNEY TUMORS. SPECIMEN TYPE: Other: Laparoscopic nephrectomy. LATERALITY: Left. TUMOR SITE: Lower pole. FOCALITY: Unifocal. TUMOR SIZE: Greatest dimension: 7.2 cm. MACROSCOPIC EXTENT OF TUMOR: Tumor limited to kidney. HISTOLOGIC TYPE: Clear cell (conventional) renal carcinoma. HISTOLOGIC GRADE (Fuhrman Nuclear Grade): G3. PATHOLOGIC STAGING (pTNM): pT3b. pNX. Number of regional lymph nodes examined: 0. pMX. MARGINS: Margins uninvolved by invasive carcinoma. ADRENAL GLAND: Not present. VENOUS (LARGE VESSEL) INVASION (V): Present. LYMPHATIC (SMALL VESSEL) INVASION (L): Absent. ADDITIONAL PATHOLOGIC FINDINGS: None identified.",T3,N0,M0,T3N0M0
TCGA-KL-8329,"Clinical Diagnosis & History: Left renal mass. Specimens Submitted: 1: SP: Left kidney and adrenal gland. 2: SP: Para-aortic lymph nodes. DIAGNOSIS: 1). KIDNEY AND ADRENAL GLAND, LEFT; EXCISION: - RENAL CELL CARCINOMA, CHROMOPHOBE CELL TYPE. - THE TUMOR'S GREATEST DIAMETER IS 5.2 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. - NO INVASION OF THE RENAL VEIN IS IDENTIFIED. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. - THE NON-NEOPLASTIC KIDNEY SHOWS CHRONIC INTERSTITIAL NEPHRITIS. - THE ADRENAL GLAND IS UNREMARKABLE. 2). LYMPH NODE, PARA-AORTIC; EXCISION: - ONE BENIGN LYMPH NODE (0/1). IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY DERSONAL or. AT I HAVE. REVIEWED AND APPROVED THIS REPORT. 1). The specimen is received fresh and is labeled left kidney and adrenal gland. It consists of a kidney, with perinephric fat, portion of ureter and hilar vessels. The adrenal gland is present. The overall dimensions of the specimen are 18x 10 x 5.5cm. The kidney weighs 495 grams. The renal capsule strips easily. The kidney measures 15x 6x4.5cm. Within the upper pole of the kidney there is a yellow tan necrotic mass measuring. 5.2 in greatest dimension. The tumor appears to be near the perirenal fat. The remainder of the renal parenchyma exhibits no lesion. The renal pelvis appears not to be involve by tumor. The renal sinus appears not to be involve by tumor. The renal vein appears not to be involve by tumor. The perirenal fat is not involved. The adrenal gland measures 4.2 x 2.6 x 2.0cm and is unremarakable. The segment of ureter measures 8 cm in length and is unremarkable. Representative sections are submitted. Summary of sections: T-tumor. TN-tumor and normal. TC-tumor and capsule. NK-normal kidney. RP-renal pelvis. UM-ureteral margin. U-random ureter. VM-vascular margin. AG adrenal gland. 2). The specimen is received in formalin, labeled ""Para-aortic lymph nodes"". It consists of a single piece of fatty tissue. measuring 3x 1.5x0.5 cm. Entirely submitted for all of the possible lymph nodes. Summary of sections: U - undesignated. Summary of Sections: Part 1: SP: Left kidney and adrenal gland. Block. Sect. Site. PCs. 1. AG. 0. 3. NK. 0. 1. RP. 0. 5. T. 0. 2. TC. 0. 3. TN. 0. 1. UM. 0. 1. VM. 0. Part 2: SP: Para-aortic lymph nodes. Block. Sect. Site. PCs. 2. U. 2.",T1,N0,M0,T1N0M0
TCGA-IB-7649,"ORIGINAL REPORT. SPECIMEN: A. Gallbladder. B. Node of importance. c. Bile duct margin - fs. D. Duodenum, pancreatic margin (long stitch), uncinate margin (short stitch). CLINICAL HISTORY: ERCP shows common bile duot and pancreatic duct stricture - brushings show. high grade epithelial neoplasia. DIAGNOSIS: A. GALLBLADDER, CHOLECYSTECTOMY: ACUTE CHOLECYSTITIS AND CROLELITHASIS. NEGATIVE FOR DYSPLASIA OR MALIGNANCY. B. NODE OF IMPORTANCE, EXCISION: ONE LYMPH NODE, NEGATIVE FOR MALIGNANCY. LYMPH NODE WITH LIPID GRANULOMAS. c. BILE DUCT MARGIN, EXCISION: NEGATIVE FOR MALIGNANCY. MIXED ACUTE AND CHRONIC INFLAMMATION. D. DUODENUM AND PORTION OF PANCREAS, PANCREATODUODEINECTOMY (WHIPPLE. PROCEDURE) : INVASIVE MODERATELY DIFFERETIATED ADENOCARCINOMA OF PANCREATIC HEAD. (SEE COMMENT). TOMOR SIZEt 3.0 X 4.0 X 2.5 CM. INFILTRATING TNTO DUODENAL WALL AND COMMON BILE DUCT. LYMPHOVASCOLAR INVASION PRESENT. PERINEURAL INVASION PRESENT. TUMOR IS PRESENT AT THE TRIMMED UNCINATE MARGIN. DUODENAL MARGINS, PANCREATIC MARGIN, AND COMMON BILE DUCT MARGIN FREE. OF TUMOR. FIVE OF THIRTEEN (5/13) LYMPH NODES POSTTIVE FOR METASTASIS. F INAL. DIAGNOSIS: GROSS DESCRIPTION: A. Received fresh ie a 10 x 3.5 x 2 cm gallbladder. The serosal surface is. smooth and shiny, A roughened area is corresponding to area attached to the. liver. On opening, the gallbladder ie filled with multiple dark brown stones,. measuring from 0.5 to 1.5 cm in size and 5 x 3 x 1.5 cm in aggregate. The. mucosal surface is trabecular and appears flattened. The wall thickness. measures 0.4 cm. Two representative sections are aubmitted in one. cassette. B. Received in formalin is a 1.5 x 1 x 0.5 cm lymph node. The node is. bisected and entirely submitted in one cassette. C. Ixregular fragment of soft tigsue measuring 0.6 x 0.3 x 0.2 cm, submitted. in toto for FS. The tissue used for frozen section is resubmitted in cassette CQS. D. Received in fresh state is a Whipple resection containing a portion of. duodenum, common bile duct and portion of pancreas. The long stitch labels the. pancreatic margin and the short stitch labels the uncinate margin,. The. duodenum measures 24 am in length and 5.7 em in circumference. The. portion. of. pancreas measures 2.5 em in length and 6 x 4.5 cm on cut surface. There. a. mesh stent in the common bile duct. The common bile duct measures 6 am in. length with a diameter of 1.3 cm. Cross sections of the pancreatic tissue. reveal; a 3 x 4 x 2.5 am tan-yellow firm mass which is grosely invading into. the duodenal wall and common bile ductal wall. Representative sections are. submitted as follows: D1. - proximal duodenal margin. D2. - distal duodenal margin. D3. - pancreatic margin. D4. - uncinate margin. D5. - common bile duct margin. - dommon bile duot with underlying pancreatic tumor. - common bile duct, duodenum and underlying tumor. D10. common bile duct. Division Hoad: Inquiry. GROSS DESCRIPTION: D11,012. - one tumor cut section including adjacent normal pancreatic tissue. D13. another tumor section. Please note the pancreatic margin and uncinate margin are trimmed and the. common bile duat margin is also a trimmed margin. Also attached to the. specimen is a 5 x 4 x 2 cm piece of adipose tissue, There are several white. tan lymph nodes identified and entirely submitted in casgette D14. FROZEN SECTION DIAGNOSIS. C. BILE DUCT MARGIN: - NEGATIVE FOR MALIGNANCY. COMNENT's. The main tumor mass is in the pancreatic head. However, the duodenal wall and. common bile duct are also infiltrated. Morphologically the tumor is either. from pancreatic duct or from bile duct. The pathological stage is IIb (pT3,N1).",T3,N1,M0,T3N1M0
TCGA-CQ-A4CH,"+. Service: Otolaryngology. Resulted: Facility: SPECIMEN(S) RECEIVED. 1. Soft-Tissue: right neck level 1. 2. Neck: Right neck level 2. 3. Neck: Right neck level 3 + 4. 4. Oral Cavity: near total glossectomy -. 5. Oral Cavity: left tongue base -. 6. Neck: Left neck level 1A + 1B. 7. Neck: Left neck level 2A + 2B. 8. Neck: Left neck level 3. 9. Neck: Left neck level 4. 10. Lymph node: Right perifacial node. 11. Surgical Waste. DIAGNOSIS. 1. Right neck; level I: - Submandibular gland with no pathologic changes. Two lymph nodes, negative for malignancy (0/2). 2. Right neck; level II: - Fibroadipose tissue, negative for malignancy. No lymph nodes. identified. 3. Right neck; levels III-IV: -. - Twenty-three lymph nodes, negative for malignancy (0/23) . 4. Near total glossectomy: - Squamous cell carcinoma, moderately differentiated. a. Maximum tumour dimension: 3.6 cm. b. Maximum tumour thickness: 1.9 cm. C. Perineural invasion is present. d. No lymphovascular invasion identified. e. Tumour is present at the left lateral margin and is very close K< 0.1. cm) to the posterior margin. 5. Left tongue base : Page : 1 of 6. Service: Otolaryngology. Visit # : Resulted: Facility: - Negative for malignancy. 6. Left neck; level IA-B: - Submandibular gland with no pathologic changes. - Eight lymph nodes, negative for malignancy (0/8). 7. Left neck; level IIA-B: - Two lymph nodes, negative for malignancy (0/2). 8. Left neck; level III: - Twelve lymph nodes, negative for malignancy (0/12) . 9. Left neck; level IV: - Seven lymph nodes, negative for malignancy (0/7). 10. Right perifacial lymph node: - One lymph node and focal parotid tissue, negative for malignancy (0/1) . 11. Surgical waste: - Skin with no gross pathologic changes (see comment) . COMMENT. 11. THIS SPECIMEN HAS BEEN EXAMINED BY GROSS VISUAL EXAMINATION ONLY. NO. MICROSCOPIC EXAMINATION HAS BEEN PERFORMED. IF THERE IS A CLINICAL. INDICATION OR SUSPICION OF AN ABNORMALITY THAT WOULD REQUIRE ADDITIONAL. STUDIES THEN THE SIGNING PATHOLOGIST (BELOW) SHOULD BE CONTACTED WITHIN. ONE MONTH OF THE ISSUING OF THIS REPORT. SYNOPTIC DATA. Specimen. Other: Near total glossectomy. Fresh. Procedure: Glossectomy: Near total. Neck (lymph node) dissection: Bilateral levels I-IV. Specimen Size : Greatest dimension: 5.7 cm. Additional dimension: 5.3 cm. Additional dimension: 2.9 cm. Specimen Laterality: Midline. Tumor Site: Lateral border of tongue. Service: Otolaryngology. Visit # : Resulted: Facility: Tumor Focality: Single focus. Tumor Size. Greatest dimension: 3.6 cm. Additional dimension: 3.1 cm. Additional dimension: 1.9 cm. Histologic Type: Squamous cell carcinoma, conventional. Histologic Grade: G2: Moderately differentiated. Margins: Margins involved by invasive. carcinoma. Margin (s) : Left lateral margin. Margin status for carcinoma in situ. is not applicable. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Present. Lymph Nodes, Extranodal Extension: Not identified. TNM Descriptors: Not applicable. Primary Tumor (pT) : pT2 : Tumor more than 2 cm but not. more than 4 cm in greatest dimension. Regional Lymph Nodes (pN) : pNO: No regional lymph node. metastasis. Number of regional lymph nodes. examined: 55. Number of regional lymph nodes. involved: 0. Distant Metastasis (pM) : Not applicable. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. GROSS DESCRIPTION. 1. The specimen container labeled with the patient's identification and. as ""soft tissue, right neck level 1"" contains a piece of fibroadipose. tissue, measuring 5.5 x 3.9 x 1.7 cm. The submandibular gland is. identified, measuring 3.3 x 2.0 x 1.7 cm. Two possible lymph nodes are. identified, measuring 1.0 x 0.7 x 0.3 cm, and 1.1 x 0.5 x 0.3 cm. Page: 3 of 6. Copath #: : Service: Otolaryngology. Visit # : Resulted: Facility: Representative sections: 1A. Submandibular gland. 1B. Two possible lymph nodes. 2. The specimen container labeled with the patient's identification and. as ""right neck level 2"" contains a single piece of skeletal muscle and. attached fibroadipose tissue, measuring 3.1 x 2.7 x 1.7 cm. No lymph. nodes are grossly identified. Representative section in 2A. 3. The specimen container labeled with the patient's identification and. as ""right neck level 3 and 4"" contains a single piece of fibroadipose. tissue, measuring 4.1 x 2.9 x 1.5 cm. 20 nodular areas are identified,. ranging in size from 0.2 x 0.2 x 0 .2 cm to 2.1 x 0.9 x 0.5 cm. Representative sections. 3A-3B. 5 nodular areas each cassette. 3C-D. 4 nodular areas each cassette. 3E-G. One nodular area, bisected in each cassette. 4. The specimen container is labeled with the patient's identification. and as ""near-total glossectomy"". It contains a glossectomy specimen,. measuring 5.3 cm SI x 5.7 cm ML x 2.9 cm AP. On the anterior left. portion of the tongue, there is an exophytic tumor measuring 1.9 cm ML. x. 3.1 cm AP x 3.6 cm SI. The tumor extends to within 0.2 cm of the left. margin, 1.3 cm of the right margin, 4.5 cm of the posterior margin, and. 1.2 cm of the deep soft tissue margin. The right aspect of the specimen. has been painted with black ink and the left aspect painted with green. ink. Sections from the posterior margin were previously submitted at the. time of frozen section. Representative sections. 4 A-B. frozen section, resubmitted (posterior margin). 4C. posterior tongue and posterior soft tissue margin. 4D-4E. tumor with left lateral margin. 4F. tumor with right lateral margin. 4G. tumor with closest approach to the deep margin. 4H-I. additional sections of tumor, with left margin in 4H. 5. The specimen container is labeled with the patient's identification. and as ""left tongue base "". It contains one piece of tissue, measuring. Page : 4 of 6. Service: Otolaryngology. Resulted: Facility: 1.8 x 0.4 x 0 .2 cm, which has previously been submitted in toto at time. of frozen section. 5A. frozen section, resubmitted. 6. The specimen container labeled with the patient's identification and. as ""left neck level 1A and 1B"" contains a single piece of fibroadipose. tissue, measuring 4.4 x 4.0 x 2.9 cm. The submandibular gland is. present, measuring 3.6 x 3.0 x 1.9 cm. Nine possible lymph nodes are. identified, ranging in size from 0.2 cm in maximal dimension to 1.2 x 1.0. x 0.5 cm. Representative sections: 6A. submandibular gland. 6B. two possible lymph nodes. 6C. three possible lymph nodes. 6D. four possible lymph nodes. 7. The specimen container is labeled with the patient's identification. and as ""left neck level 2A and 2B"". It contains a single piece of. fibroadipose tissue, measuring 3.7 x 3.2 x 1.5 cm. Two possible lymph. nodes. are identified, measuring 2.4 x 1.4 x 1 .2 cm, and 1.5 x 0.6 x 0.5. cm. Representative sections. 7A. largest lymph node, bisected. 7B. second lymph node, bisected. 8. The specimen container labeled with the patient's identification and. as ""left neck level 3"" contains a piece of fibroadipose tissue, measuring. 4.0 x 1.9 x 1.1 cm. 11 possible lymph nodes are identified, ranging in. size from 0.2 x 0.2 x 0.2 cm to 1.4 x 0.9 x 0.5 cm. 8A. four possible lymph nodes. 8B. four possible lymph nodes. 8C. two possible lymph nodes. 8D. one lymph node bisected. 9. The specimen container labeled with the patient's identification and. as left neck level 4 contains a single piece of fibroadipose tissue,. measuring 2.8 x 1.2 x 0.9 cm. Seven possible lymph nodes are identified,. ranging in size from 0.3 x 0.3 x 0.1 cm to 1.6 x 0.9 x 0.8 cm. Representative sections: 9A. 4 possible lymph nodes. 9B. 2 possible lymph nodes. Service: Otolaryngology. Visit # : Resulted: Facility: 9C. largest lymph node, bisected. 10. The specimen container labeled with the patient's identification and. as ""right perifacial node' contains a single lymph node, measuring 1.0 x. 0.6 x 0.5 cm. Submitted in toto in 10A. 11. The specimen container is labeled with the patient's identification. and as ""surgical waste"" It contains 3 pieces of skin, ranging in size. from 5.0 x 1.0 x 0.2 cm to 10.6 x 3.5 x 0.3 cm. The skin is grossly. unremarkable. No sections are submitted. QUICK SECTION. 4. Posterior margin (black ink) of interest as per surgeon bisected into. 4A, 4B: -Margin uninvolved by carcinoma up to 0.3 cm. 5. Left tongue base, biopsy: negative for carcinoma. Last slide received. reported directly to. Page : 6 of 6.",T2,N0,M0,T2N0M0
TCGA-AA-3869,"Diagnosis. Resected ileocolic sample with an ulcerated, moderately differentiated adenocarcinoma of. the colorectal type, measuring max. 7 cm in diameter, covering the cecum extensively, with. broad infiltration of the pericecal fatty tissue, circumscribed penetration of the covering. serosa and 14 local lymph node metastases. Tumor-free small and large intestine resection. margins. Tumor-free mesenteric resection margin. Tumor-free appendix. The tumor stage is pT4 pN2 (14/28) pM1 (clinical liver metastases); G2 L1, V0, R2.",T4,N2,M1,T4N2M1
TCGA-AY-A8YK,"SURGICAL PATHOLOGY REVISED REPORT. Diagnosis: A: Colon, rectosigmoid junction, resection. Tumor Histologic Type: invasive colonic adenocarcinoma (see. comment). Histologic Grade: low grade, grade 2 of 4 (moderately. differentiated). Tumor Size: 5.2 cm in diameter. Tumor Location: sigmoid colon, just proximal to rectosigmoid. junction. Depth of Invasion: through muscularis propria and into. pericolonic soft tissues. Lymphovascular Invasion: present. Perineural Invasion: not identified. Margins: Proximal margin: negative, 6.5 cm away. Distal margin: negative, 5.0 cm away. Mesenteric margin: negative. Regional Lymph Nodes: Total number with metastases: 6. Total number examined: 24. Additional Pathologic Findings none. AJCC Pathologic TNM Stage: pT3 pN2a. Note: This pathologic stage assessment is based on information. available at the time of this report and is subject to change. pending clinical review and additional information. Comment: Immunostains for mismatch repair protein expression are pending. The results will be issued as an addendum to this report. Materials will be submitted to the. for. microsatellite instability testing. These results will be issued. in a separate Molecular Pathology report. Clinical History: -year-old male with a clinical diagnosis of colon cancer. Gross Description: Received is one appropriately labeled container, additionally. labeled ""rectosigmoid junction, stitch is distal"" and holds a 15. cm in length X 3.5 cm in open circumference segment of large. bowel oriented as stated above. The proximal mucosal margin is. inked blue, the distal mucosal margin is inked black, and the. tinea and surrounding yellow lobulated fat is inked green for. identification purposes. Approximately 6.5 cm from the proximal. mucosal margin and 5.0 cm from the distal mucosal margin, there. is a 5.2 cm proximal to distal X 4.0 cm circumferential tan firm. mass with central ulceration and raised edges. The mass on section extends up to 1.2 cm through the muscularis. propria into the attached yellow lobulated fat. The mass comes. to within 0.8 cm from the yellow intact peritonealized surface. The mass is present at the rectosigmoid junction and is not. surrounded by mesorectum. No additional abnormalities are. noted. Tumor and normal are submitted to tissue procurement. Block Summary. A1 - Proximal en face mucosal margin. A2-A3 - Distal en face mucosal margin. A4 - Mesenteric vascular pedicle margin. A5 - Lymph node present at mesenteric vascular pedicle margin,. bisected. A6-A7 - Mass with extension into fat. A8 - Mass with respect to tinea. A9 - Additional section of mass with extension into fat. A10 - One lymph node trisected. A11 - One lymph node, trisected. A12-A13 - - Multiple lymph nodes, each cassette. A14 - One lymph node bisected. A15-A16 - Multiple lymph nodes each cassette. A17-A19 - - One lymph node each cassette, each sectioned. Tissue remains in formalin. Addendum. To add the results of immunostains. Addendum Comment. Immunostains for mismatch repair protein expression are performed on. block A8 and show normal expression of MLH1, PMS2, MSH2, and MSH6. within the tumor. Correlate with the results of microsatellite. instability testing.",T3,N2,M1,T3N2M1
TCGA-44-A4SS,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Lung, left upper lobe, resection: Moderately differentiated. adenocarcinoma. Pulmonary emphysema. B. Lymph node, 4L, biopsy: A single lymph node is negative for. malignancy. C. Lymph node, level VII, biopsy: There is no evidence of malignancy in. any of 3 lymph nodes. D. Lymph node, level IX, biopsy: A single lymph node is negative for. malignancy. E. Lymph node, level V, biopsy: There is no evidence of malignancy in. any of 7 lymph node pieces. F. Lymph node, level XI, biopsy: A single lymph node is negative for. malignancy. G. Lymph node, level XII, biopsy: A single lymph node is negative for. malignancy. Microscopic Description: A. Histologic type: Adenocarcinoma with eosinophilic cytoplasm. Histologic grade: 2. Mitotic index: 17 mitoses/10 HPF's (1 HPF = 0.23 sq. mm). Tumor size: 2.5 cm. Bronchial resection margin: Negative for malignancy. Pleura: Negative for malignancy. Vascular invasion: Focal histologic features adjacent to the tumor. compatible with vascular invasion. Attached lymph nodes: There is no evidence of malignancy in any 10. hilar lymph nodes. pTNM stage: T1. lon-tumorous lung: Emphysema. Specimen. A.Left upper lobe. B. 4L. lymph node. C. Level 7 lymph node. D. Level 9 lymph node. E. Level 5 lymph node. F. Level 11 lymph node. G. Level 12 lymph node. Clinical Information. Left upper lobe lesion, lung cancer, tobacco abuse, alcohol abuse. Intraoperative Consultation. A. Lung, left upper lobe, resection: Positive for carcinoma. No. carcinoma seen in tissue at bronchial margin. Gross Description. Specimen A. is received labeled left upper lobe lung lobe measuring 26. by 14 by 6 cm there is a palpable mass with some overlying puckering of. pleura that is 5.5 cm from the bronchial margin. On cut section the. mass is white and measures 2.5 cm in diameter there is an area of red. discoloration of long at one side of the specimen this area measures. 1.7 cm in greatest dimension. A portion of the tumor is taken for. frozen section diagnosis. The bronchial margin is also taken for frozen. section diagnosis. Sections after fixation. Specimen B. is received unfixed labeled 4L. lymph node and consists of. a piece of dark colored soft tissue measuring 0.6 cm in greatest. dimension. Specimen C. is received unfixed labeled level VII lymph node and. consists of multiple pieces of dark soft tissue measuring 2 cm in. greatest aggregate dimension. Specimen D. is received unfixed labeled level IX lymph node and. consists of a piece of dark colored soft tissue measuring 0.4 cm. in. greatest dimension. Specimen A. is received unfixed labeled level V lymph node and consists. of multiple pieces of dark soft tissue measuring 2 cm in greatest. aggregate dimension. Specimen F. is received unfixed labeled level XI lymph node and. consists of a piece of dark soft tissue measuring 0.7 cm in greatest. dimension. Specimen G. is received unfixed labeled level XII lymph node and. consists of a piece of dark soft tissue measuring 0.3 cm in greatest. dimension.",T1,N0,M0,T1N0M0
TCGA-AA-3975,"This is an invasive, moderately differentiated adenocarcinoma of the colon (G2) with infiltration. of the muscularis (pT2) without vascular infiltration (LO, V0). Tumor classification: ICDO-DA-M 8140/3. G2. pT2, L0, V0. pNO (0 of 14). locally R0. M classification in the context of an oncology conference.",T2,N0,M0,T2N0M0
TCGA-E3-A3DY,"Surgery Date. carcinoms, papillary and fullicular 8340/3. SPECIMENS: A. PRETRACHEAL LYMPH NODE. B. LEFT PARATRACHEAL LYMPH NODE. C. RIGHT PARATRACHEAL LYMPH NODE. D. THYROID. DIAGNOSIS: A. PRETRACHEAL LYMPH NODE, EXCISION: ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). B. LEFT PARATRACHEAL LYMPH NODE, EXCISION: - METASTATIC PAPILLARY THYROID CARCINOMA PRESENT IN ONE OF TWO LYMPH NODES. (1/2). C. RIGHT PARATRACHEAL LYMPH NODE, EXCISION: - METASTATIC PAPILLARY THRYOID CARCINOMA PRESENT IN TWO OF TWO LYMPH NODES. (2/2). D. THYROID, TOTAL THYROIDECTOMY: - MULTIFOCAL PAPILLARY THYROID CARCINOMA IN RIGHT AND LEFT THYROID, LARGEST. TUMOR FOCUS MEASURING 1.7 x 1.1 CM. - CARCINOMA FOCALLY EXTENDING TO RIGHT PERI-THYROID SOFT TISSUE. ONE LYMPH NODE ATTACHED TO RIGHT THYROID, POSITIVE FOR METASTATIC CARCINOMA. (1/1). - SURGICAL RESECTION MARGINS, NEGATIVE FOR TUMOR. - CHRONIC LYMPHOCYTIC THYROIDITIS. - SEE TEMPLATE. THYROID TEMPLATE. Specimen Type: Total thyroidectomy. Tumor Site: Right and left lobes. Tumor Focality: Multifocal. Tumor Size (Largest nodule): 1.7 cm in greatest dimension, 1.1 x 0.9 cm in additional dimension. (right); 1.0 x 1.0 cm (left); and 1 mm (right). Histologic Type: Papillary carcinoma: mixed papillary and follicular variant. Margins: Uninvolved; distance to closest margin: <1 mm. in both right. and left thyroid. Venous/Lymphatic Invasion: Present. Additional Findings: Chronic lymphocytic thyroiditis. Lymph Nodes: Right and Left. Procedure: Lymph nodes biopsy. Metastatic papillary thyroid carcinoma present in 1/2 left paratracheal lymph nodes, 2/2 right. paratracheal lymph nodes, and 1/1 right peri-thyroid lymph node. One pretracheal lymph node, negative for tumor. Pathologic Stage: pT3 N1a Mx. SPECIMEN(S): A. PRETRACHEAL LYMPH NODE B. LEFT PARATRACHEAL LYMPH NODE C. RIGHT. PARATRACHEAL LYMPH NODE D. THYROID. CLINICAL HISTORY: None given. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSB: Left paratracheal lymph node: Positive for metastatic thyroid carcinoma. By Dr., called to Dr. at. GROSS DESCRIPTION: A. PRETRACHEAL LYMPH NODE. Received in formalin and labeled as ""pretracheal lymph node"" is a piece of yellow-tan adipose tissue. measuring 2.8x0.9x0.2cm containing 2 possible lymph nodes measuring 0.3 and 0.5cm. Submitted in. toto in block A1. B. LEFT PARATRACHEAL LYMPH NODE. Received fresh for frozen section and labeled ""left paratracheal lymph node"" are 2 lymph nodes in. aggregate measuring 1.5x0.8x0.2cm. Touch preps are performed and the specimen is submitted in toto. block FSB1. C. RIGHT PARATRACHEAL LYMPH NODE. Received in formalin and labeled ""right paratracheal lymph node"" are 2 pink-tan lymph nodes. measuring 0.2 and 0.3cm. Submitted in toto in block C1. D. THYROID. Received fresh for possible tissue procurement and labeled ""thyroid"" is a 1.5gm thyroid gland. The. right lobe is 5.0x2.3x0.5cm and the left lobe is 2.5x2.3x0.3cm. Right lobe is inked blue and the left lobe. is inked yellow and the specimen is serially sectioned. Within the right lobe is a firm, tan mass,. 1.7x1.1x0.9cn In the left lobe is an area of diffuse white-tan discoloration measuring up to 0.9cm in. greatest dimension. The remainder of the thyroid tissue has a meaty red-brown coloration. Sections. are submitted for tissue procurement. Specimen is submitted in toto as follows: D1-D2: mass from the right thyroid lobe. D3-D7: remainder of the tissue from the right lobe of thyroid. D8: isthmus. D9-D10: normal appearing left thyroid lobe. D11-D13: area of discoloration from left lobe. Microscopic/Diagnostic Dictation: M.D., Pathologist. Final Review: , M.D., Pathologist. Final: , M.D., Pathologist.",T3,N1,M0,T3N1M0
TCGA-B6-A0WT,"Qurgical Pathology. CLINICAL HISTORY: Not provided. GROSS EXAMINATION: A. ""Left breast biopsy (AF1)"" fresh. A 7 x 4.9 x 1.7 cm yellow-white. fibrofatty breast biopsy notable for a 2.5 x 3.5 x 2 cm firm, white lesion. After consultation with Dr. , it was deemed that no surgical margins. or orientation are required on this specimen. The tissue surface is inked in. black, however. Tissue from the lesion is sent to the Tissue Bank for Estrogen. and Progesterone receptor study. The frozen section remnant (AF1) was taken. from the lesion area is submitted in Block A1. A representative sampling from. the lesion area is submitted in Blocks A2-A5. Due to the fact that neither. margins or orientation is an issue in the specimen, only a sampling of the. lesion is taking-- the entire breast biopsy is not submitted. B. ""Left breast"", fresh. A mastectomy specimen consisting of a 19 x 10 cm. ellipse of skin, a 24 x 15 x 5 cm breast and a 11 x 6 x 3.5 cm axillary tail. The deep surfaces of the breast are inked in black. The skin ellipse contains. the nipple and surrounding areola and is notable for a 4.5 cm freshly sutured. horizontal incision medial to the nipple. The breast specimen is notable for a 7 x 6 x 1.5 cm hollow biopsy cavity lined. by mildly firm, granular red-pink tissue 0.1 cm thick. At its closest point,. the biopsy cavity is 1.5 cm from the posterior surface, 1.7 cm from the. inferior surface, 9 cm from the superior surface, and 1.2 cm from the. overlying anterior skin surface. The remainder of breast is diffusely composed. of yellow-white fibrofatty tissue. No focal lesions are noted. BLOCK SUMMARY: B1- representative section of nipple. B2- representative section of biopsy cavity and closest approach to posterior. surface. B3- representative section of biopsy cavity and closest approach to inferior. surface. B4- biopsy cavity and closest approach to anterior skin surface. B5-B6- additional sections of biopsy cavity. B7-B8- representative sections of upper medial portion of breast. B9-B10- representative sections of lower medial portion of breast. B11-B12- representative sections of upper lateral breast. B13-B14- representative sections of lower portion of breast. B15- four lymph node candidates from most medial portion of axillary tail. B16- four lymph node candidates from mid portion of axillary tail. B17- three lymph node candidates from most lateral portion of axillary tail. B18- three lymph node candidates from most lateral portion of axillary tail. B19- three lymph node candidates from most lateral portion of axillary tail. Dr. INTRA OPERATIVE CONSULTATION: A. ""Left breast biopsy"" AF1- positive for invasive carcinoma. DIAGNOSIS: A. ""LEFT BREAST BIOPSY"": INFILTRATING DUCTAL CARCINOMA, HISTOLOGIC GRADE 3, NUCLEAR GRADE 2. N.S.A.B.P. Diagnosis Diss cite. hary. Tumat. (Tircle) primiry SUALIFIED Date 916th. MAXIMUM TUMOR SIZE 3.5 CM. IN SITU DUCTAL COMPONENT REPRESENTS APPROXIMATELY 15 TO 20% OF TUMOR MASS. B. ""LEFT BREAST"" (MASTECTOMY) : BREAST TISSUE WITH BIOPSY CAVITY. NO EVIDENCE OF MALIGNANCY. 1 OF 15 LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (SEE NOTE). BENIGN PROLIFERATIVE CHANGES OF THE BREAST INCLUDING EXTENSIVE FIBROSIS,. DUCT ECTASIA, APOCRINE METAPLASIA, AND HYPERPLASIA OF THE USUAL TYPE. NOTE: One large lymph node (B18) appears negative for malignancy but is being. reprocessed for further examination. An addendum will be issued to this. report documenting the findings in this. ADDENDUM 1: Review of a reprocessed blocks (B18) shows three lymph nodes with no evidence. of malignancy. The one large lymph node mentioned in the original report. specifically contains no evidence of ma Lignaticy.",T2,N1,M0,T2N1M0
TCGA-CJ-4638,"'atholgy Accession. DIAGNOSIS. (A) LEFT KIDNEY: RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE, FUHRMAN'S NUCLEAR GRADE 4 (15.0 CM). (SEE COMMENT). TUMOR FOCALLY INVADES RENAL SINUS FAT. TUMOR INVADING THE RENAL VEIN. RENAL VEIN MARGIN OF RESECTION FREE OF TUMOR. METASTATIC RENAL CELL CARCINOMA INVOLVING WALL OF DISTAL PORTION OFURETER. URETERAL MARGIN OF RESECTION FREE OF TUMOR,. METASTATIC RENAL CELL CARCINOMA IN MATTED HILAR LYMPH NODES (APPROXIMATELY TWENTY). Three additional hilar lymph nodes, no tumor present. Adrenal gland, no tumor present. (B) NODE BELOW THE BIFURCATION: METASTATIC RENAL CELL CARCINOMA INVOLVING ONE LYMPH NODE. COMMENT. The tumor displays focally rhabdoid features. GROSS DESCRIPTION. (A) LEFT KIDNEY - A radical nephrectomy specimen (18.0 cm X 17.0 cm x 10 cm), including a kidney (16.0 cm x 9.0 cm x 10.0 cm),. ureter (12.0 cm x 0.5 cm), hilar lymph nodes (measuring overall 15.0 X 6.0 x 6.0 cm), and adrenal gland (4.0 x 1.5 x 0.5 cm). A well-circumscribed tumor (15.0 X 8,5 x 9.0 cm) is present occupying approximately 90% of the renal parenchyma. It is yellow tan. with extensive areas of hemorrhage and necrosis. The tumor appears to invade the renal sinus and renal vein, however, the renal vein. margin is free of tumor. The tumor does not appear to extend into the perirenal fat margin. The pelvis appears nodular but has a. smooth surface. The kidney parenchyma away from tumor shows multiple tumor nodules. One centimeter from the ureteral margin is. a 0.2 cm cystic nodule. The ureteral margin is grossly free of tumor. The renal hilum is expanded (15.0 X 6.0 x 6.0 cm) and contains multiple matted lymph nodes (approximate total of 23), most of. which are grossly involved by tumor. The adrenal gland appears uninvolved by tumor. INK CODE: Black - soft tissue margin. SECTION CODE: A1,renal vein and ureteral margins; A2-A5, tumor in sinus and pelvis; A6, tumor and perinephric fat margin;A7-. A8 tumor in renal vein; A9-A10, tumor; A11-A12, tumor and adjacent kidney parenchyma; A13-A18, lymph nodes; A19, normal kidney;. A20, adrenal gland; A21, three unremarkable lymph nodes entirely submitted; A22, lesion 1 cm from ureteral margin. (B) NODE BELOW THE BIFURCATION - A lymph node (4.0 cm x 2.2 cm x 2.0 cm) grossly involved by tumor. SECTION CODE: B1-B2, representative sections of lymph node. CLINICAL HISTORY. None given.",T3,N1,M1,T3N1M1
TCGA-BQ-5889,"Clinical Diagnosis & History: Left renal mass with thrombus, left kidney tumor. Specimens Submitted: 1: SP: Caval wall, biopsy. 2: SP: Kidney and adrenal gland, left, radical nephrectomy. 3: SP. Vena cava, additional, biopsy. 4: SP: Lymph nodes, left perihilar, resection. 5 SP:Lymph nodes, paraaortic, resection. 6: SP:Lymph nodes, aortocaval, resection. 7: SP: Hernia sac. abdomen, repair. DIAGNOSIS: 1. SP: Caval wall, biopsy. -Portion of vein with a detached cluster of atypical cells admixed with fibrin in the lumen (see comment). 2. SP: Kidney and adrenal gland, left, radical nephrectomy. Tumor Type: Renal cell carcinoma, unclassified, with papillary features and high nuclear grade (see comment). Tumor Size: Greatest diameter is 8.5 cm. With multiple satellite nodules. Local Invasion (for renal cortical types): Extends through renal capsule but confined within Gerota's fascia. Extends into renal pelvis. Involves renal hilar fat. Renal Vein Invasion: Identified. Extensive vascular invasion is present. Surgical Margins: Tumor present at renal vein margin. Non-Neoplastic Kidney: Unremarkable. Renal papillary adenoma (0.2cm in greatest dimension). Adrenal Gland: Carcinoma involves the periadrenal soft lissue and abuts the capsule of the adrenal gland. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT3b Tumor grossly extends into the renal vein(s) or vena cava below the diaphragm. 3. SP: Vena cava, additional, biopsy: -Portion of vein with detached atypical cells admixed with fibrin in the lumen, favor reactive: no definite tumor seen (see. comment). 4. SP: Lymph nodes, left perihilar, resection: Lymph Nodes: Number of nodes examined: 10. Number of metastatic nodes:8. The largest metastatic node is 2.5cm. Perinodal (extracapsular) extension identified. The largest metastatic deposit measures 2.5cm in greatest dimension. 5. SP:Lymph nodes, paraaortic, resection: Lymph Nodes: Number of nodes examined:18. Number of metastatic nodes: 13. The largest metastatic node is 3.5cm. Perinodal (extracapsular) extension identified. The largest metastatic deposit measures 3.5cm in greatest dimension. 6. SP:Lymph nodes, aortocaval, resection: Lymph Nodes: Not involved. Number of nodes examined:4. 7. SP: Hernia sac, abdomen, repair: -Benign mesothelium lined fibrovascular and adipose tissue, consistent with hernia sac. Comment: The lumor cells are negative for CK7, 34BE 12 and racemase, and show focal faint staining with AE1/AE3 and CA-IX,. BAF-47 stain is non-contributory. Among the diagnostic possibilities a hereditary leiomyoma renal cell carcinoma (HLRCC) should. be considered. Selected parts (1, 2, 3 and 5) reviewed with. who concurs. Some of the immunohistochemistry and ISH tests were developed and their performance characteristics were determined by the. Department of Pathology. They have not been cleared or approved by the US Food and Drug Administration The FDA has. determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be. ligational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of. qualified to perform high complexity clinical laboratory testing. IATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL) AND THAT HIAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. AE1:AE3. CK7. RACEMASE. 34BE12. NEG CONT. IMM RECUT. BAF-47. CA-1X. NEG CONT. Gross Description: 1)The specimen is received fresh for frozen section consultation, laboled ""caval wall rule out tumor invasion"" and consists of. tan-pink tissue measuring 0.9 x 0.4 x 0.1 cm. Entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 2) The specimen is received fresh and subsequently placed in formalin labeled ""left kidney and adrenal gland, fresh and sterile"". and consists of a kidney with attached ureter, renal vessels and perinephric fat weighing 1007 g in total. The kidney measures 19 x. 12.5 X 8.5 cm. The attached ureter measures 9 cm in length and 0.2 cm in diameter. The attached renal vein measures 5.5 cm in. length and 1.7 cm in diameter. The arterial and ureteral margins are grossly unremarkable. The vein is dilated with firm. adherent,. yellow-red possible blood clot obstructing the lumen. Also in the pelvis are multiple firm to rubbery nodules, some of which appear. to be positive lymph nodes. An orange-yellow. hemorrhagic adrenal gland is identified near the hilum and measures 5 X 3 x 1.5. cm. The kidney is inked black and bivalved to reveal an 8.5x7.5 x 6 cm yellow-tan to red-brown, hemorrhagic, friable,. pseudoencapsulated mass in the upper pole which grossly invades through the renal capsule. Scattered are multiple ovoid,. circumscribed lesions which grossly involve the pelvis. Sections through the remainder of the kidney reveals scant, uninvolved. pink brown parenchyma, with a well-defined cortico-medullary junction. The cortex measures up to 1.2 cm and the calyces are. almost entirely infiltrated with tumor. Also in the container are multiple, irregular portions of red-yellow, friable, possibly necrotic. soft tissue and red-brown blood clot representing possible additional portions of the upper pole tumor. The specimen is. photographed. Representative sections are submitted for. d for permanent sections. Summary of sections: UVM -- ureteral and vessel margins. UPT upper pole tumor. SL - scatlered lesions. THF tumor with hilar fat. TSF tumor with sinus fat. UPTK - upper pole tumor with adjacent kidney. RP -- renal pelvis representative sections. K representative sections kidney. AD adrenal gland. 3) The specimen is received in formalin, labeled ""Additional vena cava"" and consists of a 1.2 x 0.4 x 0.3 cm, irregular, rubbery,. pink-white lissue fragment, which is submitted in toto. Summary of sctions: AVC -+ additional vena cava. 4) The specimen is received in formain, laceled Len periniar lymph nodes"" and consists of a 2.4.x 2.0 x 1.3 cm from of a tissue. fragment, which is sectioned to reveal five, firm, red purple lymph podes, ranging from 0.3 to 2.2 cm in greatest dimension. The. larger lymph nodes are bisected or trisected and all lymph nodes are entirely submitted. Summary of sections: LN lymph nodes. BLN - bisected lymph nodes. LTLN -- largest trisected lymph node, submitted into two cassettes. 5) The specimen is received in formainn, rabeled Fara-aoric lymph nodes"" and consists of a 3.7 x 3.6 x 2.0 cm aggregate of. fibrofatly tissue, which is sectioned to reveal 19, firm, slightly adhered to matted, tan-white lymph nodes, ranging from 0.3 to 2.6 cm. in greatest dimension. The larger lymph nodes are bisected and all lymph nodes are entirely submitted. Summary of sections: LN -- lymph nodes. BLN  bisected lymph nodes. LBLN -- largest bisected lymph node, submitted into two cassettes. 6) The specimen is received in formalin, labeled ""Aortocaval lymph nodes"" and consists of a 2.6 x 1.1 x 0.7 cm fibrolatty tissue. fragment, which is sectioned to reveal four, diffusely hemorrhagic, focally fragmented, tan-red lymph nodes, ranging from 0.7 to 1.2. cm in greatest dimension. All four lymph nodes are bisected and are entirely submitted. Summary of sections: BLN : bisected lymph nodes. 7) The specimen is received in formalin, labeled Hernia sac -- abdomen"" and consists of a 5.7 x 3.8 x 0.8 cm, irregular, rubbery,. focally fatty, tan-purple fibromombranous tissue fragment. with multiple congested tobules of adipose tissue. No lesions or lymph. nodes are identified grossly. Representative sections are submitted. Summary of sections: RS -- representative section. Summary of Sections: Part 1: SP: Caval wall, biopsy. Block. Sect. Site. PCs. 1. fsc. Part 2: SP: Kidney and adrenal gland, left, radical nephrectomy. Block. Sect. Site. PCs. 2. AD. 2. 2. K. 3. LN. 3. 1. PTK. 1. 3. RP. 4. 4. SL. THF. 1. 2. TSF. A. 2. UPT. 4. 2. UVM. 3. Part 3: SP: Vena cava, additional, biopsy. Block. Sect. Site. PCs. 1. AVC. 1. Part 4: SP: Lymph nodes, left peribilar, resection. Block. Sect. Site. PCs. 2. BLN. 4. 2. LBLN. 2. 1. LN. 2. Part 5: SP:Lymph nodes, paraaortic, resection. Block. Sect. Site. PCs. 6. BLN. 3. 12. 2. LBLN. 2. 2. LN. 12. Part 6: SP:Lymph nodes, aortocaval, resection. Block. Sect. Site. PCs. 4. BLN. 8. Part 7: SP: Hernia sac, abdomen, repair. Block. Sect. Site. PCs. 1. RS. 2. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: SP: Caval wall. PERMANENT DIAGNOSIS: SEE FINAL.",T3,N1,M1,T3N1M1
TCGA-D7-6521,"page 1 / 2. Examination: Histopathological examination (cito). Material: 1. Total organ resection - stomach. Expected time of examination. Clinical diagnosis: Cancer of the gastric body. Macroscopic description: Sent material consisting of the stomach, cut out along the greater curvature, sized 17 x 18 cm with the. omentum sized 34 x 25 cm. Tumour sized 6 x 2 x 2.5 cm in the greater curvature. Distance from the proximal end 3.5 cm, from distal. end 2.5 cm. Microscopic description: Adenocarcinoma male differentiatum partim mucocellulare. The tumour invades through the full thickness of the stomach wall, vessels, perigastric fat tissue, and. reaches the surface of the peritoneum. Incision lines free of neoplastic lesions. Part of the omentum free of neoplastic lesions. Lymph nodes: 1,2 - (periorificial): metastases carcinomatosae in lymphonodis No 11/11. Infiltratio carcinomatosa capsulae lymphonodorum. 3 - (lesser curvature): metastases carcinomatosae in lymphonodis (No VIII/VIII). Infiltratio carcinomatosa capsulae lymphonodorum. 4 - (greater curvature): metastases carcinomatosae in lymphonodis (No III/III). Infiltratio carcinomatosa capsulae lymphonodorum. 5 - (peripyloric): metastases carcinomatosae in lymphonodis (No II/IV). Infiltratio carcinomatosa capsulae lymphonodorum. Histopathological diagnosis: Adenocarcinoma male differentiatum partim mucocellulare ventriculi. Poorly differentiated and partially. mucocellular adenocarcinoma of the stomach. Metastases carcinomatosae in lymphonodis (No XV/XVII). Cancer metastases in the lymph nodes (No XV/. XVII). (G3, pT2b, pN2 typus) mixtus sec. CALL YOUR DOCTOR WITH THIS REPORT!.",T2,N2,M0,T2N2M0
TCGA-85-8072,Gross. Microscopic. Diagnosis. Comments. Description. Description. Details. Laterality. LUNG TISSUE CHECKLIST. Left-upper. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 1.5 X 1.5 X 1. cm. Histologic type: Squamous. cell carcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Not. specified. Other tumor nodules: Not. specified. Lymph nodes: Not. specified. Lymphatic invasion: Not. specified. Venous invasion: Not. specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic. findings: Not specified. Comments: None.,T1,N0,M0,T1N0M0
TCGA-AG-3892,"Diagnosis: This is a moderately differentiated adenocarcinoma of the rectum of histopathological grade G2,. with erosions of the inner tumor surface with peritumorous chronic recurrent secondary. inflammation, with tumor infiltration of the rectal wall layers extending into the submucosa and,. in places, as far as (but not into) the tunica muscularis with tumor-free lymph nodes (0/17) with a. moderate chronic lymphadenitis and tumor-free overview slices from all other resection material. portions described. According to the section preparations available, the tumor spread of the rectal carcinoma. corresponds to a tumor stage of pT1, pNO (0/17), MX, R0. Tumor classification: ICDO-DA M-8140/3.",T1,N0,M0,T1N0M0
TCGA-EL-A3CO,"ry Case. gy Report. Sex: M. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. the section ""SPECIMEN"" may have been added. DIAGNOSIS. (A) LEFT NECK DISSECTION CONTENTS (LEVEL II, III, IV, AND V): METASTATIC PAPILLARY THYROID CARCINOMA IN SIX OF TWENTY-ONE LYMPH. NODES (LEVEL II 1/3, LEVEL V 6/18), WITH EXTRANODAL EXTENSION. (SEE COMMENT). (B) RIGHT NECK DISSECTION CONTENTS (LEVEL II, III, IV AND V) : METASTATIC PAPILLARY THYROID CARCINOMA IN THREE OF SEVENTEEN LYMPH. NODES (LEVEL II 0/2, LEVEL V 3/15), WITH EXTRANODAL EXTENSION. (SEE COMMENT). DELPHIAN LYMPH NODE: METASTATIC PAPILLARY THYROID CARCINOMA IN ONE (3.0 MM GREATEST. DIMENSION) OF THREE LYMPH NODES. No extranodal extension. TOTAL THYROIDECTOMY: PAPILLARY CARCINOMA OF THYROID GLAND, MULTIFOCAL (LARGEST FOCUS 3.5. CM IN GREATEST DIMENSION) INVOLVING BOTH RIGHT AND LEFT LOBES,. WITH EXTENSION INTO CERVICAL SOFT TISSUE. No definite vascular invasion. Entire report and diagnosis completed by: Report released by: COMMENT. The largest lymph node involved by metastatic carcinoma in the left neck. dissection (specimen A) measures 2.5 cm in greatest dimension, and is located. in level II. There is extranodal extension of tumor from this lymph node. The largest lymph node involved by metastatic carcinoma in the right neck. dissection (specimen B) measures 1.9 cm in greatest dimension, and is located. in level V. GROSS DESCRIPTION. (A) LEFT NECK DISSECTION CONTENTS: LEVEL II,III, IV AND V LYMPH NODE - A neck. dissection specimen divided into levels II, III, IV and V by the surgeon. Level II consists of one piece of pink-yellow fibroadipose tissue measuring. 4. x 2.5 x 2.0 cm. Three lymph nodes are identified. The largest lymph node. measures 2.5 x 1. 8 x 1.8 cm. Level III consists of one irregular piece of. pink-yellow fibroadipose tissue measuring 7.0 x 3.0 x 0.8 cm. No distinctive. lymph nodes are identified. Level IV consists of one irregular piece of. yellowish adipose tissue measuring 4.5 x 2.0 x 1.0 cm. Four possible lymph. nodes are identified. Level V consists of one irregular piece of pink-yellow. adipose tissue measuring 5.0 x 3.5 x 2.0 cm. Total of eighteen possible lymph. nodes are identified from this level. History Case. Sex: M. MD. Case type: Surgical History. SECTION CODE: A1-A4, level II lymph nodes (A1, serial sections, one lymph. node, A2, one lymph node; A3, and A4, section of largest lymph node); A5, A6,. level III representative sections; A7, level IV lymph nodes (four possible. lymph nodes) ; A8-A15, level V lymph nodes (A8, four lymph nodes; A9, two lymph. nodes; A10, four lymph nodes; All, four lymph nodes; A12, sections of one. lymph node (submitted after decalcification); A13, one lymph node. bisected;. A14, one lymph node, bisected; A15, one lymph node, bisected). (B) RIGHT NECK DISSECTION CONTENTS (LEVEL II, III, IV, AND v) - A. neck. dissection specimen divided into levels II, III, IV and V by the surgeon. Level II consists of a fragment of fibrous adpose tissue (4.5 x 4.0 x 0.5. cm), containing tan soft lymph nodes. Level III consists of a fragment of. fibroadipose tissue (3.5 x 1.0 x 0.3 cm) with no identifiable lymph nodes. Level IV consists of a fragment of fibroadipose tissue (4.5 x 3.0 x 0.5 cm). with two possible 0.6 cm in diameter lymph nodes. Level V consists of. fragments of fibroadipose tissue (8.0 x 5.0 x 0.5 cm) containing twenty. possible lymph nodes, up to 1.9 cm in maximum dimension. The largest lymph. node is replaced by tumor. SECTION CODE: Level II (81-83) : B1, one lymph node, bisected; B2-B3,. additional possible lymph nodes, submitted in toto. Level III (B4-B5) 84,. two possible lymph nodes, B5, three possible lymph nodes. Level IV (86,87). B6, one possible lymph node; 87, two possible lymph nodes. Level V. (B8-819): B8, one lymph node, bisected; B9, one lymph node; B10, one lymph. node, bisected; B11, B12, one possible lymph node, bisected; B13, one lymph. node; B14, one lymph node, bisected; B15, two lymph nodes; B16, three possible. lymph nodes; B17. three possible lymph nodes; 818, four lymph nodes; B19, two. lymph nodes. (c). DELPHIAN NODE - An irregular fragment of pink-gray soft tissue (1.0 x 0.8. x 0.4 cm). Submitted in toto in c. TOTAL THYROIDECTOMY - A total thyroidectomy specimen (9.0 x 6.0 x 3.5. cm), distorted by a tumor located in the right lobe. This tumor measures 3.5. x 3.5 and 3.0 cm, shows yellowish discoloration and cystic degeneration, and. with dark brown fluid. In addition to the largest tumor nodule in the right. lobe there is a second nodule (0.6 x 0.5 cm) located 0.2 cm away from the main. tumor. In the left lobe there are two small nodules, ranging from 0.3 cm in. diameter to 0.6 cm in diameter. The normal appearing thyroid parenchyma is. unremarkable. SECTION CODE: D1, representative section from the left lobe; D2, left. lobe nodule; D3, representative section from left lobe; D4, representative. section from left lobe; D5-D10, representative section from the large tumor;. D11, section from the large tumor and adjacent normal thyroid parenchyma; D12,. second nodule in the right lobe: D13. D14, representative section from normal. appearing thyroid parenchyma. SNOMED CODES.",T3,N1,M0,T3N1M0
TCGA-BH-A0E2,"P.25/33. DIAGNOSIS: BREAST, RIGHT, MODIFIED RADICAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA WITH ASSOCIATED CALCIFICATIONS. B. NOTTINGHAM GRADE 3 (TUBULE FORMATION: 3, NUCLEAR PLEOMORPHISM: 3, MITOTIC ACTIVITY: 3; TOTAL. SCORE: 9/9). C. INVASIVE TUMOR MEASURES 2.5 X 2.3 X 2.0 CM. D. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 3, SOLID, CRIBRIFORM MICROPAPILLARY AND CLEAR. CELL TYPES WITH COMEDONECROSIS AND ASSOCIATED CALCIFICATIONS. E. THE DUCTAL CARCINOMA IN SITU (DCIS) CONSTITUTES 50% OF THE TOTAL TUMOR VOLUME AND IS. PRESENT ADMIXED WITH THE INVASIVE COMPONENT. F. THE DUCTAL CARCINOMA IN SITU (DCIS) IS PRESENT IN 12/22 SLIDES. G. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. H. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. DUCTAL CARCINOMA IN SITU (DCIS) IS 4.0 MM. FROM THE NEAREST ANTERIOR MARGIN, THE INVASIVE CARCINOMA IS GREATER THAN 1.0 CM FROM ALL. MARGINS. I. THE NIPPLE IS INVOLVED BY DUCTAL CARCINOMA IN SITU. J. SKIN IS NEGATIVE FOR TUMOR. K. NON-NEOPLASTIC BREAST: INTRADUCTAL PAPILLOMA AND FIBROCYSTIC CHANGES WITH. FIBROADENOMATOID NODULES,. L. BIOPSY SITE CHANGES WITH FAT NECROSIS. M. METASTATIC CARCINOMA INVOLVING FOUR OF TWENTY-SIX LYMPH NODES (4/26). N. THE LARGEST METASTATIC FOCUS MEASURES 2.0 CM. O. EXTRACAPSULAR EXTENSION IS IDENTIFIED AND MEASURES 1 MM. P. THE INVASIVE TUMOR CELLS TESTED POSITIVE FOR ESTROGEN AND WEAKLY POSITIVE FOR. PROGESTERONE RECEPTORS AND NEGATIVE FOR HER-2, AS PER PREVIOUS PATHOLOGY REPORT. LASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Lower outer quadrant. SIZE OF TUMOR: MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: Maximum dimension invasive component: 2 5 cm. TUMOR TYPE (invasive component): NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS. Nuclear grade: 3. Tubule formation: 3. Mitolic activity score: 3. Total Nottingham score: 9. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION;. Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. Solid. Micropapillary. Comedo. DCIS admixed with invasive carcnoma. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Percent of tumor occupled by in situ component 50 %. SURG MARGINS INVOLVED BY IN SITU COMPONENT: PAGET'S DISEASE OF NIPPLE: Distance of in silu disease to closest margin: 40 mm. LYMPH NODES POSITIVE: 4. LYMPH NODES EXAMINED: 26. METHOD(S) OF LYMPH NODE EXAMINATION: H/E levels. SIZE OF NODAL METASTASES: Diameter of largest lymph nodo metastasis: 20 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: Papillonia, FCD, Other: Fibroadenomatoid nodules. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pN2a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTRONE RECEPTORS: positive. HER2/NEU:",T2,N2,M0,T2N2M0
TCGA-FP-8210,"Physician Portal. TEST: Surgical Pathology. Collected Date & Time. Result Name. Reference Range. Pre-Op Diagnosis. Gastric adenocarcinoma. Post-Op Diagnosis. Nothing indicated. Clinical History. Nothing indicated. Gross Description: Received in a single container labeled. - partial. gastrectomy"" is a portion of recognizable distal stomach measuring. 15.4 cm along the greater curvature and 9.3 cm along the lesser. curvature. The specimen has been previously opened along the lesser. curvature. There is a minimal amount of lesser curvature adipose. tissue as well as a small amount of greater curvature tissue as well. as a 31.3 x 29.2 x up to 1.0 cm sheet of attached recognizable. omentum on the greatest curvature. The serosa is smooth and tan brown. with a 3.2 x 2.5 cm gray white fibrotic plaque noted at a point 2.0. cm from the distal margin on the anterior aspect extending toward the. greater curvature. The gastric wall is up to 1.0 cm edematous and. fibrotic. The lumen is lined by cobblestoned gray tan mucosa with. preservation of normal rugation. At a point 1.0 cm from the distal. margin there is a previously partially sectioned fairly well defined. 2.6 x 2.5 cm lobulated centrally ulcerated gray tan plaque like. lesion which extends to both the anterior and posterior aspects as. well as the greater curvature. This appears to focally extend to the. lesser curvature. On sectioning this lesion has a gritty gray tan. fibrotic cut surface measuring up to 1.6 cm in thickness. The lesion. appears to extend to but not through the serosa in the majority of. the specimen with a few focal areas of apparent extension in the. greater curvature in the posterior aspect. On sectioning the lesser. curvature and greater curvature adipose tissue reveals several well. defined and poorly defined gray tan to yellow nodules measuring up. to. 1.4 cm in greatest dimension. On sectioning the largest nodules have. fleshy gray tan cut surfaces. On sectioning the omentum reveals a few. areas of gray tan indurated fibrosis which are poorly defined. measuring up to 0.4 cm. Also received in the same container are three. tissue cassettes each labeled. Representative sections are. submitted labeled as follows: A - greater curvature adipose tissue. proximal; B - anterior margin proximal; C - lesser curvature margin. proximal; D - posterior margin proximal; E - greater curvature margin. distal; F - anterior margin distal; G - lesser curvature margin. distal; H - postetior margin distal; I through L - lesion to greater. curvature; M - lesion anterior wall; N - lesion lesser curvature; o -. lesion posterior wall; P - representative greater curvature mucosa; Q. - anterior mucosa; R - lesser curvature mucosa; is - posterior mucosa;. T - largest nodule from lesser curvature adipose tissue bisected; U -. whole smaller nodules from lesser curvature adipose tissue; V and W -. individual nodules from greater curvature adipose tissue bisected; X. through Z - whole smaller nodules from greater curvature adipose. tissue; AA through CC - representative omentum. Microscopic Description: See diagnosis. Final Diagnosis. Distal stomach, partial gastrectomy: Ulcerated infiltrative poorly differentiated adenocarcinoma with. focal signet rings. Diffuse type adenocarcinoma of Lauren. Tumor size: 2.6 x 2.5 cm. Tumor extends to inked serosal margin of resection. Tumor is located mainly in antrum. Lymphovascular space identified. PH sician Portal. Perineural space ide. ied. Multiple foci of tumor in perigastric adipose tissue and omentum. Proximal margin of resection is negative. Tumor is 1.0 cm from distal margin of resection. Radial margin (serosal) is positive. Three of 23 lymph nodes is positive. One positive lymph node has extracapsular extension. Remainder of stomach with focal intestinal metaplasia, acute and. chronic inflammation, and. reactive changes. Comments. This test has been finalized at the. Campus. M.D.",T3,N1,M0,T3N1M0
TCGA-DD-AAD8,"CLINICAL DIAGNOSIS: HCC in Segment 4. Specimen : Liver lateral segment. Gross Photo. GROSS: Specimen: Liver: 21.5 X 11.5 X 3.0 cm, 281.5 gm (fresh). Gallbladder: 7.0 cm in length, 4.0 cm in diameter (fresh). Operation: Lateral segmentectomy. Lesion: A well-defined mass. Size: 1.5 X 1.8 X 2.0 cm. Cut surface: Yellowish tan, and granular. Gross type. HCC: Expanding nodular. Resection margin: Not involved grossly (safety margin: 3.5 cm). Satellite nodule: No. Remaining parenchyma: Unremarkable. Portal vein invasion: No. Representative sections are submitted. Gross photo: Present. Blocks. T1- TB, bile tinged mass and surrounding liver parenchyme x 5. L, NB, nontumorous liver parenchyme x 2. RM, resection margin of liver X 1. GB, gallbladder X 1. MICROSCOPIC: Hepatocellular carcinoma: (Edmondson-Steiner grade). The worst differentiation II. The major differentiation II. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: Yes (10 %). Fibrous capsule formation: No. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Intrahepatic metastasis: No. Multicentric occurrence: No. Non-tumor liver pathology. 1. Chronic hepatitis: Yes. 1-1. Etiology: HCV. 1-2. Grade, lobular: Mild. 1-3. Grade, portoperiportal: Moderate. 1-4. Stage (fibrosis): Periportal. 1-5. Cirrhosis: No. 2. Dysplastic nodule: No. 3. Ductal epithelial dysplasia: No. 4. Other liver diseases: No. NOT reported. Gross: cervix, senile atrophy. cervix, smear, inflammation. cervix,smear, senile atrophy. Anus, ectomy, hemorrhoid. liver,ectomy,hepatocellular carcinoma. T56000, P10, M81703. gallbladder,ectomy, chronic cholecystitis,cholelithiasis. T57000, P10, M43005, M30011. DIAGNOSIS: Liver, segment 4, lateral segmentectomy: Hepatocellular carcinoma. Gallbladder, cholecystectomy: Chronic cholecystitis. Cholelithiasis. Suggestion :",T1,N0,M0,T1N0M0
TCGA-A2-A1G1,"SURGICAL REPORT. Sex. F. Date Collected: I. Date Received: M.R. Number. Doctor: Account Numbe. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. POST-OPERATIVE DIAGNOSIS. RIGHT BREAST CA. PROCEDURE. RIGHT BREAST LUMPECTOMY WITH SENTINEL LYMPH NODE BIOPSY, F.S.: POSSIBLE AXILLARY DISSECTION. TISSUES. A. BREAST EXCISION,NEEDLE LOC, SIMPLE,MARGINS,ETC - RIGHT BREAST LUMP. B. SENTINEL LYMPH NODE (S) - #1 ""FS. FS DIAGNOSIS. RIGHT BREAST LUMP (GROSS MARGINS) -. MARGINS GROSSLY NEGATIVE FOR MALIGNANCY. a. RIGHT SENTINEL LYMPH NODE #1, F.S. -. SENTINEL NODE #1, NEGATIVE FOR MALIGNANCY. (REPORTED TO SURGEON: Diagnosed by: FINAL DIAGNOSIS. A. RIGHT BREAST LUMP -. POORLY DIFFERENTIATED INFILTRATINO DUCTAL CARCINOMA WITH CENTRAL. THE TUMOR MEASURES IN MAXIMUM DIMENSION. II//II). NECROSIS (SCARFF-BLOOM-RICHARDSON GRADE. 3 CM. LYMPHOVASCULAR INVASION IDENTIFIED INSIDE THE TUMOR. ALL SURGICAL MAROINS ARE FREE OF THE TUMOR. B. RIGHT SENTINEL LYMPH NODE #1 . ONE POSITIVE LYMPH NODE (1/1). PTNM CLASSIFICATION: STAGE IIB, T2 N1 MX. PQRI CATEGORY II: 3260F. Diagnosed by: Revlewed and electronically signed out by: SURGICAL REPORT. COMMENT. Specimen ""B"" shows metastatic carcinoma which is shown in the permanent section and not In. the frozen section. This case is discussed with Dr. GROSS DESCRIPTION. The specimen is received in two separate containers labeled. designated A. and B. A. The container Is received fresh unfixed labeled ""right breast lump"" and consists of a 33 gm. ovoid. mass of apparent fatty and fibrous-encased tissue which is 5.5 x 4.5 x 2 om. In greatest overall. dimension. There are two sutures indicating superior margin inked with yellow dye, inferior Is. inked green. There Is a single short suture indicating lateral margin inked with orange dye,. medial is inked black. There is a single short suture indicating anterior margin Inked with blue. dye, posterior Is Inked red. Sectioning reveais a tumor which is 3x 2.5) 1 cm. in greatest overall. dimension and grossly appears to be 0.4 cm. from the superior/yellow, 0.9 cm. from the. inferior/green, 0.4 cm. from the medial/black, 0.3 cm. from the lateral/orange, 0.5 cm. from the. anterior/blue, 0.6 cm. from the posterior/red. The specimen is submitted In twelve blocks. Key Note Block Summary: 1-superior, 2-inferlor, 3-medial, 4-lateral, 5-anterior, 6-. posterior, 7 through - tumor, 10 through 12-random. B. The container Is received fresh unfixed labeled ""right sentinel lymph node #1 for frozen section"". and consists of an ovoid mass of apparent fat which is 1.5x x 0.6 cm. in greatest overail. dimension. Sectioning reveais a 1 cm. pink-tan firm nodule. Touch prep and frozen section are. obtained by Dr. The entire specimen including frozen section is submitted in two. blocks. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. Patient Narr. SURGICAL REPORT.",T2,N1,M0,T2N1M0
TCGA-D7-8575,"Supplement diagnosis: Most cancerous cell cells proved cytokeratin 7-positive. Histopathological Diagnosis: Stomach adenocarcinoma, partly tubular, mucous and solid. Metastases to regional lymph nodes with. invaded capsule and perlymphatic tissue (No VI/XV) G3, pT3, pN2. Macroscopic description: Specimen consisting of the stomach, having been cut out along the greater curvature, sized 16 X 15 cm with the. omentum sized 14 X 7.2 cm. Tumour with ulceration sized 8 X 5 X 2 cm in the lesser curvature region. Gastric lumen. filled with blood colts and mucosa. Macroscopically, the proliferation covers the muscular membrane and perigastric fat tissue. Distance from the proximal. end: 2 cm, from distal end: 6.5 cm. Microscopic description: Adenocarcinoma tubulre partim mucinosum partim solidum (G3). Infiltratio carcinomatosa profunda parietis ventriculi, teale adiposae curvaturae minoris et telae subserosae. (intestinal type acc. to Laurena class.). Proximal and distal borders free of cancer. The omentum free of neoplastic. lesions. Lymph nodes: (periorificial) (L, M, N) - metastases carcinomatosae in lymphonodis No (II/IV). Infiltratio carcinomatosa capsulae. lymphonodorum et telae adiposae perinodalis. (lesser curvature) (P,R) - metastases carcinomatosae in lymphonodo No (W), (greater curvature) (U,W,Y) -. metastases carcinomatosae in lymphonodis No (IIW). Infilatraio carcinomatosa capsulae lymphonodorum et telae. adiposae perinodalis. Result of immunohistochemical examination. HER2 protein stained with Ventana Rabbit Antibody.",T3,N2,M0,T3N2M0
TCGA-CV-A6K2,"M. (172. 0cm 51.Okg BSA: 1. 56m. MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) NECK, LEVEL IA, NECK DISSECTION: Eight lymph nodes, negative for tumor (0/8). (B) RIGHT SUBMANDIBULAR GANGLION: Fibrovascular tissue with thermal artifact. DETACHED FRAGMENT OF ATYPICAL CELLS SUSPICIOUS FOR CARCINOMA. (C) RIGHT NECK DISSECTION, LEVEL IB: Three lymph nodes, negative for tumor (0/3). Unremarkable submandibular gland. (D) RIGHT EXTERNAL JUGULAR LYMPH NODE: Six lymph nodes, negative for tumor (0/6). (E) RIGHT LINGUAL NERVE AT SUBMANDIBULAR GANGLION: Nerve and ganglion cells, negative for tumor. (F) RIGHT NECK DISSECTION, LEVEL IIA: Fifteen lymph nodes. negative for tumor (0/15). (G) RIGHT NECK DISSECTION, LEVEL III: Nine lymph nodes, negative for tumor (0/9). (H) RIGHT NECK DISSECTION, LEVEL IV: Three lymph nodes, negative for tumor (0/3). (I) RIGHT NECK DISSECTION, LEVEL IIB: Five lymph nodes, negative for tumor (0/5). (J) RIGHT MENTAL NERVE: Nerve tissue, negative for tumor. (K) TEETH, GROSS ID: Teeth for gross evaluation only. (L) PROXIMAL MANDIBULAR NERVE: Nerve, tissue, negative for tumor. (M) RIGHT MANDIBLE: INVASIVE SQUAMOUS CARCINOMA WELL DIFFERENTIATED INFILTRATING INTO SKELETAL MUSCLE. Tumor Features: Gross: Ulcerating. Size: 4.5 cm in largest dimension. Invasion: Present, depth 1.4 cm. Tumor Border: Infiltrative with thin cords < 4 cells. Perineural Invasion: Absent. Vascular Invasion: Absent. Bone/Cartilage Invasion: cortical bone invasion present. Lymphocyte Infiltration: Absent. (N) RIGHT BUCCAL MARGIN: Buccal mucosa, negative for tumor. (O) RIGHT FLOOR OF MOUTH MARGIN: Buccal mucosa. negative for tumor. (P) RIGHT RETROMOLAR MARGIN: Mucosa with submucosal glands, negative for tumor. Page: 2. (172.00m 51.0kg BSA: 1. 56m. GROSS DESCRIPTION. (A) NECK, LEVEL 1A, NECK DISSECTION - One pale-gray fibroadipose tissue (4.0 x 2.2 x 1.4 cm) with multiple possible lymph. nodes, (ranging from 0.3 x 0.2 x 0.2 cm to 0.9 x 0.5 x 0.4 cm). The lymph nodes are entirely submitted. SECTION CODE: A1, A2, each containing four possible lymph nodes; A3, three possible lymph nodes. (B) RIGHT SUBMANDIBULAR GANGLION - A 0.5 X 0.4 X 0.3 cm unoriented pink soft tissue fragment. SECTION CODE: B, entire specimen submitted for frozen section diagnosis. FS/DX: 1. FIBROVASCULAR TISSUE WITH THERMAL ARTIFACT. 2. DETACHED FRAGMENT OF ATYPICAL. CELLS SUSPICIOUS FOR CARCINOMA. (C) RIGHT NECK DISSECTION, LEVEL 1B - One pale-gray fibroadipose tissue (6.5 x 4.0 X 1.7 cm) including a pale-gray. unremarkable submandibular gland (2.5 X 2.5 X 1.3 cm). Multiple lymph nodes are identified (ranging from 0.6 X 0.4 x 0.4 cm to. 1.0 x 1,0 x 0.8 cm). The lymph nodes are entirely submitted. SECTION CODE: C1, C2, each containing two possible lymph nodes; C3, one possible lymph node, serially sectioned;. C4. representative section of the submandibular gland. (D) RIGHT EXTERNAL JUGULAR LYMPH NODE - One pale-gray fibroadipose tissue (1.7 x 0.7 x 0.6 cm) with two possible. lymph nodes (0.4 x 0.2 X 0.2 cm and 0.6 x 0.5 x 0.5 cm). The lymph nodes are entirely submitted. SECTION CODE: D1, two possible lymph nodes; D2, entirely submitted of the remainder of the fibrous tissue. (E) RIGHT LINGUAL NERVE AT SUBMANDIBULAR GANGLION - A 0.3 X 0.2 X 0. cm unoriented. pink. soft, nerve tissue. fragment. SECTION CODE: E, entire specimen submitted for frozen section diagnosis. FS/DX: PERIPHERAL NERVE AND GANGLION, NO TUMOR PRESENT. (F) RIGHT NECK DISSECTION, LEVEL 2A - One pale-gray fibroadipose tissue (5.5 x x 1.7 cm) with multiple possible lymph. nodes (ranging from 0.3 x 0.3 x 0.3 cm to 1.2 x 0.7 X 0.5 cm). The lymph nodes are entirely submitted. SECTION CODE: F1-F3, each containing four possible lymph nodes; F4, F5, each containing two possible lymph nodes. (G). RIGHT NECK DISSECTION, LEVEL 3 - One pale-gray fibroadipose tissue (3.0 x 2.0 x 2.0 cm) with muitiple possible lymph. nodes (ranging from 0.4 X 0.3 x 0.3 cm to 0.6 x 0.6 x 0.5 cm). The lymph nodes are entirely submitted. SECTION CODE: G1, four possible lymph nodes: G2. three possible lymph nodes; G3, two possible lymph nodes. (H) RIGHT NECK DISSECTION, LEVEL 4 - One pale-yellow fibroadipose tissue (2.5 x 2.0 x 1.5 cm) with three possible lymph. nodes (ranging from 0.3 x 0.3 x 0.3 cm to 0.6 x 0.5 x 0.4 cm). Lvmph nodes are entirely submitted. SECTION CODE: H, three possible lymph nodes. (I) RIGHT NECK DISSECTION, LEVEL 2B - One pale-gray fibroadipose tissue (3.0 x 2.8 x 1.6 cm) with six possible lymph nodes. (ranging from 0. cm to 1.2 x 0.7 x 0.6 cm). The lymph nodes are entirely submitted. SECTION CODE: 11, three possible lymph nodes; 12, two possible lymph nodes; 13, one possible lymph node. (J) RIGHT MENTAL NERVE - Received tan-pink, lobulated. irregular shaped tissue (0.6 x 0.1 X 0.1 cm). The specimen is entirely. embedded in one block for frozen section analysis. FS/DX: PERIPHERAL NERVE WITH FOCAL DISTORTION, NO TUMOR IDENTIFIED. (K) TEETH, GROSS ID - Multiple teeth (4.5 x 3.0 x 1.8 cm in aggregate). Teeth for gross evaluation only. (L) PROXIMAL MANDIBULAR NERVE - Received tan-pink, irregular shaped tissue (0.6 x 0.1 X 0.1 cm). The specimen is entirely. embedded in one block for frozen section analysis. FS/DX: PERIPHERAL NERVE, NO TUMOR PRESENT. (M) RIGHT MANDIBLE - Hemimandibulectomy (12 x 6 x 5 cm), mostly edentulous ( two teeth present). Gingiva is entirely. replaced by an ulcerated large tan, ill defined firm mass (4.5 x x 4 cm) invading into adjacent soft tissue and cortical bone. Representative sections submitted in M1-M12 (M1-2, soft tissue edges, M3-M12 tumor and adjacent/ subjacent soft tissue). M13, anterior bone resection margin en face for decalcification. (N) RIGHT BUCCAL MARGIN - One niece of pink fibromembranous tissue (3.1 x 0.3 x 0.3 cm) submitted as en face margin for. frozen section analysis in N1. FS/DX: NO TUMOR PRESENT. (O) RIGHT FLOOR OF MOUTH MARGIN - One piece of pink fibromembranous tissue (3.2 X 0.3 x 0.3 cm). Specimen is. submitted as en face margin for frozen section analysis in 01. ""FS/DX: NO TUMOR PRESENT. (P) RIGHT RETROMOLAR MARGIN - Are two pieces of pink fibromembranous tissue (2.3 X 0.2 X 0.2 cm and 0.8 X 0.2x0.2 cm). Page: 3. 51.0kg BSA: : . S6m2. Specimen is submitted in toto as en face margins for frozen section evaluation in P1. FS/DX: NO TUMOR PRESENT. CLINICAL HISTORY. SNOMED CODES. T-11180, M-80703. ""Some tests reported here may have been deveroped and performance characterstics determined by. hese tests have not been. specifically cleared or approved by the US. Food and Drug Administration "". Entire report and diagnosis completed by: Start of ADDENDUM. Page: 4. (172.0 00m 51.0kg BSA: 1. Specimen Dato/mare: ADDENDUM. This modified report is being issued to provide additional information/results. Decalcified section of anterior bone resection margin (slide M13) reveals bone and fibroconnective tissue, negative for malignancy. Entire report and diagnosis completed by.",T4,N0,M0,T4N0M0
TCGA-AN-A0XN,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. - Anatomic Site: Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: OCT. Container: block Type of Procurement: surgery Grade: 2. T Stage: 2 N Stage: 1 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,T2,N2,M0,T2N2M0
TCGA-AA-3527,"Diagnosis / Diagnoses: Right hemicolectomy specimen with an ulcerated cecum carcinoma conforming to the. histological type of a moderately differentiated colorectal adenocarcinoma, affecting. Bauhin's valve and with a greatest diameter of 4.5 cm. Invasive spread of tumor within. all layers of the intestinal wall and as far as the neighboring mesocolic fatty tissue and the. subserosa. Remainder of colon mucosal membrane with a hyperplastic polyp. Appendix with apparent post-inflammatory fibrosis of the wall. Oral and aboral resection margins and large omentum tumor-free. Fifteen mesocolic and mesenteric lymph nodes tumor-free with uncharacteristic reactive. changes. Tumor stage thus pT3 pNO (0/15) L0, V0; G2.",T3,N0,M0,T3N0M0
TCGA-60-2712,"SPECIMEN(S): A. 4R RIGHT DISTAL PARATRACHEAL. B. 4L LEFT DISTAL PARATRACHEAL. C. ADDITIONAL LOW 4R RIGHT DISTAL PARATRACHEAL. D. LEVEL 7 SUBCARINAL. E. 2R RIGHT PROXIMAL PARATRACHEAL. F. 2L LEFT PROXIMAL PARATRACHEAL. G. FIFTH RIB. H. LEVEL 5 LYMPH NODE. I. LEFT UPPER LOBE. J. 11L. LYMPH NODE. K. LEVEL 6 LYMPH NODE. L. LEVEL 9 LYMPH NODE. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Left upper lobe mass. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA, FSB, FSC, FSD, FSE, FSF: Negative for tumor. FSI1: Bronchial margin: Negative for tumor. FSI2: Tumor: Poorly differentiated souamous cell carcinoma. GROSS DESCRIPTION: A. 4R RIGHT DISTAL PARATRACHEAL. Received fresh is one fragment of tan-black soft tissue measuring 0.3 cm. Submitted in toto for. frozen section. B. 4L LEFT DISTAL PARATRACHEAL. Received fresh are multiple fragments of tan-black tissue measuring 0.5 cm in aggregate. Submitted in toto for frozen section. C. ADDITIONAL LOW 4R RIGHT DISTAL PARATRACHEAL. Received fresh are multiple fragments of tan-black soft tissue measuring 1.5 x 0.7 X 0.4 cm. Submitted in toto for frozen section. D. LEVEL 7 SUBCARINAL. Received fresh are multiple fragments of tan-black soft tissue measuring 1 x 0.8 X 0.3 cm in. aggregate. Submitted in toto for frozen section. E. 2R RIGHT PROXIMAL PARATRACHEAL. Received fresh are multiple fragments of tan-black soft tissue measuring 1.2 x 0.9 x 0.3 cm. They are submitted in toto for frozen section. F. 2L LEFT PROXIMAL PARATRACHEAL. Received fresh is one fragment of tan-black soft tissue measuring 0.3 cm in diameter and. submitted in toto for frozen section. G. FIFTH RIB. Received in formalin is a portion of rib measuring 2 x 1 x 0.8 cm. The outer surface is tan-pink. and irregular. Sections are submitted after decalcification. H. LEVEL 5 LYMPH NODE. Received in formalin is one lymph node measuring 2 x 1.5 x 0.5 cm. It is bisected to reveal. black to pink homogenous cut surface. It is submitted in toto in one cassette. I.. LUNG LEFT UPPER LOBE,LOBECTOMY. Received in fresh state is a resected upper lobe of left lung with total dimensions of 15x14x4. cm. in the upper half of the specimen located .4 cm. from the nearest bronchial margin. There is. a firm ovoid to round palpable mass which on section has a tan cream yellow tan-white tumor. with central areas of necrosis. The tumor measures 8x7x4 cm. The overlying pleura is retracted. and inked blue. At the hilum in line with the bronchus and protruding from the long is a. presumptive enlarged matted lymph node with tumor partly displacing one hilar blood vessel. Remainder of the specimen shows congestion with atelectatic change Multiple sections are. submitted and labeled as follows: portion of tissue for tissue procurement and photograph of. specimen is a well defined round to oval tan-yellow firm tumor mass with central tumor necrosis. measuring 8 x 7 x 4 cm. Sections are submitted as follows: FSI1: bronchial margin. FSI2: sections from the tumor for frozen section. I3-I7: sections from the tumor. I8: sections from the mass and lymph nodes adjacent to the tumor. 10.110 two sections from the tumor. I11-I12: section of lymph node paratracheal. I13-115: sections from the non-neoplastic lung tissue. J. 11L LYMPH NODE. Received in formalin is one irregular lymph node measuring 2 x 1.5 x 1 cm. It is trisected to. reveal black and pink homogenous cut surface. It is submitted in toto in one cassette. K. LEVEL 6 LYMPH NODE. Received in formalin is one lymph node measuring 1 x 0.8 x 0.5 cm. It is bisected to reveal. black homogenous cut surface. It is submitted in toto in one cassette. L. LEVEL 9 LYMPH NODE. Received in formalin is one lymph node measuring 0.8 x 0.7 x 0.5 cm. It is bisected to reveal a. black cut surface. It is submitted in toto in one cassette. DIAGNOSIS: A. 4 RIGHT DISTAL PARATRACHEAL LYMPH NODE: ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). B. 4 LEFT DISTAL PARATRACHEAL LYMPH NODE: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). C. ADDITIONAL LOW 4 RIGHT DISTAL PARATRACHEAL: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). D. LEVEL 7 SUBCARINAL LYMPH NODE: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). E. 2 RIGHT PROXIMAL PARATRACHEAL LYMPH NODE: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). F. 2 LEFT PROXIMAL PARATRCHEAL LYMPH NODE: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). G. FIFTH RIB: - PORTION OF RIB BONE - NEGATIVE FOR TUMOR. H. LEVEL 5 LYMPH NODE: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). I. LUNG, LEFT UPPER LOBE, LOBECTOMY SPECIMEN: SQUAMOUS CELL CARCINOMA, MODERATE TO POORLY. DIFFERENTIATED OF UPPER LOBE OF LEFT LUNG WITH METATASIS. TO ONE OUT OF TWENTY-FIVE PERIBRONCHIAL LYMPH NODES (1/25). - SIZE OF TUMOR: 8x7x4 CM. - BRONCHIAL MARGINS OF RESECTION - NEGATIVE FOR TUMOR. - CONGESTION AND FOCAL ATELECTATIC CHANGE OF LUNG. J. 11 LEFT LYMPH NODE: - ONE LYMPH NODE - NEGATIVE TUMOR (0/1). K. LEVEL 6 LYMPH NODE: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). L. LEVEL 9 LYMPH NODE: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). LUNG NEOPLASM TEMPLATE. Surgical procedure: Lobectomy. Tumor location: Central - LUL. Tumor size: 8x7x4cm. Tumor type: Squamous cell carcinoma. Histologic grade: G2-G3. Angiolymphatic invasion: Absent. Bronchial margin: Negative. Visceral pleural involvement: Absent. Satellite tumor(s): Lymph node involvement: N1: Ipsilateral Hilar (Level 10) and/or. Positive (1/26. Peribronchial (Levels 11-14). N2: Ipsilateral Mediastinal (Levels 1-9) Negative (0/4). and/or subcarinal. N3: Contralateral mediastinal/hilar. Negative (0/5). Scalene or supraclavicular. Non-neoplastic lung: Pathologic stage: pT2 N1 Mx.",T2,N1,M0,T2N1M0
TCGA-DJ-A13O,"Clinical Diagnosis & History: Papillary thyroid carcinoma. Specimens Submitted: 1: SP: Thyroid, Total thyroidectomy. 2: SP: Left paratracheal cyst. DIAGNOSIS: 1. SP: Thyroid, Total thyroidectomy: Tumor Type: with tall cell features. Papillary carcinoma, classical type. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Calcification of non-psammoma type. Psammoma bodies. Tumor Location: Right lobe. Tumor Size: Greatest diameter is 1.1 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Focal invasion. Blood Vessel Invasion: Not identified. Extrathyrold Extension: Not identified. Surgical Margins: Free of tumor. Clinical Diagnosis & History: Papillary thyroid carcinoma. I. Specimens Submitted: 1: SP: Thyroid, Total thyraidectomy. 2: SP: Left paratracheal cyst. DIAGNOSIS: 1. SP: Thyroid, Total thyroidectomy: Tumar Type: Papillary carcinoma, classical type. with tall call features. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Calcification of non-psammama type. Psammoma bodias. Tumor Location: Right lobe. Tumor Siza: Greatast diamater is 1.1 cm. Tumor Encapsulation: Complately surraunded. Capsular Invasion: Focal invasion. Blood Vessel Invasion: Not identified. Extrathyroid Extansian: Not identifiad. Surgical Margins: Fraa of tumor. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Parathyroid Glands: Not identified. - Two benign lymph nodes (0/2). 2. SP: Soft tissue, Left paratracheal cyst; Excision: - Four benign lymph nodes. - Benign cyst lined by cuboidal epithelium most probably of branchial pouch derivation. - Benign portion of thymus. ATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT i HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen Is received fresh, labeled ""total thyroidectomy stitch is right superior pole"" and consists of a thyroid weighing 27. g. The right lobe measures 5 x 2.5 x2.2cm ,the left lobe measures 4.5 x2.5 x 2.2cmand the isthmus measures 1.5x1.1 x0 .5. cm. The external surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black, and the. anterior is inked blue. Sectioning reveals a 1.1 x 0.8 x 0.7 cm solid encapsulated calcified nodule in the right upper pole. Sections. through the remaining tissue reveal no other lesions. The remaining thyroid parenchyma is red tan and beefy. Representative. sections of the specimen is submitted for TPS. The remaining tissue Is serially sectioned and 60% submitted. Summary of sections: N nodule. RL right lobe. LL left lobe. IS - isthmus. 2). Specimen is received fresh labeled ""left paratracheal cyst"" and consists of an unoriented tan, soft tissue with dimensions of 2 x. 2 by 1 cm. The external surface is inked black. Sectioning reveals a smooth walled cyst filled with clear watery fluid with a. diameter of 1.5 cm. The specimen is entirely submitted. Summary of sections: U-undesignated. Summary of Sections: Part 1: SP: Thyroid, Total thyroidectomy. Block. Sect. Site. PCs. 1. IS. 1. 4. LL. 4. 2. N. 2. 4. RL. 4. Part 2: SP: Left paratracheal cyst. Block. Sect. Site. PCs. 2. U. 2.",T1,N0,M0,T1N0M0
TCGA-B0-4690,"FINAL DIAGNOSIS. LYMPH NODE, EXCISION -. NO EVIDENCE OF NEOPLASIA IN 3 (0/3) LYMPH NODES. PART 2: KIDNEY, RIGHT, NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CLEAR CELL TYPE WITH SARCOMATOID FEATURES. B. FUHRMAN NUCLEAR GRADE IS 3 of 4. C. THE GREATEST DIAMETER OF THE NEOPLASM IS 12.0 cm. D. THE NEOPLASM EXTENDS INTO THE PERIRENAL AND PERIPELVIC FAT. E. NO EVIDENCE OF ANGIOLYMPHATIC INVASION IS IDENTIFIED. F. CARCINOMA GROSSLY EXTENDS INTO THE RENAL VEIN. G. ALL OTHER SURGICAL MARGINS ARE FREE OF THE NEOPLASM. H. NON-NEOPLASTIC KIDNEY SHOWS CHRONIC INTERSTITIAL INFLAMMATION, GLOMERULOSCLEROSIS, AND. THYROIDIZATION. I. ADRENAL GLAND WITH RENAL CELL CARCINOMA (See Comment). J. NO EVIDENCE OF NEOPLASIA IN 3 (0/3) LYMPH NODES. K. TNM STAGE: pT3b NO MX. Final Diagnosis. ESOPHAGUS, NODULE, BIOPSY -. A. REACTIVE / HYPERPLASTIC GASTRIC MUCOSA AND SCANT INFLAMED SQUAMOUS MUCOSA. B. NEGATIVE FOR INTESTINAL METAPLASIA,.",T4,N0,M1,T4N0M1
TCGA-3H-AB3X,"M. DIAGNOSIS. (A) RIGHT LUNG, BIOPSY: CONSISTENT WITH EPITHELIOID MALIGNANT MESOTHELIOMA (SEE COMMENT). COMMENT. Immunohistochemical studies show the tumor is positive for calretinin, WT-1 and D2-40; negative for CEA, CD15, MOC31, CK5/6. and mesothelin. The morphologic features together with immunoprofile are consistent with epithelioid malignant mesothelioma. GROSS DESCRIPTION. (A) RIGHT LUNG BIOPSY - Multiple pink-red core biopsy fragments ranging from 0.1 X 0.1 cm to 0.4 X 0,1 cm. Entirely. submitted in A,. CLINICAL HISTORY. Pleural based mass. SNOMED CODES. T-28000, M-90503. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration "". Entire report and diagnosis completed by: END OF REPORT-.",T3,N0,M0,T3N0M0
TCGA-IN-A6RS,"FINAL DIAGNOSIS: PART 1: TISSUE AT BASE OF LEFT GASTRIC, EXCISION -. ADIPOSE TISSUE-WITH FAT NECROSIS, NEGATIVE FOR TUMOR. PART 2: TISSUE NEAR RIGHT CRUS, EXCISION -. TWO BENIGN LYMPH NODES (0/2). PART 3: OMENTUM, EXCISION -. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. PART 4: LEVEL 7 LYMPH NODE NEAR CARINA, EXCISION -. ONE BENIGN LYMPH NODE (0/1). PART 5: ESOPHAGUS, ESOPHAGECTOMY -. A. WELL TO MODERATELY DIFFERENTIATED ADENOCARCINOMA OF THE GASTROESOPHAGEAL JUNCTION,. 2.5 CM, PREDOMINANTLY EXOPHYTIC. B. THE ADENOCARCINOMA FOCALLY INVADES INTO THE SUPERFICIAL SUBMUCOSA. C. BACKGROUND OF HIGH GRADE COLUMNAR DYSPLASIA AND FOCAL INTESTINAL METAPLASIA. D. NO ANGIOLYMPHATIC OR PERINEURAL INVASION. E. TWENTY-ONE BENIGN PARAESOPHAGEAL LYMPH NODES (0/21). F. AJCC PATHOLOGIC STAGE: pT1b NO. G. MARGINS OF RESECTION ARE NEGATIVE FOR TUMOR. H. INCIDENTAL BENIGN SPINDLE CELL TUMORLET (0.5 CM) IN THE PERIESOPHAGEAL SOFT TISSUE,. PENDING FURTHER CHARACTERIZATION TO BE REPORTED AS AN ADDENDUM. PART 6: DISTAL ESOPHAGEAL LYMPH NODE, EXCISION -. ONE BENIGN LYMPH NODE (0/1). PART 7: DISTAL ESOPHAGEAL LYMPH NODE #2, EXCISION -. TWO BENIGN LYMPH NODES (0/2). PART 8: ANASTOMOTIC RINGS, EXCISION -. PORTIONS OF ESOPHAGEAL AND GASTRIC TISSUE, NEGATIVE FOR TUMOR. PART 9: STOMACH, FINAL GASTRIC MARGIN, EXCISION -. PORTION OF PROXIMAL STOMACH, NEGATIVE FOR TUMOK. Addendum. Part 5: Morphologic findings and immunostain results (below) demonstrate that the incidental, benign pern-esopnayear. spindle cell neoplasm is best classified as a schwannoma (0.5 cm). Marker. S100. Positive. Desmin. Negative. KIT. Negative. DOG1. Negative. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY ESOPHAGEAL TUMORS. MACROSCOPIC. SPECIMEN TYPE: Esophagectomy. TUMOR SITE: Tumor midpoint centered on esophagogastric junction. TUMOR SIZE: Greatest dimension: 2,5 cm. MICROSCOPIC. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G2. PATHOLOGIC STAGING (pTNM). pT1b. pNO. Number of lymph nodes examined: 27. Number of lymph nodes involved: 0. 17 or more regional lymph nodes were identified. pM Not applicable. PRIOR TREATMENT: No prior treatment. MARGINS. Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (adventitial) margin uninvolved by invasive carcinoma. ANGIOLYMPHATIC INVASION: Absent. ADDITIONAL PATHOLOGIC FINDINGS: Intestinal metaplasia (Barrett's esophagus). High grade dysplasia.",T1,N0,M0,T1N0M0
TCGA-A8-A07I,"Diagnosis: 1. Multifocal poorly differentiated invasive ductal breast carcinoma, G III, with small. intraductal components. Largest tumor focus 2.6 cm. A second of a total of three. additional tumor foci, in some cases only microscopically visible, located in the. vicinity of the skeletal muscle that was also resected. Summary tumor classification: multifocal invasive ductal breast carcinoma with a. small intraductal component, NOS, G III, pT2(m)pN2a(5/15)LOVORO.",T2,N2,M0,T2N2M0
TCGA-ER-A19K,"PATIENT HISTORY: No clinical history is given. PRE-OP DIAGNOSIS: Scalp melanoma. POST-OP DIAGNOSIS: Same. PROCEDURE: Wide excision melanoma, says biopsy, skin graft. FINAL DIAGNOSIS: PART. SKIN, LEFT SCALP, WIDE EXCISION OF MELANOMA SITE -. A. MALIGNANT MELANOMA, FOCALLY ULCERATED. LEVEL V; 6.8 MM (see comment). B. MULTIPLE FOCI OF ANGIOLYMPHATIC INVASION PRESENT. C. MULTIPLE FOCI OF CUTANEOUS AND DERMAL SATELLITES PRESENT. D. RESECTION MARGINS, INCLUDING DEEP MARGIN, ARE FREE OF TUMOR (see comment). PART 2: LYMPH NODE, LEFT SENTINEL #1, EXCISION -. A. FIBROUS TISSUE AND SKELETAL MUSCLE. B. NO LYMPH NODE SEEN. PART 3: LYMPH NODE, LEFT SENTINEL #2, EXCISION -. FIBROMUSCULAR SOFT TISSUE AND NERVE, FREE OF TUMOR. COMMENT: PART:1 : REF-. PARTS 2&3 : NO tumor cells nor lymph nodes seen on routine stains or the immunostains for s100, Melan. a, HMB45, tyrosinase or CD68.",T4,N0,M0,T4N0M0
TCGA-MP-A4SV,"Requested RV. TISSUE DESCRIPTION: Left lower lobe lung and portion of lingula (475 grams, 17 x 9.7 x 6.3 cm), aortic. lymph nodes. (aortopulmonary and anterior mediastinal), inferior mediastinal (subcarinal and. inferior. nulmonary ligament) and N1 (interlobar) lymph nodes. A1, A2, A3, A4, A5, B1, B2, B3, B4, B5, 86, B7. DIAGNOSIS: Lung, left lower lobe and lingula, lobectomy: Grade 3 (of 4) adenocarcinoma. forming a 3.2 x 3. x 2.5 cm peripheral mass extending to but not invading the visceral pleura. The. bronchial. margin and multiple (7) intrapulmonary peribronchial 1ymph nodes are negative for. malignancy. Lymph nodes, aortic, inferior mediastinal and N1, excision: Multiple aortic (4. aortopulmonary. and 1 anterior mediastinal), inferior mediastinal (2 subcarinal and 2 inferior. pulmonary. ligament) and N1 (4 interlobar) lymph nodes are negative for tumor.",T2,N0,M0,T2N0M0
TCGA-BI-A0VR,"FINAL DIAGNOSIS: PART 1: OVARY AND FALLOPIAN TUBE, LEFT SALPINGO-OOPHORECTOMY- -. A. OVARY WITH EPITHELIAL INCLUSIONS, NO TUMOR SEEN. B. FALLOPIAN TUBE, NO TUMOR SEEN. PART 2: LYMPH NODES, LEFT PELVIC, BIOPSY -. TWO LYMPH NODES, FREE OF TUMOR (0/2). PART 3: LYMPH NODES, LEFT OBTURATOR, BIOPSY -. THIRTEEN LYMPH NODES, FREE OF TUMOR (0/13). PART 4: LYMPH NODES, RIGHT PELVIC, BIOPSY -. TWO LYMPH NODES, FREE OF TUMOR (0/2). PART 5: LYMPH NODE, RIGHT OBTURATOR, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 6: BROAD LIGAMENT, RIGHT, BIOPSY -. FIBROVASCULAR ADIPOSE TISSUE, NO TUMOR SEEN. PART 7: LYMPH NODES, LEFT PERIAORTIC, BIOPSY -. TEN LYMPH NODES, FREE OF TUMOR (0/10). PART 8: LYMPH NODES, RIGHT PERIAORTIC, BIOPSY -. THREE LYMPH NODES, FREE OF TUMOR (0/3). PART 9: LYMPH NODES, RIGHT COMMON, BIOPSY -. TWO LYMPH NODES, FREE OF TUMOR (0/2). PART 10: UTERUS WITH BOTH PERIMETRIA, RADICAL HYSTERECTOMY (92 GRAMS) -. A. UTERINE CERVIX WITH INVASIVE SQUAMOUS CELL CARCINOMA (10A-10E, 10G AND 10P), HIGH NUCLEAR. GRADE (3/3), WITH LYMPHOVASCULAR PERMEATION. 2.5 X 1.8 X 1.5 CM. THE TUMOR ARISES IN A. BACKGROUND OF CERVICAL INTRAEPITHELIAL NEOPLASIA 3, EXTENDS FROM 3 O'CLOCK TO 9. O'CLOCK AND INVOLVES THE POSTERIOR CERVIX. THE TUMOR COMES TO WITHIN 1.5 MM FROM THE. NEAREST POSTERIOR RESECTION MARGIN (AT THE 6 O'CLOCK POSITION -10A). B. CHRONIC CYSTIC CERVICITIS. C. CHANGES CONSISTENT WITH PREVIOUS BIOPSY SITE, SEE PRIOR. D. PROLIFERATIVE PATTERN ENDOMETRIUM WITH CYSTIC CHANGES. E. ENDOMETRIAL POLYP WITH CYSTIC CHANGES. F. LEIOMYOMA, UP TO 0.5 CM. G. LEFT PERIMETRIA WITH MICROMETASTATIC SQUAMOUS CELL CARCINOMA, INVOLVING ONE (1/7). LYMPH NODES (10K) (see comment). H. RIGHT PERIMETRIA INVOLVED BY METASTATIC SQUAMOUS CELL CARCINOMA (10P) AND TWO. REACTIVE LYMPH NODES (0/2) (see comment). I. VAGINAL CUFF, FREE OF TUMOR. J. PORTION OF LEFT FALLOPIAN TUBE, FREE OF TUMOR. COMMENT: The left perimetrial lymph node is involved with tumor which measures up to 0.3 mm on the slide (10K). This lymph node. is. present in the outer third of the perimetrium. The metastatic tumor in the right perimetrium is present in the outer third. of the perimetrium. PATIENT HISTORY: Not given. Date of last menstrual period: Not given. PRE OP DIAGNOSIS: Cervical cancer. POST OP DIAGNOSIS: Same. PROCEDURE: Radical hysterectomy, left salpingo-oophorectomy and lymph node biopsies. CASE SYNOPSIS: SYNOPTIC - PRIMARY UTERINE CERVIX TUMORS: HYSTERECTOMY AND CONIZATION. TUMOR TYPE: Squamous cell carcinoma. Squamous intraepithelial lesion (SIL). HISTOLOGIC GRADE: Poorly differentiated. High grade squamous intraepithelial lesion (HSIL). TUMOR SIZE: Maximum dimension: 2.5 cm. TUMOR LOCATION: Endocervix. DEPTH OF INVASION: 2/3 of cervical thickness. TUMOR THICKNESS: Tumor thickness: 15 mm. HORIZONTAL SPREAD: Horizontal Spread: 2.5 cm. STRUCTURES INVOLVED: Parametrium. NON-NEOPLASTIC UTERUS: Leiomyoma. MARGINS OF RESECTION: Vaginal margin is negative for tumor. Parametrium margin is positive for tumor. MITOTIC RATE: Mitotic rate: 100/10 HPF. ANGIOLYMPHATIC INVASION: Angiolymphatic invasion present. LYMPH NODES POSITIVE: Number of lymph nodes positive: 1. LYMPH NODES EXAMINED: Total number of lymph nodes examined: 42. LYMPH NODE GROUPS INVOLVED: Parametrial lymph nodes, Left. EXTRANODAL EXTENSION: T STAGE, PATHOLOGIC: pT2b. N STAGE, PATHOLOGIC: pN1. M STAGE, PATHOLOGIC: pMX. FIGO STAGE: IIB. RESIDUAL TUMOR: Rx.",T2,N1,M0,T2N1M0
TCGA-FZ-5924,"PART 1: HEAD OF PANCREAS AND PORTION OF SMALL BOWEL, PANCREATICODUODENECTOMY -. A. INVASIVE, MODERATE-TO-POORLY DIFFERENTIATED DUCTAL ADENOCARCINOMA (3.2 CM), INVADING. THROUGH THE DUODENAL WALL INTO THE SUBMUCOSA AND PERIPANCREATIC FAT. B. LYMPHOVASCULAR AND PERINEURAL INVASION ARE IDENTIFIED. C. TUMOR IS WITHIN 0.5 MM OF THE PANCREATIC MARGIN (see comment). D. TUMOR IS WITHIN 1.0 MM OF THE VASCULAR GROOVE RESECTION MARGIN. E. OTHER SURGICAL MARGINS ARE NEGATIVE FOR TUMOR. F. METASTATIC ADENOCARCINOMA TO TWO OUT OF EIGHTEEN LYMPH NODES (2/18). G. PATHOLOGIC STAGE pT3 N1 MX. PART 2: GALLBLADDER, CHOLECYSTECTOMY -. CHRONIC CHOLECYSTITIS,. COMMENT: The permanent sections of the pancreatic margin contain abundant volume of tumor. The original frozen sections were. reviewed. The second level of the frozen shows microscopic foci of neoplastic glands, although the first level is. equivocal whether cancer is really present on the original frozen section. have reviewed this. case as a 5% pre-sign out QC review. SYNOPTIC DATA - PRIMARY PANCREAS (EXOCRINE) TUMORS. MACROSCOPIC. SPECIMEN TYPE: Pylorus sparing pancreaticoduodenectomy, partial pancreatectomy. TUMOR SITE: Pancreatic head. TUMOR SIZE: Greatest dimension: 3.2 cm. Additional dimensions: 3 X 1.9 cm. OTHER ORGANS RESECTED: Gallbladder. MICROSCOPIC. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G3. PATHOLOGIC STAGING (pTNM): pT3. pN1a. Number of lymph nodes examined: 18. Number of lymph nodes involved: 2. pMX. Treatment: Unknown. MARGINS: Common bile duct margin uninvolved. Pancreatic parenchymal margin uninvolved. MARGINS (continued). Uncinate process/retroperitoneal margin uninvolved. Invasive neoplasm is within 2mm of inked SMV/portal vein notch margin. Proximal duodenal/gastric margin uninvolved. Distal duodenal margin uninvolved. VENOUSILYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L): Present. PERINEURAL INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN 3).",T3,N1,M0,T3N1M0
TCGA-66-2795,"Material examined: Mediastinal squamous epithelium. Clinical diagnosis and question. Bronchial carcinoma left upper lobe, attempted angioplasty upper lobe, discontinuation with central tumor in. REPORT ON FINDINGS. Macroscopy. 1.) Mediastinal squamous epithelium: 0.6 cm hard pale brownish specimen. Inflated, fixed left lung measuring. 17 x 12 cm at the base and up to 27 cm high, central bronchus resection plane located 3 cm proximal to the. bifurcation of the upper lobe bronchus. A staple suture line runs from the hilus in a ventrocaudal direction over. the upper and lower lobes for 7.5 cm in each case and dorsal over S2 and 6 for 6.5 cm in each case, evidently. corresponding staple suture lines. Main bronchus largely skeletonized. At the hilus four partly lesioned, mobile. blackish nodes between 0.4 and 0.8 cm. Resection margin of pulmonary artery shows high-grade lesion. Apical. and lateral region over S1, 2 and 3 shows a 16 x 14.5 cm area of parietal pleura that shows predominantly. extensive adhesion and marginally loose attachment in parts. Ostium of upper lobe bronchus constricted by a. central moderately firm, pale brown to whitish tumor, max. 4.9 cm in size, in the upper lobe, with a. predominantly relatively clear and arcuate demarcation and patchy grayish-black pigmentation in parts. Extension of tumor right up to hilar resection surface, where 1.5 cm is questionably part of the pericardial sac,. which is not macroscopically infiltrated. Involvement of some grayish-black nodes up to 1.5 cm in size by the. tumor. Narrowing of numerous blood vessels and questionable wall infiltration of an already patent pulmonary. artery branch of the upper lobe, with not tumor tissue discernible in the lumen. In S3 at the junction with S3. laterally below the section of parietal pleura is a 3.5 cm hemorrhagic zone, partly with a clear demarcation,. extending to the pleura. Peripheral bronchi of the upper lobe in parts slightly dilated and filled with thick. mucus, rest of parenchyma of the upper and lower lobes inconspicuous. From the bifurcation of the bronchus. into the basal lower lobe bronchi, three blackish nodes between 0.4 and 0.7 cm. In the subpleural region in S6 at. the junction with S8 a 0.3 cm flat blackish node. 3.) Repeat resection material from pulmonary artery: irregular portion of pulmonary artery measuring 3.7 x max. 1.3 cm. 4.) Interlobar LN (station 11): 0.7 cm lesioned node. 5.) Pulmonary ligament LN (station 9): 0.6 cm node with surrounding tissue. 6.) Paraesophageal LN (station 8): 0.6 cm node with surrounding tissue. 7.) Paraaortic LN (station 6): two lesioned grayish-black nodes or node parts, 0.8 and 0.4 cm. 8.) Low paratracheal LN (station 4) left: 1 cm node with surrounding tissue. 9.) Low paratracheal LN (station 4) right: 0.4 cm node. Examined: Re 1.) Rapid section remains,. Re 2.) a: Tumor with rest of parenchyma, b: tumor with ostium of upper lobe bronchus and involved nodes as. well as central blood vessels, c: tumor with pulmonary artery upper lobe branch, d: tumor with hilar resection. surface (color-marked), e: tumor with questionable portion of pericardial sac (resection margin color-marked),. f: hemorrhagic zone, g: pleural adhesion zone in S1, h: central bronchus resection plane and resection margin. pulmonary artery, i: mobile hilar nodes and resection margin pulmonary veins, j: node subpleural and at the. bronchus bifurcation of the lower lobe,. Re 3.)-9.) All material (in 3. preparation lamellated),. 16 blocks, partly Elastica-van Gieson, PAS, diastase-PAS. Microscopy. Re 1.) Immediate intraoperative evaluation. ): squamous cell carcinoma. Description of histological and cytological findings omitted for capacity reasons. EVALUATION. Primary diagnosis/diagnoses: Locally advanced, central, bronchopulmonary, histologically poorly differentiated, large-cell and. polymorphocellular, nonkeratinizing squamous cell carcinoma of the left upper lobe of the lung (G3). Tumor. classification according to this picture pT4 pN1 V1 RX(R1?), stage III. C34.M8070/3. Secondary diagnosis/diagnoses: Tumor necroses. Active resorptive alveolar and lymphofollicular interstitial inflammation in the lung. parenchyma adjacent to the tumor. Lung tissue necrosis with marginal organizing and fibrous remodeling. process under the pleural adhesion area in S1. Fresh hemorrhagic pulmonary infarction in the boundary region. of S1/S3. Fibrinous pleuritis and pleural adhesions. Moderate anthracotic pigment deposits in the lung. parenchyma and varying degrees of partly mixed dust pigment deposits in the lymph nodes with reactive. accumulation of macrophages. Remark/addendum: The carcinoma shows partially endobronchial growth as far as the ostium of the upper lobe, continuously. metastasized to local bronchopulmonary lymph nodes with invasion via the mediastinal pleura into the. mediastinum, where it reaches the resection plane in places. This finding explains the pT4 classification,. although the evidently co-resected layer of parietal pericardium is not reached or infiltrated by the tumor. The. precondition is thus also met for the R1 category. If this area is directly followed by the preparation registered. under 1.), which is likewise marginally occupied by tumor, a category of R0 may also be diagnosed. Large. pulmonary vessels are only surrounded, but not invaded by tumor. The resection margins of the main bronchus,. the large pulmonary vessels, the lower lobe of the lung and all other lymph nodes are tumor-free.",T4,N1,M0,T4N1M0
TCGA-DJ-A3VG,"Head & Neck. Head And Neck. Clinical Diagrosis & History: year ok. with history of thyroid nodule FNA CW left nodule-atypical cells follicular, B. nodules on ultrasound. Specimens Submitted: 1: SP: Thyroid, left lobe and isthmus, hemithyroidectomy. 2: SP: Right thyroid lobe. DIAGNOSIS: 1. SP: Thyroid, left lobe and isthmus, hemithyroidectomy: Tumor Type: Papillary carcinoma, follicular variant. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 1.1 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Not identified. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Not identified. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Parathyroid Glands: Not identified. 2. Thyroid, right lobe, completion thyroidectomy: -Thyroid with nodular hyperplasia. -No parathyroid glands are identified. -One benign lymph node (0/1). IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL). AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: I.D. 1. The specimen is received fresh, labeled ""left thyroid lobe and isthmus"". it consists of a left thyrold lobe and portion of isthmus. measuring 4.6 x 2.9 x 0.7 cm and weighing 7 g. The surface Is smooth. The lobe is inked black posterior, blue anterior, and the. area of the isthmus yellow. Serial sectioning reveals two nodules 0.3 cm away from each other in the mid to lower thyroid. measuring 1.1 x 0.8 x 0.7 (arbitrarily designated N1) and 0.6 x 0.6 x 0.5 cm (arbitrarily designated N2). The first nodule appears. well-circumscribed, solid, tan, firm, and bulges out of the surrounding thyroid parenchyma, 0.1 cm away from the anterior thyroid. surface. S submitted from the first nodule (N1). Cut section of the second nodule shows a non-descript pale appearance,. resembling nodular thyroid parenchyma. The remaining thyroid parenchyma is red and beefy. The specimen is entirely submitted. A photograph is taken of Nodule 1. Summary of sections: N1 - nodule 1 and surrounding thyroid tissue. N2 nodule 2. S superior thyroid. M mid thyroid. 2. The specimen is received fresh, labeled ""Right thyroid lobe"". it consists of a right thyroid lobe measuring 5.4 x 2.3 x 1.3 cm and. weighing 9 g. The surface is smooth. The lobe is Inked black posterior, blue anterior, and the area of the isthmus yellow. Serial. sectioning reveals a tan- red, well-circumscribed nodule in the mid thyroid measuring 0.4 x 0.3 x 0.3 cm which is 0.3 cm from the. anterior thyroid surface. The remaining thyroid parenchyma is mostly red and beefy. The specimen is entirely submitted. Summary of sections: N nodule. S - superior thyroid. M mid thyroid. I - inferior thyroid. Summary of Sections: Part 1: SP: Thyroid, left lobe and isthmus, hemithyroidectomy. Block. Sect. Site. PCs. 2. M. 2. 2. N1. 2. 3. N2. 4. 1. S. 1. Part 2: SP: Right thyrold lobe. Block. Sect. Site. PCs. 3. I. 3. 3. M. 3. 1. N. 1. 5. S. 5.",T1,N0,M0,T1N0M0
TCGA-CV-A6JY,"M. (174.0cm . 74.8kg BSA: 1.9m. MODIFIED REPORT REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) LEFT NECK DISSECTION, LEVEL 2A: Twelve lymph nodes, negative for tumor (0/12). (B) LEFT NECK DISSECTION, LEVEL 2B: Fibroadipose tissue without lymphoid tissue, negative for tumor. (C) LEFT NECK DISSECTION. LEVEL 3: Seven lymph nodes. negative for tumor(0/7). (D) LEFT NECK DISSECTION, LEVEL 4: Eight lymph nodes, negative for tumor(0/8). (E) LATERAL DEEP MARGIN: Fibroadipose tissue and skeletal muscle, negative for tumor. (F) MASSETER MARGIN: Skeletal muscle. negative for tumor. (G) ANTERIOR SUBLINGUAL MARGIN: Fibroadipose tissue and minor salivary gland, negative for tumor,. (H) ANTERIOR ALVEOLAR NERVE: Nerve, negative for tumor. (I) RETROMOLAR TRIGONE, DEEP MARGIN: Squamous mucosa with lymphoid stroma, negative for tumor. (J) POSTERIOR BUCCAL MARGIN: Ulcerated mucosa with fordyce granules negative for tumor. (K) POSTERIOR FLOOR OF MOUTH. MARGIN: Squamous mucosa, negative for tumor. (L) COMPOSITE RESECTION LEFT MANDIBLE. BUCCAL. FOM: INVASIVE SQUAMOUS CARCINOMA -- Well differentiated. Tumor Features: Gross: Exophytic. Size: 5.0 cm in largest dimension. Invasion: Present, depth at least 1.5 cm. Tumor Border: Infiltrative with thick cords > 4 cells. Perineural Invasion: final evaluation pending decalcification sections. Vascular Invasion: Absent. Bone / Cartilage Invasion: Pending Decalcification (see addendum). Three lymph nodes. negative for tumor (0/3). (M) TEETH: Teeth, gross only. Page: L. 74.8kg BSA: 1.9m. Specimen Date/Tice: GROSS DESCRIPTION. (A) LEFT NECK DISSECTION, LEVEL 2A - Received is a 4.0 X 2.2 x 1.0 cm fragment of fibroadipose tissue from which 14. possible lymph nodes are identified. ranging in size from 0.3 to 1.2 cm. SECTION CODE: A1, five possible lymph nodes; A2, five possible lymph nodes; A3, four lymph nodes. (B) LEFT NECK DISSECTION, LEVEL 28 - Received is a 3.0 x 1.5 x 0.3 cm fragment of fibroadipose tissue from in which no. definite lymph nodes are identified. SECTION CODE: B1, B2, tissue, entirely submitted. (C) LEFT NECK DISSECTION, LEVEL 3 - Received is a 3.3 X 3.3 x 1.0 cm fragment of adipose tissue from which seven possible. lymph nodes are identified ranging in size from 0.5 to 1.3 cm. SECTION CODE: C1, one lymph node; C2, five possible lymph nodes; C3, one lymph node. (D) LEFT NECK DISSECTION, LEVEL 4 - Received is a 4.0 x 2.8 X 0.8 cm fragment of adipose tissue from which eight possible. lymph nodes are identified, ranging in size from 0.3 to 2.0 cm. SECTION CODE: D1, one lymph node, bisected; D2, four possible lymph nodes; D3, three lymph nodes. (E) LATERAL DEEP MARGIN, TRUE MARGIN INKED, STITCH ANTERIOR - Received is a 2.9 x 1.2 X 0.3 cm fragment. of. fibroadipose tissue with ink on one side and a stitch marking anterior aspect. The true margin is inked black and the anterior. aspect is inked yellow, posterior aspect is inked green and the specimen is serially sectioned and entirely submitted in E1 and E2. for frozen section evaluation. INK CODE: True margin - blue, anterior - yellow, posterior - green. FS/DX: MARGIN NEGATIVE FOR CARCINOMA. (F) MASSETER MARGIN - Received is a fragment of muscle tissue measuring 1.3 X 1.1 x 0,5 cm, with cattery on one side. SECTION CODE: F1, entirely submitted for frozen section evaluation. FS/DX: NEGATIVE FOR CARCINOMA. (G) ANTERIOR SUBLINGUAL MARGIN - Received is a fragment of fibroadipose tissue measuring (0.9 x 0.6 X 0.3 cm). Submitted entirely for frozen section in G1. FS/DX: NEGATIVE FOR CARCINOMA. (H) ANTERIOR ALVEOLAR NERVE - Received are two fragments of pate-pink glistening firm tissue measuring 1.0 x 0.5 x 0.3. cm in aggregate. Entirely submitted for frozen section evaluation in H1. FS/DX: NEGATIVE FOR CARCINOMA. (I) RETROMOLAR TRIGONE, DEEP MARGIN. TRUE MARGIN INKED - A fragment of mucosa (1.4 X 0.6 x 0.6 cm) One surface. shows smooth glistening mucosa with a faint surgeon's ink. The mucosa is reinked black and the specimen is submitted entirely. for frozen section examination in block 11. FS/DX: NEGATIVE FOR CARCINOMA. (J) POSTERIOR BUCCAL MARGIN, INK AT TRUE MARGIN - A segment of mucosa (1.2 x 0,3 X 0.3 cm). One surface of the. mucosa shows stained surgeon's ink. The specimen is submitted entirely for frozen section examination in block J1. FS/DX: NEGATIVE FOR CARCINOMA. (K) POSTERIOR FLOOR OF MOUTH MARGIN, TRUE MARGIN INKED - A fragment of mucosa (1.6 X 0.3 x 0.3 cm). One. surface of the mucosa bears faint surgeon's ink that is reinked black and submitted entirely for frozen in K1. FS/DX: NEGATIVE FOR CARCINOMA. (L) COMPOSITE RESECTION LEFT MANDIBLE. BUCCAL, FOM - A composite resection consists of a segment of mandible,. portion of buccal mucosa and portion of the floor of mouth, overall 9.5 X 4 x 4 cm. An ulcerated lesion (2.8 X 2.5x 1 5 cm) is in the. floor of mouth however corresponds to a larger lesion extending to involve the gingival and buccal surface (~5.0 cm maximum. dimension. The surface of the mandible appears eroded. The lesion is about 0.5 cm to the closest soft tissue margin. Multiple. lymph nodes are identified. Soft tissue is entirely submitted in L1 - L10. The mandible is submitted to bone lab for further. processing. Both tumor and normal tissue were submitted to tissue bank. (M) TEETH, GROSS ONLY - Multiple pale-gray teeth (7.0 X 1.5 X 1.2 cm in aggregate) Gross ID only. CLINICAL HISTORY. SNOMED CODES. T-51200, M-80703. Gome rests reported here may have been developed and performance characteristica determined by. These tests have nct been. Page: 3. (174.00m 74.3kg BSA: 1.9m. Spectmen Date/Tire: specifically cleared or approved by the U.S. Food and Drug Administration 24. Entire report and diagnosis completed by: Start of ADDENDUM. Page: 1. (1.74.00m 71.8kg BSA: Specimen Dace/Time: ADDENDUM. This modified report is being issued to provide additional information/results. Addendum completed by. DIAGNOSIS. (L) COMPOSITE RESECTION LEFT MANDIBLE, BUCCAL AND FOM. SQUAMOUS CARCINOMA.involving bone. Anterior mandible margin, en face: Negative for tumor. GROSS DESCRIPTION. (L) COMPOSITE RESECTION LEFT MANDIBLE, BUCCAL AND FOM - The bone is serially sectioned and lesion extends to a. depth of 0.7 cm and grossly abutts the nerve. The mandible margin is grossly uninvolved. SECTION CODE: L11, anterior mandible margin, bisected and en face; L12, L13, representatives of lesion involving bone. and nerve. L11-L13 submitted after decalcification. Entire report and diagnosis completed by: END OF REPORT-.",T4,N0,M0,T4N0M0
TCGA-BR-A4QM,"Gross Description: There is a stomach with saucer-like tumor up to 6.5 cm in size, with invasion of the. whole wall layers. Lymph nodes are dense, hyperemic Omentum is with metastatic nodes up to 0.5 cm. in their diameter. Along the spleen surface there are two white spots up to 3 cm in their largest. dimension. Microscopic Description: Adenocarcinoma of the stomach, G-3, with mucinous production, with. superficial ulceration and invasion into the perigastric fat. Six examined lymph nodes of the greater and. lesser curvature demonstrated metastases. Spleen demonstrates anemia of the red pulp. Omentum is. with metastasis of the adenocarcinoma. Surgical margin is free of tumor elements. Diagnosis Details: Tumor Features: Ulcerated, Tumor Extent: Perigastric fat, Venous Invasion: Absent,. Margins: Absent, Treatment Effect: Comments: Original records read pT4N2M1. But there are no proof for M1 in the patients case history. Formatted Path Reports: STOMACH TISSUE CHECKLIST. Specimen type: Subtotal gastrectomy. Tumor site: Cardia. Tumor size: 0 x 0 X 6.5 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Other - Perigastric fat. Lymph nodes: 6/6 positive for metastasis (Greater and lesser curvature 6/6). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T3,N2,M0,T3N2M0
TCGA-Q9-A6FW,"-Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Anat Path Reports. Document Date: Histoloav. Acc #: (Age: M. Client: Submitting. Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. A. DISTAL TWO-THIRDS ESOPHAGUS AND PROXIMAL ONE-THIRD STOMACH, PARTIAL. ESOPHAGOGASTRECTOMY, A1FS: - INVASIVE ADENOCARCINOMA, MODERATELY TO POORLY DIFFERENTIATED (5.0 X 2.8 X 1.4 CM). - TUMOR EXTENDS TRANSMURALLY INTO PERI-ESOPHAGEAL AND PERI-GASTRIC SOFT TISSUES. - ARISING IN A BACKGROUND OF INTESTINAL METASPLASIA AND HIGH-GRADE DYSPLASIA AT THE. GASTROESOPHAGEAL JUNCTION. - EXTENSIVE PERINEURAL INVASION AND LYMPHOVASCULAR INVASION ARE PRESENT. - CIRCUMFERENTIAL MARGIN IS POSITIVE FOR ADENOCARCINOMA. PROXIMAL ESOPHAGEAL AND DISTAL GASTRIC MARGINS ARE NEGATIVE FOR DYSPLASIA OR CARCINOMA. - THREE OF TWENTY-TWO LYMPH NODES POSITIVE FOR METASTATIC ADENOCARCINOMA, WITH EXTRANODAL. EXTENSION (3/22). SYNOPTIC REPORT. B. LYMPH NODES, RIGHT LEVEL 8, EXCISION: TWELVE LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/12). -Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure. or reproduction of this information is strictly prohibited. Anat Path Reports. C. LYMPH NODES, 4R, EXCISION: - EIGHTTEEN LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/18). D. LYMPH NODES, LEVEL 7, EXCISION: - TEN LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/10). Assisted by: Synoptic Worksheet. A. Distal two-thirds of esophagus with proximal one-third of stomach: Specimen: Esophagus. Proximal stomach. Procedure: Esophagogastrectomy. Tumor Site: Esophagogastric junction (EGJ). Relationship of Tumor to Esophagogastric Junction: Tumor midpoint is located at the esophagogastric junction. Distance of tumor center from esophagogastric junction: 0 cm. Tumor Size: Greatest dimension: 5.0 cm. Additional dimension: 2.8 cm. Additional dimension: 1.4 cm. Histologic Type: Adenocarcinoma. Histologic Grade: G2: Moderately differentiated. Microscopic Tumor Extension: Tumor invades through the muscularis propria into the periesophageal soft. tissue (adventitia). Margins: Proximal margin uninvolved by invasive carcinoma. Proximal margin uninvolved by dysplasia. Distal margin uninvolved by invasive carcinoma. Distal margin uninvolved by dysplasia. Circumferential (adventitial) margin or Deep margin involved by invasive. carcinoma. Treatment Effect: No prior treatment. Lymph-Vascular Invasion: Present. Perineural Invasion: Present. TNM Descriptors: Not applicable. Primary Tumor (pT): pT3: Tumor invades adventitia. Regional Lymph Nodes (pN): pN2: 3 to 6 nodes involved. Number of regional lymph nodes examined: 62. -Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use. disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Number of regional lymph nodes involved: 3. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Intestinal metaplasia (Barrett's esophagus). Dysplasia, high grade. Clinical History. Esophageal cancer. Esophagogastrectomy jejunostomy tube. Specimen(s) Received. A: Distal two-thirds of esophagus with proximal one-third of stomach. B: Level 8 lymph node, right. C: 4R lymph nodes. D: 7 lymph nodes. Gross Description. Specimen A is received fresh, labeled with the patient's name and medical record number as ""distal two-thirds of esophagus with. proximal one-third of stomach."" The specimen consists of one portion of esophagus measuring 12.0 cm in length and 3.5 cm in. diameter with attached stomach measuring 12.0 x 4.0 x 3.0 cm. There is a firm area at the GE junction with muocsal ulceration. and wall thickening. The area of palpable wall firmness measures 5.0 x 2.8 x 1,4 cm, and the area of ulceration measures 2.5 x. 2.5 cm. These areas are 5.8 cm from the proximal margin and 2.3 cm from the distal margin. There are two foci of mucosal. ulceration, 1 cm proximal to the main ulcer. Otherwise, the specimen is unremarkable. Several possible lymph nodes are. identified. The radial margin is inked black. Sections are submitted as follows: Dictated by Dr. Specimen B is received fresh, labeled with the patient's name and medical record number as ""right level 8 lymph node."" The. specimen consists of multiple fragments of nodal tissue that measure 3.5 x 2.4 x 0.8 cm, in aggregate. The specimen is. submitted entirely in cassettes ""B1"" through ""B3."" (Dictated by Dr. Specimen C is received fresh, labeled with the patient's name and medical record number as ""4R lymph node."" The specimen. consists of multiple fragments of nodal tissue admixed with fat that measure 5.5 x 3.0 x 2.0 cm, in aggregate. Several fragments. of lymph nodes, as well as whole lymph nodes are identified. Possible nodal fragments are submitted in cassettes ""C1"" and ""C2"". while presumed whole lymph nodes are submitted in cassettes ""C3"" and ""C4."" (Dictated by Dr. Specimen D is received fresh, labeled with the patient's name and medical record number as ""#7 lymph node."" The specimen. consists of several fragments of nodal tissue that measure 4.3 x 3.6 x 1.3 cm, in aggregate. The largest of these fragment. measures 2.4 x 2.2 x 1.0 cm. Sections are submitted as follows. (Dictated by Dr. CASSETTE SUMMARY: A1FS: Proximal margin. A2: Representative distal margin. A3-A6: Lesion, GE junction. A7: Lesion, within stomach, one lymph node bisected. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. A8: Lesion, within stomach. A9: Representative esophagus and stomach, uninvolved. A10: Satellite areas of superficial mucosal ulceration, esophagus. A11-A15: Possible lymph nodes, whole. D1,2: Largest fragment, bisected. D3: Second largest fragment. D4: Fragmented possible lymph nodes. D5: Possible lymph nodes, whole. Intraoperative Consult Diagnosis. A1FS: ESOPHAGUS, PROXIMAL MARGIN (FROZEN SECTION): NEGATIVE FOR IN SITU OR INVASIVE CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by Dr. Microscopic Description. Microscopic examination performed.",T3,N2,M0,T3N2M0
TCGA-A6-6648,"SPECIMEN. A. Descending colon. B. Liver biopsy. CLINICAL NOTES. PRE-OP DIAGNOSIS: Descending colon cancer. GROSS DESCRIPTION. A. Received fresh, subsequently fixed in formalin labeled. ""descending colon"" is a 21 cm long portion of colon which has a. portion of omentum attached. The omentum is 25 X 13 X 4 cm. The. omentum is sectioned and palpated to show no discrete gross lesions. identified. The ends of the specimen are opened and are arbitrarily. inked blue and black. No orientation of the specimen is given. The. specimen is partially covered with pink-tan smooth glistening serosa. and abundant yellow lobular fat. The specimen shows a 2.7 X 2.7. cm. exophytic tumor which is equidistance between either end (5.7 cm). The specimen shows otherwise pink-tan smooth glistening mucosa with. normal to abundant folds having an average circumference of 6.5 cm. The cut surface of the tumor shows possible invasion into the. muscularis propria, coming within 2 cm of the deep margin. Lymph. nodes are grossly identified in the fat. Representative sections. of. the specimen are submitted as follows: block 1 - representative. luminal margins; block 2 - representative section of omentum; blocks. 3,4 - full thickness slices of tumor to radial margin. tumor to normal; blocks 6-9 - possible lymph nodes. B. Received fresh, subsequently fixed in formalin labeled. ""liver biopsy"" are multiple red-brown irregular to. cylindrical tissue fragments which have an aggregate measurement of. 1.2 X 0.4 X. cm. pecimens are entirely submitted in one. cassette. MICROSCOPIC DESCRIPTION. A&B: Histologic type Invasive adenocarcinoma, not otherwise specified. Histologic grade : Moderately differentiated. Primary tumor (pT) : Tumor invades through muscularis propria in two. pericolonic fat (pT3). Proximal margin: Negative for tumor. Distal margin: Negative for tumor. Circumferential (radial) margin: Negative for tumor. Distance of tumor from closest margin: 5.7 cm from both proximal. and distal margin. Vascular invasion: Not identified. Regional lymph nodes (pN) : 21 lymph nodes are all negative for. metastatic tumor (pN0). Non-lymph node pericolonic tumor: Not identified. Distant metastasis (pM) : Metastatic carcinoma is identified in the. liver core biopsy in specimen B (pM1). Other findings: The attached omentum is negative for tumor. The. background colonic mucosa was unremarkable. The background hepatic. parenchyma was fairly unremarkable other than reactive changes to. the tumor and some mild steatosis. 5x1, 4x1. DIAGNOSIS. A. Colon, descending, segmental resection: Invasive moderately differentiated adenocarcinoma, tumor. invades through muscularis propria into pericolonic fat (pT3) . Twenty one lymph nodes negative for metastatic tumor (pNO) . Resection margins are negative for tumor. Omentum is negative for tumor. B. Liver, core biopsies: Metastatic adenocarcinoma compatible with origin from colonic. primary.",T3,N0,M1,T3N0M1
TCGA-LK-A4O0,"FINAL DIAGNOSIS: PARTS 1. AND 2: BONES, 5TH AND 6TH RIBS, RESECTION -. SPECIMEN UNDERGOING DECALCIFICATION. ADDENDUM REPORT TO FOLLOW. PART 3: PLEURA, LEFT, PLEURECTOMY -. DIFFUSE MALIGNANT MESOTHELIOMA, PREDOMINANTLY FIBROSARCOMATOUS TYPE, ARISING IN. ASSOCIATION WITH HYALINE PLEURAL PLAQUES AND ASSOCIATED WITH CHRONIC TALC PLEURITIS. COMMENT: The malignant mesothelioma Is predominantly a fibrosarcomatous type although occasional areas of epithelioid. differentiation are seen, particularly as the mesothelioma Infiltrates adipose tissue. Immunostains show an. immunophenotype that confirms the diagnosis of mesothelioma, in particular that the neoplastic cells express nuclear. Calretinin and WT-1 and cytoplasmic D2-40 and CK5/6. Immunostains for Carcinoembryonic Antigen, B72.3, BER EP4,. Leu-M1, and TTF-1 are negative. Histochemical stains for neutral mucin including PAS/PASD and Mucicarmine stains. are negative.",T1,N0,M0,T1N0M0
TCGA-CN-5366,"Report Type. Date of Event. Authored by. Hosp/Group. PATIENT HISTORY: Carcinoma of pharynx involving larynx. PRE-OP DIAGNOSIS: Pharyngeal/laryngeal carcinoma. POST-OP DIAGNOSIS: Same. URE: Laryngopharyngectomy, bilateral neck dissection. FINAL DIAGNOSIS: PART 1 : LYMPH NODES OF RIGHT NECK, LEVEL IIB, EXCISION. A. METASTATIC SQUAMOUS CELL CARCINOMA INVOLVING ONE OF THREE LYMPH. NODES (1/3) . B. NO EXTRACAPSULAR SPREAD IDENTIFIED. PART 2: LYMPH NODES OF RIGHT NECK, LEVEL II IV, DISSECTION. A. METASTATIC SQUAMOUS CELL CARCINOMA INVOLVING THREE OF TWELVE. LYMPH. NODES (3/12) . B. POSITIVE LYMPH NODES ARE IN LEVELS II AND III. C. EXTRACAPSULAR SPREAD PRESENT IN LEVEL II LYMPH NODE. PART 3: LYMPH NODES OF LEFT NECK, LEVELS II IV, DISSECTION. A. METASTATIC SQUAMOUS CELL CARCINOMA IN FOUR OF THIRTY LYMPH NODES. (4/30) . B. POSITIVE LYMPH NODES IN LEVELS II, III AND IV. C. EXTRACAPSULAR SPREAD PRESENT IN LEVELS III AND IV. PART 4: LARYNX, PHARYNX, AND THYROID GLAND, LARYNGOPHARYNGECTOMY AND. THYROIDECTOMY. A. INFILTRATING SQUAMOUS CELL CARCINOMA OF RIGHT PYRIFORM SINUS,. MODERATELY DIFFERENTIATED, WITH INVASION INTO PARAGLOTTIC SPACE AND THYROID. AND CRICOID CARTILAGES. (See comment) . B. PERINEURAL INVASION IS SEEN. C. THYROID GLAND IS FREE OF TUMOR BUT SHOWS AREAS OF FIBROSIS AND. INFLAMMATION. D. TRACHEOSTOMY SITE WITH NO INVOLVEMENT BY TUMOR. E. FINAL MARGINS OF RESECTION ARE FREE OF TUMOR. F. PATHOLOGIC STAGE: pT4a, N2c, Mx. PART 5: ESOPHAGEAL MARGIN, EXCISION. A. NO TUMOR SEEN. B. ONE (1) BENIGN LYMPH NODE. PART 6: RIGHT BASE OF TONGUE, EXCISION. INFILTRATING SQUAMOUS CELL CARCINOMA MODERATELY DIFFERENTIATED (See. comment) . PART 7: UPPER PHARYNGEAL WALL, EXCISION. NO TUMOR SEEN. PART 8 ADDITIONAL RIGHT BASE OF TONGUE, EXCISION. NO TUMOR SEEN. PART 9: LYMPH NODE OF RIGHT NECK, LEVEL II, EXCISION. A. METASTATIC SQUAMOUS CELL CARCINOMA INVOLVING ONE LYMPH NODE. EXTRACAPSULAR SPREAD IS SEEN. cinoma has focal areas with glandular-like - differentiation, however,. it is negative for mucin utilizing mucicarmine and PAS with and without. diastase stains. This indicates that this is a squamous cell carcinoma,. acantholytic type. My siy. estation that I have personally reviewed the submitted. material (s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received in nine parts. Part 1 is received in formalin labeled with the patient' S name, initials XX. and ""level 2B right neck."" The specimen is a 4.0 X 2.5 X 1.0 cm fibroadipose. excision with three lymph nodes ranging from 0.2 to 1.2 cm. The lymph nodes. are submitted in cassette A (largest inked black and bisected) . Part 2 is received in formalin labeled with the patient S name, initials XX. and ""level 2, 3, 4, right neck. The specimen is a 15.0 X 5.0 X 2.0 cm. modified radical neck dissection. No sternocleidomastoid muscle, external. jugular vein or spinal accessory nerve present. In level 2 is a 4.0 X 3.0 X. 2.2 cm area of matted, grossly involved lymph nodes. Additionally are. multiple. separate lymph nodes, ranging from 0.1 to 1.3 cm. The lymph nodes are. submitted as follows. 2A-2B -. matted lymph nodes in level 2, full thickness section, bisected. 2C. two level 2 lymph nodes. 2D -. six level 3 lymph nodes. 2E -. nine level 4 lymph nodes. Part 3 is received fresh labeled with the patient' S name, initials XX and. ""left neck, level 2, 3, 4. The specimen is a 13.0 X 4.0 X 1.0 cm modified. radical neck dissection. No sternocleidomastoid muscle, external jugular. vein. or spinal accessory nerve present. Multiple lymph nodes range from 0.1 to. 1.7. cm are present, the largest lymph node in level 3. The lymph nodes are. submitted as follows: 3A -. level 2, node A. 3B -. level 3, node A. 3C -. level 3, node B. 3D -. level 4, node A. 3E -. level 4, node B. 3F -. level 4, node C. 3G -. level 4, node D. 3H -. eight level 2 lymph nodes. 3I -. multiple level 2 lymph nodes. 3J -. one level 3 lymph node, bisected. 3K -. six level 3 lymph nodes. 3L -. three level 4 lymph nodes. 3M -. multiple level 4 lymph nodes. Part 4 is received fresh and labeled with the patient' S name, initials. and. ""larynx and pharynx. The specimen is a laryngopharyngectomy specimen. including a total laryngectomy (11.0 cm epiglottic tip to distal trachea, 6.0. cm right to left and 7.0 cm anterior to posterior"" with attached 7.5 cm long. segment of pharynx (6.5 cm maximum circumference), 9.0 cm long by 1.5 cm. diameter hyoid bone, 5.5 X 3.5 X 1.5 cm thyroid gland with no identified. parathyroid glands and a 3.5 cm long tracheostomy site surrounded by a 4.5 X. 3.5 cm piece of skin. Five tracheal rings are present in the laryngectomy. specimen. Centered in the right inferior pyriform sinus of the hypopharynx is a 7.0 cm. long X 5.0 cm in circumference ulcerated tumor with white solid cut surface. The tumor is up to 2.3 cm in maximum depth with extension very close to the. right superior piriform sinus soft tissue and 0.9 cm from distal esophageal. margin. The tumor extensively invades the larynx submucosally involving a. large poriton on the right, undermining of the right true and false vocal. cords and invading through the right anterior thyroid cartilage with. extension. into the right and anterior perilaryngeal soft tissues closely approximating. the right lateral soft tissue margin. The tumor extends towards the base of. the epiglottis and focally involves the pre-epiglottic soft tissue and. extends. inferorly involving the posterior aspect of the cricoid cartilage with. extension to, but not into the right superior thyroid gland. Separate from. the main tumor is a 0.3 cm mucosal nodule at the inferor right epiglotic. base. The remainder of the laryngeal mucosa is tan without focal abnormalities. Thyroid and cricoid cartilages are moderately-to-severely calcified. INK CODE: Pre-epiglottic soft tissue superiorly = green anterior lateral and posterior. perilaryngeal and pharyngeal soft tissue = black. SECTION CODE : 4A -. superior pyriform sinus, shave margin (frozen section control). 4B -. tracheal margin (right half inked orange). , bisected. 4C-4D -. sagittal section from epiglottis through anterior commisure. including pre-epiglottic soft tissue, bisected (4D submitted after decal). 4E -. left true and false vocal cords. 4F -. left aryepiglottic fold (shave) and pyriform sinus (perpendicular). margins (pyriform sinus inked orange). 4G-4H -. right true and false vocal cord with underlying submucosal tumor. and tumor invading thyroid cartilage with adjacent lateral soft tissue. margin,. bisected and submitted after decal. 4I -. nodule at base of epiglottis in relation to underlying tumor with. tumor involving pre-epiglottic space. 4J-K - circumferential section through pharyngeal tumor in relation to. thyroid cartilage and posterior margin, bisected (posterior margin in K). 4L-4M -. cirumferential section of tumor in relation to cricoid cartilage,. thyroid gland and posteror margin, bisected (posterior margin in M). 4N -. tumor to trachea. 40 -. additional right thyroid gland. 4P -. right tracheostomy. 4Q -. left thyroid gland. 4R -. left tracheostomy. 4S -. left soft tissue shave margin. Part 5 is received fresh and labeled with the patient' S name, initials XX. and. ""esophgeal margin, stitch right superior. The specimen is a 2.2 cm in. circumferential section of grossly unremarkable mucosa. Deep margin inked. blue. The specimen is entirely submitted as follows: 5A -. true margin (frozen section control). 5B -. remainder of specimen. Part 6 is received in formalin and labeled with the patient' S name, initials. XX and ""right base of tongue."" The specimen is a 1.5 X 0.7 X 0.3 cm strp of. mucosa with a 0.9 cm white solid nodule. Deep margin inked blue. The. specimen. is entirely submitted in cassette 6A after frozen section examination. Part 7 is received in formalin and labeled with the patient' S name, initials. XX and ""upper pharyngeal wall. "" The specimen is a 3.5 X 2.8 cm piece of. pharyngeal wall, up to 1.3 cm thick with no grossly identified tumor. The. deep margin is inked black. The speicmen is entirely submitted in cassettes. 7A-7D. Part 8 is received fresh and labeled with the patient' S name, initials XX. and. ""right base of tongue. The specimen is a 5.0 cm in circumference strip of. mucosa. Deep margin inked black and lateral half additionally inked yellow. 8A -. true margin (frozen section contrl). 8B -. remainder of specimen. Part 9 is received in formalin and labeled with the patient' S name, iitials. XX and ""right level 2 node. The specimen consists of a 0.9 cm lymph node. with surrounding adipose tissue. The specimen is bisected and entirely. ted in cassette A. RATIVE CONSULTATION: PART 4AFS LARYNX AND PHARYNX, RIGHT SUPERIOR EPIGLOTTIC SHAVE MARGIN (frozen. section). A. MALIGNANT. B. MICROSCOPIC FOCUS OF INVASIVE SQUAMOUS CELL CARCI. PERIOR-LATERAL RIGHT PIRIFORM SINUS MARGIN. ESOPHAGEAL MARGIN"" (frozen section). A. BENIGN. B. NO TUMOR SEEN. PART 6AFS: : RIGHT BASE. on). A. MALIGNANT. B. INVASIVE SQUAMOUS CELL CARCINOMA. PART 8AFS RIGHT BASE OF TONGUE, BIOPSY. A. BENIGN. NO TUMOR SEEN. COPIC: scopic examination substantiates the above diagnosis. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH), Molecular Anatomic Pathology, and. Immunofluorescent Testing: The. d its performance characteristics determined by. the. Department of Pathology, as required by the. C. A. '. regulations. The testing has not been cleared or approved for the. S. cific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY UPPER AERODIGESTIVE TRACT AND MINOR SALIVARY. GLAND TUMORS. SPECIMEN TYPE: Resection: Laryngopharyngectomy and thyroidectomy. TUMOR SITE: Pharynx, hypopharynx. TUMOR SIZE: Greatest dimension: 7.0 cm. HISTOLOGIC TYPE: Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: G2. PATHOLOGIC STAGING (pTNM) : pT4a. pN2c. Number of regional lymph nodes examined: 47. Number of regional lymph nodes involved: 9. Extra-capsular extension of nodal tumor: Present. pMX. MARGINS. Margins uninvolved by tumor. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L) : Indeterminate. PERINEURAL INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS : None identified. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: T NECK. Stain/cil. H&E X 1. A. Part 2: IGHT NECK. Stain/o. H&E X 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E X 1. E. Part 3 : EFT NECK. Stain/ch. H&E X 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E X 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. H. H&E X 1. H&E X 1. H&E X 1. K. H&E X 1. L. H&E X 1. M. Part 4 : RYNX. Stain/c. Decal X 1. B. H&E X 1. B. H&E X 1. C. Decal X 1. D. H&E X 1. D. H&E X 1. E. H&E Recut X. 3. F. H&E X 1. F. Decal X 1. G. Decal X 1. H. Mucin X 1. PAS X 1. PASD X 1. H&E X 1. H&E X 1. K. H&E X 1. H&E X 1. M. H&E X 1. N. H&E X 1. O. H&E X 1. P. H&E X 1. Q. H&E X 1. R. H&E X 1. S. FRZ Single. X. 1. AFS. H&E X 1. AFS. Part 5: GIN. Stain/o. H&E X 1. B. FRZ Single X. 1. AFS. H&E X 1. AFS. Part 6: TONGUE. Stain/ch. FRZ Single X. 1. AFS. H&E X 1. AFS. Part 7 : AL WALL. Stain/<. H&E X 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. Part 8 : TONGUE. Stain/c. H&E X 1. B. FRZ Single X. 1. AFS. H&E X 1. AFS. Part 9: NODE. Taken: : Stain/c. X 1. A.",T4,N2,M0,T4N2M0
TCGA-W5-AA36,"Female. Surgery Date: DIAGNOSIS: Liver, segment IVB, and gallbladder, resection: Invasive grade 3 (of 4). cholangiocarcinoma forming a hilar mass (10.0 x 9.4 x 7.0 cm) . The tumor invades. into the wall of the gallbladder. The gallbladder mucosa shows cholesterolosis. The. surgical margins are negative. Omentum, biopsy: Metastatic cholangiocarcinoma. Soft tissue, peri duodenal region, excision: Metastatic cholangiocarcinoma.",T3,N0,M1,T3N0M1
TCGA-63-A5ML,"Sample Type TUMOUR. Diagnosis. Squamous Cell Carcinoma, Not Otherwise Specified (NOS). Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). Right lower lobe. Tumour Size (cm). 7. Histology. Squamous carcinoma. Grade/Differentiation. Pathological T. T2,NOS. Pathological N. Clinical M. M0. VALCSG Stage. Histology Comments. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.",T2,N0,M0,T2N0M0
TCGA-AA-3672,"Diagnosis: Right-sided hemicolectomy preparation shows tumor-free oral and aboral resection margins and. includes an ulcerated, moderately differentiated adenocarcinoma of the transverse colon with. infiltration of the perimuscular fatty tissue (G2, pT3). Follow-up report: After acetone clearing, 21 lymph nodes up to 0.7 cm in size can be prepared in the pericolic fatty. tissue adjoining the tumor. Of these, one lymph node shows metastatic infiltrates of the previously diagnosed. adenocarcinoma or colon carcinoma. In conclusion, to summarize, the disease is staged as pT3 pN1 (4/21) L0 V0 R0.",T3,N1,M0,T3N1M0
TCGA-AG-3887,"Structured findings: The material in I) is an advanced carcinoma, namely a mucinous adenocarcinoma of the colon. with penetration of all parietal layers and vascular infiltrates (G3, pT3, L1, V1), with regard to. the resection margins of the mucosa they show a regular mucosa, submucosa and muscularis,. with regard to the radial resection margin they show a free resection margin with mature fatty. connective tissue and related vascular portions,. with regard to the lymph nodes they show free lymph nodes (0/14).",T3,N0,M0,T3N0M0
TCGA-EL-A4JZ,"Sex: F. hysician: Case type: Surgical Case. DIAGNOSIS. (A) RIGHT MID JUGULAR LYMPH NODE: One lymph node, negative for tumor (0/1). (B) RIGHT SUPERIOR PARATHYROID LYMPH NODE: One lymph node, negative for tumor (0/1). (C) RIGHT MEDIASTINAL CONTENTS: Three lymph nodes, negative for tumor (0/3). (D) DELPHIAN NODE: Thyroid parenchyma and fibroconnective tissue, negative for tumor and lymph node. (E) PORTION OF LEFT SUPERIOR PARATHYROID GLAND: Minute fragments of parathyroid tissue, no tumor present. (F) LEFT NECK CONTENTS: METASTATIC PAPILLARY THYROID CARCINOMA IN ONE OF TWELVE LYMPH NODES (1/12) confined to node. (G) RIGHT PARATRACHEAL AND MEDIASTINAL CONTENTS: METASTATIC PAPILLARY THYROID CARCINOMA IN FIVE OF SIXTEEN LYMPH NODES (5/6) confined to node. (H) TOTAL THYROIDECTOMY AND LEFT PARATRACHEAL MEDIASTINAL CONTENTS: PAPILLARY THYROID CARCINOMA, CONVENTIONAL TYPE. Location: isthmus. Multi-focal: No. Size = 2.0 cm. Extrathyroidal extension: Present, extending into fibroadipose tissue. Lymphovascular invasion: Absent. Resection Margins: Negative. Background Thyroid: Chronic lymphocytic thyroiditis consistent with Hashimoto's thyroiditis. Lymph nodes: No tumor present in 2 lymph nodes. Parathyroid tissue present (H8). GROSS DESCRIPTION. Sex: F. Case type: Surgical Case. (A) RIGHT MID JUGULAR LYMPH NODE - A single possible lymph node measuring 0.7 cm in its greatest dimension. (B) RIGHT SUPERIOR PARATHYROID LYMPH NODE - A single fragment of fibrofatty tissue measuring 0.8 cm in its. Entirely submitted in cassette A. greatest dimension. Entirely submitted in cassette B. (C) RIGHT MEDIASTINAL CONTENTS - Three fragments of tiprofatty tissue measuring in aggregate 1 x 1 x 0.8 cm. Entirely. submitted in cassette C. (D) DELPHIAN NODE - A single possible lymph node with attached fatty tissue measuring 1 x 0.8 x 0.4 cm. Entirely. submitted in D. (E) PORTION OF LEFT SUPERIOR PARATHYROID GLAND - A (0.2 x 0.1 x 0.1 cm) pink-tan soft tissue fragment. Entirely. submitted for frozen section diagnosis in E. FS/DX: PARATHYROID TISSUE PRESENT. (F). LEFT NECK CONTENTS - A single fragment of fibrofatty tissue measuring 6.5 x 3 x 1 cm. Dissection reveals multiple. possible lymph nodes ranging from 0.5 up to 0.7 cm in their greatest dimension. Possible lymph nodes are entirely submitted. SECTION CODE: F1, five possible lymph nodes; F2, five possible lymph nodes; F3, five possible nodes. (G) RIGHT PARATRACHEAL AND MEDIASTINAL CONTENTS - A single fragment of fibrofatty tissue measuring 5.5 x 2. x. 1.0 cm. Dissection reveals multiple possible lymph nodes, ranging from 0.4 up to 1.1 cm in their greatest dimension. Possible lymph nodes are entirely submitted. SECTION CODE: G1, six possible lymph nodes; G2, five possible lymph nodes; G3, one sectioned possible Ivmph. node; G4, one sectioned possible lymph node; G5, one lymph node; G6, one lymph node; G7, one lymph node. (H) TOTAL THYROIDECTOMY AND LEFT PARATRACHEAL MEDIASTINAL CONTENTS - A total thyroidectomy with. anterior strap muscles covering the anterior portion of specimen (6 x 6 x 2 cm). The thyroid shows nodular changes. suggestive of chronic lymphocytic thyroiditis. The right lobe has diffuse changes of thyroiditis. Within the isthmus, a superior. nodule is firm, tan, extending and focally adherent to the skeletal muscle and extending into the left thyroid lobe (2 x 1.6 x 1.5. cm). The left lobe also shows nodular changes, suggestive of thyroiditis with a slightly firmer and inferior nodule (1.5 x 1 x 0.5. cm). Within the surrounding fibroadipose tissue, possible lymph nodes are identified. SECTION CODE: H1, H2, sections of right thigh superior to inferior; H3, H4, tumor at isthmus with attached soft. tissue; H5, H6, superior left thyroid and adjacent isthmus nodule; H7, inferior left thyroid; H8, a separate nodule submitted. with specimen, bisected; H9, additional possible lymph nodes; H10, additional adipose tissue. CLINICAL HISTORY. Thyroid lesion. SNOMED CODES. T-B6000, T-C4200, M-80503, M-B0630. Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by:",T3,N1,M0,T3N1M0
TCGA-J8-A3YE,"WUID:79889458-D78D-424C-BACE-32042C7D2D8A. Temporary Copy. FINAL DIAGNOSIS. A) Left thyroid lobe and isthmus, resection: Papillary thyroid carcinoma. (3.5 cm), extending through the capsule into the perithyroidal soft. tissues as well as focally into the attached skeletal muscle; the surgical. margins are free; multiple (2 of 2) perithyroidal lymph nodes are both. benign (synoptic report below). B) Right thyroid lobe, resection: Benign thyroid tissue. C) Central compartment lymph nodes, excision: One (of total 2) lymph. node is involved by metastatic papillary thyroid carcinoma, without. extranodal tumor extension. The specimen also includes benign thymic. tissue with a parathyroid gland. A: Thyrold Gland. HISTOLOGIC TYPE: Papillary carcinoma. Classical (usual). TUMOR FOCALITY: Unifocal. TUMOR SIZE: Greatest Dimension: 3.5 cm. HISTOLOGIC GRADE: G1: Well differentiated. PRIMARY TUMOR (pT): pT3: Tumor more than 4 cm, limited to thyroid or with minimal. extrathyroidal extension (eg, extension to sternothyroid muscle or. perithyroid soft tissues). REGIONAL LYMPH NODES (pN): pN1a: Nodal metastases to Level VI (pretracheal, paratracheal and. prelaryngeal/Delphan) lymph nodes. NUMBER OF LYMPH NODE(S) INVOLVED: 1. NUMBER OF LYMPH NODE(S) EXAMINED: 4 (specimens A and C). LYMPH NODE, EXTRANODAL EXTENSION: Not identified. rrgPath Final. Temporary Copy. DISTANT METASTASIS (pM): Not applicable. MARGINS: Margins uninvolved by carcinoma. PERINEURAL INVASION: Not identified. EXTRATHYROIDAL EXTENSION: Present. Minimal. A) LEFT THYROID LOBE AND ISTHMUS, FS. B) RIGHT THYROID LOBE. C) CENTRAL COMPARTMENT LYMPH NODES. FROZEN SECTION. A) Right thyroid lobe and isthmus, resection: Papillary thyroid carcinoma. Seen with. GROSS DESCRIPTION. A) Received fresh for frozen section labeled ""left thyroid lobe and isthmus"" is a. 12-gram lobe of thyroid with isthmus measuring overall approximately 4.5 x 2.8 X 2.4. cm. The capsule grossly appears intact. The specimen is inked on its surgical. margins. Sectioning reveals an indurated brown/tan to tan nodule measuring. approximately 3.5 cm in greatest dimension. Touch preps are made. Representative tissue is submitted for frozen section as A1-A2. The remainder of. the specimen is submitted as A3-A10 for permanent sections. Tissue is also. collected for the. B) In formalin labeled ""right thyroid lobe"". The specimen consists of a portion of. dark purple/red thyroid tissue measuring 4.3 x 2.6 x 1.5 cm, 5.5 grams. The. specimen is inked and serially sectioned revealing dark purple/red tissue. Representative sections are submitted in cassettes B1-B5. C) In formalin labeled ""central compartment lymph nodes"". The specimen consists. of an irregular portion of pink/tan to yellow/tan soft tissue measuring 1.5 x 1.5 x 0.8. cm. Multiple small lymph nodes are identified ranging in size from 0.3 up to 0.8 cm. The specimen is submitted entirely in cassette C1. CLINICAL INFORMATION. LEFT THYROID NODULE.",T3,N1,M0,T3N1M0
TCGA-77-6842,"LEFT LUNG AND LYMPH NODES. Clinical Notes: L pneumonectomy, number 7 LN, number 5 LN. Three specimens are received: 1: L LUNG. Macroscopy: Specimen consists of a left pneumonectomy specimen measuring 300 x 290 x 58 mm in the. inflated state. There is an area of adhesion between the upper and lower lobes across the. oblique fissure. The pleura otherwise appears normal. Located in the upper lobe 25 mm from. the resection margin is a large well circumscribed firm grey mass measuring 62 mm in. maximal dimension. It appears to extend across the oblique fissure into the lower lobe. It. comes close to the external pleural margin but it appears to be clear of it. The tumour shows. central necrosis and cavitation. Near its most medial aspect of the specimen, several lymph. nodes show some pale discolouration suggestive of direct invasion by tumour. Adjacent lung. tissue shows evidence of mild centri-acinar emphysema. The lung tissue distal to the tumour. in the lower lobe shows yellow discolouration suggestive of lipoid pneumonia. [Bronchial. resection margin with hilar lymph nodes, 1A; further hilar lymph nodes, 1B; tumour where it. appears to cross the oblique fissure, 1C and 1D; tumour with no pleura or margins, 1E; tumour. with pleura, 1F; ? lymph node invasion, 1G; emphysema, 1H; ? lipoid pneumonia, 1I]. Microscopy: Sections show a poorly differentiated carcinoma in which there are some squamous features. The tumour has central necrosis. It invades across the oblique fissure to involve both lobes. Blood vessel invasion is present and there is tumour within an intrapulmonary peribronchial. lymph node. The tumour is clear of the bronchial margin. Centriacinar emphysema is noted. Lung distal to the tumour shows patchy organising pneumonia and endogenous lipid. pneumonia with collections of intra-alveolar foamy macrophages. 2: NUMBER 5 LYMPH NODE. Macroscopy: Specimen consists of two grey pieces of tissue which measure 20 x 10 x 3 mm in aggregate. [BIT, 2A]. Microscopy: The lymph nodes show no evidence of malignancy. The adjacent connective tissue contains. nodules of concentric fibrotic tissue consistent with silicotic nodules. These are probably. within an obliterated node. 3: NUMBER 7 LYMPH NODE. Macroscopy: Specimen consists of three tan coloured pieces of tissue measuring 12 x 12 x 3 mm in. aggregate. [BIT, 3A]. Microscopy: The lymph nodes show no evidence of malignancy. Summary-Specimens 1-3: Left pneumonectomy and mediastinal lymph nodes: 1: Poorly differentiated squamous cell carcinoma of the upper lobe with extension. through the oblique fissure into the lower lobe, 62 mm in maximal dimension. 2: Peribronchial lymph node involvement. 3: Blood vessel and pleural invasion. 4: Clear of bronchial resection margin. 5: Pathological stage T2N1MX. T-28000 M-80703 P1-03000. Copies:",T2,N1,M0,T2N1M0
TCGA-E8-A434,Laterality:Papillary carcinoma. Path Report:Tumor type: Papillary carcinoma. Tumor size: 0.7 x 0.7 x 0.7. Laterality: Left. Focality: Unifocal. Extrathyroidal extension: Markers and special stains: Additional comments: No Lymph nodes examined.,T1,N0,M0,T1N0M0
TCGA-VF-A8AB,"Panel: Surgical Pathology Final Report. Abnormal Flags key: C Critical H Hign L Low R Review  Abnormal. Interpretation Codes: (S) Susceptible (R) Resistant (MS) Moderately Susceptible  Intermediate. Status codes: P-Preliminary F-Final C-Corrected I-In progress/incomplete X-Cancelled. Dates and times displayed below are collection dates; to see the observation date and time for a result, hold your course over the collection. time. Times are on a 24-hour clock. An asterisk  in the Note column or next to a panel name indicates a note is present. To view it, rest your mouse cursor on the. Panel. Value. Range. Note. Obs d/t: Cordered by: Final Diagnosis. 1. Testicle, right; orchiectomy: - Classical seminoma, confaned to the testes. - Tumor measures 3.1 em in greatest dimension, grossly. - No lymphovascular invasion seen,. - Tunica vaginalis, rete testes and epididymis is uninvolved. - Adjacent seminiferous tubules with tubular atrophy. - Spermatic cord, vascular, and soft tissue margins are free of tumor. The case material was reviewed and the report verified by: (Electronic signature). Verification Date: Pathologist (s). Gross Description. Specimen #1 designated ""right testicle"" is received fresh, labeled with the. patient's name and medical record number, and consists of a an orchiectomy. specimen weighing 52.0 g and beasuring 7.5 x 4.4 x 2.0 cm. The testicle is. bivalved to reveal a yellow, multilobulated, firm, ill circumscribed mass. measuring 3.9 x 3.5 x 2.0 cm over all. The external surface of the. specimen is inked entirely in blue. Representative sections are submitted. as follows: 1A and 18, vascular and soft tissue margie; IC through 1G,. tumor: 1H and 11, proximal testicle not involved by tumor; 1J, spermatic. 1 of 2. cord margin. SUMMARY OF SECTIONS: 10, multiple, representative. Clinical Information. -year-old man with history of right testicular mass. Pre-Operativa Diagnosis: Not specified. post-Operative Diagnosis: Not specified. Operation: Right radical orchiectomy. Specimen: 1. Right testicle. 2 of 2.",T1,N0,M0,T1N0M0
TCGA-46-3768,"PRIORITY : FROZEN SEC. SURGICAL PROCEDURES: RESECTION, REGIONAL LYMPH. CLINICAL HISTORY. OTHER SPECIAL CONSULTATION: TCGA STUDY. PERTINENT CLINICAL HISTORY: LEFT UPPER LOBE CA. OPERATIVE FINDINGS LEFT THORACOSCOPIC LOBECTOMY. GROSS DESCRIPTION. A. The specimen is submitted fresh for frozen section as ""level 5"" and. consists of a red black node measuring 0. cm in greatest dimension. The. specimen is submitted in toto, 1 (1) labeled ""FSP"" and used for frozen. section. FROZEN SECTION DIAGNOSIS: Negative for tumor. B. The specimen is submitted fresh for frozen section as ""level 8 left. lower (FS #2) 11 and consists of a red black node measuring 0.5 cm in. greatest dimension. The specimen is submitted in toto, 1 (1) labeled. ""FSP"" and used for frozen section. FROZEN SECTION DIAGNOSIS: Negative for tumor. C. The specimen is submitted fresh as ""left upper lobe - please ink. pleural margins"" and consists of a 448 gm (formalin fixed) 22 x 15 x 9 cm. lung lobectomy specimen received with a stapled bronchial margin measuring. 2 cm in diameter x 1 cm in length, multiple stapled vasculature margins. measuring 0.5 cm in length x 1 cm in diameter to 0.6 cm in length x 1.5 cm. in diameter and multiple stapled surgical margin measuring 1.5 cm in width. x 5 cm in length. The pleural surface shows a tan brown ragged disrupted. area with an underlying diffusely firm nodular mass. The pleural surface. overlying the mass is inked blue. The stapled resection margins are. GROSS DESCRIPTION. removed and the underlyingparenchyma is inked black. ""Sectioning reveals. an 8 x 6.8 x 6.2 cm well circumscribed gray tan to white firm focally. fleshy mass which grossly appears to abut the blue inked overlying. pleural surface measuring 0.8 cm from the closest black inked parenchyma. underlying the stapled resection margin and 1.7 cm from the bronchial. margin at the hilum. The remaining parenchyma consists of pink red spongy. homogenous and grossly unremarkable tissue. No other discrete masses or. nodularities are grossly identified. At the hilum are multiple gray tan. to white firm matted lymph nodes measuring 0.5 cm to 1.5 cm in greatest. dimension. Representative sections of the matted nodes along with. representative sections of the specimen are submitted; multiple (9) as. follows: Cassette 1: Vasculature and bronchial resection margins. Cassette 2-3 : Mass closest to blue inked pleural surface. Cassette 4: Perpendicular section of mass to closest black. inked parenchyma underlying the stapled resection. margin. Cassette 5: Perpendicular section of the hilum closest to. mass. Cassette 6: Uninvolved parenchyma and pleural surface. Cassette 7-8: Representative sections of the matted nodes at. hilum. Cassette 9: One hilar lymph node, bisected. D. The specimen is submitted fresh as ""neck of 6th rib"" and consists of. a. segment of rib measuring 2 cm in length and 1.5 cm in diameter. Representative longitudinal sections are submitted, 3 (1) for. decalcification. E. The specimen is submitted fresh as ""neck of 5th rib"" and consists of. two segments of rib measuring 1.5 and 2 cm in length and 0.7 cm each in. diameter. The pieces are friable and disrupted. The specimen is. sectioned longitudinally and submitted in toto, 4 (1) for decalcification. F. The specimen is submitted fresh as ""posterior hilar node"" and consists. of two firm red tan nodules measuring 1 and 1.5 cm each in dimension. Sectioning of each reveals friable gray black tissue. Each is bisected. and the specimen submitted in toto, 2 (1) . G. The specimen is submitted fresh as ""anterior hilar node"" and consists. of a red black node measuring 2 x 1.5 x 0.5 cm. The specimen is bisected. and submitted in toto, 2 (1). FINAL DIAGNOSIS. A. LYMPH NODE, LEVEL 5, EXCISION: LYMPH NODE, NEGATIVE FOR TUMOR (0/1) . B. LYMPH NODE, LEVEL 8 LEFT LOWER, EXCISION: LYMPH NODE, NEGATIVE FOR TUMOR (0/1). C. LUNG, LEFT UPPER LOBE, LOBECTOMY: INVASIVE SQUAMOUS CELL CARCINOMA. . SEE SYNOPTIC REPORT. D. NECK OF 6TH RIB, RESECTION: BENIGN RIB BONE. E. NECK OF 5TH RIB, RESECTION: BENIGN RIB BONE. F. LYMPH NODE, POSTERIOR HILAR, EXCISION: METASTATIC CARCINOMA INVOLVING TWO OF TWO NODES (2/2) . G. LYMPH NODE, ANTERIOR HILAR, EXCISION: LYMPH NODE, NEGATIVE FOR TUMOR (0/1). SYNOPTIC REPORT. SYNOPTIC REPORT: LUNG. (CAP/AJCC/ACS - REQUIRED ELEMENTS). SPECIMEN TYPE: LOBECTOMY. LATERALITY: LEFT. TUMOR SITE: LEFT UPPER LOBE. TUMOR SIZE: 8 CM. HISTOLOGIC TYPE: SQUAMOUS. HISTOLOGIC GRADE: G2-3 OF 4 (MODERATELY TO POORLY DIFFERENTIATED). EXTENT OF INVASION: EXTENDS TO PARIETAL PLEURA. EXTENTION TO PLEURA/OTHER STRUCTURES: PARIETAL PLEURA. SYNOPTIC REPORT. BRONCHIAL: UNINVOLVED. PARENCHYMAL: UNINVOLVED. VASCULAR: UNINVOLVED. CHEST WALL: UNINVOLVED. DISTANCE TO PERTINENT MARGIN (S) : 0.8 CM FROM THE PARENCHYMAL MARGIN. VENOUS INVASION: NOT DEFINITELY IDENTIFIED. ARTERIAL (LARGE VESSEL) INVASION: NOT DEFINITELY IDENTIFIED. LYMPH NODE: fine N1 - # INVOLVED/# EXAMINED: 5/8. f.., N2 - # INVOLVED/#EXAMINED: 0/7+. fine N3 - # INVOLVED/# EXAMINED: 0/0. OTHER PERTINENT FINDINGS: THE TUMOR IS ADHERENT TO AND FOCALLY INVADES PARIETAL PLEURA BUT. DOES NOT INVADE FAT, SKELETAL MUSCLE, OR NERVE BUNDLE. REMAINING LUNG SHOWS EMPHYSEMATOUS CHANGES. THREE POSITIVE PERIHILAR LYMPH NODES ARE IDENTIFIED ON THE LOBECTOMY. SPECIMEN. pTNM STAGE: pT3 N1 (AJCC 7TH EDITION).",T3,N1,M0,T3N1M0
TCGA-CG-4442,"Diagnosis/diagnoses. Subtotal gastrectomy resection material with extensive metaplasia evidently on an underlying. multifocal atrophic gastritis caused by previous H. pylori infection, with tumor-free resection. margins and with the inclusion of an ulcerated poorly differentiated adenocarcinoma or. gastric carcinoma of the intestinal type, located in the antrum, with infiltration of the. subserosa and without regional lymph node metastases. pT2b pNO 0/27).",T2,N0,M0,T2N0M0
TCGA-E8-A418,Laterality: Path Report:Tumor size (in cm): 9.0x9.0x6.0. Histologic type: Papillary thyroid carcinoma. Tumor extent: penetrate to fat tissue. Tumor laterality: Right. Tumor focality: Unifocal.,T4,N0,M0,T4N0M0
TCGA-VQ-AA6I,"PRIMARY SITE: Stomach (Gastroesophageal junction). ""Esophagus + stomach"": Poorly differentiated adenocarcinoma, invasive and ulcerated. Size of the neoplasm: 7.0 x 4.7 x 2.4cm (2.4cm deep). Location: esophagogastric transition. Depth of infiltration: up to subserosa. Sanguineous vascular invasion: not detected. Lymphatic vascular invasion: present. Perineural invasion: present. Adjacent gastric mucosa: intense active chronic gastritis. Omentum : - Mature adipose tissue free neoplasia. - Presence of 1 lymph node free of tumor (0/1). Surgical margins free of neoplastic involvement. 15 lymph nodes were dissected, of which 9 are compromised by neoplasia (9/15), with capsular. leakage, and distributed as follows: - Peri-tumoral nodes: 1/2. - Nodes from lesser curvature: 8/10. - Nodes from greater curvature: 0/3. ""Esophageal margin"": . Free of neoplasia. ""Terminal ileum + ascending colon"": Ileal and colonic mucosa within normal limits. Appendix: no histological particularities. 6 lymph nodes were dissected from the adjacent fat, all free of tumor (0/6). ""Gallbladder"": Intense chronic cholecystitis.",T3,N3,M0,T3N3M0
TCGA-3X-AAVC,"CONFIDENTIAL. Demographics (for. verification purposes). Date of Birth: Sex: F. Collected Date/Time. Received Date/Time. Specimen Description. A. Liver segment 4-5 and gallbladder. B. Portal tissue. Clinical Information. Gallbladder cancer. Infectious patient:No. Immunocompromised: No. History of neoplasm: No. Diagnosis. A. Liver (segment 4-5) and Gallbladder, Resection: Poorly differentiated adenocarcinoma (cholangiocarcinoma) arising. within mid and distal portion of the gallbladder, 3.8 cm in greatest. dimension (see Synoptic Report). Chronic cholecystitis and cholelethiasis with perforation (no tumor. at the perforation site). Resection margin (liver and peritoneal surfaces) free of tumor. B. Portal Tissue, Resection: Fibroadipose tissue with non-specific inflammation. No neoplasia. Verified: Responsible Resident: Synoptic Report. A: Gallbladder, Microscopic. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G3: Poorly differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades muscle layer. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1.3 mm. Specified margin: Liver parenchymal margin. LYMPH-VASCULAR INVASION: Not identified. PERINEURAL INVASION: Not identified. PRIMARY TUMOR (pT) : pT1b: Tumor invades muscle layer. REGIONAL LYMPH NODES (pN) : Number examined: 1. Number involved: 0. ADDITIONAL PATHOLOGIC FINDINGS: Cholelithiasis. Chronic cholecystitis. Acute cholecystitis. Gross Description. Received are specimen containers A to B. All requisitions and specimen containers are. labelled with the patient's name,. The cassettes and. identifiers are. labelled with the Surgical Number. A. Specimen is received fresh. The container is designated ""A. Liver segment 4-5 and. gallbladder"". The specimen consists of a gallbladder with attached liver tissue. The. gallbladder measures 11.0 cm in length and 4.0 cm in diameter. There is a cholelithiasis. measuring 1.5 cm in greatest diameter perforating through the gallbladder at the cystic. duct end. This perforation site has been painted yellow. There is also an indurated. area on the anterior side of the gallbladder without evidence of perforation externally. and this area has been painted orange. The indurated area at the anterior surface of the. gallbladder appears to be fibrosed with some necrosis on sectioning without grossly. evident tumor. The external surface of the liver resection margin has been painted blue. and appears to be uninvolved by mass lesions. The attached adjacent adipose tissue. measures 9.7 x 6.0 x 1.7 cm in greatest dimension. Within the gallbladder is a. tan/white, friable, polypoid lesion measuring 3.8 x 2.4 x 2.5 cm in greatest dimension. roughly arising from the wall and occupying the whole lumen of the mid portion of the. gallbladder Adjacent to this and close to a cystic duct is the perforated. cholelithiasis that is dark brown and ovoid in shape measuring 3.9 x 2.2 x 2.2 cm in. dimension. The tumor is seen to be attached to the perihepatic wall of the gallbladder. and has a maximum depth of invasion .1cm through the gallbladder wall into the hepatic. parenchyma as measured from the gallbladder mucosa to the deepest portion within the. adjacent liver parenchyma. At this area, the maximum depth of invasion in the hepatic. parenchyma itself as measured from the outer surface of the perihepatic gallbladder wall. into the liver parenchyma is 0.3 cm. There is necrosis and hemorrhage in the central. part of the tumor. Sections are submitted as follows: A1 - shaved cystic duct margin. A2 - grossly uninvolved part of the liver and gallbladder. A3 - site of the cholelithiasie perforation at the end towards the cystic duct. A4 - maximum depth of tumor invasion, split in half. A5 - maximum depth of tumor invasion. A6 - area of gallbladder wall induration. B. Specimen is received fresh and fixed overnight in formalin. The container is. designated ""B. portal tissue"". Within it is a tan/brown fibrous tissue with hemorrhage. The tissue measures 1.2 x 0.4 x 0.2 cm in maximum dimension. The specimen is bisected. and submitted in toto in one cassette, Bl. Encounter Number. Patient Location.",T1,N0,M0,T1N0M0
TCGA-DJ-A2PZ,"eck. Neck. Clinical Diagnosis & History: Papillary thyroid cancer. Specimens Submitted: 1: Left paratracheal lymph node (fs). 2: Left lobe of thyroid and isthmus. DIAGNOSIS: 1. Left paratracheal lymph node (fs): Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 1. 2. Left lobe of thyrold and Isthmus: Tumor Type: Papillary carcinoma, classical type. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not Identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 1.7 cm. Tumor Encapsulation: Partially surrounded. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Invades:extrathyroidal adipose tissue. Focal. Surgical Margins: Free of tumor. Tumor Multicentricity: Not identifled. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Parathyroid Glands: Not identified. 1ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT ( HAVE. REVIEWED AND APPROVED THIS REPORT. I.D. Special Studies: Special Stain. Comment. RECUT. Gross Description: M.D. 1.The specimen is received fresh and is labeled ""left para-tracheal lymph node"". It consists of one piece of tan yellow soft tissue,. measuring 0.5 x 0.5 x 0.4 cm. One lymph node is identified, measuring 0.3 cm in greatest dimension. Lymph node is entirely. submitted for frozen section. Summary of sections: FSC- frozen section control. I.D. 2). The specimen is received fresh and is labeled ""left lobe of thyroid and isthmus"". It consists of a previously incised thyroid lobe. measuring 4.5 x 2.5 x 1.5 cm and weighing 12 g. There is a 2 x 1 x 0.6 cm portion of skeletal muscle attached to the anterior. aspect.. The lobe is inked black posterior and blue anterior. Serial sectioning reveals 1.7 x 1.6 x 1.2 cm partially encapsulated hard. tan nodule with gritty cut surface in the mid to upper lobe. The specimen is entirely submitted to include TPS. Summary of sections: N nodule. RS - remaining sections. Summary of Sections: Part 1: Left paratracheal lymph node (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: Left lobe of thyroid and isthmus. Block. Sect. Site. PCs. 4. N. 4. 4. RS. 4. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative. consultation. 1. Frozen section diagnosis: Left paratracheal lymph node (fs): Benign. Permanent diagnosis:",T3,N0,M0,T3N0M0
TCGA-A7-A6VV,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Sentinel lymph node, right axilla, biopsy: One negative lymph. node (0/1). Breast, right, mastectomy: Invasive ductal carcinoma, grade 3,. size 4.5 cm in greatest dimension, with ductal carcinoma in-situ,. grade 3 with necrosis; negative margins of excision. C. Breast, left, mastectomy: Focal atypical ductal hyperplasia;. negative margins of excision. D. Lymph nodes, right axilla, regional resection: Four negative. lymph nodes (0/4). Microscopic Description: Invasive carcinoma: Histologic type: Ductal. Histologic grade: 3. Overall grade: 9/9. Architectural score: 3. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : Size 4.5 cm in greatest dimension. Specimen margins: Negative. Vessel invasion: Not identified. Nipple (Paget's : Negative. Invasion of skin or chest wall: Negative. Ductal carcinoma in situ: Histologic pattern: Solid, cribriform. Nuclear grade: 3. Central necrosis: Present. DCIS of total tumor (if mixed) : 10%. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative. Calcification: Present. Description of non-tumorous breast: Fibrocystic changes including. apocrine metaplasia with cyst formation. Comments: Prior biopsy site identified. Focal atypical ductal. hyperplasia, with partial involvement of a duct by a cribriform cell. population, is present within the left breast. Distant metastasis (pM) : Unknown. Lymph nodes: Number of positive nodes of total: 0 of. 5. Size of largest metastasis: N/A. Extracapsular extension (present/absent} : N/A. pN: pNO. Prognostic markers: See previous core biopsy at. Specimen. A. Right sentinel node (axillary). B. Right breast tumor at 12:00. C. Left breast tissue. D. Right axillary content. Clinical Information. Right breast, tumor at 12:00, large mass + for carcinoma right breast. Intraoperative Consultation. A. nno regative lymph node. Gross Description. A. Received unfixed for frozen section, labeled sentinel node right, is. a lymph node that is fat-replaced and 2 x 1.5 x 1.5 cm, entirely frozen. in 3 blocks. B. Received unfixed for tissue procurement, labeled right breast, is a. 1444 gram right breast that is unoriented and 23 cm medial to lateral,. 22 cm superior to inferior, and 4.5 cm anterior to posterior. There. is. an anterior black skin ellipse, 20 x 5 cm with 5 cm areola and 1.5 cm. nipple. There is a tan-gritty tumor at 12:00, up to 4.5 cm in greatest. dimension, and close to the anterior margin. Sections as follows: 1-6. continuous tumor, 7/8 tumor, 9 tumor, 10 RUQ random, 11 RLQ random, 12. LLQ random, 13 LUQ random, 14 nipple, 15 areola. C. Received unfixed, labeled left breast, is a portion of fibroadipose. breast tissue and skin that is 818 grams and 26 x 17 X 5 cm. Skin. is. darkly pigmented, and without focal lesions. Sectioning through the. breast tissue shows no mass lesions. Representative sections in. 8. blocks. D. Received unfixed, labeled right axillary content, is a 9 x 7 x 2 cm. portion of fatty nodal tissue. Lymph nodes are identified: 1 one. node, 2 two nodes, 3 one node.",T2,N0,M0,T2N0M0
TCGA-86-8076,"Gross. Microscopic. Diagnosis. Comments. Description. Description. Details. Laterality. LUNG TISSUE CHECKLIST. Right-upper. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 2.5 x 2.5 x 2.5. cm. Histologic type: Papillary. adenocarcinoma. Histologic grade: Well. differentiated. Tumor extent: Not. specified. Other tumor nodules: Not. specified. Lymph nodes: 0/5 positive. for metastasis (Regional. 0/5). Lymphatic invasion: Not. specified. Venous invasion: Not. specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic. findings: Not specified. Comments: TTF1+, CD15+.",T1,N0,M0,T1N0M0
TCGA-AG-A020,"This is an invasive rectal carcinoma, in this case with medium-grade differentiation, of. the mucinous type (G 2), with infiltration of all layers of the wall (pT3), lymph vessel. invasions (L1), a lymph node metastasis (pN1, 1 of 12), free resection margins in the. region of the mucosa and a free ligature area.",T3,N1,M0,T3N1M0
TCGA-85-8052,Microscopic. Diagnosis. Comments. Description. Description. Details. Laterality/lo. Date of excision. cation. LUNG TISSUE CHECKLIST. Right-upper. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 5 X 2 X 7.5 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None.,T3,N0,M0,T3N0M0
TCGA-AR-A24T,"Final Diagnosis. Breast, right, simple mastectomy: Infiltrating lobular carcinoma, Nottingham grade I (of III) [tubules 3/3, nuclei 1/3,. mitoses. 1/3;. Nottingham score 5/9], forming a mass (5.7 x 4.8 x 2.1 cm) located in the mid outer quadrant of the breast [AJCC pT3]. Lobular. carcinoma in situ is identified. Angiolymphatic invasion is present. The non-neoplastic breast parenchyma is unremarkable. Biopsy site changes are present. The tumor does not involve the nipple, overlying skin, or underlying chest wall. All surgical. resection margins, including the deep margin, are negative for tumor (minimum tumor free margin, 0.3 cm, deep margin). Lymph node, right axillary sentinel, excision: A single (1 of 1) right axillary sentinel lymph node is positive for metastatic. carcinoma. Extranodal extension is not present. Blue dye is identified. Lymph nodes, right axillary, dissection: Multiple (14 of 16) axillary lymph nodes are positive for metastatic carcinoma [AJCC. pN3]. Breast, left, simple mastectomy: Proliferative fibrocystic disease without atypia characterized by ductal hyperplasia, usual type,. sclerosing adenosis, parenchymal fibrosis, and cyst formation. Her-2/NEU has been ordered on paraffin-embedded tissue.",T3,N3,M0,T3N3M0
TCGA-VR-AA4D,"PRIMARY SITE: Esophagus (Distal). 1-""Product of esophagogastrectomy"": Moderately differentiated adenocarcinoma with papillary areas infiltrative up to. submucosa. Presence of lymphatic invasion. Perineural infiltration not detected. Infiltrative growth pattern. Absence of necrosis. Discrete peritumoral inflammatory infiltrate. Surgical margins free of neoplastic compromise. 2-""Lymphadenectomy according to standardization"": Metastatic adenocarcinoma in 6 of 25 identified lymph nodes (6/25), with no. capsular compromise, distributed as follows: 1/2 right cardiac; 2/7 left cardiac, 0/13 lesser curvature; 3/3 left gastric artery;. 0/0 celiac trunk; 0/0 inferior para-esophageal. 3- ""Greater omentum"": Free of neoplastic compromise. 4-""Esophageal margin"": Free of neoplastic compromise.",T1,N1,M0,T1N1M0
TCGA-EL-A3H8,"History Case. Sex: r. Te. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. the section ""SPECIMEN"" may have been added. DIAGNOSIS. (A) LEFT NECK, HIGHEST MOST JUGULAR FORAMEN LYMPH NODE: Lymph node, no tumor. (B) RIGHT CAROTID SHEATH LYMPH NODE: METASTATIC THYROID CARCINOMA IN LYMPH NODE. FROZEN SECTION REPORT, METASTATIC THYROID CARCINOMA IN LYMPH NODE. RIGHT NECK DISSECTION, LONG SUTURE AT LEVEL IV: METASTATIC PAPILLARY CARCINOMA IN 5 OF 14 LYMPH NODES. LEFT NECK DISSECTION, LEVEL II, III, IV AND V: METASTATIC PAPILLARY CARCINOMA OF THYROID IN 3 OF 22 LYMPH NODES. (E) LEFT SUPERIOR THYROID GLAND BIOPSY: Parathyroid tissue. (F) PARATHYROID FAT: Parathyroid tissue. MASS BENEATH RECURRENT LARYNGEAL NERVE: METASTATIC PAPILLARY CARCINOMA OF THYROID IN LYMPH NODE. RULE OUT PARATHYROID TISSUE: METASTATIC PAPILLARY CARCINOMA IN LYMPH NODE. (1) SUPERIOR MEDIAL STERNAL DISSECTION, TOTAL THYROIDECTOMY AND PARATRACHEAL. LYMPH NODE DISSECTION: PAPILLARY CARCINOMA OF THYROID INVOLVING THE LEFT LOBE WITH. EXTRAGLANDULAR EXTENSION INTO SOFT TISSUES. MICROSCOPIC FOCI OF PAPILLARY CARCINOMA OF THYROID IN RIGHT LOBE OF. THYROID. METASTATIC PAPILLARY CARCINOMA IN 6 OF 8 PARATRACHEAL LYMPH NODES. Site: thyroid. No: C73.9 how 1/3af"". Entire report and diagnosis completed by: Report released by: GROSS DESCRIPTION. (A) LEFT NECK HIGHEST MOST JUGULAR FORAMEN LYMPH NODE - Three lymph nodes. ranging in size (0.6 x 0.5 x 0.3, and 0.3 x 0.2 x 0.2 cm). specimen is. entirely submitted in A. (B) RIGHT CAROTID SHEATH - Fragment of soft tissue 0.6 x 0.5 x 0.5 cm. Bisected and submitted entirely in B for frozen section examination. (c). RIGHT NECK DISSECTION, LONG SUTURE AT LEVEL IV - Fibroadipose tissue. (14.0 x 3.0 x 2.0 cm). A stitch denoting ""lower most"" is provided. Multiple lymph nodes, the largest measuring 2.5 cm are identified. All. lymph nodes are submitted from lower most to upper most. SECTION CODE: C1, C2, one lymph node, multiple sections in two cassettes;. History Case. Department of Patholoav. Sex: F. Case type: Surgical History. C3, one lymph node, bisected; C4, multiple lymph nodes; C5, C6, one lymph. node, multiple sections in two cassettes (largest lymph node); C7, one Tymph. node, bisected; C8, one lymph node; C9, one lymph node. (D) LEFT NECK, LEVEL II, III, IV, AND V - Fibroadipose tissue 15.0 x 2.0 x. 1.0 cm. A stitch denoting ""lower most"" jugular node is provided. Multiple lymph nodes are identified. The largest lymph node measures 2.0. cm in greatest dimension. All lymph nodes are submitted from lower most to upper most. SECTION CODE: D1, multiple lymph nodes; D2, multiple lymph nodes; D3, multiple lymph. nodes; D4, multiple lymph node; D5, one lymph node; D6, one lymph node,. bisected. (E) LEFT SUPERIOR PARATHYROID GLAND BIOPSY - A piece of tan soft tissue (0.1. x 0.1 x 0.1 cm). Specimen totally submitted for frozen section in E. (F) PARATHYROID FAT - A minute Fragment of tissue, 0.1 x 0.1 x 0.1 cm. In. toto in F for frozen section examination. (G) MASS BENEATH RECURRENT LARYNGEAL NERVE AT MEMBRANE - A fragment of light. tan soft tissue, 0.9 x 0.5 x 0.5 cm. In toto in G for frozen section examination. 0.2 x 0.2 cm. specimen entirely submitted. (H) RULE OUT PARATHYROID TISSUE -. FS/DX: METASTATIC THYROID CARCINOMA. (1) SUPERIOR MEDIAL STERNAL DISSECTION, TOTAL THYROIDECTOMY - A paratracheal. lymph node dissection present consists of the thyroid gland attached with a. piece of fibroadipose tissue. The whole specimen is 10.5 x 6.8 x 2.5 cm. The. left and right thyroid lobe MSF 3.5 x 2.5 x 2.2 cm. Attached to the inferior. end of the thyroid is a piece of fibroconnective tissue 4.5 x 3.5 x 0.8 cm and. within this the seven nodules measuring up to 1.0 cm in greatest dimension. A. 2.0 x 1.7 x 1.2 cm nodule is present in one of the left thyroid lobe. The. tumor has soft papillary cut surface. The remainder of the thyroid tissue is. composed of red soft tissue with a slightly granular cut surface. The small. nodule in the fibroconnective tissue appear to have a cut surface similar to. the main tumor nodule. INK CODE: Black - external surface of the thyroid. SECTION CODE: I1-I5, one nodule, bisected, in each cassette from the. fibroconnective tissue; I6, three possible 1ymph nodes from the. the thyroid. fibroconnective tissue; 17-111, left side tumor; I12-I14, nontumorous part of. SNOMED CODES. M-80503 M-80506 T-B6000 T-C4200.",T3,N1,M0,T3N1M0
TCGA-BP-4787,"Clinical Diagnosis & History: vith laft ranal mass biapsy provan canv. Specimens Submitted: 1: KIDNEY; TOTAL NEPHRECTOMY. 2: LYMPH NODES, PARA-AORTIC, EXCISION. 3: LYMPH NODES, SUPRAHILAR PARA-AORTIC, EXCISION. DIAGNOSIS: 1. KIDNEY; TOTAL NEPHRECTOMY. Tumor Type: Ranal call carcinoma - Conventional (claar cell) type. Fuhrman Nuclear Grada: Nuclear grade IV/IV. Tumar Size: Greatest diamatar Is 9,5 cm. Local Invasion (for renal cartical types): Exlends through renal capsula but confined within Garota's fascia. Ranal Vein Invasion: Not identified. Surgical Margins: Frea of tumor. Non-Neaplastic Kidnay: Unremarkable. Adrenal Gland: Not Involved. Lymph Nodas: Free of tumor. Number of nadas examinad:3. Sea part 2 also. Staging far ranal cell carcinoma/ancacytoma: p T3a Tumor invadas the adrenal gland or perinephric tissuas but not bayand Garota's fascia. 2. LYMPH NODES, PARA-AORTIC, EXCISION. Lymph Nodes: Not Involved. Number of nodes examined: 15. 3. LYMPH NODES, SUPRAHILAR PARA-AORTIC, EXCISION. Lymph Nodes: Not Involved. Number of nodes examined:1. JATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. CHR. SYN. NEG CONT. IMM RECUT. RECUT. RECUT. RECUT. RECUT. RECUT. Gross Description: 1). The specimen Is received fresh, labeled ""left kidney"" and consisis of a kidney with attached ureter, renal vessels and. perinephric fat weighing 648 g In total. The kidney measures 14.5 X 8.5 X 8 cm. The attached ureter measures 4,5 cm In length. and 0.5 cm In diameter. The attached renal vein measures 0.5 cm in length and 0.7 cm in diemeter. The renal vessels and. ureter margins are grossly unremarkable. An adrenal gland is identified, measuring 4.5 X 3.5 x 1 cm. The kidney is inked black. and bivalved to reveal 9.5 X 7.5 X 5 cm yellow -- white relatively well-circumscribed tumor occupying the upper pole of the. specimen and extending into perinephric fat. The tumor shows multifocal areas of necrosis and hemorrhage. Sections through. the remainder of the kidney reveal a pink-brown parenchyma, with a well-defined cortico-medullary junction. The cortex measures. 1,3 cm and the calyces appear normal. Few lymph nodes are identified in the perinephric fat. Representative sections are. submitted for TPS and for permanent sections. Summery of sections: UVM -- ureteral and vessel margins. LN- lymph nodes. T-- tumor. THF- tumor with hiler fat. TK - tumor with adjacent kidney. RP -- renal pelvis representative sections. K -- representetive sections kidney. AD -- adrenal gland. 2). The specimen Is received In formalin labeled, ""para-sortic lymph nodes"", and consists of a single piece of yellow -- gold and red. ten soft tissue measuring 6.5 X 2 x 1.8 cm. Multiple lymph nodes are identified ranging in size from 0.3 to 1 cm in greatest. dimension and are submitted. Summery of sections: LN lymph nodes. 3). The specimen is received in formalin labeled, ""suprahilar para-aortic tissue"", and consists of a single piece of red tan soft tissue. measuring Entirely submitted. Summary of sections: U-. undesignated. Summary of Sections: Part 1: KIDNEY; TOTAL NEPHRECTOMY. Block. Sect. Site. PCs. 1. ad. 1. 1. k. 1. 1. In. 3. 1. pr. 1. 5. t. 5. 1. thf. 1. 3. tk. 3. 1. uvm. 3. Part 2: LYMPH NODES, PARA-AORTIC, EXCISION. Block. Sect. Site. PCs. 4. LN. 4. Part 3: LYMPH NODES, SUPRAHILAR PARA-AORTIC, EXCISION. Block. Soct. Site. PCs. 1. U. 1.",T3,N0,M1,T3N0M1
TCGA-VQ-A925,"PRIMARY SITE: Stomach (Antrum). 1 _"" Product of gastrectomy according to standardization"". Adenocarcinoma of intestinal type, tubular, moderately differentiated, ulcerated. - Lesion size: 7.5 cm. - Level of infiltration: serosa and adjacent adipose tissue. - Lymphatic and perineural invasions: present. Lymph nodes from the lesser curvature affected by metastasis, with extracapsular. extension (4/4). - Presence of multiple neoplastic nodules in the lesser curvature, without lymphoid. remnant tissue (see note). - Distal surgical margin of resection affected by the neoplasia. 2 - ""Greater omentum"": - Lymph nodes affected by metastasis, with extracapsular extension (2/2). - Presence of two neoplastic nodules, without lymphoid tissue remnant (see note). 3 - ""Biopsy of mesentery"": - Implant of adenocarcinoma. 4 - ""Esophageal margin"". - Uninvolved by neoplasia. Note: We can not determine whether the neoplastic nodules are lymph nodes totally replaced. by metastasis or implants in adipose tissue. PATHOLOGIC STAGING. Topography. Morphology. Stage. Stomach, NOS. Tubular adenocarcinoma. pT4a. givewer thit.",T3,N2,M0,T3N2M0
TCGA-67-6217,"PRIORITY: FROZEN SEC. SURGICAL PROCEDURES: LUNG-LOBECTOMY, RESECTION, REGIONAL LYMPH. CLINICAL HISTORY. PERTINENT CLINICAL HISTORY LEFT LUNG CA. GROSS DESCRIPTION. A. The specimen is submitted fresh for frozen section as ""9L"" and. consists of a single red black lymph node measuring 0.6 cm; submitted in. toto, 1 (1) labeled ""FSP"" for frozen section. FROZEN SECTION DIAGNOSIS: Lymph node: Negative for tumor. B. The specimen is submitted fresh for frozen section as ""level 5"" and. consists of four red black lymph nodes ranging from 0.5 to 0.8 cm;. submitted, 4 (1) labeled ""FSP"" for frozen section. FROZEN SECTION DIAGNOSIS: Level 5: Negative for tumor. C. The specimen is submitted fresh for frozen section as ""level 6"" and. consists of a single red black lymph node measuring 1.5 cm which is. bisected and submitted in toto, 2 (1) labeled ""FSP"" for frozen section. FROZEN SECTION DIAGNOSIS: Level 6: Negative for tumor. D. The specimen is submitted fresh for frozen section as ""anterior. mediastinal mass"" and consists of a 2.5 x 1.8 x 1.5 cm roughly spherical. lobular mass with tail of yellow adipose tissue exhibiting tan lobulated. fleshy tissue and a 0.3 cm area. Upon cut section the external surface is. marked with black dye. The specimen is sectioned and submitted in toto,. GROSS . DESCRIPTION. FROZEN SECTION DIAGNOSIS: Anterior mediastinal mass: Favor epithelioid. thymoma. Classification pending permanent. sections. E. The specimen is submitted fresh but not from frozen section as ""left. upper lobe"" and is a 114 gram of (formalin fixed), 18 X1 11 X 2..3 cm lung. lobectomy specimen received with a stapled bronchial margin measuring 3. cm in diameter and multiple adjacent stapled vasculature margin measuring. 0.5 to 2.3 cm in greatest dimension along with two stapled parenchymal. margins measuring 1.7 and 2.6 cm in diameter. The pleural surface is pink. to purple red with focal areas of anthracotic pigmentation along with an. indurated, firm well circumscribed puckered area, The pleural surface. overlying this area is inked blue. The stapled parenchymal margins are. removed and the underlying parenchyma is inked black. Sectioning of the. firm puckered area reveal a 2.5 X 2 X 1.4 cm well circumscribed gray to. white firm mass which grossly appears to abut the overlying blue inked. pleural surface measuring 0. cm from the closest parenchymal resection. margin (black ink) and 0.9 cm from the bronchial margin at the hilum. The. remaining parenchyma is tan pink to red spongy and homogenous showing. focal areas of emphysematous changes. No other discreet masses or. nodularities are grossly identified. At the hilum are multiple gray black. hilar lymph nodes measuring 0.5 to 1 cm in greatest dimension, each of. which is submitted entirely. Representative sections of the specimen are. submitted, multiple (8) as follows: 1. Vasculature and bronchial margins (submitted en face). 2. Mass with closest parenchyma underlying stapled resection margin. inked black. 3 and 4 - Mass with closest pleural surface. 5. Mass with adjacent uninvolved parenchyma. 6. Parenchyma showing emphysematous changes. Uninvolved parenchyma. 8. Hilar lymph nodes. A piece of tumor is collected for TCGA tissue collection project. F. The specimen is submitted fresh as ""posterior interlobular node"" and. consists of a single gray black elongate lymph node measuring 1 cm which. is bisected and submitted in toto, 2 (1) . FINAL DIAGNOSIS. A. LYMPH NODE, 9L, BIOPSY: LYMPH NODE, NEGATIVE FOR TUMOR. FINAL: DIAGNOSIS. B. LYMPH NODE, LEVEL 5, EXCISION: MULTIPLE LYMPH NODES, NEGATIVE FOR TUMOR. C. LYMPH NODE, LEVEL 6, EXCISION: LYMPH NODE, NEGATIVE FOR TUMOR. D. ANTERIOR MEDIASTINAL MASS, RESECTION: THYMOMA (TYPE AB) WITH MICROSCOPIC TRANSCAPSULAR INVASION. (2.5 CM) , MARGINS INVOLVED. SEE SYNOPTIC REPORT. LUNG, LEFT UPPER LOBE, LOBECTOMY: ADENOCARCINOMA (2.5 CM). SEE SYNOPTIC REPORT. METASTATIC CARCINOMA (0.3 CM FOCUS) INVOLVING ONE OF FIVE HILAR. LYMPH NODE FRAGMENTS. F. LYMPH NODE, POSTERIOR INTERLOBULAR, EXCISION: LYMPH NODE, NEGATIVE FOR TUMOR. SYNOPTIC REPORT. SYNOPTIC REPORT: THYMOMA. SPECIMEN: THYMUS. PROCEDURE: PARTIAL RESECTION. SPECIMEN INTEGRITY: INTACT. SPECIMEN WEIGHT: APPROXIMATELY 2 GRAMS. <. TUMOR SIZE: 2.5 CM. TYPE AB THYMOMA. TUMOR EXTENSION NOT IDENTIFIED. MARGINS: INVOLVED. TUMOR ABUTTS ON AND FOCALLY INVOLVES SURGICAL MARGINS. (SPECIMEN WAS RECEIVED UNORIENTED). TREATMENT EFFECT: NOT APPLICABLE. LYMPHOVASCULAR INVASION: NOT IDENTIFIED. REGIONAL LYMPH NODES NONE SAMPLED. IMPLANTS/DISTAN'TI METASTASIS: CANNOT BE ASSESSED. OTHER PERTINENT FINDINGS: - THE TUMOR IS IMMUNOREACTIVE FOR CYTOKERATIN 5/6 BUT IS NEGATIVE. FOR NEUROENDOCRINE MARKERS, SYNAPTOPHYSIN AND CHROMOGRANIN. PATHOLOGIC STAGE (MODIFIED MASAOKA) :. IIa (R1). SYNOPTIC REPORT. SYNOPTIC REPORT: LUNG. (CAP/AJCC/ACS - REQUIRED ELEMENTS). SPECIMEN TYPE: LOBECTOMY. LATERALITY: LEFT. TUMOR SITE: LEFT UPPER LOBE. TUMOR SIZE: 2.5 CM. HISTOLOGIC TYPE: ADENOCARCINOMA. HISTOLOGIC GRADE: GRADE 2 OF 3 (MODERATELY DIFFERENTIATED). EXTENT OF INVASION: VISCERAL PLEURAL INVASION PRESENT. EXTENTION TO PLEURA/OTHER STRUCTURES: ABSENT. MARGINS: BRONCHIAL: UNINVOLVED. PARENCHYMAL: UNINVOLVED. VASCULAR: UNINVOLVED. DISTANCE TO PERTINENT MARGIN (S) : TUMOR IS 0.4 CM FROM THE. PARENCHYMAL RESECTION MARGIN AND 0.9 CM FROM THE BRONCHIAL MARGIN. VENOUS INVASION: ABSENT. ARTERIAL (LARGE VESSEL) INVASION: ABSENT. LYMPH NODE: N1 - # INVOLVED/#EXAMINED: 1/8+. f,11 N2 - # INVOLVED/#EXAMINED: 0/10+. N3 - # INVOLVED/# EXAMINED: 0/0. OTHER PERTINENT FINDINGS: - AN ELASTIC STAIN HIGHLIGHTS VISCERAL PLEURAL INVASION. - UNINVOLVED LUNG SHOWS MILD EMPHYSEMA. pTNM STAGE: pT2a pN1. Unless otherwise specified, the performance characteristics of the. immunoperoxidase stains performed here have been confirmed by the. These tests have not been cleared or. approved by the U.S. Food and Drug Administration, although such approval. is not necessary. Patient Information Resources. Thymoma. This section has been reviewed and approved by the. nn. Staging. Staging is a way of describing a cancer, such as where it is located, if or where it has spread, and if it. is affecting the functions of other organs in the body. Doctors use diagnostic tests to determine the. cancer's stage, so staging may not be complete until all the tests are finished. Knowing the stage helps. the doctor to decide what kind of treatment is best and can help predict a patient's prognosis (chance. of recovery). There are different stage descriptions for different types of cancers. There is no standard system for staging thymoma; however, the most commonly used system is called. the Masaoka system. This system was developed in. and it classifies thymoma into the following. stages: Stage I: The cancer is limited to the thymus and the capsule that surrounds it. Stage II: The cancer has spread into fat surrounding the thymus or into the lining of the lung next to. the tumor, called the mediastinal pleura. Stage III: The cancer has spread to other organs that are near the thymus, such as the lung, blood. vessels, and the sac around the heart, called the pericardium. Stage IVA: The cancer has spread more extensively into the lining of the lung or the sac around the. heart. Stage IVB: The cancer has spread to organs further away from the thymus, or has spread through the. vessels carrying blood or lymph. Classification. In addition to its stage, thymoma can be classified into different categories, developed by the. ), based on what the tumor cells look like under a microscope: Type A thymoma. This is also called spindle cell thymoma or medullary thymoma. The chance of. recovery for people with type A thymoma is good, with a. survival rate (percentage of. people who survive at least. after the cancer is detected, excluding those who die from other. diseases) near. TypeAB thymoma. Also called mixed thymoma, type AB thymoma is similar to type A thymoma;. however, type AB thymoma has lymphocytes in the tumor. The chance of recovery for people with. type AB thymoma is also good, with a. survival rate of approximately. %. Type B1 thymoma. This is also known as lymphocyte-rich thymoma, lymphocytic thymoma,. predominantly cortical thymoma, and organoid thymoma. This type of thymoma has very many. lymphocytes in the tumor, but the cells of the thymus appear normal. The chance of recovery for. people with type B1 thymoma is also good, with a 20-year relative survival rate (percentage of people. who survive at least. years after the cancer is detected, excluding those who die from other. diseases) of approximately. Type B2 thymoma. Type B2 thymoma also has many lymphocytes, like type B1 thymoma; however,. the thymus cells do not appear normal. Type B2 thymoma is also known as cortical thymoma and. polygonal cell thymoma. The. Fyear relative survival rate for people with type B2 thymoma is. approximately. Type B3 thymoma. Type B3 thymoma is also known as epithelial thymoma, atypical thymoma,. squamoid thymoma, and well-differentiated thymic carcinoma. This type of thymoma has few. lymphocytes, and the thymus cells look abnormal. The. survival rate is approximately. Thymic carcinoma. Thymic carcinoma, previously called type C thymoma, is very rare and more. aggressive. Thymic carcinoma cells do not look like normal thymus cells, but like cancers in other. organs of the body. This type of tumor is often advanced when diagnosed. It is classified into two. categories: low grade, which has a better chance of recovery, and high grade, which is more likely to. grow and spread quickly. Low-grade thymic carcinoma includes basaloid, mucoepidermoid, and well-. differentiated squamous cell types. High-grade thymic carcinoma includes anaplastic/undifferentiated. clear cell, poorly differentiated squamous cell, sarcomatoid, and small cell/neuroendocrine types. The. five-year relative survival rate of people with thymic carcinoma is. rate of people with thymic carcinoma is. %. Cancer survival statistics should be interpreted with caution. These estimates are based on data from. thousands of cases of this type of cancer in the United States, but the actual risk for a particular. individual may differ. It is not possible to tell a person how long he or she will live with thymoma. < Previous. Next >.",T2,N1,M0,T2N1M0
TCGA-AR-A1AI,"Final diagnosis. Breast, left, simple mastectomy: Medullary carcinoma forming a 4.5 x 2.0 x 2.0 cm well. circumscribed mass (AJCC p T2) in the upper outer quadrant associated with prior biopsy site. The surgical margins are widely negative. Seen with Dr. Lymph nodes, left axillary sentinel, excision: Multiple (5) left axillary sentinel lymph nodes are. negative for tumor. Blue dye is not identified in any of the five left axillary sentinel lymph nodes. (AJCC pN0(i-)). Immunohistochemical cytokeratin stain was performed on the paraffin. embedded sentinel lymph node tissue and confirms the H&E impression.",T2,N0,M0,T2N0M0
TCGA-A2-A4S1,"Rg. Att. M.D. This report contains corrections; additions or deletions. Any previous versions are stored internally and are available if necessary. Specimen: Req# : Sp type: SURGICAL P. , M.D. PREOPERATIVE DIAGNOSIS. 174-RT BREAST CANCER-INVASIVE. OPERATION PERFORMED. DOCTOR (S) : PROCEDURE: MASTECTOMY PARTIAL LUMPECTOMY, ULTRASONIC NEEDLE LOC BREAST BX. PROCEDURE (CONT) : BX SENTINEL NODE. TISSUE REMOVED. A. RT PARTIAL MASTECTOMY POSSIBLE SARCOMA SHORT STITCH SUPERIOR MEDIAL. SKIN MARGIN LONG STITCH LATERAL SKIN MARGIN @. B. RT BREAST MEDIAL MARGIN AT. C. RT BREAST SUPERIOR MARGIN @. D. RT BREAST LATERAL MARGIN @. E. RT BREAST INFERIOR MARGIN AT. F. RT BREAST POSTERIOR MARGIN @. G. RT BREAST ANTERIOR MARGIN @. H. RT BREAST MEDIAL POSTERIOR MARGIN @. I. RT AXILLARY SENTINEL NODE HOT AND BLUE COUNT 241 @. GROSS DESCRIPTION. RECEIVED IN 9 PARTS. A RECEIVED LABELED. RIGHT BREAST PARTIAL MASTECTOMY. POSSIBLE SARCOMA SHORT SUPERIOR MEDIAL SKIN MARGIN LONG LATERAL SKIN. MARGIN IS A 167 GRAMS PARTIAL MASTECTOMY WITH A 10 X 4.5 CM SKIN. ELLIPSE. ON THE LATERAL PORTION OF THE SPECIMEN THERE ARE SEVERAL. ELEVATED SLIGHTLY DARKENED SKIN LESIONS THE LARGEST 0.5 X 0. CM. ONE. OF THESE IS GROSSLY FOUND TO BE A SUPERIOR LATERAL SKIN MARGIN. THERE. IS A PROMINENT PALPABLE MASS WITHIN THE SPECIMEN. THE MARGINS ARE. MARKED AS FOLLOWS USING SKIN AS THE ANTERIOR MARGIN: LATERAL ORANGE,. MEDIAL RED, INFERIOR BLUE, SUPERIOR GREEN, POSTERIOR BLACK. RED-BROWN. MUSCLE FIBERS ARE NOTED IN THE AREA OF THE MASS ON THE POSTERIOR ASPECT. WHICH OTHERWISE HAS A SMOOTH APPEARANCE. SECTIONING REVEALS A DISCRETE. Specimen. Sp type: SURGICAL P. GROSS DESCRIPTION. FIRM GRAY MASS MEASURING 3.4 x 2.8 x 2.8 CM. CENTRALLY THERE IS RED. DISCOLORATION TO THE NODULE AND ANTERIOR INFERIORLY TO THIS THERE IS A. 1.3 CM IN DIAMETER AREA OF RED-BROWN BLOOD. THE DEEP MEMBRANOUS SURFACE. EASILY SLIDES OVER THIS MASS WHICH IS ONLY COVERED GROSSLY BY THE DEEP. FASCIA AND MUSCLE FIBERS. IT IS OTHERWISE GREATER THAN 1 CM FROM ALL. MARGINS. SECTIONS ARE SUBMITTED AS. EOLLOWS.: Al--RE.PRESENTATIVE. PERPENDICULAR MEDIAL MARGIN, A2--REPRESENTATIVE PERPENDICULAR LATERAL. MARGIN, A3 THROUGH A9--FULL CROSS SECTION OF THE LESION TO INCLUDE THE. DEEP MARGIN (A3) AND THE ADJACENT HEMORRHAGIC AREA (A5), A6--OVERLYING. SKIN TO THIS NODULE, AND REPRESENTATIVE SKIN LESION, A7--REPRESENTATIVE. SUPERIOR MARGIN TO THIS LESION, A8 AND A9--REPRESENTATIVE INFERIOR. MARGIN TO THIS LESION, A10--CROSS SECTION OF LESION TO INCLUDE POSTERIOR. MARGIN, All--THE HEMORRHAGIC AREA ADJACENT TO A10, A12--LATERAL PORTION. OF LESION WITH ADJACENT HEMORRHAGIC TISSUE. NOTE: RANDOM SECTIONS OF THE MASS ARE SUBMITTED PER PROTOCOL AS P1-p5. WITH MIRROR IMAGE SECTION FROZEN OF P1 AND P2 AS WELL AS RANDOM TISSUE. FRESH FROZEN. A PORTION OF SKIN IS ALSO SUBMITTED AS P6 FROM THE AREA. OF SKIN IN A6. B RECEIVED LABELED. BREAST MEDIAL MARGIN IS A 5 x 3.9 x. 1.2 CM FRAGMENT OF YELLOW FATTY TISSUE. PURPLE-BLUE COLORATION IS NOTED. ON ONE SURFACE. THIS SURFACE IS REMARKED WITH BLUE INK WITH A PERIMETER. OF BLACK. THIS IS SECTIONED AND SUBMITTED AS B1-B9. C RECEIVED LABELED. RIGHT BREAST SUPERIOR MARGIN IS A. 3.8 x 2.8 X 1.1 CM FRAGMENT OF YELLOW FATTY TISSUE. BLUE COLORATION IS. SEEN ON ONE SIDE OF THE SPECIMEN. THIS SIDE IS REMARKED WITH BLUE INK. WITH A PERIMETER OF BLACK. THIS IS SECTIONED AND SUBMITTED AS C1-C3. D RECEIVED LABELED. RIGHT BREAST LATERAL MARGIN IS A 2.8. X 1.8 X 0.8 CM FRAGMENT OF YELLOW FATTY TISSUE. PURPLE-BLUE COLORATION. IS SEEN ON ONE SIDE OF THE SPECIMEN. THIS IS REMARKED WITH BLUE INK. WITH A PERIMETER OF BLACK. THIS IS SECTIONED AND SUBMITTED AS D1 AND D2. E RECEIVED LABELED. RIGHT BREAST INFERIOR MARGIN IS A. 4.5 x 2.7 x 1 CM FRAGMENT OF YELLOW FATTY TISSUE. PURPLE-BLUE. COLORATION IS SEEN ON APPROXIMATELY ONE-HALF OF ONE SIDE OF THE. SPECIMEN. THIS SIDE IS ENTIRELY MARKED WITH BLUE INK WITH A PERIMETER. OF BLACK. THIS IS SECTIONED AND SUBMITTED LABELED E1-E3. F RECEIVED LABELED. RIGHT BREAST POSTERIOR MARGIN IS AN. IRREGULAR FRAGMENT OF YELLOW FATTY TISSUE WITH MULTIPLE METAL CLIPS. MEASURING 4.2 X 3.7 x 0.6 CM IN GREATEST DIMENSION. PURPLE-BLUE. Specimen: tatus: Sp type: SURGICAL P. .D. GROSS DESCRIPTION. COLORATION IS SEEN ON ONE SIDE OF THE SPECIMEN WHICH IS THEN REMARKED. WITH BLUE INK WITH A PERIMETER OF BLACK. THIS IS SECTIONED AND. SUBMITTED AS F1-F3. G RECEIVED LABELED. RIGHT BREAST ANTERIOR MARGIN IS AN. IRREGULAR FRAGMENT OF YELLOW FATTY TISSUE MEASURING 5.6. X 3.5 x 1.1 CM. IN GREATEST DIMENSION. PURPLE-BLUE COLORATION IS SEEN ON ONE SIDE OF. THE SPECIMEN WHICH ALSO DEMONSTRATES BLUE DYE WITHIN THE TISSUE. THIS. SIDE IS REMARKED WITH BLUE INK WITH A PERIMETER OF BLACK. THIS IS. SECTIONED AND SUBMITTED LABELED G1-G7. H RECEIVED LABELED. RIGHT BREAST MEDIAL POSTERIOR MARGIN. IS A 4.2 X 3.2 x 0.5 CM FRAGMENT OF YELLOW FATTY TISSUE. BLUE. COLORATION IS SEEN ON ONE SIDE OF THE SPECIMEN. THIS SIDE IS REMARKED. WITH BLUE INK WITH A PERIMETER OF BLACK. THIS IS SECTIONED AND. SUBMITTED LABELED H1-H3. I RECEIVED LABELED. RIGHT AXILLARY SENTINEL NODE HOT AND. BLUE COUNT 241 IS A 5 X 3.5 X 1.5 CM FRAGMENT OF YELLOW FATTY TISSUE. EXAMINATION REVEALS 2 NODAL STRUCTURES. ONE IS 4.0 x 0.8 x 0.4 CM. THIS IS SECTIONED INTO MULTIPLE PIECES AND SUBMITTED AS Il AND 2. THE. 2ND MEASURES 0.6 x 0.4 X 0.2 CM. THIS IS SUBMITTED LABELED I3. COMMENT: THIS CASE IS IN COMPLIANCE WITH CAP. GUIDELINES OF 6-48 HOURS FORMALIN FIXATION TIME. PATH PROCEDURES. PROCEDURES: 88307/9, IMMUNOPEROXIDAS/2, A BLK/12, B BLK/9, C BLK/3, D BLK/2, E BLK/3,. F BLK/3, G BLK/7, H BLK/3, IBX X6/3. FINAL DIAGNOSIS. PART A RIGHT BREAST, PARTIAL MASTECTOMY: 1. POORLY DIFFERENTIATED MALIGNANT NEOPLASM WITH OSTEOSARCOMATOUS. FEATURES WHICH MOST LIKELY REPRESENTS A METAPLASTIC CARCINOMA OF. BREAST NUCLEAR GRADE 3 WITH HIGH MITOTIC INDEX WITH FOCI OF MALIGNANT. OSTEOID FORMATION. - LVI. Specimen: Req# : Sp type: SURGICAL P. M.D. FINAL DIAGNOSIS. 2. ADJACENT BREAST TISSUE WITH FOCI OF INTERMEDIATE TO HIGH GRADE. DUCTAL CARCINOMA IN SITU OF SOLID AND CRIBRIFORM TYPE WITH FOCI OF. INTRADUCTAL NECROSIS AND CALCIFICATION. 3. THE INVASIVE NEOPLASM MEASURES 34 MM IN GREATEST DIMENSION AND IS. PRESENT 2. MM FROM THE POSTERIOR MARGIN AND. 5. MM OR GREATER FROM ALL. OTHER MARGINS. 4. THE LARGEST FOCUS OF DCIS MEASURES 10 MM IN GREATEST DIMENSION. DCIS IS PRESENT 1 MM FROM THE INFERIOR MARGIN, 2 MM FROM THE LATERAL. MARGIN AND 5 MM OR GREATER FROM ALL OTHER MARGINS. 5. LYMPHATIC INVASION IS NOT IDENTIFIED. 6. BIOPSY SITE CHANGE WITH REACTIVE FIBROSIS AND FAT NECROSIS. 7. SEGMENT OF BENIGN SKIN. PART B RIGHT BREAST, MEDIAL MARGIN REEXCISION: FIBROCYSTIC DISEASE. WITH A FOCUS OF ATYPICAL DUCT HYPERPLASIA, DUCT HYPERPLASIA OF THE USUAL. TYPE AND SCLEROSING ADENOSIS. A FEW CALCIFICATIONS ARE PRESENT. THE. NEW INKED MARGIN IS FREE OF NEOPLASM. PART C RIGHT BREAST, SUPERIOR MARGIN REEXCISION: INTERMEDIATE GRADE. DUCTAL CARCINOMA IN SITU WITH EXTENSION INTO TERMINAL LOBULES WITH FOCAL. INTRADUCTAL NECROSIS. DCIS IS PRESENT 3 MM FROM THE NEW INKED MARGIN. RESIDUAL INVASIVE NEOPLASM IS NOT IDENTIFIED. THE AREA INVOLVED BY DCIS. HAS A CALCULATED DIMENSION OF APPROXIMATELY 8 MM. PART D RIGHT BREAST, LATERAL MARGIN REEXCISION: LIPOMATOUS BREAST TISSUE. WITH NO EVIDENCE OF RESIDUAL TUMOR. THE NEW INKED MARGIN IS FREE OF. NEOPLASM. PART E RIGHT BREAST, INFERIOR MARGIN REEXCISION: LOW GRADE DUCTAL. CARCINOMA IN SITU OF CRIBRIFORM TYPE NUCLEAR GRADE 1 WITH LOW MITOTIC. INDEX MEASURING 4 MM IN GREATEST DIMENSION. DCIS IS PRESENT 2 MM FROM. THE NEW INKED MARGIN. RESIDUAL INVASIVE TUMOR IS NOT IDENTIFIED. PART F RIGHT BREAST, POSTERIOR MARGIN REEXCISION: LIPOMATOUS TISSUE. WITH NO EVIDENCE OF RESIDUAL NEOPLASM. THE NEW INKED MARGIN IS FREE OF. NEOPLASM. PART G RIGHT BREAST, ANTERIOR MARGIN REEXCISION: NO EVIDENCE OF. RESIDUAL NEOPLASM. THE NEW INKED MARGIN IS FREE OF NEOPLASM. Specimen: Sp type: SURGICAL P. FINAL DIAGNOSIS. PROLIFERATIVE FIBROCYSTIC DISEASE WITH NUMEROUS CALCIFICATIONS PRESENT. PART H RIGHT BREAST, MEDIAL POSTERIOR MARGIN REEXCISION: LIPOMATOUS. TISSUE AND SKELETAL MUSCLE WITH NO EVIDENCE OF RESIDUAL NEOPLASM. THE. NEW INKED MARGIN IS FREE OF NEOPLASM. PART I RIGHT SENTINEL NODE, BIOPSY: LYMPH NODE (1), NEGATIVE FOR TUMOR. BY STEP SECTION AND CYTOKERATIN STAIN. COMMENT. MULTIPLE BLOCKS OF THE INVASIVE NEOPLASM ARE STAINED WITH CYTOKERATIN. STAIN AND DEMONSTRATE VIRTUALLY NO STAINING OF THE INVASIVE TUMOR. ALTHOUGH FOCI OF ADJACENT DCIS DO DEMONSTRATE STAINING. THIS TUMOR. IS. MOST LIKELY A METAPLASTIC CARCINOMA OF BREAST DUE TO THE ASSOCIATION. WITH DUCTAL CARCINOMA IN SITU. , M.D. yany. Liscrepance.",T2,N0,M0,T2N0M0
TCGA-77-A5GF,"Histopathology Report. HISTORY. Left lower lobe; L/N 10; Bronchial Ca left lower lobe; patient has mild. pulmonary fibrosis. MACROSCOPIC. Two specimens submitted. 1. The first specimen is labelled `left lower lobe' and consists of a lobe of. lung measuring 125 x 80 x 65 mm. No parietal pleura is included. The visceral. pleural surface shows focal puckering of the lateral surface. The area of. puckering measures 25 mm in diameter. Several enlarged hilar nodes are. identified. They measure between 15 mm and 30 mm in diameter. Serial slicing. shows a solitary, ill-defined subpleural tumour measuring 24 x 10 x 22 mm. It. is located immediately beneath the area of pleural puckering, and is 33 mm from. the bronchial resection margin. The non-neoplastic lung shows extensive. dilatation of the subpleural airspaces toward the apex. Some of the dilated. airspaces measure up to 35 mm in maximum diameter. Toward the base, there is. diffuse firmness of the lung parenchyma, which is associated with grey. discolouration. [1A, shave bronchial resection margin; 1B, shave vascular. resection margin; 1C-1D, composite section of tumour and associated puckered. pleura; 1E-1F, composite section of full face of tumour and its relation to the. pleura; 1G, rep TS of tumour; 1H-1I, 2 rep TS of apical lung showing. extensively dilated airspaces; 1J, rep TS of basal lung showing the firm grey. area; 1K-1N, hilar lymph nodes (1 node per block).]. 2. The second specimen is labelled `left no 10 lymph node' and consists of two. fragments of brown to black tissue measuring 16 x 8 x 7 mm and 9 X 6 x 6 mm. Each of the fragments is bisected. [BIT, 2A.]. MICROSCOPIC. 1: Sections show a poorly differentiated squamous cell carcinoma. The tumour. is subpleural and measures 27mm in maximum dimension [1G]. Pleural invasion is. identified [1G]. There is no vascular invasion or lymphatic permeation is. seen. No perineural invasion is identified. The lesion is well clear of the. bronchial resection margin. There is metastatic carcinoma within all the. identified hilar lymph nodes, with some of the lymph nodes showing transected. tumour deposits at the margins. The adjacent lung shows evidence of emphysema. and fibrosis with a usual interstitial pneumonia (UIP)-like pattern. Fibrosis. is most pronounced in the base of the lobe, where there is honeycomb change. with fibroblastic foct. 2: The No. 10 lymph node does not show evidence of metastases and contains. carbon pigment and birefringent material consistent with silica. SUMMARY. 1&2. Lung, left lower lobe and lymph nodes: - Poorly differentiated squamous cell carcinoma; 27mm in maximal dimension. - No lymphatic invasion, blood vessel and perineural invasion. - Pleural invasion identified; clear of bronchial margin. - Metastatic carcinoma in hilar lymph nodes. - No evidence of malignancy in No 10 lymph node (Specimen 2). - T2a N1 [AJCC 7th ed]. - Non-neoplastic lung: Emphysema, fibrosis with UIP-like pattern. T-28000 M-80703 M-78000 P1-03000. ANATOMICAL PATHOLOGY.",T2,N1,M0,T2N1M0
TCGA-E8-A415,"Laterality:Tumor consists of papillae having an fine fibrovascular stalk or. colloid folliculae covered by a single to mutiple layers of cuboidal epithelial cells. Tumor invades in. capsule or vessle or begnin tissue or muscle. The cells tend to maintain their polarity. Nuclei are quite. regular and contain finely dispersed chromatin, or intranuclear grooves. Tumor is fibrous. Path Report:Tumor type:Papillary carcinoma. Tumor size: 1x0.7x0.7cm. Laterality: left. Tumor focality: Unifocal. Invasion of capsule: Yes. Extrathyroidal extension: No.",T1,N1,M0,T1N1M0
TCGA-AA-3841,"Diagnosis: This material shows in I) parts of an invasive adenocarcinoma of the colon G2 with penetration. of all parietal layers (pT3, L1, V1) and with free lymph nodes,. in II) an additional adenocarcinoma, of moderate differentiation G2, with infiltration of the. muscularis (pT2, L1, V1), as well as a tubular adenoma and a lymph node metastasis, thus. corresponding to N1 (1 of 16). Tumor classification: I. ICDO-DA M-8140/3, G2, pT3, L1, V1, pNO (0 of 24). II. ICDO-DA M-8140/3, G2, pT2, L1, V1, pN1 (1 of 16).",T3,N0,M0,T3N0M0
TCGA-E2-A1B0,"SPECIMENS: A. SENTINEL NODE #1 LEFT AXILLA. B. SENTINEL NODE #2 & #3 LEFT AXILLA. C. SENTINEL NODES #4 & #5. D. SENTINEL NODE #6 LEFT AXILLA. E. SENTINEL NODE #7 & #8 LEFT AXILLA. F. SENTINEL NODE #9 LEFT AXILLA. G. LEFT BREAST. H. LEFT AXILLARY CONTENTS. DIAGNOSIS: A. SENTINEL NODE #1 LEFT AXILLA: -METASTATIC CARCINOMA TO ONE OUT OF ONE LYMPH NODE, CONSISTENT WITH. METASTASIS FROM PRIMARY BREAST CARCINOMA (1/1). B. SENTINEL NODE #2 AND #3 LEFT AXILLA: - TWO LYMPH NODES - NEGATIVE FOR TUMOR (0/2). C. SENTINEL NODE #4 AND #5: - TWO LYMPH NODES - POSITIVE FOR METASTATIC CARCINOMA (2/2). D. SENTINE NODE #6 LEFT AXILLA: - METASTATIC CARCINOMA TO TWO OUT OF THREE LYMPH NODES. WITH LYMPHOVASCULAR INVASION (2/3). E. SENTINEL NODE #7 AND #8 LEFT AXILLA: - METASTATIC CARCINOMA TO ONE OUT OF ONE LYMPH NODE. WITH PERINODAL FAT EXTENSION CONSISTENT WITH METASTASIS. FROM PRIMARY BREAST CARCINOMA. F. SENTINEL NODE #9 LEFT AXILLA: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). G. LEFT BREAST, MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, SBR GRADE III WITH ASSOCIATED. FOCI OF DUCTAL CARCINOMA IN SITU, SOLID, COMEDO PATTERN,. HIGH NUCLEAR GRADE. - SIZE OF TUMOR- 3.2 X 2.2 X 2.0 CM. - DEEP MARGINS OF RESECTION - NEGATIVE FOR TUMOR. - SKIN AND NIPPLE - NEGATIVE FOR TUMOR. - FOCAL COLUMNAR CELL CHANGE WITH FOCAL. MICROCALCIFICATIONS. - FOCAL RESORBING FAT NECROSIS AND HEMORRHAGE ,CONSISTENT WITH POST. BIOPSY SITE CHANGES. H. LEFT AXILLARY CONTENTS: - EIGHTEEN LYMPH NODES - NEGATIVE FOR TUMOR (0/18). BREAST CANCER TEMPLATE. Specimen type: Mastectomy. Needle localization: Laterality: Left. INVASIVE TUMOR: Present. Multifocal: Histologic type: Ductal. Tumor Size (cm): 3.2 x 2.2 x 2.0 cm. Size of Invasive Focus: 3.2 x 2.2 x 2.0 cm. Tumor site: Lower outer quadrant. Grade, Histologic: 3. Grade, Nuclear: 3. Grade, Mitotic: III. Modified Scarff Bloom Richardson grade: Necrosis: Present. Invasion Vasc/Lymphatic: Present. DCIS COMPONENT: DCIS Quantity: Estimate 20%. DCIS Type: Comedo; Solid. DCIS Location: Associated with invasive tumor. DCIS Size: Nuclear grade: High. Necrosis: Present. Location of Ca++: DCIS; Benign Epithelium. DCIS correlates with Ca++ in sections: Margins: Negative. Lobular Neoplasia: None. Lymph nodes: Positive (6/28); Sentinel lymph node. and axillary dissection. Isolated tumor cell clusters: Micrometastases: Extranodal extension: Non-neoplastic areas: columnar cell change. Hormone receptor status (by IHC): Biomarker report (from previous bx -. - ER, negative; PR, negative. HERCEPTEST (by IHC): Her2/neu - positive 3+ (100%). Pathologic Stage : pT2 N2. SPECIMEN(S): A. SENTINEL NODE #1 LEFT AXILLA. B. SENTINEL NODE #2 & #3 LEFT AXILLA. C. SENTINEL NODES #4 & #5. D. SENTINEL NODE #6 LEFT AXILLA. E. SENTINEL NODE #7 & #8 LEFT AXILLA. F. SENTINEL NODE #9 LEFT AXILLA. G. LEFT BREAST. H. LEFT AXILLARY CONTENTS. CLINICAL HISTORY: None given. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA: Lymph node, sentinel #1, excision: Positive for carcinoma. (Microscopic). By Dr called in at. C. Breast, left, mastectomy: Margins are grossly negative for tumor. By Dr called in at. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1, LEFT AXILLA. Received fresh for touch prep evaluation labeled with the patient name designated A. sentinel lymph. node #1 left axilla is a beige-tan lymph node measuring 0.8x0.5x0.4cm. The specimen is bisected,. touch preps are performed. The entire specimen is submitted in a cassette labeled A1. B. SENTINEL LYMPH NODES #2 & #3, LEFT AXILLA. Received fresh for touch prep evaluation labeled with the patient name designated B. sentinel lymph. nodes #2 & #3 is a portion of firm red-tan fibroadipose tissue measuring 5.5x2.0x1.0cm Two beige-tan. lymph nodes are identified. The specimen is serially sectioned, touch preps are performed. The. specimen is submitted in toto in blocks B1-B3. C. SENTINAL LYMPH NODES #4 & #5, LEFT AXILLA. Received fresh for touch prep evaluation labeled with the patient name designated C. sentinel nodes #4. & #5 are two beige-tan firm lymph nodes. The larger measuring 1.5x1.0x0.9cm. The smaller. measuring 0.4x0.3x0.3cm. The entire specimen is submitted for microscopic evaluation. Cassettes are. submitted as follows: C1: the smaller lymph node. C2: the larger lymph node serially sectioned. D. SENTINEL LYMPH NODE #6, LEFT AXILLA. Received in formalin in a container labeled with the patient name designated D. sentinel node #6 is a. firm beige-tan lymph node measuring 1.0x0.9x0.7cm. specimen is bisected and submitted entirely in. cassette D1. E. SENTINEL LYMPH NODE #7 & #8, LEFT AXILLA. Received in formalin in a container labeled with the patient name designated E. sentinel node is a group. of beige-tan, firm, matted lymph nodes, measuring in aggregate 2.2x1.9x0.7cm. The specimen is. bisected and submitted entirely in cassette E1-E2. F. SENTINEL LYMPH NODE #9, LEFT AXILLA. Received in formalin in a container labeled with the patient name designated F. sentinel node #9 left. axilla is a firm beige-tan lymph node with attached adipose tissue. The lymph node measures. 0.4x0.4x0.3cm. The entire specimen is submitted in cassette F1. G. LEFI BREAST. Received in fresh state with patient's name and identification number and labeled ""left breast"". The. specimen consists of a left mastectomy specimen weighing 797 grams and with total dimensions of. 26.0 x 19.0 x 5.5 cm. There is an attached stitch indicating the left axillary tail area of the breast. Overlying skin measures 18.0 x 12.0 cm. The nipple is erect and grossly not remarkable,and shows no. areas of ulceration. There is a firm palpable mass noted along the supero-central aspect of the. specimen, which on serial cut section shows an ill-defined, firm, nodular mass with ill-defined borders. measuring 3.2 x 2.2 and 2.0 cm with focal areas of hemorrhage. The remainder of the specimen. consists mostly of fatty breast tissue parenchyma with alternating strands of fibrous stroma. The deep. margin is inked black. Grossly, the tumor is is seen 0.9 cm from the nearest superior margin. There is. no other identifiable tumor focus and scant axillary fat shows predominantly adipose tissue with possible. tiny 0.1 cm lymph node. Multiple sections are submitted and labeled as follows: G1-G2: bisected anterior margin adjacent to mass. G3: skin and mass. G4-G5: tissue inferior to mass, bisected. G6: deep margin. G7-G12: sections of mass. G13-G14: fibrous tissue from superior inner quadrant. G15-G18: fibrous and firm tissue from superior outer quadrant. G19-G20: fibrous tissue from inferior outer quadrant. G21-G22: fibrous tissue from lower inner quadrant. G23-G24: nipple and subjacent tissue perpendicularly sectioned. G25: 1 possible axillary lymph node. H. LEFT AXILLARY CONTENTS. Received in formalin and labeled ""left axillary contents"" is an aggregate of pink-yellow soft tissue. measuring 9.0x5.5x1.8cm 16 possible lymph nodes are found, ranging in size from 0.1 to 1.7cm. Nodes are submitted in toto as follows: H1: 6 possible lymph nodes. H2-H6: 2 bisected lymph nodes each. ADDENDUM: Correction of typographical error on template regarding tumor site. Should read as follows: Tumor site - upper outer quadrant. Microscopic/Diagnostic Dictation: Pathologist,. Microscopic/Diagnostic Dictation: Pathologist. Microscopic/Diagnostic Dictation: Pathologist,. Final Review: Pathologist. Final Review: Pathologist,. Final: Pathologist,. Addendum: Pathologist,. Addendum Review: Pathologist,. Addendum Final: Pathologist,.",T2,N2,M0,T2N2M0
TCGA-BJ-A28X,"FINAL DIAGNOSIS. PART 1: LYMPH NODE, CENTRAL COMPARTMENT, SELECTIVE DISSECTION. A. METASTATIC CARCINOMA IN TWO OUT OF SIX LYMPH NODES (2/6). B. NO EXTRANODAL EXTENSION. PART 2: THYROID, TOTAL THYROIDECTOMY (17 GRAMS). A. PAPILLARY THYROID CARCINOMA, TWO.FOCI (1.2 CM AND 0.5 CM),. B. LARGEST FOCUS: LEFI LOBE, TALL CELL VARIANT WITH EXTRATHYROID EXTENSION; TUMOR. LESS THAN 0.1 CM FROM THE MARGIN. C. CHRONIC LYMPHOCYTIC THYROIDITIS. D. TWO LYMPH NODES, NO TUMOR PRESENT (0/2). E. PATHOLOGIC STAGE: pT3a N1. PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Thyroid cancer. PROCEDURE: Total thyroidectomy. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered. CHEMORADIATION THERAPY: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION: Not answered. OTHER DISEASES: Not answered. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Right Lobe, Left Lobe. TUMOR FOCALITY: Multifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 1.2 cm. HISTOLOGIC TYPE: Papillary carcinoma. TNM DESCRIPTORS: m. PRIMARY TUMOR (pT): REGIONAL LYMPH NODES (pN): pN1a. Number of regional lymph nodes examined: 6. Number of regional lymph nodes involved: 2. EXTRANODAL EXTENSION: Not identified. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Present. MARGINS: Margins uninvolved by carcinoma. Distance of invasive carcinoma to closest margin: 0.1 mm. LYMPH-VASCULAR INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Other: CHRONIC LYMPHOCITIC THYROIDITIS.",T3,N1,M0,T3N1M0
TCGA-KS-A4ID,"PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 1. SEX: F. BIRTHDATE: ADM DATE: OPER DATE: PROCEDURE: SPHS. Question papillary thyroid carcinoma. History of symptomatic papillary thyroid. carcinoma. PROCEDURE: SPGD. 1. ""Right level III lymph node, ?papillary carcinoma"" A 2.5 x 1.8 x 1 cm. portion of fibroadipose tissue containing six possible lymph nodes (0.3 to 1. cm). 1A. Three possible Lymph nodes. Frozen section control. 18. Three possible Lymph nodes. Frozen section control. fat retained). 2. ""Thyroid, stitch marks right lobe."" Received fresh for procurement in a. small container is a 17.8 gm thyroid with a 5 x 2.5 x 1.3 cm left tobe (inked. blue), a 4.5 x 3.2 x 1.3 cm right lobe (inked green) and a 1.3 x 1.0 x 0.4 cm. isthmus (inked yellow). The right tobe has a diffuse tan color and contains. a. 1.3 x 1.2 x 1.0 cm, tan, circumscribed, hemorrhagic, firm nodule, 0.1 cm. from. the thyroid capsule and a separate 0.4 x 0.5 x 0.3 cm, firm, tan,. circumscribed nodule abutting the thyroid capsule. The left tobe is diffusely. variegated, tan and red with no nodule. The isthmus is diffusely tan without. nodules. 2A. Right tobe with two nodules. 2B-C. Remainder of larger right lobe nodule. 2D. Upper and lower right Lobe (no nodules). 2E. Lower left lobe. 2F. Middle left lobe. 2G. Upper left lobe and isthmus. 3. ""Level VI lymph node. Received in formalin in a small container are. multiple portions of fibroadipose tissue aggregating to 4.5 x 3 x 1.5 cm and. containing muttiple possible lymph nodes ranging from 0.3 cm to 1.2 cm. 3A. Three possible (ymph nodes, submitted whole. 3B. Five possible lymph nodes, submitted whole. Fat retained. FROZEN SECTION REPORT. 1. Fragments of benign Lymph nodes. 1,. have reviewed and interpreted the frozen section. material at the time it was requested. Permanent sections confirm frozen section report. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 2. SEX: F. BIRTHDATE: ADM DATE: OPER DATE: PROCEDURE: SPMI. PAPILLARY THYROID CARCINOMA. Size of largest primary tumor: 1.1 cm. Location(s): Right lobe. Capsular Invasion: No. Vascular Invasion: No. Margins: Negative. Extrathyroidal extension: No. Lymph node metastases: Extranodal extension: N.A. LYMPH NODES. SIDE. LEVEL. #POSITIVE NODES. #TOTAL NODES. Right. 111. 0. 6. Right. VI. 0. 7. Total Right All. 0. 13. PROCEDURE: SPOX. 1. Lymph node, right level III, dissection: Six lymph nodes, negative for. neoplasm. 2. Thyroid, total thyroidectomy: Papillary thyroid carcinoma (1.1 cm), well. differentiated, follicular variant, confined to the thyroid. Margins negative. Please see template. 3. Lymph node, level VI, dissection: Seven lymph nodes, negative for. neoplasm. the signing staff pathologist, have.",T1,N0,M0,T1N0M0
TCGA-AA-3548,"Diagnosis: Right hemicolectomy preparation with tumor-free oral and aboral resection margins, as. well as an ulcerated, moderately differentiated adenocarcinoma in the region of the. Bauhin's valve and the bordering cecum with infiltration of the perimuscular adipose. tissue, and with four regional lymph node metastases (G2, pT3 L1 V0 local R0 pN2 4/23).",T3,N2,M0,T3N2M0
TCGA-49-6742,"fficial report. SURG PATH REPORT. 1st Specimen collected on. FINAL DIAGNOSIS. L10 LYMPH NODE (EXCISION) : ONE LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR (0/1). 2. LEFT UPPER LOBE LUNG (LOBECTOMY) : SPECIMEN TYPE: Lobectomy. TUMOR SITE: Left, Upper lobe. HISTOLOGIC TYPE: Adenocarcinoma with mucinous features. TUMOR SIZE: Greatest dimension 5. Ocm. HISTOLOGIC GRADE: G2: Moderately differentiated. LYMPH NODES: Metastatic carcinoma in 1 of 11 lymph nodes (Parts 1-5). DIRECT EXTENSION OF TUMOR: Invades visceral pleura (Movatt stain). EXTENT OF INVASION. PRIMARY TUMOR: pT2: Tumor which is: >3cm OR invades visceral pleura. REGIONAL LYMPH NODES: pN1: Metastasis in ipsilateral peribronchial,. hilar, or intrapulmonary nodes, including those involved by direct. extension. MARGINS: Margins uninvolved by invasive carcinoma. VENOUS/ARTERIAI (LARGE VESSEL) INVASION: Absent. LYMPHATIC (SMALL VESSEL) INVASION: Present. Unofficial lab results - do not file in patient chart. Contact medical records for official chart copy. UNLESS OTHERWISE NOTED ON THE DETATL PAGE.. ALL LAB REGULTO PERFORMED AT: SP-CONS - SURG PATH REPORT. ADDITIONAL PATHOLOGIC FINDINGS: Other: Focal, small non-caseating granulomas in uninvolved lung,. fungal (GMS) and acid fast bacteria (AFB) stains are negative. NOTE: This case was presented at the daily quality assurance. conference. EGFR and KRAS mutation analysis has been ordered and. will be reported in an addendum. 3. STATION 6 LYMPH NODES (EXCISION) : ONE LYMPH NODE AND AGSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 4. STATION 5 LYMPH NODE (EXCISION) : ONE LYMPH NODE AND ACSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 5. STATION 7 LYMPH NODE (EXCISION) : ONE LYMPH NODE AND ACDOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. ADDENDUM. KRAS MUTATION ANALYSIS: BLOCK TESTED: RESULT: NO MUTATION DETECTED. NOTE: No mutations were detected at codons 12 and 13 of the KRAS. gene. A copy of the complete report is available in. and is also on file in the Molecular Pathology Division ui the. Department. ADDENDUM. D. EGFR MUTATION ANALYSIS: BLOCK TESTED: RESULT: NO MUTATION DETECTED. NOTE: A copy of the complete report is available in. and is also. on file in the Molecular Pathology Division of the Department. End of Diagnosis. Clinical History: LEFT UPPER LOBE OF LUNG. See. for official report. Reported bv:",T2,N1,M0,T2N1M0
TCGA-56-A4ZK,"Acct/ Reg #. BIAGNOSIS. DIAGNOSIS: A. Right lower lobe nodule, biopsy with frozen section: Squamous cell carcinoma. Frozen section diagnosis confirmed. B. Right lower lobe. lobectomy: Tumor Characteristics: !, Histologie type Squamous cell carcinoma. 2. Histologic grade: High-grade/poorly differentiated. 3. Tumor sita: Right lowar lobe. 4. Tumor focality; Unifocal. 5. Tumor size: 22x20x1.5cm. 6, Visceral pleural invasion: Yes (See comment). 7 Lymphovascular space invasion; No. 8. Tumar extension- Tumor is confined to the lung. G. Trentment effect: Not identified. Surgical Margin Status: 1. Tumar cistance frem bronchial margin: 5.2 cm. 3. Tumor cistanca from caranchymal (stapled) margin 2.3 am. 3. Tumor distance from pleurs: surface: Positive. Lympli Node Status: 1. Total number of fymph nades received. 13 (includes all parts as wei as 3 codes in the lobectomy specimen). 2 Total number of lymph nodes containing metastatic carcinoma: 0 (0/13). Other: i Other significant findings: Inflammatory response to tumor incluces extensive multinucleated giant cell'histiccyte reacsur with epithelloid. microgranulomas. Subpleural and septal fibrosis, and areas of pronchial metanfasia and chronic inflammation. 2. pTNM stage: T2 NO MX, (Neoplasm is staged as T2 lassed on pleural invasion: C. Level 9 lymph node. blopsy: One lymph node: negative for metaslatic tumo: 10.1). (1) Level 7 lymph nodes. biopsy: Seven lymph nodes, negative for metastauc. E. Level 4R lymph node, piopa;. Two lymph noites, negative for metastatic tornor (022). Electromo signature. I. COMMENTS: Tha naoplasm is poorly dirferentiated with nests of mosily solid tumor, with cosincphilic cytoprasm and areas of apparent intercellular bridges. 4. squamous cell carcinoma is favored. hovever to furlher evaluate and exclude an adenocarcinoma component, immuncstains are performed increase. slides stain approprateig). The neoglasm stains strongiv positive for 063 and CK5/6. A TTF-1 and Mapsin inmunosten are both negative in the neoplasm. These findings support a squamcus ceit carcinoma. The tumer extends lo the pleural surface, (en elastic stain on block B4 shows tumor ruptures through elastic : astre staining,. imvasion of visceral pleura. SPECIMEN INFORMATION. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis Other lung disease. Pestoperative Diagnosis: Symploms/Radiologic Findings: SPECIMENS: A Right fower tobe nodule. B. Right lower lobe. C. Level 9 lymph node. D Level 7 lymph node. E. Level 4R lymph node. SPECIMENDATA. GROSS DESCRIPTION: A The first container A is rceived in. int lower lobe nodule.' The specimen consists of three gray-tan core biopsies measuring up to 1.0. cm. The specimen was examined at the tima of gurgery and the frozen section is subsequently entirely submitted in cassette. B. The second contairer 8 is received in formalin labeled with the patient's name. right lower lobe. The specimen consists of a lung. ichoctemy specimen with lower lobe measuring 16.5 x 9.0 x 3.5 em and weighs 236 grams. The pleural surface is gray-tan to brown-tan, slightly. anthracctic. There is an area of puckering noted wathin the central portion measuring 2.0 % 1,5 cm. The pleura has been inkad. Sectioning reveals a. circumscribed gray-tan slightly anthracolic mass that measures 2.2 x 20. x 1.5 cm that abuts the pleural surface. is 5.2 cm from the bronchial. margin. of. resection. and. vrithin. 2.3 cm of the closest staple line. The mass corresponds to the puckered area noted on the pteural aurface. The surrounding lung. tissue is red-tan spongy, congested. There are no other lesions grossly identified. Within the parabronchial soft tissue there are two gray-tan nodutes. consistent with lymph nodes 0.3 and 1.4 cm The largest is bisacted. Received with the specimen are two casseltes, one green and one yellow labeled. Representative sections are submitted in cassettes labalec. is follows: section from mass in blacks 1 through 4; shave. section. from. the staple line resection in black S; branchial vascular margin block 6: surrounding uninvolved lung block 7; sections from each of the tymph. nedes (largest bisected) in block S. c. Container C is recaived in formalin labaled. Tovel 9. The specimen consists of a gray-tan to brown-tan anthracotic nodule consistent. with lymph node 1.5 X 0.7 x 0.5 cm. The lymph node is bisected and ls entirely submitted in a single cassette. D. The fourth container is 13 received in fermalin labeler. ""level 1 lymph node The specimen consists et seven gray-tan to brown-tan. anthracotic noduies consisient with lymph nodes that measure from 0.3 to 1.1 cm in greatest dimension. The lymph nodes are entirely submitted in. cassettes labeled. as follows: three probable nodes block 1: two probable nodes each bisected black 2: two probable nodes each. bisected block 3. (n The fiftn container E is received in formalin labelec. 1 level 4R lymph node. The specimen consists cf two brown-tan anthracotic nodules. consistent with iymph nodes measuring 0.7 and 0.9 cm in greatest dimension. The lymph nodes are each bisected. entirely submitted in a single. cassella ishained. IV IRA-OPERATIVE CONSULTATION: FROZEN SECTION DIAGNOSIS Part a Non-small ceil carcinoma per.",T2,N0,M0,T2N0M0
TCGA-ED-A82E,"Gross Description: Tumor is located in a lobe, ill-margins with 6x6x4cm in size, firm, solid, necrotic gray-. white in cutting section. Microscopic Description: Tumor cells form the trabecular patterns, or acinar or sheets or tubular. patterns. The tumor cells retain apolygonal shape and have round vesicular nuclei with prominent. nucleoli. The amount of cytoplasm are moderate and the cytoplasm is basophilic or vascuolated. Nuclei. are irregularly large and hyperchromatic with prominent nucleioli. Mitoses are present. Tumor is focal. necrotic. Diagnosis Details: Hepatocellular carcinoma, moderately-differentiated. Comments: Formatted Path Reports: LIVER TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor size: 10 x 10 x 8 cm. Focality: Not specified. Histologic type: Hepatocellular carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: Not specified. Comments: None.",T3,N0,M0,T3N0M0
TCGA-SY-A9G0,"DIAGNOSIS: A-E. Bladder, prostate, and pelvic lymph nodes, excision: Procedure: Radical cystoprostatectomy. Tumor site: Right posterior lateral wall. Tumor size: 2.5 x 2.0 x 1.2 cm. Histologic type: Urothelial (transitional cell carcinoma), , with. nested pattern. Associated epithelial lesions: None identified. Histologic grade: High-grade, grade 3 (of 3) . Tumor configuration: Solid/nodule with ulceration. Microscopic tumor extension: Perivesical fat. Margins: Negative, right and left distal ureter (specimens C and. D), and urethra. Lymph-vascular invasion: Absent. Perinodal invasion: Present. Prostate: Extensive invasion by urothelial carcinoma. Immunoperoxidase studies were performed on paraffin-embedded tissue. These show that the neoplastic cells are reactive with antibodies. to p63, but not cytokeratin 5/6, prostatic acid phosphatase or. prostate-specific antigen. These findings support the diagnosis of. extensive involvement by urothelial carcinoma rather than prostatic. adenocarcinoma, as diagnosed in the review of previous outside. material. Seminal vesicles: Negative for malignancy. Lymph nodes (Specimens A and B) : Metastatic carcinoma consistent. with bladder primary, 1/3 left pelvic. Sections of the right pelvic. lymph nodes show no evidence of metastatic carcinoma, four nodes. Research tissue (block E22) : Tumor (urothelial carcinoma) and. normal prostatic tissue identified. Pathologic staging: pT4, pN1. Total number examined: Seven. Number involved: One. F. Kidney, right, radical nephrectomy : Marked chronic nephritis. with hydronephrosis. Permanent sections confirm the frozen section diagnoses. CLINICAL INFORMATION: Invasive bladder cancer. SPECIMEN (S) : A:Right pelvic lymph nodes. B:Left pelvic lymph nodes. C:Left distal ureter margin. D:Right distal ureter. E:Bladder & prostate. F:Right kidney. PRELIMINARY INTRAOPERATIVE DIAGNOSIS: Intraoperative Pathologist (s) : C. Left distal ureteral margin, frozen section diagnosis: Negative for malignancy. D. Distal right ureter, frozen section diagnosis: Negative for. carcinoma. E. Bladder and prostate, frozen section of distal urethral margin,. frozen section diagnosis: Negative for carcinoma. GROSS DESCRIPTION: A. Received fresh labeled and ""right pelvic lymph. nodes"" are multiple pieces of adipose tissue, aggregating to 7.4 x. 6.5 x 2.2 cm. Within the adipose tissue are several lymph nodes. All of the lymph nodes are submitted in cassettes labeled. as follows: A1) One lymph node; A2) one lymph node. bisected; A3) two lymph nodes, larger bisected. B. Received fresh labeled and ""left pelvic lymph. nodes"" are several pieces of adipose tissue, aggregating to 8.5 x. 4.5 x 2.5 cm. Within the adipose tissue are several fatty lymph. nodes. All of the lymph nodes are submitted in cassettes labeled. as follows: B1) One lymph node bisected; B2) one lymph. node bisected; B3) one lymph node bisected. C. Received fresh labeled and ""left distal ureteral. margin"" is a tubular segment of tan tissue consistent with ureter,. 0.6. cm in maximum dimension. Entirely submitted for frozen section. in one cassette labeled. D. Received fresh labeled and ""right distal ureter"". is a tubular segment of pink-tan tissue with attached fat, 1.2 cm in. maximum dimension. Entirely submitted for frozen section in one. cassette labeled. E. Received fresh labeled and ""bladder and. prostate"" is a radical cystoprostatectomy specimen, 195 g and 10.5 x. 6.2 x 4.2 cm. The prostate is separately 3.5 x 3.5 x 2.7 cm. The. specimen is opened through the prostatic urethra and reveals a. mucosal ulcerating mass in the right posterolateral wall, 2.5 x 2 x. 1.2 cm. The mass extends into the bladder wall and possibly. extending up to and into the right portion of the prostate. The. remaining bladder wall is edematous. The right and left ureteral. orifices appear obstructed by the mass. Fresh tissue of the tumor,. normal bladder, and prostate are submitted for. Multiple representative sections are submitted in. cassettes labeled. as follows: E1) Frozen section distal. urethral margin; E2) anterior bladder wall; E3) bladder dome; E4). right lateral wall; E5) right lateral wall; E6) posterior wall; E7). posterior wall; E8) right posterolateral wall; E9) right ureteral. bladder orifice; E10) left ureteral bladder orifice; E11) right and. left seminal vesicles; E12) right prostate apex; E13) left prostate. apex; E14) right prostate mid; E15) left prostate mid; E16) right. prostate base; E17) left prostate base; E18-E20) junction of right. prostate and right bladder wall; E21) possible parabladder lymph. nodes; E22) mirror image of tissue corresponding to research IRB. F. Received fresh labeled and ""right kidney"" is a. total nephrectomy specimen, 12 x 7.5 x 4.5 cm, 168 g. After the. perirenal fat is removed, the kidney is 80 g and 9.2 x 3.8 x 2.5 cm. The attached ureter is 15 x 0. x 0.6 cm. The capsule strips. easily. The cortices are yellow-brown and granular. The cut. surface of the kidney shows a grossly dilated renal pelvis with. blunting of the cortices, changes consistent with hydronephrosis. The corticomedullary junction is distinct. There is no evidence of. masses or cysts. The ureter is dilated which shows no evidence of. tumor. Representative sections are submitted in cassettes labeled. as follows: F1) Vascular and ureteral margins; F2-F3). sections of kidney; F4) additional sections of dilated ureter. Support for the diagnosis in this case may have included the. use of immunohistochemistry tests that were developed and whose. performance characteristics were determined by. They have not been cleared. or approved by the U.S. Food and Drug Administration (FDA) . The FDA has determined that such clearance or approval is not. necessary. These tests should not be regarded as investigational. or for research. This laboratory is certified under the Clinical. Laboratory Improvement Amendments of 1988 ('CLIA') as qualified. to perform high complexity clinical laboratory testing.",T4,N1,M0,T4N1M0
TCGA-BR-8060,Gross. Microscopic. Diagnosis. Comments. Description. Description. Details. Laterality/lo. Date of excision. cation. STOMACH TISSUE CHECKLIST. Cardia. Specimen type: Excision of tumor. Tumor site: Cardia. Tumor size: 4 X 3 X 0.4 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Muscularis propria. Lymph nodes: 4/4 positive for metastasis. (Intraabdominal 4/4). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: Invades esophagus.,T2,N2,M0,T2N2M0
TCGA-EA-A556,"Gross Description: Microscopic Description: Diagnosis Details: Comments: Formatted Path Reports: CERVIX TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Endocervix. Tumor size: 4 x 3.5 x 3 cm. Histologic type: Endometrioid adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Lesion less than 4.0 cm. Lymph nodes: 0/7 positive for metastasis (Regional 0/7). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: IHC demonstrated CA125, vementin, CK7, high molecular weight cytokeratin - positive; PR -. 30%. Some nuclei express neurospecific enolase, synaptophasin, chromogranin A, P63.",T1,N0,M0,T1N0M0
TCGA-D8-A1JM,"page 1 / 1. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Multiple organ resection - right breast. Expected time of examination: up to 8 working days. Clinical diagnosis: Right breast with tumour and right axillary lymphnodes. Macroscopic description: Right breast sized 21.4 x 16.5 x 5.4 cm removed along with axillary tissues sized 7 x 9 x 3 cm. Weight 920. g. Lesion sized 3 x 3.3 x 2.1 cm on the boundary of outer quadrants, 3 cm away from the lower boundary, 0.5. cm from the base and 2.9 cm from the skin. Microscopic description: Carcinoma ductale invasivum - NHG3 (3 + 3 +2: 26 mitoses/10 HPF, visual area diameter 0.55 mm). Invasio carcinomatosa vasorum massiva. Reactio lymphocytaria peritumoralis. Mamilla sine laesionibus. Glandular tissue showing parenchyma atrophy. Axillary lymph nodes: Metastases carcinomatosae in lymphonodis (No III/XI). Histopathological diagnosis: Carcinoma ductale invasivum mammae dextrae. Invasive ductal carcinoma of the left breast. Metastases carcinomatosae in lymphonodis axillae (No III/XI). Cancer metastases in axillary lymph nodes (No. III/XI). (NHG3, pT2, pN1a). Results of immunohistochemical examination: Estrogen receptors found in less than 10% of neoplastic cell nuclei. No progesterone receptors. found in neoplastic cell nuclei. HER2 protein stained with HercepTestM by DAKO. Negative. reaction in invasive cancerous cells ( Score = 1+ ).",T2,N1,M0,T2N1M0
TCGA-64-1679,"Clinical History/Diagnosis: Right Lung Cancer. Source of Specimen(s): 1: Portion of 6th Rib. 2: Level 9 Lymph Node. 3: Level 4R Lymph Node. 4: Right Upper Lobe. 5: Level 4R Lymph Node. 6: Pre-carinal Lymph Node. 7: Level 7 Lymph Node. Gross Description: Received in seven parts. Source of Tissue: 1. Labeled # 1, ""portion of 6th rib"". Gross Description: Received fresh in a container labeled "" patient name and medical number,. portion of 6th rib"". It consists of a fragment of rib. measuring 2.5 x 1.5 x 1.0 cm. There are no suspicious lesions or masses. Representative sections are submitted in 1A following decalcification. Source of Tissue: 2. Labeled # 2, ""level 9 lymph node"". Gross Description: Received fresh in a container labeled patient name and medical number,. level 9 lymph node"". It consists of a single gray-tan. rubbery lymph node measuring 1.3 x 0.7 x 0.7 cm. No suspicious areas are. identified. Submitted in toto in 2A. Source of Tissue: 3. Labeled # 3, ""level 4R lymph node"". Gross Description: Received fresh in a container labeled "" patient name and medical number,. level 4R lymph node"". It consists of two black potential. lymph nodes measuring respectively 0.5 and 0.7 cm in greatest dimension. They are unremarkable and submitted in toto in 3A. Source of Tissue: 4. Labeled # 4, ""right upper lobe lung"". Frozen Section Diagnosis: 4FS- NO TUMOR SEEN. Gross Description: Received fresh from O.R. for frozen section. consultation in a container labeled 11 patient name and medical number, right. upper lobe lung"". It consists of a 98-gram right upper lobe of lung. measuring 12.4 x 9.5 x 5.5 cm. The bronchial margin was procured for. frozen section and the residue is in 4FSA. The bronchial tree is opened. and is free of lesions and masses. A few hilar and peribronchial nodes. are found ranging from 0.4 up to 1.2 cm. The nodes are gray to black and. unremarkable. The vascular margin is likewise unremarkable. The pleural. surface is pink with a moderate amount of black anthracotic discoloration. and central laterally there is a marked area of pleural puckering and. thickening measuring 1.5 X 0.7 cm. Sections through this area disclose an. ill-defined gray-tan firm mass measuring 2.0 x 1.8 X 1.8 cm. This tumor. is 4.2 cm from the hilum/margin. Elsewhere the parenchyma is red, spongy. and has no additional lesions or masses. Representative sections are. submitted in 4A-E. Designation of Sections: 4FSA- bronchial margin submitted for frozen. section, 4A- vascular margins, 4B- hilar and peribronchial lymph nodes,. 4C- tumor in relationship to pleura, 4D- turnor, 4E- lung tissue uninvolved. Source of Tissue: 5. Labeled # 5, ""level 4R lymph node"". Gross Description: Received fresh in a container labeled patient name and medical number,. level 4R lymph node"". It consists of two black to red lymph. nodes measuring respectively 0.7 and 1.9 cm in greatest dimension. The. larger node is bisected and the smaller node is submitted as is. Both. nodes are grossly unremarkable. Entirely submitted in 5A. Source of Tissue: 6. Labeled # 6, ""pre-carinal lymph node"". Frozen Section Diagnosis: 6FS- METASTATIC CANCER. Gross Description: Received fresh from O.R. for frozen section. consultation in a container labeled "" patient name and medical number,. pre-carinal lymph node"". It consists of a single firm grayish black lymph. node measuring 2.0 x 1.3 X 1.0 cm. Sections disclose a black to tan firm. cut surface. Entirely submitted for frozen section and the residue is in. 6FS. Source of Tissue: 7. Labeled # 7, ""level 7 lymph node"". Gross Description: Received fresh in a container labeled "" patient name and medical number,. level 7 lymph node"". It consists of a single rubbery tan. lymph node measuring 2.8 x 2.3 x 1.0 cm. Sections show a soft grayish. black cut surface. Entirely submitted in 7A. Final Diagnosis: 1. Portion of 6th rib, resection: - Bone and hypercellular bone marrow with. trilineage hematopoiesis and lymphoid aggregates. 2. Level 9 lymph node, excision: - One lymph node, no tumor seen (0/1). 3. Level 4R lymph node, excision:- Two lymph nodes, no tumor seen (0/2). 4. Right lung, upper lobe, lobectomy: - Moderately differentiated adenocarcinoma with necrosis, 2.0 cm in. greatest dimension grossly, with acinar growth pattern. - Lymphovascular invasion is present. - Tumor does not invade into visceral pleura. - Bronchial and vascular resection margins are free of tumor. - Seven hilar and peribronchial lymph nodes, no tumor seen (0/7). 5. Level 4R lymph node, excision:- Two lymph nodes, no tumor seen (0/2). 6. Pre-carinal lymph node, excision: - One lymph node, positive for metastatic adenocarcinoma (1/1). 7. Level 7 lymph node, excision: - One lymph node, no tumor seen (0/1). - pT1 N2 Mx.",T1,N2,M0,T1N2M0
TCGA-BH-A1F2,"Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE of LMP: DATE or LAST DELIVERY. PRE-OP DIAGNOSIS: L BREAST CA. POST-OP DIAGNOSIS: SAME-. OPERATIVE PROCEDURE: L MRM. CLINICAL HISTORY: MATERIAL SUBMITTED: LEFT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. and axillary contents. ADDENDA: Addendum. FINAL DIAGNOSIS: ER/PR. IMMUNOPEROXIDASE IDENTIEICATION OF ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE ""A2"". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROGEN RECEPTOR (50%) AND PROCESTERONE RECEPTOR (40%) . THEREFORE, BOTH ARE INTERPRITED AS POSITIVE. BER-2/NEU. c-erb82 (HER-2/NEU) IMMUNOSTAINING IS CARRIED OUT ON. (BREAST CANCER) USING A. 1:300 DILUTION OF DAKO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE INTRACELLULAR DOMAIN OF c-erba2). WITHOUT ANTIGEN RETRIEVAL DISTINCT COMPLETE MEMBRANE STAINING IS IDENTIFIED IN 70% OF TUMOR CELLS. THEREFORE, o-erba2 (HER-2/NEU) IS INTERPRETED AS POSITIVE (SCORE 3+). My signature is attestation that I have ppersonallyreviewed the submitted material(s) andthe final. diagnosis reflects that evaluation. FINAL DIAGNOSIS: LEFT BREAST, MODIFIED RADICAL MASTECTOMY: - INFILTRATING, POORLY DITYERENTIATED DUCT CARCINOMA, 4.7 BY 2.5 BY 2.0 CM, INVOLVING ALL FOUR QUADRANTS. - NOTTINGHAM SCORE: 8/9 (TUBULES=3/3, NUCLEAR ATYPIA=3/3, MITOTIC INDEX=2/3). - DUCTAL CARCINOMA IN SITU INVOLVES <5% OF TOTAL TUMOR. - TUMOR EXTENDS TO INVOLVE DERMIS OF NIPPLE, DERMAL LYMPROVASCULAR PERMEATION IS PRESENT. - NIPPLE AND ADJACENT SKIN INVOLVED BY PAGET'S DISEASE. - MARGINS OF RESECTION ARE NEGATIVE FOR TUMOR, HOWEVER; TUMOR EXTENDS TO WITHIN 0.2 CM or THE DEEP NARGIN. - FIBROCYSTIC CHANGES. - DUCT ECTASIA. - NON-TUMOR ASSOCIATED MICROCALCIFICATIONS. - SIX (6) OUT or NINETEEN (19) LYMPH NODES, POSITIVE FOR METASTATIC CARCINOMA, MULTIPLE FOCI OF. EXTRANCOAL. TUMOR EXTENSION ARE SEEN. NOTE: ER/PR immunoperoxidase assay and Her-2/NEU testing will be performed on block ""A2"".",T4,N1,M0,T4N1M0
TCGA-GV-A3QK,"Encounter Date: SURGICAL PATHOLOGY (Order. Patient Info. Female. Spe. Sub. FINAL DIAGNOSIS. 1. Right colon, segment of terminal ileum and appendix, colectomy (A) -. Single focus of metastatic urothelial carcinoma present within subserosal. lymphovascular space. Segment of colon with mild crypt architectural distortion and submucosal. fibrosis, consistent with prior biopsy site changes; no evidence of. residual dysplasia or adenocarcinoma. - Hyperplastic polyp. - Submucosal lipoma. - Appendix and small bowel with no specific diagnostic alteration. - Thirty-three pericolonic lymph nodes, negative for carcinoma (0/33). - See comment. 2. Right distal ureter, excision (B) - Benign portion of ureter, negative. for urothelial dysplasia/carcinoma. 3. Left distal ureter, excision (C) - Benign portion of ureter, negative. for urothelial dysplasia/carcinoma. 4. Urethral margin, excision (D) - Benign urethral tissue, negative for. urothelial dysplasia/carcinoma. 5. Urinary bladder, uterus, cervix, and vagina, anterior exenteration. Bladder with invasive high grade papillary urothelial carcinoma,. extending through the perivesical fat and into the stroma of the endocervix. and lower uterine segment myometrium, as well as into the vaginal submucosa. (see comment). -Lymphvascular invasion is identified. -Perineural invasion is identified. -Carcinoma extends to the inked posterior serosal surface of the bladder. -Vaginal margin is negative for carcinoma. -Ureteral and urethral margins are negative for carcinoma. -Urothelial carcinoma in situ is identified in the bladder mucosa. -Unremarkable uterine cervical mucosa. -Inactive endometrium. 6. Urethral margin #2, excision (F) - Benign portion of urethra, negative. for urothelial dysplasia/carcinoma. 7. Lymph nodes, right pelvic, excision (G) - Fourteen lymph nodes negative. for carcinoma (0/14). 8. Lymph nodes, left pelvic, excision (H) - Metastatic urothelial. il. Encounter Date. carcinoma involving five of twenty-three lymph nodes (5/23). - Extranodal extension is identified. COMMENT. 1. (A) The entire previous biopsy site and colonic tissue adjacent to it. were submitted for histologic evaluation. There is no evidence of residual. dysplasia or invasive adenocarcinoma in this specimen. Slides from part A. of this case were reviewed with Dr. 5. Procedure: Anterior exenteration. Tumor Size (greatest dimension) : 5.0 cm. Histologic Type: Urothelial carcinoma. Associated Epithelial Lesions. Urothelial carcinoma in situ. Histologic grade. Urothelial Carcinoma (WHO. High-grade. Microscopic Tumor Extension: Perivesical fat. Myometrium. Endocervical stroma. Vaginal submucosa. Margins : Margins uninvolved by invasive carcinoma. Carcinoma extends to the inked. posterior serosal surface of the bladder. Ureteral margins, urethral margin, and vaginal margin negative for. carcinoma. Lymphovascular Invasion : Present. Pathologic Stage (TNM) : Number lymph nodes examined: 37. Number lymph nodes involved (any size) : 5. Primary Tumor (pT). pT4a. Regional Lymph Nodes (pN). pN2. Distant Metastasis (pM) : pMX. Slides from the cystectomy specimen were reviewed at the. with Drs. and. Encounter Date: , M.D. (Electronic Signature). SPECIMEN SUBMITTED. A: RIGHT COLECTOMY. B: RIGHT DISTAL URETER. C: LEFT DISTAL URETER. D: URETHRAL MARGIN. E: BLADDER, UTERUS AND CERVIX. F: URETHRAL MARGIN #2. G: RIGHT PELVIC LYMPH NODES. H: LEFT PELVIC LYMPH NODES. CLINICAL DATA. BLADDER CA. INTRAOPERATIVE CONSULT DIAGNOSIS. B. Negative for carcinoma (Dr. C. Mostly denuded epithelium, negative for carcinoma (Dr. D. Negative for carcinoma, however, no epithelium identified (Dr. F. Negative for carcinoma (Dr. GROSS DESCRIPTION. A. Received fresh labeled ""right colon"" is a 14.5 cm segment of right colon. with an attached 9 cm segment of terminal ileum. An appendix is identified. The serosal surface is smooth and glistening. The wall of the colon. averages 0.3 cm in thickness. The wall of the terminal ileum averages 0.2. cm in thickness. The mucosa of the colon demonstrates a brown-yellow. submucosal nodule measuring 1.3 x 1.3 cm located 5.4 cm from the distal. margin. Sectioning reveals a yellow homogenous cut surface. It does. invade the underlying wall. Multiple soft white polyps are identified. ranging in size from 0.1 to 0.4 cm. All appear superficial. In the. ascending colon, there is an irregular red slightly depressed area. resembling a possible biopsy site measuring 0.8 x 0.2 cm located 14 cm from. the distal margin. It is superficial and does not invade into the. underlying wall. The remaining mucosa is unremarkable. No firm mass lesions. are identified. The mucosa of the terminal ileum is unremarkable. The. attached appendix measures 4.7 cm in length and 0.9 cm in diameter. The. lumen is dilated to 0.2 cm and contains fecal material. No perforations or. ulcerations are seen. Sectioning through the surrounding fibroadipose. tissue reveals multiple ovoid tan firm nodules resembling lymph nodes. Representative sections are submitted as follows: Al margins (proximal. margin blue, distal margin orange), A2-A3 submucosal nodule totally. submitted, A3 biopsy site totally submitted, A4-A polyps totally. submitted, A6 appendix, A7 ileocecal valve, A8 small bowel, A9-A17 lymph. nodes. B. Received fresh at the frozen desk labeled ""right distal ureter"" is a 0.3. cm in diameter, 0.2 cm in length luminal tan-pink soft tissue fragment. The specimen is totally submitted for frozen section in one cassette. labeled B1. Encounter Date: C. Received fresh at the frozen desk labeled ""left distal ureter"" is a 0.3. cm in diameter, 0.2 cm in length tan-pink luminal soft tissue fragment The. specimen is totally submitted for frozen section in one cassette labeled. C1. D. Received fresh at the frozen desk labeled ""urethral margin"" is a 2 x 0.6. x 0.3 cm red-tan mucosal lined soft tissue fragment. The specimen is. totally submitted for frozen section in one cassette labeled D1. E. Received in formalin is a specimen consisting of a urinary bladder,. bilateral ureters, uterus, attached cervix, and portion of vagina. The. bladder measures 6.0 x 4.5 x 4.2 cm. The external surface of the bladder is. covered by a smooth serosal lining at the dome and fibroadipose tissue at. the remaining portion. After the bladder is opened, a tan fungating mass is. identified in the right anterior bladder wall extending to the left and. right trigone region measuring 5.0 x 3.1 x 1.2 cm. Upon multiple cross. sections there does appear to be gross extension beyond the bladder wall. extending to within 0.2 cm of the soft tissue margin. Also, identified on. the left bladder wall is an ulcerated indurated area of mucosa measuring. 4.2 x 3.0 cm. This area of this bladder wall extends posteriorly and is. associated with a thickened bladder wall measuring up to 2.0 cm. The. bladder wall grossly appears to be involved by a mass which extends beyond. the bladder wall, approaching the soft tissue margin. The right ureter. measures 5.0 cm and is unremarkable. The left ureter measures 6.0 cm and is. also unremarkable. The uterus measures 6.0 x 3.5 x 3.5 cm, and weighs 53.2. grams. A section of vaginal cuff and vagina are present measuring 5.0 x 1.2. cm. The vaginal mucosa is unremarkable. The ectocervix is unremarkable. The. endocervical canal measures 1.8 cm in length. Polyps are not present. The. endometrial canal measures 4.2 cm in length and 2.0 cm in greatest width. The endometrium measures 0.1 cm in thickness and has a tan, smooth and. glistening appearance. The myometrium measures 1.5 cm in thickness and is. unremarkable. Representative sections are submitted as follows: E1. additional section right ureter, E2 additional section left ureter, E3. posterior bladder wall with right ureter orifice and small portion of. possible mass, E4-E7 right bladder wall with mass with extension beyond. bladder wall with soft tissue margin, E8 anterior bladder wall, E9 left. bladder wall with mass near ureter, E10-E12 left bladder wall with mass and. soft tissue margin, E13 left trigone region with mass, E14 left trigone. region with mass and portion of vaginal mucosa, E15 right trigone region. with mass, E16 anterior bladder wall, E17-E18 posterior bladder wall with. mass, E19-E20 anterior cervix, E21 posterior cervix, E22 anterior uterine. wall, E23 posterior uterine wall. F. Received fresh at the frozen desk labeled ""urethral margin #2"" are two. fragments of red-pink soft tissue measuring 1.1 x 0.6 x 0.5 cm. The. specimen is totally submitted for frozen section in one cassette labeled. F1. G. Received in formalin labeled ""right pelvic lymph nodes"" are multiple. yellow-tan segments of nodular adipose tissue aggregating to 5.8 x 4.3 x. 1.7 cm. Palpation reveals three tan, firm nodules resembling lymph nodes. ranging in size from 1.2 to 1.8 cm in greatest dimension. Additionally a. fragmented matted segment of nodular tissue is present measuring 4.4 x 4.0. Encounter Date: cm. The nodules are totally submitted as follows G1 two nodules, G2 one. nodule bisected, totally submitted, G3-G7 fragmented matted segment totally. submitted. H. Received in formalin labeled ""left pelvic lymph nodes"" are multiple. yellow-tan segments of nodular adipose tissue aggregating to 7 x 5 x 1.5. cm. Palpation reveals 14 tan, firm nodules resembling lymph nodes ranging. in size from 0.2 to 2.4 cm in greatest dimension. Additionally one. fragmented matted segment is also received in the same container measuring. 5.5 x 2.0 cm. The nodules are totally submitted as follows : H1 four. nodules, H2 four nodules, H3 four nodules, H4 one nodule, H5 one nodule,. H6-H10 fragmented matted segment sectioned and totally submitted. Patient ID #: (Age. Submitted by: Additional Physician (a) : Test performed by. Lab and Collection. SURGICAL PATHOLOGY (Order. on. L- Lab and Collection Information. Result History. SURGICAL PATHOLOGY (Order#. Result Date and Time. Provider Status. MyChart Status: This result is currently not released to. Display Full Result Report. Display Order Report.",T4,N2,M0,T4N2M0
TCGA-CW-6088,"TISSUE DESCRIPTION: : Tissue from right kidney (3.2 x 2.5 x 1.0 cm) and right. kidney. (180grams, 12 X 6 X 4.6 cm) 10.5 cm ureter, adrenal (5.5 X. 3.5 x 1.3. cm), right hilar, paracaval, adrenal hilar, intraoarta. caval lymph. nodes. DIAGNOSIS: Kidney, right, radical nephrectomy Grade 2 (of 4) renal. cell. carcinoma clear cell type, forms a 6 X 6 X 3.5 cm mass. located in. the inferior pole of the kidney. The tumor is confined to. the. kidney. The renal vein is grossly free of tumor. The tumor. does not. involve the collecting system. Coagulative tumor necrosis. is absent. The surgical margins are negative. No renal hilar lymph. nodes are. identified. The adrenal gland is present and unremarkable. Kidney, right, biopsy: Grade 2 (of 4) renal cell. carcinoma, clear. cell type, no coagulative necrosis identified. Lymph nodes, right hilar, paracaval, intraaorta-caval,. excision: Multiple (3) right hilar, (1) right paracaval, (6) right. intra-aorta -. caval lymph nodes are negative for tumor. Soft tissue, right adrenal hilar region, excision: Nerve. tissue and. ganglion. Negative for malignancy.",T1,N0,M0,T1N0M0
TCGA-EI-6884,"page 1 / 1. copy No. 5. Examination: Histopathological examination. Material: 1. Total organ resection - rectum and sigmoid colon. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the rectosigmoid junction. Macroscopic description: A 21.3 cm length of the large intestine with mesorectum tissue of 2 cm in thickness. Ulcerous tumour sized 3.3 X 3.4 X. 0.7 cm found in the mucosa, sized 2.6 X 1.8 X 0.6 cm. The lesion surrounds 100% of the intestine circumference. narrowing its lumen, is located 12.7 cm from the proximal incision line and 3.6 cm from the distal incision line. Microscopic description: Adenocarcinoma tubulare (G2). Infiltratio carcinomatosa telae adiposae mesorecti. Incision lines clear free of neoplastic lesions. Metastases carcinomatosae in lymphonodis (No III / VIII). Histopathological diagnosis: Adenocarcinoma tubulare recti. Tubular adenocarcinoma of the rectum. Metastases carcinomatosae in lymphonodis regionalis. Cancer metastases in regional lymph nodes. (No III/VIII). (G2, Dukes C, Astler-Coller C2, pT3, pNI, RO).",T3,N1,M0,T3N1M0
TCGA-37-3792,Clinical. Index. Diagnosis. Lung. 1. Cancer. Lung. I. Cancer. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of. Amount/per. Specificati. Container. Site. Matrix. Format. containers. container. on. Lung. Primary. Tumor. Tissue. OCT. block. 1. n/a. Blood. n/a. Normal. Blood. frozen. tube. 1. n/a. Type of. Histological description. Grade. TNM Stage. TNM Stage. TNM Stage. Treatment. Procureme. (Source). (source). (N). (M). type. nt. n/a. Squamous cell carcinoma. 2. 2. 0. 0. none. n/a. blood draw. n/a. n/a. n/a. n/a. n/a. none. Component. of treatment. Tumor cell. (Chemo /. %. Horm Th. Detalls). n/a. over 50. n/a. n/a.,T2,N0,M0,T2N0M0
TCGA-EL-A3GW,"Pathology. port. Pathology,. Sex: F. Case type: Surgical Case. DIAGNOSIS. (A) DELPHIAN TISSUE: Fibroadipose tissue, negative for tumor. (B) TOTAL THYROID: PAPILLARY THYROID CARCINOMA, CONVENTIONAL AND FOLLICULAR PATTERNS. Location: Right lobe. Multi-focal: No. Size = 2.5 cm. Extrathyroidal extension: Absent. Lymphovascular invasion: Absent. Resection Margins: Negative. GROSS DESCRIPTION. (A) DELPHIAN TISSUE - One pale-gray tissue fragment (0.6 x 0.3 x 0.3 cm). Entirely submitted in A. (B). TOTAL THYROID - A total thyroidectomy with slightly symmetric lobes with the right lobe (5.0 x 3.0x2.0 cm) and left. lobe (3.5 x 1.5x1.0 cm). Within the inferior/posterior aspect of the right lobe is a variegated soft multinodular nodule (2.5 X. 1.7 x 1.5 cm) which is confined with a thin rim of tissue to the thyroid. The nodule shows varying thickness of peripheral. fibrosis and hemorrhage. The remainder of the thyroid is unremarkable. SECTION CODE: B1, B2, left lobe superior-to-inferior; B3, isthmus; B4, unremarkable superior right lobe; B5-B8,. right lobe with nodule. CLINICAL HISTORY. Papillary thyroid cancer. SNOMED CODES. T-B6000, M-80503,. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by:",T2,N0,M0,T2N0M0
TCGA-L5-A4OO,"PREVIOUS DIAGNOSIS INQUIRY. 2. SEX: M. PROCEDURE: SPHS. Longstanding GE reflux disease, now presents with a distal esophageal. adenocarcinoma. Operative Procedure/Tissue Submitted: Flexible E-scope,. transhiatal esophagectomy - cervical esophagogastric anastomosis and J-tube. placement. PROCEDURE: SPGD. 1. ""Liver biopsy."" Received fresh for frozen section in a small container is a. 1.1 x 0.5 x 0.3 cm, brown, irregular, soft tissue fragment. Frozen section. control. (1 cassette. 2. ""Fundic nodule."" Received in format in in a small container is a 1.4 x 1.0. x. 0.7 cm, tan, partially encapsulated, soft tissue fragment. A possible. resection margin is identified and inked blue. Sectioning reveals gray-yellow,. solid and focally calcified cut surfaces. (1 cassette. 3. ""Cervical esophageal margin."" Received in formalin in a small container is. a 1.8 cm in (ength x 3.3 cm in diameter, unoriented segment of esophagus. The. specimen contains one opened end and one stapled end. Both the adventitial and. mucosal surfaces are unremarkable. Bisected. 3A. Opened end submitted en face. 38. Stapled end shaved and submitted en face. Staple Line retained. 4. ""Mid right beriesophageal lymph node. Received in formal in in a small. container are two anthracotic lymph nodes (0.7 and 0.9 cm), both of which are. partially covered by adipose tissue. Both bisected and one inked blue. (1. cassette , Fat retained. 5. ""Proximal stomach distal esophagus."" Received in formalin in a small. container is an esophagectomy specimen consisting of: Distal esophagus (7.1. cm. in (ength), proximal stomach (5.6 cm in length) and attached. periesophageal/perigastrio adipose. There is a 4.1 x 3.6 cm flat, ulcerated. mass located within the GE junction, 5.9 cm from the proximal margin and 4.0. cm from the distal margin. The mass occupies 80% of the lumen's circunference. and invades through the adventitia, 0.2 cm away from the inked adipose. margin. The esophageal and gastric walls surrounding the mass are focally. indurated and thickened up to 1.4 cm. Found within the distal esophagus is a. 1.5 x 1.2 cm ill-defined area of ulcerated mucosa, located 1.2 cm proximal to. the mass and 3.4 cm from the nearest margin (proximal). Sectioning of this. area reveals unremarkable cut surfaces. The remaining GE junction, esophageal. and gastric mucosa are all unremarkable. Multiple possible lymph nodes are. identified up to 2.1 cm in greatest dimension. 5A-D. Mass with greatest depth of invasion. PREVIOUS DIAGNOSIS INQUIRY. 3. SEX: M. 5E. Cardia adjacent to mass (thickened wall). 5F. Esophagus adjacent to mass (thickened wall). 5G. Focal ulceration in mid esophagus. 5H. Seven possible Lymph nodes submitted whole. 51. Six possible Lymph nodes submitted whole. 5J. Seven possible Lymph nodes submitted whole. 5k. Seven possible lymph nodes submitted whole. 5L. Four possible lymph nodes submitted whole. 5M. Two possible lymph nodes both bisected and one inked blue. (. 5N. Two possible Lymph nodes both bisected and one inked blue. (. I. 50. Two possible Lymph nodes both bisected and one inked blue. (. 5P. One possible Lymph node serially sectioned. FROZEN SECTION REPORT. 1. Bile duct hamartoma. I. have reviewed and interpreted the frozen section. material at the time it was requested. Permanent sections confirm frozen section report. PROCEDURE: SPMI. ESOPHAGUS CARCINOMA. Gastroesophageal junction. SIZE: 4.1 x 3.6 cm. TREATED PREOPERATIVELY: No. TYPE OF CARCINOMA: Adenocarcinoma, no Barrett's mucosa identified. DEPTH OF INVASION: Adventitia and perigastric adipose tissue. NUMBER OF POSITIVE LYMPH NODES / TOTAL NUMBER OF NODES EXAMINED: 21/37. DISTANT METASTASIS: Unknown. RESECTION MARGIN INVOLVED: 13 N3. PREVIOUS DIAGNOSIS INQUIRY. 4. SEX: M. PROCEDURE: SPDX. 1. Liver, biopsy: Bile duct hamartoma. Negative for neoplasm. 2. Stomach, fundus, biopsy: Calcified gastrointestinal stromal tumor (1.4cm),. low mitotic rate, histologically benign. Tumor extends to cauterized margin. 3 and 5. Distal esophagus and proximal stomach, resection: Invasive. moderately differentiated adenocarcinoma (4.1 cm) extending into the. paraesophages! soft tissue. Twenty-one of thirty-six lymph nodes positive for. metastatic adenocarcinoma. Surgical margins negative. Please see template for. details. 4. Lymph node, right mid paraesophageal, resection: One Lymph node negative. for neoplasm. the signing staff pathologist, have personally. examined and Interpreted the slides from this case. END OF PREVIOUS DIAGNOSIS INQUIRY.",T3,N3,M0,T3N3M0
TCGA-A7-A4SE,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Breast, left, segmental mastectomy: Invasive ductal carcinoma,. grade 3, size 2.8 cm in greatest dimension; negative margins of. excision. B. Sentinel lymph node #1, biopsy: Two negative lymph nodes (0/2) . C. Sentinel lymph node #2, biopsy: One negative lymph node (0/1) . D. Breast, medial to left segmental mastectomy, biopsy: Negative for. malignancy or atypia. E. Breast, inferior to left segmental mastectomy, biopsy: Negative. for malignancy or atypia. F. Breast, posterior to left segmental mastectomy, biopsy: Skeletal. muscle; negative for malignancy or atypia. G. Breast, lateral to left segmental mastectomy, biopsy: Negative. for malignancy or atypia. H. Breast, superior to left segmental mastectomy, biopsy: Negative. for malignancy or atypia. Microscopic Description: Invasive Carcinoma. Histologic type: Ductal. Histologic grade: 3. Overall grade: 9/9. Architectural score: 3. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : 2.8 cm. Specimen margins: Negative. Vessel invasion: Not identified. Calcification: Present. Ductal carcinoma in situ: Histologic pattern: Solid. Nuclear grade: 3. Central Necrosis: Present. 8 DCIS of total tumor (if mixed) : 1%. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative. Calcification: Negative. Description of non-tumorous breast: Fibrocystic changes, with ductal. hyperplasia of usual type, a minute fibroadenoma, and apocrine. metaplasia, with calcification. Comments: Sentinel lymph nodes negative, confirmed by negative. cytokeratin immunostaining of blocks BFS1 and CFS2. Cytokeratin. staining was also performed on one block from part E, to exclude. involvement by carcinoma. Prior biopsy site identified. Extensive. central tumor necrosis is present. Prognostic markers: See core biopsy report,. 4x8, 14x2, 15x2, 20x3. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA.: Specimen. A. Left Breast. B. Left axillary sentinel lymph node #1, hot, blue,. C. Left axillary sentinel lymph node #2, not hot, not blue, but. palpable. D. Medial to segmental mastectomy left breast. E. Inferior to segmental mastectomy left breast. F. Posterior to segmental mastectomy left breast. G. Lateral to segmental mastectomy left breast. H. Superior to segmental mastectomy left breast. Clinical Information. Left breast cancer. Intraoperative Consultation. B) Left axillary sentinel node #1: Two negative lymph nodes (0/2). C) Left axillary sentinel node #2, biopsy: One negative lymph node. (0/1). Gross Description. A. Received unfixed for tissue procurement, labeled left breast. segmental mastectomy single long lateral, double long anterior, is. a 100 gram breast segmental excision that is 9 cm from anterior to. posterior, 7.5 cm medial to lateral, and 3 cm from superior to. inferior. The superior surface is inked black, and a section is. submitted for tissue procurement as requested. An additional. section of uninvolved fatty tissue is submitted from the posterior. aspect, for procurement. Additional sections after fixation. The. superior surface is inked black, medial green, lateral yellow,. inferior blue. There is a tan, firm, lobulated mass lesion in the. mid-portion of the specimen, 3.0 x 2.0 x 1.7 cm. This is 3 mm from. the green-inked medial margin (closest margin). All other margins. are grossly greater than 1 cm from the mass. Representative. sections: 1 Anterior margin, 2 adjacent section with margin, 3/4/5. contiguous tumor, possible biopsy cavity in 5, 6/7/8 contiguous,. 9-10 random medial and lateral, possible close margin, 11-14. additional posterior sections, with last section = posterior. margin. B. Received unfixed for frozen section, labeled left axillary. sentinel node #1, are 2 adjacent and attached lymph nodes, 0.9 cm. in greatest dimension each, bisected and entirely submitted in. blocks B1 and B2. C. Received unfixed for frozen section, labeled left axillary. sentinel node #2, is a single lymph node, 1.4 x 1.3 x 1.0 cm,. bisected and entirely submitted in 2 blocks. D. Received fresh and subsequently fixed in formalin labeled ""medial. to segmental mastectomy left breast ""is a 5.2 x 3.5 x 1.5 cm yellow. lobular fatty tissue fragment which has a suture designating the. new medial border. The surface is inked and the specimen is. sectioned to show yellow lobular fatty cut surface with minimal. fibrous tissue present. No discrete residual tumor is grossly. identified. The specimen is entirely submitted labeled 1 through. 10. E. Received fresh and subsequently fixed in formalin labeled. ""inferior to segmental mastectomy left breast ""is a 4.3 x 2.7 x. 2.2. cm yellow lobular fatty tissue fragment which has a suture. designating new inferior border. The surface is inked and the. specimen is sectioned to show yellow lobular fatty cut surface with. minimal fibrous tissue present. No residual tumor is grossly. identified. The specimen is entirely submitted labeled 1 through 9. F. Received fresh and subsequently fixed in formalin labeled. ""posterior to segmental mastectomy left breast ""is a 3.2 x 2.5. x. 1.0 cm yellow lobular fatty tissue fragment which is partially. covered with skeletal muscle. There is a suture designating the new. posterior margin. The surface is inked and the specimen is. sectioned to show a yellow lobular fatty cut surface with scanty. fibrous tissue present. The specimen is entirely submitted in 5. cassettes. G. Received fresh and subsequently fixed in formalin labeled ""lateral. to segmental mastectomy left breast ""is a 4.3 x 3.5 x 1.5 cm yellow. lobular fatty tissue fragment. There is a suture designating the. new lateral border. The surface is inked and the specimen is. sectioned to show yellow lobular fatty cut surface with minimal. fibrous tissue present. No residual tumor is grossly identified. The specimen is entirely submitted in 9 cassettes. H. Received fresh and subsequently fixed in formalin labeled. ""superior segmental mastectomy left breast ""is a 4.3 x 2.2 x 1.0. cm. yellow lobular fatty tissue fragment which has a suture designating. the new superior border. This is inked and the specimen is. sectioned to show yellow lobular fatty cut surface with scanty. fibrous tissue present. The specimen is entirely submitted in 4. cassettes.",T2,N0,M0,T2N0M0
TCGA-AG-3893,"Diagnosis: This is a moderately to poorly differentiated adenocarcinoma of the rectosigmoidal junction of. histopathological differentiation grade G2 to 3, with ulceration of the inner tumor surface, with. peritumorous chronic recurrent secondary inflammation with an acute inflammatory flare, with. carcinomatous lymphangitis, with tumor infiltration of the parietal layers into the subserous fatty. connective tissue, with a regional lymph node metastasis (1/14) and tumor-free overview slices. from all other resection material portions described. According to the section preparations available, the tumor spread of the rectosigmoidal. carcinoma corresponds to a tumor stage of pT3, pN1 (1/14), MX, L1, R0. Tumor classification: ICDO-DA M8140/3, G2 to 3. 8+.",T3,N1,M0,T3N1M0
TCGA-A8-A079,"Diagnosis: Ablated breast sample with a multifocal poorly differentiated invasive ductal. carcinoma (tumor diameter: 7 cm, 2.2 cm and 1.7 cm), the largest tumor focus with. focal ulceration of the skin and circumscribed intraductal spread. Focal. angioinvasion. Tumor-free dorsal resection margin. Together with the preliminary finding, this gives rise to the following tumor. classification: NOS, G III, pT4b(mult)N3aL1V0R0.",T4,N3,M0,T4N3M0
TCGA-AA-A02H,"Internal Sample. Diagnosis: This is a moderately to poorly differentiated adenocarcinoma of the colon (G2 to 3) with. infiltration of all parietal layers and vascular infiltration (L1, V1). as well as six lymph node conglomerate metastases (6/12, N2). and in II a gall bladder preparation with parts of an adenocarcinoma, possibly to be. interpreted as a further spread of the colon cancer described. in III parts of the liver with parts of the carcinoma described.",T3,N2,M1,T3N2M1
TCGA-DK-A1AF,"Med. Rer #. F. Urology. Clinical Diagnosis & History: Bladder cancer T2 disease. Specimens Submitted: 1: SP: Bladder, urethra, uterus, ovaries, fallopian tubes, perivesicle nodes and anterior vaginal wall; radical cystectomy, total. hysterectomy with bilateral salpingo-cophorectomy. 2: SP: Lymph nodes, right pelvic; dissection. 3: SP: Lymph nodes, left pelvic; dissection. 4: SP: Ureter, distal, right; resection. 5: SP: Ureter, right; resection. DIAGNOSIS: 1. SP: Bladder, urethra, uterus, ovaries, fallopian tubes, perivesicle nodes and anterior vaginal wall; radical cystectomy,. total hysterectomy with bilateral salpingo-oophorectomy: Tumor Type: Invasive urothelial carcinoma, NOS. Histologic Grade: High grade. Pattern of growth of the Non-Invasive component: Flat (in situ carcinoma). Pattern of growth of the Invasive component: Infiltrating. Tumor Multicentricity: Identified. Bladder Local Invasion: Perivesical soft tissues. Extravesical Tumor Extension: Right ureter uninvolved. Left ureter uninvolved. Urethra uninvolved. Vascular Invasion: Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Mucosa: Exhibiting ulceration. Exhibiting foreign body reaction. Female Genital Organs: Show no pathologic abnormalities. Perivesical Lymph Nodes: Not identified. The Pathologic Stage is (AJCC 2002): pT3 (Invasion of perivesicle soft tissue). 2. SP: Lymph nodes, right pelvic; dissection: Lymph Node Dissection: Metastatic urothelial carcinoma. Number of lymph nodes examined: 6. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 1.1cm. Size of the largest metastatic focus : 0.5 cm. Extranodal extension is identified. 3. SP: Lymph nodes, left pelvic; dissection: Lymph Node Dissection: Metastatic urothelial carcinoma. Number of lymph nodes examined: 8. Number of lymph nodes with metastatic disease: 3. Size of the largest lymph node involved by tumor: 1.2cm. Size of the largest metastatic focus : 1.2 cm. Extranodal extension is identified. 4. Ureter, distal, right; resection: - Partially denuded urothelium with mild to moderate urothelial atypia. 5. SP: Ureter, right; resection: - Segment of benign ureter. LATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Result Speci. al Stain. Comment. RECUT. Gross Description: 1. The specimen is received fresh labeled, Bladder, uterus, cervix, urethra, bilateral tubes and ovaries, anterior vaginal wall,. perivesical lymph nodes"". It consists of a cystohysterectomy with bilateral salpingo-oophorectomy specimen measuring 20 cm. from superior to inferior, 10 cm laterally and 5.0 cm from anterior to posterior. The uterus measures 6.5 cm superior to inferior, 5.5. cm from cornu to cornu, and 3.0 from anterior to posterior. There is a subserosal calcified nodule at the fundus of the uterus. measuring 1.1 cm in greatest dimension. The right ovary measures 2.3 x 1.5x1.5 cm. There is an adherent clear thin walled cyst. measuring 4.2 x 3.8 x 2.5 cm. The right fallopian tube measures 7 cm in length with a normal fimbriated end and a pinpoint lumen. The left ovary measures 2.5 x 1.8 x 1.5 cm. The left fallopian tube measures 7.5 cm in length with a normal fimbriated end and a. pinpoint lumen. The right aspect of the bladder is inked green and the left aspect of bladder is inked blue. The uterus is inked. black posteriorly. The cervix measures 2 cm in length. The ectocervix measures 4.5 cm in diameter. The bladder is opened along. the anterior midline to reveal an oval, ulcerated, fungating lesion measuring 2.0 x 1.5 cm in the trigone area and the posterior wall. The lesion appears to be involving the both ureteral orifices. Both ureters are probed and appear blocked. The lesion is sectioned. and revealed that the lesion is invading deeply into the muscularis layer. Extension to the inked fat is grossly not identified. The. remaining bladder mucosa is pink and edematous. Discrete perivesical lymph nodes are grossly not identified. The entire lesion is. submitted and the representative sections from the rest of the bladder are submitted. TPS is submitted. Photographs are taken. Summary of sections: RUM - right ureter margin. LUM - left ureter margin. UTHM - urethral margin. L - lesion. LUO - left ureter orifice. RUO - right ureter orifice. LP - left posterior wall. LA - left anterior wall. RP - right posterior wall. RA - right anterior wall. DOM dome. F - perivesical fat. AC - anterior cervix. PC - posterior cervix. AEM - anterior endometrium. PEM - posterior endometrium. RO - right ovary and cyst. RT - right tube. LO - left ovary. LT - left tube. VCM - vaginal cuff margin. 2.) The specimen is received in formalin, labeled ""Right pelvic lymph nodes"" and consists of a 3.8 x 3.0 x 1.0 cm aggregate of. lobulated, focally hemorrhagic, yellow adipose, which is sectioned to reveal seven, firm, tan-pink lymph nodes, ranging from 0.3 to. 2.2 cm, in greatest dimension. The larger lymph nodes are bisected and all lymph nodes are entirely submitted. Summary of sections: LN - lymph nodes. BLN - bisected lymph nodes. 3.) The specimen is received in formalin, labeled ""Left pelvic lymph nodes"" and consists of a 5.3 x 3.8 x 1.5 cm aggregate of. lobulated, focally hemorrhagic, yellow adipose, which is sectioned to reveal nine, firm, tan-pink lymph nodes, ranging from 0.3 to. 2.0 cm, in greatest dimension. The larger lymph nodes are bisected and all lymph nodes are entirely submitted. Summary of sections: LN - lymph nodes. BLN - bisected lymph nodes. 4.) The specimen is received in formalin, labeled ""Right distal ureter"" and consists of an unoriented, 0.3 cm length and 0.6 cm in. diameter portion of ureter, which is submitted in toto. Summary of sections: RDU - right distal ureter. 5.) The specimen is received in formalin, labeled ""Right ureter, clip and is proximal margin"" and consists of an oriented, 2.3 cm in. and 0.4 cm in diameter portion of ureter surrounded by a 0.4 cm thick adipose tissue. A clip marks the proximal margin,. which length is inked in blue and the opposite margin is inked in black. The specimen is serially sectioned from the proximal margin to the. opposite margin and is entirely submitted in sequential order. Summary of sections: PM - proximal margin. SS - sequential sections. OM - opposite margin. Summary of Sections: Part 1: SP: Bladder, urethra, uterus, ovaries, fallopian tubes, perivesicle nodes and anterior vaginal wall; radical. cystectomy, total hysterectomy with bilateral salpingo-oophorectomy. Block. Sect. Site. PCs. 1. AC. 1. 1. AEM. 1. 1. DOM. 1. 1. F. 1. 5. 5. 1. LA. 1. 1. LO. 1. 1. LP. 1. 1. LT. 1. 1. lum. 1. 1. PC. 1. 1. PEM. 1. 1. RA. 1. 1. RO. 1. 1. RP. 1. 1. RT. 1. 1. rum. 1. 1. RUM 2. 1. 1. RUO. 1. 1. uthm. 1. 1. VCM. 1. Part 2: SP: Lymph nodes, right pelvic; dissection. Block. Sect. Site. PCs. 3. BLN. 6. 1. LN. 4. Part 3: SP: Lymph nodes, left pelvic; dissection. Block. Sect. Site. PCs. 7. BLN. 14. 1. LN. 2. Part 4: SP: Ureter, distal, right; resection. Block. Sect. Site. PCs. 1. RDU. 1. Part 5: SP: Ureter, right; resection. Block. Sect. Site. PCs. 1. OM. 1. 1. PM. 1. 1. SS. 3.",T3,N2,M0,T3N2M0
TCGA-ZH-A8Y3,"Diagnosis: A: Liver, anterior segment 2-3 edge, biopsy. - No carcinoma identified. - Intraoperative diagnosis confirmed. B: Liver, posterior segment, 2-3 edge, biopsy. Positive for adenocarcinoma. - - Intraoperative diagnosis confirmed 816013. C: Liver, right, partial hepatectomy. Tumor histologic type: Adenocarcinoma, consistent with. intrahepatic cholangiocarcinoma (see comment). Histologic grade: Well to moderately differentiated (grade 1-2. of 4). Tumor growth pattern (per AJCC staging manual, 7th ed. ) : Mass. forming growth pattern. Tumor size and extent : 6.2 cm in largest dimension (gross. measurement). Focality: Unifocal. Tumor location: Right hepatic lobe. Vascular invasion: Present, tumor invades into portal vein. branches and into vena cava (see also specimen D). Perineural invasion: Identified in specimen D. Invasion of liver capsule: Present; tumor invades into but not. through the liver capsule. Necrosis: No significant tumor necrosis present; tumor is 90%. viable, with prominent desmoplastic stroma. Margins: - Parenchymal resection margins: Positive for carcinoma. - Vascular resection margins: Negative for carcinoma. - Bile duct margin Indefinite for dysplasia, favor reactive. epithelial changes; negative for invasive carcinoma. Background liver parenchyma: Cholestasis and moderate periportal. inflammation; mild portal fibrous expansion; no cirrhosis. present. - Although some fibrosis surrounding larger bile ducts in the. vicinity of the tumor is present, it is not the concentric. (onion-skin type) fibrosis typically seen in primary sclerosing. cholangitis (PSC) The findings are not diagnostic for PSC. Correlation with clinical and radiographic findings is. recommended. Gallbladder : Unremarkable gallbladder without calculi; negative. for malignancy. Lymph nodes : One pericystic lymph node, negative for metastatic. carcinoma (0/1). AJCC stage (7th edition) : pT2a pNO. D: Liver, caval margin, resection. - Positive for adenocarcinoma. - Perineural invasion present. Comment. Immunohistochemical stains were performed on block C4 with the. following results: Cytokeratin 7: Strongly positive in adenocarcinoma. Cytokeratin 20: Negative in adenocarcinoma. CDX2: Negative in adenocarcinoma. Estrogen receptor: Negative in adenocarcinoma. GCDFP-15: Negative in adenocarcinoma. TTF-1: Negative in adenocarcinoma. Interpretation: While the staining pattern is not entirely. specific, it is compatible with an intrahepatic. cholangiocarcinoma in the appropriate clinical setting (if other. primary sites have been excluded) . The case has been discussed at. on. Intraoperative Consult Diagnosis: A frozen section was requested by Dr. in OR. FSA1: Liver, anterior segment, 2-3 edge, biopsy. - No evidence of malignancy. FSB1: Liver, posterior segment, 2-3 edge, biopsy. - Invasive adenocarcinoma. Drs. on. at. Frozen Section Pathologist: Clinical History: -year-old female with recent diagnosis of large central liver. mass with associated biliary and right portal vein occlusion. with associated periportal/upper abdominal adenopathy; outside. pathology shows rare atypical glands suspicious for malignancy. Gross Description: Received are four formalin-filled - containers. Container A: Received fresh for frozen section and additionally. labeled ""anterior segment 2-3 edge"" is a 3.2 X 1.6 X 0.5 cm. fragment of red/tan soft tissue that is frozen section entirely. as FSA1,. Container B: Received fresh for frozen section and additionally. labeled ""posterior segment 2-3 edge"" is a 2.2 X 1.0 X 0.5 cm. fragment of red/tan soft tissue that is frozen entirely as FSB1,. Container C: Specimen Type: right lobectomy. Specimen Weight: 630 grams. Measurement: 17 X 15 X 6 cm. Mass: A 5.3 X 5.0 X 3.8 cm white circumscribed, firm, fleshy. mass with peripheral extension to nearby ducts and surrounding. the ducts. Adjacent to the mass is a 1.5 X 0.7 X 0.5 cm area of. yellow soft discoloration. The total size including this yellow. area is 6.2 X 5.5 X 4.1 cm. The mass grossly abuts the capsule. and the blue inked parenchymal margin. On the capsule there is. an area of white discoloration that is inked black. This. area is adjacent to the mass. The tumor appears to invade into. portal vein branches. Adjacent liver tissue: green/brown mottled and congested. Capsule: The capsule is normal, purple/tan, smooth and. glistening. Comment: : The parenchymal resection margin is inked blue. Major portal vein/ hepatic vein: There is no gross evidence of. vascular invasion. Gallbladder: 9.9 X 2.7 X 1.1 cm. The serosa is purple/red,. smooth and glistening. The wall averages 0.4 cm thick and is. lined by a red velvety mucosa with diffuse yellow stippling. The. gallbladder contains a small amount of red thin bile. Stones are. grossly absent. One cystic duct lymph node is identified. measuring 1.4 X 0.7 X 0.4 cm. Block summary: C1 - hilar vascular margins and cystic duct. C2 - parenchymal stapled vascular margins. C3-C5 - mass with respect to blue inked parenchymal margin and. capsule. C6 - mass with extension. C7 - mass surrounding bile duct. C8 - mass surrounding bile duct. C9 - mass surrounding bile duct. C10 - mass with adjacent uninvolved. C11 - possible area of necrosis. C12 - uninvolved. C13 - gallbladder and cystic duct lymph node. Container D is additionally labeled ""margin caval. "" It holds a. 3.6 X 2.1 X 1 cm fragment of red/tan soft tissue that is inked,. serially sectioned and submitted entirely in blocks D1-D4,.",T2,N0,M0,T2N0M0
TCGA-BR-8365,"Case ID. Gross Description. Microscopic Description. Stomach segment, mucosa is. Adenocarcinoma of the stomach,. tuberous in the area of ten. G3, with the presence of signet. centimeters diameter, it seems to. cells; with adjacent tissues. be replaced by the tumor. No. invasion. visible invasion into muscularis. Fifteen examined lymph nodes. propria. demonstrated sinus histiocytosis. Fatty tissue lymph nodes are. Omentum - hyperemia. hyperemic. Diagnosis Details. Comme. nts. Tumor Features: Ulcerated, Tumor. STOMACH TISSUE CHECKLIST. Extent: Perigastric fat , Venous. Invasion: Absent, Margins: Specimen type: Subtotal gastrectomy. Absent, Treatment Effect: Tumor site: Fundus. Tumor size: 10 X 0 X 0 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Subserosa. Lymph nodes: 0/15 positive for metastasis. (Greater and lesser omentum 0/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None. Lateralit. y.",T3,N0,M0,T3N0M0
TCGA-21-1080,"Clinical History/Diagnosis: Not entered. Source of Specimen(s): A: L4 LN. B: R4 LN. C: LEVEL 7 LN. D: CYTO. E: L LEVEL 8 LN. F: LEVEL 7 LN. G: L LEVEL 10 LN. H:L LUNG. Gross Description: GROSS DESCRIPTION: Received fresh for frozen section evaluation is a 1031. gram, 22.0 x 12.5 X 6.0cm left pneumonectomy. It is covered by a red-purple focally. anthracotic stained pleura having a 7.5 x 7.5 X 0.8cm fragment of yellow-tan attached parietal. pleura in the superior segment of the lower lobe. There is up to 1.5cm of attached bronchus. and the bronchial margin is submitted for frozen section evaluation and the frozen section. residue is submitted in one block. On sectioning the lung at the junction of the upper and. lower lobes, there is a 9.5 X 7.5 X 6.5cm firm mass. This lies beneath the previously described. parietal pleura. The cut surfaces of the mass are tan to gray-tan, variegated, firm and nodular. with focal anthracotic stain. The margins are irregular. The remaining cut surfaces of the upper. lobe are red-purple, glistening and soft. On sectioning the lower lobe the cut surfaces range. from pink-red to golden yellow having focal areas of a yellow-tan exudate. There are several. palpable hilar lymph nodes, 1.0 to 2.0cm in greatest dimension. The cut surface of each is tan. to gray-black and focally anthracotic stained. A representative section of each lymph node is. submitted. Representative sections are submitted in thirteen blocks. DESIGNATION OF SECTIONS: 8FS - frozen section, bronchial margin, 8A to 8B - vascular. margin, 8C thru 8F - tumor with inked pleura, 8G thru 8H - random tumor sections, 8I -. random sections upper lobe, 8J thru 8K -random section lower lobe, 8L thru 8M - hilar lymph. nodes. SUMMARY OF SECTIONS: 8FS-1, 8A-3, 8B-1, 8C-1, 8D-1, 8E-1, 8F-1, 8G-1, 8H-1, 8I-2,. 8J-1, 8K-1, 8L-2, 8M-3. Final Diagnosis: DIAGNOSIS: 1. L4 LYMPH NODES: - TWO NEGATIVE LYMPH NODES (0/2). 2. R4 LYMPH NODE: - TWO NEGATIVE LYMPH NODES (0/2). 3. LEVEL 7 LYMPH NODE: - ONE NEGATIVE LYMPH NODE (0/1). 4. CYTOLOGY. 5. LEFT LEVEL 8 LYMPH NODE: - ONE NEGATIVE LYMPH NODE (0/1). 6. LEVEL L7 LYMPH NODES: - FIVE NEGATIVE LYMPH NODES (0/5). 7. LEFT LEVEL 10 LYMPH NODE: - ONE NEGATIVE LYMPH NODE (0/1). 8. LEFT LUNG: SYNOPTIC REPORT FOR LUNG CANCER. - A NEOPLASM IS PRESENT. - LOCATION OF TUMOR IS LEFT LUNG. - THE HISTOLOGIC CLASSIFICATION OF THE TUMOR IS SQUAMOUS CELL. (EPIDERMOID). CARCINOMA, KERATINIZING TYPE. - POORLY DIFFERENTIATED. - THE MAXIMUM DIMENSION OF THE TUMOR IS 9.5 CM. - LYMPHATIC INVASION BY TUMOR IS ABSENT. - VENOUS INVASION BY TUMOR IS ABSENT. - ARTERIAL INVASION BY TUMOR IS ABSENT. - INVASION INTO BUT NOT THROUGH THE PLEURA BY TUMOR IS ABSENT. - INVASION THROUGH THE PLEURA BY TUMOR IS ABSENT. - TUMOR NECROSIS IS MODERATE. - THE SURGICAL MARGINS ARE UNINVOLVED BY TUMOR. - THE NON-NEOPLASTIC LUNG TISSUE SHOWS PNEUMONIA WITH ABSCESS. - THE TOTAL NUMBER OF NODES EXAMINED IS: 5. - THE TOTAL NUMBER OF POSITIVE NODES IS: 0. STAGING DATA. T2. N-0.",T2,N0,M0,T2N0M0
TCGA-AA-3518,"Diagnosis / Diagnoses: Ileocolic resectate under inclusion of a moderately differentiated adenocarcinoma of the. colorectal type, located in the cecum and of max. 5.5 cm in size, with infiltration of the. pericolic fatty tissue. No regional lymph node metastases. Small and large intestinal. resection margins tumor-free. Mesenteric resection margin tumor-free. A secondary. finding is two submucosal lipomas in the ascending colon. Tumor stage thus: pT3 pNO (0/27) pMX; G2, L0, V0, R0.",T3,N0,M0,T3N0M0
TCGA-E2-A14N,"SPECIMENS: A. SENTINEL NODE #1 RIGHT AXILLA. B. RIGHT BREAST. C. AXILLARY CONTENT. D. LEFT BREAST REDUCTION. SPECIMEN(S): A. SENTINEL NODE #1 RIGHT AXILLA. B. RIGHT BREAST. C. AXILLARY CONTENT. D. LEFT BREAST REDUCTION. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA, FSA: Sentinel lymph node #1 right axilla: Smears (touch imprint)-Negative for tumor cells, (frozen section)-. Positive for carcinoma. By Dr, called to Dr. at. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1, RIGHT AXILLA. Received fresh and labeled ""sentinel node #1 right axilla"" is a 2.8x1.0x1.2 2cm lymph node. There is blue dye staining. present. The specimen is sectioned and a touch prep is performed. A portion of the lymph node is submitted for. frozen section. The lymph node is submitted in toto as follows: FSA1: frozen section of portion of lymph node. A2-A4: remainder of lymph node. B. RIGHT BREAST,MASTECTOMY: Received is a 1,321gn right mastectomy specimen measuring 23x23x5.8c Margin of specimen oriented with a. stich indicating the lateral margin . In the medial portion of the specimen is an ellipse of tan skin measuring 6.7cm. in length with a diameter of 3.1cm. Eccentrically located on the skin is a healed scar measuring 5.5cm in length. The areola is present and measures 4.0cm in length with a width of 3.0cm. The nipple is everted and is 1.0cm. The. axillary tail is 6.5x5.0x1.5cm. The anterior surface of the specimen is inked blue, the posterior surface is inked black. and the specimen is serially sectioned. In the upper inner quadrant is a well circumscribed white-tan mass. measuring 3.8x3.2x2.9c which is located 0.5 cm from the nearest deep margin. The central portion of the mass. shows areas of hemorrhage and possible necrosis. 4.6cm lateral from the mass, located approximately 2.0cm from. the areola region, is a hemorrhagic white-tan firm mass measuring 2.5x2.0x1.8cm. It is located 2.5cm from the deep. margin. The remainder of the specimen consists of primarily adipose tissue. A few possible lymph nodes are found. within the axillary tail. Multiple sections are submitted and labelled as follows: follows: B1-10:sections from the larger tumor (medial). B11-14: sections from the smaller tumor near nipple area. B15-16 - sections from upper inner quadrant. B17-18: sections from upper outer quadrant. B19-20: sections from lower outer quadrant. B21-22: sections from lower inner quadrant. B23-24 sections from nipple and areolar area. B25-B26: possible lymph nodes. C. AXILLARY CONTENTS. Received in formalin and labeled ""axillary contents levels 1&2"" is a piece of adipose tissue, 7.3 x 5.6 x 0.9 cm. Multiple lymph nodes are found, ranging in size from 0.1 to 2.8cm. Lymph nodes are submitted in toto as follows: C1: 5 possible lymph nodes. C2-C6: 4 possible lymph nodes, each. C7: 2 possible lymph nodes. C8: 3 possible lymph nodes. C9-C10: 1 bisected lymph node, each. C11-C13: 1 lymph node each. D. LEFT BREAST REDUCTION: Received in formalin and labeled "", Left Breast Reduction mammoplasty"". The specimen consists of primarily. adipose tissue, little fibrous breast tissue is found. No masses or lesions are seen. Representative sections are. submitted as follows: D1 skin and subjacent adipose tissue, D2-D3 fibrous tissue. DIAGNOSIS: A. SENTINEL NODE #1, RIGHT AXILLA: METASTATIC CARCINOMA TO ONE OUT OF ONE LYMPH NODE, CONSISTENT WITH METASTASIS FROM. PRIMARY BREAST CARCINOMA. (1/1) see note. B. RIGHT BREAST, MASTECTOMY SPECIMEN: - INVASIVE DUCTAL CARCINOMA, SBR GRADE II WITH GEOGRAPHIC AREAS OF NECROSIS,. MULTICENTRIC. - SIZE OF TUMOR: MEDIAL ASPECT OF BREAST-3.8 x 3.2x2.9 CM. CENTRAL AREA - SIZE OF TUMOR-2.5 x 2.0 x 1.8 CM. - MARGINS OF RESECTION-NEGATIVE FOR TUMOR. - FOCAL COLUMNAR CELL CHANGE. - TWO AXILLARY LYMPH NODES-NEGATIVE FOR TUMOR (0/2). C. AXILLARY CONTENTS, RESECTION: - THIRTY-FIVE AXILLARY LYMPH NODES-NEGATIVE FOR TUMOR (0/35). D. LEFT BREAST REDUCTION: BREAST TISSUE WITH INCLUDED SKIN TISSUE-NO SPECIFIC PATHOLOGIC CHANGES-NEGATIVE FOR. TUMOR. NOTE: In specimen A,(A1) size of lymph node measured 2.8x1.0x1.2cm and metastatic tumor only seen on the. portion of lymphnode submitted for frozen and permanent section in an area measuring 5.0x2.5mm. The remainder. of the lymph node submitted as A2-A4 are negative for metastatic tumor. SYNOPTIC REPORT - BREAST. Specimens Involved. Specimens: A: SENTINEL NODE #1 RIGHT AXILLA. B: RIGHT BREAST. C: AXILLARY CONTENT. D: LEFT BREAST REDUCTION. Specimen Type: Mastectomy. Needle Localization: Laterality: Right. Invasive tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Specimen size: Size of Invasive focus 3.8cm. Additional dimensions: 3.2cm x 2.9cm. Tumor Site: Upper inner quadrant. Central. Margins: Negative. Distance from closest margin: 0.5cm. Margin: deep. Tubular score: 3 (<10% tubule). Nuclear grade: 3. Mitotic score (Olympus 40x): 3 (> -13/10 hpf). Modified Scarff Bloom Richardson Grade: III (8-9 points). Necrosis: Present. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node and axillary dissection. Lymph node status: Positive 1 / 38. Micrometastases: DCIS PRESENT?. Pathological staging (pTN): pT2N1. CLINICAL HISTORY: year old with right breast ca. PRE-OPERATIVE DIAGNOSIS: Right breast ca. ADDENDUM: BREAST ER/PR - 1. SPECIMEN. Type: Other. Mastectomy. Block Number: B9. HORMONE RECEPTOR STATUS. Laboratory: Estrogen Receptor: Negative. Allred Score: 0 = Proportion Score 0 + Intensity Score 0. Progesterone Receptor: Negative. Allred Score: 0 = Proportion Score 0 + Intensity Score 0. The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the proportion score (0. =. no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of cells staining, 4 = 31-60% of. cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak intensity of staining, 2 = intermediate. intensity of staining, 3 = strong intensity of staining), with a scoring range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score of less than or. equal to 2. Methodology: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalir. CT) for no less than 8 and TC longer than 24 hours. Antibody and Assay Methodology: Mouse anti-human ER ana. PR,. Comment: This assay can be used to select invasive breast cancer patients for hormone therapy (1). ER and PR analysis was performed on this case by immunohistochemistry utilizing the ER (ER 1D5, 1:100) and PR. (PGR 136, 1:100) antibody provided by. following the manufacturer's instructions listed in the package insert. This assay was not modified, and adherence to all instruction and guidelines were strictly followed. Interpretation of. the ER/PR immunohistochemical staining characteristics is guided by published results in the medical literature (1),. information provided by the reagent manufacturer and by internal review of staining performance within Pathology. Department. 1. Harvey JM, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for. predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 17:1474-1481, 1999. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimens Involved. Specimens: B: RIGHT BREAST. HER2 Status Results, Immunohistochemistry Evaluation. SPECIMEN. Surgical Excision. Block Number: Block. B9. Interpretation: Negative. Intensity: 0. % Tumor Staining: 0%. FISH Ordered NO. METHODOLOGY. Methodology: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin. for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Rabbit anti-human HER2,. HerceptestTM (FDA-approved test kit), (. A). Control Slides Examined: External kit-slides. provided by manufacturer (cell lines with high, low and negative HER2 protein expression), and in-house known. HER2 amplified control tissue were evaluated along with the test tissue. These control slides run along side of this. patient's sample showed appropriate staining. Adequacy of Specimen: Adequate, well preserved, clear-cut invasive. carcinoma identified for HER2 evaluation. Scoring Criterion and Scoring System: IHC Level of Expression(Score /Tumor Cell Membrane Staining Pattern. Negative (0)/Absence of Staining. Negative (1+)/Faint Incomplete membrane Staining, >10% of Cells. Equivocal (2+)/Weak complete membrane Staining, >10% of Cells. Positive (3+)/Strong complete membrane Staining, >10% of Cells. Equivocal Category for HER2 IHC results: A HER2, 2+ staining result that is interpreted as equivocal may not. indicate gene amplification. A FISH test for HER2 gene amplification will be ordered for all HER2 IHC 2+ results. COMMENT. This assay can be used to select invasive breast cancer patients for Trastuzumab (Hereptin) therapy (1,2). Clinical. Trials have shown that Trastuzumab substantially increases the likelihood for an objective response and overall. survival for patients with metastatic HER2-positive breast cancer, regardless of whether HER2 tumor status was. determined as IHC 3+ or FISH positive. Trastuzumab added to adjuvant chemotherapy substantially increase. disease-free survival and decreases the risk of disease recurrence by about 50% for patients with early-stage HER2. protein over-expressed or gene amplified invasive breast cancer (3). HER2 analysis was performed on this case by immunohistochemistry utilizing the FDA approved Dako HercepTes. (TM) test kit following the manufacturer's instructions listed in the package insert. This assay was not modified, and. adherence to all instruction and guidelines were strictly followed. Interpretation of the HER2 immunohistochemical. staining characteristics is guided by published results in the medical literature (4), information provided by the. reagent manufacturer and by internal review of staining performance within the Pathology Department. HER2 TEST VALIDATION. This HER2 immunohistochemical assay has been validated according to the recently revised recommendations and. guidelines from the NCCN HER2 testing in Breast Cancer Task Force, and the jointly issued recommendations and. guidelines from ASCO and the CAP (5). 80 randomly selected breast cancer samples were tested for HER2 by IHC. as outline above and interpreted as, negative (score 0/1+) equivocal (score 2+) and positive (score 3+) without. knowledge of the previous reported results. These cases were also blindly read using two different FISH assay as amplified or non-amplified and the. HER2/CEP17 ratios were recorded. After analyzing these results, there was 100% concordance between the IHC. and FISH results for cases that were interpreted as either positive or negative by IHC. 9 of the 80 cases were. interpreted as equivocal by IHC and of these 3/9 (33%) were non-amplified by FISH and 6/9 (66%) were found to be. amplified. The Pathology Department Immunohistochemistry laboratory takes full responsibility for this tests performance. and has programs in place to regularly monitor the proficiency and the interpretation of HER2 assays. The. laboratory also participates in external quality assurance HER2 programs including the CAP proficiency testing. program. REFERENCE. 1. Carlson RW, Anderson BO, Burstein HJ, et al., NCCN breast cancer clinical practice guidelines in oncology. J. Natl Compr Canc Netw. 2005;3:238-289. 2. Carlson RW, Brown E, Burstein HJ, et al., NCCN Task Force Report: adjuvant therapy for breast cancer. J Natl. Compr Canc Netw. 2006;4:S1-S26. 3. Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive. breast cancer. N Eng J Med 2005;353(16):1673-84. 4. Leong ASY, Formby M, Haffajee Z, et al. Refinement of immunohistologic parameters for Her2/neu scoring. validation by FISH and CISH. Appl Immunohistochem Mol Morphol. 2006;14:384-389. 5. Wolff AC, Hammond EH, Schwartz JN, et al., American Society of Clinical Oncology/College of American. Pathologists Guideline Recommendations for Human Epidermal Growth Factor Recepto 2 Testing in Breast Cancer. Arch of Path and Lab Med 2007; 131:18-43. Immunostain results done on the smaller second tumor (section B11) are as follows: ER: Negative (0%). PR: Negative (0%). SYNOPTIC REPORT - BREAST HER-2 RESULTS. HER2 Status Results, Immunohistochemistry Evaluation. SPECIMEN. Surgical Excision. Block Number: Block. B1. Interpretation: Equivocal. Intensity: 2+. % Tumor Staining: 20%. FISH Ordered YES DATE. METHODOLOGY. Methodology: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin. d,. for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Rabbit anti-human HER2,. HerceptestTM (FDA-approved test kit),. Control Slides Examined: External kit-slides. provided by manufacturer (cell lines witn nigh, low and negauve HER2 protein expression), and in-house known. HER2 amplified control tissue were evaluated along with the test tissue. These control slides run along side of this. patient's sample showed appropriate staining. Adequacy of Specimen: Adequate, well preserved, clear-cut invasive. carcinoma identified for HER2 evaluation. Scoring Criterion and Scoring System: IHC Level of Expression(Score)/Tumor Cell Membrane Staining Pattern. Negative (0)/Absence of Staining. Negative (1+)/Faint Incomplete membrane Staining, >10% of Cells. Equivocal (2+)/Weak complete membrane Staining, >10% of Cells. Positive (3+)/Strong complete membrane Staining, >10% of Cells. Equivocal Category for HER2 IHC results: A HER2, 2+ staining result that is interpreted as equivocal may not. indicate gene amplification. A FISH test for HER2 gene amplification will be ordered for all HER2 IHC 2+ results. COMMENT. This assay can be used to select invasive breast cancer patients for Trastuzumab (Hereptin) therapy (1,2). Clinical. Trials have shown that Trastuzumab substantially increases the likelihood for an objective response and overall. survival for patients with metastatic HER2-positive breast cancer, regardless of whether HER2 tumor status was. determined as IHC 3+ or FISH positive. Trastuzumab added to adjuvant chemotherapy substantially increase. disease-free survival and decreases the risk of disease recurrence by about 50% for patients with early-stage HER2. protein over-expressed or gene amplified invasive breast cancer (3). HER2 analysis was performed on this case by immunohistochemistry utilizing the FDA approved Dako HercepTest. (TM) test kit following the manufacturer's instructions listed in the package insert. This assay was not modified, and. adherence to all instruction and guidelines were strictly followed. Interpretation of the HER2 immunohistochemical. staining characteristics is guided by published results in the medical literature (4), information provided by the. reagent manufacturer and by internal review of staining performance within the Pathology Department. HER2 TEST VALIDATION. This HER2 immunohistochemical assay has been validated according to the recently revised recommendations and. guidelines from the NCCN HER2 testing in Breast Cancer Task Force, and the jointly issued recommendations and. guidelines from ASCO and the CAP (5). 80 randomly selected breast cancer samples were tested for HER2 by IHC. as outline above and interpreted as, negative (score 0/1+) equivocal (score 2+) and positive (score 3+) without. knowledge of the previous reported results. These cases were also blindly read using two different FISH assay as amplified or non-amplified and the. HER2/CEP17 ratios were recorded. After analyzing these results, there was 100% concordance between the IHC. and FISH results for cases that were interpreted as either positive or negative by IHC. 9 of the 80 cases were. interpreted as equivocal by IHC and of these 3/9 (33%) were non-amplified by FISH and 6/9 (66%) were found to be. amplified. The Pathology Department Immunohistochemistry laboratory takes full responsibility for this tests performance. and has programs in place to regularly monitor the proficiency and the interpretation of HER2 assays. The. laboratory also participates in external quality assurance HER2 programs including the CAP proficiency testing. program. REFERENCE. 1. Carlson RW, Anderson BO, Burstein HJ, et al., NCCN breast cancer clinical practice guidelines in oncology. J. Natl Compr Canc Netw. 2005;3:238-289. 2. Carison RW, Brown E, Burstein HJ, et al., NCCN Task Force Report: adjuvant therapy for breast cancer. J Natl. Compr Canc Netw. 2006;4:S1-S26. 3. Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive. breast cancer. N Eng J Med 2005;353(16):1673-84. 4. Leong ASY, Formby M, Haffajee Z, et al. Refinement of immunohistologic parameters for Her2/neu scoring. validation by FISH and CISH. Appl Immunohistochem Moi Morphol. 2006;14:384-389. 5. Wolff AC, Hammond EH, Schwartz JN, et al., American Society of Clinical Oncology/College of American. Pathologists Guideline Recommendations for Human Epidermal Growth Factor Recepto 2 Testing in Breast Cancer. Arch of Path and Lab Med 2007; 131:18-43. Microscopic/Diagnostic Dictation: Pathologist. Final Review: Pathologist,. Microscopic/Diagnostic Dictation: Pathologist, i. Microscopic/Diagnostic Dictation: Pathologist, (. Final Review: Pathologist,. Final: Pathologist,. Addendum: Pathologist,. Addendum Review: Pathologist. Addendum Final: Pathologist,. Addendum: PATHOLOGIST,. Addendum Review: PATHOLOGIST. Addendum Final: PATHOLOGIST. Addendum: Pathologist. Addendum Review: Pathologist. Addendum Final: Pathologist,. Addendum: PATHOLOGIST, (. Addendum Review: PATHOLOGIST, {. Addendum Final: PATHOLOGIST, (.",T2,N1,M0,T2N1M0
TCGA-DJ-A3V3,"Clinical Diagnosis & History: year old. with FNA left thyroid nodule positive papillary thyroid carcinoma. Specimens Submitted: 2: Total thyroidectomy and central compartment lymph nodes. 1: Delphian lymph node. DIAGNOSIS: 1. Delphian lymph node: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 1. 2. Total thyroidectomy and central compartment lymph nodes: Tumor Type: Papillary carcinoma, classical type. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Calcification of non-psammoma type. Psammoma bodies. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 2.4 cm. Tumor Encapsulation: Partially surrounded. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Not identified. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Exhibits chronic lymphocytic thyroiditis. Parathyroid Glands: Two unremarkable parathyroid glands. Lymph Nodes: Fourteen bengin lymph nodes. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh, labeled ""Delphian lymph node"" and consists of a single firm lymph node measuring 0.6 x 0.4 x. 0.3 cm. The lymph node is entirely submitted. Summary of sections: LN - lymph node. 2) The specimen is received fresh, labeled ""total thyroidectomy and central compartment lymph nodes"" and consists of a thyroid. weighing 15.5 g. The right lobe measures 4.0 x 1.8 x 1.3 cm, the left lobe measures 4.6 x 2.4 x 1.8 cm and the isthmus measures. 1.2 x 1.0 x 0.2 cm. The external surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black,. and the anterior is inked blue. Sectioning reveals three nodules in the left lobe. A 2.4 x 1.8 x 1.6cm yellow tan partially calcified. nodule-left lower lobe, a 1.1 x 0.9 x 0.7 cm tan red homogeneous nodule-left mid lobe, and a third red tan homogeneous nodule. measuring 1.1 x 0.8 x 0.6 cm-left upper pole. A central portion of the largest nodule is submitted for. The left thyroid lobe is a. sequentially from superior to inferior in its entirety. The remaining thyroid parenchyma is red tan and beefy. Representative. sections of the specimen. Submitted for. ind a photograph has been taken. The remaining tissue is serially sectioned and. submitted. Summary of sections: N nodule. RL right lobe. LL left lobe. IS isthmus. Summary of Sections: Part 1: Delphian lymph node. Block. Sect. Site. PCs. 1. LN. 1. Part 2: Total thyroidectomy and central compartment lymph nodes. Block. Sect. Site. PCs. 1. IS. 1. 8. LL. 8. 2. LN. 2. 3. LT. 3. 2. RL. 2.",T2,N0,M0,T2N0M0
TCGA-AL-3472,"Clinical History/Diagnosis: Left renal mass. Source of Specimen(s). 1: 2 Portions of 11th Rib. 2: Mass Left Renal. 3: Base of Mass. 4: Base of Mass. Gross Description: Received in four parts. Source of tissue: 1. Labeled #1, ""two portions 11th rib"". Gross description: Received fresh labeled "", ,. two portions 11th rib"" consists of two portions of pink-red bone with. minimal attached soft tissue 1.2 x 1.1 x 0.3 cm and 2.5 x 1 x 0.4 cm. Entirely submitted in cassette 1A following fixation and decalcification. Source of tissue: 2. Labeled #2, ""left renal mass"". Frozen Section Diagnosis: 2FS RENAL CELL NEOPLASM FAVOR PAPILLARY. TYPE. MARGIN IS NEGATIVE PER. Gross description: Received fresh for frozen section labeled "", , left renal mass"" consists. of a 448 gram, 11 x 9 X. 6.5 cm yellow-pink encapsulated mass. The specimen comes designated with. a clip at the base. The base is inked black and the area of the clip is. frozen for frozen section diagnosis. Further sectioning reveals yellow,. possibly necrotic cut surfaces. A piece of the specimen is sent to. Cytogenetics, and pictures are taken per surgeon. Representative sections. are submitted as designated for microscopic evaluation. Designation of sections: 2FS frozen section. 2A tumor in relation to. normal. 2B-2E random sections all in relation to capsule. Please note. that cassette 2E contains sections in relation to base. Source of tissue: 3. Labeled #3, ""base of mass"". Frozen Section Diagnosis: 3FS NO TUMOR SEEN. Gross description: Received fresh for frozen section labeled, base of mass"" consists of. 0.5 x 0.4 x 0.2 cm. fragment of pink-tan soft tissue. Entirely frozen and submitted in cassette 3FS for. microscopic evaluation. Source of tissue: 4. Labeled #4, ""lateral base of mass"". Frozen Section Diagnosis: 4FS NO TUMOR SEEN. Gross description: Received fresh for frozen section labeled , lateral base of mass"". consists of one irregular. fragment of tan soft tissue 0.5 X 0.3 x 0.2 cm. Entirely frozen and. submitted in cassette 4FS for microscopic evaluation. All specimens are placed in formalin at. Final Diagnosis: 1. Two portions, 11th rib"". - No tumor seen. 2. Left renal mass: - Renal cell cacinoma, papillary type (11.0 cm) type, I. - Angiolymphatic invasion is not identified. - Resection margin free of tumor. 3. Base of mass: - No tumor seen. 4. Lateral base of mass: - No tumor seen. pT2 No Mx. Procedures/Addenda. FC Cytogenetics Solid. Results-Comments. CYTOGENETIC ANALYSIS REPORTS. DIAGNOSIS: Papillary Renal Cell Carcinoma. KARYOTYPE: Abnormal karyotype: 47,X,. +7,+17[20]. RESULTS: The renal mass was-harvested after three and four days in. culture. The chromosomes from twenty metaphases were counted and. analyzed, and three of these metaphases were karyotyped by G-banding. The. modal chromosome number was 47, and the cells were missing. chromosome and contained an extra copy of chromosomes 7 and 17. Loss of. and trisomy for chromosomes 7 and 17 have been reported in cases of. papillary renal cell carcinoma and are consistent with this patient' S. diagnosis.",T2,N0,M0,T2N0M0
TCGA-AA-3864,"Diagnosis. Right hemicolectomy preparation with a cecal carcinoma histologically characterized as a. moderately differentiated colorectal adenocarcinoma, almost completely covering the. cecum, and measuring 5.5cm in diameter at the widest point. Invasive spreading of the. tumor within all intestinal walls up to the bordering fatty tissue and the subserosa. Oral and aboral resection margins are tumor-free as is the greater omentum. 21 mesocolic and mesenteric lymph nodes are tumor-free with uncharacteristically. reactive lesions. Therefore the tumor stage is: pT3, pNO (0/21) LO, V0; G2.",T3,N0,M0,T3N0M0
TCGA-EA-A3QE,"Laterality: Path Report:CERVIX TISSUE CHECKLIST. Specimen type: Hysterectomy, bilateral salpingo-oophorectomy. Tumor site: Cervix. Tumor size: 3 X 2 X 2 cm. Histologic type: Squamous cell carcinoma, large cell, non-keratinizing. Histologic grade: Moderately differentiated. Tumor extent: Limited to endometrium. Lymph nodes: 0/14 positive for metastasis (Pelvic 0/14). Lymphatic invasion: Not specified. Venous invasion: Not specified. Extent of myometrial invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T1,N0,M0,T1N0M0
TCGA-D5-6924,"page 1 / 1. Examination: Histopathological examination. Cost of diagnostic procedure. Material: 1. Multiple organ resection - sigmoid colon. Expected time of examination: Clinical diagnosis: Sigmoid colon with tumour. Macroscopic description: A 18.3 cm length of the large intestine with a piece of mesentery sized 19 X 9 X 4 cm. Tumour sized 5.6 X 6.3 X 1.7. found in the mucosa. The lesion surrounds 100% of the intestine circumference, is removed by 9.8 cm from the. proximal incision line, and 7.2 cm from the distal incision line. Microscopic description: Adenocarcinoma tubulopapillare (GI). Infiltratio carcinomatosa telae adiposae pericolicae. Incision lines free of neoplastic lesions. Lymphonodulitis reactiva (NO VIII). Histopathological diagnosis: Adenocarcinoma tubulopapillare coli. Tubulopapillar adenocarcinoma of the colon. (GI, Dukes B, Astler - Coller B2, pT3, pNO).",T3,N0,M0,T3N0M0
TCGA-B0-4839,"FINAL DIAGNOSIS. KIDNEY, LEFT, NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE, FUHRMAN GRADE 2 OF 4, 4.5 CM IN. GREATEST DIMENSION. B. SURGICAL MARGINS ARE FREE OF TUMOR. C. THE TUMOR IS CONFINED TO THE KIDNEY, WITH NO EVIDENCE OF INVASION INTO RENAL SINUS OR. PERINEPHRIC ADIPOSE TISSUE. D. ANGIOLYMPHATIC INVASION IS NOT PRESENT; THE RENAL VEIN IS FREE OF TUMOR. E. INCIDENTAL PAPILLARY RENAL CORTICAL NEOPLASMS, THREE, THE LARGEST 0,3 CM IN GREATEST. DIMENSION. F. NON-NEOPLASTIC KIDNEY WITH MILD CHRONIC INTERSTITIAL NEPHRITIS, FOCAL GLOBAL. GLOMERULOSCLEROSIS MODERATE ARTERIAL AND ARTERIOLAR SCLEROSIS, AND SIMPLE RENAL. CORTICAL CYSTS. G. PATHOLOGIC TNM STAGING: pT1b Nx Mx.",T1,N0,M0,T1N0M0
TCGA-AR-A1AN,"Final Diagnosis. Breast, right, 'wide local excision: Infiltrating ductal carcinoma, Nottingham grade II (of III). [tubules 3/3, nuclei 3/3, mitoses 1/3; Nottingham score 7/9], forming a mass (2.2 x 1.6 x 1.6 cm). [AJCC pT2]. Ductal carcinoma in situ is absent. Angiolymphatic invasion is absent. The non-. neoplastic breast parenchyma shows nonproliferative fibrocystic changes. Biopsy site changes. are present. All surgical resection margins, after a separately submitted re-excision of the inferior. margin, are negative for tumor (minimum tumor free margin, 0.5 cm, deep/superior margin). Lymph nodes, right axillary sentinel, excision: Multiple (5) right axillary sentinel lymph nodes. are negative for metastatic carcinoma [AJCC pNO (i-) (sn)]. Blue dye is identified in all five right. axillary sentinel lymph nodes. Immunohistochemical cytokeratin stain was performed on the. paraffin embedded sentinel lymph node tissue and confirms the H&E impression. Her-2/NEU has been ordered on paraffin-embedded tissue.",T2,N0,M0,T2N0M0
TCGA-L5-A4OW,"PREVIOUS DIAGNOSIS INQUIRY. 1. SEX: F. PROCEDURE: SPHS. vear-old female with prior gastric stapling procedure for obesity and has. now developed a distal esophageal Barrett's carcinoma. Operative procedure: Transhiatal esophagectomy. Peripancreatic soft tissue frozen. PROCEDURE: SPGD. 1. ""Peripancreatic soft tissue FS"" Received fresh in a small container is. a. 2.0 x 1.1 x 0.3 cm soft tissue. 1A.&B. Frozen section control. 2. ""Low paraesophageal left lymph node FS Received fresh in a small. container is a lymph node, 1.1 cm, bisected. Frozen section control. 3. ""Thoracic esophagus"" Received in a small container is a 7.2 cm segment of. distal esophagus with an attached 7.0 x 4.0 x 3.5 cm stomach. Attached to the. distal portion of the stomach is a 4.8 cm segment of bowel, stapled at the. margin. The GE junction is remarkable for a 3.1 x 2.3 cm fungating lesion. extending 1.6 cm to involve the esophagus, and 2.8 cm to involve the stomach,. it is tan-red and centrally ulcerated. The mass extending to within 6.0 cm. of. the esophageal margin, and 7.8 cm of the bowel margin. The surface. corresponding this area is inked black. Sectioning of the mass reveals. ill-defined tan-white cut surfaces grossly abutting the muscularis, with a. maximum thickness of 1.9 cm. The remaining esophageal mucosa is pink-tan. grossly unremarkable with an internal circumference of 4.5 cm and a wall. thickness of 1.0 cm. The gastric mucosa is tan, with grossly unremarkable. rugal folds. At the junction of the anastomosis between the bowel and the. stomach is a 0.8 x 0.5 cm full-thickness defect. The bowel mucosa is. red-brown, hemorrhagic. Attached adpose tissue has ten possible lymph nodes. ranging from 0 .2 to 0.8 cm. 3A. Tumor to esophageal mucosa. 3B. Tumor to gastric mucosa. 3c.- E. Remaining tumor. 3F. Anastomosis. 3G. Aforementioned full-thickness defect to bowel margin. 3H. Five whole possible lymph nodes. 31. Four whole possible lymph nodes. 3J. Largest possible Lymph node. Bisected. 4. ""Corvice+. margin"". in. smatt. container. 1.7. em. segment. of. esophagus with a grossly unremarkable trans surface. It is Lined by tan-white. grossly unremarkable mucosa. Wall thicknesses averages to 0.8 cm. The end. opposite the stapled end is shaved and submitted in one cassette. FROZEN SECTION REPORT: 1A.&B. One lymph node negative for carcinoma. PREVIOUS DIAGNOSIS INQUIRY. 2. SEX: F. 2. Metastatic adenocarcinoma. have reviewed and interpreted the frozen section. material at the time it was requested. Permanent sections confirm frozen section reports. PROCEDURE: SPMI. ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: Type of carcinoma: Adenocarcinoma, spanning the GE junction. Depth of invasion: Muscularis propria. Number of positive lymph nodes: 2/11. Extranodal metastasis: Unknown. Pattern of invasion: Infiltrative and expansile. Esophageal and gastric resection margins involved: No. Deep resection margin involved: No. TNM classification: T2 N1 Mx. PROCEDURE: SPDX. 1. Lymph node, peripancreatic, excision: One lymph node negative for. carcinoma. 2 Lymph-node, Left. Los paraesophageal, excisions Metestatio in. one lymph node. 3&4. Esophagus, resection: Invesive adenocarcinoma spanning the GE junction,. extending into the muscularis propria. Metastatic carcinoma in two of eleven. lymph nodes. Margins negative. Please see template for details. the signing staff pathologist, have personally examined.",T2,N1,M0,T2N1M0
TCGA-DK-AA71,"M. Urology. Clinical Diagnosis & History: T1HG per TUR-BT, large volume tumor, possible extra bladder extension per imaging. Specimens Submitted: 1: Urethral margin (fs). 2: Right common iliac lymph node. 3: Left common iliac lymph node. 4: Right distal pelvic lymph node. 5: Left distal pelvic lymph node. 6: Bladder, prostate, seminal vesicles, peri vesicle lymph nodes. 7: Presacral lymph nodes. 8: Right distal pelvic lymph nodes #2. 9: Distal left ureter. 10: Distal right ureter. DIAGNOSIS: 1. Urethral margin (fs): Benign urothelium and prostatic tissue. 2. Right common iliac lymph node: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 4. 3. Left common iliac lymph node: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 3. 4. Right distal pelvic lymph node: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 8. 5. Left distal pelvic lymph node: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 6. 6. Bladder, prostate, seminal vesicles, peri vesicle lymph nodes: a. Tumor Type: Urothelial carcinoma with squamous differentiation Per TSS, squamous differentiation = <5?. Histologic Grade: High grade. Pattern of growth of the Non-Invasive component;. Papillary and flat. Pattern of growth of the Invasive component: Infiltrating. Tumor Multicentricity: Not identified. Bladder Local Invasion: Deep half of muscularis propria. Extravesical Tumor Extension: Ureters uninvolved. Urethra uninvolved. Vascular Invasion: Identified. Perineural Invasion: Identified. Surgical Margins: Free of tumor. Non-Neoplastic Mucosa: Exhibiting chronic cystitis. Exhibiting ulceration. Prostate: Other See prostate template below. Seminal Vesicles: Not involved. Perivesical Lymph Nodes: Not identified. The Pathologic Stage is (AJCC 2002): pT2b (Invades deep half of muscularis propria). PRO (No involvement of prostate). b. Tumor Type: Adenocarcinoma. Gleason's Grade: Primary Gleason grade:3. Secondary Gleason grade:4. Total Gleason score:7. Tumor Location: Dominant tumor mass located in: left posterior apex. Vascular Invasion: Not Identified. Perineural Invasion: Not identified. Tumor Multicentricity: Not identifed. High Grade Prostatic Intraepithelial Neoplasia: Identified. Capsule: Tumor confined to prostate. Seminal Vesicles: Not involved. Bladder Neck: Not Involved. Surgical Margins: Free of tumor. Non-Neoplastic Prostate: Exhibits nodular hyperplasia. Staging (AJCC 1997): pT2a (confined to the prostate & capsule, involving one lobe). 7. Presacral lymph nodes: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 1. 8. Right distal pelvic lymph nodes #2: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 2. 9. Distal left ureter: Segment of benign and inflamed ureter. 10. Distal right ureter: Segment of benign and inflamed ureter. Note: Immunostains D2-40 and ERG were used to assess the presence of lymphovascular invasion. Some of the immunohistochemistry and ISH tests were developed and their performance characteristics were determined by the Department of Pathology. They have not been cleared or approved. by the US Food and Drug Administration The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded as. investigational or for research. This laboratory is certified under Clinical testing. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (ANDIOR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh for frozen section consultation, labeled ""Urethral margin "" and consists of a tan pink piece of soft. tissue measuring 1.2 X 1.2 X 0.3 cm. Entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 2) The specimen is received fresh, labeled ""Right common iliac lymph nodes"" and consists of five pink tan firm, fatty lymph nodes. ranging from 0.5 to 2.7 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes, BL1 - BLN3 - bisected lymph nodes #1-3. 3) The specimen is received fresh, labeled ""Left common iliac lymph node"" and consists of six pink tan firm, fatty lymph nodes. ranging from 0,6 to 2.5 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes, BLN - bisected lymph node. 4) The specimen is received fresh, labeled ""Right distal pelvic lymph nodes"" and consists of eight pink tan firm, fatty lymph nodes. ranging from 0.6 to 3.5 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes, BLN - bisected lymph nodes, TLN - trisected lymph node. QL1 - quadrisected lymph node #1, QL2 - quadrisected lymph node #2. 5) The specimen is received fresh, labeled ""Left distal pelvic lymph nodes"" and consists of thirteenth pink tan firm, fatty lymph. nodes ranging from 0.6 to 3.2 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes, BLN - bisected lymph nodes, QLN - quadrisected lymph node. 6) The specimen is received fresh, labeled ""Bladder prostate, seminal vesicles and perivesicular lymph nodes"". It consists of a. bladder with attached prostate and adnexa measuring 17 cm from superior to inferior, 9 cm laterally and 8 cm from anterior to. posterior. The bladder measures 13.5 x 9.5 x 9 cm and is markedly distorted with an underlying non palpable mass. The prostate. measures 4.5 x 4 x 3.8 cm. The right half of the prostate is inked green; the left half of the prostate is inked blue. The anterior. aspect of the bladder is inked black and the posterior blue. The prostatic urethral margin is shaved and submitted. The bladder is. opened. along the anterior midline to reveal a tan-yellow fungating predominately necrotic mass fulfilling the majority of the bladder. cavity. measuring 12.5 x 9.5 x 6.2 cm. The tumor is more closely associated with the left lateral wall, but extends into all regions of. the bladder, completely covering the left anterior and posterior wall, dome mucosa. The attachment of the tumor to the bladder. mucosa is a 1.1 cm from the right ureteral orifice, completely obliterating the left ureteral orifice and is 4.2 cm from the prosthetic. urethral margin. The tumor is sectioned to reveal extension through the bladder wall into the perivesicular fat, predominantly to the. left aspect. The remaining bladder mucosa at the right anterior/posterior wall and trigone is tan yellow and granular. The. perivesicular fat is sectioned to reveal vascularity only. No perivesicular lymph nodes are identified. The prostate is serially. sectioned. to. reveal a diffuse tan nodular parenchyma with an edematous left and right seminal vesicle. The tumor is 1.4cm from. the underlying vasa deferentia. Representative sections are submitted. The specimen is photographed. TPS is submitted. Summary of sections: UTHM - urethral margin, RUM - right ureter margin, LUM - left ureter margin, RUO - right ureter orifice. LUO. left. ureter. orifice, TAW - tumor to anterior wall and perivesicular fat, TPW - tumor to posterior wall and perivesicular fat. TF - tumor to perivesical fat, TVD - tumor to vasa deferentia, TRP - tumor to right posterior wall, TTRI - tumor to trigone. RA - right anterior wall, RAP - right apex prostate, LAP - left apex prostate, RAM - right anterior mid prostate. RPM - right posterior mid prostate, LAM - left anterior mid prostate, LPM - left posterior mid prostate. RAB - right anterior base prostate, RPB - right posterior base prostate, LAB - left anterior base prostate. LPB - left posterior base prostate, RSV - right seminal vesicle, LSV - left seminal vesicle. ADD - additional sections of the base of the tumor. 7) The specimen is received fresh, labeled ""Presacral lymph nodes"" and consists of four pink tan firm, fatty lymph nodes ranging. from 0.7 to 3.2 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. 8) The specimen is received fresh, labeled ""Right distal pelvic lymph nodes #2"" and consists of a portion of yellow and tan adipose. tissue, measuring 2.5 x 2.0 x 1.2cm, two pink tan firm, fatty lymph nodes are identified measuring 0.6 x 0.5 x 0.2 and 0.5 X 0.5 x 0.2. cm All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. 9) The specimen is received in formalin, labeled ""Distal left ureter, unclipped end is margin"" and consists of a tan-white tubular. tissue fragment measuring 4.1 cm in length and 1.0 cm in average diameter, with attached adipose tissue measuring 0.5 cm in. thickness. There is a clip at one end of the specimen. On cross sections, the mucosa appears grossly unremarkable. The. specimen is sequentially sectioned from the clipped end to the non-clipped end and submitted entirely. Summary of sections: CE = clipped end (inked black), NCE = non-clipped end (inked blue). SS = sequential sections from clipped to non-clipped end. 10) The specimen is received in formalin, labeled ""Distal right ureter, unclipped end is margin"" and consists of a tan-white tubular. tissue fragment measuring 4.2 cm in length and 1.0 cm in average diameter, with attached adipose tissue measuring 0.6 cm in. thickness. There is a clip at one end of the specimen. On cross sections, the mucosa appears grossly unremarkable. The. specimen is sequentially sectioned from the clipped end to the non-clipped end and submitted entirely. Summary of sections: CE = clipped end, NCE = non-clipped end, SS = sequential sections from clipped to non-clipped end. Summary of Sections: Part 1: Urethral margin (fs). Blocks Block Designation. PCs. 1. FSC. 1. Part 2: Right common iliac lymph node. Blocks. Block Designation. PCs. 1. BL1. 2. 1. BL2. 2. 2. BL3. 2. 1. LN. 1. Part 3: Left common iliac lymph node. Blocks Block Designation. PCs. 1. BLN. 2. 3. LN. 4. Part 4: Right distal pelvic lymph node. Blocks Block Designation. PCs. 4. BLN. 8. 1. LN. 1. 4. QL1. 4. 4. QL2. 4. 3. TLN. 3. Part 5: Left distal pelvic lymph node. Blocks Block Designation. PCs. 3. BLN. 6. 3. LN. 9. 4. QLN. 4. Part 6: Bladder, prostate, seminal vesicles, peri vesicle lymph nodes. Blocks Block Designation. PCs. 10. ADD. 10. 1. LAB. 1. 1. LAM. 1. 1. LAP. 1. 1. LPB. 1. 1. LPM. 1. 1. LSV. 1. 1. LUM. 1. 1. LUO. 1. 1. RA. 1. 1. RAB. 1. 1. RAM. 1. 1. RAP. 1. 1. RPB. 1. 1. RPM. 1. 1. RSV. 1. 1. RUM. 1. 1. RUO. 1. 4. TAW. 4. 1. TF. 1. 3. TPW. 3. 2. TRP. 2. 2. TTRI. 2. 1. TVD. 1. 1. UTHM. 1. Part 7: Presacral lymph nodes. Blocks Block Designation. PCs. 2. LN. 4. Part 8: Right distal pelvic lymph nodes #2. Blocks Block Designation. PCs. 1. LN. 1. Part 9: Distal left ureter. Blocks Block Designation. PCs. 1. CE. 1. 1. NCE. 1. 5. SS. 10. Part 10: Distal right ureter. Blocks Block Designation. PCs. 1. CE. 1. 1. NCE. 1. 5. SS. 11. Special Studies: Special Stain. Comment. IMM RECUT. P16. HPV. IMM RECUT. NEGATIVE. ERG. D2-40. ERG. D2-40. IMM RECUT. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1. FROZEN SECTION DIAGNOSIS: Benign. PERMANENT DIAGNOSIS: same.",T2,N0,M0,T2N0M0
TCGA-BH-A0DS,"P.15/33. GSIS;. TAXILLARY SENTINEL LYMPH NODE #1, BIOPSY -. B. NO EXTRACAPSULAR EXTENSION IS IDENTIFIED. ONE LYMPH NODE WITH METASTATIC CARCINOMA MEASURING 1.5 MM IN GREATEST DIMENSION (1/1). PART 2: RIGHT BREAST AT 9 O'CLOCK, SEGMENTAL MASTECTOMY. A. MULTIFOCAL INVASIVE DUCTAL CARCINOMA. NOTTINGHAM GRADE 2 (NUCLEAR GRADE 3, TUBULE. SCORE 3. MITOTIC ACTIVITY SCORE 1. TOTAL SCORE 7/9). B. MAIN TUMOR MASS MEASURES 2.2 CM AND IS ASSOCIATED WITH BIOPSY SITE CHANGES. C. A 2.5 MM SATELLITE NODULE OF INVASIVE TUMOR IS PRESENT NEAR THE LATERAL ASPECT OF THE. SPECIMEN, AWAY FROM THE MAIN TUMOR MASS. D. THIRO TUMOR FOCUS IS SEEN IN PART 3 (soe comment). E. LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. F. PERINEURAL INVASION IS IDENTIFIED. G. TUMOR NODULES CONTAIN CENTRAL FIBROSIS WITH PSEUDO DECIDUALIZED STROMAL HYPERPLASIA. (PASH) LIKE STROMAL REACTION. H. DUCTAL CARCINOMA IN SITU (DCIS). NUCLEAR GRADE 3 WITH COMEDONECROSIS AND. CALCIFICATIONS: I. MARGINS ARE NEGATIVE FOR NEOPLASM (INCLUDING BOTH TUMORS IN PART 1); INVASIVE CARCINOMA. WAS CLOSEST TO THE ANTERIOR MARGIN (3 MM) AND INTRAVASCULAR TUMOR WAS CLOSEST TO THE. SUPERIOR MARGIN (2 MM). J. CHANGES CONSISTENT WITH PREVIOUS BIOPSY SITE. K. TUMOR PREVIOUSLY REPORTED TO BE POSITIVE FOR ER AND PR, ANO NEGATIVE FOR HER-2/NEU. L.. PATHOLOGIC STAGE: PT2 pN2a pMX. PART 3: RIGHT AXILLARY CONTENTS, DISSECTION -. A. SATELLITE NODULE OF INVASIVE DUCTAL CARCINOMA AND DUCTAL CARCINOMA IN SITU. SIMILAR IN APPEARANCE TO TUMOR SEEN IN PART 2 (9.5 MM). B. SEVEN LYMPH NODES, POSITIVE FOR METASTATIC ADENOCARCINOMA MEASURING UP TO. APPROXIMATELY 6 MM EACH (7/13). C. EXTRACAPSULAR EXTENSION is PRESENT AND MEASURES LESS THAN 1 MM. D. EXTENSIVE INTRAVASCULAK IUMUR. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Upper nuter quadrant. Lower outer quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 2.2 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 3.4 cm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade 3. Tubule formation: 3. Total Nottingham score: 7. ANGIOLYMPHATIC INVASION: Nottingham giade (1, 2. 3): 2. DERMAL LYMPHATIC INVASION: CALCIFICATION;. Not applicable. TUMOR TYPE, IN SITU: Yes, malignant zones. Cribriform. Comedo. SURGICAL MARGINS INVOLVED BY INVABIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of invasive tumor to closest margin- 2 mm. LYMPH NODES POSITIVE: Distance of in situ discave to closest margin. 6 mm. 8. LYMPH NODES EXAMINED: 14. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Diameter of largest lymph node metastasis: 6 mm. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pN2a. M STAGE, PATHOLOGIC: pMx. ESTROGEN RECEPTORS: PROGESTERONE RECEPTORS: positive. HER2/NEU: positive. zero or 1+.",T2,N2,M0,T2N2M0
TCGA-B6-A0IH,"Surgical Pathology: Finat. WUID:12C64846-1CB3-42E4-B307-54C7AD12F530. CLINICAL HISTORY: S/P adenocarcinoma. Invasive adeno carcinoma of breast. GROSS EXAMINATION: A. ""Left breast biopsy (AF1)"". in formalin. The specimen consists of an. irregular ovoid fragment of firm pink and yellow-tan tissue measuring 2 x 1.5. x 0.8 cm in greatest dimension. A portion of the specimen has been previously. submitted as frozen section AF1, and portion of tissue has been previously. submitted for ER/PR evaluation. The frozen section remnant is submitted in. Block A1 and the remaining tissue is sectioned and submitted in Block A2. B. ""Left breast"", fresh. The specimen is a 500 gram, 35.5 x 16 x 5.5 cm in. aggregate dimension less mastectomy specimen and attached axillary dissection. The breast measures approximately 24 x 15.5 x 5.5 cm. The skin ellipse is 18.7. x 10.4 cm. The nipple is slightly atypical located on the skin surface away. from the axillary tail. The nipple is 1.4 cm in diameter and is slightly. depressed and surrounding areola is 4 cm in diameter. The tip of skin ellipse. closes to the axillary dissection (upper outer quadrant) exhibit a recent. sutured skin excision which is 4.5 cm long and is 2.7 cm from the superior. upper outer surgical margin. The skin also exhibit three small purple-brown. circumscribed lesion measuring from 0.1 cm to 0.2 cm in greatest dimension. scattered in several areas over the surface. The surgical margin are marked. with blue ink. The deep surface opposite the previously described suture. excision on the skin surface exhibits a focal area of suture material which. closes a 2.1 cm defect in the deep surface. This defect communicates with the. biopsy cavity. The margin in this area is inked carefully. Sectioning reveals. the biopsy cavity is approximately 2.5 x 2 x 1.5 cm in greatest dimension and. is hemorrhagic. Surrounding the biopsy cavity is a firm, poorly demarcated. tan, slightly gritty mass which is 6.2 x approximately 4 x 2.7 cm in greatest. dimension. This is well demarcated from the surrounding adipose tissue in the. outer quadrant, however, but extends toward the center of the specimen it. becomes less easily demarcated. The breast tissue of the remainder of the. specimen is firm, fibrotic with multiple cystic structures measuring up to. 1. cm in greatest dimension and filled with gray-green fluid is a second. relatively circumscribed area of soft pink-tan tissue which bulges above the. cut surfaces and measures 3 x 2.5 x 1.5 cm in greatest dimension. This is. located more centrally but in the lower outer quadrant. The larger firm mass. surrounding the biopsy cavity to within approximately 0.5 cm of the surgical. margin but the fibroadipose tissue on the deep surface is easily clear over. the lesions. Tumor extends to within 1.5 cm of the superior surgical margin. BLOCK SUMMARY: B1-B2- representative sections of mass and adjacent biopsy cavity. B3-B5- representative sections of tumor and adjacent deep surgical margin. B6-B7- representative sections of superior surgical margin closest to tumor. B8- - representative section of nipple. B9- representative section of skin and subcutaneous tissue at surgical. incision. B10- representative section of soft, tan, demarcated lesion in the lower outer. quadrant. B11- representative section through a firm area of breast tissue grossly. separate from the main lesion by approximately 2 cm also near the lower. outer quadrant. B12- representative section of dense and cystic otherwise unremarkable breast. tissue from the upper outer quadrant. B13- representative section of breast tissue from lower outer quadrant. 1 of 2. B14 - representative section of dense breast tissue from upper inner quadrant. B15- - representative section of dense breast tissue from lower inner quadrant. B16- representative section of breast tissue from beneath the nipple. B17 - representative section from small skin lesion. The axillary dissection is approximately 13 x 10 x 2 cm in greatest dimension. The specimen is divided into the usual three levels and examined for lymph. node candidates. There are numerous lymph node each of three levels. The lymph. nodes measures up to 4 cm in greatest dimension. This largest lymph node is. located in level I. Sectioning through this largest lymph node reveals that is. appears to be completely replaced by adipose tissue. BLOCK SUMMARY: B18-B21- lymph nodes from level I as follows: B18- representative section of largest lymph node. B19- two bisected lymph node, one inked blue. B20- one bisected lymph node. B21- one bisected lymph node. B22-B25- lymph nodes from level II as follows: B22- five intact lymph node candidates. B23- one bisected lymph node candidate. B24-B25- one bisected lymph node candidate (one lymph node total in Block. B24-B25) . B26-B30 lymph node candidates from level III as follows: B26- eight lymph node candidates. B27- two bisected lymph node candidates, one ink blue. B28- three intact lymph node candidates. B29- one bisected lymph node candidate. B30- one bisected lymph node candidate. for Dr. INTRA OPERATIVE CONSULTATION: A. ""Left breast biopsy"": AF1- infiltrating carcinoma. DIAGNOSIS: A. ""LEFT BREAST BIOPSY"": INFILTRATING CARCINOMA. B. ""LEFT BREAST"": EXTENSIVE INFILTRATING LOBULAR CARCINOMA (GREATEST DIMENSION IN EXCESS OF 6. CM) SEE COMMENT. METASTATIC CARCINOMA PRESENT IN TWENTY FIVE OF TWENTY SEVEN (25/27). AXILLARY LYMPH NODES. SEE COMMENT. INFILTRATING CARCINOMA EXTENDS INTO SECTIONS OF LACTIFEROUS DUCT AND NIPPLE. AS WELL AS RANDOM SECTIONS OF BREAST QUADRANT. SEE COMMENT. ALL SURGICAL MARGINS APPEAR FREE OF INVOLVEMENT. COMMENT: Because of the multifocal and extensive nature of the tumor, exact. measurement are difficult to assess. Immunohistochemical staining for keratin on each block of lymphoid tissue. reveals extensive infiltration of most lymph nodes. There does not appear to. be associated extracapsular extension. Data. 2 of 2.",T3,N1,M0,T3N1M0
TCGA-BH-A0B3,"FINAL DIAGNOSIS: PART 1: BREASI, RIGHT, SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA, NOTTINGHAM GRADE 3 (TUBULE FORMATION 3, NUCLEAR GRADE 3,. MITOTIC GRADE 3; TOTAL SCORE 9/9). B. DUCTAL CARCINOMA IN-SITU (DCIS), NUCLEAR GRADE 3, SOLID TYPE WITH COMEDO NECROSIS. C. DCIS IS ADMIXED WITH INVASIVE COMPONENT AND COMPRISES APPROXIMATELY 10% OF THE TOTAL. TUMOR VOLUME. D. THE INVASIVE COMPONENT MEASURES 2.5 CM IN GREATEST DIMENSION. E. NO DEFINITE LYMPHOVASCULAR INVASION IS IDENTIFIED. F. MARGINS OF RESECTION ARE NEGATIVE, INVASIVE CARCINOMA IS 0.7 CM AWAY FROM THE CLOSEST. (SUPERIOR) MARGIN. G. NON-NEOPLASTIC BREAST SHOWS FIBROCYSTIC CHANGES WITH APOCRINE METAPLASIA AND. SCLEROSING ADENOSIS. H. BIOPSY SITE CHANGES. I. SKIN, NEGATIVE FOR TUMOR. J. INVASIVE TUMOR IS NEGATIVE FOR ESTROGEN AND PROGESTERONE RECEPTORS AND HER-2/NEU (SCORE. 1+) AS PER PREVIOUS PATHOLOGY REPORT. PART 2: RIGHT AXILLARY #1 SENTINEL LYMPH NODE, BIOPSY -. A. ONE LYMPH NODE, POSITIVE FOR TUMOR (1/1). B. THE SIZE OF THE LYMPH NODE METASTASIS IS 0.7 CM. PART 3: RIGHT AXILLARY #2 SENTINEL LYMPH NODE, BIOPSY -. ONE OF THREE LYMPH NODES, POSITIVE FOR TUMOR (1/3). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 2.5 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS, Other Type(s): basal-like phenotype. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 3. Total Nottingham score: 9. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: Solid. DCIS admixed with invasive carcinoma. Percent of tumor occupied by in situ component: 10 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 7 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 2. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 7 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: negative. PROGESTERONE RECEPTORS: negative. HER2/NEU: zero or 1+.",T2,N1,M0,T2N1M0
TCGA-BH-A0E7,"FINAL DIAGNOSIS: PART. LEFT BREAST, SEGMENTAL BIOPSY -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 7/9 (NUCLEI 3, TUBULES 2, MITOSES 2) WITH FOCI OF. MICRO PAPILLARY FEATURES.( (See comments). B. MICRO PAPILLARY CARCINOMA ACCOUNT TO ABOUT 10 % OF THE TUMOR MASS. C. TUMOR SIZE 2.1 X 1.8 X 1.3 CM. D. DUCTAL CARCINOMA IN-SITU NUCLEAR GRADE 2, SOLID AND MICROPAPIILLARY ACCOUNTING TO. 5% OF THE TUMOR MASS, PRESENT ADJACENT AND ADMIXED WITH THE INVASIVE CARCINOMA. E. NO PROMINENT ANGIOLYMPHATIC INVASION. F. MARGINS ARE FREE OF INVASIVE AND IN SITU CARCINOMA; CLOSEST MARGIN IS POSTERIOR MARGIN. WHICH IS 1MM FROM THE TUMOR. G. FIBROCYSTIC CHANGES WITH DUCTAL EPITHELIAL HYPERPLASIA. H. MICROCALCIFICATIONS PRESENT IN BENIGN EPITHELIUM AND ARTERIAL WALL. 1. ESTROGEN RECEPTOR POSITIVE, PROGESTERONE RECEPTOR POSITIVE AND HER-2.NEU NEGATIVE (1+). PART 2: LEFT AXILLARY DISSECTION CONTENTS, DISSECTION -. A. ONE OF SEVENTEEN LYMPH NODES WITH METASTATIC TUMOR (1/17). B. THE METASTATIC CARCINOMA IN THE LYMPH NODE MEASURED 1.2X0.8 CM WITH EXTRACAPSULAR. SPREAD ABOUT. PART 3: LEFT BREAST, NEW DEEP MARGIN, LEFT. SEGMENTAL MASTECTOMY - carcinoma, infiltrating ductal, NOS. SKELETAL MUSCLE AND FIBROADIPOSE TISSUE, FREE OF TUMOR. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 2 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 2.1 cm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS, Other Type(s): micropapillary. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 2. Mitotic activity score: 2. Total Nottingham score: 7. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, benign zones. TUMOR TYPE, IN SITU: Solid, DCIS admixed with invasive carcinoma, Percent of tumor occupied by in situ. component: 5% %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 3 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 13 mm. PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 1. LYMPH NODES EXAMINED: 17. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: ONLY KERATIN POSITIVE CELLS ARE PRESENT: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 10 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: METASTASES TO IPSILATERAL INTERNAL MAMMARY LYMPH NODE (IF APPLICABLE): SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: FCD. pT2. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pN1. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: zero or 1+.",T2,N1,M0,T2N1M0
TCGA-E2-A15T,"SPECIMENS: A. SENTINEL LYMPH NODE #1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. LEFT BREAST. D. LEFT BREAST SKIN. E. RIGHT BREAST TISSUE. SPECIMEN(S): A. SENTINEL LYMPH NODE #1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. LEFT BREAST. D. LEFT BREAST SKIN. E. RIGHT BREAST TISSUE. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA/TPB-SLN #1, #2: Negative for carcinoma. Diagnosis called by Dr. to Dr. at. (A,B). GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1 LEFT AXILLA. Received fresh labeled with the patient's identification and ""sentinel LN #1"" is a fragment of yellow fibroadipose. tissue, 5 x 3 x 1 cm containing a lymph node measuring 2 x 1 x 0.9 cm. The lymph node is sectioned and a touch. prep performed; lymph node submitted entirely in A1. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. Received fresh labeled with the patient's identification and ""sentinel LN #2"" is a fragment of yellow fibroadipose. tissue measuring 2.5 x 1.5 x 1 cm containing a 1.5 x 1 x 0.9 cm lymph node. It is sectioned, a touch prep is. performed, and lymph node is submitted entirely in B1. C. LEFT BREAST. Received fresh labeled with the patient's identification and ""left breast"" is an oriented 1408 g, 28 x 20 x 4 cm. mastectomy with 17 x 7 cm skin ellipse and a 0.9 cm everted nipple. Ink code: Anterior/superior-blue,. anterior/inferior-orange, posterior-black. Specimen is serially sectioned into 12 slices from lateral to medial with. nipple in slice 7 revealing a 7.2 x 5.8 x 3.2 cm ill-defined infiltrating mass extending from the 12 to 3 o'clock positions. in the upper outer quadrant in slices 3-7 that is closest to the anterior margin at 1.2 cm. In the axillary region is a. possible lymph node, 2.3 x 1.5 x 0.6 cm. Representatively submitted: C1: slice 2, UOQ lateral to lesion. C2-C3: slice 3, UOQ lesion (bisected). C4: slice 4, UOQ superior portion of lesion. C5-C6: slice 4, UOQ lesion (bisected). C7: slice 4, LOQ inferior lesion. C8: slice 5, UOQ superior to lesion. C9: slice 5, posterior margin (grossly closest deep margin). C10: slice 6, mid section including lesion. C11: slice 7, mid section. C12: slice 8, medial to lesion. C13: slice 9, UIQ. C14: slice 11, LIQ. C15: slice 2, LOQ. C16: slice 1, UOQ. C17: possible lymph node. C18-C19: skin and nipple (bisected perpendicular sections). D. LEFT BREAST SKIN. Received in formalin labeled with the patient's identification and ""left breast skin"" is an unoriented tan pink skin. excision 32 x 1cm excised to a depth ranging from 0.4cm to 1.8cm. The skin surface is grossly unremarkable. Representatively submitted in D1-D2. E. RIGHT BREAST TISSUE. Received in formalin labeled with the patient's identification and ""right breast tissue"" is a 236g, 27 x 12 x 5.4cm. aggregate of fibrofatty tissue with attached unremarkable tan pink skin 10.5 x 4.3cm. The specimen is serially. sectioned to reveal unremarkable breast parenchyma. Representatively submitted in B1-B2. DIAGNOSIS: A. SENTINEL LYMPH NODE 1, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). B. SENTINEL LYMPH NODE 2, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). C. BREAST, LEFT SIMPLE MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, SBR GRADE 2, WITH MUCINOUS. FEATURES. - INVASIVE CARCINOMA MEASURES AT LEAST 3 CM. - MARGINS, FREE OF TUMOR. - DUCTAL CARCINOMA IN SITU (DCIS), MICROPAPILLARY, PAPILLARY,. CRIBRIFORM, AND SOLID TYPES, NUCLEAR GRADE 2, WITH NECROSIS. - SKIN, NIPPLE, AND SKELETAL MUSCLE, NO TUMOR SEEN. NOTE: The tumor involves the upper outer quadrant and consists of multiple foci of invasive carcinoma admixed with. DCIS. On a single. slide, the largest focus of invasive carcinoma measures at least 3 cm. Invasive carcinoma spans. an area - 7 cm. D. SKIN, LEFT BREAST, EXCISION: - SKIN, NO TUMOR SEEN. E. BREAST, RIGHT, EXCISION: - APOCRINE METAPLASIA AND STROMAL FIBROSIS. - BENIGN SKIN. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3cm. Tumor Site: Upper outer quadrant. Margins: Negative. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node. Lymph node status: Negative 0/2. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 35%. DCIS Type: Solid. Cribriform. Micropapillary. Papiliary. DCIS Location:Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT2N0. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. CLINICAL HISTORY;. Multicentric cancer left breast; two areas were core biopsy showed invasive cancer. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 21. CLINICAL EXPERIENCE: Patients with a recurrence score of: 21 in the clinical validation study had an average. rate of Distant Recurrence at 10 years of 14%. ER Score: 12.1 Positive. PR Score: 5.5 Positive. Her2 Score: 10.3 Negative. Interpretation: ER. Negative < 6.5. Positive >= 6.5. PR. Negative < 5.5. Positive >= 5.5. Her2 Negative <10.7 Positive >=11.5 Equivocal = 10.7 - 11.4. See separate. report for further information. Final Review: Pathologist, (. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologis.",T2,N0,M0,T2N0M0
TCGA-85-A50M,"Gross Description: Tumor is located in right upper lobes, ill - margins with 7x7x7cm in size, soft and. necrotic-gray surface. Paratracheal, subcarinall and interlobar lymph nodes are 1.5cm in maximum size, black in color. Tumor is. located in right upper lobes, ill - margins with 7x7x7cm in size, soft and necrotic-gray surface. Paratracheal, subcarinall and interlobar lymph nodes are 1.5cm in maximum size, black in color. Microscopic Description: Tumor tissue arranges in the form of group or sheets or trabeculae of tumor. cells, invading in begnin brochus tissue. The malignant cells have moderate, eosinophilic cytoplasm. The. nuclei are enlarged, variability in size and shape, containing coarse clumped chromatin with prominent. nucleoli. Mitotic figures are common. Tumor is invasion of lymphocytes. Diagnosis Details: Squamous cell carcinoma, grade II. Comments: Formatted Path Reports: LUNG TISSUE CHECKLIST. Specimen type: Pneumonectomy. Tumor site: Lung. Tumor size: 7x7x7cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 0/3 positive for metastasis (Paratracheal, subcarinal and interlobar lymph node 0/3). Lymphatic invasion: Present. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Right-upper.",T2,N0,M0,T2N0M0
TCGA-D7-A4YT,"Gender: M. Examination result No. Unit in charge: I. Clinical diagnosis (suspicion): Stomach carcinoma. Date of admission: (urgency: Standard). Material: 1) Material: stomach, Method of collection: Total organ resection. Histopathology Diagnosis: Stomach adenocarcinoma (G2, pT2, pNO). (8140/3 T-63000). Macroscopic description: Specimen consisting of the stomach, having been cut out along the greater curvature, sized 19.7 x 17.4. cm with the omentum sized 25 x 7 cm. Tumour sized 6.4 x 5.8 x 1.4 cm in the cardia region of the. lesser curvature. Distance from the proximal end: 0.9 cm, from distal end: 12.2 cm. Microscopic description: Adenocarcinoma tubulopapillare partim mucinosum G3 ventriculi. Intestinal type acc. to. Tumour penetrates the stomach muscle membrane fat tissue (pT2). Incision lines, omentum and lymph nodes. (14) - free of neoplastic lesions.",T2,N3,M0,T2N3M0
TCGA-FS-A1ZN,"Prof.Dr. x. geb. Datum: Translation of pathology report F. Gross Pathology. Cryofixated specimen with a weight of. Microscopic pathology. The H&E stained slide at hand shows an epitheloid malignant tumor with sparse amount of. connective tissue. The tumor constitute approx. 95 percent of the tissue. The tumor cells. show round to oval nuclei with granular chromatine. Some apoptotic cells are present. There is a high nucleo/cytoplasmatic ratio. The mitotic count is 8 mitoses per square. millimetre. The tumor cells have a middle sized pigmented cytoplasm. The tumor shows a sheet like growth pattern. Lymphocytic infiltrates compound approx. 3 percent of the tissue cells. Melanophages are present. Diagnosis: Parts of a malignat tumor, consistent with a metastasis of a melanoma. Dr.",T4,N1,M0,T4N1M0
TCGA-AG-A032,"Internal Sample IC. Findings and diagnosis relating to the problem concerned: This is an invasive adenocarcinoma of the colon in the position of the rectum (rectal. carcinoma, G2) with infiltration of all parietal layers (pT3), with vascular invasion (L1,. V1), with free oral and aboral resection margins, as well as a free resection margin toward. the central region and two lymph node metastases (pN1). Tumor classification: ICDO-DA M-8140/3. G2. pT3, L1, V1, pN1.",T3,N1,M0,T3N1M0
TCGA-A2-A1FX,"SURGICAL REPORT. Sexc F. Date Collected: I. Date Received: M.R. Number. Doctor: Account Number. PRE-OPERATIVE DIAGNOSIS. RIGHT BREAST CANCER. POST-OPERATIVE DIAGNOSIS. RIGHT BREASTS CANCER. PROCEDURE. RIGHT SENTINEL LYMPH NODE BIOPSY. TISSUES. A. LYMPH NODE (S) - SENT NODE #1 ""FS. B. LYMPH NODE (S) - SENT NODE #2 FS. C. BREAST EXCISION,NEEDLE LOC,SIMPLE,MARGINS,ETC.- - RIGHT BREAST MASS. D. AXILLARY - AXILLARY CONTENTS. E. MARGINS - ADDITIONAL RIGHT BREAST TISSUE. F. MARGINS - ADDITIONAL LATERAL MAGINS. WRI TISSUE -. FS DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE#1, F.S. -. ONE POSITIVE LYMPH NODE (1/M). B. FS NOT PERFORMED PER DR. DEFER. C. RIGHT BREAST MASS, F.S. -. TUMOR MASS 4.7 CM. AND INVOLVING SUPERIOR, INFERIOR,. MEDIAL, ANTERIOR SURGICAL MARGINS. TUMOR IS ALSO VERY CLOSE TO POSTERIOR AND LATERAL SURGICAL MARGINS. (WITH SMALL INDURATED NODULES). E. ADDITIONAL RIGHT BREAST TISSUE (GROSS MARGINS ONLY) -. LATERAL SURGICAL MARGIN IS POSITIVE FOR MALIGNANCY. THE REMAINING SURGICAL MARGINS ARE FREE OF TUMOR. F. ADDITIONAL LATERAL MARGIN (GROSS MARGINS ONLY) -. SURGICAL MARGIN is FREE OF LESION. SURGICAL REPORT. nology Number. (Time Reported to Surgeon: FINAL DIAGNOSIS. A. RIGHT SENTINEL LYMPH NODE #1 -. POSITIVE FOR MULTIPLE FOCI OF METASTATIC BREAST. CANCER. B. RIGHT SENTINEL LYMPH NODE #2 -. POSITIVE FOR METASTASIS, SUBCAPSULAR SINUS DEPOSITS,. MEASURING LESS THAN 0.2 MM. IN AGGREGATE (1/1). c. RIGHT BREAST MASS -. POSITIVE FOR INFILTRATING CARCINOMA MEASURING 4.7 CM. IN GREATEST. DIMENSION WITH FOCAL EXTENSION TO THE SUPERIOR, INFERIOR AND MEDIAL. MARGINS WITH EXTENSION TO WITHIN 1/2 MM. OF THE ANTERIOR AND LATERAL. MARGINS RESECTION. D. AXILLARY CONTENTS -. POSITIVE FOR METASTASIS IN FOUR OF TWENTY TWO LYMPH NODES, TWO OF FOUR. DISPLAY SUBCAPSULAR METASTASIS MEASURING MORE THAN 2 MM. IN GREATEST. DIMENSION, ONE OF FOUR DISPLAYS MICROMETASTASIS IN SUBCAPSULAR SINUS. MEASURING LESS THAN 2 MM. AND REMAINING ONE OF FOUR DISPLAYS ISOLATED. POSITIVE CELLS IN SUBCAPSULAR SINUSES (4/22). E. ADDITIONAL RIGHT BREAST TISSUE-. POSITIVE FOR ADDITIONAL CARCINOMA WITH FOCAL EXTENSION TO THE LATERAL,. ANTERIOR, SUPERIOR AND INFERIOR SURGICAL MARGINS OF RESECTION. F. ADDITIONAL LATERAL MARGINS. POSITIVE FOR FOCAL EXTENSION TO THE NEW LATERAL. SURGICAL MARGIN OF RESECTION. PTNM CLASSIFICATION: T2 N2a, MX, STAGE IIIA. Comment: This case is discussed with Dr. The Cytokeratin (AE1/AE3) performed on specimen ""B and 0"" support the diagnosis. given. E-cadherin stain on specimen ""C"" confirms the infiltrative duct carcinoma. (. Signature on file. GROSS DESCRIPTION. SURGICAL REPORT. nology Number. The specimen is received in six separate containers labeled. designated A, B, C, D, E. and F. A. The container is received fresh unfixed labeled ""right sentinel lymph node #1. for frozen section"". The specimen consist of an ovoid mass of pink-tan, firm,. rubbery tissue with attached fat measuring 1.5x 1x 1 cm in greatest overall. dimension. Touch prep and frozen section are obtained by Dr. The entire. specimen, including frozen section, submitted in two blocks. B. The container is received fresh unfixed labeled ""right sentinel lymph node #2. for frozen section"". The specimen consists of an ovoid mass of tan-gray, firm,. rubbery tissue with attached fat measuring 0.9 x 0.8 x 0.4 cm in greatest overall. dimension. A touch prep is obtained by Dr. A frozen section Is not. performed per Dr. Entire specimen one block. C. The container is received fresh unfixed labeled ""gross margins right breast. mass"". The specimen consists of an 18 gram ovoid mass of apparent fatty and fiber incased. ovoid mass which is 5.5 x 3 x 2 cm in greatest overali dimension. There is an Inserted Indicator. wire. There is an attached single suture indicating anterior margin inked with a blue dye. Posterior is inked with a black. There are two short sutures indicating superior margin inked with. a red dye. Inferior is inked with a yellow. There is a long suture indicating lateral margin Inked. with an orange. Medial is Inked with a green. Gross margins are observed by Dr. He. states tumor mass is 4.7 cm and involving superior, inferior, medial, anterior, surgical margins. Tumor mass is very close to the posterior and lateral surgical margin, with small indurated. nodules. The specimen is submitted in twelve blocks. Key note block summary: 1- superior, 2 - Inferior, 3 - anterior, 4 - posterior, 5 -. lateral, 6 - medial. All of those are perpendicular. 7 through 12 - remaining. D. The container is received fresh unfixed labeled ""exiliary contents"". The specimen. consists of an irregular mass of apparent fatty tissue measuring 10 x 8: x 3 cm in. greatest overali dimension. Serial sectioning reveais firm, purple-tan nodules. varying up to 0.9 cm in greatest dimension. The entire specimen is submitted in. five blocks. E. The container is received fresh unfixed for gross margins which are obtained by. Dr. labeled ""additional right breast tissue"". There is a single short suture indicating anterior. margin inked with an orange dye. Deep margin is inked with a black dye. There are two short. sutures indicating superior margin inked with a red dye. Inferior is inked with a yellow. There is a. single long suture indicating lateral margin inked with a green dye. Medial is inked with a blue. Sectioning reveais firm nodules varying up to 4 cm in greatest dimension. Lateral/green margin is. grossly positive. These nodules are chiefly located in the anterior lateral area and approximately. 0.2 cm from the anterior margin. The specimen is submitted in nine blocks. Key note block summary: 1 - lateral, 2 - medial, 3 - anterior, 4 - deep, 5 - superior, 6 - inferior,. 7 through 9 - random. F. The container is received fresh unfixed labeled ""additional lateral margins -. suture on new lateral margin which is inked with a green dye. Gross margins are. observed by Dr. Sectioning reveais firm paipable nodules varying up to. 0,3 cm in greatest dimension. They appear to be 0.4 cm from the new lateral. margin. The specimen is submitted as four sections in four blocks. SURGICAL REPORT. mology Number: MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SPECIAL STAINS PERFORMED: E-Cadherin (specimen C); Cytokeratin. (AE1/AE3) (specimens B and D). SURGICAL REPORT.",T3,N2,M0,T3N2M0
TCGA-AR-A24N,"Final Diagnosis. reast, left, simple mastectomy: Infiltrating ductal carcinoma, Nottingham grade II (of III), forming a 1.9 x 1.2 x 1.0 cm mass in. the superior breast (AJCC pTlc). A minor component of ductal carcinoma in situ, intermediate nuclear grade, is also present. Surgical resection margins are negative for tumor. The nearest (deep) margin is free by 0.2 cm. Lymph nodes, left axillary sentinel, excision: Multiple (3) left axillary sentinel lymph nodes are negative for tumor. Lymph. nodes No.1, and No.2A contain no blue dye, lymph node No.2B contains blue dye. Immunohistochemical cytokeratin stain. was. performed on the paraffin embedded sentinel lymph node tissue and confirms the H&E impression. Lymph node, left axillary, excision: A single left axillary lymph node is negative for tumor (AJCC pN0). Her-2/NEU analysis has been ordered on paraffin embedded tissue.",T1,N0,M0,T1N0M0
TCGA-AG-3582,"Diagnosis/diagnoses: Resected colon shows a moderately differentiated, ulcerated adenocarcinoma of the. colorectal type, measuring a max of 5 cm, with infiltration of the pericolic fatty tissue. Circumscribed - tuberous, peritoneal tumor metastasis located distally to the tumor. In. addition, tumor-free regional lymph nodes. Tumor-free mesenteric resection margin. Tumor-free colon resection margins. The tuberous, peritoneal tumor metastasis must first and foremost be assessed in relation to. a lymph node metastasis. Stage of tumor: pT3, pN1 (1/28) pM1; G2, L0, V0, R2.",T3,N1,M1,T3N1M1
TCGA-A2-A0CO,"Specimen #: (Age. F. Race WHITE. Physician (s) : AMENDED. SPECIMEN: RIGHT BREAST AND AXILLARY CONTENTS Site: breast, NOS C50.9 1/24/11 to. FINAL DIAGNOSIS: BREAST AND AXILLARY CONTENTS, RIGHT, MASTECTOMY: - INFILTRATING LOBULAR CARCINOMA. FOCAL LOBULAR CARCINOMA IN SITU AND CANCERIZATION OF TERMINAL DUCTS. - FOCAL DUCTAL CARCINOMA IN SITU,SOLID AND CRIBRIFORM TYPE. - SIZE: 5.2 CM BY GROSS MEASUREMENT. - MARGINS DEEP MARGIN POSITIVE FOR TUMOR. - NEGATIVE FOR LYMPHVASCULAR INVASION. - MICROCALCIFICATIONS ASSOCIATED WITH TUMOR. - FIBROCYSTIC CHANGES TO INCLUDE FIBROSIS, CYST FORMATION, AND APOCRINE. METAPLASIA. - 11 LYMPH NODES ARE NEGATIVE FOR TUMOR. - AJCC STAGE. COMMENT: THE AMENDMENT REFLECTS A CHANGE IN NUMBER OF LYMPH NODES FROM NINE. TO ELEVEN. COMMENT: AMENDMENT. Case amended to report results of HER2-neu - status by fluorescence in situ. hybridization. HER2-NEU: AMPLIFIED (5.0) . Note: The patient's prior core biopsy,. was negative for. HER2-neu. The tumor in the current case has areas of poorly. differentiated carcinoma (so-called pleomorphic lobular carcinoma) not. identified in the initial core biopsy; these areas are strongly positive. for HER2-neu gene amplification. Specimen # : CLINICAL DIAGNOSIS AND HISTORY: -year-old white female with two site core biopsy breast cancer. RE-OPERATIVE DIAGNOSIS: Right breast cancer. POST-OPERATIVE DIAGNOSIS: Post-Operative Diagnosis: Same as above. GROSS DESCRIPTION: RIGHT BREAST AND AXILLARY CONTENTS received fresh and consists of a 362. gram mastectomy, 15.0 x 14.0 x 2.6 cm, with attached axillary tail, 15.0 x. 3.0 x 1.0 cm. The skin ellipse measures 10.0 X 3.5 cm. The specimen is. inked as follows Axillary tail=blue dot on inferior portion,. mastectomy - blue=superior superficial, green=inferior superficial,. black=deep. Sectioning reveals an area of firmness with the superior. portion of the specimen measuring 5.2 cm approximately 5.0 mm from the. deep margin. Palpation reveals 5.0 cm area of firmness in the superior. portion of the breast. The remainder of the cut surface is yellow,. lobular, with focal areas of white fibrous tissue and small cystic. structures measuring up to 0.2 cm. No additional well-defined lesions or. nodules are noted. Sectioning thorugh the attached axillary tail reveals 11 possible lymph. nodes ranging in size from 0.3 to 2.0 cm in greatest dimension. Four representative sections are submitted for. protocol with mirror. image sections in the following cassettes: A1: Lymph node 0.7 cm. A2: Skin from lateral edge of ellipse. A3: Tumor lateral. A4: Tumor medial. A5: Grossly normal fibrous tissue approximately 5.0 cm from tumor. Additional representative sections are submitted in cassettes A6 through. A20 as follows: A6-A12: Tumor from medial to lateral in sequential order. A13: Upper inner quadrant. A14: Lower inner quadrant. A15: Lower outer quadrant. A16: Upper outer quadrant. A17: Two possible lymph nodes. A18: Five possible lymph nodes. A19: Three possible lymph nodes. A20: Section of nipple. 20CF'.",T3,N0,M0,T3N0M0
TCGA-A2-A0CS,"Specimen #: F. Race: WHITE. Physician (s) : AMENDED. SPECIMEN: A: INTERPECTORAL NODE B: LEFT BREAST AND AXILLARY CONTENTS. FINAL DIAGNOSIS: A. LYMPH NODE, LEFT INTERPECTORAL, EXCISION: - METASTATIC DUCTAL CARCINOMA WITH EXTRACAPSULAR EXTENSION. SIZE OF DEPOSIT: 0.6 CM. EXTENT OF EXTRANODAL TUMOR: 4 MM (See comment;. ONE LYMPH NODE EXAMINED. B. BREAST AND AXILLARY CONTENTS, LEFT, MASTECTOMY WITH REGIONAL LYMPH NODE. DISSECTION: INVASIVE DUCTAL CARCINOMA, WELL DIFFERENTIATED (NOTTINGHAM SCORE 5). TUBULE FORMATION 20% = 2. NUCLEAR PLEOMORPHISM = 2. MITOSES 9 per 10 HPF AT 40X FIELD AREA 0.2376 SQ. MM = 1. - INVOLVING THE DERMIS, EPIDERMIS, AND NIPPLE; WITH ULCERATION. - SIZE = 7.0 CM (GROSS DIMENSION). - DEEP (SKELETAL MUSCLE) MARGIN IS INVOLVED BY TUMOR. - LYMPH VASCULAR AND PERINEURAL INVASION IS IDENTIFIED. - SEVEN OF ELEVEN EXAMINED LYMPH NODES WITH METASTATIC CARCINOMA;. EXTRACAPSULAR EXTENSION IS PRESENT, EXTENT OF EXTRANODAL TUMOR : AT LEAST 6 MM (See comment;. MAXIMUM DIMENSION OF LARGEST DEPOSIT: 1.8 CM. - AJCC CLASSIFICATON pT4b (ulceration) N2aMX. COMMENT: The report is amended on. to add the extent of extracapsular. extension of tumor in response to a request from the tumor board. The. measurement is the distance from the estimated location of the obliterated. lymph node capsule to the outer extent of the tumor deposit on the. microscopic slide. FOR OFFICIAL USE ONLY - PERSONAL DATA. Specimen #: FINAL DIAGNOSIS (continued) : I. CLINICAL DIAGNOSIS AND HISTORY: -year-old white female with left breast cancer. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. POST-OPERATIVE DIAGNOSIS: Operative Findings Left breast cancer. Post-Operative Diagnosis: Left breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated "" INTERPECTORAL NODE"" consists of an apparent lymph node,. measuring 1.3 x 0.9 x 0.6 cm. The node is bisected revealing firm, yellow. and tan tissue. One half of the specimen is submitted for the CBCP. protocol. The remaining half is submitted for permanent section. B. Received fresh, labeled with the patient's name,. designated ""LEFT BREAST AND AXILLARY CONTENTS"" consists of a 508.0 gram. modified radical mastectomy specimen. The breast measures 17.5 x 14. 5 x. 3.8 cm, attached axillary contents measure 13.0 x 5.2 x 1.5 cm, and. overlying nipple-bearing skin measures 13.0 x 9.5 cm. INK CODE: Blue=superior superficial, green=inferior superficial, and. black=deep. The axillary contents are examined and disected from the breast and has. multiple palpable lymph nodes, many of which are suspcious for metastasis. A large portion of the skin is covered with gauze dressing, which is. removed, revealing areas of retraction and ulceration (largest 2.2 x 1.6. cm) superior to the nipple/areolar complex, overlying a large palpable. tumor. The breast is sectioned from the posterior aspect revealing a 7.0 x 5.1 x. 3.5 cm tumor, which anteriorly erodes through the skin and posteriorly. involves a 3.0 x 2.5 cm segment of skeletal muscle. The tumor is. centrally-located and extends into the upper mid and upper inner portions. of the breast. It has a firm, tan, gritty cut surface. The remaining. Specimen # : GROSS DESCRIPTION (continued) : breast tissue is predominantly fatty and unremarkable Multiple sections. are submitted for the CBCP protocol with matching paraffin sections as. follows: B1: Lymph node, lower portion of axillary tail, 1.8 x 1.7 x 1.3 cm. B2: Grossly normal lymph node, mid upper portion of tail. B3: Grossly normal skin (medial tip). B4: Skin with underlying tumor. B5: Skeletal muscle with tumor. B6: Tumor, medial aspect. B7: Tumor, lateral aspect. B8: Grossly normal fibrous tumor, inferior to tumor. B9: LIQ, 3.5 cm from tumor. B10: LOQ, 4.0 cm from tumor. B11: UOQ, 3.5 cm from tumor. B12: UIQ, 2.0 cm from tumor. B13: : Nipple. B14-B17: One lymph node, bisected, in each cassette. B18: Five potential lymph node candidates. 18CFSS.",T4,N3,M1,T4N3M1
TCGA-AH-6544,"QC Pathologist: ADDENDUM REPORT. ADDENDUM REPORT NUMBER THREE. MSI, HNPCC: NEGATIVEThe DNA demonstrated a microsatellite. stable pattern (MSS) in 5 of 5 markers tested.DNA was. extracted from tumor samples prepared by scraping tumor from. slide, Results reviewed by. M.D.Paraffin block used. : IS10. B6 (TUMOR); IS10. : B2 (NORMAL)This panel is. composed of the five Bethesda microsatellite markers which. consist of two mononucleotide repeats (i.e. BAT26 and BAT25). and three dinucleotide repeats (i.e. D5S346, D2S123 and. D17S250). This panel of markers is recommended for. colorectal neoplasia only. The 5 MSI loci are. amplified in a. single multiplex fluorescent PCR reaction. The PCR products. are then analyzd on an automated DNA sequencer with. automated allele calling and quality scoring. A tumor is. classified as microsatellite instability high (MSI-H) if two. or more of the five markers show instability. A tumor is. classifed as microsatellite instability low (MSI-L) if only. one of the five markers shows instability. A tumor is. classified as microsatellite stable (MSS) if none of the. five markers show instability. Germline mutation analysis. for the mismatch repair genes (MLH1, MSH2 and MSH6) is. recommended for individuals with MSI-H tumors. This test was. developed and its performance characteristics have been. determined by. Instituti. Performance charactenstics refer to the. analytical performance of the test. ADDENDUM REPORT NUMBER TWO. KRAS Mutation Analysis. SPECIMEN SOURCE: LIVERPARAFFIN BLOCK NUMBER: IS10 66952. AKRAS Mutation Analysis: POSITIVE(Abnormal) Results reviewed. by M.R. M.D.Based on sequence analysis,. K-Ras codon 12 GGT>GTT (G12V) mutant was detected.Activating. K-ras mutations can be found in 30 - 40% of colorectal. cancer, 15-20% of lung cancer, and 60% of pancreatic cancer. Presence of K-ras mutation in colorectal cancer has been. reported to render the tumor resistant to anti-EGFR. therapy. Total nucleic acid wa. tracted from. paraffin-embedded tissue. Foi Jach sample, 2 PCR reactions. were performed to detect mutations at exon 1 (codon 12 \& 13). and exon 2 (codon 61) of the K-ras gene. The PCR products. are then purified and sequenced in both forward and reverse. directions. Sequencing data is analyzed and compared to a. K-ras reference. The positivity of the mutation and location. will be reported. This assay may not be able to detect. mutation if the tumor constitutes less than 15-20% of. analyzed sample. However, we specifically microdissect tumor. and selectively analyze the tumor in the provided. tissue.This, test was developed and its performance'. characteristics have heen detormined by. Performance. cnaracteristics refer to the analytical performance of the. test. NRAS Mutation Analysis: TNPTNP-Reflex testing not. required.Activating N-ras mutations can be found in 3% of. colorectal cancer, 1% of lung cancer, and 25% of small. intestine cancer. Presence of N-ras mutation in colorectal. cancer has been reported to render the tumor resistant to. anti-EGFR therapy. Total nucleic acid was extracted from. paraffin-embedded tissue. For each sample, 2 PCR reactions. were performed to detect mutations at exon 1 (codon 12 \& 13). and exon 2 (codon 61) of the N-ras gene. The PCR products. are then purified and sequenced in both forward and reverse. directions. Sequencing data is analyzed and compared to a. N-ras reference. The positivity of the mutation and location. will be reported. This assay may not be able to detect. mutation if the tumor constitutes less than 15-20% of. analyzed sample. However, we specifically microdissect tumor. and selectively analyze the tumor in the provided. tissue, This test was developed and its performance. characteristice have been determined by. Performance. characteristics refer to the analytical performance of the. test. BRAF Mutation Analysis: TNPTNP-Reflex testing not. required.Cancer-activating BRAF mutations can be found in. 14% of colorectal cancer, 2% of lung cancer, and 40% of. thyroid cancer. Presence of BRAF mutation in colorectal. cancer has been reported to render the tumor resistant to. anti-EGFR therapy. Documented BRAF polymorphism is usually. not reported and is a neutral variant (no amino acid. change). This assay may not be able to detect mutation if the. tumor constitutes less than 15-20% of analyzed sample. However, we specifically microdissect tumor and selectively. analyze the tumor in the provided tissue. The BRAF mutation. analysis from. uses a DNA-based. PCR-sequencing assay to detect somatic mutations on exon 11,. 12, and 15 of BRAF, which cover 102 out of 104 reported. mutations (99.6% incidence). This test was developed and its. performance characteristics have been determined by. Performance characteristics refer to the analyticar. performance of the test. PIK3CA Mutation Analysis: NOT DETECTEDResults reviewed by. 1/1. Based on sequencing analysis, no. mutations were detected in the PIK3CA gene exons 1, 9, or. 20. Paraffin block used: IS1(1. AActivating PIK3CA. mutations have been described in a number of human cancers,. most commonly in endometrial, breast, and colorectal. cancers. PIK3CA mutations (when present) have been reported. to be associated with poor prognosis in each of these. malignancies. In addition, PIK3CA mutations have been. reported to correlate with resistance to cetuximab therapy. in colorectal cancer patients. The regions covered in this. analysis contain greater than 95% of the reported mutations. of the PIK3CA gene. Total nucleic acid is extracted and three. PCR reactions are performed to amplify the entirety of exons. 1, 9 and 20 of PIK3CA. PCR products are then purified and. sequenced in bth the forward and reverse directions. For. cases in which the tumor represents less than 10% of the. analyzed tissue, this assay may not be able to detect. mutations. Tumor samples submitted in a paraffin are usually. microdissected in order to increase the sensitivity of the. assay. This test was developed and its performance. characteristics have been determined by. Performance. characteristics refer to the analytical performance of the. test. Test performed al. ADDENDUM REPORT NUMBER ONE. B. The immunohistochemical study of DNA mismatch repair. gene expression reveals the presence of normal hMLH1, hMSH2,. hMSH6 and hPMS2 expression in the tumor (internal controls. stain appropriately). The findings do not exclude underlying. Lynch Syndrome (also know as hereditary non-polyposis. colorectal carcinoma or HNPCC), because some mutations may. result in intact protein expression. In addition,. alterations could exist in MSH3, which has not been tested. Finally, some hereditary colorectal cancers are caused by. alterations in other unknown genes (familial colorectal. cancer type X). Additional testing using a PCR based test for. microsatellite instability (MSI) on the resected tumor will. be performed on this specimen, and an additional addendum. will follow. FINAL PATHOLOGIC DIAGNOSIS: A. Liver biopsy: Metastatic adenocarcinoma consistent with colon primary. B. Rectosigmoid colon, resection: I umor Characteristics: 1. Histologic type: Adenocarcinoma. 2. Histologic grade: Low grade/moderately differentiated. (G2). 3. Tumor site: Rectosigmoid colon. 4. Tumor size: 5.3 X 2.8 X 1.0 cm. 5. Lymphovascular space invasion: Yes. 6. Microscopic tumor extension: a. Tumor invades through muscularis propria into subserosal. adipose tissue. Surgical Margin Status: 1. Proximal margin: Negative. 2. Distal margin: Negative. 3. Circumferential (radial) margin: Negative. 4. Distance of tumor from closest margin: Tumor is 0.6 cm. from radial margin/serosal surface. Lymph Node Status: 1. Total number of lymph nodes received: 20. 2. Total number of lymph nodes containing metastatic. carcinoma: 3 (3/20). Other: 1. Immunohistochemistry for DNA mismatch repair (MMR). proteins will be performed- an addendum will follow. 2. A KRAS mutation analysis will be performed as there is. metastatic disease - an addendum will follow. 3. pTNM stage: pT3 N1 M1. COMMENTS: CLINICAL HISTORY: Preoperative Diagnosis: Colon carcinoma with liver mets. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Liver biopsy. B. Rectosigmoid. PROCEDURAL DEMOGRAPHICS: GROSS DESCRIPTION: Part A received in formalin labeled. and. ""#1"" are five cylindrical, tan-white soft tissues ranging. from 0.4 X 0.1 cm to 1.8 x 0.1 cm. which are submitted in. toto in one cassette labeled. Part B received in formalin labeled. and. ""#2"" is a 17.2 cm segment of colon with a moderate amount. of attached pericolic fat. The specimen cannot be oriented. The serosa is smooth and tan-pink. The mucosa consists of. a 5.3 X 2.8 cm circumferential, firm, granular, tan-pink. mass, 3.8 cm and 8.7 cm from the stapled margins. The cut. surface pericolic fat with a thickness gray-white of 0.2 and cm. extends The remainder into the. of the mass is. of. the mucosa is tan-pink with the normal folds. No additional. mucosal masses are identified. The inner circumference. ranges from 1.8 cm to 4.1 cm and the wall thickness averages. 0.2 cm. There are multiple irregular, tan-yellow firm. tissues consistent with probable lymph node ranging from 0.2. x 0.2 X 0.1 cm to 1.3 x 0.8 x 0.7 cm. Also received in the. same container are two annular portions of tan mucosa. measuring 1.4 X 0.9 X 0,5 cm and 1.9 X 1.8 x 0.5 cm. There. is. also a 3.2 x 1.8 X 0.6 cm aggregate of gray-white firm. tissue and yellow adipose tissue. The specimen is inked,. sectioned and representative sections are submitted as. labeled: Block 1 margin closest to mass; block 2 margin. furthest from mass; blocks 3 and 4 mass to inked serosa;. blocks 5 and 6 mass to underlying pericolic fat; block 7. mass to uninvolved mucosa; blocks 8-10 five whole probable. lymph nodes in each; blocks 11 and 12 three whole probable. lymph nodes in each; block 13 one lymph node bisected; block. 14 representative sections of three lymph nodes; block 15. two annular rims of mucosa; block 16 additional aggregate of. tissue. The blocks are labeled. received is a green and yellow cassette labeled. for. genomic research study.",T3,N1,M1,T3N1M1
TCGA-KH-A6WC,"1. (Age: M. Clinical Diagnosis & History: Squamous cell carcinoma. Esophageal mass from 31 33 cm. Rule out carcinoma. Specimens Submitted: 1: Esophagus at 32 cm. DIAGNOSIS: 1. Esophagus, at 32 cm, biopsy: - Invasive squamous cell carcinoma. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1) The specimen is received in formalin, labeled ""Esophagus at 32 cm"", and. consists of 3 fragments of tan soft tissue measuring 0.3-0.4 cm. The. specimen is entirely submitted. Summary of sections: GI-GI. Summary of Sections: Part 1: Esophagus at 32 cm. Block. Sect. Site. PCs. 1. GI. 3.",T1,N0,M0,T1N0M0
TCGA-E9-A1NE,"BREAST TISSUE CHECKLIST. Specimen type: Excision of tumor. Specimen size: Not specified. Tumor site: Breast. Tumor size: 3.5 x 3.5 X 3.5 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal and lobular carcinoma. Histologic grade: Tumor extent: Not specified. Lymph nodes: 1/2 positive for metastasis (Axillary 1/2). Extracapsular invasion of the lymph nodes: Not specified. Right, lower. Margins: Not specified. outer. quadrant. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T2,N1,M0,T2N1M0
TCGA-F7-A61W,"Gross Description: Tumor is located in Left oral tongue. It is ulcerated and protruded, with 2.5x2x2cm in. size, soft and white-gray surface. Microscopic Description: Tumor tissue arranges in the form of group or sheets os trabecular of tumor. cells. The malignant cells have moderate, light eosinophilic cytoplasm and form keratinized pearls. The. nuclei are enlarged, variability in size and shape, containing coarse clumped chromatin with prominent. nucleoli. Mitotic figures are common. Tumor invades in lower muscle propria. Stroma is invasion of. inflammatory cells. Diagnosis Details: Squamous celll carcinoma, Grade II, infiltrating muscle propria. Comments: Formatted Path Reports: HEAD & NECK CHECKLIST. Specimen type: Squamous cell carcinoma of the oral cavity. Tumor Location: Tongue. Tumor grade: Moderately differentiated - grade 2. Tumor extent: Muscularis propria. Lymph nodes: 4/9 Cervical, left. Laterality: Left. Margins: Uninvolved. Lymphovascular invasion: Present. Perineural invasion: Absent. Diagnosis details: Comments:",T2,N2,M0,T2N2M0
TCGA-MP-A4T4,"surgical Pathology. TISSUE DESCRIPTION: A1 A2 81 B2 C1 C2 C3 D1 D2 E1 F1 F2 F3 F4 F5 F6 G1 H1. Right lower lobe lung (265 grams, 18.0 x 15.0 x 7.0 cm). Tissue. from the right upper lobe lung (5.0 x 2.5 x 0.6 cm) and right lower. lobe lung (8.0 x 3.3 x 1.5 cm). Superior mediastinal (right lower. paratracheal), inferior mediastinal (subcarinal) N1(interlobar,. right interlobar) and right middle lobe lymph nodes. DIAGNOSIS: Lung, right lower lobe, lobectomy: Invasive grade 4 (of 4). adenocarcinoma, forming a 3.0 x 3.0 x 2.8 cm mass located in the. right lower lobe, 6 cm from the bronchial margin. The tumor invades. the visceral pleura. The remainder lung parenchyma shows organizing. pneumonia. The bronchial margin and multiple (4) intrapulmonary. peribronchial lymph nodes are negative for tumor. Lung, right upper lobe, wedge excision: organizing pneumonia and. subpleural scar. Lung, right lower lobe, wedge excision: organizing pneumonia and. area of scarring. Lymph node, N1, excision: A single right interlobar lymph node is. involved by metastatic grade 4 (of 4) adenocarcinoma. Lymph nodes superior and inferior mediastinal, N1 and right middle. lobe, excision: Multiple (10 right lower paratracheal, 3. subcarinal, 1 interlobar, 3 right middle lobe) lymph nodes are. negative for tumor.",T2,N1,M0,T2N1M0
TCGA-93-A4JN,"FINAL CORRECTED REPORT DATED. REPLACES ALL PREVIOUS VERSIONS. Final, Corrected. CORRECTED REPORT. Cardiothoracic Surgery. Takart. Accessioned: DIAGNOSIS: LUNG, ""PARIETAL PLEURAL DEPOSIT,"" BIOPSY (INCLUDING FS1). - ADENOCARCINOMA. - HYALINIZED GRANULOMAS. - SEE COMMENT. LYMPH NODE, LEVEL 7, BIOPSY. - NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). - HYALINIZED GRANULOMA. - NO FUNGAL FORMS OR MYCOBACTERIAL SPECIES IDENTIFIED ON GMS, AFB OR FITE STAINS. LYMPH NODE, LEVEL 11, BIOPSY. - NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). - HYALINIZED GRANULOMA. LYMPH NODE, LEVEL 11, BIOPSY (INCLUDING FS2). - NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). - HYALINIZED GRANULOMA. LUNG. LINGULA, RESECTION (INCLUDING FS3). - ADENOCARCINOMA (3.2 CM). INVASIVE AND POORLY DIFFERENTIATED. - TUMOR INVADES INTO  THE VISCERAL PLEURA (T2aN0Mia . STAGE IV). - ARTERIAL INVASION IDENTIFIED. - NON-TUMORAL LUNG WITH HYALINIZED GRANULOMAS. . SEE SYNOPSIS AND COMMENTS. By the signature. ! attest that the above diagnosis is based ypon my gersonal. examination of the sides(and/or other material in the diagrosis). "". Page of 4. Intraoperative Consultation: An intraoperative non-microscopic consultation was obtained and interpreted as: ""Brought to the frozen section area is. 'lingula,' which consists of a pink-red wedge of lung, measuring 13 x 12.5 x 3 cm. Staple line removed and inked. black. Sectioned to show a light brown-tan soft mass measuring 3.2 x 2.7 cm, located approximately 0.5 cm from the. nearest inked margin. Portion frozen as FS3. Tissue taken for tuberculosis test. Rest for permanents,"" by. FS1: Pleural deposit, blopsy. - ""Hyalinized granulomas, focal small basophilic nests, question tumoriets."" by. FS2: Level 11 lymph nodes. - ""Hyalinized granulomas, focally necrotizing. no evidence of malignancy,"" by. FS3: Lingula. excision. ""Adenocarcinoma, inked margin free of tumor,"" by. Microscopic Description and Comment: Sections of the submitted lingula"" (part E) show an invasive, poorly differentiated adenocarcinoma (3.2 cm) which has. an infiltrative and poorly circumscribed border, involving the visceral pleura (PL2). The tumor invades into but not. through the visceral pleura (blockE7). All surgical resection margins are free of tumor. Of note, multiple intra-arterial. invasions with tumor cells colonizing the endothelial wall are also seen. A provisional primary tumor staging is provided. as T2a based on the staging information from the ""lngula"" specimen. Additional sections of the specimen ""pleural deposit"" (part A) show focal small basophilic nests of tumor cels with. some features of neuroendocrine differentiation. Small amount of mature adipose tissue is also present. At deeper. level, some of these areas also showed tubular and acinar architecture. These tumor cells are positive for TTF-1 and. are negative for synaptophysin and chromogranin, confirming their malignant nature. Per discussion with. we understand that the submitted ""pleural deposit"" (part A) was acquired. from distant parletal pleural site (M1a). This report is ammended to Include this information and to upstage. the lesion to STAGE IV. Numerous granulomas are seen (part B, part C, part D, part E). GMS, FITE, AFB are performed on the lymph node. specimen acquired from level 7 (part B) and the results are negative. also reviewed select sections and concurs with final diagnosis. History: The patient is. who presents with a pre-operative diagnosis of lung mass. Pre-operative biopsy show. no evidence of maagnancy in multiple lymph nodes. Operative procedure: Video-assisted lingulectomy. Specimen(s) Received: A: PLEURAL DEPOSIT. B: LYMPH-NOOE, LEVEL-1. C: LYMPH NODE, LEVEL 11. D: LYMPH NODE, LEVEL 11. E: LINGULA. Gross Description;. The specimens are received in five formalin-filled containers, each labaled with the patient's name. The first container is additionally labeled ""pleural deposit; FS1. It contains a green tissue cassette PST,. which holds multiple minute brown-tan frozen section tissue remnants, measuring 0.5 x 0.3 x 0.1 cm in aggregate. Wrapped. Labeled A1 (FS1). Jar 0. The second container is labeled ""level 7 lymph nodes. It contains a pink-tan lymph node candidate. measuring 2 x. 1. x 1 cm in greatest dimension. Bisected to show no grossly identifiable lesion. Labeled B1. Jar. 0. The third container is labeled ""level 11 lymph node."" It contains one single pink-brown lymph node candidate,. measuring 0.9 x 0.8 x 0.6 cm. Bisected. Labeled C1. Jar 0: The fourth container is labeled ""level 11 lymph node; FS2."" It contains a green tissue cassette labeled ""FS2,"" which. holds two pieces of brown-pink frozen section tissue remnants, measuring 1 x 1.2x0.3 cm and 1 x 1.2 x 0.3 cm each. Labeled D1 (FS2). Jar 0. The fifth container is labeled ""linguia; FS3 it contains a green tissue cassette labeled ""FS3,"" which holds a 1.8 x. 1.2 x 0.2 cm pink-tan frozen section tissue remnant. Labeled E1 (FS3). Also present within the container is a. previously inked and sectioned lingula lobectomy specimen. weighing 78.5 g. and measuring 13 x 12.5 x 3 cm. A. staple line is present at the site of resection. The staple line is removed and its underlying parenchymal resection. margin is inked black. Sectioned to show a 3.2 x 2.7 x 2.5 cm tumor mass, which is located approximately 0.5 cm. from the nearest inked parenchymal resection margin (sampled in E3) and is located 1.2 from the bronchial resection. margin. The pleural surface overlying the tumor shows puckering that measures 0.5 cm in the greatest dimension. The pleural surface in this area is inked blue. The uninvolved area of lung is further sectioned to show brown-tan,. spongy, unremarkable parenchyma. Upon further inspection, a 0.2 cm white-yellow, pearly lesion is present at the. periphery of the pleural surface (sampled in E8). Labeled E2 - bronchial and vascular resection margin; E3 . tumor. in. relation to the nearest inked parenchymal resection margin; E4 - tumor in relation to the pleural puckering; E5 -. additional tumor with pieural puckering; E6 - additional tumor with black inked parenchymal resection margin; E7 -. more tumor with pleural puckering; E8 - 0.4 cm pearly pleural nodule; E9 - grossly uninvolved lung. Jar 2. SYNOPTIC REPORTING FORM FOR LUNG CARCINOMA. The provided tumor staging also includes the information acquired from the patients prior biopsy specimen. NEOPLASM. A neoplasm is present. HISTOPATHOLOGIC TYPE. The histologic classification of the tumor is adenocarcinoma, acinar (usual) type. HISTOLOGIC GRADE (G). The grade of the tumor is poorly differentiated (G3). TUMOR SIZE. The maximum dimension of the tumor is 3.2 cm. LYMPHATIC INVASION. Lymphatic invasion by tumor is absent (LO). VENOUS INVASION. Venous invasion by tumor is absent (V0). ARTERIAL INVASION. Arterial invasion by tumor is present. PLEURAL INVOLVEMENT. Pleural invoivement is present; tumor invades through visceral pleura, without invoivement of parietal pleura (PL2). SAMPLED SPECIMEN MARGINS. The sampled surgical margins are uninvolved by tumor. NON-NEOPLASTIC TISSUE. The non-neoplastic lung tissue shows granulomatous inflammation. PRIMARY TUMOR (T). Tumor > 3 cm but <= 7 cm or tumor with any of the following features (T2 tumors with these features are classified as. T2a if <= 5 cm) (T2). Invades visceral pleura (PL1 or PL2). Tumor > 3 cm but <= 5 cm in greatest dimension (T2a). REGIONAL LYMPH NODES (N). No regional lymph node metastasis histologically, no examination for ITC (pNo). DISTANT METASTASIS (M). Separate tumor nodules in contralateral lobe; tumor with pleural nodules or malignant pleural or pericardial effusion. (M1a). STAGE GROUPING. The overall international stage is T2a/NO//M1a (Stage IV). The pathologic stage assigned here should be regarded as provisional, and may change after integration of clinical. data not provided with this specimen. Corrections. Corrected: Previous Signout Date: Comment: This case was corrected to change the synoptic report. Corrected: Previous Signout Date: Comment: This case wes corrected to change the synoptic report. Surgical Pathology report is available.",T2,N0,M1,T2N0M1
TCGA-BJ-A28T,"PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Papillary thyroid cancer. PROCEDURE: Total thyroid. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered. CHEMO RADIATION: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION: Not answered. OTHER DISEASES: Not answered. FINAL DIAGNOSIS: PART 1: THYROID GLAND, TOTAL THYROIDECTOMY (15 GRAMS)-. A. TWO FOCI OF PAPILLARY THYROLD CARCINOMA, CONVENTIONAL TYPE: a. 1.3 CM, RIGHT-LOBE (See comment). b. 0.1 CM, LEFT LOBE. B. EXTRATHYROIDAL EXTENSION IS ABSENT. c. CARCINOMA IS 0.1 CM FROM MARGIN. D. METASTATIC PAPILLARY THYROID CARCINOMA, UP TO 0.28 CM, IN TWO LYMPH NODES (2/3). E. CHRONIC LYMPHOCYTIC THYROIDITIS. F. T1b N1a. PART 2: CENTRAL COMPARTMENT LYMPH NODES, DISSECTION-. A. METASTATIC PAPILLARY THYROID CARCINOMA, 0.1 CM, IN ONE LYMPH NODE (1/6). B. EXTRANODAL SPREAD IS ABSENT. COMMENT: The carcinoma is associated with extensive fibrosis and was decalcified as part of routine histologic evaluation. Decalcification precludes additional molecular analysis. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Right Lobe, Left Lobe. TUMOR FOCALITY: Multifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 1.3 cm. HISTOLOGIC TYPE. Papillary carcinoma. PRIMARY TUMOR (pT): REGIONAL LYMPH NODES (pN): pNia. Number of regional lymph nodes examined: 9. Number of regional lymph nodes involved: 3. EXTRANODAL EXTENSION: Not identified. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Not identified. MARGINS: Margins uninvolved by carcinoma. Distance of invasive carcinoma to closest margin: 1 mm. LYMPH-VASCULAR INVASION: Indeterminate. ADDITIONAL PATHOLOGIC FINDINGS: Thyroiditis.",T1,N1,M0,T1N1M0
TCGA-05-4433,"Main diagnosis/diagnoses: Peripheral bronchopulmonary, histologically mucinous adenocarcinoma with very. predominant bronchioloalveolar differentiation and spread and a small component showing. destructive, infiltrative growth and localization in S10. TNM classification on the basis of this material pT2 pNO pMX R0 stage IB. C34.3 M 8255/3. Comment/supplementary remark: There is no evidence of the carcinoma having infiltrated the visceral pleura. The resection. margin of the bronchus and vessels and all the removed lymph nodes are also tumor-free.",T2,N0,M0,T2N0M0
TCGA-D7-6815,"page 1 / 1. copy No. 1. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Total organ resection - stomach. Expected time of examination: Clinical diagnosis: Gastric cancer. Macroscopic description: The tested material consisting of the stomach, having been cut out along the greater curvature sized 18 x 13 cm with. the omentum sized 23 X 7 x 2 cm. Tumour sized 5.3 X 3.9 X 1.8 cm found on the front wall. Distance from the proximal boundary: 5.4 cm, from distal boundary: 9.2 cm. Microscopic description: Adenocarcinoma tubulare necroticans venticuli (G2, intestinal type) - in tilt ratio parietis totae ventriculi. The incision lines and omentum free neoplastic lesions. Nodes of lesser curvature: metastases in lymphonodis (II/X). Nodes of greater curvature: metastases in lymphonodis (III/IX). Histopathological diagnosis: Adenocarcinoma tubulare ventriculi. Tubular adenocarcinoma of the stomach. Metastases in lymphonodis. Cancer Metastases in. lymph nodes (V/XIX). (G2, pT2, pN2).",T2,N2,M0,T2N2M0
TCGA-AR-A0TZ,"Breast, left, modified radical mastectomy: Invasive ductal carcinoma, Nottingham grade II, is identified. forming multiple (5) masses in the left breast. The largest mass is situated in the upper outer quadrant and. measures 3.2 x 2.7 x 2.3 cm (AJCC pT2) Additional nodules are situated inferior and just superior to the. main mass and range in size from 0.5 cm to 0.8 cm in diameter. There is approximately 10% component. of ductal carcinoma in situ, cribriform type, intermediate nuclear grade. Skin, nipple, and deep margin. are free of neoplasm. Multiple (6 of 30) left axillary lymph nodes are positive for metastatic carcinoma,. including multiple (2) matted lymph nodes (AJCC pN2). HER2/neu has been ordered on paraffin embedded tissues.",T2,N2,M1,T2N2M1
TCGA-B4-5832,"I. I. Specimen. I. Clinical. Ethnicity. I. I. Clinical. I. Index. I. I. label. Site #. I. (Race). Diagnosis. t. I. I. Renal. 1. T. 0. Cancer. Renal. Cancer. I. I. I. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of. Amount/per. I. I. Specificatio. I. Container. I. I. Site. Matrix. Format. I. containers. container. n. I. I. I. I. I. Kidney, left. Primary. Tumor. Tissue. Frozen. cryomold. 1. 260. mg. Blood. n/a. normal. Blood. Frozen. tube. 1. 4. ml. I. Prior. I. Type of. I. Chemo /. Histological. TNM Stage. TNM Stage. TNM Stage. Chemo /. Prior. I. Grade. Horm Th. I. description. (T). (N). (M). Hormonal. Radiation. Details. I. t. I. I. Th. I. Renal cell. no data. 2. X. 0. carcinoma. Blood draw. n/a. n/a. n/a. n/a. n/a. Cellular. Tumor %. 80. n/a.",T3,N0,M0,T3N0M0
TCGA-78-7220,"LEFT UPPER LOBE AND NUMBER 5 LYMPH NODE. Clinical Notes: Left upper lobectomy: apical lung carcinoma. Station 5 lymph node. Two specimens are received: 1: LEFT UPPER LOBE. Macroscopy: Specimen is labelled ""left upper lobe"" and consists of a lobe of lung measuring 180 X 100 X 40 mm. Enlarged peribronchial lymph nodes are seen at the resection margin. No endobronchial abnormality is. seen. The pleural surface appears normal except for at the apex where there is a subpleural tumour. measuring 30 mm in maximum diameter. There is a fibrofatty adhesion, measuring 25 X 8 X 5 mm, at. the apical surface of the tumour. The tumour is moderately well circumscribed, solid and cream in. colour with numerous small areas of necrosis seen. Non-neoplastic parenchyma displays no. abnormality. [Bronchial resection margin, A; peribronchial lymph nodes transected and BIT, B-D; RS. of tumour, E-H; apical non-neoplastic parenchyma, I; lingula parenchyma, J]. Microscopy: Sections show a poorly differentiated adenocarcinoma which invades the pleura in the region of the. fibrofatty adhesion. Vascular invasion is also noted. Focally the tumour has a cystic architecture with. papillary infolding into the cyst lumen, but it is a predominantly solid tumour. There is extensive. replacement of peribronchial lymph nodes by metastatic poorly differentiated adenocarcinoma, and. transcapsular extension of tumour is noted. Tumour emboli are noted in lymphatics in surrounding. fibrofatty tissue. The bronchial resection margin is well clear of malignancy. Non-neoplastic lung. parenchyma shows changes of respiratory bronchiolitis. 2: NUMBER 5 LYMPH NODE. Macroscopy: Specimen is labelled ""number 5 lymph node"" and consists of a lymph node measuring 20 mm in. maximum diameter. The cut surface shows a solid white nodule at one pole of the lymph node. measuring 4 mm in diameter. [Transected and BIT, 2A]. Microscopy: Sections show multiple foci of metastatic poorly differentiated adenocarcinoma within the lymph. nodes. Conclusion-Specimens 1 & 2: Left upper lobectomy and lymph node sampling: Poorly differentiated adenocarcinoma with vascular. and pleural invasion and lymph node metastases, pathological stage T2N2. T-28000 M-81403 P1-03000. Anatomical Pathologist. Copies:",T2,N2,M0,T2N2M0
TCGA-66-2785,"Material examined: Left upper lobe, among others. Clinical diagnosis and question. Bronchial carcinoma left central (squamous cell carcinoma (according to pathology in. REPORT ON FINDINGS. Macroscopy. 1.) Upper lobe: inflated, fixed left upper lobe measuring 19 X 17 x 6 cm, central bronchus resection plane. located 0.4 cm proximal to the bifurcation of the bronchus to the apical bronchi. A staple suture line runs from. the hilus in a cranial direction for 6 cm and in a dorsal direction for 6.5 cm. At the hilus two nodes, 1.4 cm and. 2.5 cm in size. Visceral pleura shows partly patchy and partly reticulate blackish pigmentation, in S3 a. paracentral irregularly protruding area of about 5 cm. Under this a moderately firm, pale brown to whitish, in. parts pale yellowish, softened tumor, max. 5.2 cm in size, with an arcuate configuration, almost completely. obstructing B3 with endobronchial growth extending to within 0.1 cm of the bifurcation of B3. The parenchyma. surrounding the tumor is partly vitreous, partly compacted and yellow brownish. Rest of parenchyma relatively. marked patches of blackish pigmentation. 2.) Lobar LN (station 12) lingula: 2.3 cm node. 3.) Interlobar LN (station 11): 1 cm node. 4.) Hilar LN (station 10) left: two nodes, 1.8 and 2 cm in size. 5.) Paraesophageal LN (station 8) left: 1.5 cm node. 6.) Low paratracheal LN (station 4) left: 0.3 cm node with abundant surrounding tissue. 7.) Prevascular and retrotracheal LN (station 3) left: 1.4 cm node with surrounding tissue. 8.) High paratracheal LN (station 2) left: 1,3 cm node with some surrounding tissue. 9.) Subcarinal LN (station 7): 2.5 cm node with some surrounding tissue. 10.) Paraaortic LN (station 6): 1.6 cm node with some surrounding tissue. 11.) Subaortic LN (aortopulmonary window) (station 5): 1 cm node. 12.) Hilar LN (station 10) right: 0.7 cm lesioned node. Examined: 1.) a: Tumor with B3, b: 2 sections of tumor with pleura, c:1 section of parenchyma in the tumor environment,. d: bronchus and vessel resection margins (tangential) and smaller hilar node, e: larger hilar node (lamellated),. 2.) - 8.) All material (in 2.) - 4.) and 7.) lamellated in each case, smaller node in 4a), larger node in 4b)),. 9.) - -1.2.) All material (in 9.) + 10.) lamellated in each case),. 18 blocks, partly Elastica-van Gieson, PAS, diastase-PAS. Microscopy. Description of histological and cytological findings omitted for capacity reasons. EVALUATION. Primary diagnosis/diagnoses: Central to paracentral, peripheral bronchopulmonary, histologically poorly. differentiated, large-cell and polymorphocellular, focal gigantocellular, nonkeratinizing squamous cell. carcinoma of the left lower lobe of the lung with a small differentiated glandular component, focal mucin. inclusions and localization in S3. TNM classification according to this picture pT2 pNO pMX R0, stage IB. C 34.1, M 8070/3,. Secondary diagnosis/diagnoses Active chronic retention pneumonia in the tumor environment (sample 1.)),. lymph nodes with reactive lesions and anthracotic pigment deposits (samples 1.) to 12.)). Remark/addendum: The carcinoma has infiltrated the paracentral visceral pleura enlarged by fibrosis and. extends with endobronchial growth to within the immediate vicinity of the bifurcation of B3. The finding is not. sufficient for the diagnosis of an adenosquamous carcinoma. The resection margin of the bronchus and vessels. and all excised and identified lymph nodes are tumor-free.",T2,N0,M0,T2N0M0
TCGA-EL-A4KH,"OB. Sex: F. 'hysician: Case type: Surgical Case. DIAGNOSIS. TOTAL THYROIDECTOMY, STICH LEFT SUPERIOR LOBE: PAPILLARY THYROID CARCINOMA, FOLLICULAR VARIANT. Location: Left lobe. Multi-focal: Yes. Size = 2.1 cm, Largest focus, left lobe. Extrathyroidal extension: Absent. Lymphovascular invasion: Absent. Resection Margins: Negative. Lymph nodes: No lymph nodes present. GROSS DESCRIPTION. (A) TOTAL THYROIDECTOMY STITCH LEFT SUPERIOR LOBE - Received is a total thyroidectomy (left lobe, 6.0 x 2.0 x. 1.0; right lobe, 5.0 x 2.0 x 1.0 cm; isthmus, 2.5 x 1.2 cm; 30 grams in toto). In the left upper lobe there is a (2.1 x 1.8 x 1.5 cm) solid cystic lesion with a pale-pink cut surface. Another small. discrete nodule (0.8 x 0.5 x 0.5 cm) prsent immediately adjacent to this nodule with cut surface displaying possible. papillations. The. remainder. of lower portion of the left lobe, isthmus, and the entire right lobe are grossly unremarkable. A. portion of the tumor is submitted to the tissue bank. SECTION CODE: A1-A3, left upper lobe nodule, entirely submitted; A4, left lobe uninvolved, representative; A5,. isthmus uninvolved, representative; A6, right lobe, representative. CLINICAL HISTORY. Papillary thyroid carcinoma. SNOMED CODES. T-B6000, M-83403, ""Some/tests reported here may have been developed and performance characteristics determined by. hese tests have not been specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by:",T2,N0,M0,T2N0M0
TCGA-IC-A6RF,"FINAL DIAGNOSIS: PART 1: DISTAL LEFT MAINSTEM, BIOPSY: A. SUBOPTIMAL, MINUTE FRAGMENT CONSISTS OF BRONCHIAL MUCOSA. B. NO TUMOR SEEN. PART 2: BRONCHUS INTERMEDIUS BIOPSY: A. MINUTE FRAGMENT OF BRONCHIAL MUCOSA WITH MINIMAL INFLAMMATION. B. NO TUMOR SEEN. PART 3: LEFT GASTRIC TISSUE, BIOPSY: FRAGMENT OF FIBROUS-ADIPOSE TISSUE WITH SINGLE LYMPH NODE NEGATIVE FOR MALIGNANCY (0/1). PART 4: PARAESOPHAGEAL LYMPH NODE NEAR PERICARDIUM, EXCISION: NO TUMOR SEEN IN TWO LYMPH NODES (0/2). PART 5: PARAESOPHAGEAL LYMPH NODE, EXCISON: NO TUMOR SEEN IN SINGLE LYMPH NODE (0/1). PART 6: PARAESOPHAGEAL LYMPH NODE NEAR CARINA: NO TUMOR SEEN IN THREE LYMPH NODES (0/3). PART 7: PARAESOPHAGEAL LYMPH NODE NEAR LEFT MAIN BRONCHUS, EXCISION: NO TUMOR CELLS IN A SINGLE LYMPH NODE (0/1). PART 8: ESOPHAGUS, ESOPHAGECTOMY: A. WELL DIFFERENTIATED SQUAMOUS CELL CARCINOMA WITH EXOPHYTIC/ PAPILLARY GROWTH PATTERN,. MULTIFOCAL (TWO POLYPOID/EXOPHYTIC MASSES IDENTIFIED 3.5 CM AND 1.5 CM IN GREATEST DIMENSION. RESPECTIVELY). a. TUMORS INVADE SUPERFICIAL DUPLICAT's LAYERS OF MUSCULARIS MUCOSAE (T1a). b. NO ANGIOLYMPHATIC INVASION PRESENT. c. NO PERINEURAL INVASION IDENTIFIED. d. NO TUMOR SEEN IN TWO LYMPH NODES (0/2). e. PROXIMAL AND GASTRIC RESECTION MARGINS (see parts 9, 10, 12 and 13) AND ADVENTITIAL. MARGINS FREE OF TUMOR. f. PATHOLOGIC STAGE (AJCC 7TH Ed): pT1b, NO. B. UNINVOLVED ESOPHAGEAL MUCOSA WITH: a. MARKED AND DIFFUSE ACANTHOSIS. b. FOCAL BARRETT S MUCOSA IDENTIFIED AT ESOPHAGEAL-GASTRIC JUNCTION. C. UNINVOLVED GASTRIC MUCOSA WITH OXYNTIC CELLS HYPERPLASIA AND FOCAL GLANDS CYSTIC. DILATATION; CHANGES SUGGESTIVE OF PROTON POMP INHIBITOR THERAPY (PPIT). PART 9: ESOPHAGEAL MARGIN, RESECTION: A. ESOPHAGEAL MARGIN NEGATIVE FOR MALIGNANCY. B. ESOPHAGEAL EPITHELIUM WITH REACTIVE CHANGES. PART 10: MOST PROXIMAL MARGIN, RESECTION: FRAGMENT OF ESOPHAGUS NEGATIVE FOR MALIGNANCY, WITH FOCAL CHRONIC INFLAMMATION. PART 11: GASTROESOPHAGEAL FAT, RESECTION: FRAGMENTS OF ADIPOSE TISSUE WITH TWELVE LYMPH NODES NEGATIVE FOR MALIGNANCY (0/12). PART 12: EEA FINAL MARGIN, RESECTION: A. FRAGMENT OF GASTRIC OXYNTIC MUCOSA, NEGATIVE FOR MALIGNANCY, WITH FOCAL CHRONIC. INFLAMMATION. B. SEPARATE FRAGMENT OF ESOPHAGUS NEGATIVE FOR MALIGNANCY. PART 13: FINAL GASTRIC MARGIN, RESECTION: A. FRAGMENT OF GASTRIC OXYNTIC MUCOSA NEGATIVE FOR MALIGNANCY. B. DIFFUSE MUCOSA CONGESTION. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY ESOPHAGEAL TUMORS. MACROSCOPIC. SPECIMEN TYPE: Esophagogastrectomy. TUMOR SITE: Midthoracic esophagus (10-15cm from EGJ). TUMOR SIZE: Greatest dimension: 3.5 cm. Additional dimensions: 2.5 x 0.3 cm. MICROSCOPIC. HISTOLOGIC TYPE: Squamous cell carcinoma. HISTOLOGIC GRADE: G1. PATHOLOGIC STAGING (pTNM). m (multiple primary tumors). pT1a. pNO. Number of lymph nodes examined: 22. Number of lymph nodes involved: 0. 17 or more regional lymph nodes were identified. pM Not applicable. PRIOR TREATMENT: No prior treatment. MARGINS. Proximal margin uninvolved by invasive carcinoma. Proximal margin uninvolved by dysplasia. Proximal margin uninvolved by intestinal metaplasia. Distal margin uninvolved by invasive carcinoma. Distal margin uninvolved by dysplasia. Distal margin uninvolved by intestinal metaplasia. Circumferential (adventitial) margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 15 mm. Specify margin: proximal resection margin. ANGIOLYMPHATIC INVASION: Absent. ADDITIONAL PATHOLOGIC FINDINGS: Intestinal metaplasia (Barrett's esophagus). High grade dysplasia. Comment: Tumor site: two lesions were identified : one cm 3.5 at midesophagus 7.0 cm far from the GE. junction and the second lesion (1.5 cm) located 5.5 cm far from GEJ.",T1,N0,M0,T1N0M0
TCGA-IB-AAUQ,"CONFIDENTIAL. Demographics (for. verification purposes). Sex: M. Collected Date/Time. Received Date/Time. Specimen Description. A. Liver biopsy at. B. Liver biopsy number 2 at. C. Liver biopsy number 3 at. D. Body and tail of pancreas at. Clinical Information. Pancreatitis. Possible pancreatic cancer. Diagnosis. A. Liver, Biopsy: Bile duct hamartoma. Negative for malignancy. B. Liver, Biopsy #2: Benign liver tissue. Negative for malignancy. C. Liver, Biopsy #3: Benign liver tissue. Negative for malignancy. D. Pancreas, Body and Tail, Distal Pancreatectomy: Invasive ductal adenocarcinoma, moderately differentiated with. focal foamy gland pattern, 4.5 x 3.5 x 3.5 cm. Prominent perineural, lymphatic, and venous invasion present. Invasive adenocarcinoma involves retroperitoneal margin and. pancreatic body margin. Thirteen of twenty-one peripancreatic lymph nodes involved by. metastatic adenocarcinoma (13/21) extranodal extension present;. largest tumor deposit 1.2 cm. Please see comment and synontin report. Verified: Synoptic Report. SPECIMEN: Body of pancreas. Tail of pancreas. PROCEDURE: Partial pancreatectomy, pancreatic tail. TUMOR SITE: Pancreatic tail. TUMOR SIZE: Greatest dimension: 4.5. cm. Additional dimensions: 3.5 x 3.5. cm. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades peripancreatic soft tissues. Tumor invades retroperitoneal soft tissue. Tumor invades other adjacent organs or structures. tumor invades wall of splenic vein. MARGINS: Margin(s) involved by invasive carcinoma. Proximal pancreatic margin. Invasive carcinoma involves posterior retroperitoneal surface of pancreas. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy). No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteric artery. REGIONAL LYMPH NODES (pN) : pN1: Regional lymph node metastasis. Number examined: 21. Number involved: 13. DISTANT METASTASIS (pM) : Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN 2. Chronic pancreatitis. Gross Description. Received are specimen containers A to D. A11 requisitions and specimen containers are. labelled with the patient's name,. The cassettes and identifiers are. labelled with the Surgical Number. A. The specimen consists of liver tissue, measuring 0.3 cm. Submitted in toto in one. cassette. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""A: Liver biopsy at. The previously frozen tissue is entirely. resubmitted for permanent sections in cassette AQS1. B. The specimen consists of liver tissue, measuring 0.2 cm. Submitted in toto in one. cassette. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""B: Liver biopsy number 2 at. The previously frozen tissue is. entirely resubmitted for permanent sections in cassette BQS1. C. The specimen consists of liver tissue, measuring 0.8 cm. Submitted in toto in one. cassette. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""C: Liver biopsy number 3 at. The previously frozen tissue is. entirely submitted for permanent sections in cassette CQS1. D. The specimen is received fresh and is subsequently placed into formalin. The. container is designated ""D: Body and tail of pancreas at. and contains a 12.0 x 6.0. x 3.5 cm portion of pancreatic body and tail. The pancreatic body margin is inked blue,. the distal margin is inked orange, and the radial margin is inked black. The specimen is. bisected longitudinally and is fixed in formalin overnight. Sectioning reveals an ill-. defined, firm, yellow-tan, 4.5 x 3.5 x 3.5 cm mass with a few punctate hemorrhagic areas. The mass is located in the anterior half of the specimen and grossly extends to the. anterior serosa, to within 1.0 cm of the blue-inked pancreatic body resection margin, and. very close (1-2 mm) to the posterior/retroperitoneal margin. The rim of pancreatic. tissue proximal to the mass is soft and tan-colored with a normal lobular configuration. The pancreatic tail tissue distal to the mass (3.5 x 1.0 cm) is attenuated, faintly. nodular, and atrophic-appearing. The pancreatic duct passes through the central. posterior aspect of the mass, and shows no obvious dilation, stricture, or intraductal. mass. Within the peripancreatic fat superior, inferior and posterior to the mass, there. are multiple vell-circumscribed ovoid, firm, white nodules, consistent with lymph nodes,. many of which appear grossly suspicious for metastatic tumor. Representative sections. are submitted as follows: D1. representative perpendicular section of pancreatic body margin closest to. tumor. D2/3. remainder of pancreatic body margin, shaved and submitted en face. D4. single grossly suspicious lymph node, superior to pancreatic mass, sectioned. D5. additional superior margin with possible lymph nodes. D6. single grossly suspicious lymph node located superior to mass, bisected. D7 to 9. additional representative sections of superior portion of tumor with. adjacent grossly. positive lymph nodes. D10 to 12. representative sections of tumor with retroperitoneal margin and grossly. suspicious. retroperitoneal lymph nodes. D13. representative section of atrophic pancreatic tail near retroperitoneum. D14. representative portion of central tumor with large vessel. D15/16. tumor with inferior margin. D17. representative portion of atrophic distal pancreatic tail with distal margin. D18. distal portion of tumor with adjacent possible lymph node. D19. tumor with adjacent anterior serosa. D20. distal peripancreatic fat with three possible lymph nodes (bisected). D21. two additional possible lymph nodes. Frozen Section Diagnosis. A. Liver Biopsy: No evidence of carcinoma. B. Liver Biopsy Number 2: Negative for malignancy. C. Liver Biopsy Number 3: Negative for carcinoma. Pathologist Comment. In case ancillary studies are desired, tumor block information is listed below: Best tumor block: D4. Best normal block: D17. Encounter Number. Patient Location.",T3,N1,M0,T3N1M0
TCGA-BP-4345,"Clinical Diagnosis & History: vith right renal mass. Specimens Submitted: 1: Kidney, right; radical nephrectomy. 2: Lymph nades, paracaval; excision. 3: Right adrenal and supra-hylar lymph nodes; adrenalectamy and lymphadenectomy. AMENDED DIAGNOSIS: 1. Kidney, right; radical nephrectomy: Tumor Type: Renal call carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grada: Nuclear grade HI/IV. Tumar Size: Greatast diamatar is 5.5 cm. Local Invasion (far renal cortical types): Invalves ranal sinus fat. Renal Vein Invasion: Not identified. Tumar invalves a large vain in the renal sinus. Surgical Margins: Frea of tumar. Non-Neoplastic Kidnay: Chranic inflammation and focal fibrosis. Adrenal Gland: Not identified. Lymph Nades: Not identified. Staging for renal cell carcinamaloncacytoma: pT3b Tumar grassly extands into the ranal vein(s) ar vana cava balow the diaphragm. 2. Lymph nodes, paracaval; excision: Lymph Nodes: Not involved. Number of nodes examined:1. 3. Right adrenal and supra-hilar lymph nodes; adrenalectomy and lymphadenectomy. Adrenal gland; no tumor identified. No lymph nodes identified withn fibroadipose tissue. Note: This document represents an amandad varsian of the surgical pathology report originally issued on. That repart is. superseded by the present document. The amendment consists of the following change: ORIGINAL REPORT: Specimen Submitted: 1: Kidney, right; partial nephrectomy. Final Diagnosis: 1: Kidney, right; partial nephrectomy. AMENDED REPORT: Specimen Submitted: 1: Kidney, right; radical nephrectomy. Final Diagnosis: 1: Kidney, right; radical nephrectomy. The responsible clinician has bean notified. Gross Description: 1). The specimen is received fresh lebeled ""right kidney"" and consists of a kidney with attached ureter, renal vessels and. perinephric fat weighing 530 g in total. The kidney measures 10.9 x 5.4 x 4.7 cm. The ettached ureter measures 4 cm in length. and 0.3 cm in diameter. The attached renal vein messures 0,5 cm in length and 0.7 cm in diameter. The renal vessels and ureter. mergins are grossly unremerkable. An adranal gland is not identified. Tha kidney is inked black and bivalved to reveal lobulated,. weil defined tumor with an orange/tan and facally hamorrhagic appearance, measuring 5.5; X 4.7 x 4.3 cm, located in the mid and. lower pala of the kidney. The tumor does not grossly extend to the inked margin, and is located et 0,4 cm from the inked surfece. Sections through the remainder of the kidney reveal a pink brown parenchyma, with a well-defined cortica-medullary junction. The. cortex measures 2.2 cm and the calyces appear normal. Possible lymph nodes are identified in the perinephric fat. Representative. sections are submitted for. and for permanent sections,. Summary of sections: UVM -- ureteral and vessel margins. T-- tumor. THF tumor with hilar fat. TSF -- tumor with sinus fat. TK -- tumor with adjacent kidney. RP -- renal pelvis representative sactians. K -- representative sections kidney. LNN -possible lymph node. 2). The speciman is raceived in formalin, lebeled ""parecaval lymph nodes"" and consists of multiple pink tan firm lymph nodes. ranging from 0.3 to 1.5 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN an lymph nodes. BLN-- bisected lymph nodes. 3). The specimen is received in formalin, labeled ""right adrenal and suprahilar lymph nodes"" and consists of a nodular,adrenal. gland measuring 3,5 x 2.8 and 1.5 centimeters with attached fibroadipose tissue. Cut section of the gland reveals a. well-delineated orange/tan nodular appearance with areas of hemorrhage. No lymph nodea are identified in the attached soft. tissues. Representative sections of the adrenal gland and possible lymph nodes are submitted for permanent section. Summary of sections: A-adrenal gland. Ln-possible lymph nodes. Summary of Sections;. Part 1: Kidney, right; radical nephrectomy. Block. Sect. Site. PCs. 1. k. 4. Inn. 1. 4. t. 4. thf. 1. 1. tk. 1. itsf. 1. uvm. Part 2: Lymph nodes, paracaval; excision. Block. Sect. Site. PCs. 1. bln. 2. In. 2. Part 3: Right adrenal and supra-hylar lymph nodes; adrenalectomy and lymphadenectomy. Block. Sect. Site. PCs. 3. a. 3. In. Amendments. Original Diagnosis: 1. Kidney, right; partial nephrectomy: Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade III/IV. Tumor Size: Greatest diameter is 5.5 cm. Local Invasion (for renal cortical types): involves renal snus fat. Renal Vein Invesion: Not identified. Tumor involves a large vein in the renal sinus. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Chronic inflammation and focal fibrosis. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Steging for renal cell carcinoma/oncocytoma: pT3b Tumor grossly extends into the renal vein(s) or vena cava below the diaphragm. 2. Lymph nodes, paracaval; excision: Lymph Nodes: Not involved. Number of nodes examined:1. 4. Right adrenal and supra-hilar lymph nodes; adrenalectomy and lymphadenectomy. Adrenal gland; no tumor identified. No lymph nodes identified within fibroadipose tissue.",T3,N0,M0,T3N0M0
TCGA-E9-A1RC,"OC ID: Gross Description: Breast with the tumor of 3.5 x3.3 cm in size, with extension under the skin. All ten examined lymph nodes demonstrate. metastases. Microscopic Description: Infiltrating duct and lobular carcinoma; G2. Skin is involved. All ten examined lymph nodes demonstrate metastases. Diagnosis Details: Tumor Features: Unknown, Tumor Extent: T4 Chest wall or (and) skin involved, Venous Invasion: Absent, Margins: Absent,. Treatment Effect: Comments: Postoperative staging reads as folloes: T4c N3a MO. Sites brust, NOS C50.9 4/x/1, h. BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 3.3 x 0 x 3.5 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal and lobular carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Skin. Lymph nodes: 10/10 positive for metastasis (Axillary 10/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Not specified. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None. Laterality: Right, upper outer quadrant.",T4,N3,M0,T4N3M0
TCGA-AA-A00N,"Diagnosis: Ileocolonic resectate under inclusion of a poorly differentiated mucinous adenocarcinoma. of the colorectal type, located in the cecum/ascending colon and of max. 7.5 cm in. diameter, with circumscribed penetration of the serosa. Tumor-free regional lymph. nodes. Tumor-free small and large intestinal resection margins. Tumor-free mesenteric. resection margin. Tumor-free omental fat tissue. Tumor stage: pT4 pNO (0/20) pMX; G3; L1, V0, locally R0. A further lymph node is still being decalcified; a follow-up report will be submitted at a. later date. Follow-up report: We now have the histological data on the decalcified lymph node. In this case, there is. also no indication of metastasis from the previously diagnosed carcinoma. Final tumor. stage therefore pT4 pN0 (0/21) pMX; G3; L1, V0, locally R0.",T4,N0,M0,T4N0M0
TCGA-18-3417,"N2: 2 of 2 nodes negative for malignancy inferior pulmonary ligament node. and subcarinal node). COMMENT: The pneumonectomy contains two tumour nodules, the dominant. residing in the right lower lobe is. considered the primary and the smaller upper lobe nodule is considered a. hematogenous metastasis. The smaller nodules in the right upper lobe are seen to be organizing. infarcts. PAGE :3. LOCATTON CONS. RESULTS VERIFIED - SIGNATURE ON FILE. Page: 10 of 10. Addended. SPECIMEN (s) RECEIVED. 1. Lymph-Node: ST9 Inf Pulm Ligament. 2. Lymph node: ST12R Lobar right. 3. Lymph node: RT TB angle ST1OR,. Lymph node: ST12R lobar right. Lymph node: interlobar ST11,. 6. Lymph node: interlobar ST11; posterior right. 7. Lymph node: subcarinal ST7. 8. LUNG: right lung bronchial resection with ribs 4 & 5. DIAGNOSIS. 1-3. Lymph nodes, biopsies (ST9 inferior pulmonary ligament, ST12R right. lobar, ST1OR right TB angle) : - Lymph nodes, negative for malignancy (x3). 4. ""Lymph node"", biopsy (ST12R right lobar) : - Fibroadipose and granulation tissue with cautery and crush. artefact, negative for malignancy. - No lymph node identified. 5. Lymph node, biopsy (ST11 interlobar). - Positive for poorly differentiated squamous carcinoma. - No lymph node identified. 6. ""Lymph node"", (ST11 interlobar; posterior right) : - Soft tissue with poorly differentiated squamous carcinoma (see. Comment). - No lymph node identified. 7. Lymph node, (subcarinal ST7) : - Lymph node, negative for malignancy. 8. Lung, right pneumonectomy and partial chest wall resection: a) poorly differentiated squamous carcinoma (see Comment) with: i) Involvement of right upper and lower lobes. ii) Greatest dimension in right lower lobe = 5.0 cm. iii) Greatest dimension in right upper lobe = 3.0 cm. iv) Visceral pleural invasion present. v) Vascular invasion present. vi) Bronchial resection margin negative for malignancy. vii) Six of thirty-one peribronchial lymph nodes positive for. carcinoma (6/31). viii) Pathological Stage: pT2N1M1. b) Lung with: i) Multifocal infarcts. ii) Patchy chronic inflammation and focal interstitial fibrosis. of uncertain significance. SYNOPTIC DATA. Specimen Type: Pneumonectomy. Laterality: Right. Tumor Site: Other: (Right upper and lower lobes). Tumor Size: Greatest dimension: 5.0 cm. Histologic Type: Squamous cell carcinoma. Histologic Grade: G3: Poorly differentiated. Pathologic Staging (pTNM) : pT2: Tumor with any of the following. features of size or extent: greater than 3 cm in greatest dimension;. involves main bronchus, 2 cm or more distal to the carina; invades the. visceral pleura; associated with atelectasis or obstructive pneumonitis. that extends to the hilar region but does not involve the entire lung. pN1: Metastasis in ipsilateral. peribronchial and/or ipsilateral hilar lymph nodes, including. intrapulmonary nodes involved by direct extension of the primary tumor. Lymph node stations. involved: 10R (Right hilar). 11R (Right interlobar). pM1: Distant metastasis; includes. separate tumor nodule (s) in a different lobe (ipsilateral or. contralateral). Margins : Margins uninvolved by invasive. rcinoma. Distance of invasive carcinoma from. Page : 2 of 10. closest margin: 15 mm. Margin: (Bronchial). Direct Extension of Tumor: Visceral pleura. Blood Vessel Invasion: Present. Lymphatic (Small Vessel) Invasion (L). Present. Additional Pathologic Findings : Inflammation (type) : Patchy chronic. interstitial inflammation. Other: Focal pulmonary infarcts. MMENT. 6. Sections of specimen 6 show soft tissue with rare small clusters of. tumour cells. One such cluster demonstrates probable perineural invasion. 8. Sections show two separate tumors composed of poorly differentiated. carcinoma with focal suggestion of squamous differentiation. The larger. tumor is found superiorly in the lower lobe. This tumor invades and. puckers the overlying pleura, but chest wall invasion and invasion into. the upper lobe are not identified. However, a second tumor is identified. more centrally in the upper lobe. This is separate from the RLL tumor,. measures 3 cm in greatest dimension, and shows similar histology to that. of the RLL tumor. The tumor demonstrates extensive vascular invasion,. including invasion of some larger vessels, and several pulmonary infarcts. are noted in the upper lobe. Multiple peribronchial lymph nodes are. involved by tumor, including by direct invasion of the RUL tumor. By. immunohistochemistry, the tumor cells show strong cytoplasmic staining. for. 5/6, focal moderate staining for high and low molecular weight. cytokeratin, and moderate to strong nuclear staining for p63. The tumor. cells are negative for cytokeratin 7 and 20, and TTF-1. The morphological. and immunohistochemical features are consistent with poorly. differentiated squamous cell carcinoma. Given the morphologic. similarities between the RUL and RLL tumors and the extent of vascular. invasion, the RUL tumor is strongly favored to represent a metastasis. from the RLL tumor. The pathologic stage is therefore assessed to be. pT2N1M1. 3 of 10. CLINICAL HISTORY. LUNG CA. GROSS DESCRIPTION. 1. The specimen labeled with the patient's name and as ""Lymph-Node: ST9. Inf Pulm Ligament"" consists of two black, firm lymph nodes covered by a. few fragments of adipose tissue; received in 10% buffered formalin. They. measure 0.6 x 0.4 x 0.4 cm and 0.7 x 0.4 x 0.3 cm. 1A. specimen is submitted in toto. The specimen is labeled with the patient's name and as ""Lymph node. !12R Lobar right/QS"". It consists of multiple fragments of dark. brown-black tissue measuring 0.5 x 0.5 x 0.3 cm in aggregate. The. specimen is submitted in toto for frozen section. 2A. frozen section control. 3. The specimen labeled with the patient's name and as ""Lymph node: RT TB. angle ST10R/QS"". Consists of five tan-black lymph nodes, the largest. measuring 0.9 x 0.8 x 0.3 cm; received fresh. The specimen is submitted. in total for frozen section. 3A-3B. frozen section control. 4. The specimen is labeled with the patient's name and as ""Lymph node: ST12R lobar right/QS"". It consists of two fragments of tan-black tissue,. the largest measuring 0.8 x 0.6 x 0.2 cm. The specimen is submitted in. toto for frozen section. 4A. frozen section control. 5. The specimen is labeled with the patient's name and as ""Lymph node: interlobar ST11/QS"". It consists of two fragments of tan-black tissue,. the largest measuring 0.3 x 0.4 x 0.3 cm. The specimen is submitted in. toto for frozen section. 5A. frozen section control. 6. The specimen is labeled with the patient's name and as ""Lymph node: interlobar ST11; posterior right/QS"". It consists of two fragments of. tan-black tissue measuring 0.5 x 0.6 x 0.3 cm. The specimen is submitted. in toto for frozen section. frozen section control. 4 of 10. 7. The specimen is labeled with the patient's name and as ""Lymph node: subcarinal ST 7/QS"". It consists of a fragment of tan-red tissue. measuring 3.0 x 2.5 x 1.0 cm. The specimen is submitted in toto for. frozen section. 7A-7C. frozen section control. 7D. remaining fragments, EIT. 8. The specimen labeled with the patient's name and as ""LUNG: right lung. bronchial resection with ribs 4 & 5/QS"". The specimen is received fresh. and subsequently placed in to 10% buffered formalin. It consists of a. right lung: upper, middle and lower lobes, with overall dimensions of. -1.0 cm SI x 21.0 cm ML x 7.5 cm AP. A small portion of unremarkable 4th. .d 5th ribs are identified on the upper lobe, measuring 5.0 x 1.4 x 0.7. cm and 7.4 x 1.4 x 0.8 cm. The pleural surfaces of all three lobes are. homogneously purple and congested, showing diffuse black pigmentation. Cross sections of the right upper lobe reveal three separate, poorly. defined lesions. The largest measuring 3.0 x 3.0 x 2.3 cm, located within. the ?anterior segment. The cut surface of this lesion is homogeneously. white and firm. Further sections.show gross invasion into the bronchus. and adjacent lymph nodes. This tumor is located ""1.5 cm from the. bronchial resection margin, and 0.6 cm from the closest pleural surface. The two smaller lesions are located 2.0 cm beneath the ribs, within the. anterior aspect. Both lesions are homogeneously tan, solid and grossly. appear to have a red hemorrhagic center measuring 1.2 x 0.7 x 0.7 cm and. 1.5 x 1.0 x 1.0 cm. The distance between the two smaller lesions is 0.6. cm. Both lesions are located ""5.0 Cm from the bronchial resection margin. and 1.1 cm from the closest pleural surface. The remaining parenchyma of. the right upper lobe is homogeneously dark brown and unremarkable. Cross sections of the right middle lobe are homogeneously dark brown,. spongy and unremarkable. Within the superior segment of the right lower lobe, a well-circumscribed. tumor is noted measuring 5.0 x 4.0 x 4.4 cm. The cut surface of the. tumor is homogeneously white and firm; located 5.5 cm from the bronchial. resection margin. Cross sections of the tumor show that it abuts the. pleural surface, causing ""pleural puckering"". Further sections reveal. gross invasion into the pleura. Approximately 1.5 cm from the larger. mor, a smaller calcified nodule is noted (within the base of the right. lower lobe) measuring 0.4 x 0.3 x 0.2 cm. The remaining parenchyma of. Page: 5 of 10. the right lower lobe is homogeneously dark brown and otherwise. unremarkable. Multiple lymph nodes are noted throughout the right lung, ranging from. 0.3 to 2.8 cm. Four pieces of tumor and four pieces of normal lung. parenchyma have been taken for tissue banking. The bronchial resection. margin has been removed (en face) and submitted for intraoperative. consultation by frozen section. Representative sections are submitted as follows: 8A. bronchial resection margin, frozen section block resubmitted. ^B-8C. smallest tumor in RUL, EIT. )-8E. mid sized tumor in RUL, EIT. 8F. section containing both smallest and mid sized tumor, RUL. 8G. representative section of largest tumor RUL, showing. invasion into bronchus. 8H. representative section of largest tumor RUL, showing. invasion into adjacent lymph nodes. 8I-8J. representative sections of largest tumor, RUL. 8K-8L. representative sections of normal lung parenchyma, RUL. 8M-80. representative sections of RML. 8P-8Q. representative sections of larger tumor within RLL with. adjacent pleura (showing invasion). 8R-8T. representative sections of larger tumor within RLL. 8U. calcified nodule within base of RLL, EIT. 8V-8W. representative sections of largest lobar lymph node, RUL. 8X. one segmental lymph node, RUL. 8Y-8AB. one bisected segmental lymph node per block, RUL. 8AC-8AD. one trisected segmental lymph node per block, RUL. 8AE. one fragmented segmental lymph node, RUL. 8AF. two subsegmental lymph nodes, RUL. 8AG. one subsegmental lymph node, RUL. 8AH-8AK. one bisected subsegmental lymph node per block, RUL. 8AL-8AM. one bisected lobar lymph node per block, RLL. 8AN. one trisected lobar lymph node, RLL. 8AO-8AP. one bisected segmental lymph node per block, RLL. 8AQ-8AR. one trisected segmental lymph node per block, RLL. 8AS. four subsegmental lymph nodes, RLL. 8AT. three subsegmental lymph nodes, RLL. 'U. one subsegmental lymph node, RLL. JAV-8AX. one bisected subsegmental lymph node per block, RLL. Page: 6 of 10. QUICK SECTION. 2A, 3A-3B, 7A-7C, 8A = negative for malignancy. 4A - atypical cell present, can't rule out malignancy. 5A - mets carcinoma, large cell type. 6A - atypical cells present, consistent with malignancy. Addendum Comment. The case was reviewed by. Services. A copy of. has been scanned into. co-path which is as LOILOWS: ADMITTING DR. : PHYSICIAN NOT ON FILE. CLINICAL DATA AND MATERIAL SUBMITTED. Page: 7 of 10. Consult received from. A. , 64 stained slides and report dated. All original stained slides will be returned along with a copy of this. FINAL DIAGNOSIS. RIGHT LUNG, PNEUMONECTOMY WITH CHEST WALL RESECTION. : SQUAMOUS CELL CARCINOMA, POORLY DIFFERENTIATED. : VISCERAL PLEURA INVOLVED BY TUMOUR. : BRONCHIAL MARGIN CLEAR. TETASTATIC SQUAMOUS CELL CARCINOMA IN RIGHT UPPER LOBE, SEE COMMENT. JULTIPLE INFARCTS, UPPER LOBE. LYMPH NODES, PERIBRONCHIAL. : METASTATIC SQUAMOUSCELL CARCINOMA (6 OF 31). LYMPH NODE, STATION 11 INTERLOBAR, BIOPSIES. : METASTATIC SQUAMOUSCELL CARCINOMA. LYMPH NODE, STATION 12 RIGHT LOBAR, BIOPSY. : FIBROUS SCARRING, NEGATIVE FOR MALIGNANCY. LYMPH NODES, STATION 9 INFERIOR PULMONARY LIGAMENT AND STATION 7. SUBCARINAL, BIOPSIES. : NEGATIVE FOR MALIGNANCY. LYMPH NODES, STATION 12 RIGHT LOBAR, STATION 10 RIGHT TB ANGLE, BIOPSIES. : NEGATIVE FOR MALIGNANCY. (Cont 'd). Page : 8 of 10. o. C. F. ADMITTING DR. : PHYSICIAN NOT ON FILE. NOPTIC REPORT FOR LUNG CANCER RESECTION. SPECIMEN TYPE: Right pneumonectomy. HISTOLOGIC TYPE : Squamous cell carcinoma. HISTOLOGIC GRADE: Poorly differentiated. PRIMARY TUMOUR SIZE: 5.0 cm x 4.0 cm x 4.4 cm. PRIMARY TUMOUR SITE: Right lower lobe. ADDITIONAL TUMOUR. NODULES: Right upper lobe nodule measuring 3.0 x. 3.0 x 2.3 cm. EXTENT OF TUMOUR. VISCERAL PLEURA: Involved by tumour. PARIETAL PLEURA: Not involved. CHEST WALL: Not involved. LYMPHATIC INVASION: Present. VASCULAR INVASION: Present. OTHER STRUCTURES: Not applicable. MARGINS OF EXCISION. BRONCHIAL MARGIN: Clear of tumour. MEDIASTINAL MARGIN: Clear of tumour. OTHER MARGINS: Not applicable. MPH NODES. N1: 6 of 31 peribronchial nodes negative malignancy. Page: 9 of 10.",T2,N1,M1,T2N1M1
TCGA-G2-A2EO,"Pathology Review. DIAGNOSIS. (A) LEFT VAS: Segment of vas deferens, no tumor present. (B) LEFT URETER: Segment of ureter with mild reactive atypia, no tumor present. (C) RIGHT VAS: Segment of vas deferens, no tumor present. (D) RIGHT URETER: Segment of ureter, no tumor present. (E) BLADDER, PROSTATE AND SEMINAL VESICLES: Bladder: UROTHELIAL CARCINOMA, NONPAPILLARY TYPE, GRADE 3. TRANSMURAL INVASION OF BLADDER WALL WITH FOCAL. EXTENSION INTO PERIVESICAL ADIPOSE. TISSUE. UROTHELIAL CARCINOMA IN SITU IN A BACKGROUND OF. DIFFUSE LOW GRADE INTRAUROTHELIAL. NEOPLASIA. Serosal and resection margins, free of tumor. Prostate: Prostate with microcystic adenomatous change. No evidence of. malignancy. (F) RIGHT COMMON ILIAC LYMPH NODES: Fibroadipose tissue, no lymph node or tumor present. (G) RIGHT EXTERNAL ILIAC LYMPH NODE: Four lymph nodes, no tumor present (0/4). (H) RIGHT OBTURATOR LYMPH NODE: Seven lymph nodes, no tumor present (0/7). (I) LEFT COMMON ILIAC: Five lymph nodes, no tumor present (0/5). (J) LEFT EXTERNAL ILIAC: Two lymph nodes, no tumor present (0/2). (K) LEFT OBTURATOR: Ten lymph nodes, no tumor present (0/10). (L) LEFT URETER, FINAL MARGIN: Wall of ureter, no tumor present. (M) RIGHT URETER, FINAL MARGIN: Wall of ureter, no tumor present. GROSS DESCRIPTION. (A) LEFT VAS - A white-tan portion of vas deferens measuring 5 cm in length x 0.3 cm. in diameter. A lumen is present on the cut surfaces. Specimen is representatively. submitted in A. (B) LEFT URETER - A segment of ureter 0.8 cm long and 0.1 cm in diameter with. surrounding fibroadipose tissue. The resection margin is inked by the surgeon and entire. specimen is submitted for frozen in block B (ink side down, en face). FS/DX: BENIGN URETER. (C) RIGHT VAS - A segment white-tan vas deferens measuring 5.5 cm in length x 0.3. cm in diameter. A pinpoint lumen is visible in the cut surfaces. Specimen is. representatively submitted in C. (D) RIGHT URETER- - A segment of ureter (1.0 x 0.7 cm). The margin, designated by. the surgeon with ink, is reinked blue and submitted en face for frozen section in D. FS/DX: BENIGN URETER. (E) BLADDER, PROSTATE AND SEMINAL VESICLES - A cystoprostatectomy. measuring overall (14 x 7.5 x 7 cm). The specimen is opened longitudinally through the. superior wall to reveal a fungating tumor (9 x 7 x 2.5 cm) involving the near entire. anterior bladder wall and dome. The tumor appears to invade the muscular wall of the. bladder but does not extend into the perivesical adipose tissue. The remaining bladder mucosa shows hemorrhage, especially in the trigone, and. is other unremarkable. INK CODE: Black - outer surface of anterior wall. SECTION CODE: E1-E48, bladder with tumor; E49-E57, prostate; E58, E59,. urethra, en face. (F) RIGHT COMMON ILIAC LYMPH NODES - A single red tan piece of tissue. measuring 2.4 x 1.5 x 1 cm. Three potential lymph nodes are palpated, ranging in size. from 0.4 to 0.6 cm in greatest dimension. No tumor is seen grossly. Specimen is entirely. submitted. SECTION CODE: F1, three potential lymph nodes; F2, remainder of specimen. (G) RIGHT EXTERNAL ILIAC LYMPH NODE - Multiple red tan pieces of adipose. tissue measuring 4.9 x 4 x 1 cm in aggregate. Five possible lymph nodes are found,. ranging in size from 0.5 to 3.7 cm in greatest dimension. No tumor is seen grossly. Specimen is entirely submitted. SECTION CODE: G1, three potential lymph nodes; G2, G3, single lymph node;. G4, G5, single lymph node. (H) RIGHT OBTURATOR LYMPH NODE - Multiple red tan pieces of adipose tissue. measuring 5 x 2.5 x 2cm in aggregate. Seven potential lymph nodes are found, ranging. in size from 0.4 to 2.6 cm in greatest dimensions. No tumor is seen grossly. SECTION CODE: H1, four potential lymph nodes; H2, one potential lymph. node; H3, one potential lymph node; H4, H5, single lymph node, sectioned. (I) LEFT COMMONILIAC - Received is a 3.5 x 3.0 x 1.0 cm portion of fibroadipose. tissue, which yields multiple possible lymph nodes, ranging from 0.6 cm to 1.5 x 0.8 x. 0.6 cm. The lymph nodes are submitted entirely. SECTION CODE: I1, three lymph nodes; I2, two lymph nodes. (J) LEFT EXTERNAL ILIAC - Received is a 5.0 x 4.2 x 1.0 cm portion of fibroadipose. tissue which yields two possible lymph nodes, measuring 2.0 x 0.8 x 0.5 cm and 3.0 x 1.5. x 0.5 cm. Both lymph nodes are submitted entirely. SECTION CODE: J1, one lymph node; J2, J3, one lymph node, serially. sectioned. (K) LEFT OBTURATOR - Multiple fibroadipose tissue fragments (6.5 x 4.0 x 1.0 cm). Eleven possible lymph nodes, ranging from 0.5 to 2.5 cm in greatest dimension are. identified and are submitted in toto. SECTION CODE: K1, four lymph nodes; K2, three lymph nodes; K3, one lymph. node, bisected; K4, one lymph node, bisected; K5, one lymph node, bisected; K6, one. lymph node, bisected. (L) LEFT URETER FINAL MARGIN - A segment of ureter (1.7 x 0.6 cm). The true. margin. designated by the surgeon with ink, is reinked blue and submitted en face in L. (M) RIGHT URETER FINAL MARGIN - A segment of ureter (0.8 x 0.8 cm). The. margin, designated by the surgeon with ink, is reinked blue and submitted en face in M. CLINICAL HISTORY. None given.",T3,N0,M0,T3N0M0
TCGA-AR-A256,"Final Diagnosis. ast, right, mastectomy: Infiltrating ductal carcinoma, Nottingham. grade III (of III), forming a 2.5 x 2.5 x 2 cm mass. Ductal carcinoma. in-situ is not identified (AJCC pT2). Surgical margins and nipple. are negative for tumor. Lymph nodes, right sentinel axillary (No. 1 and No. 2) and right axillary,. excision: Multiple (3) right sentinel axillary lymph nodes and (2) right. axillary lymph nodes are negative for tumor. Breast, right, biopsy: Small fragment of skin and adipose tissue,. negative for tumor. Breast, left, mastectomy: Proliferative fibrocystic changes characterized. by fibrosis, sclerosing adenosis and cyst formation. A single 0.5 cm. fibroadenoma with myxoid degeneration is identified. Immunohistochemical studies with antibodies against cytokeratin show the. sentinel lymph nodes #1 and #2 to be negative for metastatic carcinoma. Immunohistochemical stains for estrogen and progesterone receptors are. negative in neoplastic cells.",T2,N0,M0,T2N0M0
TCGA-AA-A01P,"Diagnosis: This is a poorly differentiated adenocarcinoma of the ascending colon with partial. neuroendocrine differentiation, with a histopathological grade G3 differentiation, with. extensive necroses, with substantial with peritumorous, chronic inflammation, with tumor. infiltration in the layers of the colon wall as far as the pericolic fatty connective tissue,. with carcinomatous lymphangiosis, with a regional lymph node metastasis (1/21), tumor-. free overview sections from the resection margins and from the attached reticular fatty. tissue, as well as chronic appendicitis. According to these prepared sections, the tumor spread of the colon carcinoma. corresponds to the tumor stage pT3, pN2, MX, L1.",T3,N1,M0,T3N1M0
TCGA-DK-AA6M,"F. Urology. Clinical Diagnosis & History: year old female, history of TCC in. , TCC Ta HG, after 6x BCG, now with bladder tumor. Specimens Submitted: 1: Bladder, right lateral wall, TURB. DIAGNOSIS: 1. Bladder, right lateral wall, TURB: Tumor Type: Invasive urothelial carcinoma, NOS. with sarcomatoid and anaplastic features. Histologic Grade: High grade. Pattern of growth of the non-invasive component: Flat (in situ carcinoma). Local Invasion: Muscularis propria. Vascular Invasion: Not identified. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1. The specimen is received in. labeled ""right lateral wall"", and consists of multiple pieces of tan soft tissue. measuring 3.0 x 2.0 x 0.7 cm in aggregate. The specimen is entirely submitted in two cassettes. Summary of Sections: Part 1: Bladder, right lateral wall, TURB. Blocks Block Designation. PCs. 2. 2.",T2,N0,M0,T2N0M0
TCGA-AA-3984,"locally R0, additionally a villous adenoma with focally severe dysplasia (intraepithelial neoplasia. of the hisk-risk type) and a serrated adneoma and free lymph nodes (pN0).",T3,N0,M0,T3N0M0
TCGA-22-5480,"DIAGNOSIS: Lung, left upper lobe, lobectomy Grade 4 (of 4) squamous cell carcinoma forming a 2.0 x 2.0 x. 1.5 cm mass located 1.8 cm away from the bronchial margin, which is negative for tumor. histologically, as are multiple (10) intrapulmonary peribronchial lymph nodes and the visceral. pleura. Soft tissue, left hilar region, excision: Grade 4 (of 4) non-small cell carcinoma with. squamous features. Lung, left lower lobe, excision: Intraparenchymal lymph node, negative for neoplasm, but non-. necrotizing granulomatous inflammation is present. The findings of special. stains. for. microorganisms (AR,GMS) will be reported separately in an addendum. Lymph nodes, superior mediastinal, aortic, inferior mediastinal, left lower lobe bronchus,. excision: Multiple superior mediastinal (9 tracheobronchial), aortic (4 aortopulmonary, 3. anterior mediastinal), inferior mediastinal (5 subcarinal, 4 inferior pulmonary ligament). and. (2) left lower lobe bronchus lymph nodes are negative for tumor.",T1,N0,M0,T1N0M0
TCGA-D5-6923,"page 1 / 1. copy No. 2. Examination: Histopathological examination. Cost of diagnostic procedure. Material: Multiple organ resection - segment of the large intestine. Expected time of examination: Clinical diagnosis: Cancer of the sigmoid colon. Macroscopic description: A 12 cm length of the large intestine with fat tissue sized 14 X 6 x 9.5 cm. Tumour sized 4 X 3 X 1.5 cm detected. in the mucosa. The lesion surrounding 50% of the intestine circumference, removed by 5 cm from one of the. incision lines, and 5.3 from the opposite one. The lesion infiltrates macroscopically the muscular membrane. Diverticulum 1 cm in diameter found outside the tumour. Microscopic description: Adenocarcinoma tubulopapillare (G2). Infiltratio carcinomatosa profunda tunicae muscularis propriae . Incision. lines free of neoplastic lesions. Lymphonodulitis reactiva (No XI). Histopathological Diagnosis: Adenocarcinoma tubulopapillare coli. Tubulopapillar adenocarcinoma of the colon. (G2, Dukes B, Astler - Coller Bl, pT2, pNO). CONTACT YOU DOCTOR WITH THIS REPORT!.",T2,N0,M0,T2N0M0
TCGA-D7-6527,"page 1 / 1. Examination: Histopathological examination. Material: 1. Total organ resection - stomach. Expected time of examination. Clinical diagnosis: Cancer of the cardia. Macroscopic description: Sent material containing the stomach, incised along the greater curvature, sized 19.6 x 12.7 cm with the omentum sized 29 x 10. cm. Tumour sized 5.2 x 4.1 x 0.4 cm with an ulceration sized 4.6 x 3.8 found in the cardiac region on the lesser curvature. Distance from the proximal end 0.5 cm, from distal end 11.8 cm. Microscopic description: Adenocarcinoma tubulare (G2). Infiltratio carcinomatosa profunda tunicae muscularis propriae ventriculi et partietis oesophagi. Emboliae carcinomatosae vasorum. Margins of normal tissues as in the macroscopic description. Incision lines free of neoplastic lesions. Outside tumour: Gastritic chronica (+++) non activa (+). Metaplasia intestinalis (+++) completa. LYMPH NODES: - periorificial (L, N) - metastases carcinomatosae in lymphonodo (No I/IV). Infiltratio carcinomatosa capsulae lymphonodi. - of lesser curvature (O, P) - lymphonodis reactiva No VIII. - of greater curvature (R) - lymphonodis reactiva No I. - peripyloric (S) - lymphonodis reactiva No I. Histpathological diagnosis: Adenocarcinoma papillare ventriculi: Papillar adenocarcinoma of the stomach. metastases in lymphonodo regionalio No I/XIV. Cancer metastases of the regional lymph nodes (No I/XIV). Emboliae carcinomatosae. Cancerous emboli. G2, pT2, pN1.",T2,N1,M0,T2N1M0
TCGA-AR-A255,"Final Diagnosis. east, right, wide local excision: Infiltrating ductal carcinoma, Nottingham grade II (of III) [tubules 3/3, nuclei 3/3, mitoses 1/3;. Nottingham score 7/9], forming a mass (1.3 x 1.3 x 1.2 cm) [AJCC pTlc]. Ductal carcinoma in situ, intermediate nuclear grade,. comprises <5% of the tumor volume. Angiolymphatic invasion is absent. Biopsy site changes are present. All surgical resection. margins are negative for tumor (minimum tumor free margin, 0.7 cm, inferior margin). Lymph nodes, right axillary sentinel, excision: Multiple (2) right axillary sentinel lymph nodes are negative for metastatic. carcinoma. [AJCC pNO (i-) (sn)]. Blue dye is identified in right axillary sentinel lymph node No. 1. Blue dye is not identified in. right axillary sentinel lymph node No. 2. Immunohistochemical cytokeratin stain was performed on the paraffin embedded sentinel lymph node tissue and confirms the. H&E impression. Faxitron done.",T1,N0,M0,T1N0M0
TCGA-UT-A97Y,"A-UT-A97Y-01A-PR. Copy Sent to. CLINICAL INFORMATION. Mesothelloma. MACROSCOPIC DESCRIPTION. then file this document. Labelled ""Right parletal pleura"". Specimen consists of multiple pieces of cream to grey and haemorrhagic fibrous and membranous. tissue measuring from 13x7x6mm up to 30x18x8mm. MICROSCOPIC DESCRIPTION. The specimen consists of portions of pleura which show abundant surface fibrinous exudate showing. transition to a zone of fibrosis containing a malignant infiltrate. The malignant cells are arranged in. poorly cohesive clusters, cords and singly in a background of fibrosis. The cells have enlarged nuclei. with focally prominent nucleoli and a variable amount of eosinophilic to slightly vacuolated cytoplasm. There are psammoma bodies associated with the infiltrate. PAS diastase stain shows. Immunohistochemistry shows the tumour is strongly positive for CK7, weakly positive for CK20,. positive for 34Beta12, strongly positive for calretinin and weakly positive for CA125. TTF-1 is negative. The findings are consistent with malignant mesothelloma, epithelial type. CONCLUSION. RIGHT PARIETAL PLEURAL BIOPSY. -- MALIGNANT MESOTHELIOMA, EPITHELIAL TYPE.",T1,N0,M0,T1N0M0
TCGA-B0-4852,"FINAL DIAGNOSIS: KIDNEY, LEFT, RADICAL LAPARASCOPIC NEPHRECTOMY-. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE. B. THE CARCINOMA MEASURES 8.8 CM IN GREATEST DIMENSION AND HAS A FUHRMAN GRADE OF 2 OUT OF 4. C. THE TUMOR IS CONFINED TO THE KIDNEY AND DOES NOT EXTEND INTO THE PERINEPHRIC FAT. D. ALL SURGICAL RESECTION MARGINS ARE FREE OF TUMOR. E. NO EVIDENCE OF ANGIOLYMPHATIO INVASION. F. PATHOLOGIC STAGE T2NxMx. G. UNINVOLVED RENAL PARENCHYMA UNREMARKABLE.",T2,N0,M0,T2N0M0
TCGA-86-A4D0,"Gross Description: Microscopic Description: Diagnosis Details: Comments: Formatted Path Reports: LUNG TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Lung. Tumor size: 6 x6x6cm. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Visceral pleura. Other tumor nodules: Not specified. Lymph nodes: 0/6 positive for metastasis (Regional 0/6). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: CK7, CD15, TTF-1 positive; CK10, P63 negattive. Comments: Right-upper.",T2,N0,M0,T2N0M0
TCGA-05-4432,"Main diagnosis/diagnoses: Peripheral bronchopulmonary, histologically mixed adenocarcinoma of the right upper lobe of. the lung with a very predominant large-cell and partly clear-cell, small acinar component,. focal mucin formation and bronchioloalveolar growth pattern at the tumor margin and. localization in S2. TNM classification on the basis of this material pT2 pN1 pMX RX, stage IIB. C34.1; M 8255/3. Comment/supplementary remark: The carcinoma shows infiltration and circumscribed perforation of the visceral pleura, which. explains the RX category. It has also produced a hilar lymph node metastasis. The resection. margin of the bronchus and vessels, the resection material from the middle lobe, the piece of. parietal pleura and the lymph nodes of samples 4 to 13 are tumor-free.",T2,N1,M0,T2N1M0
TCGA-69-8255,"De-Identified Specimen Code: M. SPECIMEN SUBMITTED: Part A: POSTERIOR SEGMENT RIGHT. UPPER LOBE. Part B: LEVEL 10 R. Final Diagnosis. 1. Right lung, upper lobe, wedge excision (A) Adenocarcinoma, solid predominant (40%) with. acinar (40%), and lepidic (20%) patterns. - Mild centrilobular emphysema. - See comment. 2. Lymph node, level 10R, excision (B) Hylanized lymph node, negative for neoplasm. Diagnosis Comment: 1. The tumor measures 1.6 cm in greatest dimension. No invasion into or through the pleural is seen. The. parenchymal margin of excision is negative for neoplasm. Further studies to define the origin of this. adenocarcinoma will be performed and the results of those studies reported as an addendum. Intraoperative Diagnosis: A. Adenocarcinoma. Margin negative. Clinical Diagnosis: LUNG NODULES. Gross Description: A. Received fresh for frozen section diagnosis labeled ""posterior segment right upper lobe"" is a wedge. of lung measuring 14.8 X 5.2 x 2.7 cm, and weighing 39.1 grams. A staple line is present and inked. orange. The pleural surface displays a puckered area measuring 1.2 X 0.8 cm and is located 3.2 cm. from the orange inked parenchymal margin. The remainder of the pleural surface is smooth and. glistening. The puckered area is inked blue. Upon sectioning, a stellate tan-gray firm nodule is identified. in the puckered region measuring 1.6 X 1.2 X 1.0 cm, and extending within 2.7 cm of the parenchymal. line of resection and appears to extend into, but not through the pleura. The remainder of the. parenchyma is unremarkable. Other masses, lesions, nodules are not present. The mass is totally. submitted. The nodule is totally submitted as follows: A1 nodule with closest pleural involvement, A2. perpendicular line of resection representative section, A3-A5 nodule with pleural surface, A6 remainder. of nodule totally submitted, A7 additional representative section of parenchymal margin, A8. representative section of apparent uninvolved tissue. B. Received fresh is a tan-black nodule resembling lymph node measuring 0.4 X 0.3 X 0.2 cm. The. specimen is not sectioned. Totally submitted in one cassette. Microscopic: {Not Entered}.",T1,N0,M0,T1N0M0
TCGA-E2-A14Z,"SPECIMENS: A. SLN #1. B. LEFT BREAST EXCISION. C. ADDITIONAL MARGIN MEDIAL, ANTERIOR, POSTERIOR. SPECIMEN(S): A. SLN #1. B. LEFT BREAST EXCISION. C. ADDITIONAL MARGIN MEDIAL, ANTERIOR, POSTERIOR. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA-SLN #1: Negative for tumor called by Dr to Dr at. B: Gross only, tumor 0.1 cm from medial margin called by Dr. to Dr. at. GROSS DESCRIPTION: A. SLN #1. Received fresh is a 3.5 x 1.1 x 0.4 cm piece of soft tissue containing a lymph node. A touch prep is performed;. lymph node is submitted in cassette A1. B. LEFT BREAST. Received fresh labeled with the patient's identification and ""left breast"" is an oriented (single-anterior, double-lateral). 43 g, 4.1 x 3.2 x 3 cm lumpectomy without radiograph. The specimen has been inked in OR per protocol: Anterior-. yellow, posterior-black, medial-green, lateral-red, superior-blue, inferior-orange. Specimen is serially sectioned from. lateral to medial into 6 slices revealing a 1.9 x 1.4 x 1.3 cm firm tan circumscribed mass that is closest to the medial. margin at less than 0.2 cm. Tissue is procured. Representatively submitted. B1: lateral margin, perpendicular sections. B2: slice 3, mid posterior, mass. B3: slice 3, posterior inferior, mass. B4: slice 4, lower anterior, mass. B5: slice 5, superior anterior. B6: slice 5, superior posterior. B7: slice 5, mid anterior. B8: slice 5, mid posterior, mass. B9: slice 5, inferior anterior. B10: slice 5, inferior posterior. B11-B12: medial margin, perpendicular sections. C. ADDITIONAL MEDIAL, ANTERIOR-POSTERIOR MARGIN. Received fresh labeled with the patient's identification and ""additional medial, anterior-posterior margin"" is an. oriented (suture at final margin) 7 g, 0.7 x 3.2 x 0.9 cm fibrofatty tissue. Final margin is inked black. Serial. sectioning reveals no discrete lesions. Entirely submitted in cassettes C1-C5. DIAGNOSIS: A. LYMPH NODES, SENTINEL #1 left axilla, excision: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). B. BREAST, LEFT, WIDE LOCAL EXCISION: - INVASIVE ductal CARCINOMA, SBR GRADE 3, MEASURING 1.6-CM. - Tumor present 2-mm from inferior surgical margin (closest margin). -biopsy site changes with fibrosis. - SEE SYNOPTIC REPORT. C. BREAST, ADDITIONAL MEDIAL ANTERIOR POSTERIOR MARGIN, EXCISION: - BREAST TISSUE, NO TUMOR SEEN. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.6cm. Tumor Site: Upper outer quadrant. Margins: Negative. Distance from closest margin: 0.2cm. inferior. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/1. DCIS not present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by IHC. Performed on Case: Pathological staging (pTN): pT 1c N 0. CLINICAL HISTORY: Left breast infiltrating cancer upper outer quadrant. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. Microscopic/Diagnostic Dictation: Final Review: Pathologist,. Final: Pathologist,.",T1,N0,M0,T1N0M0
TCGA-63-A5MB,"Sample Type TUMOUR. Diagnosis. Squamous Cell Carcinoma, Not Otherwise Specified (NOS). Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). Left upper lobe. Tumour Size (cm). 3. Histology. Squamous carcinoma. Grade/Differentiation. II. Pathological T. T2,NOS. Pathological N. Clinical M. MO. VALCSG Stage. Histology Comments. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.",T2,N0,M0,T2N0M0
TCGA-18-3412,"SPECIMEN (s) RECEIVED. 1. Lung Station 11L. 2. Lymph node: Lobar ST12. 3. Lungs Left lower lobe - bronchial resection margin. 4. Lungs Completion left pneumonectomy - bronchial resection margin. 5. Lymph node: Aorto-pulmonary ST5. DIAGNOSIS. 1., 2. Interlobar ST11, lobar ST12: - Negative for malignancy, lymph node. 3. Left lower lobe lung lobectomy : - Squamous cell carcinoma, moderately differentiated, central. Tumor greatest diameter 4.7 cm. At the hilum, tumor has invaded into peribronchial fatty tissue. 2 lobar peribronchial lymph nodes negative for tumor. Bronchial resection margin positive for tumor involvement. 4. Left completion pneumonectomy : Microscopic residual squamous cell carcinoma noted in hilar area. All 4 lobar and 3 segmental peribronchial lymph nodes negative for. tumor. One focus of effete granuloma involving pleural lymph node. Focal pleural and parenchymal fibrosis. - Remaining lung parenchyma unremarkable. Bronchial resection margin negative for tumor. 5. Aorto-pulmonary ST5: Negative for malignancy, lymph node. COMMENT. conjunction with the negative mediastinal lymph node biopsy results. this tumor is staged as a pT2NO cancer. Page: 1 of 4. CLINICAL HISTORY. CANCER OF LEFT LUNG. GROSS DESCRIPTION. 1. The specimen container labeled with the patient' s name and as. interlobar ST11"", contains two pieces of gray-black nodal tissue. asuring 1.0 x 0.4 x 0.2 cm and 1.8 x 0.8 x 0.4 cm. received in 10%. buffered formalin. The larger piece is bisected. 1A - submitted in toto. 2. The specimen container labeled with the patient S name and as ""lobar. ST12"", contains a large black lymph node measuring 1.0 x 0.8 x 0.4 cm. received in 10% buffered formalin. 2A - bisected and submitted in toto. 3. The specimen container labeled with the patient S name and as ""left. lower lobe - bronchial resection margin"", contains a lobe of lung that. measures 15.5 x 14. x 5.7 cm in formalin-inflated state. The pleura is. intact, mostly smooth and partly hemorrhagic. On the medial aspect. adjacent to the bronchus there is ragged soft tissue adhered. On the. medial anterior aspect extending from the apex to the inferior aspect. there is a staple line margin measuring 14.0 cm long. The bronchial. resection margin is examined at intraoperative consultation by frozen. section. On sectioning the lung, there is a central tumor mass present. measuring 4.7 cm in maximum diameter. The mass is solid tan-white with. some gray-black query segmental lymph nodes admixed. Grossly the tumor. appears to extend beyond the pleura and into the overlying ragged area of. soft tissue which is adjacent to the bronchus. In this area the soft. tissue is painted with silver nitrate. The tumor invades into the lobar. bronchus and into the segmental bronchi. The tumor is also 2.0 cm away. from the staple line resection margin. The rest of the lung parenchyma. ranges from unremarkable to mildly emphysematous with more prominence at. the apex. Four pieces of tumor and four pieces of grossly normal lung. prenchyma are taken for tissue banking. A. - bronchial resection margin, frozen section resubmitted. 3B-3D - tumor with overlying ragged soft tissue. Page: 2 of 4. 3E, 3F - tumor with invasion into lumen of bronchus and ?segmental lymph. nodes admixed. 3G, 3H - grossly normal lung parenchyma away from tumor. 3I - shaved staple line resection margin closest to tumor. - one possible lobar lymph node measuring 0.7 cm. 4. The specimen container labeled with the patient s name and as. ""completion left pneumonectomy bronchial resection margin"", contains a. lobe of lung received in 10% buffered formalin. It measures 17.5 x 13. 0. x. 4.5 cm in its formalin-inflated state. The pleura is intact, smooth and. shiny. The main stem bronchus is cut long measuring N 3.0 cm and is. tent and unremarkable. Along the medial aspect adjacent to the bronchus. there is a staple line which measures 16.0 cm long from the apex to. inferior aspect. Several black lobar and interlobar lymph nodes are. identified, the largest 0.8 cm in diameter. On sectioning the lung, no. lesions are identified. The parenchyma is mostly normal appearing with. very mild emphysematous changes present at the periphery. Several black. segmental lymph nodes are identified. The bronchial resection margin is. examined at intraoperative consultation by frozen section. 4A - bronchial resection margin, frozen section resubmitted. 4B - three lobar lymph nodes. 4C - one lobar lymph node bisected. 4D - ?one interlobar lymph node. 4E - three segmental lymph nodes. 4F - ?one bisected subsegmental lymph node or peripheral nodule measuring. 0.8 cm in diameter. 4G - thickened firm area of vessel. 4H-4J - lung parenchyma. 4K left lower lobe bronchial resection margin at main stem bronchus. 4L, 4M main stem bronchus serially sectioned transversely. 4N vascular resection margin. 5. The specimen container labeled with the patient' S name and as. aorto-pulmonary ST5"", contains two pieces of gray-black nodal tissue. measuring 0.3 x 0.3 x 0.3 cm and 0.9 x 0.8 x 0.4 cm. received in 10%. buffered formalin. The larger is bisected. 5A - submitted in toto. 1A ""POSSIBLE FOR SQUAMOUS CELL CA"". Page: 3 of 4. Page : 4 of 4.",T2,N0,M0,T2N0M0
TCGA-63-A5MI,"Sample Type TUMOUR. Diagnosis. Squamous Cell Carcinoma, Not Otherwise Specified (NOS). Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). Left lower lobe. Tumour Size (cm). 9.5. Histology. Squamous carcinoma. Grade/Differentiation. II. Pathological T. T2,NOS. Pathological N. N2. Clinical M. M0. VALCSG Stage. Histology Comments. Metastatic carcinoma in 4/9 segmental and lobar lymph. nodes. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.",T2,N2,M0,T2N2M0
TCGA-BP-4346,"Clinical Diagnosis & History: Right renal mass. Specimens Submitted: 1: Kidney, right, total nephrectomy. 2: Lymph node, precaval and paracaval, excision. 3: Adrenal gland and suprahilar lymph nodes, right, resection. DIAGNOSIS: 1. Kidney, right, total nephrectomy. Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade III/IV. Tumor Size: Greatest diameter is 6.9 cm,. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Invasion into renal sinus muscular branches of renal vein is identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Mild arteriosclerotic changes, and a benign cortical cyst. Adrenal Gland: Not identified. (See part 3). Lymph Nodes: Not identified. Staging for renal cell cercinoma/oncocytoma: pT3b Tumor grossly extends into the renal vein(s) or vena cava below the diaphragm. 2. Lymph node, precaval and paracaval, excision. Lymph Nodes: Not invalved. Number of nodes examined:21. 3. Adrenal gland and suprahilar lymph nodes, right, resection. Benign adrenal gland. Multiple benign adrenal cartical nodules In the surrounding soft tissue. No lymph nodes identified. Special Studies: Special Stain. Camment. RECUT. RECUT. RECUT. RECUT. RECUT. Gross Description: 1). The specimen is received fresh labeled ""Right kidney"" and consists of a kidney with attached ureter, renal vessels and. perinephric fat weighing 608 g in total. The total dimensians of the specimen are 22 x 12 x 6.5 cm. The kidney itself measures. 15 x 7.5x5cm. The outer surfece of the perinephric fat is inked black, The attached ureter measures 9.0 cm in length and 0.4. cm. in diamater. The attached renal vein measures 1.5 cm in length and 0.8 cm In diameter. The renal vessels and ureter margins are. grossly unremarkable. Adrenal gland is not identified. The kidney is bivalved to reveal a well-circumscribed, labulated, yellaw-tan. hemorrhagic cortico-medullary tumar measuring 6,9 x 4,9: x 4,0 cm. The tumar is situated in the upper pole of the kidney, and. grossly impinges the sinus fat and renal pelvis, but does not show any definite invasion. The adjacent vessels appear grossly free. of tumor. The tumor bulges into the perinephric fat, which shows possible tumor involvament. Sections through the remainder of. the kidney reveal a pink brown parenchyma, with a well-defined cortico-medullary junction. There is a cystic area identified. measuring 1.1 x 1 .0 cm, which is lined by unremarkable brown renal parenchyma and filled with clear fluid, The cartex measures. 3.0 cm and the calyces appear normal. On complete opening of the ureter, renal pelvis, and collecting ducts, they show smooth. white. tan unremarkable mucosa. No lymph nodes are identified in the perinephric fat. The specimen has baan photographed. Summary of sections: UM the ureteral margin. VM-vessel margins. FUP-representative section of fat from upper pole. T-- tumor. HF--hilar fat. TP-tumor and renal pelvis. TSF -- tumar with sinus fat. TSFV-tumar with sinus fat and adjacent vessel. TN-. tumor with adjacent kidney. RS-- representative section kidney, cystic area. TPNF - tumar and perinephric fat. 2). The specimen is received fresh, labeled ""Precaval and paracaval lympn nodes and consists of multiple pink tan fatty lymph. nodes measuring from 0.5 to 1.7 cm in greatest dimension. The lymph nodes are entirely submitted. Summary of sections: LN- lymph nades. 3). The specimen is received fresh, labeled ""Right adranal gland, and suprahilar lymph nodas"" and consists of an adrenal gland. with attached yellow tan adipose lissue measuring 8 x 4,5 . x 1 cm and weighing 20 g in total. Serial sactions reveal a golden yellow. adranal gland paranchyma measuring 4 X 1.8 X 1.5 cm. On cross sactions, the gland is grossly unremarkable. A few possible. lymph nodes are identified ranging from 0,6 to 1.4 cm in greatest dimension. Tha gland is entiraly submittad. All idantifiad lymph. nodes are submitted. Summary of sections: LN -lymph nodes. SS- serial sections adrenal gland. Summary of Sections: Part 1: Kidney, right, total nephrectomy. Block. Sect. Site. PCs. FUP. 1. HF. 1. RS. 1. 2. 2. 1. 1. TP. 4. TPNF. 4. TSFV. 1. 2. UM. 2. 1. VM. Part 2: Lymph noda, pracaval and paracaval, axcision. Block. Sect. Site. PCs. 4. LN. 4. Part 3: Adrenal gland and suprahilar lymph nodes, right, rasaction. Block. Sact. Sita. PCs. LN. 3. 8. SS. 8.",T3,N0,M0,T3N0M0
TCGA-DG-A2KK,"Sample Type TUMOUR. Sample Preparation. Fresh Frozen. Site of Primary (Event). Cervical. Site of Tissue. cervix - 12:00 position. Year of Sample Collection. Age at Sample Collection (yrs). Sample Comments. Days to Procedure Date. 0. Days to Diagnosis. 8. Type of Procedure. Surgical resection. Site of Primary (Histology). Cervix. Bilateral Disease. N/A. Tumour Size (cm). 2.5. Histology. Squamous cell carcinoma, invasive. Grade/Differentiation. Grade III (Poorly differentiated). Pathological T. T1b1. Pathological N. N1. Number of Nodes Sampled. 2. Number of Nodes Positive. 20. Clinical M. M0. Histology Comments.",T1,N1,M0,T1N1M0
TCGA-BB-4223,"RG PATH REPORT. GLECTION DATE/TIME: FINAL DIAGNOSTS. 1. SUPERIOR MUCOSAL MARGIN (Bx. ) : SALIVARY GLAND, NEGATIVE FOR. TUMOR. 2. LATERAL MARGIN (BX.) : ORAL MUCOSA, NEGATIVE FOR TUMOR. 3. INFERIOR MARGIN (BX.) : ORAL MUCOSA, NEGATIVE FOR TUMOR. 4. MEDIAL MARGIN (BX.) ORAL MUCOSA, NEGATIVE FOR TUMOR. TOOTH (EXTRACTION): TOOTH (GROSS DIAGNOSIS). LEFT NECK (MODIFIED DISSECTION) : LEVEL I: METASTATIC CARCINOMA INVOLVING ONE (1) OF SEVEN (7) LYMPH. NODES. HISTOLOGICALLY UNREMARKABLE SALIVARY GLAND. LEVEL II: METASTATIC CARCINOMA INVOLVING TWO (2) OF NINE (9) LYMPH. NODES. EX'TRACAPSULAR EXTENSION IS IDENTIFIED. LEVEL III: METASTATIC CARCINOMA INVOLVING ONE (1) OF SEVENTEEN (17). LYMPH NODES. HISTOLOGICALLY UNREMARKABLE SKELETAL MUSCLE. LEVEL IV: NINE (9) LYMPH NODES AND ASSOCIATED FIBROADIPOSE TISSUE,. NEGATIVE FOR TOMOR. LEVEL V: TEN (10) LYMPH NODES, NEGATIVE FOR TUMOR. IN TOTAL, METASTATIC CARCINOMA INVOLVES FOUR (4) OF FIFTY-TWO (52). IPH NODES. 7. LEFT TONSIL AND) SOFT PALATE (EXCISION) : INFILTRATING POORLY. DIFFERENTIATED, SQUAMOUS CELL CARCINOMA (3 CM) EXTENDING TO A DEPTH. OF 3 CM WITH INVASION OF DEEP SKELETAL MUSCLE. INFILTRATING. CARCINOMA IS PRESENT WITHIN 1 MM OF THE DEEP MARGIN. ALL OTHER. SURGICAL MARGINS ARE NEGATIVE FOR TUMOR. EXTENSIVE ANGIOLYMPHATIC. INVASION IS IDENTIFIED. ... Unofficial lab results - do not file in patient chart. Contact medical records for official chart copy. UNLESS OTHERWISE NOTED ON THR DETATI. FORMED AT:",T2,N2,M0,T2N2M0
TCGA-E2-A14W,"SPECIMENS: A. SLN #1. B. SLN #2. C. LEFT BREAST. D. SLN #3. E. UPPER OUTER QUANDRANT LEFT BREAST. F. SLN #4. G. INFERIOR MEDIAL LEFT BREAST MARGIN. SPECIMEN(S): A. SLN #1. B. SLN #2. C. LEFT BREAST. D. SLN #3. E. UPPER OUTER QUANDRANT LEFT BREAST. F. SLN #4. G. INFERIOR MEDIAL LEFT BREAST MARGIN. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA/TPB - SLN #1/SLN #2: Negative for tumor cells. TPD/TPF - SLN #3/SLI #4: Negative for tumor. Called by Dr to Dr. at. I (A, B). (D) and. (F). C - left breast: (gross exam only) 2.5 x 2 x 1.5 cm tumor located 1.2 cm from the closest/deep margin; tumor extends. to the nipple and areola, called by Dr. to Dr. at. GROSS DESCRIPTION: A. SLN #1. Received fresh is a tiny piece of lymphoid tissue within fibroadipose tissue, 0.4 x 0.2 x 0.2 cm. A touch prep is. performed; submitted entirely in cassette A1. B. SLN #2. Received fresh is a piece of lymphoid tissue within fibroadipose tissue, 0.4 x 0.2 x 0.2 cm. A touch prep is performed;. submitted entirely in cassette B1. C. LEFT BREAST, STITCH AT AXILLARY TAIL. Received fresh labeled with the patient's identification and ""left breast, stitch in axillary tail"" is an oriented 392g, 20. x. 14.5 x 2 cm mastectomy with 11.5 x 5.2 skin ellipse and 1.6cm inverted and ulcerated nipple. Ink code: Anterior/superior-blue, anterior/inferior-orange, posterior-black. The specimen is serially sectioned into 18 slices. from medial to lateral with the nipple in slice 5 revealing a 2.5 x 2 x 1.5 cm white-tan firm well-circumscribed mass. beneath the nipple, present in slices 5 to 7 that is 1.2 cm from the deep margin. A gross diagnosis was conveyed to. OR and tissue is procured. Representatively submitted: C1-C2: slice 5, mass and extension to nipple. C3: slice 5, mass and deep margin. C4: slice 6, superior posterior mass. C5: slice 6, anterior inferior mass. C6: slice 6, inferior posterior mass. C7: slice 7, mass and normal appearing parenchyma. C8: slice 8, normal appearing parenchyma adjacent to mass. C9: slice 3, upper inner quadrant. C10: slice 9, upper outer quadrant. C11: slice 10, lower outer quadrant. C12: slice 4, lower inner quadrant. C13: skin. C14-C17: nipple. C18: 1 axillary lymph node. D. SLN #3. Received fresh is a lymph node, 0.3 x 0.3 x 0.2 cm. A touch prep is performed and the lymph node is submitted. entirely for cassette D1. E. UPPER OUTER QUADRANT LEFT BREAST; STITCH AT NEW UPPER OUTER MARGIN. Received fresh labeled with the patient's identification and ""upper outer quadrant left breast; stitch at new upper. outer margin"" is an oriented 37g, 9 x 6.3 x 0.8 cm fibrofatty tissue. Final margin is inked black. Serial sectioning. reveals no discrete lesions. Representatively submitted in cassettes E1-E6. F. SLN #4. Received fresh is a lymph node, 0.3 x 0.3 x 0.2 cm. A touch prep is performed; submitted entirely in cassette F1. G. INFERIOR MEDIAL BREAST-LEFT; STITCH AT DEEP MARGIN. Received fresh labeled with the patient's identification and ""inferior medial breast-left; stitch at deep margin"" is an. oriented 3g, 4.1 x 2.5 x 0.6 cm fibrofatty tissue. Final margin is inked black. Serial sectioning reveals no discrete. lesions. Entirely submitted in cassettes G1-G4. DIAGNOSIS: A. SENTINEL LYMPH NODE #1, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). B. SENTINEL LYMPH NODE #2, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). C. BREAST, LEFT, MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED. (SBR GRADE 3), WITH ULCERATION OF THE NIPPLE. - TUMOR MEASURES 2.5 CM IN GREATEST DIMENSION. - MARGINS, NO TUMOR SEEN. - ONE LYMPH NODE WITH NON-NECROTIZING GRANULOMAS, NO TUMOR. SEEN (0/1) (SEE NOTE). NOTE: Special stains have been ordered on the lymph node and those results will be reported in an addendum. A. CD31 stain has been ordered for evaluation of lymphvascular invasion and those results will be reported in an. addendum. D. SENTINEL LYMPH NODE #3, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). E. BREAST, LEFT, UPPER OUTER QUADRANT, EXCISION: - FIBROADIPOSE TISSUE, NO TUMOR SEEN. F. SENTINEL LYMPH NODE #4, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). G. BREAST, LEFT, INFERIOR MEDIAL MARGIN, EXCISION: - FIBROADIPOSE TISSUE, NO TUMOR SEEN. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2.5cm. Tumor Site: Central. Margins: Negative. Distance from closest margin: Greater than 1cm. deep. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/5. DCIS not present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Positive by FISH. Pathological staging (pTN): pT2N0. CLINICAL HISTORK. year-old. recent dx of left breast cancer in. core biopsy. -IDC ER/PR positive, Her2. (illegible) Now for left mastectomy and sentinel lymph node biopsy-2 cm retroareolar mass. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. ADDENDUM: NOTE: A CD31 stain was performed on C4 and is negative showing no evidence of lymphvascular invasion. Special. stains (GMS, AFB, PAS) were performed on the lymph node (C18) and are negative showing no evidence of fungal. or acid fast organisms. The non-necrotizing granulomas would be consistent with the patient's history. Microscopic/Diagnostic Dictation: Pathologist,. Final Review: Pathologist,. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,.",T2,N0,M0,T2N0M0
TCGA-AA-A02W,"'nternal Sample ID: Diagnosis: This is a moderately differentiated adenocarcinoma of the sigmoid colon with. histopathological grade G2 differentiation, with erosions of the inner tumor surface, with. peritumorous, chronic recurrent concomitant inflammation, with tumor infiltration of the. parietal layers of the sigmoid colon extending to the outer layers of the tunica muscularis,. with chronic lymphadenitis of the tumor-free lymph nodes (0/12) and tumor-free overview. sections from the resection margins and from the region of the vascular ligature. According to these section preparations, the tumor spread of the sigmoid colon carcinoma. corresponds to a tumor stage of pT2, pNo, MX, R0.",T2,N0,M0,T2N0M0
TCGA-BA-A8YP,"SURGICAL PATHOLOGY REVISED REPORT. Diagnosis: A: ""Left radical neck and skin"", resection. - Metastatic squamous cell carcinoma in 2 of 66 lymph nodes. (2/66) with invasion of salivary gland and skeletal muscle;. maximum size of metastasis 6.3 cm by gross examination,. extracapsular extension identified. B: Tongue, pharynx, palate, ""left composite glossectomy;. pharyngectomy and palate resection, long suture anterior floor. of mouth, short suture medial tongue"", composite resection. Tumor histologic type: Invasive moderately differentiated. squamous cell carcinoma, focally keratinizing. Histologic grade: Moderately differentiated. Primary site: Left tonsil, left base of tongue with extension. into soft palate and floor of mouth. Tumor laterality: Left. Tumor focality: Unifocal. Tumor size: 4.7 cm by gross examination. Extent of invasion: Vascular : Present. Perineural : Not identified. Bone: Not identified. Ancillary studies: P16 IHC studies: P16 IHC has been ordered, results to be. reported in an addendum. HR, HPV ISH status High risk HPV ISH studies have been ordered,. results to be reported in an addendum. Carcinoma in situ: Present. Surgical margins: Invasive carcinoma focally involves the red. inked 6 to 9 o 'clock margin (B12) ; invasive carcinoma is. suspicious for focal involvement of the deep black inked margin. at 6 o'clock location (B21) where tumor focally extends to. cautery; multifocal deep inked margin with tumor less than 0.1. cm from margin and very close; remaining surgical resection. margins negative for definite tumor involvement. Lymph nodes : Separately submitted. Size of largest metastasis: 6.3 cm by gross examination. Extra-nodal extension: Present. AJCC Pathologic Stage: pT4a pN3. NOTE: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. C: Lymph node, left level 1, regional resection. - No tumor seen in six lymph nodes (0/6). - Benign salivary gland tissue. D: Mandible, left, excision. Decalcification pending; results to be reported in addendum. E: Mandible, right, excision. - Benign mandibular bone and mucosa with no tumor seen including. examined resection margins. F: Teeth, extraction. - Teeth for gross examination only. Clinical History: : The patient is a -year-old man with clinical T4a N3 MO left. tonsillar and tongue base squamous cell carcinoma with extension. to parotid gland, with large nodal mass of left neck with. involvement of skin and draining fistula. Gross Description: Received are six appropriately labeled containers. Container A is additionally labeled ""left radical neck and skin"". and consists of a 6.3 X 5.5 X 4.8 cm firm tan/white scirrhous. lobulated mass with approximately 10% central necrosis. The mass. grossly abuts the 4.7 cm long X 0.7 cm in diameter internal. jugular vein and is adherent to the 3.9 X 3.5 X 1.5 cm. sternocleidomastoid muscle. Overlying the sternocleidomastoi. muscle, 0.7 cm from the mass is a 3.5 X 3.0 X 0.1 cm brown skin. with a central 0.7 cm in depth tract. The tract is surrounded by. orange/yellow discoloration. Inferior to the sternocleidomastoid. muscle is a 5.5 X 4.7 X 1.0 cm soft tissue segment with. multiple lymph node candidates. The mass is consistent with. level 2 and the remainder of the specimen would be divided into. levels 3 and 4 and dissected for lymph node candidates, of which. multiple are identified up to 1.5 cm in greatest dimension. Inking: Mass is inked green. Block Summary. A1-A3 - - Mass. A4 - Mass with internal jugular vein. A5 - One lymph node candidate, bisected from level 2. A6. - One lymph node candidate, serially sectioned from level 2. A7 - Four lymph node candidates from level 2. A8. - Five lymph node candidates from level 3. A9 - Two lymph node candidates from level 3, one is inked green. and bisected. A10-A12 - Each has one lymph node candidate serially sectioned. from level 3. A13-A14 - One lymph node, serially sectioned from level 3. A15-A16 - - One lymph node, serially sectioned from level 3. A17 - Five lymph nodes from level 4. A18 - One lymph node, serially sectioned from level 4. A19-A20 - One lymph node, serially sectioned from level 4. A21-A22 - Each has one lymph node, serially sectioned from level. 4. A23 - One lymph node bisected from level 4. A24 - Two lymph nodes, each bisected, one inked green, both from. level 4. Container B is additionally labeled ""left composite glossectomy,. pharyngectomy and palate resection, long suture anterior floor. of mouth, short suture medial tongue"". Specimen fixation: Formalin. Type of specimen: Left composite glossectomy, pharyngectomy, and. palate resection. Size of specimen : 6.6 cm (medial/lateral) X 5.9 cm. (anterior/posterior) X 1.9 cm (depth). Laterality: Left. Orientation of specimen: There is a short suture medial tongue,. long suture anterior floor of mouth, and the sutures will be. designated as follows: long suture/anterior floor of mouth 12. o' 'clock, short suture medial tongue 3 b'clock, 12 to 3 o'clock. margin/yellow, 3 to 6 b'clock margin/blue, 6 to 9 o'clock. margin/red, 9 to 12 o'clock margin/green, and deep margin/black. Tumor size:Tumorsizeis4.7x3.2x1.0 cm (depth). Tumor description: Irregular shaped, centrally ulcerated, firm. gray/white mass with well-defined lobulated borders. The tumor. is endophytic. Location of tumor: Pharyngeal mucosa eroding into the tongue. Extent of tumor: The mass erodes approximately 80% of the mucosa. and extends into the tongue by up to 1.0 cm occupying. approximately 25% of the tongue. Presence/absence of bone involvement : Absent. Distance of tumor to surgical margins: 12 o'clock anterior floor. of mouth mucosal/soft tissue margin 0.1 cm, 3 o'clock medial. tongue margin 1.3 cm, 6 o'clock mucosa/soft tissue margin 0. 1. cm, 9 o' 'clock mucosa/soft tissue margin, grossly abuts deep. margin 0.1 cm. The mass grossly abuts the soft tissue margin at. approximately 10-11 o'clock. Description of remainder of tissue: The uninvolved soft tissue. and cut surface of tongue is tan and smooth. Lymph nodes: Received in separate containers. Tissue submitted for special investigations: Tumor given to. tumor procurement foundation. Digital photograph taken: No. Block Summary : Inking: 12 to 3 o'clock quadrant/yellow, 3 to 6 b'clock. quadrant/blue, 6 to 9 b'clock quadrant/red 9 to 12 o'clock. quadrant/green and deep margin/black. B1-B5 - Perpendicular sections of the 12 to 3 o'clock quadrant. in a clockwise manner at approximately every 1 cm. B6-B8 - Perpendicular sections of the 3 to 6 o'clock quadrant at. approximately every 1 cm in a clockwise fashion. B9-B14 - Perpendicular sections approximately every 1 cm of the. 6 to 9 o'clock quadrant in a clockwise manner. B15-B18 - Perpendicular sections of the 9 to 12 o'clock quadrant. at approximately every 1 cm in a clockwise manner. B19-B21 - Perpendicular of mass closest to the deep margin from. 12 o'clock towards 6 'clock. Container C is additionally labeled ""left level 1 lymph node"". and consists of a 3.9 X 3.4 X 2.8 cm portion of pink/yellow soft. tissue that contains 6 lymph node candidates up to 1.2 X 1.0 X. 0.8 cm in greatest dimension and a 9 gram (3.6 X 2.1 X 2.1 cm. unremarkable tan lobulated gland. Block Summary: C1 - Two lymph node candidates. C2 - Two lymph nodes, each bisected, one inked green. C3-C - - Each has one lymph node candidate, bisected. C5 - Gland. Container D is additionally labeled ""left mandible"" and consists. of two irregularly shaped fragments of tan bone (1. X 1.0 X 0. 4. cm and 4.6 X 1.3 X 0.7 cm) The larger fragment has adherent. soft tissue covered by a smooth and glistening gray/tan mucosa. (1.7 X 1.4 X 1.0 cm). Adjacent to the mucosa is a tooth socket. One end of the bone tapers and becomes thin and the opposite end. is flat and broad. The taper end is inked red, the flat broad. end is inked blue and the resection margin (margin opposite the. mucosa) is inked green. The bone is unremarkable on cut section. Block Summary. D1 - Smaller fragment of bone. D2 - The two ends of the larger bone en face. D3 - Perpendicular of larger bone through the soft tissue and. mucosa. D4 - Remainder of resection margin en face opposite the mucosa. D1-D4 all submitted following decalcification. Container E is additionally labeled ""right mandible"" and. consists of a 3.2 X 1.1 X 0.7 cm fragment of tan bone that. contains teeth sockets on one side that is surrounded by. purple/gray rim of mucosa (3.1 X 1.2 X 0.7 cm) The mucosal. margin is inked green and the bone margin is inked blue. The. bone is unremarkable on cut section. Block Summary: E1 - Mucosal margin, en face. E2 - Bone margin, en face, after decal. Container F is additionally labeled ""teeth"" and consists of a. 4.3 X 3.1 X 0.6 cm aggregate of tan intact teeth and teeth. fragments. The crowns are smooth, gray, of which the molar teeth. contain metallic silver fillings. The specimen is for. gross only and the teeth are retained in formalin. Addendum. To add results of special stains. Addendum Comment. B: ""Left composite glossectomy, pharyngectomy and palate. resection, long suture anterior floor of mouth, short suture. medial tongue"", resection. - Carcinoma is negative for P16 by immunohistochemistry and. negative for high risk HPV by in situ hybridization studies. Appropriate controls have been performed. Addendum. To add results of additional sections. Addendum Comment. D: Mandible, left, excision. - Benign mandibular bone and mucosa with no tumor seen including. examined resection margins.",T4,N3,M0,T4N3M0
TCGA-J8-A3NZ,"FINAL DIAGNOSIS. A) Left thyroid lobe and isthmus: Papillary thyroid carcinoma forming a 3.5. cm in greatest dimension tumor mass. The thyroid carcinoma focally. invades through the capsule into the extracapsular soft tissue. Inked. surgical margins of resection are free of tumor. Areas of chronic. thyroiditis are also noted. B) Left paratracheal nodes: Metastatic papillary thyroid carcinoma. involving one out of one lymph node (1/1). C) Pretracheal lymph nodes: Metastatic papillary thyroid carcinoma. involving one out of seven lymph nodes (1/7). D) Right thyroid lobe: Benign thyroid tissue showing chronic inflammation. with intrathyroidal parathyroid tissue. Benign lymph node without. evidence of tumor. A: Thyroid Gland. HISTOLOGIC TYPE: Papillary carcinoma. TUMOR FOCALITY: Unifocal. Left lobe. TUMOR SIZE: Greatest Dimension: 3.5 cm. HISTOLOGIC GRADE: G1: Well differentiated. PRIMARY TUMOR (pT): pT3: Tumor more than 4 cm, limited to thyroid or with minimal. extrathyroidal extension (eg, extension to sternothyroid muscle or. perithyroid soft tissues). REGIONAL LYMPH NODES (pN): pN1a: Nodal metastases to Level VI (pretracheal, paratracheal and. prelaryngeal/Delphian) lymph nodes. NUMBER OF LYMPH NODE(S) INVOLVED: 2. NUMBER OF LYMPH NODE(S) EXAMINED: 9. LYMPH NODE, EXTRANODAL EXTENSION: Not identified. DISTANT METASTASIS (pM): Not applicable. MARGINS: Margins uninvolved by carcinoma. LYMPH-VASCULAR INVASION. EXTRATHYROIDAL EXTENSION: Present. Minimal. ADDITIONAL PATHOLOGIC FINDINGS: Thyroiditis: Focal (nonspecific). -electronic signature~. A) LEFT THYROID LOBE AND ISTHMUS, FS. B) LEFT PARATRACHEAL NODES. C) PRETRACHEAL LYMPH NODES. D) RIGHT THYROID LOBE. FROZEN SECTION. A1) Left thyroid lobe and isthmus: Papillary thyroid carcinoma (3.5 cm). GROSS DESCRIPTION. A) Received fresh for frozen section labeled ""left thyroid lobe and isthmus"" is an. 18-gram lobe of thyroid lobe and isthmus, measuring overall approximately 4.8 X 4.1. X 2.5 cm. The specimen is inked on its surgical margins. Sectioning reveals an. indurated gray/tan to pink/tan nodule in the superior pole, measuring approximately. 3.5 cm in greatest dimension. Touch preps are made. A representative section of. the nodule is submitted for frozen section as A1. The nodule grossly appears to be. completely excised. Sectioning through the remainder of the specimen reveals a. red/tan nodule in the inferior pole, measuring 0.5 cm in greatest dimension. This. does not grossly appear suspicious. Permanent sections are submitted as follows: Larger nodule A2-A4, smaller nodule A5, and random thyroid A6. Tissue is also. collected for the thyroid tissue registry protocol. B) The specimen is labeled ""left paratracheal nodes"" and consists of a lymph node. measuring 0.8 cm in greatest dimension. It is bisected and completely embedded. along with a small portion of fatty tissue labeled B1. C) The specimen is labeled ""pretracheal lymph node"" and consists of an irregular. fragment of tan/yellow tissue measuring 2.5 X 1.0 X 1.0 cm. A definitive lymph node. is not identified. The specimen is entirely submitted as C1. D) The specimen is labeled ""right thyroid lobe"" and consists of the right lobe of the. thyroid measuring 5.0 X 3.5 x 1.7 cm. The specimen is serially sectioned and. reveals beefy red parenchyma without any distinct lesions. The specimen is. sampled and labeled D1 through D6. CLINICAL INFORMATION. THYROID NODULE.",T3,N1,M0,T3N1M0
TCGA-AO-A03L,"Clinical Diagnosis & History: T2 carcinoma right breast UOQ (core biopsyminvasive ductal carcinoma) for. right total mastectomy, SLNB, possible ALND. Specimens Submitted: 1: SP: Sentinel node #1, level 1, right axilla (fs) (. 2: SP: Right modified radical mastectomy with levels 1 & 2 axillary. contents with tags attached. DIAGNOSIS: 1). SENTINEL LYMPH NODE #1, LEVEL I, RIGHT AXILLA; BIOPSY: - METASTATIC CARCINOMA INVOLVING LYMPH NODE. 2). BREAST, RIGHT; MASTECTOMY WITH LEVELS I AND II AXILLARY CONTENTS: - INVASIVE DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC GRADE III/III (SLIGHT. OR NO TUBULE FORMATION), NUCLEAR GRADE III/III (MARKED VARIATION IN SIZE AND. SHAPE) MEASURING 6.5 CM IN LARGEST DIMENSION GROSSLY. THE INVASIVE CARCINOMA IS LOCATED IN THE CENTRAL AREA. - THE NIPPLE LYMPHATICS ARE INVOLVED BY INVASIVE CARCINOMA. - NO CALCIFICATIONS ARE IDENTIFIED IN THE INVASIVE CARCINOMA. - EXTENSIVE VASCULAR INVASION IS PRESENT. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY INVASIVE CARCINOMA IS. IDENTIFIED. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF POSITIVE. LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES EXAMINED) : LEVEL. I: 3/9; LEVEL II: 0/7. - THERE IS NO EXTRANODAL EXTENSION OF CARCINOMA. - RESULTS OF SPECIAL STAINS (ER, PR, HER2-NEU) WILL BE REPORTED AS AN. ADDENDUM. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: special Stain. Commen t. ER-C. PR-C. HER2-C. NEG CONT. NEG-HER2. IMM RECUT. Gross Description: M.D. , M.D. 1). The specimen is received fresh for frozen section diagnosis, labeled,. ""Sentinel node #1, level 1, right axilla"". It consists of a 3.0 x 1.8 x. cm lymph node. Trisected and one section is submitted for frozen section. Cut section shows firm tan-white tissue. The remaining tissue is submitted. as R. Entirely submitted. Summary of Sections: FSC frozen section control. R remaining lymph nodal tissue. M.D. 2). The specimen is received fresh, labeled, ""Right modified radical. mastectomy with levels 1 & 2 axillary contents with tags attached"" It. consists of a product of modified radical mastectomy, breast measuring 16.0. x 11.5 x 5.0 cm with attached axillary tissue, measuring 7.9 x 7.0 x 2.0 cm. with tags attached labeled one and two. Anteriorly, the skin ellipse. measures 9.2 x 1.5 cm bearing an unremarkable nipple and areola. The. epidermal surface is unremarkable, except for blue dye staining. Serially. sectioned from medial to lateral aspect. Cut section shows a 6.5 x 4.0 x. 2.5 cm tumor, located in the central quadrant, about 1.5 cm beneath the. overlying skin and 0.2 cm from the deep resection margin. The cut section. of the tumor has firm, tan-pink tissue with focal areas of hemorrhage. The. adjacent breast tissue is predominantly fatty with scattered fibrous. streaks. No other satellite nodules are seen. Representative sections from. the tumor and the other quadrants are submitted. Part of tissue is. submitted for TPS. Multiple lymph nodes are dissected from the axillary. tissue from levels one and two, size ranging from 0.5 cm to 1.5 x 1.0 x 1.0. cm. The larger lymph nodes are bisected. The specimen is inked as follows: superior-blue, inferior-red, posterior-black. Summary of Sections: N entirely submitted nipple and areola. T tumor. TM tumor to margin. C central quadrant, two sections. UOQ upper outer quadrant, two sections. LOQ lower outer quadrant, two sections. UIQ upper inner quadrant, two sections. LIQ lower inner quadrant, two sections. L1LN level one lymph nodes. L2LN level two lymph nodes. L1BLN level one bisected lymph nodes. Summary of Sections: Part. 1: SP: Sentinel node #1, level 1, right axilla (fs). Block. Sect. Site. PCs. FSC. 1. 1. 3. R. 3. Part. 2: SP: Right modified radical mastectomy with levels 1 & 2 axillary. contents with tags attached. Block. Sect. Site. PCs. C. 2. 1. L1BLN. 2. 1. 2. L1LN. 6. 3. L2LN. 12. 1. LIQ. 2. 1. LOQ. 2. N. 2. 2. 2. 2. TM. 4. 4. UIQ. 2. 2. 1. UOQ. 2. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. ADDENDUM. SITE: RIGHT BREAST. PART #2. ER: 70% OF NUCLEAR STAINING WITH MODERATE INTENSITY. PR: 10% OF NUCLEAR STAINING WITH MODERATE INTENSITY. HER2/NEU (HERCEPTEST) : POSITIVE (STAINING INTENSITY OF 2+) . MD PHD. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOMA. PERMANENT DIAGNOSIS: SAME. MD.",T3,N2,M0,T3N2M0
TCGA-CG-4301,"Diagnosis/diagnoses: 1. and 2.: Soft-tissue and peritoneal metastases of a poorly differentiated adenocarcinoma. Total gastrectomy preparation with the inclusion of an ulcerated poorly differentiated cardiac. adenocarcinoma with a maximum diameter of 4 cm, with infiltration of the perigastric soft. tissue and sparse involvement of the cross-striated muscle (evidently of the diaphragm). Six. regional lymph metastases. The tumor extends into the oral resection margin. Tumor-free. duodenal resection margin with evidence of heterotopic gastric mucosa islands. Tumor-free. omentum. Tumor stage: pT4 pN1.",T4,N1,M1,T4N1M1
TCGA-BT-A2LA,"FINAL DIAGNOSIS: PART 1: LYMPH NODE, RIGHT PELVIC, EXCISION -. NINE (9) BENIGN LYMPH NODES. PART 2: LYMPH NODE, LEFT PELVIC, EXCISION -. THREE (3) BENIGN LYMPH NODES. PART 3: URETER, RIGHT DISTAL, BIOPSY -. BENIGN UROTHELIUM AND UNDERLYING SUBMUCOSA WITH REACTIVE CHANGES. PART 4: URETER, LEFT DISTAL, BIOPSY -. BENIGN UROTHELIUM AND UNDERLYING SUBMUCOSA WITH REACTIVE CHANGES. PART 5: PROSTATE, BLADDER, SEMINAL VESICLES, VAS DEFERENS, RADICAL CYSTECTOMY -. BLADDER: A. INVASIVE HIGH-GRADE UROTHELIAL CARCINOMA WITH/PREDOMINANTLY SMALL CELL FEATURES (See. comment). B. THE CARCINOMA MEASURES 4.5 CM IN GREATEST DIMENSION. C. THE CARCINOMA INVOLVES THE LEFT LATERAL WALL. D. THE CARCINOMA EXTENDS INTO AND THROUGH THE DETRUSOR MUSCLE (MUSCULARIS PROPRIA) TO. INVOLVE THE PERIVESICAL SOFT TISSUE. E. FLAT CARCINOMA IN SITU (CIS) COMPONENT IS IDENTIFIED. F. THERE IS NO LYMPHOVASCULAR OR PERINEURAL INVASION. PROSTATE: A. FOCAL HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN). B. NON-NEOPLASTIC PROSTATE WITH BENIGN PROSTATIC HYPERPLASIA. COMMENT: The neoplasm consists of solid sheets of neoplastic cells, which at higher power have histological and cytological. features of a smail cell carcinoma. There is extensive necrosis. The cytoplasms have a high N:C ratio and there is. prominent nuclear molding present. Immunostains for a neuroendocrine origin were performed. The neoplastic cells are. positive for synaptophysin, NSE and CD56 and negative for chromogranin and pankeratin as well as thrombomodulin. The above immunoprofile confirms the neuroendocrine differentiation of the small cell component. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY URINARY BLADDER TUMORS. SPECIMEN TYPE: Radical cystoprostatectomy. TUMOR SITE: Left lateral wall. TUMOR SIZE: Greatest dimension: 4.7 cm. HISTOLOGIC TYPE: Small cell carcinoma. ASSOCIATED EPITHELIAL LESIONS: None identified. HISTOLOGIC GRADE: Urothelial carcinoma - High-grade. TUMOR CONFIGURATION: Solid/nodule. PATHOLOGIC STAGING (pTNM): pT3a. pNO. Number of nodes examined: 12. Number of nodes involved: 0. pMX. MARGINS: Margins uninvolved by invasive carcinoma. VENOUSILYMPHATIC (LARGE/SMALL) VESSEL INVASION (V/L): Absent. DIRECT EXTENSION OF INVASIVE TUMOR: None identified. ADDITIONAL PATHOLOGIC FINDINGS: Urothelial carcinoma in situ.",T3,N0,M0,T3N0M0
TCGA-DD-AAC8,"CLINICAL DIAGNOSIS: HCC. Specimen : Liver. Gross Photo : 1. GROSS: 1. Specimen: Liver: 26.0 x 19.0 x 10.0 cm, 1264.0 gm, unfixed. Gallbladder: 8.0 cm in length ,3.5 cm in width, and 2.0 mm in thickness, unfixed. 2. Tumor location: right lobe. Tumor number: one. Tumor size: 12.5 X 9.0 X 15.0 cm. 3. Satellite nodule: no. 4. Gross type. HCC: vaguely nodular. 5. Tumor necrosis: no. 6. Hemorrhage/peliosis: no. 7. Portal vein invasion: no. 8. Bile duct invasion: no. Gross photo present. Blocks. tumor mass X 9. resection margin X 1. non-tumorous liver parenchyme x 1. gallbladder x 2. MICROSCOPIC: 1. Hepatocellular carcinoma: yes. 1-1. Differentiation. The worst differentiation III. The major differentiation III. 1-2. Histologic type: trabecular. 1-3. Cell type: hepatic. 1-4. Fatty change: no. 2. Cholangiocarcinoma: no. 3. Combined hepatocellular and cholangiocarcinoma: no. 4. Fibrous capsule formation: partial capsule. 5. Capsular infiltration: yes. 6. Septum formation: no. 7. Surgical resection margin invasion: no, margin of the clearence (2.0 cm). 8. Serosal invasion: no. 9. Portal vein invasion: no. 10. Bile duct invasion: no. 11. Hepatic vein invasion: no. 12. Hepatic artery invasion: no. 13. Microvessel invasion: yes. 14. Intrahepatic metastasis: no. 15. Multicentric occurrence: no. Non-tumor liver pathology. 1. Chronic hepatitis: yes. 1-1. Etiology: HBV. 1-2. Grade, lobular: minimal. 1-3. Grade, portoperiportal: mild. 1-4. Stage (fibrosis): periportal. 1-5. Cirrhosis: no. 2. Dysplastic nodule: no. 3. Ductal epithelial dysplasia: no. 4. Other liver diseases: no. SPECIAL STAIN: Trichrome: positive (stage 2). NOT reported. Gross: Liver, needle, hepatocellular carcinoma. Liver, ectomy, hepatocellular carcinoma. T56000, P10, M81703. Gallbladder, ectomy, chronic cholecystitis. T57000, P10, M43005. DIAGNOSIS: Liver, right lobe, lobectomy: Hepatocellular carcinoma, moderately differentiated. Gallbladder, cholecystectomy: Chronic cholecystitis. NOTE: Recommend to order immunohistochemistry (hepatocyte, CK7, and CK19) and special. stain (mucicarmine) for block T1. Suggestion :",T1,N0,M0,T1N0M0
TCGA-GC-A3OO,"Criteria. Result Date: Final Diagnosis (Verified). Left ureter margin, biopsy with frozen section: No tumor seen. Right ureter margin, biopsy with frozen section: No tumor seen. Left pelvic lymph nodes, excision: Three (3) benign lymph nodes with no evidence of metastatic neoplasm. Right pelvic lymph nodes, excision: Three (3) benign lymph nodes with no evidence of metastatic neoplasm. Urinary bladder and prostate, resection: Invasive high-grade urothelial carcinoma of urinary bladder. Tumor is present on the right bladder wall and measures 1.6 cm in diameter. Tumor invades deeply into muscularis propria and is focally present at the border. between muscularis propria and underlying perivesical fat. No evidence of lymphovascular invasion. Negative perivesical soft tissue margin. Benign prostatic tissue. Negative seminal vesicles and vasa deferentia. AJCC pathologic stage: T2b,NO. Appendix, resection: Negative incidental appendix. Comment: Additional tissue from the urethral margin will be submitted for microscopic. evaluation and reported in an addendum report.. Signature Line. (Electronically signed by). Verified on: Frozen Section Diagnosis (Verified). FSA Left ureter - negative for dysplasia. I. FSB Right ureter - negative for dysplasia. Clinical Information (Verified). Bladder cancer. Performing Lab (Verifled). Testing performed at. Gross Description (Verified). ""FSA."" All frozen section control tissue is submitted in ""FSA."". ""FSB."" All frozen section control tissue is submitted in ""FSB."". ""Left pelvic lymph node."" The specimen consists of a 6.5 X 5.5 x3 cm aggregate of yellow-tan fatty tissue. On examination, 3 possible lymph. nodes are identified. These range in size from 4 - 9 cm. ""C1-C3,"" fragments, representative. ""Right pelvic lymph node package."" The specimen consists of a 6.5 x 6 x 1.5 cm aggregate of yellow-tan fatty tissue. On examination, 3. possible lymph nodes are identified. These range in size from 1.7 - 3.5 cm. ""D1-D3,"" fragments, representative. ""Bladder and prostate."" The specimen consists of a 14 x 14 x 6.5 cm bladder and prostate with attached soft fatty tissue. The specimen has. antorine asnect The posterior apex margin will be inked orange and the remaining prostate will be inked. dome of the bladder is a 1.6 x 1.6 cm red-brown ulcerated mass. The soft tissue margin will be inked black. This mass does grossly appear. to extend into but not beyond the bladder wall. This comes to within 1.5 cm from the inked soft tissue margin. The remaining bladder. mucosa has a blue-gray edematous appearance. The attached prostate measures 5.5 x 4 x 2.5 cm and will be inked black. On sectioning, the cut surface has a pale tan, slightly nodular. appearance. There are 2 clear fluid-filled cystic spaces. The largest of these is 0.6 cm. No definite tumor is grossly appreciated within the. prostate. ""E1,"" left apex; ""E2,"" right apex; ""E3,"" left ureteral orifice; ""E4,"" right ureteral orifice; ""E5-E7,"" mass right side bladder; ""E8,"" trigone;. ""E9,"". left side bladder; ""E10,"" dome of bladder; ""E11,"" left seminal vesicle and vas deferens; ""E12,"" right seminal vesicle and vas deferens;. ""E13,"" left anterior prostate; ""E14,"" left posterior prostate; ""E15,"" right anterior prostate; ""E16,"" right posterior prostate. Note: Please see. attached drawing. ""Portion of appendix."" The specimen consists of a 1.2 x 0.6 cm distal tip of the appendix. What remains of the serosa has a blue-gray. appearance and is slightly hemorrhagic and focally charred. On sectioning, the lumen is filled with a small amount of fecal material. A. definite fecalith is not identified. ""F1,"" distal tip; ""F2,"" margins, all. Also received are. project cassette labeled. ind. Signature Line. Completed Action List: VERIFY by.",T2,N0,M0,T2N0M0
TCGA-2H-A9GL,"Coded sample ID: Histologic diagnosis: poor differentiated adenocarcinoma in Barrett-epithelium. Anatomic site with laterality: distal esophagus. Tumor size: diameter 6 cm. Lymph node status: 15 lymph nodes, of which 2 contains tumor. Any comments or amendments: irradical resection.",T3,N1,M0,T3N1M0
TCGA-DJ-A2QC,"Date of Proceaure: Accounts 14,. Clinical Diagnosis & History: year old female with left thyroid nodule consistent with PTCA. Specimens Submitted: 1: Left thyroid lobe and part of right thyroid lobe, partial thyroidectomy. DIAGNOSIS: 1. Left thyroid lobe and part of right thyroid lobe, partial thyroidectomy: Tumor Type: Papillary carcinoma, classical type. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Calcification of non-psammoma type. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 2.3 cm. Tumor Encapsulation: None Identified. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Not identified. Adenoma(s) (away from the carcinoma): Identified. Type:Follicular type. Non-Neoplastic Inyroia: Exhibits nodular hyperplasia. Parathyroid Glands: Not identified. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1. The specimen is received fresh, labeled ""left thyroid lobe and part of right thyroid lobe"" and consists of a thyroid weighing 14.0 g. The left lobe measures 2.9 x 2.7 x 2.1 cm the fragment of right lobe measures 1.5 x 0.5 x 0.4 cm and the isthmus measures 0.6 x. 0.4 x 0.4 cm. A 3.0 x 2.0 x 0.7 minute fragment of skeletal muscle is attached to the lower pole of the left lobe. The external surface. is covered by a thin fibrous capsule. The posterior surface of the specimen Is inked black, and the anterior is inked blue. Sectioning reveals a 2.3 x 2.1 x 2.0 cm unencapsulated tan white nodule with a finely granular cut surface epicentered in the left. upper pole and a second nodule with a similar cut surface and measuring 1.4 x 1.4 x 1.2 cm epicentered in the left lower pole. There is a 0.8 x 0.6 x 0.5 cm tan white fleshy nodule in the fragment of right thyroid lobe. The remaining thyroid parenchyma is. red tan and beefy. Representative sections of the 2.3 cm nodule is submitted for TPS. The remaining tissue is serially sectioned. and entirely submitted. Summary of sections: N1 - 2.3 cm nodule. N2-1.4.4 cm nodule. RL - right lobe including the 0.8 cm nodule. IS - isthmus. SM- skeletal muscle at the lower pole of left lobe. Summary of Sections: Part 1: Left thyroid lobe and part of right thyroid lobe, partial thyroidectomy. Block. Sect. Site. PCs. 1. i. 1. 6. n1. 6. 1. n2. 1. 1. rl. 1. 2. sm. 2.",T2,N0,M0,T2N0M0
TCGA-55-1595,"Not for Permanent Storage in Medical Records / Not Valid for Signing. =====. ADDENDUM REPORT #1; COMMENT: Cytokeratin stain, performed on blocks 8 and C, are negative for metastatic. carcinoma. The control slides are reviewed and found to stain. appropriately. The final diagnosis remains unchanged. ADDENDUM REPORT #1; DIAGNOSIS: PLEASE SEE ORIGINAL DIAGNOSIS. SURGICAL PATHOLOGY REPORI. SPECIMEN DESCRIPTION: A. SUBCARINAL LYMPH NODE. 8. INFERIOR PULMONARY LIGAMENT LYMPH NODE. PROXIMAL BRONCHIAL LYMPH NODE. D. LEFT LOWER LOBE, LUNG, DPC. E. A-P WINDOW LYMPH NODE. PRE-OPERATIVE DIAGNOSIS: Left lung mass. POST-OPERATIVE DIAGNOSIS: Pending pathology. CLINICAL INFORMATION: Left lung mass; status post. left breast carcinoma with routine. neoadjuvant chemotherapy;. (year smoking history. INTRAOPERATIVE CONSULTATION: DPC DIAGNOSIS: ""Material submitted for possible genomic study"" by. GROSS DESCRIPTION: A. The specimen consists of a chalky sessile black node, measuring 0.9 X 0.6. X 0.4 cm. The specimen is bisected and is entirely submitted in one. cassette. 8. The specimen consists of three black rubbery nodules enveloped by a small. amount of adipose tissue. The nodules measure 0.2 X 0.2 X 0.1 cm, 0.6 X 0.5 X. Per. Res. Repo. 0.3 cm and 0.3 X 0.2 X 0.1 cm. The specimen is entirely submitted in one. cassette. C. The specimen consists of three irregular black rubbery fragments of. tissue, measuring 0.3 X 0.2 X 0.2 cm, 0.7 X 0.5 X 0.2 cm, and 1.0 X 0.3 X 0.1. cm. The specimen is entirely submitted in one cassette. Received fresh is a 109 gram lobe of left lung, measuring 15.0 cm from. apex to base, 13.0 cm anterior to posterior, 3.0 cm transversely. The pleural. surface is pink-purple, and has been previously inked black during pathology. consultation. The hilar aspect of the specimen has been inked blue and is. remarkable for multiple silver-colored metallic staples. At the hilum is a. portion of bronchus, measuring 1.0 X 1.0 cm. The staple line measures 4.0 cm. in length. The bronchus is now shaved. The margin of the pulmonary vessels. are also inked blue and are also now shaved. The pulmonary vessels and. bronchus are open and reveal unremarkable yellow-tan internal surfaces that. are unobstructed. The lung has been previously transected at the base of the. bronchus and is remarkable for a well-demarcated ovoid tan-gray indurated mass. that has overall dimensions of 2.0 X 1.0 X 0.7 cm. The mass is present 4.0 cm. from the bronchial margin and pulmonary vessel margins and 1.0 cm from the. closest pleural surface in the mid portion of the specimen. The remainder of. the lung is sectioned and the lung parenchyma at the apex shows marked. congestion. The lung parenchyma at the base is pink-tan and aerated. Additional masses are not identified nor palpated. Representative sections,. including the entire remainder of the mass are submitted in nine cassettes as. follows: cassette 1 - shaved pulmonary vessels and bronchial margins. cassettes 2 through 5 - remainder of mass with pleural surface in cassette 2,. mass with pleural surface and base of bronchus in cassette 3, and previously. sectioned portion of mass in cassette 5; cassettes 6 and 7 - blue inked staple. line margin; cassette 8 - lung parenchyma from apex; cassette 9 - lung. parenchyma from base. E. The specimen consists of three black irregular rubbery fragments of. tissue, each scantly covered with lobular adipose tissue. These fragments of. tissue measure 0.3 X 0.3 X 0.2 cm, 0.9 X 0.3 X 0.2 cm and 2.0 X 0.9 X 0.4. cm. The snecimen is entirely submitted in one cassette. =====. MICROSCOPIC DESCRIPTION: A. One slide is examined. Seen are sections of a lymph node. There is no. evidence of metastatic carcinoma. B. Two slides are examined. Seen are sections of three benign lymph nodes. There is no evidence of metastatic carcinoma. C. One slide is examined. Seen are sections of three benign lymph nodes. There is no evidence of metastatic carcinoma. D/DPC. Nine slides are examined. Sections of the tumor show a moderate to. poorly differentiated adenocarcinoma with a clear cell component. Carcinoma. is focally associated with a scar. Tumor does not extend to the overlying. pleura. The bronchial and vascular resection margins are negative for. tumor. There is no evidence of blood/lymphatic vessel invasion. E. One slide is examined. Seen are sections of three benign lymph nodes. There is no evidence of metastatic carcinoma. SPECIAL STAINS: ITF-1 (thyroid transcription factor-1) stain was performed on paraffin block. The neoplastic cells show strong nuclear positivity for TTF-1. This. is compatible with primary lung carcinoma. The cytokeratin stain, performed. on block C, shows a lymph node with no evidence of metastatic carcinoma. FINAL DIAGNOSIS: A. SUBCARINAL LYMPH NODE, EXCISION: ONE BENIGN LYMPH NODE WITH NO EVIDENCE. OF METASTATIC CARCINOMA (0/1). B. INFERIOR PULMONARY LIGAMENT LYMPH NODES, EXCISION: THREE BENIGN LYMPH. NODES WITH NO EVIDENCE OF METASTATIC CARCINOMA (0/3). C. PROXIMAL BRONCHIAL LYMPH NODES, EXCISION: THREE BENIGN LYMPH NODES. WITH NO EVIDENCE OF METASTATIC CARCINOMA (0/3). LEFT LOWER LOBE OF LUNG, LOBECTOMY: 1. HISTOLOGIC TYPE: ADENOCARCINOMA WITH CLEAR CELL CARCINOMA. COMPONENT. 2. HISTOLOGIC GRADE: MODERATELY-TO-POORLY DIFFERENTIATED. 3. EXTENT OF INVASION: pT1 (TUMOR MEASURES 2.0.CM-IN MAXIMUM. DIMENSION WITHOUT INVOLVEMENT OF THE OVERLYING PLEURA). 4. MARGINS: BRONCHIAL AND VASCULAR RESECTION MARGINS ARE NEGATIVE. FOR TUMOR. 5. BLOOD/LYMPHATIC VESSEL INVASION: ABSENT. 6. REGIONAL LYMPH NODES: PLEASE REFER TO SPECIMENS A THROUGH C AND. SPECIMEN E. 7. DISTANT METASTASIS: NOT ASSESSED. E. AP WINDOW LYMPH NODE, EXCISION: THREE BENIGN LYMPH NODES WITH NO. EVIDENCE OF METASTATIC CARCINOMA (0/3). A-MALIGNANT.",T1,N0,M0,T1N0M0
TCGA-39-5022,"Clinical Diagnosis &. with RUL nodule. PET positive. FNA squamous cell carcinoma. Specimens Submitted;. 1: SP: Right level ten mediastinal lymph node. 2: SP: Right level eleven mediastinal lymph node. 3: SP: Right level 11 interlobar lymph node. 4: SP: Right level eleven mediastinal lymph node. 5: SP: Right upper lung lobe. 6: SP: Right leval four mediastinal lymph node. DIAGNOSIS: 1). LYMPH NODE, RIGHT LEVEL x MEDIASTINUN; EXCISION: - NO TUMOR SEEN IN ONE LYHPH NODE. 2). LYMPH NODE, RIGNT LEVEL XY MEDIASTINUM; EXCISION: - ONE LYMPH NODE WITH OLD CALCIFIED GRANULOMAS (SEE COMMENT). - NO TUMOR IS SEEN. COMMENT: NO MYCOBACTERIA OR FUNGI ARE SEEN ON AFB, FITE OR GMS STAINS. 3). LYMPH NODE, RIGHT LEVEL xr INTERLOBAR; EXCISION: - NO TUMOR IS SEEN IN ONE LYMPK NODE. 4). LYMPH NODE, RIGHT LEVEL XI MEDIASTINUM; EXCISION: NO TUMOR IS SEEN IN ONE LYMPH NODE. 5). LUNG, RIGHT UPPER LOBE; LOBECTOMY: - SQUAMOUS CELL CARCINOMA, MODERATELY TO POORLY DIFFERENTIATED, OF. RIGHT UPPER LOBE. - THE TUMOR MEASURES 3.7 x 3.2 x 2.5 CM. - NO VASCULAR INVASION IS IDENTIFIED. - THE MAINSTEM BRONCHUS IS NOT INVOLVED BY TUMOR. - THE BRONCHIAL MARGIN IS FREE OF TUMOR. THE STAPLED PARENCHYMAL MARGIN IS PREE OF TUMOR. - THE TUMOR INVADES THE PLEURA BUT DOES NOT CROSS THE ELASTICA (PO, EVG. STAIN PERFORMED). - THE NON-NEOPIASTIC LUNG SHOWS THE FOLLOWING ABNORMALITIESt EMPHYSEMATOUS. CHANGES, FOCAL ATYPICAL ADENOMATOUS HYPERPLASIA (AAH), ORGANIZING PNEUMONIA. AND RESPIRATORY BRONCHIOLITIS. - NO TUMOR IS SEEN IN 2 PERIBRONCHIAL AND 7 INTRAPARENCHYMAL LYMPH NODES. LYMPH NODE, RIGHT LEVEL IV MEDIASTINUM; EXCISION: NO TUMOR IS SEEN IN LYMPH NODE FRAGMENTS. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL} AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. AFB. FITE. OMS. EVG. EVG. 1). The specimen is received fresh for frozen section, labeled ""Right. Level 10 Mediastinal Lymph Node. It consists of a 0.: x 0.5 x 0.2 cm lymph. node which is entirely frozen for intraoperative diagnosis. Summary OF Sections. FSC - frozen section control. 2). The specimen is received fresh for frozen section, labeled ""Right. Level. 11 Mediaatinal Lymph Node"". It consists of 1.0 x 0.5 x 0.5 cm lymph. node which is entirely frozen for intraoperative diagnosis. Summary of Sections: FSC - frozen section control. 3). The specimen is received fresh for frozen section consultation labeled,. Right level 11 interlobar lymph node"", and consists of an irregular piece. of tan soft tissue measuring 0.9 x 0.7 x 0.4 CIR. The specimen is entirely. frozen. Summary of sections: F9C frozen section control. 4). The specimen is received in formalin, labeled, ""Right level eleven. mediastinal lymph node"". It consists of a 1.0 x 0.8 x 0.3 em anthracotic. lymph node which is entirely submitted. Summary of Sections: LN - lymph node. 5). The specimen is received fresh labeled ""Right upper lobe OF lung"", and. consists of a resected lobe of lung measuring 16 x 11 x 3 cm. The pleural. surface ig pink-tan and smooth. Thore is a 17 cm staple line identified on. the modial aspeot of the specimen. The lateral aspect of the specimen shows. a 4 x 3 em area of pleural thickening. This surface is inked black. This. area also shows a 3 cm incised area containing three blue silk sutures. The stapled margin, bronchial margin, and vessel margins are shaved and. submitted entirely. There are multiple anthracotic peribronchial lymph. nodes identified and entirely submitted. On bivalving the specimen, there. is a 3.7 x 3.2 x 2.5 cm firm variegated gray-tan tumor nodule underlying the. area of pleural thickening. It is abuts the pleura and located 1.9 cm from. the bronchial margin and 2.2 cm from the stapled margin. The remainder of. the lung parenchyma showa diffuse emphysematous changes, particularly. surrounding the tumor. There are multiple intraparenchymal lymph nodes. identified and submitted entirely. on complete opening of the bronchus,. there is no lesions identified on the mucosa. Representative sections are. submitted. A sample of the tumor is given to TPS. The specimen has been. photographed. Summary of sections: SM-stapled margin. VM-veasel margins. PBN-peribronchial nodes. IPN-intraparenchymal nodes. RS-representative sections of lung parenchyma. 6). The specimen is received in formalin, labeled, Right level four. mediastinal lymph node. It consists of three fragments of dark anthracotic. lymph nodes with attached fat, measuring 2.5 x 1.5 x 0.9 em in aggregate. The largest fragment appears to be a single 1.4 cm lymph node. The specimen. is bisected and the remaining two fragments are entirely submitted whole. Summary of Sections: BN bisected lymph node. SLN single lymph node. Summary of Sections: Part 1: SP: Right level ten mediastinal lymph node. Block. Sect. site. PCB. fac. 1. Part 2: SP: Right level eleven mediastinal lymph node. Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Right level 11 interlobar lymph node. Block. Sect. Site. PCs. 1. fsc. 1. Part 4: SP: Right level eleven mediastinal lymph node. Block. Sect. Site. PCs. 1. In. 1. Part 5: SP: Right upper lung lobe. Block. Sect. Site. PCs. 2. ipn. 2. 1. pbn. 1. 5. r's. 5. 4. am. 4. 6. 6. 1. vm. 1. Part 6 : SP, Right levol four mediastinal lymph node. Block. Sect. Site. PCa. 1. bln. 1. sln. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT bragnosis: SAME. 2). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME. FROZEN SECTION DIAGNOSIS: NEGATIVE LYMPH NODES. PERMANENT DIAGNOSIS: SAME.",T2,N0,M0,T2N0M0
TCGA-4Z-AA83,"PRIMARY SITE: Bladder. Product of cystectomy: Papillary urothelial carcinoma of high grade infiltrating the corion and focally the. detrusor muscle with free surgical margins. Absence of angiolymphatic, sanguineous and perineural invasions. Margin of right and left ureters free of neoplasia. Urethral margin free of neoplasia. Prostate free of cancer. Right and left seminal vesicles free of neoplasia. Right and left vas deferens free of neoplasia. Lymph nodes free of tumor: (0/2). Left pelvic lymph nodes: Absence of neoplasia: (0/13). Right pelvic lymph nodes: Absence of neoplasia: (0/4). External left iliac lymph nodes: Absence of neoplasia: (0/3). Right iliac lymph nodes: Absence of neoplasia: (0/6). Right common lymph nodes: Absence of neoplasia: (0/3).",T2,N0,M0,T2N0M0
TCGA-BF-A5EP,Component. Clinical. Index. Tissue. Specimen. Ethnicity. Clinical. Tumor. Anatomical Site. Specificati. Specimen. Specimen. Number of. Type of. Histological. of treatment. Site #. (Race). Container. Amount/per. Grade. Diagnosis. Procurem. TNM Stage. TNM Stage. TNM Stage. Treatment. Tumor cell. label. Matrix. Format. container. description. containers. (Chemo /. on. (source). (T). (N). (M). type. %. ent. (Source). Horm Th. Details). Caucasian. Female. Melanoma. Skin. (White). Primary. Tumor. Tissue. OCT. block. 1. 200. mg. Meianoma. n/a. 4. 3. 0. none. n/a. 80. Caucasian. Female. Melanoma. Blood. n/a. (White). Normal. Blood. frozen. blood. tube. 1. 4. ml. n/a. n/a. n/a. n/a. n/a. none. n/a. n/a. draw. Criteria.,T4,N3,M0,T4N3M0
TCGA-A6-2684,"SPECIMEN. A. Apical node. B. Right hemicolectomy. CLINICAL NOTES. PRE-OP DIAGNOSIS: Adenocarcinoma of cecum. GROSS DESCRIPTION. A. Received fresh labeled ""apical node"" is an ovoid, 1.0. x. 0. 6 x 0.5 cm. soft tan pink tissue which is bisected and. entirely submitted in one block. AS-1. B. Received fresh labeled ""right hemicolectomy"" is. a. previously unopened 28 cm. segment of proximal right colon. with. attached 17 cm. of distal ileum surfaced by smooth to scabrous. tan-pink serosa with a moderate amount of attached mesocolon and. mesentery. An unremarkable 3.7 cm. appendix averaging 0.5 cm. in. diameter is present. The proximal and distal margins measure 3.9. and 6.1 cm. in circumference respectively. On opening, there is a. 5.3 x 2.0 cm. rubbery tan-pink-red lesion at the ileocecal valve. A. portion of the lesion and a portion of normal are submitted for. tissue procurement as requested. On sectioning, the lesion has a. maximal thickness of 1.3 cm., grossly extending into the muscularis. to within 0.5 cm. of the closest ink-free radial serosal surface. The remaining ileal and colonic mucosa is unremarkable, glistening. tan-pink with regular folds and the walls average 0.5 cm. in. thickness. Multiple slightly rubbery pale tan tissues in keeping. with lymph nodes measuring up to 1.0 cm. in greatest dimension are. recovered from the attached mesocolon and mesentery. Representative. sections are submitted in 12 blocks as labeled. RS-12. BLOCK SUMMARY: 1 - proximal and distal margins; 2, 3 - tumor full. thickness to ink-free radial serosal surface; 4, 5 - tumor to. GROSS DESCRIPTION. adjacent mucosa; 6 - random ileal and colonic mucosa; 7 - appendix;. 8-10 - - eight whole lymph nodes per cassette; 11 - seven whole lymph. nodes; bisected largest lymph node. MICROSCOPIC DESCRIPTION. A. The apical lymph node demonstrates one lymph node with. no evidence of metastatic disease. B. The following template applies to the right. hemicolectomy: Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Primary tumor (pT) : 5.3 cm., extending into, but not through, the. muscularis propria (pT2). Proximal margin: Negative. Distal margin: Negative. Circumferential (radial) margin: Negative. Vascular invasion: Not identified. Regional lymph nodes (pN) : No evidence of metastasis in thirty-two. additional lymph nodes (pNO). Non-lymph node pericolonic tumor: Not identified. Distant metastasis (pM) : Cannot be evaluated by this specimen. (pMX). Other findings The appendix is unremarkable. 3, 5. DIAGNOSIS. A. Apical lymph node, resection: No evidence of metastasis in one lymph node (0/1) . B. Right colon, hemicolectomy: DIAGNOSIS. Adenocarcinoma, moderately differentiated, 5.3 cm., with. extension into, but not through, muscularis propria. Surgical margins uninvolved. Thirty-two lymph nodes with no evidence of metastatic. disease. (0/32). Appendix with no pathologic abnormality.",T2,N0,M0,T2N0M0
TCGA-22-4593,"TISSUE DESCRIPTION: Right lower lobe lung (330 grams, 17 x 9 x 6.5 cm). Superior. mediastinal (upper paratracheal, lower paratracheal right. tracheobronchial), inferior mediastinal (subcarinal) and N1. (interlobar) lymph nodes. DIAGNOSIS: Lung, right lower lobe, lobectomy: Grade 3 (of 4) invasive squamous. cell carcinoma forming a centrally necrotic mass measuring 6 X 6 X 5 cm. located 1.5 cm from the bronchial resection margin. The tumor involves. the visceral pleura over an area of approximately 3 x 3 cm. The. bronchial margin is negative for tumor. Lymph nodes, superior and inferior mediastinal, N1, excision: Multiple. (1 upper paratracheal, 1 lower paratracheal, 2 right tracheobronchial, 3. subcarinal, 3 interlobar) lymph nodes are negative for tumor.",T2,N0,M0,T2N0M0
TCGA-F2-A8YN,"Diagnosis: A: Common bile duct, biopsy. - Benign bile duct. - No carcinoma identified. B: Pancreatic duct margin, biopsy. - Benign pancreatic duct. - No carcinoma identified. C: Gallbladder, cholecystectomy. - Benign gallbladder with no significant pathologic abnormality. - No carcinoma identified. D: Pancreas, duodenum, distal stomach, and common bile duct,. ancreaticoduodenectomy. Tumor Histologic Type: invasive pancreatic ductal adenocarcinoma. (see comment). Histologic grade: moderately differentiated. Tumor size: 4.8 cm. Tumor site: head of pancreas extending to involve duodenum. Microscopic tumor extension: - Tumor invades duodenal wall and peripancreatic soft tissues. Lymph-vascular invasion: present. Perineural Invasion: not identified. Margins: Uncinate process (retroperitoneal) margin: positive for. involvement by tumor (slide D6). Peripancreatic soft tissues: <1 mm from the inked peripancreatic. soft tissue margin (slide D7). Pancreatic resection margin: uninvolved by tumor, approximately. 2.5 cm away. Bile duct margin: uninvolved by tumor, approximately 4.5 cm away. Proximal (gastric) : negative, widely free. Distal (duodenal) : negative, widely free. Lymph nodes : Number of lymph nodes involved: 0. Number of lymph nodes examined: 13. Additional pathologic findings mild acute and chronic. pancreatitis with patchy autolysis. AJCC Pathologic TNM Stage: pT3 pNO. Note: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. Comment: Grossly, a 4.8 cm tumor is identified that is evenly distributed. between the duodenum and head of pancreas. While there are no. available immunohistochemical stains to reliably distinguish a. primary duodenal adenocarcinoma from a pancreatic ductal. adenocarcinoma, the tumor morphology (glandular structures. with abundant clear to pink apical cytoplasmic mucin) and the. absence of a precursor lesion within the duodenal mucosa both. favor a pancreatic primary. Intraoperative Consult Diagnosis: A frozen section consultation was requested by Dr. on. in. FSA1: Common bile duct, biopsy. - No tumor seen. - No atypical glandular mucinous epithelial proliferation. identified. - Consistent with common bile duct with chronic inflammation. Drs. and on. FSB1: : Pancreatic duct margin, biopsy. - No tumor seen. Drs. and on. Frozen Section Pathologist: , MD. Clinical History: -year-old male with a mass in the third portion of the. duodenum with a history of atypical glandular mucinous. proliferation from previous duodenal biopsy. Gross Description. Received are four appropriately labeled containers. Specimens A. and B are received fresh for frozen section. Container A is received fresh for frozen section, and. additionally labeled ""common bile duct. It holds a 6 X 3 X 3 mm. red/tan soft tissue fragment; block FSA1,. Container B holds a 5 X 5 X 3 mm red/tan soft tissue fragment;. tissue is submitted in block FSB1,. Container C: Previously opened or disrupted: yes, The gallbladder has been. opened along its long axis. Measurements: 7.8 X 4.2 X 1.2 cm. External surface: covered with a layer of smooth yellow fat. Luminal contents: none identified; the gallbladder was received. opened. Stones present: none identified. Mucosa: pale, green and velvety. Wall thickness: 2 mm. Other comments: none. Block #: C1, cystic duct margin, en face and representative. sections from the body and fundus. Tissue remains. Container D is additionally labeled 'pancreaticoduodenectomy "". Specimen fixation: formalin. Specimen type: standard Whipple. Organs received (Whipple Specimen) : Stomach (2.0 cm in length,. 2.5 cm in diameter) i Head of pancreas (8.5 X 6.3 X 3.1 cm) i. Duodenum (28.5 cm in length X 6.0 cm in circumference) ;. Common bile duct (4.5 cm in length X 0.6 cm in diameter). Orientation: Short stitch on the pancreatic duct margin, long. stitch on the common bile duct margin, and a blue stitch on the. uncinate margin. Inking: common bile duct=yellow, pancreatic neck. margin=blue, uncinate margin=black,. peripancreatic soft tissue=green. Tumor location: duodenum and head of pancreas. Tumor dimensions: 4.8 X 4.5 X 4.0 cm. Gross appearance of tumor: In the duodenum, the tumor is. ulcerated, tan and fibrous. In the pancreas, tumor is. yellow/white, firm with ill-defined edges. Extent of invasion: Confined / non-confined to the pancreas: non-confined. Involvement of the ampulla: absent. Involvement of the duodenum: present. Involvement of the bile duct: absent. Involvement of adjacent vessels: absent. Spleen (if applicable) : n/a. Gallbladder (if applicable) : please see Specimen C. Stomach (if applicable) : not involved by tumor. Surgical margins. Pancreatic body: negative to 2.5 cm. Uncinate (Retroperitoneal) : tumor is present on the black. inked uncinate margin. Common Bile duct: negative to 4.5 cm. Proximal margin (stomach) : widely negative. Distal margin (duodenum) : widely negative. Peripancreatic soft tissues: The tumor abuts the green inked. margin. Lymph nodes: Please see block summary. Other remarkable features: The uninvolved pancreas is yellow and. lobulated with intervening fat. Digital photograph taken: not taken. Tissue submitted for special investigation: Tissue submitted to. Tissue Procurement. Block Summary. D1 - proximal mucosal margin, en face. D2 - distal mucosal margin, en face. D3 - common bile duct margin, en face. D4-D5 - - blue inked pancreatic body margin, bisected. D6 - tumor with uncinate margin, perpendicular. D7 - tumor with respect to inked peripancreatic soft tissue. margin, perpendicular. D8 - tumor with respect to common bile duct. D9 - tumor, common bile duct and small bowel mucosa, bisected. D10 - tumor with respect to ampulla. D11 - tumor with respect to ampulla. D12-D14 tumor with respect to small bowel. D15 - one lymph node candidate, bisected. D16-D19 multiple lymph node candidates each. D20 - one lymph node candidate, trisected. D21 - one lymph node candidate, bisected.",T3,N0,M0,T3N0M0
TCGA-AG-A026,"Internal Sample IC. This is vascularized fatty connective tissue with an extensive, chronically granulating and. recurrent inflammation with fibrosis, acute inflammatory activity, hemorrhage and fine foci of. necrosis. No evidence of specificity or malignancy. This is a poorly differentiated adenocarcinoma of the rectum with a degree of pathological. differentiation of G 3, with carcinomatous lymphangiosis, erosions/ulcerations of the inner tumor. surface, accompanying peritumoral, chronic, recurrent inflammation with an acute purulent. abscess-forming inflammatory flare, tumor infiltration of the rectal wall layers into the perirectal. connective tissue (in I.), with similar tumor infiltrates and extensive peritumoral, chronically. granulating and recurrent inflammation in the soft tissue of the sacral cavity (in III.), moderate. chronic lymphadenitis of the tumor-free lymph nodes (0/15), tumor-free resection margins -. aborally and orally - (in I.) and tumor-free plain section from the anastomosis ring (in II.). The tumor spread of the rectal carcinoma, according to the available sections, corresponds to a. tumor stage of p T 4, p N 0, M X, L 1 and at least R 1. No evidence of carcinosis of the blood vessels. The study result was discussed by telephone. 12+.",T4,N0,M0,T4N0M0
TCGA-AA-3511,"Diagnosis: Colon resectate 18 cm in length with inclusion of a 4 cm longitudinally extended, wide,. ulcerated, moderately differentiated adenocarcinoma of colorectal type with wide. infiltration of the pericolic fatty tissue, circumscribed penetration of the overlying serosa. and evidence of lymphangiosis carcinomatosis. Tumor-free regional lymph nodes. Tumor-. free colon resection margins. Tumor stage: pT4 pNO (0/36) pMX, G2, L1 V0.",T4,N0,M0,T4N0M0
TCGA-BH-A0B0,"FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEFT BREAST, #1 SENTINEL, EXCISION -. NO EVIDENCE OF METASTATIC MAMMARY CARCINOMA IN ONE LYMPH NODE (0/1). PART 2: LYMPH NODE, LEFT BREAST, #2 SENTINEL, EXCISION -. NO EVIDENCE OF METASTATIC MAMMARY CARCINOMA IN ONE LYMPH NODE (0/1). PART 3: BREAST, LEFT, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCIAL CARCINOMA. B. NOTTINGHAM GRADE (TUBULE FORMATION: 2, NUCLEAR PLEOMORPHISM: 2, MITOTIC ACTIVITY: 1;. TOTAL SCORE 5/9). C. INVASIVE TUMOR MEASURES 1.8 CM IN LARGEST DIMENSION. D. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. E. INVASIVE CARCINOMA IS 0.8 CM FROM THE NEAREST ANTERIOR MARGIN. SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.8 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 2. Mitotic activity score: 1. Total Nottingham score: 5. Nottingham grade (1, 2, 3): 1. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 8 mm. PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 2. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNo. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: zero or 1+.",T1,N0,M0,T1N0M0
TCGA-YS-A95C,"PRIMARY SITE: Pleura. 1- Parietal pleura and right lung. Epithelioid mesothelioma infiltrating lung parenchyma, pleura and skeletal. muscle. Presence of angiolymphatic invasion. Absence of perineural invasion. Pleural margin involved by neoplasia. Bronchia margin uninvolved by neoplaisa. 2- Subcarinal node. Metastasis of mesothelioma in 4 lymph nodes of 4 dissected (4/4) with capsular. transposition. 3- Esophageal nodes. 4- Metastasis of mesothelioma in 2 lymph nodes of 3 dissected (2/3) without. capsular transposition.",T1,N2,M0,T1N2M0
TCGA-A2-A1G6,"of '. specimen: spec Type: SURGICAL P. D. RIGHT BREAST CANCER - INVASIVE. DOCTOR ($): PROCKDURE: MODIFIND BADICAL. A. RIGHT MODIFIED RADICAL MASTECTOMY. B. MEDIAL SKIN RIGHT BREAST. PART A IS RECEIVED LABELED. RIGHT MODIFIED RADICAL. MASTECTOMY STITCH MARKS 12 O'CLOCK, IS A RIGHT MODIFIED RADICAL. MASTECTOMY SPECIMEN MEASURING 26 x 18.5 x 5.5 CM IN GREATEST DIMENSIONS. THE NIPPLE IS UNREMARKABLE AND IS WITHIN A 19 x 11.7 CM SKIN ELLIPSE. IN. THE 5 TO 6 O'CLOCK AREA AT THE INFERIOR MARGIN THERE IS A 3 CM IN. DIAMETER CYSTIC STRUCTURE. THE SKIN HAS A BROWN DISCOLORED PLAQUE-LIKE. AREA AT 12 O'CLOCK. THERE IS A PALPABLE FIBROUS MASS IN THE BREAST TISSUE. BENEATH THE SUTURE SPANNING A DISTANCE OF 6 x 5 x 3.5 CM. THE SUPERFICIAL. ASPECT IS MARKED WITH BLUE INK, THE DEEP MARGIN WITH BLACK. THE AXILLARY. TAIL IS REMOVED FROM THE SPECIMEN AND WHERE IT IS REMOVED IT IS MARKED. WITH RED INK AND DOES NOT REPRESENT TRUE MARGIN. THERE IS ONE GROSSLY. POSITIVE LYMPH NODE IN THE MIDPORTION OF THE AXILLARY TAIL. THE HIGHEST. NODE GROSSLY IS NEGATIVE. SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE, A2--ONE-HALF OF A GROSSLY POSITIVE LYMPH NODE (REMAINDER. SUBMITTED PER PROTOCOL), 13--GROSSLY HIGHEST LYMPH NODE, A4--ONE LYMPH. NODE BISECTED, A5--ONE LYMPH NODE BISECTED, A6--ONE LYMPH NODE. A7--TUMOR. AND DEEP MARGIN, A8 AND A9--TUMOR AND SKIN ADDING TO A8 AN AREA OF COIL. CLIP, A10--TUMOR AT INFERIOR ASPECT ADJACENT TO FIBROUS TISSUE,. All--TISSUE IMMEDIATELY ADJACENT TO TUMOR UPPER INNER QUADRANT,. 12--TISSUE IMMEDIATELY ADJACENT TO TUMOR UPPER OUTER QUADRANT,. A13--ADDITIONAL UPPER OUTER QUADRANT, A14--LOWER OUTER QUADRANT 4.5 CM. FROM GROSS TUMOR, A15--LOWER INNER QUADRANT 3 CM FROM GROSS TUMOR,. A16--CYSTIC STRUCTURE IN 5 O'CLOCK AREA. THE AXILLARY TAIL IS THEN. FURTHER EXAMINED FOR LYMPH NODES, WHICH ARE SUBMITTED AS FOLLOWS : A17--ONE NODE BISECTED, A18--ONE BONE BISECTED, A19--ONE NODE BISECTED,. A20--ONE NODE BISECTED. ASSOCIATED WITH THE PLAQUE-LIKE AREA OF THE SKIN. IS AN UNDERLYING FIRM PINK-GRAY MASS MEASURING 3.5 x 3.3 x 3.1 CM IN. GREATEST DIMENSIONS. GROSSLY THIS EXTENDS TO WITHIN 0.8 CM OF THE DEEP. MARGIN. THE CENTRAL PORTION OF THE BREAST ALSO DEMONSTRATES DENSE. GRAY-TAN FIBROUS TISSUE WITH MULTIPLE CYSTS. ADDITIONAL SECTIONS ARE SUBMITTED AS FOLLONS FOLLONING INITIAL REVIEW OF. SLIDES: A21 AND A22--SKIN MARGIN, 23--SUPERFICIAL MARGIN. Chief of Pathology. Fhone (. (Contiaued). Speciment. Regti. spec Type: SURGICAL P. PART B IS RECEIVED. MEDIAL SKIN RIGHT BREAST. IT CONSISTS. OF AN UNORIENTED, SOMEWHAT TRIANGULAR PORTION OF SKIN WITH UNDERLYING. SUBCUTANEOUS TISSUE, APPROXIMATELY 2 x 1 x 1 CM. THE RESECTION IS INKED. THE SPECIMEN IS SECTIONED AND ENTIRELY SUBMITTED IN CASSETTES B1 AND B2. PROCEDURES: 88305, 88309, A BLK/23, B BLK/2. PART A RIGHT MODIFIED RADICAL MASTECTOMY: IN SITU AND INFILTRATING. DUCTAL CARCINOMA. THE INFILTRATING TUMOR IS MODERATELY DIFFERENTIATED,. NUCLEAR GRADE III/III WITH A MODERATE MITOTIC INDEX. THE SUPERFICIAL. ASPECT OF THE TUMOR EXTENDS INTO THE DERMIS. THE DEEP MARGIN IS FREE OF. TUMOR BY A DISTANCE OF 10 MM FOR A SUPERFICIAL TO DEEP SIZE OF 35 MM. OVER 90% OF THE TUMOR IS INVASIVE. AREAS OF PROBABLE BREAST LYMPHATIC. SPACE INVASION ARK PRESENT BUT DERMAL LYMPHATIC SPACE INVASION IS NOT. IDENTIFIED. BREAST TISSUE AWAY FROM THE PRIMARY TUMOR MASS SHONS. PROLIFERATIVE FIBROCYSTIC DISEASE. SKIN MARGINS CLOSEST TO THE TUMOR ARE. NEGATIVE. METASTATIC CARCINOMA IS PRESENT IN 4 OF 9 LYMPH NODES. PART B MEDIAL SKIN OF RIGHT BREAST, RESECTION: SKIN AND SUBCUTANEOUS FAT. WITH NO EVIDENCE OF MALIGNANCY. 1. (prelim.). (signature on file).",T2,N2,M0,T2N2M0
TCGA-D5-7000,"page 1 / 1. copy No. 2. Examination: Histopathological examination. Cost of diagnostic procedure. Material: 1. Total organ resection - cancer of the cecum. Expected time of examination: Clinical diagnosis: Cancer of the cecum. Macroscopic description: A 20 cm length of the large intestine with periintestinal fat tissue sized 18 X 5 X 3 and an 8 cm appendix. A. cauliflower-shaped tumour sized 3 X 2 cm found in the mucosa. The lesion surrounds 80% of the intestine. circumference, is located 3.5 cm from the proximal excision line and 1.5 cm from the distal excision line. Minimum. side margin is 3 cm. Microscopic description: Adenocarcinoma tubulopapillare partim mucinosum (G3). Lymphonodulitis (No XIV). Appendix - Appendicitis chronica. Preliminary result: Adenocarcinoma tubulopapillare partim mucinosum coli. Tubulopapillar and partially mucinous adenocarcinoma of. the colon. (G3; DukesA; Astler-CollerBI; pT2; pNO). Final diagnosis to be given after serial dilution of the specimens. Test result. Final result same as preliminary one. Lymphonodulitis No XVIII.",T2,N0,M0,T2N0M0
TCGA-LK-A4O2,"FINAL DIAGNOSIS: PARTS 1. AND. 2: PARIETAL PLEURA, RIGHT, BIOPSY -. DIFFUSE MALIGNANT MESOTHELIOMA, EPITHELIOID TYPE. COMMENT: The tumor cells are positive for calretinin, WT-1, D2-40 and cytokeratin 5/6 and negative for CEA, Ber-EP4, - 872.3 and. TTF-1. These results support the above diagnosis.",T3,N0,M0,T3N0M0
TCGA-B8-4154,"Diagnosis: A: Kidney, left, biopsy. - Renal cell carcinoma, clear cell type, Fuhrman grade 2 of. 4. B: Kidney, left, radical nephrectomy. Histologic tumor type/subtype: renal cell carcinoma, clear. cell type. Histologic grade (if applicable) : Fuhrman grade 2 of 4. Tumor size (greatest dimension) : 2 cm. Extent of tumor invasion: Capsular invasion/perirenal adipose tissue: negative for. carcinoma. Gerota' S fascia: negative for carcnoma. Renal vein: negative for carcinoma. Ureter: negative for carcinoma. Venous (large vessel) : negative for carcinoma. Lymphatic (small vessel) : negative for carcinoma. Histologic assessment of surgical margins: Perirenal adipose tissue: negative for carcinoma. Gerota' S fascia: negative for carcinoma. Renal vein: negative for carcinoma. Renal artery: negative for carcinoma. Ureter: negative for carcinoma. Adrenal gland: Not submitted. Lymph nodes: none identified. Other significant findings: focal glomerulosclerosis. AJCC Staging: pTla. pNx. pMx. This staging information is based on information available. at the time of this report, and is subject to change. pending clinical review and additional information. . Intraoperative Consult Diagnosis: Frozen section is requested by. FSA1: Kidney, left, biopsy. - Consistent with clear cell carcinoma. Diagnoses were made by. Frozen Section Pathologist: Clinical History: The patient is a with a 3 cm central renal mass. Gross Description: Specimen A is received in an appropriately labeled. container, additionally labeled ""left kidney tumor biopsy"". At the time of frozen section, the specimen was noted to. measure 1.2 X 0.8 X 0.3 cm. It was a red/tan soft tissue. entirely submitted as. Specimen B is received in an appropriately labeled. container, additionally labeled ""left kidney"". Specimen fixation: Formalin. Type of specimen: Left radical nephrectomy. Side of specimen: Left. Size and weight of specimen The specimen weighs 250 grams;. specimen measures 16 X 11 X 6 cm overall; the kidney. measures 10 X 5 X 4 cm. Orientation The specimen was inked blue and previously. opened through the hilum in the operating room. Presence/absence of adrenal gland: Absent. Tumor description/site The tumor has a central location. involving the renal medulla with a pushing border into the. renal pelvis (no definitive invasion into the sinus fat is. identified) i the tumor is firm, orange/yellow with visible. areas of hemorrhage; the tumor has an overall lobulated. appearance; areas of necrosis are not grossly identified. Tumor size: 2 X 2 X 2 cm. Presence/absence of multicentricity: The tumor is unifocal. Confinement/non-confinement to the kidney: The tumor is. confined to the kidney. Extent of invasion: Perirenal adipose tissue: The tumor does not involve. perirenal adipose tissue. Gerota' S fascia: Not grossly involved. Renal vein: Not grossly involved. Ureter: Not grossly involved. Other organs: Not applicable. Surgical margins: Perirenal adipose tissue: Negative. Renal vein: Negative. Renal artery: Negative. Ureter: Negative. Description of kidney away from tumor: The kidney. surrounding the tumor has a normal ratio of cortex to. medulla without specific pathologic abnormality. Lymph nodes (hilar) : The perirenal fat is palpated for. lymph nodes, but none are identified. Other significant findings: None. Tissue submitted for special investigations Tumor and. normal tissue are submitted to tissue procurement for. special investigation. Digital photograph taken: No digital picture is taken. Block summary. B1 - Vascular and ureteral margins. B2 - Tumor with extension into pelvis with closely adjacent. vascular structure. B3 - Tumor with extension into pelvis with closely adjacent. vascular structure. B4 - Tumor with hemorrhage and adjacent hilar adipose. tissue and cortex. B5 - Tumor with closest approach to cortical surface. B6 - Additional section of tumor with approach to cortical. surface. B7 - Additional section of tumor with approach to cortical. surface. B8 - Structures abutting neoplasm in hilum. B9 - Normal kidney.",T1,N0,M0,T1N0M0
TCGA-ED-A97K,"Gross Description: Tumor is ill-margins, solid and firm, gray-white in cutting section with 5x4x4cm in. size. Microscopic Description: Tumor cells form the trabecular patterns or cords or tubules or adenoids. patterns intervening in begnin tissue. Tumor invades into fibrous stroma. The amount of cytoplasm are. abundant and the cytoplasm is clear or basophilic Nuclei are irregularly large and hyperchromatic with. prominent nucleioli. Mitoses are present. Tumor is invasion of inflammatory cells and necrotic. Stroma is. marked fibrous and hyaline. Diagnosis Details: Hepatocellular carcinoma and cholangiocarcinoma, combined. Comments: Formatted Path Reports: LIVER TISSUE CHECKLIST. Specimen. type: Wedge resection, lobectomy & cholangescaremen. Tumor size: 5x4x4cm. Focality: Not specified. Histologic type: Hepatocellular carcinoma and cholangiocarcinoma, combined. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: Not specified. Comments: None.",T3,N0,M0,T3N0M0
TCGA-DK-A2I2,"Med. Rec #. F. urology. Type: Clinical Diagnosis & History: Bladder carcinoma. Specimens Submitted: 1: SP: Right ureter; segemental excision. 2: SP: Left ureter, segmental excisior. 3: SP: Lymph nodes, right comon iliac; dissection. 4: SP: Lymph nodes, right pelvic; dissection. 5: SP: Lymph nodes, left common iliac; dissection. 6: SP: Lymph nodes, left pelvic; dissection. 7: SP: Bladder, uterus, bilateral tubes and ovaries, cervix; resection. 8: SP: Left ureter #2; segmental excision. DIAGNOSIS: 1. SP: Right ureter; excision. - Benign segment of ureter. 2. SP: Left ureter, excision. Segment of ureter with urothelial carcinoma in situ. 3. SP: Lymph nodes, right comon iliac; dissection: Lymph Node Dissection: Metastatic urothelial carcinoma. Number of lymph nodes examined: 4. Number of lymph nodes with metastatic disease: 4. Size of the largest lymph node involved by tumor: 1.7cm. Size of the largest metastatic focus : 1.2 cm. Extranodal extension is identified. 4. SP: Lymph nodes, right pelvic; dissection: Lymph Node Dissection: Metastatic urothelial carcinoma. Number of lymph nodes examined: 10. Number of lymph nodes with metastatic disease: 2. Size of the largest lymph node involved by tumor: 1.7cm. Size of the largest metastatic focus : 1.6 cm. Extranodal extension is identified. 5. SP: Lymph nodes, left common iliac; dissection: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 6. 6. SP: Lymph nodes, left pelvic; dissection: Lymph Node Dissection: Metastatic urothelial carcinoma. Number of lymph nodes examined: 12. Number of lymph nodes with metastatic disease: 2. Size of the largest lymph node involved by tumor: 1.6cm. Size of the largest metastatic focus : 1.4 cm. Extranodal extension is identified. 7. SP: Bladder, uterus, bilateral tubes and ovaries, cervix; resection: Tumor Type: Urothelial carcinoma with mixed histologic features, includi ng: NOS, squamous and sarcomatoid features. Histologic Grade: High grade. Pattern of growth of the Non-Invasive component: Flat (in situ carcinoma). CIS is extensive. Pattern of growth of the Invasive component: Infiltrating. Tumor Multicentricity: Not identified. Bladder Local Invasion: Perivesical soft tissues. Extravesical Tumor Extension: Right ureter involved. Left ureter involved. Urethra involved. Vascular Invasion: Identified. Perineural Invasion: Identified. Surgical Margins: Tumor present at left ureteral margin. Non-Neoplastic Mucosa: Exhibiting chronic cystitis. Female Genital Organs: The vagina shows no pathologic abnormalities. The endometrium shows atrophy. The myometrium shows leimyomata. Remaining genital organs are unremarkable. Perivesical Lymph Nodes: LN Not involved 3. Metastatic carcinoma present in 5 nodes. Extracapsular extension is present. The Pathologic Stage is (AJCC 2002): pT3 (Invasion of perivesicle soft tissue). 8. SP: Left ureter #2; excision: - Urothelial carcinoma in situ. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: Olca. 1) The specimen received fresh, labeled ""right ureter"" and consists of 0.7x0.6x0.3 cm tan pink issue fragment. At the center a. ureter with 0.3 cm lumen is seen. Entirely submited for frozen section. Summay of sections: FSC- frozen section control. Olca. 2)The specimen received fresh, labeled ""left ureter"" and consists of 1.2x0.5x0.3 cm tan pink issue fragment. At the center a ureter. with 0.4 cm lumen is seen. Entirely submited for frozen section. Summay of sections: FSC- frozen section control. 3.) The specimen is received fresh, labeled ""Right common iliac lymph node"" and consists of a 4.6 x 2.5 x 0.9 cm aggregate of. adipose tissue, which is sectioned to reveal four, firm, ovoid, tan-pink lymph nodes, ranging from 0.6 to 2.1 cm greatest dimension. All four lymph nodes are bisected and entirely submitted. Summary of sections: BLN - bisected lymph nodes. 4. The specimen is received fresh, labeled ""right pelvic lymph nodes"" is a 7.0 x 4.0 x 1.7 cm aggregate of fibroadipose soft tissue. with multiple embedded lymph nodes measuring from 0.5 x 3.0 cm greatest dimension. One of the lymph nodes measuring 1.7. cm in greatest dimension has a firm cut surface. One half of this lymph node is submitted to the TPS. All identified lymph nodes. are submitted. Summary of sections: FLN- one half of the 1.7 cm firm lymph node. MLN1- one multisected lymph node. MLN2- one multisected lymph node. BLN-bisected lymph node. LN- yymph nodes. 5. The specimen is received fresh, labeled ""Left common iliac lymph nodes"" and consists of a 3.1 x 1.2 x 0.4 cm aggregate of. adipose tissue, which is sectioned to reveal six, firm, irregular to ovoid, tan-pink lymph nodes, ranging from 0.4 to 1.0 cm in. greatest dimension. The largest lymph node is bisected and all lymph nodes are entirely submitted. Summary of sections: LN - lymph nodes. BLN - bisected lymph node. 6. The specimen is received fresh, labeled ""Left pelvic lymph nodes"" and consists of an 8.1 x 4.3 x 1.1 cm aggregate of adipose. tissue, which is sectioned to reveal 12, firm, irregular to ovoid, tan-pink lymph nodes, ranging from 0.7. to. 1.7. cm. in. greatest. dimension. All 12 lymph nodes are bisected and entirely submitted. Summary of sections: BLN - bisected lymph nodes. 7. The specimen is received fresh, labeled ""Bladder, uterus, bilateral ovaries and tubes, cervix"". It consist of a 503.0 g, Bladder,. uterus, bilateral ovaries and tubes, cervix measuring 16.0 cm from superior to inferior, 10.5 cm laterally and 6.5 cm from anterior to. posterior. The bladder measures 6.0 x 5.0 x 2.0 cm, the uterus measures 12.0 x 7.0 x 4.5 cm, the right ovary measures 2.5 x 1.5 x. 1.3 cm, the previously ligated right fallopian tube stumps collectively measure 5.0 cm, the left ovary measures 1.8 x 1.5 x 1.0 cm,. and the previously ligated left fallopian tube stumps collectively measure 4.5 x 0.3 cm. The portion of vaginal cuff measures 3.0 x. 2.0 x 1.8 cm. The distal urethra and the vaginal cuff margin are shaved and submitted. The right ureteric stump measure 4.8 cm in. length and 0.5 cm in average diameter and shows no gross lesion, the left ureter stump measures 4.5 cm in length and 0.4 cm. in. average diameter and shows no gross lesions. The specimen is inked as left - black, right-blue and the bladder is opened. anteriorly to reveal a previously incised, 6.0 x 2.0 x 2.0 cm poorly defined, ulcerated lesion, Jocated at the trigone, circumferentially. engulfing both ureteral orifices, occupying a portion of therright posterior wall and slightly encroaching on the left posterior wall. On. sectioning, the tumor extends to a depth of 1.7 cm, and 2.0 cm to extend into the perivesical fat grossly. The remaining bladder. mucosa is congested and tan-purple. The uterus is bivalved to reveal an 8.0 x 6.0 x 0.2 cm triangular endometrial cavity containing. a 0.1 cm thick, flat, tan-pink glistening mucosa, devoid of a grossly identifiable lesion. The trabeculated tan-pink myometrium varies. from 0.7 to 1.0 cm in thickness and has multiple, rubbery, whorled, homogenous white whorled nodules, ranging from 0.7 to 5.9 cm. in greatest dimension. The ovaries and fallopian tubes show no gross lesions. The remaining specimen is submitted for lymph. node dissection and any identified lymph nodes are submitted. Tissue has previously been submitted for. by Dr. (including right trigone orifice). Gross photographs are taken. Representative sections are submitted. Summary of sections: UTHM - urethral margin. RUM - right ureter margin. LUM -left ureter margin. L -lesion, (full thickness cut in half x2). RUO -right ureteric orifice with tumor. LUO -left ureteric orifice with tumor. LP-left posterior wall with tumor. LA -left anterior wall. RP-right posterior wall with tumor. RA-right anterior wall. TRI -trigone with tumor. DOME -dome. F-perivesical fat with tumor. EMM-endomyometrium. CX-cervix. DVM -distal vaginal margin, shave. RT - right tube. RO - right ovary. LT - left tube. LO - left ovary. BLN-bisected lymph node. PLN-possible lymph nodes. 8. The specimen is received in formalin labeled ""left ureter"" is a 1.1 cm in length by 0.4 cm in average diameter segment of an. unoriented tubular structure with surrounding fat. The specimen is serially sectioned and entirely submitted. Summary of sections: U- undesignated. Summary of Sections: Part 1: SP: Right ureter; segemental excision (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 2: SP: Left ureter, segmental excision (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Lymph nodes, right comon iliac; dissection. Block. Sect. Site. PCs. 4. BLN. 8. Part 4: SP: Lymph nodes, right pelvic; dissection. Block. Sect. Site. PCs. 3. bIn. 3. 1. fin. 1. 1. In. 1. 2. mln1. 2. 2. mln2. 2. Part 5: SP: Lymph nodes, left common iliac; dissection. Block. Sect. Site. PCs. 1. BLN. 2. 1. LN. 5. Part 6: SP: Lymph nodes, left pelvic; dissection. Block. Sect. Site. PCs. 12. BLN. 24. Part 7: SP: Bladder, uterus, bilateral tubes and ovaries, cervix; resection. Block. Sect. Site. PCs. 1. BLN. 2. 2. CX. 2. 1. DOME. 1. 1. DVM. 9. 2. EMM. 3. 1. F. 1. 5. 5. 1. LA. 1. 1. LO. 1. 1. LP. 1. 1. LT. 6. 1. LUM. 1. 1. LUO. 1. 5. PLN. 14. 1. RA. 1. 1. RO. 1. 3. RP. 3. 1. RT. 6. 1. RUM. 1. 1. RUO. 1. 2. TRI. 2. 2. 2. 1. UTHM. 1. Part 8: SP: Left ureter #2; segmental excision. Block. Sect. Site. PCs. 1. u. 1. Intraoperative Consultation: 1. SP: Right ureter ,. Benign. Permanent diagnosis: Same. 2. SP: Left ureter. Carcinoma in situ. Permanent diagnosis: Same.",T3,N3,M0,T3N3M0
TCGA-37-4130,Clinical. Index. Diagnosis. Lung. 1. Cancer. Lung. Cancer. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of. Amount/per. Specificati. Container. Site. Matrix. Format. containers. container. on. 0. Lung. Primary. Tumor. Tissue. OCT. block. 1. n/a. Blood. n/a. Normal. Blood. frozen. tube. 1. n/a. Type of. Histological description. Grade. TNM Stage. TNM Stage. TNM Stage. Treatment. Procureme. (Source). (source). (T). (N). (M). type. nt. n/a. Adenocarcinoma. 2. 2. 0. 0. none. blood draw. n/a. n/a. n/a. n/a. n/a. none. n/a. Component. of treatment. Tumor cell. (Chemo /. %. Horm Th. Details). n/a. 74. n/a. n/a.,T1,N0,M0,T1N0M0
TCGA-IB-8127,"PHN: ACB: Telephone: Encounter: Collected Date: Received Date/Time: Specimen Description. A. Liver biopsy at. B. Gallbladder at. C. Portal lymph nodes at. D. Whipple's specimen at. Clinical Information. Hx: Suspicion of pancreatic adenocarcinoma. Infectious patient: No. Immunocompromised: No. History of neoplasm: No. Diagnosis. A: Liver Biopsy: Benign bile duct hamartoma. Negative for malignancy. B: Gallbladder, Cholecystectomy: Chronic cholecystitis, negative for atypia. Congested cystic duct lymph node, negative for malignancy. C: Portal Lymph Nodes: Reactive changes, negative for malignancy. Chart Request ID. Pathology: Provider - Permanent. Print Date/Time: PHN: ACB: Collected Date: D: Head of Pancreas (Whipple's Resection): Invasive duct carcinoma of the pancreas, with focal extension to. uncinate process margin. Ulceration of the distal common bile duct and ampulla, with. carcinoma invading through duodenal muscularis propria at the. level of the ampulla. Metastatic pancreatic carcinoma in three of 24 peripancreatic lymph. nodes. Synoptic Report. D: Pancreas (Exocrine), Microscopic. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades ampulla of Vater or sphincter of Oddi. Tumor invades peripancreatic soft tissues. MARGINS: Margin(s) involved by invasive carcinoma. Uncinate process (retroperitoneal) margin (nonperitonealized surface of the uncinate process). TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy): Not known. LYMPH-VASCULAR INVASION: Not identified. PERINEURAL INVASION: Not identified. PRIMARY TUMOR (pT): Chart Request ID: Print Date/Time: Pathology: Provider - Permanent. PHN: ACB: Inquil,. Collected Date: pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric. artery. REGIONAL LYMPH NODES (pN): pN1: Regional lymph node metastasis. Number examined: 24. Number involved: 3. DISTANT METASTASIS (pM): Not applicable. Gross Description. Received are specimens A to D. All requisitions and specimen containers are labelled with the patient's name. The cassettes and AP identifiers are labelled with the Surgical Number. A. The specimen consists of a liver biopsy which measures 1.0 X 0.5 X 0.5 cm. All tissue is submitted for QS in one. block. B. The specimen consists of an unopened gallbladder measuring 9.5 cm in length and up to 2.5 cm in transverse. diameter. The outer surface is unremarkable. Sectioning reveals pale green mucoid contents containing small flecks of. yellow calculous debris measuring up to 0.2 cm in size. The mucosa is smooth and velvety. A cystic duct lymph node,. 1.2. cm. in. greatest dimension, is present at the neck of the gallbladder. Representative sections of the neck, body and. fundus are submitted in B1. The cystic duct lymph node is submitted in B2. C. The specimen consists of three fragments of tissue measuring 3.7 cm, 3.0 cm, and 0.9 cm in greatest dimension. respectively. The largest fragment appears to consist of adipose tissue only and no lymph node is recognizable. Two. representative sections are submitted in C1. The second largest fragment consists entirely of a firm yellow lymph node-. like sample. Two sections are submitted in C2 and C3. The smallest fragment is submitted in C4 in its entirety. D. The specimen consists of a pancreaticoduodenectomy specimen in which the distal stomach to distal duodenal. resection margin distance is 23.0 cm. The attached head of pancreas measures approximately 8.0 X 5.0 x 6.0 cm. A. region of the ampulla is distorted by what appears to be a zone of ulceration into an underlying mass in the head of the. pancreas. The distal common bile duct opens at this area and appears to be up to 1.3 cm in diameter. The duodenal wall. around this area appears congested and indurated. Sectioning of the head of the pancreas shows a hard tumor mass. surrounding the common bile duct and measuring 4.5 X 3,5 X approximately 4.0 cm. The carcinoma lies close to the. uncinate process but also appears to encroach on the posterior surgical margin adjacent to the duodenum; this latter area. is painted orange. The uncinate process margin is painted blue. Sections are taken as follows: Pathology: Provider, - Permanent. PHN: ACB: Surqical Pathology Report. Collected Date: D1 - proximal bile duct margin. D2 - pancreatic neck resection margin. D3 - distal duodenal margin, en face. D4 and D5 - ampulla edge (D5 with posterior margin). D6 and D7 - indurated posterior margin. D8 through D12 - tumor with uncinate margin. D13 - tumor in relation to overlying duodenum. D14 - tumor in relation to overlying proximal duodenal mucosa. D15 - proximal, gastric resection margin. D16 and D17 - six possible lymph nodes from distal lesser curve. D18 - three possible lymph nodes in pancreaticoduodenal chain. D19 through D21 - 11 possible lymph nodes at the inferior aspect of the head of pancreas. Frozen Section Diagnosis. A, Liver Biopsy: Bile duct hamartoma. Negative for malignancy. Microscopic Description. A: Sections after routine processing confirm the frozen section diagnosis. A small cluster of bile ducts form a localized. nodule with no cytologic atypia. B: Sections show mild chronic cholecystitis, but no cytologic atypia. The cystic duct lymph node is congested, but no sign. of malignancy is present. C: Fragments of adipose tissue include small nerve trunks. The large lymph node-like fragment is comprised of lymph. nodes showing focal lipogranulomatosis. No sign of metastatic disease is present. D: The head of pancreas is largely replaced by an invasive moderately differentiated pancreatic duct carcinoma. The. tumor shows varying growth patterns ranging from well defined glandular spaces through to irregular tongues and islands. of carcinoma with prominent nuclear pleomorphism. Many areas show clear cytoplasm consistent with mucinous. differentiation. The carcinoma invades to the zone of the ampulla where the surface of the bile duct is large eroded and. Chart Request IC. Print Date/Time: Pathology: Provider - Permanent. PHN: ACB: gical Pathology Renort. Inquiry Numbe. Collected Date: replaced by granulation tissue. The carcinoma elements extend through the muscularis propria of the duodenum at the. level of the ampulla. Carcinoma focally extends to the uncinate process margin, but does not directly involve the posterior. soft tissue margin. Carcinoma focally extends beyond the confines of the pancreas into peripancreatic adipose tissue. Adjacent pancreatic parenchyma shows prominent inflammation and fibrosis. The en face section of the neck of the. pancreas is negative as is the proximal bile duct margin. Eight lymph nodes are incorporated in the sections of pancreas,. one of which shows metastatic pancreatic adenocarcinoma. There are 16 lymph nodes dissected from the peripancreatic. fatty tissue with metastatic duct carcinoma in two, one of which is in the pancreatico-duodena zone and one in a lymph. node along inferior margin. Pathology: Provider - Permanent.",T3,N1,M0,T3N1M0
TCGA-D8-A27V,"page 1 / 1. original. Examination: Histopathological examination. I. Age: 4. Gender: F. Material: Total organ resection - right breast . Expected time of examination: up to 8 working days. Clinical diagnosis: Examination performed or. Macroscopic description: Right breast-sized 1.,2 x 11.2 x 3.6 cm removed without axillary tissues and with a skin flap of 13.2 x 16.3 cm. Weight. 200 g. Tumour sized 3.2 x 1.8 x 2.8 cm on the boundary of outer quadrants, located 1.8 cm from the outer boundary, 0.3 cm. from the base and 0 cm from the skin. Microscopic description: Carcinoma lobulare invasivum (classical type) - NHG2 (3+2+1: 0 mitoses/10 HPF - visual area: 0.55mm). Infiltratio carcinomatosa cutis mammae. Mamilla sine laesionibus. Glandular tissue showing adenosis sclerosans et calcifications. Histopathological diagnosis: (including Examination. Carcinoma lobulare invasivum mammae dextrae. Invasive lobular carcinoma of the right breast). (NHG2, pT2, pNo/sn/).",T2,N0,M0,T2N0M0
TCGA-39-5028,"Clinical Diagnosis & History: former smoker, with right lung nodules discovered on chest CT. Blopgy => squamous caronoma. Specimens Submitted: 1: SP: Right leval four mediastinal lymph nodes. 2: SP: Left level four mediastinal lymph nodes. 3: SP: Right level 4 mediastinal lymph nodes #2. 4, SP: Level 7 subcarinal lymph nodes. 5: SP: Right upper lobe lung wadge. 6: SP: Level seven aubcarinal lymph nodea. 7: SP: Right level eleven interlobar lymph nodes. 8: SP: Right lower lobe lung. DIAGNOSIS: 1). LYMPH NODE, LEVEL IV, RIGHT MEDIASTINAL; EXCISION: - TWO BENIGN LYMPH NODES (0/2). LYMPH NODES, LEVEL IV, LEFT MEDIASTINAL; EXCISION: - MULTIPLE FRAGMENTS OF BENIGN ANTHRACOTIC LYMPH NODES. LYMPH NODES, LEVEL IV, RIGHT MEDIASTINAL #2; EXCISION: - NUL/TIPLE FRAGMENTS OF BENIGN ANTHRACOTIC LYMPH NODES. 4). LYMPH NODE, LEVEL vir, SUBCARINAL: EXCISION: - TWO FRAGMENTS or BENIGN ANTHRACOTIC LYMPK NODES. 5). LUNG, RIGKT UPPER LOBE; WEDGE RESECTION: SQUAMOUS CELL CARCINOMA OF THE RIGHT UPPER LOBE, MODERATELY. DIPFERENTIATED. THE TUMOR'S GREATEST DIAMETER IS 2.1 x 1.8 x 0.9 CM. - No VASCULAR INVASION IS IDENTIFIED. - NO PERINEURAL INVASION IS IDENTIFIED. - THE MAINSTEM BRONCHUS IS INVOLVED BY IN SITV CARCINOMA. - THE TUMOR EXTENDS SUBPLEURALLY BUT NOT TO THE PLEURAL SURFACE. - IN SITU CARCINOMA IS ALSO PRESENT. THE STAPLED MARGIN IS FREE OP TUMOR. - THE NON-NEOPIASIC LUNG SHOWS INTERSTITIAL FIBROSIS AND FOCAL. ORGANIZED PNEUMONIA. NOTE: THE TUMOR IS SIMILAR IN MORPHOLOGY TO THE TUMOR IN PART 8. 6). LYMPH NODES, LEVEL VII, SUBCARINAL; EXCISION: - TWO BENIGN LYMPH NODES (0/2). LYMPH NODES, LEVEL XI, RIGHT INTERLOBAR; EXCISION: - FOUR BENIGN LYMPH NODES (0/4). 8). LUNG, RIGHT, LOWER LOBE; LOBECTOMY: SQUAMOUS CELL CARCINOMA OF THE RIGHT LOWER LOBE, MODERATELY TO POORLY. DIPFERENTTIATED. - THE TUMOR'S GREATEST DIAMETER IS 6.6 x 5.1 x 3.4 CM. - THE MAINSTEM BRONCHUS IS INVOLVED BY INVASIVE CARCINOMA. - THE BRONCHIAL MARGIN IS FREE OF TUMOR. THE STAPLED MARGIN IS FREE OF TUMOR. - THE NON-NEOPLASTIC LUNG SHOWS EMPHYSEMAATOUS CHANGES, INTERSTITIAL. FIBROSIS AND OSSEOUS. METAPLASIA. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NOMBER OF. METASTATIC NODES IN RELATION TO THE TOTAL NUMBER OF NODES EXAMINED) : PERIBRONCHIAL 3/7. NO DIRECT TUMOR EXTENSION INTO LYMPH NODES IS IDENTIFIED. NOTE: WHILE THE FIBROSIS SHOWS FOCAL HONEYCOMBING AND FIBROTIC. CHANGES THAT RAISED. THE POSSIBILITY OF USUAL INTERSTITIAL PNEUMONIA. THE GROSS SPECIMEN SHOWS. THE FIBROTIC AREAS LOCALIZED AROUND THE TUMOR RATHER THAN DIFFOSELY FIBROTIC. CHANGE. THE CASE IS ALSO REVIEWED BY WHO AGREED WITH THE. RENDERED INTERERETATION. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1) The specimen is received fresh for intraoperative consultation, labeled. ""right level 4 mediastinal lymph nodes and consists of two pink tan firm. lymph nodes ranging from 0.6 x 0.3 x 0.3 cm to 0.7 x 0,4 x 0.3 cm in. greatest dimonsion. All identified lymph nodes are examined by frozen. section and entirely submitted. Summary of sections: FSC frozen section control. or. 2). The specimen is received fresh for intraoperative consultation, labeled. ""left level 4 mediastinal lymph nodes"" and consists of multiple pink tan. firm lymph nodes ranging from 0.3 x 0.2 x 0.2 cm to 0.5 x 0.3 x 0.3 cm in. greatest dimension. All identified lymph nodes are examined by frozen. section and entirely submitted. Summary of sections. PSC frozen section control. 3) The specimen is received fresh for intraoperative consultation, labeled. ""right level 4 mediastinal 1ymph nodes #2"" and consists of multiple pink tan. firm lymph nodes ranging from 0.2 x 0.2 x 0.1 cm to 0.4 x 0.3 x 0.2 em in. greatest dimension. All identified lymph nodes are examined by frozen. section and entirely submitted. Summary of sections: FSC frozen section control. 4). The specimen is received fresh for frozen section consultation,. labeled ""Level seven subcarinal lymph nodes and consists OF two pieces of. pink tan tissua measuring 0.3 x 0.3 x 0.2 cm each. Entirely submitted for. frozen section. Summary of sections: FSC -- frozen section control. 5). The specimon is received frash for frozen section consultation, labeled. ""Right upper lobe lung wedge"" and consists of a lung wedge measuring 5.3 x. 2.4 x 2.2 Cm. The pleural surface is pink-tan and smooth, with a centrally. located white tan and slightly puckered indurated area identified. Sectioning through this area reveals a 2 x 1.8 x 0.9 cm white-tan. 111-defined subpleural tumor nodule, which is located 0.2 cm from the. nearest stapled margin. The remainder of the lung parenchyma ig red-tan. and spongy with dilated areas identified. Representative sections of the. nodule are submitted for frozen section consultation, for permanent section. and the TPS. Sumenary of sections: FSC -- frozen section control. SM stapled margin shaved. RST-representative sections tumor. Rs representative sections. 6). The specimen is received in formalin, labeled ""Level seven subcarinal. lymph nodes and consists of two brown tan fleshy lymph nodes measuring 2.5. and 3 cm in greatest dimension. The lymph nodes are bisected and entirely. submitted,. Summary of sections: BLN- bisected lymph nodas. 7). The specimen is received in formalin, labeled ""Right level 11 interlobar. lymph nodes"" and consists of 4 brown tan fleshy lymph nodes moasuring fxom. 0.6 to 1.2 cm in greatest dimension. The lymph nodes are entirely submitted. Summary of sections: BLN- bisected lymph nodes. 8) The apecimen is received fresh, later placed in formalin, labeled. ""Right lower lobe lung"" and consists of a lung loba measuring 15 x 11.9 x. 5.9 cm. A previous incision is identified at the surface measuring 6.8 em. in greatest dimension. This area has been autured shut. The bronchial and. vascular margins are identified, and appear grosaly uninvolved by tumor. Upon opening, the bronchus is filled with thick red-tan mucoid material. The. ploural surface is pink-tan and primarily smooth. Sectioning through the. previously incised area reveals a 6.6 x 5.1 x 3.4 em ill defined gray tan. cantrally located tumor mass. The mass appears 3.5 cm from the nearest. stapled resection margin, 5.7 cm from the bronchial margin, and the edge. of. the mass abuts the pleural surface. Sectioning through the mass reveals an. extensive area of subpleural dilated spaces partially surrounding the tumor. Purther sectioning shows the mass abutting the distal bronchial wall of. the smaller portion of the bronchus, with partial possible obliteration of. the distal bronchials noted. Sectioning through the remaindex of the lung. reveals extensivo areas of dilated spaces, and few rod tan spongy soft. areas. Summary of sections: Summary of Sections. Part 1: SP: Right level four madiastinal lymph nodes. Block. Sect. Site. PCs. 1. Esc. 2. Part 2 : SP: Left level four mediastinal lymph nodes. Block. Sect. site. PCs. 1. FSC. 5. Part 3: SP: Right level 4 mediastinal lymph nodes #2. Block. Sect. site. PCS. 1. FSC. &. Part 4: SP: Level 7 subcarinal lymph nodes. Block. Sect. Site. PCg. 1. FSC. 1. Part 5: SP: Right upper lohe lung wedge. Block. Sect. site. PCs. 1. fac. 1. 2. zs. 2. 2. rst. 2. 1. sm. 1. Part 6: SP: Level seven subcarinal lymph nodes. Block. Sect. site. pCs. 3. BLN. 3. Part 7: SP: Right level eleven interlobar lymph nodes. Block. Seot. Site. PCs. 4. BLN. 8. Part 8; SP: Right lower lobe lung. Block. Sect. Site. PCs. 1. 1. 3. pbn. 3. 4. rs. 4. 2. xsb. 2. 3. rst. 3. 1. sm. 1. 2. twb. 2. 1. vm. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation,. 1). FROZEN SECTION DIAGNOSIS. BENIGN LYMPH NODE. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS. BENIGN LYMPH NODES. PERMANENT DIAGNOSIS: SAMK. FROZEN SECTION DIAGNOSIS. BENIGN LYMPH NODES. PERMANENT DIAGNOSIS: SAME. 4). FROZEN SECTION DIAGNOSIS. BENIGN LYMPH NODE. PERMANENT DIAGNOSIS: SAME. 5). FROZEN SECTION DIAGNOSIS. INFILTRATING SQUAMOUS CELL CARCINOMA. PERMANENT DIAGNOSIS:",T4,N1,M0,T4N1M0
TCGA-IQ-A61I,"REG DR: copies to: SPECIMEN ID: A. MUSCLE - DEEP MUSCLE INFERIOR MARGIN FS,. B. PALATE, NOS - LEFT SUPERIOR SOFT PALATE MARGIN FS,. C. MOUTH - RETROMOLAR MUCOSA MARGIN FS, D. TONGUE - DEEP TONGUE MARGIN FS,. E. UVULA PALATINA - UVULA FS, F. TONSIL - LEFT RADICAL TONSILLECTOMY,. G. NECK, NOS - LEFT NECK DISSECTION , H. LYMPH NODE - LEVEL 2B LYMPH NODE,. I. LYMPH NODE - LEVEL 5B LYMPH NODE. A. DEEP MUSCLE INFERIOR MARGIN: No carcinoma seen. B. LEFT SUPERIOR SOFT PALATE MARGIN: No carcinoma seen. C. RETROMOLAR MUCOSA MARGIN: No carcinoma seen. D. DEEP TONGUE MARGIN: No carcinoma seen. E. UVULA: No carcinoma seen. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. FINAL DIAGNOSIS. LEFT RADICAL TONSILLECTOMY: INVASIVE, POORLY DIFFERENTIATED, NON-KERATINIZING SQUAMOUS CELL CARCINOMA, 1.8 cm. in greatest dimension. Margins are free of carcinoma. No perineural invasion seen. Lymphovascular invasion is identified. AJCC pT1 N2b Mn/a. See Tumor Summary. By immunohistochemistry, tumor cells are positive for keratin (strong. cytoplasmic), CK5/6, p63, and negative for HLA-DR. They are positive for diffuse. cytoplasmic and focal nuclear staining for p16. HPV testing by in situ. hybridization is underway. G. LEFT NECK DISSECTION: METASTATIC CARCINOMA to two of thirty-two lymph nodes (2/32) . Largest metastatic focus measures 4.5 cm and may represent metastatic carcinoma. to a conglomerate of matted lymph nodes. Although metastatic carcinoma focally approaches lymph node capsule, no. definitive extranodal extension is identified. Salivary gland with chronic sialodenitis. H. LEVEL 2B LYMPH NODE: METASTATIC CARCINOMA to one of five lymph nodes (1/5). No extranodal extension seen. I. LEVEL 5B LYMPH NODE: This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. return the report to us by mail. FINAL DIAGNOSIS. Four lymph nodes, no carcinoma seen (0/4). Surgical Pathology Cancer Case Summary. Specimen: Left radical tonsillectomy and pharyngectomy. Received: In formalin. Procedure: Resection. Tonsillectomy. Pharyngectomy. Neck (lymph node) dissection: left. Specimen Integrity: Intact. Specimen Size: Greatest dimensions: 4.5 x 3.8 x 1.5 cm. Specimen Laterality: Left. Tumor Site: Oropharynx. Tumor Laterality: Left. Tumor Size: Greatest dimension: 1.8 cm. Additional dimensions: 1.! 5 x 1.3 cm. Histologic Type: Squamous cell carcinoma, conventional. Histologic Grade: G3: Poorly differentiated. Margins: Margins uninvolved by invasive carcinoma. Lymph-Vascular Invasion: Present. Perineural Invasion: Not identified. Lymph Nodes, Extranodal Extension: Not identified. Pathologic staging (pTNM) : Primary Tumor (pT) : pTl: Tumor 2 cm or less in greatest dimension. Regional Lymph Nodes (pN) : pN2b: Metastasis in multiple ipsilateral lymph nodes, non more than 6 cm in. greatest dimension. Number examined: 41. Number involved: 3. Distant Metastasis (pM) : Not applicable. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. return the report to us by mail. CLINICAL HISTORY-. PRE-OP DX: Not provided. PROCEDURE: Left radical tonsillectomy and pharyngectomy. RELEVANT CLINICAL HX: The patient has history of left tonsil cancer. GROSS DESCRIPTION: A. Received fresh and labeled ""Deep muscle margin inferior"" is an irregular-shaped. red-tan soft tissue fragment, 1.3 x 0.8 x 0.2 cm. Submitted in toto in one cassette. for frozen section. B. Received fresh and labeled ""Left superior soft palate margin"" is a red-tan soft tissue. fragment, 1.4 x 1.0 x 0.2 cm. Submitted in toto in one cassette for frozen section. C. Received fresh and labeled ""Retromolar mucosa margin"" is a pink-tan soft tissue. fragment, 1.7 x 0.8 x 0.2 cm. Submitted in toto in one cassette for frozen section. D. Received fresh and labeled ""Deep tongue margin"" is a pink-tan soft tissue fragment,. 1.8 x 1.0 x 0.2 cm. Submitted in toto in one cassette for frozen section. E. Received fresh and labeled ""Uvula"" is a pink-tan soft tissue fragment, 0.5 x 0.4 x 0.3. cm. Submitted in toto in one cassette for frozen section. F. Received in formalin and labeled ""Left radical tonsillectomy and left pharyngectomy"". is an irregular-shaped, pink-tan soft tissue fragment with overlying mucosa, 4.5 x 3.8. x. 1.5 cm. The specimen was oriented at the frozen section room, as follows: superior. surgical resection margin inked yellow, inferior surgical resection margin inked blue,. medial surgical resection margin inked red, lateral surgical resection margin inked. green and deep surgical resection margin inked black. The specimen is serially. sectioned and reveals an ill-circumscribed, white firm tumor arising from the tonsil,. which invades into the adjacent soft tissue, 1.8 x 1.5 x 1.3 cm. The tumor is 0.2 cm. within the deep surgical resection margin (nearest), 0.3 cm from the superior surgical. resection margin, 0.6 cm from the inferior surgical resection margin, 1.0 cm from the. medial surgical resection margin and 0.4 cm from the lateral surgical resection. margin. The specimen is submitted as follows: Cassette #1: Perpendicular superior margin. Cassette #2: Perpendicular inferior margin. Cassette #3: Perpendicular medial margin. Cassette #4&5: Composite section OF the tumor in relation with lateral, deep. and inferior margin (cassette #4: lateral margin). Cassette #6&7: Additional section of tumor in relation with deep surgical. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. return the report to us by mail. GROSS DESCRIPTION: margin. Note: There was a 0.4 cm portion of tumor sent fresh to Tissue Bank. G. Received in formalin and labeled ""Left neck dissection, level IB, IIA, III and IV"" is. an unoriented irregular-shaped, yellow-tan fibroadipose tissue fragment, 15.0 x 8.0 x. 3.5 cm. In the same container, there are four irregular-shaped, yellow-tan. fibroadipose tissue fragments, 3.0 x 2.5 x 1.0 cm in aggregate. A salivary gland is. identified, 4.5 x 3.0 x 1.5 cm. Attached to the salivary gland, there is a red-tan. lymph node, 1.5 cm in greatest dimension. There is an ovoid-shaped, white-tan solid. mass, 4.5 x 4.0 x 3.0 cm. The mass is located 3.0 cm distal to the salivary gland. Thirty two lymph nodes are dissected, ranging from 0.2 cm to 2.0 cm in greatest. dimension. Sections made through the salivary gland reveal an unremarkable. yellow-gray, lobulated salivary gland parenchyma. The specimen is submitted in twenty. seven cassettes, as follows: Cassette #1-3: Representative sections from the largest mass (level IIA, as. per surgeon). Cassette #4: Lymph node adjacent to salivary gland, bisected and in toto. Cassette #5&6: One lymph node bisected. Cassette #768: One lymph node bisected. Cassette #9-22: One lymph node bisected per cassette. Cassette #23-25: Five lymph nodes in toto per cassette. Cassette #26&27: Representative sections from salivary gland. H. Received in formalin and labeled ""Level IIB lymph node"" is an irregular-shaped,. yellow-tan fibroadipose tissue fragment, 3.5 x 2.5 x 1.8 cm. Examination of. the. specimen reveals six lymph nodes, ranging from 0.2 cm to 0.8 cm in greatest dimension. Lymph nodes are submitted in toto as follows: Cassette #1: One lymph node bisected. Cassette #2: Three possible lymph nodes in toto. Cassette #3&4: One lymph node bisected per cassette. Received in formalin and labeled ""Level VB lymph nodes"" are multiple and. irregular-shaped, yellow-tan fibroadipose tissue fragments, 3.5 x 3.5 x 2.0 cm. Four. lymph nodes are dissected, ranging from 0.2 cm to 0.8 cin in greatest dimension. Lymph. nodes are submitted in toto as follows: Cassette #1&2: One lymph node bisected, per cassette. Cassette #3: Two lymph nodes in toto. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. return the report to us by mail. GROSS DESCRIPTION: (Continued). OPERATING ROOM CONSULT (FS-CYT). AFS: Negative for carcinoma. BFS: Negative for carcinoma. CFS: Negative for carcinoma. DFS: Negative for carcinoma. EFS: Negative for carcinoma. Signed (Signature on file). This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. return the report to us by mail.",T1,N2,M0,T1N2M0
TCGA-E9-A1RD,"OC ID. Gross Description: Breast with the tumor of 2.8 x2.6 cm in size; lymph nodes are up to 1 cm in their diameter, dense, hyperemic. Microscopic Description: Infiltrating duct carcinoma; G2. Ten examined lymph nodes demonstrate sinus histiocytosis. Diagnosis Details: Tumor Features: Unknown, Tumor Extent: T2 tumor size more than 2cm not more than 5 cm, Venous Invasion: Absent,. Margins: Absent, Treatment Effect: Comments: BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Lower inner quadrant. Tumor size: 2.6 x 0 x 2.8 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 0/10 positive for metastasis (Axillary 0/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Uninvolved. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None. Laterality: Right, lower inner quadrant.",T2,N0,M0,T2N0M0
TCGA-F4-6855,"Colon segment up to 17 cm long with. Adenocarci. the tumor of 9 cm in its largest. noma; G2;. dimension; fatty tissue lymph nodes. fatty. are small, their observation is not. tissue. enough informative. infiltration. Lymph. nodes. demonstra. te reactive. changes. Tumor Features: Ulcerated, Tumor. LARGE INTESTINE TISSUE CHECKLIST. Extent: Fat, NOS, Venous Invasion: Absent, Margins: Absent, Treatment. Specimen type: Sigmoid colectomy. Effect: Specimen size: Not specified. Tumor site: Sigmoid colon. Tumor size: 0 X 0 X 9 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Pericolonic tissues. Lymph nodes: 0/12 positive for. metastasis (Adjacent fatty tissue 0/12). Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not. specified. Comments: None.",T3,N0,M0,T3N0M0
TCGA-BR-8078,Microscopic. Diagnosis. Comments. Description. Description. Details. Laterality. STOMACH TISSUE. Fundus. CHECKLIST. Specimen type: Subtotal. gastrectomy. Tumor site: Fundus. Tumor size: 14 X 13 X 2 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Adjacent. structures (specify) -. Omentum. Lymph nodes: 0/5 positive. for metastasis (Regional. 0/5). Lymphatic invasion: Not. specified. Venous invasion: Not. specified. Perineural invasion: Not. specified. Margins: Uninvolved. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic. findings: Not specified. Comments: None.,T4,N0,M0,T4N0M0
TCGA-T9-A92H,"Confidential. Site ID: Subject Number: Please complete ALL information with black ball point pen. Ensure information is legible. Retain original and email/fax. Sample Collection Date: Procured by: Time of Tumor Sample Excision. (24 hour clock): Time Zone: TUMOR-FROZEN & FRESH SAMPLES. FROZEN SAMPLES BATCH SHIPPED (dry ice); FRESH TUMOR SAMPLE, IF COLLECTED, SHIPPED ON DAY OF COLLECTION. Collect resected tumor in accordance with standard procedures. Weigh the sample and section off ~100mg. Frozen Tumor (Required). Place this sample in the cryovial labeled Frozen Tumor sample and record the weight. Place the cryovial in a cane and. then into the vapor phase dewar. Record the time placed in dewar. Weight of Tissue: 270 mg. Time placed in dewar: (tissue weight must be 100mg). (24 hour clock). H H : M M. Fresh Tumor (Optional). N/A. Locate the ""Fresh Tumor"" label in the kit and affix to the 15ml. tube (sent separately). Place anv remaining. tumor tissue into the 15ml conical tube containing. Weight of Tissue: 690 mg. Time placed in. Lot Number of. (no min. weight specified). (24 hour clock). H. H. M. M. WHOLE BLOOD SAMPLE (Required) - BATCHED SHIPPED FROZEN (dry ice). Sample Collection Date: Procured by: D. D. M. M M. Time of Blood Sample Collection. (24 hour clock): Time Zone: H. H. M. M. 1-10ml EDTA tube. Fill tube completely and mix by gentle inversion at least 8-10 times. Freeze sample on dry ice or. place in vapor phase dewar. Time placed in dry ice/dewar: (24 hour clock). H H : M M. BASIC PATHOLOGICAL INFORMATION. Clinical Diagnosis: Source of Specimen: (Ex. Lung Cancer). (Ex. Right Lung). Confidential. Valid from. Confidential. Tissue/Blood Requisition Form. Affix Label Here. Or Write in Sample iD. Site ID: Subject Number: Diagnostic Slides (Required) - SLIDES BATCHED SHIPPED. From the diagnostic FFPE block, cut 3 slides with one section N 4-5um on each slide. Label the frosted tip of the slide. in pencil with the sample ID (located on the label at the top of this form). Record the ID number of the diagnostic. histology cassette and the number of slides. H&E stain the slides and store in a slide mailer. Diagnostic Histology Cassette ID. Number of Slides Cut 3. Refen to. Study Manuai for detailed specimen processing and shipping Instructions. denotes required samples). Specimen. Transfer Tube. Shipping Status. Frozen Tumor. None. Cryovial. Same Day - Dry Ice. Frozen Blood. 1-10ml EDTA. None. Same Day - Dry Ice. Fresh Tumor. None. 15ml-. Same Day - Refrigerated. Diagnostic Slides. Histology Cassette. SuperFrost Slides. 5-Slide Mailer-Batch -. When samples are ready for shipment please notify by Email notification: Atithis time, please also provide your Sample Manifest. When the Dignostic slides re ready foi shipment please notify by Email notification: At this. time pl ease also provide your Sample Manifest. DO NOT RETURN EMPTY CONTAINTERS TO. White copy-Retain for your Records. Yellow copy-send to pathology for diagnosticslides. Confidential. Valid from. Surgleal-Pathology Final Report. Temporary Copy. Final Diagnosis. Superior hemorrhoidal lymph node: One (1) lymph node negative for neoplasm. Sigmoid colon, segmental resection: Adenocarcinoma. -Histologic grade: Moderately to poorly differentiated. -Tumor size: 6.3 cm in greatest dimension. -Tumor extension: Tumor penetrates muscularis propria and extends into. pericolonic fat. -Lymph-vascular invasion: Definite lymph-vascular invasion is not identified. -Perineural invasion: Present, focal. -Surgical margins: Proximal and distal margins negative for neoplasm. Radial margin negative for neoplasm. Mesenteric vascular margin negative for neoplasm. -Closest surgical margin: Proximal. Tumor comes to within 5.3 cm. -Lymph nodes: Thirteen (13) of thirteen (13) lymph nodes negative for. neoplasm (0/13). AJCC pathologic stage: pT3,NO. Clinical Information. Colon cancer. Gross Description. ""A, Superior hemorrhoidal lymph node."" Received is a 0.5 cm lymph node with attached fat. ""A,"" all. ""B, Sigmoid colon."" Received Is an 18.6 cm segment of colon with attached pericolonic fat. There is a stitch attached to one. end of the specimen which is designated as proximal. The proximal margin will be inked orange. There is a 6.3 x 5.8 cm full. circumferential ulcerated mass on the mucosa which is 5.3 cm from the proximal margin. There is black ink on the radial. margin adjacent to the mass. The mass grossly appears to extend through the full thickness of the wall of the colon and to. involve the adjacent pericolonic fat. No other masses or lesions are grossly identified on the remaining mucosa. There is a. vascular pedicle identified on the pericolonic fat. The mass grossly appears to come within 3.8 cm of the pedicle. The margin. of. the pedicle will be shaved and submitted. On sectioning the pericolonic fat, there are 11 possible lymph nodes ranging from. 0.4-0.8 cm. ""B1,"" proximal and distal margins and vascular pedicle margin; ""B2-B4,"" random sections mass; ""B5,"" possible. regional lymph node; ""B6,"" possible lymph nodes remaining pericolonic fat.",T3,N0,M0,T3N0M0
TCGA-B0-4693,"FINAL DIAGNOSIS. PART 1: BONE, RIB, EXCISION: A. FIBROCARTILAGINOUS TISSUE WITH NO SPECIFIC PATHOLOGIC CHANGES. B. FRAGMENT OF BONE (GROSS EXAMINATION ONLY). PART 2: KIDNEY, LEFT, RADICAL NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE WITH SARCOMATOID FEATURES, LARGE. AREAS OF NECROSIS AND HEMORRHAGE (See synoptic). B. FUHRMAN NUCLEAR GRADE IS 4 of 4. C. THE GREATEST DIAMETER OF THE NEOPLASM IS 13.0 cm. D. RENAL SINUS FAT IS INVOLVED BY CARCINOMA. THE NEOPLASM INVADES THROUGH THE RENAL CAPSULE, EXTENDS INTO THE PERIRENAL FAT AND IS. LOCATED IN CLOSE PROXIMITY TO ADRENAL GLAND,. F. NO INVASION OF THE RENAL VEIN IS IDENTIFIED. G. ANGIOLYMPHATIC INVASION IS IDENTIFIED. H. ALL SURGICAL MARGINS ARE FREE OF THE NEOPLASM. I. THE NON-NEOPLASTIC KIDNEY SHOWS CHANGES DUE TO PROXIMITY THE TUMOR. J. HISTOLOGICALLY UNREMARKABLE ADRENAL GLAND IS NOT INVOLVED BY CARCINOMA. K. TNM STAGE: pT3a NO MX. PART 3: LYMPH NODES, PERIAORTIC, EXCISION: NO CARCINOMA SEEN IN FIVE LYMPH NODES EXAMINED (0/5).",T3,N0,M0,T3N0M0
TCGA-E7-A8O8,"Gross Description: In bladder, it is invasive and protruded masse, ill - margins with 3.5x2.5x1cm in size,. soft and gray surface. Microscopic Description: Tumor is density. Tumor cells are hyperplastic to form papillary or trabeculae. Tumor cells have moderate and eosinophilic or clear cytoplasm. Nuclei are enlarged and varriability in. shape and size, irregular nuclear membranes, nucleoli and abnormal chromatin patterns. Mitoses are. present. Tumor invades in muscularis propria. Diagnosis Details: Infiltrating urothelial carcinoma, high-grade, infiltrating muscularis propria. Comments: Formatted Path Reports: BLADDER TISSUE CHECKLIST. Specimen type: Cystectomy. Tumor site: Bladder. Tumor size: 3.5 x2.5x1cm. Tumor features: None specified. Histologic type: Transitional cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Muscularis propria. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: Not specified. Comments: None.",T2,N0,M0,T2N0M0
TCGA-EL-A3TB,"Pathology. bort. atholo. Confecteo. Case type: Surgical Case. MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A-C) RIGHT NECK DISSECTION, LEVEL II, LEVEL III, LEVEL IV: LEVEL II: Two lymph nodes, no tumor present (0/2). LEVEL III: METASTATIC PAPILLARY CARCINOMA IN FOUR OF NINE LYMPH NODES (B). 1.3 CM IN GREATEST DIMENSION. LEVEL IV: METASTATIC PAPILLARY CARCINOMA IN FOUR OF NINE LYMPH NODES (4/9). METASTATIC CARCINOMA IN SOFT TISSUE. (D) RIGHT PARATRACHEAL NECK DISSECTION: METASTATIC PAPILLARY CARCINOMA IN SIX OF EIGHT LYMPH NODES (6/8). (E) LEFT SUPERIOR PARATHYROID: Parathyroid tissue, no tumor present. (F) TOTAL THYROID: PAPILLARY THYROID CARCINOMA, PRIMARILY FOLLICULAR PATTERN (2.2 CM). TUMOR EXTENDS INTO ADJACENT PARATHYROID (F6). TUMOR PRESENT AT MARGIN. METASTATIC PAPILLARY CARCINOMA IN ONE OF ONE LYMPH NODE (1/1). Entire report and diagnosis completed b,. GROSS DESCRIPTION. (A) CONTENTS, RIGHT LATERAL NECK DISSECTION, LEVEL II - An irregular fragment of fibroadipose tissue (8.0 x 3.0 x 0.8. cm). The specimen is serially sectioned and two lymph nodes are identified (1.5 x 0.6 x 0.4 and 2.0 x 0.8 x 0.8 cm). SECTION CODE: A1, one lymph node bisected; A2, one lymph node. cm). The specimen is serially sectioned and nine lymph nodes are identified ranging from 0.4 x 0.3 x 0.3 to 2.0 x 0.8 x 0.5. (B) RIGHT LEFT NECK DISSECTION, LEVEL III - An irregular fragment of fibroadipose tissue, skeletal muscle (6.0 x 3.0 x cm. 0.8. SECTION CODE: B1, representative sections of skeletal muscle; B2, three lymph nodes; B3, four lymph nodes; B4, two. (C) RIGHT CONTENTS, LEVEL IV - An irregular fragment of fibroadipose tissue (6.0 x 3.5 x 1.5 cm). The specimen is serially. lymph nodes. sectioned and 10 lymph nodes are identified ranging from 0.2 x 0.2 x 0.2 to 3.0 x 1.5 x 1.0 cm. SECTION CODE: C1, three lymph nodes; C2, C3, one lymph node bisected; C4, C5, one lymph node bisected; C6, five. lymph nodes. (D) CONTENTS, RIGHT PARATRACHEAL NECK DISSECTION - An irregular fragment of fibroadipose tissue (5.0 x 3.0 1.0 x 1.5. cm). The specimen is serially sectioned and eight lymph nodes are identified ranging from 0.4 x 0.4 x 0.3 to 2.5 x 2.0 x cm. Case type: Surgical Case. The cut surface of the largest lymph node is. filled with yellow clear liquid. SECTION CODE: D1, three lymph nodes; D2, two lymph nodes; D3, one fymph node bisected; D4, one lymph node. bisected; D5, D6, one lymph node bisected. (E) RULE OUT LEFT SUPERIOR PARATHYROID - a 0.2 x 0.2 x cm red, tan soft tissue fragment entirely submitted for frozen. section as E after touch preparation. FS/DX: PARATHYROID TISSUE. (F) TOTAL THYROID- Total thyroidectomy consists of right lobe (3.5 cm from lateral to medial, 2.5 cm from superior to inferior;. white-tan, homogeneous, and grossly does not invade the capsule. It is 1.8 cm from the isthmus, 0.5 cm from the inferior,. In the superior part of the right lobe is a firm tumor nodule which measures 2.2 x 1.4 x 1.3 cm. The cut surface of the tumor and is. 1.4 cm anterior to posterior), isthmus (1.4 x 0.8 x 0.3 cm) and left lobe (1.5 x 2.0x 1.2 cm). within less than 0.1 cm from the superior part. Tumor and uninvolved thyroid are sampled for tumor bank. SECTION CODE: F1-F6. tumor nodule in toto; from superior pole to inferior pole; F7, isthmus; F8-F10, left thyroid -. representative sections. CLINICAL HISTORY. Thyroid cancer. SNOMED CODES. T-B6000, M-80503, T-C4200, M-80506. These tests have not been specifically cleared or approved. ""Some tests reported here may have been developed and performance characteristics determined by. by the U.S. Food and Drug Administration. Released by: Case type: Surgical Case. ADDENDUM. Addendum completed by. COMMENT. One lymph node in level II showed a psammoma body surrounded by giant cells without epithelial cells identified. A cytokeratin. stain is negative for metastatic carcinoma. The above diagnosis remains unchanged. Released by:",T3,N1,M0,T3N1M0
TCGA-E2-A14P,"SPECIMENS: A. RIGHT AXILLARY CONTENTS. B. RIGHT BREAST LUMPECTOMY. C. RIGHT BREAST SUPERIOR MARGIN. SPECIMEN(S): A. RIGHT AXILLARY CONTENTS. B. RIGHT BREAST LUMPECTOMY. C. RIGHT BREAST SUPERIOR MARGIN. INTRAOPERATIVE CONSULTATION DIAGNOSIS: B. Right breast, lumpectomy (Gross examination only): 3.0 cm firm tumor, 1.5 cm from deep margin. Satellite tumor. 1 cm from main tumor, 1 cm in diameter (1.0 cm from antero medial margin). By Dr. called to Dr. at. GROSS DESCRIPTION: A. RIGHT AXILLARY CONTENTS. Received in formalin in a container labeled with the patient name designated ""a. right axillary contents"" is a portion of. red-yellow firm adipose tissue measuring 10.1 x 8.5 x 3.7 cm. Multiple firm enlarged lymph nodes are identified,. ranging in size from 0.3 x 0.2 x 0.2 up to 3.5 x 2.5 x 2.0 cm. Cassettes are submitted as follows: A1-A2: representative sections, 1 lymph node. A3-A5: 1 lymph node. A6-A8: 1 lymph node. A9-A10: 1 bisected lymph node. A11: 1 bisected lymph node. A12: 4 lymph nodes. A13: 3 lymph nodes. A14: 3 lymph nodes. A15: 2 lymph nodes. A16: 3 lymph nodes. A17: 3 lymph nodes. A18-A20: additional possible lymph nodes. B. RIGHT BREAST LUMPECTOMY. Received fresh is an oriented 226 gm lumpectomy specimen, 15 x 10 x 4 cm. The specimen is partially surfaced. with a tan-pink ellipse of skin, 11.5 x 5.5 cm. The skin surface is grossly unremarkable. The specimen is inked as. follows: anterior-blue, posterior-black, superior-red, inferior-orange, medial-green, lateral-yellow. Specimen is. serially sectioned from superior to inferior into 6 slices; slice 1 being most superior, slice 6 being most inferior to. reveal a gray-white firm well circumscribed mass, 3.0 x 2.5 x 1.7 cm located in slice 2 and 3. Mass #1 measures 1.5. cm from the closest deep margin and 2.0 cm from the anterior margin. A 2nd possible satellite nodule is identified,. 0.8 x 0.7 x 0.6 cm, 0.6 cm medial to mass #1 located in slice 2. The 2nd mass measures <1.0 cm from all margins. The 2nd mass measures 0.6 cm from the medial margin. Mass #2 measures 0.6 cm from mass #1. The remaining. cut surface reveal predominantly yellow lobulated adipose tissue inter dispersed with gray-white fibrous tissue. A. portion of the specimen is submitted for tissue procurement and representative sections are submitted as follows: B1: area immediately adjacent to mass #1 slice 1. B2: perpendicular sections of the superior margin slice 1. B3: lateral margin slice 2. B4: posterior margin slice 2. B5: mass #1 slice 2. B6-B7: mass #1, bisected slice 2. B8-B9: #2, bisected slice 2. B10: medial margin slice 2. B11: skin slice 2. B12: lateral margin slice 3. B13-B14: mass #2 slice 3. B15: area immediately adjacent to mass #2 slice 3. B16: medial margin slice 3. B17: skin slice 3. B18: posterior margin slice 3. B19: area immediately adjacent to mass #1 slice 4. B20: medial margin slice 4. B21: medial and posterior margin slice 5. B22: lateral margin slice 5. B23: perpendicular section taken of the inferior margin slice 6 as per attached diagram. B24: posterior margin. B25: superior margin. C. RIGHT BREAST SUPERIOR MARGIN. Received in formalin is a 12 gm oriented fragment of fibrofatty tissue, 9.0 x 3.0 x 1.5 cm. The new true margin is. inked blue and the specimen is serially sectioned to reveal grossly unremarkable breast parenchyma. Entirely. submitted in cassettes C1-C10. DIAGNOSIS: A. AXILLARY CONTENTS, RIGHT, DISSECTION: - METASTATIC CARCINOMA TO 10 OF 24 LYMPH NODES WITH. EXTRANODAL EXTENSION, LARGEST METASTASIS IS 3.5 CM (10/24). B. BREAST, RIGHT, LUMPECTOMY: - INVASIVE DUCTAL CARCINOMA WITH SATELLITE NODULE. - SBR GRADE 3. - TUMOR MEASURES 3 CM AND 1.1 CM. - MARGINS, NEGATIVE FOR CARCINOMA. - LYMPHOVASCULAR INVASION IS PRESENT. - DUCTAL CARCINOMA IN SITU (DCIS), SOLID AND CRIBRIFORM TYPES,. NUCLEAR GRADE 3, WITH COMEDO NECROSIS, MINOR COMPONENT. - SKIN, NEGATIVE FOR CARCINOMA. C. BREAST, RIGHT, SUPERIOR MARGIN, EXCISION: - BREAST TISSUE, NEGATIVE FOR CARCINOMA. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Right. Invasive tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3cm. Tumor site: Upper outer quadrant. Margins: Negative. Distance from closest margin: Greater than 1cm. all margins. Tubular score: 3. Nuclear grade: 3. Mitotic score: 2. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: Present. Lobular neoplasia: None. Lymph nodes: Axillary dissection. Lymph node status: Positive 10 /24 Extranodal extension. DCIS present. Margins uninvolved by DCIS: 0.4 cm from medial margin, focal. DCIS Quantity: Estimate 10%. DCIS type: Solid. Cribriform. DCIS location: Both associated and separate from invasive tumor mass. Nuclear grade: High. Necrosis: Present. ER/PR/HER2 Results. Performed on Case: ER: Negative. PR: Negative. HER2: Positive by IHC. Pathological staging (pTN): pT 2N3. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: B14. ER: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score. 0. PR: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score 0. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the proportion score (0. = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of cells staining, 4 = 31-60% of. cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak intensity of staining, 2 = intermediate. intensity of staining, 3 = strong intensity of staining), with a scoring range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score of less than or. equal to 2. Methodology: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin. -) for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Mouse anti-human ER and. PR,. Comment: This assay Car; be used to select invasive breast cancer patients for hormone therapy (1). ER and PR analysis was performed on this case by immunohistochemistry utilizing the ER (ER 1D5, 1:100) and PR. (PGR 136, 1:100) antibody provided by Dako, following the manufacturer's instructions listed in the package insert. This assay was not modified, and adherence to all instruction and guidelines were strictly followed. Interpretation of. the ER/PR immunohistochemical staining characteristics is guided by published results in the medical literature (1),. information provided by the reagent manufacturer and by internal review of staining performance within the. Pathology Department. 1. Harvey JM, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for. predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 17:1474-1481, 1999. SYNOPTIC REPORT - BREAST HER-2 RESULTS. HER2 Status Results, Immunohistochemistry Evaluation. Specimen: Surgical Excision. Block Number: B14. Interpretation: POSITIVE. Intensity: 3+. % Tumor Staining: 100%. Fish Ordered: No. METHODOLOGY. Methodology: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin. for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Rabbit anti-human HER2,. HerceptestTM (FDA-approved test kit),. ). Control Slides Examined: External kit-slides. provided by manufacturer (cell lines with mign, low and regative HER2 protein expression), and in-house known. HER2 amplified control tissue were evaluated along with the test tissue. These control slides run along side of this. patient's sample showed appropriate staining. Adequacy of Specimen: Adequate, well preserved, clear-cut invasive. carcinoma identified for HER2 evaluation. Scoring Criterion and Scoring System: IHC Level of Expression(Score) /Tumor Cell Membrane Staining Pattern. Negative (0)/Absence of Staining. Negative (1+)/Faint Incomplete membrane Staining, >10% of Cells. Equivocal (2+)/Weak complete membrane Staining, >10% of Cells. Positive (3+)/Strong complete membrane Staining, >10% of Cells. Equivocal Category for HER2 IHC results: A HER2, 2+ staining result that is interpreted as equivocal may not. indicate gene amplification. A FISH test for HER2 gene amplification will be ordered for all HER2 IHC 2+ results. COMMENT. This assay can be used to select invasive breast cancer patients for Trastuzumab (Hereptin) therapy (1,2). Clinical. Trials have shown that Trastuzumab substantially increases the likelihood for an objective response and overall. survival for patients with metastatic HER2-positive breast cancer, regardless of whether HER2 tumor status was. determined as IHC 3+ or FISH positive. Trastuzumab added to adjuvant chemotherapy substantially increase. disease-free survival and decreases the risk of disease recurrence by about 50% for patients with early-stage HER2. protein over-expressed or gene amplified invasive breast cancer (3). HER2 analysis was performed on this case by immunohistochemistry utilizing the FDA approved Dako HercepTest. (TM) test kit following the manufacturer's instructions listed in the package insert. This assay was not modified, and. adherence to all instruction and guidelines were strictly followed. Interpretation of the HER2 immunohistochemical. staining characteristics is guided by published results in the medical literature (4), information provided by the. reagent manufacturer and by internal review of staining performance within the Pathology Department. HER2 TEST VALIDATION. This HER2 immunohistochemical assay has been validated according to the recently revised recommendations and. guidelines from the NCCN HER2 testing in Breast Cancer Task Force, and the jointly issued recommendations and. guidelines from ASCO and the CAP (5). 80 randomly selected breast cancer samples were tested for HER2 by IHC. as outline above and interpreted as, negative (score 0/1+) equivocal (score 2+) and positive (score 3+) without. knowledge of the previous reported results. These cases were also blindly read using two different FISH assay as amplified or non-amplified and. the. HER2/CEP17 ratios were recorded. After analyzing these results, there was 100% concordance between the IHC. and FISH results for cases that were interpreted as either positive or negative by IHC. 9 of the 80 cases were. interpreted as equivocal by IHC and of these 3/9 (33%) were non-amplified by FISH and 6/9 (66%) were found to be. amplified. The Pathology Department Immunohistochemistry laboratory takes full responsibility for this tests performance. and has programs in place to regularly monitor the proficiency and the interpretation of HER2 assays. The. laboratory also participates in external quality assurance HER2 programs including the CAP proficiency testing. program. REFERENCE. 1. Carlson RW, Anderson BO, Burstein HJ, et al., NCCN breast cancer clinical practice guidelines in oncology. J. Natl Compr Canc Netw. 2005;3:238-289. 2. Carlson RW, Brown E, Burstein HJ, et al., NCCN Task Force Report: adjuvant therapy for breast cancer. J Nati. Compr Canc Netw. 2006;4:S1-S26. 3. Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive. breast cancer. N Eng J Med 2005;353(16):1673-84. 4. Leong ASY, Formby M, Haffajee Z, et al. Refinement of immunohistologic parameters for Her2/neu scoring. validation by FISH and CISH. Appl Immunohistochem Mol Morphol. 2006;14:384-389. 5. Wolff AC, Hammond EH, Schwartz JN, et al., American Society of Clinical Oncology/College of American. Pathologists Guideline Recommendations for Human Epidermal Growth Factor Recepto 2 Testing in Breast Cancer. Arch of Path and Lab Med 2007; 131:18-43. CLINICAL HISTORY: year old female with large right breast mass and satellite lesion (1 cm) anterior to main tumor. Now for. lumpectomy. PRE-OPERATIVE DIAGNOSIS: None given. Microscopia/Diagnostic Dictation: Pathologist,. Microscopic/Diagnostic Dictation: Pathologisi. Final Review: Pathologist,. Final: Pathologist,.",T2,N3,M0,T2N3M0
TCGA-D7-6822,"page 1 / 1. original. Examination: Histopathological examination. Material: 1. Total organ resection - stomach. Expected time of examination: Clinical diagnosis: Gastric cancer, partial resection. Macroscopic description: Specimen consisting of the stomach, after having been excised along the greater curvature, sized 14.5 X 10.5 cm with the. omentum sized 9 X 5 and 18 x 4.5 cm. A cauliflower-shaped and ulcerous tumour sized 8 X 7.5 X 4 cm in the region of the lesser curvature . Distance from the proximal. boundary 7 cm, from distal boundary, 0 cm. Microscopio description: Adenocarcinoma tubulopapillare G2. The tumour infiltrates through the full thickness of the stomach wall, perigastric fat tissue, blood vessels. Neoplastic spreads over the distal incision line. Proximal line and the omentum clear of cancerous infiltration. Outside the tumour: mucous membrane showing symptoms of chronic inflammation with features of focal intestinal. metaplasia. Lymphonodulitis reactiva No VII. Histopathological Diagnosis: Adenocarcinoma tubulopapillare ventriculi. Tubulopapillar adenocarcinoma of the stomach. G2, pT2b, pNO typus intestinalis sec. Intestinal. Results of immunohistochemical examination: HER2 protein stained with HercepTest TM by DAKO. Positive reaction in invasive cancerous cells ( Score = 0).",T2,N0,M0,T2N0M0
TCGA-IA-A83W,"Patient Info. Male. Specimen #: FINAL DIAGNOSIS. RIGHT KIDNEY, EXCISION - RENAL CELL CARCINOMA, PAPILLARY TYPE, FUHRMAN. GRADE 2 OF 4 (SEE COMMENT). - ALL MARGINS NEGATIVE FOR NEOPLASM. - BENIGN EPITHELIAL CYST. COMMENT. The neoplasm measures 5.5 cm in greatest dimension and is situated in the. upper pole of the kidney. The tumor invades the overlying renal capsule and. is present within 1 mm from the soft tissue margin, however it does not. penetrate the capsule into the perirenal fat. Renal sinus invasion or. angiolymphatic invasion are not identified. SPECIMEN SUBMITTED. A: RIGHT KIDNEY. CLINICAL DATA. RIGHT RENAL MASS. GROSS DESCRIPTION. A. Received fresh is a specimen consisting of a right kidney surrounded by. an envelope of fibroadipose tissue measuring 20. o x 13.0 x 6.5 cm and. weighing 919.34 grams. A mass involves the upper portion of the kidney. On. section, the tumor mass is roughly spherical and measures 5.5 cm in. greatest dimension. It is composed of yellow to tan soft homogenous tissue. Foci of hemorrhage or necrosis is not present. The tumor does extend into. the perirenal fat. The tumor does not invade the pelvicaliceal system or. renal sinus The tumor is sharply demarcated from the renal parenchyma. which appears essentially unremarkable. Satellite nodules of tumor are not. present. Dissection of the renal veins particularly those draining the area. of the mass does not show the intravascular present of a neoplasm. The. adrenal gland is not present. An 8.5 cm segment of ureter is present and is. essentially unremarkable. Sectioning of the renal parenchyma reveals a cyst. measuring 1.5 cm in greatest dimension. Representative sections are. submitted as follows: A1 ureter margin, A2 vascular margin, A3 pelvis and. sinus, A4 cyst, A5-A6 sinus and mass, A7-A10 mass and capsule and soft. tissue margin. Patient ID #: M. Submitted by : Lab and Collection. on. - Lab and Collection Information. Result History. SURGICAL PATHOLOGY (. on. - Order Result History Report. Result Date and Time. Provider Status. This result is currently not released to. Display Full Result Report. Display Order Report.",T1,N0,M0,T1N0M0
TCGA-5M-AAT4,"SPECIMEN: terminal ileum, cecum, right colon, appendix and transverse colon. PROCEDURE: Right hemicolectomy with distal ileostomy. MACROSCOPY. - Segment of right and transverse colons, opened along its longitudinal axis, with cecum,. appendix, and terminal ileum. Appendix shows 4.0 cm of length and 0.7 cm of diameter. - The right and transverse colons measure 22.0 cm of length and 1.5 cm of mean diameter. - A vegetating tumor with elevated infiltrative borders and central ulceration, measuring 5.0 X 4.0. cm is found in the colonic mucosa 6.5 cm from the nearest surgical margin. - Three lymph nodes are grossly identified in the 12.0 X 11.5 cm area of pericolic fat tissue. - The adjacent mucosa is pale and shows three 0.9 cm polyps each near the ileocecal valve. MICROSCOPIC EXAMINATION. - Moderately differentiated tubular adenocarcinoma of the right colon. - Microscopic tumor extension: tumor invades until the fat subserosa. - Lymph-vascular invasion: present. - Surgical margins free of neoplasia. - Moderate peritumoral lymphocytic infiltrate. - Moderate stromal desmoplasia. - Extensive areas of necrosis in the tumor. - Number of lymph nodes examined: 3. - Number of lymph nodes positive for neoplasia: 0. - Adjacent intestinal mucosa with one villous adenoma with high grade epithelial dysplasia, and. two polyps with low grade epithelial dysplasia. - Appendix displays no pathologic features. - Stage (TNM 7th edition): pT3 pNO pMx.",T3,N0,M1,T3N0M1
TCGA-AZ-4682,"FINAL DIAGNOSIS: PARTS 1,. 2 AND 3: SIGMOID COLON, COLECTOMY -. A. INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA (3.0 CM) THROUGH MUSCULARIS. PROPRIA INTO PERIRECTAL FAT. B. NO ANGIOLYMPHATIC INVASION IDENTIFIED. C. SURGICAL RESECTION MARGINS FREE OF TUMOR. D. THREE PERICOLONIC LYMPH NODES, FREE OF TUMOR (0/3). E. PATHOLOGIC STAGE pT3 NO M1. F. HYPERPLASTIC POLYPS. PART 4: LIVER, BIOPSY -. METASTATIC MODERATELY DIFFERENTIATED ADENOCARCINOMA (see comment). MICROSCOPIC: SYNOPTIC DATA - PRIMARY COLON AND RECTAL TUMORS. SPECIMEN TYPE: Rectal/rectosigmoid colon (low anterior resection). SPECIMEN LENGTH: 32.0 cm. TUMOR SITE: Rectosigmoid. TUMOR CONFIGURATION: Ulcerating. TUMOR SIZE: Greatest dimension: 3.0 cm. INTACTNESS OF MESORECTUM: Not applicable. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: Low-grade (well to moderately differentiated). PATHOLOGIC STAGING (pTNM): pT3. pNO. Number of nodes examined: 3. Number of nodes involved: 0. pM1. MARGINS: Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (radial) margin uninvolved by invasive carcinoma. Mesenteric margin cannot be assessed. ANGIOLYMPHATIC INVASION: Absent. PERINEURAL INVASION: Absent. TUMORAL LYMPHOCYTIC RESPONSE: Mild to moderate. ADDITIONAL PATHOLOGIC FINDINGS: Other polyps (type polyps.",T3,N0,M1,T3N0M1
TCGA-E7-A4XJ,"Gross Description: In bladder, there are an invasive tumor, ill - margins with 3.5x3x2cm in size, soft and. gray surface. Microscopic Description: Transitional cells are hyperplastic. Tumor cells arrange to form nests or groups. or cords one by one or sheets with central necrosis. Tumor cells have moderate and eosinophilic. cytoplasm. Nuclei are enlarged and varriability in shape and size, very irregular nuclear membranes,. nucleoli and abnormal chromatin patterns. Mitoses are common. Tumor invades in fat tissue. Diagnosis Details: Infiltrating urothelial carcinoma, High-grade, infiltrating fat tissue. Comments: Formatted Path Reports: BLADDER TISSUE CHECKLIST. Specimen type: Cystectomy. Tumor site: Bladder. Tumor size: 3.5 x3x2cm. Tumor features: None specified. Histologic type: Transitional cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Perivesical tissue (microscopic). Lymph nodes: Not specified. Lymphatic invasion: Absent. Venous invasion: Absent. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Invades fat tissue and muscle, Non-papillary. Comments: Extracapsular extension: Yes, focal; Anatomic organ subdivision: Wall, NOS.",T2,N0,M0,T2N0M0
TCGA-AK-3436,"Clinical History/Diagnosis: Left renal mass. Source of Specimen(s): A: left kidney and adrenals. B: peri aortic lymph nodes. Gross Description: Received in two parts. Source of Tissue: 1. Labeled # 1, ""Left kidney"". Gross Description: Received fresh in a container labeled with patient's. name and medical record number labeled ""left kidney"". It consists of a. left nephrectomy specimen with attached perinephric fat having an overall. measurement of 20 X 12 X 9 cm. The specimen weighs 700 gm and the adrenal. gland is identified measuring 3 X 3 X 1.5 cm. The adrenal gland is. yellowish-orange and normal appearing. The inferior pole of the kidney is. bulging. At the hilum, there is an 8 cm segment of normal appearing. ureter. The specimen is bivalved. The vessels are normal appearing. The. kidney itself measures approximately 15 x 7 x 6.5 cm and the fat is. difficult to remove. Dissection through the fat discloses no suspicious. lesions, masses, or lymph nodes. In the lower pole of the kidney there is. a yellowish-orange lobulated mass measuring 9 x 6 X 6 cm. The mass. comprises approximately 55% of the kidney and is bulging into the renal. pelvis. The tumor also bulges on the capsule, however, no gross invasion. is identified. The tumor has an appreciable amount of calcifications and. obliterates the inferior calix and distorts the central calix and renal. pelvis. Designation of Sections: 1A vascular ureter margin, 1B tumor and hilum,. 1C-1D tumor in relationship to capsule (1C is towards renal hilum), 1E. tumor, 1F normal uninvolved kidney, 1G adrenal gland, 1H-1I perinephric. fat. Summary of Sections: Representative sections are submitted in 1A-1I. Source of Tissue: 2. Labeled # 2, ""Periaortic lymph nodes"". Gross Description: Received fresh in a container labeled with patient's. name and medical record number labeled ""periaortic lymph nodes"". It. consists of a few tan rubbery lymph nodes, ranging from 0.5 up to. 3 cm. 2A-2C contains multiple single lymph nodes, 2D contains a single. bisected lymph node, and 2E contains a single bisected lymph node. Submitted entirely in 2A-2E. Final Diagnosis: 1. Left kidney and adrenal gland, radical nephrectomy: - Conventional (clear cell) renal carcinoma, Fuhrman grade II (9 cm). confined to the kidney. - No angiolymphatic invasion present. - Vascular, ureter and circumferential margins negative for tumor. - Adrenal gland negative for tumor. - Perinephric fat with ectopic adrenal gland. 2. Periaortic lymph node, excision: - Twenty-two lymph nodes negative for tumor (0/22). Stage: pT2,N0,Mx.",T2,N0,M1,T2N0M1
TCGA-4Z-AA84,"PRIMARY SITE: Bladder. Product partial cystectomy: - Urothelial high grade carcinoma, extensively necrotic, infiltrating into the perivesical. adipose tissue. - Surgical margins uninvolved, but close at top left portion (1.9 mm). - Angiolymphatic infiltration: present. - Perineural infiltration: not detected. - Absence of neoplastic infiltration of the right and left ureter and on the rectal wall. fragment. - Presence of metastases in two lymph nodes dissected (2/2). Pathological staging: pT3b, pN2, pMX.",T3,N2,M1,T3N2M1
TCGA-FR-A3R1,"Diagnosis: A: Sentinel lymph node #1, right axilla, removal. -No evidence of melanoma in 1 sentinel lymph node (0/1). -Melan A and S100 protein immunostains and levels are negative. in all four. blocks. B: Sentinel lymph node #2, right axilla, removal. -No evidence of melanoma in 1 sentinel lymph node (0/1). -Melan A and S100 protein immunostains and levels are negative. in both blocks. C: Sentinel lymph node #3, right axilla, removal. -No evidence of melanoma in 1 sentinel lymph node (0/1). -Melan A and S100 protein immunostains and levels are negative. D: Skin, right arm, wide excision. Histologic type: Nodular melanoma. Breslow depth: 63 mm (6.3 cm) - this thickness is. substantially thicker than the initial biopsy Ulceration: EXTENSIVELY PRESENT. Consumption of the epidermis: present. Margins: all margins are widely free. Clark level: V. Vertical growth phase: present. Mitoses: 3.75 per square mm. Tumor infiltrating lymphocytes: present, focally brisk. Regression: not identified. Lymphovascular space invasion: not identified. Satellite nodule: not identified. Perineural invasion: not identified. Coexisting nevus: not identified. Pigmentation: present, minimal. Solar elastosis present, mild. Other features: necrosis is also present. AJCC Staging. pT4b. pNO. pMx. This staging information is based on this pathologic specimen. and may be incomplete. A comprehensive review of all available. information is recommended to determine final staging. Comment: The frozen section diagnosis is confirmed. Intraoperative Consult Diagnosis: Frozen section was requested. FSA1: Right axillary lymph node, biopsy. - No neoplasm identified. Clinical History: -year-old. with right arm melanoma. Gross Description: Received are four formalin-filled containers. Specimen A is. submitted fresh for frozen section. Container A: Received is a 3.0 X 2.1 X 1.0 cm lymph node. Representative section is frozen as FSA1. Grossly, this area is. suspicious for hemorrhage?, remaining sections are submitted in. blocks A2-A4,. Container B is additionally labeled ""sentinel lymph node #2."". Received is a brown/tan unoriented soft tissue fragment. measuring 1.4 X 0.9 x 0.4 cm. The specimen is serially sectioned. and submitted entirely in blocks B1 and B2,. Container C is additionally labeled ""sentinel lymph node #3. "". Received is a single unoriented 1.2 X 1.1 X 0.7 cm brown/tan. soft tissue fragment. The specimen is serially sectioned and. submitted entirely in block C1,. Container D is additionally labeled ""skin, right arm melanoma,. wide excision. Specimen fixation: formalin. Specimen type: wide excision. Tumor site: right arm. Orientation of the specimen: The specimen is oriented with a. short stitch/superior designated as 12 o' clock, and a long. stitch lateral designated as 9 o' clock. Inking: yellow=12 0' clock to 3 o' clock, blue=3 O' clock to 6. o'clock, red=6 o' clock to 9 o' clock, green=9 o' clock to 12 O' ,. clock, deep margin=black except for a central recessed area. which is inked orange. Skin ellipse dimensions: 9.7 X 8.9 cm. Tumor size and description: The tumor is 10.5 X 8.7 X 6.3 cm. The tumor overhangs the skin ellipse at 3 o' clock X. approximately 2.5 cm. The tumor is exophytic, raised with. lobulated borders. Microscopic pigmentation: There are multiple white/tan nodules. ranging in diameter from 0.2 to 0.3 cm towards the posterior. aspect of the tumor, and several foci of hemorrhages mainly. towards the posterior aspect of the tumor. Satellite nodules: none identified. Distance of tumor from margins: 1.9 cm at the 12 0' clock, 2. 1. cm at 3 o' clock, 2.4 cm at 6 o' clock, and 1.8 cm at 9 0' clock. Digital photograph taken: not taken. Tissue submitted for special investigation: none. Block summary : D1, D2 - deep en face margin from 12 o' clock to 3 o' clock. D3, D4 - deep en face margin from 3 o' clock to 6 0' clock. D5-D7 - - deep en face margin from 6 o' clock to 9 o' clock. D8, D9 - deep en face margin from 9 o' clock to 12 o' clock. D10-D21 - - radial perpendicular sections from the biopsy site to. corresponding. clock number margin: D10, 12 o' clock; D11, 1. o' clock; etc. D21=11 o' clock. D22-D25 representative sections from the tumor, abutting the. orange margin. Light Microscopy: Light microscopic examination is performed. S100 protein and. Melan A immunostains were performed on each sentinel lymph node. block and were medically necessary. All are negative for. metastatic melanoma. S100 and Melan A were also utilized to. evaluate a small area in block D11. These stains are negative. thereby arguing against a satellite metastasis.",T4,N0,M0,T4N0M0
TCGA-55-5899,"FINAL PATHOLOGIC DIAGNOSIS: Lung, right upper lobe, biopsies: Adenocarcinoma - see comment. COMMENTS: Histologic sections show an invasive carcinoma consisting. primarily of sheets of cells with scattered, discrete. glandular structures. The neoplastic cells have prominent. nucleoli, and do not have the cytologic appearance of small. cell carcinoma, grade Il neuroendocrine carcinoma (atypical. carcinoid) or large cell neuroendocrine carcinoma. Immunohistochemical stains are performed. The neoplasm. stains positively for cytokeratin CK7 as well as for TTF-1. The neoplasm is negative for CK20, high molecular weight. keratin SK and p63. The findings support the diagnosis of. adenocarcinoma of lung primary. There is weak staining for. synaptophysin. It is felt in that this is an example of. non-neuroendocrine carcinoma (adenocarcinoma) that shows. positive staining for synaptophysin, and that it should not. result in classification of a neuroendocrine tumor. Current NCCN practice guidelines recommend determination of. EGFR and KRAS mutation status in adenocarcinoma of lung to. help select patients for Tyrosine-Kinase Inhibitor (TKI). therapy. EGFR-activating mutations have been shown to be. significantly associated with response to TKIs and KRAS. mutations are associated with TKI resistance. They are. mutually exclusive in NSCLC. Additionally, recent data show. that ALK (Anaplastic Lymphoma Kinase) gene rearrangements in. adenocarcinoma of lung are associated with resistance to. TKIs and have favorable response rates to Crizotinib, the. ALK inhibitor agent currently in clinical trials. Mutation. analysis for KRAS and EGFR-TK domain and ALK gene. rearrangement by FISH is available as the Lung Cancer. Mutation Panel. Testing may be performed on. paraffin-embedded tissue from the primary or metastatic. tumor or pleural fluid cell block. These tests are. available on request as a panel or as individual assays. This case has been reviewed by. who agree with the diagnosis. FINAL PATHOLOGIC DIAGNOSIS: Bronchus,right, washing: Negative for malignant cells. Respiratory epithelial cells, squamous cells and macrophages. are present. COMMENTS: CLINICAL HISTORY: The patient is a. with a right upper lobe. lung mass. CODES: 88112. GROSS DESCRIPTION: A. A liquid based preparation is reviewed that has been. prepared from 7 mls of bloody red fluid submitted as. bronchial washing.",T1,N1,M0,T1N1M0
TCGA-AO-A12C,"Cinical Diagnosis & History: y/o female with left breast IDC and DCIS, now for segmental resection and. SLNB. Specimens Submitted: 1: SP: Sentincl node #1, level 1, left axilla (fs). 2: SP: Sentinel node #2, level 1, left axilla I. 3: SP: Sentinel node #3, level 1, left axilla. 4: SP: Sentinel node #4, level 1, left axilla. 5: SP: Left axillary contents levels 1, 2 and 3. 6 : SP: Additional level 3 nodes, left axilla. 7: SP: Left breast mannographic mass. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1 LEVEL I LEFT AXILLA BIOPSY: - METASTATIC MAMMARY CARCINOMA IN ONE OF ONE LYMPH NODE (1/1) -. to EXTRANODAL EXTENSION IS PRESENT (>2 MM). LYMPH NODE, SENTINEL #2 LEVEL I LEFT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1) WITH A TUMOR EMBOLUS IN PERINODAL. LYMPHATIC VESSEL. 3). LYMPH NODE, SENTINEL #3 LEVEL I LEFT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 4). LYMPH NODE, SENTINEL #4 LEVEL I LEFT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 5). AXILLARY CONTENTS, LEFT LEVELS I, II AND III; DISSECTION: LEVEL I: A MICROSCOPIC FOCUS OF METASTATIC MAMMARY CARCINOMA IN ONE. OF THREE LYMPH NODES (1/3). - LEVEL II: EIGHTEEN BENIGN LYMPH NODES (0/18) . - LEVEL III: SIX BENIGN LYMPH NODES (0/6). LYMPH NODE, ADDITIONAL LEVEL III LEFT AXILLA; EXCISION: - BENIGN ADIPOSE TISSUE WITH MICROSCOPIC LYMPHOID AGGREGATES. 7). BREAST, LEFT; EXCISION: - MULTIPLE FOCI OF INVASIVE DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC. Page 2 or 6. GRADE II-III/III, NUCLEAR GRADE II/III, RANGING IN SIZE FROM 0.1 0x UP TO. 2.5 CM (THE TWO LARGEST FOCI OF TUMOR MEASURE 1.4 CM AND 2.5 CM GROSSLY). A FEW FOCI OF DUCTAL CARCINOMA IN SITU (DCIS), SOLID AND CRIBRIFORM TYPES. WITH INTERMEDIATE NUCLEAR GRADE. NO CALCIFICATIONS ARE IDENTIFIED IN EITHER THE INVASIVE OR IN SITU. COMPONENT. - PROMINENT VASCULAR INVASION IS PRESENT. INVASIVE CARCINOMA EXTENDS TO THE FOLLOWING SHAVED MARGINS: LATERAL (IN. 1/8 SLIDES, 0.6 CM) ; INFERIOR (IN 3/8 SLIDES, THE LARGEST FOCUS MEASURING. 0.8 CM). ANTERIOR (IN 4/19 SLIDES, THE LARGEST FOCUS MEASURING 0.5 CM): AND. POSTERIOR (IN 1/15 SLIDES, THE LARGEST FOCUS MEASURING 0.2 CM) IN. ADDITION, LYMPHATIC TUMOR EMBOLI ARE ALSO SEEN AT THE MARGINS. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY DCIS IS IDENTIFIED. - BIOPSY SITE CHANGES. - RESULTS OF SPECIAL STAINS (ER, PR, HER-2/NEU) WILL BE REPORTED AS AN. ADDENDUM. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. RECUT. RECUT. RECUT. RECUT. NEG CONT. IMM RECUT. ER-C. PR-c. HER2 C. NEG -HER2. Gross Description: 1). The specimen is received fresh for frozen section consultation. labcled, Sentinel node #1, level 1, left axilla"", and consists of a piece. of yellow-tan fatty tissue Deasuring 3.5 x 2 x 1 cm, containing firm gray. lymph node measuring 1.4 x 1 x 0.7 cm. Representative section is frozen. The remainder of the specimen is entirely submitted. Summary of Sections: FSC frozen section control. U - undesignated. vage 3 or b. 2). The specimen is received in formalin, labeled, ""Sentinel node #2,. level 1, left axilla"". It consists of a 0.9 x 0.5 x 0.4 cm tan lymph node. with attached adipose tissue. The entire lymph node is submitted. Summary of Sections: LN - lymph node. 3). The specimen is received in formalin, labeled, ""Sentinel node #3,. level 1, left axilla"". It consists of a 1.3 x 0.4 x 0.3 cm tan lymph node. The lymph node is entirely submitted. Summary of Sections: LN - lymph node. 4). The specimen is received in formalin, labeled, ""Sentinel node #4,. level 1, left axilla"". It consists of a 0.3 x 0.3 x 0.2 Cm tan lymph node. with attached adipose tissue. The lymph node is entirely submitted. Summary of Sections: LN - lymph node. 5). The specimen is received in formalin, labeled, ""Left axillary. contents levels 1, 2 and 3 (with tags attached) It consists of a. 17.0. x. 15.0 x 4.0 cm fragment of adipose tissue with metallic tags labeling levcls. 1 through 3. Multiple lymph nodes are identified within each level,. measuring from 0.2 to 2.8 ca in greatest dimension. All identified lymph. nodes are submitted. Summary of Sections: LIBLN level one bisected lymph node. LILNSS level one, one lymph node serially sectioned. LII level two lymph nodes. LIII level three lymph nodes. 6). The specimen is received in formalin, labeled, ""Additional level. 3. nodes , left axilla"". It consists of a 2.0 x 1.8 x 1.0 cm aggregate of. adipose tissue. No definite lymph nodes are identified. Entirely. submitted. Summary of Sections: U - undesignated. 7). The specimen is received fresh, labeled, ""Left breast nammographic. mass (short stitch superior, long stitch lateral)"". It consists of a 9.5 x. 8.0 x 5.3 cm fragment of fibroadipose tissue with a needle localizing wire. and sutures marking the superior and lateral margins. The specimen is inked. as follows: black-anterior and posterior, yellow-superior, green-inferior,. blue-lateral, red-medial. The margins are entirely shaved and submitted. There is a palpable mass at the lateral/inferior portion of the specimen. Serial sectioning reveals a 2.5 x 2.0 x 1.8 em firm white stellate mass,. located in the center of the specimen. closely approaching the anterior. margin. Noted adjacent to this mass, near or close to the medial margin is. a. second tan firm nodular mass, measuring 1.4 x 1.1 x 0.9 cm. The remaining. breast parenchyma is predominantly fatty with foci of fibrous tissue. NO. other lesions ure identified. Representative sections are submitted. Portions of both the larger and smaller tumors are submitted for TPS. Summary of Sections: M medial. L lateral. I inferior. A anterior. s superior. P posterior. LT larger tumor. ST smaller tumor. ADJ adjacent to tumor mass. RS representative sections. Summary of Sections: Part 1: SP: Sentinel node #1, level 1, left axilla. Block. Sect. Site. PCs. 1. fsc. 1. 1. u. 1. Part 2: SP: Sentinel node #2, level 1, left axilla. Block. Sect. Site. PCs. 1. In. 1. Part 3: SP: Sentinel node #3, level 1, left axilla. Block. Sect. Site. PCs. 1. In. 1. Part 4: SP: Sentinel node #4, level 1, left axilla. Block. Sect. Site. PCs. 1. In. 1. Part 5: SP: Left axillary contents levels 1, 2 and 3 ,. Block. Sect. Site. PCs. yage 5 of 6. 2. LIBLN. 4. 5. LII. 10. 3. LIII. 6. 5. LILNSS. 5. Part 6: SP: Additional level 3 nodes, left axilla. Block. Sect. Site. PCs. 1. u. 1. Part 7: SP: Left breast marmographic mass. Block. Sect. Site. PCs. 19. a. 19. 2. adj. 2. 8. i. 13. 8. 1. 14. 4. 1t. 4. 4. m. 10. 15. p. 15. 5. rs. 5. 4. 10. 2. st. 2. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. ADDENDUM REPORT. SITE: LEFT BREAST (PART #7). ER: 95% NUCLEAR STAINING WITH MODERATE INTENSITY. PR: 40% NUCLEAR STAINING WITH WEAK TO MODERATE INTENSITY. HER-2/NEU (HERCEPTEST) : POSITIVE (STAINING INTENSITY OF 3+). Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOMA. PERMANENT DIAGNOSIS: SAME.",T2,N1,M0,T2N1M0
TCGA-E2-A1IN,"SPECIMENS: A. WLE RIGHT BREAST NEEDLE LOCALIZATION. B. SENTINEL NODE #1. C. SENTINEL NODE #2. D. ADDITIONAL LATERAL POSTERIOR MARGIN. SPECIMEN(S): A. WLE RIGHT BREAST NEEDLE LOCALIZATION. B. SENTINEL NODE #1. C. SENTINEL NODE #2. D. ADDITIONAL LATERAL POSTERIOR MARGIN. INTRAOPERATIVE CONSULTATION DIAGNOSIS: A-WLE right breast: Gross examination only, tumor is 0.8 cm from the nearest superior margin. TPB/TPC-SLN #1, #2: Touch imprints only, negative for tumor cells. Diagnoses called by Dr. to Dr. at. (A,B, C). GROSS DESCRIPTION: A. WLE RIGHT BREAST NEEDLE LOCALIZATION. Received fresh labeled with the patient's identification and ""WLE right breast needle localization"". is. a. previously inked, oriented (single suture-anterior, double suture-lateral) 76 g, 3.7 x 3.6 x 2.9 cm needle. localized lumpectomy with radiograph. Ink code: Anterior-yellow, posterior-black, medial-green, lateral-. red, inferior-blue, inferior-orange. The specimen is serially sectioned from lateral to medial into 7 slices. revealing a 1.8 x 1.3 x 1.1 cm tan, stellate nodule that is closest to the superior margin at 0.8 cm. Tissue is procured. Representatively submitted: A1-A2: lateral margin, perpendicular sections. A3: slice 2, anterior superior. A4: slice 2, posterior superior. A5: slice 2, posterior superior. A6: slice 2, mid posterior. A7: slice 3, anterior superior (mass). A8: slice 3, posterior superior (mass). A9: slice 3, mid anterior (mass). A10: slice 3, mid posterior (mass). A11: slice 3, inferior. A12: slice 4, mid anterior (mass). A13: slice 4, mid posterior (mass). A14: slice 4, mid inferior. A15: slice 4, posterior. A16: slice 5, anterior. A17: slice 5, inferior. A18: slice 5, posterior. A19: slice 6, superior. A20-A21: slice 6, anterior. A22: slice 6, inferior. A23: slice 6, posterior. A25-A25: medial margin, perpendicular sections. B. SENTINEL LYMPH NODE #1 RIGHT AXILLA. Received fresh labeled with the patient's identification and ""SLN #1"" is a 1.5 x 0.7 x 0.4 cm lymph node. It is sectioned, a touch prep is performed, lymph node is submitted entirely in cassette B1. C. SENTINEL LYMPH NODE #2 RIGHT AXILLA. Received fresh labeled with the patient's identification and ""SLN #2"" it is a 1.7 x 0.3 x 0.1 cm lymph. node. It is sectioned, a touch prep is performed, submitted entirely in cassette C1. D. ADDITIONAL LATERAL POSTERIOR MARGIN. Received fresh labeled with the patient's identification and ""additional lateral-posterior margin"" is an. oriented (suture at final margin) 9 g, 5 x 3 x 1.2 cm fibrofatty tissue. Final margin is inked blue. Serial. sectioning reveals no discrete lesions. Entirely submitted in cassettes B1-B8. DIAGNOSIS: A. BREAST, RIGHT, WIDE LOCAL EXCISION: - INVASIVE DUCTAL CARCINOMA, SBR GRADE 3, MEASURING 1.8-CM. - HIGH NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM TYPES WITH. MICROCALCIFICATIONS. - INVASIVE TUMOR PRESENT WITHIN 1-MM FROM INFERIOR SURGICAL RESECTION MARGIN. - LOBULAR CARCINOMA IN SITU. - SEE SYNOPTIC REPORT. B. LYMPH NODE, SENTINEL #1, RIGHT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). C. LYMPH NODE, SENTINEL #2, RIGHT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). D. BREAST, ADDITIONAL LATERAL POSTERIOR MARGIN, EXCISION: - BREAST TISSUE, NO TUMOR SEEN. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Yes - For mass. Laterality: Right. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.8cm. Margins: Negative. Distance from closest margin: Less than 0.1cm. inferior. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: LCIS. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/2. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 10%. DCIS Type: Solid. Cribriform. DCIS Location: Associated with invasive tumor. Nuclear grade: High. Necrosis: Absent. Location of CA++: DCIS. Benign epithelium. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by IHC. Performed on Case: Pathological staging (pTN): pT 1c N 0. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. Distant Metastases (M): MX: Cannot be assessed. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: None given. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 14. CLINICAL EXPERIENCE: Patients with a recurrence score of: 14 in the clinical validation study. had an average rate of Distant Recurrence at 10 years of 9%. ER Score: 11.3 Positive. PR Score: 9.1 Positive. Her2 Score: 9.1 Negative. Interpretation: ER. Negative < 6.5. Positive >= 6.5. PR. Negative < 5.5. Positive >= 5.5. Her2. Negative <10.7 Positive >= 11.5 Equivocal = 10.7 - 11.4. Microscopic/Diagnostic Dictation:,. Final Review:, M.D., Pathologist. Final: M.D., Pathologist, I. Addendum: M.D., Pathologist, (. Addendum Final: M.D., Pathologist,.",T1,N0,M0,T1N0M0
TCGA-BH-A0DL,"P.7/33. FINAL DIAGNOSIS: PART 1: BREAST, LEFT, SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA (18, 1C, 1E, 1F, and 1GI) WITH METAPLASTIC CARCINOMA. COMPONENT (8QUAMOUS METAPLASIA) AND FOCAL APOCRINE FEATURES (see comment). B. THE TUMOR SIZE IS 2.5 x 1.8 x 1.8 CM. c. NOTTINGHAM SCORE IS 9/9 (TUBULES 3, NUCLEI 3, MITOSES 3). D. LYMPHOVASCULAR PERMEATION IS NOT APPRECIATED. E. DUCTAL CARCINOMA IN SITU. SOLID AND CRIBRIFORM TYPES, NUCLEAR GRADE 3. REPRESENTING. ABOUT LESS THAN 1% OF TUMOR VOLUME. DUCTAL CARCINOMA IN SITU is PRESENT ADMIXED AND. OUTSIDE OF THE INVASIVE TUMOR. F. MARGINS OF RESECTION AREFREE OF TUMOR. G. CHANGES CONSISTENT WITH PREVIOUS CORE BIOPSY, SEE PRIOR. H. FIBROCYSTIC CHANGES WITH DUCT ECTASIA, COLUMNAR CELL CHANGES AND SCLEROSING ADENOSIS. WITH ASSOCIATED MICROCALCIFICATIONS. I. SMALL INTRADUCTAL PAPILLOMA. J. CALCIFIED NODULE WITH PERIDUCTAL INFLAMMATION AND FIBROADENOMATOID NODULE (1J). K. IMMUNOHISTOCHEMICAL STAINING FOR ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR AND HER-. 2/NEU A9 PREVIOUSLY PERFORMED ON. AND WERE REPORTED AS FOLLOWS: ESTROGEN. 0). RECEPTOR - POSITIVE, PROGESTERONE RECEPTOR - NEGATIVE. AND HER-2/NEU - NEGATIVE (SCORE. PART 2: LYMPH NODE, LEFT SENTINEL #1, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 3: LYMPH NODE. LEFT SENTINEL #2, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 4: LYMPH NODE, LEFT SENTINEL #3, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 5: BREAST, LEFT, NEW POSTERIOR MARGIN, EXCISION -. A. NO TUMOR is SEEN. B. FIBROADENOMATOID NODULES WITH ASSOCIATED MICROCALCIFICATIONS. c. FIBROCYSTIC CHANGES WITH DUCTAL EPITHELIAL HYPERPLASIA AND COLUMNAR CELL CHANGES. WITH ASSOCIATED MICROCALCIFICATIONS. D. FOCAL CHRONIC INFLAMMATION WITH GIANT CELL GRANULOMATOUS REACTION. E. MEDIAL CALCIFICATION OF RI mm. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: I eft. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maxinum dimansion invasive component: 2.5 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (Invasive component): Ductal adenocarcinoma, NOS, Mctaplastic carcinoma. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score 3. Total Nottinghem score: 9. Nottingham grade (1.2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, bonign zones. TUMOR TYPE, IN SITU: Cribriform. Solid. DCIS admixed and outside of invesive carcinoma component. Percent of tumor occupled by in situ component 1%. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: o. 3. LYMPH NODES EXAMINED: METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: Fibroadenoma, FCD. T STAGE, PATHOLOGIC: p12. N STAGE, PATHOLOGIC: pNo. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: negative. HER2/NEU: zero or 1+.",T2,N0,M0,T2N0M0
TCGA-3H-AB3S,"M. DIAGNOSIS. (A) PLEURAL IMPLANT: EPTHELIOID MALIGNANT MESOTHELIOMA. GROSS DESCRIPTION. (A) PLEURAL IMPLANT - Received are four fragments of gray-white to tan-pink soft tissue ranging from 0.6 x 0.5 x 0.5 cm up to. 2.0 x 1.3 x 0.6 cm. The specimen is submitted entirely. SECTION CODE: A1, three smaller fragments; A2, A3, larger fragment serially sectioned. CLINICAL HISTORY. None given. SNOMED CODES. T-29000, M-90503. ""Some tests reported here may have been developed and performance characteristics determined by. . These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: END OF REPORT-.",T2,N0,M0,T2N0M0
TCGA-A2-A0YJ,"caie? of Pathology. Specimen: spec Type: SURGICAL P. PREOPRRAT. LEFT BREAST CANCER INVASIVE. OPERATION PERFORDED. DOCTOR (S) : PROCEDURE: MASTECTOMY MODIFTED RADICAL. RESOVER. A. LEFT MODIFIED RADICAL MASTECTOMY. B. LT DEEP MARGIN BENEATH TUMOR. GROSS. PART A RECEIVED LABELED. LEFT MODIFIED RADICAL. MASTECTOMY STITCH AT 12 O'CLOCK, IS A LEFT MODIFIED RADICAL MASTECTOMY. WITH A SKIN ELLIPSE MEASURING 20 x 8.5 CM WITH A GROSSLY UNREMARKABLE. NIPPLE. THE SPECIMEN ITSELF MEASURES 26.5 x 14 x 3.5 CM. THE AXILLARY. CONTENTS ARE DISSECTED OFF THE SPECIMEN AND THIS AREA IS MARKED WITH RED. INK DENOTING THAT THIS IS NOT A TRUE MARGIN. THE AXILLARY TAIL IS. EXAMINED FOR LYMPH NODES. IN THE LOWER AXILLARY TAIL THERE IS A 3. .7-CM. IN GREATEST DIMENSION GROSSLY POSITIVE LYMPH NODE. ADDITIONAL NODES ARE. ALSO IDENTIFIED. TWO ADDITIONAL GROSSLY POSITIVE NODES ARE SUBMITTED,. ONE SECTION EACH, IN A1 AND A2 WITH MIRROR IMAGES PER PROTOCOL. A3 IS A. GROSSLY UNREMARKABLE LYMPH NODE WITH MIRROR IMAGE IN PROTOCOL. A4--ONE. SECTION OF A GROSSLY POSITIVE LYMPH NODE WITH MIRROR IMAGE PROTOCOL,. A5--LARGEST - LYMPH NODE, A6--TWO NODES, EACH BISECTED, A7--TWO NODES, EACH. BISECTED, A8--NINE NODES. EIGHTEEN LYMPH NODES ARE IDENTIFIED IN ALL. THE SUPERFICIAL ASPECT OF THE BREAST IS THEN MARKED WITH BLUE INK, THE. DEEP WITH BLACK INK. LATERAL TO THE NIPPLE THERE IS A PINK-TAN FIRM. GRITTY MASS MEASURING 7 x 3 x 4.5 CM. THIS GROSSLY EXTENDS TO WITHIN 0.2. CM OF THE DEEP MARGIN. CENTRALLY IN THE BREAST THE TISSUE IS TAN AND. FIBROUS. THE PERIMETER OF THE SPECIMEN IS FATTY WITH FINE FIBROUS BANDS. SECTIONS OF THE BREAST ARE SUBMITTED AS FOLLOWS: A9--NIPPLE - AND SKIN. (MIRROR IMAGE TO PROTOCOL), A10--SECTION OF TUMOR TO INCLUDE DEEP MARGIN. (MIRROR IMAGE TO PROTOCOL), All THROUGH A16--A FULL CROSS SECTION FROM. SUPERIOR TO INFERIOR OF THE LESION TO INCLUDE THE DEEP MARGIN IN A11, 12,. 14, AND 16 WITH A13 AND A15 REPRESENTING THE SUPERFICIAL SECTIONS TO A12. AND A14, RESPECTIVELY, A17 --TUMOR AND DEEP MARGIN, A18--THE MOST LATERAL. ASPECT OF THE LESION, A19--THE MEDIAL ASPECT OF THE LESION (4.5 CM FROM. PREVIOUS SECTION), A20--LOWER OUTER QUADRANT, A21--UPPER OUTER QUADRANT,. A22--UPPER - INNER QUADRANT 5 CM FROM TUMOR, A23-LOWER INNER QUADRANT 5 CM. FROM TUMOR, A22 AND A23--MIRROR IMAGES TO PROTOCOL TISSUE. PART B RECEIVED LABELED. DEEP MARGIN BENEATH TUMOR. STITCH NEW MARGIN, IS AN IRREGULAR PORTION OF RED-TAN MUSCULAR TISSUE. WITH CAUTERY ARTIFACT ON THE SIDE WITH THE SUTURE DENOTING THE NEW. MARGIN. THIS MEASURES 2.7 x 2.5 x 0.4 CM IN GREATEST DIMENSIONS. THE. Chief of Pathology. Specimen: Spec Type: SURGICAL P. SIDE DESIGNATED AS THE NEW MARGIN IS MARKED WITH BLUE INK WITH A. PERIMETER OF BLACK INK. THE SPECIMEN IS SECTIONED AND ENTIRELY SUBMITTED. LABELED R1 THROUGH 3. PATH PROCEDURES. PROCEDURES: 88307, 88309, A BLK/23, B BLK/3. PART A LEFT MODIFIED RADICAL MASTECTOMY: IN SITU AND POORLY. DIFFERENTIATED INFILTRATING DUCT CARCINOMA, NUCLEAR GRADE 3 OF 3 WITH A. HIGH MITOTIC INDEX. GROSSLY THE TUMOR SPANNED A DISTANCE OF 70 MM. LYMPHATIC SPACE INVASION IS PRESENT. A HIGH-GRADE IN SITU COMPONENT OF. THE COMEDOCARCINOMA TYPE IS PRESENT. 70 TO 80% OF THE TUMOR IS. INVASIVE. INVASIVE CARCINOMA IS LOCATED IN THE LYMPHATIC SPACES AT THE. DEEP MARGIN AND WITHIN THE STROMA OF THE BREAST 1.1 MM FROM THE DEEP. MARGIN. TUMOR IS PRESENT IN A LYMPHATIC SPACE IN A SECTION FROM THE. LOWER OUTER QUADRANT OF THE BREAST AWAY FROM THE GROSSLY IDENTIFIABLE. PRIMARY LESION. METASTATIC CARCINOMA IS PRESENT IN 5 OF 18 AXILLARY. LYMPH NODES. PART B DEEP MARGIN BENEATH TUMOR, REEXCISION: SKELETAL MUSCLE WITH NO. TUMOR IDENTIFIED. 1. , M.D. (prelim.). (signature on file).",T3,N2,M0,T3N2M0
TCGA-33-6737,"SURG PATH REPORT. 1st Specimen collected on. FINAL DIAGNOSIS. 1. R4 LYMPH NODE (EXCISION) : METASTATIC CARCINOMA INVOLVING I OF. LYMPH NODE (4 MM FOCUS). 2. HIGH R4 LYMPH NODE (EXCISION) : ONE (1) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 3. R10 LYMPH NODE (EXCISION) : METASTATIC CARCINOMA INVOLVING 1 OF 1. LYMPH NODE (4 MM FOCUS). 4. RIGHT LUNG UPPER LOBE (LOBECTOMY) : SPECIMEN TYPE: Lobectomy. TUMOR SITE: Right, upper lobe. HISTOLOGIC TYPE: Adenosquamous carcinoma. TUMOR SIZE: Greatest dimension: 7.5 cm. LOCATION, SIZE, AND HISTOLOGIC TYPE OR ADDITIONAL SEPARATE TUMOR. NODULES, IF ANY: None identified. HISTOLOGIC GRADE: G3: Poorly differentiated. LYMPH NODES: Metastatic carcinoma in 3 of 9 lymph nodes. (see part 1-6). EXTENT OF INVASION (STAGING). PRIMARY TUMOR: pT2 Tumor which is >3 cm. REGIONAL LYMPH NODES: pN2: Metastasis in ipsilateral mediastinal or subcarinal lymph nodes. DISTANT METASTASIS;. pMx: Cannot be assessed. MARGINS: Margins uninvolved by invasive carcinoma. VENOUS/ARTERIAL (LARGE VESSEL) INVASION: Indeterminate. LYMPHATIC (SMALL VESSEL) INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: None identified. 5. P3 LYMPH NODE (DISSECTION) : TWO (2) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 6. STATION 7 LYMPH NODE (EXCISION) : ONE (1) LYMPH NODE AND. ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. ADDENDUM. EGFR MUTATION ANALYSIS: RESULTS: No mutation detected. K-RAS MUTATION ANALYSIS: RESULTS: No mutations were identified at codons 12 and 13. of the KRAS gene. NOTE: A copy of the complete report is available in. and is on. file in the molecular pathology laboratory. End of Diagnosis. Clinical History: ? LUNG CANCER.",T2,N2,M0,T2N2M0
TCGA-78-7162,"A : RIGHT UPPER LOBECTOMY. Previous FNA bx. : well differentiated adeno-. carcinoma ? alveolar cell carcinoma. Macroscopy: Specimen consists of right upper lobe measuring 23 X 12 X 8. cm. Cut section reveals an irregularly shaped grey mass. mesuring 4 cm in diameter. A few peribronchial lymph nodes. are present, the largest 1.5 cm. Microscopy: Sections show invasive neoplastic tissue in the pulmonary. parenchyma, composed of sheets of atypical epithelial cells. with a tendency to form papillae. PAS-diastase, PAS/Alcian. blue and CEA are positive. /Over. SUMMARY. FEATURES ARE COMPATIBLE WITH BRONCHIOLAR-ALVEOL - CARCINOMA. B : HILAR LYMPH NODE. Macroscopy: Specimen consists of lymph node measuring 1 cm. Microscopy: Sections show chronic inflammatory changes in lymph nodes. No evidence of malignancy. Registrar: Report validated by pathologist/registrar.",T1,N0,M0,T1N0M0
TCGA-AG-3583,"Diagnosis: Rectosigmoidal resection material with inclusion of a poorly differentiated mucinous. adenocarcinoma of the colorectal type, 2.5 cm from the aboral resection margin with. a. maximum diameter of 8.5 cm and with infiltration of the perirectal fatty tissue and nine. regional lymph node metastases. The tumor extends to within direct proximity of the. circumferential resection margin. Tumor-free colon resection margins. Tumor-free. mesenteric resection margin. Tubular adenoma of the colon mucosa with high-grade. dysplasia and transition to an intramucosal adenocarcinoma (synonym according to WHO: high-grade intraepithelial neoplasia; according to UICC: pTis) and also diverticulosis coli. Tumor stage: pT3 pN2 (9/34) pMX; G3 L1 V0, R1.",T3,N2,M1,T3N2M1
TCGA-BH-A0BA,"FINAL DIAGNOSIS: PART 1: LEFT AXILLA, SENTINEL LYMPH NODE #1, BIOPSY -. ONE LEFT AXILLARY SENTINEL LYMPH NODE #1 WITH METASTATIC BREAST CARCINOMA (1/1). PART 2: BREAST, LEET, MODIFIED RADICAL MASTECTOMY -. A. MULTIFOCAL INFILTRATING MIXED DUCTAL AND LOBULAR CARCINOMA (see comment). B. TUMOR MEASURES 6.0 X 5.5 X 2.5 CM. C. THE TUMOR IS LOCATED IN THE UPPER OUTER, LOWER OUTER, UPPER INNER AND LOWER INNER. QUADRANTS AND IN THE CENTRAL AREA (MULTICENTRIC TUMOR ). D. ANGIOLYMPHATIC INVASION IDENTIFIED. E. LOBULAR CARCINOMA IN SITU ACCOUNTING FOR 10% OF THE TUMOR, ADMIXED WITH THE TUMOR. F. ALL MARGINS ARE NEGATIVE FOR INVASIVE MIXED DUCTAL - LOBULAR CARCINOMA AND LOBULAR. CARCINOMA IN SITU. G. NIPPLE WITH FOCAL INVASIVE CARCINOMA IN THE DEEP STROMAL TISSUE. H. NIPPLE AND SKIN OF THE BREAST WITH DUCT ECTASIA AND CHRONIC INFLAMMATION. I. ESTROGEN RECEPTOR POSITIVE, PROGESTERONE RECEPTOR POSITIVE, HER-2/NEU NEGATIVE FOR. (SCORE +1) AS PER CORE BIOPSY. J. BIOPSY SITE CHANGES. K. FIBROCYSTIC CHANGES WITH DUCTAL EPITHELIAL HYPERPLASIA. L. COLUMNAR CELL CHANGES. M. MICROSCOPIC PERIPHERAL DUCTAL PAPILLOMA. N. AXILLARY TAIL WITH TWENTY OUT OF TWENTY LYMPH NODES WITH METASTATIC CARCINOMA (0.5 TO. 2.2 CM IN MAXIMUM DIAMETER) (20/20) TOW HAVE EXTRA CAPSULAR SPREAD-. PART 3: LEFT PECTORALIS MINOR MUSCLE, EXCISION -. STRIATED SKELETAL MUSCLE FREE OF TUMOR CONFIRM BY IMMUNOSTAIN FOR. PART 4: LEFT AXILLA, LEVEL 3, LYMPH NODE, EXCISION -. SIX LYMPH NODES LEVEL 3 ALL POSITIVE FOR METASTATIC CARCINOMA (6/6) (see comment). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Modified radical mastectomy. Central subareolar. Upper outer quadrant. Upper inner quadrant. Lower outer quadrant. Lower inner quadrant. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 6.0 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 6.3 cm. TUMOR TYPE (invasive component): Other Type(s): MIXED D &L. HISTOLOGIC TYPE: Classical, Pleomorphic. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: Yes, benign zones. SURGICAL MARGINS INVOLVED BY INVASIVE LCIS, Percent COMPONENT: of tumor occupied by in situ component: 10 %. SURG MARGINS INVOLVED BY IN SITU COMPONENT: PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 27. LYMPH NODES EXAMINED: 27. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain, Keratin stain. SENTINEL NODE METASTASIS: ONLY KERATIN POSITIVE CELLS ARE PRESENT: SIZE OF NODAL METASTASES: LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Diameter of largest lymph node metastasis: 20 mm. METASTASES TO IPSILATERAL INTERNAL MAMMARY LYMPH NODE (IF APPLICABLE): SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: ALH, Papilloma, FCD. T STAGE, PATHOLOGIC: pT3. N STAGE, PATHOLOGIC:",T3,N3,M0,T3N3M0
TCGA-E2-A14V,"SPECIMENS: A. EXCISION LEFT BREAST. B. LEFT AXILLARY SKIN TAG. C. LEFT AXILLA S.L.N. #1. D. LEFT AXILLA S.L.N. #2. E. LEFT AXILLARY CONTENTS. SPECIMEN(S): A. EXCISION LEFT BREAST. B. LEFT AXILLARY SKIN TAG. C. LEFT AXILLA S.L. N. #1. D. LEFT AXILLA S.L.N. #2. E. LEFT AXILLARY CONTENTS. GROSS DESCRIPTION: A. EXCISION LEFT BREAST. Received fresh labeled with the patient's identification, ""Excision Left Breast"" is a 130g, 8 x 11 x 4cm oriented. (Single-Anterior, Double-Lateral, Triple-Superior) left lumpectomy with 5 x 2 cm tan pink unremarkable skin ellipse. Ink Code: Anterior-Yellow, Posterior-Black, Medial-Green, Lateral-Red, Superior-Blue, Inferior-Orange. The. specimen is serially sectioned from medial to lateral into 8 slices to reveal a 3 x 3 x 2.3cm gray white firm ill defined. mass, 0.5cm from the closest anterior-superior margins in slices 3-6. A portion of the specimen is submitted for. tissue procurement. Representative sections are submitted as follows: A1: medial margin slice 1. A2-A3: superior margin slice 2. A4: area next to mass slice 2. A5: skin slice 3. A6: mass with anterior margin slice. 3. A7: mass with deep margin slice 3. A8: mass with anterior margin slice 3. A9: mass with deep margin slice 3. A10: anterior/superior margin slice 4. A11: superior margin slice 4. A12: mass with anterior margin slice 4. A13: mass with deep margin slice 4. A14: mass with anterior margin slice 4. A15: mass with anterior/inferior margin slice 4. A16: mass slice 4. A17: deep margin slice 4. A18: deep/inferior margin slice 4. A19: mass with anterior margin slice 5. A20: superior margin slice 5. A21: mass slice 5. A22: mass with deep margin slice 5. A23-A24: anterior margin slice 5. A25: mass slice 5. A26-A27: mass with deep margin slice 5. A28-A29: mass with anterior margin slice 6. A30-A31: mass slice 6. A32: deep margin slice 6. A33: next to mass slice 7. A34-A35: deep margin slice 7. A36: lateral margin slice 8. B. LEFT AXILLARY SKIN TAGS. Received in formalin are two polypoid skin tags, 0.1 and 0.3 cm in diameter. Submitted entirely in cassette B1. C. LEFT AXILLARY SLN #1. Received fresh is a tan pink lymph node 1.0 x 0.6 x 0.3cm. The specimen is bisected and a touch prep is taken. Toto. C1. D. LEFT AXILLARY SLN #2. Received fresh is a tan pink lymph node 1.5 x 1.2 x 0.6cm. The specimen is bisected and a touch prep is taken. Toto. D1. E. LEFT AXILLARY CONTENTS. Received in formalin is a piece of yellow-tan adipose tissue, 9.5 x 0.5 x 2.7 cm. Multiple lymph nodes are identified. ranging in size from 0.1 to 2.7 cm. The larger lymph nodes are bisected and have variegated pink-tan coloration. There is a blood vessel, 0.9 cm and the length and 0.4 cm in diameter, which is clipped at both ends. It contains. blood clot. Specimen is submitted entirely: E1-E2: 6 lymph nodes each. E3-E5: 2 lymph nodes each. E6-E8: 1 lymph node each. E9-E10: 1 lymph node. E11-E25: remainder of soft tissue. DIAGNOSIS: A. BREAST, LEFT, WIDE LOCAL EXCISION: - INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED. (SBR GRADE 3). - INVASIVE CARCINOMA MEASURES 3 CM IN GREATEST DIMENSION. - MARGINS, FREE OF TUMOR. - LYMPHVASCULAR INVASION IS PRESENT. - DUCTAL CARCINOMA IN SITU (DCIS), SOLID AND MICROPAPILLARY. TYPES, NUCLEAR GRADE 3, WITH NECROSIS AND MICROCALCIFICATIONS. DCIS IS WITHIN 3 MM OF THE SUPERIOR MARGIN AND IS WITHIN. 4 MM OF THE POSTERIOR MARGIN. - SKIN, NO TUMOR SEEN. B. AXILLA, LEFT, SKIN TAG, EXCISION: - ACROCHORDONS. C. SENTINEL LYMPH NODE #1, LEFT AXILLA, BIOPSY: - METASTATIC CARCINOMA (0.3 CM IN SIZE) TO ONE LYMPH NODE (1/1). D. SENTINEL LYMPH NODE #2, LEFT AXILLA, BIOPSY: - METASTATIC CARCINOMA (1.5 CM IN SIZE) TO ONE LYMPH NODE WITH. FOCAL EXTRANODAL EXTENSION (1/1). E. AXILLARY CONTENTS, LEFT, DISSECTION: - METASTATIC CARCINOMA (0.8 CM IN SIZE) TO ONE OF 22 LYMPH NODES. (1/22). SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3cm. Tumor Site: Lower inner quadrant. Margins: Negative. Distance from closest margin: 0.5cm. anterior. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: Present. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node and axillary dissection. Lymph node status: Positive 3 /24 Extranodal extension. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 40%. DCIS Type: Solid. Micropapillary. DCIS Location: Associated with invasive tumor. Nuclear grade: High. Necrosis: Present. Location of CA++: DCIS. Stroma. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Pending. Pathological staging (pTN): pT2N1. CLINICAL HISTORY: 5cm tumor-Invasive Cancer on Core Bx. Lower Inner Quadrant Left Breast. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. INTRAOPERATIVE CONSULTATION: A. GROSS INSPECTION: 3cm mass, 0.5cm from the closest Anterior margin. TPC-TPD: Positive for Adenocarcinoma. Diagnoses called to Dr. at. (A) and. (C-D) by Dr. ADDENDUM: SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Surgical Excision. Block Number: A16. Interpretation: POSITIVE. Intensity: % Tumor Staining: 100%. Fish Ordered: No. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and nn longer than 24 hours. Her2 analysis. was performed using the FDA approved Dako HercepTest (TM) test kit. using rabbit anti-. human HER2. This assay was not modified. External kit-slides provided by the manufacturer (cell lines with high,. low and negative HER2 protein expression) and in-house known HER2 amplified control tissue were evaluated along. with the test tissue. Adequate, well preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2 immunohistochemical stain is guided by published results in the medical literature,. information provided by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the 2007 joint recommendations and guidelines from ASCO. and. CAP. and from the NCCN HER2 testing in Breast Cancer Task Force. The Pathology Department takes full responsibility. for this test's performance. Microscopic/Diagnostic Dictation Pathologist,. Final Review: Pathologist,. Final Review: Pathologist. Final: Pathologist,. Addendum: Pathologist. Addendum Final: Pathoiogist, 1.",T2,N1,M0,T2N1M0
TCGA-A2-A3KC,"Chief of Pathology. Specimen: !tatus: SOUT. Spec Type: SURGICAL P. GROSS DESCRIPTION. C RECEIVED LABELED. RIGHT NONSENTINEL NODE #1 IS A 3.4. x 2 x 1.5 CM PORTION OF YELLOW FATTY TISSUE WHICH IS A GROSSLY FAT. REPLACED LYMPH NODE SUBMITTED ENTIRELY LABELED C1 THROUGH C3. D RECEIVED LABELED. RIGHT BREAST SIMPLE MASTECTOMY. STITCH AT 12 O' CLOCK IS A 1,250 GRAM SIMPLE MASTECTOMY WHICH INCLUDES. 4. IRREGULAR ADDITIONAL FRAGMENTS OF YELLOW-RED FATTY TISSUE IN AGGREGATE. MEASURING 9 x 7 x 1 CM. THIS TISSUE IS NOT ORIENTED. THE MASTECTOMY. ITSELF MEASURES 28.5 x 21 x 5 CM. THE NIPPLE IS FLATTENED AND SITS. WITHIN A 26 x 13 CM SKIN ELLIPSE. THERE IS PALPABLE FIRMNESS IN THE. LOWER OUTER QUADRANT. THE SUPERFICIAL ASPECT OF THE MASTECTOMY IS. MARKED WITH BLUE INK, THE DEEP WITH BLACK. SECTIONING REVEALS 2. DISTINCT FIRM MASSES, ONE IN THE 12 O'CLOCK AREA AND THE 2ND. CORRESPONDING TO THE PALPABLE FIRMNESS IN THE LOWER OUTER QUADRANT. THIS HAS A RIBBON CLIP AND THE 12 O' CLOCK LESION HAS A WING CLIP. THE. DEEP MARGIN ASSOCIATED WITH THE LOWER OUTER QUADRANT LESION IS FIRM AND. PINK-TAN FIBROUS TISSUE DOES EXTEND TOWARDS THE MARGIN BUT THE ACTUAL. FIRM MASS IS GROSSLY WITHIN THE CONFINES. THE LOWER OUTER MASS MEASURES. 2.5 x 2.5 x 2.5 CM. THE 12 O'CLOCK MASS IS SEPARATED BY 3 CM OF TISSUE. AND MEASURES 3.5 X 2.5 x 2.5 CM IN GREATEST DIMENSION. ADDITIONAL. PINK-TAN FIBROUS TISSUE IS FOUND IN THE MIDPORTION OF THE SPECIMEN WHICH. IS THEN SURROUNDED BY YELLOW FATTY TISSUE. SECTIONS ARE SUBMITTED AS. FOLLOWS: D1--NIPPLE, D2 AND --DEEP MARGIN OVER LOWER OUTER QUADRANT. LESION, D4--DEEP MARGIN TO 12 O' CLOCK LESION, D5 AND 6--12 O' CLOCK. LESION, D7 THROUGH --LONGITUDINAL SECTION OF 12 0'CLOCK LESION,. D10--TISSUE BETWEEN THE 2 LESIONS, D11 AND 12 -LOWER OUTER QUADRANT. LESION LONGITUDINAL SECTION, D13--TUMOR LOWER OUTER QUADRANT. THE. TISSUE TO THE 6 O'CLOCK MARGIN OF THE LOWER OUTER QUADRANT LESION IS. NODULAR AND FOCALLY THERE IS BROWN DISCOLORATION. A SECTION IS. SUBMITTED IN D14. THIS IS 1 CM FROM THE LOWER OUTER QUADRANT LESION AND. 5 CM FROM THE 12 0'CLOCK LESION. OTHER NODULES DEMONSTRATE CYSTS AS A. SECTION IN D15 DEMONSTRATES. D16--UPPER INNER QUADRANT (3 CM FROM 12. O' CLOCK LESION), 17--UPPER OUTER QUADRANT (5 CM FROM 12 O' CLOCK. LESION), D18--LOWER OUTER QUADRANT (3 CM FROM LOWER OUTER QUADRANT. LESION) , 019--LOWER INNER QUADRANT (3 CM FROM LOWER OUTER QUADRANT. LESION) THE SEPARATELY SUBMITTED PORTIONS OF FATTY TISSUE ARE GROSSLY. UNREMARKABLE AND REPRESENTATIVE TISSUE IS SUBMITTED IN D20 AND 21. E RECEIVED LABELED. RIGHT AXILLARY NODE CONTENTS IS. YELLOW-RED FATTY TISSUE MEASURING 12 x 9.5 x 2.5 CM. THE TISSUE IS. EXAMINED FOR LYMPH NODES. LYMPH NODES ARE IDENTIFIED AND SUBMITTED AS. FOLLOWS: E1--ONE-HALF OF A FIRM NODE WITH MIRROR IMAGE SUBMITTED PER. PROTOCOL, E2--1 NODE BISECTED, E3--1 NODE BISECTED (MAY ACTUALLY. REPRESENT 2 IMMEDIATELY ADJACENT NODES), E4--1 NODE TRISECTED, E5--1. NODE BISECTED, E6--1 NODE BISECTED, E7--1 NODE TRISECTED, E8--3 NODES (1. BISECTED), E9--6 NODES, E10-- NODE BISECTED. /F. Specimen. Spec Type: SURGICAL P. PREOPERATIVE DIAGNOSIS. RIGHT BREAST CANCER INVASIVE. OPERATION PERFORMED. DOCTOR (s) : PROCEDURE: SENTINEL NODE Bx/LYMPHADENECTOMY/STMPLE MASTECTOMXY/AXILLARY. PROCEDURE (CONT) : NODE DISSECTION. TISSUE REMOVED. A. RT SENTINEL NODE #1 - FS. B. RT SENTINEL NODE #2 - FS. C. RT AXILLARY NON SENTINEL NODE. D. RT BREAST SIMPLE MASTECTOMY. E. RT AXILLARY NODE CONTENTS. FROZEN SECTION DIAGNOSIS. A. NEGATIVE FOR TUMOR. B. METASTATIC CARCINOMA. GROSS DESCRIPTION. THE SPECIMEN IS RECEIVED IN 5 PARTS. PART A IS RECEIVED DESIGNATED. RIGHT AXILLARY SENTINEL. NODE 1 GAMMA. HOT AT. IT IS RECEIVED IN THE FRESH STATE FOR. FROZEN SECTION AND CONSISTS OF A 3.5 X 2.3 x 0.5 CM FRAGMENT OF. YELLOWISH-PINK FIBROADIPOSE TISSUE WITH 2 PALPABLE NODULES MEASURING 2 x. 1.2 x 0.6 CM AND 0.8 x 0.8 x 0.5 CM. EACH NODULE IS PINKISH-RED AND. SECTIONING SHOWS REDDISH-PINE CROSS SECTION. ONE-HALF OF EACH IS. SUBMITTED FOR FROZEN SECTION LABELED FSA. SUBSEQUENT TO THE FROZEN. SECTION, THE FROZEN TISSUE IS SUBMITTED FOR PERMANENTS LABELED FSA. THE. REMAINING UNFROZEN NODULES ARE SUBMITTED FOR PERMANENTS LABELED A. PART B IS RECEIVED DESIGNATED. RIGHT AXILLARY SENTINEL. NODE 2 GAMMA. HOT/BLUE AT. IT IS RECEIVED IN THE FRESH STATE. FOR FROZEN SECTION AND CONSISTS OF A 2.7 x 2.1 x 0.5 CM FRAGMENT OF. YELLOWISH-PINK FIBROADIPOSE TISSUE WITH PALPABLE NODULE. THE NODULE IS. ISOLATED AND FOUND TO MEASURE 1.7 x 1.4 X 0.5 CM. THE NODULE IS. BISECTED SHOWING A REDDISH-PINK RIM SURROUNDING YELLOW ADIPOSE TISSUE. WITH A GLISTENING WHITISH-TAN NODULE AT ONE MARGIN MEASURING 0.4 CM IN. DIAMETER. SUBSEQUENT TO THE FROZEN SECTION, THE FROZEN TISSUE IS. SUBMITTED FOR PERMANENTS LABELED FSB. THE REMAINDER OF THE NODULE IS. SUBMITTED FOR PERMANENTS LABELED B. Specimen: Req# : spec Type: SURGICAL P. GROSS DESCRIPTION. PATH PROCEDURES. PROCEDURES: 88305, 88307/2, 88309, PATH FS /2, A BLK, B BLK, C BLK, D BLK/21, E BLK/10,. FS-A, FROZ.SEC.-B. FINAL DIAGNOSIS. PART A RIGHT AXILLARY NO EVIDENCE OF %/ISN. SENTINEL LYMPH NODE #1, BIOPSY: MALIGNANCY. PART B RIGHT AXILLARY SENTINEL LYMPH NODE #2, BIOPSY: METASTATIC. BREAST CARCINOMA HAVING A MAXIMUM MICROSCOPIC DIMENSION OF 0.6 CM IS. IDENTIFIED IN 1 LYMPH NODE EXAMINED. THERE IS NO EVIDENCE OF EXTRANODAL. EXTENSION OF TUMOR. PART C RIGHT AXILLARY NONSENTINEL LYMPH NODE, BIOPSY: NO EVIDENCE OF. MALIGNANCY IN 1 LYMPH NODE EXAMINED. PART D RIGHT BREAST, SIMPLE MASTECTOMY: MULTICENTRIC INTRALOBULAR, AND INFILTRATING LOBULAR CARCINOMA OF THE. 1. PLEOMORPHIC TYPE. THE INVASIVE COMPONENT SHOWS NUCLEAR GRADE 2/3,. LOW MITOTIC INDEX, AND TUBULE FORMATION 3 WITH TOTAL NOTTINGHAM SCORE. OF 6. LCIS OF THE PLEOMORPHIC TYPE, NUCLEAR GRADE 2/3, AND LOW 50% LCIS 8 2. MITOTIC INDEX COMPRISES APPROXIMATELY 50% OF THE TUMOR. 2. THE LARGEST FOCUS OF INVASIVE TUMOR MEASURES 3.5 CM IN GREATEST. DIMENSION AND IS LOCATED IN THE 12 O'CLOCK PORTION OF THE BREAST. THE SECOND LARGEST MEASURES 2.5 CM AND IS SEEN IN THE LOWER OUTER. QUADRANT. ADDITIONAL SMALLER FOCI OF INVASION MEASURING FROM 1 MM TO. 5 MM IN GREATEST DIMENSION ARE PRESENT. LCIS IS SEEN ON 14 OF 21. BLOCKS EXAMINED HAVING A MAXIMUM CALCULATED DIMENSION OF 5.6 CM. 3. THE MARGINS OF RESECTION AND NIPPLE SKIN ARE FREE OF TUMOR. 4. LYMPHOVASCULAR INVASION IS NOT IDENTIFIED. 5. PROLIFERATVE FIBROCYSTIC CHANGES INCLUDING INTRADUCTAL PAPILLOMAS,. INTRADUCTAL PAPILLOMATOSIS, MICROSCOPIC COMPLEX SCLEROSING LESIONS,. ADENOSIS, APOCRINE METAPLASIA, MICROCYST FORMATION, PATCHY DENSE. STROMA AND RARE LUMINAL CALCIFICATIONS. Specimen: Received: (. spec Type: SURGICAL P. FINAL DIAGNOSIS. 6. THE BIOPSY SITES (. ARE PRESENT. PART E RIGHT AXILLA, LYMPH NODE DISSECTION: METASTATIC BREAST. CARCINOMA IS IDENTIFIED IN 1 OF 16 LYMPH NODES EXAMINED. NO EVIDENCE OF. EXTRANODAL EXTENSION BY TUMOR. CODE. 1. (prelim.).",T2,N1,M0,T2N1M0
TCGA-DC-6158,"Clinical Diagnosis & History: male with adenocarcinoma T2NO lesion in distal rectum. Specimens Submitted: 1: Rectum; transanal excision: 2: SP: Additional meso-rectal tissue. DIAGNOSIS: 1. Rectum; transanal excision: : Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Rectum. Tumor Size: 3.6 x 2.2 x 0.6 cm. Tumor Budding: Absent. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Not identified. Deepest Tumor Invasion: Muscularis propria. Lymphovascular Invasion: Identified. Large Venous Invasion: Not Identified. Perineural Invasion: Identified. Surgical Margins: Free of tumor. 0.2cm from distal resection margin. 0.2 cm between deepest tumor portion and deep (radial soft tissue). margin. 0.2 cm from lateral margins and 0.5 cm from proximal margin. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Lymph Nodes: Number with metastasis: 0. Total number examined: 1. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC. pT2 (Tumor invades muscularis propria). 2. RECTUM AND MESORECTAL TISSUE; EXCISION: - BENIGN RECTAL TISSUE AND FIBROADIPOSE TISSUE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1) The specimen is received fresh labeled ""Posterior transanal excision of. rectal tumor"" and consists of an oriented portion of rectal mucosa measuring. 5.8 cm (distal to proximal) x 3.7 cm (left to right) x 0.3 cm. The mucosa. displays an red tan papillary lesion measuring 3.6 x 2.2 cm located 0.2 cm. right, 0.5 cm proximal, 0.1 cm -- proximal, 0.2 cm -- left from the. mucosal margin. Gross photographs are taken. TPS has been previously taken. by the attending. The left half is inked black, the right half is inked. blue. Upon sectioning the lesion has yellow papillary extension to a depth. of 0.6 cm. Perpendicular sections of the distal and proximal margins are. submitted. The remaining specimen is serially sectioned from distal to. proximal in its entirety. Summary of sections: DM- distal margin (perpendicular). SS - sequential sections from distal to proximal. PM- proximal margin (perpendicular). 2.) The specimen is received in formalin, labeled ""Additional mesorectal. tissue"" and consists of a 3.5 x 2.4 x 0.9 cm aggregate of multiple,. irregular, fibrofatty tissue fragments, some with partially overlying,. focally congested, tan-pink mucosa. The specimen is entirely submitted. Summary of sections: MR -- mesorectal tissue. Summary of Sections: Part 1: Rectum; transanal excision: Block. Sect. Site. PCs. 5. DM. 5. 5. PM. 5. 8. SS. 8. Part 2: SP: Additional meso-rectal tissue. Block. Sect. Site. PCs. 4. 10.",T2,N0,M0,T2N0M0
TCGA-D5-6930,"page 1 / 1. copy No. 4. Examination: Histopathological examination. Material: Multiple organ resection - segment of the large intestine. Expected time of examination: Clinical diagnosis: Cancer of the hepatic flexure. Diverticula of the descending colon, polyp of the descending colon. SPECIMEN - cecum, descending, transverse and ascending colon with the greater omentum. Macroscopic description: A 63 cm length of the large intestine with periintestinal fat tissue sized 71 X 14 X 8 cm, the omentum sized 36 X 14 X 5 cm, a 5.5. cm length of the small intestine, and a 7.7 cm appendix. Cauliflower-shaped tumour sized 5 X 3.2 X 1.1 cm found in the mucosa. The lesion surrounding 90% of the intestine circumference is located 13.2 cm from the proximal incision line, 52 cm from the. distal incision line, and 6.5 cm from the Bauhin's valve. Minimum side margin is 4cm. A polyp of 3.2cm diameter outside the. tumour in the region of the descending colon. A second polyp of 1.1. diameter removed by 6.8 cm from the first one, a third. polyp of 1.2 cm diameter located opposite the second one, 6cm away. Microscopic description: Adenocarcinoma mucinosum (G3). Infiltratio carcinomatosa tunicae muscularis propriae et telae adiposae pericolicae. Intestine ends and the appendix clear of neoplastic lesions. Outside the tumour: Adenomata tubulopapillaria cum dysplasia gradus minoris ad maiorem. Diverticula. Lymphonodulitis reactiva lymphonodorum (No XX). Histopathological diagnosis: Adenocarcinoma mucinosum colli. Mucinous adenocarcinoma of the colon. (G3, Dukes B, Astler-Coller B2, pT3, pNO).",T3,N0,M0,T3N0M0
TCGA-E2-A15G,"SPECIMENS: A. WLE LEFT BREAST NEEDLE LOCALIZATION. B. SENTINEL NODE #1 LEFT AXILLA. C. MEDIAL MARGIN LEFT BREAST. SPECIMEN(S): A. WLE LEFT BREAST NEEDLE LOCALIZATION. B. SENTINEL NODE #1 LEFT AXILLA. C. MEDIAL MARGIN LEFT BREAST. INTRAOPERATIVE CONSULTATION DIAGNOSIS: Part A, Left breast, wide local excision, gross examination: Tumor (at least 3 cm in size) seen at inked green medial. margin. TPB, Sentinel lymph node #1, left axilla: Negative for tumor cells. Diagnoses called at. by Dr. GROSS DESCRIPTION: A. WLE LEFT BREAST NEEDLE LOCALIZATION. Received fresh labeled with the patient's identification and designated ""wide local excision left breast needle localization"". is an oriented, previously inked, 63-g, 8 x 5.5 x 3.7 cm needle localized lumpectomy specimen accompanied by two. radiographs. The single suture designates anterior, double-lateral. Ink code: Anterior-yellow, posterior-black, medial-. green, lateral-red, superior-blue, inferior-orange. The specimen is serially sectioned from medial to lateral into 7 slices. revealing firm tan mass (clip in slice 3), 3.5 x 2 x 1.5 cm, located at the medial margin. A second ill-defined hemorrhagic. firm area, 1 x 0.9 x 0.6 cm, is identified in slice 6, approximately 1 cm from the mass, and approaches the nearest anterior. margin at distance of 0.6-cm. A portion of the specimen is submitted for tissue procurement. The specimen is. representatively submitted: A1-A4: Perpendicular sections medial margin, entirely submitted. A5-A8: Slice 2, entirely submitted, A5-A6 demonstrate mass. A9-A12: Slice 3, entirely submitted, A10 demonstrates clip. A13: Slice 4, posterior/superior. A14: Slice 4, superior/anterior. A15: Slice 4, posterior/inferior. A16: Slice 5, posterior/superior. A17-A18: Slice 6, hemorrhagic firm area submitted entirely. A19-A20: Representative perpendicular sections, lateral margin. B. SENTINEL NODE #1 LEFT AXILLA. Received fresh labeled with the patient's identification and designated ""sentinel lymph node number one left axilla"" is a tan. lymph node measuring 3 x 1.5 x 1 cm. Touch preparations are performed. The entire specimen is submitted, B1-B2. C. MEDIAL MARGIN LEFT BREAST. Received in formalin labeled with the patient's identification and designated ""medial margin left breast"" is an oriented. (suture at final margin), 6g, 5.5 x 2.5 x 1 cm fragment of fibroadipose tissue. The final margin inked black. The specimen. is sectioned and submitted entirely, C1-C5. DIAGNOSIS: A. BREAST, LEFT, WIDE LOCAL EXCISION: - INVASIVE MIXED (DUCTAL/LOBULAR) CARCINOMA, SBR GRADE II,. MEASURING 3.5 CM. FOCAL DUCTAL CARCINOMA-IN-SITU, NUCLEAR GRADE 2/3, SOLID AND. CRIBRIFORM TYPE WITH MICROCALCIFICATIONS. - FIBROADENOMA / FIBROCYSTIC CHANGES. - PREVIOUS BIOPSY SITE CHANGES. (SEE SYNOPTIC REPORT). B. LYMPH NODE, SENTINEL #1, LEFT AXILLA, EXCISION: - ONE REACTIVE LYMPH NODE. - NO METASTATIC CARCINOMA IS SEEN (0/1). C. BREAST, LEFT, MEDIAL MARGIN, EXCISION: - BREAST TISSUE WITH FIBROCYSTIC CHANGES. NO MALIGNANCY IS SEEN. SYNOPTIC REPORT - BREAST. Specimens Involved. Specimens: A: WLE LEFT BREAST NEEDLE LOCALIZATION. B: SENTINEL NODE #1 LEFT AXILLA. C: MEDIAL MARGIN LEFT BREAST. Specimen Type: Excision. Needle Localization: Yes For mass. Laterality: Left. Invasive Turnor: Present. Multifocality: WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Mixed type carcinoma. Tumor size: 3.5cm. Additional dimensions: 2cm x 1.5cm. Tumor Site: Upper outer quadrant. Margins: Negative. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/1. Micrometastases: No. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 2%. DCIS Type: Solid. Cribriform. DCIS Location: Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Absent. Location of CA++: DCIS. Stroma. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by IHC. Performed on Case:outside slides (our consultation report). Pathological staging (pTN): pT2NO. CLINICAL HISTORY: Invasive carcinoma, UOQ left breast, with enhancement patient for intraductal extension going anteriorly. PRE-OPERATIVE DIAGNOSIS: Invasive carcinoma. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 4. CLINICAL EXPERIENCE: Patients with a recurrence score of: 4 in the clinical validation study had an average. rate of Distant Recurrence at 10 years of 5%. ER Score: 11.5 Positive. PR Score: 9.9 Positive. Her2 Score: 8.8 Negative. Interpretation: ER Negative < 6.5 Positive >= 6.5. PR. Negative < 5.5. Positive >= 5.5. Her2 Negative <10.7. Positive >=11.5 Equivocal = 10.7 - 11.4. See separate. report for further information. Microscopic/Diagnostic Dictation: Pathologist,. Final Review: Pathologist,. Final Review: Pathologist,. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist.",T2,N0,M0,T2N0M0
TCGA-VR-AA7D,"GA-VR-AA7D-01A-PR. PRIMARY SITE: Esophagus (Mid third). 1- - Material designated as ""cervical lymph node"": - Congested parathyroid showing volumetric increase. Note: depending on the correlation with clinical/radiological findings, the present case. may correspond to hyperplasia or parathyroid adenoma. 2 - ""Esophagectomy and partial gastrectomy"": - Moderately differentiated squamous cell carcinoma, measuring 7.5 cm, infiltrating the wall of the. esophagus up to periesophageal adipose tissue;. - Angiolymphatic invasion present;. - Perineural invasion present;. - Scarce peritumoral desmoplasia;. - Moderate lymphocytic peritumoral infiltrate;. - Surgical margins free of neoplasia;. - Fragments of non-neoplastic esophageal mucosa showing congestion;. Fragments of gastric mucosa with moderate chronic gastritis with atrophy and intestinal. metaplasia;. - Metastasis to 7 of 13 dissected lymph nodes (11/13). 3 - ""Margin of esophagus"": - Free of neoplasia.",T3,N3,M0,T3N3M0
TCGA-77-8143,"Histopathology Report. HISTORY. (L) UL-NSCLC. MACROSCOPIC. Four specimens received: 1: The first specimen is labelled ""(L) upper lobe"" and consists of an upper. lobectomy measuring 240 mm from superior to inferior x 100 X 35 mm. The. bronchial soft tissue resection margin measures 80 x 35 mm. A bronchial. resection margin measures 20 x 7 mm. Superior to the soft tissue resection. margin there is a stapled margin measuring 70 mm in length. Within the apex. there is a firm tumour measuring 63 x 50 X 48 mm. The overlying pleura is. puckered. On sectioning the tumour is centrally necrotic and is well defined. and cream to yellow and focally black. Tumour is > 10 mm from the stapled. resection margin and 30 mm from the bronchial resection margin. After removal. of staples the new resection margin has been inked black. The overlying pleura. has also been inked black. [1A-bronchial resection margin; 1B-? hilar lymph. nodes; 1C-tumour, inked resection margin after removal of staples and overlying. pleura; 1D-1F tumour and pleura; 1G-tumour and adjacent normal appearing lung;. 1H-RS of normal lung; 1I-tumour and adjacent bronchus. No definite bronchial. origin is identified.]. 2: The second specimen is labelled ""pulmonary vein lymph node"" and consists of. a fatty piece of tissue measuring 10 X 7 X 3 mm. On bisecting a single lymph. node measuring 3 mm in maximum extent is identified. [Submitted in toto-2A.]. 3: The third specimen is labelled ""No. 6 lymph node"" and consists of a fatty. piece of tissue measuring 35 X 30 X 8 mm. On sectioning two lymph nodes are. identified. [3A-3B lymph nodes bisected, part of each lymph node in each. cassette. [Lymph node submitted in toto.]. 4: The fourth specimen is labelled ""No. 10 lymph node"" and consists of a lymph. node measuring 16 X 7 x 5 mm. [Bisected in toto-4A.]. MICROSCOPIC. 1: Sections show a moderately to poorly differentiated squamous cell carcinoma. with areas of central necrosis and cystic change as well as areas of sclerosis. There is a moderately heavy lymphoplasmacytic infiltrate in tumour stroma. Tumour abuts but does not appear to invade the overlying pleura and the inked. resection margin is clear of malignancy. No vascular, lymphatic or perineural. invasion is identified. The bronchial resection margin shows focal squamous. metaplasia but no evidence of malignancy. Uninvolved lung parenchyma shows. emphysema. Peribronchial lymph nodes contain small silicotic nodules but there. is no evidence of metastatic carcinoma. Page 1 (. Histopathology Report. 2: Sections show an anthracotic node in which there is no evidence of. malignancy. 3: Sections show a deposit of metastatic squamous cell carcinoma in one of the. lymph nodes. There are also a few small silicotic nodules. 4: Sections show an anthracotic node in which there is no evidence of. malignancy. SUMMARY. Left upper lobectomy and lymph node sampling: Moderately to poorly differentiated squamous cell carcinoma, 63 mm in diameter. No pleural, vascular, lymphatic or perineural invasion identified. Squamous. metaplasia at bronchial resection margin. Metastasis in No. 6 lymph node. Pathological stage T2N2. Cc: Lung Cancer Registry.",T2,N2,M0,T2N2M0
TCGA-V4-A9EL,"Left eye enucleation. Macroscopy. The eye ball mesures 25 by 25 by 23 mm and presents a posterior segment of optic. nerves measuring 5 mm. At the section, the tumor measures 18 mm main line. Samples have been frozen for genetic studies then the piece has been fixed and. included entirely. Microscopy. The tumor observed macroscopically corresponds to an uveal melanoma, mainly. composed of epitheliod cells. The cell cytoplasm is often pigmented with melanin. The cyto/nuclear atypia are severe. Presence of large areas of necrosis and. hemorragy, in particular at the centre of the tumor. The lesion is located at a large distance of the optic foramen and the optic nerve on. its entire course and cut end is free of tumor. The tumor infiltrates all of the thickness. of the sclera but there is no extra-scleral tumor extension. Presence of one intra-. scleral endovascular tumor embolism. The ciliary body, the iris and the anterior. chamber are free. Conclusion. Uveal melanoma of the left eye. Epitheliod cells predominant. Size of the tumor: 18 mm. Tumor invasion of the sclera without extra-scleral extension. Intra-scleral endovascular tumor embolism. Optic nerve, ciliary body and anterior chamber free of tumor.",T4,N0,M0,T4N0M0
TCGA-D7-6526,"Examination: Histopathological examination. Material: Multiple organ resection - stomach. PROGRAM HER-2/stomach. Expected time of examination: Clinical diagnosis: Cancer of the stomach. Total gastroctomy. Macroscopic description: Sent material consisting of the stomach, cut out along the greater curvature, sized 18 x 19 cm with the omentum sized 32 x 17 cm. Tumour. sized 8 x 6.5 x2 cm in the pyloric region. Macroscopically, the Invasion covering the perigastric fat tissue. Distance from the proximal end 5. cm, from distal end 0.8 cm. Microscopic description: Adenocarcinoma tubulare G2. Tumour penetrating the full thickness of the stomach wall, the perigastric fat tissue and blood vessels. Surgical incision lines free of cancer invasion. Metastases carcinomatosae in lymphonodis No. III/XIX. Infiltratio capsulae lymphonodis et telae adiposae perinodalis. Histpoathological diagnosis: Adenocarcinoma tubulare ventriculi. Tubular adenocarcinoma of the stomach.1. Metastases carcinomatosae in lymphonodis No. III/XIX. Cancer metastases in the lymph nodes No. III/XIX. G2, pT3, pN2. Typus intestinalis sec Lauren. Results of immunohistochemical examination: HER2 protein stained with HercepTestM by DAKO. Score = 2+, verification by the FISH method recommended.",T3,N2,M0,T3N2M0
TCGA-4Z-AA7R,"(MM/DD/YYT. PRIMARY SITE: Bladder. 1- ""Bladder + prostate + bilateral obturator lymph node chain"". High grade urothelial carcinoma, ulcerated, infiltrating until detrusor muscle;. Greatest dimension: 9.5 cm;. Perivesical fat: uninvolved by neoplasia, although it exhibits peritumoral sclerosis;. Angiolymphatic invasion present;. Perineural invasion present;. Right ureter segment: compromised by neoplasia;. Left ureter segment: compromised by neoplasia;. Prostate: compromised by neoplasia;. Seminal vesicles: uninvolved by neoplasia;. Vas deferens: uninvolved by neoplasia;. Right and left ureteral margins: uninvolved by neoplasia;. Right obturator lymph node chain: uninvolved by neoplasia (0/5). Left obturator lymph node chain: uninvolved by neoplasia (0/2). 2- Uretral stump. Uninvolved by neoplasia. 3- Left obturator lymph nodes. Uninvolved by neoplasia (0/4). 4- Right obturator lymph nodes. Uninvolved by neoplasia (0/3).",T4,N0,M0,T4N0M0
TCGA-BH-A1F8,"proceuare wave. Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE OF LMP. DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: LEFT BREAST CANCER. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: LEFT MASTECTOMY. CLINICAL HISTORY: MATERIAL SUBMITTED: A) LEFY (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. B) LEFT AXILLA, PROCUREMENT BY SURGICAL PROCEDURE. NODES. FINAL DIAGNOSIS: FINAL DIAGNOSIS: A) LEFT BREAST, MODIFIED RADICAL MASTECTOMY: INFILTRATING DUCTAL CARCINOMA/ 4.0 BY 3.5 BY 3.0 CM. - HISTOLOGIC GRADE, POOR. - NUCLEAR CRADE, MODERATE. - NOTTINGHAM SCORE 7 (TUBULE 3, NUCLEI 2, MITOSIS 2). - TUMOR INVOLVING SUBAREOLAR AND NIPPLE LIMPHATICS. - TUMOR INVOLVING DERMIS AND DERMAL LYMPHATICS OVERLYING TUMOR AND EXTENDING INTO EPIDERMIS. - INTRADUCTAL COMPONENT, COMIDO VARIANT, COMPRISING 10% OF TUMOR. - INKED MARGINS INCLUDING SKIN MARGINS, FREE or TUMOR. (CROSS REFER. B) LEFT AXILLARY CONTENTS: - TWELVE OF THIRTEEN (12/13) LYMPH NODES CONTAINING METASTATIC TUMOR WITH PROMIMENT PERINODAL EXTENSION IN 6. NODES. - TWO (2) ADDITIONAL TUMOR NODULES ARE SEEN AS PERIVASCULAR TUMOR NODULES WITHOUT RECOGNIZABLE NODAL. FEATURES.",T4,N2,M0,T4N2M0
TCGA-BP-4329,"Clinical Diagnosis & History: 5 x 7 cm heterogenous lower pole mass,. Specimens Submitted: 1: SP: Right kidney. 2: SP: Right para-caval lymph nodes. DIAGNOSIS: 1). KIDNEY, RIGHT; RADICAL NEPHRECTOMY: RENAL CELL CARCINOMA, CLEAR CELL TYPE, NUCLEAR GRADE. II/IV. THE PATTERN OF GROWTH IS ACINAR. THE TUMOR GREATEST. DIAMETER IS 7.5 CM. THE TUMOR EXTENDS THROUGH THE RENAL. CAPSULE BUT IS CONFINED WITHIN GEROTA'S FASCIA. INVASION OF. THE RENAL VEIN IS PRESENT. ALL SURGICAL MARGINS ARE FREE OF. TUMOR. THE NON-NEOPLASTIC KIDNEY SHOWS PATCHY CHRONIC. INFLAMMATION. 2). LYMPH NODE, RIGHT PARA-CAVAL; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). Gross Description: 1) The specimen is received fresh, labeled ""Right kidney"". It. consists of a kidney, portion of ureter, portion of renal blood. vessels and perinephric adipose tissue weighing 580 grams. overall. The kidney measures 12.5 x 6.5 x 5.5 cm. The portion. of ureter measures 7 cm in length and 0.3 cm in diameter. The. kidney is bivalved to reveal an ill-defined tumor involving the. lower half of the kidney and measuring 7.5 x 5 X 3.5 cm. The. tumor is composed of gray-yellow focally necrotic tissue. The. Gerota's fascia is inked, The tumor is serially sectioned to. reveal that it abuts the renal capsule, however, it does not. extends into the perinephric adipose tissue. The collecting. system is free of tumor. The urothelium of the renal pelvis and. ureter is tan and smooth. The tumor involves the adipose tissue. close to renal pelvis, and is present within the lumen of the. renal vein. The renal vein surgical margin is free of tumor. The rest of the renal parenchyma is unremarkable. No adrenal. gland is identified. Representative sections are submitted. Fresh tumor is saved for TPS and EM. Gross photographs are. taken. Summary of Sections: SM - surgical margins of the ureter and renal blood vessels. TG - tumor in relation Gerota's fascia. TC - tumor in relation to renal capsule. TF - tumor within the pelvic fat. TCS - tumor and collecting system. TK - tumor and normal kidney. RV - renal vein. K - normal kidney. 2). The specimen is received in formalin, labeled, ""Right. paracaval lymph node"". It consists of a single piece of adipose. tissue measuring 5.0 x 1.0 x 0.2 cm. Embedded within the adipose. tissue is a possible lymph node which measures 4.0 cm in greatest. dimension. The possible lymph node was cut into pieces and each. fragment was further bisected. The node is submitted entirely. Summary of Sections: PLN - possible lymph node. Summary of Sections: Part. Sect. SiteBlocks Pieces. All. 1. K. 1. 1. RV. 1. 1. SM. M. TC. 3. 3. TCS. 1. TF. 2. TG. TK. 1. 2. PLN. 4. Y.",T3,N0,M0,T3N0M0
TCGA-BJ-A2N9,"ADDENDA: Addendum. MOLECULAR ANATOMIC PATHOLOGY TESTING: Part 1: Mutations in BRAF, NRAS61, HRAS61, KRAS12/13, and RET/PTC1, RET/PTC3 and PAX8/PPARg rearrangements. NOT identified. NOTE: Nucleic acids were extracted in the amount sufficient for testing. Amplification of GAPDH and KRT7 controls was. acceptable. FINAL DIAGNOSIS: PART 1: THYROID, TOTAL THYROIDECTOMY (27 GRAMS) -. A. PAPILLARY THYROID CARCINOMA, ENCAPSULATED ONCOCYTIC FOLLICULAR VARIANT (2.5 CM), RIGHT. LOBE, CONFINED TO THE THYROID; NO CAPSULAR OR ANGIOLYMPHATIC INVASION PRESENT. B. THREE (3) LYMPH NODES, NO TUMOR PRESENT (0/3). C. PATHOLOGIC STAGE: pT2 NO. D. EXUBERANT CHRONIC LYMPHOCYTIC THYROIDITIS. PART 2: LYMPH NODES, CENTRAL COMPARTMENT, SELECTIVE DISSECTION -. EIGHT (8) LYMPH NODES, NO TUMOR PRESENT (0/8). COMMENT: This case has been reviewed by my colleague,. who agrees with the above 'iagnosis. studies will be performed and reported as an addendum. CASE SYNOPSIS: SYNOPTIC DATA . PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR FOCALITY: Unifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 2.5 cm. HISTOLOGIC TYPE"": Papillary carcinoma, encapsulated follicular variant. PRIMARY TUMOR (pT): pT2. REGIONAL LYMPH NODES (pN): pNO. Number of regional lymph nodes examined: 11. Number of regional lymph nodes involved: 0. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Not identified. MARGINS: Margins uninvolved by carcinoma. LYMPH-VASCULAR INVASION: Not identified. ADDITIONAL PATHOLOGIC FINDINGS: Thyroiditis.",T2,N0,M0,T2N0M0
TCGA-44-8120,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Lymph nodes, level XI, resection: Negative for malignancy. B. Lymph nodes, level X, resection: Negative for malignancy. C. Lung, right upper lobectomy: Invasive moderately differentiated adenocarcinoma. Tumor extends into the visceral pleural surface. Bronchial and vascular margins of resection are free of tumor. D. Lymph nodes, level R II, resection: Negative for malignancy. E. Lymph nodes, level R IV, resection: Negative for malignancy. F. Lymph nodes, level VII, resection: Negative for malignancy. Microscopic Description: Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Primary tumor (pT) : Tumor measures maximally 2.6 cm in diameter and has. extended into the visceral. pleural surface (pT2a). Margins of resection: Bronchial and vascular margins are negative for. tumor. Direct extension of tumor: Absent. Venous (large vessel) invasion: Negative. Arterial (large vessel) invasion: Negative. Lymphatic (small vessel) invasion: Negative. Regional lymph nodes (pN) : All of the sampled mediastinal lymph nodes. are negative for metastatic carcinoma. (pN0) . Distant metastasis (pM) : pMx. Specimen. A. Level XI. B. Level X. C. Right upper lobe. D. R 2. E. R 4. F. Level 7. Clinical Information. Lung cancer. Gross Description. A. Received unfixed, labeled level XI, is a fragmented, black, 1.2 X. 0.6 X 0.5 cm nodal fragment, entirely submitted in one block. B. Received unfixed, labeled level X, is a fragmented, black, 1.3. X. 0.9 X 0.5 cm nodal fragment, entirely submitted in one block. C. Received unfixed for tissue procurement, labeled right upper lobe,. is a 164 g, 13 X 8 x 3.5 cm right upper lobectomy specimen. There is a. 2.5 X 2.5 cm area with central puckering on the pleural surface, with. an underlying tumor that is 2.6 X 2.5 X 2.0 cm. It has an irregular. border and a gray-white to tan cut surface, with incorporated. anthracotic pigment. The tumor does not appear to be arising from the. nearby bronchi, and the bronchial margin is at least 2.5 cm from the. tumor. No other tumors are identified. A representative portion of. tumor and normal tissue submitted for tissue procurement. Representative sections as follows: 1 Bronchial and vascular margins;. 2-4 tumor to pleural surf. 5 tumor to closest stapled margin; 6. uninvolved lung tissue. D. Received fresh labeled ""R 2"" are 6 fragmented white-pink to. gray-black tissues ranging from 0.3-1.4 cm in greatest dimension. Summary: 1 - 5 tissues; 2 - 1 tissue. E. Received fresh labeled 4"" are 5 soft tan-gray-pink tissues. ranging from 0.3-1.0 cm. F. Received fresh labeled ""level VII"" are 3 slightly rubbery tan-pink. gray-black tissues ranging from 0.7-2.5 cm in greatest dimension. mary: 1 - 2 tissues; 2 - 1 bisected tissue.",T2,N0,M0,T2N0M0
TCGA-VD-AA8R,"HISTOPATHOLOGY. Lab No. Clinical Consultant & Location. Unit No. SPECIMEN. LEFT GLOBE ENUCLEATION. Prognostic/diagnostic. CLINICAL DETAILS. Choroidal melanoma. No treatment. See diagram. Measurements: 14.10 x 13.73 x (6.55) mm. MACROSCOPIC DESCRIPTION. A fresh, intact, left globe. Dimensions: Axial 24mm, Horizontal 24mm, Vertical 23mm. Cornea: Horizontal 12mm, Vertical 11.5mm. Optic nerve: flush. On ans-illumination, a large shadow is seen inferiorly,. approximately 15mm in maximum dimension. Plane of section: vertical. Intraocular description: On opening, a solitary pale dome shaped choroidal mass is. seen, with possible ciliary body involvement. Tumour size: LBD 13mm. Height 9mm. MICROSCOPY. Sections show a virtually amelanotic melanoma consisting. predominantly of spindle cells however also including a. minor epithelioid cell component up to 10%. The tumour. occupies basically the choroid with focal extension to pars. plana. Most of tumour cells are arranged in a fascicular. pattern with nuclear palisading. In addition, there is focal. cytoplasmic vacuolation in tumour cells producing a balloon. cell appearance. The number of mitosis is approximately 4/40 high power. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. fields. Closed loops are not present in the planes of. sections. The lymphocytic infiltrate within the tumour is. minimal. Few scattered macrophages are present. Tumour. necrosis is not seen. Bruch's membrane appears focally. breached in one of the sections. There is no tumour. extension through the sclera, optic nerve or vortex veins. examined. Tumour cells are not seen at the resection. margins. Elsewhere, the cornea shows no significant abnormality. The. anterior chamber angles are open and the anterior chamber is. shallow. The iris shows no significant abnormality but the. ciliary body appears atrophic with hyalinisation of ciliary. processes. The lens shows cataractuous changes. Retina. overlying the tumour is slightly atrophic. DIAGNOSIS. Left eye, enucleation: Ciliochoroidal melanoma of mixed cell. type. COMMENT. Assessment of HSP27 expression on immunohistochemistry will. follow. In addition, molecular genetic examination of DNA. extracted from the tumour cells will be performed using. nultiplex-ligation dependent probe amplification (MLPA),. looking at chromosomes 1, 3, 6 and 8. A supplementary report. will follow in due course. SUPPLEMENTARY REPORT (MLPA). In the meantime, molecular genetic analysis of tumour DNA. extracted from the fresh uveal melanoma tissue was performed. using the technique termed multiplex ligation-dependent. probe amplification (MLPA) These investigations were. performed in the. The kit P027 from. which examines for gains or. losses in 31 loci on chromosomes 1, 3, 6 and 8, was used. The DNA concentration was measured using. and the. quality assessed using multiplex-PCR prior to the MLPA. reaction. prinied. HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. The DNA concentration was high and of good quality on. assessment. The MLPA reaction was run at least twice on. differing occasions, resulting in similar results. The results of the sequence analysis of the MLPA products is. printed on a separate report. In summary, sequence analysis. demonstrated: normal chromosome 1p,. disomy 3,. borderline gains in chromosome 6. and normal chromosome 8. Taken together, these molecular data would place the patient. in the low risk group with respect to the development of. metastatic melanoma. Consideration of clinical features of. the tumour is, however, also required. SUPPIEMENTARY REPORT -. Tumour cells express Melan-A and HSP 27 (score 2) . SUMMARY. SPECIMEN. 2= Eye. TUMOUR PRESENT. TUMOUR TYPE. 1= Melanoma. CELL TYPE. 3= Mixed. CT LOOPS. 1= No closed loops. NECROSIS. PIGMENTATION. LYMPHOCYTIC INFILTRATION. MITOTIC FREQUENCY. 4/40 HPF. DIFFUSE MELANOMA. SPREAD. 1= No. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. CLEARANCE. 2= Adequate. HSP-27 POSITIVITY. 2= 21-70%. LARGE DIAMETER. 13 mm. THICKNESS. 9 mm.",T3,N0,M0,T3N0M0
TCGA-A7-A4SF,"Final Surgical Pathology Report. Procedure. Diagnosis. A. Sentinel lymph node, right axilla, biopsy: Two negative lymph. nodes (0/2). B. Breast, right, excisional biopsy: Invasive ductal carcinoma, grade 2, size not less than 2.5 cm,. present at the medial and posterior margins; see microscopic. description. Ductal carcinoma in-situ, grade 2, present at the inferior. margin. Microscopic Description: Invasive Carcinoma: Histologic type: Ductal. Histologic grade: 2. Overall grade: 7/9. Architectural score: 3. Nuclear score: 2. Mitotic score: 1. Greatest dimension (pT2) : Not less than 2.5 cm, and possibly as. much as 4.0 cm (invasive carcinoma extends away from the main. tumor mass into the surrounding fat throughout much of the. specimen). Specimen margins: Invasive carcinoma is broadly present at. the medial and posterior margins. Vessel invasion: Not identified. Calcification: Not identified. Ductal carcinoma in situ: Histologic pattern: Solid, cribriform. Nuclear grade: 2. Central Necrosis: Focal. % DCIS of total tumor (if mixed) : 28. Extensive intraductal component (present/absent) : Absent. Specimen margins: DCIS is at the inferior margin of the. specimen. Calcification: Negative. Comments: Two prior biopsy sites are identified in the mid-portion of. the specimen. There is a confluence of tumor present microscopically. between the two apparent masses formed by the tumor, supporting the. conclusion of a single tumor mass lesion. Additionally, there is. tumor infiltrating around and beyond the tumor mass areas, into the. surrounding fat, and to the specimen margins as stated above. p63. immunostaining performed to confirm the presence of invasive carcinoma. at the margin. E-cadherin performed to exclude LCIS and confirm DCIS. at the inferior margin. Cytokeratin immunostaining performed on two lymph node blocks to. exclude metastatic carcinoma; stains are negative. Prognostic markers: See previous biopsy report. [A few of the antibodies used in our laboratory may be classified as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have not. been cleared or approved by the FDA. Specimen. A. Right axillary sentinel lymph node. B. Right breast mass, long anterior, short superior - tissue. Clinical Information. Right breast cancer;. year old black female with two side by side. cancers. Gross Description. A. Received unfixed, labeled right axillary sentinel node, are. 2. lymph nodes, 0.7 and 0.8 cm in greatest dimension each, entirely. submitted with each lymph node and a separate block (bisected). B. Received unfixed, and a transparent container, labeled right. breast mass, is a 5.5 x 4.3 x 3.0 cm portion of fibroadipose tissue. with orienting sutures. Margins are inked: Anterior black,. posterior blue, lateral green, and medial yellow. The specimen is. serially sectioned from superior to inferior. There is a 2.5 x 2.5. x 1.5 cm tumor mass, which is somewhat dumbbell-shaped, but appears. to consist of one tumor mass. Sections submitted as follows: 1. superior margin, 2 through 6 superior-most portion of tumor, 7. through 9 transition area of probable second lobe of tumor mass. (contiguous sections), 10 breast tissue intervening between tumor. mass and margin, 11 - inferior margin. Portion of tumor and normal. submitted for tissue procurement, as requested. Additional. sections submitted: RR1 intervening tissue between superior margin. and tumor; 2-4 additional superior tissue, 5-7 representative. remaining first half of specimen; 8-14 inferior half of specimen;. 15 additional inferior margin.",T2,N0,M0,T2N0M0
TCGA-BT-A0YX,"CLINICAL DIAGNOSIS AND HISTORY. CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Bladder cancer. PROCEDURE: Cystectomy/Indiana pouch.v. SPECIFIC CLINICAL QUESTION: Not stated. OUTSIDE TISSUE DIAGNOSIS: Not stated. PRIOR MALIGNANCY: Not stated. CHEMORADIATION: Not stated. ORGAN TRANSPLANT: Not stated. IMMUNOSUPPRESSION: Not stated. OTHER DISEASES: Not stated. SPECIMEN(S) RECEIVED: 1: Right Pubic Margin FS. 2: Right Ureter Margin FS. 3: Left Ureter Margin FS. 4: Bladder, Uterus, Fallopian Tubes, Ovaries. 5: Right Pelvic Lymph Node. 6: Left Pelvic Lymph Node. 7: Appendix. FINAL DIAGNOSIS. PART 1: SOFT TISSUE, RIGHT PUBIC MARGIN, EXCISION -. UROTHELIAL CARCINOMA INFILTRATING INTO SOFT TISSUE. PART 2: URETER, RIGHT MARGIN, BIOPSY -. A. SEGMENT OF URETER LINED BY BENIGN REACTIVE UROTHELIUM. B. NO UROTHELIAL CARCINOMA IN SITU (CIS) NOR INVASIVE UROTHELIAL CARCINOMA SEEN. PART 3: URETER, LEFT MARGIN, BIOPSY -. A. SEGMENT OF URETER LINED BY BENIGN REACTIVE UROTHELIUM. B. NO UROTHELIAL CARCINOMA IN SITU (CIS) NOR INVASIVE UROTHELIAL CARCINOMA SEEN. PART 4: BLADDER, VAGINA, UTERUS, BILATERAL OVARIES AND FALLOPIAN TUBES, ANTERIOR PELVIC EXENTERATION -. A. INVASIVE JROTHELIAL'CARCINOMA, HIGH GRDE (WHO/ISUP), WITH SQUAMOUS DIFFERENTIATION. B. THE CARCINOMA MEASURES 5.0 CM IN GREATEST DIMENSION. C. THE CARCINOMA EXTENSIVELY INVOLVES THE PERIVESICAL ADIPOSE TISSUE. D. THE INKED SURGICAL RESECTION MARGIN IS POSITIVE IN THE RIGHT LATERAL AND POSTERIOR REGIONS. (SLIDES 4L AND 4M). E. PERINEURAL INVASION IS IDENTIFIED. F. ANGIOLYMPHATIC INVASION IS IDENTIFIED. G. UTERUS WITH MULTIPLE LEIOMYOMATA UP TO 3.5 CM. H. UNREMARKABLE BILATERAL OVARIES AND BILATERAL FALLOPIAN TUBES. I. TNM PATHOLOGIC STAGING = pT3b NO MX. PART 5: LYMPH NODES, RIGHT PELVIC, EXCISION -. NO EVIDENCE OF METASTATIC CARCINOMA IN FOURTEEN LYMPH NODES EXAMINED (0/14). PART 6: LYMPH NODES, LEFT PELVIC, EXCISION -. NO EVIDENCE OF METASTATIC CARCINOMA IN EIGHT LYMPH NODES EXAMINED (0/8). PART 7: APPENDIX, APPENDECTOMY -. BENIGN UNREMARKABLE APPENDIX WITH FIBROUS OBLITERATION OF THE TIP AND MID-PORTION. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY URINARY BLADDER TUMORS. SPECIMEN TYPE: Anterior exenteration. TUMOR SITE: Right lateral wall, Anterior wall. TUMOR SIZE: Greatest dimension: 5.0 cm. Additional dimensions: 5.0 x 2.0 cm. HISTOLOGIC TYPE: Urothelial (transitional cell) carcinoma with squamous differentiation. ASSOCIATED EPITHELIAL LESIONS: None identified. HISTOLOGIC GRADE: Urothelial carcinoma - High-grade. TUMOR CONFIGURATION: Solid/nodule, Ulcerated. PATHOLOGIC STAGING (pTNM): pNO. Number of nodes examined: 22. Number of nodes involved: 0. pMX. MARGINS: Margin(s) involved by invasive carcinoma. Margin(s): Right lateral and posterior resection margins. VENOUS/LYMPHATIC (LARGE/SMALL) VESSEL INVASION (V/L): DIRECT EXTENSION OF INVASIVE TUMOR: Perivesical fat.",T3,N0,M0,T3N0M0
TCGA-BP-4335,"Clinical Diagnosis & History: with left renal and adrenal mass (+) bx renal cell ca. Specimens Submitted: 1: SP: l.t. kidney & adrenal gland. DIAGNOSIS: KIDNEY AND ADRENAL GLAND, LEFT; EXCISION: - RENAL CELL CARCINOMA, CLEAR CELL TYPE, NUCLEAR GRADE III/IV. THE TUMOR GREATEST DIAMETER. IS 5.5 CM. THE TUMOR EXTENDS THROUGH THE RENAL CAPSULE BUT is CONFINED WITHIN GEROTA'S. FASCIA. NO INVASION OF THE RENAL VEIN IS IDENTIFIED. ALL SURGICAL MARGINS ARE FREE OF TUMOR. THE NON-NEOPLASTIC KIDNEY SHOWS INTERSTITIAL FIBROSIS, AND CHRONIC INFLAMMATION, THE. ADRENAL GLAND IS INVOLVED BY METASTATIC CARCINOMA MEASURING 10.5 CM IN GREATEST DIAMETER. VASCULAR INVASION PRESENT IN THE RENAL SINUS. Special Studies: Special Stain. Comment. RECUT. RECUT. RECUT. The specimen Is received fresh, labeled ""Left Kidney and Adrenal Gland"". It consists of a product of left nephrectomy. consisting of a left kidney, fragment of renal blood vessel, fragment of a ureter, and adrenal gland surrounded by perinephric. adipose tissue weighing 460 grams. The kidney measures 10,5 x 8 x 4.5 cm. The fragment of ureter measures 6 cm in length. and 0.4 cm in diameter. The Gerota's fascia is inked. Upon bivalving, a large, lobulated, focally hemorrhagic, pink-orange mass. is present superiorly to the kidney within the perinephric adipose tissue abutting Gerota's fascia. The mass measures 10.5 X 10 x. 2 cm. There is approximately 20% necrosis present. On serial sectioning, the mass completely replaces the adrenal gland. parenchyma. The mass is extrarenal. Situated at the lower pole of the kidney is a subcapsular, pink-yellow, centrally necrotic. tumor measuring 5,5 x 4.5x 3 cm, Grossly, no extracapsular invasion is identified. The tumor is situated 1 cm from the Gerota's. fascia. There is a satellite tumor nodule identified within the lumen of the blood vessel. No tumor is present at the surgical. margin of the renal blood vessels. Noted is a tumor nodule at the hilar region of the kidney, extending into the perinephric adipose. tissue. Grossly, the collecting system is unremarkable. The urothelium of the renal pelvis and ureter is thin and smooth. The. rest of the renal parenchyma is unremarkable. The subcortical surface of the kidney is smooth. No lymph nodes are identified at. the hilar region of the kidney. Tumor is submitted for TPS and EM. Photographs are taken. Representative sections are. submitted. Summary of Sections: USM - urethral surgical margin. VSM - vascular surgical margin. AT - adrenal tumor. RTC - renal tumor in relation to capsule. RTK - renal tumor in relation to kidney. RT - renal tumor. THR - renal tumor at the hilar region. TBV - tumor within the lumen of the blood vessel. UK - unremarkable kidney. Summary of Sections: Part 1: SP: Lt. kidney & adrenal gland. Block. Sect. Site. PCs. 8. 8. 3. RT. 3. 3. RTC. 3. 1. RTK. 1. 1. TBV. 1. THR. 1. UK. 1. USM. 1. VSM. 3.",T3,N0,M1,T3N0M1
TCGA-BH-A18G,"PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Right breast cancer. LMP DATE: PROCEDURE: Right needle localized segmental mastectomy and right axilla sentinel node biopsy. SPECIFIC CLINICAL QUESTION: Not provided. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY: No. CHEMORADIATION THERAPY: No. OTHER DISEASES: No. FINAL DIAGNOSIS: PART 1: RIGHT AXILLARY SENTINEL LYMPH NODE #1, BIOPSY -. ONE (1) LYMPH NODE, NEGATIVE FOR NEOPLASM (0/1). PART 2: RIGHT BREAST AT 8 O'CLOCK, NEEDLE LOCALIZED SEGMENTAL MASTECTOMY -. A. INVASIVE DUCIAL CARCINOMA, NOTTINGHAM GRADE 3 (NUCLEAR GRADE 3, TUBULE SCORE 3, MITOTIC. ACTIVITY SCORE 2; TOTAL SCORE: 8/9). B. TUMOR MEASURES 2.7 CM (GROSS MEASUREMENT). C. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. D. MARGINS ARE NEGATIVE FOR NEOPLASM; TUMOR APPROACHES MOST CLOSELY TO THE SUPERIOR. MARGIN (0/9) CM. E. ATYPICAL DUCTAL HYPERPLASIA, AND RADIAL SCAR. F. SCLEROSING ADENOSIS AND FIBROCYSTIC CHANGES. G. FIBROSIS, SUGGESTIVE OF PREVIOUS BIOPSY. H. SKIN, NEGATIVE FOR TUMOR. TUMOR PREVIOUSLY REPORTED TO BE POSITIVE FOR ER AND PR AND NEGATIVE FOR HER-2/neu. J. PATHOLGIC STAGE: PT2 pNO pMX. PART 3: RIGHT BREAST, EXCISION (102 GRAMS) -. A. FAT NECROSIS AND FIBROSIS. B. FIBROCYSTIC CHANGES AND COLUMNAR CELL CHANGE. C. SKIN WITH NO SIGNIFICANT PATHOLOGIC DIAGNOSIS. PART 4: LEFT BREAST TISSUE, EXCISION (254 GRAMS) -. A. SCLEROSING ADENOSIS, COLUMNAR CELL CHANGE, AND FIBROCYSTIC CHANGES. 8. SKIN WITH NO SIGNIFICANT PATHOLOGIC DIAGNOSIS. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Lower outer quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 27 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 2. Total Nottingham score: 8. Nottingham grade (1, 2. 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 9 mm. LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 1. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. T STAGE, PATHOLOGIC: pT2. N STAGE MODIFIER: (sn). N STAGE, PATHOLOGIC: pNO. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 1+.",T1,N0,M0,T1N0M0
TCGA-ZH-A8Y5,"Diagnosis: A: Pericaval mass, biopsy. Metastatic adenocarcinoma present in one of five lymph nodes (1/5). (see comment). - Largest focus measures 1.5 cm in diameter. - Extracapsular extension present. B: Gallbladder, cholecystectomy. - Cholesterolosis. - No carcinoma identified. C: Liver, segments 6, 7, and 8, plus cava and left adrenal gland, en. bloc resection. Tumor histologic type: Poorly differentiated adenocarcinoma, favor. cholangiocarcinoma, mass forming subtype (see comment). Histologic grade: 3 of 4 (poorly differentiated). Tumor location: Segments 8 and 1. Tumor size: 5.8 cm. Focality/extent: Multifocal. Tumor necrosis/treatment effect: Not identified. Vascular invasion: No definite lymphovascular space invasion. identified; adenocarcinoma invades wall of inferior vena cava. Perineural invasion: Not identified. Capsular invasion: Present, adenocarcinoma invades perihepatic soft. tissues and adrenal gland (designated as left adrenal gland on. specimen container). Margins: Inferior vena cava margins: Negative. Hepatic parenchymal margin: Negative, 0.85 cm away at closest. approach. Perihepatic soft tissue margins: Negative. Lymph nodes: See specimen A. Background liver: No steatosis, cholestasis, or ductular reaction. identified. AJCC PATHOLOGIC TNM STAGE: pT3 pN1. NOTE: This pathologic stage assessment is based on information. available at the time of this report and is subject to change. pending clinical review and additional information. Comment: The frozen section diagnosis for specimen A is confirmed. H & E stained sections show a poorly differentiated neoplasm with. vast areas of solid growth and focal glandular differentiation. Immunostains are performed on block C8. The malignant cells are. positive for AE1/AE3 and OSCAR (pancytokeratin stains). CK7 shows. focal positive staining within the malignant cells. CK20, TTF-1,. CDX-2, CD56, chromogranin, and synaptophysin are negative. A mucicarmine stain is negative. Given the tumor location and. absence of known disease outside of the liver, these findings most. likely represent a poorly differentiated intrahepatic. cholangiocarcinoma. Other primary adenocarcinomas with CK7 staining. include lung, esophagus, stomach, pancreas, small bowel, and. gallbladder. Correlation with the clinical and radiologic findings. is suggested. Intraoperative Consult Diagnosis: An intraoperative consultation is requested by Dr. in OR. at. on. FSA1: Pericaval mass, biopsy. - Carcinoma present; defer to permanent/special stains for final. diagnosis. Drs. at. on. Frozen Section Pathologist: , MD. Clinical History: -year-old - male with a mass abutting the right hepatic vein and. narrowing the IVC by MRI. Gross Description: Specimen A is received fresh for frozen section and labeled. ""pericaval mass"" and is a cylindrical piece of tan firm tissue 3.5. in length X 0.5 cm in diameter with a loosely adherent tan nodular. mass (1.5 X 1.5 X 0.8 cm) The mass is bisected to reveal a tan. gritty cut surface and a representative section is submitted as FSA1. and the remainder is submitted in A2. The tubular fragment is. serially sectioned to reveal a lymph node which is submitted in A3,. Specimen B is labeled ""gallbladder"" and holds a 9.5 X 4.0 X 2.5 cm. intact gallbladder. The serosa is dark red and glistening. The lumen. is filled with dark red liquid. There are multiple tan granular. tissue fragments, loosely adherent to the mucosa which is tan red. and velvety. The wall is 0.2 cm thick. Block Summary: B1 - Cystic duct margin and representative sections of gallbladder. wall to include loosely adherent yellow granules. Tissue remains in formalin. Specimen C is labeled ""segments 6, 7 and 8, cava, left adrenal. gland"" and holds an en bloc resection weight 255 grams with an. overall measurement of 15.4 X 8.4 X 5.6 cm. Attached to the deep. edge of the resection is a 4 cm in length X 1.1 cm in diameter large. caliber vessel which has a pink, smooth, luminal surface. On one side of the vessel, there is a large segment of liver,. roughly 13 X 8.4 X 3.5 cm. The surgical margin of this segment is. inked black. On the opposite side of the large caliber vessel there. is a 4.5 X 2.9 X 2.8 cm segment of liver. The surgical margin of. this segment is inked blue. Adherent to the distal aspect of the. large caliber vessel is a 6.5 X 3.1 X 0.6 cm fragment of yellow. fibrofatty tissue. Within the tissue, there is a portion of adrenal. gland, 2.5 X 2.5 X 1.0 cm. The presumed adrenal gland surgical. margin is inked red. The capsule is dark maroon and intact. Sectioning reveals an approximately 5.8 X 4.0 X 3.8 cm tan firm mass. with .11-defined edges. The mass grossly appears to invade into the. attached adrenal tissue, and abuts but does not grossly appear to. invade into the large caliber vessel. Within the smaller segment of. liver there are two satellite similar appearing lesions, roughly 1. cm from the main mass. The mass comes to within 1.0 cm of the black. inked surgical margin, is 0.6 cm from the blue inked surgical margin. (satellite nodule) and is greater than 1 cm from the proximal and. distal large caliber vessel surgical margin. No additional. abnormalities are noted. The remainder of the parenchyma is dark. brown and unremarkable. Block Summary: : C1 - Proximal large caliber vessel margin, en face. C2 - Distal large caliber vessel margin, en face. C3-C4 - Mass with respect to larger caliber vessel and adrenal. gland, bisected section. C5 - Additional section of mass, large caliber vessel and adrenal. gland. C6 - Mass with respect to black inked surgical margin. C7 - Mass with respect to intraparenchymal ductal structures. C8 - Satellite lesions with respect to blue inked surgical margin,. perpendicular. C9 - Liver away from mass, larger segment. C10 - Liver away from mass, smaller segment to include capsule. Tissue remains in formalin. Normal and tumor submitted to tissue.",T3,N1,M1,T3N1M1
TCGA-B0-5110,"FINAL DIAGNOSIS. RIGHT KIDNEY, LOWER POLE, PARTIAL NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE. B. FUHRMAN NUCLEAR GRADE IS 2 of 4. C. MAXIMAL TUMOR DIAMETER IS 3.0 CM. D. CARCINOMA IS CONFINED TO THE KIDNEY, WITHOUT EXTRACAPSULAR EXTENSION. E. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. F. ALL ASSESSABLE SURGICAL RESECTION MARGINS ARE FREE OF THE NEOPLASM (See Comment). G. NON-NEOPLASTIC KIDNEY (WHICH IS ADJACENT TO THE TUMOR) SHOWS MODERATE ARTERIAL/. ARTERIOLAR SCLEROSIS AND MODERATE GLOBAL GLOMERULOSCLEROSIS, WITH WELL-PRESERVED. TUBULES AND INTERSTITIUM. H. TNM PATHOLOGIC STAGE: pT1a NX MX (See Synoptic).",T1,N0,M0,T1N0M0
TCGA-BR-7704,"Gross. Microsc. Diagnos. Comme. Case ID. Descript. opic. is. nts. ion. Descript. Details. ion. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Fundus. Tumor size: 6 X 4 X 1.5 cm. Tumor features: Exophytic (polypoid). Histologic type: Adenocarcinoma,. intestinal type. Histologic grade: Poorly differentiated. Tumor extent: Serosa (visceral. peritoneum). Lymph nodes: 0/3 positive for metastasis. (Regional 0/3). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not. specified. Comments: None. Lateralit. y. Fundus.",T3,N0,M0,T3N0M0
TCGA-BH-A0BQ,"FINAL DIAGNOSIS: PART 1: NO LYMPH EVIDENCE NODE, OF RETROMAMMARY, METASTATIC MAMMARY EXCISION CARCINOMA - IN ONE LYMPH NODE (0/1). PART 2: LEFI BREAST, TOTAL MASTECTOMY -. A. B. INVASIVE NOTTINGHAM DUCTAL GRADE CARCINOMA. Il (TUBULE FORMATION 3, NUCLEAR PLEOMORPHISM 2, MITOTIC ACTIVITY 1;. TOTAL SCORE 6/9). C. D. INVASIVE DUCTAL NECROSIS; CARCINOMA TUMOR DCIS CONSTITUTES MEASURES IN SITU (DCIS), 1.5 30% CM OF IN NUCLEAR MAXIMUM THE TOTAL GRADE DIMENSION. TUMOR 3, SOLID MASS PATTERN AND IS PRESENT WITH MODERATE ADMIXED COMEDO AND AWAY. E. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. FROM THE INVASIVE COMPONENT. CASE SYNOPSIS: SYNOPTIC-PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.5 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Solid. DCIS admixed and outside of invasive carcinoma component. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 5 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 5 mm. LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 2. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: ADH, Other: biopsy site changes. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNo. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 2+. Comment: Refer to prior left breast core biopsy specimen,. ), which. documented infiltrating duct carcinoma, nuclear grade 2.",T1,N0,M0,T1N0M0
TCGA-77-8007,"RIGHT UPPER LOBECTOMY. Clinical Details: Right upper lobectomy for carcinoma of lung. Patient has been exposed to asbestos. Four specimens submitted: 1: RIGHT UPPER LOBE. Macroscopy: The specimen consists of a lobectomy specimen measuring 170 x 70 mm with a depth of up to 80 mm. Some puckering is present over the lateral pleural surface. The tumour measures 75 x 55 x 75 mm and. abuts, does not clearly penetrate, the pleural surface. The tumour appears at least 20 mm clear of the. hilar resection margin. There is no obvious endophytic bronchial component to the tumour, although it. clearly is associated with bronchial structures. A separate small pleural nodule is identified, 45 mm. from the nearest tumour. [Bronchial resection margin, 1A; vascular resection margin, 1B; hilar lymph. nodes, 1C-1G; block 1E includes inked resection margin; pleural surface with tumour, 1H-1I; tumour. towards hilar aspect, 1J-1L; separate pleural nodule, 1M; macroscopically unremarkable lung, 1N]. Microscopy: Sections show a poorly differentiated squamous cell carcinoma with extensive central necrosis and. cavitation. A definite bronchial origin is not identified. There is no evidence of pleural invasion, and. the separate pleural nodule is shown to represent a silicotic nodule within a pleural lymph node. No. lymphatic invasion is seen, however metastatic carcinoma is present in one of the peribronchial lymph. nodes. Vascular invasion is identified. The bronchial resection margin is clear of malignancy but. shows a benign mucous gland adenoma. Lung parenchyma adjacent to the tumour shows organising. pneumonia while distant lung parenchyma shows emphysema. 2: HILAR LYMPH NODE. Macroscopy: The specimen consists of a piece of dark brown tissue, 4 x 4 x 3 mm. [BIT, 2A]. Microscopy: Sections show fragments of lymph nodes containing large numbers of pigmented macrophages but. showing no evidence of metastatic carcinoma. 3: PARTIAL BRONCHUS RIGHT SIDE. Macroscopy: The specimen consists of a portion of bronchial wall measuring 25 x 15 x 5 mm. No obvious mucosal. abnormality is identified. [Serially sectioned and all pieces blocked, 3A]. Microscopy: Sections show full thickness bronchial wall in which there is no evidence of the mucous gland. adenoma seen in the resection margin of specimen 1. However there is squamous metaplasia with. severe dysplasia which falls short of carcinoma in situ. There is no evidence of invasive malignancy. Conclusion: Partial bronchus right side: squamous metaplasia with severe dysplasia. 4: MEDIASTINAL LYMPH NODE. Macroscopy: The specimen consists of a lymph node measuring 8 x 6 x 3 mm with attached fatty tissue. [All tissue. blocked, 4A]. Microscopy: Sections show a lymph node containing numerous pigmented macrophages but showing no evidence of. metastatic carcinoma. Conclusion (Specimens 1,2 and 4): Right upper lobectomy and lymph node sampling: Poorly differentiated squamous cell carcinoma, 75 mm in diameter. Vascular invasion is present. Metastatic carcinoma in peribronchial lymph node. No pleural invasion. Mucous gland adenoma at bronchial resection margin. Pathological stage T2 N1. T-28000 M-80703 P1-03000. T-26000 M-74000 P1-03000. T-26000 M-81400 P1-03000. Pathology Registrar/Anatomical Pathologist.",T2,N1,M0,T2N1M0
TCGA-BQ-5891,"Ref Source. & History: with right renal mass and caval thrombus. Specimens Submitted: 1: SP- Right kidney, renal vein thrombus, vena caval thrombus; radical nephrectomy. 2- SP: Portion of right gonadal vein; biopsy. 3: SP. Para caval and pre caval lymph nodes; excision. 4: SP. Right renal lymph nodes; excision. DIAGNOSIS: 1. SP: Right kidney, renal vein thrombus, vena caval thrombus; radical nephrectomy: Tumor Type: Renal cell carcinoma - Unclassified type. with high nuclear grade; see note. Tumor Size: Greatest diameter is 12.2 cm. Local Invasion (for renal cortical types): Involves renal sinus fat. Involves renal hilar fat. Renal Vein Invasion: Identified. Tumor is also seen in muscular veins in the region of the renal sinus/hilum. Surgical Margins: Tumor present al renal vein margin. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT3b Tumor grossly extends into the renal vein(s) or vena cava below the diaphragm. Note: The tumor displays predominant papillary and focally solid archilecture and is composed of cells with abundant eosinophilic. cyloplasm and high nuclear grade. Immunohistochemical stains are strongly positive for racemase and CD10 (the latter in a. 'luminal"" pattern). show patchy positivity for CA-IX, and are negative for CK7, 34BE12, TFE-3, TFE-B and CEA. The combination. of these findings raises a differential diagnosis which includes Tune 2 panillary tenal-cell carcinoma and a tumor of distal nephron. origin. This case has been reviewed with. vhich concurs with the diagnosis. 2. SP: Portion of right gonadal vein; biopsy: Benign segment of vascular tissue. 3. SP: Para caval and pre caval lymph nodes; excision: Lymph Nodes: Not involved. Number of nodes examined: 11. 4. SP: Right renal lymph nodes; excision: Lymph Nodes: ganglioneuroma 1.1cm) and adjacent benign adrenal tissue are seen: no lymph nodes identified. Some of the immunohistochemistry and ISH tests were developed and their performance characteristics were determined by the Department of. Pathology. They have not been cleared or approved by the US Food and Drug Administration The FDA has determined that such clearance. or. approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research. This. laboratory is certified under the Clinical Laboratory Improvement Amendments. qualilied to perform high complexity clinical. laboratory lesting. JATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (ANDIOR OTHER MATERIAL), AND THAT HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. CA-1X. CD10. RACEMASE. CK7. CEA P. 348E12. IMM RECUT. NEG CONT. IGH. Gross Description: 1) The specimen is received fresh labeled ""right kidney, renal vein thrombus, vena caval thrombus"" and consists of a kidney with. attached ureter, renal vessels and perinephric fat weighing 526 g in total. The kidney measures 12 2 x 8.6 x 6.8 cm. The attached. ureter measures 4.5 cm in length and 0.3 cm in diameter. The attached renal vein measures 6.6 cm in length and 1.8 cm in. diameter, and is completely filled with tan, friable fleshy tumor mass. The ureter margin is grossly unremarkable. The kidney is. inked black and bivalved to reveal a 12,2 x92x7.4 cm irregular lobulated, friable tan tumor mass, completely replacing upper pole. and mid kidney. The tumor grossly invades into the renal sinus and renal vein. Sections through the remainder of the kidney reveal. a pink brown parenchyma, with a well-defined cortico-medullanriunction. The cortex measures 0.6 cm. The specimen is. photographed. Representative sections are submitted for. id for permanent sections. Summary of sections: RAM - renal artery margin. RVM renal vein margin. UM ureteral margin. T.. tumor. RV :- renal vein. f. THF tumor with hilum. TPF -- tumor to perirenal fat. K -- representative section, unaffected kidney. 2) The specimen is received in formalin, labeled ""portion of right gonadal vein"" and consisis of a segment of vein measuring 2.1 cm. in length and 1.2 cm in average diameter. Summary of sections: M--margin. U--representative section of remainder. 3) The specimen is received in formalin, labeled ""paracaval and precaval lymph nodes"" and consists of mullipte pink tan firm lymph. nodes ranging from 0.4 to 1.8 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN lymph nodes. BLN- bisected lymph nodes. 4) The specimen is received in formainn, labeled right renal lymph nodes' and consists of a portion of adrenal gland (measuring. 3.2 x 2.0 x 0.3 cm) with attached fat measuring 62 x 4.7 x 0.8 cm in overall dimension. Possible lymph nodes are also identified. The specimen is representatively submitted. Summary of sections: LN lymph nodes. TLN -trisected lymph nodes. ADR-adrenal gland. F--fat. Summary of Sections: Part 1: SP: Right kidney, renal vein thrombus, vena caval thrombus; radical nephrectomy. Block. Sect. Site. PCs. 1. K. 1. 1. RAM. 1. 2. RV. 2. 1. RVM. 1. 8. 8. 3. THF. 3. 2. TPF. 2. 1. UM. 1. Part 2: SP: Portion of right gonadal vein; blopsy. Block. Sect. Site. PCs. 1. m. 1. 1. u. Part 3: SP: Para caval and pre caval lymph nodes; excision. Block. Sect. Site. PCs. 3. bIn. 3. 3. In. 3. Part 4: SP: Right renal lymph nodes; excision. Block. Sect. Site. PCs. adr. 1. f. 1. 1. In. 1. tIn. 1.",T3,N0,M0,T3N0M0
TCGA-CR-7369,"DIAGNOSIS: 1) MARGIN #1, SKIN, BIOPSY: BENIGN SKIN, NEGATIVE FOR MALIGNANCY. 2) MARGIN #2, SKIN, BIOPSY: BENIGN SKIN, NEGATIVE FOR MALIGNANCY. 3) MARGIN #3, SKIN, BIOPSY: BENIGN SKIN, NEGATIVE FOR MALIGNANCY. 4) MARGIN #4, SKIN, BIOPSY: BENIGN SKIN, NEGATIVE FOR MALIGNANCY. 5) MARGIN, LEFT MANDIBLE, BIOPSY: FRAGMENTS OF FIBROUS TISSUE AND BONE,. NEGATIVE FOR MALIGNANCY. 6) MARGIN, RIGHT MANDIBLE, BIOPSY: FRAGMENTS OF FIBROUS TISSUE AND BONE,. NEGATIVE FOR MALIGNANCY. 7) MARGIN, RIGHT TONSIL, BIOPSY: FOCAL MODERATE DYSPLASIA, NEGATIVE FOR. INVASIVE CARCINOMA. 8) MARGIN, LEFT FLOOR OF MOUTH, BIOPSY: BENIGN SQUAMOUS MUCOSA, NEGATIVE. FOR MALIGNANCY. 9) MARGIN, RIGHT FLOOR OF MOUTH, BIOPSY: BENIGN SQUAMOUS MUCOSA, NEGATIVE. FOR MALIGNANCY. 10) MARGIN #2, TONSIL, BIOPSY: MODERATE DYSPLASIA, NEGATIVE FOR INVASIVE. CARCINOMA (SEE COMMENT #1). 11) MANDIBLE, RIGHT, RESECTION: MODERATELY-DIFFERENTIATED KERATINIZING. SQUAMOUS CELL CARCINOMA, 4.7 CM IN GREATEST EXTENT, WITH EXTENSIVE. MANDIBULAR INVASION, PRESENT 0.3 CM FROM THE SUPERIOR SURGICAL MARGIN, 0.8. CM FROM ANTERIOR SURGICAL MARGIN AND 0.7 CM FROM INFERIOR AND POSTERIOR. SURGICAL MARGINS; PERINEURAL INVASION PRESENT; NEGATIVE FOR LYMPHOVASCULAR. INVASION; 3 OF 5 LYMPH NODES POSITIVE FOR MALIGNANCY, 1 BY DIRECT. EXTENSION, (SEE COMMENT). 12) LYMPH NODES, RIGHT NECK LEVELS 2,3, EXCISION: 18 LYMPH NODES, NEGATIVE. FOR MALIGNANCY. 13) SKIN, RIGHT UPPER LIP, EXCISION: LICHENOID REACTION WITH MUCOSAL. ULCERATION, NEGATIVE FOR MALIGNANCY. COMMENT #1: Dysplasia is best seen in the original frozen section. COMMENT #2: These findings correspond to AJCC pathologic Stage IV A. (pT4a,pN2b,pMna). CLINICAL DATA. Clinical Features: Unspecified. Operator: Dr. Operation: Unspecified. Operative Findings: Unspecified. Operative Diagnosis: Unspecified. Tissue Submitted: 1) skin margin #1; 2) skin margin #2; 3). skin margin #3; 4) skin margin #4; 5). left mandible margin; 6) right mandible. margin; 7) right tonsil margin; 8) left. floor of mouth margin; 9) right floor of. mouth margin; 10) tonsil margin #2; 11). right mandible gingival cancer; 12)right. neck levels 2,3; 13) right upper lip. lesion (stitch is superior). GROSS DESCRIPTION: 1) SOURCE: Skin Margin #1. Received fresh is one fragment of skin measuring 5.1 X 0.3 X 0.3 cm. The. specimen is inked blue and entirely submitted for frozen section. evaluation. Summary of sections: 1AFSC, skin margin #1, 1/1. 2) SOURCE: Skin Margin #2. Received fresh is one fragment of skin measuring 5.8 X 0.5 X 0.3 cm. The. specimen is entirely submitted for frozen section evaluation. Summary of sections: 2AFSC, skin margin #2, 1/1. 3) SOURCE: Skin Margin #3. Received fresh is a fragment of skin measuring 7.3 cm in length X 0.3 X 0.3. cm in cross section. The specimen is inked blue and entirely submitted for. frozen section evaluation. Summary of sections: 3AFSC, skin margin #3, 1/1. 4) SOURCE: Skin Margin #4. Received fresh is one fragment of skin measuring 10.4 cm in length X 0.4 X. 0.2 cm. The specimen is entirely submitted for frozen section evaluation. Summary of sections: 4AFSC, skin margin #4, 1/1. 5) SOURCE: Left Mandible Margin. Received fresh is a fragment of soft tissue measuring 0.5 X 0.3 X 0.3 cm. The specimen is entirely submitted for frozen section evaluation. Summary of sections: 5AFSC, left mandible margin, 1/1. 6) SOURCE: Right Mandible Margin. Received fresh is one fragment of soft tissue measuring 0.8 X 0.3 X 0.3 cm. The specimen is entirely submitted for frozen section evaluation. Summary of sections: 6AFSC, right mandible margin, 1/1. 7) SOURCE: Right Tonsil Margin. Received fresh are two fragments of soft tissue measuring 1.6 X 0.6 X 0.4. cm in aggregate. The specimen is entirely submitted for frozen section. evaluation. Summary of sections: 7AFSC, right tonsil margin, 2/1. 8) SOURCE: Left Floor of Mouth Margin. Received fresh is one fragment of soft tissue measuring 1.3 X 0.7 X 0.4 cm. The specimen is entirely submitted for frozen section evaluation. Summary of sections: 8AFSC, left floor of mouth margin, 1/1. 9) SOURCE: Right Floor of Mouth Margin. Received fresh is a fragment of soft tissue measuring 1.7 X 1.0 x 0.4 cm. The specimen is entirely submitted for frozen section evaluation. Summary of sections: 9AFSC, right floor of mouth margin, 1/1. 10) SOURCE: Tonsil Margin #2. Received fresh is a fragment of soft tissue measuring 3.4 X 0.3 X 0.3 cm. The specimen is entirely submitted for frozen section evaluation. Summary of sections: 10AFSC, 1/1. 11) SOURCE: Right Mandibular Gingival Cancer. Received fresh is a skin specimen with underlying bone and soft tissue. The. overall specimen measures 8.3 cm from superior to inferior, 8.0 cm from. anterior to posterior, and 4.0 cm from superficial to deep. Present on the. surface of the specimen is an ovoid skin excision measuring 7.7 X 7.5 cm in. horizontal dimension. At the center of this skin excision is a raised,. variegated purple-black lesion measuring 4.7 X 4.0 X 0.6 cm. Numerous hair. follicles are present protruding from this lesion. The specimen is inked in. the following manner: superior-orange, inferior-yellow, deep-blue,. anterior-black, posterior-green The anterior and superior bony margins are. trimmed and submitted. The specimen is serially sectioned to reveal. invasion of the skin lesion into the subcutaneous tissue and focally into. the underlying mandible. The lesion extends focally to the posterior/deep. margin and focally to the superior margin. It extends to within 1.4 cm of. the inferior margin. Sections through the anterior portion of the specimen. reveals extension of the lesion to within 1.9 cm of the anterior margin. Representative sections are submitted. Bony fragments are decalcified prior. to submission. Summary of sections: 11A, anterior/inferior bony margin, 1/1; 11B, superior. margin, 1/1; 11C-11E, lesion invading bone, 1/1; 11F, lesion and posterior. margin, 1/1; 11G, deep margin, 2/1; 11H, 11I, lesion and gingiva, bisected,. 1/1 each; 11J, lesion and superior margin, 2/1; 11K, lesion and inferior. margin, 1/1; 11L, lesion and anterior margin, 1/1; 11M, 11N, additional. sections of lesion, 1/1 each. 12) SOURCE: Right Neck Levels 2, 3. Received fresh is one fragment of fibrous and fatty tissue measuring 7.1 X. 3.3 X 1.7 cm. Candidate lymph nodes are identified and submitted. Summary of sections: 12A, four candidate lymph nodes, 4/1; 12B, candidate. lymph nodes, 6/1; 12C, 12D, two candidate lymph nodes, bisected, 2/1 each. 13) SOURCE: Right Upper Lip Lesion (stitch is superior). Received fresh is an ellipse of skin measuring 1.89 X 1.4 cm in horizontal. dimension and excised to a depth of 0.3 cm. The skin surface contains. numerous hairs, as well as a light brown area measuring 0.5 X 0.3 cm. A. suture is present designating the superior margin. This will be designated. as 12 o'clock. The specimen is inked in the following manner: 11 o'clock to. 5. o'clock-black, 5 o'clock to 11 o'clock-blue, deep-black. The specimen is. sequentially sectioned from 12 o'clock to 6 o'clock and is entirely. submitted. Summary of sections: 13A, tips, 2/1; 13B, sequential sections, 4/1. SURGICAL PATHOLOGY INTRAOPERATIVE CONSULTATION. 1) SOURCE: Skin Margin #1. FROZEN SECTION DIAGNOSIS: NEGATIVE FOR LESION. 2) SOURCE: Skin Margin #2. FROZEN SECTION DIAGNOSIS: NEGATIVE FOR LESION. 3) SOURCE: Skin Margin #3. FROZEN SECTION DIAGNOSIS: NEGATIVE FOR LESION. 4) SOURCE: Skin Margin #4. FROZEN SECTION DIAGNOSIS: NEGATIVE FOR LESION. 5) SOURCE: Left Mandible Margin. FROZEN SECTION DIAGNOSIS: NEGATIVE FOR CARCINOMA. 6) SOURCE: Right Mandible Margin. FROZEN SECTION DIAGNOSIS: NEGATIVE FOR CARCINOMA. 7) SOURCE: Right Tonsil Margin. FROZEN SECTION DIAGNOSIS: MODERATE DYSPLASIA. 8) SOURCE: Left Floor of Mouth Margin. FROZEN SECTION DIAGNOSIS: NEGATIVE FOR CARCINOMA. 9) SOURCE: Right Floor of Mouth Margin. FROZEN SECTION DIAGNOSIS: NEGATIVE FOR CARCINOMA. 10) SOURCE: Tonsil Margin #2. FROZEN SECTION DIAGNOSIS: MODERATE DYSPLASIA, NEGATIVE FOR INVASIVE. CARCINOMA. The following special studies were performed on this case and the. interpretation is incorporated in the diagnostic report above: xDECALCIFICATION. In some tests, analyte specific reagents (ASRs) are used. In the case of an. ASR, this test was developed and its performance characteristics determined. by this laboratory. It has not been cleared or approved by the US Food and. Drug Administration. The FDA has determined that such clearance or approval. is not necessary. This test is used for clinical purposes. It should not be. regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of. (CLIA. as. qualified to perform high complexity clinical laboratory testing.",T4,N2,M0,T4N2M0
TCGA-EW-A1PD,"M. Pathologic Interpretation: A. SENTINEL NODE #1 COUNT. - METASTATIC CARCINOMA TO ONE LYMPH NODE (1/1). B. SENTINEL NODE #2 COUNT. - METASTATIC CARCINOMA TO ONE LYMPH NODE (1/1). C. RIGHT TOTAL MASTECTOMY: - INFILTRATING DUCTAL CARCINOMA, NOTTINGHAM GRADE 2 (3+2+2=7), 1.6 CM IN GREATEST. DIMENSION. - RESECTION MARGINS ARE FREE OF TUMOR, CLOSEST MARGIN AT 2.0 CM (DEEP). - PREDICTIVE MARKERS PERFORMED ON PREVIOUS BIOPSY: ER AND PR POSITIVE BY. IMMUNOHISTOCHEMISTRY AND HER2 AMPLIFIED BY FISH. - NO MALIGNANCY SEEN IN FIVE LYMPH NODES (0/5). - PLEASE SEE TUMOR SUMMARY. AJCC: pT1c, pN1a, pMn/a. Tumor Summary: Specimen: - Total breast (including nipple and skin). Procedure: - Total mastectomy (including nipple and skin). Lymph Node Sampling: Sentinel lymph node(s). - Axillary dissection (partial or complete dissection). Specimen Integrity: - Single intact specimen (margins can be evaluated). Specimen Laterality: - Right. Tumor Site: Invasive Carcinoma. - Central. Tumor Size: Size of Largest Invasive Carcinoma. - Greatest dimension of largest focus of invasion over 0.1 cm: 1.6 cm. Tumor Focality: - Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of tumor: - Skin: Invasive carcinoma does not invade into the dermis or epidermis. - Nipple: DCIS does not involve the nipple epidermis. Skeletal muscle: No skeletal muscle present. Ductal Carcinoma In (DCIS): DCIS is present. Size (Extent) of DCIS: Estimated size (extent) of DCIS (greatest dimension using gross and microscopic evaluation) is at least: 0.5 cm. Number of blocks with DCIS: 5. Number of blocks examined: 10. - Architectural Patterns: Cribriform, Solid. - Nuclear Grade: Grade III (high). - Necrosis: Present, focal (small foci or single cell necrosis). Lobular Carcinoma In Situ: Not identified. Histologic Type: - Invasive ductal carcinoma (no special type or not otherwise specified). SURGICAL PATHOL Report. Histologic Grade: Nottingham Histologic Score. Glandular (Acinar)/Tubular Differentiation: Score 3. Nuclear Pleomorphism: Score 2: Mitotic Count: Score 2. Overall Grade: Grade 2: scores of 6 or 7. Margins: - Margins uninvolved by invasive carcinoma. -Distance from closest margin: 20 mm (deep). Lymph-Vascular Invasion: Not identified. Lymph Nodes: Number of sentinel lymph nodes examined: 2. Total number of lymph nodes examined (sentinel and nonsentinel): 7. Number of lymph nodes with macrometastases (>0.2 cm): 2. Number of lymph nodes with macrometastases (>0.2 mm to 0.2 cm and/or >200 cells): 0. Size of largest metastatic deposit (if present): 1.5 cm. Extranodal Extension: Indeterminate. Method of Evaluation of Sentinel Lymph Nodes: - H&E, multiple levels. Pathologic Staging: Primary Tumor: pT1c: Tumor >10 mm but <20 mm in greatest dimension. Regional Lymph Nodes: pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mm. Distant Metastasis: Not applicable. Microcalcifications: PRESENT in DCIS. Anciliary Studies: Estrogen Receptor: - Performed on another specimen I. ); Results: Immunoreactive tumor cells present (1 %). Progesterone Receptor: - Performed on another specimen 1. ; Results: Immunoreactive tumor cells present (1 %). Her2: - Performed on another specimen. i Results: Equivocal (Score 2+). HER2 by FISH: - Performed on another specimen (. Results: AMPLIFIED (HER2 gene copy >6.0 or ratio >2.2). NOTE: IDS-ER, Some PgR immunohistochemical 636=PR, A485=HER2, II-II-EGFR. All immunohistochemical stains are used with formalin or molecular fired. paruffin embedded lissue. Detection Is by Emision Method. The are. antibodies any analyte specific reagents (ASRs) validated by our laboratory. These ASfs are clinically useful indicators that do not require FDA approval. These results clones read are used: by a. pathologist as positive or negative. As the attending pathologist, I attest that I: (i) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). MD. Intraoperative Consultation. A. Sentinel node #1 count. FS: Metastatic carcinoma seen on touch prep. B. Sentinel node #2 count. FS: Metastatic carcinoma seen on touch prep. : MD. MD. Clinical History: None provided. Operation Performed. SURGICAL PATHOL Report. Right total mastectomy with axillary node dissection and sentinel node biopsy. Pre Operative Diagnosis: Breast ductal carcinoma. Specimen(s) Received: A: Sentinel node #1 count. FS. B: Sentinel node #2 count. , FS. C: Right total mastectomy. Gross Description: A. Received fresh is a segment of tan-brown fibroadipose tissue, 1.8 x 1.5 x 0.7 cm. The specimen is bisected and. submitted in toto in two blocks. B. Received in formalin is a segment of tan-gray soft tissue, 1 x 0.9 x 0.6 cm. The specimen is bisected and submitted in. toto in one block. C. Received in formalin is a 447-gram, 18 x 17.5 x 2 cm right mastectomy specimen. There is an ellipse of pale skin, 14.2 x. 6.1 cm. The nipple/areola complex measures 2.5 x 2 cm. The nipple is retracted. The attached axillary tail measures. 11.5 x 6.5 cm. The specimen is oriented with short stitch superior, two long stitches lateral. The resection margins are. inked black. On serial sectioning, there is a tan-white, indurated, ill-defined lesion with infiltrating borders in the. retroareolar space. It occupies the central compartment and measures 3 x 1.5 x 1.5 cm. It is located 2 cm from the. deep. margin, 7.5 cm from the inferior margin, 5 cm from the superior margin, 7 cm from the medial margin, and 9 cm from the. lateral margin. No additional lesions are identified. Examination of the axillary tail reveais. multiple possible. lymph nodes. Sections are submitted as follows: 1. Nipple. 2. Deep margin (closest). 3-9. Lesion submitted in toto. 10-12. One lymph node per block. 13&14. Three lymph nodes per block.",T1,N1,M0,T1N1M0
TCGA-EA-A410,"Path Report:CERVIX TISSUE CHECKLIST. Specimen type: Hysterectomy, bilateral salpingo-oophorectomy. Tumor site: Cervix. Tumor size: 8x5x4cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Stromal invasion from 3.0 mm to 5.0 mm. Lymph nodes: 0/14 positive for metastasis (Regional 0/14). Lymphatic invasion: Absent. Venous invasion: Absent. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T2,N0,M0,T2N0M0
TCGA-DJ-A2Q4,"Accoss. Clinical Diagnosis & History: - FNA (+) for papillary carcinoma, right thyroid nodule measuring 1.5 cm. Specimens Submitted: 1: Right paratracheal node (fs). 2: Right superior mediastinal lymph node (fs). 3: Midline neck tissue. 4: Right paratracheal tissue. 5: Delphian node. 6: Total thyroid. DIAGNOSIS: 1. Right paratracheal node (fs): Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 1. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 0.8cm. Size of the largest metastatic focus : 0.050 cm. Extranodal extension is not identified. 2. Right superior mediastinal lymph node (fs): Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 2. 3. Midline neck tissue, blopsy: - Benign fibroadipose tissue. 4. Right paratracheal tissue: - Benign fibroadipose tissue. 5. Delphian node: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 1. 6. Total thyrold: Tumor Type: Papillary carcinoma, classical type. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Right lobe. Tumor Size: Greatest diameter is 1.3 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Focal invasion. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Papillary microcarcinoma 1mm in the left lobe. Adenoma(s) (away from the carcinoma): Not Identified. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Exhibits chronic lymphocytic thyroiditis. Parathyrold Glands: Identified. Two unremarkable parathyroid gland, one in each lobe. Lymph Nodes: Six benign lymph ndoes (0/6). LATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. M'. Gross Description: M.D. 1. The specimen is received fresh, labeled ""right paratracheal node"", and consists of a lymph node measuring 0.8 x 0.8 x 0.6 cm. The specimen is bisected and entirely frozen. Summary of sections: FSC - frozen section control. A.D. 2. The specimen is received fresh, labeled ""left obturator lymph node"", and consists of two lymph nodes measuring 1 x 0.6 x 0.5. cm and 1.2 x 0.5 x 0.4 cm. The lymph nodes are bisected and entirely frozen. Summary of sections: FSC - frozen section control. 3. The specimen is received in formalin, labeled ""midline neck tissue"" and consists of a 1.5 x 1.2 x 0.5 cm fragment of fatty yellow. soft tissue. Entirely submitted. Summary of sections: U - undesignated. M.D. 4. The specimen is received in formalin, labeled ""right paratracheal tissue"" and consists of a 0.8 x 0.7 x 0.5 cm fragment of fatty. yellow soft tissue. Entirely submitted. Summary of sections: U - undesignated. 5. The specimen is received in formalin, labeled ""Delphian node"" and consists of a 0.7 x 0.7 x 0.5 cm fragment of fatty yellow soft. tissue. The specimen is bisected and entirely submitted. Summary of sections: LN - lymph node. A. 6). The specimen is received in formalin, labeled ""total thyroid, stitch marks right lobe"" and consists of a 25 g thyroid. The right. lobe measures 4.9 x 3.5 x 1.5 cm with an anteriorly attached 3.5 x 1.8 x 1.5 cm portion of muscle tissue. The left lobe measures. 4. x 4 x 1.6 cm and the isthmus measures 2.3 x 1.6 x 0.5 cm. Attached to the left lobe is a 2 x 0.8 x 0.3 cm pyramidal lobe. The. external surface is covered by a thin fibrous capsule. The specimen is previously inked posterior black and anterior blue. Sectioning reveals a 1.3 x 0.8 x 0.8 cm ovoid, tan-yellow, friable nodule with a less than 0.1 cm capsule in the right mid pole. The. remaining thyroid parenchyma is red tan and meaty. A portion of the specimen is previously sent for TPS. The remaining tissue. is serially sectioned and entirely submitted. Summary of sections: RL right lobe. LL - left lobe. PL - pyramidal lobe. IS isthmus. Summary of Sections: Part 1: Right paratracheal node (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 2: Right superior mediastinal lymph node (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: Midline neck tissue. Block. Sect. Site. PCs. 1. u. 1. Part 4: Right paratracheal tissue. Block. Sect. Site. PCs. u. 1. Part 5: Delphian node. Block. Sect. Site. PCs. 1. In. 1. Part 6: Total thyroid. Block. Sect. Site. PCs. 2. IS. 2. 12. LL. 12. 2. PL. 2. 22. RL. 22. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative. consultation. 1. Frozen section diagnosis: Right paratracheal node (fs): A minute focus of metastatic thyroid carcinoma involving lymph node. (Best seen in the initial frozen section slide, not the deeper FS slide). (. Permanent diagnosis: Same. 2. Frozen section diagnosis: Right superior mediastinal lymph node (fs): Benign. Permanent diagnosis: Same.",T1,N1,M0,T1N1M0
TCGA-IG-A51D,Gross Description: Microscopic Description: Diagnosis Details: Comments: Formatted Path Reports: ESOPHAGUS TISSUE CHECKLIST. Specimen type: Resection of esophagus. Tumor site: Cervical esophagus. Tumor size: 5.5x5x1cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Lamina propria or submucosa. Lymph nodes: 1/1 positive for metastasis (Intraabdominal 1/1). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,T1,N1,M0,T1N1M0
TCGA-DD-AADF,"CLINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo : GROSS: Specimen status: Fresh. Operation: Right anterior sectionectomy (segment 5, partial segment 8). Organ: Liver (8.5 X 8.0 X 4.0 cm, 121.7 gm). Gallbladder (10.5 cm in length, 4.0 cm in diameter). [Liver]. Lesion: A hepatic mass. Size: 4.0 x 3.0 X 3.0 cm. Cut surface: Well demarcated, mahogany and nodular. Gross type: Multinodular confluent. Extent: Confined to the hepatic parenchyma. Serosal surface: Bulging but smooth. Resection margin: Not involved, grossly (safety margin: 0.8 cm). Remaining parenchyme: Cirrhosis. [Gallbladder]. Serosal surface: Yellowish pink and smooth. Mucosal surface: Dark geen and velvety. Stone: Three, black and hard (0.8 X 0.4 X 0.2 cm in aggregates). Representative sections are submitted. Gross photo: Present. Blocks. T1-4, - mass of liver x 4. RM, tumor with resection margin X 1. L, nontumorous liver parenchyme x 1. GB, gallbladder X 1. MICROSCOPIC: Tumor type: Hepatocellular carcinoma. Edmondson-steiner grade. The worst differentiation IV. The major differentiation III. Histologic type: Trabecular, pseudoglandular and cystic formation. Fatty change: No. Fibrous capsule formation: Yes. Capsular infiltration: Yes. Septum formation: Yes. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Vascular invasion: No. Bile duct invasion: No. Remaining liver parenchyme: Cirrhosis. NOT reported. Gross: cervix,smear, senile atrophy. liver,ectomy,hepatocellular carcinoma. T56000, P10, M81703. gallbladder,ectomy,chronio cholecystitis, cholelithiasis. T57000, P10, M43005, M30011. DIAGNOSIS: Liver, segment 5 and 8, right anterior sectionectomy: Hepatocellular carcinoma. Galllbladder, cholecystectomy: Chronic cholecystitis. Cholelithiasis. Suggestion :",T1,N0,M0,T1N0M0
TCGA-XF-AAMJ,"HX SURGICAL PATHOLOGY REPORT. Date - Date of Service: Contributor System: PRE-OPERATIVE DIAGNOSIS: Bladder Cancer, H/O Prostate Cancer. MICROSCOPIC DESCRIPTION: A-C: See final microscopic-diagnosis. D: Sections of the bladder show extensive sheets of cells with high N/C ratio and prominent nuclei with nucleoli. forming papillary structures and extensively invading into muscularis propria involving the entire thickness of the. bladder wall (D5-8,11). The tumor extends into the perivesical fat and up to the posterior inked bladder wall. margin (D6). The adjacent mucosa shows multifocal areas of urothelial carcinoma in situ (D7). Multiple sections. of the bladder mucosa show cystitis cystica and cystitis glandularis (D7,9,13,16,17). A section from the urethra. shows residual periurethral prostatic tissue (D18). A section of benign seminal vesicle is also identified (D20). The tumor involves the entire posterior wall and extends laterally (predominantly left lateral) into the trigone and. anterior mucosal wall. A section of left ureter (D4) shows complete obstruction of the ureter with tumor. The. tumor also involves the right ureterovesical junction (D1). Multiple lymph nodes sampled show no evidence of. metastatic disease. E-N: See final microscopic-diagnosis. Signature Line. GROSS DESCRIPTION: A: The specimen is received fresh from the O.R. and labeled ""Right distal ureter"". It consists of a segment of. ureter measuring 1 x1x0.4cm. The specimen is entirely submitted for frozen section. HX SURGICAL PATHOLOGY REPORT. B: The specimen is received fresh from the O.R. and labeled ""Left distal ureter"". It consists of a segment of. ureter measuring 0.9 x 0.8 X 0.4 cm. The specimen is entirely submitted for frozen section. C: The specimen is received fresh from the O.R. and labeled ""Urethral margin"". It consists of a strip of mucosa. and submucosal tissue measuring 1.7 x 0.5 x 0.5 cm. The specimen is entirely submitted for frozen section. D: The specimen is received fresh from the O.R. and labeled ""Bladder/prostate"" It consists of a cystectomy. measuring overall 15 x 9 x 7.5 cm. The peritoneum measures 9 x 8.5 x less than 0.2 cm and appears uninvolved. The bladder itself measures 9 x 8 x 6 cm and the anterior and posterior surface are firm and nodular to palpation,. and the left lateral end of bladder and resection of specimen is a nodule probably representing tumor. The. bladder is opened anteriorly in a ""Y"" shaped incision to reveal a large ulcerated mass occupying the entire. posterior bladder wall and extending onto the lateral wall, measuring 5 x 5 x 2 cm. The tumor involves the right. ureterovesical junction and the left ureterovesical junction is completely obscured by the tumor. The surrounding. mucosa is edematous, hemorrhagic and slightly trabeculated. The trigone is involved by tumor. The uninvolved. wall thickness measures 0.8 cm. The involved wall measures 2 cm and the tumor invades through the entire. thickness of the bladder and extends to the perivesicular fat, and abuts the inked surgical margin in the left lateral. posterior aspect of the specimen. A prostate is not identified. Bilateral ureters are explored; the right distal ureter. measures 6.5 cm in length and 1.1 cm in diameter. The left distal ureter is completely obstructed and disrupted by. the tumor. Although a 3 cm segment of the left distal ureter is identified, the remaining of the left ureter is. embedded within the tumor and is not grossly identifiable. The left ureter is dilated and measures 2.2 cm in. circumference. Representative sections are entirely submitted in twenty cassettes. E: The specimen is received fresh from the O.R. and labeled ""True posterior vascular pedicle stitch @ true. margin"". It consists of a pink-tan soft tissue fragment with suture at one end and designated as true margin. measuring 2.5 x 1 x 0.8 cm. The true margin is inked black. The specimen is serially sectioned and entirely. submitted in two cassettes. F: The specimen is received in formalin and labeled ""Left para aortic lymph nodes"". It consists of two pink-tan. soft tissue fragments measuring in aggregate 2.5 x 2 x 1.5 cm. The specimen is entirely submitted in two. cassettes. G: The specimen is received in formalin and labeled ""Right common iliac lymph nodes"". It consists of adipose. tissue fragments measuring in aggregate 3.5 x 2 x 1 cm. The specimen is entirely submitted in two cassettes. H: The specimen is received in formalin and labeled ""Left common iliac lymph nodes"". It consists of adipose. tissue fragments measuring in aggregate 3 x 2 x 1 cm. The specimen is entirely submitted in three cassettes. I: The specimen is received in formalin and labeled ""Right para cava lymph nodes"". It consists of adipose tissue. fragments measuring in aggregate 2.5 x 1.5 x 0.8 cm. The specimen is entirely submitted in two cassettes. J: The specimen is received in formalin and labeled ""Left external iliac lymph nodes"". It consists of adipose tissue. HX SURGICAL PATHOLOGY REPORT. fragments measuring in aggregate 2.5 x 2 x 1.5 cm. The specimen is entirely submitted in two cassettes. K: The specimen is received in formalin and labeled ""Left hypogastric / obturator lymph nodes"". It consists of. adipose tissue fragments measuring in aggregate 2 x 1.5 x 1 cm. The specimen is entirely submitted in one. cassette. L: The specimen is received in formalin and labeled ""Left para obturator nerve"". It consists of firm pink-tan soft. tissue and a small fragment of what grossly appears to be nerve measuring in aggregate 1.5 cm in length and 0.4. cm in diameter, attached to larger fragments. Representative sections are entirely submitted in two cassettes. M: The specimen is received in formalin and labeled ""Left proximal ureter"". It consists of a segment of ureter. measuring 0.9 cm and 0.7 cm in diameter. The specimen is trisected and entirely submitted in one cassette. N: The specimen is received in formalin and labeled ""Right proximal ureter"". It consists of a segment of ureter. and two clips measuring 1.5 cm and an average diameter measuring 0.5 cm. The specimen is trisected and. entirely submitted in one cassette. SECTIONS: AFS: frozen section, right distal ureter all embedded. BFS: frozen section, left distal ureter all embedded. CFS: frozen section, urethral margin all embedded. D1: right ureteral margin all embedded. D2: left ureteral margin all embedded. D3: right ureterovesical junction and ureter all embedded. D4: left ureter all embedded. D5-6: posterior bladder wall, full thickness all embedded. D7: posterior upper bladder wall all embedded. D8: left lateral posterior wall all embedded. D9: right lateral wall all embedded. D10: dome of bladder all embedded. D11: trigone all embedded. D12: anterior wall all embedded. D13: uninvolved wall all embedded. D14-15: additional lower posterior wall all embedded. D16-17: additional tumor all embedded. D18: urethra all embedded. D19: additional surrounding mucosa all embedded. D20: possible lymph nodes all embedded. E1,2: true posterior vascular pedicle stitch at true margin, serially sectioned all embedded. F1-2: left para aortic lymph nodes all embedded. G1: multiple nodes, one large node, bisected all embedded. HX SURGICAL PATHOLOGY REPORT. G2: remaining tissue all embedded. H1-3: left common iliac lymph nodes all embedded. I1-2: right para cava lymph nodes all embedded. J1-2: left external iliac lymph nodes all embedded. K: left hypogastric / obturator lymph nodes all embedded. L1-2: left para obturator nerve all embedded. M: left proximal ureter, trisected all embedded. N: right proximal ureter, trisected all embedded. INTRAOPERATIVE DIAGNOSIS: FROZEN SECTION DIAGNOSIS: AFS: Right distal ureter. no tumor identified. BFS: Left distal ureter. no tumor identified. CFS: Urethral margin. no tumor identified. FINAL DIAGNOSIS: RADICAL CYSTECTOMY, URINARY DIVERSION: RIGHT DISTAL URETER (A): FROZEN SECTION DIAGNOSIS: - NO TUMOR IDENTIFIED. FINAL DIAGNOSIS: - BENIGN UROTHELIUM. - NO DYSPLASIA OR MALIGNANCY IDENTIFIED. LEFT DISTAL URETER (B): FROZEN SECTION DIAGNOSIS: - NO TUMOR IDENTIFIED. FINAL DIAGNOSIS: - BENIGN UROTHELIUM. NO DYSPLASIA OR MALIGNANCY IDENTIFIED. HX SURGICAL PATHOLOGY REPORT. URETHRAL MARGIN (C): FROZEN SECTION DIAGNOSIS: - NO TUMOR IDENTIFIED. FINAL DIAGNOSIS: - BENIGN UROTHELIUM. - NO DYSPLASIA OR MALIGNANCY IDENTIFIED. BLADDER / PROSTATE (D): BLADDER ONLY (NO PROSTATE RECEIVED): - POORLY DIFFERENTIATED UROTHELIAL CARCINOMA, NUCLEAR GRADE 4/4,. INVOLVING ENTIRE BLADDER WALL AND EXTENDING INTO SURROUNDING. PERIVESICAL SOFT TISSUE. - MULTIFOCAL UROTHELIAL CARCINOMA IN SITU. - VASCULAR AND PERINEURAL INVASION IDENTIFIED. TUMOR FOCALLY EXTENDS THROUGH INKED POSTERIOR MARGIN (5% OF THE. MARGIN INVOLVE BY INVASIVE TUMOR). - DISTAL URETERAL AND URETHRAL MARGINS, FREE OF MALIGNANCY. - MULTIFOCAL CYSTITIS GLANDULARIS AND CYSTITIS CYSTICA. TRUE POSTERIOR VASCULAR PEDICLE (E): - BENIGN FIBROVASCULAR AND ADIPOSE TISSUE SHOWING FAT NECROSIS. - NO MALIGNANCY IDENTIFIED. LEFT PARAAORTIC LYMPH NODES (F): - NO EVIDENCE OF METASTATIC DISEASE IN SEVEN LYMPH NODES EXAMINED (0/7). RIGHT COMMON ILIAC LYMPH NODES (G): - NO EVIDENCE OF METASTATIC DISEASE IN NINE LYMPH NODES EXAMINED (0/9). LEFT COMMON ILIAC LYMPH NODES (H): NO EVIDENCE OF METASTATIC DISEASE IN EIGHT LYMPH NODES EXAMINED (0/8). RIGHT PARACAVAL LYMPH NODES (I): NO EVIDENCE OF METASTATIC DISEASE IN TEN LYMPH NODES EXAMINED (0/10). LEFT EXTERNAL ILIAC LYMPH NODES (J): - NO EVIDENCE OF METASTATIC DISEASE IN FOUR LYMPH NODES EXAMINED (0/4). LEFT HYPOGASTRIC / OBTURATOR LYMPH NODES (K): HX SURGICAL PATHOLOGY REPORT. - NO EVIDENCE OF METASTATIC DISEASE IN FOUR LYMPH NODES EXAMINED (0/4). LEFT PARA OBTURATOR NERVE (L): - NO EVIDENCE OF METASTATIC DISEASE IN ONE LYMPH NODE EXAMINED (0/1). BENIGN NERVE AND FIBROADIPOSE TISSUE SHOWING EXTENSIVE FAT NECROSIS. - NO MALIGNANCY IDENTIFIED. LEFT PROXIMAL URETER (M): - BENIGN UROTHELIUM. - NO DYSPLASIA OR MALIGNANCY IDENTIFIED. RIGHT PROXIMAL URETER (N): - BENIGN UROTHELIUM. - NO DYSPLASIA OR MALIGNANCY IDENTIFIED. PATHOLOGIC TNM STAGE: pT3bNOMXR1. CLINICAL DIAGNOSIS: Bladder cancer. Completed Action List:",T3,N0,M0,T3N0M0
TCGA-L6-A4EP,"Clinical Center. Birth Date: DIAGNOSIS: 1. Lymph node, deiphian, biopsy: Lymph nodes, no tumor seen. 2. Thyroid, right thyroid nodule, frozen section (1FS1): Papillary. thyroid carcinoma. 3. Thyroid, right lobe and isthmus, excision: Papillary thyroid. carcinoma (3.0 cm in greatest dimension). Please see CAP check. list below. Procedure. Right Thyroid lobectomy. Fresh. Specimen Integrity. Intact. Specimen Size. Right lobe: 5.4x3x2.5cm. Specimen Weight. Specify: 14.9 g. Tumor Focality. Cannot evaluate. Right lobe/isthmus only. Dominant Tumor. Tumor Laterality. Right lobe. Tumor Size. Greatest dimension: 3 cm. Additional dimensions: 2.4 x 2.4 cm. Histologic Type. Papillary carcinoma. Variant, specify: Classical (usual). Architecture: Classical (papillary). Cytomorphology: Classical. Margins. Margins uninvolved by carcinoma (tumor closely approaches but is not. present at inked margin). (Other). Do not file in Medical Record. Clinical Center. Birth Date: Tumor Capsule. Totally encapsulated. Tumor Capsular Invasion. Present: Multiple foci. Lymph-Vascular Invasion. Not identified. Extrathyroidal Extension. Not identified. Pathologic Staging. Primary Tumor. pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid. Regional Lymph Nodes. pNO: No regional lymph node metastasis. Specify: Number examined: 3. Number involved: 0. Distant Metastasis. Not applicable. Additional Pathologic Findings. One Parathyroid gland: Slightly hypercellular. Immunoperoxidase and in-situ hybridization tests performed here and. used for diagnosis were developed and their performance characteristics. determined by the Laboratory of Pathology,. They have not been. cleared or approved by the U.S. Food and Drug Administration. The FDA. has also determined that such clearance or approval is not necessary. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (CLIA) as qualified to perform high complexity. clinical laboratory testing. CLINICAL INFORMATION: Allocate Order to Protocol: Brief. Clinical History: right. thyroid nodule Specimen Taken For Protocol: 01 - Yes. PROCEDURE: Pre-Operative Diagnosis: as above Post-Operative. Diagnosis: as above. Operative Findings: as above. SPECIMENS SUBMITTED: 1. SERIAL 5+ 5FS, Delphian lymph node 1FS). 2. ROUTINE + 4FS, Right thyroid nodule (2FS). 3. THYROID, RIGHT LOBE, and isthmus. INTRAOPERATIVE CONSULTATION: Received fresh from the Operating Room. with the patient's name, medical record number, and labeled as: 9ther). Do not file in Medical Record. Clinical Center. Birth Date: y. 1. ""Delphian lymph node"" is a red soft tissue fragment measuring 0.6. x 0.4 x 0.3 cm. It is frozen in total as 1FS. Preliminary diagnosis: Lymph node, no definitive tumor seen. 2. ""Right thyroid nodule, rule out cancer"", consists of a yellow. piece of soft tissue fragment measuring 2.1 x 1.2 x 0,5 cm. It is. totally frozen as 2FS (4 slides). Preliminary diagnosis: Follicular papillary lesion. This is performed by. GROSS DESCRIPTION: Three specimens are received in formalin,. labeled with the patient's name, medical record number, and further. specified as follows: 1. ""Delphian lymph node"". The specimen is received in Pathology and. matches the intraoperative consultation note. The specimen is. transferred from a green cassette labeled with the patient's name. and 1FS to an orange cassette labeled. 2. ""Right thyroid nodule 2FS"". The specimen is received in. Pathology and matches the above description. The specimen is. transferred from a green cassette labeled with the patient's name. and date to an orange cassette labeled. 3. ""Right thyroid lobe and isthmus, stitch marks superior pole"" is a. partial thyroidectomy specimen consisting of a right thyroid lobe. and portion of isthmus, overall 14.9 grams. The right thyroid. lobe is 5.4 x 3 x 2.5 cm. The exterior surface is inked black. The posterior surface is over-inked blue. The right thyroid lobe. has a nodule, 3 x 2.4 x 2.4 cm. The nodule has a friable tan-pink. glistening cut surface. Gross photos are taken. The procurement. is performed by Dr. and. on. at. Approximately 50% of the right nodule is procured for Dr. } and Dr. Approximately 0.8 x 0,5 x 0.5 cm of. normal-appearing thyroid from the isthmus is procured for research. with half for Dr. and half for. The. remainder is sent to Pathology for permanent processing. The. specimen is received in Pathology and matches the above. description. The isthmus is not readily identifiable. The. specimen is sectioned from the superior aspect marked by the. double stitch to the inferior aspect. Every other segment of the. thyroid going from superior to inferior is submitted in orange. cassettes labeled. The specimens will be. processed as a rush. Intervening segments going from superior to. inferior are submitted in white cassettes labeled #3K-3P. These. will be held overnight in formalin before further processing. No consultants. (Other). Do not file in Medical Record. Clinical Center. Birth Date: <Resident Signature>. (Other). Do not file in Medical Record.",T2,N0,M0,T2N0M0
TCGA-BP-4960,"Clinical Diagnosis & History: vith left renal mass, large. Specimens Submitted: 1: SP: Kidney and adrenal gland, left; redical nephrectomy. 2: SP: Lymph nodes, pare-aortic and pre-aortic; dissection: DIAGNOSIS: 1. SP: Kidney and adrenal gland, left; radical nephrectomy: Tumor Type: Renal cell carcnoma - Conventional (clear cell) type. Fuhrmen Nuclear Grade: Nuclear grade III/IV. Tumor Size: Greatest diameter is 10.5 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins;. Free of tumor. Non-Neoplastic Kidney;. Unremarkable. Adrenal Gland: Not involved. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT2 Tumor >7.0 cm in greatest dimension limited to the kidney. 2. SP: Lymph nodes, para-aortic and pre-aortic; dissection: Lymph Nodes: Not involved. Number of nodes examined:9. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. CD3 (Leu4). CD5. CD20 L26. CD23. BCL2. NEG CONT. IMM RECUT. Gross Description: 1). The specimen is received fresh, labeled Left Kidney and Adrenal"". It consists of a resected kidney with adrenal and. perinephric fat measuring overall 20.5 X 13.4 x 8.5 cm and weighing 1,380 grams. There is a firm tumor mass palpated in the. centrel zone of the kidney. The ureteral and vescular margins are free of tumor, and the margins are submitted. The specimen. is. bivalved to reveal a centrally located, well-circumscribed, encapsulated tumor mass measuring 10,5 x 7.5 x 5,0 cm. The cut. sections of the tumor show areas that are bright yellow to tan-gray with the central portion showing tan-yellow discoloration. There. are. focal areas of hemorrhage and necrosis in the tumor mass. The tumor is located mostly in the lower pole, extending into the. central portion of the cortex, pushing into the renal pelvis, but not grossly involving the pelvic fat. The perinephric fat adjacent. to. the tumor mass is inked black. The adrenal gland measures 6.5 x 1.2 x 0.5 cm and is not involved by the tumor, A portion of the. tumor is submitted for TPS. The specimen is photographed. Representative sections of the tumor, adrenal gland and normal. kidney are submitted. Summary of Sections: UM - ureteral margin. VM - vascular mergin. T - tumor. TCP - center portion of the tumor which appears tan-yellow and fatty. NK - normal kidney. TWPF - tumor with pelvic fat. PFM - perinephric fat margin. ADR - odrenal. 2). The specimen Is received in formalin, labeled ""Pare-aortic and Preaortic Node"". It consists of en irregular plece of. tan-yellow, lobulated fatly tissue admixed with blood measuring 12.0 x 2,5 X 1.0 cm. Several tan-yellow to tan-pink lymph nodes. are dissected, measuring from 0.4 up to 3.2 cm in greatest dimension. All lymph nodes are submitted. Summary of Sections: SS1 - serial sections of one largest lymph node. SS2 - serial sections of second largest lymph node. LNB - lymph nodes bisected. LN - lymph nodes. Summary of Sections: Part 1: SP: Kidney and adrenal gland, left; radical nephrectomy: Block. Sect. Site. PCs. 1. adr. 1. 1. nk. 1. 1. pfm. 5. t. 5. 2. t-cp. 2. twnk. 2. twpf. 2. 1. um. 1. 1. vm. 1. Part 2: SP: Lymph nodes, para-aortic and pre-aortic; dissection: Block. Sect, Site. PCs. 1. In. 3. 5. Inbs. 6. ss1. 6. 5. ss2. 5.",T2,N0,M0,T2N0M0
TCGA-DJ-A2PW,"Clinical Diagnosis & History: Papillary carcinoma right thyroid lobe T2N0MO. Specimens Submitted: 1: Total thyroidectomy. 2: Left inferior parathyroid tissue?. DIAGNOSIS: 1. Total thyroidectomy: Tumor Type: Papillary carcinoma, classical type. Three foci. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Right lobe. Isthmus. Tumor Size: Right lobe: 4.6 cm carcnoma and 2.0 cm carcinoma; isthmus: 3.5 cm carcinoma. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Present. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Adenoma(s) (away from the carcinoma): Not Identified. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Parathyroid Glands: Not identified. 2. Left inferior parathyroid tissue?: Lymph Node Dissection: Number of lymph nodes examined: 1. Number of lymph nodes with metastatic disease: 1. Psammoma bodY is identified, consistent with metastatic papillary thyroid carcinoma. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: M.D. 1. The specimen is received fresh and is labeled ""total thyroidectomy short stitch - right superior pole, long stitch - left lower pole"". and consists of a thyroid weighing 33.5 g. The right lobe measures 5.1 x 3.1 x 2.3 cm the left lobe measures 4 x 2.8 x 1.1 cm. and the isthmus measures 5.2 x 3x 2.2 cm. The external surface is covered by a thin fibrous capsule. The posterior surface of. the. specimen is inked black, and the anterior is inked blue. Sectioning reveals the right lobe is predominantly replaced by a pink-tan. soft nodule measuring 4.6x 2.9x 2.6 cm (nodule 1). Immediately adjacent to the nodule is a second nodule (2 x 1.2 x 1 cm). with. a. thick capsule and filled with yellow-brown translucent fluid. The isthmus has a third nodule (3.5x 2.8x 2.3 cm) with a. heterogeneous cut surface composed of pale pink tissue with granular tan tissue. The remaining thyroid parenchyma is. red. tan. and beefy. Representative sections of nodule one and nodule three are submitted for TPS. The nodules are entirely submitted. and the left lobe Is representatively submitted. Summary of sections: N1 - nodule, right lobe. N1/2- nodule one and two. N2- nodule, right lower lobe. N3-nodule, isthmus. LL left lobe. 1.D. 2. The specimen is received fresh, ""left inferior parathyroid tissue?"" and consists of a fragment of pink-tan tissue (0.4 x 0.2 x 0.2. cm). The specimen is entirely submitted in one cassette. Summary of sections: U-undesignated. Summary of Sections: Part 1: Total thyroidectomy. Block. Sect. Site. PCs. 4. N1. 4. 1. N1/2. 1. 2. N2. 2. 7. N3. 7. Part 2: Left inferior parathyrold tissue?. Block. Sect. Site. PCs. 1. U. 1. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. PART 1: There is an additional papillary microcarcinoma (0.6 cm) with tall cell features in the isthmus. Signed out hy.",T3,N1,M0,T3N1M0
TCGA-EW-A6S9,"F. x. x. Pathologic Interpretation: A. SENTINEL NODE #1. METASTATIC CARCINOMA to one lymph node (1/1). Largest tumoral deposit is 1mm. NOTE: Metastatic deposit is not identified in frozen section slide. B. SENTINEL NODE #2. Negative for carcinoma, one lymph node (0/1). C. SENTINEL NODE #3. Negative for carcinoma, one lymph node (0/1). D. RIGHT BREAST MASS: INVASIVE DUCTAL CARCINOMA, poorly differentiated, Nottingham grade 2 (3+2+2=7), 2.0 cm. Surgical resection margins are negative for invasive carcinoma; the closest one is the anterior at 6mm. DUCTAL CARCINOMA IN SITU, intermediate grade, solid and cribriform type with necrosis and retrolobular. involvement present in five out of 15 slides examined. Surgical resection margins are negative for in situ carcinoma; the closest one is the anterior at 10 mm. Lymphovascular invasion is identified. INVASIVE CARCINOMA OF THE BREAST: Complete Excision (Less Than Total Mastectomy, Including. Specimens. Designated Biopsy, Lumpectomy, Quadrantectomy, and Partial Mastectomy With or Without Axillary. Contents) and. Mastectomy (Total, With or Without Axillary Contents; Modified Radical; Radical). Procedure. Excision without wire-guided localization. Lymph Node Sampling. Sentinel lymph node(s). Specimen Laterality. Right. Tumor Site: Invasive Carcinoma. Upper outer quadrant. Histologic Type of Invasive Carcinoma. Invasive ductal carcinoma (no special type or not otherwise specified). Tumor Size: Size of Largest Invasive Carcinoma. Greatest dimension of largest focus of invasion >1 mm: 20 mm. Additional dimensions: 15.0 x 10.0 mm. Histologic Grade: Nottingham Histologic Score. Glandular (Acinar)/Tubular Differentiation. Score 3: <10% of tumor area forming glandular/tubular structures. Nuclear Pleomorphism. Score 2: Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and. shape. Mitotic Rate. Score 2 (4-7 mitoses per mm2). Overall Grade. Grade 2: scores of 7. Tumor Focality. Single focus of invasive carcinoma. Ductal Carcinoma In Situ (DCIS). DCIS is present. Size (Extent) of DCIS. Present in five out 15 slides examined. Architectural Patterns (select all that apply). Cribriform. Nuclear Grade (see Table 2). Grade Il (intermediate). Necrosis. Present, focal (small foci or single cell necrosis). Lobular Carcinoma In Situ (LCIS). Not identified. Margins. Invasive Carcinoma. Margins uninvolved by invasive carcinoma. Distance from closest margin: 6 mm. Specify margin: Anterior. DCIS. Margins uninvolved by DCIS. Distance from closest margin: 10 mm. + Specify margin: Anterior. Lymph Nodes. Number of sentinel fymph nodes examined: 3. Total number of lymph nodes examined (sentinel and nonsentinel): 3. Number of lymph nodes with macrometastases (>2 mm): 0. Number of lymph nodes with micrometastases (>0.2 mm to 2 mm and/or >200 cells): 1. Number of lymph nodes without tumor cells identified: 2. Extranodal Extension. Not identified. Method of Evaluation of Sentinel Lymph Nodes. Hematoxylin and eosin (H&E), 1 level. Immunohistochemistry pending. Lymph-Vascular Invasion. Not identified. Pathologic Staging (based on information available to the pathologist) (pTNM). Primary Tumor (Invasive Carcinoma) (pT). pT1c: Tumor >10 mm but <20 mm in greatest dimension. Regional Lymph Nodes (pN). Modifier. (sn): Only sentinel node(s) evaluated. Category (pN). pN1mi: Micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0. mm). Distant Metastasis (pM). Not applicable. Ancillary Studies. Performed on another specimen. Specify specimen (accession number): xx. Estrogen Receptor (ER). Results and interpretation: Positive Immunoreactive tumor cells present. Quantitation: 50%. Progesterone Receptor (PgR). Results and interpretation: Positive Immunoreactive tumor cells present. Quantitation: 50%. HER2 (results for invasive carcinoma performed on this specimen or a prior core needle biopsy or incisional biopsy). Immunoperoxidase Studies. Positive (Score 3+). Preliminary AJCC Classification (7th Edition): pT1c pN1mi pMn/a. (Final classification pending evaluation of keratin immunostain on sentinel nodes). Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. Parts B-C: Immunohistochemistry for keratin is negative. Final AJCC Classification: pT1c pN1mi pMn/a. Intraoperative Consultation: A. SENTINEL NODE #1 ( ), FS: Negative lymph node. B. SENTINEL NODE #2 ( ), FS: Negative lymph node. C. SENTINEL NODE #3 ( ), FS: Negative lymph node. Reported to OR at. XX, MD. Clinical History: Not provided. Operation Performed: Right breast lumpectomy with sentinel node biopsy. Pre Operative Diagnosis: Right breast carcinoma. Specimen(s) Received/Processing Information: Fee Codes: A: A: SENTINEL NODE #1 (. ), FS Frozen section x 1, FS Perm x. 1. B: C: B: SENTINEL NODE #2 (. ), FS Frozen section x 1, FS Perm x 1, Cytokeratin Cocktail. (KER) x 1. D: C: SENTINEL NODE #3 (. 1, FS Frozen section x 1, FS Perm x 1, FSDeep 1 x 1,. Cytokeratin Cocktail (KER) x. 1. D: RIGHT BREAST MASS (1 STITCH SUPERIOR, 2 STITCHES LATERAL, 3 STITCHES. DEEP) H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1,. H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x. 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E. Gross Description: A. Specimen is received fresh and labeled ""Sentinel node #1 (. FS"". The specimen consists of one lymph. node measuring 1.6 x 0.9 x 0.4cm. Specimen is bisected and submitted in toto for frozen section. B. Specimen is received fresh and labeled ""Sentinel node #2 ( ), FS"". The specimen consists of one lymph. node measuring 1.3 x 0.9 x 0.3 cm. Specimen is bisected and submitted in toto for frozen section. C. Specimen is received fresh and labeled ""Sentinel node #3 ( ), FS"". The specimen consists of one lymph. node measuring 1.1 x 0.6 x 0.3 cm. Specimen is bisected and submitted in toto for frozen section. D. Specimen is received in formalin and labeled ""Right breast mass (1 stitch superior, 2 stitches lateral, 3. stitches deep"". The specimen consists of an 8.0 x 8.0 x 4.0 cm lumpectomy specimen, oriented with one. stitch at superior, two stitches as lateral and three stitches as deep. The specimen is inked for evaluation of margins: Posterior black. Anterior yellow. Superior blue. Inferior green. Lateral orange. Medial red. Serial sections are white-gray, ill-defined and firm. A mass is identified measuring 2.0 x 1.5 x 1.0 cm; the. mass is 1.0 cm from the superior margin, 2.0 cm from the inferior margin, 1.0 cm from the anterior margin,. 3.0 cm from the lateral margin, 1.5 cm from the medial margin and 1.0 cm from the deep margin. The. remainder of the specimen consists of yellow-white adipose tissue. No other lesions are identified. 90% of. the mass was submitted for microscopic examination. Representative sections are submitted as follows: Cassette #1. Superior margin perpendicular. Cassette #2. Inferior margin perpendicular. Cassette #3. Lateral margin perpendicular. Cassette #4. Medial margin perpendicular. Cassette #5. Anterior margin perpendicular. Cassette #6. Deep margin perpendicular. Cassettes #7-10. Mass and breast tissue adjacent. Cassettes #11-15. Other areas.",T1,N1,M0,T1N1M0
TCGA-BH-A18P,"PAIIENI MISTOKY: The patient is. a -year-old female. Clinical history is not provided Site Code : breast, lower inner quadrant. PRE-OP DIAGNOSIS: Left breast cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Left total mastectomy. +$. ADDENDA: Addendum. Fluorescence in situ hybridization analysis was performed on block 1D using the DNA probe for Her-2/neu gene. The. ratio of Her-2/neu gene signals to chromosome 17 centromere signals was determined to be 2.05. Therefore, the. interpretation is: borderline amplification of the Her-2/neu gene. que. ves. My signature is attestation that I have personally reviewed the submitted materiali. Addendum. ESTROGEN/PROGESTERONE AND HER-2/NEU REPORT. Using appropriate positive and negative controls, the test for the presence of these hormone receptor proteins is. performed by the immunoperoxidase method, and reported according to the consensus statement on adjuvant. therapy for breast cancer, of. A positive ER or PR tumor shows any nuclear immunostaining, and is. semiquantitated as indicated below. Semiquantitative Statement. ER positive. Percent cells staining as: (0 95%; 1+ 5%, 2+ 0%, 3+ 0%). PR negative. Percent cells staining as: (0 100%, 1+ 0%, 2+ 0%, 3+ 0%). HER-2/NEU DAKO HERCEPTEST: A WEAK TO MODERATE COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE. THAN 10% OF THE TUMOR CELLS. HER-2/NEU IS INTERPRETED AS WEAKLY POSITIVE ISCORE 2+I. NOTE: Her-2/Neu FISH was ordered and will be subsequently reported. The Her-2/neu and estrogen/progesterone receptor assays were performed with FDA approved. methods. FIAL DIAGNOSIS: PART 1: LEFT BREAST, TOTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA, 2.0 CM, NOTTINGHAM SCORE 7/9 (tubules 3, nuclei 2, mitosis 2),. LOCATED IN THE LOWER INNER QUADRANT AND EXTENDING TO THE LOWER OUTER QUADRANT. B. TUMOR COMES TO WITHIN 0,1 CM FROM THE INNER LOWER OF QUADRANT MARGIN. C. MICROCALCIFICATION ASSOCIATED WITH TUMOR. D. DUCTAL CARCINOMA IN SITU, NUCLEAR GRADE 2, SOLID TYPE WITH COMEDO NECROSIS,. REPRESENTING 10-15% OF THE TUMOR VOLUME. E. MARGINS FREE OF TUMOR. F. REMAINING BREAST TISSUE WITH FIBROCYSTIC CHANGES, SCLEROSING ADENOSIS AND. MICROCALCIFICATION. G. SKIN AND NIPPLE NOT REMARKABLE. H. THREE LYMPH NODES NEGATIVE FOR TUMOR. PART 2: LEFT AXILLA, SENTINEL LYMPH NODE #1, EXCISIONAL BIOPSY. ONE LYMPH NODE NEGATIVE FOR TUMOR, CONFIRMED BY NEGATIVE AE1/AE3 IMMUNOSTAIN. PART 3: LEFT AXILLA, SENTINEL LYMPH NODE #2, EXCISIONAL BIOPSY -. ONE LYMPH NODE NEGATIVE FOR TUMOR, CONFIRMED BY NEGATIVE AE1/AE3 IMMUNOSTAIN. COMMENT: Estrogen and Progesterone receptors and HER-2/Neu will be performed on block 1D and the result will follow in a. separate report.",T1,N0,M0,T1N0M0
TCGA-DJ-A13W,"Clinical Diagnosis & history: Left thyroid nodule suspicious for follicular neoplasm on FNA. Specimens Submitted: 1: SP: Para tracheal lymph node. 2: SP: peri thyroidal lymph node. 3: SP: Thyroid, total thyroidectomy. DIAGNOSIS: LYMPH NODE, PARA TRACHEAL; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 2. LYMPH NODE, PERI THYROIDAL; EXCISION: - TWO BENIGN LYMPH NODES (0/2). 3. SP: Thyroid, total thyroidectomy: Tumor Type: Papillary carcinoma, follicular variant. Histologic Grade: Well differentlated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 2.0 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Not identified. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Clinical Diagnosis & History: Left thyrold nodule suspicious for follicular neoplasm on FNA. Specimens Submitted: 1: SP: Para tracheal lymph node. 2: SP: peri thyroidal lymph node. 3: SP: Thyroid, total thyroldectomy. DIAGNOSIS: 1. LYMPH NODE, PARA TRACHEAL; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 2. LYMPH NODE, PERI THYROIDAL; EXCISION: - TWO BENIGN LYMPH NODES (0/2). 3. SP: Thyroid, total thyroidectomy: Tumor Type: Papillary carcinoma, follicular variant. Histologic Grade: Well differentlated. Mitotic Activity: Not Identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter Is 2.0 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Not identified. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Papillary microcarcinoma, 0.6cm (right lobe). Non-Neoplastic Thyroid: Exhibits chronic lymphocytic thyroiditis consistent with Hashimoto's thyroiditis. Parathyroid Glands: Not identified. Lymph Nodes: Two benign lymph nodes (0/2). IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT 1 HAVE. REVIEWED AND APPROVED THIS REPORT. Report lectronically Signed Out. Gross Description: 1.) The specimen is received fresh, labeled ""paratracheal lymph node"" and consists of a single pink tan firm lymph node(1.2 x 0.5 x. 0.4 cm). Bisected and entirely submitted. Summary of sections: BLN-- bisected lymph nodes. 2.) The specimen is received fresh, labeled ""perithyroidal lymph node"" and consists of two pink tan firm lymph nodes measuring. 0.8 and 0.5 cm in greatest dimension. Entirely submitted. Summary of sections: LN -- lymph nodes. 3.) The specimen is received fresh, labeled ""total thyroid, stitch marks left superior pole"" and consists of a thyroid weighing 20.5. grams. The right lobe measures 3.5 x 2.4 x 1.5 cm, the left lobe measures 4.5 x 2.8 x 1.8 cm and the isthmus measures 1.2 x 0.6. x 0.6 cm. The external surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black, and the. anterior is inked blue. Sectioning reveals round tan/yellow, well circumscribed mass(2.0 x 1.4 x 1.2 cm) in the lower pole of the. left lobe. Sections through the remaining tissue reveal irregular white firm area in the left upper pole, and 0.6 x 0.6 x 0.5 stellate. white fibrous area in the mid right lobe. The remaining thyrold parenchyma is red tan and meaty. Representative sections of the. specimen are submitted for TPS. The remaining tissue is serially sectioned and entirely submitted. Summary of sections: N - nodule left lobe. RL right lobe. LL left lobe. IS isthmus. Summary of Sections: Part 1: SP: Para tracheal lymph node. Block. Sect. Site. PCs. 1. BLN. 1. Part 2: SP: peri thyroidal lymph node. Block. Sect. Site. PCs. 1. LNS. 1. Part 3: SP: Thyroid, total thyroidectomy. Block. Sect. Site. PCs. 1. IS. 1. 4. LL. 4. 5. N. 5. 6. RL. 6.",T1,N0,M0,T1N0M0
TCGA-A8-A09R,"Concluding diagnosis: Left breast segment at 12 o'clock with a 3 cm moderately differentiated invasive ductal. carcinoma with concomitant low-grade DCIS grade II. The resection margins lie in healthy. tissue on all sides. Two of a total 16 lymph nodes with metastases (2/16). Tumor classification: pT2 (3 cm), pN1a (2/16), MX, R0; G2, L0, V0.",T2,N1,M0,T2N1M0
TCGA-2J-AABA,"Surgery date: DIAGNOSIS: A. Lymph nodes, common hepatic artery #1, excision: A single (1). lymph node is negative for tumor. B. Lymph nodes, common hepatic artery #2, excision: Fibroadipose. tissue with chronic inflammation. C. Soft tissue, pancreatic portal vein interface, excision: Fibrous. tissue with granulation tissue and acute inflammation. D. Pancreas, neck margin, excision: Negative for tumor. E. Head of pancreas, gallbladder, duodenum, and portion of jejunum;. Whipple resection: Invasive moderately differentiated ductal. adenocarcinoma is identified forming a solid mass (4.3 X 3.5 x 3.1. cm) located in the pancreatic head. The tumor extends beyond the. pancreas to involve the peripancreatic soft tissue, duodenal wall,. and bile duct. Both angiolymphatic and perineural invasion are. absent. Tumor necrosis is absent. The uncinate margin is positive. for invasive carcinoma whereas the portal vein groove and cystic. duct margins are negative. The adjacent non-neoplastic pancreatic. parenchyma shows marked chronic pancreatitis. A single (1) cystic. duct lymph node is negative for tumor. The gallbladder demonstrate. chronic cholecystitis. Multiple (2 of 10) regional lymph nodes are. positive for metastatic adenocarcinoma. F. Lymph nodes, peripancreatic, excision: Multiple (2) lymph nodes. are negative for tumor. G. Lymph nodes, gastrocolic, excision: Multiple (5) lymph nodes are. negative for tumor. H. Lymph nodes, celiac axis, excision: Multiple (2) lymph nodes are. negative for tumor. With available surgical material, [AJCC pT3N1] (7th edition, 2010). This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s). Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. Interpreted by: GROSS DESCRIPTION: A. Received fresh labeled ""common hepatic artery lymph nodes"" is a. 2.5 x 2.5 x 0.5 cm aggregate of adipose and lymphatic tissue. All. submitted. Grossed by. B. Received fresh labeled ""common hepatic artery lymph node #2"" is a. 2.5 x 2.1 X 0.7 cm aggregate of adipose tissue, lymphatic tissue not. identified grossly. All submitted. Grossed by. C. Received fresh labeled ""pancreatic portal vein interface"" is a. 0.7 x 0.6 X 0.2 cm portion of tan-pink tissue. All submitted. D. Received fresh labeled ""pancreatic neck margin"" is a 3.0 x 2.1 x. 0.8 cm portion of pancreatic tissue with orientation. All. submitted. Grossed by. E. Received fresh labeled ""head of pancreas, gallbladder, duodenum,. portion of jejunum, and pancreas stones"" is a Whipple specimen. consisting of 34.0 cm in length portion of duodenum, 7.0 x 5.2 X 4.8. cm portion of pancreas, and a 16.5 x 5.5 X 2.4 cm gallbladder. The. pancreatic uncinate margin is inked yellow and shaved. The portal. vein groove is inked blue and submitted perpendicularly. There is a. 4.3 x 3.5 x 3.1 cm annular and diffusely infiltrative mass within. the pancreas at the uncinate margin. The mass extends to. peripancreatic soft tissue. A stent is present within the common. bile duct. Multiple irregular fragmented stones are identified. within the pancreas and pancreatic duct system, showing obstruction. toward the ampulla and dilation toward the pancreatic neck margin. The gallbladder contains no choleliths. Peripancreatic lymph nodes. are identified. Representative sections are submitted. Grossed by. F. Received fresh labeled ""peripancreatic lymph nodes"" is a 2.9 X. 2.2 x 0.8 cm aggregate of adipose and lymphatic tissue. Lymph nodes. submitted. Grossed by. G. Received fresh labeled ""gastrocolic lymph nodes"" is a 6.7 x 2.5 x. 0.7 cm aggregate of adipose and lymphatic tissue. Lymph nodes. submitted. Grossed by. H. Received fresh labeled ""celiac axis lymph nodes"" is a 2.9 x 1.0 x. 0.8 cm aggregate of adipose and lymphatic tissue. Lymph nodes. submitted. Grossed by. BLOCK SUMMARY: Part A: Common hepatic artery lymph node. 1 Comm hepatic artery LN 1(A1). 2 Comm hepatic artery LN 1 (A2). Part B: Common hepatic artery lymph node #2. 1 Common hepat artery LN#2(B1). 2 Common hepat artery LN#2(B2). Part C: Pancreatic portal vein interface. 1 Pancreatic portal vein. Part D: Pancreatic neck margin. 1 Pancreatic neck margin 1. 2 Pancreatic neck margin 2. Part E: Head of pancreas, gallbladder, duodenum, portion jejunum,. and pancreas stone. 1 Uncinate margin 1. 2 Uncinate margin 2. 3 Uncinate margin 3. 4 Uncinate margin 4. 5 Bile duct margin. 6 Portal vein groove margin. 7 Ampulla. 8 Pancreatic duct. 9 Pancreatic duct. 10 Peripancreatic LN 1of5(E1). 11 Peripancreatic LN 20f5(E1). 12 Peripancreatic LN 3of5(E1). 13 Peripancreatic LN 4of5(E1). 14 Peripancreatic LN 5of5(E1). 15 Peripancreatic LN 4(E2). 16 Peripancreatic LN 7(E3). 17 Cystic duct LN 1(E4). 18 Gallbladder. 19 Peripancreatic LN 2(E5). 20 Pancreatic mass. 21 Pancreatic mass. Part F: Peripancreatic lymph nodes. 1 Peripancreatic LN 2 (F1). 2 Peripancreatic LN 2 (F2). Part G: Gastro colic lymph nodes. 1 Gastro colic LN 4(G1). 2 Gastro colic LN 2(G2). Part H: Celiac axis lymph nodes. 1 Celiac axis LN 2(H1).",T3,N1,M0,T3N1M0
TCGA-EL-A3ZR,"Case type: Surgical Case. DIAGNOSIS. 8340/3. (A) LEFT THYROID LOBE AND ISTHMUS: PAPILLARY THYROID CARCINOMA, FOLLICULAR VARIANT CQCF: carcinoma, papillary, theroid. Location: Left lobe. Multi-focal: No. Size = 2.2 cm. Extrathyroidal extension: Absent. Lymphovascular invasion: Present. Resection Margins: Negative. Lymph nodes: No lymph nodes present. GROSS DESCRIPTION. (A) LEFT THYROID LOBE AND ISTHMUS - A hemithyroidectomy specimen (4.0 : x 1.5 x 1.5 cm) contains a well-. circumscribed pink-tan nodule within the superior aspect of the left lobe (2.2 x 1.5 x 1.5 cm). The nodule appears confined to. the thyroid with a smooth overlying thyroid surface. The isthmus is unremarkable. The specimen is serially sectioned and. submitted from superior to inferior in A1-A6 with A7 isthmus. CLINICAL HISTORY. Follicular neoplasm, left thyroid. CONSULTANT(S). SNOMED CODES. T-B6000, M-83403,. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by:",T2,N0,M0,T2N0M0
TCGA-A6-6137,"SPECIMEN. Right hemicolectomy. CLINICAL NOTES. PRE-OP DIAGNOSIS: Hepatic flexure cancer. POST-OP DIAGNOSIS: Same. GROSS DESCRIPTION. Received fresh in a container labeled ""right hemicolectomy"". is a segment of bowel consisting of 6 cm of terminal ileum. with contiguous 23 cm of proximal colon. The serosal surface is. glistening and tan-pink, and there is a moderate amount of attached. adipose tissue. There is an unremarkable appendix present,. measuring 6.5 cm long X 0. cm in diameter. On cut surface, it is. without focal lesion, without gross evidence of inflammation. The. bowel measures 3.6 cm and 8 cm in circumference at the proximal and. distal resection margins respectively. The bowel is opened, and. there is a circumscribed 5.3 X 5 cm rubbery white-pink mass located. 11 cm proximal to the distal margin. A portion of tumor and of. normal tissue are submitted for tissue procurement per the clinical. requested. On sectioning, the tumor has a maximum thickness of 1.6. cm, and grossly extends through the musuclaris propria and into. surrounding adipose tissue. It is 1 cm from the outer surface of. the specimen. The remainder of the bowel wall averages 0.5 cm thick. and has a tan-pink glistening mucosa with a normal pattern and. folds. The adipose tissue is dissected, and soft tan lymph nodes are. identified up to 1.8 cm in greatest dimension. RS-17, following. fixation. BLOCK SUMMARY: 1 - proximal and distal resection margins; 2-6 -. tumor, including relation to uninvolved tissue; 7 - ileocecal valve;. 8 - random colon; 9 - appendix; 10-12 - multiple lymph nodes per. block; 13-15 - one sect ed lymph node per block; 16,17 - sectioned. largest lymph node. MICROSCOPIC DESCRIPTION. The following template summaries the findings in this case: Histologic type: Adenocarcinoma of the colon. Histologic grade: Moderately differentiated. Primary tumor (pT) : Adenocarcinoma invades through the full. thickness of the bowel wall and into surrounding adipose tissue. (pT3). Proximal margin: Negative. Distal margin: Negative. Circumferential (radial) margin: Negative. Distance of tumor from closest margin: See gross description. Vascular invasion: Not identified. Regional lymph nodes (pN) : pN1c. Twenty-one negative lymph nodes. are identified and they are negative for malignancy. However in. block #12, on deeper levels, there is a tumor nodule identified in. fat without histologic evidence of residual lymph node tissue, and. given the presence of this tumor deposit, this is pN1c. Non-lymph node pericolonic tumor: See above. Distant metastasis (pM) : pMX. Other findings: Appendix without specific diagnostic abnormalities. DIAGNOSIS. Terminal ileum, appendix, and right colon, excision. Moderately differentiated adenocarcinoma of the colon, invading. through the full thickness of the muscularis propria and into. surrounding adipose tissue (see microscopic description) . - Margins negative for malignancy. - Tumor deposit identified in pericolonic fat, and twenty-one. lymph nodes negative for malignancy (pN1c). ific. malities. End Of Report ---.",T3,N1,M0,T3N1M0
TCGA-A2-A0CY,"Specimen #: Race: WHITE. Physician (s) : SPECIMEN: A: RIGHT BREAST B: LEFT BREAST C: SENTINEL LYMPH NODE #1. D: LEFT AXILLARY CONTENTS E: NON SENTINAL , ,LT AXILLARY L.N. FINAL DIAGNOSIS: A. BREAST, RIGHT, MASTECTOMY: - BENIGN BREAST TISSUE WITH FIBROCYSTIC CHANGES INCLUDING SCLEROSIS,. MICROCYST FORMATION, USUAL DUCTAL HYPERPLASIA, DUCT ECTASIA, AND. FOCAL MICROCALCIFICATION . B. BREAST, LEFT, MASTECTOMY: TUMOR TYPE: INVASIVE DUCTAL CARCINOMA. NOTTINGHAM GRADE: III/III. NOTTINGHAM SCORE: 9/9. (Tubules= 3, Nuclei= 3, Mitoses= 3). TUMOR SIZE (GREATEST DIMENSION OF INVASIVE COMPONENT) : 3.5 CM. (MEASURED GROSSLY). TUMOR NECROSIS: PRESENT. VENOUS / LYMPHATIC INVASION: IDENTIFIED. MARGINS : - DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.4 CM, FROM THE. SUPERFICIAL LOWER OUTER QUADRANT (BLUE INK) MARGIN. INTRADUCTAL COMPONENT: MULTIFOCAL, HIGH GRADE, SOLID AND COMEDO TYPE. EXTENDING WELL BEYOND THE INVASIVE COMPONENT. NIPPLE INVOLVEMENT: NOT IDENTIFIED. LYMPH NODES 1 OF 22 POSITIVE FOR TUMOR (PARTS C-E). SKIN INVOLVEMENT: NOT IDENTIFIED. ESTROGEN RECEPTORS : POSITIVE (STRONG, >75% OF CELLS, FROM. HER 2 NEU by IHC: NEGATIVE (1+ STAINING, FROM. PROGESTERONE RECEPTORS: NEGATIVE (WEAK, <5% OF CELLS, FROM. PATHOLOGIC STAGE: pT2 N1 MX. ADDITIONAL PATHOLOGIC CHANGES: FIBROCYSTIC CHANGES INCLUDING MICROCYST. FORMATION, FOCAL DUCT ECTASIA, SCLEROIS, USUAL DUCTAL HYPERPLASIA, AND. APOCRINE METAPLASIA. C. LYMPH NODE, LEFT SENTINEL, EXCISION: - AND ONE (1) LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA BY HEMATOXYLIN. EOSIN AND IMMUNOHISTOCHEMICAL (CYTOKERATIN) STAINS. Specimen #: FINAL DIAGNOSIS (continued) : D. LYMPH NODE, LEFT AXILLA, EXCISION: - TWENTY (20) LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA. E. LYMPH NODE, LEFT NON-SENTINEL, EXCISION: - ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. COMMENT: confirmed on the permanent sections. In specimen ""E"" the frozen section diagnosis of metastic carcinoma is. CLINICAL DIAGNOSIS AND HISTORY: year old white female with history of left breast cancer. FROZEN SECTION DIAGNOSIS: SPECIMEN TYPE:LYMPH NODE (SPECIMEN ""E"") . REPORTED TO: AND. # BLOCKS : 1. # SCRAPE PREPS : 1. FROZEN SECTION DIAGNOSIS : POSITIVE FOR METASTATIC CARCINOMA. GROSS DESCRIPTION: A. Received in fresh labeled with the patient's name. of labeled a 927 ""RIGHT BREAST SHORT STITCH SUPERIOR, LONG STITCH LATERAL consists. and gram mastectomy specimen oriented with a short stitch superior. pigmented 1.0 superficial skin ellipse measures 17 x 11.5 cm and. superior to inferior, and 5 cm anterior to posterior. The lightly. long lateral. The specimen measures 24 cm medial to lateral, 19 cm. The deep cm centrally located everted nipple. No discharge or scar displays is noted. a. tan margin is inked in black. Serial sections reveal lobulated yellow. tissue. adipose tissue admixed with 10% moderately dense tan white fibrous. catted grey cysts measuring up to 0.4 cm in greatest dimension. blue The fibrous tissue is predominantly centrally located and shows. 1. Specimen #: GROSS DESCRIPTION (continued) : discrete mass or lesion identified. No lymph nodes are identified. Cassette summary : A1: skin. A2: central. A3: upper outer quadrant. A4: lower outer quadrant. A5: lower inner quadrant. A6: upper inner quadrant. A7: upper outer quadrant. A8: lower outer quadrant. A9: lower inner quadrant. A10: upper inner quadrant. All: representative section of nipple. Matched sections of A1-A6 are submitted in OCT for CBCP protocol. B. Received fresh labeled with the patient's name. designated ""LEFT BREAST SHORT STITCH SUPERIOR, LONG LATERAL"" is a 954. gram mastectomy specimen oriented with a short stitch superior and long. lateral. The specimen measures 24 cm medial to lateral, 18 cm superior. inferior, and 6 cm anterior to posterior. The lightly pigmented. to. superficial located skin ellipse measures 19 x 12.5 cm and displays a medially. deep inked margin is inked black and the superficial lower outer quadrant is. 1.5 cm everted nipple free of discharge. No scar is noted. The. located lobulated pink white indurated mass with focal hemorrhage. The mass. blue. Serial sections reveal 3.5 x 3.2 x 2.8 cm well defined. deep the margin and 0.4 cm of the inked superficial surface. The remainder. within the lower outer quadrant and comes within 3.5 cm of the is. tissue which is diffusely nodular and focally cystic. The admixed. specimen is composed of approximately 50% dense tan white fibrous. of. adipose tissue is unremarkable. No additional masses are identified. No. lymph nodes identified. Cassette summary: B1: skin. B2: lower outer quadrant mass. B3: lower outer quadrant. B4: upper outer quadrant. B5: upper inner quadrant. B6: lower inner quadrant. B7: representative section of closest deep margin. blue B8-B9: ink representative sections of mass with closest point of approach to. margin. 10: representative section of nipple. 10CF. Specimen #: GROSS DESCRIPTION (continued) : C. Received fresh labeled with the patient's name. designated. SENTINEL LYMPH NODE #1"" consists of a 2.0 x 1.7 x 1.0 cm. pink yellow fatty lymph node. The specimen is trisected. Two thirds of the. lymph node are placed in cassette C1 and C2. Matched section of C1 is. placed in. for CBCP protocol. D. Received fresh labeled with the patient's name. designated ""LEFT AXILLARY CONTENTS"" consists of an unoriented irregular. portion of adipose tissue measuring 9.0 x 9.0 x 2.0 cm. Sectioning reveals. multiple pink yellow fatty lymph nodes ranging in size from 0.4 to 2.4 cm. in greatest dimension. Cassette summary. D1-D3: one lymph node each. D4-D7: one lymph node bisected. D8: two lymph nodes bisected, one inked black. D9: four intact lymph nodes. D10: one lymph node bisected. D11: two lymph nodes. D12: four possible lymph nodes. 12CF. E. Received fresh labeled with the patient's name. designated ""NON SENTINEL CLINCALLY SUSPICOUS LEFT AXILLARY LYMPH NODE'. consists of a 1.7 x 1.5 x 1.3 cm lymph node. Cut surface is homogeneous. and firm. A portion is submitted for frozen section. 1C1.",T2,N1,M0,T2N1M0
TCGA-L5-A43E,"PREVIOUS DIAGNOSIS INQUIRY. 2. OPER DATE: REQ DOC: PROCEDURE: SPHS. 1. Distal esophagus proximal stomach. 2 Appendix. 3. Cervical esophageal. margin. Past medical history of esophageal cancer. GERD. Hypertension. Operative Procedure: Transhiatal esophagectomy. PROCEDURE: SPGD. 1. ""Distal esophagus proximal stomach"". Received in a medium container of. formalin is a previously opened transhiatal esophagectomy specimen consisting. of distal esophagus, 7.2 cm in length, 2.3 to 4.7 cm in internal. circumference, proximal stomach, 4.0 cm in length, 9.5 cm in internal. circumference and attached perigastric adipose tissue. Specimen is notable for. a 7.0 x 4.0 x 4.0 cm circumferential tan, multilobulated, polypoid mass. arising from nodular mucosa, 3.5 cm above the gastroesophageal junction,. measurement from short lesion, 3.0 cm from the proximal staple line and 4.5 cm. from the distal gastric resection margin. The mass has tan, solid cut surfaces. and grossly does not appear to invade into the underlying wall. The uninvolved. esophageal and gastric mucosa are unremarkable. The perigastric adipose tissue. is dissected and palpated to reveal ultiple possible lymph nodes, ranging. from 0.2 to 1.0 cm in greatest dimension. 1A-D. One continuous longitudinal section through tumor submitted from. proximal to distal to include esophageal and gastric mucosa, proximal ends. inked orange. 1E-G. Mass to include blue inked radial soft tissue margins. 1H-J. Tumor. IK-M. Lymph node candidates submitted intact. IN and o. Each contain one lymph node candidate. Bisected. Fat. retained. 2. ""Cervical esophageal margin"". Received in a tall small container of. formalin is a 0.8 cm in length, 1.2 cm in diameter stapled cuff of esophagus. The staple line is shaved and the specimen is submitted en face in cassette. 2A. Staple line retained. 3. ""Appendix"". Received in a tall small container is a 5.5 cm in length, 0.8. cm in diameter appendix with attached mesoappendix. The serosa is a tan-pink,. smooth, glistening with arborizing vessels. The appendix is serially cross. sectioned to reveal a fatty wall, 0.3 cm in greatest thickness surrounding a. pinpoint tumen. 3A, Standard sections of appendix. PREVIOUS DIAGNOSIS INQUIRY. 3. PATIENT NBR: OPER DATE: REQ DOC: PROCEDURE: SPMI. ESOPHAGUS, GASTROESOPHAGEAL JUNCTION, INCLUDING CARDIA, CARCINOMA. Distal esophagus. SIZE: 7.0 cm including both polypoid high-grade dysplasia and. carcinoma. HAS IT BEEN TREATED PREOPERATIVE WITH CHEMO/RADIATION THERAPY?: No. TYPE OF CARCINOMA: Adenocarcinoma arising in Barrett's mucosa. DEPTH OF INVASION: Superficial submucosa. NUMBER OF POSITIVE LYMPH NODES / TOTAL NUMBER OF NODES EXAMINED: 0/10. DISTANT METASTASIS: Unknown. RESECTION MARGIN INVOLVED: pT1t NO. PROCEDURE: SPDX. 1-2. Distal esophagus, resection: Invasive adenocarcinoma extending into. superficial submucosa arising from extensive Barrett's high-grade dysplasia. Margins free. Ten Lymph nodes negative for carcinoma. Please see TEMPLATE for. details. See COMMENT. 3. Appendix, resection: No significant abnormality. COMMENT: Most of the carcinoma is differentiated and confined to the mucosa. There is. one focus of undifferentiated carcinoma that extends into the superficial. submucosa.",T1,N0,M0,T1N0M0
TCGA-EL-A3GZ,"History Case. Sex: F. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. the section ""SPECIMEN"" may have been added. DIAGNOSIS. TISSUE FROM THYROID RULE OUT PARATHYROID: Lymphoid tissue, non-parathyroid. (B) THYROID, STITCH ON RIGHT LOBE: PAPILLARY CARCINOMA, LEFT LOBE, MEASURING 1.8 CM. PRESENCE OF VASCULAR INVASION WITH A FOCUS OF INTRATHYROIDAL. METASTASIS (LEFT LOBE) (< THAN 1.0 MM). Margins of resection free of tumor. Two capsular lymph nodes, (left) no tumor present. Two benign parathyroid glands (right). Entire report and diagnosis completed by: Report released by: GROSS DESCRIPTION. (A) TISSUE FROM THYROID RULE OUT PARATHYROID - Consists of a 0.2 x 0.2 x 0.2. cm tan-pink portion of soft tissue. The entire specimen is submitted for. frozen section diagnosis in A. (B) THYROID, STITCH IS ON RIGHT LOBE - A total thyroidectomy, black suture is. present at the designated positions. The right lobe measures 5.5 x 3.0 x 1.2. cm, the left lobe measures 5.3 x 2.8 x 1.4 cm. There is minimal isthmus. tissue. within the left upper lobe of thyroid, there is a 1.8 x 1.8 x 1.6 cm. ell-circumscribed, white-tan firm nodule. The tumor is approaching to the. capsular surface. NO other gross lesions are identified. The specimen is. entirely submitted. INK CODE: Capsular surface is inked black. SECTION CODE: B1-B12, left thyroid lobe; 86, 88, B9 contains tumor;. B13-B20, right thyroid lobe. SNOMED CODES. M-80503 T-86000.",T1,N0,M0,T1N0M0
TCGA-BH-A1FN,"Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE OF LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: R BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: R SEGM MAST AND AXILL NODE DISS. CLINICAL HISTORY: MATERIAL SUBMITTED: A) RIGHT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. routine sutures. B) RIGHT AXILLA, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: FROZEN SECTION: Right breast tissue; 8.0 by 8.0 by 3.0 cm. Tumor is 2.6 by 2.6 by 2.5 cm. Margins grossly. free. Frozen Section Diagnosis: Infiltrating ductal carcinoma. ER/PR taken. FINAL DIAGNOSIS: FINAL DIAGNOSIS: AEAFS) RIGHT BREAST MASS. - INFILTRATING DUCTAL CARCINOMA, NOT OTHERWISE SPECIFIED, HISTOLOGIC GRADE 3, NUCLEAR GRADE POOR, VASCULAR. INVASION PRESENT, TUMOR NECROSIS REPRESENTING 30% OF TUMOR MASS; TUMOR GREATEST DINGTER 2.6 BY 1.6 BY 2.5. CM. - INKED MARGINS FREE OF TUMOR. B) RIGHT AXILLARY NODES: - TWENTY-NINE (29) LYMPH NODES, FREE OF TUMOR. Criteria. Diagnusis riscrepancy. Primary Tumor Site Discivinary. enor Millenancy Hi tory. must/syrchionous useis (circle): initials MA Date jewed /. Re.",T2,N0,M0,T2N0M0
TCGA-MK-A4N7,"PATHOLOGIC DIAGNOSIS. THYROID, TOTAL THYROIDECTOMY: - PAPILLARY THYROID CARCINOMA, CLASSICAL VARIANT. - TUMOR FOCALITY: UNIFOCAL. - TUMOR LATERALITY: ISTHMIC. - TUMOR SIZE: GREATEST DIMENSION: 2.5 CM. - ADDITIONAL DIMENSIONS: 2.3 X 1.8 CM. - MARGINS: NEGATIVE FOR TUMOR (SEE COMMENT). - TUMOR CAPSULE: COMPLETE. - TUMOR CAPSULAR INVASION: PRESENT. - EXTENT: FOCAL. - LYMPHOVASCULAR INVASION: PRESENT. - EXTENT: FOCAL. - PERINEURAL INVASION: NOT IDENTIFIED. - EXTRATHYROIDAL EXTENSION: NOT APPLICABLE. PATHOLOGIC STAGING: PRIMARY TUMOR (pT): pT2 (TUMOR MORE THAN 2 CM,. BUT NOT MORE THAN 4 CM, LIMITED TO THYROID). REGIONAL LYMPH NODES (pN): pNO (NO REGIONAL LYMPH NODE METASTASIS). TWO LYMPH NODES IDENTIFIED, BOTH NEGATIVE FOR METASTATIC. CARCINOMA. DISTANT METASTASIS (pN): NOT APPLICABLE. PATHOLOGIC STAGE: pT2N0MX (STAGE I) (PATIENT UNDER 45 YEARS). COMMENT: At the left posterior inferior margin the tumor seems to abut the ink,. however extensive cautery artifact is present, distorting the specimen and. making interpretation extremely difficult. Deeper levels were taken and a. thin distorted fibrous capsule is identified. Final interpretation is. negative for tumor. However lymphovascular invasion is present. Clinical. correlation and close follow-up is recommended. Pertinent Clinical Information. Papillary thyroid CA. Operative Findings: 3 cm nodule in right inferior lobe. Clinical Diagnosis: Papillary thyroid CA. Gross Description. Specimen Material: Total thyroidectomy, stitch marks right superior pole. The case is received in one part labeled with the patient's name, medical record number and. given accession number. , and it. is accompanied by a requisition form labeled with the same name and. Received in formalin labeled ""TOTAL THYROIDECTOMY, STITCH MARKS RIGHT. SUPERIOR POLE"" is a 15.0 gram total thyroidectomy specimen, 6.0 x 4.0 x 1.9. cm. The specimen has a tan-red, well-encapsulated, focally shaggy surface. The anterior aspect is inked blue and the posterior aspect is inked black. Sectioning from superior to inferior displays a 2.5 x 2.3 x 1.8 cm solitary,. encapsuled nodule in the lower pole, 1.0 cm inferior to isthmus. Sectioning. of the nodule displays a mottled, tan-red cut surface. The nodule abuts the. anterior and posterior margins. The remaining thyroid parenchyma is tan-red. and spongy. No other discrete lesions are identified. The specimen is. bisected into right and left, and entirely submitted sequentially from. superior to inferior as follows: Blocks 1-8: right, with nodule present in blocks 5-8. Blocks 9-14: left, with nodule present in blocks 12-14. Microscopic Description. Sections show an encapsulated tumor composed of papillary structures with. central fibrovascular cores lined by crowded cuboidal to cylindrical cells. with high N/C ratios, nuclear grooves and optically clear nuclei,. characteristic of papillary thyroid carcinoma, classical variant. The tumor. is focally invading the capsule without extracapsular extension. Lymphovascular invasion is identified. Perineural invasion is not seen. The remainder of the thyroid parenchyma is unremarkable with focal minimal. lymphocytic aggregates between the thyroid follicles of no pathologic. diagnostic significance. Two lymph nodes are identified in one of the. sections, both negative for metastatic carcinoma. The staff pathologist listed below reviewed this case. Pathology Resident.",T2,N0,M0,T2N0M0
TCGA-44-6146,"SPECIMEN. A. Level 9 node. B. Level 10 node. C. Level 11 node. D. Left lower lobe. E. Level 5 node. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung lesion, rule out cancer. POST-OP DIAGNOSIS: Diagnosis: lung lesion. FROZEN SECTION DIAGNOSIS. lower lobe, lobectomy - Mucinous adenocarcinoma. lobe, bronchial margin - No tumor seen. GROSS DESCRIPTION. A. Received fresh labeled ""level 9 node"" is a 1.2 cm in. greatest dimension nucoid-appearing dusky gray-black. tissue. in keeping with. y. h. d. hich is bisected and entirely submitted. in one block. B. Rec. es labeled ""level 10 node"" are three. fragmented, markedly cauterized gray-black tissues ranging. 0. 1. in greatest dimension which are submitted in toto. Received fresh labeled ""level 11 node"" are two rubbery. tan-red to gray-black tissues in keeping with lymph nodes. measuring 0.35 cm in greatest dimension and 1.2 X 0.6 X 0.4 cm. The. larger tissue is bisected a. e specimens are entirely submitted. in two blocks as labeled. BLOCK S. A. 1 - Bisected larger tissue; 2 - smaller tissue in. toto. D. Received fresh labeled ""left lower lobe""it is a single. piece of lung tissue measuring 25 X 18 X 10 cm in greatest. dimensions. The pleural surface is focally puckered. Ink is. applied at the pleural surface of the specimen is serially. sectioned. On cut section the lung consists of firm tan. gelatinous/mucinous tissue which measures 21 X 14 X 10 cm in. greatest dimensions. Only a thin rim of peripheral uninvolved lung. tissue is present. The firm tan tissue does not extends to involve. the tissue surrounding the bronchial margin. RS: DFS1 and DFS2: Representative sections of lung tissue, DFS 3 bronchial margin, D1-. D13: sections of lung lesion, (D4 and D5: pleural puckering) D14 -. uninvolved lung, D15 - possible nodes. E. Received fresh labeled ""level 5 node"" are four soft. gray-black tissues ranging from. 0. C. n greatest. dimension which are submitted in toto. MICROSCOPIC DESCRIPTION. A. Sections of the level 9 node demonstrate no evidence of. metastasis in one lymph node. B. The level 10 lymph node demonstrates 3 lymph nodes with no. evidence of metastasis. C. The level 11 lymph node demonstrates no evidence of metastasis. in two lymph nodes. D. The following template applies to the left lower lobe: Histologic type: Mucinous adenocarcinoma. Histologic grade: Well-differentiated. Primary tumor: 21 cm (pT3). Margins of resection: Uninvolved. Pleura: uninvolved. Regional lymph nodes: No evidence of metastasis in 3 lymph nodes. on. this specimen and 10 additional lymph nodes in specimens A., B.,. C. and E. (pNO). Distant metastasis: Cannot be evaluated by this specimen (pMX) . Other findings: The specimen shows a well differentiated mucinous. adenocarcinoma. Much of the specimen demonstrates lepidic growth. which is suggestive of a bronchoalveolar carcinoma. Multiple foci. of invasion are identified however. Almost the entire lobe of the. lung was involved and all sections taken from the 21 cm lesion. identified grossly contain mucinous adenocarcinoma. 14, 15X2, 5, 3X4. B. There is no evidence of metastasis in 4 level V lymph nodes. DIAGNOSIS. A. Level 9 lymph node, resection: - No evidence of metastasis in one lymph node (0/1). B. Level 10 lymph nodes, resection: - No evidence of metastasis in 3 lymph nodes (0/3). C. Level 11 lymph nodes, resection: - No evidence of metastasis in 2 lymph nodes (0/2) . D. Lung, left lower lobe, lobectomy. - Mucinous adenocarcinoma, well-differentiated, and 21 cm in. greatest - No evidence of metastasis in 3 lymph nodes (0/3). - Surgical margin uninvolved. E. Level 5 lymph nodes, resection: - No evidence of metastasis in 4 lymph nodes (0/4) .",T3,N0,M0,T3N0M0
TCGA-BR-6803,STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Stomach. Tumor size: 4.5 X 5 X 1.2 cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Undifferentiated. Tumor extent: Adjacent structures. (specify) - greater omentum. Lymph nodes: 0/4 positive for. metastasis (Regional 0/4). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.,T3,N0,M0,T3N0M0
TCGA-V4-A9F5,"Enucleation of the right eye. Macroscopy: The eyeball measures 26 mm in diameter and the posterior optic nerve segment 7. mm, associated with a fragment of adipose tissue of 5 mm. Presence of an extra-. scleral nodule measuring 6 mm. At the section, an endo-ocular tumor measuring. 20X15 mm main lines is observed. Tumor specimens have been taken for. cryopreservation and genetic studies, then the piece has been fixed and included. entirely according to 13 tissue blocs. Microscopy. The tumor observed macroscopically presents the histological features of an uveal. melanoma. It is composed of a mix of epithelioid (90%) and fusiform (10%) cells, the. latter being predominant. These cells present a large nucleus with prominent. nucleolus. The cytoplasm is most often pigmented. Presence of mitotic features (up. to 10 mitoses per 10 HPF). The tumor is developed at the posterior part of the ciliary body which is partially. invaded, without extension to the iris. The tumor invades the sclera and present an. extra-scleral nodule of 6 mm observed macroscopically. The tumor is located at distance from the intra-ocular emergence of the optic nerve. Thus the optic nerve on its entire course and the meningeal sheaths are free of. tumor. The cut end of the optic nerve is also free of tumor. Conclusion: Uveal melanoma composed mainly of fusiform cells. Tumor size: 20 mm main line. Focal extension to the ciliary body without infiltration of the iris. Tumor infiltration of the sclera with an extrascleral nodule of 6 mm. Optic nerve in its entire course and cut end, and meningeal sheaths free of tumor.",T4,N0,M1,T4N0M1
TCGA-DD-AADD,"CLINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo. GROSS: Specimen status: Fresh. Operation: Right posterior sectionectomy. Organ: Liver, right posterior (15.0 X 10.5 X 8.5 cm, 780.0 gm), (16.0 x 5.0 x 3.5 cm, 75.5 gm). Adrenal gland (5.5 X 2.5 X 0.3 cm). Gallbladder (8.5 cm in length, 4.5 cm in diameter). Lesion: Heaptic mass. Size: 7.5 X 6.6 X 5.1 cm. Cut surface: Encapsulated, pale tan and nodular mass with central necrosis. Gross type: Multinodular confluent. Extent: Confined to the capsule. Resection margin: Not involved, grossly (safety margin: 1.5 cm). Remaining parenchyme: Unremarkable. [Gallbladder]. Serosal surface: Yellowish pink and smooth. Mucosal surface: Dark green and velvety, no mural nodule. Representative sections are submitted. Gross photo: Present. Blocks. T1-6, mass of liver X 6. RM, tumor with resection margin X 1. L, nontumorous liver parenchyme x 1. A1-2 tumor and adjacent adrenal gland X 2. B1-2, liver parenchyma X 2. GB, gallbladder x 1. MICROSCOPIC: Tumor type: Hepatocellular carcinoma. Edmondson-steiner grade. The worst differentiation IV. The major differentiation III. Histologic type: Cord-like and nesting. Fatty change: No. Fibrous capsule formation: Yes. Capsular infiltration: Yes, focal. Septum formation: Yes. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: Not identified. Vascular invasion: No. Bile duct invasion: No. Remaining liver parenchyme: Chronic hepatitis, HBV associated. NOT reported. Gross: liver,ectomy,Hepatocellular carcinoma. T56000, P10, M81703. adrenal gland,ectomy,no tumor. T93000, P10, M09450. gallbladder,ectomy,autolysis. T57000, P10, M54001. DIAGNOSIS: Liver, right posterior, sectionectomy: Hepatocellular carcinoma. Adrenal gland, right, adrenalectomy: No tumor present. Gallbladder, cholecystectomy: Autolysis. Suggestion :",T1,N0,M0,T1N0M0
TCGA-38-4627,"Lagnosis: A: Lung, right upper lobe, lobectomy. -- Adenocarcinoma, moderately differentiated, 2.7 cm diameter, without angiolymphatic invasion, without pleural. involvement, bronchial margin not involved. Lymph nodes, peribronchial - Metastatic adenocarcinoma (1/4), without extracapsular extension. B: Lymph node, R4, removal. No metastatic carcinoma identified (0/1). C: Lymph node, station 11, removal. - No metastatic carcinoma identified (0/1). Comment. None. Clinical History: The patient is with right NSCLC, in for right thoracotomy. Gross Description: Received are three appropriately labeled containers. Container A is additionally labeled ""RUL."". Specimen fixation: formalin. Type of specimen/parts of lung received: right upper lobectomy. Size of specimen: 13.8 x 9.2 x 3.0 cm. Weight of specimen: 215 grams. Other attached structures: n/a. umor location: central. Tumor size and description: The tumor mass is a 2.7 x 2.0 x 1.6 cm firm, tan mass with stellate borders and. focal areas of gray discoloration scattered across the cut surface. Relationship of tumor to bronchus: does not grossly involve. Distance of tumor to bronchial margin: approximately 2.9 cm. Relationship/distance of tumor to pleura: the tumor nodule is grossly abutting the overlying blue. inked. pleura. Distance of tumor to other surgical margins: There is a complex staple line running across the specimen, and the. tumor nodule is at least 0.6 cm from the staple line. Presence/absence of satellite tumor nodules: absent. Involvement of attached structures by tumor: n/a. Description of nontumorous lung: Dark, red/tan, soft, spongy and aerated lung parenchyma with no other lesions. or abnormalities identified. Comment: The following is submitted to Tissue Procurement: the bronchial margin was removed and the next cross. section. of. bronchus was given to Tissue Procurement, representative tumor and representative normal. lung were also given to Tissue procurement. Block Summary: A1 - bronchial margin and vascular margins. A2 - one peribronchial lymph node candidate, bisected. A3 - one peribronchial lymph node candidate. A4, A5 - tumor overlying pleura. A6 - tumor and adjacent parenchyma. ""7 - uninvolved lung. Container B is additionally labeled ""R4."" It holds a 0.8 x 0.5 x 0.3 cm fragment of dark purple/gray. tissue. which is bisected and submitted in block B1, NTR. Container. C. is additionally labeled ""station 11.' It holds a 0.6 x 0.5 x 0.3 cm fragment of dark gray/red soft. tissue, which is submitted in block C1,. Light Microscopy: ight microscopic examination is performed by. (Specimen A). Tumor histologic type (WHO classification) : adenocarcinoma. Tumor histologic grade (WHO classification) : moderately differentiated. Tumor size (greatest dimension) : 2.7 cm diameter. Histologic assessment of surgical margins: negative. pleural involvement: not identified. In situ carcinoma: not identified. Invasion: angiolymphatic - not identified. perineural - not identified. Lymph nodes (by node group) : peribronchial 1/4, R4 0/1, station 11 0/1. Extracapsular extension of tumor in lymph nodes: not identified. Findings in nontumorous lung: anthracotic pigment.",T1,N1,M0,T1N1M0
TCGA-60-2719,"SPECIMEN(S): A. 4R LYMPH NODE. B. LEVEL 7. C. 4L LYMPH NODE. D. RIGHT LEVEL 4 LNODE. E. RIGHT UPPER LOBE. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: RUL small cell lung ca. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA-FSD: Lymph nodes - negative for tumor. FSE: Bronchial margin - negative for tumor. GROSS DESCRIPTION: A. 4R LYMPH NODE. Received fresh for frozen section is a tan-pink lymph node 0.4 x 0.2 x 0.1 cm. The specimen is. submitted entirely for frozen section in FSA1. B. LEVEL 7. Is a tan-pink aggregate of lymphoid tissue 0.7 x 0,4 x 0.2 cm. The entire specimen is submitted. for frozen section in FSB1. C. 4L LYMPH NODE. Is an aggregate of lymphoid tissue 0,5 X 0.3 x 0.2 cm. The specimen is submitted entirely for. frozen section in FSC1. D. RIGHT LEVEL 4 LYMPH NODE. Is a tan-pink aggregate of lymphoid tissue 0.8 x 0.8 x 0.3 cm. The specimen is submitted entirely. for frozen section in FSD1. E.LUNG, RIGHT UPPER LOBE,LOBECTOMY;. Received fresh and labeled with the patient name. right upper lobe"", is a. 121-gram lobectomy specimen measuring 14.5 x 10.7 x 2.3 cm. There is a defect on the pleural. surface exposing a mass measuring 3.0 x 2.5x1.5 cm. The mass is hemorrhagic and necrotic. It. extends to within 0.3 cm of the pleural margin and 1.2 cm from the bronchial margin. A shave. section is taken of the bronchial margin for frozen section. The bronchi are opened and they. have a smooth tan appearance. The lung is sectioned and the parenchyma has a variegated pink. and anthracotic appearance as well as areas of congestion. Possible anthracotic lymph nodes are. identified. Portions of mass were submitted for tissue procurement. Representative sections are. submitted as follows: FSE1: Shave section of bronchial margin. E2-E5: Sections of mass including relationship to normal appearing parenchyma and. pleural margin. E6: Additional portions of uninvolved parenchyma. E7: Possible lymph nodes. DIAGNOSIS: A. 4R RIGHT LYMPH NODE. - ANTHRACOSIS OF ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). B. LEVEL 7 LYMPH NODE: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). C. 4L LEFT LYMPH NODE: - ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). D. RIGHT LEVEL 4 LYMPH NODE: ONE LYMPH NODE - NEGATIVE FOR TUMOR (0/1). E. LUNG, RIGHT UPPER LOBE, LOBECTOMY SPECIMEN: - NON SMALL CELL CARCINOMA (CONSISTENT WITH MODERATE TO. POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA) WITH AREAS OF. NECROSIS OF UPPER LOBE OF RIGHT LUNG. - SIZE OF TUMOR 3.0 X 2.5 X 1.5 CM. - CONGESTION AND FOCAL ATELECTATIC CHANGE. - SIX PERIBRONCHIAL LYMPH NODES - (0/6) NEGATIVE FOR TUMOR. - MARGINS OF RESECTION - NEGATIVE FOR TUMOR. SYNOPTIC REPORT - LUNG. Specimens Involved. Specimens: E: RIGHT UPPER LOBE. Surgical Procedure: Lobectomy. Laterality: Right. Tumor Site: Upper lobe. Tumor Location: Central. Tumor Size: Greatest diameter: 3cm. Additional dimensions: 2.5cm x 1.5cm. WHO CLASSIFICATION. Squamous cell carcinoma. Comment(s): Non small cell carcinoma. Histologic Grade: poorly to moderately differentiated. Angiolymphatic Invasion: Absent. Bronchial Margins: Bronchial margins uninvolved. Tumor Distance from margin: 1.2cm. Visceral Pleural Involvement: Absent. Satellite Tumor(s): Absent. Lymph Node Involvement: N1: Ipsilateral Hilar and/or Peribronchial (levels 10-14). Negative 016. N2: Ipsilateral Mediastinal and/or Subcarinal (Levels 1-9). Negative 0/3. N3: Contralateral Mediastinal/Hilar, Scalene or Supraclavicular. Negative 0/1. Non-Neoplastic Lung: Emphysematous changes. congestion and focal atelectatic change. Additional Pathologic Findings: None identified. Pathological Staging (pTNM): pT 1. M x.",T1,N0,M0,T1N0M0
TCGA-JY-A6FG,"M. Facility: Specimen(s) Received. 1. Stom-Resection: stomach and distal esophagus stitch marks proximal margin. 2. Lymph node: common hepatic nodes. 3. Lymph node: common hepatic nodes. Diagnosis. 1. Stomach and distal esophagus, total gastrectomy and distal esophagectomy: - squamous cell carcinoma, well to moderately differentiated, involving GE junction and proximal stomach with. approximately 1.5 cm extension into distal esophagus - see synoptic data and comment. - resection margins: negative for carcinoma. - metastatic squamous cell carcinoma in 5/18 lymph nodes (total lymph node count includes specimens #2 and #3). 2. Lymph node: common hepatic nodes. - lymph nodes x2: negative for carcinoma. 3. Lymph node: common hepatic nodes. - lymph nodes x3: negative for carcinoma. Comment. 1. The tumor is centered in the proximal stomach where it involves the entire gastric circumference. The tumor involves. the GE junction and approximately 1.0 cm of the distal esophagus. On the esophageal side, the tumor focally invades. adventitia and is 0.2 cm from the adventitial surface at the closest point. On the gastric side, the tumor extends into. perigastric fat and is approximately 1.2 cm from the radial margin. The tumor is a well to moderately differentiated. squamous cell carcinoma and given the presence of GEJ and distal esophageal involvement, is staged as an esophageal. carcinoma. There are a total of 18 lymph nodes identified including specimens #2 and #3, 5 of which contain metastatic. squamous cell carcinoma. Synoptic Data. Specimen Type: Esophagogastrectomy. Tumor Site: distal esophagus. Tumor Size: Greatest dimension: 17.0 cm. Additional dimensions; 6.3 x 2.2 cm. Histologic Type: Squamous cell carcinoma. Histologic Grade: G2: Moderately differentiated. Pathologic Staging (pTNM): pT3: Tumor invades adventitia. pN1b: 4 to 7 nodes involved. Number of lymph nodes examined: 18. Number of lymph nodes involved: 5. Margins: Proximal margin-Uninvolved by invasive carcinoma. Distal margin-Uninvolved by invasive carcinoma. Circumferential (Adventitial) margin-Uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 2.0 mm. Margin: adventitial. Venous (Large Vessel) Invasion (V): Absent. Lymphatic (Small Vessel) Invasion (L): Present. Pathologic Staging is based on AJCC/UICC TNM, 6th Edition. Gross Description. 1. STOMACH RESECTION FOR TUMOR. (INCLUDES GE JUNCTION TUMORS). GROSS EXAMINATION. RESECTION SPECIMEN: Distal esophagectomy and Total gastrectomy. FIXATION: Fixed. DIMENSIONS: Length along lesser curvature: 17.0 cm. Length along greater curvature: 33.0 cm. Circumference of distal gastric margin: 5.0 cm. Length of tubular esophagus: 2.0 cm. Circumference of proximal (esophageal) margin: 3.5 cm. TUMOR: - GEJ, proximal stomach and distal esophagus; grossly ~ 1.5 cm into distal esophagus and 4.8 cm into the proximal. stomach. - CONFIGURATION: exophytic, ulcerative. - DIMENSIONS: Diameters 6.3 x 17.0 cm. Depth 2.2 cm. - DESCRIPTIVE CHARACTERISTICS: Tan-brown in color, solid in consistency. With centrally ulcerated area and. irregular heaped up edges. - PERFORATION: no. - DISTANCE FROM MARGINS: - PROXIMAL: less than 1.0 cm. - DISTAL: 9.5 cm. - RADIAL: 1.2 cm (non-peritonealized soft tissue margin closest to deepest tumor penetration. ESTIMATED DEPTH OF INVASION : adventitia of esophagus and perigastric fat. LESIONS IN NONCANCEROUS STOMACH: None. LYMPH NODES: Multiple perigastric lymph nodes along the greater and lesser curvatures ranging in size from 0.7 to. 2.5-cm. Representative sections are submitted as follows: 1A-1B- frozen section blocks resubmitted. 1C-distal gastric resection margin en face. 1D- medial resection margin perpendicular sections. 1E-1H-tumor at the GE Junction and distal esophagus. 1I-1R-tumor at the proximal stomach showing it to deepest invasion. 1S-uninvolved distal stomach. 1T-1U-one lymph node each block bisected. 1V-1W-one lymph node serially sectioned. 1X-one lymph node bisected. 1Y-one lymph node bisected. 1Z-5 lymph nodes. 1AA-3 lymph nodes. Four pieces of tumor/normal were taken for tissue bank. 2. The specimen container is labeled with the patient's name and as ""Lymph Node: Common hepatic nodes. consists of two fragments tissue measuring 1.8 x 1.0 x 0.6 and in other and 4.2 x 3.1 x 0.3-cm received fresh, This is. examined at intraoperative consultation by frozen section performed on part of the specimen. On the bigger piece of. tissue there is a nodule identified measuring 1.1 x 1.0 x 0.2 cm. The specimen is submitted in toto as follows: 2A-2B- frozen section blocks resubmitted. 2C-remainder of fatty tissue. 3. The specimen container is labeled with the patient's name and as ""Lymph Node: Common hepatic nodes. consists of a piece of fatty tissue measuring 2.0 x 1.7 x 0.6 and two received in 10% buffered formalin. 3A specimen is bisected and submitted in toto. in. Quick Section Diagnosis. 1. Stomach and distal esophagus (proximal esophageal margin en face): - Tumour grossly > 1.0 cm away from margin. - En face margin is negative for malignancy. 2. Common hepatic nodes: Two lymph nodes found, negative for malignancy (0/2).",T3,N1,M0,T3N1M0
TCGA-F2-6879,"Diagnosis: FSA : Liver, segment 7, biopsy. - Benign liver with canalicular cholestasis, no carcinoma. identified. FSB: Liver, segment 3, medial, biopsy. - Benign liver with canalicular cholestasis, no carcinoma. identified. FSC: Liver, segment 2, biopsy. - Benign liver with canalicular cholestasis, no carcinoma. identified. FSD: Common bile duct margin, biopsy. - Bile duct, no carcinoma identified. FSE: Pancreatic duct margin, biopsy. - Carcinoma in situ involving pancreatic duct margin, suspicious. for stromal. invasion. FSF: Pancreatic margin, additional, biopsy. - Pancreatic parenchyma and fibrin, no carcinoma identified. - No duct for evaluation. FSG : Pancreatic margin #3, biopsy. - Pancreatic parenchyma and duct, no in situ or invasive. carcinoma identified. H: Gallbladder, cholecystectomy. - Gallbladder, focal chronic cholecystitis, no stones. identified, no carcinoma. identified. I: Stomach, duodenum and pancreas, en bloc Whipple resection. Tumor histologic Type: adenocarcinoma. Histologic grade moderately differentiated. Tumor size: 4.5 cm. Extent of invasion: - Peripancreatic soft tissues : positive (peripancreatic fat, IS,. 16, I15). - Duodenum: wall involved (I11, I12). - Ampulla wall involved (I11). Lymphatic Invasion: not identified. Venous Invasion: not identified. Perineural Invasion: not identified. Surgical margins : - Pancreatic neck: negative (4 mm to inked margin, I13). - Bile duct: negative (I1). - Circumferential/deep : negative (<1 mm to inked margin (I15) ). - Proximal (gastric) : negative (I3, I4). - Distal (duodenal) : negative (I2). Regional lymph nodes: metastatic adenocarcinoma (2/11) larger. metastasis 6 mm diameter, without extracapsular extension. Additional findings focal pancreatic parenchymal fibrosis and. atrophy,. focal peri-common bile duct acute inflammation (I1) . AJCC Stage: pT3 pN1 pMx. Note: This pathologic stage assessment is based on information. available at the. time of this report, and is subject to change pending clinical. review and. additional information. Intraoperative Consult Diagnosis: Frozen sections were requested by Dr. in. year-old. with pancreatic head mass. FSA1 Liver, segment 7, biopsy. - Benign liver with cholestasis, no tumor seen. FSB1 : Liver, segment 3, medial, biopsy. - Benign liver with cholestasis, no tumor seen. FSC1: Liver, segment 2, biopsy. - Benign liver with cholestasis, no tumor seen. FSD1 : Common bile duct margin, biopsy. - No tumor seen. FSE1 : Pancreatic duct margin, biopsy. - At least carcinoma in situ, focally suspicious for invasive. carcinoma. FSF1: Pancreatic margin, additional, biopsy. - Pancreatic parenchyma, no duct for evaluation. FSG1 : Pancreatic margin #3, biopsy. - No tumor seen. Frozen Section Pathologist: Clinical History : Not dictated. Gross Description: Specimen A is received fresh for frozen section and is a 7 X 5 X. 2 mm red/brown. soft tissue fragment, which was frozen as FSA1, NTR. Specimen B is received fresh for frozen section and is a 10 X 7. X 3 mm red/brown. soft tissue fragment, which was frozen as FSB1, NTR. Specimen C is received fresh for frozen section and is a 6 X 1 X. 1 mm red/brown. soft tissue fragment, which was frozen as FSC1, NTR. Specimen D is received fresh for frozen section and is a 9 X 6 X. 4 mm red/brown. soft tissue fragment, which was frozen as FSD1, NTR. Specimen E is received fresh for frozen section and is a 4 x 3 X. 2 mm pink/tan. soft tissue fragment, which was frozen as FSE1, NTR. Specimen F is received fresh for frozen section and is a 6 X 4. X. 2 mm red/tan. soft tissue fragment, which was frozen as FSF1, NTR. Specimen G is received fresh for frozen section and is a 2.5 X. 0. 8 x 0.3 cm. red/tan soft tissue fragment, with a stitch on one side. indicating the true. margin. The surface is inked blue. The specimen was frozen as. FSG1, NTR. Specimen H was received in a formalin-filled - container labeled. ""gallbladder"". Previously opened The presumed cystic duct is widely patent. The remainder. of the gallbladder appears complete. Measurements 10. X 3.6 X 2.0 cm. External surface: Roughened on the hepatic surface, but. otherwise. pink/tan, subtly discolored green, smooth and glistening and. unremarkable. Wall thickness : 2.5 mm on average. Mucosa: Green/brown, velvety and unremarkable with no mucosa. mass. lesions readily identified. Stones present Not identified. Other comments: Gallbladder is partially filled with sticky,. viscous. dark brown/green bile. This bile is adherent to the mucosa. Block # : H1. Specimen I : Specimen fixation: Formalin. Specimen type: Unspecified, but believed to be standard Whipple. Orientation: Inking : common bile duct/yellow, pancreatic. margin/blue, uncinate margin/black, body/green, gastric. margin/orange, duodenal. margin/red. Tumor location: Pancreatic head. Gross appearance of tumor: Solid pale yellow/white mass lesion. encompassing the majority of the pancreatic head. There are no. areas of. necrosis, hemorrhage or calcification readily identified. Tumor dimensions : 4.5 x 2.0 x 3.0 cm. Extent of invasion. Confined/nonconfined to the pancreas: Grossly the tumor appears. to. be invading through the duodenal wall and distorting the. duodenal mucosal. This. occurs in the areas of the ampulla. Involvement of the ampulla: Not grossly involved. Involvement of the duodenum: Present. Involvement of the bile duct : Absent. Involvement of adjacent blood vessels: N/A. Spleen (if applicable) : N/A. Duodenum (if applicable) : N/A. Gallbladder (if applicable) : N/A. Stomach (if applicable) : Not involved. Surgical margins: Pancreas: Blue inked pancreatic surgical margin, focally. close. Bile duct : Negative. Proximal (small bowel or stomach) margin: Negative. Distal (small bowel) margin: Negative. Peripancreatic soft tissues: Green inked pancreatic margin. focally. close. Lymph nodes : Multiple lymph node candidates are identified. from approximately 3 X 3 x 3 mm to 1.0 X 0.6 X 0.4 cm. Other remarkable findings The gastric serosa is red/tan, smooth. and glistening and unremarkable. The gastric wall is 2 mm thick. on average and the mucosa is red/tan with normal architecture. The duodenal serosa is red/tan, smooth and glistening and. unremarkable. The duodenal mucosa is dark brown/tan, glistening. with normal architecture. No duodenal abnormalities are readily. appreciated. There is some chalky yellow/white discoloration to. the pancreatic parenchyma in the distal pancreas, this may. represent fat necrosis. Digital photograph taken : No. Tissue submitted for special investigation: Tumor was given to. tissue. Block Summary : Inking : common bile duct/yellow, pancreatic margin/blue,. uncinate margin/black,. body/green, gastric margin/orange, duodenal margin/red. Il - common bile duct margin en face. I2 - duodenal margin en face. I3 - I4 - majority of gastric margin en face. I5 - I6 - perpendicular section to blue inked pancreatic body. margin. I7 - black inked uncinate margin en face. I8-I10 - - duct from ampulla towards margin, respectively. I11 - tumor involving duodenum. I12 - additional tumor and duodenum. I13 - additional tumor. I14-I15 - - distal pancreas surrounding adipose tissue (? Fat. necrosis. present). I16 - stomach. I17 - duodenum. I18 - one lymph node candidate from area of common bile duct. margin,. sectioned. I19-I20 - one lymph node candidate sectioned (adjacent to. inferior pancreas). I21-I22 - - one peripancreatic lymph node candidate, sectioned. I23 - one lymph node candidate, sectioned. I24 - one lymph node candidate, sectioned. I25 - one lymph node candidate, sectioned. I26 - one lymph node candidate. I27-I29 - - additional adipose tissue. Light Microscopy. Light microscopic examination is performed by Dr. The frozen section diagnoses are confirmed. Pancreatic duct. carcinoma in situ is identified, with associated invasion of. pancreatic parenchyma, with extension into peripancreatic fat. and wall of duodenum near the ampulla of Vater. Metastatic carcinoma is identified in nodes in blocks I18 and. I19.",T3,N1,M0,T3N1M0
TCGA-UD-AAC6,"Anatomical Pathology results - Performed from. M. Histopatliology. At least 1 Final Result. Histopathology. LAB. NO. DOCTOR. WARD. M. DATE RECEIVED. CONSULTANT. SPECIMEN: Pleura. CLINICAL : Malignant mesothelioma left pleura. MACROSCOPIC: An irregular strip of pleura 130 X 120 X 2mm. The surface is studded by several. irregular firm nodules measuring up to 10mm in diameter. Also submitted are. three separate strips of fibrous tissue the largest 30 x 10mm and the smallest. 20 X 10mm. BLOCK KEY: 1-6:Largest pleural fragment, :Sections from smaller pleural fragments. MICROSCOPIC: The sections show strips of pleura composed of fibrous connective tissue and. adipose tissue. Both tissue components show infiltration by a malignant. mesothelioma. Most of the tumour is of epithelioid type, being composed of. neoplastic. epithelial cells displaying tubulopapillary architecture and forming. irregular nodules. The neoplastic cells have large irregular nuclei with fine. chromatin,. prominent nucleoli and moderate to abundant amounts of eosinophilic. cytoplasm with often distinct cellular boundaries. There is moderate nuclear. pleomorphism. Apoptotic cells are present and mitotic figures are easily. identified. Focally the neoplasm is less cellular and displays increased amounts of fibrous. connective tissue. The constitutive cells in these areas are spindled in shape. and constitute the sarcomatoid component. Elsewhere the neoplastic cells are. separated by varying amounts of myxoid-appearing stroma. Interspersed are occasional nodular areas containing birefringent inorganic. material in keeping with tale particles. In association are epithelioid. histiocytes and occasional multinucleated foreign body-type giant cells. At the. periphery of the tumour is a moderately dense chronic inflammatory cell. infiltrate consisting predominantly of lymphocytes. There is accompanying. lymphoid aggregate formation. Some of the tissue strips show paucicellular areas composed of dense collagen,. most likely representing part of a pleural plaque. A single section shows blood. clot containing aggregates of neoplastic mesothelial cells. The PAS reaction with diastase digestion for mucin is negative. The Alcian blue. stain is positive in the areas of myxoid stroma. Immunohistochemistry: The epithelioid malignant cells are positive for cytokeratin 5/6, calretinin and. WT-1 and show strong peripheral membranous staining for EMA. The sarcomatoid. malignant cells are positive for calretinin and negative for CK5/6 and WT-1 and. show patchy cytoplasmic and membranous staining for EMA. Staining for BerEP4. and CEA is negative. CONCLUSION: Pleura - Malignant mesothelioma, epithelioid (predominantly) and sarcomatoid. patterns. Clinical history of asbestos exposure and pleural thickening is noted in the. previous report of left pleural effusion (lab ref. REGISTRAR: DOCTOR REVIEWING: Printed from: Page: I of 2. Anatomical Pathology results - Performed from. M. Electron Microscopy. At least 1 Final Result. Electron Microscopy. LAB. NO. M. WARD. DOCTOR. DATE RECEIVED. CONSULTANT. SPECIMEN: Pleura. ELECTRON MICROSCOPY: Specimen unsuitable for ultrastructural analysis. Dense collagenous fibrous. stroma only in all representative blocks. Printed from: Page: 2 01 2.",T2,N0,M0,T2N0M0
TCGA-GC-A3I6,"Sura Path Final Report. Result Date: Final Diagnosis (Verified). Distal left ureter, frozen section examination, excision: Negative for neoplasm. Distal right ureter, frozen section examination, excision: Negative for neoplasm. Additional prostatic apical tissue: Benign prostatic glandular tissue with scattered areas of squamous metaplasia. involving the duct lumen, no invasive malignancy identified. Radical cystoprostatectomy: Infiltrating high-grade urothelial carcinoma with diffuse squamous. differentiation extending through entire bladder muscular wall and to. inked. radial margin of surgical excision. Bladder tumor measures 5.5 cm in maximum dimension and is positioned on. the. posterior bladder wall. Marked necrosis is present. Prostate is negative for malignancy. Seminal vessicles are negative. Left lymph node dissection: Seven (7) negative lymph nodes. Right lymph node dissection: Four (4) negative lymph nodes. Comment: This large, partially necrotic, diffusely infiltrating, high-grade transitional cell. carcinoma shows diffuse areas of squamous differentiation. The tumor extends to the inked. radial margin of excision. This case corresponds to a pathological AJCC stage of T3a,NO. Signature Line. (Electronically signed by). Verified on: Gross Description (Verifled). ""FSA."" All frozen section control tissue is submitted in cassette ""FSA,"". ""FSB."" All frozen section control tissue is submitted in cassette ""FSB,"". ""C, Additional apical tissue."" The specimen consists of 3 unoriented soft gray-pink fragments ranging in size from 1.6 x 1.6 x 0.7 cm to 2.4 x. 1. x 0.8 cm. Inked black. ""C1-C2,"" fragments, representative. ""D, Bladder."" The specimen consists of an 11.8 x 9.5 x 6.6 cm bladder with attached fat. Attached is the prostate gland. Bilateral distal. ureters have previously been submitted for frozen section. The specimen is opened on the anterior aspect and there is a 5.5 x 3.5 cm soft. red-tan friable ulcerated mass on the posterior bladder wall which extends to the right aspect of the bladder. The mass grossly appears to. extend into the bladder musculature to a depth of 2.5 cm and grossly appears to abut the radial margin. The radial margin has been inked. black. The mass does not grossly appear to involve the left and right ureteral orifices. The remaining bladder mucosa is red-tan and. edematous and no additional areas of interest are grossly identified in the bladder. The attached prostate gland measures 4.2 x 4 x 1.8 cm. The. posterior apex will be inked orange. The remaining prostate is inked black. The seminal vesicles and vas deferens will be submitted at. their junction with the prostate. The prostatic parenchyma is tan and no discrete yellow masses are grossly identified. ""D1,"" distal urethral. margin; ""D2-D5,"" bladder mass with adjacent radial margin (NOTE: Cassette deeply represents 1 full-thickness section submitted in steps);. ""D6,"". mass;. ""D7,"" left bladder mucosa; ""D8,"" bladder dome; ""D9,"" right bladder mucosa; ""D10,"" trigone; ""D11,"" left seminal vesicle and vas. deferens; ""D12,"" right seminal vesicle and vas deferens; ""D13,"" left anterior prostate; ""D14,"" right anterior prostate; ""D15,"" left posterior. prostate; ""D16,"" right posterior prostate. ""E,. Left lymph node."" The specimen consists of a 3.6 x 3.6 x 2 cm aggregate of yellow lobulated tissue. On sectioning, 7 possible lymph. nodes are identified. These range in size from 0.3 to 1.5 cm. ""E1-E3,"" fragments, representative. ""F, Right lymph node."" The specimen consists of a 4.4 x 3.2 x 1.5 cm aggregate of yellow lobulated tissue. On sectioning, 4 possible lymph. nodes are identified. These range in size from 0.4 to 1.8 cm. ""F1-F2,"" fragments, representative. Received for research purposes is 1 yellow cassette labeled "". Signature Line. Frozen Section Diagnosis (Verified). FSA: Distal left ureter: No tumor noted. FSB: Distal right ureter: No tumor noted. Clinical Information (Verified). This year-old white male is a patient with spina bifida who has been on lifelong intermittent catheterizations. The patient has a long history. of smoking (3 to 4 packs a day). Completed Action List: VERIFY by.",T3,N0,M0,T3N0M0
TCGA-AR-A24X,"Breast, right, simple mastectomy: Invasive ductal and lobular carcinoma (mixed features), Nottingham grade II (of III) [tubules. 2/3,. nuclei 2/3, mitoses 1/3; Nottingham score 5/9], forming a mass, 2.1 x 1.4 x 1.3 cm, with associated biopsy site changes,. located in the superior/central region of the breast [AJCC pT2]. A second biopsy site is present in the subareolar region. A. separate nodule of ductal carcinoma in situ, 0.6 x 0.6 x 0.5 cm, is present in the upper inner quadrant. Lobular carcinoma in situ is. identified. The tumor does not involve the nipple, overlying skin, or underlying chest wall. All surgical resection margins,. including the deep margin, are negative for tumor (minimum tumor free margin, 0.5 cm, anterior/superior margin). Lymph. nodes, right axillary sentinel, excision: Multiple (7) right axillary sentinel lymph nodes are negative for metastatic. carcinoma [AJCC pNO (i-) (sn)]. Blue dye is not identified in any of the seven right axillary sentinel lymph nodes. Immunohistochemical cytokeratin stain was performed on the paraffin embedded sentinel lymph node tissue and confirms the. H&E impression. Breast, left, simple mastectomy: Mild proliferative changes characterized by ductal hyperplasia without atypia. The prior biopsy. site is identified. The nipple is without diagnostic abnormalities. Estrogen and progesterone receptor analysis and Her-2/NEU have been ordered on paraffin-embedded tissue.",T2,N0,M0,T2N0M0
TCGA-BH-A203,"PATIENT HISTORY: Procedure Date: DATE OF LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: R BREAST CANCER. POST-OP DIAGNOSIS: SAME. OPERATTVEPROCEDURE: R'SEGM MAST; AXILLARY DISS. CLINICAL HISTORY: MATERIAL SUBMITTED: A) RIGHT SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. E) RIGHT AXILLA, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: FROZEN SECTION: Right brcast mass, 2.1 by 2.1 by 2.0 cm, 0.4 cn from the closest posterior margin. FS. Diagnosis: Infiltzating ductal carcinoma. ER/PR taken. CONSULT: Right axillary y mph node dissection. Metastatic tumor in multiple matted Jymph nodes. FINAL DIAGNOSIS: FINAL DIAGNOSIS: A) RIGHT BREAST SEGMENTAL NASTECTOMY: - INFILTRATING DUCTAL CARCINOMA (2.1 CM), WITH EXTENSIVE LIMPHATIC PERMEATION AND CANCERIZATION OF THE. DUCTS, NUCLEAR GRADE POOR, HISTOLOGIC GRADE 3. - ALL SURGICAL RESECTION MARGINS FREE OF TUMOR. B) RIGHT AXILLA DISSECTION: - THIRTY FIVE OUT OF THIRTY NINE (35/39) LYMPH NODES, POSITIVE FOR METASTATIC INFILTRATING DUCTAL CARCINOMA,. SOME WITH EXTRACAPSULAR SPREAD. - PATHOLOGIC STAGING: T2 N2 MX.",T2,N1,M0,T2N1M0
TCGA-AO-A0JF,"Clinical Diagnosis & History: 1.2. cm invasive duct carcinoma left breast upper outer quadrant (on core. biopsy) for left wide excision SLNB, possible left ALND. Specimens Submitted: 1: SP: Sentinel node #1 level one left axilla (fs). 2: SP: Sentinel node #2 level one left axilla (fs). 3: SP: Excision of tumor left breast two o'clock. 4: SP: Superior margin left breast. 5: SP: Medial margin left breast. 6: SP: Inferior margin left breast. 7: SP: Lateral margin left breast. 8: SP: Non-sentinel node left axilla. 9: SP: Posterior margin left breast. 10: SP: Levels one and two left axillary contents. DIAGNOSIS: 1. LYMPH NODE, SENTINEL #1, LEVEL I, LEFT AXILLA; EXCISION: - METASTATIC ADENOCARCINOMA IN ONE LYMPH NODE (1/1). THE METASTATIC FOCUS MEASURES 5 MM IN GREATEST DIMENSION. - NEGATIVE FOR EXTRACAPSULAR EXTENSION. 2. LYMPH NODE, SENTINEL #2 LEVEL I LEFT AXILLA; EXCISION: METASTATIC ADENOCARCINOMA IN ONE LYMPH NODE (1/1). THE METASTATIC FOCUS MEASURES 6 MM IN GREATEST DIMENSION. - EXTRACAPSULAR EXTENSION (>2MM) IS PRESENT. 3. BREAST, LEFT, 2 O'CLOCK; EXCISION: - INVASIVE DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC GRADE II/III. (MODERATE TUBULE FORMATION), NUCLEAR GRADE I/III (SLIGHT OR NO VARIATION IN. SIZE AND SHAPE), MEASURING 2.0 CM IN LARGEST DIMENSION MICROSCOPICALLY. - DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, SOLID TYPE WITH LOW TO. INTERMEDIATE NUCLEAR GRADE. - THE DCIS CONSTITUTES LESS THAN OR EQUAL TO 25% OF THE TOTAL TUMOR MASS,. AND IS PRESENT ADMIXED WITH THE INVASIVE COMPONENT. - CALCIFICATIONS ARE PRESENT IN THE INVASIVE CARCINOMA ONLY. FOCAL VASCULAR INVASION IS PRESENT. FOR SURGICAL MARGINS SEE PARTS 4-7, AND 9. THE NON-NEOPLASTIC BREAST TISSUE THE NON-NEOPLASTIC BREAST TISSUE. SHOWS BIOPSY SITE CHANGES. RESULTS OF 108, PR, HER2-NEU) ARE AS FOLLOWS: ESTROGEN RECEPTOR. 95% nuclear staining with inhensity. PROGESTERONE RECEPTOR. 70% nucl. ith moderate intensity. HER2. Negative (1+). (<5% of invasive tumor cells exhibit weak complete membranous staining;. Uniformity of staining: absent;. Homogeneous, dark circumferential pattern: absent). Comment: Controls are satisfactory. PATHWAY anti-HER-2/neu is an. FDA-approved rabbit monoclonal primary antibody (clone 485) directed against. the internal domain of the c-erbB-2 oncoprotein (HER2) for. immunohistochemical detection of HER2 protein overexpression in breast. cancer tissue routinely processed for histologic evaluation. The HER2 test. results are reported in accordance with the ASCO/CAP guideline. recommendations for HER2 testing in breast cancer (J Clin Oncol 2007;. 25 (1) :118-145) The ER and PR rabbit monoclonal antibodies are also FDA. approved. 4. BREAST, LEFT, SUPERIOR MARGIN; EXCISION: - BENIGN BREAST TISSUE WITH PROLIFERATIVE FIBROCYSTIC CHANGES. 5. BREAST, LEFT, MEDIAL MARGIN; EXCISION: BENIGN BREAST TISSUE WITH FOCAL USUAL DUCTAL HYPERPLASIA. 6. BREAST, LEFT, INFERIOR MARGIN; EXCISION: - BENIGN BREAST TISSUE WITH FOCAL USUAL DUCTAL HYPERPLASIA. 7. BREAST, LEFT, LATERAL MARGIN; EXCISION: - BENIGN BREAST TISSUE WITH FOCAL USUAL DUCTAL HYPERPLASIA. LYMPH NODE, NON-SENTINEL, LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODK (0/1). 9. BREAST, LEFT, POSTERIOR MARGIN; EXCISION: BENIGN BREAST TISSUE PREDOMINANTLY COMPOSED OF FIBROADIPOSK. ELEMENTS. SKELETAL MUSCLE TISSUE ALSO PRESENT. 10. LYMPH NODES, LEFT AXILLARY CONTENTS, LEVELS ONE AND TWO, EXCISION: ELEVEN BENIGN LYMPH NODES (0/11). Some of the mmunohistochemistry and. :ests were developed and their. performance characteristics were determined by. They have not been cleared or approved by the US FOO ana urug. Administration. The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not. be regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of 1988 (CLIA , 88) as. qualified to perform high complexity clinical laboratory testing. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES - (AND/OR OTHER MATERIAL) . AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1. 1) The specimen is received fresh for frozen labeled, ""Sentinel node #1,. level 1, left axilla"", and consists of one fatty lymph node measuring 2.5 x. 1.5 x 1.5 cm, which is trisected and representatively submitted. A portion. of tissue sent to TPS. The remaining lymph node is submitted to permanent. Summary of sections: fac -- lymph node frozen section control. RS- remaining lymph node. 2) The specimen is received fresh for frozen labeled, ""Sentinel node #2,. level 1, left axilla"", and consists of one fatty lymph node measuring 2.4 x. 1.5 x 1.2 cm, which is trisected and representatively submitted. A portion. of tissue sent to TPS. The remaining lymph node is submitted to permanent. Summary of sections: fsc -- lymph node frozen section control. RS- remaining lymph node. 3) The specimen is received unoriented and fresh, labeled ""excision of. tumor, left breast two o' clock"" and consists of a piece of fibrofatty. breast tissue measuring 5.2 x 5.0 x 2.3 cm. The specimen is entirely inked. black. Serial sectioning reveals a spiculated, white mass measuring 1.2 x. 1.2 x 1.1 cm. Sectioning through the remaining breast tissue reveals yellow. adipose tissue. A clip is identified. The tumor is entirely submitted and. the remaining tissue is representatively submitted and a small portion is. given to TPS. Summary of sections: MT - tumor and closest tissue edge. T - tumor (clip was in block 2). SS - serial sections remaining tissue. 4) The specimen is received fresh, labeled ""superior margin left breast"" and. consists of a piece of fibrofatty breast tissue measuring 5.0 x 3.0 cm, and. 1.3 cm thick. A stitch marks the new margin of excision, which is inked. black. The tissue is serially sectioned and entirely submitted. Summary of sections: u - sequential sections. 5) The specimen is received fresh, labeled ""medial margin left breast"" and. consists of a piece of fibrofatty breast tissue measuring 3.2 x 2.5 cm, and. 1.2 cm thick. A stitch marks the new margin of excision, which is inked. black. The tissue is serially sectioned and entirely submitted. Summary of sections: u - sequential sections. 6) The specimen is received fresh, labeled inferior margin left breast"" and. consists of a piece of fibrofatty breast tissue measuring 4.0 x 3.0 cm, and. 1.3 cm thick. A stitch marks the new margin of excision, which is inked. black. The tiasue is serially sectioned and entirely submitted. Summary of sections: u - sequential sections. 7) The specimen is received fresh, labeled ""lateral margin left breast"" and. consists of a piece of fibrofatty breast tissue measuring 4.4 x 2.8 cm, and. 1.2 cm thick. A stitch marks the new margin of excision, which is inked. black. The tiasue is serially sectioned and entirely submitted. Summary of sections: u - sequential sections. 8) The specimen is received in formalin, labeled ""Non-sentinel node left. axilla"" and consists of a single pink tan fatty lymph node measuring 0.9 cm. The lymph node is bisected and entirely submitted. Summary of sections: BLN-bisected lymph node. 9). The specimen is received fresh, labeled ""posterior margin, left breast"". and consists of a piece of fibrofatty breast tissue measuring 4.2 x 3.0 cm,. and 0.5 cm thick. The specimen is unoriented, entirely inked black. sectioned and submitted in its entirety. Summary of sections: SS - sequential sections. 10) The specimen is received fresh labeled ""levels one and two left axillary. contents"" It consists of a fragment of yellow adipose tissue measuring 12.5. x 10.5 x 2.8 cm. The levels are not designated. Numerous lymph nodes are. identified ranging in size from 0.4 cm up to 2.0 cm, and all are submitted. Summary: RLN-representative lymph node (multiple). ARLN-additional representative lymph nodes. LN-lymph nodes. Summary of Sections: Part 1: SP: Sentinel node #1 level one left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. 1. rs. 1. Part 2: SP: Sentinel node #2 level one left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. 1. rs. 1. Part 3: SP: Excision of tumor left breast two o'clock. Block. Sect. Site. PCs. 1. MT. 1. 1. SS. 1. 2. T. 2. Part 4: SP: Superior margin left breast. Block. Sect. Site. PCs. 6. u. 6. Part 5: SP: Medial margin left breast. Block. Sect. Site. PCs. 6. u. 6. Part 6: SP: Inferior margin left breast. Block. Sect. Site. PCs. 6. u. 6. Part 7: SP: Lateral margin left breast. Block. Sect. Site. PCs. 6. u. 6. Part 8: SP: Non-sentinel node left axilla. Block. Sect. Site. PCs. 1. bln. 1. Part 9: SP: Posterior margin left breast. Block. Sect. Site. PCs. 6. ss. 6. Part 10: SP: Levels one and two left axillary contents. Block. Sect. Site. PCs. 5. arln. 5. 5. LN. 12. 4. RLN. 4. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: SP: Sentinel node #1 level one left. axilla (fs) : Metastatic ductal carcinoma (1/1). PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: SP: Sentinel node #2 level one. left axilla (fs) Metastatic ductal carcinoma with extranodal extension. (1/1). PERMANENT DIAGNOSIS: SAME. Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: SP: Sentinel node #1 level one left. axilla (fs) : Metastatic ductal carcinoma (1/1). PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: SP: Sentinel node #2 level one. left axilla (fs) : Metastatic ductal carcinoma with extranodal extension. (1/1). PERMANENT DIAGNOSIS: SAME.",T1,N1,M0,T1N1M0
TCGA-A6-5661,"SPECIMEN. A. Omentum. B. Right colon. CLINICAL NOTES. PRE-OP DIAGNOSIS: Right colon cancer. FROZEN SECTION DIAGNOSIS. A - Benign fibromembranous and adipose tissue. A 4 mm stone is. also. present. GROSS DESCRIPTION. A. Received fresh for frozen section labeled ""omentum. "". consists of a portion of soft glistening pink fibrofatty. tissue measuring 2.4 X 1.2 X 0.8 cm. On section it is soft and. pink. There is a 0.4 cm. hard yellow stone embedded within the tissue. The entire specimen ex r the stone is submitted in one block. for frozen section. B. The specimen consists of a ""right colon"" which is. partially covered with pink-tan smooth glistening serosa. and abundant yellow lobular fat. There is a long suture marking. the. right colic and ileocolic pedicles. The specimen is stapled at. both. ends. The specimen is predominantly covered with pink-tan smooth. glistening serosa with abundant yellow lobular fat. The small bowel. is 5.5 cm. long and the colon is 36 cm. long. The specimen is open. and partially filled with dark bloody brown diffluent fecal. material. The mucosa of the small bowel is smooth glistening. having. a circumference of 3.5 cm. There is an appendix present which is. 6.0 X 0.7 cm. The colonic mucosa is pink-tan, smooth glistening. and. edematous showing multiple lesions. There is a 3.7 X 3 X 0.5 cm. ulcerated tumor located 4.5 cm. distal from the ileocecal valve. It. is likely it extends through the muscularis propria, coming within. 0.7 cm. of the radial margin. This tumor mass is 27.8 cm. from the. GROSS DESCRIPTION. distal margin. A sample is taken for tissue procurement. There is. also a large sessile exophytic polyp which is 5.5 X 3.5 X 3.0 cm. This comes within 18 cm of the distal margin. There are a few. additional polyps grossly identified, one on the ileocecal valve. and. others toward the distal end. These average 0.5 cm. to 1.0 cm. in. greatest dimension and show no discrete invasions grossly. identified. in the large polyp previously described. Multiple lymph nodes. grossly identified in the fat. Representative sections of the. specimen are submitted as follows: Block 1 - Representative luminal. margin; block 2 - ileocecal valve with polyps; block 3 - entire. appendix, proximal end inked; blocks 4-6 - Representative section. of. tumor to radial margin, ends normal; blocks 7, 8 - additional. polypoid lesions toward distal end, full thickness; blocks 9-12 -. entire polypoid lesion full thickness; block 13 - ileocolic. pedicle,. block 14, additional tied off pedicle located distally; block 15 -. three possible lymph nodes; block 16 - four possible lymph nodes;. block 17 - four possible lymph nodes; block 18 - four possible. lymph. nodes; block 19 - four possible lymph nodes; block 20 - one. possible. lymph node. RS-20. MICROSCOPIC DESCRIPTION. A. Micro A performed. B. Multiple lesions are present within the right colon,. one of which is an ulcerated adenocarcinoma. Please see. the template below. Histologic type: Infiltrating adenocarcinoma. Histologic grade: Moderately differentiated. Primary tumor (pT) : The tumor minimally extends into pericolonic. fat, pT3. Proximal margin: Negative for tumor. Distal margin: Negative for tumor. MICROSCOPIC DESCRIPTION. Circumferential (radial) margin: Negative. Distance of tumor from closest margin: 27.8 cm from the distal. margin. Vascular invasion : Negative. Regional lymph nodes (pN) : All 21 regional lymph nodes are. negative. for. metastatic disese, 0/21, pNO . Non-lymph node pericolonic tumor: None. Distant metastasis (pM) : Cannot be assessed. Other findings: Within the right colon, there is a large sessile. tubulovillous adenoma. Additional smaller polyps are noted. including two adenomas and one hyperplastic polyp. Appendix, no significant pathology. 3,14, 5. DIAGNOSIS. A. Omentum, small excision - Benign fibroadeipose tissue with. stone. B. Right colon, right hemicolectomy - Infiltrating moderately. differentiated adenocarcinoma of the right colon, extending into. pericolonic fat, pT3. All 21 lymph nodes negative for. metastatic disease. All margins negative for tumor. Large sessile tubulovillous adenoma, also present as well as. two much. smaller adenomatous polyps and one hyperplastic polyp.",T3,N0,M0,T3N0M0
TCGA-86-8668,"Case ID Gross Description. Microscopic. Diagnosis. Description. Details. Comments. ICA ID. LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 3 X 2.5 X 2 cm. Histologic type: Bronchiolo-. alveolar carcinoma, mucinous. Histologic grade: Moderately. differentiated. Tumor extent: Not specified. Other tumor nodules: Not. specified. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not. specified. Comments: Left, lower.",T1,N0,M0,T1N0M0
TCGA-WC-A884,"DIAGNOSIS. (A) LEFT GLOBE, ENUCLEATION: UVEAL MELANOMA, MIXED EPITHELIOID AND SPINDLED TYPES, approximately 20 mm base x 10 mm height. TUMOR INVOLVING CHOROID AND CILIARY BODY WITH FOCAL EXTENSION ONTO IRIS. CHOROIDAL INVASION PRESENT. No unequivocal involvement of canal of schlemm, see comment. Optic nerve negative for tumor. Vortex veins negative for tumor. Mitoses are 5 per 10 HPF. (B) LEFT EYE FNA, BIOPSY: Sample for send out testing only, See comment. COMMENT. The tumor approximates the canal of schlemm with inflammation present without definitive invasion by tumor. Levels examir. Background changes also noted include degeneration of the retina and lens with background hyperplasia of retinal epitheliur. The specimen for part B was sent to. for further diagnostic testing ordered by. 3. which will b. reported separately within the scan documents of. GROSS DESCRIPTION. (A) LEFT GLOBE - A left intact enucleation specimen (21 x 21 x 23 cm) has an attached 13 mm optic nerve. The cornea is. 10 mm with a distorted gray iris and pupil (0.7 X 0.4 cm) irregular opening. Transillumination shows a shadow approximately. o'clock extending from near the limbus to 5 mm from the optic nerve approximately 22 X 20 mm base. Tissue is harvested remain. protocol. The vitreous is tinged yellow. The tumor is multinodular, variegated from light tan to gray with a height up to 10 mr. The tumor grossly extends to the ciliary body and is partially polypoid. The lens has disintegrated and is edematous, pale. translucent white, occupying the anterior aspect of the specimen. SECTION CODE: A1, vortex veins; A2, optic nerve margin; A3, focal tumor with harvest calotte; A4, opposite calott. tumor; A5, pupil optic-nerve section with tumor. (B) LEFT EYE FNA BIOPSY, NOT FOR PERMANENT AND SHIPPED VIA. START IMMEDIATE -80 CENTIGRADE -. Multiple tan and clear tissue with mucoid material (0.4 X 0.4 X 0.3 cm). For gross ID only. Specimen is sent out via. BIOMARKER TESTING. The following material is selected for biomarker testing: Primary. Tumor Block: A4. CLINICAL HISTORY. Uveal melanoma. SNOMED CODES. T-AA000, M-82703. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have no. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: Page: 2. END OF REPORT--.",T4,N0,M0,T4N0M0
TCGA-EL-A3ZK,"Case type: Surgical Case. DIAGNOSIS. (A) RIGHT THYROID LOBE AND ISTHMUS: PAPILLARY THYROID CARCINOMA, CONVENTIONAL TYPE. Location: Right lobe. Multifocal: No. SIZE: 2.5 CM IN GREATEST DIMENSION. Extrathyroidal extension: Absent. Lymphovascular invasion: Absent. Resection margins: Negative. No tumor present in one lymph node (0/1). (B) LEFT LOBE OF THYROID: Thyroid tissue, no tumor present. (C) PRETRACHEAL LYMPH NODE: METASTATIC PAPILLARY THYROID CARCINOMA. (D) TISSUE ANTERIOR TO INNOMINATE ARTERY: Adipose tissue, no tumor present. (E) RIGHT PARATRACHEAL AND UPPER MEDIASTINAL LYMPH NODE DISSECTION: METASTATIC THYROID CARCINOMA IN TWO OF FIFTEEN LYMPH NODES. Extracapsular extension: Absent. (F) LYMPH NODES ADJACENT TO RIGHT RECURRENT LARYNGEAL NERVE: Skeletal muscle, adipose tissue and nerve, no tumor present. (G) ADDITIONAL UPPER MEDIASTINAL TISSUE: Fibroconnective tissue, no tumor present. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) RIGHT THYROID LOBE AND ISTHMUS - A 4.0 x 3.0 x 2.0 cm right lobe of thyroid with isthmus (1.0 x 1.0 x 0.5 cm). Located in the inferior pole and extending to the superior pole, there is a 2.4 x 2.5 x 1.2 cm, well-circumscribed, golden-brown. mass. Representative sections are submitted fro frozen section evaluation. SECTION CODE: A1, A2, representative section for frozen section; A3-A7, mass from superior to inferior (A3 and A4,. one slice; A5 and A6, one slice; A7, one slice); A8, isthmus, in toto. Tissue sent for. FS/DX: PAPILLARY THYROID CARCINOMA. Case type: Surgical Case. (B) LEFT LOBE OF THYROID - A thyroidectomy specimen with left lobe of thyroid (5.0 x 2.7 x 1.5 cm) and isthmus (1.0 x 0.8. cm). The thyroid is serially sectioned from superior to inferior, there is no lesion present in the specimen. Representative. sections submitted. SECTION CODE: B1, isthmus; B2, upper portion of left thyroid, representative; B3, B4, middle portion of thyroid, left,. representative; B5, B6, lower portion of left thyroid, representative. (C) PRETRACHEAL LYMPH NODE - A tan small lymph node (0.3 x 0.2 x 0.2 cm), bisected and submitted in toto for frozen in. one cassette. FS/DX: METASTATIC PAPILLARY THYROID CARCINOMA. (D) TISSUE ANTERIOR TO INNOMINATE ARTERY - An irregular fragment of adipose tissue (0.7 x 0.5 x 0.5 cm). Entirely. submitted for frozen section diagnosis in D. FS/DX: ADIPOSE TISSUE, NO TUMOR PRESENT. (E) RIGHT PARATRACHEAL AND UPPER MEDIASTINAL LYMPH NODE DISSECTION - Multiple fragments of fibroadipose. tissue (4.0 x 3.0: x 1.0 cm in aggregate). Multiple lymph nodes are identified varying from 0.3 to 0.8 cm in greatest dimension. SECTION CODE: E1, one possible lymph node trisected; E2, one possible lymph node, trisected; E3, one possible. lymph node, bisected; E4, four possible lymph nodes; E5, four possible lymph nodes; E6, one possible lymph node, bisected;. E7, one possible lymph node, bisected; E8, four possible lymph nodes; E9, five possible lymph nodes. (F) LYMPH NODE ADJACENT TO RIGHT RECURRENT LARYNGEAL NERVE - One fragment of soft tan tissue (0.3 x 0.2 x. 0.2 cm). Entirely submitted in F. (G) ADDITIONAL UPPER MEDIASTINAL TISSUE - One fragment of irregular soft tan tissue (0.6 x 0.3 x 0.2 cm). Entirely. submitted in G. CLINICAL HISTORY. Mass of right lobe thyroid. SNOMED CODES. T-B6000, M-80506. ""Some tests reported here may have been developed and performance cheracteristics determined by : These tests have not been specifically cleared or. approved by the U.S. Food and Drug Administration."". Released by:",T2,N1,M0,T2N1M0
TCGA-A2-A0EY,"Specimen #: : WHITE. SPECIMEN: A: RIGHT BREAST LUMPECTOMY B: ADDITIONAL INFERIOR MARGIN. C: ADDITIONAL DEEP MARGINS D: SENTINEL NODE #1. E: SENTINEL LYMPH NODE #2. FINAL DIAGNOSIS: A. BREAST, RIGHT, LUMPECTOMY: - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: MODERATELY DIFFERENTIATED. - NOTTINGHAM SCORE: 6/9. (Tubules= 2, Nuclei= 3, Mitoses= 1). TUMOR SIZE (GREATEST DIMENSION) : 2.8 CM. - TUMOR NECROSIS: NOT IDENTIFIED. - MICROCALCIFICATIONS: PRESENT ASSOCIATED WITH INFILTRATING CARCINOMA. AND BENIGN DUCTS. - VENOUS / LYMPHATIC INVASION: NOT IDENTIFIED. - MARGINS : UNINVOLVED. - DISTANCE OF INVASIVE TUMOR FROM NEAREST MARGIN IS 0.3 CM, FROM. INFERIOR MARGIN. (measured microscopically). INTRADUCTAL COMPONENT: PRESENT; SOLID AND CRIBRIFORM, NUCLEAR GRADE. 3, WITH CENTRAL NECROSIS. - LYMPH NODES: SEE PARTS ""D-E"". - ONE OF TWO SENTINEL LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA. - SKIN INVOLVEMENT: NOT IDENTIFIED. - ESTROGEN RECEPTORS: POSITIVE (SEE. - PROGESTERONE RECEPTORS: NEGATIVE (SEE. - HER 2 NEU by IHC: POSITIVE (SEE. - PATHOLOGIC STAGE: pT2 N1a MX. - ADDITIONAL PATHOLOGIC CHANGES : USUAL DUCTAL HYPERPLASIA, FIBROCYSTIC. CHANGES, SCLEROSING ADENOSIS, UNREMARKABLE EPIDERMIS. B. BREAST, ""ADDITIONAL INFERIOR MARGIN"", EXCISION: - BENIGN BREAST TISSUE. - MARGINS UNINVOLVED. PATHOLOGIC CHANGES : USUAL DUCTAL HYPERPLASIA, APOCRINE METAPLASIA,. FIBROCYSTIC CHANGES, MICROCALCIFICATIONS. C. BREAST, ""ADDITIONAL DEEP MARGINS"", EXCISION: Specimen #: FINAL DIAGNOSIS (continued) : - BENIGN FIBROADIPOSE TISSUE WITH NO EVIDENCE OF MALIGNANCY. - NO BREAST GLANDULAR ELEMENTS PRESENT. - MARGINS UNINVOLVED. D. LYMPH NODE, SENTINEL NODE #1, BIOPSY: - ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA. - LARGEST METASTATIC FOCUS: 0.4 CM. - EXTRACAPSULAR EXTENSION: NOT IDENTIFIED. E. LYMPH NODE, SENTINEL NODE #2, BIOPSY: - ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA BY ROUTINE HISTOLOGY. AND CYTOKERATIN IMMUNOHISTOCHEMISTRY. Comment : The prior core biopsy specimen (. right breast,. is reviewed. This case has received intradepartmental prospective. peer review. CLINICAL DIAGNOSIS AND HISTORY: y/o female with history of right breast carcinoma. PRE-OPERATIVE DIAGNOSIS: None provided. POST-OPERATIVE DIAGNOSIS: None provided. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. and. designated ""RIGHT BREAST LUMPECTOMY"" consists of a breast lumpectomy. specimen, measuring 9.0 cm from superior to inferior; 8.8 cm from medial. to lateral; and 3.0 cm from superior to inferior. The specimen is. oriented with a long suture marking the lateral margin; and a short suture. marking the superior margin. The overlying ellipse of tan skin measures. 6. x 1.8 cm. The specimen is differentially inked as follows: blue -. superior; green - inferior; orange - anterior; black - posterior; red -. lateral; and yellow - medial. The specimen is serially sectioned from. R. Y. Specimen #: GROSS DESCRIPTION (continued) : anterior to posterior to reveal a sharply-circumscribed, firm, ovoid mass. with. a. homgenous tan cut surface, measuring 2.8 x 2.6 x 1.6 cm in overall. dimensions. This mass is located in the posterior half of the specimen,. and measures 0.4 cm from the nearest margin (inferior) . The remaining. tissue is mostly fatty with admixed areas of fibrosis, especially. posteriorly. Skin, tumor, and grossly unremarkable fibrous tissue are. sampled for the CBCP Protocol with matching paraffin sections in cassettes. A1, A2-A6 and A7. Representative sections are submitted as follows: A1-. skin; A2-tumor; A3-6 - - tumor with inferior margin; A7-fibrous tissue. with posterior and superior margins; A8 - -fibrous tissue with superior. margin; A9-10- anterior margin; A11-12- lateral margin; A13-14-medial. margin. B: Received in formalin, labeled with the patient's name,. ad designated ""ADDITIONAL INFERIOR MARGIN"" consists of an irregular. fragment of tan-yellow, lobulated adipose tissue, measuring 5.5 x 1.9 x. 0.8 cm in overall dimensions. The specimen is received oriented with. steel surgical clips marking the true new margin. This new margin is. inked blue, and the opposing surface is inked orange. The specimen is. serially sectioned to reveal a tan-yellow, fatty cut surface without. evidence of residual tumor. The specimen is entirely submitted in six. cassettes. C: Received in formalin, labeled with the patient's name,. d designated ""ADDITIONAL DEEP MARGINS"" consists of an irregular. portion of tan-yellow, lobulated adipose tissue measuring 4.7 x 3.9 x. 1.1. cm in overall dimensions. The true new margin is marked with surgical. clips, this margin is inked blue, and the opposing surface is inked. orange. The specimen is serially sectioned to reveal a homogenous. tan-yellow, fatty cut surface without exidence of residual tumor. Representative sections are submitted in six cassettes. D: Received fresh, labeled with the patient's name,. designated ""SENTINEL NODE #1"" consists of a single irregular tragment of. tan-yellow adipose tissue, measuring 2.0 x 1.8 x 0.5 cm in overall. dimensions. Palpation of the specimen reveals a single tan-pink lymph. node, measuring 1.5 x 0.7 x 0.7 cm in overall dimensions. A small portion. of the lymph node is sampled for the CBCP Protocol with matching paraffin. section in D1, and the remainder of the specimen is submitted in cassette. D2. E: Received in formalin, labeled with the patient's name,. and designated ""SENTINEL LYMPH NODE #2"" consists of a similar irregular. Specimen #: GROSS DESCRIPTION (continued) : fragment of tan-yellow, lobulated adipose tissue measuring 2.4 x 2.0 x 1.1. cm in overall dimensions. The specimen is bisected to reveal a 2.2 cm. firm, tan-pink lymph node. The specimen is entirely submitted in two. cassettes.",T2,N1,M0,T2N1M0
TCGA-D9-A4Z3,"Gender: F. Examination resul. Clinical diagnosis (suspicion) Melanoma of the left arm. Material: 1) Material:skin of the left arm. Large tumor of the left arm. Method of collection: resection of the tumor. Histopathological Diagnosis: Malignant melanoma of the skin, nodular type ulcerated. Clark V, Breslow 75 mm, MI -10 mitoses/1 mm. Cancer. infiltration of the fat tissue and muscles. Moderate lymphocytic infiltration. Immunohistochemistry: HMB45 + in few cells, MelanA-, CKAE1/3-, Ki67 50%. Macroscopic description: Tumor: 2.2 x 1.7 x 7.5 cm ulcerated lesion with skin margin from 0.5 to 1.5 cm. Muscle infiltration.",T4,N1,M0,T4N1M0
TCGA-CM-5863,"Clinical Diagnosis & History: Colon carcinoma (hepatic flexure). Specimens Submitted: 1: SP: Terminal ileum, cecum, ascending colon; right hemicolectomy. DIAGNOSIS: 1. SP: Terminal ileum, cecum, ascending colon; right hemicolectomy: Tumor Type: Mucinous adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Ascending colon. Tumor Size: Length is 6 cm. Width is 10 cm. Maximal thickness is 1 cm. Tumor Budding: Absent. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Not identified. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Suspected. Large Venous Invasion: Not Identified. Perineural Invasion: Identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Appendix: Not identified. Lymph Nodes: Number with metastasis: 3. Total number examined: 12. Tumor deposits in pericolorectal soft tissue: Identified. Tumor Staging (AJCC 7th Edition). pT3 (Tumor invades through the muscularis propria into. pricolorectal tissues). Lymph Node Stage (AJCC 7th Edition) : N1b (Metastasis in 2-3 regional lymph nodes). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1) The specimen is received fresh, labeled ""Right colon"" and consists of. a. segment of terminal ileum, cecum, and ascending colon. The terminal ileum. measures 5.5 cm in length and 4.5 cm in circumference at the proximal. resected margin. The remaining colon measures 17 in length with a. circumference of 5.4 cm at the distal resected margin. There is no. attached. appendix identified. Focally hemorrhagic lobulated yellow tan adipose. tissue spans the length of the specimen measuring up to 1.1 cm in thickness. The specimen is opened to reveal a friable polypoid mass lesion measuring. 6.0 cm in length and 10.0 cm in width. The mass is located in the ascending. colon, 10.3 cm from the proximal margin and 5.0 cm from the distal margin. Sectioning shows the tumor invades the muscularis and abuts the underlying. adipose tissue. The depth of invasion is 1.0 em grossly. There is a 1.5. x. 0.8 x 0.5 cm gelatinous filled cyst cavity identified in the tumor. The. remaining mucosa is tan-brown with the normal folds. The ileocecal valve is. grossly edematous. The attached adipose tiasue is submitted for lymph node. dissections. Representative sections of the specimen are submitted for. permanent sections and for. Summary of sections: P - proximal margin shave. D - distal margin shave. T - tumor. C -cyst. IC--ileocecal valve. RS -representative sections. LN - lymph nodes. BLN - bisected lymph nodes. Summary of Sections: Part 1: SP: Terminal ileum, cecum, ascending colon; right hemicolectomy. Block. Sect. Site. PCa. 1. C. 1. 2. DM. 4. 1. IC. 2. 6. LN. 15. 1. PM. 2. 1. RS. 2. 8. 8.",T3,N1,M0,T3N1M0
TCGA-D7-A6ET,"Gender: M. Examination result. Clinical diagnosis (suspicion) Cancer of the cardia infiltrating the oesophagus. Date of admission: Material: 1) Material: stomach, Method of collection: Total organ resection. Histopathological diagnosis. Stomach adenocarcinoma tubular. Cancer metastases in lymph nodes NO VII/XXXIV. G2, pT3, pN3a. Type intestinal sec. codes acc. to ICD-O-3 or SNOMED. Macroscopic description: Specimen consisting of the stomach, after being incised along the greater curvature, sized 20 x 13.5 cm with the. omentum sized 26.5 x 15 cm, no focal lesions found macroscopically. Tumour in the lesser curvature sized 4 x 3.7 x 1.9 cm. Distance from the proximal end: 2 cm, from distal end: 7 cm. Microscopic description: Adenocarcinoma tubulare G2. Tumour penetrates the full thickness of the stomach wall and perigastric fat tissue. Signs of massive vascular invasion. Surgical incision lines clear of cancer invasion. The omentum free of neoplastic lesions. LYMPH NODES: - 1,2/ (cardia): metastases carcinomatosae in lymphonodo No (/11). - lesser curvature: metastases carcinomatosae in lymphonodis NO VI/XXII. Infiltratio carcinomatosa capsulae lymphonodorum ettelae adiposae perinodalis. - - (greater curvature): lymphonodulitis reactiva NO V. Result of immunohistochemical examination: HER2 protein stained with. HER-2/neu (485). HER-2/neu (4B5) Rabbit Monoclonal Antibody. Negative reaction in invasive cancerous cells ( Score = 0). Pathologist: :",T3,N3,M0,T3N3M0
TCGA-3U-A98J,"Gender: Male. Race: White. Report Date: Tissue Procurement Date: FINAL PATHOLOGIC DIAGNOSIS. A. #7 lymph node; biopsy: - One anthracotic lymph node, no tumor (0/1). B. #8 lymph node; biopsy: - Six anthracotic lymph nodes, no tumor (0/6). C. #9 lymph node; biopsy: - Three anthracotic lymph nodes, no tumor (0/3). D. 4R lymph node; biopsy: One of eight lymph nodes positive for metastatic tumor (1/8). E. Right pleura, diaphragm, pericardium; resection: - Malignant mesothelioma, epithelial type. See parameters and comment. - Four of twenty-four lymph nodes positive for metastastic mesothelioma. Thoracic Mesothelioma Pathologic Parameters. Pleura/Pericardium, Resection. MACROSCOPIC. Specimen Type: Pleural and pericardial resection. Tumor Site: Right pleura. Tumor Configuration and Size: Diffuse, Maximum thickness: 1.7 cm. MICROSCOPIC. Histologic Type: Epithelioid (epithelial) mesothelioma (60% tubular, 20%. trabecular, 10% micropapillary, 10% solid). Tumor Extension: Confluent visceral pleural tumor (including fissure). Into but not through diaphragm. Lung parenchyma (E10-11). Into mediastinal fat (E1-E2). Into but not through the pericardium (E1-E2). Venous/Lymphatic (Large/Small Vessel) Invasion: Present. Margins: Cannot be assessed. Pathologic Staging (pTNM): pT3, N2. pT3: Tumor (locally advanced but potentially resectable) involves any of. the ipsilateral. pleural surfaces, with at least 1of the following: invasion of the. endothoracic. fascia, invasion into mediastinal fat, solitary completely resectable focus of. tumor. invading the soft tissues of the chest wall, non-transmural involvement of the. pericardium. Regional Lymph Nodes (pN). pN2: Metastases in the subcarinal lymph node(s) and/or the ipsilateral. internal mammary or mediastinal lymph node(s). Specify: Number examined: 24. Number involved: 4. Effective January 1, 2010 this Checklist utilizes the 7th edition TNM staging. system for pleural mesothelioma of the American Joint Committee on Cancer (AJCC). and the International Union Against Cancer (UICC). Comment. Immunohistochemistry for WT-1 (+ve), Calretinin (+ve), MOC31 (-ve) and BG8 (-ve). confirms the diagnosis of malignant mesothelioma (block E7, controls. appropriate). M.D. Interpretation performed by the Attending Pathologist and reviewed with the. Resident/Fellow, M.D. Clinical History: The patient is a. male with no a malignant pleural mesothelioma of. the right pleural space who undergoes a right thoracotomy parietal pleurectomy. and decortication. Specimens Received: A: #7 lymph node. B: ## lymph node. C:#9 lymph node. D: 4R lymph node. E: Pleura, diaphragm, pericardiuim. Gross Description: The specimens are received in five containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, ""#7 lymph node"". Received. fresh and placed in formalin is an unoriented 2.8 x 1.5 X 0.8 cm portion of. gray-brown rubbery tissue with a small amount of attached lobulated yellow. adipose. The specimen is bisected and entirely submitted as A1-A2. B. The second container is additionally identified as, ""#8 lymph node"". Received fresh and placed in formalin is a 4.3 X 2.5 x 0.5 cm portion of. lobulated yellow fibrofatty tissue. The specimen is dissected for lymph nodes to. reveal 6 gray-black apparent lymph nodes ranging from 0.2-1.2 cm in greatest. dimension. All apparent lymph nodes are submitted as follows: B1: : 3 lymph nodes. B2: 2 lymph nodes. B3: largest lymph node, bisected. C. The third container is additionally identified as, ""#9 lymph node"". Received. fresh and placed in formalin is a 2 x 1.2 x 0.5 cm unoriented portion of. lobulated yellow fibrofatty tissue. The specimen is sectioned revealing 2. gray-black rubbery apparent lymph nodes measuring 0.6 and 0.8 cm in greatest. dimension. The specimen is entirely submitted as C1. D. The fourth container is additionally identified as, ""4R"". Received fresh and. placed in formalin is a 3 x 2.3 x 0.8 cm portion of lobulated yellow fibrofatty. tissue. The specimen is dissected for lymph nodes to reveal 8 apparent tan to. gray-black rubbery lymph nodes ranging from 0.2-1 cm in greatest dimension. All. apparent lymph nodes are submitted as follows: D1-D2: 3 lymph nodes in each cassette. D3: 2 lymph nodes. E. The fifth container is additionally identified as, ""5. Pleura, diaphragm and. pericardium"". Received fresh and placed in formalin is a 629.5 g, 34.5 x 25 x 3. cm portion of visceral pleura with attached 7 X 6.5 cm glistening pink-gray. membranous tissue designated pericardium (marked by a black suture) and attached. 22.8 X 15 cm portion of diaphragm (marked by white suture). The specimen has an. overall volume of approximately 700 cc. The pericardium is smooth, glistening. and is inked blue. Adjacent to the pericardium is 8.5 x 6.5 X 2.5 cm area of. abundant yellow fibrofatty tissue in which multiple apparent tan to gray-black. rubbery lymph nodes ranging from 0.3-1.5 cm in greatest dimension are. identified. Sectioning through the pericardium reveals patchy ill-defined. gray-tan nodules ranging from 0.5-1.7 cm in greatest dimension which focally. abut the inked surface. The inner aspect of the specimen displays patchy areas. of visceral pleura measuring up to 7 x 6.7 cm. The superior inner aspect of the. specimen is covered by patchy gray-tan firm nodules ranging from 0.2-1.5 cm in. greatest dimension. The diaphragm is inked green. The diaphragm is diffusely. covered by a grey-tan firm plaque ranges from 0.5-1.7 cm in thickness. Upon. sectioning, the plaque focally invades into the diaphragm muscle extending to. within 0.3 cm of the inked surface. Gross photographs are taken. Representative. sections are submitted as follows: E1-E2: pericardium. E3-E4: sections of plaque and diaphragm, deepest invasion. E5-E7: additional sections of plaque and diaphragm. E8-E17: sections from remainder of specimen. E18-E19: 4 lymph nodes in each cassette. E20: one apparent lymph node, bisected.",T3,N2,M0,T3N2M0
TCGA-AA-3982,"This is an unequivocal finding in the sense of an adenocarcinoma of the colon with extensive. necrosis and poor differentiation (thus corresponding to G3) with penetration of all parietal. layers and vascular infiltration (thus corresponding to pT3, L1, V1) with free resection margins. in the mucosal region with a regular mucosa, submucosa and muscularis and free resection. margins in the mesenchymal region and three lymph node metastases (corresponding to pN1). In addition, there were diverticular formations. Tumor classification: ICDO-DA-M. G3. pT3. L1, V1. pN1 (3 of 13 lymph nodes).",T3,N1,M0,T3N1M0
TCGA-D6-A4ZB,"Gender: M. Examination result. Clinical diagnosis (suspicion) tumour of the larynx. Please mark the margins. Path: Site: largnx, NOS C32.9. Material: 1) Material: larynx, Method of collection: Collection of specimens for laboratory examination. Histopathological diagnosis: Invasive keratinizing squamous carcinoma of the larynx and carcinoma in situ (G2, pT2). Carcinoma planoepitheliale keratodes invasivum et in situ laryngis. G2, pT2. Macroscopic description: Surgical specimen sized 9.5 x 7.5 x 6cm, including larynx with the hyoid bone and part of the trachea 1.5. cm in length. Tumour sized 2.5 x 2.5 in the glottis region, infiltrating the supraglottal region and the. anterior commissure. Microscopic description: Carcinoma planoepitheliale keratodes invasivum G2. The tumour infiltrates all levels of the larynx, the aryepiglottic fold on the left side and the anterior. commissure region. Surgical incision lines off cancer invaded area. No signs of vascular, nerve and cartilage invasion found. Results of intraoperative examination: Result of intraoperative examination: Surgical incision lines free if cancer invasion. Final reply to be given after full. material is developed. Criteria. Diagnesis Ciscrap2.1cy. lumar Site Discrepanty. ) inchronous. Casers (circle);. QUALIFIED. levil.",T3,N0,M0,T3N0M0
TCGA-BR-8077,"Gross. Microscopic. Diagnosis. Comments. Case ID. Description. Description. Details. Laterality. STOMACH TISSUE. Fundus. CHECKLIST. Specimen type: Gastrectomy. Tumor site: Fundus. Tumor size: 6 X 4.5 X 1.5. cm. Tumor features: None. specified. Histologic type: Adenocarcinoma, intestinal. type. Histologic grade: Moderately differentiated. Tumor extent: Adjacent. structures (specify) -. Lesser omentum. Lymph nodes: 2/7 positive. for metastasis. (Intraabdominal 2/7). Lymphatic invasion: Not. specified. Venous invasion: Not. specified. Perineural invasion: Not. specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified.",T4,N1,M0,T4N1M0
TCGA-05-4396,"Main diagnosis/diagnoses: Very extensive, pneumonia-like, imposing bronchopulmonary mixed adenocarcinoma with a. predominantly tubulopapillary and bronchioloalveolar pattern, as well as slight mucin. formation and formation of numerous, in parts very small foci within the parenchyma and. minimal pleural invasion and lymphogenous metastatic spread. Comment/supplementary remark: By definition, the foci of mixed adenocarcinoma detected not only in the immediate. environment of the tumor, but in some cases only at microscopic level, are to be classified. satellite nodes in the lipsilateral lobe, which - bearing in mind the location of the lymph node. micrometastases (samples 5.), 7.) and very probably also 1.)), as well as the absence of tumor. in the resection margins of the bronchus and the vessels - gives a tumor classification of pT4. pN1 R0. But in view of the presentation of the tumor and the partial bronchioloalveolar. differentiation, the interpretation can be just as easily be supported or perhaps even favored. that this is a primary multifocal tumor manifestation. This would correspond to pT2(m). The. stage grouping IIIB thus competes with IIB. The main tumor mass lies in segments 6 and 9 of. the resected right lower lobe. The largest of the metastases found in the regional lymph nodes. is 1.2 mm. The coding is C 34.3; M 8255/3.",T4,N1,M0,T4N1M0
TCGA-D9-A4Z2,"gy. Gender: M. Examination result. Clinical diagnosis (suspicion): Skin melanoma of the suprapubic region - status post biopsy. Material: 1) Material: skin of the pelvis, melanoma of the abdomen region. Method of collection: Lesion resection. Supplement result: After the immunohistochemistry (HMB 45, S 100), the result remains the same. (8721/3. Histopathology Diagnosis: Including test No. G-20523/12: Malignant melanoma of the skin, nodular type with ulceration, Clark V, Breslow 25 mm,. MI = over 10 mitoses/ 1 mm2. pT4b, pN3. (8721/3. Macroscopic description: Skin fragment of 19 x 8.5 cm subcutaneous tissue sized of 2 cm in thickness, tumour sized 3.5 x 4 x 2.5 cm. present in the skin with adjacent invaded area of 13.5 x 7 x 1 cm. Minimum side margin of the main lesion is. 0.5 cm. Margin to the base of the main lesion is 0.4 cm. Microscopic description: Malignant melanoma of the skin of the nodular type. Level V according to Clark, thickness of 25 mm acc. to Breslow, MI= over 10 mitoses/1 mm2, pT4b. At the. foot of the lesion, there is a low-intensity lymphocytic invasion, a focus of necrosis within the tumour and. ulceration on the surface of it. Numerous satellite nodules. Signs of vascular invasion. The satellite nodules stretch up to the side incision line and multifocally to the base. (margins below 0.1 cm).",T4,N3,M0,T4N3M0
TCGA-AA-A024,"Diagnosis: The material presented is a left hemicolectomy specimen with a moderately differentiated,. invasive adenocarcinoma of the colon, G 2, of the type of a mucous carcinoma, with permeation. of all wall layers (p T 3), free resection margins, free lymph nodes (p N 0) and an additional. tubular adenoma in the mucosal region. Comment: Other diverticulum formations were also detectable over the course of the intestine.",T3,N0,M0,T3N0M0
TCGA-E9-A3Q9,Laterality:Right. Path Report BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 5.2 x 5.2x5.2 cm. Grossly evident lesion: Yes. Histologic type: Lobular carcinoma. Histologic grade: Tumor extent: Not specified. Lymph nodes: 22/22 positive for metastasis (Axillares 22/22). Extracapsular invasion of the lymph nodes: Not specified. Margins: Not specified. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,T3,N3,M0,T3N3M0
TCGA-A8-A08Z,"Diagnosis: 1. Invasive breast carcinoma with focal angioinvasion and tumor infiltration of. the skin spindle with foci of ulceration (tumor diameter: 5.0 cm). Dorsal resection margin. tumor-free. In conclusion, this is a moderately differentiated invasive ductal carcinoma with focal. angioinvasion and ulceration of the skin spindle. Tumor classification: NOS, G II, pT4bN3aLIVORO.",T4,N3,M0,T4N3M0
TCGA-VD-AA8P,"[D:EAADA209-BED3-4FA3-B39C-2428BF278EF7. HISTOPATHOLOGY. Lab No. Clinical Consultant & Location. Unit No. SPECIMEN. RIGHT GLOBE ENUCLEATION, PROGNOSTIC AND DIAGNOSTIC. CLINICAL DETAILS. See diagram. Measurements 10.63 x 10.18 x (10.37) mm. MACROSCOPIC DESCRIPTION. A fresh, intact, right globe. Dimensions: Axial 25mm, Horizontal 23.5mm, Vertical 24mm. Cornea: Horizontal 12.5mm, Vertical 12mm. Optic nerve: flesh. On trans-illumination, a shadow is seen in the inferolateral. position, approx 13mm. Plane of section: vertical. Intraocular description: A. solitary dome shaped, pigmented choroidal mass is seen. Prominent vessels arising from optic disc. IOL is present. Tumour size. LBD 12mm, Height 10. . mm. MICROSCOPY. Sections show a pigmented choroidal melanoma consisting. predominantly of spindle cells. Tumour cells express Melan-A. and HSP 27 (score 3). The number of mitosis is approximately 8/40 high power. fields. The microvasculature of the melanoma is prominent,. and closed loops are present in the planes of sections. The. lymphocytic infiltrate within the tumour is minimal. Tumour. necrosis is not seen. There is no tumour extension through. the sclera, optic nerve or vortex veins examined. Tumour. cells are not seen at the resection margins. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. Elsewhere, the cornea shows no significant abnormality. The. anterior chamber angles are open and the anterior chamber is. deep. The iris shows no significant abnormality but the. ciliary body appears atrophic with hyalinisation of ciliary. processes. Residual peripheral cataractuous lens is. identified. Retina overlying the tumour is slightly. atrophic. DIAGNOSIS. Right eye, enucleation: Choroidal melanoma of predominantly. spindle cell type. SUMMARY. SPECIMEN. 2= Eye. TUMOUR PRESENT. TUMOUR TYPE. 1= Melanoma. CELL TYPE. 2= Spindle B. CT LOOPS. 2= Closed loops. NECROSIS. PIGMENTATION. LYMPHOCYTIC INFILTRATION. MITOTIC FREQUENCY. 8/40 HPF. DIFFUSE MELANOMA. SPREAD. 1= No. CLEARANCE. 2= Adequate. HSP-27 POSITIVITY. 3= 708. LARGE DIAMETER. 12 mm. THICKNESS. 10 5 mm. COMMENT. Molecular genetic examination of DNA extracted from the. tumour cells will be performed using multiplex-ligation. printed. HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. dependent probe amplification (MLPA). looking at chromosomes. 1, 3, 6 and 8. A supplementary report will follow in due. course. SUPPLEMENTARY REPORT - MLPA. In the meantime, molecular genetic analysis of tumour DNA. extracted from the fresh uveal melanoma tissue was performed. using the technique termed multiplex ligation-dependent. probe amplification (MLPA) These investigations were. performed in the. The kit P027 from. which examines for gains or. losses in 31 loci on chromosomes 1, 3, 6 and 8, was used. The DNA concentration was measured using. and the. quality assessed using multiplex-PCR prior to the MLPA. reaction. The DNA concentration was high and of good quality on. assessment. The MLPA reaction was run at least twice on. differing occasions, resulting in similar results. The results of the sequence analysis of the MLPA products is. printed on a separate report. In summary, sequence analysis. demonstrated: loss of chromosome 1p,. monosomy 3,. normal chromosome 6. and gains in chromosome 8. Taken together, these molecular data would place the patient. in the high risk group with respect to the development of. metastatic melanoma. Consideration of clinical features of the tumour is,. however, also required.",T3,N0,M0,T3N0M0
TCGA-KL-8332,"Clinical Diagnosis & History: //o male with incidental right renal mass. Specimens Submitted: 1: SP: Right kidney, adrenal gland and hilar lymph node. DIAGNOSIS: 1). KIDNEY AND ADRENAL GLAND, RIGHT RADICAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CHROMOPHOBE CELL TYPE, NUCLEAR GRADE II/I. - THE PATTERN OF GROWTH IS SOLID. - THE TUMOR GREATEST DIAMETER IS 6.8 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. - VASCULAR INVASION IS PRESENT. (SEE NOTE.). - THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. - THE ADRENAL GLAND IS UNREMARKABLE. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OFMETASTATIC NODES IN. RELATION TO THE TOTAL NUMBER OF NODES EXAMINED): RENAL HILAR: 0/1. NOTE: A REPRESENTATIVE SLIDE WAS REVIEWED WITH DR. REUTER WHO CONCURS. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh, labeled ""Right Kidney, Adrenal Gland and Hilar Lymph Node"". It consists of a radical. nephrectomy specimen, including right kidney, adrenal gland and attached perinephric adipose tissue, entirely weighing 550 grams. and measuring 15 x 10 x 5.5 cm. The adrenal gland is identified and it measures 4.5 x 2 X 0.7 cm. It is separated from the renal. parenchyma by 2.5 cm of perinephric adipose tissue. The adrenal gland is serially sectioned and appears grossly unremarkable. The ureter is identified and it measures 2 cm in length x 0.3 cm in diameter. Renal vessels are present and measure from 0.5 to. 0.7 cm in length X 0.3 cm in diameter. The renal vessels and the distal ureter appear grossly unremarkable. Multiple hilar lymph. nodes are identified, ranging in size from 0.3 to 0.5 cm. The kidney is bivalved revealing a well-circumscribed, partially. encapsulated, tan-beige to light yellow mass measuring 6.8 X 6.5 x 3.8 cm located at the upper pole. Serial sectioning of the mass. reveals cystic degeneration with very minimal hemorrhagic and necrotic areas. The cystic component comprises about. 20%. of. the. entire mass and the solid component comprises 80% of the mass. The mass is 0.7 cm from the renal pelvis. The mass appears. to be confined within the renal parenchyma and within the renal capsule. No gross invasion of the vessels or perinephric fat is. identified. The cortical-medullary junction is distinct. The cortical thickness ranges from 0.7 to 1 cm. The uninvolved renal. parenchyma is tan-beige and appears grossly unremarkable. The renal capsule is easily stripped revealing a smooth. renocortical surface. The cortical surface is tan and smooth. Photographs are taken. Representative sections are submitted for. EM and TPS. Representative sections are submitted. Summary of Sections: UM - ureter margin. RV - renal vessels. HLN - hilar lymph nodes. AG - adrenal gland closest to the kidney. RP - renal pelvis closest to the tumor. NK - normal-appearing kidney. T - tumor. PNF - closest perinephric fat. Summary of Sections: Part 1: SP: Right kidney, adrenal gland and hilar lymph node. Block. Sect. Site. PCs. 1. AG. 2. 1. HLN. 2. 2. NK. 2. 2. PNF. 4. 2. RP. 2. 1. RV. 4. 5. T. 5. 1. UM. 1.",T1,N0,M0,T1N0M0
TCGA-50-5939,"FINAL DIAGNOSIS: SUMMARY STATEMENT: The angiolymphatic and visceral pleural invasion unassociated with lymph node metastasis. Pathologic stage;. right upper lobe apical segmentectomy shows a poorly differentiated adenocarcinoma, 3,4 cm in diameter, T2 NO with Mx. PART 1: BONE, ""PORTION 3RD RIB"", RESECTION -. PORTIONS OF UNREMARKABLE BONE WITH BONE MARROW SHOWING TRILINEAGE REPRESENTATION AND. MATURATION. NO EVIDENCE OF MALIGNANCY. PART 2: LUNG, RIGHT UPPER LOBE APICAL SEGMENT, SEGMENTECTOMY -. A. POORLY DIFFERENTIATED ADENOCARCINOMA, ACINAR AND SOLID TYPE, ARISING IN PULMONARY. PARENCHYMAL SCAR ASSOCIATED WITH ANGIOLYMPHATIC AND VISCERAL PLEURAL INVASION. DIAMETER. 3.4 CM. ALL MARGINS FREE. MILD HOST LYMPHOCYTIC RESPONSE. PATHOLOGIO STAGE; T2 NO MX. B. FOUR (4) SEGMENTAL LYMPH NODES WITH ANTHRACOSILICOTIC NODULES AND NO EVIDENCE OF. METASTATIC CARCINOMA. C. MULTIPLE PULMONARY APICAL CAPS. D. MULTIFOCAL ATYPICAL ADENOMATOUS HYPERPLASIA. E. RESPIRATORY BRONCHIOLITIS WITH EMPHYSEMATOUS CHANGE. PART 3: LYMPH NODES, RIGHT LEVEL FOUR LYMPH NODES, BIOPSY-. TWO LYMPH NODES WITH NO EVIDENCE OF METASTATIC CARCINOMA. COMMENT;. The adenocarcinoma shows a variety of cytologic features, including mucinous differentiation and clear cell change. ADDENDA: Addendum. Molecular Anatomic Pathology Testing: Block 2C: A. KRAS codon 12/13 mutation NOT identified. B. EGFR Exon 19 mutation NOT identified. C. EGFR Exon 21 mutation NOT identified. D. EGFR amplification IDENTIFIED (see In Situ Procedure). Note: KRAS codon 12/13 mutations are found in approximately 10-30% lung adenocarcinomas and associated with history. of. smoking (1). EGFR exon 19 and 21 mutations are present in about 10% of. s and up to 40% in the. population, common in non-smokers and associated with the tumor response to treatment with EGFR inhibitors (2). These mutations are mutually exclusive and their presence may have prognostic and/or therapeutic implications (3,4). Clinical studies show high EGFR gene copy number by FISH analysis (amplification) to be associated with favorable. clinical benefit (clinical response, stable disease, time to progression, and survival) in patients with advanced non-small. cell lung cancer treated with EGFR tyrosine kinase inhibitors. Sample Preparation and Gene Sequencing Analysis. For cytology samples, extraction of DNA was performed from the fluid or sample provided. For surgical specimens, manual microdissection was. performed. Specimens with the minimum of 50% of tumor calls in a microdissection target are accepted for the analysis. DNA was isolated using. standard laboratory procedure. Optical density readings were obtained. For the detection of mutation, DNA was amplified with primers for the. KRAS gene and exons 19 and 21 of the EGFR gene. Then. forward and reverse sequencing was performed using the. on. AB/3130. ). The known hotspots were analyzed for the presence of mutations with Mutation Surveyor V3.07. For. specimens with low quality and quantity of DNA, an alternative method (real-time PCR on LightCycler (Roche)) was applied for detection of KRAS. mutations. SPECIAL PROCEDURES: In Situ Procedure. Interpretation. PROBE: Vysis LSI EGFR SpectrumOrange/ CEP 7 SpectrumGreer TM Probe. Fluorescence in-situ hybridization studies performed on the adenocarcinoma shows a ratio of EGFR gene to the centromere of. chromosome 7 of 2.65 indicating EGFR amplification in the targeted region. The rate of hyperploidy for the centromere of. chromosome 7 was 25.8%, and the monosomy rate was 36.4% in the analyzed cells. The signal to nucleus ratio (SNR) for the. EGFR gene was 5.7. 66 cells were analyzed In the targeted region. Interpretation guidelines for EGFR Gene Copy Number by FISH: Ratio of EGFR to the centromere of chromosome 7: Less than 2,0: No EGFR amplification. Greater than 2.0: EGFR amplification. Hyperploidy: Greater than two centromere copies/cell. SNR. The average number of EGFR signals per analyzed cell within the targeted region. Clinical studies show high EGFR gene copy number by FISH analysis to be associated with favorable clinical benefit (clinical. response, stable disease, time to progression, and survival) in patients with advanced non-small cell lung cancer treated with. EGFR tyrosine kinase inhibitors. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY LUNG TUMORS. TUMOR LOCATION: Right Upper Lobe. LUNG SEGMENT(S) INVOLVED: Apical. PROCEDURE: Segmental. TUMOR SIZE: Maximum dimension; 3.4 cm. Minor dimension: 1.9 cm. GROSS SATELLITES: Number of gross satellite lesions: 0. TUMOR TYPE: Invasive adenocarcinoma. HISTOLOGIC GRADE: G3, Poorly differentiated. MICROSCOPIC SATELLITES: Number of microscopic satellite lesions: 0. EXTRAPULMONARY PARENCHYMAL. EXTENSION/INVASION OF TUMOR: Visceral pleura. ANGIOLYMPHATIC INVASION: TUMOR NECROSIS: < or = to 50%. SURGICAL MARGIN INVOLVEMENT: No. SURGICAL MARGIN SITE: Distance of invasive tumor to closest margin: 12 mm, Bronchial margin. INFLAMMATORY(DESMOPLASTIC) REACTION: Mild. N1 LYMPH NODES: Number of N1 lymph nodes positive: 0. Number of N1 lymph nodes examined: 4. N2 LYMPH NODES: Number of N2 lymph nodes positive: 0. Number of N2 lymph nodes examined: 2. UNDERLYING DISEASE(S): Atypical alveolar hyperplasia, Emphysema, Parenchymal scar, Smokers bronchiolitis. T STAGE, PATHOLOGIC: pT3. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ANCILLARY STUDIES: Histochemical stains, FISH studies, Molecular studies. Comment: PAS/PAS-D and mucicarmine stains are positive. Elastic tissue stains confirms. visceral pleural invasion.",T2,N0,M0,T2N0M0
TCGA-A3-3343,"DIAGNOSIS. DIAGNOSIS: A. Mesenteric nodule: Benign, fat necrosis, fibrosis, mild chronic inflammation. B. Left nephrectomy: Carcinoma. Tumor Characteristics: 1. Histologic type: Conventional (clear cell) renal cell carcinoma. 2. Tumor site: Mid pole. 3. Tumor size: Approximately 8 cm. in/greatest dimension. Macroscopic extent of tumor: Tumor limited to kidney. 4. Nuclear grade: Fuhrman grade 3/4. 5. Lympho-vascular space invasion: Yes. 6. Transcapsular invasion: No. 7. Renal vein invasion: No. 8. Vena caval invasion: Not resected. 9. Adrenal gland: Not resected. Surgical Margin Status: 1. Soft tissue margins: Negative. 2. Ureteral margin: Negative. 3. Vascular margins: Negative. Lymph Node Status: (refer to diagnosis C below). 1. Total number of lymph nodes examined: 1. 2. Number of lymph nodes containing metastatic carcinoma:List nodal sites: None. Other Significant Findings: Mild chronic pylonephritis is present. Stage: T2, NO, MX. C. Paraaortic lymph node: Benign, hyperplasia. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Renal mass - left. Postoperative Diagnosis: Same. Symptoms/Radiologic Findings: SPECIMENS: A. Mesenteric nodule. B. Left kidney. C. Paraaortic lymph nodes. SPECIMEN DATA. I. GROSS DESCRIPTION: A. Received in a single container labeled. mesenteric nodule and consists of a gray-tan nodule with attached fibroadipose tissue measuring. 1.5 x 0.5 x 0.5 cm. The specimen is bisected, the nodule has a white-tan fibrotic cut surface. Within the center there is a cavity containing red-brown. material. The specimen is sectioned and is entirely submitted in a single cassette labeled. B. Received in a single container labeled. left kidney and consists of a kidney with attached perinephric fat that measures 15: x 14x7 cm. and. weighs. 640 grams. There is no adrenal gland attached. The ureter measures 5 cm. in length and 0.3 cm. diameter and is grossly unremarkable. The renal vein stump measures 1 cm. in length and 0.3 cm. in diameter and is grossly unremarkable. The renal artery stump measures 1.7 cm. in length. and 0.5 cm. in diameter and is grossly unremarkable. The kidney has been bisected and reveals a large circumscribed golden yellow slightly lobulated. mass. that. measures. 8. cm. in. greatest dimension that is predominantly within the mid pole lesion that is beneath the capsular surface. There is no gross. invasion into the surrounding perinephric fat. The surrounding renal cortex is brown to red-tan and measures 0.7 cm. in thickness and shows a well. demarcated adrenal cortex appearance. Received with the specimen are two cassettes one green, one yellow labeled. Representative sections are submitted in cassettes labeled. gws: sections from mass in blocks 1 through 5; ureter in block 6; renal. artery and vein in block 7; uninvolved kidney in block 8. C. Received in a single container labeled. paraaortic lymph node and consists of a piece of yellow-tan fibroadipose tissue measuring 2.5. x. 1.5. x. 0.5. cm. On. sectioning. there reveals a single lymph node measuring 1 x 0.5 x 0.3 cm. The lymph node is bisected, the cut surface is pale tan. The. lymph node is entirely submitted in a single cassette labeled.",T2,N0,M0,T2N0M0
TCGA-A6-A567,"SPECIMEN. A. Lower anterior colon - sigmoid. B. Appendix. CLINICAL NOTES. PRE-OP DIAGNOSIS: Sigmoid colon cancer. POST-OP DIAGNOSIS: Rectal cancer - involvement of apical nodes. ? Implant lateral mesentery. GROSS DESCRIPTION. A. Received fresh, subsequently fixed in formalin, labeled. ""sigmoid colon"". The specimen consists of a 22 cm. long. portion of colon which is stapled at the proximal end, opened at the. distal end. The proximal end is inked blue and the distal end is. inked black. The specimen is opened to show a pink tan smooth. glistening mucosa with normal to abundant folds. The circumference. of the proximal end is 4.5 cm. and the circumference at the distal. end is 7.5 cm. The specimen shows a 4.8 x 3.5 x 1 cm. tumor which. comes within 5 cm. of the distal margin. The serosa of the specimen. is pink tan smooth glistening and predominantly covered with yellow. lobular fat. The specimen shows a 2.5 x 1.5 cm. serosal. umbilication. This umbilication is inked blue. The tumor also shows. gross invasion through the muscularis propria into the fat. Multiple. lymph nodes are grossly identified in the surrounding fat. There is. a focus of mesenteric margin (peduncle) which feels somewhat. indurated. The proximal lymph node may be present in this area. There is also a 1.5 x 1.5 irregular indurated focus on the surface. coming in within 9 cm. of the proximal margin. The cut surface of. this induration site shows possible tumor present. There is also. a. small polyp grossly identified which is 0.5 cm. this is located. 3. cm. from the distal margin. This polyp shows no invasion grossly. identified. Representative sections of the specimen are submitted. for tissue procurement. Representative sections of the remainder of. the specimen are submitted as follows: BLOCK SUMMARY: 1 - Representative luminal margins; 2 - mesenteric. margin shave; 3 - polyp full thickness; 4 - tumor to serosal. umbilication; 5 - tumor to normal; 6 - tumor to fat; 7 - radial. margin; 8 - indurated surface nodule with possible tumor; 9-12 -. nine possible lymph nodes each; 13 - four possible lymph node; 14 -. lymph node at mesenteric peduncle bisected; 15 - renresentative. section of possible mottled lymph node. RS15. B. Received in formalin labeled ""appendix"" is a 6 x 0.5. cm. unremarkable appendix partially covered with pink tan. smooth glistening serosa and yellow lobular fat. The specimen is. sectioned to show an intact wall with an average thickness of 0.3. cm. The lumen ranges from pinpoint to 0.??. Representative sections. of the specimen are submitted in one cassette with the proximal end. inked. RS1. MICROSCOPIC DESCRIPTION. Microscopic sections of the sigmoid tumor reveals a. moderate to poorly differentiated colonic adenocarcinoma. which has extended through the bowel wall into the mesenteric fat. The area of irregular indurated soft tissue at the mesenteric root. does not contain any carcinoma. There are three positive mesenteric. lymph nodes present. One of these is present at the mesenteric root. and represents the most proximal lymph node in the dissection. There is a soft tissue metastasis present in the mesentery as well. The results of the evaluation of the resection are summarized in the. following template. Histologic type: Adenocarcinoma. Histologic grade Moderate to poorly differentiated. Primary tumor (pT) : Tumor invades through the colon wall into the. mesenteric fat (pT3). Proximal margin: Negative. Distal margin: Negative. Circumferential (radial) margin: Negative. Vascular invasion: Negative. Regional lymph nodes (pN) : Three of 41 mesenteric lymph nodes. contain metastatic adenocarcinoma (pN1). Non-lymph node pericolonic tumor: Present. Distant metastasis (pM) : Tumor is present as a soft tissue. metastasis in the colonic mesentery (pM1) . Other findings: Adenomatous polyp. Appendix without significant. histopathologic findings. DIAGNOSIS. A. Colon, sigmoid, segmental resection: Invasive moderate to poorly differentiated colonic. adenocarcinoma extending through the wall of the colon into the. pericolonic fat. Proximal, distal and radial margins of resection are free of. tumor. Three of 41 mesenteric lymph nodes contain metastatic. adenocarcinoma (3/41). Soft tissue metastasis present in the soft tissues of the. lateral mesentery. Adenomatous polyp. B. Appendix, incidental appendectomy: No significant histopathologic findings.",T3,N1,M1,T3N1M1
TCGA-VQ-AA6J,"PRIMARY SITE: Stomach (Cardia). 1 - ""Product of total gastrectomy"": Poorly differentiated adenocarcinoma, invasive and ulcerated, intestinal pattern of. Laurn. Tumor size: 5.0 X 4.0 x 1.5 cm. Depth of infiltration: up to serosa. Sanguineous vascular invasion: not detected. Lymphatic vascular invasion: present. . Perineural invasion: present. Adjacent mucosa: moderate chronic gastritis. Surgical margins: free of neoplastic involvement. 27 lymph nodes were dissected from peri-gastric fat, 3 of them are compromised. by neoplasia (3/27), with capsular leakage, and distributed as follows: - Chain 1 - right paracardiac: absence of lymphoid tissue. - Chain 2 - left paracardiac: 0/3. - Chain 3 - lesser curvature: absence of lymphoid tissue. - Chain 4 - greater curvature (4sa): absence of lymphoid tissue. - Chain 4 - along the left gastroepiploic vessels (4sb): 0/1. - Chain 4 - along the right gastroepiploic vessels (4d): 0/3. - Chain 5 - suprapyloric: absence of lymphoid tissue. - Chain 6 - infrapyloric: 0/3. - Chain 7 and 9 - left gastric artery and celiac trunk: 3/7. - Chain 8 - anterior hepatic artery (8a): 0/1. - Chain 8 - posterior hepatic artery (8p): 0/4. - Chain 11 - proximal splenic artery (11p): 0/5. 2 - ""Greater omentum"": . Free of neoplasia. 3 - ""Esophageal margin"": . Free of neoplasia. 5 - ""Proximal esophageal margin"" (paraffin from frozen section): . Free of neoplasia. 6 - "" Lymph node from chain 6"" (paraffin from frozen section): . Free of neoplasia (0/1). PATHOLOGIC STAGING. Topograghy. Morphology. Stage. Stomach, NOS. Adenocarcinoma, NOS. pT4 pN2.",T4,N2,M0,T4N2M0
TCGA-97-8175,"approved by the US Food and Drug Administration. The FDA has. determined that such clearance or approval is not necessary. This. test is used for clinical purposes. It should not be regarded as. investigational or for research. The laboratory is regulated under. the Clinical Laboratory Improvement Amendments of. (CLIA) as. qualified to perform high complexity clinical testing. Addendum #4 performed by. The electronic signature attests that the named Attending. Pathologist has evaluated the specimen referred to in the signed. section of the report and formulated the diagnosis therein. This report may include one or more immunohistochemical stain. results that use analyte specific reagents. The tests were developed and their performance characteristics. determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is not. necessary. SPECIMENS: 1. F/S LUNG, LEFT UPPER LOBE WEDGE. 2. LEVEL 5 LYMPH NODE, LEFT. 3. COMPLETION LEFT UPPER LOBECTOMY. 4. LEVEL 9 LYMPH NODE. SEE ADDENDUM. Reason For Addendum #1: Molecular Studies. Reason For Addendum #2: Molecular Studies. Reason For Addendum #3: Molecular Studies. Reason For Addendum #4: Biomarker Report. DIAGNOSIS: 1,3. LUNG, LEFT UPPER LOBE: WEDGE RESECTION AND COMPLETION. LOBECTOMY. - ADENOCARCINOMA, SOLID PREDOMINANT (3.2 CM), SEE NOTE. - THE BRONCHIAL AND VASCULAR MARGINS ARE FREE OF TUMOR. SEVEN LYMPH NODES, NEGATIVE FOR CARCINOMA (0/7). Note: The tumor consists of solid (90%) and micropapillary (10%). components and measures 3.2 cm in greatest dimension. microscopically. Results of mutational studies will be reported in. addenda. 2. LYMPH NODE, LEVEL 5: BIOPSY. TWO LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2). 4. LYMPH NODE, LEVEL 9: BIOPSY. TWO LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2). Specimens: 1: F/S LUNG, LEFT UPPER LOBE WEDGE. 2: LEVEL 5 LYMPH NODE, LEFT. 3: COMPLETION LEFT UPPER LOBECTOMY. 4: LEVEL 9 LYMPH NODE. LUNG: Resection. SPECIMEN. Specimen: Lobe(s) of lung (specify). left upper lobe. Procedure: Lobectomy. Specimen Integrity: Intact. Specimen Laterality: Left. Tumor Site: Upper lobe. Tumor Focality: Unifocal. TUMOR. Histologic Type: Solid adenocarcinoma. Histologic Grade: G3: Poorly differentiated. EXTENT. Tumor Size: Greatest dimension (cm). 3.2cm. Visceral Pleura Invasion: Not identified. MARGINS. Bronchial Margin. Bronchial Margin Involvement by Invasive Carcinoma: Uninvolved by. invasive carcinoma. Vascular Margin: Uninvolved by invasive carcinoma. ACCESSORY FINDINGS. Lymph-Vascular Invasion: Not identified. STAGE (pTNM). Primary Tumor (pT): pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest. dimension surrounded by lung or visceral pleura without. bronchoscopic evidence of invasion more proximal than the lobar. bronchus (i.e., not in the main bronchus); or Tumor 5 cm or less. in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades. the visceral pleura; associated with atelectasis or obstructive. pneumonitis that extends to the hilar region but does not inolve the. entire lung. Regional Lymph Nodes (pN). pN0: No regional lymph node metastasis. Number Examined. 11. Number Involved. 0. CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS: with a 4 cm LUL mass. MACROSCOPIC DESCRIPTION: The specimen is received in four parts, each labeled with the. patient's name. 1. Part one is received fresh, labeled 'left upper lobe wedge at 084. b'. It consists of a pre-incised wedge biopsy of the lung measuring. 9 X 3.5 X 2 cm. The stapled line measures 9 cm in length. The. stapled line is shaved and the pleura around is inked black. At the. pre-incised area there is a grey-white firm nodule measuring 2 X 1.1. X 1.1 cm located 0.4 cm from the stapled line margin. The remainder. of the parenchyma is pink-red and crepitant. Frozen section. performed on the nodule and resubmitted for permanent section. Representative sections are submitted. 2. Part two is received in saline, labeled 'level 5 lymph node'. It. consists of two pieces of tan-brown soft tissue measuring 1.0 X 0.8. X 0.3 cm and 0.4 X 0.3 X 0.2 cm. Entirely submitted. 3. Part three is received fresh, labeled 'completion left upper. lobectomy'. It consists of a 176 gram left upper lobe of the lung. measuring 23 X 6.5 X 4 cm. There are two staple lines at the medial. aspect of the specimen measuring 11 cm and 11.5 cm. The staples are. removed and this margin is inked black. The pleural surface is. inked blue. The specimen is serially sectioned from superior to. inferior. There is no grossly palpable mass or lesion identified. Representative sections are submitted. 4. Part four is received in saline, labeled 'level 9 lymph node'. It consists of a piece of tan-brown soft tissue measuring 0.9 X 0.4. X 0.2 cm. Entirely submitted. SUMMARY OF SECTIONS: 1A frozen section remaining of the nodule. 1B-1E remaining of the nodule. 1F stapled line margin. 1G random section of the parenchyma. 2A in toto. 3A bronchial margins. 3B vessel margins. 3C possible hilar lymph nodes. 3D one bisected hilar lymph node. 3E-3J representative sections, including entire hilar region. 4A in toto. SPECIAL PROCEDURES: INTRA - OPERATIVE CONSULTATION: 1. Lung, left upper lobe, wedge resection: - Adenocarcinoma. ADDENDUM # 1 FOR MOLECULAR TESTS: EGFR, KRAS and ALK (FISH) was sent on. 1. for patient. The test is to be performed on tissue from case. The case report, slides, and blocks for the cited. accession number were retrieved from archives. The pathologist whose. signature appears below reviewed the original pathology report,. examined candidate H&E slides, and selected block 1C appropriate to. the specifications of the ordered molecular analysis. 1 H& E and 9. unstained slides were prepared and forwarded to. where the. subject molecular test will be performed. An addendum report will be. issued when the results of this molecular test are available. Addendum #1 performed by. ADDENDUM #2: EGFR Mutation Analysis. Body Site: Left upper lobe of lung. Clinical Data: Adenocarcinoma. RESULTS: No mutation detected. INTERPRETATION: No mutations were identified in the sample provided. for analysis. Fewer than 5% of non-small cell lung carcinoma. patients without identifiable mutations are reported to be. responsive to EGFR tyrosine kinase inhibitor therapies. COMMENT: Forty percent (40%) or more tumor cellularity is optimal. for this mutation analysis. The sample submitted showed 80% tumor. cellularity upon pathologist review. A frequently occurring sequence change 2361G>A (Q787Q) was. identified. This polymorphism is known not to have clinical. significance. Mutations in the tyrosine kinase domain of the epidermal growth. factor receptor (EGFR) gene are reported to be associated with. differential responsiveness or resistance to EGFR tyrosine kinase. inhibitor (TKI) therapies. The objective response rate among. patients with a sensitizing mutation ranges from 55 to 82%. This assay analyzes exons 18-21 of the EGFR tyrosine kinase domain;. based on the current literature, most mutations in non-small-cell. lung carcinoma (NSCLC) are expected to occur in these exons. Mutations present in less than 10-20% of extracted DNA may not be. detected by this method. Mutation status in a sample may change. during tumor progression or the course of therapy; therefore, this. result cannot be used to infer the presence or absence of a mutation. in another sample or sub-sample obtained from this tumor. This test is validated for non-small cell lung carcinoma. The. clinical significance and utility of this test in other tumor types. is unknown. METHOD: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exons 18-21 of the EGFR gene. PCR products are analyzed by. bi-directional direct DNA sequencing using capillary electrophoresis. and fluorescence detection. False positive or negative results may. occur for reasons that include genetic variants or somatic. heterogeneity of the tissue sample. DISCLAIMER: This test was developed and its performance characteristics. determined by. The laboratory is regulated under the. Clinical Laboratory Improvement Amendments of. (CLIA) as. qualified to perform high complexity clinical testing. This. particular test is not considered a stand alone test and should be. used only in the context of other diagnostic tests or clinical. work-up related to treatment decisions. Addendum #2 performed by. ADDENDUM #3: MOLECULAR ONCOLOGY. KRAS MUTATION ANALYSIS. Body Site: Left upper lobe of lung. Specimen Type: Slides. Clinical Data: Adenocarcinoma. RESULTS: Wild-type gene. INTERPRETATION: No mutations were identified at codons 12 and 13 of the KRAS gene. COMMENT: Mutations in the KRAS gene are reported to be associated with poor. prognosis, and resistance to targeted tyrosine kinase inhibitor. therapies in patients with non-small-cell lung cancer (NSCLC). KRAS. mutations occur in 15-30% of NSCLC patients and are strongly. associated with adenocarcinoma and smoking history. This assay analyzes codons 12 and 13 in exon 2 of the KRAS gene;. based on the current literature, approximately 98% of mutations are. expected to occur in these codons. The analytical sensitivity of. the assay is approximately 10%; thus mutations present in a low. percentage of cells may not be detected. This test is validated for. use in identifying KRAS codon 12 and codon 13 mutations in fresh,. frozen, or formalin-fixed paraffin embedded tissue. In particular. the test performance has been established in samples of colorectal. cancer and non-small cell lung carcinoma which harbor these. mutations, although several other tissues are also known to harbor. KRAS mutations (e.g. tumors of pancreas, bile duct, ovary, appendix,. etc.). Analysis of EGFR mutation or gene amplification status may provide. additional information regarding this patient's probability of. response to targeted tyrosine kinase inhibitor therapies, if. clinically indicated. See references. METHOD/LIMITATIONS. Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exon 2 of the KRAS gene. PCR products are subjected to single. nucleotide primer extension to detect mutations at codons 12 and 13;. primer extension products are analyzed using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. This test was developed and its performance characteristics. determined by. The laboratory is regulated under. the Clinical Laboratory Improvement Amendments of. (CLIA) as. qualified to perform high complexity clinical testing. This. particular test is not considered a stand along test and should be. used only in the context of other diagnostic tests or clinical. work-up related to treatment decisions. Addendum #3 performed by. ADDENDUM 3: Fluorescence In-Situ Hybridization (FISH). Body Site: Left upper lobe of Lung. Clinical Data: Adenocarcinoma. INTERPRETATION: Negative for a rearrangement involving the ALK gene. Probe #Nuclei Examined % Positive Nuclei %. Control values. 2p23(ALK)V 100 0 <15.0. A total of 100 cells were scored. FINDINGS: FISH was performed on paraffin embedded tissue sections. using dual color break-apart probe. to the ALK. gene at 2p23. This probe flanks the entire gene. If a rearrangement. involving ALK is present, inversion or translocation, one of the two. probe signals separates as one red (orange) and one green signal. In. this specimen, separated signals were present in 0.5% of the nuclei. scored. Based on laboratory validation data, these results are. within the normal limits. COMMENTS: Three to four copies of ALK were observed in 27.0% of. cells. This gain of intact ALK fusion hybridization signals. represents an aneuploid population with extra copies of chromosomes. 2/2p ALK region. Additional copies of ALK are not uncommon in. NSCLCs, although the significance of extra copies of the ALK gene in. lung carcinoma is unclear at this time (. ISCN RESULTS: nuc ish(ALKx3 4) [42/100]. This test was developed and its performance characteristics. determined by. It has not been cleared or.",T2,N0,M0,T2N0M0
TCGA-BP-4768,"Clinical Diagnosis & History: with incidentel left renal mess. Specimens Submitted: 1: SP: Kidnay,left, partial nephrectomy: 2: SP: Lymph nodes, para-aortic, axcision: 3: SP: Cyst wall, excision: 4: SP: Cyst wall #2, excision: DIAGNOSIS: 1. SP: Kidney,lef partial nephrectomy: Tumor Typa: Ranal call carcinoma - Convantional (claar cell) type. Fuhrman Nuclear Grede: Nuclear grade II/IV. Tumor Size: Graatest diamatar is 3.0 cm. Local Invasion (for ranal cortical types): Not Identified. Renal Vein Invasion: N/A. Surgical Margins: Free of tumor. Non-Naoplastic Kidney: Unremarkable. Adrenal Glend: N/A. Lymph Nodes: N/A. Staging for renal cell carcinome/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. 2. SP: Lymph nodes, para-sortic, excision: Lymph Nodas: Not involvad. Number of nodas examinad:7. Numbar of metestetic nodes:0. 3. SP: Cyst wall, excision: Banign cortical cyst. 4. SP: Cyst wall #2, excision: Banign cortical cyst. Gross Description: 1). The specimen is racaived frash for frozen section diagnosis, labeled, ""Left renal tumor (stitch marks daap margin)"". Il. consists of a rasacted kidnay with attached perinephric fat, maasuring averall 6.8 x 3.7 X 3.2 cm and weighing 33 gm. The. surgical margin is inkad black. Sarial sactions through the kidney ravaal a wall-circumscribed, bright yellow, focally hamarrhagic. tumar mass measuring 3.0 X 2.6 x 2.2 cm. Tha mass is located 0.2 cm from the inked surgical margin. A small portion of bright. yellow tumor mass Is seen to be infiltrating the fat on tha apposita and of tha surgical margin, maasuring 0.6 x 0,4 cm. Raprasantative sactions are submittad. A portion of tumor is submitted for. Summary of Sections: FSC - frozen saction contral. TWM - tumor wilh margins. TWF - tumar within fat. T - tumor. NK - normal kidnay, reprasantativa sactions. 2). Tha spacimen is racaived in formalin, labelad, ""Para-sortic lymph nodes"". It consists of an irregular piaca of tan-yellow. fatty tissua admixad with blood, measuring 3.7 X 2.4 x 0.6 cm. Several tan-pink lymph nodas, measuring from 0,4 up to. 0.8. cm. in. greatast dimansion ara dissacted. Tha largar lymph nodas are bisected and tha antire lymph nodes are submittad. Summary of Sections: LN1BS - lymph node one bisectad. LN2BS - lymph noda two bisacted. LN - lymph nadas. 3). Tha speciman is received in formalin, labaled, ""Cyst wall"". Il consists of an irregular piace of tan-plnk saft tissue with. attachad fat maasuring avarall 1.5 x 1.4 X 0.6 cm. The cyst wall appaars hamorrhagic and tha wall measuras 1.6 x 0.5 cm. The. spaciman is sarially sactionad and antiraly submittad. Summary of Sactions: UD - undesignated. 4). The speclmen is received in formalin, labeled, ""Cyst wall #2"". It consists of two irregular pleces of tan-pink saft tissua. measuring 1.4 and 1.7 cm in greatast dimansion. Tha antire spacimen is submittad. Summary of Sections: UD - undesignated. Summary of Sections: Part 1: SP: Kidney,left, partial nephrectomy: Block. Sect. Site. PCs. 1. fsc. 1. 1. nk. 1. 1. t. 1. 1. twf. 1. 2. twm. 2. Part 2: SP: Lymph nodes, para-aortic, exclsion: Block. Sect. Site. PCs. 2. 4. 1. In1bs. 2. In2bs. 2. Part 3: SP: Cyst wall, excision: Block. Sect. Site. PCs. 2. ud. 2. Part 4: SP: Cyst wall #2, excision: Block. Sect, Site. PCs. 1. ud. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: MARGIN FREE OF TUMOR. RENAL CORTICAL NEOPLASM, FAVOR RENAL. CELL CARCINOMA. PERMANENT DIAGNOSIS: SAME.",T1,N0,M0,T1N0M0
TCGA-JY-A93D,"M. Facility: Specimen(s) Received. 1. Lymph-Node: ST19 Splenic nodes. 2. Lymph node: Station 8. 3. Esophagogastric Resection: Thoracic esophagus + Proximal stomach with esophageal margin - QS. 4. Lymph node: Station 7. 5. Lymph node: Station 17. 6. Lymph node: Station 16. 7. Lymph node: Additional station 7. 8. Lymph node: Additional station 8. 9. Lymph node: station 4R. 10. Esophagus: Final esophageal margin. 11. Esophagus: EEA donuts. 12. Stomach Resection: Final gastric resection margin. Diagnosis. 1. Specimen labeled ""Lymph node station 19 (spienic nodes)"", excision: Benign fibroadipose tissue,. No lymph node(s) represented for evaluation in the submitted tissue. There is no evidence of malignancy. 2. Lymph node station 8, excision: Metastatic adenocarcinoma in one (1) of seven (7) lymph nodes. 3. Thoracic esophagus and proximal stomach, resection: Invasive adenocarcinoma (3.4 x 3.0 x 1.2 cm), poorty differentiated, arising in the lower esophagus in the background of. extensive Barrett's esophagus with focal high-grade dysplasia: Lymphovascular and perineural invasion are seen. All evaluated surgical resection margins are negative for carcinoma. Summary stage (incorporating all parts 1-12): pT2 pN3 pMX. See synoptic report below. 4. Lymph node station 7, excision: Metastatic adenocarcinoma in one (1) of four (4) lymph nodes. 5. Lymph node station 17, excision: Metastatic adenocarcinoma in five (5) of sixteen (16) lymph nodes. 6. Lymph node station 16, excision: Metastatic adenocarcinoma in four (4) of nine (9) lymph nodes. 7. Additional lymph node station 7, excision: Metastatic adenocarcinoma in one (1) of one (1) lymph node. 8. Specimen labeled ""Additional lymph node station 8"", excision: Benign fibroadipose tissue. No lymph node(s) represented for evaluation in the submitted tissue. There is no evidence of malignancy. 9. Lymph node station 4R, excision: There is no evidence of malignancy in two (2) of two (2) lymph nodes. 10. Final esophageal margin, resection: Benign squamous mucosa and esophageal wall. No glandular mucosa seen. There is no evidence of malignancy. 11. EGA donuts, excision: Fragment of benign squamous mucosa and esophageal wall. Fragment of benign gastric corpus-type wall. There is no evidence of malignancy, atrophy, intestinal metaplasia, or Helicobacter-like organisms. 12. Final gastric margin, resection: Benign gastric corpus-type wall. There is no evidence of malignancy, atrophy, intestinal metaplasia, or Helicobacter-like organisms. Synoptic Data. Data below integrates information from all parts 1-12. Clinical History: Barrett's esophagus. Specimen: Esophagus. Proximal stomach. Procedure: Esophagogastrectomy. Primary Tumor Site: Distal esophagus (lower thoracic esophagus). Additional Sites Involved by Tumor: Esophagogastric junction (EGJ). Proximal stomach and esophagogastric junction. Relationship of Tumor to Esophagogastric Junction: Tumor midpoint lies in the distal esophagus and tumor involves the. esophagogastric junction. Histologic Type: Adenocarcinoma. Histologic Grade: G3; Poorly differentiated. Tumor Size: Greatest dimension: 3.4 cm. Additional dimension: 3.0 cm. Additional dimension: 1.2 cm. Microscopic Tumor Extension: Tumor invades muscularis propria. Proximal Margin: Uninvolved by invasive carcinoma. Uninvolved by dysplasia. Distal Margin: Uninvolved by invasive carcinoma. Uninvolved by dysplasia. Circumferential (Adventitial) or Deep Margin: Uninvolved by invasive carcinoma. All Margin Status. All margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 3 mm. Closest margin: Circumferential. Treatment Effect: No prior treatment. Lymph-Vascular Invasion: Present. Perineural Invasion: Present. TNM Descriptors: Not applicable: No TNM prefix applicable. Primary Tumor (pT): pT2: Tumor invades muscularis propria. Regional Lymph Nodes (pN): pN3: 7 or more nodes involved. Number of regional lymph nodes examined: 39. Number of regional lymph nodes involved: 14. Distant Metastasis (pM): Not applicable: Unknown (pMX). Additional Pathologic Findings: Intestinal metaplasia (Barrett's esophagus). High grade dysplasia. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Clinical History. Esophageal adenocarcinoma; Barrett's. Gross Description. 1. The specimen container is labeled with the patient's name and as ""Lymph node station 19 (splenic nodes)"". The. specimen consists of 1 piece of fibroadipose tissue measuring 3.5 x 3.0 x 1.2 cm. No grossly obvious lymph nodes are. identified within the tissue. 1A-1C submitted in toto. 2. The specimen container is labeled with the patient's name and as ""Station 8"". The specimen consists of multiple. pieces of fibroadipose tissue measuring, in aggregate, 3.5 x 3.0 x 2.2 crn. Within the tissue are multiple possible lymph. nodes ranging from 0.1 to 0.4 cm. Representative sections, identified lymph nodes submitted intact and in toto. 2A-2B multiple intact lymph nodes per block. 3. The specimen container is labeled with the patient's name and as ""Thoracic esophagus and proximal stomach"". RESECTION SPECIMEN: Gastroesophagectomy. FIXATION: Received fresh, placed in formalin. The adventitial surface is painted with silver nitrate. DIMENSIONS: Length along lesser curvature: 8.0 cm. Length along greater curvature: 3.5 cm. Circumference of distal gastric margin: 13.0 cm. Circumference of proximal esophageal margin: 5.0 cm. Length of tubular esophagus: 6.0 cm. Width of tubular esophagus: 4.7 cm. TUMOR. - Esophagus; extending through GE junction with <5% of tumor in gastric cardia. - CONFIGURATION: Diffuse, circumferential. - DIMENSIONS: Diameters: 3.4 x 3.0 cm. Depth: 1.2 cm. DESCRIPTIVE CHARACTERISTICS: Poorly defined with a varied appearance. There is a table top lesion (with. endoscopic tip stuck in it) at the proximal aspect measuring 1.1 cm in diameter. The majority of the tumor is comprised. of. a broad based ulcerative lesion measuring 3.0 cm from proximal to distal x 3.4 cm in circumference. The distal edge of. this has a nodular appearance in an area measuring 1.1 x 0.9 cm. - PERFORATION: No. - DISTANCE FROM MARGINS: - PROXIMAL: 2.5 cm. - DISTAL: 6.5 cm. - RADIAL: 0.3 cm (inked adventitial surface). ESTIMATED DEPTH OF INVASION: Into muscularis propria. LESIONS IN NONCANCEROUS STOMACH: The stomach mucosa is congested. LYMPH NODES: No perigastric or thoracic lymph nodes are identified within the small fragments of adherent adipose. tissue. FROZEN SECTION: Representative section of the esophageal margin was submitted as block 3A. Tissue is stored frozen. Photographs are taken. Representative Sections: 3A frozen section tissue, resubmitted. 3B remaining esophageal margin, en face. 3C-3Q every other sagittal section of esophagus moving from the greater curvature in a clockwise direction through the. anterior portion first (each triplet of blocks contains one full thickness sagittal section from proximal esophagus to just. beyond GE junction trisected, with the 1st block containing the proximal portion, the 2nd block containing the midportion. and the 3rd block containing the distal portion). 3R-3T stomach. 3U-3W gastric margin, en face. 4. The specimen container is labeled with the patient's name and as ""Station 7"". The specimen consists of 1 piece of. fibroadipose tissue measuring 4.2 x 3.2 x 1.7 cm. Within the tissue are multiple lymph nodes ranging from 0.1 to 3.3 cm. Representative sections, lymph nodes submitted in toto. 4A multiple intact lymph nodes. 4B 1 lymph node, bisected. 4C-4D 1 lymph node, bisected. 5. The specimen container is labeled with the patient's name and as ""Station 17"". The specimen consists of 1 piece of. adipose tissue consistent with omentum measuring 11.0 x 7.5x2.0 cm. The tissue is congested. Within the tissue are. multiple lymph nodes ranging from 0.2 to 1.3 cm. Representative sections, lymph nodes submitted in toto. 5A-5D multiple intact lymph nodes. 5E 1 lymph node, bisected. 6. The specimen container is labeled with the patient's name and as ""Station 16"". The specimen consists of 1 piece. of. fibroadipose tissue measuring 11.0 x 5.5 x 1.8 cm. Within the tissue are multiple lymph nodes ranging from 0.1 to 0.6. cm. Representative sections, lymph nodes submitted in toto: 6A-6B multiple intact lymph nodes. 7. The specimen container is labeled with the patient's name and as ""Additional station 7"". The specimen consists of 2. pieces of fibroadipose tissue measuring, in aggregate, 2.0: x 1.0 x 0.3 cm. No grossly obvious lymph nodes are identified. within the tissue. 7A submitted in toto. 8. The specimen container is labeled with the patient's name and as ""Additional station 8"". The specimen consists of 1. piece of fibroadipose tissue measuring 2.2 x 2.3 x 1.0 cm. No grossly obvious lymph nodes are identified within the. tissue,. 8A-8B submitted in toto. 9. The specimen container is labeled with the patient's name and as ""Station 4R"". The specimen consists of 2 pieces of. tan and anthracotic tissue measuring 1.0 and 1.3 cm in maximum dimension. 9A submitted in toto. 10. The specimen container is labeled with the patient's name and as ""Final esophageal margin"". The specimen. consists of a ring of mucosa, stapled at one end, measuring 3.5 cm in diameter by 0.5 cm in length. No obvious lesion. is. identified. 10A tissue abutting staple line. 11. The specimen container is labeled with the patient's name and as ""EGA donuts"". The specimen consists of 2. pieces of pink-tan tissue consistent with mucosa. The smaller piece measures 1.2 x 0.7 0.2 cm. The larger piece is a. circular piece held together with blue suture material with a diameter of 4.0 cm and a length of 0.9 cm. No gross lesions. are identified. Submitted in toto: 11A smaller piece. 11B larger piece. 12. The specimen container is labeled with the patient's name and as ""Final gastric resection margin"". The specimen. consists of a wedge resection of stomach, stapled along both edges. The specimen has a diameter of 6.5 cm and a. maximum length of 3.3 cm. The staple lines measuring 8.0 cm each. One of the staple lines is partially opened. Adherent adipose tissue measures 3.5 x 2.5 x 0.1 cm. The gastric mucosa is congested at the open staple line but is. otherwise unremarkable. No lymph nodes are identified within the adipose tissue. Representative sections: 12A tissue along partially open staple line. 12B ventral sections. 12C tissue along opposite staple line. Quick Section Diagnosis. Part 3: Thoracic esophagus and proximal stomach; esophageal margin for QS: Esophageal margin negative for. carcinoma. Result reported at.",T2,N3,M0,T2N3M0
TCGA-A8-A0A2,"Diagnosis: Well-differentiated invasive lobular carcinoma of the right breast measuring up to 3.3 cm with. circumscribed infiltration into the dorsal resection margin in the main preparation and with. tumor-free follow-up dorsal resection material (thus tumor-free dorsal margin of at least 1.2. cm). Minimum margin 0.5 cm at 3 o'clock and carcinoma-free follow-up resection material at. 3 o'clock with moderate mammary fibrosis and focal intraductal hyperplasia without atypia. Further minimum cranial and caudal margins > 1.2 cm. No invasion of lymph vessels. Fifteen. Fifteen right axillary lymph nodes free of metastases with pre-existing lymphatic hyperplasia. and pre-existing slight scarring in isolated larger lymph nodes. Tumor classification: M-8500/3, G 1, pT 2, L .0, V / 0, pN 0 (0/15), pMX, R 0. Stage II a.",T2,N0,M0,T2N0M0
TCGA-DE-A4MB,"Diagnosis: A: Thyroid cartilage, left margin, biopsy. - Positive for invasive carcinoma, consistent with papillary. thyroid carcinoma. B: Lymph nodes, level 5, left neck, regional node dissection. - No tumor seen in five lymph nodes (0/5). - Benign skeletal muscle and soft tissue. C: Lymph nodes, level 4, left neck, regional node dissection. - No tumor seen in nine lymph nodes (0/9). - Benign skeletal muscle and soft tissue. D: Lymph nodes, level 3, left neck, regional node dissection. - Metastatic papillary thyroid carcinoma in 1 of 13 lymph nodes. (1/13) i maximum size of metastasis <0.1 cm; negative for. extracapsular extension. E: Lymph nodes, level 2, left neck, regional node dissection. - Metastatic papillary thyroid carcinoma in 2 of 9 lymph nodes. (2/9) i maximum size of metastasis 0.7 cm; negative for. extracapsular extension. F: Thyroid, total thyroidectomy. Tumor histologic type: papillary thyroid carcinoma, papillary. and follicular variants. Tumor size: 4.4 cm maximum tumor size. Tumor growth pattern: infiltrative. Tumor focality: multifocal; single dominant mass within left. lobe with multiple papillary microcarcinomas identified in right. lobe, measuring 0. 1 cm, 0.1 cm, 0.2 cm and <0.1 cm (F2). Extent of invasion: Capsular Invasion: not applicable. Lymphovascular: not identified. Blood vascular: not identified. Extra thyroidal extension: extentive invasion into perithyroidal. soft tissues with invasion of skeletal muscle identified. Surgical margins: Carcinoma extensively involves the posterior. resection margin (F5, F6, F7, F8, F9, F10, F11) i carcinoma. involves the inferior en face margin (F12) i carcinoma is very. close <0.1 cm from the anterior resection margin (F5, F8, F9,. F10) . Status of thyroid gland away from tumor: multinodular thyroid. Lymph nodes: separately submitted; total lymph node count for. all specimens is 3 of 36 lymph nodes involved by metastatic. papillary thyroid carcinoma (3/36). Size of largest metastasis (greatest dimension) : 0.7 cm. Extracapsular (perinodal) extension: not identified. Other significant findings: benign thyroid tissue. AJCC PATHOLOGIC TNM STAGE: pT3 pN1b. NOTE: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. Comment. The frozen section diagnosis is confirmed. Intraoperative Consult Diagnosis: A frozen section was requested by. FSA1: Thyroid cartilage margin, left, biopsy. - Positive for carcinoma. Dr. concurs. Frozen Section Pathologist : , MD. Clinical History: -year-old female with left thyroid mass. FNA was strongly. suspicious for malignancy papillary vs. possible medullary. Gross Description: Specimen A is labeled ""left thyroid cartilage margin"" and is a 6. X 5 X 3 mm aggregate of firm red/yellow tissue, FSA1,. Specimen B is labeled ""left neck level 5"" and is a 3.6 X 2.5 X. 1.5 cm aggregate of fibrofatty tissue and muscle. The specimen. is dissected for lymph node candidates. Four lymph node. candidates measuring up to 0.4 cm in greatest dimension are. identified. Block Summary: B1 - Four lymph node candidates. B2 - Sample from muscle. Specimen C is labeled ""left neck level 4"" and is a 3.4 X 3.2 X. 1.0 cm aggregate of yellow/tan fibrofatty tissue and attached. muscle, dissected for lymph node candidates. Lymph node. candidates measuring up to 0.6 cm in greatest dimension. are identified. Block Summary: C1 - One lymph node candidate, bisected. C2 - Five lymph node candidates. C3 - Four lymph node candidates. C4 - Representative section from skeletal muscle. Specimen D is labeled ""left neck level 3"" and is a 4.3 X 2.5 X. 1.0 cm aggregate of yellow/tan fibrofatty tissue, dissected for. lymph node candidates. Lymph node candidates measuring up to 1.2. cm in greatest dimension are identified. Block Summary. D1 - Four lymph node candidates. D2 - Three lymph node candidates. D3 - One lymph node candidate. Specimen E is labeled ""left neck level 2"" and is a 3.7 X 2.4 X. 1. 0 cm aggregate of focally cauterized yellow/tan fibrofatty. tissue, dissected for lymph node candidates. Lymph node. candidates measuring up to 1.4 cm in greatest dimension. are identified. Block Summary: E1 - Three lymph node candidates. E2 - Two lymph node candidates. E3 - One lymph node candidate. E4 - One lymph node candidate, bisected. Specimen F: Specimen fixation: Formalin. Type of specimen: Total thyroidectomy. Size and weight of specimen: 30.5 grams, 7.9 X 5.0 x 3.0 cm. overall. Composed of a 5.6 x 4.8 X 1.8 cm left lobe, 3.4 x 2.3 X. 1.1 cm right lobe. Orientation: Inking: anterior/blue, posterior/black, and. isthmus/yellow. Tumor location: The tumor involves the entire left thyroid lobe. The isthmus and right lobe are uninvolved. Focality: Unifocal. Dominant tumor: Left thyroid lobe. Tumor description: Solid, firm, ill-defined tan and gritty. Tumor size: 4.4 X 3.7 X 1.8 cm. Confinement/non-confinement : Appears to extend beyond the. thyroid gland on the left hand side posteriorly and inferiorly. and possibly superiorly. Distance of tumor to surgical margins The tumor abuts the blue-. inked anterior margin, the black inked posterior margin along. the majority of the surface. Appearance of thyroid gland away from tumor: The right lobe of. the thyroid is dark red and homogeneous with no nodules or. masses appreciated. The isthmus is grossly unremarkable. There. is a 1.2 cm in diameter colloid nodule located along the. anterior medial edge of the tumor near the isthmus. Parathyroids: Not identified. Tissue submitted for special investigations: Tumor is given to. tissue procurement. Lymph nodes: Submitted separately. Digital photograph taken: No. Block Summary: Inking: anterior/blue, posterior/black and isthmus/yellow. F1-F2 - Representative sections from right lobe. F3 - Perpendicular sections of left thyroid lobe, superior. margin. F4-F5 - Section from superior portion of nodule. F6-F7 - Representative section of mass with colloid nodule. towards isthmus. (medial). F8 - Central portion of tumor along lateral edge. F9 - Central portion of tumor showing relationship to posterior. and anterior margins. F10 - Inferior edge of tumor towards lateral edge. F11 - Inferior edge of tissue inferior edge of mass in soft. tissue. F12 - En face inferior margin. F13 - Fat attached to inferior pole of mass.",T3,N1,M0,T3N1M0
TCGA-IR-A3LF,"Specimens Submitted: 1: SP: Uterus, cervix, bilateral ovaries and bilateral tubes. 2: SP: Rt. external iliac lymph node. 3: SP: Rt. internal iliac lymph node (. 4: SP: Rt. obturator lymph node. 5: SP: Rt. common iliac lymph node I. 6: SP: Lt. external iliac lymph node. 7: SP: Lt. internal iliac lymph node 1. 8: SP: Lt. obturator lymph node. 9: SP: Lt. common iliac lymph nous. 10: SP: Lt. para-aortic lymph node. 11: SP: Rt. para-aortic lymph node. DIAGNOSIS: 1). UTERUS, BILATERAL ADNEXA; HYSTERECTOMY AND BILATERAL. SALPINGO-OOPHORECTOMY: - INVASIVE ADENOCARCINOMA OF UTERINE CERVIX, WITH ENDOMETRIOID FEATURES. (SEE NOTE), MODERATELY DIFFERENTIATED. - THE MAXIMAL THICKNESS OF THE CERVICAL STROMAL INVASION IS 6 MM. - THE THICKNESS OF THE CERVIX IN THE AREA OF MAXIMAL TUMOR INVASION IS 20. MM. - NO EVIDENCE OF TUMOR MULTICENTRICITY IS IDENTIFIED. - IN SITU ENDOCERVICAL DENOCARCINOMA IS ALSO PRESENT. - NO VASCULAR INVASION IS IDENTIFIED. - NO PERINEURAL INVASION IS IDENTIFIED. - NO VAGINAL EXTENSION IS IDENTIFIED. - THE TUMOR EXTENDS INTO THE LOWER UTERINE SEGMENT (MUCOSA AND STROMA) . - ALL SURGICAL MARGINS ARE FREE OF TUMOR. - THE ENDOMETRIUM SHOWS THE FOLLOWING ABNORMALITY: ATROPHY. - THE MYOMETRIUM SHOWS THE FOLLOWING ABNORMALITIES: ADENOMYOSIS AND. LEIOMYOMA. - ALL ADNEXAE ARE UNREMARKABLE. NOTE: IMMUNOHISTOCHEMICAL STAINS SHOW THAT THE TUMOR CELLS ARE POSITIVE FOR. CEA AND NEGATIVE FOR VIMENTIN, ER, AND PR, SUPPORTING A CERVICAL ORIGIN. 2). LYMPH NODE, RIGHT EXTERNAL ILIAC; EXCISION: - THREE BENIGN LYMPH NODES (0/3). 3). LYMPH NODE, RIGHT INTERNAL ILIAC; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 4). LYMPH NODE, RIGHT OBTURATOR; EXCISION: - TWO BENIGN LYMPH NODES (0/2). 5). LYMPH NODE, RIGHT COMMON ILIAC; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 6). LYMPH NODE, LEFT EXTERNAL ILIAC; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 7). LYMPH NODE, LEFT INTERNAL ILIAC; EXCISION: - THREE BENIGN LYMPH NODES (0/3). 8). LYMPH NODE, LEFT OBTURATOR; EXCISION: - TWO BENIGN LYMPH NODES (0/2). 9). LYMPH NODE, LEFT COMMON ILIAC; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 10). LYMPH NODE, LEFT PARA-AORTIC; EXCISION: - BENIGN FIBROUS TISSUR. (DEEPER SECTIONS PENDING) . 11). LYMPH NODE, RIGHT PARA-AORTIC; EXCISION: - TWO BENIGN LYMPH NODES (0/2). I. ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Procedures/Addenda: Addendum. Addendum Diagnosis. ADDENDUM. SITE: LEFT PARA-AORTIC LYMPH NODES, EXCISION. PART 10. - ADDITIONAL DEEPER SECTIONS CONTAIN 3 BENIGN LYMPH NODES. THE FINAL. DIAGNOSIS FOR PART 10 IS: PART 10: LEFT PARA-AORTIC LYMPH NODES, EXCISION: 3 BENIGN LYMPH NODES.",T1,N0,M0,T1N0M0
TCGA-67-3773,"i. 1. TISSUES: A. LYMPH NODE. B. LYMPH NODE. C. LYMPH NODE. D. LYMPH NODE. E. LYMPH NODE. F. LUNG-LEFT LOWER LOBE. DES: P88305 - 88305. P88307 - 88307. P88313 - 88313. P88331 - 88331. D50175 - RESECTION. D50177 - REGIONAL LYMPH. 88305TC - LEVEL IV - GROS. 88307TC - LEVEL V - GROSS. 88313TC - SPECIAL STAINS. 88331TC - PATHOLOGY CONSU. 1 - SURGICAL SPECIM. T28700 - LT LO LOBE LUNG. T08000 - LYMPH NODE. MARKERS: 88305, 88305TC, 88307, 88307TC, 88313, SPECIAL STAINS - GRP II, 88331,. PATH CONSULT FS, RES, RLN, SURGICAL SPECIMEN. CLINICAL HISTORY. PRE-OPERATIVE DIAGNOSIS: LEFT LOWER LOBE LUNG CA. FINAL DIAGNOSIS. A. ""LEVEL 9L LYMPH NODE"" : LYMPH NODE NEGATIVE FOR TUMOR. B. ""LEVEL 6 LYMPH NODES"" : MULTIPLE LYMPH NODES NEGATIVE FOR TUMOR. C. ""LEVEL 5 LYMPH NODES"": TWO (2) LYMPH NODES NEGATIVE FOR TUMOR. D. POSTERIOR HILAR LYMPH NODE"": LYMPH NODE NEGATIVE FOR TUMOR. E. "" SUPERIOR SEGMENTAL LYMPH NODE"" : LYMPH NODE NEGATIVE FOR TUMOR. F. ""SUPERIOR SEGMENT, LEFT LUNG LOWER LOBE"" (SEGMENTECTOMY) : MODERATELY. DIFFERENTIATED ADENOCARCINOMA OF LUNG SPANNING 1.! 5 CM IN DIMENSION. AND FOCALLY PENETRATING THE VISCERAL PLEURA (HIGHLIGHTED ON AN. ELASTIC STAIN) THE INKED SURGICAL MARGIN OF RESECTION IS NEGATIVE. FINAL DIAGNOSIS. FOR TUMOR. PATCHY MILD NON-SPECIFIC CHRONIC INFLAMMATION WITH. SCATTERED EPITHELIOID GRANULOMATA. GROSS DESCRIPTION. A. The specimen is submitted fresh for frozen section as ""9L"" and. consists of a 0.7 cm anthracotic lymph node; bisected and submitted, 2 (1). labeled ""FSP"" for frozen section. FROZEN SECTION DIAGNOSIS: Negative for tumor. B. The specimen is submitted fresh for frozen section as ""level 6"" and. consists of four anthracotic lymph nodes ranging 0.4 cm to 1.4 cm in. dimension. The largest nodule is inked blue and bisected. The specimen. is submitted in toto, 5 (1) labeled ""FSP"" for frozen section. FROZEN SECTION DIAGNOSIS: Multiple lymph nodes negative for tumor. C. The specimen is submitted fresh for frozen section as ""level 5 1 and. consists of two anthracotic lymph nodes measuring 0.5 cm and 1.3 cm in. greatest dimension. The smaller lymph node is inked blue. The specimen. is bisected and submitted in toto, 4 (1) labeled ""FSP"" for frozen section. FROZEN SECTION DIAGNOSIS: Multiple lymph nodes negative for tumor. D. The specimen is submitted fresh for frozen section as ""posterior hilar. node"" and consists of a 1.2 cm anthracotic lymph node; bisected and. submitted, 2 (1) labeled ""FSP"" for frozen section. FROZEN SECTION DIAGNOSIS: Negative for tumor. E. The specimen is submitted fresh for frozen section as ""superior. segmental node"" and consists of a 0.5 cm anthracotic lymph node; bisected. and submitted, 2 (1) labeled ""FSP"" for frozen section. FROZEN SECTION DIAGNOSIS: Negative for tumor. F. The specimen is submitted fresh as ""left lower lobe superior. segmentectomy"" and consists of a wedge lung resection measuring 8 x 5 x. 1.5 cm and weighing 24 gms with two stapled surgical margins measuring. 7 cm and 3 cm in length. The pleural surface is tan purple with diffuse. GROSS DESCRIPTION. anthracotic pigmentation and a 0.5 cm puckered area. A mass is palpable. underlying the puckered pleural surface. Sectioning reveals a 1.5 x 1.3 x. 1 cm pale tan firm mass 0.4 cm from the stapled margin and abutting the. pleural surface. The pleural surface is inked black and the stapled. margin is inked blue. No additional masses or lesions are identified. The lung parenchyma is red purple and spongy. Representative sections are. submitted, 6 (5) : Cassettes 1, 2 and 3: Mass. Cassettes 4 and 5: Normal lung. Note: A portion of the tumor is submitted for. studies. PRIORITY. SYNOPTIC REPORT. SYNOPTIC REPORT: LUNG. (CAP/AJCC/ACS - REQUIRED ELEMENTS). SPECIMEN TYPE: WEDGE RESECTION. LATERALITY: LEFT. TUMOR SITE: SUPERIOR SEGMENT OF LOWER LOBE. TUMOR SIZE: 1.5 CM. HISTOLOGIC TYPE: ADENOCARCINOMA. HISTOLOGIC GRADE: I-II. EXTENT OF INVASION: LUNG PARENCHYMA. EXTENTION TO PLEURA/OTHER STRUCTURES (SPECIFY) : VISCERAL PLEURA. ADDITIONAL PERTINENT FINDINGS - ATELECTASIS, PNEUMONIA, ETC: (SEE. NARRATIVE). MARGINS: BRONCHIAL: SYNOPTIC REPORT. PARENCHYMAL: NEGATIVE. VASCULAR: DISTANCE TO PERTINENT MARGIN (s) (AS APPLICABLE) : 0.4 CM. VENOUS INVASION: NOT IDENTIFIED. ARTERIAL (LARGE VESSEL) INVASION: NOT IDENTIFIED. LYMPH NODE: N1 - # INVOLVED/# EXAMINED: 0/2. N2 - # INVOLVED/#EXAMINED. 0/MULTIPLE. N3 - # INVOLVED/# EXAMINED : 0/4. OTHER PERTINENT FINDINGS: (SEE NARRATIVE). pTNM STAGE: pT2, pNo, MX. CLINICAL HISTORY. HISTORY: 2 CM SOLITARY NODULE LOCATED IN THE POSTERIOR BASAL REGION. (+) MEDIASTINAL LYMPH NODES. JUNE 2009 (ACUTE TRACHEAL BRONCHITIS). X-RAY. FINDINGS: 2 CM LEFT LUNG NODULE It PET SUV 2.6). GROSS DESCRIPTION. Tech. Slide 90 CC Fluid. X Fresh. Fixed. Type Fix. Volume may reflect total of specimen, fixative, and/or collection fluid. APPEARANCE: X Clear Cloudy Foamy Bloody. Clotted. Tissue. Color COLORLESS. PREP: 6 Smear (s). Diff Quick (s). Filter (s). 1 Cell Block (s). Cytospin (s) - 2 Singles (s). Double (s). H&E. Unstained. Comment: FINAL DIAGNOSIS. LUNG, LEFT POSTERIOR (FINE NEEDLE ASPIRATION BIOPSY) : POSITIVE FOR. MALIGNANCY. WELL DIFFERENTIATED ADENOCARCINOMA CONSISTENT WITH LUNG. PRIMARY. THE DIAGNOSIS IS SUPPORTED BY IMMUNOPHENOTYPE WITH STRONG CK7. AND TTF-1 POSITIVITY, FAINT P53 POSITIVITY AND NEGATIVE MESOTHELIAL. MARKERS (CALRETININ, CD15, WT1, CK5/6) . CK20 IS NEGATIVE, AND Ki67. PROLIFERATIVE RATE IS MILDLY ELEVATED. TUMOR IS PRESENT IN A BACKGROUND. OF INFLAMMATION AND FIBROSIS WITH BENIGN PULMONARY ELEMENTS. INTRADEPARTMENTAL CONSULTATION: FINAL DIAGNOSIS. Unless otherwise specified, the performance characteristics of the. immuoperoxidase stains performed here have been confirmed by the. approved by the U.S. Food and Drug Administration, although such approval. is not necessary. NONCONTRAST CHEST CT. INDICATION: Cough. Abnormal chest x-ray. ECHNIQUE: Axial imaging with reformatted images on acquisition scanner. FINDINGS: There is a noncalcified soft tissue mass density in the left lower lobe series 3 image #44 measured at 2.2. x 1.3 cm. This is of concern for neoplasm. There are bilateral apical opacities right greater than left. There is. posterolateral. pleural based density bilaterally right greater than left. This may be due to scarring. Mass or infiltrate. cannot be excluded and follow-up is advised. The lungs appear hyperexpanded with peribronchial thickening and. prominence of the interstitial markings. There are other regions in the right upper lobe with interstitial. density. suggesting. scarring. There is a posterior pleural based density as seen on image #25. There may be a nodular density. in the right upper lobe on image #30 versus scarring measuring 7 mm. There is a very small nodular density lateral. portion. right. upper lobe on image #33. There is no evidence of pleural fluid. There are degenerative changes in the. spine. There is vascular calcification. There are a few nodes in the mediastinum. There is a pretracheal node. measuring 1.8 X 0.8 cm. There are a few smaller nodes at the AP window. Evaluation of the hila is somewhat limited. without contrast. There is vscular calcification including coronary involvement. Adrenal glands appear mildly. thickened without definite mass. IMPRESSION: 1. There is a noncalcified mass density of concern for a neoplasm in the left lower lobe posteriorly. 2. There are bilateral apical opacities right greater than left which may be due to scarring. In light of asymmetry a. superimposed mass cannot be excluded. PET scan may be helpful to evaluate the various abnormalities. The lungs. appear hyperexpanded and there are regions of peribronchial thickening and interstitial density which are consistent.",T2,N0,M0,T2N0M0
TCGA-BR-8589,M. Case ID Gross Description. Microscopic Description. Diagnosis Details. Comments. STOMACH TISSUE CHECKLIST. Specimen type: Gastric resection. Tumor site: Fundus. Tumor size: 9 X 8 X 1 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Adjacent structures. (specify) - Lesser omentum. Lymph nodes: 1/8 positive for metastasis. (Intraabdominal 1/8). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not. specified. Comments: None.,T4,N1,M0,T4N1M0
TCGA-DD-AACT,"CLINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo : 0. GROSS: Specimen: Liver: 20.5 x 9.5 x 3.5 cm, 226.5 gm (unfixed). Operation: Left lateral segmentectomy. Lesion: A well-defined, oval, lobulated mass. Size: 6.0 X 4.0 x 4.0 cm. Cut surface: Yellowish tan with bile-pigmented (necrosis: no). Gross type: Expanding nodular. Resection margin: Not involved grossly (safety margin: 0.6 cm). Others: Satellite nodule: No. Remaining parenchyma: Unremarkable. Portal vein invasion: No. Gross photo: Present. Blocks. T1-4, tumor and surrounding tissue X 4. L, remaining parenchyme of liver X 1. RM, resection margin of liver x 1. MICROSCOPIC: Hepatocellular carcinoma: Yes. The worst differentiation II. The major differentiation II. Histologic type: Trabecular. Cell type: Hepatic (95%) and clear (5%). Fatty change: No. Fibrous capsule formation: No. Capsular infiltration: No. Septum formation: Yes. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Intrahepatic metastasis: No. Multicentric occurrence: No. Non-tumor liver pathology. 1. Chronic hepatitis: Yes. 1-1. Etiology: HBV. 1-2. Grade, lobular: Mild. 1-3. Grade, portoperiportal: Minimal. 1-4. Stage (fibrosis): Periportal. 1-5. Cirrhosis: No. 2. Dysplastic nodule: No. 3. Ductal epithelial dysplasia: No. 4. Other liver diseases: No. NOT reported. Gross: liver,ectomy,hepatocellular carcinoma. T56000, P10, M81703. DIAGNOSIS: Liver, left, lateral segmentectomy: Hepatocellular carcinoma. Suggestion :",T1,N0,M0,T1N0M0
TCGA-AA-3848,"Diagnosis: This is an invasive adenocarcinoma of the colon (G2 - sigmoid colon) with infiltration of all. parietal layers (pT3) with vascular infiltration L1, V1, with free resection margins and six lymph. node metastases (6 of 12). Tumor classification: ICDO-DA M. G2. pT3, L1, V1, locally R0, pN2 (6 of 12).",T3,N2,M0,T3N2M0
TCGA-AK-3456,"Clinical History/Diagnosis: Right renal mass. Source of Specimen(s). 1: Right Kidney with Adrenals. 2: Paracaval Lymph Nodes, Right. 3: Hernia sac. Gross Description: Received in three parts. Source of Tissue: 1. Labeled # 1, ""right kidney and adrenal"". Gross Description: Received fresh in a container labeled "", right kidney and adrenal"". It. consists of a 1,000-gram radical. nephrectomy specimen consisting of a grossly enlarged distorted right. kidney measuring 20.0 X 14.0 X 11.0 cm, perinephric fat ranging from 0.1. up to 4.0 cm and right adrenal gland measuring 4.5 x 3.2 x 1.0 cm. Sections through the adrenal gland disclose normal orange parenchyma. At. the hilum, the segment of ureter measures 9.0 X 0.7 cm and is. unremarkable. The ureter is opened and is free of lesions or masses. At. the hilum, the fat has some fullness however no obvious lymph nodes are. identified. The vascular margins are unremarkable. The kidney is. sectioned disclosing a large variegated orangish yellow to reddish brown. tumor comprising 98% of the kidney and measuring 17.0 x 13.0 x 10.0 cm. The tumor obliterates the calyceal system and comes to within 1.0 cm from. the hilum. The small amount of uninvolved, normal appearing renal. parenchyma is medial in the specimen. There are multiple areas where. tumor is pushing on the capsule however, no obvious invasion through the. capsule is found. A large amount of the tumor appears to be necrotic. Fresh tissue is procured for Cytogenetics. Representative sections are. submitted in 1A-H. Designation of Sections: 1A- adrenal gland, 1B - vascular and ureter. margins, 1C-1D- tumor in relationship to hilum and renal pelvis, 1E-1F-. potential viable tumor, 1G-tumor in relationship to capsule, 1H-. perinephric fat overlying areas of tumor. Source of Tissue: 2. Labeled # 2, ""paracaval right lymph nodes"". Gross Description: Received fresh in a container labeled "", paracaval right lymph nodes"". It consists of a single elongated. lymph node measuring 4.0 x 1.9 x 1.5 cm. Entirely submitted in 2A-C. Source of Tissue: 3. Labeled # 3, ""hernia sac"". Gross Description: Received fresh in a container labeled "" hernia sac"". It consists of. a. ragged fragment of. fibromembranous fibroadipose tissue and some skeletal muscle measuring. overall 12 x 5 x 2 cm. No suspicious areas are identified grossly. Representative sections are submitted in 3A. Final Diagnosis: AMENDED. This report is amended to change the diagnosis. 1. Right kidney and adrenal gland, nephrectomy and adrenalectomy:-Renal. cell carcinoma with Xp11.2 translocation, with necrosis, 17.0 cm in. greatest dimension grossly. - Lymphovascular invasion is not identified. - Ureteral and vascular resection margins are free of tumor. - Adrenal gland with focal cortical nodular hyperplasia. Note: Immunohistochemical stains performed on block 1D show the tumor to. be positive for vimentin and negative for CK7. The tumor is negative for. mucicarmine special stain. These findings along with histomorphology. support a clear cell carcinoma. Note #2: This is a renal tumor with combined morphological features of. clear cells and papillary architectural patterns. Clusters of histiocytes. are seen as well. Cytogenetics study shows t(X;1)(p11.2;p34). translocation. Additional immunohistochemistry stains performed on block. 1D show the tumor to be positive for RCC, CD10, whereas negative for. pancytokeratin AE1/AE3, CAM5.2, K903 (34BE12), EMA, WT-1 and MITF. Case. was discussed with. 2. Right paracaval lymph nodes, excision:- One lymph node, no tumor seen. (0/1). 3. Hernia sac, resection: - Fibrovascular tissue and fibroadipose tissue,. consistent with hernia sac. - No tumor seen. pTNM: T2 NO Mx. These tests were developed and their performance characteristics. determined by the immunohistochemistry laboratory at the. Center. These tests have not been cleared or approved by the U.S. Food. and Drug Administration. The FDA has determined that such clearance or. approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research. This. laboratory is certified under the Clinical Laboratory Improvement. (CLIA) as qualified to perform high complexity clinical. testing. ORIGINAL. 1. Right kidney and adrenal gland, nephrectomy and adrenalectomy:- Renal. cell carcinoma, clear cell type, with necrosis, 17.0 cm in greatest. dimension grossly, confined to the kidney,. nuclear grade. III/IV. - Lymphovascular invasion is not identified. - Ureteral and vascular resection margins are free of tumor. - Adrenal gland with focal cortical nodular hyperplasia. Note: Immunohistochemical stains performed on block 1D show the tumor to. be positive for vimentin and negative for CK7. The tumor is negative for. mucicarmine special stain. These findings along with histomorphology. support a clear cell carcinoma. 2. Right paracaval lymph nodes, excision:- One lymph node, no tumor seen. (0/1). 3. Hernia sac, resection: - Fibrovascular tissue and fibroadipose tissue,. consistent with hernia sac. - No tumor seen. pTNM: T2 NO Mx. FC Cytogenetics Solid. Results-Comments. CYTOGENETIC ANALYSIS REPORTS. DIAGNOSIS: Right Renal Mass. KARYOTYPE: Abnormal. karyotype: 46,Y,t(X;1)(p11.2;p34)[cp21]. RESULTS: The renal mass was harvested after seven and nine days in. culture. The chromosomes from 21 metaphases were counted and analyzed,. and three of these metaphases were karyotyped by G-banding. The modal. chromosome number was 46, and all the cells had a balanced translocation. between the p arms of chromosomes X and 1. This translocation juxtaposed. the TFE3 gene at Xp11.2 with the PSF gene at 1p34. The expression of the. resulting fusion gene, PSF-TFE3, in renal epithelial cells has been. reported to play a role in the development of renal cell carcinoma (please. see the addendum to the Surgical Pathology Report).",T2,N0,M0,T2N0M0
TCGA-AY-A69D,"Diagnosis: A: Colon, transverse, partial colectomy. Tumor Histologic Type: invasive adenocarcinoma. Histologic Grade: moderately differentiated (grade 2 of 4). Tumor Location: transverse colon. Depth of Invasion: -Through muscularis propria and into the subserosa and pericolic. soft tissue. Lymphovascular Invasion not identified Adenscareenoma NOS. Perineural Invasion: not identified. Margins. Proximal margin: negative. Distal margin: negative. Mesenteric margin: negative. Distance of carcinoma from closest margin (specify) : 6.6 cm to. the closest distal margin of resection. Regional Lymph Nodes: Total number with metastasis: 0. Total number examined: 25. Additional Pathologic Findings: Immunohistochemical stains for MLH-1, MSH-2, PSH-6 and PMS-2 are. performed on block A7. The tumor cells demonstrate appropriate. positive nuclear expression for all four markers. This is the. normal phenotype and does NOT support a diagnosis of. microsatellite instability/hereditar non-polyposis colorectal. cancer (HNPCC) Separate molecular testing for microsatellite. instability markers will be performed and reported separately. Appropriate controls are performed. AJCC Pathologic TNM Stage: pT3 pNO. Note: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. Clinical History: -year-old female with colon cancer. Gross Description: Received is one appropriately labeled container, additionally. labeled ""transverse colon and omentum. It consists of a 23.5 cm. long X 5.2 cm in circumference segment of large bowel with. attached omentum (30.4 X 15.6 X 0.8 cm), pericolonic adipose. tissue up to 4.3 cm thick and appendix is absent. There. is a 5.2 X 2.6 X 0.7 cm (protruding into lumen) firm, pink/tan,. centrally ulcerated circumferential mass with raised borders. that is 10.7 cm from the proximal margin and 6.6 cm from the. distal margin. The distal margin has an attached suture, which. is inked blue and the serosa overlying the mass is inked. black. The mass on cut section is firm, smooth, gray/white,. extends 1.1 cm through the wall and into the mesentery focally. retracting the serosa but not extending through it, and 3.5 cm. from the mesenteric margin. The uninvolved mucosa is tan with. normal folding pattern. The omentum has patchy areas of. hemorrhage but nodules are absent. The pericolonic adipose. tissue is dissected for lymph node candidates of which 29 are. identified ranging from 0.2 cm in greatest dimension up to 0.8 X. 0.8 X 0.8 cm in greatest dimension. Block summary: A1 - mesenteric margin, en face. A2-A3 - proximal mucosal margin, en face. A4-A5 - distal mucosal margin, en face. A6 - mass retracting the serosa. A7-A8 - each contains deepest extension of mass with positive. lymph node in A8. A9 - mass with distal mucosa. A10 - mass with proximal mucosa. A11 - omentum. A12-A14 - each contains six lymph node candidates. A15-A16 - each contains four lymph node candidates. A17 - two lymph node candidates, each bisected, one is inked. black. A18-A19 - one lymph node candidate, serially sectioned. Tumor and normal are given to.",T3,N0,M0,T3N0M0
TCGA-94-A5I6,"This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. ;arding. patient information. Any unauthorized use, disclosure. or reproduction of this information is strictly prohibited. Anat Path Reports. Document Date: APRPT (Verified). Acc #: Pulmonary Big. Gender: M. Client: Submitting. Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. A. LYMPH NODE, 11L, EXCISION, A1FS: - ONE BENIGN LYMPH NODE (0/1). B. LYMPH NODE, #7, EXCISION, B1FS: - ONE BENIGN LYMPH NODE (0/1). C. LYMPH NODE, ANTERIOR 11L, EXCISION, C1FS: - ONE BENIGN LYMPH NODE (0/1). D. LUNG, LEFT LOWER LOBE, LOBECTOMY, D1FS: - SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED (7.2 X 6.2 X 4.2 CM). - CARCINOMA IS LIMITED TO THE LUNG. - LYMPH-VASCULAR AND PERINEURAL INVASION ARE NOT IDENTIFIED. - ALL SURGICAL MARGINS ARE NEGATIVE FOR CARCINOMA. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. :garding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. - CARCINOMA IS 1.5 CM FROM THE BRONCHIAL MARGIN. . THREE BENIGN LYMPH NODES NEGATIVE FOR CARCINOMA (0/3). - SEE SYNOPTIC REPORT. E. LYMPH NODE, #6, EXCISION: - ONE BENIGN LYMPH NODE (0/1). Comment. Elastic stain performed on block D7 - no pleural invasion by the tumor is identified. Synoptic Worksheet. D. Left lower lobe; please freeze bronchus margin: Specimen: Lobe(s) of lung: Left Lower tobe. Procedure: Lobectomy. Specimen Integrity: Intact. Specimen Laterality: Left. Tumor Site: Lower lobe. Tumor Focality: Unifocal. Histologic Type: Squamous cell carcinoma. Histologic Grade: G2: Moderately differentiated. Tumor Size: Greatest dimension: 7.2 cm. Additional dimension: 6.2 cm. Additional dimension: 4.2 cm. Visceral Pleura Invasion: Not identified. Tumor Extension: Not identified. Bronchial Margin: Uninvolved by invasive carcinoma. Squamous cell carcinoma in situ (CIS) not identified at bronchial margin. Vascular Margin: Uninvolved by invasive carcinoma. Parenchymal Margin: Not applicable. Parietal Pleural Margin: Not applicable. Chest Wall Margin: Not applicable. Other Attached Tissue Margin: Not applicable. All Margins Uninvolved By Invasive Carcinoma: Distance of invasive carcinoma from closest margin: 15 mm. Margin closest to invasive carcinoma:: Bronchial. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Not identified. Extranodal Extension: Not identified. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. TNM Descriptors: Not applicable. Primary Tumor (pT): pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size. that directly invades any of the following: chest wall (including superior sulcus. tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium;. or Tumor of any size in the main bronchus less than 2 cm distal to the carina. but without involvement of the carina; or Tumor of any size associated with. atelectasis or obstructive pneumonitis of the entire lung; or Tumors of any. size with separate tumor nodule(s) in same lobe. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Nodes examined: 7. Nodes involved: 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: None identified. Clinical History. Left Video-assisted thorascopic surgery, left lower lobectomy. Lung ca. Specimen(s) Received. A: 11L Lymph node. B: #7 Lymph node. C: Anterior 11L Lymph node. D: Left lower lobe; please freeze bronchus margin. E: #6 Lymph node. Gross Description. Specimens A through F are received, each is labeled with the patient's name and medical record number. Specimen A is received fresh for intraoperative consultation and further labeled ""11L lymph node"" and consists of a lymph node. measuring 2.0 x 1.0 x 0.7 cm along with multiple fragments of soft tissue measuring 2.0 x 0.7 x 0.4 cm in aggregate. The soft. tissue fragments are submitted for frozen section in ""A1FS."" The lymph node is bisected and submitted for frozen section in. cassette ""A2FS."". Specimen B is received fresh for intraoperative consultation and further labeled ""#7 lymph node"" and consists of one lymph node. measuring 2.7 x 1.8 x 0.8 cm. The specimen is bisected and entirely submitted for frozen section in cassette ""B1FS.' (Dictated. Specimen C is received fresh for intraoperative consultation and further labeled ""anterior 11L lymph node"" and consists of. multiple fragmented lymph nodes measuring 2.7 x 2.0 x 0.4 cm in aggregate. The specimen is entirely submitted for frozen. section in cassette ""C1FS."". Specimen D is received fresh for intraoperative consultation and further labeled ""left lower lobe"" and consists of a lobe of lung. weighing (fixed weight) 258.3 grams and measuring 18.0 x 13.2 x 4.9 cm. The pleura is red-purple to pink, and wrinkled with. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. garding. patient information. Any unauthorized use. disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. moderate carbonaceous pigmentation. There is a staple line measuring 5.1 cm, just above the hilum. The pleura about the hilum. is ragged. There is a firm palpable mass with overlying retracted pleura measuring 7.2 x 6.2 x 4.2 cm. The mass is 1.5 cm from. the bronchial margin. The mass upon sectioning has a firm gritty cut surface with areas of necrosis and black pigmentation. The. mass abuts, and possibly involves airway, more distal. The mass is 2.2 cm from the stapled margin. The uninvolved. parenchyma is red-pink, soft and hemorrhagic, with diffuse mild carbonaceous pigmentation. A small slightly elevated. subpleural nodule is identified along the distal medial aspect measuring 0.3 x 0.2 x 0.2 cm. Three peribronchial lymph nodes. are identified measuring up to 0.8 x 0.7 x 0.7 cm. The staple line is removed and the parenchymal margin is inked green. The. pleural overlying the mass is inked blue. Representative sections are submitted for frozen and permanent sections as stated. below in the block summary. Specimen E is received in formalin, labeled with the patient's name, medical record number and ""#6 lymph node"" and consists of. a black lymph node with attached soft tissue measuring 1.5 x 1.0 x 0.5 cm. The specimen is sectioned and entirely submitted in. cassette ""E1. CASSETTE SUMMARY: D1FS: Bronchial margin, shave. D2: Vascular margins, shave. D3-5: Tumor in relation to airway. D6: Tumor in relation to adjacent uninvolved parenchyma. D7: Additional representative tumor in relation to overlying pleura. D8: Uninvolved lung proximal to mass. D9: Uninvolved lung distal to mass. D10: Smaller subpleural nodule, entirely submitted. D11: Three lymph nodes, whole. Intraoperative Consult Diagnosis. A1FS,A2FS: 11L LYMPH NODE (FROZEN SECTION): ONE BENIGN LYMPH NODE, BISECTED. MULTIPLE LYMPH. NODE FRAGMENTS NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. and the specimen was received at. B1FS: #7 LYMPH NODE (FROZEN SECTION): ONE BISECTED LYMPH NODE, NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. and the specimen was received at. C1FS: ANTERIOR 11L LYMPH NODE (FROZEN SECTION): FRAGMENTED LYMPH NODE, NEGATIVE. FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. and the specimen was received at. D1FS: LEFT LOWER LOBE, FREEZE BRONCHIAL MARGIN (FROZEN SECTION): BRONCHIAL MARGIN. NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by -. ind the specimen was received at. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use. disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Microscopic Description. Microscopic examination performed.",T3,N0,M0,T3N0M0
TCGA-CN-5359,"CORRECTED. Report Type. Date of Event. Authored by. Hosp/Group. Record Status. PATIENT HISTORY: The patient is a. year old man with squamous cell carcinoma of the. floor of. the mouth. CHIEF COMPLAINT/ PRE-OP/ POST-OP DIAGNOSIS: bilateral neck dissection. PROCEDURE: bilateral neck dissection. SPECIFIC CLINICAL QUESTION: not answered. OUTSIDE TISSUE DIAGNOSIS: not answered. PRIOR MALIGNANCY: not answered. CHEMORADIATION THERAPY : no. ORGAN TRANSPLANT: not answered. IMMUNOSUPPRESSION: not answered. E. DISEASES: not answered. ADDENDA: Addendum. Results of immunoperoxidase stains are as follows: EGFR. Positive. P16. Negative. Negative. Report Elec. My si. tation that I have personally reviewed the. submitted. material (s) and the above diagnosis reflects that evaluation. FINAL DIAGNOSIS: PART 1: MARROW, RIGHT MARGIN. BONE MARROW WITH NO SIGNIFICANT PATHOLOGIC CHANGE. PART 2: MARROW, LEFT MARGIN. BONE MARROW WITH NO SIGNIFICANT PATHOLOGIC CHANGE. PART 3: FLOOR OF MOUTH, ANTERIOR TONGUE, MANDIBLE AND BILATERAL NECK. DISSECTION S. A. INVASIVE MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA,. 4 CM,. WITH INVASION OF MANDIBULAR BONE (see comment) . B. PERINEURAL INVASION IS PRESENT. C. NO ANGIOLYMPHATIC INVASION SEEN. D. RESECTION MARGINS ARE FREE OF TUMOR. E. TWO DEEP FLOOR OF MOUTH LYMPH NODES FREE OF TUMOR. F. CHRONIC AND FOCAL ACUTE SIALADENITIS OF LEFT AND RIGHT. SUBMANDIBULAR. GLANDS. G. METASTATIC SQUAMOUS CELL CARCINOMA IN THREE OF SIXTEEN LEFT. CERVICAL. LYMPH NODES. THE POSITIVE LYMPH NODES ARE IN LEVELS II, III AND IV,. AND NO. EXTRACAPSULAR EXTENSION IS PRESENT. H. ELEVEN RIGHT CERVICAL LYMPH NODES FREE OF TUMOR. PATHOLOGIC STAGING: T4 N2b MX. NT. of EGFR, P16, CMET and HPV to follow. athologist: M.D. Report Elect. Out. , M.D. My siy. tation that I have personally reviewed the. submitted. material (s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: Part 1 is received fresh labeled with the patient' S name and ""right. marrow. margin"". It consists of multiple fragments of tan soft tissue. measuring in. largest 0.1 cm. The specimen is entirely submitted in cassette 1A. Part 2 is received fresh labeled with the patient' S name and ""left. marrow. margin"". It consists of small fragments of tan soft tissue measuring. 0.5 X. 0.1 cm. The specimen is entirely submitted in cassette 2A. is submitted fresh in a single container labeled with the. patient' S. name, medical record number, patient' S initials XX and designated. ""complex. resection"". It consists of a partial mandibulectomy specimen, 9.2 X. 6.5 X 6.0. cm, comprising eleven attached incisor, premolar and molar teeth, and. also. attached anterior tongue, floor of the mouth and a bilateral neck. dissections. (left 11.0 X 5.0 X 3.2 cm and right 10.5 X 4.5 X 3.5 cm). On. section, the. tumor is an ill-defined, infiltrative, white and nodular measuring 4.0. X 2.5 X. 2.3 cm. It is extending to the anterior of the tongue, the floor of. the. mouth, the anterior gingiva and infiltrates the anterior mandible bone. It is. situated at approximately 1.0 mm of the anterior margin, 1.2 cm to the. posterior margin, 3.0 cm to the deep margin, 2.5 cm to the right. mandible bone. margin and 2.2 cm to the left mandible bone margin. On section, the. left and. the right submandibular glands present an unremarkable lobulated. yellowish. parenchyma. The bilateral neck dissections are dissected and lymph. nodes are. d for histologic examination. Some tumor is submitted to the. Digital images are taken. Representative. are submitted for permanent histologic evaluation, some following. decalcification (3I, 3J and 3K). Ink Code: Black dorsal tongue. Blue left posterior ventral tongue/gingiva. Green right posterior ventral tongue/gingiva. Yellow anterior rim tissue banking. Cassette Summary: 3AFS - anterior margin (shave). 3BFS. - right posterior ventral tongue/gingiva margin (shave). 3CFS. - left posterior ventral tongue/gingiva margin (shave). 3D. anterior margin (shave). 3E. - posterior margin (shave). 3F. - posterior margin (shave). 3G. - deep margin (shave). 3H. - deep margin (shave). 3I. left mandible bone margin. 3J. right mandible bone margin. 3K. - tumor in relation to the anterior bone mandible. 3L. - tumor in relation to anterior tongue. 3M. - tumor in relation to the root of the tongue. 3N-3P - tumor. 3Q-3T - left submandibular gland and 2 possible lymph nodes. 3U - left, one level 1B lymph node. 3V. - left, two lymph nodes, bisected (level 2). 3W. - left, one lymph node, bisected (level 2). 3X. - left, one lymph node (level 2). 3Y. - left, one lymph node, bisected (level 3). 3Z. - left, one lymph node, bisected (level 3). 3AA. - left, two lymph nodes (level 3). 3BB. - left, one lymph node, bisected (level 4). 3CC. - left, four lymph nodes (level 4). 3DD-3FF - right submandibular gland. 3GG. - right, one level 2B lymph node. 3HH. - right, one lymph node, dissected (level 2). 3II. right, two lymph nodes (level 2). 3JJ. - right, one lymph node, dissected (level 3). 3KK. - right, one lymph node, dissected (level 3). 3LL. right, one lymph node, dissected (level 4). 3MM. - right, two lymph nodes (level 4). right, two lymph nodes (level 4). VE CONSULTATION: PART 1: RIGHT MARROW MARGIN (IN TOTAL) (frozen section). A. BENIGN. B. NO TUMOR PRESENT. PART 2: LEFT MARROW MARGIN (IN TOTAL) (frozen section). A. BENIGN. B. NO TUMOR PRESENT. PART 3A: ANTERIOR MARGIN. A. BENIGN. B. NO TUMOR PRESENT. PART 3B : RIGHT POSTERIOR. rozen section). A. BENIGN. MOR PRESENT, POSSIBLE MILD DYSPLASIA. T POSTERIOR VENTRAL BONE, GINGIVA (frozen section). A. BENIGN. TUMOR PRESENT. C: copic examination substantiates the above diagnoses. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH), Molecular Anatomic Pathology, and. Immunofluorescent Testing: The testing was developed and its performance characteristics. dete. the. Department of Pathology, as required by. '. regulations. The testing has not been cleared or approved for the. S. cific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. Tissue. fixation. ranges from a minimum of. to a maximum of. hours. This laborator. certif d under the Clin 1 Laboratory Improvement. Amendments of. (""CLIA"") as qualified to perform high-complexity. clinical. testing. Pursuant to the requirements of CLIA, ASR's used in this. laboratory. have been established and verified for accuracy and precision. Additional. information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY UPPER AERODIGESTIVE TRACT AND SALIVARY. GLAND. TUMORS. SPECIMEN TYPE: Other: Floor of the mouth, anterior tongue and. mandible. TUMOR SITE: Oral Cavity. TUMOR SIZE: Greatest dimension: 4.0 cm. Additional dimensions: 2.5 X 2.3 cm. HISTOLOGIC TYPE: Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: G2. PATHOLOGIC STAGING (pTNM) : pT4. pN2b. Number of regional lymph nodes examined: 29. Number of regional lymph nodes involved: 3. Extra-capsular extension of nodal tumor: Absent. pMX. MARGINS: Margins uninvolved by tumor. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L) : Absent. PERINEURAL INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: None identified. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: argin. Stain/c. H&E X 1. AFS. Part 2 : rgin. Stain/cil. H&E X 1. AFS. Part 3 : ction. Stain/c. H&E X 1. D. H&E X 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. H. H&E X 1. L. H&E X 1. M. ANEG X 1. N. H&E Recut X. 1. N. IHPV X 1. N. cmet X 1. N. IEGFR X 1. N. IBNKNC X 6. N. H&E X 1. N. IISH X 2. N. P16 X 1. N. V-EGFR X 1. N. H&E X 1. O. H&E X 1. P. H&E X 1. H&E X 1. H&E Recut X. 1. S. H&E X 1. S. H&E X 1. H&E X 1. U. H&E X 1. V. H&E X 1. W. H&E X 1. X. H&E X 1. Y. H&E X 1. Z. H&E X 1. AA. H&E X 1. BB. H&E X 1. CC. H&E X 1. DD. H&E X 1. EE. H&E X 1. FF. H&E X 1. GG. H&E X 1. HH. H&E X 1. H&E X 1. II. H&E Recut X. 1. JD. H&E X 1. JD. H&E X 1. H&E X 1. KD. H&E X 1. KK. H&E X 1. LL. H&E X 1. MM. H&E X 1. NN. H&E X 1. AFS. H&E X 1. BFS. X 1. CFS. CIAL Procedures: In Situ Procedure. Interpretation. PROBE: LSI EGFR/CEP7 Dual-Color Probe. Cytogenetic Location: 7p12 / 7p11.1-q11. EGFR FISH STUDIES PERFORMED ON THE SQUAMOUS CELL CARCINOMA ARE. NEGATIVE. Number of cells analyzed: 60. Ratio EGFR/CEP7:1.55. High Polysomy: 0 (0%). SNR (signal to nucleus ratio) :2.8. Low Polysomy : 0 (0%). Trisomy : 9 (15.0%). Disomy: 51 (85.0%). PROBE: c-MET/CEP7. Cytogenetic Location: 7q31.2 / 7p11.1-q11.1. C-MET FISH STUDIES PERFORMED ON THE SQUAMOUS CELL CARCINOMA ARE. NEGATIVE FOR. AMPLIFICATION. Number of cells analyzed: 62. Ratio C-MET/CEP7: 0.80. SNR (signal to nucleus ratio) : 1.6. High Polysomy : 0 (0%). Low Polysomy: 2 (3.2%). Trisomy: 12 (19.4%). 77. ogr. Report Ele. My si. tation that I have personally reviewed the. submitted. material (s) and the above diagnosis reflects that evaluation. EGFR FISH positive: High Polysomy : > four gene copies in > 40% of cells. Gene Amplification: Ratio gene/chromosome more than two or > 15 gene. copies in. > 10% of cells. EGFR FISH negative: Disomy : < two gene copies in more than 90% of the cells. Trisomy three gene copies in more than 10% of cells. Low Polysomy > four gene copies in more than 10% but less than 40% of. cells. C-MET FISH positive: Gene Amplification: Ratio gene/chromosome more than two or > 15 gene. copies in. > 10% of cells. C-MET FISH negative: Ratio gene/chromosome less than two or < 15 gene copies in < 10% of the. cells. References:",T4,N2,M0,T4N2M0
TCGA-A7-A6VY,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Right breast, excisional biopsy: Infiltrating ductal carcinoma, grade 3, 3.5 cm in greatest dimension. Invasive carcinoma 1 mm from posterior margin of resection. Ductal carcinoma in situ, solid subtype, nuclear grade 3, accounting. for less than 5% of the tumor, margins uninvolved. B. Right axillary contents, resection: Metastatic carcinoma in 2 of 14 lymph nodes, size of largest. metastasis 3.4 cm, extracapsular extension present (2/14). Microscopic Description: Microscopic examination performed. A. Invasive Carcinoma: present. Histologic type: infiltrating ductal cancer. Histologic grade: Overall grade: 3. Architectural score: 3. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : 3.5 cm, pT2. Specimen margins: negative but close, 1 mm from the. posterior margin (black in block A6). Vessel invasion: not identified. Ductal carcinoma in situ: present. Histologic pattern: solid. Nuclear grade: 3. Central Necrosis: focal. 8 DCIS of total tumor (if mixed) : < 5%. Extensive intraductal component (present/absent : absent. Specimen margins: negative, 3 mm from posterior. Calcification: not identified. B. Sections of the axillary dissection demonstrate metastatic. carcinoma in 2 of 14 lymph nodes, (pN1). The size of largest. metastasis is 3.4 cm. Extracapsular extension is present. Specimen. A. Right breast mass. B. Right axillary contents. Clinical Information. Right breast cancer -year-old black female with right cancer and. positive nodes. Gross Description. Received fresh in a transpec container, subsequently fixed in formalin. labeled ""right breast mass"" is a 6.0 x 5.5 x 4.5 cm yellow pink fatty. tissue fragment which has a short suture designating superior and a. long suture designating anterior. The margins are inked as follows. based upon the orienting sutures: superior - orange; anterior - blue;. posterior - black; inferior - green. The specimen is serially. sectioned from medial to lateral. There is a 3.5 x 3.2 x 2.5 cm ill. circumscribed white tan mass centrally located, and within 0.2 cm of. the closest margin (deep) White rice-like pellets or gross identified. in the central which we be grossly consistent with a previous biopsy. site. The specimen is received in pathology it. nd fixed in. formalin and. Representative sections of the specimen are. submitted as IOLLOWS: 1 - medial margin perpendicular, 2 - lateral. margin perpendicular. ? - 10 - representative sections of the remainder. of the specimen. B. Received fresh and subsequently fixed in formalin labeled ""right. axillary contents"" is a 12.0 x 6 x 5 x 2.5 cm aggregate of yellow fatty. tissue grossly consistent with axillary contents. The specimen has a. suture designating superior. Multiple lymph nodes are palpated the. largest measuring 3.4 cm and located midway through the specimen. The. highest is markedly indurated as is the largest lymph node. The lymph. nodes are submitted from highest to lowest as follows: 1 -lymph node. bisected, 2 - 3 possible lymph nodes, 3 - 4 - 3 possible lymph nodes. each, 5 - representative section of largest positive lymph node, /1. possible lymph node bisected, 7 - 2 possible lymph nodes, 8 - 1. possible lymph node.",T2,N1,M0,T2N1M0
TCGA-77-A5G8,"Histopathology Report. HISTORY. Mass removed (lobectomy). ?Malignant. MACROSCOPIC. Three specimens received. 1: The specimen is labelled 'right upper lobe plus ribs' and consists of a. right upper lobe measuring 180 x 105 x 45 mm. There is a vertical stapled line. rsuperior to the hilum measuring 80 mm in length. Over the apex there are two. attached short segments of ribs. Rib 1 is relatively closely adhered over the. pleural surface and measures 55 x 30 x 28 mm. This rib is cut towards one end,. 22 mm from the true resection margin. Rib 2 loosely hangs from a fibrous. fragment and measures 55 x 28 x 18 mm. Over the posterolateral aspect of the. lung is a small segment of adherent parietal pleura measuring 30 x 25 mm. Within the apex, underlying the ribs is a firm white lesion measuring 25 x 25 x. 23 mm. The mass shows focal central necrosis. The tumour is well clear of the. hilar resection margin. The apical rib is removed and the underlying pleural. surface is inked black. The true pleural margin is inked blue. The tumour. appears to invade the pleura within this region, but does not extend into the. overlying soft tissue. The remainder of the lung parenchyma shows severe. emphysema with bullae in the apical aspect surrounding the tumour. No other. focal lesions are seen or felt throughout the lobe. [1A, bronchial resection. margin including vascular margin; 1B, hilar lymph node; 1C-F, RS of tumour. mass; 1G, uninvolved fung, apex and base of lobe; 1H, peribronchial nodes; 11,. shave of soft tissue from attached rib; 1J, shave of soft tissue from loosely. adhered rib; 1K-L, rep sections rib]. 2: The specimen is labelled 'lymph node number 10' and consists of fragments of. lymph node measuring 20 x 8 x 6 mm. [BIT: 2A]. 3: The specimen is labelled ""fourth rib right' and consists of a rib fragment. with attached soft tissue. The rib measures 12 x 17 x 7 mm. The attached soft. tissue measuring 17 x 10 x 10 mm. No obvious lesion is identified within the. specimen. [3A, soft tissue BIT; 3B, rib]. Please note that sections from the ribs in specimen 1 and 3 to follow. MICROSCOPIC. 1. Sections show a peripheral moderatery-differentiated squamous cell. carcinoma. There is pronounced desmoplasia and a central area of necrosis in. association with the tumour. There is obliteration of the pleural space. overlying the tumour due to adhesions and desmoplasia. It is difficult to. interpret the layers but there is clear invasion through pleura and into chest. wall. The involved fat appears to represent lipomatous metaplasia of pleura. Printed : Histopathology Report. rather than chest wall fat. Tumour does not extend as far as the muscle or. bone and therefore the chest wall margin appears clear. The bronchial. resection margin shows no evidence of in situ or invasive malignancy. No. lymphatic, vascular or perineural invasion is seen. The sampled lymph nodes. show sinus histiocytosis with moderate amounts of carbon pigment and no. evidence of metastatic carcinoma. The surrounding lung parenchyma shows focal. lipoid pneumonia and emphysema. Collections of smokers macrophages are. present. COMMENT. No sections of the ribs have been examined at this stage as the tissue is still. being decalcified. Sections of the ribs will be examined in due course and a. final report issued. 2. Sections of lymph node show sinus histiocytosis and a moderate amount. of. carbon pigment deposition and silicate crystals. There is no evidence of. metastatic carcinoma. 3. Sections show normal intercostal muscle and adipose tissue. There is no. evidence of invasive or metastatic carcinoma. INTERIM SUMMARY. 1 - 3. Right upper lobe of lung, ribs and No10 lymph node: 1: Moderately differentiated squamous cell carcinoma; 30 mm in maximal. dimension. 2: No blood vessel, lymphatic or perineural invasion present. 3: Invasion into chest wall; clear of margins. 4: No lymph node metastases. 5: Pathological stage pT3NOMx. 6: Rib sections still pending decalcification. T-28000 M-80703 P1-03000. SUPPLEMENTARY REPORT -. The sections of rib have now been examined and these do not show any. pathological features. FINAL SUMMARY. 1 - 3. Right upper lobe of lung, ribs and No10 lymph node: 1: Moderately differentiated squamous cell carcinoma; 30 mm in maximal. Printed : Histopathology Report. dimension. 2: No blood vessel, lymphatic or perineural invasion present. 3: Invasion into chest wall; clear of margins. 4: No lymph node metastases. 5: Pathological stage pT3NOMx. Heported. Page 3 of.",T3,N0,M0,T3N0M0
TCGA-CG-5722,"Diagnosis(es): 1.: Obviously localized, highly differentiated papillary serous tumor of the peritoneum. No. metastases from the carcinoma described below. 2.: Total gastrectomy specimen including an ulcerated, weakly differentiated. adenocarcinoma (intestinal type) of maximum diameter 5 cm located in the corpus region. with wide infiltration of the perigastric fatty tissue and localized penetration of the covering. serosa and with about 14 regional lymph node metastases, in some cases invading the. capsule and merging to form a conglomerate. Tumor-free oral resection margin lined with regular squamous epithelium. Tumor-free. duodenal resection margin with evidence of heterotopic gastric corpus mucosa. Tumor-free. omental fatty tissue. 3.: Lymph node metastasis from the above carcinoma (clinically trunk). Tumor stage (taking into account the preliminary findings with admission number. pT3 pN2 (15/21) pM.",T3,N2,M1,T3N2M1
TCGA-BH-A0DV,"P.18/33. INAL DIAGNOSIS: PART 1: SENTINEL LYMPH NODE #1. LEFT AXILLA, BIOPSY -. A. METASTATIC CARCINOMA INVOLVES ONE LYMPH NODE AND FORMS A SINGLE TUMOR DEPOSIT IN. ADJACENT SOFT TISSUE (1.3 CM) (SLIDE 1A). B. THE METASTATIC FOCUS IN THE LYMPM NODE IS ALMOST ENTIRELY REPLACING THE LYMPU NONE. PARENCHYMA (0.8 CM) WITH EXTRACAPSULAR EXTENSION (0.7 x 0.3 CM). PART 2: BREAST. EFT.MODIFIED RADICAL MASTECTOMY AND LEFT AXILLARY CONTENTS -. A. INVASIVE DUCIAL CARCINOMA, TWO FOCI, 3.2 CM AND 1.5 CM (GROSS) AT 6 AND 10 O'CLOCK POSITION. RESPECTIVELY, NOTTINGHAM GRADE 1/3 (COMBINED NOTTINGHAM SCORE 5/9; TUBULE FORMATION 2/3. NUCLEAR ATYPIA 2/3, MITOTIC ACTIVITY 1/3) WITH LOBULAR FEATURES (soo comment). B. TUMOR INVADES INTO SKELETAL MUSCLE FIBERS. c. DUCTAL CARCINOMA IN-SITU, NUCLEAR GRADE 2, CRIBRIFORM TYPE ASSOCIATEO WITH INVASIVE TUMOR. AND COMPRISING 1% OF TUMOR MASS. D. LYMPHOVASCULAR INVASION is IDENTIFIED,. E. MAKGINS FREE, IUMOR WITHIN LESS THAN T MM rnum DEEP MARGINS IN BOTH THE 6 O'CLOCK AND 10. O'CLOCK POSITION. F. UNINVOLVED BREAST. PARENCHYMA WITH FIBROCYSTIC CHANGES. G. GKIN AND NIPPLE, FREE or l'UMOR. H. METASTATIC CARCINOMA INVOLVES TWO OF NINE LYMPH NODES (2/9) AND FORMS FIVE TUMOR DEPOSITS. IN AXILLARY SOFT TISSUE. 1. LARGEST TUMOR SIZE AN THE LYMPH NODE is 1.0 CM WITH EXTRACAPSULAR EXTENSION (0.9 CM.). J. AXILLARY SOFT TISSUE TUMOR DEPOSIT RANGE FROM 0.2 TO 0.6 CM. K. PATHOLOGIC STAGE (sec comment). L. ER/PR - POSITIVE, HER-2/NEU NEGATIVE (PERFORMED ON BIOPSY). PART 3: ADDITIONAL LEFT AXILLARY CONTENTS, DIOPSY -. A. METASTATIC CARCINOMA INVOLVING FIBROADIPOSE TISSUE (TUMOR DEPOSIT). B. TUMOR MEASURES 0.6 x 0.5 CM (MICROSCOPIC). SYNOPTIC - PRIMARY INVASIVE CARCINUMATUF BREAST. LATERALITY: Left. PROCEDURE: Modified radical mastectomy. upper outer quadrant. Lower outer quadrant. Lower inner quadrant. SIZE OF TUMOR: Maximum dimension invasive component. 3.2 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizet of multiple invasive tumora: 4.7 em. TUMOR TYPE (invasive component): Ductal adenocarcinoma. NOS. NOTTINGHAM SCORE: Nuclear grade. 2. Tubule formation: 2. Mitotic activity score 1. Total Nottingham score: 5. Nottingham grade (1. 2. 3) 1. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: Cribritorm. Percent or tumor occupied by in situ component: 1 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT-. SURG MARGINS INVOLVED BY IN SITU COMPONENT: PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: LYMPH NODES EXAMINED: 9. METHOD(9) OF LYMPH NODE EXAMINATION: IVE stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of lergest lymph node melastasis 10 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Yos. SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST FCD. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pN2. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: zeio ar 1+.",T2,N2,M0,T2N2M0
TCGA-44-A47F,"Final Surgical Pathology Report. Procedure. Diagnosis. A. Lymph node, level X, excision: Two lymph nodes negative for metastatic carcinoma (0/2). Vessel negative for tumor. B. Lung, left upper lobe, excision: Invasive moderately differentiated adenocarcinoma (see microscopic. description). The tumor measures 5.5 cm in dimension. Two of 8 hilar lymph nodes positive for metastatic carcinoma (2/8). C. Lymph node, level VII, excision: One lymph node negative for metastatic carcinoma (0/1) . D. Lymph node, level V, excision: One lymph node negative for metastatic carcinoma (0/1). Microscopic Description: Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Primary tumor (pT) : Tumor measures 5.5 cm in dimension and is organ. confined, pT2b. Margins of resection: Tumor is present approximately 4 mm from the. bronchial margin. The vascular margin is negative. Direct extension of tumor: Tumor shows minimal extension into the. pleura. Vessel invasion: Present in a large vessel. Regional lymph nodes (pN) : 2 hilar lymph nodes are positive for. carcinoma with one showing probable direct extension and the other. showing metastatic tumor, the remaining lymph nodes are negative, pN1. Distant metastasis (pM) : pMX. Other findings: Dr. has reviewed this case. Specimen. A. Level X. B. Left upper lobe. C. Level VII. D. Level V. Clinical Information. Lung cancer. Gross Description. A. Received fresh labeled ""level X"" are 2 soft gray-black tissues in. keeping with lymph nodes averaging 1.3 cm in greatest dimension. Also. received within the specimen container is a 1.1 x 0.4 x 0.15 cm. fragment of soft tan-pink tissue in keeping with vessel which has. several associated staples. RS 2. Summary: 1 - 2 lymph nodes in toto, 2 - possible vascular tissue. B. Received fresh labeled ""left upper lobe"" is a 233 g, 18.5 x 11.0 x. 3.8 cm lobectomy specimen with attached 1 cm in length, 3.5 x 1.0 cm in. diameter bronchial stump. The pleura is tan-pink-red with a focal area. of retraction, subsequently inked blue. An indurated focus is present. subjacent to the area of retraction. On sectioning, there is a. moderately well-circumscribed, 5.5 x 4.2 x 3.8 cm tan-white tumor mass. extends to within 0.1 cm of the inked pleural surface. The tumor. extends to the vicinity of the hilum and appears to be within the. proximal bronchial stump (to within approximately 0.8 cm of the true. bronchial stump margin, see block 5). A portion of tumor and a portion. of normal parenchyma are submitted for tissue procurement as requested. The parenchyma throughout the remainder of the specimen is spongiform. tan-pink to tan red. No additional mass lesion or abnormality is. noted. Several soft gray-black tissues in keeping with lymph nodes. measuring up to 1.3 cm in greatest dimension are recovered from the. vicinity of the hilum. RS 10. Summary: 1 - bronchial stump margin, 3 - vascular margins, 2 and 4 -. tumor to inked pleural surface, 5 - tumor extending up bronchus. (following initial removal of bronchial stump margin), 6 - tumor to. normal, 7 and 8 - random normal, 9 - 6 hilar lymph nodes, 10 - one. bisected hilar lymph node. C. Received fresh labeled ""level VII"" is a 0.5 cm slightly rubbery. gray-black tissue in keeping with lymph node with a scant amount of. associated adipose tissue. AS1. D. Received fresh labeled ""level V"" is a 0.6 cm gray-black tissue in. keeping with lymph node with a moderate amount of associated tan gold. adipose tissue. AS1.",T2,N1,M0,T2N1M0
TCGA-95-7562,"use, disclosure, or reproduction or this information IS strictly prohibited. Anat Path Reports. Anat Path Reports. Document Date: Modified. Histology. APRPT (Verified). Acc. #: M. Client: Submitting. Phys: Final Surgical Pathology Report. ADDENDUM PRESENT. Addendum Diagnosis. The diagnosis is not changed. Addendum Comment. Elastic stains (X2) were evaluated for visceral pleural invasion. Assisted by: Final Pathologic Diagnosis. A. LYMPH NODES, RIGHT LEVEL 9, EXCISION. Anat Path Reports. - FIVE LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/5). B. LYMPH NODES, LEVEL 7, EXCISION. - THIRTEEN LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/13). C. LYMPH NODES, RIGHT LEVEL 14, EXCISION. - SEVEN LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/7). D. LYMPH NODE, LEVEL 11, EXCISION. - NINE LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/9). E. LUNG, RIGHT LOWER LOBE, LOBECTOMY, E1FS & E2FS. - ADENOCARCINOMA, MODERATELY DIFFERENTIATED (3.5 X 3.1 X 2.1 CM). - TUMOR INVADES INTO VISCERAL PLEURA. - LYMPHOVASCULAR INVASION IDENTIFIED. - BRONCHIAL AND VASCULAR MARGINS NEGATIVE. - ONE OF THREE PERIBRONCHIAL LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (1/3). - SEE SYNOPTIC REPORT. Addendum / Signed Out. Synoptic Worksheet. E. Right lower lobe: Specimen: Lobe(s) of lung: Right lower. Procedure: Lobectomy. Specimen Integrity: Intact. Specimen Laterality: Right. Tumor Site: Lower lobe. Tumor Focality: Unifocal. Histologic Type: Adenocarcinoma. Histologic Grade: G2: Moderately differentiated. Tumor Size: Greatest dimension: 3.5 cm. Additional dimension: 3.1 cm. Additional dimension: 2.1 cm. Visceral Pleura Invasion: Present. Tumor Extension: Not applicable. Bronchial Margin: Uninvolved by invasive carcinoma. Anat Path Reports. Involvement by squamous cell carcinoma in situ (CIS) not applicable. Vascular Margin: Uninvolved by invasive carcinoma. Parenchymal Margin: Not applicable. Parietal Pleural Margin: Not applicable. Chest Wall Margin: Not applicable. Other Attached Tissue Margin: Not applicable. All Margins Uninvolved By Invasive Carcinoma: Distance of invasive carcinoma from closest margin: 23 mm. Margin closest to invasive carcinoma: Bronchial. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Present. Extranodal Extension: Not identified. TNM Descriptors: Not applicable. Primary Tumor (pT): pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension. surrounded by lung or visceral pleura, without bronchoscopic evidence of. invasion more proximal than the lobar bronchus (ie, not in the main. bronchus); or Tumor 5 cm or less in greatest dimension with any of the. following features of extent: involves main bronchus, 2 cm or more distal to. the carina; invades the visceral pleura; associated with atelectasis or. obstructive pneumonitis that extends to the hilar region but does not involve. th the entire lung. Regional Lymph Nodes (pN): pN1: Metastasis in lipsilateral peribronchial and/or ipsilateral hilar lymph. nodes, and intrapulmonary nodes, including involvement by direct extension. Nodes examined: 37. Nodes involved: 1. Distant Metastasis (pM): Not applicable. Clinical History. Lung cancer, right lower lobe. Right VATS and lobectomy. History of prostate cancer. History of tobacco use, one pack a day. for ten years, quit in. Specimen(s) Received. A: Right level 9 lymph nodes. B: Level 7 lymph nodes. C: Right level 14 lymph nodes. D: Level 11 lymph node. E: Right lower lobe. Gross Description. Specimen A is received in formalin, labeled with the patient's name and medical record number and as ""right level #9 lymph. node."" It consists of multiple fragments of fibroadipose tissue measuring 3.0 x 1.5x1.3 cm in aggregate. Within the tissue,. multiple lymph nodes are found, the largest of which measures 3.0 x 1.0 x 0.7 cm. Lymph nodes are submitted as stated below. Anat Path Reports. Specimen B is received in formalin, labeled with the patient's name and medical record number and as ""level #7 lymph node."" It. consists of multiple fragments of fibroadipose tissue measuring 2.5 x 1.0x 0.7 cm in aggregate. The specimen is submitted. entirely in cassettes ""B1"" and ""B2."". Specimen C is received in formalin, labeled with the patient's name and medical record number and as ""right level #14 lymph. node."" It consists of multiple fragments of fibroadipose tissue measuring 2.5 x 2.0 x 1.0 cm in aggregate. Within the tissue,. multiple lymph nodes are found. the largest of which measures 1.7 x 0.9 x 0.6 cm. The lymph nodes are submitted as stated. below. Specimen D is received in formalin, labeled with the patient's name and medical record number and as ""right level #11 lymph. node."" It consists of multiple fragments, 2.0 x 1.5 x 0.5 cm in aggregate. Multiple lymph nodes are identified within the tissue,. the largest of which measures 1.0 x 0.7 x 0.5 cm. The lymph nodes are submitted entirely in cassettes 'D1"" and ""D2."" Dictated. Specimen E is received fresh, labeled with the patient's name, medical record number and as ""right lower lobe."" The specimen. consists of a lobectomy specimen which measures 20.0 x 11.0 x 5.5 cm and weighs 289.5 grams. There is a firm, white, gritty. mass that measures 3.5 x 3.1 x 2.1 cm. The mass puckers the overlying pleura. The mass is 2.3 from the bronchial margin. The mass does not invade the vasculature or bronchus. The remainder of the lung is unremarkable. The puckered pleura is. inked blue. The bronchial margin is submitted for frozen section diagnosis and the contents of the cryoblock are transferred to. cassette ""E1FS."" A representative of the mass is submitted for frozen section diagnosis and the contents of the cryoblock are. transferred to cassette ""E2FS."" Sections are submitted as stated below. A1: Large lymph node, bisected. A2: Multiple possible lymph nodes. C1: Three lymph nodes, whole. C2: Multiple possible lymph nodes. E3: Vascular margins. E4,E5: Tumor in relation to pleura (closest area), bisected. E6: Representative section of tumor in relation to bronchus. E7: Tumor in relation to pleura. E8: Section of uninvolved lung. E9: One possible peribronchial lymph node. E10: One possible peribronchial lymph node. E11: One possible peribronchial lymph node. E12: One possible peribronchial lymph node. Intraoperative Consult Diagnosis. E1FS: RIGHT LOWER LOBE (FROZEN SECTION): BRONCHIAL MARGIN WITH RARE CRUSHED, POORLY PRESERVED. CELLS IN PERIBRONCHIAL SOFT TISSUE; DEFER TO PERMANENTS. Frozen section results were communicated to the surgical team and were repeated back by. E2FS: RIGHT LOWER LOBE (FROZEN SECTION): POORLY DIFFERENTIATED ADENOCARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. Anat Path Reports. Microscopic Description. Microscopic examination performed.",T2,N1,M0,T2N1M0
TCGA-BJ-A28R,"PATIENT HISTORY: CHIEF COMPLAINT/PRE-OPIPOST-OF DIAGNOSIS: Thyroid nodule. PROCEDURE: Unanswered. SPECIFIC CLINICAL QUESTION: Unanswered. OUTSIDE TISSUE DIAGNOSIS: Unanswered. PRIOR MALIGNANCY: Unanswered. CHEMORADIATION THERAPY: Unanswered. ORGAN TRANSPLANT: Unanswered. IMMUNOSUPPRESSION: Unanswered. OTHER DISEASES: Unanswered. FINAL DIAGNOSIS: PART 1: THYROID, TOTAL THYROIDECTOMY (21 grams)-. A. PAPILLARY THYROID CARCINOMA (1.5 CM), CONVENTIONAL TYPE, RIGHT LOBE (see comment). B. THE CARCINOMA IS CONFINED TO TRE THYROID. C. ANGIOLYMPHATIC INVASION INCLUDING PSAMMOMA BODIES IN THE INTERSTITIUM. D. THREE LYMPH NODES, NO TUMOR PRESENT (0/3). E. PATHOLOGIC STAGE: pT1b NO. F. CHRONIC LYMPHOCYTIC THYROIDITIS. G. NODULAR THYROID. H. RIGHT INFERIOR PARATHYROID TISSUE. PART 2: LYMPH NODES, BILATERAL CENTRAL COMPARTMENT, EXCISION -. A. SEVENTEEN LYMPH NODES, NO TUMOR PRESENT (0/17). B. THYROID TISSUE WITH CHRONIC LYMPHOCYTIC THYROIDITIS.-. COMMENT: Immunohistochemical stains for HBME-1 and Galactin-3 are negative excluding the possibility for an additional focus. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Right Lobe. TUMOR FOCALITY: Unifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 1.5 cm. HISTOLOGIC TYPE. Papillary carcinoma. PRIMARY TUMOR (pT): pT1b. REGIONAL LYMPH NODES (pN): pNO. Number of regional lymph nodes examined: 20. Number of regional lymph nodes involved: 0. EXTRANODAL EXTENSION: Not identified. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Not identified. MARGINS: Margins uninvolved by carcinoma. LYMPH-VASCULAR INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Other: chronic lymphocytic thyroiditis and nodular thyroid.",T1,N0,M0,T1N0M0
TCGA-LK-A4NY,"FINAL DIAGNOSIS: Summary Statement. The right pneumonectomy and lymph node dissection shows a diffuse malignant mesothelioma, mixed epithellold and. sarcomatous type, with invasion of the parietal pleura, lung, dlaphragmatic muscle, and azygous vein, but with no. evidence of lymph node metastases. Pathologic stage: T3 NO MX. PART 1: SOFT TISSUE, ""CHEST WALL ON TOP OF 5TH RIB, RIGHT"". BIOPSY -. SUTURE GRANULOMA. NO EVIDENCE OF MALIGNANCY. PART 2: BONE, ""PARTIAL RIB, RIGHT"", RESECTION -. SPECIMEN UNDERGOING DECALCIFICATION. ADDENDUM REPORT TO FOLLOW. PART 3: PLEURA, BIOPSY -. A. DIFFUSE MALIGNANT MESOTHELIOMA. B. SUTURE GRANULOMA. PART 4: BONE, ""PARTIAL RIGHT 5TH RIB"", RESECTION -. SPECIMEN UNDERGOING DECALCIFICATION. ADDENDUM REPORT TO FOLLOW. PART 5: SOFT TISSUE, CHEST WALL, BIOPSY -. ACUTE FIBRINOUS AND ORGANIZING PLEURITIS ASSOCIATED WITH FOREIGN BODY GIANT CELL REACTION. NO EVIDENCE OF MALIGNANT MESOTHELIOMA. PART 6: LYMPH NODE, LEVEL 10 LYMPH NODE, BIOPSY -. FIVE (5) FRAGMENTS OF LYMPH NODE WITH NO EVIDENCE OF MALIGNANT MESOTHELIOMA. PART 7: SOFT TISSUE, ""VAGUS"", BIOPSY -. A. LARGE NERVE WITH NO SIGNIFICANT ABNORMALITY. B. THREE (3) FRAGMENTS OF LYMPH NODE WITH NO EVIDENCE OF METASTATIC MALIGNANCY. PART 8: LYMPH NODE, SUBCARINAL LYMPM NODE, BIOPSY -. SOLITARY LYMPH NODE WITH REACTIVE CHANGE. NO EVIDENCE OF MALIGNANCY. PART 9: BRONCHUS, ""FREE END MARKS PROXIMAL MARGIN"", RESECTION -. PORTIONS OF BRONCHUS AND BRONCHIAL MUCOSA WITH NO SIGNIFICANT PATHOLOGIC ABNORMALITY. PART 10: LYMPH NODE, ""LYMPH NODE NEAR INFERIOR PULMONARY LIGAMENT"", BIOPSY -. SOLITARY LYMPH NODE WITH REACTIVE CHANGE. NO EVIDENCE OF MALIGNANCY. PART 11: LUNG, RIGHT, PLEUROPNEUMONECTOMY -. A. DIFFUSE MALIGNANT MESOTHELIOMA, MIXED EPITHELIOID AND FIBROSARCOMATOUS TYPE, WITH. INVASION OF THE PARIETAL PLEURA, PLEURAL ADIPOSE TISSUE, DIAPHRAGMATIC MUSCLE, FISSURE. AND PULMONARY PARENCHYMA WITH INTRAPARENCHYMAL NODULES. PATHOLOGIC STAGE: T3 NO. MX. B. APICAL CAP OF LEFT UPPER LOBE. C. TWENTY-FIVE (25) N1 LYMPH NODES WITH NO EVIDENCE OF METASTATIC MALIGNANT MESOTHELIOMA. PART 12: PERICARDIUM, PERICARDECTOMY -. DIFFUSE MALIGNANT MESOTHELIOMA. PART 13: SOFT TISSUE, ""NODULE ON AZYGOUS VEIN"", BIOPSY -. DIFFUSE MALIGNANT MESOTHELIOMA. COMMENT: The malignant mesothelloma for the most part shows a tubulopapillary growth pattern associated with abundant myxoid. stroma, and extracellular hyaluronic acid production. in occasional areas, a spindle cell component Is Identified and for. this reason we have classified this as a mixed epithelioid and fibrosarcomatous malignant mesothelloma. Previous material on this case has been worked up for a varlety of mesothelial markers. revealing an. immunophenotype characteristic of malignant mesothelioma. The underlying lung shows no evidence of asbestosis and Iron stains fail to reveal significant numbers of ferruginous. bodies. Addendum. Sections of the Part 2 and Part 4 bone samples representing ""partial 7th rib right"" and ""partial right 5th rib"" show normal bone and. bone marrow with trilineage representation and maturation. No evidence of malignancy is seen.",T3,N0,M0,T3N0M0
TCGA-BH-A28Q,"PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/POST-OP DIAGNOSIS: invasive ductal carcinoma right breast, positive fymph nodes, left. preventative mastectomy. LMP DATE: PROCEDURE: right modified radicat mestectomy, left total mastectomy. SPECIFIC CLINICAL QUESTION: Not provided. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY: No. CHEMORADIATION THERAPY: No. OTHER DISEASES: No. FINAL DIAGNOSIS: PART 1: BREAST, RIGHT, MASTECTOMY -. A. INVASIVE LOBULAR CARCINOMA, CLASSICAL TYPE. B. NOTTINGHAM GRADE 2 (TUBULE FORMATION: 3, NUCLEAR PLEOMORPHISM: 2, MITOTIC ACTIVITY: 1;. TOTAL SCORE: 6/9). C. THE INVASIVE TUMOR MEASURES 4.0 CM IN LARGEST DIMENSION. D. LOBULAR CARCINOMA IN SITU (LCIS) is ALSO IDENTIFIED. E. LYMPHOVASCULAR SPACE INVASION is IDENTIFIED. F. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. G. INVASIVE CARCINOMA is 1.0 CM FROM THE NEAREST (POSTERIOR) MARGIN. H. THE INVASIVE CARCINOMA IS LOCATED AT THE JUNCTION OF. UPPER OUTER QUADRANT AND LOWER. OUTER QUADRANT. I. NIPPLE IS NEGATIVE FOR TUMOR. J. SKIN is NEGATIVE FOR TUMOR. K. NON-NEOPLASTIC BREAST SHOWS SCLEROSING ADENOSIS, FIBROADENOMA, FIBROCYSTIC CHANGES,. COLUMNAR CELL CHANGES AND PSEUDOANGIOMIATOUS STROMAL HYPERPLASIA. PREVIOUS BIOPSY SITE CHANGES. M. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN RECEPTOR (H-ecore 270), POSITIVE FOR. PROGESTERONE RECEPTOR (H-ecore 270) ANO NEGATIVE FOR HER-2, AS PER THE PREVIOUS. PART 2: BREAST, LEFT, TOTAL MASTECTOMY . A. FIBROADENOMA. B. COLUMNAR CELL CHANGES. c. FIBROCYSTIC CHANGES. D. PSEUDOANGIOMATOUS STROMAL HYPERPLASIA. E. PRIOR BIOPSY SITE CHANGES. F. UNREMARKABLE NIPPLE AND SKIN. PART 3: LYMPH NODES, RIGHT AXILLA, DISSECTION- -. A. METASTATIC CARCINOMA INVOLVES TWO OF EIGHTEEN LYMPH NODES (2/18). B. THE LARGEST METASTATIC FOCUS MEASURES 1.6 CM. c. NO EXTRACAPSULAR EXTENSION is IDENTIFIED. CASE SYNOPSIS: SYNOPTIC PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Upper outer quadrant. Lower outer quadrant. SIZE OF TUMOR: Maximum dimension invesive component: 40 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): infiltrating lobular carcinoma. HISTOLOGIC TYPE: Classical. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: LCIS. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 10 mm. PAGETS DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 2. LYMPH NODES EXANINED: 18. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 16 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: Fibroadenoma, FCD. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pN1a. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive, H-score: 270. PROGESTERONE RECEPTORS: positive, H-score: 270. HER2/NEU;. 1+.",T2,N1,M0,T2N1M0
TCGA-DD-A1EK,"TISSUE DESCRIPTION : A1 B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 B11 B12 B13 B14 B15. C1 C2 C3 C4 C5 C6 C7 C8. Liver mass segment 6 (1930.0 grams, 14.5 X 13.0 X 12.0 cm) ,. liver segment 7 mass (164.0 grams), hepatic nodule (0.4 x 0.3. x. 0.1 cm). DIAGNOSIS: Liver, mass, segment VI resection: : Moderately differentiated. hepatocellulari carcinoma, forming a variegated mass with focal. necrosis measuring 14.5 X 13.0 X 12.0 cm. The tumor is partially. encapsulated with pushing border, and it shows no large vessel. invasion. The margins of resection are negative for neoplasm. (closest tumor free margin, 0.7 cm) . The morphological findings. in the adjacent non-neoplastic liver parenchyma will be reported. as an addendum. Immunoperoxidase stains show the tumor cells to be positive for. polyclonal CEA and Hep-1, and negative for AFP and cytokeratin. 7. These findings support the above diagnosis. Liver, mass, segment VII resection: Hepatocellular carcinoma. forming a solid nodule (1.3 x 1.0 X 0.9 cm), located 0.2 cm. from the surgical margin of resection. A separate nodule,. representing a cavernous hemangioma (1.2 X 1.0 X 0.5 cm) is also. identified. Liver, nodule, excision: Sclerosing hemangioma. Case seen in consultation with. ADDENDUM: Permanent sections of the non-neoplastic liver. demonstrate a mild simple steatosis with approximately 10-15%. macrovesicular steatosis of the lobular parenchyma. The. steatosis present in a non-zonal distribution, overall. The. portal areas present show no significant involvement by an. inflammatory cell infiltrate. The interlobular bile ducts are. intact and show no significant cellular injury. No significant. ductular proliferation is identified. The hepatic lobular. parenchyma is remarkable for a mild degree of macrovesicular. steatosis. Ballooning degeneration is not identified. Distinct. Mallory's hyaline formation is not identified. Apoptotic. hepatocytes are generally inconspicuous. Scattered irregular. apparently random clusters of neutrophils are present within the. lobular parenchyma and are most consistent with ""surgical. hepatitis"". The iron stain demonstrates no significant iron. accumulation within hepatocytes or Kupffer cells. The PAS stain. after diastase digestion demonstrates no significant cytoplasmic. globular inclusions within hepatocytes. The reticulin stain. demonstrates intact trabecular architecture without areas of. parenchymal collapse or abnormal plate growth. The trichrome. stain highlights the portal areas and demonstrates no. significant portal tract expansion by fibrosis and specifically. periportal, bridging, and pericellular fibrosis are not. identified. PRELIMINARY FROZEN SECTION CONSULTATION: Liver, mass, segment VI resection: Hepatocellular carcinoma. Hold to confirm with immunohistochemical stains.",T4,N0,M1,T4N0M1
TCGA-86-8358,Case ID Gross Description. Microscopic Description. Diagnosis Details. Comments. LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 3.2 X 3.2 X 3.2 cm. Histologic type: Adenocarcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 0/6 positive for. metastasis (Regional 0/6). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not. specified. Comments: Right- upper. Laterality. Right-upper.,T2,N0,M0,T2N0M0
TCGA-78-7153,"HISTORY. Large right upper lobe tumour. MACROSCOPIC. Six specimens received: 1: The specimen is labelled ""middle and upper right lobe"" and comprises right upper and middle lobe,. received fresh, and measuring 160 X 60 X 60 mm. There is a marked degree of pleural puckering and. indrawing over the postero-lateral surface of the upper lobe. The pleura overlying the middle lobe. appears normal. A stapled margin, 65 mm in length, is present above the hilum. The bronchial. resection margins and vascular resection margins show no evidence of tumour. Peribronchial lymph. nodes are black and soft. Transverse slicing reveals a somewhat ill-defined tumour mass, 47 mm. in. diameter, within the postero-lateral aspect of the upper lobe extending almost to the pleural surface and. extending to within 10 mm of the bronchial resection margin. The surrounding lung parenchyma. appears consolidated and yellowish in colour. The main tumour mass is pale grey to cream in colour. with focal carbon pigmentation. The remainder of the lung parenchyma shows no pathological. features. Towards the apex of the upper lobe there is a second contiguous lobulated tumour mass, 30. mm in diameter, which also appears clear of the pleura. This has a more tan cut surface. [1A, upper. lobe bronchial resection margin and peribronchial lymph nodes; 1B, middle lobe bronchial resection. margin and peribronchial lymph nodes; 1C-E, tumour with overlying pleura; 1F, central tumour; 1G, 2. representative TS of additional tumour mass towards apex; 1H, uninvolved lung parenchyma from. middle lobe; 11, tissue adjacent to bronchus]. 2: The specimen is labelled ""pulmonary vein lymph node"" and comprises an irregular portion of fatty. and anthracotic soft tissue, 25 X 10 X 5 mm. [BIT, 2A]. 3: The specimen is labelled ""pulmonary vein lymph node No. 2"" and comprises fragments of. anthracotic soft tissue, 20 X 10 X 5 mm in aggregate. [BIT, 3A]. 4: The specimen is labelled ""No. 10 lymph node"" and comprises two fragments of soft anthracotic. tissue, the first 5 mm in greatest diameter, and the second 15 X 15 X 7 mm. [BIT, the larger fragment. after bisection, 4A]. 5: The specimen is labelled ""right middle lobe lymph node"" and comprises an irregular fragment of. soft anthracotic tissue, 20 X 8 X 5 mm. [BIT, 5A]. 6: The specimen is labelled ""No. 4 lymph node"" and comprises a lymph node with surrounding fat,. overall size 20 X 15 X 8 mm. The lymph node is 12 X 8 X 5 mm. [BIT after bisection, 6A]. MICROSCOPY. 1: Sections show a moderately differentiated adenocarcinoma. The carcinoma has areas of mucinous. and papillary differentiation. The contiguous nodule has a similar appearance and it is considered that. these represent part of the same tumour. The main lesion is invading into an area of subpleural. elastotic scarring. Although no convincing pleural invasion is identified within the sections, special. stains will be performed. The other component also abuts the pleura but there is no pleural invasion. Blood vessel invasion is present but no lymphatic or perineural permeation is seen. The mass is well. clear of the bronchial resection margin but there is squamous metaplasia with severe dysplasia at the. middle lobe bronchial resection margin. No lymph node metastases are seen. The uninvolved lung. shows no specific abnormality. 2: Sections of the lymph nodes show reactive changes only. There is no evidence of malignancy. 3: Sections of the lymph node fragments show reactive changes only. There is no evidence of. malignancy. 4: Sections of the lymph node show reactive changes only. There is no evidence of malignancy. 5: Sections of the lymph node show reactive changes only. There is no evidence of malignancy. 6: Sections of the lymph node show reactive changes only. There is no evidence of malignancy. SUMMARY. Right upper and middle lobes and lymph nodes: 1: Moderately differentiated adenocarcinoma of right upper lobe; approximately 47 mm in maximal. dimension. 2: Blood vessel permeation identified but no lymphatic or perineural invasion present. 3: No convincing pleural invasion identified but special stains being performed; clear of bronchial. margin. 4: No lymph node metastases. 5: T2N0MX. 6: Squamous metaplasia with severe dysplasia at right middle lobe bronchial resection margin. SUPPLEMENTARY REPORT. Some of the tumour cell nuclei stain strongly with TTF 1 in keeping with a pulmonary primary. SUPPLEMENTARY REPORT. No pleural invasion is identified with special stains. T-28000 M-81403 P1-03000.",T2,N0,M0,T2N0M0
TCGA-AN-A0FW,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Left Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: Frozen. Container: cryomold Type of Procurement: Radical mastectomy Grade: 2. T Stage: 2 N Stage: 1 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,T2,N2,M0,T2N2M0
TCGA-34-5927,"FINAL DIAGNOSIS: PART :LUNG, RIGHT LOWER LOBE, LOBECTOMY -. A. POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA WITH NECROSIS (SEE. COMMENT), 2.8 X 2.6 X 1.5 CM. B. NO DEFINITIVE LYMPHOVASCULAR INVASION IDENTIFIED. C. VASCULAR, BRONCHIAL (5.0CM) AND SOFT TISSUE (7.5CM) MARGINS OF RESECTION FREE OF TUMOR. D. THREE INTRALOBAR LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA WITH ANTHRACOSIS. E. TUMOR CONFINED IN LUNG PARENCHYMA, NO VISCERAL PLEURAL PENETRATION. F. NON TUMOR LUNG PARENCHYMA WITH FOCAL EMPHYSEMATOUS CHANGES, FOCAL CHRONIC. INFLAMMATION AND HEMORRHAGE. G. AJCC PATHOLOGIC TNM STAGE: pT1 NO MX. PART 2: LUNG, RIGHT SECONDARY CARINA, BIOPSY -. MINUTE AMORPHUS MATERIAL. PART 3: LYMPH NODE, LEVEL 8, BIOPSY -. ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA WITH ANTHRACOSIS. PART 4:LYMPH NODE, LEVEL 9, BIOPSY. ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA WITH ANTHRACOSIS. PART 5: LYMPH NODE, SUPERIOR SEGMENT LEVEL 11, BIOPSY. ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA WITH ANTHRACOSIS. PART 6: :LYMPH NODE, BASILAR LEVEL 11, BIOPSY -. ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA WITH ANTHRACOSIS. PART 7:LYMPH NODE, LEVEL 10, BIOPSY. ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA WITH ANTHRACOSIS. PART 8:LYMPH NODE, LEVEL 4R, BIOPSY -. FRAGMENTS OF LYMPH NODES (MAXIMAL OF 3) NEGATIVE FOR METASTATIC CARCINOMA WITH. ANTHRACOSIS. PART 9: :LYMPH NODE, LEVEL 7, BIOPSY -. FRAGMENTS OF LYMPH NODES (MAXIMAL OF 3) NEGATIVE FOR METASTATIC CARCINOMA WITH. ANTHRACOSIS. COMMENT: The immunostains are as follows: TTF-1. Negative. Cytokeratin 7. Positive. Cytokeratin 20. focally positive. P63. Positive. Cytokeratin 5/6 Positive. The morphology and immunostaining patterns support the squamous cell carcinoma. All control slides stained. appropriately. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY LUNG TUMORS. TUMOR LOCATION: Right Lower Lobe. PROCEDURE: Lobectomy. TUMOR SIZE: Maximum dimension: 2.8 cm. GROSS SATELLITES: Number of gross satellite lesions: 0. TUMOR TYPE: Invasive squamous carcinoma. HISTOLOGIC GRADE: G3, Poorly differentiated. MICROSCOPIC SATELLITES: Number of microscopic satellite lesions: 0. EXTRAPULMONARY PARENCHYMAL. EXTENSION/INVASION OF TUMOR: None identified. ANGIOLYMPHATIC INVASION: TUMOR NECROSIS: < or = to 50%. SURGICAL MARGIN INVOLVEMENT: No. SURGICAL MARGIN SITE: Distance of invasive tumor to closest margin: 5.0 mm, Bronchial margin. INFLAMMATORY(DESMOPLASTIC) REACTION: Moderate. N1 LYMPH NODES: Number of N1 lymph nodes positive: 0. Number of N1 lymph nodes examined: 6. EXTRACAPSULAR SPREAD OF N1 METASTASES: N2 LYMPH NODES: Number of N2 lymph nodes positive: 0. Number 8. EXTRACAPSULAR SPREAD OF N2 METASTASES: UNDERLYING DISEASE(S): Emphysema. T STAGE, PATHOLOGIC: pT1. N STAGE, PATHOLOGIC: pNO. M.STAGE, PATHOLOGIC: pMX. ANCICLARY STUDIES: Immunohistochemical stains.",T1,N0,M0,T1N0M0
TCGA-66-2793,"Material examined: Left lung, among others. Clinical diagnosis and question. Adenocarcinoma right central, pleural effusion. TNM?. REPORT ON FINDINGS. Macroscopy. 1.) Inflated, fixed right lung measuring 17 x 13 cm and up to 27 cm high, central bronchus resection plane. located 2 cm proximal to the bifurcation of the upper lobe bronchus. Pleura with extensive grayish-yellow. coating and, especially in the medial region, with ragged plaques and adhesion residue, in the dorsolateral. region over segment 1 a 13 x 8 cm area of parietal pleura is in parts extensively adhesive, in parts loosely. attached. Upper pleural fissure completely obliterated. Middle lobe reduced in size and largely occupied by. parts of a tumor, max. 9.5 cm in size, predominantly with clear and arcuate demarcation, extending to adjacent. sections of the upper lobe and to central sections of the lower lobe. Extension right up to the hilar resection. surface and the paracentral medial pleura above the upper lobe and also via the middle and lower lobe in the. region of the lower pleural fissure. Involvement of several gray to blackish nodes, 1.5 cm in size, and narrowing. of central blood vessels by the tumor. Invasion of the pulmonary vein to within the proximity of the resection. margin. Wall infiltration and narrowing of lumen of the intermediate bronchus, whose mucosa shows areas of. polypous protrusion above the tumor. Sections of middle lobe bronchi completely obstructed by the tumor. tissue. Peripheral middle lobe bronchi markedly dilated and filled with thick mucus, parenchyma in the. tumor. environment, especially in the middle lobe, shows seam-like area of induration and patchy brownish-yellow. discoloration. In S2 a 4 cm area of induration with an irregular contour and brownish-red discoloration. In the. pulmonary artery a 2 cm long cylindrical, focal thrombus adhering to the wall. 2.) Pleura: flat or membranous specimen measuring 6.5 x 4.5 cm and up to 0.3 cm thick, surface turbid and in. parts patchy brownish, in parts grayish-yellow. 3.) Subcarinal LN (station 7): 0.3 cm lesioned node or node part. 4.) Low paratracheal LN (station 4) right: 1.5 cm fatty specimen, containing at least two lesioned nodes or node. parts, 1 cm and 0,4 cm in size. 5.) Hilar LN (station 10) left: 0.5 cm lesioned node with some surrounding tissue. 6.) Low paratracheal LN (station 4) left: 1 cm lesioned node or node part with some surrounding tissue. Examined: 1a: Tumor with rest of parenchyma. 1b: tumor with intermediate bronchus. 1: pulmonary artery with thrombus. 1d: tumor with hilar resection surface (color-marked). 1e: tumor with paracentral pleura. 1f: lower pleural. fissure (lower lobe part color-marked). 1 g: upper pleural fissure (upper lobe part color-marked). 1h: middle lobe. peripheral. li: S1 with pleural adhesion. 1j: central bronchus resection plane and resection margins of vessels. 1k + 1: tumor in pulmonary vein. m: induration area S2. 2.) 5 sections. 3.) - 6.) All material (in 4.) node isolated, in 6.) preparation halved). 18 blocks, partly Elastica-van Gieson, PAS, diastase-PAS. Microscopy. Description of histological and cytological findings omitted for capacity reasons.",T4,N1,M0,T4N1M0
TCGA-53-7813,"F. Pathologic Interpretation: A. Wedge resection right upper lobe,. - Moderately differentiated adenocarcinoma of lung, 1.5 cm in greatest dimension. - Multiple microscopic foci of bronchioalveolar carcinoma are present, including in the stapled resection margin. B. Hilar lymph node, 10: - One lymph node, no tissue seen. C. Right lower paratracheal, 4R: - One lymph node, no tissue seen. D. Subcourial lymph node, 7: - One lymph node, no tissue seen. E. Inferior pulmonary ligament lymph node, 9: - One lymph node, no tissue seen. F. Parabronchial lymph node, 11: - One lymph node, no tissue seen. G. Right upper lobe: - Multiple microscopic foci of bronchioalveolar carcinoma. - Atypical pneumocyte hyperplasia. H. Right upper lobe bronchial margin: - Segment of bronchus, no tumor seen. Tumor Summary: Specimen Type. - Lobectomy. Laterality. - Right. Tumor Site. - Upper lobe. Tumor Size. - Greatest dimension: 1.5 cm. Histologic Type. - Adenocarcinoma, not otherwise characterized. - Bronchioloalveolar carcinoma. Histologic Grade. - G2: Moderately differentiated. Margins. - Cannot be assessed. Direct extension of tumor: The visceral pleura is not involved by tumor. Venous (Large Vessel) Invasion (V). - Absent. Arterial (Large Vessel) Invasion. Absent. Lymphatic (Small Vessel) Invasion (L): - Absent. Regional Lymph nodes (pN): Number examined: 5. Number involved: 0. Pathologic Staging (pTNM). PT1 N pNO pMX. As the attending pathologist, I attest that I: (i) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). Intraoperative Consultation. Wedge resection right upper lobe,. Adenocarcinoma. Multiple foci of bronchoalveolar carcinoma in margins. Clinical History: None Provided. Operation Performed. Right thoracotomy. Pre Operative Diagnosis: Right upper lobe lesion. Specimen(s) Received: A: Wedge resection right upper lobe, FS. B: Hilcu lymph node, 10. C: Right lower paratracheal, 4R. D: Subcourial lymph node, 7. E: Inferior pulmonary ligament lymph node, 9. F: Parabronchial lymph node, 11. G: Right upper lobe. H: Right upper lobe bronchial margin. Gross Description: A. Received fresh for frozen section is a 50 gram wedge resection specimen. There is a 1.5 x 1.3 X 1.3 cm lobulated tan,. firm lesion. The specimen measures 7.0 X 5.0 X 4.0 cm and has extensive metal staples throughout the perimeter. Sections are submitted as follows: 1. Section through lesion for frozen section. 2&3. Margins for frozen sections. 4-7. Mass lesions, submitted in toto. 8. Satellite nodules immediately adjacent to mass lesion. 9&10. Lung parenchyma distant to mass. B. Received in formalin is a tan-white soft tissue specimen that measures 1.3 x 0.6 x 0.6 cm. Bisected and submitted in toto. in one cassette. C. Received in formalin is a 1.5 x 1.0 x 0.5 cm fibrofatty specimen that has been bisected and submitted in toto in one. cassette. D. Received in formalin is a 1.0 x 1.0 x 1.0 cm fibrofatty specimen that has potential lymph tissue, submitted and bisected in. toto in one cassette. E. Received in formalin is a 1.0 x 0.5 X 0.5 cm fibrofatty specimen that has been bisected and submitted in toto in one. cassette. F. Received in formalin is a 0.5 x 0.5 X 0.3 cm soft tissue specimen that has been submitted in toto in one cassette. G. Received in formalin is a 114 grams partial lobectomy specimen, measuring 12.0 x 5.0 x 3.0 cm. The specimen has been. serially sectioned to reveal a soft, hyperemic spongy mucosa with no masses present. Sections submitted as follows: 1. Bronchial and vascular margins. 2-6. Non adjacent section throughout parenchyma. 7-11. Additional sections of consolidated areas. H. Received in formalin is a 1.5 x 1.0 x 0.5 cm soft tissue specimen that has been submitted in one cassette.",T4,N0,M0,T4N0M0
TCGA-UF-A7JV,"PRIMARY SITE: Hypopharynx. 1 - ""Right hypopharynx biopsy"": - Moderately differentiated squamous cell carcinoma. 2 - ""Left-inferior parathyroid site"": - Fragment of fibroadipose tissue uninvolved by neoplasia. 3 - ""Left recorrential dissection specimen"": - Two of nine lymph nodes involved by metastatic carcinoma (2/9), without capsular. involvement. 5 - ""Total pharyngolaryngectomy, partial esophagectomy, left neck dissection and right. radical neck dissection with total thyroidectomy"": - Moderately differentiated squamous cell carcinoma of the hypopharynx. - Epiglottis: uninvolved by neoplasia. - Left vocal cord: uninvolved by neoplasia. - Right vocal cord: involved by neoplasia. - Thyroid, cricoid and arytenoid cartilages uninvolved by neoplasia. - Hyoid bone uninvolved by neoplasia. Surgical margins uninvolved by neoplasia, but right-posterior and right-lateral are. exiguous (measured 1.0 mm). - Esophagus involved by neoplasia with uninvolved surgical margins. - Thyroid gland with follicular papillary carcinoma, histological grade 2, with. uninvolved margins. - Tumor size: 1.2 cm. - Lymphovascular invasion: not identified. - Right neck dissection: - Three of fifteen lymph nodes involved by metastatic carcinoma (3/15), without. capsular involvement. - Left neck dissection: - Four lymph nodes uninvolved by metastatic carcinoma (0/4). 5 - ""Hypopharynx margin"": - Uninvolved by neoplasia. Addendum: Absence of neoplasia invasion on hyoid bone.",T4,N2,M0,T4N2M0
TCGA-E3-A3E1,"Surgery Date. SPECIMENS: A. RIGHT THYROID LOBE. DIAGNOSIS: A. THYROID, RIGHT, LOBECTOMY: - PAPILLARY THYROID CARCINOMA, USUAL VARIANT (see Synoptic Report). - MARGINS ARE NEGATIVE FOR CARCINOMA. - TWO LYMPH NODES WITH NO EVIDENCE OF CARCINOMA (0/2). THYROID CANCER SYNOPTIC REPORT. Specimen Type: Lobectomy, right lobe. Tumor Site: Right lobe. Tumor Focality: Unifocal. Tumor Size (Largest nodule): Greatest dimension: 1.5 cm. Additional dimensions: 1.5 x 1.0 cm. Histologic Type: Papillary carcinoma. Margins: Margins uninvolved by carcinoma. Venous/Lymphatic Invasion: Absent. Additional Findings: Nodular goiter, chronic inflammation. Lymph Nodes: 0/2; negative for carcinoma. Pathologic Stage: pT1 NO MX (2 lymph nodes). SPECIMEN(S): A. RIGHT THYROID LOBE. CLINICAL HISTORY: Not given. GROSS DESCRIPTION: A. RIGHT THYROID LOBE. Received fresh labeled with the patient's name, and designated as ""right thyroid lobe"" is an unoriented. 16 gram partial lobectomy specimen measuring 4.0 x 3.1 x 2.2 cm. The external surface is red-brown. and lobulated. The entire external surface is inked black and sectioned to reveal a 1.5 x 1.5 x 1.0 cm. white-tan, soft, well circumscribed mass located at the mid section of the specimen. Tissue is procured. from the tumor for the tissue bank. The tumor is multicystic with the cystic spaces measuring. approximately 0.1 cm in maximal diameter. No area of hemorrhage or calcification is noted. The. attached specimen is submitted serially in cassettes A1-10. Microscopic/Diagnostic Dictation: M.D., Pathologist. Microscopic/Diagnostic Dictation: M.D., Pathologist,. Final Review: M.D., Pathologist. Final: , M.D., Pathologist.",T1,N0,M0,T1N0M0
TCGA-B0-5113,"FINAL DIAGNOSIS. KIDNEY, RIGHT, RADICAL NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CLEAR CELL TYPE. B. THE CARCINOMA MEASURES 13.7 CM IN GREATEST DIMENSION AND IS PREDOMINANTLY CONFINED TO THE. UPPER POLE. C. THE TUMOR INVOLVES THE PERIRENAL SOFT TISSUE. D. FUHRMAN NUCLEAR GRADE IS 2/4. E. ANGIOLYMPHATIC INVASION IS NOT IDENTIFIED. F. ADRENAL GLAND IS PRESENT AND IS NOT INVOLVED BY TUMOR. G. TNM STAGE: T3a NO MX. H. NON-NEOPLASTIC KIDNEY WITH MILD CHRONIC INTERSTITIAL INFLAMMATION. I. THREE PERIHILAR LYMPH NODES, NEGATIVE FOR TUMOR.",T3,N0,M0,T3N0M0
TCGA-DC-6682,"Clinical Diagnosis & History: Rectosigmoid adenocarcinoma. Specimens Submitted: 1: Colon, sigmoid and upper rectum; resection. 2: Hernia contents. 3: Portion of omentum. 4: Base of IMA lymph node. 5: Proximal margin. 6: Distal margin. DIAGNOSIS: 1. Colon, sigmoid and upper rectum; resection: Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Rectosigmoid. Tumor Size: Length is 6.8 cm. Width is 8.5 cm. Maximal thickness is 0.4 cm. Tumor Budding: Absent. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Tubular adenoma. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Not identified. Large Venous Invasion: Not Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Lymph Nodes: Number with metastasis: 0. Total number examined: 24. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC 7th Edition) : pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition) : NO (No regional lymph node metastasis). 2. Hernia contents; excision: -Benign skin and fibroadipose tissue. Omentum, ""portion of""; omentectomy: -Benign mature adipose tissue. 4. Lymph node, ""base of IMA;"" excision: -Two benign lymph nodes (0/2). 5. Colon, proximal margin; excison: -Benign segment of colon. 6. Colon, distal margin; excision: -Benign segment of colon. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1) The specimen is received fresh and is labeled ""Sigmoid and upper rectum. stitch marks proximal. It consists of a rectosigmoid colon that measures. 19.0 x 7.5 cm. The serosal surface is smooth. The radial resection margin is. inked black, and the specimen is opened to reveal a tumor that is located. 12.5 cm from the proximal margin and 5.5 cm from the distal margin. The. tumor measures 6.8 cm in length and 8.5 cm in width. Serial sectioning. reveals tumor invasion to a depth of 0.9 cm, extending through the. muscularis grossly approaching into the underlying pericolic fat, which is. 4.5 cm from the closest radial margin. The remaining mucosa shows grossly. unremarkable mucosal folds. Pericolic and peri-rectal adipose tissue is. thoroughly examined for lymph nodes, and all possible nodes are submitted. Representative sections are submitted. TPS is submitted. Summary of sections: PM - proximal margin. DM - distal margin. RM - radial margin. T - tumor. RS - uninvolved mucosa. LN - lymph nodes. BLN - bisected lymph node. 2). The specimen is received fresh, labeled ""Hernia contents. "". It consists. of multiple lobulated fibrofatty soft tissue fragments measuring 17.0 x 4.5. x 5.0 cm in aggregate with multiple fragments of irregular skin measuring. 9.5 x 4.5 cm in aggregate. The specimen is sectioned to reveal grossly. unremarkable lobulated adipose tissue, no discrete lesions or gross. abnormalities are identified. Representative sections are submitted. Summary of sections: U - undesignated. 3) The specimen is received fresh, labeled ""Omentum. "" It consists of a 18. x. 15 x 5.5 cm portion of lobulated adipose tissue consistent with omentum. Serial sectioning reveals yellow-tar fatty lobulated appearance with focal. areas of hemorrhage. Representative sections are submitted. Summary of sections: o - omentum. 4). The specimen is received in formalin labeled ""Base of IMA lymph nodes. "". It consists of two lymph nodes measuring 0.3 x 0.3 cm and 1.5 x 1.4 cm in. greatest dimensions. Lymph nodes are entirely submitted. Summary of sections: LN - lymph nodes. TLN - trisected lymph node. 5) The specimen is received in formalin wrapped around an anastomotic pin,. labeled ""Proximal margin"" and consists of a ring of pink tan soft tissue. measuring 3.0 x 1.8 x 1.0 cm. Multiple sutures and staples are attached. The mucosal surface is pink tan and focally hemorrhagic. The sutures and. staples are removed and the soft tissue is entirely submitted. Summary of sections: U - undesignated. 6) The specimen is received in formalin, labeled ""Distal margin"" and. consists of a ring of pink tan soft tissue measuring 2.0 x 1.7 x 0.8 cm. Multiple sutures and staples are attached. The mucosal surface is pink tan. and focally hemorrhagic. The sutures and staples are removed and the soft. tissue is entirely submitted. Summary of sections: U - undesignated. Summary of Sections: Part 1: Colon, sigmoid and upper rectum; resection. Block. Sect. Site. PCs. 5. BLN. 10. 2. DM. 2. 10. LN. 20. 2. PM. 2. 1. RM. 1. 1. RS. 1. 4. T. 4. Part 2: Hernia contents. Block. Sect. Site. PCs. 2. U. 2. Part 3: Portion of omentum. Block. Sect. Site. PCs. 3. o. 3. Part 4: Base of IMA lymph node. Block. Sect. Site. PCs. 1. In. 1. 1. tln. 1. Part 5: Proximal margin. Block. Sect. Site. PCs. 1. u. 1. Part 6: Distal margin. Block. Sect. Site. PCs. 1. u. 1.",T3,N0,M0,T3N0M0
TCGA-GM-A3XN,"DIAGNOSIS. (A) LEFT BREAST, SEGMENTAL MASTECTOMY: INVASIVE LOBULAR CARCINOMA OF THE BREAST, MODIFIED BLACK'S NUCLEAR GRADE 1 AND 2 (LOW. AND INTERMEDIATE GRADE), PRESENT AS THREE MASSES MEASURING 2.0 CM, 1.9CM AND 1.1 CM IN. MAXIMUM DIMENSION. (SEE COMMENT). PERINEURAL INVASION IS IDENTIFIED. INVASIVE TUMOR IS NOTED WITHIN 0.1 CM FROM THE MEDIAL MARGIN, 1 MM AND 2 MM FROM THE. DEEP AND ANTERIOR MARGINS TOWARDS THE MEDIAL END OF THE SPECIMEN. LOBULAR CARCINOMA IN SITU (LCIS), MODIFIED BLACK'S NUCLEAR GRADE 1 AND 2 (LOW AND. INTERMEDIATE GRADE), WIDELY DISPERSED. Reactive changes at previous biopsy site. Fibrocystic changes. METASTATIC ADENOCARCINOMA INVOLVING ONE OF ONE SENTINEL LYMPH NODE (1/1). MAXIMUM SIZE OF METASTASIS IS 0.3 CM. Extranodal extension is not identified. (B) PALPABLE LYMPH NODE, LEFT AXILLA: METASTATIC ADENOCARCINOMA IN ONE OF ONE LYMPH NODE (1/1). MAXIMUM SIZE OF METASTASIS IS 0.9 CM. EXTRANODAL EXTENSION IS PRESENT, MEASURING 0.1 CM IN MAXIMUM DIMENSION. (C) SECOND PALPABLE LYMPH NODE: One lymph node, no tumor present (0/1). (D) ADDITIONAL DEEP MARGIN: Fibroadipose tissue and skeletal muscle, no tumor present. (E) LEFT AXILLARY CONTENTS: METASTATIC ADENOCARCINOMA IN THREE OF THIRTY-ONE LYMPH NODES (3/31). MAXIMUM SIZE OF METASTASIS IS 0.4CM. EXTRANODAL EXTENSION IS PRESENT, MEASURING 0.5MM IN MAXIMUM DIMENSION. (F)LEFT BREAST, NEW ANTERIOR MARGIN, EXCISION: No evidence of invasive carcinoma. LOBULAR CARCINOMA IN SITU (LCIS), IN FEW FOCI. Columnar alteration and ductal epithelial hyperplasia without atypia. (G) LEFT BREAST, NEW ANTERIOR MEDIAL MARGIN, EXCISION: No evidence of malignancy. COMMENT. The invasive lobular carcinoma demonstrates tubule formation in occasional small foci comprising much less than 1 % of the. entire tumor. Few signet ring cells are noted in both the in situ and invasive tumor. GROSS DESCRIPTION. (A) FOR IMMEDIATE INTRAOPERATIVE CONSULTATION AND X-RAY IMAGING LABELED LEFT SEGMENTAL. MASTECTOMY, SHORT STITCH SUPERIOR, LONG STITCH LATERAL, PURPLE IS DEEP - A breast tissue with needle. localization wires measuring 10.0 x 6.0 x 5.0 cm. Surgical margins are inked. The specimen is radiographed before and after. slicing and the radiograph is reviewed by the radiologist. The specimen is sectioned from lateral to medial aspect into seven. slices. Slice 3 contains an ill-defined, firm tan lesion #1 containing radiological clip. It measures 1.1 x 1.0 x 0.6 cm. It is more than. 1.0 cm from all the margins. Cut surface of slices 4 and 5 contains a second ill-defined indurated tan lesion with clip measuring. 2.0 x 1.2 x 1.1 cm. It is 0.4 cm from the closest anterior surgical margin. Cut surface of slice 5 and 6 shows an ill-defined lesion 3. with. clip. measuring 1.9 x 1.6 x 1.3 cm. In slice 5, lesion 3 and 2 are grossly connected to each other. Lesion 3 is 0.5 cm away. from the medial surgical margin, 0.2cm from deep margin and more than 1.0 cm from the rest of the margins. Located in fatty. tissue. at. the. inferior. aspect. of slices 1 and 2 are two possible lymph nodes ranging from 1.1 up to 1.3 cm in greatest dimension. which are indicated by the surgeon to represent the sentinel lymph nodes. Lymph nodes identified in slice 1 is sent for protocol. Representative sections are submitted. A portion of the tumor is given to tumor bank. INK CODE: Superior - blue; inferior - green; anterior - yellow; posterior - black; lateral and medial -red. SECTION CODE: A1, possible lymph submitted for protocol identified in slice 1; A2, A3, slice 3, lesion 1, mirror images;. A4. slice 3. tissue superior to lesion 1 including superior surgical margin. AR slice a tissue. posterior surgical margin; A7, slice 2, tissue laterally to lesion 1; A8, slice 5, lesion 2 in relation to the anterior surgical margin; A9,. slice 4, lesion 2; A10, slice 4, anterior surgical margin; A11, A12, slice 5, mirror images of lesions 2 and 3 in relation to each; A13,. slice. 5,. inferior. surgical margin; A14, slice 5, superior surgical margin; A15, slice 5, posterior surgical margin; A16, slice 6,. possible. continuation of lesion 2 in relation to the anterior surgical margin; A17, A18, slice 6, mirror images of lesion 3 in relation to. the. deep. surgical margin; A19, slice 6, tissue inferior to A16, including anterior surgical margin; A20, A21, lesion 3 in relation to. the medial surgical margin; A22, slice 2, sectioned possible lymph node. (B) PALPABLE NODE, LEFT AXILLA FOR FS - A single possible lymph node measuring 1.8 cm in its greatest dimension. Possible lymph node is sectioned and entirely submitted for frozen section in cassettes B1 and B2. (C. SECOND PALPABLE LYMPH NODE - A single fatty possible lymph node measuring 2.5 cm in its greatest dimension. Possible lymph node is sectioned and entirely submitted for routine Histoloav. SECTION CODE: C1-C3, one sectioned possible lymph node. (D). ADDITIONAL. DEEP MARGIN, INK ON TRUE MARGIN - A single fragment of a fatty tissue with ink indicating true measuring. 4.5 x 3.5 x 1.1 cm. Cut surface is fibrofatty. Entirely submitted. INK CODE: True surgical margin - blue. SECTION CODE: D1-D7, entire tissue. (E). LEFT. AXILLARY CONTENTS - A single fragment of a fatty tissue measuring 8.0 x 7.0 X 3.0 cm. Dissection reveals multiple. possible lymph nodes ranging from 0.3 up to 1.8 cm in greatest dimension. Possible lymph nodes are entirely. SECTION CODE: E1, five possible lymph nodes; E2, five possible lymph nodes; E3, five possible lymph nodes; E4, five. possible lymph nodes; E5, two possible lymph nodes; E6, one sectioned possible lymph node; E7, one sectioned possible lymph. node; E8, one sectioned possible lymph node; E9, one sectioned possible lymph node; E10, one sectioned possible lymph node;. E11,. one. sectioned. possible lymph node; E12, one sectioned possible lymph node; E13, one sectioned possible lymph node; E14,. one sectioned possible lymph node; E15, one sectioned possible lymph node; E16, one sectioned possible lymph node; E17, one. sectioned possible lymph node; E18, one sectioned possible lymph node. (F) NEW ANTERIOR MARGIN, INK ON TRUE MARGIN - A single fragment of a fibrofatty tissue with ink indicating true margin. measuring 3.6 x 3.2 x 1.8 cm. True surgical margin is reinked blue. Cut surface is fibrofatty. Entirely submitted. SECTION CODE: Entirely submitted in cassettes F1-F8. (G) NEW ANTERIOR MEDIAL MARGIN, INK ON TRUE MARGIN - H single fragment of a fibrofatty tissue with ink indicating true. margin measuring 4.0 x 3.0 x 0.9 cm. The surgical margin is reinked blue. Sectioned and entirely submitted. INK CODE: True surgical margin - blue. SECTION CODE: G1-G6, entire tissue. CLINICAL HISTORY. None given. SNOMED CODES. T-04050, T-C4710, M-85203, M-85206, M-85202. ""Some tests reported here may have been developed and performance characteristics determined by I. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". END OF REPORT-.",T1,N2,M0,T1N2M0
TCGA-AG-A025,"Diagnosis: Tubular adenoma of the sigmoid in No. 1 (low-grade intra-epithelial neoplasia). Well-differentiated, invasive adenocarcinoma of the sigmoid in No. 2, arising from a tubular. adenoma with atypia and with infiltration of the submucosa. Tumor classification: M-8210/3, G1. This is chronic appendicitis with obliteration of the lumen by scar tissue, with an acute. inflammatory flare in the outer wall layers with eosinophilia, acute fibrinous granulocytic. serositis (in I.), a rectal resection specimen with a mucosal-submucosal defect in the area marked. with a clip, perifocal, granulating inflammation, polypous hyperplasia of the rectal mucosa in the. area of the margin (block A), wall perforation (block B), acute hemorrhage, necrosis, acute. perifocal inflammation, acute serositis (in II.), moderate reactive lymphadenitis (in II. and IV.),. an anastomosis ring with a diverticulum (in III.) and normally layered plain sections from all. other labeled specimen segments (in II., IV. and V.). No evidence of specificity or malignancy. 15+.",T1,N0,M0,T1N0M0
TCGA-A7-A0CD,"SPECIMEN. A. Sentinel node #1. B. Sentinel node #2. C. Left breast mass. D. 6 S'clock. E. 12 o'clock. F. 9 o'clock. G. 3 o'clock. REPORT REVISED ON. AT. CLINICAL NOTES. HISTORY: Left breast ca at 10:00. Multifocal 1 cm. and 5 cm. from. nipple. REPORT REVISED ON. AT. 1. FROZEN SECTION DIAGNOSIS. A) Lymph node, sentinel node 1, excision - Negative for metastatic. carcinoma (0/1). B) Lymph node, sentinel node 2, excision - Negative for metastatic. carcinoma (0/1). REPORT REVISED ON. AT. GROSS DESCRIPTION. A. Received fresh labeled ""sentinel node #1"" is a lymph. node that measures 1.5 cm in dimension. The lymph node is. entirely frozen. B. Received fresh labeled ""sentinel lymph node #2"" is a. lymph node that measures 1 1 am in dimension. The lymph. node is entirely frozen. C. The specimen is received fresh labeled ""left breast. mass"" and. consists of a yellow piece of soft tissue measuring 10 x 7.5 x 5.4. cm. The. specimen has a long and a short suture on it. There is an. overlying. GROSS DESCRIPTION. white. ellipse of skin measuring 6.5 x 1.5 cm. which has a central. longitudinal wound in it. The external surface of the specimen is. inked as indicated below. Superior yellow, inferior orange, anterior red, lateral blue,. medial. green,. inferior black. There is a central firm tumor measuring 1.5 cm. in. greatest. cross sectional dimension. A portion of the central tumor is taken. for. research purposes. Sections after fixation. RS15. +RR11. D. Received in formalin labeled ""#6"" and consists of a. yellow and tan piece of soft tissue measuring 3 x 2 x 0.7. cm. It is not completely clear which side of the specimen is the. external side. The external surface of the specimen is inked. Sections after fixation. RS4. E. Received in formalin labeled ""#12"" and consists of. a. yellow piece of soft tissue measuring 3 x 2.5 x 1 cm. The. external surface of the specimen is inked. RS4. F. Received in formalin labeled ""9"" and consists of a. yellow piece of soft tissue measuring 3 x 1.5 x 1 cm. The. external surface of the specimen is inked. Sections after fixation. RS2. G. Received in formalin labeled ""#3"" and consists of. a. piece of yellow soft tissue measuring 3.2 X 1.5 x 1 cm. The external surface of specimen is inked. Sections after fixation. RS3. REPORT REVISED ON. AT. MICROSCOPIC DESCRIPTION. A. A single lymph node is negative for malignancy. B. A single lymph node is negative for malignancy. (At the request of some staff oncologists and in keeping. with the opinion of some experts in breast pathology,. immunohistochemical stains for keratin were not used on the. sentinel. lymph node sections in this case. These stains can be obtained if. desired. Our paraffin blocks are retained for 10 years. (Schwartz. GF et al. Cancer 94 (10):2542, 2002) ] . C. Invasive carcinoma. Tumor type : Infiltrating ductal carcinoma. Tumor grade 2 (Elston SBR grade; A/N/M =3/2/1 ). Mitotic index: 0 mitoses/10 HPFs (1 HPF = 0.196 sq mm). Tumor size: 1.5. cm. Specimen margins: Negative for malignancy. Carcinoma is 1. cm. from the nearest inked margin. Vessel invasion: Absent. Calcification: Absent. Non-tumorous breast: Apocrine metaplasia, cyst formation and. intraductal epithelial hyperplasia without atypia are present. pTNM stage: T1. Prognostic markers: See previous biopsy. D-G. Additional biopsy pieces are negative for. malignancy. Cyst formation and apocrine metaplasia are seen in. specimen. D at 6 o'clock. After discussion with Dr. specimen C was re-examined. definite second mass was identinied. An additional 11 blocks of. tissue were submitted from the inferior portion of the specimen. These showed cyst formation (up to 2 mm), focal intraductal. MICROSCOPIC DESCRIPTION. epithelial hyperplasia without atypia, periductal elastosis,. apocrine metaplasia, focal small cyst rupture, and arteriolar. medial. calcification. No additional carcinoma was identified. 4x3, 3x4, 14x2. REPORT REVISED ON. AT. DIAGNOSIS. A. Sentinel lymph node #1, biopsy: A single lymph node is negative for malignancy. B. Sentinel lymph node #2, biopsy: A single lymph node is negative for malignancy. C. Breast, left, excisional biopsy: Infiltrating ductal carcinoma, Elston SBR grade 2. Fibrocystic. changes. D-G. Breast, left, 6 o'clock, 12 o'clock, 9 o'clock, 3 o'clock,. biopsies: Mild fibrocystic changes. Negative for malignancy. Addition to microscopic description. REPORT REVISED ON. AT. M.D. (Electronic Signature). End Of Report ---.",T1,N0,M0,T1N0M0
TCGA-A8-A08H,"Diagnosis: 1. Tumor-free structurally intact lymph nodes. 2. Invasive ductal breast carcinoma (maximum diameter 2.5 cm, malignancy grade II) at the. site of the macroscopically described nodular formation. In the immediate tumor periphery. high-grade DCIS (procomponent of tumor < 10%) with inclusion also of coarse calcification. Remaining glandular tissue, rich in fatty tissue, in involution and free of atypia. Histologically. unremarkable skin spindle. Tumor classification: G2 (L0, V0), pTlc, pN0 (sn), MX, R0 (minimum width of dorsocranial. safety margin 1 cm!).",T2,N0,M0,T2N0M0
TCGA-AN-A04A,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Left Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: OCT. Container: block Type of Procurement: Radical mastectomy Grade: 2. T Stage: 2 N Stage: 2 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,T2,N2,M0,T2N2M0
TCGA-DJ-A3UZ,"Clinical Diagnosis & History: Bilateral thyroid nodules,. history left lobe PTC positive. Specimens Submitted: 1: Tissue near left upper pole (fs). 2: Left paratracheal tissue (fs). 3: Total thyroidectomy. DIAGNOSIS: 1. Tissue near left upper pole, blopsy (fs): -Benign thyroid tissue. 2. Left paratracheal tissue, excision (fs): -One benign lymph node (0/1). 3. Total thyroidectomy: Part # 3. Tumor Type: Five foci of papillary carcinoma: one classical type and four microcarcinomas. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Right lobe. The largest tumor focu is located in the right lobe. Tumor Size: Tumor foci range from 0.4 cm to 1.1 cm in greatest dimensionon. Tumor Encapsulation: Partially surrounded. for the largest tumor focus. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Invades:perithyroidal adipose tissue and parathyroid gland. Surgical Margins: Free of tumor. Tumor Multicentricity: Gross and microscopic. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Exhibits chronic lymphocytic thyroiditis. Parathyroid Glands: Identified. Two parathyroid glands, one in each lobe (the right one is intrathyroidal). Tumor involves the parathyroid gland. on teh left side. Lymph Nodes: Two benign lymph nodes (0/2). Note: The congo red stain and the immunohistochemical stains for chromogranin, synaptophysoin, CEA-M, and calcitonin were. performed on one of the thyroid nodules and they are negative. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT THA. REVIEWED AND APPROVED THIS REPORT. Report clectronically Signed Out. Special Studies: Special Stain. Comment. CHR. SYN. CEA M. CALC. CONGO. IMM RECUT. NEG CONT. Gross Description: 1) The specimen is received fresh for frozen section, labeled ""tissue near left upper pole,"" and consists of a tan pink soft tissue. measuring 0.6 x 0.4 x 0.3 cm. The specimen is entirely submitted for frozen section. Summary of sections: FSC-frozen section control. 2) The specimen is received fresh for frozen section, labeled ""left paratracheal tissue,"" and consists of a tan soft tissue measuring. 0.5 x 0.4 x 0.3 cm. The specimen is entirely submitted for frozen section. Summary of sections: FSC-frozen section control. 3) The specimen is received fresh, labeled ""total thyroidectomy, stitch marks left lobe"", and consists of a thyroid weighing 22 g. The. rightlobe measures 4.5 x3x2 cm, the left lobe measures 4.5 x 3 x 2 cm and the isthmus measures 3 x 1 x cm. The external. surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black, and the anterior is inked blue. Sectioning reveals two separate nodules measuring 0.8 cm and 0.3 cm in diameter. The nodules are located in the right lower pole,. they display white/tan cut surfaces, and / are not encapsulated. Sections through the remaining tissue reveal another nodule in. middle portion of left lobe measuring 0.5 cm in diameter and is not encapsulated. The remaining thyroid parenchyma is red brown. and beefy. Representative sections of the specimen submitted fo. ind a photograph has been taken. The entire thyroid is. submitted. A small portion of right lobe nodule is submitted for. Summary of sections: RN1 - right lobe nodule, entirely submitted. RN2-right lobe nodule ( small). RL - right lobe. LN--left lobe nodule, entirely submitted. LL left lobe. IS isthmus. Summary of Sections: Part 1: Tissue near left upper pole (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: Left paratracheal tissue (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 3: Total thyroidectomy. Block. Sect. Site. PCs. 4. IS. 5. 9. LL. 10. 2. LN. 3. 3. RL. 4. 2. RN1. 5. 2. RN2. 3. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1. Frozen Section Diagnosis: Tissue near left upper pole (fs): Benign thyroid tissue 1. Permanent Diagnosis: same. 2. Frozen Section Diagnosis: Left paratracheal tissue (fs): One benign lymph node (0/1). Permanent Diagnosis: same.",T3,N0,M0,T3N0M0
TCGA-18-3416,"Addended. SPECIMEN (S) RECEIVED. 1. Lymph-Node: ST9 Inf Pulm Ligament/. 2. Lymph node: LT TB ANGLE ST10L. 3. Lymph node: sump node/QS. LUNG: Lt upper lobe broncial margin. Lymph node: lymph node neck. DIAGNOSIS. 1. - 3. ST9 inferior pulmonary ligament, LT TB angle ST1OL, sump node,. lymph node dissection: Negative for malignancy, lymph node. (x3). 4. Left upper lobe lung lobectomy: Squamous cell carcinoma, poorly differentiated, 8 cm in greatest. diameter. (pT2). Bronchial resection margin negative for tumor. All 5 lobar lymph nodes negative for tumor. 2 of 6 segmental lymph node involved by tumor. (pN1). 1 subsegmental lymph node negative for tumor. Many lymph nodes show marked anthracosis with nodular fibrosis. Remaining lung parenchyma shows anthracotic deposits in wall of. terminal/respiratory bronchioles. 5. Lymph node neck biopsy. Normal thyroid tissue, negative for malignancy. SYNOPTIC DATA. ?pecimen Type. Lobectomy. uterality: Left. Tumor Site: LUL. Page: 1 of 5. Tumor Size: Greatest dimension: 8.0 cm. Histologic Type: Squamous cell carcinoma. Histologic Grade: G3: Poorly differentiated. Pathologic staging (pTNM) : pT2: Tumor with any of the following. features of size or extent: greater than 3 cm in greatest dimension;. involves main bronchus, 2 cm or more distal to the carina; invades the. visceral pleura; associated with atelectasis or obstructive pneumonitis. that extends to the hilar region but does not involve the entire lung. pN1: Metastasis in ipsilateral. peribronchial and/or ipsilateral hilar lymph nodes, including. intrapulmonary nodes involved by direct extension of the primary tumor. Lymph node stations. .vivolved: 13L (Left segmental). pMX: Cannot be assessed. Margins: Margins uninvolved by invasive. carcinoma. Direct Extension of Tumor: None identified. Blood Vessel Invasion: Absent. Lymphatic (Small Vessel) Invasion (L) : Absent. Additional Pathologic Findings : Other: Marked anthracosis of. peribronchial lymph nodes. COMMENT. The segmental lymph nodes involvement could be by direct invasion. CLINICAL HISTORY. GROSS DESCRIPTION. 1. The specimen labeled with the patient's name and as ""Lymph-Node: ST9. Inf Pulm Ligament/qs"" Consists of one lymph node covered by few. fragments of yellow-tan adipose tissue, measuring 1.5 x 1.0 x 0.7 cm;. ceived in 10% buffered formalin. Cross sections of the lymph node are. nomogeneously black and firm. Page: 2 of 5. specimen is bisected and submitted in toto. 2. The specimen labeled with the patient's name and as ""Lymph node: LT TB. ANGLE ST1OL"". Consists of one lymph node covered by few fragments of. yellow-tan adipose tissue, measuring 1.8 x 1.1 x 0.3 cm; received in 10%. buffered formalin. Cross sections of the lymph node are homogeneously. black and firm. 2A specimen is bisected and submitted in toto. 3. The specimen labeled with the patient's name and as ""Lymph node: sump. node/QS"". Consists of two pieces of oval, gray-black, soft tissue. ragments each measuring up to 1.0 cm; received fresh. This is examined. - intraoperative consultation by frozen section, on the entire specimen. in one block. 3A frozen section block, resubmitted toto. 4. The specimen labeled with the patient's name and as ""LUNG: Lt upper. lobe bronchial margin,. The specimen is received fresh and. subsequently placed in to 10% buffered formalin. It consists of a left. upper lobe of lung, measuring 16.5 x 15.5 x 4. cm. The pleural surface. is focally hemorrhagic and ranges in color from pink-tan to purple,. showing diffuse areas of black pigmentation. Some fibrous adhesions are. also noted. An area of infarct/ ? strip of parietal pleura is noted,. measuring 4.3 cm in length x 1.5 cm in diameter. The surface of this. area is homogeneously white, smooth and firm. Cross-sections reveal a. well-circumscribed tumor, measuring 8. x 3.8 x 3.3 cm. Cross sections. of the tumor are homogeneously white-tan and firm. Immediately adjacent. to the tumor a small yellow, firm area is noted. The tumor is located. approximately 1.5 cm from the bronchial resection margin, 1.0 cm from the. closest pleural surface and 0.7 cm from the pulmonary artery resection. margin. Further sectioning reveals multiple mall-indurated areas, which. are better palpated than seen. The bronchi all appear slightly and. dilated and partially calcified. Cross sections of the remaining lung. parenchyma are homogeneously brown-tan and grossly unremarkable. Multiple probable lymph nodes are identified, ranging from 0.3 to 2.0. cm. The bronchial resection margin has been taken en face and submitted. for intraoperative consultation by frozen section. Two large pieces of. lung tissue has also been taken for an asbestos fiber count (requested by. Representative sections are submitted as follows: frozen section block, resubmitted. 1B pulmonary artery resection margin, en face. 4C representative sections of pleural adhesions. 4D-4E tumor with ? parietal pleura/area of infarct. 4F tumor with closest pleural surface. 4G-4H tumor with adjacent normal parenchyma. 4I representative sections of fibrous/indurated areas. 4J-4K representative sections of normal lung parenchyma. 4L one representative section from base of lung. 4M representative sections of various indurated areas. 4N-4P one bisected probable lymph node are block, lobar region. 4Q-4R one trisected probable lymph node, lobar region. 4S-4T two probable lymph nodes per block, segmental region. -4V one trisected probable lymph node per block, segmental region. <W-4X two probable lymph nodes per block, subsegmental region. 5. The specimen labeled with the patient's name and as ""Lymph node: lymph. node neck"". Consists of one unoriented, irregularly shaped piece of. yellow-tan adipose tissue, measuring 1.4 x 0.8 x 0.5 cm; received in 10%. buffered formalin. Cross sections reveal one probable lymph node,. measuring 0.9 x 0.5 x 0.5 cm. The cut surface of the lymph node is. homogeneously tan and firm. 5A specimen is bisected and submitted in toto. QUICK SECTION. QS3A: ""sump"" node: Lymph nodes, negative for malignancy. QS4A: LUL: bronchial resection margin: negative for malignancy. Addendum Comment. A large number of ferruginous (asbestos) bodies are found in practically. all sections with lung parenchyma tissue. Page: 4 of 5. S TO S. ebea.",T2,N1,M0,T2N1M0
TCGA-18-3415,"SPECIMEN (S) RECEIVED. 1. Pleura: biopsy chest wall margin - QS on silk stitch. 2. Lymph node: paraesophageal node. 3. Lymph node: inf. pulm ligament ST9. Lymph node: Interlobar ST11. o. Other: chest wall margin #2 tumour QS. 6. Lymph node: Rt. TB angle ST1OR. 7. LUNGS: Rt. upper lobe QS bronchial margin. 8. LUNGS final bronchial margin. 9. Lymph node: Rt. up paratracheal ST2R. 10. Lymph node: Rt. low paratracheal ST4R. 11. Lymph node: subcarinal ST7. DIAGNOSIS. 1. Soft tissue, biopsy (chest wall margin) : - Fibroadipose tissue and lymph node, negative for malignancy. 2-4. Lymph nodes, biopsies (paraesophageal node, ST9 inferior pulmonary. Ligament, ST11 interlobar) : - Lymph nodes, negative for malignancy (x3). 5. Soft tissue, biopsy (chest wall margin #2) : - Fibroadipose tissue, negative for malignancy. 6. Lymph node, biopsy (ST1OR right TB angle) : - Lymph node, negative for malignancy. 7. Lung, resection (right upper lobe) : a) Invasive poorly differentiated squamous cell carcinoma, with (see. nomment) : i) Greatest dimension = 6.6 cm. ii) Focal invasion of visceral pleura. 1 of 6. Vascular invasion present. iv) Bronchial, lung parenchymal and soft tissue resection. margins negative for malignancy. v) Lobar lymph node, negative for malignancy. b) Lung, with: i) Peritumoral infarct, with scarring, dense pleural adhesions,. and traction bronchiectasis. ii) Mild to moderate emphysematous changes, with patchy. interstitial fibrosis (non-specific). 8. Bronchus, biopsy (final bronchial margin) : - Negative for malignancy. 9 - 11. Lymph nodes, biopsies (ST2R right upper paratracheal, ST4R right. lower paratracheal, ST7 subcarinal) : - Lymph nodes, negative for malignancy (x3). SYNOPTIC DATA. Specimen Type: Lobectomy. Laterality: Right. Tumor Site: RUL. Tumor Size: Greatest dimension: 6.6 cm. Histologic Type: Squamous cell carcinoma. Histologic Grade. G3: poorly differentiated. Pathologic staging (p'TNM) : pT2: Tumor with any of the following. features of size or extent: greater than 3 cm in greatest dimension;. involves main bronchus, 2 cm or more distal to the carina; invades the. visceral pleura; associated with atelectasis or obstructive pneumonitis. that extends to the hilar region but does not involve the entire lung. pNO: No regional lymph node. metastasis. pMX: Cannot be assessed. Margins: Margins uninvolved by invasive. carcinoma. Direct Extension of Tumor: Visceral pleura. Blood Vessel Invasion: Present. rdditional Pathologic Findings : Slight centrilobular emphysema. Other: peritumoral infarct with. pleural adhesions. Page: 2 of 6. COMMENT. 7. Sections of the tumor show a poorly differentiated squamous cell. carcinoma that focally invades through the visceral pleura. There is. associated with the tumor an area of pulmonary infarction and fibrosis,. with dense overlying pleural adhesions, but invasion of chest wall soft. tissue by tumor is not identified. The overall features are consistent. with squamous cell carcinoma, pT2NO. GROSS DESCRIPTION. 1. The specimen container is labeled with the patient's name and as. ""biopsy chest wall margin on silk stitch"" contains a single piece of an. irregular fragment of tan tissue received fresh. The tissue measures 3.8. x 1.5 x 2.5 cm. A suture is noted on the specimen. The margins are. painted with silver nitrate, the site of suture is marked India ink. This is examined at intraoperative consultation by frozen section. performed on part of the specimen. The specimen is submitted in toto as. follows: 1A frozen section resubmitted (see diagram, en face) silver nitrate the. margin India ink marks site of suture). 1B the rest of the specimen submitted in toto. 2. The specimen container labeled with the patient S name and as. ""paraesophageal node"", contains one of one of yellowish plaque tissue. measuring 0.6 x 0. x 0.3 cm. received in 10% buffered formalin. 2A submitted in toto. 3. The specimen container labeled with the patient S name and as. 'inferior pulmonary ligament ST 9. "", contains one piece of yellowish. black tissue measuring 0.6 x 0.4 x 0.3 cm. received in 10% buffered. formalin. 3A submitted in toto. 4, The specimen container labeled with the patient' S name and as. 3 of 6. "" interlobarST11"", contains two pieces of tan black tissue measuring to. 0.3 x 0.3 X 0.3 and 0.6 x 0.4 x 0.3 cm. received in 10% buffered formalin. 4A submitted in toto. 5. The specimen container is labeled with the patient's name and as. ""chest wall margin # 2. Query tumor Q. S. "" contains a single fragment of. tan tissue received fresh. The tissue measures 0.3 x 0.2 x 0.2. This is. examined at intraoperative consultation by frozen section performed on. the entire specimen. The specimen is submitted in toto as follows: 5A frozen section resubmitted. u. The specimen container labeled with the patient' S name and as ""right. TB angle ST1OR "", contains one piece of black-brown tissue measuring 0.9. x 0.6 x 0.6 cm. received in 10% buffered formalin. 6 A. specimen bisected and submitted in toto. 7. The specimen container is labeled with the patient's name and as. ""right upper lobe bronchial margin qs"" contains a lobectomy specimen. received in 10% buffered formalin. The specimen measures 14.3 x 8.5 x. 8.0 cm. (The pleural surface overlying the tumor was painted with silver. nitrate during tissue banking) On gross examination, there is a portion. of parietal pleura adhered to the lung measuring 7.0 x 5. x 0.3 cm in. thickness. The parietal pleura is yellow-tan and is firm and rubbery,. with some areas that appears to be fatty. The rest of the pleura is tan. in color and appears to be slightly thickened. On sectioning, there is a. well-circumscribed tumor measuring 6.6 x 5.5 x 5.8 cm. The tumor abuts. the pleura and has a variegated black tan appearance and is solid on the. periphery and slightly soft and friable centrally. The tumor is 1.5 cm. away from the nearest stapled resection margin. The lung parenchyma adjacent to the tumor appears to be emphysematous and. has a light yellow appearance. The rest of the lung parenchyma appears. grossly unremarkable. One lobar lymph node is identified grossly within. the hilar area measuring 1.5 x 1.5 x 0.8 cm. Representative sections are submitted as follows: 7A frozen section resubmitted bronchial margin en face. 7B-7D parietal pleura resection margin taken en face. 7E lung shave resection margin closest to tumor. 78-7J representative section of the tumor in relation to parietal pleura. : representative section of tumor in relation to parietal pleura and. severely emphysematous lung parenchyma. Page: 4 of 6. K. 7L Representative section of tumor in relation to adjacent lung. parenchyma and pleura. 7M representative section emphysematous lung parenchyma. 7N-70 representative section the parenchyma. 7P-7Q one lobar lymph node serially sectioned and submitted in toto. three pieces of tumor and three pieces of lung are taken for tissue. banking. 8. The specimen container labeled with the patient S name and as ""final. bronchial margin"", contains one piece of tan tissue measuring 0.8 x 0.4 x. 0.3 cm. received in 10% buffered formalin. \ submitted in toto. 9. The specimen container is labeled with the patient's name and as. ""right upper paratracheal ST2R"" contains two fragments of tan tissue. received fresh. The tissue measures 1.8 x 1.2 x 0.4 cm and 1.0 x 0.4 x. 0. 4 cm. This is examined at intraoperative consultation by frozen section. performed on the entire specimen. 9A frozen section resubmitted (larger node bisected). 9B frozen section resubmitted smaller node. 10. The specimen container is labeled with the patient's name and as. ""right lower paratracheal ST4R"" contains a single piece of an unoriented. fibroadipose tissue received in 10% buffered formalin. Within the fatty. tissue, multiple lymph nodes are identified grossly ranging in size from. 0.3 x 0.3 x 0.2 cm to 2.3 x 1.5 x 0.8 cm. The lymph nodes are submitted. in toto as follows: 10A four lymph nodes. 10B one lymph node bisected. 10C one lymph node bisected. 10D one lymph node trisected. 10E one lymph node bisected. 10F one lymph node bisected. 10G three lymph nodes. 11. The specimen container is labeled with the patient's name and as. ""subcarinal ST7"" contains five pieces of unoriented yellow black tissue. received in 10% buffered formalin. Within the tissue, multiple lymph. nodes are identified grossly ranging in size from 0.4 x 0.4 x 0.3 to 2.3. 1.5 x 0.6 cm. The lymph nodes are submitted in toto as follows: 11A-11B one lymph node bisected. Page: 5 of 6. 11C two lymph nodes bisected. 11D one lymph node bisected. 11E one lymph node bisected. 11F one lymph node bisected. 11G one lymph node bisected. 11 H two lymph nodes. QUICK SECTION. 1. Chest wall margin, area of stitch: - En face margin negative for carcinoma. - Chest wall margin #2: - Negative for carcinoma. 7. Bronchial resection margin negative for carcinoma. 9. Negative for carcinoma. Page: 6 of 6.",T2,N0,M0,T2N0M0
TCGA-ZJ-AAXF,"PAGE:1. SPEC #: Obtained: CLINICAL HISTORY : 233.1. SPECIMEN/PROCEDURE : : 1. CERVIX - BIOPSY. IMPRESSION : CERVIX, 1 O'CLOCK, BIOPSY: Invasive squamous coll carcinoma, large cell keratinizing type, moderate to. poorly differentiated. Entered: GROSS DESCRIPTION: This case is part of the. Received in formalin labeled "". "" and with patient name, is an irregular unoriented. tan to red tan glistening portion of tissue, 1.3 x 1 x 0.3 cm. The specimen is trisected. Specimen is entirely submitted in one cassette. Entered: CPT Codes : CERVICAL BIOPSY/88305. ICD9 Codes : 180.9. Eleotronically Signed by:",T2,N0,M0,T2N0M0
TCGA-A3-3313,"Laboratory Patient Report. Print Date/Time: Histopathological Examination. Complete : Pre-Op Diagnosis. Specimens. Kidney, Right. Frozen Diagnosis. GROSS EXAMINATION. The specimen is received in a container labeled with the. name of the patient and labeled as kidney, right. The. specimen consists of a right kidney which measures en bloc. 13 X 9.5 X 5.5 cm and weighs 312 g. There is a 3.0 cm. segment of ureter attached. Ureter and vascular margins are. sampled in block one. The ureter is opened. No tumor. within the ureter is grossly identified. The ureteropelvic. junction is sampled in block two. The kidney is bivalved. On the anterior aspect of the kidney bulging beneath the. capsule is a tan partially cystic mass which measures 4.5 X. 4. 0 X 3.5 cm. An extension of the mass extends into the. renal vein. A cross section of the vein and tumor are. submitted in block three. The capsule at the area of tumor. is marked with ink and a representative section is submitted. in block four. The capsule strips with relative ease. Tumor and adjacent normal appearing kidney tissue are. sampled in blocks 5 through 7. Tumor kidney and renal. vessel are sampled in block eight. The surface of the. kidney exhibit multiple fluid filled cystic structures which. measure up to 1.2 cm in greatest dimension and is sampled in. block nine. A section of normal appearing kidney is sampled. in block 10. The perinephric fat is examined for adrenal. tissue. Adrenal gland is not identified. Representative. sections are submitted. DIAGNOSIS BASED ON GROSS AND MICROSCOPIC EXAMINATION. SPECIMEN TYPE Radical nephrectomy. LATERALITY Right. TUMOR SITE: Middle. FOCALITY: Unifocal. TUMOR SIZE (LARGEST TUMOR IF MULTIPLE) : 4.5 X 4 x 3.5 cm. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE DISSEMINATION. OR DUPLICATION IS PROHIBITED. of 2. MACROSCOPIC EXTENT OF TUMOR: Limited to the kidney. HISTOLOGIC TYPE: Clear cell renal carcinoma. HISTOLOGIC GRADE (FUHRMAN NUCLEAR GRADE) : Fuhrman nuclear. grade III. EXTENT OF INVASION. PRIMARY TUMOR (PT) : pT1b: Tumor 7 cm or less in deep. greatest dimension, limited to the kidney. REGIONAL LYMPH NODES (PN) : pNX. DISTANT METASTASIS (PM) : pMX. MARGINS : Margins not involved by invasive carcinoma. ADRENAL GLAND: Not present. VENOUS (LARGE VESSEL) INVASION (V) : Absent. LYMPHATIC (SMALL VESSEL) INVASION (L) : Absent. [T-71000 M-83103 189. 0 P3-44070]. CASE SUMMARY: This 4.5 cm greatest diameter clear cell carcinoma, Fuhrman. nuclear grade III is confined to the kidney. The pathologic. code pT1bNXMX. Intradepartmental consultation was obtained. THIS CONFIDENTIAL AND PRIVILEGED DOCUMENT/INFORMATION IS PROTECTED BY. FEDERAL AND STATE LAW. UNAUTHORIZED DISCLOSURE, DISSEMINATION. OR DUPLICATION IS PROHIBITED. of 2.",T1,N0,M0,T1N0M0
TCGA-DS-A1OD,"""age 1 of 4. Carcinoma, squamous cell, NOS 8070/3. Attending MD: Copies To: DIAGNOSIS: ADDENDUM. 1. RIGHT PELVIC LYMPH NODE, BIOPSY: -No tumor identified in four lymph nodes (0/4). -Sinus histiocytes and focal intraparenchymal acute. inflammation. 2. RIGHT COMMON ILIAC NODE, BIOPSY: -No tumor identified in one lymph node (0/1). -Sinus histiocytes present. 3. UTERUS, RADICAL HYSTERECTOMY: -Poorly differentiated invasive squamous cell carcinoma of. uterine cervix, large cell, focally keratinizing. -The maximal thickness of the cervical stromal invasion is 19 mm. -The maximal superficial spread of the tumor is 22 mm. -The invasive squamous cell carcinoma involves all four quadrants. of the cervix. Diffuse CIN III/CIS with gland duct involvement and focal HPV. changes are also present. - Few foci suspicious for lymphovascular space invasion present. -Focal vaginal extension (upper third, posterior) is present. -The anterior and posterior lower uterine segment show no. evidence of involvement. -No parametrial involvement is identified. -All inked surgical excision margins (paracervical soft tissue. and vaginal margins) are free from involvement. -Associated acute and chronic cervicitis with squamous. metaplasia, nabothian cysts, focal calcific atherosclerosis and. ciliated cell metaplasia are also present. -The endometrium is unremarkable and shows early secretory. -The myometrium shows multiple leiomyomata (4) with evidence of. changes. hyalinization and focal degenerative necrosis (largest leiomyoma. measuring 4.5 cm) and focal adenomyosis. 4: OBTURATOR NODE, BIOPSY: -No tumor identified in four lymph nodes (0/4). 5: RIGHT TUBE AND OVARY, RIGHT SALPINGO-OOPHORECTOMY: - -Right ovary showing diminutive fibroma (0.7 cm in greatest. dimension), simple cyst, follicular cyst, involuting corpus. luteum, stromal hyperplasia, surface stromal proliferations,. surface adhesions, and focal surface epithelial inclusion cyst. - Right fallopian tube shows no significant histopathologic. changes. -No malignancy is identified. https://. LEFT TUBE AND OVARY, LEFT SALPINGO-OOPHORECTOMY. -Left ovary showing hemorrhagic corpus luteum, follicle cysts,. atretic follicles, surface epithelial inclusion cysts, surface. adhesions and focal surface stromal proliferations. -Left fallopian tube showing mesonephric duct remnants. 7: LEFT COMMON ILIAC NODE, BIOPSY: -No tumor identified in four lymph nodes (0/4). LEFT PELVIC LYMPH NODE, BIOPSY: -No tumor identified in three lymph nodes (0/3). -Reactive lymph nodes showing sinus histiocytes and focal. intraparenchymal acute inflammation. NOTE: Based on the material examined, this tumor is at least AJCC. stage IB1, T1b1 NO Mx. ADDENDUM. Although, accurate estimation of depth of invasion of the carcinoma. is precluded by suboptimal sections, in some sections it appears. to be greater than 50% invasion of the cervical wall. Foci of,. definite and other foci suspicious for lymphovascular space invasion. are present. Dr. has reviewed representative sections of. this case. HISTORY: Ovarian carcinoma. MICROSCOPIC: See Diagnosis. GROSS: 1: RIGHT PELVIC NODE. Labeled ""right pelvic node"" and received in formalin is 4.8 x 4.5 x. 2.4 Cm aggregate of adipose tissue which contains four firm, tan-pink. lymph nodes ranging from 1.1 up to 2.6 cm in greatest dimension. All. lymph nodes are entirely submitted as labeled. A. Smaller nodes - 2. B. Mid size lymph node bisected - 2. C. Largest lymph node bisected - 2. 2: RIGHT COMMON ILIAC NODE. Labeled ""right common iliac node"" and received in formalin is a 1.9 x. Page : 3. 0.9 x 0.3 cm soft, tan-pink lymph node which is entirely submitted. D. 1. 3: UTERUS. Labeled ""uterus"", received fresh in the Operating Room for gross. consultation and subsequently fixed in formalin is a 420 gram, uterus. with attached cervix. The uterus is 13. 1 cm from fundus to. ectocervix, 8.1 cm from cornu to cornu, and 6.1 cm from anterior to. posterior. The serosa is tan-red and dull with focal adhesions The. cervix is 4.2 cm in length and 4.1 cm in diameter with a 0.3 cm. patent os. There is a cuff of vaginal mucosa ranging in thickness. from 1.7 cm anteriorly to 3. cm posteriorly. The ectocervical. mucosa is tan-pink and smooth. On sectioning, the transformation. zone is distinct and the endocervical canal is 3.0 cm in length. Along the transformation zone and ectocervix is a 2.0 x 2.0 cm. granular and hemorrhagic area. The paracervical soft tissue and. vaginal margins are inked blue. The endometrial cavity is 7.4 cm. in. length and 1.6 cm in width and is lined by smooth, tan-red. https:/. endometrium. The endometrium is 0.1 cm in average thickness. The. myometrium measures up to 5.2 cm in thickness and contains four. intramural leiomyomata ranging from 0.5 up to 4.5 cm in greatest. dimension. On sectioning, the largest leiomyomata displays central. areas of hemorrhage and necrosis. Representative sections. E. Smaller leiomyomata - 3. F. Largest leiomyoma with central necrosis -2. G. Anterior uterine corpus - 1. H. Anterior lower uterine segment - 1. I-O. Entire anterior cervix - 1 each. P. Posterior uterine corpus - 1. Posterior lower uterine segment - 1. R-U. Entire posterior cervix - 1 each. 4: OBTURATOR. Labeled ""obturator"" and received in formalin is a 2.1 x 1.7 x 0.3 cm. portion of soft tan-yellow adipose tissue which is entirely. submitted. V. Multiple. 5: RIGHT TUBE OVARY. Labeled ""right tube ovary"" and received in formalin is a 4.1 cm in. length and 0.5 cm in diameter fimbriated segment of fallopian tube. The serosa is tan-pink with moderate tubo-ovarian adhesions. On. sectioning, cut surface is focally edematous with a 0.2 cm patent. lumen. The fallopian tube is adherent to a 2.6 x 2.1 x 1.9 cm firm,. tan-yellow cerebriform ovary. On sectioning, the cut surface. displays two unilocular cysts which contain a minimal amount of clear. serous fluid. The cystic locules are 0.5 and 1.7 cm in greatest. dimension. The inner cyst linings are smooth without papillary. excrescences. There is a 0.4 cm in greatest dimension firm yellow. nodule on the external surface. Representative sections. W. Fallopian tube and cysts - 3. x. Larger cyst wall - 3. Y. Ovarian parenchyma with external surface nodule - 1. 6: LEFT TUBE OVARY. Labeled ""left tube and ovary"" and received in formalin is a 3.7 cm in. length and 0. cm in diameter fimbriated segment of fallopian tube. The serosa is tan-pink and smooth. On sectioning, cut surfaces are. focally edematous with a 0.2 cm patent lumen. The fallopian tube is. adherent to a 3.6 x 2.6 x 1.1 cm lobulated and focally cerebriform. ovary with focal hemorrhage. On sectioning, two unilocular clear. fluid-filled cysts are identified which are 0.7 and 1.0 cm in. greatest dimension. No papillary excrescences are identified. There is also a 2.2 cm in greatest dimension hemorrhagic area. Representative sections. z. Fallopian tube and smaller cyst - 3. AA. Larger cyst - 2. BB. Hemorrhagic area - 3. CC. Random ovary - 1. 7: LEFT COMMON ILIAC. Labeled ""left common iliac"" and received in formalin are four firm,. tan-pink lymph nodes ranging from 0. 6 up to 1.7 cm in greatest. dimension. All lymph node tissue is entirely submitted as labeled. DD. Lymph nodes (largest node bisected) - 4. 8: LEFT PELVIC NODE. Labeled ""left pelvic node"" and received in formalin is a 3.6 x 2.7 x. https://. 1.2 cm aggregate of lobulated adipose tissue which contains three. firm, tan-pink lymph nodes ranging from 0.5 up to 1.7 cm in greatest. dimension. All lymph node tissue is entirely submitted as labeled. EE. Three lymph nodes (largest node bisected) - 4. Gross dictated by. OPERATIVE CONSULT (GROSS) : 3. Localized friable hemorrhagic area in cervix approximately 2.0. x 2.0 cm. A small portion (0.8 x 0.: cm) of friable lesion is given. fresh for Dr. research study. Special Studies: Frozen Section. See Also: , M.D. M.D. the pathologist of record, have. personally examined the specimen, interpreted the. results, reviewed this report and signed it electronically. Date Finalled: I,. M.D., the pathologist of record, have. personally examined the specimen, interpreted the. results, reviewed this report and signed it electronically. Page : 5. https://.",T1,N0,M0,T1N0M0
TCGA-L5-A8NG,"OPER DATE: REQ DOC: PROCEDURE: year-old male with long history of heartburn/food indigestion. Developed. dysphagia and weight loss. On. barium swallow showed concentric. filling defect in distal esophagus. On. chest CT showed a 1 cm. elliptical nodule in the lateral segment RML; circumferential thickening of. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 3. PATIENT NBR: SEX: M. BIRTHDATE: ADM DATE: OPER DATE: REQ DOC: the distal esophagus. Clinical Diagnosis: Cancer, primary esophagus. Operative Procedure: THE. PROCEDURE: SPGD. 1. ""Esophagus."" A 13 x 5 cm specimen consisting of 6 cm of distal esophagus. and 6.5 cm of the proximal stomach. 2 to 2.5 cm caudal to the GE junction,. there is an irregular tongue of pink, velvety mucosa, with 1 x 1 cm and 2.5. x. 1.5 cm somewhat excavated areas, suspicious for ulceration. Along the border. of pink-tan, velvety mucosa and grey-tan, normal-appearing esophageal mucosa. are multiple grey-tan papillations. The esophageal wall is up to 0.9 cm thick. at the GE junction. The proximal gastric rugae are markedly thickened. There. is a 1.2 cm mucosal punch-out defect, 1.5 cm distal to the proximal resection. edge. There is a 1.5 cm circumferential infiltrating neoplasm arising just. above the GE junction, which appears to extend into the muscularis propria. 1A. Distal gastric resection margin. 1B-1E. Sequential segments of the specimen from cephalad to caudad, proximal. end inked green. IF-1H. Deeper tumor extension. 11 & 1J. Representative sections of the tumor. 1K. Punched-out (esion in the proximal area. 1L. & 1M. Multiple Lymph nodes identified in the periesophageal fat. 2. ""Cervical margin."" A 2 x 2 cm fragment of tubular esophagus, stapled at. one end, with pink-grey, unremarkable mucosa. Bisected. Entirely submitted. with 2A being the margin. PROCEDURE: ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: Type of carcinoma: Adenocarcinoma. Adenocarcinoma arising GE junction. Depth of invasion: Adventitia. Number of positive lymph nodes: One. Extranodal metastasis: Unknown. Pattern of invasion: Infiltrative. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 4. PATIENT NBR: SEX: M. ADM DATE: BIRTHDATE: OPER DATE: REQ DOC: Esophageal and gastric resection margins involved: No (close). Deep resection margin involved: No (close). TNM classification: T3 N1 Mx. PROCEDURE: 1-2. Esophagus, transhiatal esophagectomy: Adenocarcinoma arising at the. esophagogastric junction without associated Barrett's mucosa. Neoplasm extends. through the muscularis propria to within 0.1 cm of the inked periesophageal. soft tissue surgical margin. Cervical esophageal surgical resection mergin. negative. Adenocarcinoma extends to within 0.1 cm of distal gastric resection. margin. Angiolymphatic invasion identified. Metastatic adenocarcinoma. involving one of four periesophageal Lymph nodes. Please see template for. details. the signing staff pathologist, have personally. examined and interpreted the slides from this case. Code: END OF PREVIOUS DIAGNOSIS INQUIRY.",T3,N1,M0,T3N1M0
TCGA-CG-4476,"Diagnosis: Total gastrectomy preparation with gastric carcinoma extending to within 5 cm of the oral. resection margin at most, located on the side of the lesser curvature, with a maximum. diameter of 3.5 cm, characterized histologically as a poorly differentiated adenocarcinoma. (gastric carcinoma of diffuse type). Invasive tumor spread within all parietal layers of the. stomach extending to the level of the subserosa, the perigastric tissue and circumscribed. within peripancreatic fatty tissue of a small adjacent part of the pancreas. Oral and aboral resection margin and also omentum tumor-free. Twelve of thirty-three lymph. nodes with metastases of the gastric carcinoma. Other lymph nodes with uncharacteristically. reactive lesions. Tumor stage thus pT4 pN3a (12/33) L1 V0;.",T4,N3,M0,T4N3M0
TCGA-D5-6927,"page 1 / 1. copy No. 3. Examination: Histopathological examination. Material: 1. Total organ resection - specimen from the colon. Expected time of examination: Clinical diagnosis: Cancer of the transverse colon. Macroscopic description: A 12 cm length of the large intestine with periintestinal fat tissue sized 12.5 X 4.5 X 5 cm. Ulcerous tumour sized 6.0 X. 4 X 1.6 found in the mucosa. The lesion surrounds 100% of the intestine circumference and narrows its lumen,. is. located 3 cm from one of the incision lines and 3.6 cm from the opposite one. Minimum side margin is 1.3 cm. Microscopic description: Adenocarcinoma tubulare (G2). Infiltratio carcinomatosa tunicae muscularis propriae et telae adiposae pericolicae. Incision lines clear of neoplastic lesions. Lymphonodulitis reactiva No XVI. Histopathological diagnosis: Adenocarcinoma tubulare coli. Tubular adenocarcinoma of the colon. (G2, Dukes B, Astler-Coller B2, pT3, pNO).",T3,N0,M0,T3N0M0
TCGA-75-5146,"el. Age al'Sample. Days. Days N. Sime. Type. Preperation. Diagnes's. Sample Comprents. Procedure. Type et. Tumeur. Diagnosia. Procedure. Frimary. Grade. Number. (Matology). Sizejam). Histology. Differentlation. Pathological T VALCSG Stage. Histology Comments. TUMOUR. FF. ALL. Adenocarciona. RESECT. RLL. .00. 03. i. T2,NOS. MO. BUFFY. Adenocarcinoma. RESECT ALL. 6.00. 03. T2,NOS. MO.",T2,N0,M0,T2N0M0
TCGA-A8-A08G,"Diagnosis: 1 Ablated breast sample with three foci of carcinoma: first tumor: poorly differentiated invasive ductal carcinoma (tumor diameter: 2.8 cm). with focal intraductal components. Tumor-free dorsal resection margin. Tumor classification: NOS and mucinous carcinoma, G III, pT2(mult)NOLOVORX.",T2,N0,M0,T2N0M0
TCGA-BH-AB28,"Anonymous number: Accession Date: FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEFT AXILLA SENTINEL NODE #1, BIOPSY -. METASTATIC ADENOCARCINOMA INVOLVING ONE LYMPH NODE (1/1), UP TO 7 MM (1A), CONFIRMED BY. AE1/AE3 CYTOKERATINE IMMUNOSTAINING ( (see comment). PART 2: LYMPH NODE, LEFT AXILLA, SENTINEL #2, BIOPSY -. METASTATIC ADENOCARCINOMA INVOLVING ONE LYMPH NODE (1/1), UP TO 7 MM (2B), CONFIRMED BY. AE1/AE3 CYTOKERATINE IMMUNOSTAINING ( (see comment). PART 3: LYMPH NODE, LEFT AXILLA, SENTINEL #3, BIOPSY -. METASTATIC ADENOCARCINOMA INVOLVING ONE LYMPH NODE (1/1), UP TO 4 MM (3A), CONFIRMED. AE1/AE3 CYTOKERATINE IMMUNOSTAINING ( (see comment). PART 4: LYMPH NODE, LEFT AXILLA, SENTINEL #4, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1), (see comment). PART 5: BREAST, LEFT, TOTAL MASTECTOMY -. A. INFIULTRATING LOBULAR CARCINOMA (5C, 5D, 5E,5F,5H,51,5J,5K,5L,5M,5N,50,5P, 5Q, 5R, 5S, 5T,. 5U,. 5V, and 5AA). B. THE TUMOR SIZE IS: 8.0 X 6.5 X 4.2 CM. C. NOTTINGHAM SCORE IS: 6/9 (TUBULES 3, NUCLEI 2, MITOSIS 1). D. LYMPHOVASCULAR INVASION IS NOT APPRECIATED (see comment). E. DUCTAL CARCINOMA IN-SITU, SOLID TYPE, NUCLEAR GRADE 2, WITH COMEDONECROSIS,. REPRESENTING ABOUT 1 % OF TUMOR VOLUME. F. DUCTAL CARCINOMA IS PRESENT ADMIXED WITH INVASIVE TUMOR. G. MARGINS OF RESECTION ARE FREE OF TUMOR. H. NIPPLE, NO TUMOR IS SEEN. I. SKIN, FREE OF TUMOR. J. CHANGES CONSISTENT WITH PREVIOUS CORE BIOPSY SITE,. K. LOBULAR CARCINOMA IN-SITU, CLASSIC TYPE WITH PAGETOID SPREAD INTO DUCTS (see comment). L. ATYPICAL LOBULAR HYPERPLASIA (see comment)). M. MULTIPLE MICROSCOPIC RADIAL SCARS WITH FLORID DUCTAL EPITHELIAL HYPERPLASIA AND. XOLUNAR CELL CHANGES. N. INTRADUCTAL PAPILLOMA INVOLVED WITH INFILTRATING LOBULAR CARCINOMA. O. FIBROCYSTIC CHANGES WITH FIBROADENOMATOID NODULAR CHANGES. P. PSEUDOANGIOMATOUS STROMAL HYPERPLASIA (PASH). Q. IMMUNOHISTOCHEMICAL STAINING FOR ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR AND. HER-. 2/NEU WERE PREVIOUSLY PERFORMED ON. AND WERE REPORTED AS FOLLOWS: ESTROGEN RECEPTOR - POSITIVE (H-SCORE 290), PROGESTERONE RECEPTOR - POSITIVE (H-SCORE. 200), AND HER-2/NEU - EQUIVOCAL (SCORE 2+). HER-2 FISH WAS NOT AMPLIFIED. Anonymous No.: Gender: F. Race: White. CLINICAL HISTORY. Procedure: Left total mastectomy, left sentinel lymph node biopsy, possible axillary lymph. node dissection. Number of Lesions: 1. Site and Size Lesion 1:9 cm, Histology: Invasive lobular carcinoma. Other Areas: Not provided. Neoadjuvant Therapy: No. Type of Neoadjuvant Therapy: N/A. Pretherapy Size: N/A. Clinical Findings Based On: MRI, ultrasound and mammogram. Comment: None listed. ADDENDUM. Tumor characteristics. Size: 8 cm. Nottingham score: 6. ER H-score: 290. PR H-score: 200. HER2 status: Negative. Ki-67 labeling index: 30. Based on above tumor characteristics, the estimated recurrence score. using. is reported below. 1 (includes a-f): 22.59. 2 (includes a-e): 16.19. 3 (includes c-f): 17.82. NOTE. For more scientific details, see reference: Klein ME et al. Mod Pathol. 2013;26:658-664. PMID: 23503643. ADDENDUM. This infiltrating lobular carcinoma is heterogeneous and show microscopic. foci of pleomorphic tumor component (infiltrating pleomorphic lobular. component). This case is discussed with. at. on. FINAL DIAGNOSIS. PART 1: LYMPH NODE, LEFT AXILLA SENTINEL NODE #1, BIOPSY. METASTATIC ADENOCARCINOMA INVOLVING ONE LYMPH NODE (1/1), UP TO 7 MM. (1A), CONFIRMED BY AE1/AE3 CYTOKERATINE IMMUNOSTAINING ( (see comment). PART 2: LYMPH NODE, LEFT AXILLA, SENTINEL #2, BIOPSY. METASTATIC ADENOCARCINOMA INVOLVING ONE LYMPH NODE (1/1), UP TO 7 MM. (2B), CONFIRMED BY AE1/AE3 CYTOKERATINE IMMUNOSTAINING ( (see comment). PART 3: LYMPH NODE, LEFT AXILLA, SENTINEL #3, BIOPSY. METASTATIC ADENOCARCINOMA INVOLVING ONE LYMPH NODE (1/1), UP TO 4 MM. (3A), CONFIRMED BY AE1/AE3 CYTOKERATINE IMMUNOSTAINING ( (see comment). PART 4: LYMPH NODE, LEFT AXILLA, SENTINEL #4, BIOPSY. ONE LYMPH NODE, FREE OF TUMOR (0/1), (see comment). PART 5: BREAST, LEFT, TOTAL MASTECTOMY. A. INFIULTRATING LOBULAR CARCINOMA (5C, 5D, 5E, 5F, 5H, 5l, 5J, 5K, 5L, 5M,. 5N, 50, 5P, 5Q, 5R, 5S, 5T, 5U, 5V, and 5AA). B. THE TUMOR SIZE IS: 8.0 X 6.5 X 4.2 CM. C. NOTTINGHAM SCORE IS: 6/9 (TUBULES 3, NUCLEI 2, MITOSIS 1). D. LYMPHOVASCULAR INVASION IS NOT APPRECIATED (see comment). E. DUCTAL CARCINOMA IN-SITU, SOLID TYPE, NUCLEAR GRADE 2, WITH. COMEDONECROSIS, REPRESENTING ABOUT 1 % OF TUMOR VOLUME. F. DUCTAL CARCINOMA IS PRESENT ADMIXED WITH INVASIVE TUMOR. G. MARGINS OF RESECTION ARE FREE OF TUMOR. H. NIPPLE, NO TUMOR IS SEEN. I. SKIN, FREE OF TUMOR. J. CHANGES CONSISTENT WITH PREVIOUS CORE BIOPSY SITE, SEE PRIOR. K. LOBULAR CARCINOMA IN-SITU, CLASSIC TYPE WITH PAGETOID SPREAD INTO. DUCTS (see comment). L. ATYPICAL LOBULAR HYPERPLASIA (see comment)). M. MULTIPLE MICROSCOPIC RADIAL SCARS WITH FLORID DUCTAL EPITHELIAL. HYPERPLASIA AND XOLUNAR CELL CHANGES. N. INTRADUCTAL PAPILLOMA INVOLVED WITH INFILTRATING LOBULAR. CARCINOMA. O. FIBROCYSTIC CHANGES WITH FIBROADENOMATOID NODULAR CHANGES. P. PSEUDOANGIOMATOUS STROMAL HYPERPLASIA (PASH). Q. IMMUNOHISTOCHEMICAL STAINING FOR ESTROGEN RECEPTOR,. PROGESTERONE RECEPTOR AND HER-2/NEU WERE PREVIOUSLY PERFORMED. ON. AND WERE REPORTED AS FOLLOWS: ESTROGEN RECEPTOR. POSITIVE (H-SCORE 290), PROGESTERONE RECEPTOR POSITIVE (H-SCORE 200),. AND HER-2/NEU EQUIVOCAL (SCORE 2 2+). HER-2 FISH WAS NOT AMPLIFIED. COMMENT. Part # 1, # 2, # 3, # 4, and # 5: The results of immunohistochernical stainings support the. above diagnosis (see microscopic description). Parts #1, #2 and #3: The metastatic tumor cells with thin these lymph nodes are depicted. by the AE1/AE3 cytokeratin immunostaining and are present circumferentially within the. sub capsular sinusoidal area in minute tumor cell clusters and mostly as single cells. Re-. review of the imprint slides performed at intraoperative consultation showed no metastatic. tumor cells in part 1 and part 2, and showed rare atypical cells in part 3. GROSS DESCRIPTION. The specimen is received fresh and in 5 parts. Part 1 is received for intraoperative consultation labeled with the patient's name, initials. and ""sentinel node biopsy #1 left axilla,. not blue"". It consists of a portion of. adipose tissue which measures 2.5 x 1.5 x 1.2 cm. A single pink tan probable lymph node. is identified measuring 1.5 x 1.1 x 0.8 cm. The lymph node is bisected for touch. preparation to reveal a homogenous tan-yellow cut surface. The lymph node is further. bisected longitudinally into 2-mm intervals and submitted entirely in two cassettes labeled. 1A-1B. Formalin Exposure Time: 13 hours. Part 2 is received for intraoperative consultation labeled with the patient's name, initials. and ""sentinel node biopsy #2 left axilla. not blue"". It consists of a single fatty pink. tan. probable lymph node with minimal attached adipose tissue which measures 2 x 1.7 x. 1. cm. The lymph node is bisected for touch preparation analysis to reveal a largely fatty. replaced cut surface. The lymph node halves are further bisected into 2-mm longitudinal. intervals and submitted entirely in two cassettes labeled 2A-2B. Formalin Exposure Time: 13 hours. Part 3 is received for intraoperative consultation labeled with the patient's name, initials. and ""sentinel node biopsy #3 left axilla not blue"". It consists of a portion of. adipose tissue which measures 4 x 3 x 1.5 cm. A single fatty pink tan probable lymph node. is identified measuring 1.5 x 1 x 0.8 cm. The lymph node is bisected to reveal a largely. fatty replaced cut surface. One half the lymph node is submitted for frozen section. analysis. Both halves of the lymph node are further bisected into 2-mm longitudinal. intervals and submitted entirely as follows: 3FS- lymph node half, frozen section. 3A- remaining lymph node halves. Formalin Exposure Time: 13 hours. Part 4 is labeled with the patient's name, initials. and ""sentinel node biopsy #4 left axilla. not blue"". It consists of a portion of adipose tissue which measures 4.0 x 2.7 x 1.0 cm. A single pink tan probable lymph node is identified measuring 2.0 x 1.3 x 0.6 cm. The. lymph node is bisected to reveal a pink-tan cut surface interspersed with adipose tissue. The lymph node halves are further sectioned into 2-mm longitudinal intervals and submitted. entirely in two cassettes labeled 4A-4B. Formalin Exposure Time: 13 hours. Part 5 is labeled with the patient's name, initials. and ""left total mastectomy long lateral. short superior"". It consists of a 1202 g total mastectomy specimen which measures 23.5 x. 22 x 7.5 cm. The anterior surface is remarkable for an ellipse shaped portion of light tan. skin which measures 20 x 16 cm. The areola measures 6.5 x 6 cm with a 1.1-cm. retracted, mobile nipple. No discrete skin scars or lesions are grossly identified. The. specimen is inked and sectioned to reveal a large, ill-defined slightly stellate mass (ring-. shaped biopsy clip) which is located roughly between the upper outer and lower outer. quadrants, and extends towards the central aspect of the breast. The mass measures 8.0. x. 6.5 x 4.2 cm and comes to within 1.0 cm of the closest posterior margin, 2.2 cm of the. skin and 3 cm of the anterior inked margin. The breast parenchyma directly medial of the. mass and encompassing a large portion of the upper inner and lower inner quadrants is. dense and extensively fibrocystic (approximately 10 x 4.5 x 4 cm). No additional masses. are identified grossly. The uninvolved breast parenchyma is composed of approximately. 50% adipose tissue and 50% nodular fibrous tissue. Representative sections are. submitted as follows: 5A- nipple and subareolar soft tissue. 5B- breast parenchyma directly lateral of mass. 5C- fullface mass (most lateral aspect). 5D-5K-fullface mass (central lateral aspect), 5D-5G= posterior aspect, 5E-5K= anterior. aspect. 5L-5S- fullface mass (central medial aspect), 5L-50= posterior aspect, 5P-5S= anterior. aspect. 5T-5U- fullface mass (most medial aspect). 5V- breast parenchyma directly medial of mass. 5W-5Y fibrocystic tissue adjacent to the mass. 5Z-5AA- posterior inked margin closest to mass. 5AB- anterior inked margin closest to mass. 5AC- lower outer quadrant. 5AD- lower inner quadrant. 5AE- upper inner quadrant. 5AF-upper outer quadrant. Block 1-left breast tumor infiltrating lobular carcinoma. Block 2-left breast normal fibrocystic changes. Upper outer quadrant- green. Lower outer quadrant- red. Upper inner quadrant- black. Lower inner quadrant- blue. Anterior- orange. Cold ischemic time: 28 minutes. Formalin exposure time: 12 hours 30 minutes. MICROSCOPIC DESCRIPTION. Microscopic examination substantiates the above diagnosis. The results of immunohistochemical staining are as follows for Part 1, 2, 3, and 4: Antibody/Antigen. AE1-AE3. Positive in the metastatic tumor cells in parts1, 2 & 3, negative in 4. The results of immunohistochemical staining are as follows for Part 5: Antibody/Antigen. E-Cadherin. Negative. P120. Positive cytoplasmic expression in lobular cells. D240. Highlights lymphatic spaces; no tumor cells within lymphatic. spaces. CD31. Highlights vascular c spaces; no tumor cells within vascular. spaces. Utilizing formalin-fixed (8-96 hour range), paraffin embedded tissue, immunohistology is. performed with the following selected antibodies and designated antibody clone(s), directed. against the following antigenic target(s), with adequate positive and negative internal and. external controls. Antibodies are optimized appropriate for fixation times. ANTIBODY. CLONE. TARGET ANTIGEN. VENDOR. AE1/AE3. AE1/AE3. carcinomas. e-cadherin. 36. Lobular Differentiation. p120. 98. Lobular Differentiation. D2-D2-40. D2-40. Lymphatic Endothelium. CD 31. JC70. endothelium. INTRAOPERATIVE DIAGNOSIS. 1TP: LYMPH NODE, LEFT AXILLA, SENTINEL NODE BIOPSY #1,. NOT BLUE (touch. preparation)-. A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. LYMPH NODE. 2TP: LYMPH NODE, LEFT AXILLA, SENTINEL NODE BIOPSY #2,. NOT BLUE (touch. preparation)-. A. SUFFICIENT FOR ANCILLARY STUDIES. B. BENIGN. C. LYMPH NODE. 3FS/TP: LYMPH NODE, LEFT AXILLA, SENTINEL NODE BIOPSY #3,. NOT BLUE. (frozen section and touch preparation)-. A. SUFFICIENT FOR ANCILLARY STUDIES. B. DEFER. C. LYMPH NODE WITH ATYPICAL CELLS.",T3,N1,M0,T3N1M0
TCGA-IR-A3LI,"Specimens Submitted: 1: SP: Right adnexal mass (f=) (. 2: SP: Left adnexal mass I. 3: SP: Cul-de-sac metastases. 4: SP: Posterior peritonectomy. 5: SP: Uterus, cervix, partial parametria I. 6: SP: Bladder peritoneum. 7: SP: Left external iliac lymph node. 8: SP: Left hypogastric lymph nodes (. 9: SP: Left parametrial lymph nodes (. 10: SP: Left obturator lymph nodes. 11: SP: Left common iliac lymph nodes. 12: SP: Right external iliac lymph nodes I. 13: SP: Distal right external iliac 1ymph node. 14: SP: Right hypogastric lymph nod=. 15: SP: Right obturator lymph node. 16: SP: Right para-aortic lymph node. 17: SP: Left para-aortic lymph node. 18: SP: Omentectomy. DIAGNOSIS: 1). ADNEXA, RIGHT, MASS; EXCISION: - METASTATIC ADENOCARCINOMA. 2). ADNEXA, LEFT, MASS; EXCISION: - METASTATIC ADENOCARCINOMA. 3). SOFT TISSUE, CUL-DE-SAC; BIOPSY: - METASTATIC ADENOCARCINOMA. 4). PERITONEUM, POSTERIOR; BIOPSY: REACTIVE PAPILLARY MESOTHELIAL PROLIFERATION. 5). UTERUS, CERVIX; HYSTERECTOMY: INVASIVE ADENOCARCINOMA OF UTERINE CERVIX, MODERATELY DIFFERENTIATED. THE MAXIMAL THICKNESS OF THE CERVICAL STROMAL INVASION IS 12 MM. - THE THICKNESS OF THE CERVIX IN THE AREA OF MAXIMAL TUMOR INVASION IS. 12 MM. - NO EVIDENCE OF TUMOR MULTICENTRICITY IS IDENTIFIED. - VASCULAR INVASION IS PRESENT. - NO VAGINAL EXTENSION IS IDENTIFIED. - THE TUMOR EXTENDS INTO THE LOWER UTERINE SEGMENT (MUCOSA AND STROMA) . - THE RIGHT AND LEFT PARACERVICAL SOFT TISSUE MARGINS ARE INVOLVED BY. TUMOR. - THE ENDOMETRIUM IS INACTIVE. - THE MYOMETRIUM SHOWS LEIOMYOMATA. NOTE: ER, PR VIMENTIN, P16 AND M-CEA IMMUNOHISTOCHEMICAL STAINS WERE. PERFORMED ON REPRESENTATIVE SECTIONS OF TUMOR FROM THE ADNEXAL MASS, CERVIX. AND LOWER UTERINE SEGMENT. THE RESULTS ARE GENERALLY CONCORDANT AND. SUPPPORT AN ENDOCERVICAL PRIMARY. P16 AND M-CEA ARE POSITIVE WHILE PR AND. VIMENTIN ARE NEGATIVE. SECTIONS FROM THE CERVIX AND LOWER UTERINE SEGMENT. SHOW FOCAL ER EXPRESSION. 6). BLADDER, PERITONEUM; BIOPSY: - BENIGN FIBROADIPOSE TISSUE. 7). LYMPH NODE, LEFT EXTERNAL ILIAC; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 8). LYMPH NODE, LEFT HYPOGASTRIC; EXCISION: - FIVE BENIGN LYMPH NODES (0/5). 9). LYMPH NODE, LEFT PARAMETRIAL; EXCISION: - BENIGN FIBROADIPOSE TISSUE. 10). LYMPH NODE, LEFT OBTURATOR; EXCISION: METASTATIC ADENOCARCINOMA TO ONE OF SIX LYMPH NODES (1/6). NOTE: MIB-1 AND P16 IMMUNOSTAINS SUPPORT THE DIAGNOSIS. 11). LYMPH NODE, LEFT COMMON ILIAC; EXCISION: - BENIGN FIBROADIPOSE TISSUE. 12). LYMPH NODE, RIGHT EXTERNAL ILIAC; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 13). LYMPH NODE, RIGHT DISTAL EXTERNAL ILIAC; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 14). LYMPH NODE, RIGHT HYPOGASTRIC; EXCISION: - TWO BENIGN LYMPH NODES (0/2). 15). LYMPH NODE, RIGHT OBTURATOR; EXCISION: - THREE BENIGN LYMPH NODES (0/3). 16). LYMPH NODE, RIGHT PARA-AORTIC; EXCISION: - TWO BENIGN LYMPH NODES (0/2). 17). LYMPH NODES, LEFT PARA-AORTIC; EXCISION: - FOUR BENIGN LYMPH NODES (0/4) . 18). OMENTUM; OMENTECTOMY: - BENIGN FIBROFATTY TISSUE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT.",T2,N1,M1,T2N1M1
TCGA-GM-A5PV,"DIAGNOSIS. (A) RIGHT BREAST, TOTAL MASTECTOMY: INVASIVE LOBULAR CARCINOMA, INTERMEDIATE GRADE. (SEE COMMENT). LOBULAR CARCINOMA IN SITU (LCIS), LOW AND INTERMEDIATE NUCLEAR GRADES. INVASIVE CARCINOMA MEASURES 3.0 X 1.1 CM IN CONTIGUOUS SECTIONS/SLICES. INVASIVE CARCINOMA IS PRESENT AT LEAST 1.0 CM FROM MARGINS. No lymphovascular invasion identified. Microcalcifications present in association with benign breast tissue. NIPPLE, LCIS/ATYPICAL LOBULAR HYPERPLASIA. (B) RIGHT AXILLARY SENTINEL LYMPH NODE #1, EXCISIONAL BIOPSY: METASTATIC CARCINOMA PRESENT IN ONE OF ONE LYMPH NODE (1/1). METASTATIC FOCUS MEASURES AT LEAST 1.05 CM. No definite extracapsular extension identified.. (C) RIGHT AXILLARY POSSIBLE SENTINEL LYMPH NODE #2, EXCISIONAL BIOPSY: Fibroadipose tissue, no tumor present. No lymphoid cells identified. (D) LEFT BREAST, TOTAL MASTECTOMY: Fibrocystic changes including focal florid ductal hyperplasia (usual type), cysts. Microcalcifications present in association with benign breast tissue and blood vessel wall. Nipple, no tumor present. (E) RIGHT AXILLARY POSSIBLE SENTINEL LEVEL I, EXCISIONAL BIOPSY: Fibroadipose tissue, no tumor present. (F) RIGHT AXILLA, ADDITIONAL LEVEL II LYMPH NODE, EXCISION: Two lymph node, no tumor present (0/2). (G) RIGHT AXILLA, ADDITIONAL LEVEL I LYMPH NODE, EXCISION: Three lymph node, no tumor present (0/3). (H) RIGHT AXILLARY CONTENTS, AXILLARY DISSECTION: Thirteen lymph nodes, no tumor present (0/13). (I). RIGHT AXILLA, ADDITIONAL LEVEL I LYMPH NODE #2, EXCISIONAL BIOPSY: Three lymph node, no tumor present (0/3). COMMENT. Immunohistochemical stain for E-cadherin is negative, consistent with the diagnosis. GROSS DESCRIPTION. (A) RIGHT BREAST, SHORT SUPERIOR, LONG LATERAL - A 24.0 x 23.5 x 5.5 cm mastectomy specimen that is oriented by. the surgeon with a short stitch designating superior and a long stitch designating lateral. The specimen is partly surfaced by a 22.5. x 13.0 cm ellipse of pale tan wrinkled skin. Located on the surface of the skin is a 1.3 cm everted nipple surrounded by a 4.5 cm. rim of areola, respectively. The specimen is serially sectioned from lateral to medial into thirteen slices. The nipple is located in. slices 7 and 8. In the upper portion of slices 5 through 9, a 5.0 x 2.7 x 2.0 cm gray-white, firm tumor mass with calcifications and. surrounding fibrosis that grossly comes to within 1.2 cm from the skin, 4.5 cm from the deep margin, 4.0 cm from the superior. margin, and 7.0 cm from the inferior margin. There is a metal biopsy clip located in the mass in slice 8. Located in slices 6 and 7. at the 6 o'clock position, there is a 3.8 x 1.8 X 0.6 cm gray-white firm fibrous area with calcifications, marked by the radiologist. This fibrous area grossly comes to within 0.5 cm from the deep margin and 0.8 cm from the inferior margin. Remaining cut. surfaces. are. 85%. yellow glistening adipose tissue and 15% gray-white fibrous tissue. Some tissue has been given to tumor bank. for research purposes. IOA/DX; MARGINS ARE FREE. INK CODE: Blue - superior; orange - inferior; black - deep. SECTION CODE: A1-A3, nipple from slices 7 and 8; A4-A6, mass and calcifications from 10-1 o'clock position from slice. 5; A7, representative sections from slice 4, adjacent to mass; A8, mass and calcifications from slice 6; A9, 6 o'clock marked area. from. slice. 6;. A10, 6 o'clock marked area to inferior margin from slice 6; A11, 6 o'clock marked area to deep margin from slice 6;. A12, mass and calcifications at 10-1 o'clock position from slice 7; A13-A15, 6 o'clock abnormal enhancement from slice 7; A16,. representative sections subjacent to nipple and adjacent to mass from slice 8; A17, A18, mass in area of clip and its mirror image. from. slice 8; A19, mass from slice 8; A20, representative section of tissue adjacent to mass from slice 8; A21, superior margin. from slice 8; A22, representative section from slice 8, adjacent to 6 o'clock abnormal enhancement; A23, mass at position from. slice 9; A24, representative section from slice 10, adjacent to mass position; A25, representative section from slice 5, adjacent to. 6 o'clock abnormal enhancement; A26, lower inner quadrant from slice 11. (B) RIGHT AXILLA, SENTINEL LYMPH NODE #1, BLUE, IN VIVO 4, EX VIVO 36 - A 3.5 x 2.4 x 1.0 cm lymph node submitted. entirely. FS/DX: ONE NODE, METASTATIC CARCINOMA. SECTION CODE: B1-B5, one possible lymph node serially sectioned for frozen section diagnosis. (C) RIGHT AXILLA, SENTINEL LYMPH NODE #2, BLUE, IN VIVO 0, EX VIVO 0 - A 0.8 x 0.3 x 0.1 cm possible lymph. node. submitted entirely. /DX: DEFER TO PERMANENT. SECTION CODE: C, one possible lymph node bisected for frozen section diagnosis. (D) LEFT BREAST, SHORT SUPERIOR, LONG LATERAL - A 24.0 x 23.5 x 6.0 cm mastectomy specimen that is oriented by the. surgeon. with. a. short stitch designating superior and a long stitch designating lateral. The specimen is partly surfaced by a 20.0 x. 17.0 cm ellipse of pale tan wrinkled skin. Located on the surface of the skin is an everted nipple surrounded by a rim of areola. that. measure. 1.2 and 5.5 cm in diameter, respectively. The specimen is serially sectioned from medial to lateral into twelve slices. The nipple is located in slice 7. Cut surfaces are composed of 75% yellow glistening adipose tissue and 25% dense gray-white. fibrous tissue. A definite mass is not grossly identified. Some normal tissue has been given to tumor bank for research purposes. INK CODE: Blue - superior; orange - inferior; black - deep. SECTION CODE: D1, D2, nipple from slice 7; D3, upper inner quadrant from slice 3; D4, upper inner quadrant from slice. 5;. D5, lower inner quadrant, including inferior margin from slice 4; D6, lower inner quadrant, including deep margin from slice 6;. D7, upper outer quadrant from slice 7; D8, upper outer quadrant including superior margin from slice 9; D9, lower outer quadrant. from slice 8; D10, lower outer quadrant from slice 10. (E). RIGHT AXILLA, LEVEL I LYMPH NODE - Consists of a single nodular tissue with blue dye (0.7 cm). The specimen is. submitted entirely in E. (F) RIGHT AXILLA, ADDITIONAL LEVEL II LYMPH NODE - Consists of a single fragment of yellow-red fibroadipose tissue (6.5. x. 4. x. 1.3 cm). Dissection reveals two possible lymph nodes (0.6 cm and 3.4 cm in greatest dimension). Both lymph nodes are. submitted entirely. SECTION CODE: F1, one possible lymph node; F2-F5, one possible lymph node, serially sectioned. (G). ADDITIONAL LEVEL I LYMPH NODE, RIGHT AXILLA - Consists of a single fragment of yellow-red fibroadipose tissue (6 x 3. cm). Dissection reveals three possible lymph nodes, ranging in size from 0.2 to 2.2 cm in greatest dimension. All possible lymph. nodes are entirely submitted. SECTION CODE: G1, one possible lymph node; G2, one possible lymph node; G3, G4, one possible lymph node,. sectioned. (H). RIGHT. AXILLARY CONTENTS - Consists of a single fragment of bright yellow fibroadipose tissue (9 x 3 x 3 cm). Dissection. reveals thirteen possible lymph nodes, ranging in size from 0.1 cm to 3 cm in greatest dimension. All possible lymph nodes are. entirely submitted. SECTION CODE: H1, five possible lymph nodes; H2, three possible lymph nodes; H3, two possible lymph nodes; H4,. two possible lymph nodes; H5-H7, one possible lymph node, sectioned. (I) ADDITIONAL LEVEL I LYMPH NODE #2, RIGHT AXILLA - Consists of multiple fragments of yellow-tan fibroadipose tissue. aggregating. to. 5. x 5 x 1.5 cm. Dissection reveals three possible lymph nodes ranging in size from 1 cm to 1.2 cm in greatest. dimension. All possible lymph nodes are entirely submitted. SECTION CODE: I1, two possible lymph nodes; 12, one possible lymph node, bisected. CLINICAL HISTORY. Breast cancer. SNOMED CODES. T-04050, M-Y2003. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". END OF REPORT-.",T2,N1,M0,T2N1M0
TCGA-LT-A8JT,"Pathology #: Med. Record. No.: Date of Birth: F. Date Received: Submitted by: Report also to: DIAGNOSIS: SPECIMEN. Urinary bladder, cystectomy. TUMOR. Histologic type: Urothelial (transitional cell) carcinoma. Histologic grade: High grade. Tumor size (greatest dimension): 2.2cm. Tumor configuration: Papillary. Tumor location: right and left walls. Extent of invasion: Invasion into muscularis propria (detrusor muscle). (inner half). Direct invasion of other organs/structures: None identified. Venous/lymphatic invasion: Absent. Associated epithelial lesions: None identified. MARGINS. All margins negative for malignancy. Nearest margin: Perivesical soft tissue margin. Distance to nearest margin: 5cm. Comment: Right and left ureter margins (specimens A and B) are benign. LYMPH NODES. All sampled lymph nodes are benign. Total number of nodes evaluated: 38. Comment: Lymph node dissections include: C - right obturator (5 benign nodes). D - right paracaval (1 benign node). E - right common iliac (adipose only, no lymphoid tissue). F - left external iliac (8 benign nodes). G - left obturator (7 benign nodes). H - right external iliac (3 benign nodes). I - left common iliac (3 benign nodes). J - left para-aortic (2 benign nodes). K - perivesical (5 benign nodes). L - sacral (4 benign nodes). STAGING (AJCC). Primary Tumor: pT2a. Lymph Nodes: pNO. Distant Metastasis: Cannot be assessed. CLINICAL INFORMATION: Bladder cancer. SPECIMEN(S) RECEIVED: A. Right distal ureter. B. Left distal ureter. C. Right obturator. D. Right paracaval. E. Right common iliac. F. Left external iliac. G. Left obturator. H. Right external iliac lymph nodes. I. Left common iliac. J. Left para-aortic. K. Bladder. L. Sacral nodes. GROSS DESCRIPTION: A. Received fresh is a segment of ureter measuring 8 mm in diameter x 5 mm in thickness. Entirely submitted for. frozen section. The frozen section remnant is submitted for permanent sections in A1. FROZEN SECTION DIAGNOSIS: Benign ureter margin. Reported to. intraoperatively at. B. Received fresh is a segment of ureter measuring 8 mm in diameter x 5 mm in length. Entirely submitted for. frozen section. The frozen section remnant is submitted for permanent sections in B1. FROZEN SECTION DIAGNOSIS: Benign ureter margin. Reported to. intraoperatively at. y. C. Received in formalin is an 8.0 x 4.2 x 2.0 cm irregular piece of adipose tissue containing multiple partially. fat-replaced lymph nodes ranging from several millimeters up to 4.8 x 2.0 x 1.2 cm. Sections: C1 - multiple small. nodes, intact; C2 - one lymph node; C3-C8 - one lymph node. D. Received in formalin is a 4.5 x 2.0 x 0.9 cm piece of adipose tissue containing a single 3.0 x 1.0 x 0.6 cm lymph. node. The node is sectioned and entirely submitted in D1 and D2. E. Received in formalin is a 2.5 x 2.5 x 0.9 cm aggregate of adipose tissue containing several prominent vessels. No distinct lymph nodes are identified. Entirely submitted in E1 and E2. F. Received in formalin is a 4.5 x 4.0 x 1.5 cm aggregate of adipose tissue containing multiple lymph nodes. ranging from several millimeters up to 2.2 x 1.4 x 0.8 cm. Sections: F1 - two smallest nodes, intact; F2 - one. lymph node; F3 - one lymph node; F4 - one lymph node; F5 - one lymph node; F6 - one lymph node; F7 - one. lymph node. G. Received in formalin is a 5.0 x 3.5 x 1.5 cm aggregate of adipose tissue containing multiple lymph nodes. ranging from several millimeters up to 4.3 x 1.5 x 0.7 cm. Sections: G1,G2 - smallest nodes, intact; G3-G5 -. largest lymph node. H. Received in formalin is a 3.7 x 3.0 x 0.9 cm aggregate of adipose tissue containing several small lymph nodes. measuring up to 0.7 x 0.6 x 0.4 cm. All nodular tissue is submitted in H1. I. Received in formalin is a 3.5 x 3.3 x 1.0 cm aggregate of adipose tissue containing several lymph nodes ranging. from 0.7 x 0.5 x 0.2 cm up to 1.3 x 1.2 x 0.8 cm. Sections: I1 - smallest nodes, intact; 12 - one lymph node,. bisected. J. Received in formalin is a 2.5 x 2.2 x 0.5 cm aggregate of adipose tissue containing two probable lymph nodes. measuring 0.3 x 0.2 x 0.2 cm and 0.9 x 0.8 x 0.3 cm. Submitted intact in J1. K. Received fresh is a radical cystectomy specimen with 10.0 x 6.5 x 5.2 cm bladder surrounded by perivesical. adipose tissue ranging from 0.7 to 3.2 cm in thickness. The urethra measures 5.0 cm in length x 1.7 cm in. diameter. Overlying the posterior surface of the urethra is a strip of vaginal mucosa measuring 8.0 cm in length x. 3.5 cm in width. The opened bladder displays a 4.0 x 2.5 cm ulcer on the right side. Multifocal residual papillary. tumor is noted adjacent to the ulcer. Sections reveal fibrosis and hemorrhage of the bowel wall with no. macroscopic tumor invasion. On the left anterior surface, in the region of the trigone, is a 2.2 x 2.2 x 1.1 cm. circumscribed, papillary mass with only superficial invasion into the mucosa. On the posterior surface is a 0.7 x. 0.7x 0.1 cm small red papillary focus. The remaining bladder mucosa is faintly bosselated and pink. Sectioning. through the perivesical adipose tissue reveals 4 probable lymph nodes. Tumor and normal tissue are obtained for. the (. per protocol. Sections: K1 - right posterior bladder; K2 - right lateral; K3 - right. anterior; K4 - mid anterior; K5, K6 - papillary mass, left anterior; K7 - small papillary lesion, posterior; K8 - bladder. dome; K9, K10 - right and left urethral margin and K11 - lymph nodes. A mapping diagram is utilized. L. Received in formalin is a 2.5 x 1.7 x 0.9 cm aggregate of adipose tissue containing several 0.2 to 0.6 cm lymph. nodes. All nodular tissue is submitted in L1. Slides were microscopically examined by the pathologist. Evaluation performed by.",T2,N0,M0,T2N0M0
TCGA-ZF-AA4V,"Histopathology Histopathology. Specimen Comments. SPECIMEN. 1. Right external iliac node anterior. 2. Right external iliac node common. 3. Right external iliac node posterior. 4. Right internal iliac. 5. Right obturator. 6. Left external iliac anterior. 7. Left external iliac posterior. 8. Left obturator node. 9. Left common iliac. 10. Left ureteric margin. 11. Right ureteric margin. 12. Cystectomy + lymphadenectomy. CLINICAL DETAILS. Radical cystectomy for invasive bladder cancer + lymphadenectomy. G3 T2 at. MACROSCOPY. 1. Fatty tissue measuring 45x30x5 mm. No lymph node identified. 2. Fatty tissue measuring 100x20x20 mm. 3. Fatty tissue measuring 30x25x15 mm. 4. Fatty tissue measuring 40x35x25 mm. 5. Fatty tissue measuring 65x35x20 mm. 6. Fatty tissue measuring 50x25x15 mm. 7. Fatty tissue measuring 80x20x15 mm. 8. Fatty tissue measuring 70x30x20 mm. 9. Fatty tissue measuring 35x25x20 mm. 10. Tissue measuring 9 mm max. 11. Tissue measuring up to 10 mm. 12. Specimen overall measures 115 mm superior-inferior X 120 mm medial-lateral. X 55 mm anterior-posterior. Bladder measures 95 mm superior-inferior x 60 mm. medial-lateral x 50 mm anterior-posterior. Prostate measures up to 45 mm. At. the dome of the bladder on the anterior surface, there is a solid exophytic mass. measuring 45 mm in dimension and up to 20 mm in depth. MICROSCOPY. 1. Right external iliac anterior - no lymph nodes identified. 2. Right external iliac common - two lymph nodes identified, showing no. evidence of metastasis. 3. Right external iliac posterior - three lymph nodes identified, showing no. evidence of metastasis. 4. Right internal iliac - two lymph nodes identified, showing no evidence of. metastasis. 5. Right obturator - three lymph nodes identified, showing no evidence of. metastasis. 6. Left external iliac anterior - two lymph nodes identified, showing no. evidence of metastasis. 7. Left external iliac posterior - three lymph nodes identified, showing no. evidence of metastasis. 8. Left obturator node - three lymph nodes identified, showing no evidence of. metastasis. 9. Left common iliac - 2 lymph nodes identified, showing no evidence of. metastasis. 10&11. Left and right ureteric margins are normal, with no evidence of. dysplasia or malignancy. 12. Sections show a poorly differentiated, grade 3 transitional cell carcinoma. of the bladder. It invades the entire depth of the muscularis propria and. infiltrates perivesical fat. It has a 'pushing' rather than infiltrative growth. pattern, with a moderate lymphocytic response. The circumferential and urethral. margins are clear. Adjacent urothelium shows no evidence of dysplasia. Representative sections of prostate show no significant abnormality. SUMMARY. Transitional cell carcinoma of the bladder G3 pT3 pNO pMx. Pathologists -.",T3,N0,M0,T3N0M0
TCGA-GF-A2C7,"Final Pathologic Diagnosis: A. Skin, upper back, punch biopsy: Combined nevus (intradermal nevus and blue nevus). B. Skin and subcutaneous soft tissue, scalp, vertex, excision: Nodular ulcerative basal cell carcinoma. Margins are negative for malignancy, however the tumor is less than 1 mm. from the right inferior margin. C. Lymph node, left posterior triangle, excision: 2 lymph nodes negative for malignancy (0/2). D. Lymph node, sentinel, excision: Benign fibroadipose tissue. No lymph node present. E. Skin and subcutaneous soft tissue, scalp, wide excision: Malignant melanoma, see below. Procedure. Wide excision. Site. Scalp. Laterality. Posterior. Type. Nodular. Thickness. 7 mm. Level. Clark's level IV. Ulceration. Present. Mitosis/mm2. 2/mm2. Microsatellitosis. Not identified. Lymphovascular invasion. Not identified. Regression. Not identified. Perineural invasion. Not identified. Tumor infiltrating lymphocytes. Sparse. Satellite nodule (gross finding). Not identified. Margin status. Margins free. Excisions, margin free, distance from margin. 7 mm from closest margin. (deep margin). Sentinel node, number of lymph nodes. none. Non-sentinel lymph nodes. 2 (see part C). Number of positive lymph nodes. 0. Extracapsular spread. n/a. Size of largest metastatic focus. n/a. Location of tumor (subcapsular sinus, parenchyma). n/a. pT4b, NO, MX. The examination of this case material and the preparation of this report were. Gross Description: The specimens are received in five containers labeled with the patient name. Part A is received in formalin labeled ""upper back biopsy"" and consists of a. punch biopsy that is 4 mm. The specimen is inked, bisected and submitted in. cassette A. B is received in formalin labeled ""vortex scalp, short suture is left margin,. long suture is superior margin"" and consists of a ovoid skin excision 2.7 X 2.1. cm excised to a depth of 0.7 cm. There are two sutures present, the short. suture designated left and the long suture superior. The long suture will now. be designated 12 o'clock and the short suture 9 o'clock. The specimen is inked. as follows: 9 to 12 to 3 black, 3 to 6 to 9 blue. The 9 o'clock edge is. submitted in cassette B1, the 3 o'clock edge in cassette B2, the remaining. specimen is submitted sequentially from 9 to 3 o'clock in cassettes B3 through. B7. Part C is labeled ""left posterior triangle node"" and consists of a single. pink-tan possible lymph node 1.8 X 1.2 X 0.7 cm. The specimen is sectioned and. entirely submitted in cassette C1 and C2. D is labeled ""possible sentinel node left posterior ear"" and consists of a. yellow-tan possible lymph node 1.5 X 1.1 X 1 cm. The specimen is sectioned and. entirely submitted in cassette D1 through D3. Four unstained slides requested. on cassettes D1 and D2. Part E is received fresh for Tissue Procurement subsequently placed In formalin. labeled ""scalp melanoma, short suture superior, long suture left lateral"" and. consists of a roughly ovoid skin excision 7 X 6.2 cm excised to the depth of 1.1. cm. There are two sutures present, the short designated superior and the long. left lateral. The short suture will now be designated 12 o'clock and the long. suture 9 o'clock. The surface of the skin is remarkable for a pink-tan to. gray-tan exophytic lesion 2.5 X 1.7 X 0.8 cm. The remaining skin is remarkable. for blue surgical dye. The specimen is inked as follows: 9 to 12 to 3 black,. 3 to 6 to 9 blue. The specimen is sectioned and entirely submitted as follows: E1. 9 o'clock edge;. E2,3. full-thickness cross-sections;. E4,5. one contiguous cross-section bisected;. E6,7. one contiguous cross-section bisected;. E8,9. one contiguous cross-section bisected;. E10,11. one contiguous cross-section bisected;. E12,13. one contiguous cross-section bisected;. E14-16. one contiguous cross-section trisected;. E17-19. one contiguous cross-section trisected;. E20-22. one contiguous cross-section trisected;. E23,24. one contiguous cross-section bisected;. E25,26. one contiguous cross-section bisected;. E27,28. one contiguous cross-section bisected;. E29,30. one contiguous cross-section bisected;. E31,32. one contiguous cross-section bisected;. E33,34. one contiguous cross-section bisected;. E35,36. 3 o'clock edge bisected. Final Pathologic Diagnosis: A. Skin, upper back, punch biopsy: Combined nevus (intradermal nevus and blue nevus). B. Skin and subcutaneous soft tissue, scalp, vertex, excision: Nodular ulcerative basal cell carcinoma. Margins are negative for malignancy, however the tumor is less than 1 mm. from the right inferior margin. C. Lymph node, left posterior triangle, excision: 2 lymph nodes negative for malignancy (0/2). D. Lymph node, sentinel, excision: Benign fibroadipose tissue. No lymph node present. E. Skin and subcutaneous soft tissue, scalp, wide excision: Malignant melanoma, see below. Procedure. Wide excision. Site. Scalp. Laterality. Posterior. Type. Nodular. Thickness. 7 mm. Level. Clark' S level IV. Ulceration. Present. Mitosis/mm2. 2/mm2. Microsatellitosis. Not identified. Lymphovascular invasion. Not identified. Regression. Not identified. Perineural invasion. Not identified. Tumor infiltrating lymphocytes. Sparse. Satellite nodule (gross finding). Not identified. Margin status. Margins free. Excisions, margin free, distance from margin. 7 mm from closest margin. (deep margin). Sentinel node, number of lymph nodes. none. Non-sentinel lymph nodes. 2 (see part C). Number of positive lymph nodes. 0. Extracapsular spread. n/a. Size of largest metastatic focus. n/a. Location of tumor (subcapsular sinus, parenchyma). n/a. pT4b, NO, MX. The examination of this case material and the preparation of this report were. Gross Description: The specimens are received in five containers labeled with the patient name. Part A is received in formalin labeled ""upper back biopsy"" and consists of a. punch biopsy that is 4 mm. The specimen is inked, bisected and submitted in. cassette A. B is received in formalin labeled ""vortex scalp, short suture is left margin,. long suture is superior margin"" and consists of a ovoid skin excision 2.7 X 2.1. cm excised to a depth of 0.7 cm. There are two sutures present, the short. suture designated left and the long suture superior. The long suture will now. be designated 12 o'clock and the short suture 9 o'clock. The specimen is inked. as follows: 9 to 12 to 3 black, 3 to 6 to 9 blue. The 9 o'clock edge is. submitted in cassette B1, the 3 o'clock edge in cassette B2, the remaining. specimen is submitted sequentially from 9 to 3 o'clock in cassettes B3 through. B7. Part C is labeled ""left posterior triangle node"" and consists of a single. pink-tan possible lymph node 1.8 X 1.2 X 0.7 cm. The specimen is sectioned and. entirely submitted in cassette C1 and C2. D is labeled ""possible sentinel node left posterior ear"" and consists of a. yellow-tan possible lymph node 1.5 X 1.1 X 1 cm. The specimen is sectioned and. entirely submitted in cassette D1 through D3. Four unstained slides requested. on cassettes D1 and D2. Part E is received fresh for Tissue Procurement subsequently placed In formalin. labeled ""scalp melanoma, short suture superior, long suture left lateral"" and. consists of a roughly ovoid skin excision 7 X 6.2 cm excised to the depth of 1.1. cm. There are two sutures present, the short designated superior and the long. left lateral. The short suture will now be designated 12 o'clock and the long. suture 9 o'clock. The surface of the skin is remarkable for a pink-tan to. gray-tan exophytic lesion 2.5 X 1.7 X 0.8 cm. The remaining skin is remarkable. for blue surgical dye. The specimen is inked as follows: 9 to 12 to 3 black,. 3. to 6 to 9 blue. The specimen is sectioned and entirely submitted as follows: E1. 9 o'clock edge;. E2,3. full-thickness cross-sections;. E4,5. one contiguous cross-section bisected;. E6,7. one contiguous cross-section bisected;. E8,9. one contiguous cross-section bisected;. E10,11. one contiguous cross-section bisected;. E12,13. one contiguous cross-section bisected;. E14-16. one contiguous cross-section trisected;. E17-19. one contiguous cross-section trisected;. E20-22. one contiguous cross-section trisected;. E23,24. one contiguous cross-section bisected;. E25,26. one contiguous cross-section bisected;. E27,28. one contiguous cross-section bisected;. E29,30. one contiguous cross-section bisected;. E31,32. one contiguous cross-section bisected;. E33,34. one contiguous cross-section bisected;. E35,36. 3 o'clock edge bisected. Taken:'.",T4,N0,M0,T4N0M0
TCGA-WC-A880,"DIAGNOSIS. (A) RIGHT GLOBE, ENUCLEATION: CHOROIDAL MELANOMA, PREDOMINATELY EPITHELIOID TYPE, 20 MM BASE. FOCAL CHOROIDAL INVASION PRESENT. TUMOR SURROUNDS OPTIC NERVE. Extraocular extension is not identified. Vortex veins negative for tumor. COMMENT. The tumor erodes Bruch's membrane. Mitoses are 2 per 10 high power fields. PAS highlights internal structures and vascu. GROSS DESCRIPTION. (A) RIGHT GLOBE - An intact right globe (23 X 22 X 22 mm), has an attached optic nerve (9 mm in length). The anterior ch. is clear formed by a 12 x 11 gray iris with round 8 mm pupil. A shadow is present in the posterior aspect in a curvilinear fash. beginning 6.0 mm from the limbus. The shadow corresponds to a brown tumor, with a base of 20 mm by a 9 mm height tha. surrounds the optic disc which is not visualized. The sclera beneath the tumor is grossly intact. The vitreous is clear and a. !. lens is in place. Tumor harvest is performed. SECTION CODE: A1-A4, vortex veins (superior temporai, superior nasal, inferior nasal, inferior temporal); A5, pup. nerve section; A6-A7 calottes also with tumor; A8 optic nerve including margin en face. CLINICAL HISTORY. Uveal melanoma. SNOMED CODES. T-AA000, M-87203. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have no. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: END OF REPORT-. mor. Oucrepancy. and / C. tiel.",T4,N0,M0,T4N0M0
TCGA-R2-A69V,"Specimen Number: Date of Birth: Patient location: SURGIGA) PATHOLOG. ADDENDUM REPORT. The cervical lesion is an unusual one since it is predominantly exophytic with some thinning of the. underlying normal cervix. The 0.5 cm is the exocervical resection margin from the tumor. The invasion is. one-third or less of the thickness of the cervix. The case was discussed with. on. ADDENDUM DIAGNOSIS: UTERUS, HYSTERECTOMY. CERVIX. Invasive moderately to poorly differentiated nonkeratinizing squamous cell carcinoma. invading into the endocervix. 5.2 cm in greatest dimension. pT1b2, pNo, Invasion into the cervical stroma of less than one-third of the cervical thickness. Margins are not involved. Focal lymph-vascular invasion present. (Electronically signed by). Verified: SPECIMEN. A. LYMPH NODE(S) - 1. Right obturator lymph nodes F/S. B. LYMPH NODE(S) - 2. Right external iliac artery lymph nodes. C. LYMPH NODE(S) - 3. Right periaortic lymph nodes F/S. D. LYMPH NODE(S) - 4. Right common iliac artery lymph nodes. E. LYMPH NODE(S) - 5. Left periaortic lymph nodes. F. LYMPH NODE(S) - 6. Left common iliac lymph nodes. G. LYMPH NODE(S) - 7. Left external iliac lymph nodes. H. LYMPH NODE(S) - 8. Left obturator lymph nodes FIS. I. LYMPH NODE(S) - 9. Left obturator lymph nodes. J. UTERUS - 10. Uterus, bilateral tubes, bilateral ovarles, cervix (fresh. CLINICAL INFORMATION. Stage 1B-2 squamous cell carcinoma of the cervix. GROSS DESCRIPTION. The case is received in 10 parts, all labeled with the patient's name. Part A is received in formalin labeled ""right obturator lymph nodes - F/S"" is a 4.5 x 2.5 x 1 cm aggregate. of yellow-tan fibroadipose tissue containing 4 lymph nodes, measuring 3.5 X 1.5 x 0.8 cm, 3 x 1 x 0,7 cm,. 0.9 x 0.6 x 0.4 cm, and 1 x 0.5 x 0.3 cm, respectively. Touch preparations on the two smaller nodes are. performed and part of the largest node and part of the medium node are touch prepped and frozen as. FSA1 and FSA2. The frozen section residuals are submitted in cassettes (A1) and (A2). The remainder. of the nodes are submitted in cassettes (A3) and (A4). Frozen section diagnosis: by. FSA1 - Right obturator node (largest node) - ""Negative."". FSA2 - Right obturator node (medium node) - ""Negative."". Touch prep cytology: FSA3 - Right obturator node (two small ones) - ""Negative on cytology."". Examined by. Part B is received in formalin labeled ""right external illac artery lymph nodes"" and consists of a 3 X 2.5 x. 1.5 cm aggregate of yellow-tan fibroadipose tissue, containing a single 4 x 1 X 0.3 cm serpiginous lymph. node that is bisected and submitted entirely in cassettes (B1) and (B2). Part C is received fresh in the frozen section room labeled ""right peri-aortic lymph nodes (F/S)"" and. consists of a 1,8 x 1.6 x 0.6 cm aggregate of fibroadipose tissue containing 3 lymph nodes, measuring 1.6. cm, 1.2 cm, and 0.8 cm in maximal dimension. Half of the nodes are frozen as FSC1 and touch. preparations are performed. The frozen section residual is submitted in cassette (C1). The remainder of. the nodes are submitted in cassette (C2). Frozen section diagnosis: FSC1 - Right peri-aortic lymph nodes, 3 - ""Negative for carcinoma."". Examined by. Part D is received in formaln labeled ""right common illac artery lymph nodes"" and consists of a 4 x 2.5 x 1. cm aggregate of yellow-tan fibroadipose tissue containing 3 lymph nodes, ranging from 0.8 - 4.5 cm in. greatest dimension. The following sections are submitted: SLIDE KEY. D1 - two lymph nodes (one bisected). D2 - one lymph node. Part E is received in formalin labeled ""left peri-aortic lymph nodes"" and consists of a single 1.7 x 0.9 x 0.5. cm lymph node that is bisected and submitted entirely in cassette (E1). Part F is received in formalin labeled ""left common illac lymph nodes"" and consists of a single 1.6 X 0.7 X. 0.6 cm lymph node that is bisected and submitted entirely in cassette (F1). Part G is received in formalin labeled ""external iliac artery lymph nodes"" and consists of a 4 x 2 x 1 cm. aggregate of yellow-tan fibroadipose tissue containing 2 lymph nodes, ranging from 0.5 - 3 cm in greatest. dimension. The first node is submitted entirely in cassette (G1). The second node is bisected and. submitted in cassette (G2). Part H is received fresh in the frozen section room labeled ""left obturator lymph nodes (F/S)"" and consists. of a 3 x 2.5 x 0.6 cm aggregate of yellow-tan fibroadipose tissue containing 2 lymph nodes, measuring 2 x. 0.7 x 0.6 cm and 1.5 x 0.8 x 0.6 cm, respectively. The nodes are bisected and half are frozen as FSH1. and FSH2 for frozen section interpretation. The frozen section residuals are submitted in cassettes (H1). and (H2). No residual lymph nodes are identified. Frozen section diagnosis: FSH1 and FSH2 - Right obturator lymph nodes, 2 - ""Negative for carcinoma."". Examined by. Part I is received in formalin labeled ""left obturator lymph nodes"" and consists of a 4 x 1 x 0.7 cm. cylindrical lymph node that is sectioned and submitted entirely in cassettes (I1) and (I2). Part J is received in formalin labeled ""uterus, bilateral tubes, ovaries and cervix (Genome fresh)"" is a 203. gm, 10.5 cm from cervix to fundus by 7 cm in width by 5.1 cm from anterior to posterior radical. hysterectomy specimen with a 5.2 x 4.1 x 2 cm tan granular, fungating mass protruding from the cervical. os. The tumor is 8.5 cm from the top of the endometrial cavity. Grossly, the tumor is limited to the cervix. and does not appear to invade into the lower uterine segment. The uterine serosa is purple-tan and. smooth with multifocal thin fibrous adhesions. Adjacent to the fungating mass, the cervical mucosa. is. pink-white, smooth and glistening. The endometrium is red-tan and glistening. There is a 1.1 cm. diameter white whorled nodule within the anterior myometrium. A portion of the tumor is submitted for. SLIDE KEY. J1 - anterior endometrium. J2 - posterior endometrium. J3 - myometrial nodule. J4 - anterior cervix. J5 - posterior cervix. J6-J10 - full-thickness section from cervix to fundus. J11 - anterior paracervical soft tissue. J12 - posterior paracervical soft tissue. J13 - posterior serosa. The 5 gm, 3 x 1.5 x 1.5 cm multicystic right ovary is purple-tan and cerebriform. The cut surface. demonstrates multiple cysts ranging up to 1.5 cm in diameter that are variously filled with clear mucoid. material to hemorrhage. The previously ligated 6.5 cm in length by 0.5 cm in diameter fimbriated fallopian. tube is lined by purple-tan, smooth and glistening serosa. The 4 gm, 3.2 x 1.9 x 1.2 cm pink-tan cerebriform left ovary is multicystic and demonstrates a 1 cm. diameter clear fluid-filled cyst and a 0.7 cm in greatest dimension white corpus albicantia. There is a 6. cm in length by 0.6 cm in diameter previously ligated fimbriated left fallopian tube surfaced by purple-tan,. smooth and glistening serosa. The following additional sections are submitted: SLIDE KEY. J14 - right ovary. J15 - right fallopian tube. J16 - right parametrium. J17 - left ovary. J18 - left fallopian tube. J19 - left parametrium. MICROSCOPIC DESCRIPTION. The frozen section diagnosis is confirmed. Four right obturator lymph nodes are negative for metastatic. carcinoma. One right external iliac artery lymph node is negative for metastatic carcinoma. The frozen section diagnosis is confirmed. Three right periaortic lymph nodes are negative for metastatic. adenocarcinoma. Three right common illac artery lymph nodes are negative for metastatic carcinoma. One left periaortic lymph node is negative for metastatic carcinoma. One left common iliac lymph node is negative for metastatic carcinoma. Two external iliac artery lymph nodes are negative for metastatic carcinoma. The frozen section diagnosis is confirmed. Two left obturator lymph nodes are negative for metastatic. carcinoma. One left obturator lymph node is negative for metastatic carcinoma. Sections from the radical hysterectomy demonstrate a moderately to poorly differentiated nonkeratinizing. invasive squamous cell carcinoma of the cervix that extends into the endocervix. The tumor is exophytic. and is composed of sheets of pleomorphic nuclei with abundant cytoplasm, focal intercellular bridges, and. necrosis. The cervical soft tissue margins and lower uterine segment are uninvolved. Lymphovascular. invasion Is focally identified, slide J4. Sections of the endometrium demonstrate a secretory pattern. A. single submucosal leiomyoma is present. The right ovary demonstrates a hemorrhagic corpus luteum. and various follicular cysts in varying stages of evolution. The right fallopian tube is unremarkable. The. left ovary demonstrates multiple follicular cysts in varying stages of evolution. The left fallopian tube is. unremarkable. The left and right parametrium are uninvolved by squamous cell carcinoma. Surgical Pathology Cancer Case Summary, Cervix. SPECIMEN: Cervix, uterine corpus, right ovary, left ovary, right fallopian tube, left fallopian tube. PROCEDURE: Radical hysterectomy. TUMOR SIZE: 5.2x4.1x2cm. TUMOR SITE: Circumferential, exophytic. HISTOLOGIC TYPE: Squamous cell carcinoma, non-keratinizing. HISTOLOGIC GRADE: G2-G3: Moderately to poorly differentiated. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 0.5 cm from exocervical resection. LYMPH-VASCULAR INVASION: Focally present. PATHOLOGIC STAGING: Primary tumor: pT1b2. Regional lymph nodes: pNO. Number of total lymph nodes examined: 18. Number of lymph nodes involved: 0. ADDITIONAL PATHOLOGIC FINDINGS: Submucosal leiomyoma. FINAL DIAGNOSIS. LYMPH NODES, RIGHT OBTURATOR, EXCISION. Negative for metastatic carcinoma (0/4). LYMPH NODE, RIGHT EXTERNAL ILIAC ARTERY, EXCISION. Negative for metastatic carcinoma (0/1). LYMPH NODES, RIGHT PERIAORTIC, EXCISION. Negative for metastatic carcinoma (0/3). LYMPH NODES, RIGHT COMMON ILIAC ARTERY, EXCISION. Negative for metastatic carcinoma (0/3). LYMPH NODE, LEFT PERIAORTIC, EXCISION. Negative for metastatic carcinoma (0/1). LYMPH NODE, LEFT COMMON ILIAC, EXCISION. Negative for metastatic carcinoma (0/1). LYMPH NODES, EXTERNAL ILIAC ARTERY, EXCISION. Negative for metastatic carcinoma (0/2). LYMPH NODES, LEFT OBTURATOR, EXCISION. Negative for metastatic carcinoma (0/2). LYMPH NODE, LEFT OBTURATOR, EXCISION. Negative for metastatic carcinoma (0/1). UTERUS, HYSTERECTOMY. CERVIX. Invasive moderately to poorly differentiated nonkeratinizng squamous cell carcinoma. invading into the endocervix. 5.2 cm in greatest dimension. pT1b2 pNO. Margins negative. Focal lymph-vascular present. ENDOMETRIUM. Secretory pattern. Not involved by squamous cell carcinoma. MYOMETRIUM. Submucosal leiomyoma. SEROSA. Not involved by squamous cell carcinoma. RIGHT OVARY, OOPHORECTOMY. Benign ovary with hemorrhagic corpus luteum and follicular cysts. FALLOPIAN TUBE, RIGHT, SALPINGECTOMY. Benign with mild luminal dilatation. LEFT OVARY, OOPHORECTOMY. Benign ovary with follicular cysts. FALLOPIAN TUBE, LEFT, SALPINGECTOMY. Benign with mild luminal dilatation. CPT CODES: 88309x1, 88331x3, 88332x2, 88333x1, 88307x5, 88305x4. (Electronically signed by) (Final). Verified:",T1,N0,M0,T1N0M0
TCGA-BR-A4CQ,"Gross Description: Stomach size is 209 cm with entree form tumor 44 cm, colour is white-haired,. compact. ?mentum is yellow and soft. Microscopic Description: 1) Little differential adenocarcinoma pl3. 2)In 2 Lymph nodes-metastases ?? carcinoma. Diagnosis Details: Tumor Features: -1, Tumor Extent: Head of polyp, , Venous Invasion: Absent, Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: STOMACH TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Cardia. Tumor size: 4x0x4cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Serosa (visceral peritoneum). Lymph nodes: 2/3 positive for metastasis (Regional 2/3). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T4,N1,M0,T4N1M0
TCGA-97-A4M3,"gene at 2p23. This probe flanks the entire gene. If a rearrangement. involving ALK is present, inversion or translocation, one of the two. probe signals separates as one red (orange) and one green signal. In. this specimen, separated signals were present in 0.5% of the nuclei. scored. Based on laboratory validation data, these results are. within the normal limits. COMMENTS: Three copies of ALK were observed in 32.0% of cells. This. gain of intact ALK fusion hybridization signals represents an. aneuploid population with extra copies of chromosomes 2/2p ALK. region. Additional copies of ALK are not uncommon in NSCLCs,. although the significance of extra copies of the ALK gene in lung. carcinoma is unclear at this time (Salido M. et al. J Thorac Oncol. 2011;6:21-27). ISCN RESULTS: nuc ish(ALKx3 4) [38/50]. This Vysis ALK Break Apart Probe FISH test (. is FDA. approved for use in the detection of rearrangements involving the. ALK gene via fluorescence in situ hybridization (FISH) in. formalin-fixed paraffin-embedded (FFPE) non-small cell lung cancer. (NSCLC) tissue specimens. Addendum #4 performed by. The electronic signature attests that the named Attending. Pathologist has evaluated the specimen referred to in the signed. section of the report and formulated the diagnosis therein. This report may include one or more immunohistochemical stain. results that use analyte specific reagents. The tests were developed and their performance characteristics. determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is not. necessary. SPECIMENS: 1. F/S APICAL BIOPSY. 2. F/S APICAL SEGMENT OF RIGHT UPPER LOBE. 3. 5TH RIB, RIGHT. 4. RIGHT LEVEL 10 LYMPH NODE. 5. RIGHT LEVEL 4 LYMPH NODE. 6. RIGHT LEVEL 7 LYMPH NODE. SEE ADDENDUM. Reason For Addendum #1: Molecular Studies. Reason For Addendum #2: Molecular Studies. Reason For Addendum #3: Molecular Studies. Reason For Addendum #4: Biomarker Report. DIAGNOSIS: 1. LUNG, RIGHT UPPER LOBE, APEX: BIOPSY. - ADENOCARCINOMA WITH PAPILLARY AND MICROPAPILLARY PATTERNS. 2. LUNG, RIGHT UPPER LOBE, APICAL SEGMENT: SEGMENTECTOMY. - ADENOCARCINOMA, LEPIDIC PREDOMINANT (2.9 CM), SEE NOTE. - THE BRONCHIAL AND VASCULAR MARGINS ARE FREE OF TUMOR. - SUBPLEURAL FIBROELASTOTIC SCAR, CONSISTENT WITH APICAL CAP. Note: The tumor consists of lepidic (40%), acinar (30%), papillary. (20%) and micropapillary (10%) components and measures 2.9 cm in. greatest dimension microscopically. Results of molecular studies. will be reported in addenda. 3. RIB, RIGHT 5TH: EXCISION. - BONE AND BONE MARROW WITH TRILINEAGE HEMATOPOESIS. 4. LYMPH NODE, RIGHT LEVEL 10: BIOPSY. - THREE BENIGN LYMPH NODES (0/3). 5. LYMPH NODE, RIGHT LEVEL 4: BIOPSY. - FOUR BENIGN LYMPH NODES (0/4). 6. LYMPH NODE, RIGHT LEVEL 7: BIOPSY. - FIVE BENIGN LYMPH NODES (0/5). Specimens: 1: F/S APICAL BIOPSY. 2: F/S APICAL SEGMENT OF RIGHT UPPER LOBE. 3: 5TH RIB, RIGHT. 4: RIGHT LEVEL 10 LYMPH NODE. 5: RIGHT LEVEL 4 LYMPH NODE. 6: RIGHT LEVEL 7 LYMPH NODE. LUNG: Resection. SPECIMEN. Specimen: Lobe(s) of lung (specify). right upper. Procedure: Segmentectomy. Specimen Laterality: Right. Tumor Site: Upper lobe. Tumor Focality: Unifocal. TUMOR. Histologic Type: Adenocarcinoma, mixed subtype. Histologic Grade: G1: Well differentiated. EXTENT. Tumor Size: Greatest dimension (cm). 2.9cm. Visceral Pleura Invasion: Not identified. MARGINS. Bronchial Margin. Bronchial Margin Involvement by Invasive Carcinoma: Uninvolved by. invasive carcinoma. Vascular Margin: Uninvolved by invasive carcinoma. ACCESSORY FINDINGS. Lymph-Vascular Invasion: Not identified. STAGE (pTNM). Primary Tumor (pT): pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest. dimension, surrounded by lung or visceral pleura, without. bronchoscopic evidence of invasion more proximal than the lobar. bronchus (i.e., not in the main bronchus). Regional Lymph Nodes (pN). pNO: No regional lymph node metastasis. Distant Metastases (pM): Not applicable. CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS: F ex-smoker (35-40 pack-years) with a LUL adenocarcinoma, a 2.3 cm. RUL mixed solid and ground-glass nodule and multiple additional. bilateral lung nodules. MACROSCOPIC DESCRIPTION: The specimen is received in six parts, each labeled with the. patient's name. 1. Part one is received fresh, labeled 'apical biopsy'. It consists. of one piece of tan-pink soft tissue measuring 0.7 x 0.4 x 0.3 cm. Entirely submitted in one cassette. 2. Part two is received in saline, labeled apical segment of right. upper lobe (stitch on bronchial margin)'. It consists of a 48 grams. segmentectomy specimen measuring 9 x 5.5 x 1.5 cm. The specimen has. a stapled margin which spans the length of the specimen. The. bronchial margin has a suture and it measures 0.5 cm in length. The. specimen is serially sectioned to reveal a tan-yellow nodule. measuring 1.2 x 1 x 0.4 cm. The pleural surface overlying the. nodule is inked black. The stapled line is inked blue. The. remaining lung parenchyma has a tan-red appearance. There is also a. 0.4 cm firm area seen away from the main tumor. Representative. sections submitted. 3. Part three is received in formalin, labeled '5th rib, right : It consists of one segment of rib measuring 1.4 x 1.3 x 0.6 cm. A. representative section is placed in decalcifying solution and then. submitted. 4. Part four is received in saline, labeled right level 10 lymph. node' It consists of multiple pieces of tan soft tissue measuring. 1.1 x 1 x 0.5 cm in aggregate. The specimen is submitted entirely. 5. Part five is received in saline, labeled 'right level 4 lymph. node'. It consists of multiple pieces of yellow fatty tissue. measuring 1.7 x 1.6 x 0.7 cm. Multiple possible lymph nodes are. identified, largest of which measures 0.7 cm in greatest dimension. The specimen is submitted entirely. 6. Part six is received in saline, labeled 'right level 7 lymph node. : It consists of multiple pieces of tan soft tissue measuring 1.2. x 0.7 x 0.5 cm in aggregate . The specimen is submitted entirely. SUMMARY OF SECTIONS: 1A entirely submitted. 2A froze section control, bronchial margin. 2B vascular margin. 2C tumor to pleura. 2D-2E sections of tumor. 2F tumor to stapled blue margin. 2G-2H lung parenchyma adjacent to tumor. 2I firm area grossly away from tumor. 3A representative. 4A in toto. 5A lymph node, bisected. 5B remainder of specimen. 6A in toto. SPECIAL PROCEDURES: INTRA - OPERATIVE CONSULTATION: 1. Lung, right apex: biopsy (FS). - Invasive adenocarcinoma. 2. Lung, right upper lobe, apical segment: segmentectomy (FS). - No tumor is seen at the bronchial margin. Intra-Operative Consultation #1 performed by. Final Diagnosis performed by. ADDENDUM #1 FOR MOLECULAR TESTS: KRAS, EGFR and ALK FISH were sent on. The test is to be performed on. The case report, slides, and blocks for the cited. accession number were retrieved from archives. The pathologist whose. signature appears below reviewed the original pathology report,. examined candidate H&E slides, and selected block 2C appropriate to. the specifications of the ordered molecular analysis. x1 H&E and x9. unstained slides were prepared and forwarded to. vhere the subject molecular test will be performed. An. addenaum report will be issued when the results of this molecular. test are available. Addendum #1 performed by. ADDENDUM #2: EGFR Mutation Analysis. Body Site: Right upper lobe of lung. Clinical Data: Adenocarcinoma. RESULTS: No mutation detected. INTERPRETATION: No mutations were identified in the sample provided. for analysis. Fewer than 5% of non-small cell lung carcinoma. patients without identifiable mutations are reported to be. responsive to EGFR tyrosine kinase inhibitor therapies. COMMENT: Forty percent (40%) or more tumor cellularity is optimal. for this mutation analysis. The sample submitted showed 90% tumor. cellularity upon pathologist review. A frequently occurring sequence change 2361>GA (Q787Q) was. identified. This polymorphism is known not to have clinical. significance. Mutations in the tyrosine kinase domain of the epidermal growth. factor receptor (EGFR) gene are reported to be associated with. differential responsiveness or resistance to EGFR tyrosine kinase. inhibitor (TKI) therapies. The objective response rate among. patients with a sensitizing mutation ranges from 55 to 82%. This assay analyzes exons 18-21 of the EGFR tyrosine kinase domain;. based on the current literature, most mutations in non-small-cell. lung carcinoma (NSCLC) are expected to occur in these exons. Mutations present in less than 10-20% of extracted DNA may not be. detected by this method. Mutation status in a sample may change. during tumor progression or the course of therapy; therefore, this. result cannot be used to infer the presence or absence of a mutation. in another sample or sub-sample obtained from this tumor. This test is validated for non-small cell lung carcinoma. The. clinical significance and utility of this test in other tumor types. is unknown. METHOD: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exons 18-21 of the EGFR gene. PCR products are analyzed by. bi-directional direct DNA sequencing using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. REFERENCES: 1. Azzoli CG, et al. J Clin Oncol. 20095; 27:6251-6266. 2. Jackman DM et al. Clin Carcinoma Res. 2009; 15:5267-5273. 3. Mok TS, et al. N Engl J Med. 1009; 361;947-957. 4. Sharma SV, et al. Nat Rev Carcinoma, 2007; 7:169-181. DISCLAIMER: This test was developed and its performance characteristics. determined by. The laboratory is. regulated under the Clinical Laboratory Improvement Amendments of. 1988 (CLIA) as qualified to perform high complexity clinical. testing. This particular test is not considered a stand alone test. and should be used only in the context of other diagnostic tests or. clinical work-up related to treatment decisions. Addendum #2 performed by. ADDENDUM 3: Integrated Oncology. MOLECULAR ONCOLOGY. KRAS MUTATION ANALYSIS. Clinical Data: Adenocarcinoma. RESULTS: Wild type gene. INTERPRETATION: No mutations were identified at codons 12 and 13 of. the KRAS gene. COMMENT: Mutations in the KRAS gene are reported to be associated with poor. prognosis, and resistance to targeted tyrosine kinase inhibitor. therapies in patients with non-small-cell lung cancer (NSCLC). KRAS. mutations occur in 15-30% of NSCLC patients and are strongly. associated with adenocarcinoma and smoking history. This assay analyzes codons 12 and 13 in exon 2 of the KRAS gene;. based on the current literature, approximately 98% of mutations are. expected to occur in these codons. The analytical sensitivity of. the assay is approximately 10%; thus mutations present in a low. percentage of cells may not be detected. This test is validated for. use in identifying KRAS codon 12 and codon 13 mutations in fresh,. frozen, or formalin-fixed paraffin embedded tissue. In particular. the test performance has been established in samples of colorectal. cancer and non-small cell lung carcinoma which harbor these. mutations, although several other tissues are also known to harbor. KRAS mutations (e.g. tumors of pancreas, bile duct, ovary, appendix,. etc.). Analysis of EGFR mutation or gene amplification status may provide. additional information regarding this patient's probability of. response to targeted tyrosine kinase inhibitor therapies, if. clinically indicated. See references. METHOD/LIMITATION: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exon 2 of the KRAS gene. PCR products are subjected to single. nucleotide primer extension to detect mutations at codons 12 and 13;. primer extension products are analyzed using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. REFERENCES: NSCLC. Mascaux C, Iannino N, et al. British Journal of Cancer, 2005;. 92:11-139. Pao W, Wang TY, et al. PLoS Medicine, 205;2(1):57-61. Eberhard DA, Johnson BE, et al. J Clin Oncol, 2005; 23:5900-5909. Han SW, Kim TY, et al. Clin Cancer Res. 2006; 12(8):253888888-2544. CRC. DiFiore C, Blanchard F, et al. Br J Cancer, 20007; 96:1166-1169. Lievre A, Bachet J-B, et al. Cancer Res, 2006; 66:3992-3995,. This test was developed and its performance characteristics. determined by. laboratory is. regulated under the Clinical Laboratory improvement Amendments of. 1988 (CLIA) as qualified to perform high complexity clinical. testing. This particular test is not considered a stand alone test. and should be only used in the context of other diagnostic tests or. clinical work-up related to treatment decisions. Addendum #3 performed by. ADDENDUM 4: Fluorescence In-Situ Hybridization (FISH). Body Site: Right upper lobe of lung. Clinical Data: Adenocarcinoma. INTERPRETATION: Negative for a rearrangement involving the ALK gene. Probe #Nuclei Examined % Positive Nuclei %. Control values. 2p23(ALK)V 50 0 <15.0. A total of 50 cells were scored. FINDINGS: FISH was performed on paraffin embedded tissue sections. using dual color break-apart probe (. to the ALK.",T1,N0,M0,T1N0M0
TCGA-UC-A7PD,"Patient ID: PATHOLOGY DIVISION. Date Collected: Date Received: CLINICAL DATA: Patient with an invasive squamous cell carcinoma of the uterine cervix. She is now in first trimester. gestation. GROSS DESCRIPTION: A) Received fresh intraoperatively designated ""para-aortic lymph node"" is an. approximately 3.0 cm piece of pink-tan, rubbery soft tissue. A representative section is submitted. for frozen section. The remainder of the. frozen section is submitted in block AFS1, and the remainder of the. specimen is submitted in block A2. B) Received in formalin designated ""para-aortic node #2"" are three flat. fragments of yellow-tan fibroadipose tissue ranging from 0.5 cm up to 1.5. cm in greatest dimension. Palpation fails to reveal lymph nodes. The. specimen is submitted in toto as received in block B1. C) Received in formalin designated ""cervical mass"" is a 0.8 x 0.5 x 0.2 cm. piece of white, firm tissue which is submitted in toto as received in block. C1. D) Received in formalin designated ""left tube and ovary"" is a specimen. consisting of a 3.5 X 2.0 x 1.5 cm unremarkable ovary with a bosselated. surface attached to a 5.0 cm in length x 0.7 cm in diameter unremarkable. blue-tan fallopian tube with fimbrial end identified. The ovary is. bisected revealing a 1.3 x 0.7 x 0.8 cm partially excised corpus luteum. with the remainder of the cut surface being light tan to yellow-tan with. multiple microcysts. Two representative sections of the entire cut surface. of the ovary are submitted in blocks D1 and D2 along with two cross. sections of fallopian tube in block D2. E) Received fresh intraoperatively designated ""left external iliac node"" is a. 3.5 x 2.0 x 1.5 cm pink-tan, soft lymph node which is bisected revealing,. for the most part, a homogeneous red cut surface with areas of nodularity. A representative section is submitted for frozen section. The remainder of. CONTINUED. Patient ID: GROSS DESCRIPTION: the lymph node is submitted in block E2. F) Received in formalin designated ""left external iliac node #2"" are three. flat pieces of yellow-tan fibroadipose tissue containing rubbery lymph. nodes. They range from 1.2 up to 1.7 cm in greatest dimension. The. specimen is submitted in toto as received in block F1. G) Received in formalin designated ""left obturator"" are three pieces of. yellow-tan fibroadipose tissue ranging from 1.2 cm up to 2.6 cm in greatest. dimension. The specimen is submitted in toto in block G1. H) Received in formalin designated ""right external iliac"" are four fragments. of yellow fibroadipose tissue ranging from 1.0 cm up to 2.2 cm in greatest. dimension. Palpation fails to reveal lymph nodes. The specimen is. submitted in toto in block H1. I) Received in formalin designated ""right common"" is a 2.5 x 1.0 x 0.7 cm. piece of yellow-tan, firm tissue which is submitted in toto as received in. block I1. J) Received in formalin designated ""right parametrium"" is a 1.1 x 0.4 X 0.3 cm. piece of tan, firm tissue with a smooth surface. The specimen is submitted. in toto as received in block J1. K) Received in formalin designated ""right obturator"" are three strips of. yellow-tan fibroadipose tissue ranging from 1.7 cm up to 3.7 cm in greatest. dimension. Palpation reveals multiple lymph nodes. The lymph nodes are. submitted in toto in block K1. L). Received fresh intraoperatively designated ""uterus and fetus"" is a 619. gram, 16.0 X 6.0 X 10.0 (transverse) cm, enlarged uterus with adjacent. parametrial tissue and vaginal cuff. The serosal surface is pink-tan,. smooth and unremarkable. The specimen is opened in the coronal plane. revealing the uterine cavity to be filled by a gestational sac measuring. 10.0 X 9.0 X 3.5 cm. It is opened revealing approximately 50 CC of straw. colored amniotic fluid and a 46.5 grams well developed fetus measuring 13.2. cm in length (crown-heel) with the diagonal diameter of the left foot. measuring 1.3 cm. The eyelids are bilaterally fused. The nares are. closed. The oral cavity is opened revealing no gross anomalies. The. external auditory meatus is closed. There is no evidence of any skeletal. deformity. The anal orifice is probe-patent. The ambiguous genitalia are. unremarkable for gestational age. Determination of the gender is. impossible. The placental disc measures 8.5 X 7.0 X 1.5 cm. It is entirely. implanted on the anterior endometrium. The fetal surface is blue-tan,. smooth and glistening. The umbilical cord measures 17.0 cm in length. The. gestational endometrium is tan with punctate hemorrhages, measuring. approximately 0.8 cm in greatest thickness. CONTINUED. GROSS DESCRIPTION: Examination of the cervix and the lower uterine segment reveals a 4.2 x 5.0. cm ulcerated, necrotic lesion involving the entire anterior endocervix and. lower uterine segment and most of the posterior endocervix and lower. uterine segment. Sectioning through the lesion reveals deep extension into. the anterior cervical stroma involving the entire thickness anteriorly and. partial thickness posteriorly. The edematous, pink-tan ectocervix is. unremarkable with tumor growth beneath the surface which appears uninvolved. by tumor posteriorly. The vaginal cuff mucosa is light tan, smooth and. wrinkled. The anterior and posterior vaginal cuff mucosal margins are. widely free of tumor. Sections are submitted as follows: L1, anterior vaginal cuff; L2,. posterior vaginal cuff; L3, right paracervical/parametrial tissue; L4 and. L5, left paracervical/parametrial tissue; L6-L10, five full thickness cross. sections of anterior cervical tumor; L11, cervix with tumor anterior,. longitudinal section; L12-L14, three full thickness cross sections of. posterior cervix tumor; L15, posterior endo-and ectocervix, longitudinal. section; L16, posterior endocervix with subjacent tumor, full thickness;. L17 and L18, one full thickness section of placental implantation site with. subjacent myometrium, divided in half; L19, three cross sections of the. three vessel umbilical cord; L20, placental membrane; L21 and L22, a full. thickness section of the posterior gestational endometrium with subjacent. myometrium, divided in half. INTRAOPERATIVE CONSULTATION: AFS) No evidence of metastatic carcinoma. EFS) No evidence of metastatic carcinoma. FINAL DIAGNOSIS: A, B, E-K) Bilateral pelvic lymph nodes, as designated above, excision: 11. benign reactive lymph nodes. G) Left fallopian tube and ovary, excision: 1. Unremarkable ovary with a gestational corpus luteum and multiple. physiologic cysts. No evidence of metastatic carcinoma. 2. Unremarkable left fallopian tube. L) Uterus (619 grams), excision: 1. Squamous cell carcinoma of the uterine cervix with the following. features: a. Maximum tumor size 5 cm, endophytic, cicumferential, extending into. lower uterine segment. b. Histologic type large cell keratinizing, moderately to poorly. differentiated. c. Tumor invades through more than 90% of the thickness of the cervical. stroma and is present less than 1mm from inked anterior and posterior. paracervical surgical margins, margins are otherwise free of tumor. d. Extensive perineural space and possible vascular space invasion noted. at stromal parametrial interface; parametrium otherwise free of. tumor. e. Vaginal mucosal margins are widely free of tumor. 2. Grossly unremarkable fetus in situ, adequate for gestational age with. the following parameters: a. Weight 46.5 grams. b. Crown-heel length 13.2 cm. c. Foot length 1.3 cm. 3. Unremarkable placental disc with normal-appearing chorionic villi. compatible with the gestational age. 4. Unremarkable gestational hypersecretory endometrium. Performing physician: In compliance with. regulations, the pathologist's signature on this. report indicates that the case has been personally reviewed, and the. diagnosis made or confirmed by, the verifying pathologist.",T1,N0,M0,T1N0M0
TCGA-44-7661,"Phon. Final Surgical Pathology Report. Procedure: Diagnosis. A. Right lower lobe of lung, lobectomy: Right lower lobe of lung with. subpleural poorly differentiated adenocarcinoma. Vascular invasion. present. Bronchial and vascular margins of resection negative for. tumor. B. Level II, excision: Lymph node with anthracosis, negative for. metastatic disease. C. Level VII, excision: Lymph node with anthracosis, negative for. metastatic disease. D. R4, excision Lymph nodes negative for metastatic disease. Microscopic Description: This right lower lobe of lung contains a subpleural, poorly. differentiated adenocarcinoma. Stain for TT F 1 is strongly positive,. supporting a lung primary. The tumor measures 3.5 cm in maximum. dimension. Arterial invasion is noted. Please see the template below: Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Primary tumor (pT) : pT2a. Margins of resection: Negative. Direct extension of tumor: Negative. Venous (large vessel) invasion: Negative. Arterial (large vessel) invasion: Positive. Lymphatic (small vessel) invasion: Negative. Regional lymph nodes (pN) : As per parts B. through D., all lymph nodes. are negative for metastatic disease, pNO. Distant metastasis (pM) : Cannot be assessed. Other findings: None. B. through D. microscopic examination performed. Specimen. A. Right lower lobe. B. Level II. C. Level VII. D. R4. Clinical Information. Lung cancer, endometrial cancer. Gross Description. A. The specimen is received fresh labeled ""right lower lobe "". It. consists of the right lower lobe of lung weighing 176 g and measuring. 16 X 11 X 3.7 cm. There is a 5.5 cm staple line near the hilum. Also. in the hilar area there is a stapled bronchial stump which measures. 6. mm in diameter when removing staples. A stapled vessel is also noted. in the hilum measuring 7 mm in diameter. These margins appear. unremarkable. The pleural surface is smooth and mostly pink and. glistening with minimal anthracotic pigmentation. In the superior. anterior portion, however, there is marked puckering and retraction of. the pleura. This area is painted black. On section it corresponds to. a superficial, fleshy tan dull tumor mass measuring 3.5 X 2.1 X 2.5 cm. A touch preparation is made and a sample is taken for Tissue. Procurement. Remaining pulmonary parenchyma is soft pink and spongy. Upon exploring the major vessels and bronchi, no lesions are found. Rep. sections are submitted following fixation. Blood account: 1-bronchial and vascular margins. esection ; 2. through 5-tumor; 6 through 7-noninvolved lung. B. The specimen is received unfixed labeled ""level II"". It consists of. a. single glistening soft reddish blac. dule measuring 0.7 cm in. greatest dimension. It is bisected,. C. Received fresh labeled ""level VII"" is a 1.6 X 1.2 X 0.5 cm soft. tan-red-gray tissue. The specimen is quadrasected and entirely. submitted in one block. D. Received fresh labeled ""R4"" is a 1.5 X 1.2 X 0.5 cm portion of soft. lobulated gold and yellow adipose tissue with interspersed tan grey. discoloration. The specimen is quadrasected and entirely submitted in. block.",T2,N0,M0,T2N0M0
TCGA-E2-A155,"SPECIMENS: A. LEFT BREAST AND AXILLARY CONTENTS LEVEL 1 AND 2. B. ADDITIONAL LEFT AXILLARY CONTENTS. SPECIMEN(S): A. LEFT BREAST AND AXILLARY CONTENTS LEVEL 1 AND 2. B. ADDITIONAL LEFT AXILLARY CONTENTS. GROSS DESCRIPTION: A. LEFT BREAST AND AXILLARY CONTENTS LEVEL 1 AND 2. Received fresh labeled with the patient's identification and ""left breast and axillary contents levels one and two. (suture in axillary tail)"" is an oriented 1794 g, 31 x 22 x 4.5 cm mastectomy with 27 x 16 skin ellipse and 1.1-cm flat. nipple. Skin has 4 brown macules ranging from 0.2 to 0.4 cm. In code: Anterior/superior-blue, anterior/inferior-. orange, posterior-black Specimen is serially sectioned into 11 slices from medial to lateral with nipple in slice7. #1- is a 2.5 x 2.5 x 1.7 cm firm tan stellate mass which is located at the 12 o'clock position, 4.2 cm from the deep. revealing 4 lesions. margin and 2 cm from the anterior margin (slices 6-7). #2- is a 1.3 x 1.1 x 1 cm firm tan stellate mass which is. located 0.3 cm medial to lesion #1, 5 cm from the deep margin and 1.3 cm from the anterior margin at roughly the 9. o'clock position (slice 5). #3- is a 2.5 x 2.2 x 1.5 cm firm tan stellate mass located 0.4 cm medial to lesion #2, 4 cm. from the deep margin and 1.5 cm from the anterior margin at roughly the 9 o'clock position (slice 4). #4- is a 1 x 1. x. 0.6 cm firm granular mass located 2.5 cm posterior lesion #3, 1.3 cm from the deep margin and 4.5 cm from the. anterior margin (slice 4). Adjacent to the deep margin, in slice 7, is a 0.9 x 0.6 x 0.4 cm firm tan lymph node. Within. the axillary tail are multiple lymph nodes ranging from 0.3 to 3.5 cm. The largest lymph node is nodular and a portion. is procured. Representatively submitted. A1: slice 4, lesion #3. A2: slice 4, tissue connecting lesions #3 and #4. A3: slice 4, lesion #4. A4: slice 4, deep margin lesion 4. A5: slice 5, tissue between lesions 3/4 and #2. A6: slice 5, lesion #2. A7 slice 6, tissue between lesions 2 and 1. A8: slice 6, superior to lesion 1. A9: slice 6, superior part of lesion 1. A10: slice 6, inferior part of lesion 1. A11: slice 6, inferior to lesion 1. A12: slice 6, anterior to lesion 1. A13: slice 7, lateral to lesion 1. A14: slice 3, upper inner quadrant. A15: slice 8, upper outer quadrant. A16: slice 9, lower outer quadrant. A17: slice 3, lower inner quadrant. A18-A19: nipple, perpendicular sections. A20: skin with macules. A21: intramammary lymph node. A22: 5 lymph nodes. A23: 4 lymph nodes. A24-A26: 1 lymph node each. A27-A28: 1 lymph node. A29-A30: 1 lymph node. A31-A36: 1 lymph node. B. ADDITIONAL LEFT AXILLARY CONTENTS. Received fresh labeled with the patient's identification and ""additional left axillary contents"" is a piece of fatty tissue. measuring 6.3 x 4.7 x 0.6 cm. One lymph node is identified. Submitted entirely. B1: 1 lymph node. B2-B4: remainder of soft tissue. DIAGNOSIS: A. BREAST, LEFT, MASTECTOMY WITH AXILLARY NODE DISSECTION: - MULTIPLE FOCI OF INVASIVE DUCTAL CARCINOMA, SBR GRADE 3 WITH MICROPAPILLARY FEATURES,. LARGEST FOCUS MEASURING 2.5-CM. - HIGH NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM TYPES WITH LOBULAR. EXTENSION, CENTRAL NECROSIS AND MICROCALCIFICATIONS. - SURGICAL RESECTION MARGINS NEGATIVE FOR TUMOR. - METASTATIC CARCINOMA TO ONE OF TWELVE AXILLARY LYMPH NODES (1/12), MEASURING 3.5-CM. WITH FOCAL EXTRANODAL EXTENSION. - METASTATIC CARCINOMA TO ONE OF TWO INTRAMAMMARY LYMPH NODES (1/2), MEASURING 0.8-CM. WITH FOCAL EXTRANODAL EXTENSION. - SEE SYNOPTIC REPORT AND SEE NOTE. B. LYMPH NODES, ADDITIONAL LEFT AXILLARY CONTENTS, DISSECTION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). NOTE: Four tumor nodules are grossly identified. Microscopically 3 of them are invasive ductal carcinoma that. have. the same morphology and one is DCIS. The tissues in between these nodules show scattered foci of DCIS. Therefore, these foci may be interconnected through DCIS. Largest confluent invasive tumor measures 2.5-cm. Two intramammary lymph nodes are identified, one is positive for metastatic carcinoma. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2.5cm. Tumor Site: Upper inner quadrant. Lower inner quadrant. Margins: Negative. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: Indeterminate. Lobular neoplasia: None. Lymph nodes: Axillary dissection. Lymph node status: Positive 2 / 15 Extranodal extension. DCIS present. DCIS Quantity: Estimate 10%. DCIS Type: Solid. Cribriform. DCIS Location: Associated with invasive tumor. Nuclear grade: High. Necrosis: Present. ER/PR/HER2 Results. ER: Positive. PR: Negative. HER2: Negative by IHC. Performed on Case: Pathological staging (pTN): pT 2 N 1c. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. Microscopic/Diagnostic Dictation: Pathologist. Final Review: Pathologist,. Final: Pathologist, (.",T2,N1,M0,T2N1M0
TCGA-BH-A0B1,"FINAL DIAGNOSIS: PART 1: RIGHT AXILLA, SENTINEL LYMPH NODE #1, EXCISION -. ONE LYMPH NODE, POSITIVE FOR METASTATIC DUCTAL CARCINOMA, 0.9 CM WITH FOCAL EXTRACAPSULAR. EXTENSION. PART 2: RIGHT BREAST, MODIFIED RADICAL MASTECTOMY -. A. MULTICENTRIC INFILTRATING DUCTAL CARCINOMA, NOTTINGHAM SCORE 6/9 (TUBULES 3, NUCLEI 2,. MITOSES 3) CENTRALLY LOCATED AND INVOLVING ALL OF FOUR QUADRANTS. B. TUMOR NODULES RANGES FROM 0.2 TO 4.8 CM. C. TUMOR AGGREGATES UP TO 14.3 CM. D. DUCTAL CARCINOMA IN SITU, SOLID TYPE WITH COMEDO NECROSIS REPRESENTING LESS THAN 5% OF THE. TUMOR VOLUME. E. FOCAL LOBULAR CARCINOMA IN SITU. F. EXTENSIVE LYMPHOVASCULAR SPACE INVOLVEMENT SEEN. G. TUMOR IS 0.8 CM FROM LOWER INNER QUADRANT DEEP MARGIN. H. MARGINS FREE OF TUMOR. I. SKIN AND NIPPLE WITH DERMAL LYMPHOVASCULAR SPACE INVOLVEMENT. J. CHANGES CONSISTENT WITH BIOPSY SITE. K. MICROCALCIFICATIONS ASSOCIATED WITH BENIGN CHANGES AND TUMOR. L. FIBROCYSTIC CHANGES WITH ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA, COLUMNAR CELL CHANGES. M. FOURTEEN RIGHT AXILLARY LYMPH NODES, NEGATIVE FOR TUMOR. PART 3: LEFT BREAST, 344 GRAMS, BREAST REDUCTION -. A. FIBROCYSTIC CHANGES WITH MICROCALCIFICATIONS. B. SKIN NOT REMARKABLE. CASE arner WID. Site: breast, NOS C50-9 3/13/ for. SYNOPTIC -PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Central subareolar. SIZE OF TUMOR: Maximum dimension invasive component: 4.8 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 14.3 cm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, benign zones. Yes, malignant zones. TUMOR TYPE, IN SITU: Solid. Comedo. DCIS admixed with invasive carcinoma. LCIS. Percent of tumor occupied by in situ component: 3 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 8 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: FAGE s VISCASE UF NIPPLE: LYMPH NODES POSITIVE: 1. LYMPH NODES EXAMINED: 15. METHOD(S) OF LYMPH NODE EXAMINATION: SENTINEL NODE METASTASIS: H/E stain. ONLY KERATIN POSITIVE CELLS ARE PRESENT: SIZE OF NODAL METASTASES: LYMPH NODE METASTASIS(-ES) WITH Diameter EXTRACAPSULAR of largest lymph EXTENSION: node metastasis: 9 mm. SKIN INVOLVED (ULCERATION): NON-NEOPLASTIC BREAST TISSUE: ADH. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: M STAGE, PATHOLOGIC: pN1. ESTROGEN RECEPTORS: pMX. positive. PROGESTERONE RECEPTORS: HER2/NEU: positive. zero or 1+.",T2,N1,M0,T2N1M0
TCGA-A8-A0A9,"Diagnosis: 2. Left excised breast material with a well differentiated invasive ductal breast carcinoma,. max. 2.2 cm in size, without any visible invasion of the lymph vessels with a minimum. margin of 3 mm at 6 o'clock. Surrounding lipomatous atrophic glandular tissue, no intraductal. tumor component. Tumor classification: M-8500/3, G1, pT2, pL0, pSN0 (0/2), pMX, stage II A, R0.",T2,N0,M0,T2N0M0
TCGA-A2-A25D,"TO. Patient: : Specimen #: Race: WHITE. Physician (s): SPECIMEN: A: RIGHT OUTER BREAST LUMPECTOMY. B: HIGHEST RIGHT AXILLARY LYMPH NODE. C: RIGHT AXILLARY LYMPH NODE DISSECTION. FINAL DIAGNOSIS: A. BREAST, RIGHT OUTER, LUMPECTOMY: - TUMOR TYPE: INVASIVE LOBULAR CARCINOMA, PLEOMORPHIC TYPE (SEE. COMMENT). NOTTINGHAM GRADE: POORLY DIFFERENTIATED (G3). NOTTINGHAM SCORE: 8/9 (Tubules= 3, Nuclei= 3, Mitoses= 2) . - TUMOR SIZE (GREATEST DIMENSION) : 3.2 CM (MEASURED GROSSLY) . - TUMOR FOCALITY: SINGLE FOCUS OF INVASIVE CARCINOMA. - TUMOR SIDE (QUADRANT) : RIGHT OUTER. - VENOUS/LYMPHATIC INVASION: PRESENT. - MARGINS: POSITIVE. TUMOR EXTENDS TO THE ANTERIOR AND INFERIOR INKED TISSUE EDGES. - LOBULAR CARCINOMA IN SITU: NOT IDENTIFIED. - LYMPH NODES: TWENTY-THREE (23) LYMPH NODES POSITIVE FOR METASTATIC. CARCINOMA (SEE PARTS ""B"" AND ""C""). - ESTROGEN RECEPTORS: POSITIVE (95% NUCLEI STAINING, REFER TO. - PROGESTERONE RECEPTORS: NEGATIVE (0% STAINING. REFER TO. - HER 2 NEU by IHC: NEGATIVE, 1+ (REFER TO. - AJCC PATHOLOGIC STAGE (7TH EDITION) : pT2 N3a. B. AXILLARY LYMPH NODE, RIGHT (""HIGHEST"") BIOPSY: - ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (SEE COMMENT). SIZE OF LARGEST METASTATIC DEPOSIT: 0.9 CM. EXTRACAPSULAR EXTENSION: FOCALLY PRESENT. C. AXILLARY LYMPH NODES, RIGHT, DISSECTION: - TWENTY-TW (22) OF TWENTY-THREE (23) LYMPH NODES POSITIVE FOR. METASTATIC CARCINOMA (SEE COMMENT). SIZE OF LARGEST METASTATIC DEPOSIT: 2.1 CM. EXTRACAPSULAR EXTENSION: PRESENT. Specimen #: FINAL DIAGNOSIS (continued) : Comment : The lymph node metastases seen in parts ""B"" and ""C"". demonstrate multiple foci of extracapsular extension and in most cases. represent near complete replacement of the underlying nodal architecture. This case received prospective peer review. CLINICAL DIAGNOSIS AND HISTORY: female with medical diagnosis of breast cancer (invasive. mammary adenocarcinoma, right breast breast; positive right axillary node) . PRE-OPERATIVE DIAGNOSIS: None provided. POST-OPERATIVE DIAGNOSIS: None provided. GROSS DESCRIPTION: A: Received fresh, labeled with the patient's name. and designated, ""Right Outer Breast Lumpectomy"" and consists of an. irregular portion of soft tissue oriented with a single suture - anterior;. double - lateral; and short - superior. The specimen measures 10.5. cm. superior to inferior; 7.0 cm medial to lateral; and 3.0 cm anterior to. posterior. The specimen is inked as follows: superior = blue; inferior =. green; medial = red; lateral = yellow; anterior = orange; and posterior =. black. Serial sections reveal a poorly-defined, firm tan-white mass. measuring 3.2 x 2.5 x 2.0 cm. The mass approaches the closest margin as. follows: 0.2 cm inferior; 0.5 cm deep and anterior; and 1.0 cm medial. The remainder of the specimen is composed of lobulated, yellow-tan adipose. tissue admixed with a minimal amount of fibrous tissue and is otherwise. unremarkable. Representative sections are sequentially submitted from. superior to inferior as follows A1 - superior margin; A2-A4- adjacent. normal; A5-A7- mass with deep and anterior margins; A8- - mass; A9-A10- mass. with deep margin; All-A13- - mass with deep, anterior and medial margin;. A14-A16- - mass with lateral, inferior and anterior margin; A17-A19- mass. with deep and inferior margins. Matched sections of A4 and A6-A8 - are submitted in OCT and Paraffin per. Specimen #: GROSS DESCRIPTION (continued) : CBCP protocol. Time in formalin: 28 hours. B: Received in formalin, labeled with the patient's name. and designated, ""Highest Right Axillary Lymph Node"" and consists. of an irregular fragment of tan-yellow adipose tissue measuring 1.5 x 1.0. x 0.5 cm. Blunt dissection reveals an ovoid fragment of tan, soft tissue. representing possible lymph node measuring 1.5 cm in greatest dimension. Sectioning of the possible lymph node reveals a tan-white, firm cut. surface. C: Received in formalin, labeled with the patient's name. ind designated, ""Right Axillary Lymph Node Dissection"" and. consists of an irregular fragment of tan-yellow, lobular adipose tissue. measuring 10.0 x 6.0 x 3.0 cm. The specimen is blunt dissected to reveal. 22 roughly ovoid fragments of tan-white, firm tissue representing possible. lymph nodes ranging from 0.4 to 4.3 cm in greatest dimension. Sectioning. of the possible lymph nodes reveals a tan-white, firm cut surface with. focal areas of hemorrhage. Sections are submitted as follows: C1- five. possible lymph nodes; C2- representative sections of four possible lymph. nodes; C3- - representative sections of four possible lymph node; C4-. representative sections of three possible lymph nodes; C5 - representative. sections of two possible lymph nodes; C6- representative sections of two. possible lymph nodes; C7- - representative section of one possible lymph. node; C8- - one whole possible lymph node, bisected.",T2,N3,M0,T2N3M0
TCGA-AA-3667,"Diagnosis/ diagnoses: Resected section of (sigmoid) colon with a colon carcinoma characterized histologically as. a moderately differentiated colorectal adenocarcinoma, extending to within 8 cm of a. resection margin and encircling the intestinal wall over a length of 7 cm. Invasive tumor. spread to the muscularis propria. Oral and aboral resection margins are tumor-free. Twenty-two mesocolic lymph nodes are tumor-free and have uncharacteristically reactive. lesions. Stage of tumor is therefore: pT2 pNO (0/22) LO V0; G2. Follow-up report: As requested an examination was initiated in relation to the question over microsatellite. instability of the colon tumor. According to the current consultation report (see appendix) there is no further evidence of. the presence of significant tumor disposition, particularly of the HNPCC/ Lynch syndrome. type.",T2,N0,M0,T2N0M0
TCGA-2H-A9GI,"Coded sample ID: Histologic diagnosis: moderate differentiated adenocarcinoma in Barrett-epithelium. Anatomic site with laterality: distal esophagus. Tumor size: 4x3,5 cm. Lymph node status: 8 lymph nodes, of which 4 contains tumor. Any comments or amendments: radical resection.",T3,N1,M0,T3N1M0
TCGA-CN-4740,"PATIENT HISTORY: Malignant neoplasm. PRE-OP DIAGNOSIS: Malignant neoplasm tonsil, malignant neoplasm mouth,. POST-OP DIAGNOSIS: Same. PROCEDURE: Dissection neck, free flap. FINAL DIAGNOSIS: PART 1: SOFT PALATE MARGIN, BIOPSY -. NO TUMOR SEEN. PART 2: POSTERIOR TONSILLAR PILLAR, BIOPSY -. NO TUMOR SEEN. PART 3: LYMPH NODES, RIGHT NECK LEVEL 1, BIOPSY -. A. TWO BENIGN LYMPH NODES (0/2). B. SUBMANDIBULAR GLAND WITH NO SIGNIFICANT PATHOLOGIC CHANGE. PART 4: SUPERFICIAL MANDIBLE MARGIN, BIOPSY -. NO TUMOR SEEN. PART 5: RIGHT TONSILLAR--RETROMOLAR TRIGONE REGION, COMPOSITE RESECTION -. A. INVASIVE SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED, 2.1 CM, EXTENSIVELY. INVOLVING MANDIBLE. B. NO ANGIOLYMPHATIC INVASION SEEN. C. NO PERINEURAL INVASION SEEN. D. FOCI OF INVASIVE SQUAMOUS CELL CARCINOMA INVOLVING ANTERIOR MANDIBULAR BONE MARGIN. AND LATERAL SOFT TISSUE MARGIN. E. SEVERE DYSPLASIA PRESENT AT ANTERIOR SOFT TISSUE AND MEDIAL SOFT TISSUE MARGINS. F. PATHOLOGIC STAGE: pT4 NO MX. PART 6: RIGHT ALVEOLAR NERVE, BIOPSY -. NO TUMOR SEEN. PART 7: RIGHT RETROMOLAR TRIGONE, BIOPSY -. NO TUMOR SEEN. PART 8: ANTERIOR LABIAL MARGIN, BIOPSY -. NO TUMOR SEEN. PART 9: LYMPH NODES, RIGIT NECK LEVELS 2, 3, AND t, DISSECTION -. TWENTY-FOUR BENIGN LYMPII NODES ((1/24). PART 10: BONE MARROW MANDIBLE, RIGHT, BIOPSY- -. My signature is attestation that I have personally reviewed the submitted material(s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received in a total of 10 parts. Part 1 received fresh with the patient's name, initials. labeled ""soft palate margin"" and consists of a 0.8 x 0.6 x 0.5 cm of pink-. hemorrhagic, soft fissue, entirely submitted following intraoperative consult labeled 1FS. Part 2 received fresh with the patient's name, initials. labeled ""posterior tonsillar pillar"" consists of two irregular portions of pink-. hemorrhagic, soft tissue, 1.0 x 0,5 x 0.5 cm and 0.7 x 0.4 x 0,4 cm. The soft tissue is entirely submitted following intraoperative. consult labeled 2AFS. Part 3 received unfixed with the patient's name, initials. labeled ""right neck level l"" consists of a 4.0 x 2,5 x 1.5 cm, 9.0-g light. tan submandibular gland, with an attached 3.0 x 3.0 x 0.7 cm of pink and hemorrhagic fat and soft tissue. The gland on cross-. section is grossly unremarkable. A representative section is submitted labeled 3A. Two lymph nodes dissected from the attached. fat are entirely submitted along with remaining adipose tissue labeled 3B and 3C. Part 4 received fresh with the patient's name, initials. labeled ""superficial mandible margin"" and consists of a 2.1 X 0.9 x 0.6 cm. of pink and hemorrhagic soft tissue, entirely submitted following intraoperative consult labeled 4AFS. Part 5 received fresh with the patient's name, initials labeled ""right composite resection"" consists of a right composite resection. with overall dimensions 8.0 x 5.5 x 4.4 cm. The mandible, 6.0 x 4.0 x 1.0 cm has hemorrhagic eroslon of the cortical bone at the. lateral ramus. The attached soft tissue consists of buccal mucosa, retromolar trigone and floor of mouth measuring 7.0 x 2.0 x 1.0. cm, with an irregular, tumor withln the posterior oral region measuring 2.1 x 1.7 x 1.0 cm. The lesion comes to withln 1.0 cm of the. anterlor soft tissue margin, 1.0 cm of the posterior soft tissue margin, 0.6 cm of the lateral soft tissue margin 0.7 cm of the medial. soft tissue resection margin and 0.5 cm of the deep margin of resection. A coronal section exposes tumor eroding the mandibular cortical bone at the medial aspect, possibly extending to the lateral. cortical surface. The bone resection margins are grossly free of tumor. Digital images are taken. Representative tumor and normal tissue is submitted for. banking. Ink code: Blue- lateral. Black-medial. Green- anterior. Yellow- posterlor. Orange- deep. The following sections are submitted: 5A. antetior mandIbular resection shave margin, following complex decalcification. 5B. posterior mandibular shave margin. following complex decalcification. 5C. anterior soft Ilssue shave margin. 5D. posterior soft tissue shave margin. 5E. lateral soft tissue shave margin. 5F. medial soft tissue shave margin and salivary gland. 5G. deep soft tissue. 5H. - J. additional sections of lesion with relation to tonsil and deep aspects. 5K. - L. tumor extending into mandible, following complex decalcification. Part 6 received fresh with the patient's name, initials. labeled ""right alveolar nerve"" consists of a 0.9 x 0,6 x 0.4 cm of pink, soft. tissue, entirely submitted following intraoperative consult labeled 6AFS. Part 7 received fresh with the patient's name, initials. labeled ""right retromolar trigone"" consists of a 1.4 x 0.4 x 0,4 cm resection. of pink hemorrhagic, soft tissue, entirely submitted following intraoperative consult labeled 7AFS. Part 8 received fresh with the patient's name, initials. labeled ""anterior labial margin"" consists of a 1.5 x 0.4 x 0.4 cm of pink. and hemorrhagic, soft tissue, entirely submitted following intraoperative consult labeled 8AFS. Part 9 received unfixed with the patient's name, initials. labeled ""right neck level 2, 3, 4 (stitch on two) consists of 3 pieces of. yellow and hemorrhagic fat and soft tissue ranging from 3.0 x 1.0 x 0.5 cm to 6.0 x 4.0 x 1.5 cm. The largest portion of tissue has. an attached black silk suture. Lymph nodes dissected from the larger portion are submitted as zone Il lymph nodes in cassettes. 9A through 9E. Lymph nodes dissected from the remaining tissue are also entirely submitted labeled 9F. Part 10 received fresh with the patient's name, initials. labeled ""bone marrow mandible right"" consists of a 0.4 x 0.2 X 0.2 cm of. dark red, soft to friable tissue, entirely submitted following intraoperative consult labeled 10AFS. INTRAOPERATIVE CONSULTATION: 1FS: SOFT PALATE, MARGIN, BIOPSY (frozen section)-. A. BENIGN. B. NO TUMOR SEEN. 2FS: POSTERIOR TONSILLAR PILLAR, BIOPSY (frozen section)-. A. BENIGN. B. NO TUMOR SEEN (. 4FS: SUPERFICIAL MANDIBLE MARGIN, BIOPSY (frozen sectlon)-. A. BENIGN. B. NO TUMOR SEEN. 6FS: RIGHT ALVEOLAR NERVE, BIOPSY (frozen section)-. A. BENIGN. B. NO TUMOR SEEN. 7FS: RIGHT RETROMOLAR TRIGONE, BIOPSY (frozen section)-. A. BENIGN. B. NO TUMOR SEEN. 8FS: ANTERIOR LABIAL MARGIN, BIOPSY (frozen section)-. A. BENIGN. B. NO TUMOR SEEN (. 10FS: BONE MARROW MANDIBLE, RIGHT, BIOPSY (frozen section)-. A. BENIGN. B. BONE FRAGMENTS, NO TUMOR SEEN. MICROSCOPIC: Microscopic examination substantiates the above diagnosis. The following statement applies to all Immunohistochemistry, insitu hybridization (ISH & FISH), molecular anatomic pathology, and. immunofluorescence testing: The testing was develoned and its performance characteristics determined by the. b, Department of Pathology, as. required by the CLIA regulations. The testing has not been cleared orapproved for the specificuse by the U.S. Food and Drug. Administration, has determined such approval is not necessary for clinical use. Tissue fixation ranges from a minimum of. to a maximum of. This laboratory is certified under the Clinical Laboratory Improvement Amendments of. (""CLIA"") as qualified to perform high-. complexity clinical testing. Pursuant to the requirements of CLIA, ASR's used in this laboratory have been established and verified for. accuracy and precision. Additional information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY UPPER AERODIGESTIVE TRACT AND SALIVARY GLAND TUMORS. SPECIMEN TYPE: Resection: Composite resection. TUMOR SITE: Other: Right retromolar trigone. TUMOR SIZE: Greatest dimension: 2.1 cm. HISTOLOGIC TYPE: Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: G2. PATHOLOGIC STAGING (pTNM): pT4. pNO. Number of regional lymph nodes examined: 26. Number of regional lymph nodes involved: 0. pMX. MARGINS: Margin(s) involved by tumor. Location(s): anterior mandible margin and lateral soft tissue margin. VENOUSILYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L): Absent. PERINEURAL INVASION: Absent. ADDITIONAL PATHOLOGIC FINDINGS: Epithellal dysplasia. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Soft palate margin. Stain/ch. BIOCK. H&E x. AFS. Part 2: Posterior tonsillar uillar. Block. H&E x 1. AFS. Part 3: Right nock lounl. Staln/cht. Block. H&E x 1. A. H&E x 1. B. H&E x 1. C. Part 4: Superior mandible margin. Stain/cht. Block. H&E X 1. AFS. Part 5: Right composite mandible resection. Stain/cht. Block. DC x 1. A. H&E x 1. A. H&E x 1. B. H&E x 1. C. H&E X 1. D. H&E x 1. E. H&E x 1. F. H&E x 1. G. H&E x 1. H. H&E x 1. H&E x 1. J. H&E x 1. K. H&E X 1. L. IMSU x 7. (none). Part 6: Right alveolar nerve. BIOCK. H&E x 1. AFS. Part 7: Right retramolar frigona. Stain/cht. DIOCK. HHE x 1. AFS. H&E x 1. AFS. Part 8: Anterior labial marain. Stain/cirt. BIOCK. H&E x 1. AFS. Part 9; Right neck levels , 3. A. Stain/ent. Block. H&E x 1. A. H&E x1. B. H&E x I. C. H&Ex1. D. H&Ex1. E. H&Ex1. F. Part 10: Bone marrow right mandible. Taken: 1. Stain/ci. H&E x 1. AFS. ICD-9 Diagnosis Codes: 000.",T4,N0,M0,T4N0M0
TCGA-AA-3861,"Diagnosis: Block A shows an invasive adenocarcinoma of the colon (cecal carcinoma G3), with a marked. tendency toward infiltration into the adjoining fatty connective tissue and vascular infiltration. (G3, pT3, L1, V1), while Block B shows an additional polyp, here of tubular adenoma type with. focal severe dysplasia and transition to a circumscribed adenocarcinoma with infiltration of the. submucosa (here G2, pT1), with regard to the resection margins these are free resection margins,. orally of the ileum type and distally of the colon type, as well as - with regard to the. circumferential margin - free fatty connective tissue and - with regard to the lymph nodes - free. lymph nodes (0 to 17). Tumor classification: ICDO-DA M 8140/3. G3 - pT3 L1, V1, (1st tumor). G2 - pT1 L0, V0, (polypoid lesion). Free lymph nodes (0 of 17), free resection margins, locally R0.",T3,N0,M0,T3N0M0
TCGA-05-4384,"Lung resection material with peripheral manifestation of an evidently mucin-forming. adenocarcinoma (sample 1) with a tubulopapillary structure and partly a bronchioloalveolar. growth pattern,. Comment: According to conventional histology, this is a peripheral mixed bronchopulmonary. adenocarcinoma with an acinar and papillary component and partly bronchioloalveolar. growth pattern (immunohistological analysis and confirmation to follow), which has focally. infiltrated the visceral pleura in the region of the pleural adhesion zone. The tumor extends as. far as the basal row of metal clamps. Subject to the immune profile, the TNM classification. on the basis of this material is thus pT2 pNX pMX RX (C34.3, M8255/3). 1st follow-up report: The immune profile (positivity doe cytokeratin 7 and TTF1, focally also for cytokeratin 20. and also negativity for CDX2) confirms the bronchopulmonary adenocarcinoma.",T2,N2,M0,T2N2M0
TCGA-E2-A15R,"SPECIMENS: A. SLN 1 RIGHT AXILLA. B. SLN 2 RIGHT AXILLA. C. SLN 3 RIGHT AXILLA. D. SLN 4 RIGHT AXILLA. E. RIGHT BREAST. SPECIMEN(S): A. SLN 1 RIGHT AXILLA. B. SLN 2 RIGHT AXILLA. C. SLN 3 RIGHT AXILLA. D. SLN 4 RIGHT AXILLA. E. RIGHT BREAST. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA, Lymph node, sentinel, right axilla, biopsy: Negative for carcinoma. TPB, Lymph node, sentinel, right axilla, biopsy: Negative for carcinoma. TPC, Lymph node, sentinel, right axilla, biopsy: Negative for carcinoma. TPD, Lymph node, sentinel. right axilla, biopsy: Negative for carcinoma. Diagnoses called at. by Dr. GROSS DESCRIPTION: A. SLN 1 RIGHT AXILLA. Received fresh labeled with the patient's identification and designated ""sentinel lymph node number one right axilla"". is a tan lymph node measuring 2.2 x 1 x 0.8 cm. Touch preparation is performed. Entirely submitted, A1. B. SLN 2 RIGHT AXILLA. Received fresh labeled with the patient's identification and designated ""sentinel lymph node number two right axilla"". is a tan lymph node measuring 1.5 x 1 x 0.8 cm. Touch preparation is performed. Entirely submitted, B1. C. SLN 3 RIGHT AXILLA. Received fresh labeled with the patient's identification and designated ""sentinel lymph node number three right axilla"". is a tan lymph node measuring 0.6 x 0.4 x 0.3 cm. Touch preparation is performed. Entirely submitted, C1. D. SLN 4 RIGHT AXILLA. Received fresh labeled with the patient's identification and designated ""sentinel lymph node number four right axilla"". is a tan lymph node measuring 1 x 0.6 x 0:4 cm. Touch preparation is performed. Entirely submitted, D1. E. RIGHT BREAST. Received fresh labeled with the patient's identification and designated ""right breast"" is an oriented, 27 g, 5.3 x 4.5 x 3. cm lumpectomy specimen. The short suture designates superior, long-lateral. Ink code: Anterior-yellow, posterior-. black, medial-green, lateral-red, superior-blue, inferior-orange. The specimen is serially sectioned from superior to. inferior into 5 slices to reveal a firm lobulated tan mass, 2.2 x 1.5 x 0.9 cm, located 0.1-cm from the nearest anterior. margin. The entire specimen is submitted: E1-E3: Perpendicular sections superior margin. E4-E7: Slice 2, E5 demonstrating mass and nearest anterior margin. E8-E11: Slice 3, E9, E11 demonstrating mass and nearest anterior margin. E12-E15: Slice 4, submitted entirely. E16-E18: Perpendicular sections inferior margin. DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, RIGHT AXILLA, EXCISION: - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1), MEASURING 0.3-CM WITH EXTRANODAL. EXTENSION, SEE NOTE. B. LYMPH NODE, SENTINEL #2, RIGHT AXILLA, EXCISION: - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1), MEASURING 0.1-CM WITH EXTRANODAL. EXTENSION, SEE NOTE. C. LYMPH NODE, SENTINEL #3, RIGHT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). D. LYMPH NODE, SENTINEL #4, RIGHT AXILLA, EXCISION: - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1), MEASURING 0.6-CM WITH EXTRANODAL. EXTENSION, SEE NOTE. E. BREAST, RIGHT, WIDE LOCAL EXCISION: - INVASIVE DUCTAL CARCINOMA, SBR GRADE 2, MEASURING 1.9-CM. INTERMEDIATE NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, SOLID TYPE. - INVASIVE TUMOR PRESENT 0.15-CM FROM MEDIAL AND 0.1-CM FROM ANTERIOR SURGICAL RESECTION. MARGINS. - FOCAL LYMPHOVASCULAR INVASION IDENTIFIED. - BIOPSY SITE CHANGES WITH FIBROSIS,. - SEE SYNOPTIC REPORT AND SEE NOTE. NOTE: The touch preparation of SLN #1 and 2 shows no tumor cells. Therefore the false negativity is due to. sampling error. The touch preparation of SLN #4 shows two clusters of atypical cells. Dr. concurs. A few clusters branching out and focally separated from the main tumor mass are identified in a close proximity to. the medial margin (0.15-cm). The main tumor mass is 0.1-cm from the anterior surgical resection margin. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Yes For mass. Laterality: Right. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.9cm. Margins: Negative. Distance from closest margin: Less than 0.15cm. medial and anterior. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: Present. Extent: focal. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node. Lymph node status: Positive 3 / 4 Extranodal extension. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 5%. DCIS Type: Solid. DCIS Location:Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Absent. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT 1c N 1. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. CLINICAL HISTORY: year-old female right breast mass, invasive ductal carcinoma on core bx. Right needle localization excision with. sentinel lymph node biopsy. PRE-OPERATIVE DIAGNOSIS: Carcinoma, right breast. Microscopia/Diagnostic Dictation: Pathologist,. Final Review: Pathologist,. Final: Pathologist,.",T1,N1,M0,T1N1M0
TCGA-EB-A4OY,"Laterality:Malignant melanoma, pigmented, ulcerated, formed of nevus-. like and spindle-like cells. Clark level V. Breslow's depth is 1 cm, with lymphoid infiltration. Three lymph nodes were examined, one lymph node (inguinal) demonstrated metastasis. Path Report:SKIN TISSUE CHECKLIST. Specimen type: Excision of lesion. Tumor site: Skin, foot. Tumor size: 2 x 1 x 3.5 cm. Tumor features: Ulcerated, Pigmented. Satellite nodules: Not specified. Histologic type: Malignant melanoma. Histologic grade: Lymph nodes: 1/3 positive for metastasis (Inguinal lymph node 1/3). Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Clark level V. Breslow's depth is 10 mm.",T4,N1,M0,T4N1M0
TCGA-E8-A433,Laterality:Papillary carcinoma. Path Report:Tumor type: Papillary carcinoma. Tumor size: 2.5 X 2 X 2. Laterality: Right. Focality: Unifocal. Extrathyroidal extension: Markers and special stains: Additional comments: Lymphocyte invasion - present.,T2,N0,M0,T2N0M0
TCGA-RC-A7SB,"A. Liver. poster for segmentectomy: HEPATOCELLULAR CARCINOMA with focal sarcomatous differentiation. Tumor number : two. Sateilite nodule: no. Location : S6. S7. Gross type: vaguely nodular (S7) and nodular with per inodular extension (S6). Size(cim): 2.5x2.5x2.4cm (S6) and 1.5x1.5x1.4cm (S7). Differentiation: The worst differentiation: Edmondson grade IV. The major differentiation: Edmondson grade 11. Histologic type: microtrabecular and pseudoglandular. Cell type: Hepatic and Spindle. Tumor necrosis : no. Hemorrhage : no. Fatty change : no. Fibrous capsuie : 1) complete (S6), 2) No capsule(S7). Infiltration of capsule : yes. Septum formation : yes. Surgical margin invasion : no(margin of the clearance: 0.5mm at ""S7"" mass). Serosa invasion: no. Portal vein invasion : no. Bile duct invasion : no. Hepatic vein invasion : no. Hepatic artery invasion : no. Microvessel invasion : no. Intrahepatic metastasis : no. Multicenteri ic occurrence : yes. T stage : pT2. Non-tumor liver. Chronic hepatitis : yes. Etilogy : HBV. Grade, Tobular : minimal. Grade, portoperiportal : none. Stage(fibrosis) : no. Cirrhosis : no. Dysplastic nodule : no. Ouctal epithelial dysplasia : no. Other liver disease : Fatty change. macrovesicular (about 10%). B. Falciform ligament. excision: No pathologic abnormality. C. Gallbladder. cholecystectomy: Cholesterol polyps. D. Tissue labeled as ""LN"". biopsy: Fibroadipose tissue only. < Result of immunohistochemical stain>. Hepatocyte ( block A3 and A5): Positive in tumor cells. Cytokeratin 19 ( block A3 and A5) : Negative in tumor cells. Cytokeratir 7 (block A3 and A5): Focal positive in tumor cells. Cytokeratin 7 (block A7) Bile duct positive. Vimetin (block A3); Focal positive. Cam5.2 (block A3); Positive. < Result of special stain, block A7 >. fron: Negative. A. The specimen received in formalin is a product of segmentectomy of liver,. measur ing 16.5x8x4.5cm and weighing 230gm. The capsular surface and. par enchymal resection margin are clear. On serial sections. there is a multinodular. confluent expanding nodular type mass, measuring 2.5x2.5x2.4cm The mass. abuts capsule and the cut surface is whitish solid. Also noted is a well defined. greenish mass, measuring 1.5x1.5x1.4cm. The mass is abutting capsule and is. 0. 1cm apart from parenchymal resection margin. This mass is 3cm apart from the. Targer mass. Remaining parenchyma is unremarkable. Representative sections. are embedded in 7 cassettes. (Aland2-Targer mass one plane, A3and4-larger. mass one plane. A5-small mass one plane. A6-small mass one plane. A7-normal liver). B. The specimen received in formalir is a Tump of adipose tissue, clinically labeled. as ""falciform Ligament"" measuring 12x3x1.5cm. On serial section, there is. no definite mass. Representative sections are embedded in one cassette. C. The specimen received in formalin is a gallbladder, measuring 7x2.5x2.5cm. The external surface is unremarkable. On opening. there is a black stone. measuring 0.8cm in diameter. The mucosa is greenish velvety appearance with. several tiny yellowish polyps. measuring up to 0.1cm. The wall measures 0.2cm. in thickness. Representative sections are embedded in one cassette. D. The specimen received in formalin is a compartmentalized lymph node. Entirely embedded in one cassette. H&E(10). MT(1), RTC(1). D-PAS(1). Tron(1). Cytokeratin 7(3). Hepatocyte (2). Cytokeratin 19 (2), Vimetin (1). Cam5,2(1).",T2,N0,M0,T2N0M0
TCGA-AG-3587,Diagnosis: Rectal resection preparation with tumor-free oral and aboral resection margins and. moderately differentiated adenocarcinoma (G2) in the distal rectum with superficial. invasion of the lamina muscularis propria and without regional lymph node metastases. (pT2 pNO 0/17 LO V0 RO).,T2,N0,M0,T2N0M0
TCGA-AG-A014,"Diagnosis: Resected section of colon (rectosigmoid) with an ulcerated rectal carcinoma histologically. characterized as a poorly differentiated colorectal adenocarcinoma, extending a maximum. of 1.7 cm to the aboral resection margin, and measuring a maximum of 3 cm at the widest. point. Invasive spreading of the tumor to the muscularis propria. Sigma with individual. pseudodiverticula and mild, chronically scarring peridiverticulitis. Tumor-free oral and aboral resection margin. 15 local lymph nodes are tumor-free with uncharacteristically reactive changes. Stage of tumor: pT2 pN0 (0/15) L0, V0; G3 R0.",T2,N0,M0,T2N0M0
TCGA-BR-8588,"Case ID Gross Description. Microscopic Description. Diagnosis Details. Comments. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Fundus. Tumor size: 5 X 6 X 1.2 cm. Tumor features: Ulcerated, Annular. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Serosa (visceral. peritoneum). Lymph nodes: 0/6 positive for metastasis. (Regional 0/6). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not. specified. Comments: None.",T4,N0,M0,T4N0M0
TCGA-BJ-A0Z2,"PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/ POST-OP DIAGNOSIS: Metastatic thyroid cancer. PROCEDURE: Total thyroidectomy, excision lymph node. SPECIFIC CLINICAL QUESTION: Not 'answered. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered. CHEMORADIATION THERAPY: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION: Not answered. OTHER DISEASES: Not answered. ADDENDA: Addendum. Molecular Anatomic Pathology Testing: Block 1D: A. HRAS codon 61 mutation IDENTIFIED. B. Mutations in BRAF, NRAS61, and KRAS12/13 NOT identified. Note: DNA was extracted in the amount sufficient for testing. Mutations in either BRAF or RAS genes or RET/PTC rearrangements are found in more than 70% of papillary thyroid. carcinomas (1). BRAF V600E. 1 mutation has been associated with more aggressive behavior of papillary. carcinoma (2,3). The association between BRAF V600E mutation and features of tumor aggressiveness have also been. observed in papillary microcarcinomas (4). Mutations in the RAS genes or PAX8/PPARg rearrangement occur in -70% of. follicular thyroid carcinomas and with lower frequency in oncocytic (Hrthle cell) carcinomas (5). Regarding the. specificity of these mutations for cancer, BRAF V600E mutation and RET/PTC and PAX8/PPARg rearrangements are. overall specific for malignancy in the thyroid, although they have been reported with a very low frequency in benign. thyroid lesions (6). RAS mutations occur in malignant and benign thyroid tumors, being found in ~40-50% of follicular. and anaplastic carcinomas, 30-40% of follicular adenomas and 10-15% of papillary carcinomas (6). 1. Adeniran AJ, et al. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of. thyroid papillary carcinomas. Am J Surg Pathol 2006, 30:216-222. 2. Xing. M,. et. al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 2005, 90:6373-6379. 3. Elisei R, et al. BRAF V600E mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin. Endocrinol Metab 2008, 93:3943-3949. 4. Lee X, Gao M, Ji Y, Yu Y, Feng Y, Li Y, Zhang Y, Cheng W, Zhao W. Analysis of differential BRAF(V600E) mutational status in high aggressive. papillary thyroid microcarcinoma. Ann Surg Oncol. 2009 Feb;16(2):240-5. 5. Nikiforova MN, et al. RAS point mutations and5PAX8-PPARyrearrangement in thyroid tumors: Evidence for distinct molecular pathways in. thyroid follicular carcinoma. J Clin Endocrinol Metab 2003, 88: 2318-26. 6. Nikiforov YE. Recent developments in the molecular biology of the thyroid. In: Lloyd RV., ed. Endocrine Pathology: Differential Diagnosis and. Molecular Advances. Humana Press, Totowa, 2004, 191-209. Sample Preparation and Procedure. For. paraffin-embedded surgical specimens, manual microdissection was performed to collect tumor tissue. Specimens with the minimum of 50% of. tumor cells in a microdissection target are accepted for the analysis. Optical density readings were obtained. Real-time PCR was performed on. the. atform to amplify BRAF, NRAS codon 61, HRAS codon 61, and KRAS codons 12/13 sequences. Post-PCR melting curve. analysis. was used to detect possible mutations. If required, the mutation type was confirmed by Sanger sequencing of the PCR product on. DNA from samples positive for each of these mutations was used as positive controls. Amplification at 35 cycles or earlier was. considered sufficient for the analysis. The limit of detection is approximately 10% of alleles with mutation present in the background of normal DNA. and RNA. Notifiable. Addendum. Molecular Anatomic Pathology Testing: Block D: A. Loss of heterozygosity is IDENTIFIED at chromosome 22q. B. Fractional Allelic Loss is 9% (1 locus with loss / 11 informative loci). C. LOH at the VHL gene locus (3p.26) is NOT identified. Note: Loss of tumor suppressor gene alleles is known to occur in thyroid follicular neoplasias and to correlate with tumor progression. As. reported in the literature, widely invasive carcinomas and anaplastic carcinomas frequently have a mean fractional allele loss of. -50% (1). Adenomas typically have lower frequency of LOH, frequently fewer than 10%. Minimally invasive and angioinvasive. follicular carcinomas typically have intermediate results (1,2). Some studies have shown that LOH at the VHL gene locus is. specific for malignancy and is associated with poor prognosis (2,3). However, not all tumors reveal such a correlation and,. therefore, the LOH profile should be interpreted in the context of the cytologic and histologic findings and the patient's clinical. history. Sample Preparation and LOH Analysis. For cytology samples, extraction of DNA was performed from the fluid or sample provided. For surgical specimens, manual. microdissection. was. performed to include neoplastic tissue and normal adjacent tissue. Specimens with the minimum of 50% of tumor cells in a microdissection target. are accepted for the analysis. DNA was isolated using standard laboratory procedure. Optical density readings were obtained. Fourteen microsatellite markers (listed below) that have been previously found to be involved in thyroid neoplasia and co-localize with known tumor. suppressor genes were used for analysis. PCR was performed using fluorescently labeled primers and the products of amplification were detected. using capillary electrophoresis on ABI3730 platform. Relative fluorescence was determined for individual alleles and the ratio of peaks was. calculated (GeneMappper ABI 3730). Normal tissue was examined to determine whether the patient is heterozygous at the marker (genetically. informative) and neoplastic tissue was then analyzed to detect loss of heterozygosity. Thresholds for significant allelic imbalance were determined. using normal (non-neoplastic) specimens for every marker. Loss of heterozygosity was determined using formula and reported. when allelic ratio for a particular marker was below 0.5 or above 2.0. When normal tissue was not available, peak height ratios falling outside of 2. SDs beyond the mean for each polymorphic allele paring were assessed as showing loss of heterozygosity. D1S1161. 1p. 1p35.1. D1S407. 1p. 1p36.21. D3S1038. VHL. 3P25.3. D3S1539. VHL. 3p26.3. D5S659. APC. 5q23.2. D5S1384. APC. 5q23.3. D9S251. CDKN2/p16. 9p21.3. D9S1748. CDKN2/p16. 9p22.2. D10S1171. PTEN. 10q23.31. 010S1173. PTEN. 10q23.31. D17S1844. p53. 17p13.1. D17S786. p53. 17p13.1. D22S1150. NF2. 22q12.2. D22S268. NF2. 22q12.2. References. American Journal of Surgical Pathology 2003;27:1559-64. 1. Hunt JL, et. al. Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid. 2. 2003;34:375-80. Hunt JL, et. al. A novel microdissection and genotyping of follicular-derived thyroid tumors to predict aggressiveness. Human Pathology. Dec:134(6):1043-7: discussion 1047-8.2003;134:1043-7. 3. Hunt JL, et. al. Loss of heterozygosity of the VHL gene identifies malignancy and predicts death in follicular thyroid tumors. Surgery. 2003. FINAL DIAGNOSIS: THYROID GLAND, TOTAL THYROIDECTOMY (42.5 GRAMS) -. A. ANGIOINVASIVE FOLLICULAR CARCINOMA (2.8 CM), IN THE LEFT LOBE. B. MULTIFOCAL CAPSULAR INVASION IS IDENTIFIED. C. TUMOR IS <0.1 CM FROM THE MARGIN. D. BACKGROUND THYROID WITH NODULAR HYPERPLASIA. E. pT2 NX M1 (right femur. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Left Lobe. TUMOR FOCALITY: Unifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 2.8 cm. HISTOLOGIC TYPE: Other: Follicular carcinoma. PATHOLOGIC STAGING (pTNM): pT2. pNX. Number of regional lymph nodes examined: 0. Number of regional lymph nodes involved: 0. pM1. Site(s) of metastasis: Right femur. MARGINS: Margin(s) involved by carcinoma. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L): Present. ADDITIONAL PATHOLOGIC FINDINGS: Other: Nodular thyroid hyperplasia.",T2,N0,M1,T2N0M1
TCGA-86-8672,"Case ID. Gross. Microscopic Description. Diagnosis Details. Description. Lung with a tumor of Adenocarcinoma, G-3, with focal. Tumor Features: Unknown,. 7.5x6 cm in size,. necrosis. Ten examined lymph. Tumor Extent: Localized,. with focal necrosis. nodes demonstrated hyperemia,. NOS, Venous Invasion: Hilus lymph nodes. anthracosis, reactive follicular. Absent, Margins: Absent,. are hyperemic. hyperplasia. Treatment Effect: Comments. Original records read. LUNG TISSUE CHECKLIST. pT2, but tumor size. 7.5x6 cm is referred as. Specimen type: Pneumonectomy. pT3, according to the. Tumor site: Lung. 7th edition of the TNM-. Tumor size: 6 X 0 X 7.5 cm. classification. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 0/10 positive for metastasis (Hilus. lymph nodes 0/10). Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Right- upper.",T3,N0,M0,T3N0M0
TCGA-DJ-A4UT,"leck. I Neck. Clinical Diagnosis & History: Right nodule papillary thyroid cancer. Specimens Submitted: 1: Total thyroid. DIAGNOSIS: 1. Total thyroid: Part # 1. Tumor Type: Papillary carcinoma, classical type. with focal oncocytic/tall cell features. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Psammoma bodies. Tumor Location: Right lobe. Tumor Size: Greatest diameter is 1.0 cm. Tumor Encapsulation: None Identified. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Microscopic foci present. Papillary microcarcinoma, 0.5 mm in greatest dimension (left lobe). Adenoma(s) (away from the carcinoma): Not Identified. Non-Neoplastic Thyroid: Exhibits mild chronic lymphocytic thyroiditis. Parathyroid Glands: Not identified. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh, labeled ""Total thyroid"", and consists of a thyroid weighing 8.5g. The right lobe measures 3.5 x. 2 x 0.8 cm, the left lobe measures 3 x 2 x 0.8 cm and the isthmus measures 1 x 1 x 0.4 cm. The external surface is covered by a. thin fibrous capsule. The posterior surface of the specimen is inked black, and the anterior is inked blue. Sectioning reveals a. nodule measuring 1.0 x 0.6 x 0.6 cm. The nodule is located in the middle lateral portion of the right lobe, displays white cut. surfaces, and is not encapsulated. Sections through the remaining tissue reveal unremarkable cut surfaces. The remaining. thyroid parenchyma is red brown and beefy. Representative sections of the specimen are submitted for TPS. The remainder of. the specimen is entirely submitted for permanent histologic examination. Summary of sections: N - nodule, entirely submitted. RL right lobe. LL left lobe. IS - isthmus. ADDR - remainder of the right lobe. ADDL - remainder of the left lobe. Summary of Sections: Part 1: Total thyroid. Block. Sect. Site. PCs. 4. ADDL. 4. 3. ADDR. 4. 1. IS. 0. 1. LL. 0. 1. N. 0. 1. RL. 0.",T1,N0,M0,T1N0M0
TCGA-56-8503,"Specimen Information. ADDENDUM. The N2 sites sampled for this case are: Level 7 subcarinal. Level 9 pulmonary ligament. Level 8 paraesophageal. Level 4 lower paratracheal. DIAGNOSIS. A) LYMPH NODES, LEVEL 11 INTERLOBAR, RESECTION: Two lymph nodes negative. for carcinoma (0/2). B) LYMPH NODE, LEVEL 11, RESECTION: One lymph node negative for carcinoma. (0/1). C) LYMPH NODES, LEVEL 7 SUBCARINAL, RESECTION: Four lymph nodes negative. for carcinoma (0/4). D) LUNG, RIGHT LOWER LOBE WITH EN BLOC CHEST WALL RESECTION: Well differentiated squamous cell carcinoma characterized by: a. Tumor size: 5 X 4 X 3.8 cm. b. Margins: bronchial, vascular, soft tissue, and ribs (8,9,10) are. negative for carcinoma. C. Tumor extends through visceral pleura and into parietal. pleura. d. Angiolymphatic invasion: Absent. e. Background emphysematous lung. f. One level 12 lymph node negative for carcinoma (0/1). g. Two peribronchial lymph nodes negative for carcinoma (0/2). h. Rib marrow shows trilineage hemaotpoiesis. E) LYMPH NODE, LEVEL 9, RESECTION: One lymph node negative for carcinoma. (0/1). F) LYMPH NODE, PERIESOPHAGEAL, RESECTION: One lymph node negative for. carcinoma (0/1). G) LYMPH NODE, LEVEL 10R, RESECTION: One lymph node negative for carcinoma. (0/1). H) LYMPH NODES, 4R, RESECTION: Three lymph nodes negative for carcinoma. (0/3). Final TNM: pT3NOMO. stage: IIB. MACROSCOPIC. SPECIMEN TYPE. Lobectomy with en block chest wall resection. TUMOR SITE. Right Lung-Lower Lobe. TUMOR SIZE. 5 X 4 X 3.8 cm. TUMOR FOCALITY. Unifocal. MICROSCOPIC. HISTOLOGIC TYPE. Squamous cell carcinoma. HISTOLOGICAL GRADE. G2: (moderately differentiated) of G4. VISCERAL PLEURAL INVASION. Present. LYMPHATIC VASCULAR INVASION. Absent. TREATMENT EFFECT. Not applicable. TUMOR EXTENSION. Tumor extension identified: parietal pleura. MARGINS. Uninvolved by tumor (Bronchial, Vascular, Chest Wall, Anterior and. posterior rib margins (8,9,10)). PATHOLOGIC STAGING. EXTENT OF INVASION. pT3. (Tumor invades parietal pleura). REGIONAL LYMPH NODES. pNO. (No regional lymph node metastasis). Total nodes: 17. Total positive nodes: 0. N1 nodes: 7. N1 positive nodes: 0. N2 nodes: 10 (Includes level 4R AS12-15257). N2 positive nodes: 0. DISTANT METASTASIS. pMO. (No distant metastasis). PATHOLOGIC STAGE Summary. Final TNM: pT3NOMO. stage: IIB. The pathologic stage presumes no distant metastasis. LUNG ANCILLARY TESTING PROTOCOL. HISTOLOGIC TYPE. Squamous cell carcinoma. STAGE IV STATUS. No stage IV disease pathologically. TISSUE BLOCK AVAILABLE FOR ANCILLARY TESTING. D-6. COMMENT. CLINICAL INFORMATION. Not stated. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Lymph node biopsy, interlobar. Labeled ""level 11 interlobar lymph node"" are two black anthracotic 0.5 to. 0.9 cm soft tissue fragments. The specimen is entirely submitted in one. cassette. B) SOURCE: Lymph node biopsy, level 11. Labeled ""level 11 lymph node"" is a 1 cm partially anthracotic lymph node. The specimen is entirely submitted in one cassette. C) SOURCE: Lymph node biopsy, level 7 subcarinal. Labeled ""level 7 lymph node subcarinal"" are four fragmented partially. anthracotic lymph node fragments ranging from 0.7 to 2 cm in greatest. dimension. The nodes are entirely submitted in four cassettes as follows: C1. Two nodes. C2. One node sectioned. C3-C4. Largest node sectioned. D) SOURCE: Lung, right lower lobe with en bloc chest wall resection. Received fresh labeled ""right lower lobe with en bloc chest wall resection"". consists of a right lower lobe measuring 18 X 10 X 5.8 cm with attached. ribs 8, 9, and 10 anteriorly. The anterior soft tissue of the chest wall. resection is inked orange, the anterior margins of the bone green, and. posterior bone margins red. Beneath the ribs is a palpable lesion extending. to the pleural surface, in both the anterior and posterior aspects. The. pleura overlying this mass is inked black. The resection margin displays. tan-pink tumor at the margin but not attached to the bronchus. The. bronchial margin is taken en face and submitted on chuck 1 for frozen. section diagnosis. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Bronchial. margin negative"" is rendered by. A tan-pink 1 cm lymph node is found and is considered level 12 per surgeon. One additional'0.9 cm lymph node is found at the hilum. The tumor is. sectioned from posterior to anterior revealing a mostly well-circumscribed. focally necrotic tumor mass measuring 5 X 4 X 3.8 cm. The tumor appears to. attach to the posterior soft tissue of the intercostal muscle but does not. appear to invade into the bone. The tumor is 2 cm from the nearest bony. resection margin which is the anterior aspect of rib 9. It extends to the. pleural surface both anterior and posteriorly but does not extend through. it. The anterior ribs and soft tissue are removed and the subsequent. underlying tissue of both the ribs and the tumor are inked yellow. It. appears that the tumor is firmly adherent to rib 9 and the intercostal soft. tissue between ribs 8-9 and 9-10. The ribs 8 and 10 appear to be detached. from the tumor. The anterior chest wall resection is removed from the lung. and each aspect has been inked yellow. The anterior and posterior bone. margins of the ribs are taken en face. Sections are taken of the bone at. number 9 where the tumor was attached most firmly revealing the tumor to. extend through the parietal pleura and does not appear to invade the. periosteum of the bone in rib number 9. Tumor does not appear to be within. the soft tissue proper of the intercostal soft tissue. There is a dense. desmoplastic 1 cm rind focally at the tumor, rib number 9 junction. The remainder of the parenchyma is tan-pink and spongy with moderate. anthracosis. No additional satellite lesions are seen. Note that tissue is. taken for possible ancillary studies. Note: A photograph is taken. Representative sections are submitted in 22 cassettes labeled: 1. Frozen section bronchial resection margin. 2. Level 12 lymph node sectioned. 3. One additional hilar lymph node bisected. 4. Vascular margin. 5-9. Representative tumor to area of rib (yellow ink) and pleura (black. ink). 10-12. Full thickness rib number 9 from area of tumor attachment to. anterior soft tissue margin (orange ink). 13. Rib 8 anterior margin. 14. Rib 9 anterior margin. 15. Rib 10 anterior margin. 16. Rib 8 posterior margin. 17. Rib 9 posterior margin. 18. Rib 10 posterior margin. 19-20. Longitudinal section of bronchus immediately after frozen section. to include tunfor. 21-22. Random parenchyma remote from tumor. Note that 10-18 will be decalcified. E) SOURCE: Lymph node biopsy, level 9. Labeled ""level 9 lymph node"" is a tan-gray partially anthracotic lymph node. which is sectioned and entirely submitted in a single cassette. F) SOURCE: Lymph node biopsy, peri esophageal. Labeled ""periesophageal lymph node"" is a 1 cm partially anthracotic lymph. node which is sectioned. The specimen is submitted in toto in one cassette. G) SOURCE: Lymph node biopsy, level 10 R. Labeled ""10 R lymph node"" is a single fragmented 0.7 cm anthracotic lymph. node. The specimen is entirely submitted in one cassette. H) SOURCE: Lymph node biopsy, level 4R. Labeled ""4R level lymph node"" are two separate yellow-tan focally red-black. tissues, 1.8 X 1 X 0.7 cm in aggregate, disclosing three apparent lymph. nodes ranging from 0.5 to 0.9 cm in greatest dimension. The largest lymph. node includes a small amount of attached fat. Entirely submitted in two. cassettes as follows: 1. One sectioned lymph node. 2. Two lymph nodes, in toto. MICROSCOPIC. A-H) The microscopic appearance substantiates the diagnosis. Elastic stains were performed on blocks D5-D9 to determine extent of. invasion. Dictation by. Lab and Collection. GROSS AND MICROSCOPIC SURGICAL PANE. - Lab and Collection. Information. Result History. GROSS AND MICROSCOPIC SURGICAL PANE. rder Result History. Result Date and Time. Provider Status. Lab. Parent Order. ID. Child Order ID. Specimen Information. Audit Trail. Action. User. MyChart Status: This result is currently not released to MyChart. GROSS AND MICROSCOPIC SURGICAL PANEL. Authorizing. Frequency Elements and Transportation Info. Frequency. ONE TIME. Quantity. 1. Verbal Order Info. Action. Acknowledgement Info. For. At. Placing Order. Audit Trail. Action. Comments. Must submit Histology Requisition with sample. Indicate Fungal stain if needed.",T3,N0,M0,T3N0M0
TCGA-L6-A4EQ,"Clinical Center. Birth Date: AP Supplemental Report. SUPPLEMENTAL. SUPPLEMENTAL. REASON FOR THE SUPPLEMENTAL REPORT: To clarify the location of the. lesions. Diagnosis remains unchanged. DIAGNOSIS: 1. Lymph node, delphan lymph node, biopsy: Metastatic carcinoma to. lymph node (1/1). 2. Thyroid, total thyroidectomy: Papillary thyroid carcinoma, conventional type,(3.5cm), isthmus. Hurthle cell neoplasm, favor Hurthle cell adenoma. (left lobe). See note: Multinodular goiter. The original report is as follows: DIAGNOSIS: 1. Lymph node, delphan lymph node, biopsy: Metastatic carcinoma to. lymph node (1/1). 2. Thyroid, total thyroidectomy: i,. Papillary thyrold carcinoma, conventional type,(3.5cm), left. lobe. ii. Hurthle cell neoplasm, favor Hurthle cell adenoma. (isthmus). See. note: iii. Multinodular goiter. NOTE: The Hurthle cell neoplasm shows no evidence of fibrous capsule and. capsular or vascular invasion. This lesion stains positive for. thyroglobulin and negative for Calcitonin. Dr. is informed by Dr. of presence of micrometastasis in. lymph node on. Immunoperoxidase and in-situ hybridization tests performed here and used. for diagnosis were developed and their performance characteristics. determined by the Laboratory of Pathology, They have not been. cleared or approved by the U.S. Food and Drug Administration. The FDA. has also determined that such clearance or approval is not necessary. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (CLIA) as qualified to perform high complexity. clinical laboratory testing. (Other). Do not file in Medical Record. Clinical Center. Birth Date: Clinical_History:__thyrold. cancer, papillary Specimen Taken For. Protocol: 01 - Yes. PROCEDURE: Pre-Operative Diagnosis: papillary thyroid ca. Post-Operative. Diagnosis: same Operative Findings: isthmus nodule,. left lobe nodule. SPECIMENS SUBMITTED: 1. SERIAL 5 + 3FS, Delphan lymph node (1FS). 2. THYROIDECTOMY, TOTAL. INTRAOPERATIVE CONSULTATION: 1FS: ""Delphan lymph node, rule out metastatic thyroid cancer"". 1FS Diagnosis: Lymph node with fibrotic tissue, no tumor seen. -The frozen section is performed by Dr. and Dr. - Dr. is informed by Dr. of presence of micrometastasis in. lymph node on. GROSS DESCRIPTION: Two specimens are received fresh with the. patient's name, medical record number, and further specified as follows: 1. ""Delphan lymph node, rule out metastatic thyrold cancer"". It. consists of a yellow-tan soft tissue fragment measuring 0.8 x 0.7 x 0.4. cm. Entirely frozen. In Surgical Pathology, the specimen matched the. above description and the specimen is transferred to cassette. 2. ""Total thyroid gland, long stitch right superior, short left. superior"". It is a total thyroidectomy weighing 42.7 grams (post. procurement). Gross photographs are taken. The right lobe measures 3 x. 2.5 x 1.5 cm. The left lobe 6.5 x 3 x 1.5 cm. Isthmus measures 4 x 4 x. 1.5 cm. A solid lesion measuring 3.5 x 3.2 x 2.2 is identified in the. left lobe, while a cystic lesion 3.3 x 2.5 x 2 cm in deflated state is. identified in isthmus. Approximately 1 x 1 cm of tissue is procured for. Dr. from each lesions. Procurement was performed by Dr. in OR and. on. Also 0,5 cm of each tumor and 0.5 x 1 x 1 cm of normal tissue in the. right lobe is also procured for Dr. The right anterior. aspect of the gland (right lobe and isthmus) is inked blue, the left. anterior aspect of the gland (left lobe) is inked red, and posterior. aspect of the gland is inked black. Approximately 0.8 x 0,6 x 0.3 cm of. normal-appearing thyroid tissue from the right lobe is procured In TPPF. for the normal tissue bank by. on. a.m. The remainder of the specimen is placed in formalin and submitted. for Pathology for permanent processing. In Surgical Pathology, the. specimen matched the above description and is entirely submitted. The. external capsule of the gland is grossly uninvolved by aforementioned. two lesions. The superior aspect of left lobe is grossly uninvolved. with a beefy-red cut surface and is submitted in cassettes 2A and 2B. Do not file in Medical Record. Clinical Center. I. Birth Date: ty. from superior. to inferior. The solid lesion in the inferior aspect of. left lobe is yellow-tan and well-circumscribed with multiple focal. punctate hemorrhage and multiple nodular lesion measuring around 0.5 x. 0.6 cm but no necrosis or depressed scar. The solid lesion is submitted. from left upper aspect to left lower aspect in cassette 2C-2J and right. upper to right lower aspect in 2K-2O. The cystic lesion in the isthmus. is gray-tan with a finely papillary and granular appearance and focal. punctate hemorrhage. A calcified spot around 0.8x 0.6x 0.6 cm is. identified in the right middle aspect of the cystic lesion. The isthmus. is submitted from left upper aspect to left lower aspect in 2P-2R and. right upper to right lower in. Pright aspect of isthmus and. left aspect of right lobe from left to right. right lobe from. superior to inferior. 2GG: superior aspect of very right end of right. lobe. 2HH: inferior aspect of the very right end of right lobe. No consultants. #. (Other). Do not file in Medical Record.",T2,N1,M0,T2N1M0
TCGA-F5-6814,Subject. LARGE INTESTINE TISSUE. CHECKLIST. Specimen type: Resection of. rectum. Specimen size: Not specified. Tumor site: Rectum. Tumor size: 15 X 7.5 X 10 cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Pericolonic tissues. Lymph nodes: Not specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.,T3,N0,M0,T3N0M0
TCGA-AR-A0TP,"Breast, left, wide local excision: Infiltrating ductal carcinoma, Nottingham grade III (of III) forming a 3 x. 3 x 2.5 cm mass. Less than 10% of the tumor is in situ. No vascular invasion is identified. (AJCC pT2). The margins of excision are free of tumor. Lymph nodes, left axillary sentinel No.1 and No.2, excision: Multiple (2) left axillary sentinel lymph. nodes are negative for tumor, and contain no blue dye. Cytokeratin immunostains performed on both. sentinel lymph nodes confirm the H&E impression (AJCC pNO(i-). Lymph nodes, left axillary, excision: Multiple (3) left axillary lymph nodes are negative for tumor.",T2,N0,M0,T2N0M0
TCGA-DJ-A3UO,"ck. Neck. Clinical Diagn^sis & History: year old. vith left papillary thyroid carcinoma and right thyrold nodule showing atypical cells. Specimens Submitted: 1: Right paratracheal tissue, excision (fs). 2: Right level three and four lymph nodes, excision. 3: Left neck level three and four lymph nodes, excision (fs). 4: Thyroid, total thyroidectomy. 5: Left paratracheal tisssue, excision. DIAGNOSIS: 1. Right paratracheal tissue, excision (fs): Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 1. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 0.5cm. Size of the largest metastatic focus : 0.5 cm. Extranodal extension is identified. 2. Right level three and four lymph nodes, excision: Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 10. Number of lymph nodes with metastatic disease: 2. Size of the largest lymph node involved by tumor: 0.9cm. Size of the largest metastatic focus : 0.3 cm. Extranodal extension is identified. 3. Left neck level three and four lymph nodes, excision (fs): Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 11. 4. Thyroid, total thyroidectomy: Tumor Type: Papillary carcinoma, classical type. Two foci. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Right lobe. Tumor Size: The tumor foci measure 2.8 cm (right lobe) and 1.5 cm (left lobe) in greatest dimension. Tumor Encapsulation: None Identified. Blood Vessel Invasion: Identified at 3 foci of vascular invasion including a focus in the extrathyroidal tissue. Extrathyroid Extension: Invades:perithyroid fibroadipose tissue. Surgical Margins: Free of tumor. Tumor Multicentricity: Gross foci present. Non-Neoplastic Thyrold: No abnormalities identified. Parathyroid Glands: Identified. One unremarkable parathyroid gland in the left lobe. Lymph Nodes: Metastatic papillary carcinoma involving one lymph node (1/1). the lymph node measures 0.7 cm and is almost. totally replaced by tumor. 5. Left paratracheal tisssue, excision: Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 2. Number of lymph nodes with metastatic disease: 2. Size of the largest lymph node involved by tumor: 0.4cm. Size of the largest metastatic focus : 0.4 cm. Extranodal extension is not Identified. Benign parathyroid gland is identifed. (ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Report Erectronically Signed Out. Gross Description: 1. The specimen is received fresh, labeled ""Right paratracheal tissue"". It consists of fat and a lymph node measuring 1.8 x 0.6 x 0.3. cm. The lymph node measures 0.6 x 0.5 x 0.3 cm. The lymph node is submitted entirely for frozen section. Summary of Sections: FSC- frozen section control. 2. The specimen is received fresh, labeled ""right level three and four lymph nodes"" and consists of multiple possible lymph nodes. measuring from 0.2 cm up to 1.0 cm in greatest dimensions. All possible lymph nodes are entirely submitted. Summary of sections: LN - lymph nodes. 3. The specimen is received fresh, labeled ""Left neck level III and IV lymph nodes"". It consists of fat and lymph nodes. The lymph. nodes range in size from 0.1 to 1.1 cm in greatest dimension. The lymph nodes are submitted entirely for frozen section. The. remaining fat is entirely submitted. Summary of Sections: FSCA - frozen section control, approximately 5 lymph nodes. FSCB - frozen section control, two lymph nodes. RS - remaining fat with possible lymph nodes. 4. The specimen is received fresh labeled ""total thyroidectomy, stitch marks left lobe of thyroid"" and consists of a thyroid weighing. 30.5 g. The right lobe measures keep on 3.0 x 2.0 x 2.0 cm, the left lobe measures 2.5 x 2.0 X 1.5 cm and the isthmus measures. 1.0 x 0.5 x 0.5 cm. The external surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black,. and the anterior is inked blue. Sectioning reveals one large previously open nodule in the right lobe measuring 2.8 x 1.8 x 1.0 cm. Sections through the remaining tissue reveal a nodule in the left lobe measuring 1.5 x 1.5 x 1.2 cm. The left lobe also contains. another second smaller nodule measuring 0.7 x 0.3 x 0.2 cm. The remaining thyroid parenchyma is red tan and beefy. Representative sections of the specimen are submitted for. The remaining tissue is serially sectioned and representatively. submitted. Summary of sections: RN - right nodule. LN (1)- Left nodule. LN (2)- left lobe. RL right lobe. LL left lobe. IS - isthmus. 6. 5. The specimen is received fresh, labeled ""left paratracheal tissue"" and consists of an irregular piece of adipose tissue. measuring 3.0 x 2.0 x 0.4 cm. It is dissected to reveal a lymph node measuring 0.3 x 0.3 x 0.3 cm. All identified lymph nodes are. submitted. Summary of sections: LN - lymph nodes. AD- rest of adipose tissue. Summary of Sections: Part 1: Right paratracheal tissue, excision (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: Right level three and four lymph nodes, excision. Block. Sect. Site. PCs. 4. LN. 4. Part 3: Left neck level three and four lymph nodes, excision (fs).",T3,N1,M0,T3N1M0
TCGA-4G-AAZT,"Anatomic site: intrahepatic. Histology diagnosis: moderately differentiated intrahepatic cholangiocarcinoma. Immunohistochemistry: CK7 positive, CK20, CDX2 and TTF1 negative. Histological examination: Liver: resected parenchyma of 14x10 cm containing a whitish nodule of 9.2 cm, located 1.4 cm distant from the. resection margin. Histologically it is a moderately differentiated adenocarcinoma with an. immunohistochemical profile consistent with intrahepatic cholangiocarcinoma with positivity for cytokeratin 7. and negative for cytokeratin 20, CDX2 and TTF1. The liver tissue shows mild steatosis (<5%) associated with. mild fibrosis. Reactive lymphadenitis in all the examined lymph nodes: hepatic artery lymph nodes (2), retrocardial lymph. node (1), retro portal lymph nodes (2), inter aorto-caval lymph nodes (3).",T1,N0,M0,T1N0M0
TCGA-A7-A6VW,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Sentinel lymph node, left axilla, biopsy: Two negative lymph. nodes (0/2) . B. Breast, left, excisional biopsy: Invasive ductal carcinoma, grade. 3, size 3.0 cm in greatest dimension, close to the medial and. inferior margins. Microscopic Description: Invasive carcinoma: Histologic type: Ductal. Histologic grade: 3. Overall grade: 9/9. Architectural score: 3. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT2) : Size 3.0 cm in greatest dimension. Specimen margins: Carcinoma is well-demarcated, and forms a. discrete mass lesion that is less than 1 mm from the medial. margin and 0.5 mm from the inferior margin. Vessel invasion: Not identified. Ductal carcinoma in situ: Not identified. Comment: Prior biopsy site identified. Distant metastasis (pM) : Unknown. Lymph nodes: Two negative sentinel lymph nodes, 0/2. Prognostic markers: See previous core biopsy. Specimen. A. Left axillary sentinel node. B. Left breast biopsy. Clinical Information. Left breast cancer,. yo BF with grade 3 IDC. Gross Description. A. Received unfixed, labeled left axillary sentinel node, are two. lymph nodes, the larger of which is 1.4 x 1.2 x 1.0 cm, bisected. and submitted in blocks 1-2, and an additional node, 1.0 x 0.5. x. 0.5 cm, bisected and submitted in block 3. B. Received unfixed in a. container, lapeled left breast, is. a portion of fibrofatty tissue that is oriented and 6.0 cm anterior. to posterior, 4.5 cm medial to lateral, and 2.3 cm superior to. inferior. Margins are inked: inferior blue, superior black,. medial yellow, lateral green. The specimen is serially sectioned. from anterior to posterior. There is a 3.0 x 2.0 x 1.9 cm tumor. present, adjacent to the medial and inferior margins. Representative sections, including the anterior and posterior shave. margins, sequentially submitted in 8 blocks.",T2,N0,M0,T2N0M0
TCGA-BH-A0AV,"FINAL DIAGNOSIS: PART 1: BREAST, LEFT. 11 O'CLOCK SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCTAL CARCINOMA. B. NEOPLASM MEASURES 1.5 CM ON SLIDE 1F. C. NOTTINGHAM SCORE 8/9, GRADE 3 (TUBULES 3, NUCLEI 3, MITOSES 2). D. MARGINS OF RESECTION FREE OF NEOPLASM, CLOSEST POSTERIOR AT 0.6 CM. E. NO LYMPHOVASCULAR INVASION IDENTIFIED. F. ER NEGATIVE, PR NEGATIVE, HER-2/NEU NOT AMPLIFIED PER PREVIOUS REPORTS. G. PATHOLOGIC STAGE pT1C, pNo, pMX. H. DUCTAL CARCINOMA IN SITU, SOLID TYPE, NUCLEAR GRADE 3 WITH COMEDONECROSIS AND. CALCIFICATION. I. DUCTAL CARCINOMA IN SITU IS IDENTIFIED IN FOUR OF FIFTEEN (4/15) SECTIONS, OUTSIDE OF INVASIVE. COMPONENT. J. MARGINS OF RESECTION FREE OF IN SITU CARCINOMA BY GREATER THAN 1.0 CM (see comment). K. UNREMARKABLE SKIN. L. FIBROCYSTIC CHANGES. PART 2: LYMPH NODE, LEFT AXILLARY, SENTINEL NUMBER 1, BIOPSY -. ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 3: LYMPH NODE, LEFT AXILLARY, NONSENTINEL, BIOPSY -. ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Upper inner quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 1.5 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 2. Total Nottingham score: 8. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Solid. DCIS present outside of invasive carcinoma component. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 6.0 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: o. LYMPH NODES EXAMINED: 2. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: previously performed. PROGESTERONE RECEPTORS: previously performed. HER2/NEU: zero or 1+.",T1,N0,M0,T1N0M0
TCGA-D7-6519,"page 1 / 1. Examination: Histopathological examination. Material: Total organ resection - stomach. Expected time of examination: Clinical diagnosis: Macroscopic description: Sent material containing the stomach, incised along the greater curvature, sized 19.2 x 13.2 cm with the. omentum sized 20 x 8 cm. Wall thickening in the orifice region over the area of 4.8 x 6.2 x 1.4 cm. Distance. from the proximal end: 0.8cm, from distal end: 13.1 cm. Microscopic description: Adenocarcinoma mucocellulare ventticuli ( typus mixtus S. Lauren; G3) - Infiltratio parietis totae ventriculi. pT2). Incision lines free of neoplastic lesions. Invasio vasorum. Metastases in lymphonodls (II /XVI). Histopathological diagnosis;. (including test No. G-15580/10): Adenocarcinoma mucocellulare ventriculi. (Mucocellular adenocarcinoma of the stomach. Metastases in lymphonodis (II/ XVI). lymph nodes with metastases (II/XVI). Invasio vasorum. vascular Invasion. (G3,pT2, pN1).",T2,N1,M0,T2N1M0
TCGA-S3-AA10,"Temporary Copy. Diagnosis. A. RIGHT BREAST, MASTECTOMY: - HIGH-GRADE INVASIVE DUCTAL CARCINOMA; SEE SYNOPTIC REPORT. - NEGATIVE MARGINS. - SKIN AND NIPPLE WITHOUT SIGNIFICANT PATHOLOGIC ABNORMALITY. - FOUR LYMPH NODES, NEGATIVE FOR TUMOR (0/4); SEE SPECIAL STAINS. (Electronic signature). Verified: Synoptic Report. TUMOR SIZE: SIZE OF LARGEST INVASIVE CARCINOMA: Greatest dimension of largest focus of invasion over 0.1 cm: 2.5 cm. Additional dimensions: 2.5 x 1.5 cm. TUMOR FOCALITY: Single focus of invasive carcinoma. MACROSCOPIC AND MICROSCOPIC EXTENT OF TUMOR: Skin: Invasive carcinoma does not invade into the dermis or epidermis. Nipple: DCIS does not involve the nipple epidermis. Skeletal Muscle: Skeietal muscle is present and is free of carcinoma. DUCTAL CARCINOMA IN SITU (DCIS): No DCIS is present. LOBULAR CARCINOMA IN SITU (LCIS): Not identified. HISTOLOGIC TYPE OF INVASIVE CARCINOMA: Invasive ductal carcinoma (no special type or not otherwise specified). GLANDULAR (ACINAR)/TUBULAR DIFFERENTIATION: Score 3: <10% of tumor area forming glandular/tubular structures. NUCLEAR PLEOMORPHISM: Score 3: Vesicular nuclei, often with prominent nucleoli, exhibiting marked variation in size and shape,. occasionally with very large and bizarre forms. MITOTIC COUNT: Score 3. Number of mitoses per 10 high-power fields: 88. Diameter of microscope field: 0.55 mm. OVERALL GRADE: Grade 3: scores of 8 or 9. MARGINS: Margins uninvolved by invasive carcinoma. Distance from anterior margin: 4.0 mm. Distance from posterior margin: 2.0 mm. TREATMENT EFFECT: RESPONSE TO PRESURGICAL THERAPY: IN THE BREAST: No known presurgical therapy. TREATMENT EFFECT: RESPONSE TO PRESURGICAL THERAPY: IN THE LYMPH NODES: No known presurgical therapy. LYMPH-VASCULAR INVASION: Not identified. Temporary Copy. DERMAL LYMPH-VASCULAR INVASION: Not identified. LYMPH NODES: Total number of lymph nodes examined (sentinel and nonsentinel): 4. Number of lymph nodes with macrometastases (>0.2 cm): 0. Number of lymph nodes with micrometastases (>0.2 mm to 0.2 cm and/or >200 cells): 0. METHOD OF EV /ALUATION OF SENTINAL LYMPH NODES: Hematoxylin and eosin (H&E), one level. Immunohistochemistry. PRIMARY TUMOR (INVASIVE CARCINOMA (pT): pT2: Tumor >20 mm but less than or equal to 50 mm in greatest dimension. REGIONAL LYMPH NODES (pN): pN0: No regional lymph node metastasis identified histologically. DISTANT METASTASIS (M): Not applicable. ADDITIONAL PATHOLOGIC FINDINGS: Benign breast with calcifications. ESTROGEN RECEPTOR: Performed on this specimen. No immunoreactive tumor cells present. PROGESTERONE RECEPTOR: Performed on this specimen. No immunoreactive tumor cells present. HER2/NEU IMMUNOPEROXIDASE STUDIES: Performed on this specimen. Negative (Score 0). MICROCALCIFICATIONS: Present in non-neoplastic tissue. Specimen Source. A. RT Breast and Axillary Contents. Clinical Information. None. PRE-OP DIAGNOSIS: Right breast CA. POST-OP DIAGNOSIS: Same. TYPE OF PROCEDURE: Right modified mastectomy. Gross Description. The specimen is labeled ""RIGHT BREAST AND AXILLARY CONTENTS"" and is received unfixed (the. specimen is in formalin for more than 6 hours and less than 48 hours). It consists of a 420 g right mastectomy. with axillary contents weighing 420 g measuring 18 x 10 x 3.0 cm. The axillary content measures 6.0 x 5.5 x 3.0. cm. The nipple is unremarkable measures 1.3 x 1.3 cm in maximum dimensions. Solar is unremarkable. The left. fascia is smooth and glistening. The anterior margin is inked red and the deep posterior margin is inked black. On sectioning, there is a well-circumscribed lobulated focally hemorrhagic pink-tan mass measuring 2.5 x 2.5 x. 1.5 cm. The mass is close to the deep posterior margin in the outer quadrant close to the axillary contents. The. mass is 0.7 cm from the anterior margin and approximately 12 cm from the nipple. On further sectioning the. breast parenchyma is nodular, there are no other lesions grossly identified. There are four fatty lymph nodes. Temporary Copy. ranging from 0.5-2.0 cm in maximum dimensions. Representative sections are submitted. Section Key: Al - A2 tumor markers with deep margin. A3 tumor. A4 - nipple and skin. A5 - anterior margin close to mass. A6 - upper inner quadrant. A7 - lower inner quadrant. A8 - random sections from central breast. A9 - upper outer quadrant. A10 - lower outer quadrant. All - one lymph node bisected. A12 - one lymph node bisected. A13 - two lymph nodes. Time specimen was removed from the patient (procedure time): Time specimen was placed in formalin: Ischemic time: 1 hour 20 minutes. Special Stains / Slides. IMMUNOHISTOCHEMICAL EVALUATION OF ESTROGEN RECEPTORS, PROGESTERONE. RECEPTORS, AND HER-2NEU IN INVASIVE MAMMARY CARCINOMA . ESTROGEN RECEPTORS: 0 %, NEGATIVE. PROGESTERONE RECEPTORS: 0 %, NEGATIVE. STAINING INTENSITY: HER-2NEU: SCORE 0, NEGATIVE. Immunohistochemical studies were performed on formalin fixed paraffin embedded tissue (Block A2) using the. following monoclonal antibodies; Estrogen receptor (Clone SP1), Progesterone receptor (Clone 1E2) and. Her-2neu (. Clone 4B5); control sections for HER-2Neu are provided within a kit (score 0 MCF-7, score. 1+ T-47D, score 2+ MDA-MB-453, score 3+ BT-474). Detection system used: polymer. Primary antibodies,. reagents and control sections for HER-2neu are all provided by. All controls show appropriate reactivity. Reactivity of Estrogen and Progesterone receptors is determined based on the percentage of positively. stained nuclei of tumor cells. Reference values (CAP accreditation program checklist 2010 and guidelines on. webpage): Positive: nuclear staining in 1% or greater than 1% of invasive carcinoma cells. Negative : nuclear staining in less than 1% of invasive carcinoma cells. Staining intensity: is reported as weak, moderate or strong. Temporary Copy. HER-2neu reactivity is reported applying the CAP scoring guidelines (CAP accreditation program checklist. 2010 and guidelines on webpage): Score 0 = Negative: No immunoreactivity, or faint weak immunoreactivity in <10% of tumor cells but only a. portion of the membrane is positive.. Score 1 = Negative: Faint weak immunoreactivity in 10% or >10% of tumor cells but only a portion of the. membrane is positive. Score 2+ = Equivocal: Weak to moderate complete membrane immunoreactivity in >10% of tumor cells or. circumferential intense membrane staining in <30% of cells. Score 3+ = Positive: More than 30% of the tumor cells must show circumferential intense and uniform. membrane staining. A homogeneous (chicken wire) pattern should be present. Equivocal results for HER-2neu (Score 2+) will be subsequently followed by a reflex dual-color ISH testing. Additional immunohistochemical studies fpr AE1/AE3 were performed on formalin fixed, paraffin-embedded. tissue (Blocks A11-13) with adequate positive and negative control sections. All stains were negative. The performance characteristics of these antibodies were determined by the. They have not been cleared or approved by the U.S. Food. and Drug Administration. The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical. purposes. They should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory. Improvement Amendments of 1988 (CLIA-88) as qualified to perform high-complexity clinical laboratory testing. Tissue Code.",T2,N0,M0,T2N0M0
TCGA-KL-8326,"Clinical Diagnosis & History: 7cm right renal mass. Specimens Submitted: 1: SP: Right kidney and adrer. 2: SP: Paracaval lymph node. DIAGNOSIS: 1). KIDNEY/ADRENAL, RIGHT; NEPHRECTOMY: - RENAL CELL CARCINOMA, CHROMOPHOBE TYPE, EOSINOPHILIC. VARIANT TUMOR MEASURES 6.3 CM IN GREATEST DIAMETER, AND. INVOLVES THE UPPER POLE OF THE RIGHT KIDNEY. - TUMOR INVADES THROUGH RENAL CAPSULE AND IS PRESENT WITHIN. PERINEAL SOFT TISSUE (pT3a). - NO VASCULAR INVASION IS IDENTIFIED. - BENIGN URETER AND VASCULAR MARGINS. - SURGICAL MARGINS ARE FREE OF TUMOR. - BENIGN ADRENAL. - BENIGN RENAL PARENCHYMA IS UNREMARKABLE. 2). PARACAVAL LYMPH NODE; EXCISION: - FOURTEEN BENIGN LYMPH NODES (0/14) . IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SI IDES (AND/OR OTHER MATERIAL) AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh, labeled ""Right kidney and. adrenal"". It consists of a 880 grams of nephrectomy specimen. The specimen measures 23 X 10 X 8.5 cm. The specimen consists of. kidney with surrounding perirenal soft tissue and attached. proximal segment of the ureter. The right adrenal gland is also. grossly identified at the upper pole of the specimen, measuring. 4.2 x 2 X 0.9 cm. Grossly, a bulging renal mass is present at. JURGICAL PATHOLOGY REPORT. the upper pole of the kidney. The specimen is bivalve along the. ureter to reveal a relatively circumscribed tumor mass at the. upper pole of the kidney measuring 6.3 cm in greatest diameter. The remaining kidney tissue measures 10 X 6.2 X 4 cm. The mass. shows mosaic colors of brown, tan and grey area. The texture of. the tumor is rubbery. No definite necrosis is identified. Focal. scar is also present. The tumor appears to bulge and invades. into the renal capsule. The tumor does not involve the renal. cavity. No vascular involvement of the tumor is identified. The. attached ureter measures approximately 7 cm in length and 0.4 to. 0.5 cm in diameter. The proximal ureter shows dilated appearance. and contains urine. The rest of the renal parenchyma is. unremarkable. The cut section of the adrenal is unremarkable. Representative sections are submitted. A portion of tumor is. sent for. and a small portion is kept in glutaraldehyde. definite lymph nodes are identified within the hilar perirenal. fat. Summary of Sections: - tumor. R. - random section of kidney. UM. - ureteral margin. VM. - vascular margin. ADR - adrenal. 2). The specimen is received in formalin, labeled ""Paracaval. lymph node"". It consists of two irregular pieces of yellow-tan. fibroadipose tissue, measuring 4.5 X 3.0 X 1.5 cm in aggregate,. possibly containing lymph nodes. The specimen is submitted. entirely. Summary of Sections: U - Undesignated. Summary of Sections: Part. Sect. SiteBlocks Pieces. All. 1. ADR. 1. 1. N. R. 1. 1. 9. 9. UM. 1. 1. VM. 1. 1. 2. U. 6. M. Y.",T3,N0,M0,T3N0M0
TCGA-G3-A5SI,"Note: If you do not see ""END OF PRINTED REPORT"" at the bottom of th. the report YOU DO NOT HAVE THE ENTIRE REPORT. Please try printi. CONFIDENTIAL. Relevant. information. Demographics. (for verification. Drtn of Rirth. purposes). Collected Date/Time. Received Date/Time. Specimen Description. A. Segment V and VI, and gallbladder. Clinical Information. Hepatocellular carcinoma. Infectious patient:Yes - Hep C positive. Immunocompromised: No. History of neoplasm: No. Diagnosis. A. Liver Segment V and VI, and Gallbladder, Partial Hepatectomy and Cholecystectomy: Hepatocellular carcinoma, moderately differentiated. One large tumor, 3.4 CIII in greatest dimension, with microscopic. foci of well circumscribed tumor nodules away from the main tumor,. possibly represent intrahepatic metastasis. No lymphovascular invasion identified. Background cirrhosis and chronic hepatitis. Resection margins negative for malignancy. Unremarkable gallbladder. One benign lymph node. See synoptic report. Verified: Synoptic Report. A: Liver, Resection, Microscopic. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: GII: Moderately differentiated. TUMOR EXTENSION (select all that apply) : Tumor confined to liver. PRIMARY TUMOR (pT) : pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. REGIONAL LYMPH NODES (pN) : pNO: No regional lymph node metastasis. Number examined: 1. Number involved: 0. DISTANT METASTASIS (pM) : pMX: Cannot be assessed. MARGINS: Parenchymal margin uninvolved by invasive carcinoma. VENOUS (LARGE VESSEL) INVASION (V) : Absent. ADDITIONAL PATHOLOGIC FINDINGS: Cirrhosis/fibrosis. Hepatitis (specify type) : Chronic Hepatitis. Gross Description. Received is a single specimen. The requisition and specimen container are labelled with. the patient's name. The cassette and AP identifiers are labelled with the. Surgical Number. A. The liver segment measures 7.5 x 6.0 x 5.0 cm. The liver resection margin is inked. blue. The surface is nodular and has a cirrhotic appearance. The attached gallbladder. measures 9.5 x 3.0 x 2.5 cm and has a smooth surface. There is one lymph node present. near the cystic duct resection site measuring 1.3 cm in greatest dimension. Serial. sectioning of the liver reveals a tan/yellow solid mass measuring 3.4 x 3.0 x up to 2.8. cm and has a slightly hemorrhagic area measuring 0. cm in greatest dimension on one. side; it bulges toward one area on the liver surface. The tumor has a lobular appearance. and is at least 1.5 cm from the liver resection margin. The rest of the liver parenchyma. appears nodular, with areas of green discoloration. No second mass lesion is identified. Grossly, the liver mass does not adhere or invade into the gallbladder. Opening of the. gallbladder reveals dark green velvety inner lining, with no calculi present and no. grossly identifiable lesion on the inner lining. Sections are submitted as follows: A1 - liver mass with the bulging surface. A2 - tumor with liver resection margin. A3 through A5 - mass with hemorrhagic area in A4. A6 - additional tumor with resection margin. A7 - gallbladder with underlying liver. A8 - liver tissue away from the mass. A9 - cystic duct margin. A10 - lymph node near the cystic duct, bisected. All - section of a small 0.2 cm nodular that is 0.8 cm away from the main mass. Pathologist Comment. Dr. has reviewed selected slides. Number. Encounter. Number. Patient Location. - END OF PRINTED REPORT -.",T2,N0,M0,T2N0M0
TCGA-BF-A5EQ,Component. Type of. Histological. of treatment. Tissue. Clinical. Tumor. Specimen. Specimen. Number of. Amount/per. Grade. TNM Stage. TNM Stage. TNM Stage. Treatment. Tumor cell. Clinical. Specimen. Specificati. Container. Procurem. description. (Chemo. Ethrucity. Anatomical Site. Index. (Race). Diagnosis. Matrix. containera. container. (source). (T). (N). (M). type. %. Format. Site #. (Source). Horm Th. label. on. ent. Details). 4. 0. 0. none. n/a. 75. Caucasian. Male. Melanoma. Skin. Primary. Tumor. Tissue. OCT. block. 1. 200. mg. Melanoma. n/a. (White). blood. Caucasian. Male. Melanoma. Blood. n/a. Normal. Blood. frozen. tube. 1. 4. ml. n/a. n/a. n/a. n/a. n/a. none. n/a. n/a. draw. (White). Criteria.,T4,N0,M0,T4N0M0
TCGA-HU-A4GH,"CLINICAL DIAGNOSIS: Stomach Ca. GROSS: Specimen submitted: Distal gastrectomy, unfixed. Measurement : Greater curvature 25.1 cm. Lesser curvature 17.4 cm. Proximal resection margin 18.0 cm. Distal resection margin 4.7 cm. Duodenum 1.2 cm. Tumor location: Stomach: Middle 1/3 (body), posterior wall. From proximal resection margin - 2.0 cm. From distal resection margin - 13.0 em. Tumor size: 2.5 X 2.4 cm. Tumor type: EGC I. Gross serosal invasion No. Representative sections are submitted. Gross photo: Present. Blocks. T1-4, tumor and surrounding tissue x 4. A, antral mucosa X 1. B, body mucosa x 1. P, proximal resection margin x 1. D, distal resection margin x 1. LN1-2, superior. gastric lymph nodes x 2 adenocarctions, tubular 8211/3. LN3-4, inferior gastric lymph nodes x. 2. LN5, '1' lymph nodes x 1. LN6, '4sb' lymph nodes x 1. LN7, '5' lymph nodes x 1. LN8, '6' lymph nodes X 1. LN9, '7' lymph nodes x 1. LN10, '8' lymph nodes x 1. LN11-12, '9' ymph nodes X 2. LN13, '11p' 1ymph nodes X 1. LN14, '12' lymph nodes X 1. MICROSCOPIC. Tumor type: Adenocarcinoma - tubular moderately differentiated. - over -. Depth of tumor invasion: T1: T1b-Submucosa upper 1/3 (SM1). Margins: Proximal resection margin. Distal resection margin (-). Lauren classification: Intestinal. Ming classification (Growth pattern): Infiltrative. Lymphoid reaction: Absent. Lymphovascular invasion: Present. Venous (large vessel) invasion: Absent. Perineural invasion: Absent. Lymph node metastasis: Absent. SPECIAL STAIN: Cresyl Violet stain reveals no H. pylori. NOT reported. Gross: Stomach, body, scopic, adenocarcinoma. DIAGNOSIS: Stomach, distal gastrectomy. Adenocarcinoma. moderately differentiated (earl ly cancer). Lymph node, perigastric, distal gastrectomy. Superior gastric: No tumor present (0/9). Inferior gastric: No tumor present (0/5). Lymph node, regional, biopsy: Labeled '1' : No lymphoid tissue present. Labeled '4sb': No tumor present (0/2). Labeled Labeled '5' 6' : No No tumor lymphoid present tissue (0/7). present. Labeled '7' : No tumor present (0/4). Labeled '8' No tumor present (0/2). Labeled '9' No tumor present (0/9). Labeled 11p' No tumor present (0/3). Labeled T2 : No lymphoid tissue present.",T1,N0,M0,T1N0M0
TCGA-56-8622,"GROSS AND MICROSCOPIC SURGICAL PANEL. DIAGNOSIS. A) BONE, RIGHT SIXTH RIB: 1. Rib (gross examination). 2. Marrow with trilineage maturation. 3. Negative for malignancy. B) LUNG, RIGHT LOWER LOBE, LOBECTOMY: 1. Squamous cell carcinoma, moderately differentiated, 3.5 cm. 2. Tumor is confined to the lung, negative for pleural involvement. by tumor. 3. Surgical margins are negative for tumor. 4. Negative for lymphatic/vascular invasion by tumor. 5. One intralobar (N1) lymph node, negative for metastasis (0/1). 6. Two hilar (N1) lymph nodes, negative for metastasis (0/2). 7. Please see lung cancer staging parameters below. C) LYMPH NODE, STATION 7 N2, BIOPSY: One lymph node negative for metastasis. (0/1). UNG CANCER STAGING PARAMETERS. Final TNM: pT2aNOMO. stage: IB. MACROSCOPIC. SPECIMEN TYPE. Lobectomy. TUMOR SITE. Right Lung-Lower Lobe. TUMOR SIZE. Greatest dimension is 3.5 cm. TUMOR FOCALITY. Unifocal. MICROSCOPIC. HISTOLOGIC TYPE. Squamous cell carcinoma. HISTOLOGICAL GRADE. G2: (moderately differentiated) of G4. VISCERAL PLEURAL INVASION. Not identified. LYMPHATIC VASCULAR INVASION. Absent. TREATMENT EFFECT. Not applicable. MARGINS. Uninvolved by tumor. PATHOLOGIC STAGING. EXTENT OF INVASION. pT2a. (Tumor greater than 3 cm, but 5 cm or less in greatest. dimension surrounded by lung or visceral pleura, without bronchoscopic. evidence of invasion more proximal than the lobar bronchus (ie, not in the. main bronchus); or Tumor 5 cm or less in greatest dimension with any of the. following features of extent: involves main bronchus, 2 cm or more distal. to the carina; invades the visceral pleura; associated with atelectasis or. obstructive pneumonitis that extends to the hilar region but does not. involve the entire lung). REGIONAL LYMPH NODES. pNO. (No regional lymph node metastasis). Total nodes: 4. Total positive nodes: 0. N1 nodes: 3. N1 positive nodes: 0. N2 nodes: 1. N2 positive nodes: 0. N2 sites sampled: Station 7: Subcarinal nodes. DISTANT METASTASIS. pMO. (No distant metastasis). PATHOLOGIC STAGE Summary. Final TNM: pT2aNOMO. $tage: IB. The pathologic stage presumes no distant metastasis. LUNG ANCILLARYTESTING PROTOCOL. HISTOLOGIC TYPE. Squamous cell carcinoma. STAGE IV STATUS. Stage IV status is undetermined. TISSUE BLOCK AVAILABLE FOR ANCILLARY TESTING. BFS2, B3-6. COMMENT. This patient's sample does not meet. criteria for reflex EGFR and ALK testing. No fresh tissue is available. for ancillary testing. The block identified above will be stored in. pathology for 10 vears for possible future ancillary testing. Please call. for any ancillary testing requests. lung Cancer Committee EGFR and ALK reflex testing criteria: Stage IV disease (histologically proven or clinically suspicious). Adenocarcinoma or TTF-1 positive adenosquamous cell carcinoma. Attending Pathologist: CLINICAL INFORMATION. The patient is status-post heart transplant in 2005. CT identified. ""non-caseating granulomas"" in the right lung measuring 3 X 3 cm. Two. previous FNAs were attempted on the mass. One identified noncaseating. granulomas; and the other identified normal lung parenchyma. Three. subsequent hilar lymph node biopsies identified benign lymphoid material. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Right sixth rib bone. Received fresh and labeled ""right sixth rib"" and consists of a portion of. rib measuring 6.5 X 1.5 X 0.6 cm with scant fragments of attached muscle. with cautery artifact. No surface lesions are identified. Representative. marrow is extracted and submitted into one cassette. B) SOURCE: Right lower lobe of lung. The specimen consists of a portion of lung weighing 260 gm and measuring. 18.5 X 13 X 3 cm. A single staple line is present measuring 7 cm in length;. and a stitch on the contralateral aspect of the specimen demarcates the. bronchial margin. The specimen is received partially disrupted adjacent to. the staple line. In the area of disruption, a firm, tan-white round and. well-demarcated mass measuring 3.5 X 3.0 X 2.5 cm is identified, and comes. to within 0.1 cm of the pleural surface. The pleural surface is inked blue. The tumor is located 4.5 cm from the bronchial margin. INTRAOPERATIVE PATHOLOGY CONSULTATION: ""Bronchial margin negative"" is. rendered by. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Tumor nodule. non-small cell carcinoma, favor squamous cell"" is rendered by. The staple line is removed and inked orange. The tumor is 0.4 cm from the. staple line after its removal. Subpleural anthracotic pigment is minimal. Two hilar lymph nodes are identified and submitted entirely. The remainder. of the specimen is completely sectioned revealing tan-pink crepitant. parenchyma without additional lesions. Tissue is obtained for possible ancillary studies. Sections are submitted into nine cassettes as follows: FS1. Bronchial margin. FS2. Representative tumor. B3. Tumor with overlying inked pleura. B4. Tumor towards bronchial margin. B5. Tumor with inked staple line margin. B6. Tumor with uninvolved parenchyma. B7. Uninvolved normal parenchyma with intraparenchymal lymph node. B8. Bronchial pseudo margin (true bronchial margin submitted. for frozen section). B9. Vascular margin with two hilar lymph nodes, each bisected. C) SOURCE: Station 7 lymph node. Labeled ""station 7 lymph node"" is a 2.8 x 2.1 x 2 cm lobulated maroon-brown. lymph node with several attached metal clips. Cut surfaces are maroon-black. and without discrete suspicious foci. Entirely submitted in four cassettes. This case is accessioned in. MICROSCOPIC. A-C) The microscopic appearance substantiates the diagnosis.",T2,N0,M0,T2N0M0
TCGA-DK-A3IL,"F. Urology. Clinical Diagnosis & History: Bladder carcinoma, T2. Specimens Submitted: 1: Right distal pelvic lymph nodes. 2: Left distal pelvic lymph nodes. 3: Bladder, uterus, fallopian tubes and ovary, inter vaginal wall, perivesicle tissue. 4: Right ureteral stent. 5: Left distal ureter. 6: Right distal ureter. DIAGNOSIS: 1. Right distal pelvic lymph nodes: Part #. 1. Lymph Node Dissection: Metastatic urothelial carcinoma. Number of lymph nodes examined: 3. Number of lymph nodes with metastatic disease: 2. Size of the largest lymph node involved by tumor: 1.2cm. Size of the largest metastatic focus : 1.2 cm. Extranodal extension is not identified. 2. Left distal pelvic lymph nodes: Part # 2. Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 1. 3. Bladder, uterus, fallopian tubes and ovary, inter vaginal wall, perivesicle tissue: Part # 3. Tumor Type: Invasive urothelial carcinoma, NOS. Histologic Grade: High grade. Pattern of growth of the Non-Invasive component: Flat (in situ carcinoma). Pattern of growth of the Invasive component: Infiltrating. Tumor Multicentricity: Identified. Bladder Local Invasion: Perivesical soft tissues. Extravesical Tumor Extension: Ureters uninvolved. Urethra uninvolved. Vascular Invasion: Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Mucosa: Exhibiting ulceration. Exhibiting foreign body reaction. Female Genital Organs: The right ovary shows stromal hyperplasia. The left ovary shows stromal hyperplasia. Remaining genital organs are unremarkable. Perivesical Lymph Nodes: Not involved 0/1. The Pathologic Stage is (AJCC 2002): pT3 (Invasion of perivesicle soft tissue). 4. Right ureteral stent: - Gross diagnosis only. 5. Left distal ureter; excision: - Segment of benign ureter. 6. Right distal ureter; excision: - Segment of ureter with mild to moderate urothelial atypia; no carcinoma is identified. ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh, labeled ""Right distal pelvic lymph nodes"" and consists of three pink tan firm lymph nodes. ranging from 1.5 x 0.8 cm up to 6 x 2.5 cm in greatest dimension. Half of the two smaller lymph nodes are submitted to TPS. All. remaining identified lymph nodes are submitted. Summary of sections: RLN -remaining halves of two smaller lymph nodes. LLN - largest lymph node. 2). The specimen is received fresh, labeled ""Left pelvic lymph nodes and consists of a single lymph node measuring 5.5. x. 2. x. 0.8. cm. The lymph node is entirely submitted. Summary of sections: LN - lymph node. 3). The specimen is received fresh, labeled ""bladder, uterus, fallopian tubes and ovaries, vagina wall, perivesical tissue"". It consists. of a 7 x 5 x 3 cm bladder with attached uterus in continuity with the cervix (6.8 X 3.3 x 2.4 cm), right ovary (1.8 x 1.3 x 0.6), left. ovary (1.7 x 1.2 x 0.6cm), right fallopian tube (4. .3 cm in length x 0.5 cm in average diameter) and left fallopian tube (4.7 cm in. length x 0.5 cm in average diameter) and vaginal cuff (3 6 x 2.1 x 0.5 cm). The distal urethra and the vaginal cuff margin are. shaved and submitted. The ureteric stumps measure 0.8 (right) and 0.2 (left) cm in length. The left is inked blue and the right is. inked green. The bladder is opened anteriorly to reveal an ulcerated firm lesion measuring 3.3 x 3 cm. The lesion is located in the. right lateral wall, right posterior wall, right trigone. It extends to the right urethra but does not extend to the margin. The right. ureteral orifice is located within the lesion. The left ureteric orifice is located 0.9 cm from the lesion. On sectioning, the tumor. extends 0.8 cm to the perivesical fat but not to the inked surface. The remaining bladder mucosa is unremarkable. The uterus,. ovaries and fallopian tubes are unremarkable. Tissue is submitted for. Representative sections are submitted. Summary of sections: UTHM - distal urethra. RUM - right ureter margin. LUM - left ureter margin. L lesion. LM - lesion and adjacent mucosa. RUO - right ureteric orifice. LUO - left ureteric orifice. LP- left posterior wall. LA - left anterior wall. RP- right posterior wall. RA right anterior wall. TRI trigone. DOME dome. EMM - endomyometrium. CX cervix. DVM - distal vaginal margin. RTO - right tube and ovary. LTO - left tube and ovary. 4). The specimen is received fresh labeled, ""Right ureteral stent"" and consists of an elongated tubular blue stent measuring 25 x. 0.2 cm. The specimen is photographed. Gross only. 5). The specimen is received in formalin labeled ""Left distal ureter, unclipped mark is the margin."" It consists of a segment of. ureter measuring 2.7 cm in length and 0.6 cm in diameter. There is a clip on one end of the specimen. The specimen is serially. sectioned from the tip with the clip to the non-clipped end and submitted entirely. Summary of sections: TC-tip with clip. SS-serial sections from clipped to non-clipped end. TWC-Tip without clip. 6). The specimen is received in formalin labeled ""Right distal ureter, unclipped mark is the margin."" It consists of a segment of. ureter measuring 2.4 cm in length and 0.6 cm in diameter. There is a clip on one end of the specimen. The specimen is serially. sectioned from the tip with the clip to the non-clipped end and submitted entirely. Summary of sections: TC-tip with clip. SS-serial sections from clipped to non-clipped end. TWC-Tip without clip. Summary of Sections: Part 1: Right distal pelvic lymph nodes. Block. Sect. Site. PCs. 5. LLN. 5. 1. RLN. 1. Part 2: Left distal pelvic lymph nodes. Block. Sect. Site. PCs. 5. LN. 5. Part 3: Bladder, uterus, fallopian tubes and ovary, inter vaginal wall, perivesicle tissue. Block. Sect. Site. PCs. 1. CX. 1. 1. DOME. 1. 1. DVM. 1. 1. EMM. 1. 3. L. 3. 1. LA. 1. 2. LM. 2. 1. LN. 5. 1. LP. 1. 1. LTO. 1. 1. LUM. 1. 1. LUO. 1. 1. RA. 1. 1. RP. 1. 1. RTO. 1. 1. RUM. 1. 1. RUO. 1. 1. TRI. 1. 1. UTHM. 1. Part 4: Right ureteral stent. Part 5: Left distal ureter. Block. Sect. Site. PCs. 1. SS. 1. 1. tc. 1. 1. twc. 1. Part 6: Right distal ureter. Block. Sect. Site. PCs. 1. SS. 1. 1. tc. 1. 1. twc. 1.",T3,N2,M0,T3N2M0
TCGA-95-7947,"Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Anat Path Reports. Document Date: Histology. APRPT (Verified). Acc #: M. Client: Submitting. Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. A. LUNG, LEFT UPPER LOBE, WEDGE RESECTION, A1FS: ADENOCARCINOMA, MIXED SUBTYPE, WITH ACINAR, PAPILLARY AND MICROPAPILLARY PATTERNS OF. GROWTH. THE CARCINOMA IS MODERATELY DIFFERENTIATED AND MEASURES 1.5 X 1.1 X 0.7 CM. - ANGIOLYMPHATIC INVASION IDENTIFIED. - NO VISCERAL PLEURAL INVASION IS IDENTIFIED. - SURGICAL PARENCHYMAL MARGIN IS NEGATIVE FOR CARCINOMA. - SEE SYNOPTIC REPORT. B. LYMPH NODES, #6, EXCISION, B1FS: - FIVE LYMPH NODE FRGAMENTS, NEGATIVE FOR METASTATIC CARCINOMA (0/5). - PARTIALLY CALCIFIED, FIBROTIC NODULES, NEGATIVE FOR CARCINOMA. C. LYMPH NODES, #7, EXCISION, C1FS: - THREE LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA (0/3). Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. D. LYMPH NODE, #9, EXCISION, D1FS: ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). E. LYMPH NODE, 10L, EXCISION, E1FS: - ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). F. LUNG, LEFT UPPER LOBE, MEDIAL, WEDGE RESECTION: - LUNG WITH BULLOUS EMPHYSEMATOUS CHANGES. - NEGATIVE FOR CARCINOMA. Comment. Immunohistochemical and special stains (all on block A3): CK7. positive. - CK20. negative. - TTF1. positive. - Napsin A. negative. - Pax 8. negative. - Mucicarmine. positive (focal). This staining profile is compatible with a lung primary. Synoptic Worksheet. A. Wedge excision left upper lobe: Specimen: Lung. Procedure: Wedge resection. Specimen Integrity: Intact. Specimen Laterality: Left. Tumor Site: Upper lobe. Tumor Focality: Unifocal. Histologic Type: Adenocarcinoma, mixed subtype. Histologic Grade: G2: Moderately differentiated. Tumor Size: Greatest dimension: 1.5 cm. Additional dimension: 1.1 cm. Additional dimension: 0.7 cm. Visceral Pleura Invasion: Not identified. Tumor Extension: Not applicable. Bronchial Margin: Involvement by invasive carcinoma not applicable. Involvement by squamous cell carcinoma in situ (CIS) not applicable. Vascular Margin: Not applicable. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Parenchymal Margin: Uninvolved by invasive carcinoma. Parietal Pleural Margin: Not applicable. Chest Wall Margin: Not applicable. Other Attached Tissue Margin: Not applicable. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Present. TNM Descriptors: Not applicable. Primary Tumor (pT): pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or. visceral pleura, without bronchoscopic evidence of invasion more proximal. than the lobar bronchus (ie, not in the main bronchus); or Superficial. spreading tumor of any size with its invasive component limited to the. bronchial wall, which may extend proximally to the main bronchus. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Number of nodes examined cannot be determined. Distant Metastasis (pM): Not applicable. Clinical History. Left VATS, upper lobe wedge, lymph node dissection. Laryngeal cancer. Specimen(s) Received. A: Wedge excision left upper lobe. B: #6 Lymph node. C: #7 Lymph node. D: #9 Lymph node. E: 10 L lymph node. F: Medial wedge excision left upper lobe. Gross Description. Specimen A is received fresh for intraoperative consultation, labeled with the patient's name, medical record number and labeled. ""wedge excision, left upper lobe."" It consists of a wedge of lung that weighs 23.8 gram and measures 10.8 x 4.7 x 2.2 cm. There. is a firm, well-defined lesion (that was previously incised) that measures 1.5 x 1.1 x 0.7 cm. The lesion is 0.4 cm from the. parenchymal. margin and puckers the pleura. The remainder of the lung is unremarkable. The pleura is inked blue. Sections are. submitted as follows: Dictated by. A2,A3: Lesion pleura and margin. A4;. Tumor in relation to surrounding lung. A5: Representative sections of uninvolved lung parenchyma. Specimen B is received fresh for intraoperative consultation, labeled with the patient's name, medical record number and as. additionally ""#6 lymph node for frozen.' It consists of multiple pieces of soft tissue measuring in aggregate, 1.8 x 1.7 x 0.9 cm. The tissue is partially calcified. The non-calcified portions are submitted for frozen and the contents of the cryoblock are. submitted in cassette ""B1FS."" The calcified tissue is sectioned and submitted for decal in its entirety in cassette ""B2."" Dictated. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. egarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Specimen C is received fresh for intraoperative consultation, labeled with the patient's name, medical record number and ""#7. lymph node."" It consists of four pieces of soft tissue in aggregate measuring 1.5 x 0.2 x cm The specimen is entirely. submitted for intraoperative consultation and transferred to cassette ""C1FS.' (Dictated by. Specimen D is received fresh for intraoperative consultation, labeled with the patient's name, medical record number and ""#9. lymph node."" It consists of a fatty soft tissue fragment measuring 0.6 X 0.4 x 0.3 cm. The specimen is entirely submitted for. intraoperative consultation and transferred to cassette ""D1FS."" (Dictated by. Specimen E is received fresh for intraoperative consultation, labeled with the patient's name, medical record number and ""10L. lymph node."" It consists of a soft tissue fragment measuring 0.6 x 0.5 x 0.4 cm. The fragment is entirely submitted for. intraoperative consultation and transferred to cassette ""E1FS."" (Dictated by. Specimen F is received in formalin, labeled with the patient's name, medical record number and additionally ""medial wedge. excision, left upper lobe."" It consists of a wedge of lung that measures 8.1 x 2.0 x 2.0 cm and weighs 15 grams. There is a. pleural bleb that measures 2.8 x 1.9 x 1.9 cm. The remainder of the lung is unremarkable. The parenchymal margin is inked. green and the pleura is inked blue. Sections are submitted as follows: Dictated by. F1: Section of bleb and normal lung parenchyma. F2: Normal lung parenchyma. Intraoperative Consult Diagnosis. A1FS: LUNG, LEFT UPPER LOBE (FROZEN SECTION): ADENOCARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. in at. out at. B1FS,B1TP: #6 LYMPH NODE (FROZEN SECTION AND TOUCH PREPARATION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. in at. out at. C1FS: #7 LYMPH NODES (FROZEN SECTION): THREE LYMPH NODES NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. at. and start time. D1FS: #9 LYMPH NODE (FROZEN SECTION): ONE LYMPH NODE NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. on. at. land start time. E1FS: #10 LYMPH NODE (FROZEN SECTION): ONE LYMPH NODE NEGATIVE FOR CARCINOMA,. Frozen section results were communicated to the surgical team and were repeated back by. on. at. and start time. Confidential Document. This information is subject to all Federal and State laws regarding confidentiality and privacy and to the policies and procedures of. regarding. patient information. Any unauthorized use, disclosure, or reproduction of this information is strictly prohibited. Anat Path Reports. Microscopic Description. Microscopic examination performed. ANALYTE SPECIFIC REAGENT (ASR) DISCLAIMER: Some of the above tests may use Class I ASRs. These tests were developed and their performance characteristics determined. They have not been cleared or approved by the Federal Drug Administration (FDA). The FDA. does not require these tests to go through premarket FDA review. These tests are used for clinical purposes, and should not be. regarded as investigational or for research. is certified under the Clinical Laboratory Improvement. Amendments (CLIA) as qualified to perform high complexity clinical laboratory testing.",T1,N0,M0,T1N0M0
TCGA-E8-A417,"Laterality:Tumor consists of papillae having an fine fibrovascular stalk or. folliculae covered by a single to mutiple layers of cuboidal epithelial cells. Tumor invades in capsule or. vessle or begnin tissue. The cells tend to maintain their polarity. Nuclei are quite regular and contain. finely dispersed chromatin, or intranuclear grooves. Tumor is necrotic, fibrous and invasion of skeletal. muscle. Path Report: Tumor type: Papillary carcinoma. Tumor size: 2.5x2x1.8cm. Laterality: right. Focality: unifocal. Extracapsular extension: Not specified.",T2,N1,M0,T2N1M0
TCGA-3X-AAV9,"CONFIDENTIAL. Demographics (for. verification purposes). Date of Birth: Sex: M. Collected Date/Time. Received Date/Time. Specimen Description. A. Small bowel nodule. B. Mesenteric node. C. Gallbladder. D. Right lobe liver. Clinical Information. Mass in liver. Cholangiocarcinoma - query. Colon adenocarcinoma. Diagnosis. A. Small Bowel Nodule, Biopsy: Focal fibrosis, negative for malignancy. B. Mesenteric Node, Biopsy: One lymph node, negative for malignancy. C. Gallbladder, Cholecystectomy: Unremarkable gallbladder, negative for malignancy. D. Right Lobe Liver, Wedge Resection: Moderately differentiated cholangiocarcinoma. 7.7 x 6.0 x 5.5 cm. Less than 0.1 cm to the liver resection margin and the tumor focally. involves the liver capsule. Positive perineural invasion. Surrounding background liver parenchyma shows moderate portal. inflammation, likely due to mass effect. Verified: Gross Description. Received are specimens A to D. All requisitions and specimen containers are labelled. with the patient's name. The cassettes and. identifiers are. labelled with the Surgicar. A. Two small fragments of tan soft tissue, 0.7 x 0.3 x 0.2 cm in aggregate. Submitted in. toto for FS. B. One piece of oval-shaped nodular tissue encompassing a seemingly lymph node, 1.2 cm in. greatest dimension. The node is bisected and submitted in toto in two blocks (FS1 and. FS2) for FS. C. The specimen is received fresh and is subsequently placed into formalin and consists. of an intact gallbladder measuring 8.2 x 3 x 2.1 cm. The serosal surface is tan, smooth. and glistening and the adventitial surface is tan, slightly hemorrhagic and roughened. The cystic duct resection margin is identified and is patent. The cystic duct lymph node. is grossly identified and measures 1.2 cm in maximum dimension. The lumen is filled with. thick green bile (about 4 ml). The mucosal surface is green and velvety. The wall. thickness of the gallbladder is ranging from 0.2 to 0.5 cm. The specimen is serially. sectioned and representative sections are submitted in cassettes C1 and C2, cassette. C1. representing the cystic duct resection margin and cystic duct lymph node bisected,. cassette C2 representing sections from neck, body and fundus. D. The specimen is received in formalin and consists of a lobe of liver weighing 403 g. and measuring 13.7 x 11 x 5.5 cm. The resection margin is marked with blue dye. A white. solid area is identified on the serosal surface measuring 5 x 1.5 cm. The cut surface. reveals a tan solid mass measuring 7.7 x 6 x 5.5 cm. This mass also grossly extends up. the serosal surface. The remaining cut surface appears grossly unremarkable. Sections are submitted as follows: D1 - mass in relationship with the serosal surface (white solid area on the serosal. surface). D2-3 - mass with closest inked resection margin. D4 - blood vessel within the mass. D5-6 - further sections from the mass with fascicles. D7 - grossly unremarkable parenchyma adjacent to the mass. Please note a portion of specimen D is sent for tumor banking. Frozen Section Diagnosis. A. Small Bowel Nodule: - Benign fibrous tissue, negative for malignancy. B. Mesenteric Node: - Reactive lymph node, negative for malignancy. Pathologist Comment. D. The moderately differentiated adenocarcinoma cells are strongly positive for CK7,. CK19, focally positive for CK20 and negative for TTF-1 and CDX2. This. immunohistochemical profile is consistent with cholangiocarcinoma. Encounter Number. Patient Location.",T1,N0,M0,T1N0M0
TCGA-BB-4217,"LAB RESULTS. RG PATH REPORT. LECTION DATE/TIME. 1st Specimen collected en. FINAL DIAGNOSIS. 1). LEFT TONGUE BASE (EXCISION) : SQUAMOUS MUCOSA. NEGATIVE FOR. TUMOR. 2) RIGHT POSTERIOR PHARYNGEAL WALL (EXCISION} : SQUAMOUS MUCOSA. NEGATIVE FOR TUMOR. 3) NASOPHARYNGEAL MARGIN (EXCISION) : SQUAMOUS MUCOSA. NEGATIVE FOR. TUMOR. -1). SOFT PALATE UVULA (EXCISION) : ULCERATED SQUAMOUS MUCOSA WITH. POCAL HIGH GRADE DYSPLASIA. SEE NOTE. NOTE: The focal high grade dysplasia is seen only on the frozen. section. 5) 2ND NASOPHARYNGEAL MARGIN (EXCISION) : SQUAMOUS MUCOSA WITH. CHRONIC INFLAMMATION. NEGATIVE FOR TUMOR. 6) LEFT EUSTACHIAN TUBE (EXCISION) : SQUAMOUS MUCOSA. NEGATIVE FOR. TUMOR. 1) 2ND SOFT PALATE (EXCISION) : SQUAMOUS MUCOSA. NEGATIVE FOR TUMOR. a) TUMOR AT NASOPHARYNX (EXCISION) : INFILTRATING POORLY. DIFFERENTIATED KERATINIZING SQUAMOUS CELL CARCINOMA. ADDITIONAL NASOPHARYNX (EXCISION) : RESPIRATORY MUCOSA WITH. :ONIC INFLAMMATION. NEGATIVE FOR TUMOR. 10) SOFT TISSUE RIGHT LINGUAL ARTERY (EXCISION) : BENIGN. FIBROCONNECTIVE TISSUE. NEGATIVE FOR TUMOR. :1). ADDITIONAL SOFT PALATE (EXCISION) : SQUAMOUS MUCOSA AND MINOR. SALIVARY GLAND. NEGATIVE FOR TUMOR. 2) LYMPH NODES, RIGHT NECK (DISSECTION) : TWO OF ELEVEN (2/11). LYMPH NODES POSITIVE FOR SQUAMOUS CELL CARCINOMA, ONE NODE SHOWS. EXTRACAPSULAR EXTENSION. :3) LYMPH NODES, RIGHT NECK LEVEL IV (DISSECTION) : ONE OF EIGHT. (1/8) LYMPH NODES POSITIVE FOR SQUAMOUS CELL CARCINOMA. EXTRACAPSULAR. EXTENSION IS PRESENT. 14) LYMPH NODES, LEFT NECK (DISSECTION) : THREE (3) LYMPH NODE AND. ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. LYMPH NODES, LEVELS II AND III (DISSECTION) : ONE OF SEVEN (1/7). LYMPH NODES POSITIVE FOR SQUAMOUS CELL CARCINOMA WITH EXTENSION INTO. SOFT TISSUE FORMING A NODULE OF SQUAMOUS CELL CARCINOMA. (5.0 CM). :6) LYMPH NODES, LEFT NECK LEVEL IV (DISSECTION): TWO OF SEVENTEEN. (2/17) LYMPH NODES POSITIVE FOR SQUAMOUS CELL CARCINOMA. :7) LARYNX (LARYNGOPHARYNGECTOMY) : SPECIMEN: caryngopharyngectomy. TUMOR SITE: Posterior pharyngeal space. Unofficial lab results - do not file in patient chart. Contact medical records for official chart copy. INLESS. NOTED. rus. ORMED AT: ;TOLOGIC TYPE: Squamous cell carcinoma (keratinizing). TUMOR SIZE: a cm greatest dimension. HISTOLOGIC GRADE: poorly differentiated. LYMPH NODES: Metastatic carcnoma in 6 of 51 lymph nodes: Ipsilateral,. Contralateral. Specify largest positive node: 5 cm. EXTRANODAL EXTENSION: Present. EXTENT OF INVASION. PRIMARY TUMOR. pT4: Tumor invades nasopharynx (see part 8). REGIONAL LYMPH NODES: pN2c: Metastasis in bilateral or contralateral lymph nodes, none. !arger than 6 cm in greatest dimension. DISTANT METASTASIS: oMx: Cannot be assessed. MARGINS. Margins are uninvolved. Distance of invasive carcinoma from nearest margin: 1 mm. Specify margin: Soft tissue. VENOUS/LYMPHATIC INVASION: asent. PERINEURAL INVASION: Present. NOTE: This case was reviewed with. who concurs with the. diagnosis. Reported bv: Unofficial lab results - do not file in patient chart. Contact medical records for official chart copy. UNLESS OTHEROTSE NOTED ON TUR DETATI pace ALI DEDFORMED AT:",T4,N2,M0,T4N2M0
TCGA-49-4494,"FINAL DIAGNOSIS. 1. R10 LYMPH NODE (RESECTION) : ONE (1) DIMPH NODE, TOK. TUMOR. LUNG, LEFT UPPER LOBE (LOBECTOMY) : MODERATELY-DIFFERENTIATED. MUCINOUS ADENOCARCINOMA OF THE LUNG (2.5 CM) WITH FOCI OF NECROSIS. TUMOR EXTENDS TO THE PLEURA. BRONCHIAL AND VASCULAR MARGINS ARE. NEGATIVE FOR TUMOR. TWO (2) OF FOUR (4) REGIONAL LYMPH NODES ARE. ?OSITIVE FOR METASTATIC CARCINOMA. UNINVOLVED LUNG SHOWS HEMORRHAGE. EXTENSIVE REMOLDING, SUBPLEURAL SCARRING AND ACUTE AND CHRONIC. INFLAMMATION. 3. LYMPH NODE, AP WINDOW (RESECTION) : ONE (1) LYMPH NODE POSITIVE. FOR METASTATIC ADENOCARCINOMA.",T3,N2,M0,T3N2M0
TCGA-C5-A7UC,"Accessioned: Patient THE. Fepcrted. M.D. M.D. DIAGNOSIS: UTERUS. CE RVIX, RADICAL HYSTERECTONIY. - POORLY DIFFERENTIATED NON-KERATINIZING SQUAMOUS CELL CARCINOMA. FEXTENSIVE LYMPHVASCULAR SPACE INVASION. RESECTION MARGINS FREE OF TUMOR (SEE COMMENT AND SYNOPSIS). UTERUS, ENDOMETRIUM, RADICAL HYSTERECTOMY. - SECRETORY PATTERN ENDOMETRIUM WITH-NO EVIDENCE OF MALIGNANCT. UTERUS, MYOMETRIUM, RADICA, HYSTERECTOMY. NO EVIDENCE OF MALIGNANCY. UTERUS, SE ROSAL SURFACE, RADICAL HYSTERECTOMY. - NO EVIDENCE OF MALIGNANCY. VAGINA, ANTERIOR RADICAL HYSTERECTOMY Site: Cerrix NOS C53.9. AND POSTERIOR CUFF,. NO EVIDENCE OF MALIGHANCY. OVARY, RIGHT, COPHORECTOMY. - NO EVIDENCE OF MALIGNANCY. OVARY, LEF OOPHORECTOMY. NO EVIDENCE OF MALIGNANCY. HEMORRHAGIC CORPUS LUTEUM CYST. FALLOPIAN TUBE, RIGHT, SALPINGECTOMY. NO EVIDENCE OF MALIGNANCY. FALLOPIAN UBE, LEFT, SALPINGECTOMY. NO EVIDENCE OF MALIGNANCY. . SIM PLE PARATUBAL CYST. SOFT TISSUE, PARACERIVICAL/PARAMETRIAL AREA, RADICAL HYSTERECTOMY. - NO EVIDENCE OF MALIGNANCY. - NO EVIDENCE OF MALIGNANCY IN TWO LYMPH NODES (0/2). LYMPH NODIE, ""LEFT EXTERNAL,"" DISSECT'ON (INCLUDING 'FS1). Pige 1 of 5. SURGICAL PATHOLIGG REPORT. - NO EVIDENCE OF MALIGNANCY IN FIVE LYMPH NODES (0/5). LYMPH NODIE, RIGHT OSTURATOR, DISSECTION (IN CLUDING FS2). - NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). LYMPH NODIE, LEFT EXTERNAL, DISSECTION. FIBR:AADIPOSE TISSUE WITH NO EVIDENCE OF MALIGNANCY. - NO .MMPH NODE TISSUE IDENTIFIED. LYMPH NODIE, RIGHT PERIAORTIC, DISSECTION. - NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). LYMPH NODIES, LEFT PERIAORTIC, DISSECTION. - NO EVIDENCE OF MALIGNANCY IN FOUR LYMPH NOCES (0/4). LYMPH NODIES, RIGHT OBTURATOR, DISSECTION. - NO EVIDENCE OF MALIGNANCY IN SIX LYMPH NODES (0/6). LYMPH NODIES LEFT OBTURATOR, DISSECTION. - NO EVIDENCE OF MALIGNANCY IN FOUR LYMPH NODES (0/4). LYMPH NODIES, RIGHT EXTERNAL, DISSECTION. . NO EVIDENCE OF MALIGNANCY IN FOUR LYMPH NODES (0/4). By this signature. I attest that the agove diagnosis Is tased upon my :ersonal. examination of the siides(and/st other muterial indicated in the diagnosis). M.D. "". , M.D. Diagnosis Comment. SYNOPTIC REPORTING FORM FOR UTERINE CERVICAL NEOPLASMS. 1. A neoplasm is FRESENT. 2. The HISTOLOGIC DIAGNOSIS is: Squam: IUS cell (epicermoid) carcinoma, invasive, type, non-keratinizing subtype. 3. The MAXIMUM DEPTH OF TUMOR INVASION is (5 mm. 4. The BREADTH (MAXIMUM HORIZONTAL DIMENSION) OF THE TUMOR is 23 mm. 5. The TOTAL THICKNESS OF THE CERVIX is 16 mm. 6. Lymphatic invasion by tumor IS identified and is NIDESPREAD. 7. The NUCI. EAR GRADE of the tumor is: G3 (Forly-diffenentiated). 8. The tumor DOES NOT invade through the entire thickness cf the cervix to involve contiguous pararnetr. al soft. tissues. 9. The tumoi DOES NOT involve the uterine corpus. 10. The tumor DOES NOT involve the vagina. 11. Metastas 3 to regional lymph nodes is ABSENT. 12. The total number of metastatically-involved nodes is 0. 13. The total number of regional nodes exarnined is 27. 14. Extracaprular extension of metastatic tumor through the lymph node capsule is NOT APPLICABLE; NO. METASTASIS IS SEEN. 15. DETAILED STAGING INFORMATION: A, TUMOR GROWTH: THEPRIMARY NEOPLASM IS CLASSIFIED AS: TNM HEME. FIGO SCHEME. DEFINITION. T1t. IB. Tumor confined to uterus but larger than. B. REGIONAL LYMPHAGOES are classified as: NO (Regional nodes are NOT involved by metastasis). C. DISTANT METASTASES: The status of distant tissues is: MO (distant metastases reportedly absent). 16. THE FINAL STAGE OF THE TUMOR IS: AJCC SCHEME. FIGO SCHEME. Pige 2 of 5. 1b (11b/NO/MO). IB. The pathologi: stage assigned here should be legarded as provisional, and may change after inregration o' clinical data. not provided with this specimen. Intraoperative Consultation: An intraoperar ive non-microscopic consultation was obtained and interpreted as: ""Called to operating room to pick up. ""uterus and tu bes, ovaries and cervix"" consisting of 10 x 5.5 x 4.0 cm uterus with attached unremerkable tubes and. ovaries. The parametrial tissues are inked and the uterus is opened to show a 2.3 x 2.1 cm lesion in the. posterior-later al (right) cervix. Tissue taken for Rest for permanents. Shown 10 surgeon,"" by. FS1: Lymph rode, left external, biopsy - ""No evidence of malignaricy,. FS2: Lymph rode, right obturator, biopsy - ""No evidence of malignancy,. Microscopic Description and Comment: Resection of the tumor from the cervix shows a poorly differentiated non-keratinizing squamous cell carcinoma that. invades as much as 5 mm into the cervical stroma, with a wall thickness of 16 mm. The largest measurable tumor. dimension is 23 millimeters. There is extensive.andvidespread.lymphvascular_spaco.invasion evident Tr e tumor also. undermines unremarkable squamous mucosa of the cervix. There is no tumor present in the vaginal cuff, lower uterine. segment or other areas of the uterus, and'all margins are free of tumor. The parametrial soit tissue are free of tumor as. are both adnexae and 27 lymph nodes from different locations. The anterior ectocervix also does not show tumor as. grossly suggested. For additional details, see synoptic report belov. M.D. History: The patient is a year old woman with mocenitely cifferentiated-squamou cell carcinoma of the cerv.x. Operative pro :edure: Examination under anesthesia, radical hysterectomy, bilateral salpino-oophorecionin, pelvic. lymph node d ssection,. Specimen(s) Received: A: UTERUS, TUBES, OVARIES, CERVIX. B: LEFT EXTERNAL NODE. C: LEFT EXTERNAL NODE. D: LEFT OBTURATOR. E: LEFT PERI.LORTIC LYMPH NODE. F: RIGHT EXT ERNAL LYMPH NODE. G: RIGHT OBTURATOR. H: RIGHT OBTURATOR. I: RIGHT PERIAORTIC LYMPH NODE. Gross Des ;ription: The specimens are received in nine formalin-filled containers, each labeled with the patient's name. The first is ad ditionally labeled ""uterus, tubes, ovaries and cervix."" it contains a uterus, with bilateral adnexae,. weighing. 199.5 grams, measuring 10 cm fundus to cervix, 5.5 cm cornu to cornu and 4.0 cm anteroposteriorly. There is. unremarkable anterior and posterior vaginal cuff present. The anterior vaginal cuff measures 3.4 cm in lengith x 2.0 cm. in maximum c.imension. The posterior vaginal cuff measures 10 cm in length x 2.0 cin in greatest dimension. The. smooth, glistening, tan-white ectocervix measures 4,7 cm in length x 3.0 crn in greatest dimension. It shows a. protruding ulc erated grey-white-tan 23x 2.1 cm tumor located on the posterior lip and its cervical os partion. No tumor. is evident at the anterior cervical lip. The tumor is excised to show ill-defined grey-white tissue of maximum depth of. invasion of pc ssible 0,9 cin. The lower uterine segment as well as the vaginal cuff are uninvolved by the turnor. The. distance of the turnor to the shaved resection margin of the posterior vaginal cuff is 2.0 cm. The endocervical canal. measures 3 c n in length x 1. cm in greatest dimension and shows tumor involvement at a leng:h of 2.0 crn. The. remainder of the endocervical mucosa is unremarkable, measuring 0.2 cm in greatest dimension, and has a grev-white. glistening unremarkable color. The lower uterine segment measures 2.5 cm in length x 0.5 cm in greatest dimension. it is lined by a smooth, glistening, unremarkable, 0.2 cm thick mucosa, The pear-shaped uterine cavity measures 4.0. cm in length x 2.2 cm in greatest dimension. It is lined by a smooth, glistening, unremarkable, 0.2 crn thick. Pige 3 of 5. endometrium. The myomet m varies from 1.7 to 2.2 cm and is unremarkable. The right ovar; measures 2.2 x 1.7 x. 0.5 cm and is lined by a smooth, glistening. unremarkable serosal surface. It is sectioned to shcw no abnomalities. The right fallo bian tube measures 3 cm in lengtn x 0.4x0.4 cm. It has previously been ligated. The fimbriated end. measures 2.0x 1.4 x 0.2 cm. The fallopian tube is lined by a smooth, glistening unremarkable serosal surface. The left. ovary measur is 3.0 cm in length x 1.5 x 1.2 cm. It has an unremarkable grey-white glistening sarosal suriace. However, there is a colypoid nodule in it e pos erior superior portion of the ovary notec, measurng .xx10x0.4cm. That nodule and the ovary are sectioned to shon the nocule composed of old clotted hemorhage surreunced by a. yellow rim, su gesting of a hemorrhagic corpus luteum. There is a cyst in the ovary with a smocth inteinal lining. left. fallopian tube measures 2.6 x 0.2 x 0.3 cm with the fimbriated end measuring 2.0x0.5 x 0.4 cm. It is surmonded by. measuring 0.7 x 0.5 x 0.5 cm. It contains clear fluid. No lesions are otherwise noted. The previously ligated. a. smooth, glistening, unremarkable serosal surface. Sections show no abnormalities. There is a paratubial cyst noted. measuring 1.6 x 1.0 x 1.0 cm, surrounded by a smooth, glistening, unremarkable surface. Sections show clear fluid. . The internal li ning is smooth and shiny without abnormalities. Labeled A1 - shaved anterior vaginal cuff; A.: and A3. shaved posterio: vaginal cuff; A4 to 1.7 - numor on posterior cervix in direction of paracervical  olt tissue an:t vaginal. cuff; A8 and 19 - turnor in direction of right lateral paracervical soft tissue; A10- - lower uterine segment in direction of. tumor; A11 - I osterior endometrium direction of serosal surface; A12 - anterior endometrium direction of serosal. surface; A13 anterior lower uterine segment in direction of unremarkable anterior endocervix; A14 to A16 -. unremarkable anterior ecto- and endocervix; A17 to A20 - right paracervical/parametrial adipose tissue; A21 to A24 - left. paracervical/p arametrial adipose tissue; A25 right ovary; A26 right fallopian tute; A27 - left ovary; A28 - left fallopian. tube; A29 - paratubal cyst. Jar 2. The second c ontainer is labeled ""left external node (FS1/X1)."" It contains a white cassette without labelling, containing. two pieces of vellow-tan-trown soit tissue, measuring 2.6 X 0.7 xi 0.4 cm ar.d 2.3 0.4 cm, representing remainder. of the first from:en section. Labeled B1 (FS1). Also in the same container additional piece of yellow adipose tissue,. ranging from 1.5 x 0.9 x 0.4 cm to 5,0 x 2.0x 0.4 cm. No lymph nodes are evident, Labeled B2 and B3. Jar 0. The third cont ainer is labeled ""right obturator (FS2)."" It contains white cassette, labeled ""FS2,"" containing one piece of. tan-brown-yel OW soft tissue, measuring 0.7 x 0.5 x 0.2 cm, representing the remainder of the second frozen section. Labeled C (F12). Jar 0. The fourth container is lateled ""left external node."" it contains several pieces of soft tissue ranging. from 0.3 x 0.2 x 0.2 cm to 1.0x0.5 x 0.4 cm. There is no evidence of lymphoid tissue. Labeled D. Jar O. The fifth container IS labeled ""right periaortic lymph node."" It contains one lymph node measuring 3x06x0.6 It is. bisected to sh ow no abnormalities. Labeled E. Jar 0. The sixth con ainer is labeled ""lett perlaortic lym ph node."" It contains two pieces of acipose tissue, reasuring 1.0x 0.7. x 0.4 cm and 1.9 x 1.0x0.4 cm. Two possible lymph nodes are noted measuring 0,4 x 0.3 x 02 cm and 0.6 x 0.4x 0.2. cm. They are unremarkable. Labeled F. Jar 0. The seventh ontainer is labeled ""right obturator."" It contains several pieces of tan-brown soft tissue, ranging from 0.5 x. 0.4 x 0.4 cm t) 2,8 x 1.5 x 0.4 cm. Several lymph nodes are dissected from the adipose tissue, ranging from 0.2 x 0.2. x. 0.2 cm to 2.5 ( 1 x 1 cm. The larger ones are tisected to show no abnormalities. Labeled G1 to G3 - one lymph nocle. each (entirely submitted): G4 - additional lymph nodes. .ar 1. The eighth co Itainer is labeled ""left obturator."" If contains one piece of yellow multilobulated tan-brown adicose tissue. measuring 4 m in length 1.0 x 1.0 cm. Several lymph nodes are identified ranging from 0.3 x 0.2 x0.2 em to 1.2x. 0.4 x0.4cm. The larger one is bisected to show no abnormalities. Labeled H1 .. one lymph node (entirely submitted);. H2 - possible additional lymph nodes. Jar 0. The ninth con.ainer is labeled ""right external lymph node."" Il contains one piece of yellow adipose tissue, measuring 4.0. x2.0x1.0crr. Several possible lymph nodes are dissected from the adipose tissue, ranging from 0.2x 0.1 x 0.1 cm to. 1.7x1.5x0. cm. The larger ones are bisected to show no abnonmalities. Labeled I1 and 12 - one lymph hode each. (entirely submitted); 13 - pessible additional lymph nodes. Jar 0. M.D. Surgical Pathology report is available on-line on. Pige 5 of 5.",T1,N0,M0,T1N0M0
TCGA-AG-3728,"Diagnosis: Partial colon/rectum resection material shows two colorectal carcinomas: An ulcerated carcinoma of the rectum characterized histologically as a moderately differentiated. colorectal adenocarcinoma, extending to within 3 cm of the aboral resection margin and. measuring 3.5 cm at its widest diameter. Invasive tumor spread within all layers of the intestinal. wall as far as the periproctic fatty tissue. 2.: A carcinoma of the colon characterized histologically as a moderately differentiated. colorectal adenocarcinoma, extending to within 4 cm of the oral resection margin and measuring. 2 cm at its widest diameter. Invasive tumor spread as far as the level of the muscularis propria. Oral and aboral resection margin tumor-free. Three of nineteen periproctic or mesocolic lymph nodes with metastases of the rectum or colon. carcinoma extending in some cases over the lymph node capsule. Tumor stage of the rectum carcinoma thus pT3; G2. that of the colon carcinoma pT2; G3. Lymph node status pN1 (3/19) LO V0.",T3,N1,M0,T3N1M0
TCGA-SC-A6LR,"MRNT. serviter. Data of Procedure: (Ager. M. Physiciam. Clinical Diagnosis & History. year old male with malignant mesothelioma epithelioid type. Specimens Submitted: 1: Right pleura. 2: Biopay level eight mediastinal lymph node (fs). 3, Biopay lovel neven mediastinal lymph node (fs). 4: Right leyal four mediastinal lymph node (fa). 5: Portion of right aixth rib. 6: Level seven mediastinal lymph node. 71 Right level four mediastinal lymph node. B, Level eight mediastinal lymph node. DIAGNOSIS. 1. Right pleura, biopsy: Malignant mesothelioma, epithelioid type. 2. Biopay lavel eight mediastinal lymph node, excisioni. - Malignant mesothelioma, epithelioid type. - No lymphoid tissue identified. Biopay level seven mediastinal lymph node; excision: - One benign lymph node (0/1) with non-necrotizing granuloma, gee note. 4. Right level four mediastinal lymph node; excision: - Fragments of one benign lymph node(a) with non-nedrotizing granuloma. 5. Portion of right sixth rib; exciaion: - Benign bone and cellular marrow with focal marrow fibrosis, dee note. 6, Lavel peyan mediastinal lymph node; excision: - Metastatic malignant mesothelioma to one lymph node fragment. - Non-nedrotizing granulona. 7. Right laval four mediastinal lymph node, excisions. - Fragments of one benign lymph node(s) with non-necrotizing granuloma. 8. Lavel eight mediastinal lymph node; excision: - Malignant mesothelioma, epithelioid type, see note. - No lymphoid tissue identified. Continued on next paga. Data of Report: Note: The tumor della ara positiva for calretinin, NT1, D2-40, AB1/3, CD15,. but negative for TTF1 and PCEA. Despite the positivity of CD15, the. morphology and the remaining staining pattern are consistent with malignant. mesothetioma,. In parts 3, 4, 6, and 7, non-nedrotizing granulomas ara present, GMS and. FITE staing are performed in part 3, No fungi or myoobacteria are seen on. GMS and FITE stains. In part. 5, fogal fibrosia ia presant in the hone marxay Immunostain. cKit highlights the soattered masts cells. Immunostain for 8100 is negative. The fibrotic area shown increased fibrosis by reticulin stain (1+), but. negative Giemsa staining. The selected alidea (block 5-2, HE, immuno and. special stain) have been reviewed by. who doncurs. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIENED AND APPROVKO. THIS REPORT. Special Studies: Special Stain. Comment. GMS. FITE. GMS. FITA. GIEMSA. RETIC. RECUT. Gross Descriptions. 1). The specimen is receivad freph labeled ""Right pleura,' It consists of. multiple fragmented pieces of membranous, rubbery, brown-tan soft tissue. measuring 5.0 x 4.0 x 1.5 om in aggregata. Representative sections are. submitted. Summary of sections: u - undesignated. 2). The specimen ia received frozen pection consultation labeled ""biopay. level 8 mediastinal lymph node"" and consiats of two pink to tan soft tissue. fragments measuring 1.5 x 1.5 x 0.4 cm in aggregate, which are entirely. submitted in frozen section consultation. Adgount #: Summary sections;. FSC-frozen section control. 3). The specimen is received freah for froxen section consultation labeled. biopay level 7 mediastinal lymph node"" and consists of a fatty fibrous. tiqgue measuring 5.0 x 1.5 x 0. 6cm to include a fatty possibla lymph node. Thelymphnodiaserially sectioned and entixely aubmitted for froxen. section consultation. Sunmary seations: SSCA-frosen section control. FSCB-frozen section control. 4) The specimen is received fresh for intraoperative consultation, labeled. ""right level 4 madiastinal lymph noda"", and consista of multiple anthracotic. lymph nodes and adipose tissue measuring 3.3 x 1.8 x 0.4 cm in aggregate. The specimen is entirely submitted. Summary of sections: FSC - lymph node. U - undesignated. 5) The specimen is received in formalin, labeled ""portion of right sixth. rib"" and consists of multiple shaved segments of rib measuring 3.1 x 1.4 x. 0,3 up to' 11.8 x 1.2 x 0.4 cm. Red, tan soft tissue is attached. The cut. surfaces reveal a homogenous red tan granular and bony cut surfade. The. cortical surface appeara intact, and no discrate lesions are noted. Representative sections are submitted for decalcification. Summary of aections: U -- Undesignated. 6) The speciman is received in formalin, labeled ""level 7 mediastinal lymph. node"", and consists of multiple anthracotic lymph nodes measuring 1.6 x 1.6. x 0.8 cm in aggregate, The specimen is entirely submitted. Summary of sections;. U - undesignated. 7) The apecimen is received in formalin, labeled ""right level 4 mediastinal. lymph node"", and consista of multiple anthracotic lymph nodes measuring 1.0. x 0,8 x 0.3 cm in aggregate. The specimen is entirely submitted. surmary of sectional. U - undesignated. 8) The-specimen is received fresh and placed in formalin labeled dlevel. 8. mediastinal lymph node #2"", and consists of multiple portions of white-tan. rubbery tissue measuring 1.8 x 1.5 x 0.4 cm in aggregate. TPS is not. submitted. The specimen ia entirely submitted. Summary of sections: U - undesignated. Summary of Sections: Part 1: Right pleura. Block. Seat, Site. PCs. 2. u. 2. Part. 2: Biopay lavel sight mediastinal lymph node. (Ea). Block. Sest. Sita. PCo. 1. FSC. 1. Part 3: Biopay level seven mediastinal lymph node (fs). Block. Sect. site. PCs. 1. FSCA. 1. 1. FSCB. 1. Part 4: Right level four mediastinal lymph node (fa). Block. Sect. Site. PCa. 1. fao. 1. 3. U. 3. PART 5: Portion of right eixth rib. Blook. Sect. Site. PCs. 2. U. 2. Part 6; Level seven mediastinal lymph node. Block. Seot. Site. PCa. 2. U. Physiciar. Part 7: Right level four mediastinal lymph noda. Block. Sect. site. PCa. U. Part 8: Level eight mediastinal lymph node. Block. Sect. site. PCa. 2. U. 2. Intraoperative Consultation: Note: The diagnoses given in this gection pertain only to the tisaue. sample. examined at the time of the intraoperative. consultation. FROZEN SECTION DIAGNOSIS: Biopay level sight mediastinal lymph node. (fs) $ Malignant epithelioid neoplasm. PERMANENT DIAGNOSIS: same. FROZEN SECTION DIAGNOSIS: Biopsy level seven mediastinal lymph node. (fa) Benign. PERMANENT DIAGNOSIS: name. 4. TROZEN SECTION DIAGNOSTS: Right level four mediastinal lymph node. (fs). Benign. PERMANENT DIAGNOSIS: same. Note: The diagnoses given in this section pertain only to the tissue. sample examined at the time of the intraoperative. consultation. 3. FROZEN SECTION DIAGNOSIS Biopay level eight mediastinal lymph node. (s) Malignant epithelioid neoplasm,. PERMANENT DIAGNOSIS same. FROZEN SECTION DIAGNOSTS: Biopsy level seven madiastinal lymph node. (fs) , Benign. PERMANENT DIAGNOSIS: same. 4. FROZEN SECTION DIAGNOSIS: Right leyel four mediastinal lymph node. (fe) E. Benign,. PERMANENT DIAGNOSIS: same. Phypician.",T1,N2,M0,T1N2M0
TCGA-AA-A02R,"Diagnosis: The present material involves an invasive, poorly differentiated carcinoma (G3) with penetration. of all wall layers (corresponding to at least p T 3) and with lymph and blood vessel invasion (L. 1, V 1), as well as free lymph nodes and free resection margins. Provisional tumor classification: p T at least 3, p N 0, M X, R 0. Confirmation of the epithelial nature by demonstration of what is known as total keratin. Marked S100 protein positivity. In addition, positive reaction for chromogranin, focally also synaptophysin. The findings therefore point to a neuro-endocrine carcinoma in the area stated.",T3,N0,M0,T3N0M0
TCGA-IG-A50L,"Gross Description: Tumor is located in lower esophagus. It is ulcerated and invasive, making esophagus. narrow, with 6x3x0.7cm in size, firm and white-gray surface. .Tumor is located in lower esophagus. It is. ulcerated and invasive, making esophagus narrow, with 6x3x0.7cm in size, firm and white-gray surface. Microscopic Description: Squamous cell are hyperplastic and ulcerated. Tumor tissue arranges in the. form of group or sheets os trabecular of tumor cells. The malignant cells have moderate, light. eosinophilic cytoplasm and form keratinized pearls. The nuclei are enlarged, variability in size and shape,. containing coarse clumped chromatin with prominent nucleoli. Mitotic figures are common. Tumor. invades fat tissue, in adventitia. Stroma is invasion of inflammatory cells. Diagnosis Details: Squamous celll carcinoma, Grade II, infiltrating adventitia. Comments: Formatted Path Reports: ESOPHAGUS TISSUE CHECKLIST. Specimen type: Esophagectomy. Tumor site: Abdominal esophagus. Tumor size: 6 x 3 X 0.7 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Adventitia. Lymph nodes: 1/1 positive for metastasis (Lymph node, groupvii 1/1). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T3,N1,M0,T3N1M0
TCGA-D7-A4Z0,"Gender: F. Examination result No. Unit in charge: (. Clinical diagnosis (suspicion) Stomach cancer. Date of admission: (urgency: Standard). Material: 1) Material: stomach, stomach with the tumour. Method of collection: Total organ resection. Histopathological diagnosis: Stomach adenocarcinoma mucinous with metastases to lymph nodes (G3, pT2, pNI). (8140/3 T-63000). Macroscopic description: The specimen containing the stomach, incised along the lesser curvature sized 1 9 x 13 cm. Tumour with. ulceration sized 7x5x2 cm in the pyloric region. Distance from the proximal end: 12 cm, from distal end: 0.5 cm. Microscopic description: Gastric adenocarcinoma mucocellulare (G3, diffuse type acc. to Lauren class.). The lesion invades the. submucosa and the muscular layer of the stomach wall. Incision lines free of neoplastic lesions. Metastases to 3/10 lymph nodes.",T2,N2,M0,T2N2M0
TCGA-63-A5MP,"Sample Type TUMOUR. Diagnosis. Squamous Cell Carcinoma, Not Otherwise Specified (NOS). Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). Right lower lobe. Tumour Size (cm). 6.2000000000000002. Histology. Squamous carcinoma. rade/Differentiation. II. Pathological T. T2,NOS. Pathological N. N1. Clinical M. M0. VALCSG Stage. Histology Comments. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.",T2,N1,M0,T2N1M0
TCGA-VQ-A8P5,"PRIMARY SITE: Stomach (Body). 1 - ""Chain 8p lymph node"": - Absence of neoplasia in one lymph node (0/1). 2 - ""Designated as chain 9 lymph nodes"": - Fragment of mature adipose tissue, uninvolved by neoplasia (0/0);. 3 - ""Gallbladder"": - Chronic cholecystitis with cholesterolosis. 4 - ""Stomach + omentum"": - Gastric adenocarcinoma, poorly differentiated, intestinal type, ulcerative vegetating,. measuring 6.0 cm in greatest diameter located in the anterior wall of the gastric body,. infiltrating the wall until the subserosa;. - Presence of perineural invasion;. - Angiolymphatic invasion not detected;. - Scarce peritumoral desmoplasia;. - Moderate peritumoral lymphocitary infiltrate;. - Surgical margins uninvolved by neoplasia;. - Presence of 33 lymph nodes in the perigastric adipose tissue uninvolved by neoplasia. (0/33);. - Fragments of omentum consisting of mature adipose tissue, uninvolved by neoplasia.",T3,N0,M0,T3N0M0
TCGA-CK-6748,"Report Status: Final. Type: Surgical Pathology. Specimen Type: Liver partial resection. Procedure Date: PATIEN. Resident: Pathologi: PATHOLOGIC DIAGNOSIS: A. SPECIMEN DESIGNATED ""LEFT LOBE LIVER WEDGE (104g) "" (including FSA). METASTATIC ADENOCARCINOMA, 5.0 cm, involving liver parenchyma. . Parenchymal resection margin is negative for tumor. Tumor is 1.0 cm from the parenchymal resection margin. Hepatic steatosis, mild. B. SPECIMEN DESIGNATED ""SIGMOID COLON"". ADENOCARCINOMA with mucinous differentiation, high grade, poorly. differentiated (5.0 cm in greatest dimension). Tumor is located in sigmoid colon, forms a fungating mass, is. ulcerative, and has an infiltrating border. Tumor invades through muscularis propria into serosa,. Resection margins are negative for tumor. Invasive tumor is 5.0 cm from the 4.9 cm stapled resection margin,. 7.0 cm from the 3. cm stapled resection margin, 2.6 cm from the. mesenteric resection margin, and <0.1 cm from the serosal surface,. Lymphovascular invasion is not identified. Extramural venous invasion is not identified. Perineural invasion is not identified. Peritumoral lymphoid response (including Crohn's-like infiltrate) is not. present. Residual adenoma is absent. Tattoo. Regional lymph nodes (positive:total) : 2:17. AJCC Classification (6th edition) : pT3c N1 M1. C. SPECIMEN DESIGNATED ""PROXIMAL DONUT"": Portion of colon, negative for tumor. D. SPECIMEN DESIGNATED ""DISTAL DONUT"": Portion of colon, negative for tumor. CLINICAL DATA: History: Colon cancer. Operation: Laparoscopy, wedge resection L lower lobe of liver and low anterior. resection. Operative Findings: Not provided. Clinical Diagnosis: Colon Ca. TISSUE SUBMITTED: A/1) left lobe liver wedge (FS and Tissue Bank). B/2) sigmoid colon - Tissue Bank. C/3) proximal donut. D/4) distal donut. O.R. CONSULTATION: SPECIMEN LABELED ""#1 - LEFT LOBE LIVER WEDGE"" (FSA) : Metastatic adenocarcinoma. Surgical resection margin, negative for tumor. Page: I of 3. The senior physician certifies that he/she personally conducted a gross and/or. microscopic examination of the described specimen (s) and rendered or confirmed. the rapid diagnos (es) related thereto. GROSS DESCRIPTION: The specimen is received fresh, in four parts, each labeled with the patient's. name and unit number. Part A, ""left lobe liver wedge"", consists of a 100.4-g liver wedge resection. (9.0 x 7.2 x 4.2 cm) with a cauterized parenchymal resection margin (9. x 4.2. cm, inked blue) On cut sectioning, there is a white/tan focally. (approximately 10%) necrotic tumor (5.0 x 4.5 x 3.0 cm) that grossly abuts the. liver capsule (inked black) and is located 1.0 cm to the parenchymal resection. margin. A representative section of the parenchymal resection margin is. submitted as FSA. A representative section of tumor and normal liver is. submitted for tissue banking. Representative sections are submitted for. histological examination. Micro A1: FSA remnant, 1 frag,. Micro A2: Tumor, quick fix, 2 frags,. Micro A3: Tumor and capsule and tumor and uninvolved liver parenchyma, 2 frags,. RSS. Micro A4: Uninvolved liver, 1 frag,. Part B, ""sigmoid colon"", consists of an unoriented segment of colon (16.8 x 2.9. cm in diameter) with two stapled resection margins (4.9 cm and 3.6 cm, both. inked black) The specimen is open to reveal a centrally ulcerated mass (5.0. x. 4.0 x 1.2 cm) with raised borders that is 5.0 cm to the 4.9 cm stapled. resection margin, 7.0 cm from the 3. 6 cm stapled resection margin, and 2.6 cm. to the mesenteric resection margin (16.8 x 2.3 cm, inked orange) There. are. two tan/black tattoos (#1 5. x 2.5 cm and #2 4.0 x 3.5 cm). Tattoo #1 is. located 2. 6 cm to the 4.9 cm stapled resection margin and 1.2 cm from the. ulcerated mass. Tattoo #2 is located 4.1 cm to the 3.6 cm stapled resection. margin and 1.2 cm from the centrally ulcerated mass. Tattoos #1 and #2 are. located 7.2 cm from each other and are on opposite sides of the ulcerated mass. Underlying the tattoo #1 is a submucosal firm nodule (0.8 x 0.8 cm) that is. located 0. cm from the 4.9 cm stapled resection margin and 4.0 cm to the. ulcerated mass. Underlying tattoo #2 is a submucosal nodule (1. x 0.8 cm). located 6. cm to the 3.6 cm stapled resection margin and 2.5 cm from the. ulcerated mass, There is an area of serosal puckering immediately deep to the. centrally ulcerated mass (1.5 x 0.5 cm) that is located 4.0 cm from the. mesenteric resection margin, 7.5 cm from the 4.9 cm stapled resection margin,. and 7.0 cm from the 3.6 cm stapled resection margin. Gross photos are taken. and representative sections are submitted for histological examination. Micro B1: 4.9 cm stapled resection margin to include 0.8 cm submucosal nodule;. perpendicular, 1 frag,. Micro B1: 3.6 cm stapled resection margin, perpendicular, 1 frag,. Micro B3: Remainder of 0.8 cm submucosal nodule, 1 frag,. Micro B4: 1.0 cm submucosal nodule, 2 frags,. Micro B5: Mesenteric resection margin, perpendicular, 1 frag,. Micro B6: Tumor and serosa, deepest extent of invasion, perpendicular, 1 frag,. Micro B7: Tumor and adjacent uninvolved mucosa closest to 3.6 cm stapled. resection margin, 1 frag,. Micro B8: Tumor and mucosa closest to 4.9 cm stapled resection margin, 1 frag,. Micro B9: Tumor, 2 frags,. Micro B10; ? matted lymph nodes (1.8 x 1.5 x 0.8 cm), bisected, 1 frag,. Micro B11: 5 lymph node candidates, 5 frags,. Micro B12: 5 lymph node candidates, 5 frags,. Micro B13: 4 lymph node candidates, 4 frags,. Micro B14-B17: Pericolonic adipose tissue, 1 frag each,. Part C, ""proximal donut"", consists of a circular tan/pink soft tissue fragment. (1.1 x 1.6 cm in diameter) that is attached to metallic anvil and contains a. Page: 2 of 3. black stitch. The specimen is entirely submitted for histological examination. Micro C1: Proximal donut, 1 frag,. Part D, ""distal donut"", consists of a tan/yellow soft tissue (1.5 x 1.2 x 0.5. cm) which is entirely submitted. Micro D1: Distal donut, 1 frag,. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto. Final Diagnosis by. Page: 3 of 3.",T3,N1,M1,T3N1M1
TCGA-WC-A883,"DIAGNOSIS. (A) RIGHT EYE, FNA SAMPLE FOR SEND OUT TESTING ONLY. (B) RIGHT GLOBE: CHOROIDAL MELANOMA, MIXED EPITHELIOID AND SPINDLED, 18 MM BASE. EXTRAOCULAR EXTENSION PRESENT. TUMOR INVADES SCLERA AND CANAL OF SCHLEMM, EXTENDING TO SUBCONJUNCTIVAL SURFACE. Optic nerve negative for tumor. Vortex veins negative for tumor. (See comment). COMMENT. The tumor in the extraocular space near the conjunctiva is entirely covered by conjunctiva/soft tissue ( margins negative). are 1 per 10 high-power fields. The specimen for part A was sent to. for further diagnostic testing by. which will be reported separately W. the scan documents of. GROSS DESCRIPTION. (A) RIGHT EYE, FOR SEND OUT ESTING-pale-gray semitransparent tissue (0.4 X 0.4 X 0.2 cm) within pink-red fluid (0.5. X 0.5 cm) in a sealed container. The specimen is forwarded for send out testing. (B) RIGHT GLOBE - An enucleation specimen consisting of an intact left lobe (21.0 X 20.0 x 21.0 mm) with an attached 13. optic nerve. The cornea is 11.0 x 10,0 mm with a round central 2.0 mm pupil. The iris is pale gray-yellow with possible rim C. hyperpigmentation over approximately one-third peripherally. 1.0 mm from the limbus and adjacent to the area of possible. pigmentation, a black 2.0 mm probable tumor nodule is present on the external surface of the sclera with loosely adherent. conjunctiva covering the entire surface coming to less than 1.0 mm from the resection edge. An irregular intraocular multinodular mass with a base approximately 18.0 mm in greatest dimension extends from t. and comes to 5.0 mm from the optic nerve within the choroidal space. The mass is located between 2.0 and 6 o'clock. Tum. harvested fresh per protocol. The tumor has a maximum height post harvest 4.0 mm and the tumor surface is binodular. A. suggested from the external surface, the region of extraocular extension noted on the sclera covered by cornea is visible ad. to the tumor. The tumor flattens and becomes thickened again in kind of a rolling/ binodular pattern. An artificial lens is in p. SECTION CODE: B1, regions of vortex veins; B2, optic-nerve margin; B3, B4, calottes with tumor (B3 with extraoct. extension and in extraocular tissue harvest); B5, pupil-optic section with tumor. BIOMARKER TESTING. Primary tumor B5. CLINICAL HISTORY. Right eye uveal melanoma. SNOMED CODES. T-AA000, M-87203. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have no. Page: 2. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: END OF REPORT-. Ne. / DI. Reviewed 10713.",T3,N0,M0,T3N0M0
TCGA-BP-5199,"Clinical Diagnosis & History: Left renal mass. Specimens Submitted: 1: KIDNEY, LEFT AND PROXIMAL URETER; TOTAL NEPHRECTOMY. 2: LYMPH NODES, PARA-AORTIC; EXCISION. DIAGNOSIS: 1. KIDNEY, LEFT AND PROXIMAL URETER; TOTAL NEPHRECTOMY: Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. With prominant sarcomatoid features. Fuhrman Nuclear Grade: Nuclear grade IV/IV. Tumor Size: Greatest diameter is 7.6 cm. Local Invasion (for renal cortical types): Not Identified. Renal Veln Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT2 Tumor >7.0 cm in greatest dimension limited to the kidney. 2. LYMPH NODES, PARA-AORTIC; EXCISION: Lymph Nodes: Not involved. Number of nodes examined:4. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. AE1:AE3. CA-1X. CD31. CD34. IMM RECUT. NEG CONT. Gross Description: 1) The specimen is received fresh labeled ""left kidney and proximal ureter"" and consists of a kidney with attached ureter, renal. vessels and perlnephric fat weighing 645 g in total, The kidney measures 15 .2 x 8 x 5.9 cm. The attached ureter measures 2.5. cm in length and 0.5 cm in diameter. The attached renal vein measures 3.1 cm in length and 1.2 cm in diameter. The renal. vessels and ureter margins are grossly unremarkable. An adrenal gland is not identifed. The kidney is inked black and bivalved. to. reveal a well-circumscribed multi-fobulated yellow golden hemorrhagic mass measuring 7.6 X 6.0 x 5.5 cm The mass is located. at the upper pole of the left the kidney and it appears to be abutting and confined within the renal capsule. The. renal. artery,. vein. and ureters are not involved by the tumor. The mass invades the renal sinus fat, it is about 1,5 cm from the renal hilar fat. Tumor. grossly has 40% hemorrhage and 20 % necrosis. Sections through the remainder of the kidney reveal a pink brown. parenchyma,. with a well-defined cortico-medullary junction. The cortex measures 0.8cm and the calyces appear normal. No lymph. nodes. are. identified in the perinephric fat. Representative sections are submitted for TPS and for permanent sections. Photos. are. taken. Summary of sections: UVM - ureteral and vessel margins. T-- tumor. THF tumor with hilar fat. TSF -- tumor with sinus fat. TK -- tumor with adjacent kidney. RP -- renal pelvis representative sections. K -- representative sections kidney. ADD-additional section of ureteral margin and sinus fat. 2). The specimen is received in formalin, labeled ""paraortic lymph nodes"" and consists of several red-tan lymph nodes ranging. from 1.5 to 4.3 cm in greatest dimension, which are entirely submitted. Summary of sections: BLN1 -- bisected lymph node number one. BLN2 -- bisected lymph node number two. LLN-largest lymph node, sectioned and submitted In seven cassettes. SLN-trisected lymph node. Summary of Sections: Part 1: KIDNEY, LEFT AND PROXIMAL URETER; TOTAL NEPHRECTOMY. Block. Sect. Site. PCs. 4. add. 4. 1. k. 1. 1. 1. 6. t. 6. 3. thf. 3. 2. tk. 2. 3. tsf. 3. 1. uvm. 1. Part 2: LYMPH NODES, PARA-AORTIC; EXCISION. Block. Sect. Site. PCs. 1. bIn1. 1. bln2. 1. 7. Iln. 7. 3. sIn. 3.",T2,N0,M0,T2N0M0
TCGA-2G-AAHN,Summary pathology report. Left orchidectomy; seminoma; diameter 3.0 cm; no angio-invasion present;no ivasion in rete. testis;lymphatic invasion present; no invasion of tunica albuginea; epididymis free of tumor;. surgical margin of spermatic cord free of tumor. = date of orchidectomy): pathologist.,T1,N0,M0,T1N0M0
TCGA-E2-A1B1,"SPECIMENS: A. SENTINEL LYMPH NODE 1. B. SENTINEL LYMPH NODE 2. C. SENTINEL LYMPH NODE 3. D. SENTINEL LYMPH NODE 4. E. SENTINEL LYMPH NODE 5. F. SENTINEL LYMPH NODE 6. G. SENTINEL LYMPH NODE 7. H. WLE LEFT BREAST. 1. ADDITIONAL MARGIN LEFT BREAST. DIAGNOSIS: SENTINEL LYMPH NODE, #1, EXCISION (PART A). - FRAGMENT OF FIBROADIPOSE TISSUE, NEGATIVE FOR MALIGNANCY, NEGATIVE FOR. LYMPHOID TISSUE. SENTINEL LYMPH NODE #2, EXCISION (PART B). - METASTATIC DUCTAL CARCINOMA (4 MM IN DIAMETER, FOCAL EXTRACAPSULAR. EXTENSION). SEE COMMENT. SENTINEL LYMPH NODES, #3-#7, EXCISION (PARTS C-G). - FIVE LYMPH NODES, NEGATIVE FOR MALIGNANCY (0/5). LEFI BREAST, WIDE LOCAL EXCISION (PART H). - WELL DIFFERENTIATED INFILTRATING DUCTAL CARCINOMA, WITH A MUCINOUS. COMPONENT (3.7 CM IN GREATEST DIAMETER, SBR GRADE T),. - SEE COMMENT. - SURGICAL MARGINS OF EXCISION, NEGATIVE FOR MALIGNANCY. LEFT BREAST, ADDITIONAL MARGIN, EXCISION (PART I). - FIBROGLANDULAR BREAST TISSUE, NEGATIVE FOR MALIGNANCY. SPECIMEN(S): A. SENTINEL LYMPH NODE 1. B. SENTINEL LYMPH NODE 2. C. SENTINEL LYMPH NODE 3. D. SENTINEL LYMPH NODE 4. E. SENTINEL LYMPH NODE 5. F. SENTINEL LYMPH NODE 6. G. SENTINEL LYMPH NODE 7. H. WLE LEFT BREAST. I. ADDITIONAL MARGIN LEFT BREAST. CLINICAL HISTORY: /r old white female abnormal mammogram left upper outer breast. Cone Biopsy shows well. differentiated infiltrating ductal carcinoma with mucinous features. ER+, Pr+ HER2+ by FISH. Right breast MRI showed mass at left upper outer quadrant 3x3x0.8cm. Second enhancing mass at. posterior aspect 7mm measurement. Questionable satellite lesion. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA, TPB: Lymph nodes, left axillary sentinel 1 & 2, excision: No malignancy identified, specimen A is. predominantly fat. TPC, TPD: Lymph nodes, left axillary sentinel 3 & 4, excision: No malignancy identified. TPE, TPF, TPG: Lymph nodes, left axillary sentinel 5, 6 & 7, excision: No malignancy identified. By Dr. called in at. and. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE 1: - Received fresh for touch-prep and labeled, Sentinel Lymph Node #1, Left"" is a piece of adipose tissue. measuring 2.4x2x.4cm It is bisected and a touch-prep is performed. Specimen is submitted in toto in. block A1. B. SENTINEL LYMPH NODE 2: - Received in formalin and labeled ""Sentinel Lymph Node #2, Left Axilla"" is a lymph node with fat. measuring 2x3.5x1.1cm Bisected. A touch-prep is performed and lymph node is submitted in toto in. block B1. C. SENTINEL LYMPH NODE 3: - Received in formalin and labeled Sentinel Lymph Node #3, Left Axilla"" is a tan lymph node measuring. 1.3x1.2x0.6cm. Bisected and a touch-prep is performed. Submitted in toto in block C1. D. SENTINEL LYMPH NODE 4: - Received fresh for touch-prep and labeled, Sentinel Lymph Node #4, Left Axilla"" is a piece of yellow-. tan fat and a tan lymph node measuring 1.5x1.2x0.3cm. It is bisected and a touch-prep is performed. Specimen is submitted in toto in block D1. E. SENTINEL LYMPH NODE 5: - Received fresh for touch-prep and labeled, Sentinel Lymph Node #5, Left Axilla"" is a piece of fat and a. tan lymph node measuring 2.3x1.5x0.7cm. The specimen is serially sectioned and touch-prep is. performed. Lymph node is submitted in toto in block E1-E2. F. SENTINEL LYMPH NODE 6: - Received fresh for touch-prep and labeled, Sentinel Lymph Node #6, Left Axilla"" is a piece of yellow-. tan adipose tissue containing a lymph node measuring 1.5x0.7x0.5cm. The lymph node is bisected and. a touch-prep is performed. The lymph node is submitted in toto in block F1. G. SENTINEL LYMPH NODE 7: - Received fresh for touch-prep and labeled, Sentinel Lymph Node #7, Left Axilla"" is a piece of yellow-. tan fat containing a lymph node measuring 1.0x9.0x4cm. It is bisectioned and a touch-prep is. performed. Specimen is submitted in toto in block G1. H. WLE LEFT BREAST. - Received fresh and labeled, Wide Local Excision, Left Breast with Needle Localization"" is an oval. shaped piece of yellow-tan fibrofatty soft tissue weighing 161 grams and measuring 9.2x8.1x3.2cm. The specimen is received with an accompanying radiogram which shows a needle coursing from the. medial aspect to the lateral aspect. The needle is a stellate area of increased density and a surgical. clip is present. The specimen has been oriented in surgery with short designating superior long lateral. and looped anterior. Specimen is inked as follows: inferior-orange, superior-red, lateral-yellow,. anterior-blue, medial-green and posterior black. Specimen is serially sectioned from superior to inferior. and in the inferior aspect of the specimen is an irregularly shaped firm pink-tan mass measuring. 3.7x3.5x1.5cm. Areas of hemorrhage are seen. The mass is within 1. 1cm from the lateral margin,. 1.2cm from the anterior margin, 2.2cm from the medial margin, 1.7cm from the deep margin, 1.7cm. from the inferior margin and approximately 4.4cm from the superior margin. Superior and slightly. posterior from this mass is a firm tan nodule measuring 0.7cm which is located 0.8cm from the larger. mass. It is possible that it is a continuous mass located 1.2cm from the lateral margin, 3.7cm from the. anterior margin, 1.3cm from the posterior margin and 4.8cm from the medial margin. This mass. corresponds with the increased area of density and second needle localization which is present on the. radiogram which is shown superior to the larger mass. Representative sections are submitted as. follows: H1-H6 larger mass including adjacent margins; H7-H8 breast tissue between larger mass and. smaller mass; H9 smaller mass; H10-H13 additional fibrous breast tissue; H14 superior margin; H15. inferior margin. I. ADDITIONAL MARGIN LEFT BREAST: - Received in formalin and labeled Additional Margin Left Breast. This Marks New Inferior Margin"" is. an irregularly shaped piece of yellow-tan fibrofatty breast tissue measuring 4.7x4.7x0.8cm. There is a. stitch present marking the new inferior margin. The margin is inked blue and serially sectioned. On. sectioning little fibrous tissue is seen and no masses or lesions are found. Specimen is submitted in. toto in blocks I1-I10. COMMENT: Review of the original touch prep, for sentinel lymph node #2, shows a single minute focus of metastatic. tumor cells. The metastatic deposit in sentinel lymph node #2 measures 4mm in greatest diameter, and. shows approximately 1mm of extracapsular extension focally. Gross examination of the left breast wide. local excision shows an irregularly shaped 3.7x3.5x1.5cm lesion, which is grossly away from the. margins of excision. On gross examination, there is a separate firm nodule which measures 0.7cm in. diameter which is near the larger tumor mass. Examination of microscopic sections, in the intervening. breast between these two nodules, however shows continuity of the 2nd smaller nodule with the larger. mass, consistent with an irregular, dumbbell shaped single lesion. This patient had ER, PR and HER2. IHC performed on her prior needle core biopsy . These results were ER positive, PR positive and. HER2 was found to be amplified by FISH. Specimens Involved. Specimens: H: WLE LEFT BREAST. BREAST CANCER TEMPLATE. Specimen Type: Excision. Needle Localization: Yes. Laterality: Left. Invasive tumor: Present. Multifocality: No. Specimen size: Size of Invasive focus 3.7cm. Additional dimensions: 3.5cm x 1.5cm. Tumor Site: Upper outer quadrant). Margins: Negative. Distance from closest margin: 0.4cm. Margin: anterior. Tubular score: 1 (>75% tubule). Mitotic score (Olympus 40x): 1 (0-6/10 hpf). Modified Scarff Bloom Richardson Grade: I (3-5 points). Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Nuclear score: 2. Lymph nodes: Sentinel lymph node only. Lymph node status: Positive 1/6 Extranodal extension. DCIS PRESENT?. Pathological staging (pTN): pT 2N1. Microscopic/Diagnostic Dictation: Pathologist,. Microscopic/Diagnostic Dictation: PATHOLOGIST,. Final Review: PATHOLOGIST. Final Review: PATHOLOGIST. Final:PATHOLOGIST,.",T2,N1,M0,T2N1M0
TCGA-AA-3492,"Diagnosis/Diagnoses: Right hemicolectomy specimen with tumor-free resection margins, including a small tubular and. a larger tubulovillous adenoma with moderate dysplasia, with an ulcerated, poorly differentiated. adenocarcinoma with infiltration of the perimuscular fat tissue (G3, pT3) and a moderately. differentiated adenocarcinoma with infiltration of the submucosa (G2, pT1) in the proximal large. bowel and with a detectable ulcer in the aboral section of the preparation, evidently with status. post complete endocoscopic excision of a tubulovillous adenoma with severe dysplasia (cf. most. recent preliminary findings). Tumor-free oral and aboral resection margins. Unremarkable. appendix. Tumor-free omental tissue. A follow-up report will be made on the lymph node status. Follow-up report: Only twenty-one lymph nodes of up to 0.4 cm in size in the vicinity of the tumor were dissected. out from the pericolic fatty tissue after clarification with acetone. Microscopically these were all tumor-free. In conclusion, the previously diagnosed double carcinoma of the right colon can be assigned to. category pNO (0/12).",T3,N0,M0,T3N0M0
TCGA-BA-4077,"SURGICAL PATHOLOGY RE ISED REPORT. Amended. Amendments: Amended: Reason: Additional Information. Comment: FSF, F additional line. Previous Signout Date: Diagnosis: FSA: Lymph nodes, pretracheal, biopsy. - No metastatic carcinoma identified (0/2) . FSB: Periosteum, mental, biopsy. - Skeletal muscle, no invasive carcinoma identified. FSC: Right carotid sheath, biopsy. - Fibrous connective tissue, no invasive carcinoma. identified. FSD: Right retropharyngeal space, biopsy. - Fibrous connective tissue, no invasive carcinoma. identified. FSE: Right parapharyngeal space, biopsy. - Fibrous connective tissue, no invasive carcinoma. identified. FSF, F: Larynx and tongue, glossolaryngectomy. - Invasive squamous cell carcinoma, moderately. differentiated, non-keratinizing, at least 4 cm diameter,. involving paramidline base of tongue bilaterally, floor of. mouth, valecula, and hyoid bone, without angiolymphatic. invasion, inked surgical margins not involved. - Lymph nodes, right cervical - No metastatic carcinoma. identified (0/6). . Intraoperative Consult Diagnosis: An intraoperative frozen section consultation was requested. by Dr. FSA1: Lymph node, pretracheal, biopsy. - One lymph node, no tumor seen. FSB1: Periosteum, mental, biopsy. - No tumor seen. FSC1: Right carotid sheath, biopsy. - No tumor seen, small fragment of nerve present. FSD1: Right retropharyngeal space, biopsy. - No tumor seen. FSE1: Right parapharyngeal space, biopsy. - No tumor seen. Frozen Section Pathologist: Clinical History: with a history of moderately differentiated squamous cell. carcinoma of the tongue. Gross Description: Received are six appropriately labeled containers. Container A holds a 0.8 X 0.3 X 0.3 cm lymph node. candidate; totally submitted in block FSA1,. Container B holds a 0.8 X 0.4 X 0.2 cm white/tan soft. tissue fragment; block FSB1,. Container C is received fresh in the frozen section room. and described as a 1.0 x 0.2 X 0.2 cm red/tan soft tissue. fragment which is totally submitted in block FSC1,. Container D is received in the frozen section room and. described as a 0.8 X 0.2 X 0.3 cm red/tan soft tissue. fragment which is totally submitted in block FSD1,. Container E is received fresh in the frozen section room. and described as a 0.6 X 0.4 X 0.2 cm red/tan soft tissue. fragment which is totally submitted in block FSE1,. Container F: Specimen fixation: formalin. Type of specimen: total glossectomy and total laryngectomy. with partial neck contents from Levels I, II and III. Size of specimen: The tongue measures 7.0 X 6.0 X 2.0 cm. and the larynx measures 4.0 X 3.5 X 2.5 cm with two. tracheal rings. Orientation of specimen: The specimen is inked such that. the mucosal margin and soft tissue margins on the right are. blue, and mucosal margins and soft tissue margins on the. left are black. Certain deep and posterior soft tissue. margins on the mid line are inked green. Tumor description: The tumor is a large, ulcerated,. destructive lesion measuring 4.0 cm anterior to posterior,. 3.1 cm medial to lateral, and 3.0 cm superficial to deep. It is a red, ulcerated destructive lesion involving the. posterior right tongue, the base of the tongue bilaterally,. the floor of the mouth, palatal glossal arch, and close but. not quite involving the vallecula. Multiple Polaroid photographs are taken of the fresh,. intact specimen and a. solution scan is taken a. longitudinal section through the midline of the specimen. after fixation. Location of tumor: see above. Tumor size: see above. Extent of tumor: see above. Presence/absence of bone involvement: The tumor comes very. near to the hyoid bone grossly, but involvement cannot be. assessed. Distance of tumor from surgical margins: The tumor comes to. within 7.0 cm from the tracheal margin, 1.5 cm from the. right and left anterior sublingual margins, 0.5 cm from the. lateral right lingual margin, 0. cm from the posterior. right sublingual margin, 1.2 cm from the right. aryepiglottic fold margin, 2.5 cm from the left. aryepiglottic fold margin, 1.2 cm from the posterior left. sublingual margin, 1.1 cm from the lateral left sublingual. margin, 1.0 cm from the posterior and deep soft. tissue margin, and 1.3 cm from the anterior soft tissue. margin, the tumor comes to within 0.5 cm of the lateral. right soft tissue margin and 1.4 cm from the lateral left. soft tissue margin. Description of remainder of tissue: unremarkable. Tissue submitted for special investigations: A small amount. of tumor and normal is given to Tissue Procurement. Lymph nodes: The right neck contents consists of six lymph. nodes ranging in diameter from 2 mm to 7 mm. Also, there is. a 2.5 X 2.5 X 1.0 cm salivary gland with an unremarkable. tan, lobulated architecture. The right neck contents. contain a single 0.5 cm lymph node candidate. Block Summary. F1 - anterior sublingual margin, left. F2 - lateral sublingual margin, left. F3 - posterior sublingual margin, left. F4 - aryepiglottic fold margin, left. F5 - entire tracheal margin. F6 - anterior sublingual margin, right. F7 - lateral sublingual margin, right. F8 - posterior sublingual margin, right. F9 - aryepiglottic fold margin, right. F10 - tumor at posterior tongue. F11 - tumor at base of tongue. F12 - anterior soft tissue margin, contiguous with. tissue taken in F11. F13 - deep soft tissue margin, tumor at floor of mouth. and hyoid bone. F14 - right vocal cord. F15 - tumor, floor of mouth, vallecula and epiglottis. F16, F17 - full thickness coronal section from. superficial to deep at the base of the tongue, including. lateral right soft tissue margin. F18 - tumor and lateral soft tissue margin, left. F19 - tumor at floor of the mouth and right lateral soft. tissue margin. F20 - left salivary gland. F21 - three lymph node candidates, left. F22 - three lymph node candidates, left. F23 - one lymph node candidate, right. Light Microscopy: Light microscopic examination is performed by Dr. The frozen section diagnoses are confirmed. Histologic tumor type: squamous carcinoma. Histologic grade: moderately differentiated. Tumor extent: predominantly R paramidline BOT, with. extension to FOM, vallecula, and anteriorly to hyoid bone. Presence/absence of CIS: present. Presence/absence of angiolymphatic space invasion: absent. Presence/absence of perineural space invasion: absent. Histologic assessment of surgical margins: negative. Lymph nodes: negative. Size of largest nodal metastasis (greatest dimension) : Presence/absence of extranodal extension: Other significant findings: none. AJCC staging: pT4A. pNO. pMx. This staging information is based on this pathologic. specimen and may be incomplete. A comprehensive review of. all available information is recommended to determine final. staging. Amendment Comment: Following initial case finalization, it. was brought to our attention that the diagnostic lines do. not reference the included lymph nodes.",T4,N0,M0,T4N0M0
TCGA-AA-A01S,"Diagnosis: This is an invasive, moderately differentiated adenocarcinoma in the sigmoid colon. Both resection margins are tumor-free, as is the area of the central vascular ligature. There is also a lymph node metastasis. Tumor classification: ICDO-DA M. 8140/3. G2. p T3,. p N 1 (1/19),. R 0. le): History. Reviewed. LIFKE.",T3,N1,M0,T3N1M0
TCGA-BQ-5890,"Ref Source: sis & History: ith large left renal mass. Specimens Submitted: 1: SP: Left kidney and ureter. 2: SP: Para aortic lymph nodes. 3: SP; Preaortic lymph nodes. 4: SP: Suprahilar lymph nodes and adrenal gland. DIAGNOSIS: 1. SP: Left kidney and ureter: Tumor Type: Renal cell carcinoma - Unclassified type. The tumor is high grade with a combination of papillary, tubular and clear cell features and focal desmoplastic. stroma. Tumor Size: Greatest diameter is 11.5 cm. Local Invasion (for renal cortical types): Involves renal sinus fat. Tumor involves perinephric fat. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: chronic pyelonephritis, nephrocalcinosis and focal cortical scarring and cysts. Adrenal Gland: Not identified. See part 4. Lymph Nodes: Not identified. Staging for renal cell carcinomaloncocytoma. pT3a Tumor invades the adrenal gland or perinephric tissues but not beyond Gerota's fascia. Comment: The tumor cells are diffusely immunoreactive for RACEMASE and CD10; and focally positive for CEA, 34BE12,. and CK7, CAIX and cytokeratin AE1-AE3 are negative in tumor cells. 2. Para aortic lymph nodes; dissection: -Nine benign lymph nodes (0/9). 3. Preaortic lymph nodes: - Ten benign lymph nodes (0/10). 4. Suprahilar lymphinodes and adrenal gland: - Benign adrenal tissue. . No lymphoid lissue identified. JATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL). AND THAT THAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Spocial Stain. Comment. CK7. RACEMASE. CA-1X. CD10. 348E12. CEA P. AE1:AE3. IMM RECUT. NEG CONT. Gross Description: 1) The specimen is received fresh labeled ""left kidney and ureter"" and consists of a kidney with attached ureter, renal vessels and. perinephric fat weighing 853 g in total. The kidney measures 17.5 x 11 cm. The attached ureter measures 11 cm in length. and 0.3 cm in diameter. The attached renal vein measures 1.4 Cm in length and 0.5 cm in diameter. The renal vessels and. ureter margins are grossly unremarkable. An adrenal gland is not identified. The kidney is inked black and bivalved to reveal a. hemorrhagic bright yellow to tan friable mass at the upper pole of the kidney measuring 11.5 x 9 x 8cm. The mass is sharply. circumscribed from the adjacent kidney parenchyma and grossly extends into the perinephric fat and abuts Gerota's fascia which is. inked black. Tumor extends to within 0.5 cm of the renal sinus. Sections through the remainder of the kidney reveal a pink brown. parenchyma, with a well-defined corticomedullary junction and several cortical cysts filled with straw colored serous fluid in the. inferior portion of the kidney measuring up to 2 cm in greatest dimension each. The cortex measures 0.7 cm and the calyces. appear normal. Lymph nodes are not identified in the perinephric fat. The specimen is photographed. Representative sections. are submitted for. nd for permanent sections. Summary of sections: UVM ureteral and vessel margins. T.- tumor. TPF -+ tumor with perinephric fat. TG - tumor with Gerota's fascia. SF - sinus fat closest to tumor. K .. representative sections kidney. C - cortical cysts. 2). The specimen is received in formalin, labeled Para-aortic lymph nodes"" and consists of six pink tan firm, fatty lymph nodes. ranging from 0,5 to 2.7 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN -- lymph nodes. BLN- bisected lymph node. 3). The specimen is received in formalin, labeled ""Preaortic lymph nodes"" and consists of seven pink tan firm, fatty lymph nodes. ranging from 1 to 3.2 cin in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN lymph nodes. 8LN-- bisected lymph node. 4). The specimen is received in formalin, labeled ""Suprahilar lymph nodes and adrenal gland"" and consists of a 8 x 3 x 2 cm. portion of fibroadipose tissue. Cut sections reveal three yellow tan fatty lymph nodes varying from 0.7 to 1.2 cm. A cystic golden. yellow adrenal membrane is identified measuring 1.5 x 1.5 X 0.5 cm. All identified lymph nodes are submitted. Entirely submilted,. Summary of sections: A - adrenal gland. LN - lymph nodes. Summary of Sections: Part 1: SP: Left kidney and ureter. Block. Sect. Site. PCs. 4. add. 4. 1. C. 1. 1. K. 1. 3. SF. 3. 2. 2. TG. 2. 3. TPF. :3. 1. uvm. 1. Part 2: SP: Para aortic lymph nodes. Block. Sect. Site. PCs. 2. BLN. 2. 2. LN. 5. Part 3: SP: Proaortic lymph nodes. Block. Sect. Site. PCs. 2. BLN. 2. LN. 4. Part 4: SP: Suprahilar lymph nodes and adrenal gland. Block. Sect. Site. PCs. 3. A. 3. 2. LN. 2.",T3,N0,M0,T3N0M0
TCGA-35-4122,Clinical. Index. S. Diagnosis. 1. Cancer. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of Amount/per. Specificati. Container. Site. Matrix. Format. containers. container. t. on. Lung. Primary. Tumor. Tissue. OCT. block. 1. n/a. Blood. n/a. Normal. Blood. frozen. tube. 1. n/a. Type of. Histological description. Grade. TNM Stage. TNM Stage. TNM Stage. Treatment. Procureme. (Source). (source). (T). (N). (M). type. nt. Adeno-squamous. n/a. 2. 1. 0. none. carcinoma. n/a. blood draw. n/a. n/a. n/a. n/a. n/a. none. Component. of treatment. Tumor cell. (Chemo /. %. Horm Th. Details). n/a. 75. n/a. n/a.,T1,N0,M0,T1N0M0
TCGA-DD-AACS,"CLINICAL DIAGNOSIS: HCC. Specimen : HCC. Gross Photo : GROSS: Specimen: Liver: 7.6 x 7.0 X 3.2 cm, unfixed. Gallbladder: 5.8 cm in length and 3.6 cm in diameter, stone (3.2 cm in diameter). Tumor location: Center of the specimen. Tumor number: One. Tumor size: 2.8 X 2.5 X 2.3 cm. Satellite nodule: No. Gross type. HCC: Expanding nodular. Tumor necrosis: Yes (20 %). Hemorrhage/peliosis: No. Portal vein invasion: Unknown. Bile duct invasion: Unknown. Peritumoral cirrhosis, micronodular. Gross photo present. Blocks. T1-4 and TB, mass and surrounding tissue X 5. RM, mass and resection margin X 1. A and NB, remaining liver x 2. GB, gallbladder X 1. MICROSCOPIC: Tumor type: Hepatocellular carcinoma, trabecular and solid. Differentiation, II-III. Fibrous capsule formation: Yes. Surgical resection margin invasion: Free of tumor. Non-tumor liver pathology. Chronic hepatitis: Yes. Etiology: HBV. Grade, lobular: Minimal (grade 1). Grade, portoperiportal: Minimal (grade 1). Stage (fibrosis): Septal fibrosis (stage 3). Dysplastic nodule: No. Ductal epithelial dysplasia: No. Other liver diseases: Steatosis, moderate. NOT reported. Gross: Liver, ectomy, hepatocellular carcinoma. T56000, P10, M81703. Gallbladder, ectomy, chronic inflammation, cholelithiasis. T57000, P10, M43000, M30011. DIAGNOSIS: Liver, segment 8, subsegmentectomy: Hepatocellular carcinoma, moderately differentiated. Gallbladder, cholecystectomy: Inflammation, chronic. Cholelithiasis. Suggestion :",T1,N0,M0,T1N0M0
TCGA-F7-A50J,"Gross Description: Specimen B is designated ""right oral tongue and floor of. mouth, double long stitch anterior, single long superior/medial."" The. specimen consists of an oriented portion of tongue with a double stitch. marking anterior and a medial stitch marking superior. The specimen. measures 5.5 cm anterior to posterior, 4.2 cm superior to inferior, and. 1.9 cm medial to lateral. A central exophytic irregular mass is. identified measuring 4.2 cm anterior to posterior and 3.8 cm superior to. inferior. The remaining mucosa is pale tan and slightly edematous. The. specimen is inked as follows: superior blue, anterior orange, inferior. red, posterior black, and deep green. The mass is 1.9 cm from the. superior mucosal margin, 0.4 cm to the anterior mucosal margin, 0.2 cm. from the inferior mucosal margin with a superficial are of ulceration. less than 0.1 cm from the inferior mucosal margin and 0.3 cm from the. posterior mucosal margin. The specimen is serially sectioned revealing. gray-white cut surfaces with a maximal tumor depth of 1.2 cm. It is 0.4. cm to the nearest inferior resection margin. Representative sections. are submitted.Specime B is designated ""right oral tongue and floor of. mouth, double long stitch anterior, single long superior/medial."" The. specimen consists of an oriented portion of tongue with a double stitch. marking anterior and a medial stitch marking superior. The specimen. measures 5.5 cm anterior to posterior, 4.2 cm superior to inferior, and. 1.9 cm medial to lateral. A central exophytic irregular mass is. identified measuring 4.2 cm anterior to posterior and 3.8 cm superior to. inferior. The remaining mucosa is pale tan and slightly edematous. The. specimen is inked as follows: superior blue, anterior orange, inferior. red, posterior black, and deep green. The mass is 1.9 cm from the. superior mucosal margin, 0.4 cm to the anterior mucosal margin, 0.2 cm. from the inferior mucosal margin with a superficial are of ulceration. less than 0.1 cm from the inferior mucosal margin and 0.3 cm from the. posterior mucosal margin. The specimen is serially sectioned revealing. gray-white cut surfaces with a maximal tumor depth of 1.2 cm. It is 0.4. cm to the nearest inferior resection margin. Representative sections. are submitted. Microscopic Description: N/A. Diagnosis Details: B. Right oral tongue and floor of mouth (hemiglossectomy and. resection): - Invasive moderately differentiated keratinizing squamous cell. carcinoma of the tongue (tumor size 4.2 X 3.8 cm, depth of invasion 0.9. cm). - Carcinoma invades salivary gland tissue, probably belonging to minor. salivary glands. - Angiolymphatic invasion is identified. - Perineural invasion is identified. - Carcinoma extends to within less than 1.0 mm of the inferior specimen. margin; however, no carcinoma is identified at the inked margins. Comments: N/A. Formatted Path Reports: Right oral tongue and floor of mouth (hemiglossectomy and resection): - Invasive moderately differentiated keratinizing squamous cell carcinoma of the tongue (tumor size 4.2. X 3.8 cm, depth of invasion 0.9cm). - Carcinoma invades salivary gland tissue, probably belonging to minor salivary glands. - Angiolymphatic invasion is identified. - Perineural invasion is identified. Carcinoma extends to within less than 1.0 mm of the inferior specimen margin; however, no. carcinoma is identified at the inked margins.",T3,N0,M0,T3N0M0
TCGA-W5-AA2R,"Female. Surgery Date: DIAGNOSIS: Liver, segment V and VI, excision: Invasive grade 3 (of 4) adenocarcinoma,. consistent with cholangiocarcinoma, forming a 4.8 X 3.1 x 3.0 cm mass with extensive. necrosis. Surgical resection margins, including the retroperitoneal margin, are. negative for malignancy (free by 0.7 cm). Gallbladder, cholecystectomy: Chronic cholecystitis and cholesterolosis. stones are identified.",T1,N0,M0,T1N0M0
TCGA-D6-A6EN,"Gender: M. Examination result No. Surgery and Laryngological Oncology Dept. Clinical diagnosis (suspicion) Tumour of the left cheek - Ca planoepitheliale G3 exulcerans. Date of admission: Material: 1) Material: mucous membrane. Please examine the marked margin. Method of collection: Lesion. resection. Histopathological diagnosis. Invasive non-keratinising squamous cell carcinoma. G3, pT2 (8070/3 T-51030). codes according to ICD-O-3 or SNOMED. Microscopic description: Invasive non-keratinising squamous cell carcinoma. Margin marked with two wires infiltrated by cancer, other margins uninvolved. Signs of vascular invasion, no. signs of nerve invasion. Preliminary result: Non-keratinising squamous cell carcinoma G3. Final reply to be given after full material is developed. Results of intraoperative examination: Cancer invasion on the excision line marked with two wires. Final reply to be given after the analysis of paraffin. specimens.",T2,N1,M0,T2N1M0
TCGA-86-7714,"Case ID. Gross Description. Microscopic. Subject ID. Description. Labeled right lower. Sections reveal an. lobe. There is a 3.5 X 3. invasive. X 2.5 cm wedge of. adenocarcinoma with. lung. papillary, lipidic,. tissue with intact gray. acinar, and. pleura. On cross. micropapillary. section there is a 2.1. subtypes. See checklist. cm. for additional details. subpleural tumor with. a glistening white. mucoid surface. The. tumor is 12 mm. from the nearest. stapled margin. The. pleura has been inked. blue. No. satellite nodules are. detected. The. remaining lung tissue. is brown and. spongy. Diagnosis Details. Comments. LUNG CARCINOMA. LUNG TISSUE CHECKLIST. CHECKLIST. 1. Tumor Type: Specimen type: Wedge. Adenocarcinoma, mixed. resection, lobectomy. subtype. Tumor site: Lung. 2. Tumor grade: Poorly. Tumor size: 2.1 cm. differentiated. Histologic type: 3. Tumor location: Right. Adenocarcinoma. lower lobe. Histologic grade: Poorly. 4. Tumor size: 2.1 cm. differentiated. 5. Angiolymphatic invasion: Tumor extent: Visceral. pleura. 6. Bronchial margin: N/A. Other tumor nodules: Not. 7. Pleural involvement: specified. Visceral pleura. Lymph nodes: 1/1 positive. 8. Lymph nodes: 1 positive. for metastasis (Subcarinal. out of 1 found (subcarinal. lymph node 1/1). lymph node). Lymphatic invasion: 9. Size of largest metastatic. Present. deposit: 0.25 cm. Venous invasion: Present. 10. pTNM: T2a N2 MX. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic. findings: Not specified. Comments: None. Laterality.",T1,N2,M0,T1N2M0
TCGA-IB-7893,"ORIGINAL REPORT. SPECIMEN: A. Distal pancreas to stitch marks neok of pancreas. B. Gallbladder. CLINICAL BISTORY: Pancreatic mass - body of the pancreas. DIAGNOSIS: A, DISTAL PANCREAS; RESECTION: - INVASIVE POORLY DIFFERENTIATION DUCTAL ADENOCARCINOMA (7.0 cau). FAT, PERINEURAL INVASION PRESENT, RADIAL RESECTION MARGIN POSITIVE FOR. INFILTRATING PANCREATIC PARENCHYMA AND EXTENDING INTO PERIPANCREATIC. MALIGNANCY, PROXINAL AND DISTAL RESECTION MARGINS UNINVOLVED. III). HIGH GRADE PANCREATIC INTRAEPITHELIAL NEOPLASIA (PanIN. - - EIGHT PERIPANCREATIC LYMPK NODES NEGATIVE FOR MALIGNANCY. B. GALLBLADDER; CEOLECYSTECTOMY: - CHOLEEITHIASIS, CHRONIC CHOLECYSTITIS, NEGATIVE FOR MALIGNANCY. QROSS DESCRIPTION: A. The specimen consista of diatal panoreas which measures 12.0 x 4.5 x 3.0. with silver nitrate, The body of the pancreas is almost completely occupied. cm. The proximal margin is marked by a long suture, The specimen is painted. by a firm oylindrical tumor which measures 7.0 x 2,3 x 2.0 cm. The tumor. appears to be confined within the pancreatic parenchyma and is 0.2 cm from The the. radial margin, The tumor is 2. 0 cm from the proximal resection margin. out surfaces of the tumor are fairly circumacribed, yellow-white,. predominantly solid with few small cystic areas near the periphery. The. measures 0.7 em in diameter at the distal end of the pancreas, The proximal. pancreatic duct appears to be intact in the tumor and is dilated, The duct. resection margin is painted with India ink,. 201. HISTOPATHOLOGY REPORT. pivision Head: GROSS DESCRIPTION: sections;. A1,. proximal resection margin. A2-9. tumor. A10,. distal resection margin (enface). A11. tumor. A12. one lymph node. A13,. two lymph nodes. A14. additional section of the proximal margin. A15-A16. tumor and radial margin. A17. dilated duct. B, The specimen consists of, a gallbladder which measures 10.5 x 2.3 x 2.0. cm. The outer surtace is unremarkable. The wall. measures less than 0.1 cm in. thickness and the lumen contains numerous yellow-green stones admixed with. dark areen muginous material, Sectione are submitted in one cassette. Co:",T3,N0,M0,T3N0M0
TCGA-GC-A3BM,"EPHYSICIAK. Sex: Male. (Age: MRN #: Ref Phy. DIAGNOSIS. DIAGNOSIS: A. Serosal implant: Metastatic high-grade urothelial carcinoma. B. Right ureter distal margin: Benign, no pathological diagnosis. C. Left ureter distal margin: Benign, no pathological diagnosis. D. Cystectomy and prostatectomy: Carcinoma of bladder and additional incidental carcinoma of prostate. Cystectomy: Carcinoma. Tumor Characteristics: 1. Histologic type: Urothelial. 2. Histologic grade: High-grade (grade III). 3. Tumor size: Largest representing dome of bladder approximately 1.5 x 1.0 x 0.8 cm. 4. Microscopic tumor extension: Tumor invades deep muscularis propria (outer half). 5. Lymphovascular space invasion Present. Surgical Margins: 1. Margins uninvolved. Other: 1. Associated epithelial lesions; Urothelial carcinoma in situ. 2. Other significant findings: Metastatic urothelial carcinoma is identified in specimen A as a serosal implant. 3. pTNM stage: pT2b,NO. Prostatectomy: Carcinoma. Tumor Characteristics: 1. Histologic type: Adenocarcinoma, conventional type. 2. Prostate size: 5.0 x 4.0 x 3.5 cm. 3. Turnor quantitation: Approximately 5% of gland volume. 4. Gleason grade: a. Primary pattern: 3/5. b. Secondary pattern: 3/5. c. Total Gleason score: 6/10. 5. Extraprostatic extension: No. 6. Seminal vesicle involvement: No. 7. Lymphovascular space invasion: Not identified. 8. High grade PIN: Present. 9. Treatment effect None identified. Surgical Margin Status: 1. Margins uninvolved. Lymph Node Status (utilizing specimens E and F): 1. Total number of lymph nodes received: 2. 2. Total number of fymph nodes containing metastatic carcinoma: None (0/2). Other: 1. Other significant findings: Benign prostatic hyperplasia. 2. PTNM stage: pT2c,NO. E. Right pelvic lymph node: Benign, hyperplasia (0/1). DIAGNOSS. F. Left pelvic lymph node: Benign, hyperplasia (0/1). G. Vermiform appendix. No pathological diagnosis. CLINICAL FORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Bladder CA. Postoperative Diagnosis: Symptoms/Radiokogic Findings: SPECIMENS: A. Serosal implant. B. Right ureter, clip on distal margin. C. Distal left ureter. D. Bladder, prostate. E. Right pelvic lymph node. F. Left pelvic lymph node. G. Appendix. SPECIMEN DATAY. GROSS DESCRIPTION: A. The first container A is labeled. serosal implant. The specimen consists of a gray tan nodule measuring 2.0 x 1.5 x 1.0 cm. The nodule. is bisected. A portion was examined at the time of surgery. The nodule is entirely submitted in cassettes. 3 as follows: frozen section-1;. remainder of nodule-2. B. The second container B is labeled. right ureter, clip is on distal margin. The specimen consists of a portion of ureter measuring 0.7 cm. in diameter and 0.2 cm in length. The specimen was examined at the time of surgery and is subsequently entirely submitted in a single cassette. C. The third container C is labeled. distal left ureter. The specimen consists of a portion of ureter measuring 0.6 cm in diameter and 0.2. cm in length. The specimen was examined at the time of surgery and is subsequently entirely submitted in a single cassette. D. The fourth container D is labelec. >ladder, prostate. The specimen consists of a bladder, prostate and attached perivesicular fat. measuring in total 14.0 x 10.0 x 7.0 cm and weighs 278 grams. The bladder itself measures 6.5 x 6.0 x 4.5 cm. The bladder has been received bisected. into anterior and posterior. The mucosal surface is light tan to gray tan edematous. There are multiple foci of brown tan nodules involving the dome. right and left lateral walls measuring from 0.5 to 1.5 cm. On the left lateral wall there is an area of ulceration measuring 1.0 x 0.5 cm. The most distal. nodule is within 3.2 cm of the distal resection margin at the prostatic urethra. The right and left ureters are probed and are patent and are grossly. uninvolved by the mass. The left ureter is dilated up to 0,7 cm. The most distal lesion appears to be right above the trigone. On sectioning the lesions. appear. to. extend. superficially. into underlying wall and is 1.5 cm from the inked deep margin. The prostate measures 5.0 x 4.0 x 3.5 am. The cut surface. has a gray tan nodular architecture. A lesion is not identified grossly. The left and right seminal vesicle and vas deferens are identified and appear. grossly unremarkable. On sectioning through the perivesicular fat there are no lymph nodes grossly identified. Received with the specimen are three. cassettes, one green, one yellow, one blue, labeled. Representative sections are submitted in cassettes. is follows: perpendicular sections taken from the distal margin at the prostatic urethra-1 and 2; sections from the lesions involving the dome-J; right lateral wall-4;. left lateral wall-5; sections from the large lesion involving the trigone-6 to 8; floor of bladder-9; right distal ureter-10 right proximal ureter taken at the. orifice-11; left distal ureter-12; left proximal ureter taken at the orifice-13; left lobe of prostate-14 right seminal vesicle and vas-15; right lobe of. prostate-16 left seminal vesicle and vas-17. E. The fifth container E is labeler. right pelvic lymph node. The specimen consists of a portion of fibroadipose tissue measuring 3.0 x 3.5. x 1.0 cm. Sectioning reveals a single lympn node measuring 2.5 x 1.4 1.7 cm, bisected, examined at the time of surgery and the frozen section is. subsequently entirely submitted in a single cassette. F. The sixth container F is labeled. left pelvic lymph node. The specimen consists of a portion of fibroadipose tissue measuring 4.0 x 3.0 x. 1.0 cm. Sectioning reveais a single lymph node measuring 1.0 x 1.0 x 0.6 cm. The lymph node was sectioned, examined at the time of surgery and the. frozen section is subsequently entirely submitted in a single cassette. G. The seventh container G is labeled. appendix. The specimen consists of an appendix measuring 6.0 cm in length and 0.5 cm in. diameter with attached periappendiceal fat measuring 2.0 cm in thickness that is yellow to brown tan with slight hemorrhage. The surface of the. appendix is gray to brown tan. There is no evidence of perforation grossly identified. On sectioning there is a smail amount of yellow tan material within. the lumen There are no fecaliths or lesions identified grossly. Representative sections are submitted in cassettes. On part D, additional sections from the prostate from the right lobe are submitted in blocks 18-20 and left lobe in blocks 21-23.",T2,N0,M0,T2N0M0
TCGA-78-7535,"1: LEFT UPPER LOBE. Macroscopy: Specimen consists of a left upper lobectomy measuring 205 X 135 x. approximately 60 mm and weighing 503 g in the fixed state. Situated within. the upper part of the lobe there is a large mass present medially. The pleural. surface overlying this mass appears intact. On sectioning through the lobe this. mass measures approximately 72 mm in maximum dimension. It has a. lobulated cream appearance on cut surface and comes to within 1 mm of the. pleural surface. Tumour is present surrounding the segmental bronchus but. does not appear to have eroded through the bronchial wall. The endobronchial. resection margin is clear of tumour. On sectioning through the remainder of. the lung parenchyma there is anthracosis but no evidence of emphysema and. no further lesions are identified. There is a small focus of cyst or bullous. formation present at the apex. [RS taken through hilar lymph nodes, A and B;. bronchovascular resection margin, C; tumour with overlying pleura, D-F;. tumour surrounding bronchus, G and H; tumour and adjacent lung, I; tumour. and apical blebs, J; macroscopically normal lung, K and L]. Microscopy: Sections show a poorly differentiated adenocarcinoma. The lesion is. subpleural and in areas there are features suspicious for pleural invasion. No. tumour is present on the pleural surface. Special stains to assess pleural. invasion are being performed. There is no blood vessel invasion and no. lymphatic permeation is seen. The lesion is well clear of the bronchial. resection margin. No lymph node metastases are seen. The adjacent lung. shows evidence of emphysema. 2: PULMONARY VEIN NODE. Macroscopy: Specimen consists of two fragments of dark tan tissue measuring in aggregate. 18 X 6x 4 mm. [BIT, 2A]. Microscopy: Sections of the lymph nodes show reactive changes only. There is no evidence. of malignancy. 3: INTERLOBAR NODE. Macroscopy: Specimen consists of a single piece of dark tan tissue measuring 15 x 10 x 6. mm. [Bisected and BIT, 3A]. Microscopy: Sections of the lymph nodes show reactive changes only. There is no evidence. of malignancy. 4: NUMBER 5 NODE. Macroscopy: Specimen consists of a single piece of fibrofatty tissue measuring 14 X 6 X 4. mm. [BIT, 4A]. Microscopy: Sections of the lymph nodes show reactive changes only. There is no evidence. of malignancy. 5: NUMBER 10 NODE. Macroscopy: Specimen consists of a single piece of dark tan tissue measuring 18 X 10 X 4. mm. [BIT, 5A]. Microscopy: Sections of the lymph nodes show reactive changes only. There is no evidence. of malignancy. Summary: Lung and lymph nodes: 1: Poorly differentiated adenocarcinoma; 72 mm in maximal dimension. 2: No vascular invasion present. 3: Possible pleural invasion identified; special stains are being performed. 4: Clear of bronchial margin. 5: T2N0MX. T-28000 M-81403 P1-03000. Anatomical Pathologist. ADDENDUM REPORT. The carcinoma appears to extend just through the elastic laminae of the pleura. There is no extension onto the pleural surface, though.",T2,N0,M0,T2N0M0
TCGA-B4-5835,"I. I. Specimen. I. Clinical. Ethnicity. I. I. Clinical. I. Index. I. I. label. I. Site #. I. (Race). Diagnosis. t. I. I. I. Renal. 1. Cancer. Renal. Cancer. I. I. I. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of. Amount/per. I. I. Specificatio. I. Container. I. I. Site. Matrix. Format. I. containers. container. n. I. I. I. I. I. Kidney, left. Primary. Tumor. Tissue. Frozen. cryomold. 1. 320. mg. Blood. n/a. normal. Blood. Frozen. tube. 1. 4. ml. I. Prior. I. Type of. I. Chemo /. Histological. TNM Stage. TNM Stage. TNM Stage. Chemo /. Prior. I. Grade. Horm Th. I. description. (T). (N). (M). Hormonal. Radiation. Details. I. t. I. I. I. Th. I. Renal cell. 2. 1. 0. 0. carcinoma. Blood draw. n/a. n/a. n/a. n/a. n/a. Cellular. Tumor %. 90. n/a.",T1,N0,M0,T1N0M0
TCGA-L5-A8NT,"PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE. 1. PATIENT NBR: SEX: M. BIRTHDATE: ADM DATE: OPER DATE: REQ DOC: PROCEDURE: year-old with prostate cancer. Status post radical prostatectomy. Two month. history of worsening dysphagia - EGD with biopsy and chest CT revealing tower. esophageal adenocarcinoma. PROCEDURE: 1. ""Thoracic esophagus. 5.2 cm long segment of esophagus that is 3.5 cm in. diameter. Attached is the distal cuff of stomach, 4.3 cm in length x 4.3 cm in. width x 1.3 cm thick. The mucosa of the esophagus is prominently folded and. gray-white. The gastric mucosa is a rugated tan-gray that is remarkable for a. 2.3 x 1.7 x 0.2 cm ulcerative gray-pink tumor that is 2.0 cm away from the. distal gastric margin. This tumor has been previously incised by the surgeon. Tumor arises within the gastric mucosa directly underlying the squamocolumnar. junction. The tumor has a maximum depth of 0.8 cm and extends to the serosa. into the surrounding adipose. Upon further sectioning the tumor also courses. under the mucosa through the muscular wall and extends to 1.5 CIR away from the. distal margin of resection. Four possible lymph nodes are identified ranging. from 0.3 to 1.1 cm. The largest lymph node has a gray-white surface. 1A. Tumor to distal gastric margin. 1B. Tumor to squamous columnar junction. 1C-D. Tumor to deep. 1E. Squamous columnar junction. 1F. Normal gastric and esophageal tissue. 1G. Three Lymph nodes. 1H. Largest lymph node, bivalved. 2. ""Cervical esophageal margin."" Tubular portion of pink-tan esophagus, 2.2 cm. in length and 1.7 cm in diameter. One margin is stapled with the opposite. remaining open designated the proximal margin. 2A. Proximal margin. PROCEDURE: ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: Type of carcinoma: Adenocarcinoma. Arising in: Barrett's mucosa. Depth of invasion: Adventitia. PREVIOUS DIAGNOSIS INQUIRY. 2. REPORT DATE: PATIENT NBR: SEX: M. ADM DATE: BIRTHDATE: OPER DATE: REQ DOC: Number of positive lymph nodes: 0. Extranodal metastasis: Unknown. Pattern of invasion: Infiltrative. Esophageal and gastric resection margins involved: No. Deep resection margin involved: Yes. TNM classification: T3 NO MX. PROCEDURE: 1. Esophagus and proximal stomach, resection: Transmurally invasive Per Ber review of top slide- - 0%. adenocarcinoma with mucinous features. Tumor extends to deep margin of. excision. Four lymph nodes negative for neoplasm. Short segment Barrett's. esophagus. Proximal and distal margins free of neoplasm. Please see template. 2. Cervical esophagus, excision: No Barrett's or carcinoma identified. M.D. 1,. M.D., the signing staff pathologist, have personally. examined and interpreted the slides from this case. Code: END OF PREVIOUS DIAGNOSIS INQUIRY.",T3,N0,M0,T3N0M0
TCGA-AG-3909,"Diagnosis. Rectosigmoid resected material with an ulcerated, moderately differentiated. adenocarcinoma of the colorectal type, located 3 cm from the aboral resection margin, 4. cm in diameter, with infiltration of the perirectal fatty tissue, carcinomatous lymphangitis. alongside the tumor, as well as three local lymph node metastases. Tumor-free colon. resection margins. Tumor-free mesenteric resection margin. Tumor-free circumferential. resection margin. Diverticulosa coli in addition. Tumor stage: pT3, pN1 (3/35), pMX; G2, L1, V0, local R0.",T3,N1,M0,T3N1M0
TCGA-DJ-A2Q6,"INPATIENI. Clinical Diagnosis & History: year old metastatic papillary thyroid carcinoma. Specimens Submitted: 1: Right neck skin scar. 2: Right neck level two lymph node. 3: Right neck level three lymph node. 4: Right neck level four and five-B lymph node. 5: Total thyroidectomy and right level 6 lymph nodes. DIAGNOSIS: 1. Skin, right neck; excision: - Benign skin with scar with giant cell reaction. 2. Right neck level two lymph node: Lymph Node Dissection: Metastatic papillary carcinoma. Number of lymph nodes examined: 12. Number of lymph nodes with metastatic disease: 2. Size of the largest lymph node involved by tumor: 1cm. Size of the largest metastatic focus : 0.6 cm. Extranodal extension is identified. 3. Right neck level three lymph node: Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 12. Number of lymph nodes with metastatic disease: 4. Size of the largest lymph node involved by tumor: 1.1cm. Size of the largest metastatic focus : 0.9 cm,. Extranodal extension is not identified. 4. Right neck level four and five-B lymph node: Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 5. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 0.3cm. Size of the largest metastatic focus : 0.05 cm. Extranodal extension is not identified. 5. Total thyroidectomy and right level 6 lymph nodes: Tumor Type: Multiple foci of papillary carcinoma: two classical type and six papillary microcarcinomas. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Psammoma bodies. Tumor Location: Left lobe. Right lobe. Isthmus. The two largest tumor foci are located in the right lobe. Tumor Size: Tumor foci range from 0.1 cm to 1.1 cm in greatest dimension. Tumor Encapsulation: None Identified. For the classical type carcinomas. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Invades:fibroadipose tissue. Surgical Margins: Free of tumor. Tumor is noted very close (< one high power field) from the inked margin. Tumor Multicentricity: gross and microscopic foci present. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Mild. Parathyroid Glands: Identified. One unremarkable parathyroid fragment is noted adjacent to the left lobe. Lymph Nodes: Number of nodes examined:16. The largest metastatic node is 1. 1cm. Perinodal (extracapsular) extension identified. Fifteen of sixteen lymph nodes show metastatic papilairy carcinoma (15/16). Comment: Benign large vessel is noted. IATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh, labeled ""Right neck skin scar"" and consists of a 3.5 x 1 x 0.7 cm ellipse of tan skin with a well. healed linear scar. Representative sections are submitted. Summary of sections: U - undesignated. 2). The specimen is received fresh, labeled ""Right neck level two lymph node"" and consists of multiple pink tan firm lymph nodes. ranging from 0.2 to 1.5 cm in greatest dimension. All identified lymph nodes are submitted to include TPS from grossly involved. nodes. Summary of sections: LN - lymph nodes (two TPS-ed nodes in 1). BLN - bisected lymph nodes. 3). The specimen is received fresh, labeled ""Right neck level three lymph node"" and consists of multiple pink tan firm lymph nodes. ranging from 0.2 to 1.4 cm in greatest dimension. All identified lymph nodes are submitted to include TPS from grossly involved. node. Summary of sections: LN - lymph nodes (TPS-ed node in 1). 4). The specimen is received fresh, labeled ""Right neck levels four and five B lymph nodes"" and consists of multiple pink tan firm. lymph nodes ranging from 0.3 to 0.7 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. BLN - bisected lymph nodes. 5). The specimen is received fresh, labeled ""total thyroidectomy and right level 6 lymph nodes (neck) short stitch marks right. superior pole long stitch marks left lower pole"" and consists of a thyroid with attached portion of fatty soft tissue; a separate portion. of fibroadipose tissue is also present (aggregate size of 5 x 1.5 x 0.7 cm for both fragments). The thyroid weighs 11.5 g. The right. lobe measures 3.9 x 1.8 x 1.7 cm, the left lobe measures 3.5 x 2.2 x 1.4 cm and the isthmus measures 2 x 0.7 x 0.5 cm. The. external surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black, and the anterior is. Inked blue. Sectioning reveals two nodules in the right lobe: N1 - 1.1 x 0.8 x 0.8 cm white firm solid poorly circumscribed,. in. the. upper pole, and N2 - 1 x 0.7 x 0.7 cm white firm solid poorly circumscribed in the lower pole. Sections through the left lobe reveal a. 0.3 cm firm white nodule in the mid pole (N3). The remaining thyroid parenchyma is red tan and beefy. Representative sections. of the specimen (N1 and 2) are submitted for TPS. The remaining thyroid is entirely submitted. Multiple lymph nodes are. dissected ranging from 0.2 to 1.1 cm, four of which are grossly involved by tumor - portion of these 4 nodes is given to TPS; the. remaining nodes are entirely submitted. Also 4.5 cm long segment of a vessel is present which is grossly unremarkable. Summary of sections: N 1 nodule 1. N2 nodule 2. N3 nodule 3. RL right lobe. LL left lobe. IS isthmus. LN - lymph nodes (4 TPS-ed nodes in 14). V vessel. Summary of Sections: Part 1: Right neck skin scar. Block. Sect. Site. PCs. 1. U. 1. Part 2: Right neck level two lymph node. Block. Sect. Site. PCs. 1. BLN. 6. 2. LN. 2. Part 3: Right neck level three lymph node. Block. Sect. Site. PCs. 2. LN. 5. Part 4: Right neck level four and five-B lymph node. Block. Sect. Site. PCs. 1. BLN. 2. 1. LN. 3. Part 5: Total thyroidectomy and right level 6 lymph nodes. Block. Sect. Site. PCs. 1. IS. 2. 4. LL. 4. 2. LN. 9. 2. N1. 2. 2. N2. 2. 1. N3. 2. 3. RL. 3. 1. V. 1. #2 Re. the.",T1,N1,M0,T1N1M0
TCGA-E2-A1B6,"SPECIMENS: A. SENTINEL LYMPH NODE #1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. SENTINEL LYMPH NODE #3 LEFT AXILLA. D. SENTINEL LYMPH NODE #4 LEFT AXILLA. E. LEFT BREAST. F. ADDITIONAL SKIN UPPER SUPERIOR FLAP. G. RIGHT BREAST. SPECIMEN(S): A. SENTINEL LYMPH NODE #1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. SENTINEL LYMPH NODE #3 LEFT AXILLA. D. SENTINEL LYMPH NODE #4 LEFT AXILLA. E. LEFT BREAST. F. ADDITIONAL SKIN UPPER SUPERIOR FLAP. G. RIGHT BREAST. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA-TPD: sentinel nodes #1-#4, left axilla: All negative for tumor cells on touch prep, called to Dr. at. by Dr. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1 LEFT AXILLA. Received fresh labeled with the patient's identification of a fragment of beige tan soft tissue measuring 1. x. 1 x 0.3 cm. Touch preparations are performed. The entire specimen is submitted in cassette A1. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. Received fresh labeled with the patient's identification of a fragment of beige tan soft tissue measuring 1. x 1 x 0.3 cm. Touch preparations are performed. The entire specimen is submitted in cassette B1 and. B2. C. SENTINEL LYMPH NODE # 3 LEFT AXILLA. Received fresh labeled with the patient's identification are two possible lymph nodes measuring 0.5 x. 0.5 x 0.2 cm each. Both lymph nodes are entirely submitted separately in C1 and C2. D. SENTINEL LYMPH NODE # 4 LEFT AXILLA. Received fresh labeled with the patient's identification of a fragment of beige tan soft tissue measuring. 0.7 x 0.7 x 0.5 cm. Touch preparations are performed. The entire specimen is submitted in cassette. D1. E. LEFT BREAST. Received fresh labeled with the patient's identification and designated ""Part E., left breast"" is an. orientated 399g, 18 x 17 x 3 cm mastectomy specimen with a 5.2 x 3.3 cm skin ellipse, and 1.2cm. everted nipple. Ink code: Anterior/superior-blue, anterior/inferior-orange, posterior-black. Specimen is. serially sectioned into 9 slices from medial to lateral with nipple in slice 3 revealing a 3.5 x 3.1 x 2 cm. firm beige spiculated mass at the 12 o'clock position (slices 5-7) closest to the anterior margin at 0.9cm. and located 2.2cm from the deep margin. Tissue is procured. Representatively submitted: E1: Perpendicular sections, nipple. E2: Bisected nipple base. E3: Sections of skin. E4: Tumor, slice 5. E5-E8: Tumor, slice 6. E9: Overlying deep margin, slice 6. E10: Tumor, slice 7. E11: Tumor and closest anterior margin, slice 7. E12: Additional tumor, slice 7. E13: Upper outer quadrant. E14: Lower outer quadrant. E15: Upper inner quadrant. E16: Lower inner quadrant. F. ADDITIONAL SKIN UPPER SUPERIOR FLAP. Received in formalin in a container labeled with the patient's identification is a brown tan crescent. shaped excision of skin measuring 6.1 x 2.5 x 0.3 cm. A suture designates superior. The specimen. is. inked as follows: Superior-blue, inferior-orange, deep-black. The surface of the skin demonstrates no. obvious gross abnormality. The specimen is serially sectioned from medial to lateral and submitted. entirely for microscopic evaluation. Cassettes are submitted as follows: F1: Medial tip. F2-F6: Serial sections. F7: Lateral tip. G. RIGHT BREAST. Received fresh labeled with the patient's identification and ""Right Breast-Stitch marks axillary tail"" is an. oriented 339g, 23 x 14 x 3cm simple mastectomy with 5 x 3cm tan pink skin ellipse, and a 1.3cm. centrally located, raised nipple. Ink Code: Anterior-Superior: Blue, Anterior-Inferior: Orange, Posterior: Black. The specimen is serially sectioned from lateral to medial into 15 slices. The nipple is located in. slice 12. The cut surfaces reveal a blue dome cyst 0.8 x 0.4cm in the LC of slice 12, more than 1cm. from the closest deep margin. No lesions are grossly identified. Representative sections are submitted. as follows: G1: nipple slice 12. G2: skin slice 12. G3: UOQ slice 8. G4: UOQ slice 9. G5: LOQ slice 7. G6: LOQ slice 10. G7: blue dome cyst LC slice 12. G8: LC with inferior margin slice 12. G9: UC slice 12. G10: UIQ slice 13. G11: UIQ slice 14. G12: LIQ slice 13. G13: LIQ slice 14. DIAGNOSIS: A. SENTINEL LYMPH NODE #1, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). B. SENTINEL LYMPH NODE #2, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). C. SENTINEL LYMPH NODE #3, LEFT AXILLA, BIOPSY: - TWO LYMPH NODES, NO TUMOR SEEN (0/2). D. SENTINEL LYMPH NODE #4, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). E. BREAST, LEFT, MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED. (SBR GRADE 3) (SEE NOTE). - TUMOR MEASURES 3.5 CM IN GREATEST DIMENSION. - MARGINS, FREE OF TUMOR. - DUCTAL CARCINOMA IN SITU (DCIS), SOLID TYPE, NUCLEAR GRADE 3,. WITH NECROSIS, MICROCALCIFICATIONS AND ASSOCIATED. LYMPHOID INFILTRATE. - SKIN AND NIPPLE, NO TUMOR SEEN. NOTE: Biomarkers and lymphvascular invasion status will be reported in an addendum. F. SKIN, UPPER SUPERIOR FLAP, EXCISION: - BASAL CELL CARCINOMA, SUPERFICIAL TYPE (SEE NOTE). - MARGINS, FREE OF TUMOR. NOTE: The basal cell carcinoma is focally 2 mm from the superior margin. G. BREAST, RIGHT, PROPHYLACTIC MASTECTOMY: - SMALL FIBROADENOMA, PSEUDOLACTATIONAL CHANGE, APOCRINE. METAPLASIA, STROMAL FIBROSIS, AND MICROCALCIFICATIONS. - BENIGN SKIN AND NIPPLE. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: No. Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3.5cm. Tumor Site: 12:00. Margins: Negative. Distance from closest margin: 0.5cm. anterior superior. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Present. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/5. DCIS present. Margins uninvolved by DCIS : 0.5cm from anterior superior margin. DCIS Quantity: Estimate 40%. DCIS Type: Solid. DCIS Location: Associated with invasive tumor. Nuclear grade: High. Necrosis: Present. Location of CA++: DCIS. Pathological staging (pTN): pT 2N0. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: None given. ADDENDUM: NOTE: A CD31 stain was performed on block E6 and is negative, showing no evidence of. lymphvascular invasion. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: E10. ER: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score 0. PR: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score 0. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by Dakc. bllowing the manufacturer s instructions. This. assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Surgical Excision. Block Number: E10. Interpretation: EQUIVOCAL. Intensity: 2+. % Tumor Staining: 15%. Fish Ordered: Yes, on Date. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Her2 analysis was performed using the FDA approved Dako HercepTest (TM) test kit. C. using rabbit anti-human HER2. This assay was not modified. External kit-slides. provided by the manufacturer (cell lines with high, low and negative HER2 protein expression) and in-. house known HER2 amplified control tissue were evaluated along with the test tissue. Adequate, well. preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2. immunohistochemical stain is guided by published results in the medical literature, information provided. by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the. int recommendations and guidelines from. ASCO and CAP and from the NCCN HER2 testing in Breast Cancer Task Force. The Pathology. Department takes full responsibility for this test's performance. PathVysion HER-2 DNA Probe Kit. Analytical Interpretation of Results: HER-2 NOT AMPLIFIED. Clinical Interpretation of results. Amplification of the HER-2 gene was evaluated with interphase fluorescence in-situ. hybridization (FISH) on formalin-fixed paraffin embedded tissue sections using a chromosome. 17. centromeric probe and a HER-2 probe that spans the entire HER-2 gene in the. by Dr. A majority of tumors cells displayed 2 chromosome 17. signals and 2 HER-2 signals, with a HER-2/CEP 17 Ratio </=2.0, consistent with no. amplification of the HER2/neu gene. Block used E10. Source of case: Tissue fixation. formalin-fixed tissue. Outside Case No: NA. Tissue source. breast Results interpreted: HER2/CEP17 ratio: 1.03. This ratio is derived by dividing the total number of LSI HER-2/neu signals by the total number of. CEP17 signals in at least 20 interphase nuclei with nonoverlapping nuclei in the neoplastic. mammary epithelial cells. Cells with no signals or with signals of only one color are disregarded. Method of ratio enumeration: manual count. Limitations. The Vysis PathVysion Kit is not intended for use to screen for or diagnose breast cancer. It is. intended to be used as an adjunct to other prognostic factors currently used to predict disease-free. and overall survival in stage II, node-positive breast cancer patients. In making decisions regarding. adjuvant CAF treatment, all other available clinical information should also be taken into. consideration, such as tumor size, number of involved lymph nodes, and steroid receptor status. treatment decision for stage II, node-positive breast cancer patients should be based on HER-. 2/neu. gene amplification status alone. Overview of this test. FDA APPROVED REAGENT. PathVysion HER-2 DNA Probe Kit is FDA approved for selection of. patients for whom Herceptin therapy is being considered. These tests were performed in the. under the direction. of Dr. The results of these studies should always be interpreted in the context of the. clinical, morphological, and immunophenotypic diagnosis. Microscopic/Diagnostic Dictation: Pathologist, 1. Final Review: Pathologist,. Final Review: Pathologist,. Final: Pathologist, r. Addendum: Pathologiat. Addendum Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist.",T2,N0,M0,T2N0M0
TCGA-BR-8487,"Case ID. Gross Description. Microscopic. Diagnosis Details. Description. Stomach with a polypoid. Adenocarcinoma of the. Tumor Features: Exophytic. tumour, up to 16 cm in its. stomach G2-3. In the. (polypoid), Tumor Extent: diameter, invades adjacent. exofytic component the. Perigastric fat , Venous. fatty tissue;. predominant type of growth. Invasion: Absent, Margins: fatty tissue lymph nodes. is G2. In the endophtyic. Absent, Treatment Effect: are free of metastases;. component the. omentum - hyperemia;. predominate component is. surgical margins are free of. G3 with necrosis. Tumor. metastases. invades into the perigastric. fat. Fifteen lymph nodes. demonstrated reactive. hyperplasia. Omentum is. hyperemic. Surgical. margins are free of tumor. elements. Comments. STOMACH TISSUE. CHECKLIST. Specimen type: Total. gastrectomy. Tumor site: Antrum. Tumor size: 16 X 0 X 0 cm. Tumor features: Exophytic. (polypoid). Histologic type: Adenocarcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Subserosa. Lymph nodes: 0/15. positive for metastasis. (Greater and lesser. omentum 0/15). Lymphatic invasion: Not. specified. Venous invasion: Absent. Perineural invasion: Not. specified. Margins: Uninvolved. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic. findings: Not specified. Comments: None. Laterality.",T3,N0,M0,T3N0M0
TCGA-55-6983,"Not for Permanent Storage in Medical Records / Not Valid for Signing. Date of Service. Performing Facilit. Result Provider. Report Name. Surgical Report. MICROSCOPIC DESCRIPTION: A/APC. One slide is examined. Seen are sections of one benign lymph node. There is no evidence of metastatic carcinoma. B/BPC. One slide is examined. Seen are sections of two benign lymph nodes. There is no evidence of metastatic carcinoma. C/CPC. Two slides are examined. Seen are sections of a lymph node. A focus. of metastatic carcinoma is seen in slide C/CPC-1. D. One slide is examined. Seen are sections of six lymph nodes. Metastatic. carcinoma is seen in two nodes. E/EPC. Fourteen slides, including two EPC slides, are examined. Seen are. sections of lung demonstrating an infiltrating mucinous carcinoma. Abundant. extravasated mucin is present. Carcinoma extends to the visceral pleura, but-. does not penetrate through it. Small vessel (lymphatic space) invasion is. present. Large vessel (venous) invasion is not evident. Also seen within the. non-neoplastic lung tissue are multifocal nodular areas of inflammation and. fibroblastic proliferation centered around bronchioles. These foci are. associated with prominent bronchiolar destruction. The bronchioles and. vascular resection margins are negative for tumor. ADDENDUM. The actual slides examined at the time of frozen section. are. reviewed. STides A/APC, B/BPC and C/CPC, which represent smears of lymph. nodes examined at the time of frozen section, show no evidence of metastatic. tumor. Slides E/EPC show mucinous carcinoma of the lung with negative. bronchial resection margin. SPECIAL STAINS: A panel of immunostains including CK7, CK20, and TTF-1 were performed on. paraffin block E3. The neoplastic cells show positive staining for CK7 and. TTF- 1. CK20 stain is negative. This staining profile is compatible with. primary lung carcinoma. The control slides are reviewed and found to stain appropriately. FINAL DIAGNOSIS: A/APC. INFERIOR PULMONARY LIGAMENT. LYMPH NODE, EXCISION: ONE BENIGN LYMPH. NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA (0/1). B/BPC. SUBCARINAL LYMPH NODE, EXCISION: TWO BENIGN LYMPH NODES WITH NO. EVIDENCE OF METASTATIC CARCINOMA (0/2). CPC. HILAR LYMPH NODE, EXCISION: NEGATIVE FOR CARCINOMA ON SMEAR. C. HILAR LYMPH NODE, EXCISION: METASTATIC CARCINOMA IN ONE LYMPH NODE. (1/1); PLEASE SEE COMMENT. D. PROXIMAL BRONCHIAL LYMPH NODE, EXCISION: METASTATIC CARCINOMA IN TWO. OUT OF SSIX_LYMPH-NODES-(2/6). E/EPC. LEFT LOWER LOBE OF LUNG. LOBECTOMY. Not for Permanent Storage in Medical Records / Not Valid for Signing. Date of Service. Performing Facility. Result Provider. Report Name. 1. HISTOLOGIC TYPE: MUCINOUS ADENOCARCINOMA. 2. HISTOLOGIC GRADE: WELL TO MODERATELY DIFFERENTIATED. 3. PATHOLOGIC STAGING: pT2 (TUMOR MEASURES 8.5 CM IN MAXIMAL. DIMENSION). 4. REGIONAL LYMPH NODE METASTATIC CARCINOMA PRESENT IN ONE OUT OF. THREE HILAR LYMPH NODES; PLEASE ALSO REFER. TO SPECIMENS A/APC, B/BPC & C/CPC & D. 6. MARGINS: BRONCHIAL AND VASCULAR RESECTION MARGINS ARE NEGATIVE NI. 5. DISTANT METASTASIS: NOT ASSESSED. FOR TUMOR. 7. DIRECT EXTENSION OF TUMOR: NOT ASSESSED. 8. VENOUS (LARGE) VESSEL INVASION: NOT IDENTIFIED. 9. ARTERIOLE (LARGE) VESSEL INVASION: NOT IDENTIFIED. 10. LYMPHATIC (SMALL) VESSEL INVASION: PRESENT. 11. ADDITIONAL PATHOLOGIC FINDINGS: MULTIFOCAL NODULAR AREAS OF BRONCHIOLAR PNEUMONITIS WITH A. BOOP LIKE PATTERN. COMMENT: The permanent section slides on specimen C show metastatic carcinoma. within one lymph node. The corresponding smear examined at the time of frozen. sections shows no evidence of tumor. A-MALIGNANT.",T2,N1,M0,T2N1M0
TCGA-E9-A1NC,BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 2.2 x 2.2 x 2.2 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal and lobular carcinoma. Histologic grade: Tumor extent: Not specified. Lymph nodes: 1/9 positive for metastasis (Axillaris 1/9). Right upper. Extracapsular invasion of the lymph nodes: Not specified. inner. Margins: Not specified. quadrant. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,T2,N1,M0,T2N1M0
TCGA-5C-A9VH,"M. Clinical diagnosis: Primary liver cancer. Sample: histology #. Gross description: Fifth and sixth segments of the liver and gall bladder single. block 16x9x8 cm . Gall bladder wall is 0,2 cm, mucosa is pale brown color. Liver. parenchyma shows nodular lobular mass 6,5x4cm Gall bladder shows no. signs of infiltrations. Microscopic description: Nodular mass shows signs of hepatocellular cancer. with moderate degree of differentiation and adenoid-trabecular structure with. fibrotic tissue. Lymphatic nodes and adjacent tissueshow no signs of tumor growth. Final diagnosis: Hepatocellular carcinoma. Confidential.",T1,N0,M0,T1N0M0
TCGA-BR-4361,STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor Site: Not specified. Tumor configuration: Ulcerating. Tumor size: 11. cm in diameter. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Extent of invasion: Liver. Lymph nodes: 2. nodes negative for malignancy. Margins - Proximal margin: Not specified. Distal margin: Not specified. Omental (radial) margin: Not. specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Additional pathologic. findings: Not specified. Comments: None.,T4,N0,M0,T4N0M0
TCGA-EL-A3CM,"ory Case. ogy Report. Sex: F. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. the section ""SPECIMEN"" may have been added. SUPPLEMENTAL REPORT. FINAL DATE. TO. CLINIC CUPY ic. SUPPLEMENTAL REPORT. DIAGNOSIS : (A) ANTERIOR WALL THYROID AND TRACHEAL CARTILAGE: PAPILLARY CARCINOMA OF THYROID FOCALLY INVOLVING INFERIOR. TRACHEAL MARGIN OF RESECTION. (SEE COMMENT). COMMENT: The remaining surgical margins of resection are negative for tumor. DIAGNOSIS. ANTERIOR WALL THYROID AND TRACHEAL CARTILAGE: Pending decalcification, addendum to follow. (B). BILATERAL NECK DISSECTION, TOTAL THYROIDECTOMY AND MEDIASTINAL NODE. DISSECTION: PAPILLARY CARCINOMA OF THE THYROID, 5.0 CM MAXIMUM DIMENSION,. EXTENDING INTO THE ADJACENT SOFT TISSUE AND EXTENDING TO. THE DEEP MARGIN OF RESECTION. (SEE COMMENT). METASTATIC PAPILLARY CARCINOMA IN 1 OF 8 LYMPH NODES IN THE. LEFT NECK DISSECTION (AREA 3, 0/1; AREA 4, 0/1; AREA 5, 1/1;. AREA 6, NO LYMPH NODES; AREA 7, 0/2; AREA 8, 0/3). METASTATIC PAPILLARY CARCINOMA IN 2 OF 8 LYMPH NODES IN THE. RIGHT NECK DISSECTION (AREA 3, 1/3; AREA 4, NO LYMPH NODES;. AREA 5, 0/2; AREA 6, NO LYMPH NODES; AREA 7, 1/3). COMMENT. The papillary carcinoma appears well differentiated and shows only. focal necrosis. Tumor involves almost entirely the left lobe and the isthmus. and portion of the right lobe of thyroid. Furthermore it extends into the. surrounding soft tissue and extends to the deep margin of resection. The. largest involved lymph node is present on the right side in area 7 and. measures 2.5 cm in maximum dimension with the tumor totally effacing it. There is extracapsular extension measuring 0.3 mm in maximum dimension in the. largest lymph node involved. SPECIMEN. (A) ANTERIOR WALL THYROID AND TRACHEAL CARTILAGE: (B). BILATERAL NECK DISSECTION, TOTAL THYROIDECTOMY AND MEDIASTINAL NODE. History Case. Sex: F. Pathologis. Case type: Surgical History. SNOMED CODES.",T3,N1,M0,T3N1M0
TCGA-BR-7716,Asterand Case ID. Open Clinica. Gross. Microsc. Diagnos. Subject ID. Descript. opic. is. ion. Descript. Details. ion. BR-7716. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Stomach. Tumor size: 6 X 6 X 1.5 cm. Tumor features: None. specified. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Adjacent. structures (specify) - Lesser. omentum. Lymph nodes: 1/4 positive for. metastasis (Intraabdominal. 1/4). Lymphatic invasion: Not. specified. Venous invasion: Not specified. Perineural invasion: Not. specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,T3,N1,M0,T3N1M0
TCGA-BR-7197,"Gross Description. Microscopic. Diagnos. Comme. Subject ID. Description. is. nts. Details. Stomach segment with. Adenocarcinoma,. the plate-like tumor of. with subserosa. 6 X 5.5 cm in size, with. infiltration. entire wall layers. Morphological. invasion. features of the. Greater and lesser. tumor structure. curvature lymph nodes. may suggest its. are hyperemic. neuroendocrinal. Omentum is without. origin. changes. Fifteen dissected. lymph nodes. demonstrate. reactive changes. Omentum is. without changes. Lateralit. Procure. y. ment. STOMACH TISSUE CHECKLIST. NA. Specimen type: Subtotal gastrectomy. Tumor site: Pylorus. Tumor size: 5.5 X 0 X 6 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Tumor extent: Subserosa. Lymph nodes: 0/15 positive for. metastasis (Greater and lesser omentum. 0/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not. specified. Comments: None.",T3,N0,M0,T3N0M0
TCGA-2W-A8YY,"Result date: Surgical Procedure. Contributor system: Surgical Procedure. SPECIMENS SUBMITTED: A. UTERUS, CERVIX, BILATERAL TUBES AND OVARIES. B. RIGHT PELVIC LYMPH NODE. C. LEFT PELVIC LYMPH NODE. D. RIGHT PERIAORTIC LYMPH NODE. E. SIGMOID ADHESION. DIAGNOSIS: A. UTERUS WITH CERVIX (260 GRAMS) , BILATERAL OVARIES AND FALLOPIAN. TUBES;. HYSTERECTOMY /SALPINGO-OOPHORECTOMY: ADENOSQUAMOUS CARCINOMA, INVASIVE. HISTOLOGIC GRADE: G3 = HIGH GRADE. MACROSCOPIC TUMOR SIZE: \R\8 CM (CIRCUMFERENTIAL. INVOLVEMENT;. MEASUREMENT ESTIMATED FROM CONSECUTIVE TUMOR SECTIONS OF CERVIX). TUMOR SITE: TUMOR CIRCUMFERENTIALLY INVOLVES UPPER CERVIX. STROMAL INVASION. DEPTH OF INVASION: 1.2 CM (12 mm) . HORIZONTAL SPREAD: COMPLETE CIRCUMFERENTIAL SPREAD. EXTENSION TO CORPUS: YES, EXTENSIVE AND TRANSMURAL. INMULTIPLE SECTIONS WITH ERODED ENDOMETRIUM. ADDITIONAL STRUCTURES POSITIVE FOR INVASION: NONE. ADDITIONAL STRUCTURES WITHOUT INVASION: NOT APPLICABLE. LYMPH-VASCULAR INVASION: POSITIVE IN CERVICAL LYMPHATICS. AND PARAMETRIAL VEIN. MARGINS: SOFT TISSUE: POSTERIOR SEROSA OF UTERINE BODY POSITIVE FOR. TUMOR. DISTAL MUCOSA: NEGATIVE. REGIONAL LYMPH NODES : NODE SITES NEGATIVE FOR METASTASIS: SEE BELOW. NODES SITES POSITIVE FOR METASTASIS: 0. TOTAL LYMPH NODE COUNT: 0/18 (POSITIVE/TOTAL). OTHER FINDINGS: NONE. PATHOLOGIC STAGE: T2a2/NO FIGO IIA2 BY AJCC CANCER STAGNING. MANUAL, 7TH ED. B. LYMPH NODE, RIGHT PELVIC; EXCISION: FIVE REACTIVE LYMPH NODES, NEGATIVE FOR TUMOR (0/5). C. LYMPH NODE, LEFT PELVIC; EXCISION: TEN REACTIVE LYMPH NODES NEGATIVE FOR TUMOR (0/10). D. LYMPH NODES, RIGHT PERIAORTIC; EXCISION: THREE REACTIVE LYMPH NODES, NEGATIVE FOR TUMOR (0/3) . E. SOFT TISSUE, SIGMOID ADHESIONS; EXCISION: FIBROUS CONNECTIVE TISSUE NEGATIVE FOR TUMOR. COMMENT: Immunohistochemical stains performed with appropriately reactive controls. for vimentin, p16, ER, and CEA are consistent with the above diagnosis. Tumor cells patchily express p16 and CEA with no reactivity for ER or. vimentin. REVIEWED BY: INTRAOPERATIVE DIAGNOSIS: FSA: Uterus: Extensive necrotic tumor, uterus and cervix. Gross. examination only. CLINICAL INFORMATION: stage 1 B2 adenosquamous. carcinoma of the cervix. GROSS DESCRIPTION: Number of specimen containers: five, each labeled with. patient name. and MRN. A. Container designation: ""uterus, cervix, bilateral tubes and ovaries"". -- Received unfixed is a radical hysterectomy specimen consisting of. uterus, cervix, attached bilateral adnexa and parametrial tissue weighing. 260 gm, measuring 13.5 X 6.5 X 6.0 cm. The anterior serosa is smooth, the. posterior serosa demonstrates a firm subserosal yellow-gray mass in the. body measuring 4.5 X 2.9 X 1.0 cm. Surfacing the serosa and the mass is a. 1.0 X 0.8 X 0.6 cm cystic structure occupied by clear watery fluid. The. posterior serosa and soft tissue margins are inked. The ectocervix is. pink-tan with purpuric changes surrounding the os 1.0 cm (tumor?) and an. anterior/posterior vaginal identified 1.0 and 0.8 cm in length,. respectively. Sectioning of the anterior cervix at the os is grossly. unremarkable, however, the tumor extends from within 0.9 cm of the. anterior cervical os to the fundus and appears full thickness in the lower. uterine segment and body. The posterior aspect is similar in appearance. to that of the anterior aspect. Sectioning of the tumor demonstrates a. yellow-gray purulent appearance with prominent necrosis. Representative. sections of tumor and normal are submitted to. The right ovary. measures 2.2 X 1.5 X 1.0 cm and sectioning demonstrates a thickened cortex. and pink-tan mottled stroma. The pink-tan fallopian tube with fimbriated. end measures 5.5 cm in length, 0.6 cm in external diameter and sectioning. demonstrates a pink-tan mottled stroma. The left ovary measures 3.0 X 1.5. X 1.0 cm and sectioning demonstrates a pink-tan mottled stroma. The. corresponding pink-tan fallopian tube with fimbriated end measures 6.0 cm. in length, 0.5 cm in external diameter and sectioning demonstrates a. pinpoint lumen. Sections are submitted as follows: cassette A1-posterior. body, serosa with nodule extruding; cassette A2-representative. anterior/posterior vaginal cuff (anterior inked red, posterior green) ; A3-. anterior cervix and ectocervix full thickness; cassette A4-anterior. endocervical canal full thickness; cassette A5-posterior cervix full. thickness with ectocervix; cassette A6-posterior endocervical canal;. cassette A7-anterior body; cassette. A8-posterior body full thickness; cassette A9-anterior fundus full. thickness; cassette A10-posterior fundus full thickness; cassette A11-. representative right ovary and fallopian tube; cassette A12-representative. left ovary and fallopian tube; cassette A13-parametrial tissue right. lateral wall; cassette A144-representative parametrial tissue left lateral. wall. B. Container designation: ""Right pelvic lymph node"" - Received are. multiple portions of fat aggregating to 3.5 X 3 X 1.5 cm. Five possible. lymph nodes are identified upon sectioning, the largest measuring 1.7 cm. The lymph nodes are entirely submitted as follows: B1-B5-one bisected. lymph node in each. C. Container designation: ""Left pelvic lymph node"" - Received are. multiple portions of fat aggregating to 4 X 3 X 1 cm. Eight possible. lymph nodes are identified upon sectioning, the largest measuring 1.5 cm. The lymph nodes are entirely submitted as follows: C1-four lymph nodes in. toto, C2-C4-one bisected lymph node in each, C5-four possible lymph nodes. in toto. D. Container designation: ""Right periaortic lymph node"" - Received are. three lymph nodes, the largest measuring 2 X 0.7 X 0.2 cm. The lymph. nodes are entirely submitted from D1 to D3, each containing one bisected. lymph node. E. Container designation: ""Sigmoid adhesion"" - Received is a portion of. gray-tan membranous tissue measuring 2 X 0.6 X 0.1 cm, bisected and. entirely submitted in E1. (Dictated by: MICROSCOPIC DESCRIPTION: Histologic examination performed. Any tests performed using Analytic Specific Reagents (ASR) were developed. and validated by. The U.S. Food and Drug. Administration has not approved these tests but has determined that such. clearance or approval is not necessary. These tests should be regarded. as a clinical assay for standard medical care. The. was present during the formal review and. interpretation of all slides and ancillary studies, (if performed), with. the. Specimens with only gross examination. were reviewed and interpreted by the.",T2,N0,M0,T2N0M0
TCGA-DD-AACC,":0093FD02-9219-4901-8DA2-D98AEBDCF1D5. CLINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo : 1. GROSS: 1. Specimen: Liver: 7.4 X 4.5 X 8.0 cm, 85.0 gm and 11.0 X 6.5 X 6.5 cm, 98.0 gm, unfixed. Gallbladder: 12.0 cm in length, 4.5 cm in diameter, and 0.2 cm in thickness, unfixed. 2. Tumor location: segment 6. Tumor number: one. Tumor size: 2.1 X 2.0 cm. 3. Satellite nodule: no. 4. Gross type. HCC: vaguely nodular. 5. Tumor necrosis: yes (10 %). 6. Hemorrhage/peliosis: no. 7. Portal vein invasion: no. 8. Bile duct invasion: no. Gross photo present. Blocks. RM, resection margin X 1. T1-2, tumor mass X 2. A, non-tumorous lesion X 1. GB, gallbladder X 1. MICROSCOPIC: 1. Hepatocellular carcinoma: 1-1. Differentiation. The worst differentiation II. The major differentiation I. 1-2. Histologic type: trabecular. 1-3. Cell type: hepatic. 1-4. Fatty change: yes (10%). 2. Cholangiocarcinoma: no. 3. Combined hepatocellular and cholangiocarcinoma: no. 4. Fibrous capsule formation: partial capsule. 5. Capsular infiltration: yes. 6. Septum formation: no. 7. Surgical resection margin invasion: no, margin of the clearence (0.1 cm). 8. Serosal invasion: no. 9. Portal vein invasion: no. 10. Bile duct invasion: no. 11. Hepatic vein invasion: no. 12. Hepatic artery invasion: no. 13. Microvessel invasion: no. 14. Intrahepatic metastasis: no. 15. Multicentric occurrence: no. Non-tumor liver pathology. 1. Chronic hepatitis: 1-1. Etiology: HBV. 1-2. Grade, lobular: minimal. 1-3. Grade, portoperiportal: mild. 1-4. Stage (fibrosis): cirrhosis. 1-5. Cirrhosis: micronodular. 2. Dysplastic nodule: no. 3. Ductal epithelial dysplasia: no. 4. Other liver diseases: no. SPECIAL STAIN: Trichrome: positive (cirrhosis, stage IV). NOT reported. Gross: NOT reported. Gross: Peritoneal fluid, smear, inflammation. Peritoneal fluid, smear, inflammation. Liver, ectomy, hepatocellular carcinoma. T56000, P10, M81703. Gallbladder, ectomy, autolysis. T57000, P10, M54001. DIAGNOSIS: Liver, segment 6, segmentectomy: Hepatocellular carcinoma, well differentiated. Gallbladder, cholecystectomy: Autolysis. Suggestion :",T1,N0,M0,T1N0M0
TCGA-A1-A0SI,"Final Pathologic Diagnosis: A. Sentinel lymph node #1, right axilla, biopsy: No tumor identified in one lymph. node (0/1). B. Non-sentinel lymph node #2, right axilla, biopsy: One lymph node positive for. metastatic carcinoma (1/1). C. Sentinel lymph node #2, right axilla, biopsy: No tumor identified in one lymph. node (0/1). D. Non-sentinel lymph node #1, right axilla, dissection: No tumor identified in one. lymph node (0/1). E. Non-sentinel lymph node #3, right axilla, dissection: Fibrofatty tissue, no tumor. or lymph node tissue seen on level sections. Working Draft. F. Right breast, lumpectomy: 1. Invasive ductal carcinoma, SBR grade II, 2.6 cm; see comment. 2. Lymphovascular invasion present. 3. Usual ductal hyperplasia. G. Lymph nodes, right axillary contents, dissection: No tumor identified in nineteen. lymph nodes (0/19). Note: Breast Tumor Synoptic Comment. - Laterality: Right. - Invasive tumor type: Invasive ductal carcinoma NOS. - Invasive tumor size: 2.6 cm maximum diameter (tumor spans slices 2-8, best seen in slides F4, F6,. F8, F10, F12, F13, and F15). - Invasive tumor grade (modified Bloom-Richardson): II. Nuclear grade: 2, 2 points. Mitotic count: 3 mitotic figures/10 HPF, 1 point. Tubule/papilla formation: Definite tubule formation in less than 10%, 3 points. Total points and overall grade = 6 points = grade 2. - Lymphatic-vascular invasion: Present (slide F15). - Resection margins for invasive tumor: - Deep margin: Negative; tumor is within less than 0.1 cm on slide F6 (black ink). - Medial margin: Negative. - Lateral margin: Negative. - Anterior/superior margin: Negative; tumor is within less than 0.1 cm on slide F10 (blue ink). Anterior/inferior margin: Negative; tumor is within 1 cm on slide F8 (green ink). - Ductal carcinoma in situ (DCIS) type: None identified. - Lobular carcinoma in situ (LCIS): None identified. - Lymph node status: - Number of positive lymph nodes: 1. - Total number sampled: 23. - Diameter of largest metastasis: 3 mm. - Extranodal extension: Absent. - AJCC/UICC stage: pT2N1MX. - Nontumorous breast tissue: Usual ductal hyperplasia. - Nipple: Unremarkable. - Skin/dermis: Unremarkable. Additional comments: ER, PR, and HER-2/neu stains have been ordered and will be reported in an. addendum. Intraoperative Consult Diagnosis. FS1 (A) Sentinel lymph node #1, right axilla, biopsy: One lymph node with no evidence of metastatic. carcinoma. (Dr. FS2 (B) Non-sentinel lymph node #2, right axilla, biopsy: Metastatic carcinoma. (Dr. FS3 (C) Sentinel lymph node #2, right axilla, biopsy: One lymph node with no evidence of metastatic. carcinoma. (Dr. Clinical History. The patient is a. year-old woman who undergoes a right breast lumpectomy with axillary lymph. node dissection. Gross Description. The specimen is received in seven parts, each labeled with the patient's name and unit number. Working Draft. Part A, labeled. consists of a single soft, irregular, red-tan. candidate lymph node measuring 1.2 X 0.6 x 0.4 cm. The entire specimen is frozen for frozen section. diagnosis 1, and subsequently submitted in cassette A1. Part B, labeled ""non-sentinel lymph node #2 right axilla,"" consists of a single soft, irregular, red-tan. candidate lymph node measuring 1.3 X 0.8 x 0.5 cm. The entire specimen is frozen for frozen section. diagnosis 2, and subsequently submitted in cassette B1. Part C, labeled. consists of a single soft,. irregular piece of red-yellow, fatty tissue measuring 1.5 x 1 x 0.4 cm. Fatty tissue is trimmed away,. and a single candidate lymph node is found. The candidate fymph node is entirely submitted for. frozen section diagnosis 3, and subsequently submitted in cassette C1. The remaining unused fatty. tissue is entirely submitted in cassette C2. Part D, received in formalin and labeled. consists of one soft and firm,. tan-yellow, fatty tissue fragment measuring 1.7 x 1 x 0.4 cm. The entire specimen is submitted in. cassette D1. Part E, received in formalin and labeled. consists of one soft and firm,. tan-yellow, fatty tissue fragment measuring 1.6 x 1.2 x 0.4 cm. The entire specimen is submitted in. cassette E1. Part F is received in formalin and additionally labeled. It consists of a 9-gm. breast lumpectomy specimen, measuring 1.5 cm from anterior to posterior, 5 cm from superior to. inferior, and 3.5 cm from lateral to medial. There is a short stitch designated as superior and a long. stitch designated as lateral. The specimen is inked as follows: anterior superior blue, anterior inferior. green, and posterior black. Prior to receipt by me (Dr. the posterior portion of the. breast has been incised and tissue removed for tissue banking. The specimen is serially sectioned,. from medial to lateral, into eight slices and reveals a well-circumscribed, tan, firm nodule (1.5 x 1 x. 0.9 cm) in slices 3 through 6. The tumor nodule is located approximately 1 cm from both the lateral-. and medial-most margins, 0.7 cm from the superior margin, and 1.3 cm from the inferior margin. The. closest approach to a margin is in slice 6, where it appears to abut the anterior-mid portion of the. specimen (<1 mm grossly from the blue/green-inked margin). The specimen is entirely submitted as. follows: Cassette F1: Medial-most margin. Cassette F2: Slice 2, superior. Cassette F3: Slice 2, inferior. Cassette F4: Slice 3, superior (and nodule). Cassette F5: Slice 3, inferior. Cassette F6: Slice 4, superior (and nodule). Cassette F7: Slice 4, inferior. Cassette F8: Slice 5, superior (and nodule). Cassette F9: Stice 5, inferior. Cassette F10: Slice 6, superior (and nodule). Cassette F11: Slice 6, inferior. Cassette F12: Slice 7, superior. Cassette F13: Slice 7, inferior. Cassettes F14-F15: Lateral-most margin. Part G, received in formalin and labeled. consists of multiple soft and firm,. brown-tan and yellow tissue fragments measuring 7 x 6.5 x 1.5 cm in aggregate. The specimen is. trimmed and extensively searched for lymph nodes. Multiple candidate lymph nodes are found and. submitted intact in cassettes G1-G5. Fee Codes: Working Draft. Addenda. Addendum. Date Complete: Addendum Comment. An immunohistochemical test for estrogen and progesterone receptors was performed on block F6. The test for estrogen receptors is positive. There is strong nuclear staining in ~50% of tumor cells. The test for progesterone receptors is positive. There is weak to moderate nuclear staining in ~15%. of tumor cells. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed on block F6 using the CB11 monocional antibody to. HER2/neu oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in. this category show an excellent correlation between the results of Immunohistochemical and FISH testing, and almost always show. gene amplification. The immunonerovirtase stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. s. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should. not be regarded as Investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1988 (""CLIA"") as qualified to perform high-complexity clinical testing. Other Specimens. Specimen Class: Accessioned. Specimen(s) Received: Left Breast, Fine Needle Aspiration. Final Diagnosis. Left Breast, Fine Needle Aspiration: Benign breast elements (see comment). Working Draft. Specimen Class: Accessioned. Specimen(s) Received: Vaginal/Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Vaginal/Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: Right Breast, Fine Needle Aspiration. Final Diagnosis. Right Breast, Fine Needle Aspiration: Adenocarcinoma, see note. Procedure/Addenda for. ADDENDUM. Date of Addendum.: Addendum Comment. An immunohistochemical test for estrogen and progesterone receptors as well as for HEr-2-neu was. performed on the material submitted for cell block. The test for estrogen receptors is positive There is strong nuclear staining in greater than 90% of. tumor cells. The test for progesterone receptors is Negative. There is no nuclear staining in 100% of tumor cells. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein. over-expression on a scant specimen. Repeat testing is recommended on the excisional. specimen. An immunohistochemical assay was performed on the cell button using the CB11 monoclonal antibody. to HER2/neu oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3. Carcinomas with staining intensity scores of o or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining Intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in. this category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show. gene amplification. Working Draft. the stain(s) reborted above were developed and their performance charatteristies determined by the. They have not been cleared or approved by the U. S. Food and Drug Administrauon. FDA. has. determined. that. such. clearance or approval is not necessary. These tests are used for clinical purposes. They should. not be regarded as investigational or for research. This laboratory Is certified under the Clinical Laboratory Improvement. Amendments of 1988 (""CLIA"") as qualified to perform high-complexity clinical testing. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Direct. Final Diagnosis. Cervical/Endocervical, Direct. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation; atrophic pattern with no identifiable. endocervical/transformation zone component. Cellular distortion secondary to airdrying artifact. Cellular distortion secondary to mechanical artifact. Specimen Class: Accessioned: Specimen(s) Received: A: 2:00 Right Breast, Fine Needle Aspiration, B: 5:00 Right Breast, Fine Needle Aspiration. Final Diagnosis. A. Right Breast, 2:00 o'clock, Fine Needle Aspiration: Lacatation changes; see comment. B. Right Breast, 5:00 o'clock, Fine Needle Aspiration: Lacatation changes; see comment. Specimen Class: Accessioned. Specimen(s) Received: Right breast core biopsy. Final Diagnosis. Right breast, needle core biopsy: Breast tissue with gestational lobular change and. suppurative inflammation; no in situ or invasive carcinoma seen. See comment. pecimen Class: Accessioned: Specimen(s) Received: Right Breast, Fine Needle Aspiration. Final Diagnosis. Right Breast. 2:00 o'clock, Fine Needle Aspiration: Atypical, see. note. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Vaginal/Cervical/Endocervical, Thin Prep. Final Diagnosis. Vaginal/Cervical/Endocervical, Thin Prep. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Specimen(s) Received: Uterine contents. Final Diagnosis. Uterine contents, evacuation: Decidua with chorionic villi. Specimen Class: Accessioned. Specimen(s) Received: Right Breast, Fine Needle Aspiration. Final Diagnosis. Right Breast, Fine Needle Aspiration: Lipoma; see comment. Specimen Class: Accessioned. Specimen(s) Received: Vaginal, Direct. Final Diagnosis. Vaginal, Direct. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. SPECIMEN ADEQUACY: Satisfactory for evaluation. Specimen Class: Accessioned: Specimen(s) Received: Vaginal/Cervical/Endocervical, Direct. Final Diagnosis. Vaginal/Cervical/Endocervical, Direct. CELLULAR CHANGES WITHIN NORMAL LIMITS. Working Draft. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present.",T2,N1,M0,T2N1M0
TCGA-E9-A1R0,"OC ID. Gross Description: Microscopic Description: Diagnosis Details: Comments: BREAST TISSUE CHECKLIST. Specimen type: Mastectomy. Site: breast, NOS C50.9 4/8/u for. Specimen size: Not specified. Tumor site: Breast. Tumor size: 2 x 1.5 x 1.5 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 1/12 positive for metastasis (Axillary 1/12). Extracapsular invasion of the lymph nodes: Not specified. Margins: Not specified. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T1,N1,M0,T1N1M0
TCGA-43-5670,"SPECIMEN. A. R4 lymph node. B. L4 lymph node. C. Level 5. D. Level 7. E. Level 9 lymph node. F. Level 7 lymph node. G. Level 7. H. Level 10. LLL. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung carcinoma. FROZEN SECTION DIAGNOSIS. h. R4, excision - Negative for metastatic carcinoma. L4, excision - Negative for metastatic carcinoma. cision - Negative for metastatic. carcinoma. D) Lymph no. cision - Negative for metastatic. carcinoma. . E. Level 9. sy: No tumor seen. F. Level 7 lymph node, biopsy: No tumor seen. GROSS DESCRIPTION. A. Received fresh for frozen section labeled ""R4 lymph. nodes"" are irregularly-shaped fragments of tan-red tissue. that measure 2 X 1. X 0.3 cm. in dimension. The tissue is. entirely. frozen. B. Received in formalin, labeled ""L4 lymph nodes"" are. irregularly-shaped fragments of lymph nodes that measure 1.3 X 1.2. X. 0.4 cm. in dimension. The tissue is entirely frozen. C. Received fresh labeled ""level 5"" are irregularly-. shaped. fragments of tan-red tissue that measure 2.5 X 1.8 X 0.5. cm. in dimension. The tissue is entirely frozen as FSC1 and FSC2. D. Received fresh labeled ""level 7"" are irregularly-. shaped. fragments of tan-red tissue that measure 1.2 X 0. X. 3. cm. in dimension. The tissue is entirely frozen as FSD. E. The specimen is received fresh for frozen se. o. labeled ""E. level 9 lymph node"" and consists of one large. 2.5 X 1.6 X 0.6 cm. black lymph node and two smaller lymph node. fragments measuring in aggregate 1.0 X 0.6 X 0.4 cm. The largest. lymph node is bisected to reveal a mottled gray-black appearance. cimen is entirely frozen as frozen section EFS1 and EFS2. F. The specimen is received fresh for frozen section. labeled ""level 7"" and consists of a 2.5 X 1 X 0.8 cm gray. lymph node. The specimen is bisected to reveal a gray-to-red. nodular appearance. No grossly evident metastases are identified. cimen is entirely frozen as frozen section. FS1 and 2. G. Received fresh labeled ""level 7"" is a freshly. fragmented, 5.2 X 2. X 1.3 cm tan-gray tissue in keeping. with coalesced lymph nodes. The specimen is sectioned and entirely. submitted in four blocks. AS-4. H. Received fresh labeled ""level 10"" are five intact to. slightly fragmented soft gray-black tissues in keeping. with. lymph nodes measuring up to 4 cm in greatest dimension. The. specimens are entirely submitted in four blocks. AS-4. BLOCK SUMMARY: 1 - four whole lymph nodes; 2-4 - section largest. lymph node. I. Received fresh, labelled ""LLL"" is a 312 gram, 15.0 X. 11.0 X 5.5 cm lobectomy specimen with attached, 1 cm in. length, 1.6 X 1.0 cm in diameter bronchial stump. A 7.8 cm staple. line is present superiorly. A palpable mass is noted at the hilum. and the overlying pleural surface is inked blue. On sectioning,. there is a moderately well-circumscribed, 5.5 X 5.0 X 4.0 cm. focally. necrotic tan-white tumor mass. The tumor is present within 1 cm of. the bronchial stump (following initial removal) and within 0.2 cm. of. the inked pleural surface. A portion of tumor and a portion of. normal mucosa are submitted for tissue procurement as requested. The parenchyma throughout the remainder of the specimen is. spongiform tan-pink to tan-red with diffuse anthracosis. No. additional mass lesion or abnormality is identiifed. Three. slightly. rubbery gray-black-red tissues in keeping with lymph nodes. measuring. up to 1.4 cm in greatest dimension are recovered from the hilar. region. R. ntative sections are submitted in 10 blocks as. labelled. BLOCK SUMMA. bronchial stump margin; 25 - tumor to inked. surface of specimen; 6 - tumor to normal parenchyma; 7 - two whole. lymph nodes; 8 - one bis ed lymph node; 9-10 - random from. remainder of specimen. MICROSCOPIC DESCRIPTION. Histologic type: Squamous cell carcinoma. Histologic grade: Poorly differentiated. Primary tumor (pT) : Tumor measures 5.5 cm. in dimension and. extends. through the pleura but is not identified at the outer surface of. the. specimen. Margins of resection: Negative for tumor. Direct extension of tumor: Tumor extends into the pleura which. shows a desmoplastic response to tumor; tumor is not identified at. the outer surface of the specimen. Vessel invasion: Not identified. Regional lymph nodes (pN) : pNO. Distant metastasis (pM) : pMx. Other findings Changes of chronic emphysematous disease with. dilated air spaces with variable marked fibrosis and mild. inflammation with reactive changes. 5x1, 14x6, 15x3, 3x6, 4x2. DIAGNOSIS. A. Lymph node, R4, excision - Negative for metastatic carcinoma. B. Lymph node, L4, excision - Negative for metastatic carcinoma. C. Lymph node, level 5, excision - Negative for metastatic. carcinoma. D. Lymph node, level 7, excision - Negative for metastatic. carcinoma. E. Lymph node, level 9, excision - Negative for metastatic. carcinoma. F. Lymph node, level 7, excision - Negative for metastatic. carcinoma. G. Lymph node, level 7, excision - Negative for metastatic. carcinoma. H. Lymph node, level 10, excision - Negative for metastatic. carcinoma. I. Lung, left lower lobe, excision - Invasive poorly differentiated. squamous cell carcinoma (see tumor characteristics in the lobectomy. template in the microscopic description). --- End Of Report --.",T2,N0,M0,T2N0M0
TCGA-2G-AAHG,Summary pathology report. Left orchidectomy; seminoma; diameter 1.5 cm; no angio-invasion present; no invasion. of. tunica albuginea; epididymis free of tumor;no invasion in rete testis; surgical margin of. spermatic cord free of tumor. = date of orchidectomy): pathologist.,T1,N0,M0,T1N0M0
TCGA-05-4422,"Main diagnosis/diagnoses: Peripheral bronchopulmonary, histologically predominantly well differentiated mixed. adenocarcinoma of the left lower lobe of the lung. TNM classification on the basis of this. material pT2 pNO R0, stage IB. C34.3 M8255/3. Comment/supplementary remark: The classification of the adenocarcinoma of the lung is based on the result of the. immunohistochemical analysis obtained on the previous biopsy material. The tumor has a. compact, low stromal structure, of predominantly tubulopapillary differentiation and shows a. small bronchioloalveolar component at the margin. It extends to below the pleura, which it. has not however infiltrated on the basis of the sample examined. In a central direction the. carcinoma has invaded a peripheral bronchus, this being markedly distended and largely. obstructed by a tumor plug.",T2,N0,M0,T2N0M0
TCGA-CM-6167,"Clinical Diagnosis & History: Colon cancer. Specimens Submitted: 1: SP:colon, Right ; resection. DIAGNOSIS: 1. SP:colon, Right ; resection: Tumor Type: Adenocarcinoma. Histologic Grade: Poorly differentiated. with signet ring cells. Tumor Location: Cecum. Tumor Size: Length is 8.5 cm. Width is 7.0 cm. Maximal thickness is 1.1 cm. Tumor Budding: Extensive. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Tubulovillous adenoma. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Identified. extensive. Large Venous Invasion: Identified. Perineural Invasion: Identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Tubulo-villous adenoma; number: 3. Non-Neoplastic Bowel: Unremarkable. Appendix: Unremarkable. Lymph Nodes: Number with metastasis: 11. Total number examined: 40. Tumor deposits in pericolorectal soft tissue: Identified. Identified; number: 3. Tumor Staging (AJCC 7th Edition) : pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition) : N2b (Metastasis in seven or more regional lymph nodes). NOTE: IMMUNOHISTOCHEMICAL STAINS SHOW THAT THE TUMOR CELLS ARE POSITIVE FOR. CK20, CDX2, AND VERY FOCALLY POSITIVE FOR CK7, WHILE NEGATIVE FOR. SYNAPTOPHYSIN, CHROMOGRANIN, ER AND PR. THE RESULTS ARE CONSISTENT WITH A. PRIMARY COLON CARCINOMA. Some of the immunohistochemistry and ISH tests were developed and their. performance characteristics were determined by the Department of Pathology. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not. be regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of. as. qualified to perform high complexity clinical laboratory testing. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1. The specimen is received fresh, labeled ""Right colon"" and consists of a. segment of terminal ileum, cecum with attached appendix and ascending colon. The terminal ileum measures 11.5 cm in length and 3.3 cm in circumference. at the proximal resected margin. The remaining colon measures 46 cm in. length with a circumference of 7.5 cm at the distal resected margin. The. attached appendix measures 5 cm in length and averages 0.8 cm in diameter. The appendiceal and intestinal serosa is pink tan and smooth. Focally. hemorrhagic lobulated yellow tan adipose tissue spans the length of the. specimen measuring up to 2.0 cm in thickness. The specimen is opened to. reveal a partially fungating and partially infiltrating lesion measuring 8.5. cm in length and 7 cm in width. The mass is located in the cecum, 11.5 cm. from the proximal margin and 39 cm from the distal margin. Sectioning shows. that the tumor invades possibly subserosal fibroadipose tissue. The depth of. invasion is 1.1 cm grossly. The remaining mucosa shows 3 polyps measuring. 0.2 to 2.5 cm in greatest dimension. The attached adipose tissue is. thoroughly examined and all identified lymph nodes are submitted. Representative sections of the specimen are submitted for permanent sections. and for TPS. Summary of sections: P - proximal margin shave. D - distal margin shave. T - tumor. A - appendix representative sections. RSC -representative sections of colon. RSI - representative sections of ilium. POY - polyps, representatives. LP - largest polyp, serial sections. LN - lymph nodes. BLN - bisected lymph nodes. Summary of Sections: Part 1: : SP:colon, Right ; resection. Block. Sect. Site. PCs. 2. a. 2. 1. d. 1. 12. LN. 24. 2. lp. 2. 1. p. 1. 2. poy. 2. 2. rsc. 2. 2. rsi. 2. 10. t. 10.",T3,N2,M0,T3N2M0
TCGA-JX-A5QV,"GYN. Accessioned: DIAGNOSIS: UTERUS, RADICAL HYSTERECTOMY. CERVICAL SQUAMOUS CELL CARCINOMA, POORLY DIFFERENTIATED, INVASIVE TO A DEPTH OF. 14 MM (CERVICAL THICKNESS OF 15 MM, TUMOR WIDTH APPROXIMATELY 2 CM), WITH. MULTIFOCAL LYMPHVASCULAR SPACE INVASION, WITHOUT PARAMETRIAL INVASION, RESECTION. MARGINS NOT INVOLVED. SECRETORY ENDOMETRIUM. - VAGINAL CUFF WITH NO EVIDENCE OF MALIGNANCY. VAGINA, RIGHT LATERAL MARGIN, EXCISION. - NO EVIDENCE OF MALIGNANCY. VAGINA, ADDITIONAL RIGHT MID VAGINAL MARGIN, EXCISION. . NO EVIDENCE OF MALIGNANCY. FALLOPIAN TUBES. BILATERAL. SALPINGECTOMY. - NO EVIDENCE OF MALIGNANCY. LYMPH NODES, LEFT EXTERNAL ILIAC, EXCISIONAL BIOPSY. NO EVIDENCE OF MALIGNANCY (3). LYMPH NODES. LEFT OBTURATOR, EXCISIONAL BIOPSY. NO EVIDENCE OF MALIGNANCY (3). LYMPH NODES, RIGHT EXTERNAL ILIAC, EXCISIONAL BIOPSY. . NO EVIDENCE OF MALIGNANCY (5). LYMPH NODE, RIGHT OBTURATOR, EXCISIONAL BIOPSY. MATURE ADIPOSE TISSUE, NO LYMPHOID TISSUE IDENTIFIED. - NO EVIDENCE OF MALIGNANCY. LYMPH NODE, RIGHT, PERIAORTIC, EXCISIONAL BIOPSY. NO EVIDENCE OF MALIGNANCY (1). LYMPH NODES, LEFT PERIAORTIC, EXCISIONAL BIOPSY. Page of 4. Page: 1 of 4. - NO EVIDENCE OF MALIGNANCY (2). By this signature, 1 attest that the above diagnosis is based upon my personal. examination of the sides(and/or other material indicated in the diagnosis). Intraoperative Consultation: An intraoperative non-microscopic consultation was obtained and interpreted as: ""Called to pick up 'uterus, cervix,"" is a. 197 gram specimen consisting of a uterus with an attached cervix (fundus/ectocervix: 11 cm; cornu to comu: 5.7;. anterior-posterior. 5.3 cm). Parametrial tissue is inked black. Opened to show a 1.7 x 1.5 cm cervical lesion invading to. a. depth of 1.4 cm grossly. The lesion extends up to the right parametrial inkart margin Small portion of tumor and. normal for. study. Rest for permanents. Shown to surgeon,"". Microscopic Description and Comment: Microscopic examination substantiates the above cited diagnosis. History: The patient is a year old woman with cervical cancer. Operative procedure: Radical hysterectomy, bilateral. salpingo-oophorectomy, and pelvic lymph node dissection. Specimen(s) Received: A: LEFT EXTERNAL ILIAC LYMPH NODE. B: LEFT OBTURATOR LYMPH NODE. C: RIGHT EXTERNAL ILIAC LYMPH NODE. D: RIGHT OBTURATOR LYMPH NODE. E: RIGHT PERIAORTIC LYMPH NODE. F: LEFT PERIAORTIC LYMPH NODE. G: RIGHT FALLOPIAN TUBE. H: LEFT FALLOPIAN TUBE. I: UTERUS AND CERVIX. J: RIGHT LATERAL VAGINAL MARGIN. K: ADDITIONAL RIGHT MID-VAGINAL MARGIN. Gross Description: The specimens are received in 11 formalin-filled containers, each labeled with the patient's name. The first specimen is labeled ""left external illac fymph node."" It consists of multiple fragments of fibroadipose. tissue that measure, in aggregate, 4 x 2x2 cm. On dissecting, three lymph nodes ranging from 0.4 to 1.5 cm are. identified: sections of these lymph nodes show unremarkable areas. Labeled A1 - two lymph nodes; A2 - one lymph. node. Jar 1. The second specimen is tabeled ""left obturator lymph node."" It consists of several fragments of fibroadipose tissue that. measure, in aggregate. 2.5 x 2.0 x 1.0 cm. On sectioning and dissection, three lymph nodes ranging from 0.5 to 1.5. cm in diameter are identified; sections of these lymph nodes show largely tobe composed of adipose tissue. Bisected. Labeled B1 . two lymph nodes; B2 - one lymph node. Jar (. The third specimen is labeled ""right external iliac lymph node."" It consists of several fragments of fibroadipose tissue. that measure, in aggregate, 5 x 3 x 1.5 cm. On dissecting, two lymph nodes ranging from 1.5 cm to 3 cm in maximal. Page: 2 of 4. dimensions are identified; sections of the lymph nodes show targely to be composed of adipose tissue. Labeled C1 . one fymph node (not bisected); C2 - second lymph node (3 cm) bisected. Jar 1. The fourth specimen is labeled ""right obturator lymph node,"" It consists of a single lymph node with attached adipose. tissue that measures 0.5 x 0.2 x 0.2 cm. Sectioning shows putative lymph nodal tissue. Labeled D1. Jar 0. The fifth specimen is labeled ""right periaortic lymph node."" It consists of a single fymph node measuring 4.5 x 2.5 x 1.0. cm in its maximal dimensions with attached fibroadipose tissue. On sectioning the node is shown to be composed. largely of adipose tissue. Divided into two halves. Bisected. Labeled E1 and E2. Jar 1. The sixth specimen is labeled ""left periaortic lymph node."" It consists of two lymph nodes, ranging from 0.7 to 0.9 cm. in diameter. Sections show unremarkable areas. Labeled F1 - two lymph nodes (bisected). Jar 0. The seventh specimen is labeled ""right fallopian tube."" It consists of the fallopian tube with its fimbriated end,. measuring 6 cm in length with a diameter ranging from 0.4 to 1.0 cm. A metallic clip is found in its proximal partion. (1.5 x 0.4 x 0.4 cm). Sections show compacted mucosal folds and a pinpoint lumen. Labeled G1, Jar 1. The eighth specimen is labeled ""left fallopian tube."" It consists of the fallopian tube measuring 6 cm in length with a. diameter ranging from 0.5 to 1.0 cm. Sectioning shows compacted mucosal folds and a pinpoint lumen. No focal. lesions are noted. Labeled H1. Jar 1. The ninth specimen is labeled ""uterus, cervix."" It consists of a uterus with attached bilateral parametria as described in. the intraoperative non-microscopic consultation. The ectocervix shows an excavating lesion present mainly along the. right half of the specimen, measuring 2.5 x 2 cm. On opening and further sectioning, a homogenous yellow-white. fleshy tumor is present beneath the ulcer involving the stroma of the cervical canal and extending into adjacent. parametrial tissue, measuring1.7 x 1.5 x 1.5 cm. The tumor appears to originate in the lower part of the endocervical. canal but shows significant extension into underlying right half of the cervix. Tumor is present 1.5 cm from the internal. cervical os. The endometrial cavity measures 4 x 2 cm and shows no focal lesions. The endometrium measures 0.4 cm. in thickness with a myometrial thickness of 2.5 cm. No other focal lesions are noted in the endometrium or the. myometrium. The anterior vaginal cuff measures 6 x 2 x 2 cm. The posterior vaginal cuff measures 6 x 1.5. cm. The. tumor extends close (0.2 cm) to the resected vaginal margin but does not appear to extend to it. Labeled I1 - anterior. resected margin of vaginal cuff; 12 - posterior resected margin of vaginal cuff (both shave margins); 13 to 19 - tumor,. involving right anterior cervix and parametrium; 110 to 115 - tumor with posterior portion of cervix and parametrium; 116,. 117 - anterior endomyometrium; 118 - posterior endomyometrium. Jar 2. The tenth specimen is labeled ""right lateral vaginal margin."" It consists of a single irregular fibroadipose tissue. fragment. that is partially covered by vaginal mucosa, which is distorted and irregular, measuring 3 x 1 x 0.8 cm. No. orientation is provided. Specimen inking is not possible due to the distorted nature of the specimen and the tack of. directions. Labeled J1 to J3. Jar 0. The 11th specimen is labeled ""additional right mid vaginal margin."" It consists of a portion of soft tissue that is partially. mucosal covered, that measures 2.5 x 1.5 x 1.0 cm. Multiple sutures are attached to the opposite-appearing resected. surface of the specimen. These are removed. No orientation is provided for the specimen. The surfaces opposite of the. mucosa are inked in blue. Sectioned. Labeled K1 to K2, Jar 0. SYNOPTIC REPORTING FORM FOR UTERINE CERVICAL NEOPLASMS. HISTOPATHOLOGIC TYPE. Squamous cell carcinoma, Keratinizing. Squamous. cell carcinoma, Basaloid upon review by TSS, NO basaloid differentiation, per TSS. TUMOR SIZE. The maximum depth of the tumor invasion is 1.4 cm. The breadth (maximum horizontal dimension) of the tumor is 2 cm. The total thickness of the cervix is 1.5 cm. Page: 3 of 4. LYMPHATIC INVASION. Lymphatic invasion by tumor is identified but is focal. HISTOPATHOLOGIC GRADE. The histologic grade is poorly differentiated (G3). TUMOR INVASION. The tumor does not invade through the entire thickness of the cervix to involve contiguous parametrial tissues. VAGINAL INVOLVEMENT. The tumor does not involve the vagina. TUMOR METASTASIS. Metastasis of tumor to regional fymph nodes is absent. The total number of metastatically-involved lymph nodes is 0. The total number of lymph nodes examined is 14. Extracapsular extension of metastatic tumor through the lymph node capsule is not applicable; no metastasis seen. PRIMARY TUMOR (T). Clinically visible lesion 4.0 cm or less in greatest dimension (T1b1/IB1). REGIONAL LYMPH NODES. No regional lymph node metastasis (NO). DISTANT METASTASIS. No distant metastasis (MO). STAGE GROUPING. The final stage of the tumor is Stage IB1 T1b1/NO/MO. The pathologic stage assigned here should be regarded as provisional, and may change after integration of clinical. data not provided with this specimen. Page: 4 of 4.",T1,N0,M0,T1N0M0
TCGA-AR-A0U4,"Breast, right, simple mastectomy: Breast parenchymal tissue is negative for tumor. Focal calcifications. identified. The nipple is negative for tumor. A single intraparenchymal lymph node is negative for. tumor. Breast, left, simple mastectomy: Infiltrating ductal carcinoma, Nottingham grade III (of III), [tubules 3. (of 3), nuclei 3 (of 3), mitoses 2 (of 3); Nottingham score 7-8 (of 9) forming a 4.7 x 4.0 x 2.7 cm mass,. located in the upper outer quadrant of the breast (AJCCpT2). Ductal carcinoma in situ is absent. Angiolymphatic invasion is absent. No calcifications are present. The tumor does not involve the nipple,. overlying skin, or underlying chest wall. All surgical resection margins, including deep margin, are. negative for tumor (minimum tumor free margin, 1.7 cm, deep margin). Lymph nodes, left axillary sentinel, excision: Multiple (10) sentinel lymph nodes are negative for tumor. AJCC PN0(1-)(sn). Immunohistochemical stains were performed on paraffin embedded tissue from the breast tumor using. antibodies to ER, PR, and HER2/neu. Estrogen is negative, 0% nuclear staining. Progesterone is. negative, 0% nuclear staining. HER2/neu protein overexpression is negative, score of 0, according to the. interpretation guidelines in the FDA-approved HercepTest. ER (Estrogen Receptor) test was developed and its performance characteristics determined by. It has not been cleared or approved by the U.S. Food. and Drug Administration.",T2,N0,M0,T2N0M0
TCGA-AF-A56N,"Final Surgical Pathology Report. Diagnosis. A. Uterus, bilateral ovaries and fallopian tubes, supracervical. hysterectomy: Endometrium: Benign inactive endometrium. Myometrium: Benign leiomyomata. Serosa: No pathological abnormalities. Bilateral ovaries: Benign with cystic follicles and minimal surface. adhesions. Bilateral fallopian tubes: Benign with no pathologic abnormalities. B. Rectum and sigmoid colon, excision: Adenocarcinoma, moderately differentiated, invasive into. perirectal/colonic fat (pT3). Resection margins negative for malignancy. 33 lymph nodes negative for malignancy (0/33) (pNO). C. Appendix, excision: Benign appendix with mucosal lymphoid hyperplasia, within normal limits. Microscopic Description: Microscopic examination performed. The colorectal findings from. specimen B. are summarized in the template: Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Primary tumor (pT) : Invasive into fat (pT3). Proximal margin: Negative. Distal margins: Negative. Circumferential (radial) margin: Negative. Distance of tumor from closes margin: 1.9 CM from distal/rectal margin. Vascular invasion: Not identified. Regional lymph nodes (pN) : 33 lymph nodes are negative for metastatic. tumor (pNO). Non-lymph node pericolonic tumor: Not identified. Distant metastasis (pM) : Not applicable (pMx). Other findings: There is surface ulceration of tumor and some. associated acute and chronic inflammation of the tumor with. Crohn's-like chronic inflammation deep to the tumor. The invasion into. fat is only identified in block B3. MSI testing: Ordered on block B2. Specimen. A. Uterus tubes and ovaries. B. Rectum and sigmoid. C. Appendix. Clinical Information. Rectal cancer. Intraoperative Consultation. A. Uterus, tubes and ovaries: Benign inactive endometrium. B. Rectum & sigmoid, excision: Negative for tumor. Gross Description. A. Received fresh and subsequently fixed in formalin labeled ""uterus. tubes and ovaries"" is a 294 g, supracervically amputated uterus which. is 7.5 x 7.5 x 7.5 cm. The specimen is partially covered pink-tan. smooth glistening serosa showing 3 subserosal fibroid ranging from 1.3. cm to 4.5 cm in greatest dimension. Amputation site is inked. The. specimen has attached bilateral fallopian tubes which are both. fimbriated measuring 8.0 x 0.7 cm. The ovaries are also present. averaging 3.2 x 1.7 x 1.4 cm and are pink-tan and cerebriform with a. pink-tan cystic and mottled cut surface. No papillary excrescences are. grossly identified. The specimen is opened show smooth glistening. endometrium with an average thickness of 0.2 cm. The specimen is. sectioned to show multiple intramural fibroids which range from 0.1 cm. to 5.5 cm in greatest dimension. Due to the nodular distortion of the. specimen, average thickness of the myometrium cannot be grossly. determined. Possible cystic spaces may be grossly identified subjacent. to the endometrium a 1.2 cm area. This is located within 2.8 cm of the. amputation site. Representative sections of the specimen are submitted. as follows: AFS 1 representative section of endometrium and myometrium. ,1 - representative section of amputation site 2 - 3 - representative. endomyometrium with subjacent fibroid and area of cystic spaces, 4 -. are present at section of 2 smaller subserosal fibroids, 5 -. representative section of large subserosal fibroid, 6 - 8 -. representative section of largest intramural fibroid, 9 -. representative right ovary, 10 - representative left ovary, 11 -. representative right fallopian tube with entire fimbria, 12 -. representative left fallopian tube with entire fimbria. RS 12. B. Received fresh and subsequently fixed in formalin labeled ""rectum. and sigmoid"" is a 26.5 cm long portion of rectosigmoid colon which is. partially covered with abundant yellow lobular fat and pink-tan smooth. glistening serosa. Retroperitoneal reflection is located 8.5 cm from. the distal end which is inked black. The specimen is opened to show. a. 5.5 x 4.8 x 0.8 cm exophytic tumor coming within 1.9 cm of distal. margin. The cut surface of the tumor shows invasion into the muscularis. propria but shows no discrete invasion into the fat. This comes within. 2.5 cm or greater of the radial margin. The remainder of the mucosa. is. pink-tan smooth glistening with an average circumference of 5.5 cm. showing no other discrete gross lesions identified. Multiple lymph. nodes are grossly identified in the surrounding fat. Representative. sections of the specimen are submitted as follows: BFS 1 representative. radial section of distal margin 1 - representative luminal margins, 2 -. tumor to distal margin, 3 - 5 - additional representative sections of. tumor to fat and tumor to normal, 6 - representative section of radial. margin en face, 7 - 13 - 5 possible lymph nodes in each block, 14 - 2. possible lymph nodes, 15 - 1 possible lymph node bisected. RS 15. C. Received in formalin labeled ""appendix"" is a 7.9 x 0.7 x 0.7 cm. grossly unremarkable appendix. The specimen is sectioned to show an. intact wall with no discrete gross lesions identified. Representative. sections of the specimen are submitted in 2 cassettes with the proximal. end inked blue. RS 2.",T3,N0,M0,T3N0M0
TCGA-KL-8339,"Clinical Diagnosis & History: y/o male with left renal mass with lymphadenopathy. R/o renal cell cancer. Specimens Submitted: 1: SP: Left kidney and portion of left adrenal, total nephrectomy. 2: SP: Lymph nodes, Para-aortic, excision: 3: SP: Lymph nodes, Pre-aortic, excisions. 4: SP: Lymph nodes, Interaortocaval, excision: 5: SP: Lymph nodes, Suprahilar and portion of left adrenal, excision. 6: SP: Liver, left lobe, biopsy: DIAGNOSIS: 1. SP: Left kidney and portion of left adrenal, total nephrectomy. Tumor Type: Renal cell carcinoma - Chromophobe type. Tumor Size: Greatest diameter is 13.0 cm. Local Invasion (for renal cortical types): Extends through renal capsule but confined within Gerota's fascia. Involves renal hilar fat. Renal Vein invasion: Identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: Not involved. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT3b Tumor grossly extends into the renal vein(s) or vena cava below the diaphragm. 2. SP: Lymph nodes, Para-aortic, excision: Lymph Nodes: Not involved. Number of nodes examined: 15. 3. SP: Lymph nodes, Pre-aortic, excisions. Lymph Nodes: Not involved. Number of nodes examined: 12. 4. SP: Lymph nodes, Interaortocaval, excision: Lymph Nodes: Not involved. Number of nodes examined:2. 5. SP: Lymph nodes, Suprahilar and portion of left adrenal, excision. Lymph Nodes: Number of nodes examined:4. Number of metastatic nodes:1. The largest metastatic node is 1.3cm. Perinodal (extracapsular) extension not identified. Unremarkable adrenal gland. 6. Liver, left lobe, biopsy: - Metastatic renal cell carcinoma, chromophobe type, involving liver parenchyma. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. MIB-1 (Ki-67). IMM RECUT. NEG CONT. RECUT. RECUT. RECUT. RECUT. RECUT. RECUT. RECUT. RECUT. RECUT. RECUT. Gross Description: 1) The specimen is received fresh labeled ""left kidney and portion of left adrenal"" and consists of a kidney with attached ureter,. renal vessels and perinephric fat weighing 1258 g in total. The kidney measures 13x12x10 cm. The attached ureter measures. 1.0 cm in length and0.5 cm in diameter. The attached renal vein measures 1.0 cm in length and 1.0 cm in diameter. The renal. vessels and ureter margins are grossly unremarkable. An adrenal gland is identified, measuring 4.0x1.0x1.0 cm. The kidney is. inked black and bivalved to reveal a large necrotic mass, completely replacing the entire kidney with rim normal renal parenchyma. in the hilar area and measuring 13x12x10cm. Tumor thrombus is identified in the renal vein, but the margin is free of tumor. The. renal cortex measures 0.5 cm in thickness and the calyces appear involved by the tumor. The specimen is photographed. Representative sections are submitted for. and for permanent sections. Summary of sections: UVM -- ureteral and vessel margins. T-- tumor. TH-tumor in the hilar area. TK -- tumor with adjacent kidney. Thr-tumor thrombus. K -- representative sections kidney. AD -- adrenal gland. HF-hilar fat. 2). The specimen is received in formalin, labeled ""Para-aortic nodes"" and consists of multiple pink tan firm lymph nodes ranging. from 0.6 to 3 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN -- lymph nodes. BLN-- bisected lymph nodes. 3). The specimen is received in formalin, labeled ""Pre-aortic nodes"" and consists of multiple pink tan firm lymph nodes ranging. from 0.6 to 2.6 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN -- lymph nodes. BLN-- bisected lymph nodes. 4). The specimen is received in formalin, labeled ""Interaortocaval lymph node"" and consists of two pink tan firm lymph nodes. measuring from 0.8 and 2.5 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN -- lymph nodes. BLN- bisected lymph node. 5). The specimen is received in formalin, labeled ""Suprahilar nodes and portion of left adrenal"" and consists of a piece of brown. tan fibrous adipose tissue measuring 6 x 2.7 x 1.3 cm. Multiple pink tan firm lymph nodes are isolated ranging from 1 to 1.6 cm. in greatest dimension. All identified lymph nodes are submitted. A golden yellow portion of adrenal gland is identified measuring. 3.5 x 2.2 x 1 cm. Serial sections of the gland reveal a homogeneous golden yellow parenchyma and is entirely submitted. Summary of sections: LN -- lymph nodes. BLN-- bisected lymph nodes. U- sections from adrenal gland. 6). The specimen is received in formalin, labeled ""Biopsy left lobe of liver"" and consists of a portion of brown-tan firm liver tissue. measuring 1.4 x 0.6 x 0.3 cm. The surgical margin is inked in black and the specimen is bisected and entirely submitted. Summary of sections: U-undesignated. Summary of Sections: Part 1: SP: Left kidney and portion of left adrenal, total nephrectomy. Block. Sect. Site. PCs. 1. ad. 1. 2. hf. 2. 1. k. 1. 7. t. 7. 2. th. 2. 1. thr. 1. 1. tk. 1. 1. uvm. 1. Part 2: SP: Lymph nodes, Para-aortic, excision: Block. Sect. Site. PCs. 4. BLN. 6. 3. LN. 6. Part 3: SP: Lymph nodes, Pre-aortic, excisions. Block. Sect. Site. PCs. 4. BLN. 6. 3. LN. 4. Part 4: SP: Lymph nodes, Interaortocaval, excision. Block. Sect. Site. PCs. 2. BLN. 2. 1. LN. 1. Part 5: SP: Lymph nodes, Suprahilar and portion of left adrenal, excision. Block. Sect. Site. PCs. 2. BLN. 4. 1. LN. 2. 4. U. 4. Part 6: SP: Liver, left lobe, biopsy: Block. Sect. Site. PCs. 1. U. 2.",T3,N1,M1,T3N1M1
TCGA-B0-5104,"FINAL DIAGNOSIS. KIDNEY, LEFT, RADICAL LAPAROSCOPIC NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CLEAR CELL TYPE, 4.5 CM IN DIAMETER. B. TUMOR IS CONFINED TO THE KIDNEY PARENCHYMA. C. NO ANGIOLYMPHATIC INVASION SEEN. D. NON-NEOPLASTIC RENAL PARENCHYMA WITH FOCAL CHRONIC INFLAMMATION AND FOCAL. GLOMERULOSCLEROSIS. E. SURGICAL RESECTION MARGINS ARE FREE OF NEOPLASM. F. TNM STAGE: T1NXMX. G. HISTOPATHOLOGICAL GRADE: G2.",T1,N0,M0,T1N0M0
TCGA-05-4425,"Main diagnosis/diagnoses: Peripheral bronchopulmonary, histologically mixed adenocarcinoma of the middle with. pleural invasion and a second small focus or satellite nodule of a tubular adenocarcinoma. with a small bronchiooalveolar growth component and likewise pleural infiltration (sample. 2.)). TNM classification on the basis of this material pT2 pNO pM1 (PUL) V1 RX, stage IV. C34.2 M8255/3. Comment/supplementary remark: The tumor classification as adenocarcinoma of the lung showing a predominantly. tubulopapillary structural pattern still requires confirmation by appropriate. immunohistochemical analysis. The classification of the second small tumor focus as a. (hematogenous) metastasis that - despite a certain difference in histoarchitecture and cell. morphology in places - is based on the structure of the focus, which is lacking the fibrous. remodeling or cicatricial zone here that is characteristic of a primary peripheral. bronchopulmonary carcinoma. Vascular invasion can be seen in the intratumoral, thick-walled. pulmonary vessels of the larger tumor, where there is tumor spread with endobronchial. occlusion in a subsegmental branch of the bronchus. The R1 classification is explained by the. observation that the tumor glands invading the pleura extend as far as the outer surface of the. pleura in places and the tumor cells thus remain in the pleural space. Result of immunohistochemical analysis (both tumor foci). CK7 positive throughout, CK20 negative. (in the smaller focus more than in. the larger one), only isolated tumor cells with delicate cell membrane staining for surfactant. protein B. This not only confirms that it is an adenocarcinoma of the lung and, but also supports the. view that the smaller focus represents the metastasis of the larger focus. seen in 1.) and classified as primary tumor.",T2,N0,M1,T2N0M1
TCGA-44-6148,"SPECIMEN. A. Level 10. B. Left lower lobe. C. Left upper lobe lymph node. D. Subcarinal lymph node. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung carcinoma. GROSS DESCRIPTION. A. Received fresh labeled ""level 10"" is a 2.2 X 1.4 X 0.6. cm. rubbery tan gray-black tissue in keeping with lymph. node which is bisected and entirely submitted in one block. B. Received fresh for tissue procurement labeled ""left. lower lobe"" is a 232 gram, 21.0 X 11.0 X 5.5 cm. lobectomy. specimen with attached, 1 cm. in length, 2.5 X 0.9 cm. in diameter. bronchial stump. The pleura is smooth to wrinkled tan pink-purple. A palpable mass is noted along the lateral aspect. On sectioning,. there is a well-circumscribed 3.0 X 2.8 X 2.8 cm. congested pale. tan/mucoid tumor mass which focally extends to within 0.3 cm. of. the pleural surface (inked blue) A portion of tumor and a portion. of normal parenchyma are submitted for tissue procurement as. requested. The parenchyma throughout the remainder of the specimen. is spongiform tan pink-red without additional mass lesion or. abnormality. A single 0.4 cm. gray black tissue in keeping with. lymph node is recovered from the hilum epresentative sections are. submitted in nine blocks as labeled. BLOCK SUMMARY: 1 - Bronchial stump margin; 2 - vascular margins; 3-5. tumor to inked pleural surface; 6 - tumor to normal parenchyma;. 7. and 8 - random normal; 9 - one whole hilar lymph node. C. Received fresh labeled ""left upper lobe lymph node"" is. a 0.6 X 0.5 X 0.35 cm. slightly rubbery gray black tissue. in keeping with lymph node which is bisected and entirely submitted. in one block. AS-1. D. Received in formalin labeled ""subcarinal lymph node"" is. a 1.3 X 1.0 X 0.4 cm. portion of fragmented tan gold fatty. tissue with a scant amount of gray black lymphoid tissue. cimen is bisected and entirely submitted in one block. MICROSCOPIC DESCRIPTION. A-D. Microscopic examination of the left lower lobe of. lung and the separate lymph node specimens reveals: Histologic type: Adenocarcinoma, mucinous. Histologic grade: ell-differentiated. Primary tumor (pT) : Tumor is 3 cm. in greatest dimension with no. involvement of the pleura or a large stem bronchus (pT1b). Margins of resection: The vascular and bronchial resection margins. are all negative for tumor. Direct extension of tumor: Tumor invades pulmonary parenchyma with. no extension to pleura. Venous (large vessel) invasion: Not identified. Arterial (large vessel) invasion: Not identified. Lymphatic (small vessel) invasion: Not identified. Regional lymph nodes (pN) : A single lymph node is dissected from. the left lower lobe. Additional lymph nodes are present in level 10. and the separate left upper lobe lymph node and subcarinal lymph. node all are negative for metastatic tumor (pN0). Distant metastasis (pM) : Cannot evaluate, pMx. Other findings: The background pulmonary parenchyma is fairly. unremarkable. The lymph nodes do show prominent anthracosis and. some histiocytes associated with the anthracosis. 3x3, 5. DIAGNOSIS. A. Lymph node, level 10, biopsy: Single lymph node negative for metastatic tumor (0/1). B. Lung, left lower lobe, lobectomy: Adenocarcinoma, mucinous, vell-differentiated, 3 cm. in. greatest dimension (pT1b). Single lymph node negative for metastatic tumor (0/1) . No 1 ymphovascular space invasion identified. Bronchial and. vascular margins are negative for tumor. Background pulmonary parenchyma is relatively unremarkable. C. Lymph node, left upper lobe, biopsy: Single lymph node negative for metastatic tumor (0/1). D. Subcarinal lymph node, biopsy: Single lymph node negative for metastatic tumor (0/1). End Of Report ---.",T1,N0,M0,T1N0M0
TCGA-CQ-A4C6,"Copath # : Service: Otolaryngology. Resulted: Facility: SPECIMEN (S) RECEIVED. 1. Salivary-Gland: RIGHT PAROTID DUCT. QUICK SECTION. 2. Soft Tissue: Right buccal tumor double short 12 o' clock ,double long 3. o' clock, single long 9 o'clock, blue stitch 6 o'clock. 3. Soft Tissue: Right anterior mucosa margin. 4. Soft Tissue: Right superior mucosae margin. 5. Soft Tissue: Right inferior mucosae margin. 6. Soft Tissue: Deep margin. 7. Soft Tissue: Right portion mucosae margin. 8. Soft Tissue: Right neck level 2B. 9. Soft Tissue: Cotents right neck. DIAGNOSIS. 1. Right parotid duct: - Soft tissue, negative for malignancy. 2. Right buccal; resection: - Squamous cell carcinoma, moderately differentiated. a. Tumour maximum dimension 2.5 cm. b. Tumour maximum thickness 0.7 cm. C. Perineural invasion is present. d. No lymphovascular invasion identified. e. All margins, negative for malignancy (= 0.5 cm). 3. Right anterior mucosa margin: - Squamous mucosa, negative for malignancy. 4. Right superior mucosa margin: - Squamous mucosa, negative for malignancy. 5. Right inferior mucosa margin: - Squamous mucosa, negative for malignancy. 6. Deep margin: Page : 1 of 5. Service: : Otolaryngology. Resulted: Facility: - Skeletal muscle, negative for malignancy. 7. Right posterior mucosa margin: Squamous mucosa, negative for malignancy. 8. Right neck, level IIB: Two lymph nodes, negative for malignancy (0/2) . 9. Right neck contents: - Twenty-one lymph nodes, negative for malignancy (0/21). - Submandibular gland, negative for malignancy. SYNOPTIC DATA. Specimen Type: Resection:right buccal cavity. Tumor Site: Oral Cavity. Histologic Type : Squamous cell carcinoma, conventional. Tumor Size: Greatest dimension: 2.5 cm. Tumor thickness: 0. cm. Histologic Grade: G2: Moderately differentiated. Venous/Lymphatic (Large/Small Vessel) Invasion (V/L) : Absent. Perineural Invasion: Present. Margins: Margins uninvolved by tumor. Pathologic Staging (pTNM) : pT2: Tumor of lip or oral cavity. more than 2 cm but not more than 4 cm in greatest dimension. pNO: No regional lymph node. metastasis for aerodigestive sites. Number of regional lymph nodes. examined: 23. Number of regional lymph nodes. involved: 0. pMX: Distant metastasis cannot be. assessed. Pathologic Staging is based on AJCC/UICC TNM, 6th Edition. Page: 2 of 5. Service: Otolaryngology. Resulted: Facility: GROSS DESCRIPTION. 1. The specimen container labeled with the patient' S name and as ""Right. Parotid Quick Section"", contains a piece of tissue measuring 0.5 x 0.4 x. 0.4 cm. received in 10% buffered formalin. 1A submitted in toto. 2. The specimen labeled with the patient's name and as ""Right Buccal. Tumour Double Short, 12 O'clock, Double Long 3 o'clock Single Long 9. o' clock Blue Stitch 6 o' clock consists of a piece of buccal mucosa,. oriented with 4 sutures. The specimen measures 4.0 cm in 12-6 o'clock. dimensions x 4. 1 cm in 3-9 o'clock dimension x 1.4 cm in thickness. There is an elevated ulcerated brown lesion measuring 2.5 cm 12-6 o' clock. x. 2.4 cm 3-9 o' clock x 0.7 cm depth and is located 0.6 cm from the 12. clock margin, 1.1 from the 3 o'clock margin, 0.8 cm from the 6 o' clock. margin, 1.2 cm from the 9 o' clock margin and 1.0-cm from the deep. margin. The surgical margins are painted with silver nitrate. Two. pieces of tumor and normal tissue is stored frozen. Representative sections are submitted as follows: 2A deep margin taken at frozen section. 2B tumor with 12 o' clock margin. 2C tumor with 3 o' clock margin. 2D tumor with 6 clock margin. 2E tumor with 9 o' clock margin. 2F tumor with deep margin. 3. The specimen container labeled with the patient' S name and as ""RT. Anterior Mucosal Margin"", contains a piece of tissue measuring 1.0 x 0.5. x 0.4 cm. received in 10% buffered formalin. 3A submitted in toto,. 4. The specimen container labeled with the patient' S name and as ""RT. Superior Mucosal Margin "", contains a piece of tissue measuring 1.3. x. 0.4 x 0.4 cm. received in 10% buffered formalin. 4A submitted in toto,. 5. The specimen container labeled with the patient' s name and as ""RT. Page: 3 of 5. Service: Otolaryngology. Visit #: : Resulted: Facility: Inferior Mucosal Margin"", contains a piece of tissue measuring 1.3 x 0.2. x 0.2 cm. received in 10% buffered formalin. 5A submitted in toto. 6. The specimen.container labeled with the patient' s name and as ""Deep. Margin "", contains a piece of tissue measuring 0.5 x 0.4 x 0.3 cm. received in 10% buffered formalin. 6A submitted in toto. 7. The specimen container labeled with the patient' s name and as ""RT. Posterior Mucosal Margin"", contains a piece of tissue measuring 1.1 x 0.1. x 0.1 cm. received in 10% buffered formalin. 7A submitted in toto. 8. The specimen labeled with the patient's name and as ""RT Neck Labeled. 2B.' consists of a piece of fibroadipose tissue that measures 1.5 x 1.5 x. 0.5 cm. 8A submitted in toto. 9. The specimen labeled with the patient's name and as ""Contents RT Neck"". consists of a standard right neck dissection received orientated on a. green towel with overall dimensions of 10.4 x 7.2 x 2.0 cm. The internal. jugular vein is not grossly identified. The sternocleidomastoid is. unremarkable and measures 3.0 x 2.9 x 0.9 cm. The submandibular gland. measures 4.3 x 2.8 x1.7 cm and is unremarkable. Multiple lymph nodes. ranging from 0.4 to 1.4 cm are identified in multiple levels. Representative sections are submitted. Level 1A. 9A query one lymph node. 9B submandibular gland. Level 1B. 9C submandibular gland. 9D query lymph node trisected. 9E query two lymph nodes. Level 2A. 9F 2 lymph nodes. 9G 1 lymph node bisected. 9H 1 lymph node bisected. Level 2B. 9I two lymph nodes. Level 3. Page: 4 of 5. Patient Name: : Service: Otolaryngology. Resulted: Facility: 9J one lymph node. Level 4. 9K one lymph node bisected. 9L-9N multiple lymph nodes. 90 one lymph node bisected. 9P query one lymph node bisected. QUICK SECTION. 1. Right parotid duct Negative for malignancy. 2. Right buccal resection (deep margin for. Negative for malignancy . 3-7: Margins (right anterior mucosal, right superior mucosal, right. inferior mucosal, deep and right posterior mucosal) : - Negative for malignancy . Called at. Page: 5 of 5.",T2,N0,M0,T2N0M0
TCGA-B6-A0IG,"Fatient. Surgical Pathology: Final. CLINICAL HISTORY: Breast cancer. GROSS EXAMINATION: A. ""Left breast and axilla"", received fresh. The specimen is a 22.7 x 11.5. x. 2.5 cm mastectomy specimen. The overlying skin ellipse measures 17.0 x 11.0. cm, and includes a 5.5 cm areola and 1.0 cm nipple. A well-healed 3.0 cm scar. is noted just superior to the areola in the upper inner quadrant. The. specimen includes an axillary tail which measures 11.0 cm x 7.0 cm. The. margins of the specimen are inked in blue, and the specimen is serially. sectioned to reveal a 3.5 x 3.5 x 3.0 cm tumor in the upper inner quadrant,. extending medially to the upper outer quadrant. The tumor is firm,. tannish-white, with a gritty consistency. It appears to be infiltrating. adjacent tissue. Tissue has been sent for estrogen and progesterone receptor. assays. The tumor approaches to 1 cm of the deep margin. It approaches to. 1.0 cm to the lateral margins. The remainder of the breast tissue is composed. of lobular adipose tissue intermixed with reddish pink fibrous tissue. There. is an area of dense white fibrous breast tissue in the upper outer quadrant. The axillary tail measures 13.5 x 8.0 cm. It is composed of yellow lobular. adipose tissue. Several nodes are identified grossly. A 3.1 x 1.0 cm node is. sectioned to reveal a firm 2.0 x 1.0 cm tan-white mass. The axillary tail is. amputated, divided into three sections and searched for lymph nodes which are. submitted as described below. Block Summary: A1- section of skin through nipple and areola. A2- section of breast through overlying skin with scar. A3- section of deep margin of tumor. A4- section of deep margin of tumor. A5- section of lateral margin of tumor. A6- section of tumor. A7- section of tumor. A8- section of tumor, with possible biopsy cavity. A9- tissue from the upper inner quadrant. A10- tissue from the lower inner quadrant. A11- tissue from lower outer quadrant. A12- tissue from upper outer quadrant. A13-one grossly positive lymph node, section I. A14-one lymph node, sectioned, section I. A15- six lymph nodes, section II. A16- three lymph nodes, section II. A17 one lymph node , sectioned, section II. A18- three lymph nodes, section III. A19- one lymph node, sectioned, section III. A20- three lymph nodes, section III. MICROSCOPIC EXAMINATION: The previous biopsy site is located in the center of a large tumor mass. consisting of infiltrating ductal carcinoma. Positive lymph nodes are. identified in the axillary tail in the following distribution: low axillary. tail, 2/2 (one macroscopically positive with extracapsular extension) ; mid. axillary tail, 2/8; high axillary tail, 0/6. DIAGNOSIS: A. ""LEFT BREAST AND AXILLA""; MODIFIED RADICAL MASTECTOMY: 1. RESIDUAL INFILTRATING DUCTAL CARCINOMA, NSABP NUCLEAR GRADE 2/3,. eBrowser Result for. 1 of 2. HISTOLOGIC GRADE 3/3. 2. RESIDUAL TUMOR SIZE 3.5 x 3.5 x 3.0 CM. 3. FOCAL DUCTAL CARCINOMA IN SITU, COMEDO TYPE. 4. FOCAL VASCULAR INVASION IS IDENTIFIED. 5. NIPPLE, NO PAGET'S DISEASE IDENTIFIED. 6. SKIN WITH HEALING SCAR. NO DERMAL LYMPHATIC INVASION IDENTIFIED. 7. ALL SURGICAL MARGINS ARE FREE OF TUMOR. 8. REMAINING BREAST WITH PAPILLARY APOCRINE METAPLASIA, CYSTIC CHANGE, AND. INTER- AND INTRALOBULAR FIBROSIS. 9. METASTATIC ADENOCARCINOMA INVOLVING 4 OF 16 TOTAL AXILLARY LYMPH NODES. ONE LYMPH NODE IN THE LOW AXILLA IS MACROSCOPICALLY POSITIVE AND. EXHIBITS EXTRACAPSULAR INVASION BY TUMOR. 2 of 2.",T2,N1,M0,T2N1M0
TCGA-AA-A01Z,"This tumor is a poorly differentiated invasive adenocarcinoma (in this case, ascending. carcinoma, G3), with infiltration of the fatty connective tissue and lymph vessel. invasions, L 1. The resection margins are free resection margins, orally of the ileum. type, distally of the colon type with corresponding three layers of mucosa, submucosa. and muscularis. The ligature consists of fatty connective tissue with vascular components. The lymph nodes are free lymph nodes, pN0 (0 of 12). Tumor classification: ICDO-DA-M 8140/3. G3. pT3, pN0, MX, L1.",T3,N0,M0,T3N0M0
TCGA-BA-4075,"Diagnosis: A: Tongue and mandible, total glossectomy. - Invasive squamous cell carcinoma. - Histologic grade Moderately differentiated, with surface. necrosis. - No in situ component identified. - Tumor size: 6.0 cm. - Depth of invasion: 1.3 cm. - Invasion of associated minor salivary gland: Positive. - Lymphovascular invasion: Positive. - Perineural invasion: Positive, extensive. - Associated bone : Negative for tumor. - Lymph nodes: Negative (0/10) . - Margins: Positive (tumor undermines intact mucosa at. anterior margin) All other margins are negative. B: Right neck Level II lymph nodes, removal. - Negative for tumor (0/17) . C: Right neck Level III lymph nodes, removal. - Negative for tumor (0/11) . D: Right neck Level IV lymph nodes, removal. - Negative for tumor (0/5) . - Benign skeletal muscle. E: Right neck Level V lymph nodes, removal. - Negative for tumor (0/5). F: Porta-cath, removal. - Catheter. - Gross evaluation only. Clinical History: persistent tongue cancer. Gross Description: Received are six appropriately labeled containers. Container A: Specimen fixation: formalin. Type of specimen: total glossectomy with neck dissection. Size of specimen: The specimen consists of a composite. resection consisting of right mandible (8. 5 X 3.5 X 0.9 cm). and the entire tongue (14.0 X 6.0 X 3.0 cm). Attached to. the inferior aspect of the mandible is a pedicle of. yellow/tan soft tissue that measures 6.5 X 2.0 X 0.8 cm. Orientation of specimen: The specimen is not oriented. The. margins are inked as follows: anterior/green,. posterior/blue, lateral/orange, inferior/yellow, deep/black. Tumor description: grayish/white, ulcerative lesion. Location of tumor: The tumor is situated at the tongue. root, right floor of the mouth, and right tonsillar fossa. Tumor size: 6.0 X 2.5 X 1.5 cm. Extent of tumor: The tumor extends along the entire right. lateral mucosal surface to grossly involve the anterior. soft tissue margin of resection. On cut section, the tumor. extends into the vertical muscle of the tongue to a depth. of 1.3 cm. Presence/absence of bone involvement: The tumor abuts the. submandibular fossa, does not grossly appear to be invading. into the bone. Distance of tumor from surgical margins: The tumor grossly. involves the anterior soft tissue margin of resection. Description of remainder of tissue: Embedded within the. soft tissue pedicle, extending from the inferior aspect of. the mandible, are seven apparent tan/brown lymph nodes that. measure up to 0.4 cm. In addition, the inferior aspect of. the mandible has what appears to be a segment of possible. submandibular gland that measures 2.0 X 1.0 X 0.6 cm; on. cut section, two additional apparent lymph nodes are. identified that measure up to 0.4 cm. Elsewhere, the soft. tissues are unremarkable. Tissue submitted for special investigations: A small. portion of tumor and normal tissue are given to Tissue. Block Summary: A1 - left lateral gingival margin, en face. A2 - anterior soft tissue margin, en face. A3, A4 - right palatoglossal and palatatopharyngeal soft. tissue margins, en face. A5,A6 - posterior soft tissue margin, en face. A7 - inferior medial mucosal margin, en face. A8 - additional inferior margin, en face. A9 - representative deep soft tissue margin. A10 - posterior bone margin, en face. All - anterior bone margin, en face. A12, A13 - representative sections of tumor. A14 - representative section of tumor and bone. A15, A16 - additional sections of tumor. A17 - grossly unremarkable tongue. A18 - six apparent lymph nodes from soft tissue pedicle. A19 - two apparent lymph nodes from soft tissue pedicle. A20-A22 - remainder of soft tissue pedicle, entirely. submitted. A23 - representative section of possible submandibular. gland with single apparent lymph node. A24 - representative section of possible submandibular. gland with second individual apparent lymph node. Container B is additionally labeled ""right neck, Level II. lymph nodes. "" It holds a fragment of tan/yellow soft tissue. that measures 12.5 X 4.! X 1.5 cm. Embedded within the soft. tissue are 18 apparent tan/brown lymph nodes that range in. size from a few mm' S up to 1.0 cm. B1 - eleven apparent lymph nodes, entirely submitted. B2 - five apparent lymph nodes, entirely submitted. B3 - two apparent lymph nodes, entirely submitted. Container C is additionally labeled ""right neck, Level. III.'. It holds a portion of brown/gray soft tissue that measures. 7.0 X 2.5 X 1.5 cm. Embedded within the soft tissue are. eight apparent tan/brown lymph nodes that range in size. from a few mm' S up to 1.1 cm. C1 - six apparent lymph nodes, entirely submitted. C2 - two apparent lymph nodes, entirely submitted. Container D is additionally labeled ""right neck, Level IV."". It holds a portion of yellow/brown skeletal muscle that. measures 5.0 X 3.5 X 2.5 cm. A small amount of adipose. tissue is attached to the external surface. Embedded within. the adipose tissue are six apparent tan/brown lymph nodes. that range in size from a few mm' S up to 1.2 cm. The. attached surface of the skeletal muscle is unremarkable. D1 - four apparent lymph nodes, entirely submitted. D2 - single apparent bisected lymph node, entirely. submitted. D3 - single bisected apparent lymph node, entirely. submitted. Container E is additionally labeled ""right neck, Level V."". It holds a fragment of yellow/tan soft tissue that measures. 5.5 X 3.0 X 1.3 cm. Embedded within the soft tissue are. five apparent tan lymph nodes that range in size from 0.3. up to 0.8 cm. (Block E1,. Container F is additionally labeled ""porta-cath.' It holds. a white metal reservoir that measures 2.0 X 2.0 X 1.0 cm. Attached to the reservoir is a white plastic catheter that. measures 26.5 cm in length and 0.2 cm in diameter. Inscribed on the back of the metal reservoir in the. following information: Bard E03125. The specimen is for. Gross only. Light Microscopy: Light microscopic examination is performed by Dr. (Specimen A). Histologic tumor type: Invasive squamous cell carcinoma. Histologic grade: moderately differentiated, superficial. necrosis. Tumor extent: invades 1.3 cm in to skeletal muscle,. involves. minor salivary gland. Presence/absence of CIS: absent. Presence/absence of angiolymphatic space invasion: present. Presence/absence of perineural space invasion: present,. extensive. Histologic assessment of surgical margins: positive. anterior. (A2, invasive tumor undermines intact mucosa) all other. margins and bone are negative. Lymph nodes: total 0/48. A. 0/10, 4 show partial fibrosis. B. 0/17, 6 show partial fibrosis. C. 0/11, 1 with partial fibrosis. D. 0/5, no fibrosis. E. 0/5, no fibrosis. AJCC staging: PT3. PNO. pMX. This staging information is based on this pathologic. specimen and may be incomplete. A comprehensive review of. all available information is recommended to determine final. staging.",T3,N0,M0,T3N0M0
TCGA-BR-A4PF,Gross Description: Microscopic Description: Diagnosis Details: Comments: Formatted Path Reports: STOMACH TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Antrum. Tumor size: 10 x 7 x 1.5 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Serosa (visceral peritoneum). Lymph nodes: 3/8 positive for metastasis (Intraabdominal 3/8). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Tumor penetrates through all layers of stomach and invades serosa. (visceral peritoneum). Comments: None.,T4,N2,M0,T4N2M0
TCGA-BP-4964,"Clinical Diagnosis & History: vith right renal mass,. Specimens Submitted: 1: Kidnay, right, nephrectomy. 2: Lymph nodes, precaval nodes and paracaval nodes, resection. 3: Adranal gland, right, adrenectomy. DIAGNOSIS: 1. Kidney, right, nephrectomy. Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade II/IV. Tumor Size: Greatest diameter is 3.9 cm. Local Invasion (for renal cortical types): Not Identified. the tumor abuts the renal sinus. Renal Vain Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Focal chronic inflammation. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for ranal cell carcinoma/oncocyloma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. 2. Lymph nodes, precaval nodes and paracaval nodes, rasaction. Lymph Nodes: Not involved. Number of nodes examined: 11. Number of metestatic nodes:0. 3. Adrenal gland, right, adrenectomy. Adranal gland, unremarkable. One benign lymph node. (0/1). JATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SUIDES (AND/OR OTHER MATERIAL), AND THAT THAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). Tha specimen is received fresh for frozen section consultation labeled ""right kidney"" and consists of a kidney with attached. ureter, renal vassels and perinaphric fat weighing 317.0 g in total. The kidney measures 9.6 x 6,6 x 4.0 cm. The attached ureter. measures 5,0 cm in langth and 0.3 cm in diameter. The attached renal vein maesures 3.0 cm in length and 0.6 cm in diamater. The renal vessals and ureter margins are grossly unremarkable. An adrenal gland is not identified. The kidney is inked black and. bivalved to reveal a variegated yellow and hemorrhagic well-circumscribed mass with cystic areas measuring 3.9 x 3.0 x 2.g cm. The lesion abuts but does not invade the capsule, and compresses the renal pelvis. The mess is located in the mid region adjacent. to the pelvis. Sections through the remainder of the kidney reveal a pink brown parenchyma, with a well-defined cortico-medullary. junction. Tha cortex measures 0.6 cm and the calyces appear norma). No definitive lymph nodes are identified in the. parinaphric. fat. Representative sections are submitted for TPS and for permanent sactions. Summery of sections: UVM - ureteral and vessel mergins. T-- tumor. TSF -- tumor with sinus fat. TK -- tumor with adjecent kidney. RP -- renal pelvis representativa sections. K -- representative sections kidney. F-adpose tissue. FSC-frozen section control. 2). The specimen is received in formalin is labeled ""pre-caval and paracavel lymph nodes"" and consists of multiple lymph nodes. with attached fat meesuring 4.0 x 3.5 x 0.4 cm in aggregate. Entirely submitted. Summary of sections: LN-lymph nodes. 3). The specimen is received in formalin is labaled ""right adrenal gland"" and consists of an adrenal gland with atteched fat. measuring 7.0 x 2.5 x 0,4 cm. Each from the weight of the adrenal gland is 10.5 g. On cut section the adrenal gland has an. unremarkable cortex and medulle. An attached soft tan black lymph node is identified to the surface of the adrenal measuring 2.0. x. 1.5 x 0,5 cm. Representative sections are submitted. Summery of sactions: A-adrenal gland. L-lymph node. Summary of Sections: Part 1: Kidney, right, nephrectomy. Block. Sect. Site. PCs. 1. f. 1. fsc. 1. 1. 1. 2. 2. 6. t. 6. 1. tk. 2. itsf. 2. 1. uvm. 1. Part 2: Lymph nodes, precaval nodes and paracaval nodes, resection. Block. Sect. Site. PCs. 6. In. 6. Part 3: Adrenal gland, right, adrenectomy. Block. Sect. Site. PCs. 2. a. 2. 1. I. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the lissue sample examined at the time of the intraoperative. consultation. FROZEN SECTION DIAGNOSIS RENAL CELL CARCINOMA, CONVENTIONAL TYPE. PERMANENT DIAGNOSIS: SAME.",T1,N0,M0,T1N0M0
TCGA-IN-A6RP,"FINAL DIAGNOSIS: PART 1: SOFT TISSUE, LEFT GASTRIC ARTERY, EXCISION -. A. MATURE ADIPOSE TISSUE. B. THERE IS NO EVIDENCE OF MALIGNANCY. PART 2: LYMPH NODE, BASE OF LEFT GASTRIC ARTERY, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 3: LYMPH NODE, BASE OF LEFT GASTRIC ARTERY, EXCISION -. A. MATURE ADIPOSE TISSUE. B. THERE IS NO EVIDENCE OF MALIGNANCY. PART 4: SOFT TISSUE, LEFT GASTRIC ARTERY, EXCISION -. POSITIVE FOR ADENOCARCINOMA. PART 5: SOFT TISSUE, LEFT GASTRIC ARTERY, EXCISION -. A. METASTATIC ADENOCARCINOMA TO ONE LYMPH NODE (1/1). B. EXTRANODAL LYMPHOVASCULAR INVASION PRESENT. PART 6: SOFT TISSUE, BASE OF LEFT GASTRIC ARTERY AND VEIN, EXCISION -. METASTATIC ADENOCARCINOMA TO THREE OF FIVE LYMPH NODES (3/5). PART 7: LYMPH NODE, LEVEL-7, NEAR BRONCHUS INTERMEDIUS, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 8: LYMPH NODE, LEVEL-7, NEAR TAKEOFF RIGHT LOWER LOBE, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 9: LYMPH NODE, LEVEL-7, NEAR CARINA, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN TWO LYMPH NODES (0/2). PART 10: LYMPH NODE, PARAESOPHAGEAL, NEAR DIAPHRAGM, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE REACTIVE LYMPH NODE (0/1). PART 11: LYMPH NODE, PARAESOPNAGEAL, NEAR PERICARDIUM, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 12: LYMPH NODE, PARAESOPHAGEAL, NEAR THORACIC DUCT, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE REACTIVE LYMPH NODE (0/1). PART 13: ESOPHAGUS AND STOMACH, ESOPHAGOGASTRECTOMY- -. A. ADENOCARCINOMA, MODERATELY TO POORLY DIFFERENTIATED (5.5CM) CENTERED IN DISTAL. ESOPHAGUS, INVOLVING THE SUBMUCOSA OF THE GASTROESOPHAGEAL JUNCTION AND STOMACH. B. NO MUSCULARIS PROPRIA INVOLVEMENT. C. STOMACH WITH FOCAL INTRAEPITHELIAL HIGH GRADE DYSPLASIA. D. UNREMARKABLE ESOPHAGEAL SQUAMOUS MUCOSA. E. LYMPHOVASCULAR AND PERINEURAL INVASION IDENTIFIED. F. PROXIMAL ESOPHAGEAL AND DISTAL GASTRIC AND ADVENTITIAL SURGICAL RESECTION MARGINS ARE. FREE OF TUMOR. G. METASTATIC ADENOCARCINOMA TO SEVEN OF TWENTY-EIGHT LYMPH NODES (7/28). H. PATHOLOGIC STAGE; pT1b N3 (SEE SYNOPTIC NOTE). I. IMMUNOHISTOCHEMICAL STAIN TO HER2 IS PENDING (SLIDE 13E). PART 14: STOMACH, GASTRIC RINGS, EXCISION -. A. UNREMARKABLE SEGMENT OF ESOPHAGUS AND STOMACH. B. THERE IS NO EVIDENCE OF MALIGNANCY. PART 15: STOMACH, FINAL GASTRIC MARGIN, EXCISION -. A. UNREMARKABLE SEGMENT OF STOMACH. B. THERE IS NO EVIDENCE OF MALIGNANCY. PART 16: SOFT TISSUE, GASTROESOPHAGEAL FAT, EXCISION -. A. MATURE ADIPOSE TISSUE. B. THERE IS NO EVIDENCE OF MALIGNANCY. PART 17: LYMPH NODE, NEAR GE-JUNCTION, EXCISION -. METASTATIC ADENOCARCINOMA TO ONE LYMPH NODE (1/1). PART 18: LYMPH NODE, MID PARAESOPHAGEAL, EXCISION -. METASTATIC ADENOCARCINOMA TO ONE LYMPH NODE (1/1). PART 19: LYMPH NODE, PROXIMAL PARAESOPHAGEAL, EXCISION -. A. BENIGN FIBROADIPOSE TISSUE. B. THERE IS NO EVIDENCE OF MALIGNANCY. PART 20: LYMPH NODE, SUBCARINAL, NEAR TRACHEA, EXCISION -. PART 21: LYMPH NODE, SUBCARINAL, ESOPHAGUS, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN FIVE LYMPH NODES (0/5). THERE IS NO EVIDENCE OF MALIGNANCY IN TWO LYMPH NODE (0/2). PART 22: LYMPH NODE, SUBCARINAL, NEAR AZYGOUS, EXCISION - -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 23: LYMPH NODE SUBCARINAL LYMPM NODE, EXCISION -. Addendum. THERE IS NO EVIDENCE OF MALIGNANCY IN TWO LYMPH NODES (0/2). Immunohistochemical stain to HER2 shows equivocal (2+), weak to moderate membranous staining in 10% of tumor cells. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY ESOPHAGEAL TUMORS. MACROSCOPIC. SPECIMEN TYPE: Esophagogastrectorny. TUMOR SITE: TUMOR SIZE: Tumor midpoint in distal esophagus AND tumor invoives esophagogastric junction. Greatest dimension: 5.5 cm. Additional dimensions: 3 x 1.3 cm. MICROSCOPIC. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G3. PATHOLOGIC STAGING (PTNM). pN3. Number of lymph nodes examined: 28. Number of lymph nodes involved: 7. pM Not applicable. PRIOR TREATMENT: No prior treatment. MARGINS. Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (adventitial) margin uninvolved by invasive carcinoma. Distance of invesive carcinoma from closest margin: 0.7 mm. Specify margin: Adventitial margin. ANGIOLYMPHATIC INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Other: Intraepithelial high grade dysplasia and intestitnal metaplasia of. gastric mucosa. SPECIAL PROCEDURES: In Situ Procedure. Interpretation. HER2 FISH STUDIES PERFORMED ON THE ADENOCARCINOMA ARE POSITIVE. # Cells Analyzed: 100. Ratio HER2/CEP17: 2.38. SNR: 4.0. CNR: 1.7. % Hyperdiploid: 13(13.0%). Probe: HER2. DNA Probe. Probe Description: The. HER2. DNA probe is a 190 Kb. directly labeled fluorescent DNA probe. specific for the HER2. gene locus (17q11.2-q12). The CEP 17 DNA probe is a 5.4 Kb. directly labaled. fluorescent DNA probe specific for the alpha satellite DNA sequence at the centromeric region of chromosome 17 (17p11.1-q11.1). The probes are pre-mixed and pre-denatured in hybridization buffer. Interpretation: HER2 negative: HER2 gene/chromosome 17 ratio less than 2.0. HER2 positive: HER2 gene/chromosome 17 ratio greater than 2.0. Results should be considered along with other clinical information. has modified the suggested manufacturer protocal for HER2 FISH testing. The modifications have been tested and validated. The modifications are as follows: Slides are deparaffinized. Tissue is. digested in protease 31 minutes; Tissue and probe are co-denatured at 90 C for 12 minutes; Paraffin pretreatment reagents and. control slides are prepared in house. Amplified, non-amplified, and internal (centromere 17) controls were used in the testing. The. laboratory takes responsibility for the test performance. FISH analysis was manually performed and quantitatively assessed by analysis of a minimum of 60 cells using the HER2. and the CEP17. probes.",T1,N3,M0,T1N3M0
TCGA-E2-A1IH,"SPECIMENS: A. SENTINEL NODE #1 LEFT AXILLA. B. SENTINEL NODE #2 LEFT AXILLA. C. LEFT BREAST MASS WITH NEEDLE LOCALIZATION cacF : Sik. breast, NOS C509 2/8/11. D. ADDITIONAL MARGIN LEFT BREAST. SPECIMEN(S): A. SENTINEL NODE #1 LEFT AXILLA. B. SENTINEL NODE #2 LEFT AXILLA. C. LEFT BREAST MASS WITH NEEDLE LOCALIZATION. D. ADDITIONAL MARGIN LEFT BREAST. GROSS DESCRIPTION: A. SENTINEL NODE #1 LEFT AXILLA. Received fresh is a tan pink lymph node 1.5 x 1.0 x 0.7cm. The specimen is serially sectioned and one. touch prep is taken. Toto A1. B. SLN #2 LEFT AXILLA. Received fresh is a tan pink lymph node 1.0 x 0.7 x 0.5cm. The specimen is serially sectioned and one. touch prep is taken. Toto B1. C. LEFT BREAST NEEDLE LOCALIZATION. Single stitch: Anterior. Double stitch: Lateral. Triple stitch: Superior. Received fresh is a 79g oriented WLE breast specimen 2.5cm from anterior to posterior, 7.5cm from. superior to inferior and 8.5cm from medial to lateral, with needle localization wire and attached. radiograph. The specimen is inked as follows: Anterior-Blue, Posterior-Black, Superior-Red, Inferior-. Orange, Medial-Green, Lateral-Yellow. The specimen is serially sectioned from lateral to medial in to 8. slices: slice 1 being most medial, slice 8 being most lateral. The cut surfaces reveal a gray white firm. well circumscribed mass 1.5 x 1.0 x 0.8cm, 0.6cm from the closest deep margin, 0.7cm from the. anterior margin and 0.8cm from the medial margin. The mass is located in slice 2 and 3. The remaining. cut surfaces reveal yellow lobulated adipose tissue interdispersed with gray white fibrous tissue. A. portion of the specimen is submitted for tissue procurement. Representative sections are submitted as. follows: C1-C5: medial margin perpendicular sections from superior to inferior slice 1. C6: superior margin slice 2. C7: mass with anterior and deep margin slice 2. C8: inferior margin slice 2. C9: superior margin slice 3. C10: mass with anterior margin slice 3. C11: mass with deep margin slice 3. C12: inferior margin slice 3. C13: next to mass with anterior margin slice 4. C14: next to mass with deep margin slice 4. C15: slice 5. C16: lateral margin perpendicular sections slice 8. As per attached diagram. D. ADDITIONAL MEDIAL MARGIN LEFT BREAST: Stitch at new margin. Received fresh is a 4g oriented tan pink fragment of fibrofatty tissue 5.0 x 2.0 x 1.0cm. The new true. margin is inked Black and the specimen is serially sectioned to reveal grossly unremarkable breast. parenchyma. Toto D1-D4. DIAGNOSIS: A. LYMPH NODE, SENTINE# 1, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). B. LYMPH NODE, SENTINE# 2, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). C. BREAST, LEFT, WIDE LOCAL EXCISION: - INVASIVE, LOBULAR CARCINOMA, SBR GRADE 2, MEASURING 1.5 CM. - SURGICAL MARGINS ARE NEGATIVE FOR TUMOR. - SEE SYNOPTIC REPORT AND SEE NOTE. D. BREAST, LEFT, ADDITIONAL MEDIAL MARGIN, EXCISION: - BREAST TISSUE, NO TUMOR SEEN. NOTE: The tumor is negative for E-cadherin, compatible with lobular phenotype. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Yes - For mass. Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive lobular carcinoma 8520/3. Tumor size: 1.5cm. Tumor Site: Upper inner quadrant. Margins: Negative. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/2. DCIS not present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Pending by FISH. Pathological staging (pTN): pT 1c N 0. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: ER: Positive. Allred Score: 8 = Proportion Score 5. +. Intensity Score 3. PR: Positive. Allred Score: 8 = Proportion Score 5 + Intensity Score 3. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by. following the manufacturer s instructions. This. assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Surgical Excision. Block Number: Interpretation: EQUIVOCAL. Intensity: 2+. % Tumor Staining: 20%. Fish Ordered: METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Her2 analysis was performed using the FDA approved Dako HercepTest (TM) test kit. using rabbit anti-human HER2. This assay was not modified. External kit-slides. provided by the manufacturer (cell lines with high, low and negative HER2 protein expression) and in-. house known HER2 amplified control tissue were evaluated along with the test tissue. Adequate, well. preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2. immunohistochemical stain is guided by published results in the medical literature, information provided. by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the 2007 joint recommendations and guidelines from. ASCO and CAP and from the NCCN HER2 testing in Breast Cancer Task Force. takes full responsibility for this test's performance. CLINICAL HISTORY: woman with Left Breast Ca: Invasive Ductal 11 o'clock. 1.7cm on mammogram. PRE-OPERATIVE DIAGNOSIS: Left Breast Ca. INTRAOPERATIVE CONSULTATION: TPA/TPB: Negative for tumor. Diagnosis called to Dr at. by Dr. C. GROSS INSPECTION: 1.5cm mass 0.6cm from the closest deep margin, 0.7cm from anterior. margin. Diagnosis called to Dr. at. by Dr. D. GROSS INSPECTION: New medial margin. Negative for tumor. Diagnosis called to Dr. at. 1 by. Dr. ADDENDUM: FISH for HER-2 amplification for this case was attempted multiple times using multiple blocks from this. case. In each instance the tissue would not remain on the slide for analysis. As a result of this one block. will be sent to another laboratory for further testing. This case was sent to the for second opinion for HER-2 FISH. The results reported below are the. verbatim results of this referral. HER2 Amp. Breast Cancer. FISH. Specimen. Tissue-Paraffin. Specimen ID. Source. Left breast. Reason For Referral. r/o HER2 gene amplification. Fixative. Formalin. Method: FISH using probes for HER2 (17q12) and a chromosome 17 centromere (D17Z1) control probe. (PathVysion,. Two technologists score signals in 60 total nuclei from invasive or. metastatic tumor and concurrent controls. nuc ish (D17Z1x2, Her2x3-5). The HER2 to D17Z1 ratio is 2.28. Interpretation: The invasive tumor nuclei have an amplified HER2D17Z1 ratio (per ASCO/CAP. The HER2D17Z1 ratio is 2.28. In our opinion, this result may not. guidelines). reflect centromere true HER2 and amplification. 3-5 copies of Most the HER2 nuclei gene. have 2 This copies result of the indicates chromosome the. 17 tumor has. additional copies of the HER2 gene (i.e., duplication), but does not have sufficient. copies to suggest high level HER2 amplification. It is not known if HER2. duplication is associated with HER2 over-expression in breast adenocarcinoma. ASCO/CAP reporting guidelines (Wolff et al, Arch Path Lab Med 131:18-43, 2007). A HER2D17Z1 ratio less than 1.8 indicates absence of HER2 gene amplification. A HER2D17Z1 ratio from 1.8-2.2 is equivocal for HER2 gene amplification. A HER2D17Z1 ratio greater than 2.2 indicates HER2 gene amplification. DISCLAIMER: This test was developed and its performance characteristics determined. by Laboratory Medicine and Pathology, It is intended as. an adjunct to existing prognostic clinical and pathologic information for breast cancer. patients. This test is not intended to diagnose or screen for breast cancer. Per ASCO/. CAP guidelines, HER2FISH test results are valid for non-decalcified paraffin embedded. specimens fixed in 10% neutral buffered formalin between 6 and 48 hours. Results from. specimens fixed outside these parameters should be interpreted accordingly. Consultant. Report Data. Microscopic/Diagnostic Dictation: M.D., Pathologist,. Microscopia/Diagnostic Dictation: M.D., Pathologist. Final Review: M.D., Pathologist,. Final:, M.D., Pathologist,. Addendum: M.D., Pathologist,. Addendum Final: M.D., Pathologist, I. Addendum: M.D., Pathologist. Addendum Review: M.D., Patnologi: Addendum Final: M.D., Pathologist,.",T1,N0,M0,T1N0M0
TCGA-KL-8334,"Clinical Diagnosis & History: vear old female with left renal mass. Left radical nephrectomy. Specimens Submitted: 1: Soft tissue, para-aortic dissection superior margin, biopsy. 2: Kidney and para-aortic lymph nodes, left, radical neprhectomy. 3: Rib, portion of ninth, segmental excision. 4: Lymph nodes, interaortacaval, excision. DIAGNOSIS: 1. Soft tissue, para-aortic dissection superior margin, biopsy. Benign fragment of ganglion and nerve. 2. Kidney and para-aortic lymph nodes, left, radical neprhectomy. Tumor Type: Renal cell carcinoma - Chromophobe type. Tumor Size: Greatest diameter is 17.5 cm. Local Invasion (for renal cortical types): Extends through renal capsule but confined within Gerota's fascia. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: Not involved. Lymph Nodes: Free of tumor. Number of nodes examined:2. Staging for renal cell carcinoma/oncocytoma: pT3 Tumor extends into major veins or invades the adrenal gland or perinephric tissues, but not beyond Gerota's. fascia. 3. Rib, portion of ninth, segmental excision. Benign bone and bone marrow elements. 4. Lymph nodes, interaortacaval, excision. Lymph Nodes: Not involved. Number of nodes examined:4. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. RECUT. Gross Description: 1) The specimen is received fresh for frozen section consultation, labeled, ""Para-aortic dissection superior margin"", and consists. of a piece of cylindrical soft tissue measuring 1.1 x 0.3 x 0.3 cm. It contains multiple metal clips. Cut section shows rubbery. red-tan appearance. The specimen is entirely frozen. Summary of sections: FSC - frozen section control. 2). The specimen is received fresh, labeled, ""Left kidney and para-aortic lymph nodes"". It consists of a kidney. with. surrounding perirenal adipose tissue and adrenal gland weighing 1900g and measuring 21.0 x 17.0 x 7.0 cm. The specimen is. bivalved revealing a large yellow-red mass with focal areas of fibrosis measuring 17.5 x 17.0 x 7.0 cm. It occupies. a. predominance of the kidney with only a small portion of uninvolved renal parenchyma present which measures 4.5 x 4.5 cm. in. maximal dimensions. Serial sectioning of the mass reveals it to extend through the renal capsule but the mass appears still. encapsulated itself. The tumor is serially sectioned revealing focal areas of yellow discoloration grossly consistent with. calcifications. The perirenal and peritumoral adipose tissue is serially sectioned revealing a V-shaped adrenal gland with. hemorrhage measuring 4.5 x 2.5 x 0.6 cm. The adrenal gland appears grossly free of tumor. The specimen includes a portion of. adipose tissue containing multiple red-tan lymph nodes ranging from 0.5 to 2.8 cm in greatest dimension. The 2.8 cm and 1.2 cm. lymph node are both bisected. All identified lymph nodes are submitted for histologic evaluation. Representative portions of the. tumor are submitted fo. Representative portions of the specimen are submitted for histologic evaluation. Summary of Sections: HM - vascular hilar margins. KID - kidney without tumor. AD - adrenal gland. BLN - single bisected lymph node cassettes 14 and 15. LNS - additional lymph nodes. BLN - single bisected lymph node cassette 17. T - tumor. 3). The specimen is received fresh, labeled, ""Portion of ninth rib"". It consists of a curvilinear fragment of rib measuring 15.0. cm in length x 1.0 cm in maximal diameter. The specimen is serially sectioned revealing essentially unremarkable rib. Representative sections of the specimen are submitted, pending decalcification. Summary of Sections: RIB - ninth rib. 4). The specimen is received in formalin, labeled, ""Interaortacaval lymph nodes"". It consists of an irregularly shaped. fragment of red-tan soft tissue and lymphoid tissue measuring 2.8 x 1.9x0.5 cm. The specimen is serially sectioned revealing. multiple lymph nodes ranging from 0.6 to 1.0 cm in greatest dimension. The specimen is entirely submitted. Summary of Sections: LNS - lymph nodes. Summary of Sections: Part. 1: Soft tissue, para-aortic dissection superior margin, biopsy. Block. Sect. Site. PCs. 1. fsc. 1. Part 2: Kidney and para-aortic lymph nodes, left, radical neprhectomy. Block. Sect. Site. PCs. 1. AD. 1. 3. BLN. 3. 1. HM. 1. 1. KID. 1. 1. LNS. 1. 10. T. 10. Part 3: Rib, portion of ninth, segmental excision. Block. Sect. Site. PCs. 1. RIB. 1. Part 4: Lymph nodes, interaortacaval, excision. Block. Sect. Site. PCs. 2. LNS. 2. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: BENIGN NERVE AND GANGLION. PERMANENT DIAGNOSIS: SAME.",T3,N0,M0,T3N0M0
TCGA-BR-6458,STOMACH TISSUE CHECKLIST. 11. Specimen type: Subtotal gastrectomy. Tumor site: Fundus. Tumor size: 0 X 0 X 8.5 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Subserosa. Lymph nodes: 1/15 positive for metastasis (Greater and lesser. omentum 1/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,T3,N1,M0,T3N1M0
TCGA-G4-6293,"SPECIMENS: A. RIGHT COLON & TERMINAL ILEUM. DIAGNOSIS: RIGHT COLON AND TERMINAL ILEUM, RESECTION (RIGHT HEMICOLECTOMY. SPECIMEN): EXOPHYTIC INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA. ARISING FROM TUBULOVILLOUS ADENOMA OF TRANSVERSE COLON WITH. FULL MUSCLE WALL THICKNESS INVASION, EXTENSION TO SUBSEROSAL. FAT AND METASTASES TO ONE OUT OF TWENTY SIX PERICOLIC LYMPH. NODES (1/26). -SIZE OF TUMOR - 5.5x3.5x1.0 cm. -PROXIMAL, DISTAL AND RADIAL MARGINS OF RESECTION - FREE OF. TUMOR. -APPENDIX - NO SPECIFIC PATHOLOGIC CHANGES - NEGATIVE FOR TUMOR. -PORTION OF OMENTAL FAT - NO SPECIFIC PATHOLOGIC CHANGES. GI Cancer Template. Tumor Size (cm): 5.5x3.5x1.0 cm. Grade/Differentiation: G2 moderate. Invasion Depth: Subserosa (not to perit. Surface). Invasion Vasc/Lymphatic: absent. Invasion Perineural: absent. Extension to adjacent areas: no. Margins: free. Lymph nodes: N1=Positive (1/26). Stage, Pathology: pT3 N1. Implants: absent. Precursor: present - tubulovillous adenoma. Non-neoplastic areas: NA. SPECIMEN(S): A. RIGHT COLON & TERMINAL ILEUM. CLINICAL HISTORY: Colon ca. GROSS DESCRIPTION: RIGHT COLON AND TERMINAL ILEUM, RESECTION: A right hemicolectomy specimen comprised of cecum, ascending and transverse colon and appendix. and short segment of terminal ileum. Colon measures 34 cm in length and with internal circumference. of 7-9 cm. Short segment of terminal ileum measures 3.5 cm in length. Situtated 5.5 cm from the distal resected margin (transverse colon area) 32 cm from proximal margin is. a fungating tumor that occupies 80% of the mucosal circumference. The tumor measures 5.5x3.5x1.0. cm. On sections, tumor grossly infiltrates muscle wall without gross extension to subserosal fat. Remainder of colonic mucosa is grossly not remarkable. There is no identifiable polyps or diverticuli. Cecum is not remarkable. Appendix measures 11 cm in length and external diameter of 0.5 cm. Grossly, appendix is not. remarkable. Attached portion of omentum measures 8x7x0.9 cm. Cut section shows no indurated focus. Approximately 5 lymph nodes are dissected ranging in size from 0.1 cm to 1x0.5x0.6 cm. Multiple sections submitted as follows: A1-A5: tumor. A6: proximal ileal margin. A7; distal colonic margin. A8: representative section of colonic mucosa distal to the tumor. A9: representative section of colonic mucosa proximal to the tumor and ileocecal valve. A11: four lymph nodes from portion near tumor. A12: four lymph nodes from portion near tumor. A13: four lymph nodes from portion near tumor. A14: one serially sectioned lymph node from portion near tumor. A15: five lymph nodes from middle portion of colon. A16: five lymph nodes from middle portion of colon. A17: one serially sectioned lymph node from middle portion of colon. A18: five lymph nodes from ileocecal junction. A19: six lymph nodes from ileocecal junction. ADDENDUM: ANALYSIS OF MLH1 AND MSH2 PROTEIN EXPRESSION. MLH1 Expression: Present. MSH2 Expression: Present. Tissue from this patient was retrieved from the archive and analyzed for these tumor markers. Expression of MLH1 and MSH2 in the tumor was evaluated by immunohistochemistry. Peritumoral. lymphocytes serve as an internal positive control expressing both MLH1 and MSH2. Testing for Microsatellite Instability has been ordered. The results will be issued in a separate report.",T3,N1,M0,T3N1M0
TCGA-CR-7399,"DIAGNOSIS: 1) LARYNX, BIOPSY: POORLY DIFFERENTIATED CARCINOMA. 2) LARYNX, LEFT HYPOPHARYNX MARGIN, LARYNGECTOMY: NEGATIVE FOR MALIGNANCY. 3) LARYNX, LEFT OROPHARYNX MARGIN, LARYNGECTOMY NEGATIVE FOR MALIGNANCY. 4) LARYNX, LEFT BASE OF TONGUE MARGIN, LARYNGECTOMY: NEGATIVE FOR. MALIGNANCY. 5) LARYNX, POSTCRICOID MARGIN, LARYNGECTOMY: NEGATIVE FOR MALIGNANCY. 6) LARYNX, RIGHT HYPOPHARYNX MARGIN, LARYNGECTOMY NEGATIVE FOR MALIGNANCY. 7) LARYNX, RIGHT OROPHARYNX MARGIN, LARYNGECTOMY: NEGATIVE FOR MALIGNANCY. 8) LARYNX, RIGHT BASE OF TONGUE MARGIN, LARYNGECTOMY: NEGATIVE FOR. MALIGNANCY. 9) LYMPH NODES, LEVEL 1A, EXCISION: 2 LYMPH NODES, NEGATIVE FOR MALIGNANCY. 10) LYMPH NODE, LEFT JUGULAR FORAMEN, EXCISION: 1 LYMPH NODE, NEGATIVE FOR. MALIGNANCY. 11) LYMPH NODES, LEFT LEVEL 2, 3, 4 AND 5, EXCISION: 3 OF 20 LYMPH NODES. INVOLVED BY CARCINOMA; LARGEST AT LEVEL ii, 4.8 CM IN GREATEST DIMENSION;. NEGATIVE FOR EXTRANODAL EXTENSION. 12) LYMPH NODES, LEFT LEVEL 1B, EXCISION: 1 OF 5 LYMPH NODES INVOLVED BY. CARCINOMA, 0.6 CM IN GREATEST DIMENSION, NEGATIVE FOR EXTRANODAL EXTENSION;. SALIVARY GLAND NEGATIVE FOR MALIGNANCY. 13) LYMPH NODES, RIGHT LEVEL 2, 3, 4 AND 5, EXCISION: 2 OF 23 LYMPH NODES. INVOLVED BY CARCINOMA; LARGER AT LEVEL III, 4.6 CM IN GREATEST DIMENSION,. WITH EXTRANODAL EXTENSION OF TUMOR. 14) LYMPH NODES, RIGHT SUPERIOR MEDIASTINUM, EXCISION: 1 LYMPH NODE,. NEGATIVE FOR MALIGNANCY. 15) LYMPH NODES, RIGHT LEVEL 1B, EXCISION: 5 LYMPH NODES, NEGATIVE FOR. MALIGNANCY; SALIVARY GLAND, NEGATIVE FOR MALIGNANCY. 16) SOFT TISSUE, RIGHT PERISTOMAL, EXCISION: SKIN AND SKELETAL MUSCLE WITH. ORGANIZED GRANULATION TISSUE, NEGATIVE FOR MALIGNANCY. 17) LARYNX, LARYNGECTOMY: POORLY DIFFERENTIATED SUPRAGLOTTIC SQUAMOUS CELL. CARCINOMA, 2.3 CM IN GREATEST DIMENSION, INVADING PRE-EPIGLOTTIC SPACE;. PRESENT 0.1 CM FROM RIGHT MUCOSAL AND SOFT TISSUE RESECTION MARGINS; ALL. SURGICAL MARGINS NEGATIVE FOR MALIGNANCY, NEGATIVE FOR EXTENSION INTO VOCAL. CORDS OR THYROID CARTILAGE, (SEE COMMENT). Comment: These findings correspond to AJCC stage IV A (pT3, N2c, Mn/a). disease. CLINICAL DATA. Clinical Features: Unspecified. Operator: Operation: Unspecified. Operative Findings: Unspecified. Operative Diagnosis: Unspecified. Tissue Submitted: 1) Larynx; 2) Left hypopharynx margin; 3). Left oropharynx margin; 4) Left base of. tongue; 5) Postcricoid margin; 6) Right. hypopharynx margin; 7) Right oropharynx. margin; 8) Right base of tongue; 9) Neck. nodes level 1A; 10) Left jugular foramen. node; 11) Left neck level 2, 3, 4, 5; 12). Left neck level 1B; 13) Right neck level. 2, 3, 4, 5; 14) Right superior. mediastinal lymph node; 15) Right neck. dissection level 1B; 16) Right peristomal. tissue; 17) Laryngeal cancer. GROSS DESCRIPTION: 1) SOURCE: Larynx. Received fresh are two fragments of tan soft tissue measuring 1.0 X 0.4 X. 0.4 cm. The specimens are submitted in their entirety for frozen-section. analysis. Summary of sections: 1AFSC, 2/1. 2) SOURCE: Left Hypopharynx Margin. Received fresh is a 2.9 X 0.2 X 0.2 cm strip of mucosa. The specimen is. inked black and submitted in its entirety for frozen-section analysis. Summary of sections: 2AFSC, 1/1. 3) SOURCE: Left Oropharynx Margin. Received fresh is a 3.7 X 0.2 X 0.2 cm fragment of pink-tan mucosa. The. specimen is submitted in its entirety for frozen-section analysis. Summary of sections: 3FSC, 1/1. 4) SOURCE: Left Base of Tongue. Received fresh is a 2.8 X 0.4 X 0.3 cm fragment of pink-tan mucosa. The. specimen is inked black and submitted in its entirety for frozen-section. analysis. Summary of sections: 4FSC, 1/1. 5) SOURCE: Postcricoid Margin. Received fresh is a 3.2 X 0.2 X 0.2 cm fragment of pink-tan mucosa. The. specimen is submitted in its entirety for frozen-section analysis. Summary of sections: 5AFSC, 1/1. 6) SOURCE: Right Hypopharynx. Received fresh is a 4.5 X 0.2 X 0.2 cm fragment of pink-tan mucosa. The. specimen is inked black and submitted in its entirety for frozen-section. analysis. Summary of sections: 6AFSC, 1/1. 7) SOURCE: Right Oropharynx. Received fresh is a 4.6 X 0.2 X 0.2 cm fragment of pink-tan mucosa. The. specimen is submitted in its entirety for frozen-section analysis. Summary of sections: 7AFSC, 1/1. 8) SOURCE: Right Base of Tongue. Received fresh is a 4.9 X 0.2 X 0.2 cm fragment of pink-tan soft tissue. The specimen is submitted in its entirety for frozen-section analysis. Summary of sections: 8AFSC, 1/1. 9) SOURCE: Neck Nodes Level 1A. Received fresh is as single portion of yellow-pink adipose tissue measuring. 3.7 X 3.5 X 0.8 cm. The specimen is submitted in its entirety. Summary of sections: 9A, 9B, 2/1 each; 9C, 1/1. 10) SOURCE: Left Jugular Foramen Node. Received fresh is a single pink-tan lymph node measuring 1.3 X 0.6 X 0.4. cm. The specimen is submitted in its entirety. Summary of sections: 10A, 1/1. 11) SOURCE: Left Neck Level 2,3,4,5. Received fresh is a single complicated specimen consisting of soft tissue. and embedded lymph nodes measuring 14.0 X 6.0 X 2.8 cm. A thorough search. is made for the lymph nodes and all lymph node candidates identified are. submitted. The largest node that is present measures 4.8 X 2.8 X 2.2 cm and. is firm and white on its external surface. Serial sectioning reveals. homogeneous white firm tan interior. In the level 3 area is a single white,. firm, nodular mass measuring 4.2 X 1.8 X 1.5 cm. Cross sectioning of this. specimen reveals homogeneous white firm interior. Summary of sections: 11A, large level 2 /lymph node, 1/1; 11B-11D,. additional tissue from level 2, M/1 each; 11E, large level 3 lymph node,. two slices, 2/1; 11F, 11G, additional level 3 lymph node candidates, M/1. each; 11H, level 4 lymph node candidates, M/1; 11I, level 5 lymph node. candidates, M/1. 12) SOURCE: Left Neck Level IB. Received fresh is a large portion of brown-tan salivary tissue and adherent. yellow soft tissue and lymph nodes measuring 6.5 X 4.0 X 2.0 cm. A thorough. search of the specimen is made of the lymph nodes. All lymph node. candidates identified are submitted in their entirety. Summary of sections: 12A, lymph node candidates, 3/1; 12B, lymph node. candidates, 2/1; 12C, section of salivary gland, 1/1. 13) SOURCE: Right Neck Level 2,3,4,5. Received fresh is a complicated neck section specimen with portion of the. jugular vein and sternocleidomastoid muscle measuring 13.0 X 5.5 X 3.0 cm. The specimen is grossly remarkable for several large white firm nodes with. homogeneous white cut surfaces. One at level 3 measures 4.6 X 2.0 X 1.8 cm. Another at level 4 measures 3.4 X 2.0 X 1.8 cm. Representative sections of. these are submitted, along with all other lymph node candidates identified. Summary of sections: 13A-13D, level 2 candidate lymph nodes, M/1 each; 13;. 13E, level 3 large involved lymph node, 1/1; 13F, level 4 large involved. lymph node, 1/1; 13G, additional level 4 lymph node candidates, 4/1;. 13H-13K, level 5 lymph node candidates, M/1 each; 13L, a single level 5. lymph node bisected, 1/1. 14) SOURCE: Right Superior Mediastinal Lymph node. Received fresh is a single fragment of yellow-red to black-brown soft. tissue measuring 1.8 X 1.0 X 0.8 cm. The specimen is bisected and submitted. in its entirety. Summary of sections: 14A, 2/1. 15) SOURCE: Right Neck Dissection Level IB. Received fresh is a single specimen consisting of brownish-tan salivary. gland tissue with attached fragments of yellow-red adipose tissue and lymph. nodes. The specimen measures 4.6 X 4.0 X 1.8 cm. Summary of sections: 15A, single bisected lymph node, 2/1; 15B, multiple. candidate lymph nodes, 4/1; 15C, section of salivary gland, 1/1. 16) SOURCE: Right Periostoma Tissue. Received fresh are three fragments of yellow-tan to brown adipose tissue. and granulation tissue measuring 5.5 X 4.0 X 1.0 cm. Representative. sections are submitted. Summary of sections: 16A, 16B, 2/1 each. 17) SOURCE: Laryngeal Cancer. Received fresh is a laryngectomy specimen measuring 8.0 cm from superior to. inferior X 6.5 cm transversely X 6.0 cm from anterior to posterior. The. laryngectomy portion of the specimen measures 1.9 cm in diameter at the. inferior laryngeal margin. The anterior soft tissue portion of the specimen. measures 3.5 cm from anterior to posterior X 5.0 cm transversely X 4.5 cm. from superior to inferior. The specimen ends at the superior portion in. epiglottis and aryepiglottic folds and at the bottom in a round laryngeal. tracheal ring. The specimen is inked in the following fashion: superior. yellow, inferior green, posterior black, anterior orange, right red and. left blue. It is then opened posteriorly revealing a large ulcerated mass. lying in the midline on the inferior surface of the epiglottis and. extending 2.3 cm in greatest dimension, from superior to inferior. Grossly. it lies 0.3 cm away from the vocal folds, 3.2 cm away from the inferior. margin, and 0.2 cm away from the aryepiglottic folds and 1.3 cm away from. the hypopharyngeal soft tissue margins grossly. The distance to the. anterior surface of the soft tissue margins is approximately 2.0 cm. Summary of sections: 17A, inferior tracheal margin, 1/1; 17B, 17C, cross. sections of superficial tumor, 1/1 each; 17D, anterior and superior soft. tissue margins, 2/1; 17E, right vocal fold and thyroid cartilage, 1/1; 17F,. left vocal fold and thyroid cartilage, 1/1; 17G, right mucosal margin, 1/1;. 17H, left mucosal margin, 1/1; 17I, right soft tissue margin, 1/1; 17J,. left soft tissue margin, 1/1; 17K, epiglottis, 1/1. Slides and report reviewed by Attending Pathologist. SURGICAL PATHOLOGY INTRAOPERATIVE CONSULTATION. 1) SOURCE: Larynx. FROZEN SECTION DIAGNOSIS: POORLY-DIFFERENTIATED - CARCINOMA. 2) SOURCE: Left Hypopharynx Margin. FROZEN SECTION DIAGNOSIS: BENIGN. 3) SOURCE: Left Oropharynx Margin. FROZEN SECTION DIAGNOSIS: BENIGN. 4) SOURCE: Left Base of Tongue. FROZEN SECTION DIAGNOSIS: BENIGN. 5) SOURCE: Post-Cricoid Margin. FROZEN SECTION DIAGNOSIS: BENIGN. 6) SOURCE: Right Hypopharynx. FROZEN SECTION DIAGNOSIS: BENIGN. 7) SOURCE: Right Oropharynx. FROZEN SECTION DIAGNOSIS: BENIGN. 8) SOURCE: Right Base of Tongue. FROZEN SECTION DIAGNOSIS: BENIGN. Attending Pathologist.",T3,N2,M0,T3N2M0
TCGA-18-3410,"Addended. SPECIMEN (S) RECEIVED. 1. Bone: portion seventh rt rib. 2. Lymph node: INF pulm ligament ST9. 3. Lymph node: Interlobar ST11. 4. LUNGS: Right lower lobe with 8th and 9th rib- bronchial resection. margin/QS. DIAGNOSIS. 1. Portion of seventh rib: - Consistent with normal rib bone. (GROSS DIAGNOSIS ONLY). 2. Inferior pulmonary ligament ST9 lymph node: - Negative for malignancy, lymph node. 3. Interlobar ST11 lymph node: Negative for malignancy, lymph node. 4. Right lower lobe of lung with 8th and 9th ribs, resection: Poorly differentiated squamous cell carcinoma, peripheral with. invasion into the chest wall. - Tumor greatest diameter 4 cm. - Bronchial resection margin negative for tumor but show focal squamous. metaplasia without atypia. Peribronchial lymph node negative for malignancy. - Chest wall surgical resection margins negative for tumor. COMMENT. After decalcification, the rib case will be examined again for bone. invasion. Nevertheless, this appears to be an apparent complete resection. of a pT3NO carcinoma. Page: 1 of 3. Status complete. GROSS DESCRIPTION. 1. The specimen container labeled with the patient' S name and as. 'Bone: portion seventh rt rib"". Grossly the bone is unremarkable. No. sections submitted for processing. 2. The specimen container labeled with the patient' s name and as ""Lymph. node: inferior pulmonary ligament ST9"", contains 1 node measuring 1.2 x. 0.7 x 0.5 cm in thickness received in 10% buffered formalin. bisected node submitted in toto. 3. The specimen container labeled with the patient' S name and as ""Lymph. node: Interlobar ST11"", contains a grey to black tissue measuring 0.6 x. 0.5 x 0.4 cm. received in 10% buffered formalin. 3A. submitted in toto. 4. The specimen container labeled with the patient' S name and as. ""Lungs right lower lobe with 8th and 9th rib- bronchial resection. margin"", contains a right lower lobe of lung with attached chest wall. which includes the 9th and 8th rib with layer of muscle tissue attached. on the outer surface. The specimen overall measures 16.0 x 10.0 x 5.5. cm. The two ribs together measure 9.0 x 5.5 x about 2.0 cm in. thickness. A line of staples SI are identified. A large nodule. peripherally, white, solid and lobular measuring approximately 4.0 cm in. maximum dimension. Between the rib and the tumor of the lung parenchyma. is a portion of thickened fibrous tissue. This rubbery fibrous white-tan. tissue measures 8.2 X 4.5 x 2.9 cm in maximum thickness. The lesion. appears to extend into this fibrous region crossing the pleural surface. The lesion is 3.6 cm away from- the bronchia] resection margin. There is. a small area of emphysematous change approximately 3.5 cm from the. bronchial resection margin. Four pieces of tumor and 1 piece of lung. taken for tissue frozen. Intraoperative consultation performed on the. bronchial resection margin. Representative sections are submitted as. follows: 4A-B. bronchial resection, frozen section. 4C. segmental node. 4D. emphysematous area. E. segmental node. -G-. anterior resection margin of fibrous tissue. 4H-I. posterior resection margin of fibrous tissue. Page: 2 of 3. 43. superior resection margin of fibrous tissue. 4K. inferior resection margin of fibrous tissue. 4L-M. tumor in the lung parenchyma with respect to the fibrous. tissue. 4N-p. tumor with respect to the lung parenchyma. 4Q-R. sections of consolidation and emphysematous change. Section of tumor fibrous tissue with respect to rib to be sent after decal. Addendum Comment. Additional sections that include the decalcified rib bone and adjacent. tumor shows peri-osteal invasion, but there does not appear to be. invasion through the bony cortex into the rib bone. There is no change in. the original diagnosis of the case. Page : 3 of 3.",T3,N0,M0,T3N0M0
TCGA-BH-A0B5,"FINAL DIAGNOSIS: PART 1: SENTINEL LYMPH NODE NUMBER 1, LEFT, BIOPSY -. A. ONE OF THREE LYMPH NODES, POSITIVE FOR METASTATIC LOBULAR CARCINOMA (1/3). B. METASTATIC TUMOR MEASURES 1.4 CM IN LARGEST DIMENSION. C. NO DEFINITE EXTRACAPSULAR EXTENSION IDENTIFIED. PART 2: BREAST, LEFT, MODIFIED RADICAL MASTECTOMY -. A. MULTIFOCAL ND MULTICENTRIC INVASIVE LOBULAR CARCINOMA, NOTTINGHAM GRADE 2 (TUBULAR. FORMATION 3, NUCLEAR POLYMORPHISM 2, MITOTIC FIGURES 1, TOTAL SCORE 6/9). B. INVASIVE TUMOR MASS RANGING IN SIZE FROM 1.5 TO 2.7 CM; THE LARGEST TUMOR MASS MEASURING. 2.7 CM IN LARGEST DIMENSION (GROSS MEASUREMENT). C. INVASIVE LOBULAR CARCINOMA INVOLVES ALL FOUR QUADRANTS. D. LOBULAR CARCINOMA IN SITU, NUCLEAR GRADE 2, CONSTITUTING 25% OF TOTAL TUMOR MASS,. ADMIXED AND AWAY FROM THE INVASIVE COMPONENT. E. NO LYMPHOVASCULAR INVASION IDENTIFIED. F. DEEP RESECTION MARGIN IS POSITIVE FOR INVASIVE LOBULAR CARCINOMA IN LOWER INNER. QUADRANT (SLIDE 2F). G. FIVE OF TWENTY-ONE AXILLARY LYMPH NODES POSITIVE FOR METASTATIC LOBULAR CARCINOMA. (5/21). H. METASTATIC TUMOR MEASURES 0.8 CM IN LARGEST DIMENSION AND WITH FOCAL EXTRACAPSULAR. EXTENSION. I. NIPPLE SHOWING LOBULAR CARCINOMA IN SITU WITH DUCTAL EXTENSION, 5 MM TO THE SKIN. SURFACE (SLIDE 2A). J. BIOPSY SITE CHANGES. K. FIBROCYSTIC CHANGE WITH DUCTAL EPITHELIAL HYPERPLASIA. LATERALITY: Leit. PROCEDURE: Modified radical mastectomy. Upper outer quadrant. Upper inner quadrant. Lower outer quadrant. Lower inner quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 2.7 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 7.9 cm. TUMOR TYPE (invasive component): Infiltrating lobular carcinoma. HISTOLOGIC TYPE: Classical. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: LCIS. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Yes, focal. LYMPH NODES POSITIVE: 6. LYMPH NODES EXAMINED: 24. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 14 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pN2. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONF RECEPTORS. positive.",T2,N2,M0,T2N2M0
TCGA-D8-A1X9,"page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Total organ resection - left breast with axillary tissues. Material collected on: : Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the left breast. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell. nuclei. HER2 protein stained with HercepTest by DAKO. Score = 2+, FISH verification recommended. Macroscopic description: Left breast sized 22 x 15 x 5 cm removed along with axillary tissues sized 13 x 7.5 x 1.5 cm and a skin flap of 19 x 11 cm. Retracted nipple. Tumour sized 2.5 x 2 x 2.8 cm found on the boundary of lower quadrants, located 3.5 cm from the lower. boundary, 0.4 cm from the base and 3 cm from the skin. Microscopic description: Carcinoma ductale invasivum - NHG2 (2+2+3/21 mitoses/10 HPF - visual area 0.57mm). Glandular tissue showing. lesions of the type mastopathia fibrosa et cystica, hyperplasia ductalis simplex (UDH 1. AXILLARY LYMPH NODES: Metastases carcinomatosae in lymphonodis (No III/XXIII). Infiltratio capsulae lymphonodorum. Histopathological diagnosis: Carcinoma ductale invasivum mammae sinistrae. Invasive ductal carcinoma of the left breast. Metastases carcinomatosae in lymphonodosi axillae (No III/XXIII) (NHG2, pT2, pNIa). Cancer metasta  of axillary lymph nodes (No III/XXIII) (NHG2, pT2, pNIa). S. Examination: Histopathological examination. page 2 / 2. Gender: F. Results of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 GENE AMPLIFICATION NOT FOUND.",T2,N1,M0,T2N1M0
TCGA-78-7145,"RIGHT LUNG AND LYMPH NODES. Clinical Notes: female. SOB. Ex-smoker. SCC middle lobe R. Positive pleural plaque on frozen section. Local involvement: PA, sup PV and pericardium. Four specimens are received: 1: R PLEURA FROZEN SECTION. Macroscopy: Specimen consists of a strip of pleura measuring 35 x 30 x 3 mm and bearing a central plaque. measuring 23 x 8 mm. RS taken for frozen section. Frozen Section Diagnosis: Plaque-like area in pleura containing metastatic non small cell carcinoma. Phoned to Anaesthetist by Dr. [Frozen section remnant, 1A; remainder of tissue BIT, 1B]. Microscopy: Paraffin sections confirm the frozen section diagnosis of involvement of the pleura by non-. small cell carcinoma. There is an infiltrative component in addition to tumour on the pleural. surface. 2: R MIDDLE LOBE. Macroscopy: Specimen consists of a middle lobectomy specimen measuring 125 x 100 x 22 mm in the. inflated state. On the anterolateral pleural surface there is a grey depressed puckered area. measuring 12 x 4 mm. Sectioning the lung tissue reveals a pale mass located immediately. adjacent to the pleura. This measures 25 mm in maximal dimension. It shows central necrosis. It is located more than 35 mm from the bronchial resection margin. [Bronchial resection. margin, 2A; tumour with pleura, 2B-2D; peribronchial lymph nodes and tissue deep to. bronchial resection margin, 2E; macroscopically normal lung tissue, 2F]. Microscopy: Sections show a moderately to poorly differentiated adenocarcinoma in which there is invasion. of the visceral pleura as well as vascular, lymphatic and perineural invasion. The tumour. extends proximally along the bronchovascular structures to involve the bronchial resection. margin. Peribronchial lymph nodes, including those at the margin, show extensive. replacement by metastatic carcinoma. The adjacent lung tissue shows mild emphysema. 3: R PLEURAL NODULE. Macroscopy: Specimen consists of a single rounded dark red piece of tissue measuring 6 x 6x2 mm,. [Bisected and BIT]. Microscopy: Sections show vascular fibrous connective tissue containing metastatic adenocarcinoma. 4: SUMP LYMPH NODE. Macroscopy: Specimen consists of a single black piece of tissue measuring 7 x 4 x 2 mm. [BIT, 4A]. Microscopy: The lymph node shows no evidence of malignancy. Summary: Right middle lobe: 1: Moderately to poorly differentiated adenocarcinoma; 25 mm maximal dimension. 2: Pleural invasion and separate parietal pleura deposit. 3: Vascular, lymphatic and perineural invasion. 4: Present at bronchial resection margin. 5: Peribronchial lymph node metastases. 6: Pathological stage T4N1MX. T-28000 M-81403 P1-03000. Pathology Registrar/Anatomical Pathologist.",T4,N1,M1,T4N1M1
TCGA-4K-AA1H,"Procedure: Left orchiectomy. Preoperative diagnosis: TUMOR OF THE LEFT TESTIS. Postoperative diagnosis: SEE MICROSCOPIC DIAGNOSIS BELOW. Specimen(s): 1. LEFT TESTIS. Diagnosis: 1. LEFT TESTIS: - Seminoma. Tumor invades the tunica albuginea. Vascular invasion is present. Resection margin and epididymis are free of tumor. Gross description: 1. LEFT TESTIS: Received fresh, is a left testis 5.5 x 4.5 x 3.5 cm in dimensions with a portion of the spermatic. cord 10.0 cm in length. In the testis there is a firm gray tumor 2.5 x 2.3 X 2.0 cm in dimensions.",T2,N0,M0,T2N0M0
TCGA-CM-5348,"Clinical Diagnosis & History: Colon cancer. Specimens Submitted: 1: SP: COLON; RIGHT HEMICOLECTOMY. 2: SP: OMENTUM; RESECTION. DIAGNOSIS: 1. COLON; RIGHT HEMICOLECTOMY: - TUMOR TYPE: ADENOCARCINOMA. - HISTOLOGIC GRADE: MODERATELY DIFFERENTIATED. - TUMOR LOCATION: CECUM. - TUMOR SIZE: LENGTH IS 3.2 CM, WIDTH IS 4.4 CM, MAXIMAL THICKNESS IS. 1.0 CM. - GROSS CONFIGURATION: POLYPOID. - TUMOR INVASION: INVASION INTO SUBSEROSA. - SEROSAL INVOLVEMENT: NOT IDENTIFIED. - VASCULAR INVASION: NOT IDENTIFIED. - PERINEURAL INVASION: IDENTIFIED. - SURGICAL MARGINS (FOR COLONIC TUMORS) : FREE OF TUMOK. - POLYPS (AWAY FROM THE CARCINOMA) : NUMBER IDENTIFIED: 3, TYPE. IDENTIFIED: TUBULAR ADENOMAS. - NON-NEOPLASTIC BOWEL: UNREMARKABLE. - THE PATHOLOGIC STAGE IS (AJCC. : pT3. - LYMPH NODES: NUMBER WITH METASTASES: 1, NUMBER EXAMINED: 19. THE PATHOLOGIC STAGE IS (AJCC. : pN1. 2. OMENTUM; RESECTION: - BENIGN ADIPOSE TISSUE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1. The specimen is received fresh, labeled ""Right hemicolectomy"" and. consists of a segment of terminal ileum, cecum with attached appendix and. ascending colon. The terminal ileum measures 68 cm in length and 4 cm in. circumference at the proximal resected margin. The remaining colon measures. 20.1 cm in length with a circumference of 11 cm at the distal resected. margin. The attached appendix measures 6.2 cm in length and averages 0.6 cm. in diameter, and has serosal adhesions. The intestinal serosa is pink tan. and smooth. Focally hemorrhagic lobulated yellow tan adipose tissue spans. the length of the specimen measuring up to 7.0 cm in thickness. The specimen. is opened to reveal a polypoid and focally ulcerated tumor measuring 3.2 cm. in length and 4.4 cm in width, 1.5 em distal to the ileocecal valve, and 1.8. cm from the closest radial margin. Sectioning shows that the tumor invades. into the aubserosal fat. The depth of invasion is 1.0 cm grossly. There. is. also a 0.8 x 0.8 x 0.4 cm polyp, 1.5 cm distal to the tumor. The remaining. colonic mucosa shows additional polyps, ranging in size from 0.1 to 0.3 cm. The specimen is submitted for lymph node dissection. Multiple lymph nodes. are identified in the attached adipose tissue and are submitted. Representative sections of the specimen are submitted for permanent sections. and for TPS. Summary of sections: P- proximal margin shave. D distal margin shave. A -- appendix representative sections. T -- tumor. RM radial margin. LP -- largest polyp. SP -- smaller polyps. RS representative sections, terminal ileum and colon. 2. The specimen is received fresh, labeled ""Omentum. "" It consists of a 27 x. 18 x 2 cm fragment of adipose tissue consistent with omentum. Serial. sectioning reveale an unremarkable cut surface. Representative sections are. submitted. Summary of sections: o - omentum. Summary of Sections. Part 1: SP: COLON; RIGHT HEMICOLECTOMY. Block. Sect. Site. PCs. 1. A. 3. 1. DM. 1. 8. LN. 26. 1. LP. 2. 1. PM. 1. 1. RM. 1. 1. RS. 2. 1. SP. 3. 4. 4. Part 2: SP: OMENTUM; RESECTION. Block. Sect. Site. PCs. 1. o. 1.",T3,N1,M0,T3N1M0
TCGA-AA-3986,"Diagnosis (diagnoses): Resected colon sample with a moderately differentiated adenocarcinoma of the colorectal. type, measuring a max of 5.5 cm in diameter, with infiltration of the tunica muscularis. propria up to the border of the pericolic fatty tissue. The tumor stage is: pT2, pNO (0/27) pMX; G2, L0, V0, R0.",T2,N0,M0,T2N0M0
TCGA-05-4249,"Diagnosis: 2. and 3. Two-part resection material from the right lower lobe with a peripheral, well. differentiated papillary, non-mucigenous adenocarcinoma measuring a good 50 mm and. extending as far as the visceral pleura that is just tumor-free, a tumor-free bronchial resection. level and subpleural areas of scarring as well as pleural residues of adhesion. Tumor classification: M-8140/3, G1, pT 2 2, pN 0, pMX, stage I B. R 0.",T2,N0,M0,T2N0M0
TCGA-D5-5538,"Examination: Histopathological examination. organ resection - segment of the large intestine. denera. burgery. Clinical diagnosis: Cancer of the cecum. Macroscopic description: 25.3 cm length of the large intestine with periintestinal fat tissue sized 24 x 9 x 2 cm, with a 5 cm length of. the small intestine, and a 5.5 cm appendix. Ulcerous tumour sized 4.2 x 4.1 x 0.6 cm found in the mucosa. The lesion surrounding 100% of the intestine circumference, 5 cm from the proximal cut end, 17 cm from the. distal cut end, and 1.2 cm from the ileocecal valve. Blue dye injected. Microscopic description: Adenocarcinoma tubulopapillare (G2). Infiltratio carcinomatosa valvulae Baughini et parietis llei et telae. adiposae pericolicae. Incision lines free of neoplastic lesions. Metastases carcinomatosae in lymphonodis (No. III/VI). Infiltratio carcinomatosa telae adiposae perinodalis. Other lesions of the tumour resident type. Histopathological diagnosis: (including examination No. Adenocarcinoma tubulopapillare coli. Metastases carcinomatosae in lymphonodis (No III/VI). (G2, Dukes C, Astler-Coller C2, pT3, pN1).",T3,N1,M0,T3N1M0
TCGA-AF-A56L,"SPECIMEN. A. Rectosigmoid. B. Appendix. CLINICAL NOTES. PRE-OP DIAGNOSIS: Rectosigmoid cancer. GROSS DESCRIPTION. A. Received fresh, subsequently fixed in formalin labeled. ""rectosigmoid"" is a 13 cm. long portion of colon. The specimen has. a suture marking the distal portion. This end is inked black, the. opposite end is inked blue. The ends of the specimen appear to be. not stapled. The specimen is partially covered with pink-tan,. smooth, glistening serosa and abundant yellow, lobular fat. There. is no retroperitoneal reflection. The specimen is entirely covered. with a portion of smooth, glistening serosa. The specimen is opened. to show possibly circumferential tumor which is 4.5 x 4 x 1 cm. This comes to within 3.5 cm. of the distal margin. This shows gross. evidence through muscularis propria and into the fat, coming to. within 2.5 cm. of the radial margin. There is also a slight. umbilication in the serosa (focus is inked blue) The remainder of. the mucosa is pink-tan, smooth and glistening with normal to. slightly dilated folds, both having an average circumference of 5. cm. Lymph nodes are grossly identified in the fat. Representative. sections of the specimen are submitted as follows: BLOCK SUMMARY: #A1 - Representative luminal margin; A2 - tumor to. serosal umbilication; A3 - tumor to fat; A4 - representative radial. margin; A5, 6 - nine possible lymph nodes each; A7 - six possible. lymph nodes; A8 - one possible lymph node; A9, 10 - one possibly. necrotic or positive lymph node sectioned; A11 - 12 - largest. possible lymph node, possibly centrally necrotic and positive. RS-12. B. Received fresh, subsequently fixed in formalin labeled. ""appendix"" is a grossly unremarkable appendix which is 9.5. X. 0.7 cm. This is partially covered with pink-tan, smooth,. glistening serosa and abundant yellow, lobular fat. The specimen is. sectioned to show an intact wall with an average thickness of 0.3. cm. The lumen ranges from pinpoint to 0.3 cm. and is partially. filled with red, dusky, diffluent material. No other discrete gross. lesions are identified. Representative sections of the specimen are. submitted in one cassette with the proximal end inked. RS-1. MICROSCOPIC DESCRIPTION. A. Histologic type: Invasive adenocarcinoma. Histologic grade: Moderately differentiated. Primary tumor (pT) : Tumor invades through the. muscularis propria into the pericolonic fat to a depth. of 5 mm. beyond the very attenuated muscularis. propria (pT3b). Proximal margin: Negative for tumor. Distal margin: Negative for tumor. Circumferential (radial) margin: Negative for tumor. Distance of tumor from closest margin: 2.5 cm. from. radial margin and 3.5 cm. from distal margin. Vascular invasion: Lymphatic space invasion is. identified in extranodal foci within the fat. No. venous or arterial space invasion is identified. Regional lymph nodes (pN) : 10 of 23 lymph nodes are. positive for metastatic carcinoma (pN2). Non-lymph node pericolonic tumor: Present. Distant metastasis (pM) : Cannot evaluate, pMX. Other findings: The largest metastatic lymph node. measures 1.4 cm. in greatest dimension. The surface of. the carcinoma is extensively ulcerated. A mild,. non-brisk, lymphocytic infiltrate is present. associated with the tumor. Although the. architectural features of the tumor are moderately. differentiated, in many areas, the nuclear features. of the tumor are more poorly differentiated. B. Microscopic examination reveals an appendix with. fibrous obliteration of the tip, no tumors are identified. and no acute inflammation is identified. 5x1, 1x1. DIAGNOSIS. A. Colon, rectosigmoid, segmental resection: Invasive, moderately to poorly differentiated adenocarcinoma,. invasive through muscularis propria into pericolonic fat. (pT3b). The resection margins are negative for tumor. Metastatic adenocarcinoma is present in 10 of 23 lymph nodes. (pN2). See microscopic description for template details. B. Appendix, excision: Fibrous obliteration.",T3,N2,M0,T3N2M0
TCGA-CM-6161,"Clinical Diagnosis & History: with history of rectal cancer. Specimens Submitted: 1: COLON, SIGMOID; RESECTION: 2: SP: Proximal ring. 3: SP: DIstal ring. DIAGNOSIS: 1. COLON, SIGMOID; RESECTION: : Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Sigmoid colon. Tumor Size: Length is 6.5 cm. Width is 4.5 cm. Maximal thickness is 2.5 cm. Tumor Budding: Absent. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Tubulovillous adenoma. Deepest Tumor Invasion: Muscularis propria. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Not identified. Large Venous Invasion: Not Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Tubular adenoma; number: 1. Non-Neoplastic Bowel: Unremarkable. Lymph Nodes: Number with metastasis: 0. Total number examined: 31. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC 7th Edition) : pT2 (Tumor invades muscularis propria). Lymph Node Stage (AJCC 7th Edition) : NO (No regional lymph node metastasis). NOTE: RESULTS OF IMMUNOHISTOCHEMICAL STAINING FOR DNA MISMATCH REPAIR PROTEINS ARE. AS FOLLOWS: MLH1: STAINING PRESENT IN TUMOR. MSH2: STAINING PRESENT IN TUMOR. MSH6: STAINING PRESENT IN TUMOR. PMS2: STAINING PRESENT IN TUMOR. CONCLUSION:IMMUNOHISTOCHEMICAL STAINING FOR THE TESTED DNA MISMATCH REPAIR. PROTEINS IS RETAINED IN THE TUMOR. 2. COLON, PROXIMAL RING; EXCISION: - BENIGN COLONIC TISSUE. - A DETACHED FRAGMENT OF ADENOMATOUS MUCOSA IS NOTED. COLON, DISTAL RING; EXCISION: BENIGN COLONIC TISSUE. Some of the immunohistochemistry and ISH tests were developed and their. performance characteristics were determined by the Department of Pathology. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not. be regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of. ) as. qualified to perform high complexity clinical laboratory testing. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1. The specimen is received fresh and is labeled ""Sigmoid"". It consists of. an undesignated sigmoid colon (19.5 cm in length and ranges in circumference. from 6.2 to 8.0 cm) with attached pericolonic fat (17.3 x 8.5 x 2.5 cm) . The. serosal surface is pink, glistening and intact. The presumed distal. resection margin is inked black and presumed proximal resection margin is. inked red. The specimen is opened to reveal an exophytic, bosselated, tumor. 6.5 cm in length and 4.5 cm in width) that is located 10.0 cm from the. proximal margin and 4.5 cm from the distal margin. Serial sectioning reveals. the tumor has a depth of 2.5 cm. Thorough sectioning show that the tumor. appears to be limited to the muscularis propria without invasion beyond the. muscle. There is 2nd tan polypoid mass , located 1.5 cm from the tumor which. is sampled. The remaining mucosa is grossly unremarkable. Pericolic and. perirectal adipose tissue is thoroughly examined for lymph nodes, and all. possible nodes are submitted. Representative sections are submitted. The. tumor area is extensively sampled. TPS is submitted. Summary of sections: PM - proximal margin, shave. DM - distal margin, shave. T tumor. P- polypoid mass. U - uninvolved mucosa. LN - lymph nodes. BLN - bisected lymph node. TU more sections from the tumor. 2. The specimen is received in formalin, labeled ""Proximal ring"" and. consists of a silver metal anastomotic pin measuring 7.5 x 2.8 x 1.5 cm. At. the center of the pin, a blue plastic piece is noted. A ring of pink tan. soft tissue is attached measuring 2.3 x 2.2 x 1.1 cm. The mucosal surface. is pink tan and focally hemorrhagic and the serosal surface is pink tan and. smooth. Several sutures and staples are noted. The sutures and staples are. removed and the soft tissue is entirely submitted. Summary of sections: --undesignated. 3. The specimen is received in formalin, labeled ""Distal ring"" and consists. of a ring of pink tan soft tissue measuring 2.2 x 1.9 x 0.8 cm. Multiple. sutures and staples are attached. The mucosal surface is pink tan and. focally hemorrhagic. The sutures and staples are removed and the soft tissue. is entirely submitted. Summary of sections: U--undesignated. Summary of Sections: Part 1: COLON, SIGMOID; RESECTION: Block. Sect. Site. PCs. 1. BLN. 2. 1. DM. 2. 7. Ln. 21. 1. P. 1. 1. PM. 2. 11. TU. 14. 1. U. 1. Part 2: SP: Proximal ring. Block. Sect. Site. PCs. 1. U. 8. Part 3: SP: DIstal ring. Block. Sect. Site. PCs. 1. U. 5.",T2,N0,M0,T2N0M0
TCGA-66-2791,"Material examined: Right lung. Clinical diagnosis and question. Bronchial carcinoma right central lower lobe, large-cell carcinoma. REPORT ON FINDINGS. Macroscopy. 1.) Right lung: inflated, fixed right lung measuring 14 x 12 cm at the base and up to 26 cm high, central. bronchus resection plane located 1 cm upstream of the upper lobe bronchus. Dorsomedial and basal pleura over. S10 shows an area of max. 7.5 x 4 cm with roughening or residual adhesion, in the basal region over S7 is a 3. cm similar area, Intermediate bronchus in the region of the middle lobe bronchus bifurcation and proximal. sections of the bronchi of the basal group narrowed by a moderately firm, predominantly pale brownish-white. tumor with small patches of grayish-black pigmentation, max. 4.7 cm in size, with unclear and arcuate. demarcation, with the main mass in S10 and adjacent sections of S6, S7 and S9, extending to within 0.2 cm of. the medial visceral pleura over S10. Truncation of B9 and B10 and also a subsegmental branch of B7 in the. tumor. Focal crossing of lower pleural fissure and infiltration of middle lobe. In the tumor environment some. satellite foci up to 0.2 cm in size. Peripheral sections of basal bronchial branches dilated and filled with thick. mucus. Parenchyma below the adhesion zone over S10 shows diffuse induration and a brown vitreous. appearance. In the mediocaudal region of the upper lobe bronchus bifurcation next to the pulmonary artery a 2.5. cm node firmly adherent to the vascular wall with predominantly whitish section surfaces and extension right up. to the hilar resection surface, not continuity wit tumor. At the intermediate bronchus a 0.7 cm node part. suggestive of a tumor, next to the lower lobe bronchus part a 0.5 cm grayish-black node. Apical parenchyma in. S1 shows a seam-like area of induration and grayish-brown discoloration up to 0.4 cm wide. 2.) Paraesophageal LN (station 8): 1.2 cm node. 3.) Low paratracheal LN (station 4) right: 1.4 cm node part with abundant surrounding tissue. 4.) High paratracheal LN (station 2) right: 1.4 cm node with abundant surrounding tissue and in parts whitish. section surfaces suggestive of tumor. 5.) Subcarinal LN (station 7): 3.8 cm node with some surrounding tissue and in parts whitish section surfaces. suggestive of tumor. 6.) Hilar LN (station 10) left: 1.2 cm node part and a 0.9 cm lesioned node. Examined: 1.) a: Tumor with rest of parenchyma and satellite focus, b: tumor with B10, c: 2 sections of tumor with pleura,. d: lower pleural fissure (middle lobe part color-marked), e: node at upper lobe bronchus bifurcation with hilar. resection surface (color-marked), f: S10 mediobasal, g: S1 apical and node part intermediate bronchus, h: central bronchus resection plane and resection margins of vessels and also node at lower lobe bronchus,. 2.), 3.) + 6.) All material (in 3.) lamellated),. 4.) Node (lamellated),. 5.) 2 sections,. 13 blocks, partly Elastica-van Gieson, PAS, diastase-PAS. Microscopy. Re 1.) Tumor made up to solid structures of large atypical epithelia, densely packed in parts, with copious,. mostly stained cytoplasm with the inclusion of isolated very large, otherwise often round, occasionally. deformed nuclei containing granular chromatin and always prominent nucleoli. Apoptoses, not uncommonly. several mitoses per markedly enlarged visual field (field length 0.61 mm). Occasionally a vague epidermoid. layer, often intercellular fissures and isolated visible bridges. No mucin inclusion. In places a dissociation of the. tumor cell structures. Smaller areas of necrosis. Affected lung parenchyma partly destroyed, likewise a. relatively a large bronchus here, strand of cartilage remaining. A further large bronchus partially infiltrated and. involved in the tumor, likewise in this area smaller bronchi and bronchioles whose lumen is partly dilated, the. original respiratory epithelium replaced by tumor epithelium. In adjacent region tumor cell nests and formations. of small tumor lie freely in alveoli, also tumor cell structures in dilated lymph vessels. Vascularized interlobular. septa. between the tumor formations partly loose, partly fiber-rich, collagenous connective tissue with. accumulation of inflammatory cells. Isolated small vessels here, walls thickened by elastosis and containing. tumor cells. A larger vein surrounded, loose capillary-containing fiber tissue in the lumen. Between peripheral. tumor margin and visceral pleura on the medial side a strip of free lung parenchyma with partly deficient. atelectasis and thickened alveolar septa. Lower pleural fissure and partly fused visceral pleura demarcating or. covering this fissure transcended by tumor, where large bronchi are invaded to within close proximity of the. mucosa. Large tumor node next to the upper lobe bronchus bifurcation, enclosed anthracotic pigment, tumor. cell nests here at the resection margin. In the mediastinal tissue a further tumor-compromised lymph node with. anthracotic pigment deposits and otherwise fibrous growth of connective tissue. In subpleural region of S1 a flat. remodeling zone of the lung parenchyma with development of collagenous and elastic connective tissue, with. alveolar stroma still partly recognizable. Nearby tiny radial areas of interstitial fibrosis with small patches. of. accumulated anthracotic pigment. In the basal lower lobe am relatively large area of nonoxygenated, fibrosed. lung parenchyma with inclusion of partly obliterated smaller, partly patent vessels and bronchioles. Overlying. pleura markedly enlarged and fibrotic. Otherwise here and there in dilated peripheral airways mucus and. leukocytes and also a small cluster of pigment-storing macrophages in the alveoli. At the bronchus resection. margin, sections of mucosal epithelium are interrupted, otherwise regular. Here as in the walls of the large. pulmonary vessels no evidence of tumor cells. Lymph node at the hilus with isolated secondary follicles, slight. plaque of anthracotic pigment and foci of large macrophages. Re 2.) - b.) Partly preserved lymph nodes with few secondary follicles, varying degrees of anthracotic pigment. deposits, accumulation of macrophages and isolated secondary follicles. In parts, lymph nodes are largely. occupied by solid epithelial tumor. In places, tumor manifestation also in the paranodal tissue. At one point and. in a larger lymph node only very small areas occupied by tumor cell nests. EVALUATION. Primary diagnosis/diagnoses: Central bronchopulmonary, histologically largely undifferentiated, large-cell squamous cell carcinoma of the. right lower lobe of the lung (C4) with overgrowth of the interlobar fissure and continuous growth into the. adjacent section of the middle lobe and also several in some cases large lymph node metastases. Tumor. classification according to this picture pT2 pN3 L1 V1 R1, stage III. C34.3 M8070/3. Secondary diagnosis/diagnoses: Peripheral bronchiolectasia in the lower lobe, relatively large fibrous cicatricial remodeling zone in S10. mediobasal and similar flat subpleural cicatricial zones in S1 apical. Local high-grade pleural fibrosis over S10. Tumor-associated inflammation and small tumor necroses. Slight anthracotic pigment deposits in the lung. parenchyma and relatively marked in some lymph nodes. Remark/addendum: The main mass of the carcnoma lies in S10. Centrally it has grown as far as the bifurcations of the lower lobe. main bronchus and the middle lobe bronchus, without these being destroyed or constricted. The tumor invasion. of small blood vessels only concerns the focal region, the lymphangioinvasion is more marked and is also. located in the vicinity of the tumor focus. The R1 classification is based on the finding that carcinoma nests in. the large involved lymph nodes next to the bifurcation of the upper lobe bronchus extend to the mediastinal. resection plane. Further lymph node metastases are seen at the intermediate bronchus in the mediastinum and. also in the lymph nodes located under 4.) - 6.). The pN3 classification is also made with regard to the previous. finding with carcinoma cell structures in the fine needle aspiration biopsy from LN4 left (according to clinical. data).",T2,N3,M0,T2N3M0
TCGA-BR-7722,"Asterand Case ID. Open Clinica. Gross Description. Subject ID. BR-7722. Stomach segment with the. esophagus part. Stomach segment with the. plate-like tumour, 3 cm in its. largest dimension, infiltrates. all layers of the stomach wall. and diaphragm. Greater and. lesser curvature lymph nodes. are dense, hyperemic;. esophageal margins are free. of metastases. Microscopic. Diagnosis. Description. Details. Adenocarcinoma of. Tumor Features: STOMACH TISSUE CHECKLIST. the stomach, G3, all. Ulcerated, Tumor. layers of the stomach. Extent: Adjacent. Specimen type: Total. wall invasion. Tumour. structures,. gastrectomy. invades the. Venous Invasion: Tumor site: Stomach. diaphragm, with the. Absent, Margins: Tumor size: 3 X 0 X 0 cm. foci of perineural. Absent,. Tumor features: Ulcerated. invasion. Treatment Effect: Histologic type: Surgical margins. Adenocarcinoma. along the stomach --. Histologic grade: Poorly. discoupling and. differentiated. moderate dysplasia. Tumor extent: Adjacent. of glands,. structures (specify) -. inflammatory. Diaphragm. infiltration,. Lymph nodes: 5/15 positive. haemorrhages. for metastasis (Greater and. Esophageal surgical. lesser omentum 5/15). margins are free of. Lymphatic invasion: Present. metastases. Fifteen. Venous invasion: Absent. lymph nodes were. Perineural invasion: Not. examined, five. specified. demonstrated. Margins: Uninvolved. metastases, others --. Evidence of neo-adjuvant. focal fibrosis. treatment: Not specified. Omentum --. Additional pathologic findings: haemorrhages. Not specified. Comments: None.",T3,N1,M0,T3N1M0
TCGA-85-8277,Gross. Microsco. Diagnosi. Commen. Case ID. Descripti. pic. S Details. ts. on. Descripti. on. ICA ID. LUNG TISSUE CHECKLIST. Specimen type: Pulmonectomy. Tumor site: Lung. Tumor size: 10 X 10 X 8 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Not specified. Tumor extent: Visceral pleura. Other tumor nodules: Not specified. Lymph nodes: 4/4 positive for metastasis (Intrathoracical 4/4). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None. Lateralit. y. Left-. upper.,T3,N1,M0,T3N1M0
TCGA-52-7809,"Pathologic Interpretation: A. Right distal paratracheal R4. - No tumor seen in one lymph node (0/1). B. Left distal paratracheal R4 -. - No tumor seen in one lymph node (0/1). C. Right upper lobe lesion -. - Poorly differentiated basaloid type squamous cell carcinoma, 4.5 cm. The tumor invades the visceral pleura but does not invade the pericardium. See note. - Specimen resection margins free of tumor. - Immunohistochemistry is positive for p63 and negative for chromogranin and synaptophysin. Note: The portion of pericardium is attached to the visceral pleura by a fibrous layer of tissue. See tumor summary. D. Residual upper lobe - Bronchial margin: - Bronchial margin free of tumor. - Unremarkable lung parenchyma. - No malignancy seen in three lymph nodes (0/3). E. Right distal paratracheal #4+: - No tumor seen in one lymph node (0/1). F. Subcarinal #7: - No tumor seen in one lymph node (0/1). G. Inferior pulminary ligament #7: - No tumor seen in one lymph node (0/1). H. Interlobar #11: - No tumor seen in one lymph node (0/1). Tumor Summary: Specimen Type: Lobectomy. Laterality: right. Tumor Site: Upper lobe. Tumor Size: - Greatest dimension: 4.5 cm. Histologic Type: Squamous cell carcinoma, basaloid type. Histologic Grade: G3: Poorly differentiated. Margins: Margins uninvolved by invasive carcinoma. Direct Extension of Tumor: Visceral pleura. Venous (Large Vessel) Invasion (V): Absent. Arterial (Large Vessel) Invasion: Absent. Lymphatic (Small Vessel) Invasion (L): Absent. Regional Lymph Nodes (pN): - pNO: - Number examined: 7. - Number involved: 0. Pathologic Staging (pTNM): pT2, pNO, pMX. As the attending pathologist, / attest that I: (i) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). Intraoperative Consultation. A. Right distal paratracheal R4. No tumor seen in one lymph node (0/1). B. Left distal paratracheal R4 -. No tumor seen in one lymph node (0/1). C. Right upper lobe lesion -. Poorly differentiated carcinoma. D. Residual upper lobe - Bronchial margin: Bronchial margin negative for tumor. Clinical History: None provided. Operation Performed. Mediastinoscopy, lobectomy, right upper lobe. Pre Operative Diagnosis: Lung disease. Specimen(s) Received: A: Right distal paratracheal R4. B: Left distal paratracheal R4- -. C: Right upper lobe lesion. D: Residual upper lobe - Bronchial margin. E: Right distal paratracheal #4+. F: Subcarinal #7. G: Inferior pulminary ligament #7. H: Interlobar #11. Gross Description: A. Received in formalin is a segment of tan-yellow fibroadipose tissue measuring 1 x 0.8 x 0.4 cm. The specimen is. submitted in toto in one cassette for frozen. B. Received fresh is a segment of tan-red soft tissue measuring 1.8 x 1.2 x 0.3 cm. The specimen is submitted in toto in one. cassette for frozen. C. Received fresh is a lung wedge measuring 13 x 6.5 x 4.6 cm. The specimen has been previously sectioned to reveal a. well circumscribed indurated pale-tan to yellow lesion with focal areas of necrosis and hemorrhage measuring 4.5 x 3.7 X. 3.1 cm. The lesion pushes into but does not seem to invade the visceral pleura and is present within 0.2 cm of the. surface. The lesion is present 0.2 cm from an attached segment of pericardium (inked yellow). The lesion is present 4. cm from the stapled resection margin. Sectioning through the remainder of the specimen reveals a tan-white indurated. calcified nodule situated 1 cm from the stapled resection margin. Cassettes are submitted as follow: 1. Section of the lesion submitted for frozen. 2-3. Additional representative sections of the lesion. 4. Section of the indurated nodule in relationship to stapled margin. 5. Remainder of the stapled margin. 6. Additional representative section. 7. Uninvolved lung parenchyma. 8-10. Tumor in relation to pleura and pericardium. D. Received fresh is segment of lung measuring 13 x 9 x 3.5 cm. The specimen is tan red to purple and has a smooth and. glistening surface on one side, and attached tan yellow fibroconnective tissue on the other side. There is a stapled. resection margin line measuring 7.9 cm, the bronchial margin is identified, it is grossly free of tumor. Serial sectioning. through the specimen reveals unremarkable lung parenchyma. Sections are submitted as follow: 1. Bronchial margin submitted for frozen. 2. Representative section of the stapled margin. 3-6. One possible lymph node bisected per cassette. E. Received in formalin is a segment of tan brown soft tissue measuring 3 X 2 x 1cm. The specimen is multisected submitted. in toto in one cassette. F. Received in formalin is a segment of tan-brown soft tissue measuring 1 x 0.6 X 0.4 cm. The specimen is submitted in toto. in one cassette. G. Received in formalin is a segment of clear tan to yellow fibroadipose tissue measuring 1 x 0.9 x 0.3 cm. The specimen is. submitted in toto in one cassette. H. Received in formalin is a segment of pale-tan soft tissue measuring 0,9 X 0.7 X 0.3 cm. The specimen is submitted in toto. in one cassette.",T2,N0,M0,T2N0M0
TCGA-MP-A4T8,"TISSUE DESCRIPTION: A1 B1 C1 C2 C3 C4 C5 C6 D1 D2 E1 F1. Left upper lobe lung (185.0 grams, 17.0 x 10.0 x 3.0 cm), station. 5L, 6L, 7, 9L, and IIL lymph nodes. DIAGNOSIS: Lung, left upper lobe, lobectomy: Grade 3 (of 4) adenocarcinoma. forming a bronchocentric mass (4.5 x 3.0 x 1.5 cm) not involving the. pleura. Angiolymphatic invasion is identified. The bronchial margin. is free of tumor. Lymph nodes, mediastinal, excision: Metastatic grade 3 (of 4) adenocarcinoma is identified in. a single left subaortic (station 5L) lymph node. No tumor is identified in a single left paraaortic. (station 6L) lymph node. No tumor is identified in multiple (3) subcarinal. (station 7) lymph nodes. No tumor is identified in a single left pulmonary. ligament (station 9L) lymph node. Lymph nodes, intrapulmonary/hilar, excision: Metastatic grade 3 (of 4) adenocarcinoma is identified in. multiple (2 of 6) intrapulmonary peribronchial lymph nodes. NO tumor is identified in a single left interlobar. (station 11L) lymph node. site : lung upper lobe C34.1.",T2,N2,M0,T2N2M0
TCGA-G3-AAV5,"CONFIDENTIAL. Demographics (for. verification purposes). Date of Birth: Sex: M. Collected Date/Time. Received Date/Time. Specimen Description. A. Gallbladder. B. Right liver. Clinical Information. Infectious patient: No. Immunocompromised: No. History of neoplasm: Yes. Liver mass. Diagnosis. A. Gallbladder, cholecystectomy: - No evidence of malignancy. - Lymph nodes show reactive changes, no evidence of malignancy. B. Liver, right partial hepatectomy: - Hepatocellular carcinoma, moderately differentiated, see synoptic report. Prominent vascular invasion. - Necrosis involving less than 10% of tumor. Verified: Synoptic Report. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: GII: Moderately differentiated. TUMOR EXTENSION (select all that apply) : Tumor confined to liver. PRIMARY TUMOR (pT) : pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. REGIONAL LYMPH NODES (pN) : pNX: Cannot be assessed. DISTANT METASTASIS (pM) : pMX: Cannot be assessed. MARGINS: Parenchymal margin uninvolved by invasive carcinoma. VENOUS (LARGE VESSEL) INVASION (V) : Present. ADDITIONAL PATHOLOGIC FINDINGS: Cirrhosis/fibrosis. Gross Description. Received are specimen containers A to B. All requisitions and specimen containers are. labelled with the patient's name. The cassettes and. identifiers. are labelled with the Surgical. A. Specimen is received fresh. The container is designated ""A. Gallbladder"". The. specimen consists of a bile stained intact gallbladder which measures 9.5 x 3.5 x 3.0 cm. The serosal surface is smooth and glistening. Opening the gallbladder reveals it to be. filled with green bile. No calculi are found in the gallbladder or in the specimen. container. The mucosal surface is green, velvety and the gallbladder wall averages 0.3. cm in thickness. The cystic duct is patent. Adjacent to the cystic duct is a possible. lymph node measuring 2.5 cm in greatest dimension. Three representative sections of. gallbladder submitted in cassette A1. The possible lymph node, bisected, submitted in. toto in A2. Upon handling the specimen, it fragmented into three pieces. B. Specimen is received fresh. The container is designated ""B. Right liver"". The. specimen consists of a 1.4 kg portion of liver which measures 30.0 x 15.0 x 10.0 cm. A. portion of the liver capsule is lobulated which corresponds to a tan lobulated mass. within the liver parenchyma. There are irregular areas of hemorrhage spread throughout. the mass. The mass measures approximately 17.5 x 10.0 x 10.0 cm. Adjacent to the mass. are separate nodules, however it is difficult to ascertain whether these nodules are. truly separate or lobules which connect to the main mass. These nodules range from 0.2. cm up to 1.0 cm in greatest dimension. The liver parenchyma is fibrotic, creating a. nodular appearance. The resection margin of the specimen has been inked blue. The. separate described nodules comes within 1.5 cm of the resection margin. The main mass. comes within 4.5 cm of the blue margin. Sections of the specimen are as follows: B1- - four sections of the large mass and its relationship to the liver capsule. B5. - edge of the large mass with one of the separate described nodules in the liver. parenchyma. B6. - further section of separate described nodules within the fibrotic liver. parenchyma. Sectioning. revealed these nodules come within 0.5 cm of the blue. painted resection margin. B7. - section of a query vessel filled with granular material at the blue painted. resection margin. B8. - further section of blue painted resection margin in an area where the liver. parenchyma. becomes markedly fibrotic. B9. - section of the nodules with surrounding liver parenchyma. Microscopic Description. A. Sections show congested the gallbladder, no evidence of malignancy. The cystic. node shows lipogranulomas, no evidence of malignancy. B. Sections show a hepatocellular neoplasm with a solid and trabecular growth. pattern, as well as confluent areas of necrosis, involving less than 10% of the tumor. The tumor cells show a high degree of atypia, with a high nuclear cytoplasmic ratio,. prominent nucleoli and frequent mitoses. There is prominent vascular invasion. The. adjacent liver parenchyma shows cirrhosis. tumor nodules are also present in surrounding. liver parenchyma. The painted hepatic margins are negative for umor.Embolization. material is seen in a few blood vessels. Encounter Number. Patient Location.",T2,N0,M0,T2N0M0
TCGA-49-6745,"SURG PATH REPORT. 1st Specimen collected. Accessioned OI. FINAL DIAGNOSIS. 1. LYMPH NODE, L11 (EXCISION) : METASTATIC CARCINOMA INVOLVING ONE. (1) FRAGMENTED LYMPH NODE. 2. LUNG, LEFT UPPER LOBE (LOBECTOMY) : SPECIMEN TYPE: Lobectomy. TUMOR SITE: Left upper lobe. HISTOLOGIC TYPE: Adenocarcinoma with focal papillary component. TUMOR SIZE: 4.0 cm. HISTOLOGIC GRADE: G3: Poorly differentiated. LYMPH NODES (INCLUDES ALL PARTS) : Metastatic carcinoma in 6 of 11 lymph nodes. EXTENT OF INVASION (7th Edition, AJCC) : PRIMARY TUMOR: pT2a: Tumor more than 3 cm but 5 cm or less. REGIONAL LYMPH NODES: pN2: Metastasis in ipsilateral subcarinal lymph nodes. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from nearest. margin: 4.0 mm (parenchymal). VENOUS/ARTERIAL (LARGE VESSEL) INVASION: Absent. LYMPHATIC (SMALL VESSEL) INVASION: Indeterminate. ADDITIONAL PATHOLOGIC FINDINGS: Emphysematous changes. 3. LYMPH NODES, STATION 5 (EXCISION) : TWO (2) LYMPH NODES, NEGATIVE. FOR TUMOR. 4. LYMPH NODES, STATION 7 (EXCISION) : METASTATIC CARCINOMA. INVOLVING ONE (1) OF TWO (2) LYMPH NODES. NOTE: The tumor has a focal solid component, raising the. differential diagnosis of squamous cell carcinoma. Immunohistochemically the tumor cells are strongly positive for. Napsin-A, TTF-1, focally weakly positive for p63, and negative for CK. 5/6, supporting the diagnosis of adenocarcinoma. Histochemical stain. for mucin (mucicarmine) is negative. Visceral pleura uninvolved on. VVG special stain (performed on three separate blocks). This case. was shown at the. ADDENDUM. MOLECULAR ANALYSIS FOR EGFR AND KRAS MUTATIONS WILL BE PERFORMED AND. ADDENDUM. KRAS MUTATIONAL ANALYSIS. BLOCK TESTED: 2D. RESULT: NEGATIVE. NOTE: The assay did not detect a mutation in either codon 12 or 13. of the KRAS gene. A copy of the complete report is available in EPR. (Lab. and is also on file in the. EGFR mutational analysis 13 pendilig und. will be reported as an addendum. ADDENDUM. EGFR MUTATIONAL ANALYSIS. BLOCK TESTED: 2D. RESULT: NEGATIVE. NOTE: No mutations were identified. This assay analyzed exone. 18-21. of the EGFR tyrosine kinase domain. A copy of the complere report is. available in. and is also on file in Fil. End of Diagnosis. Clinical History: QUESTION LUNG CANCER. See. Clinical Document dated. for official report.",T2,N2,M0,T2N2M0
TCGA-RD-A7BW,"CLINICAL NOTES. 1. Gastrectomy total. 2. Donuts. 3. R gastroepiploic. MACROSCOPY. a. Specimen is labelled stomach. Total gastrectomy specimen, 120mm. along the lesser curve, approximately 195mm along the greater curve. The large portion of the body of the stomach, the wall is thickened. and indurated, and the mucosa granular and congested with loss of. the normal rugal folds. No proliferative mucosal lesion is seen. There is a relatively sharp contrast with normal antral mucosa. The. fat around both lesser and greater curves, is indurated. Omentum is. included showing obvious abnormality. On slicing the thickened wall. shows some pallor. Composite longitudinal section taken from mid. portion of stomach to distal margin in blocks A1-A4. A5 & A6 also. composite blocks also representing sections to proximal margin along. lesser curve. Random section of omentum block A7. Blocks A8&A9. greater curve lymph nodes A10 lesser curve lymph nodes. X in 10 TP. b. Specimen is labelled donuts proximal oesophageal and distal small. bowel. 2 pieces of ragged tissue received in the same container, the. largest with an external diameter of approximately 17mm. Most NX in. 1P. c. Specimen is labelled right gastroepiploic nodes. Ragged piece of. fatty tissue, up to 23mm. No definite node identified. AX in 1. MICROSCOPY. a. Sections taken from the abnormal thickened area described. macroscopically showed diffuse pattern poorly differentiated. adenocarcinoma, which infiltrates through the full thickness of the. gastric wall, into perigastric fat. The cells are poorly cohesive. The minor component have a signet-ring pattern, but generally the. cells are pleomorphic, with variable quantitive cytoplasm. Tumour. extends to the gastro-oesophageal junction, where there is a small. nodule of gland forming tumour, beneath squamous epithelium. Intramucosal tumour is identified in this region, unlikely the. remainder of the stomach, where the tumour is predominantly. submucosal and intramural. Tumour extends close to the proximal. margin but does not involve it. Two (2) greater curve lymph nodes. were identified, both showing metastatic carcinoma. There is. extensive infiltration of surrounding fat by tumour. Five lesser. curve nodes were retrieved, all showing metastatic adenocarcinoma. Again there is extensive infiltration of the surrounding fat. Sections of omentum show no significant abnormality. b. Sections of proximal and distal resection rings representing. portions of oesophagus and duodenum, show no evidence of involvement. by tumour. c. Sections show fat with a single lymph node. The latter shows. extensive sinusoidal infiltration by metastatic adenocarcinoma. DIAGNOSIS. 1 & 2. Total gastrectomy specimen extensively infiltrated by. diffuse type poorly differentiated adenocarcinoma (linitis plastica. pattern), with full thickness wall infiltration and metastases in 7. of 7 lesser and greater curve lymph nodes. Surgical margins are. clear. pT3N2Mx. 3. Right gastroepiploic lymph node showing metastatic adenocarcinoma.",T2,N0,M0,T2N0M0
TCGA-EA-A97N,"Gross Description: Uterus with colli uteri is 9x6 cm in its size. In colli uteri is dense gray-rose tumor 8x4. cm in its size with invasion to serosa. Endometrial hyperplasia. Microscopic Description: 1) Colli uteri -- squamous cell carcinoma, G2. 2) Glandular hyperplasia of the endometrium. 3) Vaginal cuff -- leukoplakia of stratified squamous epithelium. 4) Right and left parametrium -- fatty and fibrosis tissues without pathological changes. 5) Right lymph nodes - 3 examined lymph nodes demonstrate lipomatosis, sinus histiocytosis. 6) Left lymph nodes -- 3 examined lymph nodes demonstrate lipomatosis, sinus histiocytosis. 7) Presacralis lymph nodes -- 4 examined lymph nodes demonstrate lipomatosis, sinus histiocytosis. Diagnosis Details: Tumor Features: Unknown, Tumor Extent: Lesion greater than 4.0cm, Venous. Invasion: Absent, Margins: Absent, Treatment Effect: Comments: 8.5. Original CRF reads T1. But tumor size more 4 cm - stage T2a2 according to the AJCC 7th. edition of TNM-classification. Formatted Path Reports: CERVIX TISSUE CHECKLIST. Specimen type: Radical hysterectomy. Tumor site: Cervix. Tumor size: 4 X 0 X 8 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 0/10 positive for metastasis (Suprailiac right, left; presacralis 0/10). Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: Not specified. Comments: None.",T1,N0,M0,T1N0M0
TCGA-44-6145,"SPECIMEN. A. Level 12 lymph nodes. B. Level 11 lymph nodes. C. Level 10 lymph node. D. Right upper lobe. E. 2R lymph node. F. 4R lymph node. G. Level 7 lymph node. H. Level 8 lymph node. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung nodule. GROSS DESCRIPTION. A. [The specimen is] Received in formalin labeled ""Level. 12 lymph nodes"" and consists of a red and black piece of. soft tissue measuring 1.2 cm. in greatest dimension. AS-1. B. Received unfixed labeled ""Level 11 lymph nodes"" and. consists of a black and e piece of soft tissue measuring. 1.6 cm. in greatest dimension. C. Received unfixed la. ""Level 10 lymph node"" and. consists of portions of red and 1 k soft tissue measuring. 2 cm. in greatest aggregate dimension. D. The specimen is received un , labeled ""right upper. lobe"" and consists of a 192 gram lung lobe measuring 12.5 X. 9.5 X 3 cm. There is a contained roughly spherical mass that is. subpleural and measures 2 cm. in diameter. A portion of the specimen. is taken for research purposes. Sections after fixation. E. Received unfixed labeled ""2R lymph node"" and consists. of three i es of yellow and red soft tissue measuring 2.5. X 3.5 X 0.4 cm. F. Rece unfixed labeled ""4R lymph node"" and consists. of multiple pieces of pink and. a. soft tissue measuring. 1 cm. in greatest aggregate dimension. G. Received unfixed labeled ""Le. lymph node"" and. consists of a yellow and black piece of soft tissue. a. ring 2.4 X 1.7 x 0.3 cm. in greatest aggregate dimension. H. Received unfixed labeled ""Level 8 lymph node"" and. consists of portions of pink and black so. issue. measuring 1 cm. in greatest aggregate dimension. MICROSCOPIC DESCRIPTION. A. A single lymph node is negative for malignancy. B. A single lymph node is negative for malignancy. C. No evidence of malignancy in multiple lymph nodes or lymph node. pieces. D. Tumor type: Adenocarcinoma. Tumor grade: 2-3 out of 3. Tumor size: 2 cm. Bronchial resection margin: Negative for malignancy. Pleura: Negative for malignancy. Vascular invasion: Absent. Attached lymph nodes. None. pTNM Stage: T1. Non-tumorous lung: Emphysema. E. There is no evidence of malignancy in any of 3 lymph nodes. F. A single lymph node is negative for malignancy. G. A single lypmh node is negative for malignancy. H. There is no evidence of malignancy in any of 4 lymph nodes. 4x2,3x6. DIAGNOSIS. A. Lymph node, level XII, biopsy: A single lymph node is negative for malignancy. B. Lymph nodes, level XI, biopsy: A single lymph node is negative for malignancy. C. Lymph node, level X, biopsy: There is no evidence of malignancy in multiple lymph nodes or. lymph node pieces. D. Lung, right upper lobe, resection: Moderately to poorly differentiated adenocarcinoma. E. Lymph node, 2R, biopsy: There is no evidence of malignancy in any of 3 lymph nodes. F. Lymph node, 4R, biopsy: A single lymph node is negative for malignancy. G. Lymph node, level VII, biopsy: A single lymph node is negative for malignancy. H. Lymph node, level VIII, biopsy: There is no evidence of malignancy in any of 4 lymph nodes. End Of Report ---.",T1,N0,M0,T1N0M0
TCGA-F5-6864,"26 cm long colon segment. At the. Adenocarci. distance of 5 cm from one of surgical. noma, G2,. margin there is a circular, ulcerated,. with. 9 cm long tumor; all rectum wall. ulceration,. layers are infiltrated, with fatty tissue. all wall. invasion. Fatty tissue lymph nodes. layers. are dense, grey, conglomerate-like. infiltration,. initial fatty. tissue. invasion,. metastase. S in the. lymph. nodes. conglomer. ate. Rectum. surgical. margins. are free of. tumor. growth. Tumor Features: Annular, Tumor. LARGE INTESTINE TISSUE CHECKLIST. Extent: Fat, NOS, Venous Invasion: Absent, Margins: Absent, Treatment. Specimen type: Resection of rectum. Effect: Specimen size: Not specified. Tumor site: Rectum. Tumor size: 9 X 0 X 0 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Perirectal tissues. Lymph nodes: 4/4 positive for metastasis. (Regional 4/4). Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not. specified. Comments: None.",T3,N2,M0,T3N2M0
TCGA-DK-AA6Q,"Addendum. F. Urology. Clinical Diagnosis & History: History of T2 bladder carcinoma with focal squamous differentiation. Specimens Submitted: 1: Right common iliac lymph nodes. 2: Left common iliac lymph nodes. 3: Right distal lymph nodes. 4: Bladder, uterus, tubes and ovaries, peri-vesicle lymph nodes. 5: Left distal pelvic lymph nodes. 6: Pre-sacral lymph nodes. 7: Abdominal wall skin scar. 8: Left distal ureter. 9: Right distal ureter. DIAGNOSIS: 1. Right common iliac lymph nodes: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 5. 2. Left common iliac lymph nodes: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 7. 3. Right distal lymph nodes: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 12. Comment: AE1/AE3 immunohistochemical staining on a selected slide fails to reveal carcinoma in lymph nodes. 4. Bladder, uterus, tubes and ovaries, peri-vesicle lymph nodes: Tumor Type: Invasive urothelial carcinoma, NOS. with focal squamous features. Histologic Grade: High grade. Pattern of growth of the Non-Invasive component: Flat (in situ carcinoma). Pattern of growth of the Invasive component: Infiltrating. Tumor Multicentricity: Identified. Bladder Local Invasion: Perivesical soft tissues. Extravesical Tumor Extension: Ureters uninvolved. Urethra uninvolved. Vascular Invasion: Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Mucosa: Exhibiting chronic cystitis. Exhibiting ulceration. Female Genital Organs: The endometrium shows atrophy. The myometrium shows a leiomyoma. The right fallopian tube shows an adenofibroma. Remaining genital organs are unremarkable. Perivesical Lymph Nodes: Not identified. The Pathologic Stage is (AJCC 2002): pT3 (Invasion of perivesicle soft tissue). Comment: Immunohistochemical stains for HPV in situ hybridization and p16 fail to reveal an association with HPV. 5. Left distal pelvic lymph nodes: Lymph Node Dissection: Metastatic urothelial carcinoma. Number of lymph nodes examined: 4. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 1.6cm. Size of the largest metastatic focus : 1.6 cm. Extranodal extension is not identified. 6. Pre-sacral lymph nodes: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 5. 7. Skin, abdominal wall skin scar: - Benign skin with scar. 8. Left distal ureter, resection: - Benign segment of ureter. 9. Right distal ureter, resection: - Benign segment of ureter. Note: Some of the immunohistochemistry and ISH tests were developed and their performance characteristics were determined. by the Department of Pathology. They have not been cleared or approved by the US Food and Drug Administration. The FDA has. determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be. regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of. 1988 (CLIA '88) as qualified to perform high complexity clinical laboratory testing. IATTEST THAT THE ABOVE DIAGNOSISIS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Procedures/Addenda: Addendum. Gross Description: 1) The specimen is received fresh, labeled ""Right common iliac lymph nodes"" and consists of a gray-tan rubbery nodule measuring. 1.7 x 0.5 x 0.3 cm. Two additional possible lymph nodes identified measuring 0.4 and 0.5 cm. The lymph node is entirely. submitted. The additional tissue is submitted. Summary of sections: LN - lymph node. RS - possible lymph nodes. 2) The specimen is received fresh, labeled ""Left common iliac lymph nodes"" and consists of multiple pink tan firm lymph nodes. ranging from 0.2 to 1.0 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes (7). BLN - bisected lymph node (1). 3) The specimen is received fresh, labeled ""Right distal lymph nodes"" and consists of multiple pink tan firm lymph nodes ranging. from 0.2 to 2.1 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes (10). BLN - bisected lymph nodes (2). 4) The specimen is received fresh, labeled ""Bladder, uterus, tubes and ovaries, peri vesicles lymph node"". It consist of a radical. cystectomy specimen with attached uterus and bilateral adnexa S organs measuring 12.0cm from superior to inferior, 9.0 cm. laterally and 4.0 cm from anterior to posterior. The bladder measures 8.0 x 7.0 x 2.0 cm, the uterus measures 8.0 x 4.0 x 2.0 cm,. the right ovary measures 4.5 x 1.5 x 0.7 cm, the right fallopian tube shows to blind segments measuring 3.0 and 3.5cm from. proximal to distal, the left ovary measures 3.5 x 1.2 x 0.7 cm, and the left fallopian tube shows to blind ends measuring 2.0 and 3.7. cm form proximal to distal. The portion of vaginal cuff measures 3.0 x 2.7 x 0.5 cm. The distal urethra and the vaginal cuff margin. are shaved and submitted. The ureteric stumps measure 3.0 x 0.4 cm and show a 0.1 cm pinpoint lumen. The specimen is inked. black( anteriorly), blue posteriorly and the bladder is opened anteriorly to reveal four white tan lesions, designated as follows: Prominent nodular lesion located on the left posterior wall measuring 1.7 x 1.5 x 0,7 cm, arbitrarily designated as lesion A. There is. a 2.2 x 1.7cm lesion located 1.7cm from right ureter orifice, embedded in a diverticulum with irregular indurated borders, located. on the right posterior wall, designated as lesion B, which measures1.2 cm in depth, and 0.5cm from the blue inked peri-adipose. tissue. The lesion lies 1.0 cm from the right ureteral orifice. A third white tan nodular lesion is identified on the right anterior wall,. measuring 0.7 x 0.6 x 0.6cm, designated as C. A fourth nodular lesion is identified on the right lateral superior wall, measuring 1.2. x 0.9 x 0.7 cm designated as D. Multiple pink red, suspicious scar-like areas are identified varying from 0.4 to 0.7cm in greatest. dimension. The remaining bladder mucosa shows a pink tan, edematous focally hemorrhagic surface. Discrete perivesical lymph. nodes are not. The uterus is bivalved to reveal a 0.1cm pink tan endometrial surface. The ovaries and fallopian tubes show. a. multicystic. cut surface. Tissue was submitted for TPS. Gross photographs are taken. Representative sections are submitted. Summary of sections: UM - distal urethra. RUM - right ureter margin. LUM - left ureter margin. RUO - right ureteric orifice. LUO - left ureteric orifice. LPW - left posterior wall. LAW - left anterior wall. RPW- right posterior wall. RAW - right anterior wall. TRI trigone. DOME dome. F - perivesical fat. EMM - endomyometrium. CX cervix. DVM - distal vaginal margin. RTO - right tube and ovary. LTO - left tube and ovary. LA - lesion A. LB - lesion B. LC - lesion C. LD - lesion D. SA - suspicious mucosal areas. LN - whole lymph nodes. BLN - bisected lymph nodes. 5) The specimen is received in formalin, labeled ""Left distal pelvic lymph nodes"" and consists of three gray tan firm, matted positive. lymph nodes. The largest positive lymph node measures 3.0 x 1.5x 1.3cm All identified lymph nodes are submitted. Sample. was given to TPS protocol. Summary of sections: LN - lymph nodes. RLN -representative lymph node. 6) The specimen is received in formalin, labeled ""Pre sacral lymph nodes"" and consists of five tan blue firm lymph nodes ranging. from 0.7 to 1.4 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. 7) The specimen is received in formalin labeled ""Abdominal wall skin scar."" It consists of a strip of white-tan skin measuring 8.5 x. 1.0 x 1.0 cm. The surface of the skin shows scarred appearance. Representative sections are submitted. Summary of sections: U-undesignated. 8) The specimen is received in formalin, labeled ""Left distal ureter, unclipped end is margin"" and consists of a tan-white tubular. tissue fragment measuring 5.2 cm in length and 0.6 cm in diameter, with attached adipose tissue measuring 0.8 cm in thickness. There is a clip at one end of the specimen. On cut section, the mucosa appears white-tan and grossly unremarkable. The. specimen is sequentially sectioned from the clipped end to the non-clipped end and submitted entirely. Summary of sections: CE - clipped end. UCE - non-clipped end. SS - sequential sections from clipped to non-clipped end. 9). The specimen is received in formalin, labeled ""Right distal ureter, unclipped end is margin"" and consists of a tan-white tubular. tissue fragment measuring 5.8 cm in length and 0.6 cm in diameter, with attached adipose tissue measuring 0.8 cm in thickness. There is a clip at one end of the specimen. On cut section, the mucosa appears white-tan and grossly unremarkable. The. specimen is sequentially sectioned from the clipped end to the non-clipped end and submitted entirely. Summary of sections: CE - clipped end. UCE - non-clipped end. SS - sequential sections from clipped to non-clipped end. Summary of Sections: Part 1: Right common iliac lymph nodes. Blocks Block Designation. PCs. 1. LN. 1. 1. RS. 2. Part 2: Left common iliac lymph nodes. Blocks Block Designation. PCs. 1. BLN. 2. 2. LN. 7. Part 3: Right distal lymph nodes. Blocks Block Designation. PCs. 2. BLN. 4. 2. LN. 10. Part 4: Bladder, uterus, tubes and ovaries, peri-vesicle lymph nodes. Blocks Block Designation. PCs. 1. CX. 2. 1. DOME. 1. 1. DVM. 1. 1. EMM. 2. 6. LA. 6. 1. LAW. 1. 5. LB. 5. 2. LC. 2. 4. LD. 4. 1. LPW. 1. 1. LTO. 4. 1. LUM. 1. 1. LUO. 1. 1. RAW. 1. 1. RPW. 1. 1. RTO. 4. 1. RUM. 1. 1. RUO. 1. 2. SA. 6. 1. TRI. 1. 1. UM. 1. Part 5: Left distal pelvic lymph nodes. Blocks Block Designation. PCs. 1. LN. 1. 1. RLN. 1. Part 6: Pre-sacral lymph nodes. Blocks Block Designation. PCs. 2. LN. 5. Part 7: Abdominal wall skin scar. Blocks Block Designation. PCs. 1. U. 1. Part 8: Left distal ureter. Blocks Block Designation. PCs. 1. CE. 1. 4. SS. 4. 1. UCE. 1. Part 9: Right distal ureter. Blocks. Block Designation. PCs. 1. CE. 1. 4. SS. 4. 1. UCE. 1. Special Studies: Special Stain. Comment. KP1 (CD68). AE1:AE3. IMM RECUT. NEG CONT. CD30(BERH2). CD3 (Leu4). CD20 (L26). EBER-ISH. P16. HPV-ISH. P16. HPV-ISH. P16. HPV-ISH. IMM RECUT. NEG CONT. IMM RECUT. NEG CONT. IMM RECUT. NEG CONT. RECUT. RECUT. RECUT. RECUT. RECUT. RECUT. RECUT. RECUT. RECUT. P16. HPV-ISH. IMM RECUT. NEG CONT.",T3,N1,M0,T3N1M0
TCGA-BH-A0HY,"FINAL DIAGNOSIS: PART 1: LEFT AXILLARY SENTINEL LYMPH NODE #1, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 2: BREASI, LEFT, TOTAL MASTECTOMY -. A. TWO FOCI OF INVASIVE DUCIAL CARCINOMA, NOTTINGHAM GRADE 2 (TUBULE FORMATION 3, NUCLEAR. GRADE 2, MITOTIC RATE 1; TOTAL SCORE 6/9) WITH ASSOCIATED MICROCALCIFICATIONS. B. THE FIRST FOCUS MEASURES 2.0 CM AND IS PRESENT AT 3 O'CLOCK POSITION AT THE JUNCTION OF. LOWER OUTER AND UPPER OUTER QUADRANTS. C. THE SECOND FOCUS MEASURES 0.15 CM (1.5 MM) AND IS PRESENT IN THE LOWER OUTER QUADRANT. D. NO LYMPHOVASCULAR SPACE INVASION IS SEEN. E. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 2, SOLID AND CRIBRIFORM TYPE WITH COMEDO. NECROSIS AND ASSOCIATED MICROCALCIFICATIONS. F. DCIS IS PRESENT ADMIXED AND OUTSIDE OF INVASIVE CARCINOMA AND COMPRISES APPROXIMATELY. 70% OF TOTAL TUMOR VOLUME. G. DCIS IS SEEN IN ELEVEN OUT OF TWENTY SLIDES IN THE UPPER OUTER AND LOWER OUTER. QUADRANTS. H. INKED MARGINS OF RESECTION ARE NEGATIVE FOR CARCINOMA. I. INVASIVE AND IN SITU CARCINOMA LESS THAN 1 MM AWAY FROM THE CLOSEST DEEP MARGIN (AT 3. O'CLOCK POSITION, LOWER OUTER QUADRANT). J. ATYPICAL DUCTAL HYPERPLASIA. K. FIBROCYSTIC CHANGES WITH BENIGN EPITHELIAL CALCIFICATIONS. L. SKIN AND NIPPLE, NEGATIVE FOR TUMOR. M. BIOPSY SITE CHANGES (see comment). N. INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN RECEPTOR, NEGATIVE FOR PROGESTERONE. RECEPTOR, AND POSITIVE FOR HER-2/NEU WITH A SCORE OF 3+, AS PER PREVIOUS PATHOLOGY. PART 3: LEFT AXILLARY SENTINEL LYMPH NODE #2, BIOPSY -. ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 4: LEFT AXILLARY SENTINEL LYMPH NODE #3, BIOPSY -. ONF I VMPH NODE. NEGATIVE FOR METASTATIC CARCINOMA (0/1). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Simple mastectomy. Upper outer quadrant. Lower outer quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 2.0 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR AGGREGATE SIZE: Sum of the sizes of multiple invasive tumors: 2.15 cm. TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Solid. DCIS admixed and outside of invasive carcinoma component. Percent of tumor occupied by in situ component: 70 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 1 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 1 mm. LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 3. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: negative. HER2/NEU: 3+.",T1,N0,M0,T1N0M0
TCGA-BH-A1F0,"Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE of LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: L BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: LEFT TOTAL MASTECTOMY, LEFT AXILLARY SAMPLING. CLINICAL HISTORY: MATERIAL SUEMITTED: LEFT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: Left breast with axillary sampling. Mass identified at 1:00 position, 2.0 by 2.0 by 2.0 cm. Second. lesion,. just lateral to first, 1.5 by 1.5 by 1.0 cm. Surgical margins grossly free for both tumors. Axillary tail. containing fatty lymph node with blue coloration (treat as sentinel node). R E V I s E D R E P o R T. IAGNOSIS: Litt BREAST BIOPSY, TOTAL MASTECTONY : TWO (2)  SEPARATE FOCI OF INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED, MULTIFOCAL IN UPPER. OUTER QUADRANT. - SIZK OF THE FOCI ARE 2.0 BY 2.0 BY 2.0 AND 1.5 BY 1.5 BY 1.0 CX. - OOTH TUMORS HAVE IDENTICAL MORPHOLOGY. - NOTTINGHAM SCORE=8 (TUBULES-3, NUCLEAR ATYPIA-3, MITOSIS-2). - ALL SURGICAL MARGINS FREE OF TUMOR. - NIPPLE AND AREOLA WITH NO DIAGNOSTIC CHANGES. - NON-NEOPLASTIC BREAST WITH NO DIAGNOSTIC CHANGES. - ONE (1) LYMPH NODE (SENTINEL) POSITIVE FOR MITASTATIC CARCINOMA (1/9). NOTE: The micrometastasis measures 1.5 mm and was identified both on HES and immunoperoxidase stain. AJCC. stage T1C N1a Mx. The two tumor nodules are located in upper outer quadrant. The tumor adjacent to the. nipple mentioned in the previous report, is part of one of the two tumor nodules  ER/PR immunoperoxidase. assay and Her-2/NEU testing will be performed on block ""A2"". REVISION (GROSS DESCRIPTION). Addendum. MATERIAL SUBMITTED: BLOCK ""A2"" AND ""A4"" FOR ER/PR AND HER-2/NEU. FINAL DIAGNOSIS: ER/PR RESULTS (""A2""). IMMUNOPEROXIDASE IDENTIFICATION OF ESTROGEN AND PROGESTZRONE RECEPTORS IS CARRIED OUT ON SLIDE ""A2"". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOCALLY FOR PROGESTERONE RECEPTOR (15%) BUT NOT FOR ESTROGEN. RECEPTOR. THEREFORE, PROGESTERONE RECEPTOR IS INTERPRETED AS BORDERLINE AND ESTROGEN RECEPTOR AS NEGATIVE. HER-2/NEU RESULTS (""A2""). AS PER THE REQUEST OF DR. c-erb82 (HER-2/NEU) IS CARRIED OUT ON PREVIOUS MAGRE. SURGICAL s. (BREAST CANCER) USING A 1:300 DILUTION or DARO'S POLYCLONAL ANTIBODY A485. (DIRECTED. AGAINST. THE INTRACELLULAR DOMAIN OF c-erb82) WITHOUT ANTIGEN RETRIEVAL. NO DISTINCT COMPLETE. MEMBRANE STAINING IS IDENTIFIED. THEREFORE, c-erbB2 (HER-2/NEU) IS INTERPRITED AS NEGATIVE (SCORE 0). ER/PR RESULTS (""A4""). IMMUNOPEROXIDASE IDENTIFICATION or ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE ""A4"". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOCALLY FOR PROGESTGERONE RECEPTOR (15%) BUT NOT FOR ESTROGEN. RECEPTOR. THEREFORE, PROGESTERONE RECEPTOR IS INTERPRETED AS BORDERLINE AND ESTROGEN RECEPTOR AS NEGATIVE. HER-2/NEU RESULTS (""A4""). AS PER THE REQUEST OF DR. c-erbB2 (HER-2/NEU) IMMUNOSTAINING IS CARRIED OUT ON PREVIOUS MAGEE. (BREAST CANCER) USING A 1:300 DILUTION or DARO'S POLYCLONAL ANTIBODY A485. (DIRECTED AGAINST THE INTRACELLULAR DOMAIN OF c-erbB2) WITHOUT ANTIGEN RETRIEVAL. NO DISTINCT COMPLETE. MEMBRANE STAINING IS IDINTIFIED. THEREFORE, c-erbB2 (HER-2/NEU) IS INTERPRETED AS NEGATIVE (SCORE 0) .",T1,N1,M0,T1N1M0
TCGA-AA-3530,"Diagnosis/Diagnoses: 1. Sections of a polypoid neoplasm of the colonic mucosa with the structure of a tubular. adenoma with high-grade dysplasia or transition to at least intramucosal adenocarcinoma in situ. (synonym according to WHO: high-grade intra-epithelial neoplasia, according to IUCC: pTis). 2.: Small, or only small portions of, tubular adenomas of the colonic mucosa with slight. dysplasia (synonym: low-grade intra-epithelial neoplasia). 3.: Tubular adenoma of the colonic mucosa with high-grade dysplasia and transition to an. intramucosal adenocarcinoma (synonym according to WHO: high-grade intra-epithelial. neoplasia, according to IUCC: pTis). In 1. and 3., no detectable transition to a manifest, deeper colon carcinoma infiltrating the wall. layers. Complete tumor resection - where not already done - is recommended. Diagnosis/Diagnoses. Right hemicolectomy specimen with an ulcerated colon carcinoma in the area of the cecal pole. measuring 4 cm in the largest diameter and displacing the appendiceal orifice, arising from a. tubulovillous adenoma with severe epithelial dysplasia (synonym: high-grade intra-epithelial. neoplasia). Invasive tumor spread as far as the muscularis propria. Appendix with formation of. an obstructive type of mucocele and with persistent or florid chronic appendicitis and. perityphlitis. Oral and aboral resection margin and greater omentum tumor-free. Twenty-four mesocolic and mesenteric lymph nodes tumor-free and with uncharacteristically. reactive changes. Tumor stage therefore pT2 pNO (0/24) L0 V0; G2.",T2,N0,M0,T2N0M0
TCGA-3U-A98G,"Gender: Male. Race: White. Report Date: Tissue Procurement Date: FINAL PATHOLOGIC DIAGNOSIS. A. #11 lymph node; biopsy: - Two lymph nodes, no tumor (0/2). B. Level 7 lymph node; dissection: - Three lymph nodes, no tumor (0/3). C. #8 lymph node; biopsy: - One lymph node, no tumor (0/1). D. 4R lymph node; biopsy: - Two lymph nodes, no tumor (0/2). E. Right parietal and visceral pleura, diaphragm and pericardium: - Malignant biphasic mesothelioma; see comment. - See parameters. Thoracic Mesothelioma Pathologic Parameters. Pleura Resection. MACROSCOPIC. Specimen Type: Pleural resection. Tumor Site: Right pleura, pericardium, and diaphragm. Tumor Configuration and Size: Diffuse, maximum thickness: 3.5 cm. MICROSCOPIC. Histologic Type: Biphasic mesothelioma (80% epithelioid, 20% sarcomatoid). Tumor Extension: Confluent visceral pleural tumor (including fissure). Into but not through diaphragm. Into and through the pericardium. Venous/Lymphatic (Large/Small Vessel) Invasion: Absent. Margins: Cannot be assessed. Pathologic Staging (pTNM): pT4, NO. Primary Tumor (pT). pT4: Tumor (locally advanced technically unresectable) involves any of the. ipsilateral pleural surfaces, with at least lof the following: diffuse or. multifocal invasion of soft tissues of the chest wall, any involvement of rib,. invasion through the diaphragm to the peritoneum, invasion of any mediastinal. organ(s), direct extension to the contralateral pleura, invasion into the spine,. extension to the internal surface of the pericardium, pericardial effusion with. positive cytology, invasion of the myocardium. Regional Lymph Nodes (pN). pN0: No regional lymph node metastasis. Specify: Number examined: 8. Number involved: 0. Comment. Immunohistochemical staining with CAM5.2 was positive in both epithelioid and. sarcomatoid mesothelioma. Of note, expansile nodules composed of sarcomatoid. mesothelioma are seen at the diaphragm with epithelioid and spindle cells. extending into the muscle. In the invasive ares, only the epithelioid cells. stain positively for CAM5.2, whereas the spindled cells are negative. This shows. epithelioid mesothelioma extension into the diaphragm, but spindled cell within. the diaphragm may reflect desmoplastic stroma. In addition, CD34 stain shows no. venous or lymphatic invasion. All controls are appropriate. Dr. has. reviewed the case and concurs. M.D. Interpretation performed by the Attending Pathologist and reviewed with the. Resident/Fellow, , MD. Clinical History: The patient is a -year-old male with mesothelioma undergoing right. thoracotomy, pleurectomy, and decortication. Specimens Received: A: #11. B: Level 7. C: #8. D: 4R. E: Right parietal visceral pleura diaphragm and pericardium. Gross Description: The specimens are received in five containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, ""1. #11"". Received fresh. and placed in formalin are 2 gray-black nodular, rubbery fibrofatty tissue. fragments measuring 0.8 x 0.7 X 0.6 cm and 1.2 x 0.7 x 0.6 cm. Each nodule is. bisected. A thin section of tissue is detached from the larger nodule during. bisection. The smaller nodule is submitted entirely in A1, and the larger nodule. along with the detached fragment is submitted in A2. B. The second container is additionally identified as, ""2. Level 7"". Received. fresh and placed in formalin are 3 grey-black nodular, rubbery fibrofatty tissue. fragments measuring 0.8 x 0.4 x 0.3 cm, 1.9 x 1.1 x 0.6 cm, and 1.9 x 1.1 x 0.8. cm. Each nodule is bisected and submitted entirely in B1-B3. C. The third container is additionally identified as, ""3. #8"". Received fresh. and placed in formalin is a grey-black nodular, rubbery fibrofatty tissue. fragment measuring 1.8 x 1.2 x 0.6 cm. The specimen is bisected and submitted. entirely in C1. D. The fourth container is additionally identified as, ""4. 4R"". Received fresh. and placed in formalin are 2 brown-tan rubbery tissue fragments measuring 1.1 x. 0.5 X 0.4 cm and 1.5 x 1 x 0.3 cm as well as a gray-black lobulated, rubbery. fibrofatty tissue fragment measuring 3.1 x 2.3 x 0.3 cm. The 2 brown-tan. fragments are submitted entirely in D1. The gray-black larger tissue fragment is. divided and submitted entirely in D2-D3. E. The fifth container is additionally identified as, ""5. Right parietal. visceral pleura, diaphragm + pericardium black stitch marks pericardium, white. stitch marks diaphragm"". Received fresh is a 575 gm, 600 ml pleurectomy specimen. measuring 31 x 16 x 3 cm. There is an attached 6.5 x 2.5 cm surface of smooth,. pink-tan pericardium, which is 0.2 cm thick. There is a 13 x 11 cm portion of. attached red-brown, ragged diaphragm, which is 0.8 cm thick. The specimen is. inked as follows: pericardial surface - blue, abdominal surface of diaphragm -. black. The specimen is sectioned to reveal white, firm, lobulated tumor present. throughout the visceral pleura. Greater than 90% of the pleura is involved by. tumor. The visceral and parietal pleura are thickened (up to 0.5 cm) and fused. The tumor invades the diaphragm up to a depth of 0.8 cm, which comes to <0.1 cm. to the inked margin. The abdominal surface of the diaphragm is free of tumor. The greatest tumor dimension is 3.5 cm. Gross photographs are taken. Representative sections are taken as follow: E1-E2: Pericardium. E3-E9: Diaphragm. E10-E15: Pleura and chest wall. MD.",T4,N0,M0,T4N0M0
TCGA-EB-A97M,"Gross Description: There is a fragment of skin 8x4 cm in its size with pigmented mass 2x1,5 cm in its. size with invasion into fatty tissue. Microscopic Description: Malignant melanona (pigmented), in cells of nevus, with ulcerating. Clarks is IV,. Breslow is 15 mm. Diagnosis Details: Tumor Features: Ulcerated, Tumor Extent: More than 4 mm with or without. ulceration, Venous Invasion: Absent, Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: SKIN TISSUE CHECKLIST. Specimen type: Excision of skin lesion. Tumor site: Skin, trunk. Tumor size: 1.5x0x2cm. Tumor features: Ulcerated, Pigmented. Satellite nodules: Not specified. Histologic type: Malignant melanoma. Histologic grade: Undifferentiated. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: Clark's level IV, Breslow is 15 mm. Comments: None.",T4,N0,M0,T4N0M0
TCGA-DD-A1ED,"TISSUE DESCRIPTION. A1 A2 A3 B1 B2 B3 B4 Portion liver segments V and VI. (200 grams; 3.6 x 3.5 x 3.2 cm) and separately submitted. gallbladder (10.0 X 5.0 X 3.0 cm). DIAGNOSIS: Liver, portion segments V and VI, resection: Well. differentiated (grade 1 of 4) hepatocellular carcinoma forming. a. well demarcated and irregular-shaped subcapsular nodule (3.6 X. 3.5 X 3.2 cm) The surgical margins are negative (closest is. 1.5 cm). Comment: The background liver is noncirrhotic, In cytochemical. stains of the tumor mass using tissue block B4, there is a loss. of normal reticulin architecture within the neoplasm supporting. the diagnosis of hepatocellular carcinoma. The presence of. pigment/hemorrhage within the lesion is likely reflective of the. previous needle biopsy (outside material. Gallbladder, cholecystectomy: Acute and chronic cholecystitis. with cholelithiasis containing multiple (12) mixed stones. ranging in size from 0.2 cm to 1.1 cm in greatest dimension. One of the stones is situated in the cystic duct near an area of. stricture (0.5 cm in diameter). PRELIMINARY FROZEN SECTION CONSULTATION: Favor focal nodular hyperplasia. HOLD OVER for permanent. sections. TISSUE DESCRIPTION: A1 A2 A3 B1 B2 B3 B4 Portion liver segments V and VI. (200 grams; 3.6 X 3.5 X 3.2 cm) and separately submitted. gallbladder (10.0 X 5.0 X 3.0 cm) . DIAGNOSIS: Liver, portion segments V and VI, resection: Well. differentiated (grade 1 of 4) hepatocellular carcinoma forming a. well demarcated and irregular-shaped subcapsular nodule (3.6 X. 3.5 x 3.2 cm) The surgical margins are negative (closest is. 1.5 cm). Comment The background liver is noncirrhotic. In cytochemical. stains of the tumor mass using tissue block B4, there is a loss. of normal reticulin architecture within the neoplasm supporting. the diagnosis of hepatocellular carcinoma. The presence of. pigment/hemorrhage within the lesion is likely reflective of the. previous needle birpsy (outside material. Gallbladder, cholecystectomy : Acute and chronic cholecystitis. with cholelithiasis containing multiple (12) mixed stones. ranging in size from 0.2 cm to 1.1 cm in greatest dimension. One of the stones is situated in the cystic duct near an area of. stricture (0.5 cm in diameter). PRELIMINARY FROZEN SECTION CONSULTATION: Favor focal nodular hyperplasia. HOLD OVER for permanent. sections.",T1,N0,M0,T1N0M0
TCGA-G3-A3CI,"PHN: ACB: Telephone: Encounter: Collected Date: Specimen Description. A. Gallbladder. B. Segment 5 and 6 of liver. Clinical Information. Hepatocellular carcinoma. Diagnosis. A. Gallbladder: - Mild chronic cholecystitis, negative for atypia. B. Liver, Segments 5 and 6, Resection: - Hepatocellular carcinoma, moderately differentiated (Gr II). - Subcapsular location, 6.5 cm greatest diameter. - Completely excised, with nearest margin of 0.5 cm. Pathology: Provider - Permanent. Collected Date: Gross Description. Received are specimens A to B. All requisitions and specimen containers are labelled with the patient's name. The cassettes and AP identifiers are labelled with the Surgical Numbe. A. The specimen is received fresh, subsequently placed into formalin and consists of a slightly congested, non intact. gallbladder, measuring 7.0 X 3.0 X 1.5 cm. The serosal surface is smooth and glistening. Opening the gallbladder reveals. green bile and green, velvety mucosa. The gallbladder wall averages 0.2 cm in thickness. The cystic duct is patent. The. cystic duct lymph node is not identified. Three representative sections are submitted in one cassette. B. The specimen is received fresh, subsequently placed into formalin and consists of a portion of liver weighing 245. grams and measuring 15.0 x 5.5 x 7.5 cm. The surgical margin is inked blue. Sectioning of the liver reveals a tan,. lobulated, circumscribed mass measuring 5.5 X 4.5 X 6.5 cm. Grossly, this mass extends to the liver capsule giving the. capsule a lobulated appearance in one area. The mass comes to within 0.5 cm of the blue-painted resection margin. There is a vague nutmeg appearance to the liver parenchyma, otherwise it is unremarkable. Sections of the specimen are as follows: B1,B3. three sections through the lobulated surface on the liver capsule. B4,B5. two sections of the mass in relation to the blue-painted margin. B6,B7. two sections of the mass with adjacent unremarkable liver parenchyma. B8. a section of unremarkable liver parenchyma. Microscopic Description. A. Sections show largely unremarkable gallbladder tissue with only minor patchy chronic inflammation in the mucosa and. focal mild subserosal fibrosis. No atypia is present. B. Sections show a relatively circumscribed but invasive hepatocellular carcinoma that extends to the liver capsule, but. does not show any sign of disruption or breaching of the capsule. The carcinoma grows in sheets with cells showing. relatively abundant cytoplasm but showing variable nuclei with mild to moderate atypia, nucleoli, and patchy. hyperchromasia. Cytoplasmic intranuclear inclusions are also prominent. The tumor cell cytoplasm shows a range of. appearances, from granular eosinophilic to through to areas of clear cell change as well as areas with well developed fatty. change. In places a vague sinusoidal architecture can be seen and intra sinusoidal collections of extramedullary. hemopoiesis are present. Focal areas of hemorrhage, edematous degeneration and focal frank necrosis are present. The interface between the carcinoma and adjacent liver tissue varies, in areas having a circumscribed and almost. encapsulated margin but elsewhere having a vague merging of cancer cells with adjacent parenchyma. No evidence of. vascular invasion can be identified. Pathology: Provider - Permanent. Cunninal Anthalance Report. . Collected Date: The adjacent liver parenchyma shows mild patchy chronic inflammation in portal tracts (nonspecific portal triaditis) as well. as focal mineral oil lipogranulomas in portal areas. There is no hemosiderin accumulation or other abnormal. intracytoplasmic inclusions. No evidence of significant fibrosis or background cirrhosis is present. Histologic evaluation of. the margin confirms the gross appearance of a clear margin of approximately 0.5 cm. Pathology: Provider - Permanent.",T1,N0,M0,T1N0M0
TCGA-HU-A4GN,"GROSS: Specimen state: Fresh. Operation: Distal gastrectomy. Measurement: Greater curvature 15.5 cm. Lesser curvature 14.4 cm. Proximal resection margin 18.3 cm. Distal resection margin 6.0 cm. Duodenum 0.8 cm. Lesion: Ulceroinfiltrative mass. Tumor size: 5.3 x 4.0 x 0.5 cm. Location: Anterior wall of proximal antrum. Tumor type: AGC (Borrmann type III). From proximal resection margin - 7.1 cm. From distal resection margin - 4.6 cm. Gross serosal invasion: No. Blocks. T1-4 and TB, tumor and surrounding tissue x 5. A, antral mucosa X 1. B and NB, body mucosa x 2. P, proximal resection margin x 1. D, distal resection margin of resected specimen X 1. DRM, labeled as 'distal margin' x 1. LN1-2, superior gastric lymph nodes x 2. LN3-4, inferior gastric lymph nodes x 2. LN5, '1' lymph nodes x 1. LN6, '4sb' lymph nodes x 1. LN7, '5' lymph nodes x 1. LN8, '6' lymph nodes x 1. LN9, '7' lymph nodes x 1. LN10-11, 88 lymph nodes x 2. LN12, '9' lymph nodes x 1. LN13-14, '11p' lymph nodes x 2. LN15, '12' lymph nodes x 1. MICROSCOPIC: Tumor type: Adenocarcinoma. Differentiation: Moderately differentiated. Depth of tumor invasion: T2: Tumor invades muscularis propria. Margins: Proximal resection margin (-). Distal resection margin (-). Lauren classification: Intestinal. Ming classification (Growth pattern): Infiltrative. Stromal reaction: Heavy acute and chronic inflammatory cells infiltrates. Lymphovascular invasion: Present. Venous (large vessel) invasion: Absent. Perineural invasion: Absent. Lymph node metastasis: Present. DIAGNOSIS: Stomach, distal gastrectomy: Adenocarcinoma, moderately differentiated, infiltrating. (advanced gastric cancer). Final <Addendum> diagnosis: Stomach Intestinal Adenocarcinoma, Tubular Type penclanification by TSS. Lymph node, perigastric, distal gastrectomy: Superior gastric: Metastatic carcinoma, primary in stomach (1/13). Inferior gastric: No tumor present (0/7). Lymph node, regional, biopsy: Labeled as '1': No lymphoid tissue. Labeled as '4sb': No tumor present (0/2). Labeled as '5': No tumor present (0/1). Labeled as '6': No tumor present (0/3). Labeled as '7': No tumor present (0/1). Labeled as '8': No tumor present (0/9). Labeled as '9': No tumor present (0/1). Labeled as '11p': No tumor present (0/9). Labeled as '12': No tumor present (0/1). Lymph node, regional, biopsy: Labeled as '1': No tumor present (0/2). Extranodal tumor extension. Labeled as '2': No tumor present (0/4). Extranodal tumor extension. Labeled as '4sa': No tumor present (0/7). Extranodal tumor extension. Labeled as '4sb': No tumor present (0/4). Labeled as '5': No tumor present (0/2). Labeled as '6': No tumor present (0/13). Labeled as '7': No tumor present (0/2). Labeled as '8a': No tumor present (0/2). Labeled as '8p': No tumor present (0/1). Labeled as '9': No tumor present (0/9). Labeled as '10"": No lymphoid tissue. Labeled as '11p': No tumor present (0/1). Labeled as '11d': No tumor present (0/1). Labeled as '12': No tumor present (0/2). Labeled as '11o': No tumor present (0/3).",T2,N1,M0,T2N1M0
TCGA-E2-A1AZ,"SPECIMENS: A. SENTINEL LMYPH NODE LEFT AXILLA #1. B. SLNODE LEFT AXILLA 2. C. SLNODE 3. D. WIDE EXCISION LEFT BREAST. E. ADDITIONAL DEEP MARGIN. F. ADDITIONAL MEDIAL MARGIN. DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, LEFT AXILLARY, RESECTION: -MICROMETASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1). B. LYMPH NODE, SENTINEL #2, LEFT AXILLARY, RESECTION: -ONE LYMPH NODE, NEGATIVE FOR METASTASIS (0/1). C. LYMPH NODE, SENTINEL #3, LEFT AXILLARY, RESECTION: -ONE LYMPH NODE, NEGATIVE FOR METASTASIS (0/1). D. BREAST/LEFT, RESECTION: INVASIVE DUCTAL CARCINOMA, SBR GRADE III/III. -TUMOR SIZE: 3.3x2.6x2.5 CM. -MARGINS FREE OF TUMOR. -SEE TEMPLATE. FIBROCYSTIC CHANGES WITH APOCRINE METAPLASIA, SCLEROSING AND BLUNT DUCT. ADENOSIS. E. BREAST, ADDITIONAL DEEP MARGIN, RESECTION: -BREAST TISSUE, NEGATIVE FOR TUMOR. F. BREAST, ADDITIONAL MEDIAL MARGINS, RESECTION: -BENIGN BREAST TISSUE WITH SCLEROSING ADENOSIS AND FOCAL ATYPICAL DUCTAL. HYPERPLASIA. Invasive Breast Cancer Template. INVASIVE TUMOR: Histologic type: Ductal. Tumor Size : 3.3x2.6x2.5 cm. Size of Invasive Focus: 3.3x2.6x2.5 cm. Grade, Histologic: 3. Grade, Nuclear: 3. Mitoses : 3. Scarff Bloom Richardson grade: III. Necrosis: present. Invasion Vasc/Lymphatic: present. DCIS component. DCIS Quantity: <25%. DCIS Type: solid. DCIS Location: Inside main mass. Nuclear grade: high. Necrosis: absent. Margins: Negative. Lymph nodes: Positive (1/3). Micrometastases: Yes. Extranodal extension: no. Stage, Pathology : pT2N1a (see below). Non-neoplastic areas: Fibrocystic changes with sclerosing and blunt duct adenosis. Hormone receptor status & HERCEPTEST: Previously done,. SPECIMEN(S): A. SENTINEL LMYPH NODE LEFT AXILLA #1 B. SLNODE LEFT AXILLA 2 C. SLNODE 3 D. WIDE. EXCISION LEFT BREAST E. ADDITIONAL DEEP MARGIN F. ADDITIONAL MEDIAL MARGIN. CLINICAL HISTORY: year old with left breast ca. FROZEN SECTION DIAGNOSIS: A. SENTINEL LYMPH NODE LEFT AXILLA #1. Touch Prep: Negative by Dr., called to Dr at. B. SENTINEL LYMPH NODE LEFT AXILLA #2. Touch Prep: Negative by Dr., called to Dr al. C. SENTINEL LYMPH NODE #3. Touch Prep: Negative by Dr., called to Dr. a. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE LEFT AXILLA #1. Received fresh is a 1.8x0.9x0.8cm. lymph node. The lymph node is bisected to reveal tan pink. homogenous cut surface. Touch preparation is made. The specimen is submitted in toto in one. cassette. B. SENTINEL LYMPH NODE LEFT AXILLA #2. Received fresh are two pieces of tan pink soft tissue measuring 0.4x0.4x0.3cm. each. One of them is. recognized as lymph node which is bisected. Touch preparations are made. The specimen is submitted. in toto in one cassette. C. SENTINEL LYMPH NODE #3. Received fresh is one lymph node measuring 1.3x0.8x0.3cm. It is bisected. Touch preparations are. made. The specimen is submitted in toto in one cassette. D. WIDE EXCISION LEFT BREAST. Received fresh is an oriented portion of firm breast tissue measuring 7.5x7x4.5cm. The specimen is. inked and sectioned to reveal a 3.3x2.6x2.5cm. white firm tumor mass, located 0.5cm. from the. posterior margin, 1.5cm. from superior margin, 0.4cm. from the medial margin, 0.7cm. from the inferior. margin. One section from the tumor is submitted for tissue procurement. A separate white nodule. measuring 0.3cm. in diameter is located 1.2cm. from the main tumor mass. This nodule is .1cm. from. the medial margin. Representative sections are submitted as follows: D1-D4: tumor mass with adjacent margin, representative. D5: separate nodule in toto. D6-D9: representative sections from normal looking breast tissue. E. ADDITIONAL DEEP MARGIN. Received in formalin is an unoriented portion of breast tissue measuring 2.2x2.5x1.5cm. The specimen. is inked and serially sectioned to reveal tan yellow lobulated cut surface. No gross lesion is identified. Representatives are submitted in two cassettes. F. ADDITIONAL MEDIAL MARGIN. Received in formalin is one fragment of tan yellow to pink soft to firm tissue measuring 2.7x2x1.5cm. The specimen is inked and serially sectioned to reveal tan fibrotic cut surface. No gross lesion is. identified. The specimen is submitted in toto in two cassettes. Microscopic/Diagnostic Dictation: Pathologist,. Microscopic/Diagnostic Dictation: Pathologist,. Final Review: Pathologist,. Final: Pathologist,.",T2,N1,M0,T2N1M0
TCGA-A7-A56D,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Left axillary sentinel lymph node, resection: No evidence of metastasis in one lymph node (0/1) . B. Left breast, simple mastectomy: Infiltrating ductal carcinoma, grade 3, 3.2 cm in greatest dimension. Surgical margins negative but close, less than 2 mm. C. Left axillary contents, resection: No evidence of metastasis in 7 lymph nodes (0/7). Microscopic Description: Microscopic examination performed. A. Sections of the sentinel lymph node demonstrate no evidence of. metastatic disease. The node is examined by multiple sectioning with. hematoxylin and eosin and by immunohistochemistry for pankeratin. Invasive Carcinoma: present. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Overall grade: 3. Architectural score: 2. Nuclear score: 3. Mitotic score: 3. Greatest dimension (pT) : 3.2 cm,. pT2. Specimen margins: Negative but close, less than 2 mm over a. distance of 5 mm. Vessel invasion: Not identified. Calcification: Not identified. Ductal carcinoma in situ: Not identified. Description of non-tumorous breast: Proliferative fibrocystic. changes with intraductal papillomatosis. Comments: None. Prognostic markers: Previously performed. C Sections of the left axillary contents demonstrate no evidence of. metastasis in 7 lymph nodes. Specimen. A. Left sentinel node-axillary. B. Left breast-tumor at 7 o'clock. C. Axillary contents. Clinical Information. Carcinoma left breast, core biopsy positive here. Intraoperative Consultation. AFS left axillary sentinel lymph node, excision: No evidence of metastasis in one lymph node. Gross Description. A. Container a is labeled with the patient's name, medical record. number and ""sentinel lymph node"". The specimen consists of a single. piece of fatty tissue which when bisected holds a single lymph node. measuring 1.0 x 0.0 0. cm. Bisected and submitted in block AFS. B. Received fresh labeled ""left breast"" is a 25.5 cm (medial to. lateral) by 17.0 cm (superior to inferior) by 4.5 cm (anterior to. posterior) soft, lobulated tan-white-gold portion of fibroadipose. tissue oriented per placement of designated tumor as stated previously. A 19.3 x 8.5 cm wrinkled tan skin ellipse with an eccentric, 1.0 x 1.0. x 0.5 cm nipple is present along the anterior aspect. A palpable mass. is evident at 7 o'clock, corresponding to the lower inner quadrant. The antero-inferior surface of the specimen in the vicinity of the mass. is inked blue. The intact deep margin is inked black and the specimen. is sectioned. There is a well-circumscribed, 3.2 cm (medial to. lateral) by 2.4 cm (anterior to posterior) by 2.0 cm (superior to. inferior) rubbery tan-white tumor mass within the lower outer quadrant. On sectioning the tumor appears to extend to within 0.2 cm of the. inked anteroinferior surface and 1.5 cm of the inked deep margin. A. portion of tumor and a portion of normal parenchyma are submitted for. tissue procurement as requested. The cut surfaces throughout the. remainder of the specimen consist predominantly of soft, lobulated tan. gold adipose tissue with a minimal amount of interspersed dense. tan-white fibrous tissue. No additional mass lesion or abnormality is. identified. Summary: 1 - tumor to inked deep margin, 2 through 4 - tumor to inked. anteroinferior margin, 5 and 6 - tumor to adjacent parenchyma, 7 -. random upper outer quadrant, 8 - upper inner quadrant, 9 - lower inner. quadrant, 10 - lower outer quadrant, 11 - junction of the 4 quadrants,. 12 - nipple. C. Received fresh labeled ""Axillary contents"" is a 9.3 x 7.8 x 1.7 cm. portion of soft, lobulated tan gold adipose tissue. A few slightly. rubbery pale tan to tan pink tissues in keeping with lymph nodes. measuring up to 3.4 cm in greatest dimension are recovered. The. lymphoid tissues are entirely submitted. RS 4. Summary: 1 - 2 lymph nodes, 2 - 1 bisected lymph node, 3 and 4 -. bisected largest lymph node. the. Criteria. Discrepancy. Temar S. Discripancy. PIP.",T2,N0,M0,T2N0M0
TCGA-AN-A03X,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Left Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: Frozen. Container: cryomold Type of Procurement: Radical mastectomy Grade: 1. T Stage: 2 N Stage: 0 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,T2,N0,M0,T2N0M0
TCGA-QK-A6II,"Anat Path Reports. Document Date: (Verified). Acc #: Head and Neck. M. Client: Submitting Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. A. MEDIAL TONGUE MARGIN,, EXCISION, A1FS: - BENIGN SQUAMOUS MUCOSA. NEGATIVE FOR HIGH GRADE DYSPLASIA AND INVASIVE CARCINOMA. B. TONGUE MARGIN, BASE, EXCISION, B1FS: - BENIGN SQUAMOUS MUCOSA. - NEGATIVE FOR HIGH GRADE DYSPLASIA AND INVASIVE CARCINOMA. C. GINGIVAL MARGIN, LEFT, EXCISION, C1FS: - BENIGN SQUAMOUS MUCOSA. - NEGATIVE FOR HIGH GRADE DYSPLASIA AND INVASIVE CARCINOMA. D. GINGIVAL MARGIN, RIGHT, EXCISION, D1FS: BENIGN SQUAMOUS MUCOSA. - NEGATIVE FOR HIGH GRADE DYSPLASIA AND INVASIVE CARCINOMA. E. TONGUE MARGIN, DEEP, EXCISION, E1FS: BENIGN SKELETAL MUSCLE. - NEGATIVE FOR INVASIVE CARCINOMA. F. GENIAL HYOID TUBERCLE, EXCISION, F1FS: BENIGN SKELETAL MUSCLE AND FIBROUS TISSUE. - NEGATIVE FOR INVASIVE CARCINOMA. G. FLOOR OF MOUTH AND TONGUE, COMPOSITE RESECTION: - INVASIVE SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED (4.3 X 4.2 X 1.6CM). - PERINEURAL INVASION IS PRESENT. - ALL SURGICAL MARGINS (SEE SEPARATELY SUBMITTED PARTS A-F) NEGATIVE FOR CARCINOMA. - SEE SYNOPTIC REPORT. H. NECK CONTENTS, LEFT LEVEL I, NECK DISSECTION: - TWO OF FIVE LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (2/5). - SALIVARY GLAND PARENCHYMA WITH CHRONIC SIALADENITIS. I. LYMPH NODES, LEFT LEVEL II, NECK DISSECTION: - ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1/1). - EXTRANODAL EXTENSION (>2MM) IS PRESENT. J. NECK CONTENTS, RIGHT LEVEL I, NECK DISSECTION: - ONE OF THREE LYMPH NODES POSITIVE FOR METASTATIC CARCINOMA (1/3). - SALIVARY GLAND PARENCHYMA WITH CHRONIC SIALADENITIS. K. LYMPH NODES, SUBMENTAL, NECK DISSECTION: THREE LYMPH NODES NEGATIVE FOR MESTASTATIC CARCINOMA (0/3). L. LYMPH NODES, ADDITIONAL LEFT NECK LEVEL II, EXCISION: - ELEVEN LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/11). M. LYMPH NODES, LEFT LEVEL III, NECK DISSECTION: SEVENTEEN LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/17). N. LYMPH NODES, LEFT LEVEL IV, NECK DISSECTION: - THREE LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/3). O. LYMPH NODES, RIGHT LEVEL II, NECK DISSECTION: - FIVE LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/5). Assisted by: Synoptic Worksheet. G. Composite resection of floor of mouth and tongue, black stitch anterior (fresh for research. study: Clinical History: No neoadjuvant therapy. Specimen: Ventral surface of tongue, not otherwise specified (NOS). Floor of mouth, NOS. Fresh. Procedure: Glossectomy: Composite resection: Ventral tongue, Floor of. mouth and suprahyoid musculature. Neck (lymph node) dissection: Submental, Right Level I, Il and. Left Level I-IV. Specimen Integrity: Intact. Specimen Size: Greatest dimension: 7.0 cm. Additional dimension: 5.5 cm. Additional dimension: 5.2 cm. Specimen Laterality: Midline. Tumor Site: Ventral surface of tongue, NOS. Floor of mouth, NOS. Tumor Focality: Single focus. Tumor Size: Greatest dimension: 4.3 cm. Additional dimension: 4.2 cm. Additional dimension: 1.6 cm. Tumor Thickness (pT1 and pT2 tumors): Tumor thickness: 1.6 mm. Macroscopic Extent of Tumor: Extension into extrinsic tongue musculature identified at time. of surgery by. Histologic Type: Squamous cell carcinoma, conventional. Histologic Grade: G2: Moderately differentiated. Microscopic Tumor Extension: Infiltration of skeletal muscle bundles and oral salivary gland. tissue. Margins: Margins uninvolved by invasive carcinoma. Margins uninvolved by carcinoma in situ (includes moderate. and severe dysplasia). Treatment Effect: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Present. Lymph Nodes, Extranodal Extension: Present. Pathologic Staging (pTNM): TNM Descriptors: Not applicable. Primary Tumor (pT): pT4a: Moderately advanced local disease. Lip: Tumor invades. through cortical bone, inferior alveolar nerve, floor of mouth, or. skin of face, ie, chin or nose. Oral cavity: Tumor invades. adjacent structures only. Regional Lymph Nodes (pN): pN2c: Metastasis in bilateral or contralateral lymph nodes,. none more than 6 cm in greatest dimension. Number of regional lymph nodes examined: 58. Number of regional lymph nodes involved: 4. Size (greatest dimension) of the largest positive lymph node: 2.0 cm. Distant Metastasis (pM): Not applicable. Clinical History. Oral cancer. Specimen(s) Received. A: Medial tongue, stitch anterior. B: Base of tongue, stitch anterior. C: Left gingival margin, stitch anterior. D: Right gingival margin. E: Deep tongue margin. F: Genial hyoid tubercle. G: Composite resection of floor of mouth and tongue, black stitch anterior (fresh for research study. H: Left neck level #1. I: Left neck level #2. J: Right neck level #1. K: Submental neck content (fresh). L: Additional left neck level 2. M: Left neck level 3. N: Left neck level 4. O: Right neck level 2. Gross Description. Specimen A is received fresh along with patient's name, medical record number and as medial tongue margin frozen. section, stitch anterior. The specimen consists of a fragment of soft tissue measuring 6.6 x 1.0 x 0.3 cm. A stitch is. present with the specimen and designated as anterior. The stitch area is inked blue. The specimen is submitted for. intraoperative consultation and entirely submitted in cassette A1FS. (Dictated by. Specimen B is received fresh along with patient's name, medical record number and as base of tongue margin, stitch. anterior, frozen section. The specimen consists of a fragment of soft tissue measuring 5.8 x 0.7 x 0.6 cm. A stitch. is. present with the specimen and designated as anterior. The stitch area is inked blue. The specimen is submitted for. intraoperative consultation and entirely submitted in cassette B1FS. (Dictated by. Specimen C is received fresh along with patient's name, medical record number and as 6 to left gingival margin,. stitch anterior, frozen section. The specimen consists of a fragment of soft tissue measuring 5.5 x 0.8 x 0.3 cm. A. stitch is present with the specimen and designated as anterior. The stitch area is inked blue. The specimen is. submitted for intraoperative consultation and entirely submitted in cassette C1FS. (Dictated. Specimen D is received fresh along with patient's name, medical record number and as right gingival margin, frozen. section. The specimen consists of a fragment of soft tissue measuring 1.2 X 0.7 x 0.2 cm. The specimen is. submitted for intraoperative consultation and entirely submitted in cassette D1FS. (Dictated. Specimen E is received fresh along with patient's name, medical record number and as deep tongue margin, frozen. section. The specimen consists of a small fragment of soft tissue measuring 2.0 x 0.8 x 0.3 cm. The specimen is. submitted for intraoperative consultation and entirely submitted in cassette E1FS. (Dictated. Specimen F is received fresh along with patient's name, medical record number and as genial hypoid tubercle, frozen. section. The specimen consists of multiple soft tissue fragments measuring 1.0 x 0.8 x 0.3 cm in aggregate. The. specimen is submitted for intraoperative consultation and entirely submitted in cassette F1FS. (Dictated by. Specimen G is received fresh along with patient's name, medical record number and as composite resection of floor. of mouth and tongue, black stitch anterior. The specimen consists of a portion of left tongue with the floor of mouth. measuring 7.0 cm from anterior-to-posterior, 5.5 cm from lateral-to-medial and 5.2 cm from superior-to-inferior. An ill-. defined friable mass lesion arising from the floor of mouth is identified in the specimen. This mass lesion is invading. into the ventral and lateral surfaces of the tongue. It also apparently crosses the midline of the tongue. This mass. lesion measures 4.3 cm from anterior-to-posterior, 4.2 cm from superior-to-inferior, 1.6 cm from medial-to-lateral. The cut surface of this mass lesion shows a homogeneous white appearance. This mass lesion is abutting the lateral. periosteum surface and also medial and inferior surface. Within the specimen, there is also a separate small. fragment of squamous mucosa is sutured and attached with the specimen. This small fragment of mucosa tissue is. unremarkable. Representative sections are submitted as follows. (Dictated by. CASSETTE SUMMARY: G1: Mass lesion in relation to the medial surface (black). G2: Mass lesion in relation to the lateral periosteum surface (blue). G3: Mass lesion in relation to the inferior surface (green). G4: Mass in relationship to the superior surface (red). G5: A representative section of mass lesion. G6: A representative section from the attached separate small fragment of tongue mucosa. Specimen H is received in formalin along with patient's name, medical record number and as left neck level 1. The. specimen consists of a fragment of fibroadipose tissue measuring 4.5 x 3.5 x 2.5 cm. A portion of salivary gland. tissue is identified within the specimen. A total of 5 potential lymph nodes are identified within the specimen. The. largest one measures 1.2 cm in diameter. Representative sections are submitted as follows. (Dictated by. CASSETTE SUMMARY: H1: One lymph node, bisected. H2: One potential lymph node, bisected. H3: One potential lymph node, bisected. H4-H7: One lymph node, quadrisected. H8-H10: One lymph node, trisected. H11: Representative section of the normal-appearing salivary gland tissue. Specimen I is received in formalin along with patient's name, medical record number and labeled as left neck level 2. The specimen consists of a grossly malignant lymph node which measures 2.0 x 1.1 x 0.9 cm. Representative. sections are submitted as follows. (Dictated by. CASSETTE SUMMARY: I1-13: Representative lymph node. Specimen J is received fresh along with patient's name, medical record number and as right neck level #1. The. specimen consists of a fragment of soft tissue measuring 6.0 x 2.5 x 1.0 cm. A total of 3 potential lymph nodes are. identified in the specimen. The largest one measures 1.5 cm in diameter. Within this largest potential lymph node,. there is a well-circumscribed firm white nodule which measures 0.9 cm in diameter. The two potential lymph nodes. are grossly unremarkable. The rest of the specimen is composed of a salivary gland. The parenchyma of the. salivary gland tissue is unremarkable. Representative sections are submitted as follows. Representative section. from the largest lymph node with the nodular lesion is submitted for tumor bank. (Dictated by. CASSETTE SUMMARY: J1, J2: Entirely submitted largest lymph node with the white nodule. J3: A potential lymph node, bisected. J4: A potential lymph node. J5: Representative section from the salivary gland. Specimen K is received fresh along with patient's name, medical record number and as submental neck contents. The specimen consists of a fragment of fibroadipose tissue which measures 4.0 x 1.6 x 1.0 cm. A total of 5 potential. lymph nodes are identified The largest one measures 1.4 cm in diameter. Representative sections are submitted as. follows. (Dictated by. CASSETTE SUMMARY: K1: One potential lymph node, bisected. K2: One potential lymph node, bisected. K3: One potential lymph node, bisected. K4: Two potential lymph nodes. Specimen L is received fresh along with patient's name, medical record number and as left neck level 2 additional,. fresh. The specimen consists of a fragment of soft tissue measuring 3.5 x 2.0 x 1.3 cm. A total of 11 potential lymph. nodes are identified within the specimen. The largest one measures 1.6 cm in diameter. Representative sections are. submitted as follows. (Dictated by. CASSETTE SUMMARY: L1: One potential lymph node, bisected. L2: One potential lymph node, bisected. L3: One potential lymph node, bisected. L4: Two potential lymph nodes. L5: Two potential lymph nodes. L6: Two potential lymph nodes. L7: Two potential lymph nodes. Specimen M is received fresh along with patient's name, medical record number and as left neck level 3, fresh. The. specimen consists of two fragments of fibroadipose tissue measuring 3.5 x 3.0 x 1.5 cm in aggregate. A total of 17. potential lymph nodes are identified in the specimen. The largest one measures 1.9 cm in diameter. Representative. sections are submitted as follows. (Dictated by. CASSETTE SUMMARY: M1: One potential lymph node, bisected. M2: One potential lymph node, bisected. M3: One potential lymph node, bisected. M4: One potential lymph node, bisected. M5: One potential lymph node, bisected. M6-M11 Each cassette has two potential lymph nodes. Specimen N is received fresh along with patient's name, medical record number and as left neck level 4, fresh. The. specimen consists of a fragment of fibroadipose tissue measuring 3.0 x 2.5 x 1.0 cm. A total of 3 potential lymph. nodes are identified in the specimen. The largest one measures 1.0 cm in diameter. Representative sections are. submitted as follows. (Dictated by. CASSETTE SUMMARY: N1: One potential lymph node, bisected. N2: One potential lymph node, bisected. N3: One potential lymph node. Specimen O is received fresh along with patient's name, medical record number and as right level 2, fresh. The. specimen consists of a fragment of soft tissue measuring 3.4 x 1.5 x 1.2 cm. A total of 5 potential lymph nodes. are. identified in the specimen. The largest one measures 1.8 cm in diameter. Representative sections are submitted as. follows. (Dictated by. CASSETTE SUMMARY: 01-03: Entirely submitted largest lymph node. O4: One lymph node, bisected. O5-O7: Each cassette has one potential lymph node. Intraoperative Consult Diagnosis. A1FS: MEDIAL TONGUE MARGIN, (FROZEN SECTION): BENIGN. B1FS: BASE OF TONGUE MARGIN, (FROZEN SECTION): BENIGN. C1FS: LEFT GINGIVAL MARGIN, (FROZEN SECTION): BENIGN. D1FS: RIGHT GINGIVAL MARGIN (FROZEN SECTION): BENIGN. E1FS: DEEP TONGUE MARGIN, (FROZEN SECTION): BENIGN. F1FS: GENIAL HYOID TUBERCLE, (FROZEN SECTION): BENIGN. Frozen section results were communicated to the surgical team and were repeated back by. on. at. In at. Microscopic Description. Microscopic examination performed.",T4,N2,M0,T4N2M0
TCGA-DJ-A3VJ,"cate 5 ricceuure. Neck. ind Neck. Clinical Diagnosis & History: Right thyroid nodule papillary FNA-thyroid cancer. Specimens Submitted: 1: Delphian nodes (fs). 2: Right para- tracheal lymph node (fs). 3: Pre-tracheal tissue midline (fs). 4: Rule out right lower para-thyroid gland (fs). 5: Total thyroidectomy. 6: Right paratracheal tissue. DIAGNOSIS: 1. Delphian nodes (fs): Lymph Node Dissection: Metastatic papillary thyroid carcinoma in the form of psammoma body. Number of lymph nodes examined: 1. Extranodal extension is not identified. The tumor was not present on the frozen section slide. 2. Right para-tracheal lymph node (fs): Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 2. Number of lymph nodes with metastatic disease: 2. Size of the largest lymph node involved by tumor: 0.6cm. Size of the largest metastatic focus : 0.19 cm. Extranodal extension is not identified. 3. Pre-tracheal tissue midline (fs): Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 2. Number of lymph nodes with metastatic disease: 2. Size of the largest lymph node involved by tumor: 0.7cm. Size of the largest metastatic focus : 0.01 cm. Extranodal extension is not identified. 4. ""Right lower para-thyroid gland"", biopsy (fs): - Benign unremarkable parathyroid gland tissue. 5. Total thyroidectomy: Tumor Type: Papillary carcinoma, diffuse sclerosing variant. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Psammoma bodies. Tumor Location: Left lobe. Right lobe. Isthmus. Tumor Size: The dominant tumor nodule is 2.0 cm in greatest dimension. Tumor Encapsulation: Partially surrounded. Blood Vessel Invasion: Extensive Invasion. Extrathyroid Extension: Invades:fibroadipose tissue. Surgical Margins: Free of tumor. Non-Neoplastic Thyroid: Exhibits chronic lymphocytic thyroiditis. Parathyrold Glands: Not identified. 6. ""Right paratracheal tissue"", excision: - Benign unremarkable parathyroid gland. (ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1. The specimen is received fresh for frozen section, labeled ""Delphian node"" and consists of one piece of tan-pink soft tissue. measuring 0.9 x 0.3 x 0.2 cm. The specimen is entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 2. The specimen is received fresh for frozen section, labeled ""right paratracheal lymph node"" and consists of two lymph nodes. measuring 0.9 x 0.4 x 0.2 cm and 0.5 x 0.3 x 0.2 cm. The specimen is entirely submitted for frozen section. Summary of sections: FSC - frozen section control. &. 3. The specimen is received fresh for frozen section, labeled ""Pre-tracheal tissue - midline"" and consists of one piece of tan-pink. soft tissue measuring 1.5 x 1.0 x 0.6 cm. The specimen is entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 4. The specimen is received fresh for frozen section, labeled ""rule out right lower parathyroid gland"" and consists of one piece of. tan-pink soft tissue measuring 0.3 x 0.2 x 0.1 cm. The specimen is entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 5. The specimen is received fresh, labeled ""total thymectomy, stitch marks right lobe"" and consists of a thyroid weighing 36 g. The. right lobe measures 6 X 4 x 2 cm, the left lobe measures 4 x 2 x 1.5 cm and the isthmus measures 1.3 x 0.5 x 0.3 cm. The external. surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black, and the anterior is inked blue. Sectioning reveals a well circumscribed nodule measuring 1.8 x 1.5 x 1.0 cm. The remaining thyroid parenchyma is red tan and. beefy. Representative sections of the specimen are submitted for TPS, and a photograph has been taken. The remaining tissue is. serially sectioned and representatively submitted. Summary of sections: N nodule. RL right lobe. LL left lobe. IS - isthmus. 6. The specimen is received fresh labeled, ""right paratracheal tissue"", and consists of multiple irregular pieces of tan soft tissue. measuring 1.0 x 0.5 x 0.3 cm aggregate. Entirely submitted. Summary of sections: U-- undesignated. Summary of Sections: Part 1: Delphian nodes (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: Right para- tracheal lymph node (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 3: Pre-tracheal tissue midline (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 4: Rule out right lower para-thyroid gland (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 5: Total thyroidectomy. Block. Sect. Site. PCs. 1. is. 1. 2. 2. 3. 3. 2. 2. Part 6: Right paratracheal tissue. Block. Sect. Site. PCs. 1. u. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1. FROZEN SECTION DIAGNOSIS: Delphian nodes (fs): Benign lymph node. PERMANENT DIAGNOSIS: SEE FINAL. 2. FROZEN SECTION DIAGNOSIS: Right para- tracheal lymph node (fs): 2 lymph nodes, both positive for metastatic PTC. (2/2). PERMANENT DIAGNOSIS: SAME. 3. FROZEN SECTION DIAGNOSIS: Pre-tracheal tissue midline (fs): Metastatic PTC; definitely involving one lymph node. Second lymph node is cauterized with no definite tumor. PERMANENT DIAGNOSIS: SAME. 4. FROZEN SECTION DIAGNOSIS: Rule out right lower para-thyroid gland (fs): Parathyroid tissue. PERMANENT DIAGNOSIS: SAME.",T3,N1,M0,T3N1M0
TCGA-44-2662,"SPECIMEN. A. Lymph node level 10. B. Right upper lobe. C. Lymph node R4. D. Lymph node level 7. CLINICAL NOTES. PRE-OP DIAGNOSIS: Right upper lobe lung cancer. FROZEN SECTION DIAGNOSIS. FSB) Right upper lobe - Poorly differentiated non-small cell. carcinoma. Bronchial margin is negative for tumor. GROSS DESCRIPTION. A. Received fresh, subsequently fixed in formalin labeled. ""level 10 lymph node"" are multiple black-tan irregular. rubbery tissue fragments which have an aggregate measurement of 2.5. X 1.5 X 0. cm. The specimens are entirely submitted in one. cassette. AS-1. B. Submitted fresh for tissue procurement labeled ""right. upper lobe of lung"" consists of a lobe of lung tissue with. an obvious large tumor mass present. The lobe measures maximally. 15. x 9 X 8 cm. The portal surface is intact, though there are several. areas of a fibrotic-like change present where the tumor mass. appears. to approach the pleural surface. The larger of these is 5 cm in. size. The smaller is 4 cm. The surrounding normal pleura is drawn. into the edge of the sclerotic foci. Numerous white tapes with. sutures are present at the point of transection of the lobe. It. has. been amputated at the level of its main bronchus, which is stapled. closed. Frozen section is obtained from the bronchial margin. closest to that staple line. Sections into the lobe reveal the. presence of a very large tumor mass occupying a large amount of the. parenchyma. It measures 8 x 7 x 6 cm and is composed of spiculated. GROSS DESCRIPTION. dark tan-gray tumor with flecks of anthracotic pigment present. within it. As noted above, it approached the pleura at least in. two. different foci. Representative portion of the tumor is submitted. for tissue procurement per request of. A portion is also. submitted for frozen section. Sections after fixation. Received fresh subsequently fixed in formalin labeled. ""lymph node R4"". The specimen consists of multiple. brown-tan - irregular rubbery tissue fragments which have an. aggregate. measurement of 3.5 X 3.0 x 0.7 cm. The specimens are entirely. submitted in one cassette. D. Received fresh subsequently fixed in formalin labeled. ""lymph node level 7"" are multiple black-tan-yellow. irregular rubbery to soft tissue fragments which have an aggregate. measurement of 2.5 X 2.0 X 0.8 cm. The specimens are entirely. submitted in one cassette. AS-1. MICROSCOPIC DESCRIPTION. Histologic type: Non-small cell carcinoma. Histologic grade: Poorly differentiated. Primary tumor (pT) : Tumor measures maximally 8 cm. in greatest. extent and does not involve the visceral pleural surface (pT2). Margins of resection: Negative. Direct extension of tumor: Absent. Venous (large vessel) invasion: Negative. Arterial (large vessel) invasion: Negative. Lymphatic (small vessel) invasion: Negative. Regional lymph nodes (pN) : Mediastinal lymph nodes level 10, R4. and. level 7 are all negative for metastatic carcinoma (pN0). Distant metastasis (pM) : Could not be assessed (pMx). 5, 3x3. DIAGNOSIS. A. Lymph node, level 10, resection: Negative for metastatic carcinoma. B. Lung, right upper lobectomy. Invasive poorly differentiated non-small cell carcinoma. Visceral pleural surface, vascular and bronchial margins of. resection are free of involvement by tumor. C. Lymph node, R4, resection: Negative for metastatic carcinoma. D. Lymph node, level 7, resection: Negative for metastatic carcinoma.",T2,N0,M0,T2N0M0
TCGA-DS-A0VL,"- Clinical Document: Date of Service : RT. CLINICAL INFORMATION: Patient is a year old female with history of CIN 3 on. biopsy and a recent pregnancy. FINAL DIAGNOSIS: UTERUS AND CERVIX (HYSTERECTOMY) : - Invasive squamous cell carcinoma, moderately. differentiated-. - Depth of invasion 0.4 cm out 2.0 cm cervical thickness. - Extensive lymphovascular invasion. - Posterior radial soft tissue margin 0.9 cm. - No invasive tumor on sections from the anterior cervix. - Closest vaginal margin 2 cm. - Parametria are negative for malignancy. - Decidualized endometrium and myometrium, consistent with. history of recent pregnancy. LYMPH NODE, RIGHT PELVIC (BIOPSY) : - Two lymph nodes negative for carcinoma (0/2). LYMPH NODE, RIGHT PERIAORTIC (BIOPSY) : - One lymph node negative for carcinoma (0/1). LYMPH NODE, LEFT PELVIC (BIOPSY). - Four lymph nodes negative for carcinoma (0/4). LYMPH NODES, LEFT PERIAORTIC (BIOPSY) : - One lymph node negative for carcinoma (0/1). MICROSCOPIC EXAM: Sections of the cervical tumor show nests of malignant. cells. The nests appear to be infiltrating cervical glands. and there are bands of collagen surrounding many of the. nests. The malignant cells are somewhat radially located. around the edges of the nests. Central necrosis within the. https:/. - Clinical Document: nests is prominent. The tumor cells have a high nuclear to. cytoplasmic ratio with nuclei containing loose chromatin and. small nucleoli. Mitotic figures are abundant. GROSS DESCRIPTION. The specimen is received fresh in five containers bearing. the patient's name and hospital number. Part #1, labeled ""uterus and cervix, "" consists of a 1128-gm. uterus and cervix with no attached adnexa. The uterus. measures 14.5 cm from cornu to cornu, 17 cm from cervical os. to top of fundus, and 9 cm from anterior to posterior. A. probe extends into the cervical os 14.5. The cervix is. round with a defect in the posterior 6 o'clock position. The defect appears to be within a lesion that is 3.5 cm from. lateral to lateral and is 2 cm from anterior to posterior. and involves the entire posterior aspect of the cervix. The. defect appears as a chunk out of this lesion that is 1.5 cm. deep and 1.5 cm on its side. The cervix itself is 5 cm from. lateral to lateral and 4 cm anterior to posterior. There. is. 2 cm of attached vaginal wall that is attached from the 6. o'clock to the 9 o'clock position. On the anterior and left. side there is approximately 1 cm of attached vaginal wall. The serosa on the uterus is pink and unremarkable. The left. parametrium is inked with black ink and the right. parametrium is inked with green ink. Upon opening. the. uterus, the cervical canal measures 3.5 cm and the. endometrial cavity is 10.5 cm vertically and 7 cm at its. widest point. The endometrial cavity is covered with a. boggy, hemorrhagic-appearing endometrium. The myometrium is. thick and boggy-appearing. The maximum thickness is 3.5 cm. The cervix is dissected away from the specimen and entirely. submitted as follows: A1-A6. 12 o'clock to 3 o'clock. A7-A13. 3 o'clock to 6 o'clock. A14-A24. 6 o'clock to 9 O'clock. A25-A30. 9 o'clock to 12 O'clock. A31-A36. right parametrium. A37-A39. left parametrium. A40-A47. uterus. Part #2, labeled ""right pelvic lymph node, "" consists of two. fragments of fibroadipose tissue. The first piece is 1.5 x. 1 x 0.7 cm and the second is 2.1 x 1.5 x 0.5 cm. The. specimen is entirely submitted in cassettes B1 and B2. Part #3, labeled ""right periaortic, If consists of one lymph. node that is 2 x 1.2 x 0.8 cm and another small piece of. fibroadipose tissue that is 1 x 0.3 x 0.2 cm. The specimen. is entirely submitted in cassettes C1. Part #4, labeled ""left pelvic lymph node, consists of a. fragment of fibroadipose tissue that is 2.5 x 0.7 x 1.2 cm. The specimen is bisected and entirely submitted in cassettes. D1 and D2. Part #5, labeled ""left periaortic lymph nodes, "" consists of. one piece of fibroadipose tissue that is 1.1 x 0.9 x 0.5 cm. The specimen is entirely submitted in cassette E1. https:/. e - Clinical Document: By his/her/their electronic signature (s), , the senior. pathologist (s) certifies that he/she/they personally. conducted a gross and/or microscopic examination (s) of the. described specimen (s) and made the diagnosis (es) juxtaposed. with his/her/their electronic signature. M.D. - , M.D. Dictated: M.D. Reference number : Document ID Number: END OF. https:",T1,N0,M0,T1N0M0
TCGA-B0-5115,"FINAL DIAGNOSIS. KIDNEY, LEFT, RADICAL NEPHRECTOMY -. A. A. RENAL CELL CARCINOMA, CLEAR CELL TYPE. B. FUHRMAN NUCLEAR GRADE IS 3 of 4. C. THE GREATEST DIAMETER OF THE NEOPLASM IS 9.0 cm. D. THE NEOPLASM IS CONFINED TO THE KIDNEY WITHOUT EXTRACAPSULAR INVASION. E. NO EVIDENCE OF ANGIOLYMPHATIC INVASION IS IDENTIFIED. F. ALL SURGICAL MARGINS ARE FREE OF THE NEOPLASM. G. NON-NEOPLASTIC KIDNEY SHOWS NON-SPECIFIC CHANGES RELATED TO PROXIMITY TO THE TUMOR. H. TNM STAGE: pT2 NX MX.",T2,N0,M1,T2N0M1
TCGA-DD-A119,"TISSUE DESCRIPTION: 1 A2 B1 C1 D1 E1 E2 F1 F2 F3 F4 F5 F6 F7. vallbladder (8.0 x 3.5 x 2.8 cm), peritoneal biopsies (No.1, 3 mm;. No.: 2, 3 mm), peri choledochal lymph node (2.0 x 1.0 x 0.8 cm), and. right adrenal gland (5.82 grams, 6 x 3.7 x 1.5 cm), right lobe. liver (2,680 grams, 27.5 x 19.5 x 12.5 cm), and cystic duct lymph. node (0.6 x 0.5 x 0.4 cm). DIAGNOSIS: Liver, right lobe, hepatectomy: Grade 3 (of 4) hepatocellular. carcinoma, usual type, forming a dominant 16 x 15 x 13 cm mass with. innumerable satellite nodules ranging in size from 0.5 cm to 6 cm. The tumor is located in the right lobe. The hepatic capsule is. involved, but adjacent organs spared. The surgical margins are. involved grossly. Extratumoral vascular invasion is identified,. involving portal veins microscopically. The tumor is partially. encapsulated, infiltration of parenchyma being of infiltrating type. A single separately submitted periportal lymph node is negative for. tumor. Information regarding the uninvolved hepatic parenchyma will. be reported in an addendum. Adrenal gland, right, excision: Metastatic grade 2 (of 4). hepatocellular carcinoma forming multiple (2) separate masses (1.4 x. 1.3 x 1.1 cm and D.4 x 0.3 x 0.3 cm). Gallbladder, cholecystectomy: Chronic cholecystitis with. cholesterolosis. Negative for tumor. Peritoneal, No.1 and No. 2, biopsies: Negative for tumor. Lymph nodes, cystic duct and pericholedochal, excision: A single. ystic duct lymph node and a single pericholedochal lymph node are. negative for tumor. ADDENDUM: The non-neoplastic liver is non-cirrhotic and shows changes that are. likely related to adjacent mass effect. No ground-glass hepatocytes. are seen. TISSUE DESCRIPTION: 06 Al A2 B1 C1 D1 E1 E2 F1 F2 F3 F4 F5 F6 F7. Gallbladder (8. 0 x 3.5 x 2.8 cm), peritoneal biopsies (No. 1, 3 mm;. No. 2, 3 mm), peri choledochal lymph node (2.0 x 1.0 x 0.8 cm), and. right adrenal gland (5.82 grams, 6 x 3.7 x 1.5 cm), right. lobe. liver (2,680 grans, 27.5 x 19.5 x 12.5 cm), and cystic duct lymph. node (0.6 x 0.5 x 0.4 cm). DIAGNOSIS: Liver, right lobe, hepatectomy: Grade 3 (of 4) hepatocellular. carcinoma, usual type, forming 6 dominant 16 x 15 x 13 cm mass with. innumerable satellite nodules ranging in size from 0.5 cm to 6 cm. The tumor is located in the right lobe. The hepatic capsule is. involved, but adjacent organs spared. The surgical margins are. involved grossly. Extratumoral vascular invasion is identified,. involving portal veins microscopically. The tumor is pertially. encapsulated, infiltration of parenchyna being of infiltrating type. A single separately submitted periportal lymph node is negative for. tumor. Information regarding the uninvolved hepatic perenchyma will. be reported in en addendum. Adrenal gland, right, excision: Metastatic grade 2 (of 4). hepatocellular carcinoma forming multiple (2) separate masses (1.4 x. 1.3 x 1.1 cm and 0. x 0.3 x 0.3 cm). Gallbladder, cholecystectony: Chronic cholecystitis with. cholesterolosis. Negative for tumor. Peritoneal, No. 1 and No. 2, biopsies: Negative for tumor. Lymph nodes, cystic duct and pericholedochal, excision: A single. Vcystic duct lymph node and a single pericholedochel lymph node are. negative for tumor. ADDENDUM: The non-neoplastic liver is non-cirrhotic and shows changes that are. likely related to adjacent mess effect. No ground-glass hepatocytes. are seen.",T3,N0,M1,T3N0M1
TCGA-AO-A0JE,"Clinical Diagnosis & History: year old female with right breast cancer diagnosed on core biopsy. 4. Specimens Submitted: 1: SP: Sentinel node #1, level 1, right axilla. 2: SP: Sentinel node #2, level 1, right axilla (fs). 3: SP: Right breast mass. 4: SP: Additional medial margin. 5: SP: Superior lateral tissue, right breast. 6: SP: Level 1 and 2, right axillary contents with tags attached. DIAGNOSIS: 1). SENTINEL NODE #1, LEVEL I, RIGHT AXILLA; EXCISION: - METASTATIC CARCINOMA INVOLVING ONE LYMPH NODE (1/1) . - NO EXTRANODAL EXTENSION IS IDENTIFIED. 2). SENTINEL NODE #2, LEVEL I, RIGHT AXILLA; EXCISION: - METASTATIC CARCINOMA INVOLVING ONE LYMPH NODE (1/1). - EXTRANODAL EXTENSION IS IDENTIFIED AND MEASURES 0.5 CM. 3). BREAST, MASS, RIGHT; EXCISION: - INVASIVE DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC GRADE III/III (SLIGHT. OR NO TUBULE FORMATION),. NUCLEAR GRADE III/III (MARKED VARIATION IN SIZE AND SHAPE) MEASURING. 2.5 CM IN LARGEST. DIMENSION MICROSCOPICALLY. - DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, SOLID TYPE, WITH. HIGH NUCLEAR GRADE. AND EXTENSIVE NECROSIS. - LOBULAR INVOLVEMENT BY DCIS IS PRESENT. - THE DCIS CONSTITUTES <25% OF THE TOTAL TUMOR MASS, AND IS PRESENT. ADMIXED WITH AND AWAY. FROM THE INVASIVE COMPONENT. - CALCIFICATIONS ARE PRESENT IN THE IN SITU, AND IN BENIGN BREAST. PARENCHYMA. - NO VASCULAR INVASION IS NOTED. - A MICROSCOPIC FOCUS OF INVASIVE CARCINOMA (<1 MM) IS PRESENT IN ONE. OUT OF SIX SECTIONS OF THE ANTERIOR SHAVED MARGIN. - DCIS INVOLVES THE FOLLOWING SHAVED MARGINS: SUPERIOR (ONE OUT OF FOUR. SLIDES) INFERIOR (ONE OUT OF SIX SLIDES) AND POSTERIOR (TWO OUT OF FIVE. SLIDES). THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES,. FIBROCYSTIC CHANGES,. AND USUAL DUCTAL HYPERPLASIA. - RECEPTOR STUDIES WERE PERFORMED ON PRIOR MATERIAL (CORE BIOPSY,. 4). BREAST, RIGHT, ADDITIONAL MEDIAL MARGIN; EXCISION: - BENIGN BREAST TISSUE WITH DUCTAL HYPERPLASIA WITHOUT ATYPIA. 5). BREAST, RIGHT, SUPEROLATERAL TISSUE; EXCISION: - FOCAL ATYPICAL DUCTAL HYPERPLASIA. 6). LYMPH NODES, LEVELS I AND II, RIGHT AXILLARY CONTENTS; DISSECTION: - LEVEL I: EIGHT BENIGN LYMPH NODES (0/8). LEVEL II: SIX OF NINETEEN LYMPH NODES POSITIVE FOR METASTATIC. CARCINOMA (6/19). - EXTRANODAL EXTENSION IS IDENTIFIED (2 MM). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Descrintion: 1) The specimen is received initially fresh for frozen section. consultation, which was later canceled, labeled, ""Sentinel node number one,. level 1, right axilla"", and consists of a single lymph node measuring 1.8 x. 1.2 x 0.6 cm. Cut section shows fleshy red-tan appearance. Specimen is. entirely submitted. Summary of sections: U bisected lymph node. 2). The specimen is received fresh for frozen section consultation labeled,. ""Sentinel node number two, level 1, right axilla"", and consists of a single. lymph node measuring 1.2 x 0.7 x 0.4 cm. The specimen is bisected and. entirely frozen. A sample is submitted to TPS. Summary of sections: FSC frozen section control. 3). The specimen is received fresh, labeled ""Right breast mass"". It. consists of a round piece of fibroadipose tissue measuring 11.5 x 10.0 x 4.0. cm. The specimen is oriented with short suture superior and long suture. lateral. The specimen is inked and the margins are entirely shaved. Sectioning of the central portion of the tissue reveals a firm stellate. shaped gray-tan mass measuring 2.0 x 2.0 x 1.5 cm located at the lateral. aspect of the tissue. A portion of the tissue is submitted for TPS. The. rest of the tumor is entirely submitted for histologic examination. Representative section of the remaining tissue are also submitted. Summary of Sections: S superior margin. I inferior margin. M medial margin. L lateral margin. A anterior margin. P posterior margin. T tumor. R representative section of remaining tissue. 4). The specimen is received fresh, labeled ""Additional medial margin,. stitch marks final margin breast"". It consists of a fragment of. fibroadipose tissue measuring 4.0 x 2.0 x 0.4 cm. The surface of the tissue. marked with stitch is inked black. The tisue is serially sectioned to. reveal a fibroadipose cut surface with no gross pathologic abnormality. The. specimen is entirely submitted. Summary of Sections: U - undesignated. 5). The specimen is received fresh, labeled ""Superior lateral tissue,. right breast"". It consists of a round piece of fibroadipose tissue. measuring 3.0 x 2.0 x 0.5 cm. The surface of the tissue marked with stitch. is inked black and the tissue is serially sectioned to reveal a fibroadipose. cut surface with no gross pathologic abnormalities. The specimen is. entirely submitted. Summary of Sections: U - undesignated. 6). The specimen is received fresh, labeled ""Levels 1 and 2, right. axillary contents, with tags attached. It consists of a fragment of. adipose tissue measuring 7 x 4 x 3 cm with attached taga designating levels. 1 and 2. Dissection of tissue reveals multiple lymph nodes ranging in size. from 0.2 x 0.2 x 0.1 cm to 1.2 x 1.0 x 0.5 cm. All lymph nodes are entirely. submitted. Summiary of Sections: LN1 - Lymph nodes, level 1. LN2 - Lymph nodes, level 2. 6. SP: Level 1 and 2, right axillary contents with tags attached (am) : Summary of Sections: Part 1: SP: Sentinel node #1, level 1, right axilla. Block. Sect. Site. PCs. 1. u. 1. Part 2: SP: Sentinel node #2, level 1, right axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Right breast mass. Block. Sect. Site. PCs. 6. A. 6. 6. I. 6. 2. L. 26. 1. M. 1. 5. P. 5. 1. R. 1. 4. S. 4. 4. 4. Part 4: SP: Additional medial margin. Block. Sect. Site. PCs. 3. u. 3. Part 5: SP: Superior lateral tissue, right breast. Block. Sect. Site. PCs. 3. u. 3. Part 6: SP: Level 1 and 2, right axillary contents with tags attached. Block. Sect. Site. PCs. 4. LNI. 8. 5. LNII. 10. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 2). FROZEN SECTION DIAGNOSIS: POSITIVE FOR CARCINOMA. PERMANENT DIAGNOSIS: SAME. a.",T2,N2,M0,T2N2M0
TCGA-DC-6681,"Clinical Diagnosis & History: female with rectal cancer. Endometrial thickening and adnexal mass. with rectal cancer. Specimens Submitted: 1: Endometrial curettings. 2: Sigmoid and rectum; resection. 3: Segment three liver resection. 4: Left tube and ovary. 5: Right tube and ovary. 6: Re-excision of sigmoid colon. 7: Distal margin. 8: Proximal margin. DIAGNOSIS: 1. Endometrium; curettage. - Scant benign strips of atrophic endometrium and endocervical mucosa. - Abundant mucus. 2. Sigmoid and rectum; resection: Tumor Type: Adenocarcinoma with mucinous features (<50% mucinous component). Histologic Grade: Moderately differentiated. Tumor Location: Rectosigmoid. Tumor Size: Length is 7.0 cm. Width is 4.0 cm. Maximal thickness is 1.3 cm. Tumor Budding: Focal. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Not identified. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Tumor is noted very close (<0.1 cm) from the serosal surface. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Suspected. Large Venous Invasion: Suspected. Perineural Invasion: Identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Lymph Nodes: Number with metastasis: 7. Total number examined: 24. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC 7th Edition) : pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition) : N2a (Metastasis in 4-6 regional lymph nodes). 3. Liver, segment three; resection: - Metastatic adenocarcinoma, moderately differentiated, consistent with. colorectal primary. - One tumor nodule, measuring 1.8 x 1.5 x 1.0cm. - Fibrosis and mucinous changes in 20% of the tumor. - The hepatic capsule is free of tumor. - The surgical margins are free of tumor by 1.6cm (gross clearance) . - The non-neoplastic liver shows mild nonspecific changes. NOTE: Material has been sent for KRAS mutation testing, and will be. reported separately. 4. Left fallopian tube and ovary; salpingo-oophorectomy: - Ovary with adenofibroma. - Fallopian tube without pathologic abnormalities. 5. Right fallopian tube and ovary; salpingo-oophorectomy. - Ovary with fibroma. - Fallopian tube without pathologic abnormalities. Sigmoid colon; re-excision: - Benign segment of colonic tissue without pathologic abnormalities. - Four benign lymph nodes (0/4) . 7. Colon, distal margin; excision: - Benign segment of colonic tissue without pathologic abnormalities. 8. Colon, proximal margin; excision: - Benign segment of colonic tissue without pathologic abnormalities. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. KRAS. Gross Description: 1) The specimen is received fresh, labeled 'Endometrial curettings"" It. consists of mostly mucus measuring 2 x 1.5 x 0.3 cm. The specimen is. submitted entirely for frozen section. Summary of Sections: FSC- frozen section control. 2) The specimen is received fresh and is labeled ""Sigmoid and rectum"". It. consists of a rectosigmoid colon that measures 25 cm in length and 7 cm in. circumference. The serosal surface is smooth. The margins are inked as. follows: proximal and radial margins - blue, distal margin black. The. specimen is opened to reveal a tumor that is located 11.5 cm from the. proximal margin and 3 cm from the distal margin. The tumor measures 7 cm. in. length and 4 cm in width. Serial sectioning reveals tumor invasion to a. depth of 1.3 cm, which is 1.5 cm from the closest radial margin. The. remaining mucosa is unremarkable. Pericolic and peri-rectal adipose tissue. is thoroughly examined for lymph nodes, and all possible nodes are. submitted. Representative sections are submitted. TPS is submitted. Summary of sections: PM - proximal margin, perpendicular. DM - distal margin, perpendicular. RM - radial margin. T - tumor. U - uninvolved mucosa. LN - lymph nodes. BLN - bisected lymph node. 3). The specimen is received fresh and labeled, ""Segment three liver. resection "". It consists of a liver lobe measuring 8.5 x 6.0 x 3.5 cm. The. hepatic capsule is grossly intact with a 1.5 x 0.8 cm raised area. There is. a rough hepatic resection margin which is inked black. Serial sectioning at. 0.5 cm intervals reveals a white lobular tumor measuring 1.8 x 1.5 x 1.0 cm. The tumor corresponds to raised area on the capsule. There is no gross. evidence of tumor within the vessels. There is no gross evidence of tumor. within the bile ducts. The closest tumor nodule is 1.6 cm from the inked. surgical resection margin. The remaining hepatic parenchyma is tan-brown. and granular. TPS is submitted. Representative sections are submitted to. include the remaining tumor. Summary of sections: VMvessel from margin. T - tumor. TC - tumor with hepatic capsule. M - margin. U - uninvolved hepatic parenchyma (away from the mass). 4) The specimen is received in formalin, labeled ""Left tube and left. ovary"" and consists of a fallopian tube with attached ovary. The fallopian. tube measures 4.5 cm in length and averages 0.4 cm in diameter. The. external surface of the tube is pink tan and smooth with a normal fimbriated. end. Cut section through the tube reveals a pinpoint lumen. The attached. ovary weighs 4.0 g and measures 3.0 x 2.0 x 1.5 cm. The external surface is. white-tan and smooth. Cut section through the ovary reveals 1.5 x 1.5 x 1.3. cm clear fluid filled cyst. Representative sections are submitted. Summary of sections: F - fallopian tube. o ovary. ---cyst. 5). The specimen is received in formalin, labeled ""Right tube and ovary"". and consists of a fallopian tube with attached ovary. The fallopian tube. measures 5.0 cm in length and averages 0.3 cm in diameter. The external. surface of the tube is pink tan and smooth with a normal fimbriated end. Cut. section through the tube reveals a pinpoint lumen. The attached ovary. weighs 2.5 g and measures 2.2 x 1.5 x 1.0 cm. The external surface is. tan-white and smooth. Cut section through the ovary reveals a 1.0 x 0.8 x. 0.8 cm white-yellow ovoid nodule. Representative sections are submitted. Summary of sections: F - fallopian tube. o ovary. N--nodule. 6) The specimen is received in formalin, labeled ""Re-excision of sigmoid. colon"" and consists of a portion of bowel measuring 4.5 cm in length, 5.0 cm. in circumference. One aspect of the specimen is stapled close, the opposing. aspect is open. The serosa is tan-pink and smooth with attached yellow. lobulated adipose tissue. The specimen is opened to reveal tan-brown mucosa. with the normal folds. No lesion is grossly identified. Representative. sections are submitted. The specimen is submitted for lymph node dissection. Summary of sections: SM--stapled margin. o -open margin. RS - -representative sections. 7). The specimen is received in formalin, labeled ""Distal margin"" and. consists of a ring of pink tan soft tissue measuring 2.5 x 2.3 x 1.0 cm. Multiple sutures and staples are attached. The mucosal surface is pink tan. and focally hemorrhagic. The sutures and staples are removed and the soft. tissue is entirely submitted. Summary of sections: U - undesignated. 8). The specimen is received in formalin, labeled ""Proximal margin"" and. consists of a silver metal anastomotic pin measuring 7.5 X 2.8 x 1.5 cm. At. the center of the pin, a green plastic piece is noted. A ring of pink tan. soft tissue is attached measuring 2.2 x 1.5 x 0.5 cm. The mucosal surface. is pink tan and focally hemorrhagic and the serosal surface is pink tan and. smooth. Several sutures and staples are noted. The sutures and staples are. removed and the soft tissue is entirely submitted. Summary of sections: U - undesignated. Summary of Sections: Part 1: Endometrial curettings. Block. Sect. Site. PCs. 1. FSC. 1. Part 2: Sigmoid and rectum; resection. Block. Sect. Site. PCs. 3. DM. 3. 6. LN. 12. 1. PM. 1. 1. RM. 1. 7. T. 7. 1. U. 1. Part 3: Segment three liver resection. Block. Sect. Site. PCs. 1. M. 2. 4. T. 6. 1. TC. 1. 2. U. 4. 1. VM. 1. Part 4: Left tube and ovary. Block. Sect. Site. PCs. 2. C. 4. 2. F. 6. 1. o. 1. Part 5: Right tube and ovary. Block. Sect. Site. PCs. 2. F. 4. 2. N. 3. 1. o. 2. Part 6: Re-excision of sigmoid colon. Block. Sect. Site. PCs. 5. LN. 5. 1. OM. 1. 2. RS. 4. 1. SM. 1. Part 7: Distal margin. Block. Sect. Site. PCs. 4. U. 6. Part 8: Proximal margin. Block. Sect. Site. PCs. 2. U. 4. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1. Frozen section diagnosis: Endometrial curettings. Benign (Fine). Permanent diagnosis: Same.",T3,N2,M1,T3N2M1
TCGA-CN-5369,"Report Type. Date of Event. Authored by. Hosp/Group. PATIENT HISTORY: Right maxillary cancer. PRE-OP DIAGNOSIS: Right maxillary cancer. POST-OP DIAGNOSIS: Same. URE: None given. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT, LEVELS 2 THROUGH 4, EXCISION. FORTY-THREE LYMPH NODES, NO TUMOR PRESENT (0/43). PARTS 2 4: LYMPH NODES, LEFT, LEVELS 2 THOROUGH 4, EXCISION. THIRTY-NINE LYMPH NODES, NO TUMOR PRESENT (0/39) . PARTS 5-9: RIGHT MAXILLA AND PALATE, RIGHT INFERIOR MAXILLARY MARGIN,. MAXILLARY BONE FRAGMENT, ADDITIONAL MAXILLA RIGHT LATERAL AND SUPERIOR MARGIN. AND ADDITIONAL LATERAL AND INFERIOR MARGIN, INFRASTRUCTURE PARTIAL. MAXILLECTOMY, AND EXCISIONS. A. POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA (4.5 CM) WITH. INVASION OF MAXILLARY BONE BONE AND SALIVARY GLAND TISSUE. B. PERINEURAL INVASION IS IDENTIFIED. C. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. D. ALL FINAL MARGINS OF RESECTION ARE FREE OF TUMOR. PATHOLOGIC STAGE pT4a, NO, MX. My si. station that I have personally reviewed the submitted. material (s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION. The specimen is received in nine parts. Part 1 is received unfixed, labeled with the patient's name, initials, XX and. ""selective node dissection right, levels 2 through 4, stitch at 2B"". The. specimen consists of a solitary 9. X 5.0 X 1.6 fibrofatty, focally. hemorrhagic tissue fragment with a black suture that marks level 2B. Lymph. nodes are dissected and are submitted as follows: 1A 1B representative level 2 lymph node. 1C level 2, two nodes. 1D level 2, four nodes. 1E level 2, four nodes. 1F level 2, two nodes. 1G level 2b four nodes. 1H level 2b three nodes. 1I level 3, four nodes. 1J level 3, four nodes. 1K level 3, one node bisected. 1L level 3, four nodes. 1M level 4, four nodes. 1N level 4, three nodes. 10 level 4, three nodes. Part 2 is received in formalin labeled with the patient's name, initials XX. and ""lymph node level 4"". The specimen consists of a 2.5 X 1.6 X 0.5 cm. focally hemorrhagic fibrofatty tissue fragment. Lymph nodes are recovered. and. submitted as follows: 2A two nodes. 2B one node. Part 3 is received in formalin labeled with the patient's name, initials XX. and ""lymph node zone 2"". The specimen consists of a 2.0 X 1.0 X 0.5 cm. fibrofatty tissue fragment. The specimen is submitted as follows: 3A one node. 3B two nodes. Part 4 is received in formalin labeled with the patient's name, initials XX. and ""lymph node 2-4"". The specimen consists of an 8.3 X 3.0 X 1.2 cm. fibrofatty tissue fragment with a suture that demarcates level 2b nodes. The. specimen is submitted as follows: 4A level 2, node A. 4B level 2, node B. 4C level 3, node A. 4D level 3, node B. 4E level 3, node C. 4F level 4, node A. 4G level 4, node B. 4H loose fragment of tissue (two nodes). 4I level 2, two nodes. 4K level 2, two nodes. 4J level 2, four nodes. 4K level 2, five nodes. 4L level 2, one node. 4M level 2, two nodes. 4N level 3, three nodes. 40 level 3, four nodes. 4P level 4, two nodes. 4Q level 4, three nodes. 4R level 4, three nodes. Part 5 is received in formalin labeled with the patient's name, initials. and ""maxillary mucosa"". The specimen consists of a 3.0 X 4.0 X 1.0 cm. fragment of mucosal lined soft tissue. A representative section is submitted. in cassette 5A. Part 6 is received unfixed for intraoperative consultation labeled with the. patient's name, initials, XX and ""right inferior maxillary, suture right. lateral margin"". The specimen consists of an oriented specimen with. resection. of the maxillary sinus. This specimen is 6.6 X 5.0 X 2.2 cm with a stitch. that demarcates the right lateral margin. The sinus mucosa is grossly. unremarkable. On the inferior aspect of the specimen there is a 4.5 X 3.0 X. 1.0 cm focally hemorrhagic friable mass that breaks through the superior. cribriform plate. The tumor breaks through the bone; however, the anterior,. superior and nasal septal bony margins appear to be grossly free. The lesion. is 1.5 cm from the anterior margin, 1.5 cm from the medial margin and 0.6 cm. from the posterior margin. However, it is close, if not approximates, the. lateral margin. A digital photograph is taken of the inferior aspect of the. specimen with the tumor. Representative sections are submitted as follows: 6AFS tissue nearest right lateral margin. 6B anterior shave. 6C medial shave. 6D posterior shave. 6E anterior bone. 6F. nasal septal bony margin (decalcification). 6G superior bony margin (posterior) (decalcification). 6H 6I tumor with bone (decalcification). 6J posterior soft tissue with tumor. 6K tumor in bone (decalcification). representative sections of tumor. is received in formalin labeled with the patient's name, initials XX. and ""maxillary bone fragment. The specimen consists of an aggregate of. fragments of bone that is 1.0 X 1.0 X 0.3 cm. The specimen is submitted for. decalcification in cassette 7A. Part 8 is received in formalin labeled with the patient's name, initials XX. and ""additional margin maxilla, right lateral plus superior. The specimen. consists of a 5.5 X 0.1 X 0.3 cm focally hemorrhagic nucosa-lined tissue. fragment. The specimen is submitted in its entirety in 8A or 8B. Part 9 is received in formalin labeled with the patient's name, initials XX. and ""additional margin lateral and inferior. The specimen consists of a 2.0. X 1.5 X 0.6 cm focally hemorrhagic, soft tissue fragment that is submitted in. S. tirety in cassettes 9A through 9B. F. IVE CONSULTATION. 6AFS. RIGHT INFERIOR MAXILLARY (frozen section). A. MALIGNANT. B. INVASIVE SQUAMOUS CELL CARCINOMA. C. TUMOR LESS THAN ONE HIGH POWERED FIELD FROM. OFT. MARGIN, ALL OTHER MARGINS GROSSLY DISTANT. COPIC: SYNOPTIC DATA - PRIMARY UPPER AERODIGESTIVE TRACT AND MINOR SALIVARY. GLAND TUMORS. SPECIMEN TYPE: Resection: maxilla and hard palate, right. TUMOR SITE: Other: hard palate and maxillary sinus. TUMOR SIZE: Greatest dimension: 4.5 cm. Additional dimensions: 3.0 X 1.0 cm. HISTOLOGIC TYPE: Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: G1. PATHOLOGIC STAGING (pTNM) : pT4a. pNO. Number of regional lymph nodes examined: 82. Number of regional lymph nodes involved: 0. pMX. MARGINS: Margins uninvolved by tumor. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L) : Absent. PERINEURAL INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Inflammation (type) : chronic. Microscopic examination substantiates the above diagnosis. PROCEDURAL NOTES: FS. PERMANENT. level II, node A. neg. neg. level II, node B. neg. neg. level III, node A. neg. neg. level III, node B. neg. neg. level III, node C. neg. neg. level IV, node A. neg. neg. IV, node B. neg. neg. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH) Molecular Anatomic Pathology, and. Immunofluorescent Testing: The. d its performance characteristics determined by. the. Department of Pathology, as required by the. C. A. '. regulations. The testing has not been cleared or approved for the. Ficific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: dissection lev. Stain/c. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E X 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. H. H&E X 1. H&E X 1. H&E X 1. K. H&E X 1. L. H&E X 1. M. H&E X 1. N. H&E X 1. O. FRZ Single X. 1. AFS. H&E X 1. AFS. Part 2 : 1 4. Stain/cil. H&E X 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E X 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. H. Part 3: 1 2. Stain/c. H&E X 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E X 1. E. Part 4 : 2-3-4. Stain/c. H&E X 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E X 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. H. H&E X 1. H&E X 1. H&E X 1. K. H&E X 1. L. H&E X 1. M. H&E X 1. N. H&E X 1. O. H&E X 1. P. H&E X 1. H&E X 1. R. Part 5 : y mucosa. Stain/c. H&E X 1. A. Part 6 : maxillary. Stain/cil. H&E X 1. A. H&E X 1. B. H&E X 1. C. H&E X 1. D. H&E X 1. E. H&E X 1. F. H&E X 1. G. H&E X 1. H. H&E X 1. H&E X 1. H&E X 1. K. H&E X 1. L. H&E X 1. M. Part 7 : fragment. Stain/ C11. H&E X 1. A. Part 8 : gin maxilla rig. perior. Stain/c. H&E X 1. A. H&E X 1. B. Part 9 : gin lateral & i. Stain/ CII. H&E X 1. A. H&E X 1. B.",T4,N0,M0,T4N0M0
TCGA-EL-A3T6,"Pathology. port. Pathology,. Case type: Surgical Case. DIAGNOSIS. (A) TOTAL THYROIDECTOMY: PAPILLARY THYROID CARCINOMA (4.5 CM). TUMOR CONFINED WITHIN THYROID TISSUE. No extracapsular extension identified. Unremarkable parathyroid tissue, no tumor present. One lymph node, no tumor present. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) TOTAL THYROIDECTOMY - A total thyroidectomy with overall measurements, 8.0 x 5.0 x 3.5 cm. The right lobe appears. unremarkable and measures 4.0 x 3.0 x 1.0 cm and mostly appears fibrotic. The left lobe measures 6.0 X 5.0 X 3.5 cm and. contains well-defined friable light tan and soft mass measuring 4.5 x 4.0 x 3.0 cm. The tumor abuts the external surface and the. capsule of the lobe. No gross involvement of the surgical margin, but tumor is noted. The tumor also appears friable and. papillary in nature. The specimen is submitted entirely in A1-A5, sequential sectioning of the right lobe from superior to inferior;. A5, A6, isthmus; A8-A22, sequential sectioning of the left lobe from superior inferior including tumor and adjacent soft. tissue. CLINICAL HISTORY. History of papillary thyroid cancer. SNOMED CODES. T-B6000, M-80503. Released by:",T3,N0,M0,T3N0M0
TCGA-A6-6649,"SPECIMEN. Right colon resected at. CLINICAL NOTES. PRE-OP DIAGNOSIS: Right colon cancer. GROSS DESCRIPTION. Received fresh labeled ""right colon"" is a previously. unopened 30 cm. segment of proximal right colon with. attached 8 cm. of distal ileum surfaced by smooth tan pink serosa. with a copious amount of attached, mesocolon, mesentery, and. unremarkable omentum. No appendix is identified. The proximal and. distal margins measure 4.0 and 8.0 cm. in circumference. respectively. On opening, there is a moderately well circumscribed,. 4.5 X 3.8 cm. rubbery tan white-pink tumor mass located 9 cm. distal. to the ileocecal valve. A portion of tumor and a portion of normal. mucosa are submitted for tissue procurement as requested. On. sectioning, the tumor has a maximal thickness of 1.8 cm., grossly. extending into the muscularis to within 0.6 cm. of the inked free. radial serosal surface. A few soft tan ink polypoid lesions. measuring up to 0.6 cm. in greatest dimension are present throughout. the remainder of the colon. The ileal and remaining colonic mucosa. is unremarkable, glistening tan pink with regular folds and the. walls average 0.5 cm. in thickness. Multiple soft to slightly. rubbery pale tan to tan-red tissues in keeping with lymph nodes. measuring up to 1.2 cm. in greatest dimension are recovered from the. attached mesocolon and mesentery. Representative sections are. submitted in 15 blocks as labeled. RS-15. BLOCK SUMMARY: 1 - Proximal and distal margins; 2, 3 - tumor full. thickness to inked free radial serosal surface; 4 - central tumor; 5. tumor to normal mucosa; 6, 7 - colonic polyps; 8 - ICV; 9 - random. colon; 10-12 - six whole lymph nod per cassette; 13-15. one. bisected lymph node per cassette. MICROSCOPIC DESCRIPTION. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Primary tumor (pT) : Tumor invades through the full thickness of the. wall into the adjacent adipose tissue, pT3. Proximal margin: Negative for tumor. Distal margin: Negative for tumor. Circumferential (radial) margin: Tumor is not identified at the. outer serosal surface of the specimen. Distance of tumor from closest margin: 21 cm from distal margin of. excision. Vascular invasion: Present in pericolonic tissue. Regional lymph nodes (pN) : Two of twenty-three lymph nodes positive. for metastatic carcinoma (2/23), pN1b. Non-lymph node pericolonic tumor: Perineural invasion by tumor is. identified. Distant metastasis (pM) : pMX. Other findings: Separate adenomatous polyps are identified within. the colon. 5x1. DIAGNOSIS. Colon, right, excision - Invasive poorly differentiated. adenocarcinoma (see tumor characteristics in the colon resection. template in the microscopic description).",T3,N1,M0,T3N1M0
TCGA-VD-AA8Q,"HISTOPATHOLOGY. Lab No. Clinical Consultant & Location. Unit No. SPECIMEN. RIGHT EYE. Diagnostic and prognostic. CLINICAL DETAILS. Right eye choroidal tumour. Right enucleation of globe. Measurements: 13.90 x 12.20 x (10.07) mm. MACROSCOPIC DESCRIPTION. A fresh intact right globe. Dimensions: Axial 26mm Horizontal 24.5mm Vertical 24mm. Cornea: Horizontal 12mm Vertical 11mm. Optic Nerve - flush. Pupil - regular. Angle normal deptn. ?Engorged vortex veins inferiorly. On transillumination, a large shadow is seen on the medial. side with a maximum diameter of 17mm. Plane of section: Horizontal. Intraocular description: On opening, a solitary dome shaped pigmented choroidal mass. is seen. Tumour SizeLBD 12mmHeight 10mm. MICROSCOPY. Sections confirm a deeply pigmented choroidal melanoma. consisting predominantly of spindle cells. Tumour cells. express Melan-A and HSP 27 (score 2) The number of mitosis. is small, approximately 1/40 high power fields. Closed loops. are not present in the planes of sections. The lymphocytic. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. infiltrate within the tumour is minimal. Scattered. macrophages are present. Tumour necrosis is not seen. There. is no tumour extension through the sclera, optic nerve or. vortex veins examined. Tumour cells are not seen at the. resection margins. Elsewhere, the cornea shows oedema in its basal cell layers. The anterior chamber angles are open and the anterior. chamber is deep. The iris shows no significant abnormality. but the ciliary body appears atrophic with hyalinisation of. ciliary processes. The lens shows subcapsular degenerative. changes. Retina overlying the tumour is slightly atrophic. DIAGNOSIS. Right eye, enucleation: Choroidal melanoma of predominantly. spindle cell type. SUMMARY. SPECIMEN. 2= Eye. TUMOUR PRESENT. TUMOUR TYPE. 1= Melanoma. CELL TYPE. 2= Spindle B. CT LOOPS. 1= No closed loops. NECROSIS. PIGMENTATION. LYMPHOCYTIC INFILTRATION. MITOTIC FREQUENCY. 1/40 HPF. DIFFUSE MELANOMA. SPREAD. 1= No. CLEARANCE. 2= Adequate. HSP-27 POSITIVITY. 2= 21-70%. LARGE DIAMETER. 12 mm. THICKNESS. 10 mm. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. COMMENT. Molecular genetic examination of DNA extracted from the. tumour cells will be performed using multiplex-ligation. dependent probe amplification (MLPA), looking at chromosomes. 1, 3, 6 and 8. A supplementary report will follow in due. course. SUPPLEMENTARY REPORT - MLPA. In the meantime, molecular genetic analysis of tumour DNA. extracted from the fresh uveal melanoma tissue was performed. using the technique termed multiplex ligation-dependent. probe amplification (MLPA) . These investigations were. performed in the. The kit P027 from. which examines for gains or. losses in 31 loci on chromosomes 1, 3, 6 and 8, was used. The DNA concentration was measured using. and the. quality assessed using multiplex-PCR prior to the MLPA. reaction. The DNA concentration was high and of good quality on. assessment. The MLPA reaction was run at least twice on. differing occasions, resulting in similar results. The results of the sequence analysis of the MLPA products is. printed on a separate report. In summary, sequence analysis. demonstrated: normal chromosome 1p,. disomy 3,. normal chromosome 6. and normal chromosome 8. Taken together, these molecular data would place the patient. in the low risk group with respect to the development of. metastatic melanoma. Consideration of clinical features of the tumour is,. however, also required.",T3,N0,M0,T3N0M0
TCGA-KS-A4I5,"PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 1. SEX: F. BIRTHOATE: ADM DATE: OPER DATE: PROCEDURE: SPHS. Source of Specimen: History of thyroid cancer. Clinical Diagnosis: Thyroid. cancer. Operative Procedure: Total thyroidectomy and central neck. dissection. PROCEDURE: SPGD. 1. ""Total thyroid"". Received fresh in a small container is an 11.9 gram thyroid, right lobe 4.5 x. 2.5 x 1.2 cm, isthmus 1.2 x 1.0 x 0.3 cm and left lobe 3.5 x 2.6 x 0.4 cm. The. right lower Lobe is remarkable for a 1.2 x 1.7 x 0.8 cm pale tan nodule with. possible cystic degeneration. Remainder of right lobe demonstrates. unremarkable parenchyma with multiple brown nodules (up to 0.7 cm) filled with. dark brown fluid. Left tobe and isthmus demonstrates unremarkable parenchyma. 1A-C. Right thyroid nodule, entirely submitted. 1D. Right mid and upper lobe. 1E. Isthmus. 1F. Left lower lobe. 1G. Left mid and upper lobe. 2. ""Central neck dissection, right central neck Lymph nodes"". Received in a small container of formalin is a 0.7 x 0.4 cm fibroadipose. tissue fragment. 2A. Entirely submitted. PROCEDURE: SPMI. PAPILLARY THYROID CARCINOMA. Size of largest primary tumor: 1.7 cm. Location(s): Right lobe. Capsular Invasion: Yes. Vascular Invasion: No. Margins: Negative. Extrathyroidal extension: No. Lymph node metastases: Extranodal extension: N/A. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 2. SEX: F. BIRTHOATE: ADM DATE: OPER DATE: SIDE. LEVEL. #POSITIVE NODES. #TOTAL NODES. Central. 0. 1. PROCEDURE: SPOX. 1. Thyroid, resection: Papillary thyroid carcinoma (1.7 cm), arising in the. right lobe and confined to the thyroid. Capsular invasion present. Negative. for vascular invasion. Surgical margins free. One perithyroidal lymph node. negative for malignancy (0/1). Please see TEMPLATE for details. 2. Soft tissue of central neck, dissection: One lymph node negative for. malignancy (0/1). 1,. the signing staff pathologist, have personally. examined and interpreted the slides from this case. Code:",T1,N1,M0,T1N1M0
TCGA-JY-A93F,"F. Facility: Specimen(s) Received. 1. Lymph-Node: ST7 Subcarinal. 2. Lymph node: Diaphragmatic nodes ST15. 3. Lymph node: Aorto-pulmonary ST5. 4. Lymph node: Inf pulm. ligament ST9L. 5. Lymph node: Para esophageal ST8. 6. Lymph node: Right upper paratracheal node. 7. Lymph node: Lt low paratracheal ST4L. 8. Lymph node: Lt up paratracheal ST2L. 9. Lymph node: Lt recurrent nerve lymph node. 10. Lymph node: Lt gastric lymph node. 11. Lymph node: Stn 19 splenic nodes. 12. Lymph node: cervical lymph node. 13. Thoracic esophagus and proximal stomach with esophageal margin. 14. Lymph node: Subcarinal ST7. 15. Lymph node: Para esophageal ST8. 16. Lymph node: Diaphragmatic nodes ST15. 17. Lymph node: Lt gastric nodes ST17. 18. Lymph node: Station 19. 19. Lymph node: Station 20. 20. Esophagus: Final esophageal margin. 21. Surgical Waste. Diagnosis. 1. Lymph-Node, ST7 Subcarinal: Regional lymph nodes (5), negative for malignancy (0/5). 2. Lymph node, Diaphragmatic nodes ST15: Regional lymph nodes (4), negative for malignancy (0/4). 3. Lymph node, Aorto-pulmonary ST5: Regional lymph nodes (2), negative for malignancy (0/2). 4. Lymph node, Inferior pulmonary ligament ST9L: Regional lymph nodes (3), negative for malignancy (0/3). 5. Lymph node, Para esophageal ST8: Fibrofatty tissue, negative for malignancy. 6. Lymph node, Right upper paratracheal node: Regional lymph node (1), negative for malignancy (0/1). 7. Lymph node, Left low paratracheal ST4L: Regional lymph nodes (1), negative for malignancy (0/1). 8. Lymph node, Left upper paratracheal ST2L: Regional lymph nodes (6), negative for malignancy (0/6). 9. Lymph node, left recurrnt nerve lymph node: Regional lymph nodes (3), negative for malignancy (0/3). 10. Lymph node, left gastric lymph node: Fibrofatty tissue, negative for malignancy. 11. Lymph node, STN 19 splenic nodes: Regional lymph nodes (1), negative for malignancy (0/1). 12. Lymph node, cervical lymph node: Fibrofatty tissue, negative for malignancy. 13. Thoracic esophagus and proximal stomach with esophageal margin: Squamous cell carcinoma, pT2N0Mx - see synoptic for details. Fundic gland polyp, stomach. 14. Lymph node, Subcarinal ST7: Regional lymph nodes (2), negative for malignancy (0/2). 15. Lymph node, Para esophageal ST8: Regional lymph nodes (2), negative for malignancy (0/2). 16. Lymph node, Diaphragmatic nodes ST15: Regional lymph nodes (2), negative for malignancy (0/2). 17. Lymph node, Left gastric nodes ST17: Regional lymph nodes (1), negative for malignancy (0/1). 18. Lymph node, Station 19: Regional lymph nodes (4), negative for malignancy (0/4). 19. Lymph node, Station 20: Regional lymph nodes (2), negative for malignancy (0/2). 20. Esophagus, Final esophageal margin: Negative for malignancy. 21. Surgical Waste: No significant pathology (gross exam only). Comment. Part 21. ""THIS CASE HAS BEEN EXAMINED BY GROSS VISUAL EXAMINATION ONLY. NO MICROSCOPIC EXAMINATION. HAS BEEN PERFORMED. IF THERE IS A CLINICAL INDICATION OR SUSPICION OF AN ABNORMALITY THAT. WOULD REQUIRE ADDITIONAL STUDIES THEN THE SIGNING PATHOLOGIST (BELOW) SHOULD BE CONTACTED. WITHIN ONE MONTH OF THE ISSUING OF THIS REPORT."". Synoptic Data. Clinical History: Not known: Specimen: Esophagus. Proximal stomach. Procedure: Esophagogastrectomy. Primary Tumor Site: Distal esophagus (lower thoracic esophagus). Additional Sites Involved by Tumor: Esophagogastric junction (EGJ). Relationship of Tumor to Esophagogastric Junction: Tumor midpoint lies in the distal esophagus and tumor involves the. esophagogastric junction. Histologic Type: Squamous cell carcinoma. Histologic Grade: G1: Well differentiated. Tumor Size: Cannot be determined: 2 lesions belong to one tumor, aggregate size is 6.5 cm x. 4.6 cm. Microscopic Tumor Extension: Tumor invades muscularis propria. Proximal Margin: Uninvolved by invasive carcinoma. Uninvolved by dysplasia. Distal Margin: Uninvolved by invasive carcinoma. Uninvolved by dysplasia. Circumferential (Adventitial) or Deep Margin: Uninvolved by invasive carcinoma. All Margin Status. All margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 2 mm. Closest margin: Circumferential. Treatment Effect: Treatment history not known. Lymph-Vascular Invasion: Not identified: Perineural Invasion: Not identified: TNM Descriptors: Not applicable: Primary Tumor (pT): pT2: Tumor invades muscularis propria. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Number of regional lymph nodes examined: 39. Number of regional lymph nodes involved: 0. Distant Metastasis (pM): Not applicable: Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Clinical History. Esophpgeal Ca. Gross Description. 1. The specimen labeled as ""lymph node ST7 subcarinal"", consists of 6 fragments of tan anthracotic tissue measuring. from 1.0 x 0.4 x 0.4 cm up to 1.6 x 1.2 x 0.4 cm which are received in 10% neutral buffered formalin. 1A --1B - a single fragment in each block. 1C - multiple individual fragments. 2. The specimen labeled as ""lymph node diaphragmatic ST15"", consists of a tan fatty tissue fragment measuring 2.5 x 2.5. x 0.4 cm which are received in 10% neutral buffered formalin. No obvious lymph nodes can be grossly identified. 2A-specimen submitted in toto. 3. The specimen labeled as ""lymph node aortopulmonary ST 5"", consists of a single tan tissue fragment measuring 1.2 x. 0.6 x 0.6 cm which is received in 10% neutral buffered formalin. Sectioning reveals a tan fatty cut surface. 3A - specimen bisected and submitted in toto. 4. The specimen labeled as ""lymph node inferior pulmonary ligament ST9L"", consists of a tan fatty tissue fragment. measuring 1.6 x 1.1 x 0.6 cm which is received in 10% neutral buffered formalin. No obvious lymph nodes can be. grossly identified. 4A - specimen bisected and submitted in toto. 5. The specimen labeled as ""lymph node paraesophageal ST 8"", consists of two tan fatty tissue fragments measuring 2.5. x 1.2 with 0.4 cm and 2.5 x 2.0 x 0.6 cm which are received in 10% neutral buffered formalin. No obvious lymph nodes. can be grossly identified. 5A - larger fragment serially sectioned submitted in toto. 5B - smaller fragment submitted in toto. 6. The specimen labeled as ""lymph node right upper paratracheal"", consists of a tan fatty lymph node measuring 1.9 x 1.4. x 0.8 cm which is received in 10% neutral buffered formalin. 6A - specimen bisected and submitted in toto. 7. The specimen labeled as ""lymph node left low paratracheal ST4L"", consists of a tan fragment of adipose measuring 2.8. x 1.5 x 0.4 cm which is received in 10% neutral buffered formalin. No obvious lymph nodes can be grossly identified. 7A-specimen submitted in toto. 8. The specimen labeled as ""lymph node left upper paratracheal ST2L."", consists of 7 tan fragments of tissue measuring. from 0.4 x 0.3 x 0.3 up to 2.0 x 1.0 x 0.8 cm which are received in 10% neutral buffered formalin. 8A - single fragment bisected and submitted in toto. 8B - remaining fragments submitted in toto. 9. The specimen labeled as ""left recurrent nerve lymph node"", consists of a tan fatty tissue fragment measuring 2.0 x 1.0 x. 0.8 cm which is received in 10% neutral buffered formalin. Sectioning reveals a tan fatty cut surface. 9A - specimen bisected and submitted in toto. 10. The specimen labeled as ""left gastric lymph node"", consists of a fragment of adipose measuring 1.5 x 1.0 x 0.3 cm. which is received in 10% neutral buffered formalin. No obvious lymph nodes can be grossly identified. 10A-specimen submitted in toto. 11. The specimen labeled as ""station 19 splenic node"", consists of a tan fatty lymph node measuring 1.3 x 1.0 x 0.3 cm. which is received in 10% neutral buffered formalin. Sectioning reveals a tan fatty cut surface. 11A - specimen bisected and submitted in toto. 12. The specimen labeled as ""cervical lymph node"", consists of a tan anthracotic tissue fragment measuring 1.5x0.6x. 0.5 cm which is received in 10% neutral buffered formalin. Sectioning reveals an anthracotic cut surface. 12A - specimen bisected and submitted in toto. 13. RESECTION SPECIMEN: Distal esophagus and proximal stomach. FIXATION: Received fresh and transferred to 10% neutral buffered formalin. DIMENSIONS: Length along lesser curvature: 2.4 cm. Length along greater curvature: 6.7 cm. Circumference of distal gastric margin: 11.5 cm. Circumference of proximal gastric margin: 3.2 cm. Length of tubular esophagus: 12.5 cm. Width of tubular esophagus: 3.2 cm. The external surface of the esophagus is painted with silver nitrate. TUMOR. There are 3 areas of interest grossly identified on the esophageal and gastric mucosa. Mass 1: There is a tan ulcerated ill-defined mass on the esophageal mucosa measuring 4.8 cm in length and 3.0-cm in. diameter. The mass occupies 75% of the circumference of the esophagus and there is a cobblestoned esophageal. mucosa continuous with the mass that extends over an area of 6.5-cm. Sectioning of the mass reveals a thickness of. 1.2-cm. The mass approaches the margins as follows: Proximal: 1.3 cm. Distal: 9.4 cm. Painted esophageal external surface: 0.2. Mass 2: There is a tan friable mass just proximal to the GE junction measuring 1.7-cm in length by 1.6-cm in diameter. The mass occupies 50% of the circumference of the esophagus and there is approximately 0.7-cm of unremarkable. esophageal mucosa separating the two mass lesions. Sectioning of the mass reveals a thickness of 0.6-cm. The mass approaches the margins as follows: Proximal: 10-cm. Distal: 4.3-cm. Painted esophageal external surface: 0.6-cm. Polyp: There is a tan polyp adjacent to the distal gastric excision margin measuring 0.5 x 0.4 x 0.2 cm. - PERFORATION: No perforations are grossly identified. ESTIMATED DEPTH OF INVASION: Mass 1 appears to invade through the muscularis but Mass 2 does not invade. through the muscularis. LESIONS IN NONCANCEROUS STOMACH: No other lesions are grossly identified. LYMPH NODES: There is little to no appreciable periesophageal and perigastric fat grossly identified and no lymph nodes. can be grossly identified. The proximal esophageal excision margin is submitted for intraoperative consult and further submitted for permanent. processing. Representative tissue is stored frozen. Photographs are taken. Representative Sections: 13A -- proximal surgical excision margin submitted en face. 13B -- 13C - distal surgical excision margin submitted en face. 13 D - 13 H. - a strip of tissue submitted from the proximal margin to the GE junction with the proximal edge of. each. piece painted with green ink including Mass 1 and Mass 2. 13 I - 13 L. - further representative sections of mass 1. 13M - 13R - remainder of mass 2 and GE junction submitted in toto. 13S -- polyp at distal margin submitted in toto. 14. The specimen labeled as ""lymph node subcarinal ST 7"", consists of a tan fatty tissue fragment measuring 2.5 x 1.2 x. 0.6 cm which is received in 10% neutral buffered formalin. The specimen is bisected revealing a tan anthracotic cut. surface. 14 A. - specimen submitted in toto. 15. The specimen labeled as ""lymph node periesophageal ST8"", consists of 2 tan fatty lymph nodes measuring 0.6 and. 0.8 cm in diameter which are received in 10% neutral buffered formalin. 15 A -specimen submitted in toto. 16. The specimen labeled as ""lymph node diaphragmatic nodes ST 15"", consists of a fragment of adipose measuring 2.8. x 2.0 x 0.4 cm which is received in 10% neutral buffered formalin. No obvious lymph nodes can be grossly identified. 16 A. -specimen submitted in toto. 17. The specimen labeled as ""lymph node left gastric nodes ST 17"", consists of a fragment of adipose measuring 6.0 x. 4.0 x 1.5 cm which is received in 10% neutral buffered formalin. Examination reveals the presence of a single tan fatty. lymph node measuring 1.8 x 1.0 x 0.8 cm which is received in 10% neutral buffered formalin. 17A - lymph node bisected and submitted in toto. 18. The specimen labeled as ""lymph node station 19"", consists of a fragment of adipose measuring 4.0 x 3.5 x 1.5 cm. which is received in 10% neutral buffered formalin. Examination reveals the presence of two tan lymph nodes measuring. 0.6 and 0.8 cm diameter. 18A - lymph nodes submitted in toto. 19. The specimen labeled as ""lymph node station 20"", consists of a fragment of adipose measuring 5.5 x 3.5 x 2.5 cm. which is received in 10% neutral buffered formalin. Examination reveals the presence of 2 tan fatty lymph nodes. measuring 0.6 and 0.8 cm diameter. 19A -specimen submitted in toto. 20. The specimen labeled as ""final esophageal margin"", consists of a tan tissue fragment measuring 2.5 x 0.6 x 0.4 cm. which is received in 10% neutral buffered formalin. 20A -specimen submitted in toto. 21. The specimen container labeled with the patient's name and as ""surgical Waste"", contains 1 piece of tissue in 10%. buffered formalin. The tissue consists of a single fragment of adipose measuring 12 x 4.5 x 2.5 cm which is received in. 10% neutral buffered formalin. No gross abnormalities are identified. No material is submitted for histologic evaluation. Quick Section Diagnosis. 13. Esophagus proximal margin, en face: Negative for carcinoma. Time reported to surgeon:",T2,N0,M0,T2N0M0
TCGA-AO-A1KP,"Clinical Diagnosis & History: y/o female with multicentric invasive CA of left breast (2 foci, at 3:00. and 5:00) For left total mastectomy, SLNB, possible ALND. Specimens Submitted: 1: SP: Sentinel node #1, level 1, lt. axilla (fs). 2: SP: Sentinel node #2, level 1, It. axilla (fs). 3 : SP: Non sentinel tissue, lt. axilla I. 4: SP: Lt. total mastectomy. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1, LEVEL I, LEFT AXILLA; EXCISION: - ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA (1/1) (SEE NOTE). - THE METASTATIC FOCUS MEASURES 0.3 CM. - EXTRANODAL EXTENSION IS IDENTIFIED. NOTE: THE METASTATIC TUMOR IS NOT PRESENT ON THE FROZEN SECTION SLIDE AND. APPEARS ONLY ON THE DEEPER PERMANENT SECTION. 2). LYMPH NODE, SENTINEL #2, LEVEL I, LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 3). LYMPH NODE, NON-SENTINEL TISSUE, LEFT AXILLA; EXCISION: - ONE BENIGN LYMPH NODE (0/1). - BENIGN FIBROADIPOSE TISSUE. 4). BREAST, LEFT TOTAL NASTECTONY: - MULTIPLE FOCI OF INVASIVE DUCTAL CARCIMONA, NOS TYPE, HISTOLOGIC. GRADE II/III (MODERATE TUBULE FORMATION), NUCLEAR GRADE II/III (MODERATE. VARIATION IN SIZE AND SHAPE), RANGING IN SIZE FROM 0.3 CK UP TO 1.8 CM. - DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, SOLID AND. MICROPAPILLARY TYPES WITH. INTERMEDIATE NUCLEAR GRADE AND MODERATE. NECROSIS. - THE DCIS CONSTITUTES <= 25% OF THE TOTAL TUMOR MASS, AND IS PRESENT. ADMIXED WITH THE. INVASIVE COMPONENT. - THE INVASIVE CARCINONA IS LOCATED IN THE LOWER INNER QUADRANT AND THE. AREA BETWEEN THE. LOWER OUTER QUADRANT AND LOWER INNER QUADRANT. - NO INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINOMA. IS IDENTIFIED. Criteria. CALCIFICATIONS ARE PRESENT IN BOTH THE IN SITU AND INVASIVE. CARCINOMA. - VASCULAR INVASION IS PRESENT. NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE ATTACHED SKELETAL MUSCLE IS NEGATIVE FOR TUMOR. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS APOCRINE METAPLASIA AND. COLUMNAR CELL. ALTERATION. - RESULTS OF SPECIAL STAINS (ER, PR, HER2-NEU) WILL BE REPORTED AS AN. ADDENDUM. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. ER-C. PR-C. HER2-C. NEG CONT. IMM RECUT. NEG-HER2. Gross Descrintion: 1). The specimen is received fresh for frozen section, labeled ""Sentinel. Node #1 Level 1 Left Axilla"". It consists of a 1 x. 1 x 0.6 cm lymph node. The lymph node is bisected and entirely frozen. Summary of Sections: FSC - frozen section control. The speciman is received fresh for frozen section, labeled ""Sentinel. Node #2 Level 1 Left Axilla"". It consists of a 1 x 0.7 x 0.6 em tan lymph. node. The lymph node is bisected and entirely frozen. Summary of Sections: FSC - frozen section control. 3). The specimen is received in formalin, labeled ""Non-sentinel Tissue. Left Axilla"". It consists of two fragments of adipose tissue measuring 1.5. x. 1 x 0.5 cm and 3 x 1.5 x 1 cm. Two possible tan lymph nodes measuring 0.2. and 0.8 am in greatest dimension are identified. The specimen is entirely. submitted. Summary of Sections: LN - lymph node. BLN - bisected lymph node. F remainder of fat. 4). The specimen is received fresh, labeled ""Left Total Mastectomy. (stitch marks axillary aspect) It consists of a breast measuring 28 x 27. x 4.5 em and weighing 1,750 grams. A suture designates the axillary aspect. of the spacimen. Identified on the anterior surface is a light tan skin. ellipse measuring 24 x 12 cm. No scars are identified on the epidermal. surface. A grossly unremarkable nipple measuring 0.7 x 0.5 x 0.3 cm is. identified. The entire deep resection margin is inked. Identified on the. deep aspect is a 6 x 2.5 x 2 cm defect near the axillary aspect of the. specimen. Serial sections through the specimen reveal two distinct tumor. masses in the lower inner quadrant and one separate tumor mass between the. lower inner and lower outer quadrants. The two masses in the lower inner. quadrant are fairly well-circumscribed. firm, spiculated with focal areas of. necrosis and measure 2 x 1 x 1 cm and 1.3 x 1 x 1 cm. The larger tumor mass. is at a distance of 4 em from the closest deep resection margin and 2 cm. from the closest superficial resection margin, The smaller tumor mass in. the lower inner quadrant is at a distance of 5 cm from the closest deep. resection margin and 4 cm from the closest anterior resection margin. The. tumor mass located between the lower inner and lower outer quadrants is. well-circumseribed, firm, tan and measures 0.7 x 0.5 x 0.5 en and in located. at a distance of 5 em from the closest deep resection margin. The remainder. of the parenchyma is comprised of approximately 5% tan-white fibrous tissue. and 95% yellow-tan adipose tissue. A portion of the largest tumor is. submitted for TPS studies. The tumors are entirely submitted. Representative sections from the remainder of the specimen are submitted. Summary of Sections: N nipple. S skin. TL larger tumor in the lower inner quadrant. TS smaller tumor in the lower inner quadrant. DL deep margin closest to larger tumor. AL anterior margin closest to larger tumor. DS deep margin closest to smaller lower inner quadrant tumor. AS anterior margin closest to smaller lower inner quadrant tumor. TIO tumor between lower inner and lower outer quadrant. D deep margin closest to tumor between lower inner and lower outer. quadrants. AM - anterior margin closest to tumor between lower inner and lower outer. quadrants. UOQ - upper outer quadrant. LOQ - lower outer quadrant. UIQ - upper inner quadrant. LIQ - lower inner quadrant. Summary of Sections: Part 1: SP: Sentinel node #1, level 1, lt. axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 2: SP: Sentinel node #2, level 1, lt. axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Non sentinel tissue, lt. axilla. Block. Sect. Site. PCs. 1. BLN. 2. 2. F. 4. 1. LN. Part 4: SP: Lt. total mastectomy. Block. Sect. Site. PCs. AL. 1. 1. AM. 1. 1. AS. 1. 1. D. 1. DL. 1. 1. DS. 1. 2. LIQ. 2. 2. LOQ. 2. 1. N. 4. 1. S. 1. TIO. 12. 4. TL. 4. 2. TS. 2. 2. UIQ. 2. 2. UOQ. 2. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. ADDENDUM. SITE: BREAST, LEFT, TOTAL MASTECTOMY. PART #4. ER: POSITIVE (ABOUT 80% OF NUCLEAR STAINING WITH STRONG INTENSITY) . PR: POSITIVE (ABOUT 40% OF NUCLEAR STAINING WITH STRONG INTENSITY). HER2/NEU (HERCEPTEST) : NEGATIVE (STAINING INTENSITY OF 1+). Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. issue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SEE FINAL DIAGNOSIS. 2). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME.",T1,N1,M0,T1N1M0
TCGA-D5-6922,"page 1 / 1. copy No. 4. Examination: Histopathological examination (cito). Cost of diagnostic procedure. Material: 1. Multiple organ resection - sigmoid colon. Expected time of examination: Clinical diagnosis: Cancer of the sigmoid colon. Macroscopic description: A 15.2 cm length of the large intestine with a piece of mesentery sized 15 X 6.5 X 2.5 cm. Ulcerous tumour sized 4.2. X 6.5 X 0.8 cm in the mucosa. The lesion surrounding 90% of the intestine circumference, removed 7.2 cm from the. incision line and 5.3 cm from the opposite one. Microscopic description: Adenocarcinoma tubulopapillare (G2). Infiltratio carcinomatosa profunda tunicae muscularis priopriae et telae adiposae mesenterii pericolicae. Incision lines free of neoplastic lesions. Metastases carcinomatosae in lymphonodo (NO I/VIII). Infiltratio carcinomatosa capsulae lymphonodi. Emboliae carcinomatosae. Histopathological Diagnosis: Adenocarcinoma tubulopapillare coli. Tubulopapillar adenocarcinoma of the colon. Metastases carcinomatosae in lymphonodo. Cancer metastases in the lymph nodes (NO I/VIII). (G2, Dukes C, Astler - Coller, C2, pT3, pNI). CONTACT YOU DOCTOR WITH THIS REPORT!.",T3,N1,M0,T3N1M0
TCGA-A8-A09N,"4. Invasive ductal breast carcinoma (max. diameter 2.2 cm, now also in some sections. malignancy grade III) with angioinvasion in the immediate tumor periphery, also with. concomitant high-grade DCIS (procomponent > 10). Distant fibrolipomatous parenchyma of. the breast (with cystic duct ectasia) with risk lesions of unsettled to atypical ductal. hyperplasia, but tumor-free. Minimal width of caudal and dorsal safety margin 0.7-0.8 cm. Histologically unremarkable skin spindle. Tumor classification: G3 (L1, V0), pT2, pN3a, MX, R0.",T2,N3,M0,T2N3M0
TCGA-DD-AAD0,"LINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo : GROSS: Specimen: Liver: 17.0 x 11.5 x 7.5 cm, 419.0 gm (fresh). Operation: Left lateral hepatectomy. Lesion: A relatively well-defined, buldging mass (13.0 X 7.5 x 6.5 cm). Cut surface: Bile-tinged, ovoid, solid, granular with necrosis. Gross type: Expanding nodular. Resection margin: Not involved grossly (safety margin: 0.2 cm). Remaining parenchyma: Cirrhotic. Portal vein invasion: No. Representative sections are submitted. Gross photo: Present. Blocks. T1- and TB, bile tinged mass and surrounding liver parenchyme X 5. L and NB, nontumorous liver parenchyme x 2. RM, resection margin of liver X 1. MICROSCOPIC: Hepatocellular carcinoma: The worst differentiation II. The major differentiation II. Histologic type: Trabecular and pseudoglandular. Cell type: Hepatic. Fatty change: Yes (30 %). Cholangiocarcinoma: No. Combined hepatocellular and cholangiocarcinoma: No. Fibrous capsule formation: Partial capsule. Capsular infiltration: Yes. Septum formation: Yes. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Intrahepatic metastasis: No. Multicentric occurrence: No. Non-tumor liver pathology. 1. Chronic hepatitis: Yes. 1-1. Etiology: HBV. 1-2. Grade, lobular: Minimal. 1-3. Grade, portoperiportal: Mild. 1-4. Stage (fibrosis): Cirrhosis. 1-5. Cirrhosis: Mixed. 2. Dysplastic nodule: No. 3. Ductal epithelial dysplasia: No. 4. Other liver diseases: No. NOT reported. Gross: Peritoneal fluid, smear, suggestive of, malignancy. Liver, left, ectomy, Hepatocellular carcinoma. T56000, left, P10, M81703. DIAGNOSIS: Liver, left, lateral hepatectomy: Hepatocellular carcinoma. Suggestion :",T1,N0,M0,T1N0M0
TCGA-CV-A45Z,"Sex: M. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. section ""SPECIMEN"" may have been added. DIAGNOSIS. (A) RIGHT FALSE CORD: INVASIVE SQUAMOUS CARCINOMA. (B) NOSE RIGHT PAROTID BULB: Lymph node, no tumor. RIGHT THYROID LOBECTOMY: Multinodular goiter. (D). LARYNGECTOMY: SQUAMOUS CARCINOMA, GRADE 3 WITH LYMPHATIC INVASION INVOLVING RIGHT. AND LEFT SUPRAGLOTTIC REGIONS. MARGINS OF RESECTION FREE,. THICKNESS OF THE TUMOR, 1.2 CM. SQUAMOUS CARCINOMA IN SITU IN RIGHT VENTRICLE. Large tracheal margin of resection free of tumor. Seven right cervical lymph nodes, no tumor. TWO cervical lymph nodes, no tumor. Entire report and diagnosis completed by: Report released by: GROSS DESCRIPTION. (A) RIGHT FALSE CORD - Three fragments of tan-pink tissue admixed with blood. clot (overall 0.5 x 0.4 x 0.2 cm). Entirely submitted for frozen section in. A. FS/DX: SQUAMOUS CELL CARCINOMA, INVASIVE. (B) NODE, RIGHT PAROTID BULB - A lymph node, 1.5 x 0.6 x 0.7 cm. Bisected in. toto in B. (c) RIGHT THYROID LOBECTOMY - A right lobe of the thyroid (5.0 x 3.0 x 1.7. cm), with several nodules, ranging from 0.2 to 1.1 cm. A more preserved. portion of thyroid tissue is at the superior aspect, it is red-brown and. meaty; the nodules range from red to light brown color. The specimen sampled. for frozen section in C1 and C2; representative sections are submitted in. C3-c6. INK CODE: vellow - isthmus margin; blue - thyroid surface. (D) LARYNGECTOMY - A laryngectomy and attached soft tissue and lymph node. dissection with overall measurements of 8.0 x 6.0 x 5.0 cm. A light tan. indurated and ulcerated lesion located in the right supraglottic area and. extending to the midline approximately 0.5 cm into the left supraglottic area. is 2.0 x 1.5 x 1.0 cm mass. The mucosal and external surfaces specimen are. uninvolved grossly by tumor. The specimen is submitted sequentially from. right to left. SECTION CODE: D1-D17, lymph nodes, right; D18-D19, lymph nodes, left. Sex: M. Case type: Surgical History. FS/DX: MUCOSA, NO TUMOR PRESENT. ADDITIONAL STUDIES. PHOTO: (A) LARYNX. SNOMED CODES. M-80703 T-24455.",T1,N0,M0,T1N0M0
TCGA-DD-AAEH,"LINICAL DIAGNOSIS: HCC. Specimen : Liver. Gross Photo : GROSS: Specimen status: Fresh. Operation: Left hemihepatectomy. Organs: Liver (21.8 X 12.5 X 4.0 cm, 398.0 gm). Lesion: A well-defined yellow to tan nodule (4.0 x 3.0 X 5.8 cm). Cut surface: A well defined yellow to tan firm and solid nodule (expanding nodular type). Resection margin: Not involved grossly (safety margin: 1.8 cm). Others: Satellite nodule: No. Remaining parenchyma: Stage 2 fibrosis. Gross photo: Present. Blocks. TB, T1- 4, mass X 5. NB, L, liver parenchyma X 2. RM, resection margin x 1. GB, gallbladder X 1. MICROSCOPIC: Tumor type: Hepatocellular carcinoma. Histologic grade (Edmondson-Steiner grade for hepatocellular carcinoma): The worst differentiation: II. The major differentiation: I. Histologic type: Trabecular and pseudoglandular. Cell type: Hepatic. Fatty change: No. Fibrous capsule formation: Partial. Capsular infiltration: Yes. Septum formation: Yes. Surgical resection margin invasion: No (safety margin - 1.8 cm). Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: Yes. Intrahepatic metastasis: Unknown. Multicentric occurrence: Unknown. NOT reported. Gross: NOT reported. Gross: ,ectomy, ,Hepatocellular carcinoma. T56000, P10, M81703. gallbladder,ectomy,chronic cholecystitis. T57000, P10, M43005. lymph node,ectomy,Reactive hyperplasia. T08000, P10, M72200. DIAGNOSIS: Liver, left, hemihepatectomy: Hepatocellular carcinoma, well differentiated. Gallbladder, cholecystectomy: Chronic cholecystitis. Lymph node, adjacent to gallbladder, cholecystectomy: Reactive hyperplasia (0/1). Suggestion :",T1,N0,M0,T1N0M0
TCGA-49-4514,"FINAL DIAGNOSIS. LYMPH NODE, STATION 5 (EXCISION) : ONE (1) LYMPH NODE AND. ISSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. :) LYMPH NODE, R11 (EXCISION) : ONE (1) LYMPH NODE AND ASSOCIATED. 'IBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. LYMPH NODE, L8 (EXCISION) : ONE (1) LYMPH NODE AND ASSOCIATED. 'IBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 1) LUNG, LEFT UPPER LOBE (LOBECTOMY) : ;PECIMEN TYPE: obectomy.",T1,N0,M0,T1N0M0
TCGA-CW-5585,"REVISED REPORT (Revised information underlined). TISSUE DESCRIPTION: 13.5 cm segment right ureter and right kidney (400 grams, 13.5 x 8.3. x 7.5 cm) and lymph nodes from intra-aortocaval and retrocaval. regions. DIAGNOSIS: Kidney, right, radical nephrectomy: Grade 2 (of 4). renal cell carcinoma, clear cell type, forms a 9.3 x 7.5 x 6.5 cm. mass located in the mid portion of the kidney. The tumor is. confined to the kidney. A tumor thrombus is present in the renal. vein, 0.8 cm in greatest linear extent. Coagulative tumor necrosis. is. absent. Sarcomatoid differentiation is absent. The surgical. margins are negative for tumor. Multiple (7) renal hilar lymph. nodes are identified. The adrenal gland is absent. Lymph nodes, intra-aortocaval and retrocaval, excision: Multiple. (7) intra-aortocaval and (3) retrocaval lymph nodes are negative for. tumor. AMENDMENTS: Revision Description. Grade misinterpreted on frozen section. Should be grade. 2. (of. 4). Original Diagnosis. Kidney, right, radical nephrectomy: Grade 3 (of 4) renal cell. carcinoma, clear cell type, forms a 9.3 x 7.5 x 6.5 cm mass located. in the mid portion of the kidney. The tumor is confined to the. kidney. A tumor thrombus is present in the renal vein, 0.8 cm in. greatest linear extent. Coagulative tumor necrosis is absent. Sarcomatoid differentiation is absent. The surgical margins are. negative for tumor. Multiple (7) renal hilar lymph nodes are. identified. The adrenal gland is absent. Lymph nodes, intra-aortocaval and retrocaval, excision: Multiple. (7) intra-aortocaval and (3) retrocaval lymph nodes are negative for. tumor. REVISED REPORT (Revised information underlined). TISSUE DESCRIPTION: 13.5 em segment right ureter and right kidney (400 grans, 13.5 x 8.: x 7.5 cm) and lymph nodes from intra-aortocaval and retrocaval. regions. DIAGNOSIS: Kidney, right, radical nephrectony; Grade 2_(of 4). renal cell garginoma, alear cell type, forms a 9.3 x 7.5 x 6.5 em. mass lodated in the mid portion of the kidney. The tumor is. confined to the kidney. A tumor thrombus is present in the renal. vein, 0.8 cm in greatest linear extent. Coagulative t.umor necrosin. is absent. Sarcomatoid differentiation is absent. Th.e surgical. margins are negative for tumor. Multiple (7) renal hilar lymph. nodes are identified. The adrenal gland is absent. Lymph nodes, intra-aortocaval and retrocaval, excision: Multiple. (7) intra-aortocaval and (3) retrocaval lymph nodes are negative for. tumor. AMENDMENTS: Revision Description: Grade misinterpreted on frozen section. Should be grade 2 (of. 4). Original Diagnosis. Kidney, right, radical nephrectorty Grade 3 (of 4) renal cell. carcinoma, clear dell type, forms a 9.3 x 7.5 x 6.5 cn mass locatel. in the mid portion of the kidney. The tumor is confined to the. kidney. A tumor thrombus is present in the renal vein, 0.8 cm in. greatest linear extent. Coagulative tumor necrosis in absent. Sarcomatoid differentiation is absent. The surgical nargins are. negative for tumor. Multiple (7) renal hilar lymph nodes are. identified. The adxenal gland is absent. Lymph nodes, Intra-aortocaval and retrocaval, excisich: Multiple. (7) intra-aortocaval and (3) retrocaval lymph nodes atte negative f >r. tumor.",T3,N0,M1,T3N0M1
TCGA-BQ-5887,"Date of Repoit. Ref Source: sis & History: vith partial nephrectomy, now with lipsilateral recurrence. Specimens submitted: 1: SP: Lymph nodes, paracaval; excisio. 2: SP: Kidney, right; total nephrectomy. 3: SP: Sofi tissue, perinephric; excision. 4: SP: Lymph nodes #2, paracaval: exo. DIAGNOSIS: 1. SP: Lymph nodes, paracaval; excision. Lymph Nodes: Not identified. Benign fibroadipose tissue; no lymph nodes identified in entirely submitted specimen. 2. SP: Kidney, right; total nephrectomy. Tumor Type: Renal cell carcinoma - Papillary type. Type 2. Fubrman Nuclear Grade: Nuclear grade III/IV. Tumor Size: Greatest diameter is 3.8 cm. Local Invasion (for renal cortical types): Involves renal hilar fat. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocyloma: pT3a Tumor invades the adrenal gland or perinephric lissues but not beyond Gerota's fascia. 3. SP: Soft tissue, perinephric; excision. Fibroadipose tissue with fibrosis, fat necrosis and camication; no tumor seen. 4. SP: Lymph nodes #2, paracaval; excisioni. Lymph Nodes: Not involved. Number of nodes examined:7. Benign segment of ureter. TATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION or THE SLIDES (AND/OR OTHER MATERIAL). AND THAT THAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh, labeled ""paracaval lymph node"" and consists of a 2.4 X 1.8x 0.4 cm fragment of tan red lissue. No definite lymph nodes are identified. Entirely submitted. Summary of sections: U + undesignated. 2) The specimen is received fresh labeled right kidney"" and consists of a kidney with attached ureter, renal vessels and. perinephric fat weighing 281.5 g in total, The kidney measures 7.9 x 5.2 X 5.0 cm. The attached ureter measures 2.4 cm in. length and 0.4 cm in diameter, The allached renal vein measures 1.9 cm in length and 0.3 cm in diameter. The renal vessels and. ureter margins are grossly unremarkable. An adrenal gland is not identified. There is a 2.9 x 2.3 cm previous excision site al a. kidney pole. The excision site is inked blue while the remainder of the kidney is inked black. The kidney is bivalved to reveal a. 3.8 x 3.7 x 3.1 cm largely hemorrhagic and partially gold - tan tumor that is located in the hilar fat. Sections through the remainder. of the kidney reveal pink- brown parenchyma, with a well-defined cortico-medullary junction. The cortex measures 0.6 the. calyces appear normal. No lymph nodes are identified in the perinephric fat. Representative sections are submitted for. and. for permanent sections. Photographs are taken. Summary of sections: UVM -- ureteral and vessel margins. T.. tumor. THF tumor with hilar fat. TSF -- tumor with sinus fat. TK -- tumor with adjacent kidney. TC -- tumor to capsule. K -- representative sections kidney. BX previous excision site. 3) The specimen is received fresh for frozen section consultation, labeled ""perinephric soft tissue stitch marks area of interest"". and consists of a fragment of fibroadipose measuring 5.0 x 3.7 x 2.4 cm. The specimen is focally surfaced by a 3.5 x 1.0 cm. fragment of fibromembranous tissue. The area around the stitch is inked black. The remainder of the specimen is inked blue. Cut surfaces show a 2.9 x 2.3 x 1.5 cm area of fat necrosis with a capsule. There are multiple surgical staples within the. specimen. Representatively submitted for frozon section. Summary of sections: FSC frozen section control. U - additional representative sections. 4) The specimen is received in formalin labeled ""paracaval lymph nodes #2"" and consists of a 3.2 x 2.0 x 0.3 cm irregular. fibrofatty soft tissue fragment to include multiple, pink tan fatty lymph nodes ranging from 0.4 cm up to 2.8 cm in greatest. dimension, All identified lymph nodes and the remaining fibrous tissue is entirely submitted. Summary of sections: BLN-bisected lymph nodes. LN-lymph nodes. U - undesignated. Summary of Sections: Part 1: SP: Lymph nodes, paracaval; excisio. Block. Sect. Site. PCs. 1. u. 2. Part 2: SP: Kidney, right; total nephrectomy. Block. Sect. Site. PCs. 1. BX. 1. K. 1. 1. 2. 1. to. 1. 1. 3. 1. TK. 2. 1. TSF. 2. 1. uvm. 3. Part 3: SP: Soft tissue, perinephric; excision. Block. Soct. Site. PCs. 1. FSC. 1. U. 4. Part 4: SP: Lymph nodes #2, paracaval; excisio. Block. Sect. Sito. PCs. 2. bIn. 2. 2. In. 2. 1. u. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative. consultation. 3). FROZEN SECTION DIAGNOSIS: PERINEPHRIC SOFT TISSUE (FS): FIBROSIS AND CALCIFICATION (LIN). PERMANENT DIAGNOSIS: SAME.",T3,N0,M0,T3N0M0
TCGA-BH-A0H3,"FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEFT AXILLA, SENTINEL NUMBER 1 -. ONE LYMPH NODE, FREE OF METASTATIC CARCINOMA (0/1). PART 2: LYMPH NODE, LEFT AXILLA, SENTINEL NUMBER 2 -. ONE LYMPH NODE, FREE OF METASTATIC CARCINOMA (0/1). PART 3: BREAST. LEFL, SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA WITH TUBULAR AND INVASIVE CRIBRIFORM FEATURES. B. NOTTINGHAM GRADEY (TUBULE FORMATION 1, NUCLEAR PLEOMORPHISM 2, MITOTIC ACTIVITY 1,. TOTAL SCORE 4/9). C. THE INVASIVE TUMOR MEASURES 1.6 CM IN GREATEST DIMENSION. D. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 2, CRIBRIFORM AND MICROPAPILLARY TYPES. DCIS CONSTITUTES 20% OF THE TOTAL TUMOR MASS AND IS PRESENT ADMIXED AND ADJACENT TO. THE INVASIVE COMPONENT. E. NO LYMPHOVASCULAR SPACE INVASION IS NOTED. F. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. G. INVASIVE DUCTAL CARCINOMA IS PRESENT 3.0 MM FROM THE POSTERIOR (CLOSEST) MARGIN; ALL. OTHER MARGINS ARE GREATER THAN 0.5 CM AWAY FROM INVASIVE CARCINOMA. H. DUCTAL CARCINOMA IN SITU IS PRESENT 4.0 MM FROM THE POSTERIOR (CLOSEST) MARGIN; ALL. OTHER MARGINS ARE GREATER THAN 0.5 CM AWAY FROM IN SITU CARCINOMA. I. ATYPICAL DUCTAL HYPERPLASIA. J. SCLEROSING ADENOSIS AND FIBROCYSTIC CHANGES. K. PREVIOUS BIOPSY SITE CHANGES. L. THE INVASIVE TUMOR CELLS ARE POSITIVE FOR ESTROGEN RECEPTOR AND PROGESTERONE. RECEPTOR AND NEGATIVE FOR HER-2/NEU (FISH NONAMPLIFIED) AS PER PREVIOUS PATHOLOGY. CASE STNUPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.6 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Other Type(s): IDC with tubular and cribriform features. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 1. Mitotic activity score: 1. Total Nottingham score: 4. Nottingham grade (1, 2, 3): 1. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, malignant zones. TUMOR TYPE, IN SITU: Cribriform. Micropapillary. Percent of tumor occupied by in situ component: 20 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 3 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 2. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. NON-NEOPLASTIC BREAST TISSUE: ADH, FCD. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 2+.",T1,N0,M0,T1N0M0
TCGA-IN-A6RL,"FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEVEL 7 NEAR BRONCHUS INTERMEDIUS, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 2: LYMPH NODE, LEVEL 7 NEAR CARINA, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 3: LYMPH NODE, LEVEL 7 NEAR LEFT MAIN BRONCHUS, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 4: LYMPH NODE, PERIESOPHAGEAL, BIOPSY -. A. BENIGN FIBROADIPOSE TISSUE. B. NO LYMPH NODE IDENTIFIED. PART 5: SOFT TISSUE, PERIESOPHAGEAL -. A. BENIGN FIBROADIPOSE TISSUE. B. NO TUMOR PRESENT. PART 6: ESOPHAGUS, ESOPHAGECTOMY -. A. MODERATELY DIFFERENTIATED ADENOCARCINOMA, 3.5 CM, INVASIVE INTO BUT NOT THROUGH THE. MUSCULARIS PROPRIA, LOCATED AT THE GASTROESOPHAGEAL JUNCTION. B. ANGIOLYMPHATIC AND PERINEURAL INVASION PRESENT. C. MARGINS FREE OF TUMOR; TUMOR IS 0.1 CM FROM THE CIRCUMFERENTIAL (ADVENTITIAL) MARGIN. D. PATHOLOGIC STAGE: pT2 pN2. E. ADDITIONAL FINDINGS: a. HIGH-GRADE COLUMNAR EPITHELIAL DYSPLASIA ASSOCIATED WITH THE INVASIVE. ADENOCARCINOMA. b. NO DEFINITIVE BARRETT'S MUCOSA IDENTIFIED. F. GASTRIC MUCOSA OTHERWISE WITHOUT SIGNIFICANT ABNORMALITY. PART 7: ANASTOMOTIC RINGS, RESECTION -. NO TUMOR PRESENT. PART 8: FINAL GASTRIC MARGIN, RESECTION -. NO TUMOR PRESENT. PART 9: GASTROESOPHAGEAL FAT, RESECTION-. A. METASTATIC ADENOCARCINOMA IN THREE OF EIGHTEEN LYMPH NODES (3/18). B. NON-NECROTIZING FIBROTIC GRANULOMAS INVOLVING ONE ANTHRACOTIC LYMPH NODE. C. RESULTS OF GROCOTT AND AFB STAINS WILL BE REPORTED IN AN ADDENDUM. PART 10: LYMPH NODE, SUBCARINAL NEAR AZYGOUS, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 11: LYMPH NODE, PERIGASTRIC, BIOPSY -. METASTATIC ADENOCARCINOMA IN ONE OF ONE LYMPH NODE (1/1). PART 12: LYMPH NODE, LEVEL 7, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 13: LYMPH NODE, SUBCARINAL ""ON ESOPHAGUS"", BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (C. PART 14: LYMPH NODE, SUBCARINAL, BIOPSY. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 15: LYMPH NODE, NEAR GASTRIC CURVE, BIOPSY -. METASTATIC ADENOCARCINOMA IN ONE OF ONE LYMPH NODE (1/1) WITH EXTRACAPSULAR EXTENSION. PART 16: LYMPH NODE, GASTRIC FAT, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). PART 17: LYMPH NODE, FAT PAD, BIOPSY -. NO TUMOR PRESENT IN ONE LYMPH NODE (0/1). COMPREHENSIVE THERANOSTIC SUMMARY. IMMUNOHISTOCHEMISTRY: Her2: EQUIVOCAL (2+). IN SITU HYBRIDIZATION / FISH: HER2 (ERBB2) amplification: NEGATIVE. Addendum. Part 9: Grocott and AFB stains are negative for fungal and mycobacterial organisms. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY ESOPHAGEAL TUMORS. MACROSCOPIC. SPECIMEN TYPE: Esophagectomy. TUMOR SITE: Tumor midpoint centered on esophagogastric junction. TUMOR SIZE: Greatest dimension: 3.5 cm. Additional dimensions: 2.0, 1.0 cm. MICROSCOPIC. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G2. PATHOLOGIC STAGING (pTNM). pT2. pN2. Number of lymph nodes examined: 29. Number of lymph nodes involved: 5. pM Not applicable. PRIOR TREATMENT: No prior treatment. MARGINS. Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (adventitial) margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1 mm. Specify margin: Circumferential. ANGIOLYMPHATIC INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: High grade dysplasia. SPECIAL PROCEDURES: In Situ Procedure. Interpretation. HER2 FISH STUDIES PERFORMED ON THE ADENOCARCINOMA ARE NEGATIVE. # Cells Analyzed: 63. Ratio HER2/CEP17: 1.28. SNR: 2.9. CNR: 2.2. % Hyperdiploid: 21(33.3%). HER2 IMMUNOPEROXIDASE STUDIES PERFORMED ON THE ADENOCARCINOMA ARE EQUIVOCAL. IHC score: 2+. INTERPRETATION GUIDELINES AND PROBE/CLONE INFORMATION: FISH: Probe: HER2. DNA Probe. Probe Description: The. HER2. DNA probe is a 190 Kb. directly labeled fluorescent DNA probe. specific for the HER2. gene locus. The CEP 17 DNA probe is a 5.4 Kb. directly labeled. fluorescent DNA probe specific for the alpha satellite DNA sequence at the centromeric region of chromosome 17. The probes are pre-mixed and pre-denatured in hybridization buffer. Interpretation: HER2 negative: HER2 gene/chromosome 17 ratio less than 2.0. HER2 positive: HER2 gene/chromosome 17 ratio greater than 2.0. Results should be considered along with other clinical information. has modified the suggested manufacturer protocol for HER2 FISH testing. The modifications have been tested and validated. The modifications are as follows: Slides are deparaffinized in. Tissue is. digested in protease 31 minutes; Tissue and probe are co-denatured at 90 C for 12 minutes; Paraffin pretreatment reagents and. control slides are prepared in house. Amplified, non-amplified, and internal (centromere 17) controls were used in the testing. The. laboratory takes responsibility for the test performance. FISH analysis was manually performed and quantitatively assessed by analysis of a minimum of 60 cells using the HER2. and the CEP17. probes. IHC: anti-HER-2/neu (4B5) Rabbit Monocional Primary Antibody. Tumors are considered POSITIVE if they show HER2 protein over-expression (3+) by IHC. IHC scoring for HER2 in gastric and GE junction cancer by type of diagnostic specimen: SCORE SURGICAL SPECIMEN-STAINING PATTERN. NEGATIVE. 0. No reactivity or membranous reactivity in <10% of tumor cells. 1+. Faint/barely perceptible membranous reactivity in 10% of tumor cells;cells are reactive only in part of their membrane. EQUIVOCAL. 2+. Weak to moderate complete, basolateral or lateral membranous reactivity in 10% of tumor cells. POSITIVE. 3+. Strong complete, basolateral or lateral membranous reactivity in 10% of tumor cells. BIOPSY SPECIMEN-STAINING PATTERN. NEGATIVE. 0. No reactivity or no membranous reactivity in any (or <5 clustered) tumor cells. 1+. Tumor cell cluster ( 5 cells) with a faint/barely perceptible membranous reactivity irrespective of percentage of tumor. cells stained. EQUIVOCAL. 2+. Tumor cell cluster ( 5 cells) with a weak to moderate complete, basolateral or lateral membranous reactivity irrespective. of percentage of tumor cells stained. POSITIVE. 3+. Tumor cell cluster ( 5 cells) with a strong complete, basolateral or lateral membranous reactivity irrespective of. percentage of tumor cells stained.",T2,N1,M0,T2N1M0
TCGA-KO-8407,"DIAGNOSIS. (A) LEFT KIDNEY AND ADRENAL GLAND: RENAL CELL CARCINOMA, CHROMOPHOBE TYPE, FUHRMAN NUCLEAR GRADE 3. (10.5 CM). TUMOR CONFINED TO THE KIDNEY. (SEE COMMENT). Ureteral, vascular and soft tissue margins of resection free of. tumor. One perinephric lymph node, no tumor present. Adrenal gland, no tumor present. (B) RETROPERITONEAL LYMPH NODES: Ten lymph nodes, no tumor present. COMMENT. Although the tumor is in close proximity to the renal sinus, multiple. sections failed to demonstrate invasion into the renal sinus adipose. tissue. Tumor is present within vascular/lymphatic spaces in the sinus. GROSS DESCRIPTION. (A) LEFT KIDNEY AND ADRENAL GLAND - A left kidney with surrounding. perinephric fat (21.0 X 12.5 X 10.5 cm, overall), and adrenal gland (7.5. X 1.5 X 0.3 cm). The kidney (21.0 X 12.3 X 9.0 cm) contains a variegated tan-red. well-circumscribed mass (10.5 X 12.3 X 9.0 cm), that replaces about 90%. of renal parenchyma, pushes into the perinephric fat and into the pelvis. and has possible extensive involvement of the renal sinus. The remainder of the renal parenchyma appears unremarkable with a well. defined cortico-medullary junction. The renal vein, artery and ureter. margins appear unremarkable. Cut section of the adrenal gland reveals. unremarkable adrenal parenchyma. One lymph node (0.8 X 0.6 X 0.5 cm) is. identified in the perinephric fat. INK CODE: Black - perinephric fat margin. SECTION CODE: A1, renal artery, vein and ureter margin, en face;. A2-A4, tumor to perinephric fat margin (closest to tumor); A5, one. bisected lymph node; A6-A8, tumor to renal pelvis; A9-A14,. representative sections of tumor (A12 contains section with probable. tumor in parenchymal vessel; A15, A16, tumor to normal kidney. parenchyma; A17, uninvolved renal parenchyma; A18, adrenal gland;. A19-A21, additional sections from tumor adjacent to renal sinus. (B) RETROPERITONEAL LYMPH NODES - A fragment of soft tissue measuring. 8.0 X 2.0 X 0.4 cm. Multiple lymph nodes ranging from 0.6 X 0.4 X 0.4. cm to 2.2 X 0.8 X 0.6 cm identified. SECTION CODE: B1, three lymph nodes; B2, two lymph nodes; B3, one. lymph node (1.8 cm), bisected; B4, one lymph node, sectioned; B5, one. lymph node, bisected; B6, one lymph node (2.2 cm), bisected; B7, one. lymph node. CLINICAL HISTORY. Left renal mass, retroperitoneal mass. SNOMED CODES. 1.",T2,N0,M0,T2N0M0
TCGA-BR-6564,STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Stomach. Tumor size: 6 X 6 X 1 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Adjacent structures. (specify) - greater omentum. Lymph nodes: 3/7 positive for. metastasis (Intraabdominal 3/7). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.,T3,N2,M0,T3N2M0
TCGA-BR-6453,Case ID. Subject. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Stomach. Tumor size: Not specified. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Muscularis propria. Lymph nodes: 1/1 positive for metastasis. (Intraabdominal 1/1). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None.,T2,N1,M0,T2N1M0
TCGA-P4-A5E8,"Patholgy Accession No: Patient ID: Normal Sample ID: DIAGNOSIS. (A) LEFT KIDNEY WITH REGIONAL LYMPH NODES: PAPILLARY RENAL CELL CARCINOMA (10.0 CM MAXIMUM DIMENSION), FUHRMAN. NUCLEAR GRADE 3,. WITH VASCULAR-LYMPHATIC INVASION, CONFINED TO THE KIDNEY. (SEE COMMENT). Margins of resection free of tumor. Adrenal gland, no tumor present. METASTATIC PAPILLARY RENAL CELL CARCINOMA IN THREE OF THREE LYMPH. NODES. (B) PARA-AORTIC LYMPH NODES: METASTATIC PAPILLARY RENAL CELL CARCINOMA IN MATTED LYMPH NODES. (SEE COMMENT). COMMENT. The papillary renal cell carcinoma is composed of papillae lined by tall columnar cells. Most tumor cells have eosinophilic. cytoplasm, and some cells have clear cytoplasm. These morphologic features are consistent with type 2 papillary renal cell. carcinoma. The tumor appears to be confined to the kidney and does not show invasion into the renal sinus adipose tissue,. perinephric fat or the renal vein. The para-aortic lymph nodes (specimen B) involved by metastatic renal cell carcinoma are matted together, hence the exact. number of lymph nodes cannot be assessed. In addition to tumor in the lymph nodes there are small foci of tumor within vascular-. lymphatic spaces in the perinodal adipose tissue. GROSS DESCRIPTION. (A). LEFT KIDNEY WITH REGIONAL LYMPH NODE, VACCINE PROTOCOL - A radical nephrectomy specimen (21.0 x 15.0 x 8.5. cm) including the left kidney (12.5 x 11.0 x 7.3 cm), a segment of renal artery, the renal vein and ureter (1.4 cm in length and 0.5. cm average diameter) and the adrenal gland (5.5 x 2.0 x 1.4 cm). There is a 10.0 x 8.5 x 8.5 cm well circumscribed tumor in the lower/mid pole of the kidney. The tumor is tan-gray and friable. with focal areas of hemorrhage and necrosis throughout. The tumor is well circumscribed and does not grossly invade into. perinephric adipose tissue, renal sinus, or renal vein. The tumor does not extend to Gerota's fascia. Three enlarged lymph nodes. (0.6 to 2.9 cm in greatest dimension) are identified in the hilum of the kidney. These are grossly involved by tumor. The adjacent kidney parenchyma is unremarkable. The pelvicalyceal system is smooth and devoid of any lesions. Serial cross. sections of the left adrenal gland show unremarkable cortex and medulla. Tumor has been submitted for the vaccine protocol. Portions of the tumor have also been submitted for possible electron. microscopy. Photographs were obtained. INK CODE: Blue - Gerota's fascia. SECTION CODE: A1, renal vein, renal artery, and ureter margins; A2, adrenal gland, representative sections; A3, tumor with. nearest soft tissue margin; A4-A6, tumor and adjacent uninvolved kidney; A7, A8, tumor and renal sinus; A9-A12, representative. sections of tumor; A13, one hilar lymph node, representative section; A14, one hilar lymph node, representative section; A15, one. hilar lymph node bisected. (B) PARA-AORTIC LYMPH NODE - Three irregular fragments of soft tissue (8.0 X 5.0 X 3.0 cm in aggregate). On cut surface it. appears to be a matted aggregate of variegated white-yellow-red tumor. No residual lymph node tissue is grossly identified. Representative sections. submitted in B1-B5. CLINICAL HISTORY. None given. SNOMED CODES. T-71000, M-83123, M-Y1593, T-C4400, M-83126, M-Y1596. 1. Patholgy Accession No: Patient ID: Normal Sample ID: Tumor Sample ID: ""Some tests reported here may have been developed and performance. characteristics determined by. These tests have not been specifically cleared or approved by. the U.S. Food and Drug Administration."". 2.",T2,N1,M0,T2N1M0
TCGA-AO-A03T,"Clinical Diagnosis & History: Palpable left breast cancer showing IDC on core. Specimens Submitted: 1: SP: Sentinel node #1, level one, left axilla (fs). 2: SP: Sentinel node #2, level one, left axilla (fs). 3: SP: Sentinel node #3, level one, left axilla (fa). 4: SP: Left breast. 5: SP: Level one anu two lymph nodes left axilla. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1, LEFT AXILLA LEVEL I, BIOPSY: - METASTATIC CARCINOMA INVOLVING ONE OUT OF ONE LYMPH NODE (1/1). - NO EXTRANODAL EXTENSION SEEN. 2). LYMPH NODE. SENTINEL #2, LEFT AXILLA LEVEL I, BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 3). LYMPH NODE, SENTINEL #3, LEFT AXILLA LEVEL I, BIOPSY: - METASTATIC CARCINOMA INVOLVING ONE OUT OF ONE LYMPH NODE (1/1). - NO EXTRANODAL EXTENSION SEEN. 4). BREAST, LEFT, TOTAL MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC GRADE III/III (SLIGHT. OR NO TUBULE FORMATION),. NUCLEAR GRADE II/III (MODERATE VARIATION IN. SIZE AND SHAPE), MEASURING 2.5 CM, GROSSLY. - DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, SOLID TYPE WITH. INTERMEDIATE NUCLEAR GRADE AND MODERATE NECROSIS. LOBULAR INVOLVEMENT BY DCIS IS PRESENT. - THE DCIS CONSTITUTES <= 25% OF THE TOTAL TUMOR MASS, AND IS PRESENT. ADMIXED WITH AND AWAY. FROM THE INVASIVE COMPONENT. - THE INVASIVE CARCINOMA IS LOCATED NI THE UPPER OUTER QUADRANT AND. CENTRAL AREA. - THE DCIS IS LOCATED IN THE UPPER OUTER QUADRANT AND CENTRAL AREA. - NO INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINOMA. IS IDENTIFIED. VASCULAR INVASION IS PRESENT. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES, STROMAL. FIBROSIS, ADENOSIS. AND FIBROCYSTIC CHANGES. - RESULTS OF SPECIAL STAINS (ARE AS FOLLOWS: Immunohistochemical stains were performed on formalin-fixed tissue with the. following results for invasive carcinoma (block 4 T 11). ESTROGEN RECEPTOR (6F11,. 95% nuclear staining with moderate intensity. PROGESTERONE RECEPTOR (1E2;. 60% nuclear staining with moderate intensity. HER2 (HercepTest; -. Negative (0 ). Controls are satisfactory. Comment: HercepTestTM. ) is an FDA-approved method for assessment of. HER2 protein overexpression in breast cancer tissue routinely processed for. histological evaluation. The HER2 test results are reported in accordance. with the ASCO/CAP guideline recommendations for HER2 testing in breast. cancer (J Clin Oncol 2007; 25 (1) :1-28) . 5). LYMPH NODES, LEFT AXILLA LEVELS I AND II, RESECTION: - NINE BENIGN LYMPH NODES (0/9). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. NEG-HER2. Gross Description: 1) The specimen is received fresh for frozen section consultation, labeled. ""sentinel node number one level 1 left axilla"" and consists of a pink-tan. lymph node measuring 1.2 x 1.0 x 0.4 cm. Bisected and entirely submitted. for frozen section. Summary of sections: FSC -- frozen section control. 2) The snecimen is received fresh for frozen section consultation, labeled. ""sentinel node number two level 1 left axilla"" and consists of tan lymph. node measuring 1.0 x 0.5 x 0.5 cm. Bisected and entirely submitted for. frozen section. Summary of sections: FSC frozen section control. 3) The specimen is received fresh for frozen section consultation, labeled. ""sentinel node number three level 1 left axilla"" and consists of a tan lymph. node measuring 1.5 x 0.8 x 0.8 cm. Bisected and entirely submitted for. frozen section. Summary of sections: FSC - frozen section control. 4). The specimen is received fresh, labeled ""left breast stitch marks. axillary tail"" and consists of a breast measuring 21.5 x 17.5 x 4 cm with. overlying skin ellipse measuring 9.5 x 3 cm. Situated centrally on the skin. surface is an everted nipple measuring 1.5 x 1.2 x 0.8 cm and areola. measuring 3.4 x 2.5 cm. A suture demarcates the axillary aspect. The. posterior surface of the breast is inked black and the specimen is serially. sectioned to reveal a centrally located white-tan firm tumor measuring 2.5 x. 2.5 x 2 cm with extension into upper outer quadrant, and located 1.1 cm from. the deep margin. A metal clip marking the previous biopsy site is. identified. Sectioning of the axillary aspect reveals no grossly. identifiable lymph nodes. Representative sections are submitted. TPS. is. taken. Summary of sections: N - nipple. NB - nipple base. D - deep margin. BX - biopsy site with tumor. T - tumor. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. 5) The specimen is received fresh, labeled ""level 1 and 2 lymph nodes left. axilla"" It consists of a 8 x 8 x 1.5 cm fragment of fibroadipose tissue. without orientation. Multiple lymph nodes are identified, ranging in size. from 0.3 cm to 1.2 cm. All identified lymph nodes are submitted. Summary of sections: LN - whole lymph nodes. Summary of Sections: Part. 1: SP: Sentinel node #1, level one, left axilla (fs). Block. Sect. Site. PC's. 1. FSC. 1. Part 2: SP: Sentinel node #2, level one, left axilla (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 3: SP: Sentinel node #3, level one, left axilla (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 4: SP: Left breast. Block. Sect. Site. PCs. 5. BX. 5. 1. D. 1. 2. LIQ. 2. 2. LOQ. 2. 2. N. 2. 1. NB. 1. 7. T. 7. 20. TEST. 20. 2. UIQ. 2. 2. UOQ. 2. Part 5: SP: Level one and two lymph nodes left axilla. Block. Sect. Site. PCs. 4. LN. 9. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: METASTATIC DUCT CARCINOMA. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: BENIGN. PERMANENT DIAGNOSIS: SAME. 3). FROZEN SECTION DIAGNOSIS: METASTATIC DUCT CARCINOMA. PERMANENT DIAGNOSIS: SAME. M.D.",T2,N1,M0,T2N1M0
TCGA-EL-A4KG,"Sex: F. Case type: Surgical Case. DIAGNOSIS. (A) RIGHT THYROID LOBE AND ISTHMUS. PAPILLARY THYROID CARCINOMA, CONVENTIONAL TYPE. Location: Right lobe. Multi-focal: No. Size = 2 cm. Extrathyroidal extension: Present, extending into fibroadipose tissue. Lymphovascular invasion: Not identified. Resection Margins: Negative. Lymph nodes: No tumor present in 1 lymph node. Parathyroid tissue, negative for tumor. (B) RULE OUT PORTION OF RIGHT INFERIOR PARATHYROID GLAND. Parathyroid and Thymic tissue. (C) RULE OUT PORTION RIGHT SUPERIOR PARATHYROID GLAND. Hypercellular parathyroid tissue. (D) MIDLINE TISSUE, RULE OUT PARATHYROID. Hypercellular parathyroid tissue. (E) LEFT THYROID LOBE. Colloid nodule. GROSS DESCRIPTION. (A) RIGHT THYROID LOBE AND ISTHMUS - The specimen consists of a right lobe (3.5 x 3.0 x 1.5 cm) with attached. isthmus 1.0 x 0.5 x 0.5 cm. The specimen is serially sectioned from superior-to-inferior to reveal a white mass (2.0 x 1.5 x 1.0 cm) located mainly. in the middle and inferior part of the right lobe. Representative sections are submitted for tissue bank. The specimen is submitted entirely in nine cassettes. SECTION CODE: A1-A8, right lobe from superior to inferior (tumor from cassette #4 to cassette #8); A9, the isthmus. (B) RULE OUT PORTION OF RIGHT INFERIOR PARATHYROID GLAND - The specimen consists of 0.2 x 0.2 x 0.1 cm tan. soft tissue. The specimen is submitted entirely for frozen section diagnosis in one cassette. Touch prep is done on the. specimen. FS/DX: parathyroid and Thymic tissue. (C) RULE OUT PORTION RIGHT SUPERIOR PARATHYROID GLAND - The specimen consists of a 0.3 x 0.2 x 0.2 cm tan. soft tissue. The specimen is submitted entirely for frozen section diagnosis in one cassette. Sex: F. Case type: Surgical Case. FS/DX: parathyroid hyperplasia. (D) MIDLINE TISSUE, RULE OUT PARATHYROID - The specimen is 0.3 x 0.2 x 0.1 cm tan soft tissue. The specimen is. submitted entirely for frozen section diagnosis in one cassette. FS/DX: parathyroid hyperplasia. (E) LEFT THYROID LOBE - A lobe of thyroid (4.3 x 3.0 x 1.4 cm) with smooth glistening capsule. Specimen is serially. sectioned. from superior to inferior to reveal a circumscribed pale tan, shiny, homogenous nodule (1.1 x 1.0 x 0.7 cm) that is. predominantly located in the superior pole. The remaining thyroid parenchyma is red-brown and homogenous. Representative sections submitted. SECTION CODE: Representative sections submitted in sequential order from superior to inferior with nodule located. in E1 and E2. CLINICAL HISTORY. PTC right lobe. SNOMED CODES. T-B6000, M-80503, T-C4200, M-00110, ""Some tests reported here may have been developed and performance characteristics determined by. se tests have not been specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by:",T3,N0,M0,T3N0M0
TCGA-UF-A7JO,"PRIMARY SITE: Floor of mouth. 1 - ""Lymph Nodes - Level 3 - Left"": - Thirteen lymph nodes uninvolved by metastatic carcinoma (0/13). 2 - ""Lymph Nodes - Level 2 - Left"": - Seven lymph nodes uninvolved by metastatic carcinoma (0/7). 3 - ""Lymph Nodes - Level 1 - Left"": - Seven lymph nodes uninvolved by metastatic carcinoma (0/7). 4 - ""Lymph Nodes - Level 2 - Right"": - Four of teen lymph nodes involved by metastatic carcinoma (4/10), with capsular. involvement. 5 - ""Floor of mouth tumor + left jaw"": - Invasive squamous cell carcinoma, grade 2: - Ulceration: present. - Tumor size 4.5 cm. - Soft tissue infiltration until muscular layer. - Osseous tissue involved by neoplasia. - Lymphatic invasion: not identified. - Vascular invasion: not identified. - Perineural invasion: not identified. - Posterior margin of the jaw involved by squamous cell carcinoma. - Other surgical margins uninvolved by carcinoma.",T4,N0,M0,T4N0M0
TCGA-W5-AA38,"SLIDE DISPOSITION: DIAGNOSIS: A. Liver, portion of segment VIII, wedge resection: Subcapsular. fibrosis with associated acellular debris (2.8 X 1.8 X 0.8 cm) . Negative for tumor. B. Liver, additional portion of segment VIII, wedge resection: Poorly-differentiated cholangiocarcinoma forming a 1.4 X 1.2 x 1.1. cm mass. The surgical resection margin is negative for tumor (free. by 0. cm). This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s) Hematoxylin and Eosin (H&E) permanent sections are. reviewed to confirm these findings. Any substantive changes. identified on permanent section review will be reflected in a. revised report. GROSS DESCRIPTION: A. Received fresh labeled ""liver, portion of segment VIII"" is a. 10.92 gram, 3.8 X 2.9 x 2.2 cm liver wedge specimen. A 2.8 x 1.8. X. 0.8 cm necrotic mass is present, located 0.4 cm from the closest. surgical resection margin, which is inked black and submitted. perpendicularly. Representative sections are submitted. Grossed by. B. Received fresh labeled ""liver, additional portion of segment. VIII"" is a 9.19 gram, 3.7 x 2.3 x 1.9 cm liver wedge specimen. A. single 1. 4 x 1.2 x 1.1 cm tan-white mass is present, located 0.6 cm. from the closest surgical resection margin, which is submitted. perpendicularly. Representative sections are submitted. Grossed by. BLOCK SUMMARY: Part A: Liver-portion of segment. 8. 1 Liver segment 8-1. 2 Liver segment 8-2. 3 Liver segment 8-3. 4 Liver segment 8-4. 5 Liver segment 8-5. Part B: Liver-additional portion segment 8. 1 Liver segment 8 normal. 2 Add liver seg 8 mass. 3 Add liver seg 8 capsule.",T1,N0,M0,T1N0M0
TCGA-BH-A0DD,"FINAL DIAGNOSIS: RART SENTINEL LYMPH NODE #1, RIGHT AXILLA, BIOPSY -. 1: CARCINOMA INVOLVING ONE LYMPH NODE (1/1). A. METASTATIC METASTATIC FOCUS MEASURES 3.0 CM IN GREATEST DIAMETER 0.1 (ENTIRE CM. LYMPH NODE). B. c. EXTRACAPSULAR EXTENSION IS IDENTIFIED MEASURING 0.2 X. PART 2: BREAST, LEFT, SIMPLE MASTECTOMY -. A. DUCTAL EPITHELIAL HYPERPLASIA. B. PREDOMINANTLY ADIPOSE BREAST PARENCHYMA. c. SKIN AND NIPPLE HISTOLOGICALLY UNREMARKABLE. PART 3: A. BREAST. INVASIVE RIGHT, DUCTAL MODIFIED CARCINOMA RADICAL 3.0 MASTECTOMY 3/3, CM NUCLEAR (GROSS) NOTTINGHAM PLEOMORPHISM - GRADE 2/3, MITOTIC 3 (COMBINED ACTIVITY NOTTINGHAM 3/3) WITH. TUBULE. LYMPHOPLASMACYTIC SCORE 8/9: INFILTRATE AND NECROSIS. B. DEFINITIVE LYMPHOVASCULAR. C. DUCTAL CARCINOMA IN SITU IS NOTIBENTIFIED. D. RESECTION MARGINS FREE. E. DUCTAL EPITHELIAL HYPERPLASIAL. F. G. SKIN TWENTY-TWO AND NIPPLE, LYMPH HISTOLOGICALLY NODES, NEGATIVE UNREMARKABLE FOR METASTATIC CARCINOMA (0/22). H. PATHOLOGIC STAGE (see comment): I. RECEPTOR STATUS (see comment). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Upper inner quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 3.0 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 3. Total Nottingham score: 8. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 1. LYMPH NODES EXAMINED: 23. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 30.0 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: SKIN INVOLVED (ULCERATION): T STAGE, PATHOLOGIC: p12. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: positive. HER2/NEU: 2+.",T2,N1,M0,T2N1M0
TCGA-86-8279,"Gross. Microsc. Diagnos. Comme. Descript. opic. is. nts. ion. Descript. Details. ion. OpenCli. nica ID. LUNG TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Lung. Tumor size: 3 X 3 X 3 cm. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Visceral pleura. Other tumor nodules: Not specified. Lymph nodes: 1/1 positive for metastasis (Intrathoracical 1/1). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Positive for CD15, CK7, TTF1, CEA; negative for CK20,. CDX2. Lateralit. y. Right-. upper.",T2,N1,M0,T2N1M0
TCGA-BH-A18R,"PATIENT HISTORY: DATE OF LAST DELIVERY: DATE of LMP: PRE-OP DIAGNOSIS: RIGHT BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: RIGHT MODIFIED RADICAL MASTECTOMY. CLINICAL HISTORY: MATERIAL SUBMITTED: RIGHT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. FINAL DIAGNOSIS: FINAL DIAGNOSIS: RIGNT MODIFIED RADICAL MASTECTOMY: INFILTRATING DUCTAL CARCINOMA, NOTTINGHAM SCORZ 9/9 (TUBULES 3, NUCLEI 3, MITOSIS 3), 8.0 BY 3.0 BY 1.5 CM. (CROSS REFER. - DUCTAL CARCINOMA IN-SITU, NON-COMEDO AND SOLID TYPE, POOR NUCLEAR GRADE, REPRESENTING 5% OF THE TUMOR. VOLUME. - LYMPHOVASCULAR PERMEATION IS SEEN. - MARGINS FREE OF TUMOR. - NIPPLE NEGATIVE FOR PAGET'S DISEASE. - TEN OF FIFTEEN (10/15) LYMPH NODES, POSITIVE FOR METASTATIC CARCINOMA WITH EXTRACAPSULAR EXTENSION (3). NOTE ER/PR immunoperoxidase assay and Her-2/NEU testing will be performed on block ""A4"". ESTROGEN/PROGESTERONE RECEPTORS AND HER-2/NEU PERFORMED ON RIGHT BREAST TISSUE. ESTROGEN RECEPTOR (0-85%; 1-10%; 2-5%; 3-0%) HSCORE OF 20. ESTROGEN RECEPTOR IS INTERPRETED AS BORDERLINE. PROGESTERONE RECEPTOR (0-1004) HSCORE OF 0. PROGESTERONE RECEPTOR IS INTERPRETED AS NEGATIVE. HSCORE: <= 15 NEGATIVE. > 15 <= 30 BORDERLINE. > 30 POSITIVE. HER-2/NEU - DAKO HERCEPTEST: A STRONG COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE THAN 10% OF THE TUMOR. CELLS. HER-2/NEU IS INTERPRETED AS POSITIVE (SCORE 3+).",T2,N1,M0,T2N1M0
TCGA-05-4430,"Main diagnosis/diagnoses: Peripheral bronchopulmonary, histologically mixed-cell adenocarcinoma of the left lower. lobe of the lung with a predominant acinar and small large-cell solid component, a. bronchioloalveolar pattern of spread in the tumor periphery and main localization in S6. TNM classification on the basis of this material pT2 pNO pMX R0, stage IB. C34.3; M 8255/3. Comment/supplementary remark: The carcinoma has infiltrated the visceral pleura. The resection margin of the bronchus and. vessels and all the lymph nodes removed are tumor-free.",T2,N0,M0,T2N0M0
TCGA-EB-A44O,"Laterality:Malignan: melanoma of the skin without superficial ulceration. Breslow's depth is 5 mm. Path Report:SKIN TISSUE CHECKLIST. Specimen type: Excision of skin lesion. Tumor site: Skin, trunk. Tumor size: 0.7 x 0 x 1.2 cm. Tumor features: Pigmented. Satellite nodules: Not specified. Histologic type: Malignant melanoma. Histologic grade: Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Breslow's depth is 5 mm.",T4,N0,M0,T4N0M0
TCGA-63-A5MV,"Sample Type TUMOUR. Diagnosis. Squamous Cell Carcinoma, Not Otherwise Specified (NOS). Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). Right lower lobe. Tumour Size (cm). 6.9000000000000004. Histology. Squamous carcinoma. Grade/Differentiation. II. Pathological T. T2b. Pathological N. Clinical M. MO. VALCSG Stage. Histology Comments. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.",T2,N0,M0,T2N0M0
TCGA-HG-A2PA,"SPECIMENS: A. LEFT PELVIC LYMPH NODE. B. LEFT PELVIC LYMPH NODES. C. RIGHT PELVIC LYMPH NODES. D. UTERUS AND CERVIX. E. PARA-AORTIC LYMPH NODES. F. APPENDIX. SPECIMEN(S): A. LEFT PELVIC LYMPH NODE. B. LEFT PELVIC LYMPH NODES. C. RIGHT PELVIC LYMPH NODES. D. UTERUS AND CERVIX. E. PARA-AORTIC LYMPH NODES. F. APPENDIX. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA-left belvic lymph node: Negative for squamous cell carcinoma; diagnosis called by Dr. to Dr. at. D: Uterus, TAH (GROSS). 3.5 cm fungating tumor involving exo/endo cervix and likely lower uterine. segment. Closest mucosal margin 1.5 posterior. Called by Dr. to Dr. at. DIAGNOSIS: A. LYMPH NODE, LEFT PELVIC, EXCISION: - REACTIVE LYMPH NODE (0/1). B. LYMPH NODES, LEFT PELVIC, EXCISION: - REACTIVE LYMPH NODES (0/13). C. LYMPH NODES, RIGHT PELVIC, EXCISION: - REACTIVE LYMPH NODES (0/8). D. UTERUS AND CERVIX, RADICAL HYSTERECTOMY: MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA OF THE. CERVIX MEASURING 8 X 6 CM, IT IS OF 1.5 CM OF DEPTH OF STROMAL INVASION AND. IT IS INVOLVING THE ENDOMETRIUM. - PARAMETRIUM AND VAGINAL MARGIN ARE FREE OF TUMOR. - LYMPHATIC INVASION IS SEEN. - SECRETORY ENDOMETRIUM WITH CHRONIC ENDOMETRITIS. - INTRA-UTERINE DEVICE (GROSS). - SEE SYNOPTIC REPORT. E. LYMPH NODES, PARA-AORTIC, EXCISION: - REACTIVE LYMPH NODES (0/4). F. APPENDIX, APPENDECTOMY: - APPENDIX WITH NO PATHOLOGIC ABNORMALITIES. SYNOPTIC REPORT - UTERINE CERVIX. Specimen Type: Radical hysterectomy. Tumor Site: Anterior and Posterior cervix. Tumor Size: Greatest dimension: 8cm. Additional dimensions: 6cm x 2.5cm. Other Organs Present: Vagina, Uterine corpus and Appendix. WHO CLASSIFICATION. Squamous cell carcinoma, NOS 8070/3. Histologic Grade: G2: Moderately differentiated. Depth of Invasion: Invasion present. Depth: 1.5cm. Horizontal spread: 8cm. Extent of Invasion: Uterine involvement. No Parametrial involvment. No Vaginal involvement. Venous/Lymphatic (Large/Small Vessel) Invasion (V/L): Present. Margins: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1cm. Specific margin: vaginal mucosa. Distance of invasive carcinoma from parametrium: 1.5cm. Lymph Node Dissection: Right pelvic 0 / 8 Left pelvic 0/14 Para-aortic - 0/8. Non-Lymph Node Metastases: None. Other Pathologic Findings: chronic endometriosis. Pathologic Staging (pTNM [FIGO]): pT 1b2 N 0 M X. GROSS DESCRIPTION: A. LEFT PELVIC LYMPH NODE. Received fresh labeled with matching patient identifiers is a 2.7 x 1.8 x 1.2 cm lymph node. Specimen. is serially sectioned and has a uniform pink-tan cut surface. Touch prep is performed and the specimen. is submitted entirely for frozen section diagnosis in cassettes FSA1-FSA3. B. LEFT PELVIC LYMPH NODES. Received in formalin labeled with the patient's identification and ""left pelvic lymph nodes"" are 8 x 5 x. 2cm of adipose tissue, within which, thirteen possible lymph nodes are identified. The nodes range. from 0.2 cm to 4.0 x 1.5 x 0.7 cm. The cut surfaces are firm white to tan-pink. The nodes are entirely. submitted: B1-five lymph nodes. B2-four lymph nodes. B3-one bisected lymph node. B4-B5-one lymph node, serially sectioned. B6-B7-one lymph node, serially sectioned. B8-B11-one lymph node, serially sectioned. C. RIGHT PELVIC LYMPH NODES. Received in formalin labeled with the patient's identification and ""right pelvic lymph nodes"" are 7.5 x 5.5. x 2.0 cm of adipose tissue, within which, ten possible lymph nodes are identified. The nodes range. from 0.5 cm to 4.5 x 1.0 x 0.6 cm. The cut surfaces are firm white to tan-pink. Representative sections: C1- two bisected lymph nodes (one node inked blue). C2-one bisected lymph node. C3-one bisected lymph node. C4-two lymph nodes. C5-one lymph node. C6-8 one lymph node, serially sectioned. D.UTERUS AND CERVIX: Specimen is labeled ""uterus and cervix"" and consists of a 265 gram radical hysterectomy specimen. The uterus measures 6.5 x 7 x 5 cm. The cervix measuring 5 x 7 x 6 cm. The right parametrium soft. tissue measures 2.0 x 1.0 x 0.5 cm. The left parametrium soft tissue measures 2 x 1 x 0.6 cm. Both. are unremarkable. The serosa of the posterior uterus is entirely inked black, and the anterior is entirely. inked blue. The uterus is laterally bisected along the longitudinal axis to reveal fungating 8 x 6 x 2.5 cm. mass originating from the cervix and involving a vast majority of the endometrial cavity. The mass is. white, soft, and friable. It is at least 2cm of depth of invasion at the anterior cervix and 1.5cm at the. posterior cervix. It is at 1.0 cm from the vaginal mucosal margin and at 1.5 cm from the nearest. parametrium (right). Also, the uterine cavity showed a T shape intra-uterine device (3.5 x 3 cm). The. endometrial cavity is 3.3 cm from cornu to cornu, and 5 cm from superior to inferior. The myometrium. has maximum thickness of 3.5cm. The endometrium is of 0.3 cm thick. The following representative. sections are submitted: D1: right parametrium. D2: left parametrium. D3: right cul de sac tissue. D4: left cul de sac tissue. D5-D9: complete cross section through the anterior cervix (D7 and D8 are one section from. superior to inferior, respectively) (D5 also contains the nearest vaginal margin). D10: additional vaginal margin. D11-D13: sections through the posterior cervix. D14: complete cross section of the myometrium from the anterior cavity. D15: complete cross section from the posterior myometrium and cavity. D16-D17: uninvolved posterior and anterior upper endometrium. E. PARA-AORTIC LYMPH NODES. Received in formalin labeled with the patient's identification and ""para-aortic lymph nodes"" are four. lymph nodes, ranging from 0.5 x 0.5 x 0.3 cm to 1.5 x 0.8 X 0.5 cm. The cut surfaces are firm tan-pink. Entirely submitted: E1- two bisected lymph nodes (one inked black, one inked blue). E2-one whole lymph node (inked blue) and one bisected (inked black). F. APPENDIX. Received in formalin labeled with the patient's identification and ""appendix"" is a 6.5 X 0.5 X 0.5 cm. vermiform appendix. It has a smooth tan-pink serosa. It has an intact 0.3 cm wall. The lumen is. dilated, proximally, ranging from 0.1 cm to 0.6 cm, and contains soft feces. No tumor is identified. Representative sections, E1. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Cervical cancer. Microscopic/Diagnostic Dictation:,. Microscopic/Diagnostic Dictation:, M.D., PATHOLOGIST,. Microscopic/Diagnostic Dictation:, M.D., PATHOLOGIST,. Final Review: M.D., PATHOLOGIST,. Final Review:, M.D., PATHOLOGIST. Final Review, M.D., PATHOLOGIST,. Final Review, M.D., PATHOLOGIST,. Final, M.D., PATHOLOGIST,.",T1,N0,M0,T1N0M0
TCGA-AR-A1AP,"B1961 Final Diagnosis. Breast, left, wide local excision: Infiltrating ductal carcinoma with mucinous features,. Nottingham grade III (of III), forming a mass (1.9 x 1.0 x 0.9 cm) [AJCC pTlc]. Ductal. carcinoma in situ, high nuclear grade, comprises approximately 5-25% of the tumor volume and. extends beyond the main mass. Angiolymphatic invasion is absent. The non-neoplastic breast. parenchyma shows proliferative fibrocystic changes. The medial margin, after multiple (3). separately submitted re-excisions, is positive for ductal carcinoma in situ. Breast, left, simple mastectomy: Microscopic residual ductal carcinoma in situ is identified in the. region of the prior biopsy site in the upper inner quadrant. No residual invasive neoplasm. identified. The skin, nipple, and deep surgical margin are free of neoplasm. Sentinel lymph node, left axillary, sentinel biopsy: A single left axillary sentinel lymph node. with blue dye is negative for metastatic carcinoma [AJCC pNO (i-) (sn)]. Immunohistochemical. cytokeratin stain was performed on the paraffin embedded sentinel lymph node tissue and. confirms the H&E impression. Her-2/NEU has been ordered on paraffin-embedded tissue.",T1,N0,M0,T1N0M0
TCGA-66-2742,"Material examined: Right lung and others. Clinical diagnosis and question. Squamous cell carcinoma of right upper lobe, malignancy?. REPORT ON FINDINGS. Macroscopy. 1.) LN right middle lobe: 1.5 cm lesioned node, section surfaces speckled black in places, grayish-white patches in places. and indurated. 2.) LN right upper lobe: 1.5 cm lesioned node, section surfaces with section surfaces as described under 1.). 3.) Right lung: inflated, fixed lung measuring 19 x 15 cm at the base and up to 24 cm in length, central bronchus. resection line located 0.5 cm proximal to the point where the upper lobe bronchus arises. S1 with deep notch in the. sagittal plane extending close to the hilus. Upper pleural fissure largely obliterated, only recognizable in a short segment. of the dorsal region. Pleura with intensive, partly diffuse and partly reticular or patchy black pigmentation. Pleura above. Segments 1 + 3 shows diffuse grayish-white dioscoloration especially in the lateral region. At the point where the upper. lobe bronchus arises and its first branch is located a moderately solid tumor, max. 8.5 cm in size, with the primary mass. in the upper lobe, of unclear and somewhat arcuate demarcation, predominantly pale brownish and in sections patho. grayish-black pigmentation, with excentric cavity of irregular configuation and max. 2.6 cm in size. Initial extension of. tumor to the middle lobe at the pleural fissure. Tumor extension to the star-shaped area of shrinkage there in the. ventrolateral visceral pleura above Segment 3 and and as far as the pleura above Segment 1 in the region of the whitish. discoloration. Distance from hilar resection surface at least 0.3 cm. Marked narrowing of central and intermediate. sections of the upper lobe bronchi and also truncation of peripheral branches of B1-3 in the tumor. Involvement of some. black pigmented nodes up to 1.5 cm in size by the tumor, one of these located at the hilus. In the middle lobe, 0.7 cm. pale brown-whitish tumor of unclear demarcation at least 0.8 cm from tumor margin in the proximity of the pleural. fissure. Parenchyma in the tumor environment partly indurated and brownish-yellow in patches, peripheral bronchi of. the upper lobe dilated and filled with thick mucus. In the lower lobe, especially in the dorsal segment, numerous hard. areas measuring up to 0.2 cm partly in the subpleural region and partly in the parenchyma. In the subpleural region of. Segment 7, a whitish strip-like area 0.3 cm in size. Remaining parenchyma, especially in the subpleural and basal region. in the lower lobe, diffusely indurated with suggestion of grayish-white reticular pattern, lung surface in these sections. partly suggestive of pavement relief. At the hilus three grayish-black node lesions between 0.7 and 1.1 cm in size. 4.) Right parietal pleura: Flat or membranous area measuring 14 x max. 4.5 cm and up to 0,2 cm thick. Surface. predominantly smooth, fatty tissue on the other side. 5.) Hilar LN (Item 10) right: 1.8 cm lesioned grayish-black node with some surrounding tissue. 6.) Subcarinal LN (Item 7): 2.5 cm lesioned grayish-black node with some surrounding tissue. 7.) Deep paratracheal LN (Item 4) right: two lesioned grayish-black nodes, 0.5 and 1.3 cm in size. 8.) Hilar LN (Item 10) left: 1.5 cm lesioned grayish-black node. Examined: 1.) + 2.) Rapid section remains + residual material,. 3.) Tumor with remaining parenchyma, including involved nodes + proxicmal section of B2, 2 sections with lateral. pleura above S3, 2 sections with pleura above S1, hilar resection surface (color marking), main bronchus, upper pleural. fissure (color marking), secondary tumor in middle lobe, 5 sections of hard areas in S10+9, strip-like white-speckled zone. in Segment 7 (halved), S9 basal, S10 dorsal, central bronchus resection line + resection margins vessels, hilar nodes,. 4.) 5 sections,. 5.) nodes (halved),. 6.) - -8.) All material (in 6. nodes, in 7. large nodes halved in each case),. 24 blocks, partly. PAS, and diastase-PAS, iron. Microscopy. 1.) + 2.) Immediate intraoperative evaluation. ): LN with anthracotic pigment deposit and sclerosis zones, no. evidence of tumor in the samples. Description of histological and cytological findings omitted for capacity reasons. EVALUATION. Primary diagnosis/diagnoses. Extensive, large cell, non-keratinizing, bronchopulmonary squamous cell carcinoma of the upper lobe of the. right lung with poor histological differentiation, extending from central to peripheral regions, with partially. extensive necrotic changes. Tumor classification based on the existing picture pT2 pNI pMI V1 R0, stage IV. C34.1 M8070/3. G3. Secondary diagnosis/diagnoses. Overall still slight discontinuous interstitial fibrosis of the lung parenchyms in the mantle zone with perifocal. emphysema. Subpleural fibrous remodeled area of lung parenchyma in S7. Moderately marked mixed. pigmenting storage of dust in the lung tissue and in places high-grade (appears to be a word missing here) of. lymph nodes with inclusion of very small anisotropic particles. Marked cluster of alveolar siderophages in. places. Peritumoral accentuated slight active and partly resorptive pneumonia. Small foci of mature metaplastic. ossification of lung tissue. Diffuse and nodular zones of sclerosis in lymph nodes. Slight, focally accentuated. chronic parietal pleuritis with short sections of reactive mesothelial proliferation and likewise short sections of. slight fibrosis (sample 4.)). Remark/addendum. The carcinoma has grown centrally as ar as the main bronchus and in peripheral regions shows areas of slight. invasion of the hypocellular fibrosed visceral pleura. It is therefore not possible to decide whether the. carcinoma has arisen in the periphery of the lung or in the center of the bronchial pathway. The lymph node. metastases, like the isolated invasions of small vessels, lie wthin the tumor or the bronchopulmonaary region. Apart from the main tumor, which has penetrated focally across the transverse pleural fissure into the adjacent. section of middle lobe, a separate small tumor focus has been detected in the middle lobe. This is classified as a. satellite nodule in another lobe, although histologically it hardly shows a squamous epithelial differentiation and. contains a small light-cell solid component. A tumor-associated high-grade inflammation is also found here. The etiology of the interstitial pulmonary fibrosis, which shows only minimal process activity, is histologically. unclear: there may be an association with respiratory bronchiolitis.",T2,N1,M1,T2N1M1
TCGA-75-5147,"Sample Collection Detalis. Histology and staging. Year of. Days to. Site of. Age at Sample. Days to. Type of. Tumour. Grade: Site of Tissue. Diagnosis. Sam ple. Type. Comments. Procedure. Preparation. Diagnosis. Procedure. Primary. Size (em). Histology. Ditterentiation. Pathological T. VALCSO Stage. Histology Comment. Number. (Histology). TUMOUR. FF. Adenocarcinoma. RESECT. RUL. 2.00. 03. I. T2,NOS. MO. BUFFY. FF. Adenocarcinoma. RESECT. RUL. 2.00. 03. I. T2,NOS. M0.",T2,N0,M0,T2N0M0
TCGA-HU-8245,"Stomach, total gastrectomy: Advanced gastric carcinoma. Muc2(+/-)/Muc5AC(-)/Muc6(-)/CD10(+)/cERB2(-),Itype). 1. Location : upper third, Center at upper body, posterior wall. 2. Gross type : Borrmann type 2. 3. Histologic type : papillary adenocarcinoma (70% of tumor mass). >> >poorly differentiated-nor solid (por2). 4. Histologic type by Lauren : intestinal. 5. Growth pattern: mixed expanding and infiltrative growth pattern. 6. Size : 6.2X4.7X1.7 cm. 7. Depth of invasion : invades subserosa (pT3). 8. Resection margin: free from carcinoma. - safety margin: distal 12.1 cm, proximal 1.2 cm. 9. Lymph node metastasis : no metastasis in all 60 regional lymph nodes (pNO). (lesser curvature 0/28, greater curvature 0/32). 10. Lymphatic invasion : not identified. 11. Venous invasion : not identified. 12. Perineural invasion : present, moderate. 13. Associated findings. 1) foveolar hyperplasia with pit dysplasia. #. Immunohistochemistry : CD10, MUC2, MUC5ac, MUC6, C-erb B2.",T3,N0,M0,T3N0M0
TCGA-52-7812,"Pathologic Interpretation: A. Left upper lobe biopsy. - No malignancy seen. B. Left secondary carina,. - No malignancy seen. C. Station 4L mediastinal lymph node,. - Fragmented one (1) lymph node, no malignancy seen. D. Left lung tumor for frozen section for bronchiall margins,. - Poorly differentiated squamous cell carcinoma, 6.0 cm'ingreatest dimension. - Large vessel invasion is present. - Pleural invasion is present. - Bronchial margin free of tumor. - Non-neoplastic lung shows post-obstructive pneumonia. - One (1) intraparenchymal lymph node, no malignancy seen. AJCC: pTX N2 MX (Section of chest wall lesion on specimen I pending). E. Station 5 lymph node # 1: - Metastatic carcinoma in one lymph node (1/1). F. Station 5 lymph node # 2: - Metastatic carcinoma in two lymph nodes examined (2/2). G. Station 5 lymph node # 3: - No malignancy seen in two (2) lymph nodes examined. H. Station 9 lymph node: - No malignancy seen in one (1) lymph node examined. I. Left chest with ribs 2 R3 for representation margins short stitch superior, long stitch lateral, FS: - Fibrosis and chronic inflammation. - The external surface is free of malignancy. - Section of bone and soft tissue pending. Tumor Summary: Specimen Type. - Pneumonectomy. Laterality. - Left. Tumor Site. - Not specified. Tumor Size. - Greatest dimension: 6 cm. Additional dimensions: 5 x 4.5 cm. Histologic Type. - Squamous cell carcinoma. Histologic Grade. - G3: Poorly differentiated. Margins. - Margins uninvolved by invasive carcinoma. - Distance of invasive carcinoma from closest margin: 2 mm. - Specify margin: Bronchial. Direct Extension of Tumor. - Visceral pleura. Venous (Large Vessel) Invasion (V). - Present. As the attending pathologist, 1 attest that I: (i) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). Procedures/Addenda. Addendum. Addendum Diagnosis. E. Station 5 lymph node #1: - Sections of bone and surrounding soft tissue show extensive fibrosis and adhesions. However, no malignancy is. present. - Therefore the tumor is considered: pT2, pN2, pMX. Addendum. Addendum Diagnosis. Addendum (I): - Bone fragments with trilineage hematopoietic elements. - No carcinoma seen. Intraoperative Consultation. A. Left upper lobe biopsy, FS: Negative for malignancy. B. Left secondary carina,. Negative for malignancy. C. Station 4L mediastinal lymph node,. Negative for malignancy. D. Left lung tumor for frozen section for bronchial margins. Bronchial margin free of tumor. I. Left chest with ribs 2 R3 for representation margins short stitch superior, long stitch lateral. Chest wall margins (superior. and superficial intercostal margins) free of tumor. Clinical History: None Provided. Operation Performed. Bronchoscopy, mediastinoscopy, left upper lobectomy. Pre Operative Diagnosis: Left lung cancer. Specimen(s) Received: A: Left upper lobe biopsy,. B: Left secondary carina,. C: Station 4L mediastinal lymph node,. D: Left lung tumor for frozen section for bronchiall margins. E: Station 5 lymph node # 1. F: Station 5 lymph node # 2. G: Station 5 lymph node # 3. H: Station 9 lymph node. I: Left chest with ribs 2 R3 for representation margins short stitch superior, long stitch lateral,. Gross Description: A. Received fresh is a pale tan tissue fragment, 0.2 x 0.1 x 0.1 cm and dark tissue fragment, 0.1 x 0.1 x 0.1 cm. In toto in. one cassette for frozen section. B. Received fresh is a pale tan tissue fragment, 0.2 X 0.1 x 0.1 cm. In toto in one cassette for frozen section. C. Received fresh is a dark tissue fragment, 1.5 x 1.0 x 0.2 cm. Submitted in toto in one cassette for frozen section. D. Received in formalin is a left lung, weighing 718 grams, measuring 21.0 x 15.0 x 6.0 cm. There is a segment of bronchus. 1.0 cm in length, 2.0 cm in diameter. The pleural surface is red-purple, smooth. At the upper pole, the pleural surface. shows multiple elevated lesions, ranging from 0.1 to 1.0 cm in greatest dimension. One centimeter from bronchial. resection margin, there is tumor mass 6.0 x 5.0 x 4.5 cm with hemorrhagic and necrotic areas. The pleural surface is. inked in black. At the upper pole, there is a firm, consolidated area approximately 4.0 X 4.0 X 4.0 cm. Also at the hilum,. there is an ovoid possible lymph node, 2.0 cm in greatest dimensions. Representative sections are submitted in ten. cassettes as follows: 1. Bronchial margin for frozen section. 2. Bronchus, 1.0 and 0.2 cm from resection margin. 3-7. Tumor and lung parenchyma. 8. Area at the apex of the lobe (consolidated area). 9&10. Lymph node bisected (submitted in toto), half in each cassette. E. Received in formalin is an ovoid, yellow, pale tan tissue fragment, 1.0 X 1.0 x 0.2 cm. Bisected and submitted in toto in. one cassette. F. Received in formalin is an ovoid pale tan tissue fragment, 2.0 x 1.0 x 1.0 cm. There are two possible lymph nodes, 1.0 cm. each. One of them is bisected, the second one is trisected. Submitted in toto in two cassettes as follows: 1. One possible lymph node bisected. 2. One possible lymph node trisected, submitted in toto. G. Received in formalin are two ovoid pink-tan tissue fragments. The smaller one is 0.5 x 0.2 x 0.2 cm. The larger is 0.7 x. 0.5 x 0.5 cm. The larger is inked in black. They are bisected and submitted in toto in one cassette. H. Received in formalin is an ovoid pale tan tissue fragment, 0.5 x 0.3 x 0.2 cm. The specimen is bisected and submitted in. toto in one cassette. I. Received fresh is a segment of muscle tissue with attached ribs, 9.0 x 6,0 x 1.0 cm. The specimen is oriented with a short. suture superior and long suture lateral. The inner aspect is inked in black. Representative sections are submitted in six. cassettes as follows: 1-4. For frozen section. 5&6. Bone tissue from the ribs for decalcification.",T2,N2,M0,T2N2M0
TCGA-CM-5861,"Clinical Diagnosis & History: Adenocarcinoma of colon. Specimens Submitted: 1: SP: Colon, right; segmental regection. 2: SP: Omentum, omentectomy. DIAGNOSIS: 1. SP: Colon, right; segmental resection: Tumor Type: Adenocarcinoma with mucinous features (<50%-mucinous component). Histologic Grade: Moderately differentiated. Tumor Location: Cecum. Tumor Size: Length is 5 cm. Width is 8 cm. Maximal thickness is 0.4 cm. Tumor Budding: Absent. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Tubulovillous adenoma. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Tumor is seen within 1 mm of the serosal surface in an area of. serositis. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Not identified. Large Venous Invasion: Not Identified. Perineural Invasion: Identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Appendix: Not identified. Lymph Nodes: Number with metastasis: 0. Total number examined: 28. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC 7th Edition) : pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition). NO (No regional lymph node metastasis). 2. OMENTUM; OMENTECTOMY: -BENIGN MATURE ADIPOSE TISSUE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1) The specimen is received fresh, labeled ""Right colon"" and consists of. a. segment of terminal ileum, cecum, and ascending colon. The appendix is not. grossly identified. The terminal ileum measures 12 cm in length and 4 cm in. circumference at the proximal resected margin. The remaining colon measures. 23 in length with a circumference of 7.2 cm at the distal resected margin. The intestinal serosa is pink tan and smooth. Focally hemorrhagic lobulated. yellow tan adipose tissue spans the length of the specimen measuring up to. 5.5 cm in thickness, The specimen is opened to reveal a friable, polypoid. mass lesion measuring 5.0 cm in length and 8.0 cm in width. The mass. is. located in the large intestine, 14 cm from the proximal margin and 20 cm. from the distal margin. Sectioning shows that the tumor grossly invades. through the muscularis and involves the underlying adipose tissue, and 1.5. em from the ileocecal valve. The depth of invasion is 0.4 cm grossly. The. ileocecal valve is granular and markedly edematous. The remaining mucosa is. tan-brown with the normal fords. The attached adipose tissue is submitted. for lymph node dissection. Representative sections of the specimen are. submitted for permanent sections and for TPS. Summary of sections: P - proximal margin shave. D - distal margin shave. T - tumor. I - ileocecal valve. RS -representative sections. LN - lymph nodes. BLN - bisected lymph nodes. 2) The specimen is received fresh, labeled ""Omentum. "" It consists of a 24 x. 8.5 x 0.5 cm portion of lobulated adipose tissue consistent with omentum. Serial sectioning reveals a yellow lobulated surface. No lymph nodes are. groasly identified. Representative sections are submitted. Summary of sections: o - omentum. Summary of Sections: Part 1: SP: Colon, right; segmental resection. Block. Sect. Site. PCs. 2. DM. 4. 2. 2. 10. LN. 24. 1. PM. 2. 4. RS. 8. 11. 11. Part 2: SP: Omentum; omentectomy. Block. Sect. Site. PCs. 3. o. 6.",T3,N0,M0,T3N0M0
TCGA-A3-3331,"DIAGNOSIS. DIAGNOSIS: Right kidney, nephrectomy: Tumor Characteristics: 1. Histologic type: Clear cell adenocarcinoma. 2. Tumor site: Lower pole. 3. Tumor size: 3.7 x 3.0 cm. 4. Macroscopic extent of tumor: Tumor extends to the capsule of the kidney but does not extend through the capsule. 5. Nuclear grade: Fuhrman grade: 2/4. 6. Lymphovascular space invasion: No. 7. Transcapsular invasion: No. 8. Renal vein invasion: No. 9. Adrenal gland: Not resected. Surgical Margin Status: 1. Soft tissue margins: Negative. 2. Ureteral margin: Negative. 3. Vascular Margins: Negative. Staging sheet #18. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: Right kidney. SPECIMENTATA. GROSS DESCRIPTION: The specimen is received in a single container labeled with the patient's name, L. and right kidney. The specimen consists of a kidney with. attached perinephric fat that measures 14.0 x 8.0 x 7.0 cm and weighs 365 gm. There is no adrenal gland attached. The ureter stump measures 4.0 cm. in length and 0.3 cm in diameter and is grossly unremarkable. The renal artery stump measures 1.5 cm in length and 0.5 Gm in diameter and is. unremarkable. The renal vein stump measures 1.5 cm in length and 0.5 cm in diameter and is grossly unremarkable. On sectioning, there reveals a. circumscribed, golden yellow mass within the lower pole that measures 3.7 x 3.0 cm that is beneath the capsular surface. The mass does not appear to. penetrate through the capsule into the surrounding perinephric fat. The surrounding cortex is brown-tan and measures 0.7 cm and shows a well. demarcated renal cortex and pyramid junction. Representative sections were taken for genomic studies and placed in orange cassettes labeled. A. through D. Also received with the specimen are three cassettes; one green, one yellow, and one blue labeled. Representative sections are. submitted in cassettes : as follows: Sections from mass in blocks 1 through 4; ureter in block 5; renal artery and vein in block 6; uninvolved. renal cortex in block 7.",T1,N0,M0,T1N0M0
TCGA-E9-A22E,"Laterality: Right, upper inner quadrant. Path Report:BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 3.5 x 3.5 X 3.5 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 4/10 positive for metastasis (Axillary 4/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Not specified. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T2,N2,M0,T2N2M0
TCGA-BF-A1PV,Project #. Tissue. Specimen. Clinical. Ethnicity. Anatomical. Tumor. Specimen. Specimen. Index. Clinical Diagnosis. procuremen. Specificatio. label. Site #. (Race). Site. Matrix. Format. t. n. Caucasian. 1. 5. Melanoma. Female. Skin. Primary. Tumor. Tissue. Frozen. (White). Caucasian. 5. Melanoma. Female. Blood. n/a. normal. Blood. Frozen. (White). Prior. Chemo /. Number of. Amount/per. Type of. Histological. TNM Stage. TNM Stage. TNM Stage. Chemo /. Prior. Cellular. Container. Grade. Horm Th. containers. container. description. (T). (N). (M). Hormonal. Radiation. Tumor %. Details. cryomold. 1. 200. mg. Melanoma. n/a. 4b. 0. 0. 90. tube. 1. 4. ml. Blood draw. n/a. n/a. n/a. n/a. n/a. n/a. Criteria.,T4,N0,M0,T4N0M0
TCGA-CI-6622,"PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Rectal bleeding, diverticulosis, rectal mass. PROCEDURE: Colonoscopy with blopsy. SPECIFIC CLINICAL QUESTION: NOT answereu. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered. CHEMORADIATION: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION Not answered. OTHER DISEASES: Not answered. FINAL DIAGNOSIS: RECTUM, MASS, BIOPSY -. INVSIVE ADENOCARCINOMA, WELL-TO-MODERATELY DIFFERENTIATED.",T4,N0,M0,T4N0M0
TCGA-CZ-4864,"Report Status : Amend/A. Type: Surgical Pathology. Specimen Type: Kidney partial or total resection. Procedure Date: Addended Report. PATHOLOGIC DIAGNOSIS : SPECIMEN LABELED ""LEFT KIDNEY"". RENAL CELL CARCINOMA, (5 cm). clear cell type, Fuhrman grade III/IV. Tumor invades renal vein. Ureter, renal artery, and renal vein margins are negative for tumor. Separate fibrotic nodule (6 cm) consistent with prior cryoablation; no. residual viable tumor identified. Adrenal gland with no significant pathologic change. The. non-neoplastic kidney will be evaluated by Renal Pathology, and the. findings will be reported in an addendum. CLINICAL DATA: History: RCC S/P cryo X2. Operation: Left radical nephrectomy. Clinical Diagnosis: L renal tumor. TISSUE SUBMITTED: A/1) left kidney (s.s.), adrenal. GROSS DESCRIPTION: The specimen is received fresh, labeled with the patients nam, unit number,. and ""#1 - left kidney"", and consists of an 873.5 gram radical nephrectomy. specimen, measuring 23.5 x 11.5 x 7 cm in total. There is a kidney measuring. 10.5 x- 7.2 x 5 cm, an adrenal gland measuring 3.5 x 2x 1.2 cm, a ureter. measuring 8 cm in length x 0.4 cm in diameter, a renal artery measuring 0.8 cm. in length x 0.6 cm in diameter, and a bifurcating renal vein measuring 4.5 cm. in length, and ranging from 0.4-1.4 cm in diameter. There are grossly two. distinct masses in the renal parenchyma (T1 and T2) Mass T1 is a yellow/red,. ill-defined hemorrhagic mass measuring 5 x 3.5 x 3 cm in the lower pole. T1. extends beyond the kidney to within less than 0.2 cm of Gerota's fascia (inked. black) T1 also invades into the renal vein. The T1 tumor is found in both. segments of the vein bifurcation, completely blocking one branch. There is. also a large cortical cyst adjacent to mass T1 that measures 7 x 5.2 x 1 cm. The cyst is lined by pink, smooth tissue with multiple small white nodules. The mass T1 is located 9 cm from the ureter margin, 2 cm from the vein margin,. 4. cm from the artery margin. Mass T2 has a pale tan necrotic and fibrotic. component (4.9 x 4.5 x 3.5 cm) and a yellow component (6 x 4.2 x 2 cm) . T2 is. located in the upper pole and extends beyond the renal parenchyma. Mass T2 is. 1.5 cm from the renal artery and vein margins, 8 cm from the ureter margin, and. 4.2 cm from the Gerota's fascia. There is one simple renal cyst measuring 2 cm. in diameter in the surface of the upper pole. No lymph nodes are grossly. identified. Tissue from tumors T1 and T2 are taken for Tissue Bank and. cytogenetics. Tissue from T1 is taken for electron microscopy. Normal cortex. is taken for electron microscopy and nmunofluorescence. Micro A1: renal artery, vein, ureter margins 3 frags,. Micro A2: T2 in relationship to fat, 1 frag,. Micro A3: mass T2, 1 frag,. Micro A4: relationship of mass T2 to kidney parenchyma, 1 frag,. Micro A5: additional section of mass T2 in relationship to kidney. parenchyma, 1 frag,. Micro A6: cross-section of adrenal gland, 1 frag,. Micro A7: mass T1 in relationship to kidney parenchyma and large cyst, 1. frag,. Micro A8: closest approach of mass T1 to Gerota's fascia (black-inked),. frag,. Micro A9: additional mass T1 in relationship to Gerota's fascia. frag,. Micro A10: longitudinal section of renal vein branch partially obstructed. tumor, 1 frag,. Micro All: cross-section of renal vein branch completely obstructed by. tumor,. 1 frag,. Micro A12: uninvolved renal parenchyma, 1 frag,. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen(s) and rendered or confirmed the diagnosis (es). related thereto. ADDENDUM. RENAL PATHOLOGY EVALUATION OF KIDNEY PARENCHYMA: LEFT KIDNEY, NEPHRECTOMY: DIFFUSE MESANGIAL AND FOCAL NODULAR GLOMERULOSCLEROSIS, MOST LIKELY. REPRESENTING EARLY DIABETIC CHANGES WITH A SUPERIMPOSED PRIMARY. VASCULAR INJURY (SEE NOTE). MODERATELY ADVANCED CHRONIC CHANGES OF THE KIDNEY PARENCHYMA, INCLUDING. - FOCAL GLOBAL AND SEGMENTAL GLOMERULOSCLEROSIS, MODERATE (25% OF. GLOMERULI AFFECTED). MOST LIKELY SECONDARY TO VASCULAR DISEASE. - TUBULAR ATROPHY AND INTERSTITIAL FIBROSIS, MODERATE (30-40% OF CORTEX). - ARTERIAL AND ARTERIOLAR SCLEROSIS WITH HYALINOSIS, MODERATE TO. SEVERE (SEE NOTE). NOTE: The glomeruli show diffuse sclerosis of the mesangial areas with focal nodule. formation. Nodular glomerulosclerosis is most often seen in the setting of. diabetic glomerulosclerosis, although similar changes also characterize. paraprotein deposition diseases, immune complex-mediated glomerulonephritis, or. primary forms of vascular injury with endothelial damage and subsequent. mesangial scarring. Paraprotein and immune complex deposition diseases can be. ruled out since the immunofluorescence microscopy shows no immunoglobulin. deposits. Because the history in this patient's electronic medical record does. not include mention of diabetes mellitus, additional studies were performed on. the kidney tissue to further define the nature of the glomerular disease. Based on the results of the immunofluorescence examination, the process seen. here is most likely mediated, at least in part, by diabetes mellitus/metabolic. syndrome (or related conditions characterized by hyperglycemia and products of. glycosylation) potentially with a superimposed primary form of vascular injury. Repeated endothelial or vascular injury may be reflective of an underlying. inherited or acquired procoagulant state (e.g., idiopathic or systemic lupus. erythematosus-associated antiphospholipid antibody syndrome, thrombophilic. dysfibrinogenemia, the prothrombin G20210A mutation, the factor V Leiden. mutation, and other forms of resistance to activated protein C), a prior. pre-eclamptic gestation, autoimmune disorders (e.g., systemic lupus. erythematosus, scleroderma, overlap syndrome) a healed episode of. hemolytic-uremic syndrome or thrombotic thrombocytopenic purpura, angiotoxic. drugs, physical factors (e.g., irradiation, status post bone marrow. transplantation), malignant hypertension and, potentially, paraproteinemias or. other metabolic diseases with an important vascular component (e.g., gout,. hyperhomocysteinemia). Moderately advanced chronic changes of the kidney parenchyma are present. These changes are a result of functional adaptations to nephron loss from any. glomerular, tubular, interstitial, vascular, or mass-replacing process. While. some degree of parenchymal scarring may be due to local compression effects of. the ipsilateral masses, most of the chronic damage is likely secondary to. vascular scarring. Therefore, a similar degree of chronic damage would be. expected in the contralateral kidney. This patient, therefore, may be at risk. for persistent or progressive proteinuria and renal insufficiency. The kidney parenchyma has been reviewed by Dr. Renal. MICROSCOPIC DESCRIPTION: Sections of formalin-fixed paraffin-embedded tissue (block A12) were evaluated. using HE, PAS, Jones silver methenamine, and AFOG (trichrome) stains; an. HE-stained frozen section was also evaluated by light microscopy. The sample consists of cortex and medulla. There are 251 glomeruli present, of. which 54 are globally sclerosed and 8 are segmentally sclerosed. The remaining. glomeruli show expansion of the mesangial areas diffusely, with focal nodule. formation. There are no discernible craters or spikes of the glomerular. capillary wall basement membranes. Several double contours are identified. Approximately 30-40% of the cortical parenchyma shows tubular atrophy and. interstitial fibrosis. Arteries and arterioles exhibit a moderate to severe. degree of sclerosis with hyalinosis. IMMUNOFLUORESCENCE MICROSCOPY REPORT. Sections of frozen tissue were incubated with antibodies specific for the heavy. chains of IgG, IgA, and IgM, kappa and lambda light chains, C3, Clq, albumin,. and fibrin-related antigens. The sample consists of kidney cortex and medulla. There are 27 glomeruli. present, of which 11 are globally sclerosed. There is minimal granular. deposition of IgA (trace) in the mesangial areas. There is also segmental. deposition of IgM and C3 in the mesangial areas. There is diffuse linear. deposition of albumin (++/4+) and IgG (+/4+) along all basement membranes. Tubules contain reabsorbed proteins in the form of diffuse reabsorption. droplets. Tubular basement membranes reveal focal deposition of C3 (++/4+). Many casts in the distal tubules are reactive for polyclonal IgA. Arterioles. show focal C3 reactivity. There is no difference noted in the intensity of the. staining for kappa and lambda light chains in the deposits, casts, or. background of the tissue. ELECTRON MICROSCOPY REPORT. Blocks: 7. Blocks examined: 3 thick sections; 0 thin sections. Tissue submitted for electron microscopy contained no glomeruli. Thin sections. were not evaluated ultrastructurally. (Clinical history: chronic renal insufficiency (creatinine 2-3 for years),. hypertension]. Report Status : Type: Cytogenetics. Cytogeneticist: KARYOTYPE: T2;45,X, - Y(9]/46, XY [1). METAPHASES COUNTED: 10. ANALYZED: 5. SCORED 5. BANDING : GTG. INTERPRETATION: No metaphases were available from specimen labeled T1, therefore the. cytogenetic analysis could not be performed. Nine of 10 metaphases from the specimen labeled T2 contained loss of the Y. chromosome. Loss of the Y chromosome can be seen in nonneoplastic cells in. older men, and this finding is not characteristic of any particular type of. tumor. COMMENTS: Mosaicism and small chromosome anomalies may not be detectable using the. standard methods employed. Chromosome analysis was performed at a level of 400. bands or greater. INDICATION FOR TEST: ? RCC vs Oncocytic RCC.",T2,N0,M0,T2N0M0
TCGA-BP-4970,"ovurce. Clinical Diagnosis & History: ith a 3.8 right lower pole renal mass. Specimens Submitted: 1: SP:Kidney, right, total nephrectyomy. 2: SP:Perihilar lymph node, right, excision. DIAGNOSIS: 1. SP:Kidney, right, total nephrectyomy. Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. the tumor Is partialy cystic. Fuhrmen Nuclear Grade: Nuclear grade III/IV. Tumor Size: Greatest diameter is 3,5 cm. Local Invasion (for renal cortical types): Not Identified. the tumor abuts the renal sinus. Renal Vein Invesion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: A small (0.5 cm) renal medullary fibroma is present. Adrenal Gland: Not identified. Lymph Nodes: Free of tumor. Number of metastatic nodes:2. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. 2. SP:Peribilar lymph node, right, excision. Lymph Nodes: Not identified. Benign fibroadipose tissue. IATTEST THAT THE ABOVE DIAGNOSIS is BASEO UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh labeled ""right kidney"" and consists of a kidney with attached ureter, renal vessels and. parinaphric fat welghing 253 g in total. The kidney measuras 12.5 x 8.0 x 4.0 cm. The atteched uretar measures 1.5 cm in length. and 0.4 cm in diameter. The attached renal vein measures 1.0 cm in length and 0.3 cm in diametar. The ranal vessals and ureter. margins are grossly unremarkable, An adrenal gland is not identifed. The kidney is inked black and bivalved to reveal 3.5 x 3.0 x. 2.2 cm wall circumscribed mass in the lower pole adjacent to the renal sinus. The cut surface of the mess is solid and cystic, tan. yellow and hemorrhagic. A second 0.5 x 0.4 X 0.3 cm tan nodule distal to the first mass is identified with a firm cut surface. Sections through the remainder of the kidney raveal a pink brown parenchyma, with a well-defined cortico-medullary junction. The. cortex measures 0.7 cm and the calyces appear normal. Representativa sactions are submitted for TPS and for permanent. sections. Summary of sections: UVM -- ureteral and vessel margins. T-- tumor. T2 - second nodule. THF- tumor with hilar fat. TSF -- tumor with sinus fat. TK -- tumor with adjacent kidnay. RP - representative of kidney. 2). The specimen is received in formalin, labeled ""right parihilar lympn hode and consists 013 portion of adipose tissua. No. lymph node identified. Entirely submitted. Summary of sactions: U- possible lymph node. Summary of Sections: Part 1: SP:Kidney, right, total nephrectyomy. Block. Sect. Site. PCs. 2. rp. 2. 3. t. 3. (2. 1. 2. thf. 2. 2. tk. 2. 2. tsf. 2. 1. uvm. 1. Part 2: SP:Peribilar lymph node, right, excision. Block. Sect. Site. PCs. 2. u. 2.",T1,N1,M0,T1N1M0
TCGA-80-5608,"A description for each data field can be found in the 'Data description' worksheet (yellow tab). Sample Collection Details. Type. BUFFY. TUMOUR. Histology and staging. Site of. Year of. Age at. Days to. Days to. Type of. Site of. Preparatio. Tissue. Comments. Procedure. Diagnosis. Procedure. Primary. n. (Histology). (yrs). FF. Adenocarci. RESECT. FF. RUL lung. Adenocarci. RESECT. Tumour. Histology. Grade/. Pathologic Pathologic Clinical M. VALCSG. Histology. Slide URL. Size (cm). Differentiat al T. al N. Stage. Comments. ion. RUL. 2.50. 03. I. T2,NOS. M0. RUL. 2.50. 03. I. T2,NOS. M0.",T1,N0,M0,T1N0M0
TCGA-VQ-A91U,"PRIMARY SITE: Stomach (Gastroesophageal junction). 1-Stomach + greater omentum + distal esophagus: Moderately differentiated adenocarcinoma, intestinal Lauren pattern (size: 9.5cm),. infiltrating to subserosa. Foci of vascular invasion present. Proximal and distal surgical margins uninvolved by neoplasia. Metastasis in 2 perigastric lymph nodes (2/24). Omentum uninvolved by neoplasia. Pathologic stage: pT3 pN1. 2-Esophageal margin: Uninvolved by neoplasia. Absence of squamous epithelium in this sample. 3-Duodenal margin: Uninvolved by neoplasia.",T3,N1,M0,T3N1M0
TCGA-DD-AADK,"CLINICAL DIAGNOSIS: R/O HCC. Specimen : liver. Gross Photo : GROSS: Specimen status: Fresh. Operation: Partial resection of the mass located in the segment 3. Wedge resection of the mass located in the segment 7. Organ: Liver. Segment 3 (5.5 X 4.0 X 3.0 cm, 30.0 gm). Segment 7 (4.0 X 2.0 X 1.5 cm, 10.9 gm). Lesions: [Mass 1]. Tumor location: Segment 3. Size: 3.5 X 2.5 X 2.5 cm. Cut surface: Well demarcated, pale tan, solid and lobulated mass. Gross type: Multinodular confluent. Extent: Bulging by mass, but smooth. Resection margin: Not involved, grossly (safety margin: 1.1 cm). [Mass 2]. Tumor location: Segment 7. Size: 0.9 X 0.8 X 0.8 cm. Cut surface: Well demarcated, homogenous, pale tan and solid mass. Gross type: Multinodular confluent. Extent: Bulging by mass, but smooth. Resection margin: Not involved, grossly (safety margin: 0.6 cm). Remaining parenchyme: Cirrhosis. Representative sections submitted. Gross photo: Present. Ink key: Resection margins: Green. Capsular surface: Black. Blocks. T1-4, mass of segment 3 [Mass 1] X 4. T5-6, mass of segment 7 [Mass 2] x 2. RM, resection margin of segment 3 X. 1. L, nontumorous liver parenchyme X 1. X1-2, fibrofatty tissue x 2. MICROSCOPIC: [Mass 1]. Tumor location: Segment 3. Tumor type: Hepatocellular carcinoma. The worst differentiation III. The major differentiation III. Histologic type: Trabecular, insular. Cell type: Hepatic. Fatty change: Yes. Cholangiocarcinoma: No. Fibrous capsule formation: No. Septum formation: Yes. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Vascular invasion: Yes. Bile duct invasion: No. [Mass 2]. Tumor location: Segment 7. Tumor type: Hepatocellular carcinoma. The worst differentiation III. The major differentiation II. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: Yes. Cholangiocarcinomal No. Fibrous capsule formation: No. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Vascular invasion: No. Bile duct invasion: No. Remaining liver parenchyme: Cirrhosis, mixed steatosis, mild. NOT reported. Gross: Cervix, smear, inflammation, atrophy. Cervix, smear, inflammation, atrophy. Cervix, smear, inflammation, atrophy. Cervix, smear, inflammation. Cervix, smear, atrophy. Cervix, smear, atrophy. Cervix, smear, atrophy. stomach,body,scopic,erosion,chronic gastritis. Large intestine, ascending colon, ectomy, hyperplastic polyp. liver,resection,hepatocellular carcinoma. T56000, P17, M81703. DIAGNOSIS: Liver, segment 3, partial resection: Hepatocellular carcinoma. Liver, segment 7, wedge resection: Hepatocellular carcinoma. Suggestion :",T2,N0,M0,T2N0M0
TCGA-AA-3663,"Diagnosis/ diagnoses: Right hemicolectomy preparation with tumor-free oral and aboral resection margins and a. hyperplastic polyp in the ascending colon. It also includes an ulcerated, in parts poorly. differentiated adenocarcinoma of the cecum with widespread and deep infiltration of the. perimuscular fatty tissue (G3, pT3). Follow-up report: Following acetone clarification, 40 lymph nodes in the pericolic fatty tissue bordering the. tumor were prepared, measuring up to 1.5 cm. These proved to be microscopically tumor-free throughout. In conclusion and in summary a stage of pT3 pNO (0/40) LO V0 R0 is established.",T3,N0,M0,T3N0M0
TCGA-96-8169,"SPECIMENS: 1. RIGHT LOWER LOBE WEDGE RESECTION. 2. STATION 9 LYMPH NODE. 3. STATION 7 LYMPH NODE. 4. STATION 4 LYMPH NODE. DIAGNOSIS: 1. LUNG, RIGHT LOWER LOBE: WEDGE RESECTION. SQUAMOUS CELL CARCINOMA, POORLY DIFFERENTIATED (1.6 CM), SEE. NOTE. - THE STAPLE LINE MARGIN IS FREE OF TUMOR. Note: Immunohistochemical stains show that the tumor cells are. positive for p63 while negative for TTF-1, supporting the diagnosis. A mucin stain is negative. 2. LYMPH NODE, LEVEL 9: BIOPSY. - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). 3. LYMPH NODE, LEVEL 7: BIOPSY. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). 4. LYMPH NODE, LEVEL 4: BIOPSY. - TWO LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2). Specimens: 1: RIGHT LOWER LOBE WEDGE RESECTION. 2: STATION 9 LYMPH NODE. 3: STATION 7 LYMPH NODE. 4: STATION 4 LYMPH NODE. LUNG: Resection. SPECIMEN. Specimen: Lung. Procedure: Wedge resection. Specimen Integrity: Intact. Specimen Laterality: Right. Tumor Site: Lower lobe. Tumor Focality: Unifocal. TUMOR. Histologic Type: Squamous cell carcinoma. Histologic Grade: G3: Poorly differentiated. EXTENT. Tumor Size: Greatest dimension (cm). 1.6cm. Visceral Pleura Invasion: Not identified. MARGINS. Parenchymal Margin: Uninvolved by invasive carcinoma. ACCESSORY FINDINGS. Lymph-Vascular Invasion: Not identified. LYMPH NODES. Extranodal Extension: Not identified. STAGE (pTNM). Primary Tumor (pT): pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung. or visceral pleura, without bronchoscopic evidence of invasion more. proximal than the lobar bronchus (i.e., not in the main bronchus);. or Superficial spreading tumor of any size with its invasive. component limited to the bronchial wall, which may extend proximally. to the main bronchus. Regional Lymph Nodes (pN). pNO: No regional lymph node metastasis. Number Examined. 4. Number Involved. 0. ADDITIONAL NON-TUMOR. Additional Pathologic Finding(s): Emphysema. CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS: ex-smoker with RLL NSCLC. MACROSCOPIC DESCRIPTION: The specimen is received in saline, in four parts, each labeled with. the patient's name. 1. Part one is labeled 'right lower lobe wedge resection'. It. consists of a wedge biopsy of the lung measuring 11 X 7 X 2.8 cm. The staple line measures 14 cm. The pleura are gray pink and. glistening. There is a yellow tan sub pleural firm nodule with ill. defined borders measuring 2 X 1.8 X 1.3 cm, located 1.6 cm from the. staple line margin. The staple line is shaved and the pleura around. the staple is inked blue. The pleural surface above the nodule is. inked black. The remainder of the parenchyma is pink red blotchy and. crepitant. No other nodule grossly identified. Representative. sections are submitted. 2. Part two is labeled 'station #9 lymph node'. It consists of one. soft red-black lymph node measuring 1 X 0.5 X 0.4 cm, which is. bisected. Entirely submitted in one cassette. 3. Part three is labeled 'station #7 lymph node'. It consists of. one soft red-black lymph node measuring 2.3 X 1 X 0.6 cm, which is. bisected. Entirely submitted in one cassette. 4. Part four is labeled 'station #4 lymph node'. It consists of two. soft red-black lymph nodes measuring 0.8 X 0.6 X 0.5 cm in. aggregate. Entirely submitted in one cassette. Duct/. (part 1). Dct/. (parts 2-4). SUMMARY OF SECTIONS: 1A-1D nodules. 1E staple line margin. 1F random section of parenchyma. 2A in toto. 3A in toto. 4A in toto. SPECIAL PROCEDURES: Mucin. This report may include one or more immunohistochemical stain. results that use analyte specific reagents. The tests were developed and their performance characteristics. determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is not. necessary.",T1,N0,M0,T1N0M0
TCGA-62-A46P,"Pathology Report-Summary: Material: lung, left, upper lobe: 17.0 X 16.0 X 5.0 cm. tumor diameter: 6.0 cm. Diagnosis: Adenocarcinoma mixed subtype (predominantely papillary, partially acinar, BAC). pT2, pNO (0/7), pMx, G2.",T2,N0,M0,T2N0M0
TCGA-BH-A1FR,"Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE OF LMP. DATE or LAST DELIVERY: PRE-OP DIAGNOSIS: R BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: R SEGM MASTECTOMY. CLINICAL HISTORY: MATERIAL SUBMITTED: RIGHT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: CONSULT: Right breast mass: core biopsy positive for carcinoma. ER/PR's were done. An ellipse of skin with. breast tissue, 8.5 by 6.5 by 5.0 cm, shows a tumor mass, 2.2 by 1.7 by 3.0 cm, located 2.0 cm from post. margin and 1.0 cm from anterior margin. ADDENDA: Addendum. DATE or LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: R BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: R SEGM MASTECTOMY. CLINICAL HISTORY: MATERIAL SUBMITTED: RIGHT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTTRAOPERATVR CONSULTATION: CONSULT: Right breast mass : core biopsy positive for carcinoma. ER/PR's were done. An ellipse of skin. with. breast tissue, 8.5 by 6.5 by 5.0 cm, shows a tumor mass, 2.2 by 1.7 by 3.0 cm, located 2.0 cm from post. margin and 1.0 cm from anterior margin. MACROSCOPIC DESCRIPTION: S U P P L E M is N T A L R P. specimen is received fresh labeled with the patient's name and ""right breast mass"". It consists of an. oval, yellow, soft, lobulated breast tissue, 8.5 by 6.5 by 5.0 cm with surgical sutures and an ellipse of. white-tan skin attached, 5.5 by 1.6 cm in greatest dimension, and is grossly unremarkable. The specimen is. previously inked and sectioned which reveals a 3.0 by 2.2 by 1.7 cm tumor mass, located 2.0 cm from. posterior resection margin and 1.0 cm from anterior resection margin. The tumor mass if firm and focally. hemorrhagic. Representative sections are submitted labeled ""A1-A2"" tumor and anterior resection margin;. ""A3-. A4"" tumor and superior resection margin; ""A5-A6"" lateral resection margin; ""A9-A10"" posterior resection. margin; ""All-A12"" medial resection margin; ""A13-A14"" additional sections of the tumor; ""A15"" skin with. underlying tissue. My signature below is attestation that I have reviewed all slides and agree with the findings as noted. below. FINAL DIAGNOSIS: RIGHT SEGMENTAL MASTECTONT: - MIXED INFILTRATING DUCT AND MUCINOUS CARCINOMA, 3.0 BY 2.2 BY 1.7 CM., GOOD NUCLEAR GRADE (SEE NOTE). - SURGICAL MRGINS ARE NGATIVE FOR TUMOR. DUCTAL CARCINOMA IN-SITU, NON-COMEDO TYPE, PRESENT AT PERIPHERY AND WITHIN THE TUMOR. - SKIN, UNREMARKABLE. NOTE: Neuroendocrine markers will be performed and results will be reported if positive Special stains. including NSE and Grimelius, are positive and support the presence of neuroendocrine features often seen in. this type of breast carcinoma.",T4,N1,M0,T4N1M0
TCGA-GM-A4E0,"DIAGNOSIS. (A) LEFT AXILLARY SENTINEL LYMPH NODE #1, BIOPSY: METASTATIC CARCINOMA IN ONE LYMPH NODE. LYMPH NODE METASTASIS MEASURES 7.0 MM IN GREATEST MICROSCOPIC DIMENSION. EXTRANODAL EXTENSION IS PRESENT AND MEASURES 2.0 MM IN GREATEST DIMENSION. CYTOKERATIN IMMUNOSTAINING ON REPRESENTATIVE SECTION CONFIRMS THE PRESENCE OF. METASTATIC CARCINOMA. (B) LEFT BREAST, MASTECTOMY: INVASIVE LOBULAR CARCINOMA, MODIFIED BLACK'S NUCLEAR GRADE 1-2 (LOW TO INTERMEDIATE. GRADE) WITH FOCAL SIGNET RING CELL FEATURES. L 9% signate ring pw TSS . INVASIVE CARCINOMA INVOLVES AN AREA OF APPROXIMATELY 8.5 CM IN THE LATERAL ASPECT. Definitive lymphovascular invasion is not identified. A SMALL FOCUS OF INVASIVE CARCINOMA IS PRESENT 8.0 MM FROM THE INFERIOR MARGIN. Other resection margins widely free of tumor. Stromal fibrosis, columnar cell change and cysts. Nipple skin with basaloid follicular hamartoma; no carcinoma identified. (C) LEFT AXILLARY CONTENTS, DISSECTION: METASTATIC CARCINOMA IN NINE OF TWENTY-ONE LYMPH NODES. LARGEST LYMPH NODE METASTASIS MEASURES 5.0 MM IN GREATEST MICROSCOPIC DIMENSION. Focal extranodal extension is present. Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) LEFT AXILLARY SLN #1, BLUE IN VIVO 13, EX VIVO 31 - One blue lymph node 3.0 x 2.0 x 0.7 cm. Serially sectioned and. entirely submitted in A1-A3 for frozen evaluation (A1, suture to hot spot). FS/DX: METASTATIC CARCINOMA. (B) LEFT BREAST - A total mastectomy specimen 26.0 X 21.0 x 8.5 cm with white-tan skin (26.0 x 17.5 cm and nipple 1.2 cm in. diameter). The specimen is oriented with stitch at 12 o'clock. The superior margin inked blue, inferior margin inked orange, deep. margin inked black. The specimen is serially sliced from medial to lateral in twelve slices and nipple at slice #4. An irregular tumor. 8.5 x 4.5 x 2.0 cm is identified in the lateral portion (slice #7-slice #9). The tumor is 2.0 cm to the inferior margin, 5.0 cm to the. superior margin and 6.0 cm to the deep margin. SECTION CODE: B1, B2, nipple B3, tissue adjacent to the tumor from slice #6; B4-B6, tumor from slice #7 from superior. to inferior; B7-B12, tumor and margins from slice #8 (B7-B10, tumor from superior to inferior); B11, inferior margin; B12 (deep. margin); B13-B17, tumor and inferior margin from slice #9; from superior to inferior (B17 including inferior margin); B18, tissue. adjacent to the tumor from slice #10; B19, representative section from upper inner quadrant including superior margin; B20,. representative. section from lower inner quadrant including inferior margin; B21, fibrous tissue from upper outer quadrant with. superior margin from slice #5; B22, fibrous tissue from upper outer quadrant with superior margin from slice #6; B23,. representative section from lower outer quadrant including inferior margin. (C) LEFT AXILLARY CONTENTS - Adipose tissue (11.0 x 5.5 X 2.5 cm). Twenty-two lymph nodes are identified, ranging from. (0.2 x 0.2 x 0.2 cm to 4.5 x 1.5 X 1.0 cm). SECTION CODE: C1-C3, each cassette containing six lymph nodes; C4, three lymph nodes; C5-C9, one lymph node,. serially sectioned. NICAL HISTORY. Left breast cancer. CONSULTANT(S). SNOMED CODES. T-04050, M-85203, T-C4710, M-85206. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Released by:",T3,N3,M0,T3N3M0
TCGA-PD-A5DF,"SPECIMEN: Sex: F. Date Collected: Date Received. Clinical History/Diagnosis: Right Liver Lobe ""Hepatoma"". Source of Specimen(s): 1: Right colonic mesenteric lymph node. 2: right lobe liver sigment. 3: gallbladder, segment 5 and 6 of liver, right colon. Gross Description: Received in three parts. Source of Tissue: 1. Labeled #1, ""right colonic mesenteric lymph node"". Gross Description: Received fresh labeled ""right colonic mesenteric lymph node"". It. consists of a firm yellow-tan lymph node measuring 0.7 x 0.5 x 0.5 cm. The lymph node. is bisected and entirely submitted in 1A. Source of Tissue: 2. Labeled #2, ""right lobe liver segment"". Frozen Section Diagnosis: 2FS- CONSISTENT WITH HEPATOCELLULAR. CARCINOMA. PER. Gross Description: Received fresh labeled ""right lobe liver segment"". It consists of a firm. white-tan well-circumscribed nodule measuring 0.5 x 0.5 x 0.3 cm. The nodule is. bisected and entirely submitted in 2FS. Source of Tissue: 3. Labeled #3, ""gallbladder, segments 5 and 6 of liver,. right colon"". Gross Description: Received fresh labeled ""gallbladder, segments 5 and 6 of liver, right. colon"". It consists of a large liver mass with attached gallbladder and attached segment of. large bowel. The liver mass measures 21 x 17 x 13.5 cm in greatest dimension. The mass is serially sectioned to reveal a golden-yellow, soft diffusely. necrotic cut surface. Also the mass comes within 2 cm of the closest. cauterized liver margin. A suture is identified at the liver margin. The. margin is inked green. The attached short segment of terminal ileum. measures 7 cm in length and 3 cm in circumference. The terminal ileum is. opened to show a diffusely hemorrhagic smooth mucosal lining with no. discrete masses present. The appendix measures 8.5 x 0.5 x 0.5 cm. The. appendix is sectioned to reveal a homogeneous, soft tan-pink cut surface. with no discrete masses present. The attached segment of large bowel is. completely adhesed to the previously described liver mass and measures 39. cm in length and 5 cm in circumference. The tumor does not appear to. infiltrate the large bowel wall. The large bowel mucosa is red-brown and. diffusely hemorrhagic with no discrete lesions identified. The gallbladder. measures 8 x 4 x 4 cm. The gallbladder is also grossly adhesed to tumor. The cystic duct is patent measuring 0.5 cm in diameter. The gallbladder is. opened to reveal approximately 20 cc of dark-green viscid bile. The mucosa. is velvety, bile stained with no mucosal ulcerations or polyps identified. Representative sections submitted in 3A-3K. Designation of Sections: 3A- tumor with closest liver margin inked green,. 3B- additional perpendicular sections of the liver margin, 3C-3D- tumor. with closest capsule, 3E- tumor with adjacent normal liver, 3F- proximal. and distal right colon margin, 3G-3H- tumor in relation to right colon,. 3I- cystic duct, 3J- tumor in relation to gallbladder, 3K- appendix. Final Diagnosis: 1. Right colonic mesenteric lymph node, excision: No tumor seen in one lymph node (0/1). 2. Liver, right lobe segment, excision: Hepatocellular carcinoma. 3. Gallbladder, segments 5 and 6 of liver, right colon, excision: Hepatocellular carcinoma, grade II/IV. - The 21 cm carcinoma invades serosa of ascending colon. - Angiolymphatic invasion is identified. - Surgical resection margins are free of carcinoma. Gallbladder with chronic cholecystitis. Cecum and terminal ileum with no diagnostic abnormalities recognized. Appendix with partial fibrosis obliteration of the lumen. pTNM: T4 NO Mx.",T4,N0,M0,T4N0M0
TCGA-BH-A18K,"FATIENI MISTURT: DATE of LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: LEFT BREAST CANCER. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: LEFT SEG MAST AND AXILLARY DISSECTION. CLINICAL HISTORY: MATERIAL SUBMITTED: A) LEFT AXILLA, PROCUREMENT BY SURGICAL PROCEDURE. B) LEFT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: CONSULT: 2) left breast tissue with usual markings; 7.5 by 7.0 by 2.0 cm breast mass with specimen. radiograph. Specimen is received inked and previously sectioned by Dr. There is a medial 1.8 by 1.5. by 1.1 cm firm to hard area which is 0.4 cm from theposterior margin and 0.3cmfrom the anterior. margin;. lateral to this mass is an area of calcification on radiograph. Section thru this area shows ill defined. fibrous tissue, approximately 1.2 by 1.0 by 0.8 cm with white punctate tissue, < 0.1 cm. ADDENDA: Addendum. MACROSCOPIC DESCRIPTION: BLOCKS B3 AND B8 SUBMITTED FOR ER/PR AND HER-2/NEU. FINAL DIAGNOSIS: My signature is attestation that I have personally reviewed the submitted material(s) and the final. diagnosis reflects that `evaluation. ER/PR. IMMUNOPEROXIDASE IDENTTIFICATION OF ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON BLOCKS B3 AND B8. DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROGEN RECEPTOR (90%) AND FOR PROGESTERONE RECEPTOR. (60%) THEREFORE, BOTH ARE INTERPRETED AS POSITIVE. HER-2/NEU. c-erbB2 (HER-2/NEU) IMMUNOSTAINING IS CARRIED OUT ON BLOCKS B3 AND 88 (BREAST CANCER) USING A 1:300 DILUTION. OF DAKO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE INTRACELLULAR DOMAIN or c-erbB2) WITHOUT ANTIGEN. RETRIEVAL. DISTINCT COMPLETE MEMBRANE STAINING IS IDENTIFIED ONLY RARELY IN 5% OF TUMOR CELLS. THEREFORE, c-. erbB2 (HER-2/NEU) IS INTERPRETED AS NEGATIVE (SCORE 1+). FINAL DIAGNOSIS: FINAL DIAGNOSIS: PREVIOUS REPORTS. A) LEET AXILLARY CONTENTS: - ELEVEN (11) LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA. B) LEFT BREAST, SEGMENTAL MASTECTOMY: INFILTRATING MULTIFOCAL, POORLY DIFFERENTIATED. DUCT CARCINONA, 1.8 CM AND 1.2 CM (CR. 300-312,. SEE. NOTE). - NOTTINGHAM SCORE FOR BOTH TUMORS - 8/9 (TUBULES - 3, NUCLEAR ATYPIA - 3, MITOTIC INDEX. - DUCTAL CARCINOMA IN SITU, COMEDO AND NON-COMEDO TYPE, COMPRISES <5% OF EACH TUMOR. - MARGINS OF RESECTION ARE FREE OF INFILTRATING TUMOR; HOWEVER, DUCTAL CARCINOMA IN SITU EXTENDS TO INVOLVE. INKED ANTERIOR MARGIN AND INFILTRATING TUMOR EXTENDS TO WITHIN 0.3 CM OF THE ANTERIOR MARGIN. - LYMPHOVASCULAR PERMEATION IS IDENTIFIED. - TUMOR AND NON-TUMOR ASSOCIATED MICROCALCITICATIONS. - CHANGES CONSISTENT WITH PREVIOUS BIOPSY. - FIBROCYSTIC CHANGES. NOTE: Both tumor nodules have similar architectural and cytologic features NOTE: ER/PR immunoparoxidase. assay and Her-2/NEU testing will be performed on both tumors (blocks 93 and B8).",T1,N0,M0,T1N0M0
TCGA-21-1071,"Source of Specimen(s): A: R4. B: PORTION OF 6TH RIB. C: R9 L.N. D: R10 L.N. E: R11 L.N. F: RUL. G: NO.7 L.N. Sunquest Archived Tests: NATURE OF SPECIMEN : RESECTION, FROZEN SECTION. Gross Description: GROSS DESCRIPTION: Received in seven parts. SOURCE OF TISSUE: 1. Labeled #1, ""R4"". FROZEN SECTION DIAGNOSIS: 1FS - NO TUMOR SEEN. GROSS DESCRIPTION: Received fresh for frozen section evaluation is a 0.8 Cm in greatest. dimension red-purple firm lymph node. It is submitted in toto for frozen section evaluation. and the frozen itself is submitted in one block. DESIGNATION OF SECTIONS: 1FS. SUMMARY OF SECTIONS: FS-1. SOURCE OF TISSUE: 2. Labeled #2, ""portion of 6th rib"". GROSS DESCRIPTION: Received fresh is a 2.0 cm in greatest dimension tan fragment of rib. with attached soft tissue. A representative section is submitted in one block, following. decalcification. DESIGNATION OF SECTIONS: block 2. SUMMARY OF SECTIONS: undesignated - 1. SOURCE OF TISSUE: 3. Labeled #3, ""R9 lymph node"". - HISTOLOGIC CLASSIFICATION OF TUMOR IS SQUAOUS CELL (EPIDERMOID). CARCINOMA, NON-KERATINIZING TYPE. - GRADE OF TUMOR IS POORLY DIFFERENTIATED. - MAXIMUM DIMENSION OF TUMOR IS 7.5 CM. - LYMPHATIC INVASION BY TUMOR IS ABSENT. - ARTERIAL INVASION BY TUMOR IS ABSENT. - INVASION INTO BUT NOT THROUGH THE PLEURA BY TUMOR IS PRESENT. - INVASION THROUGH THE PLEURA BY TUMOR IS ABSENT. - TUMOR NECROSIS IS MARKED. - SURGICAL MARGINS ARE UNINVOLVED BY TUMOR. - NON-NEOPLASTIC LUNG TISSUE SHOWS EMPHYSEMA. - TOTAL NUMBER OF NODES EXAMINED IS 20. - TOTAL NUMBER OF POSITIVE NODES IS 0. - STAGING: T2.",T2,N0,M0,T2N0M0
TCGA-05-4427,"Main diagnosis/diagnoses: Large peripheral to central, histologically predominantly undifferentiated mixed large-cell and. polymorphocellular adenocarcinoma of the left upper lobe of the lung. TNM classification on. the basis of this material pT2 pN1 R0, stage IIB. C34.1 M8255/3, G3. Comment/supplementary remark: Histologically, the large-cell and polymorphocellular solid component of the carcinoma. predominates, with a clear-cell appearance in small sections and the possibility of a. neuroendocrine differentiation (immunohistochemical analysis to follow). In all likelihood, it. is a primary peripheral carcinoma of the lung that has invaded the overlying visceral pleura to. a minimal extent and also shows central bronchopulmonary and hilar lymph node metastases. The other hilus lymph nodes and other lymph nodes removed are tumor-free. Result of immunohistochemical analysis. A high proportion of tumor cells positive for low. molecular weight keratins. and a small proportion also for high molecular weight. keratins. Relatively high proportion positive for TTF1. Negative for synaptophysin. and NCAM. The tumor classification of mixed-type adenocarcinoma of the lung is thus confirmed.",T2,N1,M0,T2N1M0
TCGA-BH-A1EX,"PATIENT HISTORY: SPECIMENS TAKEN BY PATH DATE of LMP: (NOT LISTED ON REQUISITION). DATE or LAST DELIVERY: PRE-OP DIAGNOSIS: RIGHT BREAST CANCER. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: R SENTINEL LYMPH NODE, R SEGMENTAL MASTECTOMY. CLINICAL HISTORY: SPECIMENS TAKEN BY PATH. MATERIAL SUBMITTED: A) RIGHT SENTINEL LYMPH NODE, PROCUREMENT BY SURGICAL PROCEDURE. B) RIGHT BREAST BICPSY/TISSUE, PROCUREMENT BY SURGICAL PROCEDURE. Long-lat,med-med, sht-superior. INTRAOPERATIVE CONSULTATION: R SENTINEL LYMPH NODE #1: One lymph node, 0.8 by 0.6 by 0.5 cm. Touch Prep. Diagnosis: Negative. ADDENDA: Addendum. FISH analysis using DNA probe for Her-2/neu gene showed that, the ratio of Her-2/neu signals to chromosome 17. centromere signais is 0.94 (> 2.0 ratio is considered amplified). Therefore, Her-2/neu gene is not amplified. Bv Pathologi. My signature is attestation that I have personally reviewed the submitted material(s) and the above diagnosis reflects that evaluation. Addendum. MATERIAL SUBMITTED: BLOCK ""B3"" FOR ER/PR AND HER-2/NEU (BREAST CANCER). FINAL DIAGNOSIS: ESTROGEN/PROGESTERONT RECEPTORS AND HER-2/NEU PERFORMED ON RIGHT BREAST TISSUE. ESTROGEN RECEPTOR (0- 40%; 1+ 40%; 2+ 10%; 3+ 10%) HSCORE OF 90. ESTROGEN RECEPTOR IS INTERPRETED AS. POSITIVE. PROGESTERONS RECEPTOR (0- 70%; 1+ 10%; 2+ 10%; 3+ 10%) HSCORE OF 60. PROGESTERONI RECEPTOR IS INTERPRETED AS. POSITIVE. HER-2/NEU-DAKO HERCEPTEST. A WEAK TO MODERATE COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE THAN 10% OF THE. TUMOR CELLS. HER-2/NEU IS INTERPRETED AS POSITIVE (SCORE 2+). HSCORE: <= 15 NEGATIVE. >15<=30 BORDERLINE. FINAL DIAGNOSIS: FINAL DIAGNOSIS: A) RIGHT SENTINEL LYMPH NODE #1: - MICROMIETASTATIC DUCTAL CARCINOMA OF THE BREAST (SEE NOTE). B) RIGHT SEGMENTAL MASTECTOMY: INFILTRATING MODERATELY DIFFERENTIATED DUCTAL CARCINOMA) NOTTINGHAM SCORE 6/9 (TUBULES=3, NUCLEI=2,. MITOSIS-1) SIZE 2.5 BY 2.0 BY 1.5 CX. - DUCTAL CARCINOMA IN SITU, NON-COMEDO TYPE, SOLID AND CRIBRIFORK) NUCLEAR GRADK 1, CONSTITUTES 5% or. ENTIRE. TUMOR MASS. - SEVERAL MICROSCOPIC FOCI OF INFILTRATING ADENOCARCINOMA, UP TO 0.5 CM, IN THE REMAINING BREAST TISSUE. #9, #12). - LATERAL AND INFERIOR SURGICAL MARGINS POSITIVE FOR INVASIVE TUMOR. - INTRADUCTAL PAPILLOMA AND PROLIFERATIVE FIBROCYSTIC CHANGES IN THE REMAINING BREAST TISSUE. FOCAL NECROSIS AND GRANULATION TISSUL, STATUS-POST CORE BIOPSY or BREAST (CROSS REFER. NOTE: Minute clusters of metastatic ductal carcinoma was found in serial section ""Al"", but it ie best. visualized with the immunoperoxidase stain AB1/AR3 in serial section A2. The immunostain was repeated and. the presence of metastatic neoplastic cells in the lymph node section ""Al"" was confirmed by. immunostaining (""A26A3""). The later serial sections of the lymph nodes are negative. The touch prep of. the. sentinel node was re- reviewed and no malignant cells are identified ER/PR immunoperoxidase assay and Her-. 2/NEU testing will be performed on block ""B3"". The special stains and/or immunoperoxidase tests used in thi ~ase hatra bean and their performance. characterietics determined by the Department of Pathology at. They have not been cleared or approved by the U.S. Food and Drug Administration.",T2,N1,M0,T2N1M0
TCGA-FD-A3SM,"Gender: Male. Race: Report Date: FINAL PATHOLOGIC DIAGNOSIS. A. Right pelvic lymph nodes; biopsy: - Eight benign lymph nodes (0/8). B. Left pelvic lymph nodes; biopsy: - One lymph node with metastatic urothelial carcinoma (1/1). - No extranodal extension. C. Left pelvic lymph nodes; biopsy: - Three of sixteen lymph nodes with metastatic urothelial carcinoma (3/16). - No extranodal extension. D. Bladder and prostate; radical cystectomy: - Invasive urothelial carcinoma, see parameters. E. Right distal ureter, resection: - Fragment of ureter, no tumor. Urothelial Carcinoma Pathologic Parameters. 1. Tumor type: Papillary urothelial carcinoma. 2. Grade of tumor: High grade. 3. Depth of invasion: Extravesicular soft tissue. 4. Tumor distribution: Solitary, 9 x 6.5 X 3 cm. Dome. Right lateral wall. Left lateral wall. Anterior wall. Posterior wall. 5. Ureteral margins: Negative. 6. Distal urethral margin: Negative. 7. Soft tissue margin or serosa: Negative (< 1 mm from cauterized and inked. margin). 8. Lymph nodes: Positive left pelvic lymph nodes (4/17), negative right pelvic. lymph nodes (0/8). 9. pTNM: pT3a, N2. Effective. this Checklist utilizes the edition TNM staging. system for Bladder of the American Joint Committee on Cancer (AJCC) and the. International Union Against Cancer (UICC). , M.D. Interpretation performed by the Attending Pathologist and reviewed with the. Resident/Fellow,  MD. Clinical History: The patient is a. -year-old male with malignant neoplasm of bladder undergoing. a radical cystectomy with Neo-bladder. Specimens Received: A: Right pelvic lymph nodes. B: Left pelvic lymph node. C: Left pelvic lymph nodes. D: Bladder, prostate. E: Right distal ureter, stitch on non-margin side. Gross Description: The specimens are received in five containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, ""1. Right pelvic lymph. nodes"". Received fresh and placed in formalin is a 7 x 6 x 2 cm aggregate of. yellow-tan fibrofatty tissue. 10 lymph node candidates are identified ranging. from 0.3 x 0.2 x 0.2 cm to 2 x 1 x 1 cm. The lymph node candidates are submitted. as follows: A1-A2: 3 lymph node candidate in each cassette. A3: 2 lymph node candidates. A4: 1 serially sectioned lymph node candidate. A5-A6: 1 serially sectioned lymph node candidate. B. The second container is additionally identified as, ""2. Left pelvic lymph. node"". Received fresh and placed in formalin is a 12 gm, 5.0 x 3.5 x 2.5 cm. pink-tan nodule consistent with lymph node. The lymph node candidate is serially. sectioned to reveal white-tan and firm focal with cystic and necrotic tissue. The specimen is representatively submitted for frozen section diagnosis and read. as ""one lymph node frozen, positive for carcinoma, approximately 2 cm"" per Dr. The frozen section remnant is submitted in blocks B1FS-B2FS. Representative sections are submitted as follows: B1FS-B2FS: Frozen remnant. B3: Section of lymph node. C. The third container is additionally identified as, ""3. Left pelvic lymph. nodes"". Received fresh and placed in formalin is a 7 x 5 x 2 cm aggregate of. yellow-tan fibrofatty tissue. 18 lymph node candidates are identified ranging. from 0.4 x 0.3 x 0.2 cm to 2 x 1.5 x 1 cm. The lymph node candidates are. submitted as follows: C1-C2: 4 lymph node candidates in each cassette. C3-C4: 3 lymph node candidate in each cassette. C5: 1 serially sectioned lymph node candidate. C6: 1 serially sectioned lymph node candidate. C7-C8: 1 serially sectioned lymph node candidate. C9-C10: 1 serially sectioned lymph node candidate. D. The fourth container is additionally identified as, ""4. Bladder, prostate"". Received fresh and placed in formalin is a 525.1 g, 16.5 x 11.5 x 5.5 cm. cystoprostatectomy specimen consisting of a 9.0 x 8.5 x 4.0 cm bladder with. attached pericystic adipose tissue and a 5.5 x 4.5 x 3.5 cm prostate. The right. seminal vesicles measure 5.5 x 2.0 x 0.8 cm and right vas deferens measures 15.5. cm in length by 0.2-0.5 cm in diameter. The left seminal vesicles measures 4.5 x. 1.8 x 0.8 cm and left vas deferens measures 13.5 cm in length by 0.2-0.7 cm in. diameter. The right ureteral stump measures 1.4 x 0.5 cm, the left measures 1.1. x 0.5 cm, and the urethral stump measures 1.4 x 0.7 cm, which demonstrate. intact, patent lumens. The right half of the prostate is inked blue, the left half is inked black, and. the reminder of outer surface of the specimen is inked black. The bladder and. prostate are opened along the posterior aspect due to the location of the. bladder tumor. The prostate is surrounded by thin, shaggy membranous tissue and. sectioning demonstrates rubbery, pink-tan, and spongy with no discrete masses. and indurations. The opened bladder reveals a 9.0 x 6.5 x 3.0 cm fungating, shaggy, gray-tan firm. to friable mass occupying the entire anterior and lateral walls of the right and. left sides. Approximately 30% of the posterior wall is also involved. On cut. section, the mass is diffusely solid and white-tan with focal yellow-tan areas. consistent with necrosis. The mass extends through the muscularis propria and. focally abuts the deep margin with a maximal wall thickness of 3.0 cm, and. located 3.5 cm from the urethral margin. The remaining surrounding bladder mucosa is wrinkled, white-tan with a uniform. 1.1 cm wall thickness. Bilateral ureteral orifices, adjacent to the trigone, are. identified and probe patent. The pericystic adipose tissue is dissected for lymph node candidates. No lymph. nodes are identified. Also received is a detached vessel 5.0 cm in length by 0.2-0.3 cm in diameter. Gross photographs are taken. Representative sections are submitted as follows: D1: Right ureter resection margin. D2: Left ureter resection margin. D3: Distal urethral margin. D4-D5: Apical prostatic margin, perpendicularly sectioned. D6-D7: Bladder mass, including deep margin (tandem sections). D8: Bladder mass and uninvolved mucosa, anterior wall. D9: Bladder mass and uninvolved mucosa, dome. D10-D11:Additional bladder mass. D12: Uninvolved bladder mucosa, dome. D13: Uninvolved bladder mucosa, posterior wall. D14: Uninvolved trigone. D15: Representative prostate through verumontanum. D16: Representative prostate above verumontanum. D17: Bilateral seminal vesicles and vasa deferentia. E. The fifth container is additionally identified as, ""5. Right distal ureter,. stitch on non-margin site"". Received fresh and placed in formalin is a 1.5 cm in. length and 0.6 cm in diameter tubal structure consistent with ureter. A stitch. is designating non-margin side, and opposite side is inked blue. The specimen is. sectioned to reveal a 0.3 cm lumen and a wall thickness 0.2 cm. The outer. surface of the specimen is pink-tan to yellow-tan, and shaggy. The inner surface. is gray-tan and smooth. The marginal side is submitted en face as E1. Intraoperative Consult Diagnosis: B1FS-B2FS: ""one lymph node frozen, positive for carcinoma, approximately 2 cm"" "". per Dr.",T3,N2,M1,T3N2M1
TCGA-E9-A22D,Laterality:Right upper outer quadrant. Path Report: BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 2.4 x2.4x2.4 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 0/10 positive for metastasis (Regional 0/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Not specified. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,T2,N0,M0,T2N0M0
TCGA-B0-5400,"PATIENT HISTORY: No clinical history is given. PRE-OP DIAGNOSIS: Right renal mass. POST-OP DIAGNOSIS: Same. PROCEDURE: Right nephrectomy. FINAL DIAGNOSIS: KIDNEY, RIGHT, NEPHRECTOMY +++++++. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE WITH MASSIVE NECROSIS, CALCIFICATIONS. AND FOCAL SARCOMATOID CHANGES WITH RHABDOID MORPHOLOGY (SLIDE J). B. FUHRMAN NUCLEAR GRADE IV/IV. C. THE GREATEST DIAMETER OF THE NEOPLASM IS 8.0 cm. D. THE NEOPLASM FOCALLY EXTENDS INTO THE RENAL SINUS FAT (SLIDE E). E. RENAL VEIN TUMOR THROMBUS IS IDENTIFIED. F. RENAL VEIN MARGIN IS INVOLVED BY CARCINOMA. ALL OTHER SURGICAL MARGINS ARE FREE OF THE. NEOPLASM. G. THE NON-NEOPLASTIC KIDNEY SHOWS FOCAL GLOBAL GLOMERULOSCLEROSIS, FOCAL TUBULAR. ATROPHY AND PROMINENT LYMPHOCYTIC INTERSTITIAL INFILTRATE. H. TNM STAGE: pT3b NX MX. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY KIDNEY TUMORS. SPECIMEN TYPE: Other: NEPHRECTOMY. LATERALITY: Right. TUMOR SITE: Lower pole. FOCALITY: Unifocal. TUMOR SIZE: Greatest dimension: 8.0 cm. Additional dimensions: 7.8 cm. MACROSCOPIC EXTENT OF TUMOR: Tumor extension into perinephric tissues. Tumor extension into major veins. HISTOLOGIC TYPE: Clear cell (conventional) renal carcinoma. Sarcomatoid carcinoma arising in renal cell carcinoma. Subtype and % of sarcomatoid element: RHABDOID, 5%. HISTOLOGIC GRADE (Fuhrman Nuclear Grade): G4. PATHOLOGIC STAGING (pTNM): pT3b. pNX. Number of regional lymph nodes examined: 0. pMX. MARGINS: Margin(s) involved by invasive carcinoma. Renal vein margin. ADRENAL GLAND: Not present. VENOUS (LARGE VESSEL) INVASION (V): Present. LYMPHATIC (SMALL VESSEL) INVASION (L): Present. ADDITIONAL PATHOLOGIC FINDINGS: Glomerular disease (type): GLOBAL FOCAL GLOMERULOSCLEROSIS. Interstitial disease (type): LYMPHOCYTIC INFILTRATE.",T3,N0,M0,T3N0M0
TCGA-43-7658,"SPECIMEN. A. Right upper lobe of lung. The entire specimen weighs 142.5. grams. B. Lymph node, station 7. C. Station 9 lymph node. CLINICAL NOTES. GROSS DESCRIPTION. A. Received fresh in a single container labelled with the. patient's name, medical record number and ""right upper. lobe"" is a single lobe of lung parenchyma that weighs 145.2 grams. and measures 16.8 X 7.5 X 2.7 cm. in greatest dimensions. A staple. line is present along the medial aspect of the specimen that. measures 12.8 cm. in length. The nodule is palpated in the. parenchyma that measures 2.1 X 1.7 X 1.8 cm. in greatest dimensions. The pleural surface overlying this nodule is attenuated with some. evidence of retraction. The pleural surface overlying this area is. inked black. The specimen is sectioned through the tumor. Representative tumor and surrounding normal tissue are submitted for. tissue procurement. Additional representative sections are taken. through the specimen. The cut surfaces show no additional mass. lesions with the exception of the tumor described above. Representative sections were taken for histology according to the. block summary: The block summary will be dictated later. Two extra. specimens are received. B. Lymph node, station 7. Received is a single fragment of. gray-tan tissue that measures 1.5 cm. in diameter. This. specimen is bisected and entirely submitted in block B. C. Station 9 lymph node. Received fresh in a single. container labelled with the patient's name, medical record. number and ""station 9 lymph node"" are multiple fragments of. yellow-orange fatty tissue that contain several lymph nodes. These. lymph nodes are entirely submitted in blocks C1 and C2. MICROSCOPIC DESCRIPTION. A. The sections of the mass lesion in the right upper lobe. of the lung shows a non-keratinizing poorly differentiated. squamous cell carcinoma, as described in the template below: Histologic type: Non-keratinizing squamous cell carcinoma. Histologic grade: G3, poorly differeniated. Primary tumor (pT) : pT1;2.1 X 1.7 X 1.8 cm in greatest dimensions. Margins of resection: The parenchymal, pleural, and bronchial. margins are free of tumor. Direct extension of tumor: Not identified. Venous (large vessel) invasion: Not identified. Arterial (large vessel) invasion: Not identified. Lymphatic (small vessel) invasion: Not identified. Regional lymph nodes (pN) : pN 0. No tumor is identified in a total. of eight (0/8) lymph nodes in parts A, B and C combined. Distant metastasis (pM) : Mx. Other findings: The tumor is well circumscribed from the. surrounding non-neoplastic pulmonary parenchyma and does not involve. the overlying pleura at all. Two hilar lymph nodes are identified. on the lobectomy specimen. No tumor is seen within the hilar. lymph nodes (0/2) . B. A single lymph node is present designated as ""station. 7"". No tumor is seen within this lymph node (0/1). C. A total of five lymph nodes are identified in the. station 9 specimen. No tumor is seen within these five. lymph nodes (0/5) . 5,3x2. DIAGNOSIS. A. Lung, right upper lobe, lobectomy : Poorly differentiated non-keratinizing squamous cell. carcinoma; margins free of tumor (see report). No tumor seen in two lymph nodes (0/2) . B. Station 7 lymph nodes, removal: No tumor is seen in one lymph node (0/1) . C. Station 9 1 ymph nodes, removal: No tumor is seen in five lymph nodes (0/5). End Of Report ---.",T1,N0,M0,T1N0M0
TCGA-E2-A10B,"SPECIMENS: A. BREAST CA INFERIOR LEFT BREAST. B. SENTINEL LYMPH NODE #1. C. SENTINEL LYMPH NODE #2. D. COMPLETE AXILLARY CONTENTS-LEFT. SPECIMEN(S): A. BREAST CA INFERIOR LEFT BREAST. B. SENTINEL LYMPH NODE #1. C. SENTINEL LYMPH NODE #2. D. COMPLETE AXILLARY CONTENTS-LEFT. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA: Breast cancer, inferior, left breast: One mass measures 3.8 x 3.4 x 2.6 cm. The mass is 0.3 cm. from medial margin and 0.3 cm from lateral margin. called to. at. TPB. Sentinel lymph node #1: Metastatic carcinoma. By Dr, called to Dr. at. GROSS DESCRIPTION: A. BREAST CA INFERIOR LEF BREAST. Received fresh labeled with patient name designated ""a. breast ca inferior left breast"" is a portion of. resected breast tissue weighing 50 gm and measuring 6.0 x 4.0 X 3.5 cm. The overlying beige-tan. ellipse of skin measures 5.0 X 3.0 cm. The surface of the skin has a thickened rough appearance. The. specimen is received with orientation, the single suture designating anterior, double-lateral and triple-. superior. Specimen is inked as follows: superior-red, inferior-orange, posterior-black, medial-green,. lateral-yellow. The specimen is serially sectioned from superior to inferior. Cut section shows a firm ill. defined beige-tan mass measuring 3.8 X 3.4 x 2.6 cm approaching the closest medial margin at. distance of 0.3 cm and lateral margin at distance of 0.3 cm. The skin appears grossly involved by the. lesion. The remainder of the specimen shows dark yellow lobulated adipose tissue with focal areas of. firm white fibrous parenchyma. A portion of the specimen is submitted for tissue procurement. Representative sections are submitted as follows: A1-A2: slice 1, bisected serial section of the mass and skin with lateral and medial margins. A3-A4: sections of inferior margin with skin, slice 1. A5-A6: slice 2 additional lesion and skin with medial and lateral margins. A7-A8: slice 2 additional sections of lesion with lateral and posterior margins. A9-A14: slice 3 totally submitted. A15-A18: slice 4 entirely submitted. A19-A20: perpendicular sections superior margin. B. SENTINEL LYMPH NODE #1. Received fresh labeled with the patient name designated ""b. sentinel lymph node #1"" are 2 firm lymph. nodes measuring 0.9 x 0.6 x 0.5 cm and 0.8 x 0.5 x 0.5 cm. Both lymph nodes are bisected to show. white cut surface. Touch preps are performed. Both lymph nodes are entirely submitted in cassettes. B1-B2. C. SENTINEL LYMPH NODE #2. Received fresh labeled with the patient name designated ""c. sentinel lymph node #2"" is a fragment of. firm yellow-tan fibroadipose tissue measuring 5.0 x 1.5 x 0.5 cm. The entire specimen is submitted in. cassettes C1-C2. D. COMPLETE AXILLARY CONTENTS-LEFT. Received in formalin in a container labeled with patient name designated ""d. complete axillary contents-. left"" is a portion of yellow-tan fibroadipose tissue measuring 9.4 x 6.2 x 3.1 cm. Multiple possible lymph. nodes are identified ranging in size from 2.2 X 0.5 x 0.5 to 0.2 X 0.1 X 0.1 cm. Cassettes are submitted. as follows: D1: 2 possible lymph nodes. D2:3 possible lymph nodes. D3; 3 possible lymph nodes. D4: 3 possible lymph nodes. D5-D15: multiple additional possible lymph nodes. DIAGNOSIS: A. BREAST, LEFT INFERIOR, EXCISIONAL BIOPSY: INVASIVE, DUCTAL CARCINOMA, SBR GRADE 3, MEASURING 2.6-CM,. INVOLVING FIBROADENOMA AND EXTENDING INTO SUPERFICIAL DERMIS. - INTERMEDIATE, NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, WITH. CENTRAL NECROSIS, CRIBRIFORM AND SOLID TYPES. - TUMOR PRESENT WITHIN 1 MM FROM MEDIAL, LATERAL, AND SUPERIOR. SURGICAL RESECTION MARGINS. - PERINEURAL INVASION AND FOCAL LYMPHOVASCULAR INVASION. IDENTIFIED. FIBROCYSTIC CHANGES WITH FIBROSIS AND SCLEROSING ADENOSIS. - SEE SYNOPTIC REPORT. B. LYMPH NODE, SENTINEL #1, LEFT, BIOPSY: METASTATIC CARCINOMA TO TWO OF TWO LYMPH NODES (2/2),. LARGEST MEASURING 0.8 CM, WITH FOCAL EXTRANODAL EXTENSION. C. LYMPH NODE, SENTINEL #2, LEFT, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). D. LYMPH NODES, LEFT AXILLARY CONTENTS, EXCISIONAL BIOPSY: - TWENTY FIVE LYMPH NODES, NEGATIVE FOR METASTASES (0/25). SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Left. Invasive tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2.6cm. Tumor site: Not specified. Margins: Negative. Distance from closest margin: 0.1cm. medial lateral and superior. Tubular score: 3. Nuclear grade: 2. Mitotic score:3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Absent. Vascular/Lymphatic Invasion: Present. Extent: focal. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node and axillary dissection. Lymph node status: Positive 2 / 28. DCIS present. Margins uninvolved by DCIS: DCIS Quantity: Estimate 5%. DCIS type: Solid. Cribriform. DCIS location: Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Present. ER/PR/HER2 Results. ER: Pending. PR: Pending. HER2: Pending. Pathological staging (pTN): pT 2 N 1a. CLINICAL HISTORY: Left breast cancer invading skin. PRE-OPERATIVE DIAGNOSIS: Left breast ca. ADDENDUM: SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: A1. ER: Positive. Allred Score: 8 = Proportion score: 5 + Intensity Score 3. PR: Positive Allred Score: 8 = Proportion Score 5 + Intensity Score 3. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score of. less than or equal to 2. Methodology: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin (. ) for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Mouse anti-human ER and PR,. Comment: This assay can be used to select invasive preast cancer patients for hormone therapy (1). ER and PR analysis was performed on this case by immunohistochemistry utilizing the ER (ER 1D5,. 1:100) and PR (PGR 136, 1:100) antibody provided by. following the manufacturer's instructions. listed in the package insert. This assay was not modified, and adherence to all instruction and. guidelines were strictly followed. Interpretation of the ER/PR immunohistochemical staining. characteristics is guided by published results in the medical literature (1), information provided by the. reagent manufacturer and by internal review of staining performance within the Pathology Department. 1. Harvey JM, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding. assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 17:1474-. 1481, 1999. SYNOPTIC REPORT - BREAST HER-2 RESULTS. HER2 Status Results, Immunohistochemistry Evaluation. Specimen: Surgical Excision. Block Number: A1. Interpretation: EQUIVOCAL. Intensity: 2+. % Tumor Staining: 10%. Fish Ordered: Yes, on Date. METHODOLOGY. Methodoloav: Fixation Type and Length: Tissue was fixed in 10% neutral buffered formalin (. ) for no less than 8 and no longer than 24 hours. Antibody and Assay Methodology: Rabbit anti-human HER2, HerceptestTM (FDA-approved test kit),. Control. Slides Examined: External kit-slides provided by manufacturer (cell lines with high, low and negative. HER2 protein expression), and in-house known HER2 amplified control tissue were evaluated along. with the test tissue. These control slides run along side of this patient's sample showed appropriate. staining. Adequacy of Specimen: Adequate, well preserved, clear-cut invasive carcinoma identified for. HER2 evaluation. Scoring Criterion and Scoring System: IHC Level of Expression(Score) /Tumor Cell Membrane Staining Pattern. Negative (0)/Absence of Staining. Negative (1+)/Faint Incomplete membrane Staining, 10% of Cells. Equivocal (2+)/Weak complete membrane Staining, >10% of Cells. Positive (3+)/Strong complete membrane Staining, >10% of Cells. Equivocal Category for HER2 IHC results: A HER2, 2+ staining result that is interpreted as equivocal. may not indicate gene amplification. A FISH test for HER2 gene amplification will be ordered for all. HER2 IHC 2+ results. COMMENT. This assay can be used to select invasive breast cancer patients for Trastuzumab (Hereptin) therapy. (1,2). Clinical Trials have shown that Trastuzumab substantially increases the likelihood for an objective. response and overall survival for patients with metastatic HER2-positive breast cancer, regardless of. whether HER2 tumor status was determined as IHC 3+ or FISH positive. Trastuzumab added to. adjuvant chemotherapy substantially increase disease-free survival and decreases the risk of disease. recurrence by about 50% for patients with early-stage HER2 protein over-expressed or gene amplified. invasive breast cancer (3). HER2 analysis was performed on this case by immunohistochemistry utilizing the FDA approved. HercepTest (TM) test kit following the manufacturer's instructions listed in the package insert. This. assay was not modified, and adherence to all instruction and guidelines were strictly followed. Interpretation of the HER2 immunohistochemical staining characteristics is guided by published results. in the medical literature (4), information provided by the reagent manufacturer and by internal review of. staining performance within the Pathology Department. HER2 TEST VALIDATION. This HER2 immunohistochemical assay has been validated according to the recently revised. recommendations and guidelines from the NCCN HER2 testing in Breast Cancer Task Force, and the. jointly issued recommendations and guidelines from ASCO and the CAP (5). 80 randomly selected. breast cancer samples were tested for HER2 by IHC as outline above and interpreted as, negative. (score 0/1+) equivocal (score 2+) and positive (score 3+) without knowledge of the previous reported. results. These cases were also blindly read using two different FISH assay as amplified or non-amplified and. the HER2/CEP17 ratios were recorded. After analyzing these results, there was 100% concordance. between the IHC and FISH results for cases that were interpreted as either positive or negative by IHC. 9 of the 80 cases were interpreted as equivocal by IHC and of these 3/9 (33%) were non-amplified by. FISH and 6/9 (66%) were found to be amplified. The Pathology Department Immunohistochemistry laboratory takes full responsibility for this tests. performance and has programs in place to regularly monitor the proficiency and the interpretation of. HER2 assays. The laboratory also participates in external quality assurance HER2 programs including. the CAP proficiency testing program. REFERENCE. 1. Carlson RW, Anderson BO, Burstein HJ, et al., NCCN breast cancer clinical practice guidelines in. oncology. J Natl Compr Canc Netw. 2005;3:238-289. 2. Carlson RW, Brown E, Burstein HJ, et al., NCCN Task Force Report: adjuvant therapy for breast. cancer. J Natl Compr Canc Netw. 2006;4:S1-S26. 3. Romond EH, Perez EA, Bryant J, et al. Trastuzumab plus adjuvant chemotherapy for operable. HER2-positive breast cancer. N Eng J Med 2005;353(16):1673-84. 4. Leong ASY, Formby M, Haffajee Z, et al. Refinement of immunohistologic parameters for Her2/neu. scoring validation by FISH and CISH. Appl Immunohistochem Mol Morphol. 2006;14:384-389. 5. Wolff AC, Hammond EH, Schwartz JN, et al., American Society of Clinical Oncology/College of. American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Recepto 2. Testing in Breast Cancer. Arch of Path and Lab Med 2007; 131:18-43. PathVysion HER-2 DNA Probe Kit. Analytical Interpretation of Results: HER-2 NOT AMPLIFIED. Clinical Interpretation of results. Amplification of the HER-2 gene was evaluated with interphase fluorescence in-situ. hybridization (FISH) on formalin-fixed paraffin embedded tissue sections using a chromosome. 17 centromeric probe and a HER-2 probe that spans the entire HER-2 gene in the. A majority of tumors cells displayed 2 chromosome 17. signals and 2 HER-2 signals, with a HER-2/CEP 17 Ratio </=2.0, consistent with no. amplification of the HER2/neu gene. Block used A1. Source of case: RPCI. Tissue fixation. formalin-fixed tissue. Outside Case No: NA. Tissue source. breast Results interpreted: HER2/CEP17 ratio: 1.11. This ratio is derived by dividing the total number of LSI HER-2/neu signals by the total number of. CEP17 signals in at least 20 interphase nuclei with nonoverlapping nuclei in the neoplastic. mammary epithelial cells. Cells with no signals or with signals of only one color are disregarded. Method of ratio enumeration: manual count. Limitations. The Vysis PathVysion Kit is not intended for use to screen for or diagnose breast cancer. It is. intended to be used as an adjunct to other prognostic factors currently used to predict disease-free. and overall survival in stage II, node-positive breast cancer patients. In making decisions regarding. adjuvant CAF treatment, all other available clinical information should also be taken into. consideration, such as tumor size, number of involved lymph nodes, and steroid receptor status. treatment decision for stage II, node-positive breast cancer patients should be based on HER-. 2/neu. gene amplification status alone. Overview of this test. FDA APPROVED REAGENT. PathVysion HER-2 DNA Probe Kit is FDA approved for selection of. patients for whom Herceptin therapy is being considered. These tests were performed in the. under the direction. of Dr.. The results of these studies should always be interpreted in the context of the. clinical, morphological, and immunophenotypic diagnosis. Microscopic/Diagnostic Dictation:. Pathologist,. Final Review: Pathologist. Final: Pathologis. Addendum: Pathologist,. Addendum Final:. Pathologist. Addendum: Pathologist,. Addendum Final:., Pathologist,.",T2,N1,M0,T2N1M0
TCGA-D6-8569,"Unit in charge: L -. Clinical diagnosis (suspicion): Tumour of the tongue and floor of the mouth, left side. Date of admission: (urgency: Standard). Material: 1). Material: mouth - tongue. Method of collection: Please examine the marked margin. Method of collection: Collection. of specimens for direct examination. Histopathological diagnosis: Carcinoma planoepitheliale keratodes invasivum linguae. G2, pT2. Invasive keratinizing squamous carcinoma of the tongue. Macroscopic description: Surgical segment sized 3.5 X 3 X 1.5 cm with the tumour sized 2.4x2x0.9cm. Microscopic description: Carcinoma planoepitheliale keratodes invasivum G2. Minimum margin of healthy tissues to the side of the surgical specimen: 0.4 cm Minimum margin of healthy tissues. from the base of the surgical specimen: 0.6 cm. No proliferation into vessels and nerve stems found. Pathologist: : Result of intraoperative examination. 1-4 No neoplastic lesions found. Final reply to be given after full material is developed.",T2,N0,M0,T2N0M0
TCGA-67-3771,"PRIORITY: FROZEN SEC. SURGICAL PROCEDURES: LUNG-LOBECTOMY, REGIONAL LYMPH. CRINICAL HISTORY. PERTINENT CLINICAL HISTORY: LEFT LUNG CA. GROSS DESCRIPTION. A. The specimen is submitted fresh for frozen section as ""level 5"" and. consists of a red black 1.9 cm nodule; bisected and submitted in toto,. 2 (1) labeled ""FSP"" for frozen section. A touch prep has been taken. FROZEN SECTION DIAGNOSIS: Node negative for tumor. B. The specimen is submitted fresh for frozen section as ""level 6"" and. consists of two black nodular segments measuring 0.6 cm and 1.8 cm in. dimension; each is bisected and submitted in toto 4 (1) labeled ""FSP"" for. frozen section. A touch prep has been taken. FROZEN SECTION DIAGNOSIS: Nodes negative for tumor. C. The specimen is submitted fresh for frozen section as ""level 9L"" and. consists of a pink red 1.1 cm nodule; bisected and submitted in toto, 2. (1) and labeled ""FSP"" for frozen section. A touch prep has been taken. FROZEN SECTION DIAGNOSIS: Nodes negative for tumor. D. The specimen is submitted fresh for TCGA study as ""left upper lobe. (time of resection 2:01) "" and consists of a lobe of lung weighing 162. grams and measuring 23 x 9 x 2 cm. The pleural surface is deep red purple. and reticulated by carbon pigment with a firm puckered 2 x 2 cm area along. the lateral apex. There is an adjacent 2 x 2 cm roughened focally. hemorrhagic area. The hilum exhibits a 4.5 cm staple line. Removal of. the staple line reveals two segments of bronchi measuring approximate 1 cm. GROSS DESCRIPTION. each in diameter and four vessel margins varying 0.3 cm to 0.5 cm in. diameter. Several grey black friable nodules are clustered about the. hilum. Sectioning reveals a 2.5 X 2.5 x 1.8 cm yellow tan tumor which. appears to abut the puckered area of the pleura previously described and. is 4 cm from bronchial margin. The adjacent roughening corresponds to the. diffusely thickened pleura measuring up to 0.3 cm in maximum thickness. The pulmonary parenchyma distal to the tumor is deep red and honeycombed. The remaining pulmonary parenchyma is deep red and airless. Representative sections are submitted, multiple (9) : Cassette 1: Bronchial margin. Cassette 2: Vessel margin. Cassette 3: Nodules clustered about the hilum. Cassettes 4 - 6: Tumor (pleural surface; black). Cassette 7: Thickened pleural area. Cassette 8: Representative pulmonary parenchyma distal. to the tumor. Cassette 9: Representative uninvolved pulmonary. parenchyma. Please note: A tumor sample is collected and submitted for TCGA studies. E. The specimen is submitted fresh as ""anterior hilar node"" and consists. of a soft red black tissue fragment measuring 1.5 x 1 x 0.3 cm. The. specimen is submitted in toto, 1 (1). F. The specimen is submitted fresh as ""posterior hilar node"" and consists. of a soft red black tissue fragment measuring 1.3 x 1 x 0.3 cm. The. specimen is wrapped in tissue paper and submitted in toto, 1 (1). G. The specimen is submitted fresh as ""lobar node"" and consists of a soft. red black tissue fragment measuring 0.6 x 0.5 X 0.2 cm. The specimen is. wrapped in tissue paper and submitted in toto, 1 (1). H. The specimen is submitted fresh as ""interlobar node (sump) "" and. consists of three red black tissue fragments ranging 0.6 to 0.8 8 cm in. dimension. The specimen is wrapped in tissue paper and submitted in toto,. 3 (1). I. The specimen is submitted fresh as ""lingular node"" and consists of two. soft friable red black tissue fragments measuring 0. 6 and 0.8 cm in. dimension. The specimen is wrapped in tissue paper and submitted in toto,. 2 (1). FIVAS DIAGNOSIS. A. LYMPH NODE, LEVEL 9: LYMPH NODE, NEGATIVE FOR TUMOR. B. LYMPH NODE, LEVEL 6: TWO LYMPH NODES, NEGATIVE FOR TUMOR. C. LYMPH NODE, LEVEL 9: LYMPH NODE, NEGATIVE FOR TUMOR. D. LUNG, LEFT UPPER LOBE, LOBECTOMY: ADENOCARCINOMA. SEE SYNOPTIC REPORT. E. LYMPH NODE, ANTERIOR HILAR: LYMPH NODE, NEGATIVE FOR TUMOR. F. LYMPH NODE, POSTERIOR HILAR: LYMPH NODE, NEGATIVE FOR TUMOR. G. LYMPH NODE, LOBAR: LYMPH NODE, NEGATIVE FOR TUMOR. H. LYMPH NODE, INTRALOBAR (SUMP) : LYMPH NODE FRAGMENTS X 3, NEGATIVE FOR TUMOR. LYMPH NODE, LINGULAR: FRAGMENTS OF LYMPH NODES, NEGATIVE FOR TUMOR. SYNOPTIC REPORT. TUMOR SITE: LEFT UPPER LOBE. TUMOR SIZE: 2.5 CM. HISTOLOGIC TYPE: ADENOCARCINOMA. HISTOLOGIC GRADE: 2-3 (MODERATELY TO POORLY DIFFERENTIATED). EXTENT OF INVASION: CONFINED TO LUNG. EXTENTION TO PLEURA/OTHER STRUCTURES (SPECIFY) : NONE IDENTIFIED. ADDITIONAL PERTINENT FINDINGS - NO ATELECTASIS OR PNEUMONIA IDENTIFIED. MARGINS: BRONCHIAL: UNINVOLVED. PARENCHYMAL: UNINVOLVED. VASCULAR: UNINVOLVED. DISTANCE TO PERTINENT MARGIN (s) : 4 CM TO BRONCHIAL MARGIN. VENOUS INVASION: ABSENT. ARTERIAL (LARGE VESSEL) INVASION: ABSENT. LYMPH NODE: fine N1 - # INVOLVED/# EXAMINED : 0/5+. N2 - # INVOLVED/#EXAMINED: 0/8+. fine N3 - # INVOLVED/# EXAMINED: 0/0. OTHER PERTINENT FINDINGS: - NO VISCERAL PLEURAL INVASION IDENTIFIED. pTNM STAGE: pT1 NO. GROSS DESCRIPTION. Slide 32.5 CC Fluid. X Fresh. Fixed. Type Fix. Volume may reflect total of specimen, fixative, and/or collection fluid. APPEARANCE: X Clear. Cloudy. Foamy. Bloody. Clotted. Tissue. Color COLORLESS. PREP: 6 Smear (s). Diff Quick (s). Filter (s). 2 Cell Block (s). Cytospin (s) - 2 Singles (s). Double (s). H&E. Unstained. Comment : FINAL DIAGNOSIS. LEFT UPPER LUNG, LEFT UPPER LOBE (FINE NEEDLE ASPIRATION BIOPSY) : POSITIVE FOR MALIGNANT CELLS. NON SMALL CELL CARCINOMA WITH FEATURES OF ADENOCARCINOMA OF THE LUNG. IMMUNOHISTOCHEMISTRY FOR CYTOKERATIN 7 IS POSITIVE, AND CK20, CK5/6,. AND P63 ARE NEGATIVE. TTF-1 IS ALSO NEGATIVE, AND RESULTS OF REPEAT. TTF-1 WILL BE ISSUED AS AN ADDENDUM. INTRADEPARTMEN'TAL CONSULTATION:",T1,N0,M0,T1N0M0
TCGA-ZH-A8Y1,"Diagnosis: A: Liver lesion, ""Level 5"", excision. - Adenocarcinoma, moderately differentiated, of intrahepatic. bile ducts (primary hepatic cholangiocarcinoma), 4.5 mm. - Carcinoma is less than 1 mm from inked parenchymal margin. - Dysplasia of the intraductal biliary epithelium (see comment). B: Liver, Segment 8, excision. - Adenocarcinoma, moderately differentiated, of intrahepatic. bile ducts (primary hepatic cholangiocarcinoma), at least two. separate foci by gross examination, 0.4 and 0.8 cm. - Inked parenchymal margin (definitive margin) positive for. carcinoma (B2). - Dysplasia of the intraductal biliary epithelium and. intraductal biliary papillary carcinoma in situ, mutlifocal. C: Liver, Segments 2-5, partial hepatectomy. Adenocarcinoma, moderately differentiated, of intrahepatic. bile ducts (primary hepatic cholangiocarcinoma), at least 11.2. cm by gross measurement. - Dysplasia of the intraductal biliary epithelium and. intraductal biliary papillary carcinoma in situ, mutlifocal. - Inked parenchymal margin is extensively positive for invasive. carcinoma (C1). - Bile duct margin is positive for dysplasia (C9). Invasive carcinoma extends into perihepatic fibroadipose. tissue. - Lymphovascular space invasion is identified. - AJCC stage: pT3 pN1 (see comment). D: Lymph nodes, perihepatic, excision. - One of eleven lymph nodes positive for metastatic. adenocarcinoma (1/11). - Size of metastasis is 0.6 cm. - Extracapsular extension identified. Comment: The liver displays a spectrum of intraductal biliary neoplasia. In some bile duct profiles the epithelium is dysplastic without. papillary structure formation. In other bile duct profiles,. intraductal biliary papillomatosis is present as multifocal. papillary lesions. Intraductal papillary carcinoma is. considered to be to be the in situ lesion for the invasive. cholangiocarcinoma, and is related to the pancreatic intraductal. mucinous neoplasm. Dysplasia of the bile duct epithelium without. papillomatosis most likely is part of the same neoplastic. process in this case. The invasive tumor does not have papillary. architecture, and is a conventional gland-forming. adenocarcinoma. Invasive carcinoma is present as large mass. lesions/nodules (mass forming subtype). Extensive peri-ductal invasion (carcinoma spread along intact. biliary tree) is not identified. The tumor is staged as a. pathologic T3 because of invasion into perihepatic fibroadipose. tissue at the round ligament. Clinical History: -year-old female with intrahepatic malignant neoplasm. consistent with cholangiocarcinoma. Gross Description: Received are four formalin-filled containers. Container A is additionally labeled ""Level 5 liver lesion. "" It. holds a 0.8 X 0.7 X 0.4 cm wedge-shaped fragment of gray/tan. liver which is partially covered with a smooth capsule. The. parenchymal surface is inked black and the specimen is. sectioned to reveal a 0.5 X 0.4 X 0.3 cm circumscribed white. subcapsular nodule abutting the black inked parenchymal margin. The specimen is serially sectioned and entirely submitted in. block A1,. Container B is additionally labeled ""Segment 8 liver. "" The. requisition states: stitch marks definitive segment 8 margin. It holds a 3.1 gram, 2.4 X 2.2 X 1.7 cm friable fragment of. liver tissue with two sutures present on one surface. designating definitive margin. This surface is inked black, and. the opposite surface is inked red for identification purposes. The specimen is sectioned perpendicular to the black inked. margin and entirely submitted in blocks B1-B5. Sectioning reveals two white circumscribed nodules which are 0.4. and 0.8 cm in greatest dimension. Each nodule abuts the red. inked margin opposite the sutured margin. The smaller nodule. comes within 0.2 cm of the black inked sutured margin. (B3) , and the larger nodule comes within 0.3 cm of the black. inked sutured margin (B1). Block Summary : B1-B5,. Container C is additionally labeled ""Liver, Segments 2-5. "" It. consists of a 545 gram, 18 X 13 X 5 cm partial hepatectomy. specimen composed of Segments 2-5. The capsule is brown/gray,. focally plaque-like. The parenchymal margin is inked blue. There. is a small amount of attached fat along the inferior edge of. Segment 5. Along the medial edge of the parenchymal margin there. is a 3.4 X 2.9 cm fragment of fibromembranous tissue and. cauterized fat. This area is adherent upon the capsule. Sectioning demonstrates a dominate nodule surrounded by. multiple butting nodules off its edge and within the remainder. of the parenchyma. The dominate nodule is 11.2 X 9.8 X 4.4 cm. The smaller nodule within the parenchyma and subcapsular range. from 0.1 to 4 cm in greatest dimension. The closest approach to. the parenchymal margin (inked black) is 0.2 cm. The tumor has a. solid gritty yellow/tan cut surface with areas of firm,. white tissue at the periphery. The surrounding hepatic. parenchyma is homogeneous tan/gray with no micronodular pattern. identified. Tumor and normal are given to Tissue Procurement. Block Summary: C1 - tumor nodules at closest approach to black inked. parenchymal margin. C2-C3 - fibromembranous tissue adherent near surgical margin. C4-C5 - additional section near adherent fatty tissue at round. ligament insertion. C6 - edge of tumor and large caliber lumina. C7-C8 - additional sections of tumor. C9-C11 - additional sections, en face, from surgical margin,. lumina. Container D is additionally labeled ""perihepatic lymph node.' It. consists of a 3.7 X 2.6 X 1.5 cm aggregate of cauterized. yellow/tan fibrofatty tissue which is dissected for lymph node. candidates. Lymph node candidates up to 3.1 cm in greatest. dimension are identified. Block summary : D1 - four lymph node candidates. D2 - two lymph node candidates. D3 - one bisected lymph node candidate. D4-D5 - - one sectioned lymph node candidate. A small amount of fat remains in formalin.",T3,N1,M0,T3N1M0
TCGA-G4-6626,"SPECIMENS: A. RIGHT COLON, TERMINAL ILEUM. DIAGNOSIS: A. RIGHT COLON, TERMINAL ILEUM, RIGHT HEMICOLECTOMY: - INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA OF THE. COLON, WITH INVASION INTO SUBSEROSAL ADIPOSE TISSUE (4.2X3X0.7. CM). - ALL SURGICAL MARGINS OF EXCISION, NEGATIVE FOR NEOPLASM. - SEPARATE TUBULOVILLOUS ADENOMA, ADJACENT TO THE APPENDICEAL. ORIFICE. - APPENDIX WITH FIBROUS OBLITERATION OF THE DISTAL PORTION. - PORTION OF TERMINAL ILEUM WITH NO SIGNIFICANT PATHOLOGIC. CHANGES. - SIXTEEN MESENTERIC LYMPH NODES, NEGATIVE FOR MALIGNANCY. (0/16). - SEE TEMPLATE. COLORECTAL CANCER TEMPLATE. Specimen Type: Right hemicolectomy. Tumor Site: Right (ascending) colon. Tumor Configuration: Ulceration. Tumor Size: 4.2x3x0.6cm. Histologic Type: Adenocarcinoma. Histologic Grade: G2: Moderately differentiated. Extent of Invasion: Subserosa. Margins: Margins uninvolved by invasive carcinoma (proximal. distal, radial). Venous/Lymphatic Invasion: Absent. Perineural Invasion: Absent. Additional Pathologic Findings: Adenoma. Extent of Resection: R0: Complete resection with grossly and. microscopically negative margins. Lymph Nodes: Negative (0/16). Implants: Absent. Pathologic Stage: pT3a NO Mx. SPECIMEN(S): A. RIGHT COLON, TERMINAL ILEUM. CLINICAL HISTORY: Not given. GROSS DESCRIPTION: A. RIGHT COLON, TERMINAL ILEUM. Received fresh for tissue procurement is a segment of terminal ileum with attached right colon. The. terminal ileum is 4 cm in length and 4 cm in circumference and is grossly unremarkable. A segment of. the right colon is 25 cm in length and 9.5 cm in maximum circumference. The serosal surface is tan-. pink, smooth and grossly unremarkable. The attached appendix is 7 cm in length and 0.4 cm in. diameter and shows unremarkable external and cut surfaces. The specimen is opened and shows a. 4.2. X 3 X 0.6 cm tumor mass with central ulceration located at the mid portion of the right colon at 8 cm. from the closest (distal margin) and 12.5 cm from the ileo-cecal valve. This lesion involves the portion. of the colon which is not covered with serosa. It invades through the muscularis into the subserosa. A. second polypoid lesion is identified in the area corresponding to the base of the appendix. This lesion. measures 2.5 X 2.3 X 0.7 cm. Sectioning shows the lesion to be confined to the mucosa without definite. evidence of invasion. The remainder of the colon shows an unremarkable tan pink mucosa. Throughout the pericolic adipose tissue, multiple presumptive lymph nodes are identified ranging. between 0.3 and 0.6 cm in greatest dimension. All the lymph nodes and representative sections of the. specimen are submitted as follows: A1: appendix. A2: proximal margin. A3: distal margin. A4-7: sections of tumor. A8-12: sections of cecal polypoid mass in the area of the appendiceal orifice. A13: uninvolved colon proximal to the tumor. A14: uninvolved colon distal to the tumor. A15-16: lymph node underlying the tumor. A17-18: lymph node from the ileocecal artery region. Tissue procurement was performed on the specimen. Gross photographs are taken of the specimen.",T3,N0,M0,T3N0M0
TCGA-H2-A3RH,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Thyroid, total thyroidectomy: Papillary carcinoma, follicular. variant of the left lobe, organ confined and completely resected. Single ipsilateral focus of papillary microcarcinoma also present. Right lobe of thyroid with multinodular goiter. B. Central cervical nodes, dissection: 3 lymph nodes all negative for. metastatic disease, 0/3. Microscopic Description: A, B. The. right lobe of this thyroid contains several benign nodules. consistent with multinodular goiter. The left lobe contains a. follicular variant of papillary carcinoma, measuring 1.7 cm in maximum. dimension. It discloses nuclear clearing, nuclear grooves and psammoma. bodies. It is mostly but not entirely encapsulated. Nearby, there is. a. 0.3 mm satellite focus of papillary microcarcinoma. The tumor is. origan confined and completely resected. Histologic type: Papillary carcinoma, follicular variant. Primary tumor (pT) : pTlb. Margins of resection: Negative. Vascular invasion: Negative. Regional lymph nodes (pN) : As per part B., all 3 lymph nodes are. negative for metastatic disease, 0/3, pNO. Distant metastasis (pM) : pMO. Other findings: Multinodular goiter within right lobe. Within the left. lobe a 2nd focus of papillary microcarcinoma is noted. Specimen. A. Total thyroid silk right upper pole. B. Central cervical node dissection. Clinical Information. Papillary cancer of thyroid. Gross Description. A. Received fresh for frozen section labeled ""total thyroid"" is an. 11.7 g, roughly symmetrical total thyroidectomy with right and left. lobes averaging 3.9 x 3.1 x 1.2 cm. The capsule is delicate tan-pink. without identifiable lymphoid or parathyroid tissues posteriorly. The. right lobe is inked blue and the left lobe is inked black. A. well-circumscribed, 1.7 x 1.3 x 1.0 cm rubbery pale tan nodule is. present within the superior pole of the left lobe. The nodule extends. to within 0.1 cm of the capsular surface. A representative section is. submitted for Tissue Procurement. The remaining parenchyma throughout. the specimen is beefy red-hrown with a few additional pale tan nodules. measuring up to 0.8 cm. Summary: 1 through 4 - right lobe, superior to inferior; 5 through 9 -. left lobe, superior to inferior. B. Received fresh labeled ""central cervical node dissection"" is a 1.4. X 1.2 x 0.3 cm aggregate of soft, lobulated tan gold adipose tissue. 2. slightly rubbery tan-pink tissues in keeping with lymph nodes measuring. up to 0.3 cm are recovered. Summary: 1 - 2 lymph nodes; 2 - residual adipose tissue.",T1,N0,M0,T1N0M0
TCGA-BR-8289,"Microscopic Description. Diagnosis Details. Comments. STOMACH TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Fundus. Tumor size: 12 X 9 X 2.5 cm. Tumor features: None specified. Histologic type: Adenocarcinoma, intestinal type. Histologic grade: Poorly differentiated. Tumor extent: Adjacent structures (specify) -. Lesser omentum. Lymph nodes: 11/11 positive for metastasis. (Intraabdominal 11/11). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: mets to liver; HER2NEU 2+. Case ID.",T4,N3,M1,T4N3M1
TCGA-4Z-AA7M,"PRIMARY SITE: Bladder. 1 - ""Bladder + prostate"": High-grade urothelial carcinoma of the bladder characterized as follows: Measure of neoplasia in its major axis: 6.2 cm. Ulcerated and infiltrative neoplasia affecting all layers of the bladder and perivisceral. fat. Prostate, seminal vesicles, vas deferens, ureters and urethra free of neoplastic. involvement. Neural infiltration not observed. Lymphatic vascular invasion not detected. . Sanguineous vascular invasion not detected. Surgical margins free of neoplastic involvement. Ulcerated granulomatous cystitis. Acinar adenocarcinoma of the prostate associated, characterized as follows: Measure of neoplasia in its major axis: 0.5 cm. Located between the base and left mid-zone. Gleson score 6 (3+3). Neural infiltration not observed. . Lymphatic vascular invasion not detected. Sanguineous vascular invasion not detected. Surgical margins free of neoplastic involvement. Lymph nodes free of neoplastic involvement (0/3). 2 - ""Right pelvic lymphadenectomy"": Free of neoplastic involvement (0/6). 3 - ""Left pelvic lymphadenectomy"": Lymph nodes free of neoplastic involvement (0/19). PATHOLOGICAL STAGING. Topography. Morphology. Stage. Bladder, NOS. Transitional cell carcinoma, NOS. pT3 pNO.",T3,N0,M0,T3N0M0
TCGA-MQ-A4LP,"Result date: SPECIMEN DESCRIPTION. SPECIMEN DESCRIPTION. PERICARDIAL FAT & PLEURA. DIAPHRAGMATIC PLEURA. LEVEL 4 LYMPH NODE (TRACHEOBRONCHIAL). LEVEL 8 LYMPH NODE (PARAESOPHAGEAL). LEVEL 7 LYMPH NODE (SUBCARINAL). PLEURA. 6TH RIB,. PATHOLOGY NO. HOSPITAL ID. HOSPITAL NO.: ACCOUNT NO. : M. DATE RECEIVED: PHYSICIAN (S) : ACCN REQ. NO. : NOT GIVEN. DIAGNOSIS: A. PERICARDIAL FAT AND PLEURA, EXCISION: MALIGNANT MESOTHELIOMA, BIPHASIC,. INFILTRATING FIBROADIPOSE TISSUE WITH ASSOCIATED FIBRINOUS SEROSITIS. B. DIAPHRAGMATIC PLEURA: MALIGNANT MESOTHELIOMA, BIPHASIC INVADING. FIBROCONNECTIVE TISSUE WITH ASSOCIATED ORGANIZING FIBRINOUS PLEURITIS AND. HYALINE PLAQUE. C. LEVEL FOUR LYMPH NODE (TRACHEOBRONCHIAL), BIOPSY: MULTIPLE (FOUR). ANTHRACOTIC LYMPH NODES, NEGATIVE FOR METASTASES. D. LEVEL EIGHT LYMPH NODE (PARAESOPHAGEAL), BIOPSY: ONE ANTHRACOTIC LYMPH. NODE, NEGATIVE FOR METASTASIS. E. LEVEL SEVEN LYMPH NODE (SUBCARINAL), BIOPSY: MULTIPLE (14) ANTHRACOTIC. LYMPH NODES, NEGATIVE FOR METASTASIS. F. PLEURA, PLEURECTOMY: MALIGNANT MESOTHELIOMA, BIPHASIC, INFILTRATING. FIBROCONNECTIVE TISSUE. ADDENDUM: Special stains for immunohistochemistry are pending. An addendum. will be issued with these results. SPECIMEN: A. PERICARDIAL FAT & PLEURA. B. DIAPHRAGMATIC PLEURA. C. LEVEL 4 LYMPH NODE (TRACHEOBRONCHIAL). D. LEVEL 8 LYMPH NODE (PARAESOPHAGEAL). E. LEVEL 7 LYMPH NODE (SUBCARINAL). F. PLEURA. G. 6TH RIB,. OPERATION: RT THORACOTOMY, PLEURECTOMY. PRE-OP DIAGNOSIS: MESOTHELIOMA. POST-OP DIAGNOSIS: NOT GIVEN. CLINICAL DATA: NOT GIVEN. GROSS DESCRIPTION: Multiple parts. Part A, received fresh labeled pericardial fat and pleura. The specimen. consists of an irregular shaped portion of yellow lobulated glistening adipose. tissue admixed with tan-pink fibrous tissue measuring 27 cm x 11 cm x 2.5 cm. overall. One surface shows a glistening tan-pink membranous tissue. The. opposite shows multiple nodules and pleural plaques ranging in size from 0.6 to. 6 cm. Upon sectioning the nodules, the cut surface is tan-white firm and. nodular, in areas becoming more glistening and fleshy, focal areas of necrosis. are present. Representative sections are submitted in 5 cassettes. The. section is submitted for frozen tumor bank. Part B received fresh labeled diaphragmatic pleura. The specimen consists of. two fragments of soft tissue. The largest fragment is 15 cm x 8 cm x 1 cm in. maximum dimension, one surface is tan-pink and roughened with fibrous. adhesions, the opposite side shows tan-white firm nodules, and plaque which. range in size from 1 cm to 6 cm. Grossly, the mass does not appear to invade. the skeletal muscle tissue. The second fragment of tissue is composed of a. tan-pink glistening membranous tissue measuring 9 cm x 3.5 x 0.2 cm. The. specimen has some firm nodularity present. Representative sections submitted. as follows: Cassettes 1-4-largest fragment,. Cassette 5-second fragment. Part C received fresh labeled level 4 lymph node (tracheal bronchial), the. specimen consists of an irregular portion of anthracotically pigmented lymph. nodes and soft tissue measuring 3.5 x 1.2 x 1 cm. Specimen is submitted in. toto in two cassettes. Part D received fresh labeled level 8 lymph node. The specimen consists of a. tan-brown rubbery lymph node measuring 1.2 x 0.4 x 0.2 cm. Specimen is. submitted in toto in one cassette labeled D. Part E received fresh labeled level 7 lymph node (subcarinal) . The specimen. consists of multiple fragments of anthracotically pigmented lymph nodes. aggregating to 6 cm x 3 cm x 0.3 cm. Largest lymph node is fragmented,. measures 2.5 x 1.2 x 1 cm. One of the fragments is composed of a yellow-tan. calcified nodule measuring 0.6 x 0.4 x 0.3 cm. Summary of sections is as follows: Cassette 1-one lymph node,. Cassette 2-one lymph node,. Cassette 3-three lymph nodes,. Cassette 4-five lymph nodes,. Cassette 5-four lymph nodes. Cassette 6-five lymph nodes,. Cassette 7-largest lymph node, one half,. Cassette 8-second half of the largest lymph node. Part F received fresh labeled pleura. The specimen consists of tan-pink. glistening tissue on one surface, the opposite surface shows white-tan nodular. plaque, the specimen measures 25 cm x 13 cm x 0.5 cm overall. Multiple nodules. across this surface range in size from 0.1 to 12 cm, the 12 cm mass is a. tan-white firm plaque. Second fragment of tissue is composed of a portion of. soft tissue measuring 15 cm x 10 cm x 1 cm. One surface is tan-pink smooth and. glistening, the opposite shows fibrous adhesions, the entire surface has a. yellow-tan nodular plaque present. In addition, there is a separate tan-brown. nodular mass that has been incised in multiple areas measuring 4 cm x 2 x 1 cm. Representative sections are submitted in 5 cassettes. CPT CODE: PATHOLOGY NO. : HOSPITAL ID.: : HOSPITAL NO. : ACCOUNT NO. : M. DATE RECEIVED: PHYSICIAN (S) : ACCN REQ. NO. : NOT GIVEN. ADDENDUM REPORT. Immunohistochemical stain support the diagnosis of malignant mesothelioma as. the proliferating cells are positive with cytokeratin, Wilm's tumor marker,. calretinin, and thrombomodulin. They are negative with actin cytokeratin 5/6. SPECIMEN: A. PERICARDIAL FAT & PLEURA. B. DIAPHRAGMATIC PLEURA. C. LEVEL 4 LYMPH NODE (TRACHEOBRONCHIAL). D. LEVEL 8 LYMPH NODE (PARAESOPHAGEAL). E. LEVEL 7 LYMPH NODE (SUBCARINAL). F. PLEURA. G. 6TH RIB,. OPERATION: RT THORACOTOMY, PLEURECTOMY. PRE-OP DIAGNOSIS: MESOTHELIOMA. POST-OP DIAGNOSIS: NOT GIVEN. CLINICAL DATA: NOT GIVEN. CPT CODE: Completed Action List:",T3,N0,M0,T3N0M0
TCGA-66-2766,"Material examined: Left lung, among others. Clinical diagnosis and question. Colliquating squamous cell carcinoma of the left upper lobe. REPORT ON FINDINGS. Macroscopy. 1.) Inflated, fixed left lung measuring 17 x 14 cm at the base and up to 28 cm in length, central bronchus. resection plane located 3 cm proximal to the bifurcation of the upper lobe bronchus. At the hilus a 2.3 cm. mobile node with pale brownish-white section surfaces suggestive of a tumor. Pleural fissure obliterated in. middle third, at the junction of segment 3 with segment the parietal pleura shows an extensive 4 7 x 5.5 cm area. of adhesion. Under this is a centrally soft, but otherwise soft to moderately solid tumor, max. 1.0 cm in size,. pale brownish white at the margin, with a relatively clear and somewhat arcuate demarcation, the main mass. being in segments 3 and 2 and adjacent sections of the lingula, extending to the pleura in the region of the. adhesion and involvement of some nodes up to 2.5cm in size, especially at central sites, extending here right up. to the hilar resection surface. Narrowing of proximal upper lobe segmental bronchi by the tumor. Tumor spread. to the pleural fissure, lower lobe shows no macroscopic infiltration. Parenchyma in the tumor environment and. peripherally especially in segment 3 partly diffuse, partly patchy induration and of brownish-yellow color. Rest. of parenchyma especially in the subpleural region shows slight rarefaction in parts, accentuation of apical. lesions in segment 1, with lacunae or lacuna systems up to 0.5 cm here. In the lower lobe at the branch into the. bronchi of the basal group two grayish-black nodes up to 0.6 cm. 2.) Pleural tissue from repeat resection: flat or membranous tissue measuring 6.5 x 4 cm and up to 0.2 cm thick. Surface partly smooth, partly rough. 3.) Hilar LN (station 10) left: 1 cm lesioned grayish-black node. 4.) Pulmonary ligament LN (station 9) 1.5 cm fatty tissue with two nodes, 0.8 and 0,5cm in size. 5.) Paraesophageal LN (station 8) left: 1 cm node,. 6.) Subcarinal LN (station 7): 1.2 cm node with some surrounding tissue. 7.) Subaortic LN (aortopulmonary window) (station 5): two nodes with some surrounding tissue, 2.2 and 1.2 cm. in size. 8.) Low paratracheal LN (station 4) left: two lesioned grayish-black nodes or node parts, 1.4 and 1.3 cm in size,. the larger on the section surfaces with 0.3 cm hard yellowish area. 9.) Prevascular and retrotracheal LN (station 3) upper lobe vein: 1.2 cm node with some surrounding tissue. 10.) Hilar LN (station 10) right: 2 cm node. 11.) Paraesophageal LN (station 8) right: two lesioned nodes, 1.6 and 1 cm in size. 12.) Low paratracheal LN (station 4) right: 1.8 cm lesioned node or node part. On the section surfaces 0.3 cm. hard yellowish area. Examined: 1.) 2 sections of tumor with remaining parenchyma (partly with narrowed bronchial branches), with pleural. fissure, 2 sections of tumor with pleura or pleural adhesion., 2 sections of involved nodes with hilar resection. surface (color-marked), S3 peripheral, lower lobe node, S1 apical, central bronchus resection plane and. resection margins of vessels, hilar nodes (lamellated),. 2.) All material (lamellated),. 3.) - 12.) All material (in 4. nodes isolated, in 6., 8., 9. + 12. nodes halved in each case, in 7. larger preparation,. in 10. nodes multi-segmented),. 22 blocks, partly Elastica-van Gieson, PAS, diastase-PAS, decalcification. Microscopy. Description of histological and cytological findings omitted for capacity reasons. EVALUATION. Primary diagnosis/diagnoses: Large, central to peripheral bronchopulmonary, histologically poorly differentiated, large-cell and. polymorphocellular, nonkeratinizing squamous cell carcinoma of the upper lobe of the left lung. TNM. classification according to this picture pT2 pN2 V1 R0, stage MA. C 34.1; M 8070/3; 3. Secondary diagnosis/diagnoses: Tumor necrosis varying in extent with the formation of a lacuna. Chronic resorptive and organizing pneumonia. in the tumor environment and S3 periphery. Emphysematous stromal remodeling of lung parenchyma with. formation of small subpleural cysts in the apex. Suspected respiratory bronchiolitis. Pleural adhesion zones and. chronic fibrosing parietal pleuritis (sample 2.)). Lymph nodes with reactive follicular hyperplasia in some cases. (e.g. samples 6.), 8.) and 12.)), in some cases sinus enlargement and an overall rather minor anthracotic pigment. deposit. Remark/addendum: The main tumor mass lies in segments 3 and 2. Since the central segmental bronchi are tumor-free, it appears to. be a primarily peripheral carcinoma of the lung, which has invaded the pleura of the pleural fissure and the. adhesion zone, although at the latter site the tumor manifestation appears confined to the visceral layer. Most. lymph node metastases, some of which are rather large, are found in the hilus region. A micro-metastasis is. detected in sample. 8.), which explains the nodal classification pN2.",T2,N2,M0,T2N2M0
TCGA-CX-A4AQ,"Surgical Final Repor. Temporary Copy. Final Pathologic Diagnosis. A) LEVEL II, RIGHT NECK (DISSECTION): Fibroadipose tissue, negative for tumor. B) LEVEL IIB, RIGHT NECK (DISSECTION): One lymph node, negative for tumor (0/1). C) LEVEL III, RIGHT NECK (DISSECTION): Fibroadipose tissue, negative for tumor. D) SELECTIVE NECK DISSECTION, RIGHT (DISSECTION): Metastatic squamous cell carcinoma involving two of forty lymph nodes. (2/40). Salivary gland with chronic inflammation, negative for tumor. E) DEEP MARGIN (BIOPSY): Skeletal muscle, negative for tumor. F) MEDIAL MARGIN (BIOPSY): Squamous mucosa, negative for tumor. G) LATERAL MARGIN (BIOPSY): Squamous mucosa, negative for tumor. H) ANTERIOR MARGIN (BIOPSY): Squamous mucosa, negative for tumor. I) RIGHT FLOOR OF MOUTH (RESECTION): Poorly differentiated squamous cell carcinoma with basaloid features. (see synoptic report). Anterior, deep and posterior resection margins are positive for tumor. TNM Stage: pT2 N2b Mx. J) ANTERIOR MARGIN OF MANDIBLE (RESECTION): Bone, negative for tumor. SYNOPTIC REPORT. MACROSCOPIC. Specimen Type. Surgical Final Report. Temporary Copy. Location: /. Resection (specify type): Marginal Mandibulectomy. Tumor Site: Oral cavity. Tumor Size. Greatest dimension:2.4 cm. Additional dimensions:2.3 x 1.0 cm. MICROSCOPIC. Histologic Type. Carcinomas of the Upper Aerodigestive Tract. Basaloid squamous cell carcinoma. Histologic Grade. G3: Poorly differentiated. Pathologic Staging (p TNM) (see appropriate site below). Primary Tumor (pT): Lip and Oral Cavity. pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. Regional Lymph Nodes (pN): All Aerodigestive Sites Except Nasopharynx. pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in. greatest dimension. Specify: Number examined: 41. Number involved: 2 [One lymph node is at level I (measures 4cm) and the. other is at level III (measures 1.4cm)]. Distant Metastasis (pM). pMX: Cannot be assessed. Margins (check all that apply). Carcinoma in situ is identified but does not involve a margin. Margin(s) involved by tumor. Specify margins(s), if possible:Anterior, deep and posterior. Venous/Lymphatic (Large/Small Vessel) Invasion (V/L). Present. Perineural Invasion. Absent. Additional Pathologic Findings. Carcinoma in situ. Comment(s). Surgical Final Report. Temporary Copy. 1 attest I have personally reviewed the specimen/slides and agree with the above findings. Verified: Resident: Intraoperative Diagnosis. FS E1: Negative. FS F1: Negative. FS G1: Negative. FS H1: Negative. Clinical History. y/o male with T1N2AMo SCCA right floor of mouth with adherence to mandibular periosteum. Pre/Post-operative Diagnosis. T1NZAMO of floor mouth. Gross Anatomic Description. (Dictated by. or. ; Reviewed by. Specimens received in ten containers. Specimen A: Designated ""right neck level II"" is received in formalin labeled with the patient's name. and 'right neck level II"". Specimen consists of a fragment of yellow/ tan lobulated fibrofatty tissue. measuring 2 x 1.5 X 0.2 cm. Section code: A1 - single cassette, entire specimen bisected. Specimen B: Designated ""right neck level IIB"" is received in formalin labeled with the patient's name. and ""right neck level IIB"". Specimen consists of a fragment of yellow/ tan lobulated fibrofatty tissue. measuring 3.5 x 1.5 x 0.2 cm. Section code: B1-B2 - entire specimen. Specimen C: Designated ""right neck level III"" is received in formalin labeled with the patient's name,. MRN and ""right neck level III"". Specimen consists of a single fragment of yellow/ tan lobulated. fibrofatty tissue measuring 2.5 x 1.3 X 0.2 cm. Section code: C1-C2 - single cassette, entire specimen. Specimen D: Designated ""right selective neck dissection, short stitch level // long stitch level IV"" is. received fresh for Tumor Bank labeled with the patient's name and ""right selective neck dissection,. short stitch level I/ long stitch level IV"". Specimen consists of a 15 X 6.5 X 2.5 cm right neck. dissection consisting of sternocleidomastoid muscle, and lymph node levels 1-IV. The specimen is. oriented by suture (short = level I, long = level IV). The submandibular gland is not identified grossly. Surgical Final Report. Temporary Copy. The sternocleidomastoid muscle (7.5 X 4 X 1.8 cm) is red/ brown and adherent to adjacent lymph. nodes. The entire jugular vein (8 cm in length, 0.3 cm in diameter) has a smooth inner lining and is. grossly uninvolved by tumor. Level one contains a 4 X 2.2 X 1.5 cm lymph node. Measurements for. the lymph node - containing soft levels, are as follows: Level I = 8 X 6.0 X 2.5 cm. Level II = 6.5 X 3 X. 1.5 cm. Level III = 7 x 3 X 1.5 cm and level IV = 6 X 3 X 1.5, and level V = 2.0 X 2.0 X 1.5 cm. No. nodes are identified in level 2. Section code: D1-D2 - Representative sections of largest node in level 1; D3 - sternocleidomastoid. muscle; D4 - internal jugular vein from level III area; D5-D8 remainder of suspected nodes from level. I; D5 - bisected; D6 - bisected; D7 - bisected D8 - two suspected nodes; D9-D14 - suspected nodes. from level 3, D9 (one node bisected); D10 - one node trisected; D11 - two suspected nodes; D12 -. three suspected nodes; D13 - three suspected nodes; D14 - four suspected nodes; D15-D19 - level. IV nodes, D15 (bisected); D2-D21 - level V nodes. Specimen E: Designated ""deep margin"" is received fresh for intraoperative consultation and frozen. section on. and reported at. labeled with the patient's name and ""deep. margin"". Specimen consists of one fragment of red/ tan soft tissue measuring 0.5 X 0.3 X 0.2 cm. The. specimen is entirely frozen. Section code: E1 - frozen section control. Specimen F: Designated ""medial margin"" is received fresh for intraoperative consultation and frozen. section on. and reported at. labeled with the patient's name and ""medial. margin"". Specimen consists of one fragment of red/ tan soft tissue measuring 0.7 X 0.4 X 0.3 cm. The. specimen is entirely frozen. Section code: F1 - frozen section control. Specimen G: Designated ""lateral margin"" is received fresh for intraoperative consultation and frozen. section on. and reported at. labeled with the patient's name and ""lateral. margin"". Specimen consists of one fragment of red/ tan soft tissue measuring 2.2 X 0.2 X 0.2 cm. The. specimen is entirely frozen. Section code: G1 - frozen section control. Specimen H: Designated ""anterior margin"" is received fresh for intraoperative consultation and frozen. section on. at. and reported at. labeled with the patient's name and ""anterior. margin"". Specimen consists or one fragment of red/ tan soft tissue measuring 1.0 X 0.1 X 0.1 cm. The. specimen is entirely frozen. Section code: H1 - single cassette, frozen section control. Specimen I: Designated ""right floor of mouth, short stitch equals anterior/ long stitch equals posterior"". is received in formalin labeled with the patient's name and ""right floor of mouth, short stitch equals. anterior/ long stitch equals posterior"". Specimen consists of a red/ brown fragment of soft tissue. measuring 4.5 X 2.5 x 2.0 cm. There is a stitch to indicate the anterior portion and a long stitch to. indicate the posterior portion. On the superior/anterior aspect of the specimen, there is a gray/ tan. membranous fragment of tissue that measures 3. X 1.6 X 0.2 cm. Cut surface reveals a white/ tan. centrally located mass that measures 2.3 x 1 X 2.4 cm. The mass is 2.2 cm from the medial margin,. 0.8 cm from the lateral margin and abuts the anterior and posterior margins as well as deep and. mucosal margins. Specimen is serially sectioned. Inking code: Green - anterior; Black - posterior; Red - medial; Yellow - lateral; ; Blue - deep. Section code: 11 - medial margin, perpendicularly sectioned; 12 - lateral margin, perpendicularly. sectioned; 14-17 - remainder of specimen submitted from medial to lateral. Surgical Final Report. Temporary Copy. Location: ;. Specimen J: Designated ""anterior margin of mandible"" is received in formalin labeled with the. patient's name,. and ""anterior margin of mandible"". Specimen consists of a fragment of light tan. bone measuring 3 x 0.7 x 0.3 cm. Section code: J1-J2 - entire specimen, serially sectioned and entirely submitted after decalcification.",T2,N2,M0,T2N2M0
TCGA-A8-A07C,"Diagnosis: 1. and 2. Bifocal poorly differentiated invasive ductal carcinoma (tumor diameters: 2.8 and. 0.8 cm). Concluding tumor classification: NOS, G III, pT2(mult)NOLOVORO.",T2,N0,M0,T2N0M0
TCGA-HU-A4H5,"Stomach, total gastrectomy: Advanced gastric carcinoma. Muc2(-)/Muc5AC(+)/Muc6(+)/CD10(++)/cERB2(-),GI(I) type). 1. Location : upper third, Center at fundus and posterior wall. 2. Gross type : Borrman type 1 (fungating). 3. Histologic type : papillary adenocarcinoma (pap). 4. Histologic type by Lauren : intestinal. 5. Growth pattern: mixed expanding and infiltrative growth pattern. 6. Size : 6.5x5.0cm. 7. Depth of invasion : invades proper muscle (pT2). 8. Resection margins and anvil ring : free from carcinoma. safety margins: distal 21.0cm, proximal 4.5cm. 9. Lymph node metastasis : no metastasis in 73 regional lymph nodes (pNO). (lesser curvature 0/32, greater curvature 0/37, #14v 0/0, LN 0/4). 10. Lymphatic invasion : not identified. 11. Venous invasion : not identified. 12. Perineural invasion : not identified. 13. Associated finding: peritumoral lymphocytic infiltration, moderate. 14. Other finding: jejunum - no tumor. # Immunohistochemistry : CD10, MUC2, MUC5ac, MUC6, C-erb B2.",T2,N0,M0,T2N0M0
TCGA-33-4583,"FINAL DIAGNOSIS. 1. BRONCHIAL MARGIN (EXCISION) : NEGATIVE FOR TUMOR. 2. LUNG, LEFT LOWER LOBE (LOBECTOMY) : MODERATELY DIFFERENTIATED. SOUAMOUS CELL CARCINOMA (3.0 CM) . BRONCHIAL AND VASCULAR MARGINS ARE. ATIVE FOR TUMOR. TWO (2) OF TWO (2) HILAR LYMPH NODES AND TWO (2). OF TWO (2) INTRAPULMONARY LYMPH NODES ARE NEGATIVE FOR TUMOR. AN. EXTENSIVE LIPOID AND FOREIGN BODY PNEUMONIA IS PRESENT. THIS FEATURE. SUGGESTS ASPIRATION. THE PATHOLOGICAL STAGE IS pT1 NO MX. 3. LYMPH NODES, UPPER LOBE (EXCISION) : ONE (1) LYMPH NODES,. NEGATIVE FOR TUMOR. 4. LYMPH NODE, LEVEL 5 (EXCISION) : ONE (1) LYMPH NODE, NEGATIVE FOR. TUMOR.",T1,N0,M0,T1N0M0
TCGA-QK-AA3J,"Anat Path Reports. Document Date: Acc #: Head and Neck. M. Client: Submitting Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. ARYTENOID, RIGHT, BIOPSY: - INVASIVE SQUAMOUS CELL CARCINOMA, POORLY DIFFERENTIATED WITH BASALOID FEATURES. Clinical History. Panendoscopy. Specimen(s) Received. A: Right arytenoid. Gross Description. The specimen is received fresh for frozen section diagnosis labeled with the patient's name, medical record number. and ""panendoscopy"" on the container and consists of multiple pink-red soft tissue fragments, collectively 1.0 x 0.8 x. 0.2 cm. Approximately 2/3 of the specimen is submitted for frozen section diagnosis in cassette A1FS. The. remaining specimen is submitted to tissue procurement services. (Dictated by. Intraoperative Consult Diagnosis. A1FS (2 slides): (FROZEN SECTION): invasive carcinoma, consistent with squamous cell carcinoma. Frozen section results were communicated to the surgical team and were repeated back by. on.",T1,N0,M0,T1N0M0
TCGA-A3-3387,"Sex Male. SPECIMENINFO. DIAGNOSIS. DIAGNOSIS: Kidney, left, nephrectomy: Tumor Characteristics: 1. Histologic type: Clear cell (conventional) renal cell adenocarcinoma. 2. Tumor site: Upper pole. 3. Tumor size: 4.0 x4.0x25cm. 4. Macroscopic extent of tumor: Tumor limited to kidney. 5. Nuclear grade: Fuhrman grade: 2/4. 6. Lymphovascular space invasion: Present. 7. Transcapsular invasion: No. 8. Renal vein invasion: No. 9. Venacaval invasion: Not resected. 10. Adrenal gland: Not resected. Surgical Margin Status: 1. Soft tissue margins: Negative. 2. Ureteral margin: Negative. 3. Vascular Margins: Negative. Lymph Node Status: 1. Total number of lymph nodes examined: 0. Other Significant Findings: 2. pTNM stage: T1a NX MX. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: Left kidney. SPECIMENDATA. GROSS DESCRIPTION: The specimen is received in one container labeled. I and left kidney and consists of a previously bisected kidney with attached perinephric fat. measuring 25.0 x 15.0 x 7.5 cm and weighs 930 grams. There is no adrenal gland attached to the specimen. The ureter stump is identified measuring. 6.0 cm in length and 0.4 cm in diameter. The surface is gray to brown-tan with slight adhesions. On opening the mucosal surface lining the ureter is. gray-tan. There are no lesions seen grossly. The renal artery stump is identified measuring 2.5 cm in length and 0.5 cm in diameter and contains. clotted. blood,. but. is. otherwise unremarkable. The renal vein stump measures 0.7 cm in length and 0.5 cm in diameter and is grossly unremarkable. The deep margin of the kidney has been inked. The cut surface of the kidney is brown-tan and reveals a circumscribed golden yellow partially. hemorrhagic. mass within the upper pole measuring 4.0 x 4.0 x 2.5 cm that on sectioning comes to within 0.1 cm of the inked deep margin, but does not. appear. to. penetrate through the capsule into the surrounding perinephric fat. The surrounding renal cortex is brown-tan measuring 0.5 cm and shows a. well. demarcated cortex and renal pyramids. The renal pelvis and calices are gray-tan and uninvolved by the mass and appear grossly unremarkable. There are no other lesions seen grossly. On sectioning through the surrounding perinephric fat reveals there are no lymph nodes grossly identified. Representative sections were taken for genomic studies and placed in orange cassettes labeled A-D. Also received with the specimen are two. cassettes, one green and one yellow, labeled. Representative sections are submitted in cassettes. as follows: sections. from mass in relationship to inked deep 3, auditional sections from mass and surrounding kidney-4 and 5; sections from surrounding. uninvolved kidney-6; ureter margin-7; renal artery and vein-B.",T1,N0,M0,T1N0M0
TCGA-B4-5836,"0. I. I. Specimen. I. Clinical. Clinical. I. I. Ethnicity. I. Index. I. I. label. I. Site #. I. (Race). Diagnosis. t. I. I. I. Renal. 1. Cancer. Renal. Cancer. I. I. I. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of. Amount/per. I. I. Specificatio. I. Container. I. I. Site. Matrix. Format. I. containers. container. n. I. I. I. I. I. Kidney,. Primary. Tumor. Tissue. Frozen. cryomold. 1. 280. mg. right. Blood. n/a. normal. Blood. Frozen. tube. 1. 4. ml. I. Prior. I. Type of. I. Chemo /. Histological. TNM Stage. TNM Stage. TNM Stage. Chemo /. Prior. I. Grade. Horm Th. I. description. I. (T). (N). (M). Hormonal. Radiation. Details. I. t. I. I. I. Th. I. Renal cell. 2. no data. no data. no data. carcinoma. Blood draw. n/a. n/a. n/a. n/a. n/a. Cellular. Tumor %. 90. n/a.",T1,N0,M0,T1N0M0
TCGA-AF-3913,"SPECIMEN. A. Right pelvic lymph nodes grossly suspicious only. B. Left pelvic lymph nodes grossly suspicious only. C. Prostate. D. spleinc flexure colon. E. Recto-sigmoid colon. F. Appendix. CLINICAL NOTES. PRE-OP DIAGNOSIS: Cancer of the rectum and prostate. FROZEN SECTION DIAGNOSIS. FSA) No frozen section done. FSB) No frozen section done. GROSS DESCRIPTION. A. Is submitted fresh for possible frozen, labeled ""right. pelvic lymph nodes"" It consists of a 6 x 4 X 2 cm. portion of lymph node-bearing fat, which contains numerous steel. clips. The section of the fat reveals the presence of five. suspected lymph nodes. The smallest of these is 5 mm. in size, the. largest 3 cm. Bisecting all of the lymph nodes shows them to be. made up of soft fleshy reddish-brown tissue without grossly. suspicious areas of metastasis, therefore no frozen sections are. performed as per request of Dr. BLOCK SUMMARY: Block [09-30] - Quadrisected lymph node, [09-. 30) in each. cassette; blocks 5,6 - bisected lymph node, half in each cassette;. block 7 - two additional lymph nodes. RS-7. B. Is submitted fresh, labeled ""left pelvic nodes"" and. consists of a 3 X 3 x 2 cm. mass of lymph node-bearing. fat. The section of fat reveals a large single lymph node present,. measuring 4 X 2 x 1 cm. Bisecting the node shows it to be soft,. without evidence of any firm or suspicious areas. Therefore, no. GROSS DESCRIPTION. frozen section is done per request of Dr. 1). The single node is. bisected, half submitted in each cassette. RS-2. C. Received fresh, subsequently fixed in formalin,. labeled. ""prostate"" is a 28 gm prostate. This has an inserted catheter and. the prostate, itself, is 4.5 x 3.5 x 3.2 cm. This has attached. bilateral adnexa. The seminal vesicles average 2.2 x 1 x 0.7 cm. and. the vasa deferentia average 2.2 x 0.5 cm. The right side is inked. blue and the left side is inked black. The adnexa is amputated. from. the specimen and the apical and bladder margins are coned from the. specimen. The remainder of the specimen is sectioned from apex to. base to show a pink-tan rubbery and nodular cut surface with no. other discrete gross lesions identified. Representative sections. of. the specimen which include the entire prostate are submitted as. follows Block 1 - apical margin; block 2 - bladder margin; blocks. 3, 4 - slice 1 full thickness composite; blocks 5, 6 - slice 2 full. thickness composite; blocks 7, 8 - slice 3 full thickness. composite;. blocks 9, 10 - slice 4 full thickness composite; blocks 11, 12 -. slice 5 full thickness composite; blocks 13, 14 - slice 6 full. thickness composite; block 15 - last slice, slice 7, bisected full. thickness composite; block 16 - base of adnexa and possible vas. deferential margin. RS-16 (entire prostate submitted). D. Received fresh, subsequently fixed in formalin,. labeled. ""splenic flexure colon. The specimen consists of a 7 cm. long portion of colon which is stapled at both ends. The ends of. the specimen are arbitrarily inked blue and black. The serosa is. pink-tan smooth glistening and the specimen is partially covered. with fat. The specimen is previously opened to show a pink-tan. smooth glistening mucosa, having a circumference of 8.5 cm. There. is a large exophytic mass measuring 4 X 3.2 x 2.2 cm. This is. located equidistant in the specimen. There are two additional. small. polyps grossly identified in the mucosa which are 0.2 cm and 0.3 cm. in greatest dimension. The smaller is located 2 cm from the. nearest. luminal margin (inked black) and the larger is located 1.5 cm from. GROSS DESCRIPTION. the tumor located equidistant between both luminal margins. Lymph. nodes are grossly identified in fat. The cut surface of the tumor. shows minimal invasion into the muscularis propria, not through the. muscularis propria, and comes within 1.5 cm of the deep more radial. margin. Representative sections of the specimen are as follows : BLOCK SUMMARY: Block 1 - Representative luminal margins; block 2 -. small polyp; blocks [11-30] - representative sections of tumor. to normal. and radial margin; block 6 - has two possible lymph nodes. RS-6. E. Received fresh, subsequently fixed in formalin,. labeled. ""rectum and sigmoid. "" The specimen consists of a. rectosigmoid colon which is 13 cm long. The specimen is opened at. one end (inked blue) and at the opposite end is stapled. The. stapled end is inked black. The specimen is partially covered with. pink-tan, smooth glistening serosa and yellow lobular fat. The. retroperitoneal reflection is located 5 cm from the black inked end. The specimen is opened to show a pink-tar smooth glistening mucosa. with an average circumference of 7 cm. There is a large exophytic. mass which is 5.5 x 3.5 X 1.2 cm located 2.5 cm from the distal. margin. There are additional small polyps which range from 0.5 cm. to 1 cm. These are located within 0.5 cm of the blue-inked end to. 5. cm of the black inked end. The cut surface of the small polyps. shows no discrete invasions of muscularis propria. The cut surface. has a large mass and shows invasion through the muscularis propria. and comes within 2.5 cm of the radial margin. Lymph nodes are. grossly identified in the fat. Representative sections of the. specimen are as follows : BLOCK SUMMARY : Block 1 - representative luminal margins which. include small polyp at proximal end; blocks 2, 3 - additional. polyps; blocks [01-01] - tumor to normal and deep; block 7. representative radial margin; blocks 8, 9 - have nine possible. lymph. nodes each; block 10 - has five possible lymph nodes; block 11 -. has. four possible lymph nodes; block 12 - has one possible lymph node. GROSS DESCRIPTION. bisected. RS-12. -. F. Received in formalin labeled ""appendix"" is a grossly. unremarkable appendix, partially covered with yellow. lobular fat and pink-tan smooth glistening serosa. The specimen. is. 6.5 X 0.5 cm. The specimen is sectioned to show an intact wall. with. an average thickness of 0.4 cm. The lumen ranges from pinpoint to. 0.3 cm. No other discrete gross lesions are identified. Representative sections of the specimen are submitted in one. cassette with the proximal end inked. RS-1. MICROSCOPIC DESCRIPTION. A-C: Prostate, seminal vesicles, and bilateral pelvic nodes -. Histologic type: Adenocarcinoma, NOS. Histologic (Gleason) grade 7 (3+4). Primary tumor (pT) : Tumor involves the left lobe of the prostate. gland and exhibits extraprostatic extension (pT3a). Extraprostatic extension: Present. Seminal vesicle invasion: Negative. Margins of resection: Negative. Regional lymph nodes (pN) : Right and left pelvic nodes are. negative. for metastatic carcinoma (pNo). Distant metastasis (pM) : Cannot be assessed (pMx) . Vascular invasion: Negative. Other findings : Perineural invasion by tumor is present. D. Splenic flexure colon -. Histologic type: Adenocarcinoma. Histologic grade: Moderately-differentiated. Primary tumor (pT) : Tumor has invaded into, but not through, the. MICROSCOPIC DESCRIPTION. muscularis propria (pT2). Proximal margin: Negative. Distal margin Negative. Circumferential (radial) margin: Negative. Vascular invasion: Negative. Regional lymph nodes (pN) : Two mesenteric lymph nodes are negative. for metastatic carcinoma (pNo). Non-lymph node pericolonic tumor: Absent. Distant metastasis (pM) : Cannot be assessed (pMx) . Other findings : The tumor has arisen in a tubulovillous adenoma. Hyperplastic polyp. E. Rectosigmoid colon -. Histologic type Adenocarcinoma. Histologic grade: Moderately-differentiated. Primary tumor (pT) : The tumor has extended through the muscularis. propria into the pericolonic fat (pT3) . Proximal margin: Negative. Distal margin: Negative. Circumferential (radial) margin: Negative. Vascular invasion : Negative. Regional lymph nodes (pN) : One of 26 mesenteric lymph nodes. contains metastatic adenocarcinoma (pN1a) . Non-lymph node pericolonic tumor Absent. Distant metastasis (pM) : Cannot be assessed (pMx). Other findings : 6 hyperplastic polyps. 5x3, 4, 3, 1, 13x2. DIAGNOSIS. A. Lymph nodes, right pelvic resection: Four lymph nodes negative for metastatic carcinoma (0/4). DIAGNOSIS. B. Lymph node, left pelvic, resection: Single lymph node negative for metastatic carcinoma (0/1) . C. Prostate and seminal vesicles, resection: Invasive moderate to poorly-differentiated prostatic. adenocarcinoma, Gleason's grade 7 (3+4) involving the left. lobe of the prostate gland. Extraprostatic extension is. present. The apex, bladder neck, and capsular margin of resection are. free of involvement by tumor. Seminal vesicles negative for involvement by tumor. Perineural invasion by tumor is present. D. Colon, splenic flexure, segmental resection. Invasive moderately-differentiated adenocarcinoma arising in. a. tubulovillous adenoma. Carcinoma has extended into, but not through, the muscularis. propria. Proximal, distal and radial margins of resection. free of tumor. Two mesenteric lymph nodes negative for metastatic carcinoma. (0/2) Hyperplastic polyp. E. Colon, rectosigmoid, segmental resection. Invasive moderately-differentiated colonic adenocarcinoma. extending through the wall of the colon into the serosal fat. Proximal, distal and radial margins of resection are free of. tumor. One of 26 mesenteric lymph nodes contains metastatic. adenocarcinoma. Six hyperplastic polyps. DIAGNOSIS. F. Appendix, incidental appendectomy : No significant histopathologic findings. 3. --- End Of Report.",T3,N1,M1,T3N1M1
TCGA-77-8154,"#REC.: No collection time was given. Received time has been entere. Histopathology Report. HISTORY. Lung cancer. MACROSCOPIC. Two specimens received: 1: The specimen is labelled 'right lower lobe' and consists of a right lower. lobectomy with inflated measurements of 135 X 130 x 65 mm. There is a line of. staples measuring 80 mm. Sectioning reveals a pale firm mass measuring 28 X 25. x 25 mm. The mass is greater than 30 mm from the bronchial resection margin,. 30 mm from the hilar resection margin and 5 mm from the overlying diaphragmatic. pleura. The mass appears to involve a bronchus. Distal to the tumour, the. lung parenchyma is mottled and yellow. Away from the tumour, the lung. parenchyma shows diffuse black deposits. [Representative sections: 1A, shave. of bronchial resection margin en face; 1B, LS bronchial resection margin; 1C,. tumour and pleura; 1D-E, tumour and bronchus; 1F, peribronchial node adjacent. to tumour; 1G, mottled lung adjacent to tumour; 1H, peribronchial nodes; 11,. lung distal to tumour; 1J, TS lung away from lesion]. 2: The specimen is labelled 'hilar lymph node' and consists of three blackened. fatty fragments of tissue measuring in aggregate 20 x 15 x 3 mm. [BIT, 2A]. MICROSCOPY. 1: Sections reveal a moderately differentiated squamous cell carcinoma. The. lesion partially obliterates a bronchus which shows a focal area in keeping. with carcinoma in situ. Tumour does not involve the visceral pleura and is. clear of the bronchial resection margin. No lymphatic invasion or perineural. permeation by tumour is seen. No definite vascular invasion is identified. Some peribronchial lymph nodes show silicotic nodules characterised by. hyalinised fibrous tissue, calcification and scattered flecks of birefringent. material. No tumour is identified within peribronchial lymph nodes. Lung. parenchyma immediately adjacent to the tumour shows features of obstructive. pneumonitis, acute bronchopneumonia and pulmonary oedema. Distant lung. parenchyma contains scattered mixed dust macules with focal mild interstitial. fibrosis noted. Mild emphysema is also present. 2: Sections of the lymph nodes reveal silicotic nodules, sinus histiocytosis. and carbon pigment deposition. No tumour is identified. SUMMARY. 1&2: Right lower lobectomy and separately submitted hilar lymph node: Moderately differentiated squamous cell carcinoma. Tumour size 28mm in diameter. Visceral pleura not involved. Bronchial resection margin clear. Page 10. #REC.: No colle. Histopathology Report. No lymphatic, vascular or perineural invasion identified. Lymph nodes not involved by tumour. Pathological stage: T1 NO. Anthracosilicosis, emphysema; pneumonia in lung parenchyma immediately adjacent. to tumour. CC Lung Cancer Registry.",T1,N0,M0,T1N0M0
TCGA-A1-A0SG,"Final Pathologic Diagnosis: A. Right axillary sentinel lymph node #1, count = 3500, dissection: Metastatic. adenocarcinoma in one of two lymph nodes (1/2). B. Right axillary sentinel lymph node #2, count = 500, dissection: No tumor in two. lymph nodes (0/2). C. Right breast, partial mastectomy: 1. Invasive micropapillary carcinoma, 2.1 cm, associated with microcalcifications; see. comment. 2. Atypical lobular hyperplasia. 3. Fibroadenoma. 4. Microcalcifications in benign ducts. D. Sentinel lymph node #3, count = 350, dissection: No tumor in two lymph nodes. (0/2). Note: Breast Tumor Synoptic Comment. - Laterality: Right. - Invasive tumor type: Invasive micropapillary carcinoma. - Invasive tumor size: 2.1 cm maximum diameter. The tumor is present in slices 4, 5, 9, and 10; however. the tumor has been banked from slices 6, 7, and 8. Therefore, the tumor extends through seven. consecutive slices, each with a width of approximately 0.3 cm, for a total maximum diameter of 2.1 cm. - Invasive tumor grade (modified Bloom-Richardson): 2. Nuclear grade: 3, 3 points. Mitotic count: < 10 mitotic figures/1 HPF, 1 point. Tubule/papilla formation: Definite tubule formation in <10%, 3 points. Working Draft. Total points and SBR grade - 7 points, grade 2. - Lymphatic-vascular invasion: None identified. - Perineural invasion: None identified. - Resection margins for invasive tumor: - Deep margin: Negative (1 cm). - Medial margin: Negative (0.9 cm). - Lateral margin: Negative (0.6 cm). - Anterior/superio: margin: Negative (0.5 cm). - Anterior/inferior margin: Negative (greater than 1 cm). - Ductal carcnoma in situ (DCIS) type: None identified. Microcalcifications: Present involving both benign ducts and invasive carcinoma. - Lobular carcinoma in situ (LCIS): None identified. - Lymph node status: - Number of positive lymph nodes: 1. - Total number sampled: 6. - Diameter of largest metastasis: 2.1 mm. - Extranodal extension: Absent. - AJCC/UICC stage: pT2N1aMX. - Nontumorous breast tissue: Atypical lobular hyperplasia, fibroadenoma, and sclerosing adenosis. - Additional comments: We reviewed the original frozen section slides and concur with the frozen section. diagnosis rendered. The metastatic tumor in Part A was only present in the additionally submitted. sections of the lymph node (slide A2). Level sections on A2-A4 confirms the diagnosis. Select slides from. part C were shown at the. the faculty in attendance concurred. with the above diagnosis of micropapillary type of invasive carcinoma. Dr. has reviewed A2. and concurs with the diagnosis. An immunohistochemical test for estrogen and progesterone receptors was performed on block C9. The test for estrogen receptors is positive. There is 3+ nuclear staining in >95% of tumor cells. The test for progesterone receptors is positive. There is 3+ nuclear staining in >95% of tumor cells. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed on block C9 using the CB11 monoclonal antibody to. HER2/neu oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3. Carcinomas with staining intensity scores of 0 or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered indeterminate. We and others have observed that many carcinomas with. staining intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore. submitted for FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in this. category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show gene. amplification. Slide A2 was shown at the departmental Consensus Conference, and the faculty in attendance concurred. with the above diagnosis. Intraoperative Consult Diagnosis. FS1 (A) Right axillary SLN #1, biopsy: Negative for carcinoma. (Dr. Clinical History. The patient is a. year-old woman with right breast carcinoma. Working Draft. Gross Description. The specimen is received in four parts, each labeled with the patient's name and medical record number. Part A is received fresh and labeled. It consists of one pink-yellow,. soft, fatty tissue that measures 3.1 x 2.5 x 0.8 cm. The specimen is strained and two candidate lymph. nodes are found, the smallest is inked blue and submitted with a representative section of the largest. submitted for frozen diagnosis #1, thereafter submitted in cassette A1. The remnant of the largest lymph. node is transected and entirely submitted in cassettes A2-A3, and the remnant of the yellow fatty tissue is. submitted in cassette A4. Part B, additionally labeled. consists of a single fragment of yellow,. fibrofatty tissue measuring 2 x 1.8 x 0.4 cm. The specimen is entirely submitted in cassette B1. Part C, additionally labeled. consists of a right breast specimen oriented. with a short superior and a long stitch lateral. The specimen measures 3.2 cm from anterior to posterior,. 5 cm from medial to lateral and 6.5 cm from superior to inferior. The resection margins are inked as. follows for microscopic evaluation: anterior superior in blue, anterior inferior in green and posterior in. black. The specimen is serially sectioned from medial to lateral into twelve slices. There is gray-white,. fibrous tissue in the superior half of the specimen in slices 3-11, measuring 2.4 x 2 x 1.5 cm. White. fibrous tissue extends from this area to the anterior inferior aspect in slices 5-8. The gray-white fibrous. tissue appears extend to the inked margin in the posterior superior aspect of slices 3 and 4, and appears. to be 0.5 cm from the anterior superior inked margins in slices 5 and 9. Representative sections are. submitted as follows: Cassette C1: Representative medial margin, slice 1, bread-loafed. Cassette C2: Representative section of slice 3. Cassettes C3-C5: Slice 4. Cassette C6: Representative section of slice 5. Cassette C7: Representative section of slice 6. Cassette C8: Representative section of slice 8. Cassette C9: Representative section of slice 9. Cassettes C10-C11: Representative sections of slice 10. Cassette C12: Representative section of slice 11. Cassette C13: Representative lateral margin, slice 12, bread-loafed. Part D, additionally labeled. consists of a single, yellow, fibrofatty tissue fragment. measuring 2.5 x 1.5 x 0.4 cm. The specimen is entirely submitted in cassette D1. The immunoperoxidase stain(s) reported above were developed and their performance characteristics determined by the. They have not been cleared or approved by the U. S. Food and Drug Administration The FDA has. determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded. as. investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (""CLIA""). as qualified to perform high-complexity clinical testing. Fee Codes: Other Specimens. pecimen Class: Accessioned: Specimen(s) Received: Right axillary contents. Final Diagnosis. Axilla, right, ""contents,"" excision: 1. Scar tissue, fat necrosis and suture with giant cell reaction. No malignancy is. identified. Working Draft. 2. No metastatic tumor identified in five lymph nodes. (0/5). Specimen Class: Accessioned: Specimen(s) Received: Final Diagnosis. Review of. from : Breast, right, 10 o'clock, core biopsies: Infiltrating ductal carcinoma, SBR Grade 2; see. comment. FND OF REPORT.",T2,N1,M0,T2N1M0
TCGA-EW-A1P8,"F. Pathologic Interpretation: A. LEFT BREAST LUMPECTOMY 1 STITCH SUPERIOR, 2 STITCHES LATERAL, SKIN IS ANTERIOR: - Invasive poorly differentiated ductal carcinoma, 2.2 cm in greatest linear dimension, Nottingham Grade 3 (3+3+3). Tumor is less than 0.1 cm from the posterior and lateral margins. - Lymphovascular invasion is present. - Tumor cells are negative for ER, PR, HER-2 by immunohistochemistry. B. SENTINEL LYMPH NODE #1 COUNT 171: - Metastatic carcinoma in one lymph node with extranodal extension (1/1). C. SENTINEL LYMPH NODE #2 COUNT 82: - Metastatic carcinoma in one lymph node with extranodal extension (1/1). D. NON-SENTINEL NODE: - Metastatic carcinoma in one lymph node with extranodal extension (1/1). E. LEFT AXILLARY CONTENTS: - Metastatic carcinoma in eleven out of twelve lymph nodes (11/12) with extranodal extension. Tumor Summary. Specimen: Partial breast. "". Procedure: Excision without wire-gulded localization. Lymph Node Sampling: Sentinel lymph node. Axillary dissection. Specimen Integrity: Single intact specimen. Specimen Size: Greatest dimension: 9 cm. Additional dimensions: 5 x 6 cm. Specimen Laterality: Left. Tumor Size: Greatest dimension of largest focus of invasion over 0.1 cm: 2.2 cm. Tumor Focality: Single focus of invasive carcinoma. Macroscopic Extent of Tumor: Skin: Invasive carcinoma does not invade into the dermis or epidermis. Skeletal Muscle: No skeletal muscle present. Histologic Type: - Invasive ductal carcinoma. Histologic Grade (Nottingham Histologic Score): Score 3. Nuclear Pleomorphism: Score 3: Mitotic Count: Score 3. Overali Grade: - Grade 3: Margins: - Uninvolved by invasive carcinoma. - Distance from closest margin: <1.0 mm. SURGICAL PATHOL Report. - Distance from posterior margin: <1.0 mm. - Distance from lateral margin: <1.0 mm. Treatment Effect: - In the breast: - No known presurgical therapy. In the Lymph Nodes: No known presurgical therapy. Lymph-Vascular Invasion: Present. Dermal Lymph-Vascular Invasion: Not identified. Extranodal Extension: - Present. Method of Evaluation of Sentinel Lymph Nodes: - H&E multiple levels. Pathologic Staging (pTNM): - Primary Tumor (pT): pT2. - Regional Lymph Nodes (pN): pN3a. - Distant Metastasis (pM): Not applicable. Anciliary Studies: - Estrogen Receptor: - Performed on this specimen: Results: Less than 1% immunoreactive cells present. - Progesterone Receptor: Performed on this specimen: Results: Less than 1% immunoreactive cells present. - HER2/neu: - Performed on this specimen: Results: Negative (Score 0). Microcalcifications: Present in invasive carcinoma. NOTE: IDS-ER, Some PgR immunohissochemical 636=PR. 1485=HER2, antibodies H-II=EGFR. are analyte All immunohistac specific reugents hemical (ASRs) stains validated are used by with our formalin laboratory. or molecular These ASRs fixed, are paraffin clinically embedded useful indicators tissue. Detection that do not is by requdre Emision FDA Method. approval. The These results clones are read are used: by a. pathologist as positive or negative. As the attending pathologist, I attest that I: (1) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). , MD. Intraoperative Consultation. B. Sentinel lymph node #1 count. FS: Metastatic carcinoma in lymph nodes, consistent with a breast primary. C. Sentinel lymph node #2 count , FS: Metastatic carcinoma in lymph node. MD. Clinical History: None provided. SURGICAL PATHOL Report. Operation Performed. Left breast lumpectomy with sentinel node biopsy. Pre Operative Diagnosis: Left breast mass. Specimen(s) Received: A: Left breast lumpectomy 1 stitch superior, 2 stitches lateral, skin is anterior (permanent). B: Sentinel lymph node #1 count. C: Sentinel lymph node #2 count. FS. D: Non-sentinel node. E: Left axillary contents. Gross Description: A. Received in formalin is a yellow ovoid tissue weighing 74 grams and measuring 9 x 5 x 6 cm. The specimen is oriented. with one short suture-superior margin and double black sutures-lateral margin. At the anterior aspect, there is an ellipse of. white skin, 4 x 1.2x0.3 cm. Margins inked as follows: superior margin in blue, inferior margin in green, lateral margin in. orange, medial margin in red, anterior margin in yellow and posterior margin in black. On multiple cross sections, there is. an ill-defined firm tumoral mass with focally hemorrhagic areas measuring 2.2 x 2 x 2 cm, present at less than 0.1 cm from. deep margin (closest margin) and 0.5 cm from anterior margin, 2 cm from superior and inferior margins. The rest of the. breast presents a white fibrotic breast tissue, the stroma to fat ratio is approximately 30-70%. Representative sections are. submitted in twelve cassettes as follows: 1. Superior margin. 2. Inferior margin. 3. Lateral margin. 4. Medial margin. 5. Anterior margin (skin). 6&7. Deep margin with tumor. 8-10. Tumor. 11&12. Breast stroma. B. Received fresh are two lymph nodes measuring from 1 cm to 4 x 1 x 0.8 cm. Submitted in toto in three cassettes for. frozen section as follows: 1. Small lymph node. 2&3. Large lymph node. C. Received fresh is a possible lymph node, 1.5 x 1 x 0.6 cm. Submitted in toto in one cassette for frozen section. D. Received in formalin are two yellow, pale tan tissue fragments, the smaller one is 1.2 x 1 x 0.2 cm and the bigger one is. 1.5 x 1.4 x 0,5 cm. Submitted in toto in two cassettes as follows: 1. Smaller tissue. 2. Bigger tissue, bisected, submitted in toto. E. Received is a yellow fibroadipose tissue segment, 11 x 9 x 2 cm. There are twelve possible lymph nodes ranging from 0.5. to 1.8 cm in greatest dimension. They are bisected. Representative sections are submitted In twelve cassettes as follows: One possible lymph node, bisected per block.",T2,N3,M0,T2N3M0
TCGA-A3-3347,"DIAGNOSIS. DIAGNOSIS: A. Kidney, right, radical nephrectomy: Renal cell carcinoma (see tumor characteristics). Tumor Characteristics: 1. Histologic type: Renal cell carcinoma, clear cell type. 2. Tumor site: Right kidney, mid-portion. 3. Tumor size: 6.5 x 4 x 3.5 cm. 4. Macroscopic extent of tumor. Tumor extends into periadrenal adipose tissue. 5. Nuclear grade: Fuhrman grade: 2 of 4. 6. Lymphovascular space invasion: Yes. 7. Transcapsular invasion: No. 8. Renal vein invasion: No. 9. Venacaval invasion: Not resected. 10. Adrenal gland: Not involved by tumor; however, the periadrenal adipose tissue demonstrates extension of tumor. Surgical Margin Status: 1. Soft tissue margins: No evidence of malignancy. 2. Ureteral margin: No evidence of malignancy. 3. Vascular Margins: No evidence of malignancy. Lymph Node Status: 1. Total number of lymph nodes examined: One (precaval - see part B). 2. Number of lymph nodes containing metastatic carcinoma: 1 of 1 (precaval) -. Other Significant Findings: 1. Other significant findings: In focal areas, the tumor cells demonstrate a spindled morphology, however, they still demonstrate. clear cytoplasm and are therefore not interpreted as being sarcomatoid. 2. pTNM stage: pT3a N1 MX. Staging sheet #18. B. Lymph node, precaval, excision: Metastatic renal cell carcinoma infiltrating of 1 of 1 lymph node. COMMENTS: A. For quality assurance, this case is reviewed be. who concurs with the diagnosis. B. Although a lymph node dissection is not received, a single lymph node labeled 'precaval' is received in surgical pathology. This demonstrates. metastatic renal cell carcinoma. CLINICALINFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Renal mass. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Right kidney. B. Precaval lymph node. SPECIMEN DAJA. GROSS DESCRIPTION: A. Container A is labeled and consists of a 158 gram right kidney measuring 10 x 6.5 x 3.8 cm in greatest dimension. The capsule is tan-gray,. glistening and displaying an abundant amount of adherent adipose tissue as well as nodular mass in the mid-portion of the kidney. The superior pole. also displays an orange brown firm adrenal gland, measuring 3.5 x 2.0 x 0.8 cm as well as a 0.6 cm. firm gray-tan nodule adjacent to it. The hilar region. displays abundant adipose tissue with a portion of ureter measuring 4 cm in length and 0.8 cm in diameter. Bivalving the kidney reveals fat-filled calyces. and blunted pyramids with a central tan yellow firm lobular mass, measuring 6.5 x 4.0 x 3.5 cm in greatest dimension. This mass does not appear to. grossly invade the ureter or surrounding vessels. No other gross lesions are noted. Samples are taken for genomic studies. Representative samples. are submitted in eight cassettes labeledi. and are designated as follows: Blood vessels and ureteral margin submitted as block 1; adrenal gland and adjacent gray-tan nodule 2; inked capsule 3; lesion 4-7; normal renal tissue. 8. B. Container B is labeled. nd consists of a tan yellow rubbery firm nodule, 2.0 x 1.8 x 1.5 cm in greatest dimension. Samples of this nodule are. submitted in two cassettes labeleda.",T1,N1,M0,T1N1M0
TCGA-AA-3851,"Diagnosis: The material available is an invasive, moderately differentiated adenocarcinoma of the colon,. G2, with penetration of all parietal layers pT3, with vascular infiltration L1, V1, with free. resection margins locally R0 and free lymph nodes (pN0, 0 of 14). Remark: In Block D, the polyps were examined separately. They were found to be serrated adenomas with. dentate form cylindrical epithelia and goblet cells, as well as bleeding in the stroma. The polyps. did not show any evidence of invasive structures. Tumor classification: ICDO-DA-M 8140/3. G2. pT3, pNO (0/14). Locally R0. M classification in oncology conference.",T3,N0,M0,T3N0M0
TCGA-55-7995,"GROSS AND MICROSCOPIO SURGICAL PANEI. Specimen Information. SURGICAL PANEL: LAB: DIAGNOSIS. A) WEDGE RESECTION, LEFT UPPER LOBE: 1. Poorly differentiated adenocarcinoma forming a mass measuring 2.6 X. 2.4 X 1.7 cm. 2. Tumor abuts but does infiltrate within visceral pleura. 3. Tumor is situated 0.6 cm from nearest inked stapled parenchymal. resection margin. B) LYMPH NODE, LEVEL 9L, BIOPSY: 1. Benign anthracotic lymph node. 2. No evidence of metastatic carcinoma. C) LYMPH NODE, LEVEL 5, EXCISION: 1. Benign anthracotic lymph node. 2. No evidence of metastatic adenocarcinoma. D) LYMPH NODE, LEVEL 6, EXCISION: 1. Benign anthracotic lymph node. 2. No evidence of metastatic adenocarcinoma. E) LYMPH NODE, LEVEL 7, EXCISION: 1. Benign anthracotic lymph node. 2. No evidence of metastatic adenocarcinoma. F) LYMPH NODE, LEVEL 12L, EXCISION: 1. Benign anthracotic lymph node. 2. No evidence of metastatic adenocarcinoma. G) LUNG, LEFT UPPER LOBE, LOBECTOMY: 1. No residual adenocarcinoma identified. 2. Benign bronchial and vascular resection margins. 3. Patchy interstitial fibrosis with nonspecific emphysematous changes. within pulmonary parenchyma. 4. Three benign hilar lymph nodes with marked anthracosis. LUNG CANCER STAGING PARAMETERS. atient name: Final TNM: pT1bNOMO. stage: IA. MACROSCOPIC. SPECIMEN TYPE. Lobectomy. TUMOR SITE. Left Lung-Upper Lobe. TUMOR SIZE. 2.6 X 2.4X1.7 cm. TUMOR FOCALITY. Unifocal. MICROSCOPIC. HISTOLOGIC TYPE. Solid adenocarcinoma. HISTOLOGICAL GRADE. G3: (poorly differentiated) of G4. VISCERAL PLEURAL INVASION. Not identified. LYMPHATIC VASCULAR INVASION. Absent. TREATMENT EFFECT. Not applicable. TUMOR EXTENSION. Not applicable. MARGINS. Uninvolved by tumor (Bronchial). Distance of tumor from closest margin is 4.5 cm. PATHOLOGIC STAGING. EXTENT OF INVASION. pT1b. [Tumor greater than 2 cm, but 3 cm or less in greatest. dimension, surrounded by lung or visceral pleura, without bronchoscopic. evidence of invasion more proximal than the lobar bronchus (ie, not in the. main bronchus)]. REGIONAL LYMPH NODES. pNO. (No regional lymph node metastasis). Total nodes: 8. Total positive nodes: 0. N1 nodes: 4. N1 positive nodes: 0. N2 nodes: 4. N2 positive nodes: 0. N2 sites sampled: Station 9: Pulmonary ligament nodes. Station 5: Subaortic nodes (aorto-pulmonary window). Station 6: Para-aortic nodes (ascending aorta or phrenic). Station 7: Subcarinal nodes. DISTANT METASTASIS. pMO. (No distant metastasis). PATHOLOGIC STAGE Summary. Final TNM: T1bNOM0. stage: IA. The pathologic stage presumes no distant metastasis. LUNG ANCILLARY TESTING PROTOCOL. HISTOLOGIC TYPE. Solid adenocarcinoma. STAGE IV STATUS. No stage IV disease pathologically. TISSUE BLOCK AVAILABLE FOR ANCILLARY TESTING. COMMENT. This patient's sample does not meet. criteria for reflex EGFR and ALK testing. No fresh tissue is available. for ancillary testing. The block identified above will be stored in. pathology. for possible future ancillary testing. Please call. for any ancillary testing requests. EGFR and ALK reflex testing criteria: Stage IV disease (histologically proven or clinically suspicious). Adenocarcinoma or TTF-1 positive adenosquamous cell carcinoma. Attending Pathologist: CLINICAL INFORMATION. Lung mass; cancer study. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Wedge resection left upper lobe lung. Labeled ""wedge resection left upper lobe lung"" is a 23 gram, 8 X 4 x 3 cm. lung wedge excision with an incorporated staple line (8.5 X 0.5 cm). The. red-tan pleural surface includes a discrete indurated puckered 1 X 0.8 cm. area centrally (inked green). The stapled margin is trimmed and subjacent. tissue inked black. Cut surfaces disclose a 2.6 X 2.4 X 1.7 cm solid. gray-tan tumor mass with partially circumscribed to focally infiltrating. borders, abutting the green-inked puckered serosa and 0.6 cm from the. black-inked staple resection surface. Central tumor is submitted on one block for frozen microscopy. INTRAOPERATIVE PATHOLOGY CONSUL TATION WITH FROZEN SECTION: ""Non-small cell. carcinoma"" is rendered b. Fresh tumor is banked for additional ancillary studies. The remaining cut surfaces are soft red-tan, with mild emphysematous change. and no additional discrete lesions. Representative sections are submitted in seven cassettes as follows: 1. Frozen section residue. 2. Black-inked staple margin nearest tumor. 3-6. Tumor mass with green-inked puckered pleural surface. 7. Lung with emphysematous change. The specimen is remoyed from the patient at. and placed in. formalin at. for a minimum of. fixation per. protocol. B) SOURCE: Lymph node biopsy, level 9L. The specimen is received in formalin labeled ""level 9L lymph node."" It. consists of three red-black soft tissues aggregating 0.7 X 0.5 X 0.2 cm. The specimen is submitted in toto in one cassette. C) SOURCE: Lymph node biopsy, level 5. The specimen is received fresh labeled ""level 5 lymph node."" It consists of. 1 X 1 X 0.2 cm of fragmented black-red tissue which is submitted in toto. for frozen on one block. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Negative for. carcinoma."" is rendered by. D) SOURCE: Lymph node biopsy, level 6. The specimen is received in formalin labeled ""level 6 lymph node."" It. consists of two tan-red soft tissues aggregating 0.9 X 0.4 X 0.2 cm. The. specimen is submitted in toto in one cassette. E) SOURCE: Lymph node biopsy, level 7. The specimen is received labeled ""level 7 lymph node."" It consists of a. single 1.2 cm anthracotic lymph node. The specimen is entirely submitted in. one cassette. F) SOURCE: Lymph node biopsy, level 12L. The specimen is received labeled ""level 12L lymph nodes."" It consists of. three anthracotic lymph nodes ranging from 0.5 to 0.8 cm in greatest. dimension. The specimen is submitted in toto in one cassette. G) SOURCE: Left upper lobe bronchial margin for frozen section. Received fresh from the OR labeled ""left upper lobe bronchial margin for. frozen section and consists of a 3 g lung lobe (19 X 12 X 4 cm). The. bronchial resection margin is received stapled. The staple line is removed. and the subjacent tissue is taken en face for frozen section diagnosis. INTRAOPERATIVE PATHOLOGY CONSUL TATION WITH FROZEN SECTION: ""Benign. bronchial margin"" is rendered by. The vascular margins and hilar lymph nodes are taken. The pleural surface. is tan-red to red-purple, smooth and glistening. There is a 9 cm staple. line grossly corresponding to the earlier wedge resection. The staple line. is removed and the subjacent tissue is inked blue. The staple line lies 4.5. cm from the bronchial resection margin. The lung lobe is sectioned. revealing pink-tan to red-purple spongy tissue. No discrete masses or. lesions are identified. Representative sections of the specimen are submitted in nine cassettes as. follows: 1. Frozen section bronchial resection margin. 2. Hilar lymph nodes. 3. Vascular resection margins, en face. 4. Staple line nearest bronchial margin. 5. Additional inked staple line. 6-9. Grossly unremarkable lung parenchyma. This case is accessioned in. MICROSCOPIC. A) Sections through the wedge resection from the left upper lobe confirm. the presence of non-small cell carcinoma. The tumor is predominantly. composed of solid nests of cells with large vesicular nuclei and abundant. eosinophilic cytoplasm. Mitotic activity is fairly abundant and areas of. tumor necrosis are seen. The tumor is predominantly growing in solid nests. with minimal acinar formation, although occasional foci of both. intracellular and extracellular mucin are suggested. This lesion abuts but. does not appear to specifically infiltrate within the overlying visceral. pleura. Assessment in this regard includes an elastic stain on block A6. Noninvolved pulmonary parenchyma demonstrates nonspecific emphysematous. changes but is otherwise unremarkable. A limited immunohistochemical. evaluation of this lesion is performed with results as follows: TTF-1: Positive. Napsin A: Negative. Negative. P63: Limited/focal positivity is seen. The combination of TTF-1 positivity with apparent focal mucin production by. this neoplasm would confirm a poorly differentiated adenocarcinoma. B-G) The microscopic appearance substantiates the diagnosis. Interpreted at. ACCESSIONED. Lab and Collection. GROSS AND MICROSCOPIC SURGICAL PANEL. on. - Lab and Collection. Information. Result History. GROSS AND MICROSCOPIC SURGICAL PANE. Result Date and Time. Provider Status. Lab. Parent Order ID. Child Order ID. Specimen Information. Specimen Source. Other. Audit Trail. Action. User. Date/Time. This result is currently not released to.",T1,N0,M0,T1N0M0
TCGA-CR-7394,"DIAGNOSIS: 1) LYMPH NODES, LEVEL 2 & 3, RIGHT NECK, EXCISION: 21 LYMPH NODES, NEGATIVE. FOR MALIGNANCY (0/21). 2) LYMPH NODES, LEVEL 1B AND PERIFASCIAL NODE, LEFT, EXCISION: SALIVARY. GLAND AND 2 LYMPH NODES, NEGATIVE FOR MALIGNANCY (0/2). 3) LYMPH NODES, LEVEL 2 & 3, LEFT NECK, EXCISION: 26 LYMPH NODES, NEGATIVE. FOR MALIGNANCY (0/26). 4) LYMPH NODES, LEVEL 1A, NECK, EXCISION: 4 LYMPH NODES, NEGATIVE FOR. MALIGNANCY (0/4). 5) TONGUE AND RIGHT LEVEL 1, RESECTION: MODERATELY DIFFERENTIATED INVASIVE. SQUAMOUS CELL CARCINOMA OF THE TONGUE, 7.5 CM IN GREATEST DIMENSION; ALL. SURGICAL MARGINS NEGATIVE FOR MALIGNANCY (TUMOR EXTENDS TO WITHIN 0.3 CM OF. RIGHT SURGICAL MARGIN); PERINEURAL INVASION PRESENT; 4 LYMPH NODES,. NEGATIVE FOR MALIGNANCY (0/4) (SEE COMMENT & SUMMARY FINDINGS). Upper Aerodigestive Tract and Minor Salivary Glands Carcinoma. Summary of Findings: Specimen Type: total glossectomy & neck lymph node dissection. Tumor Site: tongue. Tumor Size: 7.5 cm in greatest dimension. Histologic Type: squamous cell carcinoma. Histologic Grade: moderately differentiated (grade II/III). Pathologic Staging (pTMN): IVA. Primary tumor (pT): pT4. Regional Lymph Nodes (pN): pNO. Number examined: 57. Numbered involved: 0. Perineural invasion: present. Bony/Cartilage Invasion: Not evaluable. HPV testing ordered: Yes. COMMENT: These findings correspond to AJCC pathologic Stage IVA (pT4a, pNo,. pMn/a). M.D. CLINICAL DATA. Clinical Features: unspecified. Operator: Operative Findings: unspecified. Operative Diagnosis: unspecified. Tissue Submitted: 1) right neck level 2,3, 2) left level 1B. and perifascial node, 3) left neck level. 2, 3; 4) neck dissection, level 1A; 5). total glossectomy, right level 1. GROSS DESCRIPTION: 1) SOURCE: Right Neck Level 2, 3. Received fresh, labeled ""right neck level 2, 3,"" per requisition, is a 6.0. X 5.5 X 2.cm portion of partially circumscribed yellow-tan lobular adipose. tissue with a nodularity noted on palpation. The dissected lymph nodes are. submitted as follows: Summary of sections: 1A, 9 lymph nodes, 9/1; 1B, 2 lymph nodes, each. bisected (1 inked black), 4/1; 1C, 2 lymph nodes each bisected (1 inked. black) 4/1; 1D-1I, 1 lymph node, bisected, 2/1 each. 2) SOURCE: Left level 1B and perifascial node. Received fresh labeled ""left level 1B and perifascial node"", per. requisition, is a 5 X 4 X 1.6.cm portion of partially circumscribed. yellow-tan lobular adipose tissue with a nodularity noted on palpation. Serial sectioning shows a few circumscribed lymph nodes and a gold-tan. trabecular cut surface consistent with a gland. Summary of sections: 2A, 4 lymph nodes, 4/1; 2B, section of gland tissue,. 2/1. 3) SOURCE: Left Neck level 2, 3. Received fresh, labeled ""left neck level 2, 3"" per requisition, is a 5 X 4. X 1.8 cm aggregate of partially circumscribed yellow-tan lobular adipose. tissue with a nodularity noted on palpation. Summary of sections: 3A, 5 lymph nodes, 5/1; 3B, 6 lymph nodes, 6/1; 3C, 2. lymph nodes, each bisected, (1 inked black), 4/1; 3D, 2 lymph nodes, each. bisected 1 inked black), 4/1; 3E, 4lymph nodes, 4/1; 3F-3G, 1 lymph node,. bisected, 2/1 each. 4) SOURCE: Neck dissection level 1A. Received fresh, labeled ""neck dissection level 1A"", per requisition, is a 4. X 3 X 1.2 cm portion of partially circumscribed, yellow-tan lobular adipose. tissue with a nodularity noted on palpation. Summary of sections: 4A, four lymph nodes, 4/1. 5) SOURCE: Total glossectomy right level 1. Received fresh in a container labeled with the patient's name and ""total. glossectomy right level 1"" is a 224 gram total glossectomy specimen. measuring 10.5 cm anterior to posterior by 9 cm from right to left by 6.2. cm from superior to inferior. There are no orientation instructions. received along with the specimen. The specimen consists of a grossly. identifiable tongue with a pink-tan, shaggy mucosal surface which measures. 10.5 cm from anterior to posterior by 6.5 cm from right to left by. approximately 3.5 cm superior to inferior. There is a small amount of. adjacent pink-tan, shiny mucosa, which is consistent with the floor of the. mouth. The surface of the specimen opposite the mucosa is pink-red, shaggy,. and consistent with a surgical resection margin. Using anatomic landmarks. for orientation, the specimen has been inked in the following manner: anterior is orange, posterior is black, right is red, left is yellow, and. inferior is green. The mucosal surface is notable for an ulcerated, friable. mass that is present on the right floor of mouth, extending to the lateral. aspect of the tongue and measures approximately 7.5 X 5.0 cm in area. Grossly, the mass extends to within 1.0 cm of the right lateral margin and. 1.5 cm of the anterior margin. The specimen is serially sectioned to reveal. a cheesy, white-yellow mass extending approximately 4.0 cm deep to the. ulceration and grossly extending to within 0.7 cm of the inferior inked. margin, 0.3 cm of the right inked margin, 0.6 cm of the anterior inked. margin, 0.5 cm of the posterior inked margin, and appears widely free of. the left inked margin. Representative sections are submitted for. evaluation. Summary of sections: 5A, left anterior mucosal margin and left anterior. deep, 3/1; 5B, left lateral mucosal margin and left lateral deep, 2/1; 5C,. left hypopharynx margin and left hypopharynx deep, 2/1; 5D, posterior. mucosal margin and posterior deep, 2/1; 5E, right hypopharynx margin and. hypopharynx deep, 2/1; 5F, right lateral mucosal margin and right lateral. deep, 2/1; 5G-H, perpendicular sections of tumor approaching right lateral. mucosal margin, 1/1 each; 5I-J, tumor approaching right anterior mucosal. margin, 1/1 each; 5K, right anterior deep margin, 1/1; 5L, inferior margin,. 1/1; 5M-N, representative sections of mass, 1/1 each; 50,right floor mass,. 1/1; 5P, normal appearing posterior tongue, 1/1; 5Q, normal appearing left. lateral tongue, 1/1; 5R, normal appearing anterior tongue, 1/1. (ASCP) for. Slides and report reviewed by Attending Pathologist.",T4,N0,M0,T4N0M0
TCGA-VQ-A91Q,"PRIMARY SITE: Stomach (Cardia). I-) Product of esophagogastrectomy: -Poorly differentiated tubular adenocarcinoma of cardia, with largest tumor size. measuring 6.5 cm. - -Tumor infiltrates distal esophagus including adventitia. - -Tumor infiltrates stomach wall including perigastric fat. -Presence of foci of lymphatic invasion and perineural invasion. - -Margin in esophageal adventitia involved by neoplasia. -Proximal and distal margins uninvolved by neoplasia. Lymphadenectomy according to standardization: Right paracardic lymph nodes: -Metastatic adenocarcinoma (2/2), with capsular invasion. Left paracardic lymph nodes: -Metastatic adenocarcinoma (2/2), with capsular invasion. Lesser curvature lymph nodes: -Metastatic adenocarcinoma (8/8), with capsular invasion. Suprapyloric lymph node: -Uninvolved by neoplasia (0/1). -Lymphatic neoplastic thrombi in perilymph node fat. Left gastric artery lymph nodes: -Metastatic adenocarcinoma (8/8), with capsular invasion. -Lymphatic neoplastic thrombi in perilymph node fat. Celiac trunk lymph nodes: -Metastatic adenocarcinoma (4/6), with capsular invasion. -Lymphatic neoplastic thrombi in perilymph node fat. Paraesophageal lymph node: -Metastatic adenocarcinoma (1/1), without capsular invasion. -Lymphatic neoplastic trombi in perilymph node fat. II-) )Esophageal margin: Uninvolved by neoplasia. III-)Omentum: Uninvolved by neoplasia. IV-)Gallbladder: -Cholelithiasis.",T3,N3,M0,T3N3M0
TCGA-EL-A3GV,"Pathology. bort. athology. Sex: F. Case type: Surgical Case. DIAGNOSIS. (A) TOTAL THYROIDECTOMY. PAPILLARY THYROID CARCINOMA, CONVENTIONAL TYPE. Location: Left lobe. Multi-focal: No. Size = 1.9 cm. Extrathyroidal extension: Present, into soft tissue. Lymphovascular invasion: Absent. Resection Margins: Negative. Lymph nodes: No tumor present in 1 lymph nodes (0/1). (B) LEFT INFERIOR PARATHYROID: Parathyroid tissue, no tumor present. GROSS DESCRIPTION. (A) TOTAL THYROIDECTOMY - A total thyroid with right lobe (2.5 x 2.2 x 1.1 cm), isthmus (1.2 x 1.5 x 0.5 cm) and left lobe. (3.5 x 2.0 x 1.5 cm). The right lobe and isthmus are unremarkable. Within the soft tissues in the superior aspect of the. isthmus are several possible lymph nodes. The left lobe contains a well-circumscribed solid mass at lower portion (1 9 X 1.5 x. 1.0 cm). The nodule is confined to the thyroid. SECTION CODE: A1, A2, representative sections from right lobe, superior to inferior; A3, possible Ivmph nodes; A4,. section of isthmus; A5-A10, sections of left lobe from superior to inferior including the dominant nodule. (B) LEFT INFERIOR PARATHYROID, P/S RULE OUT - Received are two fragments of pale yellow and pink soft tissue. fragments both measuring 0.3 cm in greatest dimension and has a combined weight of 0.0092 grams. The specimen is. submitted entirely in B for frozen section evaluation. Touch preps are performed. FS/DX: PARATHYROID TISSUE PRESENT. CLINICAL HISTORY. Papillary thyroid carcinoma. SNOMED CODES. T-86000, M-80503, T-C4200, M-00110,. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration."". Sex: F. Case type: Surgical Case. Entire report and diagnosis completed by:",T3,N0,M0,T3N0M0
TCGA-55-8206,"GROSS AND MICROSCOPIC SURGICAL PANEL. Specimen Information. SURGICAL PANEL: DIAGNOSIS. A) LUNG, RIGHT UPPER LOBE, LOBECTOMY: 1. Moderately differentiated adenocarcinoma forming a mass measuring 2.3. X 2.2 x 2.2 cm. 2. Tumor abuts but does not invade visceral pleura. 3. Benign bronchial and vascular resection margins. 4. Three benign variably anthracotic lymph nodes. 5. Histologically unremarkable surrounding pulmonary parenchyma. B) HILAR LYMPH NODE, EXCISION: 1. Benign anthracotic lymph node. 2. No evidence of metastatic carcinoma. LUNG CANCER STAGING PARAMETERS. Final TNM: pT1bNOMO. stage: IA. MACROSCOPIC. SPECIMEN TYPE. Lobectomy. TUMOR SITE. Right Lung-Upper Lobe. TUMOR SIZE. 2.3X2.2X2.2 cm. TUMOR FOCALITY. Unifocal. MICROSCOPIC. HISTOLOGIC TYPE. Adenocarcinoma. HISTOLOGICAL GRADE. G2: (moderately differentiated) of G4. VISCERAL PLEURAL INVASION. Not identified. LYMPHATIC VASCULAR INVASION. Absent. TREATMENT EFFECT. Not applicable. TUMOR EXTENSION. Not applicable. MARGINS. Uninvolved by tumor (Bronchial). Distance of tumor from closest margin is 4 cm. PATHOLOGIC STAGING. EXTENT OF INVASION. pT1b. [Tumor greater than 2 cm, but 3 cm or less in greatest. dimension, surrounded by lung or visceral pleura, without bronchoscopic. evidence of invasion more proximal than the lobar bronchus (ie, not in the. main bronchus)]. REGIONAL LYMPH NODES. pNO. (No regional lymph node metastasis). Total nodes: 4. Total positive nodes: 0. N1 nodes: 4. N1 positive nodes: 0. DISTANT METASTASIS. pMO. (No distant metastasis). PATHOLOGIC STAGE Summary. Final TNM: pT1bNOMO. stage: IA. The pathologic stage presumes no distant metastasis. LUNG ANCILLARY TESTING PROTOCOL. HISTOLOGIC TYPE. Adenocarcinoma. STAGE IV STATUS. Stage IV status is undetermined. TISSUE BLOCK AVAILABLE FOR ANCILLARY TESTING. A7. COMMENT. This patient's sample does not meet. criteria for reflex EGFR and ALK testing. NO tresh tissue is available. for ancillary testing. The block identified above will be stored in. pathology for 10 years for possible future ancillary testing. Please call. for any ancillary testing requests. EGFR and ALK reflex testing criteria: Stage IV disease (histologically proven or clinically suspicious). Adenocarcinoma or TTF-1 positive adenosquamous cell carcinoma. Attending Pathologist: CLINICAL INFORMATION. Adenocarcinoma. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Lung, right upper lobe. Received fresh labeled ""right upper lobe lung"" and consists of a 14 X 11 X. 2.5 cm lobe of lung. The bronchial margin is taken en face and submitted on. one chuck for frozen section diagnosis. INTRAOPERATIVE PATHOLOGY CONSUL TATION WITH FROZEN SECTION: ""Bronchial. margin negative"" is rendered by. On cut section, there is a palpable 2.3 X 2.2 X 2.2 cm mass in the upper. portion of the lobe. It puckers the pleural surface which has been inked. black. The mass is 4 cm from the nearest bronchial margin. The remainder of. the parenchyma is spongy tan-pink with very mild anthracosis. Part of the tissue is taken for possible ancillary study. Representative sections are submitted in 10 cassettes labeled: 1. Frozen section. 2. Vascular margins. 3. Hilar lymph nodes. 4-7. Tumor to pleural surface in normal parenchyma. 8-10. Random normal parenchyma remote from tumor. B) SOURCE: Hilar lymph node. Labeled ""hilar lymph node"" is a 0.7 cm anthracotic lymph node. The specimen. is submitted in toto in one cassette. This case is accessioned in. MICROSCOPIC. A,B) The microscopic appearance substantiates the diagnosis. An elastic. stain is obtained on block A5 to assess for possible visceral pleural. involvement. Dictation by. ACCESSIONED. Lab and Collection. GROSS AND MICROSCOPIC SURGICAL PANEL. Lab and Collection. Information. Result History. GROSS AND MICROSCOPIC SURGICAL PANEL. Reviewed bu 1 lict. Result Date and Time. Provider Status. Lab. Parent Order in.",T1,N0,M0,T1N0M0
TCGA-L5-A8NS,"OPER DATE: REQ DOC: PROCEDURE: -vear-old with heartburn, dysphagia and nocturnal food regurgitation. On. had esophageal biopsy which showed moderate to poorly differentiated. adenocarcinoma. On. had barium swallow for achalasia with stricture of. distal esophageal narrowing to 8 mm over (ength of 2 cm. PREVIOUS DIAGNOSIS INQUIRY. 2. REPORT DATF. PATIENT NBR: SEX: M. ADM DATE: BIRTHDATE: OPER DATE: REQ DOC: PROCEDURE: 1. ""Thoracic esophagus"" A 6.5 cm long segment of esophagus that has a 6.2 cm. internal circumference. The proximal stomach measures 9.2 x 5.0 x 0.5 cm. The. mucosa of the esophagus is gray-tan, finely folded. The mucosa of the stomach. has a rugated, tan appearance that is remarkable for a 2.5 x 2.3 x 2.3 cm. fungating tan-gray to pink tumor that has been previously incised by the. surgeon. This tumor is located 2.1 cm away from the distal margin of. resection. It partially involves the squamocolumnar junction. However, the. tumor is found distal to the squamocolumnar junction. The tumor has a maximum. depth of 1.3 cm and extends through to the adherent fibroadipose tissue. Upon. sectioning the underlying tumor is 3.6 x 2.5 x 1.3 cm. One tongue of. salmon-colored mucosa extending proximally from the squamocolumnar junction. Three possible Lymph nodes are identified ranging up to 0.5 cm. 1A. Tumor to gastric margin. 1B-D. Tumor to deep. 1E. Tumor to squamocolumnar junction. 1F. Squamocolumnar junction. 1G. Three Lymph nodes. 2. ""Cervical esophageal margin."" Tubular portion of tan-gray tissue consistent. with esophagus, 1.9 cm in length and 2.3 cm in diameter. One aspect is stapled. with the other aspect being open. The mucosa is tan-gray. No lesions are. grossly noted. 2A. The opened margin. PROCEDURE: ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: Type of carcinoma: Adenocarcinoma. Arising in: Barrett's mucosa. Depth of invasion: Adventitia. Number of positive lymph nodes: 0. Extranodal metastasis: Unknown. Pattern of invasion: Infiltrative. PREVIOUS DIAGNOS!S INQUIRY. REPORT DATE: PATIENT NBR: SEX: M. ADM DATE: BIRTHDATE: OPER DATE: REQ DOC: Esophageal and gastric resection margins involved: No. Deep resection margin involved: No. TNM classification: T3 NO MX. PROCEDURE: 1. Esophagus and proximal stomach, resection: Transmurally invasive. adenocarcinoma. Tumor arising in dysplastic intestinal metaplasia, presumably. Barrett's mucosa. Three lymph nodes negative for carcinoma. Margins free. Perineurial invasion identified. Please see template. 2. Cervical esophagus, excision: Negative for Barrett's or neoplasm. 1,. the signing staff pathologist, have personally. and interpreted the slides from this case. Code: END OF PREVIOUS DIAGNOSIS INQUIRY.",T3,N0,M0,T3N0M0
TCGA-AA-3555,"Diagnosis: 1. : Right hemicolectomy preparation with tumor-free resection margins; in the area of. Bauhin's valve and the ascending colon there are a few tubular and tubulovillous. adenomas with focal to severe dysplasia (synonymously: profound intraepithelial. neoplasia), together with a poorly differentiated, mucinous adenocarcinoma in the area. of the right colic flexure with infiltration of the perimuscular adipose tissue and without. regional lymph node metastases (G3, pT3 LO V0 RO pNO 0/26). 2. : Further tubular mucosal adenoma with moderate dysplasia (synonymously: mild. intraepithelial neoplasia). 3. : Highly differentiated papillary mesothelioma (without any sign of malignancy) in the. area of the small intestinal serous membrane.",T3,N0,M0,T3N0M0
TCGA-AA-3976,"Diagnosis: Resected rectosigmoid sample including a moderately differentiated adenocarcinoma of the. colorectal type, located 3.5 cm aborally of the aboral resection margin, measuring max 2.3. cm in diameter, with infiltration of the tunica muscularis propria and two regional lymph. node metastases. Stage of tumor: pT2, pN1 (2/16) MX; G2, V0, R0.",T2,N1,M0,T2N1M0
TCGA-95-7567,"Anat Path Reports. Document Date: APRPT (Verified). Client: Submitting. Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. A. LYMPH NODES, #7, EXCISION, A1FS, A2FS, A3FS: - FRAGMENTED NODAL TISSUE, NEGATIVE FOR METASTATIC CARCINOMA. B. LYMPH NODES, 4R, EXCISION, B1FS, B2FS: SIX LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/6). C. LYMPH NODE, 11R, EXCISION, C1FS: - ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1). D. SKIN, RIGHT POSTERIOR CHEST, EXCISION: - SEBORRHEIC KERATOSIS. E. LYMPH NODES, POSTERIOR 11R, EXCISION: - TWO LYMPH NODES NEGATIVE FOR METASTATIC CARCINOMA (0/2). F. LYMPH NODE, 12R, EXCISION: Anat Path Reports. - FRAGMENTS OF ADENOCARCINOMA WITH DETACHED MINUTE FRAGMENT OF LYMPHOID TISSUE. G. LUNG, RIGHT UPPER LOBE, LOBECTOMY, G1FS, G2FS: - ADENOCARCINOMA, MIXED SUBTYPE, WITH SOLID AND MICROPAPILLARY PATTERNS. - THE TUMOR MEASURES 6.3 x 6.3 x 5.0 CM. - PERINEURAL INVASION IDENTIFIED. - VISCERAL PLEURAL INVASION IS IDENTIFIED. - RESECTION MARGINS NEGATIVE FOR CARCINOMA. - METASTATIC CARCINOMA INVOLVING ONE OF SEVEN PERIBRONCHIAL LYMPH NODES (1/7). - EMPHYSEMATOUS CHANGES. - SEE SYNOPTIC REPORT. Comment. Visceral pleural invasion is confirmed with an elastic stain. Il. Synoptic Worksheet. G. Right upper lobe: Specimen: Lobe(s) of lung: right upper. Procedure: Lobectomy. Specimen Integrity: Intact. Specimen Laterality: Right. Tumor Site: Upper lobe. Tumor Focality: Unifocal. Histologic Type: Adenocarcinoma, mixed subtype. Histologic Grade: G3: Poorly differentiated. Tumor Size: Greatest dimension: 6.3 cm. Additional dimension: 6.3 cm. Additional dimension: 5.0 cm. Visceral Pleura Invasion: Present. Tumor Extension: Not identified. Bronchial Margin: Uninvolved by invasive carcinoma. Involvement by squamous cell carcinoma in situ (CIS) not applicable. Vascular Margin: Uninvolved by invasive carcinoma. Parenchymal Margin: Not applicable. Parietal Pleural Margin: Uninvolved by invasive carcinoma. Chest Wall Margin: Uninvolved by invasive carcinoma. Other Attached Tissue Margin: Not applicable. All Margins Uninvolved By Invasive Carcinoma: Anat Path Reports. Distance of invasive carcinoma from closest margin: 5 mm. Margin closest to invasive carcinoma:: bronchial and vascular margins. Treatment Effect: Not applicable. Lymph-Vascular Invasion: Not identified. TNM Descriptors: Not applicable. Primary Tumor (pT): pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension. Regional Lymph Nodes (pN): pN1: Metastasis in ipsilateral peribronchial and/or lipsilateral hilar lymph. nodes, and intrapulmonary nodes, including involvement by direct extension. Involved nodal station(s): see above. Distant Metastasis (pM): Not applicable. Clinical History. Right lung cancer. Right thoracotomy. Adenocarcinoma, right lung. Right upper lobectomy. Specimen(s) Received. A: #7 lymph node. B: 4R lymph node. C: 11R Sump nod. D: Right posterior chest lesion. E: Posterior 11R Sump. F: 12R lymph node. G: Right upper lobe. Gross Description. Specimen A is received fresh for frozen section diagnosis, labeled with the patient's name, medical record number and as ""#7. lymph node."" The specimen consists of multiple soft tissue fragments measuring 2.5 x 2.0 x 1.0 cm in aggregate. Multiple lymph. node fragments are identified, and submitted entirely for frozen section diagnosis as ""A1FS"" through ""A3FS."" The remaining. adipose tissue is submitted in cassette ""A4."" Dictated by. Specimen B is received fresh for intraoperative diagnosis, labeled with the patient's name, medical record number and as ""4R. lymph node."" The specimen consists of a soft tissue fragment measuring 3.5 X 2.0 x 0.5 cm. Two lymph nodes are identified. measuring 1.5 and 1.2 cm in greatest dimension, respectively. The smaller lymph node is submitted entirely for. frozen. section. diagnosis as ""B1FS"" and the larger lymph node is submitted entirely for frozen section diagnosis as ""B2FS."" The remaining. adipose tissue is submitted in cassette ""B3"" and ""B4."" Dictated. Specimen C is received fresh for intraoperative consultation and is labeled ""11R sump node."" It consists of a single lymph node. measuring 8x08x04cm The specimen is submitted entirely for frozan cartion dinanacia in cassette ""C1FS."" This frozen. was done by. Specimen D consists of a skin ellipse measuring 5.0 X 1.1 cm excised to a depth of 1.2 cm. A crusted round lesion is present on. the skin surface measuring 1.4 x 0.9 cm and located less than 1.0 mm from one resection edge and 2.0 mm from the opposite. resection edge. Representative sections of the specimen are submitted as described below. D1: Skin tip. Anat Path Reports. D2: Opposite skin tip. D3-5: Lesional area, serially sectioned. Specimen E is received in formalin, labeled with the patient's name, medical record number and ""posterior 11R sump."" The. specimen consists of a fragment of soft tissue measuring 1.3 X 1.0 X 0.9 cm. The specimen is entirely submitted in cassette. ""E1.'. Specimen F is received in formalin, labeled with the patient's name, medical record number and ""12R lymph node."" The. specimen consists of soft tissue measuring 1.4 x 1.2 x 0.9 cm. The specimen is entirely submitted in cassette ""F1."" (Dictated by. Specimen G is received fresh for intraoperative consultation and labeled with the patient's name, medical record number and as. ""right upper lobe' The specimen consists of a lobe of lung measuring 18.0 x 9.0 X 7.5 cm, weighing 325 grams. A firm tumor. with irregular border and necrosis is present in the hilar invading the bronchus measuring 6.3 X 6.3 X 5.0 cm. The tumor is 0.5. cm from the bronchial and vascular margins, and abuts the pleura. Parietal pleura is focally adhered to the posterior lung, and is. identified by the surgeon, and inked blue. This area is 3.5 cm from tumor. A slightly firm nodule is present on the visceral pleura. adjacent to the parietal pleura measuring 0.6 X 0.4 x 0.3 cm. The remaining lung is unremarkable. The shave bronchial margin. is. submitted for frozen section diagnosis as ""G1FS."" A representative section of the tumor is submitted for frozen section. diagnosis as ""G2FS; and a touch prep of the tumor is submitted as ""G2TP."" The specimen is inked as follows: visceral pleura. black, parietal pleura blue Representative sections of the tumor and normal lung are submitted for Tissue Procurement. (Dictated by. G1FS: Bronchial margin, shave. G2FS: Representative section of tumor. G3: Vascular margins. G4: Tumor in relation to bronchus. G5: Tumor in relation to visceral pleura. G6,7: Representative sections of the tumor. G8: Representative sections of parietal pleura and visceral pleural nodule. G9: Representative sections of uninvolved lung. G10: One peribronchial lymph node, bisected. G11: One peribronchial lymph node, bisected. G12: Two peribronchial lymph nodes. G13: One peribronchial lymph node, bisected. G14,15: One peribronchial lymph node, bisected. Intraoperative Consult Diagnosis. A1FS-A3FS: #7 LYMPH NODE (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results communicated to the surgical team and were repeated back by. B1FS,B2FS 4R LYMPH NODE (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. C1FS: 11R NODE (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. G1FS: BRONCHIAL MARGIN (FROZEN SECTION): NEGATIVE FOR CARCINOMA. Anat Path Reports. G2FS,G2TP: TUMOR (FROZEN SECTION): ADENOCARCINOMA. Frozen section results were communicated to the surgical team and were repeated back by. Microscopic Description. Microscopic examination has been performed.",T2,N1,M0,T2N1M0
TCGA-DD-A4NV,"TISSUE DESCRIPTION: A1 B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 B11 B12 B13. Tissue from liver segment VI (needle core biopsy, two cores, 1.3 cm. in length and 1.5 cm in length) and separately submitted liver. segments V and VI (resection, 1445.0 grams, 21.4 x 13.8 x 11.4 cm) . DIAGNOSIS: Liver, segments V and VI, resection: Grade 1 to 2 (of 4). hepatocellular carcinoma forming multiple (2) masses (1.7 x 1.6 x. 1.5 cm and 11.8 x 11.3 x 10.2 cm) located 0.9 cm to the nearest. negative surgical resection margin. Also present, are multiple (6). bile duct hamartomas (ranging in size from 0.2 cm to 0.4 cm in. greatest dimension) . The surrounding hepatic parenchyma displays. steatohepatitis. Liver, segment VI, needle core biopsy Grade 1 to 2 (of 4). hepatocellular carcinoma.",T3,N0,M0,T3N0M0
TCGA-LK-A4O4,"FINAL DIAGNOSIS: Summary Statement. The left upper lobe wedge blopsies and left lower lobectomy demonstrate a diffuse malignant mesothelioma,. predominantly epithelloid type, involving the visceral parietal pleura and lung parenchyma with involvement of a level 11. lymph node. Pathology stage: T2N1Mx. PART 1: BONE, ""PORTION OF SIXTH RIB"", RESECTION -. PORTIONS OF NORMAL BONE AND BONE MARROW WITH HYPERCELLULARITY WITH TRILINEAGE. REPRESENTATION AND MATURATION. NO EVIDENCE OF MALIGNANCY. PART 2: LYMPH NODE, LEVEL 9 LYMPH NODE, BIOPSY -. SOLITARY LYMPH NODE WITH REACTIVE CHANGE. NO EVIDENCE OF MALIGNANCY. PART 3: LYMPH NODE, PERIAORTIC LYMPH NODE, BIOPSY -. THREE FRAGMENTS OF LYMPH NODE WITH REACTIVE CHANGE. NO EVIDENCE OF MALIGNANCY. PARTS 4,. 7, 8 AND 9: LUNG, ""LEFT UPPER LOBE WEDGE"", ""LEFT LOWER LOBE WEDGE"", ""LEFT LUNG"", AND ""LEFT LOWER. LOBE"", MULTIPLE WEDGE BIOPSIES WITH COMPLETION LEFT LOWER LOBECTOMY -. A. DIFFUSE MALIGNANT MESOTHELIOMA, PREDOMINANTLY EPITHELIOID TYPE, WITH INVASION OF THE. VISCERAL AND PARIETAL PLEURA AND LUNG. ALL EVALUABLE MARGINS FREE (see comment). B. RESPIRATORY BRONCHIOLITIS WITH EMPHYSEMATOUS CHANGE. C. FOREIGN BODY GIANT CELL REACTION TO EXOGENOUS MATERIAL (HISTORY OF PREVIOUS. PLEURECTOMY). D. FIVE (5) HILAR LYMPH NODES WITH NO EVIDENCE OF MALIGNANT MESOTHELIOMA. CALCIFIED. GRANULOMAS IDENTIFIED. E. HYALINE PLEURAL PLAQUES. PART 5: SOFT TISSUE, ""PLEURA"", BIOPSY -. PORTIONS OF FIBROADIPOSE TISSUE AND PLEURA ASSOCIATED WITH NERVES AND BLOOD VESSELS. NO. EVIDENCE OF MALIGNANCY. PART 6: LYMPH NODE, LEVEL 11 LYMPH NODE, BIOPSY -. A. SOLITARY LYMPH NODE WITH METASTATIC MALIGNANT MESOTHELIOMA. B. OLD FIBROCASEOCALCIFIC GRANULOMA. GROCOTT AND ACID FAST STAIN SHOW FOUR MICRON. BUDDING YEAST FORMS SUGGESTIVE OF HISTOPLASMA ORGANISMS. CORRELATION WITH CULTURE. STUDIES SUGGESTED.. PART 10: DIAPHRAGM, BIOPSY -. CHRONIC PLEURITIS WITH HYALINE PLEURAL PLAQUES. NO EVIDENCE OF MALIGNANCY. PART 11: LYMPH NODE, ""SEGMENT 11 LYMPH NODE"", BIOPSY -. THREE (3) FRAGMENTS OF LYMPH NODE WITH NO EVIDENCE OF MALIGNANT MESOTHELIOMA. COMMENT: The left lung specimens demonstrate a diffuse malignant mesothelioma, predominantly epithelloid type showing. papillary, hyaline and solid tumor growth associated with vascular invasion and focal extensive necrosis. The. mesothelloma is unequivocally predominantly of an epithelloid type although very focal zones of spindle growth are. identified. While the pleura show hyaline pleural plaques, the underlying lung parenchyma shows tobacco Induce lung injury,. predominantly respiratory bronchiolitis and emphysematous change. No evidence of diffuse fibrosis as one would. expect in asbestosis is seen, and iron stain failed to demonstrate significant numbers of asbestos type ferruginous. bodies.",T2,N1,M0,T2N1M0
TCGA-22-5479,"DIAGNOSIS: Lung, left, resection: Grade 3 (of 4) squamous cell carcinoma. forming a central 4.5 x 3.0 x 3.0 cm mass arising from the left. lower bronchus, near the bifurcation. No pleural invasion is. present. The bronchial lumen is occluded and distal obstructive. pneumonia is observed. The bronchial margin is negative. Multiple. (4) intrapulmonary peribronchial lymph nodes are negative for tumor. Lymph nodes, superior mediastinal, aortic, inferior mediastinal, and. N1, excision: Multiple superior mediastinal (17 right lower. paratracheal, 7 left lower paratracheal), aortic (3 subaortic),. inferior mediastinal (14 subcarinal), and N1 (1 hilar) lymph nodes. are negative for tumor.",T2,N0,M0,T2N0M0
TCGA-BF-A1Q0,Project #. Tissue. Specimen. Clinical. Ethnicity. Anatomical. Tumor. Specimen. Specimen. Index. label. Clinical Diagnosis. procuremen. Specificatio. Site #. (Race). Site. Matrix. Format. t. n. Caucasian. 1. Melanoma. Female. Skin. Primary. Tumor. Tissue. Frozen. (White). Caucasian. Melanoma. Female. Blood. n/a. normal. Blood. Frozen. (White). Prior. Chemo /. Number of. Container. Amount/per. Type of. Histological. TNM Stage. TNM Stage. TNM Stage. Chemo /. Prior. Cellular. Grade. Horm Th. containers. container. description. (T). (N). (M). Hormonal. Radiation. Tumor %. Details. Th. cryomold. 1. 200. mg. Melanoma. n/a. 4. 0. 0. 70. tube. 1. 4. ml. Blood draw. n/a. n/a. n/a. n/a. n/a. n/a.,T4,N0,M0,T4N0M0
TCGA-AC-A3EH,"Sex: Female. DIAGNOSIS. DIAGNOSIS: Breast, right, axillary contents; modified radical mastectomy and axillary node dissection: Tumor Characteristics: 1. Histologic type: Pleomorphic lobular carcinoma, confirmed by negative e-cadherin stain. 2. Size: 10.0 x 10.0 x 7.2 cm. 3. Tumor focality: Unifocal. 4. Elston modification of Bloom-Richardson grade: a. Architectural score: 3/3. b. Nuclear score: 2/3. C. Mitotic score: 1/3. d. Total score: 6/9 = Grade: II. 5. In situ component: Not identified. 6. Lymphovascular space invasion: Present. 7. Skin involvement Not identified. 8. Microcalcifications: Present and associated with invasive carcinoma. Surgical Margin Status: 1. Deep surgical margin free of tumor by 2.5 cm as measured grossly. Lymph Node Status: 1. Total number of lymph nodes received: 12. 2. Total number of lymph nodes containing metastatic carcinoma: 3. Size of largest metastasis: 2.5 cm. 4. Extracapsular extension of tumor: Present. Other: 1. pTNM stage: pT3 N2. CLINICAL INFORMATION: CLINICAL HISTORY: Preoperative Diagnosie: Right MET. Postoperative Diagnosis: Symptams/Radiologic Findings: SPECIMENS: Right breast and axillary contents. at. SPECIMEN DATA. GROSS DESCRIPTION: The specimen is received. right breast and axillary contents the specimen consists of a portion of fibroadipose breast tissue and overlying. skin that measures 18.0 by 8.0 cm and weighs 1,529 gm. The skin surface measures 23.0 x 13.8 cm is light tan wrinkled there is a scar within the outer. quadrant measuring 3.0 cm that is 9.2 cm in the nipple there is slight ecchymosis noted within the upper outer quadrant. No other lesions are identified. The. nipple. is. eccentrically. placed appears grossly unremarkable. Sectioning reveais a firm gray-tan lobular mass that measures 10.0 x 10.0 x 7.2 cm. that is centrally located it is within 2.5 cm of the deep margin of resection the surrounding breast tissue reveais yellow-tan fatty fibroadipose tissue with. areas. of. gray fibrous tissue. Attached to the specimen is a portion of axillary contents measuring 10.0 x 6.0 x 3.0 cm there are twelve possible lymph. nodes that measure from 0.3 to 2.7 cm. Received with the specimen is a separate piece of skin and underlying subcutaneous tisaue 14.0 x 4.0 x 1.5. cm. sectioning cut surface is yellow-tan fatty fibroadipose tissue lesions not identified grossly. Received with specimen are three cassettes labeled. with. a. yellow. one. additionally. labeled -16 green one additionally labeled - 17 and the blue one additionally labeled - 18. Representative. sections are submitted in cassettes labeled. las follows: Nipple - block 1; Deep margin overlying mass - block 2; Sections from the mass -. blocks 3-8; Random sections from the upper inner quadrant - block 9; Lower inner quadrant - block 10; Lower outer quadrant - block 11; Upper outer. quadrant - block 12; Six probable nodes - block 13; Two probable nodes each bisected - block 14; One probable node bisected block 15; One probable. node. trisected - block 16-18; One probable node bisected - block 19; One probable lymph node sectioned - blocks 20-23; Sections from separately.",T3,N3,M0,T3N3M0
TCGA-A6-3808,"SPECIMEN. Right colon. CLINICAL NOTES. PRE-OP DIAGNOSIS: Carcinoma right colon. GROSS DESCRIPTION. Received fresh for tissue procurement labeled ""right. colon"". is a previously unopened 15 cm. segment of proximal right. colon with attached 15 cm. distal ileum surfaced by smooth to. scabrous tan pink serosa with a copious amount of attached. mesocolon. and mesentery. No appendix is present. The proximal and distal. margins measure 3.2 and 5.2 cm. in circumference respectively. On. opening there is a well circumscribed, 4.4 x 4.0 cm. rubbery tan. white-red tumor mass within the cecal pouch, 1 cm. distal to the. ileocecal valve. A portion of tumor and a portion of normal are. submitted for tissue procurement as requested. On sectioning, the. tumor has a maximal thickness of 1.1 cm., grossly extending through. the muscularis to within 0.1 cm. of the inked free serosal surface. The ileal mucosa and remaining colonic mucosa is unremarkable. glistening tan pink with irregular folds and the walls average 0.5. cm. in thickness. Multiple soft pale tan to tan pink tissues in. keeping with lymph nodes measuring up to 1.4 cm. in greatest. dimension are recovered from the attached mesocolon and mesentery. Representative sections are submitted in 13 blocks as labeled. RS13. BLOCK SUMMARY: 1 - Proximal and distal margins; 2-4 - tumor full. thickness to inked free radial serosal surface; 5 - tumor to. normal;. 6 - ileum; 7 - ICB; 8 - colon; 9 and 10 - eight whole lymph nodes. per cassette; 11 - six whole lymph nodes; 12 and 13 - one bisected. lymph node per cassette. MICROSCOPIC DESCRIPTION. Histologic type: Adenocarcinoma with mucinous differentiation. Histologic grade Moderately-differentiated. Primary tumor (pT) : Tumor invades through the muscularis propria. into the pericolonic fat (pT3). Proximal margin: Negative. Distal margin: Negative. Circumferential (radial) margin: Negative. Vascular invasion: Negative. Regional lymph nodes (pN) : 24 lymph nodes are negative for. metastatic carcinoma (pN0). Non-lymph node pericolonic tumor: Absent. Distant metastasis (pM) : Cannot be assessed (pMx) . DIAGNOSIS. Colon, right and terminal ileum, resection: Invasive moderately-differentiated colonic adenocarcinoma with. mucinous differentiation extending through the wall of the colon. into the pericolonic fat. The proximal, distal and radial margins of resection are free of. tumor. Twenty four mesenteric lymph nodes are negative for. metastatic carcinoma (0/24).",T3,N0,M0,T3N0M0
TCGA-IB-AAUM,"CONFIDENTIAL. Demographics (for. verification purposes). Date of Birth: Sex: M. Collected Date/Time. Received Date/Time. (Pager: Specimen Description. A: Paraportal lymph node at. B: Gallbladder at. C: Whipple at. D: Distal bile duct margin at. E: Pancreatic bile duct margin at. F: Retroperitoneal margin at. Clinical Information. Pancreatic cancer, tumor. Infectious patient: No. Immunocompromised: Not given. History of neoplasm: Not given. Diagnosis. A: Paraportal Lymph Node: Fibrofatty tissue only. B: Gallbladder: Chronic cholecystitis. C: Whipple: Ductal carcinoma, mucinous variant. Pancreatic intraepithelial neoplasia. One peripancreatic lymph node with metastatic carcinoma present. by the bile duct margin (positive margin). D: Distal Bile Duct Margin: Negative for malignancy. E: Pancreatic Bile Duct Margin: Negative for malignancy. F: Retroperitoneal Margin: Negative for malignancy. Verified: Synoptic Report. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G3: Poorly differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades duodenal wall. MARGINS : Margin (s) involved by invasive carcinoma. Common bile duct margin. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy) : No prior treatment. LYMPH-VASCULAR INVASION: Not identified. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT). pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. REGIONAL LYMPH NODES (pN) : pN1: Regional lymph node metastasis. Number examined: 1. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN low grade ). Gross Description. Received are specimen containers A to F. All remisitions and specimen containers are. labelled with the patient's name,. The cassettes and. identifiers. are labelled with the Surgical Number. A: The specimen is received fresh and is subsequently placed into formalin and. designated as A paraportal lymph node and contains a yellow hemorrhagic irregular portion. of adipose tissue measuring 3.8 cm in maximum dimension. Specimen is serially sectioned. No possible lymph nodes are identified on the cut surface. A1/2. serial sectioned specimen in toto. B: The specimen is received fresh and is subsequently placed into formalin and. designated as B gallbladder and contains a non intact gallbladder measuring 7.5 x 3.2 x. 1.5 cm. Cystic duct resection margin is identified and appears patent. Cystic duct. lymph node is not grossly identified. The serosal surface reveals slightly congested. smooth glistening appearance. The advential surface is non intact and reveals green. stained roughened appearance. Mucosal surface of the gallbladder reveals dark brown. slightly velvety appearance. No stones are identified inside the lumen or in the. container. The wall thickness of the gallbladder ranges from 0.1 to 0.5 cm. A thickened. area of the wall is identified at the neck and body. B1. sections from neck, body, and fundus, cystic duct resection margin. B2. further sections from the thickened area of the wall. C: The specimen is received fresh and is subsequently placed into formalin and. designated as C Whipple and contains a portion of distal stomach with attached portion. of. duodenum and attached portion of pancreas. The portion of distal stomach measures 5 cm. in length and 6 cm circumference at the proximal resection margin. The attached adipose. tissue at the proximal end measures 2.3 cm in maximum depth. The mucosal surface of the. distal end of the stomach reveals multiple tan mucosal nodules. These nodules range from. less than 0.1 to 0.4 cm. These nodules are spreading circumferentially in an area. measuring 6 cm transversely by 1.8 cm longitudinally. This nodular area comes to within. 2.3 cm of the closest proximal resection margin and 4 cm away from the ampulla of Vater. Cut surface of the nodular area reveals light tan homogeneous appearance contained in the. wall of the stomach. This homogeneous area comes to within 0.2 cm of the serosal surface. of the stomach. The remaining mucosal surface of the stomach reveals grossly. unremarkable. The attached portion of duodenum measures 19.5 cm in length and 10 cm. circumference at the distal resection margin. A light tan firm polypoid lesion is. identified on the mucosal surface of the proximal duodenum measuring 1.2 cm transversely. by 1.1 cm longitudinally. This area comes to within approximately 1.5 cm of the distal. end of the stomach, 16.5 cm of the distal resection margin of the duodenum, 5.8 cm of. the. proximal resection margin of the stomach. This area also identified 1.4 cm proximal to. the ampulla of Vater. The mucosal surface surrounding the ampulla of Vater reveals. multiple mucosal polyps ranging from 0.3 to 0.5 cm. The mucosal surface between the. polypoid lesion on the proximal end of the duodenum and ampulla of Vater reveals slightly. congested firm appearance. This area measures 2.1 x 2 cm. Cut surface of the firm. polypoid area on the proximal mucosa surface of the duodenum reveals light tan. homogeneous appearance grossly extending to the bowel wall and grossly coming to within. 0.2 cm of the pancreatic tissue. The homogenous area measures 0.5 cm in maximum depth. A tan sessile polyp is identified distal to the ampulla of Vater and measures 0.6 cm in. maximum dimension. This polyp is identified 3 cm away from the slightly congested firm. area on the mucosal surface surrounding the ampulla of Vater. The remaining mucosal. surface of the duodenum reveal tan to congested otherwise grossly unremarkable. appearance. The serosal surface of the duodenum reveals tan smooth appearance. The attached pancreas measures 5.7 x 4 x 1.5 cm. The pancreatic neck margin is marked. with orange dye and the distal pancreatic margin is marked with blue dye. The vessel bed. is marked with green dye. The bile duct resection margin is identified and measures 0.5. cm at the distal end. The cut surface of the pancreas reveals light tan ill defined. slightly firm area occupying more than 50% of the cut surface of the pancreas and. approximately measuring 3 x 1.5 x 1 cm. This area grossly comes to within less than 0.1. cm of the orange inked pancreatic margin and grossly extending to the vessel bed and the. distal pancreatic margin. The inner wall of the bile duct reveals tan grossly unremarkable appearance, however, the. lumen circumference of the bile duct ranges from 0.9 to 2.4 cm. The most dilated area of. the lumen is identified at the distal end and this area measures 3 cm in length. Photos. are taken. Sections are submitted as follows: C1. distal bile duct resection margin. C2/3. longitudinal sections from the proximal end of the stomach including. polypoid nodular. area on the mucosal surface (distal margin margin with blue dye). C4. remaining proximal resection margin of the stomach shaved and in toto. C5-7. further sections from the nodular area on the mucosal surface of the distal. stomach. C8/9. contiguous sections bisected from proximal to distal including nodular area. on the distal. stomach and light tan firm polypoid lesion on proximal duodenum. C10-14. sections from light tan firm polypoid lesion in toto, C10 including portion. of bile duct and. C13/14 including pancreatic tissue and pancreatic duct. C15-17. polypoid area of the ampulla of Vater in toto including adjacent pancreatic. tissue. C18/19. further sections from the bile duct, longitudinal sections, also including. pancreatic tissue. C20. slightly firm congested area surrounding the ampulla of Vater in toto. C21. tan sessile polyp on the duodenal mucosa in toto. C22. random sections from the remaining duodenal mucosa. C23-25. distal duodenal resection margin shaved. C26-29. sections from the pancreatic tissue including pancreatic neck margin, vessel. bed, and. pancreatic distal margin. D: The specimen consists of soft tissue fragment 0.8 x 0.3 x 0.2 cm, submitted in toto. for frozen section. Specimen is received fresh. The container is designated D distal bile duct margin. E: The specimen consists of soft tissue fragment 1.2 x 0.8 x 0.2 cm, submitted in toto. for frozen section. The specimen is received fresh and designated E pancreatic duct margin. F: The specimen consists of soft tissue fragment 0.9 x 0.7 x 0.2 cm, submitted in toto. fro frozen section. Specimen is received fresh. The container is designated F retroperitoneal margin. Frozen Section Diagnosis. D: Distal Bile Duct Margin: Negative for malignancy. E: Pancreatic Duct Margin: Negative for malignancy. F: Retroperitoneal Margin: Negative for malignancy. Encounter Number. Patient Location.",T2,N1,M0,T2N1M0
TCGA-A1-A0SF,"Working Draft. CELLULAR CHANGES WITHIN NORMAL LIMITS. Inflammation. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Specimen Class: Accessioned: Specimen(s) Received: Endometrium, biopsy. Final Diagnosis. Endometrium, biopsy: Benign dyssynchronous secretory endometrium; no hyperplasia or carcinoma. identified. Specimen Class: Accessioned: Signed Out: (. Specimen(s) Received: Cervical. Endocervical, Direct. Final Diagnosis. Cervical/Endocervical, Direct. CELLULAR CHANGES WITHIN NORMAL LIMITS. Inflammation. Endocervical cells present. SPECIMEN ADEQUACY: Satisfactory for evaluation but limited by obscuring white blood cells. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Direct. Final Diagnosis. Cervical/Endocervical, Direct. CELLULAR CHANGES WITHIN NORMAL LIMITS. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Specimen Class: Accessioned. Specimen(s) Received: Bladder Washing. Final Diagnosis. Bladder Washing. BENIGN. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Urine, catheterized. Final Diagnosis. BENIGN. See Below. Specimen Class: Accessioned. {HighRisk Specimen}. Specimen(s) Received: Vaginal/Cervical/Endocervical. Final Diagnosis. CELLULAR CHANGES WITHIN NORMAL LIMITS. Squamous metaplasia. SPECIMEN ADEQUACY: Satisfactory for evaluation. Endocervical cells present. Specimen Class: Accessioned. Specimen(s) Received: BLADDER WASH. Final Diagnosis. BENIGN. Conversion. Specimen Class: Accessioned: Specimen(s) Received: BLADDER WASH. Final Diagnosis. BENIGN. Conversion. Specimen Class: Accessioned: Specimen(s) Received: BLADDER WASH. Fina) Diagnosis. BENIGN. Conversion. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: VAGINALCERVICAU/ENDOCERVICAI. Final Diagnosis. BETHESDA: CELLULAR CHANGES WITHIN NORMAL LIMITS. BENIGN. Inflammation. Conversion. Specimen Class: Accessioned: Specimen(s) Received: URINE, CATHETERIZED. Final Diagnosis. BENIGN. Conversion. Specimen Class: Accessioned: Signed Out: &. Specimen(s) Received: VAGINAL/CERVICAL/ENDOCERVICAL. Final Diagnosis. DESCRIPTIVE DIAGNOSIS. Diagnosis Deferred. Conversion. Specimen Class: Accessioned: Specimen(s) Received: SITE NOT SPECIFIED. Final Diagnosis. DESCRIPTIVE DIAGNOSIS. Diagnosis Deferred. Inflammation. Conversion. Specimen Class: Accessioned. Specimen(s) Received: VAGINAL/CERVICAL/ENDOCERVICAL. Final Diagnosis. BENIGN. Conversion. FND OF REPORT. Final Pathologic Diagnosis: A. Sentinel lymph node #1, left axilla, biopsy: No carcinoma identified in one lymph. node (0/1). B. Sentinel lymph node #2, left axilla, biopsy: No carcinoma identified in one lymph. node (0/1). Working Draft. C. Left breast, mastectomy;. 1. Infiltrating ductal carcinoma, SBR grade 2, 2.4 cm; see comment. 2. Intermediate to high grade ductal carcinoma in-situ, cribriform and comedo types. 3. Non-proliferative fibrocystic changes. 4. Duct ectasia. D. Right breast, mastectomy: 1. Atypical lobular hyperplasia. 2. Non-proliferative fibrocystic changes. 3. Duct ectasia. 4. Microcalcifications associated with benign ducts and stroma. 5. No carcinoma identified. E. Soft tissue, right breast, excision: Fibroadipose tissue with skeletal muscle; no breast. parenchyma or carcinoma identified. F. Left ovary and fallopian tube, salpingooophorectomy: - Ovary: No significant pathologic abnormality. - Fallopian tube: Benign paratubal cyst. G. Right ovary and fallopian tube, salpingooophorectomy: - Ovary: No significant pathologic abnormality. - Fallopian tube: Benign paratubal cyst. H. Omentum, biopsy: Benign fibrous nodule. I. Soft tissue, left upper peritoneum, biopsy: Benign fibroadipose tissue. J. Omentum, omentectomy: No significant pathologic abnormality. Note: Breast Tumor Synoptic Comment. - Laterality: Left. - Invasive tumor type: Infiltrating ductal. - Invasive tumor size: 2.4 cm maximum diameter. - Invasive tumor grade (modified Bloom-Richardson): Nuclear grade: 3, 3 points. Mitotic count: 7 mitotic figures/1 HPF, 1 point. Tubule/papilla formation: > 10% but <75%, 2 points. Total points and SBR grade - 6 points, grade 2. - Lymphatic-vascular invasion: None identified. - Perineural invasion: None identified. - Invasive tumor necrosis: None identified. - Mononuclear cell reaction: None/minimal. - Resection margins for invasive tumor: Widely clear. - Deep margin: Widely clear; closest distance of tumor 2 cm. - Medial margin: Widely clear; closest distance of tumor > 6 cm. - Lateral margin: Widely clear; closest distance of tumor 2.8 cm. Anterior/superior margin: Widely clear; closest distance of tumor 5.5 cm. Anterior/inferior margin: Widely clear; closest distance of tumor >6 cm. - Ductal carcinoma in situ (DCIS) type: Cribriform and comedo. - Ductal carcinoma in situ size: ~2.0 cm in maximum diameter. Ductal carcinoma in situ nuclear grade: Intermediate to high grade. - Necrosis in ductal carcinoma in situ: Present. - Microcalcifications: Not identified. Working Draft. - Resection margins for ductal carcinoma in situ: Widely clear (see above for invasive tumor. - Lobular carcinoma in situ (LCIS): Not identified. - Number of lobules involved: N/A. - Nuclear type/size: N/A. - Resection margins for pleomorphic lobular carcinoma in situ: N/A. - Lymph node status: Negative. - Number of positive lymph nodes: 0. - Total number sampled: 2. - AJCC/UICC stage: pT2NOMx. - Nontumorous breast tissue: Non-proliferative fibrocystic change; duct ectasia. - Nipple: Unremarkable. - Skin/dermis: Unremarkable. Pagetoid spread of carcinoma is seen in benign ducts adjacent to the tumor. No such spread is seen away. from the tumor. Atypical lobular hyperplasia is present in the contralateral (right) breast. An immunohistochemical test for estrogen and progesterone receptors as well as for HER2 was performed. on block C3. The test for estrogen receptors is positve. There is moderate nuclear staining in >95% of tumor cells. Internal positive control is positive. The test for progesterone receptors is positive. There is moderate to strong nuclear staining in 90% of. tumor cells. Internal positive control is positive. Result of HER2/neu test: This carcinoma is negative for HER2/neu oncoprotein over-expression. An immunohistochemical assay was performed using the CB11 monoclonal antibody to HER2/neu. oncoprotein. The staining intensity of this carcinoma was 1 on a scale of 0-3 (HER2 test interpreted by. Dr. Carcinomas with staining intensity scores of o or 1 are considered negative for over-expression of HER2/neu oncoprotein. Those with a staining intensity score of 2 are considered borderline. We and others have observed that many carcinomas with staining. intensity scores of 2 do not show gene amplification. All carcinomas with staining intensity scores of 2 are therefore submitted for. FISH testing. The results of the FISH test are issued directly from the molecular cytogenetics laboratory. Carcinomas with staining intensity scores of 3 are considered positive for over-expression of HER2/neu oncoprotein. Tumors in this. category show an excellent correlation between the results of immunohistochemical and FISH testing, and almost always show gene. amplification. Intraoperative Consult Diagnosis. FS1 (A) Sentinel lymph node # 1, left axilla, biopsy: No carcinoma. FS2 (B) Sentinel lymph node #2, left axilla, biopsy: No carcinoma. FS3 (G) Right adnexa, salpingo-oophorectomy: Paratubal cyst with hemorrhage. FS4 (H) Omentum, biopsy: Dense fibrous connective tissue, no carcinoma. FS5 (I) Left upper quadrant, peritoneum, biopsy: No carcinoma. F. Left adnexa, salpingo-oophorectomy: Paratubal cyst (gross diagnosis only). Clinical History. Working Draft. The patient is a .year-old woman with left breast cancer. She undergoes bilateral mastectomies. Gross Description. The specimen is received in ten parts, each labeled with the patient's name and unit number. Parts A. through I are received fresh, and Part J is received in formalin. Part A, additionally labeled ""1. consists of one pink, unoriented,. fibroadipose tissue fragment measuring 1.5 x 0.8 x 0.8 cm. The entire specimen is frozen for frozen. section diagnosis 1, and subsequently submitted in cassette A1. Part B, additionally labeled. consists of one pink-red, unoriented,. fibroadipose tissue fragment measuring 1.3 x 0.8 x 0.7 cm. The entire specimen is frozen for frozen. section diagnosis 2, and subsequently submitted in cassette B1. Part C is additionally labeled. It consists of a mastectomy specimen, measuring. 15.8 cm from superior to inferior, 15.6 cm from medial to lateral, and 8.2 cm from anterior to posterior. The specimen weighs 442.5 gm. In the lateral aspect of the specimen is a spiculated, firm, tan mass,. measuring 2.4 x 1.2 x 1.2 cm. This mass is 2.0 cm from the deep margin, 5.5 cm from the superior. margin, >6 cm from the inferior margin, 2.8 cm from the lateral margin, and >6 cm from the medial. margin. In the anterior-inferior portion of the breast, there are dilated ducts, filled with cheesy material. This area is 0.2 cm from the deep margin. The remainder of the breast parenchyma is unremarkable. Two. pieces of tumor are banked, one for tissue banking and one for the epithelial cell study. Representative. sections are submitted as follows: Cassette C1: Nipple. Cassettes C2-C3: Spiculated mass. Cassette C4: Deep margin beneath tumor. Cassette C5: Lateral margin. Cassette C6: Lower outer quadrant. Cassette C7: Lower inner quadrant. Cassette C8: Medial margin. Cassette C9: Upper inner quadrant. Cassette C10: Anterior-inferior area with duct ectasia. Part D is additionally labeled. It consists of a mastectomy specimen, measuring. 18.2 cm from superior to inferior, 16.2 cm from medial to lateral, and 4.8 cm from anterior to posterior. The specimen weighs 688 gm. A short stitch is designated by the surgeon as superior, and a long stitch is. designated by the surgeon as lateral. In the inferior-medial portion of the specimen is a fragment of skin,. measuring 7.5 x 4.9 cm. It is white and unremarkable. There is a nipple, measuring 1.3 x 1.5 x 1.6 cm. The specimen is notable for dilated ducts with a viscous, yellow-tan material within them. This material. extends into one of the nipple ducts. No masses are noted, nor are any areas suspicious for DCIS. appreciated. The anterior-superior portion of the specimen is inked blue, the anterior-inferior portion of. the specimen is inked green, and the posterior aspect of the specimen is inked black. Multiple sections of. unremarkable breast parenchyma are taken for two studies, including a high-risk study and an epithelial. cell study. Representative sections are submitted as follows: Cassettes D1-D2: Nipple and surrounding skin. Cassette D3: Representative section of anterior-inferior breast with dilated duct. Cassette D4: Representative section of lower inner breast with dilated ducts. Cassette D5: Representative section of upper inner breast. Cassette D6: Representative section of medial breast. Cassette D7: Representative section of upper outer breast. Cassette D8: Representative section of upper inner breast. Cassette D9: Representative section of lateral breast. Part E is additionally labeled. It consists of a single irregular fragment of soft, yellow tissue, measuring 5.4 x 3.8 x 1.5 cm. A suture. has been placed on one aspect of the specimen and is designated the new margin. That aspect of the. specimen is inked black, and the specimen is serially sectioned and entirely submitted in cassettes E1. through E5. Part F is received fresh labeled,. It consists of an. Working Draft. ovary, measuring 4.3 x 2 x 0.8 cm, with attached fallopian tube, measuring 0.8 x 0.5 x 6 cm. There is a. simple paratubal cyst, measuring 1.5 x 1.5 x 0.5 cm. This is received undisrupted, with a thin 0.1 cm. translucent wall, and contains 20 CC of clear fluid. In addition, there is a second small paratubal cyst,. measuring 0.5 x 0.5 x 0.5 cm. The ovary is serially sectioned, and no abnormalities are detected, other. than a 0.5 x 0.5 x 0.5 cm small white firm area. The fallopian tube is serially sectioned, and no. abnormalities are detected. Cassettes are submitted as follows: Cassettes F1-F9: Ovary, entirely submitted (firm, white area in cassette F7). Cassettes F10-F12: Fallopian tube, entirely submitted. Cassette F13: Representative section of the paratubal cyst and smaller, 0.5-cm paratubal cyst. Cassette F14: Representative section of broad ligament. Part G is additionally labeled. It consists of an ovary with attached fallopian tube,. weighing 15.9 gm. There is a disrupted hemorrhagic, cystic mass in the broad ligament, measuring 2.3 x. 1.6 x 1.5 cm, no capsule is visualized. A representative section of the cystic mass is submitted for frozen. section diagnosis as FS3. The ovary and tube do not appear involved by the lesion. The ovary is inked. black, it contains a simple corpus luteal cyst measuring 1.5 x 1.6 x 0.8 cm. The ovary measures 3.5 x 3. x. 1 cm, and the tube measures 6.5 x 0.8 cm. The ovary and fallopian tube are serially sectioned, and no. abnormalities are detected. Cassettes are submitted as follows: Cassettes G1-G6: Ovary, entirely submitted. Cassettes G7-G10: Fallopian tube, entirely submitted. Cassettes G11-G12: Lesion in broad ligament, entirely submitted. Cassette G13: Frozen section remnant. Part H is additionally labeled. It consists of an unoriented piece of yellow,. adipose tissue, measuring 5 x 1.3 x 0.4 cm, with a white-tan, soft nodule, measuring 0.3 x 0.3 x 0.3 cm,. attached to one end. This is entirely submitted for frozen section diagnosis as FS4, with the frozen. section remnant submitted in cassette H1. The remaining omentum is entirely submitted in cassette H2. Part I is additionally labeled. It consists of multiple unoriented. fragments of tissue, measuring 1 x 0.3 x 0.1 cm in aggregate. The specimen is entirely submitted for. frozen section diagnosis as FS5, with the frozen section remnant submitted in cassette 11. Part J is additionally labeled. It consists of an aggregate of fatty tissue, measuring 4 x 2 x 0.5. cm. No abnormalities are detected. Tne specimen is entirely submitted in cassettes J1 through J3. /Pathology Resident. Fee Codes: Other Specimens. Specimen Class: Accessioned: Specimen(s) Received: Right Breast, Fine Needle Aspiration. Final Diagnosis. Right Breast, Fine Needle Aspiration: Benign scar tissue, see comment. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Vaginal/Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Vaginal/Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Reactive cellular changes. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: Right Breast, implant capsule. Final Diagnosis. Right breast, implant capsule, capsulectomy: Peri-prosthetic capsule. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. No transformation zone components are identified. Specimen Class: Accessioned: Specimen(s) Received: Endometrium, biopsy. Final Diagnosis. Endometrium, biopsy: Fragments of benign endocervical tissue and no definitive. endometrium, see comment. Working Draft. Specimen Class: Accessioned: Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: A: Left breast capsule, B: Right breast capsule. Final Diagnosis. A. Breast capsule, left, excision: Dense fibrous tissue with chronic inflammation. B. Breast capsule, right, excision: Dense fibrous tissue with chronic inflammation. Specimen Class: Accessioned: Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Atrophic changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned: Specimen(s) Received: A: Skin, biopsy, shave, right scalp, B: Skin, biopsy, shave, left scalp, C: Skin, biopsy, punch, left upper. arm. Final Diagnosis. (Final Report Not Signed Out}. {Not Entered}. Specimen Class: Accessioned. Specimen(s) Received: A: Pelvic Washing, B: Diaphragm Washing. Working Draft. Final Diagnosis. A: Pelvic Washing. BENIGN. Reactive mesothelial cells. B: Diaphragm Washing. BENIGN. Reactive mesothelial cells. Specimen Class: Accessioned: Specimen(s) Received: Left Breast, Fine Needle Aspiration. Final Diagnosis. Left Breast, Fine Needle Aspiration: Adenocarcinoma, morphologically consistent. with a primary breast carcinoma. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Thin Prep Imaged. Final Diagnosis. Cervical/Endocervical, Thin Prep Imaged. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. Reactive cellular changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned: Specimen(s) Received: Right foot foreign body. Final Diagnosis. Foot, right, excision: Fragment of hyperkeratotic squamous epithelium. Specimen Class: Accessioned. Specimen(s) Received: Cytology, GYN, Site Not Specified, Thin Prep. Final Diagnosis. Cytology, GYN, Site Not Specified, Thin Prep. Working Draft. NEGATIVE FOR INTRAEPITHELIAL. LESION OR MALIGNANCY. Reactive cellular changes. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: Cervical/Endocervical, Thin Prep. Fina) Diagnosis. Cervical/Endocervical, Thin Prep. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. SPECIMEN ADEQUACY: Satisfactory for evaluation. Transformation zone components are present. Specimen Class: Accessioned. Specimen(s) Received: Vaginal/Cervical/Endocervical, Direct. Final Diagnosis. Vaginal/Cervical/Endocervical,Direct. CELLULAR CHANGES WITHIN NORMAL LIMITS. Endocervical cells present. SPECIMEN ADEQUACY: Satisfactory for evaluation but limited by obscuring white blood cells. Gpecimen Class: Accessioned: Specimen(s) Received: Skin, biopsy, left chin. Final Diagnosis. {Final Report Not Signed Out}. (Not Entered}. Specimen Class: Accessioned. Specimen(s) Received: Cervical, Direct. Final Diagnosis. Cervical, Direct.",T2,N0,M0,T2N0M0
TCGA-B0-5108,"FINAL DIAGNOSIS. KIDNEY, LEFT, NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CLEAR CELL TYPE, CONVENTIONAL (CLEAR CELL TYPE) WITH CYSTIC AND. MYXOID CHANGES. B. FUHRMAN NUCLEAR GRADE IS 2 OF 4. C. THE GREATEST DIAMETER OF THE NEOPLASM IS 5.5 CM. D. THE CARCINOMA EXTENDS TO THE RENAL SINUS FAT (SLIDES E AND F). E. THE NEOPLASM IS CONFINED TO THE RENAL CAPSULE. F. NO RENAL VEIN INVASION IS IDENTIFIED. G. NO EVIDENCE OF ANGIOLYMPHATIC INVASION IS IDENTIFIED. H. ALL SURGICAL MARGINS ARE FREE OF THE NEOPLASM. I. THE NON-NEOPLASTIC KIDNEY SHOWS CHRONIC INTERSTITIAL INFLAMMATION. J. TNM STAGE: pT3a NX MX.",T3,N0,M0,T3N0M0
TCGA-H7-8502,"Operative Procedure: Bilateral neck dissection, mandible resection. A: Right perifacial lymph node. B: Level 1A neck dissection. C: Right mental nerve. D: Right masseter margin. E: Right buccal fat pad margin. F: Right distal lingual nerve. G: Right hammulus. H: Right proximal lingual nerve. I: Deep soft palate margin. J: Right composite mandible resection. K: Additional right lateral pterygoid. L: Right lateral pterygoid margin. M: Additional right medial pterygoid. N: Right parapharyngeal fat margin. O: Right medial pterygoid margin. P: Floor of mouth. Q: Right tongue base. R: Right hard palate. S: Right soft palate. T: Right lateral pharyngeal wall. U: Right buccal. V: Right neck dissection 2-4. W: Right proximal mandible margin. X: Right distal mandible margin. Final Pathologic Diagnosis: Mandible composite, right, mandibulectomy: Keratinizing squamous cell. carcinoma, moderately differentiated. Histologic type/grade: Keratinizing squamous cell carcinoma,. moderately differentiated. Tumor size: 5.4 cm (greatest dimension). Depth of invasion: 2.9 cm (greatest dimension). Lymph-vascular invasion: Identified. Perineural invasion: Identified. Tumor site: Right retromolar trigone. Tumor focality: Unifocal. Margins: Margins involved by invasive carcinoma. Specify margin, per orientation: Proximal (posterior) bone margin positive on permanent sections. Margins involved by moderate epithelial dysplasia. Specify margin, per orientation: Right hard and soft palate, right lateral pharyngeal wall. Lymph nodes, extranodal extension: Metastatic squamous cell carcinoma. (2/40 positive, maximal dimension 2.0 cm, extranodal extension identified). Pathologic staging (pTNM): TNM descriptors: None. Primary tumor: pT4a. Regional lymph nodes: pN2b. Number examined: 40. Number involved: 2 (size of the largest positive lymph node: 2.0 cm). Distant metastasis: pMX. Additional pathologic findings: None. Specimen: Right mandible. In formalin. Procedure: Mandibulectomy, right. Specimen size: 9.0 X 8.5 X 6.1 cm. Specimen laterality: Right. A. Lymph node, right perifacial, resection: Three lymph nodes, negative for malignancy (0/3). B. Lymph node, 1A, neck dissection: One lymph node, negative for malignancy (0/1). C. Nerve, right mental, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. D. Masseter, right, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. E. Buccal fat pad, right, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. F. Nerve, right distal lingual, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. G. Hamulus, right, excision: Negative for malignancy. H. Nerve, right proximal lingual, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. I. Soft palate, deep margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. J. Mandible, right, resection. Squamous cell carcinoma -- see synoptic report above. Five benign lymph nodes (0/5). K. Lateral pterygoid, additional right, biopsy: Negative for malignancy. L. Lateral pterygoid, right margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. M. Medial pterygoid, additional right, biopsy: Negative for malignancy. N. Parapharyngeal fat, right margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. O. Medial pterygoid, right margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. P. Mouth, floor, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. Q. Tongue, right base, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. R. Hard palate, right, biopsy: Moderate epithelial dysplasia, negative for invasion. Frozen section diagnosis confirmed. S. Soft palate, right, biopsy: Moderate epithelial dysplasia, negative for invasion. Frozen section diagnosis confirmed. T. Pharyngeal wall, right lateral, biopsy: Moderate epithelial dysplasia, negative for invasion. Frozen section diagnosis confirmed. U. Right buccal biopsy: Negative for malignancy. Frozen section diagnosis confirmed. V. Lymph node, right, neck dissection, 2-4: Metastatic squamous cell carcinoma (2/30 lymph nodes involved, maximal. dimension 2.0 cm, extranodal extension present). W. Mandible, right proximal margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. X. Mandible, right distal margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. The examination of this case material and the preparation of this report were. Intraoperative Consult Diagnosis: FSC: Right mental nerve: No tumor in sections examined. FSD: Right masseter margin: No tumor in sections examined. FSE: Right buccal fat margin: No tumor in sections examined. F/S TAT: 20 mins. FSF: Right distal lingual nerve: No tumor in sections examined. FSH: Right proximal lingual nerve: No tumor in sections examined. FSI: Deep soft palate margin: No tumor in sections examined. FSL: Right lateral pterygoid margin: No tumor in sections examined. FSN: Right parapharyngeal fat margin: No tumor in sections examined. F/S TAT: 30 mins. FSO: Right medial pterygoid margin: No tumor in sections examined. FSP: Floor of mouth: No tumor in sections examined. FSQ: Right tongue base: No tumor in sections examined. FSR: Right hard palate: No tumor in sections examined. FSS: Right soft palate: No tumor in sections examined. F/S TAT: 50 mins. FST: Right lateral pharyngeal wall: Focal squamous dysplasia-favor low grade. FSU: Right buccal: No tumor in sections examined. F/S TAT: 50 mins. FSW: Right proximal mandible margin: No tumor in sections examined. FSX: Right distal mandible margin: No tumor in sections examined. F/S TAT: 10 mins. Gross Description: A. Received in formalin, labeled ""right perifacial lymph. nodes"" are two tan-pink, irregular, lobulated soft tissues, 0.8 X 0.3 X 0.2 cm. and 2.3 X 0.9 X 0.2 cm, submitted in toto in one cassette. B. Received in formalin, labeled ""level 1A neck dissection"". is a 3.9 X 3.0 X 0.8 cm tan, lobulated irregular fatty tissue. A submandibular. gland is not present. Sectioning reveals two tan-pink, rubbery possible lymph. nodes, 0.2 cm and 0.4 cm. Representative sections are submitted as follows: B1. one whole lymph node bisected;. B2. one whole possible lymph node. C. Received without fixative labeled ""right mental nerve"" is. a. 0.4 X 0.3 X 0.2 cm tan, irregular soft tissue, submitted in toto for frozen. section microscopy, now in cassette C. D. Received without fixative labeled ""right masseter margin"". is a 1.8 X 0.7 X 0.4 cm tan, irregular soft tissue. A representative section is. submitted for frozen section microscopy, now in cassette D1. The remaining. tissue is entirely submitted in cassette D2. E. Received without fixative labeled ""right buccal fat pad. margin"" is a 3.0 X 2.2 X 0.9 cm aggregate of tan, lobulated irregular fatty. tissue. Representative sections are submitted for frozen section microscopy, now. in cassette E1. Representative sections of the remaining tissue are submitted in. cassette E2. F. Received without fixative labeled ""right distal lingual. nerve"" are three tan, irregular soft tissues, ranging from 0.3 X 0.1 X 0.1 cm to. 0.5 X 0.4 X 0.1 cm, submitted in toto for frozen section microscopy, now in. cassette F. G. Received in formalin, labeled ""right hamulus"" is a 1.4 X. 1.4 X 0.3 cm aggregate of tan, irregular soft tissue admixed with scant bone,. submitted in toto in one cassette following decalcification. H. Received without fixative labeled ""right proximal lingual. nerve"" are four tan, irregular soft tissues, ranging from 0.3 X 0.1 X 0.1 cm to. 0.9 X 0.5 X 0.1 cm, submitted in toto for frozen section microscopy, now in. cassette H. I. Received without fixative labeled ""deep soft palate. margin"" is a 0.9 X 0.4 X 0.2 cm tan, irregular soft tissue, submitted in toto. for frozen section microscopy, now in cassette I. J. Received in formalin, labeled ""right composite mandible. resection including right level 1B dissection"" is a 9.0 X 8.5 X 6.1 cm composite. resection, which consists of a 6.9 X 6.1 X 1.3 cm partial right posterior. mandible, 3.5 X 2.4 X 2.4 cm right partial base of tongue (double suture), 2.0 X. 1.2 X 0.9 cm apparent right tonsil, 3.9 X 3.1 X 1.8 cm right submandibular. gland, minimal adherent soft palate (single suture) and associated soft tissues. Involving the retromolar trigone is a 5.4 X 4.2 cm tan-pink, irregular well. delineated ulcerated mass, which comes to within 0.5 cm from the nearest/soft. palate mucosal edge, 0.5 cm from the anterior mucosal edge and 0.6 cm from the. nearest tongue mucosal edge. This mass on sectioning is tan, firm, heterogeneous. with a total thickness of 2.9 cm, abutting the lateral soft tissue edge and. coming to within 1.2 cm from the posterior inked soft tissue edge. The mass. appears to involve the tonsil with no definite extension into the submandibular. gland. There is focal apparent bony involvement. The uninvolved mucosa is. tan-pink and smooth. The uninvolved tonsil on sectioning is tan and homogeneous. The uninvolved submandibular gland is tan and lobulated. A few tan-pink, rubbery. lymph nodes are identified adjacent to the submandibular gland, up to 1.9 cm. Representative sections are submitted as follows: J1. anterior mandibular margin taken en face, submitted following. decalcification;. J2. posterior mandibular margin taken en face, submitted following. decalcification;. J3. mass to nearest/posterior palate mucosal edge;. J4. mass to base of tongue mucosal edge;. J5. mass to tonsil;. J6. mass to lateral soft tissue edge;. J7. mass to posterior soft tissue edge;. J8. mass to mandible, submitted following decalcification;. J9. mass to submandibular gland;. J10. whole possible lymph nodes adjacent to submandibular gland;. J11. representative section from one lymph node adjacent to. submandibular gland. K. Received in formalin, labeled ""additional right lateral. pterygoid"" is a 2.6 X 2.0 X 1.3 cm tan, irregular ragged soft tissue. Representative sections are submitted in one cassette. L. Received without fixative labeled ""right lateral. pterygoid margin"" is a 1.4 X 1.4 X 0.2 cm tan, irregular soft tissue, submitted. in toto for frozen section microscopy, now in cassette L. M. Received in formalin, labeled ""additional right medial. pterygoid"" are three tan, irregular soft tissues, ranging from 0.3 X 0.2 X 0.2. cm to 1.5 X 0.9 X 0.4 cm. The specimens are step sectioned and entirely. submitted in one cassette. N. Received without fixative labeled ""right parapharyngeal. fat margin"" is a 1.6 X 1.3 X 0.2 cm tan, irregular soft tissue, submitted in. toto for frozen section microscopy, now in cassette N. O. Received without fixative labeled ""right medial pterygoid. margin"" is a 1.8 X 1.3 X 0.3 cm tan, irregular soft tissue, submitted in toto. for frozen section microscopy, now in cassette O. P. Received without fixative labeled ""floor of mouth"" is a. 2.4 X 0.5 X 0.2 cm tan, irregular soft tissue, submitted in toto for frozen. section microscopy, now in cassette P. Q. Received without fixative labeled ""right tongue base"" are. two tan, irregular soft tissues, 2.5 X 0.6 X 0.2 cm and 3.0 X 0.6 X 0.2 cm,. submitted in toto for frozen section microscopy, now in cassette Q. R. Received without fixative labeled ""right hard palate"" is. a. 1.3 X 0.3 X 0.2 cm tan, irregular soft tissue, submitted in toto for frozen. section microscopy, now in cassette R. S. Received without fixative labeled ""right soft palate"" are. three tan, irregular soft tissues ranging from 0.7 X 0.7 X 0.2 cm to 2.3 X 0.3 X. 0.2 cm, submitted in toto for frozen section microscopy, now in cassette S. T. Received without fixative labeled ""right lateral. pharyngeal wall"" are two tan, irregular soft tissues, 0.9 X 0.5 X 0.2 cm and 1.3. X 0.5 X 0.2 cm, submitted in toto for frozen section microscopy, now in cassette. T. U. Received without fixative labeled ""right buccal"" is a 3.8. X 0.5 X 0.2 cm tan, irregular soft tissue, submitted in toto for frozen section. microscopy, now in cassette U. V. Received in formalin, labeled ""right neck dissection. level 2-4"" is a 12.8 X 4.7 X 3.5 cm tan, lobulated irregular soft tissue with. attached single suture designating level 2 and double suture designating level. 4. The specimen is divided into levels 2-4. Sectioning reveals multiple. tan-pink, rubbery to firm lymph nodes up to 3.1 cm. Representative sections are submitted as follows: V1. multiple whole lymph nodes, level 2;. V2. representative section from one lymph node, level 2;. V3. representative section from one lymph node, level 2;. V4. multiple whole lymph nodes, level 3;. V5. one whole lymph node bisected, level 3;. V6. whole possible lymph nodes, level 3;. V7. whole possible lymph nodes, level 3;. V8. one whole lymph node bisected, level 4;. V9-10 whole possible lymph nodes, level 4. W. Received without fixative labeled ""right proximal. mandible margin"" is a 0.3 X 0.3 X 0.2 cm tan, irregular soft tissue with minimal. bone. The soft tissue is submitted for frozen section microscopy, now in. cassette W. The remaining tissue is entirely submitted in cassette 2 following. decalcification. X. Received without fixative labeled ""right distal mandible. margin"" is a 0.3 X 0.2 x 0.2 cm tan, irregular soft tissue with minimal bone. Representative sections of the soft tissue are submitted for frozen section. microscopy, now in cassette X1. The remaining tissue is entirely submitted in. cassette X2 following decalcification. Microscopic Description: H&E stained sections of tumor reveal islands and cords of cells with squamous. differentiation. Multiple areas of keratin pearls are identified throughout the. specimen. Please see final diagnosis for further description.",T4,N2,M0,T4N2M0
TCGA-D5-6931,"page 1 / 1. copy No. 2. Examination: Histopathological examination. Material: Partial organ resection - left half of the colon along with cancer infiltrated first loop of the small intestine. Expected time of examination: Clinical diagnosis: left half of the colon along with cancer infiltrated first loop of the small intestine. Macroscopic description: A 25 cm length of the large intestine with periintestinal fat tissue sized 28 X 6.8 X 2.5 cm, and part of the omentum sized 25 X 10 X. 0.5cm. Additionally an 8 cm segment of the small intestine consolidated with the wall of the large intestine at the site of neoplastic. proliferation. Ulcerous tumour sized 7 X 5 cm found in the mucosa. The lesion surrounds 100% of the intestine circumference. narrowing its lumen, is located 6 cm from the proximal incision line, and 12 cm from the distal incision line. The lesion infiltrates. macroscopically through the whole thickness of the large intestine wall, periintestinal fat tissue and the small intestine wall at. the site of the consolidation. Neighbouring lymph nodes are macroscopically metastatic. Microscopic description: Adenocarcinoma tubulopapillare (G2). Infiltratio carcinomatosa profunda tunicae muscularis priopriae. et serosae coli et parietis ilei et telae adiposae mesenterii pericolicae. Intestine ends clear of neoplastic lesions. Metastases carcinomatosae in lymphonodis (NO IV/XIV). Infdrtratio carcinomatosa capsulae lymphonodorum et telae adiposae perinodalis. Emboliae carcinomatosae. Histopathological diagnosis: Adenocarcinoma tubulopapillare coli. Tubulopapillar adenocarcinoma of the colon. Metastases carcinomatosae in lymphonodis. Cancer metastases in the lymph nodes. (No IV/XIV). (G2, Dukes C, Astler - Coller C2, pT4b, pN2).",T4,N2,M0,T4N2M0
TCGA-FU-A3HZ,"Hospital of Origin: QC Pathologist: FINAL PATHOLOGIC DIAGNOSIS: A. Lymph nodes, left pelvic, dissection: Negative for neoplasm, four nodes examined (0/4). B. Lymph nodes, right pelvic, dissection: Negative for neoplasm, five nodes examined (0/5). C. Uterus, bilateral ovaries and fallopian tubes, radical. hysterectomy and bilateral salpingo-oophorectomy: Cervix, invasive squamous cell carcinoma. Grade III. Tumor located in endocervix with extension into lower. uterine segment. endometrial cavity and myometrium of. uterine corpus. Tumor size: 7 x 5 cm. Tumor invades completely through myometrium to involve. serosa (25 mm depth). Lymphovascular space invasion present. Surgical margins free of tumor (cervical and parametrial: no. tumor involves serosa of the uterine corpus). Endometrium, completely replaced by squamous carcinoma. Myometrium, no additional diagnoses. Right ovary, benign simple cyst. Left ovary, benign simple cyst. Bilateral fallopian tubes, no pathologic change. D. Uterine artery, biopsy: No pathologic change. Staging (AJCC 2010): pT2a2,NO (FIGO: IIA2). COMMENTS: The tumor is a poorly differentiated invasive large cell. non-keratinizing squamous cell carcinoma, The tumor has an. unusual distribution of completely replacing the endometrium. with diffuse invasion through the myometrium to involve the. serosa of the uterine corpus. Sections including the cervix. show an unremarkable transformation zone, but squamous cell. carcinoma is present in the proximal portion of the. endocervix and lower uterine segment region. The. possibility of the squamous cell carcinoma arising in the. endometrium was considered since the tumor appears to be. centered in the uterine corpus and squamous cell carcinomas. primary of the endometrium (. on vary rare occasions. However, endocervical origin is favored since there is tumor. present in the upper portion of the endocervix. It is felt. to be more likely that the tumor originated in the. endocervix, which is much more common than endometrium, with. subsequent extension into the uterine corpus The diagnosis. of primary squamous cell carcinoma of the endometrium is. generally made only when the cervix and endocervix are free. of neoplasm. CI.INICAL. HISTORY: Preoperative Diagnosis: Endometrial cancer. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Left peivic lymph nodes. B. Right pelvic lymph nodes. C. Uterus, cervix. BSO. D. Ureter and artery. CODES: 88307. 88307. 88309. 88304. PROCEDURAL DEMOGRAPHICS: Accession Date/Time: GROSS DESCRIPTION: A. The first container A is labeled. #1. The. specimen consists of a portion of fibroadipose tissue. measuring 5.5 x 5.0 x 1.5 cm. Sectioning reveals five. probable lymph nodes measuring from 0.7 to 1.5 cm. Representative sections from the lymph nodes were examined. at the time of surgery. The Ivmph nodes are entirely. submitted in cassettes. as follows: frozen. section-1; lymph nodes remnants-2. B. The second container B is labeled. #2. The. specimen consists of a portion of fibroadipose tissue. measuring 6.5 x 4.0 x 1.5 cm. Sectioning reveals five. probable lymph nodes measuring from 1.0 to 2.5 cm. Sections. from the lymph nodes were examined at the time of surgery. The lymph nodes are subsequently entirely submitted in. cassettes. as follows: frozen section FS1--1;. frozen section FS2--2; lymph node remnants--3. C. The third container C is labeled. uterus,. cervix, BSO. The specimen consists of a previously bisected. uterus with attached cervix, attached right adnexa and. separately submitted left adnexa The uterus measures 8 0 x. 7,5 x 5.0 cm and weighs 191 grams. The serosal surface of. the uterus is gray tan to brown tan. The serosa has been. inked. Sections from the parametrium have been taken. The. cervix measures 4.0 cm in length and 3.0 cm in diameter. The ectocervix is gray to brow. n with hemorrhage. There. is bilateral paracervical tissue attached to the specimen. The uterus is bisected. The endocervical canal is light tan. to brown tan. On sectioning through the wall the cu!. surface is yellow gray fibrous. Within the upper portion of. the endocervical canal there is a yellow gray nodular mass,. which appears to be an extension of the endometrial mass. noted. The endometrial cavity is obliterated by a yellow. gray mass measuring 7.0 x 5.0 cm, which extends through the. lower uterine segment and as previously mentioned describes. portions of the upper endocervical canal. On sectioning the. mass shows full thickness invasion and abuts the inked. serosal surface. The lesion involves almost the entire. myometrium and there is focal areas of rim of normal gray. tan trabecular myometrium identified. The attached right. ovary measures 2.0 x 1.0 x 0.5 cm. The surface is yellow. gray. On sectioning the cut surface is yellow tan. There. are no lesions identified. The right fallopian tube. measures 6.0 cm in length and up to 0.4 cm in diameter. There are two metal clips noted within the proximal portion. The surface is gray to brown tan. On sectioning there is. no material or lesions identified within the lumen. The. separately submitted left ovary measures 4.0 x 2.0 x 1.5 cm. The surface is yellow to gray tan. On sectioning there. reveals a serous cyst measuring up to 2.0 cm containing. clear serous fluid. There are no excrescences noted. The. left fallopian tube measures 3.0 cm in length and 0.3 cm in. diameter. The surface is gray to brown tan. On sectioning. there are is no material or lesions identified within the. lumen. The fallopian tube appears grossly unremarkable. Received with the specimen are two cassettes, one green and. one yellow, labeled. Representative sections are. submitted in cassettes. as follows: cervix from. 12:00 to 3:00--1; 3:00 to 6:00--2; 6:00 to 9:00--3; 9:00 to. 12:00--4; full thickness sections from the lesion--5 to 9;. lower uterine segment--10; left paracervical tissue-11. right paracervical tissue--12 left parametrial tissue-13. right parametrial tissue--14; right ovary-15 right. fallopian tube--16; left ovary--17; left fallopian tube-18. D. The fourth container D is labeled. left. ureter and artery. The specimen consists of a piece of. yellow brown fibroadipose tissue measuring 1.5 x 1.0 x 0.2. cm. The specimen is entirely submitted in a single cassette. INTRA-PROCEDURE CONSULTATION: FSA: 'Left pelvic lymph nodes: Negative for neoplasm (four. nodes)'. FSB: Right pelvic nodes: Negative for neoplasm (five nodus). C.",T2,N0,M0,T2N0M0
TCGA-44-5643,"SPECIMEN. A. Right lower lobe tissue procurement. B. Completion right pneumonectomy. C. Level 7 lymph node. D. 4R lymph node. E. Mediastinal cyst. F. 2R lymph node. G. Superior vein stump. CLINICAL NOTES. PRE-OP DIAGNOSIS: Lung cancer. POST-OP DIAGNOSIS: Lung cancer. GROSS DESCRIPTION. A. Received fresh labeled ""right lower lobe"" is a 363-. gram,. 19 X 11 X 5.5 cm lobectomy specimen with attached 1 cm in. length, 1.8 X 1.4 cm in diameter bronchial stump. The pleura is. smooth glistening tan-pink and focally retracted with a subjacent. palpable mass lesion. On sectioning, there is a well-. circumscribed,. 6.8 X 6.5 X 5 cm focally cystic tan-white lesion, which focally. approaches the inked pleural surface within less than 0. cm. A. portion of tumor and a portion of normal tissue are submitted for. tissue procurement, as requested. In addition, the tumor extends. to. within 2 cm of the bronchial stump margin. The remaining. parenchyma. is spongiform, red-purple, with a 4-cm ill-defined, focus of. consolidation inferior to the tumor (see block 10) . No additional. abnormality is noted. Three slight rubbery tan-gray-black tissue. in. keeping with lymph nodes measuring up 1.3 cm in greatest dimension. are recovered from the hilar region. Representative sections are. submitted in 12 blocks as labeled. RS-12. BLOCK SUMMARY: 1 - Bronchial stump margin, 2 - vascular margin, 3-. 5. - tumor to inked pleural surface, 6 - tumor to bronchial stump, 7 -. central tumor, 8 - tumor to normal, 9 - random normal, 10 - area of. 1. GROSS DESCRIPTION. consolid. 11 - two whole lymph nodes, 12 - one trisected lymph. node. B. Received fresh, labeled ""completion right. pneumonectomy"" is a 223 gram, 13.5 X 10.5 X 6.0 cm. lobectomy specimen with attached 2.5 cm. in length, 2.8 X 1.8 cm. in. diameter bronchial stump. The pleura is wrinkled pink purple. On. sectioning the parenchyma is spongiform red purple with scant. diffuse anthracosis. No discrete mass lesion or abnormality is. identified. Four slightly rubbery tan gray-black tissues in. keeping. with lymph nodes measuring up to 1.8 cm. in greatest dimension are. recovered from the hilum. Representative sections are submitted in. 7 blocks as labeled. RS7. BLOCK SUMMARY: 1 - Bronchial stump margin; 2 - vascular margin; 3-5. - random parenchyma; 6 - three whole peri. nodes; 7 -. trisected largest perihilar lymph node. C. Received fresh, labeled ""level 7 lymph node"" are four. intact to slightly fragmented soft pale tan to tan red. tissue in keeping with lymph nodes ranging from 0.7 cm. in greatest. dimension up to 4.5 X 2.8 x 1.3 cm. (the largest possibly. representing a nodule aggregate) The specimen is entirely. submitted in five blocks as labeled. AS-5. BLOCK SUMMARY: 1 - Three whole tissues; 2-5 - section largest. tissue. D. Received fresh, labeled ""4R lymph nodes"" are two soft. tan white to tan red tissues measuring 0.7 and 1.3 cm. in. greatest dimension which are submitted in toto. AS-1. E. Received fresh, labeled ""mediastinal cyst"" are four. diffusely cauterized slightly rubbery white pink tissue. fragments averaging 1.3 X 0.8 X 0.15 cm. The specimens are. bisected. and entirely submitted in two blocks. F. Received fresh, labeled ""2R lymph nodes"" are two. diffusely cauterized fragmented, soft golden yellow fatty. portions of tissue measuring 1.3 and 1.8 cm. in greatest dimension. No definitive lymphoid tissues are recovered. The specimens are. submitted in toto independently in two blocks. AS-2. G. Received fresh, labeled ""superior vein stump"" is an. irregular, 0.6 X 0.4 X 0.15 cm. fragment of rubbery white. pink tissue with numerous silver metallic staples. The staples are. d and the specimen is entirely submitted in one block. AS-1. MICROSCOPIC DESCRIPTION. Histologic type: Non-small cell carcinoma. Histologic grade: Poorly differentiated. Primary tumor (pT) : Tumor measures maximally 6.8 cm in size and is. confined to the lung (pT2b) . Margins of resection: Negative. Direct extension of tumor: Absent. Venous (large vessel) invasion: Positive. Arterial (large vessel) invasion: Negative. Lymphatic (small vessel) invasion: Positive. Regional lymph nodes (pN) : Eight peribronchial and perihilar lymph. nodes. are negative for metastatic carcinoma. One of four level 7. mediastinal. nodes contains metastatic adenocarcinoma. 4R and 2R lymph nodes. are. negative for tumor (pN2). Distant metastasis (pM) : Cannot be assessed (pMX). Other findings: Post-obstructive pneumonitis and pulmonary edema. are. present. Benign mediastinal cyst. 5,4x2,3x3. DIAGNOSIS. A,B. Lung, right pneumonectomy : Poorly differentiated non-small cell carcinoma involving. the. right lower lobe. The bronchial and vascular margins of resection are free of. tumor. The tumor does not extend beyond the visceral. pleural surface. Lymphovascular space invasion and. medium-sized venous invasion by tumor is present. Post-obstructive pneumonitis with pulmonary edema. Eight peribronchial and perihilar lymph nodes negative for. metastatic carcinoma (0/8) . C. Lymph nodes, level 7, resection: One of four lymph nodes contains metastatic carcinoma (1/4) . D. Lymph node, 4R, resection: Single lymph node negative for metastatic carcinoma (0/1) . E. Mediastinum, resection of lesion: Benign fibrofatty tissue with a mesothelial- - lined cyst. Negative for malignancy. F. Lymph nodes, 2R, resection: Two lymph nodes negative for metastatic carcinoma (0/2) . G. Vein, superior vein stump, resection: DIAGNOSIS. No significant histopathologio findings. Negative for malignancy. End Of Report ---.",T2,N2,M0,T2N2M0
TCGA-4Z-AA7W,"PRIMARY SITE: Bladder. 1 - ""Left Ureter."". - Absence of neoplasia. 2 - ""Right Ureter."". - Absence of neoplasia. 3 - ""Bladder + prostate "". - Bladder: - Urothelial high grade carcinoma. - Size: 3.0x2.0x1.5 cm. - Invasion reaching the muscular layer of the bladder. - Angiolymphatic and perineural invasions: not detected. - Prostate presenting miofibroepitelial hyperplasia. - Surgical margins uninvolved by neoplasia. 4 - ""Left lymphadenectomy.'. - Presence of 10 lymph nodes uninvolved by neoplasia (0/10). 5 - ""Right lymphadenectomy."". - Presence of 6 lymph nodes uninvolved by neoplasia (0/6). Topography: bladder, NOS. Morphology: transitional cell carcinoma, NOS. Staging: pT2b pNO.",T2,N0,M0,T2N0M0
TCGA-A8-A07F,"Diagnosis: 1. Ablated (left) breast sample with a moderately differentiated invasive ductal. carcinoma with an intraductal component (tumor diameter: 5.0 cm. Tumor classification: NOS, G II, pT2N1aLOVORO.",T2,N1,M0,T2N1M0
TCGA-AR-A0TQ,"Breast, right, simple mastectomy: Infiltrating ductal carcinoma, Nottingham grade III (of III) [tubules. 3/3, nuclei 3/3, mitoses 2/3; Nottingham score 8/9], forming a single mass (7.2 x 4.5 x 3.4 cm) located in. the upper inner and upper central quadrant of the breast [AJCC pT2]. Angiolymphatic invasion is absent. The non-neoplastic breast parenchyma shows nonproliferative fibrocystic changes. Calcifications are. present in malignant ducts. Biopsy site changes are present. All surgical resection margins, including the. deep margin, are negative for tumor (minimum tumor free margin, 7.0 cm, deep margin). Breast, right, supranumerary nipple excision: Intradermal nevus (0.6 cm in greatest dimension). Lymph nodes, right axillary, dissection: Multiple (2 of 9) right axillary lymph nodes are positive for. metastatic carcinoma. The largest lymph node measures 1.4 cm. No extranodal extension identified. Lymph nodes, highest right axillary, dissection: Multiple (6) highest right axillary lymph nodes are. negative for tumor. Breast, left, simple mastectomy: Nonproliferative fibrocystic changes. Her-2/NEU has been ordered on paraffin-embedded tissue.",T3,N1,M0,T3N1M0
TCGA-AA-3516,"Diagnosis / Diagnoses: Right hemicolectomy specimen with an ulcerated colon carcinoma conforming to the. histological type of a moderately differentiated, partially mucus-producing, colorectal. adenocarcinoma, located 3.5 cm aborally from. and almost circularly. occupying the intestinal wall over a length of 4 cm. Invasive tumor spread within all. layers of the intestinal wall and extending into the neighboring mesocolic fatty tissue. Appendix with apparent post-inflammatory fibrosis of the wall. Oral and aboral resection margins and large omentum tumor-free. Seven of twenty-six lymph nodes with metastases from the colon carcinoma that are. restricted to the lymph nodes. Remaining lymph nodes with uncharacteristic reactive. changes. Tumor stage thus: pT3 pN2 (7/26), L0, V0; G2. Based on histological findings sent for information purposes (Examination no. not clearly. legible, findings of. dermatopathological test laboratory,. there is a skin metastasis from an adenocarcinoma in a location that. is not indicated. Based on the negative CK-20 results for the tumor cells, this is. apparently not a skin metastasis from a colorectal carcinoma, but a skin metastasis from a. primary tumor located elsewhere.",T3,N2,M0,T3N2M0
TCGA-BH-A0AW,"FINAL DIAGNOSIS: PART 1: BREAST, EET-SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 2 (TUBULE FORMATION - 3, NUCLEAR GRADE - 2,. MITOTIC RATE - 2; TOTAL SCORE 7/9). B. INVASIVE CARCINOMA MEASURES 2.0 CM IN GREATEST DIMENSION. C. DUCTAL CARCINOMA IN-SITU (DCIS), NUCLEAR GRADE 2-3, CRIBRIFORM, SOLID AND MICROPAPILLARY. TYPE, WITH COMEDONECROSIS. D. DCIS IS PRESENT ADMIXED AND OUTSIDE OF THE INVASIVE COMPONENT IN 8 OUT OF 19 SLIDES AND. COMPRISES APPROXIMATELY 50% OF THE TOTAL TUMOR VOLUME. E. NO LYMPHOVASCULAR SPACE INVASION IS IDENTIFIED. F. MARGINS OF RESECTION ARE NEGATIVE FOR INVASIVE COMPONENT, WITH ALL THE MARGINS BEING. MORE THAN 1 CM AWAY. G. MARGINS OF RESECTION ARE NEGATIVE FOR DCIS; HOWEVER, DCIS IS LESS THAN 1 MM FROM. ANTERIOR MARGIN AND 1.5 MM FROM POSTERIOR MARGIN OF RESECTION. H. FIBROCYSTIC CHANGES WITH FIBROADENOMATOID NODULE. I. BIOPSY SITE CHANGES. J. INVASIVE TUMOR CELLS ARE WEAKLY POSITIVE FOR ESTROGEN RECEPTOR, NEGATIVE FOR. PROGESTERONE RECEPTOR, AND POSITIVE FOR HER-1/NEU (SCORE 3+), AS PER PREVIOUS. PART 2: LEFT AXILLARY LYMPH NODE, DISSECTION -. A. TWO OUT OF TWELVE LYMPH NODES, POSITIVE FOR METASTATIC CARCINOMA (2/12). B. THE SIZE OF THE LARGEST METASTASIS IS OVER 2 CM (see comment). C. NO EXTRACAPSULAR EXTENSION IS SEEN. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 2.0 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 2. Total Nottingham score: 7. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: TUMOR TYPE, IN SITU: Cribriform. Solid. Micropapillary. DCIS admixed and outside of invasive carcinoma component. Percent of tumor occupied by in situ component: 50 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 1 mm. LYMPH NODES POSITIVE: 2. LYMPH NODES EXAMINED: 12. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 20 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pN1a. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: negative. HER2/NEU: 3+.",T1,N1,M0,T1N1M0
TCGA-E8-A432,Laterality:Papillary carcinoma. Path Report:Tumor type: Papillary carcinoma. Tumor size: 2.5x2x1cm. Laterality: left. Focality: Unifocal. Extrathyroidal extension: No. TSH: 0.8 mclU/ml.,T2,N0,M0,T2N0M0
TCGA-AA-3955,"Diagnosis: 1. and 3.: resected section of colon (descending and sigmoid colon) with tumor-free oral. and aboral resection margins and including an ulcerated, moderately differentiated. adenocarcinoma with infiltration of the lamina muscularis propria, with several regional. lymph node metastases (G2, pT2 L1 V0 R0 pN2a 5/31) and with distinctive, florid,. perifocal inflammation (3.), encroaching on the peritoneum of the abdominal wall (1.).",T2,N2,M0,T2N2M0
TCGA-60-2710,"SPECIMEN(S): A. APICAL POSTERIOR SEGMENT LEFT LUNG BX. B. LEVEL 5 LYMPH NODE. C. LEVEL 6 LYMPH NODE. D. LEVEL 7 LYMPH NODE. E. LEVEL 9 LYMPH NODE. F. LEFT UPPER LOBE. CLINICAL HISTORY: PRE-OPERATIVE DIAGNOSIS: Left apical lung mass. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSB, FSC, FSD, FSE: Lymph nodes, levels 5, 6, 7, 9, biopsies: Negative for carcinoma, See. comment. Comment: Half of each node submitted for protocol after touch preparations. Receiving half. frozen. FSF: Lung, left upper lobe, lobectomy: Bronchial margin negative for carcinoma. GROSS DESCRIPTION: A. APICAL POSTERIOR SEGMENT LEFT LUNG BIOPSY. Received in formalin is a tiny pink-tan segment of soft tissue obtained after filtration through the. biopsy bag, measuring 0.3x0.2x0.1cm. The entire tissue is submitted with the biopsy bag in a. single cassette A1. B. LEVEL 5 LYMPH NODE. Received fresh and consists of multiple tan-black lymph nodes, measuring 1.8x1.1cm in. aggregate. The specimen is bisected. Touch preps are made. Half of the specimen is sent for. procurement and the remaining specimen is frozen for intraoperative diagnosis. C. LEVEL 6 LYMPH NODE. Received fresh and consists of small tan-black lymph nodes, measuring 1.2x1.0cm. The. specimen is bisected. Touch preps are made. Half of the specimen is submitted for procurement. and remaining half is frozen for intraoperative diagnosis. D. LEVEL 7 LYMPH NODE. Received fresh and consists of tan-black lymph nodes, measuring 1.1x1.0cm. Specimen is. bisected and touch preps are made. Half of the specimen is sent for procurement and rest of the. specimen is submitted for frozen section for intraoperative diagnosis. E. LEVEL 9 LYMPH NODE. Received fresh and consists of multiple black lymph nodes, measuring 0.7x0.5cm. Touch preps. are made. Half of the specimen is submitted for procurement and rest of the specimen is. submitted for frozen section for intraoperative diagnosis. F. LEFT UPPER LOBE. Received fresh and subsequently fixed is a left upper lobe weighing 172gm, measuring. (15x11x2cm). An ill-defined, gray-tan, firm, sub pleural nodular lesion is identified in the. peripheral region measuring 2.0x1.7x1.5cm which is 4.0cm from the bronchial margin and 2.0. cm from the pleural surface. The overlying tumor surface is slightly retracted and puckered. A. firm, anthracotic (1.0x0.8x0.6cm) lymph node is identified near the bronchial margin. Rest of the. lung parenchyma is sectioned to reveal moderate emphysematous changes. Representative. sections are submitted as follows: F1 - F2: bronchial margin. F3: sections from the lymph node. F4-F6: nodular lesion in toto with adjacent pleural margin. F7: lung tissue adjacent to the nodule. grossly unremarkable random section of lung tissue. DIAGNOSIS: A. APICAL POSTERIOR SEGMENT, LEFT LUNG, BIOPSY: - SMALL FRAGMENT OF FIBROUS TISSUE CONTAINING PORTION OF. BRONCHIAL EPITHELIUM, NO MALIGNANCY IDENTIFIED. B. LEVEL 5 LYMPH NODE, EXCISION: - ONE LYMPH NODE SHOWING ANTHRACOTIC PIGMENT, NO MALIGNANCY. IDENTIFIED. C. LEVEL 6 LYMPH NODE, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR TUMOR, PENDING CYTOKERATIN. STAIN. D. LEVEL 7 LYMPH NODE, EXCISION: - ONE LYMPH NODE, NO TUMOR SEEN (0/1). E. LEVEL 9 LYMPH NODE, EXCISION: - ONE LYMPH NODE SHOWING ANTHRACOTIC PIGMENT, NO TUMOR SEEN. (0/1). F. LEFT UPPER LOBE, LOBECTOMY: - SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED, TUMOR. SIZE 2 X 1.7 CM. - METASTATIC CARCINOMA PRESENT IN ONE PERIBRONCHIAL LYMPH. NODE (1/1). - PLEURAL SURFACE, NEGATIVE FOR TUMOR. - BRONCHIAL MARGIN, NEGATIVE FOR TUMOR. - SEE TEMPLATE. LUNG NEOPLASM TEMPLATE. Surgical procedure: Lobectomy. Tumor location: Peripheral LUL. Tumor size: 2.0 x 1.7 cm. Tumor type: Squamous cell carcinoma. Histologic grade: G2: Moderately differentiated. Angiolymphatic invasion: Present based on the positive lymph node. Bronchial margin: Negative. Visceral pleural involvement: Absent. Satellite tumor(s): Lymph node involvement: N1: Ipsilateral Hilar (Level 10) and/or. Peribronchial (Levels 11-14): Positive (1/1). N2: Ipsilateral Mediastinal (Levels 1-9). and/or subcarinal: Negative (0/4). N3: Contralateral mediastinal/hilar,. Scalene or supraclavicular: NA. Non-neoplastic lung: Unremarkable. Pathologic stage: pT1 N1 MX.",T1,N1,M0,T1N1M0
TCGA-VQ-A8P3,"PRIMARY SITE: Stomach (Body). 1 - ""Hepato duodenal ligament"": Adipose tissue uninvolved by neoplasia. 2 - ""Posterior hepatic"": Two lymph nodes uninvolved by neoplasia (0/2). 3 - ""Right paracardic"": Muscles and adipose tissue uninvolved by neoplasia. 4 - ""Splenic 11d"": Adipose and connective tissue uninvolved by neoplasia. 5 - ""Margin of the esophagus"": Esophageal fragment uninvolved by neoplasia. 6 - ""Gallbladder"": Chronic cholecystitis. 7 - ""Stomach / omentum + lymphadenectomy"": Intestinal pattern adenocarcinoma, tubular moderately differentiated. Level of infiltration: perigastric adipose tissue. Presence of satellite nodes in the adipose tissue. Bormann Classification: Type III. Surgical resection margins uninvolved by neoplasia. Angiolymphatic, and perineural invasion undetected. Presence of lymph node metastasis in 1 of 7 resected of the lesser curvature (1/7). Absence of lymph node metastasis in the greater curvature 5 (0/5).",T4,N1,M0,T4N1M0
TCGA-64-5815,"Clinical History/Diagnosis: Lung cancer. Source of Specimen(s): 1: Cytology -no fee code. 2: Level nine lymph nodes. 3: 10R lymph nodes. 4: Level seven lymph nodes. 5: Level 11 lymph node. 6: Level 11 lymph node at bifurcation of middle and lower lobe. 7: Right upper and middle lobe. Final Diagnosis: 1. Cytology. 2. Level nine lymph nodes, excision: - No tumor seen in one lymph node (0/1). 3. 10R lymph nodes, excision: - Metastatic carcinoma in two of two lymph nodes (2/2). 4. Level seven lymph nodes, excision: - No tumor seen in seven lymph nodes (0/7). 5. Level 11 lymph node, excision: - No tumor seen in one lymph node (0/1). 6. Level 11 lymph node at bifurcation of middle and lower lobe, excision: - No tumor seen in one lymph node (0/1). 7. Right upper and middle lobe, resection: - Invasive poorly differentiated adenosquamous carcinoma, 6.5 cm of the. upper lobe. - Carcinoma invades through visceral pleura. - Angiolymphatic invasion is not identified. - Bronchial and vascular margins are free of carcinoma. - No tumor seen in five parabronchial lymph nodes (0/5). - pT2 N1 Mx. Gross Description: Received in seven parts. Source of Tissue: 1. Cytology. Source of Tissue: 2. Labeled #2, ""level 9 lymph nodes"". Gross Description: Received fresh labeled,. level 9 lymph nodes"". It consists of a firm light-brown lymph node. measuring 1.5 x 0.8 X 0.5 cm. The lymph node is bisected and entirely. submitted in 2A. Source of Tissue: 3. Labeled #3, ""10R lymph nodes"". Gross Description: Received fresh labeled "" ,. 1OR lymph nodes"". It consists of black-brown soft anthracotic lymph nodes. measuring from 1 up to 1.5 cm in greatest dimension. Each lymph node is. bisected and entirely submitted in 3A-3B. Source of Tissue: 4. Labeled #4, ""level 7 lymph nodes"". Gross Description: Received fresh labeled. level 7 lymph nodes"". It consists of multiple soft black-brown anthracotic. lymph nodes measuring from 0.2 up to 2.0 cm in greatest dimension. Entirely submitted in 4A-4E. Designation of Sections: 4A-4B- one large bisected lymph node, 4C- one. bisected lymph node, 4D- two bisected lymph nodes, 4E- multiple small. potential lymph nodes. Source of Tissue: 5. Labeled #5, ""level 11 lymph node"". Gross Description: Received fresh labeled. level 11 lymph node"". It consists of a soft black-brown anthracotic lymph. node measuring 1.2 x 0.5 x 0.5 cm. The lymph node is bisected and entirely. submitted in 5A. Source of Tissue: 6. Labeled #6, ""level 11 lymph node at bifurcation ofmiddle and lower. lobe"". Gross Description: Received fresh labeled,. level 11 lymph node at bifurcation of middle and lower lobe"". It consists. of a soft black-brown anthracotic lymph node measuring 0.8 x 0.7 x 0.6 cm. The lymph node is bisected and entirely submitted in 6A. Source of Tissue: 7. Labeled #7, ""right upper and middle lobe"". Intraoperative Consultation: UPPER LOBE BRONCHIAL MARGIN- NO TUMOR. SEENPER. Gross Description: Received fresh labeled. right upper and middle lobe"". It consists of two lobes of lung weighing a. total of 292 grams. The upper lobe measures 13.5 x 11.5 x 5 cm in greatest. dimension. The pleura is gray-tan, smooth except for a 1.2 cm puckered. area located approximately 6 cm from the closest upper lobe margin and. approximately 4.5 cm from the middle lobe bronchial margin. The middle. lobe measures 10.5 X 10.5 x 4.5 cm. The pleura is gray-tan and smooth. Both the bronchial margin and vascular margin from both upper and middle. lobes are unremarkable. The upper lobe is sectioned to reveal a 6.5 x 4.5. x 4.5 cm ill-defined firm brown mass located approximately 3.5 cm from the. closest upper lobe bronchial and vascular margins. The mass corresponds to. the previously described pleural puckering of the upper lobe. The middle. lobe is sectioned to reveal a congested soft tan-pink cut surface with no. masses present. The horizontal fissure appears grossly unremarkable. The. upper lobe bronchial margin is entirely frozen in 7FS. Additional random. sections of the remainder of the specimen are submitted in 7A-7J. Designation of Sections: 7FS- frozen section, 7A- - right upper lobe. vascular margin, 7B-7D- random section of tumor, 7E- tumor with adjacent. uninvolved parenchyma, 7F- middle lobe bronchial margin, 7G- middle lobe. vascular margin, 7H- horizontal fissure, 7I- uninvolved middle lobe, 7J-. peribronchial lymph nodes. LUNG TEMPLATE. Specimen Type. Right upper and middle lobes. Laterality. Right. Tumor Site. Upper lobe. Middle lobe. Tumor Size. Greatest dimension: 6.5 cm (T1 if <=3.0 cm; otherwise T2). Histologic Type. Adenosquamous carcinoma. Histologic Grade. Poorly differentiated. Extension of Tumor. Carcinoma invades into/through visceral pleura (T2). Venous (Large Vessel) Invasion. Absent. Arterial (Large Vessel) Invasion. Absent. Margins. Margins uninvolved by invasive carcinoma. Distance from closest margin: 3.5 cm. Regional Lymph Nodes. 17 regional lymph nodes examined. Regional lymph node metastasis. 2 ipsilateral peribronchial and/or hilar lymph node(s) with. metastatic carcinoma (N1). pTNM: T2 N1 Mx.",T2,N1,M0,T2N1M0
TCGA-CG-5728,"Diagnosis(es): Total gastrectomy specimen including an extensively ulcerated, weakly differentiated. adenocarcinoma (intestinal type under Lauren's classification) of maximum diameter. 7.5 cm located in the antrum with infiltration of the perimuscular or subserosal soft tissue. and evidence of lymphatic invasion. Tumor-free regional lymph nodes Free-free oral and. aboral resection margin. Free-free omental fatty tissue. Free stage: pT2b pNO (0/36) pMX;.",T2,N0,M0,T2N0M0
TCGA-78-7161,"HISTORY. Lt upper lobe bronchial ca. MACROSCOPIC. Four specimens received. 1: The specimen is labelled 'left upper lobe' and consists of a lobe of lung (132 x 85 x. 70), weighing 381 grams in the fixed state. Adherent to the visceral surface is a strip. of parietal pleura measuring 127 X 52 mm. Within the parenchyma is a large cream. tumour mass. The tumour comprises a relatively circumscribed cream nodule with. areas of necrosis (57 mm in maximum diameter), merging with an ill-defined firm. cream to tan area. The maximum diameter of the entire lesion (discrete nodule plus. ill-defined area) measures 91 mm. The tumour invades visceral pleura and is adherent. to parietal pleura. The discrete tumour nodule is 31 mm from the bronchial resection. margin. The ill-defined lesion is 5 mm from the bronchial margin and extends to the. hilar resection margin. Parenchyma distal to the tumour has a speckled yellow. appearance. The minimal amount of uninvolved parenchyma away from the tumour is. unremarkable. No other lesions are identified. [1A, bronchial resection margin; 1B,. hilar lymph nodes; 1C, tumour with parietal pleura; 1D, discrete tumour nodule with. adjacent ill-defined lesion; 1E, ill-defined area with adjacent uninvolved lung. parenchyma; 1F, lesion involving bronchial wall, including hilar margin; 1G, lesion. with hilar margin; 1H, parenchyma distal to tumour, with edge of tumour included;. 1I-J, uninvolved lung parenchyma]. 2: The specimen is labelled ""left lymph node no 5' and consists of two separate pieces. of tan to grey nodal tissue measuring 15 X 11 X 12 mm and 12 X 6 X 4 mm. [Specimen. BIT: 2A, larger piece trisected; 2B, smaller piece bisected]. 3: The specimen is labelled ""left lymph node no 10' and consists of a single piece of. tan to grey nodal tissue measuring 15 X 14 X 10 mm. [Trisected and BIT: 3A]. 4: The specimen is labelled ""left no 10 lymph nodes' and consists of two separate. pieces of nodal tissue measuring 14 X 6 X 6 mm and 7 X 5 X 2 mm. [Specimen BIT: 4A, larger node bisected; 4B, smaller node bisected. MICROSCOPIC. DIAGNOSTIC SUMMARY: Moderately differentiated adenocarcinoma; Stage. pT3N0; focal involvement of hilar soft tissue margin (R1); extension into parietal. pleura. CARCINOMA. 1. Histological type: Adenocarcinoma; acinar and papillary patterns, with a smaller. component of lepidic and solid. There is extensive necrosis. 2. Histological grade: Moderately differentiated. 3. Tumour size: 91mm (macroscopic). 4. Pleural invasion: Tumour invades the visceral pleura and parietal pleura (Block. 1C). 5. Vessel invasion: Not identified. 6. Perineural invasion: Not identified. 7. Carcinoma in situ: Not identified. MARGINS. 1. Bronchial margin: - Invasive carcinoma: Clear (at least 4mm). 2. Vascular margin: Not identified. 3. Other margins: Adenocarcinoma focally extends to the hilar soft tissue margin. (1G). 4. Residual tumour status: R1. 5. Contiguous structures: Present, parietal pleura. LYMPH NODES. 1. Peribronchial: There is no evidence of metastatic adenocarcinoma in hilar lymph. nodes or in the other lymph nodes submitted (specimens 3-4). 2. Mediastinal: Not involved (specimen 2). PATHOLOGICAL STAGE: pT3N0. NON-NEOPLASTIC LUNG: There is lipoid pneumonia and pulmonary oedema. adjacent to the tumour. Moderate emphysematous change is identified. Focally, there. is eccentric intimal thickening of blood vessels. T-28000 M-81403 P1-03000.",T3,N0,M0,T3N0M0
TCGA-77-8009,"HISTORY. Frozen section. Right lower and middle lobectomy. (L) nodes hilar. Lung Ca. MACROSCOPIC. Three specimens received: 1: The specimen is received fresh for frozen section and is labelled 'arterial margin' and consists of a. piece of muscular artery wall measuring 15 X 4 X 1 mm. No abnormalities are apparent. [BIT for. frozen section, 1A]. FROZEN SECTION DIAGNOSIS. No evidence of malignancy. Result phoned to. on the. 2: The specimen is labelled 'right lung lower and middle' and consists of the right middle and lower. lobes as stated. The lower lobe measures 155 x 100 x 40 mm and the middle lobe 135 x 90 x 30 mm. There is a stapled resection margin along the middle lobe, 150 mm in length. A rounded endobronchial. tumour plug extends to the bronchial resection margin, however there is no attachment to the bronchial. wall in this region. The pleural surface appears indurated and tethered on the anterior apical part of the. lower lobe over an area approximately 25 x 30 mm. Sectioning reveals a tumour within the apical. segment of the lower lobe measuring 50 x 45 x 45mm with endobronchial extension up to a distance of. 40mm. The entire lesion measuring approximately 75mm in maximal dimension. The endobronchial. plug of tumour extends to involve the proximal portion of the middle lobe bronchus and is focally. tethered to the wall at this point. The alveolated parenchyma of the middle lobe appears clear of. tumour and no tumour is present at the stapled resection margin. The endobronchial plug of tumour. also extends up the bronchus to the bronchial resection margin. However, as mentioned previously the. tumour is not attached to the bronchial wall in this region. A peribronchial lymph node appears to be. involved by tumour, possibly by direct extension. The bronchial and peribronchial resection margins. appear macroscopically clear of the tumour. Localised bronchiectasis is present distal to the. endobronchial tumour plug. [2A, 5 hilar lymph nodes; 2B, bronchial resection margin en face; 2C-D,. LS to inked peribronchial resection margin; 2E, tumour plug; 2F, RS tumour plus at branch of. bronchus intermedius; 2G, RS of attachment of tumour plug; 2H, RS tumour extending into bronchus;. 2I, RS tumour and attachment of tumour plug; 2J, branching of bronchus intermedius with. peribronchial tumour and involved peribronchial lymph nodes; 2K, RS tumour and pleural surface; 2L,. RS lower lobe uninvolved; 2M, RS middle lobe uninvolved]. 3: The specimen is labelled ""No. 7 node' and consists of two pieces of fibrofatty tissue, 35 x 23 x 13. mm and 25 X 24 x 6 mm. Within both pieces of tissue there appears to be a lymph node, 24 mm and 34. mm in maximum extent. [3A-B, first lymph node bisected; 3C-D, second lymph node bisected]. MICROSCOPIC. 1: Paraffin sections confirm the frozen section diagnosis of an elastic walled artery with no evidence of. tumour. 2: Sections reveal a poorly differentiated squamous cell carcinoma involving the apical segment of the. right lower lobe with extensive endobronchial extension. The tumour does not invade the visceral. pleura. The bronchial resection margin is clear of tumour. Tumour extends into peribronchial. connective tissue adjacent to the resection margin but is 0.3mm clear of the peribronchial resection. margin. Within peribronchial connective tissue in this region perineural permeation by tumour is. identified. The involved nerve measures 350um in diameter and in the section examined is 1.3mm. clear of the peribronchial resection margin. Lymphatic invasion is identified. Some small blood. vessels show evidence of recanalisation, however no unequivocal vascular invasion is seen. A. peribronchial lymph node is involved by tumour, possibly by direct extension. Peribronchial lymph. nodes also show evidence of sinus histiocytosis, carbon pigment deposition, fibrosis and scattered. flecks of birefringent material consistent with silicate. Within adjacent lung parenchyma there is. bronchiectasis with mucoid plugging and focal endogenous lipoid pneumonia consistent with. obstructive pneumonitis. The section of right middle lobe alveolated lung parenchyma shows. bronchiectasis with mucoid plugging, however no tumour is identified. Rare mixed duct macules are. present within the remaining alveolated lung parenchyma which is otherwise unremarkable. 3: Sections of the lymph node show reactive changes with sinus histiocytosis, follicular hyperplasia,. carbon pigment deposition, fibrosis and scattered flecks of birefringent material consistent with silicate. No tumour is identified. SUMMARY. 1-3: Right lower and middle lobes, separately submitted No. 7 lymph node: Poorly differentiated squamous cell carcinoma involving the apical segment of the right lower lobe. Tumour size 75mm in maximal dimension. Extensive endobronchial extension by tumour, endobronchial tumour attached at origin of right middle. lobe bronchus (macroscopic finding). Visceral pleura not involved. Resection margins clear of tumour. Perineural permeation by tumour within peribronchial tissue adjacent to margin (see microscopic. description). Lymphatic invasion present. No vascular invasion seen. Peribronchial lymph node involved by tumour, no tumour in separately submitted No. 7 lymph node. Pathological stage: T2 N1. Bronchiectasis and focal endogenous lipoid pneumonia in adjacent lung parenchyma. T-28000 M-80703 P1-03000.",T2,N1,M0,T2N1M0
TCGA-E9-A229,"Laterality:Right, lower inner quadrant. Path Report:BREAST TISSUE CHECKLIST. Specimen type: Mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 2 x 1.5 X 2 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: Not specified. Extracapsular invasion of the lymph nodes: Not specified. Margins: Not specified. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T1,N0,M0,T1N0M0
TCGA-BR-A4J8,"Gross Description: Fragment of the stomach with the fragment of the esophagus with tumor up to. 7.5x5.2 cm in size with invasion of whole wall thickness. In fatty tissue there are dense hyperemic lymph. nodes up to 1.5 cm in their largest dimension. Omentum, spleen and surgical margins are without. macroscopic changes. Microscopic Description: Adenocarcinoma of the stomach, G3, with invasion into the perigastric fatty. tissue. In the blood vessels lumen there are tumor emboli. Seven examined lymph nodes from the. greater curvature and five examined lymph nodes form the lesser curvature demonstrated metastases. of the adenocarcinoma. Surgical margins are without evidence of tumor growth. Omentum is with focal. haemorrhages. Spleen demonstrates anaemia of the red pulp. Separately collected lymph nodes. demonstrated histiocytosis, anthracosis. Diagnosis Details: Tumor Features: Ulcerating, Tumor Extent: Perigastric fat, Venous Invasion: Present,. Margins: Absent, Treatment Effect: Comments: According to the 7th edition of the AJCC stage is T3N3aM0 (IIIb). Formatted Path Reports: STOMACH TISSUE CHECKLIST. Specimen type: Subtotal gastrectomy. Tumor site: Cardia. Tumor size: 5.2x0x7.5cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Subserosa. Lymph nodes: 12/12 positive for metastasis (Greater and lesser curvature 12/12). Lymphatic invasion: Not specified. Venous invasion: Present. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T3,N3,M0,T3N3M0
TCGA-DJ-A2QB,"Date of Original Rep. Date of Amendment. ccount #: Clinical Diagnosis & History: Papillary thyroid cancer, metastatic papillary carcinoma . Specimens Submitted: 1: Right neck contents level 2. 2: Right neck contents level 3. 3: Right neck contents level 4. 4: Right neck contents level 5. 5: Soft tissue, central compartment of neck. 6: Thyroid and central compartment lymph nodes. AMENDED DIAGNOSIS: 1. Right neck contents level 2: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 12. 2. Right neck contents level 3: Lymph Node Dissection: Metastatic metatstaic papillary carcinoma. Number of lymph nodes examined: 9. Number of lymph nodes with metastatic disease: 1. Size of the largest metastatic focus : 0.15 cm. Size of the largest lymph node involved by tumor: 0.5cm. Extranodal extension is not identified. 3. Right neck contents level 4: Lymph Node Dissection: Metastatic papillary thyrold carcinoma. Number of lymph nodes examined: 13. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 2cm. Size of the largest metastatic focus : 2 cm. Extranodal extension is not identified. 4. Right neck contents level 5: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 3. 5. Soft tissue, central compartment of neck: Lymph Node Dissection: Benign fibroadipose tissue. 6. Thyroid and central compartment lymph nodes: Tumor Type: Multiple foci of papillary carcinoma: One follicular variant with oncocytic features and multiple microcarcinomas. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Calcification of non-psammoma type. Psammoma bodies. Tumor Location: Left lobe. Right lobe. The largest tumor focus is located in the right lobe. Tumor Size: The tumor foci range from 0.15 cm up to 1.6 cm in greatest dimension. Tumor Encapsulation: Partially surrounded. For the largest focus. Blood Vessel Invasion: Not identified. Extrathyrold Extension: Invades:perithyroidal fibroadipose tissue. Surgical Margins: Tumor is noted focally at the cauterized margin. Tumor Multicentricity: At least six foci of papillary microcarcinoma are noted in both lobes, ranging from 0.9 to 0.2 cm. Non-Neoplastic Thyroid: No abnormalities identified. Parathyroid Glands: Not identified. Lymph Nodes: Perinodal (extracapsular) extension not identified. Metastatic papillary thyroid carcinoma involving three of seventeen lymph nodes (3/17). In one lymph node the. metastasis is represented by psamommatous calcifications. The largest lymph node with metastasis measures 0.23 cm. and metastasis measures 0.2 cm. Note: This document represents an amended version of the surgical pathology report originally issued on. That report is. superseded by the present document. The amendment consists of the following change: ORIGINAL REPORT. Specimen submitted. 6. Lymph Nodes: Perinodal (extracapsular) extension not identified. Metastatic papillary thyroid carcinoma involving three of seventeen lymph nodes (3/7). In one lymph node the metastasis. is represented by psamommatous calcifications. The largest lymph node with metastasis measures 0.23 cm and metastasis. measures 0.2 cm. AMENDED REPORT. Specimen submitted. 6. Lymph Nodes: Perinodal (extracapsular) extension not identified. Metastatic papillary thyroid carcinoma involving three of seventeen lymph nodes (3/17). In one lymph node. the. metastasis is represented by psamommatous calcifications. The largest lymph node with metastasis measures 0.23 cm and. metastasis measures 0.2 cm. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT (HAVE. REVIEWED AND APPROVED THIS REPORT. M.D. Special Studies: Special Stain. Comment. RECUT. Gross Description: M.D. 1.) The specimen is received fresh, labeled ""right neck contents-level 2"" and consists of multiple pink tan firm lymph nodes ranging. from 0.2 cm to 2 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. M.D. 2.) The specimen is received fresh, labeled ""right neck contents-level 3"" and consists of multiple pink tan firm lymph nodes ranging. from 0.2 cm to 1cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. A.D. 3.) The specimen is received fresh, labeled ""right neck contents-level 4"" and consists of multiple pink tan firm lymph nodes ranging. from 0.2 cm to 2.8 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. BLN - half of grossly positive lymph node (remaining half submitted for TPS). M.D. 4.) The specimen is received fresh, labeled ""right neck contents-level 5"" and consists of tan-yellow adipose tissue measuring 3.7 x. 2.1 x 1 cm. No obvious lymph nodes are identified. The specimen is entirely submitted. Summary of sections: U - undesignated. R, M.D. 5)The specimen is received fresh, labeled ""soft tissue, central compartment of neck"" and consists of 8x2x0.9 cm portion of soft. tissue without orientation. Cut sections reveal lobulated adipose tissue. No lymph node is identified. Representative sections are. submitted. Summary of sections: U-unspecified. ..D. 6) The specimen is received fresh, labeled ""thyroid gland and central component lymph nodes"" and consists of a thyroid. weighing. 20.5 g. The right lobe measures 5.5x2.3x1 cm the left lobe measures 3x2.5x1.5 cm and the isthmus measures 1x2.2x0.6 cm. The external surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black, and the anterior is. inked blue. Sectioning reveals 7 well circumscribed nodules (3 in right lobe and 4 in left lobe) ranging from 0.4 cm to 1.6 cm in. greatest dimension. The largest nodule has tan brown fleshy cut surface and is located within the right lobe. Other nodules have. yellowish cut surface. No lymph node is identified. Representative sections of the largest nodule is submitted for TPS. The. remaining tissue is serially sectioned and entirely submitted. Summary of sections: RL - right lobe. (Cassettes 2&3, 1st nodule; cassette 4, 2nd nodule; cassettes 5&6, 3rd nodule). LL left lobe. IS - isthmus. (Cassettes 9&10, 4th and 5th nodules; cassette 11, 6th nodule; cassettes 12 & 13, 7th nodule). Rest-reminder of the tissue. Summary of Sections: Part 1: Right neck contents level 2. Block. Sect. Site. PCs-. 4. LN. 4. Part 2: Right neck contents level 3. Block. Sect. Site. PCs. 4. LN. 4. Part 3: Right neck contents level 4. Block. Sect. Site. PCs. 1. BLN. 1. 3. LN. 3. Part 4: Right neck contents level 5. Block. Sect. Site. PCs. 2. U. 2. Part 5: Soft tissue, central compartment of neck. Block. Sect. Site. PCs. 2. u. 2. Part 6: Thyrold and central compartment lymph nodes. Block. Sect. Site. PCs. 2. ist. 2. 6. Il. 6. 2. rest. 2. 6. 6. Amendments. Amend Date: Amended By: Original Diagnosis: 1. Right neck contents level 2: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 12. 2. Right neck contents level 3: Lymph Node Dissection: Metastatic metatstalc papillary carcinoma. Number of lymph nodes examined: 9. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 0.5cm. Size of the largest metastatic focus : 0.15 cm. Extranodal extension is not identified. 3. Right neck contents level 4: Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 13. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 2cm. Size of the largest metastatic focus : 2 cm. Extranodal extension is not identified. 4. Right neck contents level 5: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 3. 5. Soft tissue, central compartment of neck: Lymph Node Dissection: Benign fibroadipose tissue. 6. Thyroid and central compartment lymph nodes: Tumor Type: Multiple foci of papillary carcinoma: One follicular varlant with oncocytic features and multiple microc. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Calcification of non-psammoma type. Psammoma bodies. Tumor Location: Left lobe. Right lobe. The largest tumor focus is located in the right lobe. Tumor Size: The tumor foci range from 0.15 cm up to 1.6 cm in greatest dimension. Tumor Encapsulation: Partially surrounded. For the largest focus. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Invades:perithyroidal fibroadipose tissue. Surgical Margins: Tumor is noted focally at the cauterized margin. Tumor Multicentricity: At least six foci of papillary microcarcinoma are noted in both lobes, ranging from 0.9 to 0.2 cm. Non-Neoplastic Thyroid: No abnormalities identified. Parathyroid Glands: Not identified. Lymph Nodes: Perinodal (extracapsular) extension not identified. Metastatic papillary thyroid carcinoma involving three of seventeen lymph nodes (3/7). In one lymph node the. metastasis is represented by psamommatous calcifications. The largest lymph node with metastasis measures 0.23 cm. and metastasis measures 0.2 cm. Referring Physician Contacted. ria email on.",T3,N1,M0,T3N1M0
TCGA-86-8359,"Case ID. Gross Description. Lung of increased volume with free. lobar bronchus; the lower lobar. bronchus is free on the proximal. portion and obstructed in the distal. portion by a tumoral process which. occupies approximately 2 thirds of. the lower lobe; on section, a. tumoral structure of 12/10 cm; the. tumor is well-limited, white, with. small areas of necrosis and. hemorrhage, with mucous. secretions on surface. Microscopic Description. Diagnosis Details. TUMOR FRAGMENT: Bronchopulmonary neoplasm of differentiated. muciparous adenocarcinoma type, formed of tubular-. papillary structures, covered by a layered cylindrical. epithelium, with moderate cellular pleomorphism and. rare mitoses. Some of the cells are vacuolated, with. intracellular necrotic content and inside the glandular. spaces. The tumoral stroma with fibrous structure and. numerous vessels with stasis and moderate diffuse. lymphocytic infiltrate. PULMONARY PARENCHYMA: Diffuse interstitial moderate fibrosis, stasis and. accumulations of macrophages in the alveoli. Small. hotbeds of emphysema with subpleural localization. LYMPH NODE STATION VI: Mediastinal tissue with lymph node with sinus. histiocytosis and stasis. Without neoplastic infiltrates. LYMPH NODE STATION V: Stasis, follicular hyperplasia and sinus histiocytosis with. numerous alveolar macrophages. Without neoplastic. infiltrates. PHRENIC CHAIN LYMPH NODE: Fibrosis and sinus histiocytosis. Without neoplastic. infiltrates. TRIANGULAR LIGAMENT LYMPH NODE: Reactive follicular hyperplasia and sinus histiocytosis,. with numerous alveolar macrophages. PARAESOPHAGEAL LYMPH NODE: Lymph node with metastasis of the muciparous tubular-. papillary adenocarcinoma. Comments. LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 12 X 10 cm. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 1/7 positive for. metastasis (St.5,6,10,7,6 0/6. Paraesophageal 1/1). Lymphatic invasion: Present. Venous invasion: Present. Margins: Uninvolved. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not. specified. Comments: Left- lower with. obstruction of distal lobular. bronchus. Laterality. Left-lower.",T3,N2,M0,T3N2M0
TCGA-D6-A4Z9,"Gender: M. Examination result. Clinical diagnosis (suspicion) Cancer of the tongue - left side Histopathology result: Carcinoma planoepitheliale. keratodes infiltrans G2. Material: 1) Material: Oral cavity - tongue. Please examine the marked margin. Method of collection: Collection of. specimens for laboratory examination. Histopathological Diagnosis: Invasive squamous carcinoma of the tongue partially keratinizing and ulcerating (G2). Carcinoma planoepitheliale partim keratodes invasivum exulcerans (G2). Excisio completa. All wire-marked margins free of neoplastic lesions. (8071/3. Macroscopic description: Surgical specimen sized 4.5 x 4 x 2cm with flat raised, ulcerated tumour sized 3.5 x 2.0 x 0.8cm. Minimum margin at the side of the 4 wiress 1.1 cm. Results of intraoperative examination: No cancerous lesions found within the margins marked with stitches.",T2,N2,M0,T2N2M0
TCGA-BR-8483,"Case ID. Gross Description. Microscopic. Diagnosis Details. Description. Stomach with saucer-like. Gastric adenocarcinoma,. Tumor Features: Ulcerated,. tumor up to 9.5 cm in size,. intestinal type, G-2. Tumor Extent: Perigastric. with invasion into the. Invasion into the perigastic. fat , Venous Invasion: perigastric fatty tissue. In. fat. There are foci of tumor. Absent, Margins: Absent,. the fatty tisseu there are. growth in the fat tissue of. Treatment Effect: dense hyperemic lymph. greater and lesser. nodes. Omentum is. omentum. For of twelve. hyperemic. examined lymph nodes. demonstrated metastasis. Comments. Original records say N1. STOMACH TISSUE. CHECKLIST. Specimen type: Subtotal. gastrectomy. Tumor site: Antrum. Tumor size: 0 X 0 X 9.5 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma, intestinal. type. Histologic grade: Moderately differentiated. Tumor extent: Subserosa. Lymph nodes: 4/15. positive for metastasis. (Greater and lesser. curvature 4/15). Lymphatic invasion: Not. specified. Venous invasion: Absent. Perineural invasion: Not. specified. Margins: Uninvolved. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic. findings: Not specified. Comments: None. Laterality.",T3,N2,M0,T3N2M0
TCGA-BH-A0HP,"FINAL DIAGNOSIS: BREAST, LEFT, MODIFIED RADICAL MASTECTOMY -. A. INVASIVE LOBULARICARCINOMA, NOTTINGHAM GRADE 2 (TUBULAR FORMATION 3, NUCLEAR ATYPIA 2,. MITOTIC ACTIVITY 1; TOTAL SCORE 6/9). B. THE INVASIVE TUMOR INVOLVES ALL FOUR BREAST QUADRANTS, MEASURING 11.0 CM IN LARGEST. DIMENSION (GROSS MEASUREMENT). C. THE INVASIVE TUMOR FOCALLY POSITIVE IN DEEP MARGIN IN LOWER-INNER QUADRANT (SLIDE R). D. MICROCALCIFICATIONS ASSOCIATED WITH INVASIVE CARCINOMA. E. LOBULAR CARCINOMA IN-SITU, NUCLEAR GRADE 2, ADMIXED AND AWAY FROM INVASIVE COMPONENT. F. LOBULAR CARCINOMA IN-SITU IS 1.5 CM TO THE NIPPLE SURFACE. G. PAPILLOMA, FIBROCYSTIC CHANGE, AND COLUMNAR CELL CHANGE. H. EIGHT OF SEVENTEEN LYMPH NODES, POSITIVE FOR METASTATIC LOBULAR CARCINOMA (8/17). I. METASTATIC TUMOR MEASURES 1.5 CM IN LARGEST DIMENSION AND SHOWS EXTRACAPISULAR. EXTENSION. J. BIOPSY SITE CHANGES. K. INVASIVE TUMOR IS ER POSITIVE, PR NEGATIVE, AND HER-2/NEU NEGATIVE. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: PROCEDURE: Left. Modified radical mastectomy. Upper outer quadrant. Upper inner quadrant. Lower outer quadrant. SIZE OF TUMOR: Lower inner quadrant. MULTICENTRICITY/MULTIFOCALITY OF Maximum dimension invasive component: 11 cm. INVASIVE FOCI: TUMOR TYPE (invasive component): HISTOLOGIC TYPE: Infiltrating lobular carcinoma. ANGIOLYMPHATIC INVASION: Classical. DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: Yes, malignant zones. LCIS. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: LYMPH NODES EXAMINED: Yes, focal. 17. METHOD(S) OF LYMPH NODE EXAMINATION: SENTINEL NODE METASTASIS: H/E stain. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pT3. M STAGE, PATHOLOGIC: pN2a. ESTROGEN RECEPTORS: pMX. PROGESTERONE RECEPTORS: positive. HER2/NEU: negative. zero or 1+.",T3,N2,M0,T3N2M0
TCGA-D8-A13Y,"""/a 2/10. page 1 / 1. copy No. Examination: Histopathological examination. PESEL: Gender: F. Material: Multiple organ resection - right breast. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the right breast. Results of immunohistochemical examination: Estrogen receptors found in 10-75% of neoplastic cell nuclei. Progesterone receptors found in 10-75% of. neoplastic cell nuclei. HER2 protein stained with HercepTest by DAKO. Negative reaction in invasive. cancerous cells I Score = 1+. Macroscopic description: Right breast, sized 16.6 x 12.4 x 4.8 cm, removed along with axillary tissues sized 8 x 6 x 2 cm and a skin flap. of 10,7 x 8,4 cm. Weight 513 g. Tumour sized 1,5 x 1,9 x 1,0 cm in the upper outer quadrant, placed 3.3 cm from the upper edge, 0.1 cm. from the base and 0.8 cm from the skin. Microscopic description: Carcinoma ductale invasivum - NHG3 (3 + 3 +3: 52 mitoses/ 10 HPF, visual area diameter: 0.55 m). Tumour of. ""basal - like carcinoma"" morphology ? Ma mi 11 a sine laesionibus. Glandular tissue showing lesions of the type mastopathia fibrosa et cystica. Additional parenchyma atrophy. AXILLARY LYMPH NODES. Lymphonodulitis chronica et sinus histiocytosis lymphonodorum (No VI). Examination result: Carcinoma ductale invasivum mammae dextrae. (NHG3, pTIc, pNO). Tumour of ""basal - like carcinoma"" morphology.",T1,N0,M0,T1N0M0
TCGA-BP-4799,"Date of Recelpt: Clinical Diagnosis & History: Renal call carcinoma. Specimens Submitted: 1: SP: Right kidney and adranal gland, radical naphrectomy. 2; SP: Lymph nodes, retrocaval, axcision. DIAGNOSIS: 1. SP: Right kidney and adranal gland, radical nephractomy: Tumor Typa: Renal call carcinoma - Conventional (clear call) type. Fuhrman Nuclear Grade: Nuclear grade III/IV. Tumor Siza: Graatest diameter is 6,0 cm. Local Invasion (for renal cortical types): Extends through renal capsule but confined within Garota's fascia. Involvas renal sinus fat. Ranal Vein Invasion: Not identified. Howavar, muscular branches of renal vein in the hilum are inveded by the tumor. Surgical Margins: Free of tumor. Non-Neoplastic Kidnay: Mild artariosclerotic changas, benign cortical cysts, perirenal organizing hemorrhaga. Adrenal Gland: Not involved. Multiple foci of cortical amyloidosis (congo rad positive); vessels and soft tissuas not involved by amyloidosis. Stains to charactarize the amyloid deposists are being performad, and rasults on thase will ba reported as an addandum,. Lymph Nodes: Not identified. Staging for renal call carcinoma/oncocytoma: pT3b Tumor grossly extends into the ranal vain(s) or vena cava below the diaphragm. 2. Lymph nodes, retrocaval, excision: Malignant lymphoma, marginal zone type (see nota). - Immunostains show that most lymphocytes are positive for CD20, BCL-2, and CD43, while negative for. CD3, Cyclin D1, CD6, CD10, and CD23. Rare cells are positive for BCL-6. MIB-1 staining shows. a proliferation rate of approximately 5%. - No evidenca of amyloid deposition is seen. - No metastatic carcinoma is Identified. Benign adrenal tissue with focal emylold deposils. Nota: Review of the original core biopsy. shows a malignant lymphoma with morphologic and. immunohistochemical featuras similar to the present material, and consistant with a marginal zone lymphoma. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT 1 HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. CONGO RED. CD3 (Leu4). CD20 L26. CD138. K. L. CONGO RED. CONGO RED. NEG CONT. IMM RECUT. RECUT. CD3 (Leu4). CD5. CD10. CD20 L26. CD23. CD43 Leu22. BCL2. BCL6. CYD1. MIB-1. NEG CONT. IMM RECUT. Gross Description: 1) The spacimen is received fresh labeled ""right kidney and adrenal gland"" and consists of a kidney with attached ureter, renal. vessels and perinephric fet weighing 1783 g in total. The kidnay measuras 28 X 12 X 11.5 cm. The attached ureter measures 2.0. cm in length and 1.0 cm in diameter. The attached renal vein measures .4 cm in length and 0.6 cm in diameter. The renal vessels. and ureter margins are grossly unremarkable. An adrenal gland is identified. The kidney is inked black and bivalved to reveal. large a hamatoma along the lateral aspect of tha kidnay measuring up to 17 cm. A multiloculated mess with variagated yellow to. hemorrhagic cut-surface is identified in the mid portion of the kidnay, approaching the hilum, and measuring 6,0 x 4.2 x 2.6 cm. Most of the remeining kidney is tan and fibrotic. The corticomedullary junction Is indistinct. Few clear-fluid-filled thin-walled cysts. are present In the cortex. The calices are filled with blood. No lymph nodas are idantified in the perinephric fat. Representative. sections are submitted for TPS and for permanent sections. Photographs are taken. Summary of sactions: A - adrenal gland. UVM ureteral and vessel margins. T-- tumor. THF tumor with hiler fat. TSF -- tumor with sinus fat and spleen. TK -- tumor with adjecent kidney. RP -- renal pelvis representative sections. K -- representative sections kidney. 2). The specimen is received in formalin, labeled ""retrocaval lymph nodes"" and consists of two pink tan firm lymph nodes measuring. to 3.0 and 4.0 cm in greatest dimension respectively. All identified lymph nodes are submitted. Summary of sections: LN1 - - lymph node number one. LN2 -- lymph node number two. Summary of Sections: Part 1: SP: Right kidney and adrenal gland, radical nephrectomy. Block. Sect. Site. PCs. 1. a. 1. 2. adda. 2. 3. 3. rp. 1. 8. t. 8. 1. thf. 1. 2. tk. 2. 3. tsf. 3. uvm. 1. Part 2: SP: Lymph nodes, retrocaval, excision. Block. Sect. Site. PCs. 4. In1. 4. 6. In2. 6. Procedures/Addenda: Addendum. Addendum Diagnosis. Immunostains for kappa and lambda show non-specific staining, without association with lymphocytes or plasma cells. Congo-red stein performed on sections from non-neoplastic renal parenchyma do not reveal any amyloldosis in the kidney.",T3,N0,M0,T3N0M0
TCGA-D8-A1XA,"page 1 / 2. copy No. Examination: Intraoperative examination. Cost of diagnostic procedure. Gender: F. Material: Lesion resection - from the left breast with - outer quad. boundary. Expected time of examination: 20 minutes (from receipt of the material). Clinical diagnosis: Cancer of the left breast,/Cancer of the left breast. Lesion on the boundary of outer quadrants. Marked. typically. Please evaluate the margins. Results of immunohistochemical examination: Part of the breast sized 9 x 7 x 4 cm with a skin flap of 5 x 1.5 cm. Margins: 1.3 cm to the base, 1.6 cm to the skin, 2.5 cm to the. sternum, 2.5 cm to the axilla, 3 cm to the shoulder, 2 cm to the lower boundary. Result of intraoperative examination: Carcinoma invasivum. Macroscopic description: Part of the breast sized 9 x 7 x 4 cm with a skin flap of 5 x 1.5 cm. Margins: 1.3 cm to the base, 1.6 cm to the skin, 2.5 cm to the. sternum, 2.5 cm to the axilla, 3 cm to the shoulder, 2 cm to the lower boundary. Microscopic description: Carcinoma ductale invasivum - NHG2 (3+2+1/5 mitoses/10 HPF - visual area 0.55mm). Additionally, benign lesions of the type adenosis sclerosans et ""blunt duet"" and lymph node free of neoplastic. metastasis. Margins as in the macroscopic description. Histopathological diagnosis: Carcinoma ductale invasivum mammae sinistrae. (NHG2, pTIc, pNO /sn/). Invasive ductal carcinoma of the left breast. (NHG2, pTIc, pNO /sn/). Examination: Intraoperative examination. page 2 / 2. Gender: F. Result of immunohistochemical test: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of. neoplastic cell nuclei. HER2 protein stained with HercepTestM by DAKO. Negative reaction in invasive carcinoma. cells ( Score = 1+ 1.",T1,N0,M0,T1N0M0
TCGA-AG-3906,"Diagnosis. Resected rectosigmoid material with a centrally ulcerated, moderately differentiated. adenocarcinoma of the colorectal type, located 2.5 cm from the aboral resection margin,. measuring 2.5 cm in diameter, with infiltration deep into the tunica muscularis propria to. the border of the perirectal fatty tissue. Tumor-free local lymph nodes. Tumor-free colon. resection margins. Tumor-free mesenteric resection margin. Tumor stage: pT2, pNO (0/26) pMX; G2, LO, V0, R0.",T2,N0,M0,T2N0M0
TCGA-KS-A41I,"PREVIOUS DIAGNOSIS INQUIRY. OPER DATE: REQ DOC: PROCEDURE: SPHS. year-old with significant PMH with right thyroid mass and shortness of. breath with chest CT positive for bilateral LAD suspicious for sarcoid vs. lymphoma. FNA positive for follicular (esion. Clinical Diagnosis: Right. thyroid nodule, hilum LAD. Operative Procedure: Right vs total thyroidectomy,. mediast inoscopy. PROCEDURE: SPGD. 1. ""Mediastinal lymph node."" A 0.3 cm lymph node. Frozen section control. 2. ""Right thyroid lobe, rle out follicular variant of papillary carcinoma. A. 6.0 x 3.5 x 2.0 cm, 14.4 gram, lobe of thyroid containing a 2.0 x 1.5 x 1.0 cm. and a 1.0 x 0.6 x 0.6 cm well-defined somewhat lobular nodule. Two additional,. tan, poorly defined areas are present. Remainder of parenchyma is dark brown. and fairly homogenous. Inked black. Tissue procured. 2A. Large nodule. Frozen section control. 2B-H. All nodules and areas of tan discoloration submitted. 3. ""Mediastinal lymph node level IV R."" Several tan soft tissue fragments, 0.5. x 0.5 x 0.3 cm in aggregate. 4. ""Delphian lymph node."" A 1.0 x 0.5 cm brown soft tissue fragment. 5. ""Left lobe thyroid."" A 9.8 gram, 6.0 x 3.0 x 2.0 cm lobe of thyroid. Inked. black. Fairly homogenous beefy red upon sectioning with no discrete nodules. 5A-C. Sampled. FROZEN SECTION REPORT: 1. Non-necrotizing granulomatous inflammation; negative for neoplasm. PREVIOUS DIAGNOSIS INQUIRY. 3. REPORT DATE: PATIENT NBR: SEX: F. NAME: : ADM DATE: BIRTHDATE: OPER DATE: REQ DOC: 2. Follicular lesion, suspicious for vascular invasion. I,. have reviewed and interpreted the frozen section. material at the time it was requested. 1,. have reviewed and interpreted the frozen section. material at the time it was requested. 1,. have reviewed and interpreted the frozen section. material at the time it was requested. Permanent sections confirm frozen section report. PROCEDURE: SPDX. 1 & 3. Mediastinal lymph nodes, biopsy: Non-necrotizing granulomas. Negative. for neoplasm. 2. Thyroid, right lobe, lobectomy: Papillary carcinoma, follicular variant, 2. cm. Margins free of neoplasm. Lymphocytic thyroiditis. Non-necrotizing. granuloma. 4. Delphian lymph nodes, biopsy: Negative for neoplasm. 5. Thyroid, left lobe, lobectomy: Lymphocytic thyroiditis. I,. the signing staff pathologist, have personally. examined and interpreted the slides from this case. END OF PREVIOUS DIAGNOSIS INQUIRY.",T1,N0,M0,T1N0M0
TCGA-63-7020,A description for each data field can be found in the 'Data description' worksheet (yellow tab). Sample Collection Details. Type. BUFFY. TUMOUR. Histology and staging. Site of. Year of. Age at. Days to. Days to. Type of. Site of. Preparatio. Tissue. Comments. Procedure. Diagnosis. Procedure. Primary. n. (Histology). (yrs). FF. 0. 11 RESECT. RUL. FF. RUL lung. 0. 11 RESECT. RUL. Tumour. Histology. Grade/. Pathologic Pathologic Clinical M. VALCSG. Histology. Slide URL. Size (cm). Differentiat al T. al N. Stage. Comments. ion. 1.5. 7 II. T1. M0. 1.5. 7 II. T1. M0.,T1,N0,M0,T1N0M0
TCGA-DD-A1EA,"TISSUE DESCRIPTION. Left lateral liver (250 grams, 18 x 9.5 X 5 cm). A1. A2,. DIAGNOSIS: Liver, left lateral, sectorectomy: Grade 2 (of 4). hepatocellular carcinoma, forming a 4 X 3 X 3 cm mass. The. surgical margins are negative for tumor by 5.0 cm. ADDENDUM. Special stains (reticulin and trichrome) demonstrate grade 1. chronic hepatitis and minimal periportal fibrosis. Sections of. tumor also demonstrate vascular invasion on permanent sections. TISSUE DESCRIPTION: Left lateral liver (250 grams, 18 x 9.5 X 5 cm). A1. A2,. DIAGNOSIS: Liver, left lateral, sectorectomy : Grade 2 (of 4). hepatocellular carcinoma, forming a 4 X 3 X 3 cm mass. The. surgical margins are negative for tumor by 5.0 cm. ADDENDUM. Special stains (reticulin and trichrome) demonstrate grade 1. chronic hepatitis and minimal periportal fibrosis. Sections of. tumor also demonstrate vascular invasion on permanent sections.",T2,N0,M0,T2N0M0
TCGA-BP-4160,"Clinical Diagnosis & History: Left renal tumor. Specimens Submitted: 1: SP: Lt. kidney and adrenal gland. 2: SP: Para-aortic lymph nodes. DIAGNOSIS: 1). KIDNEY AND ADRENAL GLAND, LEFT; NEPHRECTOMY AND. ADRENALECTOMY: - RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE,. NUCLEAR GRADE II/IV. THE PATTERN OF GROWTH IS ACINAR. THE. TUMOR GREATEST DIAMETER IS 4.5 CM. THE TUMOR EXTENDS. THROUGH THE RENAL CAPSULE BUT IS CONFINED WITHIN GEROTA'S. FASCIA. NO INVASION OF THE RENAL VEIN IS IDENTIFIED. ALL. SURGICAL MARGINS ARE FREE OF TUMOR. THE NON-NEOPLASTIC. KIDNEY IS UNREMARKABLE. THE ADRENAL GLAND SHOWS FOCAL. NODULAR HYPERPLASIA. 2). LYMPH NODES, PARA-AORTIC; EXCISION: - THREE BENIGN LYMPH NODES (0/3) . Gross Description: 1). The specimen is received fresh for frozen section, labeled. ""Left kidney and adrenal gland"". It consists of a left kidney,. segment of ureter, fragments of the renal blood vessel,. perinephric adipose tissue and a portion of adrenal gland,. weighing 450 grams. The kidney measures 11.0 x 6.0 X 5.0 cm. The portion of ureter measures 7.0 cm in length and 0.5 cm in. circumference. Sectioning of the kidney reveals a well-. circumscribed tumor which grossly breaks through the renal. capsule and extends to the perinephric adpose tissue, coming. within 0.1 cm from the inked Gerota's fascia. The tumor is. composed of pink-red to bright yellow, soft to focally fibrous. parenchyma. The dimension of the tumor is 4.5 x 3.0 X 0.5 cm and. it involves the mid-lower portion of the kidney. Grossly, the. collecting system is free of tumor. The urothelium of the pelvis. and ureter is pink-tan and smooth. The hilar region of the. kidney is, free of tumor. The renal vein is free of tumor. The. rest of the renal parenchyma is grossly unremarkable. The. portion of renal gland measures 3.5 X 2.0 x 1.0 cm. Serial. sectioning of the adrenal gland reveals intramedullary. hemorrhage; otherwise, the parenchymal adrenal gland is. unremarkable. No lymph nodes are identified at the region of the. kidney. Representative sections are submitted. A small portion. of tumor is taken for TPS. Tumor is also fixed in glutaraldehyde. for EM studies. Gross photographs of the specimen are taken. Summary of Sections: FSC - Frozen section control. SM. - Ureteral and renal blood vessel surgical margin. TGF - Tumor closest to inked Gerota's fascia. - Representative sections of tumor. - Representative sections of renal parenchyma. AG - Representative sections of adrenal gland. 2) The specimen is received in formalin, labeled ""Para-aortic. Lymph Nodes"". It consists of pieces of fibroadipose tissue. measuring 7 x 6 x 2.5 cm in aggregate. On sectioning, multiple. lymph nodes ranging in size from 0. to 4.5 cm are identified. The largest lymph node is almost 99% replaced by the adipose. tissue. Lymph nodes are submitted in two blocks. Summary of Sections: LNS - lymph nodes. LN. - lymphoid tissue from the largest lymph node. Summary of Sections: Part. Sect. SiteBlocks Pieces. All. AG. 1. M. N. FSC. 1. 1. RS. 1. 2. SM. 1. 3. M. TGF. 3. M. 2. LN. 1. M. Y. LNS. 1. M. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the. intraoperative consultation. FROZEN SECTION DIAGNOSIS: RENAL CELL CARCINOMA. PERMANENT DIAGNOSIS: SAME.",T3,N0,M0,T3N0M0
TCGA-B0-4945,"FINAL DIAGNOSIS: KIDNEY, RIGHT, RADICAL NEPHRECTOMY-. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR AND GRANULAR CELL) TYPE, FUHRMAN'S NUCLEAR GRADE. 2 OF 4. B. THE GREATEST DIAMETER OF THE NEOPLASM IS 4.0 CM. C. THE NEOPLASM IS CONFINED TO THE KIDNEY WITHOUT EXTRACAPSULAR EXTENSION, NOR INVOLVEMENT OF. THE RENAL PELVIS/RENAL SINUS. D. NO EVIDENCE OF ANGIOLYMPHATIC INVASION IS IDENTIFIED. E. SEPARATE SMALL PAPILLARY RENAL TUBULAR EPITHELIAL NEOPLASM OF LOW MALGNANT POTENTIAL. (ADENOMA, SLIDE F). F. THE NON-NEOPLASTIC KIDNEY SHOWS FOCAL GLOBAL GLOMERULOSCLEROSIS INVOLVING 5-10% OF. GLOMERULI, OTHERWISE IS UNREMARKABLE. G. BENIGN PROXIMAL URETER AND PERI-RENAL ADIPOSE TISSUE. H. TNM STAGE: pT1a Nx MX. I. TNM HISTOLOGIC GRADE = G2.",T1,N0,M0,T1N0M0
TCGA-E2-A15D,"SPECIMENS: A. RIGHT BREAST CANCER. B. SENTINEL L.N. #1 RIGHT AXILLA. C. SENTINEL L.N. #2 RIGHT AXIL;LA. D. SENTINEL L.N. #3 RIGHT AXILLA. E. SENTINEL L.N. #4 RIGHT AXILLA. SPECIMEN(S): A. RIGHT BREAST CANCER. B. SENTINEL L.N. #1 RIGHT AXILLA. C. SENTINEL L.N. #2 RIGHT AXIL;LA. D. SENTINEL L.N. #3 RIGHT AXILLA. E. SENTINEL L.N. #4 RIGHT AXILLA. GROSS DESCRIPTION: A. RIGHT BREAST CANCER. Received fresh labeled with the patient's identification and ""right breast needle localization"" is a previously inked 53g,. 6 x 5 x 4cm needle localized lumpectomy with radiograph. Ink code: anterior-yellow, posterior-black, superior-blue,. inferior-orange, medial-green, lateral-red. Specimen is serially sectioned from lateral to medial into 8 slices revealing. a 2.5 x 2.3 x 1. 5cm tan white firm well circumscribed mass, 0.6cm from the closest inferior margin in slices 2-7. A. surgical clip is identified in slice 5. A portion of the specimen is submitted for tissue procurement. Representatively. submitted: A1-A2: lateral margin slice 1. A3-A5: slice 2. A6-A8: slice 3. A9-A15: slice 4. A16: slice 5 with clip ID. A17-A18: slice 6. A19-A20: slice 7. A21: medial margin. B. SENTINEL L.N. #1 RIGHT AXILLA. Received fresh is a tan pink lymph node 1.2 x 1 x 1cm. The specimen is sectioned and a touch prep is taken. Toto. B1. C. SENTINEL L.N. #2 RIGHT AXILLA. Received fresh is a tan pink lymph node 0.8 x 0.6 x 0.5cm. The specimen is bisected and a touch prep is taken. Toto. C1. D. SENTINEL L.N. #3 RIGHT AXILLA. Received fresh is a tan pink lymph node 1.2 x 1 x 0.8cm. The specimen is bisected and a touch prep is taken. Toto. D1. E. SENTINEL L.N. #4 RIGHT AXILLA. Received fresh is a tan pink lymph node 1.4 x 1 x 0.6cm. The specimen is bisected and a touch prep is taken. Toto. E1. DIAGNOSIS: A. BREAST, RIGHT, WIDE LOCAL EXCISION: INVASIVE DUCTAL CARCINOMA, SBR GRADE 1, MEASURING 2.2-CM. INTERMEDIATE NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, CRIBRIFORM TYPE WITH CENTRAL. NECROSIS. - SURGICAL RESECTION MARGINS NEGATIVE FOR TUMOR. DCIS PRESENT WITHIN 0.15-CM FROM INFERIOR SURGICAL RESECTION MARGIN. - BIOPSY SITE CHANGES WITH FIBROSIS AND GRANULATION TISSUE. - SEE SYNOPTIC REPORT. B. LYMPH NODE, SENTINEL #1, RIGHT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). C. LYMPH NODE, SENTINEL #2, RIGHT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). D. LYMPH NODE, SENTINEL #3, RIGHT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). E. LYMPH NODE, SENTINEL #4, RIGHT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Yes For mass. Laterality: ( Right. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2.2cm. Tumor Site: Not specified. Margins: Negative. Distance from closest margin: 0.4cm. inferior. Tubular Score: 2. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 1. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0 / 4. DCIS present. Margins uninvolved by DCIS 0.15-cm from inferior. DCIS Quantity Estimate 30%. DCIS Type: Cribriform. DCIS Location: Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT 2N0. CLINICAL HISTORY: None provided. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. INTRAOPERATIVE CONSULTATION: A. GROSS CY^MINATION: Right breast-mass is 2.5cm and 0.6cm from the closest inferior margin. Diagnosis called. to Dr. at. by Dr. TPB-TPC-TPD-TPE SLN #1-4: Negative for carcinoma. Diagnosis called to Dr. at. by Dr. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 17. CLINICAL EXPERIENCE: Patients with a recurrence score of: 17 in the clinical validation study had an average. rate of Distant Recurrence at 10 years of 11%. ER Score: 9.8 Positive. PR Score: 8.4 Positive. Her2 Score: 9.5 Negative. Interpretation: ER. Negative < 6.5 Positive >= 6.5. PR. Negative < 5.5 Positive >= 5.5. Her2 Negative <10.7 Positive >=11.5 Equivocal = 10.7 - 11.4. See separate. report for further information. Microscopic/Diagnostic Dictation: Pathologist,. Final Review: Pathologiet. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,.",T2,N0,M0,T2N0M0
TCGA-BR-A4J5,"Gross Description: In lesser curvature-antrum there is a large ulcerated tumor with 3x4x1.5cm in size,. firm and myxoid gray surface. Microscopic Description: Mucosa is ulcerated. The tumor is composed of large pools of extracellular. mucin that contain malignant epithelium as cord or acinar or adenoid structures or signet ring cells. Tumor in invasion in serosa. Nuclei are hyperchromatic and irregular enlarged with prominent nucleoli. Mitoses are present. Diagnosis Details: Mucinous Adenocarcinoma, infiltrating serosa. Comments: Formatted Path Reports: STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Antrum. Tumor size: 3 x 4 X 1.5 cm. Tumor features: Ulcerated. Histologic type: Mucinous adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Serosa (visceral peritoneum). Lymph nodes: 1/5 positive for metastasis (Adjacent lymph node 1/5). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T4,N1,M0,T4N1M0
TCGA-UF-A7JK,"PRIMARY SITE: Larynx. 1- Recorrential node. One lymph node uninvolved by neoplasia (0/1). 2- Neck resection - Left: Five lymph nodes uninvolved by neoplasia (0/5). 3-Recorrential node - Left: Squamous cell carcinoma metastasis in one lymph node compromising focally its. structure and presenting capsular involvement with associated desmoplasia (1/1). 4 - Total Laryngectomy. Tumor site: Larynx. Squamous cell carcinoma, grade 2 histological with keratinizing pattern. Tumor size: 5.5 cm. Ulceration: present. Discrete tumor lymphocitary infiltrate. Discrete desmoplasia. Mucosa, cartilage plan and skeletal muscle invasion. Lymphatic invasion: present. Vascular invasion: not detected. Scarce intratumor neural invasion. Thyroid gland uninvolved by neoplasia with lymphocytic chronic thyroiditis. Metastasis in two lymph nodes without capsular involvement among eleven lymph. nodes (2/11).",T4,N2,M0,T4N2M0
TCGA-E9-A1RA,"OC ID. Gross Description: Lump with the tumor of 1.2 x 1.3 cm in size. Fatty tissue lymph nodes are dense, hyperemic. Microscopic Description: Infiltrating duct carcinoma, G2. Ten dissected lymph nodes demonstrate reactive changes. Diagnosis Details: Tumor Features: Unknown, Tumor Extent: T1 tumor size 2 cm or less, Venous Invasion: Absent, Margins: Absent, Treatment. Effect: Comments: BREAST TISSUE CHECKLIST. Specimen type: Lumpectomy. Specimen size: Not specified. Tumor site: Upper outer quadrant. Tumor size: 1.2 x 1.3 x 0 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 0/10 positive for metastasis (Axillary 0/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Uninvolved. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None. Laterality: Left, upper outer quadrant.",T1,N0,M0,T1N0M0
TCGA-A2-A0CR,"Specimen #: F. Race: WHITE. Physician (s) : SPECIMEN: LEFT BREAST MASTECTOMY. FINAL DIAGNOSIS: BREAST, LEFT, MASTECTOMY: INFILTRATING LOBULAR CARCINOMA. - ELL-DIFFERENTIATED BY COMBINED HISTOLOGIC CRITERIA. - SIZE: 9 CM. - ANGIOLYMPHATIC INVASION IDENTIFIED (A12) . - FOCAL DERMAL LYMPHATIC INVOLVEMENT (NIPPLE, SLIDE A8). - TUMOR WITHIN 1 MM OF DEEP MARGIN (A9, A10). - 16 LYMPH NODES IDENTIFIED, ALL NEGATIVE FOR MALIGNANCY. - AJCC STAGE IIB (T3 NO MX). - FOCAL LOBULAR CARCNOMA IN SITU (A5) . - INTRADUCTAL HYPERPLASIA, FLORID. - FIBROCYTSTIC CHANGES. COMMENT: Hormone receptor and HER2 studies previously reported. CLINICAL DIAGNOSIS AND HISTORY: -year-old female with breast carcinoma, left. GROSS DESCRIPTION: LEFT BRFAST MASTECTOMY received fresh, labeled with the patient's name,. designated ""LEFT BREAST AND AXILLARY CONTENTS"" consists. of a 1,044.0 gram modified radical mastectomy specimen. It measures 20.5. cm medial to lateral, 20.0 cm superior to inferior, 4.5 cm anterior to. posterior, with an attached axillary tail, 11.0 x 7.0 x 3.7 cm, and an. overlying ellipse of nipple bearing skin, measuring 18. x 9.5 cm. The. nipple is inverted and the skin is otherwise unremarkable. Ink code: Blue=superior superficial, green=inferior superficial, black=deep. Sectioning reveals a poorly defined, indurated mass in the upper inner. quadrant focally abutting the deep margin. Continuous with this lesion and. extending laterally to the outer portion of the breast is a broad area of. Specimen # : GROSS DESCRIPTION (continued). variably indurated fibrous tissue (overall maximum dimension of mass plus. indurated fibrous tissue = 9.0 cm) . Multiple sections are harvested for. the. protocol with matching paraffin sections as follows : A1: Skin (medial tip). A2: Lymph node, 1.8 cm, mid/upper axillary tail. A3: Tumor, upper inner quadrant. A4: Indurated fibrous tissue (5.0 cm from medial extent of tumor). central. A5: Indurated fibrous tissue (7.0 cm from medial extent of tumor) ,. central. A6: Indurated fibrous tissue (9.0 cm from medial extent of tumor) ,. mid center. A7: Grossly normal fibrofatty tissue, lower outer quadrant. Sectioning through the axillary tail reveals 14 possible lymph nodes. ranging in size from 0.2 cm to 3.0 cm in greatest dimension. Additional. representative sections are submitted in cassettes A8 through A22, as. follows: A8: Nipple. A9-A11: Mass upper inner quadrant . A12: Centralized fibrous area. Al3: Upper inner quadrant. A14: Lower inner quadrant. A15: Lower outer quadrant. A16: Upper outer quadrant. A17: Five possible lymph nodes. A18: Five possible lymph nodes. A19: Two possible lymph nodes, largest lymph node bisected and submitted. in its entirety. A20: One lymph node bisected and submitted in its entirety. A21-A22: One lymph node bisected and submitted in its entirety in two. cassettes. 22CF.",T3,N0,M0,T3N0M0
TCGA-AA-3560,"Diagnosis: Resected colon (sigma) with tumor-free oral and aboral resection margins, including a. hyperplastic polyp and several tubular adenoma with mild to moderate dysplasia. (synonymously: mild intraepithelial neoplasia) and with an ulcerated, moderately. differentiated adenocarcinoma with infiltration of the perimuscular adipose tissue and with. several lymph node metastases in the region (G2, pT3, L1, V0, local R0, pN2, 5/25).",T3,N2,M0,T3N2M0
TCGA-G4-6309,"SPECIMENS: A. SIGMOID COLON. B. PROXIMAL DONUT. C. DISTAL DONUT. SPECIMEN(S): A. SIGMOID COLON. B. PROXIMAL DONUT. C. DISTAL DONUT. GROSS DESCRIPTION: A. SIGMOID COLON. Received fresh for tissue procurement and labeled with the patient's name and ""sigmoid colon"" is a. closed, unoriented segment of colon measuring 13 cm in length with a diameter of 5 cm. There is. an. area of stricture measuring 1.2 cm, which is 4.5 cm from the nearest surgical margin. This region is. inked black. The colon is opened and there is a fungating exophytic polypoid mass with serpentine. border measuring 3.9 cm in length with a diameter of 3.0 cm. It appears to invade through the. muscularis propria. It is located 3.5 cm from the nearest surgical margin and approximately 7.5 cm from. the distant margin. The mucosa, extending from the mass to its nearest surgical margin, has a granular. appearance. Sections of mass and normal appearing mucosa are submitted for tissue procurement. Normal mucosa is submitted for RNA study. Representative sections are submitted as follows: A1: margin closest to mass. A2: margin distal to mass. A3-A4: sections of mass and deep margin. A5-A6: granular mucosa. A7: normal-appearing mucosa. A8-A9: six possible lymph nodes each distal to mass. A10-A11: four possible lymph nodes each in proximity to mass. A12: two bisected lymph nodes adjacent to mass. B. PROXIMAL DONUT. Received in formalin and labeled with the patient's name and ""proximal donut"" is a donut of pink-tan. mucosal tissue measuring 3.2 X 2.4 X 0.6 cm. There is a blue suture throughout the specimen. It is. bisected and the mucosa is unremarkable. Representative section is submitted in block B1. C. DISTAL DONUT. Received in formalin and labeled with the patient's name and ""distal donut"" is a donut of pink-tan. mucosal tissue measuring 2.2 X 1.7 X 0.5 cm. The mucosal surface has pinpoint areas of hemorrhage. There are surgical staple present. Representative section is submitted in block C1. DIAGNOSIS: A. COLON, SIGMOID, SEGMENTAL RESECTION: INVASIVE ADENOCARCINOMA, MODERATELY AND POORLY DIFFERENTIATED, SEE. SYNOPSIS. - 3.9 CM IN GREATEST DIMENSION. - 3.0 X 1.2 CM IN ADDITIONAL DIMENSIONS. - INVADING INTO THE SUBSEROSA. - THE PROXIMAL, DISTAL, AND RADIAL MARGINS ARE NEGATIVE FOR TUMOR. THE TUMOR IS 3.5 CM FROM THE PROXIMAL MARGIN (CLOSEST MARGIN). - SUSPICIOUS FOR ANGIOLYMPHATIC INVASION. - NO PERINEURAL INVASION IDENTIFIED. - ASSOCIATED WITH A TUBULAR ADENOMA. - METASTATIC CARCINOMA TO TWO OF TWENTY FOUR LYMPH NODES (2/24), WITH. EXTRANODAL EXTENSION. B. COLON, PROXIMAL MARGIN, SEGMENTAL RESECTION: - NO MALIGNANCY IDENTIFIED. C. COLON, DISTAL MARGIN, SEGMENTAL RESECTION: - NO MALIGNANCY IDENTIFIED. COMMENT: THE RESULTS OF EXPRESSION OF MISMATCH REPAIR PROTEINS WILL BE ISSUED. AS AN ADDENDUM. SYNOPTIC REPORT - COLON & RECTUM. Specimens Involved. Specimens: A: SIGMOID COLON. Specimen Type: Sigmoidectomy. Tumor Site: Sigmoid colon. Tumor Configuration: Exophytic (polypoid). Tumor size: 3.9cm Additional dimensions 3cm X 1.2cm. WHO Classification. Adenocarcinoma 8140/3. Histologic Grade: G3: Poorly differentiated. Extent of Invasion: Subserosa. Margins: Margin(s) uninvolved by invasive carcinoma (Proximal, Distal, Radial). Distance of invasive carcinoma from closest margin: 3.5cm. Venous/Lymphatic Invasion: Absent. Perineural Invasion: Absent. Additional Pathologic Findings: Adenoma. Extent of Resection: R0: Complete resection with grossly and microscopically negative margins. Lymph Nodes: Positive 2/24. Extranodal extension: Present. Implants: Absent. Pathological Staging (pTNM): pT 3 N 1 M X. CLINICAL HISTORY: None provided. PRE-OPERATIVE DIAGNOSIS: Colon ca. ADDENDUM: ANALYSIS OF MISMATCH REPAIR PROTEIN EXPRESSION. SUMMARY OF IMMUNOHISTOCHEMISTRYISPECIAL STAINS. Material: Block A4. Population: Tumor Cells. Stain/Marker:Result: Comment: MLH1. Positive. MSH2. Positive. MSH6. Positive. PMS2. Negative. The interpretation of the above immunohistochemistry stain or stains is guided by published results in. the medical literature, provided package information from the manufacturer and by internal review of. staining performance and assay validation within the. of the. The use. of one or more reagents in the above tests is regulated as an analyte specific reagent (ASR). These. tests were developed and their performance characteristic determined by the. at. They have not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. INTERPRETATION: No expression of PMS2 identified. Expression of MLH1, MSH2, MSH6, and PMS2 in the tumor was evaluated by immunohistochemistry. Peritumoral lymphocytes and normal glands serve as internal positive controls expressing MLH1,. MSH2, MSH6, and PMS2. Testing for Microsatellite Instability has been ordered. The results will be issued in a separate report.",T3,N1,M0,T3N1M0
TCGA-DD-AACI,"CLINICAL DIAGNOSIS: R/O Carcinosarcoma. Specimen : liver. Gross Photo : 1. GROSS: 1. Specimen: Liver: 10.0 X 9.0 X 12.0 cm, fixed. 2. Tumor location: left. Tumor number: one. Tumor size: 5.5 X 3.5 X 5.0 cm. 3. Satellite nodule: no. 4. Gross type. HCC: expanding nodular. 5. Tumor necrosis: no. 6. Hemorrhage/peliosis: no. 7. Portal vein invasion: yes. 8. Bile duct invasion: no. 9. Others: dystrophic calcification in the fibrotic septa, central. Gross photo present. Blocks. T1-4, TB, tumor and surrounding liver tissue X 5. L, NB, remaining liver tissue X 2. RM, resection margin of liver X 1. A, labeled ""tumor emboli"" X 1. MICROSCOPIC: 1. Hepatocellular carcinoma: yes. 1-1. Differentiation. The worst differentiation: III. The major differentiation: III. 1-2. Histologic type: trabecular and solid. 1-3. Cell type: hepatic. 1-4. Fatty change: yes (30-40 %). 2. Other tumor: no. 3. Fibrous capsule formation: partial. 4. Capsular infiltration: yes. 5. Septum formation: partial. 6. Surgical resection margin invasion: no. 7. Serosal invasion: no. 8. Portal vein invasion: yes. 9. Bile duct invasion: no. 10. Hepatic vein invasion: no. 11. Hepatic artery invasion: no. 12. Microvessel invasion: no. 13. Intrahepatic metastasis: no. 14. Multicentric occurrence: no. 15. Others: dystrophic calcification is present. Non-tumor liver pathology. 1. Chronic hepatitis: yes. 1-1. Etiology: unknown cause. 1-2. Grade, lobular: minimal (grade I). 1-3. Grade, portoperiportal: minimal (grade I). 1-4. Stage (fibrosis): precirrhotic (stage III-IV). 2. Dysplastic nodule: no. 3. Ductal epithelial dysplasia: no. 4. Other liver diseases: no. SPECIAL STAIN: Reticulum stain shows arrangement of tumor cells. Trichrome stain shows fibrotic septum. NOT reported. Gross: Bile duct, smear, inflammation. Bile duct, smear, inflammation. ver,needle,hepatocellular carcinoma. Liver, ectomy, hepatocellular carcinoma, cholangiocytic differentiation, precirrhotic fibrosis. T56000, P10, M81703, cholangiocytic differentiation, precirrhotic fibrosis. DIAGNOSIS: Liver, segment, left, segmentectomy: Hepatocellular carcinoma, moderately differentiated,. with cholangiocytic differentiation (see NOTE). Precirrhotic fibrosis. NOTE: Tumor. cholangiocytic differentiation. hepatocellular carcinoma. Suggestion :",T2,N0,M0,T2N0M0
TCGA-EL-A3CW,"ry Case. gy Report. Pathology,. Sex: F. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. the section ""SPECIMEN"" may have been added. GNOSIS. (A) RIGHT LOBE AND ISTHMUS WITH RIGHT PARATRACHEAL AND MID-JUGULAR NODE. DISSECTION: PAPILLARY THYROID CARCINOMA. METASTATIC PAPILLARY CARCINOMA IN 4 OF 6 LYMPH NODES FROM LEVEL 4. METASTATIC PAPILLARY CARCINOMA IN 10 OF 15 PARATRACHEAL LYMPH NODES. One perithyroidal lymph node, no tumor present. Isthmic surgical margin, no tumor present. Parathyroid gland, one, unremarkable. Entire report and diagnosis completed by: Report released by: GROSS DESCRIPTION. (A) RIGHT LOBE AND ISTHMUS - A right paratracheal and mid-jugular node. dissection ( an irregular, pink-red portion of soft tissue 15.0 x 4.5 x 3.0. cm) with a right thyroid lobe (5.0 x 4.0 x 2.0 cm). The specimen is oriented. by the surgeon. A firm, gray-tan, unencapsulated tumor (3.5 x 3.0 x 2.0 cm) is noted in. the right thyroid lobe. The tumor appears to be confined to the thyroid. The. isthmus margin is taken for frozen section. Multiple lymph nodes are detected. from levels 4, 5, and paratracheal areas. The lymph nodes vary in size from. 0.2 to 1.5 cm. No abnormalities are identified in the lymph node. Representative sections are submitted in 20 cassettes. INKING CODE: Black-thyroid. SECTION CODE: A1, isthmus, margin frozen section; A2-A12, thyroid from. superior to inferior; A13-A15, lymph nodes from level 4 (A13, 3 possible lymph. nodes; A14, 1 lymph node bisected; A15, 1 possible lymph node; A16, A17,. possible lymph nodes from level 5 (A16, 1 possible lymph node and soft tissue;. A17, soft tissue) ; A18-A20, paratracheal lymph node (A18, 8 possible lymph. nodes; A19, 6 possible lymph nodes; A20, 1 lymph node bisected). FS/DX: NO TUMOR PRESENT. SNOMED CODES.",T2,N1,M0,T2N1M0
TCGA-CG-5723,"Diagnosis(es): Total gastrectomy specimen including an extensively ulcerated, weakly differentiated. gastric adenocarcinoma of maximum diameter 5 cm located in the area of the cardia with. only very localized signet ring cell differentiation and with infiltration of the perigastric. fatty tissue and one regional lymph node metastasis. Tumor-free esophageal resection. margin lined with typical squamous epithelium and tumor-free aboral resection margin. lined with unremarkable duodenal mucosa. Tumor stage: pT2b pN1 (1/31) pMX;.",T2,N1,M0,T2N1M0
TCGA-85-8287,Microscopic Description. Diagnosis Details. Comments. LUNG TISSUE CHECKLIST. Specimen type: Pulmonectomy. Tumor site: Lung. Tumor size: 3 X 2.5 X 2.5 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 0/3 positive for metastasis. (Regional 0/3). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: Left- upper. Laterality. Left- upper. Case ID.,T1,N0,M0,T1N0M0
TCGA-B6-A0I5,"Sex: F. Date of Birth: ars. Not for patient's chart. DIAGNOSIS. ORIGINAL TEXT: FEMALE BREAST, RIGHT. RIGHT BREAST MASS; MULTIFOCAL INTRADUCTAL AND INFILTRATING. DUCTAL CARCINOMA, GRADE 2/3, NUCLEAR GRADE MODERATELY. DIFFERENTIATED, THE TUMOR EXTENDS TO WITHIN 0.1MM OF THE. SURGICAL MARGIN. ORIGINAL VER ID. AT 00:00 BY.",T2,N1,M0,T2N1M0
TCGA-2H-A9GQ,"Coded sample ID: Histologic diagnosis: poor differentiated adenocarcinoma located in Barrett-epithelium. Anatomic site with laterality: distal esophagus. Tumor size: max. diameter 3.5 cm. Lymph node status: 14 lymph nodes, of which 2 contain tumor. Any comments or amendments: radical resection.",T3,N1,M0,T3N1M0
TCGA-CI-6619,"STRESFY. RESTILL. POSTOPERATIVE DIAGNOSIS: poure, LEGION :N RECTUM. ATESTORY: A. TRANSVERSE COLOS - pours. "", MECTOM . 13% OF. ADRNOMATONIS WITH GRACE DYSPLABIA, TRANAVERGE COLOR. a. BIOPSY GPECIMINN, RECTEM, ABIONING. INFILTRATING. or QUANTITATIVE : ARE. MICROSCOFECI.",T3,N1,M1,T3N1M1
TCGA-53-7624,"Pathologic Interpretation: A. Intra lobar lymph node #11: - One lymph node with anthracosis. - No tumor seen. B. Right upper lobe, lobectomy for frozen section: - Moderately to poorly differentiated adenocarcinoma, 6.2 cm. in greatest dimension. - The tumor penetrates visceral pleura. - Margins free of tumor. - Four lymph nodes, no malignancy seen (0/4). - AJCC pT2, NO, MX. - See Tumor Summary. C. Parabronchial lymph node, biopsy: - One lymph node, no malignancy seen (0/1). D. Paraesophageal lymph node #8: - One lymph node, no malignancy seen (0/1). E. Visceral pleural nodule, biopsy: - Lung parenchyma with foci of bronchioloalveolar hyperplasia. - No carcinoma seen. F. Right tracheal angle lymph node #10: - Two lymph nodes, no malignancy seen (0/2). G. Right superior lobe segment: - Lung parenchyma with foci of bronchioloalveolar hyperplasia. - No carcinoma seen. H. Subcarinal lymph node #7: - Two lymph nodes, no malignancy seen (0/2). I. Inferior pulmonary lymph node #9: - Two lymph nodes, no malignancy seen (0/2). J. Right distal paratracheal lymph node #R4: - Four lymph nodes, no malignancy seen (0/4). Tumor Summary: Specimen Type: Lobectomy. Laterality: Right. Tumor Site: Upper lobe. Tumor Size: Greatest dimension: 6.2 cm. Additional dimensions: 3 X 2.4 cm. Histologic Type: Adenocarcinoma, not otherwise characterized. Histologic Grade: Poorly differentiated. Pathologic Staging: PT2: Tumor with any of the following features of size or extent: greater than 3cm in greatest dimension. pNO: No regional lymph node metastasis. pMX: Cannot be assessed. Margins: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 2 mm. Specify margin: Soft tissue (chest wall). Venous (Large Vessel) Invasion (V): Absent. Arterial (Large Vessel) Invasion: Absent. Lymphatic (Small Vessel) Invasion (L): Absent. Pathologic Staging: pT2, NO, MX. As the attending pathologist, I attest that I: (i) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). Amendments. Reason: Diagnosis editing/clarification. Addendum Diagnosis. This addendum is issued after a second review of the gross specimen and the pulmonary conference to clarify that there are. adhesions between the tumor and an attached fragment of membranous sotf tissue/parietal pleura? which measures approximately. 7.5x2.0x0.4 cm. However; the tumor does not penetrate through to reach into the soft tissue margin (section B6). This case was. reviewed with. Intraoperative Consultation. B. Right upper lobe, FS: Bronchial margin, free of tumor. Tumor: Carcinoma, favor adenocarcinoma. Clinical History: None Provided. Operation Performed. Right thoracotomy. Pre Operative Diagnosis: Cancer. Specimen(s) Received: A: Intra lobar lymph node #11. B: Right upper lobe. C: Parabronchial lymph node. D: Paraesophageal lymph node #8. E: Visceral pleural nodule. F: Right tracheal angle lymph node #10. G: Right superior lobe segment. H: Subcarinal lymph node #7. I: Inferior pulmonary lymph node #9. J: Right distal paratracheal lymph node #R4. Gross Description: A. Received in formalin is an ovoid fragment of tan and yellow tissue with anthracotic pigment, measuring 1.2 x 0.9 X 0.5 cm. The fragment is bisected and submitted in toto in one cassette. B. Received fresh for frozen section is a 189 grams, 11.7 x 9.3 X 4.7 cm lobe of lung. The pleural surface is smooth,. glistening, grey and purple. Upon sectioning, a well-defined, firm, tan and white mass, measuring 6.2 x 3.0x2.4 cm is. identified. The mass is grossly in contact with the visceral pleura It has an area of cystic degeneration, measuring 1.8 x. 1.3 x 1.2 cm. The mass is up to 6.0 cm from the parenchymal bronchial and vascular resection margins. Other areas of. the lung parenchyma are congested and spongy. Four lymph nodes are identified in the hilum. Representative sections. are submitted as follows: 1. Bronchial and vascular margins for frozen section. 2. Representative section of the mass for frozen section. 3&4. Section of the mass in relation with the pleural surface. 5&6. Mass in relation with adjacent cystic cavity. 7. Mass in relation with the pulmonary parenchyma. 8. Other areas of the lung. 9. Section of the cystic area. 10. Perihilar lymph nodes. C. Received in formalin are two ovoid fragments of grey and tan tissue, measuring 0.2 x 0.2 x 0.1 cm in aggregate. Submitted in toto in one cassette. D. Received in formalin is an ovoid fragment of tan and grey tissue, measuring 1.3 x 0.7 x 0.3 cm. The fragment is bisected. and submitted in toto in one cassette. E. Received in formalin is a long wedge biopsy, measuring 3.9 x 0.7 x 0.7 cm. In the pleural surface, a well defined white. nodule, measuring 0.1 x 0.1 x 0.1 cm is identified. This lesion is 1.1 cm from the surgical resection margin. The lesion is. submitted in toto with the surrounding lung parenchyma in one cassette. F. Received in formalin is an irregular fragment of tan and yellow tissue, measuring 1.6 x 0.7 X 0.6 cm. The lymph nodes are. identified. The lymph nodes are bisected and submitted in toto in one cassette. One inked in black. G. Received in formalin is a lung wedge biopsy, measuring 4.4 x 1.0 x 0.5 cm. The pleural surface is slightly irregular. Upon. sectioning, it is spongy, tan and brown. The tissue is submitted in toto for the second margin is one cassette. H. Received in formalin are two ovoid fragments of soft, tan and brown tissue with grey discoloration. The largest measures. 2.2 x 1.1 x 0.7 cm. The smallest measures 0.5 x 0.4 x 0.2 cm. The specimen is submitted in toto as follows: 1. Largest fragment in toto, bisected. 2. The smallest fragment. I. Received in formalin are two ovoid fragments of soft, tan and yellow tissue with anthracotic pigment. The largest. measures 1.3 x 0.7 x 0.3 cm. The smallest measures 0.5 x 0.3 x 0.2 cm. The fragments are bisected and submitted in. toto in one cassette (the smallest fragment inked in black). J. Received in formalin is an irregular fragment of fibroadipose tissue, measuring 3.5 X 2.7 x 1.0 cm. Four lymph nodes are. identified. The lymph nodes are submitted in toto as follows: 1. One lymph node bisected. 2. One lymph node bisected. 3. Two lymph nodes.",T2,N0,M1,T2N0M1
TCGA-2G-AAFE,Summary pathology report. Left orchidectomy; seminoma; diameter 4 cm; tumor confined to testis in available slides;. angio-invasion present; no invasion in rete testis. = date of orchidectomy): pathologist.,T2,N1,M0,T2N1M0
TCGA-AG-3608,"Diagnosis: Resection material from colon (sigmoid/rectum) with tumor-free oral, aboral and perirectal. resection margins, with non-inflamed diverticula, with three tubular adenomas of the colon. mucosa with severe dysplasia in parts (synonym: high-grade intraepithelial neoplasia) and. with inclusion of a moderately differentiated adenocarcinoma or rectal carcinoma with. infiltration of the perimuscular fatty tissue and without regional lymph node metastases. (G2, pT3 L0, V0, R0 pNO 0/16).",T3,N0,M0,T3N0M0
TCGA-D8-A1X8,"page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Multiple organ resection - left breast with axillary tissues. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the left breast. Macroscopic description: Left breast sized 22.4 x 17.8 x 6.4 cm removed along with axillary tissues sized 12 x 5 x 3 cm and a skin flap of 24.2 x 11.3 cm. Weight 950 g. Tumour sized 2.7 x 1.4 x 2.8 cm found in the central part, removed 6.0 cm from the lower boundary, 0.3 cm from the base and 1.4. cm from the skin. Microscopic description: Carcinoma lobulare invasivum (classical type, partly solid) multifocale - NHG2 (3+2+1/0 mitoses/10 HPF - visual area. 0.55mm). Infiltratio carcinomatosa mamillae. In situ lesions of the type pagetoid spread and hyperplasia within the foci of adenosis sclerosans. Glandular tissue. showing lesions of the type fibrosa et cystica, adenosis sclerosans. AXILLARY LYMPH NODES: Metastases. carcinomatosae in lymphonodis (No IX/XI). Test result: Carcinoma lobulare mixtum invasivum mammae sinistrae. Metastases carcinomatosae in lymphonodis axillae (No IX/XI) (NHG2, pTIc, pN2a). Examination performed or. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 protein stained with HercepTestM by DAKO. Score = 2+. FISH verification recommended. Compliance validated by: 1. Examination: Histopathological examination. page 2 / 2. Gender: F. Histopathological diagnosis: Carcinoma lobulare invasivum mammae sinistrae. Invasive lobular carcinoma of the left breast. Metastases in lymphonodis axillae (No IX/XI) (NHG2, pTIc, pN2a). Cancer metastases in axillary lymph nodes (No IX/XI) (NHG2, pTIc, pN2a). Results of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 GENE AMPLIFICATION NOT FOUND.",T1,N2,M0,T1N2M0
TCGA-D7-5577,"Examination: Histopathological examination. collected on: Clinical diagnosis: Adenocarcinoma ventriculi G2, intestinal type, invasive tumour of the gastric body. Examination performed or. Macroscopic description: Sent material consisting of the stomach, having been cut out along the greater curvature, sized 15 x 15.5 cm. with the omentum sized 30 x 14 cm. Ulcerous tumour on the lesser curvature sized 5 x 6 x 1.1 cm. Distance from the proximal end 0.7 cm, from. distal end, 8 cm. Microscopic description: Adenocarcinoma tubulare G2,. Tumour penetrated the full thickness of the stomach wall and perlintestinal fat tissue reaching the. peritoneum membrane. Surgical incision lines off cancer invaded area. Invasio carcinomatosa vassorum. Reactlo lymphocytaria. peritumoralis. Mucosa free of cancer, showing features of chronic immflamation. Omentum sine metastasibus lien. sccessorius. LYMPH NODES: - periorificial: metastases carcinomatosae in lymphonodis (No XII/XXI). Infiltratio carcinomatosa capsulae lymphonodorum et telae adiposae perinodalis. of lesser curvature: metastases carcinomatosae in lymphonodis (No II/II). Infiltratio carcinomatosa capsulae lymphonodorum et telae adiposae perinodalis. - of greater curvature: metastases carcinomatosae in lymphonodis (No II/III). Infiltratio carcinomatosa capsulae lymphonodorum et telae adiposae perinodalis. - peripyloric: metastases carcinomatosae in lymphonodis (No III/VIII). Infiltratio carcinomatosa capsulae lymphonodorum et telae adiposae perinodalis. Examination result: Adenocarcinoma tubulare ventriculi. Metastases carcinomatosae in lymphonodis NO XIX/XXXTV. G2, pT2b, pN3 ty pus intestinalis sec. lauren. METASTATIO LAMPH MODES Validated by: Results of immunohistochemical examination: HER2 protein stained with HercepTestM by DAKO. Negative reaction in invasive cancerous cells ( Score = 0).",T2,N3,M0,T2N3M0
TCGA-BF-A1PZ,Project #. Tissue. Specimen. Clinical. Ethnicity. Anatomical. Tumor. Specimen. Specimen. Index. Clinical Diagnosis. procuremen. Specificatio. label. Site #. (Race). Site. Matrix. Format. t. n. Caucasian. 1. 52. Melanoma. Female. Skin. Primary. Tumor. Tissue. Frozen. (White). Caucasian. 52. Melanoma. Female. Blood. n/a. normal. Blood. Frozen. (White). Prior. Chemo /. Number of. Amount/per. Type of. Histological. TNM Stage. TNM Stage. TNM Stage. Chemo /. Prior. Cellular. Container. Grade. Horm Th. containers. container. description. (T). (N). (M). Hormonal. Radiation. Tumor %. Details. cryomold. 1. 200. mg. Melanoma. n/a. 4. 0. 0. 90. tube. 1. 4. ml. Blood draw. n/a. n/a. n/a. n/a. n/a. n/a. Criteria.,T4,N0,M0,T4N0M0
TCGA-QK-A8ZB,"Anat Path Reports. Document Date: Histoloav. Acc #: Head and Neck. M. Client: Submitting Phys: Final Surgical Pathology Report. Final Pathologic Diagnosis. A. LARYNX, TOTAL LARYNGECTOMY: - INVASIVE SQUAMOUS CELL CARCINOMA, MODERATELY DIFFERENTIATED (2.5 X 2.2X 1.9 CM). - TUMOR INVOLVES THE LEFT TRUE VOCAL CORD, VENTRICLE, ANTERIOR COMMISSURE, AND. INVADES TROUGH THE THYROID CARTILAGE. - SUBCUTANEOUS TISSUE WITH ABSCESS AND KERATINACEOUS DEBRIS. SURGICAL MARGINS NEGATIVE. - SEE SYNOPTIC REPORT. B. LYMPH NODES, LEVEL 1A, EXCISION: - THREE LYMPH NODES NEGATIVE FOR CARCINOMA (0/3). C. LYMPH NODES, LEFT NECK 2B, EXCISION: - EIGHT LYMPH NODES NEGATIVE FOR CARCINOMA (0/8). D. LYMPH NODES, RIGHT NECK LEVEL 2A, EXCISION: - TWELVE LYMPH NODES NEGATIVE FOR CARCINOMA (0/12). E. LYMPH NODES, RIGHT NECK LEVEL 3, EXCISION: ELEVEN LYMPH NODES NEGATIVE FOR CARCINOMA (0/11). F. LYMPH NODES, RIGHT NECK LEVEL 4, EXCISION: - EIGHT LYMPH NODES NEGATIVE FOR CARCINOMA (0/8). G. LYMPH NODES, LEFT NECK LEVEL 2, EXCISION: - TWELVE LYMPH NODES NEGATIVE FOR CARCINOMA (0/12). H. LYMPH NODES, LEFT NECK LEVEL 3, EXCISION: TWENTY LYMPH NODES NEGATIVE FOR CARCINOMA (0/20). I. LYMPH NODES, LEFT NECK LEVEL 4, EXCISION: - SEVEN LYMPH NODES NEGATIVE FOR CARCINOMA (0/7). Synoptic Worksheet. A. Total laryngectomy (study case): Clinical History: No Neoadjuvant therapy. Specimen: Larynx, glottis. Fresh. Procedure: Total laryngectomy. Neck (lymph node) dissection: Level 1A, Left neck (2B,. 2, 3, 4), Right neck (2A, 3, 4). Specimen Integrity: Intact. Laryngectomy: Unopened. Specimen Size: Greatest dimension: 9.3 cm. Additional dimension: 5.2 cm. Additional dimension: 4.3 cm. Tumor Laterality: Left. Tumor Site: Larynx, glottis, true vocal cord. Larynx, glottis, anterior commissure. Transglottic: Additional Sites Involved by Tumor: Ventricle. Tumor Focality: Single focus. Tumor Description: Endophytic. Ulcerated. Histologic Type: Squamous cell carcinoma, conventional. Histologic Grade: G2: Moderately differentiated. Tumor Size: Greatest dimension: 2.5 cm. Additional dimension: 1.9 cm. Additional dimension: 2.2 cm. Margins: Margins uninvolved by invasive carcinoma. Margins uninvolved by carcinoma in situ (includes. moderate and severe dysplasia). Treatment Effect: Not identified: Lymph-Vascular Invasion: Not indentified: Perineural Invasion: Not indentified: Lymph Nodes, Extranodal Extension: Not indentified: Primary Tumor (pT): Glottis pT4a: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid. cartilage and/or invades tissues beyond the larynx (eg,. trachea, soft tissues of neck including deep extrinsic. muscle of the tongue, strap muscles, thyroid, or. esophagus). Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Number of regional lymph nodes examined: 81. Number of regional lymph nodes involved: none. identified. Distant Metastasis (pM): Not applicable: not applicable. Mucosal Melanoma Distant Metastasis (pM): Not applicable: Additional Pathologic Findings: Inflammation (type):absess involving subcutaneous. tissue with keratin debris. Clinical History. Laryngeal cancer. Total laryngectomy, neck dissection, pectoralis flap, direct laryngoscopy. Specimen(s) Received. A: Total laryngectomy (study case). B: Level 1A. C: Left neck 2B. D: Right neck level 2A. E: Right neck level 3. F: Right neck level 4. G: Left neck level 2. H: Left neck level 3. I: Left neck level 4. Gross Description. Specimen A is received fresh in a container labeled with the patient's name, medical record number and identified. as. ""total laryngectomy."" The specimen consists of a total laryngectomy specimen measuring 9.3 x 5.2 x 4.3 cm in total. dimension from the tip of the epiglottis to the inferior tracheal edge with attached hyoid bone measuring 9.5 x 0.5 x. 0.7 cm and the left thyroid lobe measuring 4.1 x 3.3 x 2.2 cm. The larynx is opened posteriorly on the midline at the. time of frozen section analysis. There are three tracheal rings attached. There is a tan-white appearing mass measuring 2.5 X 1.9 cm in surface area and 2.2 cm in thickness involving the. glottic larynx. The mass is grossly located on the bilateral false cord, vestibule true cord and crosses the midline. The mass does not appear to involve pyriform sinus. Grossly, the mass extends 2.4 cm from the tip of the epiglottic. mucosal edge, 2.3 cm from the base of the tongue mucosal edge, 2.4 cm from the lateral right mucosal edge, 1.1 cm. from the lateral left mucosal edge and 3.1 cm from the distal tracheal edge. None of the tracheal rings grossly. appear involved the mass. On the anterior aspect of the specimen is an ellipse of abnormal skin measuring 4.5 x 4.3. x 1.0 cm. The inferior aspect of the skin ellipse measures 2.3 cm from the distal tracheal edge. A tan-white, irregular. ulceration is identified measuring 2.2 x 1.7 cm and is present 2.5 cm from the inferior skin edge, 1.6 cm from the left. skin edge, 1.1 cm from the right skin edge and 0.9 cm from the superior skin edge. The skin defect grossly does not. appear to communicate with the mass lesion. There is a left lobe of the thyroid gland present. The cut surface is. homogenous and beefy red. A colloid nodule measuring 1.3 x 1.1 x 0.5 cm is noted. On sectioning, the lesion. grossly invades the anterior commissure as well as the pre-epiglottic space as well as possible full thickness invasion. of the thyroid cartilage. Sections are taken as listed in the cassette summary after decalcification. Representative. section of tumor is submitted for Tumor Bank at the time of frozen section analysis. The specimen is inked as listed. in the inking code. Dictated by. Ink Code: Left blue. Right black. CASSETTE SUMMARY: A1FS - tracheal margin. A2FS - posterior margin. A3FS - right pharyngeal margin. A4FS - left pharyngeal margin. A5FS - tongue base margin. A6 - skin margin, superior shave. A7 - right skin margin, shave. A8FS - inferior skin margin, shave. A9FS - left skin margin, shave. A10 - right epiglottis, decal. A11,A12 - right false cord, ventricle, true cord and tumor submitted superior to inferiorly, decal. A13 - right aryepiglottic fold, decal. A14 - right anterior soft tissue anterior to the cord. A15-A16 - midline epiglottis (A16 submitted in decal). A17-A18 - superior anterior commissure and anterior soft tissues and skin submitted deep to superficial (A17. submitted in decal). A19-A20 - inferior, anterior commissure and anterior soft tissues and skin submitted from deep to superficial. A21 - left aryepiglottic foid. A22 - left epiglottis, decal. A23 - left false cord, decal. A24 - left soft tissues anterior to cord. A25 - left thyroid lobe with colloid nodule, representative sections. Specimens B through I are received in formalin, in containers labeled with the patient's name and medical record. number. Specimen B is identified as ""level 1A."" The specimen consists of a firm portion of fibrofatty tissue measuring 2.5 x 1.4. x 0.3 cm. The specimen is submitted entirely in cassettes ""B1"" and ""B2."" Dictated by. CASSETTE SUMMARY: B1,2 - level 1A. Specimen C is identified as ""left neck level 1B."" The specimen consists of a firm portion of fibrofatty tissue measuring. 3.0 x 1.4 x 1.3 cm. The specimen is submitted entirely in cassettes ""C1"" through ""C3."" Dictated by. CASSETTE SUMMARY: C1-3 - left neck level 1B, submitted entirely. Specimen D is identified as ""right neck level 2A."" The specimen consists of a portion of fibrofatty tissue measuring. 4.0x2.1 x 0.7 cm. Multiple possible Ivmph nodes are identified. Sections are submitted as listed in the cassette. summary. Dictated by. CASSETTE SUMMARY: D1-3 - multiple possible lymph nodes. Specimen E is identified as ""right neck level 3."" The specimen consists of two pieces of fibrofatty tissue measuring. 4.3 x 3.6 x 1.1 cm in aggregate. The specimen consists of multiple possible lymph nodes. Sections are submitted as. listed in the cassette summary. Dictated by. CASSETTE SUMMARY: E1-3 - multiple possible lymph nodes. E4 - one lymph node, bisected. E5 - one lymph node, bisected. Specimen F is identified as ""right neck level 4."" The specimen consists of a portion of fibrofatty tissue measuring 3.0. x 2.2 x 0.6 cm. Multiple possible lymph nodes are identified. Sections are submitted as listed in the cassette. summary. Dictated by. CASSETTE SUMMARY: F1,2 - multiple possible lymph nodes. F3 - one lymph node, bisected. F4 - one lymph node, bisected. Specimen G is identified as ""left neck level 2."" The specimen consists of multiple pieces of fibrofatty tissue. measuring 5.0 x 4.7 x 0.5 cm. Multiple possible lymph nodes are identified. Sections are submitted as listed in the. cassette summary. Dictated by. CASSETTE SUMMARY: G1-3 - multiple possible lymph nodes. G4 - one lymph node, bisected. Specimen H is identified as ""left neck level 3."" The specimen consists of a portion of fibrofatty tissue measuring 4.1 x. 3.0x1.0 cm. Multiple possible lymph nodes are identified within the tissue. Sections are submitted as listed in the. cassette summary. Dictated by. CASSETTE SUMMARY: H1-4 - multiple possible lymph nodes. H5 - one lymph node, bisected. H6 - one lymph node, bisected. H7 - one lymph node, bisected. Specimen I is identified as ""left neck level 4."" The specimen consists of a portion of fibrofatty tissue measuring 3.5. x. 2.7 x 1.6 cm. Multiple possible lymph nodes are identified. Sections are submitted as listed in the cassette summary. CASSETTE SUMMARY: 11,2 - multiple possible lymph nodes. 13,4 - one lymph node. Intraoperative Consult Diagnosis. A1FS-A5FS: LARYNGECTOMY (FROZEN SECTION): MARGINS NEGATIVE, MUCOSAL AND SKIN. Frozen section results were communicated to the surgical team and were repeated back by. and the specimen is received at.",T4,N0,M0,T4N0M0
TCGA-HU-8608,"Stomach, near total gastrectomy: Advanced gastric carcinoma. (Muc2(-)/Muc5AC(-)/Muc6(-)/CD10(-)/cERB2(-),Null type). 1. Location : upper third, Center at mid-body, anterior wall. 2. Gross type : Borrmann type 2. 3. Histologic type : Adenocarcinoma, poorly differentiated, non-solid type (por2). with prominent lymphoid stroma. 4. Histologic type by Lauren : diffuse. 5. Growth pattern: mixed expanding and infiltrative growth pattern. 6. Size : 7.8x6.5cm. 7. Depth of invasion : invades serosa (pT4a). 8. Resection margin : free from carcinoma. safety margins: distal 10.5cm, proximal 1.3cm. 9. Lymph node metastasis : 4 metastasis in 64 regional lymph nodes (pN2). (lesser curvature 3/42, greater curvature 1/22, LN 0/2). 10. Lymphatic invasion : not identified. 11. Venous invasion : not identified. 12. Perineural invasion : present, mild. 13. Associated finding: 1) prominent lymphoid stroma. 2) foveolar hyperplasia with pit dysplasia. Stomach, labeled as ""stomach #2"", biopsy: No tumor. Soft tissue, omentum, biopsy: No tumor. # Immunohistochemistry : CD10, MUC2, MUC5ac, MUC6, C-erb B2.",T4,N2,M0,T4N2M0
TCGA-62-A472,"Pathology Report-Summary: Material: lung, right, lower lobe: 14.0 X 4.0 X 2.8 cm. tumor 1: 2.5 X 2.2x2.1 cm. tumor 2: 1.5.0 x 1.4 X 1.3 cm. Diagnosis: Both tumors Adenocarcinoma (NOS). Tumor 1 infiltrates and breaks pleura visceralis. pT3, pNo (0/2), pMx, G3.",T3,N0,M0,T3N0M0
TCGA-AA-3973,"Diagnosis (diagnoses): Colon resection sample with a moderately differentiated adenocarcinoma of the colorectal. type, measuring a max of 3 cm in diameter, with infiltration of the pericolic fatty tissue,. circumscribed penetration of the covering serosa and three local lymph node metastases. Tumor-free colon resection margins. Tumor-free mesenteric resection margin. The tumor stage is: pT4, pN1 (3/21) pM1 (clinical liver and lung metastasis) L0, V0;. clinically G2.",T4,N1,M1,T4N1M1
TCGA-CR-7365,"DIAGNOSIS: 1) VOCAL CORD, LEFT TRUE, BIOPSY: MINUTE FRAGMENTS OF KERATIN DEBRIS. WITH ACUTE AND CHRONIC INFLAMMATION, NEGATIVE FOR MALIGNANCY;. 2) MENTAL NERVE, BIOPSY: FIBROUS TISSUE AND SKELETAL MUSCLE, NEGATIVE. FOR MALIGNANCY. 3) MARGIN, POSTERIOR BUCCAL, BIOPSY: SQUAMOUS MUCOSA WITH CHRONIC. INFLAMMATION, NEGATIVE FOR MALIGNANCY. 4) MARGIN, ANTERIOR BUCCAL, BIOPSY: SQUAMOUS MUCOSA WITH CHRONIC. INFLAMMATION; NEGATIVE FOR MALIGNANCY. 5) NERVE, INFERIOR ALVEOLAR, BIOPSY: BENIGN NERVE, NEGATIVE FOR. MALIGNANCY. 6) PARAPHARYNGEAL FAT, BIOPSY: SALIVARY GLAND AND ADIPOSE TISSUE,. NEGATIVE FOR MALIGNANCY. 7) NERVE, RIGHT PROXIMAL LINGUAL, BIOPSY: NERVE AND FIBROUS TISSUE,. NEGATIVE FOR MALIGNANCY. 8) MAXILLARY TUBEROSITY, BIOPSY: SQUAMOUS MUCOSA, SKELETAL MUSCLE,. FIBROUS AND GLANDULAR TISSUE, NEGATIVE FOR MALIGNANCY. 9) SOFT PALATE, BIOPSY: SQUAMOUS MUCOSA, NEGATIVE FOR MALIGNANCY. 10) PROXIMAL PERIOSTEUM, BIOPSY: FIBROUS AND ADIPOSE TISSUE WITH ACUTE. INFLAMMATION; MINUTE FRAGMENT OF BONE, NEGATIVE FOR MALIGNANCY. 11) MARGIN, DEEP TONGUE, BIOPSY: SKELETAL MUSCLE AND ADIPOSE TISSUE,. NEGATIVE FOR MALIGNANCY. 12) TONGUE, DEEP, EXCISION: ORAL MUCOSA AND SKELETAL MUSCLE, NEGATIVE. FOR MALIGNANCY. 13) MANDIBLE, RIGHT, PARTIAL RESECTION: INVASIVE. MODERATELY-DIFFERENTIATED SQUAMOUS CELL CARCINOMA, 4.2 CM IN GREATEST. EXTENT, INVASIVE INTO THE MANDIBLE; PERINEURAL INVASION IS IDENTIFIED;. THE TUMOR INVOLVES THE POSTERIOR AND ANTERIOR BONE MARGINS, THE. POSTERIOR SOFT TISSUE MARGIN, AND THE SUPERIOR MUCOSAL MARGIN; THE TUMOR. EXTENDS TO WITHIN 0.1 CM OF MEDIAL SOFT TISSUE MARGIN AND TO WITHIN 0.4. CM OF THE LATERAL SOFT TISSUE MARGIN; 45 LYMPH NODES, NEGATIVE FOR. MALIGNANCY (0/45) (SEE COMMENT). 14) LYMPH NODE, RIGHT LEVEL 2B, EXCISION: ONE LYMPH NODE, NEGATIVE FOR. MALIGNANCY (0/1). 15) LYMPH NODE, RIGHT NECK, EXCISION: 5 LYMPH NODES, NEGATIVE FOR. MALIGNANCY (0/5). 16) SOFT TISSUE, NERVE, V3, NEUROVASCULAR BUNDLE, BIOPSY: FOCALLY. INVOLVED BY CARCINOMA WITHIN SOFT TISSUE AND BONE; NERVE PRESENT AND. UNINVOLVED. COMMENT: This corresponds to AJCC stage IVA (pT4a,pN0,pMx). CLINICAL DATA. Clinical Features/Dx: unspecified. Operator: Operation: unspecified. Operative Findings: unspecified. Operative Diagnosis: unspecified. Tissue Submitted: 1) left true vocal cord, 2) mental nerve, 3). posterior buccal, 4) anterior buccal, 5). inferior alveolar nerve, 6) parapharyngeal fat,. 7) right proximal lingual nerve, 8) maxillary. tuberosity, 9) soft palate, 10) proximal. periosteum, 11) deep tongue margin, 12) deep. tongue specimen 13) composite resection 14). right level 2 B 15) right selective neck 16) V-3. neurovascular bundle. GROSS DESCRIPTION: 1) SOURCE: Left True Vocal cord. Received fresh are two minute fragments of soft tissue, measuring 0.2 X. 0.1 X 0.1 cm. These fragments are inked and entirely submitted for. frozen section evaluation. Summary of sections: 1AFSC, (sectioning has cut through most of the. tissue), 2/1. 2) SOURCE: Mental Nerve. Received in saline is a fragment of soft tissue, measuring 0.7 X 0.2 X. 0.2 cm. The specimen is entirely submitted for frozen section. evaluation. Summary of sections: 2AFSC, 1/1. 3) SOURCE: Posterior Buccal. Received fresh is one fragment of light pink soft tissue, measuring 1.6. X 0.6 X 0.4 cm. The specimen is entirely submitted for frozen section. evaluation. Summary of sections: 3AFSC, posterior buccal margin, 1/1. 4) SOURCE: Anterior Buccal. Received fresh is a fragment of light tan soft tissue, measuring 3.0 X. 0.5 X 0.5 cm. The specimen is inked black and is entirely submitted for. frozen section evaluation. Summary of sections: 4AFSC, anterior buccal margin, 1/1. 5) SOURCE: Inferior Alveolar Nerve. Received fresh is a fragment of pale white soft tissue, measuring 0.4 X. 0.3 X 0.3 cm. The specimen is entirely submitted for frozen section. evaluation. Summary of sections: 5AFSC, 1/1. 6) SOURCE: Parapharyngeal Fat. Received fresh is a fragment of soft tissue and salivary gland tissue,. measuring 2.7 X 2.5 X 0.8 cm. The specimen is entirely submitted for. frozen section evaluation. Summary of sections: 6AFSC, 1/1. 7) SOURCE: Right Proximal Lingual Nerve. Received fresh is a fragment of pale white soft tissue, measuring 0.4 X. 0.3 X 0.3 cm. The specimen is inked black. The specimen is entirely. submitted for frozen section evaluation. Summary of sections: 7AFSC, 1/1. 8) SOURCE: Maxillary Tuberosity. Received fresh is a fragment of light pink soft tissue, measuring 1.2 X. 0.4 X 0.4 cm. The specimen is entirely submitted for frozen section. evaluation. Summary of sections: 8AFSC, 1/1. 9) SOURCE: Palate, Soft. Received fresh is a fragment of white-red soft tissue, measuring 1.6 X. 0.3 X 0.5 cm. The outer surface of the specimen is inked black. The. specimen is entirely submitted for frozen section evaluation. Summary of sections: 9AFSC, 1/1. 10) SOURCE: Proximal Periosteum. Received fresh is a fragment of light red soft tissue, measuring 1.3 X. 0.3 X 0.4 cm. The specimen is entirely submitted for frozen section. evaluation. Summary of sections: 10AFSC, 1/1. 11) SOURCE: Deep Tongue Margin. Received fresh is a fragment of light brown soft tissue, measuring 0.8 x. 0.6 X 0.4 cm. The outer surface of the specimen is inked black. The. specimen is entirely submitted for frozen section evaluation. Summary of sections: 11AFSC, 1/1. 12) SOURCE: Deep Tongue Specimen. Received in saline is a fragment of soft tissue, measuring 2.3 X 1.7 X. 1.5 cm. One edge of the specimen contains a mucosal surface, measuring. 2.2 X 0.6 cm in horizontal dimension. A metallic staple is present,. clamping off a portion of the specimen. The remaining surfaces of the. specimen show cauterization artifact. The mucosal surface contains no. grossly apparent lesions. The specimen is serially sectioned to reveal. muscular tissue with no grossly apparent areas of firmness. No lesions. are identified. The specimen is entirely submitted. Summary of sections: 12A-B, deep tongue, 12A, 3/1, 12B, 2/1. 13) SOURCE: Composite Resection. ""Composite resection"" is received fresh and consists of a partial. mandibulectomy specimen that is 10.0 cm from anterior to posterior, 9.0. cm from superior to inferior, and 5.0 cm from medial to lateral. The. specimen contains a rectangular fragment of fibroadipose tissue (neck. dissection) which measures 12.0 X 4.0 X 1.6 cm. The specimen is inked in. the following manner: the superior surface is inked yellow, the inferior. surface is inked black, the medial surface is inked orange, the lateral. surface is inked green, the anterior surface is inked red, and the. posterior surface is inked blue. The specimen is serially sectioned to. reveal an irregular, lobulated, firm tan-gray lesion that measures 4.2 X. 2.8 X 2.3 X cm. This lesion appears to arise from the mucosa of the. floor of the mouth and is eroding the submucosal surface down to the. mandible. The lesion grossly abuts the mandible but invasion cannot be. identified grossly. This lesion abuts the medial soft tissue margin. The. lesion appears to be 1.9 cm from the anterior margin, appears grossly to. abut the superior margin, 0.5 cm from the lateral margin, 0.6 cm from. the posterior margin, and 0.3 cm from the inferior margin. Bony shave. margins are taken of the ramus (posterior) and the mandibular bony. resection margin (anterior margin, shaved). A portion of the tumor is. saved in RPMI, saved in the -80 freezer, saved in glutaraldehyde, and a. small portion given to research. Bony shaved margins, soft tissue. margins, and representative sections of tumor are submitted for. evaluation following decalcification as follows: Summary of sections: 13A-13B, posterior ramus bony shave margins, 13A,. 1/1; 13B, 2/1; 13C, anterior shave margin (mandible margin), 1/1; 13D,. cross section of anterior most lesion, 1/1; 13E, anterior aspect of. lesion in cross section, 1/1; 13F, lesion approaching medial resection. margin, 2/1; 13G, cross section of lesion superior/lateral aspect, 1/1;. 13H, cross section of lesion, 1/1; 13I, lesion as it approaches mandibl. e, 1/1; 13J, lesion approaching medial margin, 2/1; 13K, cross section. of lesion adjacent to mandible, 1/1; 13L, cross section of lesion. (medial to lateral), 1/1; 13M, lesion approaching inferior margin, 1/1;. 13N, lesion approaching soft tissue aspect of lateral margin, 1/1; 130,. lesion approaching medial resection margin, 1/1; 13P, lesion approaching. posterior resection margin, 1/1; 13Q, inferior soft tissue resection. margin, 1/1; 13R-AA, lymph node dissection, submitted in order from most. proximal to lesion to most distal to lesion (superior to inferior): 13T,. three lymph nodes, largest bisected and inked blue, 4/1; 13S, three. candidate lymph nodes, 3/1; 13P, one candidate lymph node, bisected,. 2/1; 13U, three candidate lymph nodes, largest inked black and bisected,. 4/1; 13V, five candidate lymph nodes, 5/1; 13W, one candidate lymph node. serially sectioned, 4/1; 13X, four candidate lymph nodes, 4/1; 13Y, six. candidate lymph nodes, 6/1; 13Z, six candidate lymph nodes, 6/1; 13AA,. six candidate lymph nodes, 6/1. 14) SOURCE: Right Level 2B. The specimen is received in a container labeled, ""right level 2B."" The. specimen is composed of fibroadipose tissue with lymph nodes and. measures 3.5 X 2.0 X 0.2 cm in aggregate. Candidate lymph nodes are. identified and dissected and submitted. Summary of sections: 1A, candidate lymph nodes, 3/1. 15) SOURCE: Right Selective Neck. ""Right selective neck"" is received fresh and consists of a segment of. fibroadipose tissue that is 4.7 X 2.1 X 0.7 cm. The specimen is. carefully examined and candidate lymph nodes are submitted for. evaluation as follows (approximately 50% of the specimen is submitted): Summary of sections: 15A, large candidate lymph node trisected, 3/1;. 15B, five candidate lymph nodes, 5/1. 16) SOURCE: V-3 Neurovascular Bundle. ""V-3 neurovascular bundle"" is received fresh and consists of a fragment. of fibromuscular tissue containing two cylindrical vessels that is 2.7 X. 1.5 X 0.6 cm. The specimen is serially sectioned and submitted in its. entirety for evaluation as follows: Summary of sections: 16A, neurovascular bundle, 5/1; 16B, remainder of. specimen, 2/1. 4. source 14. Slides and report reviewed by Attending Pathologist. SURGICAL PATHOLOGY INTRAOPERATIVE CONSULTATION. 1) SOURCE: Left True Vocal cord. FROZEN SECTION DIAGNOSIS: INFLAMMATION, KERATINIZED DEBRIS AND BACTERIA. 2) SOURCE: Mental Nerve. FROZEN SECTION DIAGNOSIS: BENIGN. 3) SOURCE: Posterior Buccal. FROZEN SECTION DIAGNOSIS: BENIGN. 4) SOURCE: Anterior Buccal. FROZEN SECTION DIAGNOSIS: BENIGN. 5) SOURCE: right alveolar nerve. FROZEN SECTION DIAGNOSIS: BENIGN. 6) SOURCE: ParaPharyngeal Fat. FROZEN SECTION DIAGNOSIS: BENIGN. 7) SOURCE: Right Proximal Lingual Nerve. FROZEN SECTION DIAGNOSIS: BENIGN. 8) SOURCE: Maxillary Tuberosity. FROZEN SECTION DIAGNOSIS: BENIGN. 9) SOURCE: Palate, , Soft. FROZEN SECTION DIAGNOSIS: BENIGN. 10) SOURCE: Proximal Periosteum. FROZEN SECTION DIAGNOSIS: BENIGN. 11) SOURCE: Deep Tongue Margin. FROZEN SECTION DIAGNOSIS: BENIGN. SNOMED: T-11180,M-80703,.",T4,N0,M0,T4N0M0
TCGA-UC-A7PF,"Patient ID: SPECIMEN (S) : Lymph node sampling. SPECIMEN (S) : Lymph node sampling. SPECIMEN (S) : Lymph node sampling. SPECIMEN (S) : Ovary, left. SPECIMEN (S) : Lymph node sampling. SPECIMEN (S) : Lymph node sampling. SPECIMEN (S) : Lymph node sampling. SPECIMEN (S) : Soft tissue mass biopsy. SPECIMEN (S) : Uterus. SPECIMEN (S) : Surgical margins. SPECIMEN (S) : Surgical margins. SPECIMEN (S) : Appendix, incidental. CLINICAL DATA: Cervical cancer. GROSS DESCRIPTION: A) Received in formalin designated ""right external iliac node"" are. multiple. fragments of fatty tissue measuring 2 X 2 X 1 cm in aggregate. Three. potential. lymph nodes are identified and submitted in cassette A1. B) Received in formalin designated ""right obturator node"" are multiple. fragments of fatty tissue measuring 3 x 2 x 1 cm in aggregate. Several. potential lymph nodes are identified and submitted in cassette B1. C) Received in formalin designated ""right common para-aortic nodes"" are. multiple fragments of soft tissue measuring 1 X 1 x 1 cm. No lymph nodes. are. identified and the specimen is entirely submitted in cassette C1. D) Received in formalin designated ""left ovary"" is an ovary without. attached. tube measuring 3.5 x 3 X 2.5 cm. Multiple cysts (up to 0.8 cm) and. adhesions. are identified on the surface. The specimen is bivalved and cut surfaces. reveal. a cyst measuring 1 cm. Representative sections are submitted in cassettes. D1. and D2. E) Received in formalin designated ""left external iliac nodes"" are. multiple. fragments of fatty tissue measuring 4 x 2 X 1 cm in aggregate. Several. potential lymph nodes are identified and submitted in cassettes E1-E3. F). Received in formalin designated ""left obturator nodes"" are multiple. fragments of fatty tissue and blood clot. No lymph nodes are identified. and the. specimen is entirely submitted in cassettes F1 and F2. G) Received in formalin designated ""left common iliac nodes"" are multiple. fragments of fatty tissue measuring 2 X 1 x 0.8 cm in aggregate. One. lymph node. is identified and submitted in cassette G1. H). Received in formalin designated ""right parametria"" is a fragment of. fibroadipose tissue measuring 2 x 2 x 0.5 cm in aggregate. The specimen. is. submitted in toto in cassette H1. I) Received in formalin designated ""uterus, tube, ovary and parametrium"". is a. uterus with attached ovary and fallopian tube measuring 11 x 6 x 5 cm and. weighs. 190 grams. The uterus is covered with pink, smooth, glistening serosa. with no. focal lesions identified. The ectocervix has a pink, smooth mucosa; the. cervical canal is patent. The cervix measures 3.5 x 3.5 cm. The. parametrium. area is inked as follows: anterior blue, posterior green. No lymph. nodes. are identified in the parametrium. Bivalving the specimen reveals a 5 x. 1.5 cm. endometrial cavity The endometrium measures up to 0.2 cm in thickness and. the. myometrium measures up to 2.5 cm. in thickness. The specimen is sectioned;. sequential cut surfaces reveal multiple small leiomyomas in the myometrium. measuring up to 1.5 cm in diameter. A firm, predominantly submucosal tumor. mass,. which measures up to 1.5 cm in depth, 2.5 cm in length and which. circumferentially involves all the quadrants of cervix, is identified. within the. parenchyma of the cervix. The cut surfaces appears homogeneously white. Grossly,. The lesion does not extend to the surgical resection margin; the nearest. margin. is 0. cm from the lesion. Representative sections are submitted as. follows: Il. vaginal cuff, anterior; I2 vaginal cuff, posterior; I3 parametrium,. anterior; I4 parametrium, posterior; I5-I6 cervix, anterior left. quadrant;. I7-I8 anterior right quadrant. Cassettes I9-I10 cervix posterior. right. quadrant. Cassettes I11-I12 cervix posterior left quadrant. I13 lower. segment of uterus; I14 uterus, fundus portion and representative. sections of. leiomyoma. J) Received in formalin designated ""left post vaginal margin"" is a. fragment of mucosa measuring 4 x 1 x 0.5 cm. A suture is identified on. one side of the specimen. The specimen is sectioned and the margin near. the suture is submitted in cassette J1. K). Received in formalin designated ""right post vaginal margin"" is a. fragment of mucosa measuring 5 x 0.8 x 0.5 cm. The specimen is sectioned. and submitted in toto in cassette K1. L) Received in formalin designated ""appendix"" is an appendix with. attached fatty tissue measuring 7.5 x 2.5 X 1.5 cm. The appendix measures. 6.5 x 5 X 5. cm. The appendix is covered with pink, smooth serosa. No focal lesions. are identified. Representative sections of the tip, mid portion, and. resection margin are submitted in cassette L1. FINAL DIAGNOSIS: A) Right external iliac node, resection: Three lymph nodes, negative for. tumor. B) Right obturator node, resection: Six lymph nodes, negative for tumor. C). Right common para-aortic nodes, resection: Two lymph nodes, negative. for. tumor. D) Left ovary, resection: Serous cystadenoma (1.0 cm in diameter) . E) Left external iliac lymph node, resection: 4 out of 13 lymph nodes. positive. for metastatic tumor. F) Left obturator nodes, resection: Four lymph nodes, negative for. tumor. G) Left common iliac nodes, resection: One negative lymph node. H) Right parametrium, resection: Fibroadipose tissue; no evidence of. malignancy. I) Uterus, tubes, ovaries, and parametrium, resection: Moderately-differentiated squamous cell carcinoma of the cervix. with the following features: 1. Proportionate depth of invasion: Maximum depth of invasion is 88% of. the. 1.7 cm thick wall (1.5/1.7 cm) i tumor is circumferential. 2. Parametrium: One positive lymph node in anterior parametrium; no. tumor. invasive of soft tissue of the parametrium. 3. All surgical margins are free of tumor; nearest margin 0.2 cm from. the. tumor; vaginal cuff resection margin free of tumor. 4. Microscopic angiolymphatic invasion is present. Left post-vaginal margin, resection: Negative for tumor. K). Right post-vaginal margin, resection: Negative for tumor. L). Appendix, resection: Appendix without diagnostic abnormality. Rendering Diagnostician: In compliance with. regulations, the pathologists signature on this. indicates that the case has been personally reviewed, and the diagnosis. made or. confirmed by, the Attending Pathologist.",T1,N1,M0,T1N1M0
TCGA-BR-8485,Case ID. Gross Description. croscopic. Diagnosis Details. Description. Comments. STOMACH TISSUE. CHECKLIST. Specimen type: Excision of. tumor. Tumor site: Fundus. Tumor size: 9.5 X 6 X 1.5. cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Adjacent. structures (specify) -. Esophagus; lesser. omentum. Lymph nodes: 7/13. positive for metastasis. (Intraabdominal 7/13). Lymphatic invasion: Not. specified. Venous invasion: Not. specified. Perineural invasion: Not. specified. Margins: Uninvolved. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic. findinace Not chorified. Laterality.,T4,N3,M0,T4N3M0
TCGA-RD-A8N0,"(Specimen Collected: Comment for. HISTO. HISTOPATHOLOGY REPORT. REQUEST DETAILS. Gastrectomy. MACROSCOPIC DESCRIPTION. Specimen labelled ""subtotal gastrectomy"". The specimen is difficult. to orientate but comprises a portion of stomach, 120 X 45 X 45mm. The specimen measures 120mm along the greater curvature where there. is attached adipose tissue and omentum. The presumed proximal. resection margin is stapled and is 45mm in length. The presumed. distal resection margin is also stapied and is 35mm in length. Further adipose tissue is adherent to the lesser curvature. 35mm. from the distal resection margin on the greater curvature of the. specimen, is an ulcerated crater-like tumour with raised edges. measuring 30mm in maxinum dimension. There is thickening of the. stomach wall in this region and the serosa beneath the tumour. appears pale with some te hering of adipose tissue. The remaining. gastric mucosa is unremarkable. Margins marked with black ink. Blocks selected 1.1-1.2 proximal resection margin, 1.3-1.4 distal. resection margin, 1.5-1.6 tumour, 1.7 lesser curvature, 1.8 lesser. curvature lymph nodes, 1.9-1.10 greater curvature lymph nodes. MICROSCOPIC DESGRIPTION. There is an direr in the gastric wail, which has been. but which extends into muscularis propria. Ar. the bas. of the ulcer, and expanding the adjacent lamina propria is. a population of atypical epithelioid cells with some gland. formation. Similar atypica epithelioid cells arranged singly and. in smali clusters extend through the submucosa and muscularis. propria to abut the serosa of Lhe specimen and to infiltrate. subserosal adipose tissue. Perineural and intraneural invasion is. identified. There is no adjacent mucosal dysplasia or intestinal. n-taplasia. The tumour is ciear of the proximal and distal. resection margins. Elsewhere, there is a moderately dense. infiltrate of acute and chronic inflammatory cells within lamina. propria of body and antral mucosa, and small numbers of Helicobacter. pylori are identified. Numerous small deposits of tumour are. identified within adipose tissue from the lesser and gr-ater. curvatures. Twenty lymph nodes are identified within fat from the. lesser curve, three of which contain tumour. Sixteen lymph nodes. are identified within fat from the greater curve, seven of which. contain tumour. Duoienai mucosa at the distal resection margin is. unremarkable. PIAGNOSIS. Subtotal gastrectomy: Loorly differentiated adenocarcinoma, difluse. type, with extension through muscularis propria to the serosal. margin. Proximal and distal margins are free of tumour. There is. metastatic ad nocarcinoma within ten of thirty-six lymph nodes. identifi-d.",T3,N2,M0,T3N2M0
TCGA-EL-A3CN,"ry Case. gy Report. Sex: F. 0. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. the section ""SPECIMEN"" may have been added. DIAGNOSIS. (A) SKIN ANTERIOR NECK: Intradermal nevus. (B). LEFT MIDJUGULAR LYMPH NODE: One lymph node, no tumor present. (c). PRE-THYROID LYMPH NODE: One lymph node, no tumor present. THYROID AND PARATRACHEAL LYMPH NODES: PAPILLARY CARCINOMA (1.5 CM DIAMETER) INVOLVING LEFT LOBE. TUMOR FOCALLY EXTENDS TO INKED MARGIN OF RESECTION. EXTRATHYROIDAL EXTENSION PRESENT. NO vascular/lymphatic invasion identified. Adenomatous nodules of right lobe. (see comment). Focal chronic lymphocytic thyroiditis. Seven lymph nodes, no tumor present. LEFT PARATHYROID TISSUE: Parathyroid tissue, no tumor present. Entire report and diagnosis completed bv: Report released by: COMMENT. In specimen D, the right lobe of the thyroid contains two adenomatous nodules. which are. 0.5 cm and 0.4 cm in greatest dimension. GROSS DESCRIPTION. (A) SKIN FROM THE ANTERIOR NECK - A strip of white skin (2.5 cm in length x. 0.4 x 0. cm). No lesions are identified. Entire specimen is submitted in. cassette A. (B) LEFT MIDJUGULAR LYMPH NODE - A single pink unremarkable lymph node (0.5 x. 0.5 x 0.5 cm). The entire lymph node is submitted in cassette B. CC/kk. (c) PRE-THYROID LYMPH NODE - A single pink unremarkable lymph node (0.4 x 0.4. x 0. 4 cm). Entire lymph node is submitted in cassette C. (D) THYROID AND PARATRACHEAL LYMPH NODES - A bilobed thyroid and attached. fibroadipose tissue with overall measurements of 6.0 x 5.5 x 1.5 cm. Grossly,. the left lobe is slightly enlarged and contains a firm nodule. The nodule is. 1.5 x 1.3 x 1.3 cm in diameter. The nodule is light tan and slightly firm and. well demarcated from the surrounding normal thyroid tissue. The nodule abuts. the anterior surgical margin. No other lesions are identified. INK CODE: Black - external surface. SECTION CODE: D1-D4, representative sections of the right lobe; D5-D9,. nodule in left lobe; D10, multiple lymph nodes. (E) LEFT PARATHYROID TISSUE - A fragment of maroon-tan tissue (0.4 x 0.4 x. n , am in greatest dimension), entirely submitted for frozen section in E. FS/DX: PARATHYROID TISSUE, NO TUMOR PRESENT. S. History Case. Sex: F. Case type: Surgical History. CONSULTATION. SNOMED CODES.",T3,N0,M0,T3N0M0
TCGA-V4-A9EE,"Right eye enucleation. Macroscopy. The eyeball measures 25 mm of diameter before fixation, with a posterior segment of optic. nerve of 6 mm. At the section, at the lateral and posterior part of the eyeball, slightly distant. from the ciliary body, distant from the intraocular emergence of the optic nerve, a tumor is. found which is massively protruding in the vitreous cavity. It measures 16 mm main line for. 12 mm of maximum thickness and is partly cystic. The anterior chamber is free. Samples have. been made for cryopreservation and cytogenetic studies. Two samples have been made for. cryopreservation and the specimen has been then included entirely after fixation. Microscopy. The tumor seen macroscopically correspond to a malignant proliferation made nearly only. with medium or large epithelioid cells, with large eosinophilic cytoplasm sometimes loaded. with melanin pigment. The nuclei are irregular in shape and size sometimes monstrous. They. are often strongly nucleolated.A few mitotic figures are observed. The tumor proliferation,. stuck to the internal face of the sclera, infiltrates the most internal sheaths on less than one. third of its thickness. The tumor proliferation stays distant to the ciliary body which is free as. well as the iris and the anterior chamber. At the posterior part it stays distant to the. intraocular emergence of the optic nerve which is free on its entire course( pre and post. laminar, optic foramen meningeal sheaths and cut end) no extrasclrale extension was. observed. Conclusion. Choroidal melanoma with epitheloid cells measuring 16 mm main line by 12 mm maximal. thickness. The tumor proliferation infiltrates the internal part of the sclera on less than one third.No extra. ocular extension was seen. The ciliary body, the iris and the anterior chamber as well as the optic nerve on its entire. course (pre and post laminar, optic foramen, meningeal sheaths and cut end) are free.",T3,N0,M0,T3N0M0
TCGA-22-4613,"TISSUE DESCRIPTION: Left upper lobe lung (100 grams, 15.0 x 7.5 x 5.0 cm), superior. mediastinal (left lower paratracheal) aortic (subaortic,. para-aortic), inferior mediastinal (subcarinal, left pulmonary. ligament) and Nl (interlobar, lobar) lymph nodes. DIAGNOSIS: Lung, left upper lobe, lobectomy: Invasive grade 3 (of 4) squamous. cell carcinoma, forming a 2.3 x 2.0 x 1.3 cm nodule in the left. upper lobe. The pleura is uninvolved. The tumor is 4.5 cm from the. bronchial margin. The bronchial resection margin and multiple (4). intrapulmonary peribronchial lymph nodes are negative for tumor. Lymph nodes, superior and inferior mediastinal, aortic, N1,. excision: Multiple (2 left lower paratracheal, 6 subaortic, 1. para-aortic, 14 subcarinal, 2 left pulmonary artery, 1 interlobar, 1. lobar) lymph nodes are negative for tumor.",T1,N0,M0,T1N0M0
TCGA-A3-3374,"Not for Permanent Storage in Medical Records / Not Valid for Signing. sted by: Date of Service. Performing Facility. Result Provider. Report Name. PROCEDURE DATE: SPECIMEN DESCRIPTION: Right kidney. PRE-OPERATIVE DIAGNOSIS: Right renal mass. POST-OPERATIVE DIAGNOSIS: Same. CLINICAL INFORMATION: Same. GROSS DESCRIPTION: The specimen consists of a kidney with small amounts of attached perirenal. fat. The specimen weighs 253 g. It measures 12.5 X 7.4 X 4.5 cm in greatest. dimension. The capsule strips with ease. In the superior pole of the kidney,. there is a bulging mass. The kidney is bisected revealing a relatively well. circumscribed tumor mass which is yellow to grayish-brown in color with foci. of hemorrhage` and cyst formation. The tumor measures 5.0 X 3.6 X 4.0 cm in. greatest dimension. The renal pelvis and ureter are unremarkable. The renal. vessels appear to be widely patent. No tumor thrombi is identified grossly. Representative tissue is submitted in a total of eight cassettes. MICROSCOPIC DESCRIPTION: Sections from the renal mass show a clear cell carcinoma with some papillary. features. The malignant cells are present in sheets and also show tubule and. papillary formation. The cells show mild nuclear pleomorphism with some. nuclear enlargement. Occasional nuclei have distinct nucleoli. The cells. have moderate to abundant amounts of pale pink to clear cytoplasm. Some of. the cells lining the papillary structures appear to contain hemosiderin. pigment. The tumor shows several foci of calcification with the stroma. appearing hyalinized. The tumor is well demarcated from the adjacent. uninvolved renal tissue. The tumor does not extend to the capsule. There is. a thin rim of atrophic renal tissue between the tumor and the capsule. No. renal vein invasion is identified. The remaining renal parenchyma is. unremarkable. Sections from the pelvis and ureter show no significant. pathologic changes. The renal arteries show minimal intimal fibrosis. FINAL DIAGNOSIS: RIGHT RADICAL NEPHRECTOMY: RENAL CELL CARCINOMA, CLEAR CELL TYPE WITH CALCIFICATION AND FOCI OF. Not for Permanent Storage in Medical Records / Not Valid for Signing. ted by: Date of Service. Performing Facility. Result Provider. Report Name. PAPILLARY CHANGE, CONFINED TO THE KIDNEY. CODE 1,6. SUMMARY. PROCEDURE. Right radical nephrectomy. TUMOR LOCATION: Upper pole. TUMOR SIZE: 5.0 X 3.6 X 4.0 cm, tumor confined to the. kidney. NUCLEAR GRADE: II. PATHOLOGIC STAGING: T1,NX.M). MARGINS: Not involved. ADRENAL GLAND: Not identified. M.D. (Electroni.",T1,N0,M0,T1N0M0
TCGA-AN-A0FJ,iex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Left Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: OCT. Container: block Type of Procurement: surgery Grade: 2. T Stage: 2 N Stage: 1 M Stage: 1 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,T2,N2,M1,T2N2M1
TCGA-BF-A5ER,Tisaue. Component. index. Clinical Site #. Clinical. Ethnucity (Race). Anatomica. Tumor. Specimen. Specimen. Diagnosis. Site. Specificati. Number of. Amount/per. Type of. Histologica. of treatment. Specamen label. Container. Matrix. Format. Grade. containers. container. Procureme. TNM Stage. TNM Stage. TNM Stage. Treatment. Tumor ceit. description (Source). (Chemo /. on. (source). (T). (N). (M). type. nt. Horm Th. Detaila). Caucasian. Male. (White). Melanoma. Sikin. Primary. Tumor. Tissue. OCT. block. 1. n/a. n/a. Melanoma. n/a. 4. o. 0. none. n/a. 80. Caucasian. Male. Melanoma. (White). Blood. n/a. Normal. Blood. frozen. tube. 1. blood. n/a. n/a. n/a. n/a. draw. n/a. n/a. n/a. none. n/a. n/a. 1.,T4,N0,M0,T4N0M0
TCGA-CZ-4863,"Report Status: Amend/Ac. Type: Surgical Pathology. Specimen Type: Kidney, partial or total resection. Procedure Date: Addended Report. PATHOLOGIC DIAGNOSIS: A. SPECIMEN DESIGNATED YLEFT KIDNEY"": RENAL CELL CARCINOMA, Clear cell type (7.5 cm), Fuhrman nuclear. grade III/IV. Tumor extends into the perinephric adipose tissue. Tumor extends into renal vein (to within 2 cm of vein margin). Renal vein, artery, and ureteric margins are negative for tumor. AJCC Classification (6th Edition) : T3b' NO MX. The evaluation of this biopsy included PAS and trichrome stains. B. SPECIMEN DESIGNATED ""REGIONAL LYMPH NODES"": Eleven lymph nodes, no tumor present (0:11) . CLINICAL DATA: History: female with incidental renal mass left 9 x 6 cm enhancing. left hydro and 1 cm lymph node. Operation: Left radical nephrectomy. Clinical Diagnosis: L renal mass. TISSUE SUBMITTED: A/1) left kidney - #/s. b/2) regional lymph nodes. GROSS DESCRIPTION: The specimen is received fresh, in two parts, each labeled with the patients. name and unit number. Part A is received fresh in the frozen section lab, labeled ""#1 - L kidney"",. and consists of a left radical nephrectomy specimen (574 grams, 18.5 x 12.5 x 7. cm), to include left kidney (15 x 11 x 6.5 cm), ureter (6.5 cm in length x 0.6. cm in diameter) renal vein (1.4 cm in length x 0.8 cm in diameter). renal. artery (1.6 cm in length x 0.4 cm in diameter), and a moderate amount of. attached perinephric fat. Definitive Gerota's fascia is not identified. The. outer surface is inked black and the specimen is bivalved, revealing a. red/golden yellow, hemorrhagic, firm, fairly well circumscribed mass (7.5 x. 6.5. x 6. cm) within the upper to mid-pole, focally protruding into the hilum,. extending into the renal vein, coming to within 2 cm of the renal vein margin,. 2.5 cm of the renal artery margin, and 7.9 cm of the ureteral margin. The mass. grossly appears to invade the renal capsule but does not definitively extend. through into the perinephric fat; as a result, coming to within 0.2 cm of the. overlying black-inked soft tissue. The mass appears to extend into the renal. sinus, focally impinging upon the renal pelvis and calyceal system. The. renal. parenchyma adjacent to the mass is focally pale tan and discolored. The. corticomedullary junction is well-defined. Representative sections of the mass. (T1A - T1C) are submitted to the Tissue Bank for special studies. Adjacent. sections of tissue (corresponding to T1A - T1C) are submitted for quick fix. Representative sections of the mass are submitted for cytogenetics,. as. well. as. normal cortex, which are submitted for electron microscopy and. immunofluorescence. Photographs are taken. No lymph nodes are identified. within the attached perinephric fat. Micro A1: ureter, renal vein and renal artery margins (en face), 3. frags,. Micro A2+A3 : renal mass in relationship to renal vein, renal artery, and. pelvis at hilum, 2 frags total,. Micro A4: renal mass in relationship to pelvis/possible renal vein. involvement, 1 frag,. Micro A5-A7: renal mass at deep extension to include adjacent parenchyma. and renal sinus/hilar adipose tissue, 3 frags total,. Micro A8: corticomedullary junction and pelvis, 1 frag,. Micro A9: ""quick fix T1A"", 1 frag,. Micro A10: ""quick fix T1B"" 1 frag,. Micro All: ""quick fix T1C"", 1 frag,. Part B, labeled ""#2 - regional lymph node"", and consists of a portion of yellow. lobulated adipose tissue (4.5 x 2.2 x 1.2 cm), within which multiple tan/pink. rubbery lymph nodes (ranging from 0.4 cm up to 1.9 Cm in greatest dimension) : Micro B1: five single whole lymph nodes, 5 frags. Micro B2: two single whole lymph nodes, 2 frags,. Micro B3: three single whole lymph nodes, 3 frag. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto. ADDENDUM. RENAL PATHOLOGY EVALUATION OF KIDNEY PARENCHYMA: LEFT KIDNEY, NEPHRECTOMY: MILD CHRONIC CHANGES OF THE KIDNEY, WITH: - FOCAL GLOBAL GLOMERULOSCLEROSIS (1.2% OF GLOMERULI) ;. - TUBULAR ATROPHY AND INTERSTITIAL FIBROSIS (LESS THAN 2% OF THE. PARENCHYMA). - ARTERIAL AND ARTERIOLAR SCLEROSIS, MILD. FOCAL CORTICAL SCAR, MOST LIKELY SECONDARY TO CHRONIC TUMOR-RELATED. VASCULAR COMPROMISE (SEE NOTE). NOTE: The sample of tissue chosen for evaluation of the kidney shows an area of focal. cortical atrophy and scarring, most likely the result of chronic vascular. compression by the large ipsilateral tumor. Features of obstructive uropathy. are not seen at this time despite the mild degree of hydronephrosis. The. remainder of the kidney parenchyma shows minimal chronic changes, within the. expected range for. a. woman. There is minimal focal global. glomerulosclerosis (1.2% of glomeruli), minimal tubular atrophy and. interstitial fibrosis (less than 2% of the parenchyma), and a mild degree of. vascular sclerosis. The kidney parenchyma has been reviewed by Dr. Renal. MICROSCOPIC DESCRIPTION: Sections of formalin-fixed, paraffin-embedded tissue (block A8) were evaluated. using HE, PAS, Jones silver methenamine, and AFOG (trichrome) stains. The sample consists of cortex and medulla. There are 333 glomeruli present, of. which 4 (1.2%) are globally sclerosed. The remaining glomeruli show no. significant expansion of the mesangial areas but are diffusely hypoperfused. There are no discernible craters or double contours of the glomerular capillary. wall basement membranes. Less than 2% of the cortical parenchyma shows tubular. atrophy and interstitial fibrosis. Arteries exhibit a mild degree of. sclerosis. The kidney cortex was also evaluated in block A7 (HE) This sample comes from. an area of the kidney close to the tumor. There is prominent. and signs of hypoperfusion of glomeruli, a chronic. interstitial inflammatory infiltrate, scattered tubular distention, and mar. cortical atrophy. Overt vascular damage is not seen in the arterial vessel. included in this sample. (Clinical history: mild hydronephrosis, left renal mass). Addendum #1 by. Report Status: Final. Type: Cytogenetics. Cytogeneticist: KARYOTYPE: See below. METAPHASES COUNTED: 0. ANALYZED: 0. SCORED: 0. BANDING: GTG. INTERPRETATION: No metaphases were available from this specimen, therefore the cytogenetic. analysis could not be performed. INDICATION FOR TEST: ? Kidney tumor.",T3,N0,M0,T3N0M0
TCGA-AN-A03Y,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Left Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: Frozen. Container: cryomold Type of Procurement: Radical mastectomy Grade: 2. T Stage: 2 N Stage: 0 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,T2,N0,M0,T2N0M0
TCGA-BH-A201,"PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/POST-OP DIAGNOSIS: Left breast cancer. LMP DATE. Not applicable. PROCEDURE: Left segmental mastectomy with wire localization, sentinel node biopsy and mapping. SPECIFIC CLINICAL QUESTION: Not provided. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY: No. CHEMORADIATION THERAPY No. OTHER DISEASES: No. FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEFT AXILLA, SENTINEL NODE #1, BIOPSY -. ONE BENIGN LYMPH NODE, NO EVIDENCE OF MALIGNANCY (0/1). PART 2: LYMPH NODE, LEFT AXILLA, SENTINEL NODE #2, BIOPSY-. ONE BENIGN LYMPH NODE, NO EVIDENCE OF MALIGNANCY (0/1). PART 3: BREAST, LEFT, SEGMENTAL MASTECTOMY WITH WIRE LOCALIZATION -. A. INVASIVE DUCTAL CARCINOMA, NOTTINGHAM GRADE 2 (TUBULAR FORMATION: 3, NUCLEAR. PLEOMORPHISM: 2, MITOTIC ACTIVITY: 2; TOTAL SCORE 7/9). B. INVASIVE TUMOR MEASURES 1.5 CM IN GREATEST DIMENSION (GROSS MEASUREMENT). c. LYMPHOVASCULAR SPACE INVASION IS PRESENT. D. DUCTAL CARCINOMA IN-SITU (DCIS), NUCLEAR GRADE 2, SOLID TYPE.. E. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA; CARCINOMA IS 2 MM FROM NEAREST. (ANTERIOR), MARGIN. F. FIBROCYSTIC CHANGES, DUCTAL EPITHELIAL HYPERPLASIA AND SCLEROSING ADENOSIS. G. BIOPSY SITE CHANGES. H. CALCIFICATIONS ASSOCIATED WITH BENIGN AND MALIGNANT AREAS. I. TUMOR REPORTED TO BE POSITIVE FOR ER AND PR, AND NEGATIVE FOR HER-2/NEU. J. TATHOLOGIC STAGE: pT1a pNO. SYNOPTIC-PRIMARY - INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Clock position: 12:00. SIZE OF TUMOR: Maximum dimension invasive component: 15 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 2. Total Nottingham score: 7. Nottingham grade (1. 2. 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicabl. CALCIFICATION: Yes, benign zones. Yes, malignant zones. TUMOR TYPE, IN SITU: Solid. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Percent of tumor occupied by in situ component: 10 %. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of invasive tumor to closest margin: 3 mm. LYMPH NODES POSITIVE: Distance of in situ disease to closest margin: 2 mm. 0. LYMPH NODES EXAMINED: 2. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. T STAGE, PATHOLOGIC: pT1a. N STAGE MODIFIER: (sn). N STAGE, PATHOLOGIC: pNO. M STAGE: CESA-BH-A201-01A-PR. Not applicable. ESTROGEN RECEPTORS: positive, H-score: 205. PROGESTERONE RECEPTORS: positive, H-score: 225. HER2/NEU: 1+.",T1,N0,M0,T1N0M0
TCGA-BJ-A45I,"FINAL DIAGNOSIS: THYROID, TOTAL THYROIDECTOMY (15 GRAMS) -. A. PAPILLARY THYROID CARCINOMA, LOCATED IN THE RIGHT LOBE (2.1 M) AND LEFT LOBE (0.3 CM). B. 2.1 CM FOCUS IS TALL CELL VARIANT WITH EXTRATHYROIDAL EXTENSION AND EXTENSION TO RESECTION. MARGIN. C. NO ANGIOLYMPHATIC INVASION. D. FIVE RIGHT PARATHYROIDAL AND ONE LEFT PARATHYROIDAL LYMPH NODES, FREE OF TUMOR (0/6). E. PATHOLOGIC STAGE: pT3, NO. F. NODULAR THYROID HYPEROPLASIA WITH CHRONIC LYMPHOCYTIC THYROIDITIS. Addendum. Prior molecular testing of Right Thyrold, Fine Needle Aspiration (. itified a BRAF mutation. Therefore, molecular testing was not repeated on the total thyroldectomy specimen. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Right Lobe, Left Lobe. TUMOR FOCALITY: Multifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 2.1 cm. HISTOLOGIC TYPE. Papillary carcinoma, tall cell variant. PRIMARY TUMOR (pT): pT3. REGIONAL LYMPH NODES (pN): pNO. Number of regional lvmph nodac. Number of regional lymph nodes involved: 0. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Present. MARGINS: Margin(s) involved by carcinoma. LYMPH-VASCULAR INVASION: Not identified. ADDITIONAL PATHOLOGIC FINDINGS: Thyroiditis. Other: Nodular thyroid.",T3,N0,M0,T3N0M0
TCGA-E2-A1L7,"SPECIMENS: A. RIGHT BREAST WITH AXILLARY CONTENTS LEVELS 1,2. B. ADDITIONAL AXILLARY CONTENTS. SPECIMEN(S): A. RIGHT BREAST WITH AXILLARY CONTENTS LEVELS 1,2. B. ADDITIONAL AXILLARY CONTENTS. GROSS DESCRIPTION: A. RIGHT BREAST WITH AXILLARY CONTENTS LEVELS 1,2. Received fresh labeled with the patient's identification and ""right breast with axilla"" is a 934g, 28 x 25 x. 5cm oriented (stitch in axilla) modified radical mastectomy with attached 19 x 9cm tan pink skin ellipse. and 1.3cm everted nipple. Ink code: anterior-superior: blue, anterior-inferior: orange, posterior-black. The specimen is serially sectioned from lateral to medial into 10 slices with nipple in slice 7, revealing a. 3 x 2.5 x 2cm tan white firm well circumscribed mass, 1.5cm from the skin margin and 3cm from the. deep margin in the UOQ and UC of slices 5-7. A surgical clip is identified in the UOQ of slice 8. The. axillary tail is 9 X 7 x 5cm. Dissection reveals 19 possible lymph nodes ranging from 0.7 x 0.5 x 0.5cm. to. 4 x 3 x 3cm. The largest lymph node is serially sectioned to reveal a tan white firm homogenous cut. surface. A portion of the specimen is submitted for tissue procurement. Representatively submitted: A1-A2: nipple slice 7. A3: UOQ slice 2. A4: LOQ slice 4. A5: UOQ slice 4. A6: mass UIQ slice 5. A7: LOQ slice 5. A8-A10: mass with clip ID in A9 slice 6. A11-A12: mass slice 6. A13: deep margin slice 6. A14: skin slice 6. A15: mass UC slice 7. A16: LC slice 7. A17: UIQ slice 8. A18: LIQ slice 8. A19: UIQ slice 9. A20: 4 lymph nodes. A21: 4 lymph nodes. A22: 4 lymph nodes. A23: 2 lymph nodes. A24: 1 lymph node. A25-A26: 1 lymph node. A27: 1 lymph node. A28-A29: 1 lymph node. A30-A32: representative section of largest lymph node. A33-A38: UIQ. B. ADDITIONAL AXILLARY CONTENTS. Received fresh are two tan pink-white firm lymph nodes 1.5 x 1.5 x 1cm and 2 x 1.5 x 1.5cm. B1-B2: 1 lymph node. B3-B4: 1 lymph node. DIAGNOSIS: A. BREAST, RIGHT, MODIFIED RADICAL MASTECTOMY: - TWO FOCI OF INVASIVE DUCTAL CARCINOMA, SBR GRADE 3, WITH. EXTENSIVE NECROSIS AND MICROCALCIFICATIONS. - TUMOR MEASURES 3 CM AND 1.5 CM. - MARGINS, FREE OF TUMOR. - DUCTAL CARCINOMA IN SITU (DCIS), SOLID TYPE, NUCLEAR GRADE 3,. WITH NECROSIS AND MICROCALCIFICATIONS. - SKIN AND NIPPLE, NO TUMOR SEEN. - METASTATIC CARCINOMA IN 5 OF 18 LYMPH NODES WITH. EXTRANODAL EXTENSION, LARGEST METASTASIS IS 4 CM (5/18). NOTE: Invasive carcinoma is present in the upper outer quadrant and upper inner quadrant. B. ADDITIONAL AXILLARY CONTENTS, EXCISION: - METASTATIC CARCINOMA IN 2 OF 2 LYMPH NODES WITH. EXTRANODAL EXTENSION (2/2). - LARGEST METASTASIS IS 2 CM. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: ( Right. Invasive Tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3cm. Tumor Site: Upper outer quadrant. Upper inner quadrant. Margins: Negative. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 3. Modified Scarff Bloom Richardson Grade: 3. Necrosis: Present. Vascular/Lymphatic Invasion: Present. Lobular neoplasia: None. Lymph nodes: Axillary dissection. Lymph node status: Positive 7 / 20 Extranodal extension. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 15%. DCIS Type: Solid. DCIS Location: Associated with invasive tumor. Nuclear grade: High. Necrosis: Present. Location of CA++. DCIS. ER/PR/HER2 Results. ER: Negative. PR: Negative. HER2: Negative by IHC. Pathological staging (pTN): pT 2 N 2. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: A31. ER: Negative Allred Score: 2 = Proportion Score 1 + Intensity Score 1. PR: Negative Allred Score: 0 = Proportion Score 0 + Intensity Score 0. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by. following the manufacturer s instructions. This. assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. CLINICAL HISTORY: None provided. PRE-OPERATIVE DIAGNOSIS: Right breast cancer. ADDENDUM: SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: A17 (smaller tumor). ER: Positive Allred Score: 3 = Proportion Score 2 + Intensity Score 1. PR: Positive Allred Score: 7 = Proportion Score 4 + Intensity Score 3. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by. following the manufacturer s instructions. This. assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Surgical Excision. Block Number: A17 (smaller tumor). Interpretation: EQUIVOCAL. Intensity: 2+. % Tumor Staining: 40%. Fish Ordered: Yes, on Date. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Her2 analysis was performed using the FDA approved Dako HercepTest (TM) test kit. using rabbit anti-human HER2. This assay was not modified. External kit-slides. provided by the manufacturer (cell lines with high, low and negative HER2 protein expression) and in-. house known HER2 amplified control tissue were evaluated along with the test tissue. Adequate, well. preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2. immunohistochemical stain is guided by published results in the medical literature, information provided. by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the 2007 joint recommendations and guidelines from. ASCO and CAP and from the NCCN HER2 testing in Breast Cancer Task Force. The Pathology. Department takes full responsibility for this test's performance. PathVysion HER-2 DNA Probe Kit. Analytical Interpretation of Results: HER-2 NOT AMPLIFIED. Clinical Interpretation of results. Amplification of the HER-2 gene was evaluated with interphase fluorescence in-situ. hybridization (FISH) on formalin-fixed paraffin embedded tissue sections using a chromosome. 17 centromeric probe and a HER-2 probe that spans the entire HER-2 gene in the. majority of tumors cells displayed 2 chromosome 17. signals and 2 HER-2 signals, with a HER-2/CEP 17 Ratio </=2.0, consistent with no. amplification of the HER2/neu gene. Block used A17. Source of case: Tissue fixation. formalin-fixed tissue. Outside Case No: NA. Tissue source. breast Results interpreted: HER2/CEP17 ratio: 1.06. This ratio is derived by dividing the total number of LSI HER-2/neu signals by the total number of. CEP17 signals in at least 20 interphase nuclei with nonoverlapping nuclei in the neoplastic. mammary epithelial cells. Cells with no signals or with signals of only one color are disregarded. Method of ratio enumeration: manual count. Limitations. The Vysis PathVysion Kit is not intended for use to screen for or diagnose breast cancer. It is. intended to be used as an adjunct to other prognostic factors currently used to predict disease-free. and overall survival in stage II, node-positive breast cancer patients. In making decisions regarding. adjuvant CAF treatment, all other available clinical information should also be taken into. consideration, such as tumor size, number of involved lymph nodes, and steroid receptor status. treatment decision for stage II, node-positive breast cancer patients should be based on HER-. 2/neu. gene amplification status alone. Overview of this test. FDA APPROVED REAGENT. PathVysion HER-2 DNA Probe Kit is FDA approved for selection of. patients for whom Herceptin therans insidered. These tests were performed in the. under the direction. of Dr.. The results of these studies should always be interpreted in the context of the. clinical, morphological, and immunophenotypic diagnosis. Microscopic/Diagnostic DictationPathologist,. Final Review: Pathologist,. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist, 1.",T2,N2,M0,T2N2M0
TCGA-ER-A196,"PATIENT HISTORY: No clinical history is given. PRE-OP DIAGNOSIS: Left leg melanoma. POST-OP DIAGNOSIS: Same. PROCEDURE: Wide local excision of skin and SLNB and skin graft. FINAL DIAGNOSIS: PART ISKIN, FOOT. LEFT, WIDE LOCAL EXCISION -. A. ULCERATED NODULAR MELANOMA, ACRAL LENTIGINOUS TYPE. B. CLARK LEVEL IV; 22 MM IN MAXIMUM THICKNESS. C. NO TUMOR INFILTRATING LYMPHOCYTES. D. MARGIN FREE OF TUMOR. E. NO ANGIOLYMPHATIC INVASION IDENTIFIED. F. POSSIBLE PERINEURAL INVASION SEEN. PART 2: SENTINEL LYMPH NODE #1, GROIN, LEFT, BIOPSY -. LYMPH NODE, NEGATIVE FOR TUMOR CELLS.(see comment). PART 3: SENTINAL LYMPH NODE #2, GROIN, LEFT, BIOPSY -. LYMPH NODE, NEGATIVE FOR TUMOR CELLS. (see comment). PART 4: SENTINEL LYMPH NODE #3, GROIN, LEFT, BIOPSY -. LYMPH NODE, NEGATIVE FOR TUMOR CELLS. PART 5: SENTINEL LYMPH NODE #4, GROIN, LEFT, BIOPSY -. LYMPH NODE, NEGATIVE FOR TUMOR CELLS. PART 6: SENTINEL LYMPH NODE #1, POPLITEAL, LEFT, BIOPSY -. LYMPH NODE, NEGATIVE FOR TUMOR CELLS. .(see comment). COMMENT: No tumor cells found on immunostains with HMB 45, S100, melan A, CD58, tyrosinase in groin sentinel lymph nodes in. parts #1 and #2 and popliteal sentinel lymph node in part #6. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY CUTANEOUS MELANOMA. Family history of melanoma is unknown. Family history of dysplastic nevi is unknown. TUMOR LOCATION: Lower extremities. TYPE OF PROCEDURE: Wide excision. SIZE OF TUMOR: Maximum surface diameter of neoplasm: 66 mm. GROSS ULCERATION: GROSS SATELLITES: HISTOLOGIC TYPE: Acral lentiginous. SURFACE ULCERATION: < 50%. CLARK'S LEVEL: IV. BRESLOW'S THICKNESS: 22 mm. ANGIOLYMPHATIC INVASION: None. PERINEURAL INVASION: EVIDENCE OF REGRESSION: MICROSCOPIC SATELLITES: PREEXISTING NEVUS: No preexisting nevus. TUMOR INFILTRATING LYMPHOID INFILTRATE: None (absent). MITOTIC RATE: 10/10 HPF. VASCULARITY: Not increased to focally increased. SURGICAL MARGIN INVOLVEMENT: Deep margin is free of tumor, Lateral margin is free of tumor. SENTINEL LYMPH NODE MAPPING: Yes. SENTINEL LYMPH NODE INVOLVEMENT: Number of sentinel lymph nodes positive: 0. LYMPH NODES EXAMINED: Total number of lymph nodes examined: 5. COMPLETION DISSECTION: EXTRACAPSULAR SPREAD: None. T STAGE, PATHOLOGIC: pT4b. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX.",T4,N0,M0,T4N0M0
TCGA-CM-6677,"Clinical Diagnosis & History: Colon carcinoma. Specimens Submitted: 1: Terminal ileum, appendix, and ascending colon; Resection. DIAGNOSIS: 1. Terminal ileum, appendix, and ascending colon; Resection: Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Hepatic flexure. Tumor Size: Length is 3.5 cm. Width is 8 cm. Maximal thickness is 0.6 cm. Tumor Budding: Absent. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Not identified. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Not identified. Large Venous Invasion: Not Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Tubular adenoma; number: 2. Non-Neoplastic Bowel: Unremarkable. Appendix: Unremarkable. Lymph Nodes: Number with metastasis: 0. Total number examined: 20. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC 7th Edition) : pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition) : NO (No regional lymph node metastasis). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1. The specimen is received fresh, labeled ""Right colon"" and consists of a. segment of terminal ileum, cecum with attached appendix and ascending colon. The terminal ileum measures 15.2 cm in length and 4.1 cm in circumference. at the proximal resected margin. The remaining colon measures 41.6 in. length with a circumference of 8.2 cm at the distal resected margin. The. attached appendix measures 9 cm in length and averages 0.8 cm in diameter. The appendiceal and intestinal serosa are pink tan and smooth. The colonic. serosa has a focus of retraction and is inked black. Focally hemorrhagic. lobulated yellow tan adipose tissue spans the length of the specimen. measuring up to 6 cm in thickness. There is also omentum (17.2 to 15 x 1 cm). which is serially sectioned revealing unremarkable adipose tissue. The. specimen is opened to reveal a circumferential tan-pink mass measuring 3.5. cm in length and 8 cm in width. The mass is located in the transverse colon,. immediately adjacent to a tattoo site, 32.2 cm from the proximal margin,. 10.3 cm from the distal margin, and 16.5 cm from the ileocecal valve. Sectioning shows that the tumor invades the muscularis. The depth of. invasion is 0.3 cm grossly; the tumor has a thickness of 0.6 centimeters. There are two tan-pink polypoidal masses (1.1 cm and 0.4 cm in greatest. dimension) located 3.0 cm and 4.5 cm from ileocecal valve, respectively. The. remaining mucosa is unremarkable. The attached adipose tissue is thoroughly. examined and all identified lymph nodes are submitted. Representative. sections of the specimen are submitted for permanent sections and for. Summary of sections: P - proximal margin shave. D - distal margin shave. T tumor. P-polypoid masses. RS -representative sections. A appendix, representative sections. LN - lymph nodes. BLN - bisected lymph nodes. Summary of Sections: Part 1: Terminal ileum, appendix, and ascending colon; Resection. Block. Sect. Site. PCs. 1. A. 1. 5. BLN. 10. 1. DM. 1. 8. LN. 24. 1. P. 1. 1. PM. 1. 1. RS. 1. 5. T. 5.",T3,N0,M0,T3N0M0
TCGA-85-8049,Requisition. Microscopic. Diagnosis. Comments. Description. Description. Details. Laterality/lo. Date of excision. cation. LUNG TISSUE CHECKLIST. Left-lower. Specimen type: Pneumonectomy. Tumor site: Lung. Tumor size: 3.5 X 2.5 X 3 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None.,T2,N0,M0,T2N0M0
TCGA-78-7156,"HISTORY. ? Bronchiolo-alveolar carcinoma. MACROSCOPIC. Five specimens received: 1: The first specimen which is a frozen section is labelled ""Lung Bx, frozen section' and consists of a. wedge of lung tissue with overlying visceral pleura measuring 20 X 12 x 4 mm. Serial sections taken. through specimen. No discrete lesion identified. [BIT for FS.]. FROZEN SECTION DIAGNOSIS: Adenocarcinoma (abuts diathermy margin). Result phoned to. [Frozen section remnants, 1A.]. 2: The second specimen is labelled with the patient's details only and consists of a left. pneumonectomy specimen. The left upper lobe measures 250 (SI) X 150 (AP) x 70 mm (ML). The left. lower lobe measures 230 (SI) x 140 (AP) x 70 mm (ML). There is an incomplete fissure on the lateral. surface of the left lower lobe. Over the lateral aspect of the pleura of the left upper lobe there is a. broad area of pallor under which the lung parenchyma is firm. This area measures approximately 140. X 110 mm. Similar subpleural firm pale areas are present throughout the lingula and are present on. both. the lateral and medial aspects of the pleura and varying in size from 3 mm up to 30 mm. At the. hilar aspect of the lung the bronchial resection margin measures 20 mm in diameter and is raised 30. mm from the surrounding tissue. A single area of pale subpleural thickening is noted in the left lower. lobe measuring 11 mm in maximum dimension. This area occurs on the anterior aspect of the left. lower lobe in the interlobar fissure. There are three areas of pleural deficiency on the left upper lobe;. one anterior and lateral measuring 30 mm in diameter and one overlying the pale area posteriorly and. superiorly measuring 30 mm in diameter where the pleura appears pulled back and is able to be laid. over the deficit. A third sutured area of pleural deficit and an underlying parenchymal defect is noted. at the postero-inferior edge of the left upper lobe laterally. This area measures 30 mm in diameter. On sectioning the lung, the majority of the left upper lobe is replaced by confluent pale tumour. measuring 165 (SI) X 120 (AP) x up to 60 mm (ML). There are numerous other deposits in the lingula. and in the most inferior aspect of the left upper lobe varying in size from 1 mm up to 20 mm. There is. extensive subpleural tumour with the large majority of the lateral aspect of the pleura appearing to be. involved by tumour. Further sectioning reveals tumour to abut the pleura on the medial aspect of the. left upper lobe adjacent to the hilum. Tumour approaches but does not appear to reach the hilar. resection margin. There is no definite tumour on the visceral pleural surface. Sectioning the left lower lobe also reveals multiple deposits of pale tumour both in superior and. inferior aspects of the lobe. These tumour deposits vary in size from 5 up to 30 mm in maximum. extent. [Bronchial resection margin, 2A; hilar lymph nodes, 2B; vascular resection margins, 2C; hilar and. peribronchial lymph nodes, 2D-2E; tumour underlying pleura and adjacent inked hilar resection. margin, 2F; tumour underlying pleura of left upper lobe adjacent to hilar resection margin, 2G; solid. area of tumour medial left upper lobe no pleura, 2H; inferior left upper lobe tumour and overlying. pleura, 2I; superior, 2J; lateral area of inferior left upper lobe in region of sutured pleural defect (?. Frozen site), 2K; lateral left upper lobe, 2L; left lower lobe inferior, two separate tumour deposits, 2M;. left lower lobe superiorly, 2N-20; uninvolved lung left lower lobe, 2P.]. 3: The third specimen is labelled ""hilar lymph node' and consists of three lymph nodes which measure. 18. X. 20 X 15 mm in maximum extent. wo bisected, 3A; third bisected, 3B.]. 4: The fourth specimen is labelled ""mediastinal lymph node' and consists of five fragments of lymph. node varying in size from 5 up to 12 mm in maximum extent and one piece of fat measuring 5 mm. [Lymph nodes bisected in toto, 4A.]. 5: The fifth specimen is labelled ""hilar lymph node' and consists of a single lymph node measuring 12. mm in maximum extent. [Bisected in toto, 5A.]. MIICROSCOPIC. 1: Paraffin sections confirm the frozen section diagnosis of adenocarcinoma. Lepidic extension of. tumour is also noted. The overlying visceral pleura is not infiltrated by tumour, Tumour involves the. diathermied margin. 2: Within the upper and lower lobes there are multiple deposits of well differentiated adenocarcinoma. which in areas show relatively extensive lepidic extension. The invasive tumour shows a predominant. papillary architecture and is composed of mucinous and non-mucinous cells. Tumour deposits abut the. visceral pleura in number of areas and there is focal visceral pleural invasion. No pleural surface. involvement is seen. There is distension of some lymphatic channels. No unequivocal lymphatic. invasion is seen. No vascular invasion or perineural permeation is identified. The bronchial resection. margin is clear of tumour. Tumour approaches to within 30um of the peri-hilar margin in an area. devoid of pleura. Although this margin is closely approached, tumour is not transected in this region. Tumour abuts the area of diathermy artefact within the upper lobe corresponding to the biopsy site for. frozen section. In a separate area, tumour abuts visceral pleura which shows diathermy artefact. precluding further assessment. Tumour infiltrates one of the lymph nodes within the hilar region. direct extension. The remaining lymph nodes are not involved. Lung parenchyma away from the. tumours shows emphysema together with foci of atypical adenomatous hyperplasia. 3-5: The lymph nodes show reactive changes with sinus histiocytosis, carbon pigment deposition and. mild follicular hyperplasia. There is no evidence of malignancy. SUMMARY. Left lung and lymph nodes (hilar and mediastinal): Well differentiated adenocarcinoma. Multiple separate lesions involving the upper and lower lobes. Largest tumour deposit 165 mm in diameter. Visceral pleura focally involved, no surface involvement identified. No unequivocal lymphatic invasion seen. No vascular invasion or perineural permeation identified. Bronchial resection margin clear, peri-hilar margin closely approached. Perihilar lymph node involved by direct extension of tumour. Remaining hilar lymph nodes and mediastinal nodes not involved by tumour. Non-neoplastic lung: Emphysema and foci of atypical adenomatous hyperplasia. Pathological stage: T4 N1 M1. T-28000 M-81403 P1-03000.",T4,N1,M1,T4N1M1
TCGA-DD-A11C,"TISSUE DESCRIPTION: .1 A2 B1 C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14. C15. Right lobe liver (2890.0 grams, 24.3 x 22.0 x 13.3 cm), a. pericholedochal lymph node (2.1 x 1.1 x 0.8 cm) , and gallbladder. (9.2 x 4.4 x 2. 1 cm) . DIAGNOSIS: Liver, right lobe, resection: Grade 3 (of 4) hepatocellular. carcinoma forming a 22.0 x 15.3 x 12.8 cm mass in the right lobe of. noncirrhotic liver. The surgical margins are free of tumor by a. minimum of 1.1 cm. A large (10.3 x 7.4 x 5.5 cm) subcapsular. hematoma is also present. Lymph node, pericholedochal, excision: A single pericholedochal. lymph node is negative for tumor. Gallbladder, cholecystectomy: Mild chronic cholecystitis with. cholesterolosis and a single benign cystic duct lymph node are. identified. TISSUE DESCRIPTION: A1 A2 B1 C1 C2 C3 C4 C5 C6 C7 CB C9 C10 C11 C12 C13 C14. C15. Right lobe liver (2890.0 grams, 24.3 x 22.0 x 13.3 cm), a. pericholedochal lymph node (2.1 x 1.1 x 0.8 cm), and gallbladder. (9.2 x 4.4 x 2.1 cm) . DIAGNOSIS: Liver, right lobe, resection: Grade 3 (of 4) hepatocellular. carcinome forming a 22.0 x 15.3 x 12.8 cm mass in the right lobe of. noncirrhotic liver. The surgical margins are free of tumor by a. minimum of 1.1 cm. A large (10.3 x 7.4 x 5.5 cm) subcapsular. hematome is also present. Lymph node, pericholedochal, excision: A single pericholedochal. lymph node is negative for tumor. Gallbladder, cholecystectomy Mild chronic cholecystitis with. cholesterolosis and a single benign cystic duct lymph node are. identified.",T1,N0,M0,T1N0M0
TCGA-DK-A6B5,"(Age-. M. Urology. Clinical Diagnosis & History: ear old male with recurrent T1HG, Tis despite BCG. Specimens Submitted: 1: Left distal ureter; excision. 2: Lymph nodes, left pelvic; dissection. 3: Left ureter #2; excision. 4: Right ureter; excision. 5: Bladder, prostate, seminal vesicles, urethra; cystoprostatectomy. 6: Lymph nodes, right common iliac; dissection. 7: Lymph nodes, right pelvic; dissection. 8: Lymph nodes, right hypo gastric; dissection. 9: Lymph nodes, left common iliac; dissection. 10: Lymph node, left pelvic # 2; biopsy. 11: Lymph node, left hypo gastric; biopsy. 12: Right vas deferens; excision. 13: Left vas deferens; excision. DIAGNOSIS: 1. Left distal ureter; excision: - Urothelial carcinoma in situ. 2. Lymph nodes, left pelvic; dissection: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 5. 3. Left ureter #2; excision: - Urothelial carcinoma in situ, best seen on actual frozen section. 4. Right ureter; excision: - Benign segment of ureter. 5. Bladder, prostate, seminal vesicles, urethra; cystoprostatectomy: Tumor Type: Invasive urothelial carcinoma, NOS. Histologic Grade: High grade. Pattern of growth of the Non-Invasive component: Flat (in situ carcinoma). An inverted non-invasive component is also present but CIS predominates. Pattern of growth of the Invasive component: Infiltrating. Tumor Multicentricity: Identified. Multiple foci of invasive disease are present but the lesion in the left anteriorwall is themost invasive, extending. into perivesicle fat. Bladder Local Invasion: Perivesical soft tissues. Extravesical Tumor Extension: Right ureter uninvolved. Left ureter involved. Urethra uninvolved,. The intramural right ufeter contains carcinoma. Vascular Invasion: Identified. LVI is multifocal. Perineural invasin: Identified. Surgical Margins: Tumor present at left ureteral margin. See specimen number 3 for true left ureteral margin. Non-Neoplastic Mucosa: Exhibiting chronic cystitis. Exhibiting granulomatous cystitis. Exhibiting foreign body reaction. Exhibiting proliferative cystitis (Brunn's nests, cystitis cystica, cystitis glandularis). Prostate: Nodular hyperplasia. Other The prostatic urethral is involved by urothelial carcinoma with underlying focal superficial stroma invasion. Seminal Vesicles: Not involved. Perivesical Lymph Nodes: Metastatic carcinoma present in 2 of 3 nodes. The Pathologic Stage is (AJCC 2002): pT3 (Invasion of perivesicle soft tissue). PR1 (Prostatic stromal invasion). Comment: The nodal metastases consist of isolated cells or small clusters of cells present within the peripheral sinus. without evidence of extranodal extension. 6. Lymph nodes, right common iliac; dissection: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 8. 7. Lymph nodes, right pelvic; dissection: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 8. Necrotizing granulomatous inflammation consistent with BCG treatment. 8. Lymph nodes, right hypo gastric; dissection: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 4. 9. Lymph nodes, left common iliac; dissection: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 10. 10. Lymph node, left pelvic # 2; biopsy: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 2. 11. Lymph node, left hypo gastric; biopsy: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 1. 12. Right vas deferens; excision: - Benign segment of vas deferens. 13. Left vas deferens; excision: - Benign segment of vas deferens. I ATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh, labeled ""Left distal ureter"". It consists of a 0.3 x 0.3 x 0.2 cm segment of ureter. Entirely frozen. Summary of sections. FSC- frozen section control. 2) The specimen is received fresh, labeled ""Left pelvic lymph nodes"". It consists of five lymph nodes ranging from 0.3 to 2.5 cm. Entirely frozen. Summary of sections. FSCA- frozen section control, one lymph node, bissected. FSCB- frozen section control, one lymph node, bissected. FSCC- frozen section control, three lymph nodes. 3) The specimen is received fresh, labeled ""Left ureter #2"". It consists of a 0.3 x 0.3 cm fragment of mucosa with attched 0.4 cm. adipose tissue. The mucosa is entirely frozen. Summary of sections. FSC- frozen section control. 4) The specimen is received fresh, labeled ""Right ureter"". It consists of a 0.5 x 0.4 x 0.3 cm segment of ureter. Entirely frozen. Summary of sections. FSC- frozen section control. 5. The specimen is received fresh labeled, Cystoprostatectomy"". It consists of a bladder or prostate and seminal vesicle. specimen. measuring 13 cm from superior to inferior, 13.5 Cm laterally and 5.5 cm from anterior to posterior. The specimen is. inked as follows: The right side is inked green and the left side is inked blue. The prostatic urethral margin is shaved and submitted. for frozen section. The bladder measures 9.5 x 9.3 x 4.5 and is opened along the anterior midline to reveal an irregular ulcerating. lesion measuring 2 x 1.5 cm which is grossly situated within the left anterior wall The lesion is situated 1 cm from the left orifice. and 3 cm from the right. Both ureters are probe patent measuring up to 0.2 cm in maximum diameter. The lesion is sectioned to. reveal. possible extension into muscularis. Extension to the inked fat is grossly not identified. A second irregular ulcerating lesion. measuring 2.6 X 1.5 cm is seen 2.7 cm from the first tumor and grossly situated within the right anterior / lateral wall. The. lesion. is present within 0.3 cm from the right orifice and 2.5 Cm from the left. Both ureters are probe patent measuring up to. 0.2 cm in maximum diameter. The lesion is sectioned and appears limited to lamina propria. Extension to the inked fat is grossly. not identified. A third tan polypoid nodule is present at the dome of the bladder measuring 0.9 x 0.9 cm and 4.5 cm from the first. lesion. A fourth possible lesion is identified also in the dome about 1 cm from the nodule. The remaining bladder mucosa is. grossly unremarkable. Discrete perivesical lymph nodes are grossly not identified. The prostate measures 3.5 x 2.5 x 2 cm. and. is. serially sectioned to reveal unremarkable fibromuscular tissue. Representative section of the specimen, including entire lesions. are submitted including two sections from each prostatic quadrant and transition zone. TPS is submitted. The specimen is. submitted for lymph node dissection and all possible lymph nodes are submitted. Summary of sections: FSC - frozen control (urethral margin). RUM - right ureter margin. LUM - left ureter margin. L1 - lesion in left anterior wall. L2- lesion in right anterior/ lateral wall. N- nodule in dome. L4- fourth possible lesion. RUO - right ureter orifice. LUO left ureter orifice. LP - left posterior wall. RP - right posterior wall (right and left anterior walls are almost entirely submitted with lesions). TRI -- trigone. DOM dome. F perivesical fat. RSV - right seminal vesicle. LSV - left seminal vesicle. RAP - right apex prostate. LAP - left apex prostate. RAM - right anterior mid prostate. RPM - right posterior mid prostate. LAM - left anterior mid prostate. LPM - left posterior mid prostate. RAB - right anterior base prostate. RPB - right posterior base prostate. LAB - left anterior base prostate. LPB - left posterior base prostate. 6). The specimen is received fresh, labeled ""Right common iliac lymph node"" and consists of two tan firm lymph nodes measuring. 1.3 x 0.8 x 0.3 and 1.5 x 0.8 X 0.4 cm. The lymph nodes are bisected and entirely submitted. Summary of sections: BLN - lymph nodes. PLN--possible lymph nodes. 7). The specimen is received fresh, labeled ""Right pelvic lymph nodes"" and consists of multiple pink tan firm lymph nodes ranging. from 0.3 to 3.1 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. BLN - bisected lymph node. S1--serially -- sectioned lymph node. S2--serially sectioned lymph node. 8). The specimen is received fresh, labeled ""Right hypogastric lymph node"" and consists of multiple pink tan firm lymph nodes. ranging from 0.2 to 0.4 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. PLB--possible lymph node. 9). The specimen is received fresh, labeled ""Left common iliac lymph nodes"" and consists of multiple pink tan firm lymph nodes. ranging from 0.2 to 2.2 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. BLN - bisected lymph nodes. 10). The specimen is received fresh, labeled ""Left pelvic lymph node # 2"" and consists of a firm tan lymph node measuring 3.5 x. 2.0 x 1.0 cm. The lymph node is serially sectioned and entirely submitted. Summary of sections: SL-serially sectioned lymph node. PLN--possible lymph nodes. 11). The specimen is received fresh, labeled ""Left hypogastric node"" and consists of a firm tan lymph node measuring 0.6 X 0.5. x. 0.3 cm. The lymph node is entirely submitted. Summary of sections: LN - lymph node. 12). The specimen is received in formalin, labeled, ""right vas deferens"" and consists of two cylindrical portions of tan-white soft. tissue averaging 2.5 x 0.4 cm. Sectioning reveals tan-white, pinpoint lumens. The specimen is entirely submitted. Summary of sections: U -- undesignated. 13). The specimen is received in formalin, labeled, ""left vas deferens"" and consists of a single cylindrical portion of tan-white soft. tissue averaging 5 x 0.3 cm with attached tan-purple, membranous tissue. Sectioning reveals a tan-white, pinpoint lumen. The. specimen is entirely submitted. Summary of sections: U -- undesignated. Summary of Sections: Part 1: Left distal ureter; excision. Block. Sect. Site. PCs. 1. fsc. 1. Part 2: Lymph nodes, left pelvic; dissection. Block. Sect. Site. PCs. 1. fsca. 1. 1. fscb. 1. 1. fscc. 1. Part 3: Left ureter #2; excision. Block. Sect. Site. PCs. 1. fsc. 1. Part 4: Right ureter; excision. Block. Sect. Site. PCs. 1. fsc. 1. Part 5: Bladder, prostate, seminal vesicles, urethra; cystoprostatectomy. Block. Sect. Site. PCs. 1. BLN. 2. 1. DOM. 1. 1. F. 1. 1. fsc. 1. 5. L1. 5. 4. L2. 4. 2. L4. 2. 1. LAB. 1. 1. LAM. 1. 1. LAP. 1. 1. LN. 4. 1. LP. 1. 1. LPB. 1. 1. LPM. 1. 1. LSV. 1. 1. LUM. 1. 1. LUO. 1. 2. N. 2. 1. RAB. 1. 1. RAM. 1. 1. RAP. 1. 1. RP. 1. 1. RPB. 1. 1. RPM. 1. 1. RSV. 1. 1. RUM. 1. 1. RUO. 1. 1. TRI. 1. Part 6: Lymph nodes, right common iliac; dissection. Block. Sect. Site. PCs. 2. BLN. 4. 1. PLN. 3. Part 7: Lymph nodes, right pelvic; dissection. Block. Sect. Site. PCs. 1. BLN. 2. 2. LN. 5. 3. S1. 6. 3. S2. 6. Part 8: Lymph nodes, right hypo gastric; dissection. Block. Sect. Site. PCs. 1. LN. 4. 1. PLN. 1. Part 9: Lymph nodes, left common iliac; dissection. Block. Sect. Site. PCs. 1. BLN. 2. 3. LN. 8. 1. PLN. 1. Part 10: Lymph node, left pelvic # 2; biopsy. Block. Sect. Site. PCs. 1. PLN. 2. 4. SL. 8. Part 11: Lymph node, left hypo gastric; biopsy. Block. Sect. Site. PCs. 1. LN. 1. Part 12: Right vas deferens; excision. Block. Sect. Site. PCs. 3. U. 30. Part 13: Left vas deferens; excision. Block. Sect. Site. PCs. 3. U. 15. Intraoperative Consultation: 1. Frozen section diagnosis: Left distal ureter (fs): Carcinoma in situ. Permanent diagnosis: same. 2. Frozen section diagnosis: Left pelvic lymph nodes (fs): Benign lymph nodes (0/5). Permanent diagnosis: same. 3. Frozen section diagnosis: Left ureter #2 (fs): Carcinoma in situ. Permanent diagnosis: same. 4. Frozen section diagnosis: Right ureter (fs): Benign. Permanent diagnosis: same. 5. Frozen section diagnosis: Bladder, prostate, seminal vesicles urethra (fs): Benign urethral margin. Permanent diagnosis: same.",T4,N2,M0,T4N2M0
TCGA-KR-A7K7,"PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 4. !. SEX: F. BIRTHDATE: ADM DATE: OPER DATE: PROCEDURE: SPDX. (1) Uterus, excision: focal residual adenocarcinoma in-situ of endometrium. Adenomatous hyperplasia of endometrium. Squamous metaplasia of cervix. (2) Ovaries and fallopian tubes, excision: tubo-ovarian adhesions. Follicular cysts. (3) Right interiliac and external iliac Lymph nodes, excision: four lymph. nodes. all negative for neoplasm. Code: FC: 23209. M-72000 M-72420 M-81403 T-82000. OPER DATE: PROCEDURE: SPHS. History with mass in left hepatic lobe. Tissue Submitted: Left lateral segment. liver. PROCEDURE: SPGD. 1. ""Left lateral segment of liver"" Received in formalin in an extra large. container is a 2040 gram the Lobe of liver designated left and is 20 x 8 x. 10. cm. Extending from the anterior aspect is a protuberant partially encapsulated. massive lesion, 14 x 13 x 10.2 cm. Capsule surrounding the liver segment is. tan and focally nodular. The margin of resection is inked blue. Cut surface of. the liver is a tan-brown nodular tissue, It is remarkable for the. aforementioned mass that has a hemorrhagic necrotic red-tan softened cut. surface with bright focal areas of fat necrosis. A central yellow-gray scar is. identified. The tumor is 2.2 cm away from the margin of resection. It extends. to the capsule and appears to press into the attached liver parenchyma. No. other lesions are identified. Photographs have been taken. 1A. Tumor to margin of resection. 1B. Tumor to liver and capsule. 1C. Tumor to necrotic area. 1D. Possible viable tumor to liver. 1E. Tumor to capsule. 1F. Normal liver. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 5. SEX: F. BIRTHDATE: ADM DATE: OPER DATE: PROCEDURE: SPMI. LIVER: HEPATOCELLULAR CARCINOMA. WAS THE TUMOR PREVIOUSLY TREATED?: No. TUMOR TYPE: Ordinary. SINGLE OR MULTIPLE MASSES: Single. MAXIMUM DIAMETER OF LARGEST MASS: 14 cm. ARE THE MARGINS OF RESECTION FREE OF TUMOR?: Yes. VASCULAR INVASION?: Yes. INVASION THROUGH THE CAPSULE TO THE SEROSAL SURFACE?: No. LYMPH NODE METASTASES?: Unknown. DISTANT METASTASES?: Unknown. IS THE LIVER CIRRHOTIC?: Yes. pT2 NX. PROCEDURE: SPDX. 1. Left lateral segment of liver, excision: Hepatocellular carcinoma (14cm),. with vascular invasion. Margins free. Please see template for full details. Background liver with cirrhosis and steatohepatitis. 1,. the signing staff pathologist, have personal I ly. examined and interpreted the slides from this case. Code:",T2,N0,M0,T2N0M0
TCGA-D8-A27M,"page 1 / 1. copy No. 4. Examination: Histopathological examination. Gender: F. Material: Total organ resection - left breast. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the left breast. PCI: Cellulae carcinomatosae. Results of immunohistochemical examination: No estrogen receptors found in the neoplastic cell nuclei. No progesterone receptors found in the neoplastic cell nuclei. HER2 protein stained with HER2 protein stained with. Ventana's Pathway HER-2/neu (4B5) Rabbit Monoclonal Antibody. Negative reaction in invasive cancerous cells (Score=0). dr. Macroscopic description: Left breast sized 17.3 x 15.4 x 4.8 cm removed without axillary tissues and with a skin flap of 17.3 x 6.3 cm. Weight. 600 g. Tumour sized 1.6 x 1.2 x 1.8 cm found in the upper outer quadrant, located 3.8 cm from the upper. boundary, 1.2 cm from the base and 1.6 cm from the skin. Microscopic description: Carcinoma ductale invasivum. NHG3 (2 + 3 +3:30 mitoses/10 HPF - visual area: 0.55mm). Glandular texture showing parenchymal atrophy. Histopathological Diagnosis: Carcinoma ductale invasivum mammae sinistrae. Invasive ductal carcinoma of the left breast (NHG3, pTlc, pNO (SN).",T1,N0,M0,T1N0M0
TCGA-A8-A09G,"Diagnosis: ) Poorly differentiated invasive carcinoma (tumor diameter: 5.5 cm). Concluding tumor classification: NOS, G III, pT3N3aL0V0R0.",T3,N3,M0,T3N3M0
TCGA-43-3920,"SPECIMEN. A. Level 10. B. Level 11. C. Level 12. D. Right upper lobe. E. 2R. F. 4R. G. Level 8. H. Level 7. I. Level 9. CLINICAL NOTES. GROSS DESCRIPTION. A. Received fresh, subsequently fixed in formalin labeled. ""level 10"" is a 1 X 0.8 x 0.4 cm. black-tan irregular soft. tissue fragment which is bisected and entirely submitted in one. cassette. AS-1. B. Received fresh, subsequently fixed in formalin labeled. ""level 11"" is a 0.9 X 0.6 x 0.4 cm. pink-black irregular. soft tissue fragment. The specimen is bisected and entirely. submitted in one cassette. AS-1. C. Received fresh, subsequently fixed in formalin labeled. ""level 12"" are two black-tan irregular soft tissue. fragments which are 1.8 cm. and 1 cm. in greatest dimension. The. specimens are entirely submitted in one cassette. AS-1. D. Received fresh, subsequently fixed in formalin labeled. ""right upper lobe"" is a 15 x 14 x 5 cm. lobe of lung. The. specimen shows a 3.5 cm. indurated focus on the pleura. This area. is inked blue. The specimen is sectioned to show a large white tan. indurated mass which is 5.0 x 5.0 x 4.5 cm. This specimen is. sectioned to show the tumor coming within 1.5 cm. from the surgical. stapled margin (inked black) This also comes within 3.5 cm. from. GROSS DESCRIPTION. the hilum. The tumor mass is firm and indurated. The remainder of. the cut surface shows a pink-red spongy parenchyma. No discrete. hilar nodes are grossly identified. Representative sections of the. specimen are submitted as follows: Block 1, 2 - tumor to pleura;. block 3 - tumor to surgical margin; block 4 - tumor to normal;. block. 5 - representative normal; block 6 - hilar and vascular margins;. block 7 - possible hilar nodes. RS-7. E. Received fresh, subsequently fixed in formalin labeled. ""2R"" are three yellow-red fatty tissue fragments which may. contain possible lymphoid tissue. These range from 0. cm. to 1.2. cm. in greatest dimension. The specimens are entirely submitted in. one cassette. AS-1. F. Received fresh, subsequently fixed in formalin labeled. ""4R"" is a 1.2 cm. pink fleshy nodule which shows black. discoloration on cut surface. There is also a minute aggregate. measuring 0.4 X 0.3 x 0.2 cm. The larger is bisected and the. specimens are entirely submitted as follows block 1 - larger lymph. node; 2 - smaller aggregate. G. Received fresh, subsequently fixed in formalin labeled. ""level 8"" is a 0.6 x 0.4 x 0.3 cm. pink-red irregular soft. tissue fragment which is entirely submitted in one cassette. AS-1. H. Received fresh, subsequently fixed in formalin labeled. 'level 7"" is an aggregate of yellow-pink-red irregular. soft. tissue fragment which may contain lymphoid tissue measuring 1.5 x. 0.8 x 0.3 cm. The specimens are entirely submitted in one cassette. AS-1. I. Received fresh, subsequently fixed in formalin labeled. ""level 9"" are two black-pink irregular soft tissue. fragments which are 1.2 cm. and 0.5 cm. in greatest dimension. The. specimens are entirely submitted in one cassette with the larger. bi-valved. The specimens are entirely submitted in one cassette. AS-1. GROSS DESCRIPTION. MICROSCOPIC DESCRIPTION. A-C. Sections of the level 10, level 11, and level 12. lymph. nodes demonstrate no evidence of metastatic disease in one. lymph node each. D. The following template applies to the right upper. lobe. Histologic type Squamous cell carcinoma. Histologic grade Poorly differentiated. Primary tumor : measures 5 cm, (pT2) : Margins of resection: Uninvolved. Direct extension of tumor : Not identified. Venous (large vessel) invasion: Not identified. Arterial (large vessel) invasion : Not identified. Lymphatic (small vessel) invasion Not identified. Regional lymph nodes (pN) : Negative as described in other. specimens. (pN0). Distant metastasis (pM) : Cannot evaluated by this specimen (pMX) . Other findings Four lymph nodes are negative for metastatic. disease. E. There is no evidence of metastatic disease to four 2R. lymph nodes. F. There is no evidence of metastatic disease to 3 4R. lymph. nodes. G. There is no evidence of metastatic disease to one level. 8 lymph node. H. There is no evidence of metastatic disease to four. level. 7 lymph nodes. I. There is no evidence of metastatic disease to two level. 9 lymph nodes. MICROSCOPIC DESCRIPTION. 3x7, 4x2. DIAGNOSIS. A. Level 2 lymph node, resection -. No evidence of resection to one lymph node (0/1) . B. Level 11 lymph node, resection -. No evidence of metastasis to one lymph node (0/1). C. Level 12 lymph nodes, resection. No evidence of metastasis to one lymph node (0/1) . D. Lung, right upper lobe, lobectomy -. Poorly differentiated squamous cell carcinoma, 5 cm. in. greatest dimension. Surgical margins uninvolved. Four lymph nodes with no evidence of metastatic disease. E. 2R lymph nodes, resection -. No evidence of metastasis to 4 lymph nodes (0/4). F. 4R lymph nodes, resection. No evidence of metastasis to 3 lymph nodes (0/3). G. Level 8 lymph node, resection -. No evidence of metastasis to 1 lymph node (0/1). H. Level 7 lymph node, resection -. No evidence of metastasis to 4 lymph nodes (0/4). I. Level 9 lymph node, resection -. No evidence of metastasis to 2 lymph nodes (0/2). ---- End Of Report --.",T2,N0,M0,T2N0M0
TCGA-B4-5843,"I. I. Specimen. I. Clinical. Ethnicity. I. I. Clinical. I. Index. I. I. label. I. Site #. I. (Race). Diagnosis. t. I. I. I. Renal. 1. Cancer. Renal. Cancer. I. I. I. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of. Amount/per. I. I. Specificatio. I. Container. I. I. Site. Matrix. Format. I. containers. container. n. I. I. I. I. I. Kidney,. Primary. Tumor. Tissue. Frozen. cryomold. 1. 270. mg. right. Blood. n/a. normal. Blood. Frozen. tube. 1. 4. ml. I. Prior. I. Type of. I. Chemo /. Histological. TNM Stage. TNM Stage. TNM Stage. Chemo /. Prior. I. Grade. Horm Th. I. description. (T). (N). (M). Hormonal. Radiation. Details. I. t. I. I. I. Th. I. Renal cell. 2. 1. 0. 0. carcinoma. Blood draw. n/a. n/a. n/a. n/a. n/a. Cellular. Tumor %. 90. n/a.",T1,N0,M0,T1N0M0
TCGA-BP-4771,"not. Clinical Diagnosis & History: ith right renal mass. Specimens Submitted: 1: SP: Right kidney. 2: SP: Retroperitoneal lymph nodes. DIAGNOSIS: 1). KIDNEY, RIGHT; RADICAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CLEAR CELL TYPE, WITH SARCOMATOID TRANSFORMATION, NUCLEAR GRADE. IV/IV. - THE TUMOR GREATEST DIAMETER IS 5.7 CM. - THE TUMOR EXTENDS THROUGH THE RENAL CAPSULE BUT IS CONFINED WITHIN GEROTA'S FASCIA. - THE TUMOR EXTENDS INTO THE RENAL SINUS FAT. - NO INVASION OF THE RENAL VEIN IS IDENTIFIED. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. - THE NON-NEOPLASTIC KIDNEY SHOWS PATCHY CHRONIC INTERSTITIAL NEPHRITIS. - THE ADRENAL GLAND IS NOT SUBMITTED. THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF METASTATIC NODES IN. RELATION TO THE TOTAL NUMBER OF NODES EXAMINED): RENAL HILAR: 0/1. 2). LYMPH NODES, RETROPERITONEUM; EXCISION: - FIVE BENIGN LYMPH NODES (0/5). 1). The specimen is received fresh, labeled, ""Right kidney"". It consists of a 535 grams nephrectomy specimen with attached. parirenal fat, measuring 19.5 x 13.0 x 5.5 cm. The trimmed kidney weighs 290 grams and measures 11.5 X 7.0 x 5.0 cm, with a. 6.0. x. 0.2. x 0.2 cm segment of ureter. A firm palpable mass is identifiad antariorly in the perirenal fat. The remalning external. surface of the kidney Is tan-brown and grossly unremarkabla. The area overlying the palpable mass is inked black and tha. specimen is bivalvad to show a 5.7 X 5.3 x 4.0 cm, well-circumscribed, tan-yellow lobulated mass with focal hemorrhage which. arises in the cortex and which extends into the renal sinus. The specimen does not grossly involve the renal pelvis. The turnor. abuts the overlying renal capsule, but does not grossly extend into the perirenal adipose tissue. The tumor does not grossly. Involva tha ranal vasculature. The remaining uninvolved renal parenchyma is ramarkable for a 0,6 x 0.6 x 0.5 cm, cortical cyst,. located in the upper pole. The remaining cortex measures 0.8 cm in greatest width and is grossly unremarkabla. Tha adrenal. gland is not identified. One possible lymph node measuring 0.4 cm in greatest dimension is Identified in the renal hilar fat. Photographs are taken. Sections are taken for TPS. Representative sections are submitted. Summary of Sections: UVM - ureter and vascular margins. TUMSINUS - tumor and sinus. TUMPELV - tumar and palvis. TUMCAPS - tumar with ovarlying capsula. TUMADJ - tumor with adjacent kidnay. CYST - upper pole cyst. UNKID - representativa sections from uninvalvad kidney. PLN - possible lymph nodes. 2). The spaciman is raceivad In farmalin, labaled, ""Retroperitoneal lymph nodes"". It consists of multiple fragments of. hemarrhagic fibroadipasa tissua measuring 4.6 X 3.5 X 1.4 cm in aggregate. Multiple lymph nadas are identified maasuring. from. 0.3 cm to 1.4 cm in greatest dimension. All lymph nodas ara submitted. Summary of Sections: U - undesignated. Summary of Sections: Part 1: SP: Right kidney. Black. Sect. Site. PCs. 1. cyst. 1. 1. pin. 1. tumadj. 1. 2. tumcaps. 2. 1. tumpelv. 1. 2. tumsinus. 2. 2. unkid. 2. 1. uvm. 1. Part 2: SP: Retroperitoneal lymph nodes. Black. Sect. Site. PCs. 1. u. 1.",T3,N0,M1,T3N0M1
TCGA-5M-AAT6,"SPECIMEN: Terminal ileum, cecum, appendix, ascending and transverse colon. PROCEDURE: Right hemicolectomy. MACROSCOPY. - Product of right hemicolectomy. - Segment of terminal ileum, cecum, segment of ascending colon and appendix. - The serosa is focally irregular, and displays multiple nodules in addition to a perforation 2.0 x. 1.5 cm large, which is continuous to an ulcerative, vegetative luminal lesion measuring 8.0 x 8.0. cm, located 8.0 cm from the nearest surgical margin. The lesion penetrates the colon wall to the serosa. - 11 lymph nodes were dissected from the pericolic fat; sizes ranging from 0.3 to 0.6 cm. MICROSCOPIC EXAMINATION. - Moderately differentiated tubular adenocarcinoma of the ascending colon;. - Microscopic tumor extension: invasion of pericolic soft tissues;. - Perineural invasion: present;. - Lymph-vascular invasion: present;. - Moderate desmoplastic stromal reaction;. - Surgical margins free of neoplastic involvement;. - Number of lymph nodes examined: 11;. - Number of lymph nodes involved: 10;. - Stage: pT4c/d, pN2.",T4,N2,M1,T4N2M1
TCGA-3H-AB3M,"DIAGNOSIS. (A) PLEURAL BIOPSY: MALIGNANT EPITHELIOID MESOTHELIOMA (SEE COMMENT). COMMENT: Immunohistochemical studies done on tumor sections show strong positive staining for WT-1, mesothelin and keratin 5/6 and. negative staining for MOC-31 in the neoplastic cells. The immunohistochemical patterns supports the above diagnosis. GROSS DESCRIPTION. (A) PLEURAL BIOPSY - Two pieces of tan-white tissue (0.2 X 0.2 x 0.2 and 1.2 x 0.5 x 0.3 cm). The smallest piece and half of. the larger piece are submitted for frozen section. The remaining tissue is submitted for permanent. SECTION CODE: A1, frozen section (three pieces of tissue); A2, remaining pleural biopsy. FS/DX: MALIGNANT NEOPLASM CONSISTENT WITH HISTORY OF MALIGNANT MESOTHELIOMA. CLINICAL HISTORY. Left pleural mesothelioma. SNOMED CODES. T-29000, M-90503. ""Some tests reported here may have been developed and performance characteristics determined by. . These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: END OF REPORT--.",T3,N2,M0,T3N2M0
TCGA-F5-6811,LARGE INTESTINE TISSUE. CHECKLIST. Specimen type: Excision of tumor. Specimen size: Not specified. Tumor site: Rectosigmoid junction. Tumor size: 2.5 X 0.5 cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Perirectal tissues. Lymph nodes: 0/8 positive for. metastasis (Pericolonic 0/8). Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.,T3,N0,M0,T3N0M0
TCGA-CJ-4639,"atholgy Accessic. DIAGNOSIS. (A) 12TH RIB: Unremarkable segment of rib (gross examination only). (B) PERINEPHRIC FAT: Mature adipose tissue, no tumor present. (C) LEFT KIDNEY AND ADRENAL: RENAL CELL CARCINOMA (7.7 CM MAXIMUM DIMENSION), CONVENTIONAL TYPE. (100% CLEAR CELLS),. FUHRMAN NUCLEAR GRADE 2, CONFINED TO THE KIDNEY. (SEE COMMENT). Adrenal gland, no tumor present. Margins of resection free of tumor. COMMENT. The renal cell carcinoma in the left kidney is confined to the kidney. and does not invade into the renal vein, perinephric adipose tissue or. renal sinus adipose tissue. GROSS DESCRIPTION. (A) 12TH RIB, GROSS ONLY - A segment of bone (3.2 x 1.1 x 0.8 cm),. which is grossly unremarkable. (B) PERINEPHRIC FAT - A segment of adipose tissue (16.0 x 10.0 x 0.5. cm). No discrete lesion is identified. Representative sections are. submitted in B1-B3. (C) LEFT KIDNEY AND ADRENAL - A radical nephrectomy specimen (26.0 x. 16.5 x 5.5 cm), including the adrenal gland (7.0 x 5.0 x 1.5 cm). The. adrenal gland appears unremarkable. A tan-yellow, focally gelatinous tumor (7.7 x 7.0 x 5.5 cm) is. present in the lower pole of the kidney. The tumor does not appear to. involve the renal vein or the renal sinus. It is confined by a capsule. and the closest external surface is 0.3 cm away. The uninvolved renal. parenchyma appears unremarkable. INK CODE: Black - external surface close to the tumor. SECTION CODE: C1, ureter, renal vein, renal artery margins; C2,. representative sections of adrenal gland; C3-C4, sections of tumor and. renal sinus; C5-C8, sections of tumor with closest perinephric fat. surface; C9-C10, representative sections of tumor; C11-C12,. representative sections of uninvolved kidney. CLINICAL HISTORY. Left renal mass. 1.",T2,N0,M0,T2N0M0
TCGA-AG-3586,"Diagnosis: 1.: Rectosigmoid colon shows a rectal carcinoma characterized histologically as a. moderately differentiated, partially mucinous, colorectal adenocarcinoma, extending at. most to within 3 cm of the aboral resection margin, with lymphatic tumor processes. Invasive tumor spread within all parietal layers of the intestine extending to the adjacent. periproctic fatty tissue. Oral and aboral resection margin tumor-free. Four periproctic or mesocolic lymph nodes with metastases of the rectal carcinoma. spreading over the lymph node capsule in some cases. Other lymph nodes with non-. characteristic reactive lesions. 2.: Mesocolic fatty tissue with signs of old necrotic lesions. Tumor stage therefore pT3 pN2 (4/19) L0, V0; G2.",T3,N2,M0,T3N2M0
TCGA-DD-AADC,"LINICAL DIAGNOSIS: Known HCC. Specimen : liver. Gross Photo : GROSS: Specimen status: Fresh. Operation: Central bissectionectomy (segment 5-8). Organ: Liver (13.1 x 9.5 X 6.2 cm, 267.5 gm). Gallbladder (10.0 cm in length, 4.0 cm in diameter). Tissues, labeled as 'portal vein thrombi'. (1.5 X 1.5 X 0.4 cm in aggregates). Lesion: Heaptic mass. Size: 7.5 X 6.6 X 5.1 cm. Cut surface: Poorly demarcated, pale tan and nodular mass. Gross type: Multinodular confluent. Extent: Confined to the capsule. Resection margin: Not involved, grossly (safety margin: 1.5 cm). Remaining parenchyme: Cirrhosis. [Gallbladder]. Serosal surface: Yellowish pink and smooth. Mucosal surface: Dark geen and velvety, no mural nodule. Representative sections are submitted. Gross photo: Present. Blocks. T1-4, mass of liver x 4. RM, tumor with resection margin x 1. L, nontumorous liver parenchyme x 1. A, labeled as 'portal vein thrombi' x 1. GB, gallbladder X 1. MICROSCOPIC: Tumor type: Hepatocellular carcinoma. Edmondson-Steiner grade. The worst differentiation III. The major differentiation III. Histologic type: Trabecular and nesting. Fatty change: No. Fibrous capsule formation: Partial. Capsular infiltration: Yes. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: Yes (separately submitted tissue, labeled as 'portal vein thrombi'). Vascular invasion: Yes. Bile duct invasion: No. Remaining liver parenchyme: Cirrhosis. NOT reported. Gross: stomach,antrum,scopic,chronic gastritis, h. pylori, associated. Liver, needle ,Chronic hepatitis, HBV associated. liver,ectomy,Hepatocellular carcinoma. T56000, P10, M81703. portal vein thrombi,biopsy,tumor cells present. portal vein thrombi, P50, M80011. gallbladder,ectomy,autolysis. T57000, P10, M54001. DIAGNOSIS: Liver, segment 5-8, central bissectionectomy: Hepatocellular carcinoma. Labeled as 'portal vein thrombi', biopsy: Tumor cells present. Galllbladder, cholecystectomy: Suggestion :",T1,N0,M0,T1N0M0
TCGA-AC-A2FK,"Specimen(s) Received. A: Right breast tissue. B: Sentinel node #1. C: Sentinel node #2. D: Left breast tissue. E: Sentinel node #3. Pathologic Diagnosis. A. Right breast tissue, mastectomy: Benign breast tissue with multiple intraductal papillomas and. proliferative fibrocystic change. B. Sentinel node #1: One lymph node positive for metastatio lobular carolnoma. The deposit measures. 1.6 cm in greatest dimension. Superficial extranodal extension is present. C. Sentinel node #2: One lymph node positive metastatic lobular carcinoma. The deposit measures 1.3. cm. Superficial extranodal extension is present. D. Left breast tissue: Histologio Type: Invasive lobular oaroinoma. Modified B-R Grade: 2. Tubular score: 3. Nuclear score: 2. Mitosis score: 1. Tumor Size: Greatest dimension: 3.4 cm. Additional dimensions: 3 X. 1.2 cm. Margins of Invasive Carcinoma: Negative. Invasive carcinoma is located: 1.8 cm. away from the deep margin. Lymphovascular Invasion: Absent. Duotal Caroinoma In Situ: Absent. Paget's Disease: Absent. Distant Metastasis: Cannot be assessed. Specimen Type: Mastectomy. Tumor Laterality: Left. Tumor Site: Upper outer quadrant. Lymph Node Sampling: Sentinel lymph nodes only. ChartMax Final Reporte. Surgical Pathology Report - Page 1/3. Comment: Small intraductal papillomas present. Hormone receptors were performed on previous. specimen. E. Sentinel node #3: One lymph node positive for metastatic lobular carcinoma. The deposit measures. 1.2 cm in greatest dimension. Superficial extranodal extension Is present. PATHOLOGIC STAGE: pT2, pNX, pMX. All three nodes sampled are positive and, therefore, the nodal stage Is at least pN1a. NOTE: information on pathology stage and the operative procedure is transmitted to this Institution's Cancer Registry as required. for accreditation by the Commission on Cancer. Pathology stage is based solely upon the current tissue specimen being evaluated. and does not incorporate other relevant data. Pathology stage is only a component to be considered in determining the clinical. stage and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative. Clinical History. Breast carcinoma. Gross Description. ""A"" - The specimen is received in formalin labeled ""right breast. It consists of an unoriented mastectomy. specimen without axillary tissue measuring 18 x 17.5 x 4 cm and welghing 719 grams. There is an. overlying tan-white ellipse of skin measuring 12.2 x 9 cm showing a slightly eccentric, wrinkled pale tan. areola, measuring 4.6 x 4.5 cm. In the center of the areola, there is an everted pale tan soft nipple. measuring 1 x 1 x 0,5 cm. There are grossly no blopsy sites or healed incisions on the skin surface. The. deep margin is inked black and the specimen is serially sectioned to reveal lobulated fat interspersed with. a moderate amount soft-to-firm pink-tan nonfatty breast tissue. There are scattered pink-tan soft. circumscribed nodules measuring up to 0.4 cm in diameter. Also noted are cysts filled with brown fluid. measuring up to 0.3 cm in diameter. There Is grossly no evidence of malignity. Representative sections. are submitted in seven cassettes. Block summary: ""A1"" - vertical section of nipple; ""A2"" - cross section of. nipple; ""A3"" - tissue underlying the nipple; ""A4 ""A7"" - tissue and nodules from each quadrant with the cyst. included in cassette ""4"". The specimen Is revlewed with. ""B"" - The specimen is received in formalin labeled ""sentinel node #1"". It consists of a firm pink-tan lymph. node and attached fat measuring overall 1.5 x 1 x 0.2 cm. The specimen is bisected and totally submitted. in cassette ""B"". ""C"" - The specimen is received in formalin labeled ""sentinel node #2"". It consists of a pink-tan lymph node. with attached fat measuring overall 1.3 x 0.8 x 0.6 cm. The specimen is bisected and totally submitted in. cassette ""C"". ""D"" - The specimen is received in formalin labeled ""left breast"". It consists of an unoriented mastectomy. specimen without axillary tissue measuring 20 x 17 x 4 cm and weighing 744 grams. There is an overlying. tan-white ellipse of skin measuring 11.5 x 8 cm showing a slightly eccentrio, wrinkled pale tan areola,. measuring 4.5 x 4.5 cm. In the center of the areola, there is an everted pale tan soft nipple measuring 1. x. 1 x 0,5 cm. There are grossly no blopsy sites or healed incisions on the skin surface. However, a papule. is identifled 0.3 cm from the nearest margin of the skin ellipse, measuring 0.4 x 0.3 cm. The deep margin. is inked black and the specimen is serially sectioned to reveal a firm pale pink-tan mass which appears to. Surgical Pathology Report - Page 2/3. be within the upper outer quadrant measuring 3.4 x 3 x 1.2 cm. The mass comes to within 1.8 cm of the. deep margin and 1 cm of the nearest superficial margin (inked blue). The mass comes to within 3.2 cm of. the nipple. The deep margin is inked black and the specimen is serially sectioned to reveal lobulated fat. interspersed with a moderate amount soft-to-firm pink-tan nonfatty breast tissue. The tumor shows. adjacent linear and focal areas of induration extending predominantly lateral and medial. No lymph nodes. are grossly identified at the axillary margin. Representative sections are submitted in 12 cassettes. Block. summary: ""D1"" - vertical section of nipple; ""D2"" - cross section of nipple; ""D3"" - tumor and nearest. superficial margin; ""D4"" - tumor and nearest deep margin; ""D6"" - tumor away from the surgical margin; ""D6"". and ""D7"" - irregular firm tissue approximately 1.5 cm medial to the tumor within the upper inner quadrant,. ""D8"" and ""D9"" - Irregularly firm tissue within the upper outer quadrant lateral to the tumor, ""D10"" - lower. inner quadrant; ""D11"" - lower outer quadrant; ""D12"" - tissue underlying the nipple. The specimen Is. reviewed with 1. ""E"" - The specimen is received in formalin labeled ""sentinel node #3"". It consists of a tan-yellow portion of. fatty tissue measuring 2 x 1.5 x 0.6 cm. Sectioning reveals a pink-tan lymph node measuring 1.7 x 0.6 x. 0.4 cm. the lymph node is totally submitted in cassette ""E"". Microscopic Description. Microscopio examination has been performed on all slides. The pathologic diagnosis encompasses the. essential microscopic findings of this case. ChartMax Final Reporte. Surgical Pathology Report - Page 3/3. ge 11.",T2,N3,M0,T2N3M0
TCGA-DD-AAE3,"CLINICAL DIAGNOSIS: Hepatocellular carcinoma suggested. Specimen : Liver and Liver mass. Gross Photo : ROSS: Specimen status: Fresh. Operation: Partial hepatectomy. Cholecystectomy. Organs: Liver (19.0 X 13.0 X 8.5 cm, 741.5 gm). Gallbladder (9.0 cm in length, 3.3 cm in diameter, and 0.5 cm in thickness). Lesion: <Liver>. A large dark red round tumor mass (16.5 X 12.0 cm). Cut surface: Yellowish tan and solid with area of necrosis. Gross type: HCC: Expanding nodular, multinodular confluent. Resection margin: Not involved grossly (safety margin: 0.5 cm). Others: Satellite nodule: No. Remaining parenchyma: Periportal-septal (stage 2-3). <Gallbladder>. No stone. Representative sections submitted. Gross photo: Present. Blocks. TB, T1-6, tumor mass X 7. L,NB, liver parenchyma X 2. GB, gallbladder X 1. MICROSCOPIC: Hepatocellular carcinoma: Yes. The worst differentiation II. The major differentiation II. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: No. Fibrous capsule formation: No. Septum formation: No. Surgical resection margin invasion: No, safety margin (0.5 cm). Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Intrahepatic metastasis: No. Multicentric occurrence: No. NOT reported. Gross: liver,ectomy ,hepatocellular carcinoma. T56000, P10, M81703. gallbladder,ectomy,chronic cholecystitis. T57000, P10, M43005. lymph node, biopsy,no tumor. T08000, P50, M09450. DIAGNOSIS: Liver, partial hepatectomy: Hepatocellular carcinoma, well differentiated. Gallbladder, cholecystectomy: Chronic cholecystitis. Lymph node, pericystic, biopsy: No tumor present (0/1). Suggestion :",T1,N0,M0,T1N0M0
TCGA-E2-A1B5,"SPECIMENS: A. LEFT AXILLARY SENTINEL LYMPH NODE #1. B. LEFT AXILLARY SENTINEL LYMPH NODE #2. C. LEFT AXILLARY SENTINEL LYMPH NODE 3#. D. WLE LEFT BREAST NEEDLE LOCALIZATION. E. ADDITIONAL RETROAREOLAR TISSUE LEFT BREAST. F. LEFT AXILLARY LYMPH NODES. SPECIMEN(S): A. LEFT AXILLARY SENTINEL LYMPH NODE #1. B. LEFT AXILLARY SENTINEL LYMPH NODE #2. C. LEFT AXILLARY SENTINEL LYMPH NODE 3#. D. WLE LEFT BREAST NEEDLE LOCALIZATION. E. ADDITIONAL RETROAREOLAR TISSUE LEFT BREAST. F. LEFT AXILLARY LYMPH NODES. GROSS DESCRIPTION: A. LEFT AXILLARY SENTINEL LYMPH NODE #1. Received fresh is a tan pink lymph node 1.5 x 0.8 x 0.5cm. The specimen is serially sectioned and a. touch prep is taken. Toto A1. B. LEFT AXILLARY SENTINEL LYMPH NODE #2. Received fresh is a tan pink lymph node 1.0 x 0.8 x 0.6cm. The specimen is serially sectioned and a. touch prep is taken. Toto B1. C. LEFT AXILLARY SENTINEL LYMPH NODE #3. Received fresh are 2 tan pink lymph nodes 1.2 x 0.8 x 0.8cm and 1.9 x 1.5 x 0.8cm. The specimens are. serially sectioned and 2 touch preps are taken. C1: 1 lymph node. C2: 1 lymph node. D. LEFT BREAST NEEDLE LOCALIZATION. Received fresh labeled with matching patient identifiers and designated ""wide local excision left breast"". is a portion of resected breast tissue weighing 290 g and measuring 11 x 9 6 cm. The specimen is. accompanied by a mammogram and needle localization wire. The specimen is received with. orientation, the single short suture designates superior, long suture designates the lateral. The. specimen is inked as follows: Anterior-blue, posterior-black, superior-rer4 orange, medial-green,. lateral-yellow. The specimen is serially sectioned from lateral to medial into 10 sections. Cut section. shows a firm beige ill-defined mass located 0.4-cm from the anterior/inferior margin. The mass. measures 1.7 x 1.1 x 1 cm. the remainder of the specimen shows areas of white fibrous streaking. septae adjacent to the lesion (medial aspect). The specimen was taken to mammography, sections. were x-rayed. Representative sections are submitted as follows: D1: Perpendicular sections lateral margin (section 1). D2: Anterior, demonstrates metallic clip (section 4). D3-D4: Anterior, dense tissue (section 4). D5: Inferior, dense tissue (section 4). D6-D9: Mass, anterior/inferior margin (section 5). D10-D12: Anterior/inferior (section 6). D13-D15: Anterior/superior (section 7). D16-D17: Anterior/posterior (section 8). D18-D19: Anterior/inferior (section 9). D20-D21: Perpendicular sections medial margin (section 10). t. ADDITIONAL RETROAREOLAR TISSUE LEFT BREAST. Blue-Anterior portion. Received in formalin is an oriented tan pink fragment of fibrofatty tissue 1.0 x 0.8 x 0.5cm. The anterior. portion is inked Blue and the specimen is trisected. Toto E1. F. LEFT AXILLARY NON SENTINEL LYMPH NODES. Received in formalin are multiple tan pink soft tissue fragments aggregating to 5.0 x 3.0 x 2.0cm. Dissection reveals 1 fatty lymph node 2.2 X 2.0 x 1.4cm. F1-F2: 1 lymph node. F3: remainder of specimen. DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, LEFT AXILLARY, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). - AE 1/3 NEGATIVE. B. LYMPH NODE, SENTINEL #2, LEFT AXILLARY, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). - AE 1/3 NEGATIVE. C. LYMPH NODE, SENTINEL #3 AND #4, LEFT AXILLARY, BIOPSY: - TWO LYMPH NODES, NEGATIVE FOR METASTASES (0/2). - AE 1/3 NEGATIVE. - S100 MARKS CAPSULAR NEVUS. D. BREAST, LEFT, WIDE LOCAL EXCISION: INVASIVE, LOBULAR CARCINOMA, SBR GRADE 2, MEASURING 2.1-CM. - INVASIVE TUMOR PRESENT AT THE ANTERIOR SURGICAL RESECTION. MARGIN. - PLEOMORPHIC LOBULAR CARCINOMA IN SITU. - SEE SYNOPTIC REPORT AND SEE NOTE. E. BREAST, ADDITIONAL RETROAREOLAR TISSUE, BIOPSY: - INVASIVE LOBULAR CARCINOMA PRESENT AT INKED SURGICAL. RESECTION MARGIN, SEE NOTE. F. LYMPH NODE, LEFT AXILLARY, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). NOTE: The specimen was serially sectioned and x-rayed. The main mass was identified in slice #5. In. slices #6 and 7, suspicious density is identified. This corresponds to the extending density seen on the. mammogram. The main mass and the extending density microscopically are invasive lobular. carcinoma. Also identified is metallic clip (area submitted in #D2). This are shows focus of LCIS. The. largest invasive tumor measured on the slide (2.1-cm). The tumor is present at the anterior surgical resection margin (slide #D7) at a distance of 7-mm. The. additional retroareolar tissue (part E.) also shows invasive tumor, presents at the anterior marked. margin at a distance of 2-mm. Breast biomarkers pending and addendum report to follow. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Yes - For mass. Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive lobular carcinoma 8520/3. Tumor size: 2.1cm. Tumor Site: Not specified. Margins: Involved at. anterior. Extent:: see note. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: LCIS. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/5. DCIS not present. ER/PR/HER2 Results. ER: Pending. PR: Pending. HER2: Pending. Pathological staging (pTN): pT 2N0. CLINICAL HISTORY: 46 year old with Left Breast Cancer. PRE-OPERATIVE DIAGNOSIS: Left Breast Cancer. INTRAOPERATIVE CONSULTATION. TPA-TPB: Negative for tumor. Diagnosis called to Dr at. (A) and. (B) by Dr. TPC1-TPC2: Atypical (both lymph nodes). Diagnosis called to Dr. at. by Dr. ADDENDUM: E-cadherin is negative compatible with lobular carcinoma phenotype. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: D7. ER: Positive. Allred Score: 8 = Proportion Score 5. +. Intensity Score 3. PR: Positive. Allred Score: 5. = Proportion Score. 2. +. Intensity Score 3. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by Dako (Dako, Carpenteria, CA) following the manufacturer S instructions. This. assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimen: Surgical Excision. Block Number: D7. Interpretation: NEGATIVE. Intensity: 0. % Tumor Staining: 0%. Fish Ordered: METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Her2 analysis was performed using the FDA approved Dako HercepTest (TM) test kit (. sing rabbit anti-human HER2. This assay was not modified. External kit-slides. provided by the manufacturer (cell lines with high, low and negative HER2 protein expression) and in-. house known HER2 amplified control tissue were evaluated along with the test tissue. Adequate, well. preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2. immunohistochemical stain is guided by published results in the medical literature, information provided. by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the. joint recommendations and guidelines from. ASCO and CAP and from the NCCN HER2 testing in Breast Cancer Task Force. The Pathology. Department takes full responsibility for this test's performance. ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 29. CLINICAL EXPERIENCE: Patients with a recurrence score of: 29 in the clinical validation study. had an average rate of Distant Recurrence at 10 years of 19%. ER Score: 7.2 Positive. PR Score: 5.8 Positive. Her2 Score: 7.6 Negative. Interpretation: ER. Negative < 6.5. Positive >= 6.5. PR. Negative < 5.5. Positive >= 5.5. Her2 Negative <10.7 Positive =11.5 Equivocal = 10.7 - 11.4. See separate. report for further information. Microscopic/Diagnostic Dictation: Pathologist,. Final Review: Pathologist,. Final Review: Pathologist. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist. Addendum: Pathologist,. Addendum Final: Pathologis:",T2,N0,M0,T2N0M0
TCGA-F4-6570,LARGE INTESTINE TISSUE CHECKLIST. Specimen type: Hemicolectomy. Specimen size: Not specified. Tumor site: Colon. Tumor size: 9 X 8.5 X 8 cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Pericolonic tissues. Lymph nodes: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,T3,N0,M0,T3N0M0
TCGA-55-6987,"Date of Service. Performing Facility. Result Provider. Report Name. SEE REPORT. RGICAL PATHOLOGY REPORT. PROCEDURE DATE. SPECIMEN DESCRIPTION: LEFT LOWER LOBE, LUNG, WEDGE BIOPSY. APC. B. REMAINING LEFT LOWER LOBE OF LUNG. AP WINDOW LYMPH NODE. D. SUBCARINAL LYMPH NODE. PRE-OPERATIVE DIAGNOSIS: Left lower lobe lung mass. ==== POST-OPERATIVE DIAGNOSIS: Same, pending pathology. CLINICAL INFORMATION: Left lower lobe lung mass, status post smoking history. INTRAOPERATIVE CONSULTATION. APC DIAGNOSIS: (Gross) pleural-based tumor, 2.0 cm from staple line; (smear). non-small cell carcinoma 1.0 cm tumon and non-tumor tissue. fragments for research"" by. ====. GROSS DESCRIPTION: A/APC. The specimen consists of a wedge of lung, measuring 9.5 X 4.0 X 2.8. cm. The pleural surface reveals an irregular retracted area, measuring. approximately 0.8 X 0.3 cm. A branching staple line, measuring 11 cm in. length, is present. The specimen has been sectioned during pathology. consultation. Sections show a well-defined subpleural mass, measuring 2.4 x. 2.2 X 1. 8 cm The mass is composed of tan-white firm tissue. It is located. 2.0 cm from the staple line. The remaining specimen shows tan-pink congested. pulmonary parenchyma, with emphysematous changes. Representative sections are. submitted in five cassettes as follows: cassette 1 - staple line; cassettes 2. through 4 - mass; cassette 5 - sections away from the mass. B. The specimen consists of the left lower lobe, measuring 19 X 14 X 5 cm and. weighing 198 grams. The pleural surface is congested with three staple lines,. measuring 5 cm, 6 cm, and 10 cm in length. The staple lines are inked black. and the specimen is serially sectioned to reveal congested pulmonary. parenchyma. No discrete mass is identified. The bronchial and vascular. margins are unremarkable. Representative sections are submitted in six. cassettes as follows: cassette 1 - bronchial margin; cassette 2 - vascular. margin; cassette 3 - staple lines; cassettes 4 through 6 - random lung. C. The specimen consists of two portions of irregular tan-gray soft tissue,. Date of Service. Performing Facility. Result Provider. Report Name. Surgical Report. DXSTIC. X. measuring 1.0 X 0.3 X 0.2 cm and 1.4 X 1.2 X 0.3 cm. The specimen is. submitted intact in one cassette. D. The specimen consists of one portion of irregular tan-gray soft tissue,. measuring 0.4 X 0.3 X 0.2 cm. The specimen is submitted intact in one. cassette. ====. MICROSCOPIC DESCRIPTION: A/APC. Five slides are examined. Slide 1 shows tissue from the region of the. staple line. There is inflammation, but no tumor is identified. Sections of. tumor appear on slides 2 through 5. This is non-small cell carcinoma,. measuring about 2.2 cm in maximal dimension. The morphology is that of. poorly-differentiated adenocarcinoma with predominantly solid areas, but. occasional gland formation is identified. Foci consistent with lymphovascular. invasion are present, seen on slide 3. Emphysematous lung is present on slide. 5. B. Six slides are examined. The bronchial margin shows no evidence of tumor. involvement. The vascular margin is also free of tumor. Patchy emphysema is. present in the remaining lung tissue. C. One slide is examined. Sections of anthracotic lung tissue are present,. without evidence of metastatic carcinoma. D. One slide is examined. A section of anthracotic lymph node is. identified. No evidence of metastatic tumor is present. ====. FINAL DIAGNOSIS: A/APC & B. LEFT LOWER LOBE OF LUNG: 1. TUMOR TYPE: ADENOCARCINOMA, POORLY DIFFERENTIATED (G3). MEASURING ABOUT 2.2 CM IN MAXIMAL DIMENSION. 2. FOCAL LYMPHOVASCULAR INVASION IS IDENTIFIED. 3. CLEAR VASCULAR AND BRONCHIAL RESECTION MARGINS. 4. REMAINING LUNG SHOWS MODERATE EMPHYSEMA. 5. TNM CLASSIFICATION: pT1.NO.MX. C. LYMPH NODE, AP WINDOW: ANTHRACOSIS, NO TUMOR IDENTIFIED. D. LYMPH NODE, SUBCARINAL: ANTHRACOSIS, NO TUMOR IDENTIFIED. A-MALIGNANT.",T1,N0,M0,T1N0M0
TCGA-BP-5007,"Clinical Diagnosis & History: ith left ranal mass; Upper pola tumor. Specimens Submitted: 1: SP: KIDNEY, LEFT, NEPHRECTOMY. 2: SP: LYMPH NODES, PARA AORTIC, EXCISION. DIAGNOSIS: 1. SP: KIDNEY, LEFT, NEPHRECTOMY: Tumor Typa: Ranal call carcinoma - Conventional (clear call) type. Ses comment. Fuhrman Nuclear Grade: Nuclear grade II/IV. Tumor Size: Greatest diameter is 10.0 cm. Local Invasion (for renal cortical types): Not Idantified. Ranal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidnay: Mild glomerulosclerosis. Adrenal Gland: Not involved. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT2 Tumor >7.0 cm in greatest dimension limited to the kidnay. Comment: The tumor shows multifocal areas of fibrosis and osseous metaplasia. 2. SP: LYMPH NODES, PARA AORTIC, EXCISION: Lymph Nodes: Not involved. Number of nodes examined:10. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh labeled ""left kidney"" and consists of 3 kidney with attached ureter, renal vessels and perinephric. fat weighing 725 g in total. The kidney measures 14.5 X 9.0 x 7.8 cm. The attached ureter measures 9.0 cm in length and 0,3 cm. in diameter. The attached renal vein measures 0,5 cm in length and 0.4 cm in diameter. The renal vessels and ureter margins are. grossly unremarkable. An adrenal gland is identified weighing 12.1 9 and measuring 7.5 x 2.5 X 1.5 with a hemorrhagic cortex. The kidney is inked black and bivalved to reveal large multilcculated and calcified golden yellow tan mess measuring 10,0 x 10.0 x. 7.0. cm. Sections through the remainder of the kidney reveal a pink brown parenchyma, with a well-defined cortico-medullary. junction. The cortex measures 2,8 cm and the calyces appear compressed. No lymph nodes are identified in the perinephric fat. Representative sections are submitted for TPS and for permanent sections. Photographs are taken. Summary of sections: UVM -- ureteral and vessel margins. A - adrenal gland. T-- tumor. TSF - tumor with sinus fat. TK tumor with adjacent kidney. RP -- rena) pelvis representative sections. K -- representative sections kidney. 2). The specimen is received in formalin, labeled ""para-aortic lymph nodes"" and consists of multiple pink tan firm lymph nodes. ranging from 0.5 to 1.2 cm in greatest dimension. All Identified lymph nodes are submitted. Summary of sections: LN -- lymph nodes. BLN-- bisected lymph nodes. Summary of Sections: Part 1: SP: KIDNEY, LEFT, NEPHRECTOMY. Block. Sect. Site. PCs. 1. a. 1. 3. add. 3. 2. k. 2. 1. 1. 8. 7. tk. 7. 1. tsf. 1. 1. uvm. Part 2: SP: LYMPH NODES, PARA AORTIC, EXCISION. Block. Sect. Site. PCs. 3. bIn. 3. 2. In. 2.",T2,N0,M0,T2N0M0
TCGA-VQ-A94R,"PRIMARY SITE: Stomach (Antrum). ""1-Subtotal gastrectomy + omentum: Moderately differentiated gastric adenocarcinoma, intestinal pattern of Lauren (size: 5.0cm), infiltrating to perigastric adipose tissue. Present foci of vascular invasion. Perineural invasion not observed. Surgical margins uninvolved by neoplasia. Metastasis in 6 perigastric lymph nodes, with extranodal invasion (6/32). 2-Lymph node from chain 8A: One lymph node uninvolved by neoplasia (0/1). 3-Lymph nodes from chain 8P: Five lymph nodes uninvolved by neoplasia (0/5). 4-Lymph nodes from lesser curvature and celiac trunk: Seventeen lymph nodes uninvolved by neoplasia (0/17)."". Criteria. Diagnissis Discrepanty. primary Tuinner lite Discrepancy. Prom Millinnancy hater. PE mai Nuteu- DEQUALITIES. Cas: Review is Initials m4 H= =.",T4,N2,M0,T4N2M0
TCGA-JY-A6FE,"M. Facility: Specimen(s) Received. 1. Lymph-Node: ST9 Inf Puim Ligament. 2. Lymph node: Subcarinal ST7. 3. Esophagus: Final esophageal margin. 4. Esophagus: Thoracic esophagus & proximal stomach. Diagnosis. 1. ST9 inferior pulmonary ligament lymph node: one reactive lymph node, negative for malignancy (0/1). 2. Subcarinal ST7 lymph node: one lymph node positive for metastatic carcinoma (1/1). 3. Final esophageal margin: esophageal wall negative for malignancy. 4. Thoracic esophagus & proximal stomach resection specimen: poorly differentiated squamous cell carcinoma with sarcomatoid and. rhabdoid features, distal esophagus, invading into the periesophageal fat, 7 of 33 lymph nodes positive for metastatic carcinoma. (7/33),. (pT3N1c),. proximal and distal resection margins clear, radial margin positive for carcinoma. See synoptic report, microscopic. description and comment. Comment. The synoptic report includes all the lymph nodes present for this patient. In specimen #4, the pTN stage includes all the lymph nodes present for this patient. Synoptic Data. Specimen Type: Esophagogastrectomy. Tumor Site: distal esophagus. Tumor Size: Greatest dimension: 10.6 cm. Additional dimensions: 9.0 x 5.5 cm. Histologic Type: Squamous cell carcinoma. Histologic Grade: G3: Poorly differentiated. Pathologic Staging (pTNM): pT3: Tumor invades adventitia. pN1c: More than 7 nodes involved. Number of lymph nodes examined: 35. Number of lymph nodes involved: 8. Margins: Proximal margin-Uninvolved by invasive carcinoma. Distal margin-Uninvolved by invasive carcinoma. Circumferential (Adventitial) margin-Involved by invasive carcinoma. Margin: radial. Venous (Large Vessel) Invasion (V): Absent. Lymphatic (Small Vessel) Invasion (L): Absent. Additonal Pathologic Findings: None identified. Gross Description. 1. The specimen is labeled with the patient's name and as ""station 9"". One piece of fibroadipose tissue measuring 0.6 X 0.6 x 0.2 cm. 1A submitted in toto. 2. The specimen is labeled with the patient's identification and as ""subcarinal ST7"". Number of tissue pieces: 1. Lymph nodes: Multiple coalesced lymph nodes measuring 4.0 x 3.0 x 2.6 cm in maximum dimension grossly thought to. be involved by tumor. 2A representative section. 3. The specimen is labeled with the patient's identification and as ""Final esophageal margin"". It consists of a segment. of luminal tissue measuring 1.2 cm in length with a diameter of 2.0 cm. It is stapled at one end. 3A full-thickness section adjacent to stapled margin. 4. The specimen is labeled with the patient's identification and as ""thoracic esophagus and proximal stomach"". RESECTION SPECIMEN: e.g. Subtotal gastro-esophagectomy. FIXATION: Received fresh, placed in formalin. DIMENSIONS: Length along lesser curvature: 2.0 cm. Length along greater curvature: 6.0 cm. Circumference of distal gastric margin: 11.0 cm. Circumference of proximal gastric margin: Not applicable. Length of tubular esophagus: 16.5-cm. Width of tubular esophagus: Proximal 7.5 cm - 4.5cm. Distal 11.0 cm - 9.5 cm. TUMOR: -Esophagus only: CONFIGURATION: Exophytic, necrotic, almost circumferential (2.5 cm of spared mucosa). - DIMENSIONS: Diameters: 10.6 x 9.0 cm. Depth: 5.5 cm. DESCRIPTIVE CHARACTERISTICS: Fleshy, yellow-tan with congested areas. - PERFORATION: No. - DISTANCE FROM MARGINS: - PROXIMAL 7.5 cm. - DISTAL. 2.2 cm. - RADIAL. 0.1 cm. ESTIMATED DEPTH OF INVASION: Serosa. LESIONS IN NONCANCEROUS STOMACH: None. LYMPH NODES: Multiple lymph nodes measuring up to 4.5 cm in greatest dimension. TUMOR BANKING: 3 pieces of tumor, 2 pieces of esophageal mucosa, 1 piece of gastric mucosa. Photographs are taken of the specimen. Representative sections: 4A proximal margin, en face. 4B esophagus, proximal to tumor. 4C proximal edge of tumor with adjacent mucosa. 4D-41 tumor, proximal to distal. 4J-4K distal edge of tumor with adjacent mucosa including GE junction. 4L gastric mucosa. 4M-4N distal margin, en face. 40 multiple lymph nodes, paraesophageal. 4P 1 lymph node, bisected, paraesophageal. 4Q 1 representative slice, 1 lymph node, paraesophageal. 4R-4W multiple lymph nodes, per block, gastric. 4X 1 lymph node, bisected, gastric. 4Y-4AA 1 representative slice of 1 lymph node, per block, gastric. Microscopic Description. Neoplastic cells show patchy positivity for pan-CK and CK7 and diffuse positivity for p63, negative for LMWK, HMWK, CK20,. S100, desmin and caldesmon.",T3,N1,M0,T3N1M0
TCGA-2G-AAGW,Summary pathology report. Right orchidectomy; nonseminoma (YST 100%); tumor diameter 4 + 2 cm; tumor confined to. testis; no angio-invasion; no invasion of rete testis. = date of orchidectomy): pathologist.,T1,N0,M0,T1N0M0
TCGA-B8-4620,"Diagnosis: idney, left, nephrectomy and adrenalectomy. Tumor histologic type/subtype: renal cell carcinoma, clear cell subtype. Histologic grade (if applicable) : 2 (of 4, Fuhrman classification). Tumor size: 6.2 cm. Extent of invasion: through capsule into perirenal fat, posterior (A5) and perihilar (A9). Vascular invasion: present, renal vein. Intraepithelial abnormality: n/a. Surgical margins: not involved. Lymph nodes: 0/2. Other organs: adrenal, left no carcinoma identified. AJCC stage: pT3a pNx pMx. This staging information is based on information available at the time of this report, and is subject to change. pending clinical review and additional information. Clinical History: a renal mass. Gross Description: Specimen A is labeled ""left kidney"". Specimen fixation: ""ype of specimen: Radical nephrectomy. side of specimen: Left. Size and weight of specimen: 600 grams; overall dimensions of 25 x 12 x 9 cm composed of a 10 x 8 x 6 cm. kidney,. 3.5 x 2.5 x 0.6 cm fragment of adrenal and perinephric fat and 4.5 x 0.4 cm of attached ureter. Orientation: The external surface is marked with blue ink and the adrenal is marked with yellow ink. Presence/absence of adrenal gland: Present, 3.5 x 2.5 cm fragment. Tumor description/site: The tumor is a fleshy friable dark red/brown mass with a polypoid component extending. into. the. renal pelvis. The tumor is predominantly located in the central medial aspect along the posterior. surface. The. mass has overlying adherent blood clot which extends into the renal pelvis. The blood clot overlies. the. polypoid. component. of the tumor which extends into the renal pelvis and focally into the ureter. The distal. ureter. does. not appear obstructed. The renal pelvis is slightly dilated. The tumor also has a polypoid component. extending into the renal vein (A2). Tumor. size: 6.2 x 4.3 x 3.5 cm. This is the overall tumor dimension. The polypoid component extending into the. pelvis is 3.5 x 2.2 x 1.8 cm. Presence/absence of multicentricity: Absent. Confinement/non-confinement to the kidney: Focally appears to extend into the perirenal fat along the posterior. lateral aspect. Otherwise confined to the kidney. Extent of invasion: Perirenal adipose tissue: Suspicious posteriorly. Gerota' s fascia: Negative. Renal vein: Polypoid tumor growth within the lumen not. necessarily adherent to the vascular wall. Ureter: Polypoid tumor growth of blood clot into the ureter, loosely adherent. Other organs: The adrenal gland is grossly unremarkable and uninvolved. irgical margins: cirenal adipose tissue: Tumor comes within 0.3 cm of the posterior lateral blue inked soft tissue margin. kenal vein: Negative. Renal artery: Negative. Ureter: Negative. Description of kidney away from tumor: Pale pink/tan with no cortical lesions identified. The remaining pelvic. urothelium is glistening white/pink. Lymph nodes (hilar) : None identified, but representative from hilar fat is submitted. Other significant findings: None. Tissue submitted for special investigations: Tumor and normal are given to tissue procurement. Digital photograph taken: No. Block Summary: A1 - Vascular and ureter margins of resection. A2 - Perpendicular section of tumor growing into renal vein at hilum. A3 - Adrenal gland. A4 - Tumor and overlying urothelium. A5 - Tumor in relationship to posterior fat and blue inked margin. A6 - Tumor and adjacent parenchyma. A7 - Polypoid component of tumor. A8 - Additional section of tumor posteriorly extending into the perinephric. fat and the blue inked surgical margin. A9 - Additional section of tumor towards hilar structures. A10 - Section of tumor with adjacent blood clot and parenchyma. All - Central tumor. A12 - Representative from normal appearing parenchyma inferior pole. A13 - Representative sections from hilar fat.",T3,N0,M0,T3N0M0
TCGA-AO-A1KQ,"Clinical Diagnosis & History: y/o male with left breast cancer (invasive ductal carcinoma (IDC)). Specimens Submitted: 1: SP: Sentinel node #1, level 1, left axilla (fs). 2: SP: Left breast with levels one and two axillary contents. DIAGNOSIS: 1). LYMPH NODE, LEFT AXILLA, SENTINEL LYMPH NODE #1; LEVEL 1; BIOPSY: METASTATIC CARCINOMA IN ONE LYMPH NODE (1/1). - THE METASTATIC DEPOSIT IS SEEN ONLY ON THE ACTUAL FROZEN SECTION AND. MEASURES AT LEAST. 2 MM. NO EXTRANODAL EXTENSION IDENTIFIED. - THE LYMPH NODE EXHIBITS INCIDENTAL BENIGN CAPSULAR NEVUS CELL. AGGREGATES. 2). BREAST. LEET: MASTECTOMY: - INVASIVE DUCTAL CARCINOMA. NOS TYPE. HISTOLOGIC GRADE III/III (SLIGHT. OR NO TUBULE FORMATION), NUCLEAR GRADE III/III (MARKED VARIATION IN SIZE AND. SHAPE) MEASURING 2.2 CM IN LARGEST DIMENSION MICROSCOPICALLY. - DUCTAL CARCINOMA IN-SITU (DCIS) IS ALSO IDENTIFIED, SOLID, CRIBRIFORM TYPE. WITH HIGH NUCLEAR GRADE AND MODERATE NECROSIS. - THE DCIS CONSTITUTES <= 25% OF THE TOTAL TUMOR MASS, AND IS PRESENT. ADMIXED WITH AND AWAY FROM THE INVASIVE COMPONENT. - THE INVASIVE CARCINOMA IS LOCATED IN THE LOWER INNER QUADRANT AND CENTRAL. AREA (RETROAREOLAR). - THE NIPPLE IS INVOLVED BY INVASIVE CARCINOMA. - A FOCUS OF PERINEURAL INVASION BY CARCINOMA IS SEEN IN THE DERMIS OF. THE NIPPLE REGION. THERE IS ALSO FOCAL LYMPHATIC INVASION IN THE NIPPLE. REGION. - CALCIFICATIONS ARE PRESENT IN THE IN SITU CARCINOMA. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. THE ION-NEOPLASTIC BREAST TISSUE IS UNRENORKAELE. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF. POSITIVE LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES. EXAMINED) : METASTATIC CARCINONA IN ONE OF EIGHT LYMPH NODES (1/8). THIS IS A MACROMETASTASIS (1.8 CM). - THERE IS NO EXTRANODAL EXTENSION OF CARCINOMA. Nc. - RESULTS OF SPECIAL STAINS (ER, PR, HER2-NEU) WILL BE REPORTED AS AN. ADDENDUM. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. ER-C. PR-C. HER2-0. NEG CONT. NEG-HER2. IMM RECUT. Gross Description: 1) The specimen is received fresh for frozen section consultation labeled,. Sentinel node #1, level 1, left axilla"", and consists of one lymph node. measuring 1.5 x 1.0 x 0.8 cm. The lymph node is bisected and submitted for. frozen section diagnosis. Summary sections: FSC - frozen section control. 2) The specimen is received fresh labeled, ""Left breast with levels one and. two axillary contents, stitch marks axillary tail"" and consists of a breast. measuring 19 x 18 x 3.5 cm with overlying skin ellipse measuring 19 x 11 cm,. attached axillary contents measuring 11 x 10 x 3 cm. The axillary tail is. marked with a black suture. Situated centrally on the skin surface is. a. flattened nipple measuring 0.8 x 0.8 em and areola measuring 2.5 x 2.5 cm. There are no scars or lesions noted on the skin. A suture demarcates the. axillary aspect. The posterior surface of the breast is inked black and the. specimen is serially sectioned to reveal a well circumscribed stony hard. white-tan tumor measuring 2.0 x 2.0 x 1.7 cm, and located 1.8 cm from the. deep margin. The tumor is located subjacent to the nipple The remainder. of. the breast tissue is yellow tan fatty and lobulated. The specimen is. submitted for lymph node dissection. Representative sections are submitted. A sample of the tumor is given to. Summary of sections: N nipple. NB - nipple base. DM - deep margin. T - tumor. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. LN-lymph nodes. Summary of Sections: Part 1: SP: Sentinel node #1, level 1, left axilla (fs). Block. Sect. Site. PCs. 1. FSC. 1. Part 2: SP: Left breast with levels one and two axillary contents. Block. Sect. Site. PCs. 1. dm. 1. 1. lig. 1. 5. LN. 8. 1. log. 1. 1. n. 1. 1. nb. 1. 6. 6. 1. uiq. 1. uog. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. ADDEN. SITK: #2, LEFT BREAST. ER: >95% OF NUCLEAR STAINING WITH STRONG INTENSITY. - PR: >80% OF NUCLEAR STAINING WITH STRONG TO NODERATE INTENSITY. - HER-2/NEU. (Hexcep Test) : NEGATIVE (STAINING INTENSITY OF FOCAL 1+). - CONTROLS ARZ SATISFACTORY. Intracperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOMA. PERMANENT DIAGNOSIS: SAME.",T4,N1,M0,T4N1M0
TCGA-A6-6652,"SPECIMEN. A. Sigmoid colon. B. Liver lesion. CLINICAL NOTES. PRE-OP DIAGNOSIS: Sigmoid colon cancer. FROZEN SECTION DIAGNOSIS. B. Subcapsular nodule c/w colonic adenocarcinoma. GROSS DESCRIPTION. A. Received fresh in a container labeled ""sigmoid colon"". is a 24 cm long segment of colon, which is received open at. one end, which is inked black black, and which is stapled at the. opposite end, which is inked blue. It is 5 cm in circumference. at. the open end of the specimen, and 9 cm in circumference at the. stapled end of the specimen. The serosal surface is generally. tan-pink and glistening, with an area with tattoo pigmented 11 cm. from the open end of the specimen. There is a palpable mass within. the bowel in this area, although there is not gross tumor. penetration to the serosal surface. The specimen is opened,. revealing a near circumferential 7.5 X 6.5 X 1.5 cm mass lesion,. coming to within 4.5 cm of the open end of the specimen. On cut. suface, there is invasion of tumor through the full thickness of the. bowel wall and into the surrounding adipose tissue, but the tumor is. not near the radial margin. The mucosa away from this area is area. is tan-pink and glistening, with multiple polyps, ranging from 0.3. cm to 0.7 cm in greatest dimension. There is no other worrisome. lesion in the bowel. The adipose tissue is dissected, and multiple. soft tan-pink lymph nodes are identified. RS-16, according to the. accompanying block summary, following fixation. BLOCK SUMMARY: A1 - proximal and distal resection margins; A2-A6 -. polyps; A7 - radial margin; A8-A10 - tumor; A11-A15 - lymph nodes,. h multiple lymph nodes per block; A16 - one sectioned lymph node. B. Received fresh in a container labeled ""segment for. liver lesion"" is a wedge-shaped portion of tissue, with. a. generally tan glistening capsular surface, but with an area of. tan-white discoloration on the capsular surface, and with the. non-capsular surface of the biopsy irregulary roughened and. cauterized. The specimen spans an area 2 X 1.5 X 1.1 cm. On cut. surface there is a nodular area approximately 0.6 cm in greatest. extent in the subcapsular region, corresponding to the discoloraton. noted on the capsular surface. Two sections are submitted for. frozen section, with the apparent lesion in block BFS1, and the. remainder of the specimen is submitted for permanent sections one. additional block. MICROSCOPIC DESCRIPTION. The following template summarizes the findings in this case: Histologic type: Adenocarcinoma of the colon. Histologic grade: Moderately differentiated. Primary tumor (pT) : Adenocarcinoma invades through the full. thickness of the bowel wall into surrounding adipose tissue (pT3). Proximal margin: Negative. Distal margin: Negative. Circumferential (radial) margin: Negative. Distance of tumor from closest margin: See gross description. Vascular invasion: Not definitively identified. Regional lymph nodes (pN) : pNO . Twenty-two lymph nodes are. identified, and they are negative for malignancy. Distant metastasis (pM) : pM1. There is metastatic colonic. adenocarcinoma in part B. Other findings: There are multiple hyperplastic polyps and an. adenomatous polyp in the colon away from the mass lesion. The liver. outside the metastasis is notable for steatosis with mild chronic. inflammation and a slight increase in fibrous tissue, though this. is difficult to assess given the supcapsular nature of the biopsy. and being adjacent to the metastasis. There no significant. stainable iron. Please note that in part B, in addition to. examining H&E stained sections, PAS, PAS-diastase, trichrome,. reticulin, and iron-stained sections are examined. 5,4,14,15,18x5. DIAGNOSIS. A. Colon, sigmoid, excision. - Moderately differentiated adenocarcinoma, invading through. the full thickness of the bowel wall and into surrounding. adipose tissue (see microscopic description). - Margins negative for malignancy. - Twenty-two lymph nodes negative for malignancy. - Hyperplastic polyps and adenomatous polyp. B. Liver, biopsy. - Metastatic colonic adenocarcinoma (see microscopic. description).",T3,N0,M1,T3N0M1
TCGA-05-4420,"Main diagnosis/diagnoses: Central to peripheral bronchopulmonary, histologically mixed adenocarcinoma of the right. lower lobe of the lung with a predominant papillary and small acinar component, slight mucin. formation and main localization in segments 7 to 9. TNM classification on the basis of this material pT2 pN0 pMX R0, stage IB. C34.3 M8255/3. Comment/supplementary remark: The tumor has extended to S4 of the middle lobe, the resection margin of the bronchus and. the vessels as well as all the lymph nodes removed and identified are tumor-free.",T2,N0,M0,T2N0M0
TCGA-F7-A50G,Gross Description: Microscopic Description: Diagnosis Details: Comments: Formatted Path Reports: Tumor site: Tongue. Tumor. size: 4 X 6 x 4cm. Histologic type: Squamous cell carcinoma. Histological grade: Well differentiated. Laterality: Midline. Margins: Not specified.,T3,N1,M0,T3N1M0
TCGA-AR-A5QP,"A. Breast, left, lumpectomy: Infiltrating lobular carcinoma, Nottingham grade I (of III) [tubules. 3/3, nuclei 1/3, mitoses 1/3; Nottingham score 5/9], forming a 2.2 x 2.1 x 1.6 cm mass. Angiolymphatic invasion is absent. The non-neoplastic breast parenchyma shows. nonproliferative fibrocystic changes. Biopsy site changes present. All surgical resection margins. are negative for tumor (minimum tumor free margin, 0.4 cm, deep margin, and 0.6 cm, anterior. margin). B. Lymph node, left, sentinel biopsy: One (of 2) axillary sentinel lymph nodes is positive with. multiple (5) metastases, the largest measuring 3.5 mm in greatest dimension. Extranodal. extension is focally present. With available surgical material [AJCCpT2N1(sn)], (7th edition, 2010).",T2,N1,M0,T2N1M0
TCGA-VD-AA8T,"HISTOPATHOLOGY. Lab No. Clinical Consultant & Location. Unit No. SPECIMEN. LEFT GLOBE ENUCLEATION (FOR DIAGNOSTIC AND PROGNOSTIC). CLINICAL DETAILS. See diagram. Measurements 14.28 x 14.26 x (9.49) mm. MACROSCOPIC DESCRIPTION. A fresh, intact left globe. Dimensions: Axial 24. . mm, Horizontal 24mm, Vertical 24mm. Cornea: Horizontal 11.5mm, Vertical 10. 8mm. Description: arcus senilis. Optic nerve. Length 7mm, diameter 4mm. Pupil: very dilated. On. trans-illumination, a large shadow is seen on the medium 100/30/14. side. Approx 18mm. Plane of section: horizontal. Intraocular description: On opening, a solitary pigmented dome shaped choroidal mass. is seen. There is probable ciliary body involvement. Posterior edge is 11mm from optic disc. Tumour size. LBD 12mm, Height 9mm. MICROSCOPY. Sections show a partially pigmented ciliochoroidal melanoma. consisting predominantly of spindle cells. The number of. mitosis is approximately 2/40 high power fields. Closed. loops are present in the planes of sections. The lymphocytic. infiltrate within the tumour is minimal. Scattered. macrophages are present. Tumour necrosis is not seen. Bruch's membrane appears breached in the sections examined. printed. HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. There is no tumour extension through the sclera, optic nerve. or vortex veins examined. Tumour extends very close to. anterior chamber angle and trabecular meshwork however no. definitive evidence of ring pattern of spread is seen. Tumour cells are not seen at the resection margins. Elsewhere, the cornea shows no significant abnormality apart. from oedema in basal epithelial cells. The anterior chamber. angles are open and the anterior chamber is deep. The iris. shows no significant abnormality but the ciliary body away. from the tumour appears atrophic with hyalinisation of. ciliary processes. Lens remnants show cataractuous changes. Retina overlying the tumour is slightly atrophic. DIAGNOSIS. Left eye, enucleation: Ciliochoroidal melanoma of. predominantly spindle cell type. COMMENT. Assessment of Melan-A and HSP 27 expression will be carried. out . In addition, molecular genetic examination of DNA. extracted from the tumour cells will be performed using. multiplex-ligation dependent probe amplification (MLPA),. looking at chromosomes 1, 3, 6 and 8. A supplementary report. will follow in due course. SUPPLEMENTARY REPORT. In the meantime, immunohistochemical stains were performed. The tumour cells stain for MelanA and partially for HSP-27. (score 1). SUPPLEMENTARY REPORT (MLPA). In the meantime, molecular genetic analysis of tumour DNA. extracted from the fresh uveal melanoma tissue was performed. using the technique termed multiplex ligation-dependent. probe amplification (MLPA) . These investigations were. performed in the. The kit P027 from. which examines for gains or. printec. HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. losses in 31 loci on chromosomes 1, 3, 6 and 8, was used. The DNA concentration was measured using. and the. quality assessed using multiplex-PCR prior to the MLPA. reaction. The DNA concentration was high and of good quality on. assessment. The MLPA reaction was run at least twice on. differing occasions, resulting in similar results. The results of the sequence analysis of the MLPA products is. printed on a separate report. In summary, sequence analysis. demonstrated: Loss of chromosome lp,. monosomy 3,. normal chromosome 6. and gains in chromosome 8. These molecular data require correlation with the clinical. and morphological data for metastatic risk assessment.",T2,N0,M0,T2N0M0
TCGA-85-7697,Gross. Microsc. Diagnos. Comme. Case ID. Descript. opic. is. nts. ion. Descript. Details. ion. LUNG TISSUE CHECKLIST. Specimen type: Pneumonectomy. Tumor site: Lung. Tumor size: 4 X 3.5 X 3 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Well differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not. specified. Comments: None. Lateralit. y. Left-upper.,T3,N0,M0,T3N0M0
TCGA-A8-A07O,"Diagnosis: 1. Poorly differentiated invasive solid carcinoma, clearly consistent with. a. ductal breast carcinoma (maximum reconstructed tumor diameter: 3.0 cm; forming. a ventral margin, caudal distance 0.5 cm, lateral 1 cm, cranial 1.2 cm, medial and. dorsal 1.5 cm). The tumor-free, ink-stained resection margin of the ventral follow-up resection. material (preparation 4) gives rise to the following tumor classification: NOS, G III,. pT2 pN0(0/13)LOVORO.",T2,N0,M0,T2N0M0
TCGA-E2-A1IL,"SPECIMENS: A. WLE LEFT BREAST NEEDLE LOCALIZATION. B. SENTINEL LYMPH NODE #1 LEFT AXILLA. C. SENTINEL LYMPH NODE #2 LEFT AXILLA. D. SENTINEL LYMPH NODE #3 LEFT AXILLA. E. SENTINEL LYMPH NODE #4 LEFT AXILLA. F. SENTINEL LYMPH NODE #5 LEFT AXILLA. SPECIMEN(S): A. WLE LEFT BREAST NEEDLE LOCALIZATION. B. SENTINEL LYMPH NODE #1 LEFT AXILLA. C. SENTINEL LYMPH NODE #2 LEFT AXILLA. D. SENTINEL LYMPH NODE #3 LEFT AXILLA. E. SENTINEL LYMPH NODE #4 LEFT AXILLA. F. SENTINEL LYMPH NODE #5 LEFT AXILLA. INTRAOPERATIVE CONSULTATION DIAGNOSIS: Part A, WLE Left breast, needle localization, gross examination: Tumor is 1 cm from posterior/inferior. margin. TPB, Sentinel node #1, biopsy: No tumor seen. TPC, Sentinel node #2, biopsy: No lymphoid tissue grossly identified, no lymphocytes or tumor seen. TPD, Sentinel node #3, biopsy: No tumor seen. TPE, Sentinel node #4, biopsy: No tumor seen. TPF, Sentinel node #5, biopsy: No tumor seen. Diagnoses called at. (Part A) and. (Parts B-F) by Dr. GROSS DESCRIPTION: A. WLE LEFT BREAST NEEDLE LOCALIZATION. Received fresh labeled with the patient's identification and designated ""wide local excision left breast. needle localization"" is an oriented, previously inked, 39-g, 25 x 5.2 x 2.7 cm needle localized. lumpectomy specimen accompanied by two radiographs. The single suture designates anterior,. double-lateral. Ink code: Anterior-yellow, posterior-black, medial-green, lateral-red, superior-blue,. inferior-orange. The specimen is serially sectioned from medial to lateral into 6 slices revealing a firm. tan mass with surgical clip (slice 3), 1.5 x 1 x 0.9 cm, located 1 cm from the nearest posterior/inferior. margin. A portion of the specimen is submitted for tissue procurement. The specimen is. representatively submitted: A1-A5: Medial margin, perpendicular sections, entirely submitted. A6: Mass, slice 2 with posterior and anterior margins. A7-A11: Slice 3 entirely submitted, A7-A8 demonstrating tumor (clip) and nearest posterior/inferior. margins. A12-A15: Slice 4 entirely submitted, A12 demonstrating mass. A16-A17: Slice 5, posterior/inferior, inferior/anterior, respectively. A18: Representative sections lateral margin. B. SENTINEL LYMPH NODE #1 LEFT AXILLA. Received fresh labeled with the patient's identification and designated ""Sentinel lymph node number. one left axilla"" is a beige tan lymph node measuring 2 x 1.5 X 1 cm. Touch preparation is performed. Entirely submitted, B1. C. SENTINEL LYMPH NODE #2 LEFT AXILLA. Received fresh labeled with the patient's identification and designated ""Sentinel lymph node number. two left axilla"" is a fragment of fibroadipose tissue measuring 2 x 2 x 0.8 cm. Touch preparation is. performed. Entirely submitted, C1. D. SENTINEL LYMPH NODE #3 LEFT AXILLA. Received fresh labeled with the patient's identification and designated ""sentinel lymph node number 3. left axilla"" is a portion of adipose tissue measuring 4 X 3 X 1 cm, demonstrating one lymph node. measuring 0.7-cm in greatest dimension. Touch preparation is performed. The entire lymph node is. submitted, D1. E. SENTINEL LYMPH NODE #4 LEFT AXILLA. Received fresh labeled with the patient's identification and designated ""Sentinel lymph node number 4. left axilla"" is a fragment of lymphoid tissue measuring 2 x 1 x 1 cm. Touch preparation is performed. Entirely submitted, E1. F. SENTINEL LYMPH NODE #5 LEFT AXILLA. left axilla"" is a tan lymph node measuring 1.2 x 1 x 0.6 cm. Touch preparation is performed. Entirely. Received fresh labeled with the patient's identification and designated ""Sentinel lymph node number 5. submitted, F1. DIAGNOSIS: A. BREAST, LEFT, EXCISION: - INVASIVE LOBULAR CARCINOMA, MEASURING 1.5-CM, SBR GRADE II,. NUCLEAR GRADE 2. - DUCTAL CARCINOMA- IN -SITU, NUCLEAR GRADE 1-2/3. - RADIAL SCAR. - PREVIOUS BIOPSY SITE CHANGES. - SURGICAL RESECTION MARGINS ARE NEGATIVE FOR TUMOR. SEE SYNOPTIC REPORT. B. SENTINEL LYMPH NODE #1, LEFT AXILLA, EXCISION: - ONE REACTIVE LYMPH NODE. - NEGATIVE FOR METASTATIC CARCINOMA (0/1). C. SENTINEL LYMPH NODE #2, LEFT AXILLA, EXCISION: - BREAST TISSUE WITH STROMAL FIBROSIS. - NO MALIGNANCY IS SEEN. D. SENTINEL LYMPH NODE #3, LEFT AXILLA, EXCISION: - ONE LYMPH NODE, POSITIVE FOR METASTATIC LOBULAR CARCINOMA (1/1). E. SENTINEL LYMPH NODE #4, LEFT AXILLA, EXCISION: - ONE REACTIVE LYMPH NODE. - NO METASTATIC CARCINOMA IS SEEN (0/1). F. SENTINEL LYMPH NODE #5, LEFT AXILLA, EXCISION: - ONE REACTIVE LYMPH NODE. - NO METASTATIC CARCINOMA IS SEEN (0/1). SYNOPTIC REPORT - BREAST. Specimens Involved. Specimens: A: WLE LEFT BREAST NEEDLE LOCALIZATION. Specimen Type: Excision. Needle Localization: Yes - For mass. Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive lobular carcinoma 8520/3. Tumor size: 1.5cm. Additional dimensions: 1cm x 0.9cm. Tumor Site: Upper outer quadrant. Margins: Negative. Distance from closest margin: Greater than 1cm. inferior. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: Indeterminate. Lymph nodes: Sentinel lymph node only. Lymph node status: Positive 1/4. Micrometastases: DCIS present. DCIS Quantity: Estimate 5%. DCIS Type: Solid. DCIS Location: Associated with invasive tumor. Nuclear grade: Low. Necrosis: Absent. Location of CA++: Benign epithelium. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by IHC. Performed on Case: Pathological staging (pTN): pT 1c N 1a. Comment(s): Few microcalcifications are seen in the invasive tumor. CLINICAL HISTORY: Core biopsy proven cancer upper outer quadrant left breast. PRE-OPERATIVE DIAGNOSIS: Left breast carcinoma. Microscopic/Diagnostic Dictation:, M.D. Path^logist,. Final Review:, M.D., Pathologist,. Final:, M.D., Pathologist, 9.",T1,N1,M0,T1N1M0
TCGA-34-5928,"PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: l. PROCEDURE: Lung lobectomy, thoracotomy. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered. CHEMORADIATION: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION: Not answered. OTHER DISEASES: Not answered. FINAL DIAGNOSIS: Summary Statement. The left lower lobe neoplasm is an invasive moderately differentiated squamous cell carcinoma measuring 3.7 cm. Visceral pleural invasion is identified. Anglolymphatic invasion is identified. One N1 lymph node is involved by. metastatic squamous cell carcinoma. All the margins of resection are free of tumor. The stage is T2 N1 MX. PART 1: LYMPH NODE, LEFT LEVEL 9, BIOPSY -. ONE (1) REACTIVE LYMPH NODE. NO TUMOR SEEN. PART 2: LYMPH NODES, LEFT LEVEL 10 NEAR INFERIOR PULMONARY VEIN, BIOPSY -. THREE (3) REACTIVE LYMPH NODES WITH. FOCAL NECROTIZING GRANULOMAS AND CALCIFICATIONS. NO. TUMOR SEEN. PART 3: LYMPH NODE, LEFT LEVEL 11 NEAR PULMONARY ARTERY, BIOPSY -. ONE (1) REACTIVE LYMPH NODE WITH NECROTIZING GRANULOMAS AND CALCIFICATIONS. NO TUMOR. SEEN. PART 4: LYMPH NODE, LEVEL 5, BIOPSY -. ONE (1) REACTIVE LYMPH NODE. NO TUMOR SEEN. PART 5: LYMPH NODES, LEVEL 6, BIOPSY -. TWO (2) REACTIVE LYMPH NODES. NO TUMOR SEEN. PART 6: LYMPH NODE, LEFT LEVEL 10, BIOPSY -. ONE (1) REACTIVE LYMPH NODE WITH NECROTIZING GRANULOMAS AND CALCIFICATIONS. NO TUMOR. SEEN. PARTIT: LOBE,. A. INVASIVE MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA WITH FOCAL BASALOID. AREAS (3.7 CM). B. ANGIOLYMPHATIC INVASION IDENTIFIED. C. VISCERAL PLEURAL INVASION IDENTIFIED. D. MARGINS OF RESECTION FREE OF TUMOR. E. METASTATIC SQUAMOUS CELL CARCINOMA INVOLVING ONE (1) OF SIX (6) PERIBRONCHIAL LYMPH. NODES. F. CALCIFIED AND FIBROTIC GRANULOMA (1.0 CM). G. ANTHRACOTIC AND FIBROTIC NODULE (0.2 CM). H. BACKGROUND LUNG SHOWING EMPHYSEMA, PERIBRONCHIOLAR METAPLASIA, ALVEOLAR EDEMA,. BRONCHIECTASIS, BRONCHIOLOECTASIS, AND PULMONARY HYPERPLASTIC ARTERIOPATHY. I. STAGE: T2 N1 MX. PART 8: LYMPH NODE, LEVEL 12, BIOPSY -. TWO REACTIVE LYMPH NODES. NO TUMOR SEEN. PART 9: LYMPH NODE, BRONCHIAL LYMPH NODE NEAR LEFT LOWER BRONCHUS, BIOPSY -. ONE LYMPH NODE WITH NECROTIZING GRANULOMA AND CALCIFICATIONS NO TUMOR SEEN. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY LUNG TUMORS. TUMOR LOCATION: Left Lower Lobe. PROCEDURE: Lobectomy. TUMOR SIZE: Maximum dimension: 3.7 cm. GROSS SATELLITES: Number of gross satellite lesions: 0. TUMOR TYPE: Invasive squamous carcinoma. HISTOLOGIC GRADE: G2, Moderately differentiated. MICROSCOPIC SATELLITES: Number of microscopic satellite lesions. 0. EXTRAPULMONARY PARENCHYMAL. EXTENSION/INVASIO OF TUMOR: Visceral pleura. ANGIOLYMPHATIC INVASION;. TUMOR NECROSIS: < OF = to 50%. SURGICAL MARGIN INVOLVEMENT: No. INFLAMMATORY(DESMOPLASTIC) REACTION: Mild. N1 LYMPH NODES: Number of N1 lymph nodes positive: 1. Number of N1 lymph nodes examined: 14. N2 LYMPH NODES: Number of N2 lymph nodes positive: 0. Number of N2 lymph nodes examined: 4. UNDERLYING DISEASE(S): Bronchiectasis, Emphysema. T STAGE, PATHOLOGIC: pT2. ADDENDA: Addendum. PROBE: LSI EGFR/CEP7. EGFR FISH STUDIES PERFORMED ON THE SQUAMOUS CELL CARCINOMA ARE POSITIVE BY COLORADO CRITERIA. Number of cells analyzed: 60. Ratio EGFRICEP7: 1.18. SNR (signal to nucleus ratio): 2.0. Hyperdiploid rate for CEP 7: 8.3%. > 4 copies of the EGFR signal: 5(8.3%). Small gene cluster (4-10 copies): 0(0%). Larger and brighter EGFR signals than CEP7 signals: 11 1(18.3%). 15 copies of EGFR signals: 0(0%). PROBE: LSI ALK Dual-Color Break-apart Probe 2p23. ALK FISH STUDIES PERFORMED ON THE SQUAMOUS CELL CARCINOMA ARE NEGATIVE. Number of cells analyzed: 60. % of cells positive for the ALK rearrangement: 0%. Only split 0 & G (single o and single G in the same nucleus: 0%. Fusion + split o and G in the same nucleus: 0%. Only single O: 0%. Fusion + single O: 0%. % of the cells with the normal pattern: 60(100%). EGFR FISH analysis was manually performed and quantitatively assessed by analysis of a minimum of 60 cells using the EGFR. SpectrumOrang and the CEP7 SpectrumGreen probes. ALK FISH analysis was manually performed and quantitatively assessed by analysis of a minimum of 60 cells using the ALK. SpectrumOrange (telomeric) and the ALK SpectrumGreen (centromeric) probes. UCCC criteria for stratification of NSCLC patients: EGFR FISH positive: 1) EGFR gene amplification defined as one of the following: a) EGFR gene to CEP7 ratio > 2. b) Small gene cluster (4-10 copies) or innumerable tight gene cluster'in > 10% of tumor cells. c) Larger and brighter EGFR signals than CEP7 signals in A 10% of tumor cells, while EGFR signals are smaller than the CEP7. signals in the adjacent stromal and reactive cells. d) 7 15 copies of the EGFR signals in > 10% of tumor cells or. 2) Specimens with > 40% of cells displaying A 4 copies of the EGFR signal. EGFR FISH negative: Specimens without gene amplification as defined above and with 40% of cells displaying > 4 copies of the EGFR signal. Clinical studies show high EGFR gene copy number by FISH analysis to be associated with favorable clinical benefit (clinical. response, stable disease, time to progression, and survival) in patients with advanced non-small cell lung cancer treated with. EGFR tyrosine kinase inhibitors. ALK translocation is detected as follows: ALK negative: 0-15% of cells positive for the ALK rearrangement. Normal cells without the ALK translocation show green and orange signals in juxtaposition. ALK positive: Greater than 15% of cells positive for the ALK rearrangement. Cells. with. the ALK translocation show one of the following patterns: One pair of signals (green and orange) fused or in juxtaposition. and one green and one orange signal separated; Only split o & G (single O. and single G in the same nucleus); Only single O;. Fusion + single O. Addendum. The granulomas in the left lower lobe lung specimen (Part 7) and left lower lobe bronchial lymph node (Part 9) show small fungal. yeast forms on the Grocott stain that are negative on the mucicarmine stains. These fungal forms most likely represent. Histoplasma species. Clinical correlation is suggested. AFB stains are negative.",T2,N1,M0,T2N1M0
TCGA-97-A4M2,"A total of 50 cells were scored. FINDINGS: FISH was performed on paraffin embedded tissue sections using the. Vysis ALK Break Apart Probe for the ALK gene at 2p23 (. FDA approved). When a rearrangement involving ALK is. present, either inversion or translocation, one of the two fusion. signals separates as one red and one green signal. In this. specimen, separated signals were present in 0% of the nuclei scored. This result is within the normal limits. COMMENTS: Three to four copies of ALK were observed in 26.0% of. cells. This gain of intact ALK fusion hybridization signals. represents an aneuploid population with extra copies of chromosome. 2/2p ALK region. Additional copies of ALK are not uncommon in. NSCLCs, although the significance of extra copies of the ALK gene in. lung carcinoma is unclear at this time (Salido M. et al. J Thorac. Oncol. 2011;6:21-27). References: (1). Soda M, et al. Identification of the transforming. EML4-ALK fusion gene in non-small cell lung cancer. Nature. 2007:448:561-566; (2). Rodrig S, et al. Unique clinicopathologic. features characterize ALK-rearranged lung adenocarcinoma in the. western population. Clin Cancer Res. 2009:15:5216-5223; (3). Shaw. A, et al. Clinical features and outcome of patients with non-small. cell lung cancer who harbor EML4-ALK. J Clin Oncol. 2009:27:4247-4253; (4). Koivunen J, et al. EML4-ALK fusion gene and. efficacy of an ALK kinase Inhibitor in lung cancer. Clin Cancer. Res. 2008:14:4275-4283; (5). Kwak EL. et al. Anaplastic lymphoma. kinase inhibition in non-small cell lung cancer. N Engl J Med. 2010:363(18):1693-1703 (6). The FDA approved Vysis ALK Break Apart. FISH Probe Kit. ISCN RESULTS: nuc ish(ALKx3 4)[59/100]. The Vysis ALK Break Apart Probe FISH test (. 1 is FDA. approved for use in the detection of rearrangements involving the. ALK gene via fluorescence in situ hybridization (FISH) in. formalin-fixed paraffin-embedded (FFPE) non-small cell lung cancer. (NSCLC) tissue specimens. Addendum #4 performed by. The electronic signature attests that the. Pathologist has evaluated the specimen referred to in the signed. section of the report and formulated the diagnosis therein. This report may include one or more immunohistochemical stain. results that use analyte specific reagents. The tests were developed and their performance characteristics. determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is not. necessary. SPECIMENS: 1. F/S RIGHT MIDDLE LOBE NODULE. 2. STATION 9 LYMPH NODE, RIGHT CHEST. 3. STATION 10 LYMPH NODE, RIGHT CHEST. 4. COMPLETION OF RIGHT MIDDLE LOBECTOMY. 5. STATION 4 LYMPH NODE. 6. STATION 7 LYMPH NODE. SEE ADDENDUM. Reason For Addendum #1: Molecular Studies. Reason For Addendum #2: Molecular Studies. Reason For Addendum #3: Molecular Studies. Reason For Addendum #4: Biomarker Report. DIAGNOSIS: 1. LUNG, RIGHT MIDDLE LOBE: WEDGE RESECTION. - ADENOCARCINOMA, PAPILLARY PREDOMINANT (1.1 CM), SEE NOTE. - THE STAPLE LINE MARGIN IS FREE OF TUMOR. Note: The tumor consists of papillary (70%) and micropapillary. (30%) components. Results of molecular studies will be reported in. addenda. 2. LYMPH NODE, RIGHT LEVEL 9: BIOPSY. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). 3. LYMPH NODE, RIGHT LEVEL 10: BIOPSY. TWO LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2). 4. LUNG, RIGHT MIDDLE LOBE: COMPLETION LOBECTOMY. - NO RESIDUAL TUMOR IS SEEN. - THE BRONCHIAL AND VASCULAR MARGINS ARE FREE OF TUMOR. - ONE INTRAPARENCHYMAL LYMPH NODE, NEGATIVE FOR CARCINOMA. (0/1). 5. LYMPH NODE, LEVEL 4: BIOPSY. - THREE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/3). 6. LYMPH NODE, LEVEL 7: BIOPSY. - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). Specimens: 1: F/S RIGHT MIDDLE LOBE NODULE. 2: STATION 9 LYMPH NODE, RIGHT CHEST. 3: STATION 10 LYMPH NODE, RIGHT CHEST. 4: COMPLETION OF RIGHT MIDDLE LOBECTOMY. 5: STATION 4 LYMPH NODE. 6: STATION 7 LYMPH NODE. LUNG: Resection. SPECIMEN. Specimen: Lobe(s) of lung (specify). right middle. Procedure: Lobectomy. Specimen Laterality: Right. Tumor Site: Middle lobe. Tumor Focality: Unifocal. TUMOR. Histologic Type: Adenocarcinoma, mixed subtype. Histologic Grade: G2: Moderately differentiated. EXTENT. Tumor Size: Greatest dimension (cm). 1.1cm. Visceral Pleura Invasion: Not identified. MARGINS. Bronchial Margin. Bronchial Margin Involvement by Invasive Carcinoma: Uninvolved by. invasive carcinoma. Vascular Margin: Uninvolved by invasive carcinoma. ACCESSORY FINDINGS. Lymph-Vascular Invasion: Not identified. STAGE (pTNM). Primary Tumor (pT): pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung. or visceral pleura, without bronchoscopic evidence of invasion more. proximal than the lobar bronchus (i.e., not in the main bronchus);. or Superficial spreading tumor of any size with its invasive. component limited to the bronchial wall, which may extend proximally. to the main bronchus. Regional Lymph Nodes (pN). pNO: No regional lymph node metastasis. Distant Metastases (pM): Not applicable. ADDITIONAL NON-TUMOR. Additional Pathologic Finding(s): Emphysema. CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS: M smoker (100 pack-years) with hx of prostate cancer (. ) and. COPD, now with a 1.5 cm RML mixed solid and ground-glass nodule and. multiple additional bilateral lung nodules. MACROSCOPIC DESCRIPTION: The specimen is received fresh, in six parts, each labeled with the. patient's name. 1. Part one is labeled 'right middle lobe nodule'. It consists of a. wedge shaped portion of lung measuring 11 x 5 x 2 cm. There is a. staple line identified on the specimen, measuring 10 cm in length. There is a cut identified on the specimen measuring 1.5 cm in. length. On further sectioning there is a gray white ill defined area. measuring 1.1 x 1 cm is identified. This area is 0.3 cm from the. staple line and 0.4 cm from the pleural surface. The staple line is. inked blue. Further sectioning of the lung reveals spongy tan maroon. parenchyma. One portion from the ill defined area is submitted for. frozen section analysis. Representative sections are submitted. 2. Part two is labeled 'station #9 lymph node'. It consists of a. single lymph node measuring 2.4 x 1.5 x 1 cm. The cut surface is. grey-black. Entirely submitted in one cassette. 3. Part three is labeled 'station #10 lymph node'. It consists of. multiple irregular fragments of grey-black lymph nodes measuring 1.5. x 0.8 x 0.5 cm in aggregate. Entirely submitted in one cassette. 4. Part four is labeled 'completion of right middle lobectomy'. It. consists of a lobe of lung measuring 10.5 x 5.5 x 2 cm and weighing. 38 grams. Two staple lines, measuring 8 cm and 6 cm in length are. noted. The bronchial and vascular margins are identified. The. serosal surface is grey-purple and shows a subpleural grey-black. nodule measuring 0.9 x 0.8 cm. Sectioning reveals an unremarkable. red beefy lung parenchyma. The subpleural nodule likely represents. the lymph node. No discrete mass lesions are noted. Representative. sections are submitted. 5. Part five is labeled 'station #4 lymph node'. It consists of. three irregular segments of grey-black lymph nodes ranging from 0.2. to 0.5 cm in greatest dimension. Entirely submitted in one. cassette. 6. Part six is labeled 'station #7 lymph node'. It consists of a. single grey-black lymph node measuring 0.8 x 0.5 x 0.3 cm. Entirely. submitted in one cassette. SUMMARY OF SECTIONS: 1A frozen section control, ill defined area. 1B area adjacent to ill defined area. 1C area adjacent to ill defined area. 1D area adjacent to ill defined area. 1E unremarkable lung parenchyma. 1F stapled line. 2A in toto. 3A in toto. 4A bronchial and vascular margins. 4B entire subpleural nodule. 4C-4E lung, representative. 5A in toto. 6A in toto. SPECIAL PROCEDURES: INTRA - OPERATIVE CONSULTATION: 1. Lung, right middle lobe: wedge resection (FS). - Invasive adenocarcinoma. Intra-Operative Consultation #1 performed by. Final Diagnosis performed by. ADDENDUM #1 FOR MOLECULAR TESTS: KRAS, EGFR and ALK FISH were sent on. The test is to be performed on tissue from case. The case report, slides, and blocks for the cited. accession number were retrieved from archives. The pathologist whose. signature appears below reviewed the original pathology report,. examined candidate H&E slides, and selected block 1A appropriate to. the specifications of the ordered molecular analysis. x1 H&E and x9. unstained slides were prepared and forwarded to. where the subject molecular test will be performed. An. addendum report will be issued when the results of this molecular. test are available. Addendum #1 performed by. ADDENDUM #2: MOLECULAR ONCOLOGY. KRAS MUTATION ANALYSIS. Body Site: Right middle lobe of lung. Specimen Type: Slides. Clinical Data: Adenocarcinoma. RESULTS: Wild-type gene. INTERPRETATION: No mutations were identified at codons 12 and 13 of the KRAS gene. COMMENT: Mutations in the KRAS gene are reported to be associated with poor. prognosis, and resistance to targeted tyrosine kinase inhibitor. therapies in patients with non-small-cell lung cancer (NSCLC). KRAS. mutations occur in 15-30% of NSCLC patients and are strongly. associated with adenocarcinoma and smoking history. This assay analyzes codons 12 and 13 in exon 2 of the KRAS gene;. based on the current literature, approximately 98% of mutations are. expected to occur in these codons. The analytical sensitivity of. the assay is approximately 10%; thus mutations present in a low. percentage of cells may not be detected. This test is validated. for use in identifying KRAS codon 12 and codon 13 mutations in. fresh, frozen, or formalin-fixed paraffin embedded tissue. In. particular the test performance has been established in samples of. colorectal cancer and non-small cell lung carcinoma which harbor. these mutations, although several other tissues are also known to. harbor KRAS mutations (e.g. tumors of pancreas, bile duct, ovary,. appendix, etc.). Analysis of EGFR mutation or gene amplification status may provide. additional information regarding this patient's probability of. response to targeted tyrosine kinase inhibitor therapies, if. clinically indicated. See references. METHOD/LIMITATION: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exon 2 of the KRAS gene. PCR products are subjected to single. nucleotide primer extension to detect mutations at codons 12 and 13;. primer extension products are analyzed using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. REFERENCES: NSCLC. Mascaux C, Iannino N, et al. British Journal of Cancer, 2005;. 92:11-139. Pao W, Wang TY, et al. PLoS Medicine, 205; 2(1):57-61. Eberhard DA, Johnson BE, et al. J Clin Oncol, 2005; 23:5900-5909. Han SW, Kim TY, et al. Clin Cancer Res. 2006; 12(8):253888888-2544. CRC. DiFiore C, Blanchard F, et al. Br J Cancer, 20007; 96:1166-1169. Lievre A, Bachet J-B, et al. Cancer Res, 2006; 66:3992-3995,. This test was developed and its performance characteristics. determined by. The laboratory is. regulated under the Clinical Laboratory Improvement Amendments of. 1988 (CLIA) as qualified to perform high complexity clinical. testing. This particular test is not considered a stand along test. and should be used only in the context of other diagnostic tests or. clinical work-up related to treatment decisions. Addendum #2 performed by. ADDENDUM #3: EGFR Mutation Analysis. Body Site: Right middle lobe of lung. Clinical Data: Adenocarcinoma. RESULTS: No mutation detected. INTERPRETATION: No mutations were identified in the sample provided. for analysis. Fewer than 5% of non-small cell lung carcinoma. patients without identifiable mutations are reported to be. responsive to EGFR tyrosine kinase inhibitor therapies. COMMENT: Forty percent (40%) or more tumor cellularity is optimal. for this mutation analysis. The sample submitted showed 70% tumor. cellularity upon pathologist review. A frequently occurring sequence change 2361>GA (Q787Q) was. identified. This polymorphism is known not to have clinical. significance. Mutations in the tyrosine kinase domain of the epidermal growth. factor receptor (EGFR) gene are reported to be associated with. differential responsiveness or resistance to EGFR tyrosine kinase. inhibitor (TKI) therapies. The objective response rate among. patients with a sensitizing mutation ranges from 55 to 82%. This assay analyzes exons 18-21 of the EGFR tyrosine kinase domain;. based on the current literature, most mutations in non-small-cell. lung carcinoma (NSCLC) are expected to occur in these exons. Mutations present in less than 10-20% of extracted DNA may not be. detected by this method. Mutation status in a sample may change. during tumor progression or the course of therapy; therefore, this. result cannot be used to infer the presence or absence of a mutation. in another sample or sub-sample obtained from this tumor. This test is validated for non-small cell lung carcinoma. The. clinical significance and utility of this test in other tumor types. is unknown. METHOD: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exons 18-21 of the EGFR gene. PCR products are analyzed by. bi-directional direct DNA sequencing using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. REFERENCES: 1. Azzoli CG, et al. J Clin Oncol. 20095; 27:6251-6266. 2. Jackman DM et al. Clin Carcinoma Res. 2009; 15:5267-5273. 3. Mok TS, et al. N Engl J Med. 1009; 361;947-957. 4. Sharma SV, et al. Nat Rev Carcinoma, 2007; 7:169-181. DISCLAIMER: This test was developed and its performance characteristics. determined by. The laboratory is. regulated under the Clinical Laboratory Improvement Amendments of. 1988 (CLIA) as qualified to perform high complexity clinical. testing. This particular test is not considered a stand alone test. and should be used only in the context of other diagnostic tests or. clinical work-up related to treatment decisions. Addendum #3 performed by. ADDENDUM 4: INTEGRATED ONCOLOGY. Fluorescence In-Situ Hybridization (FISH). Body Site: Right middle lobe of lung. Clinical Data: Adenocarcinoma. INTERPRETATION: Negative for a rearrangement involving the ALK gene. Probe #Nuclei Examined % Positive Nuclei %. Control values. 2p23(ALK) 50 0.0 <15.",T1,N0,M0,T1N0M0
TCGA-AG-3611,"Diagnosis: Rectosigmoid colon with a carcinoma evidently of the colorectal junction extending to a. maximum of 2.5 cm within the resection margin with a maximum diameter of 3.5 cm,. characterized histologically as a moderately differentiated colorectal adenocarcinoma. Invasive tumor spread within all parietal layers of the intestine as far as the adjacent. mesocolic or periproctic fatty tissue. Colon shows a tubulovillous adenoma of the colon mucosa with a diameter of 3 cm,. epithelial dysplasia that is severe in parts (synonym: high-grade intraepithelial neoplasia). and also adenoma of the tubular mucosa with a diameter of 0.8 cm and epithelial dysplasia. that is severe in parts (synonym: high-grade intraepithelial neoplasia). Oral and aboral resection margins tumor-free. Ten regional lymph nodes tumor-free with non-characteristic reactive lesions . Tumor stage therefore pT3 pNO (0/19) LO V0; G2 R0.",T3,N0,M0,T3N0M0
TCGA-EL-A3T0,"y Case. IV Report. Case type: Surgical History. Case imported from. computer system. The format of this report does not match the original case. For cases prior to. section ""SPECIMEN"" may have been added. DIAGNOSIS. (A) LEVEL IIA AND IIIA LYMPH NODES: Four lymph nodes, no tumor present. (8) LEVEL IIB, IIIB, IVB AND VB LYMPH NODES: NO tumor present in five of level IIB lymph nodes. METASTATIC PAPILLARY CARCINOMA OF THYROID IN 3/10 OF LEVEL IIIB. LYMPH NODES. METASTATIC PAPILLARY CARCINOMA OF THYROID IN 1/5 LEVEL IVB LYMPH. NODES. No tumor present in six of level V lymph nodes. (c). INFERIOR RIGHT PRETRACHEAL MASS: METASTATIC PAPILLARY CARCINOMA OF THYROID IN 2/2 LYMPH NODES. (D) THYROID, TOTAL THYROIDECTOMY: PAPILLARY CARCINOMA OF THYROID WITH COMBINED PAPILLARY AND FOLLICULAR. COMPONENTS, EXTENDING INTO ADJACENT SOFT TISSUE. METASTASIS INTO 1/1 PARATHYROID LYMPH NODE. (E) RIGHT UPPER PARATRACHEAL MASS: METASTATIC PAPILLARY CARCINOMA OF THYROID IN 3/3 LYMPH NODES. Entire report and diagnosis completed bv: Report released by: GROSS DESCRIPTION. (A) LEVEL II AND III A LYMPH NODES - A single piece of fibrofatty tissue (3.5. x 2.0 x 0.8 cm). Four separate lymph nodes are identified within this tissue. They range in maximum dimension from 0.5 to 1.8 cm. SECTION CODE: A1, largest lymph node hicerted; A2, two possible lymph. nodes; A3, one possible Tymph node. (B) LEVEL IIB, IIIB, IVB, AND VB LYMPH NODES - A right neck dissection. including fibrofatty tissue, muscle folds, lymph nodes, and vascular tissue. which is 9.5 x 5.0 x 3.0 cm. The largest 1ymph node recovered is 3.5 x 3.0. x. 2.7 cm, and is grossly positive for tumor. It is located in level 3. Other. lymph nodes in level 3 and level 4 are also grossly positive for tumor. SECTION CODE: Lymph nodes submitted as follows: Level 2B - B1, three possible lymph nodes; B2, four possible lymph nodes. Level 38 - representative sections B3, 84, representative sections of. largest, grossly positive lymph node; B5, representative sections of. additional grossly positive lymph node; B6, B7, four possible lymph nodes,. each cassette; B8, three possible lymph nodes. Lymph nodes from level 4B - B9, one lymph node, bisected; 810, four. possible lymph nodes; B11, five possible Tymph nodes. I evel 5 Tymph nodes: B12, B13, four possible lymph nodes, each cassette. (c) INFERIOR RIGHT PRETRACHEAL MASS - Two tan ovoid firm nodules measuring. History Case. Dathology Report. Pathologis. Case type: Surgical History. 1.3 and 0.5 cm, respectively. They are entirely submitted as follows: SECTION CODE: C1, C2, larger nodule; C3, smaller nodule. (D) THYROID - A thyroidectomy specimen (7.0 x 4.5 x 2.3 cm). The right lobe. contains a tan firm nodule measuring 2.0 cm in greatest dimension. A second. nodule is present in the left lobe (0.8 cm). INK CODE: Black - capsule. SECTION CODE: D1-D5, right lobe nodule; D6, right lobe, representative. section of uninvolved parenchyma; D7-D8, left lobe nodule; 09, left lobe. representative resection. RIGHT UPPER PARATRACHEAL MASS - Three tan ovoid nodules measuring 3.0,. 1.1 and 1.0 cm, respectively in greatest dimension. The cut surfaces are tan. and lobulated. All the nodules are submitted in toto as follows: SECTION CODE: E1-E4, largest nodule; E5, mid size nodule; E6, smallest. nodule. SNOMED CODES. M-80503 M-80506 T-B6000 T-C4100.",T3,N1,M0,T3N1M0
TCGA-H7-A6C5,"Operative Procedure: Not provided. Pre-Operative Diagnosis: Not provided. Post-Operative Diagnosis: Not provided. A: Right neck dissection; 2 stitch=inferior, 1 stitch=superior. B: Left level 1 lymph node (FS). C: Left neck dissection. D: Possible parathyroid tissue (FS). E: Total laryngectomy, right hemi-thyroidectomy. F: Right tongue base margin (FS). G: Right tongue base #2 (FS). H: Right superior pharyngeal margin (FS). I: Right inferior pharyngeal margin (FS). J: Post cricoid margin (FS). K: Left inferior pharyngeal margin (FS). L: Left superior pharyngeal margin (FS). M: Left tongue base (FS). N: Tracheal margin (FS). O: Right tracheal esophageal groove. Final Pathologic Diagnosis: Larynx and right lobe of thyroid, total laryngectomy and hemi-thyroidectomy: Keratinizing squamous cell carcinoma, moderately. differentiated. Histologic type: Keratinizing squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor size: 4.4 cm (greatest dimension). Depth of invasion: 2.0 cm (greatest dimension). Lymph-vascular invasion: Not identified. Perineural invasion: Not identified. Tumor site: Supraglottis: Epiglottis, Right pyriform sinus, Right. false vocal cord, Right ventricle. Tumor focality: Single focus. Margins: Margins uninvolved by invasive carcinoma. Distance from closest margin: 0.1 cm. Specify margin: Right superior. pharyngeal (pyriform) margin (See note). Margins uninvolved by carcinoma in situ {includes. moderate and severe dysplasia}. Lymph nodes, extranodal extension: Not identified. Pathologic Staging (pTNM). TNM descriptors: None known. Primary tumor (pT): pT2. Regional lymph nodes (pN): pNO. Number examined: 76 (including parts A-C, O). Number involved: 0. Distant metastasis (pM): pMX. Additional pathologic findings: Stoma site with ulceration and. granulation tissue. Unremarkable thyroid gland. Specimen: Larynx; Right lobe of thyroid. Fresh. Procedure: Total laryngectomy; Right hemi-thyroidectomy. Laryngectomy: Opened. Specimen size: 11 x 6 X 6 cm (greatest dimensions). Tumor laterality: Right. A. Lymph node, right neck dissection: 31 lymph nodes, negative for malignancy (0/31). B. Lymph node, left level 1, regional resection: Three lymph nodes, negative for malignancy (0/3). Frozen section diagnosis confirmed. C. Lymph node, left neck dissection: 31 lymph nodes, negative for malignancy (0/31). D. Parathyroid, excision: Hypercellular parathyroid tissue. Frozen section diagnosis confirmed. E. Larynx and right lobe of thyroid, total laryngectomy and hemi-thyroidectomy: Keratinizing squamous cell carcinoma, moderately differentiated (see. synoptic report for details). F. Tongue, right base margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. G. Tongue, right base margin #2, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. H. Pharynx, right superior margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. I. Pharynx, right inferior margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. J. Posterior cricoid margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. K. Pharynx, left inferior margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. L. Pharynx, left superior margin, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. M. Tongue, left base, biopsy: Negative for malignancy. Frozen section diagnosis confirmed. N. Trachea, margin, biopsy: Negative for malignancy. O. Lymph node, right tracheal-esophageal groove, regional resection: 11 lymph nodes, negative for malignancy (0/11). The examination of this case material and the preparation of this report were. Note: The right superior pharyngeal margin sent for frozen section evaluation was. negative for invasive carcinoma (part H). Invasive carcinoma does extend to this. margin on the main resection specimen; however, this does not represent a true. margin. Intraoperative Consult Diagnosis: FSB: Left level 1 lymph node: Negative for malignancy. FSB TAT: 13 mins. FSD: Possible parathyroid tissue: Hypercellular parathyroid tissue identified. FSD TAT: 8 mins. FSF: Right tongue base margin #1: Negative for malignancy. FSG: Right tongue base margin #2: Negative for malignancy. FSH: Right superior pharyngeal margin: Negative for malignancy. FSI: Right inferior pharyngeal margin: Negative for malignancy. FSJ: Posterior cricoid margin: Negative for malignancy. FSK: Left inferior pharyngeal margin: Negative for malignancy. FSL: Left superior pharyngeal margin: Negative for malignancy. FSM: Left tongue base: Negative for malignancy. FSN: Tracheal margin: Moderate squamous dysplasia. FSF through FSN TAT: 35 mins. combined. Gross Description: Received are fifteen containers all labeled with the patient's name. Parts A, C, E and O are received in formalin. All others are received fresh for. frozen section evaluation. Part A is received additionally labeled ""right neck dissection, 1 stitch. superior, 2 stitch inferior."" The specimen consists of a portion of pink-tan to. yellow, fibromembranous and fibrofatty soft tissue having dimensions of 9 x 3.5. cm by up to 1.5 cm. There are two sutures in place as previously indicated. Beginning in the ""superior aspect,"" there are thirteen probable lymph nodes that. range from 0.2 to 2.2 cm in greatest dimension. These lymph node candidates are. submitted as follows: A1. five whole probable lymph nodes;. A2. two whole probable lymph nodes;. A3. two whole probable lymph node;. A4-6. one whole lymph node each cassette, each bisected;. A7-8. one whole lymph node bisected, one-half in each cassette. There is no gross evidence of tumor involvement in these lymph nodes. Within the aspect indicated as inferior, there are twenty-one probable lymph. nodes that range from 0.2 to 1.8 cm in greatest dimension. These lymph node. candidates are submitted as follows: A9-12 five whole lymph nodes each cassette;. A13. one whole lymph node bisected. Part B is received fresh for frozen section evaluation additionally labeled. ""left level 1 lymph node (FSB+X)."" The specimen consists of a 1.5 X 1 X 0.5 cm. portion of yellow, lobulated, fibrofatty tissue. Within this tissue is a lymph. node which is submitted for frozen section evaluation (FSB), with residual. frozen section tissue submitted in cassette B1, and remaining tissues submitted. entirely in cassette B2. The specimen has been submitted in its entirety. Part C is received additionally labeled ""left neck dissection"" and consists of a. portion of yellow, lobulated, fibrofatty tissue as well as pink-tan. fibromembranous tissue, all of which have aggregate dimensions of 11 X 3.5 cm by. up to 2 cm. There is no additional orientation offered with the specimen, and a. lack of anatomic landmarks precludes orientation. Within these tissues, there. are thirty-three lymph node candidates that range from 0.2 to 2 cm in greatest. dimension. These lymph node candidates are submitted as follows: C1-5 five whole lymph nodes each cassette;. C6. four whole probable lymph nodes;. C7. two whole probable lymph nodes;. C8-9 one whole lymph node each cassette, each bisected. Part D is received additionally labeled ""possible parathyroid tissue (FSD)"" and. consists of a single 5 mm in greatest dimension, tan-yellow soft tissue which is. submitted for frozen section evaluation (FSD), with residual frozen section. tissue submitted in cassette D. Part E is received additionally labeled ""total laryngectomy, right. hemithyroidectomy."". Specimen/procedure: The specimen is the product of a total laryngectomy to. include right lobe of thyroid. Received: The specimen is received initially fresh and placed in formalin. Aggregate specimen dimensions: The specimen has overall dimensions of 11 x 6 X. 6 cm and includes hyoid bone, right lobe of thyroid with associated right. paralaryngeal soft tissues, anterior soft tissues to include site of stoma, and. left paralaryngeal soft tissues. Tumor: Site: The specimen has been previously incised on its posterior aspect and. reveals a large fungating mass arising on the right lateral wall of the larynx. having exophytic dimensions of 4.4 x 3 x 1.1 cm. Traverses midline: No however it does abut the midline. Size and appearance of lesion: This mass is a tan-white exophytic mass. Depth of invasion: This lesion invades laterally for a depth of 2 cm and. anteriorly for a depth of 1 cm. Extension into: Cartilage/Preepiglottic space: It ablates the right aspect of the. thyroid cartilage, abuts and pushes the preepiglottic space with possible. involvement deferred to microscopic analysis (see cassettes E6-7). Hyoid: It abuts the hyoid bone with possible involvement deferred to. microscopic analysis. Pyriform, thyroid, aryepiglottic: The right piriform sinus is abutted. by tumor without gross evidence of direct extension. Focality: This is a singular focus mass. Margins: The lesion approaches to within 3 mm of the epiglottic superior margin. and to within 2 mm at its right of center (see cassette E2). This mass ablates. the false vocal cord as well as ventricle and abuts the true vocal cord right. side. The left true, false and ventricle components appear uninvolved. Additionally, this mass approaches to within 4 cm of the distal margin of. surgical resection and 0.5 cm from the right lateral margin of surgical. resection. It does not appear to involve the right lobe of the thyroid. Lymph nodes: There are no lymph nodes grossly identified. Other gross findings: No other masses are grossly identified. Block List. Section are submitted as follows: E1. midline epiglottis;. E2. epiglottis right of midline;. E3 stoma;. E4-5 hyoid bone and thyroid cartilage/calcified following. decalcification;. E6-7. sections of right lateral pharyngeal mass to include preepiglottic. space;. E8-9. right and left piriform sinuses, respectively;. E10-11 right and left ventricle, true and false cords;. E12. uninvolved thyroid gland. See also gross photographs. Part F is received additionally labeled ""right tongue base margin (FSF)"" and. consists of multiple fragments of pink-tan, irregular soft tissue having. aggregate dimensions of 1.4 x 0.8 x 0.2 cm, submitted for frozen section. evaluation (FSF), with residual frozen section tissue submitted in cassette F. Part G is received additionally labeled ""right tongue base margin #2 (FSG)"" and. consists of a crescentic portion of pink-tan soft tissue which is 1.3 x 1.2 x. 0.3 cm, submitted for frozen section evaluation (FSG), with residual frozen. section tissue submitted in cassette G. Part H is received additionally labeled ""right superior pharyngeal margin (FSH)"". and consists of a single 1 cm in greatest dimension, tan-yellow, irregular soft. tissue which is submitted for frozen section evaluation (FSH), with residual. frozen section tissue submitted in cassette H. Part I is received additionally labeled ""right inferior pharyngeal margin (FSI)"". and consists of a crescentic portion of tan-yellow soft tissue, 1.5 cm in. greatest dimension, submitted for frozen section evaluation (FSI), with residual. frozen section tissue submitted in cassette I. Part J is received additionally labeled ""post cricoid margin (FSJ)"" and consists. of two portions of tan-yellow soft tissue having aggregate dimensions of 5 x 1.2. X 0.3 cm and submitted for frozen section evaluation (FSJ), with residual frozen. section tissue submitted in cassette J. Part K is received additionally labeled ""left inferior pharyngeal margin (FSK)"". and consists of two portions of tan-yellow, irregular soft tissue having. aggregate dimensions of 0.8 x 0.8 X 0.2 cm, submitted for frozen section. evaluation (FSK), with residual frozen section tissue submitted in cassette K. Part L is received additionally labeled ""left superior pharyngeal margin (FSL)"". and consists of tan-yellow, irregular soft tissues which are 1.1 x 0.8 x 0.3 cm,. submitted for frozen section evaluation (FSL), with residual frozen section. tissue submitted in cassette L. Part M is received additionally labeled ""left tongue base (FSM)"" and consists of. a crescentic portion of pink-tan soft tissue, 1.5 X 1 x 0.3 cm, submitted for. frozen section evaluation (FSM), with residual frozen section tissue submitted. in cassette M. Part N is received additionally labeled ""tracheal margin (FSN)"" and consists of. two strips of tan-yellow soft tissue, 1 and 1.5 cm, not otherwise designated,. submitted for frozen section evaluation (FSN), with residual frozen section. tissue submitted in cassette N. Part O is received additionally labeled ""right tracheal esophageal groove"" and. consists of a portion of yellow, lobulated, fibrofatty tissue, 4.5 x 3.2 cm by. up to 1 cm with no additional orientation offered or possible. Within these. tissues, there are eleven probable lymph nodes that range from 0.3 to 0.9 cm in. greatest dimension. These lymph node candidates are submitted as follows: O1. five whole probable lymph nodes;. O2. four whole probable lymph nodes;. O3. two whole probable lymph nodes. Microscopic Description: The laryngectomy specimen reveals an invasive keratinizing squamous cell. carcinoma with numerous keratin pearls and with focal areas of more pronounced. nuclear pleomorphism and a high mitotic rate. The margins of resection are. negative for invasive carcinoma. (Age: ) Gender: M.",T2,N0,M0,T2N0M0
TCGA-IB-A5SQ,"Note: If you do not see ""END OF PRINTED REPORT"" at the bottom of t. the report YOU DO NOT HAVE THE ENTIRE REPORT. Please try pri. CONFIDENTIAL. Relevant. Information. Demographics. Date of Birth. (for verification. purposes). Sex: F. Collected Date/Time. Received Date/Time. Specimen Description. A. Biopsy lesion L- liver at. B. Gallbladder at. C. Proximal bile duct margin at. D. Pancreatic margin at. E. Superior mesenteric lymph node at. F. Whipple's specimen at. Clinical Information. Pancreatic mass. Diagnosis. Liver, (Left), Biopsy: Benign sclerctic lesion; consistent with sclerotic. hemangioma. B. Gallbladder, Cholecystectomy: Unremarkable gallbladder with no evidence of malignancy. C. (Proximal Bile Duct Margin), Biopsy: Benign bile duct tissue. D. Pancreas, (Margin), Biopsy: Benign pancreatic tissue. E. Lymph Node, (Superior Mesenteric), Excision: One benign lymph node (0/1). F. Duodenum and Head of Pancreas, Whipple Resection: Moderately differentiated adenocarcinoma of the pancreas. measuring 2.5 cm (see synoptic report for details). Synoptic Report. F: Pancreas (Exocrine) , Microscopic. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades ampulla of Vater or sphincter of Oddi. Tumor invades duodenal wall. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 3.0. mm. Specified margin: pancreatic. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy) : Not known. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. REGIONAL LYMPH NODES (pN) : pNO: No regional lymph node metastasis. Number examined: 9. Number involved: 0. CLINICAL HISTORY: Not specified. COMMENT (S) : Lymph node count includes the superior mesenteric lymph node (submitted separately as. Gross Description. Received are specimens A t. TA. All requisitions and specimen containers are labelled. with the patient's name,. 1. The cassettes and AP identifiers are labelled with. the Surgical Number. A. Specimen is received fresh for frozen section labelled as ""biopsy lesion left liver"". 0.7 x 0.6 x 0.2 cm piece of white to yellow tissue. All frozen. B. Specimen is received fresh for frozen section labelled as ""gallbladder"" and consists. of a cholecystectomy specimen measuring 9.0 x 4.8 x 2.5 cm. The serosal surface is. unremarkable. On opening, the gallbladder contains thick green bile but no stones. The mucosal surface. green and velvety. Representative sections are submitted in B1. C. Specimen is received fresh for frozen section labelled as ""proximal bile duct margin"". 0.6 x 0.3 x 0.1 cm strip tan tissue. Totally frozen. D. Specimen is received fresh for frozen section labelled as ""pancreatic margin"". 0.8 x 0.4 x 0.2 cm tan fragment. Totally frozen. E. Specimen is received fresh labelled as ""mesenteric lymph node"" and consists of a firm. tan lymph node covered by fat which measures 1.0 x 0.8 x 0.5 cm, submitted in toto in one. cassette. F. Specimen is received fresh labelled as ""whipple's specimen"" and consist of a resection. of the distal stomach, proximal duodenum and head of pancreas. The distal gastric portion. measures 2.0 cm with a circumference of 3.0 cm. It is unremarkable. The ampulla is. identified which has somewhat prominent circumferential thickening. The proximal small. bowel measures 18.0 cm in length with a uniform circumference of 5.0 cm. The head of. pancreas section measures 6.0 x 4.0 x 2.0 cm. The resection margin is inked with blue ink. On sectioning, just deep to the ampulla is a. firm poorly defined white yellow mass measuring 2.0 x 2.5 x 2.3 cm. It is closely opposed. to the deep pancreatic margin but is not seen to extend beyond the pancreas. The. surrounding pancreas is otherwise unremarkable. F1. - proximal margin. F2. - distal margin. F3. - pancreatic margin. F4. - normal stomach. F5. - normal small bowel. F6-9. - pancreatic tumor. F10. - normal pancreas. F11, 12, 13 - potential lymph nodes. Frozen Section Diagnosis. A. Biopsy Lesion Left Liver: - Benign sclerotic nodule, probable old hemangioma. Conf # 54. C. Proximal Bile Duct Margin: - Benign bile duct tissue. Conf # 57. D. Pancreatic Margin: - Benign cauterized pancreatic tissue. Conf # 58. Number. Encounter. Number. Patient Location. - END OF PRINTED REPORT -.",T2,N0,M0,T2N0M0
TCGA-AR-A2LE,"Final Diagnosis. Breast, right, excision: Infiltrating lobular carcinoma, Nottingham I (of. III) forming a 1.6 x 1.5 x 1.3 cm mass (AJCC pT1c) The carcinoma shows. ductular involvement. No angiolymphatic involvement is present. The. surgical resection margins, including the separately submitted margins,. are negative for tumor. Lymph nodes, right sentinel, excision: Negative for tumor. Immunohistochemical cytokeratin stain was performed on the paraffin. embedded sentinel lymph node tissue and confirms the H&E impression. The infiltrating breast carcinoma is positive for estrogen receptor and. negative for progesterone receptor.",T1,N0,M0,T1N0M0
TCGA-E9-A1NA,"BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 2.4 X 2.4 X 2.4 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal and lobular carcinoma. Histologic grade: Tumor extent: Not specified. Lymph nodes: 0/11 positive for metastasis ( 0/11). Extracapsular invasion of the lymph nodes: Not specified. Left,lower. outer. Margins: Not specified. quadrant. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments; None.",T2,N0,M0,T2N0M0
TCGA-CG-4306,"Diagnosis: I) shows liver metastases of a poorly differentiated carcinoma,. in II) there is a lymph node metastasis of a poorly differentiated carcinoma and. in III) gastric resection material showing parts of an invasive of a poorly differentiated. carcinoma with infiltration of all parietal layers extending to the serosa and also lymph node. metastases. The immediate resection margins of the material described under III) in the region of the. mucosa were tumor-free. Tumor classification: ICDO-DA M. 8140/3. pT3,. pN2,. L1,V1,. pM1.",T3,N2,M1,T3N2M1
TCGA-DC-4745,"Addendum. Clinical Diagnosis & History: Rectosigmoid adenocarcinoma,. Specimens Submitted: 1: SP; Sigmoid and upper rectum. 2: SP: Proximal anastomotic ring. 3: SP: Distal anastomotic ring. DIAGNOSIS: 1). SIGNOID AND UPPER RECTUM; PARTIAL COLECTOMY: INVASIVE ADENOCARCINOMA, MODERATELY DIFFERENTIATED. TUMOR LOCATION: RECTOSIGMOID. - TUMOR SIZE, LENGTH IS 3 CM, WIDTH IS 3 CM AND MAXIMAL THICKNESS IS 0.6 CM. - PREEXISTING POLYP (AT THE SITE OF THE CARCINOMA) : NOT IDENTIFIED. - TUMOR INVASION: INVASION INTO SUBSEROSA. - SEROSAL INVOLVEMENT: NOT IDENTIFIED,. - VASCULAR INVASION: NOT IDENTIFIED,. - PERINEURAL INVASION: NOT IDENTIFIED. - SURGICAL MARGINS: FREE OF TUMOR, 3 CM PROM THE DISTAL RESECTION. MARGIN; 3 CM BETWEEN DEEPEST TUMOR PORTION AND DEEP (RADIAL SOFT TISSUE). MARGIN. - POLYPS (AWAY FROM THE CARCINOMA) : NOT IDENTIFIED. - NON-NEOPLASTIC BOWEL: UNREMARKABL. - THE PATHOLOGIC STAGE IS. pT3. LYMPH NODES: NUMBER WITH METASTASES (1), NUMBER EXAMINED (22). - THE PATHOLOGIC STAGE IS. : pN1. - THE RESULTS OF IMMUNOHISTOCHENICAL. STAINS FOR MISMATCH REPAIR. PROTEINS WILL BE REPORTED IN AN ADDENDUM. 2). COLON, ANASTOMOTIC RING, PROXIMAL; EXCISION: - SEGMENT OF COLON WITH NO PATHOLOGIC DIAGNOSIS. 3). RECTUM, ANASTOMOTIC RING, DISTAL; EXCISION: - SEGMENT OF COLON WITH NO PATHOLOGIC DIAGNOSIS. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. 1).The specimen is received fresh and is labeled ""sigmoid and upper rectum,. stitch marks proximal. It consists of. a rectosigmoid colon that measure. 16.0 x 5.0 x 0.6 cm, The sexosal surface is tan-pink, smooth and grossly. unremarkable, The radial resection margin and serosa are inked black. Specimen is opened to reveal a tumor that is located 10.0 em from the. proximal margin and 3,00m from the distal margin. The tumor measures 3.0. en. in length and 3.0 cm in width. Serial Bectioning reveals tumox is 0.6 cm in. depth and is .0cm from the closest radial margin. There is no muscular. invasion grossly. The remaining mugosa is tan-pink and grossly unremarkable. Perioolio and peri-rectal adipose tissue is thoroughly examined for lymph. nodes, and all possible nodes are submitted. Representative sections are. submitted TPS is submitted. Summary of sections;. PM - proximal margin. DM - distal margin. RM - radial margin. T tumor. U - uninvolved mucosa. LN - lymph nodes. 2) The specimen is received in formalin, labeled ""proximal anastomotic. ring"" and consists of a silver metal anastomotic pin measuring 7.5 x 2.8 x. 1.5 cm. At the center of the pin, a ,Sem long blue plastic piece is noted,. A ring of pink tan soft tisque is attached measuring 1.8cm in diameter and. 1. .2cm in length. The mugosal surface is pink tan and focally hemorthagic. and the serosal surface is pink tan and smooth, Several sutures and staples. are noted. The sutures and staples are removed and the representative. section of soft tissue is submitted. Summary of sections: U - undesignated. 3) The specimen is received in formalin, labeled ""distal anastomotic donut"". and consists of a ring of pink tan soft tissue measuring 1.7x1,5x1.0 Cm. Multiple sutures and staples are attached. The mucosal surface is pink tan. and focally hemorrhagic. The sutures and staples are removed and. representative section of soft tissue ig submitted,. Summary of sections: U - undesignated. Summary of Sections: 1: SP: Sigmoid and upper rectum. Sect. site. PCs. Block. 5. {not entered). DM. 1. LN. 18. 6. 1. PM. 1. Part. 2: SP: Proximal anastomotic ring. Block. Seot. site. PCs. 1. Part. 3: SP: Distal anastomotic ring. Sect. site. PCa. Block. 1. 1. Addendum Diagnosis. Results of imenunohistochemical staining for DNA mismatch repair proteins are. as follows: MLH1: (x ) Staining present in tumor. ( ) staining absent in tumor. ) Staining inconclusive. MSH2: (x ) staining present in tumor. ( ) staining abgent in tumor. ) staining inconclusive. MSH6: (X ) staining present in tumor. ( ) Staining absent in tumor. ( ) Staining inconclusive. PMS2: (x) Staining present in tumor. ( ) staining absent in tumor. { ) staining inconclusive. Conclusion: - Inmunohistochemical staining for the tested DNA mismatch repair proteins. is retained in the tumor. Some of the immunohistochemistry and ISH tests were developed and their. performance characteristics were detexmined by the bepartment of Pathology. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not. be regarded as investigational or for research, This laboratory is certified. under the Clinical Laboratory Improvement. as. qualified to perform high complexity clinical laboratory testing,.",T3,N1,M0,T3N1M0
TCGA-IB-AAUN,"CONFIDENTIAL. Demographics (for. verification purposes). Sex: F. Collected Date/Time. Received Date/Time. Specimen Description. A. Lymph node of group A at. B. Bile duct margin at. c. Whipple's specimen at. D. Portal vein margin at. Clinical Information. Pancreatic mass- head of pancreas. Diagnosis. A. Lymph nodes, group A, excision: - Seven lymph nodes, negative for malignancy (0/7). B. ""Bile duct margin"", excision: - Benign bile duct with focal acute inflammation and reactive changes. - Negative for malignancy. C. ""Whipple's specimen"": - Invasive ductal adenocarcinoma, moderately differentiated, 2.3 cm, see. synaptic report. - Margins of resection negative (0.1 cm away from the nearest distal. pancreatic margin and 0.1 cm away from the nearest uncinate margin). - Extensive perineural invasion. - Tumor extends to the vascular bed edge of the specimen, see comment. - Eight peripancreatic lymph nodes, negative for malignancy (0/8). D. Portal vein margin, Excision: - Negative for carcinoma. Verified: Synoptic Report. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor is confined to pancreas. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1. mm. Specified margin: Uncinate and distal pancreatic margins. LYMPH-VASCULAR INVASION: Not identified. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. REGIONAL LYMPH NODES (pN) : pNO: No regional lymph node metastasis. Number examined: 15. Number involved: o. Gross Description. Received are specimen containers A to T. nin requisitions and specimen containers are. labelled with the patient's name,. The cassettes and identifiers are. labelled with the Surgical Number. A. Specimen is received in formalin. The container is designated ""A: Lymph node of group. A"". The specimen consists of a fibrofatty soft tissue measuring 2.2 x 1.7 x 0.7 cm. In. consists of four potential lymph node candidates, measuring 0.5 to 1.1 cm in maximum. diameter. Specimen is submitted as follows: A1. four lymph node candidates. A2. three lymph node candidates. B. The specimen consists of irregularly shaped fragment; 1.2 x 0.5 x 0.3 cm. There is an. edge that possibly represents the bile duct wall, but no circular structure is present. Submitted in toto in one cassette. Specimen is received fresh. The container is designated ""B: Bile duct margin"". The. specimen contains an irregularly shaped fragment of soft tissue, measuring 1.2 x 0.5 x. 0.3 cm. There is an edge that represents a possible epithelial duct wall, but no circular. structures present. The specimen is entirely submitted for frozen section diagnosis. C. Specimen is received fresh. The container is designated ""C: Whipple's specimen"". It. consists of a Whipple resection specimen including duodenum, head of the pancreas, and. common bile duct stump. The proximal margin of the specimen measures 6.0 cm in. circumference. The inferior margin measures 5.0 cm (circumference). The duodenum is 25.0. cm in length, 4.5 cm in average circumference and 0.4 cm in wall thickness. The pancreas. measures 3.8 x 3.5 x 2.5 cm. The common bile duct stump is 6.1 cm in length and 1.2 cm in. diameter at the margin. The specimen is inked as follows: pancreatic body margin. (distal) - blue, uncinate process- orange, vessel bed area- black. When opened, the. duodenal mucosa is velvety and grossly unremarkable. The ampulla of vater is identified. and is open to show a 1.2 cm diameter ampulla. Serial sectioning of the pancreas reveals. a mass measuring 2.3 x 2.1 x 1.8 cm with non-homogenous white-tan cut surface. The mass. is. located. approximately 1.2 cm away from the duodenal wall and grossly abutting blue and. orange resection margins. The uninvolved pancreas is pink/tan. Multiple lymph nodes are. identified in the soft tissue around the pancreas, measuring 0.3 to 1.1 cm in greater. dimension. One node shows hemorrhagic changes. Representative sections of the specimen. are submitted as follows: C1. proximal bile duct margin, cross section. C2 to 4. distal pancreatic margin, posterior to anterior. C5. representative proximal gastric/ duodenal margin. C6. representative distal duodenal margin. C7/8. mass with uncinate margin. C9. representative section of common bile duct, cross section. C10 to 16. mass with the closest common bile duct (C10-11 contiguous sections). C17. uninvolved pancreas. C18. hemorrhagic nodule. C19/20. six lymph node candidates (three lymph nodes each). C21. two lymph node candidates. D. Specimen is received in formalin. The container is designated ""D: Portal vein. margin"". It consists of an unorientated fragment of soft tissue measuring 1.5 x 1.0 x 0.3. cm. The specimen is bisected and submitted entirely in cassette D1. Frozen Section Diagnosis. B. Bile Duct Margin: Negative for malignancy. Frozen Section Microscopic. B. Prominent inflammation; loss of surface epithelium; and reactive changes in periductal. glands. Pathologist Comment. The tumor extends into the black inked edge of the specimen designated as vascular bed. However, a separate portal vein margin is separately submitted (specimen D) which is. negative for malignancy. Encounter Number. Patient Location.",T2,N0,M0,T2N0M0
TCGA-BP-4353,"Clinical Diagnosis & History: Left renal mass; patient with history of lymphoma. Specimens Submitted: 1: KIDNEY, LEFT; PARTIAL NEPHRECTOMY. DIAGNOSIS: 1. KIDNEY, LEFT; PARTIAL NEPHRECTOMY: Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade II/IV. Tumor Size: Greatest diameter is 3.g cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Exhibits mild focal interstitial fibrosis. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. JATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (ANDIOR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The spacimen is received fresh for frozen section consultation and is labeled ""left renal mass"". Il consists of a 7.7: x 4.8 x 4.7 cm. wedge shaped portion of kidney with 10.5 x 7.5 X 2,5 cm of overlying perirenal fat. The margin is inked black and the specimen is. serially sectioned to reveal a well-circumscribed golden yellow focally hemormhagic and cystic cortical mass measuring 3.9 x 3.1 X. 2.5 cm. The tumor does not appear to grossly infiltrate the overlying fat. The clearance from the resection margin is 0.6 cm. sectioning through the attached fat reveals no gross abnormalities. A representative section of the nearest margin is submitted for. frozen section diagnosis. Representatively submitted. Photographs are taken, Portions of the tumor are submitted for. Summary of sections: FSC - frozen section control. T tumor. M margin. RS - representative sections. Summary of Sections: Part 1: KIDNEY, LEFT; PARTIAL NEPHRECTOMY. Block. Sect. Site. PCs. fsc. 1. 3. M. 3. 2. RS. 2. 4. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: RENAL CELL CARCINOMA, MARGIN NEGATIVE ON REPRESENTATIVE. SECTION. PERMANENT DIAGNOSIS: SAME.",T1,N0,M0,T1N0M0
TCGA-CZ-4859,"Report Status: Amend/Addenda. Type: Surgical Pathology. Specimen Type: Kidney, partial or total resection. Procedure Date: Resident : Pathologis. PATHOLOGIC DIAGNOSIS: RIGHT KIDNEY, NEPHRECTOMY (including FSA) : RENAL CELL CARCINOMA, (5.0 cm) clear cell type, Fuhrman grade 2 ((of 4) . Tumor is confined to the kidney. No LVI is identified. Vascular and ureteric margins of resection are negative for tumor. AJCC Classification (6th Edition) : T1 NO MX. Special stains to assess adjacent uninvolved renal parenchyma will be performed. and results will be issued as an addendum. CLINICAL DATA: History: Not provided. Operation: Hand assisted laparoscopic right nephrectomy. Clinical Diagnosis: Right renal mass. TISSUE SUBMITTED. A/1. Right kidney - Frozen section. O.R. CONSULTATION: SPECIMEN LABELED ""HI. RIGHT KIDNEY"" (FSA) : Renal cell carcinoma. OR Consultation bv: Resident. The senior physician certifies that he/she personally conducted a gross and/or. microscopic examination of the described specimen (s) and rendered or confirmed. the rapid diagnos (es) related thereto,. GROSS DESCRIPTION: The specimen is received fresh, labeled with the patient?s name, unit number,. and ""#1. Right kidney"", and consists of a 313.5 gm right kidney that measures. 11.0. x 6.5 x 4.3 cm with a ureter (8.8 x 0.3 cm), stapled renal vein (2.1 x 1.2. cm), and renal artery (3.5 x 0.3 cm) The specimen is inked and bivalved. to. reveal a 5.0 x 4.3 x 2.5 cm a well-circumscribed tan/yellow, focally cystic. mass that is approximately 9.0 cm to ureter, 2.0 cm to the vein, and 1.8 cm to. the renal artery. The tumor does not grossly appear to involve the renal vein. Tumor appears confined to the kidney. Representative section of the tumor is. submitted as FSA. In addition, a representative section is sent for. Cytogenetics, EM, and tissue banking. A representative section of the normal. kidney is sent for EM, IF, and tissue banking. Micro A1: FSA remnant, 1 frag,. Micro A2: Vascular and ureteral margins, 3 frags,. Micro A3: Contents of cassette labeled ""T1"" (received along with FSA remnant) ,. 2 frags,. Micro A4: Tumor capsule and perirenal fat, 1 frag,. Micro A5: Additional tumor with respect to renal capsule, 2 frags,. Micro A6: Tumor and adjacent normal kidney, 1 frag,. Micro A7: Normal kidney, 1 frag,. By his/her signature below, the senior physician certifies that he/she. I report. personally conducted a microscopic examination (""gross only"" exam if so. stated). of the described specimen (s) and rendered or confirmed the diagnosis(esf. related thereto. Resident Review by. Final Diagnosis by. ADDENDUM. RENAL PATHOLOGY EVALUATION OF NON-NEOPLASTIC KIDNEY PARENCHYMA. RIGHT KIDNEY, NEPHRECTOMY: MINIMAL CHRONIC CHANGES OF THE KIDNEY PARENCHYMA, MOST LIKELY AGE-. RELATED (SEE NOTE). NOTE: The non-neoplastic renal parenchyma sample examined shows minimal chronic. changes, within the expected rnge for a. year-old woman. There is. minimal focal global glomerulosclerosis involving 2.0% of glomeruli, minimal. tubular atrophy and interstitial fibrosis (less than 10% of the parenchyma),. and a mild degree of arterial sclerosis. The non-neoplastic kidney parenchyma has been reviewed by Dr. Renal Pathologist. MICROSCOPIC DESCRIPTION: Sections of formalin-fixed paraffin-embedded tissue (block A7) were evaluated. using HE, PAS, Jones silver methenamine, and trichrome (AFOG) stains. The. sample consists of cortex and medulla. There are 245 glomeruli present, of. which 5 (2.0%) are globally sclerosed. The remaining glomeruli show a very. mild expansion of the mesangial areas by extracellular matrix material. The. basement membranes show no significant craters or double contours. Rare distal. tubules contain PAS-positive hyaline casts, Less than 10% of the cortical. parenchyma shows tubular atrophy and interstitial fibrosis. The arteries. exhibit mild subintimal sclerosis. Tathology Report. Report Status. Type: Cytogenetics. KARYOTYPE: see interpretation. METAPHASES COUNTED: 0. ANALYZED: 0. SCORED: 0. BANDING: GTG. INTERPRETATION: No metaphases were available from this specimen, therefore the cytogenetic. analysis could not be performed. INDICATION FOR TEST: ? RCC.",T1,N0,M0,T1N0M0
TCGA-AA-A00R,"Cample ID #. Diagnosis: 1.: Tumor-free lipomatous atrophic lymph node. 2.: Right hemicolectomy specimen with tumor-free resection margins and under inclusion. of an ulcerated, malignant, solid tumor in the cecum, conforming to the type of a poorly. differentiated adenocarcinoma, with infiltration of the lamina muscularis propria and. without regional lymph node metastases (G3, pT2 L0 V0 R0 pN0 0/27). Additional immunohistological investigations are being conducted due to the histological. peculiarities of the tumor. A follow-up report on this will be submitted at a later date. Follow-up report: From an immunohistological perspective, the tumor cells were positive for broad-. spectrum cytokeratins. Large numbers of CD3-positive and CD20-negative or T-. lymphocytes are also interspersed. Based on the histology and immunohistology, this is thus a poorly differentiated. colorectal adenocarcinoma, or cecum carcinoma, with a dense lymphocytic stromal. infiltrate. The poor tumor differentiation and the dense lymphocytic inflammatory infiltration may. be indicators of the presence of a microsatellite unstable (possibly HNPCC-associated). colorectal carcinoma.",T2,N0,M0,T2N0M0
TCGA-2H-A9GF,"Coded sample ID: Histologic diagnosis: poor differentiated adenocarcinoma. Anatomic site with laterality: distal esophagus. Tumor size: diameter 7,0 cm. Lymph node status: 7 positive lymph nodes. Any comments or amendments: irradical resection.",T3,N1,M0,T3N1M0
TCGA-BT-A20Q,"PATIENT HISTORY: Clinical history is not given. PRE-OP DIAGNOSIS: Bladder cancer. POST-OP DIAGNOSIS: Same. PROCEDURE: Cystoprostatectomy / neobladder construction. ADDENDA: Addendum. Multiple additional deeper levels were evaluated from the right distal ureteral margin (part 4). These deeper sections show. fibrovascular, neural and adipose tissue. No lining urothelial Is seen. No evidence of urothelial carcinoma nor urothelial. carcinoma in situ (CIS) are seen. This completes my current evaluation of this case. The diagnoses rendered earlier remain unchanged. Thank you for. involving us in the care of this patient. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, EXCISION -. A. METASTATIC CARCINOMA IN ONE OF ELEVEN LYMPH NODES (1/11). B. NO EXTRACAPSULAR EXTENSION PRESENT. PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. A. METASTATIC CARCINOMA IN THREE OF TWELVE LYMPH NODES (3/12). B. EXTRACAPSULAR EXTENSION PRESENT. PART 3: BLADDER, PROSTATE AND BILATERAL SEMINAL VESICLES, RADICAL CYSTOPROSTATECTOMY -. A. INVASIVE UROTHELIAL CARCINOMA (3.3 CM), HIGH GRADE (WHO/ISUP), GRADE 3 OF 4 (ASH). B. THE CARCINOMA"" EXTENDS INTO THE PERIVESICAL ADIPOSE TISSUE. C. THE INKED PERIVESICAL SOFT TISSUE SURGICAL MARGIN IS INVOLVED VERY FOCALLY IN THE LEFT TRIGONE/. LEFT LATERAL WALL REGION OF THE BLADDER (SLIDE 3C). D. METASTATIC ADENOCARCINOMA IN ONE OF ONE LEFT PERIVESICAL LYMPH NODES (1/1). E. NO CARCINOMA IN SITU (CIS) IDENTIFIED. F. ANGIOLYMPHATIC INVASION IDENTIFIED. G. TNM PATHOLOGIC STAGING = T3b N2 MX. H. TNM HISTOPATHOLOGIC GRADE = G3. I. BENIGN PROSTATIC TISSUE WITH FOCAL CHRONIC INFLAMMATION. PART 4: URETER, RIGHT DISTAL, BIOPSY -. A. BENIGN FIBROADIPOSE TISSUE. B. NO TUMOR PRESENT. MICROSCOPIC: SYNOPTIC DATA - PRIMARY URINARY BLADDER TUMORS. SPECIMEN TYPE: Radical cystoprostatectomy. TUMOR SITE: Trigone. Left lateral wall. TUMOR SIZE: Greatest dimension: 3.3 cm. HISTOLOGIC TYPE: Urothelial (transitional cell) carcinoma. ASSOCIATED EPITHELIAL LESIONS: None identified. HISTOLOGIC GRADE: Urothelial carcinoma - High-grade. TUMOR CONFIGURATION: Solid/nodule, Ulcerated. PATHOLOGIC STAGING (pTNM): pT3b. pN2. Number of nodes examined: 23. Number of nodes involved: 4. pMX. MARGINS: Margin(s) involved by invasive carcinoma. Margin(s): left utereal. VENOUS/LYMPHATIC (LARGE/SMALL) VESSEL INVASION (V/L): Present. DIRECT EXTENSION OF INVASIVE TUMOR: Perivesical fat. ADDITIONAL PATHOLOGIC FINDINGS: Inflammation/regenerative changes.",T3,N2,M0,T3N2M0
TCGA-BF-AAP6,"Male. Clinical diagnosis: Melanoma. Gross description: The material presented - skin flap from right leg. Microscopic description: Skin and fat flap 15x8 cm with dark-brown mushroom formation of 4x3 cm wide. leg 2 cm thick mushroom shape epithelioid melanoma with ulceration, Breslow -. 20 mm, Clark - IV. Stage III, T4. N2, MO. Final diagnosis: Epithelioid cell melanoma. Confidential.",T4,N2,M0,T4N2M0
TCGA-50-5932,"PRE-OP DIAGNOSIS: Right lung mass. POST-OP DIAGNOSIS: Same. PROCEDURE: Right upper lobectomy, mediastinoscopy, lymph node dissection. FINAL DIAGNOSIS: PART 1: LUNG, RIGHT UPPER LOBE, LOBECTOMY -. A. WELL DIFFERENTIATED ADENOCARCINOMA WITH BRONCHIOALVEOLAR FEATURES (4.2CM; see. comment). B. THE NEOPLASM ABUTS THE VISCERAL PLEURA BUT DOES NOT PENETRATE IT. .(see comment). C. BRONCHIAL, VASCULAR AND PARENCHYMAL MARGINS ARE FREE OF NEOPLASM. D. EMPHYSEMATOUS CHANGES OF THE NON NEOPLASTIC LUNG. E. ONE OF SEVEN PERIHILAR LYMPH NODES WITH METASTATIC ADENOCARCINOMA; NO EXTERNAL NODE. SPREAD IS PRESENT (1/7). F. TNM PATHOLOGIC STAGE: T2; N1; MX. G. HISTOPATHOLOGIC GRADE = G1. PART 2: LYMPH NODES, PERIBRONCHIAL, SITE IS NOT SPECIFIED, EXCISION -. A. FOUR BENIGN LYMPH NODES. B. NEGATIVE FOR NEOPLASIA (0/4). PART 3: LYMPH NODES, PERIAORTIC AND PERIAZYGOS, EXCISION -. A. SEVEN BENIGN LYMPH NODES,. NEGATIVE FOR NEOPLASIA (0/7). COMMENT: Special stains performed on a section of the neoplasm showed neoplastic cells strongly positive for cytokeratin 7 and. negative cytokeratin 20 and thyroid transcription factor(TTF (-) probably due to technical problems). Special stain for. mucin (PAS with and without diastase) were positive for intracellular mucin. The histologic features and the pattern of. immunostaining is compatible with a primary adenocarcinoma (mucinous BAC) of the lung. Elastic stain showed no. invasion of the elastic layer of the visceral pleura. SYNQPTIC - PRIMARY LUNG TUMORS. A. Location: 1. 1. RUL. 3. RLL. 5. LUL. 2. RML. 4. LLL. 6. Bronchus intermedius. B. Procedure: 2. 1. Wedge/Segmental. 3. Bilobectomy. 2. Lobectomy. 4. Pneumonectomy. C. Size of tumor (maximum dimension): 4.2 cm. D. Satellite nodules: 2. 1. yes. 2. No. D1. If yes, Where: #. 1. Same lobe. 2. Psilateral lobes. 3. Central lobe. E. Type: 3. 1. Invasive squamous carcinoma. 11. Fetal type adenocarcinoma. 2. Basaloid squamous carcinoma. 12. Small cell carcinoma. 3. Invasive adenocarcinoma. 13. Carcinoid. 4. Bronchioloalveolar carcinoma, nonmucinous type. 14. Atypical carcinoid. 5. Bronchioloalveolar carcinoma, mucinous type. 15. Sarcoma. 6. Large cell carcinoma. 16. Adenosquamous carcinoma. 7. Clear cell carcinoma. 17. Mixed non-small cell carcinoma, NOS. 8. Giant cell carcinoma. 18. Carcinosarcoma. 9. Sarcomatoid carcinoma. 19. Other. 10. Blastoma. F. Architectural grade: 1. 1. well. 2. moderate. 3. poor/undifferentiated. G. Nuclear grade: 1. 1. Low. 2. Intermediate. 3. High. H. Central VS. peripheral origin: 1. 1. yes. 2. no. I. Visceral pleural invasion through elastica: 2. 1. yes. 2. no. J. Parietal pleural invasion: 2. 1. yes. 2. no. K. Chest wall invasion (into skeletal muscle or soft tissue): 2. 1. yes. 2. no. L. Angiolymphatic invasion: 2. 1. yes. 2.no. M. Necrosis: 1. 1. 50%. 2. >>50%. N. Surgical margins involved: 2. 1. yes. 2. no. O. Inflammatory (desmoplastic) reaction: 1. 1. mild. 2. moderate. 3. severe. P. Hilar lymph node involvement (N1 nodes): 1. 1. yes. 2. no. Q. If hilar lymph nodes involved, number of positive lymph nodes: 1/7. R. Total number of hilar lymph nodes examined: 2. S. Extracapsular spread of hilar lymph node metastases: N/A. 1. yes. 2. no. T. Mediastinal nodes involved: 2. 1. yes. 2.no. 3. not applicable. U. Mediastinal node group(s) involved (N2 nodes): #/#/#/#/#/ #. 1. Level 4R. 4. Level 7R. 7. Level 4L. 10. Level 7L. 2. Level 5R. 5. Level 9R. 8. Level 5L. 11. Level 9L. 3. Level 6R. 6. Level 10R. 9. Level 6L. 12. Level 10L. V. Number of positive mediastinal nodes: NA. W. Total number of mediastinal nodes examined: 7. X. Extracapsular spread of mediastinal lymph node metastases: NA. 1. yes. 2. No. Y. Underlying disease(s): 1/#/#/#. 1. Emphysema. 4. Smokers bronchiolitis. 7. Pneumoconiosis, NOS. 2. Bronchiectasis. 5. Asthma. 8. Chronic interstitial pneumonia. 3. Tumorlets. 6. Parenchymal scar. Z. TNM Stage: T 1. N 1.",T2,N1,M0,T2N1M0
TCGA-CW-6087,"REVISED REPORT (Addendum/Procedure included). TISSUE DESCRIPTION: Right kidney (515 grams, 16.5 x 7.5 x 5.4 cm) with 9 cm of. attached. ureter, left adrenal gland (36.42 grams, 7.5 x 4 x 3.2. cm). paracaval lymph node (1.5 X 1.5 X 1 cm), and inter aortic. caval. lymph node (2.5 x 1 x 1 cm) . DIAGNOSIS: Kidney, right, radical nephrectomy Grade 4 (of 4) renal. cell. carcinoma, clear cell type, forming a 8.2 x 6.2 X 5.3 cm. mass. located in the inferior pole. The tumor extends into the. peripheral. perinephric fat. The renal vein is grossly free of tumor. The. tumor invades into the collecting system. Coagulative. tumor. necrosis is present. The surgical margins are negative. No renal. hilar lymph nodes are identified. Adrenal gland, left, adrenalectomy Metastatic renal cell. carcinoma. forming a mass (7.3 X 3.8 X 3 cm) within the adrenal. parenchyma. Lymph node, paracaval, excision: A single paracaval lymph. node is. positive for metastatic renal cell carcinoma. Lymph node, inter aortic caval, excision: A single inter. aortic. caval lymph node is negative for tumor. ADDENDUM: On permanent sections, sarcomatoid differentiation is. identified.",T3,N1,M1,T3N1M1
TCGA-BT-A2LB,"FINAL DIAGNOSIS: PART 1: URETER, RIGHT, MARGIN, BIOPSY -. A. SEGMENT OF URETER LINED BY BENIGN REACTIVE UROTHELIUM. B. NO UROTHELIAL CARCINOMA IN SITU (CIS) NOR INVASIVE UROTHELIAL CARCINOMA SEEN. PART 2: URETER, LEFT, MARGIN, BIOPSY -. A. SEGMENT OF URETER LINED BY BENIGN REACTIVE UROTHELIUM. B. NO UROTHELIAL CARCINOMA IN SITU (CIS) NOR INVASIVE UROTHELIAL CARCINOMA SEEN. PART 3: URINARY BLADDER, BLADDER NECK, BIOPSY -. A. BENIGN FIBROMUSCULAR TISSUE WITH FOCAL REACTIVE UROTHELIUM. B. NO EVIDENCE OF MALIGNANCY. PART 4: BLADDER, VAGINA, UTERUS, BILATERAL OVARIES AND FALLOPIAN TUBES, ANTERIOR PELVIC EXENTERATION -. A. MULTIFOCAL INVASIVE UROTHELIAL CARCINOMA, HIGH GRADE (WHO/ISUP). B. THE CARCINOMA MEASURES 2.1 CM IN GREATEST DIMENSION. C. THE CARCINOMA EXTENSIVELY INVOLVES THE DETRUSOR MUSCLE AND INVADES INTO THE PERIVESICAL. ADIPOSE TISSUE. D. ALL SURGICAL MARGINS OF RESECTION ARE FREE OF CARCINOMA. E. UROTHELIAL CARCINOMA IN SITU (CIS) IS IDENTIFIED. F. PERINEURAL INVASION IS IDENTIFIED. G. ANGIOLYMPHATIC INVASION IS IDENTIFIED (SLIDE 4G). H. UTERUS, BILATERAL OVARIES AND FALLOPIAN TUBES WITH NO SIGNIFICANT PATHOLOGIC ABNORMALITY. I. TNM PATHOLOGIC STAGING (AJCC 7 TH EDITION): pT3a NO MX. PART 5: LYMPH NODES, RIGHT PELVIC, EXCISION -. NO EVIDENCE OF MALIGNANCY IN SEVEN LYMPH NODES EXAMINED (0/7). PART 6: LYMPH NODE, LEFT PELVIC, EXCISION -. NO EVIDENCE OF MALIGNANCY IN SEVEN LYMPH NODES EXAMINED (0/7). CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY URINARY BLADDER TUMORS. SPECIMEN TYPE: TUMOR SITE: Anterior exenteration. TUMOR SIZE: Right lateral wall, Dome. Greatest dimension: 2.1 cm. HISTOLOGIC TYPE: Additional dimensions: 1.4 x 1.2 and 0.6 x 0.5 x 0.3 cm. ASSOCIATED EPITHELIAL LESIONS: Urothelial (transitional cell) carcinoma. HISTOLOGIC GRADE: None identified. TUMOR CONFIGURATION: Urothelial carcinoma - High-grade. PATHOLOGIC STAGING (pTNM): Solid/nodule, Ulcerated. pT3a. pNo. Number of nodes examined: 14. Number of nades involved: 0. MARGINS: pMX. VENOUS/LYMPHATIC (LARGE/SMALL) Margins VESSEL uninvolved INVASION by (V/L): invasive carcinoma Present. DIRECT EXTENSION OF INVASIVE TUMOR: ADDITIONAL PATHOLOGIC FINDINGS: Perivesical fat. Urothelial carcinoma in situ.",T3,N0,M0,T3N0M0
TCGA-BR-A452,"Laterality:Mucosa is ulcerated. Tumor is invasion into serosa and lymph. node. Tumor is composed of adenoid goups. Some tubules are dialated to form cyst containing necrosis. Glands are variability in size and shape. Tumor cells are moderately straitified. Mitotic index is present. Nuclei are hyperchromatic and irregularly enlarged and prominent nucleoli. Stroma is invasion of. inflammatory cells. Path Report:STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Antrum. Tumor size: 8 x 7 X 5 cm. Tumor features: Ulcerated. Histologic type: Tubular adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Serosa (visceral peritoneum). Lymph nodes: 2/4 positive for metastasis (Regional lymph node, goup vii 0/1, Regional lymph node,. goup i 0/1, Regional lymph node, goup viii 2/2). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T4,N1,M0,T4N1M0
TCGA-B0-5702,"PATIENT HISTORY;. PRE-OP DIAGNOSIS: Left kidney cancer. POST-OP DIAGNOSIS: Same. Laparoscopic nephrectomy. FINAL DIAGNOSIS: KIDNEY, LEFT, NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE WITH PROMINENT CYSTIC CHANGE,. NECROSIS AND MYXOID DEGENERATION. B. FUHRMAN NUCLEAR GRADE IS II OF IV. C. THE GREATEST DIAMETER OF THE NEOPLASM IS 5.3 cm. D. THE NEOPLASM IS CONFINED WITHIN THE RENAL CAPSULE. E. NO INVASION OF THE RENAL VEIN IS IDENTIFIED. F. NO EVIDENCE OF ANGIOLYMPHATIC INVASION IS IDENTIFIED. G. ALL SURGICAL MARGINS ARE FREE OF THE NEOPLASM. H. THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. l. TNM STAGE: pT1b NX MX. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY KIDNEY TUMORS. SPECIMEN TYPE: Other: Laparoscopic nephrectomy. LATERALITY: Left. TUMOR SITE: Upper pole. FOCALITY: Unifocal. TUMOR SIZE: Greatest dimension: 5.3 cm. Additional dimensions: 4.5x3.5 cm. MACROSCOPIC EXTENT OF TUMOR: Tumor limited to kidney. HISTOLOGIC TYPE: Clear cell (conventional) renal carcinoma. HISTOLOGIC GRADE (Fuhrman Nuclear Grade): G2. PATHOLOGIC STAGING (pTNM): pT1b. pNX. Number of regional lymph nodes examined: 0. pMX. MARGINS: Margins uninvolved by invasive carcinoma. ADRENAL GLAND: Not present. VENOUS (LARGE VESSEL) INVASION (V): Absent. LYMPHATIC (SMALL VESSEL) INVASION (L): Absent. ADDITIONAL PATHOLOGIC FINDINGS: None identified.",T1,N0,M0,T1N0M0
TCGA-DD-A3A8,"TISSUE DESCRIPTION: Gallbladder (10.3 x 5.2 x 2 cm), cm), pericholedochal lymph node (3.2 x 2.3 x 0.7. cm), spleen 165 grams, 11.2 x 6.5 x 4.2 cm) and right lobe liver (1110 grams, 17.5 x. 14.5 X 8 cm). A1, B1, C1, D1, D2, D3, D4. DIAGNOSIS: Liver, right lobe, resection: Grade 2 (of 4) hepatocellular carcinoma, usual type,. forming a multinodular 7.5 x 5.8 x 5 cm mass. The tumor is located in the right lobe. The hepatic capsule is free of tumor. The surgical margins are free of tumor, the. clearance being 0.1 cm microscopically. Extratumoral vascular invasion is not. identified. The tumor is entirely encapsulated without capsular tumor extension. Spleen, excision: Without diagnostic abnormality. Lymph node, pericholedochal, excision: A single benign lymph node. Gallbladder, cholecystectomy: Chronic cholecystitis. No stones are present. (Seen with. ADDENDUM: Immunohistochemical studies performed on paraffin-embedded sections of the. liver show the. neoplastic cells are negative for insulin.",T2,N0,M0,T2N0M0
TCGA-77-A5G3,"Histopathology Report. HISTORY. Right pneumonectomy. Right upper lobe NSCLC first dissected in attempted. lobectomy. MACROSCOPIC. Three specimens received. 1: The specimen is received fresh and is labelled ""right lung"" and consists of. a right pneumonectomy specimen measuring 230 x 135 x 40 mm. Arising in the. right lower bronchus, 17 mm from the bronchial resection margin, is an. ulcerated friable cream tumour bulging into the bronchial lumen and invading. through the wall into the lung parenchyma. The tumour measures 35 x 35 x 20. mm. The bronchus distal to this lesion shows bronchiectasis. The surrounding. pleura shows multiple subpleural lymph nodes extending towards the inferior. aspect of the lower lobe. Sectioning the tumour mass shows multiple involved. nodes in direct contact with the tumour. Distal to the tumour there is also. focal collapse with or without consolidation. At the inferior (diaphragmatic). aspect of the lower lobe is an area of pleural thickening which appears. unrelated to the tumour. [1A, bronchial resection margin; 1B-C, hilar lymph. nodes; 1D-G, RS of tumour including junction with normal-appearing bronchus and. extension into local lymph nodes and possibly down local bronchi; 1H, deeper. tissue; 11, distal collapse; 1J, subpleural nodules; 1K, diaphragmatic pleural. thickening; 1L, uninvolved lung; 1F and 1G are contiguous]. 2: The specimen is labelled ""hilar lymph node 1"" and consists of a ragged. portion of haemorrhagic tissue measuring 10 x 7 x 4 mm. [BIT, 2A]. 3: The specimen is labelled ""subcarinal"" and consists of a portion of. haemorrhagic tissue measuring 20 x 12 x 4 mm. [BIT, 3A]. MICROSCOPIC. 1: Sections show a poorly differentiated carcinoma showing features of squamous. cell carcinoma. The lesion is arising in the region of a major bronchus. Pleural invasion is not identified. There is prominent blood vessel invasion. but no lymphatic permeation is seen. No perineural permeation is identified. The lesion is well clear of the bronchial resection margin. Peribronchial/peritumoral lymph node metastases are seen. The subpleural. nodules are lymph nodes showing reactive changes only. The lung distal to the. tumour shows acute and organising pneumonia. The area of pleural thickening is. a zone of irregular pleural scarring with overlying organising fibrinous. exudate. The pattern of the pleural scarring is in keeping with round. atelectasis. 2: Sections of the lymph nodes show reactive changes only. There is no. evidence of malignancy. 3: Sections of the lymph nodes show reactive changes only. There is no. evidence of malignancy. SUMMARY. Right lung and lymph nodes: 1: Poorly differentiated squamous cell carcinoma; 35 mm in maximal dimension. 2: Blood vessel permeation present; no lymphatic or perineural invasion is. seen. 3: No pleural invasion identified; clear of bronchial margin. 4: Peribronchial lymph node metastases. 5: T2N1MX. 6: Distal acute and organising pneumonia; focal round atelectasis. SUPPLEMENTARY REPORT. The tumour cells fail to stain with neuroendocrine markers. The lesion is a. squamous cell carcinoma without evidence of neuroendocrine differentiation. T-28000 M-80703 P1-03000. Copies: ANATOMICAL PATHOLOGY. Report generated:",T2,N1,M0,T2N1M0
TCGA-A4-7583,"Pre-Operative/Clinical History. Left renal mass. Specimen(s) Received. A: MARGIN - BASE OF TUMOR, LEFT KIDNEY MASS. B: LEFT RENAL MASS. Gross Description. Specimen A, received fresh for frozen section labeled margin (base) of tumor, left kidney mass, consists of three friable,. tan soft tissue fragments that measure 0.2 to 0.5 cm in greatest dimension. The fragments are entirely submitted for. frozen section in (A1 FS. Specimen B, received in formalin labeled left renal mass, consists of a 12 gm, 4.0 x 4.0 x 2.5 cm aggregate of multiple. pink, friable to papillary soft tissue fragments admixed with a small amount of adipose tissue. Representative sections are. submitted in (B1-6). Intraoperative Consultation. Specimen A, frozen section diagnosis of ""neoplasm present in one of three fragments"" is rendered by. Microscopic Description. Sections of the first specimen reveal a fragment of adipose tissue, a fragment of benign renal parenchyma, and a single. small fragment of papillary renal cell carcinoma, as described below. Summary of Pathologic Findings. Renal Carcinoma. Specimen B: Operative procedure: Enucleation; robotically-assisted laparoscopic left partial nephrectomy. Tumor size: The specimen was received morcellated and measured 4.0 x 4.0 x 2.5. cm in aggregate. Clinically, the tumor measured approximately 2.7 cm in. maximum dimension. Laterality and focality: Left, unifocal. Histologic type: Papillary carcinoma, type I. (The tumor demonstrates a papillary. architecture with delicate fibrovascular cores lined by small cells with low. grade nuclear features. Clusters of foamy histiocytes are present within. HISTOLOGY REPORT. some of the cores. There is no evidence of necrosis or vascular invasion. The specimen contains small fragments of adjacent renal parenchyma.). Sarcomatoid features: Absent. Histologic grade: Grade I. Extent of invasion: Cannot be determined. Lymph/vascular invasion: Cannot be determined. Margins: Cannot be assessed. Adrenal gland: Not submitted. Regional lymph nodes: Not submitted. Special studies: The following immunostains are performed with the tumor cells staining as follows: Pax-8. Positive. P504S. Positive. CK7. Positive. CK20. Negative. Vimentin. Negative. CD10. Negative. TTF-1. Negative. These immunohistochemical features are compatible with a diagnosis of papillary renal cell carcinoma. pTNM stage: The specimen was received morsellated, precluding an accurate pTNM stage. Staging in this. case relies on the clinical imaging. Pathologic findings in nonneoplastic kidney: Insufficient tissue. Diagnosis. LEFT RENAL MASS, ROBOTICALLY-ASSISTED LAPAROSCOPIC LEFT PARTIAL NEPHRECTOMY: LOW GRADE PAPILLARY RENAL CELL CARCINOMA. Intradepartmental Consult. Comment. Positive and negative controls react satisfactorily. HISTOLOGY REPORT.",T1,N0,M0,T1N0M0
TCGA-MT-A51W,"TEST(S): 1 Slide,. FINAL DIAGNOSIS: Tonsil, left fossa, biopsy. - Invasive squamous cell carcinoma, moderately-differentiated. (keratinizing). COMMENT: We agree with the referring pathologist's report and appreciate the. opportunity to review this case. CLINICAL HISTORY: The patient is a. year-old female with newly diagnosed tonsil cancer. GROSS: Received one stained slide labeled) and a copy of the referring pathologist's report with patient. identifying information. One slide is returned. MICROSCOPIC: Microscopic examination is performed. SPECIMEN(S): A: Wide local excision left RMT and tonsillar fossa. B: Left anterior RMT margin. C: Superior buccal margin. D: Maxillary tuberosity. E: Superior medial palatal margin. F: Tongue base. FINAL DIAGNOSIS: A. Wide local excision left RMT and tonsillar fossa: - Squamous cell carcinoma, moderately differentiated, invasive. - Tumor size: 2.0 x 1.8 x0.7 cm (Maximum depth of invasion: 0.7 cm). - Margins: All margins free of tumor. - Closest, deep margin at 0.1 cm from tumor. - No evidence of vascular or perineural invasion. B. Left anterior RMT margin: No evidence of high-grade dysplasia or malignancy. C. Superior buccal margin: - No evidence of high-grade dysplasia or malignancy. D. Maxillary tuberosity: - No evidence of high-grade dysplasia or malignancy. E. Superior medial palatal margin: - No evidence of high-grade dysplasia or malignancy. F. Tongue base: - No evidence of high-grade dysplasia or malignancy. COMMENT: All frozen section diagnoses are confirmed on permanent sections. CLINICAL HISTORY: The patient is a. year-old female with a history of tonsil cancer. GROSS: Received are six containers labeled with the patient's name. and medical record number. All tissue was received fresh. A. The first container is additionally labeled ""wide local excision,. left retromolar trigone and tonsillar fossa"" consists of a 4.0 x 2.7 cm. portion of tan-red rubbery mucosa and submucosa tissue which is excised. to a depth of 1.2 cm. The surgeon is present in the gross room and. oriented the specimen. A 2.0 X 1.8 cm ulcerated and ill-defined firm. mass is present on the mucosal surface. The specimen is inked as. follows: Anterior = blue, superior = green, lateral = red, medial =. orange, deep = black. On sectioning, the mass measures up to 0.7 cm in. thickness and is less than 0.1 cm from the deep margin. The mass is 0.2. cm to lateral, 1.0 cm to medial, 1.3 cm to anterior, and 0.9 cm to. superior margin. Representative tissue was procured for potential. future studies from specimen A. Summary of sections: Representative sections: A1 - anterior margin, perpendicular. A2-A4 - mass full thickness with medial and lateral margins. =. A5 - mass with superior margin, perpendicular. B. The next container is additionally labeled ""B - left anterior. retromolar trigone margin"" and consists of a 0.4 X 0.3 x 0.2 cm tan-pink. soft tissue, entirely submitted for frozen section and remnant in B1FS. C. The next container is additionally labeled ""C - superior buccal. margin"" and contains a 1.1 x 0.4 x 0.3 cm tan-pink soft tissue, entirely. submitted for frozen section as remnant C1FS. D. The next container is additionally labeled ""D - maxillary. tuberosity"" and contains a 0.7 X 0.5 x 0.2 cm tan soft tissue. Entirely. submitted for frozen section remnant in D1FS. E. The next container is additionally labeled ""E - superomedial palatal. margin"" contains a 0.6 X 0.4 X 0.2 cm tan-pink soft tissue, entirely. submitted for frozen section remnant in E1FS. F. The next container is additionally labeled ""F - tongue base"" and. contains a 1.0 X 0.5 X 0.3 cm tan-red soft tissue, entirely submitted. for frozen section remnant in F1FS. INTRAOPERATIVE CONSULTATION: FROZEN SECTION DIAGNOSIS: BFS1: Oral cavity, left anterior right molar trigone margin excision -. ""No evidence of malignancy.'. CFS1: Oral cavity, superior buccal margin - ""No evidence of high grade. dysplasia or malignancy.'. DFS1: Oral cavity, maxillary tuberosity excision - ""No evidence of high. grade dysplasia or malignancy.'. EFS1: Oral cavity, superomedial palatal margin excision - ""No evidence. of high grade dysplasia or malignancy."". FFS1: Oropharynx, tongue base, excision - ""No evidence of malignancy."". MICROSCOPIC: Microscopic examination is performed.",T1,N0,M0,T1N0M0
TCGA-78-7152,"HISTORY. Right upper lobectomy. MACROSCOPIC. Two specimens submitted. 1: The first specimen is labelled ""right upper lobe"" and consists of a right upper lobe of lung measuring. 115 X 100 X 35 mm. A solid mass is palpable in the upper lateral segment of the lung (segment 2). The. pleura overlying this mass appears puckered and there is an attached piece of pleura measuring. approximately 120 mm in length. On sectioning of the lung a tumour measuring 28 X 25 X 40 mm is. seen. It has a cream and grey-black cut surface. The margins of the tumour appear irregular. The. tumour abuts the anterior pleura but is well clear of the posterior pleural surface. There is no gross. bronchial involvement seen. The remaining lung tissue appears emphysematous. [1A, bronchial. resection margins; 1B, parabronchial lymph nodes; 1C-1E, RS of tumour; 1F, uninvolved lung.]. 2: The second specimen is labelled ""No. 10 lymph node"" and consists of two pieces of darkly. pigmented tissue resembling a lymph node and measuring in aggregate 12 X 12 X 5 mm. [Wrapped and. blocked in toto, 2A]. MICROSCOPIC. 1: Sections show a well differentiated to moderately differentiated mucin-secreting adenocarcinoma. with a predominant papillary and lepidic architecture. Centrally tumour acini infiltrate dense. fibroelastotic scar tissue. The tumour abuts and focally invades into the overlying pleura. Definite. vascular, lymphatic or perineural invasion is not identified. Adjacent lung parenchyma shows bullous. emphysema and organising pneumonia. The bronchial resection margin is clear of malignancy and. shows no evidence of squamous metaplasia or dysplasia. Peribronchial lymph nodes do not contain. metastatic adenocarcinoma. 2: Sections show lymph nodes in which there is no evidence of malignancy. SUMMARY. Right upper lobectomy and lymph node sampling: Well to moderately differentiated adenocarcinoma, 40 mm in diameter. Pleural invasion present. No vascular, lymphatic or perineural invasion found. No lymph node metastases. Pathological stage T2 NO. T-28000 M-81403 P1-03000.",T2,N0,M0,T2N0M0
TCGA-DD-A4NR,"REVISED REPORT (Addendum/Procedure included). TISSUE DESCRIPTION: A1 A2 A3 A4 A5. Portion of liver segment VIII (110 grams, 8.5 x 8.5 x 6.0 cm) . DIAGNOSIS: Liver, segment VIII, excision: Grade 3 (of 4) hepatocellular. carcinoma, usual type, forming a 5.0 x 4.5 x 4.0 cm mass. The tumor. is located in segment VIII. The hepatic capsule is free of tumor. The surgical margins are free of tumor, the clearance being 1.6 cm. grossly. Extratumoral vascular invasion is not identified. The. tumor is not encapsulated, infiltration of parenchyma being of. pushing type. Non-neoplastic liver will be reported in an addendum. ADDENDUM: The non-neoplastic liver is consistent with primary biliary. cirrhosis stage 4 (of 4) . Iron is negative for hemosiderosis. Trichrome stain highlights bridging fibrosis with regenerative. nodules.",T1,N0,M0,T1N0M0
TCGA-V4-A9ED,"Left eye enucleation. Macroscopy. The eyeball measures 27 mm main line with a posterior segment of optic nerve of 7 mm. At. the section , the tumor seen measures 12 mm main line. A large number of samples have. been made for cryopreservation and cytogenetic studies. Microscopy. The cut end of the optic nerve as well as the optic nerve on his entire course including the. optic foramen are free of tumor. An uveal melanoma can be found, developed in the ciliary. processes. The tumor is nearly only made with fusiform cells organize in short little bundles,. separated by conjunctival vascular septum. The nuclear atypia are moderate. The nuclei are. ovoid with a small nucleolus. There are a few mitotic figures. Some of the cells are. pigmented. There is no visible endo lymphatic embolus. The tumor infiltrates the thickness of. the choroid but does not infiltrates the sclera. The anterior chamber is free. Conclusion. Melanoma of the choroid of the left eye, originating at the ciliary processes. Size of the tumor: 12 mm. Infiltration of the choroid. Sclera free of tumor , optic nerve on his entire course including the cut end free of tumor.",T3,N0,M0,T3N0M0
TCGA-G3-AAV7,"CONFIDENTIAL. Demographics (for. verification purposes). Date of Birth: Sex: M. Collected Date/Time. Received Date/Time. Specimen Description. Liver segment 2,3 at. Clinical Information. Hep B. Liver tumor. Hepatocellular carcinoma. Diagnosis. A. Liver segment 2,3, Wedge Resection: Moderately differentiated hepatocellular carcinoma. (please see synoptic report for details) ;. Lymphovascular invasion noted in small vessels;. Tumor present less than 1 mm from hepatic capsule;. Resection margin negative (more than 1 cm). Verified: Responsible Resident: (Resident). Synoptic Report. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: GII: Moderately differentiated. TUMOR EXTENSION (select all that apply) : Tumor confined to liver. PRIMARY TUMOR (pT) : pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. REGIONAL LYMPH NODES (pN) : pNX: Cannot be assessed. DISTANT METASTASIS (pM) : pMX: Cannot be assessed. MARGINS: Parenchymal margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 10.0 mm. VENOUS (LARGE VESSEL) INVASION (V) : Absent. ADDITIONAL PATHOLOGIC FINDINGS: Cirrhosis/fibrosis (Fibrosis Score: Ishak score 5 (marked bridging (portal to portal and. portal to central) with occasional nodules)). Hepatitis (specify type) : Hepatitis B (Chronic Hepatitis: Grade 2 (mild periportal. inflammation and piecemeal necrosis or focal hepatocellular necrosis) ). Mild steatosis 1<5% of total liver parenchyma). Gross Description. Received is a single specimen container. The requisition and specimen container are. labelled with the patient's name,. The cassette and identifiers are. labelled with the Surgical Number. The specimen is received fresh and is subsequently placed into formalin. The container. is designated ""Liver segment 2, 3"". Specimen consists of a liver segment that weights. 169.3 g and measures 15.0 x 7.5 x 4.0 cm. Serial sections through the liver reveals a. well circumscribed yellow mass beneath the liver capsule, that measures 2.7 x 2.3 x 2.1. cm. The mass is solid, with focal areas of necrosis and punctate hemorrhage. The mass. lies just beneath the liver capsule. The remainder of the liver is deep yellow in color. and grossly nodular. The surgical resection margin has been painted blue and the liver. capsule adjacent to the mass has been painted green. There is a defect in the capsule of. the liver 2.0 cm away from the mass that has been painted yellow. The mass lies more. than 1.0 cm from the surgical resection margin. Sections are submitted as follows: A1 to 10. the liver mass in toto. All. the closest surgical resection margin. A12. uninvolved liver parenchyma. A13. sample of the previously described defect. Microscopic Description. Sections show a well circumscribed moderately differentiated hepatocellular. carcinoma with pushing borders. The carcinoma has a trabecular pattern >4 cells thick. with notable areas of pseudoglandular architecture with pleomorphic hyperchromatic foci. The morphology suggests a mixed hepatocellular-cholangiocarcinoma with stem cell. features. However, the immunoprofile failed to support this diagnosis. The tumor is diffusely and strongly positive for glypican-3 indicating. hepatocellular origin. It shows patchy moderate positivity alpha-1 antitrypsin, very. focal mild HepParl. Other markers of hepatocellular differentiation (alpha fetoprotein,. polyclonal CEA, cytoplasmic TTF-1, BHCG and OCT3/4 are largely negative. Markers of cholangiocytic differentiation (CK7, CK19 and polyclonal CEA). There. is however, patchy strong staining for EMA. Stem cell features are only supported by focal positivity for CD56 while CD19 and. C-KIT are negative. This does not support the presence of any stem cell component. CD30 is negative. Tumor block = A9; Non tumor block = A12. Pathologist Comment. Dr. reviewed this case and rendered his expert opinion. Encounter Number. Patient Location.",T2,N0,M0,T2N0M0
TCGA-IQ-7630,"Pathologic Interpretation: A. SOFT TISSUE TOOTH SOCKET #17: INVASIVE CARCINOMA. B. ALVEOLAR RIDGE LATERAL: No malignancy seen. c. BUCCAL MUCOSA INFERIOR: No malignancy seen. D. BUCCAL MUCOSA SUPERIOR: No malignancy seen. E. HARD PALATE: No malignancy seen. F. ANTERIOR TONSIL PILLAR: No malignancy seen. G. BASE OF TONGUE: No malignancy seen. H. LEFT MAXILLARY TUBEROSITY: No malignancy seen. I. LEFT FLOOR OF MOUTH: No malignancy seen. J. LINGUAL ALVEOLAR RIDGE OF MANDIBLE: No malignancy seen. K. BASE OF TONGUE DEEP: No malignancy seen. L. PTERYGOID: No malignancy seen. M. RETROMOLAR TRIGONE RESECTION WITH TOOTH #18 STITCH ANTERIOR SUPERIOR: INVASIVE POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA, 3.5 cm with mucosal ulceration. No Perineural nor lymphovascular space invasion identified. Specimen margins are negative for tumor. Tooth; for gross description only. See tumor Summary. N. PROXIMAL MANDIBLE: No malignancy seen. O. TISSUE MEDIAL TO PROXIMAL MANDIBLE: INVASIVE CARCINOMA. P. NARROW DISTAL MANDIBLE MARGIN: No malignancy seen on frozen section. Tissue did not survive processing for permanent section. Q. ADDITIONAL TISSUE MEDIAL TO MANDIBLE: No malignancy seen. R. LEFT EXTERNAL JUGULAR NODE: No malignancy seen in one lymph node (0/1). S. LEFT NECK DISSECTION 2,3,4: No malignancy seen in twenty-five lymph nodes (0/25). T. TOOTH # 15, 16: For gross description only. U. LEFT NECK DISSECTION LEVEL 1: No malignancy seen in one lymph node and salivary gland tissue (0/1). V. ADDITIONAL PTERYGOID: No malignancy seen. W. SEGMENTAL MANDIBLE: Pending decalcification. X. LEFT MAXILLARY TUBEROSITY: Pending decalcification. Pathology Cancer Case Summary. Specimen: Oropharynx. In formalin. Procedure: Resection. Other: Retromolar trigone resection. Specimen Integrity: Intact. Specimen Size: Greatest dimensions: 6 X 5x3 cm. Specimen Laterality: Left. Tumor Site: Oropharynx. Other (specify): Retromolar trigone. Tumor Laterality: Left. Tumor Focality: Single focus. Tumor Size: Greatest dimension: 3.5 cm. Additional dimensions: 2.0 x 1.6 cm. Tumor Description: Ulcerated. Histologic Type: Squamous cell carcinoma, conventional. Histologic Grade: Poorly Differentiated. Margins: Margins uninvolved by Invasive carcinoma. Lymph-Vascular Invasion: Not present. Perineural Invasion: Not identified. Primary Tumor (pT): pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Specify: Number examined: 27. Number involved: 0. Distant Metastasis (pM): Not applicable. As the attending pathologist, I attest that I: (i) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). Procedures/Addenda. Addendum. Addendum Diagnosis. W. SEGMENTAL MANDIBLE: No malignancy seen in bone. X. LEFT MAXILLARY TUBEROSITY: No malignancy seen in bone. Intraoperative Consultation. A. SOFT TISSUE TOOTH SOCKET #17, FS: Carcinoma invasive. B. ALVEOLAR RIDGE LATERAL, FS: No malignancy seen. C. BUCCAL MUCOSA INFERIOR, FS: No malignancy seen. D. BUCCAL MUCOSA SUPERIOR, FS: No malignancy seen. E. HARD PALATE, FS: Negative for malignancy. F. ANTERIOR TONSIL PILLAR, FS: Negative for malignancy. G. BASE OF TONGUE, FS: Negative for malignancy. H. LEFT MAXILLARY TUBEROSITY, FS: Negative for malignancy. I. LEFT FLOOR OF MOUTH, FS: Negative for malignancy. J. LINGUAL ALVEOLAR RIDGE OF MANDIBLE, FS: Negative for malignancy. K. BASE OF TONGUE DEEP, FS: Negative for malignancy. L. PTERYGOID, FS: Negative for malignancy. N. PROXIMAL MANDIBLE, FS: Negative for malignancy. O. TISSUE MEDIAL TO PROXIMAL MANDIBLE, FS: Infiltrating Squamous cell carcinoma. P. NARROW DISTAL MANDIBLE MARGIN, FS: Negative for malignancy. Q. ADDITIONAL TISSUE MEDIAL TO MANDIBLE, FS: Skeletal muscle; negative for malignancy. Clinical History: None Provided. Operation Performed. Composite resection tracheostomy, free flap skin graft laryngoscopy. Pre Operative Diagnosis: Malignant neoplasm of the mandible. Specimen(s) Received: A: SOFT TISSUE TOOTH SOCKET #17. B: ALVEOLAR RIDGE LATERAL,. C: BUCCAL MUCOSA INFERIOR. D: BUCCAL MUCOSA SUPERIOR. E: HARD PALATE. F: ANTERIOR TONSIL PILLAR,. G: BASE OF TONGUE. H: LEFT MAXILLARY TUBEROSITY. I: LEFT FLOOR OF MOUTH,. J: LINGUAL ALVEOLAR RIDGE OF MANDIBLE,. K: BASE OF TONGUE DEEP. L: PTERYGOID. M: RETROMOLAR TRIGONE RESECTION WITH TOOTH #18 STITCH ANTERIOR SUPERIOR. N: PROXIMAL MANDIBLE. O: TISSUE MEDIAL TO PROXIMAL MANDIBLE. P: NARROW DISTAL MANDIBLE MARGIN,. Q: ADDITIONAL TISSUE MEDIAL TO MANDIBLE,. R: LEFT EXTERNAL JUGULAR NODE. S: LEFT NECK DISSECTION 2,3,4. T: TOOTH # 15, 16. U: LEFT NECK DISSECTION LEVEL 1. V: ADDITIONAL PTERYGOID. W: SEGMENTAL MANDIBLE. X: LEFT MAXILLARY TUBEROSITY. Gross Description: A. Received fresh labeled ""Soft tissue tooth socket #17"" is a piece of smooth tissue that measures 1.4 X 0.7 cm. Submitted. in toto in one cassette for frozen section. B. Received fresh labeled ""Alveolar ridge lateral"" is a piece of smooth tissue, measuring 1.0 x 0.5 x 0.1 cm. Submitted in. toto in one cassette for frozen section. C. Received fresh labeled ""Buccal mucosa inferior"" are two pieces of soft tissue, measuring 2.0 x 1.0 x 0.1 cm and the other. one measures 0.4 X 0.3 X 0.1 cm. Both pieces are submitted in toto in one cassette for frozen section. D. Received fresh labeled ""Buccal mucosa superior"" is a piece of soft tissue that measures 1.5: X 1.2 x 0.2 cm. Submitted in. toto in one cassette for frozen section. E. Received fresh labeled ""Hard palate"" is a piece of soft tissue that measures 1.1 X 0.4 x 0.1 cm. Submitted in toto in one. cassette for frozen section. F. Received fresh labeled ""Anterior tonsil pillar"" is piece of soft tissue that measures 2.0 x 1.0 x 0.1 cm. Submitted in toto in. one cassette for frozen section. G. Received fresh labeled ""Base of tongue"" is a piece of soft tissue, measuring 2.0 x 1.2 x 0.2 cm. Submitted in toto in one. cassette for frozen section. H. Received fresh labeled ""Left maxillary tuberosity"" are two small pieces of soft tissue measuring 0.3 x0.1 x 0.1 cm each. Submitted in toto in one cassette for frozen section. I. Received fresh labeled ""Left floor or mouth"" is a piece of soft tissue, measuring 1.0 X 0.4 X 0.1 cm. Submitted in toto in. one cassette for frozen section. J. Received fresh labeled ""Lingual alveolar ridge of mandible"" are three pieces of soft tissue, measuring 0.1 cm in diameter. each. Submitted in toto in one cassette for frozen section. K. Received fresh labeled ""Base of tongue deep"" is a piece of soft tissue that measures 1.2 x 1.0 X 0.3 cm. Submitted in toto. in one cassette for frozen section. L. Received fresh labeled ""Pterygoid"" is a fragmented piece of soft tissue that measures 2.8 x 1.8 X 0.3 cm. Submitted in. toto in one cassette for frozen section. M. Received in formalin labeled ""Retro molar trigone resection with tooth #18 stitch anterior superior"" is a round piece of soft. tissue, measuring 6.0 x 5.0 x 3.0 cm. It has a stitch also attached on the anterior superior margin, arbitrarily labeled as 12. o'clock. There is a tooth at 3 o'clock. There is tumor at the center of the specimen with a heaped up mucosa that. measures 3.5 x 2.0 x 1.6 cm. A portion of the 12 o'clock area of the tumor is taken for tumor tissue bank. The specimen is. inked as follows: From 12 to 6 o'clock - the edge is inked in black as well as the deep aspect of the specimen is also inked. in black. From 6 o'clock to 12 o'clock it is inked in blue. The tumor is 1.0 cm away from the 3 o'clock margin, 0.3 cm away. from the 6 o'clock, 0.8 cm away from the 9 o'clock margin and 0.8 cm from the 12 o'clock margin. Representative sections. are taken and submitted as follows: Cassette #1. 12 o'clock margin. Cassette #2. 3 o'clock margin. Cassette #3. 6 o'clock margin. Cassette #4. 9 o'clock margin. Cassette #5. Deep margin. N. Received fresh labeled ""Proximal mandible"" are four pieces of soft tissue. The largest one measure 0.5 X 0.3 X 0.1 cm. and. the smallest one measure 0.2 x 0.1 X 0.1 cm. Both of these specimens are submitted in toto in one cassette for frozen. section. O. Received fresh labeled ""Tissue medial to proximal mandible"" is a piece of tissue measuring 1.5 x 0.7: X 0.2 cm. Submitted. in toto in one cassette for frozen section. P. Received fresh labeled ""Marrow, distal mandibular margin"" is a tiny piece of soft tissue, measuring 0.1 x 0.1: x 0.1 cm. Submitted in toto in one cassette for frozen section. Received fresh labeled ""Additional tissue medial to mandible"" is a piece of soft tissue, measuring 1.0 x 0.5 0.1 cm. Submitted in toto in one cassette. R. Received in formalin labeled ""left external jugular node"" is a hemorrhagic piece of soft tissue, measuring 1.5 x 1.0 x 0.5. cm. Bisected and submitted in toto in one cassette. S. Received in formalin labeled ""left neck dissection 2,3,4"" is a round piece of adipose tissue, measuring 6.0 x 4.5 x 2.0 cm. The surface is irregular, tan and hemorrhagic. Twenty-two lymph nodes are found. Two of them which are the largest. measure 2.0 x 1.0 0.5 cm each and the smallest one measures 0.2 cm in diameter. Sections are submitted as follows: Cassettes #1-5 Bisected lymph nodes. Cassette #6. Contains eight possible lymph nodes. Cassette #7. Contains four lymph nodes. Cassette #8. Contains seven possible lymph nodes. T. Received fresh labeled ""Teeth #15, 16"" are two teeth probably molars that measure 2.0x 1.0 x 1.0 cm each. For gross. description only. U. Received in formalin labeled ""Left neck dissection"" is a round pale yellow white hemorrhagic mass of adipose tissue that. measures 5.5 x 4.0 x 3.0 cm. On cut section it seems like a salivary gland that measures 4.5 x 4.0 x 2.0 cm with no lymph. nodes in side and any abnormalities macroscopically seen. Sections are submitted as follows: Cassette #1. Contains a possible lymph node. Cassette #2. Section from salivary gland. V. Received in formalin labeled ""Additional pterygoid"" is an irregular necrotic piece of tissue that measures 3.0 x 2.5 x 1.8. cm. The specimen is not oriented. Cross section reveals muscle and adipose tissue. No malignancy is grossly identified. No lymph nodes, no mucosa and no bones are identified. Representative sections in two cassettes. W. Received in formalin labeled ""Segmental mandible"" is an unoriented piece of mandible measuring 8.0 cm superior to. inferior and 4.5 cm posterior to anterior and 2.0 cm medial to lateral. Sections are taken and submitted as follows: Cassette #1. Anterior margin. Cassette #2. Contains posterior margin, two cassettes for decalcification. X. Received in formalin is an irregular piece of bone measuring 3.0 x 1.8 X 1.5 cm. No abnormal lesions are grossly. identified. The specimen is and sections are submitted in one cassette for decalcification.",T2,N0,M0,T2N0M0
TCGA-A6-5666,"SPECIMEN. A. Sigmoid colon, upper rectum and adherent posterior bladder wall. and small intestines. B. Appendix. CLINICAL NOTES. PRE-OP DIAGNOSIS: Rectal cancer. GROSS DESCRIPTION. A. Received fresh subsequently fixed in formalin labeled. ""sigmoid, upper rectum with adherent posterior bladder. wall. and small intestines"". The specimen consists of a rectosigmoid. colon with adherent portions of small bowel and possible portion of. bladder. A segment of small bowel was 12 cm long, stapled at both. ends, which are arbitrarily inked blue and black. A portion of. colon is 46 cm long. Both ends are stapled, inked blue and the. opposite is opened and is inked black. There is also a small. portion of possible bladder, which is 7 X 5 cm. This is smooth to. slightly velvety and the margin of this is inked blue. Orientation. cannot be determined. One end away from the tumor is inked blue. The opposite end close to the tumor is inked black. The specimen. is. opened to show a large fungating mass, which is 12 X 11.5 X 3.5 cm. This comes within 2.5 cm of the black inked margin. This tumor is. centrally necrotic and goes through the wall of the colon, into the. surrounding fat and through the wall of the small bowel into the. mucosa of the small bowel. The remainder of the mucosa of small. bowel is pink-tan smooth glistening with normal slightly dilated. poles having an average circumference of 6.5 cm and the mucosal. alteration of tumor is 3.5 X 3.5 cm. This comes within equidistant. luminal margins of the small bowel. The tumor also comes through. the wall into the fat and possibly involves the mucosa of the. portion of bladder. This is velvety, coming within 0.5 cm of the. nearest peripheral margin. The remainder of the mucosa of the. specimen is pink-tan smooth glistening with an average. circumference. of 9.5 cm. The tumor comes within 1.5 cm of being circumferential. and shows a markedly necrotic central focus. Lymph nodes are. grossly identified. Representative sections of the specimen are. submitted as follows: BLOCK SUMMARY: 1 - Representative luminal margins of small bowel,. 2. - representative section of small bowel tumor, 3-4 - representative. section of bladder to tumor, 5 - representative luminal margins of. the colon, 6 - representative section of tumor to normal, 7 and 8 -. representative sections of tumor to fat, 9-12 - have six possible. lymph nodes. - have four possible lymph nodes each. RS-15. B. Received in formalin labelled ""appendix"" is a 6.3 X 0. 7. cm. appendix. which is partially covered with pink-tan smooth glistening serosa. and yellow. lobular fat. The specimen is sectioned to show an intact wall with. an average thickness of 0.4 cm. The lumen ranges from pinpoint to. 0.4 cm and shows. possible diverticula present. No other discrete gross lesions are. identified. The entire specimen with the exception of the fat is. submitted in t. settes. AS-2 (fat retained) proximal end. inked. AS-2. MICROSCOPIC DESCRIPTION. A. Microscopic exam of the resection shows: Histologic type Adenocarcinoma, not otherwise specified. Histologic grade: Moderately differentiated. Primary tumor (pT) : Tumor invades through the entire colonic wall. and through the entire adhesed small intestinal wall into the lumen. of the small intestine. The tumor also invades into the. muscularis. propria of the bladder wall (pT4b). Proximal margin: Negative for tumor. Distal margin: Negative for tumor. Circumferential (radial) margin: Negative for tumor although not. truly applicable given the resection of the adhered additional. organs. Distance of tumor from closest margin: 2.5 from one of the. colonic. margins. Vascular invasion: Not identified. Regional lymph nodes (pN) : 30 lymph nodes are dissected from the. specimen and they are all negative for metastatic (pNO) . Non-lymph node pericolonic tumor: Present in the soft tissue. adhesing the small intestine and the bladder to the upper. rectal/sigmoid colon resection. No discrete additional nodules. of. pericolonic tumor seen. Distant metastasis (pM) : Cannot evaluate pMX. Other findings: There is significant necrosis of the tumor in the. central areas. B. Microscopic examination of the appendix reveals a. benign. mucocele at the tip. No dysplasia or malignancy is. identified. There is focal fibrous obliteration of the tip. including obliteration of the diverticulum. There is acute. serositis. and ahdesions. 5x1, 2x1, 3260F. DIAGNOSIS. A. Sigmoid colon, upper rectum and adherent posterior bladder wall. and small intestines, resection: Invasive moderately differentiated adenocarcinoma. Tumor invades through the entire colonic wall and through the. entire adhesed small intestinal wall into the mucosa of the. small intestine. Tumor invades into the muscularis propria. of the bladder (pT4b) . Thirty lymph nodes are negative for metastatic tumor (0/30). (pNO). Resection margins are negative for tumor. B. Appendix, excision: Hyperplastic mucinous epithelium consistent with benign. mucocele. Resection margins are negative. Serosal. adhesions. --- End Of Report ---.",T4,N0,M0,T4N0M0
TCGA-EA-A3Y4,"Laterality:Tumor Features: -1, Tumor Extent: Lesion less than 4.0cm,. Venous Invasion: Absent, Margins: Absent, Treatment Effect: Path Report:CERVIX TISSUE CHECKLIST. Specimen type: Simple hysterectomy. Tumor site: Endocervix. Tumor size: 1.5x2x3cm. Histologic type: Squamous cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Lesion less than 4.0 cm. Lymph nodes: 0/12 positive for metastasis (Pelvic fatty tissue 0/12). Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T1,N0,M0,T1N0M0
TCGA-AA-A01D,"Diagnosis: Resected section of colon (rectosigmoid) with an ulcerated colon carcinoma characterized. histologically as a poorly differentiated, partially mucinous adenocarcinoma of the. colorectal type, extending a max of 10 cm to a resection margin, and measuring a. maximum of 2.5 cm in diameter at the widest point. Invasive spread of the tumor within all. intestinal wall layers to the neighboring mesocolic fatty tissue. Numerous lymphatic. processes in the region of the tumor margin. The remaining intestinal wall has no relevant. pathological findings; in particular, no evidence of pseudodiverticula. Tumor-free oral and aboral resection margin. 12 local lymph nodes with metastases of the rectal carcinoma partly transgressing the. lymph node capsules. Stage of tumor: pT3, pN2 (12/12) L1 V0; G3 R0.",T3,N2,M0,T3N2M0
TCGA-XV-A9VZ,Patient ID: F. Clinical Dx: Melanoma. Tumor Location: Skin. Localization: Lleft femur. Source: Epithelial melanoma. Clark Level (1-5): 4. Breslow (mm): 5. Tumor: 4. Normal: 0. Metastasis: 0. Stage (I-IV): II. Tumor size (mm x mm): 4x5. NeoAdj Immuno Tx:,T4,N0,M0,T4N0M0
TCGA-D8-A1XV,"page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Total organ resection - right breast. Internal referral. Expected time of examination: up to 8 working days. Clinical diagnosis: Based on PCI, cellulae carcinomatosae - lesion covering the lower part of the breast. Macroscopic description: Right breast sized 27 x 23 x 3 cm removed without axillary tissues and with a skin flap of 27 x 14 cm. Skin injected with blue dye. Tumour sized 2 x 1.8 x 2.5 cm found on the boundary of lower quadrants, located 3.0 cm from the lower edge, 1.0 cm from the. base and 2.5 cm from the skin. The other tumour sized 3.2 x 1.9 x 4.5 cm found 2 cm away from the first one (margins: lower boundary 1.0 cm, base 1.0 cm, skin. 3 cm). Microscopic description: Carcinoma mucinosum invasivum bifocale - NHG2 (3+2+1/5 mitoses/10 HPF - visual area 0.55mm). Foci of carcinoma ductale in situ (DCIS) found within the tumour (papillary, solid, mucous type, with. medium nuclear atypia, without necrosis, 20% of the tumour). Carcinoma intraductale mamillae. Glandular tissue showing parenchymal atrophy. Histopathological diagnosis: Including test No. ,. Carcinoma mucinosum invasivum et ductale in situ mammae dextrae. Invasive mucinous carcinoma and ductal carcinoma in situ. of the right breast. (NHG2, pT2, pNO (sn)). Compliance valid. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 protein stained using rabbit antibody Ventana PATHWAY HER-2/neu (4B5). Score = 2+ FISH verification recommended. Compliance validated bv: Examination: Histopathological examination. page 2 / 2. Gender: F. Result of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe. Kit FINAL RESULT: HER-2 GENE AMPLIFICATION NOT FOUND.",T2,N0,M0,T2N0M0
TCGA-KL-8335,"Clinical Diagnosis & History: 13.6 cm left renal mass. Radical nephrectomy specimen. Specimens Submitted: 1: SP: Kidney, adrenal gland and enbloc lymph node dissection, left, radical nephrectomy. 2: SP: Lymph node, para-aortic, excision. DIAGNOSIS: 1. SP: Kidney, adrenal gland and enbloc lymph node dissection, left, radical nephrectomy. Tumor Type: Renal cell carcinoma - Chromophobe type. Fuhrman Nuclear Grade: N/A. Tumor Size: Greatest diameter is 13.0 cm. The tumor is associated with extensive necrosis. Local Invasion (for renal cortical types): Extends through renal capsule but confined within Gerota's fascia. Involves renal sinus fat. Renal Vein Invasion: Not identified. Vascular invasion of small to medium sized vessels is present. Surgical Margins: Free of tumor. Unremarkable ureter. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: Not involved. The tumor approaches but does not invade the adrenal gland. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT3a Tumor invades the adrenal gland or perinephric tissues but not beyond Gerota's fascia. 2. SP: Lymph node, para-aortic, excision. Lymph Nodes: Not involved. Number of nodes examined: 8. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh, labeled ""Left kidney, adrenal gland and en bloc lymph node dissection"". It consists of a. radical nephrectomy specimen composed of kidney and perirenal fat measuring 30.0 x 12.0 x 10.0 cm and weighing 2252 gm. After bivalving the specimen a kidney measuring 21.0 x 11.0 x 8.8 cm reveals at the upper pole a 13.0 x 12.0 x 10.0 cm partially. necrotic yellow-tan centrally scarred tumor. The tumor appears to be well-encapsulated but pushes into the perirenal fat. Gross. no evidence of capsule breakthrough is noted. Tumor appears to also deform and abut the calyceal pelvic system with no. breakthrough. Serial sectioning of the tumor reveals a hemorrhagic multiple variegated yellow-tan and red tumor with a central. area of scarring. Sectioning through the hilar fat reveals multiple lymph nodes. A 14.3 x 0.5 cm attached ureter is identified. which probe patent and negative for lesions. The ureteral margin is shaved and submitted together with the vacular margins. which. appear also grossly negative. Sectioning through the perirenal fat reveals a 3.8 x 2.8 x 1.2 cm adrenal gland which abuts. the superior surface of the tumor. The tumor appears not to invade the adrenal gland. Gross photographs are taken and TPS is. taken. Summary of Sections: MAR - vascular and ureteral margins. LN - lymph nodes of renal hilum. TNCP - tumor with renal capsule. TMSIN - tumor with renal sinus. TM - tumor. TMPL - tumor and pelvis. ADR - adrenal gland with tumor abutting. NK - normal kidney. TMKI - tumor with adjacent normal kidney. 2). The specimen is received in formalin labeled, ""Paraaortic lymph node"", and consists of five possible lymph nodes measuring. 4.5 x 3 x 1.6 cm in aggregate. Lymph nodes are entirely submitted. Summary of sections: TLN- trisected lymph node. BLN-bisected lymph node. LN-whole lymph nodes. Summary of Sections: Part 1: SP: Kidney, adrenal gland and enbloc lymph node dissection, left, radical nephrectomy (tl). Block. Sect. Site. PCs. 4. adr. 4. 8. In. 8. 1. mar. 1. 2. nk. 2. 6. tm. 6. 8. tmcap. 8. 1. tmki. 1. 1. tmpel. 1. 3. tmsin. 3. Part 2: SP: Lymph node, para-aortic, excision. Block. Sect. Site. PCs. 2. bIn. 2. 3. IIn. 3. 1. In. 1.",T3,N0,M0,T3N0M0
TCGA-HD-8224,"Final Diagnosis. Anterior deep margin of tongue (FSA1), biopsy: Diffusely infiltrating squamous cell carcinoma. Middle deep margin of tongue (FSA2): Diffusely infiltrating squamous cell carcinoma. Almost total glossectomy with frozen section examination: Posterior shaved margin positive for squamous cell carcinoma. Medial shaved margin positive for squamous cell carcinoma. Areas of lymphovascular invasion are identified. Perineural invasion identified. Random sections of tongue show diffuse invasive squamous cell carcinoma. extending through multiple areas of the posterior and medial margins. P16 immunostain will be done on block B2 and reported in an addendum. Tumor extends all the way to tip of tongue. Completion of total glossectomy with left lateral border of tongue with new deep and. posterior surgical margin with operating room consultation and inking of margins: New posterior margin positive for squamous cell carcinoma. New deep margin positive for squamous cell carcinoma. All inked margins positive for squamous cell carcinoma. Level 1A lymph node dissection: Four (4) of 4 lymph nodes positive for squamous cell carcinoma. 4/4+. Right level 1B lymph node dissection: Submandibular salivary gland is negative for malignancy. Two (2) lymph nodes positive for metastatic squamous cell carcinoma. Right level 2A lymph node dissection: Three (3) of ten (10) lymph nodes positive, several nodes show extensive +3/10. extracapsular extension. Right level 2B lymph node dissection: Six (6) negative nodes. Right level 3 lymph node dissection: Three (3) of four (4) lymph nodes positive. Right level 4 lymph node dissection: Ten (10) negative nodes. Left level 1B lymph node dissection: Unremarkable submandibular salivary gland. Two (2) positive lymph nodes. Left level 4 lymph node dissection: Two (2) of seven (7) lymph nodes positive. Left level 3 lymph node dissection: Four (4) of seven (7) lymph nodes positive. Left level 2B lymph node dissection: One (1) lymph node positive. Left level 2A lymph node dissection: Two (2) of four (4) lymph nodes positive. Comment: All resected margins were positive for squamous cell carcinoma. This. case corresponds to a pathological AJCC stage of T3,N2c. GENERAL COMMENT REGARDING IMMUNOPEROXIDASE STUDIES: ""Performance characteristics for some analytes have been determined by. They have not been cleared or approved by the U.S Food and Drug Administration The FDA has determined that such clearance or approval is not necessary. These. tests are used for clinical purpases eyshould not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory. Improvement Amendments of. as qualified to perform high complexity clinical laboratory testing."". Clinical Information. Cancer of tongue with mets. Frozen Section Diagnosis. CA post dorsal tongue. FSA1: Anterior deep (green) margin (small). Positive for SCC. FSA2: Middle deep (black) margin (larger). Positive for SCC. FSB1 - posterior (shave) - positive. FSB2 - medial (shave) - positive. -80% of shaved margin (+) for CA. Operating Room Consultation. ORC-C Left lateral tongue with new posterior and deep and anterior margins. Gross Description. ""FSA1."" All frozen section tissue is submitted in cassette ""FSA1."" Tea bag. ""FSA2."" All frozen section tissue is submitted in cassette ""FSA2."". ""FSB1."" All frozen section tissue is submitted in cassette ""FSB1."". ""FSB2."" All frozen section tissue is submitted in cassette ""FSB2."". ""B,. "". The specimen consists of a 5.7 x 4.0 x 2.5 cm right lateral portion of tongue. The posterior margin has previously. been inked green, and the medial margin has been inked black. A portion of the deep margin has remained uninked. This. area will be inked orange. The surface of the tongue has a gray-tan to white-tan, thickened, nodular appearance. There is a. 2.2. X 1.7 cm gray-tan, firm central mass, which extends to the posterior, medial, and deep margins. ""B1-B2,"" mass to include. medial and deep margins; ""B3-B4,"" step sections, ""B3,"" central tongue towards anterior tip, ""B4,"" anterior tip; ""B5,"" mass to. include deep and posterior margins; ""B6,"" right lateral tongue, representative. ""C,. "" The specimen consists of a 5.5 X 6.0 X 3.0 cm left lateral portion of tongue with new posterior, deep, and anterior. margins. The tongue has a gray-tan, wrinkled appearance. The new anterior deep margin has previously been inked black,. and the new posterior margin has been inked green. Definite tumor is grossly difficult to identify. ""C1,"" posterior margin; ""C2,"". new anterior deep margin; ""C3-C5,"" posterior margin; ""C5-C8,"" anterior deep margin; ""C9-C10,"" anterior deep margin; ""C11,"". posterior tongue; ""C12,"" central tongue; ""C13,"" anterior tongue. This case is also received with a single yellow cassette labeled. ""D, Level 1A."" The specimen consists of a 4.2 X 2.7 x 1.5 cm yellow-tan, fatty fragment. On examination, 4 possible lymph. nodes are identified. These range in size from 0.5 to 1.0 cm. ""D,"" 4p, representative. ""E, Right level 1B."" The specimen consists of a 4.5 X 3.0 x 2.5 cm grossly unremarkable submandibular gland. On sectioning,. the cut surface is yellow-tan and lobulated. Also free in the container is a 3.0 X 1.5 x 1.0 cm aggregate of yellow, fatty tissue. On examination 2 possible lymph nodes are. identified. These measure 0.5 and 0.6 cm. ""E1-E2,"" submandibular gland; ""E3,"" possible lymph nodes, representative. ""F, Right level 2A."" The specimen consists of a 6.5 x 2.5 x 1.5 cm aggregate of yellow-tan, fatty tissue. On sectioning,. examination, 11 possible lymph nodes are identified. These range in size from 0.2 to 1.5 cm. ""F1-F3,"" fragments,. representative. ""G, Right level 2B."" The specimen consists of a 4.5 X 2.6 x 1.5 cm fragment of yellow-tan, fatty tissue. On examination, 6. possible lymph nodes are identified. These range in size from 0.3 to 0.6 cm. ""G1-G2,"" fragments, representative. ""H, Right level 3."" The specimen consists of a 5.0 x 4.0 x 2.0 cm aggregate of yellow-tan, fatty tissue. On examination, 5. possible lymph nodes are identified. These range in size from 0.5 to 0.7 cm. ""H1-H2,"" fragments, representative. ""I, Right level 4."" The specimen consists of a 4.3 X 3.0 x 1.2 cm aggregate of yellow-tan, fatty tissue. Eleven possible lymph. nodes are identified. These range in size from 0.2 to 1.0 cm. ""I1-12,"" fragments, representative. ""J, Left level 1B."" The specimen consists of a 4.0 x 3.0 x 2.5 cm grossly unremarkable submandibular gland. On sectioning,. the cut surface is yellow-tan and lobulated. Attached to the gland is a 2.7 x 2.5 x 1.0 cm aggregate of yellow-tan, fatty tissue. On examination, 2 possible lymph nodes are identified. These measure 0.3 and 0.4 cm. ""J1-J2,"" submandibular gland; ""J3,"". possible lymph nodes, representative. ""K, Left level 4."" The specimen consists of a 4.7 x 3.0 X 1.5 cm aggregate of yellow, fatty tissue. On examination 7 possible. lymph nodes are identified. These range in size from 0.5 to 2.3 cm. ""K1-K2,"" fragments, representative. ""L, Left level 3."" The specimen consists of a 4.0 x 2.5 x 2.0 cm aggregate of yellow-tan, fatty tissue. On examination, 7. possible lymph nodes are identified. These range in size from 0.3 to 0.7 cm. ""L1-L2,"" fragments, representative. ""M, Left level 2B."" The specimen consists of a 3.5 x 2.2 X 1.5 cm aggregate of yellow-tan, fatty tissue. On examination 4. possible lymph nodes are identified. These range in size from 0.7 to 1.5 cm. ""M,"" 4p, representative. ""N, Left level 2A."" The specimen consists of a 3.5 x 3.0 x 1.5 cm fragment of yellow, fatty tissue. On examination, a single 2.0. cm lymph node is identified. ""N,"" 1p, representative. NOTE: SEND THIS CASE TO. Performing Lab. Testing performed at.",T3,N2,M0,T3N2M0
TCGA-B6-A2IU,"Patientel. !. CLINICAL HISTORY: Not provided. I. GROSS EXAMINATION: A. ""Right breast and axillary contents"", received fresh. A 1,330 grams, 33.0. x. 16.0 x 6.8 cm. The specimen is breast with attached fibrofatty tissue. The. breast itself measures 27.5 x 16.0 x 6.8, the axillary tail measures 10.5 x. 9.0 x 3.5 cm. The attached ellipse of skin measures 24 x 12.2 cm, with a 4.0. cm areola and a 1.4 cm nipple. The surgical margin of the specimen are inked. and the specimen is sliced serially. There is a 5.0 x 5.0 x 2.8 cm firm, ill. defined mass in the central region of the breast. It is 2.2 cm from the. closest (posterior) margin. BLOCK SUMMARY: A1- cross sections from the nipple. A2- hard mass with closest surgical margin. A3-A6- representative sections of the mass. A7- representative sections from the upper outer quadrant. A8- representative sections from the lower outer quadrant. A9- representative sections from the lower inner quadrant. A10- representative sections from the upper inner quadrant. A11- seven lymph node candidates from the proximal axillary fat. A12- seven lymph node candidates from the middle axillary fat. A13- six lymph node candidates from the middle axillary fat. A14- four lymph node candidates from the distal axillary fat. A15- one lymph node candidate from the distal axillary fat, bisected. A16- four lymph node candidates from the distal axillary fat. A17- one lymph node candidate from the distal axillary fat. A18- five lymph node candidates from the distal axillary fat. DIAGNOSIS: A. ""RIGHT BREAST AND AXILLARY CONTENTS"" (MODIFIED RADICAL MASTECTOMY) : INFILTRATING CARCINOMA PRESENT, HISTOLOGIC TYPE LOBULAR. N.S.A.B.P. NUCLEAR GRADE 2 OF 3. N.S.A.B.P. HISTOLOGIC GRADE: NOT APPLICABLE. GROSS TUMOR SIZE: 5.0 x 5.0 x 2.8 CM. SIZE OF INVASIVE COMPONENT 5.0 x 5.0 x 2.8 CM. LOCATION OF THE TUMOR, CENTRAL. LYMPHATIC/VASCULAR INVASION ABSENT. MULTIFOCAL TUMOR PRESENT, EXTENSIVE, SEE COMMENT. IN SITU CARCINOMA ABSENT. NIPPLE STATUS, FREE OF TUMOR. SKIN STATUS, FREE OF TUMOR. MUSCLE STATUS, NOT SAMPLED. STATUS OF NON-NEOPLASTIC BREAST TISSUE: BENIGN FIBROCYSTIC CHANGES. SURGICAL MARGIN STATUS: NEGATIVE. LYMPH NODE STATUS: TWENTY-EIGHT AXILLARY LYMPH NODES, NO EVIDENCE OF. MALIGNANCY (0/28). ESTROGEN/PROGESTERONE RECEPTOR AND CELL CYCLE ANALYSIS PENDING. METHODOLOGY: IMMUNOHISTOCHEMISTRY, PARAFFIN BLOCK A3. RESULTS WILL BE ISSUED IN AN ADDENDUM. COMMENT: There is very extensive mmultifocal/multicentric disease, with random. sections distant from the main tumor mass showing foci of infiltrating lobular. carcinoma involving all four quadrants of the breast. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) . ADDENDUM 1: Tissue was sent to the. for assay of the estrogen. and progesterone receptors. The estrogen receptor activity was judged to be. positive with an estimated FMOL value of 30. The progesterone receptor. activity was judged as positive with an estimated FMOL of value of 101. Please refer to. for a complete report. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). https://.",T2,N0,M0,T2N0M0
TCGA-IB-AAUO,"CONFIDENTIAL. Demographics (for. verification purposes). Sex: F. Collected Date/Time. Received Date/Time. Specimen Description. A: Node 8 at. B: Periportal lymph node at. C: Proximal bile duct margin at. D: Whipple's specimen at. Clinical Information. Pancreatic cancer. Diagnosis. A. Node 8: Metastatic adenocarcinoma with focal extracapsular extension. B. Periportal Lymph Node: Fibroadipose tissue only. C. Proximal bile duct margin: Inflammatory changes, no neoplasia. D. Whipples specimen: Poorly differentiated ductal carcinoma invasive into duodenum with. perineural, lymphatic and arterial channel invasion, present at the. uncinate resection margin. Four peripancreatic lymph nodes with metastatic adenocarcinoma. Verified: Synoptic Report. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G3: Poorly differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades duodenal wall. MARGINS: Margin(s) involved by invasive carcinoma. Uncinate process (retroperitoneal) margin (nonperitonealized surface of the uncinate. process). TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy) : No prior treatment. LYMPH-VASCULAR INVASION: Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension. REGIONAL LYMPH NODES (pN) : pN1: Regional lymph node metastasis. Number examined: 5. Number involved: 5. ADDITIONAL PATHOLOGIC FINDINGS: Chronic pancreatitis. Gross Description. Received are specimen containers A to D all requisitions and specimen containers are. labelled with the patient's name,. The cassettes and. identifiers. are labelled with the Surgical Numper. A: The specimen is received fresh and is subsequently placed into formalin. The. container is designated A node 8. The specimen consists of a single possible fragment of. lymph node that measures 2.8 x 1.3 x 0.6 cm with attached adipose tissue. The specimen. is serially sectioned. The possible lymph node is submitted in A1/2 and the remaining. adipose tissue is submitted in A3. B: Specimen is received fresh. The container is designated B periportal lymph node. The specimen consists of two irregular portions of fibrofatty tissue measuring in. aggregate 4 x 2.5 x 0.5 cm. One piece is submitted in toto in B1, other piece is bisected. and submitted in toto in B2/3. C: The specimen consists of a ring-shaped piece of duct which measures 0.2 cm in length. and 0.9 cm in diameter. Submitted in toto for quick section in one block. Specimen is received fresh. The container is designated C proximal bile duct margin. D: Specimen is received fresh. The container is designated Whipple's The specimen. consists of a segment of duodenum with attached head of pancreas. The bowel measures. approximately 25 cm in length with a circumference which ranges from 4 to 6.5 cm. The. attached head of pancreas measures 6 x 5 x 2.5 cm. The pancreatic body margin is inked. blue, the mesenteric vessel bed margin inked orange, and the uncinate process inked. black. Sectioning the pancreas reveals a firm light tan ill defined mass near the. uncinate process measuring approximately 2.5 x 2.7 x 1.5 cm. Grossly, the mass comes. within 0.1 to 0.2 cm of the black painted uncinate process margin. It is approximately. 2.5 cm away from the blue painted pancreatic body margin. Grossly, the mass comes within. less than 0.1 cm of the external smooth mesothelial surface of the pancreas. The bile. duct is identified and upon opening, contains a stent. The bile duct measures 7 cm in. length and has a circumference of 2.5 cm at the proximal resection margin. The. circumference as it nears the ampulla is 1.5 cm. The mucosa of the bile duct is tan and. is hemorrhagic where the stent is found. The mucosal surface surrounding the ampulla is. firm and indurated. Where the mucosa of the ampulla and the duodenum is firm and. indurated, also corresponds to the location of the tumor which is found in the pancreas. Found in the adipose adjacent to the pancreas, are four possible lymph nodes ranging in. size from 0.7 to 2 cm in greatest dimension. Sections of the specimen as follows: D1. bile duct margin. D2/3. one section of the mass in the pancreas bisected. These sections also. demonstrate the. black painted uncinate process/retroperitoneal margin, as well as the. indurated duodenal. mucosa. D4/5. one section of the mass in the pancreas bisected. This section also shows. the black. painted uncinate process/retroperitoneal margin, as well as the indurated. duodenal. mucosa. three sections of bile duct and ampulla. D8/9. shave section of pancreatic body margin bisected. D10. section of grossly unremarkable pancreas with identifiable pancreatic duct. Also includes. a section of bile duct where the stent was located. D11/12. two further sections of bile duct where the stent was found. D13/14. proximal resection margin of duodenum ? distal portion of stomach bisected. D15. shave section distal margin of duodenum bisected. D16. one possible lymph node bisected. D17. two possible lymph nodes. D18/19. one possible lymph node bisected. Frozen Section Diagnosis. C: Proximal Bile Duct Margin: Low grade dysplasia. Negative for carcinoma. Encounter Number. Patient Location.",T3,N1,M0,T3N1M0
TCGA-58-8388,"Pathology Report-Summary: Material: Lung, left, upper lobe: 21.5 X 16.5 X 4.5 cm. Tumor: 3.5 X 3.0 X 4.5 cm. Diagnosis: Squamous Cell Carcinoma, mostly basaloid. pT2a, pNO (0/35), pMx, G3. Supplementary examinations: IHC: Tumor positiv for p63, CK5/6, some cells for CK14. Tumor cells negative for: CD56, Chromogranin A, SPA, synaptophysin, TTF1. Proliferation rate: 40 - 60%.",T2,N0,M0,T2N0M0
TCGA-AO-A0JG,"Clinical Diagnosis & History: year old female with 2.7 cm right breast cancer, lower outer quadrant and. FNA (+) metastatic right lymph node. Specimens Submitted: 1: SP: Right breast and axillary contents levels one and two with tags. attached. 2: SP: Subscapular nodes, right axilla level one. DIAGNOSIS: 1. BREAST, RIGHT; MASTECTOMY AND AXILLARY DISSECTION: - INVASIVE DUCTAL CARCINOMA, MIXED MUCINOUS & NOS TYPE AND WITH. SOLID-PAPILLARY FEATURES, HISTOLOGIC GRADE III/III (SLIGHT OR NO TUBULE. FORMATION), NUCLEAR GRADE II/III (MODERATE VARIATION IN SIZE AND SHAPE). MEASURING 2.3 CM IN LARGEST DIMENSION MICROSCOPICALLY. - (DCIS) IS ALSO IDENTIFIED, SOLID AND CRIBRIFORM TYPES WITH. INTERMEDIATE NUCLEAR GRADE. AND MINIMAL NECROSIS. - LOBULAR INVOLVEMENT BY DCIS IS PRESENT. - THE DCIS CONSTITUTES LESS THAN OR EQUAL TO 25% OF THE TOTAL TUMOR. MASS, AND IS PRESENT. ADMIXED WITH AND AWAY FROM THE INVASIVE COMPONENT. - THE INVASIVE CARCINOMA IS LOCATED IN THE LOWER OUTER QUADRANT. - THE DCIS IS LOCATED IN THE LOWER OUTER QUADRANT AND LOWER INNER. QUADRANT. - NO INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINOMA. IS IDENTIFIED. - CALCIFICATIONS ARE PRESENT IN BENIGN BREAST PARENCHYMA. - VASCULAR INVASION IS PRESENT. - INVASIVE CARCINOMA IS CLOSE (LESS THAN OR EQUAL TO 1 MM) TO THE. FOLLOWING SURGICAL. MARGIN(S) : BLUE INKED MARGIN (ANTERIOR). NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES AND. PROLIFERATIVE FIBROCYSTIC. CHANGES INCLUDING INTRADUCTAL PAPILLOMA. - LEVEL 1: METASTATIC ADENOCARCINOMA TO FOUR OUT OF TEN LYMPH NODES. (4/10). THE LARGEST METASTATIC FOCUS MEASURES 2.5 CM. THERE IS EXTRANODAL EXTENSION OF CARCINOMA, FOCAL. - LEVEL 2 : THREE BENIGN LYMPH NODES (0/3). Page or. IMMUNOHISTOCHEMICAL STAIN WAS PERFORMED ON FORMALIN-FIXED TISSUE WITH THE. FOLLOWING RESULTS FOR INVASIVE CARCINOMA (BLOCK 1T6) : HER2. NEGATIVE (0 / 1+). 5% OF INVASIVE TUMOR CELLS EXHIBIT COMPLETE MEMBRANOUS STAINING;. UNIFORMITY OF STAINING: ABSENT. HOMOGENEOUS, DARK CIRCUMFERENTIAL PATTERN: ABSENT. Comment: Controls are satisfactory. s PATHWAY anti-HER-2/neu is an. FDA-approved rabbit monoclonal primary antibody (clone 4B5) directed against. the internal domain of the c-erbB-2 oncoprotein (HER2) for. immunohistochemical detection of HER2 protein overexpression in breast. cancer tissue routinely processed for histologic evaluation. The HER2 test. results are reported in accordance with the ASCO/CAP guideline. recommendations for HER2 testing in breast cancer (J Clin Oncol 2007;. 25 (1) :118-145) The ER and PR rabbit monoclonal antibodies are also FDA. approved. 2. LYMPH NODES, RIGHT AXILLA LEVEL ONE, SUBCAPSULAR: - SIX BENIGN LYMPH NODES (0/6). Some of the immunohistochemistry and. tests were develoned and their. performance characteristics were determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not. be regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of 1988 (CLIA , 88) as. qualified to perform high complexity clinical laboratory testing. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1) The specimen is received fresh labeled, ""right breast and axillary. contents levels one and two with tags attached and consists of a breast. measuring 19 x 18 x 3 cm with overlying skin ellipse measuring 11 x 3 cm. Situated centrally on the skin surface is an everted nipple measuring 1 x 1. x 0.6 cm and areola measuring 3 x 3 cm. A suture demarcates the axillary. contents which measures 11 x 7 x 3 cm. Two tags are present, designating. levels one and two. The posterior surface of the breast is inked black, the. anterior blue and the axillary aspect is inked yellow. The specimen is. serially sectioned to reveal a 2.5 cm diameter mass in the lower outer. Page 3 or. quadrant and 1 cm from the deep margin. A clip is identified in the mass. The remaining breast tissue shows nodular fibroadipose tissue. The axillary. tisbue is dissected to reveal multiple lymph nodes, ranging in size from 0.5. cm to 2.5 cm. Representative sections are submitted. All dissected lymph. nodes are entirely submitted. Summary of sections: N - nipple. NB - nipple base. D - deep margin. T - tumor. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. L1 lymph nodes, level 1. L2 lymph nodes level2. 2). The specimen is received in formalin, labeled ""subscapular nodes right. axilla level one"" and consists of pink tan firm lymph nodes ranging from 0.8. to up 2 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN lymph nodes. BLN- bisected lymph nodes. Summary of Sections: Part 1: SP: Right breast and axillary contents levels one and two with tags. attached. Block. Sect. Site. PCs. 1. D. 1. 6. L1. 6. 1. L2. 2. 1. LIQ. 1. 1. LOQ. 1. 2. N. 2. 1. NB. 1. 3. 3. 1. UIQ. 1. 1. UOQ. 1. Part 2: SP: Subscapular nodes, right axilla level one. Block. Sect. Site. PCs. 2. BLN. 2. 1. LN. 1. Page 4 or.",T2,N2,M0,T2N2M0
TCGA-D7-A4YX,"Gender: M. Examination result No. Clinical diagnosis (suspicion): Stomach carcinoma. Date of admission: (urgency: Standard). Material: 1) Material: stomach, Method of collection: Total organ resection. Histopathological Diagnosis: Adenocarcinoma male differentiatum ventriculi. Stomach adenocarcinoma poorly differentiated. Cancer. metastases in lymph nodes NO I/XIX. G3, pT3, pNI, Intestinal type: sec. Lauren. (8140/3 T-63000). Macroscopic description: Specimen consisting of the stomach, having been cut out along the greater curvature, sized 21.5 x 18 cm with the. omentum sized 35 X 18 cm. Cauliflower-shaped tumour on the posterior sized 9.5 x 6.5 x 3.1 cm. Distance from the proximal end: 1.3 cm, from distal. end: 9.5 cm. Microscopic description: Adenocarcinoma male diferentiatum. Infiltratio carcinomatosa tunicae muscularis priopriae et telae adiposae periventricularis. Surgical incision lines clear of cancerous invasion (proximal line under microscopic examination 0.4 cm). Emboliae carcinomatosae vasorum. Omentum sine metastasibus. LYMPH NODES: - cardia: metastases carcinomatosae in lymphonodo No (I/I). Infiltratio carcinomatosa capsulae lymphonodo. - lesser curvature: lymphonodulitis reactiva (No VII). - greater curvature: lymphonodulitis reactiva (No VII). - pyrolic: lymphonodulitis reactiva (No II). Result of immunohistochemical examination. HER2 protein stained with Ventana's Pathway HER-2/neu (4B5) Rabbit Monoclonal. Antibody. Positive reaction in invasive cancerous cells (Score = 3+).",T3,N1,M0,T3N1M0
TCGA-2F-A9KQ,Histologic diagnosis. High grade muscle invasive urothelial cell carcinoma covering most of the bladder wall. T3aG3 NO M0. Anatomic site and laterality. Bladder wall NOS. Tumor size. 5.5cm diameter. Lymph node status. A total of 18 lymph nodes all without tumor localization.,T3,N0,M0,T3N0M0
TCGA-F7-A623,Gross Description: Microscopic Description: Diagnosis Details: Tumor location: Subglottis. Comments: Formatted Path Reports: LARYNX TISSUE CHECKLIST. Specimen type: Laryngectomy. Tumor site: Larynx. Tumor size: 3 x 4x2.5cm. Histologic type: Squamous cell carcinoma. Histologic grade: Well differentiated. Tumor extent: Not specified. Lymph nodes: 2/6 positive for metastasis (Regional 2/6). Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Comments: Tumor location: Subglottis.,T1,N2,M0,T1N2M0
TCGA-DJ-A2PR,"Clinical Diagnosis & History: 'ear old with papillary carcinoma left thyroid. Papillary thyroid carcinoma,. Specimens Submitted: 1: Thyroid gland, right lobe; hemithyoidectomy. 2: Thyroid gland, left lobe; hemithyoidectomy. 3: Lymph nodes, left paratracheal; dissection. DIAGNOSIS: 1. Thyroid gland, right lobe; hemithyoidectomy: - Papillary thyroid microcarcinoma, 0.15 cm in greatest dimension, located in the right lobe. - No extrathyroidal extension or vascular invasion is noted. - Margins are free of tumor. - Psammoma bodies are noted in the surrounding thyroid tissue. - Chronic lymphocytic thyroiditis and nodular hyperplasia. - Two psammoma bodies are noted involving one of two lymph nodes consistent with metastatic papillary thyroid carcinoma. (1/2). 2. Thyrold gland, left lobe; hemithyoidectomy: Tumor Type: Papillary carcinoma, classical type. Histologic Grade: Weil differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 2 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Focal invasion. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Invades:extrathyroidal adipose tissue. focal. Surgical Margins: Free of tumor. Tumor Multicentricity: Microscopic foci present. One focus of papillary microcarcinoma is noted in the left lobe measuring 0.2 cm. Adenoma(s) (away from the carcinoma): Not Identified. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Exhibits chronic lymphocytic thyroiditis. Parathyrold Glands: Not identified. Comment: Psammoma bodies are noted in the non-neoplastic thyroid tissue. 3. Lymph nodes, left paratracheal; dissection: Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 12. Number of lymph nodes with metastatic disease: 6. Size of the largest lymph node involved by tumor: 0.6cm. Size of the largest metastatic focus : 0.4 cm. Extranodal extension is not identified. Comment: Some of the positive lymph nodes show only psammoma bodies. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: M.D. 1. The specimen is received fresh, labeled ""right thyroid"" and consists of a 6.5g, 4.3 x 2.2 x 1.2 cm right thyroid lobe oriented by a. long and a short stitch as per requisition. The external surface is free of abnormalities; the posterior is inked black, the anterior is. inked blue and the isthmus green. The cut surface reveals a slightly pale, firm cut surface, free of focal lesions. The entire lobe is. submitted. Summary of sections: RL - right lobe of thyroid, serially sectioned, submitted from superior to inferior. ,, M.D. 2. The specimen is received fresh, labeled ""left thyroid lobe"" and consists of a 25g left lobe of thyroid and isthmus, 5.0 x 2.0 x 2.5. cm, oriented by a long and a short stitch as per requisition. The external surface is free of abnormalities. The posterior is inked. black, the anterior is inked blue and the isthmus green. The cut surface reveals a bright yellow papillary soft lesion in the lower. pole, 2.0 x 1.8 x 1.6 cm, surrounding by some fibrosis. It is 0.2 cm from the anterior and posterior surfaces and 0.6 cm from the. isthmic margin. The tumor is entirely submitted for TPS and permanent sections. The remaining thyroid lobe is entirely submitted. Summary of sections: T - lesion, serially sectioned. LL - remaining. 3) The specimen is received fresh, labeled ""left para-tracheal lymph node"" and consists of multiple pink tan firm lymph nodes. ranging from 0.2 x 0.2 x 0.2 cm to 0.5 x 0.3 x 0.2 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. Summary of Sections: Part 1: Thyroid gland, right lobe; hemithyoidectomy. Block. Sect. Site. PCs. 6. RL. 6. Part 2: Thyroid gland, left lobe; hemithyoidectomy. Block. Sect. Site. PCs. 6. LL. 6. 3. T. 3. Part 3: Lymph nodes, left paratracheal; dissection. Block. Sect. Site. PCs. 2. In. 2.",T3,N1,M0,T3N1M0
TCGA-G4-6586,"SPECIMENS: A. RIGHT AND TRANSVERSE COLON. SPECIMEN(S): A. RIGHT AND TRANSVERSE COLON. GROSS DESCRIPTION: A. RIGHT AND TRANSVERSE COLON. Received fresh and labeled ""right transverse colon"", it consists of a right hemicolectomy with a portion. of terminal ileum. The segment of terminal ileum measures 7.0 cm in length. The right colon measures. 33.0 cm in length. The proximal (ileal) surgical margin measures 3.5 cm in circumference, and the. distal (colonic) surgical margin measures 8.0 cm in circumference. An appendix is identified and. measures 5.5 cm in length X 0.6 cm in width. Upon opening the specimen, a tumor mass is identified,. located 7.0 cm from the distal surgical margin. This mass is tan colored, measures 4.0 X 4.0 X 1.1 cm. and has heaped-up edges around its periphery, without obvious central ulceration. In addition to the. primary mass, there are several minute (0.2 to 0.4 cm in diameter) polypoid lesions, 3-4 in the proximal. ascending colon (proximal to the primary mass) and 1 in the distal aspect of the specimen (distal to the. tumor mass). No other mucosal lesions are identified. Portions of the primary tumor mass and. representative normal colon are procured. Summary of sections: A1: Proximal surgical margin. A2: Distal surgical margin. A3-A9: Primary tumor mass, blocked out and submitted entirely. A10: Additional subserosal fat subjacent to primary mass. A11: Representative terminal ileum. A12: Representative cecum. A13: Representative proximal colon with polypoid lesion. A14: Representative distal colon with polypoid lesion. A15: Appendix base and mid-portion. A16: Appendix tip. A17-A21: Each have one lymph node, bisected. A22: Two lymph nodes, each bisected (one is inked black). A23: Six possible lymph nodes. A24: Four possible lymph nodes. A25: Six possible lymph nodes. A26: One lymph node, bisected. DIAGNOSIS: A. COLON, RIGHT AND TRANSVERSE, RESECTION: INVASIVE ADENOCARCINOMA, WITH MUCINOUS FEATURES, MODERATELY. DIFFERENTIATED. - 4.0 CM IN GREATEST DIMENSION. - 4.0 X 1.1 CM IN ADDITIONAL DIMENSIONS. - INVADING INTO THE SUBSEROSA. - THE PROXIMAL, DISTAL, AND RADIAL MARGINS ARE NEGATIVE FOR TUMOR. - ANGIOLYMPHATIC INVASION IS PRESENT. - NO PERINEURAL INVASION IDENTIFIED. - ASSOCIATED WITH ADENOMATOUS CHANGE. - TUBULAR ADENOMAS ARE PRESENT AWAY FROM THE TUMOR. - APPENDIX WITH NO HISTOPATHOLOGICAL ABNORMALITIES. NO MALIGNANCY IDENTIFIED IN SEVENTEEN LYMPH NODES (0/17). SYNOPTIC REPORT - COLON & RECTUM. Specimens Involved. Specimens: A: RIGHT AND TRANSVERSE COLON. Specimen Type: Right hemicolectomy. Tumor Site: Right (ascending) colon. Tumor Configuration: Infiltrative. Tumor size: 4cm Additional dimensions 4cm X 1. .1cm. WHO Classification. Adenocarcinoma 8140/3. Histologic Grade: G2: Moderately differentiated. Extent of Invasion: Subserosa. Margins: Margin(s) uninvolved by invasive carcinoma (Proximal, Distal, Radial). Venous/Lymphatic Invasion: Present. Perineural Invasion: Absent. Additional Pathologic Findings: None identified. Extent of Resection: R0: Complete resection with grossly and microscopically negative margins. Lymph Nodes: Negative 0 / 17. Implants: Absent. Pathological Staging (pTNM): pT 3 N 0 M X. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Colon ca.",T3,N0,M0,T3N0M0
TCGA-SX-A7SP,"Encounter. info: REVISED REPORT. Clinic Number: DIAGNOSIS: AMENDMENT REPORT. This amendment is being performed to. correct the AJCC pathologic stage grouping. The stage grouping will. be changed to pT1b,NO. Procedure/laterality: Kidney, left, partial nephrectomy. Histologic type: Papillary renal cell carcinoma, type 1. Nuclear grade (Fuhrman, 1-4) : 2 of 4. Tumor size: 5.5 cm in greatest dimension. Tumor site: Midportion left kidney. Tumor focality: Unifocal. Sarcomatoid features: Absent. Tumor necrosis: Absent. Microscopic tumor extension: Extension into perinephric tissue: Not applicable. Extension beyond Gerota's fascia: Not applicable. Extension into renal sinus: Not applicable. Extension into renal vein: Not applicable. Extension into collecting system: Not applicable. Extension into adrenal gland (if applicable) : Not applicable. Surgical margins : Negative. Lymph-vascular invasion: Absent. Lymph nodes: Not applicable. Pathologic findings in nonneoplastic kidney: There is insufficient. non-neoplastic kidney available for evaluation. Pathologic staging: pT1b, NO. Biorepository sample (if applicable) : Positive for malignancy. Block (s) containing malignancy suitable for additional testing: A1-A6. DIAGNOSIS COMMENT: Frozen section diagnosis confirmed on permanent sections. Representative sections shared with. who concurs. AMENDMENTS: (Previous Signout Date: Revision Description: See final report for amendment reason. Original Diagnosis. Procedure/laterality: Kidney, left, partial nephrectomy. Histologic type: Papillary renal cell carcinoma, type 1. Nuclear grade (Fuhrman, 1-4) : 2 of 4. Tumor size: 5.5 cm in greatest dimension. Tumor site: Midportion left kidney. Tumor focality: Unifocal. Sarcomatoid features: Absent. Tumor necrosis: Absent. Microscopic tumor extension: Extension into perinephric tissue: Not applicable. Extension beyond Gerota's fascia: Not applicable. Extension into renal sinus: Not applicable. Extension into renal vein: Not applicable. Extension into collecting system: Not applicable. Extension into adrenal gland (if applicable) : Not applicable. Surgical margins: Negative. Lymph-vascular invasion: Absent. Lymph nodes: Not applicable. Pathologic findings in nonneoplastic kidney: There is insufficient. non-neoplastic kidney available for evaluation. Pathologic staging: pT2, NX. Biorepository sample (if applicable) : Positive for malignancy. Block (s) containing malignancy suitable for additional testing: A1-A6. CLINICAL INFORMATION: Left kidney mass. SPECIMEN (S) : A:Left renal mass. PRELIMINARY INTRAOPERATIVE DIAGNOSIS: Intraoperative Pathologist (s) : A. Left renal mass, frozen section diagnosis: A1) Papillary renal cell carcinoma. GROSS DESCRIPTION: A. Received fresh labeled and ""left renal mass"". Procedure : Partial nephrectomy. Specimen laterality: Left. Tumor site: Midportion of left kidney, as indicated in the. radiologic imaging. Tumor size: 5.5 x 4.5 x 3.5 cm. Tumor focality: Unifocal. Gross extent of tumor: Extension into perinephric tissue: Absent. Extension beyond Gerota's fascia: Absent. Extension into renal sinus: Not grossly apparent. Extension into renal vein: Not grossly apparent. Extension into collecting system: Not grossly apparent. Adrenal gland: Absent. Gross notes: Gross tumor characteristics: Tan-yellow, centrally hemorrhagic,. well-demarcated, solid mass with diffusely soft cut surfaces. Kidney weight: 43 g. Kidney dimensions: 5.5 x 4.5 x 3.5 cm. Distance to margin: The tumor grossly appears to abut the inked. parenchymal margin. Lymph nodes: Absent. Inking details: The parenchymal resection margin is inked black. and the margin is designated by the surgeon. Biorepository sample submitted: Yes, see block key. Other: Representative sections from the cut surface of the tumor. are submitted for frozen section in one block. Block key for specimen A: A1) Representative sections from cut surface of tumor, submitted for. frozen section. A2-A4) Additional sections of tumor in relation to inked parenchymal. margin. A5) Mirror image of tissue submitted for IRB study. A6) Section of tumor in relation to outermost surface (renal. capsule) . Support for the diagnosis in this case may have included the. use of mmunohistochemistry tests that were developed and whose. performance characteristics were determined by. They have not been cleared. or approved by the U.S. Food and Drug Administration (FDA) . The FDA has determined that such clearance or approval is not. necessary. These tests should not be regarded as investigational. or for research. This laboratory is certified under the Clinical. Laboratory Improvement Amendments of 1988 ('CLIA') as qualified. to perform high complexity clinical laboratory testing.",T1,N0,M0,T1N0M0
TCGA-VD-AA8S,"HISTOPATHOLOGY. Lab No. Clinical Consultant & Location. Unit No. SPECIMEN. RIGHT ENUCLEATED GLOBE, PROGNOSTIC AND DIAGNOSTIC TESTS. CLINICAL DETAILS. Right eye choroidal melanoma, involved optic nerve. Tumour size: 13.36 x 13.42mm (thickness 6.43) mm. MACROSCOPIC DESCRIPTION. A fresh, intact, right globe. Dimensions: Axial 25mm, Horizontal 25mm, Vertical 25mm. Cornea: Horizontal 12.4mm, Vertical 12mm. Optic nerve. Length 5mm, Diameter 4mm. Pupil: dilated. On trans-illumination, a shadow is seen posteriorly in the. infero medial quadrant 12mm, query involvement of the disc. Plane of section: vertical. Intraocular description: On opening, a solitary, dome shaped, pigmented tumour is. seen involving the optic disc. Cut surface of optic nerve is. dusky - ? infiltration with tumour. Tumour size. LBD 13mm, Height 6mm. MICROSCOPY. Histologically, the enucleated eye demonstrates a normal. anterior segment with an unremarkable cornea, a deep. anterior chamber and open angles. The iris leaves are. unremarkable. The ciliary muscles are moderately atrophic. There is mild hyalinisation of the ciliary processes. The. lens shows moderately advanced cataractous changes. printed: HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. In the posterior segment, close to the optic nerve head, a. choroidal melanoma can be seen. This is dome-shaped with a. small accompanying exudative retinal detachment. The retina. overlying the tumour is atrophic with degenerative changes. Focally, at the apex of the tumour, there is retinal. invasion. The tumour is partially pigmented and consists predominantly. of spindle cells. The melanoma cells are immunoreactive for. MelanA, CD117 and HSP-27 (score 3). The number of mitoses is approx. 2/40 high power fields. The microvasculature of the melanoma is not prominent, and. closed loops are not present in the tissue planes evaluated. Occasional ""vascular lakes"" can be observed; in these tumour. cells can be see located within the lumen. The lymphocytic. infiltrate within tumour is minimal. Macrophages are. scattered throughout the tumour in a mild density.There is. no evidence of scleral invasion or of extraocular growth. The optic nerve is tumour free, and demonstrates mild. atrophic changes. The examined vortex veins are free of. tumour. FINAL DIAGNOSIS. Choroidal melanoma of spindle cell type. COMMENT. In the meantime, molecular genetic analysis of tumour DNA. extracted from the fresh uveal melanoma tissue was performed. using the technique termed multiplex ligation-dependent. probe amplification (MLPA) These investigations were. performed in the. The kit P027 from. which examines for gains or. losses in 31 loci on chromosomes 1, 3, 6 and 8, was used. The DNA concentration was measured using. and the. quality assessed using multiplex-PCR prior to the MLPA. reaction. printed: : HISTOPATHOLOGY REPORT. Lab No. Clinical Consultant & Location. Unit No. The DNA concentration was high and of good quality on. assessment. The MLPA reaction was run at least twice. on. differing occasions, resulting in similar results. The results of the sequence analysis of the MLPA products is. printed on a separate report. In summary, sequence analysis. demonstrated: normal chromosome 1,. three borderline losses of chromosome 3,. gains of chromosome 6. and gains in chromosome 8. These molecular data require correlation with the clinical. and morphological data for metastatic risk assessment.",T2,N0,M0,T2N0M0
TCGA-AA-A02O,"Diagnosis: This is an invasive, moderately differentiated adenocarcinoma of the colon, G2,. with permeation of all wall layers, p T3,. with lymphatic vessel invasion, L 1,. otherwise free lymph nodes (0 of 18). Tumor classification: ICD-O-DA M 8140/3. G 2,. p T 3, p N 0, L 2. The resection margins were free.",T3,N0,M0,T3N0M0
TCGA-CZ-5451,"Report Status: Amend/Addenda. Type: Surgical Pathology. Specimen Type: Kidney, partial or total resection. Procedure Date: PATHOLOGIC DIAGNOSIS : A. LEFT KIDNEY, RADICAL NEPHRECTOMY: RENAL CELL CARCINOMA, CLEAR CELL TYPE (8.7 cm), Fuhrman grade III, unifocal,. involving the lower pole. No capsular extension identified. Soft tissue, ureteral, and vascular margins negative for tumor. Adrnal gland negative for tumor. Cortical simple cysts (3.5 cm largest). AJCC (8th edition classification T2 NO Mx. B. SPECIMEN LABELED ""10th RIB SEGMENT"": Bone, cartilage, and skeletal muscle, negative for tumor. Maturing trilineage hematopoiesis. C. SPECIMEN LABELED ""REGIONAL NODE"" : Thirteen (13) lymph nodes with negative for tumor. CLINICAL DATA: History: with weight loss, fatigue found renal mass by CT. Operation: Nephrectomy. Operative Findings: Not provided. Clinical Diagnosis: Renal mass by CT. TISSUE SUBMITTED: A. (L) kidney. B. 10th rib segment. C. Regional node. GROSS DESCRIPTION: The specimen is received fresh, in three parts, each labeled with the patients. name and unit number. Part A, labeled ""1. L kidney"", consists of a 1449 gm left nephrectomy specimen. (26.0 x 11.5 x 8.5 cm) including kidney (18.5 x 8.0 x 7.0 cm) ureter (8.2. cm. in length x 0.5 cm in diameter), renal vein (0.5 cm in length, x 0.2 cm in. diameter), renal artery (2.6 cm in length x 0.6 cm in diameter) and attached. yellow/tan perinephric adipose tissue (up to 3.5 cm in thickness) The. specimen is bivalved. In the lower pole, 8.5 cm from the ureteral margin, 4.9. cm from the renal artery margin, and 3.5 cm from the renal vein margin, there. is a well encapsulated yellow/red hemorrhagic centrally fibrotic mass (8.7 x. 7.4 x 5.7 cm) compressing and distorting the renal parenchyma and the renal. capsule. Upon sectioning, the mass is approximately 90% solid and 10% cystic. The mass comes to within 0.3 cm of the blue inked deep/perinephric fat margin. The mass focally compresses and distorts but does not grossly appear to invade. into the inferior pelvocaliceal system and renal sinus. The uninvolved kidney parenchyma is tan/brown with a moderately distinct. cortical medullary junction and approximately six smooth walled tan simple. cortical cyst (ranging from 0.7 to 3.5 cm in greatest dimension) scattered. throughout the mid and superior poles. Each of the cysts is filled with clear. serous fluid, with no excrescences grossly identified. The pelvocaliceal. system is moderately dilated and exhibits smooth glistening tan mucosa. The. adrenal gland (6.2 x 2.5 x 1.2 cm) is present and exhibits an unremarkable. golden yellow cortex (0.2 cm in maximum thickness) and red/brown medulla (0.1. cm in maximum thickness). examined. There is no evidence of active glomerulitis, proliferative lesions or's. fibrinoid necrosis. The kidney parenchyma has been reviewed by Dr. Renal. MICROSCOPIC DESCRIPTION: Sections of formalin-fixed paraffin-embedded tissue (block A8) were evaluated. using HE, PAS, Jones silver methenamine, and AFOG (trichrome) stains. The sample consists of cortex and medulla. There are 155 glomeruli present, of. which 16 (10.3 %) are globally sclerosed. The remaining glomeruli show mild. signs of hypertrophy of the tuft. There is very mild, focal expansion of the. mesangial areas. On PAS and Jones silver stains there are no discernible. crater-like defects or ""spikes"", and only isolated double contours of the. glomerular capillary wall basement membranes are recognized. Several distal. tubules contain PAS-positive hyaline casts. Isolated distension of tubules is. recognized in the cortical area. Approximately 5% of the cortical parenchyma. shows tubular atrophy and interstitial fibrosis as seen in the trichrome stain. (AFOG). Arteries and arterioles exhibit moderate degree of sclerosis, with. focal hyaline accumulation in the subintima in the arterioles. Report Status: Final. Type: Cytogenetics. Cytogeneticist: KARYOTYPE: 46,XY[15]. METAPHASES COUNTED: 15. ANALYZED: 5. SCORED: 10. BANDING: GTG. INTERPRETATION: No cytogenetic aberrations were identified in metaphases analyzed from this. specimen. This normal result does not exclude a neoplastic proliferation. COMMENTS: Mosaicism and small chromosome anomalies may not be detectable using the. standard methods employed. Chromosome analysis was performed at a level of 400. bands or greater. INDICATION FOR TEST: RCC.",T2,N0,M0,T2N0M0
TCGA-MP-A4TC,";urgical Pathology. TISSUE DESCRIPTION: A1 A2 A3 A4 A5 J1 K1 K2 B1 C1 C2 C3 C4 C5 C6 D1 D2 E1 F1. F2 G1 H1 H2 H3 H4 H5 H6 Il. Right middle/lower lobes lung (295.0 grams), tissue from right lung. fissure (0.4 x 0.4 x 0.3 cm), station 2R lymph nodes, station 4R. lymph nodes (2 sets), station 7 lymph nodes (2 sets) station 9R. lymph nodes, station 10R lymph nodes, bronchus intermedius lymph. nodes, right upper lobe lung superior pulmonary vein lymph node. DIAGNOSIS: Lung, right middle and lower lobes, bilobectomy: Invasive grade 4. (of 4) adenocarcinoma, forming a well-circumscribed 1.6 x 1.5 x 1.5. cm cm subpleural mass. visceral pleural invasion is absent. Angiolymphatic invasion is present. The bronchial margin is. negative for tumor (by 8.2 cm). with available surgical material,. AJCCpT1pN2. Lung, right fissure, biopsy: Grade 4 (of 4) adenocarcinoma. Lymph nodes, intrapulmonary/hilar, excision: Metastatic adenocarcinoma is identified in multiple (3 of. 4) intrapulmonary peribronchial lymph nodes. Extranodal extension. is identified and extends through the major fissure. No tumor is identified in a single (1) right hilar. (station 10R) lymph node. Lymph nodes, mediastinal, excision: Metastatic adenocarcinoma is identified in a single (1 of. 21) right lower paratracheal (station 4R) lymph node. Metastatic adenocarcinoma is identified in a single (1 of. 18) subcarinal (station 7) lymph node. No tumor is identified in multiple (5) right upper. paratracheal (station 2R) lymph nodes. No tumor is identified in multiple (2) right pulmonary. ligament (station 9R) lymph nodes. Lymph nodes, bronchus intermedius, excision: Metastatic. adenocarcinoma is identified in a single (1 of 3) bronchus. intermedius lymph nodes. Lymph nodes, right upper lobe lung superior pulmonary vein,. excision: A single (1) right upper lobe lung superior pulmonary vein. lymph node is negative for tumor.",T1,N2,M0,T1N2M0
TCGA-DD-A11D,"TISSUE DESCRIPTION: A1 B1 B2 B3 B4. Right lobe liver (1,585 grams; 21.0 x 16.0 x 9.0 cm) and gallbladder. (8.5 x 2.0 x 2.0 cm). DIAGNOSIS: Liver, right lobe, resection: Grade 2 (of 4) hepatocellular. carcinoma forming a 4. x 3.8 x 3.7 cm mass located 3.0 cm from the. surgical margin. The uninvolved liver shows moderate cirrhosis. Gallbladder, cholecystectomy: Gallbladder without diagnostic. abnormalities. A single benign cystic duct lymph node is. identified. TISSUE DESCRIPTION: A1 B1 B2 B3 B4. Right lobe liver (1, 585 grams; 21.0 x 16.0 x 9.0 cm) and gallbladder. (8.5 x 2.0 x 2.0 cm). DIAGNOSIS: Liver, right lobe, resection: Grade 2 (of 4) hepatocellular. carcinoma forming a 4.4 x 3.8 x 3.7 cm mass located 3.0 cm from the. surgical margin. The uninvolved liver shows moderate cirrhosis. Gallbladder, cholecystectomy: Gallbladder without diagnostic. ebnormelities. A single benign cystic duct lymph node is. identified.",T1,N0,M0,T1N0M0
TCGA-A8-A0A4,"Diagnosis: 1. Invasive lobular breast carcinoma in the classical differentiation. variant (G II) with extensive infiltration of the skin but no ulceration of the skin (tumor. diameter 3 cm, minimum distance from dorsal resection margin 2.5 cm). Summary tumor classification: invasive lobular breast carcinoma, G II,. pT2pN0(0/10)LOVORO, positive for estrogen and progesterone receptors, negative for. C-erb B-2 oncoprotein. Follow-up finding: three times) A metastatic infiltration and also an influx of. individual cells of the invasive lobular beast carcinoma into the excised axillary lymph. node is definitely excluded. The pNO status is thus confirmed.",T2,N0,M0,T2N0M0
TCGA-BH-A1FU,"Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: DATE OF LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: R BREAST CANCER. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: RIGHT MODIFIED RADICAL MASTECTOMY. CLINICAL HISTORY. MATERIAL SUBMITTED: RIGHT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: FROZEN SECTION: Right breast measuring 18.0 by 17.0 by 5.2 cm with 16.0 by 6.3 cm skin and nipple and. partial axillary contents. A tan-white irregular mass measuring 1.8 by 1.0 by 1.2 Cm is identified 1.3 cm. from the deep resection margin. Mass lies in the center of the mass. FS Diagnosis: Infiltrating duct. carcinoma. ER/PRS taken. (1. Delow. FINAL DIAGNOSIS: RIGHT BREAST MASS AND AXILLARY CONTENTS: - MULTIFOCAL INVASIVE DUCTAL CARCINOMA, 1.8 BY 1.2 BY 1.0 CM., POOR NUCLEAR GRADE. - EXTENSIVE DUCTAL CARCINOMA IN-SITU, COMEDO TYPE. - VASCULAR PERMEATION SEEN. - SKIN, NIPPLE AND DEEP MARGINS FREE OF TUMOR. - FIVE (5) LYMPH NODES FREE OF TUMOR. - HEMORRHAGE AND HEMOSIDERIN LADEN MACROPHAGES CONSISTENT WITH BIOPSY SITES. - FIBROCYSTIC CHANGES. NOTE: Within the invasive tumor, the ductal carcinoma ;in-situ component is about 30%. S U P P L x M E N T R E P o R T. (HER2/NEU). My signature below is attestation that I have reviewed all slides and agree with the findings as noted. below. AS PER THE REQUEST OF. OF THE. c-erb82 (HER-2/NEU). DMMUNOSTAINING IS CARRIED OUT ON PREVIOUS MAGKE SURGICAS. BBOCK ""A4"" (BREAST CANCER) USING A 1:300. DILUTION of DAKO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE INTRACELLULAR DOMAIN OF c-erbB2) WITHOUT. ANTIGEN RETRIEVAL. DISTINCT COMPLETE MEMBRANE STAINING IS IDENTIFIED IN 90% OF TUMOR CELLS THEREFORE, c-. erbB2 (HER-2/NEU) IS INTERPRETED AS POSITIVE (SCORE 3+). SIGNED COPY ON FILE. s. (ER/PR). My signature below is attestation that I have reviewed all slides and agree with the findings as noted. below. IMMUNOPEROXIDASE IDENTIFICATION OF ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE. ""A4"". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED TOCALLY FOR PROGESTERONIS RECEPTOR (20%) BUT NOT FOR. ESTROGEN RECEPTOR. THEREFORE, PROGESTERONE RECEPTOR IS INTERPRITED AS BOR DERLINE AND ESTROGEN RECEPTOR AS. NEGATIVE.",T1,N0,M0,T1N0M0
TCGA-55-A48X,"PROCEDURE DATE: RECEIVED DATE: REPORT DATE: Pre-Op Diagnosis. Lung mass. Post-Op Diagnosis. Same. Clinical History. Nothing indicated on requisition. Gross Description: Five parts. Container labeled. 1 - level 10 lymph node left lung"". is a 2.0 x 1.5 x 1.0 cm of gray black focally shaggy fleshy. appearing tissue fragments entirely submitted in a single cassette. Container labeled. 2 - level 7 lymph node left lung"". is a 0.8 x 0.6 x 0.3 cm of gray black fleshy tissue fragments. entirely submitted in a single cassette. Container labeled. 3 - level 5 lymph node left lung"". is a 1.1 x 0.8 x 0.3 cm of gray yellow to brown black fleshy and. fibrofatty appearing tissue fragments which are entirely submitted. in a single cassette. Container labeled. 4 - left lower lobe left lung"" is a. 129 gram previously partially sectioned portion of recognizable. pulmonary parenchyma grossly consistent with left lower lobe of. lung. The specimen as received is 15.0 x 7.9 x 12.0 cm and as its. margin of resection multiple staple lines one of which appears to be. a bifurcated tertiary bronchus. The pleura is slightly wrinkled tan. pink with focal anthracotic streaking. The specimen has been. partially sectioned at the apex to reveal a subpleural 2.6 X 2.2 x. 1.9 cm previously sectioned nodular lesion with a gritty focally. anthracotic streaked gray tan fibrotic cut surface. The lesion. grossly extends to but not through the pleura. This is noted at its. nearest point 2.9 cm from the bronchial margin. An apparent. bronchial connection is identified. The specimen is received after. tissue harvest for genomic study. Within the specimen container are. three tissue cassettes labeled. ""he remaining. parenchyma is spongy pink red with moderate anthracotic streaking. No additional gross lesions are identified. Representative sections. are submitted labeled as follows: A - shaved bronchial margin, B. through E - remaining lesion and surrounding tissue, F - random. uninvolved parenchyma. Container labeled. 5 - level 6 lymph node left lung"". is a 1.6 x 0.7 x 0.3 cm elongated portion of gray tan to pink yellow. fleshy and fibroadipose tissue fragments which are entirely. submitted in a single cassette. Microscopic Description: The slides labeled. are examined. See diagnosis. Final Diagnosis. Left lung, left lower lobe (lobectomy): Specimen integrity: Specimen intact, margins can be evaluated. Specimen laterality: Left. Tumor site: Left lower lobe. Tumor size: 2.6 cm in greatest diameter. Focality: Unifocal. Histologic type: Adenocarcinoma. Grade: Moderately differentiated. Visceral pleural invasion: Not identified. Tumor extension: Not identified. Surgical margin status: Bronchial margin: No carcinoma identified. Vascular margin: Not applicable. Parenchymal margin: Not applicable. Parietal pleural margin: Not applicable. Chest wall margin: Not applicable. Visceral pleura: Carcinoma extends up to but not into and through. visceral pleura. Distance of invasive carcinoma from closest margin: Less than 1 mm. from the visceral pleural margin. Treatment effect: Unknown. Lymphovascular space invasion: No unequivocal lymphovascular space. invasion identified. Lymph nodes: Carcinoma identified within one of two peribronchial. lymph nodes (1/2) (see comment). See below diagnoses for. remaining lymph nodes. Other findings: Emphysematous changes. Left lung, level 10 lymph nodes: Multiple fragments of lymph node demonstrating reactive sinus. histiocytosis and anthrasilicosis, no metastatic carcinoma. identified (see comment). Left 7 lymph node, left lung: Fragments of lymph node demonstrating reactive sinus histiocytosis. and anthrasilicosis, no metastatic carcinoma identified. Level 5 lymph node, left lung: Fragments of lymph node demonstrating reactive sinus histiocytosis. and anthrasilicosis, no metastatic carcinoma identified. Level 6 lymph node, left lung: Two fragments of lymph node demonstrating reactive sinus. histiocytosis and anthrasilicosis, no metastatic carcinoma. identified. Stage: pT1b N1(see comment). Comments. Two peribronchial lymph nodes were identified within specimen #4,. the left lower lobe lobeetemy. One of the twe bronchial mph nodes. demonstrates a small focus of adenocarcinoma. Therefore, this is. staged as a pN1. The level 10 lymph nodes left lung, level 7 lymph nodes left lung,. and level 5 lymph nodes left lung were all received fragmented and. therefore an accurate node count cannot be performed. An elastic stain was performed which demonstrates the adenocarcinoma. to extend up to but not into or through the visceral pleura (with. appropriate positive control). At the request of the undersigned pathologist, these slides have. been additionally reviewed by Dr. who concurs with the. diagnosis.",T1,N1,M0,T1N1M0
TCGA-AG-3726,"Diagnosis: Resection material from the colon or rectum shows tumor-free resection margins and includes a. moderately differentiated adenocarcinoma or rectal carcinoma with incipient infiltration of the. perimuscular fatty tissue without regional lymph node metastases (G2, pT3 pNO 0/34) L0 V0. RO).",T2,N0,M0,T2N0M0
TCGA-DJ-A2Q3,"Ret. Source: Clinical Diagnosis & History: year old female with left thyroid nodule status post FNA positive for papillary thyroid CA. Specimens Submitted: 1: Total thyroidectomy. 2: Delphian node. 3: Additional Delphian node. 4: Right paratracheal tissue. DIAGNOSIS: 1. Total thyroidectomy: Tumor Type: Papillary carcinoma, tall cell variant. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Marked stromal reaction. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 0.8 cm. Tumor Encapsulation: None Identified. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Invades:perithyroidal soft tissue and focally skeletal muscle. Surgical Margins: Free of tumor. Tumor Multicentricity: Not identified. Adenoma(s) (away from the carcinoma): Not Identified. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Exhibits chronic lymphocytic thyroiditis. Parathyroid Glands: Not identified. Lymph Nodes: Perinodal (extracapsular) extension not identified. One of two lymph nodes are positive for metastatic thyroid carcinoma (1/2). The involved lymph node measures. 0.55 cm and the metastatic focus measures <0.1 cm. 2. Delphian node: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 1. 3. Additional Delphian node: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 2. 4. Right paratracheal tissue: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 1. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL). AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. THYROG. IMM RECUT. NEG CONT. Gross Description: 1. The specimen is received fresh, labeled ""total thyroidectomy"" and consists of a total thyroidectomy, measuring as follows: right. lobe 5.0 x 2.9 X 0.6 cm; the left lobe 4.6 x 2.3 x 0.7 cm and the isthmus 1.0 x 0.3 x 1.3cm. The external surface is covered by a thin. fibrous capsule. The posterior surface of the specimen is inked black, and the anterior is inked blue. Sectioning reveals a single nodule in the left lobe of the thyroid,in the upper pole, 0.7 x 0.8 x 0.6cm, with a white-yellow firm cut. surface. Sections through the remaining tissue reveal red tan and beefy parenchyma. TPS is submitted. The entire thyroid is. submitted. Summary of sections: N - Left thyroid, upper lobe, nodule, entirely submitted. RL - right lobe, remainder. LL - left lobe, remainder. IS - isthmus. MD. 2. The specimen is received in formalin labeled ""Delphian node"" and consists of a 0.8 x 0.5 x 0.4 cm possible lymph node. Entirely. submitted. Summary of sections. LN- possible lymph node. ..MD. 3. The specimen is received in formalin labeled ""Additional Delphian node"" and consists of a 1 x 0.5 x 0.4 cm possible lymph node. Entirely submitted. Summary of sections. LN- possible lymph node. 1 MD. 4. The specimen is received in formalin labeled ""Right paratracheal tissue"" and consists of a 2x 1 x 0.4 cm fragment of. fibro-adipose tissue with two 0.3 and 0.4 cm lymph nodes. Specimen entirely submitted. Summary of sections. LN- lymph nodes and fibro-adipose tissue. Summary of Sections: Part 1: Total thyroidectomy. Block. Sect. Site. PCs. 1. IS. 1. 4. LL. 4. 2. N. 2. 5. RL. 5. Part 2: Delphian node. Block. Sect. Site. PCs. 1. LN. 1. Part 3: Additional Delphian node. Block. Sect. Site. PCs. 1. LN. 1. Part 4: Right paratracheal tissue. Block. Sect. Site. PCs. 1. LN. 1.",T3,N1,M0,T3N1M0
TCGA-BT-A20U,"PATIENT HISTORY: None given. PRE-OP DIAGNOSIS: Bladder cancer,. POST-OP DIAGNOSIS: Same. PROCEDURE: Radical cystectomv. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, EXCISION -. NO EVIDENCE OF CARCINOMA IN FIVE (5) LYMPH NODES EXAMINED. PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. NO EVIDENCE OF CARCINOMA IN TWO (2) LYMPH NODES EXAMINED. PART 3: RIGHT PELVIC CYST, EXCISION -. LEIOMYOMA WITH HYALINIZATION AND DEGENERATION. PART 4: BLADDER, UTERUS, BILATERAL FALLOPIAN TUBES AND OVARIES, RADICAL CYSTECTOMY, HYSTERECTOMY, AND. BILATERAL SALPINGO-OOPHORECTOMY -. A. INVASIVE UROTHELIAL CARCINOMA (3.5 CM), HIGH GRADE (WHO/ISUP). B. CARCINOMA INVADES THE DETRUSOR MUSCLE (INNER AND OUTER) AND PERIVESICAL FAT. C. SURGICAL MARGINS ARE FREE OF TUMOR. D. NO CARCINOMA IN SITU IS IDENTIFIED. E. PERINEURAL INVASION IS IDENTIFIED. F. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. G. TNM PATHOLOGIC STAGING . T3a NO MX. H. M.HISTOPATHOLOGIC GRADE = G3. I. EXTENSIVE SQUAMOUS METAPLASIA WITH HYPERPLASIA AND REACTIVE ATYPIA. J. VAGINA IS FREE OF TUMOR. K. CERVIX SHOWS MULTIPLE NABOTHIAN CYSTS AND IS FREE OF TUMOR. L. UTERUS SHOWS ATROPHIC ENDOMETRIUM, LEIOMYOMATA, AND IS FREE OF TUMOR. M. FALLOPIAN TUBES AND OVARIES SHOW NO SPECIFIC PATHOLOGIC ABNORMALITY, FREE OF TUMOR. PART 5: LYMPH NODES, RIGHT PELVIC, EXCISION -. NO EVIDENCE OF CARCINOMA IN ONE (1) LYMPH NODE. PART 6: DISTAL URETERAL MARGIN, RIGHT, EXCISION -. NO EVIDENCE OF CARCINOMA. PART 7: DISTAL URETERAL MARGIN, LEFT, EXCISION -. NO EVIDENCE OF CARCINOMA. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY URINARY BLADDER TUMORS. SPECIMEN TYPE: Other: Hysterectomy & Salpingo-cophorectomy. TUMOR SITE: Trigone, Right lateral wall, Left lateral wall. TUMOR SIZE: Greatest dimension: 3.5 cm. Additional dimensions: 3.5 x 1 cm. HISTOLOGIC TYPE: Urothelial (transitional cell) carcinoma. ASSOCIATED EPITHELIAL LESIONS: None identified. HISTOLOGIC GRADE: Urothelial carcinoma - High-grade. TUMOR CONFIGURATION: Ulcerated. PATHOLOGIC STAGING (pTNM): pT3a. pNO. Number of nodes examined: 8. pMX. MARGINS: Margins uninvolved by invasive carcinoma. Distance of tumor from closest margin: 5 mm. Margin: Anterior. VENOUS/LYMPHATIC (LARGE/SMALL) VESSEL INVASION (V/L): Absent. DIRECT EXTENSION OF INVASIVE TUMOR: None identified. ADDITIONAL PATHOLOGIC FINDINGS: Cystitis cystica glandularis. Other: Extensive squamous metaplasia.",T3,N0,M0,T3N0M0
TCGA-33-4533,"E. .AL DIAGNOSIS. LEFT LUNG (RESECTION) : POORLY DIFFERENTIATED. NON-SMALL CELL CARCINOMA OF THE LUNG. THE CARCINOMA SHOWS BOTH. DISTINCTIVE SQUAMOUS AND HIGH-GRADE SPINDLE CELL FEATURES. THE. CARCINOMA INVOLVES THE PLEURAL SURFACE. ALL OTHER SURGICAL MARGINS. OF. RESECTION ARE NEGATIVE FOR TUMOR. ONE (1) HILAR LYMPH NODE AND. ASSOCIATED FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. THE UNINVOLVED. LUNG PARENCHYMA DEMONSTRATES EMPHYSEMATOUS CHANGE. SEE NOTE. 2. LYMPH NODE, STATION 5 (BX) : ONE (1) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR. 3. LYMPH NODE, L11 (BX. ) : ONE (1) LYMPH NODE AND ASSOCIATED. FIBROADIPOSE TISSUE, NEGATIVE FOR TUMOR.",T2,N0,M0,T2N0M0
TCGA-E5-A4U1,"SPECIMEN(S): A. TURBT LEFT WALL BLADDER. B. TURBT DEEP BITES LEFT WALL. C. TURBT BLADDER NECK. D. TURBT PROSTATIC URETHRA. CLINICAL HISTORY: TURBT. PRE-OPERATIVE DIAGNOSIS: Bladder cancer. GROSS DESCRIPTION: A. TURBT LEFT WALL BLADDER. Received fresh labeled with the patient's identification and ""left wall bladder"" aggregate of pink-. tan friable tissue chips weighing 4.98 g and measuring 3.5 x 2.5 x 1.3 cm; tissue is procured and. the remainder submitted entirely in cassettes A1-A4. B. TURBT DEEP BITES LEFT WALL. Received fresh labeled with the patient's identification and ""deep bite left wall"" are pink-tan. tissue chips in aggregate weighing 0.33 g and measuring 2.1 x 1.7 x 0.5 cm. They are bisected. and a portion is submitted for tissue procurement; remainder submitted entirely in cassette B1. C. TURBT BLADDER NECK. Received fresh labeled with the patient's identification and ""bladder neck"" are pink-tan tissue. chips in aggregate weighing 0.59 g and measuring 2.2 X 1.4 x 0.6 cm. A portion is submitted for. tissue procurement and the remainder submitted entirely in cassette C1. D. TURBT PROSTATIC URETHRA. Received fresh labeled with the patient's identification and ""prostate urethra"" are pink-tan. tissue chips in aggregate weighing 0.15 g and measuring 1.5 X 0.8 x 0.5 cm. The largest piece is. bisected and is submitted for tissue procurement; remainder submitted entirely in cassette 01. DIAGNOSIS: A. BLADDER, LEFT WALL, TRANSURETHRAL RESECTION: - INVASIVE UROTHELIAL CELL CARCINOMA, HIGH GRADE. - INVADING INTO THE MUSCULARIS PROPRIA. - SUSPICIOUS FOR ANGIOLYMPHATIC INVASION. B. BLADDER, LEFT WALL, TRANSURETHRAL RESECTION: - INVASIVE UROTHELIAL CELL CARCINOMA, HIGH GRADE. - INVADING INTO THE MUSCULARIS PROPRIA. C. BLADDER, NECK, TRANSURETHRAL RESECTION: - PAPILLARY UROTHELIAL CELL CARCINOMA, HIGH GRADE. - NO INVASION IDENTIFIED. D. URETHRA, PROSTATIC, TRANSURETHRAL RESECTION: - URETHRA DENUDED OF MUCOSA. - NO MALIGNANCY IDENTIFIED.",T2,N0,M0,T2N0M0
TCGA-XF-A9SV,"Date - Date of Service: Author: Authenticated By: Contributor system: MICROSCOPIC EXAMINATION: A-D: See final microscopic-diagnoses. E: Sections of the urinary bladder show invasive, moderately to poorly. differentiated papillary urothelial carcinoma, characterized by single strands and. small nests of enlarged malignant cells with correspondingly enlarged nucleoli and. scanty cytoplasm. The tumor extends through the full thickness of the bladder wall. and involves seminal vesicles, vasa deferentia, and rectum. The tumor cells. involve serosa, muscularis propria, and is attached to the underlying surface of. the rectal mucosa. The distal resection margin of the rectum is involved by tumor. The proximal resection margin is free of tumor. There is extensive perineural and. lymphovascular space invasion. Bilateral ureteral mucosa show mild to severe. atypia. Representative sections of prostate are unremarkable. F-Q: See final microscopic-diagnoses. INTRAOPERATIVE FROZEN CONSULTATION: AFS: Periaorta: metastatic carcinoma. BFS: Right perirenal lymph node: metastatic carcinoma. CFS: Right ureter: - mild to moderate atypia of ureter. metastatic urothelial carcinoma. DFS: Left ureter: severe dysplasia of ureter. GROSS EXAMINATION: A: The specimen is received fresh from the O.R. and labelled ""Retroperitoneum"". (Periaortic) . It consists of a piece of tan-yellow soft tissue measuring 0.8 x 0.8. x. 0.4 cm. The specimen is entirely submitted for frozen section in cassette AFS. B: The specimen is received fresh from the O.R. and labelled ""Right perirenal. FS"". It consists of a piece of tan soft tissue measuring 5 x 0.8 x 0.4 cm. Half. of the specimen is submitted for frozen section and the remaining tissue is. submitted for permanent section. The specimen is received fresh from the O.R. and labelled ""Rt ureter"". It. consists of ureter measuring 0.5 cm in length and 0.4 cm in diameter and. surrounding soft tissue measuring 0.7 x 0.5 x 0.4 cm. The specimen is submitted. for frozen section in cassette CFS. D: The specimen is received fresh from the O.R. and labelled ""Lt ureter"". It. consists of ureter measuring 0.4 cm in length and 0.4 cm in diameter and. surrounding soft tissue measuring 0.5 x 0.3 x 0.3 cm. The specimen is entirely. submitted for frozen section in cassette DFS. E: The specimen is received fresh from the O.R. and labelled ""Bladder, prostate &. rectum"". It consists of prostate, urinary bladder, bilateral ureters, rectum and. peritoneum. Overall, the specimen measures 13 x 18 x 5 cm. The peritoneum. measures 15 x 5 x 0.1 cm. The bladder measures 8 x 5 x 2 cm. The rectum measures. 20 cm in length and 7 to 10 cm in circumference. The prostate measures 6 x 5 x 5. cm. The prostate is opened anteriorly through the prostatic urethra and then the. urinary bladder is opened anteriorly. There are multiple polypoid tumors in the. urinary bladder mucosa measuring from 0.5 cm to 1.5 cm in greatest dimension. A. polypoid tumor is adjacent to the left ureterovesical junction. The right. ureterovesical junction is 1.5 cm from the closest polypoid tumor. The left ureter. measures 5 cm in length and 0.6 cm in circumference. The right ureter measures 5. cm in length and 0.6 cm in circumference. There is a constricted area in the right. ureter, which measures 0.3 cm in circumference and is approximately 1 cm from the. right ureterovesical junction. This constriction is due to the deeply infiltrating. tumor in the urinary wall around the ureter. The tumor also involves bilateral. seminal vesicles and vasa deferentia. The tumor is close to but does not involve. the colonic mucosa. The right resection margins appears grossly involved by tumor. The prostate is cross sectioned perpendicular to the prostatic urethra and is. unremarkable. The proximal and distal resection margins of the rectum are both. grossly free of tumor. The peritoneum is unremarkable. Representative sections. are submitted in a total of 15 cassettes. F: The specimen is received in formalin and labelled ""Right common iliac LN"". It. consists of a two pieces of tan soft tissue measuring 3 x 1.5 x 0.4 cm in. aggregate. The specimen is entirely submitted in two cassettes. G: The specimen is received in formalin and labelled ""Para caval LN"". It. consists of two pieces of tan soft tissue measuring 2.2 x 0.8 x 0.4 cm in. aggregate. The specimen is entirely submitted in one cassette. H: The specimen is received in formalin and labelled ""Left common iliac LN"". It. consists of two pieces of tan soft tissue measuring 2.5 x 1 x 0.4 cm in aggregate. The specimen is entirely submitted in one cassette. I: The specimen is received in formalin and labelled ""Right LN of Cloquet"". It. consists of a piece of soft tan tissue measuring 0.8 x 0.6 x 0.4 cm. The specimen. is entirely submitted in one cassette. J: The specimen is received in formalin and labelled ""Rt external iliac LN"". It. consists of multiple tan soft tissue fragments measuring 4 x 1.5 x 0.2 cm in. aggregate. The specimen is entirely submitted in three cassettes. K: The specimen is received in formalin and labelled ""Right hypogastric/obturator. LN"". It consists of multiple tan soft tissue fragments measuring 3 x 2 x 0.4 cm in. aggregate. The specimen is entirely submitted in three cassettes. L: The specimen is received in formalin and labelled ""Left external iliac LN"". It consists of multiple tan-yellow, soft, fibroadipose tissue fragments measuring. 3.5 x 1.5 x 0.4 cm in aggregate. The specimen is entirely submitted in three. cassettes. M: The specimen is received in formalin and labelled ""Left LN of Cloquet"". It. consists of a piece of tan soft tissue measuring 0.8 x 0.6 x 0.2 cm. Entirely. submitted in one cassette. N: The specimen is received in formalin and labelled ""Left obturator/hypogastrio. lymph node"". It consists of multiple tan-yellow fibroadipose tissue fragments. measuring 3 x 2 x 0.4 cm in aggregate. The specimen is entirely submitted in three. cassettes. O: The specimen is received in formalin and labelled ""Para aortic LN"". It. consists of two pieces of tan soft adipose tissue measuring 1.2 x 0.8 x 0.6 cm in. aggregate. The specimen is entirely submitted in one cassette. P: The specimen is received in formalin and labelled ""Proximal left ureter"". It. consists a segment of ureter measuring 0.8 cm in length and 0.3 cm in diameter. The specimen is entirely submitted in one cassette. Q: The specimen is received in formalin and labelled ""Right proximal ureter"". It. consists of a segment of ureter measuring 0.4 cm in length and 0.5 cm in diameter. The specimen is entirely submitted in one cassette. SECTIONS. AFS: : frozen section, retroperitoneum - all embedded. BFS : frozen section, right perirenal. BRT : remaining tissue. CFS : frozen section, right ureter - all embedded. DFS : frozen section, left ureter - all embedded. E1 : proximal resection margin of rectum. E2 : distal resection margin of rectum. E3 : rectal mucosa. E4 : mucosa with adjacent tumor. E5 : left ureterovesical junction. E6 : right ureter in constricted area and ureterovesical junction. E7, 8 : urinary bladder mucosa, polypoid nodule. E9 : vasa deferentia. E10 : seminal vesicles. E11: right perivesical radial margin. E12 : left perivesical radial margin. E13, 14: prostate. E15 : peritoneum. F1, 2. right common iliac lymph node - all embedded. G: paracaval lymph node - all embedded. H: left common iliac lymph node - all embedded. right lymph node of Cloquet - all embedded. J1-3: right external iliac lymph node - all embedded. K1-3 : right hypogastric/obturator lymph node - all embedded. L1-3: left external iliac lymph node - all embedded. M: left lymph node of Cloquet - all embedded. N1-3: left obturator/hypogastric lymph node - all embedded. O: para-aortic lymph node - all embedded. P: proximal left ureter - all embedded. right proximal ureter - all embedded. Signature Line. CLINICAL INFORMATION: Pre-Op - Dx: Prostate cancer. Post-op - Dx: Same. SPECIMEN SOURCE: A: ""Retroperitoneum"" (Periaortic). B: ""Right perirenal FS"". C: ""Rt ureter"". D: ""Lt ureter"". E: ""Bladder, prostate & rectum"". F: ""Right common iliac LN"". G: ""Para caval LN"". H: ""Left common iliac LN"". I: ""Right LN of Cloquet"". J: ""Rt external iliac LN"". K: ""Right hypogastric/obturator LN"". L: ""Left external iliac LN"". M: ""Left LN of Cloquet"". N: ""Left obturator"". O: ""Para aortic LN"". P: ""Proximal left ureter"". Q: ""Right proximal ureter"". DIAGNOSIS: RADICAL CYSTECTOMY WITH ILEAL CONDUIT: RETROPERITONEUM"" [PERIAORTA] (A) : FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOMA. FINAL DIAGNOSIS: - METASTATIC UROTHELIAL CARCINOMA. RIGHT PERIRENAL LYMPH NODE (B) : FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOMA. FINAL DIAGNOSIS: - METASTATIC UROTHELIAL CARCINOMA. RIGHT URETER (C) : FROZEN SECTION DIAGNOSIS: - MILD TO MODERATE ATYPIA OF URETER. - METASTATIC UROTHELIAL CARCINOMA. FINAL DIAGNOSIS: MILD ATYPIA OF URETER. - METASTATIC UROTHELIAL CARCINOMA. LEFT URETER (D) : FROZEN SECTION DIAGNOSIS. SEVERE DYSPLASIA OF URETER. FINAL DIAGNOSIS: SEVERE DYSPLASIA OF URETER. - MICROSCOPIC METASTATIC UROTHELIAL CARCINOMA. BLADDER, PROSTATE AND RECTUM (E) : BLADDER: - INVASIVE, MODERATELY TO POORLY DIFFERENTIATED PAPILLARY UROTHELIAL. CARCINOMA, EXTENDING THROUGH MUSCULARIS PROPRIA INTO PERIVESICAL FAT AND. RECTUM. PAPILLARY UROTHELIAL CARCINOMA, GRADE 3/4. PERINEURAL AND LYMPHOVASCULAR SPACE INVASION IDENTIFIED. BILATERAL SEMINAL VESICLES AND VASA DEFERENTIA INVOLVED BY TUMOR. COLON: - METASTATIC UROTHELIAL CARCINOMA INVOLVING MUSCULAR WALL AND SUBMUCOSA. - DISTAL RESECTION MARGIN INVOLVED BY UROTHELIAL CARCINOMA. PROXIMAL RESECTION MARGIN, FREE OF TUMOR. PROSTATE: BENIGN GLANDULAR AND STROMAL HYPERPLASIA. RIGHT COMMON ILIAC LYMPH NODES (F) : - METASTATIC CARCINOMA IDENTIFIED IN ONE OF THREE LYMPH NODES (1/3). PERINODAL LYMPHATIC SPACE INVOLVEMENT. PARACAVAL LYMPH NODES (G) : - NO TUMOR IDENTIFIED IN 11 LYMPH NODES (0/11). LEFT COMMON ILIAC LYMPH NODES (H) : NO TUMOR IDENTIFIED IN SEVEN LYMPH NODES (0/7). RIGHT LYMPH NODE OF CLOQUET (I) : - NO TUMOR IDENTIFIED IN ONE LYMPH NODE (0/1). RIGHT EXTERNAL ILIAC LYMPH NODES (J) : - METASTATIC CARCINOMA IDENTIFIED IN ONE OF 14 LYMPH NODES (1/14). RIGHT HYPOGASTRIC/OBTURATOR LYMPH NODES (K) : - NO TUMOR IDENTIFIED IN 23 LYMPH NODES (0/23). LEFT EXTERNAL ILIAC LYMPH NODES (L) : - NO TUMOR IDENTIFIED IN SEVEN LYMPH NODES (0/7). SEGMENT OF VAS DEFERENS. LEFT LYMPH NODE OF CLOQUET (M) : NO TUMOR IDENTIFIED IN ONE LYMPH NODE (0/1). LEFT OBTURATOR/HYPOGASTRIC LYMPH NODES (N) : METASTATIC CARCINOMA IDENTIFIED IN ONE OF 24 LYMPH NODES (1/24). PARA-AORTIC LYMPH NODES (0) : METASTATIC CARCINOMA IDENTIFIED IN TWO LYMPH NODES (2/2). LEFT PROXIMAL URETER (P) : - MICROSCOPIC METASTATIC UROTHELIAL CARCINOMA. BENIGN UROTHELIAL MUCOSA. RIGHT PROXIMAL URETER (Q) : MICROSCOPIC METASTATIC UROTHELIAL CARCINOMA. BENIGN UROTHELIAL MUCOSA. PATHOLOGIC TNM STAGE:pT4a,N2 (5/93), M1. Signature Line.",T4,N2,M1,T4N2M1
TCGA-3X-AAVB,"CONFIDENTIAL. Demographics (for. verification purposes). Date of Birth: . Sex: F. Collected Date/Time. Received Date/Time. Specimen Description. A. Lymph node #8 at. B. Gallbladder at. C. Portal lymph node at. D. Pancreatic duct margin at. E. Whipple specimen at. Clinical Information. Pancreatic cancer. Is 0/20/14. Infectious patient:No. Immunocompromised: Yes. History of neoplasm: Yes. Diagnosis. A. Lymph Node # 8: One reactive lymph node, negative for malignancy. B. Gallbladder: Unremarkable gallbladder. Negative for malignancy or dysplasia. c. Portal Lymph Node: One reactive lymph node, negative for malignancy. D. Pancreatic Duct Margin: Negative for malignancy. E. Pancreas and Duodenum, Partial Pancreaticoduodenectomy: Invasive moderately differentiated adenocarcinoma with mucinous. features in the periampullary region, most consistent with biliary. (common bile duct) origin. Tumor invaded into pancreas and periampullary duodenal wall. (muscle layer only) . Tumor invaded into peripancreatic fat. Positive for perineural invasion. Positive for lymphatic channel invasion. PanIN 2 and 3.. Resection margins free of tumor: 0.2 cm from vascular bed margin,. 0.4 cm from the outer surface of the peripancreatic fat, 0.2 cm from. uncinate margin, and 0.7 cm from pancreatic distal transection. margin. One incidental pancreatic well differentiated neuroendocrine tumor. (0.15 cm) in the midst of infiltrating adenocarcinoma. 5 of 15 peripancreatic /biliary lymph nodes positive for metastatic. carcinoma. See Synoptic report and Comment. Verified: Synoptic Report. E: Extrahepatic Bile Ducts, Macroscopic. SPECIMEN: Common bile duct. OTHER ORGANS RECEIVED: Duodenum. Pancreas. Ampulla. Gallbladder. PROCEDURE: Pancreaticoduodenectomy. TUMOR SITE: Common bile duct. Extrapancreatic. Intrapancreatic. TUMOR SIZE: Greatest dimension: 2.5 cm. E: Extrahepatic Bile Ducts, Microscopic. HISTOLOGIC TYPE: Adenocarcinoma (not otherwise characterized). HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades beyond the wall of the bile duct. Tumor invades the duodenum. Tumor invades the pancreas. MARGINS: SEGMENTAL RESECTION SPECIMEN. MARGINS: PANCREATICODUODENAL RESECTION SPECIMEN: Uninvolved by invasive carcinoma. Uninvolved by invasive carcinoma. Uninvolved by invasive carcinoma. Margin uninvolved by invasive carcinoma. Margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 0.2 cm. Specified margin: Uncinate. LYMPHATIC (SMALL VESSEL) INVASION (L) : Present. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT3 : Tumor invades the gallbladder, pancreas, duodenum, or other adjacent organs without. involvement of the celiac axs or the superior mesenteric artery. REGIONAL LYMPH NODES (pN) : pN1: Regional lymph node metastasis. DISTANT METASTASIS (pM) : Not applicable. Gross Description. Received are specimen containers A to E. All requisitions and specimen containers are. labelled with the patient's name,. The cassettes and. identifiers are. labelled with the Surgical Number. A The specimen is received in formalin and designated as ""lymph node #8"". The specimen. consists of one piece of fibroadipose tissue measuring 1.4 x 1.2 x 0.4 cm. One lymph. node is retrieved, 1.1 cm in greatest dimension. The specimen is submitted entirely in. one cassette. B. The specimen is received fresh and is subsequently placed into formalin, designated. as ""gallbladder. The specimen consists of an intact cholecystectomy specimen. The. gallbladder measures 9.0 x 4.0 x 3.0 cm. The serosal surface is smooth. The cystic duct. is patent. No gallstones are identified. The cystic mucosa is smooth and velvety with. no obvious lesions identified. Representative sections are submitted in one cassette. c. The specimen is received fresh and designated as ""portal lymph node"" The specimen. consists of one piece of lymph node measuring 1.3 cm in greatest dimension. The lymph. node is bisected and submitted in two cassettes. D. The specimen consists of a piece of pancreatic tissue which measures 1.2 x 0.7 cm. All tissue submitted for QS in one block. E. The specimen is designated as ""Whipple specimen"". The specimen consists of a partial. pancreaticoduodenal resection specimen including a segment of duodenum 22.0 cm in length. and 5.4 cm in maximum circumference, and portion of pancreatic head attached. The. portion of pancreas measures 3.5 x 3.5 x 3.3 cm. A portion of common bile duct is. identified, 2.8 cm in length and 1.5 cm in the circumference at the proximal resection. margin. The distal portion of the common bile duct appears to be compressed by the. surrounding structure. The ampullary region is prominent. The rest of the duodenal. mucosa appears unremarkable. The resection margin of pancreas is inked blue, the. vascular bed inked green, and margin of uncinate inked in orange. Serial cross sections. through the pancreas reveal an ill-defined firm mass lesion, 2.5 cm in greatest. dimension. On cut surface, the pancreatic mass appears homogenous and whitish with no. necrosis, hemorrhage or cystic changes. The tissue around the common bile duct appears. to be fibrotic and involved by tumor. Grossly, the tumor is 0.7 cm from the closest. resection margin of pancreas, approximately 0.1 cm from the vascular bed margin, and 0.2. cm from the uncinate margin. Representative sections are submitted in cassettes labelled as follows: E1. proximal margin of duodenum. E2. distal margin of duodenum. E3. shaved proximal margin of common bile duct. E4. cross section of common bile duct next to shaved margin with vascular bed. margin. E5-6. single cross section next to E4 with E6 including uncinate margin. E7. peripancreatic fat and lymph node next to E6. E8. cross section through common bile duct and surrounding tissue, next to E5 and. E6. E9. cross section through distal common bile duct and surrounding tissue, next to. E8. E10-11. single cross section, including uncinate margin, vascular bed margin and. pancreatic. resection margin. E12-13. single cross section through the pancreatic mass and ampulla. E14-16. single cross section through the pancreatic tumor and ampullary region. E17. cross section through ampullary region and underlying mass. E18. tumor with uncinate margin. E19. resection margin of pancreas. E20. tumor with uncinate margin. E21. pancreatic resection margin. E22-23. tumor with resection margin. E24. peripancreatic fat with nodule under serosal surface. E25. peripancreatic lymph nodes. Frozen Section Diagnosis. D. Pancreatic Duct Margin: Negative for malignancy. Pathologist Comment. The carcinoma is mostly invaded around the common bile duct and involves the bile ductal. mucosa. Based on the microscopic findings, this tumor is considered biliary primary,. although panIN is present. The incidental neuroendocrine tumor is confirmed by its strong immunopositivity for. synaptophysin and chromogranin, while the surrounding adenocarcinoma is negative. Encounter Number. Patient Location.",T3,N1,M1,T3N1M1
TCGA-49-4505,"INAL DIAGNOSIS. RIGHT LOWER LOBE, LUNG (LOBECTOMY) : INFILTRATING WELL. FFERENTIATED ADENOCARCINOMA. THE CARCINOMA MEASURES 5.5 CM IN. REATEST DIMENSION AND EXTENDS THROUGH THE VISCERAL PLEURA. METASTATIC. ARCINOMA IN ONE (1) OF SIX (6) LYMPH NODES. THE BRONCHIAL AND. ASCULAR MARGINS ARE NEGATIVE FOR TUMOR. SEE NOTE. BRONCHIAL MARGIN (BX) : NEGATIVE FOR TUMOR. 11 R LYMPH NODE (BX) : METASTATIC ADENOCARCINOMA IN ONE (1) LYMPH. )DE. LUNG, RIGHT UPPER LOBE (WEDGE RESECTION) : CAVITARY FIBROTIC. CYST. DLONIZED BY BRANCHING HYPHAL FUNGAL FORMS MORPHOLOGICALLY CONSISTENT. ITH ASPERGILLUS. NEGATIVE FOR TUMOR. LUNG, RIGHT UPPER LOBE (WEDGE RESECTION) : INFILTRATING WELL. [FFERENTIATED ADENOCARCINOMA. THE CARCINOMA MEASURES 1.5 CM IN.",T2,N1,M0,T2N1M0
TCGA-GU-A763,"BIOPSY OR SURGICAL SPECIMEN (Order. Patient Information. Male. le. Provider Status. Component. Lab. Specimen. Procedure/Addenda. Image Analysis Date Ordered: Date Complete: Interpretation. Prognostic markers performed on block M27. BLADDER CANCER RECURRENCE SCORE. p21 by IHC and IMAGE QUANTITATION: Unaltered. Percent Positive Average: 69%. Staining Intensity Grade: 2. HistoScore: 7. p21 altered range (<10%). p27 by IHC and IMAGE QUANTITATION: Altered. Percent Positive Average: 4%. Staining Intensity Grade: 1. HistoScore: 3. p27 altered range (<30%). p53 by IHC and IMAGE QUANTITATION: Altered. Percent Positive Average: 74%. Staining Intensity Grade: 2. HistoScore: 7. p53 altered range (>=10%). Ki-67 by IHC and Image QUANTITATION: Altered. 1. Percent Positive Average: 35%. Staining Intensity Grade: 2. HistoScore: 5. Ki-67 altered range (>10%). Cyclin E by IHC and IMAGE QUANTITATION: Unaltered. Percent Positive Average: 80%. Staining Intensity Grade: 2. HistoScore: 7. Cyclin E altered range (<30%). INTERPRETATION: Prognostic Significance: Unfavorable. 3 Biomarker(s) altered. Range: Favorable < = 2 altered biomarkers. Unfavorable > 2 altered biomarkers. Comment: In the above tumor profile the number of altered biomarkers improves the. predictive accuracy for patients with PTa-T3 NO Bladder Cancer. Greater than 2. altered biomarkers are associated with increased risk of recurrence. Note: Staining intensity based on 0 (neg) to 3+ (highest). Percent Positive Average: Percentage of tumor cells staining. HistoScore = Percentage of tumor cells staining (Scale 0-5) + Intensity. (Scale 0-3). These tests were performed IHC in conjunction with automated image. analysis. The performance characteristics of the above tests have been. determined in the. While some antibodies have not been. approved by the FDA, clearance / approval is not mandated. These antibodies. are well documented and clinically accepted prognostic indicators. These tests should not be regarded as part of research investigations. Known. positive and negative control tissue show appropriate staining. The above tumor bio-markers were performed per reflex protocol. The system used for image quantitation is the. The method used for antigen retrieval is heat induced. epitope retrieval. College of American Pathologists (CAP) required information for. predictive/prognostic markers. Type of specimen fixation and detection system: polymer detection kits are used on formalin-fixed paraffin-embedded sections. Clones user: p21 (SX118); p27(SX53G8); p53 (DO-7); Ki-67 (MIB-1); Cyclin E. (HE12). Prognostic markers performed at. the. Results-Comments. (Not Entered}. Final Diagnosis. A. Right ureter, ureterectomy: - Reactive urothelium. - No dysplasia or carcinoma identified. - Frozen section diagnosis confirmed. B. Left ureter, ureterectomy: - Benign ureter. - No dysplasia or carcinoma identified. - Frozen section diagnosis confirmed. C. Left vas deferens, resection: - Fragment of vas deference with mostly denuded epithelium. D. Left internal and external illac lymph nodes, dissection: - Three lymph nodes, negative for tumor (0/3). E. Left obturator lymph nodes, dissection: - Three lymph nodes, negative for tumor (0/3). F. Left common iliac lymph nodes, dissection: - Five lymph nodes, negative for tumor (0/5). G. Preaortic lymph nodes, dissection: - Three lymph nodes, negative for tumor (0/3). H. Right common iliac lymph nodes, dissection: - One lymph node, negative for tumor (0/1). I. Precaval and paracaval lymph nodes, dissection: - Six lymph nodes, negative for tumor (0/6). J. Presacral lymph nodes, dissection: - Two lymph nodes, negative for tumor (0/2). K. Right Internal and external lymph nodes, dissection: - Two lymph nodes, negative for tumor (0/2). L. Right obturator lymph nodes, dissection: - Two lymph nodes, negative for tumor (0/2). M. Bladder and prostate, radical cystectomy and prostatectomy: - Invasive, high-grade papillary urothelial carcinoma extending into prostate. parenchyma. - Prostatic adenocarcinoma, Gleason score 7 (4+3) (See attached CAP template). - High-grade prostatic intraepithelial neoplasia. - Resection margins negative for tumor. Specimen: Bladder. Other (specify): Prostate, vas deferens, lymph node. dissection, appendix. Procedure: Radical cystoprostatectomy. Tumor Site: Right lateral wall. Prostatic urethra and prostate. Tumor Size: Greatest dimension: 2.1 cm. Histologic Type: Urothelial (transitional cell) carcinoma. Associated Epithelial Lesions: None identified. Urothelial Carcinoma (WHO 2004/ISUP): High-grade. Microscopic Tumor Extension: Prostatic stroma. Margins: Margins uninvolved by invasive carcinoma. Lymph-Vascular Invasion: Not identified. Pathologic Staging (pTNM): Primary Tumor (pT): pT4a: Tumor invades prostatic stroma. Regional Lymph Nodes (pN): pNO: No lymph node metastasis. Specify: Number examined: 27. Number involved (any size): 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Adenocarcinoma of prostate (see attached. separate CAP template). Ancillary Studies: Block M27 sent for ancillary studies, report to follow. Procedure: Other (specify): Cystoprostatectomy. Prostate Size: Weight: Not available. Size: 3.8 X 3.1 x 3.0 cm. Lymph Node Sampling: Pelvic lymph node dissection. Histologic Type: Adenocarcinoma (acinar, not otherwise specified). Other (specify): Urothelial carcinoma (see above). Histologic Grade. Gleason Pattern. Primary Pattern: Grade 3. Secondary Pattern: Grade 4. Tertiary Pattern: Not applicable. Total Gleason Score: 7. Tumor Quantitation. Proportion (percentage) of prostate involved by tumor: 5%. Extraprostatic Extension: Not identified. Seminal Vesicle Invasion: Not identified. Margins: Margins uninvolved by invasive carcinoma. Treatment Effect on Carcinoma: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Pathologic Staging (pTNM). Primary Tumor (pT): pT2a: Unilateral, involving one-half of 1 side or less. Regional Lymph Nodes (pN): pNO: No regional lymph node metastasis. Specify: Number examined: 27. Specify: Number involved: 0. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: High-grade prostatic intraepithelial neoplasia. (PIN). Ancillary Studies: Block M20 can be used for further studies if needed. The above pathology diagnosis incorporates data elements as outlined in the CAP. Cancer Protocols and Checklists which are based on the AJCC/UICC TNM, 7th. edition. N. Appendix, appendectomy: - Obliterated appendix. - No malignancy identified. O. Ureter, left distal margin, ureterectomy: - Benign fragment of ureter. - No dysplasia or carcinoma identified. P. Ureter, right distal margin, ureterectomy: - Benign fragment of ureter. - No dysplasia or carcinoma identified. Note. This case was reviewed at the. Clinical History. Bladder cancer. Radical cystectomy, prostatectomy, lymph node dissection ileal conduit. All. other indicated procedures. Source: A: Right ureter. B: Left ureter. C: Left vas deferens. D: Left internal and external liac lymph nodes. E: Left obturator lymph nodes. F: Left common illac lymph nodes. G: Preaortic lymph nodes. H: Right common illac lymph nodes. I: Precaval and paracaval lymph nodes. J: Presacral lymph nodes. K: Right internal and external lymph nodes. L: Rigt obturator lymph nodes. M: Bladder and prostate. N: Appendix. O: Left distal margin (ureter). P: Right distal margin (ureter). Gross Description. Specimen A, received fresh labeled with the patient's name and designated ""right. ureter"", is an oriented tan tubular segment of tissue, 1.4 cm in length and 0.4. cm in diameter. There Is a black silk suture at one end designated as distal per. the surgeon. The opposing proximal end is submitted for frozen section as A1. Specimen B, received fresh labeled with the patient's name and designated ""left. ureter"", is an oriented tubular segment of tissue, 1.5 cm in length and 0.4 in. diameter. There is a Prolene suture at one end designated as distal per the. surgeon. The opposing proximal end is submitted for frozen section diagnosis as. B1. (. Specimen C, received in formalin labeled with the patient's name and designated. ""left vas deferens"", is a portion of adipose tissue, 3.6 x 2.0 x 1.1 cm. One. surface is pink and glistening and serosalized. The opposing surface is focally. hemorrhagic adipose tissue. Specimen is serially sectioned showing focally. hemorrhagic adipose tissue and a tubular vessel, consistent with a blood vessel. A discrete vas deferens is not identified. There are two cramped edges. approximately 1.0 cm in length. The specimen is submitted entirely with the. exception of the cramped edges at C1-C5. Specimen D, received in formalin labeled with the patient's name and designated. ""left internal and external iliac lymph nodes"", is fragmented fibrofatty tissue,. 7.5 X 6.0 2.0 cm in aggregate. There are three possible nodes and a tan. tubular segment of tissue. The nodes are 0.5 cm to 2.0 x 0.7 x 0.4 cm. The. tubular segment of tissue is 4.0 cm in length and 0.6 cm in diameter. The. luminous is pinpoint and ill-defined. The wall surrounding the lumen is white. and fibrous, not resembling lymph node parenchyma. Representative sections are. submitted as follows: Section key: D1 two whole nodes. D2 one node serially sectioned into five pieces. D3 tan tubular tissue submitted entirely. D4 fibrous tissue for microscopic nodes. Specimen E, received in formalin labeled with the patient's name and designated. ""left obturator lymph nodes"", is fragmented adipose tissue, 5.5 x 4.0 x 1.2 cm. There are three possible lymph nodes, 0.5 cm to 3.2 x 1.0 x 0.7 cm. The nodes. are submitted entirely as follows: Section key: E1 two whole nodes. E2-E3 one node serially sectioned into eight pieces. Specimen F, received in formalin labeled with the patient's name and designated. ""left common iliac lymph nodes"", is 4.0 x 2.5 x 1.0 cm of fragmented adipose. tissue, There are three possible nodes, 0.6 cm to 2.0 cm. The nodes are. submitted entirely as follows: Section key: F1 two whole nodes. F2 one node serially sectioned into five pieces. F3 fibrous tissue for microscopic node. Specimen G, received in formalin labeled with the patient's name and designated. ""preaortic lymph nodes"", is fragmented fibrofatty tissue with two staples. There. is a 0.2 cm tan node adjacent to one of the staples. The specimen is submitted. entirely as follows: Section key: G1 one lymph node. G2 fibrous tissue for microscopic nodes. Specimen H, received in formalin labeled with the patient's name and designated. ""right common iliac lymph nodes"" is fragmented adipose tissue, 4.0 x 2.5 x 0.6. cm. There is one 0.3 cm tan node. Representative sections are submitted as. follows: H1 - one node. H2-H3 - fibrous tissue for microscopic nodes. Specimen I, received in formalin labeled with the patient's name and designated. ""precaval and paracaval lymph nodes"" is fragmented adipose tissue, 4.0 x 3.5 x. 1.2 cm. There are seven possible nodes, 0.3 cm to 1.2 cm. The specimen is. submitted entirely as follows: 11 - five whole nodes. 12 - two whole nodes. Specimen J, received in formalin labeled with the patient's name and designated. ""presacral lymph nodes"" is fragmented adipose tissue, 3.2 x 2.4 x 1.1 cm. There. are three possible lymph nodes, 0.2 cm to 1.2 cm. The nodes and representative. fibrous tissue are submitted as follows: J1 - two whole nodes. J2 - one node bisected. J3 - fibrous tissue for microscopic nodes. Specimen K, received in formalin labeled with the patient's name and designated. ""right internal and external iliac lymph nodes"" is fragmented adipose tissue,. 3.0 x 3.0 x 0.8 cm. There are two lymph nodes, 0.3 cm and 1.9 cm. The nodes. are submitted entirely as follows: K1 - one whole node. K2 - one node serially sectioned into five pieces. Specimen L, received in formalin labeled with the patient's name and designated. ""right obturator lymph nodes"" is fragmented adipose tissue, 4.5 x 3.0 x 1.1 cm. There are three possible nodes, 0.2 cm, 0.5 cm, and 5.0 x 1.2 X 1.0 cm. The. nodes are submitted entirely as follows: L1 - two whole nodes. L2-L3 - one node serially sectioned into nine pieces. Specimen M: Type of specimen: Urinary bladder, ureter stumps, prostate and seminal vesicles. The patient's name and case number on the specimen container match the. accompanying paperwork and cassettes. Procedure: Radical cystectomy and prostatectomy. Fixative: Formalin. Dimensions: Bladder - 6.0 cm - superior to inferior x 7.5 cm - medial to lateral X 3.5 cm -. anterior to posterior. Right ureter - 1.6 cm in length, 0.4 cm in diameter. Left ureter - 1.3 cm in length, 0.4 cm in diameter. Prostate, 3.1 cm - apex to base, 3.8 cm - right to left X 3.0 cm - anterior to. posterior. Description of findings: Tumor: There is a tan, fluffy, lobulated tumor in the right lateral wall, 2.1 x. 1.1 cm. The tumor extends through the mucosa into the muscle and is greater. than 1.0 cm from the inked posterior adipose tissue. Involvement of important adjacencies: None. Uninvolved mucosa: The mucosa in the left bladder is edematous. Prostate, seminal vesicles and vasa deferentia: The prostate is serially. sectioned apex to base into six slabs. The seminal vesicles are present. In. slabs 3, 4 and 5, there is a firm nodule, 1.6 x 1.5 x 1.0 cm. This nodule has a. weil-defined smooth border. It does not appear to cross the midline into the. right lobe. Ink code: Bladder anterior - blue, bladder posterior - orange, right prostate - orange,. left prostate - blue. Section key: M1 - right ureteral orifice to ureter edge. M2 - left ureteral orifice to ureter edge. M3, M4 - bladder neck, green ink at edge of tumor for orientation. M5-M12 - tumor submitted entirely from the right wall, superior to Inferior. M13 - mucosa, right dome. M14 - mucosa, anterior wall. M15 - mucosa, left dome. M16, M17 - mucosa, left lateral wall. M18 - mucosa, posterior wall. M19 - slab 1, prostate, right apex, serially sectioned. M20 - slab 2, left. M21 - slab 4, right posterior. M22 - slab 5, right posterior. M23 - slab 6, right posterior. M24 - slab 6, right seminal vesicle, right seminal vesicle, prostatic interface. M25 - slab 1, left apex, serially sectioned. M26 - slab 2, left plus a trimming piece. M27 - slab 3, left. M28 - slab 4, left anterior. M29 - slab 4, left posterior. M30 - slab 5, left anterior. M31 - slab 5, left posterior. M32 - slab 6, left posterior with seminal vesicle prostatic interface (. Specimen N, received in formalin labeled with the patient's name and designated. ""appendix"" is a vermiform appendix with attached mesoappendix. The appendix is. 7.0 cm in length and 0.6 cm in diameter. The mesoappendix is 6.5 x 2.5 x 1.2. cm. The serosa is tan, smooth, and glistening. The cut surface of the appendix. shows a 0.1 cm thick wall. the surface shows diffuse infiltrating adipose. tissue extending from approximately 1.0 cm from the proximal margin to the. distal tip. Representative sections are submitted as follows: N1 cross sections, proximal margin inked orange distal tip. N2 representative cross sections. Specimen o, received in formalin labeled with the patient's name and designated. ""left distal ureter margin"" is a strip of mucosa, 1.5 cm in length and 0.7 cm in. diameter. There is a Prolene suture at one end of the strip of mucosa. This. end of the specimen is inked grange. The specimen is bisected and submitted. entirely as 01. Specimen P, received in formalin labeled with the patient's name and designated. ""right distal ureter"" is a roughly square portion of mucosa, 0.7 x 0.7 cm. There is a black silk suture on one side. The sutured side is inked orange. The specimen is bisected and submitted entirely as P1. Microscopic Description. The stain quality is acceptable. A-P. The microscopic findings are reflected in the diagnosis rendered. Intraoperative Diagnosis. Time in: Time out: A1-FS. Right ureter: ""Negative for tumor or high-grade dysplasia."". B1-FS. Left ureter. ""Negative for tumor or high-grade dysplasia."". Reported to. Pathology Report - Scan on. : Bladder Cancer Recurrence Score. Pathology Report - Scan on 4. Intraoperative Consultation Report. Result History. BIOPSY OR SURGICAL SPECIMEN. Specimen Source. Date and Time. Other.",T4,N0,M0,T4N0M0
TCGA-A3-3367,"TEST: Surgical Pathology. Collected Date & Time: Result Name. Reference Range. Pre-Op Diagnosis. Left renal mass. Post-Op Diagnosis. Same. Clinical History. Nothing dictated. Gross Description: Received in a single container labeled. - left. kidney and adrenal"" is an 800 gram previously partially sectioned. partially fragmented left nephrectomy specimen surrounded by a large. amount of perinephric adpose tissue and faced anteriorly by Gerota's. fascia. On reconstruction the specimen as received measures 26.2 x. 11.6 x 8.9 cm. Within the superior antral medial aspect of the. surrounding adipose tissue is a 7.2 x 5.0 x 1.6 cm grossly. unremarkable adrenal gland. Within the hilar adpose tissue is a well. defined 0.3 x 0.3 x 0.2 cm nodule of chalky appearing yellow orange. tissue which may be consistent with adrenal rest. The nephrectomy. specimen has as its margins of resection 1.9 cm of grossly patent. renal artery, 0.5 cm of grossly patent renal vein, and 3.7 cm of. grossly patent ureter. The capsule strips with slight difficulty to. reveal an organ which on reconstruction measures 13.2 x 8.5 x 6.4 cm. The cortex is granular and slightly lobulated red to brown with a. 1.8 cm previously opened thin walled cystic structure with a smooth. inner lining. A second cystic structure is noted on the anterior. aspect of the lower pole measuring 1.8 cm. On sectioning this has. a. smooth inner lining and contains viscid gray brown mucoid fluid. Within the lower pole immediately adjacent to this cystic structure. is a previously partially sectioned well circumscribed 4.9 x 4.4 x. 3.9 cm nodular lesion with a focally hyalinized focally hemorrhagic. gray pink to yellow cut surface. This grossly appears to extend. beyond the plane of kidney but is well encapsuled without evidence of. transection or infiltration into the surrounding adipose tissue. The. lesion grossly appears to compress the surrounding parenchyma and. focally appears to locally extend into vasculature. The remaining. parenchyma has a cortex measuring up to 0.8 cm which is homogenous. and red brown. The cortical medullary junction is well defined. The. medulla is slight hyalinized tan gray to brown with sharp papillae. Calices and pelvis are lined by smooth gray white mucosa extending. into the ureters. Also received in the same container are three tissue cassettes each. labeled. Representative sections are submitted labeled. as follows: A - vascular and ureteral margins, B through E -. representative lesion and surrounding tissue, F - random uninvolved. parenchyma, G - representative adrenal gland, H - nodule from hilar. adipose tissue. Microscopic Description: The slides are reviewed labeled. Final Diagnosis. Left kidney and adrenal: Tumor characteristics: 1. Histologic type: Renal cell carcnoma, clear cell type. Site: Lower pole left kidney. 3. Size: 4.9 x 4.4 x 3.9 cm. 4. Extent of tumor: Tumor limited to kidney and does not extend. into perinephric tissues. 5. Nuclear grade: Fuhrman grade 3/4. Lymphovascular space invasion: No. Transcapsular invasion: No. Renal vein invasion: No. 9. Vena caval invasion: Not resected. 10. Adrenal gland: Adrenal cortical hyperplasia; no metastatic. carcinoma identified. Surgical margin status: 1. Soft tissue margins: Negative. 2. Ureteral margin: Negative. 3. Vascular margin: Negative. Other significant findings: 1. Chronic pyelonephritis. 2. Glomerulosclerosis. Benign retention cysts. 4. Nephrocalcinosis. 5. Hilar adrenal rest. PAS 9 SPC-A. Stage: pT1bNXMX. CPT: 88307 x 2. Comments. This test has been finalized at the. Campus . #.",T1,N0,M0,T1N0M0
TCGA-AA-A022,"Diagnosis: This is a poorly differentiated carcinoma (in this case, conforming to the neuro-endocrine. type, G3), with infiltration of the terminal ileum and the serosa (p T 4) and with. extensive infiltration of the lymph and blood vessels (L 1, V 1), furthermore, with free. resection margins in the region of the mucosal membrane and a free ligature area and free. lymph nodes (p N 0). Tumor classification: ICDO-DA-M 8140/3. G3. p T 4, L 1, V 1, p NO, MX.",T4,N0,M0,T4N0M0
TCGA-CM-6680,"Clinical Diagnosis & History: year old female with colorectal carcinoma. Specimens Submitted: 1: Right hemicolectomy. DIAGNOSIS: 1. Right hemicolectomy. Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Cecum. Tumor Size: Length is 3 cm. Width is 3.4 cm. Maximal thickness is 1.1 cm. Tumor Budding: Focal. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Tubulovillous adenoma. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Gross Tumor Perforation: Not identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Appendix: Not identified. Lymph Nodes: Number with metastasis: 4. Total number examined: 17. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC 7th Edition) : pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition). N2a (Metastasis in 4-6 regional lymph nodes). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1) The specimen is received fresh, labeled ""Right hemicolectomy"" and. consists of a segment of terminal ileum, cecum with attached appendix and. ascending colon. The terminal ileum measures 11.5 cm in length and 3.0 cm. in circumference at the proximal resected margin. The remaining colon. measures 20.0 cm in length with a circumference of 7.0 cm at the distal. resected margin. There is no attached appendix, and serosa displays a 0.7 x. 5cm white ill-defined fibrotic focus of a possible previous appendectomy. site which is submitted. The intestinal serosa is pink tan and smooth. Focally hemorrhagic lobulated yellow tan adipose tissue spans the length of. the specimen measuring up to 4.5 cm in thickness. The specimen is opened to. reveal a papillary tumor measuring 3.0 Cm in length and 3.4 Cm in width. The. tumor is located distal to the cecum, . 2 cm from the ileocecal valve, 14.8. cm from the proximal margin and 15.0 cm from the distal margin. Sectioning. shows that the tumor invades to a depth of 1. 1cm grossly extending into the. muscularis. The remaining mucosa is otherwise tan yellow and grossly. unremarkable. The attached adipose tissue is thoroughly examined and all. identified lymph nodes are submitted. Representative sections of the. specimen are submitted for permanent sections and for. Summary of sections: PM - proximal margin shave. DM - distal margin shave. T - tumor. A - possible previous appendectomy site. RS representative sections. LN - lymph nodes. BLN - bisected lymph nodes. Summary of Sections: Part 1: Right hemicolectomy. Block. Sect. Site. PCs. 1. A. 1. 2. DM. 2. 7. LN. 17. 1. PM. 1. 1. RS. 1. 3. T. 3.",T3,N2,M0,T3N2M0
TCGA-AY-4070,"SURGICAL PATHOLOGY REVISED REPORT. Amended. A: Implant, uterine, biopsy. - Nodule of benign smooth muscle consistent with leiomyoma,. no tumor seen. B: Colon, right, hemicolectomy. Tumor Histologic Type: adenocarcinoma. Histologic Grade: poorly differentiated. Depth of Invasion: through muscularis propria into. pericolic adipose tissue. Lymphatic (Small Vessel) Invasion: present. Venous (Large Vessel) Invasion: present. Perineural space invasion: present. Margins: Proximal margin: free of tumor. Distal margin: free of tumor. Circumferential (radial) margin: involved with tumor (block. B11). Regional lymph nodes: Total number with metastasis: 5. Total number examined: 15. AJCC PATHOLOGIC TNM STAGE: at least pT3, cannot exclude pT4. pN2 pMx. Note: This pathologic stage assessment is based on. information available at the. time of this report, and is subject to change pending. clinical review and. additional information. Additional pathologic findings: The appendix shows fibrous. obliteration. The attached portion of small bowel shows no pathologic. abnormality. Intraoperative Consult Diagnosis: A frozen section was requested by. FSA1 : ""Uterine implant"", biopsy. - Benign fibromuscular tissue, no carcinoma seen. Clinical History: a clinical diagnosis of colon cancer, now undergoes right. hemicolectomy. Gross Description: Received are two appropriately labeled containers. Container A is additionally labeled ""uterine implant. "" It. contains a 0.4 X 0.3 X. 0.3 cm white and red soft tissue fragment; block FSA1, NTR. Container B is additionally labeled ""right colon. Specimen fixation: formalin. Parts of bowel received: terminal ileum, cecum, proximal. ascending colon,. appendix. Specimen length: terminal ileum, 11 cm; cecum/colon, 36 cm;. appendix, 7 cm. Orientation: By anatomic landmarks. Inking: radial. margin/blue. Tumor location: cecum. Gross appearance of tumor: The tumor on the mucosal surface. is present as an indurated depression with a rolled border. Cross sectioning reveals additional rubbery firm white. solid tissue with focal yellow necrosis. This is present in. the pericecal adipose tissue/subserosa. The tumor mass here. has an infiltrative border with a stellate pattern of. extension, including to the radial margin. Tumor dimensions: 6.5 X 3.0 X 3.0 cm. Circumferential growth: 40%. Gross depth of invasion: Tumor invades through the. muscularis propria into the. subserosa/pericecal adipose tissue. Gross evidence of perforation through visceral peritoneum: Tumor is at least. very close to the peritoneum. Luminal obstruction: not appreciable. Bowel circumference at tumor site: 7 cm. Gross distance of tumor from margins: 11 cm to terminal. ileum margin, 32 cm to. colon margin, radial margin is at least within 1. mm, may be positive. Lymph nodes: per block summary. Other remarkable findings: Within the subserosa directly. below the primary tumor. mass, there are multiple foci of yellow/white. tumor nodules distending circumferential fibrous tissue. These may. represent lymph nodes completely replaced by tumor,. vascular invasion, and/or exuberant desmoplastic response. to subserosal. tumor deposits. Tissue submitted for special investigation: Tumor and. normal tissue to Tissue procurement. Digital photograph taken. Block Summary: Inking : radial margin is blue. B1,B2 - terminal ileum margin of resection, en face. B3-B5 - colonic margin of resection, en face. B6-B8 - full thickness cross section of tumor, from mucosa. to positive. radial margin. B9-B11 - full thickness cross section of tumor, from mucosa. to positive. radial margin. B12 - additional view of subserosal invasion. B13-B15 - additional views of grossly positive radial. margin. B16,B17 - subserosal tumor deposits with circumferential. fibrous tissue. B18,B19 - tumor, transition to normal mucosa. B20 - normal colon, distal from tumor. B21 - normal terminal ileum, distal from tumor. B22 - appendix, cross section of tip and en face sections. of base and middle. B23 - two lymph node candidates, one bisected and inked. blue. B24 - tumor replaced lymph node versus vascular invasion. B25 - two lymph node candidates, larger bisected and inked. blue. B26 - two lymph node candidates. B27 - three lymph node candidates. B28 - two lymph node candidates. B29 - three very small lymph node candidates. B30 - two lymph node candidates. B31-B40 - - perivascular adipose tissue. Grossing Pathologist: Light Microscopy : Light microscopic examination is performed by.",T3,N2,M0,T3N2M0
TCGA-33-4586,"FINAL DIAGNOSIS. 1. LUNG, LEFT LOWER LOBE WITH RIBS 6 AND 7. (RESECTION) : SPECIMEN TYPE: Lobectomy. TUMOR SITE: Left lower lobe. HISTOLOGIC TYPE: Squamous cell carcinoma. TUMOR SIZE: Greatest dimension: 8.5 cm.",T2,N2,M0,T2N2M0
TCGA-UF-A7JH,"PRIMARY SITE: Larynx. 1- ""Right SCF skin biopsy"". Exudative inflammatory process. Absence of neoplasia. 2- ""Total pharyngolaryngectomy + bilateral wide field ressection + bilateral recorrential. ressection"": Well-differentiated squamous cell carcinoma, measuring 6.0 cm, occupying. supraglottis, glottis and subglottis, crossing the midline. Presence of bilateral vocal folds infiltration. Presence of arytenoid and thyroid cartilages infiltration. Vascular and perineural invasion not detected. Epiglottis and pre-glottic fat uninvolved by neoplasia. Thyroid uninvolved by neoplasia. Surgical margins uninvolved by neoplasia. Twenty-four lymph nodes uninvolved by neoplasia (0/24).",T4,N0,M0,T4N0M0
TCGA-IQ-A61K,"REG DR. Copies to: SPECIMEN ID: A. LYMPH NODE - RIGHT NECK LEVEL 3,4, B. LYMPH NODE - RIGHT NECK LEVEL 1,. C. LYMPH NODE - RIGHT NECK LEVEL2, D. LYMPH NODE - ADD'S RT LEVEL 4 TISSUE,. E. TONGUE - RT GLOSSECTOMY STITCH ANTERIOR FS, F. TONGUE - DORSAL TONGUE FS,. G. NERVE - PROXIMAL MARGIN RIGHT LINGUAL NERVE FS, H. TONGUE - RIGHT BASE OF TONGUE. FS,. I. TONSIL - RT ANTERIOR TONSILLAR PILLAR FS, J. MOUTH - RETRO-MOLAR TRIGONE. FS,. K. MOUTH - RT FLOOR OF MOUTH FS, L. TONGUE - VENTRAL TONGUE FS,. M. TONGUE - DEEP MARGIN BASE OF TONGUE FS, N. TONGUE - DEEP MARGIN ANTERIOR. FS,. o. TONGUE - DEEP MARGIN-DEEP TONGUE FS, P. LYMPH NODE - LEVEL 5 LYMPH NODE. FS,. Q. MOUTH - DISTAL RIGHT HYPOGLOSSAL FS, R. MOUTH - SUBMENTAL TRIANGLE. FINAL DIAGNOSIS. A. RIGHT NECK LEVEL 3,4: METASTATIC CARCINOMA to two of nineteen lymph nodes (2/23) . Largest focus of carcinoma is 3.0 mm. Extranodal extension is absent. B. RIGHT NECK LEVEL 1: METASTATIC CARCINOMA to one of five lymph nodes (1/5). Largest focus of carcinoma is 0.9 cm. Extranodal extensive is present. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. and. return the report to us by mail. FINAL DIAGNOSIS. C. RICHT NECK LEVEL 2: METASTATIC CARCINOMA to one of thirteen lymph nodes (1/13) . Largest focus of carcinoma is 1.2 cm. Extranodal extension is present. D. ADDITIONAL RIGHT LEVEL 4 TISSUE: One lymph node, negative for carcinoma (0/1) . E. RIGHT GLOSSECTOMY: INVASIVE KERATINIZING SQUAMOUS CELL CARCINOMA, ulcerating, 4.1 cm- in greatest. dimension. Surgical resection margins are negative. Closest proximally is 5 mm from anterior resection margin. Perineural invasion is present. No definitive lymphovascular invasion is identified. AJCC Classification (7th edition) : pT3 N2b MX. See Tumor Summary. F. DORSAL TONGUE: Squamous mucosa and skeletal muscle, negative for carcinoma. G. PROXIMAL MARGIN RIGHT LINGUAL NERVE: This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. return the report to us by mail. FINAL DIAGNOSIS. Nerve, negative for carcinoma. H. RIGHT BASE OF TONGUE: Squamous mucosa, negative for carcinoma. I. RIGHT ANTERIOR TONSILLAR PILLAR: Squamous mucosa, negative for carcinoma. J. RETRO-MOLAR TRIGONE: Squamous mucosa, negative for carcinoma. K. RIGHT FLOOR OF MOUTH: Squamous mucosa, negative for carcinoma. L. VENTRAL TONGUE: Skeletal muscle and connective tissue, negative for carcinoma. M. DEEP MARGIN BASE OF TONGUE: Skeletal muscle and connective tissue, negative for carcinoma. N. DEEP MARGIN ANTERIOR. Fibroadipose tissue, negative for carcinoma. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. return the report to us by mail. FINAL DIAGNOSIS. o. DEEP MARGIN DEEP TONGUE: Fibroadipose tissue, negative for carcinoma. P. LEVEL 5 LYMPH NODE: One lymph node, negative for carcinoma (0/1). o. DISTAL RIGHT HYPOGLOSSAL: Nerve, negative for carcinoma. R. SUBMENTAL TRIANGLE: Five lymph nodes, negative for carcinoma (0/5). Surgical Pathology Cancer Case Summary : LIP AND ORAL CAVITY: Incisional Biopsy, Excisional Biopsy, Resection. Specimen: Dorsal surface of tongue, NOS. Anterior two-thirds of tongue, NOS per clinical notes. Received: In formalin. Procedure: Resection. Glossectomy (specify) : Hemiglossectomy. Specimen Integrity: Intact. Specimen Size: Greatest dimensions: 6.1 x 4.1 x 3.6 cm. Specimen Laterality: Right. Tumor Site: Anterior two-thirds of tongue, NOS. Tumor Size: Greatest dimension: 4. 1 cm. Additional dimensions 3.1 x 0.2 cm. Tumor Description: Ulcerated. Histologic Type Squamous cell carcinoma, conventional. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. return the report to us by mail. FINAL DIAGNOSIS. Histologic Grade: G2: Moderately differentiated. Margins: Uninvolved by invasive carcinoma. Distance from closest margin: 0.5 cm. Specify margin (s), per orientation, if possible: Anterior. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Present. Lymph Nodes, Extranodal Extension: Present. Pathologic Staging: Primary Tumor: pT3. Regional Lymph Nodes: pN2b. Number of Lymph Nodes Examined: 44. Number of Lymph Nodes Involved: 4. Distant Metastasis: Not applicable. CLINICAL HISTORY- -. PRE-OP DX: NONE PROVIDED. PROCEDURE: NONE PROVIDED. RELEVANT CLINICAL HX : NONE PROVIDED. GROSS DESCRIPTION: A. Received in formalin labeled ""Right neck level 3&4"" consists of an unoriented portion. of fibroadipose tissue 6.2 x 2.1 x 1.4 cm. Sixteen possible lymph nodes are. identified. The largest of which 0.6 cm in greatest dimension. Cassettes are. submitted as follows: Cassettes #1-3 Four lymph nodes per cassette. Cassettes #4&5 Three lymph nodes per cassette. Cassettes #6-8 Indurated fatty tissue. B. Received in formalin labeled ""Right neck level 1"" is a portion of fibrofatty tissue. 4.1 x 2.3 x 1.2 cm. One grossly positive lymph node is identified which measures 1.1. cm in greatest dimension. Four other lymph nodes are identified. Portion of salivary. gland is present 3.1 x 2. x 1.1 cm. Cassettes are submitted as follows: Cassette #1 Grossly positive lymph node, bisected and submitted in toto in one. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. return the report to us by mail. GROSS DESCRIPTION: cassette. Cassette #2. Three possible lymph nodes. Cassette #3. One lymph node. Cassettes #4&5 Resection of salivary gland. Received in formalin labeled ""Right neck level 2"" is an unoriented portion of. fibrofatty tissue 4.9 x 3.6 x 4.5 cm. One grossly positive lymph node is identified. 2.2 x 1.5 x 1.1 cm. No other lymph nodes are identified. Cassettes are submitted as. follows: Cassettes #1-4 Large lymph node, submitted in toto and multisected. Cassettes #5&6 Sections of indurated fatty tissue. D. Received in formalin labeled ""Additional right level 4 tissue"" consists of a portion. of gray-tan tissue 0.7 x 0.4 x 0.3 cm. Submitted in toto in one cassette. E. Received is a ""Partial glossectomy specimen"" measuring 6.1 cm from the anterior to. posterior, 4.1 cm from superior to inferior and 3.6 cm from lateral to lateral. The. margins are oriented as follows: Yellow is anterior. Red is medial. Black is posterior. Ulcerated tumor is present 4.1 x 3.1 cm in diameter. The lesion is 0.5 cm from the. anterior margin. 0.6 cm from the posterior resection margin, and 3mm from. the medial margin. The depth of the lesion upon sectioning is 0.7 cm. Cassettes are. submitted as follows: Cassette #1. Perpendicular anterior margin. Cassette #2. Perpendicular posterior margin. Cassettes#3- Sections of lesion in relation to medial margin. F. Received fresh for frozen section labeled ""Dorsal tongue"" are multiple portions of. red-tan tissue 2.1 x 1.1 x 0.3 cm in aggregate. Submitted in toto in one cassette. G. Received fresh for frozen section labeled ""Proximal margin right lingual nerve"" is a. portion of red-tan tissue 0.6 x 0.5 x 0.3 cm. Submitted in toto in one cassette. H. Received fresh for frozen section labeled ""Right base of tongue"" is a portion of. red-tan tissue 1.9 x 0.4 x 0.3 cm. Submitted in toto in one cassette for frozen. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. return the report to us by mail. GEDSS DESCRIPTION: section. I. Received fresh for frozen section labeled ""Right anterior tonsillar pillar"" is a. portion of red-tan tissue 0.4 x 0.4 x 0.3 cm. Submitted in toto in one cassette for. frozen section. J. Received in formalin labeled ""Retromolar trigone"" is a portion of red-tan tissue 1.2 x. 0.3 x 0.3 cm. Submitted in toto in one cassette for frozen section. K. Received in formalin labeled ""Right floor of mouth"" is a portion of red-tan tissue 1.5. x 0.4 x 0.3 cm in greatest dimension. Submitted in toto in one cassette for frozen. section. L. Received fresh for frozen section labeled ""Ventral tongue"" are multiple portions of. red-tan tissue 1.1 x 0.4 x 0.3 cm. Submitted in toto in one cassette for frozen. section. M. Received fresh for frozen section labeled ""Deep margin base of tongue"" is a portion. of red-tan tissue 0.6 x 0.5 x 0.3 cm. Submitted in toto in one cassette for frozen. section. N. Received fresh for frozen section labeled ""Deep margin anterior"" is a portion of. red-tan tissue 0.5 x 0.4 x 0.3 cm. Submitted in toto in one cassette for frozen. section. o. Received in formalin labeled ""Deep margin-deep tongue"" is a portion of red-tan tissue. 0.5 x 0.4 x 0.3 cm. Submitted in toto in one cassette for frozen section. P. Received fresh for frozen section labeled ""Level V lymph node"" is a portion of fatty. tissue 2.6 x 1.5 x 0.3 cm. One minute lymph node is identified. Possible lymph. nodes. identified 0.2 x 0.2 x 0.1 cm. The lymph node is bisected. The touch prep is taken. and submitted in toto in one cassette for frozen section. Remaining tissue is. submitted in toto for permanent section. Received in formalin labeled ""Distal right hypoglossal"" is a portion of red-tan. tissue. 0.5 x 0.3 x 0.2 cm. Submitted in toto in one cassette for frozen section. R. Received in formalin labeled ""Submental triangle"" is a portion of fibrofatty tissue. 3.1 x 1.5 x 1.1 cm. Three possible lymph nodes are identified. Largest of which. measures 0.6 cm in diameter. The specimen is submitted in toto as follows: This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. return the report to us by mail. GROSS DESCRIPTION: Cassette #1. Three lymph nodes in toto. Cassettes #2&3 Remaining tissue in toto. Sig. This report is privileged, confidential and exempt from disclosure under applicable law. If you receive this report inadvertently, please call. return the report to us by mail.",T3,N2,M0,T3N2M0
TCGA-CG-4455,"Diagnosis/diagnoses. Residual gastrectomy preparation of a stomach that had previously undergone B-II. gastrectomy showing tumor-free resection margins and the inclusion of a poorly. differentiated, highly mucigenous or mucinous adenocarcinoma with an extensive signet ring. cell component (so-called gastric carcinoma of the diffuse type) in the region of the lesser. curvature covering almost the entire gastric stump from the heart to the anastomosis, with. infiltration of the subserosa and two regional lymph node metastases. , pT2b pN1 2/17 LO.",T2,N1,M0,T2N1M0
TCGA-A8-A07J,"Diagnosis: 1. Breast segment with a bifocal invasive ductal carcinoma (G II; tumor diameter: 3. cm and 0.8 cm) with focal intraductal components. Tumor classification: NOS, G II, pT2(m) pN1a(1/18)LOV0R0.",T2,N1,M0,T2N1M0
TCGA-IN-A6RO,"FINAL DIAGNOSIS: PART 1: ESOPHAGUS, ESOPHAGECTOMY -. A. ADENOCARCINOMA, MODERATELY DIFFERENTIATED, SCM, INVASIVE INTO THE SUBMUCOSA (pT1b). B. NEGATIVE FOR ANGIOLYMPHATIC AND PERINEURAL INVASION. C. SURGICAL RESECTION MARGINS (PROXIMAL ESOPHAGUS, DISTAL STOMACH AND ADVENTITIAL MARGIN). ARE NEGATIVE FOR NEOPLASTIC INVOLVEMENT. D. THE TUMOR COMES WITHIN 0.2CM OF THE RADIAL/ADVENTITIAL SURGICAL RESECTION MARGIN. E. 1.6CM DISTALLY FROM THE MAIN TUMOR IS A 0.9CM FOCUS OF HIGH GRADE DYSPLASIA. F. BACKGROUND GASTROESOPHAGEAL MUCOSA WITH BARRETT'S MUCOSA. G. THERE IS NO EVIDENCE OF MALIGNANCY IN NINE LYMPH NODES (0/9). H. AJCC STAGING: pT1b NO. PART 2: LYMPH NODE, SUBCARINAL NEAR LEFT MAIN BRONCHUS, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 3: LYMPH NODE, SUBCARINAL NEAR RIGHT MAIN BRONCHUS, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 4: LYMPH NODE, SUBCARINAL NEAR PERICARDIUM, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 5: LYMPH NODE, SUBCARINAL NEAR THORACIC DUCT, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 6: LYMPH NODE, PARAESOPHAGEAL NEAR LEFT VEIN, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 7: LYMPH NODE, PARAESOPHAGEAL NEAR RIGHT CRUS, EXCISION -. A. FIBROADIPOSE TISSUE, NO LYMPH NODES IDENTIFIED. B. THERE IS NO EVIDENCE OF MALIGNANCY. PART 8: LYMPH NODE, NEAR VAGUS, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 9: LYMPH NODE, SUBCARINAL NEAR ATRIUM, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 10: LYMPH NODE, LESSER CURVE, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 11: LYMPH NODE, NEAR LEFT GASTRIC ARTERY, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 12: LYMPH NODE, GASTRIC FAT, EXCISION -. A. SKELETAL MUSCLE AND FIBROADIPOSE TISSUE, NO LYMPH NODE IDENTIFIED. B. THERE IS NO EVIDENCE OF MALIGNANCY. PART 13: LYMPH NODE, NEAR AZYGOUS, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 14: LYMPH NODE, FAT PAD, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 15: LYMPH NODE, PERIESOPHAGEAL AND FAT PAD NEAR DIAPHRAGM, EXCISION -. THERE IS NO EVIDENCE OF MALIGNANCY IN TWO LYMPH NODES (0/2). PART 16: ANASTOMOTIC RINGS, EXCISION -. A. RING OF STOMACH WITH OXYNTIC MUCOSA. B. RING OF ESOPHAGUS WITH SKELETAL MUSCLE. C. THERE IS NO EVIDENCE OF MALIGNANCY. PART 17: FINAL GASTRIC MARGIN, EXCISION -. A. STOMACH WITH OXYNTIC MUCOSA. B. THERE IS NO EVIDENCE OF MALIGNANCY. COMMENT: Part one. Esophagus, esophagectomy: The 5.0cm present at the gastroesophageal junction is similar to previous blopsy. by report as siides are not available for review. The tumor. comes to within 2mm of the adventitial surgical resection margin. There is a separate 0.9cm lesion with high grade. dysplasia located 1.6 cm distally to the main 5cm adenocarcinoma. No anglolymphatic invasion Is seen using double. immunohistochemical stain D240/AE1/3. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY ESOPHAGEAL TUMORS. MACROSCOPIC. SPECIMEN TYPE: Esophagogastrectomy. TUMOR SITE: Esophagogastric junction (EGJ) region (tumor involves EGJ and epicenter within 5cm. of EGJ). TUMOR SIZE: Greatest dimension: 5 cm. Additional dimensions: 2.3 cm. MICROSCOPIC. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G2. PATHOLOGIC STAGING (PTNM). pT1b. pNO. Number of lymph nodes examined: 22. Number of lymph nodes Involved: 0. pM Not applicable. PRIOR TREATMENT: No prior treatment. MARGINS. Proximal margin uninvolved by invasive carcinoma. Proximal margin uninvolved by dysplasia. Proximal margin uninvolved by intestinal metaplasia. Distal margin uninvolved by invasive carcinoma. Distal margin uninvolved by dysplasia. Distal margin uninvolved by intestinal metaplasia. Circumferential (adventitial) margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 4 mm. Specify margin: adventitial margin. ANGIOLYMPHATIC INVASION: Absent. ADDITIONAL PATHOLOGIC FINDINGS: Intestinal metaplasia (Barrett's esophagus). High grade dysplasia.",T1,N0,M0,T1N0M0
TCGA-AG-3592,"Diagnosis/ diagnoses: Rectosigmoid colon with an ulcerated rectal carcinoma characterized histologically as a. moderately differentiated colorectal adenoma, extending at most to within 4 cm of the. aboral resection margin, with a diameter of 3 cm at the widest point. Invasive tumor spread. to the periproctic fatty tissue. The minimum distance from the soft tissue resection margin. is 2 cm. Mucosa of both the rectum and colon shows a tubular adenoma of the colon. mucosa, with moderate epithelial dysplasia (synonym: mild intraepithelial neoplasia). In. addition, the mucosa of the colon and rectum show pseudomelanosis. Oral and aboral resection margins tumor-free. 32 periproctic and mesocolic lymph nodes tumor-free and with non-characteristic reactive. lesions. Tumor stage therefore pT3, pNO, (0/32) LO V0; G2.",T3,N0,M0,T3N0M0
TCGA-5R-AAAM,"years / F. go 5/21/14. Procedure: Resection of the liver. Preoperative diagnosis: CARCINOMA OF THE LIVER. Postoperative diagnosis: SEE MICROSCOPIC DIAGNOSIS BELOW. Specimen(s): 1. LIVER, SEGMENT I 2. HILAR LYMPH NODES. Diagnosis: 1. LIVER, SEGMENT I: Moderately differentiated hepatocellular carcinoma. Satellites. Vascular invasion is present. Remaining hepatic tissue shows micronodular cirrhosis (Metavir fibrosis score 4,. Knodell histological activity index score 4, Ishak fibrosis score 6). Resection margin is free of tumor. 2. HILAR LYMPH NODES: Lymph node is negative for metastatic carcinoma. Gross description: 1. LIVER, SEGMENT I: Received fresh, is a part of the liver 7.5 x 5.0 x 2.0 cm in dimensions. At a distance of 1.5 cm. from the resection margin the well-circumscribed lobulated brown-gray tumor 3.2 x 2.2 x 3.0 cm. in dimensions is present. In the surrounding hepatic tissue there are two similar lesions 0.3 and. 0.7 cm in diameter. The remaining hepatic tissue consists of firm brownish nodules ranging from. 0.1 to 0.3 cm in diameter. 2. HILAR LYMPH NODES: Received fresh, is a portion of adipose tissue with a lymph node 1.3 cm in greatest dimension.",T2,N0,M0,T2N0M0
TCGA-22-4601,"TISSUE DESCRIPTION: Tissue from right upper lobe lung (7.5 X 4 X 2.2 cm), , right lower lobe. lung (7 X 5 X 2.7 cm) and from right upper lobe hilar region (2 X 1.5 X 0.6. cm), superior (right lower paratracheal) and inferior (subcarinal, inferior. pulmonary ligament) mediastinal lymph nodes. DIAGNOSIS: Lung, right upper lobe, wedge excision: Invasive grade 3 (of 4). squamous cell carcinoma, forming a 0.7 X 0.5 X 0.5 cm nodule. The pleura. and surgical margin are negative for neoplasm. Lung, right lower lobe, wedge excision: Invasive grade 3 (of 4). squamous cell carcinoma forming a 2 x 2 X 1.2 cm mass with focal. retraction and involvement of the pleura. Soft tissue, right upper lobe hilar region, excision: Positive for. invasive grade 3 (of 4) squamous cell carcinoma. Lymph nodes, superior and inferior mediastinal, excision : Multiple. superior (8 right lower paratracheal) and inferior (2 subcarinal, 2. inferior pulmonary ligament) mediastinal lymph nodes are negative for. tumor.",T4,N0,M0,T4N0M0
TCGA-A7-A5ZW,"Final Surgical Pathology Report. Procedure. Diagnosis. A. Breast, right, lumpectomy: Invasive ductal carcinoma, grade 2; 1.7 cm (pT1c). Ductal carcinoma in situ, cribriform type, nuclear grade 2. Resection margins negative for invasive and in situ carcinoma. Unremarkable skin. B. Right axillary sentinel lymph node, excisional biopsy: Metastatic ductal carcinoma, 7 mm size with extranodal extension. (snpNla). Microscopic Description. Microscopic examination performed. A. Microscopic examination of the right breast lumpectomy specimen is. summarized in the template below: Invasive Carcinoma: Histologic type: Invasive ductal carcinoma. Histologic grade: 2. Overall grade: Architectural score: 2. Nuclear score: 2. Mitotic score: 2. Greatest dimension (pT) : 1.7 CM (pT1c). Specimen margins: Negative for carcinoma. Closest margin is. superior where tumor is 5 mm from the margin. Vessel invasion: Not identified. Calcification: Present. Ductal carcinoma in situ: Histologic pattern: -Cribriform. Nuclear grade: 2. Central Necrosis: Absent. % DCIS of total tumor (if mixed) : Approximately 10%. Extensive intraductal component (present/absent) : Absent. Specimen margins: Negative for DCIS. Calcification: Focally present. Description of non-tumorous breast: Fibrosis, apocrine metaplasia,. microcysts and ordinary ductal hyperplasia and adenosis. Comments: Core biopsy site changes are present. The tumor areas of. slightly higher grade than the original core biopsy interpretation due. to more mitotic activity. The skin is histologically unremarkable with. no extension of tumor into the skin ellipse. Prognostic markers: Performed on the prior core biopsy. B. Microscopic examination of the sentinel node involve the evaluation. of 3 H&E-stained sections of each of the 3 tissue blocks. Metastatic. ductal carcinoma is identified in blocks 1 and 2 and extranodal tumor. is identified in block 1. The size of the tumor is 7 mm (. Specimen. A. Right breast segments. B. Right sentinel lymph node axilla (hot/blue 812). Clinical Information. Breast cancer. Gross Description. A. Received fresh and subsequently fixed in formalin labeled ""right. breast segment"" is a 9.3 x 8.7 x 4.3 cm yellow lobular fatty tissue. fragment showing gross evidence of blue ink staining. The specimen is. received in a transpect container and is partially covered with a 5.7 x. 1.3 cm brown-tan wrinkled skin ellipse. The specimen has a double. suture designating anterior and a single suture designating lateral. The specimen is inked as follows The margins are inked as follows. based upon the orienting sutures: superior - orange; anterior - blue;. posterior - black; inferior - green. The specimen is serially. sectioned from medial to lateral. The specimen shows a yellow white,. fibrofatty cut surface with a 1.7 x 1.5 x 1.5 cm ill circumscribed. white tan firm lesion which comes within 0.5 cm of the superior margin,. 1.5 cm of the inferior margin, within 2 cm of the skin, greater than. 5. cm of the posterior margin and greater than 2.5 cm of the medial and. lateral margins. The lesion is stellate and shows white rice-like. pellets, grossly consistent with previous biopsy site. No additional. gross lesions are identified. The specimen is received in pathology at. and fixed in formalin at. Representative sections of. the specimen are submitted as follows: 1 - representative medial. margin, 2 - representative lateral margin, 3 - representative section. of the deep/ posterior margin, 4 - 10 - representative sections of. tumor to closest margin and skin. RS 10. B. Received fresh and subsequently fixed in formalin labeled ""right. sentinel node"" is a 2.4 x 1.5 x 1.0 cm blue stained pink yellow. irregular rubbery tissue fragment. The specimen is trisected to show an. irregular white firm central focus measuring 0.7 cm in greatest. dimension. AS- 3.",T1,N1,M0,T1N1M0
TCGA-46-3769,"SURGICAL PROCEDURES: BRON BRUSH RUL, BIOPSY. GROSS DESCRIPTION. Received for second opinion at the request of. are eight. outside slides from The. labeled as follows: (1 slide) , indicated by the. accompanying pathology report to be right upper lobe transbronchial. biopsies;. (two slides) , indicated to be bronchial brushing right. upper lobe;. (two slides), indicated to be post bronchoscopy. sputum specimen; and. (three slides) , indicated to be pooled. bronchial. washings. All specimens were obtained from the patient on. Slides and interpretive report to be returned following. completion of studies. FINAL DIAGNOSIS. LUNG, RIGHT UPPER LOBE (BIOPSY,. BRONCHIAL BRUSHINGS,. SPUTUM,. 0; WASHINGS,. RIGHT UPPER LOBE TRANSBRONCHIAL BIOPSY: POORLY DIFFERENTIATED NON-SMALL. CELL CARCINOMA, FAVOR ADENOCARCINOMA. BRONCHIAL BRUSHINGS: INCONCLUSIVE. ALTHOUGH FEW ATYPICAL CELLS ARE. IDENTIFIED, THEY LIKELY REPRESENT REACTIVE PNEUMOCYTES AND ALVEOLAR. MACROPHAGES. SPECIMEN IS NOT DIAGNOSTIC OF MALIGNANCY. SPUTUM: NO MALIGNANCY IDENTIFIED. THE SPECIMEN IS COMPRISED OF ORAL. MATERIAL ONLY AND IS NOT REPRESENTATIVE OF LOWER RESPIRATORY PATHOLOGY. BRONCHIAL WASHINGS: NO MALIGNANCY IDENTIFIED. THE SPECIMEN IS NOT. DIAGNOSTIC, WITH BLOOD AND ACUTE INFLAMMATION ONLY. REASON FOR VISIT: LUNG CANCER. SLIDES: 88304/2, 88305/5, 88309, 88311/2, 88331/2, 88342/2, LEVEL III - GRO/2,. LEVEL IV - GROS/5, LEVEL VI - GROS, DECALCIFICATION/2, PATHOLOGY CONSU/2,. IMMUNOPEROXIDAS/2, SURGICAL SPECIM. COMMENTS: TISSUES: A. LYMPH NODE. B. CHEST WALL. C. LUNG-RIGHT UPPER LOBE. D. RIB. - 5TH. E. RIB. - 4TH. F. LUNG, NOS - TOP OF SUPERIOR SEGMENT. G. LYMPH NODE. H. LYMPH NODE. CODES: P88304 - 88304. P88305 - 88305. P88309 - 88309. P88311 - 88311. P88331 - 88331. D50175 - RESECTION. 88304TC - LEVEL III - GRO. 88305TC - LEVEL IV - GROS. 88309TC - LEVEL VI - GROS. 88311TC - DECALCIFICATION. 88331TC - PATHOLOGY CONSU. 88342TC - IMMUNOPEROXIDAS. 1 - SURGICAL SPECIM. TY2150 - CHEST. T08000 - LYMPH NODE. T28000 - LU. T10350 - RIB. T28200 I M80414 - RT UP LOBE LUNG I NON SMALL CELL. 2. ICD CODES: 162.3 - MAL NEO UPPER LOBE LUNG. MARKERS: 88304, 88304TC, 88305, 88305TC, 88309, 88309TC, 88311, DECAL, 88331,. PATH CONSULT FS, IMMUNOPEROXIDASE, RES, SURGICAL SPECIMEN. CLINICAL HISTORY. RERTINENT CLINTCAL HISTORY ADENOCARCINOMA; UPPER, RIGHT LOBE LUNG CA. FINAL DIAGNOSIS. A. LYMPH NODE, LEVEL 9R, EXCISION: TWO LYMPH NODES, NEGATIVE FOR TUMOR. B. RIGHT POSTERIOR SUPERIOR CHEST WALL PLAQUE, EXCISION: METASTATIC NON-SMALL CELL CARCINOMA. TUMOR IS PRESENT AT THE CAUTERIZED EDGES OF THE SPECIMEN. C. LUNG, RIGHT UPPER LOBE, LOBECTOMY: FINAL DIAGNOSIS. POORLY DIFFERENTIATED NON-SMALL CELL CARCINOMA WITH. SQUAMOUS FEATURES. SEE SYNOPTIC REPORT. D. NECK OF 5TH RIB, RESECTION: BENIGN BONE. E. 4TH RIB, RESECTION: BENIGN BONE. TIP OF SUPERIOR SEGMENT, RESECTION: SEGMENT OF BENIGN LUNG, PLEURAL ADHESIONS, FOCAL CHRONIC. INFLAMMATION, AND EMPHYSEMATOUS CHANGE. NO MALIGNANCY IS NOTED. G. LYMPH NODE, RIGHT TRACHEOBRONCHIAL ANGLE, EXCISION: BENIGN LYMPH NODE (0/1). H. LYMPH NODE, RIGHT LOBAR UPPER, EXCISION: LYMPH NODE, NEGATIVE FOR TUMOR (0/1). Unless otherwise specified, the performance characteristics of the. immunoperoxidase stains performed here have been confirmed by the. A. The specimen is submitted fresh for frozen section as ""level 9 R"" and. consists of two pink black 0.4 and 0.5 cm nodules. The smaller will be. marked with black dye and the larger bisected. The specimen is submitted. in toto; 3 (1) labeled FSP for frozen section. FROZEN SECTION DIAGNOSIS 9R: Two lymph nodes, negative for tumor. COMMENTS Touch prep has been taken. GROSS DESCRIPTION. B. The specimen is submitted fresh for frozen section as ""right posterior. superior chest wall"" and consists of three pink red glistening segments of. apparent fibrous tissue ranging 2 x 1 x 0.4 cm to 2. 4 x 1 x 0.- 4 cm. Sectioning is unremarkable. Representative sections are submitted, 3 (1). labeled ""FSP"" used for frozen section. FROZEN SECTION DIAGNOSIS: Right superior chest wall plaque. Metastatic carcinoma. C. The specimen is submitted fresh but not for frozen section as ""right. upper lobe"" and consists of a 650 gram (formalin fixed) 16 x 14.5 x 7.3. cm lung lobectomy with an 11 x 9 cm diffusely firm tan white nodular area. with focal areas of gray tan shaggy fibromembranous adhesions. The. lobectomy is received with a stapled bronchial margin measuring 2.5 cm in. diameter along with multiple stapled vascular margins measuring 0.5 cm in. length x 1.2 cm in diameter to 0.6 cm in length x 2 cm in diameter, and. three stapled margins measuring 3.5 to 4 cm in diameter. The stapled. margins are removed and the underlying parenchyma inked black. The shaggy. pleural surface overlying the firm area is inked blue. Sectioning reveals. a 14.4 x 8.5 x 7 cm well circumscribed gray white mass with a diffusely. friable pink tan centrally necrotic center which extends throughout the. entire lobe grossly appearing to abut the blue inked outer pleural surface. measuring 1 cm from the hilum and 1.3 cm from the closest stapled. resection margin. The remaining uninvolved parenchyma is maroon to red,. spongy, homogenous and grossly unremarkable. No other discrete masses or. nodularities are grossly identified. At the hilum is a 0.5 cm in greatest. dimension gray black lymph node which is submitted entirely intact. Also. noted are multiple gray black to white matted lymph nodes within the. previously described mass measuring 0.8 to 2.2 cm in greatest dimension. Representative sections of the matted lymph nodes are submitted. Representative sections are submitted, multiple (10) as follows: 1: Vascular and bronchial margins submitted en face. 2-4: Mass with closest pleural surface including overlying. fibromembranous shaggy soft tissue. 5 and 6. Mass with closest stapled margin and adjacent hilum. 7 and 8 : Representative sections of the matted lymph nodes. 9: Uninvolved parenchyma pleural surface. 10 : One possible hilar lymph node submitted intact. D. The specimen is submitted fresh as ""neck of fifth rib"" and consists. of a segment of bone consistent with rib measuring 1.8 cm in length and. 1.4 4 cm in diameter. A representative section is submitted, 1 (1) for. decalcification. GROSS DESCRIPTION. E. The specimen is submitted fresh as ""fourth rib"" and consists of two. segments of bone consistent with rib measuring 1.7 x 0.7 x 0.4 cm and 1.8. x 1.5 x 0.8 cm. A representative section is submitted, 1 (1) for. decalcification. F. The specimen is submitted fresh as ""tip of superior segment"" and. consists of a wedge of pulmonary tissue measuring 4 x 0.9 X 0.6 cm with. stapled surgical margin. The pleural surface is gray and slightly. reticulated with deposits of black carbon pigment. The staple line is. removed and the margin marked with black dye. Serial sectioning is. unremarkable; submitted in toto, 7 (1). G. The specimen is submitted fresh as ""right tracheobronchial angle node"". and consists of a gray 1 cm nodular segment of tissue bisected and. submitted in toto, 2 (1). H. The specimen is submitted fresh as ""right lobar node upper"" and. consists of a gray moderately firm nodule bisected; submitted in toto, 2. (1). PRIORITY. PRIORITY: FROZEN SEC. SURGICAL PROCEDURES: RESECTION. SYNOPTIC REPORT. SYNOPTIC REPORT: LUNG. (CAP/AJCC/ACS - REQUIRED ELEMENTS). SPECIMEN TYPE: LOBECTOMY. LATERALITY RIGHT. TUMOR SITE: RIGHT UPPER LOBE. TUMOR SIZE: 14.4 CM. HISTOLOGIC TYPE: NON-SMALL CELL WITH SQUAMOUS FEATURES. HISTOLOGIC GRADE: 3 OF 4 (POORLY DIFFERENTIATED). EXTENT OF INVASION: TUMOR INVADES AT LEAST THE VISCERAL PLEURA, TUMOR ALSO. SYNOPTIC REPORT. INVOLVES CHEST WALL IN SEPARATELY SUBMITTED TISSUE (PART B) . EXTENTION TO PLEURA/OTHER STRUCTURES : TUMOR INVOLVES CHEST WALL IN. SEPARATELY SUBMITTED TISSUE (PART B). MARGINS. BRONCHIAL: UNINVOLVED. PARENCHYMAL: UNINVOLVED. VASCULAR: UNINVOLVED. DISTANCE TO PERTINENT MARGIN(S) : 1 CM FROM THE HILAR MARGIN AND IS 0.2 CM. FROM THE SOFT TISSUE MARGIN ON LUNG LOBECTOMY SPECIMEN. VENOUS INVASION: ABSENT. ARTERIAL (LARGE VESSEL) INVASION: ABSENT. LYMPH NODE: N1 - # INVOLVED/# EXAMINED: 0/8+. N2 - # INVOLVED/#EXAMINED: 0/8+. N3 - # INVOLVED/# EXAMINED: N/A. OTHER PERTINENT FINDINGS: THE TUMOR IS POORLY DIFFERENTIATED SHOWING FEATURES CONSISTENT WITH. SQUAMOUS DIFFERENTIATION (P63+, TTF-1-) AND SCATTERED ANAPLASTIC. CELLS. THE TUMOR DOES NOT TO EXTEND TO THE SOFT TISSUE MARGIN ON THE. LOBECTOMY SPECIMEN; HOWEVER, THERE IS A SEPARATELY SUBMITTED. CHEST WALL TISSUE (SPECIMEN PART B) WHICH IS INVOLVED BY TUMOR. IT. IS UNCLEAR WHETHER THE CHEST WALL TUMOR REPRESENTS DIRECT INVASION BY. THE LUNG TUMOR OR A METASTASIS. CLINICAL AND RADIOLOGIC CORRELATION. IS INDICATED. pTNM STAGE: pT3 NO MX. Unless otherwise specified, the performance characteristics of the. immunoperoxidase stains performed here have been confirmed by the. These tests have not been cleared or. approved by the U.S. Food and Drug Administration, although such approval. is not necessary. I. 1.",T4,N0,M0,T4N0M0
TCGA-DJ-A1QO,"Clinical Diagnosis & History: year old male with thyroid mass, FNA- PTC. Specimens Submitted: 1: SP: Subcutaneous lymph node. 2: SP: Thyroid and isthmus, total thyroidectomy. DIAGNOSIS: 1. Lymph node, subcutaneous, excision: -Benign fibroadipose tissue. Note: No fymph nodes are identified in the entirely submitted specimen. 2. SP: Thyroid and isthmus, total thyroidectomy: Tumor Type: Papiliary carcinoma, classical type. with tall cell features. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Isthmus. Tumor Size: Greatest diameter is 2.2 cm. Tumor Encapsulation: Partially surrounded. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Invades:the extrathyroidal adipose tissue. Surgical Margins: Tumor is present at the inked anterior margin. Tumor Multicentricity: Microscopic foci present. Two foci of papillary microcarcinoma are noted in right and left lobes measuring 0.2 cm and 0.22 cm in greatest. dimension respectively. Non-Neoplastic Thyrold: Exhibits nodular hyperplasia. Exhibits chronic lymphocytic thyroiditis. Parathyroid Glands: Not identified. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT 1 HAVE. REVIEWED AND APPROVED THIS REPORT. Report Erectronically Signed Out. Gross Description: 1). The specimen is received fresh, labeled ""Subcutaneous lymph node"" and consists of a single fatty lymph node measuring 0.7 x. 0.5 x 0,3 cm. The specimen is entirely submitted. Summary of sections: LN - lymph node. 2). The specimen is received fresh, labeled ""Total thyroidectomy and isthmus tumor"" and consists of a previously sectioned. (isthmus) thyroid weighing 17.5 g. The right lobe measures 3.7 x 2.2 x 1.4 cm, the left lobe measures 2.4 x 2.0 x 0.8 cm and the. isthmus measures 4.3 x 2.6 x 1.2 cm. The external surface is covered by a thin fibrous capsule. The posterior surface of the. specimen is inked black, and the anterior is inked blue. Sectioning the isthmus reveals a 2.2 x 1.8 x 1.1 cm well-circumscribed. red-tan fleshy mass and a1.3 cm cystic lesion adjacent or within the mass. The remaining thyroid parenchyma is red tan and. beefy. Representative section of the specimen is submitted for. a photograph has been taken. The remaining tissue is. serially sectioned and entirely submitted. Summary of sections: N nodule. RL right lobe. LL left lobe. Summary of Sections: Part 1: SP: Subcutaneous lymph node. Block. Sect. Site. PCs. 1. LN. 1. Part 2: SP: Thyroid and isthmus, total thyroidectomy. Block. Sect. Site. PCs. 3. LL. 6. 5. N. 5. 7. RL. 8.",T3,N0,M0,T3N0M0
TCGA-CQ-7071,"Visit Number. Event Date and Time. Procedure Ordered. Specimen #. supplemental. Accession Dat. Result Date: Addended. SPECIMEN(S) RECEIVED. 1. Nck: Left Neck Zones 1,2,3. Single stitch = perifacial nodes, double. stitch=inferior zone 3 nodes. 2. anterior lip margin. 3. marginal mandibulectomy left anterior alveolus. 1. Surgical Waste. DIAGNOSIS. 1. Left neck zones I, II, II. Metastatic squamous cell carcinoma involving one of twenty-two lymph nodes. [1/22). 1. The involved lymph node measures 2.0 cm. ). The involved lymph node is in level I. :. Negative for extranodal invasion. Submandibular gland with no pathologic changes. ?. Anterior lip margin. Negative for tumor. 1. Oral cavity; marginal mandibulectomy and left anterior alveolus. Squamous cell carcinoma, moderately differentiated. L. Tumor maximum diameter 3.9 cm. >. Tumor thickness 1.6 cm. ;. Negative for lymphovascular invasion. 1. Negative for perineural invasion. : Sections of bone are pending decalcification. An addendum report will. follow. (Please see comment). Tumor is close to anterior (0.2 cm), and medial (0.2 cm) mucosal. nargins. The remaining margins are negative (>0.5 cm) for tumor. 1. Surgical waste. Seven teeth with no pathologic diagnosis. (Gross examination only). SYNOPTIC DATA. Clinical History: No neoadjuvant therapy. Specimen: Mandible. Received: Fresh. Procedure: Mandibulectomy: left. Neck (lymph node) dissection: left neck. Specimen Integrity: Intact. Specimen Size: Greatest dimension: 4.4 cm. Additional dimension: 3.1 cm. Additional dimension: 2.3 cm. Specimen Laterality: Left. Tumor Site: Lower gingiva (gum). Lower alveolar process. Mandible. Tumor Focality: Single focus. Tumor Size: Greatest dimension: 3.9 cm. Tumor Description: Exophytic, Ulcerated. Histologic Type: Squamous cell carcinoma, conventional. Histologic Grade: G2: Moderately differentiated. Margins: Margins uninvolved by invasive carcinoma. Distance from closest margin: 0.2 cm. Margin(s): anterior and medial. Margin status for carcinoma in situ is not. applicable. Treatment Effect: Not identified. Lymph-Vascular Invasion: Not identified. Perineural Invasion: Not identified. Lymph Nodes, Extranodal Extension: Not identified. TNM Descriptors: Not applicable. Primary Tumor (pT): T2:Tumor more than 2 cm but not more than. 4 cm in greatest dimension. Regional Lymph Nodes (pN): pN1: Metastasis in a single ipsilateral. lymph node, 3 cm or less in greatest dimension. Number of regional lymph nodes examined: 22. Number of regional lymph nodes involved: 1. Size (greatest dimension) of the largest. positive lymph node: 2.0 cm. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: None identified. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. COMMENT. Tumor staging may change if bone invasion is found in decalcified section. GROSS DESCRIPTION. 1. The specimen is labeled with the patient' S name and ""left neck zones 1, 2,. 3"". The specimen consists of an oriented left neck dissection measuring 9.5 x. 7.0 x 2.0 cm. Twenty-two (22) lymph nodes are identified ranging from 0.2 to. 2.0 cm. The submandibular gland measures 5.5 x 4.0 x 1.5 cm and is. unremarkable. Levels I and II. IA four lymph nodes. IB four lymph nodes. IC one lymph node. Level III. ID five lymph nodes. IE four lymph nodes. IF one lymph node. IG one lymph node. IH one lymph node. 11 one lymph node. LJ submandibular gland. : The specimen is labeled with the patient' s name and ""anterior lip margin. It consists of skin measuring 3.0 x 0.5 x 0.2 cm. The specimen is. submitted in toto for frozen section. 'A frozen section control. 1. The specimen is labeled with the patient' S name and ""mandibulectomy left. interior alveolus"". The specimen consists of a partial mandibulectomy. neasuring AP 4.4 x ML 3.1 x SI 2.3 cm. There is an exophytic papillary, and. alcerated mass, measuring AP 3.9 x 2.4 ML x SI 1.6. The mass is involving the. nandible, extending into the gingiva proximally, and sulcus and buccal mucosa. listally. The mass is located at 0.6 cm from the deep resection margin, 0.6 cm. rom the posterior resection margin, 0.2 cm from the anterior resection margin,. 1.2 cm from the medial (gingival/floor of mouth) resection margin, and 0,4 cm. rom the lateral (buccal) resection margin. The mandible measures AP 3.3 x SI. .5 x ML 0.8 cm. All the margins are painted with silver nitrate. The deep. nargin is painted green, and the circumferential (including anterior,. osterior, and lateral/buccal areas) margins are painted black. Representative. ections are submitted. A anterior margin with tumour. 3B posterior margin with tumour. 3C-3F lateral/buccal and deep margins with tumour. 3G medial margin. decalcified sections. 3H anterior mandibular margin, en face. 3I posterior mandibular margin, en face. 3J midsections with tumor with deep and medial margins. 3K deepomandibular resection margin, en face. 4. The specimen is labeled with the patient' S name and ""surgical waste"". It. consists of consists of seven (7) teeth and one bridge. These are grossly. unremarkable. No sections are submitted for histology. QUICK SECTION. 2A. Anterior lip margin for. : Negative for invasive carcinoma. Result reported at. Addendum Status: Signed Out. Addendum Comment. Decalcified sections of bone show superficial invasion of cortex by squamous. cell carcinoma. The bone margins are negative for tumor.",T2,N1,M0,T2N1M0
TCGA-22-5472,"DIAGNOSIS: Lung, right middle lobe, wedge biopsy: Subpleural fibrosis and. focal osseous metaplasia. Lung, right lower lobe, lobectomy: Invasive grade 3 (of 4). non-keratinizing squamous cell carcinoma forming a 3.8 x 3.0 x 1.8. cm subpleural mass that involves the visceral pleura. The margins. of resection are negative for tumor. The surrounding lung. parenchyma shows septal and subpleural fibrosis, focal honeycomb. change, and areas of organizing pneumonia (see comment). Lymph nodes, mediastinal, excision: - No tumor is identified in multiple (4) right lower. paratracheal (station 4R) lymph nodes. No tumor is identified in multiple (3) subcarinal. (station 7) lymph nodes. Lymph nodes, hilar/intrapulmonary, excision: No tumor is identified in multiple (8) intrapulmonary. peribronchial lymph nodes.",T2,N0,M0,T2N0M0
TCGA-86-7713,Asterand Case ID. Open Clinica. Gross. Microsc. Diagnos. Subject ID. Descript. opic. is. ion. Descript. Details. ion. 86-7713. LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 6 X 6 X 6 cm. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Not specified. Other tumor nodules: Not. specified. Lymph nodes: 0/1 positive for. metastasis (Regional 0/1). Lymphatic invasion: Not. specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,T2,N0,M0,T2N0M0
TCGA-CN-6024,"CORRECTED. Report Type. Date of Event. Authored by. Hosp/Group. Record Status. CORRECTED. PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Malignant neoplasm pharynx. PROCEDURE: Mandibulectomy, glossectomy and neck dissection. SPECIFIC CLINICAL QUESTION: Not given. OUTSIDE TISSUE DIAGNOSIS: Not given. PRIOR MALIGNANCY: Not given. CHEMORADIATION THERAPY: Not given. ORGAN TRANSPLANT: Not given. IMMUNOSUPPRESSION: Not given. OTHER DISEASES: Not given. ADDENDA: Addendum. Immunohistochemical stain and in-situ hybridization for p16 and HPV are both. negative. My signature is attestation that I have personally reviewed the submitted. material(s) and the above diagnosis reflects that evaluation. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT NECK, DISSECTION. A. MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA IN ONE LYMPH. NODE OUT OF EIGHTEEN (1/18). B. THE METASTATIC TUMOR IS PRESENT IN A LEVEL 1B LYMPH NODE. C. NO EXTRACAPSULAR SPREAD. D. SUBMANDIBULAR GLAND WITHOUT SIGNIFICANT PATHOLOGIC CHANGE. PART 2: TEETH, EXTRACTION -. THREE TEETH (gross diagnosis only). PART 3: TONGUE, RIGHT POSTERIOR, BIOPSY. A. SQUAMOUS MUCOSA WITH ADIPOSE TISSUE, SKELETAL MUSCLE AND MINOR. SALIVARY GLAND. B. NO TUMOR SEEN. PART 4: LEFT MANDIBULAR MARROW, BIOPSY -. MICROSCOPIC FOCUS OF SQUAMOUS CELL CARCINOMA PRESENT ONLY ON FROZEN. SECTION SLIDES. PART 5: RIGHT MANDIBULAR MARROW, BIOPSY -. NO TUMOR SEEN. PART 6: LEFT ORAL TONGUE, BIOPSY. A. SQUAMOUS MUCOSA. B. NO TUMOR SEEN. PART 7: RIGHT DORSAL TONGUE, BIOPSY. A. SQUAMOUS MUCOSA WITH BACTERIAL OVERGROWTH AND UNDERLYING MUSCLE. TISSUE. B. NO TUMOR SEEN. PART 8: LEFT PHARYNX, BIOPSY. A. SQUAMOUS MUCOSA WITH LYMPHOID STROMA. B. NO TUMOR SEEN. PART 9: RIGHT FLOOR OF MOUTH, BIOPSY. A. SQUAMOUS MUCOSA WITH ADIPOSE TISSUE. B. NO TUMOR SEEN. PART 10: LEFT FLOOR OF MOUTH, BIOPSY. A. SQUAMOUS MUCOSA WITH SKELETAL MUSCLE. B. NO TUMOR SEEN. PART 11: TONGUE AND MANDIBULE, LEFT SUBTOTAL GLOSSECTOMY AND MANDIBULECTOMY. A. INVASIVE MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA, 5.0. CM. B. EXTENSIVE PERINEURAL INVASION SEEN. C. VENOUS INVASION PRESENT. D. SEGMENT OF MANDIBLE FREE OF TUMOR. E. ALL TRUE SOFT TISSUE AND BONY MARGINS ARE FREE OF TUMOR (SEE PARTS 3,. 5, 6, 7, 8, 9, 10 AND 13). F. pT4a N2c MX. PART 12: LYMPH NODES, LEFT CERVICAL, DISSECTION. A. METASTATIC SQUAMOUS CELL CARCINOMA IN FIVE OF TWENTY-ONE LYMPH. NODES (5/21). B. THE POSITIVE LYMPH NODES ARE FROM LEVELS 1A, 1B AND 4. C. EXTRACAPSULAR EXTENSION OF TUMOR IS PRESENT AND THERE IS FOCAL DIRECT. MICROSCOPIC EXTENSION OF TUMOR INTO THE SUBMANDIBULAR GLAND. D. SUBMANDIBULAR GLAND WITH CHRONIC SIALADENITIS. PART 13: LEFT MANDIBULAR MARROW #2, BIOPSY. NO TUMOR SEEN. COMMENT: Part 2: The specimen labeled ""dental extraction "" has been subjected to a. gross examination only. If it is desired that this specimen be processed for. additional studies, particularly microscopic examination, it is suggested that. the case pathologist be notified within two weeks of the sign out date of this. report. This is particularly important as specimens are routinely discarded. after a prescribed period of time. Thank you for involving us in the care of. this patient. My signature is attestation that I have personally reviewed the submitted. material(s) and the final diagnosis reflects that evaluation. GROSS DESCRIPTION: The specimen is received fresh in thirteen parts. Part 1 is received labeled with the patient's name, initials, XXX and ""right. neck dissection"". It consists of a specimen, 14.0 X 6.0 X 3.5 cm containing a. submandibular gland of 11.4 grams and 4.0 X 3.0 X 2.3 cm. The submandibular. gland is yellow and finely lobulated without evidence of any lesion or mass. The peri-submandibular gland adipose tissue contains multiple nodes ranging. from 0.2 to 0.9 cm. The upper half of fat attached to the specimen contains. multiple nodes ranging from 0.1 to 0.4 cm and the lower half contains nodules. ranging from 0.1 to 0.4 cm. Representative sections are submitted as follows: 1A submandibular gland. 1B one bisected lymph node from peri-submandibular gland tissue. 1C multiple lymph nodes from peri-submandibular gland tissue. 1D 1G multiple lymph nodes from level 2. 1H multiple lymph nodes from level 3. 11 1J multiple lymph nodes from level 3. Part 2 is received labeled with the patient's name, initials, XXX and ""dental. extraction"". Three complete teeth with possible carious lesion. Gross. examination only. Part 3 is received labeled with the patient's name, initials, XXX and ""right. posterior tongue"". It consists of a tan-pink mucosal fragment of 2.0 x 0.5 x. 0.3 cm. After frozen section specimen is entirely submitted in cassette. labeled 3AFS. Part 4 is received labeled with the patient's name, initials, XXX and ""left. mandibular marrow"". It consists of multiple white fragments of 0.4 x 0.2 x. 0.1 cm. After frozen section the specimen is entirely submitted in cassette. 4AFS. Part 5 is received labeled with the patient's name, initials, XXX and ""right. mandible marrow"". It consists of multiple pink to white fragments with a. total dimension of 0.2 X 0.2 X 0.2 cm. After frozen section the specimen. is. submitted entirely in cassette labeled 5AFS. Part 6 is received labeled with the patient's name, initials, XXX and ""left. oral tongue"". It consists of a fragment of pink-tan mucosa of 2.0 X 0.5 X 0.3. cm. After frozen section the specimen is totally submitted in cassette. labeled 6AFS. Part 7 is received labeled with the patient's name, initials, XXX and ""right. dorsal tongue"". It consists of a fragment of pink-tan mucosa of 2.2 X 1.0 X. 0.5 cm. After frozen section the specimen is totally submitted in cassette. labeled 7AFS. Part 8 is received labeled with the patient's name, initials, XXX and ""left. pharynx"". It consists of a pink fragment of tissue, 0.7 X 0.2 X 0.2 cm. After frozen section the specimen is totally submitted in cassette labeled. 8AFS. Part 9 is received labeled with the patient's name, initials, XXX and ""right. floor of mouth"". It consists of a pink fragment of soft tissue of 1.0 X 0.5. X. 0.2 cm. After frozen section the specimen is totally submitted in a cassette. labeled 9AFS. Part 10 is received labeled with the patient's name, initials, XXX and ""left. floor of mouth"". It consists of a fragment of pink-red tissue of 2.0 X 0.8. X. 0.2 cm. After frozen section the specimen is totally submitted in a cassette. labeled 10AFS. Part 11 is received labeled with the patient's name, initials, XXX and ""tongue. (long stitch left lateral, short stitch left tongue base and subtotal. glossectomy with mandibulectomy)"". It consists of a portion of mandible (4.5. X 2.9 x 1.5 cm) and left tongue and floor of mouth (7.0 X 4.0 x 4.0 cm). The. lateral tongue, lateral floor of mouth and gingival mucosa is involved by. a. large, ulcerated, white, firm mass of 5.0 X 2.7 X 1.7 cm. The lesion appears. to potentially infiltrate bone superficially at gross exam. The mass is at 0.1. cm from the medial soft tissue margin, 0.1 cm from the lateral soft tissue. margin, 0.1 cm from the posterior soft tissue margin, and 0.5 cm from the. inferior soft tissue margin and 0.4 cm from the anterior soft tissue margin. A portion of tumor was submitted for the. tissue bank. Digital images are. taken. Ink code: Black lateral margin. Blue medial margin. Red banked area. Representative sections are submitted as follows: 11A lateral mucosa shave. 11B posterior tongue mucosa shave. 11C medial tongue shave. 11D anterior soft tissue shave. 11E inferior soft tissue shave. 11F posterior soft tissue perpendicular. 11G anterior bone margin. 11H posterior bone margin. 11I bone underneath tumor. 11J tumor and lateral soft tissue. 11K tumor and medial soft tissue. 11L 11M tumor and possible submandibular gland?. 11N Tumor, nodular appearing, possible lymph node by direct extension?. Part 12 is received labeled with the patient's name, initials, XXX and ""left. neck dissection"". It consists of a specimen of 9.5 x 5.5 x 1.0 cm containing. a fragment of submandibular gland of 2.5 X 2.0 X 0.8 cm. Close to the. fragment of submandibular gland but not involving it is a white, firm, nodular. lesion of 2.5 X 1.8 X 1.0 cm. The remainder of the specimen is made up of. lobulated, yellow adipose tissue. Representative sections are submitted as. follows: 12A 12B white mass next to submandibular gland, submitted entirely. 12C representative section of submandibular gland. 12D multiple lymph nodes found in level 1. 12E multiple lymph nodes found in level 2. 12F multiple lymph nodes, level 3. 12G single lymph node trisected from level 4. 12H 12I multiple lymph nodes from level 4. Part 13 is received labeled with the patient's name, initials, XXX and ""left. mandible marrow #2"". It consists of multiple fragments of white to red. hemorrhagic soft tissue of 0.4 x 0.3 x <0.1 cm. After frozen section, the. specimen is totally submitted in a cassette labeled 13AFS. INTRAOPERATIVE CONSULTATION: 3AFS: RIGHT POSTERIOR TONGUE (frozen section). A. BENIGN. B. NO TUMOR SEEN. 4AFS: LEFT MANDIBULAR MARROW (frozen section). A. MALIGNANT. B. SQUAMOUS CELL CARCINOMA. C. CANNOT RULE OUT CONTAMINATION? ATROPHIC MUSCLE AROUND. 5AFS: RIGHT MANDIBULAR MARROW (frozen section). A. BENIGN. B. NO TUMOR SEEN. 6AFS: LEFT ORAL TONGUE (frozen section). A. BENIGN. B. NO TUMOR SEEN. 7AFS: RIGHT DORSAL TONGUE (frozen section). A. BENIGN. B. NO TUMOR SEEN. 8AFS: LEFT LARYNX (frozen section). A. BENIGN. B. NO TUMOR SEEN. 9AFS: RIGHT FLOOR OF MOUTH (frozen section). A. BENIGN. B. NO TUMOR SEEN. 10AFS: LEFT FLOOR OF MOUTH (frozen section). A. BENIGN. B. NO TUMOR SEEN. 13AFS: LEFT MANDIBULAR MARROW #2 (frozen section). A. BENIGN. B. NO TUMOR, BONY SPICULES. MICROSCOPIC: Parts 1 through 13, excluding Part 2: Microscopic examination substantiates. the above diagnosis. Three (3) H&E recuts and one (1) immunohistochemical. stain are performed on Part 6. Part 2: None. The following statement applies to all immunohistochemistry, Insitu. Hybridization Assays (ISH & FISH), Molecular Anatomic Pathology, and. Immunofluorescent Testing: The testing was developed and its performance characteristics determined by. the. Department of Pathology, as required by the CLIA. regulations. The testing has not been cleared or approved for the. specific use by the U.S. Food and Drug Administration, but the FDA has. determined such approval is not necessary for clinical use. Tissue fixation. ranges from a minimum of. to a maximum of. hours. This laboratory is certified under the Clinical Laboratory Improvement. Amendments of. (""CLIA"") as qualified to perform high-complexity clinical. testing. Pursuant to the requirements of CLIA, ASR's used in this laboratory. have been established and verified for accuracy and precision. Additional. information about this type of test is available upon request. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY UPPER AERODIGESTIVE TRACT AND SALIVARY GLAND. TUMORS. SPECIMEN TYPE: Resection: Left subtotalglossectomy and mandibulectomy. TUMOR SITE: Oral Cavity. TUMOR SIZE: Greatest dimension: 5.0 cm. HISTOLOGIC TYPE: Squamous cell carcinoma, conventional. HISTOLOGIC GRADE: G2. PRIMARY TUMOR (pT): pT4a. REGIONAL LYMPH NODES (pN): pN2c. Number of regional lymph nodes examined: 39. Number of regional lymph nodes involved: 6. DISTANT METASTASIS (pM): pMX. MARGINS: Margins uninvolved by tumor. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L): Present. PERINEURAL INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: None identified. HISTO TISSUE SUMMARY/SLIDES REVIEWED: Part 1: Right Neck Dissection. Stain/cnt. Block. H&E x 1. A. H&E x 1. B. H&E X 1. C. H&E X 1. D. H&E x 1. E. H&E x 1. F. H&E X 1. G. H&E X 1. H. H&E x 1. I. H&E X 1. J. Part 2: Dental Extraction. Part 3: Right Post Tongue. Stain/cnt. Block. H&E x 1. AFS. Part 4: Left Mandible Marrow. Stain/cnt. Block. H&E X 1. AFS. Part 5: Right Mandible Marrow. Stain/cnt. Block. H&E X 1. AFS. Part 6: Left Oral Tongue. Stain/cnt. Block. ANEG X 1. AFS. AE1/3 X 1. AFS. H&E Recut X 1. AFS. RHHE Lev. X 1. AFS. RHHE Lev. x 1. AFS. H&E X 1. AFS. Part 7: Right Dorsal Tongue. Stain/cnt. Block. H&E X 1. AFS. Part 8: Left Pharynx. Stain/cnt. Block. H&E X 1. AFS. Part 9: Right Floor of Mouth. Stain/cnt. Block. H&E X 1. AFS. Part 10: Left Floor of Mouth. Stain/cnt. Block. H&E x 1. AFS. Part 11: Total Subglossectomy. Stain/cnt. Block. H&E x 1. A. H&E X 1. B. H&E x 1. C. H&E x 1. D. H&E x 1. E. H&E x 1. F. H&E X 1. J. ANEG x 1. K. IHPV x 1. K. IBNKNC x 1. K. IBNKNC X 1. K. H&E x 1. K. IISH x 1. K. IISH x 1. K. P16 x 1. K. H&E x 1. L. H&E x 1. M. H&E X 1. N. H&E X 1. H&E X 1. H&E X 1. Part 12: Left Neck Dissection. Stain/cnt. Block. H&E x 1. A. H&E x 1. B. H&E X 1. C. H&E x 1. D. H&E x 1. E. H&E x 1. F. H&E x 1. G. H&E X 1. H. H&E x 1. I. Part 13: Left Mandible Marrow #2. Stain/cnt Block. H&E x 1. AFS.",T4,N2,M0,T4N2M0
TCGA-AG-A011,"Diagnosis: 1.: Resectate of the rectum with a mainly poorly differentiated adenocarcinoma, with. infiltration of the pericolic fatty tissue, tumor-free resection margins and tumor-free. lymph nodes (fourteen lymph nodes examined). 2.: Superficial splenic tissue with capsule defects and hemorrhaging. No indication of. malignancy. Tumor classification: adenocarcinoma G3, pT3 NO (0/14) L0 V0 R0. Criteria.",T3,N0,M0,T3N0M0
TCGA-77-7465,"HISTORY. R upper lobectomy for SCC. MACROSCOPIC. Three specimens received. 1: The specimen is labelled 'right upper lobe' and consists of a lobectomy specimen. measuring 140 X 120 X 75 mm in its partially inflated state. Two bronchi are present. at the margin measuring 10 to 12 mm in diameter respectively. Two staple lines are. also present radiating from the bronchial margin to the periphery. They measure 35. and 80 mm in length. A large lymph node is present adjacent to the bronchial. resection margin. The cut surface of the lung shows a central lobulated tumour. measuring 39 X 32 X 30 mm. The cut surface has areas of necrosis and carbon. pigment. It appears to overrun several central peribronchial lymph nodes. Numerous. smaller non-involved peribronchial lymph nodes are also identified. Tumour. compresses one of the main bronchi towards the hilum. It lies approximately 10 mm. from the bronchial margin and appears clear of the soft tissue margin. It is 5 mm. from the nearest pleural surface. The distal lung shows evidence of collapse,. consolidation and bronchiectasis. There also areas of parenchymal haemorrhage,. likely iatrogenic. Two 1 to 2 mm tan nodules are seen within the collapsed zone,. distal to the tumour. There are also two firm granular areas within the lung. parenchyma away from the tumour. These range in size from 4 to 5 mm in greatest. dimension. The residual lung parenchyma shows mild emphysema away from the. areas of collapse, however this is difficult to assess. [1A, bronchial resection margin;. 1B-1C, one peribronchial lymph node bisected; 1D-1F, RS tumour and adjacent main. bronchus; 1G, RS tumour and closest pleural surface; 1H, peribronchial lymph nodes;. 1I, RS lung parenchyma distal to tumour; 1J, RS two small nodules distal to tumour;. 1K, RS lung parenchyma away from tumour; 1L, two firm granular lesions.]. 2: The specimen is labelled ""number 4 lymph node' and consists of a grey to black. piece of soft tissue consistent with a node measuring 15 mm in greatest dimension. The node has a black to white cut surface. [Trisected, BIT, 2A.]. 3: The specimen is labelled ""number 5 right side lymph node' and consists of a grey. piece of soft tissue consistent with a lymph node measuring 28 mm in greatest. dimension. The cut surface contains numerous white nodules. [Trisected, BIT, 3A-. 3B.1. MICROSCOPIC. 1: Sections show a moderately to poorly differentiated squamous cell carcinoma. which appears to arise from a segmental bronchus close to the hilum and which. obliterates several segmental bronchi. Tumour involves peribronchial fat at the hilum. but appears clear of the surgical resection margin. The bronchial resection margin. shows no evidence of squamous metaplasia or dysplasia. Tumour directly invades. and appears to replace at lease one peribronchial lymph node. A number of silicotic. nodules are present within other peribronchial lymph nodes. Several foci of vascular. invasion are present, including involvement of a major branch of the pulmonary artery. which contains tumour within its lumen. Definite lymphatic or perineural invasion is. not identified. Distant lung parenchyma contains dust macules and fibromuscular. scars and shows severe emphysema. There are also vascular changes in keeping with. organised thrombi distal to the tumour. 2 & 3: Sections show anthracotic lymph nodes containing a few small silicotic. nodules but no evidence of metastatic carcinoma. SUMMARY. Right upper lobectomy, no. 4 and no. 5 lymph nodes: Squamous cell carcinoma, 39 mm in diameter. Vascular invasion present. No pleural, lymphatic or perineural invasion identified. Direct invasion of peribronchial lymph node. Pathological stage T2a N1. T-28000 M-80703 P1-03000. cc: Lung Cancer Registry.",T2,N1,M0,T2N1M0
TCGA-G6-A5PC,"SPECIMENS: A. LEFT KIDNEY. SPECIMEN(S): A. LEFT KIDNEY. DIAGNOSIS: A. KIDNEY, LEFT, NEPHRECTOMY: - RENAL CELL CARCINOMA, CLEAR CELL TYPE, FURHMAN GRADE 4, MEASURING 6.4-CM,. CONFINED TO RENAL CAPSULE. - URETERAL MARGIN NEGATIVE FOR TUMOR. - ADRENAL GLAND, NO TUMOR SEEN. - ONE HILAR LYMPH NODE NEGATIVE FOR CARCINOMA (0/1). - SEE SYNOPTIC REPORT AND SEE NOTE. NOTE: The tumor has solid and papillary architecture. The cells show clear cytoplasm. Part of the tumor. has high grade nuclei (Furhman grade 4). Theimmunoprofileiscompatible with clear cell carcinoma. phenotype. The patient has tumor metastases to the lung . Dr. concurs. SUMMARY OF MMUNOHISTOCHEMISTRYISPECIAL STAINS. Material: Block A4. Population: Tumor Cells. Stain/Marker:Result: Comment: CYTOKERATIN 7. Negative. PIN-4 HMWCK (CK5 & CK14) Negative. PIN-4 P504S Positive. PIN-4 p63. Negative. CD 10. Positive. The interpretation of the above immunohistochemistry stain or stains is guided by published results in. the medical literature, provided package information from the manufacturer and by internal review of. staining performance and assay validation within the. The use of one or more reagents in the above tests is regulated as an analyte. specific reagent (ASR). These tests were developed and their performance characteristic determined. by the. They have not been. cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such. clearance or approval is not necessary. Special stains and/or immunohistochemical stains were performed with appropriately stained positive. and/or negative controls. SYNOPTIC REPORT - KIDNEY (PARTIAL OR RADICAL). Specimen Type: Radical nephrectomy. With adrenal gland. Laterality: Left. Tumor Site: Not specified. Focality: Unifocal. Tumor Size (largest tumor if multiple): Greatest dimension: 6.4cm. Macroscopic Extent of Tumor: Tumor limited to kidney. WHO CLASSIFICATION. Clear cell renal cell carcinoma 8310/3. Histologic Grade (Fuhrman Nuclear Grade): G4: Nuclei bizarre and multilobated, 20 u or greater, nucleoli prominent, chromatin clumped. Invasion of Vascular/Lymphatic: Absent. Perinephric Tissue Invasion: Absent. Margins: Margins uninvolved by invasive carcinoma. Adrenal Gland: Uninvolved by tumor. Regional Lymph Nodes: Negative 0 / 1. Additional Findings: None identified. Pathological Staging (pTNM): pT 1b N 0 M 1. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. GROSS DESCRIPTION: A. LEFT KIDNEY. Received fresh labeled with patient's identification and ""left kidney"" is an intact kidney with attached. perinephric fat weighing 322 g and measuring 12 X 7 x 5 cm. The adrenal gland is 5.2 x 2.2 x 0.5 cm; it. has a golden orange coloration. The ureter is 8.3 x 0.5 cm. On opening, it is smooth and tan in. coloration. There is a hilar lymph node, 0.4 cm in diameter. The capsular and perinephric fat are inked. black and the kidney is bisected. There is an orange-tan mass, 6.4 x 6.2 x 5.2 cm which extends to. within 0.2 cm of the capsule. It is hemorrhagic and fibrotic and pushes on the renal pelvis resulting in its. dilation. Photograph is taken and tissue is procured; representatively submitted: A1: vasculature margins. A2: bisected hilar lymph node. A3-A5: mass and relationship to capsule and perinephric fat. A6-A7: mass in relationship to renal pelvis. A8: mass and relationship to normal-appearing parenchyma. A9: normal-appearing parenchyma. A10: adrenal gland. A11. Ureter margin. CLINICAL HISTORY: None Given. PRE-OPERATIVE DIAGNOSIS: None Given.",T1,N0,M1,T1N0M1
TCGA-F2-7273,"Diagnosis : FSA: Liver, biopsy. - Cholestasis, mesothelial lined cyst, no metastatic carcinoma. identified. FSB : Common bile duct margin, excision. - No carcinoma identified. FSC : Pancreatic duct margin, excision. - No carcinoma identified. D: Portal lymph nodes, dissection. - No metastatic carcinoma identified (0/9). E: Hepatic artery lymph nodes, dissection. No metastatic carcinoma identified (0/12 lymph nodes and lymph. node fragments). F: Gallbladder, cholecystectomy. - Chronic cholecystitis, no stones identified. G: Pancreaticoduodenectomy Whipple procedure. Tumor Histologic Type invasive ductal adenocarcinoma. Histologic grade: moderate to poorly differentiated. Tumor size: 4.2 cm. Extent of invasion: Peripancreatic soft tissues: involved (G9). Duodenum involved (G14). Ampulla : involved (G7). Lymphatic Invasion: present (G12). Venous Invasion: not identified. Perineural Invasion: present. Surgical Margins : Pancreatic neck: not involved. Bile duct: not involved. Posterior pancreatic surface (deep radial margin) : positive at. site of SMA (G9) and site of portal vein (G11). Peripancreatic soft tissues: involved posteriorly, see above. Proximal (gastric) : not involved. Distal (duodenal) : not involved. Regional lymph nodes: Total number with metastasis: 3. Total number examined: 32. Additional pathologic findings : none. AJCC Stage: pT3 pN1 pMx. Note: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. Intraoperative Consult Diagnosis: A frozen section consultation was requested by. at. FSA1: Liver, biopsy. - Liver with bile stasis, mild inflammation and detached. peritoneum versus mesothelial cyst. No malignancy identified. FSB1 : Bile duct margin, excision. - No carcinoma identified. FSC1: Pancreatic duct margin, excision. - Chronic pancreatitis with fibrosis; no carcinoma identified. Drs. at. Drs. at. Frozen Section Pathologist : M.D., Ph.D. Clinical History : year-old male with a mass in the pancreatic head and. obstructive jaundice. The mass was not previously biopsied. Gross Description: Received are seven appropriately labeled containers. Container A is additionally labeled ""liver biopsy. The. container holds three beige/tan soft tissue fragments measuring. in aggregate 1.5 X 1.0 X 0.7 cm frozen and totally submitted as. FSA1,. Container B is additionally labeled ""common bile duct margin. The container holds a 1.5 x 0.2 X 0.2 cm red/beige/tan soft. tissue fragment frozen and totally submitted as FSB1,. Container C is additionally labeled ""pancreatic duct margin. The container holds a 0.9 X 0.2 X 0.2 cm red/beige/tan soft. tissue fragment frozen and totally submitted as FSC1,. Container D is additionally labeled ""portal lymph nodes. The. container holds a 3.5 X 1.5 X 0.2 cm tan fibroadipose soft. tissue fragment with several small lymph node candidates. palpated within ranging in size from 0.2 to 0.6 cm. The. specimen is totally submitted in blocks D1 and D2,. Container E is additionally labeled ""hepatic artery lymph. nodes. "" The container holds an aggregate of tan fibroadipose. soft tissue fragments loosely measuring 3 X 2 X 0.7 cm. Several. firm lymph node fragments are palpated within the specimen. The. specimen is totally submitted in blocks E1 and E2,. Container F is additionally labeled ""gallbladder. "" The container. holds a cholecystectomy specimen measuring 8 X 3.5 X 2.5 cm. The. serosal surface is pink/tan and smooth with a rough liver bed. resection surface. The mucosa is hemorrhagic, velvety and finely. trabeculated. The wall is uniform 0.2 to 0. cm in thickness. There are no stones. There are scant hemorrhagic luminal. contents. No mucosal or mural lesions are noted. Block summary : F1 - resection margin with cystic duct and artery and. representative section from fundus. F2 - representative sections from mid body and neck. Container G is additionally labeled ""pancreaticoduodenectomy. with short stitch at uncinate, long stitch at SMA. "" The. container holds a standard Whipple specimen with the following. measurements: distal stomach 7.5 X 5 cm; portion of greater. omentum attached to stomach 11 X 4.5 X 1.5 cm; duodenum 24 cm in. length X 2.5 cm in average diameter (after fixation) ; pancreatic. head and neck 6 X 4.5 X 4.5 cm. A long stitch marks the. pancreatic margin at the SMA and a short stitch marks the. uncinate process margin. Inking common bile duct=yellow,. resection margin at pancreatic neck=blue, uncinate. process=black, peripancreatic soft tissue=green. The serosal surface of the stomach and duodenum is tan and. smooth. The pancreatic head is very firm. Opening the duodenum. reveals erythematous coarse and thickened mucosa at the ampulla. The remainder of the stomach and duodenal mucosa is beige/tan,. unremarkable, and appropriately folded. The pancreas is. sectioned revealing a 4.2 X 4.0 X 4.0 cm white/tan/yellow solid. firm mass occupying most of the pancreatic parenchyma in the. specimen. The mass has areas of necrotic cystic change along the. dorsal pancreatic surface. The tumor constricts the common bile. duct to lumen diameter of 1-2 mm. It comes up into the ampulla. and undermines the duodenal mucosa. The tumor infiltrates into. the duodenal wall proximal to the ampulla as well, extending up. to and possibly into the submucosa. The tumor does not involve. the pylorus. There is relatively poor demarcation between the. mass and the pancreatic neck. To assess distance to pancreatic. neck margin the resection surface of the neck is inked blue and. sections are taken perpendicular to this surface (true surgical. margin at the neck is superseded by the en face G2 section) . The. mass extends to the inked uncinate margin at short stitch and. the margin at the SMA at long stitch. It also abuts. peripancreatic soft tissue. Distance to mucosal margins: stomach. margin 16 cm, duodenal margin 13 cm, common bile duct margin 1.5. cm. A number of firm lymph nodes are identified in the. peripancreatic soft tissue ranging in size from 0.2 to 0.6 cm,. submitted per block summary. Tumor was collected by Tissue. Block Summary : G1 - common bile duct margin, en face. G2 - pancreatic neck margin, en face. G3 - gastric mucosal margin, en face. G4 - duodenal mucosal margin, en face. G5 - lymph node candidate at the common bile duct, bisected. G6 - perpendicular sections to the pancreatic neck (inked blue). G7 - ampulla section. G8 - perpendicular margin at uncinate at the surgeon' S short. stitch (black ink). G9 - perpendicular section at the SMA margin at long stitch. (green ink). G10-G11 representative sections to green inked pancreatic. surface, G10 near common bile duct, G11. near the portal vein groove. G12 - ulcerated duodenal mucosa at ampulla. G13 - tumor in relation to the common bile duct, two sections. G14 - tumor undermining duodenal wall. G15 - pylorus, representative section. G16 - representative sections of stomach and duodenum. G17 - multiple peripancreatic lymph node candidates. G18 - multiple peripancreatic lymph node candidates at base of. common bile duct. G19 - multiple peripancreatic lymph node candidates. G20-G22 - multiple perigastric lymph nodes candidates, each. cassette, greater omentum. Light Microscopy: Light microscopic examination is performed by. The frozen. section diagnoses are confirmed. Permanent sections show invasive ductal adenocarcinoma with mucinous. features within pancreatic head, extending into peripancreatic fat,. extending through the duodenal wall to undermine the mucosa, and. extending posteriorly to the pancreatic posterior soft tissue margin. at the site of the SMA and the portal vein. Definite nodal metastasis. is identified in block G18. Two soft tissue nodules in block G17 are. interpreted as most consistent with complete effacement by metastatic. carcinoma.",T3,N1,M0,T3N1M0
TCGA-CV-A45R,"Sex: M. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. the section ""SPECIMEN"" may have been added. DIAGNOSIS. RIGHT SUPRAOMOHYOID NECK DISSECTION: METASTATIC SQUAMOUS CARCINOMA IN 1 OF 13 REGIONAL LYMPH NODES WITH. FOCAL EXTENSION INTO EXTRA-NODAL CONNECTIVE TISSUE DISTRIBUTED. AS FOLLOWS: Three submental/submandibular lymph nodes, no tumor present. METASTATIC SQUAMOUS CARCINOMA IN ONE OF TWO SUBDIGASTRIC. LYMPH NODES WITH FOCAL EXTENSION INTO EXTRA-NODAL CONNECTIVE. TISSUE. Eight midjugular lymph nodes, no tumor present. Submandibular gland, no tumor present. (B). ""RIGHT BASE OF TONGUE"": Focal mucosal ulceration; there is no diagnostic evidence of. malignancy. ""SUBTOTAL GLOSSECTOMY"". INVASIVE GRADE I-II SQUAMOUS CARCINOMA; RESECTION MARGINS FREE OF. TUMOR. (SEE COMMENT). COMMENT. The morphological features of this neoplasm are those of. a. relatively low-grade (i.e., grade I-II) invasive, keratinizing squamous. carcinoma. Tumor invades underlying submucosal connective tissue,. superficial muscle and deep muscle. Tumor forms an ulcerated 2.5 x 2.0 cm. mass that invades to a depth of approximately 1.5 cm. Peri-neural invasion. is present. There are morphological features strongly suggestive of. lympho-vascular invasion by tumor. The final resection margins are free of. tumor. SPECIMEN. (A). RIGHT SUPRAOMOHYOID NECK DISSECTION: ""RIGHT BASE OF TONGUE' : (c). SUBTOTAL GLOSSECTOMY"". SNOMED CODES. T-53000, M-80703.",T2,N1,M0,T2N1M0
TCGA-BP-4331,"Clinical Diagnosis & History: Left renal mass. Specimens Submitted: 1: SP: Lt. posterior mid-pole renal mass. 2: SP: Peri-nephric fat left. DIAGNOSIS: KIDNEY, POSTERIOR MID-POLE, LEFT, PARTIAL RESECTION: - RENAL CELL CARCINOMA, CLEAR CELL TYPE, NUCLEAR GRADE II/IV. THE PATTERN OF GROWTH IS. ACINAR. THE TUMOR GREATEST DIAMETER IS 3.7 CM. THE TUMOR IS CONFINED WITHIN THE RENAL. CAPSULE. ALL SURGICAL MARGINS ARE FREE OF TUMOR. THE TUMOR IS WITHIN 1.0 MM OF RENAL. PARENCHYMAL MARGIN. THE NON-NEOPLASTIC KIDNEY SHOWS CHRONIC PYELONEPHRITIS,. NEPHROSCLEROSIS AND PAPILLARY ADENOMA, THE ADRENAL GLAND is NOT SUBMITTED. 2). SOFT TISSUE, LEFT, PERI-NEPHRIC FAT; EXCISION: - BENIGN ADIPOSE TISSUE. Gross Description: The specimen is received fresh for frozen section, labeled, ""Left posterior mid-pole renal mass, stitch marks deep margin. It consists of portion of rectum specimen measuring 5.5 x 5.0 x 3.5 cm with a stitch desingating the deep marign which is inked. black. Sectioning reveals a well-defined capsular tumor measuring 3.7 x 3.7 x 3.0 cm. The cut surface of the specimen is. hemorrhagic and bright yellow in color. Representative sections of the specimen are submitted for frozen. The margin opposite. to the staple and margin designated as deep Is inked yellow. The mass is sitated grossly 0.3 cm from the stapled margin and. 0,7. cm from margin opposite to it. Representative sections of the tumor including inked margin are submitted. Summary of Sections;. FSC - frozen section control. U - undesignated. 2). The specimen is received fresh, labeled, 'Peri-nephric fat left' It consists of a piece of adipose tissue measuring 25. 0x. 18 x 4.0 cm, Sectioning reveals a discrete mass. Representative sections of the specimen are submitted. Summary of Sections: U - undesignated. Summary of Sections: Part 1: SP: Lt. posterior mid-pole renal mass. Block. Sect. Site. PCs. 1. FSC. 1. 9. 9. Part 2: SP: Peri-nephric fat left. Block. Sect. Site. PCs. 3. U. 3. Intraoperative Consultation: Note: the diagnosis given in this section pertain only to the tissue semple examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: RENAL CELL CARCINOMA (CLOSE WITHIN. 1.0 MM) MARGIN MARKED WITH STITCH,. PERMANENT DIAGNOSIS: SAME.",T1,N0,M0,T1N0M0
TCGA-J8-A3YD,"SurgPath Final. Temporary Copy. FINAL DIAGNOSIS. A) Right thyroid lobe and isthmus: Papillary thyroid carcinoma (1.5 x 1.0 x. 0.8 cm) with fibrosis and surrounding adenomatous thyroid hyperplasia. Negative for definite lymphatic/vascular invasion. Surgical margins of. resection free of tumor. B) Left thyroid lobe: Adenomatous hyperplasia without diagnostic. evidence of neoplasm. C) Central compartment lymph nodes: Metastatic papillary thyroid. carcinoma in two of six lymph nodes (2/6). Thymic epithellum is also. identified. Comment: Selective slides reviewed with Dr. A) RIGHT THYROID LOBE AND ISTHMUS, F/S. B) LEFT THYROID LOBE. C) CENTRAL COMPARTMENT LYMPH NODES. FROZEN SECTION. A) Right thyroid lobe and isthmus: Papillary thyroid carcinoma. GROSS DESCRIPTION. A) Received fresh for frozen section labeled ""right thyroid lobe and isthmus"" is a. lobe of thyroid weighing 18 grams and measuring 5.0 x 3.5 x 2.8 cm. The red/tan. capsular surface appears intact. The specimen is inked on its surgical margins with. black ink, serially sectioned and reveals a 1.5 x 1.0 x 0.8 cm white/tan indurated. focally calcified lesion, which grossly comes to within approximately 0.3 cm of the. inked capsular margin. Touch preps are made from the lesion and a representative. portion is submitted for frozen section as A1. The remainder of the thyroid displays. beefy red/tan thyroid parenchyma. No additional lesions are identified. A portion of. mass is submitted for the 7. Additional sections are. submitted for permanent section as follows: A2 and A3 remainder of mass, A4. through A7 sections of thyroid. SurgPath Final. Temporary Copy. B) Received fresh labeled ""left thyroid lobe"" is a lobe of thyroid weighing 13 grams. and measuring 5.5 x 3.0 x 1.5 cm. The red/tan capsule appears intact. The. specimen is inked on its surgical margins with black ink, serially sectioned and. reveals a 0.8 cm yellow/tan nodule in the mid portion of the specimen. This nodule. focally abuts the inked capsule. The remainder of the thyroid displays beefy red/tan. thyroid parenchyma. Representative sections are submitted as follows: B1 entirely. submitted bisected nodule, B2 through B6 additional sections of thyroid. C) Received in formalin labeled ""central compartment lymph node"" is an ovoid. portion of yellow lobulated adipose tissue measuring 3.5 x 2.5 x 0.4 cm. Dissection. yields multiple small embedded lymph nodes measuring up to 0.3 cm in greatest. dimension. The specimen is entirely submitted in C1-C2. CLINICAL INFORMATION. THYROID MASS. 1.",T1,N1,M0,T1N1M0
TCGA-A2-A0ST,"Patient: : Specimen # : Race: WHITE. AMENDED. SPECIMEN: A: RIGHT BREAST BIOPSY B: SENTINEL LYMPH NODE#1. C: SENTINEL LYMPH NODE#2. FINAL DIAGNOSIS: A. BREAST, RIGHT; EXCISION: - INFILTRATING DUCTAL CARCINOMA, POORLY DIFFERENTIATED (MODIFIED. BLOOM-RICHARDSON GRADE 9: MITOSES=3, NUCLEAR PLEOMORPHISM=3, TUBULE. FORMATION=3). -TUMOR SIZE 2.0 CM. - -TUMOR IS LESS THAN 0.1 CM FROM ANTERIOR AND MEDIAL SURGICAL MARGINS. - -ASSOCIATED FINDINGS: FIBROCYSTIC CHANGES INCLUDING STROMAL SCLEROSIS. AND MICROCYSTS. -MICROCALCIFICATIONS IDENTIFIED, ASSOCIATED WITH BENIGN BREAST TISSUE. - IMMUNOHISTOCHEMICAL STAINS FOR ESTROGEN AND PROGESTERONE AS FOLLOWS. ESTROGEN RECEPTOR: NEGATIVE. PROGESTERONE RECEPTOR: POSITIVE. -HER2/NEU (FISH METHODOLOGY) : NOT AMPLIFIED (1.3). B. LYMPH NODE, SENTINEL LYMPH NODE#1, BIOPSY: -ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA ON H AND E AND. IMMUNOHISTOLOGIC SECTIONS. -TUMOR SEEN IS APPROXIMATELY 0.5 CM IN SIZE. C. LYMPH NODE, SENTINEL LYMPH NODE#2, BIOPSY: -ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA ON H AND E AND. IMMUNOHISTOLOGIC SECTIONS. -TUMOR SEEN LESS THAN 0.1 CM IN SIZE. COMMENT: This case is amended to reflect the review of. immunohistochemical stains for estrogen and progesterone receptors and. FISH for Her2/neu amplification. There is no change in diagnosis. COMMENT. ge 1. specimen #: FINAL DIAGNOSIS (continued) : Case amended. to report results of HER2 analysis by. immunohistochemistry (DAKO Hercep Test) : HER2/NEU PROTEIN OVEREXPRESSION: NEGATIVE (SCORE: 1+) . CLINICAL DIAGNOSIS AND HISTORY: -year-old female with palpable mass on right breast with no ultrasound. or mammographic correlation. GROSS DESCRIPTION: A. RIGHT BREAST BIOPSY received in formalin, labeled with the patient's. name, designated ""RIGHT BREAST EXCISIONAL BIOPSY"" is a lumpectomy specimen. measuring 10.2 x 7.0 x 3.0 cm in dimension. The specimen is composed. largely of yellow, lobulated, glistening adipose tissue admixed with white. fibrous areas. The specimen will be inked and oriented as follows: Black=deep, yellow=anterior, blue=medial, green=lateral, and red denotes. superficial and inferior. The specimen is serially sectioned from superior. to inferior revealing a fiarly well-defined, grey/tan nodule, 1.5 cm in. greatest dimension, abutting the anterior margin in the mid portion of the. specimen. Immediately adjacent to this nodule is a 1.5 cm patch of. indurated fibrous tissue involving the anterior and medial margins. The. remaining tissue consists of an admixture of fibrous tissue (approximately. 40%) and fat (approximately 60%) . The fibrous tissue is variably. indurated, particularly in the inferior half of the specimen. Sections of. nodule and fibrous tissue are harvested for the CBCP protocol. Matching. paraffin sections are as follows: A1: Nodule. A2: Indurated fibrous tissue adjacent to A1. A3: Fibrous tissue 3.0 cm inferior to nodule. A4: Fibrous tissue 6.0 cm inferior to nodule at the inferior margin. The remainder of the specimen is serially sectioned and submitted from. superior to inferior as follows: A5-A12: Representative section from each level from superior to inferior. Specimen #: GROSS DESCRIPTION (continued) : A13-A14: Next lower level. A15-A16: Next lower level. A17-A18 Inferior most section. B. SENTINEL LYMPH NODE#1 received in formalin, labeled with the patient'. name, designated ""SUPERIOR LYMPH NODE NUMBER ONE"" is a 1.7 x 1.3 x 0.8 cm. lymph node. A small portion of the node is harvested for the CBCP. protocol. The remaining tissue is entirely submitted in cassette B1. C. SENTINEL LYMPH NODE#2 received in formalin, labeled with the patient' S. name, designated ""SENTINEL LYMPH NODE NUMBER TWO"" is a 1.2 x 0.8 x 0.5 cm. tan/brown lymph node. The tissue is entirely submitted in cassette C1.",T1,N1,M0,T1N1M0
TCGA-DD-A39W,"cincervind, NUS 8/70/3. TISSUE DESCRIPTION: Portion right lobe liver (16 x 12 x 5.5 cm) with attached gallbladder (together. weighing 575 grams) and separately submitted choledochal lymph node (2.5 X 1.5 x. 1 cm). A1, B1, B2 B3, B4, B5, B6, B7, B8, B9, B10, B11, B12, B13, B14,. DIAGNOSIS: Grade 2 hepatocellular carcinoma forming a mass, 13 x 10 x 5.0 cm. The. nonneoplastic liver shows no evidence of cirrhosis. A separate fibrous nodule. measuring 3.5 x 2.5 x 2.5 cm shows old granuloma, as well as hepatocellular. carcinoma. The surgical resection margins are clear by at least 0.4 cm. The attached. gallbladder shows cholesterolosis. A pericholedochal lymph node received with the. liver specimen and a separately submitted choledochal lymph node show reactive. lymphoid hyperplasia; negative for tumor. Choledochal lymph node: All embedded. PHOTOGRAPHED IN LAB. REVISION DESCRIPTION: SIGNED OUT ACCIDENTALLY, CORRECTION WAS NEEDED. ORIGINAL FOLLOWS. A1, B1, B2, B3, B4, B5, B6, B7, B8, B9, B10, B11, B12, B13, B14. DIAGNOSIS: Grade 2 hepatocellular carcinoma forming a mass, 13 x 10 5.0 cm. The. nonneoplastic liver shows no evidence of cirrhosis. A separate fibrous nodule. measuring 3.5 x 2.5 X 2.5 cm shows old granuloma, as well as hepatocellular. carcinoma. The surgical resection margins are clear by at least 0.4 cm. The attached. gallbladder shows cholesterolosis. A pericholedocahl lymph node received with the. liver specimen and a separately submitted choledochal lymph node show reactive. lymphoid hyperplasia; negative for tumor. Choledochal lymph node: All embedded. ADDENDUM: Special stains for acid fast bacilli and fungi are performed on the sections of old. granuloma. They are negative.",T3,N0,M0,T3N0M0
TCGA-B4-5834,"I. Specimen. Clinical. Ethnicity. Clinical. I. Index. procuremen. label. Site #. (Race). Diagnosis. t. Renal. 1. Male. Cancer. Renal. Male. Cancer. I. Tissue. I. I Anatomical. Tumor. Specimen. Specimen. Number of. Amount/per. Specificatio. Container. I. Site. Matrix. Format. containers. container. I. I. n. Kidney, left. Primary. Tumor. Tissue. Frozen. cryomold. 1. 330. mg. Blood. n/a. normal. Blood. Frozen. tube. 1. 4. ml. Prior. I. Type of. Chemo /. I. I. Histological. TNM Stage. TNM Stage. TNM Stage. Chemo /. Prior. Procuremen. Grade. Horm Th. description. (T). (N). (M). Hormonal. Radiation. I. I. t. Details. Th. Renal cell. no data. 2. 0. 0. carcinoma. Blood draw. n/a. n/a. n/a. n/a. n/a. Cellular. Tumor %. 85. n/a.",T1,N0,M0,T1N0M0
TCGA-EA-A4BA,"Gross Description: Uterus with cervix, upper third of vagina, adnexa uterine, fatty tissue and omentum. The whole area of exocervix and endocervix is replaced by the tumor up to 6.5x4x1.5 cm in size. Endometrium is of normal structure. Ovaries and Fallopian tubes are hyperemic. Fatty tissue fragments. are with dense hyperemic lymph nodes up to 1.5 cm in its diameter. Microscopic Description: Adenocarcinoma of the endocervix with spread on the exocervix, G-2. Tumor. size is 6.5x4x1.5 cm. Vagina is of normal structure. Endometrium is hypo-plastic with reactive metaplasia. of superficial epithelium. Leiomyoma of the uterus. Ovaries and Fallopian tubes are of normal structure. Four examined lymph nodes from the left side and six lymph nodes from the right side demonstrated. reactive changes. Omentum is of normal structure. Diagnosis Details: Tumor Features: Indeterminate, Tumor Extent: Lesion greater than 4.0cm, Venous. Invasion: Absent, Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: CERVIX TISSUE CHECKLIST. Specimen type: Simple hysterectomy. Tumor site: Cervix. Tumor size: 4 X 1.5 X 6.5 cm. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Tumor extent: Lesion greater than 4.0 cm. Lymph nodes: 0/10 positive for metastasis (Pelvic lymph nodes 0/10). Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T1,N0,M0,T1N0M0
TCGA-D9-A3Z4,": xxx. Examination result. Clinical diagnosis (suspicion): Skin melanoma on the right arm. Date of admission: (urgency: Standard). Material: 1) Material: skin of the arm, Method of collection: Lesion resection. Histopathological diagnosis: Malignant melanoma of the skin with ulceration. 12 mm, diameter 24 mm. pT4b, pN3. Macroscopic description: A flap of skin with subcutaneous tissue sized: 1 8 x 8 x 2 cm. Tumour sized 2.4 x 2.4 x 1 cm on the skin,. brown-coloured, ulcerous, placed 1 cm from the base and 2 cm from the side edge. Small satellite tumours on the skin from 0.1 to 0,6 cm (side margin 0.6 cm, from the base 0.4 cm). Proliferation sized 3 x 1.7 x 3.5 cm in the subcutaneous tissue, reaching the base. Microscopic description: Malignant melanoma of the skin. Clinical data and histology suggestive of a primary lesion - nodular type. Level V according to. thickness of 12 mm acc. to. the largest tumour size is 24 mm. A faint. lymphocitary proliferation at the foot of the lesion, no signs of regression. Ulceration and satellite lesions. No. remnants of the pre-existing naevus. Minimum margin of healthy tissues to the side of the surgical specimen: 0.3 cm Minimum margin of healthy tissues. from the base of the surgical specimen: 0 cm.",T4,N3,M0,T4N3M0
TCGA-KQ-A41O,"Surgical Pathology Laboratory. al Pathology Report. Report Date: Submitted by: Telephone: CLINICAL INFORMATION: Urothelial carcinoma of the bladder. Radical cystoprostatectomy. Specimen submitted: A. Right pelvic lymph node; B. Bladder, prostate, seminal vesicles; C. Right pelvic lymph node; D. Left. pelvic lymph node; E. Left distal ureter; F. Right distal ureter. DIAGNOSIS: A. Pelvis, right, lymph nodes (excision): Nodular deposits of urothelial carcinoma in fibroadipose (lymph node replacement cannot be excluded). B. Bladder, prostate, seminal vesicles (resection): Bladder: - High grade, papillary urothelial carcinoma with focal micropapillary pattern, 6.0 cm, involving. entire bladder (all walls). - There is multifocal invasion of muscularis propria and focal extension into perivesical tissue. - Lymphatic (B4,B9) and venous (B8) invasion is identified. - Multifocal urothelial carcinoma in situ of bladder, extending into the distal left ureter and. bladder neck. - Ulcers with foreign body giant cell reaction, consistent with previous biopsy sites. - Margins of resection, including urethral and ureteral, are negative for invasive carcinoma. - One lymph node, negative for metastatic carcinoma (0/1). - TNM staging: pT3, N1, MX (See specimen C below.). Prostate: Benign prostatic hyperplasia with acute and chronic inflammation. Histologically unremarkable seminal vesicles. C. Pelvis, right, lymph nodes (excision): Highgrade urothelial carcinoma with micropapillary pattern in fibroadipose tissue suggestive of. metastatic carcinoma replacement of lymph node. D. Pelvis, left, lymph nodes (excision): Ten lymph nodes, negative for metastatic carcinoma (0/10). E. Ureter, left, distal (excision): Urothelial carcinoma in situ of dilated ureter. F. Ureter, right, distal (excision): Benign dilated ureter. GROSS DESCRIPTION: A. Received fresh, the specimen is labeled ""right pelvic lymph node,"" and consists of a 3.5 x 1.2 x 0.5 cm piece of fibromuscular. tissue with two lymph nodes, both of which are entirely frozen. The remaining tissue is entirely submitted. Summary of sections: AFSC-lymph nodes; Al-remaining tissue. B. Received fresh, the specimen is labeled ""bladder, prostate and seminal vesicles,"" and consists of a cystoprostatectomy specimen. measuring 14.0 x 9.0 x 5.5 cm. The prostate measures 5.5 x 4.5 x 3.5 cm and the bladder measures 7.0 x 5.5 x 4.5 cm. The right. seminal vesicle measures 2.0 x 1.5 x 1.5 cm, the left seminal vesicle measures 3.5 x 1.5 x 1.0 cm, the right vas deferens measures. 5.0 x 0.5 cm and the left vas deferens measures 8.0 x 0.4 cm. The left ureter measures 2.0 x 0.9 cm and the right ureter measures. 1.8 x 1.0 cm. Both ureters are shaved and submitted. The distal urethral margin is shaved and submitted. The right aspect of the. prostate is inked green and the left aspect of the prostate is inked black. The anterior perivesical fat is inked green and the posterior. perivesical fat is inked black. The bladder is opened anteriorly to reveal a fungating tumor measuring 6.0 x 5.5 x 3.0 cm located at. the left dome, left lateral wall and anterior wall. No tumor grossly extends outside of the muscle. Additionally. there are multiple. erythematous polypoid lesions on both right and left lateral and posterior walls measuring up to 1.2 cm. The prostate is serially. sectioned and sections are labeled from A through H from apex to bladder neck. On cut section, the prostate shows multiple cystic. and. nodular areas and is otherwise unremarkable. The prostate is submitted in alternating sections and representative sections of the. bladder including tumor are submitted. Summary of sections: B1-distal urethral margin; B2-right ureter margin; B3-left ureter. margin;. B4-right ureterovesical junction; B5-left ureterovesical junction; B6-trigone of bladder to prostatic urethra; B7-trigone to. right wall; B8-left wall; B9-right wall; B10 and 311-posterior wall; B12-dome; B13-right and posterior wall; B14-anterior wall;. B15-deep to B14; B16-left wall; B17-section adjacent to B16; B18-anterior wall; B19-left wall; B20-anterior wall; B21-section. deep. to. B20; B22-? tumor in fat near left wall; B23 and B24-additional perivesical fat; B25-RA apex; B26-RP apex; B27-LA apex;. B28-LP apex; B29-ARA; B30-ARP; B31-ALA; B32-ALP mid; B33-ALP lateral; B34-CRA; B35-CRM; B36-CRP; B37-CLA;. B38-CLM; B39-CLP; B40-ERA; B41-ERM; B42-ERP; B43-ELA; B44-ELM; B45-ELP; B46-GRA mid; B47-GRA lat; B48-GRP. mid; B49-GRP lat; B50-GLA; B51-GLP. C. Received fresh, the specimen is labeled ""right pelvic lymph nodes,"" and consists of a 4.0 x 3.5 x 0.5 cm piece of fibromuscular. tissue and possible lymph nodes. The specimen is entirely submitted. Summary of sections: CI through C3-fibromuscular tissue. which is firm, serially sectioned and entirely submitted; C4-remaining tissue. D. Received. i the specimen is labeled ""left pelvic lymph nodes,"" and consists of a 3.8 x 2.5 x 1.0 cm aggregate of lymph nodes. and fibrofatty 1. ,ue. is entirely submitted. Summary of sections: DI through D3. E. Received fresh, !. is labeled ""left distal ureter,"" and consists of a 2.2 cm segment of ureter up to 1.1 cm in diameter. One end is clipped an. site end is taken as the true margin. Representative sections of the remaining ureter are submitted. Summary of sect ons: tel-true margin; E2-representative sections. F. Received fresh. timen is labeled ""right distal ureter,"" and consists of a 5.3 cm segment of ureter measuring up to 0.7 cm. in diameter. One. 1 and the opposite end is taken to be the true margin. Representative sections of the remaining ureter. are submitted. ,. nons: FI-true margin; F2-representative sections. (. INTRAOPERATIVE D. CNOSIS: A. Frozen section diagnosis: Positive for carcinoma. Reported to: Attending Pathologist. The attending pathologist whose signature appears on this report has reviewed the diagnostic slides,. and has edited the gross and microscopic portions of the report in rendering the final diagnosis. Slides: A-3,B-51, C-4. D-3. E-2. F-2.",T3,N1,M0,T3N1M0
TCGA-BR-8484,Case ID. Gross Description. Microscopic. Diagnosis Details. Description. Comments. STOMACH TISSUE. CHECKLIST. Specimen type: Gastrectomy. Tumor site: Fundus. Tumor size: 8 X 8 X 8 cm. Tumor features: None. specified. Histologic type: Adenocarcinoma. Histologic grade: Moderately differentiated. Tumor extent: Serosa. (visceral peritoneum). Lymph nodes: 2/7 positive. for metastasis (Regional. 2/7). Lymphatic invasion: Not. specified. Venous invasion: Not. specified. Perineural invasion: Not. specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic. findings: Not specified. Laterality.,T4,N1,M0,T4N1M0
TCGA-AN-A0XL,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: OCT. Container: block Type of Procurement: surgery Grade: 2. T Stage: 2 N Stage: 0 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,T2,N0,M0,T2N0M0
TCGA-AO-A0J7,"Clinical Diagnosis & History: Invasive duct carcinoma left breast 5:0 and severe ADH left breast 11:00 (on. core biopsy): for left total mastectomy, SLNB, possible left ALND and. immediate reconstruction. Specimens Submitted: 1: SENTINEL NODE #1, LEVEL ONE LEFT AXILLA, EXCISION: 2: SENTINEL NODE #2, LEVEL ONE LEFT AXILLA, EXCISION. 3: NON-SENTINEL NODE, LEFT AXILLA, EXCISION. 4: BREAST, LEFT, SIMPLE MASTECTOMY. DIAGNOSIS: SUMMARY OF FINDINGS IN THIS CASK: Invasive ductal carcinoma present as two foci spaning 28 mm and 2 mm and is. 3.6 cm from the closest inked margin. The nipple dermis is involved by invasive ductal carcinoma. Mucinous carcinoma spans 2.5 mm and does not involve the inked margin. All foci of invasive carcinoma (ductal and mucinous) are ER positive, HER2. negative. DCIS is present and is 3.6 cm from the closest inked margin. Sentinel lymph nodes: 2/3. Non-sentinel lymph nodes: 1/1. Total lymph nodes: 3/4. Type of metastasis: macrometastasis (6 mm) to an intramammary lymph node. 1. SENTINEL NODE #1, LEVEL ONE LEFT AXILLA, EXCISION: Sentinel Lymph Node Status: Number of Sentinel Lymph Nodes Examined: 1. Number of Sentinel Lymph Nodes with carcinoma: 1. Size of Largest Metastatic Focus: >= 0.2 mm to =< 2 mm (micrometastasis). The metastatic focus spans 0.4 mm. Level of Detection: Initial H&E stained section. Extracapsular Extension: Not present. 2. SENTINEL NODE #2, LEVEL ONE LEFT AXILLA, EXCISION: Sentinel Lymph Node Status: Number of Sentinel Lymph Nodes Examined: 1. Number of Sentinel Lymph Nodes with carcinoma: 1. Size of Largest Metastatic Focus: > 2 nm. The metastatic focus spans 3 mm. Level of Detection: Initial H&E stained section. Extracapsular Extension: Present, measuring < 2mm in largest diameter. The metastatic carcinoma is negative for WT1. 3. Non-sentinel node, left axilla, excision: - One benign lymph node (0/1). 4. BREAST, LEFT, SIMPLE MASTECTOMY: Invasive Carcinoma: Ductal, NOS type. Focal mucinous carcinoma (see note). Histologic Grade: III/III: Minimal or no tubule formation K< 10% of tumor). Nuclear Grade: III/III (marked variation in size and shape). Tumor Size: Two foci (size specified below). the invasive ductal carcinoma spans 28 mm and 2 mm. Ductal carcinoma in situ (DCIS) : Present. DCIS, Architecture: Solid. Papillary. DCIS Nuclear Grade: High. Necrosis in DCIS: Minimal. Extensive intraductal component (>25% of tumor mass) : Not Identified. Lobular Neoplasia: Lobular carcinoma in situ (LCIS) classical type. Location of Invasive Carcinoma: Upper inner quadrant (UIQ). Lower inner quadrant (LIQ). Location of DCIS: Upper inner quadrant (UIQ). Lower inner quadrant (LIQ). Nipple Involvement: Invasive carcinoma involves the nipple stroma. Skin: Tumor emboli are present in dermal lymphatic channels. The examined skin margins are uninvolved by carcinoma. Calcification: In benign breast tissue. In invasive carcinoma. Lymphovascular Invasion: Present. Surgical Margins: Invasive carcinoma is 36 mm from the closest margin. DCIS is 36 mm from the closest margin. Benign Breast Tissue: Atypical ductal hyperplasia (ADH). Fibrocystic changes, including apocrine metaplasia, cyst formation. and stromal fibrosis. Biopsy site changes. Columnar cell changes. Lymph Nodes: LN - Number of lymph nodes with metastatic carcinoma: 1. Number of lymph nodes examined: 1. The mass identified in the UOQ at 1:00 is an intramammary lymph. node, almost enrtirely replaced by metastaic carcinoma. The metastaic. carcinoma measures 0.6 cm and is negative for WT1. Results of immunostains. for calponin and p63 support the diagnosis. A 2.5 mm focus of invasive mucinous carcinoma is also identified, with. nuclear grade II/III. Immunohistochemical stains were performed on formalin-fixed tissue with the. following results for. INVASIVE DUCTAL CARCINOMA (block 4-5) : ESTROGEN RECEPTOR (6F11,. 90% nuclear staining with strong. intensity. PROGESTERONE RECEPTOR (1E2;. negative (no nuclear staining). HER2 (4B5,. Negative (0 / 1+). The invasive ductal carcinoma is negative for WT1. The smaller focus of invasive ductal carcinoma has similar immunoprofile. Positive membranous imunoreactivity for E-cadherin supports ductal. differentiation. MUCINOUS CARCINOMA (block 4-19) : ESTROGEN RECEPTOR. 95% nuclear staining with strong. intensity. PROGESTERONE RECEPTOR (. 95% nuclear staining with strong. intensity. HER2 (. Negative (0). The mucinous carcinoma is positive for WT1. Comment: Controls are satisfactory. PATHWAY anti-HER-2/neu is. an 7DA-approved rabbit monoclonal primary antibody (clone 4B5) directed. against the internal domain of the c-erbB-2 oncoprotein (HER2) for. immunohistochemical detection of HER2 protein overexpression in breast. cancer tissue routinely processed for histologic evaluation. The HER2 test. results are reported in accordance with the ASCO/CAP guideline. recommendations for HER2 testing in breast cancer (J Clin Oncol 2007;. 6(1):118-145). The ER and PR rabbit monoclonal antibodies are also FDA. approved. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL). , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1) The specimen is received fresh for frozen section consultation, labeled. ""sentinel node #1, level one, left axilla"" and consists of a single node. measuring 1 cm. Bisected and entirely submitted for frozen section. Summary of sections: FSC -- frozen section control. 2) The specimen is received fresh for frozen section consultation, labeled. ""sentinel node #2, level one, left axilla"" and consists of a single node. measuring 2.0 cm. Bisected and entirely submitted for frozen section. Summary of sections: FSC -- frozen section control. 3) The specimen is received fresh for frozen section consultation, labeled. 'non-sentinel node left axilla"" and consists of a single fatty node. measuring 0.7 cm. Bisected and entirely submitted for frozen section. Summary of sections: FSC frozen section control. 4.) The specimen is received fresh labeled, ""Left total mastectomy, suture. marks axillary aspect"" and consists of a previously incised, 24.1 x 19.5 x. 4.6 cm breast with a partially overlying, 11.7 x 3.5 x 0.1 cm skin ellipse. Situated centrally on the skin surface is a 1.2 x 1.2 x 0.1 cm, crusty,. partially inverted, diffusely indurated, nipple with smooth, pink-white. suspicious cut surfaces surrounded by a 4.7 x 3.4 cm areola. The wrinkled,. tan-white skin is free of any gross abnormalities. A suture demarcates the. 7.2 x 4.6 x 0.5 cm axillary aspect. The posterior surface of the breast is. inked black, the anterior blue and the axillary aspect is inked yellow. The. specimen is serially sectioned to reveal a 2.8 x 2.4 x 2.1 cm, firm, lobular. to fatty infiltrating bordered, pink-white mass, located in the lower inner. and outer quadrants, from 5 ''clock to 7 o'clock, underlying the nipple, 0.5. cm from the nipple base and 3.6 cm from the deep margin, (designated Mass. #1) The mass grossly appears to be separate from the suspicious indurated. nipple. Also, 5.9 cm superior and 1.5 cm medial to Mass #1, is a 2.5 x 2.2. x 1.3 cm, biopsy site partially surrounded by moderately dense, focally;. cystic, nodular and hemorrhagic, white fibrous tissue, located within the. apper outer quadrant, at 1 o'clock, 5.1 cm the nipple and 3.2 cm from the. deep margin, (designated Biopsy site #1) In addition, partially abutting. biopsy site #1 is a twist-clip situated within a 2.6 x 1.6 x 1.4 cm. well-healed biopsy site with a peripherally attached 0.9 x 0.9 x 0.7 cm,. ovoid, firm, smooth to nodular bordered, white to indigo blue ink-tinged. mass, located within the upper outer quadrant, at 2 o'clock, 5.5 cm from the. nipple and 4.2 cm the deep margin (designated Biopay site #2 and Mass #2). The remaining breast parenchyma consists of lobules of yellow adipose. separated by bands of mild to moderately dense, focally nodular and cystic,. white fibrous tissue. Sectioning of the axillary aspect reveals no grosalv. identifiable lymph nodes. TPS is submitted of Mass #1, per protocol. Representative sections are submitted. Additional sections are submitted. following microscopic review of the specimen. Summary of sections: N - nipple. NB - nipple base. D - deep margin. M1 Mass #1. BX1 Biopsy site #1. BX12 Biopsy sites #1 & #2. BX2 -- Biopsy site #2. M2BX2 Mass #2 with Biopsy site #2. M2 Mass #2. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. AD12 skin additional sections, 12 o'clock. AD3 skin additional sections, 3 o'clock. AD6 skin additional sections, 6 o'clock. AD9 skin additional sections, 9 o'clock. Summary of Sections: Part 1: SENTINEL NODE #1, LEVEL ONE LEFT AXILLA, EXCISION: Block. Sect. Site. PCs. 1. FSC. 1. Part 2: SENTINEL NODE #2, LEVEL ONE LEFT AXILLA, EXCISION. Block. Sect. Site. PCs. 1. FSC. 1. Part 3: NON-SENTINEL NODE, LEFT AXILLA, EXCISION. Block. Sect. Site. PCs. 1. FSC. 1. Part 4: BREAST, LEFT, SIMPLE MASTECTOMY. Block. Sect. Site. PCs. 1. AD12. 1. 1. AD3. 1. 1. AD6. 1. 1. AD9. 1. 4. BX1. 5. 1. BX12. 1. 1. BX2. 1. 1. D. 1. 1. LIQ. 2. 1. LOQ. 2. 6. M1. 6. 1. M2. 1. 1. M2BX2. 1. 2. N. 5. 1. NB. 1. 1. UIQ. 2. 1. UOO. 2. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1. FROZEN SECTION DIAGNOSIS: SP: Sentinel node #1 level 1 left axilla (fs). Benign. PERMANENT DIAGNOSIS: SEE FINAL DIAGNOSIS. 2. FROZEN SPATTON DIAGNOSIS: SP: Sentinel node #2 level 1 left axilla (fs) : Benign. PERMANENT DIAGNOSIS: SEE FINAL DIAGNOSIS. FROZEN SECTION DIAGNOSIS: SP: Non-sentinel node left axilla (fs) : Benign. PERMANENT DIAGNOSIS: SAME.",T2,N1,M0,T2N1M0
TCGA-A6-6141,"SPECIMEN. Right hemicolectomy with en block resection of abdominal wall muscle. and fascia. CLINICAL NOTES. PRE-OP DIAGNOSIS: Tumor of cecum. POST-OP DIAGNOSIS: Same. GROSS DESCRIPTION. Received fresh for tissue procurement labeled ""right. hemicolectomy with en bloc"" is a previously unopened, 24 cm. segment of proximal right colon with attached 17 cm of distal ileum. surfaced by smooth to scabrous tan-pink serosa with a moderate. amount of attached mesocolon, mesentery and unremarkable omentum. An irregular 5 X 5 X 2.5 cm fragment of red-brown skeletal muscle. is. present in the vicinity of the cecal pouch. The cauterized surface. of the portion of abdominal wall is inked blue (representing true. surgical resection margin in that area). A scant amount of adherent. omentum and retracted serosal surface are also present in the. vicinity of the attached portion of abdominal wall (subsequently. inked orange and representing the free radial serosal surface) . An. unremarkable 7.2 cm in length, 0.9 cm in diameter appendix is. present. The proximal and distal margins measure 4 and 8 cm in. circumference respectively. On opening, there is a nearly. circumferential rubbery tan-white tumor mass at the ileocecal valve. measuring 11.0 X 5.7 cm. On sectioning, the tumor has a maximal. thickness of 2.8 cm, grossly extending into the muscularis to within. 0.5 cm of the inked cauterized resection margin (abdominal wall). (see paired contiguous sections blocks 2&3 and 4&5) and within 0.6. cm of the inked free radial serosal surface (see bisected contiguous. sections block 6 and 7). The ileal and remaining colonic mucosa is. unremarkable glistening can-pink with regular folds and the walls. average 0.4 cm in thickness. Two palpable rubbery tan-pink-red. apical lymph nodes averaging 1.3 cm in greatest dimension are. recovered from the attached mesocolon. Numerous additional rubbery. pale tan lymph nodes, 2.8 cm in greatest dimension, are recovered. from the remainder of the mesocolon and mesentery. A portion of. tumor and a portion of normal mucosa are submitted for tissue. procurement as requeste. presentative sections are submitted in. 25 blocks as labeled. BLOCK SUMMARY: 1 - Pro ma and distal margins; 2&3, 4&5 - tumor to. inked cauterized abdominal wall margin and serosal surface with. points of continuity inked red and green respectively; 6&7 -. bisected sections, tumor full thickness to inked free radial serosal. surface, point of continuity inked black; 8 - tumor to proximal. mucosa/at ICV; 9&10 - additional bisected section of tumor to. abdominal wall (point of continuity inked violet) ; 11 - random ileum. and colon; 12 - appendix; 13&14 - bisected apical lymph node (one. bisected node per cassette) ; 15&16 - six whole lymph nodes per. cassette; 17-21 - one bisected lymph node per cassette; 22&23 - one. bisected lymph node (1/2 p cassette) ; 24&25 - one bisected lymph. node (1/2 per cassette). MICROSCOPIC DESCRIPTION. Histologic type: Adenocarcinoma, NOS. Histologic grade: Moderately-differentiated. Primary tumor (pT) : Tumor invades through the muscularis propria. into the serosal fat (pT3) . Proximal margin: Negative. Distal margin: Negative. Circumferential (radial) margin: Negative. Vascular invasion: Negative. Regional lymph nodes (pN) : 19 mesenteric lymph nodes are negative. for metastatic carcinoma (0/19) (pNO) . Non-lymph node pericolonic tumor: Absent. Distant metastasis (pM) : pMx. Other findings: There is a large area of pericolonic abscess. formation and inflammatory activity present next to the tumor which. has produced adhesion of the abdominal wall to the colon. No. direct invasion by tumor is present at that site. Appendix without. significant histopathologic finding. 5. DIAGNOSIS. Terminal ileum, appendix, right colon and abdominal wall, en bloc. resection: Invasive moderately-differentiated colonic adenocarcinoma. extending through the wall of the cecum into the serosal fat. There are areas of abscess formation and inflammation between the. abdominal wall and cecum producing adhesion of the abdominal wall. to the colon. No direct invasion of this area by tumor is present. The proximal, distal and radial margins of resection are free of. tumor. Nineteen mesenteric lymph nodes negative for metastatic. carcinoma (0/19) Appendix without significant histopathologic. finding. End Of Report ---.",T3,N0,M0,T3N0M0
TCGA-ZJ-AAXU,"PAGE:1. SPEC #: Obtained: CLINICAL HISTORY : 233.1. SPECIMEN/PROCEDURE. 1. CERVIX - 4:00. IMPRESSION: CERVIX, 4 O'CLOCK, BIOPSY: Invasive squamous cell carcinoma, large cell nonkeratinizing type, moderately. differentiatad. Entered: COMMENT: The case is reviewed with. who concurs. Entered: GROSS DESCRIPTTTON : 1. Received in formalin labeled with the patient's name and succeed 4 O'clock. Received. is a pale pink to red tan tissue fragment that is 0.6 X 0.5 x 0.2 cm. The specimen is. entirely submitted in one cassette. Diotated by: Entexed: CPT Codes : CERVICAL BIOPSY/88305. ICD9 Codes: 180.9.",T2,N0,M0,T2N0M0
TCGA-VQ-A91D,"PRIMARY SITE: Stomach (Body). ""1-Stomach + D2 lymphadenectomy + right extended colectomy: -Invasive ulcerated moderately differentiated adenocarcinoma, Lauren's intestinal type. -Size of neoplasia: 5.0x4.5x4.0 cm. -Invasion level: serosa and adjacent fat tissue, with involvement of omentum and colon. to submucosa, with ulceration of mucosa. -Blood vessel invasion: present. -Lymphatic invasion: present. -Perineural invasion: present. -Adjacent mucosa: inactive discrete chronic gastritis. -Surgical margins (stomach and colon): uninvolved by neopalsia. -Five out of 33 examined perigastric lymph nodes involved by neoplasia (5/33), with. capsular invasion, without conglomerate formation. 2-Perisplenic omentum: -Lymph node uninvolved by neoplasia (0/1). 3-Transverse mesocolon lymph node: -Uninvolved by neoplasia (0/3). 4-Esophageal margin: -Uninvolved by neoplasia. 5- Lymph nodes following standardization: - -Five lymph nodes uninvolved by neoplasia (0/5), distributed as follows: -Chain 8 -- anterior hepatic artery (8a): 0/1. - -Chain 11 - proximal splenic artery (11p): 0/3. -Chain 12 - hepatoduodenal ligament (12a): 0/1."".",T4,N2,M0,T4N2M0
TCGA-JW-AAVH,"Component. (note). Date of Birth. Hospital Number. PATHOLOGIC DIAGNOSIS. A. LEFT PARAMETRIUM, EXCISION: - BENIGN FIBROADIPOSE TISSUE. B. UTERUS, BILATERAL FALLOPIAN TUBE AND OVARIES, RADICAL. HYSTERECTOMY AND BILATERAL SALPINGO-OOPHORECTOMY: UTERUS: - CERVIX. - INVASIVE SQUAMOUS CELL CARCINOMA. - TUMOR SIZE: 3.0 CM IN GREATEST DIMENSION. (SEE COMMENT). - NONKERATINIZING. - MODERATELY DIFFERENTIATED. MARGINS UNINVOLVED (SEE COMMENT). - LYMPHATIC INVASION PRESENT, MULTIFOCAL. - SEE CAP SYNOPTIC REPORT. - ENDOMETRIUM. - DISORDERED PROLIFERATIVE ENDOMETRIUM. - MYOMETRIUM. - LEIOMYOMA, 1.5 CM IN GREATEST DIMENSION. - SEROSA. - NO DIAGNOSTIC PATHOLOGIC ALTERATION IDENTIFIED. - RIGHT OVARY: - BENIGN UNILOCULAR FOLLICULAR CYST. - RIGHT FALLOPIAN TUBE: - BENIGN PARATUBAL CYST. - LEFT OVARY: - NO DIAGNOSTIC PATHOLOGIC ALTERATION IDENTIFIED. - LEFT FALLOPIAN TUBE. - NO DIAGNOSRIC PATHOLOGIC ALTERATION IDENTIFIED. C. LYMPH NODES, LEFT PELVIC, REGIONAL DISSECTION: - SIX BENIGN LYMPH NODES IDENTIFIED (0/6). D. LYMPH NODES, RIGHT PELVIC, REGIONAL DISSECTION: - NINE BENIGN LYMPH NODES IDENTIFIED (0/9). PATHOLOGIC STAGING: Primary Tumor (pT) : pT1b1. Regional Lymph Nodes (pN) : pNO. Number of lymph nodes examined: 15. Number of lymph nodes involved: 0. Distant Metastasis (pM) : Not applicable. Pathologic Stage Grouping: IB1. Comment. The grossly visible cervical squamous cell carcinoma, which measures 3.0 x. 2.5 x 1.2 cm, is microscopically located 1.5 mm from the nearest inked. serosa. The tumor extends to a maximum depth of 12 mm in a 13.5 mm thick. section of cervix (section B13) The invasive carcinoma is grossly located. 2.0 cm from the nearest vaginal cuff margin. Pertinent Clinical Information. -year-old female with cervical cancer. Clinical Impression: SCCA. Gross Description. Specimen Material: A. Left parametrium, B. Radical hysterectomy, bilateral. tubes and ovaries, C. Left pelvic lymph node, D. Right pelvic lymph node. The case is received in four parts, each labeled with the patient's name. , medical record number and given accession number. and it is accompanied by a requisition form labeled with the same. name and accession number. Part A. Received in formalin labeled ""LEFT PARAMETRIUM"" is an irregular. portion of fibrofatty tissue measuring 2.7 x 1.5 x 0.5 cm with an attached. suture. Within the fibrofatty tissue, an elongated gray-white vessel is. identified measuring 2.0 cm in length x 0.3 cm in diameter. There are no. discrete masses seen within the lumen. The specimen is submitted in its. entirety in cassettes A1-A3 with the vascular tissue adjacent to the suture. inked black to facilitate the embedding process in A1. Part B. Received in formalin labeled ""RADICAL HYSTERECTOMY BILATERAL TUBES. AND OVARIES"", is a 148 gram, 9 cm from superior to inferior x 7 cm from. cornu to cornu x 2.8 cm from anterior to posterior uterus with bilateral. attached adnexa and attached cervix measuring 3.0 cm x 3.5 cm with a 0.7 cm. slit-like external os. The anterior surface is inked blue and posterior. surface is inked black. The serosa is tan-pink and hyperemic. The vaginal. cuff is present measuring 4 x 1.2 cm x 0.2 cm. The parametrial tissue is. present measuring 2 x 1 x 0.2 cm (right) and 1.5 x 1 x 0.5 cm (left) The. endometrium measures 0.2 cm thick; no focal lesions are seen. The. endometrial cavity measures 3 x 0.3 cm. There is a 1.5 x 1.2 cm gray-white. circumscribed submucosal nodule; the cut surface displays whorled, firm,. homogeneous tissue. The myometrium measures 1.5 cm thick. The cervix displays a tan-yellow centrally ulcerative mass (3.0 x 2.5 x 1. cm) located on the posterior and anterior surface of the endocervix. The. mass appears to invade to a depth of 1.2 cm but is grossly 0.4 cm from the. outer surface. The mass extends into the lower uterine segment. The mass. is. located approximately 1.0 cm from the lower uterine segment and 2.0 cm. from vaginal cuff margin. The right adnexa include a 4 x 2 x 1.5 cm ovary. The surface is tan-yellow,. smooth, hyperemic and glistening. There is a 1.5 x 1 x 0.6 cm smooth. unilocular cyst with serosanguineous fluid. The cut surface displays. tan-white to tan-yellow soft homogeneous tissue. There is a 4 cm in length. x 0.6 cm in diameter fimbriated right fallopian tube. The surface of the. fallopian tube is tan-pink, smooth and hyperemic. The cut surface displays. a pinpoint lumen. The left adnexa include a 2 x 1.5 x 0.5 ovary with 4 cm in length, 0.6 cm in. diameter fimbriated fallopian tube. The surface of the ovary is tan-yellow,. smooth, and glistening; no lesion or excrescence is seen. The cut surface. displays tan-white to tan-yellow unremarkable tissue. The left fallopian. tube serosa is tan-pink, smooth and hyperemic. The cut surface displays a. pinpoint lumen. Representative sections are submitted as follows: B1-B4 vaginal cuff margin in its entirety; clock designation: 12-3, 3-6,. 6-9, 9-13. B5 right, parametrium tissue, en face. B6 left parametrial tissue, en face. B7-B10 anterior longitudinal section from fundus to cervix, sequentially. from superior to inferior. B11-B14 posterior longitudinal section, sequentially from superior to. inferior. B15 cervical, greatest depth of tumor invasion. B16 tumor to exocervix. B17 myometrial nodule. B18 right ovary. B19 right ovarian cyst. B20 right fallopian tube. B21- left ovary. B22 left fallopian tube. Part C. Received in formalin labeled ""LEFT PELVIC LYMPH NODE"" is an. irregular portion of fibrofatty tissue measuring 6.5 x 0.8 cm. Within the. fibrofatty tissue, multiple lymph nodes are identified ranging from 0.3 to 2. cm in greatest dimension. The lymph nodes are entirely submitted as. follows: C1 four possible whole nodes. C2 two whole possible nodes. C3 two whole possible nodes. Part D. Received in formalin labeled ""RIGHT PELVIC LYMPH NODE"" is an. irregular portion of fibrofatty tissue measuring 6.7 x 5.5 x 1.5 cm. Within. the fibrofatty tissue, multiple possible lymph nodes are identified ranging. from 0.4 to 2.2 cm in greatest dimension. The cut surface of the larger. nodes displays fatty firm lymphoid tissue. The lymph nodes are submitted in. their entirety as follows: D1 five possible whole nodes. D2 three whole possible nodes. D3-D4 one serially sectioned possible node. D5 one bisected possible node. Pathology Resident. Microscopic Description. A, C, D: Performed. B. H&E stained sections show cervical invasive squamous cell carcinoma. with lymphatic invasion. The endometrium shows a proliferative pattern with. an occasional mildly dilated gland lumen; no atypia, hyperplasia or. carcinoma is seen. The myometrium shows a leiomyoma without increased. mitotic activity, atypia, increased cellularity or tumor necrosis found. Other than a benign right ovarian cyst, the fallopian tubes and ovaries are. unremarkable. CAP SYNOPTIC REPORT: Specimen: Cervix, uterine corpus, both ovaries and fallopian tubes. Procedure: Radical hysterectomy. Tumor Size: Greatest dimension 3 cm; 2.5 x 1 cm. Tumor Site: All quadrants (essentially circumferential). Histologic Type: Squamous cell carcinoma, nonkeratinized. Histological Grade: Moderately differentiated (G2). Margins: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1.5 mm (cervical. serosa). Lymphatic Invasion: Present, multifocal. Vascular Invasion: Not identified. TNM Pathologic Tumor Staging: Primary Tumor (pT) : pT1b1; Clinically visible lesion less than or equal to. 4 cm in greatest dimension. Regional Lymph Node (pN) : pNO. Number of Lymph Nodes Examined: 15. Number of Lymph Nodes Involved: 0. Distance Metastasis (pM) : Not applicable. Stage Grouping: IB1. The staff pathologist listed below has reviewed this case. Pathology Resident. Result History. - Order Result History Report. Resulting Lab. Result Date and Time. Priority. Routine. Received Date/Time. Authorizing Provider. Encounter Provider. None. Encounter. View Encounter. Administration Details. No Administrations. Recorded. Release Date/Time. Start Date/Time. End Date/Time. Frequency. Duration. Priorily. ONCE. 1 occurrence. Routine. Normal. Quantity. 1. Comments. Original Order. Authorizing Provider. Attending Provider(s). Admitting Provider. PCP. Encounter. There are no order-level documents. View Encounter. None.",T1,N0,M0,T1N0M0
TCGA-D5-6532,"page 1 / 1. Examination: Histopathological examination. Cost of diagnostic procedure. Material: 1. Multiple organ resection - sigmoid colon. Expected time of examination: Clinical diagnosis: Cancer of the sigmoid colon. Hist. Pat adenocarcinoma invasivum. Macroscopic description: 21 cm length of the large intestine with fat tissue of 22 x 10 x 5 cm. Ulcerous tumour sized 8 x 5 X 1.5 cm in the mucosa. The. lesion surrounds 55% of the intestine circumference, narrowing its lumen; is located 11 cm from one of the cut ends and 2 cm. from the opposite one. The lesion macroscopically invades through the periintestinal tissue. Minimum side margin is 0.1 cm. Microscopic description: Adenocarcinoma tubulare (G2). Infiltratio carcinomatosa tunicae muscularis priopriae et telae adiposae pericolicae. Incision lines free of neoplastic lesions. Lymphonodulitis reactiva (No X). Final diagnosis after immunohistochemical tests No. are performed. Histopathological diagnosis: Adenocarcinoma tubulare coli. Tubular adenocarcinoma of the colon. (G2, Dukes B, Astler - Coller B2, pT3, pNO).",T3,N0,M0,T3N0M0
TCGA-BH-A18S,"PATIENT HISTORY: The patient is a. year-old woman with a core biopsy in. showing infiltrating ductal carcinoma, mucinous type,. nuclear grade 1 (ER and PR positive, and HER-2/neu negative). PRE-OP DIAGNOSIS: Right breast cancer; postmenopausal bleeding. POST-OP DIAGNOSIS: Same. PROCEDURE: Right total mastectomy, sentinel node biopsy, hysteroscopy, D&C. FINAL DIAGNOSIS: PART 1: BREAST/RIGHT, TOTAL MASTECTOMY -. A. MULTIFOCAL INFILTRATING DUCTAL CARCINOMA, MUCINOUS TYPE, INVOLVING THELOWER INNER. QUADRANT. B. THE TWO FOCI OF INVASIVE CARCINOMA ARE BOTH 1.5 CM IN GREATEST DIMENSION. C. NOTTINGHAM SCORE 4 (TUBULE FORMATION, 2; NUCLEAR PLEOMORPHISM, 1; MITOTIC INDEX 1). D. DUCTAL CARCINOMA IN SITU (DCIS), SOLID TYPE, NUCLEAR GRADE 1. E. DCIS CONSTITUTES APPROXIMATELY 15% OF THE TUMOR MASS. F. NO ANGIOLYMPHATIC INVASION IS IDENTIFIED. G. SURGICAL MARGINS FREE OF CARCINOMA. H. PREVIOUS BIOPSY SITE IS IDENTIFIED. I. BENIGN BREAST TISSUE. J. SKIN AND NIPPLE NOT REMARKABLE. K. ONE LYMPH NODE NEGATIVE FOR CARCINOMA (0/1). PART 2: RIGHT AXILLA, SENTINEL LYMPH NODE#1, BIOPSY -. ONE LYMPH NODE NEGATIVE FOR MALIGNANCY (0/1). PART 3: ENDOCERVIX, CURETTAGE -. A. RARE BENIGN ENDOCERVICAL CELLS AND MUCUS,. B. NEGATIVE FOR ATYPIA OR CARCINOMA. PART 4: ENDOMETRIUM, CURETTAGE -. A. SCANT BENING ENDOMETRIUM WITH MUCUS AND CELL DEBRIES (Cross refer. B. NEGATIVE FOR ATYPIA OR CARCINOMA. COMMENT: Estrogen and progesterone receptors and HER2/neu, performed on the previous core biopsy. were. reported as follows: ER positive, PR positive, HER-2/neu negative (score 1+).",T1,N0,M0,T1N0M0
TCGA-EB-A3HV,"Caterality: Path Report:SKIN TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Skin. Tumor size: 5.5x4.5x1.3 cm. Tumor features: Raised, Pigmented. Satellite nodules: Not specified. Histologic type: Nodular melanoma. Histologic grade: Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Clark level 4. Gross Description: Microscopic Description: Diagnosis Details:",T4,N0,M0,T4N0M0
TCGA-2G-AAF6,Summary pathology report. Right orchidectomy; seminoma; diameter 6 cm; tumor confined to testis in available slides; no. angio-invasion; no invasion in rete testis. = date of orchidectomy): pathologist.,T1,N0,M0,T1N0M0
TCGA-CM-6168,"Clinical Diagnosis & History: with. colonoscopy on. showed 3cm semi-circumferential - mass 10cm from ileocecal valve, cecal. adenocarcinoma. Specimens Submitted: 1: SP:Right colon; hemicolectomy. DIAGNOSIS: 1. SP:Right colon; hemicolectomy : Tumor Type: Adenocarcinoma with mucinous features (<50% mucinous component). Histologic Grade: Moderately differentiated. Tumor Location: Ascending colon. Tumor Size: Length is 2.1 cm. Width is 2.8 cm. Maximal thickness is 0.4 cm. Tumor Budding: Absent. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Tubular adenoma. Deepest Tumor Invasion: Subserosal adipose tissue and/or mesenteric fat. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Identified. Large Venous Invasion: Not Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic - Bowel: Unremarkable. Appendix: Unremarkable. Lymph Nodes: Number with metastasis: 0. Total number examined: 31. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC 7th Edition) : pT3 (Tumor invades through the muscularis propria into. pericolorectal tissues). Lymph Node Stage (AJCC 7th Edition) : NO (No regional lymph node metastasis). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1). The specimen is received fresh, labeled ""Right colon"" and consists of a. segment of terminal ileum, cecum with attached appendix and ascending colon. The terminal ileum measures 12.0 cm in length and 3.6 cm in circumference. at the proximal resected margin. The remaining colon measures 14.0 in. length with a circumference of 5.4 cm at the distal resected margin. The. attached appendix measures 5.8 cm in length and averages 0.7 cm in diameter. The appendiceal and intestinal serosa is pink tan and smooth. Focally. hemorrhagic lobulated yellow tan adipose tissue spans the length of the. specimen measuring up to the 3.8 cm in thickness. The specimen is opened to. reveal a mass lesion measuring 2.1 cm in length and 2.8 cm in width. The. mass is located in the right colon, 3.8 cm distal to the ileocecal valve,. 17.0 cm from the proximal margin and 6.5 cm from the distal margin. Sectioning shows that the tumor invades the underlying muscularis. The depth. of invasion is 0.5 cm grossly. The remaining mucosa is remarkable for a 0.7. x 0.1 to 0.4 cm sessile polyp 1.0 cm distal to the tumor. The attached. adipose tissue is thoroughly examined and all identified lymph nodes are. submitted. Representative sections of the specimen are submitted for. permanent sections and for TPS. Summary of sections: P - proximal margin shave. D - distal margin shave. T - tumor. A - appendix representative sections. PL polyp. RS -representative sections. LN - lymph nodes. BLN - bisected lymph nodes. Summary of Sections: Part 1: SP:Right colon; hemicolectomy. Block. Sect. Site. PCs. 1. A. 1. 2. D. 2. 1. DV. 1. 8. LN. 36. 1. P. 1. 1. PL. 1. 1. RS. 1. 3. T. 3.",T3,N0,M0,T3N0M0
TCGA-DD-AADG,"CLINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo : GROSS: Specimen status: Fresh. Operation: Right hemihepatectomy. Cholecystectomy. Organs: [1] Liver: A segment of liver tissue (16.0 x 13.0 X 6.5 cm and 580.5 gm). Lesion: Two well-defined masses. Size: 7.0 X 6.0 X 5.0 cm (segment 6, 7, and 8) and 2.0 x 1.5 x 1.5 cm. (segment 6). Cut surface: Yellowish tan, and granular with necrosis (30 %). Gross type: HCC: Multinodular confluent. Resection margin: Not involved grossly (safety margin: 1.5 cm). Remaining parenchyma: Cirrhotic. [2] Gallbladder: 11.0 cm in length, 4.5 cm in diameter, 0.2 cm in wall thickness. Mucosal surface: Green and velvety/ diffusely necrotic mucosa (no stone). Serosal surface: Brown and smooth. [3] Labeled as 'parasite' (three pieces, 0.8 X 0.6 X 0.3 cm, entirely submitted). Representative sections are submitted. Gross photo: Present. Blocks. T1-3 and TB, larger mass and surrounding liver parenchyme x 4. T4, smaller mass and surrounding liver parenchyme X 1. L and NB, nontumorous liver parenchyme x 2. RM, resection margin of liver x 1. A, labeled as 'parasite' X 1. GB, gallbladder and cystic duct resection margin X 1. MICROSCOPIC: [1] Main mass (segment 6, 7, and 8). Hepatocellular carcinoma: The worst differentiation III/IV. The major differentiation II/IV. Histologic type: Trabecular. Cell type: Hepatic and clear. Fatty change: No. Fibrous capsule formation: No. Capsular infiltration: No. Septum formation: No. [2] Smaller mass (segment 6). Hepatocellular carcinoma: The worst differentiation III/IV. The major differentiation III/IV. Histologic type: Trabecular. Cell type: Hepatic and clear. Fatty change: No. Fibrous capsule formation: No. Capsular infiltration: No. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Microvessel invasion: No. Intrahepatic metastasis: No. Multicentric occurrence: Yes. Non-tumor liver pathology. 1. Chronic hepatitis: 1-1. Etiology: HBV. 1 -2. Grade, lobular: Minimal. -3. Grade, portoperiportal: Mild. 1-4. Stage (fibrosis): Septal. 2. Dysplastic nodule: No. 3. Ductal epithelial dysplasia: No. 4. Other liver diseases: Clonorchis sinensis infestation. NOT reported. Gross: NOT reported. Gross: Liver, right,ectomy, Hepatocellular carcinoma. T56000, right, P10, M81703. Gallbladder, ectomy, Chronic cholecystitis. T57000, P10, M43005. Tissue labeled as ""parasite"", biopsy, Clonorchis sinensis infestation. Tissue labeled as ""parasite"", P50, Clonorchis sinensis infestation. DIAGNOSIS: Liver, right hemihepatectomy: Hepatocellular carcinoma. Gallbladder, cholecystectomy: Chronic cholecystitis. Tissue labeled as ""parasite"", biopsy: Clonorchis sinensis infestation. Suggestion :",T3,N0,M0,T3N0M0
TCGA-G3-A3CK,"Latest Version. Encounter Number. Lab Patient Demographics. (for verification purposes). Collected Date/Time. Received Date/Time. Specimen Description. A. Gallbladder. B. Liver section 5 - 6. Clinical Information. A. year old male with hepatocellular carcinoma related to chronic hepatitis B. infection. Diagnosis. A: Gallbladder, Cholecystectomy: Unremarkable gallbladder. B: Liver, Partial Resection: Hepatocellular carcinoma (see synoptic report). Focal vascular invasion present. Resection margin free of carcinoma. Bile duct adenoma. 1. httns./. Synoptic Report. B: Liver, Resection, Macroscopic. Specimen: Liver. Gallbladder. PROCEDURE: Partial hepatectomy. Minor hepatectomy (leas than 3 segments). TUMOR SIZE: Greatest dimension: 2.5 cm. Additional dimensions: 2.3 x 2.2 cm. TUMOR FOCALITY: Solitary (specify location) : segments 5, 6. B: Liver, Resection, Microscopic. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: GII: Moderately differentiated. TUMOR EXTENSION (select all that apply) : Tumor confined to liver. PRIMARY TUMOR (pT) : pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. REGIONAL LYMPH NODES (pN) : pNX: Cannot be assessed. DISTANT METASTASIS (pM) : pMX: Cannot be assessed. MARGINS: Parenchymal margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin. 12. mm. VENOUS (LARGE VESSEL) INVASION (V) : Absent. ADDITIONAL PATHOLOGIC FINDINGS: Cirrhosis/fibrosis. Hepatitis (specify type) b. COMMENT (s) : There are tumor emboli in the small vessels adjacent to the tumor mass. Gross Description. Received are specimens A to B. All requisitions and specimen containers are labelled. with the patient's name. The cassettes and AP identifiers are labelled. with the Surgical Number. A. The specimen is received fresh, subsequently placed into formalin and consists of an. intact gallbladder measuring 8.0 x 3.5 x 2.5 cm. The serosal surface is tan and smooth. The lumen contains bile and multiple friable yellow calculi measuring up to 0.2 cm in. thickness. The mucosal surface is bile stained and velvety with areas of yellow. speckling. The wall averages 0.2 cm in thickness. The cystic duct is patent. The cystic. duct lymph node is not grossly identified. Representative sections are submitted in one. cassette. B. The specimen is originally received fresh, subsequently placed into into formalin and. consists of a portion of liver weighing 199.4 grams and measuring 12.7 x 9.0 x 5.5 cm. The resection margin is dyed blue. The capsular surface is slightly nodular. Upon. sectioning, two firm tan nodules are identified. The smaller nodule measures 0.8 x 0.7. x. 0.5 cm. This nodule grossly involves the blue-painted resection margin and comes to. within 0.5 cm of the capsular surface. The second mass measures 2.5 x 2.3 x 2.2 cm. This. mass is 2.0 cm from the first mass and grossly comes to within less than 0.1 cm from the. capsular surface and 1.2 cm from the blue-painted resection margin. The remainder of the. liver parenchyma is grossly unremarkable. Representative sections are submitted as follows: B1. section of the smallest mass in relation to the blue-painted resection margin. B2. section of the smaller mass in relation to the capsular surface. B3. section of grossly unremarkable liver between the first and second mass. B4. section of the second mass in relation to the capsular surface. B5. section of the second mass in relation to the blue-painted resection margin. B6. further section of the second mass. B7. section of grossly unremarkable liver. Please note, sections have been taken for tumor banking. Additional Information. Encounter Number. Patient Location.",T1,N0,M0,T1N0M0
TCGA-BH-A202,"PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/ POST-OP DIAGNOSIS Left breast invasive ductal carcinoma. LMP DATE Not applicable. PROCEDURE Left segmental mastectomy with sentinel lymph node blopay. SPECIFIC CLINICAL QUESTION Not listed. OUTSIDE TISSUE DIAGNOSIS Not listed. PRIOR MALIGNANCY. Not listed. CHEMORADIATION THERAPY: Not listed. OTHER DISEASFS Not listed. FINAL DIAGNOSIS: PART 1: LYMPH NODE, NON-SENTINEL, BIOPSY -. ONE (1) LYMPH NODE, NEGATIVE FOR METASTATIC.CARCINOMA1). PART 2: LYMPH NODE, LEFT AXILLA, SENTINEL #1, BIOPSY -. ONE (1) LYMPH NODE. NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 3: LYMPH NODE, LEFT AXILLA, SENTINEL #2, BIOPSY -. ONE (1) LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 4: BREAST, LEFT. SEGMENTAL MASTECTOMY -. A. INVASIVE DUCTAL CARCINOMA, NO SPECIAL TYPE. B. NOTTINGHAM GRADE III (TUBULE FORMATION: 3, NUCLEAR PLEOMORPHISM: 3, MITOTIC ACTIVITY: 3;. TOTAL SCORE: 9/9). c. THE INVASIVE TUMOR MEASURES 2.6 CM IN LARGEST DIMENSION. D. DUCTAL CARCINOMA IN SITU, NUCLEAR GRADE 3, SOLID TYPE WITH COMEDO NECROSIS. E. THE DUCTAL CARCINOMA IN SITU CONSTITUTES 40% OF THE TOTAL TUMOR VOLUME ANO IS PRESENT. ADMIXED WITH THE INVASIVE COMPONENT. F. NO LYMPHOVASCULAR SPACE INVASION is NOTED. G. RESECTION MARGINS ARE NEGATIVE FOR CARCINOMA. H. INVASIVE CARCINOMA IS 0.4 CM FROM THE NEAREST (ANTERIOR) MARGIN. I. DUCTAL CARCINOMA IN SITU IS 0.3 CM FROM THE NEAREST (ANTERIOR) MARGIN. J. ATYPICAL DUCTAL HYPERPLASIA. K. THE NON-NEOPLASTIC BREAST SHOWS DUCTAL EPITHELIAL HYPERPLASIA, INTRADUCTAL PAPILLOMA,. RADIAL SCAR, COLUMNAR CELL CHANGES, AND FIBROCYSTIC CHANGES. L. PREVIOUS BIOPSY SITE CHANGES. PART 5: LYMPH NODE, LEFT ""WTRAMAMMARY"", EXCISIONAL BIOPSY -. A. ONE/1 LYMPN NODE, NEGATIVE/FOR. B. BENIGN PERINODAL ADIPOSE TISSUE. C. NO OUCTAL BREAST TISSUE SEEN. COMMENT: Part 4: The invasive tumor was reported to be positive for Estrogen Receptora (H-ecore: 250), positive for Progesterone. Receptors (H-score: 75) and also positive for HER2, as per previous pathology report. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Clock position. 12. SIZE OF TUMOR: Maximum dimension invasive component: 26 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nucleer grade: 3. Tubule formation: 3. Mitotic activity score 3. Total Nottingham score: 9. Nottingham grade (1. 2. 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: TUMOR TYPE, IN SITU: Solid. Comedo. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 4 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disesse to closest margin: 3 mm. LYMPH NODES POSITIVE;. o. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: Radial scar, Papilloma, FCD. T STAGE, PATHOLOGIC: pT2. N STAGE MODIFIER: (sn). N STAGE, PATHOLOGIC: pNO. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive, H-score 250. PROGESTERONE RECEPTORS: positive, H-score: 75. HER2/NEU:",T2,N0,M0,T2N0M0
TCGA-IR-A3LK,"Specimens Submitted: 1: SP: Uterus, cervix, bilateral fallopian tubes and ovaries, radical. hysterectomy and bilateral salpingo-oophorectomy. 2: SP: Right external iliac lymph node, excisional biopsy. 3: SP: Additional vagina, biopsy. 4: SP: Right pelvic lymph nodes, excisional biopsy. 5: SP: Left pelvic lymph nodes, excisional biopsy. DIAGNOSIS: 1. UTERUS, CERVIX, FALLOPIAN TUBES AND OVARIES; RADICAL. HYSTERECTOMY AND BILATERAL SALPINGO-OOPHORECTOMY: - MODERATELY TO POORLY DIFFERENTIATED INVASIVE SQUAMOUS CELL CARCINOMA. OF THE CERVIX. - THE TUMOR INVADES THE FULL THICKNESS OF THE 15 MM CERVICAL STROMA. - THE TUMOR EXTENDS INTO THE LEFT PARAMETRIUM. - THE POSTERIOR CERVICAL RESECTION MARGIN IS POSITIVE FOR CARCINOMA. - ALL OTHER RESECTION MARGINS ARE NOT INVOLVED. - BENIGN ENDOMETRIAL POLYP. - UNREMARKABLE MYOMETRIUM. - UNREMARKABLE BILATERAL FALLOPIAN TUBES AND LEFT OVARY. - THREE BENIGN PARAMETRIAL LYMPH NODES (0/3). 2. LYMPH NODE, RIGHT EXTERNAL ILIAC; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 3. ADDITIONAL VAGINA; EXCISION: BENIGN SQUAMOUS MUCOSA. 4. LYMPH NODES, RIGHT PELVIC; EXCISION: - SIX BENIGN LYMPH NODES (0/6). 5. LYMPH NODES, LEFT PELVIC; EXCISION: - SEVEN BENIGN LYMPH NODES (0/7). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) . AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT.",T1,N0,M0,T1N0M0
TCGA-BP-5182,"Clinical Diagnosis & History: Left renal mass. Specimens Submitted: 1: SP: Kidney, left, partial nephrectorny. 2: SP: Kidney, left renal margin, biopsy. 3: SP: Bone, left 11th rib, partial resection. 4: SP: Soft tissue, left peri-nephric, biopsy. 5: SP: Soft tissue, over tumor, left kidney, blopsy. 6: SP: Lymph node, left hilar, biopsy. DIAGNOSIS: 1. SP: Kidney, left, partial nephrectomy. Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. Fuhrman Nuclear Grade: Nuclear grade III/IV. Tumor Size: Greatest diameter is 3.0 cm. Local Invasion (for renal cortical types): Not Identified. Renal Vein Invasion: Not identified. Small vessel angiolymphatic invasion is also not identified. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Mild arteriosclerotic changes. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT1 Tumor <= 7.0 cm in greatest dimension limited to the kidney. 2. SP: Kidney, left renal margin, biopsy. Benign renal parenchyma. 3. SP: Bone, left 11th rib, partial resection. Benign segment of rib. 4. SP: Soft tissue, left peri-nephric, blopsy. Benign fibroadipose tissue. 5. SP: Soft tissue, periapical, left kidney, blopsy. Benign fibroadipose tissue. 6. SP: Lymph node, left hilar, biopsy. Not identified. Benign fibroadipose tissue; entirely submitted. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT THAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh for frozen section consultation and is labeled ""Left renal mass"". It consists of a 5 x 3.5 x 3.5 cm. wedge shaped portion of kidney with a suture marking the deep margin. The margin is inked blue and the specimen is serially. sectioned to reveal a fairly circumscribed, hemorrhagic to yellow and focally calcified tumor measuring 3 x 2.2 x 2 cm. The. clearance from the resection margin is 0.2 cm. A representative section of the nearest margin is submitted for frozen section. diagnosis. Representatively submitted. Portions of the tumor are submitted for TPS. The specimen is photographed. Summary of sections: FSC - frozen section control. T tumor. M margin. L - representative sections. 2). The specimen is received fresh for frozen section consultation, labeled ""Left renal margin"" and consists of a fragment of pink. tan soft tissue measuring 0,3 x 0.3 x 0.3 cm. Entirely submitted for frozen section. Summary of sections: FSC -- frozen section control. 3). The specimen is received fresh labeled ""Portion of left eleven Rib"" and consists of a segment of rib measuring 7.5 x 1.2 x 0,6. cm. Red, tan soft tissue is attached. The specimen is bisected to reveal a homogenous red tan granular and bony cut surface. The cortical surface appears intact, and no discrete lesions are noted. Representative sections are submitted for decalcification. Summary of sections: U - undesignated. 4). The specimen is received fresh, labeled ""Perinephric fat"" and consists of several irregularly shaped pieces of yellow tan. lobulated adipose tissue measuring 18 x 12 x 0.5 cm in aggregate. No abnormalities are noted. Representative section are. submitted. Summary of sections: U -- undesignated. 5). The specimen is received in formalin labeled, ""fat over tumor left the kidney"", and consists of multiple pieces of adipose tissue. measuring 6 X 6x2 cm in aggregate. Representative sections are submitted. Summary of sections: U-- undesignated. 6). The specimen is received in formalin labeled, ""left hilar lymph node"", and consists of 2 pieces of fatty lymphoid tissue measuring. 2.0 X 1.5 X 0.4 cm and 1.5 about 1.0 X 0,4 cm respectively. The specimen is entirely submitted. Summary of sections: LN-lymph nodes. Summary of Sections: Part 1: SP: Kidney, left, partial nephrectomy (. Block. Sect. Site. PCs. 1. FSC. 1. L. 1. 1. M. 2. T. 2. Part 2: SP: Kidney, left renal margin, blopsy. Block. Sect. Site. PCs. 1. FSC. 1. Part 3: SP: Bone, left 11th rib, partial resection. Block. Sect. Site. PCs. 1. U. Part 4: SP: Soft tissue, left peri-nephric, blopsy. Block. Sect. Site. PCs. 1. U. 1. Part 5: SP: Soft tissue, over tumor, left kidney, biopsy. Block. Sect. Site. PCs. 1. u. Part 6: SP: Lymph node, left hilar, biopsy. Block. Sect. Site. PCs. 2. In. 2. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: RENAL CORTICAL TUMOR. FAVOR CONVENTIONAL RENAL CELL CARCINOMA,. NEGATIVE MARGIN. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: BENIGN KIDNEY. PERMANENT DIAGNOSIS: SAME.",T1,N0,M0,T1N0M0
TCGA-BR-7703,Gross. Microsc. Diagnos. Comme. Descript. opic. is. nts. ion. Descript. Details. ion. STOMACH TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Stomach. Tumor size: 2.5 X 2 X 0.7 cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Submucosa. Lymph nodes: 0/4 positive for metastasis. (Regional 0/4). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not. specified. Comments: None. Lateralit. y. Fundus.,T1,N0,M0,T1N0M0
TCGA-AD-6895,"PROCEDURE DATE: RECEIVED DATE: REPORT DATE. Pre-Op Diagnosis. Colon cancer. Post-Op Diagnosis. Same as above. Clinical History. Nothing indicated. Gross Description: Container labeled II. right colon"" is an. approximately 14 cm previously opened moderately distorted portion. of large bowel including cecum, as well as 4.5 cm of previously. opened terminal ileum. The specimen is covered by a moderate amount. of pericolic and epiploic adipose tissue in which a 4.3 X 0.6 x 0.6. grossly unremarkable vermiform appendix is identified. The visible. serosa is shaggy and gray-brown with several fibrofatty adhesions. The wall is up to 0.6 cm edematous and fibrotic. The lumen is lined. by gray-tan mucosa with preservation of intestinal folds and a small. amount of submucosal edema. Noted within the cecal pouch at a point. 0.3 cm from the ileocecal valve there is a previously sectioned. moderately distorted fairly well defined approximately 3.0 X 2.8 cm. centrally ulcerated finely granular tan brown plaque like lesion. with slightly raised rolled borders. This appears to have a gritty. gray-tan fibrotic cut surface measuring up to 0.7 cm in thickness. This grossly appears to focally extend through the wall focally. shallowly into the surrounding adipose tissue adjacent to the. ileocecal valve. In addition, this lesion focally appears to extend. into the appendiceal orifice but does not grossly appear to obstruct. the appendix. On sectioning, the surrounding adipose tissue shows. several poorly defined gray tan to brown nodules up to 0.6 cm. Also. received in the same container are three tissue cassettes each. labeled. Representative sections are submitted. labeled as follows: A - proximal margin; B - distal margin with a. portion of proximal margin included; C-F - representative lesion and. surrounding tissue; G - random uninvolved bowel; H - representative. more distal aspect of appendix; I - appendix near appendiceal. orifice; J-L - nodules from pericolic fat. Microscopic Description: The slides labeled. are examined. See diagnosis. Final Diagnosis. Tumor characteristics: Histologic type: Adenocarcinoma. Location of tumor: Cecal pouch. Size: 3.0 x 2.8 X 0.7 cm in greatest dimension. Grade: Poorly differentiated. Lymphovascular space invasion: Yes. Perforation of Visceral peritoneum: No. Presence of mesenteric deposits: No. Depth of invasion: Carcinoma extends through muscularis propria. into subserosal adipose tissue. Surgical Margin Status: Proximal Margin: No carcinoma identified. Distal Margin: No carcinoma identified. Radial Margin: No carcinoma identified. Distance of tumor from closet margin: Carcinoma extends to. within 1 mm of the serosal surface but does not perforate or. extend to the serosal surface. Lymph Node Status: Total number of lymph nodes examined: 17. Total number of lymph nodes with metastatic carcinoma: 1 (1/17). PAS 9. Appendix: Fibrous obliteration of the lumen. PAS 4 SPC-A. CPT: 88309. Stage: pT3N1a. Comments. At the request of the undersigned pathologist, these slides have. been additionally reviewed by Dr. who concurs with the. diagnosis. This test has been finalized at the. Campus.",T3,N1,M0,T3N1M0
TCGA-G3-A25Z,"PHN: ACB: Telephone: Encounter: Surgical Patholoav Report. Collected Date: Received Date/Time: Specimen Description. A. Gallbladder. B. Liver. Clinical Information. Hepatocellular carcinoma, hepatitis B. Diagnosis. A. Gallbladder: No pathologic diagnosis. B. Liver: Chronic hepatitis B of mild activity (Grade 2). Fibrosis, severe, (Stage 3). Hepatocellular carcinoma, moderately differentiated, 3.0 cm in the. greatest dimension (progressed type), completely excised. No. Chart Request ID: Pathology: Provider - Permanent. Print Date/Time: www. PHN: ACB: Collected Date: Received Date/Time: evidence of endothellum-tined space invasion. Gross Description. Received are specimens A to B. All requisitions and specimen containers are labelled with the patient's name. The cassettes and AP identifiers are labelled with the Surgical Number. A. The specimen is received fresh and is subsequently placed into formalin and consists of an intact gallbladder. measuring 7.5 x 4.0 X 3.0 cm. The serosal surface is tan and smooth. The lumen contains bile. Calculi are not grossly. identified. The mucosal surface is bile stained and velvety. The wall averages 0.2 cm in thickness. The cystic duct is. patent. The cystic duct lymph node is identified. Representative sections are submitted in one cassette. B. The specimen is received fresh and is subsequently placed into formalin and consists of a portion of liver weighing. 101.8. g. and. measuring 10 x 6 x 5.4 cm. The resection margin is dyed blue. Upon sectioning a firm tan mass is identified. measuring 3.0 X 2.0 x 1.7 cm. This mass is located 0.5 cm from the capsular surface and comes within 1.0 cm of the blue. painted resection margin. The remainder of the liver parenchyma is grossly unremarkable. Representative sections are. submitted as follows: B1 - section of the mass in relation to the capsular surface. B2 - section of the mass in relation to the closest blue painted margin. B3 - further section of the mass. B4 - section of grossly unremarkable liver parenchyma. One section was also submitted for the. study. Chart Request ID: Pathology: Provider - Permanent. Print Date/Time: www.",T1,N0,M0,T1N0M0
TCGA-VQ-A8PQ,"PRIMARY SITE: Stomach (Cardia). Product of resection of stomach, spleen and liver segments II and III. - Moderately differentiated tubular gastric adenocarcinoma (intestinal type of Lauren). measuring 4.5 x 3.5 x 2.0 cm. - Tumor involves the gastric body, cardia, esophagus and transposes all the gastric wall. infiltrating the liver and the omentum. - Presence of multiple tumoral implants in lesser and greater omentum. - Presence of lymphatic and perineural infiltration. - Non tumoral gastric mucosae exhibiting alkaline gastritis with areas presenting deep. cystic gastritis. - Proximal margin uninvolved by neoplasia, but only 3 mm distant from the tumor. - Hepatic and distal margins uninvolved by neoplasia. - Spleen uninvolved by neoplasia. - Metastatic adenocarcinoma in the 2 of 6 lymph nodes dissected of the lesser curvature. (2/6). - 4 of 6 lymph nodes involved by metastatic adenocarcinoma of the greater curvature. (4/6).",T4,N1,M1,T4N1M1
TCGA-BP-4340,"Clinical Diagnosis & History: Right renal cortical tumor. Laparoscopic right nephrectomy. Specimens Submitted: 1: SP: Right kidney (sr). DIAGNOSIS: 1). KIDNEY, RIGHT; LAPAROSCOPIC NEPHRECTOMY: - RENAL CELL CARCINOMA, CLEAR CELL TYPE, NUCLEAR GRADE II/IV. - THE PATTERN OF GROWTH IS SOLID. - THE TUMOR GREATEST DIAMETER IS 4.5 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. - NO INVASION OF THE RENAL VEIN IS IDENTIFIED. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. THE NON-NEOPLASTIC KIDNEY SHOWS GLOMERULOSCLEROSIS AND INTERSTITIAL INFLAMMATION,. - THE ADRENAL GLAND IS NOT SUBMITTED. Special Studies: Special Stain. Comment. RECUT. Gross Description: The specimen is received fresh, labeled ""Right Kidney"". It consists of a kidney with focally attached perirenal fat,. superiorly, inferiorly and posteriorly measuring 440 grams, 20 x 8.6 x 4,5 cm altogether. The kidney measures 12 X 8 X 4 cm with. attached ureter measuring 6 x 0.3 cm, The anterior renal capsule is exposed. The posterior renal capsule is also focally. exposed. The margin is inked, The ureter and the vascular margins are taken, The specimen is bivalved revealing a. subcapsular, well-circumscribed, yellow-brown mass with a central scar measuring 4.5 x 4,5 : x 4,0 cm. The tumor is limited to the. renal cortex and abuts the renal capsule, but does not panatrate it. The renal calyces and pelvis are uninvolved. The renal vein,. artery and ureter are also uninvolved. Representative sections are submitted. A portion of the specimen is given to TPS. A. photograph is taken. Summary of Sections: UM - ureteral margin. VM - vascular margin. TAM - tumor with anterior margin. TPM - tumor with posterior margin. TP - tumor with renal pelvis. N - normal parenchyma. HF - hilar fat, for possible lymph nodes. Summary of Sections: Part 1: SP: Right kidney (sr). Block. Sect. Site. PCs. 1. HF. 2. 1. N. 1. 2. TAM. 2. 1. TP. 1. 2. TPM. 2. UM. 1. VM. 2.",T1,N0,M0,T1N0M0
TCGA-AR-A1AO,"Final diagnosis. Breast, left wide local excision: Infiltrating ductal carcinoma, Nottingham grade III (of III). [tubules 3/3, nuclei 3/3, mitoses 2/3, Nottingham score 8/9], forming a 1.7 x 1.6 x 1.2 cm mass. [AJCC pTlc]. Ductal carcinoma in situ, intermediate nuclear grade, comprising less than 5% of. tumor volume. Angiolymphatic invasion is absent. Biopsy site changes present. All surgical. resection margins, after re-excisions of the medial and superior margins, are negative for tumor. (minimum tumor free margin, 0.9 cm, superior margin). A single intramammary lymph node,. present at the medial margin, is positive for metastatic carcinoma. The involved lymph node. measures 1.5 mm in maximum dimension. Lymph nodes, left axillary sentinel, excision: A single (of 2) left axillary lymph node is positive. for metastatic carcinoma [AJCC pN1]. Blue dye is identified in both left axillary sentinel lymph. nodes. Immunohistochemical cytokeratin stain was performed on the paraffin embedded sentinel. lymph node tissue and confirms the H&E impression. Lymph nodes, left axillary, dissection: Multiple (36) left axillary lymph nodes are negative for. tumor. Faxitron done. Estrogen and progesterone receptor analysis and Her-2/NEU have been ordered on paraffin. embedded tissue.",T1,N1,M0,T1N1M0
TCGA-AA-3489,"Diagnosis / Diagnoses: 24-cm-long resection of the colon under inclusion of a poorly differentiated, largely. ulcerated adenocarcinoma, of a maximum of 3.5 cm in diameter and of the colorectal. type, with infiltration of the pericolic fatty tissue (pT3; G3). Tumor-free resection. margins of the colon. Three tubular adenomas in the colonic mucosa with low- to. moderate-grade dysplasia in the remainder. A follow-up report will be made on the lymph node status. Follow-up report: A total of 28 histologically tumor-free lymph nodes of a maximum of 0.8 cm in diameter. were determined after acetone fixation. Final tumor stage: pT3 pNO (0/28) pMX; G3.",T3,N0,M0,T3N0M0
TCGA-SH-A7BH,"PAGE 02/03. Sex: F. Date Collected: Date Received: Date Printed: SPECIMEN DETAILS. Pleural biopsies, right. CLINICAL INFORMATION. SOBOE. Right pleural effusion. Known sarcomatoid. mesothelioma Per TSS, Known sercometoid on. Previous L LAT - pleurodesed Per TSS, pleviodesis took place 10 minutes after procurement. Ex-smoker. Asbestos exposure known. MACROSCOPIC DESCRIPTION. Two pieces of red and cream coloured tissue measuring 0.8 x 0.8 x 0.3 cm and 1 x 0.5 x 0.3 cm in maximum. dimension respectively. 2 in 1 AP. MICROSCOPIC REPORT. The sections reveal irregular pieces of pleural tissue diffusely infiltrated a biphasic tumour showing areas of. epithelioid tumour cells with visible nucleoli and a moderate amount of cytoplasm, which merge with areas of. tumour displaying a more sarcomatoid morphology with oval to plump spindle shaped cells set in fibrous stroma. Immunohistochemistry - The tumour, mainly in the epithelioid areas, is variably positive for MNF116, AE1AE3,. CD34, Bcl-2, CD99 (weak) and EMA (weak, focally membranous), but shows only one small focus where a few. cells stain for calretinin. There is no significant staining for CK5/6, mesothelin, CD31, HMB45 and TTF-1. WT-1. shows variable cytoplasmic staining. but no significant nuclear positivity. Despite the lack of specific staining for mesothelial markers, the morphological appearances favour biphasic. mesothelioma. Clinical-radiologicai-pathological correlation is advised. Reporting Pathologist: Authorising Pathologist: Reports are authorised electronically.",T3,N0,M0,T3N0M0
TCGA-37-3783,Index. S. 1. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of. Amount/per. Specificati. Container. Site. Matrix. Format. containers. container. on. Lung. Primary. Tumor. Tissue. OCT. block. 1. n/a. Blood. n/a. Normal. Blood. frozen. tube. 1. n/a. Type of. Histological description. Grade. TNM Stage. TNM Stage. TNM Stage. Treatment. Procureme. (Source). (source). (T). (N). (M). type. nt. n/a. Squamous cell carcinoma. 3. 3. 2. 0. none. n/a. blood draw. n/a. n/a. n/a. n/a. n/a. none. Component. of treatment. Tumor cell. (Chemo /. %. Horm Th. Details). n/a. over 50. n/a. n/a.,T3,N2,M0,T3N2M0
TCGA-BJ-A0ZG,"PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OF DIAGNOSIS: Hyperparathyroidism. PROCEDURE: Not answered. SPECIFIC CLINICAL QUESTION: Not answered. OUTSIDE TISSUE DIAGNOSIS: Not answered. PRIOR MALIGNANCY: Not answered is. CHEMO RADIATION: Not answered. ORGAN TRANSPLANT: Not answered. IMMUNOSUPPRESSION: Not answered. OTHER DISEASES: Not answered. ADDENDA: Addendum. MOLECULAR ANATOMIC PATHOLOGY TESTING: Block 2A: A. BRAF mutation POSITIVE (p.V600E, c.1799T>A). B. Mutations in NRAS61, HRAS61, KRAS12/13 NOT identified. C. FISH test results are negative for RET/PTC rearrangement. NOTE: DNA was extracted in the amount sufficient for testing. BACKGROUND: Mutations in either BRAF or RAS genes or RET/PTC rearrangements are found in more than 70% of papillary thyroid carcinomas. (1). BRAF V600E (T1799A) mutation has been associated with more aggressive behavior of papillary carcinoma (2,3). The. association between BRAFV600E mutation and features of tumor aggressiveness have also been observed in papillary. microcarcinomas (4). Mutations in the RAS genes or PAX8/PPARg rearrangement occur in - -70% of follicular thyroid carcinomas. and with lower frequency in oncocytic (Hrthle cell) carcinomas (5). Regarding the specificity of these mutations for cancer, BRAF. V600E mutation and RET/PTC and PAX8/PPARg rearrangements are overall specific for malignancy in the thyroid, although they. have. been reported with a very low frequency in benign thyroid lesions (6). RAS mutations occur in malignant and benign thyroid. tumors,. being found in -40-50% of follicular and anaplastic carcinomas, 30-40% of follicular adenomas and 10-15% of papillary. carcinomas (6). 1. Adeniran. AJ, et al. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of. thyroid papillary carcinomas. Am J Surg Pathol 2006, 30:216-222. 2. Xing. M,. et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 2005, 90:6373-6379. 3. Elisei. R,. et al. BRAF V600E mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin. Endocrinol Metab 2008, 93:3943-3949. 4. Lee X, Gao M, Ji Y, Yu Y, Feng Y, LI Y, Zhang Y, Cheng W, Zhao W. Analysis of differential BRAF(V600E) mutational status in high aggressive. papillary thyroid microcarcinoma. Ann Surg Oncol. 2009 Feb;16(2):240-5. 5. Nikiforova MN, et al. RAS point mutations and5PAX8-PPARy rearrangement in thyroid tumors: Evidence for distinct molecular pathways in. thyroid follicular carcinoma. J Clin Endocrinol Metab 2003, 88: 2318-26. 6. Nikiforov YE. Recent developments in the molecular biology of the thyrold. In: Lloyd RV., ed. Endocrine Pathology: Differential Diagnosis and. Molecular Advances. Humana Press, Totowa, 2004, 191-209. MUTATIONAL ANALYSIS: For paraffin-embedded surgical specimens, manual microdissection was performed to collect tumor tissue. Specimens with the minimum of 50% of. tumor. cells in a microdissection target are accepted for the analysis. Optical density readings were obtained. Real-time PCR was performed on the. platform to amplify BRAF codons 599-601, NRAS codon 61, HRAS codon 61, and KRAS codons 12/13 sequences. Post-PCR melting. curve analysis was used to detect possible mutations. If required, the mutation type was confirmed by. r sequencing of the PCR product on. DNA from samples positive for each of these mutations was used as positive controls. Amplification at 35 cycles or earlier was. considered sufficient for the analysis. The limit of detection is approximately 10-20% of alleles with mutation present in the background of normal. DNA. Addendum. MOLECULAR ANATOMIC PATHOLOGY TESTING: Block 1A: D. Loss of heterozygosity IDENTIFIED at 1p, 10q, and 13q. E. Allelic loss 38% (5/13 informative loci). F. Loss of heterozygosity of 1p IDENTIFIED; Loss of Heterozygosity of 13q (RB1) IDENTIFIED. NOTE: The quantity and quality of isolated DNA was acceptable for testing. BACKGROUND: Loss of tumor suppressor gene alleles is known to occur in parathyroid neoplasms and to correlate with tumor progression. As. reported in the literature, parathyroid carcinomas frequently have a mean fractional allele loss of - 63%, and many of these tumors. have retinoblastoma gene deletions at 13q14 (1,2). Parathyroid adenomas typically have lower frequency of LOH, frequently. fewer. than 11% (1). Some studies have shown that parathyroid adenomas and carcinomas often have identifiable LOH on chromosome. 1p,. while. hyperplasia is less commonly, affected by this genetic loss (1,3). However, not all tumors reveal such a correlation and,. therefore, the LOH profile should be interpreted in the context of the cytologic and histologic findings and the patient's clinical. history. 1. Hunt J, et al. Am J Surg Pathol. 2005;29:1049-55. 2. Cetani F, et. al. Clinical Endocrinology. 2004;60:99-106. 3. Valimaki S, et. al. International Journal of Oncology. 2002;21:727-35. LOSS OF HETEROZYGOSITY ANALYSIS: For cytology samples, extraction of DNA was performed from the fluid or sample provided. For surgical specimens, manual microdissection. was. performed. to. include neoplastic tissue and normal adjacent tissue. Specimens with the minimum of 50% of tumor cells in a microdissection target. are accepted for the analysis. DNA was isolated using standard laboratory procedure. Optical density readings were obtained. Sixteen. microsatellite markers (D1S407 (p21, 1p36.21), D1S1161 (p21, 1p35.1), D1S1183 (HRPT2, 1q25.3), D3S1516 (VHL, 3p25.3), D5S659 (APC,. 5a23.2), D9S251 )p16, 9p21.3), D10S520 (PTEN, 10q23.31), D10S1173 (PTEN, 10q23.31), D11S1319 (KAI1, 11p11.2) D11S4177 11p15.5),. D11S916 (MEN1, 11q23), D11S387 (MEN1, 11q25), D13S161 (RB, 13q14.3), D13S319 (RB, 13q14.3), D17S516 (p53, 17p13.1) D17S1844 (p53,. 17p13.1) D17S1877 (17q21), D22S1150 (NF2, 22q12.2) that have been previously found to be involved in parathyroid neoplasia and co-localize. with known tumor suppressor genes were used for analysis. PCR was performed using fluorescently labeled primers and the products of. amplification were detected using capillary electrophoresis on. ) platform. Relative fluorescence was determined for individual alleles and. the ratio of peaks was calculated. i). Normal tissue was examined to determine whether the patient is heterozygous at the. marker (genetically informative) and neoplastic tissue was then analyzed to detect loss of heterozygosity. Thresholds for significant allelic. imbalance were determined using normal (non-neoplastic) specimens for every marker. Loss of heterozygosity was determined using (NL/NS). (TL/TS) formula and reported when allelic ratio for a particular marker was below 0.5 or above 2.0. When normal tissue was not available, peak. boight catios falling outside of 2 SDs bevond the mean for each polymorphic allele paring were assessed as showing loss of heterozygosity. FINAL DIAGNOSIS: PART 1: PARATHYROID, RIGHT SUPERIOR, EXCISION (948 MG) -. ENLARGED AND HYPERCELLULAR PARATHYROID GLAND WITH FIBROSIS, SEE COMMENT. PART 2: THYROID, TOTAL THYROIDESTOMY -. A. B. PAPILLARY MICROCARCINOMA, 0.7 CM, LOCATED IN RIGHT LOBE, SEE COMMENT. NO INGIOLYMPHATIC INVASION OR EXTRATHYROIDAL EXTENSION. C. ALL MARGINS ARE FREE OF TUMOR. D. BACKGROUND THYROID SHOWS NODULAR HYPERPLASIA WITH A DOMINANT HYPERPLASTIC NODULE,. 2.0 CM, LOCATED IN LEFT LOBE. COMMENT: additionally gland, which, in addition to the microscopic appearance, is consistent with an adenoma. The parathyroid gland. Part 1: The intraoperative PTH level dropped from 512 pg/ml to 78 pg/ml after excision of the right superior parathyroid. additional tissue. During surgery, this parathyroid gland was found to be mildly adherent to the right thyroid lobe. To provide soft. shows significant fibrosis, mostly in the peripheral location, but no definitive Invasion into adjacent. and information on the nature of this apparently adenomatous lesion, the molecular LOH test will be performed. reported as an addendum. growth. Molecular mutational test will be performed and reported as an addendum. Part 2: The focus of papillary microcarcinoma shows follicular architecture, is encapsulated, and reveals no infiltrative. RET/PTC Methodology Description: Probe: RET/PTC Probe (10q11.2) and RET/PTC1 Dual-Color Fusion Probe 10q11.2-10q21. Probe Description: The RET probe (labeled SpectrumGreen) is a 207 kb DNA probe located at band 10q11.2. The. H4 and 369 probes are approximately 100kb each (labeled in SpectrumOrange), and are located at band 10q21. RET/PTC rearrangement is suggested to be present when three RET signals are identified in greater than 8% of the analyzed. cells. RET. /PTC1. rearrangement detection is as follows: Normal cells without the RET/PTC1 rearrangement show two pair of green and. orange. signals separated. Cells with the RET/PTC1 rearrangement show two pair of signals (green and orange) in juxtaposition. and one green and one orange signal separated in greater than 8% of analyzed cells within the targeted area. RET/PTC FISH analysis was manually performed and quantitatively assessed by analysis of a minimum of 60 cells using the PTC. (369/H4) SpectrumOrange and the RET SpectrumGreer probes.",T1,N0,M0,T1N0M0
TCGA-5R-AA1D,"Procedure: Right hemihepatectomy, cholecystectomy. Preoperative diagnosis: CARCINOMA OF THE LIVER. Postoperative diagnosis: SEE MICROSCOPIC DIAGNOSIS BELOW. Specimen(s): 1. LIVER, RIGHT LOBE 2. GALLBLADDER 3. RETROPANCREATIC. LYMPH NODES 4. COMMON HEPATIC LYMPH NODES. Diagnosis: 1. LIVER, RIGHT LOBE: Poorly differentiated hepatocellular carcinoma. Vascular invasion is present. Satellite. Metavir fibrosis score 0, Knodell histological activity index score 0, Ishak fibrosis. score 0. Resection margin is free of tumor. 2. GALLBLADDER: - Autolysis. 3. RETROPANCREATIC LYMPH NODES: All (two) lymph nodes are negative for metastatic carcinoma. 4. COMMON HEPATIC LYMPH NODES: All (seven) lymph nodes are negative for metastatic carcinoma. Gross description: 1. LIVER, RIGHT LOBE: Received fresh, is a right lobe of the liver 19.0 x 15.0 x 6.0 cm in dimensions. At a distance of. 2.0 cm from the resection margin the well-circumscribed firm lobulated green-brown tumor 11.0. x 6.5 X 8.0 cm in dimensions is present. Near the tumor there is a satellite 2.0 cm in diameter. The remaining hepatic tissue is flabby and reddish-brown. 2. GALLBLADDER: Received fresh, is a gallbladder 6.5 x 2.0 x 1.5 cm in dimensions with a smooth greenish serosa. and a plush greenish mucosa. The gallbladder contains bile. 3. RETROPANCREATIC LYMPH NODES: Received fresh, is a portion of adipose tissue with two lymph nodes to 2.5 cm in greatest. dimension. 4. COMMON HEPATIC LYMPH NODES: Received fresh, is a portion of adipose tissue with seven lymph nodes ranging from 0.5 to 1.5 cm. in greatest dimension.",T3,N0,M0,T3N0M0
TCGA-50-5933,"FINAL DIAGNOSIS: PART 1: LUNG, LEFT, BIOPSY OF MASS -. ALVEOLATED LUNG FRAGMENTS POSITIVE FOR POORLY DIFFERENTIATED NON-SMALL CELL CARCINOMA. PART 2: LUNG, LEFT, PNEUMONECTOMY -. A. MODERATE TO POORLY DIFFERENTIATED ADENOCARCINOMA PREDOMINANTLY IN THE LEFT LOWER. LOBE WITH CONTIGUOUS SPREAD TO THE LEFT UPPER LOBE (13.2 CM). B. THE NEOPLASM EXTENDS INTO BUT NOT THROUGH THE VISCERAL PLEURA (SLIDES 2E; see comment). C. MICROSCOPIC FOCUS OF TUMOR PRESENT IN ARTERIAL WALL AT VASCULAR MARGIN OF RESECTION. (see comment). D. BRONCHIAL AND ALL OTHER VASCULAR MARGINS OF RESECTION ARE FREE OF NEOPLASM. E. THE NON-NEOPLASTIC LUNG SHOWS CHANGES OF EMPHYSEMA. F. SIX PERIHILAR LYMPH NODES FREE OF NEOPLASM (0/6). G. PATHOLOGIC STAGE: PT4, N2, Mx; GRADE: G2 (see comment). PART 3: BRONCHUS, LEFT MAINSTEM, EXCISION -. A. SEGMENT OF BRONCHIAL WALL WITH NO SPECIFIC PATHOLOGIC CHANGE; NEGATIVE FOR NEOPLASM. B. NO SECONDARY CARCINOMA SEEN IN ONE LYMPH NODE EXAMINED (0/1). PART 4: ""ANTERIOR CHEST WALL"", EXCISION -. A. LUNG TISSUE WITH EMPHYSEMA. B. FIBROADIPOSE TISSUE FRAGMENTS WITH DENSE SCLEROSIS. C. NEGATIVE FOR NEOPLASM. PART 5: ""POSTERIOR CHEST WALL MARGIN"", EXCISION -. A. FIBROADIPOSE TISSUE WITH DENSE SCLEROSIS AND CHRONIC INFLAMMATION. B. NEGATIVE FOR NEOPLASM. PART 6: ""APICAL CHEST WALL MARGIN"", EXCISION -. A. FIBROADIPOSE TISSUE FRAGMENTS. B. NEGATIVE FOR NEOPLASM. PART 7: ""NODULE ON AORTIC ARCH"", EXCISION -. MICROSCOPIC FOCUS OF METASTATIC CARCINOMA WITHIN THE VESSEL WALL (see comment). PART 8: PORTION OF 6TH RIB, SIDE NOT SPECIFIED, EXCISION -. SEGMENT OF BONE WITH NO SPECIFIC PATHOLOGIC CHANGE. PART 9: LYMPH NODES, SUBCARINAL, EXCISION -. NO SECONDARY CARCINOMA SEEN IN TEN LYMPH NODES EXAMINED (0/10). PART 10: LYMPH NODE, PERIAORTIC, EXCISION -. SECONDARY CARCINOMA PRESENT IN ONE OF ONE LYMPH NODE EXAMINED WITH EXTRANODAL SPREAD. (1/1). PART 11: LYMPH NODE, AP WINDOW, EXCISION -. NO SECONDARY CARCINOMA SEEN IN ONE LYMPH NODE EXAMINED (0/1). PART 12: LYMPH NODES, PARAESOPHAGEAL, EXCISION -. NO SECONDARY CARCINOMA PRESENT IN ONE LYMPH NODE EXAMINED (0/1). PART 13: ""NEO-PULMONARY ARTERY RESECTION MARGIN"", EXCISION -. FRAGMENTS OF VESSEL WALL NEGATIVE FOR NEOPLASM. PART 14: ""PLEURAL MARGIN"", EXCISION -. A. CHRONIC FIBROUS AND-FIBRINOUS PLEURITIS. NEGATIVE FOR NEOPLASM. COMMENT: In Part 2, special stain for elastin shows that the neoplasm extends into but not through the visceral pleura. A. microscopic focus of neoplastic cells is present within the arterial wall at the vascular margin of resection. This. neoplastic focus is seen on the frozen section and not on permanent section. Deeper levels of this margin. are. non-. contributory. The frozen section slide was reviewed and our diagnosis regarding this margin remains unchanged. Given. the positive vascular margin, the tumor clusters in part 7( nodule on aortic arch) likely represents contiguos spread rather. than a true etastsis. Hence, this lesion is best classifies as Pt4 N2 Mx. In Part 7, cytokeratin stain confirms the presence of neoplastic cells of epithelial origin within the vessel wall. has been. ordered to confirm the epithelial origin of the neoplastic cells. SYNOPTIC - PRIMARY LUNG TUMORS. A. Location: 4,5. 1. RUL. 3. RLL'. 5. LUL. 2. RML. 4. LLL. 6. Bronchus intermedius. B. Procedure: 4. 1. Wedge/Segmental. 3. Bilobectomy. 2. Lobectomy. 4. Pneumonectomy. C. Size of tumor (maximum dimension): 13.2 cm. D. Satellite nodules: 2. 1. yes. 2. No. D1. If yes, Where: N/A. 1. Same lobe. 2. Psilateral lobes. 3. Central lobe. E. Type: 3. 1. Invasive squamous carcinoma. 11. Fetal type adenocarcinoma. 2. Basaloid squamous carcinoma. 12. Small cell carcinoma. 3. Invasive adenocarcinoma. 13. Carcinoid. 4. Bronchioloalveolar carcinoma, nonmucinous type. 14. Atypical carcinoid. 5. Bronchioloalveolar carcinoma, mucinous type. 15. Sarcoma. 6. Large cell carcinoma. 16. Adenosquamous carcinoma. 7. Clear cell carcinoma. 17. Mixed non-small cell carcinoma, NOS. 8. Giant cell carcinoma. 18. Carcinosarcoma. 9. Sarcomatoid carcinoma. 19. Other. 10. Blastoma. F. Architectural.grade: 3. 1. well. 2. moderate. 3. poor/undifferentiated. G. Nuclear grade: 3. 1. Low. 2. Intermediate. 3. High. H. Central vs. peripheral origin: 1. 1. yes. 2. no. I. Visceral pleural invasion through elastica: 1. 1. yes. 2. no. J. Parietal pleural invasion: 2. 1. yes. 2. no. K. Chest wall invasion (into skeletal muscle or soft tissue): 2. 1. yes. 2. no. L. Angiolymphatic invasion: 2. 1. yes. 2. no. M. Necrosis: 2. 1. <50%. 2. >50%. N. Surgical margins involved: 2. 1. yes. 2. no. O. Inflammatory (desmoplastic) reaction: 3. 1, mild. 2. moderate. 3. severe. P. Hilar lymph node involvement (N1 nodes): 2. 1. yes. 2. no. Q. If hilar lymph nodes involved, number of positive lymph nodes: N/A. R. Total number of hilar lymph nodes examined: 6. S. Extracapsular spread of hilar lymph node metastases: N/A. 1. yes. 2. no. T. Mediastinal nodes involved: 1. 1. yes. 2. no. 3. not applicable. U. Mediastinal node group(s) involved (N2 nodes): periaortic, side not specified. 1. Level 4R. 4. Level 7R. 7. Level 4L. 10. Level 7L. 2. Level 5R. 5. Level 9R. 8. Level 5L. 11. Level 9L. 3. Level 6R. 6. Level 10R. 9. Level 6L. 12. Level 10L. V. Number of positive mediastinal nodes: 1. W. Total number of mediastinal nodes examined: 12. X. Extracapsular spread of mediastinal lymph node metastases: 1. 1. yes. 2. No. Y. Underlying disease(s) 1/#/#/#. 1. Emphysema. 4. Smokers bronchiolitis. 7. Pneumoconiosis, NOS. 2. Bronchiectasis. 5. Asthma. 8. Chronic interstitial pneumonia. 3. Tumorlets. 6. Parenchymal scar. z. TNM Stage: T 4. N 2. M X.",T4,N2,M0,T4N2M0
TCGA-EI-6511,"page 1 / 1. Examination: Histopathological examination (cito). Material: Total organ resection - rectum. Expected time of examination. Clinical diagnosis: Macroscopic description: 16.4 cm length of the large intestine with the whole mesorectum fat tissue of 2.5 cm in thickness. An ulcurous tumour sized 4,2 x. 6.7 x 1.1 cm found in the mucosa. The lesion covers 100% of the intestine circumference, located 7.1 cm from one of the cut lines. and 3.4 cm from the opposite one. Minimum side margin is 0,2 cm. Microscopic description: Adenocarcinoma tubulopapillare (G2). Infiltratio carcinomatosa telae adiposae mesorecti. Intestine ends free of. neoplastic lesions. Metastases carcinomatosae in lymphonodis (No IV/XVIII). Histopathological diagnosis: Adenocarcinoma tubulopapillare. Tubulopapillar adenocarcinoma of the rectum. Metastases carcinomatosae in lymphonodis regionalis (No IV/XVIII). Cancer metastases in regional lymph nodes. (G2; Dukes C, Astler-Coller C2; pN1; RO).",T3,N1,M0,T3N1M0
TCGA-CV-A6JU,"F. (159.0cm 39. 3kg BSA: 1.32m. MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) LEFT AE FOLD: Squamous mucosa with mild dysplasia. (B) RIGHT NECK SENTINEL LYMPH NODE #1. Two lymph nodes, negative for tumor (0/2). (C) RIGHT NECK, SENTINEL LYMPH NODE #2: One lymph node, negative for tumor (0/1). (D) RIGHT NECK DISSECTION, LEVEL IB: Two lymph nodes, negative for tumor (0/2). (E) RIGHT SENTINEL LYMPH NODE #3: One lymph node, negative for tumor (0/1). (F) RIGHT NECK DISSECTION, LEVEL IIB: Three lymph nodes, negative for tumor (0/3). (G) RIGHT SENTINEL LYMPH NODE #4, LEVEL III: One lymph node, negative for tumor (0/1). (H) RIGHT SENTINEL LYMPH NODE #5: One lymph node, negative for tumor (0/1). (I) RIGHT NECK DISSECTION, LEVEL IIA AND IIB: Seventeen lymph nodes, negative for tumor (0/17). (J) RIGHT NECK DISSECTION. LEVEL III;. Eleven lymph nodes, negative for tumor (0/11). (K) RIGHT NECK DISSECTION, LEVEL IV: Two lymph nodes, negative for tumor (0/2). (L) RIGHT SENTINEL LYMPH NODE #6, LEVEL IV: One lymph node, negative for tumor (0/1). (M) LEFT PAROTID LYMPH NODE: One lymph node, negative for tumor (0/1). (N) LEFT NECK, LEVEL IIA, SENTINEL LYMPH NODE #7;. One lymph node, negative for tumor (0/1). (O) SENTINEL LYMPH NODE #8. LEFT NECK, LEVEL III: One lymph node. negative for tumor (0/1). (P) LEFT NECK DISSECTION, LEVEL 11: Fourteen lymph nodes, negative for tumor (0/14). (Q) PORTION OF FATTY TISSUE: eage: L. (159.Com 39.3kg BSA: 1.32m4. Fifteen lymph nodes, negative for tumor (0/15). (R) LEFT NECK DISSECTION LEVEL IV: Five lymph nodes, negative for tumor (0/5). (S) LEFT NECK, LEVEL II, SENTINEL LYMPH NODE #9: One lymph node, negative for tumor (0/1). (T) LEFT NECK. LEVEL II, SENTINEL LYMPH NODE #10: One lymph node, negative for tumor (0/1). (U) LEFT NECK, LEVEL III, SENTINEL LYMPH NODE #11: One lymph node. negative for tumor (0/1). (V) COMPOSITE RESECTION MANDIBLE FLOOR OF MOUTH AND TONGUE: INVASIVE SQUAMOUS CARCINOMA -- Moderately differentiated. Tumor Features: Gross: Ulcerating. Size: 2.5 cm in largest dimension. Invasion: Present, depth 1.5 cm. Tumor Border: Infiltrative with thin cords < 4 cells. Perineural Invasion: Present, Extensive. Vascular Invasion: Absent. Bone/Cartilage Invasion: Pending Decalcification (see addendum). Eleven lymph nodes, negative for carcinoma (0/11). (W) LEFT POSTERIOR TONGUE MARGIN. TRUE MARGIN INKED: Skeletal muscle and salivary gland tissue, negative for tumor. (X) POSTERIOR DEEP TONGUE: Skeletal muscle, negative for tumor. (Y) LEFT MYOHYOID: Skeletal muscle, negative for tumor. (Z) DIGASTRIC MUSCLE: Skeletal muscle and adipose tissue, negative for tumor. GROSS DESCRIPTION. (A) LEFT AE FOLD - A single fragment of tan-pink soft tissue (0.4 cm) that is submitted entirely in A. (B) RIGHT NECK SENTINEL LYMPH NODE #1 - Two possible lymph nodes, 1 2 X 0.8 X 0.6 cm and. SECTION CODE: A smaller lymph node is designated as 81 and the larger lymph node will be designated as 82. Lymph. nodes are serially sectioned and submitted entirely. Smaller lymph node submitted in cassette B1. Larger lymph node submitted. in cassette B2. (C) RIGHT NECK, SENTINEL LYMPH NODE #2 - One possible lymph node (0.5 X 0.5 X 4 cm) that is bisected and submitted. entirely in C. (D) RIGHT NECK DISSECTION, LEVEL IB - One piece of fibroadipose tissue with attached salivary gland overall (3.6 x 2.8 X 1.4. cm) yielding four possible lymph nodes ranging from 0.2 to 0.8 cm and salivary gland tissue (3.1 X 2.7 X 1.1 cm). SECTION CODE: D1, one possible lymph node; D2, one possible lymph node bisected; D3, one possible lymph node. bisected; D4, one possible lymph node; D5-D8, salivary gland submitted in toto. (E) RIGHT SENTINEL LYMPH NODE #3 - One possible lymph node (0.9 x 0.7 X 0.5 cm) that is trisected and submitted entirely in. E. Page: 3. F. (159.000 39.3Kg BSA: 1.32m'. (F) RIGHT NECK DISSECTION, LEVEL IIB - Three possible lymph nodes ranging in greatest dimension from 0.4 to 0.7 cm. SECTION CODE: F1, three possible lymph nodes. (G) RIGHT SENTINEL LYMPH NODE #4, LEVEL III - One possible lymph node (0.6 X 0.2 x 0.2 cm) that is trisected and. submitted entirely submitted in G. (H) RIGHT SENTINEL LYMPH NODE #5 - One possible lymph node (1.0 X 0.7 x 0.4 cm) that is serially sectioned and submitted. entirely in H. (I) RIGHT NECK DISSECTION, LEVEL IIA AND II B - A piece of fibroadipose tissue (5.3 x 2.5 x 0.8 cm). SECTION CODE: 11, one possible node bisected: 12, one possible lymph node bisected; 13, one possible lymph node. bisected; 14, one possible lymph node bisected; 15, one possible lymph node bisected; 16, five possible lymph nodes; 17, five. possible lymph nodes; 18, two possible lymph nodes; 19, two possible lymph nodes. (J) RIGHT NECK DISSECTION, LEVEL III - Two pieces of fibroadipose tissue (4.5 X 2.8 X 0.8 cm and 2.5 X 3.0 X 0.4 cm) yielding. eleven possible lymph nodes ranging in greatest dimension from 0.1 to 1.1 cm. SECTION CODE: J1, three lymph nodes; J2, eight possible lymph nodes; J3, one lymph node bisected. (K) RIGHT NECK DISSECTION, LEVEL IV - One piece of fibroadipose tissue (2.8 X 2.0 x 0.6 cm) yielding one possible lymph. node (0.5 X 04 X 0.4 cm). SECTION CODE: K1. one possible lymph node; K2, K3, remaining fibroadipose tissue submitted in toto. (L). RIGHT SENTINEL LYMPH NODE #6, LEVEL IV - One possible lymph node (0.6 X 0.5 x 0.3 cm) that is trisected and submitted. entirely in L. (M) LEFT PAROTID LYMPH NODE - One possible lymph node (1.5 x 0.5 X 0.4 cm) that is submitted entirely in M. (N) LEFT NECK, LEVEL HA SENTINEL LYMPH NODE #7 - One possible lymph node (1.1 x 1.1 x 0.7 cm) that is serially. sectioned and is submitted entirely in N. (O) SENTINEL LYMPH NODE #8 LEFT NECK, LEVEL III - One possible lymph node (0.9 x 0.7 x 0.4 cm) that is trisected and. submitted entirely in O. (P) LEFT NECK DISSECTION LEVEL Il - A portion of fatty tissue (4.0 x 3.0x1.7 cm) that is dissected to reveal fourteen possible. lymph nodes ranging from 0.1 up to 1.5 cm in greatest dimension. Lymph nodes submitted entirely. SECTION CODE: P1, five possible lymph nodes; P2, five possible lymph nodes; P3, four lymph nodes. (Q) PORTION OF FATTY TISSUE - A 3.5 x 2.0 X 1.5 cm that is dissected to reveal fifteen possible lymph nodes ranging from 0.2. up to 1.5 cm in greatest dimension. Lymph nodes submitted entirely. SECTION CODE: Q1, five possible lymph nodes; Q2. five possible lymph nodes; Q3, five lymph nodes. (R) LEFT NECK DISSECTION LEVEL IV - A portion of fatty tissue (3.5 X 3.1 x 1.2 cm) that is dissected to reveal five possible. lymph nodes ranging from 0.2 up to 1.3 cm in greatest dimension. Lymph nodes submitted entirely. SECTION CODE: R1, four possible lymph nodes: R2, one possible lymph node, bisected. (S). LEFT NECK, LEVEL Il SENTINEL LYMPH NODE #9 - A pale pink fragment of possible lymph node (0.5 x 0.4 x 0.3 cm). The. specimen is bisected and submitted in toto in cassette S1. (T) LEFT NECK. LEVEL II, SENTINEL LYMPH NODE #10 - A lymph node (0.6 x 0.6 x 0.4 cm). serially sectioned and submitted in. toto in T1. (U) LEFT NECK, LEVEL III, SENTINEL LYMPH NODE #11 - A single lymph node (1.0 X 0.7 x 0.4 cm), serially sectioned and. submitted entirely in U1. (V) COMPOSITE RESECTION MANDIBLE FLOOR OF MOUTH AND TONGUE - A partial left mandibulectomy and left tongue. and floor of mouth (13.0 X 4.0 X 3.5 cm overall). There is a light tan, firm infiltrating mass (2.5 X 2.0 X 1.5 cm) located in the center. of the left side of the tongue and extends to the base of tongue. The margins of resection are grossly uninvolved. The closest. margin is the posteroinferior aspect of the tongue (0.3 cm). The remainder of the specimen is sent to the bone lab for. decalcification and further processing. SECTION CODE: V1, frozen section; V2-V15, representative sections of tongue from anterior to posterior; V16, two. possible lymph nodes; V17-V18, one bisected node in each cassette; V19-V22, remainder of surrounding adipose tissue; V23. anterior mandible resection margin, en face for decalcification; V24, posterior mandible resection margin, en face for. decalcification; V25-V27. representative sections of possible tumor to mandible bone submitted for decalcification. FS/DX: DEEP MEDIAL MARGIN, FREE OF TUMOR. (W) LEFT POSTERIOR TONGUE MARGIN, TRUE MARGIN INKED - A portion of tan, maroon tissue (2.8 X 0.9 X 1.8 cm). The. specimen is inked at one edge. The specimen is bisected along its length and the true margin is submitted ink side down, en face,. for frozen section. INK CODE: Blue - true margin. SECTION CODE: W1. true margin. en face, for frozen section. W2, remainder of the specimen. FS/DX: NO TUMOR PRESENT. (X) POSTERIOR DEEP TONGUE - Two fragments of tan-pink soft tissue, both measuring 0.7 cm in greatest dimension. The. Page: 4. F. (159.0cm 39.3kg BSA: 1.32m-. specimen is submitted entirely in X. (Y) LEFT MYOHYOID - Two fragments of tan-pink skeletal muscle (0.5 and 1.4 cm in greatest dimension) Specimen is. submitted entirely in Y. (Z) DIGASTRIC MUSCLES - A portion of skeletal muscle (3.0 X 3.0 x 1.0 cm), that is serially sectioned to reveal unremarkable. cut surfaces. Representative sections are submitted in Z. CLINICAL HISTORY. SNOMED CODES. T-53000, T-11180, T-C4200, M-80703,. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the US Food and Drug Administration. Entire report and diagnosis completed by: Start of ADDENDUM. Page: 5. 159.00m 3. .3kg BSA: : . .32m. ADDENDUM. This modified report is being issued to report the results of decalcification. Addendum completed by. DIAGNOSIS. (V) COMPOSITE RESECTION MANDIBLE FLOOR OF MOUTH AND TONGUE: SQUAMOUS CARCINOMA INVADING BONE. Bone margins: Negative for carcinoma. Entire report and diagnosis completed by:",T4,N0,M0,T4N0M0
TCGA-JL-A3YX,1. LAB NO. C.P #. CLINICAL INFORMATIONICOMMENTS: FEMALE YEARS Loc. PR. PATIENT CODE 1. CONSULTANT. Histogathology Biopsy Small. Clinical Note: Carcinoma breast left side. Microscopic Features: Section examined reveal breast tissue an infiltrative neoplastic lesion composed of cells. showing moderate pleomorphism with nuclear hyperchromasia and eosinophilic cytoplasm. Few mitotic figures are seen. Almost 100% of the tumor is viable. No areas of necrosis are. seen. Conclusion: Carcinoma left breast :-. Infiltrating Lobular Carcinoma grade II. 100% of tumor is viable. No areas of necrosis are seen. Additional Report. Necrosis. : 0%. Percent of tumor nuclei 90%. Other nuclei. : 10%.,T2,N0,M0,T2N0M0
TCGA-2J-AABR,"Surgery date: DIAGNOSIS: C. Pancreatic head, duodenum, common bile duct, Whipple. resection: Invasive moderately differentiated, grade 3 (of 4). ductal adenocarcinoma is identified forming a mass (3.2 x 2.3 x 1.6. cm) located in the pancreatic head and neck. The tumor extends. beyond pancreas to involve peripancreatic soft tissue. The. pancreatic duct is also involved. Angiolymphatic invasion is. absent. Perineural invasion is present. The portal vein groove. margin is focally positive for invasive carcinoma. However, after. re-excision of this area (see part D below), all surgical margins,. including uncinate, common hepatic duct, and pancreatic neck (see. parts A and B below), are negative for tumor. The patient has had. no prior treatment. The adjacent non-neoplastic pancratic. parenchyma shows marked chronic pancreatitis. The gallbladder is. unremarkable. Multiple (14) regional lymph nodes are negative for. tumor. The pancreatic parenchyma is distorted with curvilinear. change possibly related to preoperative abscess formation and tumor. growth as it extends into peripancreatic fat. A. Hepatic duct, common, margin, excision: Negative for tumor. B. Pancreas, neck, margin, excision: Negative for tumor. D. Portal vein, excision: Focally involved by grade 3 (of 4). adenocarcinoma in the mid-region of the segmentally-resected portal. vein. However, the superior and inferior margins are negative for. tumor. AJCC stage (with available surgical material): pT3N0 (7th edition). Frozen section histologic interpretation of portion of portal vein. This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s). A revised report will be issued to document the final. interpretation after review of the Hematoxylin and Eosin (H&E). permanent sections. ADDENDUM: Frozen section interpretation has been confirmed by Hematoxylin and. Eosin (H&E) permanent section review. GROSS DESCRIPTION: A. Received fresh labeled ""common hepatic duct"" is a 1.3 X 1.1 X. 0.4 cm portion of pink mucosa with a lumen with orientation. All. submitted en face. Grossed by. B. Received fresh labeled ""pancratic neck margin"" is a 2.8 x 1.4. x 0.5 cm portion of pancreas with orientation. Margin submitted. C. Received fresh labeled ""head of pancreas, gallbladder,. duodenum, common bile duct, portion jejunum"" is a Whipple specimen. consisting of 29.0 cm in length portion of duodenum, 6.9 X 4.2 x 3.1. cm portion of pancreas, 9.1 x 2.5 x 2.5 cm gallbladder. The. pancreatic uncinate margin is inked yellow and shaved, the portal. vein groove is inked black and submitted perpendicularly. There is. a 3.3 x 2.3 x 1.6 cm infiltrative mass within the neck/head,. abutting the portal vein groove margin. The mass extends to. peripancreatic fat. A stent is present within the common bile duct. The gallbladder contains no choleliths. Surrounding the proximal. duodenum and pancreatic head is extensive necrosis and exudate,. which involves the pancreatic parenchyma. Peripancreatic lymph. nodes and periduodenal lymph nodes are identified. Representative. sections are submitted. Research tissue collected,. D. Received fresh labeled ""portion portal vein"" is a 1.4 cm in. length medium caliber vein with orientation. The superior and. inferior vein margins are submitted en face. The central part of. the vein is focally indurated, 0.3 cm to the inferior margin. BLOCK SUMMARY: Part A: Common hepatic duct. 1 Common hepatic duct margin. Part B: Pancreatic neck margin. 1 Pancreatic neck margin. Part C: Head of pancreas, gallbladder, duodenum, common bile duct,. portion jejunum, and stent. 1 Portal vein margin 1. 2 Portal vein margin 2. 3 Uncinate margin 1. 4 Uncinate margin 1. 5 Uncinate margin 2. 6 Uncinate margin 3. 7 Tumor-peripancreatic fat. 8 Tumor 1. 9 Tumor 1. 10 Tumor main duct. 11 Tumor 2. 12 Ampulla. 13 Abscess. 14 Abscess. 15 Gallbladder. 16 Periduodenal LN 1 (C1). 17 Periduodenal LN 2 (C2). 18 Peripancreatic LN 2 (C3). 19 Peripancreatic LN 5 (C4). 20 Peripancreatic 1 (C5). 21 Peripancreatic LNs 3 (C6). Part D: Portion portal vein. 1 Superior portal vein margin. 2 Inferior portal vein margin. 3 Portal vein mid.",T3,N0,M0,T3N0M0
TCGA-LK-A4O6,"FINAL DIAGNOSIS: Summary Statement. This extrapleural pneumonectomy specimen shows a biphasic mesothelioma diffusely Involving the visceral and parietal. pleural. The histolgy Is predominantly epithelioid, with a minor spindle cell component. The tumor Invades the. diaphragm (non-transmural) and paricardial fat. Isolated tumor nodules within the lung parenchyma, together with the. angiolymphatic Invasion seen in the lung, are best interpreted as metastatic disease. Almost all submitted lymph nodes. are Involved by tumor. Pertinent negatives include the absence of pleural plaques, ferruginous/asbestos bodies. [pT3N1M1 AJCC 7th Ed.). PART 1: LUNG, LEFT LOWER LOBE, WEDGE RESECTION -. MESOTHELIOMA, INVOLVING THE VISCERAL PLEURA. PART 2: PLEURA, PARIETAL, INCISIONAL BIOPSY -. MESOTHELIOMA. PART 3: LYMPH NODE, LEVEL 10, BIOPSY -. MESOTHELIOMA IN SUBCAPSULAR SINUSES. PART 4: LYMPH NODE, LEVEL 11, BIOPSY -. MESOTHELIOMA. PART 5: LYMPH NODE, NEAR INFERIOR PULMONARY VEIN, BIOPSY -. MESOTHELIOMA. PART 6: PERICARDIAL FAT, BIOPSY -. MESOTHELIOMA, FORMING MULTIPLE SMALL FOCI IN ADIPOSE TISSUE. PART 7: DIAPHRAGM FAT, BIOPSY -. MESOTHELIOMA, FORMING ONE SMALL (0.1 CM) IMPLANT IN ADIPOSE TISSUE. PART 8: LUNG, LEFT, EXTRAPLEURAL PNEUMONECTOMY -. A. BIPHASIC MESOTHELIOMA, PREDOMINANTLY EPITHELIOID WITH MINOR SPINDLE CELL COMPONENT,. CIRCUMFERENTALLY AND DIFFUSELY INVOLVING THE VISCERAL AND PARIETAL PLEURA.. a. SURGICAL MARGINS ARE POSITIVE FOR TUMOR AT THE LATERAL PARIETAL AND INFERIOR. PARIETAL PLEURAL MARGINS!. b. BRONCHOVASCULAR MARGINS AR NEGATIVE FOR TUMOR: c. ANGIOLYMPHATIC INVASION is PRESENT. y a. d. PATHOLOGIC STAGE: PT3N1MA (AJCC 7th Ed.). B. METASTATIC MESOTHELIOMA FORMING'ISOLATED PULMONARY NDULES: c. FIVE N1 LYMPH NODES WITH METASTATIC MESOTHELIOMA (5/6). o. NO FERRUGINOUSIASBESTOS BODIES IDENTIFIED ON IRON STAINS OF TWO SECTIONS. E. NO PLEURAL PLAQUE IDENTIFIED. F NON-NEOPLASTIC LUNG SHOWING BRONCHIECTASIS AND BRONCHIOLECTASIS WITHOUT INTERSTITIAL. FIBROSIS. PART 9: DIAPHRAGM, RESECTION -. MSOTHELIOMA, INFILTRATING SKELETAL MUSCLE (NON-TRANSMURAL). COMMENT: Immunohistochemial staining shows tumor cells to be positive for AE1/2, Cam5.2 and focally positive for calretinin,. CK5/6, WT1, D2-40, BerEp4 and CD15. Tumor cells are negative for TAG72, MOC31, monocional CEA, PAX-8, Inhibin, and. TTF-1. Mucin stains-muclcarmine, PASD) are negative. Immunoreactivity for BerEp4 and CD15 is less extensivo than that. for the other mesottiellal markers. The mesothelial markers highlight predominantly the epitheliold component, while the. spindle cell component ruostyl stains with cytokeratin antibodies. A pancytokeratin also stain highilghts the tumar cells. in the level 10 lympri node (Part op: IIA,. CASE SYNOPSIS: SYNOPTIC DATA, PRIMARY MESOTHELIOMA. SPECIMEN: IMA. Pleura. Other; Lung. PROCEDURE: Extrapleural pneumonectomy. SPECIMEN INTEGRITY: Disjupted. SPECIMEN LATERALITI. Left,. TUMOR SITE: Parietal pieura,. 8. Diaphragm. 1. Pericardium. Other Lung. TUMOR FOCALITY: Diffse. HISTOLOGIC TYPE: Biphasic mesothelloma. TUMOR EXTENSION. Confluent viscral pleural tumor (including fissure). Into but not thrbugh diaphragm. Lurg parenchyma. Diffse or multiple foci invading soft tissue of chest wall. Into but not through pericardiura. MARGINS: Margin(s) involved by mesothelioma. Margin(s): Outer soft tissue margin, multifocal. TREATMENT EFFECT: Not-applicable. PATHOLOGIC STAGING (pTNM). pN1. Number examined: 9. Number involved: 8. pM1. Site(s): Lung. ADDITIONAL PATHOLOGIC FINDINGS: None identified. ANCILLARY STUDIES: Immpunohistechemical stain. Histochemical stain(s).",T3,N1,M0,T3N1M0
TCGA-56-7730,"Specimen Information. SURGICAL PANEL. DIAGNOSIS. A) RIGHT PARATRACHEAL LYMPH NODE, EXCISION: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. B) RIGHT PARATRACHEAL LYMPH NODES, STATION 4R LYMPH NODE, EXCISION: 1. Four benign lymph nodes. 2. No evidence of metastatic carcinoma. C) STATION 10R LYMPH NODE, RIGHT CHEST, EXCISION: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. D) THORACIC LYMPH NODE, STATION 11R, EXCISION: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. E) TRACHEOBRONCHIAL ANGLE LYMPH NODE, EXCISION: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. F) LUNG, RIGHT UPPER LOBE, LOBECTOMY: 1. Moderately to poorly differentiated invasive squamous cell. carcinoma forming a mass measuring 6.5 X 4.3 X 3 cm. 2. Tumor infiltrates up to but not within visceral pleura. 3. Focal in-situ and superficially invasive squamous cell carcinoma is. present in the en face section of the proximal bronchial resection. margin. 4. Patchy hemorrhage and post-obstructive pneumonia present in. non-involved pulmonary parenchyma. 5. Ten (10) benign right hilar lymph nodes. Final TNM: pT2bN0M0. stage: IIA. MACROSCOPIC. SPECIMEN TYPE. Lobectomy. TUMOR SITE. Right Lung-Upper Lobe. TUMOR SIZE. 6.5 X 4.3 X 3.0 cm. TUMOR FOCALITY. Unifocal. MICROSCOPIC. HISTOLOGIC TYPE. Squamous cell carcinoma. HISTOLOGICAL GRADE. (moderately differentiated). VISCERAL PLEURAL INVASION. Not identified. LYMPHATIC VASCULAR INVASION. Absent. TREATMENT EFFECT. Not applicable. TUMOR EXTENSION. Not applicable. MARGINS. Margins involved by tumor (Bronchial). PATHOLOGIC STAGING. EXTENT OF INVASION. pT2b. (Tumor greater than 5 cm, but 7 cm or less in greatest. dimension). REGIONAL LYMPH NODES. pNO. (No regional lymph node metastasis). Total nodes: 18. Total positive nodes: 0. N1 nodes: 12. N1 positive nodes: 0. N2 nodes: 6. N2 positive nodes: 0. N2 sites sampled: Station 4: Lower paratracheal nodes. DISTANT METASTASIS. pMO. (No distant metastasis). PATHOLOGIC STAGE Summary. Final TNM: pT2bN0M0. stage: IIA. The pathologic stage presumes no distant metastasis. CLINICAL INFORMATION. History of lung cancer. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Right paratracheal lymph node. The specimen is received fresh from the OR labeled ""right paratracheal. lymph node"" and consists of a 0.3-0.4 cm diameter adipose tissue with a. possible 0.2-0.3 cm lymph node frozen in toto on one block. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Negative for. tumor"" is rendered by. B) SOURCE: Right paratracheal lymph nodes #2 4R lymph node. Received fresh labeled ""right paratracheal lymph node #2 4R lymph nodes"". consists of multiple anthracotic lymph node fragments and fat aggregating. to 3 cm in greatest dimension. The tissue is entirely submitted on two. chucks for frozen section diagnosis. INTRAOPFRATIVE PATHOLOG CONSULTATION WITH FROZEN SECTION: ""Negative"" is. C) SOURCE: Right chest 10 R lymph node. Labeled ""10 R node right chest"" is a 0.6 cm anthracotic apparent lymph. node. The specimen is entirely submitted in one cassette. D) SOURCE: Thoracic 11 R lymph node. Received fresh labeled ""11 R lymph node thoracic"" is a 1.5 cm aggregate of. black anthracotic apparent lymph node fragments in fat. It is entirely. submitted on one chuck for frozen section diagnosis. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Negative"" is. E) SOURCE: Tracheal lymph node bronchial angle. The specimen is received fresh from the OR labeled ""tracheal bronchial. angle lymph node."" It consists of a 1.3 cm in diameter black-red lymph node. sectioned into four pieces and entirely frozen on one block. INTRAOPERATIVE DATHOL nay CONSULTATION WITH FROZEN SECTION: ""Negative"" is. rendered. F) SOURCE: Right upper lobe lung. The specimen is received fresh labeled ""right upper lobe."" It consists of a. tan-pink, 19 x 15 X 5.5 cm portion of right upper lobe. The bronchial. margin is patent and a tan-pink tumor is seen 0.7 cm distal to the margin. There is an intact, 12-cm staple line. The pleural surface is tan-pink and. mottled with a palpable mass seen just superior to the bronchus. This area. is inked blue. The staple line is removed, the specimen is sectioned. Cut. section of the specimen reveals a white lobulated tumor mass corresponding. to that seen at the mainstem bronchus and palpated. There are dilated. airways throughout the specimen that are filled with thick yellow-tan. mucoid material surrounded by tan-pink spongy mildly anthracotic. parenchyma. The tumor measures 6.5 x 4.3 x 3 cm. The tumor is 1.5 cm from. the nearest orange-inked staple line. No additional satellite lesions are. seen. A photograph is taken. Tissue is banked for possible ancillary. studies. The tumor extends to the inked pleural surface but does not. grossly extend through it. The hilum displays a 3-cm aggregate of lymph. nodes. Representative sections are submitted in 14 cassettes as follows: 1. Mainstem bronchus margin. 2. Vascular margin. 3. Closest staple line, no tumor. 4-5. Mainstem bronchus and tumor. 6. Tumor to inked pleura. 7-8. Random tumor. 9-11. Random parenchyma with no tumor. 12-14. Hilar lymph nodes. This case is accessioned in. MICROSCOPIC. A-E) The microscopic appearance substantiates the diagnosis. F) Sections through the right upper lobe tumor mass confirm the presence of. a moderately to poorly differentiated infiltrating squamous cell carcinoma. forming a mass measuring 6.5 cm in greatest dimension. Tumor infiltrates up. to but not within contiguous visceral pleura. An en face section from the. proximal bronchial resection margin demonstrates focal in-situ and. superficially invasive squamous cell carcinoma within bronchial mucosa. The. non-involved pulmonary parenchyma demonstrates areas of post-obstructive. pneumonia and patchy hemorrhage. Ten benign hilar lymph nodes are included. Interpreted at. Lab and Collection. GROSS AND MICROSCOPIC SURGICAL PANEL. Lab and Collection. Information. Result History. GROSS AND MICROSCOPIC SURGICAL PANEL. - Order Result History. Result Date and Time. Provider Status. Lab. Parent Order ID. Child Order ID. Specimen Information. Specimen Source. Other. Audit Trail.",T2,N0,M0,T2N0M0
TCGA-AN-A0FF,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Left Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: OCT. Container: block Type of Procurement: surgery Grade: 2. T Stage: 1 N Stage: 0 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,T1,N0,M0,T1N0M0
TCGA-EW-A1P5,"F. Pathologic Interpretation: A. Sentinel node # 1 count. - Metastatic carcinoma to one lymph node, (0/1). - Metastatic deposit: 0.6 cm. NOTE: Metastatic deposit is only present on permanent slides. B. Sentinel node # 2 count. - No carcinoma seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. C. Right breast 1 short superior, 1 long lateral: - Invasiye and in situ moderately differentiated ductal carcinoma, Nottingham grade 2 (3+2+1), 2.5 cm in greatest. dimension. - Resection margins are free of tumor (closest margin at 1.0 cm: inferior). - Lymphovascular invasion is not present. - DCIS, intermediate nuclear grade without necrosis, cribriform type, present in 2 of 15 slides examined. - See Tumor Summary. Tumor Summary: Specimen: - Total breast. Procedure: - Total mastectomy. Lymph Node Sampling: - Sentinel lymph node. Specimen Integrity: - Single intact specimen. Specimen Laterality: - Right. Tumor Size: - Greatest dimension of largest focus of invasion: 2.5 cm. Tumor Focality: - Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of Tumor: - Skin: Invasive carcinoma does not invade into the dermis or epidermis. - Skeletal Muscle: No skeletal muscle present. Ductal Carcinoma in Situ (DCIS): - DCIS is present: - Extensive intraductal component (EIC) negative. - Size (Extent) of DCIS: - Number of blocks with DCIS: 2. - Number of blocks examined: 15. Architectural Pattern: - Cribriform. Nuclear Grade: - Grade II (Intermediate). Necrosis: - Not identified. Lobular Carcinoma in Situ: - Not identified. Histologic Type of Invasive Carcinoma: - Invasive ductal carcinoma. Histologic Grade: SURGICAL PATHOL Report. - Glandular (Acinar)/Tubular Differentiation: - Score 3: <10 of tumor area forming glandular/tubular structures. - Nuclear Pleomorphism: - Score 2: Cells larger than no9rmal with open vesicular nuclei, visible nucieoli, and moderate variability. in both size and shape. - Mitotic Count: - Score 1. - Overall Grade: - Grade 2. Margins: - Margins uninvolved by invasive carcinoma: Distance from closest margin: 10 mm (Inferior). Lymph-Vascular Invasion: - Not identified. Dermal Lymph-Vascular Invasion: - Not identified. Lymph Nodes: Number of sentinel lymph nodes examined: 2. Total number of lymph nodes examined (sentinei and nonsentinel): 2. Number of lymph nodes with macrometastases (>0.2 cm): 1. Number of lymph nodes with micrometastases (>0.2 mm to 0.2 cm and /or > 200 cells): 0. Number of lymph nodes with Isolated tumor cells (1.2 mm and <200 cells): 0. Size of largest Metastatic deposit: 0.6 cm. Extranodal Extension: Not identified. Method of Evaluation of Sentinel Lymph Nodes: - Hematoxylin and eosin (H&E), one level. - Immunohistochemistry. Ancillary Studies: Estrogen Receptor: Pending. Progesterone Receptor: Pending. Her2/neu FISH: Performed on another specimer. Results: Not amplified (HER2 gene copy <4.0 or ratio < 1.8). Pathologic Staging: Primary Tumor (Invasive Carcinoma) (pT): pT2. Regional Lymph Nodes (pN) Modifier: (sn) pN1a. Distant Metastasis (M): Not applicable. Pathologic Staging: pT2, pN1a, MX. NOTE: Some FDA approval. These clones antibodies are used: are ID5=ER, analyte specific PgR 636=PR, reagents A485-HER2, (ASRs) validated H-11=EGFR, by our leboretory CCH2/DOG9=CMV, (Her 2, Parvo, F39.4. H. pylort, 1=AR and HBcore). HPV by Thase ISH. ASRs AI immunohistochertic are cilinically uselui indicators stains are that used. do. not with require formalin or molecular fixed, paraffin embedded tissue. Detection is by LSAB. The results are read by . pathologist as positive or negative. As the attending pathologist, , attest that I: (1) Exemined the relevent. preparation(s) for the specimen(s); and (4) Renderedithe diagnosis(es). Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. ""B"" Immunohistochemistry for keratin is negative for carcinoma. SURGICAL PATHOL Report. ""C"" The tumor cells are positive for ER and PR and negative for HER-2 by Immunohistochemistry. MD. Intraoperative Consultation. AFS. Sentinel node # 1 count. ) fs: Negative for carcinoma. BFS. Sentinel node # 2 count : fs: Lymph node; negative for tumor. CFS. Right breast 1 short superior, 1 long lateral fs. Inferior margin; negative for tumor (grossly and microscopically 1.0 cm from margin). Superficial margin-negative for tumor (gross and microscopic microscopically 3 cm from tumor). :, MD. Clinical History: Patient is a. I female with right breast cancer. Pre Operative Diagnosis: Right breast cancer, tissue study patient. Specimen(s) Received: A: Sentinel node # 1 count. fs. B: Sentinel node # 2 count : fs. C: Right breast 1 short superior, 1 long lateral fs. Gross Description: A. Received in formalin and labeled ""sentinel node # 1 count. fs"" consists of irregular shaped, adipose tissue fragment,. 1.5 x 1.1 x 0.6 cm. Specimen submitted as follows. 1. Section for frozen. 2&4. The reminders of the specimen in toto. B. Received in formalin and labeled ""sentinel node # 2 count. fs"" consists of irregular shaped, adipose tissue fragment,. 2.6 x 1.8 x 0.5 cm. Specimen submitted as follows. 1. Sections for frozen. 2&3. Reminders of specimen in toto. C. Received in formalin and labeled ""right breast 1 short superior, 1 long lateral fs"" consists of a mastectomy specimen. weighing 6.63 grams and measures 20.0 x 16.0 x 4.0 cm. Specimen is oriented with a short stitch superior and a long. stitch lateral. There is an ellipse of skin present, 10.0 x 5.5 cm the nipple and areola are present. The areola complex. measure 5.0 cm in greatest dimension. The nipple is inverted, distracted and measures 0.7 cm in greatest dimension. For. gross purpose the specimen is inked as follow: Superior resection margin inked blue, inferior resection margin inked. green, medial resection margin inked red, lateral resection margin inked orange, anterior margin inked yellow and. posterior surgical resection margin inked black. Sectioning of the specimen reveals an ill-defined, pale-tan, firm mass, 2.5. x 1.5 x 1.5 cm. This mass is grossly located 1.0 cm from inferior resection margin and 3.0 cm from lateral resection. margin. It is located 2.0 cm from the anterior resection margin and 1.0 cm from the deep resection margin. upon. sectioning the stroma is composed of yellow, lobulated adipose tissue. The firm, white area is closely associated with the. skin. No other lesions are identified. Specimen submitted as follows. 1. Inferior margin for frozen sections. SURGICAL PATHOL Report. 2. Lateral margin for frozen sections. 3. Nipple. 4-6. Sections of mass. 7. Prior biopsy site with clip. 8. Closest deep margin. 9. Mass with skin. 10. Medial margin. 11. Superior margin. 12. lower inner quadrant. 13. Upper inner quadrant. 14. Upper outer quadrant. 15. Lower outer quadrant. ICD-9(s): 196.3 174.8. Anatomic Pathology Consult Report. F. Client: Interpretation: RIGHT BREAST: INFILTRATING DUCTAL CARCINOMA, INTERMEDIATE NUCLEAR GRADE. IMMUNOHISTOCHEMISTRY IS REPORTED TO BE POSITIVE FOR ESTROGEN RECEPTOR AND. PROGESTERONE RECEPTOR (IN THE ORIGINAL LABORATORY). HER2-FISH IS REPORTED TO BE NEGATIVE (IN THE ORIGINAL LABORATORY). NOTE: Some are amalyses spectic reagents (ASRe) by our Inboratury (Her 2 Parvo, H. Thear ASRs are clinically - indicators that - not require FDA appreval Then clanes. IDS-ER. PgR 6J6-PR, 1485-HER2. H.II-EGFR. CCH2DDG9-CMV, F39 4. /-AR and HPV by ISH A# - are ased - formalia - moleculer Delection is by Method The resulte are - tya. patholagiar or - or -. MD. As the pathologiaz, I Offest that I: (4) the relevant. preparation(s) for the speciman(s); and (ii) Rendered the dagnosts(es). Clinical History: Right breast core biopsy from a. female. Specimen(s) Received: SP consult, slides only. Slide(s)/Block(s) Received: RECEIVED 1 SLIDE LABELED.",T2,N1,M0,T2N1M0
TCGA-33-4538,"AL DIAGNOSIS. 1. R4 LYMPH NODE (EXCISION) : ONE (1) LYMPH NODE, NEGATIVE FOR TUMOR. BRONCHIAL MARGIN (EXCISION) : NEGATIVE FOR TUMOR. 3. STATION 5 LYMPH NODE (EXCISION) : ONE (1) LYMPH NODE, NEGATIVE. FOR TUMOR. 4-6. L9, STATION 5, L10 LYMPH NODES (EXCISION) : ONE (1) LYMPH NODE. NEGATIVE FOR TUMOR. LUNG, LEFT UPPER LOBE (LOBECTOMY) : INFILTRATING MODERATELY. DIFFERENTIATED SQUAMOUS CELL CARCINOMA (4.8 CM) INVOLVING THE LEFT. UPPER LOBAR BRONCHUS. TUMOR EXTENSIVELY ERODES THE BRONCHIAL. CARTILAGE AND GROWS INTO THE BRONCHIAL LUMEN AND LUNG. VASCULAR.",T2,N2,M0,T2N2M0
TCGA-BA-A4II,"Diagnosis: A: Pharyngeal wall lesion, posterior, partial pharyngectomy. Tumor histologic type/subtype: squamous cell carcinoma, well. differentiated. Primary site: oropharynx. Size: 2.2 cm. Extent of invasion: Angiolymphatic invasion: not identified. Perineural Invasion: not identified. Bone invasion: not identified. Carcinoma in situ: present, 0.2 cm from the green superior inked. margin. Surgical Margins: Free of tumor: invasive carcinoma comes to. within 0.6 cm of the black medial margin, 0.5 cm of the green. superior margin, 0.8 cm from the lateral margin, and grossly. <0.7 cm from the yellow inferior margin. AJCC PATHOLOGIC TNM STAGE: pT2 pNx. NOTE: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. B: Soft tissue, lateral margin, biopsy. - Benign squamous mucosa and lymphoid tissue. C: Soft tissue, anterior floor of mouth lesion, biopsy. - Benign squamous mucosa. D: Soft tissue, floor of mouth lesion, biopsy. - Invasive squamous cell carcinoma, well differentiated. - Carcinoma extends to inked cauterized margins. E: Soft tissue, posterior margin, floor of mouth lesion, biopsy. - Invasive squamous cell carcinoma with marked cautery artifact. F: Soft tissue, gingiva, biopsy. - Invasive squamous cell carcinoma, well differentiated. Clinical History: -year-old male with throat cancer who presents for radical. pharyngectomy, excision of floor of mouth lesion. Gross Description: Received are six appropriately labeled containers. Container A is additionally labeled ""posterior pharyngeal wall. lesion, stitch is lateral"" and holds a roughly rectangular. shaped piece of tan/pink mucosa oriented as stated above. The. specimen is 3.3 cm from superior to inferior, 2.7 cm from. lateral to medial, and up to 1.3 cm from superficial to deep. The margins are differentially inked lateral edge blue, superior. edge green, inferior edge yellow, and medial and deep margins,. black. On the surface there is a 2.2 X 2.1 cm tan raised soft. somewhat circumscribed lesion. The lesion comes to within 0.5 cm. of the black inked medial margin, green inked superior margin,. and is 0.3 cm from the blue inked lateral margin, and is >0.7 cm. from the yellow inked inferior margin. The specimen is sectioned. from lateral towards medial to reveal that the lesion extends. 0.3 cm into the underlying soft tissue, and to within 0.6 cm of. the black inked deep margin. Block Summary: A1-A2 - Lateral margin, perpendicular. A3-A7 - Sequential sections moving from lateral towards medial. to include superior, inferior, and deep margins, perpendicular. A8 - Medial edge of specimen, en face,. Tumor is submitted to tissue procurement. Container B is additionally labeled ""lateral margin. It holds a. piece of tan glistening mucosa, 2.0 X 0.6 X 0.4 cm. The surgical. margin is inked black. The specimen is serially sectioned. perpendicular to the black inked surface and submitted in block. B1,. Container C is additionally labeled ""anterior margin, floor of. mouth lesion. It holds a 4 X 4 X 4 mm tan soft tissue fragment;. block C1,. Container D is additionally labeled ""floor of mouth lesion. It. holds a 1.6 X 0.6 X 0.4 cm tan/red soft tissue fragment. One. surface is cauterized and inked black. The specimen is sectioned. perpendicular to the black inked surface and submitted in block. Container E is additionally labeled ""posterior margin, floor of. mouth lesion. It holds a 1.0 X 0.4 X 0.4 cm red/tan soft tissue. fragment. One edge is cauterized and inked black. The specimen. is sectioned perpendicular to the black inked edge and submitted. in block E1,. Container F is additionally labeled ""gingiva."" It holds three. pieces of tan soft tissue, 6 X 5 X 4 mm in aggregate. (Block F1,.",T2,N0,M0,T2N0M0
TCGA-85-7843,Case ID. OC ID Gross. Microscopic. Diagnosis. Comme. Description. Description. Details. nts. OpenCli. Lateralit. nica ID. y. LUNG TISSUE CHECKLIST. Left-. upper. Specimen type: Pulmonectomy. Tumor site: Lung. Tumor size: 4.5 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Tumor in main bronchus. Other tumor nodules: Not specified. Lymph nodes: 2/7 positive for metastasis. (Intrathoracical 2/7). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None.,T2,N1,M0,T2N1M0
TCGA-CM-5864,"Clinical Diagnosis & History: CRC of ascending colon. Specimens Submitted: 1: SP: Right colon, partial colectomy. 2: SP: Portion of omentum. DIAGNOSIS: 1. SP: Right colon, partial colectomy. Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Cecum. Tumor Size: Length is 6.5 cm. width is 10 cm. Maximal thickness is 2.0 cm. Tumor Budding: Absent. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Tubulovillous adenoma. Deepest Tumor Invasion: Muscularis propria. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Not identified. Large Venous Invasion: Not Identified. Perineural Invasion: Not identified. Surgical Margins: Free of tumor. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Appendix: Unremarkable. Lymph Nodes: Number with metastasis: 0. Total number examined: 33. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC 7th Edition): pT2 (Tumor invades muscularis propria). Lymph Node Stage (AJCC 7th Edition) : NO (No regional lymph node metastasis). 2. PORTION OF OMENTUM, EXCISION: BENIGN MATURE ADIPOSE TISSUE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1) The specimen is received fresh, labeled ""Right colon"" and consists of a. segment of terminal ileum, cecum with attached appendix and ascending colon. The terminal ileum measures nine cm in length and five cm in circumference. at. the proximal resected margin. The remaining colon measures 24 in length. with a circumference of 8.5 cm at the distal resected margin. The attached. appendix measures six cm in length and averages 0.7 em in diameter. The. appendiceal and intestinal serosa is pink tan and smooth. Focally. hemorrhagic lobulated yellow tan adipose tissue spans the length of the. specimen measuring up to five cm in thickness. The specimen is opened to. reveal a large sessile lesion measuring 6.5 cm in length, 10 cm in width,. and to 2 cm in thickness. The mass is located in the cecum, eight cm from. the proximal margin and 18 cm from the distal margin. Sectioning reveals. probable invasion into the submucosa. There is questionable muscularis. propria invasion and the tumor does not appear to invade through the. muscularis propria. The depth of invasion is 0.2 cm grossly, The remaining. mucosa is tan with normal folds. The attached adipose tissue is thoroughly. examined and all identified lymph nodes are submitted. Representative. sections of the specimen are submitted for permanent sections and for TPS. Summary of sections: P - proximal margin shave. D - distal margin shave. T - tumor. A - appendix representative sections. RS -representative sections. LN - lymph nodes. BLN - bisected lymph nodes. ""LN-trisected lymph node. SLN-one lymph node sectioned. 2) The specimen is received fresh, labeled ""Portion of omentum. "" It. consists of a 16.0 x 11.0 x 0.5 cm portion of lobulated adipose tissue. consistent with omentum. Serial sectioning reveals a lobulated surface. Representative sections are submitted. Summary of sections: o omentum. Summary of Sections: Part 1: SP: Right colon, partial colectomy. Block. Sect. Site. PCs. 1. A. 3. 5. BLN. 10. 1. D. 1. 9. LN. 27. 1. P. 1. 1. RS. 2. 3. SLN. 5. 10. T. 10. 1. TLN. 3. Part 2: SP: Portion of omentum. Block. Sect. Site. PCs. 2. o. 4. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. #1) SITE: LARGE BOWEL. - IMMUNOHISTOCHEMICAL STAINING FOR DNA MISMATCH REPAIR PROTEINS HAS BEEN. PERFORMED PER CLINICAL REQUEST. THE RESULTS ARE AS FOLLOWS: MLH1 : STAINING PRESENT IN TUMOR. MSH2 : STAINING PRESENT IN TUMOR. MSH6. STAINING PRESENT IN TUMOR. PMS2: STAINING PRESENT IN TUMOR. CONCLUSION: IMMUNOHISTOCHEMICAL STAINING FOR THE TESTED DNA MISMATCH REPAIR. PROTEINS IS RETAINED IN THE TUMOR. Some of the immunohistochemistry and ISH tests were developed and their. performance characteristics were determined by the Department of Pathology,. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is. not necessary. These tests are used for clinical purposes. They should not. be regarded as investigational or for research. This laboratory is certified. under the Clinical Laboratory Improvement Amendments of. as. qualified to perform high complexity clinical laboratory testing.",T2,N0,M0,T2N0M0
TCGA-BR-8686,"Case ID. Microscopic. Diagnosis. Description. Details. In leser c?vat?e, there is an. Tumor is invasion. Adenocarcinoma. enlarged ulcerated tumor. into serosa. Tumor is. poorly-. occupying lumen, with. composed of cords. differentiated,. 10x8x3cm in size, firm and. or trabeculae or. infiltrating. gray surface. arranging in diffuse. serosa. or adenoids. Mitotic. index is present. Nuclei are. hyperchromatic and. irregularly enlarged. and prominent. nucleoli. Cytoplasm. are scant and. eosinophilic. Stroma. is invasion of. prominent. lymphocytes. Comments. ICA ID. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Antrum. Tumor size: 10 X 8 x 3 cm. Tumor features: Ulcerated. Histologic type: Tubular. adenocarcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Serosa (visceral. peritoneum). Lymph nodes: 2/2 positive for. metastasis (Adjacent lymph node. 2/2). Lymphatic invasion: Present. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.",T4,N1,M0,T4N1M0
TCGA-50-5072,"FINAL DIAGNOSIS;. PART 1: LYMPH NODE, LEVEL 10 LYMPH NODE, BIOPSY -. ONE (1) OF ONE (1) LYMPH NODE WITH METASTATIC ADENOCARCINOMA WITH EXTRACAPSULAR. EXTENSION. PART 2: LYMPH NODE, LEVEL 5 LYMPH NODE, BIOPSY -. ONE (1) OF ONE (1) LYMPH NODE WITH METASTATIC ADENOCARCINOMA WITH EXTRACAPSULAR. EXTENSION. PART 3: LYMPH NODE, LEVEL 11 LYMPH NODE, BIOPSY -. ONE (1) OF ONE (1) LYMPH NODE WITH METASTATIC ADENOCARCINOMA. PART 4: BONE, ""PORTION OF FOURTH RIB"", RESECTION -. SPECIMEN UNDERGOING DECALCIFICATION. ADDENDUM REPORT TO FOLLOW. PART 5: LYMPH NODE, ""LEVEL 11 LYMPH NODE #2"", BIOPSY -. ONE (1) OF FIVE (5) LYMPH NODES WITH METASTATIC ADENOCARCINOMA. PART 6: LUNG, LEFT UPPER LOBE, LOBECTOMY -. A. POORLY-DIFFERENTIATED ADENOCARCINOMA, SOLID AND ACINAR TYPE WITH CLEAR CELL CHANGE. ASSOCIATED WITH VISCERAL PLEURAL AND ANGIOLYMPHATIC INVASION WITH LYMPHANGITIC SPREAD. ADJACENT TO TUMOR. DIAMETER 4.5 CM. ALL MARGINS FREE. MILD HOST LYMPHOCYTIC RESPONSE. PATHOLOGIC STAGE: ypT2 N2 M0. B. SIX (6) OF EIGHT (8) N1 LYMPH NODES POSITIVE FOR METASTATIC ADENOCARCINOMA. C. RESPIRATORY BRONCHIOLITIS WITH EMPHYSEMATOUS CHANGE.",T2,N2,M0,T2N2M0
TCGA-AN-A0FV,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Right Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: Frozen. Container: cryomold Type of Procurement: Radical mastectomy Grade: 2. T Stage: 2 N Stage: 0 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,T2,N0,M0,T2N0M0
TCGA-77-8138,"See supplementary report below,. HISTORY. (R) upper lobectomy. NSCLC. MACROSCOPIC. One specimen received. The specimen is labelled ""left upper lobe"" and consists of a lobe of lung. measuring 152 X 90 x 40 mm. There is an obvious tumour mass within the. specimen and there is puckering of the overlying pleura. There is fat adherent. to the pleura in this area. Sectioning the specimen reveals a large tumour. mass measuring 50 x 34 X 50 mm in maximal extent. There is prominent. cavitation of this tumour centrally. The adjacent lung is unremarkable. No. endobronchial lesions are seen. [1A, bronchial resection margin; 1B-1C,. peribronchial lymph nodes; 1D-1F, RS of tumour with pleura; 1G, uninvolved. lung.]. A. MICROSCOPY. Sections show a moderately to poorly differentiated squamous cell carcinoma. N. with extensive central necrosis. There is invasion of the pleura but not of. A. overlying chest wall fat, and soft tissue resection margins are clear of. malignancy. Vascular invasion is identified but no lymphatic permeation is. T. seen and no perineural infiltration is found. Peribronchial lymph nodes show. no evidence of metastatic carcinoma. The bronchial resection margin is well. O. clear of malignancy and shows no evidence of squamous metaplasia or dysplasia. M. Distant lung parenchyma shows emphysema while lung parenchyma adjacent to the. tumour shows organising obstructive pneumonitis. I. C. SUMMARY. Right upper lobectomy: A. Moderately to poorly differentiated squamous cell carcinoma, 50 mm in diameter. Pleural and vascular invasion present. L. No lymphatic or perineural invasion found. No lymph metastases. Pathological stage T2 NO. P. A. T. H. O. CC: Lung Cancer Registry. L. SUPPLEMENTARY REPORT. O. G. Y. Please note that the specimen was a left upper lobectomy, as indicated on the. specimen container, not a right upper lobe as stated on the request slip. SUMMARY. Left upper lobectomy: Moderately to poorly differentiated squamous cell carcinoma, 50 mm in diameter. Pleural and vascular invasion present. No lymphatic or perineural invasion found. No lymph metastases. Pathological stage T2 NO. A. N. P. Y.",T2,N0,M0,T2N0M0
TCGA-G3-A6UC,"CONFIDENTIAL. Demographics (for. verification purposes). Sex: M. Collected Date/Tir. Received Date/Time. Specimen Description. A. Gallbladder at. B. Liver segment 6 at. Clinical Information. Cirrhosis secondary to ETOH with likely HCC. Diagnosis. A. Gallbladder: Cholelithiasis. B. Liver segment 6: Chronic hepatitis, mild. Cirrhosis, micronodular. Hepatocellular carcinoma, moderately differentiated, solid variant,. 2.5 cms in the greast dimension, with metastases to the portal veins. and intrahepatic metastases. Tumor 0.3 cm away from the resection margin. Verified: Gross Description. Received are specimen containers A to B. All requisitions and specimen containers are. labelled with the patient's name,. The cassettes and AP identifiers are. labelled with the Surgical Number. A. Specimen is received fresh. The container is designated ""A. Gallbladder"". The. specimen consists of a congested intact gallbladder measuring 11.0 x 3.5 x 3.5 cm. The. serosal surface is smooth and glistening. Opening reveals the gallbladder to be filled. with green bile. Also found in the gallbladder are five black irregular calculi ranging. from 0.4 cm up to 1.5 cm in greatest dimension. The mucosal surface is dark green, rough. and the gallbladder wall averages between 0.1 to 0.2 cm in thickness. Found at the neck. and near the cystic duct are two firm palpable nodules within the adipose tissue, the. first measuring 1.0 cm, the other 1.5 cm in greatest dimension. Sections are as follows: A1. - three sections of gallbladder. A2. - the smaller node bisected. A3. - the larger node bisected. B. Specimen is received fresh. The container is designated ""Liver segment 6"". The. specimen consists of a portion of liver weighing 50.8 g and measuring 6.5 x 5.0 x 2.5 cm. The liver capsule is nodular and the surgical resection margin has been inked blue. Sectioning reveals a green circumscribed mass measuring 2.5 x 2.3 x 2.5 cm. Adjacent. to. the green circumscribed mass is a hemorrhagic circumscribed mass measuring 1.0 x 1.0 x. 1.0 cm. The green mass comes within 0.3 cm of the blue painted surgical resection margin. and the hemorrhagic mass 0.1 cm to the blue painted surgical resection margin. The green. mass comes with less than 0.1 cm of the liver capsule and the hemorrhagic mass comes. within 0.7 cm of the liver capsule. Sections are as follows: B1. - section of the green mass and its relationship to the liver capsule. B2. - section of the green mass and its relationship to the blue painted surgical. resection margin. B3. - hemorrhagic mass with a portion of the adjacent green mass and the relationship. to the blue. painted surgical margin. B4. - further section of hemorrhagic mass and relationship to blue painted surgical. resection margin. Please note that upon sectioning of the hemorrhagic mass, it is found to have a. cut surface. which is granular and the substance easily pulls out of the. circumscribed area, query blood. vessel. B5. - representative section of liver parenchyma. Encounter Number. Patient Location.",T3,N0,M0,T3N0M0
TCGA-ZF-A9R1,"Reporting pathologist(s): CONSULTANT. (TYPE UNSPECIFIED) Collected. HISTOLOGY. HISTOLOGY. SPECIMEN. A - Bladder & prostate. B - Peri-bladder nodes. C - Right external iliac node. D - Right anterior obturator node. E - Right posterior obturator node. F - Left external iliac node. G - Left anterior obturator node. H - Left posterior obturator node. I - Left ureteric margin. J - Right ureteric margin. CLINICAL DETAILS. Radical cystoprostatectomy for G3 pT2 TCC diagnosed at. MACROSCOPY. A - Cystoprostatectomy specimen with bladder approximately 50 mm in. diameter, attached adipose tissue 112 mm x 60 mm. Prostate measuring. 35 mm supero-inferiorly x 45 mm lateral x 28 mm anterior-posterior. Opened for research sampling. The right side of the bladder has an indurated and ulcerated area. measuring 20 mm maximum with associated pale firm tumour extending. into adjacent adipose tissue and coming close to the anterior and. right surgical margin (blue ink). Elsewhere bladder mucosa appears. normal. The prostate shows a minor degree of nodular hyperplasia. Blocks: Al = urthra RM; A2 = left side prostate; A4,5, 6 & 7 =. composite slices of tumour; A8 = tumour; A9 & A10= right side bladder. (composite); All = apex; A12 = anterior and left; A13 = bladder neck. B - Adipose tissue 60 mm, containing ? 3 LNs. Two of them are dense. and white with tumour, max size 9 mm. 1 LN per cassette. C - Two pieces of adipose tissue, together measuring 65 mm, containing. a LN. Blocks: C1&C2=1LN. D - Fatty tissue measuring 40 mm, containing 1 large and 1 small LN. Blocks: D1 = small LN; D2 & D3 & D4 = large LN. E - Fatty tissue measuring 60 mm, containing ?2 LNs. F - Fatty tissue measuring 50 mm, containing 2 LNs. Blocks: F1 = 1 LN; F2 & F3 = 1 LN. G - Fatty tissue measuring 60 mm, containing 2 LNs. H - Fatty tissue measuring 40 mm, containing 2 LNs. I - 5 mm length of ureter. J - 9 mm length of ureter. MICROSCOPY. A - Bladder and prostate: Sections from the macroscopically. identified lesion confirm a poorly differentiated predominantly solid. urothelial carcinoma extending with discohesive clusters the entire. thickness of the bladder wall into the perivesical fat. The tumour. extends to less than 1 mm of the circumferential surgical resection. margin on the right side which is composed of compressed soft tissue. There is no lymphocytic infiltrate at the tumour host interface. Sections away from the main tumour mass contain foreign body-type. multinucleated giant cell aggregates in the lamina propria indicative. of site of previous biopsy. Lymphovascular invasion is noted. There is no perineural invasion. The adjacent urothelium does not show evidence of dysplasia or. carcinoma in situ. There is tumour and ulceration. Sections of the prostate confirm high grade PIN but there is no. evidence of microacinar adenocarcinoma. Some of the acinar structures. contain a chronic inflammatory cell infiltrate with an occasional. giant cell and is most likely to represent reaction to BCG. The. urothelium included does not show any evidence of dysplasia, carcinoma. in situ or a papillary urothelial carcinoma. The urethral surgical margin is within morphologically normal limits. B. - Peri-bladder nodes: Two lymph nodes, both with metastatic. urothelial carcinoma. One node shows extracapsular extension. C - Right external iliac node: One lymph node without metastatic. carcinoma. D - Right anterior obturator nodes: Two lymph nodes with florid sinus. hyperplasia. No metastatic carcinoma. E - Right posterior obturator nodes: Two nodes without metastatic. carcinoma. F - Left external iliac nodes: Two lymph nodes with sinus. hyperplasia. No metastatic carcinoma. G - Left anterior obturator nodes: Two lymph nodes with no metastatic. carcinoma. H - Left posterior obturator nodes: Two lymph nodes with no. metastatic carcinoma. I - Left ureteric margin: This is morphologically normal ureter. J - Right ureteric margin: This is morphologically normal ureter. SUMMARY (Parts A - )) -. Poorly differentiated ulcerated urothelial carcinoma pT3b pN1 R0 (but. close circumferential margin on the right side).",T3,N1,M0,T3N1M0
TCGA-85-A50Z,Gross Description: Microscopic Description: Diagnosis Details: Comments: Formatted Path Reports: LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 6.5 x 5.5x5.5cm. Histologic type: Squamous cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 0/6 positive for metastasis (0/6). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Right-upper. has 11/8/12 Yes. Criteria. Pima-y Torne: Site Discrupanny. Discrepancy. Malignancy Histon. Cont/Fyncry onous Primary listed. Cisa is. VALIFIED. Coin classed: Reviewer.,T2,N0,M0,T2N0M0
TCGA-BR-A4J9,"Gross Description: Stomach with the plate-like tumor up to 7 X 6.5 cm in size, with invasion into the. muscle layer. Fatty tissue of the greater and lesser curvature and omentum are of normal structure. Microscopic Description: Adenocarcinoma of the stomach, G-3, with intra-and extracellular mucin. production, with invasion of the whole wall thickness. Fatty tissue of the greater and lesser curvature. and omentum demonstrates hyperemia. Diagnosis Details: Tumor Features: Ulcerated, Tumor Extent: Subserosa, Venous Invasion: Absent,. Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: STOMACH TISSUE CHECKLIST. Specimen type: Subtotal gastrectomy. Tumor site: Antrum. Tumor size: 6.5 X 0 x 7 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Subserosa. Lymph nodes: 0/10 positive for metastasis (Greater and lesser curvature and omentum 0/10). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T3,N0,M0,T3N0M0
TCGA-A6-A5ZU,"Final Surgical Pathology Report. Procedure : Diagnosis. Colon, ileocolectomy: Moderately differentiated adenocarcinoma of the transverse colon. invasive through muscular wall into attached greater omentum (pT3). Metastatic adenocarcinoma in 1 of 60 lymph nodes (pN1). Extranodal tumor present. Serosal adhesions. Appendix with serosal adhesions. Resection margins negative. Microscopic Description: Microscopic examination performed. Histologic type: Adenocarcinoma, not otherwise specified. Histologic grade: Moderately differentiated. Primary tumor (pT) : Invasive through muscularis propria of transverse. colon into attached greater omentum (pT3). Proximal margin: Negative. Distal margins : Negative. Circumferential (radial) margin: Negative. Distance of tumor from closes margin: 8 cm from distal margin. Vascular invasion: Not identified. Regional lymph nodes (pN) : One 60 lymph nodes is positive for. metastatic tumor (pN1). Non-lymph node pericolonic tumor: Present. Distant metastasis (pM) : Not applicable (pMX). Other findings: Serosal adhesions. Clinical obstruction. Appendix. with serosal adhesions. No specific additional pathologic. abnormalities identified the colon or the ileum. MSI testing: Ordered on block A2. Pathologic stage T3N1 IIIB. Specimen. Right hemicolectomy. Clinical Information. Transverse colon cancer with clinical obstruction. Gross Description. Received fresh labeled ""right hemicolectomy"" is a previously unopened. 40 cm segment of proximal right colon with attached 15 cm of distal. ileum and an abundant amount of attached mesocolon, mesentery, and. omentum. An unremarkable 9 cm appendix averaging 0.5 cm in diameter is. present. The proximal and distal margins measure 5.2 and 7.8 cm in. circumference respectively. On opening, there is a circumferential,. 6.0 x 3.9 cm rubbery tan-white-red tumor mass which is 8 cm from the. distal margin. On sectioning, the tumor has a maximal thickness of 2. cm, grossly extending through the muscularis and into the attached. mesocolon. The tumor is present within 0.2 cm of the inked free radial. serosal surface and visually appears to extend into the attached. omentum. A 3 cm in greatest dimension area of tan red discoloration is. noted within the distal ileum, 5 cm proximal to the ileocecal valve. The remaining ileal and colonic mucosa is unremarkable tan-pink with. regular folds and the walls average 0.5 cm. A portion of tumor and a. portion of normal colonic mucosa are submitted for tissue procurement. as requested. Multiple soft to slightly rubbery tan-pink tissues in. keeping with lymph nodes measuring up to 1.3 cm are recovered from the. attached mesocolon and mesentery. RS 21. Summary: 1 - margins, 2 through 4 - tumor to inked free radial serosal. surface (cassettes 3 and 4 including attached omentum), 5 and 6 -. central tumor, 7 - discolored area of ileum, 8 - ICV, 9 and 10 the. random from remainder of colon, 11 - appendix, 12 through 18 - 8 lymph. nodes per cassette, 19 - 6 lymph nodes, 20 and 21 - 1 bisected lymph. node per cassette.",T3,N1,M0,T3N1M0
TCGA-AG-A023,"Diagnosis: Preparation I) is an invasive colonic adenocarcinoma type of carcinoma, of moderate. differentiation, G2,. with infiltration of all parietal layers, pT3,. invasions of lymph and blood vessels (L1, V1),. and also substantial concomitant inflammation. As regards the lymph nodes, there are also sox sections of lymph node metastases of the. carcinoma described (pN2),. in the attached segment there is a squamous epithelial mucosa that is infiltrated by a. tumor from the outside,. as regards the resection margins of the mucosa and the ligature area, the tumor was. completely removed. Preparation II) comprises smooth muscle fiber elements, possibly from the area close to. the tubes, with further extensive portions of the carcinoma. Preparation III) comprises regular anastomosis rings, in this case of the cryptic. epithelium type with attached submucosa and muscularis.",T4,N2,M1,T4N2M1
TCGA-V4-A9EA,"Left eye enucleation. Macroscopy. The enucleation specimen contains a fragment of optic nerve of 12 mm. There is no visible. extrascleral extension. Samples have been made for cryo preservation and for xenografts.The. specimen has been then included entirely. Microscopy. Analysis of the specimen shows an intraocular tumor which morphological characteristics are. those of a melanoma. The lesion is composed of fusiform cells. The pigment content is. moderate. The mitotic index is low (less mitosis by field at the 40 magnification.) There are no. necrosis. The lesion is implanted at the posterior pole, covering the emergence of the optic. nerve. It measures 13 mm at the basis with 7 mm of thickness. It stays distant from the ciliary. processes. At the posterior pole, the optic foramen, the optic nerve and the meningeal sheaths. are free. The cut end of the optic nerve is also free. Conclusion. Choroidal melanoma with fusiform cells. Size of the tumor: 10 mm. Neither involvement of the sclera nor extrascleral extension. Ciliary processes, optic foramen and optic nerve are free.",T4,N0,M0,T4N0M0
TCGA-91-6835,"Final Pathologic Diagnosis: A: Lymph node, 4R subcarinal, resection: Eight benign lymph nodes. B: LUNG, Resection: Specimen: Right Lung; Lower lobe of lung;. Procedure: lobectomy. Specimen laterality: Right. Tumor site: Right lower lobe. Specimen integrity: Intact. Tumor size (greatest dimension): 2.4x 2.4cm. Tumor focality: Unifocal. Tumor histologic type: Adenocarcinoma. Tumor grade: Moderately differentiated. Visceral pleura invasion: Present. Tumor Extension: Not identified. Margins: Bronchial: Uninvolved by invasive carcinoma. Vascular: Uninvolved by invasive carcinoma. Parenchymal: Uninvolved by invasive carcinoma. Parietal pleural: Not applicable. Chest wall: Not applicable. Other attached tissue margin: Not applicable. If all margins uninvolved by invasive carcinoma: Distance of invasive carcinoma from closest margin: less than 1mm. Specify margin: visceral pleura. Treatment effect: Not applicable. Lymph-vascular invasion: Not identified. Pathologic staging (pTNM): TNM Descriptors: none. Primary tumor: pT. Regional lymph nodes: pNO. Number examined: 14. Number involved: 0. Distant metastasis: pMX. Additional pathologic findings: Emphysematous changes in uninvolved. lung parachyma. C: Lymph nodes, #9 inferior pulmonary, excision: Two benign lymph nodes. D: Lymph nodes, lower paratracheal, excision: Four benign lymph nodes. The examination of this case material and the preparation of this report were. Signing Location: Gross Description: Received are three specimen containers, each labeled with the patient's name,. "". Part A is received in formalin additionally labeled ""subcarinal lymph node"" and. consists of multiple red-brown nodular portions of soft tissue, some of which. have a gray-black tinge, grossly consistent with probable anthracotic pigment. Sectioning of the tissue reveals at least eight probable lymph nodes, which. range from 0.6 to 1.5 cm in greatest dimension. These lymph node candidates are. submitted as follows: A1. four whole probable lymph nodes;. A2. three whole probable lymph nodes;. A3. remaining soft tissues with possible additional lymph node for. microscopic analysis. This specimen has been submitted in its entirety. Part B is additionally labeled ""right lower lobe"" and consists of a lobe of lung. with overall dimensions of 15 X 10.2 X 2.2 cm. The pleural surface is. purple-tan to pink-gray with focal gray-black pigmentation. The specimen is. received with a portion of black ink along one side. There are multiple staple. lines present without designation. Additional sectioning reveals a gray-tan to. red-brown, firm, well circumscribed, focally degenerative mass with overall. dimensions of 2.4 X 2.4 X 2.1 cm. This mass is approximately 3 cm from the. bronchial margin of resection. Also this mass corresponds to the overlying. inked pleural surface. The remaining lung parenchyma is red-brown to pink-tan. and spongy. Representative sections are submitted as follows: B1. vascular and bronchial margin;. B2. possible lymph node adjacent to bronchial margin;. B3-6. sections of mass;. B7,8. uninvolved lung parenchyma. Part C is received additionally labeled ""inferior pulmonary ligament"" and. consists of a single nodular portion of tan-yellow soft tissue, containing two. probable lymph nodes, having greatest dimensions of 0.5 and 0.8 cm. These. tissues are submitted entirely in cassette C. Part D is received additionally labeled ""4R lower paratracheal lymph node"" and. consists of a single nodular portion of red-brown nodular soft tissue, which is. 5 mm in greatest dimension. This tissue is submitted in toto in cassette D. Microscopic Description: The final diagnosis of each specimen incorporates the microscopic examination. findings.",T1,N0,M0,T1N0M0
TCGA-BH-A18M,"PATIENT HISTORY: nnDATE of LMP: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: LEFT BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: LEFT MOD. RADICAL MASTECTOMY, TRAM. CLINICAL HISTORY. MATERIAL SUBMITTED: LEFT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. & axillary contents. INTRAOPERATIVE CONSULTATION: Skin: 6.0 by 4.5 cm. Overall breast: 17.0 by 24.0 by 5.0 cm. Tumor mass: 2.5 by 2.0 by 3.5 cm. Close to. anterior margin. Possible tumor approximately 1.0 cm close to inferior margin. ADDENDA: Addendum. HER-2/neu AMPLIFICATION ANALYSIS (FISH). AS PER THE REQUEST OF FLUORESCENCE IN SITU HYBRIDIZATION (FISH) WAS PERFORMED ON SURGICAL. CANCER) USING THE VYSIS DNA PROBE FOR THE HER-2/neu GENE. - (BREAST. CHROMOSOME 17 CENTROMERE SIGNALS WAS DETERMINED TO BE 2.05. A RATIO OF 2.0 OR GREATER IS CONSIDERED. THE RATIO OF HER-2/neu SIGNALS TO. AMPLIFIED; THEREFORE, THIS SPECIMEN IS AMPLIFIED,. Addendum. MATERIAL SUBMITTED: BLOCK ""A2"" FOR ER/PR AND HER-2/NEU (BREAST CANCER). FINAL DIAGNOSIS: ESTROGEN/PROGESTERONE RECEPTORS AND HER-2/NEU PERFORMED ON LEFT BREAST TISSUE. ESTROGEN RECEPTOR 20%; 1+ 30%; 2+ 30%; 3+ 20%) HSCORE OF 150. ESTROGEN RECEPTOR IS INTERPRETED AS. POSITIVE. PROGESTERONIE RECEPTOR (0- 10%; 1+ 10%; 2+ 20%; 3+ 60%) HSCORE OF 230. PROGESTERONE RECEPTOR IS INTERPRETED. AS POSITIVE. HSCORE: <= 15 NEGATIVE. > 15 <= 30 BORDERLINIS. > 30 POSITIVE. HER-2/NEU - DAKO HERCEPTEST: A WEAK TO MODERATE COMPLETE MEMBRANE STAINING IS OBSERVED IN MORE THAN 10% OF. THE TUMOR CELLS. HER-2/NEU IS INTERPRETED AS WEAKLY POSITIVE (SCORE 2+). NOTE: Hor-2/Neu FISH was ordered. The Her-2/NEU and estrogen assays were performed with FDA approved. methods. The progesterone receptor. immunoperoxidase test used in this case has been devaloned and the performance characteristics determined by. the Department of Pathology at. They have not been cleared. or. approved by the U.S Food and Drug Adinistration. HSCORE is modified from: Estrogen Receptor Analysis, Arch. Pathol Lab Med 1985; 109:716-721. My signature is attestation that I have personally reviewed the submitted material(s) and the final. diagnosis reflects that evaluation. FINAL DIAGNOSIS: FINAT. DIAGNOSIS: LEFT BREAST AND AXILLARY CONTENTS. - INFILTRATING MULTIFOCAL AND MULTICENTRIE-DUCTAL CARCINONA WITH FOCAL LOBULAR FEATURES, 2.5 BY 2.0 BY 3.5. CM, NOTTINGHAM SCORE 6/9 (TUBULES 3, NUCLEI 2, MITOSIS 1) WITH DUCTAL CARCINOMA IN-SITU, NON-COMEDO WITH. CENTRAL NECROSIS AND CRIBRIFORM TYPE. - DUCTAL CARCINOMA IN-SITU REPRESENT APPROXIMATELY 20% OF THE TUMOR VOLUME. - FIBROCYSTIC CHANGES. TWO (2) SEPARATE NODULE OF INFILTRATING DUCTAL CARCINOMA ARE PRESENT IN THE LOWER INNER QUADRANT, 0.8 CM,. AND UPPER INNER QUADRANT, 0.5 CM. - TUMOR IN THE LOWER INNER QUADRANT IS WITHIN 1.0 MM FROM THE MARGIN OF RESECTION. - ALL MARGINS OF RESECTION ARE FREE OF TUMOR. - FOUR OF SIX (4/6) LYMPH NODES ARE POSITIVE FOR METASTATIC TUMOR. - TWO (2) LYMPH NODES SHOW EXTRACAPSULAR SPREAD. - THREE (3) SMALL FIRM NODULES SIMULATING LYMPH NODES IN THE AXILLARY CONTENTS SHOW INFILTRATING DUCTAL. CARCINOMA. NOTE: ER/PR immunoperoxidase assay and Her-2/NEU testing will be performed on block ""A2"".",T3,N1,M0,T3N1M0
TCGA-L5-A8NM,"OPER DATE: REQ DOC: PROCEDURE: rear-old with chest pain and dysphagia. Clinical Diagnosis: Positive adeno. of the CEGA, J-tube, esophagoscopy. PROCEDURE: 1. ""Left cervical mass."" A 2 x 1.5 x 0.8 cm tan-red soft tissue nodule with. glistening lobular tan parenchyma. Bisected. 1A. Frozen section control. 18. Rest of specimen. 2. ""Esophagus."" Received in formalin in a large container is a 6.1 cm long,. 3.2 cm wide and approximately 0.6 cm deep. Esophagus is attached to a 7 x 4 x. 3 cm portion of stomach and attached fibroadipose tissue. The esophageal. mucosa is pink to grey and folded. At the gastroesophageal junction is a 2 x 2. cm firm, white-tan, ulcer. This lies 5 cm from the esophageal margin and 2 cm. from the gastric margins of resection. The radial margin is inked black. The. rest of the gastric mucosa is tan-brown with appropriate rugae. Cut sections. reveal a white-tan tumor which abuts the inked black radial margin. At this. point, the tumor is 0.7 cm thick. At least two lymph nodes are identified in. the paraesophageal fat up to 1.5 x 1.1 x 0.6 cm. 2A through 2E. Tumor and escohaaus. 2F. Tumor to stomach. 2G. Gastric margin of resection. 2H. Possible Lymph node. 21 & 2J. One bisected Lymph node each. 3. ""Proximal cervical esophageal margin."" Received in formalin in a smal l. container is a 1 cm length of proximal esophagus, 1.5 x 1.5 cm. Surgical. staples present. 4. ""Paraesophageal Lymph node. Received in formalin in a small container is. a. 0.5 cm tan bit. 5. ""Celiac assess Lymph node."" Received in formalin in a small container is. a. 1 x 0.8 x 0.5 cm tan-white lymph node. FROZEN SECTION REPORT: Hyperplastic thyroid tissue with macro follicles. PREVIOUS DIAGNOSIS INQUIRY. 3. REPORT DATE: SEX: F. PATIENT NBR: ADM DATE: BIRTHDATE: REQ DOC: OPER DATE: have reviewed and interpreted the frozen section material. at the time it was requested. Permanent sections confirm frozen section report. PROCEDURE: ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: Type of carcinoma: Adenocarcinoma. If adenocarcinoma, it is arising in: GE junction. Depth of invasion: Muscularis propria. Number of positive lymph nodes: 1/5. Extranodal metastasis: Unknown. Pattern of invasion: Expansile. Esophageal and gastric resection margins involved: No. Deep resection margin involved: No. TNM classification: T2 N1 Mx. PROCEDURE: 2 & 3. Esophagus, resection: Adenocarcinoma arising at the GE junction. surgical margins free. Please see template for details. 4. Paraesophageal soft tissue, excision: Skeletal muscle. No lymph node. present. 5. Celiac Lymph node, excision: One Lymph node negative for metastatic. carcinoma. 1. Soft tissue of left cervix, excision: Hyperplastic thyroid tissue. PREVIOUS DIAGNOSIS INQUIRY. 4. REPORT DATE: SEX: F. PATIENT NBR: ADM DATE: BIRTHDATE: REQ DOC: OPER DATE: the signing staff pathologist, have personally examined and. interpreted the slides from this case. Code: END OF PREVIOUS DIAGNOSIS INQUIRY.",T2,N1,M0,T2N1M0
TCGA-A7-A3RF,"Final Surgical Pathology Report. Procedure: Diagnosis. A. Left axillary sentinel nodes, excision: 2 lymph nodes negative for. metastatic disease, 0/2. B. Left breast mass, excision: Invasive mucinous carcinoma, Elston SBR. grade 2. Tumor is less than 1 mm from the deep margin and at least. extremely close to the lateral margin. C. Pectoralis fascia, excision: Adipose tissue and skeletal muscle. present. Mucinous carcinoma present in the adipose tissue at the inked. medial margin of resection. Microscopic Description: A. 2 sentinel nodes are present examined in their entirety at multiple. levels. They are both negative for metastatic disease, 0/2. B. This excision discloses invasive mucinous adenocarcinoma. Of note,. it has a higher nuclear grade the usual mucinous carcinoma. Also,. particularly in block #5, there was a suspicion for lymphatic invasion. This is considered not to be the case, however, based on stains for. D240 and CD34. The negative staining for p63 also helps to exclude in. situ tumor. Please see the template below: Invasive Carcinoma: Histologic type: Invasive mucinous carcinoma. Histologic grade: Elston SBR grade 2. Overall grade: Architectural score: 2. Nuclear score: 3. Mitotic score: 1. Greatest dimension (pT): 3.7 cm, pT 2. Specimen margins: Tumor is present less than 1 mm from the. deep margin and at least extremely close to the lateral margin. Vessel invasion: Negative. Calcification: Rare. Description of non-tumorous breast: No significant pathology. Comments: Attached skin negative for tumor. Prognostic markers: Previously performed. C. Microscopic examination performed. Specimen. A. Left axillary sentinel node. B. Left breast mass, long anterior, short superior. C. Pectoralis/posterior, long anterior short superior. Clinical Information. PRE-OP DIAGNOSIS: Left breast cancer. HISTORY: -year-old white female with left mucinous breast cancer. Gross Description. A. Received fresh labeled ""left axillary sentinel node"" are 2 soft tan. gold-pink tissues averaging 1.8 cm in greatest dimension. The. specimens are bisected and entirely submitted independently in. 2. blocks. B. Received fresh for tissue procurement within a. container. labeled ""left breast mass"" is a 7.5 cm (medial to lateral) by 5.0 cm. (superior to inferior) by 4.2 cm (anterior to posterior) soft,. lobulated tan gold-white portion of fibroadipose tissue with 2 sutures. as stated previously. A 2.7 x 1.3 cm wrinkled tan-white portion of. skin is present along the anterior aspect. The margins are inked as. follows: Anterior blue, posterior black, superior green, and inferior. orange. The specimen is sectioned from medial to lateral. There. is. a. well-circumscribed, 3.7 cm (medial to lateral) by 3.2 cm (superior to. inferior) by 2.7 cm (anterior to posterior) rubbery tan white mucinous. tumor mass within the lateral half of the specimen. A portion of tumor. and a portion of normal parenchyma are submitted for tissue procurement. as requested. The tumor focally extends to within less than 0.1 cm of. the inked posterior margin. Several cylindrical tan-white structures. in keeping with those associated with needle core biopsy are present. The remaining cut surfaces consist predominantly of soft, lobulated tan. gold adipose tissue with a scant amount of interspersed delicate. Fan-white fibrous tissue. Summary: 1 - perpendicular sections medial margin, 2 through 9 -. sequential sections, 10 - perpendicular sections lateral margin. Specimen is fixed at. C. Received fresh labeled ""pectoralis fascia posterior"" is a 3.0 cm. (superior to inferior) by 2.5 cm (medial to lateral) by 0.7 cm anterior. to posterior) soft, lobulated tan gold-white portion of fibroadipose. tissue with 2 sutures as stated previously. The margins are inked as. follows: Anterior blue, posterior black, medial green, and lateral. orange. The specimen is sectioned from superior to inferior. The cut. surfaces consist predominantly of soft, lobulated tan gold adipose. tissue with a scant amount of interspersed delicate tan-white fibrous. tissue. No residual mass lesion or abnormality is identified grossly. Summary: 1 - perpendicular sections superior margin, 2 through 4. sequential sections, 5 - perpendicular sections inferior margin. Specimen is fixed at.",T2,N0,M0,T2N0M0
TCGA-JY-A6FD,"F. Facility: Specimen(s) Received. 1. Lymph-Node: ST10L TB Angle. 2. GE Resection: proximal stomach and total thoracic esophagus. 3. Esophagogastric Resection: Final esophageal margin. 4. Stomach Resection: Final gastric margin. Diagnosis. 1. Lymph-Node: ST10L TB Angle: - lymph node x1: negative for malignancy. 2. Proximal stomach and total thoracic esophagus, resection: - squamous cell carcinoma of distal esophagus, well differentiated, extending into periadventitial tissue, lymph node. negative (0/26), pT3pNO - see synoptic data and comment. 3. Esophago-gastric Resection: Final esophageal margin: - portion of esophagus: negative for malignancy. 4. Stomach Resection: Final gastric margin: - portion of stomach: negative for malignancy. Comment. 2. The tumor focally extends into adventitial tissue and is 0.1 cm from the painted outside surface of the specimen at the. closest point. The tumor extends to the level of the GE junction. There is no evidence of involvement of the stomach. Synoptic Data. Specimen Type: Esophagogastrectomy. Tumor Site: distal esophagus. Tumor Size: Greatest dimension: 7.0 cm. Additional dimensions: 4.5 x 1.2 cm. Histologic Type: Squamous cell carcinoma. Histologic Grade: G1: Well differentiated. Pathologic Staging (pTNM): pT3: Tumor invades adventitia. pNO: No regional lymph node metastasis. Number of lymph nodes examined: 26. Number of lymph nodes involved: 0. Margins: Proximal margin-Uninvolved by invasive carcinoma. Distal margin-Uninvolved by invasive carcinoma. Circumferential (Adventitial) margin-Uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 1.0 mm. Margin: adventitial. Venous (Large Vessel) Invasion (V): Absent. Lymphatic (Small Vessel) Invasion (L): Absent. Additonal Pathologic Findings: Gastritis (type): chronic inactive gastritis, negative for H. pylori. Gross Description. 1. The specimen is labeled with the patient's name and as ""lymph-node: ST10L TB angle"". One lymph node measuring 1.0 x 0.9 x 0.3 cm. 1A bisected and submitted in toto. 2. The specimen is labeled with the patient's name and as ""GE resection: Proximal stomach and total thoracic. esophagus"". Resection specimen: gastro-esophagectomy. Fixation: Received fresh. DIMENSIONS: Length of tubular esophagus: 8.0 cm. Circumference of tubular esophagus at proximal resection margin: 4.0 cm. Length of stomach: 3.0 cm. Circumference of stomach at distal resection margin: 7.0 cm. TUMOR: Measurement: 7.0 cm in length x 4.5 cm circumferentially at the gastroesophageal junction x 1.2 cm in depth. Configuration: Oval, with tumor within the distal esophagus, extending to GE junction and ? proximal stomach. Description: Raised, exophytic borders, with depressed, ulcerating base. Depth of invasion: Through muscle wall. RESECTION MARGINS: Proximal esophageal: 5.0 cm. Distal gastric: 4.2 cm. Adventitial: 0.2 cm. The adventitial margin is painted with green dye in sections submitted. LESIONS IN NONCANCEROUS ESOPHAGUS AND/OR STOMACH: None. Barrett's esophagus cannot be grossly. appreciated. ADDITIONAL STRUCTURES: None. FROZEN SECTION: The esophageal margin is submitted in toto en face in two blocks for intraoperative consultation by frozen section. An en face margin of the gastric margin closest to the tumor is submitted in a third block for intraoperative consultation by. frozen section. LYMPH NODES: Multiple lymph nodes measuring from 0.2 to 3.5 cm in maximum dimension are identified within the. perigastric and paraesophageal soft tissue. TISSUE BANKING: The tumor (three pieces) and normal tissue (two pieces) are sampled for tissue banking. Representative sections are submitted as follows: 2A-2B esophageal resection margin in toto en face, bisected, frozen section blocks resubmitted. 2C gastric resection margin closest to tumor en face, frozen section block resubmitted. 2D-2F esophagus proximal to tumor. 2G-2M gastroesophageal tumor, full thickness sections. 2N-2O stomach distal to tumor. 2P representative en face distal gastric margin. 2Q-2T one quadrisected paraesophageal lymph node. 2U-2W one bisected paraesophageal lymph node per block. 2X-2AB two paraesophageal lymph nodes per block. 2AC one bisected perigastric lymph node. 2AD-2AF two perigastric lymph nodes per block. 2AG three perigastric lymph nodes. 2H two perigastric lymph nodes. 3. The specimen is labeled with the patient's name and as ""esophagogastric resection: Final esophageal margin"". One unoriented ring-shaped piece of soft tissue measuring 2.5x2.3 x 0.4 cm. 3A submitted in toto. 4. The specimen is labeled with the patient's name and as ""stomach resection: Final gastric margin"". One unoriented piece of gastric tissue measuring 9.7 x 4.0 x 0.4 cm. A staple line is present along one margin. 4A-4D stapled margin in toto en face (staple line removed). Quick Section Diagnosis. 2. Proximal stomach and total thoracic esophagus: Esophageal resection margin en face - 2A, 2B: Negative for malignancy. Gastric resection margin at point closest to tumor, one representative section en face - 2C: Negative for malignancy. Reported to.",T3,N0,M0,T3N0M0
TCGA-77-7463,"LEFT UPPER LOBECTOMY. Clinical Details: FNA: Squamous cell carcinoma. Macroscopy: The specimen weighs 180 g and comprises a lobe of lung with appearances in keeping with left upper. lobe. Within the superior lingular segment there is a tumour nodule measuring 30 x 28 x 25 mm. It is. situated at a distance of 25 mm from the bronchial resection margin. The tumour has caused puckering. of the overlying pleura. No pleural surface involvement is seen macroscopically. Inferior to this. nodule, at a distance of 20 mm, there is a hard circumscribed fibrous nodule showing central caseation,. measuring 14 mm in maximum diameter. Within the anterior segment there is a subpleural dark grey. nodule measuring 6 mm in maximum diameter. The lung parenchyma otherwise appears normal. [A,. bronchial resection margin to lingular segment; B, bronchial resection margin to anterior and apico-. posterior segments; C, lymph nodes at resection margin; D, small subpleural nodule anterior segment;. E, apex; F, anterior segment; G, nodule lingular segment; H-K, RS of tumour including pleura in each. section (note: an endobronchial origin is not identified macroscopically)]. Microscopy: Sections show a moderately differentiated squamous cell carcinoma which abuts but does not directly. invade the pleura. However there is lymphatic permeation which does involve pleural lymphatics. No. vascular invasion is identified. Peribronchial lymph nodes show no evidence of malignancy. The. subpleural nodule in the anterior segment is shown to represent a silicotic nodule. The larger nodule in. the lingular segment has a similar histological appearance but shows extensive central necrosis. Special stains will be performed to exclude superimposed infection. Conclusion: Left upper lobectomy: Moderately differentiated squamous cell carcinoma, 30 mm in diameter. Lymphatic invasion present, involving pleura. No vascular invasion is seen. No lymph node metastasis present. Pathological stage T2 NO. T-28000 M-80703 P1-03000. Anatomical Pathologist. Copies: Lung cancer registry. Eurther renort. stains show no evidence of infective organisms. Anatomical Pathologist.",T2,N0,M0,T2N0M0
TCGA-DD-AAED,"CLINICAL DIAGNOSIS: Hepatocellular carcinoma suggested. Specimen : Liver ,LN. Gross Photo : GROSS: Specimen status: Fresh. Operation: Partial hepatectomy. Organ: Liver (18.0 x 9.5 X 7.0 cm, 617.0 gm). Gallbladder (7.3 cm in length, 3.1 cm in diameter, 0,3 cm in thickness). [Liver]. Lesion: A hepatic mass. Size: 8,5 x 7.8 X 10.5 cm. Cut surface: Well demarcated, nodular lesion with area of necrosis. Gross type: Expansile. Extent: Confined to the hepatic parenchyma. Serosal surface: Bulging but smooth. Resection margin: Not involved, grossly (safety margin: 0.4 cm). Remaining parenchyme: Non-cirrhotic. [Gallbladder]. Serosal surface: Yellowish pink and smooth. Mucosal surface: Dark green and velvety. Stone: No stone. Representative sections submitted. Gross photo: Present. Blocks. T1-4, TB, mass of liver X 5. RM, resection margin X 1. L, NB, nontumorous liver parenchyme x 2. LN, fatty tissue x 1. GB, gallbladder X 1. MICROSCOPIC: Tumor type: Hepatocellular carcinoma. Edmondson-steiner grade. The worst differentiation III. The major differentiation III. Histologic type: Trabecular. Fatty change: No. Fibrous capsule formation: Yes. Capsular infiltration: Yes. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Vascular invasion: Yes. Bile duct invasion: No. Remaining liver parenchyme: Periportal fibrosis (stage 2) with mild steatosis. NOT reported. Gross: liver,ectomy,hepatocellular carcinoma, Periportal fibrosis, mild steatosis. T56000, P10, M81703, Periportal fibrosis, mild steatosis. gallbladder,ectomy,autolysis. T57000, P10, M54001. DIAGNOSIS: Liver, partial hepatectomy: Hepatocellular carcinoma, moderately differentiated. Periportal fibrosis with mild steatosis. Galllbladder, cholecystectomy: Autolysis. Suggestion :",T1,N0,M0,T1N0M0
TCGA-AD-6965,"Pre-Op Diagnosis. Nothing indicated. Post-Op Diagnosis. Nothing indicated. Clinical History. Nothing indicated. Gross Description: Received in a single container labeled. - right colon"". is a previously opened portion of large bowel including cecum, as. well as cm of previously opened portion of terminal ileum. The. specimen is received after formalin fixation and shows the large. bowel to measure 20.6 cm and the ileum to be 9.4 cm. The specimen is. covered by a moderate amount of pericolic and epiploic adipose. tissue in which an 8.0 x 0.6 x 0.6 cm grossly unremarkable vermiform. appendix is identified. The visible serosa is shaggy gray tan to. brown. The wall is up to 0.6 cm edematous and fibrotic. The lumen. is lined by gray-tan mucosa with preservation of intestinal folds. Noted within the cecal pouch extending to the ileocecal valve is a. 4.6 X 3.0 cm centrally ulcerated finely granular tan-gray to pink. lesion with raised rolled borders. This is stated during specimen. opening to be noted at its nearest point 26 cm from the distal. margin and 14 cm from the proximal margin. This has a gritty gray. tan fibrotic cut surface measuring up to 1.9 cm in thickness. This. grossly extends focally through the muscularis into the surrounding. adipose tissue where it is seen at its nearest point 0.7 cm from the. nearest outer margin. In addition, in one area the lesion. umbilicates to the serosa and grossly appears to extend through the. serosa. No other gross lesions are identified. On sectioning, the. surrounding adipose tissue shows several well defined and poorly. defined gray tan nodules measuring up to 1.2 cm in greatest. dimension. The largest nodules have fibrotic necrotic cut surfaces. Also received in the same container are three tissue cassettes each. labeled. Representative sections are submitted. labeled as follows: A - proximal margin; B - distal margin; C-. ileocecal valve; D-G - representative lesion and surrounding tissue;. H - random uninvolved bowel; I - appendix; J-L - representative. sections of grossly positive nodules; M-N - whole smaller pericolic. nodules. Microscopic Description: The slides labeled fare examined. See diagnosis. Final Diagnosis. Distal ileum and right colon (right hemicolectomy): Distal ileum: No pathologic diagnosis. PAS 1. Right colon: Tumor characteristics: Histologic type: Adenocarcinoma. Location of tumor: Cecal pouch. Size: 4.6 X 3.0 cm in greatest dimension. Grade: Moderately differentiated. Lymphovascular space invasion: Yes. Perforation of Visceral peritoneum: Yes (see comment). Presence of mesenteric deposits: No. Depth of invasion: Carcinoma extends through muscularis propria. into subserosal adipose tissue and focally perforates visceral. peritoneum to involve serosal surface focally. Surgical Margin Status: Proximal Margin: No carcinoma identified. Distal Margin: No carcinoma identified. Deep Radial Margin: Carcinoma focally perforated visceral. peritoneum to involve serosal surface focally (see comment). Distance of tumor from closet margin: See above diagnoses. Lymph Node Status: Total number of lymph nodes examined: 17. Total number of lymph nodes with metastatic carcinoma: 11. (11/17) PAS 9. Appendix: Fibrous obliteration of the luminal tip, no carcinoma identified. PAS 4 SPC-A. CPT: 88309. Stage: pT4aN2bVL (see comment). Comments. Grossly in one area, the lesion umbilicated to the serosa and. grossly appears to extend through the serosa. Microscopically,. carcinoma is present focally extending through the visceral. peritoneum to focally involve the serosal surface. Therefore, this. is staged as pT4a. Eleven of 17 lymph nodes demonstrate metastatic. carcinoma. Some of the nodes are completely replaced by carcinoma. with no residual nodal tissue identified. These are counted as lymph. nodes totally replaced by tumor. Therefore, this is staged as a. pN2b. In addition, lymphovascular space invasion is identified and. the additional classifications of VL are therefore used. The final. stage should be performed in conjunction with knowledge of the. clinical stage. At the request of the undersigned pathologist, these slides have. been additionally reviewed by Dr. who concurs with the. diagnosis.",T4,N2,M0,T4N2M0
TCGA-85-A5B5,"Gross Description: In the upper lobe bronchus there is a tumor with irregular shape and fibrous density. which narrows bronchus lumen. Tumor size is 3x2.5x2.5 cm. There are nine black bronchopulmonal. lymph nodes and five hilar lymph nodes, up to 0.3-1 cm in size. Separately there is a surgical margin. Microscopic Description: Squamous cell carcinoma of the lung, G-3. Surgical margin and vessels are free. of tumor elements. Examined lymph nodes are without signs of metastases. Diagnosis Details: Tumor Features: Indeterminate, Tumor Extent: Localized, NOS, Venous Invasion: Absent, Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: LUNG TISSUE CHECKLIST. Specimen type: Pneumonectomy. Tumor site: Lung. Tumor size: 2.5 x 2.5 x 3 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 0/14 positive for metastasis (Bronchopulmonal, hilar 0/14). Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Right-upper.",T1,N0,M0,T1N0M0
TCGA-DD-AAE7,"CLINICAL DIAGNOSIS: Hepatocellular carcinoma suggested. Specimen : Liver and Liver mass. Gross Photo : GROSS: Specimen status: Fresh. Operation: Partial hepatectomy. Organs: Liver (10.0 X 9.0 X 2.5 cm, 155.5 gm). Lesion: A well-defined pale yellow to tan solid and firm mass (3.3 X 2.0 x 2.8 cm). Cut surface: Yellowish tan, and solid without necrosis. Gross type: HCC: Vaguely nodular. Resection margin: Not involved grossly (safety margin: 1.5 cm). Others: Satellite nodule: No. Remaining parenchyma: Steatosis, mild. Representative sections submitted. Gross photo: Present. Blocks. TB, T1-4, tumor mass X 5. L, NB, liver parenchyma X 2. RM, resection margin x 1. MICROSCOPIC: Hepatocellular carcinoma: Yes. The worst differentiation II. The major differentiation II. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: Yes (5%). Fibrous capsule formation: No. Septum formation: No. Surgical resection margin invasion: No, safety margin (1.5 cm). Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Intrahepatic metastasis: Unknown. Multicentric occurrence: Unknown. NOT reported. Gross: NOT reported. Gross: Stomach,antrum, dissection, adenocarcinoma, arising in, tubular adenoma. liver, ,ectomy,Hepatocellular carcinoma, well differentiated,steatosis. T56000, P10, M81703, well differentiated, M50080. DIAGNOSIS: Liver, segment 5-8, partial hepatectomy: Hepatocellular carcinoma, well differentiated. Steatosis, mild. Suggestion :",T1,N0,M0,T1N0M0
TCGA-KS-A4I1,"PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 2. PATIENT NBR: SEX: F. BIRTHDATE: ADM DATE: OPER DATE: REQ DOC: PROCEDURE: SPHS. A. year-old female with papillary thyroid cancer. PROCEDURE: SPGD. 1. ?parathyroid tissue"". Received is a 0.002 gram, 0.3 cm red tissue bit submitted for frozen section. analysis. 1A. Frozen section control. 2. ""Thyroid"" Received in formalin in a small container is a thyroidectomy. specimen, 25.01 gm consisting of a right lobe, 5.5 cm x 3.2 x 1.5 cm, a left. lobe, 4.5 x 2.2 x 1.6 cm, and an isthmus, 3.0 x 1.5 x 0.8 cm. The right lobe. is serially sectioned by tissue procurement to reveal a 2.2 cm white. encapsulated Lesion appearing free of margins and unremarkable mahogany. parenchyma in other cut sections. The isthmus is serially sectioned to reveal. unremarkable tan mahogany parenchyma as is the right lobe of thyroid which. shows a 0.4 cm white whorled nodule. 2A-C. Representative sections through right lobe lesion. 2D. Sections sampling grossly unremarkable right (green), left (blue) and. isthmus (yellow of thyroid). 2E-F. Small lesion described in left lobe of thyroid. 3. ""Level VI Lymph node"". Received in a small container filled with formalin is an aggregate of. fibroadipose material 4.5 cm x 1.5 cm 0.5 cm. Specimen is dissected and does. not reveal definitive lymph node candidates. in 4 cassettes. FROZEN SECTION REPORT. 1. Parathyroid tissue present. 1. , have reviewed and interpreted the frozen section. material at the time it was requested. Permanent sections confirm frozen section report. PROCEDURE: SPMI. PAPILLARY THYROID CARCINOMA. Size of largest primary tumor: 2.2 cm. Location(s): Right lobe. PREVIOUS DIAGNOSIS INQUIRY. REPORT DATE: 3. SEX: F. BIRTHDATE: ADM DATE: OPER DATE: REQ DOC: Capsular Invasion: Yes. Vascular Invasion: No. Margins: Positive (Right lobe). Extrathyroidal extension: No. Lymph node metastases: No. SIDE. LEVEL. #POSITIVE NODES. #TOTAL NODES. Right. VI. 0. 4. Total Right ALI (add above). 0. 4. PROCEDURE: SPDX. 1. ""Parathyroid tissue"", excision: Unremarkable parathyroid tissue. 2. Thyroid, total thyroidectomy: Right papillary thyroid carcinoma (2.2 cm). Capsular invasion noted. Margins focally positive on right lobe. Small focus. of papillary thyroid carcinoma in left lobe (0.4 cm), left margins negative. Please see TEMPLATE for details. 3. ""Level VI (ymph node"", excision: Four lymph nodes, negative for malignancy. (0/4). Unremarkable thymus tissue. 1,. the signing staff pathologist, have personally. examined and interpreted the slides from this case. Code: Code: FC: END OF PREVIOUS DIAGNOSIS INQUIRY.",T2,N0,M0,T2N0M0
TCGA-A2-A0CV,"Specimen #: F. Race: ASIAN - PACIFIC ISLANDERTaken: Physician (s) : SPECIMEN: A: SENTINEL LYMPH NODE #1 LEFT. B: NON SENTINEL LYMPH NODE LEFT. C: LEFT BREAST AND AXILLARY CONTENT. FINAL DIAGNOSIS: A-C. TUMOR BREAST, TYPE: LEFT, MASTECTOMY WITH AXILLARY AND SENTINEL LYMPH NODES. INVASIVE (70-80% intraductal DUCTAL CARCINOMA WITH AN EXTENSIVE INTRADUCTAL COMPONENT. NOTTINGHAM SCORE: 6. NOTTINGHAM GRADE: GRADE tumor II (MODERATELY largely intermixed DIFFERENTIATED) with invasive). TUMOR TUMOR (Tubules= NECROSIS: SIZE (GREATEST 2, Nuclei= NOT IDENTIFIED. DIMENSION) 3, Mitoses= : 4.1 1; CM mitotic (MEASURED count GROSSLY) <1 per 10 HPF). MICROCALCIFICATIONS. MARGINS LYMPHATIC INVASION: PRESENT. VENOUS PRESENT / IN INVASIVE AND IN SITU TUMOR AND IN BENIGN DUCTS. NEGATIVE. NEAREST NEAREST MARGIN, MARGIN, IN-SITU INVASIVE TUMOR: TUMOR: 2.5 MM (DEEP, SLIDE C6). INTRADUCTAL NUCLEAR GRADE: COMPONENT: 3 DUCTAL CARCINOMA 3 MM (DEEP, IN SITU, SLIDE CRIBRIFORM C6) TYPE. LYMPH ONE - NODES: (1) SENTINEL METASTASIS LYMPH IN NODE TWO (SPECIMEN OF EIGHTEEN A) : (2/18) POSITIVE EXAMINED LYMPH NODES. EXTRANODAL EXTENSION: PRESENT, 4 MM. ONE (1) LYMPH NODE (SPECIMEN C, LOW, C12) : POSITIVE. NIPPLE IDENTIFIED. - EXTENSION: PRESENT, 1 MM. SKIN IDENTIFIED. MULTICENTRICITY: NOT. EXTRANODAL INVOLVEMENT: INVOLVEMENT: NOT NOT PRESENT. ESTROGEN, PREVIOUSLY PROGESTERONE RECEPTOR STATUS AND HER 2 NEU WERE REPORTED. IN SURGICAL. ADDITIONAL PATHOLOGIC COLUMNAR pT2N1aMX CHANGES: CASE. STAGE: PATHOLOGIC. SCLEROSING ADENOSIS. CELL CHANGE WITH ATYPIA. FIBROCYSTIC CHANGES, USUAL DUCTAL HYPERPLASIA, FIBROADENOMA. MMENT. Specimen #: FINAL DIAGNOSIS (continued) : The earlier report,. of a core biopsy indicates hormone receptors. are POSITIVE (100% strong staining for both estrogen and progesterone. receptors) and Her2 by immunihistochemistry is NEGATIVE (1+). CLINICAL DIAGNOSIS AND HISTORY: year old with left breast 4 X 4 cm mass in left upper outer quadrant. detected with 1cm lymph node. PRE-OPERATIVE DIAGNOSIS: left breast cancer. POST-OPERATIVE DIAGNOSIS: same. FROZEN SECTION DIAGNOSIS: SPECIMEN TYPE: LYMPH NODE. REPORTED TO: DR. REPORTED BY: DR. # BLOCKS: 2. # SCRAPE PREPS 2. FROZEN SECTION DIAGNOSIS : POSITIVE FOR METASTATIC CARCINOMA. GROSS DESCRIPTION: A. Received fresh for intraoperative consultation labeled with patient's. designated ""SENTINEL NODE #1 COUNT 104"" consists of a 1.0 x. 0. 8 x 0.5 cm very firm lymph node with homogeneous yellow tan cut surface. Touch preps are prepared. Half of node submitted for CBCP protocol and. remaining half submitted for paraffin section. B. Received fresh labeled with the patient's name. designated. NON-SENTINEL LYMPH NODE LEFT"" is tan pink soft tissue measuring 0.7 x 0.5. x. 0.2 cm. The presumed lymph node is bisected and submitted entirely. Received fresh labeled with patient's name. designated ""BREAST. Specimen #: GROSS DESCRIPTION (continued) : AND AXILLARY CONTENTS"" consists of 380 gram left mastectomy oriented with. single stitch medial, two stitches superior, stitch on highest axillary. portion. Specimen measures 23 cm medial to lateral 15 cm superior to. inferior, 3 cm anterior to posterior. Attached skin ellipse displays a. centrally located everted nipple measuring 1 cm. No discharge is. identified. No scars are identified. There is a well-defined pink white firm gritty mass in the left outer. quadrant measuring 4.1 x 3.5 x 1.5 cm. Tissue surrounding the mass is. remarkably nodular and firm with possible superior extension of primary. lesion to approximately 5 cm (C4) Focal hemorrhage consistent with. previous biopsy is also noted. Remaining quadrants are also composed of. remarkably nodular focally indurated dense fibrous tissue. No additional. masses identified. Fatty tissue comprises 20% of specimen and is. unremarkable. The attached axillary tail measures 9 x 3.5 x 1.5 cm. Sectioning reveals. sixteen lymph nodes ranging from 0.5 x 0.7 cm in greatest dimension. Sectioning of lowest lymph node shows a firm pink white cut surface with. possible involvement by lesion. INK KEY. blue superficial. black: deep. SUMMARY OF SECTIONS: C1: skin. C2: lower outer quadrant mass. C3: margin of C2. C4: possible extension of tumor. C5 : margin of C4. C6: mass with deep margin. C7: additional mass. C8: lower outer quadrant. C9: upper outer quadrant. C10: upper inner quadrant. C11: lower inner quadrant. C12: one low lymph node. C13: two low bisected lymph nodes, one inked blue. C14: three low lymph nodes. C15: one high lymph node. C16: two high lymph nodes bisected, one blue. C17: one high lymph node intact. Matched sections of C1 C7-C12 and C15 are submitted in OCT for CBCP. rotocol. Specimen #: GROSS DESCRIPTION (continued) : C18 : nipple. C19: mass with deep margin. C20 : : mass with deep and superficial margin. C21: six additional lymph nodes. 21CF.",T2,N1,M0,T2N1M0
TCGA-BR-A4CS,Gross Description: Microscopic Description: Diagnosis Details: Comments: Formatted Path Reports: STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Fundus. Tumor size: 5 x4x1.5cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Adjacent structures (specify) - Greater omentum. Lymph nodes: 7/15 positive for metastasis (Intraabdominal 7/15). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,T4,N3,M0,T4N3M0
TCGA-Z6-A9VB,"M. Clinical diagnosis: Squamous cell carcinoma of the esophagus. Sample: histology #. Gross description: Esophageal fragment with gastric patcha12,5 cm. Gastric. patch - 1,5 cm. Esophageal mucosa shows infiltrative oval ulcerated tumor. 4x1,5 cm, 4,5 from proximal resection line and 4 cm from distal resection line. Section reveals gray tumor mass 1 cm in thickness Paraesophageal adipose. tissue contains 25 consolidations 0,3-0,7 cm in diameter. Paraesophageal. lymphatic node 1,5x0,4 cm with dark-red surface. Microscopic description: Sections reveal ulcerative infiltrated tumor,. moderately differentiated squamous cell carcinoma, infiltrating all laminas and. adventitia. Surgical borders are clear. Paraesophageal lymphatic node shows. metastatic cells. Paragastric lymphatic nodes and greater omentum show no sign. of metastasis. Final diagnosis: Moderately differentiated squamous cell carcinoma of the. esophagus. Confidential.",T3,N1,M0,T3N1M0
TCGA-BQ-5885,"Ref Source: Clinical Diagnosis & History: Patient with left renal mass history of DM, obesity. HTN. Specimens Submitted: 1: SP: Kidney, left, radical nephrectomy. 2: SP: Lymph nodes, para-aortic and preaortic, excision. 3: SP: Adrenal and suprahilar lymph nodes, Left, resecti. DIAGNOSIS;. 1. SP: Kidney, left, radical nephrectomy. Two discrete tumor masses are identified: a. High grade renal cell carcinoma with extensive tubular and tubulopapillary architecture, favored to be a tumor of distal nephron. origin; see comment. - The tumor measures 7.1 cm. - Local invasion: not identified. - Renal vein invasion: not identified. . Surgical margins: free of tumor. - Adrenal gland: not identified (see Part 3). - Lymph nodes: not identified. - Non-neoplastic kidney: unremarkable. Pathologic Stage: pT2 (tumor > 7.0 cm in greatest dimension limited to the kidney). Comment The tumor demonstrates marked cytologic atypia in the form of nucleo- and nucleolomegaly, as well as focal. desmoplasia. Immunohistochemical stains are positive for CK7 (focal, strong), Racemase (diffuse, strong). c-kit (patchy,. moderale). and CA-IX (focal, weak). while negative for 34BE12, Allhough the growth pattern of this tumor is unusual, ils rande. of. features is felt to be most compatible with a distal nephron/collecting duct tumor, This case has been reviewed with the. ich concurs with the diagnosis. b. Renal cell carcinoma, clear cell (conventional) type uhrman nuclear grade II/IV. - The tumor measures 2.6 cm. - Local invasion: tumor invades through the renal capsule but is confined within Gerota's fascia. . Renal vein invasion: not identified. Surgical margins: free of tumor. - Adrenal gland: not identified (see Part 3). . Lymph nodes: not identified. Non-neoplastic kidney: unremarkable. - Pathologic Stage: pT3 (tumor invades peri-nephric tissues but not beyond Gerota's fascia. 2. SP: Lymph nodes, para-aortic and preaortic, excision. Lymph Nodes: Not involved. Number of nodes examined:15. 3. SP: Adrenal and suprahilar lymph nodes, left, resection. Benign adrenal gland. No lymph nodes identified. REVIEWED AND APPROVED THIS REPORT. ATTEST THAT THE ABOVE DIAGNOSIS is BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. Special Studies: Special Stain. Comment. RECUT. CK7. RACEMASE. 34BE12. CA-1X. CD117. NEG CONT. IMM RECUT. Gross Description: 1). The specimen is received fresh labeled ""left kidney"" and consists of a kidney with attached ureter, renal vessels and perinephric. fat weighing 1174 g in total. The entire specimen measures 25 x 13.5 x 7.5 cm. The kidney measures 13.5 X 6 x 5,5 cm. The. attached ureter measures 7.5 cm in length and 2,4 cm in diameter. The attached renal vein measures 0.9 cm in diameter, The. renal vessels and ureter margins are grossly unremarkable. No adrenal gland identified. The kidney is inked black and bivalved to. reveal two masses. The first mass is a well-circumscribed white tan mass arising from the middle pole of the kidney measuring 7.1. X 7 X 3.2 cm. The mass shows areas of necrosis and hemorhhage. The mass is partially encapsulated and is abutting the pelvis. but does not grossly involve it. The mass appears to bulge into the perirenal fat but appears to be contained within the capsule. There is no gross extension into the peribilar fat. The second mass is located in the lower polo of the kidney, measuring 2.6 x 2 x. 1.6 cm, the mass is yellow orange and lobulated, and appears to invade the perirenal fat. Sections through the remainder of the. kidney reveal a pink brown parenchyma, with a well-defined cortico-medullary junction. The cortex measures 0.7 cm and the. calyces appear normal. No lymph nodes are identified in the perinephric fat. The specimen is photographed. Representative. sections are submilted for TPS and for permanent sections. Summary of sections: UVM -- ureteral and vessel margins. TU -tumor. THF -- tumor with hilar fat. THS -- tumor with sinus fat. TK tumor with adjacent kidney. TP -- tumor to renal pelvis. K -- uninvolved kidney. M2 - representative section of the second mass. M2F - second mass with perirenal fat. ADDM2 - additional second mass with radial margin. 2) The specimen is received in formalin labeled ""paraortic and preaortic lymph nodes"" and consists of multiple pink tan fatty lymph. nodes with attached fatty fibrous tissue ranging from 0.3 cm up to 2.2 cm in greatest dimension. All identified lymph nodes are. submitted. Summary of sections: LN1- sectioned largest lymph node. BLN-bisected lymph nodes. LN-lymph nodes. 2). The specimen is received fresh labeled ""left adrenal and suprahilar lymph nodes"". The specimen consists of the adrenal. gland with surrounding adipose tissue weighing 70 g. and measures 10 X 5 X 3,5 cm. The entire outer surface is inked blue. The. specimen is serially sectioned and shows unremarkable parenchyma, with thin yellow orange cortex and brown medulla. No. grossly identifiable tesion. Representative sections of the adrenal gland are submitted. Possible lymph nodes are submitted. Summary of sections: A -- adrenal gland. PLN - possible lymph nodes. Summary of Sections: Part 1: SP: Kidney, left, radical nephrectomy. Block. Sect. Site. PCs. 1. ADDM2. 1. 1. K. 1. 2. M2. 2. 1. M2F. 1. 1. THF. 1. 1. THS. 1. 1. TK. 1. 2. TP. 2. 5. TU. 5. 1. UVM. 1. Part 2: SP: Lymph nodes, para-aortic-and preaortic, excision. Block. Sect. Site. PCs. 5. bln. 5. In. 4. 3. In 1. 3. Part 3: SP: Adrenal and suprahilar lymph nodes, Left, resection. Block. Sect. Site. PCs. 2. A. 2. 2. PLN. 2.",T3,N0,M0,T3N0M0
TCGA-22-4594,"TISSUE DESCRIPTION: Left upper lobe lung (190 grams; 21 X 11 X 5 cm) and superior. (paratracheal) and inferior (subcarinal) mediastinal, left pulmonary. artery and left lower lobe lung lymph nodes. DIAGNOSIS: Lung, left upper lobe, lobectomy : Grade 4 (of 4) squamous cell. carcinoma, forming a 4.2 X 4.0 X 3.5 cm peripheral mass, invading through. the pleura into the chest wall soft tissue. The bronchial and chest wall. resection margins are negative for malignancy. 2 (of 4) intrapulmonary. peribronchial lymph nodes are positive for metastatic squamous cell. carcinoma. Lymph nodes, superior mediastinal (paratracheal) excision: Metastatic. grade 4 (of 4) squamous cell carcinoma in 2 (of 4) lymph nodes. Lymph nodes, inferior mediastinal (subcarinal), left pulmonary artery. and left lower lobe lung, excision Multiple inferior mediastinal (3. subcarinal), left pulmonary artery (6) and left lower lobe lung (6) lymph. nodes are negative for tumor.",T3,N2,M0,T3N2M0
TCGA-D8-A3Z5,"page 1 / 1. Examination: Histopathological examination. KXX. Material: 1. Total organ resection - right breast and axillary lymph nodes. Unit in charge: : Material collected or. Material received or. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the right breast. Macroscopic description: Right breast, sized 27.8 x 17.2 x 6.8 cm, removed along with axillary tissues sized 13 x 9 x 4 cm and a skin flap of 21.8 x. 10.3 cm. Weight 940 g. Tumour sized 4.2 x 2.4 x 1.4 cm found on the boundary of outer quadrants, placed 2.2 cm from the outer boundary, 1.6 cm from the. base and 2.6 cm from the skin. Lymph nodes of 1 cm in length. Microscopic description: Carcinoma lobulare invasivum (classical type) - NHG1 (3 + 1 + 1/0 mitoses/ 10 HPF - visual area 0,55 mm). Infiltratio carcinomatosa mamillae. Lesions in situ of the type: carcinoma lobulare in situ (LCIS). Glandular tissue showing parenchyma atrophy. AXILLAR. LYMPH NODES: Metastases carcinomatosae in lymphonodis (No XIX/XXI). Infiltratio telae perinodalis. Histopathological Diagnosis. Carcinoma lobulare invasivum mammae dextrae. Lubular invasive carcinoma of the right breast. Metastases carcinomatosae in lymphonodis axillae (No XIX/XXI) (NHG1, pT2, pN3a). Cancer metastases in the axillary. lymph nodes No XIX/XXI. Result of immunohistochemical examination. Estrogen receptors found in 75% of neoplastic cell nuclei. Progesterone receptors found in 75% of neoplastic cell. nuclei. HER2 protein stained with. ). Negative reaction in invasive cancerous cells ( Score =1+).",T2,N3,M0,T2N3M0
TCGA-IR-A3LB,"Specimens Submitted: 1: SP: Left lower common iliac lympb nodes (fs). 2: SP: Right para-aortic nodes (fs) i. 3: SP: Left para-aortic lymph nodes (fa). 4: SP: Radical trialectomy w/ bilateral adnexae. 5: SP:Left external iliac lymph nodas. 6: SP: Left obturator lymph node (. 7: SP: Left hypogastric lymph nodes. 8: SP: Right external iliac lymph nodes. 9: SP: Right common iliac lymph nodes. 10: SP: Right obturator lymph node. 11: SP: Right hypogastric lymph node I. 12: SP: Portion of omentum. DIAGNOSIS: 1). LYMPH NODE, COMMON ILIAC, LEFT; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 2). LYMPH NODES, PARA-AORTIC, RIGHT; EXCISION: - THREE BENIGN LYMPH NODES (0/3). 3). LYMPH NODES, PARA-AORTIC, LEFT; EXCISION: - FOUR BENIGN LYMPH NODES (0/4). 4). RADICAL TRIALECTOMY WITH BILATERAL ADNEXAE; RESECTION: INVASIVE ADENOCARCINOMA OF UTERINE CERVIX, NOS, WITH MODERATELY AND. POORLY DIFFERENTIATED COMPONENTS. - THE MAXIMAL THICKNESS OF THE CERVICAL STROMAL INVASION IS 18 MM. - THE THICKNESS OF THE CERVIX IN THE AREA OF MAXIMAL TUMOR INVASION IS 20. MM. - TUMOR EXTENDS INTO PERICERVICAL SOFT TISSUE. - VASCULAR INVASION IS PRESENT. - PERINEURAL INVASION IS PRESENT. - NO VAGINAL EXTENSION IS IDENTIFIED. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. - THE RIGHT OVARY SHOWS A CYSTADENOFIBROMA. - ALL OTHER ADNEXAE ARE UNREMARKABLE. 5). LYMPH NODES, EXTERNAL ILIAC; EXCISION: - SIX BENIGN LYMPH NODES (0/6). LYMPH NODES, OBTURATOR, LEFT; EXCISION: - TWO BENIGN LYMPH NODES (0/2). LYMPH NODE, HYPOGASTRIC, LEFT; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 8). LYMPH NODE, EXTERNAL ILIAC, RIGHT; EXCISION: SEVEN BENIGN LYMPH NODES (0/7). 9). LYMPH NODES, COMMON ILIAC, RIGHT; EXCISION: - THREE BENIGN LYMPH NODES (0/3). 10). LYMPH NODES, OBTURATOR, RIGHT; EXCISION: - TWO BENIGN LYMPH NODES (0/2). 11). LYMPH NODE, HYPOGASTRIC, RIGHT; EXCISION: - BENIGN VASCULAR AND ADIPOSE TISSUE. 12). OMENTUM; BIOPSY: - BENIGN ADIPOSE TISSUE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT.",T1,N0,M0,T1N0M0
TCGA-D8-A1XC,"page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Multiple organ resection - right breast. Expected time of examination: 5 working days. Clinical diagnosis: Right breast - advanced cancer of both breasts, toilet mastectomy of both breasts. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell. nuclei. HER2 protein stained with HercepTestM by DAKO. Negative reaction in invasive carcinoma cells ( Score = 1+. Macroscopic description: Right breast sized 19 x 9 x 6 cm removed along with axillary tissues sized 7 x 3 x 2 cm and a skin flap of 13 x 9.5 cm. Weight 370. g. Tumour sized 7 x 4 x 8 cm found in the central part. Margin to the lower boundary - uncertain, margin to the base - uncertain,. margin to the skin 0.1 cm. Histopathological diagnosis: Carcinoma mucinosum invasivum - NHG2 (3+2+1/5 mitoses/10 HPF - visual area 0.55mm). Invasive mucinous carcinoma of the right breast. Numerous foci of carcinoma ductale found outside the tumour (cribrate type, with medium nuclear atypia, without. necrosis) and lesions of the type mastopathia fibrosa et cystica, hyperplasia ductalis simplex (UDH) AXILLARY LYMPH. NODES: Micrometastases carcinomatosae in lymphonodo (No I/XX). Examination: Histopathological examination. page 2 / 2. cxamination No.: Gender: F. Complementary diagnosis: Complementary macroscopic description: Extensive skin proliferation. Minor ulceration in the skin. Skin proliferation confirmed microscopically. Focal. tumour pattern along the incision line at the side of the base and lower boundary. Test result: Carcinoma mucinosum invasivum with a neuroendocrinic component mammae dextrae. Micrometastasis. carcinomatosa in lymphonodo axillae (No 1/XX) (NHG2, pT4b, pNIa mi). Immunophenotype: CK7+/- (Only part of the. cells exhibit positive reaction, CK5/6 p63-, calponin ambiguous reaction, synaptophysin +, chromogranin -/+). Compliance validated k,.",T4,N1,M0,T4N1M0
TCGA-UB-A7MA,"Result Impression. Sex: Female. Soc. Sec. #: Service Date: Client: FINAL PATHOLOGIC DIAGNOSIS. A. Bile duct margin, biopsy: No tumor. B. Liver, left lobe, partial hepatectomy: Mixed. lepatocellular/cholangiocarcinoma extending to margin and invading. large vessels; see comment. C. Hepatic artery lymph node, excision: No carcinoma in one lymph node. (0/1). D. Anterior common hepatic artery lymph node, excision: No carcinoma. in one lymph node (0/1). E. Portacaval lymph node, excision: No carcinoma in one lymph node. (0/1). COMMENT: Liver Tumor, Including Intrahepatic Bile Duct, Synoptic Comment. - Tumor type: Mixed hepatocellular/cholangiocarcinoma. - Histologic grade: Moderately differentiated. Tumor size (maximum diameter of largest lesion) : 12.1 cm. - Tumor necrosis: <30%. Multifocality (more than one tumor separated by nontumorous liver. parenchyma) : Present. - Estimated total tumor diameter of all HCC foci: >12 cm. - Vascular invasion: Present in both large and small vessels (B2, B3,. B8). - Hepatic capsule: Tumor abuts capsule. - Local extension of tumor: Confined to liver. - Hepatic surgical margins: Positive (slide B3) ; see comment. - Bile duct margin (for cholangiocarcinoma) : Negative. - Non-neoplastic liver: No significant pathologic abnormality. - Lymph node status: Negative. - Negative; total number of nodes examined: 3. - AJCC Stage: pT3bNO. Immunoperoxidase and special stains were performed to confirm the. diagnosis and show the following staining pattern in tumor cells: - Chromogranin: Negative. - Synaptophysin: Negative. Arginase: Patchy positive, negative in some areas showing glandular. lifferentiation. - CK19: Strong and diffusely positive. - Mucicarmine: Negative. - MIB1: Briskly positive, with nuclear staining up to 40-50% of cells. Overall, the histopathology and immunohistochemical profile support a. diagnosis of mixed hepatocellular/cholangiocarcinoma. Histologic. sections show divergent differentiation with some larger cells showing. eosinophilic cytoplasm or fatty differentiation. These cells are. arranged in a trabecular architecture. Both the morphology as well as. strong positive staining for arginase supports hepatoid differentiation. in these areas. In other areas, discrete glands within sclerotic stroma. are seen. Luminal necrosis is seen within glands. A subset of these. areas of glandular differerentiation lack arginase staining. This. finding, along with the presence of necrosis provide evidence for a. component of cholangiocarcinoma. Of note, a mucicarmine stain is. negative, indicating a lack of mucin; however, this does not preclude a. diagnosis of cholangiocarcinoma. MIB1 staining shows a proliferative. index of up to 40-50%, suggesting a highly proliferative malignancy. Negative staining for synaptophysin and chromogranin argues against. neuroendocrine differentiation. Sections at the periphery of the main mass show multiple smaller. nodules, some of which are only apparent microscopically One of these. small nodules is found at the margin (slide B3) It is possible that. this nodule may represent venous invasion. have reviewed portions of this case. and concur with the diagnosis. Specimen (s) Received. A:Bile duct left (ink marks distal margin) FS. B:Left lobe liver. C:Hepatic artery lymph node. D:Anterior common hepatic artery lymph node. E:Portacaval lymph node. Intraoperative Diagnosis. FS1. (A) Bile duct, left, biopsy: Benign bile duct, almost entirely. denuded. Dr. agrees. Clinical History. The patient is a. -year-old woman with a left-sided liver mass. According to. she presented with left upper quadrant in. and a CT. at that time revealed a left-sided liver mass and no risk. factors for hepatocellular carcinoma. A core biopsy revealed. hepatocellular carcinoma with focal glandular differentiation. CK19-positive, AFP-negative, arginase-positive) . She is additionally. noted to have a history of splenectomy for hereditary spherocytosis and. is status post cholecystectomy in. for cholecystitis, which work-up. revealed papillary stenosis with a narrowing of the common bile duct. Gross Description. The case is received in five parts, labeled with the patient's name and. medical record number. Part A is received fresh and additionally labeled ""2 bile duct left ink. marks distal margin frozen, and consists of a single fragment of. red-tan soft tissue (0.7 x 0.3 x 0.1 cm) marked by a circle of black ink. on the one end. The entire specimen is frozen for frozen section. diagnosis 1, and subsequently submitted in cassette A1. Part B is received fresh and additionally labeled ""left lobe liver. orientation P, and consists of a partial hepatectomy (739.5 gm fixed;. 14.5 cm from right to left x 16.5 cm from anterior to posterior x 8.3 cm. from superior to inferior) without attached gallbladder. The specimen. is previously disrupted at the capsule with a section taken by the. surgeon for banking prior to receipt in Pathology. GROSS ABNORMALITIES: There is a white-tan, firm, multinodular. well-circumscribed mass (12.1 cm from right to left x 8 cm from superior. to inferior x 14 cm from anterior to posterior) that extends to the. capsule, which is distorted and contracted by the mass. The mass is. noted 0.5 cm from the resection margin (slice 6). There is no grossly. evident necrosis within the mass. Additionally, scattered smaller. white-tan nodules are seen adjacent to, but apparently distinct from the. mass. The liver parenchyma is otherwise red-brown, firm, and. unremarkable. No gallbladder is present. No lymph nodes are. identified. ORIENTED BY: Anatomic landmarks; hepatic ligament. INKING: - Liver capsule overlying mass: Inferior in blue and superior in green. - Resection margin: Black. POTENTIAL STUDIES: Normal and tumor are taken for tissue banking. CASSETTES: Representative sections are submitted: B1-B2: Mass, approach to margin, and vessels, slice 6. B3: Mass, approach to margin, and vessels, slice 7. B4-B9: Representative sections of mass, including mass. adjacent to capsule. B10: Uninvolved liver. Part C. is received fresh and additionally labeled ""hepatic artery. lymph node, "" and consists of a single, curved/irregular, soft, rubbery. red-tan lymph node (2.5 x 1 x 0.7 cm). The specimen is bisected and. entirely submitted in cassettes C1-C2. Part D is received fresh and additionally labeled ""anterior common. hepatic artery lymph node, "" and consists of a single, roughly ovoid,. soft, rubbery pink-tan lymph node (2.8 x 1.2 x 0.6 cm). The specimen is. bisected and entirely submitted in cassettes D1-D2. Part E is received fresh and additionally labeled ""porta caval lymph. node, "" and consists of a single, irregular, soft, rubbery pink-tan lymph. node (2.8 x 1.6 x 1 cm). The specimen is trisected and entirely. submitted in cassettes C1-C3. Diagnosis based on gross and microscopic examinations. Final diagnosis. made by attending pathologist following review of all pathology slides. The attending pathologist has reviewed all dictations and preliminary. interpretations performed by any resident involved in the case and. performed all necessary edits before signing the final report. Pathology PDF Report. Show images for Surgical Pathology. Authorizing. Date/Time. Result History. This is NOT a Requisition. Requisition hyperlink below. Surgical Pathology (Order. Authorizing: Pathology and Cytology. Department: Images. Show images for Surgical Pathology. Release Date/Time. Start Date/Time. End Date/Time. Release Information. Released On. Released By. Frequency. Duration. Priority. Once. 1 occurence. Routine. Normal. Lab Collection and Receipt Information. Collect Time. Collected By. Lab Receipt Date. Lab Receipt Time. Office. Pager/beeper E-mail. Authorizing Provider. Parent Status: Completed. Result Impression. Sex: Female. Soc. Sec. #: FINAL PATHOLOGIC DIAGNOSIS. Histochemical staining for iron and interpretation on. Background liver with 2+ positive staining (0-4+) . . COMMENT: A histochemical stain for iron was performed on block B10 of. This shows 2+ staining of hepatocytes and kupfer cells (scale 0-4+). Gross Description. block B10 is selected for histochemical staining. Clinical History. The patient is a -year-old woman with mixed. nepatocellular/cholangiocarcinoma and a history of hereditary. spherocytosis. An iron stain was requested by. Diagnosis based on gross and microscopic examinations. Final diagnosis. made by attending pathologist following review of all pathology slides. The attending pathologist has reviewed all dictations and preliminary. interpretations performed by any resident involved in the case and. performed all necessary edits before signing the final report. Pathology PDF Report. Show images for Surgical Pathology. Authorizing Provider Information. Result History. This is NOT a Requisition. Requisition hyperlink below. Surgical Pathology (Order. Pathology and Cytology. Department: Show images for Surgical Pathology. Release Date/Time. Start Date/Time. End Date/Time. Release Information. Released On. Released By. Frequency. Duration. Priority. Once. 1 occurrence. Routine. Normal. Lab Collection and Receipt Information. Collect Time. Collected By. Lab Receipt Date. Lab Receipt Time. Office. Authorizing Provider. Parent Status: Completed. (This order does not yet have any children).",T2,N0,M0,T2N0M0
TCGA-50-5055,"FINAL DIAGNOSIS: Summary Statement. The left lower lobe wedge resection demonstrates a 2.5 cm invasive moderately differentiated adenocarcinoma without. visceral pleural invasion and involving one of five N1 lymph nodes. All margins free. Pathologic stage T1, N1, MX. PART 1: LUNG, LEFT LOWER LOBE, SEGMENTAL RESECTION -. A. MODERATELY DIFFERENTIATED ADENOCARCINOMA WITH ACINAR, PAPILLARY AND. BRONCHIOLOALVEOLAR FEATURES. DIAMETER 2.5 CM. FOCAL ANGIOLYMPHATIC INVASION. IDENTIFIED. NO EVIDENCE OF VISCERAL PLEURAL INVASION. MARKED HOST LYMPHOCYTIC. RESPONSE. ALL MARGINS FREE. PATHOLOGIC STAGE T1, N1, MX,. B. EMPHYSEMATOUS CHANGE WITH FOCAL ORGANIZING PNEUMONIA. C. MULTIPLE SMALL CARCINOID TUMORLETS. PART 2: LUNG, INFERIOR LEFT LOWER LOBE NODULE, WEDGE RESECTION -. PULMONARY HAMARTOMA. MARGINS FREE. PART 3: INTERLOBAR LYMPH NODE, BIOPSY -. THREE FRAGMENTS OF LYMPH NODE WITH NO EVIDENCE OF METASTATIC CARCINOMA. PART 4: LYMPH NODE, POSTERIOR HILAR LYMPH NODE, BIOPSY -. ONE OF TWO LYMPH NODES WITH METASTATIC ADENOCARCINOMA. PART 5: LYMPH NODE, AP WINDOW LYMPH NODE, BIOPSY -. SOLITARY FRAGMENT OF LYMPH NODE WITH NO EVIDENCE OF METASTATIC ADENOCARCINOMA.",T1,N1,M0,T1N1M0
TCGA-CK-5916,"1). SPECIMEN LABELED ""RIGHT COLON"": ADENOCARCINOMA (11.8 cm), poorly differentiated, with neuroendocrine. and signet ring cell features and focal mucin production. Tumor extends through the muscularis propria and involves the visceral. peritoneum. The proximal, distal, and radial resection margins are free of tumor. Lymphovascular invasion is present. Appendix with fibrous obliteration and peri-appendiceal adhesions. METASTATIC CARCINOMA in one of thirty two (1:32) lymph nodes. CLINICAL DATA: History: None given. Operation: Rt colectomy. Clinical Diagnosis: Colon cancer. The specimen is received fresh, in the frozen section room, Tabeled with the. patient's name, unit number, and ""1) Rt colon (tumor bank) and consists of a. partial colectomy specimen consisting of terminal ileum (8 cm length, 3.1 cm. diameter) colon (27 cm length, 4.5 cm diameter), appendix (4.5 cm length, 0.5. cm diameter), proximal stapled resection margin (4.1 cm) , and distal stapled. resection margin (4.6 cm). There is a red/tan, ulcerating, necrotic mass (11.8. x 5.5 x 5.0 cm) with raised, rolled borders at the ileocecal valve, extending. through the wall creating a large, matted mass within the pericolonic fat,. extending to and possibly involving the appendix. The mass is 8 cm from the. proximal stapled resection margin, and 23 cm. from the distal stapled resection. margin. A tan mucosal polyp (0.4 x 0.3 x 0.2 cm) is present 5.5 cm distal to. the aforementioned ileocecal valve mass, and comes to within 18 cm of the. distal stapled resection margin, and 17 cm of the proximal stapled resection. margin. The remaining colonic mucosa is tan/pink with normal folds. The. ileomucosa is tan/pink and velvety, with focally flattened folds adjacent to. the mass. Multiple tan/white, indurated to tan/pink, rubbery lymph nodes are. identified, ranging from 0.5-1.5 cm in greatest dimension. Representative. sections of the tumor and normal colon, as well as half of a lymph node are. submitted to the tumor bank for special studies. Micro 1: proximal stapled resection margin, en face, 2 frag,. Micro 2: distal stapled resection margin, en face, 2 frag,. Micro 3: appendix tip - bisected, and mid appendix, 3 frag,. Micro 4: appendiceal os in relation to cecal/ileocecal mass,. Micro 5-6: ileocecal valve mass, deepest extension, 2 frag,. Micro 7: mass in relation to right colon, 1 frag,. Micro 8: mass in relation to ileocecal valve and terminal ileum, 1 frag,. Micro 9: additional colon mucosal polyp, 2 frag,. Micro 10: remaining half of grossly positive lymph node (remainder to bank) ,. 1 frag,. Micro 11: five single whole lymph nodes, 5 frag,. Micro 12: seven single whole lymph nodes, 7 frag. Micro 13: eight single whole lymph nodes, 8 frag. Micro 14: six single whole lymph nodes, 6 frag,. Micro 15: five signle whole lymph nodes, 5 frag,. SPECIMEN TYPE: COLON, SEGMENTAL RESECT FOR TUMOR.",T1,N0,M0,T1N0M0
TCGA-D5-6538,"page 1 / 2. Examination: Histopathological examination. Material: Total organ resection - colon and caecum. Expected time of examination. Clinical diagnosis: Cancer of the hepatic flexure. Examination performed. Macroscopic description: A 11,2 cm length of large intestine with a fragment of mesentery sized 16 x 9 x 3 cm, an 8 cm section of a and 5.5. cm appendix. Ulcerous tumour sized 5.4 X 6.9 X 1.8 cm in the mucosa. The lesion surrounds 100% of the intestine. circumference, removed 9, 3 cm from the proximal incision, 3.1 cm from the distal incision, and 1.3 cm from the. Bauhin's valve. Microscopic description: Adenocarcinoma tubulopapillare partim mucinosum (G3). Infiltratio carcinomatosa profunda tunicae muscularis. propriae et telae adiposae mesenteril pericolicae. Incision lines are free of neoplastic lesions. Metastases. carcinomatosae in lymphonodis (No X/XIV). Infiltratio carcinomatosa capsulae lymphonodorum et telae adiposae. perinodalis. Emboliae carcinomatosae. Appendix - Appendicitis follicularis. Histopathologic diagnosis: Adenocarcinoma tubulopapillare partim mucinosum coli. Metastases carcinomatosae in lymphonodis (No X/XIV). Tubulopapillar and partially mucinous adenocarcinoma of the colon. Cancer metastases in lymph nodes (No X/XIV). (G3, Dukes C, Astler-Coller C2, pT3, pN2).",T3,N2,M0,T3N2M0
TCGA-77-6843,"HISTORY. No details received. MACROSCOPIC. Two specimens received. 1: The specimen is labelled ""right upper lobe"" and consists of an upper lobe measuring 150 x 85 x 50. mm in the fresh state. 15 mm lateral to the bronchial resection margin and hilum, there is a nodular,. firm subpleural mass measuring 20 mm in diameter. On sectioning, the mass is pale, fleshy and. measures 27 mm in diameter. It underlies a proximal bronchus but is well clear of the bronchial. resection margins. [Sections taken; bronchial resection margin and hilar and peribronchial lymph. nodes, 1A; tumour with overlying pleura, 1B-1D; section of uninvolved lung, 1E]. 2: The specimen is labelled ""hilar lymph node"" and consists of two pieces of blackened lymph node,. each measuring 14 and 8 mm in maximal dimensions. The largest piece is bisected. [Wrapped and. blocked in toto, 2A]. MICROSCOPY. 1: Sections show a poorly differentiated squamous cell carcinoma. The tumour shows areas of clear. cell change. The lesion is subpleural but definite pleural invasion is not identified. Special stains will. be performed to assess this. The tumour is also in the region of a bronchus. In this area there appears. to be an in situ component. There is focal blood vessel invasion but no lymphatic permeation is seen. Perineural permeation is identified. The lesion is well clear of the bronchial resection margin. No. lymph node metastases are seen. The adjacent lung shows evidence of emphysema. 2: A deposit of poorly differentiated carcinoma is present within the lymph node cortex. SUMMARY. Right upper lobe and hilar lymph nodes: 1: Poorly differentiated squamous cell carcinoma; 27 mm in maximal dimension. 2: Blood vessel and perineural invasion present but no lymphatic permeation seen. 3: No definite pleural invasion identified; clear of bronchial margin. 4: Hilar lymph node metastases. 5: T1N1MX. SUPPLEMENTARY REPORT. Focal neuroendocrine positivity is identified within the tumour with chromogranin, synaptophysin and. CD 56. The positive areas appear to be in the better differentiated squamous areas. Therefore the. tumour is a poorly differentiated squamous cell carcinoma showing focal neuroendocrine. differentiation. T-28000 M-80703 P1-03000. Copies:",T1,N1,M0,T1N1M0
TCGA-97-8179,"Addendum #3 performed by. ADDENDUM #4: Fluorescence In-Situ Hybridization (FISH). Specimen. MD. Body Site: Right upper lobe of lung. Specimen Type: Slides. Clinical Data: Adenocarcinoma. INTERPRETATION: Negative for a rearrangement involving the ALK gene. Probe #Nuclei Examined % Positive Nuclei %. Control values. 2p23(ALK) 100 0 <15.0. A total of 100 cells were scored. FINDINGS: FISH was performed on paraffin embedded tissue sections using the. Vysis ALK Break Apart Probe for the ALK gene at 2p23. When a rearrangement involving ALK is. present, either inversion or translocation, one of the two fusion. signals separates as one red and one green signal. In this. specimen, separated signals were present in 0% of the nuclei scored. This result is within the normal limits. COMMENTS: Three to four copies of ALK were observed in 59.0% of. cells. This gain of intact ALK fusion hybridization signals. represents an aneuploid population with extra copies of chromosome. 2/2p ALK region. Additional copies of ALK are not uncommon in. NSCLCs, although the significance of extra copies of the ALK gene in. lung carcinoma is unclear at this time. ISCN RESULTS: nuc ish(ALKx3 4)[59/100]. The Vysis ALK Break Apart Probe FISH test. is FDA. approved for use in the detection of rearrangements involving the. ALK gene via fluorescence in situ hybridization (FISH) in. formalin-fixed paraffin-embedded (FFPE) non-small cell lung cancer. (NSCLC) tissue specimens. Addendum #4 performed by. The electronic signature attests that the named Attending. Pathologist has evaluated the specimen referred to in the signed. section of the report and formulated the diagnosis therein. This report may include one or more immunohistochemical stain. results that use analyte specific reagents. The tests were developed and their performance characteristics. determined by. They have not been cleared or approved by the US Food and Drug. Administration. The FDA has determined that such clearance or approval is not. necessary. SPECIMENS: 1. F/S LUNG, RIGHT UPPER LOBE NODULE. 2. DEEPER MARGIN POSTERIOR SEGMENT RIGHT UPPER LOBE. 3. STATION 11 LYMPH NODE, RIGHT. 4. LUNG, RIGHT UPPER LOBE. 5. STATION 4 LYMPH NODE, RIGHT. 6. LEVEL 9 LYMPH NODE, RIGHT. 7. STATION 7 LYMPH NODE, RIGHT. SEE ADDENDUM. Reason For Addendum #1: Molecular Studies. Reason For Addendum #2: Molecular Studies. Reason For Addendum #3: Molecular Studies. Reason For Addendum #4: Molecular Studies. DIAGNOSIS: 1. LUNG, RIGHT UPPER LOBE: WEDGE RESECTION. - ADENOCARCINOMA, ACINAR PREDOMINANT (1.2 CM), SEE NOTE. - THE STAPLE LINE MARGIN IS FREE OF TUMOR. Note: The tumor consists of acinar (60%) and lepidic (40%). components. Results of mutational studies will be reported in. addenda. 2. LUNG, RIGHT UPPER LOBE, POSTERIOR SEGMENT, DEEPER MARGIN: WEDGE. RESECTION: - -FIBROELASTOTIC SCAR, CONSISTENT WITH APICAL CAP. - NO TUMOR OR GRANULOMAS ARE SEEN. 3. LYMPH NODE, RIGHT LEVEL 11: BIOPSY. FOUR LYMPH NODES, NEGATIVE FOR CARCINOMA (0/4). 4. LUNG, RIGHT UPPER LOBE: COMPLETION LOBECTOMY. - NO RESIDUAL TUMOR IS SEEN. - THE BRONCHIAL AND VASCULAR MARGINS ARE FREE OF TUMOR. ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). 5. LYMPH NODE, RIGHT LEVEL 4: BIOPSY. - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). 6. LYMPH NODE, RIGHT LEVEL 9: BIOPSY. - BENIGN ALVEOLAR PARENCHYMA. - NO LYMPHOID TISSUE, TUMOR OR GRANULOMAS ARE SEEN. 7. LYMPH NODE, RIGHT LEVEL 7: BIOPSY. THREE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/3). Specimens: 1: F/S LUNG, RIGHT UPPER LOBE NODULE. 2: DEEPER MARGIN POSTERIOR SEGMENT RIGHT UPPER LOBE. 3: STATION 11 LYMPH NODE, RIGHT. 4: LUNG, RIGHT UPPER LOBE. 5: STATION 4 LYMPH NODE, RIGHT. 6: LEVEL 9 LYMPH NODE, RIGHT. 7: STATION 7 LYMPH NODE, RIGHT. LUNG: Resection. SPECIMEN. Specimen: Lung. Procedure: Lobectomy. Specimen Laterality: Right. Tumor Site: Upper lobe. Tumor Focality: Unifocal. TUMOR. Histologic Type: Adenocarcinoma. Histologic Grade: G2: Moderately differentiated. EXTENT. Tumor Size: Greatest dimension (cm). 1.2cm. Visceral Pleura Invasion: Not identified. MARGINS. Bronchial Margin. Bronchial Margin Involvement by Invasive Carcinoma: Uninvolved by. invasive carcinoma. Vascular Margin: Uninvolved by invasive carcinoma. ACCESSORY FINDINGS. Lymph-Vascular Invasion: Not identified. LYMPH NODES. Extranodal Extension: Not identified. STAGE (pTNM). Primary Tumor (pT): pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung. or visceral pleura, without bronchoscopic evidence of invasion more. proximal than the lobar bronchus (i.e., not in the main bronchus);. or Superficial spreading tumor of any size with its invasive. component limited to the bronchial wall, which may extend proximally. to the main bronchus. Regional Lymph Nodes (pN). pN0: No regional lymph node metastasis. Number Examined. 9. Number Involved. 0. ADDITIONAL NON-TUMOR. Additional Pathologic Finding(s): Emphysema. CLINICAL HISTORY AND PRE - OPERATIVE DIAGNOSIS: ex-smoker (60 pack-years) with a 1.3 cm RUL solid nodule and. multiple bilateral ground-glass nodules. MACROSCOPIC DESCRIPTION: The specimen is received in seven parts, each labeled with the. patient's name. 1. Part one is received fresh, labeled 'right upper lobe nodule'. It consists of a pre-cut wedge biopsy of the lung measuring 7.5 X 2. X 1.6 cm. The staple line measures 7.8 cm, and is shaved. The. parenchyma around it is inked in black. Also noted, is a second. piece of tissue, which contains part of the nodule, measuring 1 X 1. X 0.3 cm. At the pre-cut opened area, there is a grey-pink nodule. measuring 1 X 0.9 cm. This mass is located 0.4 cm from the staple. line margin. Frozen section is performed on the nodule and. re-submitted for permanent section. Representative sections are. submitted. 2. Part two is received fresh, labeled 'deeper margin posterior. segment right upper lobe'. It consists of a pre cut wedge biopsy of. the lung, measuring 8.5 X 4 X 3 cm. The staple line measures 9 cm. which is shaved and the parenchyma around the staple line is inked. in black. At the pre cut area the pleura is gray pink thickened and. with a bleb. Beneath the thickened pleura the parenchyma is dark red. firm and no nodule is grossly identified. Representative sections. are submitted. 3. Part three is received in saline, labeled 'station #11, lymph. node'. It consists of four pieces of tan brown soft tissue, ranging. in size from 0.5 cm to 1.2 cm in greatest dimension. The specimen is. entirely submitted. 4. Part four is received fresh, labeled 'right upper lobe'. It. consists of a 168 gram lobectomy, measuring 14 X 7 X 2 cm. The. bronchial margin measures 2 cm in length. There is also a staple. line spanning the length of the specimen. The bronchial and vascular. margin are shaved and submitted entirely. The pleural surface has a. tan purple appearance with multiple black streaks. No palpable. masses are grossly identified. The staple line is inked blue and. shaved and representative section is submitted. The specimen is. serially sectioned revealing a homogenous tan red cut surface. No. gross nodules are identified. Representative sections are submitted. 5. Part five is received in saline, labeled 'station #4 lymph node'. It consists of multiple pieces of fibrofatty tissue, ranging in size. from 0.6 cm to 1 cm in greatest dimension. The specimen is entirely. submitted in one cassette. 6. Part six is received in saline, labeled 'level #9 lymph node'. It consists of one piece of tan soft tissue measuring 0.7 X 0.3 X. 0.3 cm. The specimen is entirely submitted in one cassette. 7. Part seven is received in saline, labeled 'station #7 lymph. node'. It consists of four pieces of tan soft tissue, ranging in. size from 0.4 cm to 0.6 cm in greatest dimension. The specimen is. entirely submitted in one cassette. SUMMARY OF SECTIONS: 1A frozen section, remainder of the nodule. 1B-1D remainder of the nodular area. 1E adjacent section to the nodule. 1F staple line margin. 2A-2C thickened pleura and underlying parenchyma. 2D bleb area. 2E staple line margin. 3A entirely submitted. 4A vascular and bronchial margin, shaved. 4B parenchymal margin. 4C-4F representative section of lung. 5A entirely submitted. 6A entirely submitted. 7A entirely submitted. SPECIAL PROCEDURES: INTRA - OPERATIVE CONSULTATION: 1. Lung, right upper lobe nodule; frozen section. Adenocarcinoma. Results reported by. and repeat-back provided by. Intra-Operative Consultation #1 performed by. Final Diagnosis performed by. ADDENDUM #1 FOR MOLECULAR TESTS: KRAS, EGFR and ALK FISH were sent on. for patient,. The test is to be performed on. tissue from case. The case report, slides, and blocks for the cited. accession number were retrieved from archives. The pathologist whose. signature appears below reviewed the original pathology report,. examined candidate H&E slides, and selected block 1D appropriate to. the specifications of the ordered molecular analysis. x1 H&E and x9. unstained slides were prepared and forwarded to. where the. subject molecular test will be performed. An addendum report will be. issued when the results of this molecular test are available. Addendum #1 performed by. MOLECULAR ONCOLOGY. KRAS MUTATION ANALYSIS. Clinical Data: Adenocarcinoma. RESULTS: Wild type gene. INTERPRETATION: No mutations were identified at codons 12 and 13 of. the KRAS gene. COMMENT: Mutations in the KRAS gene are reported to be associated with poor. prognosis, and resistance to targeted tyrosine kinase inhibitor. therapies in patients with non-small-cell lung cancer (NSCLC). KRAS. mutations occur in 15-30% of NSCLC patients and are strongly. associated with adenocarcinoma and smoking history. This assay analyzes codons 12 and 13 in exon 2 of the KRAS gene;. based on the current literature, approximately 98% of mutations are. expected to occur in these codons. The analytical sensitivity of. the assay is approximately 10%; thus mutations present in a low. percentage of cells may not be detected. This test is validated for. use in identifying KRAS codon 12 and codon 13 mutations in fresh,. frozen, or formalin-fixed paraffin embedded tissue. In particular. the test performance has been established in samples of colorectal. cancer and non-small cell lung carcinoma which harbor these. mutations, although several other tissues are also known to harbor. KRAS mutations (e.g. tumors of pancreas, bile duct, ovary, appendix,. etc.). Analysis of EGFR mutation or gene amplification status may provide. additional information regarding this patient's probability of. response to targeted tyrosine kinase inhibitor therapies, if. clinically indicated. See references. METHOD/LIMITATION: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the sample, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exon 2 of the KRAS gene. PCR products are subjected to single. nucleotide primer extension to detect mutations at codons 12 and 13;. primer extension products are analyzed using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. REFERENCES: This test was developed and its performance characteristics. determined by. The laboratory is. regulated under the Clinical Laboratory Improvement Amendments of. as qualified to perform high complexity clinical. testing. This particular test is not considered a stand alone test. and should be only used in the context of other diagnostic tests or. clinical work-up related to treatment decisions. is a business unit of. a. wholly-owned subsidiary of. Addendum #2 performed by. ADDENDUM #3: EGFR Mutation Analysis. Body Site: Right upper lobe of lung. Clinical Data: Adenocarcinoma. RESULTS: No mutation detected. INTERPRETATION: No mutations were identified in the sample provided. for analysis. Fewer than 5% of non-small cell lung carcinoma. patients without identifiable mutations are reported to be. responsive to EGFR tyrosine kinase inhibitor therapies. COMMENT: Forty percent (40%) or more tumor cellularity is optimal. for this mutation analysis. The sample submitted showed 30% tumor. cellularity upon pathologist review. A frequently occurring sequence change 2361G>A (Q787Q) was. identified. This polymorphism is known not to have clinical. significance. Mutations in the tyrosine domain of the epidermal growth factor. receptor (EGFR) gene are reported to be associated with differential. responsiveness or resistance to EGFR tyrosine kinase inhibitor (TKI). therapies. The objective response rate among patients with a. sensitizing mutation ranges from 55 to 82%. This assay analyzes exons 18-21 of the EGFR tyrosine kinase domain;. based on the current literature, most mutations in non-small-cell. lung carcinoma (NSCLC) are expected to occur in these exons. Mutations present in less than 10-20% of extracted DNA may not be. detected by this method. Mutation status in a sample may change. during tumor progression or the course of therapy; therefore, this. result cannot be used to infer the presence or absence of a mutation. in another sample or sub-sample obtained from this tumor. This test is validated for non-small cell lung carcinoma. The. clinical significance and utility of this test in other tumor types. is unknown. METHOD/LIMITATION: Tissue sections are reviewed by a pathologist and relevant tumor is. selected for analysis. DNA is isolated from the samples, quantified. and amplified by polymerase chain reaction (PCR) using primers to. exons 18-21 of the EGFR gene. PCR products are analyzed by. bi-directional direct DNA sequencing using capillary gel. electrophoresis and fluorescence detection. False positive or. negative results may occur for reasons that include genetic variants. or somatic heterogeneity of the tissue sample. DISCLAIMER: The test was developed and its performance characteristics. determined by. The laboratory is. regulated under the Clinical Laboratory Improvement Amendments of. (CLIA) as qualified to perform high complexity clinical. testing. This particular test is not considered a stand alone test. and should be used only in the context of other diagnostic tests or. clinical work-up related to treatment decisions.",T1,N0,M0,T1N0M0
TCGA-CV-A468,"Sex: M. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original  case. For cases prior to. the section ""SPECIMEN"" may have been added. SUPPLEMENTAL REPORT. COMMENT: Additional sections of the mandible are received from the bone lab after. decalcification and sectioning. The section code is as follows: Cassettes I17 and I18, cross sections of the mandible; cassette I19,. mandibular margin, en face; cassette I20 and I21, right mandibular margin, en. face. ADDITIONAL DIAGNOSIS: All sections of bony mandibular tissue are free of carcinoma. ICD-O - -3. Entire report and diagnosis completed bv: Report released by: DIAGNOSIS. SUBMENTAL TRIANGLE: METASTATIC SQUAMOUS CARCINOMA IN 1 (FOCAL 0.6 MM) OF 3 LYMPH NODES. (1/3). (B) LEVEL IB LEFT NECK: METASTATIC SQUAMOUS CARCINOMA IN 1 OF 5 LYMPH NODES (1/5), EXTRANODAL. EXTENSION OF TUMOR IS PRESENT. (c) LEVEL II LEFT NECK: Eleven lymph nodes, no tumor present (0/11). (D) LEVEL III LEFT NECK: Fifteen lymph nodes, no tumor present (0/15). (E). RIGHT MENTAL NERVE: Segment of nerve, no tumor present. LEFT INFERIOR ALVEOLAR NERVE: Segment of nerve, no tumor present. (G). SUPERIOR LIP MARGIN: NO tumor present. (H). INFERIOR LIP MARGIN: No tumor present. MARGINAL MANDIBULECTOMY INCLUDING UPPER AND LOWER LIP: DEEPLY INVASIVE KERATINIZED SQUAMOUS CARCINOMA, MODERATELY. DIFFERENTIATED IN SUBMUCOSA AND EXTENDING TO THE SKIN WITH. PERINEURAL INVASION. Margins free of tumor. Sex: M. Case type: Surgical History. (J) TEETH: Teeth and tooth fragments (gross examination only). Entire report and diagnosis completed bv: Report released by: GROSS DESCRIPTION. (A) SUBMENTAL TRIANGLE - An irregular fragment of fibroadipose tissue (4.0 x. 3.0 x 2.0 cm) containing multiple tan unremarkable 1ymph nodes. No salivary. gland is identified. A single area of fibrosis is present. This measures 1.5. cm in greatest dimension. SECTION CODE: A1, two lymph nodes; A2, three possible lymph nodes; A3,. one lvmph node; A4, multiple possible lymph nodes; A5, area of fibrosis. (B) LEVEL IB LEFT NECK - A portion of salivary gland (4.0 x 4.0 x 3.0 cm). with attached fibroadipose tissue containing multiple Tymph nodes ranging in. size from 0.5 to 1.5 cm. The salivary gland parenchyma is unremarkable. The. lymph nodes are ovoid and also unremarkable. No tumor is seen. SECTION CODE: B1, representative section of salivary gland; B2-B3, one. lymph node serially sectioned; B4, three lymph nodes. OT/ymb. (c) LEVEL II LEFT NECK - An irregular fragment of fibroadipose tissue (6.0 x. 4.0 x 2.0 cm) containing multiple tan ovoid unremarkable lymph nodes ranging. in size from 0.3 to 3.0 cm. SECTION CODE: C1, four lymph nodes: C2, two possible lymph nodes; C3,. two possible lymph nodes; C4, two possible lymph nodes; C5, one lymph node. bisected; C6, one lymph node bisected; C7-c1i, one entire 1ymph node; C12-C15,. one entire lymph node. (D) LEVEL III LEFT NECK - An irregular fragment of fibroadipose tissue with. attached skeletal muscle (4.0 x 4.0 x 3.0 cm) containing multiple tan. unremarkable lymph nodes ranging in size from 0.3 to 3.0 cm. SECTION CODE: D1, D2, one 1ymph node, bisected; D3, two lymph nodes; D4,. two possible lymph nodes; D5, three lymph nodes; D6, two possible lymph nodes;. D7, four lymph nodes; D8, four possible lymph nodes. (E) RIGHT MENTAL NERVE - one fragment of tan soft tissue measuring 0.3 cm in. greatest dimension. Entirely submitted in E for frozen section. FS/DX: SEGMENT OF NERVE, NO TUMOR PRESENT. LEFT INFERIOR ALVEOLAR NERVE - A 0.3 x 0.2 x 0.2 cm soft tissue fragment,. entirely submitted as FSF. FS.DX: SEGMENT OF NERVE, NO TUMOR PRESENT. (G). SUPERIOR LIP MARGIN - A single flat piece of soft tissue (1.5 x 1.0 x 0.3. cm). one surface of the specimen is marked with blue ink. The specimen is. submitted entirely for frozen section in a slide G. FS/DX: NO TUMOR PRESENT. (H) INFERIOR LIP MARGIN - A single piece of fatty, tan-red soft tissue (2.0 x. 1.5 x 0.2 cm) One surface of the specimen is marked with blue ink. The. specimen is bisected and entirely submitted en face for frozen section. Sex: M. Case type: Surgical History. FS/DX: NO TUMOR PRESENT. MARGINAL MANDIBULECTOMY INCLUDING UPPER AND LOWER LIP - A partial. mandibulectomy specimen (superior to inferior, 9.0 cm; medial to lateral,. 7.5. cm;. anterior to posterior, 2.5 cm) including the anterior portion of the. anterior mandible (including the alveolar ridge) and mental portion. The. inferior alveolar nerve is included with the mandible as well as skin on the. anterior portion and oral mucosa on the posterior portion. A purple, multinodular, and raised at the left corner of the mouth. Additional tumor nodules of varying size ranging from 0.3 to 0.6 cm in. diameter are dispersed throughout the rest of the specimen. The skin margins. are grossly free of tumor. One of the satellite tumor nodules is located 0.9. cm from the upper lip medial margin. An additional nodule is located 1.5 cm. from the lower lip margin. Nodules are present on the oral mucosa, but the. surface mucosa is intact, smooth, and glistening. The anterior mandible is unremarkable. Tumor invades to within 0.2 cm of. the bone. No tumor invasion of bone is grossly identified. No teeth are. included with the specimen. INK CODE: Blue-margins from area separately submitted by surgeon as. specimens G and H. Black-soft tissue margins from remainder of specimen. SECTION CODE: Il and I2, left upper lip margin, perpendicular; I3, tumor. left upper lip; I4 and I5, full thickness cross section including soft tissue. margin of resection; I6 and 17, tumor from left upper lip; I8, cross section. of skin and mucosa; I9 and I10, closest soft tissue margin from lateral. specimen (perpendicular) I11-113, tumor from left lower lip; I14, alveolar. mucosal margin, en face; I15, I16, left lower lip margin, perpendicular: The tumor is transferred to the bone lab for further processing. (]) TEETH - Multiple teeth and fragments of teeth, 5.5 x 5.0 x 3.0 cm in. aggregate. The teeth include molars, pre-molars, and canine. Focally, the. teeth show dental caries. No sections are taken. SNOMED CODES. M-80703 M-80706 T-02120 T-03120 T-51300 T-C4200.",T4,N2,M0,T4N2M0
TCGA-EL-A3CS,"al Pathology. Sex: F. Case type: Surgical Case. DIAGNOSIS. (A) RIGHT NECK LEVEL II LYMPH NODE: One lymph node, no tumor present (0/1). (B) RIGHT NECK LEVEL II, III, IV: Three lymph nodes, no tumor present (0/3). Pending sections. (C). COMPLETION THYROIDECTOMY, RADICAL RESECTION OF TRACHEA, ESOPHAGEAL, PARTIAL. ARYNGECTOMY: PAPILLARY THYROID CARCINOMA EXTENDING INTO PERITHYROID SOFT TISSUE AND TRACHEA (4.0 CM). Sixteen lymph nodes, no tumor present (0/16). Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) RIGHT NECK LEVEL II LYMPH NODE - A single lymph node measuring 2.0 x 1.0 x 0.8 cm. Serially sectioned and entirely. submitted in A. (B) RIGHT NECK, LEVELS II, III, AND IV - A 12,0 x 4.0 x 1.0 cm piece of fibroadipose tissue, unoriented. The specimen is. serially sectioned and multiple lymph nodes are identified ranging in size from 0.5 to 1.0 cm in diameter. The lymph nodes are. submitted in cassettes B1-B4 (multiple lymph nodes per cassette). NOTE: The surgeon was contacted about the orientation of. the specimen. Levels of the specimen was not a issue. (C) COMPLETION THYROIDECTOMY, RADICAL RESECTION OF TRACHEA, ESOPHAGEAL PARTIAL LARYNGECTOMY. RESECTION - Thyroidectomy and partial laryngectomy specimen with overall measurements of 4.5 x 5.0 x 3.5 cm. Attached. soft tissue and muscles are noted. The tumor is hemorrhagic, friable, light-tan to firm and measure approximately 3.0 x 2.0 x. 4.0 cm. The tumor extends to the soft tissue but no involvement of the external margins of resection are noted. The tumor. abuts and perhaps superficially invades the trachea anteriorly, but no involvement of the inner side of the tracheal surface is. noted. The specimen is submitted under C1-C11, representative section of the tumor and the trachea and soft tissue from right. to left. The remaining of the left soft tissue is examined and a total of 18 possible lymph nodes are identified. Representative. sections as per section code. SECTION CODE: C1-C11, representative section of the tumor and the trachea and soft tissue from right to left. The. remaining of the left soft tissue is examined and a total of 18 possible lymph nodes are identified. Representative sections as. per section code; C12-C14, four possible lymph node, each, from left soft tissue; C15, two possible lymph nodes, from left soft. tissue; C16-C19, one possible lymph node, bisected, each, from left soft tissue; C20, two possible lymph nodes, from anterior. soft tissue; C21, two possible lymph nodes from inferior soft tissue. CLINICAL HISTORY. Sex: F. Collected: i. 9. Case type: Surgical Case. None given. SNOMED CODES. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or. approved by the U.S. Food and Drug Administration. Released by:",T4,N0,M0,T4N0M0
TCGA-AA-3549,"Diagnosis: Right hemicolectomy preparation with an ulcerated colon carcinoma of histological type of. a moderately differentiated colorectal adenocarcinoma, measuring 3.5 cm in diameter at the. widest point, located in the passage from the cecum to the ascending colon. Invasive. spreading of the tumor to the muscularis propria. Colonic mucous membrane with a small solitary tubular adenoma with moderate epithelial. dysplasia (synonymously: mild intraepithelial neoplasia). A coarse, nodular calcified focus of the mesenterium. It is most likely a completely. calcified lymph node. Oral and aboral resection margin is tumor-free. 31 regular lymph nodes are tumor-free with uncharacteristically reactive changes. Tumor stage therefore pT2 nNO (0/31) V0 L0; G2 RO.",T2,N0,M0,T2N0M0
TCGA-YG-AA3N,"Surgical Pathology and Cytopathology. Lab No. Rec.Number. Phys. Ins. Plan. Date of Birth. Room No. Date Received. Date Report. Tissue Examination Report: Specimen : A) SPECIMEN labeled right chest, Skin melanoma, consists of an elliptical. fragment of skin measuring 6 x 3 x 0.7 cm. The epidermal surface is brownish,. with an elevated brownish nodularity that measures 1.6 cm in diameter, being. at 0.9 cm from its nearest peripheral margin. On section the lesion presents. a grayish brown color, being homogeneous and smooth. Beneath it tannish,. rubbery tissue, as well as yellowish adipose tissue are observed; the lesion. being at 0.5 cm from the deep margin. Margins inked. Lesion totally submitted. Peripheral margins. (9 cassettes). B) SPECIMEN labeled right axillary sentinel lymph node #1, consists of an irregular. fragment of yellowish adipose tissue measuring 2.5 x 1,6 cm. On section one lymph. node is identified measuring 2.5 X 1.5 cm, presenting a yellowish, homogeneous,. rubbery parenchyma. 2 cassettes ). C) SPECIMEN labeled left axillary sentinel lymph node #2, consists of an irregular. fragment of yellowish adipose tissue measuring 4.5 x 4.3 x 0,6 cm. On section. two lymph nodes are identified, the larger one measuring 2.5 x 2 cm and the. other measuring 1.5 x 1.4 cm, presenting tannish, homogeneous, rubbery paren-. chymas. Lymph nodes totally submitted. Larger lymph node; II. Second. larger lymph node; III. Addipose tissue. (6 cassettes). Pg. 1 of 2. This report is confidential and contains privileged information. Inappropriate disclosure is prohibited by law. if by accident you receive this report please contact us immediately. Surgical Pathology and Cvtopathology. Lab No. Rec.Number. Phys. Ins. Plan. Date of Birth. Room No. Date Received. Date Report. Tissue Examination Report: DIAGNOSIS: A) RIGHT CHEST, SKIN BIOPSY: - MALIGNANT MELANOMA, NODULAR TYPE, CLARK LEVEL IV, 6 MM IN. DEPTH. - MITOTIC INDEX 1 / MM. - LYMPH-VASCULAR INVASION NOT IDENTIFIED. - TUMOR INFILTRATING LYMPHOCYTES PRESENT, NON-BRISK. - ULCERATION PRESENT. - INKED MARGINS OF THE SPECIMEN, FREE OF TUMOR. B) RIGHT SENTINEL LYMPH NODE #1: - NEGATIVE FOR METASTASIS. C) LEFT SENTINEL LYMPH NODE #2: - TWO (2) LYMPH NODES NEGATIVE FOR METASTASIS. Pathologic Staging: pT4b pNo pMx. Note B), C) : Special stains in progress, report will follow. Pg. 2 of 2. Surgical Pathology and Cytopathologv. Lab No. Rec.Number. Phys. Ins. Plan. Date of Birth. Room No. Date Received. Date Report. Tissue Examination Report: Specimen : ADDENDUM. B & C) IMMUNOPEROXIDASE STAINS FOR HMB45 AND S-100 WERE DONE. AT "". "" AND REPORTED. NEGATIVE. This report is confidential and contains privileged information. Inappropriate disclosure IS pronibited by law. If by accident you receive this report please contact us Immediately.",T4,N0,M0,T4N0M0
TCGA-B6-A0RV,"1. argical Pathology. CLINICAL HISTORY: year old woman with a large right breast cancer. GROSS EXAMINATION: A. ""Large right breast cancer"". Received fresh is right modified radical. mastectomy, 630 grams, and 25 x 16.5 x 3.6 cm. The overlying skin ellipse. measures 15.3 x 10.6 cm. The areolar is 6.8 cm in diameter, and the nipple,. 1.5 cm. Serial sectioning reveals extensive involvement of the breast tissue. by a large, white/light yellow tumor 12 x 9.5 x 4 cm, which grows in an. infiltrative fashion and demonstrates focal calcification. It is located. approximately 0.5 cm from the closest superior margin, 1.5 cm from the. inferior margin, 0.1 cm from the deepest margin, 1.5 cm from the medial. margin, and 3 cm from the axillary appendage. Focal hemorrhage is present in. the subcutaneous portion of the breast. Dissection through the axillary. appendage demonstrates multiple enlarged lymph nodes up to 2.4 cm in size. A. portion of the fresh tumor tissue is submitted for ER/PR studies and for. tissue bank. The representative sections of the specimen are submitted. BLOCK SUMMARY: A1-A2- tumor and the closest deep margin. A3- upper inner quadrant. A4- upper outer quadrant. A5- lower inner quadrant. A6- lower outer quadrant. A7- skin and underlying hemorrhage. A8- nipple. A9-A10- level 1 lymph node candidates. A11- A12- level 2 lymph node candidates. A13-A14- level 3 lymph node candidates. DIAGNOSIS: A. ""RIGHT BREAST (MODIFIED RADICAL MASTECTOMY) "": INFILTRATING CARCINOMA PRESENT. HISTOLOGIC TYPE DUCTAL WITH PROMINENT LOBULAR COMPONENT. N.S.A.B.P. HISTOLOGIC GRADE, 3 OF 3. N.S.A.B.P. NUCLEAR GRADE, 2 OF 3. GROSS TUMOR SIZE, 12 x 9.5 x 4 CM. SIZE OF INVASIVE COMPONENT, 12 x 9.5 x 4 CM. THE TUMOR IS PRESENT IN ALL QUADRANTS OF THE BREAST. IN-SITU CARCINOMA, PRESENT. OCCUPYING 5% OF THE TUMOR. TYPE OF IN-SITU CARCINOMA, LOBULAR. EXTENSIVE INTRADUCTAL COMPONENT, ABSENT. MULTIFOCAL TUMOR IS PRESENT. STATUS OF NON-NEOPLASTIC BREAST TISSUE: FIBROCYSTIC CHANGE INCLUDING. INTRADUCTAL HYPERPLASIA, DUCTAL ECTASIA, AND APOCRINE METAPLASIA. LYMPHATIC/VASCULAR INVASION IS PRESENT (BLOCK A5) . SURGICAL MARGIN IS NEGATIVE FOR CARCINOMA. NIPPLE STATUS: PAGET'S DISEASE ABSENT. SKIN STATUS: UNINVOLVED BY CARCINOMA. MUSCLE STAUS; UNINVOLVED BY CARCINOMA. METASTATIC CARCINOMA PRESENT IN FIVE OF TEN LYMPH NODES. THE LARGEST INVOLVED LYMPH NODE IS 2.4 CM. EXTRACAPSULAR EXTENSION IS PRESENT. MICROCALCIFICATIONS ARE PRESENT, IN ASSOCIATION WITH CARCINOMA. ESTROGEN/PROGESTERONE AND CELL CYCLE ANALYSIS PENDING. METHODOLOGY, FRESH TISSUE. 1 of 2. RESULTS WILL BE ISSUED IN AN ADDENDUM. ADDENDUM 1: Tissue was sent to. for assay of the Estrogen. and Progesterone receptors. The Estrogen receptor was judged as positive with. an estimated fmol valve of 95. The Progesterone receptor activity was judged. as positive with an estimated fmol valve of 90. Please refer to report. For complete details. 2 of 2.",T3,N2,M0,T3N2M0
TCGA-BH-A1EV,"Procedure Date: Procedure Physician: Attending Physician/Copies To: PATIENT HISTORY: .1 nnDATE of LMP. DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: L BREAST CA. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: L NOD RAD WAT. CLINICAL HISTORY: MATERIAL SUEMITTED RIGHT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. INTRAOPERATIVE CONSULTATION: CONSULT: Left breast tissue: Breast tissue with nipple/areola complex: Multilobed, diffuse breast mass. with. multifocal, individual firm secondary masses, malignant. Total dimension to be determined with gross. ADDENDA: Addendum. FINAL DIAGNOSIS: ER/PR. IMMUNOPEROXIDASE IDENTIFICATION OF ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE. ""A2"". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROGKN RECEPTOR (90%) AND PROGESTERONE RECEPTOR. (40%) THEREFORE, BOTH ARE INTERPRETED AS POSITIVE. HER-2/NEU. c-erbB2 (HER-2/NEU) IMMUSTAINING IS CARRIED OUT ON SURGICAL. BLOCK ""A2"" (BREAST CANCER) USING A. 1:300 DILUTION OF DARO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE INTRACELLULAR DOMAIN or c-erb82). WITHOUT ANTIGEN RETRIEVAL. DISTINCT COMPLETE MEMGRANE STAINING IS IDENTIFIED IN 30% or TUMOR CELLS. THEREFORE, c-erb82 (BER-2/NEU) IS INTERPRETED AS POSITIVE (SCORE 2+). My. signature is attestation that I have personally reviowed the submitted material(s) and the final. diagnosis reflects that evaluation. LEFT BREAST, MODIFIED RADICAL MASTECTOMY: INFILTRATING DAND INTRADUCTAL CARCINOMA OF THE BREAST, POOR NUCLEAR GRADE, 9 CM. - INTRADUCTAL CARCINOMA IS COMEDO-TYPE AND COMPRISES APPROXIMATELY 35% OF TUMOR VOLUME. - IN-SITU COMPONENT EXTENDS TO INVOLVE LARGE NIPPLE DUCTS. - NIPPLE SHOWING PAGST'S DISEASE. - TUMOR VASCULAR SPACE INVOLVING IS NOT PROMINENT. - SURGICAL MARGINS TREE OF TUMOR IN PLANES OF SECTION. - TUMOR INVOLVES ALL FOUR QUADRANTS, HOWEVER, RANDOM SECTIONS or QUADRANTS ARE NEGATIVE FOR TUMOR. - METASTATIC CARCINOMA INVOLVING THREE OF TEN (3/10) AXILLARY LYMPH NODES. NOTE: ER/PR immunoperoxidase assay and Her-2/NEU testing will be performed on block ""A2"".",T3,N1,M0,T3N1M0
TCGA-DD-AAE1,"CLINICAL DIAGNOSIS: Hepatocellular carcinoma suggested. Specimen : Liver and Liver mass. Gross Photo : GROSS: Specimen status: Fresh, previously-opened status. Operation: Partial hepatectomy. Organs: Liver (9.0 X 9.0 X 3.7 cm, 126.5 gm). Lesion: A well-defined multinodular golden yellow solid mass (3.5 x 2.4 X 2.0 cm). Gross type: HCC: Expanding nodular. Resection margin: Not involved grossly (safety margin: 1.3 cm). Others: Satellite nodule: No. Remaining parenchyma: Cirrhotic. Representative sections submitted. Gross photo: Present. Blocks. T1-4, TB, mass X 5. L, NB, liver parenchyma X 2. MICROSCOPIC: Hepatocellular carcinoma: Yes. The worst differentiation III. The major differentiation III. Histologic type: Trabecular. Cell type: Hepatic. Fatty change: No. Fibrous capsule formation: Partial capsule. Capsular infiltration: No. Septum formation: No. Surgical resection margin invasion: No, safety margin (1.3 cm). Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Intrahepatic metastasis: Unknown. Multicentric occurrence: Unknown. NOT reported. Gross: liver,ectomy, ,,Hepatocellular carcinoma,cirrhosis,steatosis. T56000, P10, M81703, M49500, M50080. DIAGNOSIS: Liver, partial hepatectomy: Hepatocellular carcinoma, moderately differentiated. Cirrhosis. Steatosis, mild. Suggestion :",T1,N0,M0,T1N0M0
TCGA-A4-7585,"DIAGNOSIS. DIAGNOSIS: Left kidney, radical nephrectomy: Infiltrating renal carcinoma. Tumor Characteristics: 1. Histologic type: Papillary (chromophil) renal cell carcinoma, oncocylic variant, with extensive degenerative changes and necrosis. 2. Tumor site: Left kidney. 3. Macroscopic extent of tumor: Tumor involves perinephric adipose tissue. 4. Nuclear grade: Fuhrman grade: 2/4. 5. Lymphovascular space invasion: Not identified. 6. Transcapsular invasion: Tumor focally infiltrates through renal capsule to involve perinephritic adipose tissue. 7. Renal vein invasion: Not identified. 8. Venacaval invasion: Not resected. 9. Adrenal gland: Not identified. Surgical Margin Status: 1. Soft tissue margins: Negative for tumor. 2. Ureteral margin: Negative for tumor. 3. Vascular Margins: Negative for tumor. Lymph Node Status: No lymph nodes identified. Other Significant Findings: 1. pTNM stage: T3a NX MX, stage III. Staging Sheet. CLINICAL INFORMATION. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Left renal mass. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: Left kidney. SPECIMEN PATA. GROSS DESCRIPTION: Received in formalin labeled t. and #1 is a. nephrectomy specimen, consisting of a 10.5 x 5.8 x 3.1 cm kidney, with a moderate. amount of attached perinephric fat. The specimen has been previously bivalved. There is a minimal amount of identifiable ureter and a minimal amount. of. possible. renal. vein. and artery. The capsule is smooth and tan. The cut surface consists of a 5.2 x 4.5 x 4.1 cm focally cystic tan red to orange mass,. which diffusely involves the adipose tissue, and abuts the inked perinephric fat. The adipose tissue adjacent to the mass has a glistening yellow. appearance. The remainder of the cut surface consists of tan pink parenchyma, with a 0.4 cm tan brown cyst. The cortical medullary junction is ill. defined. The urothelium is gray white. No enlarged lymph nodes are identified. The adrenal gland is not present. The specimen is inked, serially. sectioned,. and. representative sections are submitted as labeled: 1-ureterovascular margins; 2 to 4--mass to inked perinephric fat; 5-mass; 6-mass to. uninvolved. parenchyma: 7--alistening yellow adipose tissue adjacent to mass; 8--uninvolved parenchyma to include cyst; 9--uninvolved parenchyma. The blacks are inholed. Jso received in the same container are two orange cassettes labeled A and C and a green and yellow cassette. labeled. or genomic research study.",T3,N0,M0,T3N0M0
TCGA-50-6597,"PATIENT HISTORY: PRE-OP DIAGNOSIS: Lung cancer (right lung). POST-OP DIAGNOSIS: Same. PROCEDURE: Bronchoscopy, mediastinoscopy and thoracotomy. ADDENDA: Addendum. Motecular Anatomic Pathology Microdissection Genotyping Testing. A. KRAS Exon 1 mutation NOT identified. B. EGFR Exon 19 mutation NOT identified. C. EGFR Exon 21 mutation NOT identified. Note: KRAS codon 12/13 mutations are found in approximately 10-30% lung adenocarcinomas and associated with history of smoking. (1). EGFR exon 19 and 21 mutations are present in about 10% of non-Asians and up to 40% in the Asian population, common in. non-smokers and associated with the tumor response to treatment with EGFR inhibitors (2). These mutations are mutually. exclusive and their presence may have prognostic and/or therapeutic implications (3,4). Addendum. PROBE Vysis LSI EGFR SpectrumOrange/ CEP 7 SpectrumGreen Probe. TM. Fluorescence in-situ hybridization studies performed on the adenocarcinoma shows a ratio of EGFR gene to the centromere of. chromosome 7 of 1.07 indicating no EGFR amplification in the targeted region. The rate of hyperploidy for the centromere of. chromosome 7 was 30% of the analyzed cells. The signal to nucleus ratio (SNR) for the EGFR gene was 2.5. 60 cells were. analyzed in the targeted region. Interpretation guidelines for EGFR Gene Copy Number by FISH: Ratio of EGFR to the centromere of chromosome 7: Less than 2.0: No EGFR amplification. Greater than 2.0: EGFR amplification. Hyperploidy: Greater than two centromere copies/cell. SNR: The average number of EGFR signals per analyzed cell within the targeted region. Clinical studies show high EGFR gene copy number by FISH analysis to be associated with favorable clinical benefit (clinical. response, stable disease, time to progression, and survival) in patients with advanced non-small cell lung cancer treated with. EGFR tyrosine kinase inhibitors. FINAL DIAGNOSIS: Summary Statement. The right lower lobe superior segment demonstrates a 2.5 cm invasive moderately differentiated adenocarcinoma. associated with visceral pleural and angiolymphatic invasion. All sampled lymph nodes are benign. Surgical resection. margins are free of tumor. The pathologic stage is T2N0Mx. The right middle lobe demonstrates a 0.6 cm typical carcinoid. Numerous carcinold tumorlets and diffuse. neuroendocrine cell hyperplasia are seen throughout the right upper, right lower and right middle lobes. PART 1: LYMPH NODE, SUBCARINAL, BIOPSY -. FIVE (5) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 2: LYMPH NODES, RIGHT TB ANGLE, BIOPSY -. THREE (3) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 3: LYMPH NODES, LEFT TB ANGLE, BIOPSY -. TWO (2) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 4: LYMPH NODES, LEFT PARATRACHEAL, BIOPSY -. TWO (2) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 5: LYMPH NODE, RIGHT PARATRACHEAL, BIOPSY -. ONE (1) LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 6: LYMPH NODES, SUBINNOMINATE, BIOPSY -. TWO (2) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 7: LYMPH NODES, POSTERIOR HILAR, BIOPSY -. TWO (2) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 8: LYMPH NODES, ANTERIOR HILAR, BIOPSY -. TWO (2) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 9: LYMPH NODE, INTRALOBAR LOBE, BIOPSY -. ONE (1) LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 10: LYMPH NODES, RIGHT LOWER LOBE / SUPERIOR SEGMENT, BIOPSY -. TWO (2) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 11: LUNG, RIGHT LOWER LOBE SUPERIOR SEGMENT, SUPERIOR SEGMENTECTOMY. A. INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA (2.5 CM IN DIAMETER) ARISING IN A SCAR. AND ASSOCITED WITH ANGIOLYMPHATIC AND VISCERAL PLEURAL INVASIN. MODERATE LYMPHOCYTIC. HOST RESPONSE. PATHOLOGIC STAGE: T2NOMX. B. SURGICAL RESECTION MARGINS ARE FREE OF TUMOR. C. BACKGROUND LUNG WITH EMPHYSEMATOUS CHANGE, CALCIFIED NODULE, AND MULTIPLE CARCINOID. TUMORLETS. PART 12: LUNG, RIGHT UPPER LOBE, WEDGE BIOPSY -. LUNG PARENCHYMA WITH MILD EMPHYSEMATOUS CHANGE AND DUST MACULES. PART 13: LUNG, RIGHT UPPER LOBE, WEDGE BIOPSY -. LUNG PARENCHYMA WITH CARCINOID TUMORLET AND MILD EMPHYSEMATOUS CHANGE. PART 14: LUNG, RIGHT LOWER LOBE, WEDGE BIOPSY -. LUNG PARENCHYMA WITH MILD EMPHYSEMATOUS CHANGE. PART 15: LUNG, RIGHT MIDDLE LOBE, WEDGE BIOPSY -. TYPICAL CARCINOID (0.6 CM IN DIAMETER), ASSOCIATED WITH CARCONOID TUMORLETS AND. NEUROENDOCRINE CELL HYPERPLASIA. (See comment). COMMENT: This case in addition to invasive moderately differentiated adenocarcinoma demonstrates typical carcinoid in the right. middle lobe associated with numerous carcinoid tumorlets and diffuse neuroendocrine cell hyperplasia. A primary lung. origin of carcinoid is confirmed by positive TTF-1 and synaptophysin immunostalning. CDX2 and calcitonin are negative. Surgical resection margin of the right middle lobe demonstrates scattered small microscopic foci of neuroendocrine. cells. However, based on the gross description it seems that margin is negative for tumor and these neuroendocrine. cells may represent another focus of tumoriet. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY LUNG TUMORS. TUMOR LOCATION: Right Lower Lobe. LUNG SEGMENT(S) INVOLVED: Superior. PROCEDURE;. Segmental. TUMOR SIZE: Maximum dimension: 2.5 cm. Minor dimension: 0,9 cm. GROSS SATELLITES: Number of gross satellite lesions: 0. TUMOR TYPE: Invasive adenocarcinoma, Carcinoid. HISTOLOGIC GRADE: G2, Moderately differentiated. MICROSCOPIC SATELLITES: Number of microscopic satellite lesions: 0. EXTRAPULMONARY PARENCHYMAL. EXTENSION/INVASION OF TUMOR: Visceral pleura. NGIOLYMPHATIC INVASION: TUMOR NECROSIS: < or = to 50%. SURGICAL MARGIN INVOLVEMENT: No. SURGICAL MARGIN SITE: Distance of invasive tumor to closest margin: 12 mm, Parenchymal margin. INFLAMMATORY(DESMOPLASTIC) REACTION: Moderate. N1 LYMPH NODES: Number of N1 lymph nodes positive: 0. Number of N1 lymph nodes examined: 7. EXTRACAPSULAR SPREAD OF N1 METASTASES: N2 LYMPH NODES: Number of N2 lymph nodes positive: 0. Number of N2 lymph nodes examined: 15. UNDERLYING DISEASE(S): Emphysema, Parenchymal scar, Tumorlets. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ANCILLARY STUDIES: Histochemical stains, Immunohistochemical stains, FISH studies, Molecular studies.",T2,N0,M0,T2N0M0
TCGA-CG-5732,"Diagnosis(es): Total gastrectomy specimen including an extensive, extensively ulcerated, moderately. differentiated gastric adenocarcinoma (intestinal type) located in the cardia/corpus area. with wide infiltration of the perimuscular soft tissue and with 17 regional lymph node. metastases. Tumour-free oesophageal resection margin lined with unremarkable squamous. epithelium and tumour-free duodenal resection margin. Tumour stage: pT2b pN3 (17/31) pMX;.",T2,N3,M0,T2N3M0
TCGA-DJ-A13X,"Clinical Diagnosis & History: Right thyroid nodule FNA showed papillary thyroid cancer. Specimens Submitted: 1: SP: Delphian lymph node (fs). 2: SP: Total thyroid; Thyroldectomy. DIAGNOSIS: 1. SP: Lymph node, Delphian; Excision (fs): -One benign lymph node (0/1). 2.- SP: Total thyroid; Thyroidectomy: Tumor Type: Papillary carcinoma, follicular variant. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Right lobe. Tumor Size: Greatest diameter is 6.5 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Focal invasion. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Not identified. Bateof-Report: Clinical Diagnosis & History: Right thyroid nodule FNA showed papiliary thyroid cancer. Specimens Submitted: 1: SP: Delphian lymph node (fs). 2: SP: Total thyroid; Thyroidectomy. I. DIAGNOSIS: 1. SP: Lymph node, Delphian; Excision (fs): -One benign lymph node (0/1). 2. SP: Total thyroid; Thyroidectomy: Tumor Type: Papillary carcinoma, follicular variant. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Right lobe. Tumor Size: Greatest diameter is 6.5 cm. Tumor Encapsulation: Completely surrounded. Capsular Invasion: Focal invasion. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Not identified. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. mild. Parathyrold Glands: Not identified. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh for frozen section consultation, labeled ""Delphian lymph node"" and consists of one tan lymph. node measuring 0.6 Cm in greatest dimansion. Entirely submitted for frozen section. Summary of sactions: FSC - frazen section control. 2) The specimen is received fresh labaled ""total thyroid stitch marks right lobe"" and consists of a thyroid weighing 42.5 G. The. right lobe measuras 7 x 6 x cm the left loba measures 3 x 1.5 x 1.0 Cm and the isthmus measures 2.0 x 0.5 x 0.3 Cm. The. external surface is covered by a thin fibrous capsule. The posterior surface of the specimen is inked black, and the anterior is. inked blue. Sectioning reveals a large tumor in the right lobe measuring 6.5 x 5.5x4.0 cm with fleshy, tan brown cut surface. Sections through the remaining tissue reveal unremarkable thyroid parenchyma. The remaining thyroid parenchyma is red tan. and beefy. Representative sections of the specimen are submitted for TPS, and a photograph has been takan. Summary of sactions: N nodula. RL right loba. LL left loba. IS isthmus. Summary of Sections: Part 1: SP: Delphian lymph node (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 2: SP: Total thyroid; Thyroidectomy. Block. Sect. Site. PCs. 1. is. 1. 1. Il. 1. 8. n. 8. 1. rl. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 1. FROZEN SECTION DIAGNOSIS: SP: DELPHIAN LYMPH NODE (FS): BENIGN LYMPH NODE. PERMANENT DIAGNOSIS: SAME.",T3,N0,M0,T3N0M0
TCGA-DC-6156,"Clinical Diagnosis & History: Abdominal pain and underwent colonoscopy found mass at 20cm from. . CT. scan revealed multiple liver metastases and sigmoid mass biopsy confirmed. invasive adenocarcinoma carcinoma at sigmoid colon with liver metastasis. Specimens Submitted: 1: SP: SIGMOID AND UPPER RECTUM; RESECTION. 2: SP: Proximal ring. 3: SP: Distal ring. 4: SP: Umbilical hernia sac. DIAGNOSIS: 1. SP: SIGMOID AND UPPER RECTUM; RESECTION: Tumor Type: Adenocarcinoma. Histologic Grade: Moderately differentiated. Tumor Location: Rectosigmoid. Tumor Size: Length is 5.5 cm. Width is 3.5 cm. Maximal thickness is 2.5 cm. Tumor Budding: Extensive. Increased Tumor Infiltrating Lymphocytes: Absent. Precursor Lesions: Not identified. Deepest Tumor Invasion: Serosal surface. Gross Tumor Perforation: Not identified. Lymphovascular Invasion: Suspected. Large Venous Invasion: Suspected. Perineural Invasion: Identified. Surgical Margins: Free of tumor. Surgical Margins: Free of tumor. 0.15 cm between deepest tumor portion and deep (radial soft. tissue) margin. Polyps/Mucosa Dysplasia (away from the carcinoma) : Not Identified. Non-Neoplastic Bowel: Unremarkable. Lymph Nodes: Number with metastasis: 7. Total number examined: 22. Tumor deposits in pericolorectal soft tissue: Not Identified. Tumor Staging (AJCC. pT4a (Tumor penetrates to the surface of thevisceral peritoneum). Lymph Node Stage (AJCC. N2b (Metastasis in seven or more regional lymph nodes). 2. COLON, PROXIMAL RING; EXCISION: -BENIGN COLONIC TISSUE. COLON, DISTAL RING; EXCISION: -BENIGN COLONIC TISSUE. 4. HERNIA SAC, UMBILICAL; HERNIORRHAPHY: -METASTATIC ADENOCARCINOMA, MODERATELY DIFFERENTIATED, CONSISTENT WITH. COLONIC PRIMARY. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) , AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1) The specimen is received fresh and is labeled ""sigmoid and upper. rectum"". It consists of a rectosigmoid colon that measure 20 x 12 x 8 cm. The radial resection margin is inked black and the serosa is inked blue. The serosa shows a large area of retraction 7 cm from the distal margin. The specimen is opened to reveal a circumferential, constricting tumor that. is located 11 cm from the proximal margin and 7 cm from the distal margin. The tumor measures 5.5 cm in length and 3.5 cm in width. Serial sectioning. reveals tumor invasion to a depth of 2.5 cm, which is 0.5 cm from the. closest radial margin. The remaining mucosa shows no abnormality. Pericolic and peri-rectal adipose tissue is submitted for lymph node. dissection, and all possible nodes are submitted. Also received is a. separate portion of omentum with dimensions of 15 x 9 x 2 cm. The omentum. is diffusely involved by firm white tumor. Representative sections are. submitted. TPS is submitted. Summary of sections: PM - proximal margin. DM - distal margin. TS- tumor to serosa. TR- tumor to radial margin. T tumor. U - uninvolved mucosa. o- omentum. LN - lymph nodes. BLN - bisected lymph node. 2) The specimen is received in formalin, labeled ""Proximal ring"" and. consists of a silver metal anastomotic pin measuring 7.5 X 2.8 x 1.5 cm. At. the center of the pin, a white plastic piece is noted. A ring of pink tan. soft tissue is attached measuring 2 x 1.5 x 1 cm. The mucosal surface is. pink tan and focally hemorrhagic and the serosal surface is pink tan and. smooth. Several sutures and staples are noted. The sutures and staples are. removed and the soft tissue is entirely submitted. Summary of sections: U undesignated. 3) The specimen is received in formalin, labeled ""Distal ring"" and consists. of a ring of pink tan soft tissue measuring 2.2 x 2 x 1 cm. Multiple. sutures and staples are attached. The mucosal surface is pink tan and. focally hemorrhagic. The sutures and staples are removed and the soft. tissue is entirely submitted. Summary of sections: U undesignated. 4) The specimen is received in formalin, labeled ""Umbilical hernia sac"" and. consists of a pink tan fibromembranous tissue measuring 5.5 x 3.5 x 0.6 cm. Serial sectioning reveals a white-tan firm mass measuring 1.1 x 1.0 x 0.7. cm. Representative sections are submitted. Summary of sections: M mass. RS - remaining specimen, representatively. Summary of Sections: Part 1: SP: SIGMOID AND UPPER RECTUM; RESECTION. Block. Sect. Site. PCs. 1. BLN. 2. 1. DM. 1. 8. LN. 23. 2. o. 2. 1. PM. 1. 3. T. 3. 2. TR. 2. 2. TS. 2. Part 2: SP: Proximal ring. Block. Sect. Site. PCs. 1. U. 1. Part 3: SP: Distal ring. Block. Sect. Site. PCs. 1. U. 1. Part 4: SP: Umbilical hernia sac. Block. Sect. Site. PCs. 2. M. 4. 2. RS. 4.",T4,N2,M1,T4N2M1
TCGA-BP-4352,"Clinical Diagnosis & History: Right renal mass. Specimens Submitted: 1: KIDNEY AND PARTIAL ADRENAL, RIGHT; TOTAL NEPHRECTOMY AND PARTIAL ADRENALECTOMY. 2: LYMPH NODES, PARACAVAL: EXCISION. 3: LYMPH NODES, HILUM; EXCISON. DIAGNOSIS: 1. KIDNEY AND PARTIAL ADRENAL, RIGHT; TOTAL NEPHRECTOMY AND PARTIAL ADRENALECTOMY: Tumor Type: Renal cell carcinoma - Conventional (clear cell) type. with extensive (>75%) sarcomatoid differentiation. Fuhrman Nuclear Grade: Nuclear grade IV/IV. Tumor Size: Greatest diameter is 10 cm. Local Invasion (for renal cortical types): Involves Gerota's fascia. Extends into renal pelvis. Involves renal sinus fat. Involves renal hilar fat. (Forms polypoid mass protruding into renal pelvis without ulcerating the epithelium). Renal Vein Invasion: Identified. Small vessel angiolymphatic invasion also identified. Surgical Margins: Tumor present at soft tissue margin. Non-Neoplastic Kidney: Mild arteriosclerotic changes. Adrenal Gland: Not involved. Lymph Nodes: Not identified. Staging for renal cell carcinomaloncocytoma: pT3b Tumor grossly extends into the renal vein(s) or vena cava below the diaphragm. 2. LYMPH NODES, PARACAVAL; EXCISION: Lymph Nodes: Number of nodes examined:1. Number of metastatic nodes:0. 3. LYMPH NODES, HILUM; EXCISON: Lymph Nodes: Number of nodes examined:9. Number of metastatic nodes:0. JATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL). AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. CA-1X. CD10. NEG CONT. IMM RECUT. Gross Description: 1) The specimen is received fresh labeled ""right kidney and partial adrenal and consists of a kidney with attached ureter, renal. vessels, partial adrenal and perinephric fat weighing 607 g in total. The kidney measures 14.5 x 10.0 x 7.0 cm. The attached. ureter measures 8.0 cm in length and 0.2 cm in diameter. The attached renal vein measures 1.5 cm in length and 2.0 cm in. diameter. The renal vessel and ureteric margins are grossly free of tumor. A partial adrenal gland is identified, measuring 4.0x. o.g x 0.2 cm and weighing 1.06 g. The kidney is inked black and bivalved to reveal a 10.0 x 10.0 X 6.5 cm tumor Sectioning. reveals tan-red to orange yellow, focally necrotic soft areas and gray white firm areas. The tumor grossly extends to the perirenal. fat. All of the surgical margins are grossly negative. A tumor embolus is identified in the renal vein. A 0.4 cm in diameter tan. nodule is identified on the pelvic mucosa. Sections through the remainder of the kidney reveal a pink brown parenchyma, with a. well-defined cortico-medullary junction. The cortex measures 0.6 cm and the calyces appear normal. The adrenal gland is. grossly unremarkable. No lymph nodes are identified in the perinephric fat. The specimen is photographed. Representative. sections are submitted for TPS and for permanent sections. Summary of sections: UVM -- ureteral and vessel margins. T-- tumor. THE tumor with hilar fat. TSF -- tumor with sinus fat. TK -- tumor with adjacent kidney. RP -- renal pelvis representative sections with nodule. K representative sections kidney. AD -- adrenal gland. RVT -- renal vein with tumor thrombus. 2). The specimen is received in formalin labeled ""Paracaval lymph nodes"" and consists of a single lymph node measuring 2x 1.3. x 0.8 cm. The lymph node is sectioned and entirely submitted. Summary of sections: LN- yymph node. 3). The specimen is received in formalin labeled ""Hilum and lymph nodes"". It consists of multiple lymph nodes ranging from 0.3. x. 0.3 cm up to 2.0 cm X 1.5 cm in greatest dimensions. The lymph nodes are entirely submitted. Summary of sections: LN-lymph nodes. LN1-lymph node number one. LN2-lymph node number two. Summary of Sections: Part 1: KIDNEY AND PARTIAL ADRENAL, RIGHT; TOTAL NEPHRECTOMY AND PARTIAL ADRENALECTOMY. Block. Sect. Site. PCs. 1. ad. 1. 1. 1. 1. rp. 1. 1. rvt. 1. 10. t. 10. 1. thf. 1. 2. tk. 2. tsf. 1. 1. uvm. 1. Part 2: LYMPH NODES, PARACAVAL; EXCISION. Block. Sect. Site. PCs. 2. In. 2. Part 3: LYMPH NODES, HILUM; EXCISON. Block. Sect. Site. PCs. 2. In. 2. 2. In 1. 2. 1. in2. 1.",T3,N0,M1,T3N0M1
TCGA-BP-4173,"Clinical Diagnosis & History: with large 9 x 9 cm right renal mass. Specimens Submitted: 1: SP: Right kidney. 2: SP: Paracaval nodes. DIAGNOSIS: 1). KIDNEY, RIGHT; RADICAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE, NUCLEAR GRADE III/IV. - THE PATTERN OF GROWTH IS SOLID. - THE TUMOR GREATEST DAMETER IS 9.5 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. - ALL SURGICAL MARGINS ARE FREE OF TUMOR,. - THE NON-NEOPLASTIC KIDNEY SHOWS FOCAL CHRONIC PYELONEPHRITIS AND GLOMERULOSCLEROSIS. - THE ADRENAL GLAND IS NOT SUBMITTED. 2). LYMPH NODES, PARACAVAL; EXCISION: - FIVE BENIGN LYMPH NODES (0/5). The specimen is received fresh, labeled ""Right Kidney"". It consists of a total nephrectomy specimen weighing 892 grams. and measuring 15.5 X 10.2 x 6.4 cm in overall dimensions. No adrenal gland identified. The tumor measures 9.5 x 7.2 X. 5.9. cm. and is located at the lower pole of the kidney, extending to the middle portion. The tumor is lobulated with a brown-yellow. parenchyma and multiple areas of hemorrhage and necrosis. The renal pelvis is not directly involved by tumor. The. non-neoplastic kidney has a normal architecture. The surface of the specimen is inked and a portion of the specimen. is. submitted for TPS. Photographs are taken before and after the bisection. Representative sections are submitted. Summary of Sections: FSC - frozen section control. T - tumor. NL - normal kidney. RPV - renal pelvis. TPCE - tumor with possible pericortical extension. MS - margin sections. 2). The specimen is received in formalin labeled, ""Paracaval nodes"". It consists of multiple pieces of yellow tan fatty tissue. measuring 4.0 x 3.0 x 0.8 cm in aggregate. On dissection, there are multiple lymph nodes identified measuring 1:2 X 1.2 X. 0.4. cm in aggregate. The lymph nodes are entirely submitted. Summary of sections: U - undesignated. Summary of Sections: Part 1: SP: Right kidney (fs) (tl/Img). Block. Sect. Site. PCs. 1. fsc. 1. 1. ms. 1. 1. ni. 1. rpv. 1. 6. t. 6. 2. tpce. 2. Part 2: SP: Paracaval nodes (tl). Block. Sect. Site. PCs. 1. u. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: CORTICAL NEOPLASM, FAVORING RENAL CELL CARCINOMA, CONVENTIONAL. CLEAR CELL TYPE. PERMANENT DIAGNOSIS: SAME.",T2,N0,M0,T2N0M0
TCGA-D8-A1JU,"page 1 / 1. Examination: Histopathological examination. PESEL: Gender: F. Material: Multiple organ resection - left breast. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the left breast - lesion in the upper outer quadrant. Results of immunohistochemical examination: Estrogen receptors found in 75% of neoplastic cell nuclei. Progesterone receptors found in 75% of neoplastic. cell. nuclei. HER2 protein stained with HercepTest by DAKO. Negative reaction in invasive cancerous cells. (Score = 1+ ). Macroscopic description: Left breast sized 20 x 13 x 2 cm removed without axillary tissues. Skin flap. 20 x 9.5 cm in size. Tumour sized 1.7 x 1.8 x 1.5 cm found on the boundary of outer quadrants, placed 2 cm. from the lower edge, 0.2 cm from the base and 1.0 cm from the skin. Cysts of 0.1 - 0.5 cm in the crass-. section. Microscopic description: Carcinoma ductale invasivum NHG1 (2+2+1 /1 mitosis /10 HPF, vision area diameter 0.57 mm). Additionally, focuses of carcinoma ductale in situ: cribrate type with medium nuclear atopia, no. necrosis, found in the glandular tissue (30% of the tumour cross-section). Glandular tissue showing lesions of the type: mastopathia fibrosa et cystica, adenosis sclerosans,. fiat epithellal atypia ( FEA). fibrocystic changes, sclerosing adenosis. Histopathological diagnosis: (including test No. G-15785/10): Carcinoma ductale invasivum et in situ mammae sinistrae. ( NHG 1, pT1c, pNo/sn/). Invasive and in situ ductal carcinoma of the left breast.",T1,N0,M0,T1N0M0
TCGA-AG-3574,"Diagnosis/ diagnoses: Rectal resection preparation with an ulcerated rectal carcinoma histologically characterized. as a moderately differentiated colorectal adenocarcinoma, extending at most to within 4 cm. of the aboral resection margin, and with a maximum diameter of 6 cm at the widest point. Invasive tumor spread within all rectal wall layers up to the bordering periproctic soft. tissue. Oral and aboral resection margins are tumor-free. 18 periproctic and pericolic lymph nodes are tumor-free with non-characteristic reactive. lesions. Stage of tumor: pT3 pNO (0/18) LO V0; G2.",T3,N0,M0,T3N0M0
TCGA-AQ-A7U7,"Diagnosis: A: Breast, left, total mastectomy. Tumor type: invasive lobular carcinoma. Nottingham combined histologic grade: 2. Tubule formation score: 3. Nuclear pleomorphism score: 2. Mitotic count score: 1. Focality of tumor: single focus. Tumor site: upper outer and lower outer quadrants. Tumor size (greatest dimension) : 4.1 cm (see comment). Lymphovascular invasion: none identified. Ductal carcinoma in situ (DCIS) : none identified. Lobular carcinoma in situ (LCIS) : present. Nipple involvement : not involved. Skin involvement : not involved. Skeletal muscle involvement: not applicable. Margin status: Invasive component : Margins free of carcinoma, closest is black. inked posterior margin at 2 mm. Size of largest metastasis : 4.1 cm. Extracapsular extension: absent. Axillary lymph nodes (from parts B-G) : Total number with metastasis : 2. Total number examined: 7. Size of largest metastatic focus: 0.7 cm. Extracapsular extension: absent. Microcalcifications: associated with benign breast changes. Other pathologic findings: Extensive stromal fibrosis with patchy amyloid deposition. - Fibrocystic changes. - Columnar cell change. - Epidermal inclusion cyst. - Previous biopsy site changes. AJCC PATHOLOGIC TNM STAGE: pT2 pN1a. BREAST STAGE GROUPING: IIB. Note: This pathologic stage assessment is based on information. available at the time of this report, and is subject to change. pending clinical review and additional information. Ancillary studies previously performed on core biopsy case and. reported as : Estrogen receptor: positive, 88%, 3+. Progesterone receptor: positive, 82%, 3+. HER2/neu: negative for overexpression, 0. B: Lymph node, left axillary sentinel lymph node #1, biopsy. - One lymph node positive for metastatic carcinoma (1/1) based. on H & E and cytokeratin stained slides. - Metastatic focus measures 0.5 cm. - No extracapsular extension is identified. - Amyloid present. C: Lymph node, left axillary sentinel lymph node #2, biopsy. - One lymph node negative for metastatic carcinoma (0/1) based. on H & E and cytokeratin stained slides. - Amyloid present. D: Lymph node, left axillary sentinel lymph node #3, biopsy. - One lymph node positive for metastatic carcinoma (1/1) based. on H & E and cytokeratin stained slides. - Metastatic focus measures 0.7 cm. - No extracapsular extension is identified. - Amyloid present. E: Lymph node, left axillary sentinel lymph node #4, biopsy. - Two lymph nodes negative for metastatic carcinoma (0/2) based. on H & E and cytokeratin stained slides. - Amyloid present. F: Lymph node, left axillary sentinel lymph node #5, biopsy. - One lymph node negative for metastatic carcinoma (0/1) based. on H & E and cytokeratin stained slides. - Amyloid present. G: Lymph node, left axillary sentinel lymph node #6, biopsy. - One lymph node negative for metastatic carcinoma (0/1) based. on H & E and cytokeratin stained slides. - Amyloid present. Clinical History: -year-old female with left breast invasive lobular carcinoma. Gross Description: Received are seven appropriately labeled containers. Container A: Specimen fixation: formalin. Time in fixative: 33 hours. Cold ischemic time: 71 mins. Type of mastectomy: left total mastectomy. Weight of specimen: 330 grams. Size of specimen: anterior to posterior, 2.5 cm; superior to. inferior, 19.0 cm; medial to lateral, 20.0 cm. Orientation of specimen: The specimen is oriented with a stitch. in the axillary tail. Inking: anterior=blue, posterior=black, axillary tail=dotted. yellow. Skin ellipse dimensions: 19.0 X 5.8 cm. Nipple/areola 1.4 cm/3.0 cm. Axillary tail: present, minimal tissue. Biopsy site: absent. Discrete Mass (es) : Area of fibrotic, homogeneously firm,. white/tar tissue. Number of discrete masses : one. Size of fibrotic tissue: 7.5 cm from medial to lateral, 6.7 cm. from superior to inferior, and 3.5 cm from anterior to posterior. Location of fibrotic tissue: upper inner quadrant, upper outer. quadrant, lower outer quadrant (includes the area deep to the. nipple/areola). Distance of mass/biopsy site from surgical margin: The fibrotic. tissue abuts the black inked deep margin extensively, it also. abuts the blue inked anterior margin in multiple slices. Gross involvement of skin or fascia/muscle by tumor: The tumor. extends very close to the skin, however, does not appear to. grossly involve the skin. Description of remaining breast : predominantly yellow lobular. adipose tissue. Other remarkable features : none. Tissue submitted for special investigations: Tumor and normal. submitted to Tissue Procurement foundation. Block Summary: A1 - nipple, perpendicular sections, in relation to the tumor. A2 - nipple, perpendicular sections, in relation to the tumor. A3, A4 - perpendicular sections of the areola, in relationship to. the deep tumor. A5, A6 - representative section of the tumor, in relation to the. blue inked inferior margin. A7, A8 - representative section of the tumor, in relation to the. black inked deep margin. A9,A10 - additional representative sections of the mass. A11 - representative section, upper outer quadrant. A12 - representative section, lower outer quadrant. A13 - representative section, upper inner quadrant. A14 - representative section, lower inner quadrant. Additional sections, upper outer quadrant surrounding metallic. clip, lateral to medial: A19 - one section bisected. A20 - one section bisected. A21-A22 - - one section bisected. A23-A24 - one section bisected. A25 - one section. A26 - one section. A27 - one section. A15-A18, A28-A67 additional sections from lateral towards. medial, respectively. Container B is additionally labeled ""lymph node, left axillary. sentinel lymph node #1. Received is a single, unoriented,. yellow lobular adipose tissue fragment, 3.7 X 3.0 X 1.0 cm. A. single lymph node candidate, 2.2 X 1.3 X 0.8 cm is identified. and is sequentially sectioned at 2 mm intervals. The entire. lymph node is submitted in blocks B1 and B2. Adipose tissue. remains in the container. Container C is additionally labeled ""lymph node, left axillary. sentinel lymph node #2. Received is a single, unoriented,. brown/tan fibroadipose tissue fragment, 3.4 X 2.3 X 1.3 cm. A. single, possibly two, lymph node candidates matted together are. identified, 2.3 X 2.3 X 0.8 cm. The lymph node candidate is. serially sectioned at approximately 2 mm intervals and is. entirely submitted in blocks C1-C3. Adipose tissue remains in. the container. Container D is additionally labeled ""lymph node, left axillary. sentinel lymph node #3. "" Received is a single, unoriented,. brown/tan fibroadipose tissue fragment, 1.8 X 1.8 X 1.5 cm. A. single lymph node candidate, 1.2 X 0.8 X 0.8 cm is identified,. is serially sectioned at approximately 2 mm intervals and. entirely submitted in blocks D1 and D2. Adipose tissue remains. in the container. Container E is additionally labeled ""lymph node, left axillary. sentinel lymph node #4. "" Received is a brown/tan, single,. unoriented fibroadipose tissue fragment, 1.5 X 1.0 X 0.9 cm. Two. lymph node candidates, 0.5 and 0.2 cm in diameter are. identified. The larger lymph node is bisected and submitted in. block E1. The smaller lymph node is submitted in block E2. without sectioning. Adipose tissue remains in the container. Container F is additionally labeled ""lymph node, left axillary. lymph node #5. "" Received is a single, unoriented, brown/tan. fibroadipose tissue fragment, 1.2 X 1.2 X 0.6 cm. A single lymph. node candidate, 1.1 X 0.8 X 0.6 cm is identified. The lymph node candidate is serially sectioned at approximately. 2 mm intervals and entirely submitted in block F1. Adipose. tissue remains in the container. Container G is additionally labeled ""lymph node, left axillary. sentinel lymph node #6. Received is a single, gray/tan,. unoriented, 1.0 X 0.9 x 0.6 cm lymph node candidate. The. specimen is serially sectioned, at approximately 2 mm. intervals, and entirely submitted in blocks G1 and G2,.",T2,N2,M0,T2N2M0
TCGA-HV-A5A6,"Pancreas Cancer. <Slide key: A: pancreatic resection margin, B. #13, C: LN #14, D: omentum,. E: LN #5, F: LN #8, G: LN #12, H: LN 13#, 1: LN 16#, 1: 2-5: duodenum. (2: ampulla of vater, 3. 6: duodenum. 7-8: CBD. 9: CBI. 0-11: GB. (10: CBD opening. , 12: 13: ampulla of vater. MICRO (25HE). DIAGNOSIS: Head of pancreas, duodenum, common bile duct and gallbladder,. pylorus-preserving pancreat ticoduodenectomy: Ductal adenocarcinoma, well differentiated, pancreas. with 1) tumor size: 3.5x2.3cm. 2) extension to per ipancreatic soft tissue. 3) invasion to duodenum, common bile duct and ampulla of Vater. 4) perineural invasion, multifocal. 5) venous invasion: not identified. 6) clear pancreatic, common bile duct and duodenal resection margins. 7) metastasis to two out of 22 regional Tymph nodes. (LN #13: 0/4, LN #14: 0/1, LN #5: 0/0, LN #8: 0/2, LN #12: 0/11,. LN #16: 0/13, per ipancreatic LN: 1/1). 8) pathologic staging: pT3 N1b.",T3,N1,M0,T3N1M0
TCGA-E2-A1L8,"SPECIMENS: A. SLN#1 LEFT AXILLA. B. LEFT BREAST AND AXILLARY CONTENTS. C. SENTINEL LYMPH NODE BX. RIGHT AXILLA. D. SENTINEL LYMPH NODE #2 RIGHT AXILLA. E. RIGHT BREAST & AXILLARY CONTENTS. F. ADDITIONAL AXILLARY TISSUE. SPECIMEN(S): A. SLN#1 LEFT AXILLA. B. LEFT BREAST AND AXILLARY CONTENTS. C. SENTINEL LYMPH NODE BX. RIGHT AXILLA. D. SENTINEL LYMPH NODE #2 RIGHT AXILLA. E. RIGHT BREAST & AXILLARY CONTENTS. F. ADDITIONAL AXILLARY TISSUE. GROSS DESCRIPTION: A. SLN#1 LEFT AXILLA. Received fresh is a tan white firm lymph node 2.6 x 2.1 x 1.4cm. The lymph node is serially sectioned. and a portion of the specimen is submitted in FSA. A portion of the specimen is submitted for tissue. procurement. The remainder of the specimen is submitted in A2-A3. B. LEFT BREAST AND AXILLARY CONTENTS. STITCH IN AXILLA. Received fresh is a 1651g oriented total mastectomy specimen 29.5 x 27.0 x 4.0cm. The specimen is. partially surfaced with a tan brown ellipse of skin 26.5 x 11cm. The centrally located partially raised. nipple is 0.9cm and the areolar rim is 1.2cm. The skin surface is remarkable for a well healed scar. 1.5cm, 2.0cm from the nipple in the Upper Outer Quadrant. The specimen is inked as follows: Anterior/Superior-Blue, Anterior/Inferior-Orange, Posterior-Black. The specimen is serially sectioned. from medial to lateral in to 13 slices; slice 1 being most medial, slice 13 being most lateral. The nipple is. located in slice 10. The cut surfaces reveal a gray white stellate mass 2.3 x 2.0 x 2.0cm in the UOQ and. UCQ of slice 9, 10 and 11. The mass is greater than 2.0cm from the deep margin. The remaining breast. parenchyma is grossly unremarkable. The axillary tail is 6.0 x 4.0 x 2.0cm. Dissection reveals 15. possible lymph nodes ranging from 0.3 x 0.2 x 0.2cm to 2.0 x 1.5 x 1.5cm. A portion of the specimen is. submitted for tissue procurement. Representative sections are submitted as follows: B1: nipple slice 10. B2: base of nipple slice 10. B3: skin with possible scar slice 8. B4: UIQ slice 7. B5: LIQ slice 7. B6: area adjacent to mass UIQ slice 8. B7-B8: mass UIQ slice 9. B9: deep margin slice 9. B10: superior/anterior margin slice 9. B11: inferior/anterior margin slice 9. B12-B14: mass slice 10. B15: deep margin slice 10. B16: mass UOQ slice 11. B17: deep margin slice 11. B18: LOQ with deep margin slice 11. B19: LOQ with inferior margin slice 12. B20: 5 lymph nodes. B21: 5 lymph nodes. B22: 3 lymph nodes. B23: 1 lymph node serially sectioned. B24: 1 lymph node serially sectioned. C. SLN# 2 RIGHT AXILLA. Received fresh is a tan white firm lymph node 1.5 x 1.0 x 0.6cm. The lymph node is serially sectioned. and a portion of the specimen is submitted in FSC. The remainder of the specimen is submitted in C2. D. SLN # 3 RIGHT AXILLA. Received fresh is a tan white firm lymph node 0.9 x 0.6 x 0.4cm. The lymph node is serially sectioned. and a portion of the specimen is submitted in FSD. The remainder of the specimen is submitted in D2. E. RIGHT BREAST AND AXILLARY CONTENTS. Received in formalin is an oriented simple mastectomy specimen weighing 1892 g and measuring 38.5. x 33 x 4.2 cm. There is a stitch designating the axillary tail. On the surface is an ellipse of brown-tan. skin measuring 26.5 cm in length and 10.3 cm in width. The skin surface is unremarkable. The areola. is 3.8 cm in diameter with an everted nipple measuring 1.4 cm. The anterior surface of the specimen is. inked blue and the posterior/deep margin is inked black. The specimen is serially sectioned from. medial to lateral. Within the upper inner quadrant and 8 cm from the deep margin is a firm tan stellate. lesion {#1} measuring 3.3 X 2.5 x 1.3 cm which extends into an hour-glass configuration. Approximately. 2.3 cm lateral and inferior to this lesion is a firm tan stellate lesion {#2} measuring 1.3 x 1 x 0.8 cm. It is. 3.8 cm from the anterior/skin. The remainder of the parenchyma is unremarkable. The axillary tail was. serially sectioned and fixed in O-Fix. Two hemorrhagic lymph nodes are identified measuring 1.8 and. 2.3 cm. Representative sections are submitted as follows: E1: Margin deep to lesion. E2-E6: Lesion #1 submitted from medial to lateral. E7-E8: Lesion #1and adjacent deep tissue. E9: Tissue inferior to lesion #1 from blocks 7 and 8. E10: Left lateral portion of lesion #1. E11: Tissue inferior to block 10. E12-E15: Tissue adjoining lesion #1 and lesion #2. E16-E17: Lesion #2. E18-E19: Fibrous tissue from upper outer quadrant. E20-E21: Fibrous tissue from lower outer quadrant. E22-E23: Fibrous tissue from lower inner quadrant. E24: Skin. E25-E26: Nipple. E27-E28: 1 lymph node each. E29-E30: presumptive lymph nodes from the axillary region. F. ADDITIONAL LEFT AXILLARY TISSUE. Received in formalin is a piece of yellow-tan adipose tissue measuring 8.5 x 3.5 x 0.6 cm. Two lymph. nodes are identified measuring 0.8 and 1.4 cm. Specimen is submitted entirely as follows: F1-F2: one lymph node each. F3-F6: remainder of soft tissue. DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, LEFT AXILLA, BIOPSY: - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1),. MEASURING 2-CM WITH EXTRANODAL EXTENSION. B. BREAST, LEFT, MASTECTOMY AND AXILLARY LYMPH NODE DISSECTION: - INVASIVE, LOBULAR CARCINOMA, SBR GRADE 2, MEASURING 2.2-CM. - SURGICAL RESECTION MARGINS NEGATIVE FOR TUMOR. - METASTATIC CARCINOMA TO ONE OF 12 LYMPH NODES (1/12). - SEE SYNOPTIC REPORT. C. LYMPH NODE, SENTINEL #2, RIGHT AXILLA, BIOPSY: - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1),. MEASURING 0.6-CM, WITH NO EXTRANODAL EXTENSION. D. LYMPH NODE, SENTINEL #3, RIGHT AXILLA, BIOPSY: - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1). E. BREAST, RIGHT, MASTECTOMY AND AXILLARY LYMPH NODE DISSECTION: - INVASIVE, DUCTAL CARCINOMA, SBR GRADE 2, MEASURING 3.3-CM,. PRESENT IN A BACKGROUND OF EXTENSIVE DUCTAL CARCINOMA IN. SITU. - INTERMEDIATE NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU,. CRIBRIFORM AND SOLID TYPES WITH CENTRAL NECROSIS, INVOLVING. THE CENTRAL PORTION OF THE BREAST WITH EXTENSION TO MAJOR. DUCTS OF NIPPLE, UPPER INNER AND LOWER INNER QUADRANTS. - SURGICAL RESECTION MARGINS NEGATIVE FOR TUMOR. - THREE LYMPH NODES, NEGATIVE FOR METASTASES (0/3). - SEE SYNOPTIC REPORT AND SEE NOTE. F. LYMPH NODES, ADDITIONAL AXILLARY, DISSECTION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). NOTE: The right breast is involved by extensive DCIS. There are two grossly identified tumor masses,. microscopically show invasive ductal carcinoma. The submitted tissue between these two masses. shows microscopic foci of invasive tumor as well as DCIS. The largest confluent invasive tumor. measures 3.3-cm. Breast biomarkers were ordered on the right breast tumor and addendum report to follow. These. markers were reported on the needle biopsy of the left breast . SYNOPTIC REPORT - BREAST. Specimens Involved. Specimens: A: SLN#1 LEFT AXILLA. B: LEFT BREAST AND AXILLARY CONTENTS. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive lobular carcinoma 8520/3. Tumor size: 2.2cm. Tumor Site: Upper outer quadrant. Upper inner quadrant. Margins: Negative. Tubular Score: 3. Nuclear Grade: 3. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node and axillary dissection. Lymph node status: Positive 2 / 13 Extranodal extension. DCIS not present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT 2 N 1a. SYNOPTIC REPORT - BREAST. Specimens Involved. Specimens: C: SENTINEL LYMPH NODE BX. RIGHT AXILLA. D: SENTINEL LYMPH NODE #2 RIGHT AXILLA. E: RIGHT BREAST & AXILLARY CONTENTS. F: ADDITIONAL AXILLARY TISSUE. Specimen Type: Mastectomy. Needle Localization: Laterality: Right. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3.3cm. Tumor Site: Upper inner quadrant. Lower inner quadrant. Central. Margins: Negative. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node and axillary dissection. Lymph node status: Positive 2/6 Extranodal extension. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 75%. DCIS Type: Solid. Cribriform. DCIS Location: Both associated and separate from invasive tumor mass. Nuclear grade: Intermediate. Necrosis: Present. ER/PR/HER2 Results. ER: Pending. PR: Pending. HER2: Pending. Pathological staging (pTN): pT2N1a. CLINICAL HISTORY: year old post menopausal AA woman with abnormal screening mammogram and bilateral breast. neoplasia. Left breast 2.5 x 1.5cm mass at 12:00 is invasive lobular Ca. Right breast with 2, 1cm foci of. DCIS at 3 o'clock medial and subareolar position. No prior chemo. PRE-OPERATIVE DIAGNOSIS: R and L breast Ca. INTRAOPERATIVE CONSULTATION. FSA: Metastatic carcinoma extensively involving one lymph node. Diagnosis called to Dr. at. Dr. FSC/FSD: Metastatic carcinoma extensively involving one lymph node. Diagnosis called to Dr at. by Dr. ADDENDUM: SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimens Involved. Specimens: E: RIGHT BREAST & AXILLARY CONTENTS. Specimen: Surgical Excision. Block Number: E6. ER: Positive. Allred Score: 8 = Proportion Score 5 + Intensity Score 3. PR: Positive Allred Score: 6 = Proportion Score 4 + Intensity Score 2. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the. proportion score (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of. cells staining, 4 = 31-60% of cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak. intensity of staining, 2 = intermediate intensity of staining, 3 = strong intensity of staining), with a scoring. range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score. of less than or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistry was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR. 136, 1:100) provided by. following the manufacturer S instructions. This. assay was not modified. Interpretation of the ER/PR immunohistochemical stain is guided by published. results in the medical literature, information provided by the reagent manufacturer and by internal. review of staining performance. SYNOPTIC REPORT - BREAST HER-2 RESULTS. Specimens Involved. Specimens: E: RIGHT BREAST & AXILLARY CONTENTS. Specimen: Surgical Excision. Block Number: E6. Interpretation: EQUIVOCAL. Intensity: 2+. % Tumor Staining: 20%. Fish Ordered: Yes, on Date. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Her2 analysis was performed using the FDA approved. HercepTes (TM) test kit. using rabbit anti-human HER2. This assay was not modified. External kit-slides. provided by the manufacturer (cell lines with high, low and negative HER2 protein expression) and in-. house known HER2 amplified control tissue were evaluated along with the test tissue. Adequate, well. preserved, clear-cut invasive carcinoma was identified for HER2 evaluation. Interpretation of the HER2. immunohistochemical stain is guided by published results in the medical literature, information provided. by the reagent manufacturer and by internal review of staining performance. This assay has been validated according to the 2007 joint recommendations and guidelines from. ASCO and CAP and from the NCCN HER2 testing in Breast Cancer Task Force. The Pathology. Department takes full responsibility for this test's performance. Additional presumptive lymph nodes from part E (right mastectomy) were submitted in 15 blocks, from. E31 to E45. Three additional lymph nodes are identified, negative for metastasis (0/3). PathVysion HER-2 DNA Probe Kit. Analytical Interpretation of Results: HER-2 NOT AMPLIFIED. Clinical Interpretation of results. Amplification of the HER-2 gene was evaluated with interphase fluorescence in-situ. hybridization (FISH) on formalin-fixed paraffin embedded tissue sections using a chromosome. 17 centromeric probe and a HER-2 probe that spans the entire HER-2 gene in the. by Dr. majority of tumors cells displayed extensive polysomy 17. with 4 to 8 chromosome 17 signals and 4 to 8 HER-2 signals, with a HER-2/CEP 17 Ratio </=2.0,. consistent with no amplification of the HER2/neu gene. Block used E6. Source of case: Tissue fixation. formalin-fixed tissue. Outside Case No: NA. Tissue source. breast Results interpreted: HER2/CEP17 ratio: 0.95. This ratio is derived by dividing the total number of LSI HER-2/neu signals by the total number of. CEP17 signals in at least 20 interphase nuclei with nonoverlapping nuclei in the neoplastic. mammary epithelial cells. Cells with no signals or with signals of only one color are disregarded. Method of ratio enumeration: manual count. Limitations. The Vysis PathVysion Kit is not intended for use to screen for or diagnose breast cancer. It is. intended to be used as an adjunct to other prognostic factors currently used to predict disease-free. and overall survival in stage II, node-positive breast cancer patients. In making decisions regarding. adjuvant CAF treatment, all other available clinical information should also be taken into. consideration, such as tumor size, number of involved lymph nodes, and steroid receptor status. treatment decision for stage II, node-positive breast cancer patients should be based on HER-. 2/neu. gene amplification status alone. Overview of this test. FDA APPROVED REAGENT. PathVysion HER-2 DNA Probe Kit is FDA approved for selection of. patients for whom Herceptin therapv is being considered. These tests were performed in the. under the direction. of Dr.. The results of these studies should always be interpreted in the context of the. clinical, morphological, and immunophenotypic diagnosis. Microscopic/Diagnostic Dictation: Pathologist, (. Final Review: Pathologis. Final Review: Pathologis: Final: Pathologist, C. Addendum: Pathologist,. Addendum Final: Pathologist, L. Addendum: Pathologist, 0. Addendum Final: Pathologis. Addendum: Pathologist. Addendum Final: Pathologist,.",T2,N1,M0,T2N1M0
TCGA-EB-A5VU,"Gross Description: A mass is located in 3rd and 4th toes-feet. It is ulcerated and invasive, with. 5x4x1.5cm, firm, brown, black-gray surface. Microscopic Description: Epidermis is ulcerated and necrotic. Tumor is composed of sheets or groups of. spindle or oval tumor cells with quitely abundant cytoplasm. Sometime, the cytoplasm contains finely. divided melanin pigment granulaes. Tumor cells have a quite low nucleo-cytoplasmic ratio. Nucleus. varies in shape and size with large esinophilic nucleoli. Mitotic figures are common. Tumor is invasion of. lymph node, or fat tissue. Diagnosis Details: Malignant melanoma. Comments: Formatted Path Reports: SKIN TISSUE CHECKLIST. Specimen type: Surgical resection. Tumor site: Skin, foot. Tumor size: 3 x 3 x 1.5 cm. Tumor features: Ulcerated. Satellite nodules: Not specified. Histologic type: Malignant melanoma. Histologic grade: Poorly differentiated. Lymph nodes: 1/5 positive for metastasis (Left inguinal lymph node 1/5). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Breslow Thickness = 15 mm. Comments: None.",T4,N1,M0,T4N1M0
TCGA-CG-5721,"Diagnosis(es): 1. Distal gastric section with an ulcerated gastric carcinoma of maximum diameter 7.5 cm. extending up to 5 cm from the oral and 4 cm from the aboral resection margin and localized. on the greater curvature side, of the histological type of a moderately differentiated. adenocarcinoma (gastric carcinoma of the intestinal type). Invasive tumor dissemination. within all gastric wall layers into the perigastric fatty tissue, subserosa and localized. contiguous infiltration of all wall layers of the transverse colon adhering to the gastric wall. with the formation of a gastrocolic fistula. Oral and aboral resection margin of the distal gastric resection specimen as well as of the. colon and greater omentum tumor-free. One of nineteen perigastric and mesocolic lymph nodes with metastasis from the gastric. carcinoma and otherwise uncharacteristically reactive changes. Antral mucosa with fairly minor, florid, moderately chronic gastritis and foveolar. hyperplasia, and corpus mucosa with non-florid, fairly minor chronic gastritis of the. superficial type with evidence of Helicobacter pylori. 2.: Small wedge excision specimen of the liver including a subcapsularly localized biliary. harmatoma (von Meyenburg complex). 3.: Proximal partial gastric resection specimen including the esophageal cuff without. further fragments of the carcinoma mentioned under 1. 4.: Five tumor-free lymph nodes (hepatic artery) with uncharacteristically reactive changes. Therefore tumor stage: pT4 pN1 (1/24),.",T4,N1,M0,T4N1M0
TCGA-B9-7268,"Diagnosis: Kidney, left, partial nephrectomy. Histologic tumor type/subtype: papillary renal cell carcinoma,. type 2. Sarcomatoid features not identified. Histologic grade (if applicable) : Fuhrman nuclear grade 2 (of 4). Tumor size (greatest dimension) : 8.5 cm. Tumor focality: : focal. Extent of tumor invasion (if present specify if macroscopic or. microscopic) : Capsular invasion/perirenal adipose tissue: absent. Gerota' S fascia : absent. Renal sinus : not applicable. Major veins (renal vein or segmental branches, IVC) : not. applicable. Ureter: not applicable. Venous (large vessel) : absent. Lymphatic (small vessel) : absent. Histologic assessment of surgical margins : Renal parenchymal margin (partial nephrectomy only) : negative. Renal capsular margin (partial nephrectomy only) : negative. Paranephric adipose tissue margin (partial nephrectomy only) : negative. Gerota' S fascia (nephrectomy) : not applicable. Renal vein (nephrectomy) : not applicable. Ureter (nephrectomy) : not applicable. Adrenal gland: not submitted. Lymph nodes: none identified. AJCC Staging: pT2 pNx. This staging information is based on information available at. the time of this report, and is subject to change pending. clinical review and additional information. inical History : -year-old male with a left renal mass. Gross Description: Received is one appropriately labeled container, additionally. labeled ""left kidney"" and is a 159.8 gram 8.5 X 7.3 X 5.5 cm. circumscribed soft nodule, partially covered with a. predominantly intact capsule with a 1.3 cm irregular area of. disruption. The exposed parenchymal margin is 5.7 X 5.2 cm and. is inked black. The intact capsule is inked blue. Sectioning. demonstrates a solid soft golden yellow/tan cut surface abutting. blue and black inked capsular and parenchymal margins,. respectively. It also communicates with the orange inked. previously described defect. No cystic component is identified. There is a rim of renal parenchyma along the black inked. surgical margin. There is a small amount of attached perinephric. fat. The renal tissue at the periphery grossly appears. unremarkable. Block Summary: Inking: : capsule/blue, parenchyma/black, defect/yellow. A1 - tumor in relationship to black inked parenchymal margin. A2-A3 - - tumor and overlying capsule. A4 - edge of defect. A5-A6 - - central tumor.",T2,N0,M0,T2N0M0
TCGA-EK-A2R7,"Surgical Final Report. Temporary Copy. MS Specimen. A) Right common iliac lymph node. B) Uterus, cervix, bilateral ovaries/fallopian tubes. C). Right pelvic lymph nodes. D) Precaval and right periaortic lymph node. E) Left pelvic lymph. nodes. F) Left upper common and periaortic lymph nodes. MS Clinical History. Cervical cancer. MS Gross Description. The specimen is received fresh in 6 containers designated with the patient's name. Part A is designated ""right common iliac lymph node"". The specimen consists of a 2.7 cm in. greatest dimension single lymph node. The cut surface is tan to pink with a slight lobular. architecture. The lymph node appears grossly positive for tumor involvement. A portion of. the lymph node is taken for the. protocol. A1. Additional cross sections of the lymph node. Part B is designated ""cervix, uterus, bilateral tubes and ovaries"". The specimen consists of a. 9.7 x 6.0 x 4.9 cm, 192 g uterus with bilateral attached ovaries and fallopian tubes. The. uterine serosal surface is tan to pink and distended by underlying myometrial nodules. There are bilateral attached ovaries and fallopian tubes. The cervix is 3.2 cm in diameter. Surrounding the cervix is a vaginal cuff from 2.3 cm to 2.7 cm in width. The vaginal mucosa. is tan and grossly normal. The left fallopian tube is 3.2 cm in length with a diameter of 0.6. cm and has a normal architecture. The left ovary is 2.7 cm in greatest dimension. The. ovarian cut surface contains a unilocular simple cyst, 0.7 cm in greatest dimension. The. right fallopian tube is 4.3 cm in length with a diameter of 0.6 cm and has a normal. architecture. The right ovary contains 2 unilocular cysts, 0.4 cm and 0.7 cm in greatest. dimension. The cervix contains a 2.3 x 1.4 x 0.5 cm tan lobular mass primarily involving the. posterior cervix. The cut surface of the mass demonstrates a lesion extending to a depth of. approximately 0.3 cm. The mass is 4 cm from the posterior vaginal surgical margin and 2.1. cm from the posterior paracervical soft tissue surgical margin, 2.7 cm from the left soft. tissue surgical margin, 3.3 cm from the right soft tissue surgical margin, and 2.7 cm from the. anterior soft tissue margin. The cut surface demonstrates the mass does superficially. extend to involve the anterior cervix. The mass does not grossly involve the lower uterine. segment. B1. Representative sections of the left ovary and fallopian tube. B2. Representative sections of the right ovary and fallopian tube. B3-B4. Full thickness section of the anterior uterus. B5-B6. Full thickness section from the posterior uterus. B7-B9. Representative sections of the myometrial nodules. B10-B11. En face posterior vaginal mucosa surgical margin. Surgical Final Report . Temporary Copy. B12. En face anterior vaginal mucosa surgical margin. B13-B14. Full thickness section of the posterior cervix including underlying soft tissue. surgical margin. B15. Left cervical mass. B16. Right cervical mass. B17-B18. Anterior cervical mass, bisected (includes the anterior soft tissue margin). B19. Lower uterine segment. Part C is designated ""right pelvic lymph nodes"". The specimen consists of a portion of. fibroadipose tissue containing 11 lymph nodes up to 2.3 cm in greatest dimension. C1. Two lymph nodes, each bisected, one inked black. C2. Two lymph nodes, each bisected, one inked black. C3. Two lymph nodes, one is trisected, the remaining lymph node is inked black. and left intact. C4. One lymph node, trisected. C5. One lymph node, bisected. C6. One lymph node. C7. One lymph node, bisected. C8-C10. One lymph node. Part D is designated ""precaval + right periaortic lymph nodes"". The specimen consists of a. portion of fibroadipose tissue containing a single lymph node up to 0.7 cm in greatest. dimension. D1. One lymph node, bisected. Part E is designated ""left pelvic lymph nodes"". The specimen consists of a portion of. fibroadipose tissue containing 7 lymph nodes up to 2.8 cm in greatest dimension. E1. One lymph node. E2. One lymph node. E3. One lymph node. E4. One lymph node, bisected. E5-E6. One lymph node, bisected. E7. One lymph node, bisected. E8-E12. One lymph node. Part F is designated ""left upper common + periaortic lymph node"". The specimen consists of. a portion of fibroadipose tissue containing 2 lymph nodes, 0.7 cm and 0.9 cm in greatest. dimension. F1. One lymph node, trisected. F2. One lymph node, bisected. Surgical Final Report -. Temporary Copy. MS Microscopic Description. B13-B16: Sections of squamous cell carcinoma. B13: Representative section of tumor. A1: Metastatic lymph node. MS Diagnosis. A: Right common iliac lymph node: Metastatic squamous cell carcinoma (1/1, 1.2 cm, negative for extranodal extension). B: Uterus, cervix, bilateral tubes and ovaries, hysterectomy: Poorly differentiated squamous cell carcinoma of cervix, pT1b1. Benign inactive endometrium. Leiomyomata. Paratubal endometriosis. Unremarkable bilateral ovaries with follicular cysts. C: Right pelvic lymph nodes, regional disection: Negative for malignancy (0/11). D: Precaval and right periaortic lymph nodes: Negative for malignancy (0/1). E: Left pelvic lymph nodes, regional disection: Negative for malignancy (0/7). F: Left upper common and periaortic lymph nodes: Negative for malignancy (0/2). MS Comment. B: Cervix, Microscopic. HISTOLOGIC TYPE: Squamous cell carcinoma. HISTOLOGIC GRADE: G3: Poorly differentiated. PRIMARY TUMOR (pT) TNM [FIGO]: pT1b1 [IB1]: Cervical carcinoma confined to uterus, clinically visible lesion 4.0 cm or. less in greatest dimension. REGIONAL LYMPH NODES (pN): pN1: Regional lymph node metastasis. Number examined: 22. Number involved: 1. MARGINS: Margins uninvolved by invasive carcinoma. Distance of tumor from closest margin: 21 mm. Specify margin, if possible: Paracervical margin, posterior. Carcinoma in situ absent at distal margin. VENOUS/LYMPHATIC (LARGE/SMALL VESSEL) INVASION (V/L): Surgical Final Report. Temporary Copy. ID: : Present. MS Transcribed: MD. (Electronic Signature).",T1,N1,M0,T1N1M0
TCGA-A8-A07P,"On the basis of these findings, the following overall diagnosis is established: Left breast segment at 2 o'clock with a 3.5 cm invasive ductal breast carcinoma grade 3. (3/3/2) with minimum distance of 1 mm from dorsal resection margin and cranial resection. margin of 3 mm with very small components of ductal carcinoma in situ grade 3 with comedo. necrosis, as well as a lymph node with a tumor (1/11). Tumor classification: pT2 (3.5 cm), pN1 (1/11), MX grade 3 (LO/V0), R0 (dorsal 1 mm,. cranial 3 mm).",T2,N1,M0,T2N1M0
TCGA-DD-AADB,"CLINICAL DIAGNOSIS: Hepatocellular carcinoma. Specimen : liver. Gross Photo : GROSS: Specimen status: Fresh. Operation: Laparoscopic wedge resection. Organ: Liver (9.0 X 5.0 X 3.5 cm, 49.0 gm). Lesion: Hepatic mass. Size: 1.5 X 1.2 X 1.0 cm. Cut surface: Encapsulated, pale tan, solid and lobulated mass. No necrosis and hemorrhage. Gross type: Multinodular confluent. Extent: Abuts but confined to the capsule. Resection margin: Not involved, grossly (safety margin: 2.0 cm). Remaining parenchyme: Unremarkable, grossly. Representative sections are submitted. Gross photo: Present. Blocks. T1-4, mass of liver X 4. RM, mass with resection margin x 1. L, nontumorous liver parenchyme X 1. MICROSCOPIC: Tumor type: Hepatocellular carcinoma. The worst differentiation IV. The major differentiation III. Histologic type: Nesting. Cell type: Hepatic. Fatty change: No. Fibrous capsule formation: Yes. Capsular infiltration: Focal. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Vascular invasion: No. Bile duct invasion: No. Remaining liver parenchyme: Cirrhosis. IMMUNOHISTOCHEMISTRY: CD34 (-). NOT reported. Gross: Liver, resection, hepatocellular carcinoma. T56000, P17, M81703. DIAGNOSIS: Liver, segment 2-3, left, laparoscopic wedge resection: Hepatocellular carcinoma. NOTE: Suggestion :",T1,N0,M0,T1N0M0
TCGA-AO-A03R,"Clinical Diagnosis & History: y/o femnle with left breast cancer on core biopsy IDC/DCIS. Specimens Submitted: 1: SP: Sentinel node #1, level one . left axilla (fs). 2: SP: Sentinel node #2, level one, left axilla (fs). 3: SP: Sentinel node #3, level one, left axilla (fs). 4: SP: Left breast. 5: SP: Levels one and two left axillary contents (. 6: SP: Level two left axillary contents. 7: SP: Level three left axillary contents. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1 LEVEL I LEFT AXILLA; BIOPSY: - METASTATIC CARCINOMA IN ONE LYMPH NODE (1/1). - THERE IS EXTRANODAL CAPSULAR EXTENSION OF CARCINOMA (<2 MN). 2). LYMPH NODES, SENTINEL #2 LEVEL I LEFT AXILLA; BIOPSY: - METASTATIC CARCINOMA IN ONE LYMPH NODE (1/1), 2.1 MM FOCUS, SEE NOTE. THERE IS NO EXTRANODAL EXTENSION OF CARCINOMA. NOTE: THE CARCINOMA IS NO LONGER PRESENT ON DEEPER H&E STAINED SECTIONS. 3). LYMPH NODE, SENTINEL #3 LEVEL I LEFT AXILLA; BIOPSY: - ONE BENIGN LYMPH NODE (0/1). 4). BREAST, LEFT; TOTAL MASTECTOMY: - INVASIVE POORLY DIFFERENTIATED DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC. GRADE III/III (SLIGHT OR NO TUBULE FORMATION) NUCLEAR GRADE III/III (MARKED. VARIATION IN SIZE AND SHAPE) MEASURING 5.0 CM IN LARGEST DIMENSION GROSSLY. DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, SOLID AND CRIBRIFORM. TYPES, WITH HIGH NUCLEAR GRADE AND MODERATE NECROSIS. THE DCIS CONSTITUTES <= 25% OF THE TOTAL TUMOR MASS, AND IS PRESENT. ADMIXED WITH AND AWAY FROM THE INVASIVE COMPONENT. - THE INVASIVE CARCINOMA IS LOCATED IN THE UPPER OUTER QUADRANT AND UPPER. INNER QUADRANT. THE DCIS IS LOCATED IN THE UPPER INNER QUADRANT AND LOWER INNER QUADRANT. - NO INVOLVEMENT OF THE NIPPLE BY EITHER IN SITU OR INVASIVE CARCINOMA IS. IDENTIFIED. NO CALCIFICATIONS ARE IDENTIFIED IN EITHER THE INVASIVE OR IN SITU. COMPONENT. - CALCIFICATIONS ARE PRESENT IN THE BENIGN BREAST PARENCHYMA. - EXTENSIVE VASCULAR INVASION IS PRESENT. - POSITIVE PERINEURAL INVASION. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE ATTACHED SKELETAL MUSCLE IS NEGATIVE FOR TUMOR. THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES, FIBROCYSTIC. CHANGES AND FIBROADENOMATOUS CHANGES. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF POSITIVE. LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES EXAMINED) : LEVEL. I: 0/1. 5). LYMPH NODES, LEVELS I AND II LEFT AXILLARY CONTENTS; EXCISION: - MICROMETASTATIC CARCINOMA IN ONE OUT OF EIGHTEEN LYMPH NODES (1/18). - THERE IS NO EXTRANODAL EXTENSION OF CARCINOMA. 6). LYMPH NODE, LEVEL II LEFT AXILLARY CONTENTS; EXCISION: - UNREMARKABLE FIBROADIPOSE TISSUE. 7). LYMPH NODES, LEVEL III LEFT AXILLARY CONTENTS; EXCISION: FOUR BENIGN LYMPH NODES (0/4). NOTE: RESULTS OF SPECIAL STAINS (ER,PR,HER2-neu) WILL BE REPORTED AS AN. ADDENDUM. SUMMARY OF LYMPH NODES: 3/26. TUMOR STAGE: T2, pN1a, MX STAGE GROUPING IIB. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL) . AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. M.D.,. Special Studies: Special Stain. Comment. RECUT. level. ER-C. PR-C. HER2-0. NEG CONT. IMM RECUT. NEG-HER2. Gross Description: 1) The specimen is received fresh for frozen section consultation, labeled. ""Sentinel node number one, level 1, left axilla"" and consists of a single. lymph node measuring 1.3 x 0.9 x 0.7 cm. The specimen is bisected. Entirely. submitted for frozen section. Summary of sections: FSC -- frozen section control. 2). The specimen is received fresh for frozen section consultation, labeled. ""Sentinel node number two, level 1, left axilla"" and consists of two lymph. nodes measuring 1.1 x 0.5 x 0.5 and 0.8 x 0.6 x 0.4 cm. The larger lymph. node is inked black. Entirely submitted for frozen section. Summary of sections: FSC -- frozen section control. 3) The specimen is received fresh for frozen section consultation, labeled. ""Sentinel node number three, level 1, left axilla"" and consists of a single. lymph node measuring 1.0 x 0.7 x 0.6 cm. Lymph node is bisected. Entirely. submitted for frozen section. Summary of sections: FSC -- frozen section control. 4). The specimen is received fresh labeled, ""left breast, stitch marks. axillary tail"" and consists of a breast with attached axillary tail. The. breast measures 28.0 x 25.0 x 5.0 cm with overlying skin ellipse measuring. 22.0 x 10.0 cm. Situated eccentrically on the skin surface is a nipple. measuring 1.2 x 1.2 cm and areola measuring 2.0 x 2.0 cm. A suture. demarcates the axillary tail which measures 6.0 x 5.0 cm. The posterior. surface of the breast is inked black, anterior superior - blue, anterior. inferior - green and the specimen is serially sectioned to reveal a firm. white mass measuring 5.0 x 2.5 x 2.0 cm, and located in the upper inner. quadrant extending to the upper outer quadrant, measuring 2.0 cm from the. closest deep margin. The remaining breast tissue shows a fibrofatty cut. surface. The axillary tissue is dissected to reveal a lymph node. Representative sections are submitted, including the lymph node. Summary of sections: N nipple. NB - nipple base. S skim. D - deep margin. T - tumor. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. AA-axillary tail. AALN-a bisected lymph node in axillary area. 5). The specimen is received fresh, labeled ""Levels 1 and 2 left axillary. contents"". It consists of a 3 x 2 x 1 cm portion of fibroadipose tissue. Multiple lymph nodes identified measuring from 0.5 to 1.1 cm in greatest. dimension. All lymph nodes are submitted. Summary of sections: LN - lymph nodes. 6) The specimen is received in formalin, labeled ""level 2, left axillary. contents"" and consists of a 1.7 x 1.3 x 0.3 cm portion of fatty tissue. Entirely submitted. Summary of sections: U-undesignated. 7) The specimen is received in formalin, labeled ""level 3, left axillary. contents"" and consists of two lymph nodes measuring 0.5 cm and 1.3 cm in. maximum dimension. Entirely submitted. Summary of sections: LN- lymph node. BLN- bisected lymph node. Summary of Sections: Part 1: SP: Sentinel node #1, level one , left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 2: SP: Sentinel node #2, level one, left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Sentinel node #3, level one, left axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 4: SP: Left breast. Block. Sect. Site. PCs. 1. aa. 1. aaln. 2. d. 2. 3. liq. 3. 2. loq. 2. 1. n. 1. 1. nb. 1. 1. s. 1. 10. 10. 2. uiq. 2. 2. uog. 2. Part 5: SP: Levels one and two left axillary contents. Block. Sect. Site. PCs. 6. LN. 18. Part 6: SP: Level two left axillary contents. Block. Sect. Site. PCs. 1. u. 1. Part 7: SP: Level three left axillary contents. Block. Sect. Site. PCs. 1. bln. 1. 1. In. 1. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. ADDENDUM REPORT. SITE: LEFT BREAST (PART 4). ER: 95% NUCLEAR STAINING WITH MODERATE INTENSITY. PR: <5% NUCLEAR STAINING WITH MODERATE INTENSITY. HER2/NEU (HERCEPTEST) : NEGATIVE (STAINING INTENSITY OF 0). CONTROLS ARE SATISFACTORY. . M.D. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOM'. PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOMA. PERMANENT DIAGNOSIS: SAME. 3). FROZEN SECTION DIAGNOSIS: BENIGN LYMPH NODE. PERMANENT DIAGNOSIS: SAME.",T2,N1,M0,T2N1M0
TCGA-DJ-A2PS,"Clinical Diagnosis & History: Papillary thyroid cancer. Specimens Submitted: 1: Right para-tracheal tissue; biopsy. 2: Right superior mediastinal tissue; biopsy. 3: Thyroid, total thyroidectomy. 4: Delphian lymph node; biopsy. DIAGNOSIS: 1. Right para-tracheal tissue; blopsy: - Benign fibroadipose tissue. 2. Right superior mediastinal tissue; blopsy. Lymph Node Dissection: Metastatic papillary thyroid carcinoma consisting of a few psammoma bodies. Number of lymph nodes examined: 1. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 0.2cm. Extranodal extension is not identified. Comment: The psammoma bodies diagnostic of carcinoma were not present on the frozen section slide. 3. Thyroid, total thyroidectomy: Tumor Type: Multicentric papillary carcinoma, classical, tall and microcarcinoma variants. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Psammoma bodies. Tumor Location: Left lobe. Right lobe. Isthmus. Tumor Size: Greatest diameter is 1.1 cm. for the classical type, tall cell (0.3 cm), microcarcinoma (0.25 and 0.35 cm). Tumor Encapsulation: The classical type is encapsulated, the other foci are unencapsulated. Capsular Invasion: Extensive invasion. of tumor capsule by the classical type. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Very focal extra-thyroid extension into adipose tissue by the isthmic microcarcinoma. Surgical Margins: Free of tumor. Non-Neoplastic Thyroid: Exhibits chronic lymphocytic thyroiditis. Parathyroid Glands: One intrathyroldal parathyroid Involved by carcinoma. Lymph Nodes: One benign lymph node (0/1). 4. Delphian lymph node; blopsy: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 2. ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. "". Gross Description: 1) The specimen is received fresh for frozen section consultation labeled ""Right para-tracheal tissue"", and consists of three. fragments of yellow/pink soft tissue measuring 1.0 x 0.6x0.3 cm in aggregate. The specimen is entirely submitted for frozen. section diagnosis. Summary sections: FSC - frozen section control. 2) The specimen is received fresh for frozen section consultation labeled ""Right superior mediastinal tissue"", and consists of fatty. yellow soft tissue measuring 1.0 x1.0 x 0.3 cm. The specimen is entirely submitted for frozen section diagnosis. Summary sections: FSC - frozen section control. 3) The specimen is received fresh, labeled ""total thyroidectomy stitch marks right lobe of thyroid"" and consists of a thyroid weighing. 10.05 g. The right lobe measures 4.0 x 2.2x1.1 cm, the left lobe measures 3.8 x 2.5 x 0.8 cm and the isthmus measures 1.0 x 0.8. x 0.3 cm. There is a 2.5 x 0.8 x 0.5 cm portion of skeletal muscle attached to the right lower lobe. The external surface is covered. by a thin fibrous capsule. The posterior surface of the specimen is inked black, and the anterior is inked blue. Sectioning reveals a. 1.1 x 0.8 x 0.7 cm white solid nodule in the right lower lobe (N1), and a 0.3 cm white solid nodule in left mid lobe (N2). The. remaining thyrold parenchyma is red tan and beefy. Representative sections of the specimen are submitted for TPS. The. remaining tissue is serially sectioned and entirely submitted. Summary of sections: N1 - nodule in the right lobe. N2 - nodule in the left lobe. RL right lobe. LL left lobe. IS - isthmus and skeletal muscle. 4) The specimen is received in formalin, labeled ""Delphian lymph node"" and consists of single fatty lymph node measuring 0.5 x. 0.4 x 0.3 cm. Entirely submitted. Summary of sections: LN - lymph node. Summary of Sections: Part 1: Right para-tracheal tissue; blopsy. Block. Sect. Site. PCs. 1. FSC. 3. Part 2: Right superior mediastinal tissue; biopsy. Block. Sect. Site. PCs. 1. FSC. 1. Part 3: Thyroid, total thyroidectomy. Block. Sect. Site. PCs. 1. IS. 4. 2. LL. 4. 2. N1. 3. 1. N2. 2. 2. RL. 4. Part 4: Delphian lymph node; biopsy. Block. Sect. Site. PCs. 1. LN. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the Intraoperative consultation. 1. Frozen Section Diagnosis: Right para-tracheal tissue (fs): Benign. Permanent Diagnosis: Same. 2. Frozen Section Diagnosis: Right superior mediastinal tissue (fs): Benign. Permanent Diagnosis: See final.",T3,N1,M0,T3N1M0
TCGA-DD-A4NP,"TISSUE DESCRIPTION: A1 B1 C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14 C15. C16 C17 C18 C19 C20 C21 C22 C23. Gallbladder (9.0 x 4.0 x 2.4 cm), left portal lymph node (2.0 x 1.3. x 8 cm) and left lobe liver (1065 grams, 19.3 x 16.5 x 11.2 cm). DIAGNOSIS: Liver, left lobe, resection: Grade 3 (of 4) hepatocellular. carcinoma forming a 15.4 x 11.3 x 10.7 cm mass, arising in. histologically unremarkable liver. The margins are negative for. tumor (closest margin is free by .4cm) No necrosis or. angiovascular invasion is identified. Gallbladder, cholecystectomy: Chronic cholecystitis. A single. cystic duct lymph node is negative for tumor. Lymph node, left portal, excision: A single left portal lymph node. is negative for tumor. PHOTOGRAPHED IN LAB. PRELIMINARY FROZEN SECTION CONSULTATION: Liver, left lobe, resection: Hepatocellular carcinoma. HOLD OVER. for immunostains.",T1,N0,M0,T1N0M0
TCGA-DS-A1OB,"Copies To: DIAGNOSIS: A. LEFT PELVIC LYMPH NODES, EXCISION: Metastatic squamous cell carcinoma to three of seven lymph nodes with perinodal venous. involvement (3/7). B. LEFT OBTURATOR LYMPH NODES, EXCISION: Metastatic squamous cell carcinoma to two of two lymph nodes with perinodal venous. involvement (2/2). C. LEFT COMMON LYMPH NODES, EXCISION: Four lymph nodes with no evidence of malignancy (4). D. RIGHT COMMON LYMPH NODES, EXCISION: Metastatic squamous cell carcinoma replacing multiple matted lymph nodes, involving. perinodal fat, maximum dimension of 3.0 cm. E. RIGHT PERIAORTIC LYMPH NODES, EXCISION: Metastatic squamous cell carcinoma to five of five lymph nodes and extensively replacing. nodal tissue (5/5). The largest lymph node measures 2.0 cm in greatest dimension. F. RIGHT PELVIC LYMPH NODES, EXCISION: Metastatic squamous cell carcinoma to three of seven lymph nodes (3/7). G. RIGHT OBTURATOR LYMPH NODES, EXCISION: Metastatic squamous cell carcinoma to multiple matted lymph nodes measuring 4.5 cm in. greatest dimension, with vascular invasion. Three additional lymph nodes negative for malignancy (3). H. LEFT ADNEXA, LEFT SALPINGO-OOPHORECTOMY: Ovary negative for malignancy. Fallopian tube, negative for malignancy; paratubal cyst. I. RIGHT ADNEXA, SALPINGO-OOPHORECTOMY: Ovary negative for malignancy. Fallopian tube, negative for malignancy; paratubal cyst. J. PARAMETRIUM, EXCISION: Negative for malignancy. K. ANTERIOR VAGINAL MARGIN, EXCISION: PATIENT NOTIFIED OF RESULTS. DR: NURSE: PATIENT: 1. Negative for malignancy. L. UTERUS AND CERVIX, HYSTERECTOMY: Cervix. Invasive squamous cell carcinoma of the uterine cervix, keratinizing type, moderately. differentiated. Tumor located within the cervix and involving lower uterine segment myometrium. Tumor dimension, approximately 4.0 cm. Maximum depth of invasion 3.8 cm in a section measuring 4.3 cm. High-grade squamous intraepithelial lesion flanking both sides of the tumor. Lymphovascular invasion is present. Vaginal involvement is not identified. All surgical margins, anterior and posterior vaginal cuffs are negative. Pathologic tumor stage: pTlb, N1 (AJCC Cancer Staging Handbook, 6th Ed., 2002). pT1b2/pN1. Endometrium. Involved by invasive squamous cell carcinoma, keratinizing type, moderately. differentiated in lower uterine segment. Background weakly proliferative pattern endometrium. Myometrium. Involved by invasive squamous cell carcinoma, keratinizing type, moderately. differentiated in lower uterine segment with angiolymphatic invasion. Leiomyomata. - Adenomyosis. Serosa and parametria negative for malignancy. Focal endometriosis involving uterine serosa. HISTORY: Cervical cancer, squamous cell carcinoma of the cervix, exploratory laparotomy, total abdominal. hysterectomy, bilateral salpingo-oophorectomy and lymph node dissection. MICROSCOPIC: See diagnosis. GROSS: A. LEFT PELVIC LYMPH NODE. Labeled with the patient's name, labeled ""left pelvic lymph node"", and received in formalin is a 4.0 x 2.5 x 0.6 cm. portion of fibrofatty tissue. Six soft, tan lymph nodes were identified ranging from 0.7 to 2.8 cm in maximum. dimension. The specimen is entirely submitted. A1. One lymph node, bisected - 2. A2. One lymph node, bisected - 2. A3. Two lymph nodes - 2. A4. One lymph node and fatty tissue - multiple. A5. One lymph node and fatty tissue - multiple. B. LEFT OBTURATOR LYMPH NODE. Labeled with the patient's name, labeled ""left obturator lymph node"", and received in formalin is a 2.2 x 3.0 x 0.6. cm portion of fibrofatty tissue. Two firm, tan lymph nodes are identified ranging from 0.5 to 1.5 cm in maximum. dimension. The specimen is entirely submitted. B1. Two lymph nodes - 2. B2. Fibrofatty tissue - multiple. C. LEFT COMMON LYMPH NODE. Labeled with the patient's name, labeled ""left common lymph node"", and fixed in formalin is a 3.0 x 0.8 x 0.4 cm. portion of fibrofatty tissue. Three firm, tan lymph nodes ranging from 0.3 to 1.1 cm is identified. The specimen is. entirely submitted. C1. Two lymph nodes - 2. C2. One lymph node and fatty tissue - multiple. D. RIGHT COMMON LYMPH NODE. Labeled with the patient's name, labeled ""right common lymph node"", and received in formalin is a 3.0 x 2.5 x 1.0. cm portion of firm, nodular tissue with minimal adherent fat. The nodules are adherent to each other and range. from 0.3 to 1.0 cm in maximum dimension. Cut sections reveal a homogenous, firm white surface. The specimen is. entirely submitted. DI. Multiple. D2. Multiple. D3. Multiple. E. RIGHT PERIAORTIC LYMPH NODE. Labeled with the patient's name, labeled ""right periaortic lymph node"", and received in formalin is a 3.5 x 2.0 x 0.6. cm portion of fibrofatty tissue. Five firm, tan lymph nodes ranging from 0.6 to 2.0 cm were identified. The. specimen is entirely submitted. E1, E2. Largest lymph node, bisected - I each. E3. Four lymph nodes. F. RIGHT PELVIC LYMPH NODE. Labeled with the patient's name, labeled ""right pelvic lymph node"", and received in formalin is a 4.0 x 2.5 x 1.0 cm. portion of fibrofatty tissue. Six firm tan lymph nodes are identified ranging from 0.6 to 1.5 cm in maximum. dimension. The specimen is entirely submitted. F1. Three lymph nodes - 3. F2. Three lymph nodes - 3. F3. Fibrofatty tissue - multiple. F4. Fibrofatty tissue - multiple. G. RIGHT OBTURATOR LYMPH NODE. Labeled with the patient's name, labeled ""right obturator lymph node"", and received in formalin is a 6.5 x 3.5 x 3.0. cm portion of fibrofatty tissue. 13 firm, white-tan lymph nodes are identified ranging from 0.5 to 4.5 cm in. maximum dimension. The largest lymph node measures 4.5 x 2.5 x 1.5 cm and cut surface reveals a white-tan. surface with multiple yellow irregular foci. Representative sections submitted of the largest lymph node and the rest. of the specimen is entirely submitted. G1. Largest lymph node, bisected along the long axis and perpendicularly sectioned, edges of bisected half - 2. G2. Portion of other bisected half - 3. G3. Mid portion of first bisected - 3. G4. Four lymph nodes - 4. G5. Three lymph nodes - 3. G6. One lymph node - I. G7, G8. Fibrofatty tissue - multiple. H. LEFT ADNEXA. Labeled with the patient's name, labeled ""left adnexa"", and received in formalin is a 10.5 gram, salpingo-. oophorectomy specimen. The ovary is 3.5 x 1.5 x 1.0 cm. The fallopian tube with fimbriae at one end is 4.5 cm. long and ranges from 0.5 to 0.7 cm in diameter. The serosa of the ovary is smooth and tan with one 0.7 x 0.6 cm firm yellow nodule on one surface. There are two. cysts within the ovary measuring 1.1 x 1.0 x 1.0 cm and 0.7 x 0.6 x 0.5 cm. The larger cyst contains a clear yellow. fluid and the smaller cyst contains a red, hemorrhagic fluid. There is a 2.0 x 1.5 x 1.5 cm paratubal cyst containing. a clear yellow liquid adjacent to the distal portion of the fallopian tube. The ovary and fallopian tube are otherwise unremarkable. No gross tumors are identified. Representative sections are submitted. Ink key: Proximal fallopian tube - black. Slide key: H1. Ovary - I. H2. Section of ovary with yellow nodule and section of ovary with smaller ovarian cyst - 2. H3. Fallopian tube - 3. H4. Fallopian tube with paratubal cyst - 1. I. RIGHT ADNEXA. Labeled with the patient's name, labeled ""right adnexa"", and received in formalin is a 13.5 gram, salpingo-. oophorectomy specimen. The ovary is 3.5 x 2.0 x 1.5 cm. The fallopian tube with fimbriae at one end is 4.5 cm. long and ranges from 0.5 to 0.8 cm in diameter. The serosa of the ovary is smooth and tan. There are two cysts within the ovary, one measuring 1.4 x 1.0 x 1.0 cm. and is filled with red-brown hemorrhagic material and the other cyst measures 1.0 x 0.7 x 0.4 cm and is filled with a. clear pale yellow fluid. The cysts are both lined by smooth tan tissue. There is a paratubal cyst measuring 0.4 x 0.3. x 0.3 cm filled with a clear yellow mucinous material. The remaining ovarian tissue and fallopian tube is grossly free of tumor. Ink key: Proximal fallopian tube inked black. Representative sections are submitted. II. Ovary with two cysts - 1. 12. Ovary 2. 13. Fallopian tube - 3. 14. Broad ligament - 3. J. PARAMETRIUM. Labeled with the patient's name, labeled ""perimetria"", and received in formalin is a yellow-tan irregular portion of. fibrofatty tissue measuring 1.7 x 1.2 x 0.2 cm. No gross tumors are identified. The specimen entirely submitted. J1. 1. K. ANTERIOR VAGINAL MARGINS. Labeled with the patient's name, labeled ""anterior vaginal margins"", and received in formalin is an irregular portion. of wrinkled tan mucosa measuring 4.5 x 1.7 x 0.7 cm. The specimen is not oriented. No gross lesions are. identified. The specimen is serially sectioned into 12 slices and entirely submitted. Ink key: Deep margins - black. Slide key: KI. Slice 1. edge/perpendicular sections - 3. K2. Slice 2, 3, 4 - 3. K3. Slice 5, 6, 7 - 3. K4. Slice 8, 9 - 2. K5. Slice 10, 11 - 2. K6. Slice 12, edge/perpendicular sections - 3. L. UTERUS/CERVIX. Labeled with the patient's name, labeled ""uterus/cervix"" received fresh for gross intraoperative consultation and. subsequently fixed in formalin is a 260 gram previously opened uterus and cervix specimen. The uterus measures. 12.5 x 8.5 x 6.0 cm. Exocervix measures 6.5 x 5.0 cm. The endocervical canal measures 5.0 cm in length. The. endome. vial cavity measures 4.2 x 3.2 x 0.2 cm. Attached to the uterus are unremarkable right and left parametria. measuring 3.5 x 1.5 x 0.3 cm and 3.0 x 2.0 x 0.4 cm respectively. Attached to the anterior cervix is an. unremarkable pink-tan vaginal cuff with the anterior vaginal cuff measuring 6.0 x 1.5 cm and the posterior vaginal. cuff measuring 5.8 x 1.7 cm. Located on the posterior ectocervix is an irregular, firm brown-tan nodular mass measuring 4.0 x 3.0 x 2.5 cm. extending 2.5 cm into the endocervical canal. The posterior cervix is serially sectioned into sixteen slices. Cut. surface reveals a firm white-yellow nodular mass. Tumor does not grossly extend to the parametrial or into any of. the margins of resection. The myometrium has four firm, white-tan nodular masses ranging from 1.3 to 2.0 cm in maximum dimension. There is a 0.3 x 0.3 cm cyst filled with clear mucin located in the anterior cervix. The remaining endometrium and cervix are unremarkable. Ink key: Deep margins - black. Representative sections are submitted. L1. Left parametria - 1. L2. Right parametria - 1. L3. Anterior vaginal cuff margin, trisected - 3. L4,L5,L6. Posterior vaginal cuff, trisected submitted from right to left sequentially - 1 each. L7. Posterior cervix, tumor from the right, slice I - 1. L8. Posterior cervix, tumor from the right, slice 2 - 1. L9. Posterior cervix, tumor from the right, slice 4 - 1. L10-L11. Posterior cervix, tumor from the right, slice 6, bisected - 1 each. L12-L13. Posterior cervix, tumor from the right, slice 8, bisected - 1 each. L14-L15. Posterior cervix, tumor from the right, slice 10, bisected - 1 each. L16-L17. Posterior cervix, tumor from the right, slice 11, bisected - 1 each. L18-L19. Posterior cervix, tumor from the right, slice 12, bisected - 1 each. L20-L21. Posterior cervix, tumor from the right, slice 13, bisected - 1 each. L22. Posterior cervix, tumor from the right, slice 15 - 1. L23. Posterior cervix, tumor from the right, slice 16, bisected - 2. L24. Anterior cervix, right margin - 1. L25,L26. Middle anterior cervix - 1 each. L27. Left anterior cervix, left margin - 1. L28. Posterior lower uterine segment - 1. L29. Posterior lower uterine segment - 1. L30. Anterior lower uterine segment - 1. L31,L32. Posterior endometrium and one leiomyoma - 1 each. L33,L34. Anterior endometrium and leiomyoma - 1 each. L35. Anterior endometrium leiomyoma - 1. L36. Posterior endometrium, leiomyoma - 1. Gross dictated by 1. M.D.: : (parts H-K, operative call): (part L). OPERATIVE CALL. PATIENT: I. OPERATIVE CONSULT (GROSS): L. UTERUS/CERVIX: Large tumor, deeply invasive, extending possibly up to the lower uterine segment. Margins grossly negative. Portions of tissue from cervical lesion and uninvolved endometrium procured for research. I, M.D.,. M.D.). If this report includes immunohistochemical rest results, please note the following. Numerous immunohistochemical tests were developed and their performance characteristics determined by (. and. Those immunohistochemical tests have not been cleared or approved by the. wind rood and Drug Administration (FDA), and FDA approval is not required. I. have personally examined the specimen, interpreted the results, reviewed the report and signed it electronically.",T1,N1,M0,T1N1M0
TCGA-EL-A3N2,"Sex: F. Case type: Surgical Case. DIAGNOSIS. (A) LEFT LATERAL NECK DISSECTION: METASTATIC PAPILLARY THYROID CARCINOMA IN 2 OF 17 LYMPH NODES (2/17). (B) LEFT LARYNGEAL NERVE, QUERY TUMOR: PAPILLARY THYROID CARCINOMA IN SOFT TISSUE. (C) QUESTION ""LEFT SUPERIOR PARATHYROID"": Fibroadipose tissue, negative for tumor. (D)TOTAL THYROID AND BILATERAL LEVEL VI: PAPILLARY THYROID CARCINOMA, CONVENTIONAL TYPE. Location: Left lobe. Multi-focal: No. Size = 3.5 cm. Extrathyroidal extension: Present, extending into fibroadipose tissue and abutting skeletal muscle. Resection Margins: Negative. Lymph nodes: METASTATIC PAPILLARY THYROID CARCINOMA IN 3 OF 10 LYMPH NODES (3/10). Location: Bilateral, level VI. Extracapsular extension: Present. Parathyroid, negative for tumor. Thymus parenchyma, negative for tumor. GROSS DESCRIPTION. (A) LEFT LATERAL NECK DISSECTION - An unoriented fragment of tan-yellow adipose tissue (11.0 X 5.0: X 1.0 cm). Two possibly grossly positive lymph nodes are present, 1.5 and 2.5 cm. The larger positive lymph node has a cystic. component. Remainder of the specimen consists of multiple possible lymph nodes ranging from 0.3 to 1.3 cm. SECTION CODE: A1, largest positive lymph node entirely submitted; A2, second possibly positive lymph node. entirely submitted; A3, A4, one possible lymph node in each bisected; A5, four possible lymph nodes; A6-A8, three possible. lymph nodes in each. (B) LEFT LARYNGEAL NERVE, QUERY TUMOR - A single fragment of red-brown tissue (0.4 X 0.3 x 0.1 cm). Entirely. submitted in B1 for frozen section diagnosis. PAPILLARY THYROID CARCINOMA PRESENT IN NEUROVASCULAR BUNDLE. Sex: F. T. Case type: Surgical Case. (C) QUESTION LEFT SUPERIOR PARATHYROID - A tiny soft tissue (0.1 X 0.1 x 0.1 cm, weighing 0.005 grams) is. submitted entirely in C1 for frozen diagnosis. FS/DX: BENIGN FIBROADIPOSE TISSUE. (D) TOTAL THYROIDECTOMY AND BILATERAL LEVEL VI - A (4.5 x 3.5 x 1.5 cm) left thyroid lobe with attached (3.5 X 2.5 x. 0.2 cm) fragment of adipose tissue and a detached right thyroid lobe (4.0 x 2.0 x 1.0 cm). The entire specimen weighs 0.02 kg. A yellow to brown mass entirely replaces the left lobe. This mass extends to involve the external surface where there. is a 2.0cm are of papillary excrescences. The cut surface of this lesion is also diffusely firm with no areas of hemorrhage or. necrosis. The right lobe consists of red-brown unremarkable thyroid tissue. The attached adipose tissue is sectioned to reveal. multiple lymph nodes ranging from 0.3 to 0.7 cm with a 0.7 cm lymph node grossly positive. SECTION CODE: D1-D7, lesion in left lobe with cassettes 1-5 containing papillary external surface extension; D8-. D10, representative right lobe; D11, one grossly positive lymph node entirely submitted; D12, three possible lymph nodes;. D13, four possible lymph nodes; D14-D16, remainder of adipose tissue entirely submitted. CLINICAL HISTORY. Papillary Thyroid cancer. SNOMED CODES. T-86000, M-80503, T-C4200, M-80506, ""Some tests reported here may have been developed and performance characteristics determined b. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by:",T2,N1,M0,T2N1M0
TCGA-BH-A18J,"PATIENT HISTORY: DATE of LMP: DATE OF LAST DELIVERY. PRE-OP DIAGNOSIS: STAGE IV RIGHT BREAST CANCER. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: MODIFIED RADICAL RIGHT MASTECTOMY. CLINICAL HISTORY: MATERIAL SUBMITTED: RIGHT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE. ADDENDA: Addendum. MATERIAL SUBMITTED: MWH Slide for ER/PR and Her-2/Neu. FINAL DIAGNOSIS: My signature is attestation that I have personally reviewed the submitted material(s) and the final. diagnosis reflects that evaluation. ER/PR. IMMUNOPEROXIDASE IDENTIFICATION OF ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE. ""A4"". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR ESTROGEN RECEPTOR (50%) AND ALSO TOR PROGESTERONT. RECEPTOR. (40%) . THEREFORE, BOTH ARE INTERPRITED AS POSITIVE. HER-2/NEU. c-erb82 (HER-2/NEU) IMMUNOSTAINING IS CARRIED OUT ON. BLOCK ""A4"" (BREAST CANCER). USING A 1:300 DILUTION OF DANO'S POLYCLONAL ANTIBODY A485 (DIRBCTED AGAINST THE INTRACELLULAR DOMAIN OF c-. erb82) WITHOUT ANTIGEN RETRIEVAL. NO DISTINCT COMPLETE MEMBRANE STAINING IS IDENTIFIED. THEREFORE,. c-exbB2. (HER-2/NEU) IS INTERPRETED AS NEGATIVE (SCORE 0). FINAL DIAGNOSIS: RIGHT; BREAST MODIFIED RADICAL MASTECTOMY : INFILTRATING POORLY DIFFERENTIATED DUCT CARCINOMA, 9.0 BY 8.5 BY 4.0 CM, INVOLVING ALL FOUR QUADRANTS. (SKX NOTE). - NOTTINGHAM SCORE 8/9 (TUBULES 3, NUCLEAR ATYPIA 3, MITOTIC INDEX 2). - TUMOR EXTENDS TO INVOLVE NIPPLE AND EPIDERMIS OF OVERLYING ULCERATED SKIN. - INTRADUCTAL CARCINOMA, COMEDO-TYPE, INVOLVES <54 OF TOTAL TUMOR. - MARGINS OF RESECTION ARE NEGATIVE FOR TUMOR. - MULTIPLE MATTED LYMPH NODES WITH NEARLY COMPLETE ARCHITECTURAL EFTACEMENT BY METASTATIC CARCINOMA (SEE. NOTE). NOTE: ER/PR immunoperoxidase assay and Her-2/NEU testing will be performed on block ""A4"". A prior HER-2/NEU immunostain was performed on a paraffin block received from Shadyside Rospital and was. interpreted as negative. Due to possible differences in fixation among institutions, the HER-. 2/NEU study will be repeated on the present specimen. The axillary lymph nodes are extensively matted, indicative of extracapsular extension by tumor. For this. reason, an accurate lymph node count cannot be made.",T4,N2,M1,T4N2M1
TCGA-AC-A62V,"FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: A. Breast;left complete mastectomy. B. Breast;right modified radical mastectomy. Clinical History/Operative Dx: None provided. Gross Description: A. The specimen is labeled left breast complete mastectomy and is received in formalin. It consists of a. mastectomy specimen which weighs 227 grams. A black suture with a metallic clip marks the ""tail of the. breast"". With this orientation the specimen measures 18,5 cm from medial to lateral, 11.8 cm from. superior to inferior, and 2.5 cm superficial to deep. There is an overlying broad ellipse of dark brown skin. which measures 17 x 6.5 cm. Centrally and slightly superiorly within the skin is a 2,3 cm areola and a. protuberant 0.7 cm nipple. The anterior-superior margin is inked blue, the anterior-interior margin is inked. green, and the posterior margin, which consists of smooth fascial tissue, is inked black. The specimen is serially sectioned at close intervals to reveal lobulated fatty tissue and centrally located. tan-white fibrous parenchyma. There are no areas which have a stellate or retracted appearance. suggestive of neoplasm. In the lateral portion of the specimen, 2 cm from the lateral edge, there is a. circumscribed 0.7 cm pale red lymph node. Representative sections are submitted. Section summary: A1) nipple and tissue just deep to nipple,. A2) representative upper inner quadrant,. A3) representative lower inner quadrant,. A4) representative upper outer quadrant,. A5) representative lower outer quadrant. A6) representative central breast and representative central deep margin,. A7) lateral lymph node. Printed: This report continues. (FINAL). Acct No -. Pathology - Page 4/6. Job. Page 4 Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. B. The specimen is labeled right breast modified radical mastectomy and is received without fixative. It. consists of a mastectomy specimen together with axillary tissue weighing 292 grams. The breast measures. 16 cm from medial to lateral, 9 cm from superior to inferior and up to 4 cm from superticial to deep. There. is an overlying etlipse of dark brown skin which measures 15.5 X 7.6 cm. Slightly medially located within. the skin is a circumscribed 2.5 cm areola and a protuberant 0.6 cm nipple. The skin is unremarkable,. Axillary tissue is present and measures 15 x 6.5 x 1.8 cm. The anterior-superior margin is inked blue, the. anterior-inferior margin is inked green, and the posterior margin, which consists of smooth facial tissue, is. inked black. In the central lateral portion of the deep margin, there is a 3 X 0.5 cm band of skeletal muscle. which is indicated by the surgeon as pectoralis major behind the tumor. The specimen is serially sectioned at close intervals to reveal a relatively well-circumscribed, firm,. tan-white tumor mass beginning directly underneath the nipple and extending laterally within the breast,. This tumor mass measures 4.7 cm from medial to lateral, 4.5 cm from superior to inferior, and 3.5 cm from. superficial to deep. This neoplasm is 3.5 cm from the closest medial margin, 5 cm from the axillary tail,. 2.5 cm from the closest superior margin, and 2.2 cm from the closest interior margin. Centrally, it is grossly. 0,2 cm from the closest deep margin and does not appear to extend into the small strip of pectoralis. muscle. The remainder of the breast is composed of soft fatty tissue without other palpable masses. Representative tumor and adjacent breast parenchyma are obtained for research purposes. In the medial. portion of the axillary tail, there is a prominent firm 1.5 cm lymph node suspicious for metastatic. involvement Representative tissue from this lymph node is obtained for research purposes also. The. axillary tissue is dissected for nodes. Representaitve sections are submitted. Section summary: B1) nipple and tissue just deep to nipple,. B2) representative lateral skin overlying tumor,. B3) medial edge of tumor,. B4-B11) sections of tumor progressing from medial to lateral,. B12) section of tumor and closest approach to deep margin,. B13) deep margin with pectoralis muscle,. B14) representative upper inner quadrant. B15) representative lower inner quadrant,. B16) representative upper outer quadrant,. B17) representative lower outer quadrant,. 818) medial axillary node (some submitted for research),. B19) single node, multiply sectioned,. B20) single node, multiply sectioned,. B21) one larger node, serially sectioned, two smaller nodes inked and bivalved,. B22) two nodes, serially sectioned (one inked). B23-B24) smaller possible nodes, intact. Microscopic Description: A. Microscopic sections have been examined. The microscopic findings are retlected in the diagnosis. rendered. B. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. Printed: This report continues. (FINAL). Acct No. Patholegy a Page 5/6. age 5 Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. rendered. Printed: END O REPORT (FINAL). Acct No. -. Pathology - Page 6/6. Page 6 Ooc# 1. Gender: M. Rel#: Provider Group. Date of Service: Date Received: ADDENDUM SURGICAL PATHOLOGY REPORT. Addendum Information: This addendum report is issued to the provide results of breast carcinoma biomarker. studies, performed on the previous ultrasound-guided core needle biopsy of the primary. breast carcinoma (. biomarker results-. Estrogen receptor: 100% positive cells, strong intensity. Progesterone receptor: Less than 1% positive cells. HER2: IHC score O. Ki-67 proliferative index: 35% positive cells. The above results are similar to the those obtained on the metastatic carcinoma in the left. iliac bone. Diagnosis: A. LEFT BREAST, PROPHYLACTIC MASTECTOMY: - Gynecomastia. - Unremarkable skin and nipple. - Negative for malignancy. B. RIGHT BREAST, MODIFIED RADICAL MASTECTOMY: - Invasive ductal carcinoma, Nottingham grade 3. - Tumor size: 4.7 cm in diameter. - Focal features of invasive micropapillary carcinoma. Ductal carcinoma in situ (DCIS), high nuclear grade. - Cribriform and papillary architecture. - Comedo necrosis and calcifications present. DCIS present adjacent to invasive carcinoma, in lactiferous ducts,. and focally in upper inner quadrant. - Mastectomy margins are free of tumor. - Carcinoma is 0.2 cm from the deep margin, and is at least. 2 cm from all other margins. - Metastatic carcinoma in 3 of 17 axillary lymph nodes. Printed: This report continues. MR No, a. Acct No. Pathology - Page 1/6. 1. Page 1 Doc# 1. ADDENDUM SURGICAL PATHOLOGY REPORT. - No extranodal extension is identified. - Largest metastatic focus measures 1.3 cm in diameter. - Gynecomastia. PATHOLOGIC TUMOR STAGING SYNOPSIS: Type and grade (invasive): Invasive ductal carcinoma, Nottingham grade 3. Primary tumor: pT2. Regional lymph nodes: pN1a. Distant metastasis: pM1 (metastasis to iliac bone). Lymphovascular invasion: Present. Pathologic stage: IV. Margin status: Negative. Invasive Breast Cancer Tumor Staging Information. AJCC Cancer Staging Handbook, 7th Ed., and CAP Protocol (revised June 2012). Previous pathology specimens: (breast biopsy),. left iliac bone biopsy). Printed. This report continues. Acct No. atient Name -. Pathology - Page 2/6. Page 2 Dec# 1. SPECIMEN IDENTIFICATION. Procedure/specimentype: Modified radical mastectomy. Laterality: Right. Lymph node sampling: Lymph node dissection. INVASIVE CARCINOMA TUMOR CHARACTERISTICS. Histologic type: Invasive ductal carcinoma. Tumor site: Upper outer quadrant. Tumor size: 4.7 cm. Tumor focality: Single focus of invasive carcinoma. Histologic grade (Nottingham Score): 3 of 3. Tubule formation: 3 of 3. Nuclear pleomorphism: 3 of 3. Mitotic rate: 3 of 3. Lymphovascular invasion: Present,. Macroscopic and microscopic extent of tumor: No skin or chest wall invasion identified,. DUCTAL CARCINOMA IN SITU (DCIS): high nuclear grade. MARGINS. Invasive carcinoma: 0.2 cm from deep margin, at least 2 cm from all. other margins. Ductal carcinoma in situ: at least 1 cm from all margins. LYMPH NODES. Total lymph nodes examined. 17. Number of lymph nodes involved. 3. Size of largest metastatic deposit: 1.3 cm. Extranodal extension: Not identified. PATHOLOGIC STAGING: Primary Tumor (pT): pT2. Regional lymph nodes (pN): pN1a. Distant metastasis (pM): pM1. AJCC Stage: IV,. ANCILLARY STUDIES: ProPath,. performed on bone biopsy. Estrogen receptor: 100% positive cells, strong intensity. Progesterone receptor: 0% positive cells. HER2: IHC score 1+. Ki-67;. 15% positive cells. Page, 3. Printed: ,. This report continues. MR No. -. Acct No, -. Pathology - Page 3/6. Page 3 Doc# 1. ADDENDUM SURGICAL PATHOLOGY REPORT. Source of Specimen: A. Breast:left complete mastectomy. B. Breast;right modified radical mastectomy. Clinical History/Operative Dx: None provided. Gross Description: A. The specimen is labeled left breast complete mastectomy and is received in formalin. It consists of a. mastectomy specimen which weighs 227 grams. A black suture with a metallic clip marks the ""tail of the. breast"". With this orientation the specimen measures 18.5 cm from medial to lateral, 11.8 cm from. superior to inferior, and 2.5 cm superficial to deep. There is an overlying broad ellipse of dark brown skin. which measures 17 x 6.5 cm. Centrally and slightly superiorly within the skin is a 2.3 cm areola and a. protuberant 0.7 cm nipple. The anterior-superior margin is inked blue, the anterior-inferior margin is inked. green, and the posterior margin, which consists of smooth fascial tissue, is inked black. The specimen is serially sectioned at close intervals to reveal lobulated fatty tissue and centrally located. tan-white fibrous parenchyma. There are no areas which have a stellate or retracted appearance. suggestive of neoplasm. In the lateral portion of the specimen, 2 cm from the lateral edge, there is a. circumscribed 0,7 cm pale red lymph node. Representative sections are submitted, Section summary: A1) nipple and tissue just deep to nipple,. A2) representative upper inner quadrant,. A3) representative lower inner quadrant,. A4) representative upper outer quadrant. A5) representative lower outer quadrant,. A6) representative central breast and representative central deep margin,. A7) lateral lymph node. Printed: This report continues. Acct No. -. Pathology - Page 4/6. - Page 4 Doc# 1. ADDENDUM SURGICAL PATHOLOGY REPORT. B. The specimen is labeled right breast modified radical mastectomy and is received without fixative. It. consists of a mastectomy specimen together with axillary ussue weighing 292 grams. The breast measures. 16 cm from medial to lateral, 9 cm from superior to inferior and up to 4 cm from superficial to deep. There. is an overlying ellipse of dark brown skin which measures 15.5 x 7.6 cm. Slightly medially located within. the skin is a circumscribed 2,5 cm areola and a protuberant 0,6 cm nipple, The skin is unremarkable. Axillary tissue is present and measures 15 x 6.5 X 1.8 cm. The anterior-superior margin is inked blue, the. auterior-inferior margin is inked green, and the posterior margin, which consists of smooth facial tissue, is. inked black. in the central lateral portion of the deep margin, there is a 3 x 0,5 cm band of skeletal muscle. which is indicated by the surgeon as pectoralis major behind the tumor. The specimen is serially sectioned at close intervals to reveal a relatively well-circumscribed. firm,. tan-white tumor mass beginning directly underneath the nipple and extending laterally within the breast. This tumor mass measures 4,7 cm from medial to lateral, 4.5 em from superior to inferior, and 3.5 cm from. superticial to deep. This neoplasm is 3.5 cm from the closest medial margin, 5 cm from the axillary tail,. 2.5 cm from the closest superior margin, and 2.2 cm from the closest inferior margin. Centrally, it is grossly. 0.2 cm from the closest deep margin and does not appear to extend into the small strip of pectoralis. muscle. The remainder of the breast is composed of soft fatty tissue without other palpable masses. Representative tumor and adjacent breast parenchyma are obtained for research purposes. In the medial. portion of the axillary tail, there is a prominent firm 1.5 cm lymph node suspicious for metastatic. involvement. Representative tissue from this lymph node is obtained for research purposes also. The. axillary tissue is dissected for nodes. Representaitve sections are submitted. Section summary: B1) nipple and tissue just deep to nipple,. B2) representative lateral skin overlying tumor,. B3) medial edge of tumor,. B4-B11) sections of tumor progressing from medial to lateral,. B12) section of tumor and closest approach to deep margin,. B13) deep margin with pectoralis muscle,. B14) representative upper inner quadrant,. B15) representative lower inner quadrant,. B16) representative upper outer quadrant,. B17) representative lower outer quadrant,. B18) medial axillary node (some submitted for research),. B19) single node, multiply sectioned,. B20) single node, multiply sectioned,. 821) one larger node, serially sectioned, two smaller nodes inked and bivalved,. 822) two nodes, serially sectioned (one inked),. B23-B24) smaller possible nodes, intact. Microscopic Description: A. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. B. Microscopic sections have been examined. The microscopic findings are retlected in the diagnosis. Case i. Printed: : his report ontinues. MR No. -. Acct No. Pathology - Page 5/6. Job. Page 5 Doc# 1. ADDENDUM SURGICAL PATHOLOGY REPORT. rendered. Final report originally signed by. Printed. END OF REPORT (ADDENCUM). MR No. -. Acct No. Pathology - Page 6/6. Page h Doc# 1. Gender: M. Provider Group : Date of Service: Date Received: FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. LEFT BREAST, PROPHYLACTIC MASTECTOMY: - Gynecomastia. - Unremarkable skin and nipple. - Negative for malignancy. B. RIGHT BREAST, MODIFIED RADICAL MASTECTOMY: - Invasive ductal carcinoma, Nottingham grade 3. - Tumor size: 4.7 cm in diameter. - Focal features of invasive micropapillary carcinoma. - Ductal carcinoma in situ (DCIS), high nuclear grade. - Cribriform and papillary architecture. - Comedo necrosis and calcifications present. DCIS present adjacent to invasive carcinoma, in lactiferous ducts,. and focally in upper inner quadrant. - Mastectomy margins are free of tumor. Carcinoma is 0.2 cm from the deep margin, and is at least. 2 cm from all other margins. - Metastatic carcinoma in 3 of 17 axillary lymph nodes. - No extranodal extension is identified. Largest metastatic focus measures 1.3 cm in diameter. - Gynecomastia. PATHOLOGIC TUMOR STAGING SYNOPSIS: Type and grade (invasive): Invasive ductal carcinoma, Nottingham grade 3. Primary tumor: pT2. Regional lymph nodes: pN1a. Distant metastasis: pM1 (metastasis to iliac bone). Lymphovascular invasion: Present. Pathologic stage: IV. Margin status: Negative. Printed: Tnis report continues. (I INAL). MR No. -. Acct No -. Pathology - Page 1/6. 1 Doc# 1. FINAL SURGICAL PATHOLOGY REPORT. Invasive Breast Cancer Tumor Staging Information. AJCC Cancer Staging Handbook, 7th Ed., and CAP Protocol (revised June 2012). Previous pathology specimens: 1 (breast biopsy). (left iliac bone biopsy). Case 4. Printed: This report continues - (FINAL). Acct No. Patient Name - T. Pathology - Page 2/6. Job. Page 2 Doc# 1. SPECIMEN IDENTIFICATION. Procedure/specimen type: Modified radical mastectomy. Laterality: Right. Lymph node sampling: Lymph node dissection. INVASIVE CARCINOMA TUMOR CHARACTERISTICS. Histologic type: Invasive ductal carcinoma. Tumor site: Upper outer quadrant. Tumor size: 4.7 cm. Tumor focalify: Single focus of invasive carcinoma. Histologic grade (Nottingham Score): 3 of 3. Tubule formation: 3 of 3. Nuclear pleomorphism: 3 of 3. Mitotic rate: 3 of 3. Lymphovascular invasion: Present. Macroscopic and microscopic extent of tumor: No skin or chest wall invasion identified. DUCTAL CARCINOMA IN SITU (DCIS): high nuclear grade. MARGINS. Invasive carcinoma: 0.2 cm from deep margin, at least 2 cm from all. other margins. Ductal carcinoma in situ: at least 1 cm from all margins. LYMPH NODES. Total lymph nodes examined. 17. Number of lymph nodes involved. 3. Size of largest metastatic deposit. 1.3 cm. Extranodal extension: Not identified. PATHOLOGIC STAGING: Primary Tumor (pT): pT2. Regional lymph nodes (pN): pN1a. Distant metastasis (pM): pM1. AJCC Stage: IV. ANCILLARY STUDIES: ProPath,. (performed on bone. biopsy). Estrogen receptor: 100% positive cells, strong intensity. Progesterone receptor. 0% positive cells. HER2: IHC score 1+. Kj-67: 15% positive cells. Printed: This report continues (FINAL). Acct No. Pathology - Page 3/6. Jo. Page 3 Doc# 1.",T2,N1,M1,T2N1M1
TCGA-EW-A6SB,"X. F. X. X. x. x. x. Pathologic Interpretation: A. LEFT AXILLARY # 1. Negative for carcinoma, four lymph nodes examined (0/4). Keratin immunostain is pending. B. LEFT AXILLARY,. , PALPABLE: Negative for carcinoma, four lymph nodes examined (0/4). Keratin immunostain is pending. C. LEFT SEGMENTAL MASTECTOMY: INVASIVE DUCTAL CARCINOMA, poorly differentiated, Nottingham grade 3 (3+3+3=9), 3.1 cm in greatest. dimension. Immunohistochemical studies performed on previous biopsy showed the following results: Estrogen Receptor: NEGATIVE (< 1%). Progesterone Receptor: NEGATIVE (< 1%). Her2/neu. NEGATIVE (0). Androgen Receptor: NEGATIVE. EGFR: POSITIVE. GCDFP: NEGATIVE. HLA-DR: Immunohistochemistry is pending. Skin is uninvolved by tumor. Resection margins are uninvolved by invasive carcinoma; the tumor is at less than 1 mm from the deep. resection margin. Negative for lymphatic space invasion. SURGICAL PATHOLOGY CANCER CASE SUMMARY. Procedure. Excision without wire-guided localization. Lymph Node. Sentinel lymph node(s). Specimen Laterality. Left. Histologic Type of Invasive Carcinoma. Invasive ductal carcinoma (no special type or not otherwise specified). Tumor Size: Size of Largest Invasive Carcinoma. Greatest dimension of largest focus of invasion >1 mm: 31 mm. Histologic Grade: Nottingham Histologic Score. Glandular (Acinar)/Tubular Differentiation. Score 3: <10% of tumor area forming glandular/tubular structures. Nuclear Pleomorphism. Score 3: Vesicular nuclei, often with prominent nucleoli, exhibiting marked variation in size and. shape, occasionally with very large and bizarre forms. Mitotic Rate. Score 3 (>8 mitoses per mm) (see Table 1). Overall Grade. Grade 3: scores of 8 or 9. Tumor Focality. Single focus of invasive carcinoma. Ductal Carcinoma In Situ (DCIS). No DCIS is present. Lobular Carcinoma In Situ (LCIS). Not identified. Margins. Invasive Carcinoma. Margins uninvolved by invasive carcinoma. Distance from closest margin: 1 mm. Specify margin: Deep. Lymph Nodes. Number of sentinel lymph nodes examined: 8. Total number of lymph nodes examined (sentinel and nonsentinel): 0. Number of lymph nodes without tumor cells identified: 8. Method of Evaluation of Sentinel Lymph Nodes. Hematoxylin and eosin (H&E), 1 level. Immunohistochemistry. Treatment Effect: Response to Presurgical (Neoadjuvant) Therapy. In the Breast. No known presurgical therapy. In the Lymph Nodes. No known presurgical therapy. Lymph-Vascular Invasion. Not identified. Dermal Lymph-Vascular Invasion. Not identified. Pathologic Staging (based on information available to the pathologist) (pTNM). Primary Tumor (Invasive Carcinoma) (pT). pT2: Tumor >20 mm but <50 mm in greatest dimension. Regional Lymph Nodes (pN). pNO: No regional lymph node metastasis identified histologically. Distant Metastasis (pM). Not applicable. Ancillary Studies. Performed on another specimen. Specify specimen (accession number): xxx. Estrogen Receptor (ER). Results and interpretation: Negative (<1% of tumor cells with nuclear positivity). Progesterone Receptor (PgR). Results and interpretation: Negative (<1% of tumor cells with nuclear positivity). HER2 Immunoperoxidase Studies. Negative (Score 0). AJCC Classification (7th edition): pT2, pNo, pMn/a. Procedures/Addenda: Addendum. Date Complete: Addendum Diagnosis. A. LEFT AXILLARY #1. Keratin immunohistochemistry is negative. B. LEFT AXILLARY,. PALPABLE: Keratin immunohistochemistry is negative. Final AJCC Classification (7th edition): pT2 (sn)NO(i -) Mn/a. Addendum Diagnosis. ADDENDUM C: Immunohistochemistry for HLA-DR is positive in tumoral cells. This neoplasm is consistent with an invasive ductal carcinoma, medullary type. Intraoperative Consultation: A. Left axillary #1,. FS: No malignancy seen. B. Left axillary. palpable, FS1-3: No malignancy seen. x. Clinical History: Patient with palpable breast cancer, please evaluate margins and lymph nodes. Operation Performed: Left segmental mastectomy with sentinel lymph node biopsy, possible axillary node dissection. Pre Operative Diagnosis: Carcinoma left breast. Specimen(s) Received/Processing Information: Fee Codes: A: LEFT AXILLARY # 1. FS Frozen section x 1, FS Perm x 1, Touch Prep. Histology x 1, FSDeep 1 x 1, Cytokeratin Cocktail (KER) x 1, H&E, Initial x 1. A: B: B: LEFT AXILLARY,. , PALPABLE FS Frozen section x 1, FS Perm x 1, Touch. Prep Histology x 1, Cytokeratin Cocktail (KER) x 1, Frozen section x 1, FS Perm x 1,. C: Cytokeratin Cocktail (KER) x 1, Frozen section x 1, FS Perm x 1, Cytokeratin Cocktail (KER) x. 1, H&E, Initial x 1, Cytokeratin Cock. C: LEFT SEGMENTAL MASTECTOMY (1 SUTURE -SUPEIOR, 2 SUTURES - MEDIAL). H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x. 1, H&E, Initial x 1, H&E, Initial x 1, H&E, Initial x 1, HLA-DR (IP) x 1, H&E, Initial x 1, H&E,. Initial x 1, H&E, Initial x 1, H&E, Initial x 1, H&E,. Gross Description: A.Received fresh labeled ""Left axillary #1,. FS"" is a fragment of adipose tissue that measures 5 x 4 x 2 cm. There are four palpable lymph nodes present. The lymph nodes are bisected and submitted for frozen section. (cassette #1FS). Representative sections of the remaining adipose tissue are submitted in cassette #2. B. .Received fresh labeled ""Left axillary. palpable, FS"" is a fragment of adipose tissue that measures 4 x 4 x. 2 cm. There are four palpable lymph nodes present. The lymph nodes are bisected and submitted for frozen section. in cassettes #1-3FS. The rest of the specimen is submitted in cassettes #4-8. C. Received in formalin labeled ""Left segmental mastectomy (1 suture -superior, 2 sutures -medial)"" is a lumpectomy. specimen weighing 120 grams and measuring 9 x8 x 3.5 cm, with an unremarkable dark skin ellipse measuring. 3.3 x 1.3 cm. The specimen is inked as follows: superior-blue, inferior-green, anterior-yellow, deep-black, medial-. red, lateral-orange. Upon sectioning, there is a 3.1 x 3.0 x 3.0 cm well circumscribed, nodular tumor, white-tan, with. an elastic consistency and central cavity. A metallic clip is identified in the central of the tumor. The tumor is grossly. at less than 0.1 cm from the deep margin, 0.4 cm from the superior margin, 1.0 cm from the lateral margin, 2.0 cm. from the medial margin, 2.5 cm from the anterior and skin margin, 4.0 cm from the inferior margin. The rest of the. specimen has a cut surface, yellow-tan and homogeneous. Cassettes are submitted as follows: Cassette #1. Tumor in relation with deep and superior margins. Cassette #2. Medial margin. Cassette #3. Lateral margin. Cassette #4. Anterior margin (and skin). Cassette #5. Inferior margin. Cassette #6. Area of tumor with clip. Cassettes #7&8. Composite section of the tumor. Cassettes #9-12 Additional sections of the tumor. Cassettes #13-15 Representative sections of the rest of specimen.",T2,N0,M0,T2N0M0
TCGA-BP-4342,"tion;. ice: Clininal Diagnosis & History: male with a kidney tumor, left. Past medical history of bladder cancer. Specimens Submitted: 1: SP: Left kidney and adrenal. 2: SP: Para-aortic lymph nodes. 3: SP: Part of the left kidney. DIAGNOSIS: 1). KIDNEY, LEFT; NEPHRECTOMY: - RENAL CELL CARCINOMA, CLEAR CELL TYPE, NUCLEAR GRADE III/IV. - THE PATTERN OF GROWTH IS ACINAR. - THE TUMOR GREATEST DIAMETER IS 11 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE,. - INVASION OF THE RENAL VEIN IS PRESENT. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. - THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. - THE ADRENAL GLAND IS UNREMARKABLE,. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF METASTATIC NODES IN. RELATION TO THE TOTAL NUMBER OF NODES EXAMINED): ONE BENIGN PERINEPHRITIC LYMPH NODE (0/1). 2). LYMPH NODES, PARA-AORTIC; EXCISION: SIX BENIGN LYMPH NODES (0/6). 3). KIDNEY, PART OF LEFT; EXCISION: - FRAGMENT OF ADIPOSE TISSUE,. - NO TUMOR SEEN. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), ANO THAT THAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: The specimen is received fresh and sterile, labeled, ""Left kidney and adrenal"". It consists of a nephrectomy specimen. with attached perinephric adipose tissue. The specimen measures 30.0 x 18.0 x 10.0 cm. The specimen Is bisected to reveal a. hemorrhagic, yellowish mass located in the superior aspect of the kidney, measuring 11,0 x 9.0 x 5.0 cm, which extends just. underneath the kidney capsule and grossly confined into the capsule. There is another tan-white cyst located at the inferior. portion of the kidney, measuring 5.0 x 4.0 x 3.0 cm with a smooth internal surface and Is also confined into the renal capsule. About 80% of the renal parenchyma is replaced by the mass and the remaining kidney parenchyma measures 5,0 x 3.0 x 3.0 cm. The resection margin of the renal vein and ureter are identified, grossly unremerkable. Sectioning of the tumor displays. yellowish-brown, hemorrhagic cut surface with focal necrosis. The tumor involves the pelvis and renal vein grossly. Sectioning of. the. remaining renal parenchyma is tan-brown and unremarkable. The adrenal gland is identified, measuring about 3.0 x 2.0 x 0.6. cm. Sectioning of the perinephric fatty tissue is unremarkable. No definite lymph nodes are identified. Representative sections. from the ureter, vascular margin, from the tumor, renal parenchyma and adrenal gland are submitted. Summary of Sections: UM - ureteral margin. VM - vascular margin. AD - adrenal gland. T - tumor section. U - undesignated renal parenchyma. F - fatty tissue. 2). The specimen is received in formalin, labeled, ""Para-aortic lymph nodes"". It consists of two fragments of fatly tissue,. measuring 5.0 x 5.0 x 2.5 cm and sectioning reveals multiple lymph nodes, measuring 0.3 up to 1.0 cm in greatest dimension,. The entire lymph nodes are submilled. Summary of Sections: LN - lymph nodes. 3). The specimen is received fresh, labeled, ""Part of the left kidney"". Il consists of a fragment of adipose tissue, measuring. 20.0 x 9,0 x 1.5 cm. Serial sectioning reveals mature edipose tissue. No nodules in the renal parenchyma are identified. Representative sections are submitted. Summary of Sections: F - fatly tissue. Summary of Sections: Part 1: SP: Left kidney and adrenal. Block. Sect. Site. PCs. 1. AD. 1. 1. F. 10. S. 10. 1. U. 1. UM. 1. VM. 1. Part 2: SP: Para-aortic lymph nodes (pjm). Block. Sect. Site. PCs. 4. LN. 4. Part 3: SP: Part of the left kidney (pjm). Block. Sect. Site. PCs. F. 1.",T2,N0,M0,T2N0M0
TCGA-E7-A677,"Patient ID: Gross Description: In bladder, there are an invasive tumor, ill - margins with 3x2x2cm in size, soft and. gray surface. Microscopic Description: Transitional cells are hyperplastic. Tumor cells arrange to form papillary or. trabeculae. Tumor cells have moderate and eosinophilic cytoplasm. Nuclei are enlarged and varriability. in shape and size, very irregular nuclear membranes, nucleoli and abnormal chromatin patterns. Mitoses. are present. Tumor invades in deeply muscularis propria. Diagnosis Details: Infiltrating urothelial carcinoma, low-grade, infiltrating outer half muscularis propria. ICS-8-9. Comments: Formatted Path Reports: BLADDER TISSUE CHECKLIST. Specimen type: Cystectomy. Tumor site: Bladder. Tumor size: 3 X 2 x 2 cm. Tumor features: None specified. Histologic type: Transitional cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Muscularis propria. Lymph nodes: Not specified. Lymphatic invasion: Absent. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T2,N0,M0,T2N0M0
TCGA-B7-A5TI,"Compone. Clinical. Index. Ethnicity. Clinical. Tissue. Specimen. Tumor. Anatomical Site. Specimen. Specificati. Specimen. Number of. Amount/p. Type of. nt of. Site. Container. Matrix. er. containers. Procurem. listological. Grade. TNM Stage. TNM Stage. (Race). TNM Stage. Treatment. treatment. Tumor cell. label. Diagnosis. Format. on. container. description. ent. (T). (N). (M). type. (Chemo /. %. Horm Th. Stomach. Detaile). Caucasian. Gastric. male. (White). Stomach, fundus. Primary. Tumor. Tissue. cancer. OCT. block. 1. 200. Adenocarcino. mg. 1. 4. ma, diffuse. 3. 0. none. n/a. 70. Caucasian. Gastric. male. (White). Blood. n/a. Normal. Blood. frozen. tube. 1. blood. cancer. 4. ml. n/a. n/a. draw. n/a. n/a. n/a. none. n/a. n/a. Criteria.",T4,N3,M0,T4N3M0
TCGA-DJ-A3UU,"care UI - noceuure. Clinical Diagnosis & History: Bilateral thyroid nodularity with a diagnosis of papillary carcinoma of the right lobe. Specimens Submitted: 1: Thyroid; total thyroidectomy. 2: Lymph nodes, delphian; excision. DIAGNOSIS: 1. Thyroid; total thyroidectomy: Tumor Type: Papillary carcinoma, classical type. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Right lobe. Tumor Size: Greatest diameter is 1.1 cm. Tumor Encapsulation: None Identified. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Invades the extrathyroidal fibroadipose tissue. Surgical Margins: Tumor is present at inked anterior margin. Tumor Multicentricity: Papillary microcarcinoma (0.7 cm) present In left lobe. Non-Neoplastic Thyroid: Exhibits nodular hyperplasia. Exhibits chronic lymphocytic thyroiditis. Parathyroid Glands: Not identified. 2. Lymph nodes, delphian; excision: Lymph Node Dissection: Benign lymph nodes. Number of lymph nodes examined: 2. Number of lymph nodes with metastatic disease: 0. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh, labeled ""total thyroidectomy, stitch marks right lobe and consists of a thyroid weighing 16.5. g. A stitch is not grossly identified. The right lobe measures 3.5 x 1.5 x 1.1 cm, the left lobe measures 3.3 x 2.5 x 0.9 cm and. the isthmus measures 2 X 0.9 x 0,4 cm. The external surface is covered by a thin fibrous capsule. The posterior surface of the. specimen is inked black, and the anterior is inked blue. Sectioning reveals a 1.1 x 1.0 x 1.0 CM firm white nodule (N) in the right. lobe, focally abutting the anterior and posterior thyroid capsule. Sections through the left lobe reveals two small nodules measuring. respectively 0.3 and 0.4 cm in greatest dimension (N1 and N2). Sections through the isthmus reveals one nodule measuring 0.5. cm. in greatest dimension (N3). The remaining thyroid parenchyma is red tan and beefy. Representative sections of the specimen. submitted for. The remaining tissue is serially sectioned and representatively submitted. Summary of sections: N - nodule, right lobe, entirely submitted. N1- nodule 1, left lobe, entirely submitted. N2 - nodule 2, left lobe, entirely submitted. RL - right lobe. LL left lobe. IS isthmus. N3- nodule, isthmus, entirely submitted. 2. The specimen is received in formalin labeled, ""Delphian nodes"", and consists of two tan lymph nodes measuring 0.2 to 0.3 Cm. in greatest dimension. Entirely submitted. Summary of sections: LN - lymph nodes. Summary of Sections: Part 1: Thyroid; total thyroidectomy. Block. Sect. Site. PCs. 1. IS. 1. 1. LL. 2. N. 2. 2. N1. 2. 1. N2. 1. 1. N3. 1. 1. RL. Part 2: Lymph nodes, delphian; excision. Block. Sect. Site. PCs. 1. In. 1.",T3,N0,M0,T3N0M0
TCGA-AA-3956,"Diagnosis (diagnoses): Resected ileocolic sample with a moderately differentiated adenocarcinoma of the. colorectal type, located in the cecum, max. 4 cm in diameter, with infiltration of the. pericecal fatty tissue. Circumscribed fibrinous serositis in the area of the tumor. Stage of tumor: pT3, pNO (0/36), pMX; G2, L0, V0, R0.",T3,N0,M0,T3N0M0
TCGA-77-8136,"Histopathology Report. HISTORY. Left pneumonectomy plus lymph node biopsies. [Note previous cytology from. Bronchial brushings showing. atypia suspicious for malignancy; bronchial washings negative.]. MACROSCOPIC. Three specimens received. 1: The specimen is labelled ""left pneumonectomy"" and consists of a left lung. which measures 240 mm from the apex to the base, 165 mm from posterior to. anterior and up to 50 mm from lateral to medial. It weighs 343 g. The hilum. is distorted by a large tumour nodule which appears to involve both the apical. segment of the lower lobe and the superior lingular segment of the upper lobe. Mucopus protrudes from the bronchial resection margin and anteroinferior to. this margin there is a small firm nodule which may represent an involved lymph. node. The mediastinal pleural surface has a nodular appearance but elsewhere. the surface is smooth. Sectioning of the tumour reveals that it invades the. bronchial wall and projects within the lumen of the bronchus proximally towards. the margin. Tumour is present 11 mm from the bronchial resection margin. The. lesion measures 65 X 60 x 40 mm. The centre of the lesion is necrotic and. liquid but elsewhere the tumour has a firm variegated cut surface with areas of. cream, yellow and tan discolouration. The lesion abuts the overlying. mediastinal pleural surface. Extending from the tumour and into the lower lobe. there is an area of firm yellow discolouration which is demarcated along one. edge by interlobular septa. It extends over an area measuring 55 x 30 X 30 mm. and lies beneath the pleura along the anterior border of the lower lobe. This. area ends distally at a small 10 cm nodule which has a yellow focally. haemorrhagic cut surface. This nodule measures 12 mm in maximum extent. The. remaining lung parenchyma is otherwise unremarkable. [1A, bronchial, vascular. and soft tissue resection margin; 1B, peribronchial lymph nodes; 1C-1D,. endobronchial tumour and adjacent lung; 1E-1F, tumour with overlying. mediastinal pleura; 1G, area of yellow consolidation; 1H, distal nodule; 11,. uninvolved apical lung parenchyma.]. 2: The specimen is labelled ""hilar node"" and consists of a single fragment of. reddish black tissue which measures 24 x 15 x up to 10 mm. [Bisected, 2A.]. 3: The specimen is labelled ""No. 8 lymph node"" and consists of a single. fragment of fibrofatty tissue which measures 20 x 15 x 10 mm. Sectioning. reveals a blackened lymph node. [Bisected, 3A.]. MICROSCOPIC. 1: Sections show a non-small cell carcinoma with multifocal necrosis. The. majority of the tumour comprises patternless sheets of smallish cells with. granular chromatin and somewhat fibrillar or granular eosinophilic cytoplasm. Page 1 o. Histopathology Report. In a few areas there is cytoplasmic clearing. There are scattered small foci. suggestive of squamous differentiation in the form of larger cells with more. eosinophilic cytoplasm, larger more vesicular nuclei, prominent nucleoli and. sometimes multinucleation. However there is no evidence of keratinisation and. no intercellular bridges are found. Mitoses are frequent and often abnormal. Immunoperoxidase staining for neuroendocrine markers (chromogranin,. synaptophysin and CD56) is negative. The tumour includes endobronchial and. parenchymal components. A tiny strip of metaplastic squamous epithelium. showing moderate dysplasia is noted in one large bronchus adjacent to the. tumour (1D), and several other airways within the tumour appear to show. squamous carcinoma in situ. Vascular invasion is identified (1D, 1E) and there. is invasion into, but not through, the mediastinal pleura (1E). Lymphatic. invasion is not identified but metastatic carcinoma is present in peribronchial. lymph nodes. No perineural invasion is seen. The bronchial resection margin. is clear of dysplasia and invasive malignancy, although a small amount of. largely necrotic tumour appears to lie free in the lumen. The inked. mediastinal soft tissue resection margin is also clear of malignancy. The. area. of yellowish consolidation in the lower lobe is the result of organising. obstructive pneumonitis. This shows focal cavitation resulting in the nodule. noted macroscopically, but no organisms are identified in routine or special. stains. 2 & 3: Sections of the separately submitted hilar and no. 8 lymph nodes show. reactive lymphoid hyperplasia and aggregates of pigmented histiocytes but no. evidence of metastatic carcinoma. SUMMARY. Left pneumonectomy and lymph node sampling: Poorly differentiated squamous cell carcinoma, 65 mm in greatest diameter. Vascular and pleural invasion present. No perineural invasion found. Metastases in peribronchial lymph nodes. Pathological stage T2 N1. Lung Cancer Registry.",T2,N1,M0,T2N1M0
TCGA-AA-A017,"Sample ID%. Diagnosis: Resected colon with an extensive, ulcerated, moderately differentiated adenocarcinoma of. the colorectal type with infiltration of the pericolic fatty tissue, and measuring a max of. 3.5 cm. Tumor-free local lymph nodes. Tumor-free colon resection margins. Tumor-free. mesocolic amputation margin. Tumor classification: pT3 pNO (0/18), pMX; G2, L1, V0, R0.",T3,N0,M0,T3N0M0
TCGA-55-7576,"PROCEDURE. Right thoracotomy. SPECIMEN: A. Right upper lobe FS. B. R4 lymph node. C. Subcarinal. lymph node. HISTORY. Right upper lobe nodules (x2). GROSS. A. ""Right upper lobe freeze bronchial margins. "" Received fresh for. immediate evaluation and frozen section analysis is a partly. collapsed lobe of lung, which has a small amount of hemorrhage over. the surface. Most of the pleural surfaces are smooth, glistening. and light to medium purple-brown. It weighs 240 grams. The. bronchial resection margin portion of the most hilar aspect of the. specimen is a bronchus 1.1 x 0.9 cm across. This resection margin. is shaved from the specimen and submitted as a frozen section block. Two nodules are palpated in the upper aspect of the lobe and both. show some degree of overlying puckering of the pleural surfaces. These are marked by me with blue dye. The more lateral lesion is. cut across and reveals a subpleural, white and gray speckled lesion. 2.0 x 1.7 cm on cut surface. A portion of this is removed for the. tumor genome project in the usual manner. The second nodule, which. is more apically situated, has its epicenter about 2 cm away from. the lesion mentioned above and has more of a yellowish cut surface,. is well circumscribed and up to 1.8 x 1.7 cm and presents focally. just beneath the pleural surface, also with some overlying puckering. of plerua. A portion of this tumor is also sampled for the tumor. genome project. After preparation of the frozen section, the frozen section remnant. is placed in a block and the remainder of the tissue is fixed prior. to further processing. After fixation of the specimen, the frozen section control is. processed as block FSA1. Additional tissues in the region of the. vascular and bronchial margins are taken after removing staples, in. block A2, which include apparent vascular margins, additional. bronchial tissue and parabronchial lymph nodes. The more lateral. tumor site is then sampled as multiple pieces in blocks A3 and A4,. including overlying puckered pleural surfaces. A5. This is a vertical section taken between the two foci of. tumors, which appears to be free of gross tumor. This section will. let us know whether there is direct connection between the nodules. or not, on a microscopic level. A6-A7. More apical, second focus and overlying puckered pleural. surface. Upon further inspecting the specimen after fixation, the two foci of. tumors appear to be fairly close together, perhaps as close as 5 mm,. and may be continuous as a ""dumbbell"" fashion if connected. A. section of uninvolved lung tissue from the lower aspect of the lobe. is taken as block A8. B. ""R4 lymph node. A mostly dark black and focally yellow piece. of tissue is 1.4 x 1.2 x up to 0.5 cm. It is bisected. C. ""Subcarinal lymph node. "" Three pieces of jet black tissue are. from 4, 9 and 16 mm across. Only the largest is bisected but all. material is then processed as one block. FROZEN SECTION DIAGNOSIS. A. Bronchial resection margin negative for tumor. MICROSCOPIC. A. The frozen section control confirms the frozen section findings. of a proximal bronchial resection margin that is negative for tumor. The two foci containing gross tumor, the more laterally situated and. the more atypically situated have identical histology with areas. showing adenocarcinoma growing in scar tissue with some areas. showing more clear cell patterns to the cytoplasm and other areas. having more eosinophilic and darker cytoplasm. Some of the latter. tumor grows in a lepidic pattern including focally into the visceral. pleura, with at least one small focus deposited and stuck to the. outside of the visceral pleura. Deeper sections have been. made of these foci. The section taken between the two nodules,. although not grossly involved, has microscopic involvement of. additional invasive adenocarcinoma which therefore shows a. connection between these two otherwise apparently separate nodules. Thus, I think this is a single tumor with a so-called dumbbell shape. and both foci of tumors making the larger nodules have mixtures of. clear-type cytoplasm and eosinophilic-type cytoplasm. Emphysema is. also found within the lung. A focus of tumor shows growth into a thick-walled blood vessel,. probably a vein. A single parabronchial lymph node is found and is. negative for metastatic disease. B. The lymph node is studied at multiple cuts through the node and. is enlarged and has reactive changes, but does not contain. metastatic disease. C. The lymph node is enlarged, has reactive changes and is negative. for metastatic disease. The case is seen by Dr. who is in agreement with the. following diagnoses. DIAGNOSIS. A. Right upper lung lobe, biopsy with frozen section: Invasive moderately differentiated adenocarcinoma. CPT 88307, 88331. Parabronchial lymph node negative for metastatic disease. CPT 88305. B. R4 lymph node, biopsy. Reactive lymph node, negative for tumor. CPT 88305. C. Subcarinal lymph node, biopsy: Reactive lymph node negative for tumor. CPT 88305. SYNOPTIC REPORT - LUNG`. SPECIMEN: Lung. PROCEDURE: Lobectomy. SPECIMEN INTEGRITY: Single, intact. SPECIMEN LATERALITY: Right. TUMOR SITE: Upper lobe. TUMOR SIZE: Approximately 4.3 cm (dumbbell shaped, two nearby. nodules connected microscopically). TUMOR FOCALITY: Single focus but with two dominant nodules. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: 2. VISCERAL PLEURA INVASION: Yes. TUMOR EXTENSION: Tiny amount on outer surface of visceral pleura. MARGINS: Neg. Bronchial margin: Neg. Vascular margin: Neg. Parenchymal margin: Neg. Parietal pleural margin: Not sampled. Chest wall margin: Not sampled. Other attached tissue margin: Not sampled. Distance of invasive carcinoma from closest margin: About 5. cm. TREATMENT EFFECT: None. LYMPH-VASCULAR INVASION: Not identified. LYMPH NODES Negative, reactive. OTHER FINDINGS: Emphysema. PATHOLOGICAL TNM (AJCC 7th ed. ) : TNM DESCRIPTORS. pT: 2a PL2 . pN: 0. (Electronic Signature). Completed Action List: Type: Title:",T2,N0,M0,T2N0M0
TCGA-4K-AA1I,"Procedure: Left orchiectomy. Preoperative diagnosis: TUMOR OF THE LEFT TESTIS. Postoperative diagnosis: SEE MICROSCOPIC DIAGNOSIS BELOW. Specimen(s): 1. LEFT TESTIS. Diagnosis: 1. LEFT TESTIS: - Seminoma. Tumor does not invade the tunica albuginea and the epididymis. Vascular invasion is not present. Resection margin is free of tumor. Gross description: 1. LEFT TESTIS: Received fresh, is a left testis 8.0 X 5.0 x 2.5 cm in dimensions with a portion of the spermatic. cord 5.0 cm in length. In the testis there is a solid firm whitish-gray tumor 4.5 x 4.0 x 4.0 cm in. dimensions.",T1,N0,M0,T1N0M0
TCGA-AG-3725,"Diagnosis/ diagnoses: Resected rectosigmoid sample (23.5 cm in length) includes a moderately differentiated. adenocarcinoma of the colorectal type, located 4 cm from the aboral resection margin,. measuring a max of 3.5 cm in diameter, with widespread infiltration of the perirectal fatty. tissue and with five regional lymph node metastases. Tumor-free colon resection margins. The minimum distance between the tumor and the circumferential resection margin is 1. cm. In addition, diverticulosis coli. Stage of tumor: pT3 pN2 (5/18) pMX; G2, L1, V1, local R0.",T3,N2,M0,T3N2M0
TCGA-FU-A3TX,"GROSS AND MICROSCOPIC SURGICAL PANEL. Specimen Information. SURGICAL PANEL: LAB: DIAGNOSIS. A) UTERUS, CERVIX, PARAMETRIA, OVARIES, AND FALLOPIAN TUBES, RADICAL. HYSTERECTOMY WITH BILATERAL SALPINGO-OOPHORECTOMY. 1. Squamous cell carcinoma of the cervix. a. Histologic grade: Poorly differentiated (G3). b. Maximum tumor size: 4.9 cm (horizontal extent). C. Maximum depth of invasion: 0.4 cm. Cervical wall thickness: 0.9 cm. d. Parametrial involvement: Negative. e. Associated CIN: Absent. f. Margins: Clear. g. Angiolymphatic invasion: Absent. h. Three left parametrial lymph nodes negative for carcinoma (0/3). i. One right parametrial lymph node negative for carcinoma (0/1). 2. Bilateral parametria, vaginal cuff, endometrium, myometrium,. ovaries and fallopian tubes negative for carcinoma. 3. Additional findings: a. Uterine weight: 83.9 grams. b. Right ovary with benign cystic follicle. C. Atrophic endometrium. 4. See staging parameters below. B) RIGHT PELVIC LYMPH NODES, REGIONAL RESECTION: Ten lymph nodes negative for carcinoma (0/10). C) RIGHT PERIAORTIC LYMPH NODES, REGIONAL RESECTION: Two lymph nodes negative for carcinoma (0/2). D) LEFT PELVIC LYMPH NODES, REGIONAL RESECTION: Thirteen lymph nodes negative for carcinoma (0/13). E) LEFT PERIAORTIC LYMPH NODE, BIOPSY: One lymph node negative for carcinoma (0/1). CERVIX CANCER STAGING PARAMETERS. MACROSCOPIC. PROCEDURES. Radical hysterectomy, Bilateral salpingo-oophorectomy,. Regional lymph node dissections. SPECIMEN TYPE. Uterus, cervix, and parametrium, Ovaries, Fallopian tubes,. Regional lymph nodes. TUMOR SITE. Circumferential lesion (all quadrants involved). MACROSCOPIC TUMOR SIZE. Greatest dimension: 4.9 cm. MICROSCOPIC. HISTOLOGIC TYPE. Squamous cell carcinoma, keratinizing. HISTOLOGIC GRADE. Poorly differentiated (G3). MICROSCOPIC TUMOR SIZE. CERVICAL STROMAL INVASION. Maximum horizontal extent: 4.9 cm. Maximum depth of invasion: 0.3 cm. Cervical wall thickness: 0.9 cm. PARAMETRIAL INVOLVEMENT. Absent. ASSOCIATED EPITHELIAL LESIONS. Absent. LYMPHATIC/VASCULAR INVASION. Not identified. MARGINS. Uninvolved by invasive carcinoma. Distance of invasive carcinoma to closest margin: 2.4 cm. Location: Vaginal cuff. Uninvolved by intraepithelial neoplasia. PATHOLOGIC STAGING. EXTENT OF INVASION. pT1b2. (Clinically visible lesion more than 4.0 cm in. greatest dimension). REGIONAL LYMPH NODES. pNO. (No regional lymph node metastasis). Total nodes: 30. Total positive nodes: 0. DISTANT METASTASIS. pMO. (No distant metastasis). PATHOLOGIC STAGE Summary. Final TNM: pT1b2NOM0. FIGO stage: IB2. The pathologic stage presumes no distant metastasis. Attending Pathologist: CLINICAL INFORMATION. Squamous cell cancer of the cervix. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Uterus, cervix, bilateral tubes and ovaries, radical abdominal. hysterectomy. Received is a radical hysterectomy specimen measuring 83.9 gm without. attached fallopian tubes and ovaries. It measures 10.5 cm from superior to. inferior, 5.0 cm from cornu to cornu and 2.0 cm in thickness. There is. approximately 2.5 cm of vaginal cuff present. The anterior portion of the. uterus is inked blue and the posterior is inked black. The perimetria is. removed and submitted sequentially from medial to lateral. The specimen. displays pink-tan slightly ragged serosal surfaces. Upon opening the. specimen there is a 4.9 x 3.5 X 2.3 cm exophytic fungating cervical mass. The mass obscures the ectocervix completely. The vaginal cuff margin is. grossly free of tumor and is submitted en face. The tumor is located 2.4 cm. from the closest vaginal cuff margin (anterior side). On cut section the. tumor appears to invade 2-3 mm out of an average cervical wall thickness of. 9 mm. Additionally the tumor appears to involve a portion of the. endocervix. The endometrium is tan and glistening and has an average thickness of 0.1. cm. The myometrium is homogeneous pink-tan, has an average thickness of 1.1. cm and is slightly trabeculated. There are no masses or lesions identified. in the endomyometrium. The left ovary measures 1.5 X 1.0 X 0.4 cm and has a pink-tan smooth. bosselated external appearance. Cut section shows white-tan parenchyma with. no masses or lesions identified. There is a ligated fallopian tube. measuring 1.5 cm in length X 0.5 cm in diameter with a fimbriated end. On. cut section the tube is patent and stellate throughout. The right ovary measures 1.3 x 0.6 x 0.4 cm. The cut surface shows. yellow-tan parenchyma with multiple small cysts. No masses or lesions are. identified. There is a 1.5 cm segment of fimbriated fallopian tube. The. tube measures 0.4 cm in diameter and displays a stellate patent lumen. throughout. A gross photograph is taken. Tissue is taken for tumor banking. The. specimen is submitted in 33 cassettes. Summary of cassettes: 1-6. Right parametrium. 7-13. Left parametrium. 14. Vaginal cuff from 12 o'clock to 3 o'clock, en face. 15. Vaginal cuff 3 o'clock to 6 o'clock, en face. 16. Vaginal cuff 6 o'clock to 9 o'clock, en face. 17. Vaginal cuff 9 o'clock to 12 o'clock, en face. 18-20. Tumor at deepest point of invasion (anterior-12 o'clock,. submitted in thirds sequentially from vaginal cuff to lower. uterine segment- upper cut edge is inked yellow). 21-23. Tumor at deepest point of invasion (anterior 12-o'clock,. submitted in thirds sequentially from vaginal cuff to lower. uterine segment- upper cut edge is inked yellow). 24-25 Tumor at deepest point of invasion (posterior- 6 o'clock,. submitted sequentially from vaginal cuff to lower uterine. segment bisected- upper cut edge is inked yellow). 26-27. Tumor at deepest point of invasion (posterior- 6_o'clock,. submitted sequentially from vaginal cuff to lower uterine. segment bisected- upper cut edge is inked yellow). 28. Anterior endomyometrium. 29. Posterior endomyometrium. 30. Left ovary. 31. Left tube. 32. Right ovary. 33. Right tube. This case is accessioned in. B) SOURCE: Lymph node resection, pelvic, right. Labeled ""right pelvic lymph nodes"" are multiple yellow-tan, ragged fatty. soft tissues aggregating to 5.5 x 4.8 x 2.5 cm. The tissues are searched. for lymph nodes. Six discrete lymph nodes which range from 1.7-4.5 cm in. greatest dimension are identified. The specimen is entirely submitted in 12. cassettes as follows: B1. One lymph node. 2. One lymph node, sectioned. 3. One lymph node, sectioned. 4. One lymph node, sectioned. 5,6. One lymph node, sectioned. 7-9. One lymph node, sectioned. 10-12. Remaining soft tissues. C) SOURCE: Lymph node resection, right periaortic. Labeled ""right periaortic fymph nodes"" is a single 1.7 cm tan ragged, fatty. soft tissue. The tissue is examined for lymph nodes, and no discrete nodal. tissue is identified. The soft tissue is entirely submitted in toto in a. single cassette. D) SOURCE: Lymph node resection, pelvic, left. Labeled ""left pelvic lymph nodes"" are multiple yellow-tan, ragged fatty. soft tissues which aggregate to 5 x 3.5 x 2.8 cm. The tissue is searched. for lymph nodes, five lymph nodes which range from 0.7-4 cm in greatest. dimension are identified. The specimen is entirely submitted in 8 cassettes. as follows: D1. Two lymph nodes. 2. One lymph node. 3. One lymph node, sectioned. 4-6. One lymph node, sectioned. 7,8. Remaining soft tissue. E) SOURCE: Lymph node resection, left aortic. Labeled ""left aortic lymph node"" are multiple yellow-tan, ragged fatty soft. tissues aggregating to 2.2 cm in greatest dimension. The tissues are. searched for lymph nodes, a single apparent lymph node measuring 1.3 cm in. greatest dimension is identified. The specimen is entirely submitted in two. cassettes as follows: E1. One lymph node. 2. Remaining soft tissue. MICROSCOPIC. The microscopic appearance substantiates the diagnasis. Interpreted at. ACCESSIONED: Lab and Collection. GROSS AND MICROSCOPIC SURGICAL PANEL. - Lab and Collection. Information. Result History. GROSS AND MICROSCOPIC SURGICAL PANEL. - Order Result History.",T1,N0,M0,T1N0M0
TCGA-EB-A85J,"Gross Description: There is a skin flap with a black node on the broad base, up to 4 X 3.5 cm in its size,. up to 1 cm thick. Separately there is a resection margin. Microscopic Description: Malignant melanoma of the skin without superficial ulceration. Breslow tumor. thickness is 5.5 mm. In the resection margin there is fibrous, fatty and bone tissue. Diagnosis Details: Tumor Features: Pigmented, Tumor Extent: More than 4 mm with or without. ulceration, Venous Invasion: Absent, Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: SKIN TISSUE CHECKLIST. Specimen type: Excision of skin lesion. Tumor site: Skin, hip. Tumor size: 3.5 X 0.55 x 4 cm. Tumor features: Pigmented. Satellite nodules: Not specified. Histologic type: Malignant melanoma. Histologic grade: Not specified. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: Breslow tumor thickness is 5.5 mm. Comments: None.",T4,N0,M0,T4N0M0
TCGA-EB-A299,OC#: Eaterality:NA. Path Report:SKIN TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Skin. Tumor size: 2.5x2x1cm. Tumor features: None specified. Satellite nodules: Not specified. Histologic type: flanoma/. Histologic grade: Moderately differentiated. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Clark level III invasion.,T2,N0,M0,T2N0M0
TCGA-E2-A2P6,"SPECIMENS: A. WIDE LOCAL EXCISION LEFT BREAST. B. SENTINEL LYMPH NODE #1 LEFT AXILLA. C. SENTINEL LYMPH NODE #2 LEFT AXILLA. D. SENTINEL LYMPH NODE #3 LEFT AXILLA. E. SENTINEL LYMPH NODE #4 LEFT AXILLA. F. SENTINEL LYMPH NODE #5 LEFT AXILLA. SPECIMEN(S): A. WIDE LOCAL EXCISION LEFT BREAST. B. SENTINEL LYMPH NODE #1 LEFT AXILLA. C. SENTINEL LYMPH NODE #2 LEFT AXILLA. D. SENTINEL LYMPH NODE #3 LEFT AXILLA. E. SENTINEL LYMPH NODE #4 LEFT AXILLA. F. SENTINEL LYMPH NODE #5 LEFT AXILLA. DIAGNOSIS: A. BREAST, LEFT, WIDE LOCAL EXCISION: - MULTIFOCAL INVASIVE LOBULAR CARCINOMA, NOTTINGHAM GRADE 2. - LARGEST FOCUS IS 3.5 CM. INVASIVE CARCINOMA IS PRESENT AT THE SUPERIOR MARGIN. AND IS WITHIN 0.1 CM OF THE INFERIOR MARGIN. - LOBULAR CARCINOMA IN SITU (LCIS). NOTE: Several foci of invasive carcinoma are seen, spanning throughout a 6.4 cm lumpectomy. B. SENTINEL LYMPH NODE 1, LEFT AXILLA, BIOPSY: - METASTATIC CARCINOMA (1.9 CM IN SIZE) IN ONE LYMPH NODE. WITH FOCAL EXTRANODAL EXTENSION (1/1). C. SENTINEL LYMPH NODE 2, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). D. SENTINEL LYMPH NODE 3, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). E. SENTINEL LYMPH NODE 4, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). F. SENTINEL LYMPH NODE 5, LEFT AXILLA, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive lobular carcinoma 8520/3. Tumor size: 3.5cm. Tumor Site: Upper outer quadrant. Margins: Involved at. superior. Extent:: 0.2 cm. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: LCIS. Lymph nodes: Sentinel lymph node. Lymph node status: Positive 1/5 Extranodal extension. Non-neoplastic areas: columnar cell change. DCIS not present. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT 2 N 1. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. GROSS DESCRIPTION: A. WIDE LOCAL EXCISION LEFT BREAST. Received fresh labeled with the patient's identification and designated ""left breast wide local excision"" is. an oriented, previously inked, 55 g, 6.4 x 5.5 x 3.3 cm lumpectomy. The single suture designates. anterior, double-lateral, triple-superior. Ink code: Anterior-yellow, posterior-green, medial-black, lateral-. red, superior-blue, inferior-orange. The specimen is serially sectioned from posterior to anterior into 5. slices revealing a 2.5 x 2.1 x 1.9 cm, ill-defined firm pale tan mass, located 0.6 cm from the lateral. margin. The remainder of the specimen shows focal areas of white dense fibrous parenchyma. Tissue. is procured. The specimen is representatively submitted: A1-A2: Representative section posterior margin (green ink). A3: Slice 2, inferior/lateral. A4-A5: Slice 2, lateral/medial, respectively. A6-A11: Slice 3, entirely submitted, A7 demonstrating mass and nearest the lateral margin. A12-A13: Slice 4, mass, lateral margin. A14-A15: Slice 4, medial/inferior, respectively. A16: Slice 4, superior. A17-A18: Representative perpendicular sections anterior margin. B. SENTINEL LYMPH NODE #1 LEFT AXILLA. Received fresh labeled with the patient's identification and designated ""sentinel lymph node #1 left. axilla"" is a yellow-tan lymph node measuring 1.9 x 1.7 x 1.5 cm. The specimen is sectioned, entirely. submitted, B1. C. SENTINEL LYMPH NODE #2 LEFT AXILLA. Received fresh labeled with the patient's identification and designated ""sentinel lymph node #2 left. axilla"" is a yellow-tan lymph node measuring 2.4 x 0.8 x 0.4 cm. The specimen is sectioned, entirely. submitted, C1. D. SENTINEL LYMPH NODE #3 LEFT AXILLA. Received fresh labeled with the patient's identification and designated ""sentinel lymph node #3 left. axilla"" is a tan lymph node measuring 1.6 x 1 x 0.5 cm. The specimen is sectioned, entirely submitted,. D1. E. SENTINEL LYMPH NODE #4 LEFT AXILLA. Received fresh labeled with the patient's identification and designated ""sentinel lymph node #4 left. axilla"" is a yellow-tan lymph node measuring 1.5 x 1.1 x 0.3 cm. The specimen is sectioned, entirely. submitted, E1. F. SENTINEL LYMPH NODE #5 LEFT AXILLA. Received fresh labeled with the patient's identification and designated ""sentinel lymph node #5 left. axilla"" is a tan lymph node measuring 0.8 x 0.5 X 0.2 cm. Entirely submitted, F1. CLINICAL HISTORY: 1.5-2 cm invasive cancer upper outer quadrant left breast. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. FROZEN SECTION INTRAOPERATIVE REPORT: Part A: Breast, left, wide local excision, gross examination: 2.4 cm tumor mass located approximately. 0.6 cm to the lateral margin, gross examination only. Diagnosis called at. by Dr. Microscopic/Diagnostic Dictation: Patnologist,. Final Review: Pathologist,. Final: Pathologist,.",T2,N1,M0,T2N1M0
TCGA-LD-A74U,"DATE OBTAINED: DATE RECEIVED: DIAGNOSIS. 1. RIGHT BREAST, PARTIAL MASTECTOMY: INVASIVE LOBULAR CARCINOMA mixed. SIZE (INVASIVE): Approximately 70 mm; see comment. LATERALITY: Right. TUMOR FOCALITY: Unifocal. LESIONAL SITE: 9:00 (according to operative report). HISTOLOGIC TYPE: Invasive lobular carcinoma, classical type, focal pleomorphic type. NUCLEAR GRADE: I of III (classical type) and II-III of III (pleomorphic type). HISTOLOGIC GRADE: N/A. (invasive lobular carcinoma). IN-SITU COMPONENT: Not present. LYMPH NODE SAMPLING: Positive (11/12), (largest 45mm; with extranodal Involvement); see specimen #2. AJCC CATEGORIES: Stage IIIC. (assuming cM0"" status). pTNM: pT3. pN3a. cTNM: cT2. cN1. cMO. INTEGRITY/ORIENTATION: Intact specimen with designated margins. MARGINS (Invasive lobular): Negative. <0.1mm superior margin (1P, highlighted by CK7 Immunostain); 0.2mm medial margin. (1EE) and 1mm posterior margin (1N); other margins >3mm. LYMPHOVASCULAR INVASION: Focal suspicious for LVI. MICROCALCIFICATIONS: Not identified. NIPPLE/SKIN: (if applicable). Negative skin. SKELETAL MUSCLE: Not present. OTHER: Focal atypical lobular hyperplasia, sclerosing adenosis, usual ductal hyperplasia,. apocrine metaplasia and prior blopsy site changes. 2. RIGHT AXILLARY NODE CONTENTS, DISSECTION: ELEVEN OUT OF TWELVE LYMPH NODES TOTALLY. REPLACED BY METASTATIC LOBULAR CARCINOMA (11/12), LARGEST TUMOR 4.5 CM, EXTRANODAL. EXTENSION PRESENT; ADDITIONAL INVASIVE LOBULAR CARCINOMA WITHIN THE FAT (ABOUT 2CM). 3. OMENTUM, RESECTION: ADIPOSE TISSUE; NEGATIVE FOR TUMOR. COMMENT. Tumor grossly is 5.3 cm. In the axillary contents (#2), sizeable tumor mass within the fat is also present in multiple blocks, which. most likely represents a direct extension from the lumpectomy, and thus the tumor size is estimated to be 7cm. 88307x2, 88305, 88329, 88342. Clinical Diagnosis and History: Right breast cancer, gastric cancer. cT2,cN1,cM0 clinical stage Il. Tissue(s) Submitted: 1: RIGHT BREAST MASS SHORT SUTURE SUPERIOR LONG SUTURE LATERAL. 2: RIGHT AXILLARY NODE CONTENTS. 3: OMENTUM. Gross Description: Specimen #1 is received fresh for intraoperative consultation, labeled with the patient's name and right breast mass, and consists. of an 11.3 cm (medial to lateral) X 8.5 cm (superior to inferior) x 4.5 cm (anterior to posterior) product of partial mastectomy which. is surfaced by a 6.9 x 2.2 x 0.2 cm ellipse of unremarkable white tan skin. No nipple is identified. A short suture designating. superior and a long suture designating lateral are present. Two needle localization wires are entering the specimen in the superior. and inferior aspects. The specimen is radiographed and differentially inked as follows: superior-blue, inferior-green, lateral-yellow,. medial-red, posterior/deep-black and serially sectioned from lateral to medial into 10 slices. No biopsy clip is identified. An ill-. defined, rubbery to firm, white-tan area measuring 5.3 x 5.0 x 3.5 cm is identified in slices 4 to 10. This area of fibrous tissue. shows. some. extensions to the posterior, inferior, superior, and medial margins. This fibrous area is also 2.0 cm from the overlying. skin. other. lesions are grossly identified. The breast parenchyma consists of tan-yellow, lobulated adipose tissue (60%) and. fibrous tissue (40%). Time in formalin: Some tumor and normal tissue is frozen for TCGA studies. Representative sections of all slices (with the exception of slices 2 and 3) are submitted as follows: 1A-1B: slice #1, lateral margin, perpendicular (representative). 1C-1D: slice #4, irregular fibrous area. 1E: slice #4, fibrous area to posterior margin. 1F: slice #4, fibrous area to superior margin. 1G-1H: slice #5, fibrous area contiguous section. 11: slice #5, posterior margin. 1J: slice #5, inferior and posterior margins. 1K: overlying skin. 1L-1M: slice #6, contiguous section of fibrous area to inferior margin. 1N-10: posterior margin. 1P: superior margin. 1Q-1T: slice #7, contiguous section from superior to inferior (orange ink denotes contiguous section). 1U: overlying skin. 1V: slice #8, fibrous area. 1W: superior margin. 1X: inferior margin. 1Y: posterior margin. 1Z: slice #9, inferior margin. 1AA: slice #9, irregular fibrous area. 1BB: superior margin. 1CC: posterior margin. 1DD-1GG: slice #10, medial margin, perpendicular (representative). Specimen #2 is received in formalin labeled right axillary dissection, and consists of 11.0 x 10.0 x 2.5 cm yellow adipose tissue. The specimen was serially sectioned to reveal 16 lymph nodes ranging in size from 1.5 to 4.5 cm. The lymph nodes are entirely. submitted and labeled as follows: 2A: Two lymph nodes intact. 2B: Two lymph nodes intact. 2C: Four lymph nodes intact. 2D: One lymph node, bisected. 2E: One lymph node, bisected. 2F: One lymph node, bisected. 2G: One lymph node, bisected. 2H: One lymph node, representative section. 21: One lymph node, representative section. 2J: One lymph node, representative section. 2K-2L: One lymph node, representative section. Specimen #3 is received fresh labeled omentum, and consists of a 20 x 20 x 5.0 yellow lobulated adipose tissue. The specimen is. serially sectioned and no lesion is grossly identified. Representative sections are submitted labeled 3A-3B. Intraoperative Consult Diagnosis. 1A/GDX: NEEDLE LOC WIRE ENTERS SUPERIORLY AND ONE OTHER ENTERS INFERIORLY. VAGUE AREA, NO. DISCRETE MASS; MARGINS HARD TO DETERMINE; QUESTION POSTERIOR, INFERIOR, AND MEDIAL MARGIN.",T3,N3,M0,T3N3M0
TCGA-IN-AB1X,"Anonymous number: Accession Date: FINAL DIAGNOSIS: PART 10: SOFT TISSUE, LEFT GASTRIC, EXCISION -. TWO (2) ANTHRACOTIC LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA. PART 2: LYMPH NODE, INFERIOR PULMONARY LIGAMENT, EXCISION -. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. PART 3: LYMPH NODE, LEVEL 7 NEAR BRONCHUS INTERMEDIUS, EXCISION -. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. PART 4: LYMPH NODE, NEAR PERICARDIUM, EXCISION -. ONE (1) MINUTE ANTHRACOTIC LYMPH NODE FRAGMENT, NEGATIVE FOR METASTATIC CARCINOMA. PART 5: LYMPH NODE, NEAR LEFT MAINSTEM, EXCISION -. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. PART 6: LYMPH NODE, PARAESOPHAGEAL NEAR LUNG, EXCISION -. A. ONE (1) LYMPH NODE FRAGMENT WITH MINUTE HYALINIZED NODULE, NEGATIVE FOR METASTATIC. CARCINOMA. B. AFB AND GMS ARE NEGATIVE FOR FUNGAL ORGANISMS. PART 7: LYMPH NODE, LEVEL 7 NEAR AORTA, EXCISION -. TWO (2) ANTHRACOTIC LYMPH NODE FRAGMENTS, NEGATIVE FOR METASTATIC CARCINOMA. PART 8: LYMPH NODE, LEVEL 7 NEAR LEFT DISTAL MAINSTEM, EXCISION -. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. PART 9: LYMPH NODE, SUBCARINAL, EXCISION -. TWO (2) ANTHRACOTIC LYMPH NODE FRAGMENTS, NEGATIVE FOR METASTATIC CARCINOMA. PART 10: LYMPH NODE, SUBCARINAL ON ESOPHAGUS, EXCISION -. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. PART 11: LYMPH NODE, SUBCARINAL NEAR AZYGOUS, EXCISION -. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA. PART 12: ESOPHAGUS AND STOMACH, ESOPHAGOGASTRECTOMY -. A. INVASIVE POORLY DIFFERENTIATED ADENO CARCINOMA WITH SQUAMOUS DIFFERENTIATION,. INVOLVING GASTROESOPHAGEAL JUNCTION, 2.2 CM. B. CARCINOMA INVADES FOCALLY THROUGH MUSCULARIS PROPRIA INTO SUBADVENTITIAL TISSUE. C. NEGATIVE FOR LYMPHVASCULAR SPACE INVASION. Anonymous No.: Gender: F. Race: White. CLINICAL HISTORY. PRE-OP DIAGNOSIS: Esophageal cancer. POST-OP DIAGNOSIS: Same/ pending. PROCEDURE: Esophagogastroduodenoscopy bronchoscopy, laparoscopic. staging, MIV IVOR, laparoscopic Lewis esophagectomy. FINAL DIAGNOSIS. PART 10: SOFT TISSUE, LEFT GASTRIC, EXCISION. TWO (2) ANTHRACOTIC LYMPH NODES, NEGATIVE FOR METASTATIC. CARCINOMA. PART 2: LYMPH NODE, INFERIOR PULMONARY LIGAMENT, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 3: LYMPH NODE, LEVEL 7 NEAR BRONCHUS INTERMEDIUS, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 4: LYMPH NODE, NEAR PERICARDIUM, EXCISION. ONE (1) MINUTE ANTHRACOTIC LYMPH NODE FRAGMENT, NEGATIVE FOR. METASTATIC CARCINOMA. PART 5: LYMPH NODE, NEAR LEFT MAINSTEM, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 6: LYMPH NODE, PARAESOPHAGEAL NEAR LUNG, EXCISION. A. ONE (1) LYMPH NODE FRAGMENT WITH MINUTE HYALINIZED NODULE,. NEGATIVE FOR METASTATIC. CARCINOMA. B. AFB AND GMS ARE NEGATIVE FOR FUNGAL ORGANISMS. PART 7: LYMPH NODE, LEVEL 7 NEAR AORTA, EXCISION. TWO (2) ANTHRACOTIC LYMPH NODE FRAGMENTS, NEGATIVE FOR. METASTATIC CARCINOMA. PART 8: LYMPH NODE, LEVEL 7 NEAR LEFT DISTAL MAINSTEM, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 9: LYMPH NODE, SUBCARINAL, EXCISION. TWO (2) ANTHRACOTIC LYMPH NODE FRAGMENTS, NEGATIVE FOR. METASTATIC CARCINOMA. PART 10: LYMPH NODE, SUBCARINAL ON ESOPHAGUS, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 11: LYMPH NODE, SUBCARINAL NEAR AZYGOUS, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 12: ESOPHAGUS AND STOMACH, ESOPHAGOGASTRECTOMY. A. INVASIVE. POORLY DIFFERENTIATED ADENO CARCINOMA WITH SQUAMOUS per TSS, squamous = 5%. DIFFERENTIATION,. INVOLVING GASTROESOPHAGEAL JUNCTION, 2.2 CM. B. CARCINOMA INVADES FOCALLY THROUGH MUSCULARIS PROPRIA INTO. SUBADVENTITIAL TISSUE. C. NEGATIVE FOR LYMPHVASCULAR SPACE INVASION. D. TWENTY FIVE LYMPH NODES, NEGATIVE FOR METASTATIC CARCINOMA. (0/25). E. MARGINS NEGATIVE FOR CARCINOMA. F. AJCC 7TH EDITION PATHOLOGIC TUMOR STAGE IS: pT3 NO. PART 13: LYMPH NODE, PROXIMAL PARAESOPHAGEAL, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 14: LYMPH NODE, MID PARAESOPHAGEAL, EXCISION. ONE (1) ANTHRACOTIC LYMPH NODE, NEGATIVE FOR METASTATIC. CARCINOMA. PART 15: LYMPH NODE, PARAESOPHAGEAL NEAR DIAPHRAGM, EXCISION. SCANT FRAGMENT OF ANTHRACOTIC LYMPH NODE, NEGATIVE FOR. METASTATIC CARCINOMA. PART 16: ANASTOMOTIC RING, ESOPHAGOGASTRECTOMY. BENIGN SQUAMOUS AND GASTRIC MARGINS. PART 17: FINAL GASTRIC MARGIN, ESOPHAGOGASTRECTOMY. BENIGN GASTRIC MARGIN. PART 18: OMENTUM, OMENTECTOMY. BENIGN FIBROADIPOSE TISSUE, NEGATIVE FOR METASTATIC CARCINOMA. COMMENT. reviewed select slides from part 12 and agrees with the above. interpretaiton. GRGSS DESCRIPTIONved in 18 parts. Part 1 is received in formalin labeled with the patient name, initiais and ""left gastric. tissue"". The specimen consists of two portions of yellow fatty tissue, the larger is 2.5 x 1.4. x. 0.3 cm. No lesions are seen or palpated. The smaller portion of tissue is 0.7 x 0.5 x 0.3. cm. No lesions are seen or palpated. The specimen is entirely submitted in a cassette. labeled 1A. 1A x 2, entirely submitted. Part 2 is received in formalin labeled with the patient name, initiais. and ""inferior. pulmonary ligament node"". The specimen consists of a black nodule, 0.7 x 0.7 x 0.6 cm. The specimen is bisected and the cut surface has a homogenous black appearance. The. specimen is entirely submitted in a cassette labeled 2A. 2A x 2, entirely submitted. Part 3 is received in formalin labeled with the patient name, initials. and ""level 7 LN near. bronchus intermedius"". The specimen consists of an irregular portion of black soft tissue,. 1.0 x 0.5 x 0.3 cm. The specimen is entirely submitted in a cassette labeled 3A. 3A x 1, entirely submitted. Part 4 is received in formalin labeled with the patient name, initiais and ""lymph node. near pericardium"". The specimen consists of a tiny black fragment of soft tissue, 0.1 cm in. greatest dimension. The specimen is entirely submitted in a cassette labeled 4A. 4A x 1, entirely submitted. Part 5 is received in formalin labeled with the patient name, initials. and ""lymph node. near left mainstem"". The specimen consists of a fragment of gray-tan soft tissue, 0.3 x 0.2. x 0.1 cm. The specimen is entirely submitted in a cassette labeled 5A. 5A x 1, entirely submitted. Part 6 is received in formalin labeled with the patient name, initials. and. ""paraesophageal lymph node near lung"". The specimen consists of a black nodule, 0.6 x. 0.5 x 0.1 cm. The specimen consists of a black nodule, 0.6 x 0.5 x 0.1 cm. The specimen. is entirely submitted in a cassette labeled 6A. 6A x 1, entirely submitted. Part 7 is received in formalin labeled with the patient name, initiais and ""level 7 LN near. aorta"". The specimen consists of two black portions of soft tissue, the larger is 0.7 x 0.5 x. 0.4 cm, the smaller is 0.4 x 0.2 x 0.2 cm. The specimen is entirely submitted in a cassette. labeled 7A. 7A x 2, entirely submitted. Part 8 is received in formalin labeled with the patient name, initials and ""level 7 near. distal left mainstem"". The specimen consists of a black nodule, 0.6 x 0.6 x 0.3 cm. The. specimen is entirely submitted in a cassette labeled 8A. 8A x 1, entirely submitted. Part 9 is received in formalin labeled with the patient name, initials. and ""subcarinal. lymph node'. The specimen consists of four yellow-black portions of soft tissue, the. largest is 0.7 x 0.7 x 0.3 cm, the smallest is 0.5 x 0.3 x 0.2 cm. The specimen is entirely. submitted in a cassette labeled 9A. 9A x 4, entirely submitted. Part 10 is received in formalin labeled with the patient name, initials and ""subcarinal. lymph node on esophagus"". The specimen consists of a black nodule, 1.0 x 0.9 x 0.4 cm. The cut surface has a homogenous black appearance. The specimen is entirely submitted. in a cassette labeled 10A. 10A x 1, entirely submitted. Part 11 is received in formalin labeled with the patient name, initials and ""subcarinal. lymph node near azygous"". The specimen consists of a black nodule, 1.4 x 1.0 x 0.5 cm. The cut surface reveals a homogenous black appearance. The specimen is bisected and. entirely submitted in a cassette labeled 11A. 11A x 2, entirely submitted. Part 12 is received fresh labeled with the patient name, initials. and. ""esophagogastrectomy"". The specimen consists of a portion of esophagus and stomach. The esophagus is 8.0 cm in length. The esophageal margin 6.5 cm in circumference. The. stomach is up to 6.8 cm in length. The gastric margin is 11.0 cm in circumference. Located in the esophagus, 6.0 cm from the esophageal resection edge is an ulcerated. gray-white lesion, 2.2 x 2.0 x 0.7 cm. This grossly involves the gastroesophageal junction. It is also 5.5 cm away from the closest gastric margin. The esophageal margin and the. gastric margin were used for frozen section. On sectioning the lesion extends into the. muscularis but not through the entire thickness of the muscularis. Remaining esophageal. mucosa has a gray-white appearance. The gastric mucosa is red-tan. The attached fat is. 5.5 x 4.0 x 2.5 cm. Serial sectioning reveais multiple pink-tan and red-tan nodules within. the fat, the largest is 0.9 x 0.4 x 0.3 cm, the smallest is 0.3 x 0.4 x 0.2 cm. Representative. sections are submitted labeled: 12AFS x 1, esophageal margin used for frozen section. 12BFS x 1, gastric margin used for frozen section. 12C-12D x 1 each, remainder of the gastric margin taken as a shav. 12E-12K x 1 each, lesion, entirely submitted. 12L-12M x 1 each, esophagus proximal to the lesion. 12N-120 x 1 each, stomach distal to the lesion. 12P-12R x multiple each, lymph nodes. 12S-12Al x multiple each, fat entirely submitted. The soft tissues beneath the lesion are painted with blue ink. Part 13 is received in formalin labeled with the patient name, initiais and ""proximal. paraesophageal lymph node"". The specimen consists of a black nodule, 0.8 x 0.7 x 0.6. cm. The cut surface reveals a gray-black tissue. The specimen is entirely submitted in a. cassette labeled 13A. 13A x 2, entirely submitted. Part 14 is received in formalin labeled with the patient name, initials and ""mid. paraesophageal lymph node"". The specimen consists of a pink-tan nodule, 1.3 x 1.0 x 0.3. cm. The specimen is entirely submitted in a cassette labeled 14A. 14A x 1, entirely submitted. Part 15 is received in formalin labeled with the patient name, initials. and. ""paraesophageal lymph node near diaphragm"". The specimen consists of an irregular. portion of gray-black soft tissue, 1.2 x 0.5 x 0.2 cm. The specimen is entirely submitted in. a cassette labeled 15A. 15A x 1, entirely submitted. Part 16 is received in formalin labeled with the patient name, initials. and ""anastomotic. ring"". The specimen consists of two ring-shaped portions of mucosal tissue attached to a. metal anvil, each is approximately 1.5 cm in diameter, 1.3 cm in length. On sectioning. tissue contains metal staples and sutures. Representative section of ach is submitted in. a cassette labeled: 16A x 2, soft tissue. Part 17 is received in formalin labeled with the patient name, initials. and ""final gastric. margin"". The specimen consists of a previously opened portion of stomach, 4.0 cm in. length, 3.8 cm in diameter. One edge of the specimen is closed with metal staples. The. end opposite this is left open and it contains green sutures and metal staples. The. mucosal surface has a pink-tan to red-tan appearance. No lesions are seen. Representative sections are submitted labeled: 17A x 2, shave of each margin. 17B x 2, random section. The stapled margin is painted with blue ink, the open margin is painted with black ink. Part 18 is received in formalin labeled with the patient name, initials and ""omentum"". The specimen consists of lobulated portion of fatty tissue, 7.0 X 3.0x0.3 cm. The cut. surface reveals a pale yellow tissue. No masses are seen or palpated. The specimen is. entirely submitted labeled: 18A-18E x 2 each, entirely submitted. MICROSCOPIC DESCRIPTION. AFB and GMS control slides reacted appropriately. Microscopic examination substantiates. the above diagnosis. INTRAOPERATIVE DIAGNOSIS. ESOF HAGOGASTRECTOMY (FROZEN SECTION). A. SUFFICIENT FOR ANCILLARY STUDIES. B. DEFER. C. GASTRIC AND ESOPHAGEAL MARGINS NEGATIVE. Reported to. on.",T3,N0,M0,T3N0M0
TCGA-BJ-A45J,"FINAL DIAGNOSIS: PART 1: THYROID, TOTAL THYROIDECTOMY (26 GRAMS) - 50% fall cell pen TSS. A. PAPILLARY THYROID MICROCARCINOMA TALL CELL VARIANT (0.3 CM) CONFINED TO THE LEFT LOBE. B. METASTATIC CYSTIC PAPILLARY THYROID CARCINOMA IN LYMPH NODE, ISTHMUS; MICROSCOPIC. EXTRANODAL EXTENSION PRESENT (1/1) (see comment). c. PATHOLOGIC STAGE: pTia N1a. PART 2: LYMPH NODES, CENTRAL COMPARTMENT, SELECTIVE NECK DISSECTION -. A. METASTATIC PAPILLARY THYROID CARCINOMA IN ONE OF ONE LYMPH NODE (1/1); NO EXTRANODAL. EXTENSION. B. UNREMARKABLE THYROID TISSUE. C. SPECIMEN ENTIRELY SUBMITTED FOR HISTOLOGIC EVALUATION. COMMENT: The Isthmus nodule that was previously aspirated with a low level BRAF mutation (V600E) is in fact the. aforementioned lymph node in Part 1. The presumed primary tumor Is a 0.3 cm microcarcinoma, tall cell variant with abundant fibrosis, though not subcapsular. In location. Molecular testing on this focus will be performed and reported in an addendum. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidctomy. TUMOR SITE: Left Lobe. TUMOR FOCALITY: Unifocal. TUMOR Size (largest nodule): Greatest Dimension: 0.3 cm. HISTOLOGIC TYPE"": Papillary carcinoma, tall cell variant. PRIMARY TUMOR (pT): pTia. REGIONAL LYMPH NODES (pN): pN1a. Number of regional lymph nodes examined: 2. Number of regional lymph nodes Involved: 2. EXTRANODAL EXTENSION: Present. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Not identified. MARGINS: Margins uninvolved by carcinoma. LYMPH-VASCULAR INVASION: Present. Addendum. MOLECULAR ANATOMIC PATHOLOGY TESTING: Block 11 (THYROID, LEFT LOBE, PAPILLARY THYROID MICROCARCINOMA, 0.3 CM): A. BRAF mutation IDENTIFIED (p.V600E. c.1799T>A). B. Mutations in NRAS61, HRAS61, KRAS12/13 and RET/PTC1 and RET/PTC3 rearrangements. NOT identified. NOTE: Nucleic acids were extracted In the amount sufficient for testing. BACKGROUND: Mutations in either BRAF or RAS genes or RET/PTC rearrangements are found in more than 70% of papiliary thyroid carcinamas. (1). BRAF V800E (T1799A) mutation has been associated with.more aggressive behavior of papillary carcinoma (2. 3). The. association between BRAF V600E mutation and features of tumor aggressiveness have also been observed in papiliary. microcarcinomas (4). Mutations in the RAS genes or PAX8/PPARD rearrangement occur in -70% of follicutar thyroid carcinomas. and with lower frequency in oncocytic (Hrthie cell) carcinomas (5). Regarding the specificity of these mutations for cancer, BRAF. V600E mutation and RET/PTC and PAX8/PPARg rearrangements are overall specific for malignancy in the thyroid, although they. have been reported with a very low frequency in benign thyrold lesions (8). RAS mutations occur in malignant and benign thyrold. tumors, being found in -40-50% of follicular and anaplastic carcinomas, 30-40% of follicular adenomas and 10-15% of papiliary. carcinomas (6). 1. Adeniran AJ. et al. Correlation between genetic alterations and microscodic features, clinical manifestations, and prognostic charecteristics of. thyrold papillary carcinomas. Am J Surg Pathol 2006, 30:216-222. 2. Xing M, et al. BRAF mutation predicts . poorer clinical prognosis for papillary thyrold cancer. J Clin Endocrino/ Motab 2005, 90:6373-6379. 3. Ellsei R, et al. BRAF V600E mutation and outcome of patients with papiliary thyroid carcinoma: a 15-year median follow-up study. J Clin. Endocrino/ Metab 2008, 93:3943-3949. 4. Lee x. Gao M, Ji Y, Yu Y, Feng Y, uy Zhang Y, Cheng W. Zhao W. Analysis of differential BRAF(V600E) mutational status in high aggressive. papiliary thyroid inicrocarcinorha. Ann Surg Oncol. 2009 Feb:16(2):240-5. 5. MN, et al. RAS point mutations and5PAX8-PPARy rearrangement in thyrold tumors: Evidence for distinct molecular pethways in. thyrold fatticular carcinama. J Clln Endocrino/ Metab 2003, 88: 2318-26. 6. Nikiforov YE Recent developments in the molecular biology of the thyroid. in: Lloyd RV., ed. Endocrine Pathology: Differential Diagnosis and. Molecular Advances. Humana Press, Totowa, 2004, 191-209. MUTATIONAL ANALYSIS: For surgical specimens, manual microdissection was performed to collect tumor tissue. Specimens with the minimum of 50%. of tumor cells in a microdissection target are accepted for the analysis. Optical density readings were obtained. Real-time PCR was performed on. the LightCycler platform to amplify BRAF codons 599-601, NRAS codon 61, HRAS codon 61, and KRAS codons 12/13 sequences. Post-PCR. meiting curve analysis was used to detect possible mutations. Single-step real-time RT-PCR was performed to amplify the fusion points of. RET/PTC1 and RET/PTC3 rearrangements on AB/7500. If required, the mutation type was confirmed by Sanger sequencing of the PCR. products. on. AB/3130. Amplification af the KRT7 genes was used to control quality and quantity of RNA and amount of epithella/ cells present in the. specimen. DNA FRNA from samples positive for each of these mutations were used as positive controis. Amplification at 35 cycies or earlier. was. considered sufficient for the analysis. The limit of detection is approximately 10-20% of alleles with mutation present in the background of norma/. DNA and RNA,.",T1,N1,M0,T1N1M0
TCGA-V4-A9EJ,"Right eye enucleation. Macroscopy. The eyeball measures 25 by 25 mm with a segment of optic nerve of 10 mm. There is a. posterior tumor close to the intraocular emergence of the optic nerve, pigmented, measuring. 15 mm main line. Samples have been made for cryopreservation . The specimen has been then. included entirely after fixation. Microscopy. Choroidal melanoma with fusiform cells measuring 15 by 12 mm. The lesion, very posterior,. is situated at the periphery, slightly distant from the intraocular emergence of the optic nerve. which is free on its entire course( prelaminar, optic foramen, post laminar part , cut end and. meningeal sheaths)The proliferation superficially infiltrates the sclera but there is no. extrasclrale extension. The lesion stays distant from the ciliary body, the iris, the anterior. chamber which are free. Conclusion. Choroidal melanoma with fusiform cells measuring 15 by 12 mm. The lesion, very posterior, is situated at the periphery, slightly distant from the intraocular. emergence of the optic nerve which is free on its entire course. ( prelaminar,. optic foramen, post laminar part, cut end and meningeal sheaths). The proliferation superficially infiltrates the sclera but there is no extrasclrale extension. The lesion stays distant from the ciliary body, the iris, the anterior chamber which is free.",T3,N0,M0,T3N0M0
TCGA-86-6851,"86-6851. A. Labeled left upper lobe lesion. Sections show a. Received fresh for intraoperative. poorly differentiated. consultation is a previously incised and. invasive. diffusely ragged wedge of lung. adenocarcinoma with. measuring 7 X 3 X 2.2 cm. There are 2. both. firm gray and brown lesion measuring. acinar and solid. 1.0 and 1.4 cm in greatest dimension. growth patterns. The. tumor extends to the. B. Labeled left upper lobe bronchial. subpleura. margin. Received fresh for. Immunohistochemica. intraoperative consultation is a 150 g lobe. stains are performed. of lung measuring approximately. with appropriate. 15 X 10 X 4 cm. the pleural surface is tan. control reactions. to red and smooth to slightly. to confirm this. wrinkled with two staple lines adjacent to. histologic impression. the hilum measuring 3.8 and 13. The malignant cells. cm in length. The larger passes through a. are positive for. 2.5 X 2.2 cm firm white-tan to. cytokeratin 7, TTF-1,. red mass that comes to within 2.0 cm of. Napsin-A while. the bronchial margin. Immediately. negative for. adjacent to the bronchial margin is a 1.5. cytokeratin 5/6. The. cm gray-white lymph node grossly. malignant cells show. positive for metastatic tumor. The. rare focal positivity. bronchial margin and adjacent lymph. for p63. An elastin. node. stain shows. are sampled for frozen section. The. no convincing. background lung is tan to red and. penetration of the. spongy with no other nodules or masses. visceral pleural elastic. lesions. Another hilar lymph node is. layer by the. not identified. tumor. LUNG CARCINOMA CHECKLIST. LUNG TISSUE. 1. Tumor type: Adenocarcinoma. CHECKLIST. 2. Histologic grade: Poorly. differentiated. Specimen type: 3. Tumor location: Left upper lobe. Lobectomy. 4. Tumor size: 2.5 X 2.2 cm. Tumor site: Lung. 5. Angiolymphatic invasion: Yes. Tumor size: 2.5 X 2.2. 6. Bronchial margin: The bronchus. cm. is free of tumor. However, a. Histologic type: peribronchial lymph node at the. Adenocarcinoma. resection margin contained. Histologic grade: metastatic tumor. Poorly differentiated. with extranodal extension into. Tumor extent: Not. peribronchial soft tissues. specified. 7. Parenchymal margin: Involved. Other tumor nodules: by carcinoma. Not specified. 8. Vascular margins: Free of tumor. Lymph nodes: 1/7. 9. Pleural involvement: Subpleural. positive for metastasis. 10. Lymph nodes: One of two. (Regional 1/7). peribronchial lymph nodes positive. Lymphatic invasion: for. Present. metastatic tumor (1/2). One benign. Venous invasion: para-aortic lymph node (0/1). Four. Present. benign hilar lymph nodes (0/4). Margins: Involved. 11. Size of largest metastatic. Evidence of neo-. deposit: 1.3 cm. adjuvant treatment: 12. TNM: pT1b, pN1, pMX. Not specified. Additional pathologic. findings: Not specified. Comments: None.",T1,N1,M0,T1N1M0
TCGA-A2-A0YG,"Chief of Pathology. Specimen: spec Type: SURGICAL P. OPERATION PERFORMED. DOCTOR (8) : TISSUE RENOVED. A. LT AXILLARY NODE DISSECTION. B. LT PARTIAL MASTECTOMY. GROSS DESCRIPTION. PART A RECEIVED FRESH LABELED. LEFT AXILLARY NODE. DISSECTION, IS YELLOW-RED FATTY TISSUE MEASURING 15 x 12.5 x 4.0 CM. THIS IS EXAMINED FOR LYMPH NODES. THE NODAL TISSUE IS IDENTIFIED. PRIMARILY AT ONE END OF THE SPECIMEN, NITH 75% CONSISTING OF BLAND YELLOW. FATTY TISSUE. MULTIPLE LYMPH NODES ARE IDENTIFIED AND GROSSLY POSITIVE. SECTIONS ARE SUBMITTED AS FOLLOWS: A1 THROUGH A8 ---ONE SECTION EACH OF. GROSSLY POSITIVE LYMPH NODES WITH A RIBBON CLIP IDENTIFIED IN THE NODE. CORRESPONDING TO A2. NOTE THAT MIRROR IMAGE RESEARCH BLOCKS ARE TAKEN ON. EACH. A9 AND 10--ONE NODE EACH BISECTED, All--TWO NODES EACH BISECTED,. A12-- TWO NODES, A13--ONE NODE BISECTED, A14--ONE NODE BISECTED, A15--ONE. NODE BISECTED, A16 THROUGH A19--ONI GROSSLY FAT-REPLACED NODE TOTAL. PART B RECEIVED FRESH LABELED. LEFT PARTIAL MASTECTOMY. LONG STITCH LATERAL SHORT STITCH SUPERIOR, IS AN OVOID PORTION OF. YELLOW-PINK FATTY TISSUE MEASURING 11.5 x 7 x 4.7 CM IN GREATEST. DIMENSIONS. THE SPECIMEN IS ORIENTED BY TWO SUTURES. A LARGE PALPABLE. MASS IS PRESENT MEDIALLY. SECTIONING REVEALS THIS PALPABLE MASS TO HAVE. A FIRM PINK-TAN GRITTY CUT SURFACE MEASURING 4.0 x 2.8 x 3 CM IN GREATEST. DIMENSIONS. THIS LESION EXTENDS TO THE INFERIOR MARGIN AND IS 0.4 CM. FROM THE MARGIN GROSSLY. IT IS 0.6 CM FROM THE DEEP MARGIN, 0.8 CM FROM. THE SUPERFICIAL MARGIN AND GREATER THAN 1 CM FROM ALL OTHER MARGINS. SECTIONING THE LATERAL ASPECT OF THE SPECIMEN CONSISTS OF BLAND YELLOW. FATTY TISSUE. SECTIONS ARE SUBMITTED AS FOLLOWS: B1 --PBRPENDICULAR. MEDIAL MARGIN, B2--TUMOR (MIRROR IMAGE TO PROTOCOL) B3--LESION AND DEEP. MARGIN, 84--LESION AND DEEP INFERIOR MARGIN CLOSEST TO TUMOR,. B5 --INFERIOR SUPERFICIAL MARGIN WITH LESION, B6--LESION AND SUPERFICIAL. MARGIN (MIRROR IMAGE TO PROTOCOL), B7 - -SUPERFICIAL SUPERIOR MARGIN,. B8--SUPERIOR - DEEP MARGIN. NOTE THAT B2 THROUGH B8 CONSTITUTE ONE FULL. CROSS-SECTION OF THE LESION IN ITS GREATEST DIMENSION. B9 - -PERPENDICULAR. LATERAL MARGIN, B10--TISSUE FROM LATERAL ASPECT OF THE SPECIMEN,. B11 - -TUMOR AND SUPERFICIAL MARGIN (MIRROR IMAGE TO PROTOCOL) B12--TUMOR. (MIRROR IMAGE TO PROTOCOL). Chief of Pathology. Specimen: Spec Type: SURGICAL P. PATH PROCEDURES. PROCEDURES: 88307/2, A BLK/19, B BLK/12. FINAL DIAGNOSIS. PART A LEFT AXILLA, LYMPH NODE DISSECTION: METASTATIC BREAST CARCINOMA. IS IDENTIFIED IN 14 OF 18 NODES EXAMINED AND EXTRANODAL EXTENSION IS. MULTIFOCALLY PRESENT. PART B LEFT BREAST, PARTIAL MASTECTOMY: 1. POORLY DIFFERENTIATED INTRADUCTAL AND INFILTRATING DUCT CARCINOMA,. NUCLEAR GRADE III, HIGH MITOTIC INDEX AND TUBULE FORMATION 2, FOR A. TOTAL NOTTINGHAM SCORE OF 8. DCIS OF THE SOLID TYPE COMPRISES. APPROXIMATELY 5% OF THE TUMOR. 2. THE GROSS TUMOR HAS A MAXIMUM DIMENSION OF 4 CM. 3. THE INVASIVE TUMOR IS IDENTIFIED 6 MM OR MORE FROM THE INKED MARGINS. OF EXCISION. 4. LYMPHOVASCULAR INVASION IS PRESENT. 5. BIOPSY CHANGES. ARE PRESENT. COBS. 1. , (prelim.). (signature on file). I.D.",T2,N3,M0,T2N3M0
TCGA-AG-3727,"Diagnosis: 1.: Soft tissue shows inflammatory, chronic resorptive cell lesions with pseudocyst formation. (possibly so-called oil cysts). 2.: Rectosigmoidal resection material includes foci of poorly differentiated adenocarcinoma of. the colorectal type 3 cm from the aboral resection margin and measuring a maximum of 4 cm in. diameter, with infiltration of the pericolic fatty tissue, marked carcinomatous lymphangiosis. accompanying the tumor and two regional lymph node metastases. Tumor-free colon resection. margins and tumor-free mesenteric resection margin. Tumor stage: pT3 pN1 (2/25) pMX; G3, L1, V0, R0.",T3,N1,M0,T3N1M0
TCGA-W5-AA2J,"Female. Surgery Date: DIAGNOSIS: A. Lymph nodes, hepatic hilar, biopsy: Multiple (4) lymph nodes are. negative for tumor. B. Hepatic duct, left margin, excision: Negative for tumor. c. Liver, left lobe, partial hepatectomy: Cholangiocarcinoma, moderately. differentiated (grade 2 of 4), forming two masses, ranging from 1.5 cm to 0.9 cm in. greatest microscopic dimension. Multiple additional microscopic foci of periductal. infiltrating carcinoma along the duct associated with moderate to severe dysplasia are. present. The tumor is confined to hepatic parenchyma. The hepatic parenchymal resection margin is negative for tumor (tumor-free margin,. 4.5 cm grossly). Major vessel invasion is absent. Microscopic (small vessel). invasion is absent. No regional lymph nodes identified in specimen. The non-. neoplastic hepatic parenchyma will be reviewed on permanent sections with special. stains and the result will be reported in an addendum. D. Gallbladder, cholecystectomy: Benign gallbladder with chronic inflammation.",T4,N0,M0,T4N0M0
TCGA-AA-3845,"Diagnosis: This is a poorly differentiated solid carcinoma in the ascending colon of histopathological. differentiation grade G3, with necrosis, with ulceration of the inner tumor surface, with. peritumorous chronic recurrent secondary inflammation with acute inflammatory activity,. with carcinomatous lymphangitis, with tumor infiltration of the layers of the colon wall. extending to the extramuscular subserous fatty connective tissue,. with tumor-free lymph nodes (0/12) and also. tumor-free overview slices from all other portions of the preparation described. No evidence of serous carcinosis. The tumor spread of the colon carcinoma according to the section preparations available. corresponds to a tumor stage of pT3, pNO (0/12), MX, L1, R0. Tumor classification: ICDO-DA M-8140/3, G3.",T3,N0,M0,T3N0M0
TCGA-IN-A6RJ,"FINAL DIAGNOSIS: PART 1: LYMPH NODES, LEVEL 8, BIOPSY -. THREE ANTHRACOTIC LYMPH NODES FREE OF TUMOR. PART 2: ""GASTRIC TISSUE"", BIOPSY -. ADIPOSE TISSUE WITH NO PATHOLOGIC CHANGE. PART 3: LYMPH NODE, OMENTAL, BIOPSY -. ONE ANTHRACOTIC LYMPH NODE FREE OF TUMOR. PART 4: LYMPH NODES, LEVEL 7, BIOPSY -. THREE ANTHRACOTIC LYMPH NODES FREE OF TUMOR. PART 5: LYMPH NODE, LEVEL 11, BIOPSY -. ONE ANTHRACOTIC LYMPH NODE FREE OF TUMOR. PART 6: ""LYMPH NODE"", NEAR THORACIC DUCT, BIOPSY -. A. ADIPOSE TISSUE AND BLOOD VESSELS WITH NO PATHOLOGIC CHANGE. B. NO LYMPH NODE PRESENT. PART 7: ESOPHAGUS AND STOMACH, ESOPHAGOGASTRECTOMY- -. A. INVASIVE POORLY DIFFERENTIATED ADENOCARCINOMA WITH SIGNET RING CELLS OF. GASTROESOPHAGEAL JUNCTION WITH EXTENSION INTO SUBMUCOSA (0.8 CM). B. PROXIMAL (ESOPHAGEAL), DISTAL (GASTRIC), AND CIRCUMFERENTIAL RESECTION MARGINS ARE FREE. OF TUMOR. C. NO PERINEURAL OR ANGIOLYMPHATIC INVASION SEEN. D. FIVE LYMPH NODES FREE OF TUMOR. E. PATHOLOGIC STAGE: pT1bNO. PART 8: LYMPH NODE, SUBCARINAL, NEAR PULMONARY ARTERY, BIOPSY -. ONE ANTHRACOTIC LYMPH NODE FREE OF TUMOR. PART 9: LYMPH NODE, SUBCARINAL, NEAR RIGHT MAIN BRONCHUS, BIOPSY -. ONE ANTHRACOTIC LYMPH NODE FREE OF TUMOR. PART 10: GASTROESOPHAGEAL FAT, BIOPSY -. A. TWO LYMPH NODES FREE OF TUMOR. B. ADIPOSE TISSUE WITH NO PATHOLOGIC CHANGE. PART 11: LYMPH NODE, SUBCARINAL NEAR LEFT ATRIUM, BIOPSY -. ONE ANTHRACOTIC LYMPH NODE FREE OF TUMOR. PART 12: LYMPH NODE, PROXIMAL PARAESOPHAGEAL, BIOPSY -. ONE ANTHRACOTIC LYMPH NODE FREE OF TUMOR. PART 13: LYMPH NODE, SUBCARINAL ON ESOPHAGUS, BIOPSY -. ONE ANTHRACOTIC LYMPH NODE FREE OF TUMOR. PART 14: LYMPH NODE, SUBCARINAL, LEFT MAIN BRONCHUS, BIOPSY -. ONE ANTHRACOTIC LYMPH NODE FREE OF TUMOR. PART 15: LYMPH NODES, UPPER PARAESOPHAGEAL, BIOPSY -. THREE ANTHRACOTIC LYMPH NODES FREE OF TUMOR. PART 16: ESOPHAGUS AND STOMACH, RINGS -. SEGMENTS OF ESOPHAGUS AND STOMACH FREE OF TUMOR. PART 17: STOMACH, GASTRIC MARGIN -. SEGMENT OF STOMACH FREE OF TUMOR AND LINED BY OXYNTIC MUCOSA. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY ESOPHAGEAL TUMORS. MACROSCOPIC. SPECIMEN TYPE: Esophagogastrectomy. TUMOR SITE: Esophagogastric junction (EGJ) region (tumor involves EGJ and epicenter within 5cm. of EGJ). TUMOR SIZE: Greatest dimension: 0.8 cm. MICROSCOPIC. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G3. PATHOLOGIC STAGING (pTNM). pT1b. pNO. Number of lymph nodes examined: 24. Number of lymph nodes involved: 0. pM Not applicable. PRIOR TREATMENT: No prior treatment. MARGINS. Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (adventitial) margin uninvolved by invasive carcinoma. ANGIOLYMPHATIC INVASION: Absent. ADDITIONAL PATHOLOGIC FINDINGS: None identified. COMPREHENSIVE THERANOSTIC SUMMARY. IN SITU HYBRIDIZATION / FISH: HER2 (ERBB2) amplification: NEGATIVE. ""See Special Procedure reports below for additional details and background on. In situ/FISH and/or. testing as pertinent. SPECIAL PROCEDURES: In Situ Procedure. Interpretation. HER2 FISH STUDIES PERFORMED ON THE ADENOCARCINOMA ARE NEGATIVE. # Cells Analyzed: 60. Ratio HER2/CEP17: 1.05. SNR: 2.6. CNR: 2.5. % Hyperdiploid: 30(50.0%). INTERPRETATION GUIDELINES AND PROBE INFORMATION: Probe: HER2. DNA Probe. Probe Description: The. HER2. DNA probe is a 190 Kb. directly labeled fluorescent DNA probe. specific for the HER2. gene locus. The CEP 17 DNA probe is a 5.4 Kb. directly labeled. fluorescent DNA probe specific for the alpha satellite DNA sequence at the centromeric region of chromosome 17. The probes are pre-mixed and pre-denatured in hybridization buffer. Interpretation: HER2 negative: HER2 gene/chromosome 17 ratio less than 2.0. HER2 positive: HER2 gene/chromosome 17 ratio greater than 2.0. Results should be considered along with other clinical information. has modified the suggested manufacturer protocol for HER2 FISH testing. The modifications have been tested and validated. The modifications are as follows: Slides are deparaffinized in. Tissue is. digested in protease 31 minutes; Tissue and probe are co-denatured at 90 C for 12 minutes; Paraffin pretreatment reagents and. control slides are prepared in house. Amplified, non-amplified, and internal (centromere 17) controls were used in the testing. The. laboratory takes responsibility for the test performance. FISH analysis was manually performed and quantitatively assessed by analysis of a minimum of 60 cells using the HER2. and the CEP17. probes.",T1,N0,M0,T1N0M0
TCGA-BR-7707,Gross. Microscopic. Diagnosis. Comme. Case ID Description. Description. Details. nts. Lateralit. y. STOMACH TISSUE CHECKLIST. Fundus. Specimen type: Excision of tumor. Tumor site: Fundus. Tumor size: 6 X 6 X 1 cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Muscularis propria. Lymph nodes: 0/2 positive for metastasis. (Regional 0/2). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not. specified. Comments: None.,T2,N0,M0,T2N0M0
TCGA-B1-A655,"AMENDEDICORRECTED REPORT: Amended date: Reason: Correct laterality designation of the partial nephrectomy. Paragraph of what changed: From right side to left side of Part 2 (diagnosis field). No other changes are made to the report. Communicated to. by email on. Original sign-out date: This Amended Report supersedes all prior reports under this accession number and should be the only one used for patient. management. All reports, both original and amended, are maintained in electronic archives and are available upon request. FINAL DIAGNOSIS: PART 1: FAT, OVERLYING TUMOR, RESECTION. PORTION OF FIBROADIPOSE TISSUE AND ONE DETACHED SMALL FRAGMENT (0.1 CM) OF RENAL CELL. CARCINOMA PRESENT (See Comment). PART 2: LEFT KIDNEY, PARTIAL NEPHRECTOMY-. A. RENAL CELL CARCINOMA WITH ONCOCYTIC FEATURES, FOAMY MACROPHAGES WITH FOCAL HEMOSIDERIN. PIGMENT, AND IMMUNOREACTIVITY FOR ALPHA-METHYLACYL CoA RACEMASE; FAVOR RENAL CELL. CARCINOMA, PAPILLARY TYPE 2 WITH A PREDOMINANTLY SOLID ARCHITECTURE. B. FUHRMAN NUCLEAR GRADE IS 3 OUT OF 4. C. NEOPLASM MEASURES 2.9 CM IN MAXIMUM DIMENSION. D. NEOPLASM APPEARS LIMITED TO THE KIDNEY WITH NO DEFINITIVE EXTRACAPSULAR EXTENSION. IDENTIFIED. E. NEOPLASM IS PRESENT FOCALLY AT THE INKED CAPSULAR AND INKED PARENCHYMAL RESECTION. MARGINS. F. NO LYMPHOVASCULAR INVASION IS IDENTIFIED. G. NON-NEOPLASTIC KIDNEY SHOWS CHRONIC CHANGES ASSOCIATED WITH PROXIMITY TO THE TUMOR. H. TNM PATHOLOGIC STAGE: pT1a Nx Mx (See Synoptic and Comment). COMMENT: Part 2: The renal mass consists of an oncocytic epithelial neoplasm with prominent foamy macrophages and. hemosiderin laden macrophages associated with hemorrhage. The epithelial cells are arranged in solid, acinar, and. focally papillary architectures. The neoplastic cells have large nuclei with prominent nucleoli and round nuclear. contours. A limited panel of immunohistochemical stains is performed. The neoplastic cells are strongly immunoreactive. for P504S (alpha-methylacy! CoA racemase) and are negative for cytokeratin 7 and carbonic anhydrase IX. Parvalbumin. immunostain is equivocal, with a high background. The overall pathology favors a type 2 papillary renal cell carcinoma. Parts 1 and 2: The renal cell carcinoma Is focally present at the capsular resection margin in an area where the capsule is. not intact (? capsular incision) and the parenchymal resection margin on the partial nephrectomy specimen. A. microscopic detached fragment of carcinoma is present in the fat overlying the tumor (part 1). It is uncertain whether any. microscopic residual carcinoma is present. Clinical / radiologic follow-up is recommended. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY KIDNEY TUMORS. SPECIMEN TYPE: Partial nephrectomy. LATERALITY: Left. TUMOR SITE: Upper pole. FOCALITY: Unifocal. TUMOR SIZE: Greatest dimension: 2.9 cm. Additional dimensions: 2.5 X 1.4 cm. MACROSCOPIC EXTENT OF TUMOR: Tumor limited to kidney. HISTOLOGIC TYPE: Other: Oncocytic renal cell carcinoma, favor type 2 papillary histologic type. HISTOLOGIC GRADE (Fuhrman Nuclear Grade): G3. PATHOLOGIC STAGING (pTNM): pT1a. pNX. Number of regional lymph nodes examined: 0. pMX. MARGINS: Margin(s) involved by invasive carcinoma. Renal capsular margin. Perinephric fat margin. Renal parenchymal margin. ADRENAL GLAND: Not present. LYMPH-VASCULAR INVASION (LVI): Absent/not identified.",T1,N0,M0,T1N0M0
TCGA-BR-7717,Asterand Case ID. Open Clinica. Gross. Microsc. Diagnos. Subject ID. Descript. opic. is. ion. Descript. Details. ion. BR-7717. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Stomach. Tumor size: 5 X 4.5 X 1 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Adjacent. structures (specify) - lesser. omentum. Lymph nodes: 2/8 positive for. metastasis (Intraabdominal. 2/8). Lymphatic invasion: Not. specified. Venous invasion: Not specified. Perineural invasion: Not. specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,T4,N1,M0,T4N1M0
TCGA-60-2696,"SPECIMEN(S): A. 2R LYMPH NODE. B. 4R LYMPH NODE. C. LEFT UPPER LOBECTOMY. D. 11 L LYMPH NODE. E. 10 L LYMPH NODE. F. ANTERIOR SUPERIOR MEDIASTINAL MARGIN. CLINICAL HISTORY: None provided. PRE-OPERATIVE DIAGNOSIS: Left lung cancer. INTRAOPERATIVE CONSULTATION: FSA-FSB: No tumor seen. Diagnosis called. FSC, Left upper lobe, bronchial margin: Negative for malignancy. FSF, Anterior/superior mediastinal margin: Negative for malignancy. Diagnoses called at. GROSS DESCRIPTION: A. 2R LYMPH NODE. Received fresh for frozen section are two tan pink lymph nodes 0.6 x 0.3 x 0.2cm and 0.5 x 0,4 x. 0.2cm. Toto FSA. B. 4R LYMPH NODE. Received fresh for frozen section are two tan pink lymph nodes 0.2 X 0.2 x 0.2cm and 0.2 x 0.2 x. 0.1cm. Toto FSB. HW. C. LEFT UPPER LOBECTOMY. Received fresh labeled with the patient's identification and designated ""left upper lobectomy"" is a. resected lobe of lung weighing 903 g and measuring 22 x 14.5 X 2.5 cm. The overlying visceral. pleura is smooth and red. A palpable mass lies subjacent to the bronchial margin. Sectioning. shows a firm beige centrally friable mass measuring 5.5 X 3.5 X 3 cm approaching the bronchial. margin at distance of 0.2-cm, and 0.5-cm from the pleural surface. No additional lesions or. nodules are grossly appreciated. The remainder of the specimen shows deep red consolidated. lung parenchyma. A portion of the specimen is submitted for tissue procurement. Representatively submitted: FSC: Bronchial margin. C2: Additional bronchial margin. C3-C5: Possible peribronchial lymph nodes. C6-C7: Perpendicular sections, mass and bronchial margin. C8: Mass and overlying pleura. C9: Mass and normal appearing lung parenchyma. C10-C11: Uninvolved lung parenchyma. D. 11 L LYMPH NODE. Received in formalin labeled with the patient's identification and designated ""11L lymph node"". are two fragments of brown-tan soft tissue measuring 1.1 X 0,6 x 0.3 cm in aggregate. Entirely. submitted, D1. E. 10 L LYMPH NODE. Received in formalin labeled with the patient's identification and designated ""10 L lymph node"". is a fragment of brown-tan soft tissue measuring 0.4 x 0.2 x 0,2 cm. Entirely submitted, E1. F. ANTERIOR/SUPERIOR MEDIASTINAL MARGIN. Received fresh labeled with the patient's identification and designated ""anterior/superior. mediastinal margin"" are two pieces of tan-red soft tissue measuring 0.6 x 0.3 X 0.2 cm and 0.7 x. 0.5 x 0,2 cm. Entirely submitted for frozen section, FSF. DIAGNOSIS: A. 2R LYMPH NODE, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). B. 4R LYMPH NODE, EXCISION: ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). C. LEFT UPPER LOBE, LOBECTOMY: - MODERATELY DIFFERENTIATED SQUAMOUS CELL CARCINOMA, TUMOR. SIZE 5.5 X 3.5 X 3.0 CM. BRONCHIAL MARGIN, NEGATIVE FOR TUMOR. - TWO PERIBRONCHIAL LYMPH NODES, NEGATIVE FOR TUMOR (0/2). - SEE TEMPLATE. D. 11L LYMPH NODE, EXCISION: - TINY PIECE OF BLOOD CLOT, NO LYMPH NODE OR TUMOR IDENTIFIED. E. 10L LYMPH NODE, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR TUMOR (0/1). F. ANTERIOR SUPERIOR MEDIASTINAL MARGIN, EXCISION: - BENIGN LUNG PARENCHYMA AND FIBROADIPOSE TISSUE, NEGATIVE FOR. TUMOR. SYNOPTIC REPORT - LUNG. Surgical Procedure: Lobectomy. Laterality: Left. Tumor Site: Upper lobe. Tumor Location: Central. Tumor Size: Greatest diameter: 5.5cm. Additional dimensions: 3.5cm x 3cm. WHO CLASSIFICATION. Squamous cell carcinoma. Conventional type 8070/3. Histologic Grade: G2: Moderately differentiated. Angiolymphatic Invasion: Absent. Bronchial Margins: Bronchial margins uninvolved. Visceral Pleural Involvement: Absent. Satellite Tumor(s): Absent. Lymph Node Involvement: NI: Ipsilateral Hilar and/or Peribronchial (levels 10-14). Negative 0/3. N2: Ipsilateral Mediastinal and/or Subcarinal (Levels 1-9). N/A. N3: Contralateral Mediastinal/Hilar, Scalene or Supraclavicular. Negative 0/2. Non-Neoplastic Lung: Emphysematous changes. Hemorrhage. Additional Pathologic Findings: None identified. Pathological Staging (pTNM): pT 2. N 0. M X.",T2,N0,M0,T2N0M0
TCGA-EA-A3HU,".aterality: Path Report:UTERUS TISSUE CHECKLIST. Specimen type: Hysterectomy, bilateral salpingo-oophorectomy. Tumor site: Cervix. Tumor size: 5 x 4 X 2.5 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Greater than 1/2 myometrium. Lymph nodes: 0/14 positive for metastasis (Regional 0/14). Lymphatic invasion: Not specified. Venous invasion: Not specified. Extent of myometrial invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None. Gross Description: Microscopic Description: Diagnosis Details:",T2,N0,M0,T2N0M0
TCGA-HF-A5NB,"Sample Type TUMOUR. Diagnosis. Adenocarcinoma, intestinal. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). Stomach (antrum). Tumour Size (cm). 7.5. Histology. Adenocarcinoma, intestinal. Grade/Differentiation. III. Pathological T. T4a. Pathological N. N3a. Clinical M. M0. Histology Comments. Tumour invades into duodenum. Omentum also involved. Histology: Intestinal adenocarcinoma with a mucinous. component which comprises < 50% of the tumour. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.",T4,N3,M0,T4N3M0
TCGA-A8-A091,"Diagnosis: 1. Poorly differentiated invasive breast carcinoma with focal in situ spread. (tumor diameter: 2.2 cm). In conclusion, this is a poorly differentiated invasive ductal carcinoma with focal. neuroendocrine characteristics. In conjunction with the preliminary finding, this gives rise to the following tumor. classification: NOS, G III, pT2N0(sn)LOVORO.",T2,N0,M0,T2N0M0
TCGA-AG-3896,"Structured brief findings (cito processing) and diagnosis relating to the clinical problem: This material shows an invasive adenocarcinoma of the colon (rectal carcinoma G2) of moderate. differentiation with extensive infiltration of the muscularis, corresponding to pT2, vascular. infiltration (corresponding to L1, V1),. it further shows free resection margins with regard to the deep resection margin and the resection. margins in the mucosa region, as well as free lymph nodes and a free anastomosis ring. Tumor classification: ICDO-DA M 8140/3. G2. pT2 L1, V1, pNO (0/12).",T2,N0,M0,T2N0M0
TCGA-AO-A0JL,"clinical Diagnosis & History: %/O female with left breast mass. Mammo showed 2 lesions in UOQ left. breast. Core biopaies IDC and DCIS. Proceeding to MRM. Specimens Submitted: 1: SP: Left breast with level 1 and low level 2 axillary contents. 2: SP: Additional level 2 left axillary contents. 3: SP: Left level 2 and level 3 axillary contents. DIAGNOSIS: 1). BREAST WITH LEVEL I AND LOW LEVEL II AXILLARY CONTENTS, LEFT;. MODIFIED RADICAL MASTECTOMY AND AXILLARY LYMPH NODE DISSECTION: - TWO SEPARATE TUMOR NODULES: ONE IS LOCATED IN THE UPPER OUTER. QUADRANT AND SHOWS AN INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED. (HISTOLOGIC GRADE III/III, NUCLEAR GRADE III/III), MEASURING 3.9 CM IN. LARGEST DIMENSION GROSSLY. THE SECOND IS LOCATED IN THE UPPER AND LOWER OUTER QUADRANTS AT 3:00 AND IS. COMPOSED OF PREDOMINANTLY DUCTAL CARCINOMA IN SITU (DCIS) WITH SEVERAL FOCI. OF INVASIVE DUCTAL CARCINOMA, POORLY DIFFERENTIATED AND SIMILAR TO ABOVE,. RANGING IN SIZE FROM LESS THAN 0.1 CM TO ABOUT 0.4 CM. - THE DUCTAL CARCINOMA IN SITU (DCIS) IS OF THE SOLID AND CRIBRIFORM TYPES. WITH HIGH NUCLEAR GRADE, EXTENSIVE NECROSIS AND FOCALLY INVOLVES A LARGE. LACTIFEROUS DUCT OF THE NIPPLE. - CALCIFICATIONS ARE PRESENT IN THE IN SITU AND INVASIVE CARCINOMA, AND IN. BENIGN BREAST PARENCHYMA. - VASCULAR INVASION IS PRESENT. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY EITHER INVASIVE OR IN SITU. CARCINOMA IS IDENTIFIED. - NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE REMAINING BREAST TISSUE SHOWS PREVIOUS BIOPSY SITE AND MILD. FIBROCYSTIC CHANGES. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF POSITIVE. LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES EXAMINED) : THERE IS EXTRANODAL TUMOR EXTENSION (>2 MM). - RESULTS OF IMMUNOHISTOCHEMICAL STAINS ARE AS FOLLOWS: ER: 0% NUCLEAR STAINING. PR: 0% NUCLEAR STAINING. HER-2/NEU (HERCEPTEST) : NEGATIVE (STAINING INTENSITY OF 1+). 2). AXILLARY CONTENTS, LEFT ADDITIONAL LEVEL II; DISSECTION: TWELVE BENIGN LYMPH NODES (0/12). 3). AXILLARY CONTENTS, LEFT LEVELS II AND III; DISSECTION: - THREE BENIGN LYMPH NODES (0/3). I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Special Studies: Special Stain. Comment. ER-C. PR-C. HER2-0. NEG CONT. IMM RECUT. NEG-HER2. Gross Description: 1). The specimen is received fresh labeled, ""Left breast with level 1 and. low level 2 axillary contents, stitch marks axillary contents and consists. of a breast with attached axillary tail. The breast measures 37.0 x 26.0. x. 6.7 cm with overlying skin ellipse measuring 36.5 x 18.0 cm. Situated on. the skin surface is an everted nipple measuring 1.4 x 1.2 x 0.1 cm and. areola measuring 4.8 x 4.5 cm. The skin shows no visible scars. A suture. demarcates the axillary tail which measures 11.0 x 4.0 x 3.5 cm. The. posterior surface of the breast is inked black and the specimen is serially. sectioned to reveal a white tan firm ill-defined mass in the upper outer. quadrant measuring 3.9 x 3.7 x 3.3 cm, located 1.5 from the deep margin. There is a biopsy site identified in the lower outer quadrant, corresponding. to the three o'clock position, measuring 2.0 x 2.0 x 1.5 cm. The remaining. breast tissue shows predominantly yellow lobulated adipose tissue admixed. with white-tan fibrous soft tissue with no other gross identifiable lesions. The axillary tissue is dissected to reveal several grossly positive lymph. nodes, measuring up to 4.5 cm. Representative sections of the mastectomy. specimen and all identified axillary lymph nodes are submitted (the large. grossly positive lymph nodes are representatively submitted). Tissue. is. taken for TPS. Summary of sections: N - nipple. NB - nipple base. s skin. D - deep margin. T tumor. BX - separate biopsy site. UIQ - upper inner quadrant. LIQ - lower inner quadrant. UOQ - upper outer quadrant. LOQ - lower outer quadrant. LN - individual lymph nodes. 2). The specimen is received in formalin, labeled ""Additional level 2. left axillary contents"" and consists of an axillary dissection measuring 7 x. 4.5 x 0.8 cm. The specimen consists of soft yellow-tan lobulated tissue. with several pink-tan lymph nodes identified on cut section ranging from 0.2. cm to 1.8 cm in greatest dimension. The specimen is submitted for lymph. node digest dissection. Summary of sections: LN - lymph nodes. 3). The specimen is received in formalin, labeled ""Left level 2 and level. 3 axillary contents"" and consists of an unoriented axillary dissection. measuring 7.5 x 4.7 x 1.8 cm. The specimen consists of yellow tan lobulated. tissue, which on sectioning reveals several pink-tan lymph nodes ranging. from 0.2 cm to 2.3 cm in greatest dimension. The specimen is submitted for. lymph node dissection. Summary of sections: LN - lymph nodes. Summary of Sections: Part 1: SP: Left breast with level 1 and low level 2 axillary contents. Block. Sect. Site. PCs. 3. BX. 3. 1. D. 1. 2. LIQ. 2. 4. LN. 4. 2. LOQ. 2. 1. N. 1. 1. NB. 1. 1. s. 1. 3. T. 3. 2. UIQ. 2. 2. 2. Part 2: SP: Additional level 2 left axillary contents. Block. Sect. Site. PCs. 4. LN. 4. 2art 3: . SP: Left level 2 and level 3 axillary contents. Block. Sect. Site. PCs. 2. LN. 2.",T2,N2,M0,T2N2M0
TCGA-52-7811,"Pathologic Interpretation: A. Station 8 lymph node: - One (1) lymph ode, no tumor seen. B. Station 9 lymph node: - One (1) lymph node, no tumor seen. C. Left 6th rib: - Pending decalcifdication. D. Posterior hjilar node: - One (1) lymph node, no tumor seen. E. Posterior hilar lymph node 2: - One (1) lymph node, no tumor seen. F. Inter-lobar lymph node: - One (1) lymph node, no tumor seen. G. Inter-lobar lymph node # 2: - One (1) ymph node, no tumor seen. H. Bronchial margin left lower lobe. - Poorly differentiated squamous cell carcinoma (4.8 cm in greatest dimension). - Bronchial and vascular margins are free of tumor. - No pleural involvement is present. - Three (3) lymph nodes, no tumor seen. - AJCC stage pT2, pNo, pMx. - See tumor summary. I. Station 7 lymph node: - One (1) lymph node, no tumor seen. J. Station 9 lymph node # 2: - Two (2) lymph odes, no tumor seen. K. Station 7 lymph node,. - One (1) lymph node, no tumor seen. L. AP window: - One (1) lymph node no tumor seen. Tumor Summary: Specimen Type: Lobectomy. Laterality: Left. Tumor Site: Lower lobe. Tumor Size: -Greatest dimension: 4.8 cm. -Additional dimensions: 4.5 x 3.0 cm. Histologic Type: Squamous cell carcinoma. Histologic Grade: G3: Poorly differentiated. Pathologic Staging: -Primary Tumor: pT2. - Regional Lymph Nodes: pNO. Specify: Number examined: 14. Number involved: 0. -Distant Metastasis: pMX. Margins: Uninvolved by invasive carcinoma. - Distance of invasive carcinoma from closest margin: 6 mm. - Specify margin: stapeled margin. Direct Extension of Tumor: None identified. As the attending pathologist, 1 attest that 1: (i) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). Procedures/Addenda. Addendum. Addendum Diagnosis. C. Left 6th rib: - Fragments of bone and skeletal muscle, no tumor seen. Clinical History: None Provided. Operation Performed. Left thoracotomy. Pre Operative Diagnosis: Left lower lobe lung cancer. Specimen(s) Received: A: Station 8 lymph node. B: Station 9 lymph node. C: Left 6th rib. D: Posterior hjilar node. E: Posterior hilar lymph node 2. F: Inter-lobar lymph node. G: Inter-lobar lymph node # 2. H: Bronchial margin left lower lobe,. I: Station 7 lymph node. J: Station 9 lymph node # 2. K: Station 7 lymph node,. L: AP window. Gross Description: A. Received in formalin is a single dark brown tissue fragment (lymph node), measuring 0.2 x0.1 cm. In toto in one. cassette. B. Received in formalin is a brown lymph node, measuring 1.0 x 0.6 cm. Bisected in toto in one cassette. C. Received in formalin is a segment of bone (rib), measuring 2.0 x 1.0 x 0.8 cm. Sections in one cassette for decalcification. D. Received in formalin is a single dark brown lymph node, measuring 0.5 x 0.4 cm. Bisected in toto in one cassette. E. Received in formalin is a single dark brown tissue fragment, 0.3 X 0.2 cm. In toto in one cassette. F. Received in formalin is a lymph node, measuring 1.0 x 0.8 cm. Trisected in toto in one cassette. G. Received in formalin is a dark brown tissue fragment, 0.5 x 0.4 cm. Bisected in toto in one cassette. H. Received in formalin is a lung lobe (left lower), weighing 240 grams, measuring 14.0 X 12.0 x 4.0 cm. There is a line. of. staple that measures approximately 8.0 cm in length, 2.0 cm in width. The pleura is light brown, inked black. Cross. section through the specimen shows a red-brown parenchyma. There is an ill-defined light brown to grey firm mass,. measuring 4.8 x 4.5 x 3.0 cm. The mass appears situated to within 3.0 cm from the pleural and appears to invade the. medium size bronchus. At the hilum, two lymph nodes are identified, measuring up to 0.7 x 0.4 cm. Sections submitted. as follows: 1&2. For frozen section. 3. Vascular margin. 4. Section from the mass invading the medium size bronchus. 5. Section from the mass in relation with the stapled line of resection. 6-8. Additional section from the mass in relation with the pleura. 9. Additional section from the mass in relation with the bronchus (disrupted). 10. Two lymph nodes in toto. I. Received is a lymph node, measuring 0.7 x 0.5 cm. Bisected in toto in one cassette. J. Received in formalin are two lymph nodes, measuring up to 0.5 x 0.4 cm. Submitted in toto in one cassette. K. Received fresh is a single light brown tissue fragment, measuring 2.0 x 1.5 x 0.1 cm. In toto in one cassette. L. Received in formalin are multiple light brown tissue fragments, measuring 2.0 X 2.0 x 0.1 cm. Two possible lymph nodes. are grossly present, measuring up to 0.7 x 0.4 cm. In toto in one cassette.",T2,N0,M0,T2N0M0
TCGA-38-4626,"agnosis: Lung, left upper lobe, lobectomy. Adenocarcinoma, poorly differentiated, 5.3 cm diameter, bronchial and pleural margins not involved. - Lymph nodes, peribronchial - No metastatic carcinoma identified (0/8) . B: Lymph nodes, station 5, removal. - No metastatic carcinoma identified (0/2). C: Lymph nodes, L10, removal. - No metastatic carcinoma identified (0/2). D: Lymph nodes, station 11, removal. - No metastatic carcinoma identified (0/2). Comment. None. Intraoperative Consultation: Frozen section is requested by Dr. FSA1: Lung, left upper lobe, lobectomy, bronchial margin, biopsy. No tumor seen in bronchial margin. - TWO lymph nodes, no tumor seen (0/2). Clinical History: with adenocarcinoma of the left upper lobe of the lung. Gross Description: Received are four appropriately containers. Container A: Specimen fixation: formalin. Yype of specimen/parts of lung received: left upper lobe lobectomy. Size of specimen: 17.5 x 11.0 x 5.8 cm. Weight of specimen: 340 g. Other attached structures: none. Tumor location: left upper lobe superior segment. Tumor size: 5.3 x 5.0 x 5.0 cm. Sectioning of the tumor reveals a firm, tan, slightly whorled, solid. mass. with pushing of regular borders which is somewhat circumscribed. The specimen almost has a cauliflower. appearance. Relationship of tumor to bronchus: Tumor does not grossly appear to be involving the bronchus. Distance of tumor to bronchial margin: 1.1 cm. Relationship/distance of tumor to pleura: closest distance is 0.4 cm. Distance of tumor to other surgical margins: 1.1 cm from bronchial margin; tumor is 1.4 cm away from stapled. surgical margin. Presence/absence of satellite tumor nodules: absent. Involvement of attached structures by tumor: no attached structures present. Description of nontumorous lung: remaining lung is red/tan and diffusely aerated. There are focal areas which. appear consolidated. Tissue submitted for special studies: yes, next section of bronchial margin, a representative section of tumor. and representative section of normal lung parenchyma. 'ock Summary: JA1 - bronchial margin. A1 - stapled surgical margin. A2 - representative section of tumor at pleura. A3 - representative section of tumor at pleura. A4 - representative section of tumor and adjacent uninvolved lung. A5 - representative section of tumor. A6 - representative section of uninvolved lung, inferior segment. A7 - two lymph node candidates. A8 - one lymph node candidate. A9 - representative section of tumor to distance of bronchus. Container B is additionally labeled ""station 5"". Within the container are two fragments of soft tissue which. measure 1.5 x 1.8 x 0.4 cm in aggregate. The specimens are tan/brown and consistent with lymph nodes. B1 - one lymph node candidate, bisected. B2 - one lymph node candidate, bisected,. Container C is additionally labeled ""L10"". Within the container is a 1.5 x 0.5 x 0.4 cm, single, tan,. irregular. soft tissue fragment consistent with lymph node. C1 - one lymph node candidate, bisected,. Container D is additionally labeled ""station 11"". Within the container is a 0.5 x 0.5 x 0.3 cm, red/tan tissue. fragment consistent with lymph node. The specimen is bisected in D1. Light Microscopy: Light microscopic examination is performed by Dr. The frozen section diagnosis is confirmed. Tumor histologic type (WHO classification) : adenocarcinoma. Tumor histologic grade (WHO classification) : poorly differentiated. Tumor size (greatest dimension) : 5.3 cm. Histologic assessment of surgical margins: not involved. Pleural involvement: not identified. In situ carcinoma: not identified. nvasion: ugiolymphatic - not identified. perineural - not identified. Lymph nodes (by node group) : 0/8 peribronchial 0/2 station 5 0/1 L10 0/1 station 11. Extracapsular extension of tumor in lymph nodes: n/a. Findings in nontumorous lung: hemosiderin-lader macrophages and post-obstructive. changes.",T2,N0,M0,T2N0M0
TCGA-BR-8683,"Case ID. Gross. Microscopic Description. Diagnosis Details. Description. In pre-pylorus,. Mucosa is ulcerated and necrotic. Tubular adenocarcinoma,. lesser curvature,. Tumor is invasion into serosa. poorly-differentiated,. there is an ulcerated. Tumor is composed of tubules or. infiltrating serosa. tumor with 4x3x1cm. small groups. Glands are variability. in size, firm and. in size and shape. Tumor cells are. gray surface. moderately straitified. Mitotic index. is present. Nuclei are. hyperchromatic and irregularly. enlarged and prominent nucleoli. Stroma is invasion of lymphocytes. Comments. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Antrum. Tumor size: 4 X 3 X 1 cm. Tumor features: Ulcerated. Histologic type: Tubular adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Serosa (visceral peritoneum). Lymph nodes: 3/5 positive for metastasis (Adjacent. lymph node 3/5). Lymphatic invasion: Present. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T4,N2,M0,T4N2M0
TCGA-B6-A0I1,"Patient:4. Surgical Pathology: Additional Info. CLINICAL HISTORY: Left breast carcinoma. GROSS EXAMINATION: A. ""Left breast tissue 3.5 x 2 x 2 AF1"", received fresh. A previously. incised unoriented 5.4 x 4.8 x 3.5 cm portion of yellow-white fibrofatty. tissue. There is a 3.5 x 2 x 2 cm firm variegated yellow-gray sabulous mass. focally abutting the margin. Representative tissue from the mass is frozen as. AF1, the remnant is submitted as A1. The majority of the remainder of the. mass is submitted as A2-A5. B. ""Left breast"", received fresh. A 10360 gram 33 x 21 x 5. 5 cm mastectomy. composed of a 29 x 16.3 cm ellipse of tan brown skin with underlying 28 x 21. x. 5.5 cm of fibrofatty breast tissue and contiguous 9.0 x 5.8 x 2.4 cm of. axillary contents. There is a central 5.5 cm areolar with a central everted. 1.3 cm nipple. 6 cm lateral to the edge of the areolar is an 8 cm freshly. sutured incision. The surgical margin is marked with blue ink and the. specimen is sectioned to reveal an approximately 6 cm diameter cavity 0.6 cm. subjacent to the previously described skin incision. The cavity is within 1.4. cm of the deep margin and 3 cm from the closest soft tissue margin. (inferior) The biopsy cavity is in the outer half of the specimen and has. slightly indurated borders but no residual tumor grossly appreciated. The. remainder of the breast parenchyma is composed primarily of yellow adipose. tissue intermixed with focal dense pink fibroconnective tissue and no. additional lesions noted. Block Summary: B1 - Nipple. B2 - Edge of incision and underlying cavity. B3 - Cavity in relationship to deep margin. B4 - Representative of closest soft tissue margin (inferior) . B5- Representative random cavity wall. B7 - Random lower outer quadrant. B8 Random upper outer quadrant. B9 - Representative central parenchyma. B10 - Lower inner quadrant. B11 - Upper inner quadrant. B12 - One lymph node candidate, proximal. B13 - Four lymph node candidates, mid. B14 - One bisected lymph node candidate, mid. B15-17 Largest section of lymph node candidate, mid (4.7 x 2.4 x 0.9 cm. B18 - Two lymph node candidates, distal. INTRA OPERATIVE CONSULTATION: A. ""Left breast tissue"": AF1 - invasive carcinoma present. DIAGNOSIS: A. ""LEFT BREAST TISSUE"" (EXCISIONAL BIOPSY) : INFILTRATING CARCINOMA PRESENT, HISTOLOGIC TYPE. DUCTAL. N.S.A.B.P. NUCLEAR GRADE 3 OF 3. N.S.A.B.P HISTOLOGIC GRADE 3 OF 3. GROSS TUMOR SIZE: 3.5 x 2 x 2 CM. SIZE OF INVASIVE COMPONENT: 3.5 X 2 x 2 CM. LYMPHATIC/VASCULAR INVASION: ABSENT. MULTIFOCAL TUMOR: ABSENT. 1 of 2. IN-SITU CARCINOMA: PRESENT, OCCUPYING 50% OF TUMOR (SEE COMMENT). TYPE OF IN-SITU CARCINOMA: COMEDO, MICROPAPILLARY. SIZE OF IN-SITU CARCINOMA: APPROXIMATELY SIZE OF BIOPSY (5.4 CM) . EXTENSIVE INTRADUCTAL COMPONENT: PRESENT. STATUS OF NON-NEOPLASTIC BREAST TISSUE: NOT APPLICABLE. SIZE OF BIOPSY: 5.4 x 4.8 x 3.5 CM. MICROCALCIFICATIONS: FOCALLY PRESENT. SURGICAL MARGIN STATUS: NOT EVALUATED. ESTROGEN/PROGESTERONE RECEPTOR AND CELL CYCLE ANALYSIS: PENDING. METHODOLOGY: IMMUNOHISTOCHEMISTRY, PARAFFIN BLOCK A4. RESULTS WILL BE ISSUED IN AN ADDENDUM. COMMENT: The tumor mass is a complex admixture of invasive and in-situ. carcinoma. The exact percentage of invasive carcinoma is difficult to. determine with certainty, but is estimated at approximately 50%. B. ""LEFT BREAST (MODIFIED RADICAL MASTECTOMY) : RESIDUAL INFILTRATING CARCINOMA ABSENT. RESIDUAL IN SITU CARCINOMA PRESENT. TYPE OF IN-SITU CARCINOMA MICROPAPILLARY. SIZE OF IN-SITU CARCINOMA: SEE COMMENT, EXTENSIVE. NIPPLE STATUS, FREE OF TUMOR. SKIN STATUS, FREE OF TUMOR. MUSCLE STATUS, NOT SAMPLED. STATUS OF NON-NEOPLASTIC BREAST TISSUE: FIBROCYSTIC CHANGES. SURGICAL MARGIN STATUS: NEGATIVE. LYMPH NODE STATUS: SEVEN LYMPH NODES, NO EVIDENCE OF MALIGNANCY (0/7). COMMENT: Random sections around the biopsy site show foci of residual in-situ. carcinoma. In addition, a random section in the central breast several cm. away from the biopsy site is also positive for in-situ carcinoma, indicating a. rather large area involved by residual in-situ disease. The margins of. resection are negative, however. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). ADDENDUM 1: Tissue was sent to the image cytometry laboratory for assay of the estrogen. and progesterone receptors. The estrogen receptor activity was judged to be. negative with an estimated FMOL value of 0. The progesterone receptor activity. was judged as negative with an estimated FMOL value of 0. Please refer to. For a complete report. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es). 2 of 2.",T2,N0,M0,T2N0M0
TCGA-3H-AB3T,"[D:4F0240DA-BF51-4D8D-A378-1B39EEFDSFEA. M. DIAGNOSIS. (A) RIGHT CHEST WALL MASS, BIOPSY: MALIGNANT BIPHASIC TUMOR CONSISTENT WITH MESOTHELIOMA. GROSS DESCRIPTION. (A) RIGHT CHEST WALL MASS - A single unoriented red-tan soft tissue fragment (0.8 x 0.6 x 0.4 cm). The entire specimen. submitted for frozen section evaluation, telfa side down in A. FS/DX: MALIGNANT NEOPLASM, DEFER TO PERMANENT CLASSIFICATION. CLINICAL HISTORY. Right lung mesothelioma. SNOMED CODES. T-D3050, M-90503. ""Some tests reported here may have been developed and performance characteristics determined by. . These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: END OF REPORT-.",T1,N0,M0,T1N0M0
TCGA-CG-5726,"Diagnosis: This is a moderately differentiated gastric carcinoma of the intestinal type according to. Moderate degree of differentiation. Dissemination pattern: Infiltration of submucosa, therefore corresponding to pT1. Otherwise free resection margins and free lymph nodes. Tumor classification: ICDO-DA-M 8140/3. PT1,pNO.",T1,N0,M0,T1N0M0
TCGA-M8-A5N4,Sample Type TUMOUR. Diagnosis. ductal adenocarcinoma. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. RESECT. Site of Tissue/Primary (Histology). pancreas. Tumour Size (cm). 3.3999999999999999. Histology. ductal adenocarcinoma. Grade/Differentiation. II. Pathological T. T3. Pathological N. Clinical M. M0. Histology Comments. pancreatic head. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.,T3,N0,M0,T3N0M0
TCGA-AA-3685,"Diagnosis: Colon resection material includes a moderately differentiated colorectal type of adenocarcinoma,. max. 3.8 cm in size, with infiltration of the pericolic fatty tissue and focal evidence of. carcinomatous lymphangiosis. Tumor-free regional lymph nodes. Tumor-free colon resection. margins. Tumor-free mesenteric resection margin. Tumor stage: pT3 pNO (0/24) pMX; G2 L1 V0 R0.",T3,N0,M0,T3N0M0
TCGA-F4-6854,LARGE INTESTINE TISSUE CHECKLIST. Specimen type: Sigmoid colectomy. Specimen size: Not specified. Tumor site: Sigmoid colon. Tumor size: 8.5 X 4.5 X 1.5 cm. Tumor features: None specified. Histologic type: Adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Pericolonic tissues. Lymph nodes: 0/8 positive for metastasis. (Regional 0/8). Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not. specified. Comments: None.,T3,N0,M0,T3N0M0
TCGA-L5-A4OX,"PREVIOUS DIAGNOSIS INQUIRY. 2. SEX: M. PROCEDURE: SPHS. A. year-old with esophageal cancer arising in Barrett's. PROCEDURE: SPGD. 1. ""Esophagogastrectomy"". Received in format in in a large container is a. esophagogastrectomy specimen comprised of 8.5 cm long, 5 cm circumference. distal esophagus with 5 cm x 12 cm circumference proximal stomach with. attached perigastric adipose ranging up to 5 cm. Adventitia and serosal. surface is grossly unremarkable. No perforations. Esophageal mucosa is. wrinkled grey at most proximal 3 cm with a 6 cm length of saimon colored. Barrett's mucosa extending to the gastroesophageal junction with a 3.3 x 2.5. cm ulcer with heaped-up borders at the gastroesophageal junction. Ulcer. extends through the esophageal mucosa to a maximum depth of 1.0 cm (grossly. abutting but not penetrating muscularis propria). Gastric mucosa wrinkled, tan. with normal folds. No ulcers or other masses. Several lymph nodes identified. in perigastric adipose tissue. 1A. Neoplasm at greatest depth and with respect to proximal. 18. Lesion with respect to distal. 1C and D. Proximal and distal including gastroesophageal junction. respectively. each). 1E. Barrett's mucosa to proximal esophagus. 1F. Barrett's mucosa to gastroesophageal junction. 1G. Multiple tymph nodes. 1H. Two lymph nodes, one inked blue. Each bisected. 11. One grossly positive lymph node. Trisected. 1J. One grossly positive Lymph node. Sectioned. 2. Cervical esophagus margin"". Received in formal in in a small container is a. 1.8 cm long, 1 cm internal diameter segment of esophagus with intact. adventitial lining and wrinkled grey mucosa. One stapled and open margin. Sampled at open end. 3. ""Esophageal Lymph pode"" Recaived in formalin in a smait containen is. 1.2. cm anthracotic lymph node. Bisected. PROCEDURE: SPMI. ESOPHAGEAL, CARDIAC AND GASTROESOPHAGEAL JUNCTION CARCINOMA: PREVIOUS DIAGNOSIS INQUIRY. 3. SEX: M. Type of carcinoma: Adenocarcinoma. If adenocarcinoma, it is arising in: Barrett's mucosa. Depth of invasion: Muscularis propria. Number of positive lymph nodes: 3/15. Extranodal metastasis: Unknown. Pattern of invasion: Expansile. Esophageal and gastric resection margins involved: No. Deep resection margin involved: No. TNM classification: T2 N1 Mx. PROCEDURE: SPOX. 1. Esophagus and proximal stomach, resection: Invasive adenocarcinoma. arising in Barrett's mucosa, extending focally into superficial muscularis. propria. Resection margins negative. Angiolymphatic invasion present. Metastatic adenocarcinoma present in 3 of 15 lymph nodes. Incidental. esophageal leiomyoma. Please see template for details. 2. Cervical esophageal margin, resection: Esophagus, negative for neoplasm. 3. Esophageal lymph node, excision: 1 lymph node, negative for neoplasm. 1,. the signing staff pathologist, have personally. examined and interpreted the slides from this case. END OF PREVIOUS DIAGNOSIS INOUIRY.",T2,N1,M0,T2N1M0
TCGA-AA-3970,"Diagnosis: Left hemicolectomy preparation with a moderately differentiated, invasive adenocarcinoma. with infiltration of the pericolic fatty tissue. There is a further tubulovillous adenoma with. focal, severe dysplasia (synonym: severe intraepithelial neoplasia). The tumor classification of the adenocarcinoma is: G2, pT3 NO (0/27) LO V0 R0.",T3,N0,M0,T3N0M0
TCGA-B6-A0IK,"Surgical Pathology: Pinat. CLINICAL HISTORY: Inflammatory breast cancer. GROSS EXAMINATION: A. ""Biopsy of left_breast"", fresh. The specimen consists of a 2 x 0.6 cm. ellipse of tan skin with underlying disc of subcutaneous tissue measuring 3 x. 1.5 x 0.5 cm. Within the subcutaneous tissue is a firm, tan, ill-defined. lesion measuring approximately 2.2 cm in greatest dimension. A portion of the. specimen is submitted for ER/PR studies and to the tissue bank. The remainder. of the specimen is sectioned and submitted in Block A1-A3. Dr. DIAGNOSIS: A. ""BIOPSY OF LEFT BREAST"": BREAST WITH INFILTRATING DUCTAL CARCINOMA (2.2 CM), N.S.A.B.E NUCLEAR GRADE. MODERATELY-DIFFERENTIATED, HISTOLOGIC GRADE 3. COMEDO TYPE INTRADUCTAL CARCINOMA IS PRESENT REPRESENTING 5% OF THE TOTAL. TUMOR VOLUME. LYMPHATIC/VASCULAR INVASION IS PRESENT, BUT NO TUMOR IS SEEN IN DERMAL. LYMPHATICS. SURGICAL MARGINS ARE POSITIVE FOR CARCINOMA. Data. eBrowser Result for. 1 of 1.",T4,N1,M0,T4N1M0
TCGA-D7-A4YU,"PESEL: : XXX. Gender: M. Examination result No. Unit in charge: 1. ef. no. Clinical diagnosis (suspicion): malignancy of the stomach - Stomach, undefined - Gastric cancer. Date of admission: (urgency: Standard). Material: 1) Material: stomach, Method of collection: Total organ resection. Histopathological Diagnosis: Tubular and partially mucinous adenocarcinoma of the stomach. Cancer metastases in the. lymph nodes NO XI/XXV. G3, pT3, pN3a Mixed type sec. (8140/3 T-63000). Macroscopic description: The specimen containing the stomach, after being incised along the greater curvature sized: 21.5 x 11 cm. with the omentum sized: 40 x 23 cm. Ulcerous tumour in the region of the lesser curvature sized 5.5 x 1.2 x 1.1 cm. Distance from the proximal. end: 1.5 cm, from distal end: 9.5 cm. Another, elevated tumour in the greater curvature region. 3.5 x 2.3 x 1,5 cm, 5.5 cm from the proximal line. and 6.5 cm from the distal line. Microscopic description: Adenocarcinoma tubulare partim mucocellulare G3 bifocale. Tumour penetrates the full thickness of the stomach wall and perigastric fat tissue. Surgical incision lines and the omentum free of neoplastic lesions. Signs of vascular invasion. Lymph nodes: - lesser curvature: metastases carcinomatosae in lymphonodis NO V/XII. Infiltratio carcinomatosa. capsulae lymphonodorum et telae adiposae perinodalis. - greater curvature: metastases carcinomatosae in lymphonodis No IV/VIII. Infiltratio carcinomatosa. capsulae lymphonodorum. peripyloric: metastases carcinomatosae in lymphonodis No II/V. Infiltratio. carcinomatosa capsulae lymphonodorum. Result of immunohistochemical examination: HER2 protein stained with Ventana's Pathway HER-2/neu (4B5) Rabbit Monoclonal Antibody. Negative reaction in invasive cancerous cells ( Score = 0). CONTACT YOUR DOCTOR WITH THIS.",T3,N3,M0,T3N3M0
TCGA-4Z-AA86,"PRIMARY SITE: Bladder. 1 - ""Appendix"": Chronic nonspecific periappendicitis. Absence of neoplasia in the analyzed material. 2 - ""Prostate + seminal vesicles + bladder"": Urothelial cell carcinoma of high-grade characterized as follows: Measure of neoplasia in its major axis: 5.0 cm. Infiltration of the whole thickness of the bladder wall and adjacent perivesical fat. Ulceration present. Perforation of the bladder peritoneum with formation of fistulae in the perivesical fat. Neural infiltration not observed. Lymphatic vascular invasion present. Sanguineous vascular invasion not detected. Prostate and seminal vesicles free of neoplastic involvement. Surgical margins free of neoplastic involvement. 3 - ""Left iliac obturator lymph nodes"": Urothelial carcinoma metastatic to one lymph node without capsular perforation (1/7). 4 - ""Right iliac obturator lymph nodes"": Free of neoplastic involvement (0/8).",T3,N1,M0,T3N1M0
TCGA-CJ-4894,"DIAGNOSIS. (A) LEFT KIDNEY, ADRENAL GLAND AND RENAL VEIN THROMBUS: RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL TYPE), FUHRMAN NUCLEAR GRADE 3. TUMOR MEASURES 11.0 CM IN MAXIMUM DIMENSION. TUMOR THROMBUS IN RENAL VEIN. TUMOR FOCALLY INVADES PERIRENAL ADIPOSE TISSUE. Margins of resection, free of tumor. Renal parenchyma with focal cortical hemorrhages, interstitial nephritis and fibrosis. Renal cortical (simple) cysts. Adrenal gland, no tumor present. (B) RETROPERITONEAL LYMPH NODES: Three lymph nodes, no tumor present. GROSS DESCRIPTION. (A) LEFT KIDNEY, ADRENAL GLAND, AND RENAL VEIN THROMBUS - A radical nephrectomy specimen (27.0 X 13.0 X 8.0. cm in toto) including kidney (15 X 7 X 6 cm), with the attached ureter (1.1 X 0.5 cm) and the unremarkable adrenal gland (6.0 X. 4.5 X 1.0 cm). A thrombus (2.5 X 1.5 X 1.5 cm) is present within the renal vein and is focally attached to the vascular wall. An ill-. defined multilobulated tumor (11.0 X 7.5 X 7.0 cm) replaces majority of the inferior half of the kidney, invading into the. perinephric adipose tissue inferiorly and pushes into the renal sinus adipose tissue. The tumor has a heterogeneous. appearance with large areas of hemorrhage and tan-brown solid areas. A large cyst (3.5 X 3.0 X 2.5 cm) is filled with clear fluid in the mid pole of the kidney, and multiple other small cysts (0.2. cm in greatest dimension) filled with clear fluid are in the remaining upper pole kidney. Multiple areas of cortical hemorrhage. (1.0. cm. in. greatest dimension) are present diffusely in the remaining upper pole kidney parenchyma. The adrenal gland is far. from the tumor (8.0 cm away). SECTION CODE: A1, ureter margin en face; A2, vascular margin en face; A3, A4, thrombus inside the renal vein, with. the vascular wall; A5-A9, tumor; A10-A13, tumor with adjacent inferior perinephric adipose tissue; A14-A17, tumor with sinus. adipose tissue invasion; A17-A19, tumor with pelvis; A20, A21, the larger cyst wall in the mid pole; A22, smaller cyst in upper. pole; A23, A24, hemorrhagic areas in the cortex of upper pole; A25, unremarkable parenchyma; A26, adrenal gland. (B) RETROPERITONEAL LYMPH NODES - Fragments of adipose tissue including three lymph nodes (3.0 X 2.5 X 1.5 cm in. aggregate). The lymph nodes measure from 1.5 to 1.8 cm in greatest dimension. The lymph nodes are entirely submitted as. follows: B1, B2, one lymph node serially sectioned; B3, one lymph node; B4, B5, one lymph node serially sectioned. CLINICAL HISTORY. Left renal mass. SNOMED CODES.",T3,N0,M0,T3N0M0
TCGA-CW-5584,"TISSUE DESCRIPTION: Right kidney (285 grams, 12.0 x 9.0 x 6.0 cm), right periaortic. tissue (aggregating 4.0 x 4.0 x1.9 cm). right retroperitoneal lymph. node, and anterior vena cava lymph node. DIAGNOSIS: Kidney, right, radical nephrectomy: Grade 3 (of 4) renal cell. carcinoma, clear cell type, forms a 6.0 x 4.5 x 4.0 cm mass located. in the mid pole. The tumor extends into the peripheral perinephric. fat. A tumor thrombus is present in the renal vein. Coagulative. tumor necrosis is absent. Sarcomatoid differentiation is absent. The surgical margins are negative. No renal hilar lymph nodes are. identified. The adrenal gland is present and unremarkable. A. separate 4.0 x 4.0 x 4.0 cm benign cyst is present in the inferior. pole. Soft tissue, right periaortic, excision: Metastatic grade 3 (of. 4). renal cell carcinoma, clear cell type. Lymph node, right retroperitoneal, excision: One (of 1) lymph node. shows metastatic grade 3 (of 4) renal cell carcinoma, clear cell. type. Lymph node, anterior vena cava, excision: One (of 1) lymph node. shows metastatic grade 3 (of 4) renal cell carcinoma, clear cell. type. TISSUE DESCRIPTION: Right kidney (285 grams, 12.0 x 9.0 x 6.0 cm), right periaortic. tissue (aggregating 4.0 x 4.0 x1.9 cm). right retroperitoneal lymg h. node, and anterior vena cava lymph node. DIAGNOSIS: Kidney, right, radical nephrectomy: Grade 3 (of 4) wenal cell. carcnoma, clear dell type, forms a 6.0 x 4.5 x 4.0 em mass lodated. in the mid pole. The tumor extends into the peripheral perinephric. fat. A tumox thrombus is present in the renal vein. Coagulative. tumor necrosis is absent. Sarcomatoid differentiation is absent. The surgical margins are negative. No renal hilar lymph nodes are. identified. The adrenal gland is present and unremarkable. A. separate 4.0 x 4.0 x 4.0 om benign cyst is present in the inferior. pole. Soft tissue, right periaortic, excision: Metastatic grade 3 (of. 4). renal cell carcinoma, clear cell type. Lymph node, right retroperitoneal, excision; One (of 1) lymph no e. shows metastatic grade 3 (of 4) renal cell carcinoma, clear cell. type,. Lymph node, antexior vena dava, excision: one (of 1.1 lymph node. shows metastatic grade 3 (of 4) renal cell carcinoma, clear gell. type.",T3,N1,M0,T3N1M0
TCGA-BR-6455,STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Stomach. Tumor size: 12 X 7 X 2 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Adjacent structures. (specify) - Lesser and greater. omentum. Lymph nodes: 2/19 positive for. metastasis (Intraabdominal 2/19). Lymphatic invasion: Not specified. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.,T3,N1,M0,T3N1M0
TCGA-E9-A245,"OC#: 3/1/2011 Laterality:Left, upper outer quadrant. Path Report:BREAST TISSUE CHECKLIST. Specimen type: Lumpectomy. Specimen size: Not specified. Tumor site: Upper outer quadrant. Tumor size: 2 x 0 x 2.2 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Lymph nodes: 3/10 positive for metastasis (Axillary 3/10). Extracapsular invasion of the lymph nodes: Not specified. Margins: Uninvolved. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T2,N1,M0,T2N1M0
TCGA-D5-6531,"page 1 / 1. Examination: Histopathological examination. Material: 1. Partial resection of organ - colon and caecum. Expected time of examination: Clinical diagnosis: Cancer of the hepatic flexure. Macroscopic description: 25 cm length of the large intestine with periintestinal fat tissue of 25 x 8 X 2cm. Omentum sized 12 x 10 cm. Edge-thickened ulceration sized 4 X 3 cm in the mucosa. The lesion covers 100% of the intestine circumference, located 12 cm from the proximal cut end and 8 cm. from the distal cut end. The lesion macroscopically infiltrates the periintestinal tissue. Microscopic description: Adenocarcinoma tubulare (G2). Infiltratio carcinomatosa telae adiposae pericolicae. Intestine ends clear of neoplastic lesions. Lymphonodulitis reactiva (No IV). Histopathological diagnosis: Adenocarcinoma tubulare coli. Tubular adenocarcinoma of the colont. (G2; Dukes B; Astler-Coller B2; pT3; pNO).",T3,N0,M0,T3N0M0
TCGA-BH-A0B6,"FINAL DIAGNOSIS: PART 1: LYMPH NODE, LEFT SENTINEL #1, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 2: LYMPH NODE, LEFT SENTINEL #2, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 3: BREAST, LEFT, SEGMENTAL MASTECTOMY -. A. (NEILTRATING DUCIAL CARCINOMA (3A, 3B, 3C, 3D, 3E, AND 3F). THE TUMOR COMES TO WITHIN 1.0 MM. FROM THE NEAREST ANTERIOR RESECTION MARGIN (3A AND 3B). B. THE TUMOR SIZE IS 1.5 X 1.2 X 1.1 CM. C. NOTTINGHAM SCORE IS 6/9 (TUBULES 3, NUCLEI 2, MITOSIS 1). D. LYMPHOVASCULAR PERMEATION IS NOT APPRECIATED. E. DUCTAL CARCINOMA IN SITU, CRIBRIFORM AND SOLID TYPES, NUCLEAR GRADE 2, REPRESENTING. ABOUT 2% OF TUMOR VOLUME. F. DUCTAL CARCINOMA IN SITU IS ADMIXED WITH INVASIVE TUMOR AND COMES TO WITHIN 1.0 MM FROM. THE NEAREST ANTERIOR RESECTION MARGIN. G. CHANGES CONSISTENT WITH PREVIOUS BIOPSY SITE, SEE PRIOR. H. FIBROCYSTIC CHANGES WITH FIBROADENOMATOID CHANGES, DUCTAL EPITHELIAL HYPERPLASIA,. COLUMNAR CELL CHANGES AND ASSOCIATED MULTIFOCAL MICROCALCIFICATIONS. I. IMMUNOHISTOCHEMICAL STAINING FOR ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR AND HER-. 2/NEU WERE PREVIOUSLY PERFORMED ON. AND WERE REPORTED AS FOLLOWS: ESTROGEN RECEPTOR - POSITIVE, PROGESTERONE RECEPTOR - POSITIVE, HER-2/NEU - NEGATIVE. (SCORE +1). PART 4: LYMPH NODE, LEFT SENTINEL #3, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). PART 5: LYMPH NODE, LEFT SENTINEL #4, BIOPSY -. ONE LYMPH NODE, FREE OF TUMOR (0/1). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Left. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.5 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: Yes, benign zones. TUMOR TYPE, IN SITU: Cribriform, Solid, DCIS admixed with invasive carcinoma, Percent of tumor occupied. by in situ component: 2 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 1 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of in situ disease to closest margin: 1 mm. LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 4. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. T PATHOLOGIC: NON-NEOPLASTIC STAGE, BREAST TISSUE: Fibroadenoma, FCD. pT1c. N STAGE, PATHOLOGIC: M STAGE, PATHOLOGIC: pNo. ESTROGEN RECEPTORS: pMX. PROGESTERONE RECEPTORS: positive. positive. HER2/NEU: zero or 1+.",T1,N0,M0,T1N0M0
TCGA-A8-A08J,"Diagnosis: Ablated (right) breast sample with moderately differentiated invasive and focal ductal. 1. discrete intraductal components, angioinvasion resection ulceration of. the carcinoma skin. Tumor with size at least 7 cm. Paget's disease of the nipple. Dorsal. margin tumor-free. Tumor classification: NOS, G II, pT4bN1aL1 1VORO.",T4,N3,M1,T4N3M1
TCGA-EI-6512,"page 1 / 1. Examination: Histopathological examination. Material: 1. Total organ resection - colon and rectum. Expected time of examination: Clinical diagnosis: Cancer of the rectos gmoid junction. Macroscopic description: 17 cm length of the large intestine with periintestinal tissue sized 2.5 x 15 x 8 cm. Cauliflower-shaped ulcerous. tumour sized 6 X 6 X 1 cm found in the mucosa. The lesion surrounds 100% of the intestine circumference, located. 5 cm from one of the excision lines and 5 cm from the opposite one. Microscopic description: Adenocarcinoma tubulare (G2). Infiltratio carcinomatosa telae adiposae pericolicae. Intestine ends free of neoplastic lesions. Metastases carcinomatosae in lymphonodis (No I/XVII). Histopathological diagnosis: Adenocarcinoma tubulare coli. Tubulopapillar adenocarcinoma of the colon. Metastases carcinomatosae in lymphonodis (No I/XVII). Cancer metastases in the lymph nodes (No I/XVII). (G2, Dukes C, Astler-Coller C2, pT3, pN1).",T3,N1,M0,T3N1M0
TCGA-AK-3427,"Clinical History/Diagnosis: ? Renal Cell CA vs. TCC. Left Renal Mass. Source of Specimen(s): A: Left kidney, para aortic lymph nodes and left adrenal gland. B: Additional para aortic lymph nodes. C: Left common iliac lymph nodes. Gross Description: Received in three parts. Source of Tissue: 1. Labeled #1, left kidney, para aortic lymph nodes,. left adrenal gland. Frozen Section Diagnosis: 1FS- ONCOCYTOMA PER. Gross Description: Received fresh is a left kidney with attached. perinephric fat weighing 580 grams with an overall measurement of 20 x 13. X 9 cm. In the superior aspect of the perinephric fat is the adrenal. gland measuring 3 x 2.5 x 1.3 cm and it is grossly normal appearing. No. lymph nodes are found in the attached fat. At the hilum, there is a 10.5. x 0.5 cm segment of ureter which is opened and is normal appearing. The. vascular margins are free of any lesions or masses. The specimen is. bivalved and the kidney itself measures 12.5 X 7.5 x 4.7 cm. In the lower. pole of the kidney there is a large round tumor measuring 6.5 x 5.0 x 4.0. cm. The lesion pushes on the capsule and grossly approaches the inferior. and middle. However, no gross invasion is found. Representative sections. of the tumor are submitted for frozen section consultation in 1FS. The. second lesion is found in the mid lateral aspect of the kidney and. measures 1.4 X 1.4 x 1.2 cm and is orangish-brown in color and soft. This. lesion is 2 cm from the above mentioned mass. Further sectioning through. the superior pole discloses an ill-defined circumscribed potential lesion. that measures 0.8 x 0.8 cm and may represent a third tumor. The superior. pole lesion is 5.6 cm from the inferior pole mass. Designation of Sections: 1A- ureter margin, 1B- vascular margin, 1C-. adrenal gland, 1D- large mass in relationship to hilum, 1E- large mass in. relationship to normal appearing parenchyma, 1F- tumor in relationship to. capsule and fat, 1G-1H- smaller tumor in middle of kidney, 1I-1J- smaller. potential lesion superior left kidney, 1K-1L- uninvolved kidney, 1M-1N-. perinephric fat. Summary of Sections: 1A-1N. Tissue is procured for cytogenetic studies. Source of Tissue: 2. Labeled #2, additional para aortic lymph nodes. Gross Description: Received fresh are five fatty lymph nodes measuring. from 1 up to 3 cm. Designation of Sections: 2A-2B- - four single lymph nodes, 2C- single. bisected node. Summary of Sections: Source of Tissue: 3. Labeled #3, left common iliac lymph nodes. Gross Description: Received fresh are three yellow to red firm lymph nodes. measuring respectively 1 x 0.8 x 0.8, 1.2 X 0.9 X 0.8 and 1.4 X 0.9 X 0.9. cm. Submitted as is in 3A. Designation of Sections: 3A. Summary of Sections: Final Diagnosis: 1. Left kidney, adrenal gland and para aortic lymph nodes; radical. nephrectomy: - Three tumors confined to the kidney. - Two oncocytomas located at the lower pole (6.5 cm) and upper pole (0.8. cm). - One chromophobe renal cell carcinoma located in the middle portion (1.4. cm). - Ureteral and vascular resection margins and one lymph node are all. negative for tumor (0/1). - Adrenal gland is negative for tumor, see note. 2. Additional para aortic lymph nodes: - No tumor seen in all ten lymph nodes (0/10). 3. Left common iliac lymph nodes: - No tumor seen in all four lymph nodes (0/4). Note: On immunohistochemica stains the oncocytoma tumor cells are. positive for CD10 (cytoplasmic) and E-cadherin (variable and weak. membranous staining) and are negative for vimentin and cytokeratin CK7. The chromophobe renal cell carcinoma tumor cells are positive for. cytokeratin CK7 and E-cadherin (strong membranous), and are negative for. vimentin and CD10. This case was presented at our intradepartmental. conference on. with agreement in diagnosis. See cytogenetics. These tests were developed and their performance characteristics. determined by the immunohistochemistry laboratory at the. r. These tests have not been cleared or approved by the U.S. Food. and Drug Administration. The FDA has determined that such clearance or. approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research. This. laboratory is certified under the Clinical Laboratory Improvement. (CLIA) as qualified to perform high complexity clinical. testing. Procedures/Addenda. FC Cytogenetics Tumor. Results-Comments. CYTOGENETIC ANALYSIS REPORTS. KARYOTYPE: Abnormal mosaic. karyotype: 44,X,-Y,-1,+7,-14,+20,-21[8)/46,XY[12]. The renal mass was sent to a commercial laboratory for cytogenetic. analysis. The chromosomes from the cells of nine- and ten-day adherent cultures were. counted and analyzed, and two of these metaphases were karyotyped by G-. banding. Eight cells had a modal chromosome number of 44 and were. characterized by the loss of chromosomes Y, 1, 14, and 21 and gain of. chromosomes 7 and 20. Twelve cells had a modal chromosome number of. 46 and appeared to have a normal karyotype. Cytogenetic abnormalities. involving the numerical loss of chromosomes Y and 1, often without. additional changes, have been reported in renal oncocytomas.",T1,N0,M0,T1N0M0
TCGA-SW-A7EA,"Subiect ID. Final Pathology Template. Final Pathology Report Information (Surgical Tissue Case). 1.1. Tissue Specimen ID Code: 1.2. Date of Excision: (MM/DD/YYY). 1.3. Tumor Location (anatomic site): Stomach, Antrum. 1.4. Tumor Size: 3,0x 4,0 (cm). 1.5. Lymph Node Status: 1.5.1. Number Nodes Examined: 11. 1.5.2. Number Nodes Positive: 0. 1.5.3. Lymph Node Locations (Involved Nodes): 8 greater curvature,. 3. lesser curvature. 1.6. Metastasis: 1.6.1. Metastasis Present: Unknown. 1.6.2. Number of Mets: 1.6.3. Site(s) Of Metastasis: 1.7. ICD-9 Code for Specimen Diagnosis: C 16.3. 1.8. Final Pathology Details: (Please suppy de-identified copy of original language final pathology report in. addition to information below). 1.8.1 Macroscopic Description: Surgical specimen of stomach,. measuring 16 cm in combination with greater omentum. At. 1,0 cm from the resection margin, ulcerative formation. with irregular borders 3.0 x 4.0 cm in dimension,. macroscopically not infiltrating gastric wall. Greater. omentum is intact. 11 lymph nodes (8 - greater. curvatures, 3 - lessen curvature). 1.8.2 Microscopic Description: Adenocarcinoma diffuse type. undifferentiated of stomach, with signet ring cell type. regions. Tumor invades through muscularis propria. Margins resection is intact. Greater omentum is intact. Lymph node status negative: greater curvature (8 from 8). and lesser curvature (3 form 3). 1.8.3. Comment (if applicable): 1.8.4. Clinical Diagnosis: Gastric cancer of antrum. 1.8.5. Stage: T2a NO M0 (TxNxMx). hu8819913 Yes. PROPRIETARY AND CONFIDENTIAL.",T2,N0,M0,T2N0M0
TCGA-2L-AAQE,"male. Surgery date: Macroscopic evaluation. 1. Pancreatic head: unfixed, an irregular, partially indurated, 2 cm in diameter tissue specimen. 2. Cutting edge of the pancreas: unfixed, pancreas lamellae with central ductus pancreaticus, 3x2x0.5 cm. 3. Skin nodule abdominal wall: fixed, spindle-shaped 3.5x0.8x1 cm large Skin/Hypoderm resection. specimen. Above the skin a 0.6 cm in diameter exophytic brown-grey knot with a lobate surface. The. knot is located 0.1 cm away from the lateral resection margin, towards the top of the spindles minimum. 0.5 cm. Embedding of the top of the spindles and the central parts in relation to the papillary knot. 4. Gall bladder: fixed, a 8.5x4x1.2 cm large gall bladder, resected after 0.5 cm from the D. cysticus. The. lumen of the gall bladder is filled with coagulated blood. At the branching of the D. cysticus a 1.2 cm. large lymph node. 5. Lymph node A. hepatica: fixed, fragmented fatty tissue, in total 4x3x1 cm with multiple max. 3 cm. large partially fragmented lymph nodes. 6. Liver hilum: soft tissue: fixed, fragmented soft tissue, in total max. 3 cm with multiple max. 3 cm large. grey-glass-like lymph nodes. 7. Pancreatic head: fixed, resection specimen pancreas/duodenum, composed of a 30 cm long small. intestine and a 8.5x7.5x4.5 cm large pancreas head. Centrally within the pancreatic head a 3.5x6x3.5 cm. large cyst, corresponding with the widened pancreas duct. The cyst was opened intra surgically from. ventral with single sutures more than 6 cm. The cyst was reddish-brown covered, the adjacent tissue. grey/glass-like. Caudal to the cyst a 4.5x4x3 cm large diffusely defined dense tumor with solid grey/glass-. like margin. Infiltration into the adjacent fatty tissue dorsal and medial. Peripancreatic lymph nodes max. 1.2 cm. Distances of the tumor to the resection margins: medial 0.1 cm, dorsal 0.3 cm, resection margin. pancreas distal 0.5 cm. Several max. 1.2 cm large peripancreatic lymph nodes. Ink mark: resection margin. medial: green, dorsal black, ventral blue. A.-C. a central cross section of the tumor in relation to the resection margin and the cyst. D. cyst in relation to the tumor and the intra-surgical opening ventral. E. Cyst in relation to the bile duct. F. resection margin pancreas distal and resection margin bile duct (tangential). G. aboral resection margin duodenum. H. oral resection margin duodenum. J.-K. lymph nodes upper rim of the pancreas. L.-M. lymph nodes lower rim of the pancreas. 8. Omentum majus: fixed, a 26x12x0.7 cm large omentum with focal fresh hemorrhages. No tumor. Instantaneous section report. 1. Adenocarcinoma. 2. without tumor. Processed: 19 blocks, H&E, 1xEvG, 1xPAS, 2x instantaneous section. Microscopy. 1. Confirmation of the diagnosis made by instantaneous section, invasive glandular adenocarcinoma. 2. Confirmation of the diagnosis made by instantaneous section, resection margin without tumor. 3. Naevus, papillary, dermal. Within the healthy tissue, benign. 4. Gall bladder without tumor, fresh hemorrhages and leucocyte infiltration, most likely due to the. surgery. Lymph node without tumor. 5. Metastasis-free lymph nodes (0/3). 6. Metastasis-free lymph nodes (0/3). 7. Block A without tumor. Block B invasive carcinoma, glandular growth pattern, partially highly. dissociated with abortive glands and solid tumor cell nests, focus forming just moderately. Partiall large. complex glands. The proliferation is moderate, continuous infiltration of a lymph node. Infiltration of the. peripancreatic soft tissue. Marked chronic and acute pancreatitis with extensive fibrosis, partially. ductectasia. Formation of a pseudo cyst. Chronic erosive inflammation im ductus choledochus with. regenerating epithelium. Enteric resection margins without tumor. Chronic lymphadenitis and partially. perilymphadenitis or perinodular soft tissue infiltration due to the carcinoma. Additional lymph nodes. without tumor (0/13). 8. Omentum majus without malignancy, moderate fibrosis of the serosa, fresh leucocyte infiltration with. hemorrhage, due to the surgery. Short report on diagnostic findings. Pancreatic carcinoma (head). Moderately differentiated invasive ductal adenocarcinoma, tumor size max. 4.5 cm. Infiltration of the. peripancreatic soft tissue. Single regional lymph node metastases peripancreatically at the main. specimen (1/15). Severe chronic fibrotic pancreatitis with pancreatic pseudocyst (8.). Enteric, parenchymatous, and. deeper resection margins all without tumor (2., 7.). Omentum majus without tumor with focal fibrosis (8.). Chronic cholecystitis with metastasis-free lymph node at the D. cysticus (4.). Metastases-free lymph nodes at the A.hepatica (0/3) (5.) and metastasis-free lymph nodes at the liver. hilum (0/3) (6.). TNM classification (UICC, 7th Edition 2010): pT3, pN1 (1/22), cM0, Pn1, LO, vo, RO, G2.",T3,N1,M0,T3N1M0
TCGA-AA-3877,"Diagnosis/ diagnoses. Resected section of colon (transverse colon) with a colon carcinoma characterized. histologically as a moderately differentiated, partially mucinous colorectal. adenocarcinoma, located at the base of a tubulovillous adenoma with severe epithelial. dysplasia (synonymous: profound intraepithelial neoplasia), extending a max of 5 cm to a. resection margin and measuring 2 cm in diameter at the widest point. Invasive spreading of. the tumor to the submucosa level. Located 4 cm from the same resection margin there is a microscopically small section or. remains of an adenoma of the colon mucosa, tubular in form and with slight epithelial. dysplasia (synonym: mild intraepithelial neoplasia). In addition, in the centre of the. preparation there is a microscopically small tubular adenoma of the colon mucosa or. remains of an adenoma with moderate epithelial dysplasia (synonym: mild intraepithelial. neoplasia). Oral and aboral resection margins are tumor-free as is the greater omentum. 18 mesocolic lymph nodes are tumor-free with uncharacteristic reactive lesions. Therefore the tumor stage is pT1 pNO (0/18) LO V0 R0; G2.",T1,N0,M0,T1N0M0
TCGA-50-5044,"FINAL DIAGNOSIS: Summary Statement. The right lower lobe neoplasm is an invasive poorly differentiated adenocarcinoma, measuring 6.5 cm. Additional. satellite nodules of adenocarcinoma are present. There is-evidence of visceral pleural invasion and angiolymphatic. invasion. All margins of resections are free of tumor. The interlobar (Part 4) and anterior hilar (Part 8) lymph nodes show. evidence of metastatic carcinoma. The stage is T4 N1 Mx. PART 1: LUNG, RIGHT LOWER LOBE, BIOPSY -. INVASIVE POORLY DIFFERENTIATED ADENOCARCINOMA. PART 2: LUNG, RIGHT LOWER LOBE, LOBECTOMY -. A. INVASIVE POORLY DIFFERENTIATED ADENOCARCINOMA (6.5 CM) WITH EXTENSIVE NECROSIS,. ABSCESS FORMATION, AND FOUR SATELLITE NODULES OF ADENOCARCINOMA (0.5 TO 2.0 CM). GRAM,. GROCOTT, AND AFB STAINS ARE NEGATIVE FOR BACTERIAL, FUNGAL, AND MYCOBACTERIAL. ORGANISMS IN THE INFLAMED NECROTIC AREA WITH ABSCESS FORMATION,. B. VISCERAL PLEURAL INVASION IS IDENTIFIED. C. ALL MARGINS OF RESECTION FREE OF TUMOR. D. ANGIOLYMPHATIC INVASION IDENTIFIED. E. FOUR BENIGN REACTIVE PERIBRONCHIAL LYMPH NODES. NO CARCINOMA SEEN. F. BACKGROUND LUNG SHOWING EMPHYSEMA. G. STAGE T4 N1 MX. PART 3: BONE, 6TH RIB, RESECTION -. SEGMENT OF BENIGN RIB WITH NO SIGNIFICANT ABNORMALITY. NO CARCINOMA SEEN. PART 4: LYMPH NODE, INTERLOBAR, BIOPSY -. TWO OF FOUR (2/4) LYMPH NODES WITH METASTATIC CARCINOMA. PART 5: LYMPH NODE, RIGHT LOWER LOBE, BIOPSY -. ONE BENIGN REACTIVE LYMPH NODE. NO CARCINOMA SEEN. PART 6: LUNG, RIGHT MIDDLE LOBE, WEDGE RESECTION -. FOCUS OF ATYPICAL ADENOMATOUS HYPERPLASIA (0.8 CM). NO CARCINOMA SEEN. PART 7: LUNG, RIGHT UPPER LOBE, WEDGE RESECTION -. PORTION OF BENIGN LUNG. NO CARCINOMA SEEN. PART 8: LYMPH NODE, ANTERIOR HILAR, BIOPSY -. ONE LYMPH NODE WITH METASTATIC CARCINOMA. PART 9: LYMPH NODE, SUBCARINAL, BIOPSY -. ONE BENIGN REACTIVE LYMPH NODE. NO CARCINOMA SEEN,.",T4,N1,M0,T4N1M0
TCGA-67-6216,"PRIORITY: FROZEN SEC. JURGICAL PROCEDURES: LUNG-LOBECTOMY, REGIONAL LYMPH. CLINICAL HISTORY. PERTINENT CLINICAL HISTORY. RIGHT MEDDLE LOBE MASS. GROSS DESCRIPTION. The specimen is submitted fresh for frozen section as ""right middle. Lobe - please assess resection margins (TCGA) 11 and consists of a wedge. shaped segment of lung measuring 10 x 4.5 x 2.5 cm. The surgical margin. exhibits a line of metallic staples measuring 9 cm. The pleural surface. is pink and smooth. After removal of the staples; there are several. ligated vessels which measure 'up to 0.4 cm in length and 0.3 cm in. diameter. Sectioning of the lung exhibits pink slightly air filled tissue. exhibiting a firm pale white tumor measuring 1.8 X 1.3 x 0.9 cm. The. tumor approaches to within approximately 2 cm from the bronchial margin. Representative sections are submitted in 9 cassettes as follows: Cassette 1: Bronchial margin and vessel margin. Cassettes 2-5: Tumor showing surrounding normal parenchyma and. bronchus. Cassette 6: Remaining small segments of tumor not used for. Cassettes 7 and 8: Normal lung. FSP: Used for frozen section. FROZEN SECTION DIAGNOSIS: Right middle lobe: Adenocarcinomia extending to. within 3-4 mm of the parenchymal margin and. > 2 cm of bronchial margin. B. The specimen is submitted fresh as ""right middle lobar node' and. consists of a gray black lymph node measuring 1 cm in dimension; bisected. and submitted in toto; 2 (1).-. GROSS: DESCRIPTION. C. The specimen is submitted fresh as ""right lower lobar node"" and. consists of a gray black lymph node measuring 1.3 cm in dimension;. bisected and submitted in toto; 2 (1). FINAL DIAGNOSIS. A. RIGHT MIDDLE LOBE (LOBECTOMY SPECIMEN) : MODERATELY DIFFERENTIATED. GLAND FORMING AND PAPILLARY ADENOCARCINOMA WITH FOCAL PSAMMOMA BODY. FORMATION, GRADE II, 1.8 CM MAXIMUM DIAMETER. THE TUMOR IS CONFINED. WITHIN THE LUNG, AND EXTENDS TO WITHIN APPROXIMATELY 4 MM OF THE. PARENCHYMAL MARGIN AT ITS CLOSEST APPROACH AND > 2 CM FROM THE. BRONCHIAL MARGIN. VASCULAR MARGINS AND FOUR HILAR LYMPH NODES ARE. FREE OF DISEASE. RANDOM SECTIONS OF THE REMAINING LUNG ARE. UNREMARKABLE. B. RIGHT MIDDLE LOBAR LYMPH NODE: SINGLE. LYMPH NODE WITH NO EVIDENCE OF. MALIGNANCY. C. RIGHT LOWER LOBAR LYMPH NODE: SINGLE LYMPH NODE WITH NO EVIDENCE OF. MALIGNANCY. SYNOPTIC REPORT. SYNOPTIC REPORT: LUNG. (CAP/AJCC/ACS - REQUIRED ELEMENTS). SPECIMEN TYPE: LOBECTOMY. SPECIMEN INTEGRITY : INTACT. LATERALITY: FRIGHT. TUMOR SITE. MIDDLE LOBE. TUMOR SIZE: 1.8 CM. TUMOR FOCALITY (SPECIFY) : UNIFOCAL. HISTOLOGIC TYPE: ADENOCARCINOMA. HISTOLOGIC GRADE: EXTENT OF INVASION: CONFINED WITHIN LUNG. EXTENTION TO PLEURA/OTHER STRUCTURES (SPECIFY) : NOT IDENTIFIED. ADDITIONAL PERTINENT FINDINGS - ATELECTASIS, PNEUMONIA, ETC: (SEE. NARRATIVE). MARGINS: BRONCHIAL: UNINVOLVED. PARENCHYMAL: UNINVOLVED. VASCULAR: UNINVOLVED. OTHER. MARGINS (PARIETAL PLEURAL/CHEST WALL, ETC. IF APPLICABLE) : N/A. SYNOPTIC. REPORT. DISTANCE TO PERTINENT MARGIN (S) (AS APPLICABLE) : 4. MM FROM STAPLED. PARENCHYMAL MARGIN. NEOADJUVANT TREATMENT EFFECT (IF APPLICABLE) : N/A. VENOUS INVASION: NOT IDENTIFIED. ARTERIAL (LARGE VESSEL) INVASION: NOT IDENTIFIED. LYMPHATIC INVASION:NOT IDENTIFIED. LYMPH NODE (INCLUDING 10:S19905) : N1 - # INVOLVED/# EXAMINED: 0/6. N2 - # INVOLVED/#EXAMINED: 0/4+. N3 - # INVOLVED/# EXAMINED : 0/1+. OTHER PERTINENT FINDINGS: (SEE NARRATIVE). pTNM STAGE: pTla NO MX.",T1,N0,M0,T1N0M0
TCGA-37-4133,Index. S. 1. Tissue. Anatomical. Tumor. Specimen. Specimen. Number of. Amount/per. Specificati. Container. Site. Matrix. Format. containers. container. on. Lung. Primary. Tumor. Tissue. OCT. block. 1. n/a. Blood. n/a. Normal. Blood. frozen. tube. 1. n/a. Type of. Histological description. Grade. TNM Stage. TNM Stage. TNM Stage. Treatment. Procureme. (Source). (source). (T). (N). (M). type. nt. Adeno-squamous cell. n/a. 3. 4. 0. 0. none. carcinoma. n/a. blood draw. n/a. n/a. n/a. n/a. n/a. none. Component : of treatment. Tumor cell. (Chemo /. %. Horm Th. Details). n/a. 72. n/a. n/a.,T4,N0,M0,T4N0M0
TCGA-IB-A5SP,"Note: If you do not see ""END OF PRINTED REPORT"" at the bottom of the last page of. the report YOU DO NOT HAVE THE ENTIRE REPORT Please try printing it again. CONFIDENTIAL. Relevant. Information. Demographics. Date of Birth. (for verification. Sex: M. purposes). Surgical Pathology Rep. Collected Date/Time. Received Date/Time. Specimen Description. A. Mesenteric nodule DV at. B. Gallbladder at. c. Node of importance DV at. D. Whipple's specimen devitalized at. Clinical Information. Likely pancreatic cancer. Diagnosis. A. Mesencerio Nodule, Biopsy: Fibrous tissue, negative for maliganncy. B. Gallbladder, Choleaystectomy: Chronic cholecystitis. C. Lymph Node (Nods of Importance), Excision: 1 lymph node, negative for malignancy (0/1). D. Pancreas and Duodenum, Whipple Resection: Invasive moderately-differentiated ductal adenocarcinoma (see. Synoptic Report). Pancreatic intraepithel:al neoplasia (Pan1N), grade 3/3. Extrapancreatic extension with perineural invasion involving groove. and partial resected wall of superior mesenterio vein with positive. pancreatic uncinate margin (see Comment). 14 lymph nodes, negative for malignancy (0/14). Synoptic Report. D: Pancreas (Exocrine), Microscopic. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades peripancreatic soft tissues. Tumor invades retroperitoneal soft tissue. MARGING: Margin(3) involved by invasive carcinoma. Uncinate procese (retroperitoneal) margin (nonperatonealized surface of the uncinate. process). LYMPH-VASCULAP. INVASION: Not identified. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteria artery. REGIONAL LYMPH NODES (pN) : pNO: No regional lymph node metastasis. Number examined: 15. Number involved: o. ADDITIONAL PATHOLOGIC FINDINGS: Pancreatic intraepithelial neoplasia (highest grade: PanIN 3. D: Pancreas (Exccrine), Macroscopic. SPECIMEN: Head of pancreas. Duodenum. Gallbladder. Adjacent large vessels. Superior mesenterio vein. PROCEDURE: Panereaticoduodenectomy (Whipple resection), partial pancreatectomy. TUMOR SITE: Pancreatic head. PUMOR SIZE: Greatest dimension: 3 em. Gross Description. Received are specimens A to D. ALL requisition3 and specimen containers are labelled. with the patient's name. The cassettes and AP identifiers are labelled. with the Surgical Number. A. One fragment of tan tissue 0.8 x 0.3 x 0.2 cm, submitted entirely for FS. B. The specimen consists of a cholecystectomy specimen (9.0 2 4.5 x 2.2 cm). The. overlying mesentery is unremarkable. The subhepatic roughened area is hemorrhagic, but. otherwise unremarkable. Gallbladder wall measures 0.5 cm in maximum thickness and is. otherwise unremarkable. The nucosa is roughened, but grossly unremarkable. The. gallbladder contains some mucoid bile, but is otherwise unremarkable. Representative. sections are submitted in cassette B1. one lymph node, 1.3 em in greatest dimension. Bisected and submitted entirely for. FS. D. The specimen consists of a length of stomach (4.5 x 6.0 cm in circumference), small. bowel (23.0 cm in length and up to 6.5 cm in diameter), and attached pancreas and. peripancreatic tissue (4.0 x 5.0 x 4.3 cm). Both the bile duct and pancreatic duct are. grossly dilated. At 0.5 em inferior to the pancreatic duct margin there is a 2.0 cm. length of what appears to be a partial wall of a blood vessel within pancreatic groove. The common bile duct LS patent to the ampulla. The pancreatic duat is patent only to 2.5. cm distally before it is occluded. Upon sectioning of the pancreas, there is a poorly. defined fibrous white mass measuring 2.5 x 2.0 x. 3.0 cm. It completely surrounds. the. pancreatic duct and abuts the bile duct. Grossly abuts the black painted pancreatic. groove and blue painted retroperitoneal margin. The remaining surrounding soft tissue. is. grossly unremarkable. Representative sections are submitted as follows: D1. pancreatic resection margin. D2. bile duct margin. D3. tumor to black painted pancreatic margin and pancreatic duct. D4. tumor to vessel in groove. tumor to pancreatic margin. D7. tumpr abutting bile duct and bile duct margin. D8. tumor surrounding pancreatic tissue. D9-10. tumor to blue painted etroperitoneal margin. D11. normal pancreas. D12. one lymph node bisected. D13. two lymph nodes. D14. one lymph node bisected. D15. three lymph nodes. D16. three lymph nodes. IC/csh. Frozen Section Diagnosis. A. Mesenteric Nodule: Benign fibrous tissue only. Negative for malignancy. Cont #. Node of Importance: Negative for malignancy. Pathologism Comment. Tamor willh perineural extension is seen surrounding the partially resected superior. mesenteric vein and involving the soft tissue painted margin surrounding the vein and. incinate Tretroperitoneal uncinate margin positive for malignancy). Number. Encounter. Number. - END OF PRINTED REPORT -. Triterna. Giagnosi, Ciscrepancy. Turnar Sire Discrepancy. any. isses !circlei: ( lewer Ir: Gals.",T3,N0,M0,T3N0M0
TCGA-56-A4ZJ,"Pre-Op Diagnosis. Right lower lobe squamous cell cancer. Post-Op Diagnosis. Same as above. Clinical History. Nothing indicated. Gross Description: Four parts. Received in formalin labeled "". 1 - level 9 lymph. node right lung"" is a 1.1 x 0.8 x 0.3 cm irregular black soft tissue. consistent with probable lymph node, which is bisected and submitted. in its entirety in one cassette. Received in formalin labeled. 2 - level 10 lymph. node right lung"" are three irregular granular black soft tissues. consistent with probable lymph node ranging from 0.5 x 0.4 x 0.2 cm. to 1.1 x 0.7 x 0.3 cm, which are submitted in toto in one cassette. Received labeled. 3 - right lower lung lobe"" is a. 185 gram, 19.4 x 10.5 x 3.2 cm lower lung lobe with an attached 0.8. cm segment of bronchus. The pleura is smooth to wrinkled and. tan-pink to gray-purple with black anthracotic areas. There is a 3.1. cm linear staple line adjacent to the hilum. No additional. parenchymal staple lines are identified. There is a 1.4 x 1.1 cm. slightly ill-defined umbilicated area of pleura 2.2 cm from the. hilum. The cut surface of this area consists of a 1.8 x 1.5 x 1.2 cm. well circumscribed tan nodule, 3.4 cm from the bronchial margin and. 3.8 cm from the staple line. The remainder of the cut surface. consists of spongy tan-red parenchyma. There are two tan-white. nodules measuring 0.1 cm and 0.2 cm in greatest dimension which abut. the pleura near the periphery of the specimen. The nodules are 3.6. cm from each other. No additional parenchymal lesions are. identified. No obvious intraparenchymal or hilar lymph nodes are. identified. The specimen is inked, serially sectioned and. representative sections are submitted as labeled: A - bronchial and. vascular margins (en face) ; B - pleural margin (perpendicular) i C-F. - lesion, entirely submitted; G - larger nodule, entirely submitted;. H - smaller nodule, in toto. Also received in the same container is. a blue, yellow and green cassette labeled. genomic. research study. Received in formalin labeled. 4 - level 4 lymph. node right lung"" is a 2.8 x 1.7 x 0.5 cm irregular fibroadipose. tissue bearing three irregular black firm tissues consistent with. probable lymph node ranging from 1.1 x 0.5 x 0.3 cm to 1.2 x 0.8 x. 0.5 cm. The specimen is sectioned and representative sections are. submitted, to include the lymph nodes in their entirety, as labeled: A-C - one lymph node, bisected in each. Microscopic Description: See diagnosis. Final Diagnosis. Lymph node, right lung, level 9, excision: Reactive hyperplasia, negative for malignancy, one node. Lymph node, right lung, level 10, excision: Reactive hyperplasia, negative for malignancy, three nodes. Lung, right lower lobe, lobectomy: Tumor characteristics: Specimen integrity: Intact, margins can be evaluated. Specimen laterality: Right side. Histologic type: Squamous cell carcinoma, non-keratinizing. Histologic grade: 2 (moderately differentiated). Tumor site: Right lower lobe. Tumor focality: Unifocal. Tumor size: 1.8 x 1.5 x 1.2 cm. Visceral pleural invasion: Not identified. Lymphovascular space invasion: Not identified. Tumor extension: Not identified. Treatment effect: Not identified (no specific history provided). Surgical margin status: Tumor distance from bronchial margin: 3.4 cm. Tumor distance from stapled margin: 3.8 cm. Tumor distance from pleural surface: 0.1 cm. Lymph node status: Total number of lymph nodes received (includes all four parts of. this case) : 10. Total number of lymph nodes containing metastatic carcinoma: 0. Other significant findings: Two small subpleural fibrous nodules are present consistent with. areas of scarring. pTN stage: pTla, NO PAS 9 SPC-NP. Comments. The history of ""back lower lobe squamous cell carcinoma"" is noted. There is however no prior material identified in our files for. review and comparison. The two small subpleural nodules identified grossly, separate from. the malignancy, are both areas of fibrosis containing some. histiocytes and reactive alveolar lining cells, possibly. representing areas of resold pneumonia. At the request of the undersigned pathologist, these slides have. been additionally reviewed by Dr. who concurs with the. diagnosis.",T1,N0,M0,T1N0M0
TCGA-W5-AA2Q,"Male. Surgery Date: DIAGNOSIS: Liver left lobe, hepatectomy: Intrahepatic cholangiocarcinoma, grade 2 (of 4), is. identified forming a multinodular, discrete, firm mass (12.3 X 11.5 x 10.0 cm). occupying the majority of the resected left hepatic lobe with extension to the. attached caudate lobe. A single satellite tumor is identified in the dome of the. liver and forms a 0.8 cm diameter tumor. The margins of resection are negative for. tumor. The carcinoma is 0.1 cm from the parenchymal resection margin as well as 0.2. cm from the bile duct margin. The. hepatic vein and portal vein margins are negative for tumor. A single hilar. lymph. node is negative for tumor. The non-neoplastic liver will be assessed on permanent. section and reported as an addendum. Gallbladder, cholecystectomy Mild chronic cholecystitis. gallstones are. identified. The pericystic duct lymph node is negative for tumor. Lymph nodes, hepatoduodenal, excision: Multiple (24) hepatoduodenal lymph nodes are. negative for tumor. Lymph nodes, para-aortic, excision: Multiple (3) para-aortic lymph nodes are. negative for tumor.",T2,N0,M0,T2N0M0
TCGA-86-8585,"Gross Description. Case ID. Lung lobe with the tumor of up to 3.5 X 3 cm in. its size. Hilar lymph nodes are soft, hyperemic. Microscopic Description. Diagnosis Details. Adenocarcinoma of the lung with solid type of. Tumor Features: Unknown, Tumor Extent: qrowth, G-3. Seven examined hilar lymph. Localized, NOS, Venous Invasion: Absent,. nodes demonstrated reactive changes. Margins: Absent, Treatment Effect: Comments. LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 3 X 0 X 3.5 cm. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 0/7 positive for metastasis. (Hilar peribronchial lymph nodes 0/7). Lymphatic invasion: Not specified. Venous invasion: Absent. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: Left- upper.",T2,N0,M0,T2N0M0
TCGA-E9-A22G,Laterality:Left upper outer quadrant. Path Report:BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 3.5x3x3cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Lymph nodes: 0/6 positive for metastasis (Regional 0/6). Extracapsular invasion of the lymph nodes: Not specified. Margins: Not specified. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,T2,N0,M0,T2N0M0
TCGA-IB-7890,"ORIGINAL REPORT. SPECIMEN: A: Distal pancreas and spleen. B: Gallbladder. CLINICAL HISTORY: Pancreatic cancer. DIAGNOSIS: A: PANCREAS, DISTAL: - INVASIVE POORLY DIFFERENTTATED DUCTAL ADENOCARCINOMA (2.8 CM). - RESECTION MARGINS NEGATIVE FOR MALIGNANCY. - LYMPHVASCULAR (VENOUS) INVASION BY TUMOR,. - 11/11 LYMPH NODES, NEGATIVE FOR MALIGNANCY. - POSITIVE FOR PERINEURAL INVASION. SPLEEN: - WITHIN NORMAL LIMITS. OMENTUM: - ACCESSORY SPLENULE IDENTIFIED,. B: GALLBLADDER, CHOLECYSTECTOMY: - CHOLELITHIASIS. - INTESTINAL METAPLASIA WITHOUT DYSPLASTA. GROSS DESCRIPTION: A: The specimen consists of pancreatic tail (5.0 cm in length x 4.5 x 2.2. cm), spleen (9.9 x 8.8 x 5.5 cm) , and attached portion of fatty tissue (19.5. x. 10.5 x 3.8 cm) The entire specimen is painted with silver nitrate. The. proximal pancreatic resection margin is painted blue. On cut section of the pancreas, there is white, firm, fibrotic tumor measuring. 2.8 x 2.5 x 1.5 cm in width. The tumor is located 1.3 cm from the surgical. HISTOPATHOLOGY REPORT. Division Head. GROSS DESCRIPTION: pancreatic resection margin, 1.1 Cm from the superior resection margin, 1.1 an. from the inferior soft tissue resection margin, and 0.6 cm from the the. posterior soft tissue resection margin. The tumor is abutting but not. involving the splenic vein. The tumor does not extend into the splenic hilum. soft tissue. The splenic tissue is unremarkable. Upon the attached omental. fat, there is a 0.6 6 cm attached splenule. The remaining fatty tissue is. grossly unremarkable. The specimen is submitted as follows: Al and A2 - painted blue resection margin. A3 - vascular margins,. A4 - tumor and closest superior margin. A5 - tumor and closest posterior margin. A6 - tumor and closest inferior margin. A7 through A9 - representative sections of tumor. A10 - representative section of spleen. A11 .. splenule bisected,. A12 - thrombosed vessel in splenic hilum. A13 - normal appearing pancreas. A14 - potential Jymph node (hilar spleen) . A15 - four putative lymph nodes. A16-19, additional lymph nodes. B: The specimen consists of a cholecystectomy specimen (9.1 cm in length and. up to 4.5 cm in diameter) The entire specimen is painted with silver. nitrate. The outer surface of the gallbladder is smooth and unremarkable. The. lumen contains enumerable numbers of yellow cholesterol stones with. hemorrhagic centers ranging in size between 1.0 cm and 0.: cm. The. gallbladder wall is thin (measuring 0.1 em in greatest thickness) and. attenuated. Representative sections of the gallbladder wall and resection margin are. submitted in cassette B. MICROSCOPIC DESCRIPTION: Sections of pancreas demonstrate a pancreatic intraductal neoplasia of low. grade dysplasia (panIN 1) that extends to resection margin. HISTOPATHOLOGY REPORT. Division Head. RESIDENT:",T2,N0,M0,T2N0M0
TCGA-AZ-4616,"OMENTUM, RIGHT HEMICOLECTOMY. RENTATED ADENOCARCINOMA OF THE CECUM (6.5 CM). THE MUSCULARIS PROPRIA INTO PERICECAL FAT WITH MULTIPLE ISOLATED. SEROSAL INVASION IS IDENTIFIED. PRESENT AT THE RADIAL PERICECAL SOFT TISSUE MARGIN AND INTRAVASCULAR TUMOR IS. ATHEPROXIMAL MESENTERIC MARGIN (see comment). IEANGIOLYMPHATIC, VASCULAR, AND PERINEURAL INVASION. SOT. ANEDFOCI OF METASTATIC ADENOCARCINOMA ARE PRESENT ON THE SURFACE OF THE OMENTUM. NITHINTTE MUSCULARIS PROPRIA OF THE TERMINAL ILEUM. (MALILEUM AND DISTAL COLON MARGINS OF RESECTION ARE FREE OF CARCINOMA. G. METASTATIC ADENOCARCINOMA IN THIRTEEN OF TWENTY-THREE LYMPH NODES (13/23). H. SEPARATE TUBULAR ADENOMA. I. PATHOLOGIC STAGE: pT3c/d N2 M1. J. APPENDIX NOT IDENTIFIED. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY COLON, RECTAL, APPENDIX TUMORS. SPECIMEN TYPE: Right hemicolectomy. SPECIMEN LENGTH: 40 cm. TUMOR SITE: Cecum. TUMOR CONFIGURATION: Infiltrative. TUMOR SIZE: Greatest dimension: 6.5 cm. Additional dimensions: 6.0 x 5.5 cm. INTACTNESS OF MESORECTUM: Not applicable. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIO GRADE: High-grade (poorly differentiated to undifferentiated). PATHOLOGIC STAGING (pTNM): pT3c/d. pN2. Number of nodes examined: 23. Number of nodes involved: 13. pM1. Site(s): omentum, muscularis propria of ileum. Treatment: Untreated. MARGINS: Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (radial) margin involved by invasive carcinoma (tumor present 0-1 mm. from CRM). Mesenteric margin involved by invasive carcinoma. ANGIOLYMPHATIC INVASION: Present. PERINEURAL INVASION: Present. TUMOR BORDER CONFIGURATION: Infiltrating. ADDITIONAL TUMOR CHARACTERISTICS: None. ADDITIONAL PATH FINDINGS (check all that apply): Adenoma(s).",T3,N2,M1,T3N2M1
TCGA-E7-A85H,"Gross Description: Tumor occupies bladder wall. It is invasive and protruded, ill - margins with. 2x1.5x1.2cm in size, soft and gray surface. Microscopic Description: Tumor cells are hyperplastic to arrange to form sheets or nest or groups or. cords one by one. Tumor cells have moderate and eosinophilic. Nuclei are very enlarged and varriability. in shape and size, irregular nuclear membranes, nucleoli and abnormal chromatin patterns. Mitoses are. common. Tumor invades in musculari propria and vessel. Diagnosis Details: Infiltrating urothelial carcinoma, high-grade, infiltrating in one half of muscularis. propria. Comments: Reports: BLADDER TISSUE CHECKLIST Carcenoma urothelial NOS 8120/3. Specimen type: Cystectomy. Tumor site: Bladder. Tumor size: 2 X 1.5x1.2 cm. Tumor features: None specified. Histologic type: Transitional cell carcinoma. qut 0/5/14. Histologic grade: Poorly differentiated. Tumor extent: Muscularis propria. Lymph nodes: 0/2 positive for metastasis (Inguinal lymph node 0/2). Lymphatic invasion: Not specified. Venous invasion: Present. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: Focal extracapsular extension (bladder wall, vessel). Comments: None. lw 10/24/13 Yes.",T3,N0,M0,T3N0M0
TCGA-B0-5092,"AL DIAGNOSIS. NEY, LEFT, NEPHRECTOMY -. A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR CELL) TYPE WITH EXTENSIVE MYXOID CHANGES. B. FUHRMAN NUCLEAR GRADE IS III OF IV. C. THE GREATEST DIAMETER OF THE NEOPLASM IS 3.8 cm. D. THE NEOPLASM IS CONFINED WITHIN THE RENAL CAPSULE. E. NO INVASION OF THE RENAL VEIN IS IDENTIFIED. F. NO EVIDENCE OF ANGIOLYMPHATIC INVASION IS IDENTIFIED. G. ALL SURGICAL MARGINS ARE FREE OF THE NEOPLASM. H. THE NON-NEOPLASTIC ADJACENT KIDNEY SHOWS FEATURES DUE TO PROXIMITY THE TUMOR. I. TNM STAGE: pT1a NX MX.",T1,N0,M1,T1N0M1
TCGA-AR-A24H,"Final Diagnosis. Breast, right, excision: Invasive lobular carcinoma, Nottingham II (of. III), forming a 2.8 x 2.6 6 x 2 cm mass (AJCCpt2) No lymphovascular. involvement or carcinoma in situ component is identified. The surgical. resection margins, after one re-excision are negative for tumor. The. uninvolved breast tissue shows duct ectasia and stromal fibrosis. Lymph node, right axilla, sentinel, excision: A single right sentinel. lymph node is negative for tumor. Lymph nodes, right axilla, excision: Multiple (3) right axillary lymph. nodes are negative for tumor. Staining for estrogen and progesterone receptors is positive.",T2,N0,M0,T2N0M0
TCGA-73-7498,"SPECIMENS: A. 4R RIGHT PARATRACHEAL LYMPH NODE. B. LEVEL 7 LYMPH NODE. C. RIGHT LOWER LOBE WEDGE. D. LEVEL 8 LYMPH NODE. E. LEVEL 9 LYMPH NODE. F. RIGHT LOWER LOBE. SPECIMEN(S): A. 4R RIGHT PARATRACHEAL LYMPH NODE. B. LEVEL 7 LYMPH NODE. C. RIGHT LOWER LOBE WEDGE. D. LEVEL 8 LYMPH NODE. E. LEVEL 9 LYMPH NODE. F. RIGHT LOWER LOBE. INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA, Lymph node, 4R right paratracheal, biopsy: Negative for malignancy. FSB, Lymph node, level 7, biopsy: Negative for malignancy. FSC, Lung, right lower lobe, wedge biopsy: Positive for malignancy non-small cell carcinoma, favor. adenocarcinoma, diagnoses called at. and. FSF, lung, right lower, lobectomy: Bronchial margin negative for malignancy, diagnosis called at. DIAGNOSIS: A. LYMPH NODE, RIGHT PARATRACHEAL - 4R, EXCISION: - NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). B. LYMPH NODE, LEVEL 7, EXCISION: - NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). C. LUNG, RIGHT LOWER LOBE, WEDGE RESECTION: ADENOCARCINOMA, MODERATELY DIFFERENTIATED WITH BRONCHIOLOALVEOLAR. FEATURES. - 2.5 CM IN GREATEST DIMENSION. - 1.8 X 1.0 CM IN ADDITIONAL DIMENSIONS. - THE PLEURAL SURFACE IS NEGATIVE FOR TUMOR. - NO ANGIOLYMPHATIC INVASION IDENTIFIED. - MILD EMPHYSEMATOUS CHANGES. D. LYMPH NODE, LEVEL 8, EXCISION: - NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). E. LYMPH NODE, LEVEL 9, EXCISION: - NO MALIGNANCY IDENTIFIED IN ONE LYMPH NODE (0/1). F. LUNG, RIGHT LOWER LOBE, COMPLETION LOBECTOMY: - SEPARATE MICROSCOPIC FOCUS OF ADENOCARCINOMA, BRONCHIOLOALVEOLAR TYPE. - 0.9 CM IN GREATEST DIMENSION (MEASURED MICROSCOPICALLY). - THE PLEURAL SURFACE IS NEGATIVE FOR TUMOR. - THE BRONCHIAL MARGIN IS NEGATIVE FOR TUMOR. - NO ANGIOLYMPHATIC INVASION IDENTIFIED. - PLEURAL PLAQUE. - NO MALIGNANCY IDENTIFIED IN TWO LYMPH NODES (0/2). - MILD EMPHYSEMATOUS CHANGES. COMMENT: Two tumors are identified. The tumor in part C was identified grossly, and the tumor in part. F was only identified microscopically. These tumors are consistent with synchronous primary tumors,. and the tumor in part C will be used for the synoptic report. This case was shown to. and he agrees. SYNOPTIC REPORT - LUNG. Specimens Involved. Specimens: C: RIGHT LOWER LOBE WEDGE. Surgical Procedure: Lobectomy. Laterality: Right. Tumor Site: Lower lobe. Tumor Location: Peripheral. Tumor Size: Greatest diameter: 2.5cm. Additional dimensions: 1.8cm X 1cm. WHO CLASSIFICATION. Adenocarcinoma. Histologic Grade: G2: Moderately differentiated. Angiolymphatic Invasion: Absent. Bronchial Margins: Bronchial margins uninvolved. Visceral Pleural Involvement: Absent. Satellite Tumor(s). Absent. Lymph Node Involvement: N1: Ipsilateral Hilar and/or Peribronchial (levels 10-14). Negative 0/2. N2: Ipsilateral Mediastinal and/or Subcarinal (Levels 1-9). Negative 0/4. N3: Contralateral Mediastinal/Hilar, Scalene or Supraclavicular. N/A. Non-Neoplastic Lung: Emphysematous changes. Additional Pathologic Findings: None identified. Pathological Staging (pTNM): pT 1b. N 0. M X. Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition. GROSS DESCRIPTION: A. 4R RIGHT PARATRACHEAL LYMPH NODE. Received fresh labeled with the patient's identification and designated ""4R right paratracheal lymph. node"" is a fragment of tan-pink to anthracotic soft tissue measuring 1 X 0.5 and 0.2-cm. Specimen is. bisected. Touch preparation performed. Submitted entirely for frozen section, FSA. B. LEVEL 7 LYMPH NODE. Received fresh labeled with the patient's identification and designated ""level 7 lymph node"" is a. fragment of tan-pink soft tissue measuring 0.7 X 0.5 X 0.2 cm. Specimen is bisected. Touch. preparation performed. Submitted entirely for frozen section, FSB. C. RIGHT LOWER LOBE WEDGE. Received fresh labeled with the patient's identification and designated ""right lower lobe wedge"" is a. stapled wedge of lung tissue weighing 15 g and measuring 6.5 X 3 X 2 cm. The pleural surface inked. black, staple line inked blue. Sectioning shows a firm ill-defined tan mass measuring 2.5 X 1.8 x 1 cm,. located 0.5-cm from the stapled margin. A portion of the specimen is submitted for tissue procurement. The specimen representatively submitted: FSC1: Mass, frozen section sample. C2: Remainder of mass and pleural surface. C3: Uninvolved lung parenchyma. D. LEVEL 8 LYMPH NODE. Received in formalin labeled with the patient's identification and designated ""level 8 lymph node"" is a. fragment of yellow-tan soft tissue measuring 0.6 X 0.3 X 0.2 cm. Entirely submitted, D1. E. LEVEL 9 LYMPH NODE. Received in formalin labeled with the patient's identification and designated ""level 9 lymph node"" is a. fragment of red-tan soft tissue measuring 0.8 X 0.5 X 0.2 cm. Entirely submitted, E1. F. RIGHT LOWER LOBE. Received fresh labeled with the patient's identification and designated ""right lower lobe"" it the resected. lobectomy specimen weighing 182 g and measuring 13.5 X 11 X 3 cm. The pleural surface. demonstrates two 0.3-cm plaque like areas, both located approximately 4-cm from the bronchial margin. Sectioning shows deep red consolidated lung parenchyma. No lesions or nodules are grossly. appreciated. A portion of the specimen is submitted for tissue procurement. The specimen. is. representatively submitted: FSF1: Shaved bronchial margin. F2: Plaque like areas, entirely submitted. F3: Possible peribronchial lymph nodes. F4-F5: Random sections lung parenchyma. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Right lower lobe lung nodule.",T1,N0,M0,T1N0M0
TCGA-3H-AB3K,"DIAGNOSIS. (A) LYMPH NODE, STATION 7, BIOPSY: Negative for tumor. (B) PLEURA, RIGHT, BIOPSY: ATYPICAL MESOTHELIAL PROLIFERATION, FAVOR MALIGNANT MESOTHELIOMA. Immunohistochemical studies show positive staining for calretinin and keratin 5/6 while negative for CEA and MOC-31. GROSS DESCRIPTION. (A) STATION 7 LYMPH NODE - Received is one possible lymph node (0.4 x 0.4 x 0.3 cm). Entirely submitted in A, for frozen. section evaluation. FS/DX: ONE LYMPH NODE, NO TUMOR PRESENT. (B) PLEURAL BIOPSY, RIGHT SIDE - Three fragments of white-tan-yellow soft tissue (0.4 X 0.4 X 0.3 cm each). Entirely. submitted in B. CLINICAL HISTORY. Mesothelioma. SNOMED CODES. T-29000, M-90503. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: END OF REPORT----.",T2,N0,M0,T2N0M0
TCGA-KL-8338,"Clinical Diagnosis & History: y/o male with large left renal mass found incidentally. Left radical nephrectomy today. Specimens Submitted: 1: SP: kidney, left, radical nephrectomy. 2: SP: lymph nodes, left periaortic, excision. 3: SP: lymph nodes, left hilar, excision. DIAGNOSIS: 1. SP: kidney, left, radical nephrectomy. Tumor Type: Renal cell carcinoma - Chromophobe type. Tumor Size: Greatest diameter is 12.5 cm. Local Invasion (for renal cortical types): Involves renal sinus fat. Renal Vein Invasion: Not identified. Vessels with muscular wall are involved by tumor in the renal sinus. Surgical Margins: Free of tumor. Non-Neoplastic Kidney: Unremarkable. Adrenal Gland: Not identified. Lymph Nodes: Not identified. Staging for renal cell carcinoma/oncocytoma: pT3a Tumor invades the adrenal gland or perinephric tissues but not beyond Gerota's fascia. 2. SP: lymph nodes, left periaortic, excision. Lymph Nodes: Number of nodes examined:5. Number of metastatic nodes:0. 3. SP: lymph nodes, left hilar, excision. Lymph Nodes: Number of nodes examined:1. Number of metastatic nodes:0. Unremarkable ectopic adrenal tissue. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh labeled ""left kidney"" and consists of a kidney with attached ureter, renal vessels and perinephric. fat weighing 1100 g in total. The kidney measures 15.0 X 11.0: 7.0 cm. The attached ureter measures 7.0 cm in length and 0.2. cm in diameter. The attached renal vein measures 1.0 cm in length and 0.5 cm in diameter. The renal vessels and ureter margins. are grossly unremarkable. An adrenal gland is not identified. The kidney is inked black and bivalved to reveal a 12.5 X 10.0 X 7.0. cm cortical mass located in the mid portion of the kidney. The cut surface of the mass is tan, hemorrhagic and necrotic. The. mass invades the Gerota's fascia grossly but does not invade the renal pelvis Sections through the remainder of the kidney. reveal a pink brown parenchyma, with a well-defined corticomedullary junction. The cortex measures 0.5 cm and the calyces. appear normal. No lymph nodes identified. Representative sections are submitted for TPS and for permanent sections. Photograph has been taken. Summary of sections: UVM -- ureteral and vessel margins. T-- tumor. THF tumor with hilar fat. TSF -- tumor with sinus fat. TK -- tumor with adjacent kidney. U -- ureter representative sections. K -- representative sections of kidney. TG -tumor with capsule. 2). The specimen is received in formalin, labeled ""left periaortic lymph node"" and consists of multiple pink tan firm lymph nodes. ranging from 0.5 to 2.0 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN -- lymph nodes. 3). The specimen is received in formalin, labeled ""left hilar lymph node"" and consists of 1.0: x 1.0 X 0.5 cm portion of adipose tissue. No lymph node identified. Entirely submitted. Summary of sections: U- undesignated. Summary of Sections: Part 1: SP: kidney, left, radical nephrectomy. Block. Sect. Site. PCs. 2. k. 2. 7. t. 7. 4. tg. 4. 1. thf. 1. 2. tk. 2. 2. tsf. 2. 1. u. 1. 1. uvm. 1. Part 2: SP: lymph nodes, left periaortic, excision. Block. Sect. Site. PCs. 3. In. 3. Part 3: SP: lymph nodes, left hilar, excision. Block. Sect. Site. PCs. 1. u. 1.",T3,N0,M0,T3N0M0
TCGA-IN-A6RN,"FINAL DIAGNOSIS: PART 1: LIVER, LEFT LATERAL SEGMENT, BIOPSY -. A. SUBCAPSULAR LIVER BIOPSY WITH FOCAL FIBROSIS AND BILE DUCTULAR PROLIFERATION. B. THERE IS NO EVIDENCE OF MALIGNANCY. PART 2: LYMPH NODE, LEFT GASTRIC TISSUE, RESECTION -. METASTATIC ADENOCARCINOMA TO ONE OF TWO LYMPH NODES (1/2) CONFIRMED USING. IMMUNOHISTOCHEMICAL STAIN TO AE1/3. PART 3: LYMPH NODE, LEVEL 7, RESECTION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE ANTHRACOTIC LYMPH NODE (0/1). PART 4: LYMPH NODE, PARAESOPHAGEAL NEAR PERICARDIUM, RESECTION -. A. NERVE AND FIBROADIPOSE TISSUE. B. THERE IS NO EVIDENCE OF MALIGNANCY. PART 5: ESOPHAGUS AND STOMACH, ESOPHAGOGASTRECTOMY -. A. ADENOCARCINOMA, MODERATELY DIFFERENTIATED (2.0 CM) CENTERED IN PROXIMAL GASTRIC MUCOSA,. INVOLVING GE JUNCTION SQUAMOUS MUCOSA AND EXTENDING INTO BUT NOT THROUGH SUBMUCOSA. B. LYMPHOVASCULAR INVASION PRESENT. C. PERINEURAL INVASION NOT IDENTIFIED. D. METASTATIC ADENOCARCINOMA INVOLVING FOUR OF FIFTEEN LYMPH NODES (4/15). E. SURGICAL MARGINS (PROXIMAL, DISTAL AND ADVENTITIAL) NEGATIVE FOR MALIGNANCY. F. PATHOLOGIC STAGE - pT1b N2 (see synoptic note). G. NON-TUMOROUS GE JUNCTION MUCOSA WITH BARRETT'S ESOPHAGUS. H. NEGATIVE HER2 (1+) STAINING, SEE COMMENT. PART 6: LYMPH NODE, PERIGASTRIC, RESECTION -. METASTATIC ADENOCARCINOMA TO ONE LYMPH NODE (1/1). PART 7: LYMPH NODE, UPPER PARAESOPHAGEAL, RESECTION -. A. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). B. MNCKEBERG'S ARTERIOSCLEROSIS. PART 8: LYMPH NODE, MID PARAESOPHAGEAL, RESECTION-. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 9: LYMPH NODE, PROXIMAL PARAESOPHAGEAL, RESECTION -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 10: LYMPH NODE, SUBCARINAL, LEVEL VII, RESECTION - -. THERE IS NO EVIDENCE OF MALIGNANCY IN ONE LYMPH NODE (0/1). PART 11: LYMPH NODE, GASTRIC FAT, RESECTION -. METASTATIC ADENOCARCINOMA TO ONE OUT OF TWO LYMPH NODES (1/2) WITH EXTRANODAL. LYMPHOVASCULAR INVASION PRESENT. PART 12: LYMPH NODE, GASTROESOPHAGEAL FAT, RESECTION -. METASTATIC ADENOCARCINOMA TO TWO OUT OF FIVE LYMPH NODES (2/5) WITH EXTRANODAL. LYMPHOVASCULAR INVASION IDENTIFIED. PART 13: ESOPHAGUS AND STOMACH, EEA RINGS, RESECTION -. A. SEGMENT OF ESOPHAGEAL WALL WITH UNREMARKABLE SQUAMOUS MUCOSA. B. SEGMENT OF GASTRIC WALL WITH REACTIVE OXYNTIC MUCOSA. C. THERE IS NO EVIDENCE OF MALIGNANCY. PART 14: STOMACH, FINAL GASTRIC MARGIN, RESECTION -. A. GASTRIC WALL WITH REACTIVE OXYNTIC MUCOSA. B. THERE IS NO EVIDENCE OF MALIGNANCY. COMMENT: Part 5. Esophagus and stomach, esophagogastrectomy -. This morphology of the similar to previous adenocarcinoma seen in Part one of the gastrocardiac retroflex. blopsy. from. Slides 5G and 5E and Immunohistochemical stain to HER2 were revlewed at. at. on. All agreed that HER2 is negative with 1+ staining,. defined by some membranous reactivity In >10% of cells. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY ESOPHAGEAL TUMORS. MACROSCOPIC. SPECIMEN TYPE: Esophagogastrectomy. TUMOR SITE: Tumor midpoint in proximal stomach or cardia (within 5cm of EGJ) AND tumor. involves esophagogastric junction. TUMOR SIZE: Greatest dimension: 2.0 cm. Additional dimensions: 1.5 X0.3 cm. MICROSCOPIC. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G2. PATHOLOGIC STAGING (pTNM). pT1b. pN2. Number of lymph nodes examined: 15. Number of lymph nodes involved: 5. pM Not applicable. PRIOR TREATMENT: No prior treatment. MARGINS. Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (adventitial) margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 0.5 mm. Specify margin: adeventitial margin. ANGIOLYMPHATIC INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: Intestinal metaplasia (Barrett's esophagus).",T1,N2,M0,T1N2M0
TCGA-BP-4330,"Clinical Diagnosis & History: Left renal mass. Specimens Submitted: 1: SP: Left kidney and adrenal gland. 2: SP: Superhilar periaortic lymph node. 3: SP: Para-aortic lymph node. DIAGNOSIS: 1). KIDNEY, LEFT; RADICAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CLEAR CELL TYPE, NUCLEAR GRADE. II/IV. THE PATTERN OF GROWTH IS ACINAR. THE TUMOR GREATEST. DIAMETER IS 12.0 CM. THE TUMOR EXTENDS THROUGH THE RENAL. CAPSULE BUT IS CONFINED WITHIN GEROTA'S FASCIA. NO INVASION. OF THE RENAL VEIN IS IDENTIFIED. ALL SURGICAL MARGINS ARE. FREE OF TUMOR. THE NON-NEOPLASTIC KIDNEY SHOWS A SINGLE. CYST, 2.0 CM IN GREATEST DIMENSION. THE ADRENAL GLAND IS. UNREMARKABLE. 2). LYMPH NODE, SUPERHILAR PERIAORTIC; EXCISION: - THREE LYMPH NODES, NEGATIVE FOR TUMOR (0/3) . 3). LYMPH NODE, PARA-AORTIC; EXCISION: - TEN LYMPH NODES, NEGATIVE FOR TUMOR (0/10) (SEE NOTE). NOTE: SOME OF THE LYMP8 NODES SHOW GRANULOMATOUS LYMPHADENI'TIS. FEW OF THE GRANULOMAS SHOW NECROSIS. SPECIAL STAINS FOR. MICROORGANISMS WILL BE REPORTED AS AN ADDENDUM. A BENIGN. VASCULAR LESION IS IDENTIFIED IN THE PERIRENAL ADIPOSE TISSUE. IMMUNOHISTOCHEMICAL EVALUATION TO FOLLOW,. Gross Description: 1). The specimen is received fresh for frozen section, labeled,. ""Left Kidney and Adrenal Gland"". It consists of a product of a. left radical nephrectomy weighing 1,050 grams and measures 17. 0. cm from superior to inferior, 14.0 cm from medial to lateral and. 8.0 cm from anterior to posterior. The periadrenal adipose. tissue in the superior aspect is serially sectioned to reveal a. adrenal gland which measures approximately 3.5 x 2.0 x 1.5 cm. Serial sectioning reveals unremarkable, cut surfaces. Approximately, 3.0 cm medial to the adrenal gland is a perirenal. lymph node which measures 1.5 x 1.0 x 1.0 cm. The renal vein is. patent, the attached segment of ureter measures approximately. 10.0 cm and is patent throughout. The ureter is opened and. unremarkable. Serial sectioning reveals the mass measures 12.0 x. 11.5 x 8.0 cm. Cut surfaces are yellow-orange and focally. hemorrhagic. Focal area of tan-white, fibrous regions are. identified. In the superior pole is a simple renal cyst which. measures 2.0 cm in greatest dimension. It occupies approximately. 80% of the kidney. The fibrous component represent approximately. 20% of the tumor. Summary of Sections: FSC - frozen section control. A - adrenal. LN - lymph node. UM - ureteral margin. VM - vascular margin. R - representative section. C - cyst. I - tumor. 2). The specimen is received in formalin, labeled, ""Super Hilar. peri-aortic lymph node"". It consists of multiple lymph nodes. measuring 6.0 x 3.0 x 2.0 cm. Multiple possible lymph nodes are. identified. Summary of. Sections: LN - lymph node. LNB - lymph node bisected. 3). The specimen is received in formalin, labeled ""Para-aortic. lymph node"" It consists of an aggregate of lobulated adpose. tissue and possible lymph nodes which measure 6.0 x 3.0 x 3.0 cm. Multiple possible lymph nodes are identified. Summary of Sections: L - lymph nodes intact. LB - lymph node bisected. Histo Stain Results/Comments: Stain/Procedure Name. Comment. MELANOMA-E (HMB-45). NEGATIVE. SMOOTH MUSCLE ACTIN. POSITIVE. CD31. POSITIVE. NEGATIVE CONTROL. IMMUNO RECUT. AFB. PAS-D. METH Ag (GMS). AFB. PAS-D. METH Ag (GMS). Summary of Sections: Part. Sect. SiteBlocks Pieces. All. 1. A. 2. N. C. 1. 2. FSC. 1. 1. LN. 2. R. 1. 1. T. 7. M. UM. 1. 1. VM. 1. 2. 2. LB. M. N. 3. L. 2. M. N. SPECIAL STAINS FOR MICRO-ORGANISMS INCLODING GMS, AFB. AND PAS-D, PERFORMED ON THE NECROTIZING GRANULOMAS, ARE NEGATIVE. THE BENIGN VASCULAR LESION IDENTIFIED ON THE PERINEPHRIC. ADIPOSE TISSUE WAS STAINED WITH CD31, SMA AND HMB-45. THE. LESION IS CD31 AND SMA POSITIVE AND HMB-45 NEGATIVE INDICATING. THAT IT IS AN HEMANGIOMA. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the. intraoperative consultation. 1). FROZEN SECTION DIAGNOSIS: RENAL CORTICAL NEOPLASM. FAVOR. CARCINOMA. PERMANENT DIAGNOSIS: SAME.",T3,N0,M0,T3N0M0
TCGA-A2-A4S0,"Status: DIS-IN. M.D. Specimen: Sp type: SURGICAL P. M.D. PREOPERATIVE DIAGNOSIS. BREAST CA. OPERATION PERFORMED. DOCTOR (S) : PROCEDURE : TOTAL MASTECTOMY; EXCISION OF AXILLARY SENTINEL NODE. TISSUE REMOVED. A. RIGHT BREAST STITCH AT 12 O'CLOCK. B. RIGHT SENTINEL NODE #1. GROSS DESCRIPTION. RECEIVED IN 2 PARTS. A RECEIVED LABELED. RIGHT BREAST STITCH AT 12 O'CLOCK IS. A 2041 SIMPLE MASTECTOMY MEASURING 33.5 CM FROM MEDIAL TO LATERAL, 28 CM. FROM SUPERIOR TO INFERIOR, AND UP TO 5.5 CM FROM ANTERIOR TO POSTERIOR. THE NIPPLE IS INVERTED WITHIN A 31 X 17 CM SKIN ELLIPSE. A SUTURE. DENOTES 12 O'CLOCK. 4 CM LATERAL TO THE NIPPLE AT 9 O'CLOCK IS A. LOBULATED RED-TAN GLISTENING MASS MEASURING 2.2 CM FROM SUPERIOR TO. INFERIOR, 2 CM FROM ANTERIOR TO POSTERIOR, AND 4.5 CM FROM MEDIAL TO. LATERAL. THIS LESION IS 2.5 CM FROM THE DEEP MARGIN. TOWARDS THE. LATERAL EDGE THERE IS A 2ND NODULE ADJACENT BY LESS THAN 1 CM MEASURING. 1 x 1 X 1 CM. THERE IS A RIBBON CLIP ASSOCIATED WITH THIS AREA. THE. REMAINING BREAST TISSUE CONSISTS OF BLAND YELLOW FATTY TISSUE WITH FINE. FIBROUS BANDS. A WING CLIP IS IDENTIFIED IN THE LARGER LESION. REPRESENTATIVE SECTIONS ARE SUBMITTED AS FOLLOWS: A1--NIPPLE, A2--DEEP. MARGIN TO LARGER LESION, A3--THE MOST LATERAL PORTION OF THE LARGER. LESION, A4--THE MOST MEDIAL PORTION OF THE LARGER LESION 4.5 CM FROM A3,. A5 THROUGH A7--ADDITIONAL SECTIONS OF LARGER LESION, A8 AND --SMALLER. SUPERIOR RIBBON CLIP LESION, A10--UPPER INNER QUADRANT 10 CM FROM THE. LESION, All--UPPER OUTER QUADRANT 4 CM FROM LESION, A12--LOWER OUTER. QUADRANT 4 CM FROM LESION, A13--LOWER INNER QUADRANT 10 CM FROM LESION. TISSUE IS TAKEN PER CLINICAL BREAST CARE PROJECT RESEARCH PROTOCOL OF. THE LARGER LESION LABELED P1-p5 WITH FROZEN OCT SAMPLES AS MIRROR IMAGES. TO P1 AND P2. IN ADDITION A MIRROR IMAGE SECTION OF THE NIPPLE (A1) IS. SUBMITTED FROZEN IN OCT ALONG WITH THE 4 RANDOM QUADRANT SECTIONS. Specimen: Sp type: SURGICAL P. D. GROSS DESCRIPTION. A10-A13. B RECEIVED LABELED. RIGHT SENTINEL NODE #1 HOT AND BLUE. COUNT 39252 IS A PORTION OF PINK-TAN TISSUE WITH BLUE COLORATION. MEASURING 1.3 X 0.8 X 0. . 4 CM. THE SPECIMEN IS BISECTED AND SUBMITTED. LABELED B. COMMENT: THIS CASE EXCEEDS THE MAXIMUM CAP/ASCO. GUIDELINE OF 48 HOURS FORMALIN FIXATION. PATH PROCEDURES. PROCEDURES: 88307/2, IMMUNOPEROXIDAS, A BLK/13, BBX X6. FINAL DIAGNOSIS. PART A RIGHT BREAST, SIMPLE MASTECTOMY: 1. Macinous CA 1/1/1. INVASIVE MUCINOUS CARCINOMAS (2) GRADE I WITH NUCLEAR GRADE 1 AND. LOW MITOTIC INDEX. 2. THE TUMORS MEASURE 4.5 AND 1.0 CM IN GREATEST DIMENSION. THE NIPPLE. AND DEEP MARGIN ARE FREE OF NEOPLASM. 3. LYMPHATIC INVASION IS NOT IDENTIFIED. 4. BIOPSY SITE CHANGES WITH CLIPS PRESENT. 5. PROLIFERATIVE FIBROCYSTIC DISEASE WITH CALCIFICATIONS PRESENT. PART B RIGHT SENTINEL NODE 1: LYMPH NODE (1), NEGATIVE FOR TUMOR BY. STEP SECTION AND CYTOKERATIN STAIN. , M.D.",T2,N0,M0,T2N0M0
TCGA-85-6560,LUNG TISSUE CHECKLIST. Specimen type: Pneumonectomy. Tumor site: Lung. Tumor size: 3 X 2.5 X 2 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 2/12 positive for metastasis (Hilar. 2/12). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.,T1,N1,M0,T1N1M0
TCGA-BH-A0BL,"DE #1, BIOPSY -. PLASM (0/1) (see comment). PARI. ODE #2, BIOPSY -. EOPLASM (0/1). PART 3: RIGHICE. ECTOMY AT 11 O'CLOCK -. A. INFILIRAT. OMA, NOTTINGHAM GRADE 3/3 (TUBULE SCORE 3, NUCLEAR GRADE 3,. MITOSIS SCORE3, TOTAL SCORE 9/9) (see comment). B. ALL MARGINS ARE NEGATIVE FOR NEOPLASM. C. TUMOR SIZE IS 1.3 CM IN GREATEST DIMENSION (gross measurement). D. DEFINITE INGIOLYMPHATIC INVASION IS NOT IDENTIFIED. E. BIOPSY SITE CHANGES. F. FIBROCYSTIC CHANGES, COLUMNAR CELL CHANGE, AND PSEUDOANGIOMATOUS STROMAL. HYPERPLASIA (PASH). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Upper outer quadrant. SIZE OF TUMOR: Maximum dimension invasive component: 1.3 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 3. Total Nottingham score: 9. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: Not applicable. CALCIFICATION: SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: LYMPH NODES POSITIVE: Distance of invasive tumor to closest margin: 8 mm. 0. LYMPH NODES EXAMINED: 2. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain, Keratin stain. SENTINEL NODE METASTASIS: NON-NEOPLASTIC BREAST TISSUE: FCD, Other: columnar cell change and PASH. T STAGE, PATHOLOGIC: pT1c. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ESTROGEN RECEPTORS: unknown. PROGESTERONE RECEPTORS: unknown. HER2/NEU: unknown.",T1,N0,M0,T1N0M0
TCGA-IN-A7NR,"FINAL DIAGNOSIS: PART :LIVER, NODULE, EXCISION -. A. NO VIABLE TUMOR CELLS SEEN. B. DEGENERATEDINECROTC NODULE WITH HEMORRHAGE AND FIBRINOUS DEBRIS. PART 2: ESOPHAGUS AND STOMACH AND JEJUNUM, ESOPHAGOGASTRECTOMY. A. INVASIVE POORLY DIFFERENTIATED ADENOCARCINOMA, MEASURING 2.5 CM, INVOLVING. GASTROESOPHAGEAL JUNCTION. B. TUMOR INVADES INTO ADVENTITIAL SOFT TISSUES. C. ALL SURGICAL MARGINS (PROXIMAL, DISTAL AND RADIAL) ARE FREE OF TUMOR. D. EXTENSIVE LYMPHOVASCULAR SPACE PERMEATION PRESENT. E. PERINEURAL INVASION PRESENT. F. METASTATIC ADENOCARCINOMA INVOLVING NINE (9) OF SEVENTEEN (17) REGIONAL LYMPH NODES. WITH EXTRACAPSULAR EXTENSION. G. FOCAL SUTURE GRANULOMA. H. AJCC PATHOLOGIC TUMOR STAGE: pT3 N3 M1. PART 3:LYMPH NODE, JEJUNAL MESENTERIC, BIOPSY -. METASTATIC ADENOCARCINOMA INVOLVING ONE (1) OF ONE (1) LYMPH NODE. PART 4:POSSIBLE JEJUNAL MESENTERY, EXCISION -. METASTATIC ADENOCARCINOMA INVOLVING SEVEN (7) OF SEVEN (7) LYMPH NODES. PART 5:PROXIMAL SMALL BOWEL, RESECTION -. BENIGN SMALL INTESTINAL TISSUE. PART 6: SMALL BOWEL, RESECTION -. BENIGN SMALL INTESTINAL TISSUE. PART 7: FINAL ANASTOMOSIS, EXCISION -. BENIGN ESOPHAGEAL AND SMALL INTESTINAL TISSUE. PART 8:HERNIA SAC, EXCISION -. HERNIA SAC,. COMMENT: Part 1: AFB, PAS and silver stains are negative for acid fast and fungal organisms. Parts 1&2: reviewed select slides and agrees with the Interpretation. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY ESOPHAGEAL TUMORS. MACROSCOPIC. SPECIMEN TYPE: Esophagogastrectomy. TUMOR SITE: Esophagogastric junction (EGJ) region (tumor involves EGJ and epicenter within 5cm. of EGJ). TUMOR SIZE: Greatest dimension: 2.5 cm. Additional dimensions: 1.6 cm. MICROSCOPIC. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: G3. PATHOLOGIC STAGING (pTNM). pT3. pN3. Number of lymph nodes examined: 17. Number of lymph nodes involved: 9. 17 or more regional lymph nodes were identified. pM1. Specify site(s): Jejunal mesenteric lymph nodes. PRIOR TREATMENT: Treatment history not known. MARGINS. Proximal margin uninvolved by invasive carcinoma. Distal margin uninvolved by invasive carcinoma. Circumferential (adventitial) margin uninvolved by invasive carcinoma. ANGIOLYMPHATIC INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: None identified. he 8/20/13 Yes.",T3,N3,M1,T3N3M1
TCGA-66-2734,"Material examined: Left lung and other specimens. Clinical diagnosis and question. Right hilum, left lower lobe. REPORT ON FINDINGS. Macroscopy. 1.) Left lung: In filled, fixed condition, left lung of 16 x 11 cm in size at base and up to 28 cm high, central bronchial. resection line 3 cm proximal to the branch of the upper lobular bronchus. On the hilum, six blackish and partially. damaged nodes of between 0.4 and 2.2 cm in size. The dorsal portion of the gap between the lobes has been largely. obliterated. In this region, covering an area of approx. 9 cm, pleura unclearly delimited and discolored whitish,. thickened, with flat retraction. Below this, with its main mass located in the border regions of segments 6 and 8 - 10, a. moderately solid, pale brownish tumor with unclear demarcation and max. 7.8 cm in size. Eccentrically, a malacic area of. approx. 3.5 cm in size. No demonstrable connection to bronchial branches that can be dissected out. Tumor extends as. far as the pleura in the region of the retraction and approx. 1.5 cm deep into the upper lobe in the region of S4. Parenchyma indurated peripheral to the tumor and yellow-brownish in color. Color of the rest of the lung tissue normal. 2.) Left hilar LN (station 10): Gray-blackish node of 2 cm in size. 3.) Left pulmonary ligament LN (station 9): Damaged, gray-blackish node of 1.5 cm in size. 4.) Left paraesophageal LN (station 8): Gray-blackish node of 5 cm in size with some surrounding tissue. 5.) Subcarinal LN (station 7): Gray-blackish node of 9 mm in size. 6.) Paraaortic LN (station 6): Damaged, gray-blackish node of 8 mm in size. 7.) Subaortic LN (aortopulmonary window) (station 5): Gray-blackish node of 8 mm in size with some surrounding tissue. 8.) Left prevascular and retrotracheal LN (station 3): Clear portion of the lung of 9 mm in size. 9.) Right hilar LN (station 10): Two damaged gray-blackish nodes of 1 and 1.1 cm in size with some surrounding tissue. Investigated: 1.) Tumor with lung parenchyma in margin, tumor with pleura, tumor with gap between lobes (upper lobe stained),. central bronchial resection line, vascular resection margins (1 larger one split in half + separate in lungs),. 2.)-9.) - in each case, entire material (split in half for 8.),. 14 blocks, in some cases. PAS, diastase-PAS. Microscopy. on 1.) Tumor structure composed of variably sized, partially branched, solid, focal atypical epidermoid epithelia, also. focally arranged in trabecular groups. Moderately eosinophilic cytoplasm of intermediate width to wide, partially. extended lengthways to spindly. Focal intercellular bridges. Nuclei round to oval, up to strongly anisomorphic, with. coarse chromatin, mainly small to moderately large nucleoli and relatively numerous mitoses. Extensive necroses. Desmoplastic tumor stroma and groups of the atypical epithelia infiltrated with mixed inflammatory cells or. predominantly with granulocytes. Expansion of the atypical epithelia across the fibrosed obliterated interlobular gap. into the neighboring segments of the upper lobe. Dissected visceral pleura also focally infiltrated and notably strongly. fibrously expanded here, as well as with superficial fibrin precipitates that are both external and incorporated. Sections. of the tumor margins with up to high densities of intraalveolar granulocytes and macrophages, alveolar septa sometimes. with strong edematous-fibrous expansion and infiltrated with mixed inflammatory cells, as well as surrounded by. proliferated pneumocytes. Resection margin of bronchus and vessels as well as hilar lymph nodes free of tumors. The. latter with normal lymphate. Cells with development of numerous activated follicles, minor to moderate deposits of. fine-grained blackish pigments and fewer anisotropic particles within macrophages, as well as partially with nodular,. fibrous zones with few spindle cells and, in sections, old necrotic zones, sometimes with the inclusion of planar calcium. salt precipitates and focally minimal bony tissue. on 2.) - 5.), 7.), + 9.) Lymph nodes as described under 1.). on 6.) Incompletely filled peripheral lung tissue with, at the level of the visceral pleura, small, sometimes squashed. lymph nodes with normal lymphatic cells and more extended aggregates of macrophages with minor deposits of. blackish, grainy pigment. on 8.) Peripheral lung tissue with subpleurally expanded alveolar spaces and rarefied and enlarged alveolar septa. Mainly pleural, up to moderate deposits of blackish, grainy pigment within macrophages. EVALUATION. Primary diagnosis/diagnoses: Large, peripheral, bronchopulmonary, partially necrotically altered, with poor. differentiation histologically, nonkeratinizing squamous epithelial carcinoma (G3) of the left lower lobe of the lung,. located in the border region of segments 6 and 8 to 10. TNM classification pT2 pNO RO, Stage IB. c 34.3 M 8070/3. Secondary diagnosis/diagnoses: Active chronic pneumonia in the areas around the tumor and fibrinous inflammation of. the visceral pleura with markedly fibrous expansion over the tumor. Lymph nodes in this region (samples 1.) - 7.) and. 9.)) with abnormal reactive changes, anthracotic pigment deposits and sometimes partially calcified, old necrotic or. ossified nodular sclerosed zones. Mild focal emphysema of the lung (sample 8.)). Remark/addendum: The carcinoma has expanded across the lobular gap into the neighboring sections of segment 4 of. the upper lobe. The resection margin of the bronchus and vessels as well as all lymph nodes that were removed or those. that were identified are tumor-free.",T2,N0,M0,T2N0M0
TCGA-G3-A25V,"Laboratory Services. PHN: ACB: Telephone: Encounter: Received Date/Time: Specimen Description. A. Gallbladder - FS. B. Liver segment 5. Clinical Information. Liver mass which looks like hepatocellular carcinoma; patient has known cirrhosis secondary to alcohol ingestion. Liver. Ca. Diagnosis. A. Gallbladder: - Chronic cholecystitis. B. Liver Segment 5: - Moderately-differentiated hepatocellular carcinoma, 1.5 cm in the. greatest dimension. Resection margins are free of tumor. - Cirrhosis. Pathology: Provider - Permanent. Surgical. Pathology Report. Received Date/Time: Gross Description. Received are specimens A to B. All requisitions and specimen containers are labelled with the patient's name. The cassettes and AP identifiers are labelled with the Surgical Number. A. The specimen consists of a gallbladder measuring 10.0 x 3.5 X 1.2 cm. The gallbladder is filled with yellow-greenish. bile. without. stones. The mucosa is velvety and granular. There is no tumor identified. AgNO3. One random section. taken for QS. Three further representative sections of the specimen are submitted in cassette A2. B. The specimen is received fresh and is subsequently placed into formalin and consists of a congested wedge of liver. weighing 17.9 grams and measuring 4.0 x 3.0 x 3.0 cm. The resection margin is inked blue. Specimen is sectioned and. the liver parenchyma grossly appears to be cirrhotic. Within the specimen is a yellow/tan circumscribed lesion measuring. 1.5 X 1.5 X 1.0 cm. Grossly, this lesion comes within 0.6 cm of the blue-painted margin and 0.2 cm through the capsule. The mass is submitted in toto in cassettes B1 to B4. Further representative sections of liver are submitted in cassette B5. Frozen Section Diagnosis. A. Gallbladder: - Negative for malignancy. Pathology: Provider - Permanent. www.",T1,N0,M0,T1N0M0
TCGA-BR-8381,"Patient ID: Gross Description: Stomach part with saucer-like tumor up to 5x4.5 cm in size, with invasion into the. perigastric fat tissue. In the fatty tissue there are hyperemic lymph nodes up to 0.6 cm in size. Omentum is of normal structure. Microscopic Description: Gastric adenocarcinoma, G-3, with invasion into the fatty tissue. One from. fifteen examined lymph nodes demonstrated metastasis. Diagnosis Details: Tumor Features: Ulcerated, Tumor Extent: Perigastric fat, Venous Invasion: Absent,. Margins: Absent, Treatment Effect: Comments: Formatted Path Reports: STOMACH TISSUE CHECKLIST. Specimen type: Subtotal gastrectomy. Tumor site: Fundus. Tumor size: 4.5x0x5cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly differentiated. Tumor extent: Subserosa. Lymph nodes: 1/15 positive for metastasis (Greater and lesser curvature. 1/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T3,N1,M0,T3N1M0
TCGA-BR-8680,"Gross. Microscopic Description. Diagnosis Details. Description. In lesser curvature,. Mucosa is ulcerated. Tumor is. Tubular adenocarcinoma,. there is an ulcerated. invasion into serosa. Tumor is. moderately-differentiated,. tumor, with. composed of tubules containing. infiltrating serosa. 3x3x1cm in size,. necrosis or trabeculae. Glands are. firm and gray. variability in size and shape. Tumor. surface. cells are moderately straitified. Mitotic index is present. Nuclei are. hyperchromatic and irregularly. enlarged and prominent nucleoli. Stroma is invasion of prominent. lymphocytes. Tumor is necrotic. Comments. STOMACH TISSUE CHECKLIST. Specimen type: Gastrectomy. Tumor site: Antrum. Tumor size: 3 X 3 X 1 cm. Tumor features: Ulcerated. Histologic type: Tubular adenocarcinoma. Histologic grade: Moderately differentiated. Tumor extent: Serosa (visceral peritoneum). Lymph nodes: 3/10 positive for metastasis (Adjacent. lymph node 3/10). Lymphatic invasion: Present. Venous invasion: Not specified. Perineural invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T4,N2,M1,T4N2M1
TCGA-51-6867,"Diagnosis. A: Lung, right upper lobe, wedge resection. - Invasive moderately differentiated squamous cell carcinoma,. tumor size 2.0 cm in greatest dimension (see comment) . - Surgical margins free of tumor. B: Lymph node, R4, removal. - No tumor seen in two lymph nodes (0/2) . Comment: This patient has a history of a prior laryngeal T4 squamous cell. carcinoma. We have reviewed the tumor in the lung and the tumor. of the larynx, and the tumors appear similar, with the laryngeal. tumor showing slightly less squamous differentiation It is not. possible to determine if the tumor in the lung represents. metastatic disease or a new primary. Review of the clinical. workstation reveals that the multidicsiplinary thoracic oncology. conference favored a new primary lung cancer. Clinical History. The patient is a. -year-old female with right upper lobe. lesion. Gross Description: Received are two appropriately labeled containers. Container A is additionally labeled ""RUL wedge resection. "". Specimen fixation: formalin. Type of specimen/parts of lung received: right upper lobe wedge. resection. Size of specimen: 10 X 4.8 X 1.5 cm. Weight of specimen: 38.7 grams. Other attached structures: n/a. Tumor location: peripheral. Tumor size: There is a complex staple line running the length of. the specimen;. there is a 1.4 cm pleural disruption (2.4 cm from closest staple. line) and a 0.6 cm. second pleural disruption which is 0.3 cm from the larger. disrupted area (1.0 cm to. staple line) . The pleural is red/tan and mottled. The staple. line is inked blue, the. pleural is inked yellow and the disrupted areas are outlined in. yellow. Sectioning. exhibits a 2 X approximately 1.3 X 0.6 cm tan, firm nodule with. scalloped/lobulated. borders which is immediately beneath the largest disrupted site. Immediately. adjacent to the noted nodule, there is a cavitary, necrotic area. which is believed. to be necrotic nodule. Relationship of tumor to bronchus: n/a. Distance of tumor to bronchial margin: n/a. Relationship/distance of tumor to pleura: approximately 0.6 cm,. however, the nodule. is immediately beneath a. disrupted site. Distance of tumor to other surgical margins: 1.0 cm. Presence/absence of satellite tumor nodules: absent. Involvement of attached structures by tumor: n/a. Description of nontumorous lung: the remainder of the lung. parenchyma is dark. red/tan, soft, spongy and aerated;. no other lesions, masses, or abnormalities are. identified. Comment: A small slice of tumor and a small slice of normal was. given to Tissue. Block Summary. A1 - staple line closest to nodule. A2 - nodule. A3 - cavity necrotic area. A4 - additional tumor and adjacent lung parenchyma. A5 - uninvolved lung. Container B is additionally labeled ""R-4 lymph node.' It holds a. 2.3 X 2.0 X 0.5 cm. aggregate of two fragments, one large and one small, of. red/gray, focally cauterized. lymphoid tissue which are submitted in block B1, NTR. Light Microscopy : Light microscopic examination is performed by Dr. Tumor histologic type (WHO classification) : squamous cell. carcinoma. Tumor histologic grade (WHO classification) : moderately. differentiated. Tumor size (greatest dimension) : 2.0 cm. Histologic assessment of surgical margins: : surgical margins free. of tumor. Pleural involvement: not identified. In situ carcinoma: not identified. Invasion: angiolymphatic - not identified. perineural - not identified. Lymph nodes (by node group) : no tumor seen in 2 R4 lymph nodes. (0/2). Findings in nontumorous lung: emphysematous changes.",T1,N0,M0,T1N0M0
TCGA-CG-4477,"Diagnosis: This is a poorly differentiated adenocarcinoma of the cardiac and fundus region (gastric. carcinoma of the intestinal type) of histopathological differentiation grade G3, with necroses,. erosions/ulcerations of the inner tumor surface, with necroses, with solid tumor areas, with. peritumorous chronic recurrent concomitant inflammation with acute inflammatory activity,. with carcinomatous lymphangitis, with tumor infiltration of the parietal layers of the stomach. extending into the outer layers of the tunica muscularis, with tumor-free lymph nodes (0/17). with a chronic lymphadenitis and tumor-free overview slices from all the parts of the. resection material described. According to the section preparations available, the tumor spread of the gastric carcinoma. corresponds to a tumor stage of pT2a pNO (0/174) MX; L1, R0. Tumor classification: ICDO-DA M 8140/3.",T2,N0,M0,T2N0M0
TCGA-AA-3502,"Diagnosis / Diagnoses: Resected cross-section of the colon with tumor-free resection margins, under inclusion of. a tubular adenoma with mild dysplasia (synonym: low-grade intra-epithelial neoplasia). and a tubulovillous adenoma with focal severe dysplasia (synonym: high-grade intra-. epithelial neoplasia) and with a well to moderately differentiated colorectal. adenocarcinoma (G1 to 2) with infiltration of the lamina muscularis propria and without. regional lymph node metastases (pT2 pNO 0/31) on the base of a further tubulovillous. adenoma with severe dysplasia. Final preliminary results.",T2,N0,M0,T2N0M0
TCGA-DD-AACP,"CLINICAL DIAGNOSIS: HCC. Specimen : HCC--liver. Gross Photo : GROSS: Specimen: Liver: 4.5 X 4.5 x 3.5 and 45.5 gm, unfixed. Gallbladder: 8.5 cm in length and 4.0 cm in diameter, unfixed. Tumor location: segment 5. Tumor number: one. Tumor size: 3.3 X 3.1 X 3.0 cm. Satellite nodule: no. Gross type. HCC: pedunculated type. Tumor necrosis: no. Hemorrhage/peliosis: yes (10%). Portal vein invasion: no. Bile duct invasion: Other organ: Gallbladder: Unremarkable (0.2 cm in wall thickness). Gross photo present. Blocks. T1- mass with liver parenchyma x 4. RM, resection margin x 1. GB, gallbladder X 1. MICROSCOPIC: Hepatocellular carcinoma: yes. Differentiation. The worst differentiation III. The major differentiation II. Histologic type: trabecular. Cell type: hepatic. Fatty change: no. Cholangiocarcinomal no. Combined hepatocellular and cholangiocarcinomal no. Other tumor: no. Fibrous capsule formation: complete capsule. Capsular infiltration: no. Septum formation: yes. Surgical resection margin invasion: no, margin of the clearence (0.4 cm). Serosal invasion: no. Portal vein invasion: no. Bile duct invasion: no. Hepatic vein invasion: no. Hepatic artery invasion: no. Microvessel invasion: Intrahepatic metastasis: no. Multicentric occurrence: no. Non-tumor liver pathology: micronodular cirrhosis. NOT reported. Gross: NOT reported. Gross: Stomach, body,antrum, scopic, hyperplastic polyp. Stomach, antrum, scopic, tubular adenoma, high grade, dysplasia. Stomach, antrum, dissection, tubular adenoma, high grade, dysplasia. liver,needle,hepatocellular carcinoma,cirrhosis. Liver, resection, hepatocellular carcinoma. T56000, P17, M81703. Gallbladder, ectomy, chronic cholecystitis. T57000, P10, M43005. DIAGNOSIS: Liver, segment 5, resection: Hepatocellular carcinoma. Gallbladder, cholecystectomy: Chronic cholecystitis, no tumor present. Suggestion :",T1,N0,M0,T1N0M0
TCGA-ZJ-AAXD,"PAGE: 1. SPEC #: Obtained: CLINICAL HISTORY: 233.1. SPECIMEN/PROCEDURE : 1. CERVIX - BX. IMPRESSION : CERVICAL BIOPSY: Squamous cell carcinoma, favor invasive for large cell, nonkeratinizing, grade 2. Entered: GROSS DESCRIPTION. 1. Received in formalin labeled with the patient's name and cervical biopsy. Received is. a. 1.3 x 1-0.3 cm aggregate of pale pink to red tan irregular tissue fragments. The. specimen is entirely submitted in one cassette. Diotated by: Entered: CPT Codes : CERVICAL BIOPSY/88305. ICD9 Codes : 180.9. Eleotronically Signed by:",T3,N0,M0,T3N0M0
TCGA-21-1072,"Clinical History/Diagnosis: Not entered. Source of Specimen(s): A: PORTION OF 6TH RIB. B: L9 NODES. C: LEVEL 7 NODES. D: LYMPH NODE ON INFERIOR PULMONARY VEIN. E: LT LUNG. F: LEVEL 5 NODES. GROSS DESCRIPTION: The specimen is received in six parts. SOURCE OF TISSUE: 1. Labeled #1 ""portion of 6th rib"". GROSS DESCRIPTION: The specimen consists of a portion of rib measuring 1.4 cm in. length with an average diameter of 0.7 cm. There is a scant amount of soft tissue attached to. the specimen. A representative section is submitted in one block following decalcification. DESIGNATION OF SECTIONS: Block 1. SUMMARY OF SECTIONS: Undesignated - 1. SOURCE OF TISSUE: 2. Labeled #2 ""left level 9 node"". GROSS DESCRIPTION: The specimen consists of a yellow-tan portion of soft tissue. measuring 0.6 X 0.5 X 0.3 cm. The specimen contains a focal area of anthracotic. pigmentation. The specimen is submitted in toto in one block. DESIGNATION OF SECTIONS: Block 2. SUMMARY OF SECTIONS: Undesignated - 1. SOURCE OF TISSUE: 3. Labeled #3 ""level 7 lymph node"". GROSS DESCRIPTION: The specimen consists of two fragments of gray-black soft. tissue with anthracotic pigmentation measuring 1.3 x 0.9 x 0.4 cm. The specimen is. submitted in toto in one block. DESIGNATION OF SECTIONS: Block 3. SUMMARY OF SECTIONS: Undesignated - 3. SOURCE OF TISSUE: 4. Labeled #4 ""lymph node in inferior pulmonary vein"". GROSS DESCRIPTION: The specimen consists of a gray-tan anthracotic stained soft tissue. measuring 1.3 X 0.6 x 0.5 cm. The specimen is submitted in toto in one block. DESIGNATION OF SECTIONS: Block 4. SUMMARY OF SECTIONS: Undesignated - 1. SOURCE OF TISSUE: 5. Labeled #5 ""left lung"". FROZEN SECTION DIAGNOSIS: 5FS - BRONCHIAL MARGIN NEGATIVE FOR. TUMOR. GROSS DESCRIPTION: The specimen was received fresh for frozen section. The specimen. consists of a left pneumonectomy measuring 22.0 X 14.5 X 3.0 cm. The specimen contains. a. bronchus measuring 4.0 cm in length with a diameter of 2.0 cm. The pleura is pink-tan with. diffuse areas of anthracotic pigmentation. There are no areas of puckering or induration. identified grossly on the pleura. The bronchial tree was dissected to reveal the upper. bronchus containing a pink-tan soft mass which obliterates the bronchiole. The mass. measures 2.4 X 2.5 cm in greatest dimension. The surrounding lung parenchyma contains. mucous plugs. The surrounding vasculature is not involved with the tumor. The bronchial. margin was frozen and the frozen section residue is submitted in one block. Representative. sections are submitted in eight blocks. DESIGNATION OF SECTIONS: 5FS, 5A-5G. SUMMARY OF SECTIONS: 5FS frozen section residue, 5A vascular margin, 5B four. lymph nodes, 5C four lymph nodes, 5D-5E bronchus with tumor, 5F the parenchyma nearest. to the tumor and 5G normal lung. SOURCE OF TISSUE: 6. Labeled #6 ""level 5 lymph node"". GROSS DESCRIPTION: The specimen consists of a gray-black anthracotic stained soft. tissue measuring 1.2 X 0.9 X 0.5 cm. The specimen is bisected and submitted in toto in one. block. DESIGNATION OF SECTIONS: Block 6. SUMMARY OF SECTIONS: Undesignated - 2. Final Diagnosis: DIAGNOSIS: 1. PORTION OF 6TH RIB: - NO TUMOR SEEN. 2. L9 LYMPH NODE: - NO TUMOR SEEN (0/1). 3. LEVEL 7 LYMPH NODE: - NO TUMOR SEEN (0/2). 4. LYMPH NODE IN INFERIOR PULMONARY VEIN: - NO TUMOR SEEN (0/1). 5. LEFT LUNG (PNEUMONECTOMY): - KERATINIZING SQUAMOUS CELL CARCINOMA GRADE II (2.5 CM). - PLEURA, BRONCHIAL AND VASCULAR MARGINS NEGATIVE FOR TUMOR. - NEGATIVE PERIBRONCHIAL LYMPH NODES (0/9) (PT2N0) (INVOLVEMENT OF. THE. LEFT MAIN BRONCHUS). - NON-NEOPLASTIC LUNG REVEALS ATELECTASIS. 6. LEVEL 5 LYMPH NODE: - NO TUMOR SEEN (0/1).",T2,N0,M0,T2N0M0
TCGA-BH-A204,"PATIENT HISTORY: DATE OF LMP: Procedure Date: DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: CARCINOMA LEFT BREAST. POST-OP DIAGNOSIS: SAME. OPERATIVE PROCEDURE: EXC BREAST LEST BR FS - LEFT MOD RAD MASTECTOMY. MATERIAL SUBMITTED: A) LEFT GREAST BIOPSY/TISSUE, PROCUREMENT BY SURGICAL PROCRDURE. CLINICAL HISTORY: B) LEFT (MOD) RADICAL MASTECTOMY, PROCUREMENT nY SURGICAL PROCEDURE. and axillary contents. Frozen section: ""Left breast mass biopsy"" 1.5 by cm x 2' biopsies. F's duct Ca. INTRAOPERATIVE CONSULTATION: ER/PR taken. Tissue taken for DNA studtes. FINAL DIAGNOSIS: FINAL DIAGNOSIS: AEAFS) LEFT BREAST AND AXILLA: - INFILTRATING DUCTAL CARCINOMA, 4.0 CM, POOR NUCLEAR GRADE. - MICROSCOPIC FOCI OF DUCTAL CARCINOMA IN SITU. - ANGIOLYMPHATIC AND PERINEURAL INVASION SEEN. - TUMOR INVOLVES SKELETAL MUSCLE. - RESECTION MARGINS ARE FREE OF CARCINOMA. TWO OF SIXTEEN (2/16) LYMPR NODES ARE POSITIVE FOR CARCINOMA. - NOTE: The large 2.5 em axillary lymph node is totally replaced by tumor with extracapeular extension.",T2,N1,M0,T2N1M0
TCGA-DD-AAD1,"CLINICAL DIAGNOSIS: HCC. Specimen : liver. Photo. GROSS: Specimen: Liver: 9.0 x 7.5 x 5.5 cm, 203.0 gm (unfixed). Operation: Segmentectomy. Lesion: A well-defined mass (6.3 X 5.0 X 3.5 cm). Cut surface: Yellowish tan, and granular. Gross type. HCC: Multinodular confluent. Resection margin: Involved by tumor. Others: Satellite nodule: no. Remaining parenchyma: Unremarkable. Portal vein invasion: No. Gross photo: Present. Blocks. T1-5 and TB, tumor and surrounding tissue X 6. RM, resection margin X 1. NB, remaining hepatic parenchyme X 1. MICROSCOPIC: Hepatocellular carcinoma: Yes. The worst differentiation IV/IV. The major differentiation III/IV. Histologic type: Trabecular, pseudoglandular, compact. Cell type: Hepatic, clear. Fatty change: No. Cholangiocarcinoma: No. Combined hepatocellular and cholangiocarcinoma: No. Fibrous capsule formation: No. Septum formation: Yes. Surgical resection margin invasion: Yes. Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. NOT reported. Gross: Liver, ectomy, hepatocellular carcinoma. T56000, P10, M81703. DIAGNOSIS: Liver, segment 7, segmentectomy: Hepatocellular carcinoma. Suggestion :",T1,N0,M0,T1N0M0
TCGA-55-1594,"Back to List. REPORT STATUS: Final. FACILITY: SURGICAL P. Specimen (s) Received. A: Right lower lobe. B: Level 3 sub carinal lymph node. C: Level 4 lymph node peritoneal. Pathologic Diagnosis. A. Right lower lobe: Histologic Type: Adenocarcinoma. Histologic Grade: Poorly differentiated. Tumor Size: Greatest dimension: 3.7 cm T2. Additional dimension: 3.3 cm. Specimen Type. Lobectomy. Extent of Invasion: Tumor is confined to the lung. Regional Lymph Nodes: Number involved: 0. Number examined: 13. Distant Metastasis: Cannot be assessed. Margins : Margins uninvolved by invasive carcinoma. Tumor does not extend to pleural surface. Tumor distance from pleural surface: 0.1cm. Lymphovascular Invasion: Absent. Venous Invasion: Absent. Arterial Invasion: Absent. ""A"" -. Lung, right lower Lobe, lobectomy: Grade 3. adenocarcinoma (3.7 cm) subpleural in location) benign bronchial. resection margin and 13 benign regional symptronodes including 2. subpleural nodes and 2 nodes loose in the container. ""B"" -. Lymph nodes, level 7 subcarinal, biopsy: Metastatic poorly-differentiated carcinoma (0. cm) to one of. nine lymph nodes (extranodal extension is not identified). ""C"" -. Lymph node, level 4, biopsy: Three benign lymph nodes. PATHOLOGIC STAGE: pT2 pN2 pMX. NOTE Information on pathology stage and the operative procedure. tal. is transmitted to this Institution S Cancer Registry as required. for accreditation by the. Pathology stage. is based solely upon the current tissue specimen being evaluated. and does not incorporate other relevant data. Pathology stage is. only a component to be considered in determining the clinical. stage and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon' S. operative report. stage. b. Clinical History. Right posterior lung mass. Intraoperative Consultation. A. Right lower lobe: Bronchial margin negative. (microscopic. frozen section). Gross Description. A: Received fresh for frozen section labeled ""right lower lobe"". is a 197 gram (post fixation weight) 15 x 12.5 x 4 cm lobe of. lung. The bronchial margin is removed and frozen as ""FS-A1"". The. frozen section remnant is submitted as ""Al"". Received with the. lung are two separate lymph nodes, each 1.0 cm in greatest. dimension, These detached lymph nodes are submitted intact as. ""A2"". The pleura of the lung is tan-brown and focally retracted. The retracted pleura is inked blue. Underlying the retracted. pleura is a slightly soft white-gray 3.7 X 3.3 x 2.2 cm mass. which comes to within approximately 4.5 cm of the bronchial. margin. The remaining pleura demonstrates a moderate amount of. anthracotic mottling. There are two potential subpleural lymph. nodes identified between the mass and the bronchial margin. There are multiple lymph nodes identified near the bronchial. margin within the parenchyma. Sectioning through the remaining. specimen demonstrates soft tan-pink crepitus parenchyma with no. additional masses or lesions identified. ""A3 and A4"" - mass with. relationship to retracted pleura, ""A5"" - mass with relationship. to adjacent parenchyma. ""A6"" - four potential intraparenchymal. lymph nodes, ""A7"" - grossly unremarkable parenchyma greater than. 2 cm from mass, ""A8"" - two intact potential subpleural lymph. nodes, ""A9 and A10"" - vascular margins and intact potential lymph. nodes and parenchyma surrounding bronchial vascular margins. B: Received in formalin labeled ""level 7 subcarinal lymph. node"" is a 3 x 3 X 1.: 5 cm aggregate of multiple matted gray-black. lymph nodes with a small amount of attached adipose tissue. ""B1"" - seven intact potential lymph nodes, ""B2"" - two bisected. lymph nodes (one blue, one black). C: Received in formalin labeled ""level 4 paratracheal"" is a 1.7. X 1.: x 0.3 cm aggregate of gray-black lymph nodes and adipose. tissue. The specimen is submitted intact in ""C1"". Microscopic Description. Microscopic examination has been performed on all slides. The. pathologic diagnosis encompasses the essential microscopic.",T2,N2,M0,T2N2M0
TCGA-F1-6874,"SURGICAL PATHOLOGY REVISED REPORT. Diagnosis: A: Stomach, subtotal gastrectomy. Histologic tumor type/subtype: moderately to poorly. differentiated. adenocarcinoma, intestinal type. Histologic grade: moderately to poorly differentiated. Tumor location: proximal stomach. Depth of invasion: into muscularis propria. Lymphovascular invasion: not identified. Perineural invasion: not identified. Histologic assessment of surgical margins: Proximal surgical margin: negative for malignancy, ; tumor is 1.9. cm from the proximal margin; see comment. Distal surgical margin: negative for malignancy; margin is. widely negative. Radial (adventitial) margin : negative for malignancy, tumor is. 0.4 cm from the radial margin. Lymph nodes: 32 lymph nodes, negative for malignancy (0/32). Other significant findings: - Chronic gastritis with extensive intestinal metaplasia. - No Helicobacter pylori identified. - Acute and chronic serositis. - Hyperplastic polyp. AJCC Staging : pT2 pNO. This staging information is based on this pathologic specimen. and may be. incomplete. A comprehensive review of all available information. is recommended. to determine final staging. B: Greater omentum #1, partial omentectomy. - Mature benign fibroadipose tissue consistent with omentum. - No carcinoma identified. C: Greater omentum #2, partial omentectomy. - Mature benign fibroadipose tissue consistent with omentum. - No carcinoma identified. D: Greater omentum #3, partial omentectomy. - Mature benign fibroadipose tissue consistent with omentum. - No carcinoma identified. E: Greater omentum #4, partial omentectomy. - Mature benign fibroadipose tissue consistent with omentum. - No carcinoma identified. F: Greater omentum #5, partial omentectomy. - Mature benign fibroadipose tissue consistent with omentum. - No carcinoma identified. G: Lymph node, celiac, hepatic, removal. - Six lymph nodes, negative for malignancy (0/6). Comment: Gross examination estimates the tumor mass to be 3 cm from the. proximal margin. Microscopic examination demonstrates no tumor at the proximal. margin with a microscopic distance of 1.9 cm between tumor and. the proximal margin. This case was reviewed with the frozen section pathologist. regarding proximal margin status. Intraoperative Consult Diagnosis: A frozen section was requested by. FSA1: Distal margin, gastrectomy. - No tumor seen. FSA2: Proximal margin, gastrectomy. - No tumor seen at margin, approximately 3 cm. with biopsy proven poorly differentiated. cinoma. Gross Description: Received are seven appropriately labeled containers. Container A is additionally labeled ""subtotal gastrectomy with. perigastric lymph. node, stitch marks greater curve. "" The specimen is a 20 X 16 X. 3.5 cm overall. gastrectomy specimen composed of a 20.0 X 4.5 X 3.5 cm stomach. with attached. greater and lesser omentum. The specimen is received oriented. with a stitch. along the proximal margin greater curvature. The anterior serosa. is. predominantly smooth, tan/pink with a 0.4 cm solitary soft. fluctuant nodule. The. posterior serosa is smooth, tan/pink and unremarkable. Both. margins have been. received stapled and the proximal margin staple line is inked. blue and the. distal staple line is inked black. The specimen is opened along. the greater. curvature. Opening demonstrates a 5.5 X 5.0 X 2.5 cm fleshy. broad-based polypoid. mass extending into the muscularis propria and within 0.1 cm of. the underlying. posterior serosa which is grossly intact. This mass is covered. with granular and. discolored necrotic appearing mucosa. The mass is located 3 cm. from the proximal. staple line. The proximal and distal margins are frozen as FSA1. and FSA2 The. remaining gastric mucosa is brown/red, granular with prominent. rugal folds and. some flattening adjacent to the polyp. There is a second 0.6 X. 0.5 X 0.4 cm. polyp located 10 cm distal to the first mass. Sectioning through. the mass. reveals a fleshy, yellow/tan cut surface. Normal and tumor have been given to Tissue Procurement. Block summary: FSA1 - distal margin. FSA1 - proximal margin. A1 - anterior wall serosal nodule. A2-A3 - - full thickness sections of tumor to include serosa. A4 - proximal edge of tumor. A5 - distal edge of tumor. A6 - superficial section of tumor. A7 - polyp, distal. A8 - representative sections from erythematous and slightly. flattened. gastric mucosa. A9 - five lymph node candidates, lesser curvature. A10 - five lymph node candidates, lesser curvature. A11 - three lymph node candidates, lesser curvature. A12-A13 - one lymph node candidate, sectioned, lesser curvature. A14 - five lymph node candidates, greater curvature. A15 - five lymph node candidates, greater curvature. A16 - six lymph node candidates, greater curvature. A17 - five lymph node candidates. A18 - two lymph node candidates. Container B is additionally labeled ""greater omentum #1."" It. holds a 14.8 X 9.2. X 2.3 cm fragment of finely lobulated yellow/tan fibrofatty. tissue with focal. cautery artifact and areas of hemorrhage. The surfaces are. smooth and. glistening. Sectioning reveals lobulated yellow/tan cut surfaces. with no nodules. or masses appreciated. Representative sections are submitted in. blocks B1-B3. Container C is additionally labeled ""greater omentum #2."" It. holds a 16.4 X 13.3. X 2.4 cm fragment of finely lobulated yellow/tan fibrofatty. tissue with. predominantly smooth glistening surfaces. There is focal cautery. artifact and. small areas of hemorrhage. No discrete mass or nodule is. appreciated upon. sectioning. Representative sections are submitted in blocks C1-. C3. Container D is additionally labeled ""greater omentum #3. "" It. holds a 15.4 X 10.: 2. X 2.4 cm lobulated fragment of yellow/tan fibrofatty tissue with. a predominantly. glistening surface. There are small areas of hemorrhage and. minimal cautery. Sectioning reveals lobulated, grossly unremarkable fatty cut. surfaces with no. discrete mass or nodule appreciated. Representative sections are. submitted in. blocks D1-D3. -. Container E is additionally labeled ""greater omentum #4. "" It. holds a 21 X 12.5 X. 2.2 cm lobulated fragment of yellow/tan fibrofatty tissue. The. surfaces are. predominantly smooth and glistening with small areas of. hemorrhage. Sectioning. reveals lobulated yellow/tan fatty cut surfaces with no discrete. mass or nodule. appreciated. Representative sections are submitted in blocks E1-. E3. Container F is additionally labeled ""greater omentum #5. "" It. holds a 15.3 X 12.8. X 2.6 4 cm lobulated fragment of yellow/tan fibrofatty tissue. consistent with. omentum. The surface is predominantly smooth and glistening with. small areas of. erythema. Sectioning reveals lobulated yellow/tan fatty cut. surfaces with no. discrete lesions identified. Representative sections are. submitted in blocks. F1-F3. Container G is additionally labeled ""celiac and common hepatic. lymph nodes. "" It. holds a 4.5 X 3.3 X 1.2 cm aggregate of cauterized yellow/tan. fibrofatty tissue. which is dissected for lymph node candidates. Four lymph node. candidates. measuring up to 1.4 cm in greatest dimension are identified. Block summary: G1 - three lymph node candidates. G2 - one lymph node candid. G3-G5 - - remainder of fat,.",T2,N0,M0,T2N0M0
TCGA-3U-A98D,"Gender: Male. Race: White. Report Date: Tissue Procurement Date: FINAL PATHOLOGIC DIAGNOSIS. A. Parietal visceral pleura; pleurectomy: - Biphasic mesothelioma, see parameters. B. Parietal visceral pleura; pleurectomy: - Biphasic mesothelioma, see parameters and comment. C. Lymph node #7; biopsy: - Two of four lymph nodes with metastatic mesothelioma, epithelioid (2/4). D. Lymph node 4R; biopsy: - Five of five lymph nodes, no tumor (0/5). E. Lymph node #8; biopsy: - One lymph node with metastatic mesothelioma, epithelioid (1/1). F. Lymph node #11; biopsy: - Two lymph nodes, no tumor (0/2). Thoracic Mesothelioma Pathologic Parameters. Pleura/Pericardium, Resection. MACROSCOPIC. Specimen Type: Pleural resection. Tumor Site: Right pleura. Tumor Configuration and Size: Diffuse, maximum thickness: 4.6 cm. MICROSCOPIC. Histologic Type: Biphasic mesothelioma (40% epithelioid, 60% sarcomatoid). Tumor Extension: Into but not through diaphragm. Lung parenchyma. Venous/Lymphatic (Large/Small Vessel) Invasion: Absent. Margins: Cannot be assessed. Additional Pathologic Findings: Pleural plaques with focal calcifications. Pathologic Staging (pTNM). Primary Tumor (pT). pT2: Tumor involves any of the ipsilateral pleural surfaces with at. least 1 of the following: invasion of diaphragmatic muscle, invasion of lung. parenchyma. Regional Lymph Nodes (pN). pN2: Metastases in the subcarinal lymph node(s) and/or the lipsilateral. internal mammary or mediastinal lymph node(s). Number examined: 12. Number involved: 3. Effective January 1, 2010 this Checklist utilizes the 7th edition TNM staging. system for pleural mesothelioma of the American Joint Committee on Cancer (AJCC). and the International Union Against Cancer (UICC). Comment. Immunohistochemistry with appropriate controls demonstrates that the epithelioid. component is positive for calretinin and nuclear WT-1 and negative for MOC31. consistent with mesothelioma. The sarcomatoid component has weaker staining. with both mesothelial markers. M.D. Interpretation performed by the Attending Pathologist and reviewed with the. Resident/Fellow,  M.D., Ph.D. M.D. Clinical History: The patient is an .year-old male with mesothelioma of the lung undergoing a. right thoracotomy, pleurectomy and bronchoscopy. Specimens Received: A: Mesothelioma parietal visceral pleura. B: Mesothelioma parietal visceral pleura. C: #7. D: 4R. E: #8. F: #11. Gross Description: The specimens are received in six containers each labeled with the patient's. name and medical record number. A. The first container is additionally identified as, ""1. Mesothelioma parietal. visceral pleura"". Received fresh and placed in formalin is an oriented 806.7 g,. 25 X 15 x 6 cm in overall dimension pleurectomy specimen. The specimen has a. volumetric displacement of approximately 650-700 mL. A stitch designates the. diaphragmatic surface. The ragged red-brown diaphragmatic surface measures 21 x. 14.5 cm, is up to 0.8 cm maximum thickness and is inked black. There is a 13.5 x. 7.5 cm portion of smooth, pink-white abdominal peritoneum which measures up to. 0.1 cm in thickness and is inked blue. Serial sectioning reveals diffusely,. nodular, firm tan-pink parietal pleura and visceral pleura containing shaggy,. soft gray-brown remnants of lung parenchyma with scattered anthracotic pigment. Serial sectioning reveals firm, solid whorled white confluent nodules scattered. throughout with a thickness up to 0.9 cm. The largest area of thickening is. located along the peripheral edge of the diaphragmatic surface, measures up to. 4.6 cm maximum thickness, abuts black ink and bulges into the surrounding soft. lobules of adipose tissue. This portion has an intervening septum of soft,. glistening yellow adipose tissue. Additional thickened areas subjacent to the. diaphragmatic surface focally come to within 0.2 cm of blue ink (abdominal. peritoneum). No pericardium is grossly identified. Gross photographs are taken. Representative sections are taken as follows: A1-A2: Nodule to black ink (diaphragmatic surface). A3: Nodule to blue ink (diaphragmatic peritoneum). A4: Bulging nodule into the surrounding adipose. A5-A7: Fused visceral and parietal pleura with remnants of lung parenchyma. A8: Thickest area of remaining red-brown muscle fibers of the. diaphragm and nodule. B. The second container is additionally identified as, ""2. mesothelioma. parietal visceral pleura "". Received fresh and placed in formalin is a 218.7 g,. 20 x 15 x 3 cm in overall dimension unoriented, slightly conical-shaped. pleurectomy specimen. The specimen has a volumetric displacement of. approximately 250 mL. The specimen is diffusely thickened and fused. The outer. surface is shaggy, mottled tan-pink to gray with yellow streaks and with visible. ridged imprints of the ribs. The inner lining of the visceral pleura contains. soft, shaggy remnants of brown lung parenchyma with scattered anthracotic. pigment. Serial sectioning reveals confluent nodular white-gray cut surfaces. measuring up to 1.4 cm maximum thickness. There are also scattered areas of. calcification. Gross photographs are taken. Representative sections are. submitted as B1-B6 (B6 after slight decalcification). C. The third container is additionally identified as, ""#7"". Received fresh and. placed in formalin is a 2.7 X 2.1 x 1.1 cm aggregate of rubbery, tan-yellow to. gray-black tissue fragments (4 total). 4 rubbery, partially fragmented lymph. node candidates are identified ranging in size from 0.8-1.9 cm greatest. dimension. The specimen is submitted entirely as follows: C1: 3 lymph nodes. C2: One lymph node, bisected. D. The fourth container is additionally identified as, ""4R"". Received fresh. and placed in formalin is a 2.2 X 2.1 x 0.9 cm aggregate of rubbery, tan-yellow. to gray-black tissue fragments (5 total). Each fragment contains gray-black. fragmented lymph node candidates ranging in size from 0.6-1.3 cm in greatest. dimension. The specimen is submitted entirely as follows: D1: 2 lymph nodes. D2: 3 lymph nodes. E. The fifth container is additionally identified as, ""#8"". Received fresh and. placed in formalin is a 1.1 x 0.9 x 0.4 cm ovoid, rubbery gray-black lymph node. candidate. The specimen is bisected and submitted entirely as E1. F. The sixth container is additionally identified as, ""#11"". Received fresh. and placed in formalin are 2 fragments of rubbery, gray-black to tan-yellow. lymph node candidates ranging in size from 0.5-0.6 cm greatest dimension. The. specimen is submitted in toto as F1.",T2,N2,M0,T2N2M0
TCGA-EL-A4K0,"oex: F. Case type: Surgical Case. DIAGNOSIS. (A) TOTAL THYROIDECTOMY: PAPILLARY THYROID CARCINOMA, CONVENTIONAL TYPE. Location: Right lobe. Multi-focal: No. Size = 1.1 cm. Extrathyroidal extension: Absent. Lymphovascular invasion: Absent. Resection Margins: Negative. Background Thyroid: Multinodular adenomatous goiter. Lymph nodes: No tumor present in 1 lymph node. GROSS DESCRIPTION. (A) TOTAL THYROIDECTOMY - Consists of thyroid including right lobe (3.5 x 2.5 x 1.5 cm); left lobe (4.0 x 3.0 x 2.0 cm) and. isthmus (1.3 x 1.0 x 0.7 cm). The outer surface is tan-brown, smooth. Sectioning reveals a well-circumscribed tan yellow. nodule (1.1 x 1.0 x 1.0 cm), located in the right lobe, another additional two nodules, 0.7 cm and 0.4 cm on the right lobe. identified. A tan brown nodule in the left lobe, 0.9 cm in greatest dimension identified. SECTION CODE: A1, A2, right lobe, largest nodule; A3, A4, two additional nodules, right lobe; A5, A6, left lobe. nodule; A7, A8, left lobe representative; A9, isthmus. CLINICAL HISTORY. Papillary thyroid cancer. SNOMED CODES. T-B6000 M-80503 M-Y3420. T-C4200, M-00110, ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration. Entire report and diagnosis completed by:",T1,N0,M0,T1N0M0
TCGA-39-5037,"Clinical Diagnosis & History: with LLL lesion (+) PET. Specimens Submitted: 1: SPI para-aortic aventitia tissue. 2: SP: Loft lower lobe lung. 3: SP: Left level eleven lymph nodo. 4: SP: Level seven lymph node. 5: SP: Left level ten lymph node. DIAGNOSIS: SOFT TISSUE, PARA-AORTIC-AORTIO ADVENTITIA, EXCISION: - BENION VESSEL WALL. 2). LUNG, LEFT LOWER LOBE, LOBECTOMY. - SQUAMOUS CELL CARCINONA, MODERATELY TO POORLY. DIFYERENTTIAPED/UNDIFPERENTIATED, OF LEFT LOWER LOBE,. - THE TUMOR MEASURES 2.3 x 2.2 x 2.0 CM. - NO VASCULAR INVASION IS IDENTIFIED. - NO PERINEURAL INVASION IS IDENTIFIED. - THE MAINSTEM BRONCHUS xs NOT INVOLVED BY TUMOR. - THE BRONCHIAL MARGIN IS PREE OF TUMOR. - THE PLEURA IS FREE OF TUMOR. - THE LUNG IS UNREMARKABLE. THE NON-NEOPLASTIC LUNG IS UNREMARKABLE. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF. METASTATIC NODES IN RELATION TO THE TOTAL NUMBER OF NODES EXAMINED) 1. PERIBRONCHIAL: 1/2, HILAR: 0/6. 3). LYMPH NODE, LEFT, LRVEL XI, EXCISION: - BENIGN LYMPH NODE. 4). LYMPH NODE, LEVEL VII, EXCISION: - BENIGN LYMPH NODE. 5). LYMPH NODE, LEFT LEVEL x, EXCISION: BENIGN LYMPK NODE. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. 1). The spocimen is received fregh for frozen section consultation, labeled. ""Para aortic avontitia"" and consists of two fragments of soft tissue. measuring 0.4 am and 0.5 em in greatest dimension, which are entirely. submitted for frozen section congultation. Summary of sections: FSC-frozen section control. 2). The specimen is received fresh, labeled, ""left lower lobs lung"". consists of a 16.0 x 13.5 x 4.8 em lung lobe with attached branchus and. blood vessols, which weighs 244 gm. There is no stapled margin, The. attached bronchus measures 1.0 cm in length by 1.1 cm in diameter, Thore. is. a 5.0 x 2.0 em surgical defect on the anterior aspect. The pleural surface. showg multiple areas of fibrous adhesions. The pleural surface is inked. black. Serial sectioning reveals a 2.3 x 2.2 x 2.0 cm white-tan, stellate. tunor. The tumor is ill-defined. The tumor is situated in the mid lung. parenchyma, located 2.2 em from the bronchial margin. The tumor is within. the parenchyma 1.2 em from the pleura. The tumor grossly does not involve. the bronchus without causing bronchial obstruction. The bronchial mucosa is. smooth and glistening. There are no satellite lesions, Peribronchial. anthracotic lymph nodes are identified and submitted. The uninvolved lung. paranchyma is unremarkable. The bronchial margin and a representative. section of tumor were sent for frozen section. Representative sections. including the entire tumor are submitted. TPS is submitted. Photographs are. taken. Summary of sections: FSCA -- frozen section control, bronchial margin. FSCB -- frozen section control, tumor. VM vascular margin. TP tumor with pleura. TB - tumor with bronchus. TV - tumor with adjacent pulmonary parenchyma. RA - random lung parenchyma at loast 3 cm away from main tumor. RC - random lung parenchyma closo to tumor (within 3 cm of main tumor). LN -- lymph nodes. 3). The specimen is received in formalin, labeled left level 11 lymph. node and consiats of an anthracotic lymphoid fragment measuring 0.8 cm in. greatest dimension, which is antirely submitted whole. Summary of sections: U-undesignated. 4). The specimen is raceived in formalin, labeled ""Level 7 lymph node"" and. consists of an anthracotic lymph node measuring 1 cm in greatest dimension,. which is bisected and submitted entirely. Summary of sections: BLN - bisected lymph node. 5). The specimen is received in formalin, laboled ""Left leval 10 lymph. node"" and consists of a 1.2 cm flattened anthracotic lymph node which is. submitted entirely. Summary of aections: U-undesignated. Summary of Sections: Part 1; SP: Para-aortic aventitia tissue. Block. Sect. Site. PCs. 1. fsc. 1. Part 2: SP: Loft lower lobe lung. Block. Sect. site. PCs. 1. fsca. 1. 1. fscb. 2. In. 2. ra. 1. ro. 1. 2. 2. tp. 1. 6. tu. 6. vm. 1. Part 3: SP: Left level eleven lymph node. Block. Sect. Site. PCa. 1. u. Continued on noxt page. Part 4: SP: Level seven lymph node. Block. Sect. site. PCa. 1. bln. 1. Part 51 SP: Left level ten lymph node. Block. Sect. Site. PCs. 1. u. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: PARA-AORTIC AVENT TISSUE. BENIGN. SMOOTH MUSCLE. PERMANENT DIAGNOSIS: SAME. 2A). FROZEN SECTION DIAGNOSIS: LEFT LOWER LOBE LUNG. BENIGN. BRONCHIAL MARGIN. PERMANENT DIAGNOSIS: SAME. 2B). FROZEN SECTION DIAGNOSIS: LEFT LOWER LOBE LUNG. POORLY. SQUAMOUS CELL CARCINOMA. PERMANENT DIAGNOSIS: SAME. Note: The diagnoses given in this section pertain only to the. tissue sample examined at the time of the intraoperative. consultation. 1). FROZEN SECTION DIAGNOSIS: PARA-AORTIC AVENT TISSUE. BENIGN. SMOOTH MUSCLE. PERMANENT DIAGNOSIS: SAME. 2A). FROZEN SECTION DIAGNOSIS: LEFT LOWER LOBE LUNG. BENIGN. BRONCHIAL MARGIN,. PERMANENT DIAGNOSIS: SAME. 2B). FROZEN SECTION DIAGNOSIS: LEFT LOWER LOBE LUNG. POORLY. DIFFERETHAITED SQUAMOUS CELL CARCINOMA. PERMANENT DIAGNOSIS: SAME.",T1,N1,M0,T1N1M0
TCGA-EI-6514,"Examination: Histopathological examination. Material: 1. Multiple organ resection - colon and sigmoid. Expected time of examination: Clinical diagnosis: Cancer of the rectosigmoid junction. Macroscopic description: 15.8 cm length of the large intestine with a fragment of the mesorectum sized 17 x 6 x 3 cm. Ulcerous tumour sized 6.3 x 6.6 x. 0.9 cm found in the mucosa. The lesion surrounds 100% of the intestine circumference, located 0.5 cm from one of the excision. lines and 2.9 cm from the opposite line. Microscopic description: Adenocarcinoma tubulopapillare (G2). Infiltratio carcinomatosa telae adiposae mesenterii (spec. B). Excision lines free of neoplastic lesions. Lymphonodulitis reactiva (No VIII). Histopathological diagnosis: Adenocarcinoma tubulopapillare coli. Tubulopapillar adenocarcinoma of the colon. (G2; Dukes B; Astler-Coller B2; pT3; pNO).",T3,N0,M0,T3N0M0
TCGA-55-8085,"GROSS AND MICROSCOPIC SURGICAL PANEL. Specimen Information. SURGICAL PANEL: DIAGNOSIS. A) LYMPH NODE, LEVEL 9, LEFT, BIOPSY: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. B) LYMPH NODE, LEVEL 9, LEFT, BIOPSY: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. C) LUNG, LEFT LOWER LOBE, WEDGE RESECTION: 1. Moderately differentiated adenocarcinoma with papillary features. forming a mass measuring 2.5 X 2.2 X 1.6 cm. 2. Stapled parenchymal resection margin and visceral pleura free of. involvement. 3. Two benign peribronchial lymph nodes. 4. Emphysematous changes are present in surrounding non-involved. pulmonary parenchyma. D) LUNG, LEFT UPPER LOBE, WEDGE RESECTION: 1. Severe emphysematous changes with subpleural bullous formation. 2. Apical fibrous scar. 3. No evidence of active inflammation or neoplasia. E) LYMPH NODE, LEVEL 7, LEFT, BIOPSY: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. F) LYMPH NODE, LEVEL 5, LEFT, BIOPSY: 1. Benign lymph node. 2. No evidence of metastatic carcinoma. Final TNM: stage: IA. MACROSCOPIC. SPECIMEN TYPE. Wedge resection. TUMOR SITE. Left Lung-Lower Lobe. TUMOR SIZE. 2.5 X2.2X 1.6 cm. TUMOR FOCALITY. Unifocal. MICROSCOPIC. HISTOLOGIC TYPE. Papillary adenocarcinoma. HISTOLOGICAL GRADE. G2: (moderately differentiated) of G4. VISCERAL PLEURAL INVASION. Not identified. LYMPHATIC VASCULAR INVASION. Absent. TREATMENT EFFECT. Not applicable. TUMOR EXTENSION. Not applicable. MARGINS. Uninvolved by tumor (Parenchymal). Distance of tumor from closest margin is 1.5 cm. PATHOLOGIC STAGING. EXTENT OF INVASION. pT1b. [Tumor greater than 2 cm, but 3 cm or less in greatest. dimension, surrounded by lung or visceral pleura, without bronchoscopic. evidence of invasion more proximal than the lobar bronchus (ie, not in the. main bronchus)]. REGIONAL LYMPH NODES. pNO. (No regional lymph node metastasis). Total nodes: 6. Total positive nodes: 0. N1 nodes: 2. N1 positive nodes: 0. N2 nodes: 4. N2 positive nodes: 0. N2 sites sampled: Station 9: Pulmonary ligament nodes. Station 7: Subcarinal nodes. Station 5: Subaortic nodes (aorto-pulmonary window). DISTANT METASTASIS. pMO. (No distant metastasis). PATHOLOGIC STAGE Summary. Final TNM: 5T1bNOM0. stage: IA. The pathologic stage presumes no distant metastasis. LUNG ANCILLARY TESTING PROTOCOL. HISTOLOGIC TYPE. Papillary adenocarcinoma. STAGE IV STATUS. Stage IV status is undetermined. TISSUE BLOCK AVAILABLE FOR ANCILLARY TESTING. C5. COMMENT. This patient's sample does not meet. criteria for reflex EGFR and ALK testing. No fresh tissue is available. for ancillary testing. The block identified above will be stored in. pathology for 10 years for possible future ancillary testing. Please call. for any ancillary testing requests. EGFR and ALK reflex testing criteria: Stage IV disease (histologically proven or clinically suspicious). Adenocarcinoma or TTF-1 positive adenosquamous cell carcinoma. Attending Pathologist: CLINICAL INFORMATION. Lung cancer. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Lymph node biopsy, level 9, left. The specimen is received labeled ""level 9 lymph node (left),' received in. formalin, is a 0.8 cm red-black partially yellow and fatty thin lymph node. Submitted in toto in one cassette. B) SOURCE: Lymph node biopsy, level 9, left, additional tissue. The specimen is received labeled ""additional level 9 lymph node (left). It. consists of a 1.2 cm gray-black lymph node. Longitudinally bisected and. entirely submitted in one cassette. C) SOURCE: Lung wedge resection -frozen section, left lower lobe. The specimen is received labeled ""wedge resection, left lower lobe.' It. consists of a 48-gram, 9 X 4.5 X 3 cm lung wedge resection with two. partially intersecting staple lines (9.5 X 0.5 cm) in aggregate. The. visceral pleural red-tan surfaces include a minimal amount of subpleural. anthracosis. The stapled margin is trimmed and immediately subjacent tissue. inked black. The intact smooth pleural surfaces are inked green. Cut. surfaces disclose a solid firm gray-tan tumor mass, measuring 2.5 X 2.2 X. 1.6 cm, 1.5 cm from the black-inked stapled resection margin and 0.2 cm. from the green-inked smooth pleural surface. A representative section of the tumor mass is submitted on one block for. frozen microscopy. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Adenocarcinoma,. margin negative. Approximately 2.5 cm tumor, approximately 1.5 cm from. margin."" is rendered by. The remaining lung parenchyma discloses diffuse mild emphysematous change. and a single black peribronchial, 0.3 cm lymph node without evidence of. gross tumor. Note: Fresh tumor is retained for additional possible ancillary studies. Representative sections are submitted in eight cassettes as follows: 1. Frozen section residue. 2-3. Stapled resection margin, perpendicular to black ink. 4-6. Tumor with green-inked pleural surface. 7. Normal lung, at least 1.5 cm away from tumor. 8. One peribronchial lymph node. Note: The specimen is placed in formalin at approximately. on. for a minimum of six hours fixation. This case is accessioned in. D) SOURCE: Left upper lobe wedge resection lung. Labeled ""left upper lobe wedge resection lung"" received in formalin is a. 10.5 X X 4 cm, 55 gram lung wedge. The pleural surface is purple-pink. focally ragged with a staple line present along one edge. The staple line. is removed from underlying tissues inked green. The lung is serially. sectioned revealing a 4 X 3 X 3 cm air pocket surrounded by white-tan dense. tissue. The remaining lung parenchyma is red-tan hemorrhagic and spongy. without masses or lesions identified. Representative sections are submitted. in five cassettes. E) SOURCE: Level 7 lymph node, left. Labeled ""level 7 lymph node, left"" is a 0.8 cm red-brown rubbery lymph. node. The specimen is entirely submitted in one cassette. F) SOURCE: Level 5 lymph node, left. Labeled ""level 5 lymph node, left"" is a 0.6 cm anthracotic lymph node. The. specimen is submitted in toto in one cassette. MICROSCOPIC. A-F) The microscopic appearance substantiates the diagnosis. Dictation by. iscribed by: ACCESSIONED. Lab and Collection. GROSS AND MICROSCOPIC SURGICAL PANEL. - Lab and Collection. Information. Result History. GROSS AND MICROSCOPIC SURGICAL PANEL. Result Date and Time. Provider Status. Lab. Parent Order ID. Child Order ID. Specimen Information,. Specimen Source. Lung. Audit Trail.",T1,N0,M0,T1N0M0
TCGA-CM-4744,"Clinical Diagnosis & History: year old male with history of colon carcinoma. Specimens Submitted: 1: terminal ileum, appendix, and ascending colon; Right hemicolectomy. DIAGNOSIS: 1. TERMINAL ILEUM, APPENDIX, AND ASCENDING COLON; RIGHT. HEMICOLECTOMY: - TUMOR TYPE: ADENOCARCINOMA. - HISTOLOGIC GRADE: MODERATELY DIFFERENTIATED. - TUMOR LOCATION: CECUM. - TUMOR SIZE: LENGTH IS 4.5 CM. WIDTH IS 4.0 CM. MAXIMAL THICKNESS IS 0.5 CM. PREEXISTING POLYP (AT THE SITE OF THE CARCINOMA) : TUBULOVILLOUS. ADENOMA. - TUMOR INVASION: INVASION INTO MUSCULARIS PROPRIA. - SEROSAL INVOLVEMENT: NOT IDENTIFIED. - VASCULAR INVASION: IDENTIFIED. - PERINEURAL INVASION: NOT IDENTIFIED. - SURGICAL MARGINS : FREE OF TUMOR. - POLYPS (AWAY FROM THE CARCINOMA} : NOT IDENTIFIED. - NON-NEOPLASTIC BOWEL: UNREMARKABLE. - THE PATHOLOGIC STAGE IS (AJCC. pT2. - LYMPH NODES: TWENTY-EIGHT BENIGN LYMPH NODES (0/28). - THE PATHOLOGIC STAGE IS (AJCC. : pNO. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. Gross Description: 1. The specimen is received fresh, labeled ""Right hemicolectomy"" and. consists of a segment of terminal ileum, cecum with attached appendix and. ascending colon. The terminal ileum measures 9.0 am in length and 4.5 cm in. circumference at the proximal resected margin. The remaining colon measures. 18.5 cm in length with a circumference of 8.3 am at the distal resected. margin. The attached appendix measures 6.0 cm in length and averages 0.5 cm. in diameter. The appendiceal and intestinal serosa is pink tan and smooth. Focally hemorrhagic lobulated yellow tan adipose tissue spans the length of. the specimen measuring up to 4.0 cm in thickness. The specimen is opened to. reveal a mass lesion in the cecum, 0.5 cm distal to the ileocecal valve,. measuring 4.5 cm in length and 4.0 cm in width. Sectioning show that the. tumor invades into the muscle wall. The depth of invasion is 0.5 cm grossly. The remaining mucosa is unremarkable. The specimen is submitted for lymph. node dissection. Multiple lymph nodes are identified in the attached adipose. tissue and are submitted. Representative sections of the specimen are. submitted for permanent sections and for TPS. Summary of sections: p-- proximal margin shave. D -m distal margin shave. M-- mass. A appendix representative sections. RS -representative sections. BLN -- bisected lymph nodes. LN- - lymph nodes. Summary of Sections: Part. 1: terminal ileum, appendix, and ascending colon; Right hemicolectomy. Block. Sect. Site. PCs. 1. AP. 3. 2. BLN. 4. DM. 1. 6. LN. 22. 1. PM. 1. 1. RS. 1. 6. 6.",T2,N0,M0,T2N0M0
TCGA-L5-A4OS,"REVIOUS DIAGNOSIS INQUIRY. 2. SEX: F. - adenocarinoma, NOS 8140/3. PROCEDURE: SPHS. Poorty-differentiated adenocarcinoma with extensive necrosis. Clinical. Diagnosis: Esophageal cancer. Operative Procedure: PROCEDURE: SPGD. 1. ""Proximal stomach distal esophagus"". Received in formalin in a large. container is a 6.5 cm long distal esophagus with a 6.5 x 4.2 x 1.3 cm attached. proximal stomach. The adventitia is ragged. The mucosa of the esophagus is. gray-white and prominently folded. The mucosa of the stomach is tan and. rugated. The esophageal mucosa is remarkable for a 4.2 x 3.3 x 1.3 cm gray-tan. necrotic Lesion that is located at the esophageal gastric junction however the. mid point of the tumor is 1.5 cm above the esophageal gastric junction. The. tumor is 4.1 cm away the proximal margin of resection and 2.2 cm away from the. gastric margin of resection. The tumor has a maximum depth of 0.3 cm and. extends to the muscularis, The tumor is friable and mostly necrotic. Multiple. possible lymph nodes are identified ranging up to 1.2 cm. The cut surface of. the largest is gray-white. No other abnormalities are noted. 1A. Tumor to adjacent proximal normal. 1B. Tumor to adjacent distal. 16 Tumer to deepr. 1E and F. Additional esophageal gastric junction. 1G. Multiple possible Lymph nodes. 1H and 1. One bisected lymph node. each). 2. ""Lesser curvature"". Received in format in in a small container is a 3.7 x. 3.2 x 1.1 cm irregular portion of yellow fibroadipose tissue. Two possible. lymph nodes are identified, 0.7 and 1.1 cm. 2A and B. One bisected tymph node each. Fat retained. 3. ""Lesser curvature gastric node"". Received in formalin in a small container. is a 1.3 cm possible lymph node. Bisected. 4. ""Celiac node"". Received in formalin in a small container is a 1.1 cm. PREVIOUS DIAGNOSIS INQUIRY. 3. SEX: F. possible lymph node. Bisected. 5. ""Cervical esophago-gastric margin"". Received in formalir in a small. container is a 1.1 cm long segment of esophagus that is 2.2 cm in diameter. Staple line is present on one aspect with the other being left open. Tissue is. removed from the staple line. Staple line retained. PROCEDURE: SPM!. GASTROESOPHAGEAL JUNCTION. Gastroesophageal junction. SIZE: 4.2 cm. TYPE OF CARCINOMA: Adenocarcinoma not arising in Barrett's mucosa. DEPTH OF INVASION: Muscutaris propria. NUMBER OF POSITIVE LYMPH NOOES / TOTAL NUMBER OF NODES EXAMINED: 1/13. DISTANT METASTASIS: Unknown. RESECTION MARGIN INVOLVED: No. T2 N1. PROCEDURE: SPDX. 1&5. Distal esophagus and proximal stomach, resection: Invasive,. peen. the. gestroesephegee+. junction. and invading into the muscularis propria (4.2 cm). No intestinal metaplasia. No vascular invasion. Margins negative. Metastatic carcinoma in one of nine. Lymph nodes (1/9). 2. Lymph nodes, lesser curvature of stomach, excision: Two lymph nodes. negative for neoplasm (0/2). 3. Lymph node, lesser curvature of stomach, excision: One lymph node negative. for neoplasm (0/1). PREVIOUS DIAGNOSIS INQUIRY. 4. SEX: F. 4. Lymph node, celiac, excision: One tymph node negative for neoplasm (0/1). the signing staff pathologist, have personally. examined and interpreted the slides from this case. ENO OF PREVIOUS DIAGNOSIS INQUIRY.",T2,N1,M0,T2N1M0
TCGA-RC-A7SK,"A and C. Liver, left. lobectony : HEPATOCELLULAR CARCINOMA. Tumor number : one. Satellite nodule: no. Gross type: nodular with perinodular extension. Size(cm): : 4x3.5x3. Differentiation: The worst differentiation: Edmondson grade IV. Differentiation: The major differentiation: Edmondson grade 111. Histologic type : microtrabecular. Cell type : hepatic. Tumor necrosis : yes (10%). Hemorrhage : no. Fatty change : no. Fibrous capsule : partial. Infiltration of capsule : yes. Septum formation : yes. Surgical margin invasion : no(margin of the clearance : 0.3 cm). Serosa invasion: no. Portal vein invasion : no. Bile duct invasion : no. Hepatic vein invasion : no. Hepatic artery invasion : no. Microvesse invasion : yes. Intrahepati netastasis : no. Multicenteric occurrence : no. r stage : pll. N stage: No metastasis in all 1 Tymph node(pNO). Non-tumor liver. Chronic hepatitis : yes. Etilogy : HCV. Grade. Icbular : minimal. Grade. portoperiportal mild. Stage(fibrosis) : periportal. Cirrhosis : no. Dysplastic nodule : no. Ouctal epithelial dysplasia : no. Other liver disease : no. Fatty change, macrovesicular (10%). B. Garibladder, cholecystectomy : Chronic cholecystitis. <Result of special stain>. fron(Block #A9) : Negative. <Results of immunohistochemical stain>. Cytokeratir 7(Block #A9) : Positive in bile duct. Cytokeratin 7. Cytokeratin 19, Hepatocyte(Bloci #A8) : Negative. A. The specimen received in formalin is a product of lobectomy of liver. measuring. 12x8x4cm and weighing 175gn. The external surface shows a protruding. subcapsular mass, The parenchyma resection margin is clear. On section, there. are nodular with per inodular extension Type mass. measuring 4x3.5x3cm. The mass is 0.3cm apart from parenchymal resection margin. On serial section. the remaining parenchyina is unremarkable, Representative sections are embedded. in 9 cassettes. (A1104-one plane. A5to8-one plane. A9-background / iver). B. The specimen received in formalin consists of a gallbladder. ineasur ing 9cm In length and 1.5cm in diameter. The capsular surface is. unremarkable. The wall measures 0.2cm in maximal thickness. The mucosa is. greenish velvety. There is no stone or polyp. Representative sections are. embedded in one cassette. C. The specimen received in formalin is a Tump of adipose issue labeled. ""Tymph node"" Entirely embedded in one cassette. H&E(11), MT(1). RTC(1). D-PAS(1) fron(i). Cytokeratin 7(1). Cytokeratin 19(1). Hepatocyte(1).",T1,N0,M0,T1N0M0
TCGA-B8-5553,"Diagnosis: A: Kidney, left, partial nephrectomy. Tumor histologic type/subtype: clear cell renal cell carcinoma. Sarcomatoid features: not identified. Histologic grade (if applicable): 2 (of 4, Fuhrman classification). Tumor size (greatest dimension): 5.5 cm diameter. Tumor focality: unifocal. Extent of invasion: Extra-capsular invasion into perirenal adipose tissue: not identified. Venous (large vessel): not identified. Lymphatic (small vessel): not identified. Surgical margins: Renal parenchymal margin (partial nephrectomy only): not involved. Renal capsular margin (partial nephrectomy only): not involved. Perinephric adipose tissue margin (partial nephrectomy only): not involved. Adrenal gland: not received. Lymph nodes: none received. Other significant findings: none. AJCC Stage: T1b pNx pMx. This staging information is based on information available at the time of this report, and is subject to change pending clinical review and. additional information. B: Fat, overlying mass, biopsy. - Mature fat, no carcinoma identified. Clinical History: a left renal mass. Gross Description: Received are two appropriately labeled containers. Container A is additionally labeled ""left partial nephrectomy."" It holds a 62.7 gram, 6.5 X 5.4 X 3.6 cm partial nephrectomy specimen. composed of a 5.4 X 4.2 X 2.8 cm fragment of kidney with overlying attached perinephric fat. The parenchymal margin is marked with black. ink and the perinephric fat margin is marked with blue ink. The specimen is sectioned to reveal a 5.5 x 3.8 x 3.2 cm circumscribed cortical. nodule with a solid, variegated dark red to orange/brown cut surface. This nodule focally abuts multiple black inked surgical margins and. expands the capsule. The overlying perinephric fat appears intact and unremarkable. The small amount of renal tissue identified is. compressed and grossly unremarkable. Tumor and normal are given to Tissue Procurement. Block Summary: Al - perpendicular sections of tumor and black inked parenchymal margin. A2 - tumor expanding capsule. A3 - tumor and overlying capsule (inked blue). A4,A5 - central tumor. Container B is additionally labeled ""fat overlying tumor."" It holds a 2.7 X 1.9 x 0.6 cm fragment of markedly cauterized unoriented. yellow/tan fibrofatty tissue which is serially sectioned and entirely submitted in blocks B1-B2, NTR. Light Microscopy: Light microscopic examination is performed by Dr. Attending Pathologist: I have personally conducted the evaluation of the above specimens and have. rendered the above diagnosis(es).",T1,N0,M0,T1N0M0
TCGA-KB-A6F5,"M. Facility: Specimen(s) Received. 1. Lymph-Node: Para Esophageal. 2. Stomach Resection: Total stomach and proximal esophagus qs on esophagus margin. 3. Esophagus: Final esophageal margin #1. 4. Esophagus: Final esophageal margin #2. Diagnosis. 1. Lymph-Node: Para Esophageal: - lymph node x1: negative for carcinoma. 2. Stomach and distal esophagus, total gastrectomy and distal esophagectomy: - adenocarcinoma of proximal stomach, moderately to poorly differentiated, intestinal type, extending into distal. oesophagus, invading perigastric fat - see synoptic data and comment. metastatic adenocarcinoma in 4/16 lymph nodes. - resection margins: negative for carcinoma. - chronic atrophic pan-gastritis with marked intestinal metaplasia. 3. Esophagus: Final esophageal margin #1: - negative for carcinoma. 4. Esophagus: Final esophageal margin #2: - negative for carcinoma. Comment. 2. The tumor has features of an intestinal type adenocarcinoma and is focally poorly differentiated. There is chronic. pangastritis with marked intestinal metaplasia. No H. pylori are identified. Synoptic Data. Clinical History: Not known. Specimen: Stomach. Distal esophagus. Procedure: Total gastrectomy. Tumor Site: Fundus. Body - Anterior wall. Body - Posterior wall. Body - Lesser curvature. Body - Greater curvature. Tumor Size: Greatest dimension: 11.5 cm. Additional dimension: 7.5 cm. Additional dimension: 1.7 cm. Histologic Type: Adenocarcinoma, intestinal type. Histologic Grade: G3: Poorly differentiated. Microscopic Extent of Tumor: Tumor invades subserosal connective tissue. Proximal Margin: Uninvolved by invasive carcinoma. Carcinoma in situ/adenoma not identified at proximal margin. Distal Margin: Uninvolved by invasive carcinoma. Carcinoma in situ/adenoma not identified at distal margin. Omental (Radial) Margin: Uninvolved by invasive carcinoma. Deep Margin: Deep margin not applicable. Status of All Margins: All margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 11,0 mm. Closest margin: Proximal margin. Treatment Effect: No prior treatment. Lymph-Vascular Invasion: Present. Perineural Invasion: Present. TNM Descriptors: Not applicable. Primary Tumor (pT): pT3: Tumor invades subserosal connective tissue, without involvement of. visceral peritoneum or adjacent structures. Regional Lymph Nodes (pN): pN2: Metastasis in 3 to 6 perigastric lymph nodes. Number of lymph nodes examined: 16. Number of lymph nodes involved: 4. Distant Metastasis (pM): Not applicable. Additional Pathologic Findings: Intestinal metaplasia. Other gastritis: chronic atrophic gastritis. Pathologic Staging is based on AJCC/UICC TNM, 7th Edition. Gross Description. 1. The specimen container labeled with the patient's name and as a. para esophageal"" contains two pieces of yellowish. black nodal tissue measuring 0.4 X 0.4 x 0.2 cm and 0.6 x 0.3 x 0.2 cm received in 10% buffered formalin. 1A submitted in toto. 2. STOMACH RESECTION FOR TUMOR. (INCLUDES GE JUNCTION TUMORS). GROSS EXAMINATION. RESECTION SPECIMEN: e.g. Total stomach, subtotal and proximal esophagus. on the esophageal margin,. perigastric fat and omentum. FIXATION: Fixed. DIMENSIONS: Length along lesser curvature 14.5 cm. Length along greater curvature 30 cm. Circumference of distal gastric margin 8 cm. Circumference of proximal gastric margin n/a. Length of tubular esophagus if present 5-cm. circumference of tubular esophagus if present 5-cm. TUMOR: - cardia, fundus, GEJ, body. - Greater and lesser curvature. - Anterior and posterior wall. - 90% of tumor located in the stomach. - CONFIGURATION: exophytic with ulcerative center, annular/circumferential. - DIMENSIONS: Diameters 11.5 cm in circumference, 7.5 cm in length. Depth 1.7 cm. DESCRIPTIVE CHARACTERISTICS: solid and homogeneous tan white on cut surface. - PERFORATION: no. - DISTANCE FROM MARGINS: - PROXIMAL 1.1 cm. - DISTAL. 10.0 cm. - RADIAL 9.0 cm (non-peritonealized soft tissue margin closest to deepest tumor penetration. ESTIMATED DEPTH OF INVASION: perigastric fat. LESIONS IN NONCANCEROUS STOMACH: None. LYMPH NODES: Multiple perigastric lymph nodes along the greater and lesser curvatures ranging in size from 0.3 to 3.0. cm. ADDITIONAL STRUCTURESS: The greater omentum measures 37 x 17 x 2 cm. On serially sectioning no nodules. identified. Tissue is stored frozen. Representative Sections: 2A, 2B esophageal resection margin en face, frozen section blocks resubmitted. 2C-2F one full length section of tumor from esophageal end to gastric wall just distal to tumor, includes a section of lymph. node). Both ends painted with India ink-they are NOT MARGINS). 2G, 2H, tumor with extension into perigastric fat and the remainder of greater curvature lymph node from block 2E. 21 tumor with a section of lymph node from lesser curvature. 2J tumor abutting serosa. 2K gastric wall adjacent to tumor. 2L gastric body. 2M gastric antrum. 2N pylorus. 20-2S omentum. Lesser curvature lymph nodes: 2T, 2U multiple lymph nodes, each block. 2V, one lymph node bisected. 2W one lymph node trisected. 2X, 2Y representative sections from one large lymph node. Greater curvature lymph nodes: 2Z multiple lymph nodes. 2AA, 2AB one lymph node, bisected, each block. 2AC, 2AD query quadrisected lymph node vs splenule. ADDITIONAL BLOCKS: 2AE-2AF stomach < 5cm from tumour. 2AG-2AH stomach > 5cm from tumour. 2AI distal resection margin, en face. 3. The specimen container labeled with the patient's name and as ""final esophageal margin #1"" contains a circular ring of. tan tissue, grossly consistent with esophagus measuring 3 x 1.2 x 1.1 cm received in 10% buffered formalin. There is a. staple line along one side of the specimen. No gross abnormality noted. 3A full face section opposite to staple line en face. 4. The specimen container labeled with the patient's name and as ""final esophageal margin #2"" contains a piece of. gray-tan, partly hemormhagic tissue, grossly consistent with esophagus measuring 4.5 x 1.2 x 0.5 cm received in 10%. buffered formalin. The surface of the tissue is smooth to slightly nodular. No staple line is identified. 4A, 4B, bisected and submitted in toto. Quick Section Diagnosis. 2A,B (esophageal margin): negative for carcinoma. Reviewed with.",T3,N2,M0,T3N2M0
TCGA-UT-A88C,"HISTOPATHOLOGY REPORT : CLINICAL NOTES: Probable mesothelloma on needle blopsy R chest wall. MACROSCOPIC: 'Parletal pleura'. The specimen consists of six strips of grey soft tissue ranging between 5mm and 100mm In maximal. dimension. There is a 5mm separate fatty nodule. No definite tumour Is Identified. The tissue Is divided and all embedded. (Blocks A & B). MICROSCOPIC: Surge. The previous pathology (FNA and core blopsy,. noted, however, Is unavailable currently for. Use. review. This specimen consists of portlons of pleura including pleural adipose tissue and skeletal muscle. It contains an infiltrate of. Norma. large, epithelioid malignant cells arranged in cohesive aggregates with a pseudoacinar, tubular and micropapillary patterns. The cells have large irregular nuclei with prominent nucleoll and a variable amount of eosinophilic to clear cytoplasm. There. Is a background fibrous stroma. The malignant cells Infiltrate into and amongst adipose tissue. No necrosis Is seen. No. No-Actlo. sarcomatold areas are identified. Immunohlstochemistry shows strong positive staining of the malignant cells for calretinin. File. 34BE12, HBME1 and CK7, and patchy staining for CK5/6. There Is no significant staining for CEA, MOC31, CK20 and. TTF1. The histologic features and Immunohlstochemical profile are compatible with the diagnosis of malignant mesothelloma of. Contac. epithellold type. DIAGNOSIS: See. RIGHT PARIETAL PLEURA - MALIGNANT MESOTHELIOMA, EPITHELIOID SUBTYPE. See File. Continue. Treatmen.",T3,N2,M0,T3N2M0
TCGA-A2-A3XX,"Specimen #: (Age. Race. SPECIMEN: A: SENTINEL NODE #1 B: LEFT BREAST TISSUE. FINAL DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, BIOPSY: - ONE (1) LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA BY H&E AND. IMMUNOSTAINS. B. BREAST, LEFT, MASTECTOMY: - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: 3 OUT OF 3. - NOTTINGHAM SCORE: 8 OUT OF 9 (Tubules= 3, Nuclei= 2, Mitoses= 3. mitotic count 22 per 10 HPF at 40x power). TUMOR SIZE (GREATEST DIMENSION) : 2.2 CM (MEASURED GROSSLY). - TUMOR NECROSIS: PRESENT IN BOTH THE INVASIVE AND IN SITU COMPONENTS. - MICROCALCIFICATIONS: ABSENT. - VENOUS / LYMPHATIC INVASION: ABSENT. - MARGINS NEGATIVE. DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.1 CM, FROM THE. SUPERFICIAL (GREEN INKED) MARGIN. (MEASURED MICROSCOPICALLY) (SLIDE. B6). - INTRADUCTAL COMPONENT: PRESENT. DUCTAL CARCINOMA; HIGH NUCLEAR GRADE. (GRADE III) SOLID SUBTYPE WITH CENTRAL NECROSIS. - LYMPH NODES: ONE (1) NEGATIVE FOR TUMOR. (SEE PART A). - NIPPLE INVOLVEMENT: ABSENT. - SKIN INVOLVEMENT: ABSENT. - MULTICENTRICITY: ABSENT. - ESTROGEN RECEPTORS: NEGATIVE (SEE CASE. - PROGESTERONE RECEPTORS : NEGATIVE (SEE CASE. - HER 2 NEU by IHC: NEGATIVE (SEE CASE. - PATHOLOGIC STAGE: pT2 NO (i-) MX. - ADDITIONAL PATHOLOGIC CHANGES. INTRADUCTAL PAPILLOMA. FIBROADENOMATOUS CHANGES. FIBROCYSTIC CHANGES. COMMENT: Cytokeratin staining of part A supports the above diagnosis. This case received prospective intradepartmental peer review. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT OF. FOR OFFICIAL US ONLY - PERSONAL DATA - PRIVACY ACT or. Specimen #. FINAL DIAGNOSIS (continued). CLINICAL DIAGNOSIS AND HISTORY: yr old. with left breast cancer. PRE-OPERATIVE DIAGNOSIS: none provided. POST-OPERATIVE DIAGNOSIS: none provided. GROSS DESCRIPTION: A: Received fresh, labeled with the patient's name,. Id. designated ""Sentinel Node #1 with markings; suture marks hottest point at. 1152 hours"" is a 2.5 x 2.5 x 0.7 cm irregular portion of soft tissue. Sectioning reveals a 2.5 x 1.5 x 0,5 cm pink-tan lymph node with attached. adipose tissue. The specimen is entirely submitted as follows: Cassette Summary: A1- sentinel lymph node; A2- adipose tissue. At the time of submission the specimen will have been in formalin for. approximately 23 hours Matched sections of cassette A1 are. submitted in OCT for. Protocol. B: Received fresh, labeled with the patient's name,. and. designated ""Left Breast Tissue, long-lateral, short-superior 1 pm' is. a. 468 gm left mastectomy specimen oriented with a short stitch at the. superior aspect and long stitch at the lateral aspect. The specimen. measures 20.0 cm from superior to inferior by 18.0 cm from medial to. lateral by 3.0 cm from anterior to posterior. The darkly pigmented skin. ellipse measures 9.5 x 3.5 cm and displays a 1.5 cm centrally located,. everted nipple free of discharge. The deep margin is inked in black, and. the left outer quadrant superficial margin is inked in green. Serial. sectioning reveals a 11-circumscribed 2.2 x 2. x 1.8 cm mass in the. lower outer quadrant located 0.3 cm from the superficial margin and 0. cm. from the deep margin. The cut surface is firm gritty pink-red and focally. congested. The remainder of the specimen is composed of evenly. distributed pink-tan fibrous tissue admixed adipose tissue. No additional. lesions are identified. No lymph nodes are identified within the specimen. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT OF. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY ACT or. specimen #: GROSS DESCRIPTION (continued) : Representative sections are submitted. At the time of submission the. specimen has fixed in formalin for approximately 21 hours. Cassette Summary: B1- - skin; B2-B3 - lower outer quadrant deep margin;. B4-B6- mass with superficial margin; B7 - representative section of grossly. normal breast parenchyma from the upper outer quadrant; B8- representative. section of grossly normal breast parenchyma from the upper inner quadrant;. B9 representative section of grossly normal breast parenchyma from the. lower inner quadrant; B10- representative section of grossly normal breast. parenchyma from the lower outer quadrant; B11- - representative section of. grossly normal breast parenchyma from the central area; B12-. representative section of nipple with associated subcutaneous tissue. Matched sections of cassette B1, B4-B5, B7-B11 are submitted in OCT for. ) Protocol. FOR OFFICIAL USE ONLY - PERSONAL DATA - PRIVACY.",T2,N0,M0,T2N0M0
TCGA-86-8280,Gross. Microsc. Diagnos. Comme. OpenCli. Descrip. opic. is. nts. nica ID. tion. Descrip. Details. tion. LUNG TISSUE. CHECKLIST. Specimen type: Pneumonectomy. Tumor site: Lung. Tumor size: 6 X 5 X 2. cm. Histologic type: Bronchiolo-alveolar. adenocarcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Not. specified. Other tumor nodules: Not specified. Lymph nodes: Not. specified. Lymphatic invasion: Not. specified. Venous invasion: Not. specified. Margins: Not specified. Evidence of neo-. adjuvant treatment: Not specified. Additional pathologic. findings: Not specified. Excision. Laterali. ty. Left-. lower.,T2,N0,M0,T2N0M0
TCGA-A8-A095,"2. Invasive ductal breast carcinoma (maximum diameter 1.8 cm, malignancy grade II) with. angioinvasion and infiltration of the neural sheath in the tumor periphery. Likewise in the. tumor periphery a concomitant DCIS (malignancy grade II, procomponent of tumor < 10%). Distant fibrocystic parenchyma of the breast with fibroadenoma buds free of tumor and/or. DCIS. Tumor classification: G2 (L1, V0), pTlc, pNO (sn), MX, R0 (minimum width of dorsocranial. safety margin 1 cm!). 1711E1.",T1,N0,M0,T1N0M0
TCGA-AR-A1AJ,"Final Diagnosis. Breast right, wide local excision: Infiltrating ductal carcinoma, Nottingham grade III (of III),. forming a mass, 1.2 x 1.1 x 0.9 cm. (AJCC pTIc). Angiolymphatic invasion is not identified. The surgical margins are negative for tumor. The closest margin (inferior) is free by 0.3 cm. Lymph nodes, right axillary sentinel, excision: Multiple (2) right axillary sentinel lymph nodes. are negative for tumor. Blue dye is not identified in either of the right axillary sentinel lymph. nodes. Immunohistochemical cytokeratin stain was performed on the paraffin embedded sentinel. lymph node tissue and confirms the H&E impression [AJCCpTN(i-)]. Lymph nodes, right axillary, excision: Multiple (6) right axillary lymph nodes are negative for. tumor. HER2/neu protein overexpression is negative, score of 0, according to the interpretation. guidelines in the FDA-approved HercepTest.",T1,N0,M0,T1N0M0
TCGA-HU-A4GQ,"CLINICAL DIAGNOSIS: Stomach cancer. GROSS: Specimen submitted: Total gastrectomy, unfixed and tissue labeled 'mesocolon'. Measurement : [For stomach]. Greater curvature 30.0 cm. Lesser curvature 14.0 cm. Proximal resection margin 6.0 cm. Distal resection margin 6.0 cm. Esophagus 1,0 cm. Duodenum 0.5 cm. [For tissue labeled 'mesocolon']. One piece, 4.0 x 1.7 x 0.4 cm. Tumor location: Stomach: Lower 1/3 (antrum). From proximal resection margin - 7.0 cm. From distal resection margin - 4.0 cm. Tumor size: 10.0 x 6.0 x 1.6 cm. Tumor type: AGC (Borrmann type) III. Gross serosal invasion: Yes. Representative sections are submitted. Gross photo: Present. Blocks. 11-8, tumor and surrounding tissue x 8. A, antral mucosa x 1. B, body mucosa x 1. P, proximal resection margin of main specimen x 1. PRM, separately submitted 'proximal resection margin' x. 1. D, distal resection margin x 1. LN1-4, superior gastric lymph nodes x 4. LN5-13, inferior gastric lymph nodes x 9. LN4, '1' lymph nodes x 1. LN15. '2' Lymph nodes X. LN16, 4sa' lymph nodes x 1. LN17, 4sb' lymph nodes X 1. - over -. LN18, '5' lymph nodes x 1. LN19-21, '6' lymph, nodes x 3. LN22, '7' lymph nodes x 1. LN23-24, '9' lymph nodes x 2. LN25, '10' lymph nodes X 1. LN26, '11P' lymph nodes x 1. LN27, '11D' lymph nodes x 1. LN28. '12' lymph nodes x 1. A1-2, tissue labeled 'mesocolon' x 2. MICROSCOPIC: Tumor type: Adenocarcinoma, tubular moderately differentiated. Depth of tumor invasion: T4: T4b-Tumor invades adjacent structures (peripancreatic fat and. mesocolon). Margins: Proximal resection margin (-). Distal resection margin (-). Lauren classification: Intestinal. Ming classification (Growth pattern): Infiltrative. Lymphoid reaction: Present. Lymphovascular invasion: Present. Perineural invasion: Present. Lymph node metastases: N2: Metastasis in 3-6 regional lymph nodes. number of involved nodes 4 total number of nodes 105. perinodal extension: Yes. Distance metastasis: Not applicable. Pathologic stage: pT4bN2Mx (AJCC 7th edition). SPECIAL STAIN: Cresyl Violet stain reveals moderate amount of H. pylori. )carcinoma. DIAGNOSIS: Stomach, total gastrectomy: Adenocarcinoma, moderately differentiated, infiltrating. (advanced gastric cancer). Lymph node, perigastric, total gastrectomy: Superior gastric: No tumor present (0/16). Inferior gastric: Metastatic carcinoma, primary in stomach (4/49). Lymph node, regional, biopsy: Labeled 1': No tumor present (0/3). Labeled : No tumor present (0/6). Labeled , 4sa' No tumor present (0/2). Labeled 4sb' : No tumor present (0/2). Labeled '5' No tumor present (0/1). Labeled '6' : No tumor present (0/7). Labeled '7': No tumor present (0/4). Labeled '9' : No tumor present (0/10). Labeled '10' : No tumor present (0/1). Labeled '11P': No tumor present (0/1). Labeled '11D' : No tumor present (0/2). Labeled '12' : No tumor present (0/1). Tissue labeled 'mesocolon', biopsy: Chronic inflammation, no tumor present.",T4,N2,M0,T4N2M0
TCGA-BL-A13I,"SPECIMEN. A. Right ureter. B. Left ureter. C. Urethral margin. D. Bladder, uterus, bilateral tubes and ovaries. E. Left pelvic node. F. Right pelvic node. G. Appendix. CLINICAL NOTES. CLINICAL HISTORY: Bladder cancer. FROZEN SECTION DIAGNOSIS. A. Right ureter, margin: Negative for malignancy. B. Left ureter, margin: Negative for malignancy. C) Urethral margin, biopsy: Negative for malignancy. GROSS DESCRIPTION. A. The specimen is received fresh for frozen section. labeled ""A - right ureter"" and consists of a 0. cm in. diameter, 0.3 cm in length, piece of tubular tan tissue with a. pinpoint lumen. The specimen is entirely frozen as frozen section. AFS-1. B. Received fresh for frozen section labeled ""B - left. ureter"" is a 0.3 x 0.3 X 0.2 cm piece of tubular tan. tissue. with a pinpoint lumen. The specimen is entirely frozen as frozen. section. C. The specimen is received unfixed labeled ""urethral. margin"" and consists of a piece of pink soft tissue. measuring 1.2 x 1 X 0.2 cm. The specimen is dissected and. submitted. for frozen section diagnosis. D. The specimen is received unfixed labeled ""bladder,. uterus, bilateral tubes and ovaries"" and consists of a. GROSS DESCRIPTION. urinary bladder with attached uterus and bilateral adnexa. The. uterus measures 7 X 4 X 2 cm. The right ovary is tan-white and. measures 4.2 X 1 X 0.2 cm. Right uterine tube is pink and measures. 7 cm. in length and 0.3 cm. in diameter. The left ovary is tan-white. and measures 3.5 X 1 X 0.4 cm. The left uterine tube is purple to. pink and measures 8 cm. in length and 0.3 cm. in diameter. The. ectocervix is white and measures 2.7 X 3 cm. The external os. measures 0.2 X <0. 1 cm. There is an adjacent cuff of vaginal tissue. measuring 6 X 3.5 cm. The urethra is identified and is inked. The. bladder is opened without inflation for tissue procurement. There. is a red tumor measuring approximately 2 x 1.2 X 2 cm. The tumor is. in the superior posterior right side of the specimen. There is. stenosis of the internal os. The uterine cavity is not well seen. on. initial sectioning. There is a polyp in the high endocervical. canal. measuring 1 cm. X 0.5 x 0.3 cm. Sections after fixation. Block summary: D1 left ovary; D2 left uterine tube; D3 right ovary;. D4 right uterine tube; D5,D6 vaginal cuff; D7, D8 uterine cervix;. D9, D10 endocervical polyp; D11, D12 endomyometrium; D13-D16. bladder. tumor; D17 right trigone; D. 18 right bladder wall up to tumor;. D19. left trigone; D20 left bladder wall; D 21 dome of bladder; D22. right. side of bladder; D23 left side of bladder; D 24-D26. Perivesicle. fat. E. Received unfixed labeled ""left pelvic nodes"" and. consists of multiple pieces of yellow soft tissue. measuring. 4.5 X 4.5 X 1.5 cm. Sections after fixation. F. Received unfixed labeled ""right pelvic node"" and. consists of white pelvic nodes and consists of multiple. pieces of yellow and red soft tissue measuring 3. X 2.5 X 1.4 cm. Sections after fixation. G. Received in formalin labeled ""appendix"" and consists. of. a thin white vermiform appendix measuring 5.2 cm. in. length. GROSS DESCRIPTION. and 0.3 cm. in diameter. There is an attached mesoappendix. measuring 2 X 4.5 X 1 cm. No serosal exudate is seen. MICROSCOPIC DESCRIPTION. A. Sections of the right ureter negative for malignancy. B. Sections of the left ureter negative for malignancy. C. Sections of the urethral margin are negative for malignancy. D. The patient's tumor is unusually high grade. Since the surrounding. bladder is relatively normal appearing, the possibility of a. metastasis was considered - including metastatic melanoma. Immunostains show no keratin staining. There is weak MART-1. staining of uncertain significance, but HMB-45 is negative. S-100. is equivocal with possible focal tumor cell staining. The. immunostain results are equivocal; in the absence of any history of. another tumor, the tumor probably represents a high grade. urothelial. cell carcinoma. Tumor grade: 4 (out of 4), WHO grade: High grade. Tumor size: 2 cm. Mitotic rate: 30 mitoses/10 HPFs (1 HPF = 0.196 sq mm). Multicentricity: Absent. Depth of invasion: Carcinoma invades through the. muscularis propria into perivesical soft tissue. Vascular invasion: Absent. Perineural invasion: Absent. Ureteral margins: Negative for malignancy. Urethral margin: Negative for malignancy. Adjacent bladder mucosa: Unremarkable. pTNM Stage: T3 NO. MICROSCOPIC DESCRIPTION. Sections of the uterus show benign endocervical polyp and other. otherwise unremarkable. Sections of the ovaries and uterine tubes. are unremarkable. The vaginal cuff is unremarkable. Antibody. Comment. AE1-AE3. Negative. CK7. Negative. CK20. Negative. EMA. Negative. MART1. Weakly positive. HMB-45. Negative. S-100. Equivocal. Paraffin sections; 10% neutral buffered formalin. [A few of the antibodies used in our laboratory may be classified. as. analyte specific reagents. These antibodies are monitored and. controlled in our laboratory and their performance for in vitro. diagnosis is well described in the medical literature. They have. not been cleared or approved by the FDA. ]. D. There is no evidence of malignancy in any of 7 lymph nodes. F. There is no evidence of malignancy in any of 5 lymph nodes. G. Sections of appendix show fibrous obliteration of the. appendiceal. lumen. 3x3, 2, 5, 4x2 , 20x7. DIAGNOSIS. A. Ureter, right, biopsy: Negative for malignancy. B. Ureter, left, biopsy: Negative for malignancy. C. Urethral margin, biopsy: Negative for malignancy. D. Bladder, uterus and bilateral adnexa, resection: Urinary bladder: Poorly differentiated malignant tumor (see. micro). Uterine cervix: Benign endocervical polyp. Endometrium: Inactive-type endometrium. Myometrium: No pathological diagnosis. Ovaries, left and right: No pathological diagnosis. Uterine tubes, left and right: No pathological diagnosis. E. Lymph nodes, left pelvic biopsy: There is no evidence of malignancy in any of 7 lymph nodes. F. Lymph nodes, right pelvic, biopsy: There is no evidence of malignancy in any of 5 lymph nodes. G. Vermiform appendix, resection: Negative for malignancy. (Electronic Signature). --- End Of Report.",T3,N0,M0,T3N0M0
TCGA-AG-A00C,"Diagnosis/Diagnoses: Rectosigmoid amputation specimen under inclusion of an ulcerated, moderately. differentiated adenocarcinoma of the colorectal type, located immediately above the. dentate line and measuring a maximum of 7 cm in diameter, with infiltration of the. perirectal fatty tissue and a regional lymph node metastasis. Minimum distance between. the tumor and the circumferential resection margin, 0.6 cm. Tumor-free oral and aboral. amputation margin. Tumor-free mesenteric resection margin. Tumor stage pT3 pN1 (1/24) pMX; G2, L1, V0, locally R0.",T3,N1,M0,T3N1M0
TCGA-CK-4951,"Addandad Report. Resident: Pathologis. PATHOLOGIC DIAGNOSIS: SPECIMEN LABELED ""RIGHT HEMICOLECTOMY"": MUCINOUS ADENOCARCINOMA (~508 mucinous component), MODERATELY. DIFFERENTIATED (3.0 cm in greatest dimension). Tumor is located in the cecum/ascending colon, forms a polypoid mass, is. ulcerative and has an infiltrating border. Tumor invades through muscularis propria and into pericolonic adipose. tissue. Proximal, distal and radial resection margins are negative for tumor. Invasive tumor is 9.9 cm from proximal resection margin, 9.5 cm from. distal resection margin, and 7.2 cm from radial resection margin. Lymphovascular invasion is not identified. Venous invasion is not identified. Perineural invasion is not identified. Peritumoral lymphoid response (including Crohn's-like infiltrate) is. mild. Residual adenoma is absent. REGIONAL LYMPH NODE (POSITIVE/TOTAL) : Zero (0) / thirty (30). One (1) separate adenoma. Mural pigment consistent with tattoo site. Associated diseases include diverticulosis. Appendix and terminal ileum with no significant pathologic change. AJCC Classification. T3 NO MX. NOTE: Levels examined on block A5. CLINICAL DATA: History: None given. Operation: None given. Operative Findings: None given. Clinical Diagnosis: Colon cancer. TISSUE SUBMITTED: A/1. Hemicolectomy. GROSS DESCRIPTION: The specimen is received in formalin, labeled with the patient's name, unit. number, and ""#1. Right hemicolectomy"", and consists of a portion of terminal. ileum (2.2 x 2.8 cm), and attached cecum and ascending colon (20.3 cm in length. x. 4.5 cm in diameter), and attached appendix (5. x 0.8 cm), a 3.2 cm proximal. resection margin, and a 2.8 cm distal staple resection margin. An ulcerated. mass (3.0 x 2.2 x 0.5 cm) is present in the cecum/ascending colon, 6.5 cm. distal to the ileocecal valve, 9.9 cm from the proximal stapled resection. margin, and 9.5 cm from the distal staple resection margin. Approximately 15. other mucosal ridges (polyps) are present in the ascending colon, measuring 0.2. to 0.5 cm in greatest dimension, and they may actually represent hyperplastic. folds of mucosa. Representative sections of normal mucosa and tumor are. submitted for tissue bank. Radial margin is 7.2 cm from the mass. Occasional. diverticula are present, with impact of fecaliths. An area of submucosal. tattoo pigment is identified 1.8 cm proximal to the mass. Micro A1: Proximal resection margin (en face), 1 frag,. Micro A2: Distal resection margin with diverticulum (en race), 2 frags,. Page: 1 of 2. Micro A3: Appendix tip, 2 frags,. Micro A4: Appendix cross sections, 2 frags,. Micro A5-A7: Mass, 1 frag each,. Micro A8: Tattoo site with mucosal polyps, 3 frags. Micro A9-A10: Mucosal fold/polyps, 3 frags each,. Micro A11: 1 lymph node, 2 frags,. Micro A12-A19: 4 possible lymph nodes each, 4 frags each,. Micro A20: 3 possible lymph nodes, 3 frags,. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto. Addendum: Upon re-review of this case, there is a focus of possible invasion into a. venule outside of muscularis propria. In that focus, a tumor cell nest is. surrounded by discontinuous smooth muscle cells, which probably represent. residual venular wall. Addendum #1 by. Addendum #2: This primary tumor is still classified as T3. The focus mentioned in the. previous addendum is suspicious for extramural venous invasion. Addendum #2 by. Page: 2 of 2.",T3,N0,M0,T3N0M0
TCGA-AZ-4681,"FINAL DIAGNOSIS: PART 1: RIGHT OVARY AND FALLOPIAN TUBE, RIGHT SALPINGO-OOPHORECTOMY -. A. ATROPHIC OVARY WITH OVARIAN FIBROMA, 1.2 CM. B. FALLOPIAN TUBE WITH MULTIPLE PARATUBAL CYSTS. C. THERE IS NO EVIDENCE OF MALIGNANCY. PART 2: LEFT OVARY AND FALLOPIAN TUBE, LEFT SALPINGO-OOPHORECTOMY -. A. ATROPHIC OVARY WITH OVARIAN FIBROMATA, 2.8 CM AND 2.0 CM. B. FALLOPIAN TUBE WITH PARATUBAL CYSTS. C. THERE IS NO EVIDENCE OF MALIGNANCY. PART 3: RECTUM, PROCTECTOMY -. A. RECTAL ADENOCARCINOMA, MODERATELY DIFFERENTIATED, 2.5 CM IN GREATEST EXTENT. B. TUMOR EXTENDS THROUGH THE FULL THICKNESS OF THE MUSCULARIS PROPRIA INTO PERIRECTAL. ADIPOSE TISSUE. C. THE MARGINS OF RESECTION ARE FREE OF MALIGNANCY. D. EIGHT LYMPH NODES, NO TUMOR SEEN (0/8). E. HISTOPATHOLOGIC STAGE: pTNM = T3 NO MX. F. INCIDENTAL HYPERPLASTIC POLYPS. G. DIVERTICULAR DISEASE. PART 4: RECTUM, MARGINS, RESECTION -. RECTUM, NO TUMOR SEEN. PART 5: COLON, RIGHT, RIGHT HEMICOLECTOMY -. A. COLONIC ADENOCARCINOMA, MODERATELY DIFFERENTIATED, 2.5 CM IN GREATEST EXTENT. B. TUMOR EXTENDS THROUGH THE FULL THICKNESS OF THE MUSCULARIS PROPRIA, INTO PERICOLONIC. ADIPOSE TISSUE. C. THE MARGINS OF RESECTION ARE FREE OF MALIGNANCY. D. FIVE LYMPH NODES, NO TUMOR SEEN (0/5). E. HISTOPATHOLOGIC STAGE: pTNM = T3 NO MX. F. APPENDIX WITH FIBROUS OBLITERATION OF THE TIP. G. DIVERTICULAR DISEASE. PART 6: GALLBLADDER, CHOLECYSTECTOMY -. CHRONIC CHOLECYSTITIS AND CHOLELITHIASIS.",T3,N0,M0,T3N0M0
TCGA-CI-6624,"PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Rectal mass. PROCEDURE: Flexible sigmoidoscopy with biopsy. SPECIFIC CLINICAL QUESTION: Cancer. OUTSIDE TISSUE DIAGNOSIS: No. PRIOR MALIGNANCY: No. CHEMORADIATION: No. ORGAN TRANSPLANT: No. IMMUNOSUPPRESSION: No. OTHER DISEASES: No. FINAL DIAGNOSIS: RECTUM, MASS, BIOPSY -. INVASIVE ADENOCARCINOMA (See comment). COMMENT: Multiple tissue levels have been examined.",T2,N0,M0,T2N0M0
TCGA-IR-A3LH,"Specimens Submitted: 1: SP: Right periaortic lymph node (fs). 2: SP: Left para-aortic lymph nodes (fs). 3: SP: Posterior vaginal margin (fs). 4: SP: Radical hysterectomy with bilateral tubes and ovaries (fs). 5: SP: Right external iliac lymph node. 6: SP: Right external iliac lymph node, lateral. 7: SP: Right common iliac lymph node I. 8: SP: Right obturator lymph node. 9: SP: Right hypogastric lymph node. 10: SP: Left external iliac lymph nodes. 11: SP: Left common iliac lymph node. 12: SP: Left obturator lymph node. 13: SP: Left hypogastric lymph node. 14: SP: Left parametrium (. DIAGNOSIS: 1). LYMPH NODES, RIGHT PERIAORTIC; EXCISION: - TWO BENIGN LYMPH NODES (0/2). - ENDOSALPINGIOSIS INVOLVES ONE LYMPH NODE. 2). LYMPH NODE, LEFT PARA-AORTIC; EXCISION: - ONE BENIGN LYMPH NODE WITH ENDOSALPINGOSIS (0/1). 3). VAGINA, POSTERIOR MARGIN; EXCISION: - INVASIVE SQUAMOUS CELL CARCINOMA, POORLY DIFFERENTIATED. - ULCER IS PRESENT IN PROXIMAL PORTIONS OF THIS TISSUE. - THE TUMOR IS PRESENT AT THE LEFT LATERAL DISTAL MARGIN. NOTE: WE CONFIRM THAT THE MARGIN SAMPLED AT THE TIME OF FROZEN SECTION WAS. BENIGN. WAS CONTACTED ABOUT THIS BY EMAIL ON. 4). UTERUS, CERVIX, BILATERAL OVARIES AND TUBES, BILATERAL PARAMETRIUM;. RADICAL HYSTERECTOMY. AND BILATERAL SALPINGO-OOPHORECTOMY: - INVASIVE SQUAMOUS CELL CARCINOMA OF UTERINE CERVIX, POORLY. DIFFERENTIATED/UNDIFFERENTIATED. - TUMOR THICKNESS IS 8 MM OUT OF 12 MM. - NO EVIDENCE OF TUMOR MULTICENTRICITY IS IDENTIFIED. - IN SITU CARCINOMA IS ALSO PRESENT. - NO VASCULAR INVASION IS IDENTIFIED. - NO PERINEURAL INVASION IS IDENTIFIED. - VAGINAL EXTENSION IS PRESENT (SEE NOTE). - NO PARAMETRIAL INVOLVEMENT IS IDENTIFIED. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. - THE ENDOMETRIUM IS UNREMARKABLE. - THE MYOMETRIUM SHOWS THE FOLLOWING ABNORMALITY: ADENOMYOSIS. - THE RIGHT OVARY SHOWS SEROUS CYSTADENOMA. - ALL OTHER ADNEXAE ARE UNREMARKABLE. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF. METASTATIC NODES IN RELATION TO THE TOTAL NUMBER OF NODES EXAMINED) : SEVEN. BENIGN RIGHT PARAMETRIAL LYMPH NODES (0/7). - INCIDENTAL ADRENAL REST AND OCCLUDED BLOOD VESSELS IDENTIFIED IN. RIGHT PARAMETRIUM. NOTE: THE POSTERIOR VAGINAL CUFF MARGIN OF THIS STPECIMEN IS EXTENSIVELY. ULCERATED AND INFLAMED. ALTHOUGH DEFINITE INVASIVE CARCINOMA IS NOT. IDENTIFIED DISTALLY IN THIS SPECIMEN, WE NOTE THAT INVASIVE CARCINOMA IS. PRESENT IN THE ADDITIONAL POSTERIOR MARGIN (PART 3) . 5). LYMPH NODES, RIGHT EXTERNAL ILIAC; EXCISION: - SIX BENIGN LYMPH NODES (0/6). 6). LYMPH NODES, RIGHT EXTERNAL ILIAC, LATERAL; EXCISION: - THREE BENIGN LYMPH NODES (0/3). LYMPH NODES, RIGHT COMMON ILIAC; EXCISION: - THREE BENIGN LYMPH NODES (0/3). 8). LYMPH NODES, RIGHT OBTURATOR; EXCISION: - TWO BENIGN LYMPH NODES (0/2). 9). LYMPH NODE, RIGHT HYPOGASTRIC; EXCISION: ONE BENIGN LYMPH NODE (0/1). 10). LYMPH NODES, LEFT EXTERNAL ILIAC; EXCISION: - FIVE BENIGN LYMPH NODES (0/5) . 11). LYMPH NODES, LEFT COMMON ILIAC; EXCISION: - TWO BENIGN LYMPH NODES (0/2) . 12). LYMPH NODES, LEFT OBTURATOR; EXCISION: - SIX BENIGN LYMPH NODES (0/6) . - ENDOSALPINGIOSIS INVOLVING ONE LYMPH NODE. 13). LYMPH NODE, LEFT HYPOGASTRIC; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 14). PARAMETRIUM, LEFT; EXCISION: - BENIGN FIBROCONNECTIVE TISSUE. - ONE BENIGN LYMPH NODE (0/1). 1. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT.",T2,N0,M0,T2N0M0
TCGA-B0-4710,"FINAL DIAGNOSIS: PART 1: KIDNEY, RIGHT, RADICAL NEPHRECTOMY -. A. A. RENAL CELL CARCINOMA, CLEAR CELL TYPE. B. FUHRMAN NUCLEAR GRADE IS 3 of 4. C. THE GREATEST DIAMETER OF THE NEOPLASM IS 10.6 cm. D. THE NEOPLASM EXTENDS OUTSIDE THE RENAL CAPSULE INTO THE PERINEPHRIC FAT. E. NO EVIDENCE OF ANGIOLYMPHATIC INVASION IS IDENTIFIED. F. UPPER POLE SOFT TISSUE RESECTION MARGIN IS INVOLVED BY NEOPLASM (ALSO SEE PART 2). G. NON-NEOPLASTIC KIDNEY ADJACENT TO TUMOR SHOWS MILD INTERSTITIAL CHRONIC INFLAMMATION,. MODERATE ARTERIAL AND ARTERIOLAR SCLEROSIS. H. TNM STAGE: pT3a NX MX. PART 2: SOFT TISSUE, RIGHT UPPER POLE MARGIN, RESECTION -. A. RENAL CELL CARCINOMA WITH FAT INVASION. B. MARGIN IS INVOLVED BY CARCINOMA (SEE COMMENT). PART 3: ADRENAL GLAND, LEFT, ADRENALECTOMY (31.5 GRAMS) -. A. ADRENOCORTICAL ADENOMA (2.0 CM). B. NO INVOLVEMENT BY RENAL CELL CARCINOMA. COMMENT: Grossly and microscopically, the tumor shows extracapsular extension at upper pole with positive margin at disrupted. edge in part 1. Upper pole margin received separately in Part 2 shows the margin involved by cauterized tumor. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY KIDNEY TUMORS. SPECIMEN TYPE: Radical nephrectomy. LATERALITY: Right. TUMOR SITE: Upper pole. FOCALITY: Unifocal. TUMOR SIZE: Greatest dimension: 10.6 cm. Additional dimensions: 8.0 x 7.5 cm. MACROSCOPIC EXTENT OF TUMOR: Tumor extension into perinephric tissues. Tumor extension beyond Gerota's fascia. HISTOLOGIC TYPE: Clear cell (conventional) renal carcinoma. HISTOLOGIC GRADE (Fuhrman Nuclear Grade): G3. PATHOLOGIC STAGING (pTNM): pT3a. pNX. Number of regional lymph nodes examined: 0. Number of regional lymph nodes involved: 0. pMX. MARGINS: Margin(s) involved by invasive carcinoma. ADRENAL GLAND: Uninvolved by tumor. VENOUS (LARGE VESSEL) INVASION (V): Absent. LYMPHATIC (SMALL VESSEL) INVASION (L): Absent. ADDITIONAL PATHOLOGIC FINDINGS: Inflammation (type): chronic. Other: moderate arterial and arteriolar sclerosis.",T3,N0,M0,T3N0M0
TCGA-22-1016,"V3.00 110614. Instructions: The TCGA Missing Pathology Report Form should be completed for cases for which a pathology report is not. available. General Pathology Report Information. #. Data Element. Entry Alternatives. Working Instructions. Provide the tumor type of the case. 1. Tumor type: Indicate to which BCR location the case was originally sent. 2. BCR specimen originally sent. NCH. to: IGC. Biospecimen Core Resource (BCR). Date specimen received at. 3. BCR: ICD-0-3 Histology Code: Provide the histology code for the sample from the Case. Quality Control Form (CQCF) and the overall case (patient. For Specimen: (CQCF). diagnosis, if different). 4. For Case: (patient. diagnosis, if available. elsewhere). ICD-0-3 Site Code: Provide the site code for the sample from the Case Quality. Control Form (CQCF) and the overall case (patient diagnosis, if. different). For Specimen: (CQCF). 5. For Case: (patient. diagnosis, if available. elsewhere).",T2,N0,M0,T2N0M0
TCGA-CZ-4854,"Report Status : Type: Surgical Pathology. Specimen Type: tamnsh mode hionsy (non-heme). Procedure Date: Resident: Pathologis. PATHOLOGIC DIAGNOSIS: REGIONAL LYMPH NODE, BIOPSY (including FSA) : Two lymph nodes, negative for tumor (0:2) . RIGHT KIDNEY, NEPHRECTOMY. RENAL CELL CARCINOMA, Clear cell type (5.7 cm), Fuhrman nuclear grade II. Tumor is confined to the kidney. No lymphovascular invasion is identified. Vascular, ureteric, and soft tissue margins are negative for tumor. Simple cortical cyst. AJCC Classification (6th Edition) : T1b NO MX. Selected slides of this case were reviewed by. Service, who concurs. RENAL PATHOLOGY EVALUATION OF NON-NEOPLASTIC RENAL PARENCHYMA. DIFFUSE MESANGIAL EXPANSION WITH FOCAL NODULAR GLOMERULOSCLEROSIS. CONSISTENT WITH EARLY DIABETIC NEPHROPATHY (SEE NOTE). FOCAL GLOBAL AND SEGMENTAL GLOMERULOSCLEROSIS, MOST LIKELY SECONDARY TO. FUNCTIONAL AND STRUCTURAL ADAPTATIONS (SEE NOTE) . SEVERE ARTERIAL AND HYALINE ARTERIOLAR SCLEROSIS (SEE NOTE). NOTE: The non-neoplastic renal parenchyma shows changes consistent with early. diabetic glomerulosclerosis, as well as extensive global glomerulosclerosis and. severe vascular scarring. Prominent vascular sclerosis has traditionally been. considered part of the structural changes seen in diabetic patients with kidney. disease, although it is important to note that these lesions are non-specific,. and they can result from a number of etiologies, including the. microangiopathies from inherited or acquired procoagulant states, the healed. phases of hemolytic-uremic syndrome or thrombotic thrombocytopenic purpura,. angiotoxic drugs, radiation, and other metabolic diseases, Therefore, a. primary form of vascular injury superimposed on renal damage from diabetes. mellitus cannot be definitively ruled out. Segmental or global glomerulosclerosis is frequently. the consequence of. adaptations for hemodynamic changes and glomerular hypertrophy following loss. of functioning nephrons. Such loss of nephrons is often the result of an. independent primary glomerular, tubular, interstitial, neoplastic, or vascular. disease. These patients often show subtotal visceral epithelial cell foot. process effacement ultrastructurally, and they may be at risk for persistent. sub-nphrotic proteinuria; they do not often manifest hypoalbuminemia or edema. In this patient, diabetic sclerosis, severe vascular scarring, healed episodes. of interstitial nephritis from antineoplastic or pharmaceutical agents, and the. resected mass all may have contributed to nephron loss with subsequent. glomerular obsolescence. Dr. Renal Pathologist, has reviewed the. non-neoplastic renal. parenchyma. MICROSCOPIC DESCRIPTION. The section for light microscopy (block B7) contains cortex and medulla, and. was evaluated using HE, PAS, Jones silver methenamine, and trichrome (AFOG). stains. There are 187 glomeruli present, of which 47 (25.1%). sclerosed and 3 are segmentally sclerosed. Many glomeruli show enlargement of. the glomerular tuft with diffuse sclerosis of the mesangium and slight increase. in mesangial cells. A few mesangial areas reveal early nodular expansion. The. glomerular capillary wall basement membranes are often thickened, and there are. occasional double contours; spikes or craters are not prominent. The. interstitium contains a scattered, mild mononuclear inflammatory. Approximately 40% of the sample shows tubular atrophy and interstitial. fibrosis. Arteries reveal severe intimal and medial sclerosis with narrowing. of the arterial lumen. Afferent and efferent arteriolar walls show prominent. hyaline degeneration and sclerosis, with extensive ""onion-skinning."". CLINICAL DATA: History. with incidental finding of R renal mass, Hx of TCC (bladder). Operation:\ Nephrectomy. Operative Findings: None given. Clinical Diagnosis: None given. TISSUE SUBMITTED: A/1. Regional lymph node. B/2. Right kidney. O.R. CONSULTATION: SPECIMEN LABELED: ""#1. REGIONAL LYMPH NODE"" (INCLUDING FSA1-2) : Lymph nodes with fat replacement and focus of atypical cells with. eosinophilic cytoplasm, pending permanent sections and. immunohistochemistry, most likely muscle. Dr. reviewed the case and. concurs with the diagnosis. OR Consultation by: Resident: The senior physician certifies that he/she personally conducted a gross and/or. microscopic examination of the described specimen (s) and rendered or confirmed. the rapid diagnos (es) related thereto. GROSS DESCRIPTION: The specimen is received fresh, in two parts, each labeled with the patient?s. name and unit number. Part A, Received fresh in the frozen section lab labeled ""#1. Regional lymph. node"", and consists of a single fragment of yellow/red soft tissue (2.6 x 0.9 x. 0.6 cm) within which two lymph node candidates (0.5 x 0.5 x 0.4 cm and 0.9 x. 0.6 x 0.5 cm) are identified. The smaller lymph node candidate is frozen as. FSA1 and the larger is frozen as FSA2. Micro A1: ""FSA1"" remnant, 1 frag,. Micro A2: ""FSA2"" remnant, 1 frag,. Micro A3: Non frozen tissue, 2 frags. Part B, Received fresh in frozen section lab labeled ""#2. Right kidney"", and. consists of a right radical nephrectomy specimen (1121.5 grams; 27.5 x 14 x 6.2. cm), to include right kidney (12.0 x 7.2 x 7.0 cm), renal artery (1.8 cm in. length x 0.5 cm in diameter), renal vein (0.4 cm in length x 0.7 cm in. diameter) ureter (10 cm in length x 0.3 cm in diameter), abundant. paranephritic fat and Gerota's fascia (13 x 9 x 0.1 cm) An adrenal gland is. not present. Within the mid pole, there is a yellow/red, focally hemorrhagic,. solid partially encapsulated mass (5.7 x 5.2 x 4.3 cm) 10.3 cm of the ureteral. margin, 6.5 cm from the renal artery margin, and 2.5 cm of the renal vein. margin. The mass grossly appears to impinge upon but not involve the renal. pelvis or caliceal system and grossly abuts but does not invade the renal. capsule (at the anterior lateral aspect). . There is a 1.2 x 1.0 x 0. cm clear. fluid filled cortical cyst at the nterior/superior aspect of the kidney which. abuts the Gerota's fascia (inked black) 1 There are two additional cystic. structures (1.0 x 0.6 x 0.5 cm and 1.5 x 1.0 x 1.0 cm) present in the anterior. aspect of the kidney adjacent to the renal mass which display no excrescences. The remainder of the parenchyma is red/tan with a well defined cortical. medullary junction. The pelvis and ureter display a tan, glistening lining. anntinno of the tumor are submitted to. cytogenetics and electron microscopy. Representative renal cortex is held for. electron microscopy and immunofluorescence. Additionally, representative. sections of the renal mass and normal kidney are submitted to the tissue bank. for special studies. Photographs are taken. No lymph nodes are identified. Micro B1. Renal vein, renal artery and ureteral margins (en face), 3. frags,. Micro B2-B3: Renal mass at deepest extension, 2 frags,. Micro B4: Renal mass in relationship to pelvis, artery and largest cyst,. frag,. Micro B5: Renal mass in relation to adjacent normal parenchyma and. additional pelvis, 1 frag,. Micro B6: Cyst adjacent to Gerota's fascia and relation to renal mass,. 1 frag,. Micro B7: Cortical medullary junction to include additional smaller cyst, 1. frag,. Micro B8: Ureter and pelvis, 1 frag,. By his/her signature below, the senior physician certifies that he/she. personally conducted a microscopic examination (""gross only"" exam if so stated). of the described specimen (s) and rendered or confirmed the diagnosis (es). related thereto. Resident Review by. Final Diagnosis by. Report Status: Type: Cytogenetics. Cytogeneticist. KARYOTYPE: 42-53,X,-Y,del(1) (p22) , del (3) (p21) , add (6) (q27) ,+7,-8,-10, - +11, +12, -17, +19, add (1. 9) (q13),+20,+21, +mar(cp9)/46, XY [4]. METAPHASES COUNTED: 14. ANALYZED: 12. SCORED: 0. BANDING: GTG. INTERPRETATION: 9 of 14 metaphases contained the clonal aberrations that included deletion of. the chromosome 3 short arm (3p) - This aberration is a characteristic finding. in renal cell carcinoma, clear cell type. The abnormal karyotype was seen in metaphases from tumor parts labeled T1 and. COMMENTS: INDICATION FOR TEST: Renal cell carcinoma. CLINICAL DATA: year old male. REPORT by. Final Diagnosis by.",T1,N0,M0,T1N0M0
TCGA-E2-A14T,"SPECIMENS: A. SLN #1. B. SLN #2. C. SENTINEL NODE #3 LEFT AXILLA. D. LEFT BREAST AND LOWER AXILLA TAIL. SPECIMEN(S): A. SLN #1. B. SLN #2. C. SENTINEL NODE #3 LEFT AXILLA. D. LEFT BREAST AND LOWER AXILLA TAIL. GROSS DESCRIPTION: A. SLN #1. Received fresh are two tan pink lymph nodes 0.9 x 0.6 x 0.5cm and 0.5 x 0.4 x 0 2cm. The specimen is serially. sectioned and two touch preps are taken. A1: 1 lymph node. A2: 1 lymph node. B. SLN #2. Received fresh is a tan pink lymph node 0.6 x 0.4 x 0.3cm. The specimen is serially sectioned and a touch prep is. taken. Toto B1. C. SLN #3 LEFT AXILLA. Received fresh is a tan pink lymph node 1.1 x 0.9 x 0.6cm. The specimen is serially sectioned and a touch prep is. taken. Toto C1. D. LEFT BREAST AND LOWER AXILLA-Stitch in axilla. Received fresh is an oriented 1314g, 30 x 28 x 6cm mastectomy with 15 x 6cm tan pink skin ellipse, 1.2 cm centrally. located, partially raised nipple and 1.5 cm areolar rim. The specimen is inked as follows: Anterior/Superior-Blue,. Anterior/Inferior-Orange, Posterior-Black. The specimen is serially sectioned from medial to lateral into 12 slices,. slice 1 being most medial, slice 12 being most lateral. The nipple is located in slice 7. The cut surfaces reveal a gray. white ill defined firm mass 3.5 x 2.8 x 2cm, 1.8cm from the deep margin located in slices 4, 5, 6 and 7. The area. surrounding the mass is remarkable for fibrosis and possible fat necrosis. The lower axillary tail is 6 x 5 x 3cm. Dissection reveals 4 possible lymph nodes ranging from 0.5 x 0.5 x 0.5cm to 0.8 x 0.8 x 0.5cm. A portion of. the. specimen is submitted for tissue procurement. Representative sections are submitted as follows: D1: nipple slice 7. D2: base of nipple slice 7. D3: UIQ area next to mass slice 3. D4-D5: mass bisected UIQ slice 4. D6: anterior margin UIQ slice 4. D7: deep margin UIQ slice 4. D8: mass UIQ slice 5. D9: deep margin UIQ slice 5. D10: skin slice 5. D11-D12: mass UIQ slice 6. D13: deep margin UIQ slice 6. D14: LIQ slice 6. D15-D16: mass bisected UC slice 7. D17: deep margin UC slice 7. D18: LC with inferior margin slice 7. D19: UOQ next to mass slice 8. D20: LOQ slice 8. D21: 2 lymph nodes. D22: 2 lymph nodes. D23-D26: lower axillary tissue. DIAGNOSIS: A. SENTINEL LYMPH NODE #1, LEFT BREAST, BIOPSY: - TWO LYMPH NODES, NEGATIVE FOR CARCINOMA (0/2). B. SENTINEL LYMPH NODE #2, LEFT BREAST, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). C. SENTINEL LYMPH NODE #3, LEFT BREAST, BIOPSY: - ONE LYMPH NODE, NEGATIVE FOR CARCINOMA (0/1). D. BREAST, LEFT, MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, MODERATELY DIFFERENTIATED. (SBR GRADE 2), WITH MICROPAPILLARY FEATURES (SEE NOTE). - TUMOR MEASURES 3.5 CM IN GREATEST DIMENSION. - MARGINS, NEGATIVE FOR CARCINOMA. - DUCTAL CARCINOMA IN SITU, CRIBRIFORM AND SOLID TYPES,. NUCLEAR GRADE 2, WITH NECROSIS AND MICROCALCIFICATIONS. MINOR COMPONENT. - PREVIOUS BIOPSY SITE CHANGES PRESENT. - SKIN AND NIPPLE, NEGATIVE FOR CARCINOMA. - THREE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/3). NOTE: A CD31 immunostain has been ordered to rule out lymphvascular invasion and ER, PR, and Her FISH has. been ordered. Those results will be reported in an addendum. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 3.5cm. Tumor Site: Upper inner quadrant. Margins: Negative. Distance from closest margin: Greater than 1cm. deep. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/7. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 5%. DCIS Type: Solid. Cribriform. DCIS Location: Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Present. Location of CA++: DCIS. Pathological staging (pTN): pT 2N0. CLINICAL HISTORY: year old with multifocal Invasive Cancer in Upper Inner Quadrant of Left Breast. PRE-OPERATIVE DIAGNOSIS: Left Breast Cancer. INTRAOPERATIVE CONSULTATION: TPA/TPB/TPC: Negative for tumor. Diagnosis called to Dr. at. y Dr. ADDENDUM: SUMMARY OF MMUNOHISTOCHEMISTRY/SPECIAL STAINS. Material: Block D12. Population: Tumor Cells. Stain/Marker: Comment: CD31. Negative Shows no evidence of lymphvascular invasion. The interpretation of the above immunohistochemistry stain or stains is guided by published results in the medical. literature, provided package information from the manufacturer and by internal review of staining performance and. assay validation within the Immunohistochemistry Laboratory. The use of one or more reagents in the above tests is. regulated as an analyte specific reagent (ASR). These tests were developed and their performance characteristic. determined by the Department of Pathology Laboratory. They have not been cleared or approved by the U.S. Food. and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Special stains and/or immunohistochemical stains were performed with appropriately stained positive and negative. controls. SYNOPTIC REPORT - BREAST, ER/PR RESULTS. Specimen: Surgical Excision. Block Number: D11. ER: Positive Allred Score: 8 = Proportion Score 5 + Intensity Score 3. PR: Positive Allred Score: 4 = Proportion Score 2 + Intensity Score. 2. COMMENT: The Allred score for estrogen and progesterone receptors is calculated by adding the sum of the proportion score. (0 = no staining, 1 = <1% of cells staining, 2 = 1 - 10% of cells staining, 3 = 11-30% of cells staining, 4 = 31-60% of. cells staining, 5 = >60% of cells staining) to the intensity score (1 = weak intensity of staining, 2 = intermediate. intensity of staining, 3 = strong intensity of staining), with a scoring range from 0 to 8. ER/PR positive is defined as an Allred score of >2 and ER/PR negative is defined as an Allred score of less than. or equal to 2. METHODOLOGY: Tissue was fixed in 10% neutral buffered formalin for no less than 8 and no longer than 24 hours. Immunohistochemistrv was performed using the mouse anti-human ER (ER 1D5, 1:100) and PR (PGR 136, 1:100). provided by Dako (. following the manufacturer S instructions. This assay was not modified. Interpretation of the ER/PR immunohistocnemical stain is guided by published results in the medical literature,. information provided by the reagent manufacturer and by internal review of staining performance. PathVysion HER-2 DNA Probe Kit. Analytical Interpretation of Results: HER-2 NOT AMPLIFIED. Clinical Interpretation of results. Amplification of the HER-2 gene was evaluated with interphase fluorescence in-situ. hybridization (FISH) on formalin-fixed paraffin embedded tissue sections using a chromosome. 17 centromeric probe and a HER-2 probe that spans the entire HER-2 gene in the. by Dr. A majority of tumors cells displayed extensive polysomy 17. with 4 to 6 chromosome 17 signals and 2 to 3 HER-2 signals, with a HER-2/CEP 17 Ratio </=2.0,. consistent with no amplification of the HER2/neu gene. Block used. D11. Source of case: Tissue fixation formalin-fixed tissue Outside Case No: NA. Tissue source breast Results interpreted: yes. HER2/CEP17 ratio: 1.29. This ratio is derived by dividing the total number of LSI HER-2/neu signals by the total number of. CEP17 signals in at least 20 interphase nuclei with nonoverlapping nuclei in the neoplastic. mammary epithelial cells. Cells with no signals or with signals of only one color are disregarded. Method of ratio enumeration: manual count. Limitations. The Vysis PathVysion Kit is not intended for use to screen for or diagnose breast cancer. It is. intended to be used as an adjunct to other prognostic factors currently used to predict disease-free. and overall survival in stage II, node-positive breast cancer patients. In making decisions regarding. adjuvant CAF treatment, all other available clinical information should also be taken into. consideration, such as tumor size, number of involved lymph nodes, and steroid receptor status. No. treatment decision for stage II, node-positive breast cancer patients should be based on HER-2/neu. gene amplification status alone. Overview of this test. FDA APPROVED REAGENT. PathVysion HER-2 DNA Probe Kit is FDA approved for selection of. patients for whom Herceptin therapy is being considered. These tests were performed in the. under the direction. of Dr. The results of these studies should always be interpreted in the context of the. clinical, morphological, and immunophenotypic diagnosis. Microscopic/Diagnostic Dictation: Pathologist. Final Review: Pathologist. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist. Addendum: Pathologist,. Addendum Final: Pathol.",T2,N0,M0,T2N0M0
TCGA-CG-4460,"Diagnosis: Total gastrectomy preparation with an ulcerated gastric carcinoma located on the side of the. greater curvature, extending to within a maximum of 7 cm of the oral resection margin and. with a maximum diameter of 16 cm encompassing the corpus segment of the stomach in an. almost circular growth, with a prominent exophytic component characterized histologically as. a moderately differentiated adenocarcinoma (gastric carcinoma of the intestinal type). Invasive tumor spread within all the parietal layers of the stomach extending into the adjacent. subserous fatty tissue and encroaching on the peritoneal side of the atrophic gastritis (type A). Antrum mucosa with discrete non-florid chronic gastritis and foveolar hyperplasia. No. evidence of Helicobacter pylori. Oral and aboral resection margin and also greater omentum and diaphragm in the section. levels presented are tumor-free. After acetone clarification 33 lymph nodes measuring up to 1.5 cm in the perigastric fatty. tissue are prepared. Of these, two show metastatic infiltrates of the previously diagnosed adenocarcinoma or. gastric carcinoma. In conclusion and in summary, taking into account the infiltration of the diaphragm and with. the correction of the data given in the first set of findings, the following stage is arrived at: pT4 pN1 (2/33).",T4,N1,M1,T4N1M1
TCGA-VQ-A8E2,"PRIMARY SITE: Stomach (Body). 1 - ""8p lymph node"": Lymph node uninvolved by neoplasia (0/1). 2 - ""Esophageal margin"": Uninvolved by neoplasia. 3 - ""Stomach + omentum"": Adenocarcinoma: Histological pattern observed: tubular. Histological grade: II - moderately differentiated. Greatest dimension of the tumor: 7.5 cm. Ulceration: Present. Involvement of: Mucosa. Muscularis mucosa. Submucosa. Muscular own. Adjacent adipose tissue. Type of tumor invasion: spiculated. Inflammatory reaction: Moderate. Tumor implantation in peri-visceral adipose tissue: Not detected. Proximal margin. uninvolved. Distal margin. uninvolved. Radial margin: uninvolved. Neural infiltration: Not detected. Lymphatic vascular invasion: Present. Blood vascular invasion: Not detected. Lymph Nodes: 4 involved by neoplasia among 15 dissected (4/15). Great omentum: uninvolved by neoplasia. Distribution of lymph nodes: Lesser curvature: 4/5. Large curvature: 0/9.",T3,N2,M0,T3N2M0
TCGA-EL-A3D1,"al Pathology. of Pathology. F/. Case type: Surgical Case. MODIFIED REPORT - REVIEW ADDENDUM SECTION. Case has been amended. DIAGNOSIS. (A) RIGHT NECK CONTENTS: Eleven lymph nodes, no tumor present (0/11). (B) TOTAL THYROID GLAND AND LEFT NECK CONTENTS: PAPILLARY THYROID CARCINOMA, MULTIFOCAL, LEFT LOBE (3.0 CM), CONFINED TO THYROID. Adenomatous nodules. Eight lymph nodes, no tumor present (0/8) with one lymph node showing psammoma bodies (levels pending). Parathyroid tissue present. Entire report and diagnosis completed by. COMMENT. This report is amended to correct the diagnosis text for Specimen B from ""thymoma"" to ""psammoma"". GROSS DESCRIPTION. (A) RIGHT NECK CONTENTS - Eleven possible lymph nodes are identified (0.1 x 0.1 x 0.1 cm to 0.7 x 0.4 x 0.3 cm). SECTION CODE: A1, one lymph node bisected; A2, four lymph nodes; A3, six possible lymph nodes. (B) TOTAL THYROID GLAND AND LEFT NECK CONTENTS - A total thyroidectomy specimen measuring 9.5 x 5.0 x 1.5 cm. with attached soft tissue (9.0 x 3.0 x 1.0 cm). The right lobe measures 4.0 x 2.0 x 1.5 cm. The left lobe measures 5.5 x 4.0 x. 1.5 cm. The isthmus measures 2.5 x 2.5 x 1.0 cm. In the right upper pole is a 0.3 cm white nodule. In the isthmus is a 1.4 x. 0.7 x 0.7 cm homogeneous pink-tan nodule. Also identified is a friable encapsulated tan-pink tumor in the left lower pole (3.0 x. 2.0 x 2.0 cm). The remainder of the thyroid parenchyma is homogeneous dark-red. Five lymph nodes are identified in the. attached soft tissue ranging in size between 0.3 - 0.8 cm. Representative sections of the largest tumor nodule and non-. neoplastic thyroid were submitted to the tumor bank. SECTION CODE: B1-B3, right lobe from superior to inferior with the nodule in B2; B4-86, isthmus from right to left; B7-. B11, left lobe from superior to inferior with the mass in B9-B11; B12, three lymph nodes; B13, two lymph nodes. CLINICAL HISTORY. Papillary thyroid cancer. Sex: M. Case type: Surgical Case. SNOMED CODES. ""Some tests reported here may have been developed and performance characteristics determined b. . These tests have not been specifically cleared or. approved by the U.S. Food and Drug Administration."". Released by: Released by: Sex: M. Case type: Surgical Case. ADDENDUM. Addendum completed by. COMMENT. Additional levels reviewed of lymph node with psammomas, no metastatic carcinoma identified. The above diagnosis remains. unchanged. Released by:",T2,N0,M0,T2N0M0
TCGA-G3-AAUZ,"CONFIDENTIAL. Demographics (for. verification purposes). Date of Birth: Sex: M. Site : Liver (22.0. Collected Date/Time. Received Date/Time. Specimen Description. A. Gallbladder @. B. Segment 4/5 liver @. c. Final margin @. Clinical Information. Hx. htc and hep B. Diagnosis. A. Gallbladder, Cholecystectomy: Negative for malignancy. B. Liver, Segment 4/5, Resection: Well differentiated hepatocellular carcinoma, 4.4 x 2.7 x 2.3 cm. 0.1 cm to the blue inked specimen margin. Background liver show portal inflammation and steatosis (20%). c. Final Margin, Biopsy: Liver parenchyma, negative for hepatocellular carcinoma. Verified: Gross Description. Received are specimen containers A to C. All remisitions and specimen containers are. labelled with the patient's name,. The cassettes and. identifiers are. labelled with the Surgical Number. A. Specimen is received in formalin. The container is designated ""gallbladder @. The specimen consists of a non-intact gallbladder measuring 6.8 x 2.3 x 1.2 cm. The. serosal surface appears smooth and unremarkable. The lumen contains green bile and no. calculi, and the cystic duct appears patent. The mucosa is granular, and the wall. averages 0.2 cm in thickness. The cystic duct lymph node is identified and measures 0.6. cm in greatest dimension. Representative sections of the gallbladder are submitted in. A1. The entire lymph node is bisected and submitted in A2. B. Specimen is received fresh and is submitted in formalin. The container is. designated. ""segment 4/5 liver @. The specimen consists of an 81.3 g partial hepatectomy. specimen measuring 6.4 x 6.2 x 5.6 cm. The capsular surface appears smooth and. unremarkable. Roughened surgical resection margin is dyed with blue ink. The specimen. is serially sectioned to reveal a well circumscribed, ovoid mass which has lobular. features on cut surface. This mass measures 4.4 x 2.7 x 2.3 cm and grossly comes right. to the capsular surface, but does not grossly appear to invade the surface and to within. 0.1 cm of the blue inked surgical resection margin. No other lesions are grossly. identified. B1-B3. representative sections of the tumor and grossly closest point of invasion. to both capsular. surface and blue inked surgical resection margin. B4. further representative .section of the tumor. B5. representative section of normal liver adjacent to the liver. Specimen is received fresh and submitted in formalin. The container is designated. final margin. and consists of a single, soft, dark tan, triangular portion of. tissue measuring 1.5 x 1.0 x 0.7 cm. Surgical resection margin is grossly identified. which is dyed with blue ink. The specimen is serially sectioned and submitted in toto. in. one block. Pathologist Comment. Case seen in review by. Encounter Number. Patient Location.",T1,N0,M0,T1N0M0
TCGA-78-7633,"SEE SUPPLEMENTARY REPORT BELOW. HISTORY. Adenocarcinoma. MACROSCOPIC. Two specimens submitted. 1: The first specimen is labelled ""left upper lobe' and consists of a lobe of lung. measuring 200 X 80 X 20 mm in the fresh state. Overlying the apex and the lateral. aspect of the apex of the lobe is an area of pleural tethering with an underlying tumour. mass. The remainder of the pleural surface shows no specific abnormality apart from. extensive carbon pigmentation. The lobar bronchus has been transected flush with the. hilar soft tissue and has two lumens at this point. Small peribronchial anthracotic. nodes are noted, none of which appears macroscopically to be involved by a tumour. Sectioning reveals an apical tumour mass which appears to be bilobed. The combined. maximum size of this lesion is 32 mm. The more superior lobule is approximately 20. mm in diameter and shows foci of central necrosis. The more lateral and inferior. lesion is approximately 12 mm in diameter and has a solid cream to tan cut surface. In some areas the lobules appear to be separated by 2 to 3 mm of unremarkable lung. parenchyma. Both lobules abut the overlying pleura. No other lesions are identified. on serial slicing through the parenchyma. However there is severe emphysema. [1A,. bronchial resection margin; 1B, peribronchial lymph nodes; 1C-1D longitudinal. sections through tumour including overlying pleura and both lobules; 1E, sections of. inferolateral solid nodule with overlying pleura; 1F, uninvolved lung parenchyma.]. 2: The second specimen is labelled ""left hilar lymph node' and consists of three. fragments of focally anthracotic and fatty tissue. [BIT, 2A.]. MICROSCOPY. 1: Sections show two adenocarcinomas. The first has a predominantly acinar architecture with a small. amount of surrounding bronchioloalveolar type growth. Extensive blood vessel invasion is noted and. there is possible lymphatic permeation. The other lesion is a papillary adenocarcinoma. The lesions. are separated by approximately 5 mm by unremarkable lung. A third focus of adenocarcinoma with a. bronchioloalveolar pattern is present within the random section of lung. This measures 5 mm in. diameter. Overlying both tumours, there is scarring of the pleura and features suspicious for invasion. Special stains will be performed. No perineural permeation is identified. The lesion is well clear of the. bronchial resection margin. No lymph node metastases are seen. The uninvolved lung shows evidence. of emphysema. 2: Sections of the lymph nodes show reactive changes only. There is no evidence of malignancy. SUMMARY. 1-2: Left upper lobe and left hilar lymph nodes: A: Three foci of moderately differentiated adenocarcinoma; 20 mm (acinar), 12 mm (papillary) and 5. mm (bronchioloalveolar) in maximal dimension. B: Extensive blood vessel invasion; probable lymphatic permeation but no perineural permeation. present. C: Possible pleural invasion identified; special stains being performed; clear of bronchial margin. D: No lymph node metastases. E: T1NO (awaiting pleural stains). F: Non-neoplastic lung: Mild emphysema. SUPPLEMENTARY REPORT. 1: Tumour invades into the visceral pleura overlying the tumour with the acinar architecture. It is not. definitely on the pleural surface. There is no invasion of the visceral pleura by the papillary carcinoma. Both tumours stain positively for CK 7 and TTF 1. CK 20 is negative. This indicates both lesions are. pulmonary in origin but considering their different architecture as they appear to represent synchronous. tumours. SUMMARY. 1-2: Left upper lobe and left hilar lymph nodes: A: Three foci of moderately differentiated adenocarcinoma; 20 mm (acinar), 12 mm (papillary) and 5. mm (bronchioloalveolar) in maximal dimension. B: Extensive blood vessel invasion; probable lymphatic permeation but no perineural permeation. present. C: Visceral pleural invasion identified overlying the acinar pattern carcinoma; clear of bronchial. margin. D: No lymph node metastases. E: T2 NO (acinar pattern carcinoma) T1N0 (papillary and bronchioloalveolar pattern carcinomas). F: Non-neoplastic lung: Mild emphysema. T-28000 M-81403 P1-03000.",T2,N0,M0,T2N0M0
TCGA-EL-A3MX,"Sex: F. Tel. -. Case type: Surgical Case. DIAGNOSIS. (A) LYMPH NODE, LEFT PARATRACHEAL, BIOPSY: One benign lymph node (0/1). (B) PARATHYROID TISSUE, BIOPSY: Parathyroid tissue identified. (C) THYROID, TOTAL THYROIDECTOMY: PAPILLARY THYROID CARCINOMA (5.0 CM IN GREATEST DIMENSION). TUMOR CONFINED TO THYROID. One parathyroid lymph node, negative for tumor (0/1). Entire report and diagnosis completed by. GROSS DESCRIPTION. (A) LEFT PARATRACHEAL LYMPH NODE - A 0.6 cm in diameter lymph node bisected and entirely submitted for frozen section. diagnosis in A. FS/DX: BENIGN LYMPH NODE. (B) PARATHYROID TISSUE - A tiny soft tan-pink tissue measuring < 0.1 x 0.1 x 0.1 cm. Entirely submitted for frozen diagnosis. in B. FS/DX: PARATHYROID PRESENT. TOTAL THYROIDECTOMY - A total thyroidectomy (6.0 x 5.5 x 4.0 cm). The right thyroid lobe is unremarkable. The left. thyroid (C) lobe is entirely replaced by a fleshy tan tumor. Within the central portion of the tumor there is an area that is more solid. and also contains calcifications. The tumor is surrounded by a thin capsule. The tumor measures 5.0 x 4.1 x 4.0 cm. A portion of abnormal thyroid and tumor submitted to the tissue bank. SECTION CODE: C1-C3, representative sections of the right thyroid; C4, isthmus; C5-C20, representative sections of. the left thyroid tumor to include capsule. CLINICAL HISTORY. History of thyroid cancer. SNOMED CODES. T-B6000, M-80503. Department of Patholog. Sex: F. Te. Physician: : Case type: Surgical Case. These tests have not been specifically cleared or approved. ""Some tests reported here may have been developed and performance characteristics determined by. by the U.S. Food and Drug Administration. Released by:",T4,N1,M1,T4N1M1
TCGA-A2-A0T2,"SURGICAL REPORT. Sex: F. Date Collected: Date Received: M.R. Number. Doctor: Account Numbe. PRE-OPERATIVE DIAGNOSIS. CA RIGHT BREAST. POST-OPERATIVE DIAGNOSIS. CA RIGHT BREAST. PROCEDURE. MODIFIED RADICAL MASTECTOMY RIGHT BREAST, INSERTION MEDIPORT. TISSUES. BREAST MASTECTOMY (WMV) NODES - RIGHT BREAST AND AXILLARY CONTENTS. FINAL DIAGNOSIS. RIGHT BREAST AND AXILLARY CONTENTS -. POORLY DIFFERENTIATED INFILTRATING DUCTAL CARCINOMA, SCARFF-. BLOOM-RICHARDSON GRADE III/III. THE TUMOR MEASURES 10.5 CM. IN MAXIMUM. DIMENSION. LYMPHOVASCULAR INVASION IDENTIFIED INSIDE THE TUMOR. ALL SURGICAL MARGINS ARE FREE OF THE LESION. THE CLOSEST SURCICAL. MARGIN IS THE DEEP SURGICAL MARGIN WHICH IS 1.2 MM. FROM THE TUMOR (JUST. ABOVE THE MUSCLE). BENIGN SKIN AND NIPPLE. TEN OF FOURTEEN LYMPH NODES ARE POSITIVE FOR METASTATIC. CARCINOMA (10/14). TUMOR STAGE: STAGE IIIC, T3, N3, MX. PQRI CATEGORY II: 3260F. Diagnosed by: COMMENT. This case is discussed with. GROSS DESCRIPTION. The container is received fresh unfixed labele. ight breast and axillary contents"" and. consists of a 788 gm. apparent right breast which is 24x 17 x 5 cm. in greatest overall dimension. The. attached skin ellipse is 11.5 x 8.5 cm. There is an eccentrically attached nipple. There is also an. SURGICAL REPORT. of 2. attached suture indicating superior lateral/upper outer aspect inked with an orange dye. The lower outer. is inked green, the upper inner is inked black, the lower inner is inked red. The deep surgical margin is. inked yellow. Sectioning reveals a dense gray-white slightly swirled tumor mass which is 10.5 x 5.5 x 4. cm. in greatest overall dimension and grossly appears to be 3 cm. from the superior lateral/upper outer, 3. cm. from the upper inner and appears to be 3.5 cm. from the lower outer and 4 cm. from the lower inner. It grossly appears to be 0.8 cm. from the deep surgical margin. The tumor mass has scattered yellow-tan. chalky areas varying up to 0.2 cm. and hemorrhagic areas varying up to 0.1 cm. Sectioning through the. axillary fat reveals tan-gray nodules varying up to 2.5 cm. in greatest dimension, each are bisected, one-. half submitted. Twenty blocks. Key Note Block Summary: 1-nipple, 2-deep surgical margin, 3-superior lateral/upper. outer, 4--lower outer, 5-upper inner, 6-lower inner, 7 through 10-tumor, 11 through 13-random, 14. through 20-apparent nodes. MICROSCOPIC EXAM. MICROSCOPIC EXAMINATION CONDUCTED BY PATHOLOGIST CONFIRMS FINAL DIAGNOSIS. SURGICAL REPORT.",T3,N3,M1,T3N3M1
TCGA-66-2759,"Material examined: Left lower lobe, among others. Clinical diagnosis and question. Space-occupying lesion left lower lobe S6, (poorly differentiated large-cell, nonkeratinizing squamous cell carcinoma),. status post asbestos exposure. REPORT ON FINDINGS. Macroscopy. 1.) Left lower lobe: inflated, fixed left lower lobe of lung measuring 20 x 15 cm at the base and up to 17 cm in length,. central bronchus resection plane located 0.3 cm proximal to the bifurcation of B6. A 7 cm long branched staple suture. line runs in a ventrocaudal direction from the hilus. In the medioventral region over S6 a cusp-shaped part of the upper. lobe measuring 4 x 1.5 x 1.2 cm is attached, closed by a staple suture line. In the laterodorsal region over S6 and. adjacent sections of S10, part of the parietal pleura, measuring 9.5 x 5.5 cm, is mostly adhesive over an extensive area. and loosely attached in parts at the margin. At the hilus are 3 mobile grayish-black nodes between 0.2 and 0.7 cm in size. Ostium of B6 completely obstructed by endobronchial parts of a central, moderately solid, pale brownish, focally soft. tumor, max. 6 cm in size, located in S6, with unclear demarcation and extending right up to the ventral visceral pleura. over S6 and to within 0.2 cm of the hilar resection surface. Apparent central involvement of some grayish-black. parabronchial nodes up to 1.5 cm in size by the tumor. Macroscopically questionable infiltration of the attached part of. the upper lobe, minimal distance from the resection plane of the pulmonary wedge after removal of the metal staple. line 0.3 cm. Parenchyma peripheral to the tumor in S6 and adjacent sections of S10 right up to the dorsal pleura and to. the pleural adhesion area over S6, with unclear demarcation, shows diffuse induration and a brownish-yellow color. Rest. of parenchyma inconspicuous. Medially in the attached fatty tissue close to the basal margin are 4 grayish-black nodes. between 0.2 and 1.1 cm in size. 2.) Peribronchial tissue left: 0.9 cm flat reddish tissue. 3.) Hilar LN (station 10) left: 1.4 cm grayish-black node or node part with some surrounding tissue. 4.) Pulmonary ligament LN (station 9) left: 2.2 cm grayish-black node with some surrounding tissue, section surfaces. partly indurated and pale grayish-white suggestive of tumor. 5.) Paraesophageal LN (station 8) left: two 2.5 cm specimens of fatty tissue, containing 1 cm node with section surfaces. suggestive of tumor. 6.) Paraaortic LN (station 6):1.2 cm node part with some surrounding tissue. 7.) Subaortic LN (aortopulmonary window) (station 5): two lesioned grayish-black nodes or node parts with. some surrounding tissue, 1.5 and 0.8 cm in size. Examined: 1.) Rapid section remains and resection margins of vessels and hilar nodes, tumor with remaining parenchyma,. endobronchial tumor part in B6, tumor with ventral visceral pleura over S6, 3 sections of hilar resection surface. (color-marked), 2 sections with attached upper lobe part (resection plane after removal of staple suture line. color-marked), brownish-yellow parenchyma and pleural adhesion zone, S10 dorsal, node in basal fatty tissue, 2. further sections with attached upper lobe part (resection plane after removal of staple suture line color-marked),. 2.) Rapid section remains,. 3.), 4.), 6.) + 7.) All material (in 4.) + 6.) nodes halved or multi-segmented, in 7.) nodes isolated),. 5.) Nodes (halved),. 17 blocks, partly Elastica-van Gieson, PAS, diastase-PAS, iron staining. Microscopy. Re 1.) Immediate intraoperative evaluation. bronchus resection margin tumor-free. Re 2.) Immediate intraoperative evaluation (. ): fatty tissue supplied by vessels and nerves shows. scarring, but no evidence of tumor. After paraffin embedding: Description of histological and cytological findings omitted for capacity reasons. EVALUATION. Primary diagnosis/diagnoses: Central to peripheral, histologically poorly differentiate, large-cell, nonkeratinizing squamous cell carcinoma of. the lower lobe of the left lung located in S6. TNM classification according to this picture pT2 pN2 pMX R0, stage IIIA. C 34.3, M 8070/3. Secondary diagnosis/diagnoses: Advanced, active, small foci of colliquating, chronic organizing and focal retention pneumonia accompanied by. fibrous remodeling of the parenchyma peripheral to the tumor associated with a pleural adhesion zone (sample. 1.)). Hilar lymph nodes of the main preparation and lymph nodes of samples 6.) and 7.) with uncharacteristic. reactive lesions, anthracotic pigment deposits and an old, nodular, cicatricially encapsulated area of necrosis. (sample 6.)). Remark/addendum: The tumor has obstructed B6 at its bifurcation, continuously infiltrated parabronchial lymph nodes and extended. focally to within at least 0.2 mm of the hilar resection surface. It has also grown across the pleural fissure. initially and into the co-resected tissue from the upper lobe and has formed further lymph node metastases in. samples 3.) - 5.). The resection lines of the bronchus and vessels, the resection plane of the wedge resection. specimen from the upper lobe and the lymph nodes located at the hilus of the main preparation (sample 1)), the. repeat resection specimen of sample 2.) and the lymph nodes of samples 6.) and 7.) are tumor-free. No asbestos bodies are found in the prepared section planes. However, very much further-reaching investigations, in. particular dust analytical studies, are needed to settle the question of asbestos dust exposure.",T2,N2,M0,T2N2M0
TCGA-05-4250,"2. and 3. Resection material from the right lower lobe with a locally advanced, poorly. differentiated, adenosquamous carcinoma measuring at least 65 mm, almost complete pleural. infiltration and penetration of S6, excision here does not extend into the healthy tissue and in. the central direction there are tongue-shaped extensions in the peribronchial, hilar fatty. connective tissue with lymph node metastases that show necrotic destruction here. In addition,. a multifocal invasion of the blood vessels. Assessment: According to these findings, complete removal of the carcinoma is not definite. Tumor classification: M-8140/3, G3, pT3, pV1, pN1, pMx, stage III A. R2.",T3,N1,M0,T3N1M0
TCGA-39-5035,"Clinical Diagnosis & History: with CT C/A/P. Right lower loba mass. Specmeno Submitted: 1: SP: Level seven mediastinal 1ymph nodes. 2: SP: Level seven madiastinal lymph node #2. 3: SP: Right pleural biopay. 4: SP: Right mediastinal lymph node level XI. 5: SP: Right lower lobe lung. DIAGNOSIS: LYMPH NODE, LEVEL VII MEDIASTINAL; EXCISION: - ONE BENIGN LYMPH NODE (0/1). 2). LYMPH NODE, LEVEL VII MEDIASTINAL; EXCISION: ONE BENIGN LYMPH NODE (0/1). 3). PLEURA, RIGHT; BIOPSY;. - FIBROCONECTIVE, TISSUE. 4). LYMPH NODE, RIGHT GEVEL XI MEDIASTINAL, EXCISION: THREE BENIGN LYMPH NODES (0/3). 5). LUNG, RIGHT LOWER LOBE; LOBECTOMY: - MODERATELY TO POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA OF RIGHT. LOWER LOBE (SEE NOTE). - THE TUMOR MEASURES 2.9 x 2.5 x 1.8 CM. - NO VASCULAR INVASION IS IDENTIFIED. - NO PERINEURAL INVASION IS IDENTIFIED. - THE BRONCHIAL MARGIN IS FREE OF TUMOR. - THE TUMOR EXTENDS SUBPLEURALLY BUT NOT TO THE PLEURAL SURFACE. - THE NON-NEOPLASTIC LUNG SHOWS THE FOLLOWING ABNORMALITIES: PLEURAL. SCAR AND FOCAL ORGANIZING PNEUMONIS. THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF METASTATIC. NODES IN RELATION TO THE TOTAL NUMBER OF NODES EXAMINED) : PERIBRONCHIALt. Note: IMMUNOSTAINS PERFORMED ON THE TUMOR ARE AS FOLLOWS: 4A4 AND P63 POSITIVE;. TTP-1, SYNAPTOPHYSIN, CHROMOGRANIN, AND MUCIN ARE NEGATIVE. THE PROFILE,. SUPPORTS THE ABOVE DIAGNOSIS. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. Special studies: 1. The specimen is received fresh for frozen section consultation, labeled. level 7 mediastinal lymph nodes"" and consists of one lymph node moasuring. 1.1 x 0.7 x 0.5 cm. Entirely submitted for frozen section. Summary of sections: FSC -- frozen section. 2). Tho specimen ie received fresh for frozen section consultation,. laboled Level 7 modiastinal lymph node number two"" and congists of a. red-tan oval piece of soft tissue measuring 0.9 x 0.4 x 0.3 cm. Entirely. submitted for frozen section. Summary of sections: FSC -- frozen section control. 3). The specimen is received in formalin, labeled ""Right pleural biopsy"". and consiots of a piece of white tan soft and membranous tissue measuring. 1.0 x 0.7 x 0.2 cm. At the surface, a 0.2 cm nodular area ig noted the. specimen is bisected and submitted entirely. Summary of sections. U-undesignated. 4). The specimen is received in formalin, labeled iright mediastinal lymph. node level 11 "" and consists of three dark pink anthracotic lymph nodes. ranging in size from 0.5 to 1.0 cm in greatest dimension, which are entirely. submitted. "". Summary of sections: U-undesignated. 5). The specimen is received fresh and is labeled, right lower lobe lung"". It consists of a 14.3 x 14.2 x 6.4 cm lung lobe with attached bronchus and. blood vessels straddled by multiple staple lines. The attached bronchus. measures 0.9 cm, The pleural surface shows a 2.5 x 2.2 em pleural soar with. adhesions and a prior incision with sutures. The pleural surface is inked. black. Serial sectioning reveals a 2.9 x 2.5 x 1.8 em (ramaining tumor). tan, stellate tumor abutting the ploural scar. The tumor is ill-defined,. located 6.0 cm from the bronchial margin and 9.0 em from the closest staple. line. The tumor grossly does not involve the bronchus. A peribronchial. anthracotic lymph node is identified and submitted. The uninvolved lung. parenchyma is unremarkable. Representative sections are submitted. TPS. is. submitted photographs are taken. Summary of sections: BM -- bronchial margin. VM -- vascular margin. TP -- tumor with pleura. TU - tumor with adjacent pulmonary parenchyma. RA - random lung parenchyma at least 3 cm away from main tumor. RC - random lung parenchyma close to tumor (within 3 cm of main tumor). LN -- lymph node. Summary of Sections: Part 1: SP: Laval seven mediastinal lymph nodes. Block. Sect. Site. PCs. 1. fsc. o. Part 2: SP: Level seven mediastinal lymph node #2. Block. Sect. site. PCs. 1. fac. 1. Part 3: SP: Right pleural biopsy. Block. Sect. site. PCs. 1. u. 1. Part 4: SP: Right mediastinal 1ymph node level XI. Block. Sect. Site. PCa. 1. u. 1. Part 5: SP: Right lower lobe lung. Block. Sect. site. PCa. BM. 1. LN. 1. 3. RA. 3. 3. RC. 3. 2. TP. 2. 3. 3. 1. VH. 1. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. 1. FROZEN SECTION DIAGNOSIS: SP: LEVEL SEVEN MEDIAST. LYMPK NODES. NEGATIVE LYMPH NODE. PERMANENT DIAGNOSIS: SAME. 2. FROZEN SECTION DIAGNOSIS: gpt LEVEL SEVEN MEDIASTINAL. LYMPH NODE #2. '. NEGATIVE LYMPH NODE. PERMANENT DIAGNOSIS: SAME,. "".",T1,N0,M0,T1N0M0
TCGA-AN-A0AK,Sex: Female. Diagnosis: Breast Cancer Histological description: Infiltrative ductal carcinoma. Anatomic Site: Left Breast Tumor location: Primary. Tissue Specification: Tumor Specimen Matrix: Tissue Specimen Format: OCT. Container: block Type of Procurement: surgery Grade: 2. T Stage: 2 N Stage: 0 M Stage: 0 Treatment: none. Treatment Details: n/a. Normal Sample. Anatomic Site: Blood Sample Type: Normal Type of Procurement: blood draw. Matrix: Blood Specimen Format: frozen Container: tube.,T2,N0,M0,T2N0M0
TCGA-AA-3558,"Diagnosis: Resected colon (sigma) with tumor-free oral and aboral resection margins, with a stalked,. tubular adenoma with severe dysplasia (synonymously: profound intraepithelial neoplasia),. including a polypoid, moderately differentiated adenocarcinoma with infiltration of the. lamina muscularis propria and not displaying any lymph node metastases in the region (G2,. pT2, L0, V0, R0, pNO 0/46).",T2,N0,M0,T2N0M0
TCGA-AR-A0TR,"Breast, left, modified radical mastectomy: Infiltrating ductal carcinoma, Nottingham grade II (of III),. forming a mass (2.3 x 2.1 x 1.7 cm) located in the superior/central aspect of the breast [AJCC pT2]. Ductal carcinoma in situ, intermediate nuclear grade, comprises approximately 5-25% of the tumor. volume. Angiolymphatic invasion is present. The non-neoplastic breast parenchyma shows. nonproliferative fibrocystic changes. The tumor does not involve the nipple, overlying skin, or. underlying chest wall. All surgical resection margins, after re-excision of the anterior/superior margin,. are negative for tumor (minimum tumor free margin, 0.7 cm, anterior/superior margin). The deep margin. is negative for tumor (free by 0.8 cm). Multiple (22) left mid/low axillary lymph nodes are negative for. metastatic carcinoma. Lymph nodes, left high axillary, excision: Multiple (3) left high axillary lymph nodes are negative for. tumor. Lymph node, left axillary sentinel, excision: A single left axillary sentinel lymph node is positive for. metastatic adenocarcinoma with one metastasis measuring 2.5 x 2.5 x 1.3 cm [AJCC pN1]. Extranodal. extension is not present. Blue dye is not identified.",T2,N1,M0,T2N1M0
TCGA-A6-6654,"Date Coll: SPECIMEN. Left hemicolectomy. CLINICAL NOTES. PRE-OP DIAGNOSIS: Descending colon cancer. GROSS DESCRIPTION. Received fresh subsequently fixed in formalin labeled ""left. hemicolectomy"" is a 28 cm. long portion of colon. The specimen is. open at both ends, arbitrarily inked blue and black. There is. pink-tan smooth glistening serosa. The peritoneal reflections. cannot be grossly identified. The specimen shows an umbilication. midway through the specimen. This area of umbilication is inked. orange. The specimen is opened to show a pink-tan smooth,. glistening mucosa with normal to abundant folds with an average. circumference of 5 cm. Located near the umbilication is a 4.8 X. 4.0. cm. circumferential ulcerated lesion. The cut surface of this. lesion shows invasion into the muscularis propria, coming within 7.5. cm. of the radial margin, contiguous with the umbilication. previously described. The cut surface shows multiple diverticula. present. No discrete gross evidence of submucosal abscess or. perforation identified. There is a firm nodule in the fatty tissue. on cut surface it is grossly consistent with a diverticula. containing firm formed fecal material. No other discrete gross. lesions identified. Multiple lymph nodes are grossly identified. Representative sections of the specimen are submitted as follows: BLOCK SUMMARY: 1 - Representative luminal margins; 2 -. representative section of diverticula with firm fecal material; 3 -. tumor to umbilication; 4 - tumor to normal; 5 - tumor to fat; 6. representative section of radial margin; 7 - possible mottled lymph. node subjacent to tumor; 8 - 3 possible lymph nodes; 9 - 8 possible. lymph nodes; 10 - 9 possible lymph nodes; 11 - 10 possible lymph. nodes; 12-14 - 9 possible lymph nodes; 12-15 - 9 possible lymph. nodes; 16 - 6 possible lymph nodes; 17 - 6 possible lymph nod. 18. - 3 possible lymph nodes. AS-18. MICROSCOPIC DESCRIPTION. Histologic type: Adenocarcinoma. Histologic grade: Moderately-differentiated. Primary tumor (pT3) : Carcinoma into and through muscularis propria,. into the subserosal fat. Proximal/distal/radial margins: Negative. Vascular invasion: Not identified. Regional lymph nodes (pN) : Metastatic carcinoma in 1 of 65 lymph. nodes (1/65) . Non-lymph node pericolonic tumor: One focus, in area of main tumor. mass (possibly a lymph node replaced by carcinoma) . Other findings: diverticuli, multiple. 5. DIAGNOSIS. Colon, left hemicolectomy: Adenocarcinoma, noderately-differentiated, with invasion. through the muscularis propria into the subserosa. Negative margins of excision. Metastatic carcinoma in one of sixty-five lymph nodes (1/65). One focus of pericolonic tumor (possible lymph node), adjacent. to main tumor mass.",T3,N1,M0,T3N1M0
TCGA-A6-3810,"SPECIMEN. A. Sigmoid colon - stitch on distal and staple line at proximal end. B. Proximal margin of sigmoid colon. CLINICAL NOTES. PRE-OP DIAGNOSIS: Left colon cancer. GROSS DESCRIPTION. A. The specimen is received unfixed, labeled ""sigmoid. colon"", and consists of a segment of large bowel,. measuring. 20 cm. in length and 2.8 cm. in diameter. There is abundant. pericolonic fat and the entire specimen is up to 10 cm. in. diameter. There is a suture at the open end of the specimen, the opposite end. is stapled. There is an area of narrowing where an appendix. epiploica is adherent to the serosal surface of the colon. This. area is 6 cm. from the open end. The bowel is opened with a. single. incision on the antimesenteric surface. There is a napkin ring-. like. fungating mucosal tumor, measuring 6 cm. in length and 1.2 cm. in. depth. The tumor is circumferential. It is 6 cm. from the distal. margin of resection and approximately 11 cm. from the proximal. margin. Sections after fixation and clearing. A portion of the. specimen is taken for research purposes. The fat is dissected off. the colon and there is an area that probably represents pericolonic. abscess immediately adjacent to the tumor. This area might be. associated with diverticulum. MLM:men. Block summary: 1, 2 margins of resection; 3 - 7 tumor; A. 10-22. pericolonic lymph nodes. B. The specimen is received unfixed labeled ""proximal. margin of sigmoid colon"" and consists of a piece of white. and yellow soft tissue with stapes in it. The specimen measures 4. 1 X 0.4 cm. RS-1. MICROSCOPIC DESCRIPTION. A. Tumor type : Colonic adenocarcinoma. Tumor grade 2 out of. 3. Tumor size: 6 cm. Distance to nearest margin: 6 cm. Level of penetration: Carcinoma penetrates into. pericolonic fat. Margins of resection: Negative for malignancy. Vascular invasion: Absent. Host response: Marked acute and chronic inflammation. One. area resembles a diverticulum with pericolonic abscess,. diverticulum destruction and carcinoma. (block A7). Attached lymph nodes: There is no evidence of malignancy. in any of 30 lymph nodes. Non-lymph node pericolonic tumor: Absent. pTNM Stage: T3 NO. B. Negative for malignancy. 5, 3. DIAGNOSIS. A. Sigmoid colon, segmental resection: Moderately differentiated colonic adenocarcinoma. Note: Carcinoma invades through the muscularis propria into. pericolonic soft tissue. There is no evidence of malignancy. in any of 30 pericolonic lymph nodes. B. Sigmoid colon, proximal margin, biopsy: Negative for malignancy.",T3,N0,M0,T3N0M0
TCGA-75-6206,"A description for each data field can be found in the 'Data description' worksheet (yellow tab). Sample Collection Details. Histology and staging. Site of Tissue. Year of. Age at Sample. Days to. Days to. Type of. Site of. Tumour. Histology. Number. Type. Preparation. Comments. Procedure. Diagnosis. Procedure. Primary. Size (cm). (Histology). TUMOUR. FF. RUL. RESECT. RUL. 4.00. 03. BUFFY. FF. RESECT. RUL. 4.00. 03. 11. Grade/. Pathological T Pathological N Clinical M VALCSG Stage Histology Comments. Slide URL. Differentiation. II. T2,NOS. MO. II. T2,NOS. MO.",T2,N0,M0,T2N0M0
TCGA-BL-A13J,"SPECIMEN. A. Right distal ureter. B. Left distal ureter. C. Left pelvic lymph node. D. Bladder and prostate. E. Right pelvic nodes. F. Left pelvic nodes. G. Appendix. H. Sigmoid colon. CLINICAL NOTES. CLINICAL HISTORY: Bladder cancer. PRE-OP DIAGNOSIS: Bladder cancer. FROZEN SECTION DIAGNOSIS. A) Ureter, right distal, excision - Inflammation with variable. epithelial atypia. B) Ureter, left distal, excision - Inflammation with variable. epithelial atypia. C) Lymph node, left pelvic, excision - Metastatic carcinoma. GROSS DESCRIPTION. A. Received fresh for frozen section labelled ""right. distal. ureter"" is a segment of ureter that measures 0.4 X 0.4 X. 0.3 cm in dimension. Tissue is entirely frozen. B. Received fresh for frozen section labelled ""left distal. ureter"" is a segment of ureter that has a dilated lumen. and. measures 0.8 X 0.7 x 0.3 cm in dimension. Tissue is entirely. frozen. C. Received fresh labelled ""left pelvic lymph node"" is an. irregular-shaped fragment of fibroadipose tissue that measures 3.5. X. 1.5 X 1.2 cm in dimension. Within the tissue, a lymph node is. identified that measures 1.7 cm in dimension. The lymph node is. GROSS DESCRIPTION. entirely frozen as FSC1 and FSC2. D. Received fresh and subsequently fixed in formalin. labeled ""bladder and prostate"" is a 21 X 10 X 6.5 cm. bladder and prostate, which is partially covered with abundant. yellow lobular fat. The bladder itself is approximately 8.5 x 7.8. X. 6 cm and the prostate is approximately 35 grams, 4.5 x 3.5 x 3.2. cm. The left ureter is approximately 5 cm X 0.7 cm and is markedly. dilated. The right ureter is approximately 4.5 X 0.5 cm. There. are. adhesions on the posterior aspect of the bladder wall in a 4 X 3.5. cm area. The right half of the specimen is inked blue and the left. posterior aspect of the specimen is inked black. The left anterior. aspect of the specimen is inked also blue. The specimen is opened. in a Y-shaped incision to show a friable area of tumor in the. posterior wall. There is also tumor present in the left lateral. wall. This entire area is 6.7 X 6.5 cm. This comes within 5.5 cm. of the prostatic urethral margin. There is also a tumor polyp. measuring 1 cm in the right anterior part of the wall, which is. located 7 cm from the prostatic urethra. The cut surface of the. polyp showed no discrete invasion through the wall; however, the. cut. surface of the large tumor mass shows invasion through the left. lateral wall and through the posterior wall. This comes within 0.1. cm of the radial margin. No discrete tumor is grossly identified. within the left ureter; however, the ureter is markedly dilated up. to 0.7 cm in diameter. No lymph nodes are grossly identified in. the. surrounding fat. The seminal vesicles average 3.5 X 1.5 X 0.8 cm. The vasa deferentia could not be grossly identified. Representative sections of the specimen are submitted following. further fixation. BLOCK SUMMARY: 1 - apical bladder margin with prostatic urethral. margin en face; 2-3 - prostatic urethra, with full-thickness. prostate composite slice; 4 - bilateral ureteral margins and. representative seminal vesicles; 5 - representative anterior. bladder; 6 - representative dome of bladder to tumor,. GROSS DESCRIPTION. full-thickness; 7 - trigone full-thickness; 8 - representative. section of bladder to posterior margin full-thickness; 9 - right. side bladder to ureteral orifice; 10 - right posterior bladder. full-thickness; 11-12 - left side full-thickness composite bladder. with ureteral orifice; 13 - possible representative left side vas. deferens within tumor and representative section of right-side. seminal vesicle; 14 - additional representative section of. ull-thickness tumor to posterior wall; 15 - entire right-sided. polyp full-thickness; 16-22 - representative section of prostate as. follows: Block 1 - full-thickness composite; 17-18 - full-thickness. composite; 19-20 - full-thickness composite; 21-22 - full-thickness. composite. RS-22. E. Received fresh, subsequently fixed in formalin labeled. ""right pelvic nodes"" is a 4.5 X 3.2 X 2.0 cm aggregate of. yellow lobular fatty tissue. Lymph nodes are grossly identified. which range from 0.5 cm to 3.5 cm in greatest dimension. The lymph. nodes are entirely submitted as follows: BLOCK SUMMARY: 1 - three possible lymph nodes; 2 - one possible. lymph node bisected; 3-4 - one possible lymph node bisected,. one-half in each. F. Received fresh, subsequently fixed in formalin. labeled. ""left pelvic lymph nodes"" is 4.5 X 4.0 X 2.2. The. specimen. is palpated to identify multiple lymph nodes which range from 1.2. cm. to 7.5 cm in greatest dimension. The lymph nodes are entirely. submitted as follows: BLOCK SUMMARY: 1 - three possible lymph nodes; 2-5 - one possible. lymph node sectioned. G. Received fresh, subsequently fixed in formalin. labeled. ""appendix"" is a 5.5 X 0.5 cm appendix which is partially covered. with pink-tan smooth glistening serosa and yellow lobular fat. The. specimen is sectioned to show an intact wall with an average. thickness of 0.3 cm. The lumen ranges from pinpoint to 0.2 cm. other discrete gross lesions are identified. The appendix is. GROSS DESCRIPTION. entirely submitted in two cassettes with the proximal end inked. (fat. and staples retained) . AS-2. H. Received fresh subsequently fixed in formalin labeled. ""sigmoid colon"" is a 14.5 cm. long portion of colon which. is opened at one end inked blue and the opposite end is stapled and. is inked black. The serosa of the specimen is pink tan, smooth and. glistening and is partially covered with abundant yellow lobular. fat. There are a few adhesions on the specimen, however, no. hemorrhage or fibrinous exudate is grossly identified. The. specimen. is opened to show pink tan smooth glistening mucosa with an average. circumference of 4.5 cm. There is a 0.3 cm. sessile polyp which is. located on a fold, 4.5 cm. to the blue inked margin. A few. diverticula are grossly identified and show no gross evidence of. submucosal abscesses or perforation present. Representative. sections of the specimen are submitted as follows: BLOCK SUMMARY: 1 - representative luminal margins; 2 - sessile. polyp; 3 - representative normal; 4 through 8 - representative. sections of the remainder of the specimen including diverticula. RS-8. MICROSCOPIC DESCRIPTION. Histologic type: Urothelial carcinoma. Histologic grade: High grade. Associated epithelial lesions: Papillary urothelial carcinoma,. high. grade and carcinoma in situ. Primary tumor (pT) : Tumor invades through the full thickness of. the. wall into the adjacent adipose tissue and invades into prostatic. stroma from the prostatic urethra, pT4. Margins of resection: Tumor extends to the soft tissue margin of. excision on the posterior surface of the bladder and is present at. MICROSCOPIC DESCRIPTION. the prostatic urethral margin. Regional lymph nodes (pN) : 2 of 11 lymph nodes positive for. metastatic carcinoma (2/11), pN2 . Distant metastasis (pM) : pMx. Vascular invasion: Present. Other findings Perineural invasion by tumor is present. Tumor is. present surrounding the left side vas deferens. The prostatic. urethra shows changes of carcinoma in situ and invasive urothelial. carcinoma extending from glands into prostatic stroma. The. prostate. shows glandular and stromal hyperplasia. 14x3, 15x1, 3x3, 5x1, 4x3, 2x1. DIAGNOSIS. A. Urethra, right distal, excision - Focal urothelial atypia with. associated inflammation. B. Urethra, left distal, excision - Focal urothelial atypia with. associated inflammation. C. Lymph node, left pelvic, excision - 1 lymph node positive for. metastatic urothelial carcinoma (1/1) . The size of the metastasis is 1.7 cm. in greatest dimension. Extracapsular extension by tumor is identified. D. Bladder and prostate, excision - Invasive poorly differentiated. urothelial carcinoma involving the bladder and prostatic urethra. Tumor extends through the full thickness of the wall into the. adjacent soft tissue and is present at the posterior soft. tissue margin of excision. Tumor extends to the prostatic urethral margin of excision. Tumor is present within the prostatic urethra and invasive. urothelial carcinoma is present in prostatic stroma (see tumor. characteristics in the prostatectomy template) . E. Lymph nodes, right pelvic, excision - 1 of 4 lymph nodes. positive. DIAGNOSIS. for metastatic carcinoma (1/4). F. Lymph nodes, left pelvic, excision - 6 lymph nodes negative for. metastatic carcinoma (0/6) . G. Appendix, appendectomy - No significant histopathologic. abnormality. H. Colon, sigmoid, excision - Diverticulosis with diverticulitis. with focal changes consistent with chronic diverticulitis with. associated fibrosis in the pericolonic adipose tissue with. inflammation and reactive changes. Adenomatous polyp. The margins of excision do not show adenomatous change. (Electronic Signature). --- End Of Report ---.",T4,N2,M0,T4N2M0
TCGA-IB-A5ST,"Note: If you do not see ""END OF PRINTED REPORT"" at the bottom of the. the report YOU DO NOT HAVE THE ENTIRE REPORT. Please try print. CONFIDENTIAL. Relevant. Information. Demographics. (for verification. Date of Birth: purposes). Sex: F. Collected Date/Time. Received Date/Time. Specimen Description. A. Gallbladder at. B. 8A node at. C. Whipple specimen at. Clinical Information. Pancreatic mass. Infectious patient:No. Immunocompromised: No. History of neoplasm: No. Diagnosis. A. Gallbladder, Cholecystectomy: Mild acute and chronic cholecystitis. Negative for dysplasia or malignancy. Cystic duct lymph node negative for malignancy. B. ""8A Lymph Node"": Mineral oil lipogranulomatosis. Negative for malignancy. C. Head of Pancreas, Whipple's Resection: Invasive well to moderate differentiated pancreatic duct. adenocarcinoma. Margins clear. Metastatic carcinoma involving two of sixteen peripancreatic lymph nodes. Synoptic Report. C: Pancreas (Exocrine) Macroscopic. SPECIMEN: Head of pancreas. Duodenum. Common bile duct. Gallbladder. PROCEDURE: Pancreaticoduodenectomy (Whipple resection) . partial pancreatectomy. TUMOR SITE: Pancreatic head. TUMOR SIZE: Greatest dimension: 3.2. cm. Additional dimensions: 2.5 x 2.0 cm. C: Pancreas (Exocrine), Microscopic. HISTOLOGIC TYPE: Ductal adenocarcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. MICROSCOPIC TUMOR EXTENSION: Tumor invades duodenal wall. Tumor invades peripancreatic soft tissues. MARGINS: Margins uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 2 mm. Specified margin: Uncinate margin. TREATMENT EFFECT (applicable to carcinomas treated with neoadjuvant therapy) : Not known. LYMPH-VASCULAR INVASION: Not identified. PERINEURAL INVASION: Present. PRIMARY TUMOR (pT) : pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the. superior mesenteric artery. REGIONAL LYMPH NODES (pN) : pN1: Regional lymph node metastasis. Number examined: 2. Number involved: 16. DISTANT METASTASIS (pM) : Not applicable. Gross Description. Received are specimen containers A to C. All requisitions and specimen containers are. labelled with the patient's name,. The cassettes and AP. identifiers are labelled with the Surgical number. A. The specimen is received fresh and is subsequently placed into formalin. The. container is designated "" Gallbladder"" and consists of an unopened gallbladder, measuring. 11.0 cm in length x 5.0 x 3.5 cm. The outer peritoneal surface is smooth and. unremarkable. The lumen contains green mucoid bile as well as an oval, slightly lobulated. gallstone, measuring 2.7 x 1.6 x 1.5 cm. On fracturing the stone has a typical. crystalline appearance of a cholesterol stone. The mucosa shows a focal sessile polypoid. area, 0.4 cm in greatest dimension, but is otherwise velvety and smooth and the. gallbladder wall has a thickness of 0.2 cm. A small cystic duct lymph node, 0.7 cm in. greatest dimension is present adjacent to the cystic duct resection margin. Sections are. taken as follows: A1. resection margin with cystic duct lymph node as well as section from fundus. A2. sections of body with small polypoid protrusions. B. Specimen is received in formalin. The container is designated as "" 8A node"" and. consists of a old fragment of firm, grey tan tissue, measuring 2.0 x 1.1 x 0. cm. Bisected and submitted in toto in one cassette. C. The specimen is received fresh and is subsequently placed into formalin. The. container is designated as "" Whipple specimen"". This consists of a. pancreaticoduodenectomy specimen, the segment of distal stomach and small bowel,. measuring 17.0 cm in length. The head of pancreas measures approximately 5.0 x 4.5 x 3.5. cm. The neck of the pancreas is painted blue, the uncinate process margin is painted. orange. The mucosa of the duodenum is unremarkable with no tumor. The ampulla of Vater. is. unremarkable. The common bile duct is opened in the fresh state revealing a branching at. the superior edge of the pancreas where the cystic duct joins the common hepatic duct. The common bile duct, measures 3.5 cm in length. The attached portion of cystic duct,. measures 2.7 cm and the attached portion of common hepatic duct, measures approximately. 1.0 cm. The mucosal surface of the ducts are unremarkable. A coronal section into the. head of pancreas reveals a firm tumorish mass occupying much of the head of pancreas,. with dimensions of 3.2 x 2.5 x 2.0 cm. The tumor appears to approach close to the. inferior and uncinate margins, but small portion of pancreatic tissue superior to the. tumor and extending to the pancreatic neck resection margin has a fibrous consistency. The section of soft tissue around the head of pancreas reveals scatter lymph nodes. Sections are taken as follows: C1. proximal resection margin common bile duct. C2. proximal resection margin cystic duct. C3. pancreatic neck resection margin, en face. C4-6. sections of ampulla of Vater with underlying tumor. C7-10. tumor including uncinate margin and posterior soft tissue margin. C11. possible lymph nodes in a fatty tissue operative curvature. C12-14. three possible large lymph nodes along superior aspect of head of pancreas. C15. three lymph nodes in gastroduodenal region. C16. proximal resection margin/antral mucosa. C17. gastroduodenal junction. C18/19. distal resection margin duodenum. Microscopic Description. A. Sections show mild acute and chronic inflammation involving the gallbladder with. focal polypoid protrusions in the mucosa bed without any evidence of dysplasia or. malignancy. The cystic duct lymph node shows slight granulomatosis and is negative for. malignancy. B. Sections show lymph node tissue with lipogranulomatosis. There is no evidence of. malignancy. C. There is an invasive well to moderately differentiated adenocarcinoma involving much. of. the head of the pancreas. The carcinoma invades through the muscularis propria in the. vicinity of the common bile duct, but does not reach the duodenal mucosa. The common. bile duct mucosa is partly effaced by the invasive carcinoma. The tumor shows prominent. perineural invasion and extends into peripancreatic adipose tissue. The tumor lies close. to the uncinate resection margin, but there is a narrow rim of fatty tissue with a clear. margin of approximately 0.2 cm. The posterior retroperitoneal margin is clear as well. The pancreatic neck margin shows prominent fibrosis with loss of pancreatic tissue or. chronic pancreatitis, possibly related to the development of carcinoma. No. calcifications are present. The section from the proximal bile duct and cystic duct. margins show mild inflammation and reactive changes, but no sign of dysplasia or. malignancy. The carcinoma invades directly into two peripancreatic lymph nodes regarded as positive. for nodal involvement, although distant lymph nodes do not show tumor. Number. Encounter. Number. Patient Location. - END OF PRINTED REPORT -.",T3,N1,M0,T3N1M0
TCGA-BJ-A0ZB,"PATIENT HISTORY: CHIEF COMPLAINT/ PRE-OP/ POST-OP DIAGNOSIS: Thyroid carcinoma. PROCEDURE: Total thyroidectomy/right neck dissection. SPECIFIC CLINICAL QUESTION: Not given. OUTSIDE TISSUE DIAGNOSIS: Not given. PRIOR MALIGNANCY: Not given. CHEMORADIATION THERAPY: Not given. ORGAN TRANSPLANT: Not given. IMMUNOSUPPRESSION: Not given. OTHER DISEASES: Not given. ADDENDA: Addendum. MOLECULAR ANATOMIC PATHOLOGY TESTING: Block 2B: A. BRAF V600E mutation IDENTIFIED. B. Mutations in NRAS61, HRAS61, KRAS12/13 NOT identified. C. FISH test results are negative for RET/PTC rearrangement. NOTE: DNA was extracted in the amount sufficient for testing. BACKGROUND: Mutations in either BRAF or RAS genes or RET/PTC rearrangements are found in more than 70% of papillary thyroid carcinomas. (1). BRAF V600E (T1799A) mutation has been associated with more aggressive behavior of papillary carcinoma (2, 3). The. association between BRAF V600E mutation and features of tumor aggressiveness have also been observed in papillary. microcarcinomas (4). Mutations in the RAS genes or PAX8/PPARg rearrangement occur in -70% of follicular thyroid carcinomas. and with lower frequency in oncocytic (Hrthle cell) carcinomas (5). Regarding the specificity of these mutations for cancer, BRAF. V600E mutation and RET/PTC and PAX8/PPARg rearrangements are overall specific for malignancy in the thyroid, although they. have been reported with a very low frequency in benign thyroid lesions (6). RAS mutations occur in malignant and benign thyroid. tumors, being found in -40-50% of follicular and anaplastic carcinomas, 30-40% of follicular adenomas and 10-15% of papillary. carcinomas (6). 1. Adeniran AJ, et al. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of. thyroid papillary carcinomas. Am J Surg Pathol 2006, 30:216-222. 2. Xing M, et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 2005, 90:6373-6379. 3. Elisei R, et al. BRAF V600E mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin. Endocrinol Metab 2008, 93:3943-3949. 4. Lee X, Gao M, Ji Y, Yu Y, Feng Y, Li Y, Zhang Y, Cheng W, Zhao W. Analysis of differential BRAF(V600E) mutational status in high aggressive. papillary thyroid microcarcinoma. Ann Surg Oncol. 2009 Feb;16(2):240-5. 5. Nikiforova. MN, et al. RAS point mutations and5PAX8-PPARyrearrangement in thyroid tumors: Evidence for distinct molecular pathways in. thyroid follicular carcinoma. J Clin Endocrinol Metab 2003, 88: 2318-26. 6. Nikiforov YE. Recent developments in the molecular biology of the thyroid. In: Lloyd RV., ed. Endocrine Pathology: Differential Diagnosis and. Molecular Advances. Humana Press, Totowa, 2004, 191-209. MUTATIONAL ANALYSIS: For. paraffin-embedded surgical specimens, manual microdissection was performed to collect tumor tissue. Specimens with the minimum of 50% of. tumor cells in a microdissection target are accepted for the analysis. Optical density readings were obtained. Real-time PCR was performed. on. the. LightCycler platform to amplify BRAF codons 599-601, NRAS codon 61, HRAS codon 61, and KRAS codons 12/13 sequences. Post-PCR. melting. curve analysis was used to detect possible mutations. If required, the mutation type was confirmed by Sanger sequencing of the PCR product. on. DNA from samples positive for each of these mutations was used as positive controls. Amplification at 35 cycles or earlier was. considered sufficient for the analysis. The limit of detection is approximately 10-20% of alleles with mutation present in the background of. normal. DNA. Addendum. PROBE: MEC 1 Dual Color Break-apart Probe (. Cytogenetic Location: 11q21. MEC1 FISH STUDIES ARE NEGATIVE FOR TRANSLOCATION. # cells analyzed: 60. # cells with translocation pattern: 0. # cells with the normal pattern: 60(100%). MAML2 translocation detection is as follows: Normal cells without the MAML2 translocation contain two fusion signals. Cells with. the translocation pattern show one fused signal (green and orange fusion) and one separate green and one separate orange. signal. Targeted areas containing greater than 20% of cells with the translocation pattern are considered positive. MEC1 FISH analysis was manually performed and quantitatively assessed by analysis of a minimum of 60 cells using the MAML2. SpectrumOrange (telomeric) and the MAML2 SpectrumGreen (centromeric) probes. References: Behboudi A, Enlund F, Winnes M, Andrn Y, Nordkvist A, Leivo I, Flaberg E, Szekely L, Mkitie A, Grenman R, Mark J, Stenman. G. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene._. Genes Chromosomes Cancer. 2006 May;45(5):470-81. Okabe M, Miyabe S, Nagatsuka H, Terada A, Hanai N, Yokoi M, Shimozato K, Eimoto T, Nakamura S, Nagai N, Hasegawa Y,. Inagaki H. MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma. Clin Cancer Res. 2006 Jul. 1;12(13):3902-7. Tonon G. Modi S. Wu L. Kubo A, Coxon AB, Komiva T, O'Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR, Kaye FJ. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling. pathway. Nat Genet. 2003 Feb;33(2):208-13. Epub 2003 Jan 21. Erratum in: Nat Genet. 2003 Mar;33(3):430. FINAL DIAGNOSIS: PART 1: LYMPH NODE, CENTRAL COMPARTMENT, RIGHT SIDE, RIGHT NECK DISSECTION -. A. METASTATIC PAPILLARY THYROID CARCINOMA, TALL CELL VARIANT IN FIVE OF SIX LYMPH NODES (5/6). B. EXTRANODAL SPREAD IS SEEN. C. VENOUS INVASION IS IDENTIFIED. PART 2: THYROID, TOTAL THYROIDECTOMY (16.0 GRAMS) -. A. PAPILLARY THYROID CARCINOMA, TALL CELL VARIANT, 2.4 CM, RIGHT LOBE (see comment). B. EXTRATHYROIDAL EXTENSION IS SEEN. C. THE TUMOR EXTENDS TO THE MARGIN. D. NODULAR THYROID WITH HYALINIZATION AND CALCIFICATION. E. NO PARATHYROID GLANDS ARE SEEN. F. PATHOLOGIC STAGE pT3, N1b, MX. PART 3: LYMPH NODE, RIGHT LATERAL COMPARTMENT, RIGHT NECK DISSECTION -. A. SOFT TISSUE (?LYMPH NODE) WITH METASTATIC PAPILLARY CARCINOMA, TALL CELL VARIANT WITH. EXTENSIVE SQUAMOUS METAPLASIA. B. TEN BENIGN LYMPH NODES (0/10). COMMENT: This case has been reviewed by. , and all concur with the above diagnosis. Molecular studies for thyroid carcinoma are being done and the results will follow in an addendum. We are also. doing. FISH study for MAML2 to further evaluate the areas of squamous metaplasia and, more specifically, to rule out. a. primary. mucoepidermoid carcinoma of the thyroid. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Right Lobe. TUMOR FOCALITY: Unifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 2.4 cm. Additional Dimensions: 1.6 X1.2 cm. HISTOLOGIC TYPE: Papillary carcinoma, tall cell variant. PATHOLOGIC STAGING (pTNM): pT3. pN1b. Number of regional lymph nodes examined: 17. Number of regional fymph nodes involved: 6. pMX. MARGINS: Margin(s) involved by carcinoma. Site(s) of involvement: right lobe. VENOUS/LYMPHATIO (LARGE/SMALL VESSEL) INVASION (V/L): Present. ADDITIONAL PATHOLOGIC FINDINGS: Nodular goiter. SPECIAL PROCEDURES: In Situ Procedure. Interpretation. RET/PTC: The targeted area of the tissue showed 1(1.6%) of the cells with the rearrangement pattern and 60(98.4%) of the cells. with the normal pattern. The targeted area is considered NOT rearranged for the RET/PTC region. The RET/PTC1 Probe did not contain the rearrangement pattern. My signature is attestation that I have personally reviewed the submitted material(s) and the above diagnosis reflects that evaluation. RET/PTC Methodology Description: Probe: RET/PTC Probe (10q11.2) and RET/PTC1 Dual-Color Fusion Probe 10q11.2-10q21. Probe Description: The RET probe (labeled SpectrumGreen) is a 207 kb DNA probe located at band 10q11.2. The H4 and 369 probes are approximately 100kb each (labeled in. ), and are located at band 10q21. RET/PTC rearrangement is suggested to be present when three RET signals are identified in greater than 8% of the analyzed. cells. RET /PTC1 rearrangement detection is as follows: Normal cells without the RET/PTC1 rearrangement show two pair of green and. orange signals separated. Cells with the RET/PTC1 rearrangement show two pair of signals (green and orange) in juxtaposition. and one green and one orange signal separated in greater than 8% of analyzed cells within the targeted area. RET/PTC FISH analysis was manually performed and quantitatively assessed by analysis of a minimum of 60 cells using the PTC. (369/H4) SpectrumOrange and the RET. probes.",T3,N1,M0,T3N1M0
TCGA-BH-A0BV,"FINAL DIAGNOSIS: PART 1: BREAST, RIGHT, MODIFIED RADICAL MASTECTOMY-. A. INFILTRATING DUCTAL CARCINOMA. B. NEOPLASM MEASURES 3.0 CM ON GROSS EXAM. C. NOTTINGHAM SCORE 7/9, GRADE 2 (TUBULES 3, NUCLEI 3, MITOSES 1). D. MARGINS OF RESECTION FREE OF NEOPLASM, CLOSEST ANTERIOR AT 2.0 CM. E. LYMPHOVASCULAR INVASION IDENTIFIED. F. UNREMARKABLE SKIN AND NIPPLE. G. ER POSITIVE, PR POSITIVE, HER-2/NEU NEGATIVE (SCORE 0) PER PREVIOUS REPORT. H. PATHOLOGIC STAGE T2 N1 MX. I. DUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM TYPES, NUCLEAR GRADE 3 WITH ASSOCIATED. CALCIFICATIONS. J. DUCTAL CARCINOMA IN SITU, ADMIXED WITH INVASIVE COMPONENT. K. MARGINS OF RESECTION FREE OF DUCTAL CARCINOMA IN SITU, CLOSEST ANTERIOR AT 2.0 CM. L. ATYPICAL DUCTAL HYPERPLASIA. M. INTRADUCTAL PAPILLOMA. N. PSEUDOANGIOMATOUS STROMAL HYPERPLASIA. O. FIBROCYSTIC CHANGES WITH DUCTAL EPITHELIAL HYPERPLASIA AND COLUMNAR CELL CHANGE. PART 2: LYMPH NODE, RIGHT AXILLA, SENTINEL NODE #1, LYMPH NODE BIOPSY -. ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 3: LYMPH NODE, RIGHT AXILLA, SENTINEL NODE #2, LYMPH NODE BIOPSY -. ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART 4: LYMPH NODE, RIGHT AXILLA, SENTINEL NODE #3, LYMPH NODE BIOPSY -. ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA, 2 MM (0.2 CM) METASTATIC FOCUS (1/1). PART 5: LYMPH NODE, RIGHT AXILLA, SENTINEL NODE #4, LYMPH NODE BIOPSY -. ONE LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA, 1.5 CM METASTASIS WITH 3 MM OF. EXTRACAPSULAR EXTENSION (1/1). PART 6: LYMPH NODE, RIGHT AXILLA, SENTINEL NODE, LYMPH NODE BIOPSY -. ONE LYMPH NODE NEGATIVE FOR METASTATIC CARCINOMA (0/1). PART. 7: AXILLARY CONTENTS, RIGHT, RIGHT AXILLARY DISSECTION. CASE SYNOPSIS: TWENTY LYMPH NODES NEGATIVE FOR METASTATIC CAPCINOM -. SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Upper inner quadrant. JILE ur. Lower inner quadrant. MULTICENTRICITY/MULTIFOCALITY OF maximum INVASIVE dimiension FOCI; invasive component: 3.0 cm. TUMOR TYPE (invasive component): NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS. Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 7. INGIOLYMPHATIC INVASION: Nottingham grade (1, 2, 3): 2. DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: Yes, malignant zones. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: by situ component: 5 %. Cribriform, in Solid, DCIS admixed with invasive carcinoma, Percent of tumor occupied. SURG MARGINS INVOLVED BY IN SITU Distance COMPONENT: of invasive tumor to closest margin: 20 mm. PAGET'S DISEASE OF NIPPLE: Yes Distance of in situ disease to closest margin: 20 mm. LYMPH NODES POSITIVE: 2. LYMPH NODES EXAMINED: 25. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SENTINEL NODE METASTASIS: ONLY KERATIN POSITIVE CELLS ARE PRESENT: SIZE OF NODAL METASTASES: LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Diameter of largest lymph node metastasis: 15 mm.",T2,N1,M0,T2N1M0
TCGA-G3-A3CJ,"PHN: ACB: Telephone: Encounter: Collected Date: Received Date/Time: Specimen Description. A. Gallbladder. B. Right lobe of liver. Clinical Information. Hep C and new hepatocellular cancer right liver; previous Interferon and Ribavirin several years ago; pre-op portal vein. embolization. INFECTIOUS PATIENT: YES - Hep C. Diagnosis. A. Gallbladder: Within Normal Limits. 1 Normal Cystic Duct Lymph node also Identified (0/1). B. Right lobe of liver: 1)Hepatocellular Carcinoma, Grade 2/4 (Size 12.0 cm). With Lymphvascular Invasion. Primary tumor 1.0 cm away from inked resection margin. Portal Vein Metastases come to within 0.4 cm of the inked margin. Post embolization changes noted within portal vein including. foreign body type giant cell reaction and thrombus formation. Chart Request ID: Print Date/Time: Pathology: Provider - Permanent. Chart ID: PHN: ACB: Collected Date: Received Date/Time: 2) Chronic Hepatitis C infection, Mildly Active. Verified: Synoptic Report. B: Liver, Resection, Macroscopic. Specimen: Liver. Gallbladder. PROCEDURE: Partial hepatectomy. Major hepatectomy (3 segments or more). TUMOR SIZE: Greatest dimension: 12 cm. TUMOR FOCALITY: Solitary (specify location): Right Lobe. B: Liver, Resection, Microscopic. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: Gll: Moderately differentiated. TUMOR EXTENSION (select all that apply): Tumor confined to liver. PRIMARY TUMOR (pT): pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. REGIONAL LYMPH NODES (pN): pNX: Cannot be assessed. DISTANT METASTASIS (pM): Chart Request ID: Pathology: Provider - Permanent. Print Date/Time: PHN: ACB: Collected Date: Received Date/Time: pMX: Cannot be assessed. MARGINS: Parenchymal margin uninvolved by invasive carcinoma. Distance of invasive carcinoma from closest margin: 10 mm. VENOUS (LARGE VESSEL) INVASION (V): Present. ADDITIONAL PATHOLOGIC FINDINGS: Hepatitis (specify type): Hepatitis C. Gross Description. Received are specimens A to B. All requisitions and specimen containers are labelled with the patient's name. The cassettes and AP identifiers are labelled with the Surgical Number. Gross photos are taken of the specimen. A. Devitalization - Fixation Times. Devitalization Time: 1054. Fixation Start Time: Not specified on requisition. Total Fixation Time: Not specified on requisition. The specimen consists of an intact formalin-fixed gallbladder measuring 7.5 X 4.0 X 2.5 cm. A cystic duct lymph node. is. identified. No gallstones are noted in the gallbladder and mucosal wall appears normal in thickness. No masses or. nodules are seen in the gallbladder either. Representative sections are submitted in a single cassette. B. Devitalization - Fixation Times. Devitalization Time: 1131. Fixation Start Time: Not specified on requisition. Total Fixation Time: Not specified on requisition. The specimen consists of a right lobe of liver weighing 1254 g. Within the liver, there is a circumscribed tumor mass. measuring 12.0 cm in maximum dimension. The nodule has areas of hemorrhage and necrosis. Smaller nodules are. noted in the surrounding hepatic parenchyma measuring between 0.1 cm to 4.0 mm. Also, the hepatic vein seems to have. a clot in it, the largest clot measuring up to 0.5 cm in diameter. The surrounding liver appears congested but is not. definitely cirrhotic. The multiple smaller nodules are tumor noted may be grossly consistent with vascular invasion. The. Chart Request ID: Print Date/Time: Pathology: Provider - Permanent. PHN: ACB: Inquiry Numbe. Collected Date: Received Date/Time: main tumor mass comes to within 1.0 cm of the inked resection margin, though the smaller possible intravascular ones. come closer to within 0.4 cm. The tumor has a greenish appearance to it. Representative sections are taken as follows: B1. section. of. liver. and. nearest. resection. margin. to. the. tumor. B2 - representative sections of uninvolved liver. B3 - sections of intravascular blood clot. B4 through B9 - sections of tumor. Chart Request ID: Pathology: Provider - Permanent. Print Date/Time:",T2,N0,M0,T2N0M0
TCGA-EL-A3CU,"GA-EL-A3CU-01A-PR. ry Case. gy Report. Pathology,. Sex: F. Case type: Surgical History. Case imported from legacy computer system. The format of this report does not match the original case. For cases prior to. , the section ""SPECIMEN"" may have been added. DIAGNOSIS. (A) RIGHT MID JUGULAR LYMPH NODE: Lymph node, no tumor. (B) RIGHT UPPER POLE NODULE: Lymph node, no tumor. RIGHT INFERIOR PARATHYROID: Vessel and lymphoid tissue, no parathyroid tissue present. TOTAL THYROIDECTOMY: PAPILLARY CARCINOMA OF THYROID MEASURES (1.5 CM), TUMOR CLOSE TO. RESECTION MARGIN, TUMOR AT LESS THAN 1.0 MM FROM MARGIN OF. RESECTION. METASTATIC PAPILLARY CARCINOMA OF THYROID IN 4 OF 5 REGIONAL. LYMPH NODES. Parathyroid gland, no tumor. Entire report and diagnosis completed by: Report released by: GROSS DESCRIPTION. (A) RIGHT MID JUGULAR LYMPH NODE - A single lymph node, (0. 2 v 0.2 x 0.2. cm). Submitted entirely for frozen section diagnosis in A. FS/DX: ONE LYMPH NODE, NO TUMOR PRESENT. (B) RIGHT UPPER POLE NODULE - One fragment of tan SOTT tissue (0.5 x 0.4 x. 0.3 cm) Submitted in toto for frozen section diagnosis in B. FS/DX: ONE LYMPH NODE, NO TUMOR PRESENT. (C) RIGHT INFERIOR PARATHYROID - Two tissue fragments, (U.2 and 0.6 cm in. greatest dimension). Specimen is entirely submitted for frozen section. diagnosis in c. FS/DX: VESSEL AND LYMPHOID TISSUE. TOTAL THYROIDECTOMY - The product of overall thyroidectomy with overall. measurement of 7.0 x 4.0 x 1.5 cm. The right lobe is larger than the left. lobe and contain a light tan and firm nodule on the lateral right aspect of. the specimen. The tumor measures 1.5 x 1.0 x 1.0 cm. Tumor abuting grossly. the margin of resection. The specimen is submitted as follows: SECTION CODE: D1, D2, representative section of the left lobe; D3-D10,. sequential sectioning of the right lobe and the tumor from superior to. inferior. Additional tissue is received with the main specimen, which consists. of two fragments of soft tissue (0.5 and 1.5 cm in greatest dimension. Submitted in toto in 011. SNOMED CODES.",T1,N1,M0,T1N1M0
TCGA-E2-A1LA,"SPECIMENS: A. SENTINEL NODE #1 AND #2. B. RIGHT BREAST. C. RIGHT AXILLARY CONTENTS. SPECIMEN(S): A. SENTINEL NODE #1 AND #2. B. RIGHT BREAST. C. RIGHT AXILLARY CONTENTS. GROSS DESCRIPTION: A. SENTINEL NODE #1 AND #2. Received fresh labeled with the patient's identification and ""sentinel node #1 and #2, right axilla"" is a 1.8. x 1.5 x 0.6 cm portion of adipose tissue, within which, two lymph nodes are identified, 0.4 cm( #2) and. 0.8 cm( #1). A touch preparation is made on each node. The specimen is entirely submitted as follows: A1- lymph node #1. A2-lymph node #2. B. RIGHT BREAST. Received fresh labeled with the patient's identification and designated ""right breast"" is an oriented. (suture in axilla), 358 g, 21 x 17 x 5 cm mastectomy specimen with 7.5 x 5.4 cm beige skin ellipse. showing a 1 cm diameter retracted nipple. Ink code: Posterior-deep, anterior/superior-blue,. anterior/inferior-orange. The specimen is serially sectioned from lateral to medial into 13 slices. revealing two possible lesions. Mass #1, in the upper inner quadrant (two o'clock, slices 9-10), 2 x 1.5 x. 1.4 cm, is located 2.2-cm from the deep margin and 1.4-cm from anterior. Approximately 4.5-cm from. mass #1, a second mass is demonstrated in the upper outer quadrant (slice 8), 2 x 1.5 x 1 cm, located. 2.5-cm from the deep margin and 1 cm from anterior. A portion of the specimen is submitted for tissue. procurement (mass #1). Representatively submitted: B1-B2: Nipple. B3: Skin. B4-B5: Mass #1, two o'clock, UIQ, slice 9. B6-B7: Mass #1, two o'clock, UIQ, slice 9. B8: Deep margin overlying mass #1, slice 9. B9: Firm tissue adjacent to mass #1, slice 9. B10-B12: Mass #2, UOQ, slice 8. B13: Deep margin, mass #2, slice 8. B14: Representative section, LOQ, slice 6. B15-B16: Representative sections, LIQ, slice 12. B17: Possible axillary lymph nodes. C. RIGHT AXILLARY CONTENTS. Received fresh labeled with the patient's identification and "" axillary contents"" is a 10.5 x 10.0 x 2.5 cm. portion of adipose tissue, within which, 34 possible lymph nodes are identified, ranging from 0.1 to 2.5. cm. The cut surfaces of the larger nodes are fatty to soft tan-pink. No evidence of tumor is grossly. noted. The specimen is entirely submitted as follows: C1-six lymph nodes. C2-six lymph nodes. C3-six lymph nodes. C4-six lymph nodes. C5-seven lymph nodes. C6-one lymph node bisected. C7-one lymph node bisected. C8-C9-one lymph node. C10-C14-remaining soft tissue. DIAGNOSIS: A. LYMPH NODE, SENTINEL #1 and #2, RIGHT AXILLA, EXCISION: - METASTATIC CARCINOMA TO ONE OF ONE LYMPH NODE (1/1),. MEASURING 8-MM WITH EXTRANODAL EXTENSION. B. BREAST, RIGHT, MASTECTOMY: - INVASIVE DUCTAL CARCINOMA, SBR GRADE 2, MEASURING 1.1 CM, PRESENT IN UPPER. INNER QUADRANT. - HIGH NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, SOLID type. - SURGICAL RESECTION MARGINS NEGATIVE FOR TUMOR. BIOPSY SITE CHANGES WITH FIBROSIS, GRANULATION TISSUE. - usual ductal hyperplasia without atypia. - fibroadenoma (0/.7-CM) AND INTRADUCTAL PAPILLOMA (0.2-CM). SEE SYNOPTIC REPORT. C. LYMPH NODES, RIGHT, AXILLARY DISSECTION: - Thirty-FOUR LYMPH NODES, NEGATIVE FOR METASTASES (0/34). NOTE: Two nodules are grossly identified, one located in the upper inner quadrant and one located in. the upper outer quadrant. Microscopically, the former is invasive ductal carcinoma and the later is. fibroadenoma. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: No. Laterality: Right. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.1cm. Tumor Site: Upper inner quadrant. Margins: Negative. Tubular Score: 3. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node and axillary dissection. Lymph node status: Positive 1 /35 Extranodal extension. Micrometastases: DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 5%. DCIS Type: Solid. DCIS Location: Associated with invasive tumor. Nuclear grade: High. Necrosis: Absent. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT 1c N 1a. CLINICAL HISTORY: year old with right breast cancer, previous biopsy. PRE-OPERATIVE DIAGNOSIS: None given. INTRAOPERATIVE CONSULTATION. TPA: Positive for carcinoma. Called by Dr. to Dr at. Right breast, gross examination: Two possible lesions, mass number one, 1.5-cm located 3.2-cm from. deep margin and 1.4-cm from anterior, mass number two, 2-cm in size located 2.5-cm from deep and. 1cm from anterior. Diagnosis called at. by Dr. ADDENDUM: PathVysion HER-2 DNA Probe Kit. Case oAnalytical Interpretation of Results: HER-2 NOT AMPLIFIED. Clinical Interpretation of results. Amplification of the HER-2 gene was evaluated with interphase fluorescence in-situ. hybridization (FISH) on formalin-fixed paraffin embedded tissue sections using a chromosome. 17 centromeric probe and a HER-2 probe that spans the entire HER-2 gene in the. by Dr.. A majority of tumors cells displayed 2 chromosome 17. signals and 2 HER-2 signals, with a HER-2/CEP 17 Ratio </=2.0, consistent with no. amplification of the HER2/neu gene. Block used B7. Source of case: Tissue fixation. formalin-fixed tissue. Outside Case No: NA. Tissue source. breast Results interpreted: HER2/CEP17 ratio: 1.15. This ratio is derived by dividing the total number of LSI HER-2/neu signals by the total number of. CEP17 signals in at least 20 interphase nuclei with nonoverlapping nuclei in the neoplastic. mammary epithelial cells. Cells with no signals or with signals of only one color are disregarded. Method of ratio enumeration: manual count. Limitations. The Vysis PathVysion Kit is not intended for use to screen for or diagnose breast cancer. It is. intended to be used as an adjunct to other prognostic factors currently used to predict disease-free. and overall survival in stage II, node-positive breast cancer patients. In making decisions regarding. adjuvant CAF treatment, all other available clinical information should also be taken into. consideration, such as tumor size, number of involved lymph nodes, and steroid receptor status. treatment decision for stage II, node-positive breast cancer patients should be based on HER-. 2/neu. gene amplification status alone. Overview of this test. FDA APPROVED REAGENT. PathVysion HER-2 DNA Probe Kit is FDA approved for selection of. natients for whom Herceptin therapy is being considered. These tests were performed in the. under the direction. of Dr.. The results of these studies should always be interpreted in the context of the. clinical, morphological, and immunophenotypic diagnosis. Microscopic/Diagnostic Dictation:,. Microscopic/Diagnostic Dictation: Final Review:,. Microscopic/Diagnostic Dictation:, I. Final Review: Pathologist,. Final: Pathologist. Addendum:. Pathologist,. Addendum Final: Pathologist.",T1,N1,M0,T1N1M0
TCGA-CR-7386,"DIAGNOSIS: 1) SOFT TISSUE, RIGHT LINGUAL ALVEOLAR MARGIN, BIOPSY: MICROSCOPIC FOCUS. OF INVASIVE SQUAMOUS CELL CARCINOMA; (SEE COMMENT#1). 2) SOFT TISSUE, LEFT MANDIBULAR MARROW, BIOPSY: REACTIVE BONE AND. FIBROSIS, NEGATIVE FOR MALIGNANCY. 3) SOFT TISSUE, RIGHT MANDIBULAR MARROW, BIOPSY: REACTIVE BONE AND. FIBROSIS, NEGATIVE FOR MALIGNANCY. 4) LYMPH NODES, RIGHT LEVEL I, EXCISION: 2 OF 4 LYMPH NODES POSITIVE FOR. SQUAMOUS CELL CARCINOMA (2/4), BENIGN SALIVARY GLAND TISSUE, NEGATIVE FOR. MALIGNANCY. 5) LYMPH NODES, LEFT LEVEL IB, EXCISION: 2 OF 4 LYMPH NODES POSITIVE FOR. SQUAMOUS CELL CARCINOMA (2/4), LARGEST MEASURING 1.8 CM WITH EXTRACAPSULAR. EXTENSION AND FOCAL INVASION OF SALIVARY GLAND. 6) LYMPH NODES, LEFT LEVEL II, III, EXCISION: 6 LYMPH NODES, NEGATIVE FOR. MALIGNANCY (0/6). 7) LYMPH NODES, LEFT LEVEL III, EXCISION: 2 LYMPH NODES, NEGATIVE FOR. MALIGNANCY (0/2). 8) LYMPH NODE, LEFT LEVEL IB, EXCISION: 1 LYMPH NODE, NEGATIVE FOR. MALIGNANCY (0/1). 9) SOFT TISSUE, LEVEL IB RIGHT, EXCISION: SKELETAL MUSCLE, ADIPOSE AND. VASCULAR TISSUE, NEGATIVE FOR MALIGNANCY. 10) LYMPH NODES, RIGHT LEVEL II, EXCISION: 3 LYMPH NODES, NEGATIVE FOR. MALIGNANCY (0/3). 11) LYMPH NODES, RIGHT LEVEL II, III, IV, EXCISION: 23 LYMPH NODES,. NEGATIVE FOR MALIGNANCY (0/23). 12) LYMPH NODES, BILATERAL LEVEL IA, EXCISION: 4 LYMPH NODES, NEGATIVE FOR. MALIGNANCY (0/4). 13) MANDIBLE, PARTIAL RESECTION: WELL-DIFFERENTIATED SQUAMOUS CELL. CARCINOMA, 2.0 CM IN GREATEST EXTENT, LESION EXTENSIVELY INVADES THE. MANDIBLE AND FOCALLY INVOLVES ADJACENT SALIVARY GLAND; LEFT AND RIGHT ENDS. OF MANDIBLE BONE INVOLVED BY TUMOR; LESION FOCALLY INVOLVES THE SUPERIOR. SOFT TISSUE MARGIN AND EXTENDS TO WITHIN 0.1 CM OF THE LEFT AND RIGHT SOFT. TISSUE MARGINS; (SEE COMMENT#2). 14) SOFT TISSUE, RIGHT ALVEOLAR BONE MARGIN, BIOPSY: NEGATIVE FOR. MALIGNANCY. COMMENT #1: Tumor is best seen in the original frozen section slides. COMMENT#2: The right and left mandibular ends of this specimen are. superseded by specimens 2 and 3 per the surgeon and these final margins are. negative for tumor. This corresponds to AJCC pathologic stage IVA. (pT4a,N2c,M n/a). CLINICAL DATA. Clinical Features: Unspecified. Operator: Dr. Operation: Unspecified. Operative Findings: Unspecified. Operative Diagnosis: Unspecified. Tissue Submitted: 1) )right lingual alveolar margin. GROSS DESCRIPTION: 1) SOURCE: Right Lingual Alveolar Margin. Received fresh is a fragment of soft tissue measuring 1.1 X 0.4 X 0.4 cm. One side of the specimen possesses a smooth, shiny, glistening mucosal. surface. The specimen is entirely submitted for frozen section evaluation. Summary of sections: 1AFSC, 1/1. 2) SOURCE: Left Mandibular Marrow Tissue. Received fresh are two fragments of soft tissue and bone measuring in. aggregate 0.8 X 0.4 X 0.4 cm. The specimen is entirely submitted for frozen. section evaluation. Summary of sections: 2AFSC, left mandibular marrow tissue, 2/1. 3) SOURCE: Right Mandibular Marrow Tissue. Received fresh are two fragments of bone and soft tissue measuring in. aggregate 0.6 X 0.4 x 0.4 cm. The specimen is inked blue and entirely. submitted for frozen section evaluation. Summary of sections: 3AFSC, right mandible marrow tissue, 2/1. 4) SOURCE: Right Level I. Received in saline are multiple fragments of fatty tissue and lymphoid. tissue measuring in aggregate 8.1 X 7.3 X 1.7 cm. Present within the. specimen is also a small fragment of salivary gland tissue measuring 5.5 X. 3.6 X 1.8 cm. Four candidate lymph nodes are identified and submitted. Representative sections of salivary gland tissue is submitted. Summary of sections: 4A, two candidate lymph nodes, two bisected, (one. inked black), 4/1; 4B, two candidate lymph nodes, two bisected, (one inked. black), 4C, representative salivary gland tissue, 2/1. 5) SOURCE: Left Level IB. Received fresh is one fragment of lymphoid and fatty tissue measuring 8.5 x. 4.6 X 1.5 cm. The majority of the soft tissue is that of salivary gland,. measuring 5.5 X 3.5 X 1.2 cm. Candidate lymph nodes are identified and. submitted. Representative sections of salivary gland tissue are submitted. Summary of sections: 5A, two candidate lymph nodes, one bisected (bisected. lymph node not inked), 2/1; 5B, one candidate lymph node, bisected, 1/1;. 5C, 5D, one candidate lymph node, serially sectioned, 2/1 each; 5E,. salivary gland tissue, 3/1. 6) SOURCE: Left Level II, III. Received in saline is one fragment of lymphoid and fatty tissue measuring. 7.7 X 4.5 X 1.7 cm. Candidate lymph nodes are identified and submitted. Summary of sections: 6A, four candidate lymph nodes, 4/1; 6B, one candidate. lymph node, bisected, 1/1; 6C, one candidate lymph node, bisected, 1/1. 7) SOURCE: Left Level III. Received in saline is one fragment of fatty and fibrous tissue measuring. 2.4 X 1.4 X 0.7 cm. Two candidate lymph nodes are identified and submitted. The specimen is entirely submitted. Summary of sections: 7A, one candidate lymph node, bisected, 1/1; 7B, one. candidate lymph node, bisected and remainder of specimen, 1/1. 8) SOURCE: Left Level IB. Received in saline is one fragment of soft tissue measuring 2.5 X 1.2 X 0.6. cm. No lymphoid candidates are identified within the specimen. The specimen. is bisected and entirely submitted. Summary of sections: 8A, level IB, left lymph node, soft tissue, 1/1. 9) SOURCE: Right Level IB Soft Tissue. Received in saline is one fragment of soft tissue measuring 2.5 X 1.0 X 0.4. cm. No lymph node candidates are directly palpable or identified grossly. The specimen is entirely submitted. Summary of sections: 9A, soft tissue level 1B, 1/1. 10) SOURCE: Right Level II. Received in saline is one fragment of lymphoid and fatty tissue measuring. 2.6 X 1.4 X 0.5 cm. One candidate lymph node is identified. The specimen is. bisected and the specimen is entirely submitted. Summary of sections: 10A, right level II, 1/1. 11) SOURCE: Right Level II, III, IV. Received in saline is one fragment of lymphoid and fatty tissue measuring. 6.6 X 5.2 X 0.9 cm. Candidate lymph nodes are identified and submitted. Summary of sections: 11A, candidate lymph nodes, M/1; 11B, candidate lymph. nodes, M/1; 11C, candidate lymph nodes, 3/1; 11D, two candidate lymph. nodes, two bisected (one inked blue), 2/1. 12) SOURCE: Bilateral Level IA. Received in saline is one fragment of lymphoid and fatty tissue measuring. 4.2 X 3.0 X 1.1 cm. Candidate lymph nodes are identified and submitted. Summary of sections: 12A, three candidate lymph nodes, 3/1; 12B, one. candidate lymph node, bisected, 1/1; 12C, 12D, remainder of specimen, 12C,. 2/1, 12D, 1/1. 13) SOURCE: Composite Resection. Received fresh is a portion of lower mandible, skin, teeth, and associated. skeletal muscle measuring 6.5 cm from anterior to posterior, 4.5 cm from. superior to inferior, and 4.2 cm transversely. The portion of skin that is. present is previously incised and measures 9.0 X 4.8 cm. It extends to a. depth of 2.0 cm. The mandible itself measures 5.0 X 4.0 X 1.0 cm, and has. four teeth attached. The teeth show variable amounts of dental caries. The. muscle fragment, which is attached to the posterior aspect of the mandible,. measures 4.5 X 4.0 X 3.5 cm. Also present is a small mucosal surface which. is attached to the posterior/superior portion of the specimen; this. measures 4.0 X 2.0 X 1.8 cm. The specimen is inked in the following manner: the right surgical margin is inked black, the left surgical margin is inked. blue, the superior surgical margin is inked yellow, the inferior surgical. margin is inked orange, and the deep surgical margin is inked red. The. specimen is bisected to reveal a pale white mass involving the soft tissue. between the teeth and the oral mucosa. This lesion measures 2.0 X 2.0 X 1.0. cm. This lesion focally penetrates into the mandible, involves the adjacent. soft cutaneous tissue, and extends partially into the oral mucosa. The. adjacent skeletal muscle does not appear to be grossly involved. This. lesion extends to within 0.2 cm of the deep margin (red) and to within 1.8. cm of the inferior margin (orange). It appears to focally involve the left. surgical margin (blue) as well as the right surgical margin (black). A. representative section of the tumor is given to research. Another. representative section is placed in glutaraldehyde for potential future. studies. Representative sections of the specimen are submitted. Specimen. containing bone are decalcified prior to submission. Summary of sections: 13A, right mandibular margin, 1/1; 13B, left. mandibular margin, 3/1; 13C, lesion invading bone, 1/1; 13D, lesion,. adjacent mucosa, and deep margin, 1/1; 3E-3F, lesion and adjacent skin,. bisected, bisected margin inked green, 1/1 each; 13G, inferior margin, 1/1;. 13H, lesion and superior and left margin, 1/1; 13I, lesion and right. surgical margin, 2/1; 13J, lesion and adjacent skin, 1/1; 13K, additional. sections of lesion, 3/1; 13L, additional sections of lesion, 3/1. 14) SOURCE: Right Alveolar Bone Margin. Source 14 is received fresh labeled ""right alveolar bone margin"" and. consists of a 1.5 X 1.0 X 0.4 cm wedge of tan-red bone. The specimen is. sectioned and entirely submitted following decalcification. Summary of sections: 14A, M/1. Slides and report reviewed by Attending Pathologist. SURGICAL PATHOLOGY INTRAOPERATIVE CONSULTATION. 1) SOURCE: Right Lingual Aveolar Margin. FROZEN SECTION DIAGNOSIS: MICROSCOPIC FOCUS OF SUPERFICIALLY INVASIVE. SQUAMOUS CELL CARCINOMA. 2) SOURCE: Left Mandibular Marrow Tissue. FROZEN SECTION DIAGNOSIS: BENIGN. 3) SOURCE: Right Mandibular Marrow Tissue. FROZEN SECTION DIAGNOSIS: BENIGN. The following special studies were performed on this case and the. interpretation is incorporated in the diagnostic report above: 2xDECALCIFICATION. SNOMED: T-11180,T-11180,M-80703, -.",T4,N2,M0,T4N2M0
TCGA-MQ-A4LC,"Result date: SPECIMEN DESCRIPTION. SPECIMEN DESCRIPTION. LEVEL NO 7 LYMPH NODE. TUMOR RIGHT LUNG. RIGHT LUNG. LEVEL NO 8 LYMPH NODE. LEVEL NO 9 LYMPH NODE. DIAPHRAGMATIC TUMOR. LEVEL NO 4 LYMPH NODE. 6TH RIGHT RIB FOR. PATHOLOGY NO.: HOSPITAL ID: HOSPITAL NO. : ACCOUNT NO.: DATE RECEIVED: PHYSICIAN (S) : ACCN REQ. NO. : NOT GIVEN. DIAGNOSIS: A. LEVEL VII LYMPH NODE, EXCISION: ELEVEN LYMPH NODES NEGATIVE FOR MALIGNANCY. B. RIGHT LUNG, TUMOR EXCISION: MALIGNANT MESOTHELIOMA, TUBULOPAPILLARY TYPE. c. RIGHT LUNG, EXTRAPLEURAL PNEUMONECTOMY: MALIGNANT MESOTHELIOMA, EPITHELIAL, TUBULOPAPILLARY TYPE, DIFFUSE. BRONCHIAL MARGIN NEGATIVE FOR TUMOR. LUNG PARENCHYMA FREE OF TUMOR. NINE HILAR LYMPH NODES NEGATIVE FOR MALIGNANCY. LEVEL VIII LYMPH NODE, EXCISION: THREE LYMPH NODES NEGATIVE FOR MALIGNANCY. E. LEVEL IX LYMPH NODE, EXCISION: ONE LYMPH NODE NEGATIVE FOR MALIGNANCY. F. LABELED DIAPHRAGMATIC TUMOR: MALIGNANT MESOTHELIOMA, EPITHELIAL, TUBULOPAPILLARY TYPE, INVADING. FIBROCOLLAGENOUS TISSUE AND FOCALLY THE SKELETAL MUSCLE. G. LEVEL IV LYMPH NODE, EXCISION: FOUR LYMPH NODES NEGATIVE FOR MALIGNANCY. H. RIB, RESECTION: FOR GROSS ONLY. COMMENT: The tumor present in specimens B, C and F is formed by epithelial. cells with eosinophilic cytoplasm. round nucleus and prominent nucleoli. These cells are arranged in glands and. form papilla as well as nests. The immunohistochemical studies confirm the. diagnosis of malignant mesothelioma: the tumor cells are positive for. calretinin, thrombomodulin , WT-1, cytokeratin and negative for B72.3, CEA, and. BEREP-4. SPECIMEN: A. LEVEL NO 7 LYMPH NODE. B. TUMOR RIGHT LUNG. C. RIGHT LUNG. D. LEVEL NO 8 LYMPH NODE. E. LEVEL NO 9 LYMPH NODE. F. DIAPHRAGMATIC TUMOR. G. LEVEL NO 4 LYMPH NODE. H. 6TH RIGHT RIB FOR. OPERATION: R EXTRAPLEURAL PNEUMONECTOMY. PRE-OP DIAGNOSIS: LUNG CANCER RT. POST-OP DIAGNOSIS: SAME. CLINICAL DATA: NOT GIVEN. GROSS DESCRIPTION: The specimen is received in eight separate containers. A. Received fresh labeled level 7 lymph node is one fragment of fibroadipose. tissue measuring 5.5 x 2.0 x 0.5 cm. Summary of sections: 1- one lymph node bisected,. 2- two possible lymph nodes,. 3- one lymph node bisected,. 4- two lymph nodes bisected,. 5- one lymph node bisected,. 6- one lymph node bisected,. 7- one lymph node,. 8= one lymph node bisected. B. Received fresh labeled tumor right lung is one fragment of fibroadipose. tissue measuring 2.0 x 1.0 x 0.2 cm. Entirely submitted in two cassettes. C. Received fresh labeled right lung is a right extrapleural pneumonectomy. specimen measuring 20.0 X 15.0 X 4.0 m.weighing 800 gm.total. The parietal. pleura is attached at the superior part of the specimen and measures 30 x 15. cm, with 0.2 cm thickness. The thoracic, diaphragmatic, and mediastinal. surface of the lung is almost entirely covered by granular, tan indurated. nodules. The lung is serially sectioned. The lung's parenchyma is soft, red,. and free of tumor, except at the mediastinal aspect of the lung where the tumor. appears to invade the lung parenchyma. The parietal pleura also shows multiple. nodules, the largest measuring 10 x 3 x 3 cm and appears to invade the lung. Summary of sections: 162-sections from the tumor,. 3-bronchial margin with two lymph nodes,. 4-vessels with one hilar Tymph node,. 5-three possible lymph nodes,. 6 -three possible lymph nodes,. 7-tumor to lung parenchyma,. 8&9-tumor and parietal pleura. 10-tumor. D. Received fresh labeled level 8 lymph node is a piece of tissue measuring. 1.5 x 0.8 x 0.3 cm. Two lymph nodes are identified measuring 0.5 and 0.7 cm. Summary of sections: D1- one lymph node bisected,. D2- one lymph node bisected. E. Received fresh labeled level 9 lymph node is one lymph node measuring 1.0 x. 0.5 x 0.2 cm. The specimen is bisected and entirely submitted in one cassette. F. Received fresh labeled tumor diaphragmatic are multiple fragments of. fibroadipose tissue with fibrous white granular tissue aggregating to 5.0 x 5.0. x 1.0 cm. Representative sections are submitted in two cassettes. G. Received fresh are two anthrocotic lymph nodes measuring 1.2 and 0.5 cm. Summary of cassettes: 1- - one lymph node bisected,. 2- one lymph node. H. Received fresh labeled ribs are six fragments of bone submitted for Dr. study. CPT CODE: Completed Action List: Perform by.",T2,N0,M0,T2N0M0
TCGA-DD-AADJ,"CLINICAL DIAGNOSIS: Hepatocellular carcinoma. Specimen : Liver. Photo : GROSS: Specimen: Liver (16.0 X 9.5 X 2.5 cm, 250 gm, unfixed). Gallbladder (6.2 cm in length, 3.2 cm in diameter, 0.2 cm in wall thickness,. unfixed). Operation: Partial hepatectomy. Lesion: - A well-defined mass: 2.5 X 2.5 X 2.0 cm at the segment 4. - Cut surface: Round to ovoid, pale tan to yellow, and solid mass with hemorrhage and. necrosis (30-40%). Gross type: HCC: Expanding nodular. Resection margin: Not involved grossly (safety margin: 0.3 cm). Others: Satellite nodule: No. Remaining parenchyma: Cirrhotic. Portal vein invasion: No. Gross photo: Present. Blocks. T1-5, round to ovoid and solid mass and surrounding tissue x. 5. L, cirrhotic liver X 1. RM, blood vessel X 1. GB, gallbladder X 1. MICROSCOPIC: Hepatocellular carcinoma: Yes. Edmondson-Steiner grade. The worst grade III. The major grade II. Histologic type: Trabecular and solid. Cell type: Hepatic. Fatty change: No. Fibrous capsule formation: No. Capsular infiltration: No. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Microvessel invasion: No. Intrahepatic metastasis: No. Multicentric occurrence: No. NOT reported. Gross: cervix,smear,inflammation. Cervix, smear, atrophy. Cervix, smear, inflammation, atrophy. Large intestine, cecum, scopic, suggestive of, hyperplastic polyp. Liver, ectomy, hepatocellular carcinoma, cirrhosis. T56000, P10, M81703, M49500. Gallbladder, ectomy, chronic cholecystitis. T57000, P10, M43005. DIAGNOSIS: Liver, partial hepatectomy: Hepatocellular carcinoma. Cirrhosis, micronodular. Gallbladder, cholecystectomy: Chronic cholecystitis. Suggestion :",T1,N0,M0,T1N0M0
TCGA-G4-6297,"SPECIMENS: A. RIGHT COLON. DIAGNOSIS: A. RIGHT COLON, RIGHT HEMICOLECTOMY: - EXOPHYTIC CIRCUMFERENTIAL ULCERATED INVASIVE MODERATE TO. POORLY DIFFERENTIATED ADENOCARCINOMA OF CECUM, PROXIMAL. ASCENDING COLON WITH EXTENSION TO ILEOCECAL VALVE, WITH. FULL MUSCLE WALL THICKNESS INVASION, EXTENSION TO SUB-. SEROSAL FAT., METASTASIS TO SIX OF THIRTY-SIX (6/36) PERICOLIC. LYMPH NODES (WITH PERINODAL FAT EXTENSION). - SIZE OF TUMOR- 8X4X1CM. - TUBULOVILLOUS ADENOMA (1.2 X 1.1 CM). - VERMIFORM APPENDIX - NEGATIVE FOR TUMOR. PROXIMAL, DISTAL AND RADIAL MARGINS OF RESECTION - NEGATIVE. FOR TUMOR. COLORECTAL CANCER TEMPLATE. Specimen Type: Right hemicolectomy. Tumor Site: Cecum,proximal ascending coln. Tumor Configuration: Exophytic (polypoid), Infiltrative, Ulcerating. Tumor Size: 8.0 X 4.0 X 1.0 cm. Histologic Type: Adenocarcinoma. Histologic Grade: G3. Extent of Invasion: Subserosa. Margins: Margins uninvolved by invasive carcinoma. Venous/Lymphatic Invasion: Present. Perineural Invasion: Present. Additional Pathologic Findings: Adenoma. Extent of Resection: R0. Lymph Nodes: Positive (6/36). Implants: Absent. EGFR Expression: Pending. Pathologic Stage: pT3 N2 MX. ADDENDUM: Additional report: Results of immunostain: EGFR ( section with tumor,#A5) - negative immunoreactivity. SPECIMEN(S): A. RIGHT COLON. GROSS DESCRIPTION: A. RIGHT COLON TERMINAL ILEUM: Received fresh labeled with the patient's name, unit number and ""right colon terminal ileum"" is a. 28.5x8.5x4 cm. right hemicolectomy specimen. The ileum is 8 cm. long and 7 cm. in circumference,. the. colon is 20.5 cm. long, 8.5 cm. in circumference and the attached appendix is 5.8 cm. long and 0.9 cm. in diameter. The serosal surface of the specimen is tan, smooth and multiple firm lymph nodes are. palpated throughout the adherent pericolonic fat at the cecum. The specimen when opened shows a. circumferential exophytic centrally ulcerated tumor with raised indurated peripheral borders occupying. proximal ascending olon,cecum, and extending to involved the iliocecal valve,measuring 8x4x1.0 cm. Tumor 14.5 cm from distal, and 5.5cm from proximal margin. Cut sections show tan white granular. surface.and tumor seen infiltrating muscle wall and grossly appears to extend to subjacent subserosal. fat. The rest of colonic mucosa shows a flattened appearance .with a small polyp along hepatic flexure. measuring 1.2x1.1 cm. Dissection of the adherent pericolonic fat shows multiple lymph nodes, the. largest measuring 2x1.1x0.9 cm. Appendix is grossly free of tumor. Multiple sections submitted as. follows in 30 cassettes labeled A1-A17. Block summary: A1: margin. A2: apex. A3,A4,A5,A6: tumor and tandom section from ileum to colon. A7,A8: tumor. A9-A11: tumor deep section. A12: polyp. A13: three lymph nodes ileum. A14: three lymph nodes ileum. A15 lymph nodes cecum colon. A16: lymph nodes cecum colon. A17: two lymph nodes distal colon. A19-21: lymph nodes distal colon. A22-25: lymph nodes cecum. A26-30: sections of tumor, A29 and A30 are random sections.",T3,N2,M1,T3N2M1
TCGA-22-5478,"DIAGNOSIS: Lung, right lower lobe, lobectomy: Grade 3 (of 4) squamous cell. carcinoma forms a 3.8 x 3.7 x 3.5 cm mass that invades through the. visceral pleura. Multiple (8) intrapulmonary peribronchial lymph. nodes are negative for tumor. The bronchial margin is negative for. tumor. Lymph nodes, superior and inferior mediastinal, excision: Multiple. superior mediastinal (3 right paratracheal) and inferior mediastinal. (4 subcarinal) lymph nodes are negative for tumor.",T2,N0,M0,T2N0M0
TCGA-VR-AA7I,"PRIMARY SITE: Esophagus (Mid third). 1 - ""Product of esophagectomy"": Squamous cell carcinoma of the esophagus characterized as follows: Histological grade 1. Measurement of neoplasia in its longest axis: 5.3 cm. Measurement of neoplasia in depth: 1.3 cm. Ulceration present. Involvement of mucosa, submucosa, muscularis propria and adventitia. Spiculated pattern of infiltration. Mild inflammatory infiltrate. Proximal and distal surgical margins free of neoplastic involvement. Radial margin is tangential. Surgical margins free of neoplastic involvement. Lymph nodes free of neoplastic involvement (0/15) distributed as follows: right paracardic: 0/2. left paracardic: 0/2. along the lesser curvature: 0/5. along the left gastric artery: 0/2. around the celiac trunk: 0/2. 2 - ""Esophageal margin"": Free of neoplastic involvement.",T4,N0,M0,T4N0M0
TCGA-B6-A401,"AP Surgical Pathology: Additional Info. CLINICAL HISTORY: Not provided. GROSS EXAMINATION: A. ""Sentinel node #1, hot (AF1-3) "", received for frozen section are three. lymph node candidates. One lymph node is bisected and submitted for frozen. section as AF1-AF2, and the remnant sections are submitted in blocks A1-2. Two additional lymph nodes are submitted for frozen section as AF3, and the. remnant is submitted as block A3. B. ""Axillary fat"", received in formalin is a 11.3 x 4 x 1.5 cm fragment of. yellow-tan adipose tissue which is dissected to reveal one lymph node. candidate measuring 0.8 x 0.7 x 0.5 cm, which is submitted entirely in block. B1. C. ""Left breast cancer, two clips medial, one clip inferior, long stitch. lateral, short stitch superior"", received in formalin is a 8 cm medial to. lateral, 7 cm superior to inferior, 2.7 cm anterior to posterior lumpectomy. specimen inked as follows: superior-yellow, inferior-red, anterior-blue and. posterior-black. The specimen is sectioned from medial to lateral to reveal a. 2.0 x 1.5 x 1 cm mass lesion located 0.4 cm from the posterior margin, 0.7 cm. from the anterior margin, 2.7 cm from the medial margin, 2.7 cm from the. lateral margin, 1.3 cm from the superior margin and 3.2 cm from the superior. margin. The remainder of the breast tissue demonstrates fibrofatty lobulated. adipose tissue that is otherwise grossly unremarkable. Sections are submitted. as follows per the block diagram: BLOCK SUMMARY: C1-. medial edge. C2-4. representative medial breast. C5-28 mass submitted entirely. C29-31 representative lateral breast. C32-34 lateral edge. D. ""Superior medial margin"", received in formalin is a 7.2 x 6.4 x 2.3 cm. fragment of adipose tissue with a stitch marking final margin. The final. margin is inked blue and the opposite margin is inked black. Every other. section is submitted in blocks D1-10. E. ""Medial and superior margin"", received in formalin is a 5.5 x 3.5 x 2.2 cm. fragment of yellow-tan adipose tissue with a stitch in place marking the final. margin. The stitched margin is inked blue, and the opposite margin is inked. black. The specimen is sectioned to reveal no focal lesions. Every other. section is submitted in blocks E1-12. F. ""Inferior to lateral margin"", received in formalin is a 6.5 x 5.2 x 2.1 cm. fragment of yellow-tan adipose tissue with a suture marking the final. margin. The final margin is inked blue and the opposite margin is inked. black. The specimen is sectioned to reveal no focal lesions. Every other. section is submitted in blocks F1-11. G. ""Anterior skin"", received in formalin is a 7.5 x 5 x 2 cm unoriented. aggregate of brown skin with subcutaneous tissue that is grossly. unremarkable. Representative sections are submitted in blocks G1-3. INTRA OPERATIVE CONSULTATION: A. ""Sentinel node #1, hot and blue"": AF1-2 (one lymph node candidate, bisected) -positive for carcinoma. AF3 (two lymph node candidates) -negative for malignancy. MICROSCOPIC EXAMINATION: Microscopic examination is performed. PATHOLOGIC STAGE: PROCEDURE: Partial mastectomy, sentinel lymph node biopsy. PATHOLOGIC STAGE (AJCC. Edition) : pT1c pN1a (sn) pMX. NOTE: Information on pathology stage and the operative procedure is. transmitted to this Institution's Cancer Registry as required for. accreditation by the Commission on Cancer. Pathology stage is based solely. upon the current tissue specimen being evaluated, and does not incorporate. information on any specimens submitted separately to our Cytology section,. past pathology information, imaging studies, or clinical or operative. findings. Pathology stage is only a component to be considered in determining. the clinical stage, and should not be confused with nor substituted for it. The exact operative procedure is available in the surgeon's operative report. DIAGNOSIS: A. ""SENTINEL LYMPH NODE #1"" (BIOPSY) : METASTATIC ADENOCARCINOMA IN ONE OF THREE LYMPH NODES (1/3). SIZE OF METASTASIS: 5 MILLIMETERS. EXTRANODAL INVASION: ABSENT. B. ""AXILLARY FAT"" (EXCISION) : ONE LYMPH NODE, NO EVIDENCE OF MALIGNANCY (0/1) . SEE COMMENT. COMMENT: The specimen is re-examined and only one lymph node is identified. C. ""LEFT BREAST CANCER"" (PARTIAL MASTECTOMY) : INVASIVE ADENOCARCINOMA OF THE BREAST. HISTOLOGIC TYPE: DUCTAL. NOTTINGHAM COMBINED HISTOLOGIC GRADE: 3 OF 3. TUBULE FORMATION SCORE: 3. NUCLEAR PLEOMORPHISM SCORE: 3. MITOTIC RATE SCORE: 2. GROSS TUMOR SIZE: 2 x 1.5 X 1 CM. SIZE OF INVASIVE COMPONENT: 2.0 CM. LYMPHATIC/VASCULAR INVASION: ABSENT. MULTIFOCAL TUMOR: ABSENT. IN-SITU CARCINOMA: PRESENT. TYPE OF IN-SITU CARCINOMA: CRIBRIFORM. NUCLEAR GRADE OF IN-SITU CARCINOMA: 3 OF 3. NECROSIS: ABSENT. DCIS EXTENDING OUTSIDE INVASIVE TUMOR MASS: ABSENT. SIZE OF IN-SITU CARCINOMA: NOT APPLICABLE. STATUS OF NON-NEOPLASTIC BREAST TISSUE: INTRADUCTAL PAPILLOMA, RECENT. NEEDLE CORE BIOPSY SITE. SIZE OF BIOPSY: 8 X 7 x 2.7 CM. MICROCALCIFICATIONS: ABSENT. SURGICAL MARGIN STATUS: NEGATIVE (GREATER THAN 2 MM) . ESTROGEN/PROGESTERONE RECEPTOR, CELL CYCLE, EGFR AND HER2/NEU ANALYSIS: PENDING. PARAFFIN BLOCK NUMBER: C14. RESULTS WILL BE ISSUED IN SEPARATE REPORT FROM. D. ""SUPERIOR MEDIAL MARGIN, LEFT BREAST"" (RE-EXCISION) : BREAST TISSUE, NO EVIDENCE OF MALIGNANCY. FINAL MARGIN FREE OF TUMOR. E. ""MEDIAL AND SUPERIOR MARGIN, LEFT BREAST"" (RE-EXCISION). BREAST TISSUE, NO EVIDENCE OF MALIGNANCY. FINAL MARGIN FREE OF TUMOR. F. ""INFERIOR TO LATERAL"" (RE-EXCISION) : BREAST TISSUE, NO EVIDENCE OF MALIGNANCY. FINAL MARGIN FREE OF TUMOR. G. ""ANTERIOR SKIN"" (BIOPSY) : SKIN AND SUBCUTANEOUS TISSUE, NO EVIDENCE OF MALIGNANCY. FINAL MARGIN IS NEGATIVE FOR MALIGNANCY. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) . ADDENDUM 1: Please see. for results of supplementary. tests. I certify that I personally conducted the diagnostic evaluation of the above. specimen (s) and have rendered the above diagnosis (es) .",T1,N1,M0,T1N1M0
TCGA-98-A53A,"Observation Date. Last Edited Date. Diagnosis. A. Lymph node, level IX-A, excision: - Negative for malignancy. B. Lymph node, level IX-B, excision:- - Negative for malignancy. C. Lymph node, level VIII, excision: - Negative for malignancy. D. Lymph node, level VII-A, excision: - Negative for malignancy. E. Lymph node, level VII-B, excision: - Negative for malignancy. F. Lymph node, level VII-C, excision: - Negative for malignancy. G. Lymph node, level VII-D, excision: - Negative for malignancy. H. Lymph node, level VII-E, excision: - Negative for malignancy. I. Lymph node, level VII-F, excision:- Negative for malignancy. J. Lymph node, level X, excision: - Negative for malignancy. K. Lymph node, level II-R, excision: - Negative for malignancy. L. Lymph node, level IV-A, excision: - Negative for malignancy. M. Lymph node, level IV-B, excision: - Negative for malignancy. N. Lymph node, level IV-C, excision: - Negative for malignancy. O. Lymph node, level IV-D, excision: - Negative for malignancy. P. Lymph node, level IV-E, excision: - Negative for malignancy. Q. Lymph node, level XII, excision: - Negative for malignancy. R. Lung, right middle lobe, excision: - Squamous cell carcinoma, moderately differentiated. - The tumor measures. 3.5 cm in maximum dimension. - Vascular invasion is present. - The pleura is uninvolved by tumor. S. Bronchial margin, biopsy: - Negative for malignancy. Clinical Information: The patient is a. year old black male with right middle lobe mass. Frozen Section Diagnosis. RFS1: Lung, right middle lobe, lobectomy:- - Squamous cell carcinoma. SFS1: Bronchial margin, excision: - Negative for carcinoma. Gross Description. The specimen is received in nineteen containers, each labeled with the patients name and medical record number. The first container is labeled ""level 9 lymph node - A."" It consists of 1 cm in greatest dimension yellow-tan tissue,. submitted in its entirety. The second container is labeled ""level 9 lymph node -B."" It consists of nodal tissue measuring 0.8 cm in greatest. dimension, it is placed in a single cassette in its entirety. The third container is labeled ""level 8 lymph node."" It consists of nodal tissue measuring 0.7 cm in greatest. dimension, submitted in its entirety. The fourth container is labeled ""level 7 lymph node - A."" It consists of fragmented and black-yellow tissue measuring. 1.5 cm in greatest dimension, submitted in its entirety. K1-. Level 2R lymph node. L1-. Level 4 lymph node - A. M1-. Level 4 lymph node - B. N1-. Level 4 lymph node - C. O1-. Level 4 lymph node - D. P1-. Level 4 lymph node - E. Q1-. Level 12 lymph node. R1-. Frozen section. R2-R3. Stapled margin. R4-R10. Tumor. R11-. Representative section through uninvolved lung. S1-. Bronchial margin. Microscopic Description. A microscopic examination has been performed. SP Synoptic Report R: Thorax Lung. SPECIMEN: Lobe(s) of lung: RML. PROCEDURE: Lobectomy. SPECIMEN INTEGRITY: Intact. SPECIMEN LATERALITY: Right. TUMOR SITE: Middle lobe. TUMOR SIZE: Greatest dimension: 3.5 cm. TUMOR FOCALITY: Unifocal. HISTOLOGIC TYPE: Squamous cell carcinoma. HISTOLOGIC GRADE: G2: Moderately differentiated. VISCERAL PLEURA INVASION: Not identified. TUMOR EXTENSION: Not identified. BRONCHIAL MARGIN: Uninvolved by invasive carcinoma. LYMPH-VASCULAR INVASION: Present. PRIMARY TUMOR (pT): pT2a: Tumor > 3 cm, and < 5 cm in greatest dimension surrounded by lung or visceral. pleura, without bronchoscopic evidence of invasion in the main bronchus; or Tumor < 5 cm in greatest dimension with. any of the following: involves main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated. with atelectasis or obstructive pneumonitis that extends to the hilar region. REGIONAL LYMPH NODES (pN): pNO: No regional lymph node metastasis. DISTANT METASTASIS (pM): Not applicable.",T2,N0,M0,T2N0M0
TCGA-WC-A87Y,"DIAGNOSIS. (A) RIGHT GLOBE, ENUCLEATION: CHOROIDAL MELANOMA, MIXED EPITHELIOID AND SPINDLED TYPE, 13 MM BASE. VORTEX VEIN INVASION PRESENT. TUMOR EXTENDS EXTRAOCULARLY IN VORTEX VEIN (A2). Optic nerve negative for tumor. Ciliary body negative for tumor. See comment. COMMENT. The tumor is mitotically active at 1 per 10 high-power fields. The PAS is examined for intraocular structures. GROSS DESCRIPTION. (A) RIGHT GLOBE - An intact globe (22 X 22 X 21 mm) has an intact 4.0 mm optic nerve, The anterior chamber is formed. gray iris (10 X 11 mm) surrounding a round 6.0 mm pupil. The sclera is unremarkable. By transillumination a shadow is pres. from 1-3 o'clock present 6.0 mm from the optic nerve and 2.0 mm from the limbus. The shadow corresponds to a choroidal. brown tumor with 13 mm base and 7.0 mm height. The vitreous is clear. The sclera beneath the tumor is grossly intact. SECTION CODE: A1-A4, vortex vein and tissue in regions (superior temporal, superior nasal, inferior nasal, inferior. temporal); A5, pupil-optic nerve section; A6 calotte with tumor; A7, additional calotte; A8, optic nerve margin and lens. CLINICAL HISTORY. Melanoma. SNOMED CODES. T-AA000, M-87203. ""Some tests reported here may have been developed and performance characteristics determined by. These tests have not. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: "" teria. Premary Site C crepancy. AADiscrepancy. /.",T3,N0,M0,T3N0M0
TCGA-B6-A0IE,"Surgical Pathology: Final. CLINICAL HISTORY: Inflammatory breast ca. Breast cancer. GROSS EXAMINATION: A. ""Left breast biopsy, received fresh. A fragment of skin which is 3.3 cm. long and 0.4 cm in diameter attached to underlying fibroadipose tissue which. is 2.7 cm thick x 3.5 x 1 cm in greatest dimensions. The specimen has been. previously partially sectioned revealing a poorly defined area of pink tissue. measuring approximately 2.5 x 1.5 x 1 cm in greatest dimensions. This does. not represent the true sides of the lesion. Portions of the tissue have. submitted for ER/PR evaluation. It is noted that this is a representative. fragment of larger lesion and margins are not require for the specimen. Representative sections are submitted in Blocks A1 and A2. DIAGNOSIS: A. BREAST, LEFT, INCISIONAL BIOPSY: POORLY DIFFERENTIATED CARCINOMA WITH EXTENSIVE VASCULAR INVASION. IN SITU CARCINOMA IS NOT PRESENT. NOTE: THE TUMOR HAS FEATURES OF LOBULAR CARCINOMA, BUT AN IN SITU COMPONENT. IS NOT PRESENT. eBrowser Result for: 1 of 1.",T3,N1,M0,T3N1M0
TCGA-AG-3591,"Diagnosis/ diagnoses: Rectosigmoid resection preparation with a moderately differentiated adenocarcinoma of the. colorectal type, located 2 cm above the dentate line, and a maximum of 3 cm in diameter,. with wide infiltration of the perirectal fatty tissue. Tumor-free regional lymph nodes. Resection margins are tumor-free. The minimum distance between the tumor and the. circumferential resection margin is 1.5 mm. Peritumorous, focally marked, chronic, florid,. fibrosing and resorptive cellular inflammation. Tumor stage: pT3 pNO (0/16) pMX; G2, L0, V0, R0.",T3,N0,M0,T3N0M0
TCGA-55-8089,"SPECIMEN INFORMATION. Acct / Reg. DIAGNOSIS. DIAGNOSIS: A. Lymph nodes, level 12, right upper lobe, excision: Anthracosis and reactive changes, lymph node fragments. Negative for malignancy. B. Lymph nodes, level 10, right upper lobe, excision: Anthracosis and reactive changes, lymph node fragments. Negative for malignancy. U. Lung, right upper lobe, resection: Tumor Characteristics: 1. Histologic type: Adenocarcinoma. 2. Histologic grade: III (poorly differentiated). 3. Tumor site: Peripheral, subpleural. 4. Tumor focality: Unifocal. 5. Tumor size: 1.8 x 1,7 x 1.3 cm. 6. Visceral pleural invasion: Not identified. 7. Lymphovascular space invasion: Not identified. 8. Tumor extension: None. 9. Treatment effect: Not identified. Surgical Margin Status: 1. Tumor distance from bronchial margin: 8.0 cm. 2. Tumor distance from parenchymal (stapled) margin: 4.0 cm. 3. Tumor distance from pleural surface: <0.1 cm. Lymph Node Status: 1. Total number of lymph nodes received: At least eleven (see comment). 2. Total number of lymph nodes containing metastatic carcinoma: Zero (0/11). Other: 1. pTNM stage: pT1a, NO. D. Lymph nodes, level 9, right, biopsy: Anthracosis and reactive change. Negative for malignancy, one node (0/1). E. Lymph nodes, level 2/4, right, excision: Anthracosis and reactive change. Negative for malignancy, lymph node fragments. 1. COMMENTS: An accurate lymph node count is not possible, as several sites were received as multiple individual fragments. The number eleven is a minimum possible. number. ne malignancy is poorly differentiated, and associated peripherally with an area of apparent scarring. Focally, there is a rare suggestion of gland. formation. No squamous differentiation is identified. Accordingly, a series of immunohistochemical stains is performed. Sections are examined along. with appropriately staining positive an negative controls. with the followina resulte. CK5/6 negative. CK7 - strongly and diffusely positive. TTF-1 negative. p63- negative. The staining pattern favors the diagnosis of poorly differentiated adenocarcinoma. No prior material is identified in our files for review and comparison, and this appear to represent a new pulmonary adenocarcinoma diagnosis. Accordingly, studies of the EGFR/KRAS/ALK mutation cascade have been requested, and will be reported as an addendum. Sections have also been reviewed. CINCAEINEORMATION. CLINICAL HISTORY: Preoperative Diagnosis: year old male right upper lung cancer. Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Level 12 lymph node right upper lobe. e Right level 10 lymph node. L. Right upper lobe. D. Right level 9 lymph node. E. Right level 2/4. SPECIMEN DATA. GROSS DESCRIPTION: Specimen is received in five formalin filled containers labeled with the patient's nar. A. Additionally labeled level 12 lymph node right upper lobe and contains a 2.8 x 1.2: x 0.7 cm aggregate of dark brown to black rubbery soft tissue. consistent with anthracotic lymph nodes. The specimen is wrapped in tissue paper and entirely submitted in cassette A labeled. B. Additionally labeled right level 10 lymph node and contains a 2.8 X 1.4 X 1.0 cm aggregate of yellow-gray rubberv. irregular soft tissue consistent with. Anthracotic lymph nodes. The specimen is wrapped in tissue paper and entirely submitted in cassette B labeler. C. Additionally labeled right upper lobe and contains a 17.0 X 11.0 x 6.0 cm purple-gray anthracotic lung lobe. A 1.5 cm in length by 1.8 cm in diameter. stapled bronchial margin is identified. The bronchus is opened to reveal a pink-tan glistening endothelium and contains blood tinged mucus. discrete. endobronchial lesions are identified. Adjacent to the bronchus are segments of clamped vasculature as well as four staple lines ranging from 0,7 up to. 3.7 cm in greatest dimension. All staple lines are removed to reveal two areas of exposed parenchymal margin 6,5 x 4,5 cm and 2.0 x 1.5 cm. Both of. these. are. adjacent to the aforementioned bronchus and vasculature. The specimen is serially sectioned to reveal a 1.8 X 1.7 x 1.3 cm gray-white nodule. that approaches to within <0.1 cm of the inked pleura to within 4.0 cm of the closest (largest) exposed parenchymal margin, 8.0 cm of the bronchial. margin and 5.5 cm of the closest vascular margin. The remainder of the cut surface is comprised of congested red-pink spongy parenchyma. No. additional lesions are identified. On palpation, six ill defined black parabronchial nodules are identified consistent with anthracotic lymph nodes. These. range from 0.3 to 0.6 cm in greatest dimension. Representative sections are submitted in cassettes C1-9 labeled. signated as follows: 1--. bronchial and vascular margins, en face; 2-5-entire mass to inked pleura, perpendicular; 6-perpendicular parenchymar margin closest to mass; 7--. perpendicular. parenchymal margin furthest from mass; B-uninvolved parenchyma; 9--whole possible lymph nodes. Additionally, a yellow green and blue. cassette are submitted for Genomics research each labele. 5. D. Additionally labeled right level 9 lymph node and contains a 0.6 cm black rubbery nodule consistent with anthracotic lymph node. The specimen is. wrapped in tissue paper and entirely submitted in cassette D labeled. E. Additionally labeled right level 2/4 and contains a 2.3: x 1.8 x 1.0 cm aggregate of yellow-gray rubberv. nodular soft tissue consistent with lymph. nodes. The specimen is wrapped in tissue paper and entirely submitted in cassette E labeled.",T1,N0,M0,T1N0M0
TCGA-GC-A3RD,"Result Date: al Report. Final Diagnosis (Verified). Left ureteral margin, biopsy with frozen section: Segment of ureter demonstrating marked chronic inflammation and prominent. denudation of epithelium. Right ureteral margin, biopsy with frozen section: No tumor seen. Additional left ureteral margin, biopsy with frozen section: Chronically inflamed ureter segment with prominent denudation of surface epithelium,. however, no malignancy is seen. Urinary bladder, resection: Invasive high grade transitional cell carcinoma. Maximum tumor diameter is 1.5 cm. Tumor invades through muscular propria into underlying perivesical soft tissue. Tumor comes to within 1.8 mm of the inked perivesical soft tissue margin. No evidence of lymphovascular invasion. Negative urethral margin. Right pelvic lymph nodes, excision: Six (6) benign lymph nodes with no evidence of metastatic neoplasm. Appendix, resection: Negative appendix with luminal fibrosis and distal appendix. Left pelvic lymph nodes, excision: Two (2) benign lymph nodes with no evidence of metastatic neoplasm. Comment: AJCC pathologic stage T3a,NO. Signature Line. (Electronically signed by). Verified on: Performing Lab (Verified). Testing performed at. Gross Description (Verified). ""FSA."" All frozen section tissue is submitted in cassette ""FSA,"". ""FSB."" All frozen section tissue is submitted in cassette ""FSB,"". ""FSC."" All frozen section tissue is submitted in cassette ""FSC,"". ""D, Bladder."" The specimen consists of a previously opened bladder with attached fatty tissue with an overall measurement of 10.1 x 7.2 x. 3.7 cm. Upon reconstruction, the bladder measures 4.4 x 6.4 x 4.5 cm. The urethral margin is inked black, shaved, and submitted. The. bladder. has. previously been opened along the anterior aspect to reveal a 1.5 1.3 cm pale tan, firm, well circumscribed mass located on the. left central anterior aspect of the bladder wall. The anterior soft tissue margin is inked black. On sectioning, this mass measures 0.9 cm in. thickness, grossly appears to extend through the bladder wall and comes to within 0.1 cm of the inked soft tissue margin. The left ureteral. orifice is identified and was probe patent. A possible right ureteral orifice is identified. The mass does not grossly appear to involve the left. or. right ureteral orifices. The remaining bladder mucosa has a pale tan to gray-tan appearance. No cysts or areas of interest are identified. ""D1,"" urethral margin; ""D2-D3,"" mass to include anterior soft tissue margin; ""D4,"" mass to include left ureteral orifice; ""D5,"" possible right. ureteral orifice; ""D6,"" posterior bladder; ""D7,"" trigone; ""D8,"" right bladder wall, representative. NOTE: Please see attached drawing. ""E, Right pelvic lymph node."" The specimen consists of 2 yellow-tan fatty fragments measuring 3.8 x 0.7 x 0.8 cm and 3.8 x 2.2 x 1.2 cm. On examination, 6 possible lymph nodes are identified. These range in size from 0.7 to 2.2 cm. Representative sections are submitted into. cassettes ""E1-E2,"" representative. ""F, Appendix."" The specimen consists of a 5.3 x 0.4 cm appendix with a small amount of attached periappendiceal fat. The serosa is. gray-tan with no adhesions. On sectioning, the lumen has a pale tan thickened appearance. No fecaliths or perforations are identified. The. margin is inked black. ""F,"" fragments, representative. ""G, Left pelvic lymph node.' The specimen consists of a 4.4 x 3.8 x 1.8 cm aggregate of yellow-tan fatty tissue. On examination, 3 possible. lymph nodes are identified. These range in size from 0.5 to 3.8 cm. The 2 smaller lymph nodes are submitted in toto. A representative. section of the larger lymph node is submitted. Free in the container is a 3.0 x 0.4 cm tan-brown cylindrical vessel. ""G,"" 4p, representative. Signature Line. Frozen Section Diagnosis (Verified). FSA: ""Left ureteral margin"" measuring 0.5 cm diameter x 0.4 cm length, black ink on true margin. FSB: ""Right ureteral margin"" measuring 0.5 cm diameter x 0.4 cm length, black ink on true margin. FSC: ""2nd left ureteral margin"" measures 0.5 cm diameter x 0.3 cm length, ink at true margin. Staple removed from opposite end. FSA: ""Left ureteral margin,"" frozen section: Predominantly denuded epithelium with small attached portion of carcinoma in situ. No invasive. component present. FSB: ""Right ureteral margin,"" frozen section: Negative for malignancy. FSC: ""Left ureretal margin, second,"" frozen section: Negative for malignancy. ""Bladder"" Received fresh, previously opened by surgeon is a bladder. Section of tumor and adjacent normal bladder submitted for tumor. studies. Clinical Information (Verified). Bladder cancer. Completed Action List: VERIFY by.",T3,N0,M0,T3N0M0
TCGA-34-8455,"FINAL DIAGNOSIS: Summary Statement. The left upper lobe demonstrates a 7.8 cm squamous cell carcinoma extending into the left lower lobe and associated. with grossly identified four tumor nodules of morphologically similar squamous cell carcinoma measuring up to 0.4. cm in diameter. There is no evidence of visceral pleural invasion. All sampled lymph nodes are benign (see Comment). PART 1: LYMPH NODE, LEVEL 5, BIOPSY. THREE (3) FRAGMENTS OF BENIGN LYMPH NODE. PART 2: LYMPH NODE, INFERIOR PULMONARY LIGAMENT, BIOPSY -. ONE (1) LYMPH NODE. PART 3: BONE, SIXTH (6TH) RIB, RESECTION -. UNREMARKABLE BONE AND BONE MARROW. PART 4: LYMPH NODE, LEVEL 10, BIOPSY -. ONE (1) BENIGN LYMPH NODE. PART 5: LYMPH NODE, LEVEL 11, BIOPSY -. ONE (1) BENIGN LYMPH NODE. PART 6: LYMPH NODE, LEVEL 10, BIOPSY -. FOUR (4) FRAGMENTS OF BENIGN LYMPH NODE. PART 7: LYMPH NODE, LEVEL 11, BIOPSY -. ONE (1) BENIGN LYMPH NODE. PART 8: LYMPH NODE, LEVEL 10, BIOPSY. A. UNREMARKABLE FIBROADIPOSE TISSUE. B. NO LYMPHOID TISSUE IDENTIFIED. PART 9: LYMPH NODE, LEVEL 10 NEAR INFERIOR VEIN, BIOPSY -. ONE (1) BENIGN LYMPH NODE. PART 10: LYMPH NODE, LEVEL 11 NEAR UPPER LOBE PULMONARY ARTERY, BIOPSY -. ONE (1) BENIGN LYMPH NODE. PART 11: TISSUE NEAR LEVEL 12, BIOPSY -. FIBROADIPOSE TISSUE WITH MILD CHRONIC INFLAMMATION, MOST SUGGESTIVE OF SCAR. PART 12: LYMPH NODE, LEVEL 11 NEAR DEEP FISSURE, BIOPSY -. SIX (6) FRAGMENTS OF BENIGN LYMPH NODE. PART 13: LYMPH NODE, TISSUE NEAR INFERIOR FISSURE, BIOPSY -. UNREMARKABLE FIBROADIPOSE TISSUE. PART 14: LYMPH NODE, LEVEL 12, BIOPSY -. ONE (1) BENIGN LYMPH NODE. PART 15: LUNG, LFT UPPER LOBE, LOBECTOMY. A. SQUAMOUS CELL CARCINOMA (7.8 CM IN DIAMETER) ASSOCIATED WITH FOUR GROSSLY IDENTIFIED. TUMOR NODULES OF MORPHOLOGICALLY SIMILAR SQUAMOUS CELL CARCINOMA. MILD. LYMPHOCYTIC HOST RESPONSE. NO EVIDENCE OF VISCERAL PLEURAL INVASION. FOUR (4). FRAGMENTS OF BENIGN N1 LYMPH NODES (see comment). B. SURGICAL RESECTION MARGINS ARE BENIGN. C. BACKGROUND LUNG WITH EMPHYSEMATOUS CHANGE AND RESPIRATORY BRONCHIOLITIS. COMMENT: The pathologic staging of this tumor is challenging. We are aware of the patient's CT guided FNA of the right upper lobe. that was positive for non-small cell carcinoma, favor squamous cell carcinoma. It is uncertain. whether tumor in the current specimen and tumor in the right upper lobe represent two independent primaries or a. metastases. If these two tumors represent an independent primaries then the current tumor would be staged as T3NO. If the tumor in the right upper lobe represents a metastasis of the tumor in the left upper lobe then the stage would be. T3 NO M1a. Clinical correlation is suggested.",T4,N0,M1,T4N0M1
TCGA-E9-A1N6,"BREAST TISSUE CHECKLIST. Specimen type: Radical mastectomy. Specimen size: Not specified. Tumor site: Breast. Tumor size: 2.3 x 2.3 X 2 cm. Grossly evident lesion: Yes. Histologic type: Infiltrating ductal carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Lymph nodes: 2/10 positive for metastasis (Axillary 2/10). Left, upper. Extracapsular invasion of the lymph nodes: Not specified. outer. Margins: Not specified. quadrant. Nottingham Histologic Score. Tubule formation: Not specified. Nuclear pleomorphism: Not specified. Mitotic count (25x): Not specified. Mitotic count (40x): Not specified. Total Nottingham Score: Score cannot be determined. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: Nope.",T2,N1,M0,T2N1M0
TCGA-HQ-A5NE,Sample Type TUMOUR. Diagnosis. invasive transitional cell (urothelial) carcinoma. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis. Type of Procedure. Resection - radical cystoprostatectomy. Site of Tissue/Primary (Histology). Bladder. Tumour Size (cm). 4. Histology. invasive transitional cell (urothelial) carcinoma. Grade/Differentiation. III. Pathological T. T3. Pathological N. Clinical M. MO. Histology Comments. Sample Type BUFFY. Year of Sample Collection. Age at Sample Collection (yrs). Days to Procedure Date. Days to Diagnosis.,T3,N0,M0,T3N0M0
TCGA-ED-A7XO,"Gross Description: Tumor is located in a sublobes VI, VII, ill-margins with 7x7x7cm in size, soft, solid,. gray-white in cutting section. Microscopic Description: Tumor cells form the trabecular patterns connecting each other, or sheets. patterns. The tumor cells retain apolygonal shape and have round vesicular nuclei with prominent. nucleoli. The amount of cytoplasm are moderate and the cytoplasm is basophilic or vascuolated. Nuclei. are irregularly large and hyperchromatic with prominent nucleioli. Mitoses are present. Tumor invades. into vessels or normal hepatic tissue. Stroma is fibrous. Diagnosis Details: Hepatocellular carcinoma, moderately-differentiated. Comments: Formatted Path Reports: LIVER TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor size: 7x7x5cm. Focality: Not specified. Histologic type: Hepatocellular carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Multiple tumors more than 5.0 cm. Lymph nodes: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: No. Additional pathologic findings: Tumor in sublobes 6 and 7. Comments: None.",T3,N0,M0,T3N0M0
TCGA-D3-A5GT,"DIAGNOSIS. (A) RIGHT INGUINAL CONTENTS WITH EN BLOC WITH RIGHT MEDIAL GROIN, EXCISION: MELANOMA, INVASIVE, SUPERFICIAL SPREADING TYPE. CLARK LEVEL, IV. BRESLOW THICKNESS, 10.0 MM. RADIAL (NON-TUMORIGENIC) GROWTH PHASE, PRESENT. VERTICAL (TUMORIGENIC) GROWTH PHASE, PRESENT. MITOTIC FIGURES/MM2, 14. ULCERATION, PRESENT (5MM). REGRESSION, PRESENT, FOCAL. VASCULAR INVASION, PRESENT. MICROSCOPIC SATELLITOSIS, PRESENT. SURGICAL MARGINS: FREE OF MALIGNANCY. Skin and subcutis with healing surgical wound. (Correlation with. is recommended). MELANOMA, METASTATIC TO TWO OF TEN LYMPH NODES (2/10). Tumor location: Subcapsular and intraparencchymal. Largest tumor deposit size: 40.0 X 35.0 mm. (per gross exam). Extracapsular extension: Present. (B) RIGHT ILIAC AND OBTURATOR CONTENTS, EXCISON: MELANOMA, METASTATIC TO TWO OF SEVEN LYMPH NODES (2/7). Largest tumor deposit size: 12.0 x 10.0 mm. (as measured on slide). Extracapsular extension: Not identified. GROSS DESCRIPTION. (A) LABELED ""RIGHT INGUINAL CONTENTS WITH EN BLOC CONTINUITY 2 CM MARGIN MELANOMA, RIGHT. MEDIAL. GROIN"" - A surgeon oriented right groin dissection specimen that includes medial scrotal aspect with overall dimensions (21.0 X. 9.5 X 4.1 cm). The hairy curved tan portion of skin includes the inguinal/groin contents and scrotal aspect along the medial. aspect. The curved skin ellipse measures 21 cm in length and 6 cm in depth. There is a skin mass that is dark red to black, measuring 2.2 x 2.0 x 1.7 cm which is located 1.5 cm from the superior. margin, 1.5 cm from the medial scrotal skin margin and 2.0 cm from the inferior skin margin. There is pigmented dark brown flat. area of lateral extension in an area, measuring 2 X 1 cm. The lab. tissue bank from this primary skin melanotic lesion will. be submitted as well as a metastatic lymph node as the #2 source. There are multiple enlarged groin lymph nodes, the largest. measures 4.0 x 3.5 cm and will be harvested. The margins are inked, serially sectioned, medial to lateral to reveal additional. lymph nodes that range from 0.3 cm up to 3 cm, some have gross fatty replacement. All of the possible groin lymph nodes are. submitted. INK CODE: Blue - superior margin; yellow - inferior margin; red - inferior aspect of the medial skin melanotic lesion, not. a true margin, for orientation purposes/inferior aspect of lesion. SECTION CODE: A1, A2, en face skin, superior margin, ink side up; A3, A4, en face, medial skin margin, ink side up; A5,. A6,. en. face,. inferior skin margin, ink side up; A7, lateral skin apical tip, ink side up; A8-A15, primary skin lesion in consecutive. order; A16, A17, deep margin, beneath primary skin lesion, ink side up; A18, A19, lymph node with metastatic melanoma and. closest inked deep margin; A20, A21, largest lymph node with melanoma infiltrates (harvest site #2); A22, three possible intact. lymph nodes; A23-A25, one possible bisected lymph node, each cassette; A26, A27, one possible bisected lymph node; A28, one. possible bisected lymph node; A29-A31, one possible serially sectioned lymph node. (B) RIGHT ILIAC AND OBTURATOR CONTENTS - Three pink-red irregular pieces of soft tissue aggregating 5.5 x 3.5 x 1.1 cm. There are multiple pink-red lymph nodes that range from 0.3 cm up to 5.0 cm in greatest length. SECTION CODE: B1, B2, three possible intact lymph nodes, each cassette; B3, one possible bisected lymph node; B4-. B7, one possible serially sectioned lymph node; B8-B12, one possible serially sectioned lymph node. CLINICAL HISTORY. Melanoma. SNOMED CODES. M-87203, M-87206. Some tests reported here may have been developed and performance characteristics determined by. hese tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by:",T2,N3,M0,T2N3M0
TCGA-A6-6142,"SPECIMEN. A. Liver lesion. B. Paraaortic lymph node. C. Rectosigmoid colon. CLINICAL NOTES. CLINICAL HISTORY: Sigmoid colon cancer. FROZEN SECTION DIAGNOSIS. A. , left lobe, excision: Metastatic adenocarcinoma. 0. GROSS DESCRIPTION. A. The specimen is received fresh for frozen section. labeled ""A. Left liver lesion"" and consists of a tan 0.8 X. 0.3 X 0. rubbery tissue, entirely frozen as frozen. section. in formalin labeled ""paraaortic lymph node"" is. a 1.2 X 0.8 X 0.3 cm. rubbery tan pink tissue in keeping. with lym. de which is quadrisected and entirely submitted in one. block. Received fresh for tissue for permanent labeled. ""rectosigmoid colon"" is a previously unopened, 22 cm. segment of distal colon, surfaced by smooth glistening tan-pink. serosa and scabrous adventitia, with an abundant amount of attached. mesocolon. The specimen is oriented by anatomic landmarks and both. proximal and distal margins average 8.5 cm. in circumference. On. opening, there is a circumferential, 7.8 X 4.6 cm. centrally. necrotic rubbery, tan-red tumor mass, with raised rolled edges. located 5.5 cm. from the distal margin. A portion of tumor and. a. portion of normal mucosa are submitted for tissue procurement as. requested. On sectioning, the tumor extends into the muscularis. to. within 0.2 cm. of the inked free radial serosal surface (see blocks. #3 and 4) . The tumor is greater than 5 cm. from the adventitial. resection margins (represented in block #2) The mucosa throughout. the remainder of the specimen is focally tattooed tan-pink to. gray-black, with regular folds in the wall averages 6.0 cm. in. thickness. No additional mass lesion or abnormality is identified. grossly. soft to slightly rubbery tan-pink to gray-black. tissues in keeping with lymph nodes measuring up to 1.2 cm. are. recovered from the attached mesocolon. R r entative. sections. are. submitted in fifteen blocks as labeled. BLOCK SUMMARY: #1 - Proximal and distal margins (proximal inked. blue) ; 2 - adventitial surface adjacent to tumor (inked green) ; 3-5. - tumor full thickness to inked free radial serosal surface; 6 -. tumor to normal mucosa; 7 - random from remainder of specimen; 8-11. nine (9) whole lymph nodes assette; 12-15 - one bisected. lymph node per cassette. S. MICROSCOPIC DESCRIPTION. A, B, C. Microscopic examination of the rectosigmoid. resection, as well as the liver lesion and para-aortic. lymph node biopsy reveals -. Histologic type: Adenocarcinoma. Histologic grade: Moderately to poorly differentiated. Primary tumor (pT) : Tumor invades through muscularis propria into. subserosa (pT3). Proximal margin: Negative for tumor. Distal margin: Negative for tumor. Circumferential (radial) margin: Negative for tumor. Distance of tumor from closest margin: 5.5 cm from the distal. margin and greater than 5 cm from adventitial/radial margin. Vascular invasion: Lymphatic space invasion is identified and is. prominent in blocks C4 and C5. No large vessel invasion is. identified. Regional lymph nodes (pN) : Metastatic adenocarcinoma is identified. in 1 of 37 lymph nodes and measures 2 mm in greatest dimension in. slide C15. (pN1a). Non-lymph node pericolonic tumor: Not identified. Distant metastasis (pM) : In liver biopsy in specimen A (pM1a). Other findings: The para-aortic lymph node is negative for. malignancy in specimen B. The background colonic mucosa appears. unremarkable. 4x1, 14x1, 3x1, 5x1. DIAGNOSIS. A. Liver lesion, incisional biopsy: Metastatic adenocarcinoma of colonic type consistent with. origin from rectosigmoid tumor. B. Para-aortic lymph node, excisional biopsy: Single lymph node negative for metastatic tumor (0/1) . C. Colon, rectosigmoid, segmental resection: Adenocarcinoma, moderately to poorly differentiated, invasive. through muscularis propria into subserosal tissue (pT3). Metastatic adenocarcinoma present in 1 of 37 lymph nodes. (pN1a). Lymphatic space invasion present. Resection margins are negative for tumor. See microscopic description for template details.",T3,N1,M1,T3N1M1
TCGA-IB-7885,"Collected Date: Received Date/Time: Specimen Description. A. Gallbladder. B, Node of Importance. C. Whipple's specimen. Clinical Information. Cancer in the head of the pancreas with malignant-appearing structure of the common bile duct ns well as a double duot. sign. Diagnonie. A. Cholecystectomy: Chronic cholecystitis. B. Node Of. Importance: One-lymph node negative for carcinama (0/1). C. Pancreaticoduodertectomy (Whipple resection), Partial Pancreatectomy: Ductal adenocarcnoma-. Site: pancreatic head. Size: 2.4 cm. Grade 2. Tumor invades retropancreatic soft tissue. Margins uninvolved by Invasive carcinoma. Distance of invasive carcinoma from closest margin: 0.5 mm. (nonperitonealized retropanereaticluncinate margin). Lymph-vascular invasion Identified. annual Datholony Renart. Collected Date: Qaraived Date/Time: Pathologiat: Perineural invasion identified. Three out of 12 lymph nodes directly Invaded by tumor (3/12). Pancreatic intraepithelial neoplasia (PanIN-2). Chronic pancreatitis. Gross Description. Received are specimens A to C. All requisitions and specimen containers are tabelled with the patient's name. The cassettes and AP idantifiers are labelled with the Surgical Number. A. Gallbladden meesuring 9.5 x 4.5 x 1.6 cm. The cystic duct is short. The gallbladder is closed. After opaning, It Is filled. with green bile and no calculus. The wall thickness Is 3 mm. The mucosa is smooth with yellow surfece. The serocal. surface is smooth. There is bilar lymph node Identified, Representativa sections submitted In A1,. B. Node of importance. Ohe lymph node 2.6 cm In diameter, bisected in B1 and B2. C, Devitalization time starts at. The specimen consists of a duodenum. measuring 19.0 cm In length and 5.0 to 6,0 cm in circumierence, There is a portion of gastric tissue 2,5 em in tength. The. common bile duct measures 5,3 cm In length and 1.6 cm In clrcumference. At 1.7 cm distal from the ampulla of Vater,. there Is stenosis of the common bile duct. The pancreas measures 5.0 x 2,5 x 2,0 cm, The nonperitonealized uncinate. inked margin is inked in blue, There is a second minor duadenal papilla in addition to the major duodenal papilla. within. the head of the pancreas, there Is a not well-demarcated tumor measuring 2.4 x 2,0 cm, The tumor shows some cystic. areas toward-the minor duodenal papilla, and is otherwise solid yellow/white and seems to approach the retropancreatic. margin grosslyiquite closaly. 01 common bile duct margin. C2 proximal gastric margin. AWD. Chenical Patholoay Report. Collected Date: Received Date/Time: C3 distal intestinal margin. C4 minor duodenal papilla. C6-C10 ampulia of Vater perpendicular sections. C11 en-face transverse section below C6-C10. C12-013 tumor in relation to conmon bile duct. 014C17 tumor in relation to nonpertonealized uncinate Inked margin. 018 pancreatic parenchyma margin. 018 lymph nodes. C20 one lymph node bisected. 021 further pancreatic parenchyma from the head. C:22 further ? lymph node. MKO/ct. Due to an unexplained technical problem. no synoptic report could be assessed.",T3,N1,M0,T3N1M0
TCGA-A8-A06X,"Diagnosis: Invasive ductal breast carcinoma (maximum diameter 5.5 cm, malignancy grade. III) with angioinvasion and a mediocranial safety margin at least 3 mm wide. Tumor classification: G3 (L0, V0), pT3, Nx, Mx. Diagnosis: Tumor-free lymph nodes (total N = 11, pN0).",T3,N0,M0,T3N0M0
TCGA-A6-2672,"SPECIMEN. Right colon. CLINICAL NOTES. PRE-OP DIAGNOSIS: Colon cancer. GROSS DESCRIPTION. Received fresh, subsequently fixed in formalin labelled. ""right colon"" which is partially covered with pink-tan. smooth glistening serosa and yellow lobular fat. The specimen. shows. a 6.5 X 0.7 cm appendix and the specimen is predominately covered. with abundant yellow lobular fat. The specimen is opened and has. a. 6.5 cm portion of small bowel and 26 cm of cecum and colon The. specimen shows a large ectophytic mass which is 7.0 x 5.5 x 1.2 cm. This is located 6.5 cm from the distal margin. The cut surface of. the tumor shows gross invasion into the muscularis propria,. however,. showing possible invasion into the fat. This comes within 6.5 cm. of. the radial margin. No other discrete gross lesions are identified. The average circumference of the small bowel is 4.0 cm and the. average circumference of the cecum and colon is 7.0 cm. Representative sections of the specimen are submitted as follows: BLOCK SUMMARY: 1 - representative luminal margins and ileocecal. valve; 2 - representative section of appendix with proximal end. inked; 3-5 - representative sections of tumor to normal and fat; 6. radial margin with lymph node at radial margin; 7-8 - nine possible. lymph nodes; 9 - six possible lymph nodes; 10 - three possible. 1 ymph. nodes; 11 - three possible lymph nodes; 12 - one possible lymph. node. from near radial margin; 13-14 - one lymph node bisected. RS-14. MICROSCOPIC DESCRIPTION. Histologic type: Adenocarcinoma. Histologic grade: Moderately-differentiated. Primary tumor: pT3 (carcinoma penetrates through the muscularis. propria, into the subserosal fat) . Proximal margin: Negative. Distal margin: Negative. Circumferential (radial) margin: Negative. Vascular invasion: Probable. Regional lymph nodes (pN) : One of twenty-nine lymph nodes with. metastatic carcinoma. Non-lymph node pericolonic tumor: Not identified. Other findings: Appendix with serosal fat necrosis and otherwise. unremarkable; small bowel unremarkable. 5. DIAGNOSIS. Right Colon with appendix, small bowel, right hemicolectomy: Adenocarcinoma, moderately differentiated, with invasion through. the muscularis propria, into the subserosal fat (pT3) . Margins of excision negative. One of twenty-nine lymph nodes with metastatic carcinoma.",T3,N1,M0,T3N1M0
TCGA-BR-6706,STOMACH TISSUE CHECKLIST. Specimen type: Subtotal gastrectomy. Tumor site: Stomach. Tumor size: 7.5 X 0 X 8.5 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Subserosa. Lymph nodes: 5/15 positive for. metastasis (Lesser and greater. curvature omentum 5/15). Lymphatic invasion: Not specified. Venous invasion: Absent. Perineural invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not. specified. Comments: None.,T3,N1,M0,T3N1M0
TCGA-CG-4437,Diagnosis/diagnoses: Gastrectomy preparation with tumor-free resection margins and with the inclusion of a. moderately differentiated adenocarcinoma (intestinal type) of the esophagogastric junction. with infiltration of the perimuscular fatty tissue and with three regional lymph node. metastases (pT2b N1 3/29.,T2,N1,M0,T2N1M0
TCGA-85-8479,"Gross Description. Microscopic. Diagnosis Details. Description. Lower lobe, slightly. TUMOR FRAGMENT: increased in volume, with a. Bronchopulmonary. white, intrabronchial. neoplasm of the. tumoral structure of 1/2/1. spinocellular epidermoid. cm in diameter, almost. carcinoma type without. completely obstructed, with. keratinization, G2, with. budding surface. papillary pattern, with. monomorphous cellularity,. nuclear atypias and isolated. atypical mitoses, with. hotbeds of necrosis and. abundant fibrous-. inflammatory stroma. RETROSTENOTIC. PARENCHYMA: Pulmonary parenchyma. with fibrin-leukocytic. alveolitis. INTERLOBAR SPUR: Without tumoral aspect. INTERLOBAR LYMPH. NODE: No metastases. LYMPH NODE STATION VII: No metastases. SUBAORTIC LYMPH NODE: No metastases. LYMPH NODE STATION VII: No metastases. PARAAORTIC LYMPH. NODE. Comments. LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 2 X 1 X 1 cm. Histologic type: Papillary. squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Tumor in. main bronchus. Other tumor nodules: Not. specified. Lymph nodes: 0/7 positive. for metastasis (St.11,7,6,5. 0/7). Lymphatic invasion: Present. Venous invasion: Not. specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic. findings: Not specified. Comments: None. Laterality. Left- lower.",T1,N0,M0,T1N0M0
TCGA-B0-4838,"FINAL DIAGNOSIS: KIDNEY, RIGHT, LAPAROSCOPIC NEPHRECTOMY: A. RENAL CELL CARCINOMA, CONVENTIONAL (CLEAR) CELL TYPE. B. FUHRMAN' S NUCLEAR GRADE IS 3 OF 4. C. THE GREATEST DIAMETER OF THE NEOPLASM IS 4.2 CM. D. THE NEOPLASM IS CONFINED WITHIN THE RENAL CAPSULE. E. NO INVASION OF THE RENAL VEIN IS IDENTIFIED. F. ALL SURGICAL MARGINS ARE FREE OF THE NEOPLASM. G. THE NON-NEOPLASTIC KIDNEY REVEALS FOCAL GLOMERULOSCLEROSIS. H. THE ADRENAL GLAND IS NOT SUBMITTED. I. TNM STAGE: pT1b NX MX. J. TNM HISTOLOGIC GRADE = G3.",T1,N0,M0,T1N0M0
TCGA-BT-A20T,"3. PATIENT HISTORY: -year-old-man with detrusor muscle-invasive, high-grade urothelial carcinoma-. with bladder base and possible. prostatic involvement. PRE-OP DIAGNOSIS: Bladder cancer. POST-OP DIAGNOSIS: Not given. PROCEDURE: Radical cystoprostatectomy with construction of orthotopic neobladder. FINAL DIAGNOSIS: PART 1: LYMPH NODES, RIGHT PELVIC, EXCISION -. THREE BENIGN LYMPH NODES (0/3). NEGATIVE FOR MALIGNANCY (0/3). PART 2: LYMPH NODES, LEFT PELVIC, EXCISION -. TWO BENIGN LYMPH NODES (0/2). NEGATIVE FOR MALIGNANCY (0/2). PART 3: RIGHT URETER, MARGIN, SHAVE BIOPSY -. A. SEGMENT OF BENIGN URETER. B. NEGATIVE FOR NEOPLASIA. PART 4: LEFT URETER, MARGIN, SHAVE BIOPSY -. A. SEGMENT OF BENIGN URETER. B. NEGATIVE FOR NEOPLASIA. PART 5: URINARY BLADDER, DISTAL URETERS, BILATERAL URETERS, PROSTATE, BILATERAL SEMINAL VESICLES,. AND VAS DEFERENTIA, RADICAL CYSTOPBOSTATECTOMY -. URINARY BLADDER AND DISTAL URETERS: A. ULCERATED, INVASIVE UROTHELIAL CARCINOMA, HIGH-GRADE (2004 WHO/ISUP), PRESENT ON THE. RIGHT ANTERIOR WALL OF THE URINARY BLADDER. CARCINOMA INFILTRATES THROUGH THE. MUSCULARIS PROPRIA WITH EXTENSION (GROSSLY EVIDENT) INTO THE PERIVESICAL ADIPOSE TISSUE. B. MAXIMAL TUMOR DIAMETER IS 2.1 CM. C. RARE PERINEURAL INVASION IS PRESENT (SLIDE 5AA). D. PRESUMED CARCINOMATOUS ANGIOLYMPHATIC INVASION IS PRESENT, BUT NOT IDENTIFIED. HISTOLOGICALLY (SEE DIAGNOSIS F). E. MUTIFOCAL, EXTENSIVE, FLAT UROTHELIAL CARCINOMA IN-SITU IS PRESENT WITHIN THE URINARY. BLADDER AND PROSTATIC URETHRA. F. MICROSCOPIC FOCUS OF METASTATIC UROTHELIAL CARCINOMA IS PRESENT IN ONE PERIVESICAL. LYMPH NODE (1/1) (SLIDE 5Z). THE METASTATIC FOCUS MEASURES 0.2 CM AND IS CONFINED TO THE. LYMPH NODE, WITH NO EXTRACAPSULAR EXTENSION IDENTIFIED. G. TNM PATHOLOGIC STAGE (UROTHELIAL CARCINOMA): T3b, N1, MX. H. HISTOLOGIC GRADE: G3 (SEE SYNOPTIC). PROSTATE, BILATERAL SEMINAL VESICLES, AND DISTAL VASA DEFERNTIA: A. PROSTATIC ADENOCARCINOMA, ACINAR TYPE, GLEASON SCORE 3 + 4 = 7 (SLIDES 5P, 5Q, 5DD, 5FF,. 5JJ). GLEASON PATTERN 4 COMPONENT COMPRISES APPROXIMATELY 40% OF THE PROSTATE. CARCINOMA VOLUME (SLIDES 5P, 5Q). B. PROSTATIC CARCINOMA IS PRESENT, LIMITED TO THE RIGHT LOBE OF THE PROSTATE GLAND. C. GREATEST NODULAR DIAMETER OF THE PROSTATIC ADENOCARCINOMA IS 0.6 CM, INVOLVING LESS. THAN 5% OF THE SAMPLED PROSTATE GLAND VOLUME. D. PROSTATE CARCINOMA IS CONFINED TO THE PROSTATE GLAND, WITHOUT EXTRACAPSULAR. EXTENSION NOR INVOLVEMENT OF THE URINARY BLADDER. E. BILATERAL SEMINAL VESICLES AND DISTAL VASA DEFERENTIA ARE FREE OF NEOPLASIA. F. FOCAL PERINEURAL INVASION BY PROSTATIC ADENOCARCINOMA IS IDENTIFIED (SLIDE 5Q). G. NO INGIOLYMPHATIC INVASION IS IDENTIFIED. H. MULTIFOCAL HIGH-GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (HGPIN) IS PRESENT. I. INTRADUCTAL UROTHELIAL CARCINOMA IS PRESENT IN THE PROSTATE IN PERIURETHRAL DUCTS IN. CONTINUITY WITH URETHRAL FLAT UROTHELIAL CARCINOMA IN-SITU (SLIDES 5B, 5C, SDD, 5GG). J. TNM PATHOLOGIC STAGE (PROSTATIC ADENOCARCINOMA): T2a, NO, MX. K. HISTOLOGIC GRADE: G3-4 (SEE SYNOPTIC). SYNOPTIC DATA - PRIMARY URINARY BLADDER TUMORS. SPECIMEN TYPE: Radical cystoprostatectomy. TUMOR SITE: Anterior wall. TUMOR SIZE: Greatest dimension: 2.1 cm. Additional dimensions: 1.5 X 1.2 cm. HISTOLOGIC TYPE: Urothelial (transitional cell) carcinoma. ASSOCIATED EPITHELIAL LESIONS: None identified. HISTOLOGIC GRADE: Urothelial carcinoma . High-grade. TUMOR CONFIGURATION: Ulcerated. PATHOLOGIC STAGING (pTNM): Number of nodes examined: 6. Number of nodes involved: 1. pMX. MARGINS: Margins uninvolved by invasive carcinoma. VENOUS/LYMPHATIC (LARGE/SMALL) VESSEL INVASION (V/L): Present. DIRECT EXTENSION OF INVASIVE TUMOR: Perivesical fat. ADDITIONAL PATHOLOGIC FINDINGS: Urothelial dysplasia (low-grade intraurothelial neoplasia). SYNOPTIC DATA - PRIMARY PROSTATE TUMORS. INVASIVE CA IDENTIFIED?: TUMOR HISTOLOGY: Adenocarcinoma NOS. PRIMARY GLEASON GRADE: 3. SECONDARY GLEASON GRADE: 4. GLEASON SUM SCORE: 7. GLEASON 4/5 PERCENTAGE: 40%. WEIGHT OF PROSTATE: 30gm. TUMOR SIZE: Maximum dimension: 0.6 cm. LOBE LATERALITY: Right Lobe. PERCENT OF SPECIMEN INVOLVED BY TUMOR: < 5% of specimen involved by invasive tumor. MULTIFOCAL DISEASE: HIGH GRADE PIN: Yes - multifocal. EXTRAPROSTATIC EXTENSION: PERINEURAL INVASION: ANGIOLYMPHATIC INVASIN: SEMINAL VESICLE INVASION: SURGICAL MARGIN INVOLVEMENT: All surgical margins free of tumor. LYMPH NODES EXAMINED: 6. LYMPH NODES POSITIVE: 0. T STAGE, PATHOLOGIC: pT2a. N STAGE, PATHOLOGIC: pNX. M STAGE, PATHOLOGIC: pMX. HISTOLOGIC GRADE: G2, Moderately differentiated. Note. ou. Da revieweg.",T3,N1,M0,T3N1M0
TCGA-G3-AAV0,"CONFIDENTIAL. Demographics (for. verification purposes). Date of Birth: Sex: M. Collected Date/Time. Received Date/Time. Specimen Description. Liver segments 6 and 7 @. Clinical Information. Hepatocellular cancer. Diagnosis. Liver (Segment 6 and .7), Resection: Moderately differentiated hepatocellular carcinoma, 5.5 cm in. greatest dimension, tumor confined within liver capsule, resection. margin uninvolved. Iron overload (2+). Verified: Synoptic Report. Specimen. Liver. PROCEDURE: Partial hepatectomy. Minor hepatectomy (less than 3 segments). TUMOR SIZE: Greatest dimension: 5.5. cm. Additional dimensions: 5 x 5 cm. TUMOR FOCALITY: Solitary (specify location) : segments 6 and 7. HISTOLOGIC TYPE: Hepatocellular carcinoma. HISTOLOGIC GRADE: GII: Moderately differentiated. TUMOR EXTENSION (select all that apply) : Tumor confined to liver. PRIMARY TUMOR (pT) : pT1: Solitary tumor with no vascular invasion. REGIONAL LYMPH NODES (pN) : pNX: Cannot be assessed. DISTANT METASTASIS (pM) : pMX: Cannot be assessed. MARGINS: Parenchymal margin uninvolved. VENOUS (LARGE VESSEL) INVASION (V) : Absent. ADDITIONAL PATHOLOGIC FINDINGS: None identified. Gross Description. Received is a single specimen container. quisition and specimen container are. labelled with the patient's name,. The cassette and identifiers are. labelled with the Surgical Number. The specimen is received fresh and is subsequently placed into formalin The container. is designated liver segment 6 and 7. The specimen consists of a wedge-shaped piece of. liver which measures 12.5 x 7.5 x 5.5 cm. The capsule has a nodular appearance and shows. peritoneal adhesions. The resection margin is painted black. The specimen is serially. sectioned. The liver parenchyma underneath the nodular adhesion shows a circumscribed. yellow tan single tumor which measures 5.5 x 5 x 5 cm. Sections: A1. representative section of grossly normal liver parenchyma. A2-4. tumor with overlying capsule. A5-7. tumor. A8. A9. tumor and closest resection margin. The closest margin is 1 cm from the tumor. Microscopic Description. Sections of the grossly described tumor show moderately differentiated hepatocellular. carcinoma which is confined within the liver capsule. The tumor shows clear cell change. in many of the sections. Intracellular and canalicular bile pigment is noted in the. neoplastic tissue. The resection margin is uninvolved. The surrounding liver parenchyma. has a normal architecture and shows no significant histologic abnormalities. special. stain for iron shows iron overload (2+) and special stain for alpha1-antitrypsin globule. is negative. Encounter Number. Patient Location.",T1,N0,M0,T1N0M0
TCGA-IG-A3QL,"Laterality:Distal. Path Report: :ESOPHAGUS TISSUE CHECKLIST. Specimen type: Excision of tumor. Tumor site: Esophagus. Tumor size: 2 X 1.5 x 0.3 cm. Histologic type: Squamous cell carcinoma, keratinizing. Histologic grade: Moderately differentiated. Tumor extent: Muscularis propria. Lymph nodes: 0/7 positive for metastasis (Regional 0/7). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Uninvolved. Evidence of neo-adjuvant treatment: Not specified. Additional pathologic findings: Not specified. Comments: None.",T2,N0,M0,T2N0M0
TCGA-BR-7196,"Gross Description. Microscopic Description. Diagnos. is. Subject. Details. Stomach segment with the. Adenocarcinoma of the stomach, G3;. plate-like tumor of 8.4 cm in with perigastric fat invasion, foci of. size; whole wall is invaded. perineural invasion. Fifteen lymph. Greater and lesser curvature. nodes were dissected, eleven lymph. lymph nodes are dense,. nodes demonstrated metastases. hyperemic; omentum --. Omentum demonstrates metastases,. hyperemia. focal lymphoid infiltration,. mesothelium proliferation. Comme. nts. Lateralit. y. STOMACH TISSUE. NA. CHECKLIST. Specimen type: Subtotal. gastrectomy. Tumor site: Stomach. Tumor size: 8.4 X 0 X 0 cm. Tumor features: Ulcerated. Histologic type: Adenocarcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Subserosa. Lymph nodes: 11/15. positive for metastasis. (Greater and lesser. omentum 11/15). Lymphatic invasion: Not. specified. Venous invasion: Absent. Perineural invasion: Not. specified. Margins: Uninvolved. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic. findings: Not specified. Comments: None.",T3,N3,M1,T3N3M1
TCGA-D8-A1JS,"page 1 / 2. copy No. 2. Examination: Intraoperative examination. Cost of diagnostic procedure. Gender: F. Material: Multiple organ resection - right breast. Expected time of examination: 20 minutes (from receipt of the material). Clinical diagnosis: Suspected cancer of the right breast. Lesion on the boundary of the upper quadrants. Examination performed or. Result of intraoperative examination: Carcinoma probabiliter invasivum. Final diagnosis after paraffin specimens are analysed. Compliance validated by: (. Macroscopic description: Surgical specimen sized 5 x 4 x 2 cm with a skin flap of 4 x 0.5 cm. Minimum side margin 0.2 cm. Result of intraoperative examination: Carcinoma papillare probabiliter invasivum. Foci DCIS typus cribrosus cum atypia gradus levioris ad mediocrum sine necrosis. Final diagnosis after immunohistochemical tests. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 protein stained with HercepTestM by DAKO. Negative reaction in invasive cancerous cells ( Score = 0). Examination: Intraoperative examination. page 2 / 2. Gender: F. Histopathological diagnosis: Carcinoma papillare probabiliter invasivum NHG1 (2 + 2 +1/0 mitoses/ 10 HPF, visual area diameter: 0.55 m). Corresponds to invasive papillary carcinoma of the right breast. Solitary foci of DCIS (cribrate type with medium nuclear atypia, without necrosis). The immunohistochemical test showed the absence of a myoepithelial cell stratum around the foci of the. invasive lesion (p63-, SMA'). The cells show negative reaction withCK5/6. Cytokeratin 7 present in part of the. cells. Suplementary test. Expression of the Ki67 proliferation antigen showed in 5% of cellular nuclei (20% in hot spots).",T1,N0,M0,T1N0M0
TCGA-GM-A3NY,"MODIFIED REPORT - REVIEW ADDENDUM SECTION. DIAGNOSIS. (A) LEFT BREAST, SEGMENTAL MASTECTOMY: INVASIVE LOBULAR CARCINOMA, CLASSICAL TYPE, MODIFIED BLACK'S NUCLEAR GRADES 1 AND. 2. INVASIVE CARCINOMA COVERS AN AREA OF APPROXIMATELY 3 CM.. INVASIVE CARCINOMA EXTENDS TO WITHIN 3.0 MM OF DEEP, 3.0 MM OF INFERIOR AND 5.0 MM OF. SUPERFICIAL MARGINS. LYMPHOVASCULAR INVASION IDENTIFIED. LOBULAR CARCINOMA IN SITU. Intraductal papilloma. Fibrocystic changes including duct epithelial hyperplasia without atypia, apocrine metaplasia, radial scar and cyst. Microcalcifications present and associated with fibrocystic changes. (B) LEFT BREAST CAPSULE, CAPSULECTOMY: Dense fibrous connective tissue, no tumor present. (C) LEFT BREAST, NEW SUPERFICIAL INFERIOR MARGIN, EXCISION: Breast parenchyma with fibrocystic changes including florid ductal hyperplasia without atypia, apocrine metaplasia. and microcysts. No evidence of malignancy. (D) LEFT BREAST, ADDITIONAL SUPERFICIAL MARGIN, EXCISION: Skin and subcutaneous adipose tissue, no evidence of malignancy. (E) LEFT AXILLA, LEVEL 1 AND 2 LYMPH NODES, EXCISION: METASTATIC CARCINOMA IN ONE OF TWELVE LYMPH NODES. METASTATIC CARCINOMA MEASURES 2.8 CM IN GREATEST DIMENSION. EXTRANODAL EXTENSION UP TO 3.0 MM PRESENT. (F) LEFT AXILLARY LEVEL 3 LYMPH NODE: One lymph node, no tumor present. GROSS DESCRIPTION. (A) LEFT SEGMENTAL MASTECTOMY, SHORT SUPERIOR, LONG LATERAL, PURPLE INK DEEP - One pale-yellow. segmental mastectomy specimen (9.5 x 8.0 x 4.2 cm) with a short stitch to mark the superior, long stitch to mark lateral and purple. ink to mark the deep. The specimen is inked, serially sectioned from medial to lateral into twelve slices. Located at slice 3 through. slice 8, there is one pale-gray, firm, ill-defined nodule (3.2 x 21.8 x 2.7 cm) is identified, located at 0.2 cm from deep margin, 0.2. cm from the anterior margin, 0.2 cm from superior margin, 1.2 cm from inferior margin, 0.6 cm from medial margin and 2.2 cm. from lateral margin. One clip is identified at slice 5, central portion. A portion of normal tissue and tumor is submitted for tumor. bank. INK CODE: Blue - superior; green - inferior; yellow - superficial; black - deep; red - lateral and medial. SECTION CODE: A1, slice 1, entirely submitted of the slice, perpendicular for medial margin; A2, slice 12, central portion. lateral margin perpendicular; A3, slice 2, central portion with deep margin section adjacent to the lesion at slice 3; A4, slice 3,. central portion nodule with anterior margin; A5, slice 3, central portion nodule with deep margin; A6, slice 3, central to inferior. portion with the anterior margin; A7, slice 3 central to inferior portion tumor with the deep margin; A8-A14, entirely submitted of. the. slice 4 from superior to inferior direction; A15-A20, entirely submitted of the slice 5 from superior to inferior direction (A16. associated with clip); A21-A28, slice 6, entirely submitted of the slice submitted from superior to inferior direction; A29, slice 7,. inferior portion with inferior and deep margin; A30, slice 8, superior portion with the superior margin; A31, A32, slice 8, central. portion nodule with the deep nodule submitted from superior to inferior direction; A33, slice 9, central portion section adjacent to. the lesion at slice 8. GROSS EVALUATION: TUMOR EXTENDS SUPERFICIAL/SUPERIOR AND DEEP MARGINS. (B) LEFT BREAST IMPLANT AND PARTIAL CAPSULECTOMY - An 11.5 X 11.5 x 2.5 cm tan-yellow plastic breast implant. devoid of contents. There is a 7.0 x 2.5 x 1.0 cm irregular piece of tan-yellow fibroadipose tissue attached to the surface of the. breast implant. No inscriptions are noted. Representative sections of the fibroadipose tissue is submitted in B1-B2. Photos are also taken. (C). NEW SUPERFICIAL INFERIOR MARGIN, INK MARKS TRUE MARGIN - One pale-yellow fibroadipose tissue (4.5 x 1.8 x 0.6. cm). with one side inked with purple to mark the true margin. The true margin is reinked and the specimen is serially sectioned and. entirely submitted. INK CODE: Blue - true margin. SECTION CODE: C1-C4, entirely submitted of the specimen. (D) ADDITIONAL SUPERFICIAL MARGIN, INK ON TRUE MARGIN - One pale-yellow fibroadipose tissue (2.5 X 1.6 x 0.6 cm). with purple ink to mark the true margin. The true margin is inked and the specimen is serially sectioned and entirely submitted. Also in the container, there are two unremarkable pale-gray skin strips (5.2 x 0.5 X 0.5 cm, 3.6 X 0.4 x 0.6 cm, respectively). The. resection margin of the skin is inked and specimen is serially sectioned and entirely submitted. INK CODE: Blue - resection margin. SECTION CODE: D1, entirely submitted of the fibroadipose tissue; D2, D3, each containing one piece of skin strip. (E). LEFT. AXILLARY, LEVEL 1 AND 2 LYMPH NODES - An 11.0 X 7.5 x 2.5 cm portion of yellow fibroadipose tissue which yields. multiple possible lymph nodes ranging from 0.5 cm to 4.0 x 3.2 x 1.5 cm. The largest lymph node has a solid tan-white lobulated. cut surface suggestive of metastases. The lymph nodes are submitted entirely. SECTION CODE: E1-E4, one lymph node bisected in each cassette; E5, two lymph nodes; E6, four lymph nodes; E7,. largest lymph node. (F) LEFT AXILLARY LEVEL 3 LYMPH NODE - A 3.0 x 2.5 X 0.8 cm portion of yellow fibroadipose tissue which yields two. possible lymph nodes, both measuring 1.0 cm in greatest dimension. The lymph nodes are submitted entirely in F. CLINICAL HISTORY. None given. SNOMED CODES. T-04050, M-85203, T-C4710, M-85206. ""Some tests reported here may have been developed and performance characteristics determined by. .. These tests have not been. specifically cleared or approved by the U.S. Food and Drug Administration."". Entire report and diagnosis completed by: Start of ADDENDUM. This report is issued to give Immunohistochemistry results. Immunohistochemical staining is performed on a representative Pen-. Fixed, paraffin-embedded section of METASTATIC CARCINOMA, axillary lymph node, block E7. MARKER. Clone/Vendor. STAINING. SCORE. HER2 overexpression. AB8 (NeoMarkers). Negative. 0. FOOTNOTE. Breast. specimens used for determining prognostic / predictive markers are fixed in either formalin or Pen-Fix (buffered alcoholic. formalin fixative) for 6 - 48 hours. For ER & PR: Positive. 10 100%. Low Positive. 1-9%. For Ki-67. Low Positive. <17%. Intermediate Positive. 17-35%. High Positive. >35%. Entire report and diagnosis completed by: END OF REPORT-.",T2,N1,M0,T2N1M0
TCGA-05-4415,"/diagnoses: Both centrally and peripherally there are large manifestations of bronchopulmonary, large-cell. and polymorphocellular, in part also giant-cell adenocarcinoma of the left lung with mucin. inclusions. TNM classification on the basis of these samples pT4 pN2 pMX V1 R0, stage IIIB. C34.3 M8255/3. Comment/supplementary remark: The assumed primary, central tumor involves upper and lower lobes, with obliteration and. stenosis of central bronchus segments and continuous infiltration of parabronchial lymph. nodes. The peripheral manifestation is in S6 and leaves the visceral pleura tumor-free. Sample. 3.) contains a further lymph node metastasis. The two carcinomas show tumor invasions in. small intratumoral blood vessels. The resection margin of the bronchus and vessels and also. the hilar resection surface of the main preparation and the lymph nodes of samples 2.) and 4.). to 6.) are tumor-free.",T4,N2,M0,T4N2M0
TCGA-BJ-A3PU,"FINAL DIAGNOSIS: PART1: CONTENTS, CENTRAL COMPARTMENT, EXCISION - -. A. SIX OF SIX LYMPH NODES POSITIVE FOR METASTATIC PAPILLARY THYROID CARCINOMA (6/6). B. PARATHYROID PROFILE (1). PART 2: THYROID, TOTAL THYROIDECTOMY -. A. PAPILLARY THYROID CARCINOMA, FOLLICULAR VARIANT, OF LEFT LOBE, 2.6 CM. B. CARCINOMA INVADES PERI-THYROIDAL SOFT TISSUE. C. CARCINOMA FOCALLY INVOLVES THE SKELETAL MUSCLE. D. E. CARCINOMA EXTENSIVELY PRESENT AT THE PERIPHERAL SURGICAL MARGINS. LYMPHOVASCULAR INVASION IDENTIFIED. F. ONE CENTRAL LYMPH NODE, POSITIVE FOR METASTATIC PAPILLARY THYROID CARCINOMA (1/1). G. TNM STAGE (AJCC, 7th Edition): p T3. N1. PART 3: PARATHYROID, LEFT SURERIOR, BIOPSY -. NORMOCELLULAR PARATHYROID TISSUE, 20 MILLIGRAMS. COMMENT: Selected sildes of part 2 of this case are also revlewed by Dr. who agrees with the diagnosis. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Left Lobe. TUMOR FOCALITY: Unifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 2.6 cm. Additional Dimensions: 2.0 cm. HISTOLOGIC TYPE: Papillary carcinoma. PRIMARY TUMOR (pT): pT3. REGIONAL LYMPH NODES (pN): pN1a. Number of regional lymph nodes examined: 7. Number of regional lymph nodes involved: 7. EXTRANODAL EXTENSION: Not identified. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Present. MARGINS: Margin(s) involved by carcinoma. LYMPH-VASCULAR INVASION: Present. ADDITIONAL PATHOLOGIC FINDINGS: None Identified. ADDENDA: Addendum. This addendum Is to clarify the diagnosis in part 2 of this case. The first line of the diagnosis should read: PAPILLARY THYROID CARCINOMA, OF LEFT LOBE, 2.6 CM.",T3,N1,M0,T3N1M0
TCGA-85-8584,"Gross Description. Case ID. Lobe with the lobar bronchus obstructed by a. parahilar tumoral structure of 4/4/3.5 cm in. diameter; the tumor is well-limited, with. accentuated anthracotic tattoo. Microscopic Description. Diagnosis Details. TUMOR FRAGMENT: Bronchopulmonary neoplasm of the. spinocellular epidermoid carcinoma type. without keratinization, G2, formed of a. monomorphous cellularity with nuclear atypias. and hotbeds of necrosis, with papillary pattern;. fibrous-inflammatory stromal reaction. INTERLOBAR LYMPH NODE: No metastases. LYMPH NODE STATION X: Lymph node with neoplastic infiltrates of. epidermoid carcinoma and small hotbeds of. necrosis. Comments. LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 4 X 4 X 3.5 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Moderately differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: 1/2 positive for metastasis. (Regional 1/2). Lymphatic invasion: Present. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: Right- upper.",T2,N1,M0,T2N1M0
TCGA-05-5425,"V3.00 110614. Instructions: The TCGA Missing Pathology Report Form should be completed for cases for which a pathology report is not. available. Completed. General Pathology Report Information. #. Data Element. Entry Alternatives. Working Instructions. Provide the tumor type of the case. 1. Tumor type: Indicate to which BCR location the case was originally sent. 2. BCR specimen originally sent. NCH. to: IGC. Biospecimen Core Resource (BCR). Date specimen received at. 3. BCR: ICD-0-3 Histology Code: Provide the histology code for the sample from the Case. Quality Control Form (CQCF) and the overall case (patient. For Specimen: (CQCF). diagnosis, if different). 4. For Case: (patient. diagnosis, if available. elsewhere). ICD-0-3 Site Code: Provide the site code for the sample from the Case Quality. Control Form (CQCF) and the overall case (patient diagnosis, if. different). For Specimen: (CQCF). 5. For Case: (patient. diagnosis, if available. elsewhere).",T2,N1,M0,T2N1M0
TCGA-2F-A9KT,"Histologic diagnosis. High grade muscle invasive urothelial cell carcinoma. pT2bG3 NO. Anatomic site and laterality. Posterior bladder wall, right side. Tumor size. 7x6x2,5cm. Lymph node status. In total 20 lymph nodes all without tumor localization. Descriptions.",T2,N0,M0,T2N0M0
TCGA-50-6594,"PATIENT HISTORY: CHIEF COMPLAINT/PRE-OP/POST-OP DIAGNOSIS: Lung mass. PROCEDURE: Left VATS. SPECIFIC CLINICAL QUESTION: Not given. OUTSIDE TISSUE DIAGNOSIS: Not given. PRIOR MALIGNANCY: Not given. CHEMOTHERAPY: Not given. ORGAN TRANSPLANT; Not given. IMMUNOSUPPRESSION: Not given. OTHER DISEASES: Not given. ADDENDA: Addendum. Molecular Anatomic Pathology Testing: Block 7D: A. KRAS codon 12/13 mutation NOT identified. B. EGFR Exon 19 mutation NOT identified. C. EGFR Exon 21 mutation NOT identified. D. EGFR amplification NOT identified (see In Situ Procedure). E. EML4/ALK rearrangement NOT identified (see In Situ Procedure). Note: KRAS codon 12/13 mutations are found in approximately 10-30% lung adenocarcinomas and associated with history of. smoking. The presence of KRAS mutation leads to resistance to EGFR targeted therapies (1). EGFR exon 19 and 21. mutations are present in about 10% of. and up to 40% in the. population, common in. and. associated with the clinical response to treatment with EGFR inhibitors (2). These mutations are mutually exclusive and. their presence may have prognostic and/or therapeutic implications (3,4). Clinical studies show high EGFR gene copy. number by FISH analysis (amplification) to be associated with favorable clinical benefit (clinical response, stable disease,. time to progression, and survival) in patients with advanced non-small cell lung cancer treated with EGFR tyrosine kinase. inhibitors. Approximately 3% of lung adenocarcinomas within the Asian population have an interstitial deletion and inversion in. chromosome 2p resulting in the EML4/ALK fusion gene (ALK+) which is sensitive to ALK inhibitors (5,6). The prevalence. of this abnormality in the Western population is still unknown. Detection of this abnormality is critical for identifying. patients eligible for therapies that target ALK enzymatic activity. EML4/ALK rearrangements are mutually exclusive with. KRAS and EGFR mutations. FINAL DIAGNOSIS: SUMMARY STATEMENT. The posterior segmentectomy demonstrates a 2.5 cm poorly differentiated adenocarcinoma associated with. angiolymphatic and parietal pleural invasion. Metastatic adenocarcinoma is present in posterior and apical segment. level 11, level 10 and level 5 lymph nodes. Surgical resection margins are free of tumor. Pathologic stage is T3N2Mx. PARTS 1. AND 2: PLEURA, LEFT, PLEURORECOMTY-. POORLY DIFFERENTIATED ADENOCARCINOMA. PART 3: LYMPH NODE, POSTERIOR SEGMENT LEVEL 11, BIOPSY -. METASTATIC ADENOCARCINOMA. PART 4: LYMPH NODE, LEVEL 10, BIOPSY -. METASTATIC POORLY DIFFERENTIATED ADENOCARCINOMA WITH EXTRACAPSULAR EXTENSION. PART 5: LYMPH NODE, APICAL SEGMENT LEVEL 11, BIOPSY -. POORLY DIFFERENTIATED ADENOCARCINOMA. PART 6: LYMPH NODE, LEVEL 5, BIOPSY -. METASTATIC POORLY DIFFERENTIATED ADENOCARCINOMA. PART 7: LUNG, LEFT UPPER LOBE, EXTENDED POSTERIOR SEGMENTECTOMY -. A. INVASIVE POORLY DIFFERENTIATED ADENOCARCINOMA (2.5 CM IN DIAMETER), ASSOCIATED WITH. ANGIOLYMPHATIC AND VISCERAL PLEURAL INVASION. MILD LYMPHOCYTIC HOST RESPONSE. PATHOLOGIC STAGE: T3N2MX. B. SURGICAL RESECTION MARGINS ARE FREE OF TUMOR. C. BACKGROUND WITH EMPHYSEMATOUS CHANGE AND RESPIRATORY BRONCHIOLITIS. CASE SYNOPSIS: SYNOPTIC DATA . PRIMARY LUNG TUMORS. TUMOR LOCATION: Left Upper Lobe. LUNG SEGMENT(S) INVOLVED: Posterior. PROCEDURE: Segmental. TUMOR SIZE: Maximum dimension: 2.5 cm. Minor dimension: 1.9 cm. GROSS SATELLITES: Number of gross satellite lesions: 0. TUMOR TYPE: Invasive adenocarcinoma. HISTOLOGIC GRADE: G3, Poorly differentiated. MICROSCOPIC SATELLITES: Number of microscopic satellite lesions: 0. EXTRAPULMONARY PARENCHYMAL. EXTENSION/INVASION OF TUMOR: Visceral pleura. Parietal pleura. ANGIOLYMPHATIC INVASION: TUMOR NECROSIS: < or = to 50%. SURGICAL MARGIN INVOLVEMENT: No. SURGICAL MARGIN SITE: Distance of invasive tumor to closest margin: 40 mm, Parenchymal margin. INFLAMMATORY(DESMOPLASTIC) REACTION: Mild. N1 LYMPH NODES: Number of N1 lymph nodes positive: 3. Number of N1 lymph nodes examined: 3. EXTRACAPSULAR SPREAD OF N1 METASTASES: N2 LYMPH NODE GROUPS INVOLVED: Level 5. N2 LYMPH NODES: Number of N2 lymph nodes positive: 1. Number of N2 lymph nodes examined: 1. EXTRACAPSULAR SPREAD OF N2 METASTASES: UNDERLYING DISEASE(S): Emphysema, Smokers bronchiotitis. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pN2. M STAGE, PATHOLOGIC: pMX. ANCILLARY STUDIES: Histochemical stains, FISH studies, Molecular studies.",T3,N2,M0,T3N2M0
TCGA-69-A59K,"825513. SPECIMEN SUBMITTED: Part A: #1. Part B: #3. Part C: R 9. Part D: 10 R. Part E: 11 R. Part F: 12 R. Part G: RIGHT UPPER LOBE. Final Diagnosis. 1. Lymph node #1, #3, R9, 11R, 12R, excision (A-C, E-F) - Lymph nodes, negative for malignancy. 2. Lymph node, 10R, excision (D) - Fibrous tissue and adjacent lung, negative for neoplasm. 3. Right lung, upper lobe, lobectomy (G) Adenocarcinoma, solid predominant (80%) and acinar. (20%)large mass; Acinar preominent (80%) and micropapillary (20%) smaller mass. Centrilobular emphysema. - Three lymph nodes, negative for malignancy (0/3). - See comment. Diagnosis Comment: LUNG SYNOPTIC REPORT. SPECIMEN: Lobes of lung right upper. PROCEDURE: Lobectomy. SPECIMEN INTEGRITY: Intact. SPECIMEN LATERALITY: Right. TUMOR SITE: Upper lobe. TUMOR SIZE: Greatest dimension 3.7 cm, 2.9 x 2.8 cm and 1.2 cm x 0.8 cm x 0.7cm. TUMOR FOCALITY: Separate tumor nodules in same lobe. HISTOLOGIC TYPE: Adenocarcinoma. HISTOLOGIC GRADE: NA. VISCERAL PLEURAL INVASION: No invasion into visceral pleura by either mass. TUMOR EXTENSION: Not identified. MARGINS: - Bronchial margin: Uninvolved by invasive carcinoma. - Vascular Margin: Uninvolved by invasive carcinoma. - Parenchymal margin: Uninvolved by invasive carcinoma. - Parietal pleural margin: NA. - Chest wall margin: NA. - Distance of invasive carcinoma from closest margin; 3.4 cm. -- Specify margin: Parenchymal margin. TREATMENT EFFECT: Not applicable. LYMPH-VASCULAR INVASION: Not identified. PATHOLOGIC STAGING: Stage IIB. pT3. pNO. Number of lymph nodes examined: 11. Number of lymph nodes involved: 0. pM Not applicable. Additional pathologic findings: Centrilobular emphysema. Ancillary studies: Epidermal growth factor receptor (EGFR) mutational analysis will be performed on both. masses and the results reported as an addendum. Immunohistochemical studies reveal diffuse strong. positivity to TTF-1 and no staining for p63, supporting the diagnosis of adenocarcinoma (larger mass). Procedure: EGFR Mutation Analysis Re. Text: EGFR Mutation Analysis (. Diagnosis of neoplasm: No EGFR alteration detected . Genotype result: Wild type. EGFR Mutation Analysis. Diagnosis of neoplasm: No EGFR alteration detected. Genotype result; Wild type. Intraoperative Diagnosis: A. Negative for malignancy. B. Negative for malignancy. G. Bronchial margin negative for malignancy. Clinical Diagnosis: LUNG NODULES. Gross Description: A. Received fresh for frozen section examination labeled ""#1"" are two black-tan soft tissue measuring in. aggregate 0.7 x 0.4 X 0.2 cm. The specimen is totally submitted in cassette FSA1. B. Received fresh for frozen section examination labeled ""#3"" are multiple red-black soft tissue. measuring in aggregate 0.4 x 0.2 x 0.2 cm. The specimen is totally submitted in cassette FSB1. C. Received in formalin is a tan-gray nodule resembling a lymph node measuring 0.2 x 0.2 x 0.2 cm. Totally submitted in one cassette. D. Received in formalin is a tan-gray nodule resembling a lymph node measuring 0.3 X 0.3 x 0.2 cm. Totally submitted in one cassette. E. Received fresh is a tan-black nodule resembling a lymph node measuring 0.6 x 0.5 x 0,2 cm. Totally. submitted in one cassette. F. Received in formalin is a tan-black nodule resembling a lymph node measuring 0.4 x 0.3 x 0.2 cm. Totally submitted in one cassette. G. Received in formalin is a specimen labeled ""right upper lobe"" consisting of a single lobe of right lung. measuring 16.5 x 13.0 X 4.6 cm, and weighing 297.0 grams. A bronchial stump is present measuring. 1.0 cm in length with a luminal diameter of 0.8 cm. Numerous anthracotic lymph nodes are identified. within the hilar region. The pleural surface has a tan-pink smooth patchy appearance. A small portion. of. the pleural surface appears slightly puckered by an underlying mass. Upon multiple cross sections, the. mass measures 3.7 X 2.9 x 2.8 cm, and is located near the periphery of the specimen. The mass has a. tan-white lobulated appearance with focal area of hemorrhage. The mass extends to within <0,1 cm of. the pleural margin and to within 5.0 cm of both the bronchial and vascular margins. In addition, the. mass extends within 3.4 cm of the nearest staple line of resection. The pleural margin above the mass. is inked blue. Located approximately 1.0 cm from the main mass is a smaller ill-defined tan-black mass. measuring 1.2 x 0.8 x 0.7 cm. This mass extends to within 1.5 cm of the pleural margin. In addition, a. small area of possible emphysematous changes are identified. Representative sections are submitted. as follows: G1 frozen section bronchial margin, G2 additional section of bronchus, G3 vascular margin,. G4-G5 lymph nodes, G6-G9 section of larger mass in relation to pleural margin, G10 larger mass with. adjacent lung parenchyma, G11 smaller mass with adjacent normal appearing lung parenchyma and. smaller portion of larger mass, G12-G13 remainder of smaller mass, G14 section of uninvolved lung. parenchyma, G15 area of possible emphysematous changes. Microscopic: {Not Entered}.",T3,N0,M0,T3N0M0
TCGA-85-8352,Case ID Gross Description. Microscopic Description. Diagnosis Details. Comments. LUNG TISSUE CHECKLIST. Specimen type: Pulmonectomy. Tumor site: Lung. Tumor size: 8x7x7cm. Histologic type: Squamous cell. carcinoma. Histologic grade: Poorly. differentiated. Tumor extent: Visceral pleura. Other tumor nodules: Not specified. Lymph nodes: 3/8 positive for. metastasis (Intrathoracical 3/8). Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not. specified. Comments: Right-upper. Laterality. Right-upper.,T3,N1,M0,T3N1M0
TCGA-AA-3697,"Diagnosis: (I) shows colon mucous membrane with parallel crypts and associated mucosa and. submucosa. (II) shows a moderately differentiated adenocarcinoma (colon carcinoma, G2) with. penetration of all parietal layers (pT3), and lymph vessel invasion. There are also lymph. node metastases of the carcinoma described (pN2). (III) shows free anastomosis rings. There was no evidence of any residual tumor in preparations I. and III., so that the. resection margins were free in relation to this situation. Preliminary information is being compiled. Tumor classification: ICDO-DA-M 8140/3. G2. pT3, pN2, L1.",T3,N0,M0,T3N0M0
TCGA-85-8048,Requisition. case OpenClinica ID Gross. Microscopic. Diagnosis. Comments. Description. Description. Details. Laterality/lo. Date of excision. cation. LUNG TISSUE CHECKLIST. Left-lower. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 2 X 3 X 2.5 cm. Histologic type: Squamous cell carcinoma. Histologic grade: Poorly differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant treatment: Not. specified. Additional pathologic findings: Not specified. Comments: None.,T1,N0,M0,T1N0M0
TCGA-A8-A0A7,"Diagnosis: 1. Polymorphocellular undifferentiated breast, G II (maximum tumor diameter 2.8 cm). showing infiltrative growth, with marked chronic secondary inflammation, focal. invasion of lymph vessels and spread to just below the skin. The conventional histological findings are consistent with the polymorphocellular. variant of invasive lobular breast carcinoma. The nodular tumor infiltration in the. axillary tissue described under 6. is to be interpreted as a lymph node metastasis. extending beyond the capsule into the surrounding soft tissue. This gives rise to the. following summary tumor classification: G II, pT2pN1a(1/14)L1VORO negative for. estrogen and progesterone receptors, positive for C-erb B-2 oncoprotein.",T2,N1,M0,T2N1M0
TCGA-BJ-A45D,"FINAL DIAGNOSIS: PART 1: THYROID, TOTAL THYROIDECTOMY (27 GRAMS) -. A. PAPILLARY THYROID CARCINOMA, ENCAPSULATED FOLLICULAR VARIANT (2.5 CM) WITH EXTENSIVE. POST ASPIRATE DEGENERATIVE CHANGES, CONFINED TO THE ISTHMUS. B. NO (tumoral-) CAPSULAR OR TRUE ANGIOLYMPHATIC INVASION (see comment). C. ONE (1) ISTHMIC LYMPH NODE, NO TUMOR PRESENT (0/1). D. PATHOLOGIC STAGE pT2 NO. PART 2: PARATHYROID, LEFT INFERIOR, PARATHYROIDECTOMY (143 MG) -. SLIGHTLY ENLARGED BUT NORMOCELLULAR PARATHYROID. COMMENT: There Is a fragment of degenerated hemorrhagic tumor in a vessel that appears to have been displaced by the fine needle. aspiration. Foci such as these are generally not regarded as true vascular invasion. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY THYROID TUMORS. SPECIMEN TYPE: Total Thyroidectomy. TUMOR SITE: Isthmus. TUMOR FOCALITY: Unifocal. TUMOR SIZE (largest nodule): Greatest Dimension: 2.5 cm. HISTOLOGIC TYPE: Papillary carcinoma, encapsulated follicular variant. PRIMARY TUMOR (pT): REGIONAL LYMPH NODES (pN): pNO. Number of regional lymph nodes examined: 1. Number of regional lymph nodes involved: 0. DISTANT METASTASIS (pM): Not applicable. EXTRATHYROIDAL EXTENSION: Not identified. MARGINS: Margins uninvolved by carcinoma. LYMPH-VASCULAR INVASION: Indeterminate.",T2,N0,M0,T2N0M0
TCGA-EI-6506,"page 1 / 1. Examination: Histopathological examination. Material: 1. Partial organ resection - segment of the large intestine. Clinical diagnosis: 1/ Ca. recti. SPECIMEN - (distal segment of the sigmoid colon and proximal segment of the rectum with the. tumour, Proximal end marked with a thread. 2/ Ca. recti. SPECIMEN - rings of the sigmoid colon-rectum anastomosis. Macroscopic description: 1. 13 cm length of the large intestine with a segment of the mesenterium sized 14 x 6 x 2.5 cm. Ulcerous, flat-elevated, cauliflower-shaped tumour sized 4.5 x 3.5cm found in the mucosa. The. lesion surrounds 90% of the intestine circumference and narrows its cross section, located 5.5 cm. from one of the incision lines and 4.5 cm from the opposite one. Lesion invading macroscopically. the periintestinal tissue. Minimum side margin is 2.3cm. 2. Two surgical specimens sized 2.5 x 1.8 X 1.2 cm and 2.5 x 2.0 x 1.3 cm. Microscopic description: 1. Adenocarcinoma tubulare (G2). Infiltratio carcinomatosa tunicae muscularis propriae et telae adiposae pericolicae. Incision lines free of neoplastic lesions. Lymphonodulitis reactiva No XIX. 2. Anastomosis rings free of cancer invasion. Examination result/Histopathological diagnosis: Adenocarcinoma tubulare coll. Tubullar adenocarcinoma of the colon. (G2, Dukes B, Astler-Coller B2, pT3, pNo).",T3,N0,M0,T3N0M0
TCGA-B8-4151,"Accession # : Diagnosis: Right kidney, nephrectomy. Histologic tumor type/subtype: renal cell carcinoma, clear. cell type. Histologic grade (if applicable) : 2 (of 4,. classification). Tumor size (greatest dimension) : 6.7 cm diameter (gross). Extent of tumor invasion: Extra-capsular invasion: present, perihilar / renal sinus. fat (A9). Renal vein: tributary involved (A11) , but not involving. renal vein margin (A1). Ureter: not identified. Venous (large vessel) : see above. Lymphatic (small vessel) : not identified. Depth of invasion: n/a. Adjacent organs: none received. Surgical margins: Perirenal adipose tissue: not involved. Renal vein: not involved. Renal artery not identified. Ureter: not identified. Adrenal gland: not received. Lymph nodes: not received. Other significant findings : none. AJCC Staging: pT3 pNx pMx. This staging information is based on information available. at the time of this report, and is subject to change. pending clinical review and additional information. Clinical History: The patient is a with a clinical diagnosis of a kidney mass. in the right kidney. As per. abdominal CT shows a. mass of the right kidney that extends from the medial to. interpolar region and measures 7.3 X 5.6 cm. Smaller. lesions are also noted in the lower pole but are too small. to characterize. Gross Description: Received is one appropriately labeled container. Specimen A is additionally labeled ""right kidney"". Specimen fixation: formalin. Type of specimen: total nephrectomy, right side. Side of specimen: right. Size and weight of specimen: Weight 600 g; the specimen. measures 16.0 X 9.5 X 6.5 cm overall; the kidney measures. 12.5 X 5.6 X 6.0 cm. Orientation: The specimen has been previously opened and. the perirenal fat has been inked blue. Presence/absence of adrenal gland: absent. Tumor description/site: The tumor is located in the lower. pole of the kidney and measures 6.7 X 3.7 X 2.5 cm; there. appears to be a thin capsule surrounding a portion of the. tumor; the tumor itself is yellow to gold in color with. focal areas of brown discoloration. No necrosis is evident. Tumor size: 6.7 X 3.7 X 2.5 cm. Presence/absence of multicentricity: absent. Confinement/non-confinement to the kidney: confined. Extent of invasion: Perirenal adipose tissue: does not grossly involve. Gerota' S fascia: not present. Renal vein: does not grossly involve. Ureter: does not grossly involve. Other organs: not applicable. Surgical margins: Perirenal adipose tissue: negative; closest margin of. resection is 0.5 cm. Renal vein: negative; 2.0 cm away. Renal artery: negative; 2.0 cm away. Ureter: negative; 2.0 cm away. Description of kidney away from tumor: The remainder of the. kidney appears tan-brown in color with no evidence of other. satellite lesions or masses; the average medullary region. measures 1.2 cm and the average cortical region measures. 0.6 cm. Lymph nodes (hilar) : non-identified. Other significant findings: no. Tissue submitted for special investigations: no. Digital photograph taken : no. Block Summary: Blue = perirenal fat; (margin of resection). A1 - vascular and ureteral margins. A2 - tumor in closest inked perinephric soft tissue. A3 - tumor and renal capsule. A4 - tumor with transition into normal parenchyma. A5-A6 - central tumor (two slices per cassette). A7 - normal kidney, upper pole, one representative section. A8-A9 - tumor and adjacent urothelium. A10 - hilar fat, en face. A11 - additional section of tumor with urothelium.",T3,N0,M0,T3N0M0
TCGA-DK-A2I6,"M. Urology. Type: Clinical Diagnosis & History: male with primary T2 high grade TCC involving right hemitrigone with right hydronephrosis. Specimens Submitted: 1: SP: Bladder, seminal vesicle, prostate and perivesical nodes, radical cystoprostatectomy. 2: SP: Vas deferens, right, resection. 3: SP: Vas deferens, left, resection. 4: SP: Lymph nodes, left pelvic, excision. 5: SP: Lymph nodes, right pelvic, excision. 6: SP: Fat, anterior prostate, resection. 7: SP: Soft tissue, left anterior abdominal wall, resection. 8: SP: Ureter, left, excision,. 9: SP: Ureter, right, excision. DIAGNOSIS: 1. SP: Bladder, seminal vesicle, prostate and perivesical nodes, radical cystoprostatectomy. a. Tumor Type: Invasive urothelial carcinoma, NOS. Histologic Grade: High grade. Pattern of growth of the Non-Invasive component: Flat (in situ carcinoma). Pattern of growth of the Invasive component: Infiltrating. Tumor Multicentricity: Not identified. Bladder Local Invasion: Deep half of muscularis propria. Extravesical Tumor Extension: The right ureter shows focal marked atypia at the margin of resection. Vacular Invasion: Identified. Perineural Invasion: Identified. Surgical Margins: The right ureter shows focal marked atypia at the margin of resection. Non-Neoplastic Mucosa: Exhibiting proliferative cystitis (Brunn's nests, cystitis cystica, cystitis glandularis). Prostate: Other See separate form. Seminal Vesicles: Not involved. Perivesical Lymph Nodes: LN Not involved 0/1. The Pathologic Stage is (AJCC 2002): pT2b (Invades deep half of muscularis propria). PRO (No involvement of prostate). b. Tumor Type: Adenocarcinoma. Gleason's Grade: Primary Gleason grade: 3. Secondary Gleason grade:4. Total Gleason score:7. Tumor Location: Involves Right anterior. Involves Left posterior. Involves Left anterior. Vascular Invasion: Not Identified. Perineural Invasion: Not identified. Tumor Multicentricity: Multicentric foci of invasive carcinoma are present. High Grade Prostatic Intraepithelial Neoplasia: Not Identified. Capsule: Tumor confined to prostate. Seminal Vesicles: Not involved. Bladder Neck: Not Involved. Surgical Margins: Free of tumor. Non-Neoplastic Prostate: Unremarkable. Staging (AJCC 1997): pT2b (confined to the prostate & capsule, involving both lobes). 2. SP: Vas deferens, right, resection. Segment of benign vas deferens. 3. SP: Vas deferens, left, resection. Segment of benign vas deferens. 4. SP: Lymph nodes, left pelvic, excision. Lymph Nodes: Number of nodes examined:8. Number of metastatic nodes:0. 5. SP: Lymph nodes, right pelvic, excision. Lymph Nodes: Number of nodes examined: 21. Number of metastatic nodes: 1. The largest metastatic node is 0.7cm. Perinodal (extracapsular) extension not identified. 6. SP: Fat, anterior prostate, resection. One benign lymph node( 0/1). 7. SP: Soft tissue, left anterior abdominal wall, resection. Benign adipose tissue. 8. SP: Ureter, left, excisiion,. Segment of benign ureter. 9. SP: Ureter, right, excision. Segment of benign ureter. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh, labeled ""Bladder, Seminal Vesicle, Prostate and Perivesical Nodes"". It consists of. a. bladder measuring 9.5 x 8 x 2 cm and a prostate measuring 5 x 3 x 2.5 cm. Overall the specimen measures 23 x 15 x 3.8 cm. The bladder is opened anteriorly to reveal a round, firm, exophytic mass on the right aspect of the trigone measuring 3 x 2 x 1 cm. The rest of the mucosa is markedly edematous showing prominent trabeculation. The tumor is compressing on the right ureteral. orifice and the right ureter is markedlu dilated ( o4 cm). Sectioning of the tumor reveals a gray-tan, homogeneous, firm,. well-delineated cut surface. Grossly, the tumor does not infiltrate through the muscular wall and measures 1.8 cm in maximum. thickness. Sectioning the prostate reveals no gross pathologic abnormalities. Representative sections are submitted. The. perivesical fat is dissected in searched for perivesical lymph nodes which are not seen grossly. Tissue is submitted for TPS. Photographs are taken. Summary of Sections: UM - urethral margin. URM - ureteral margin (green ink on right ureter). T - tumor. TR - trigone. LUO - left ureteral orifice. PW - posterior wall. AW - anterior wall. RW - right wall. LW - left wall. DO - dome. AA - anterior apex, ( first block from the right). AP - posterior apex. AM - anterior mid. PM - posterior mid portion of the prostate. AB - anterior base. PB - psoterior base. RSV - right seminal vesicle. LSV - left seminal vesicle. PVLN - perivesical lymph nodes. PA - posterior apex. 2). The specimen is received in formalin, labeled ""Right Vas Deferens"". It consists of a vas deferens measuring 2 cm in. length and 0.2 cm in diameter. The specimen is entirely submitted. Summary of Sections: U - undesignated. 3). The specimen is received in formalin, labeled ""Left Vas Deferens"". It consists of a vas deferens measuring 1.7 cm in. length and 0.2 cm in diameter. The specimen is entirely submitted. Summary of Sections: U - undesignated. 4). The specimen is received in formalin, labeled ""Left Pelvic Lymph Nodes"". It consists of an irregular fragment of adipose. tissue measuring 6 x 3.5 x 1 cm in aggregate. Multiple lymph nodes are identified. The specimen is entirely submitted. Summary of Sections: BLN - bisected lymph node. MLN - multiple lymph nodes. 5). The specimen is received in formalin, labeled ""Right Pelvic Lymph Nodes"". It consists of multiple fragments of yellow-tan. adipose tissue measuring 3.5 x 5 x 1.8 cm in aggregate. Multiple lymph nodes are dissected ranging in size from 0.2 x 0.2 x 0.1. cm to 2 x 1 x 0,7 cm. The largest lymph node is bisected. All lymph nodes are submitted. Summary of Sections: BLN - bisected lymph node. LN - lymph nodes. 6). The specimen is received in formalin, labeled ""Anterior Prostate Fat"". It consists of a fragment of yellow-tan adipose. tissue measuring 3 x 2x1 cm. Presumably one lymph node is dissected measuring 0.4 x 0.4 x 0.2 cm. The lymph node and the. remaining tissue are entirely submitted. Summary of Sections: LN - lymph nodes. U - undesignated. 7). The specimen is received in formalin, labeled ""Left Anterior Abdominal Wall Fat"". It consists of two fragments of adipose. tissue measuring 3 x 2.5 x 0.7 cm in aggregate. Sectioning through the tissue reveals no gross pathologic abnormalities. The. specimen is entirely submitted. Summary of Sections: U - undesignated. 8). The specimen is received in formalin, labeled ""Left Ureter (clip on the most distal end)"". It consists of a piece of pink-tan. and white-tan tissue measuring 1.5 x 1 x 0.8 cm. One side of the tissue is oriented with a clip at te distal end of the ureter. Sectioning of the tissue reveals a white-tan, tube-like structure that grossly shows no significant pathologic abnormalities. The. specimen is entirely submitted. Summary of Sections: DE - distal end of ureter. PE - proximal end of ureter. M - mid portion of the tissue. 9). The specimen is received in formalin, labeled ""Right Ureter"". It consists of a ureter with surrounding adipose tissue with. clip on distal end, measuring 2 cm in length and 0.4 cm in diameter. The specimen is entirely submitted. Summary of Sections: DM - distal margin. PM -proximal margin. SS - serially sectioned ureter. Summary of Sections: Part. 1: SP: Bladder, seminal vesicle, prostate and perivesical nodes, radical cystoprostatectomy. Block. Sect. Site. PCs. 2. ab. 2. 2. am. 2. 2. ap. 2. 1. law. 1. 1. do. 1. 1. Isv. 1. 1. luo. 1. 1. Iw. 1. 2. pa. 2. 2. pb. 2. 2. pm. 2. 1. pvln. 1. 1. pw. 1. 1. rsv. 1. 1. rw. 1. 4. t. 4. 1. tr. 1. 1. um. 1. 1. urm. 1. Part 2: SP: Vas deferens, right, resection (tl). Block. Sect. Site. PCs. 2. u. 7. Part 3: SP: Vas deferens, left, resection (tl). Block. Sect. Site. PCs. 2. u. 5. Part 4: SP: Lymph nodes, left pelvic, excision (tl). Block. Sect. Site. PCs. 3. bIn. 6. 1. mln. 4. Part 5: SP: Lymph nodes, right pelvic, excision. Block. Sect. Site. PCs. 1. bin. 1. 6. In. 6. Part 6: SP: Fat, anterior prostate, resection (tl). Block. Sect. Site. PCs. 1. In. 1. 1. u. 1. Part 7: SP: Soft tissue, left anterior abdominal wall, resectio"". Block. Sect. Site. PCs. 2. u. 2. Part 8: SP: Ureter, left, excisilon,. Block. Sect. Site. PCs. 1. de. 1. 1. m. 1. 1. pe. 1. Part 9: SP: Ureter, right, excision. Block. Sect. Site. PCs. 1. dm. 1. 1. pm. 1. 1. SS. 3.",T2,N1,M0,T2N1M0
TCGA-43-A474,"Final Surgical Pathology Report. Procedure: Diagnosis. E. and F. Lung, Left Upper Lobe lobectomy and subsequent bronchial. margin: Invasive squamous cell carcinoma, poorly differentiated, 5.6 cm. (pT2b). Tumor involves the main bronchus. Final bronchial margin (specimen F.) negative for tumor. Pleura negative for malignancy. No lymphatic or vascular space invasion identified. Venous and arterial margins negative for tumor. 4 peribronchial lymph nodes negative for tumor (0/4). K. Completion left pneumonectomy: Pulmonary hemorrhage compatible with procedural effects. Focal hemosiderin compatible with more remote hemorrhage. Atelectasis. Bronchial and vascular margins unremarkable. A. Lymph node level #5, biopsy: Single lymph node negative for. metastatic tumor (0/1). B. Lymph node, level #6, biopsy: Single lymph node negative for. metastatic tumor (0/1). C. Lymph node, level #4, biopsy: Single lymph node negative for. metastatic tumor (0/1). D. Lymph node, level #9, biopsy: Single lymph node negative for. metastatic tumor (0/1). G. Lymph node, level #11, biopsy: Single lymph node negative for. metastatic tumor (0/1). H. Lymph node, level #7, biopsy: Single lymph node negative for. metastatic tumor (0/1). I. Lymph node, level #4, biopsy: Single lymph node negative for. metastatic tumor (0/1). J. Lymph node, level #10, biopsy: Single lymph node negative for. metastatic tumor (0/1). Microscopic Description: A-J. Microscopic examination performed and summarized in the template. below: Histologic type: Invasive squamous carcinoma. Histologic grade: Poorly differentiated. Primary tumor (pT) : 5.6 cm in greatest dimension (pT2b). Margins of resection: Final bronchial margin in specimen F. negative. for tumor. Bronchial margins negative for tumor. Direct extension of tumor: Tumor involves the main bronchus of the left. upper lobe and invades pulmonary parenchyma. No extension into the. pleura is identified. Venous (large vessel) invasion: Negative. Arterial (large vessel) invasion: Negative. Lymphatic (small vessel) invasion: Negative. Regional lymph nodes (pN) : All examined lymph nodes are negative for. malignancy. Prominent anthracosis is present. (pNO). Distant metastasis (pM) : Not evaluated (pMX). Other findings: Mild emphysematous change is present. Areas of. anthracosis are present. Some bronchiectasis and some nonspecific. focal interstitial fibrosis is noted away from the main tumor in the. left upper lobe. The left lower lobe is notable for marked hemorrhage. within the alveoli and prominent atelectasis. Anthracosis and. hemosiderin laden macrophages are also prominent. No malignancy is. identified in the left lower lobe. Specimen. A. Level #5 lymph node, biopsy. B. Level #6 lymph node, biopsy. C. Level #4 lymph node, biopsy. D. Level #9 lymph nodes, biopsy: E. Lung, left upper lobe, lobectomy. F. Bronchial margin. G. Level #11 lymph node, biopsy. H. Level #7 node. I. Level #4 node. J. Level #10 node. K. Completion left pneumonectomy. Clinical Information. Lung cancer. Intraoperative Consultation. E. Lung left upper lobe, excision: Non-small cell carcinoma. consistent. with squamous cell carcinoma on frozen section. F. Bronchial margin: Negative for malignancy. Gross Description. A. Received fresh and subsequently fixed in formalin labeled ""level #5. node ""is a 1.0 x 0.6 x 0.5 cm gray-tar irregular soft nodular tissue. fragment which is bisected and entirely submitted in one cassette. AS1. B. Received fresh and subsequently fixed in formalin labeled ""level #6. node ""is a 1.3 x 1.2 x 0.8 cm gray-tan nodular tissue fragment. The. specimen is trisected and entirely submitted in one cassette. AS1. C. Received fresh and subsequently fixed in formalin labeled ""level #4. node ""is a 0.3 x 0.2 x 0.2 cm gray-tan irregular nodular tissue. fragment which is entirely submitted in one cassette. AS1. D. Received fresh and subsequently fixed in formalin labeled ""level #9. node ""is a 0.3 x 0.3 x 0.3 cm black red irregular soft tissue fragment. AS1. E. Received fresh and subsequently fixed in formalin labeled ""left. upper lobe of lung ""is a 26.0 x 16.0 x 6.0 cm lobe of lung. The. specimen is partially covered with a pink-tan smooth glistening pleura. showing diffuse black stippling. The specimen shows a firm mass near. the hilar surface. No discrete pleura umbilication is grossly. identified however the mass can be palpated. The specimen is sectioned. to show a large white tan ill circumscribed lesion which is 5.6 x 5.5. x. 4.3 cm. It does not appear to grossly involve the pleura surface and. comes within 0.2 cm of the bronchial margin. Tumor is grossly present. within the bronchus. No discrete hilar nodes are grossly identified. The remainder of the cut surface of the specimen is pink red and spongy. with diffuse black stippling present. Representative sections of the. specimen are submitted as follows: 1 - bronchial and vascular margins,. 2 - tumor to pleura, 3 - tumor in bronchus, 4 - possible hilar nodes. bisected, 5 - tumor to normal, 6 - additional tumor to normal, 7. representative normal. RS 7. F. Received fresh for frozen section labeled ""F. bronchial margin"" is. a 4 X 0.6 x 0.6 cm piece of stapled tan rubbery cartilaginous tissue. The staples are removed and the specimen is frozen as frozen section. FFS 1. G. Received rresh and subsequently fixed in formalin labeled ""level #11. node ""is a 0.6 x 0.5 x 0.3 cm black red irregular soft tissue fragment. which is bisected and entirely submitted in one cassette. AS1. H. Received fresh and subsequently fixed in formalin labeled ""level #7. node ""is a 2.2 X 1.5 x 0.5 cm gray-tan irregular nodular tissue. fragment is bisected and entirely submitted in 2 cassettes. I. Received fresh and subsequently fixed in formalin labeled ""level #4. node ""is a 1.0 x 0.6 x 0.5 cm gray-tan irregular soft tissue fragment. which is bisected and entirely submitted in one cassette. AS1. J. Received fresh and subsequently fixed in formalin labeled ""labeled. ""level #10 node ""is a 1.2 x 0.6 x 0.5 cm gray-tan irregular nodule. which is bisected and entirely submitted in one cassette. AS1. K. Received fresh and subsequently fixed in formalin labeled. ""completion left pneumonectomy ""is a 20.5 x 8.5 x 3.5 cm lobe of lung. with an extended portion of bronchus measuring 5 cm in length. The. pleura is violaceous smooth glistening with diffuse black stippling. present. The specimen is palpated to identify no discrete gross. lesions. The specimen is sectioned to show pink red spongy cut surface. with no other discrete gross lesions identified. No discrete hilar. lymph nodes are grossly identified. Representative sections of the. specimen are submitted as follows: 1 - representative normal, 2 -. bronchial margin, vascular margins with possible lymph node. 4 - 5 -. additional representative sections of the specimen.",T2,N0,M0,T2N0M0
TCGA-2G-AAFY,Summary pathology report. Left orchidectomy; nonseminoma (EC 100%); diameter 2.5 cm; tumor confined to testis; angio-. invasion present; no invasion of rete testis. = date of orchidectomy). pathologist.,T2,N1,M0,T2N1M0
TCGA-2J-AABT,"Surgery date: REVISED REPORT (Addendum/Procedure included). DIAGNOSIS: A. Lymph node, hepatic artery, biopsy: A single (1) lymph node is. negative for tumor. B. Common hepatic duct, margin, excision: Negative for tumor. C. Pancreatic neck, margin, excision: Negative for tumor. D. Head of pancreas, duodenum, common bile duct, portion jejunum,. stent, whipple resection: Invasive moderately differentiated ductal. adenocarcinoma is identified forming a solid 4.5 x 4.0 X 2.6 cm. mass, situated predominantly within the pancreas. The tumor extends. beyond pancreas to involve peripancreatic soft tissue, ampulla of. Vater, and the duodenal wall. Tumor necrosis is absent. All. surgical resection margins, including the uncinate, pancreatic neck,. bile duct, and soft tissue margins, are negative for tumor (minimum. tumor-free margin, 0.1 cm, portal vein groove). The adjacent. non-neoplastic pancreatic parenchyma shows chronic pancreatitis. A. single (1 of 20) regional lymph node is positive for metastatic. ductal adenocarcinoma. AJCC stage (with available surgical material): pT3N1 (7th edition). This final pathology report is based on the gross/macroscopic. examination and the frozen section histologic evaluation of the. specimen(s). A revised report will be issued to document the final. interpretation after review of the Hematoxylin and Eosin (H&E). permanent sections. Interpreted by: ADDENDUM: Frozen section interpretation has been confirmed by Hematoxylin and. Eosin (H&E) permanent section review. GROSS DESCRIPTION: A. Received fresh labeled ""hepatic artery lymph node"" is a 3.9 x 1.7. X 0.7 cm lymph node. Lymph node submitted. Grossed by. B. Received fresh labeled ""common hepatic duct margin"" is a 1.6. x. 1.4 x 0.7 cm portion of tan-red tubular tissue with orientation. All submitted. Grossed by. C. Received fresh labeled ""pancreatic neck margin"" is a 3.2 X 1.3 x. 0.9 cm portion of pancreatic tissue with orientation. All. submitted. Grossed by. D. Received fresh labeled ""head pancreas, duodenum, common bile. duct, portion of jejunum, stent"" is a Whipple specimen consisting of. 29.5 cm in length portion of duodenum, 5.4 x 4.4 x 3.0 cm portion of. pancreas. The pancreatic uncinate margin is inked yellow and. shaved, the portal vein groove is inked black and submitted. perpendicularly. There is a 4.5 x 4.0 x 2.6 cm diffusely. infiltrative mass within the pancreas, 0.1 cm from the portal vein. groove margin. The mass extends and ulcerates (1.5 x 0.9 cm) the. duodenal mucosa. The ulcer is 3.4 cm from the proximal margin. The. mass extends to but does not involve the common bile duct. A stent. is present within the common bile duct. Peripancreatic lymph nodes. and periduodenal lymph nodes are identified. Representative. sections are submitted. Grossed by. BLOCK SUMMARY: Part A: Hepatic artery lymph node. 1 Hepatic artery LN 1of2(A1). 2 Hepatic artery LN2of2(A1). Part B: Common hepatic duct margin. 1 Com hepatic duct margin. Part C: Pancreatic neck margin. 1 Pancreatic neck margin 1. 2 Pancreatic neck margin 2. Part D: Head pancreas,duodenum,common bile duct,portion. jejunum,sten. 1 Uncinate margin 1. 2 Uncinate margin 1. 3 Uncinate margin 2. 4 Uncinate margin 2. 5 Portal vein groove margin. 6 Ampulla. 7 Bile duct with tumor. 8 Pancreas with panc duct. 9 Duodenum with mass. 10 Mass with peripanc ST. 11 Pancreas mass 1. 12 Pancreas mass 2. 13 Peripancreatic LN 5(D1). 14 Peripancreatic LN1of2(D2). 15 Peripancreatic LN2of2(D2). 16 Peripancreatic LN 1(D3). 17 Peripancreatic LN 5(D4). 18 Peripancreatic LN 2(D5). 19 Peripancreatic LN 1(D6). 20 Peripancreatic LN2(D7). 21 Peripancreatic LN2(D8).",T3,N1,M0,T3N1M0
TCGA-66-2777,"Material examined: Middle lobe. Clinical diagnosis and question. Space-occupying lesion S4 right, squamous cell carcinoma with S4 bronchial obstruction; status post GIST rectum and. urothelial carcinoma. 6). REPORT ON FINDINGS. Macroscopy. 1.) Middle lobe: inflated, fixed lobe of lung measuring 12 x 11 x 3.3 cm, central bronchus resection plane. located 0.4 cm proximal to the bifurcation into the segmental bronchi and closed by a 6 cm long staple suture. line running horizontally in a ventrodorsal direction. Similarly a 5 cm long staple suture line runs cranially to. the hilus. At the hilus two partly lesioned blackish nodes, 1.3 and 0,4 cm in size. Pleura of partly turbid and. cloudy appearance, irregular patches of blackish pigment with partially bloody coating or hemorrhagic patches. over S4. Pleura over S4 shows slight central protrusion in an area of about 1 cm, central retraction and cranially. a flat protrusion in an area of about 3 cm. Under this is a relatively firm, predominantly whitish, centrally. grayish vitreous tumor, max. 3.2 cm in size, with partly blackish pigmentation, an arcuate demarcation,. extending close to the visceral pleura with endobronchial growth in and obstruction of a subsegmental branch of. B4; distance of endobronchial tumor growth from the bronchus resection plane about 0.9 cm. Tumor extending. close to the staple suture line first described and separated from this by whitish hardened tissue. Other airways. and rest of parenchyma inconspicuous, only vessels prominent and relatively dilated. Also in S5 a peripheral,. subpleural compact area, max. 2 cm in size, section surfaces pale brownish, max. thickness 0.2 cm. 2.) Interlobar LN (station 11) right: 1 cm lesioned node or node part. 3.) Hilar LN (station 10) right: two lesioned nodes or node parts with some surrounding tissue, 0.6 and 0.2 cm. 4.) Subcarinal LN (station 7): 1.5 cm lesioned node or node part some surrounding tissue. Examined: 1.) 1 section of tumor with immediately adjacent visceral pleura, 1 section of tumor with whitish area to first-. named staple suture line (staple suture line marked green), 1 section of tumor with endobronchial tumor growth,. described area in S5 peripheral (3 sections), bronchial and vascular resection margins (tangential) and also hilar. nodes,. 2.) - 4.) All material,. 8 blocks, partly Elastica-van Gieson, PAS, diastase-PAS. Microscopy. Description of histological and cytological findings omitted for capacity reasons. EVALUATION. Primary diagnosis/diagnoses: Peripheral bronchopulmonary, large-cell and polymorphocellular, slightly keratinizing squamous cell carcinoma. of middle lobe of lung (right). TNM classification according to this picture pT2 pNO R0, stage IB. C 34,2; M. 8070/3. Secondary diagnosis/diagnoses: Tumor-associated chronic inflammation and peripheral bronchitis. In part highly vascularized fibrosis of the. visceral pleura covering the tumor with follicular chronic pleuritis. Perifocal cluster of alveolar pigmented. macrophages. Slight emphysematous stromal remodeling and flat subpleural fibrous cicatricial zone of lung. parenchyma. Slight to moderate anthracotic pigment deposits of lymph nodes with reactive macrophage cluster. Remark/addendum: The carcinoma lies in the subpleural region of S4, invasion of the pleura is not found in the samples examined. Centrally there is a connection between the tumor and the bronchial system, one intermediate branch of B4. being largely destroyed and obstructed by the tumor.",T2,N0,M0,T2N0M0
TCGA-A2-A0CW,"Specimen #: F Race: WHITE. Physician( (s) : 3. SPECIMEN: A: SENTINEL LYMPH NODE #1 B: NON-SENTINEL - LYMPH NODE. C: RIGHT BREAST LUMPECTOMY. FINAL DIAGNOSIS: A. LYMPH NODE, SENTINEL, EXCISION: ONE (1) SENTINEL LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA WITH. THE LARGEST FOCUS MEASURING 0.4 CM. - TUMOR IDENTIFIED IN THE PERINODAL SOFT TISSUE. B. LYMPH NODE, NON-SENTINEL, EXCISION: ONE (1) LYMPH NODE COMPLETELY REPLACED BY METASTATIC CARCINOMA. MEASURING 1.5 CM. EXTRANODAL EXTENSION CANNOT BE ASSESSED DUE TO LACK OF PERINODAL. SOFT TISSUE. C. BREAST. RIGHT, LUMPECTOMY: - INFILTRATING DUCTAL CARCINOMA, POORLY DIFFERENTIATED. - -NOTTINGHAM SCORE: 9/9 (TUBULES=3, NUCLEI=3, MITOSES=3). - TUMOR SIZE: 2.7 CM (MEASURED GROSSLY). - TUMOR NECROSIS: ABSENT. - MICROCALIFICATIONS: ABSENT. - VENOUS / LYMPHATIC INVASION: PRESENT. - INVASIVE TUMOR INVOLVES THE SMOOTH MUSCLE OF THE NIPPLE. - MARGINS: NEGATIVE. - DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.6 CM,. FROM NEAREST (SUPERIOR) MARGIN. - INTRADUCTAL COMPONENT DUCTAL CARCINOMA IN SITU, SOLID TYPE,. NUCLEAR GRADE II, WITH NECROSIS (<5% OF TUMOR). - ESTROGEN RECEPTORS, PROGESTERONE RECEPTORS, AND HER 2 NEU. PERFORMED ON PREVIOUS SPECIMEN (SEE COMMENT). - PATHOLOGIC STAGE: pT2 N1a MX. - ADDITIONAL PATHOLOGIC CHANGES: PRIOR BIOPSY SITE CHANGES. COMMENT: E. Hormone receptors performed on previous biopsy. and are as. follows: - Estrogen Receptor: Positive (approximately 100% nuclear staining). - Progesterone Receptor: Positive (25% nuclear staining). - ER-2-NEU - Postive (3+, strongly positive). Specimen #: FINAL DIAGNOSIS (continued) : CLINICAL DIAGNOSIS AND HISTORY: year old female with right breast invasive cancer. PRE-OPERATIVE DIAGNOSIS: Right breast invasive cancer. POST-OPERATIVE DIAGNOSIS: Right breast invasive cancer. GROSS DESCRIPTION. A. Received fresh labeled with patient's name. designated ""SENTINEL LYMPH NODE"" is a 1.5 x 0.5 x 0.3 cm lymph node with. attached fibrous fatty tissue. Specimen is bisected and entirely submitted. in cassette one. B. Received fresh labeled with patient's name. designated 'NON-SENTINEL LYMPH NODE"" are two irregular portions of. presumed previously intact lymph node each measuring 1.5 x 1.5 x 0. 1 cm. Sectioning reveals uniform tan and whtie cut surface. Specimen entirely. submitted in three cassettes as follows. B1-B2: first portion of node (match of B1 submitted in OCT for CBCP. protocol). B3: remaining portion of lymph node. C. Received fresh labeled with patient's name. designated ""RIGHT BREAST LUMPECTOMY"" consists of an irregular portion of. fibrofatty tissue oriented with single stitch medial and two stitches. superior. The specimen measures 10 cm medial to lateral, 7 cm anterior to. posterior and 3 cm superior to inferior. Superficial surface displays an 8. x 4 cm lightly pigmented skin ellipse with centrally located fimr inverted. nipple. No discharge or scar is identified. Specimen is inked as follows : superior blue, inferior green, medial red, lateral yellow, posterior. black. Serial sections reveal well defined 2.7 x 2.7 x 2.2 cm firm pink. white gritty mass subadjacent to and involving the nipple. Surrounding. breast tissue is fibrofatty and otherwise unremarkable. Cassette key. Specimen # : GROSS DESCRIPTION (continued). C1: mass. C2: normal fibrous 1 cm away. C3: normal skin. C4: : nipple with mass. C5-C10: representative sections of presumed mass with close proximity to. margin. C11: medial margin. C12: lateral margin. 12CM.",T2,N1,M0,T2N1M0
TCGA-B8-5545,"Diagnosis: Histologic tumor type/subtype: 3 separate tumors of renal cell carcinoma, clear cell type, all of the tumors are at least partially cystic. Sarcomatoid features: None identified. Histologic grade (if applicable): Fuhrman grade 2. Tumor size (greatest dimension): 4.0 cm, largest tumor. Tumor focality: Multifocal. Extent of tumor invasion (if present specify if macroscopic or microscopic): Capsular invasion/perirenal adipose tissue: Not involved. Gerota's fascia: Not involved. Renal sinus: Not involved. Major veins (renal vein or segmental breeches, IVC): Not involved. Ureter: Not involved. Venous (large vessel): Not involved. Lymphatic (small vessel): Not involved. Histologic assessment of surgical margins: Gerota's fascia (nephrectomy): Negative. Renal vein (nephrectomy): Negative. Ureter (nephrectomy): Negative. Adrenal gland: Not present in specimen. Lymph node: None present in specimen. Other significant findings: Moderate to severe arterionephrosclerosis. AJCC Staging: pTla. pNx. This staging information is based on information available at the time of this report, and is subject to change pending clinical review and. additional information. Clinical History: left renal mass. Gross Description: Specimen fixation: Formalin. Type of specimen: Laparoscopic nephrectomy. Side of specimen: Left. Size and weight of specimen: 360 grams, 13.5 x 8.7 x 5.2 cm nephrectomy, kidney size 11.4x5.7x 5.7 cm. Orientation: Perinephric soft tissue blue. Presence/absence of adrenal gland: Absent. Tumor description/site: Within the inferior pole of the cortex/medulla is a well-circumscribed variegated hemorrhagic and cystic. mass. Tumor size: 4.0 X 3.3 X 3.3 cm. Presence/absence of multicentricity: Absent. Confinement/non-confinement to the kidney: Confined, bulges the capsule but does not extend through it and is 1.0 cm to the perinephric. adipose tissue margin. Extent of invasion: Perirenal adipose tissue: Does not involve. Gerota's fascia: Does not involve. Renal vein: Does not involve. Ureter: Does not involve. Other organs: Does not involve. Surgical margins: Perirenal adipose tissue: Negative, 1.0 cm from perirenal adipose tissue margin. Renal vein: Negative. Renal artery: Negative. Ureter: Negative. Description of kidney away from tumor: The remainder of the parenchyma is red/brown with a well-demarcated cortex medulla. Throughout. the cortex are six cysts ranging from 0.6 x 0.6 X 0.5 cm in greatest dimension up to 3.1 x 3.0 X 2.6 cm in greatest dimension. One of the. smaller cysts is simple and has an adherent orange material along the inner wall. This cyst is 2.6 cm from the inferior pole mass. The larger. cyst bulged the capsule, are multiloculated and have a wall thickness of 0.1 cm. The inner wall is white and smooth. The cysts. are filled with a scant amount of red/brown mucoid material. The renal pelvis and ureter are unremarkable. Lymph nodes (hilar): None. Other significant findings: None. Tissue submitted for special investigations: Normal kidney away from tumor and tumor given to tissue procurement foundation. Digital photograph taken: No. Block Summary: A1 - Ureter margin, renal artery margin and renal vein margin, en face. A2-A5 - Representative mass closest to the perinephric adipose tissue margin. A6 - Small simple cyst with orange discoloration along the inner wall. A7 - Representative largest cyst from superior pole. A8 Hilum. A9 - Renal pelvis with normal kidney away from tumor. Light Microscopy: Light microscopic examination is performed by.",T1,N0,M0,T1N0M0
TCGA-D8-A27P,"page 1 / 1. copy No. 5. Examination: Histopathological examination. Gender: F. Material: Multiple organ right breast. Expected time of examination: up to 8 working days. Clinical diagnosis: Cancer of the right breast. Macroscopic description: Right breast sized 17.2 x 13.2 x 4.4 cm removed without axillary tissues and with a skin flap of 14.4 x 7.2 cm. Weight. 345 g. Tumour sized 1.2 x 1.4 x 0.9 cm found on the boundary of upper quadrants, located 4.3 cm from the upper. boundary, 0.8 cm from the base and 1.6 cm from the skin. Microscopic description: Carcinoma ductale invasivum - NHG1 (1 + 2 + 1 : 0 mitoses/10 HPF - visual area: 0.55mm). Numerous foci of carcinoma ductale in situ DCIS found within the tumour (micropapillary type with medium nuclear. atypia and comedo necrosis, 70% of the tumour volume). Mamilla sine laesionibus. Glandular tissue showing parenchymal atrophy. Examination result: Carcinoma ductale invasivum mammae dextrae. Invasive ductal carcinoma of the right breast. (NHG1, pTic, pNO (SN)). Examination performed G. Results of immunohistochemical examination: Estrogen receptors found in 75% of neoplastic cell nuclei. Progesterone receptors found in 10% of neoplastic cell nuclei. HER2 protein stained with Ventana's Pathway HER-2/neu (4B5) Rabbit Monoclonal Antibody. Negative reaction in invasive cancerous cells (Score=1+).",T1,N0,M0,T1N0M0
TCGA-A3-3380,"Result Name. Reference Range. Pre-Op Diagnosis. Renal mass. Post-Op Diagnosis. Same as above. Clinical History. Nothing indicated. Gross Description: Received in a single container labeled. - is. a. previously partially sectioned left nephrectomy specimen surrounded. b a moderate amount of partially stripped perinephric adipose tissue. The specimen as received weighs 570 grams and on reconstruction. measures approximately 19.4 x 12.9 x 5.8 cm. The margin of resection. include 2.5 cm of grossly patent renal artery, 1.0 cm grossly patent. renal vein and 9.0 cm of grossly patent ureter. The capsule strips. with ease to reveal an organ measuring on reconstruction 12.4 x 7.5. x. 5.0 cm. This has a lobular homogeneous red brown outer surface. Noted on the posterior aspect in the mid region of the specimen is a. 3.0 X 3.0 X 2. 8 cm well circumscribed tan yellow nodular lesion with. a slightly bulging focally hemorrhagic centrally hyalinized fleshy. tan yellow cut surface. This appears to be thinly encapsulated. This extends beyond the plane of the .cortical parenchyma but appears. grossly intact with a surrounding thin layer of attenuated cortical. parenchyma. The lesion appears to slightly compress the surrounding. parenchyma but does not grossly appear to extend beyond the lesional. capsule into this parenchyma. The remaining parenchyma shows a. i. cortex measuring up to 0.9 cm which is homogeneous and red brown. Noted in the cortex on the antral lateral aspect in the mid region of. the specimen 2 9. 9. am gyste structure with a slightly. trabeculated inner gray white inner lining. Within the cystic. structure is. spiky appearing brown. black. calculus. The cortical medullary junction is poorly defined. The medulla is tan brown with sharp papillae. The calices and pelvis. are lined by smooth tan white mucosa that extends into the ureter. Also received in the same container are twouthissue cassettes-eaoh-. Representative sections are submitted labeled as. follows: A - vascular and ureteral margins; B-E - representative. lesion and surrounding tissue; F-G - representative cystic structure;. H - random uninvolved parenchyma. NOTE: D. examined this case in the fresh state for tumor. harvesting. The tumor, at the time, was noted in the periphery of. the kidney and was clearly bulging above the plane of the kidney. surface, however, gross extension into perinephric tissue was not. appreciated. Microscopic Description: See diagnosis. Final Diagnosis. Left nephrectomy: Carcinoma. Histologic type renal carcinoma. Tumor site: Posterior aspect in mid region. Tumor size: 2, 8/2gm. Macroscopic extent of tumor Tumor limited to kidney. Nuclear grade: Fuhrman Grade 2/4. Lymphovascular space invasion: No. Transcapsular invasion: No. Renal vein invasion: No. Vena caval invasion: Not resected. Adrenal gland: Not resected. Surgical margin status: Soft tissue margins: Negative. Ureteral margin: Negative. Vascular margin: Negative. Lymph node status: Total number of lymph nodes examined: 0. Frozen section correlation statement: None. Other significant findings: None. PAS 9. Stage: pT1. CPT: 88309. Comments. This test has been finalized at the.",T1,N0,M0,T1N0M0
TCGA-DD-AACE,"CLINICAL DIAGNOSIS: HCC. Specimen : liver. Gross Photo : GROSS: 1. Specimen: Liver: 13.0 X 7.5 x 4.5 cm, 185.0 gm, unfixed. 2. Tumor location: segment 8. Tumor number: one. Tumor size: 4.0 X 3.0 X 3.8 cm. 3. Satellite nodule: no. 4. Gross type. HCC: expanding nodular. 5. Tumor necrosis: no. 6. Hemorrhage/peliosis: no. 7. Portal vein invasion: no. 8. Bile duct invasion: no. Gross photo present. Blocks. TB, T1-4, tumor mass X 5. RM, resection margin X 1. NB, A, non-tumorous liver parenchyme x 2. MICROSCOPIC: 1. Hepatocellular carcinoma: yes. -1. Differentiation. The worst differentiation III. The major differentiation II. 1-2. Histologic type: trabecular, pseudoglandular. 1-3. Cell type: hepatic. 1-4. Fatty change: no. 2. Fibrous capsule formation: complete capsule. 3. Capsular infiltration: no. 4. Septum formation: no. 5. Surgical resection margin invasion: no, margin of the clearence (1.0 cm). 6. Serosal invasion: no. 7. Portal vein invasion: no. 8. Bile duct invasion: no. 9. Hepatic vein invasion: no. 10. Hepatic artery invasion: no. 11. Microvessel invasion: no. 12. Intrahepatic metastasis: no. 13. Multicentric occurrence: no. Non-tumor liver pathology. 1. Chronic hepatitis: yes. 1-1. Etiology: HBV. 1-2. Grade, lobular: minimal. 1-3. Grade, portoperiportal: minimal. 1-4. Stage (fibrosis): cirrhosis. 1-5. Cirrhosis: micronodular. 2. Dysplastic nodule: no. 3. Ductal epithelial dysplasia: no. 4. Other liver diseases: no. SPECIAL STAIN: Trichrome (+ stage (3-4)). NOT reported. Gross: Tunica vaginalis, inguinal, ligation, Hernial sac. Stomach, angle, scopic, chronic gastritis, H. pylori, associated. Stomach, angle, scopic, ulcer. Liver, ectomy, hepatocellular carcinoma, cirrhosis. T56000, P10, M81703, M49500. DIAGNOSIS: Liver, segment 8, segmentectomy: Hepatocellular carcinoma, moderately differentiated. Cirrhosis, micronodular. Suggestion :",T1,N0,M0,T1N0M0
TCGA-DD-A1EB,"TISSUE DESCRIPTION. Right lobe liver (22 x 14.3 X 9.5 cm) and gallbladder (7.5 X 3.5. X 1.5 cm) and submitted en bloc (1,475 grams) . A1, A2, A3, A4, A5, A6, A7, A8, A9, A10, A11, A12,. A13, A14, A15, A16, A17, A18, A19,A20, A21, A22, A23, A24, A25,. A26, A27, A28, A29, A30, A31, A32, A33, A34. DIAGNOSIS: Liver, right lobe, hepatectomy: Grade 2 (of 4) hepatocellular. carcinoma forming a 12 X 11 X 8 cm mass. No vascular invasion. is identified. Surgical margins are free by 1 cm. Gallbladder, hepatectomy: Mild chronic cholecystitis. No. stones identified. TISSUE DESCRIPTION: Right lobe liver (22 x 14.3 x 9.5 cm) and gallbladder (7.5 x 3.5. X. 1.5 cm) and submitted en bloc (1,475 grams) . A1, A2, A3, A4, A5, A6, A7, A8, A9, A10, A11, A12,. A13, A14, A15, A16, A17, A18, A19,A20, A21, A22, A23, A24, A25,. A26, A27, A28, A29, A30, A31, A32, A33, A34. DIAGNOSIS: Liver, right lobe, hepatectomy: Grade 2 (of 4) hepatocellular. carcinoma forming a 12 x 11 x 8 cm mass. No vascular invasion. is identified. Surgical margins are free by 1 cm. Gallbladder, hepatectomy: Mild chronic cholecystitis. No. stones identified.",T1,N0,M0,T1N0M0
TCGA-50-5935,"FINAL DIAGNOSIS: The left upper division segmentectomy demonstrates a 3.0 cm moderately differentiated adenocarcinoma with papillary. differentiation arising in a scar. There is no evidence of visceral pleural or angiolymphatic invasion. All sampled lymph. nodes are benign. Surgical resection margins are free of tumor. Pathologic stage: T1N0Mx. PART 1: LUNG, LEFT UPPER LOBE, ENDOBRONCHIAL BIOPSY -. UNREMARKABLE RESPIRATORY MUCOSA. PART 2: LYMPH NODE, LEVEL 11, BIOPSY. SIX (6) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT. PART 3: LUNG, LEFT UPPER DIVISION, SEGMENTECTOMY -. A. INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA WITH PAPILLARY DIFFERENTIATION (3.0. CM IN DIAMETER) ARISING IN A SCAR. NO EVIDENCE OF VISCERAL PLEURAL OR ANGIOLYMPHATIC. INVASION. MILD LYMPHOCYTIC HOST RESPONSE. PATHOLOGIC STAGE: T1N0MX. B. SURGICAL RESECTION MARGINS ARE FREE OF TUMOR. C. BACKGROUND LUNG WITH EMPHYSEMATOUS CHANGE AND RESPIRATORY BRONCHIOLITIS. PART 4: LYMPH NODE, LEVEL 5, BIOPSY. ONE (1) LYMPH NODE WITH ANTHRACOTIC PIGMENT. ADDENDA: Addendum. Fluorescence in-situ hybridization studies performed on the adenocarcinoma shows a ratio of EGFR gene to the centromere of. chromosome 7 of 1.0 indicating no EGFR amplification in the targeted region. The rate of hyperploidy for the centromere of. chromosome 7 was 7.1% of the analyzed cells. The signal to nucleus ratio (SNR) for the EGFR gene was 1.6. Interpretation guidelines for EGFR Gene Copy Number by FISH: Ratio of EGFR to the centromere of chromosome 7: Less than 2.0: No EGFR amplification. Greater than 2.0: EGFR amplification. Hyperploidy: Greater than two centromere copies/cell. SNR: The average number of EGFR signals per analyzed cell within the targeted region. Clinical studies show high EGFR gene copy number by FISH analysis to be associated with favorable clinical benefit (clinical. response, stable disease, time to progression, and survival) in patients with advanced non-small cell lung cancer treated with. EGFR tyrosine kinase inhibitors. CASE SYNOPSIS: SYNOPTIC DATA - PRIMARY LUNG TUMORS. TUMOR LOCATION: Left Upper Lobe. LUNG SEGMENT(S) INVOLVED: Superior. PROCEDURE: Segmental. TUMOR SIZE: Maximum dimension: 3 cm. Minor dimension: 3 cm. GROSS SATELLITES: Number of gross satellite lesions: 0. TUMOR TYPE: Invasive adenocarcinoma. HISTOLOGIC GRADE: G2, Moderately differentiated. MICROSCOPIC SATELLITES: Number of microscopic satellite lesions: 0. EXTRAPULMONARY PARENCHYMAL. EXTENSION/INVASION OF TUMOR: None identified. ANGIOLYMPHATIC INVASION: TUMOR NECROSIS: < or = to 50%. SURGICAL MARGIN INVOLVEMENT: No. SURGICAL MARGIN SITE: Distance of invasive tumor to closest margin: 50 mm, Bronchial margin. INFLAMMATORY(DESMOPLASTIC) REACTION: Mild. N1 LYMPH NODES: Number of N1 lymph nodes positive: 0. Number of N1 lymph nodes examined: 6. N2 LYMPH NODES: Number of N2 lymph nodes positive: 0. Number of N2 lymph nodes examined: 1. EXTRACAPSULAR SPREAD OF N2 METASTASES: UNDERLYING DISEASE(S): Emphysema, Parenchymal scar, Smokers bronchiolitis. T STAGE, PATHOLOGIC: pT1. N STAGE, PATHOLOGIC: pNO. M STAGE, PATHOLOGIC: pMX. ANCILLARY STUDIES: Histochemical stains, FISH studies, Molecular studies. SPECIAL PROCEDURES: Microdissection Genotyping. Interpretation. Molecular Anatomic Pathology testing: A. KRAS Exon 1 mutation not identified. B. EGFR Exon 19 mutation IDENTIFIED (15 bp deletion). C. EGFR Exon 21 mutation not identified. Note: EGFR mutations are present in about 10% of. and up to 40% in the. population. EGFR mutations are not. thought to occur in high prevalence in other types of tumors (3,4,7). KRAS mutations are also found in approximately 30% lung. adenocarcinomas, but not in combination with EGFR mutations, which implies different pathogenic mechanisms (2,3). The. presence of these mutations may have prognostic and or therapeutic implications (1,5,6). Sample Preparation. For cytology samples, extraction of DNA was performed from the fluid or sample provided. For surgical specimens,. microdissection was performed to include neoplastic tissue and normal adjacent tissue. Optical density readings were obtained. Gene Sequencing. PCR was performed using primers that flank exon 1 in the KRAS gene and exon 19 and 21 of the EGFR gene. Analysis of the. PCR products was first performed for the EGFR 19 to detect aberrant length PCR product. A sequencing analysis, using the. BigDye Terminator Kit (Applied Biosystems, Inc.) was then performed. The known hotspots were analyzed for the presence of. mutations. Both forward and the reverse sequencing was performed.",T1,N0,M0,T1N0M0
TCGA-UD-AABZ,"Printed. Sex: M. Date of Service: CLINICAL HISTORY: ? Mesothelioma ? Mucinous adenocarcinoma ? Lymphoma. Normal. MACROSCOPIC: File. 1. Left chest wall: Nodular piece of solid grey-white tissue. measuring 25mm x 20mm x 10mm. Slightly shiny cut surface (FS, A-D,. Notes. Requirer. 1r). 2. Left lingula: A wedge shaped section of lung tissue measuring 60mm. Motified. x 20mm x 10mm. A staple margin is seen at one edge. The pleural. surface shows a diffuse firm area of white thickening measuring 60mm x. Patrent. 10mm. The cut surface shows the lung parenchyma to be replaced by firm. Will Ca!. white tissue. FROZEN SECTION REPORT: Make. Appointm. 1. INVASIVE MALIGNANCY. Provisional diagnosis mesothelioma vs. adenocarcinoma. Await paraffin and IPOX for definite diagnosis. Prescripti. MICROSCOPIC: On Corte. 1. Paraffin sections confirm an infiltrating malignant epithelioid. Treatmer. neoplasm- with luminal formation. There are ragged nests and. infiltrating glandular type structures present with some focal areas of. Check "". Doctor. necrosis lying within a fibroblastic stroma. Some areas show a. sheet-like - growth pattern and large nested areas of growth also seen. The tumour appears predominantly infiltrative however there is also. Normal. some surface atypical proliferation with papillary pattern also. File. present. Notes. 2. Sections show infiltrating malignant tumour with overall similar. Require. appearance to that described in specimen 1. The tumour involves the. pleural surface and has breached the visceral pleural and extends into. Patrent. Notifiet. the underlying pulmonary parenchyma. Growth is on a broad front. Focal surface overlying fibrin exudation seen. There is also extension. Pauen. in small vascular spaces along the septae. Focally there is a visceral. Will Ca. pleural atypical papillary proliferation of mesothelial cells. Special. Make. stains of infiltrating tumour show mucin stains are negative without. Appointit. definite intracytoplasmic neutral mucin positivity. Immunoperoxidase. stains show infiltrating tumour CALRETININ positive, TTF- 1 negative,. Cotlec. Prescript. CAM 5.2 positive, CK 7 positive, CK20 patchy weak to moderate. positivity, EMA positive with cytoplasmic and rim positivity, AE 1/3. On Corr. positive, PSA negative, CD15 negative, CEA negative, CK5/6 patchy. Trezime. moderate positivity. Check "". Docto. M. Printed. M. Sex: M. - 3 -. Normal. File. CONCLUSION: 1. & 2. Left chest wall - and left lingula: MALIGNANT MESOTHELIOMA. Required. (nodular and diffuse growth pattern). Noilfied. Will Cart. Make. Appointment. Prescription. On Correct. Treatment. Check with. Docior. M.",T2,N0,M0,T2N0M0
TCGA-SO-A8JP,"Normal Blood ID: SPECIMEN(S): Left testicle. FINAL DIAGNOSIS: Testicle, left, radical orchiectomy: - Histologic type: Seminoma, classical, pure. - Intratubular germ cell neoplasia: Present. - Extent of invasion: 1. Invasion or penetration of tunica albuginea: Absent. 2. Invasion of tunica vaginalis: Absent. 3. Involvement of paratesticular structures (epididymis or. cord): Absent. 4. Angiolymphatic invasion: Absent. - Resection margins (including spermatic cord): All margins. negative. - Lymph nodes: Not included in specimen. COMMENT: Sections of the tumor show a classical seminoma; it does not extend. through the tunica albuginea. The adjacent testicular tissue shows. intratubular germ cell neoplasia, hypospermatogenesis and maturation. arrest. There is no evidence of vascular invasion. CLINICAL HISTORY: The patient is a. -year-old male with left testicle mass. GROSS: One formalin-filled container is received labeled with the patient's. name, medical record number. The container is labeled ""left testicle."" The specimen consists of a. 5.8 X 4.9 x 3.4 cm, 64.0 gm left orchiectomy specimen with attached 10.0. cm in length and 1.2 cm in diameter segment of spermatic cord. The. resection margins are inked. Serial sectioning along the long axis of. the testicle demonstrates a 4.4 X 4.3 X 3.2 cm mixed pink-tan and dark. red circumscribed tumor with focal areas of hemorrhage. The tumor is. 11.0 cm from the closest spermatic cord resection margin, 0.2 cm from. the tunica vaginalis margin and 0.4 cm from the epididymis. The tumor. occupies 70% of total testicle volume. Representative tissue was. procured for potential future studies. Representative sections are. submitted in twelve cassettes. Summary of sections: 1 - distal spermatic cord resection margin. 2 - closest tunica vaginalis margin. 3 - epididymis. 4 - intersection between the proximal spermatic cord and tumor. 5 through 10 - tumor. 11 - normal testicle parenchyma. 12 - representative section of spermatic cord at middle and distal. segment. MICROSCOPIC: Microscopic evaluation is performed.",T1,N0,M0,T1N0M0
TCGA-21-1081,"Clinical History/Diagnosis: Not entered. Source of Specimen(s): A: R2 LYMPH NODE. B: R4 LYMPH NODE. C: R4 LYMPH NODE. D: LEVEL 7 LYMPH NODE. E: CYTOLOGY. F: PORTION OF 6TH RIB. G: LLL LUNG. H: LEVEL 5 LN. Gross Description: GROSS DESCRIPTION: Received fresh is a 1.0cm in greatest dimension gray- black. anthracotic stained lymph node. It is submitted in toto in one block. DESIGNATION OF SECTIONS: 8. SUMMARY OF SECTIONS: Undesignated - 1. SOURCE OF TISSUE: 9 - SENT TO CYTOLOGY. Final Diagnosis: DIAGNOSIS: 1. LYMPH NODES, R2, BIOPSY: - TWO LYMPH NODES NEGATIVE FOR TUMOR (0/2). 2. LYMPH NODE, R4, BIOPSY: - ONE LYMPH NODE NEGATIVE FOR TUMOR (0/1). 3. LYMPH NODES, R4, BIOPSY: - TWO LYMPH NODES BOTH NEGATIVE FOR TUMOR (0/1). 4. LYMPH NODES, LEVEL 7, BIOPSY: - TWO LYMPH NODES BOTH NEGATIVE FOR TUMOR (0/2). 5. CYTOLOGY. 6. PORTION OF 6TH RIB, EXCISION: - NO TUMOR SEEN. 7. LUNG, LEFT LOWER LOBE, LOBECTOMY: - POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA (8.5 CM.) WITH. INVASION OF. PLEURA. - LYMPHATIC INVASION PRESENT. METASTATIC CARCINOMA IN ONE OF TWO HILAR LYMPH NODES (1/2). - NEGATIVE BRONCHIAL AND VASCULAR MARGINS. - NON-NEOPLASTIC LUNG SHOWS ACUTE BRONCHOPNEUMONIA. 8. LYMPH NODE, LEVEL 5, BIOPSY: - CALCIFIED GRANULOMA, NO TUMOR SEEN IN ONE LYMPH NODE (0/1). SYNOPTIC REPORT FOR LUNG CANCER. A NEOPLASM IS PRESENT. LOCATION OF THE TUMOR IS LEFT LOWER LOBE. THE HISTOLOGIC CLASSIFICATION OF THE TUMOR IS SQUAMOUS CELL. 9EPIDERMOID). CARCINOMA, NON-KERATINIZING TYPE. THE GRADE OF THE TUMOR IS POORLY DIFFERENTIATED (GRADE III). THE MAXIMUM DIMENSION OF THE TUMOR IS 8.5 CM. LYMPHATIC INVASION BY TUMOR IS PRESENT. VENOUS INVASION BY TUMOR IS ABSENT. ARTERIAL INVASION BY TUMOR IS ABSENT. INVASION THROUGH THE PLEURA BY TUMOR IS PRESENT. TUMOR NECROSIS IS MODERATE. THE NON-NEOPLASTIC LUNG TISSUE SHOWS ACUTE BRONCHOPNEUMONIA. LYMPH NODES DEMONSTRATE NO EXTRACAPSULAR EXTENSION OF TUMOR. THE TOTAL NUMBER OF NODES EXAMINED IS: 9. THE TOTAL NUMBER OF POSITIVE NODES IS: 1 (HILAR LYMPH NODES). STAGING DATA. T2. N-1.",T2,N1,M0,T2N1M0
TCGA-67-3772,"I 22. TISSUES: A. LYMPH NODE. B. LYMPH NODE. C. LUNG-RIGHT UPPER LOBE. D. LYMPH NODE. CODES: P88305 - 88305. p88309 - 88309. P88331 - 88331. D50175 - RESECTION. D50177 - REGIONAL LYMPH. 88305TC - LEVEL IV - GROS. 88309TC - LEVEL VI - GROS. 88331TC - PATHOLOGY CONSU. 88342TC - IMMUNOPEROXIDAS. 1 - SURGICAL SPECIM. T08000 - LYMPH NODE. T28200 - RT UP LOBE LUNG. T282001M81403 - RT UP LOBE LUNG ADENOCARCINOMA,. ICD CODES: 162.9 - MAL NEO BRONCH/LUNG NOS. MARKERS: 88305, 88305TC, 88309, 88309TC, 88331, PATH CONSULT FS, IMMUNOPEROXIDASE, RES, RLN,. CHICATON SDRCIMEN. CLINICAL HISTORY. PERTINENT CLINICAL HISTORY: RT LUNG CA. FINAL DIAGNOSIS. A. RIGHT DIAPHRAGMATIC NODULE, BIOPSY: FIBROADIPOSE TISSUE WITH MESOTHELIAL PROLIFERATION AND CHRONIC. INFLAMMATION. NO MALIGNANCY IS IDENTIFIED. B. LYMPH NODE, RIGHT SUPERIOR HILAR 10R: THREE LYMPH NODES, NEGATIVE FOR TUMOR. C. LUNG, RIGHT UPPER LOBE, LOBECTOMY: MODERATELY DIFFERENTIATED ADENOCARCINOMA WITH FOCAL PAPILLARY. FEATURES, SEE SYNOPTIC REPORT. D. LUNG, RIGHT UPPER NODE: MATTED LYMPH NODE, NEGATIVE FOR TUMOR. E. LYMPH NODE, RIGHT POSTERIOR SUPERIOR HILAR: LYMPH NODE, NEGATIVE FOR TUMOR. GROSS DESCRIPTION. A. The specimen is submitted fresh for frozen section as ""right. diaphramatic nodule"" and consists of five tan tissue fragments ranging. from 0.2 to 0.3 cm in dimension; submitted 5 (1) labeled ""FSP"" for frozen. section. FROZEN SECTION DIAGNOSIS: Focal cluster of atypical cells of uncertain. nature; ? mesothelial cells, dissimilar to. primary lung adenoca in recent aspiration. B. The specimen is submitted fresh for frozen section as ""right superior. hilar node 10R"" and consists of three red black nodes ranging from 0. to. 1.1 cm in dimension. Each is sectioned and the specimen submitted in. toto, 5 (1) labeled ""FSP"" for frozen section. FROZEN SECTION DIAGNOSIS: Negative for tumor. C. The specimen is submitted fresh as ""right upper lobe"" and consists of. a 131 gram (416), 16 x 7 x 3 cm lung lobe. The pleural surface shows a. 2.2 x 2 cm firm puckered indurated area. The pleural surface overlying. this area is inked blue. The pleural surface also shows four ill-defined. tan white firm subpleural nodules measuring 0. to 0.4 cm with the closest. located 6.5 cm from the puckered area. The specimen is received with. multiple stapled margins measuring 3.5 to 7 cm in length along with a. stapled bronchial margin measuring 2.5 cm in diameter and several adjacent. stapled vascular margins measuring 0.2 cm in length x 0.5 cm in diameter. to 0.5 cm in length x 1 cm in diameter. The stapled margins are removed. and the underlying parenchyma inked black. Sectioning reveals a 4.3 x 3 x. 2.2 cm well circumscribed tan yellow to white firm, focally hemorrhagic. mass corresponding to the previous described puckered and indurated area. on the pleural surface grossly appearing to abut the pleural surface. measuring 0. cm from the closest black inked parenchyma underlying the. stapled resection margin and 3 cm from the bronchial margin. The. remaining parenchyma is red to maroon, spongy, homogenous and grossly. unremarkable. No other discrete masses or nodularities are grossly. evident. Also identified at the hilum is a 1 cm in greatest dimension. gray black possible hilar lymph node which is trisected and submitted. entirely. Representative sections are submitted, multiple (7) as follows: Cassette 1: Vasculature and bronchial margins submitted en face. Cassette 2: Subpleural nodules submitted entirely. Cassette 3: Mass with closest pleural surface. Cassette 4: Perpendicular section of mass to the closest stapled. resection margin. GROSS DESCRIPTION. Cassette 5: Additional section of mass with adjacent uninvolved. parenchyma. Cassette 6: Uninvolved parenchyma. Cassette 7: One possible hilar lymph node, trisected. D. The specimen is submitted fresh as ""right upper node"" and consists of. a cluster of multiple gray black to deep red nodules ranging from 0.3 to. 0.7 cm in dimension, the individual nodes separated and the specimen. submitted in toto, multiple (1) -. E. The specimen is submitted fresh as ""right posterior superior hilar. node"" and consists of a single deep red 1. 1 cm nodule, bisected and. submitted in toto, 2 (1). PRIORITY. PRIORITY: FROZEN SEC. SURGICAL PROCEDURES: RESECTION, REGIONAL LYMPH. SYNOPTIC REPORT. SYNOPTIC REPORT: LUNG. (CAP/AJCC/ACS - REQUIRED ELEMENTS). SPECIMEN TYPE: LOBECTOMY. LATERALITY: RIGHT. TUMOR SITE: RIGHT UPPER LOBE. TUMOR SIZE: 4.3 CM. HISTOLOGIC TYPE: ADENOCARCINOMA WITH FOCAL PAPILLARY FEATURES. HISTOLOGIC GRADE: 2 (MODERATELY DIFFERENTIATED). EXTENT OF INVASION: TUMOR INVADES VISCERAL PLEURA. EXTENTION TO PLEURA/OTHER STRUCTURES: NONE IDENTIFIED. MARGINS: BRONCHIAL: UNINVOLVED. PARENCHYMAL: UNINVOLVED. VASCULAR: UNINVOLVED. SYNOPTIC REPORT. DISTANCE TO PERTINENT MARGIN: 3 CM FROM THE BRONCHIAL MARGIN. VENOUS INVASION: ABSENT. ARTERIAL (LARGE VESSEL) INVASION: ABSENT. LYMPH NODE: N1 - # INVOLVED/# EXAMINED: 0/6. N2 - # INVOLVED/#EXAMINED: 0/8. N3 - # INVOLVED/# EXAMINED: 0/0. OTHER PERTINENT FINDINGS: INCIDENTAL PULMONARY MENINOGOTHELIAL-LIKI NODULES/CHEMODECTOMAS (0.3-. 0.4 CM) THESE ARE PR+, CD56+ AND CHROMOGRANIN-. pTNM STAGE: pT2 NO (AJCC 6TH ADDITION). Unless otherwise specified, the performance characteristics of the. immunoperoxidase stains performed here have been confirmed by the St. These tests have not been cleared or. approved by the U.S. Food and Drug Administration, although such approval. is not necessary. Preli. IMMUNOPEROXIDAS. CLINICAL HISTORY. HISTORY: RUL CAVITARY MASS (2 CM) PICKED UP AS AN INCIDENTAL FINDING ON CT SCAN. RENAL MASS - CRYO ABLATION. X-RAY FINDINGS: 2 CM RUL LUNG MASS. GROSS DESCRIPTION. Slide 40 CC Fluid. X Fresh. Fixed. Type Fix. Volume may reflect total of specimen, fixative, and/or collection fluid. APPEARANCE: X Clear. Cloudy. Foamy. Bloody. Clotted. Tissue. Color COLORLESS. PREP : 6 Smear (s). Diff Quick (s). Filter(s). 1 Cell Block (s). Cytospin (s) - 2 Singles (s). Double (s). H&E. Unstained. Comment: FINAL DIAGNOSIS. LUNG, RIGHT UPPER LOBE, NEEDLE ASPIRATION BIOPSY: POSITIVE FOR MALIGNANT CELLS. - ADENOCARCINOMA CONSISTENT WITH LUNG PRIMARY. COMMENT: THE TUMOR SHOWS GLAND FORMATION AND APPEARS MODERATELY. DIFFERENTIATED. A TTF-1 STAIN IS POSITIVE. THE TUMOR MORPHOLOGY IS DISSIMILAR TO THE TUMOR IN THE KIDNEY. SURGICAL PROCEDURES : REGIONAL LYMPH. CLINICAL HISTORY. PERTINENT CLINICAL HISTORY: NON-SMALL CELL LUNG CA, RIGHT. GROSS DESCRIPTION. A. The specimen is submitted fresh as ""4L left lower paratracheal"" and. consists of three pink to red lymph nodes ranging 0.2 cm to 0.8 cm in. dimension. The largest lymph node is bisected. The specimen is submitted. in toto, 4 (1) The largest lymph node is inked with blue dye. B. The specimen is submitted fresh as ""10L left tracheobronchial angle"". and consists of a 0.6 cm grey black lymph node; bisected and submitted,. 2 (1). C. The specimen is submitted fresh as ""2R right upper paratracheal' and. consists of multiple segments of adipose tissue intermixed with pink to. red possible lymph nodes with aggregate dimension 2 x 1.5 x 0.4 cm with. the lymph nodes measuring up to approximately 0. cm. The specimen is. submitted in toto, multiple (1) . D. The specimen is submitted fresh as ""4R right lower paratracheal"" and. consists of multiple segments of yellow adipose tissue intermixed with. pink to purple tan lymph nodes with aggregate dimension 2.3 x 1.6 X 0.4 cm. with the lymph nodes measuring up to 0.5 cm; submitted, multiple (1). E. The specimen is submitted fresh as ""3A lower pretracheal"" and consists. of multiple segments of yellow adipose tissue intermixed with pink lymph. nodes with aggregate dimension 2 x 1.5 x 0.4 cm with the lymph nodes. measuring up to approximately 0.5 cm; submitted, multiple (1). F. The specimen is submitted fresh as ""7 subcarinal"" and consists of. multiple segments of yellow adipose tissue intermixed with pink to red. lymph nodes with aggregate dimension 2 x 2 x 0.3 cm with the lymph nodes. measuring up to approximately 0. cm; submitted, multiple (1) . GROSS DESCRIPTION. G. The specimen is submitted fresh as ""2L left upper paratracheal"" and. consists of a segment of adipose tissue measuring 1.5 X 1 x 0.2 cm with a. single red to pink elongate lymph node measuring 0.8 cm. The lymph node. is bisected and submitted, 2 (1). FINAL DIAGNOSIS. A. 4L LEFT LOWER PARATRACHEAL: THREE LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR TUMOR. (0/3). B. 10L LEFT TRACHEOBRONCHIAL ANGLE: SINGLE LYMPH NODE SHOWING ANTHRACOSIS; NEGATIVE FOR TUMOR (0/1) . C. 2R RIGHT UPPER PARATRACHEAL: MULTIPLE SMALL LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR. TUMOR. D. 4R RIGHT LOWER PARATRACHEAL: MULTIPLE SMALL LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR. TUMOR. E. 3A LOWER PRETRACHEAL: MULTIPLE SMALL LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR. TUMOR. F. 7 SUBCARINAL: MULTIPLE SMALL LYMPH NODES SHOWING ANTHRACOSIS; NEGATIVE FOR. TUMOR. G. 2L LEFT UPPER PARATRACHEAL: SINGLE LYMPH NODE AND ADJACENT ADIPOSE TISSUE, NEGATIVE FOR. TUMOR (0/1) .",T2,N0,M0,T2N0M0
TCGA-55-8620,"DIAGNOSIS. DIAGNOSIS: A. Level VII lymph node, excision: One lymph node positive for metastatic carcinoma. B. Lung, upper lobe, excision: Tumor Characteristics: 1. Histologic type: Adenocarcinoma. 2. Histologic grade: Grade II-III, moderate to poorly differentiated. 3. Tumor site: Left upper lobe. 4. Tumor focality: Unifocal. 5. Tumor size: 1.9x1.8x1.5cm. 6. Visceral pleural invasion: Not identified. 7. Lymphovascular space invasion: Not identified. Surgical Margin Status: 1. Tumor distance from parenchymal margin: 2.5 cm. 2. Tumor distance from pleural surface: 0.1 cm. Lymph Node Status: 1. See parts A, C. Other: 1. pTNM stage: pT1a N1. C. Level V and VI lymph nodes, excision: Four lymph nodes, negative for metastatic disease. CLINICAL INFORMATION. CLINICAL HISTORY: Preoperative Diagnosis: Postoperative Diagnosis: Symptoms/Radiologic Findings: SPECIMENS: A. Level VII lymph node. B. Left upper lobe. C. Level V and VI lymph nodes. SPECIMEN DATA. GROSS DESCRIPTION: The specimen is received in three formalin-filled containers labeled with the patient's name I. A. Container A is additionally labeled level VII lymph node, and contains a 2.2 x 1.3 x 1.0 cm, yellow-tan, firm rubbery nodule consistent with lymph. node. The specimen is bisected and entirely submitted in cassette A1, labeled. B. Container B is additionally labeled left upper lobe and contains a 20.0 x 9.0 x 4.5 cm, purple-gray lung lobe. The pleura is remarkable for a 2.5 x 1.4. x. 0.5 cm, area of umbilication which is inked blue. A 10.5 x 4.0 cm area of exposed parenchyma is identified. Within this area are multiple segments of. the. surrounding. and vasculature. Discrete masses are not identified. The a bronchial 1.9 x 1.8 x and 1.5 vascular cm, ill-defined, margins gray-white, were taken mass en is face, that comprised approaches and of beefy to within red, less. exposed parenchyma bronchi is inked black. The specimen is 2.5 serially cm of sectioned the inked to parenchymal reveal margin. The remainder nodes of the are cut not surface identified. Representative sections. than. 0.1. cm. of. the. inked. pleura. parenchyma and to within with focal areas of emphysematous follows: change. B1-2 Discrete en face lymph vascular and bronchial margins; representative 3 - inked sections parenchymal of. anthracotic are submitted perpendicular; and congested 4-5 B1-9, - mass labeled to inked pieura; b-/ - , designated remainder each labeled of as mass: 8 - emphysematous - change; 9 - additional. in cassettes. margin, parenchyma. C. palpation, Container four Three C firm is additionally fatty genomics poccible cassettes labeled humnh level nodes are V also and are submitted, VI identified as lymph follows: nodes, ranging C1 and - from three contains 0.4 whole up to a possible 3.4 1.8 x cm 2.3 in lymph x greatest 1.0 cm, nodes; yellow-tan, dimension. C2 - one lobulated They whole are possible entirely fibrofatty bisected submitted soft tissue. lymph in On node. lesignated.",T1,N1,M1,T1N1M1
TCGA-AL-3466,"Clinical History/Diagnosis: Right renal cancer, IVC thrombus. Source of Specimen(s). A: Lymph Node, inter aorta caval. B: Thrombus. C: Right kidney. D: Lymph Node, retro caval. Gross Description: Received in four parts. Source of Tissue: 1. Labeled #1 'inter-aortocaval lymph node"". Gross Description: The specimen is received fresh and consists of a. reddish-tan ovoid rubbery nodule measuring 3 x 2.5 x 2.5 cm. Sections. show tan homogeneous cut surface consistent with metastatic disease. Representative sections in 1A. Designation of Sections: Summary of Sections: Source of Tissue: 2. Labeled #2 ""thrombus"". Gross Description: The specimen is received fresh and consists of a few. fragments of tan to red friable tissue and some blood clot measuring. collectively 4 x 3.5 x 1.5 cm. It appears to be predominantly lesional. tissue. Representative sections in 2A. Designation of Sections: Summary of Sections: Source of Tissue: 3. Labeled #3 ""right kidney"". Gross Description: The specimen is received fresh and consists of a right. kidney weighing 640 gm and measuring 12 x 10 x 8 cm. A small amount of. attached perinephric fat is present measuring up to 2 cm from point of. attachment. No adrenal gland is found. At the hilum, a segment of ureter. is present measuring 8 x 0.4 cm and is unremarkable. Also at the hilum,. is a renal vein. The renal vein is markedly distended, ragged, and. grossly contains tan friable lesional tissue. There is also an. appreciable amount of subcapsular hemorrhage posteriorly. The specimen is. bivalved revealing a large white firm tumor measuring 8 X 6 X 6.7 cm. The. tumor infiltrates throughout the kidney and grossly comprises. approximately 80% of the left kidney. The calyceal system is grossly. involved by tumor and it comes to within 1 cm from the hilum. There is. a. small amount of somewhat normal appearing kidney with the usual cortical. medullary rays. No additional lymph nodes are found. Photographs were. taken. Fresh tissue procured for cytogenetic studies. Designation of Sections: 3A ureter and vascular margins, 3B additional. section of renal vein adjacent to margin, 3C tumor, 3D tumor in. relationship to hilum/ureter, 3E tumor in relationship to capsule, 3F. tumor in relationship to normal adjacent tissue and subcapsular. hemorrhage, 3G tumor in relationship to inferior calyx, 3H uninvolved left. kidney, 3I-3J perinephric fat. Summary of Sections: A-J. Source of Tissue: 4. Labeled #4 ""retrocaval lymph node"". Gross Description: The specimen is received fresh and consists of an ovoid. reddish-tan rubbery nodule measuring 6.5 x 5.5 x 3.5 cm. Sections show. approximately 25% of the node to be necrotic. Elsewhere, tan cut surface. consistent with metastatic disease is present. Representative sections. submitted in 4A and 4B. Designation of Sections: Summary of Sections: Final Diagnosis: 1. Lymph node, inter-aortocaval (excision): - Metastatic papillary renal cell carcinoma. 2. Thrombus, site not specified (excision): - Papillary renal cell carcinoma present. 3. Right kidney (right nephrectomy): - Renal cell carcinoma papillary type,. - The tumor measures 8 cm in greatest diameter. - Tumor invades into renal vein and extends to the renal vein margin of. resection. Tumor involves the lymphatics of the vascular margin. - Negative ureteral margin. 4. Lymph node, retrocaval (excision): - Metastatic papillary renal cell carcinoma. Note: The tumor shows extensive lymphatic invasion. Procedures/Addenda. Results-Comments. CYTOGENETIC ANALYSIS REPORTS. KARYOTYPE: karyotype with nonclonal abnormality: 46,XY[19]/38,X,-Y,7add(1. p13),del(3)(p11.2),-4,-4,-6,-7,del(9)(p22),+?13,-14,-17,-18,-18,-19,-21,. add(21)(p11.2),-22,+3mar[1]. The renal tumor sample was sent to a commercial laboratory for cytogenetic. analysis. The chromosomes from twenty metaphases were counted and. analyzed, and two of these metaphases were karyotyped by G-banding. Nineteen cells had a modal chromosome number of 46, and the cells. appeared to have a normal karyotype. One nonclonal cell contained. nonrepetitive chromosomal changes that included a deletion in the short. arm. of chromosome 3. This deletion has been reported in cases of nonpapillary. renal cell carcinoma. Partial analysis of additional metaphases failed to. detect other aberrant cells.",T3,N1,M1,T3N1M1
TCGA-AA-3952,"This is an invasive, poorly differentiated adenocarcinoma of the colon (according to clinical. findings the descending colon) with penetration of all the parietal layers and vascular infiltrates. (pT3, L1, V1) with six lymph node metastases (6/14). Tumor classification: ICDO-DA-M. 8140/3. G3. pT3. L1, V1,. pN2 (6/14).",T3,N2,M0,T3N2M0
TCGA-BA-4074,"Diagnosis: A: Vallecular lesion, biopsy. - Fragment of lymphoid tissue and squamous epithelium. forming squamous crypts, no. tumor seen. B: Posterior lateral tongue mucosa, removal. - No tumor seen. C: Right surface mucosa, margin, biopsy. - No tumor seen. D: Left surface mucosa, margin, biopsy. - No tumor seen. E: Posterior muscle margin, biopsy. - No tumor seen. F: Right muscle margin, biopsy. - No tumor seen. G: Floor of mouth mucosa margin, biopsy. - No tumor seen. H: Floor of mouth muscle margin, biopsy. - No tumor seen. I: Left tongue, hemiglossectomy. - Squamous cell carcinoma, poorly differentiated, tumor. extensively involves specimen with tumor size approximately. 4.0 cm in greatest dimension, and diffusely involves deep. margin of resection (black ink). - Medial and lateral margins free of tumor. J: Right neck lymph nodes and neck contents, regional node. dissection. Metastatic squamous cell carcinoma involving 2 of 22. lymph nodes (lymph node count by level Level I - 1 of 2,. Level II - 1 of 4, Level III - 0 of 5, Level IV. - 0 of 8, Level V - 0 of 3), size of largest metastasis 2. 0. cm in greatest dimension, with extracapsular extension of. tumor identified. Submandibular gland with no tumor seen. K: Left neck lymph nodes and cervical contents, regional. node dissection. Metastatic squamous cell in 3 of 25 lymph nodes ( lymph. node count by level: Level 1 - 2 of 4, Level II - 1 of 9,. Level III - 0 of 8, Level IV - 0 of 4), , size. of largest metastasis 1. cm, with extracapsular extension. of tumor identified. - Tumor abuts the connective tissue around the. submandibular gland, but no definite intrasubmandibular. extension of tumor identified. L: Left Level I fibrofatty tissue, removal. - Fibrosis and acute and chronic inflammation, no tumor. seen. M: Floor of mouth, partial removal. - Fragment of squamous mucosa and submucosa with minor. salivary glands present,. no tumor seen. Comment: Intraoperative Consultation: A frozen section consultation was requested by. FSA1: Vallecular lesion, biopsy. - No tumor seen, lymphoid tissue and squamous crypt present. FSB1 : Posterior lateral tongue mucosa, removal. - No tumor identified. FSC1: Right surface mucosa, margin, biopsy. - No tumor identified. FSD1: Left surface mucosa, margin, biopsy. - No tumor identified. FSE1: Posterior muscle margin, biopsy. - No tumor identified. FSF1: Right muscle margin, biopsy. - No tumor identified. FSG1: Floor of mouth mucosa margin, biopsy. - No tumor identified. FSH1: Floor of mouth muscle margin, biopsy. - No tumor identified. Clinical History: The patient is with T2N2M0 squamous cell carcinoma of the. tongueand separate lesion on the right vallecula who. undergoes bilateral radical neck dissection and. nemiglossectomy. Gross Description: Container A holds two fragments of pink soft tissue. measuring 0.8 X 0.8 X 0.4 cm in. aggregate. (Block FSA1, NTR). Container B holds a 0.8 X 0.3 X 0.3 cm red soft tissue. fragment; block FSB1, NTR. Container C holds a 1.1x0.4x0.3cmred/tan soft tissue. fragment; block FSC1,. Container D holds a 0.5 X 0.3 X 0.2 cm red/tan soft tissue. fragment; block FSD1,. Container E holds a 0.4 X 0.2 x 0.2 cm red/tan soft tissue. fragment; block FSE1,. Container F holds a 0.4 X 0.3 X 0.2 cm red/tan soft tissue. fragment; block FSF1,. Container G holds a 0.5 X 0.2 X 0.2 cm soft tissue. fragment; block FSG1,. Container H holds a 0.5 x 0.2 X 0.2 cm soft tissue. fragment; block FSH1,. Container I: Specimen fixation: received fresh and fixed in formalin. Type of specimen: left hemiglossectomy. Size of specimen: 4.4 cm anterior to posterior, 3.4 cm. medial to lateral, and 2 cm superficial to deep. Orientation of specimen: A short stitch marks lateral, a. long stitch marks anterior; the medial margin is inked. green, the deep margin is inked black. Tumor description: white, solid mass with an infiltrative. border; no necrosis or hemorrhage is identified. Location of tumor: tumor is located on the deep aspect and. runs almost the entire length anterior to posterior and. is located more medially. Tumor size: 4 cm anterior to posterior, 2.5 cm medial to. lateral, 1.2 cm superficial to deep. Extent of tumor: not applicable. Presence/absence of bone involvement: not applicable. Distance of tumor from surgical margins: 1.8 cm from the. anterior surface, 0.7 cm from the posterior surface, 0.6. cm from the lateral surface, abuts medial margin,. superseded by frozen; abuts deep margin, superseded by. frozen; abuts superficial surface. Description of remainder of tissue: The surface of the. tongue is pink/tan with a 1 X 0.2 cm disruption on the. lateral/posterior aspect. Tissue submitted for special investigation none. Lymph nodes: submitted separately as neck dissection. Block Summary: Sections submitted from anterior to posterior. I1-I4 - representative sections of tumor abutting deep. margin. I5 - representative section of lateral superficial. disruption. I6 - representative section of tumor abutting medial margin. Container J is additionally labeled ""right neck contents. "". It contains a 14 X 8 X 2 cm segment of soft tissue. including Levels I-V. Level I contains a 4 X 2 X 0.7 cm. gland with a tan lobulated cut surface which does not. appear involved by tumor. Three lymph node candidates are. identified ranging in size from 0.5 to 1.4 cm. The. largest is bisected. J1 - one lymph node candidate, bisected; two additional. candidates. J2 - additional fatty tissue. J3 - representative section of gland. Level II contains a 2 X 1.8 X 1.2 cm lymph node candidate. identified which is grossly positive for tumor with a tan. cut surface exhibiting areas of hemorrhage and. necrosis. A 1 cm portion of vessel with a diameter of 0.7. cm is identified and opened to reveal a smooth surface. uninvolved by tumor. J4,J5 - large lymph node candidate, quadrisected. J6,J7 - additional representative tissue. In Level III, two lymph node candidates are identified. ranging in size from 0.4 to 0.9 cm as well as additional. adipose tissue and skeletal muscle. J8 - lymph node candidate, submitted whole. J9, J10 - additional tissue with possible lymph node. candidate. Level IV: Four lymph node candidates are identified ranging. in size from 0.3 to 0.5 cm. J11 - four lymph node candidates. J12, J13 - additional fatty tissue with possible lymph node. candidates. Level V: No large nodes are identified. J14,J15 - soft tissue with possible lymph node candidate. Container K is additionally labeled ""left neck. "" It. contains a 16 X 7.2 X 3.2 cm segment of tissue with Levels. I-IV. Level I contains a 5 X 2 X 1 cm gland with tan lobulated. cut surface on one end and. a white/tan grossly positive cut surface of the other end. One lymph node candidate. is identified measuring 2 cm in greatest diameter and is. grossly positive on cut. surface. K1-K2 - representative sections of grossly involved gland. K3 - representative section of uninvolved portion of gland. with one. lymph node candidate. K4 - one lymph node candidate, bisected. Level II contains seven lymph node candidates ranging in. size from 0.6 to 1.7 cm. The largest is bisected to reveal a white cut surface. K5 - largest node, bisected and two additional small nodes. K6 - four lymph node candidates. K7-K8 - additional tissue with possible lymph node. candidate. Level III contains five lymph node candidates ranging in. size from 0.6 to 0.9 cm. K9 - five lymph node candidates. K10 - additional representative tissue with possible lymph. node candidate. K11, K12 - additional representative tissue with possible. lymph node candidate. Level IV contains no large lymph node candidates. The soft. tissue is submitted in. blocks K13-K15. Container L is additionally labeled ""left Level I. fibrofatty tissue. It contains a. 1.5 X 1.0 X 0.5 cm segment of pink/tan soft tissue; block. L1, NTR. Container M is additionally labeled ""floor of mouth."" It. contains a 1.6 X 1.0 x 0.4 cm segment of brown soft tissue;. block M1,. Light Microscopy: Light microscopic examination is performed by. (Specimen I). Histologic tumor type: squamous cell carcinoma. Histologic grade: poorly differentiated. Tumor extent: Tumor extensively involves the glossectomy. specimen and measures approximately 4.0 cm in greatest. dimension. Presence/absence of angiolymphatic space invasion: not. definitively identified. Histologic assessment of surgical margins: deep margin. extensively involved with tumor. Lymph nodes: Metastatic squamous cell carcinoma in 2 of 22. right neck nodes, metastatic squamous cell carcinoma in 3. of 25 left neck nodes. Size of largest nodal metastasis (greatest dimension) : 2.0. cm on right, 1.8 cm on left. Presence/absence of extranodal extension: present,. bilaterally. Other significant findings not applicable.",T2,N2,M0,T2N2M0
TCGA-85-8350,Asterand Case ID Gross Description. Microscopic Description. Diagnosis Details. Comments. LUNG TISSUE CHECKLIST. Specimen type: Lobectomy. Tumor site: Lung. Tumor size: 1 .2 x 2.5 X 3 cm. Histologic type: Squamous cell. carcinoma. Histologic grade: Moderately. differentiated. Tumor extent: Not specified. Other tumor nodules: Not specified. Lymph nodes: Not specified. Lymphatic invasion: Not specified. Venous invasion: Not specified. Margins: Not specified. Evidence of neo-adjuvant. treatment: Not specified. Additional pathologic findings: Not. specified. Comments: Right-upper. Laterality. Right-upper.,T1,N0,M0,T1N0M0
TCGA-BP-4158,"Clinical Diagnosis & History: Metastatic workup for recently diagnosed prostate cancer;. incidental finding of right renal mass. Specimens Submitted: 1: SP: Right kidney. 2: SP: Paracaval lymph nodes. DIAGNOSIS: 1). KIDNEY, RIGHT; NEPHRECTOMY: - RENAL CELL CARCINOMA, CLEAR CELL TYPE, NUCLEAR GRADE. II/IV. THE PATTERN OF GROWTH IS ACINAR. THE TUMOR's. GREATEST DIAMETER IS 7.0 CM. - THE TUMOR IS CONFINED WITHIN THE RENAL CAPSULE. - VASCULAR INVASION IS IDENTIFIED. - ALL SURGICAL MARGINS ARE FREE OF TUMOR. - THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. - THE ADRENAL GLAND IS NOT SUBMITTED. 2). LYMPH NODES, PARACAVAL; EXCISION: - FIVE LYMPH NODES, NEGATIVE FOR CARCINOMA (0/5) . JATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1) The specimen is received fresh, labeled ""Right Kidney"". It. consists of nephrectomy specimen entirely measuring 23.13 x 0.5. cm and weighing 700 gm. The kidney measures 12.5 x 7.5 x 0.5 cm. after stripping fat and weighs 280 gm. A 11 cm segment of. ureter is identified. A well-circumscribed yellow, focally. hylinized, tumor is present towards the upper pole measuring 0.7. x. 5.8 cm. There is no necrosis identified within tumor. It. seems to be grossly confined within the renal capsule and bulges. into the renal pelvis. There is no invasion of renal vein. grossly. The kidney away from the tumor appears unremarkable. Summary of Sections: T - tumor. TC - tumor with HILUM. TK - tumor with sounding kidney. TP - tumdr with pelvis. K - kidney away from tumor. STM - soft tissue margin. UM - ureteric margin. VM - vascular margin. FAD - perinephritic fat. ADD - tumor with capsule. 2). The specimen is received in formalin, labeled,. ""Paracaval Lymph Nodes"" It consists of fatty tissue measuring. 5. x 4. X 2.0 cm in aggregate. Multiple lymph nodes are. identified, with the largest measuring 2.5 cm. All lymph nodes. identified are submitted. Summary of Sections. BI - one bisected lymph node in two cassettes. LNB - bisected lymph nodes. LN - multiple lymph nodes. Summary of Sections: Part. Sect. SiteBlocks Pieces. All. 1. ADD. 1. M. FAT. M. K. 1. M. STM. 1. M. 4. M. TC. 1. M. TK. 1. M. TP. 1. M. UM. 1. M. VM. 1. M. 2. BI. 2. M. LN. 1. M. LNB. 1. M.",T1,N0,M0,T1N0M0
TCGA-DD-AAD6,"CLINICAL DIAGNOSIS: S8 HCC / S5 CCC. Specimen : Rt liver. Gross Photo : GROSS: Specimen status: Fresh. Operation: Subsegmentectomy, segment 8. Tumorectomy, segment 5. Organ: Liver. Segment 8 (17.0 x 9.5 x 7.0 cm, 395.0 gm). Segment 5 (7.6 X 4.1 X 2.0 cm, 65.0 gm). Gallbladder (13.0 cm in length, 5.0 cm in diameter). [Liver]. Lesions: [Mass 1]. Tumor location: Segment 8. Size: 10,0 X 7.0 X 6.0 cm. Cut surface: Encapsulated, pale tan, solid and lobulated mass. Focal necrosis and hemorrhage. Gross type: Multinodular confluent. Extent: Abuts but confined to the capsule. Resection margin: Not involved, grossly (safety margin: 0.2 cm). [Mass 2]. Tumor location: Segment 8. Size: 2.2 X 2.0 X 2.0 cm. Cut surface: Encapsulated, pale green to tan, solid and lobulated mass. Extensive necrosis and hemorrhage. Gross type: Multinodular confluent. Extent: Abuts but confined to the capsule. Resection margin: Not involved, grossly (safety margin: 1.5 cm). Remaining parenchyme: Cirrhosis. [Gallbladder]. Serosa: Yellowish pink and smooth. Mucosa: Dark green and velvety. Wall: 0.2 cm in thickness. Representative sections are submitted. Gross photo: Present. Blocks. T1-4, mass of segment 8 [Mass 1] X 4. A1-3 mass of segment 5 [Mass 2] X 3. RM1, resection margin of segment 8 X 1. RM2, resection margin of segment 5 X 1. L, nontumorous liver parenchyme X 1. GB, gallbladder X 1. MICROSCOPIC: [Mass 1]. Tumor location: Segment 8. Tumor type: Hepatocellular carcinoma. Edmondson-Steiner grade. The worst: III. The major: II. Histologic type: Trabecular and solid. Cell type: Hepatic. Fatty change: No. Fibrous capsule formation: Yes. Capsular infiltration: Yes. Septum formation: Yes. Surgical resection margin invasion: No. Gleason's capsule invasion: Present. Portal vein invasion: No. Vascular invasion: No. Bile duct invasion: No. [Mass 2]. Tumor location: Segment 5. Tumor type: Hepatocellular carcinoma. Edmondson-Steiner grade. The worst: III. The major: II. Histologic type: Trabecular and solid. Cell type: Hepatic. Fatty change: No. Fibrous capsule formation: Yes. Capsular infiltration: No. Septum formation: No. Surgical resection margin invasion: No. Serosal invasion: No. Portal vein invasion: No. Vascular invasion: No. Bile duct invasion: No. Remaining liver parenchyme: Cirrhosis, active. SPECIAL STAIN: Trichrome reveals fibrotic change of hepatic parenchyme. NOT reported. Gross: NOT reported. Gross: Pleural fluid, smear, inflammation. Peritoneal fluid, smear, inflammation. Peritoneal fluid, smear, inflammation. Peritoneal fluid, smear, inflammation. Peritoneal fluid, smear, inflammation. Peritoneal fluid, smear, inflammation. liver,ectomy,hepatocellular carcinoma. T56000, P10, M81703. gallbladder,ectomy, chronic tholecystitis,cholesterolosis. T57000, P10, M43005, M55250. DIAGNOSIS: Liver, segment 8, subsegmentectomy: Hepatocellular carcinoma. Liver, segment 5, tumorectomy: Hepatocellular carcinoma. Gallbladder, cholecystectomy: Chronic cholecystitis. Cholesterolosis. Suggestion :",T3,N0,M0,T3N0M0
TCGA-DJ-A4UP,"Neck. nd Neck. Clinical Diagnosis & History: year old female with papillary thyroid carcinoma with positive right upper lobe nodular on FNA and right submandibular LN. positive for papillary thyroid carcinoma. Specimens Submitted: 1: Rule out right upper parathyroid (fs). 2: Lymph node near the right recurrent nerve. 3: Right thyroid lobe and isthmus. 4: Left thyroid lobe and isthmus. 5: Right neck contents levels 2,3 and 4. 6: Lowest level 4 lymph nodes, right neck. DIAGNOSIS: 1. Soft tissue, ""rule out right upper parathyroid""; blopsy: Micrometastatic papillary thyroid carcinoma involving one lymph node (1/1). - The metastatic lymph node is 3 mm. - The metastatic focus is less than 1 mm. - Extranodal extension not identified. Note: the micrometastatic focus was not present on the original frozen section slide. 2. Lymph node near the right recurrent nerve; biopsy: - One benign lymph node (0/1). 3. Right thyroid lobe and isthmus: Part # 3. Tumor Type: Papillary carcinoma, classical type. Histologic Grade: Well differentiated. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Other Tumor Features: Psammoma bodies. Tumor Location: Right lobe. Tumor Size: Greatest diameter is 1.6 cm. Tumor Encapsulation: None Identified. Blood Vessel Invasion: Not identified. Extrathyroid Extension: Not identified. Surgical Margins: Free of tumor. Tumor Multicentricity: Not identified. Adenoma(s) (away from the carcinoma): Not Identified. Non-Neoplastic Thyrold: Exhibits chronic lymphocytic thyroiditis consistent with Hashimoto's thyroiditis. Parathyroid Glands: Not identified. Lymph Nodes: Metastatic papillary thyroid carcinoma involving 1 out of 6 lymph nodes (1/6), lymph node with metastasis is 5. mm in greatest dimension, largest tumor deposit is 2.6 mm. No extranodal extension identified. 4. Left thyroid lobe and isthmus; hemithyroidectorny: - Chronic lymphocytic thyroiditis consistent with Hashimoto's thyroiditis. - Four benign lymph nodes (0/4). 5. Right neck contents levels 2,3 and 4: Part # 5. Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 30. Number of lymph nodes with metastatic disease: 3. Size of the largest lymph node involved by tumor: 1.5cm. Size of the largest metastatic focus : 1.45 cm. Extranodal extension is not identified. Benign skeletal muscle. 6. Lowest level 4 lymph nodes, right neck; excision: - Seven benign lymph nodes (0/7). IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Gross Description: 1). The specimen is received fresh for frozen section consultation, labeled ""rule out right upper parathyroid"" and consists of single. plece of tissue measuring 0.2 x 0.1 x 0.1 cm. The specimen is entirely submitted for frozen section. Summary of sections: FSC - frozen section control. 2). The specimen is received fresh, labeled ""lymph node near the right recurrent nerve"" and consists of a single pink tan firm lymph. node measuring 0.8 x 0.5 x 0.2 cm. The lymph node is entirely submitted. Summary of sections: LN - lymph node. 3). The specimen is received fresh labeled ""right thyroid lobe and isthmus"". It consists pf a 25.5 g, 7.4 x 3.8 x 2.6 cm thyrold lobe. The surface is purple-pink with an intact capsule. The lobe is inked black posterior and blue anterior. Serial sectioning reveals a. 1.6 x 1.5 x 1.1 cm ovoid, tan-white, firm, unencapsulated nodule in the upper pole which abuts the anterior aspect and 0.2 cm from. the posterior aspect. The remainder of the cut surface is red-pink, nodular meaty. At the medial aspect are multiple pink-tan, firm. lymph nodes ranging from 0.4 to 1.2 cm in greatest dimension. No isthmus is identified. A portion of the specimen is sent for. TPS. Representative sections are submitted, including all identifiable lymph nodes. Summary of sections: RLN - right lobe nodule. RL right lobe. LN - lymph nodes. 4). The specimen is received fresh labeled ""left lobe and isthmus"". It consists of a 5.5 x 3.5 x 2.3 cm thyroid lobe with a 4 x. 1.8. x. 1.6. cm. isthmus. The surface is purple-pink with an intact capsule. The lobe is inked black posterior and blue anterior. Serial. sectioning reveals red-pink, nodular, meaty cut surfaces with no gross lesions identified. At the medial aspect are two pink-tan,. firm lymph nodes measuring 0.7 and 0.9 cm in greatest dimension. Representative sections are submitted, including all. identifiable lymph nodes. Summary of sections: LL left lobe. IS isthmus. LN lymph node. BLN - bisected lymph node. 5). The specimen is received fresh labeled ""right neck contents levels 2, 3 and 4"". It consists of a 11.5 x 4.4 x 1.5 cm portion of. red-pink to yellow-tan, fibroadipose tissue with attached 3 x 1.5 x 0.8 cm portion of skeletal muscle, but no submandibular gland. or. segment of a major vein. The specimen is sent for lymph node dissection to reveal multiple lymph nodes ranging from 0.2 to 1.5. cm in greatest dimension. All identified lymph nodes and representative sections of the remaining specimen are submitted. Summary of sections: M muscle. LN - lymph nodes. BLN - bisected lymph nodes. Pag 3 of 4. 6) The specimen is received fresh, labeled ""lowest level 4 lymph nodes-right neck"" and consists of multiple pink tan firm lymph. nodes ranging from 0.4 to 1.2 cm in greatest dimension. All identified lymph nodes are submitted. Summary of sections: LN - lymph nodes. Summary of Sections: Part 1: Rule out right upper parathyroid (fs). Block. Sect. Site. PCs. 1. FSC. 2. Part. 2: Lymph node near the right recurrent nerve. Block. Sect. Site. PCs. 1. LN. 1. Part 3: Right thyroid lobe and isthmus. Block. Sect. Site. PCs. 3. LN. 9. 3. RL. 3. 3. RLN. 3. Part 4: Left thyroid lobe and isthmus. Block. Sect. Site. PCs. 1. BLN. 2. 1. IS. 1. 4. LL. 5. 1. LN. 1. Part 5: Right neck contents levels 2,3 and 4. Block. Sect. Site. PCs. 5. BLN. 10. 6. LN. 30. 1. M. 1. Part 6: Lowest level 4 lymph nodes, right neck. Block. Sect. Site. PCs. 2. LN. 4. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative. consultation. 1. FROZEN SECTION DIAGNOSIS: Benign lymph node. PERMANENT DIAGNOSIS: see final.",T1,N1,M0,T1N1M0
TCGA-BP-4337,"Clinical Diagnosis & History: Patient with left renal mass, Status-post left nephrectomy today. Now right renal re-vascularization. Specimens Submitted: 1: SP: Left kidney, adrenal gland, perinephric fat and renal vein thrombus. 2: SP: Para-aortic lymph node. 3: SP: Right renal artery thrombus (. 4: SP: Right renal artery intima. 5: SP: Spleen. DIAGNOSIS: 1). KIDNEY, LEFT, ADRENAL GLAND AND PERINEPHRIC ADIPOSE TISSUE; RADICAL NEPHRECTOMY: - RENAL CELL CARCINOMA, CONVENTIONAL TYPE, NUCLEAR GRADE IV/IV. - THE PATTERN OF GROWTH IS ACINAR. - THE TUMOR GREATEST DIAMETER IS 6,8 CM. - THE TUMOR EXTENDS THROUGH THE RENAL CAPSULE BUT IS CONFINED WITHIN GEROTA'S FASCIA. - INVASION OF THE RENAL VEIN IS PRESENT. - WE ALSO NOTE TUMOR EMBOLI IN SMALL VESSELS. - ALL SURGICAL MARGINS ARE FREE OF TUMOR,. - THE NON-NEOPLASTIC KIDNEY IS UNREMARKABLE. - THE ADRENAL GLAND IS UNREMARKABLE. - NO RENAL HILAR LYMPH NODES IDENTIFIED. 2). LYMPH NODE, PARA-AORTIC; EXCISION: - ONE BENIGN LYMPH NODE. 3). RENAL ARTERY THROMBUS, RIGHT; BIOPSY: - FRESH BLOOD, FIBRIN AND LEUKOCYTES. - NO TUMOR SEEN. 4). RENAL ARTERY INTIMA, RIGHT; BIOPSY: - BENIGN VASCULAR WALL. - NO TUMOR SEEN. 5). SPLEEN; SPLENECTOMY: - BENIGN SPLEEN,. . THREE BENIGN LYMPH NODES (0/3). - NO TUMOR SEEN. Special Studies: Special Stain. Comment. RECUT. Gross Description: 1). The specimen is received fresh, labeled, ""Left kidney, adrenal gland, perinephric fat and renal vein thrombus"". It consists. of a redical nephrectomy specimen composed of a kidney, adrenal gland and perinephric adipose tissue, weighing 330 grams and. measuring. 13.2 x 9.8 X 3.4 cm. The external surface is inked black. The upper half of the kidney is replaced by an ill-defined,. vaguely, lobulated, variegated tumor mass, measuring 6,8 x 5.7 x 3.2 cm, located 1.1 cm from the adrenal gland. The tumor. extends into the renal vein from which the tumor grows distally as an exophytic polypoid mass, measuring 3.6 cm in length. The. tumor also extends into the pelvis. However, grossly ureter margin and vascular margins are free of tumor. The tumor appears. to extend to, but not through, the overlying renal capsule. On cut sections, the tumor is yellow-tan, friable tissue with multiple. cystic degeneration and necrosis. The remaining kidney appears to be unremarkable. The adrenal gland measures 4,2 x 2.0 X. 0.7 cm, and is unremarkable. No lymph nodes are identified in the perinephric adipose tissue, therefore, representative sections. are submitted for histology. Photographs are taken. Small samples are given to TPS. Summary of Sections: M - margin (1-M1 contains the margin of the renal vein that contains the tumor). T - tumor (1-T3 contains the tumor in the renal vein). LT - random sections of the non-tumor kidney. FAT - perinephric adipose tissue. 2). The specimen is received in formalin, labeled, ""Para-aortic lymph node"". It consists of a lymph node, measuring 1.9 x 0,5. x 0.3 cm. Entirely submitted. Summary of Sections: LN - lymph node. 3). The specimen is received in formalin, labeled, ""Right renal artery thrombus"". it consists of multiple fragments of blood. clot, measuring up to 0.6 cm in greatest dimension in aggregate. Entirely submitted. Summary of Sections: U - undesignated. 4). The specimen is received in formalin, labeled, ""Right renal artery intima"". It consists of a single minute piece of pink-tan. soft tissue, measuring 0.1 cm In greatest dimension. Entirely submitted and is dabbed in Mercurochrome. Summary of Sections: U - undesignated. 5). The specimen is received fresh, labeled, ""Spleen "". It consists of a spleen measuring 12.5 x 7.5 x 2.2 cm and weighing. 220 grams. The splenic capsule is purple gray, intact and glistening. Attached to the hilum of the spleen is the fatty tissue,. marked by a clip, where embedded are probable splenic nodes measuring up to 0.2 cm in greatest dimension, The spleen. is. serially sectioned revealing hemorrhagic, glistening slightly granular cut surface without any discrete mass. Random sections of. the specimen are submitted. Summary of Sections: VM - vascular margin. PHM - probable hilar nodes. U - undesignated random section of the capsule with the splenic parenchyma. Summary of Sections: Part. 1: SP: Left kidney, adrenal gland, perinephric fat and renal vain thrombus. Block. Sect. Site. PCs. 1. FAT. 2. 2. LK. 2. 2. 5. 11. T. 13. Part 2: SP: Para-aortic lymph node. Block. Sect. Site. PCs. 1. In. 1. Part 3: SP: Right renal artery thrombus. Block. Sect. Site. PCs. 1. u. 10. Part 4: SP: Right renal artery intima. Block. Sact. Site. PCs. 1. 1. Part 5: SP: Spleen. Block. Sect. Site. PCs. 2. PLN. 2. 5. U. 5. VM. 10.",T3,N0,M0,T3N0M0
TCGA-AO-A0JM,"Clinical Diagnosis & History: y/o female with right lower inner quadrant carcinoma IDC/DCIS with. microcalcifications, Right 3:00 => IDC poorly differentiated; DCIS with. microcalcification. Specimens Submitted: 1: SP: Senitnle node #1, level one, right axilla (fp). 2: SP: Sentinel node #2, level one, right axilla (fi. 3: SP: Sentinel node #3, level two, right axilla (fs. 4: SP: Right breast and axillary contents levels 1, 2 and 3. DIAGNOSIS: 1). LYMPH NODE, SENTINEL #1 LEVEL I RIGHT AXILLA; BIOPSY: METASTATIC CARCINOMA IN ONE OUT OF SIX LYMPH NODES (1/6). - THERE IS NO EXTRANODAL EXTENSION OF CARCINOMA. 2). LYMPH NODE, SENTINEL #2 LEVEL I RIGHT AXILLA; BIOPSY: - METASTATIC CARCINOMA IN ONE OF ONE LYMPH NODE (1/1) (SEE NOTE). - NO EXTRANODAL EXTENSION SEEN. NOTE: THE METASTASIS IS PRESENT ON DEEPER LEVEL PERMANENT SECTION ONLY. 3). LYMPH NODE, SENTINEL #3 LEVEL II RIGHT AXILLA; BIOPSY: - TWO BENIGN LYMPH NODES (0/2). 4). BREAST AND AXILLARY CONTENTS, RIGHT LEVELS I, II, AND III;. MASTECTOMY: - MULTIPLE FOCI OF INVASIVE DUCTAL CARCINOMA, NOS TYPE, HISTOLOGIC. GRADE III/III (SLIGHT OR NO TUBULE FORMATION) NUCLEAR GRADE III/III (MARKED. VARIATION IN SIZE AND SHAPE), RANGING IN SIZE FROM 0.1 CM UP TO 3 CM. - DUCTAL CARCINOMA IN SITU (DCIS) IS ALSO IDENTIFIED, SOLID, CRIBRIFORM, AND. MICROPAPILLARY TYPES WITH HIGH NUCLEAR GRADE AND MODERATE NECROSIS. - LOBULAR INVOLVEMENT BY DCIS IS PRESENT. - THE DCIS CONSTITUTES >= 25% OF THE TOTAL TUMOR MASS, AND IS PRESENT. ADMIXED WITH AND AWAY FROM THE INVASIVE COMPONENT. - THE INVASIVE CARCINOMA IS LOCATED IN THE LOWER OUTER QUADRANT AND LOWER. INNER QUADRANT. - THE DCIS IS LOCATED IN THE LOWER OUTER QUADRANT AND LOWER INNER QUADRANT. - DCIS INVOLVES THE LARGE LACTIFEROUS DUCTS. - CALCIFICATIONS ARE PRESENT IN BOTH THE IN SITU AND INVASIVE CARCINOMA. - VASCULAR INVASION IS PRESENT. - NO INVOLVEMENT OF THE SURGICAL MARGINS BY INVASIVE CARCINOMA IS. IDENTIFIED. - RARE FOCI OF DCIS/IN SITU CARCINOMA ARE CLOSE (1 MM) TO THE FOLLOWING. SURGICAL MARGIN: DEEP. - NO SKIN INVOLVEMENT BY CARCINOMA IS IDENTIFIED. - THE ATTACHED SKELETAL MUSCLE IS NEGATIVE FOR TUMOR. - THE NON-NEOPLASTIC BREAST TISSUE SHOWS BIOPSY SITE CHANGES. - THE LYMPH NODE STATUS IS AS FOLLOWS (EXPRESSED AS THE NUMBER OF POSITIVE. LYMPH NODES IN RELATION TO THE TOTAL NUMBER OF LYMPH NODES EXAMINED) : LEVEL. I: 0/13; LEVEL II: 0/9; AND LEVEL III: 0/2. RESULTS OF SPECIAL STAINS (ER, PR, HER2-NEU) WILL BE REPORTED AS AN. ADDENDUM. I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF. THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE REVIEWED AND APPROVED. THIS REPORT. El .conically Signed Out. Special Studies: Special Stain. Comment. ER-C. PR-C. HER2-C. IMM RECUT. NEG CONT. Gross. MD. 1). The specimen is received fresh for frozen section consultation,. labeled ""Sentinel node number one, level 1, right axilla"" and consists of 7. lymph nodes and measure 3.5 x 2.6 x 1.0 cm in aggregate. One lymph node is. blue and has been bisected, and the lymph nodes are entirely submitted in. two cassettes. Summary of sections: FSCA- frozen section control A. FSCB--frozen section control B. 2) The specimen is received fresh for frozen section consultation,. labeled ""Sentinel node number two, level 1, left axilla"" and consists of a. soft lymph node measuring 0.6 x 0.5 x 0.5 cm, bisected and entirely. submitted for frozen section. Summary of sections: FSC-frozen section control. PA. 3). The specimen is received fresh for frozen section consultation,. labeled ""Sentinel node number three, level 2, right axilla"" and consists of. two soft tan lymph nodes totaling 2.0 x 1.2 x 0.6 cm, entirely submitted for. frozen section. Summary of sections: FSC-frozen section control. MD. 4). The specimen is received fresh in a container, labeled ""Right breast and. axillary contents levels 1, 2 and 3 with tags attached"". The specimen. consists of a mastectomy measuring 30 x 19 x 3 cm. That axillary tail. measures 13 x 8 x 2 cm. The overlying ellipse of skin measures 10 x 3 cm. No scar can be identified on the skin. The nipple measures 1 x 1 cm and it. is grossly unremarkable. The deep resection margin is inked blue. The. specimen is serially sectioned revealing a pinkish red, relatively. well-circumscribed and firm lesion measuring 3 x 1.5 x 1 cm which closely. abuts the inked resection margin. The lesion is 2 cm away from the skin. The lesion is located in the lower inner quadrant. Surrounding the lesion,. are areas of fibrosis which show punctate areas of cheesy necrosis. Away. from this lesion, in the lower outer quadrant is a vaguely defined area of. fibrosis and nodularity. Approximate measurements of this area are 10 x 6. cm. The upper inner and outer quadrants show mainly fatty tissue. An. axillary dissection is performed revealing 3 level one lymph nodes, 4 level. two lymph nodes and 2 level three lymph nodes. Summary of sections: TRM-tumor in relation to inked resection margin. TRS-tumor in relation to skin. LIQ-lower inner quadrant. LOQ-lower outer quadrant. UOQ-upper outer quadrant. UIQ-upper inner quadrant. N-nipple. L1-level one lymph nodes. L2-level two lymph nodes. L3-level three lymph nodes. Summary of Sections: Part 1: SP: Senitnle node #1, level one, right axilla (fa). Block. Sect. Site. PCs. 1. {not entered}. 1. 1. fsc. 1. Part 2: SP: Sentinel node #2, level one, right axilla (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 3: SP: Sentinel node #3, level two, right axilla (fs). Block. Sect. Site. PCs. 1. fsc. Part 4: SP: Right breast and axillary contents levels 1, 2 and 3. Block. Sect. Site. PCs. 1. 11. 1. 1. 12. 1. 1. 13. 1. 11. lig. 11. 15. log. 15. 1. n. 1. 3. trm. 3. 1. trs. 1. 1. uiq. 1. 1. uoq. 1. Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. ADDENDUM. SITE; RIGHT BREAST. PART #4. ER: 90% OF NUCLEAR STAINING WITH MODERATE INTENSITY. PR: 1% OF NUCLEAR STAINING WITH MODERATE TO WEAK INTENSITY. HER2/NEU (HERCEPTEST) : POSITIVE (STAINING INTENSITY OF 3+). MD. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample. examined at the time of the intraoperative consultation. Page 5 of. 5. 1). FROZEN SECTION DIAGNOSIS: METASTATIC CARCINOMA (SLIDE B) . PERMANENT DIAGNOSIS: SAME. 2). FROZEN SECTION DIAGNOSIS: NEGATIVE LYMPH NODE. PERMANENT DIAGNOSIS: SEE FINAL DIAGNOSIS. 3). FROZEN SECTION DIAGNOSIS: NEGATIVE LYMPH NODE. PERMANENT DIAGNOSIS: SAME.",T2,N1,M0,T2N1M0
TCGA-E2-A1LI,"SPECIMENS: A. SENTINEL LYMPH NODE LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. WIDE LOCAL EXCISION LEFT BREAST. DIAGNOSIS: A. SENTINEL LYMPH NODE #1, LEFT AXILLA: -ONE LYMPH NODE, NO TUMOR SEEN (0/1). B. SENTINEL LYMPH NODE #2, LEFT AXILLA: -ONE LYMPH NODE, NO TUMOR SEEN (0/1). C. WIDE LOCAL EXCISION, LEFT BREAST: -INVASIVE AND IN-SITU DUCTAL CARCINOMA, SBR GRADE III/III WITH. EXTENSIVE NECROSIS AND CANCERIZATION OF LOBULES, SEE TEMPLATE. Invasive Breast Cancer Template. INVASIVE TUMOR: Histologic type: ductal. Tumor Size (cm): 2.5 cm. Size of Invasive Focus: 2.5 cm. Grade, Histologic: 3. Grade, Nuclear: 3. Mitoses. 3. Scarff Bloom Richardson grade: III. Necrosis: present. Invasion Vasc/Lymphatic: absent. DCIS component. DCIS Quantity: <25%. DCIS Type: Clining. DCIS Location: outside main mass: diffuse. Nuclear grade: high. Necrosis: absent. Margins: DCIS present within 1 hpf of lateral and 1 mm of deep and medial margins. Lymph nodes: Negative (0/2). Stage, Pathology : T2N1. Hormone receptor status (by IHC): ER & PR: PENDING. HERCEPTEST (by IHC): Pending. ADDENDUM. The ER/PR/HER2 status of the invasive breast carcinoma was determined by immunohistochemistry. and quantitated via ACIS (image analysis). Results are as follows: ER. 0%. PR. 0%. HER2. 2.3 (borderline). A separate ACIS report has been generated. NOTE: FISH analysis for HER2 gene amplification has been ordered. Addendum. Fluorescence in situ hybridization (FISH) for Her-2 gene amplification. Her-2/neu gene: Not amplified. Ratio of Her-2/neu to CEP17: 1.21. The assay is performed on formalin fixed, paraffin embedded section using Her-2 DNA probe kit from. Vysis. The quality of the fluorescence signals and tissue section is adequate for analysis. The signals of. both Her-2 and CEP17 are counted in 60 invasive tumor nuclei. The Her-2 gene is considered amplified. when the ratio of Her-2 to CEP17 signal is >2.0. SPECIMEN(S): A. SENTINEL LYMPH NODE LEFT AXILLA B. SENTINEL LYMPH NODE #2 LEFT AXILLA C. WIDE. LOCAL EXCISION LEFT BREAST. CLINICAL HISTORY: None. FROZEN SECTION DIAGNOSIS: A. SENTINEL LYMPH NODE LEFT AXILLA. Touch prep: No tumor seen by Dr. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. Touch prep: No tumor seen by Dr. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE LEFT AXILLA. Received fresh is a 1x0.8x0.5cm. lymph node. It is bisected and touch prep done. Specimen entirely. submitted for permanent section. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. Received fresh is sentinel lymph node left axilla measuring 0.7x0.5x0.4cm. It is bisected and touch prep. done. Submitted in toto in cassette B for permanent section. C. WIDE LOCAL EXCISION LEFT BREAST. Received fresh is an oriented portion of breast tissue measuring 6x5.5x2.7cm Sectioning shows a well. circumscribed tan nodular tumor mass measuring 2.5x1.8x1cm. It closely approaches the superior. posterior medial margin. Specimen is inked as follows: superior red, inferior orange, medial green,. lateral yellow, posterior black. Tumor tissue and normal tissue given for tissue procurement and tumor. sent for flow cytometry. Representative sections submitted in seventeen cassettes. Microscopic/Diagnostic Dictation: Pathologist. Final Review: Pathologist. Final: Pathologist. Addendum: Pathologist. Addendum Review: Pathologist. Addendum Final: Pathologist. Addendum: Pathologist, 1. Addendum Review: Pathologist,. Addendum Final: Pathologis.",T2,N1,M0,T2N1M0
TCGA-UF-A719,"Colect date. PRIMARY SITE: Floor of mouth. 1 - ""Lymph Nodes - Level la- Right"": - Absence of neoplasia: (0/1). 2 - ""Lymph Nodes - Level 2a- Right"": - Absence of neoplasia: (0/5). 3 - ""Lymph Nodes - Level 3- Right: - Absence of neoplasia: (0/1). 4 - ""Lymph Nodes - Level 1b- Right"": - Absence of neoplasia: (0/6). - Salivary gland, chronic nonspecific intense sialadenitis, free of neoplastic involvement. 5- ""Right Pelvi-glossectomy"": - Squamous cell carcinoma. - Histologic grade: well differentiated. - Tumor size ( greatest dimension): 3,5 cm. - Tumor thickness/depth of invasion: 1,0 cm. - Moderate chronic inflammatory infiltrate. - Infiltration of minor salivary gland. - Perineural invasion: not identified. - Lymph-vascular invasion: not identified. - Margins uninvolved by invasive tumor.",T2,N0,M0,T2N0M0
TCGA-21-1070,"Clinical History/Diagnosis: LEFT LUNG CA, HX OF LEFT BREAST CA. WITH LUMPECTOMY AND AXILLARY DISSECTION, CHEMO AND RADIATION. Specimen(s): 1. PORTION OF POSTERIOR 5TH RIB LEFT. 2. PORTION OF POSTERIOR 4TH RIB LEFT. 3. PORTION OF POSTERIOR 3RD RIB. 4. LEVEL NINE LYMPH NODE. 5. LEVEL FIVE LYMPH NODE LEFT. 6. LEFT ELEVEN LYMPH NODE. 7. LEFT UPPER LOBE OF LUNG WITH CHEST WALL. 8. LEVEL 7 LYMPH NODE. GROSS DESCRIPTION Received in eight parts. SOURCE OF TISSUE: 1. Labeled #1 """"posterior left fifth rib"""". GROSS DESCRIPTION: Received fresh is a 1.0cm in greatest dimension, tan-. pink fragment of rib which is bisected and entirely submitted in one block,. following decalcification. DESIGNATION OF SECTIONS: Block 1. SUMMARY OF SECTIONS: Undesignated-2. SOURCE OF TISSUE: 2. Labeled #2, """"portion of posterior left fourth rib"""". GROSS DESCRIPTION: Received fresh is a 1.5cm in greatest dimension tan-pink. fragment of rib which is bisected and entirely submitted in one block,. following decalcification. DESIGNATION OF SECTIONS: Block 2. SUMMARY OF SECTIONS: Undesignated-2. SOURCE OF TISSUE: 3. Labeled #3, ""portion of posterior left third rib"""". GROSS DESCRIPTION: Received fresh is a 1.5cm in greatest dimension, tan-. pink fragment of rib which is bisected and entirely submitted in one block,. following decalcification. DESIGNATION OF SECTIONS: Block 3. SUMMARY OF SECTIONS: Undesignated-2. SOURCE OF TISSUE: 4. Labeled #4, """"level 9 lymph node"""". GROSS DESCRIPTION: Received fresh are several gray-black, anthracotic-. stained lymph nodes with attached adipose tissue, 0.8cm in greatest. dimension. They are submitted in toto in one block. DESIGNATION OF SECTIONS: Block 4. SUMMARY OF SECTIONS: Undesignated-2. SOURCE OF TISSUE: 5. Labeled #5, """"left level 5 lymph node"""". FROZEN SECTION DIAGNOSIS: 5FS - NO TUMOR SEEN. GROSS DESCRIPTION: Received fresh for frozen section evaluation are two tan. to gray-black, focally anthracotic stained lymph nodes, 0.8 and 1.5cm in. greatest dimension. A representative section of each lymph node is. submitted for frozen section evaluation and the frozen section residue is. submitted in one block. The remaining tissue is entirely submitted in one. block. DESIGNATION OF SECTIONS: 5FS, 5. SUMMARY OF SECTIONS: 5FS-2, Undesignated-multiple. SOURCE OF TISSUE: 6. Labeled #6, """"left 11 lymph node"""". GROSS DESCRIPTION: Received fresh is a 25cm in greatest dimension, gray-tan. anthracotic stained lymph node which is sectioned and entirely submitted in. two blocks. DESIGNATION OF SECTIONS: 6A-6B. SUMMARY OF SECTIONS: 6A-2, 6B-1. SOURCE OF TISSUE: 7. Labeled #7, """"left upper lobe with chest wall"". FROZEN SECTION DIAGNOSIS: 7FS - NEGATIVE BRONCHIAL MARGIN. GROSS DESCRIPTION: Received fresh for frozen section evaluation is a 330. gram, 18.0 X 9.5 X 4.5cm left upper lobectomy of lung. It is covered by a. red-purple, focally anthracotic-stained pleura having a 10.5 X 8.0 X 1.0cm. portion of overlying chest wall and ribs. There is up to 0.8cm of attached. bronchus. The bronchial resection margin is submitted for frozen section. evaluation and the frozen section residue is submitted in one block. On. sectioning through the apical segment, there is an 8.0 X 4.5 x 4.0cm firm. mass, having gray-tan cut surfaces. This grossly appears to involve the. overlying ribs. The remaining cut surfaces of lung are gray-tan to pink and. focally anthracotic stained. There are several palpable hilar lymph nodes,. 1.0cm in greatest dimension. Representative sections are submitted in. fourteen blocks. DESIGNATION OF SECTIONS: 7FS - frozen section, bronchial resection margin,. 7A - vascular margins, 7B-7D - tumor with inked pleural margin, 7E-7F -. random lung sections, 7G-7I - rib margins, following decalcification, 7J-7L. - tumor with overlying rib, following decalcification, 7M-7N - hilar lymph. nodes. SUMMARY OF SECTIONS: 7FS-1, 7A-2, 7B-1, 7C-1, 7D-1, 7E-2, 7F-2, 7G-2, 7H-2,. 7I-2, 7J-1, 7K-1, 7L-1, 7M-3, 7N-2. SOURCE OF TISSUE: 8. Labeled #8, """"left 7 lymph node"""". GROSS DESCRIPTION: Received fresh is a 0.8cm in greatest dimension, gray-. tan, firm lymph node. It is bisected and entirely submitted in one block. DESIGNATION OF SECTIONS: Block 8. SUMMARY OF SECTIONS: Undesignated-2. DIAGNOSIS: 1. PORTION OF POSTERIOR LEFT FIFTH RIB: - NO TUMOR SEEN. 2. PORTION OF POSTERIOR LEFT FOURTH RIB: - NO TUMOR SEEN. 3. PORTION OF POSTERIOR LEFT THIRD RIB: - NO TUMOR SEEN. 4. LEVEL 9 LYMPH NODE: - ONE NEGATIVE LYMPH NODE (0/1). 5. LEVEL 5 LYMPH NODE: - ONE NEGATIVE LYMPH NODE (0/1). 6. LEFT 11 LYMPH NODE: - ONE NEGATIVE LYMPH NODE. 7. LEFT UPPER LOBE OF LUNG WITH CHEST WALL: - POORLY DIFFERENTIATED SQUAMOUS CELL CARCINOMA, 9CM, INVADING. INTO THE OVERLYING RIBS (pT3). - VASCULAR INVASION PRESENT. - BRONCHIAL AND VASCULAR RESECTION MARGINS ARE NEGATIVE. SEVEN HILAR LYMPH NODES NEGATIVE FOR TUMOR (0/7). 8. LEVEL 7 LYMPH NODE: - ONE NEGATIVE LYMPH NODE (0/1). SYNOPTIC REPORT FOR LUNG CARCINOMA: A NEOPLASM IS PRESENT. LOCATION OF TUMOR: LEFT UPPER LOBE. HISTOLOGIC CLASSIFICATION: SQUAMOUS CELL CARCINOMA, NON-. KERATINIZING TYPE. GRADE: POORLY DIFFERENTIATED, GRADE III. MAXIMUM DIMENSION OF TUMOR: 9CM. VENOUS INVASION: PRESENT. INVASION THROUGH PLEURA: PRESENT. TUMOR NECROSIS: SLIGHT. SURGICAL MARGINS: UNINVOLVED. NON-NEOPLASTIC LUNG SHOWS: NON-SPECIFIC INTERSTITIAL FIBROSIS. TOTAL NODES EXAMINED: 9. TOTAL POSITIVE NODES: 0. STAGING: T3.",T3,N0,M0,T3N0M0
TCGA-CZ-5989,"PATHOLOGIC DIAGNOSIS: A. RIGHT KIDNEY, REDICAL NEPHRECTOMY. RENAL CELL CARCINOMA, clear cell type, Fuhrman nuclear grade II/IV (9.0 cm) . Tumor is located in the upper pole and limited to kidney. No lymphovascular invasion is present. The vascular and ureteral margins are negative for tumor. The non-neoplastic kidney will be evaluated by Renal Pathology, and the. findings will be reported in an addendum. B. RIGHT REGIONAL NODES: One (1) lymph node, negative for tumor. AJCC Classification (6th Edition) : T2 No Mx. CLINICAL DATA: History: None given. Operation: Right radical nephrectomy. Operative Findings None given. Clinical Diagnosis: Right renal mass. TISSUE SUBMITTED: A/1. Right kidney. B/2. Right regional nodes. GROSS DESCRIPTION: The specimen is received fresh, in two parts, each labeled with the patient's. name and unit number. Part A, ""#1. Rt kidney"", consists of a 549 gram radical nephrectomy specimen,. comprised of right kidney (15.0 x 8.5 x 8.0 cm), with contiguous 7.0 cm ureter. (diameter is 0. cm), 2.1 cm renal artery (diameter 0.6 cm), and 1.2 cm renal. vein (diameter 1.8 cm) Specimen has been previously inked and sectioned,. revealing a 9. x 8.0 x 8.0 cm well-circumscribed tan/yellow to tan/red. irregular, encapsulated mass, which is located in the upper pole and abuts the. renal capsule as well as the inked surgical margin. Mass is 11.2 cm from the. ureteral margin, 2.8 cm from the renal artery margin and 0.6 cm from the renal. vein margin. Representative mass has been previously sent for cytogenetics,. quick fix and tissue bank. Representative normal renal parenchyma has been. sent to tissue bank, EM, IF. Mass occupies at least 60% of the renal. parenchyma, the remaining of which is unremarkable. Corticomedullary junctions. are distinct. Urothelium is tan/white and unremarkable. Gerota's fascia is. not seen grossly. Adrenal gland is not identified within the specimen. Micro A1: Artery, ureter, vein margins, 3 frags,. Micro A2: Tumor, quick fix section, 1 frag,. Micro A3-A4: Tumor and renal capsule, black - inked margin, 4 frags. total,. Micro A5: Tumor and adjacent renal vein, 2 frags, RSS. Micro A6: Tumor with respect to uninvolved renal parenchyma, 1 frag,. RSS. Micro A7: Uninvolved renal parenchyma, 1 frag,. Part B, ""#2. Rt regional lymph node"", consists of 1.4 cm lymph node, bisected. ADDENDUM #1. RENAL PATHOLOGY EVALUATION OF KIDNEY PARENCHYMA: RIGHT KIDNEY, NEPHRECTOMY: MINIMAL CHRONIC CHANGES OF THE KIDNEY PARENCHYMA (SEE NOTE). ARTERIAL AND ARTERIOLAR SCLEROSIS, MILD (SEE NOTE). NOTE: The kidney parenchyma shows minimal chronic changes, within the expected range. for a sixty year-old man. There is isolated focal global glomerulosclerosis. (0.77% of glomeruli) and minimal tubular atrophy and interstitial fibrosis. (less than 5% of the parenchyma). The arteries and arterioles show a mild. degree of vascular sclerosis. MICROSCOPIC DESCRIPTION: Sections of formalin-fixed, paraffin-embedded tissue (block A7) were evaluated. using H&E, PAS,. silver methenamine, and AFOG (trichrome) stains. The sample consists of cortex and medulla. There are 129 glomeruli present, of. which one (0.77%) is globally sclerosed. The glomeruli show no significant. pathologic changes. There are only isolated irregularities of the glomerular. capillary wall basement membranes. Rare distal tubules contain PAS-positive. hyaline casts. Less than 5% of the cortical parenchyma shows tubular atrophy. and interstitial fibrosis. Arteries and arterioles exhibit a mild degree of. subintimal sclerosis. KARYOTYPE: 46,XY, ins (2;3) (q33; p13p23) (5). METAPHASES COUNTED: 5. ANALYZED: 5. SCORED: 0. BANDING: GTG. INTERPRETATION : All five metaphases contained an insertion between chromosomes 2 and 3. Rearrangements involving chromosome 3p are common findings in clear cell. carcinoma. COMMENTS: Mosaicism and small chromosome anomalies may not be detectable using the. standard methods employed. Chromosome analysis was performed at a level of 400. bands or greater. INDICATION FOR TEST: RCC; Kidney tumor. -_-.",T2,N0,M0,T2N0M0
TCGA-DJ-A3UQ,"4 Neck. and Neck. Clinical Diagnosis & History: Left lobe- papillary carcinoma. Specimens Submitted: 1: Pretracheal tissue. 2: Tissue near the left upper pole. 3: Left paratracheal tissue (fs). 4: Left superior mediastinal tissue. 5: Right paratracheal tissue. 6: Total thyroidectomy. DIAGNOSIS: 1. Pretracheal tissue; biopsy: - Benign fibroadipose tissue. 2. Tissue near the left upper pole; blopsy: -Benign thyroid tissue. 3. Left paratracheal tissue (fs): Part # 3. Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 3. Number of lymph nodes with metastatic disease: 3. Size of the largest lymph node involved by tumor: 0.5cm. Size of the largest metastatic focus : 0.3 cm. Extranodal extension is not identified. Comment: Three lymph nodes are Identified on the permanent section of the frozen section residue; however, only one. lymph node is present on the original frozen section slide. 4. Left superior mediastinal tissue: Part # 4. Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 1. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 0.15cm. Size of the largest metastatic focus : 0.02 cm. Extranodal extension is not identified. 5. Right paratracheal tissue: Part # 5. Lymph Node Dissection: Metastatic papillary thyroid carcinoma. Number of lymph nodes examined: 2. Number of lymph nodes with metastatic disease: 1. Size of the largest lymph node involved by tumor: 0.6cm. Size of the largest metastatic focus : 0.2 cm. Extranodal extension is not identified. 6. Total thyroidectomy: Part # 6. Tumor Type: Papillary. microcarcinoma with focal tall cell and columnar cell features Tall all > 50% per TSS In. Mitotic Activity: Not identified. Tumor Necrosis: Not identified. Tumor Location: Left lobe. Tumor Size: Greatest diameter is 0.8 cm. Tumor Encapsulation: None Identified. Blood Vessel Invasion: Areas suggestive but not diagnostic. Extrathyroid Extension: Invades:perithyroidal fibroadipose tissue. Surgical Margins: Free of tumor. Tumor Multicentricity: Microscopic foci present. Papillary microcarcinoma with sclerosis, cystic change and squamous metaplasia, 0.6 cm in greatest dimension. (right lobe). Adenoma(s) (away from the carcinoma): Not Identified. Non-Neoplastic Thyroid: No abnormalities identified. Parathyroid Glands: Not identified. IATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF THE SLIDES (AND/OR OTHER MATERIAL), AND THAT I HAVE. REVIEWED AND APPROVED THIS REPORT. Special Studies: Special Stain. Comment. RECUT. RECUT. RECUT. Gross Description: 1). The specimen is received in formalin, labeled ""Pre-tracheal tissue"" and consists of an irregular fragment tan soft tissue. measuring 0.6 x 0.6 X 0.4 cm. The specimen is entirely submitted. Summary of sections: U-- undesignated. 2). The specimen is received in formalin, labeled ""Tissue near the left upper pole"" and consists of an irregular fragment tan soft. tissue measuring 0.3 X 0.2 x 0.1 cm. The specimen is entirely submitted. Summary of sections: U-- undesignated. 3) The specimen is received fresh for frozen section and is labeled ""left paratracheal tissue"". It consists of a portion of tan soft. tissue measuring 0.6 x 0.4 x 0.3 cm. The specimen is entirely submitted. Summary of sections: FSC-frozen section control. 4) The specimen is received in formalin, labeled ""Left superior mediastinal tissue"", and consists of a fragment of tan soft tissue. measuring 0.4 x 0.3 x 0.2 cm. The specimen is submitted entirely. Summary of sections: U - undesignated. 5) The specimen is received in formalin, labeled ""Right paratracheal tissue"", and consists of a fragment of tan soft tissue. measuring 0.9 X 0.7 X 0.3 cm. The specimen is submitted entirely. Summary of sections: U - undesignated. $. 6) The specimen is received fresh, labeled ""Total thyroidectomy"", and consists of a thyroid weighing 17g. A stitch marks the left. lobe of thyroid. The right lobe measures 4.3 x 2.3 x 1.8 cm, the left lobe measures 4.1 x 2.1 x 1.3 cm and the isthmus measures. 2.1 x 0.5 x 0.3 cm. The external surface is covered by a thin fibrous capsule. The posterior surface of the specimen is Inked black,. and the anterior is inked blue. Sectioning reveals a tan firm nodule. The nodule is located in the superior pole of the left lobe,. measuring 0.7 x 0.6 x 0.6 cm; and is not encapsulated. Also identified is a cystic podule located in the middle portion of the right. lobe, measuring 0.6 x 0.5 x 0.4 cm. The remaining thyrold parenchyma is red brown and beefy. Representative sections of the. specimen are submitted for. The remaining tissue is serially sectioned and entirely submitted. Summary of sections: N - nodule in the left lobe, entirely submitted. CN - cystic nodule in the right lobe, entirely submitted. RL - remaining right lobe. LL - remaining left lobe. IS isthmus. Summary of Sections: Part 1: Pretracheal tissue. sect. wite. - us. 1. 1. Part 2: Tissue near the left upper pole. Block. Sect. Site. PCs. 1. U. 1. Part 3: Left paratracheal tissue (fs). Block. Sect. Site. PCs. 1. fsc. 1. Part 4: Left superior mediastinal tissue. Block. Sect. Site. PCs. 1. U. 1. Part 5: Right paratracheal tissue. Block. Sect. Site. PCs. 1. U. 1. Part 6: Total thyroldectomy. Block. Sect. Site. PCs. 2. CN. 2. IS. 2. 4. LL. 5. 2. N. 2. 3. RL. 4. Intraoperative Consultation: Note: The diagnoses given in this section pertain only to the tissue sample examined at the time of the intraoperative consultation. 3. Frozen Section Diagnosis: Left paratracheal tissue (fs): Metastatic carcinoma (1/1). Permanent Diagnosis: See final.",T3,N1,M0,T3N1M0
TCGA-RC-A7SH,"(Ver ified). A-D. Liver, right lobectomy: HEPATOCELLULAR CARCINOMA. Tumor number : one. Satellite nodule: no. Gross type: nodular with per inodular extension. Size(on) : 7.5x6.5x4.0cm. Differentiation: The worst differentiation: Edmondson grade IV. Differentiation: The major differentiation: Edmondson grade III. Histologic type : Macrotrabecular, Microtrabecular, Pseudoglandular. Cell type: Hepatic. Clear. Tumor necrosis : no. Hemorrhage : yes ( less than 5%). Fatity change : no. Fibrous capsule : partial. Infiltration of capsule : yes. Septum formation : yes. Surgical margin invasion : no(margin of the clearance 5.5 cm). Serosa invasion: no. Portal vein invasion : no. Bile duct invasion : no. Hepatic vein invasion : no. Hepatic artery invasion : no. Microvesse| invasion : yes. Intrahepatic metastasis : no. Multicenteric occurrence : no. T stage : pT2. N stage: No metastasis in all 1 Tymph node(pNO). [ 0/1: per ipor tal vein (0/1)]. Non-tumor liver. Chronic hepatitis : yes. Etilogy : HBV. Grade, lobular : minimal. Grade, portoperiportal : none. Stage(tibrosis) : septal. Cirrhosis : no. Dysplastic nodule : no. (Verified). Ductal epithelial dysplasia : no. Other liver disease : no. Gallbladder : No pathologic abnormality. Falciforin Ligament: No pathologic abnormality. < Immunohistochemical stain results >. Iron (block A11) : Negative. Cytokeratin 7 (block A11): Positive in bile ducts. Cytokeratin 19(block A5): Negative. Cytokeratin 7 (block A5): Focal positive. Hepatocyte (block A5): Positive. A. The speciment received in formali consists of a lobectomy of liver. measuring. 16x12x8cm and weighing 800gm. The external surface shows a huge capsular. mass. The parenchyme resection margins are clear. The vascular resection. margin also clear. On section, there is an nodular mass with perinodular. extension. measuring 7.5x6.5x4cm. The mass is 5.5cm apart from parenchyme. resection margin. The remaining parenchyme shows cirrhotic change. Representative sections are embedded. (A1-Periportal vain lymph node. A2 to 8- tumor one plane, A9 and 10- tumor with capsuie. A11- background liver). B. The specimen. received in formalir consists of a gallbladder. measuring 8cm. in length and 3cm in diameter. The capsular surface is unremarkable. The wall measures 0. .2cm in maximal thickness. The mucosa is greenish velvety. There is no stone or polyo Representative sections are embedded in. one cassette. C. The specimen received in formalin consists of compartmentalized Tymph nodes. All Tymph nodes found are entirely embedded. (C-LN). 0. The soecimen received in formalin consists of a Tump of adipose tissue. clinically labeled as ""falciform higament"" measuring 4x3xicm. On serial section. there is no definite mass. Representat ive sections are embedded in a cassette. H&E(14). MT(1), RTC(1). D-PAS(1). Tron(1). Cytokeratin 7(7). Cytokeratin 19(1). tron (1). (Ver if fied).",T2,N0,M0,T2N0M0
TCGA-62-A470,"Pathology Report-Summary: Material: lung, right, upper lobe: 16.0 X 11.0 x 8.0 cm. tumor: 6.5 x 5.0 X 4.5 cm. Diagnosis: Adenocarcinoma, predominantely acinar. Infiltration of pleura visceralis. pT2, pNO (0/14), pMx, G2.",T2,N0,M0,T2N0M0
TCGA-HZ-7918,"GROSS AND MICROSCOPIC SURGICAL PANEL. Specimen Information. SURGICAL PANEL: LAB: DIAGNOSIS. A) LEFT HEPATIC LIGAMENT, BIOPSY: 1. Benign simple cyst. 2. Background hepatic parenchyma is benign. 3. Negative for malignancy. B) LYMPH NODE, HEPATIC ARTERY, BIOPSY: 1. One (1) benign lymph node is identified. 2. Negative for malignancy. C) GALLBLADDER, CHOLECYSTECTOMY: 1. Unremarkable gallbladder. 2. Negative for malignancy. 3. A single (1) cystic duct lymph node is identified and is negative or. malignancy. D) PANCREAS, PROXIMAL PARTIAL PANCREATECTOMY WITH TOTAL DUODENECTOMY AND. ANASTOMOSIS (STANDARD WHIPPLE RESECTION): 1. Poorly differentiated adenocarcinoma, characterized by: a. Tumor size: 5.5 X 5 X 3.2 cm. b. Tumor location: Pancreatic head. C. Tumor extent: Extensive infiltration of the pancreatic parenchyma. with extension into the peripancreatic adipose tissue. 2. Extensive angiolymphatic space invasion and perineural invasion. identified. 3. Adenocarcinoma extends to involve the portal vein groove and portal. vein margin (small fragment identified); remaining margins are. negative- though the tumor comes to within 0.1 cm on the uncinate. margin. 4. Metastatic adenocarcinoma is identified in multiple (11 of 21). peripancreatic lymph nodes. a. Extracapsular extension is identified. b. The largest metastatic focus is 1.5 cm in greatest dimension. 5. See staging summary. E) PORTAL VEIN, SEGMENTAL RE-EXCISION: 1. Portion of portal vein identified. 2. Negative for malignancy. PANCREATIC CANCER STAGING PARAMETERS. Final TNM: p T3N1M0. stage: IIB. MACROSCOPIC. SPECIMEN TYPE. Whipple, Standard. TUMOR SITE. Pancreatic head. TUMOR SIZE. 5.5 X5X3.2cm. MICROSCOPIC. HISTOLOGIC TYPE. Ductal Adenocarcinoma. HISTOLOGIC GRADE. G3: (poorly differentiated) of G4. MARGINS - PANCREATICODUODECTOMY. Negative for invasive carcinoma, following re-excision of portal. vein segment (specimen E). Location(s): Portal vein groove and portal vein (from main. specimen, part D). Margin(s) evaluated: Bile duct, Distal pancreatic, Pancreatic. retroperitoneal (uncinate). LYMPHATIC/VASCULAR INVASION. Present: Lymph-vascular invasion present/Identified. PERINEURAL INVASION. Present. PATHOLOGIC STAGING. EXTENT OF INVASION. pT3. (Tumor extends beyond the pancreas but without involvement of. the celiac axis or the superior mesenteric artery). REGIONAL LYMPH NODES. pN1. (Regional lymph node metastasis). Total nodes: 21. Total positive nodes: 11. DISTANT METASTASIS. pM0. (No distant metastasis). PATHOLOGIC STAGE SUMMARY. Final TNM: pT3N1M0. stage: IIB. The pathologic stage presumes no distant metastasis. Attending Pathologist: CLINICAL INFORMATION. A. vear-old male patient with pancreatic adenocarcinoma. SPECIMEN/GROSS DESCRIPTION. A) SOURCE: Left hepatic ligament. Received fresh labeled ""left hepatic ligament"" is a 0.8 X 0.6 X 0.4 cm. clear fluid-filled, smooth-walled translucent cyst. The cyst is bisected. and entirely submitted on one chuck for frozen section diagnosis. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Benign cyst"" is. rendered by. B) SOURCE: Hepatic artery lymph node. The specimen is received fresh labeled ""hepatic artery lymph node."". It. consists of a 2.3 x 2 X 1.1 cm tan-red lymph node. It is serially sectioned. and has a tan-red cut surface. It is entirely submitted for frozen on three. blocks. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""One (1) benign. lymph node (0/1)"" is rendered by. C) SOURCE: Gallbladder. Labeled ""gallbladder"" is a purple-tan smooth surfaced 11 X 4 X 4 cm. gallbladder. The serosal surface is smooth and glistening. The cystic duct. is identified with a 0.3 cm luminal diameter. A 0.5 cm cystic duct lymph. node is also seen. The specimen is opened revealing approximately 20 ml of. thin green-brown bile. There are no calculi grossly identified. The mucosa. is. orange-green and velvety. The average wall thickness is 0.2 cm. Multiple. representative sections of gallbladder wall, en face cystic duct margin and. cystic duct lymph node are submitted in a single cassette. D) SOURCE: Whipple. Received fresh labeled ""Whipple"" is a Whipple specimen which includes a 12. X 7 X 2.5 cm portion of stomach, 28 cm in length and averaging 3 cm in. diameter segment of duodenum and a 9 X 6 X 4.5 cm portion of pancreas. The. specimen is received inked in the usual fashion. The common bile duct is. identified, displaying it to be dilated to 1.5 cm. It is taken en face and. submitted on chuck #1. The distal pancreatic margin is taken en face and. submitted on chuck #2. At the portal vein bed is an area of orange ink. indicated by the surgeon as being an area of portal vein. This area is. taken perpendicular and submitted on chuck #3. INTRAOPERATIVE PATHOLOGY CONSULTATION WITH FROZEN SECTION: ""Common bile. duct margin negative for carcinoma. Distal pancreas en face margin. negative. Portal vein groove and veins show involvement hv poorly. differentiated adenocarcinoma"" is rendered by. The common bile duct has a pigtail stent in place and is probe patent. It. is opened revealing it to be slightly granular and focally stenosed to 0.5. cm. The pancreatic duct cannot be probed. The specimen is sectioned. revealing a firm white tumor mass encompassing the majority of the pancreas. measuring 5.5 X 5 X 3.2 cm. It extends to the portal vein bed, 0.1 cm from. the distal pancreatic margin, 0.5 cm from the uncinate margin, 0.5 cm from. the retroperitoneal margin. The tumor mass pushes the mucosa of the. duodenum but does not extend through it. It has obliterated the pancreatic. duct. There is a small area of normal-appearing pancreatic parenchyma in. the proximal portion of the specimen. The ampulla is granular but. otherwise unremarkable. The stomach and duodenum mucosa are unremarkable and display no lesions. Note: Tissue is taken for possible ancillary studies. Photographs are taken. The pancreatic fat is searched revealing 13 tan-pink lymph nodes, some of. which are found in the parenchyma. They range from 0.5-2.6 cm in greatest. dimension. The gastric fat is searched revealing no lymph nodes. Sections of the pncreas are submitted from distal to proximal. Representative sections are submitted in 27 cassettes labeled: DFS1. Frozen section, common bile duct. DFS2. Frozen section, distal pancreatic margin. DFS3. Frozen section, portal vein bed with portal vein. 4. Proximal gastric margin. 5. Distal duodenal margin. 6. Random normal gastric and duodenal mucosa, unremarkable. 7,8. Uncinate with retroperitoneum and portal vein bed margin. 9. Distal tumor with adjacent lymph node. 10-14. Representative tumor with common bile duct from distal to. proximal with adjacent normal pancreas. 15. Deep tumor serosa and possible lymph node. 16. Three pancreatic lymph nodes, one bisected, inked blue. 17. One lymph node. 18. Two lymph nodes. 19. One lymph node. 20. Two lymph nodes, each bisected, one inked blue. 21-23. Remainder of pancreatic fat. 24,25. Representative gastric fat. 26. Largest pancreatic lymph node, greatest dimension of tumor,. representative. 27. One pancreatic lymph node bisected. E) SOURCE: Vein segment, portal. Labeled ""portal vein stitch on area of importance"" consists of a wrinkled. unoriented segment of apparent vasculature that has been previously opened. There are sutures on the outer aspect. The outer aspect with suture of area. of importance is inked orange. The specimen is sectioned transversely and. entirely submitted in a single cassette. This case is accessioned in. MICROSCOPIC. A-E) The microscopic appearance substantiates the diagnosis. Dictation by: Interpreted at. ACCESSIONED. Lab and Collection. Result History. Result Date and Time. Provider Status.",T3,N1,M0,T3N1M0
